Vaccine,Dose,Geography Type,Geography,Birth Year/Birth Cohort,Dimension Type,Dimension,Estimate (%),95% CI (%),Sample Size
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,93.5,88.0 to 96.6,263
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,95.2,91.0 to 97.5,293
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,91.8,88.3 to 94.3,556
Polio,≥3 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,89.4,81.9 to 94.1,143
Polio,≥2 Doses,States/Local Areas,North Dakota,2021,Age,5 Months,79.3,69.0 to 86.8,143
Polio,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,91.7,87.4 to 94.7,391
DTaP,≥2 Doses,States/Local Areas,North Dakota,2021,Age,5 Months,79.3,69.0 to 86.8,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,88.4,80.8 to 93.3,143
PCV,≥1 Dose,States/Local Areas,North Dakota,2021,Age,3 Months,89.2,81.7 to 93.9,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,92.0,87.8 to 94.9,391
≥1 Dose Varicella,,States/Local Areas,North Dakota,2021,Age,13 Months,62.7,51.0 to 73.0,143
≥1 Dose MMR,,States/Local Areas,North Dakota,2021,Age,19 Months,79.9,69.5 to 87.3,143
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2020-2021,Age,0-2 Days,86.9,81.6 to 90.9,391
Hib,Full Series,States/Local Areas,North Dakota,2020-2021,Age,19 Months,72.9,66.0 to 78.9,391
Hep A,≥2 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,39.8,29.5 to 51.2,143
PCV,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,72.1,65.4 to 78.0,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,89.5,84.7 to 92.8,391
Hib,Full Series,States/Local Areas,North Dakota,2020-2021,Age,35 Months,86.5,74.5 to 94.6,391
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,78.9,72.6 to 84.1,391
PCV,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,90.5,85.8 to 93.7,391
Influenza,,States/Local Areas,North Dakota,2020-2021,Age,24 Months,67.3,60.5 to 74.0,391
Hib,Primary Series,States/Local Areas,North Dakota,2021,Age,13 Months,88.5,80.8 to 93.4,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,96.9,91.0 to 99.3,143
DTaP,≥4 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,77.2,67.0 to 86.1,143
Hib,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,3 Months,87.1,82.0 to 90.9,391
PCV,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,90.5,86.2 to 93.9,391
Combined 7 Series,,States/Local Areas,North Dakota,2020-2021,Age,24 Months,71.9,65.1 to 78.3,391
Combined 7 Series,,States/Local Areas,North Dakota,2020-2021,Age,35 Months,80.6,67.7 to 90.8,391
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020-2021,Age,24 Months,86.5,81.1 to 91.0,391
Hep A,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,19 Months,83.1,76.9 to 87.8,391
Hib,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,85.3,79.6 to 89.6,391
Combined 7 Series,,States/Local Areas,North Dakota,2021,Age,24 Months,72.1,61.3 to 82.1,143
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2020-2021,Age,0-1 Days,84.5,78.6 to 88.9,391
Hib,Primary Series,States/Local Areas,North Dakota,2020-2021,Age,35 Months,92.4,88.1 to 95.6,391
Hib,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,88.8,83.8 to 92.8,391
Hep B,≥2 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,92.2,86.0 to 95.8,143
≥1 Dose Varicella,,States/Local Areas,North Dakota,2021,Age,35 Months,88.6,78.3 to 95.4,143
Rotavirus,,States/Local Areas,North Dakota,2020-2021,Age,8 Months,77.6,71.0 to 83.0,391
PCV,≥4 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,79.4,72.9 to 84.6,391
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2020-2021,Age,0-3 Days,86.9,81.6 to 90.9,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,90.3,86.0 to 93.7,391
Polio,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,5 Months,78.9,72.6 to 84.1,391
PCV,≥4 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,80.6,74.4 to 86.0,391
Polio,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,87.5,82.1 to 91.4,391
≥1 Dose MMR,,States/Local Areas,North Dakota,2020-2021,Age,35 Months,91.0,85.0 to 95.2,391
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020-2021,Age,19 Months,84.1,77.9 to 88.8,391
Hep B,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,90.3,85.5 to 93.6,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,93.4,85.5 to 97.8,143
Hib,Full Series,States/Local Areas,North Dakota,2021,Age,35 Months,78.7,68.9 to 87.1,143
Hib,Primary Series,States/Local Areas,North Dakota,2020-2021,Age,7 Months,76.3,69.7 to 81.9,391
Polio,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,93.6,89.0 to 96.7,391
DTaP,≥4 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,68.8,61.8 to 75.1,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,73.6,67.0 to 79.3,391
Hib,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,5 Months,78.6,72.2 to 83.8,391
Hep B,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,5 Months,89.2,84.4 to 92.7,391
Polio,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,3 Months,87.3,82.2 to 91.1,391
Hib,Primary Series,States/Local Areas,North Dakota,2021,Age,35 Months,91.1,83.9 to 96.0,143
Rotavirus,,States/Local Areas,North Dakota,2021,Age,8 Months,77.2,66.5 to 85.2,143
Hib,≥3 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,68.6,57.9 to 77.7,143
PCV,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,90.5,86.2 to 93.9,391
Polio,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,90.3,85.7 to 93.6,391
Hib,≥2 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,89.8,82.2 to 94.3,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,92.3,88.4 to 95.3,391
PCV,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,87.4,82.1 to 91.4,391
Hep A,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,58.0,50.6 to 65.6,391
≥1 Dose MMR,,States/Local Areas,North Dakota,2020-2021,Age,19 Months,83.8,77.6 to 88.5,391
Polio,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,90.3,86.0 to 93.7,391
Hep A,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,79.7,71.2 to 87.1,391
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2021,Age,0-3 Days,84.1,74.9 to 90.4,143
Hib,≥3 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,89.6,82.0 to 94.9,143
PCV,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,3 Months,86.5,81.2 to 90.4,391
DTaP,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,5 Months,78.9,72.5 to 84.1,391
Hib,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,64.5,57.6 to 70.9,391
Hep B,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,3 Months,95.1,91.7 to 97.2,391
Hib,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,87.4,82.0 to 91.3,391
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020-2021,Age,13 Months,61.7,54.5 to 68.5,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,89.4,82.6 to 94.4,143
≥1 Dose MMR,,States/Local Areas,North Dakota,2021,Age,13 Months,62.7,51.1 to 73.0,143
Hib,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,7 Months,47.1,40.0 to 54.4,391
Hep A,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,24 Months,84.3,78.5 to 89.3,391
Polio,≥2 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,89.9,82.3 to 94.4,143
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.6 to 97.9,695
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,87.6,83.8 to 91.5,695
Influenza,,States/Local Areas,North Dakota,2014-2017,Overall,Overall,66.1,62.3 to 70.0,830
Influenza,,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,54.8,45.7 to 64.0,155
Influenza,,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,65.2,59.7 to 70.8,408
Hib,Full Series,States/Local Areas,North Dakota,2020-2021,Age,24 Months,79.6,73.4 to 85.2,391
Influenza,,States/Local Areas,North Dakota,2021,Age,24 Months,64.9,54.1 to 75.6,143
Hep B,≥1 Dose,States/Local Areas,North Dakota,2021,Age,3 Months,93.4,87.4 to 96.6,143
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.7,49.5 to 77.9,120
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,90.7,87.7 to 93.6,695
Influenza,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.4,64.1 to 72.6,637
Influenza,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,75.9,70.2 to 81.6,285
Influenza,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.0,56.9 to 77.1,124
Influenza,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,57.2,51.5 to 62.9,421
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.9,69.4 to 88.3,120
Influenza,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,72.9,68.6 to 77.2,562
Influenza,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,52.1,33.1 to 71.1,42
Influenza,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,53.6,37.2 to 69.9,48
Influenza,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.0,54.5 to 75.4,123
Influenza,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,55.9,48.1 to 63.8,209
Influenza,,States/Local Areas,North Dakota,2016,Age,24 Months,72.2,65.0 to 79.0,227
Influenza,,States/Local Areas,North Dakota,2016-2017,Age,24 Months,69.1,64.0 to 74.1,525
Influenza,,States/Local Areas,North Dakota,2017,Age,24 Months,66.0,58.8 to 73.0,298
Influenza,,States/Local Areas,North Dakota,2017-2018,Age,24 Months,70.1,64.8 to 75.2,591
Influenza,,States/Local Areas,North Dakota,2018,Age,24 Months,74.5,66.8 to 81.7,293
Influenza,,States/Local Areas,North Dakota,2018-2019,Age,24 Months,75.7,70.5 to 80.7,556
Influenza,,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,76.5,70.7 to 82.4,267
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,80.2 to 90.5,795
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,87.5,82.4 to 92.6,236
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,92.3,89.4 to 95.2,695
Influenza,,States/Local Areas,North Dakota,2019,Age,24 Months,77.0,70.0 to 83.5,263
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,82.7,70.4 to 95.0,42
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,91.5,86.3 to 94.9,227
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,90.8,87.2 to 93.4,525
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,95.0,91.8 to 97.0,217
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,93.3,90.0 to 95.5,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,94.0,89.7 to 96.6,230
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,94.5,91.8 to 96.3,447
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,90.0,84.5 to 93.6,298
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,92.5,89.2 to 94.8,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,89.0,83.3 to 92.9,227
Hib,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,87.8,83.9 to 90.8,525
Polio,≥3 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,93.9,90.0 to 96.7,227
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,93.2,90.4 to 95.4,525
Hib,≥3 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,86.6,80.8 to 90.8,298
Hib,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,86.3,82.1 to 89.6,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,86.0,79.3 to 90.8,293
Hib,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,72.8,67.4 to 77.5,556
Polio,≥3 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,89.6,83.4 to 94.3,237
Polio,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,92.0,88.4 to 94.8,467
Hib,≥3 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,83.9,62.7 to 94.2,237
Hib,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,85.9,78.2 to 91.2,467
Hib,≥3 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,87.8,81.8 to 92.0,230
Hib,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,89.9,86.3 to 92.7,447
Polio,≥3 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,92.6,88.1 to 95.9,294
Polio,≥3 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,91.8,86.8 to 95.5,299
Polio,≥3 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,94.6,90.3 to 97.1,293
Polio,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,70.3,64.8 to 75.3,556
Polio,≥3 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,92.8,87.3 to 96.0,263
Polio,≥3 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,94.2,90.2 to 96.9,230
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,94.3,91.7 to 96.3,447
Polio,≥3 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,94.4,90.6 to 97.0,217
Polio,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,94.1,91.4 to 96.3,444
Polio,≥2 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,93.7,88.4 to 96.6,248
Hib,≥3 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,92.1,89.7 to 94.0,217
Hib,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,90.6,87.0 to 93.3,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,94.6,90.3 to 97.4,299
Hib,Full Series,States/Local Areas,North Dakota,2015,Age,24 Months,86.8,81.1 to 91.4,217
Hib,Full Series,States/Local Areas,North Dakota,2015-2016,Age,24 Months,86.4,82.4 to 89.9,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,90.9,84.8 to 95.3,237
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,93.1,89.7 to 95.7,467
DTaP,≥3 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,94.4,90.1 to 97.3,294
Polio,≥3 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,92.5,88.2 to 95.6,298
Polio,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,93.7,90.9 to 95.9,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,87.9,81.9 to 92.1,263
Polio,≥3 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,95.6,91.5 to 98.1,263
Polio,≥3 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,95.0,91.1 to 97.6,293
Polio,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,95.3,92.6 to 97.2,556
Polio,≥3 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,92.2,86.9 to 96.0,299
Hib,Full Series,States/Local Areas,North Dakota,2018,Age,24 Months,89.3,84.1 to 93.4,293
Hib,Full Series,States/Local Areas,North Dakota,2018-2019,Age,24 Months,86.0,82.0 to 89.5,556
Hib,Full Series,States/Local Areas,North Dakota,2016,Age,24 Months,86.1,80.3 to 90.9,227
Hib,Full Series,States/Local Areas,North Dakota,2016-2017,Age,24 Months,84.7,80.5 to 88.4,525
Hib,Full Series,States/Local Areas,North Dakota,2017,Age,24 Months,83.2,77.0 to 88.5,298
Hib,Full Series,States/Local Areas,North Dakota,2017-2018,Age,24 Months,86.1,82.1 to 89.6,591
Polio,≥3 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,94.4,90.6 to 97.0,217
Polio,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,94.5,91.8 to 96.6,444
Hib,≥3 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,92.9,88.2 to 96.3,299
Hib,≥3 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,93.6,89.2 to 96.7,294
Hib,≥3 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,87.0,80.3 to 92.3,237
Hib,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,89.1,85.0 to 92.5,467
DTaP,≥2 Doses,States/Local Areas,North Dakota,2015,Age,5 Months,82.9,76.0 to 88.2,217
DTaP,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,5 Months,83.4,78.8 to 87.1,444
Polio,≥3 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,94.6,90.8 to 97.2,227
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,94.6,91.6 to 96.8,525
Polio,≥3 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,94.5,89.4 to 97.6,298
Polio,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,95.4,92.1 to 97.6,591
DTaP,≥2 Doses,States/Local Areas,North Dakota,2014,Age,5 Months,79.0,71.4 to 85.1,230
DTaP,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,5 Months,81.0,77.1 to 84.3,447
Hib,≥3 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,91.0,86.0 to 94.7,230
Hib,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,92.7,89.7 to 95.1,447
Polio,≥3 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,97.1,92.6 to 99.2,294
Hib,Full Series,States/Local Areas,North Dakota,2013,Age,35 Months,82.0,74.8 to 88.1,237
Hib,Full Series,States/Local Areas,North Dakota,2013-2014,Age,35 Months,85.3,80.6 to 89.4,467
Polio,≥3 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,93.1,88.0 to 96.5,237
Polio,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,94.5,91.5 to 96.7,467
Polio,≥3 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,95.8,92.1 to 98.1,230
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,95.2,92.7 to 97.1,447
Hib,Full Series,States/Local Areas,North Dakota,2019,Age,24 Months,82.9,76.7 to 88.2,263
Hib,Full Series,States/Local Areas,North Dakota,2012,Age,35 Months,83.1,76.4 to 88.7,294
Hib,Full Series,States/Local Areas,North Dakota,2011,Age,35 Months,82.3,74.3 to 89.1,299
Hib,Full Series,States/Local Areas,North Dakota,2016,Age,35 Months,87.6,81.7 to 92.3,227
Hib,Full Series,States/Local Areas,North Dakota,2016-2017,Age,35 Months,86.4,82.2 to 90.1,525
Polio,≥3 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,96.3,91.9 to 98.7,293
Polio,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,96.2,93.5 to 98.0,556
Hib,Full Series,States/Local Areas,North Dakota,2017,Age,35 Months,85.2,78.9 to 90.4,298
Hib,Full Series,States/Local Areas,North Dakota,2017-2018,Age,35 Months,89.4,85.1 to 92.8,591
DTaP,≥2 Doses,States/Local Areas,North Dakota,2011,Age,5 Months,79.8,76.8 to 82.5,299
DTaP,≥2 Doses,States/Local Areas,North Dakota,2012,Age,5 Months,80.0,76.4 to 83.2,294
DTaP,≥2 Doses,States/Local Areas,North Dakota,2013,Age,5 Months,77.4,67.3 to 85.0,237
DTaP,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,5 Months,78.2,73.5 to 82.3,467
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,95.5,93.4 to 97.6,562
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,90.4,86.1 to 94.8,209
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,95.0,88.9 to 100.0,42
Polio,≥3 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,96.2,92.1 to 98.6,263
Hib,Full Series,States/Local Areas,North Dakota,2014,Age,35 Months,88.3,82.2 to 93.1,230
Hib,Full Series,States/Local Areas,North Dakota,2014-2015,Age,35 Months,90.1,86.4 to 93.2,447
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,87.7,84.0 to 91.4,562
Hib,Full Series,States/Local Areas,North Dakota,2015,Age,35 Months,91.8,87.3 to 95.2,217
Hib,Full Series,States/Local Areas,North Dakota,2015-2016,Age,35 Months,90.0,86.2 to 93.0,444
Hib,Full Series,States/Local Areas,North Dakota,2019,Age,35 Months,84.9,78.7 to 90.1,263
Hib,Full Series,States/Local Areas,North Dakota,2018,Age,35 Months,94.3,88.2 to 97.8,293
Hib,Full Series,States/Local Areas,North Dakota,2018-2019,Age,35 Months,89.3,85.1 to 92.7,556
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,80.0,73.8 to 86.2,209
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.4,70.9 to 87.8,124
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,87.5,75.4 to 99.7,48
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.6 to 98.2,123
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.8,92.8 to 96.7,637
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,94.6,91.5 to 97.8,285
Hib,Primary Series,States/Local Areas,North Dakota,2011,Age,7 Months,72.4,68.9 to 75.6,299
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,87.3,82.8 to 91.8,267
Hib,Primary Series,States/Local Areas,North Dakota,2012,Age,7 Months,73.8,67.2 to 79.5,294
Hep A,≥1 Dose,States/Local Areas,North Dakota,2017,Age,35 Months,93.8,87.8 to 97.4,298
Hep A,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,35 Months,94.1,90.2 to 96.9,591
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,78.1,63.6 to 92.6,48
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,77.1 to 91.9,123
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.3 to 90.1,637
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,85.4,80.0 to 90.7,285
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,92.4,87.2 to 97.6,285
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,86.0,73.7 to 98.2,48
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.6,71.5 to 95.7,123
≥1 Dose Varicella,,States/Local Areas,North Dakota,2011,Age,13 Months,58.0,54.7 to 61.3,299
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Overall,Overall,84.7,81.6 to 87.8,830
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,86.1,82.1 to 90.0,421
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,80.8,73.7 to 87.8,155
Hib,Full Series,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,84.8,80.1 to 89.5,408
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016,Age,35 Months,93.2,88.2 to 96.5,227
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,35 Months,93.8,89.9 to 96.6,525
Hep A,≥2 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,84.2,75.3 to 91.2,237
Hep A,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,85.2,79.6 to 90.0,467
Hep A,≥2 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,71.6,62.4 to 80.3,294
Hep A,≥2 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,77.4,66.2 to 87.0,299
Hep A,≥2 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,66.7,58.9 to 74.4,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,80.7,74.1 to 86.0,227
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,77.5,72.8 to 81.6,525
Polio,≥2 Doses,States/Local Areas,North Dakota,2015,Age,5 Months,82.3,75.2 to 87.6,217
Polio,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,5 Months,82.9,78.3 to 86.7,444
DTaP,≥4 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,85.7,79.6 to 90.7,217
DTaP,≥4 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,83.5,79.0 to 87.5,444
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,81.1,74.3 to 87.0,227
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,79.1,74.4 to 83.5,525
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,85.2,78.2 to 90.9,230
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,85.4,80.9 to 89.4,447
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013,Age,13 Months,59.1,47.4 to 69.9,237
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013-2014,Age,13 Months,61.2,59.1 to 63.2,467
Polio,≥2 Doses,States/Local Areas,North Dakota,2018,Age,5 Months,85.6,79.3 to 90.2,293
Polio,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,5 Months,85.1,80.8 to 88.6,556
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,86.4,76.5 to 96.3,42
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,91.8,89.1 to 94.5,562
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,85.9,80.4 to 91.4,209
Hep A,≥1 Dose,States/Local Areas,North Dakota,2019,Age,35 Months,93.6,88.7 to 96.9,263
≥1 Dose Varicella,,States/Local Areas,North Dakota,2012,Age,13 Months,62.3,56.7 to 67.6,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014,Age,13 Months,63.1,55.0 to 70.5,230
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2015,Age,13 Months,65.3,59.8 to 70.4,447
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,86.4,78.9 to 92.2,230
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,87.8,82.7 to 92.0,447
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,83.1,76.8 to 87.9,263
Hep A,≥2 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,88.7,81.7 to 93.9,217
Hep A,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,86.2,80.1 to 91.2,444
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,82.2,70.9 to 91.0,227
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,79.9,73.5 to 85.7,525
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,81.2,74.3 to 86.5,293
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,82.1,77.6 to 85.9,556
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,74.1,67.0 to 80.1,298
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,77.5,72.7 to 81.7,591
Polio,≥2 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,89.0,87.3 to 90.5,299
Polio,≥2 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,88.9,84.0 to 92.4,294
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,81.1,67.7 to 94.4,48
Polio,≥2 Doses,States/Local Areas,North Dakota,2019,Age,5 Months,84.6,78.2 to 89.4,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,79.7,72.4 to 85.4,217
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,80.2,75.4 to 84.3,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,81.9,75.5 to 86.9,230
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,80.8,76.1 to 84.7,447
Polio,≥2 Doses,States/Local Areas,North Dakota,2017,Age,5 Months,78.5,71.8 to 84.0,298
Polio,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,5 Months,81.9,77.5 to 85.7,591
Polio,≥2 Doses,States/Local Areas,North Dakota,2016,Age,5 Months,83.6,77.4 to 88.3,227
Polio,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,5 Months,81.1,76.7 to 84.9,525
Hep A,≥1 Dose,States/Local Areas,North Dakota,2018,Age,35 Months,94.2,88.4 to 97.7,293
Hep A,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,35 Months,94.0,90.4 to 96.6,556
Hep A,≥2 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,47.6,39.8 to 56.1,237
Hep A,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,49.7,44.1 to 55.7,467
DTaP,≥4 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,72.4,64.4 to 79.1,293
DTaP,≥4 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,94.4,91.3 to 96.5,556
DTaP,≥4 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,67.5,60.2 to 74.1,298
DTaP,≥4 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,69.9,64.5 to 74.8,591
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,70.9,63.2 to 77.5,227
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,69.2,63.9 to 74.1,525
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,87.5,75.4 to 99.7,48
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,88.5 to 98.8,123
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,93.0 to 96.8,637
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.5 to 98.3,285
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.0,86.8 to 97.3,124
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,93.9,91.2 to 96.5,421
PCV,≥2 Doses,States/Local Areas,North Dakota,2017,Age,5 Months,77.2,70.4 to 82.9,298
PCV,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,5 Months,81.6,77.1 to 85.4,591
PCV,≥2 Doses,States/Local Areas,North Dakota,2019,Age,5 Months,87.8,81.6 to 92.1,263
PCV,≥2 Doses,States/Local Areas,North Dakota,2018,Age,5 Months,86.3,79.8 to 90.9,293
PCV,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,5 Months,87.0,82.8 to 90.4,556
Hib,≥3 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,92.0,86.9 to 95.6,263
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,51.7,43.8 to 60.2,230
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,47.8,42.2 to 53.8,447
Hep A,≥2 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,44.1,36.5 to 52.6,217
Hep A,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,46.1,40.5 to 52.0,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,94.2,92.3 to 96.0,830
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014,Age,35 Months,93.3,88.8 to 96.5,230
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,35 Months,92.9,89.9 to 95.3,447
Hep A,≥1 Dose,States/Local Areas,North Dakota,2013,Age,35 Months,91.4,86.0 to 95.2,237
Hep A,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,35 Months,92.3,89.0 to 95.0,467
DTaP,≥4 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,81.5,75.2 to 87.0,294
DTaP,≥4 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,78.5,71.9 to 84.4,299
DTaP,≥4 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,68.2,60.5 to 75.0,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,76.7,62.2 to 86.7,237
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,79.4,72.6 to 84.8,467
Hep B,≥3 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,70.4,67.0 to 73.5,299
Hep B,≥3 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,76.7,72.5 to 80.5,294
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,94.8,92.2 to 97.4,408
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,96.1,93.6 to 98.6,267
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,90.5,85.5 to 95.4,155
Polio,≥2 Doses,States/Local Areas,North Dakota,2014,Age,5 Months,78.8,71.1 to 84.8,230
Polio,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,5 Months,80.5,77.1 to 83.6,447
Polio,≥2 Doses,States/Local Areas,North Dakota,2013,Age,5 Months,76.5,65.5 to 84.8,237
Polio,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,5 Months,77.7,72.5 to 82.1,467
Hep A,≥1 Dose,States/Local Areas,North Dakota,2012,Age,35 Months,93.6,87.7 to 97.3,294
Polio,≥2 Doses,States/Local Areas,North Dakota,2011,Age,5 Months,79.8,76.8 to 82.5,299
Polio,≥2 Doses,States/Local Areas,North Dakota,2012,Age,5 Months,79.8,76.0 to 83.1,294
Hep A,≥1 Dose,States/Local Areas,North Dakota,2015,Age,35 Months,92.4,88.0 to 95.7,217
Hep A,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,35 Months,92.7,89.4 to 95.2,444
DTaP,≥4 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,76.3,68.9 to 83.1,237
DTaP,≥4 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,80.9,75.9 to 85.4,467
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,48.2,40.2 to 56.9,227
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,50.6,45.1 to 56.3,525
Hep A,≥2 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,53.3,46.0 to 60.9,298
Hep A,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,50.3,44.7 to 56.2,591
Hep A,≥2 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,47.2,38.9 to 56.3,293
Hep A,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,56.8,50.9 to 62.9,556
Polio,≥2 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,95.0,90.9 to 97.3,293
Polio,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,92.8,89.6 to 95.1,556
Polio,≥2 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,84.7,78.5 to 89.4,298
Polio,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,89.7,86.0 to 92.5,591
Polio,≥2 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,92.8,88.5 to 95.6,227
Polio,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,88.9,85.2 to 91.7,525
Hep B,≥1 Dose,States/Local Areas,North Dakota,2014,Age,3 Months,97.0,94.1 to 98.5,230
Hep B,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,3 Months,97.3,95.5 to 98.3,447
Hep B,≥1 Dose,States/Local Areas,North Dakota,2011,Age,3 Months,97.5,93.0 to 99.2,299
Hep B,≥1 Dose,States/Local Areas,North Dakota,2012,Age,3 Months,95.7,94.4 to 96.8,294
Hep B,≥1 Dose,States/Local Areas,North Dakota,2013,Age,3 Months,91.1,76.0 to 97.1,237
Hep B,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,3 Months,94.2,90.1 to 96.6,467
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,89.2,84.1 to 92.8,298
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,91.6,88.5 to 94.0,591
DTaP,≥4 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,91.2,85.9 to 95.1,217
DTaP,≥4 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,90.2,86.1 to 93.5,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,95.3,91.7 to 97.4,217
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,93.2,90.2 to 95.4,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,91.0,86.0 to 94.4,227
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,90.2,86.8 to 92.8,525
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,89.4,82.8 to 94.2,227
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,86.1,81.1 to 90.3,525
DTaP,≥4 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,82.5,75.3 to 88.6,298
DTaP,≥4 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,87.2,82.4 to 91.3,591
Hep B,≥1 Dose,States/Local Areas,North Dakota,2016,Age,3 Months,96.9,93.4 to 98.6,227
Hep B,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,3 Months,96.5,94.4 to 97.9,525
Hep B,≥1 Dose,States/Local Areas,North Dakota,2015,Age,3 Months,97.5,94.9 to 98.8,217
Hep B,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,3 Months,97.2,95.3 to 98.4,444
Polio,≥2 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,93.8,89.2 to 96.5,230
Polio,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,94.8,92.1 to 96.6,447
Polio,≥2 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,91.3,74.0 to 97.5,237
Polio,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,92.6,86.2 to 96.2,467
Polio,≥2 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,94.9,93.2 to 96.1,299
Polio,≥2 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,93.8,91.9 to 95.2,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013,Age,19 Months,86.2,73.0 to 93.5,237
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013-2014,Age,19 Months,87.8,82.3 to 91.7,467
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015,Age,19 Months,90.7,87.5 to 93.1,217
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015-2016,Age,19 Months,89.4,85.6 to 92.3,444
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014,Age,19 Months,89.3,83.4 to 93.3,230
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2015,Age,19 Months,90.0,86.3 to 92.8,447
≥1 Dose MMR,,States/Local Areas,North Dakota,2018,Age,13 Months,69.9,61.7 to 77.0,293
≥1 Dose MMR,,States/Local Areas,North Dakota,2018-2019,Age,13 Months,70.3,64.8 to 75.3,556
≥1 Dose MMR,,States/Local Areas,North Dakota,2017,Age,13 Months,67.1,60.0 to 73.5,298
≥1 Dose MMR,,States/Local Areas,North Dakota,2017-2018,Age,13 Months,68.5,63.1 to 73.4,591
Hep B,≥3 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,86.9,80.7 to 91.4,299
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,89.7,86.2 to 93.3,408
Polio,≥2 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,93.8,88.9 to 96.6,217
Polio,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,93.3,90.1 to 95.5,444
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Overall,Overall,89.3,86.9 to 91.8,830
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,87.3,81.5 to 93.1,155
Polio,≥2 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,85.3,70.7 to 93.3,237
Polio,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,88.4,83.0 to 92.2,467
Polio,≥2 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,91.2,86.1 to 94.6,230
Polio,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,92.5,89.2 to 94.9,447
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.0,87.3 to 92.7,637
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,90.2,86.2 to 94.2,285
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.2,78.1 to 92.2,124
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,90.2,86.9 to 93.5,421
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,80.8 to 94.5,123
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015,Age,13 Months,67.5,59.9 to 74.2,217
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015-2016,Age,13 Months,67.8,62.4 to 72.8,444
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017,Age,13 Months,63.9,56.6 to 70.7,298
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017-2018,Age,13 Months,65.2,59.7 to 70.3,591
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016,Age,13 Months,68.1,60.2 to 75.1,227
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2017,Age,13 Months,66.1,60.8 to 71.0,525
DTaP,≥4 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,77.2,70.5 to 83.4,298
DTaP,≥4 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,82.2,77.7 to 86.2,591
DTaP,≥4 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,87.5,81.9 to 92.1,293
DTaP,≥4 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,85.0,80.7 to 88.7,556
DTaP,≥4 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,84.1,76.0 to 90.6,299
DTaP,≥4 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,82.4,75.9 to 88.0,263
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,81.7,72.1 to 91.3,155
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,86.2,82.2 to 90.2,830
Polio,≥2 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,90.5,85.0 to 94.1,263
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.9,69.5 to 90.4,124
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,82.7,76.3 to 89.0,421
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.1,81.5 to 90.7,637
≥1 Dose MMR,,States/Local Areas,North Dakota,2011,Age,13 Months,57.2,50.8 to 63.3,299
≥1 Dose MMR,,States/Local Areas,North Dakota,2012,Age,13 Months,62.7,57.8 to 67.4,294
≥1 Dose MMR,,States/Local Areas,North Dakota,2013,Age,13 Months,60.3,50.5 to 69.3,237
≥1 Dose MMR,,States/Local Areas,North Dakota,2013-2014,Age,13 Months,62.9,61.2 to 64.6,467
Hep A,≥2 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,78.6,70.8 to 85.5,298
Hep A,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,78.5,72.6 to 83.9,591
Hep A,≥2 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,78.3,69.2 to 86.2,293
Hep A,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,82.5,76.5 to 87.7,556
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,91.6,86.8 to 94.8,230
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,93.5,90.6 to 95.5,447
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,88.3,68.8 to 96.3,237
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,90.1,82.9 to 94.4,467
DTaP,≥4 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,83.0,75.4 to 89.3,237
DTaP,≥4 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,88.8,84.3 to 92.5,467
Hep B,≥3 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,89.2,85.0 to 92.3,294
Hep A,≥2 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,86.8,79.0 to 92.8,263
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,94.0,89.0 to 97.2,230
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,92.6,89.2 to 95.3,447
DTaP,≥4 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,87.2,80.6 to 92.3,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018,Age,13 Months,66.6,58.3 to 74.0,293
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018-2019,Age,13 Months,67.5,61.8 to 72.6,556
≥1 Dose MMR,,States/Local Areas,North Dakota,2016,Age,13 Months,68.5,60.7 to 75.5,227
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2017,Age,13 Months,67.8,62.6 to 72.7,525
PCV,≥4 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,82.5,75.0 to 88.8,248
≥1 Dose Varicella,,States/Local Areas,North Dakota,2012,Age,19 Months,88.7,86.3 to 90.7,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2011,Age,19 Months,83.2,80.2 to 85.9,299
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019,Age,13 Months,68.4,60.7 to 75.2,263
≥1 Dose MMR,,States/Local Areas,North Dakota,2015,Age,13 Months,71.5,64.3 to 77.8,217
≥1 Dose MMR,,States/Local Areas,North Dakota,2015-2016,Age,13 Months,70.1,64.7 to 74.9,444
≥1 Dose MMR,,States/Local Areas,North Dakota,2014,Age,13 Months,65.4,57.3 to 72.7,230
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2015,Age,13 Months,68.4,63.0 to 73.4,447
Hep B,≥2 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,95.3,91.6 to 97.4,293
Hep B,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,95.5,93.2 to 97.1,556
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2019,Age,0-2 Days,86.2,79.1 to 91.2,263
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2018,Age,0-2 Days,84.9,78.3 to 89.7,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2018-2019,Age,0-2 Days,85.5,80.8 to 89.2,556
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2017,Age,0-2 Days,81.8,75.1 to 87.0,298
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2017-2018,Age,0-2 Days,83.3,78.8 to 87.0,591
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017,Age,35 Months,92.7,87.6 to 96.2,298
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017-2018,Age,35 Months,95.2,91.9 to 97.4,591
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018,Age,35 Months,97.2,93.4 to 99.1,293
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018-2019,Age,35 Months,94.7,91.4 to 97.0,556
Hep B,≥2 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,96.5,93.6 to 98.1,217
Hep B,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,95.4,93.0 to 97.0,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,95.3,91.6 to 97.7,293
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,95.9,93.6 to 97.5,556
PCV,≥3 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,91.9,87.1 to 95.0,217
PCV,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,91.0,87.5 to 93.6,444
PCV,≥3 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,90.7,85.7 to 94.1,230
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,91.3,88.0 to 93.8,447
Hep B,≥2 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,92.7,88.4 to 95.5,298
Hep B,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,94.0,91.3 to 95.9,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,83.4,62.7 to 93.8,237
PCV,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,87.2,79.4 to 92.4,467
Hep B,≥2 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,94.3,90.4 to 96.6,227
Hep B,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,93.5,90.8 to 95.5,525
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2016,Age,0-2 Days,81.6,74.2 to 87.2,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2016-2017,Age,0-2 Days,81.7,76.9 to 85.7,525
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,92.9,88.7 to 96.0,230
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,94.1,91.6 to 96.1,447
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,95.3,92.1 to 97.5,217
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,94.3,91.7 to 96.3,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,93.2,89.2 to 96.1,227
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,93.5,90.8 to 95.6,525
PCV,≥3 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,90.2,86.6 to 92.9,294
≥1 Dose MMR,,States/Local Areas,North Dakota,2016,Age,24 Months,92.1,87.7 to 95.4,227
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2017,Age,24 Months,93.2,90.5 to 95.4,525
≥1 Dose MMR,,States/Local Areas,North Dakota,2017,Age,24 Months,94.4,90.9 to 96.9,298
≥1 Dose MMR,,States/Local Areas,North Dakota,2017-2018,Age,24 Months,94.9,92.5 to 96.8,591
PCV,≥4 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,89.2,83.7 to 93.1,293
PCV,≥4 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,85.6,80.2 to 89.7,462
PCV,≥4 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,77.5,70.5 to 83.3,298
PCV,≥4 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,83.2,78.8 to 86.9,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,86.6,83.9 to 88.8,299
PCV,≥3 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,80.2,73.4 to 85.6,263
PCV,≥3 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,78.5,71.4 to 84.3,293
PCV,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,79.4,74.6 to 83.5,556
Hep B,≥2 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,93.4,89.1 to 96.1,294
Hep B,≥2 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,92.8,88.0 to 95.7,230
Hep B,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,94.6,92.0 to 96.4,447
Hep B,≥2 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,90.4,75.2 to 96.7,237
Hep B,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,91.6,85.2 to 95.5,467
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2012,Age,0-2 Days,79.8,74.6 to 84.1,294
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2013,Age,0-2 Days,80.9,66.9 to 89.9,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2013-2014,Age,0-2 Days,81.8,76.2 to 86.4,467
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2011,Age,0-2 Days,85.9,85.0 to 86.8,299
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2019,Age,0-1 Days,85.0,77.8 to 90.1,263
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2018,Age,0-1 Days,82.1,75.2 to 87.4,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2018-2019,Age,0-1 Days,83.5,78.7 to 87.4,556
Hep B,≥3 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,91.2,86.3 to 94.8,299
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,96.4,93.1 to 98.1,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,90.7,85.0 to 94.9,237
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,91.9,88.4 to 94.6,467
Hep B,≥3 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,91.7,86.9 to 95.3,294
PCV,≥3 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,72.8,65.4 to 79.1,227
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,69.7,64.5 to 74.5,525
PCV,≥4 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,82.5,75.9 to 87.6,227
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,80.1,75.4 to 84.1,525
PCV,≥4 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,85.3,81.9 to 88.2,217
PCV,≥4 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,83.9,79.5 to 87.6,444
PCV,≥4 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,85.6,79.2 to 90.3,230
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,85.5,81.1 to 88.9,447
PCV,≥3 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,71.1,63.3 to 77.9,217
PCV,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,71.9,66.6 to 76.7,444
PCV,≥3 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,66.5,59.1 to 73.1,298
PCV,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,72.3,67.1 to 77.0,591
≥1 Dose MMR,,States/Local Areas,North Dakota,2013,Age,24 Months,92.6,87.2 to 96.3,237
≥1 Dose MMR,,States/Local Areas,North Dakota,2013-2014,Age,24 Months,92.7,89.3 to 95.4,467
≥1 Dose MMR,,States/Local Areas,North Dakota,2014,Age,24 Months,92.6,87.7 to 96.1,230
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2015,Age,24 Months,93.0,90.0 to 95.4,447
≥1 Dose MMR,,States/Local Areas,North Dakota,2015,Age,24 Months,93.4,89.4 to 96.3,217
≥1 Dose MMR,,States/Local Areas,North Dakota,2015-2016,Age,24 Months,92.7,89.8 to 95.1,444
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018,Age,24 Months,94.0,89.8 to 96.9,293
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018-2019,Age,24 Months,92.5,89.3 to 95.1,556
≥1 Dose Varicella,,States/Local Areas,North Dakota,2012,Age,35 Months,95.9,92.2 to 98.2,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2011,Age,35 Months,93.3,84.2 to 98.1,299
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019,Age,24 Months,90.9,85.8 to 94.8,263
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017,Age,24 Months,91.2,86.4 to 94.8,298
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017-2018,Age,24 Months,92.6,89.5 to 95.0,591
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2015,Age,0-1 Days,78.8,71.6 to 84.6,217
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2015-2016,Age,0-1 Days,75.1,69.9 to 79.6,444
Hep B,≥2 Doses,States/Local Areas,North Dakota,2015,Age,5 Months,94.5,90.6 to 96.9,217
Hep B,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,5 Months,93.0,89.9 to 95.1,444
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2014,Age,0-1 Days,74.7,67.2 to 81.0,230
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2014-2015,Age,0-1 Days,76.8,71.7 to 81.2,447
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2013,Age,0-1 Days,66.5,59.5 to 72.8,237
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2013-2014,Age,0-1 Days,70.7,68.3 to 73.0,467
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013,Age,24 Months,93.0,88.1 to 96.4,237
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013-2014,Age,24 Months,91.9,88.6 to 94.6,467
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014,Age,24 Months,90.8,85.8 to 94.7,230
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2015,Age,24 Months,91.0,87.6 to 93.7,447
Polio,≥2 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,92.5,88.0 to 95.4,298
Polio,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,94.0,91.1 to 95.9,591
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019,Age,19 Months,88.5,82.7 to 92.5,263
Polio,≥2 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,93.3,87.9 to 96.4,263
Polio,≥2 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,95.5,91.3 to 97.8,293
Polio,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,94.4,91.3 to 96.5,556
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2012,Age,0-1 Days,63.7,54.0 to 72.3,294
Hep B,≥2 Doses,States/Local Areas,North Dakota,2014,Age,5 Months,91.2,86.3 to 94.5,230
Hep B,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,5 Months,92.9,90.5 to 94.7,447
Hep B,≥2 Doses,States/Local Areas,North Dakota,2016,Age,5 Months,91.3,86.3 to 94.6,227
Hep B,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,5 Months,90.6,87.2 to 93.1,525
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,94.6,90.3 to 97.0,293
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,92.8,89.6 to 95.1,556
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,91.7,86.8 to 94.9,298
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,93.1,90.0 to 95.3,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,70.1,65.3 to 74.6,294
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,82.1,77.4 to 86.7,408
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,88.2,83.8 to 92.7,267
PCV,≥3 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,71.2,63.2 to 78.1,230
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,71.2,65.7 to 76.1,447
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,91.7,86.7 to 94.9,227
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,91.7,88.4 to 94.1,525
PCV,≥3 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,67.4,64.3 to 70.3,299
PCV,≥3 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,65.2,47.5 to 79.6,237
PCV,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,68.3,61.0 to 74.9,467
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013,Age,35 Months,94.2,89.6 to 97.2,237
≥1 Dose Varicella,,States/Local Areas,North Dakota,2013-2014,Age,35 Months,94.2,91.1 to 96.4,467
≥1 Dose MMR,,States/Local Areas,North Dakota,2018,Age,24 Months,95.4,91.6 to 97.9,293
≥1 Dose MMR,,States/Local Areas,North Dakota,2018-2019,Age,24 Months,94.1,91.2 to 96.4,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,84.5,77.8 to 89.4,263
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014,Age,35 Months,94.3,89.6 to 97.3,230
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2015,Age,35 Months,92.9,89.8 to 95.4,447
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015,Age,35 Months,91.6,86.8 to 95.1,217
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015-2016,Age,35 Months,93.0,89.9 to 95.5,444
PCV,≥4 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,81.9,75.6 to 87.4,299
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2015,Age,0-2 Days,86.8,80.6 to 91.2,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2015-2016,Age,0-2 Days,84.3,79.7 to 88.0,444
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2014,Age,0-2 Days,82.7,75.9 to 87.8,230
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2014-2015,Age,0-2 Days,84.7,80.3 to 88.3,447
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016,Age,24 Months,92.1,87.7 to 95.4,227
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2017,Age,24 Months,91.6,88.5 to 94.2,525
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015,Age,24 Months,91.1,86.3 to 94.7,217
≥1 Dose Varicella,,States/Local Areas,North Dakota,2015-2016,Age,24 Months,91.5,88.3 to 94.2,444
≥1 Dose MMR,,States/Local Areas,North Dakota,2012,Age,24 Months,92.8,88.6 to 95.8,294
≥1 Dose MMR,,States/Local Areas,North Dakota,2011,Age,24 Months,91.2,85.9 to 95.1,299
≥1 Dose MMR,,States/Local Areas,North Dakota,2019,Age,19 Months,90.5,85.0 to 94.1,263
≥1 Dose MMR,,States/Local Areas,North Dakota,2018,Age,19 Months,92.2,86.8 to 95.5,293
≥1 Dose MMR,,States/Local Areas,North Dakota,2018-2019,Age,19 Months,94.0,90.8 to 96.1,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,78.2,76.6 to 79.8,299
PCV,≥4 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,82.9,78.7 to 86.4,294
PCV,≥4 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,78.8,54.9 to 91.9,237
PCV,≥4 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,82.3,72.9 to 89.0,467
Hep B,≥1 Dose,States/Local Areas,North Dakota,2017,Age,3 Months,96.1,93.0 to 97.9,298
Hep B,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,3 Months,97.3,95.5 to 98.4,591
Polio,≥2 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,94.6,90.6 to 97.0,227
Polio,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,93.6,90.8 to 95.6,525
Polio,≥2 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,95.7,92.2 to 97.7,217
Polio,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,95.2,92.5 to 96.9,444
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016,Age,19 Months,88.1,82.1 to 92.2,227
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2017,Age,19 Months,88.1,84.1 to 91.2,525
≥1 Dose MMR,,States/Local Areas,North Dakota,2019,Age,13 Months,70.8,63.1 to 77.4,263
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018,Age,19 Months,90.1,83.9 to 94.0,293
≥1 Dose Varicella,,States/Local Areas,North Dakota,2018-2019,Age,19 Months,67.5,61.8 to 72.6,556
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017,Age,19 Months,88.1,82.3 to 92.1,298
≥1 Dose Varicella,,States/Local Areas,North Dakota,2017-2018,Age,19 Months,89.0,85.1 to 92.0,591
≥1 Dose MMR,,States/Local Areas,North Dakota,2012,Age,19 Months,87.5,84.4 to 90.1,294
≥1 Dose MMR,,States/Local Areas,North Dakota,2014,Age,19 Months,89.7,83.8 to 93.7,230
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2015,Age,19 Months,91.0,87.5 to 93.7,447
≥1 Dose MMR,,States/Local Areas,North Dakota,2013,Age,19 Months,85.8,77.1 to 91.6,237
≥1 Dose MMR,,States/Local Areas,North Dakota,2013-2014,Age,19 Months,87.8,84.2 to 90.7,467
≥1 Dose MMR,,States/Local Areas,North Dakota,2011,Age,19 Months,82.5,80.4 to 84.4,299
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,71.5,56.1 to 86.8,42
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,87.4,84.0 to 90.8,562
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,76.2,69.3 to 83.1,209
DTaP,≥4 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,91.7,85.4 to 96.0,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,95.3,91.9 to 97.3,217
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,93.5,90.5 to 95.7,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,92.0,87.2 to 95.1,230
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,93.7,90.8 to 95.7,447
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,88.3,82.6 to 94.0,267
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,89.5,72.1 to 96.5,237
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,90.8,84.3 to 94.8,467
Hep B,≥2 Doses,States/Local Areas,North Dakota,2013,Age,5 Months,87.1,73.7 to 94.2,237
Hep B,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,5 Months,89.2,84.3 to 92.8,467
Hep B,≥2 Doses,States/Local Areas,North Dakota,2011,Age,5 Months,89.4,86.6 to 91.6,299
Hep B,≥2 Doses,States/Local Areas,North Dakota,2012,Age,5 Months,90.3,85.5 to 93.6,294
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2011,Age,0-1 Days,69.0,63.8 to 73.8,299
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,87.2,81.3 to 93.0,408
Hep B,≥1 Dose,States/Local Areas,North Dakota,2019,Age,3 Months,98.6,96.4 to 99.5,263
Hep B,≥1 Dose,States/Local Areas,North Dakota,2018,Age,3 Months,98.6,95.9 to 99.5,293
Hep B,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,3 Months,98.6,97.2 to 99.3,556
≥1 Dose Varicella,,States/Local Areas,North Dakota,2012,Age,24 Months,92.2,87.8 to 95.4,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2011,Age,24 Months,88.4,82.8 to 92.9,299
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,77.2,69.5 to 85.0,155
≥1 Dose MMR,,States/Local Areas,North Dakota,2017,Age,19 Months,90.3,85.1 to 93.8,298
≥1 Dose MMR,,States/Local Areas,North Dakota,2017-2018,Age,19 Months,91.2,87.7 to 93.8,591
≥1 Dose MMR,,States/Local Areas,North Dakota,2016,Age,19 Months,88.3,82.4 to 92.4,227
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2017,Age,19 Months,89.3,85.5 to 92.1,525
≥1 Dose MMR,,States/Local Areas,North Dakota,2015,Age,19 Months,92.4,90.0 to 94.2,217
≥1 Dose MMR,,States/Local Areas,North Dakota,2015-2016,Age,19 Months,90.4,86.8 to 93.1,444
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,85.9,81.0 to 90.7,285
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.2,65.8 to 84.5,124
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,82.8,79.6 to 85.9,830
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,82.8,78.4 to 87.2,421
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.4,66.1 to 84.8,123
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.1,81.7 to 88.4,637
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,81.4,67.7 to 95.1,48
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,89.1,83.8 to 94.3,562
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,86.0,78.5 to 93.4,209
Hep B,≥2 Doses,States/Local Areas,North Dakota,2018,Age,5 Months,92.5,87.3 to 95.6,293
Hep B,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,5 Months,93.7,90.8 to 95.8,556
Hep B,≥2 Doses,States/Local Areas,North Dakota,2017,Age,5 Months,89.9,84.8 to 93.4,298
Hep B,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,5 Months,91.1,87.8 to 93.6,591
Hep B,≥2 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,93.5,91.9 to 94.8,299
Hep B,≥2 Doses,States/Local Areas,North Dakota,2019,Age,5 Months,95.0,91.6 to 97.1,263
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2017,Age,0-1 Days,78.4,71.6 to 83.9,298
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2017-2018,Age,0-1 Days,80.2,75.5 to 84.1,591
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2016,Age,0-1 Days,71.1,63.2 to 77.9,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2016-2017,Age,0-1 Days,74.6,69.5 to 79.2,525
DTaP,≥4 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,92.2,85.5 to 96.5,293
DTaP,≥4 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,91.8,87.4 to 95.1,556
Hep B,≥3 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,90.3,87.2 to 92.7,299
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,91.4,86.0 to 94.9,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,94.2,90.0 to 96.7,293
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,92.8,89.6 to 95.1,556
Hep B,≥3 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,91.4,86.5 to 94.6,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016,Age,35 Months,94.7,90.7 to 97.4,227
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2017,Age,35 Months,93.8,90.7 to 96.1,525
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,72.7,55.6 to 89.8,42
Hep A,≥1 Dose,States/Local Areas,North Dakota,2020,Age,35 Months,87.5,80.8 to 92.8,248
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,89.9,85.9 to 93.9,267
≥1 Dose MMR,,States/Local Areas,North Carolina,2020,Age,13 Months,71.4,64.9 to 77.1,459
Hib,Full Series,States/Local Areas,North Carolina,2015,Age,19 Months,78.5,71.9 to 83.8,320
Hib,Full Series,States/Local Areas,North Carolina,2015-2016,Age,19 Months,78.8,74.2 to 82.8,672
Hib,Full Series,States/Local Areas,North Carolina,2016,Age,19 Months,79.1,72.6 to 84.4,352
Hib,Full Series,States/Local Areas,North Carolina,2016-2017,Age,19 Months,80.3,75.6 to 84.4,644
Hib,Full Series,States/Local Areas,North Carolina,2011,Age,24 Months,89.1,83.2 to 93.7,252
Hib,Full Series,States/Local Areas,North Carolina,2012,Age,24 Months,84.6,78.0 to 90.1,271
Hib,Full Series,States/Local Areas,North Carolina,2014,Age,19 Months,73.7,65.8 to 80.4,287
Hib,Full Series,States/Local Areas,North Carolina,2014-2015,Age,19 Months,76.1,71.2 to 80.5,607
Hib,Full Series,States/Local Areas,North Carolina,2018,Age,19 Months,80.1,71.8 to 86.4,271
Hib,Full Series,States/Local Areas,North Carolina,2018-2019,Age,19 Months,98.1,96.5 to 99.0,585
Hib,Full Series,States/Local Areas,North Carolina,2019,Age,19 Months,84.2,76.9 to 89.4,314
Hib,Full Series,States/Local Areas,North Carolina,2017,Age,19 Months,81.5,74.2 to 87.1,292
Hib,Full Series,States/Local Areas,North Carolina,2017-2018,Age,19 Months,80.8,75.5 to 85.2,563
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,74.0,66.1 to 81.8,198
Combined 7 Series,,States/Local Areas,North Carolina,2018,Age,35 Months,81.4,70.7 to 90.1,271
Combined 7 Series,,States/Local Areas,North Carolina,2018-2019,Age,35 Months,86.5,80.1 to 91.6,585
Combined 7 Series,,States/Local Areas,North Carolina,2019,Age,35 Months,90.9,85.0 to 95.1,314
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,72.3,66.8 to 77.8,419
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,78.1,73.6 to 82.5,673
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,55.7,34.6 to 76.8,34
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,74.5,66.1 to 82.8,180
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Overall,Overall,74.2,70.7 to 77.8,1155
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.9,66.6 to 85.3,125
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,69.0,62.4 to 75.6,302
Hib,Full Series,States/Local Areas,North Carolina,2013,Age,19 Months,79.1,73.5 to 83.8,271
Hib,Full Series,States/Local Areas,North Carolina,2013-2014,Age,19 Months,76.4,72.0 to 80.3,558
Hib,Full Series,States/Local Areas,North Carolina,2012,Age,19 Months,79.1,72.5 to 84.5,271
Hib,Full Series,States/Local Areas,North Carolina,2011,Age,19 Months,79.8,72.7 to 85.4,252
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,84.7,79.6 to 89.9,379
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,72.6,67.0 to 78.3,474
Hib,Full Series,States/Local Areas,North Carolina,2014,Age,24 Months,80.2,72.9 to 86.6,287
Hib,Full Series,States/Local Areas,North Carolina,2014-2015,Age,24 Months,80.9,76.4 to 85.1,607
Hib,Full Series,States/Local Areas,North Carolina,2013,Age,24 Months,83.0,76.3 to 88.7,271
Hib,Full Series,States/Local Areas,North Carolina,2013-2014,Age,24 Months,81.6,76.7 to 86.0,558
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.9,67.3 to 78.5,469
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,75.2,69.7 to 80.6,506
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.8,71.4 to 80.1,703
Combined 7 Series,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.3,51.1 to 75.5,129
Hib,Primary Series,States/Local Areas,North Carolina,2018,Age,35 Months,94.5,89.3 to 97.7,271
Hib,Primary Series,States/Local Areas,North Carolina,2018-2019,Age,35 Months,95.9,93.0 to 97.8,585
Combined 7 Series,,States/Local Areas,North Carolina,2015,Age,24 Months,73.0,66.3 to 79.4,320
Combined 7 Series,,States/Local Areas,North Carolina,2015-2016,Age,24 Months,75.4,70.7 to 79.9,672
Combined 7 Series,,States/Local Areas,North Carolina,2014,Age,24 Months,69.9,62.0 to 77.5,287
Combined 7 Series,,States/Local Areas,North Carolina,2014-2015,Age,24 Months,71.5,66.4 to 76.5,607
Hib,Primary Series,States/Local Areas,North Carolina,2015,Age,19 Months,94.2,92.6 to 95.5,320
Hib,Primary Series,States/Local Areas,North Carolina,2015-2016,Age,19 Months,94.3,91.1 to 96.3,672
Hib,Primary Series,States/Local Areas,North Carolina,2013,Age,7 Months,71.8,69.3 to 74.2,271
Hib,Primary Series,States/Local Areas,North Carolina,2013-2014,Age,7 Months,74.1,69.2 to 78.5,558
Hib,Primary Series,States/Local Areas,North Carolina,2016,Age,24 Months,95.3,91.9 to 97.6,352
Hib,Primary Series,States/Local Areas,North Carolina,2016-2017,Age,24 Months,94.4,91.3 to 96.7,644
Hib,Primary Series,States/Local Areas,North Carolina,2013,Age,13 Months,89.1,85.8 to 91.7,271
Hib,Primary Series,States/Local Areas,North Carolina,2013-2014,Age,13 Months,87.9,85.0 to 90.4,558
Hib,Primary Series,States/Local Areas,North Carolina,2012,Age,13 Months,94.3,91.2 to 96.4,271
Hib,Primary Series,States/Local Areas,North Carolina,2011,Age,13 Months,92.5,86.1 to 96.1,252
Hib,Primary Series,States/Local Areas,North Carolina,2019,Age,7 Months,85.7,79.4 to 90.4,314
Hib,Primary Series,States/Local Areas,North Carolina,2018,Age,7 Months,84.0,77.0 to 89.2,271
Hib,Primary Series,States/Local Areas,North Carolina,2018-2019,Age,7 Months,84.9,80.4 to 88.5,585
Hib,Primary Series,States/Local Areas,North Carolina,2014,Age,13 Months,86.8,79.2 to 91.9,287
Hib,Primary Series,States/Local Areas,North Carolina,2014-2015,Age,13 Months,87.8,83.6 to 91.1,607
Hib,Primary Series,States/Local Areas,North Carolina,2015,Age,13 Months,88.9,84.0 to 92.4,320
Hib,Primary Series,States/Local Areas,North Carolina,2015-2016,Age,13 Months,90.5,87.1 to 93.2,672
Hib,Primary Series,States/Local Areas,North Carolina,2014,Age,24 Months,90.7,84.2 to 95.2,287
Hib,Primary Series,States/Local Areas,North Carolina,2014-2015,Age,24 Months,93.0,89.4 to 95.7,607
Hib,Primary Series,States/Local Areas,North Carolina,2015,Age,24 Months,95.2,91.7 to 97.6,320
Hib,Primary Series,States/Local Areas,North Carolina,2015-2016,Age,24 Months,95.3,92.5 to 97.3,672
Hib,Primary Series,States/Local Areas,North Carolina,2018,Age,24 Months,94.5,89.3 to 97.7,271
Hib,Primary Series,States/Local Areas,North Carolina,2018-2019,Age,24 Months,95.8,92.9 to 97.8,585
Hib,Primary Series,States/Local Areas,North Carolina,2013,Age,35 Months,92.7,87.3 to 96.4,271
Hib,Primary Series,States/Local Areas,North Carolina,2013-2014,Age,35 Months,91.7,87.7 to 94.9,558
Hib,Primary Series,States/Local Areas,North Carolina,2019,Age,24 Months,97.1,94.0 to 98.9,314
Hib,Primary Series,States/Local Areas,North Carolina,2011,Age,35 Months,94.0,88.5 to 97.4,252
Hib,Primary Series,States/Local Areas,North Carolina,2014,Age,35 Months,90.7,84.2 to 95.2,287
Hib,Primary Series,States/Local Areas,North Carolina,2014-2015,Age,35 Months,93.0,89.4 to 95.7,607
Hib,Primary Series,States/Local Areas,North Carolina,2012,Age,35 Months,96.3,92.7 to 98.4,271
Hib,Primary Series,States/Local Areas,North Carolina,2013,Age,24 Months,92.7,87.3 to 96.4,271
Hib,Primary Series,States/Local Areas,North Carolina,2013-2014,Age,24 Months,91.7,87.7 to 94.9,558
Hib,Primary Series,States/Local Areas,North Carolina,2017,Age,24 Months,93.4,88.1 to 96.8,292
Hib,Primary Series,States/Local Areas,North Carolina,2017-2018,Age,24 Months,93.9,90.5 to 96.5,563
Combined 7 Series,,States/Local Areas,North Carolina,2013,Age,24 Months,71.2,63.6 to 78.5,271
Combined 7 Series,,States/Local Areas,North Carolina,2013-2014,Age,24 Months,70.7,65.2 to 76.0,558
Combined 7 Series,,States/Local Areas,North Carolina,2011,Age,24 Months,72.0,63.9 to 79.7,252
Combined 7 Series,,States/Local Areas,North Carolina,2012,Age,24 Months,76.3,68.5 to 83.3,271
Hib,Primary Series,States/Local Areas,North Carolina,2015,Age,35 Months,95.3,91.7 to 97.6,320
Hib,Primary Series,States/Local Areas,North Carolina,2015-2016,Age,35 Months,95.3,92.5 to 97.3,672
Combined 7 Series,,States/Local Areas,North Carolina,2013,Age,35 Months,79.5,71.0 to 86.9,271
Combined 7 Series,,States/Local Areas,North Carolina,2013-2014,Age,35 Months,75.7,70.0 to 81.0,558
Combined 7 Series,,States/Local Areas,North Carolina,2014,Age,35 Months,72.7,64.7 to 80.2,287
Combined 7 Series,,States/Local Areas,North Carolina,2014-2015,Age,35 Months,76.0,70.8 to 80.9,607
Combined 7 Series,,States/Local Areas,North Carolina,2012,Age,35 Months,83.8,76.7 to 89.7,271
Hib,Primary Series,States/Local Areas,North Carolina,2016,Age,35 Months,95.3,91.9 to 97.6,352
Hib,Primary Series,States/Local Areas,North Carolina,2016-2017,Age,35 Months,95.7,92.8 to 97.7,644
Hib,Primary Series,States/Local Areas,North Carolina,2017,Age,35 Months,95.8,90.8 to 98.5,292
Hib,Primary Series,States/Local Areas,North Carolina,2017-2018,Age,35 Months,95.3,91.9 to 97.6,563
Combined 7 Series,,States/Local Areas,North Carolina,2017,Age,35 Months,82.4,75.0 to 88.7,292
Combined 7 Series,,States/Local Areas,North Carolina,2017-2018,Age,35 Months,83.2,75.2 to 89.8,563
Combined 7 Series,,States/Local Areas,North Carolina,2016,Age,35 Months,80.0,73.7 to 85.6,352
Combined 7 Series,,States/Local Areas,North Carolina,2016-2017,Age,35 Months,81.2,76.4 to 85.6,644
Combined 7 Series,,States/Local Areas,North Carolina,2019,Age,24 Months,85.1,78.7 to 90.4,314
Combined 7 Series,,States/Local Areas,North Carolina,2018,Age,24 Months,67.9,59.3 to 76.2,271
Combined 7 Series,,States/Local Areas,North Carolina,2018-2019,Age,24 Months,76.4,70.9 to 81.6,585
Combined 7 Series,,States/Local Areas,North Carolina,2017,Age,24 Months,80.3,72.8 to 86.8,292
Combined 7 Series,,States/Local Areas,North Carolina,2017-2018,Age,24 Months,74.0,68.3 to 79.5,563
Hib,Primary Series,States/Local Areas,North Carolina,2019,Age,35 Months,97.4,94.4 to 99.0,314
Combined 7 Series,,States/Local Areas,North Carolina,2016,Age,24 Months,77.9,71.5 to 83.6,352
Combined 7 Series,,States/Local Areas,North Carolina,2016-2017,Age,24 Months,79.1,74.3 to 83.6,644
Combined 7 Series,,States/Local Areas,North Carolina,2015,Age,35 Months,79.8,72.8 to 86.0,320
Combined 7 Series,,States/Local Areas,North Carolina,2015-2016,Age,35 Months,79.9,75.1 to 84.3,672
Hib,Primary Series,States/Local Areas,North Carolina,2016,Age,13 Months,92.2,87.8 to 95.1,352
Hib,Primary Series,States/Local Areas,North Carolina,2016-2017,Age,13 Months,91.9,88.4 to 94.4,644
Hib,Primary Series,States/Local Areas,North Carolina,2018,Age,13 Months,91.5,85.1 to 95.3,271
Hib,Primary Series,States/Local Areas,North Carolina,2018-2019,Age,13 Months,93.3,89.8 to 95.7,585
Hib,Primary Series,States/Local Areas,North Carolina,2019,Age,13 Months,95.2,91.4 to 97.4,314
Hib,Primary Series,States/Local Areas,North Carolina,2017,Age,19 Months,93.4,87.5 to 96.6,292
Hib,Primary Series,States/Local Areas,North Carolina,2017-2018,Age,19 Months,93.9,90.1 to 96.3,563
Hib,Primary Series,States/Local Areas,North Carolina,2019,Age,19 Months,96.4,92.7 to 98.3,314
Hib,Primary Series,States/Local Areas,North Carolina,2018,Age,19 Months,94.5,88.6 to 97.4,271
Hib,Primary Series,States/Local Areas,North Carolina,2018-2019,Age,19 Months,93.3,89.8 to 95.7,585
Hib,Primary Series,States/Local Areas,North Carolina,2014,Age,7 Months,76.4,68.4 to 82.9,287
Hib,Primary Series,States/Local Areas,North Carolina,2014-2015,Age,7 Months,74.8,69.5 to 79.4,607
Hib,Primary Series,States/Local Areas,North Carolina,2015,Age,7 Months,73.1,65.8 to 79.4,320
Hib,Primary Series,States/Local Areas,North Carolina,2015-2016,Age,7 Months,76.8,71.8 to 81.0,672
Hib,Primary Series,States/Local Areas,North Carolina,2012,Age,24 Months,95.5,92.0 to 97.7,271
Hib,Primary Series,States/Local Areas,North Carolina,2011,Age,24 Months,94.0,88.5 to 97.4,252
Hib,Primary Series,States/Local Areas,North Carolina,2016,Age,7 Months,80.5,74.0 to 85.6,352
Hib,Primary Series,States/Local Areas,North Carolina,2016-2017,Age,7 Months,79.3,74.3 to 83.5,644
Hib,Primary Series,States/Local Areas,North Carolina,2017,Age,7 Months,78.2,70.3 to 84.4,292
Hib,Primary Series,States/Local Areas,North Carolina,2017-2018,Age,7 Months,81.1,75.9 to 85.3,563
Hib,Primary Series,States/Local Areas,North Carolina,2012,Age,19 Months,95.4,92.4 to 97.3,271
Hib,Primary Series,States/Local Areas,North Carolina,2016,Age,19 Months,94.3,90.2 to 96.8,352
Hib,Primary Series,States/Local Areas,North Carolina,2016-2017,Age,19 Months,93.8,90.4 to 96.1,644
Hib,Primary Series,States/Local Areas,North Carolina,2013,Age,19 Months,91.5,89.7 to 93.1,271
Hib,Primary Series,States/Local Areas,North Carolina,2013-2014,Age,19 Months,91.1,89.2 to 92.7,558
Hib,Primary Series,States/Local Areas,North Carolina,2011,Age,19 Months,93.9,86.6 to 97.4,252
Hib,Primary Series,States/Local Areas,North Carolina,2014,Age,19 Months,90.7,83.5 to 94.9,287
Hib,Primary Series,States/Local Areas,North Carolina,2014-2015,Age,19 Months,92.4,88.6 to 95.1,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,95.5,91.7 to 97.9,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,94.0,88.5 to 97.4,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,93.2,87.1 to 97.1,292
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,94.8,91.4 to 97.1,563
PCV,≥2 Doses,States/Local Areas,North Carolina,2013,Age,5 Months,73.5,67.3 to 78.8,271
PCV,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,5 Months,76.9,74.6 to 79.1,558
PCV,≥2 Doses,States/Local Areas,North Carolina,2012,Age,5 Months,81.6,78.0 to 84.7,271
PCV,≥2 Doses,States/Local Areas,North Carolina,2011,Age,5 Months,82.0,78.0 to 85.4,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,96.4,92.7 to 98.6,320
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,96.6,93.6 to 98.4,672
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,96.7,93.2 to 98.7,352
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,94.9,91.4 to 97.3,644
DTaP,≥4 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,68.5,64.5 to 72.2,252
DTaP,≥4 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,73.3,66.1 to 79.5,271
Hib,Primary Series,States/Local Areas,North Carolina,2017,Age,13 Months,91.6,85.7 to 95.2,292
Hib,Primary Series,States/Local Areas,North Carolina,2017-2018,Age,13 Months,91.6,87.5 to 94.4,563
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016,Age,19 Months,76.5,69.8 to 82.2,352
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,19 Months,80.1,75.2 to 84.2,644
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,98.3,95.6 to 99.5,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2018,Age,24 Months,85.3,77.7 to 91.4,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,24 Months,88.4,83.8 to 92.2,585
Hep A,≥1 Dose,States/Local Areas,North Carolina,2019,Age,24 Months,91.6,86.2 to 95.5,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2011,Age,35 Months,91.4,84.0 to 96.3,252
Hib,≥3 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,92.5,88.3 to 95.6,320
Hib,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,93.1,89.9 to 95.6,672
Hib,≥3 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,93.7,89.3 to 96.7,352
Hib,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,91.8,88.0 to 94.8,644
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,97.9,95.0 to 99.3,314
Hib,≥3 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,89.8,83.5 to 94.4,292
Hib,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,90.9,86.7 to 94.2,563
Hib,≥3 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,93.3,87.0 to 97.2,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,95.7,92.1 to 97.9,585
Hep A,≥2 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,35.2,27.4 to 44.5,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,82.6,63.5 to 100.0,34
DTaP,≥4 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,70.9,64.9 to 76.3,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,70.1,66.2 to 73.7,558
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,69.3,61.0 to 76.5,287
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,71.5,66.2 to 76.3,607
DTaP,≥4 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,73.7,67.2 to 79.4,320
DTaP,≥4 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,71.6,66.5 to 76.2,672
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,93.3,89.9 to 96.7,419
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,96.0,93.7 to 98.2,673
Hib,≥3 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,94.1,89.7 to 97.0,352
Hib,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,93.6,89.9 to 96.3,644
Hib,≥3 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,93.0,86.7 to 97.0,292
Hib,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,93.4,89.2 to 96.5,563
Hep A,≥2 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,24.0,17.8 to 31.4,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,25.9,20.1 to 32.6,442
Hep A,≥2 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,27.8,21.0 to 35.7,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,33.2,25.4 to 42.6,252
Hep A,≥1 Dose,States/Local Areas,North Carolina,2017,Age,19 Months,83.6,76.1 to 89.1,292
Hep A,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,19 Months,83.8,78.5 to 88.0,563
Hep A,≥1 Dose,States/Local Areas,North Carolina,2018,Age,19 Months,84.1,75.9 to 89.9,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,19 Months,86.1,80.4 to 90.3,442
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,92.1,86.4 to 96.1,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,91.5,87.4 to 94.8,558
DTaP,≥3 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,97.2,93.5 to 99.0,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,95.0,89.5 to 98.2,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,91.0,84.5 to 95.5,287
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,93.6,90.0 to 96.3,607
Hep A,≥2 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,18.0,14.6 to 21.9,252
DTaP,≥2 Doses,States/Local Areas,North Carolina,2019,Age,5 Months,87.5,80.7 to 92.1,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,20.1,17.3 to 23.3,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,19.4,17.7 to 21.1,558
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,18.6,13.0 to 25.9,287
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,19.3,15.4 to 24.0,607
Hep A,≥2 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,17.7,12.5 to 24.3,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,92.0,86.0 to 96.1,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,94.7,91.3 to 97.1,585
Hib,≥3 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,97.4,94.7 to 99.0,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,20.1,17.2 to 23.3,320
Hep A,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,18.5,15.1 to 22.6,672
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,17.0,12.8 to 22.2,352
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,22.3,18.3 to 26.9,644
Hib,≥3 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,90.3,84.3 to 94.7,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,89.4,85.1 to 93.0,558
Hib,≥3 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,88.5,81.9 to 93.6,287
Hib,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,91.0,87.1 to 94.1,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,93.5,89.3 to 96.5,320
Hib,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,93.8,90.6 to 96.3,672
Hep A,≥2 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,27.6,21.2 to 35.2,292
Hep A,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,25.8,21.3 to 30.9,563
Hep A,≥1 Dose,States/Local Areas,North Carolina,2019,Age,19 Months,85.2,77.9 to 90.3,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2011,Age,24 Months,85.2,78.1 to 91.0,252
Hep A,≥1 Dose,States/Local Areas,North Carolina,2013,Age,24 Months,80.8,74.0 to 86.7,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,24 Months,78.9,73.9 to 83.5,558
Hep A,≥1 Dose,States/Local Areas,North Carolina,2012,Age,24 Months,82.7,75.6 to 88.7,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2015,Age,24 Months,81.9,75.4 to 87.6,320
Hep A,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,24 Months,82.2,77.7 to 86.3,672
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016,Age,24 Months,82.5,76.4 to 87.8,352
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,24 Months,84.6,80.2 to 88.6,644
PCV,≥2 Doses,States/Local Areas,North Carolina,2014,Age,5 Months,80.4,72.5 to 86.4,287
PCV,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,5 Months,81.3,78.8 to 83.6,607
PCV,≥2 Doses,States/Local Areas,North Carolina,2015,Age,5 Months,82.3,75.8 to 87.4,320
PCV,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,5 Months,80.5,75.7 to 84.6,672
PCV,≥2 Doses,States/Local Areas,North Carolina,2016,Age,5 Months,78.7,71.6 to 84.4,352
PCV,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,5 Months,79.2,74.0 to 83.6,644
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,96.3,93.0 to 98.3,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,97.2,95.2 to 98.5,585
DTaP,≥1 Dose,States/Local Areas,North Carolina,2013,Age,3 Months,87.3,83.4 to 90.4,271
DTaP,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,3 Months,88.4,86.3 to 90.3,558
DTaP,≥1 Dose,States/Local Areas,North Carolina,2014,Age,3 Months,89.5,82.6 to 93.9,287
DTaP,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,3 Months,90.1,86.0 to 93.1,607
DTaP,≥1 Dose,States/Local Areas,North Carolina,2015,Age,3 Months,90.7,85.2 to 94.3,320
DTaP,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,3 Months,90.7,86.8 to 93.6,672
DTaP,≥1 Dose,States/Local Areas,North Carolina,2016,Age,3 Months,90.8,85.4 to 94.3,352
DTaP,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,3 Months,90.9,86.9 to 93.8,644
Hib,≥1 Dose,States/Local Areas,North Carolina,2021,Age,3 Months,83.4,75.8 to 88.9,305
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.8,76.2 to 85.4,640
DTaP,≥1 Dose,States/Local Areas,North Carolina,2012,Age,3 Months,91.9,89.6 to 93.7,271
DTaP,≥1 Dose,States/Local Areas,North Carolina,2011,Age,3 Months,89.1,81.8 to 93.7,252
Combined 7 Series,,States/Local Areas,North Carolina,2021,Age,35 Months,77.4,69.4 to 84.7,305
PCV,≥2 Doses,States/Local Areas,North Carolina,2021,Age,5 Months,82.8,75.4 to 88.3,305
Polio,≥2 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,91.0,84.6 to 94.9,305
Hep B,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,96.0,94.0 to 97.3,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,96.1,93.7 to 97.6,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,74.1,66.2 to 80.7,305
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,92.1,89.2 to 94.3,764
DTaP,≥2 Doses,States/Local Areas,North Carolina,2017,Age,5 Months,80.5,72.5 to 86.6,292
DTaP,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,5 Months,84.9,79.9 to 88.8,563
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,91.9,86.5 to 97.3,180
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,88.9 to 96.4,469
DTaP,≥2 Doses,States/Local Areas,North Carolina,2016,Age,5 Months,81.1,74.0 to 86.6,352
DTaP,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,5 Months,80.8,75.6 to 85.1,644
DTaP,≥2 Doses,States/Local Areas,North Carolina,2018,Age,5 Months,89.5,83.0 to 93.6,271
DTaP,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,5 Months,88.5,84.1 to 91.8,585
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,91.6,85.3 to 95.9,292
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,93.9,90.4 to 96.5,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,96.3,93.0 to 98.3,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,97.1,95.1 to 98.4,585
Hep A,≥1 Dose,States/Local Areas,North Carolina,2017,Age,24 Months,86.7,80.0 to 92.0,292
Hep A,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,24 Months,86.0,81.0 to 90.2,563
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,96.4,94.0 to 98.8,379
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,91.8,87.8 to 95.9,474
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,91.2,87.0 to 95.4,302
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,92.7,90.4 to 95.0,1155
Hep A,≥1 Dose,States/Local Areas,North Carolina,2013,Age,19 Months,78.5,73.1 to 83.1,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,19 Months,75.6,69.5 to 80.9,558
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014,Age,19 Months,72.8,64.7 to 79.7,287
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,19 Months,73.3,67.8 to 78.1,607
Hep A,≥1 Dose,States/Local Areas,North Carolina,2015,Age,19 Months,73.7,68.3 to 78.4,320
Hep A,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,19 Months,75.1,70.1 to 79.5,672
Hep A,≥1 Dose,States/Local Areas,North Carolina,2012,Age,19 Months,78.0,75.8 to 80.1,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,95.9,92.5 to 98.1,352
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,93.8,90.2 to 96.4,644
DTaP,≥1 Dose,States/Local Areas,North Carolina,2019,Age,3 Months,95.8,91.4 to 98.0,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2011,Age,19 Months,73.9,69.8 to 77.7,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,92.2,88.1 to 95.0,459
DTaP,≥1 Dose,States/Local Areas,North Carolina,2017,Age,3 Months,91.0,84.5 to 95.0,292
DTaP,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,3 Months,91.3,86.8 to 94.3,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,91.0,84.5 to 95.5,287
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,93.3,89.7 to 95.9,607
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,95.6,92.1 to 97.8,320
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,95.8,92.9 to 97.7,672
DTaP,≥1 Dose,States/Local Areas,North Carolina,2018,Age,3 Months,91.5,84.2 to 95.6,271
DTaP,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,3 Months,93.6,89.7 to 96.1,585
Hib,Full Series,States/Local Areas,North Carolina,2021,Age,19 Months,74.6,66.8 to 81.1,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014,Age,24 Months,77.0,69.6 to 83.7,287
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,24 Months,79.4,74.5 to 83.8,607
Hep B,≥3 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,95.0,90.9 to 97.3,305
DTaP,≥4 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,89.1,84.6 to 92.7,764
≥1 Dose Varicella,,States/Local Areas,North Carolina,2021,Age,19 Months,95.2,91.1 to 97.5,305
Hib,Primary Series,States/Local Areas,North Carolina,2021,Age,7 Months,73.5,65.4 to 80.3,305
PCV,≥4 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,85.8,78.9 to 90.7,305
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,95.8,92.0 to 99.6,140
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,87.3,83.0 to 91.6,518
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,88.6 to 96.4,428
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,94.2 to 97.8,640
PCV,≥3 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,93.0,87.5 to 96.2,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,35 Months,92.2,88.4 to 95.1,764
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020-2021,Age,35 Months,95.5,92.8 to 97.4,764
Rotavirus,,States/Local Areas,North Carolina,2019-2020,Age,8 Months,81.6,77.1 to 85.3,773
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,85.4,80.8 to 90.0,518
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.4,62.8 to 84.0,428
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,79.9,71.1 to 88.7,140
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,91.5,85.7 to 97.3,140
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,78.3,70.7 to 86.0,518
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.8,91.5 to 98.2,428
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,94.9,92.0 to 97.7,518
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,85.6,76.8 to 94.4,140
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,78.8 to 90.5,428
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,84.1,79.2 to 88.9,518
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,95.0,92.1 to 97.9,518
Hib,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,3 Months,89.8,86.4 to 92.4,773
Polio,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,3 Months,91.4,88.0 to 93.9,773
DTaP,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,3 Months,92.7,89.7 to 94.9,773
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,94.7,92.2 to 96.4,773
Hib,Primary Series,States/Local Areas,North Carolina,2019-2020,Age,7 Months,79.5,75.0 to 83.4,773
Polio,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,96.2,93.6 to 97.7,773
DTaP,≥4 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,72.5,67.3 to 77.1,773
Hib,Primary Series,States/Local Areas,North Carolina,2021,Age,19 Months,94.9,90.4 to 97.3,305
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.2,88.5 to 99.8,109
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,59.2 to 82.3,143
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,91.4,84.9 to 97.9,194
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,88.9 to 96.6,428
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,95.0,90.9 to 99.0,140
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.6,90.1 to 97.1,428
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,93.9,90.6 to 97.2,518
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,90.1,84.3 to 95.9,140
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,79.5 to 89.9,428
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,82.0,72.9 to 91.1,140
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.8,66.2 to 79.4,428
Influenza,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,70.0,63.8 to 76.2,518
Influenza,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.4,63.1 to 75.7,428
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,77.9,72.1 to 83.7,518
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.8,73.9 to 85.6,428
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,89.8,83.1 to 96.4,140
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.4,78.7 to 90.1,428
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,86.4,81.9 to 90.9,518
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.8,90.4 to 97.1,428
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,89.2 to 96.4,518
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,89.9,84.1 to 95.8,140
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,79.1 to 90.1,428
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,75.5,63.0 to 87.9,140
Influenza,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,57.1,44.7 to 69.6,140
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.7,91.3 to 98.1,428
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,91.1 to 97.1,518
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,95.0,90.9 to 99.1,140
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,72.6 to 83.4,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,81.7,76.7 to 86.6,518
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,94.6,90.1 to 99.1,140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.6,68.2 to 81.0,428
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,93.8,90.2 to 97.3,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,91.5,86.2 to 96.9,140
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,97.9,96.0 to 99.7,403
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Overall,Overall,85.7,82.5 to 88.9,1086
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,94.4,90.9 to 98.0,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,80.6,74.1 to 87.2,256
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,95.8,93.3 to 98.3,403
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,67.4,59.7 to 75.1,256
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,94.3,90.8 to 97.9,427
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,84.9,80.1 to 89.7,403
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,79.6,73.7 to 85.5,427
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,98.0,96.1 to 99.8,403
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Overall,Overall,92.6,90.2 to 95.0,1086
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Overall,Overall,78.9,75.1 to 82.6,1086
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Overall,Overall,76.5,72.7 to 80.4,1086
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,76.1,70.1 to 82.1,1086
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,93.0,88.9 to 97.1,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Overall,Overall,80.2,76.7 to 83.8,1086
Influenza,,States/Local Areas,North Carolina,2016-2019,Overall,Overall,68.0,63.8 to 72.3,1086
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,91.4,87.1 to 95.7,256
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,93.9,90.2 to 97.5,427
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,80.0,69.7 to 90.2,427
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Overall,Overall,86.0,82.8 to 89.3,1086
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,91.6,84.4 to 98.7,403
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,81.1,74.6 to 87.5,256
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,86.7,83.7 to 89.7,1086
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,85.4,80.1 to 90.7,427
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Overall,Overall,93.0,90.8 to 95.3,1086
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,76.4,69.3 to 83.5,256
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,93.9,91.8 to 96.1,1086
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,92.0,88.5 to 95.4,403
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,94.4,92.4 to 96.5,1086
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,84.5,81.0 to 87.9,1086
Influenza,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,68.8,59.8 to 77.9,194
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,91.1,87.2 to 94.9,379
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.6 to 98.1,656
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.1 to 100.0,143
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,99.2,97.5 to 100.0,30
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.8,72.1 to 91.4,143
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,84.1,76.4 to 91.7,194
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.6,65.2 to 85.9,109
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.1,89.6 to 100.0,143
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,68.7,58.9 to 78.5,379
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,84.8,78.9 to 90.8,656
Polio,≥1 Dose,States/Local Areas,North Carolina,2020,Age,3 Months,88.9,83.9 to 92.4,459
Hib,≥1 Dose,States/Local Areas,North Carolina,2020,Age,3 Months,84.7,79.1 to 88.9,459
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,92.8,89.0 to 95.6,459
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,61.4,54.8 to 67.7,459
PCV,≥3 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,67.5,60.8 to 73.5,459
Polio,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,97.9,96.2 to 98.9,773
DTaP,≥4 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,93.6,90.2 to 96.1,773
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,97.8,96.2 to 98.9,773
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,97.3,95.5 to 98.4,773
Combined 7 Series,,States/Local Areas,North Carolina,2019-2020,Age,24 Months,76.4,71.8 to 80.7,773
PCV,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,93.7,91.0 to 95.6,773
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019-2020,Age,13 Months,70.2,64.9 to 75.0,773
Hib,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,93.5,90.5 to 95.6,773
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,91.9,88.4 to 94.3,773
Polio,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,93.2,90.0 to 95.5,773
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,72.0,66.7 to 76.7,773
PCV,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,5 Months,82.9,78.6 to 86.5,773
Hep B,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,5 Months,92.4,89.4 to 94.6,773
Hep B,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,96.7,94.9 to 97.9,773
Hib,Primary Series,States/Local Areas,North Carolina,2019-2020,Age,13 Months,93.0,90.3 to 95.0,773
Hib,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,96.2,93.9 to 97.6,773
Hib,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,65.9,60.5 to 70.8,773
≥1 Dose MMR,,States/Local Areas,North Carolina,2019-2020,Age,13 Months,75.3,70.3 to 79.7,773
Polio,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,13 Months,96.5,94.4 to 97.9,773
Hib,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,5 Months,81.3,76.7 to 85.1,773
Polio,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,5 Months,82.8,78.2 to 86.5,773
DTaP,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,5 Months,84.1,79.7 to 87.7,773
PCV,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,3 Months,91.0,87.8 to 93.5,773
Hep B,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,3 Months,97.4,95.5 to 98.5,773
≥1 Dose MMR,,States/Local Areas,North Carolina,2019-2020,Age,24 Months,95.1,92.6 to 97.0,773
Polio,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,97.5,95.7 to 98.6,773
DTaP,≥4 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,86.1,82.1 to 89.6,773
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,97.6,96.0 to 98.7,773
PCV,≥4 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,93.4,90.7 to 95.5,773
PCV,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,96.1,94.0 to 97.7,773
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019-2020,Age,35 Months,96.4,93.9 to 98.0,773
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,94.7,91.6 to 96.9,773
Hib,Primary Series,States/Local Areas,North Carolina,2019-2020,Age,35 Months,96.7,94.7 to 98.1,773
Hib,Full Series,States/Local Areas,North Carolina,2019-2020,Age,35 Months,90.6,87.2 to 93.3,773
Hib,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,97.0,95.0 to 98.3,773
≥1 Dose MMR,,States/Local Areas,North Carolina,2019-2020,Age,35 Months,96.6,94.3 to 98.1,773
Hib,Primary Series,States/Local Areas,North Carolina,2019-2020,Age,19 Months,96.2,94.0 to 97.6,773
Hib,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,91.0,87.3 to 93.7,773
Hep A,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,23.5,19.3 to 28.2,773
≥1 Dose MMR,,States/Local Areas,North Carolina,2019-2020,Age,19 Months,92.4,88.9 to 94.8,773
PCV,≥4 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,91.2,88.2 to 93.7,773
PCV,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,96.0,93.9 to 97.6,773
PCV,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,70.4,65.2 to 75.2,773
Hib,Full Series,States/Local Areas,North Carolina,2019-2020,Age,24 Months,86.7,83.0 to 90.0,773
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2019-2020,Age,0-3 Days,87.7,84.1 to 90.6,773
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,94.2,91.2 to 96.4,773
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019-2020,Age,24 Months,94.6,92.0 to 96.6,773
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2019-2020,Age,0-2 Days,86.0,82.1 to 89.2,773
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2019-2020,Age,0-1 Days,84.2,80.1 to 87.7,773
Hep A,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,19 Months,83.8,79.4 to 87.4,773
PCV,≥4 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,86.5,82.5 to 89.7,773
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,92.6,89.1 to 95.0,773
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019-2020,Age,19 Months,92.8,89.5 to 95.2,773
Hib,Full Series,States/Local Areas,North Carolina,2019-2020,Age,19 Months,79.7,75.0 to 83.7,773
Hib,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,44.5,39.2 to 50.0,773
Combined 7 Series,,States/Local Areas,North Carolina,2019-2020,Age,35 Months,82.2,77.6 to 86.2,773
Hib,Primary Series,States/Local Areas,North Carolina,2019-2020,Age,24 Months,96.6,94.6 to 98.0,773
Hib,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,96.5,94.6 to 97.9,773
Influenza,,States/Local Areas,North Carolina,2019-2020,Age,24 Months,61.1,55.7 to 66.5,773
Hep A,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,35 Months,92.3,88.8 to 95.0,773
Hep A,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,35 Months,77.8,71.8 to 83.3,773
Hep A,≥1 Dose,States/Local Areas,North Carolina,2019-2020,Age,24 Months,88.5,84.9 to 91.6,773
Hep A,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,24 Months,39.6,34.5 to 45.3,773
Polio,≥2 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,95.6,92.4 to 97.5,459
Combined 7 Series,,States/Local Areas,North Carolina,2020,Age,35 Months,71.9,65.3 to 78.2,459
Hep A,≥2 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,75.4,68.2 to 82.1,459
Hep A,≥2 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,19.4,15.0 to 24.7,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2020,Age,0-1 Days,82.7,77.4 to 87.0,459
Hep A,≥1 Dose,States/Local Areas,North Carolina,2020,Age,19 Months,81.6,75.7 to 86.3,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2020,Age,0-2 Days,83.6,78.3 to 87.8,459
Hib,≥2 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,90.8,86.4 to 93.9,459
DTaP,≥1 Dose,States/Local Areas,North Carolina,2020,Age,3 Months,89.4,84.5 to 92.9,459
Polio,≥2 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,91.6,87.4 to 94.5,459
Hib,≥3 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,42.1,35.7 to 48.8,459
Hib,Primary Series,States/Local Areas,North Carolina,2020,Age,7 Months,73.2,66.9 to 78.8,459
Hep B,≥2 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,92.6,88.6 to 95.2,459
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,97.4,95.4 to 98.7,459
DTaP,≥4 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,79.6,73.6 to 85.0,459
Polio,≥3 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,96.8,94.5 to 98.2,459
≥1 Dose MMR,,States/Local Areas,North Carolina,2020,Age,24 Months,92.0,87.6 to 95.3,459
Hib,≥3 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,95.4,92.4 to 97.4,459
Hib,Primary Series,States/Local Areas,North Carolina,2020,Age,24 Months,96.0,93.2 to 97.9,459
≥1 Dose MMR,,States/Local Areas,North Carolina,2020,Age,35 Months,94.1,89.9 to 97.0,459
Hib,Primary Series,States/Local Areas,North Carolina,2020,Age,35 Months,96.0,93.2 to 97.9,459
Hib,≥3 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,95.7,92.8 to 97.7,459
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,93.4,89.6 to 96.1,459
Hib,Full Series,States/Local Areas,North Carolina,2020,Age,35 Months,86.6,81.0 to 91.2,459
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020,Age,35 Months,93.8,89.3 to 96.9,459
Hib,Primary Series,States/Local Areas,North Carolina,2020,Age,19 Months,96.0,92.9 to 97.7,459
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,92.5,88.4 to 95.2,459
Hib,Full Series,States/Local Areas,North Carolina,2020,Age,19 Months,74.7,68.2 to 80.2,459
PCV,≥3 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,94.1,90.5 to 96.5,459
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020,Age,19 Months,90.9,85.9 to 94.2,459
DTaP,≥4 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,88.1,82.0 to 92.9,459
Polio,≥3 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,96.9,94.7 to 98.4,459
PCV,≥4 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,82.5,76.6 to 87.1,459
PCV,≥3 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,94.3,90.9 to 96.8,459
PCV,≥4 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,90.1,85.6 to 93.7,459
Hib,≥3 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,66.1,59.6 to 72.1,459
Hib,Primary Series,States/Local Areas,North Carolina,2020,Age,13 Months,90.6,86.3 to 93.6,459
Hep B,≥2 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,94.8,91.4 to 96.9,459
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,91.3,87.2 to 94.1,459
PCV,≥3 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,90.7,86.2 to 93.8,459
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020,Age,13 Months,70.5,64.0 to 76.3,459
PCV,≥2 Doses,States/Local Areas,North Carolina,2020,Age,5 Months,77.8,71.7 to 83.0,459
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020,Age,7 Months,70.3,63.7 to 76.2,459
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,96.9,94.5 to 98.2,459
DTaP,≥4 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,66.8,60.0 to 72.9,459
Polio,≥3 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,96.3,93.7 to 97.9,459
≥1 Dose MMR,,States/Local Areas,North Carolina,2020,Age,19 Months,89.8,84.6 to 93.4,459
Hib,≥3 Doses,States/Local Areas,North Carolina,2020,Age,19 Months,89.6,84.5 to 93.2,459
Influenza,,States/Local Areas,North Carolina,2020,Age,24 Months,52.7,46.2 to 59.5,459
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2020,Age,0-3 Days,84.3,79.0 to 88.4,459
Rotavirus,,States/Local Areas,North Carolina,2020,Age,8 Months,75.7,69.3 to 81.2,459
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020,Age,35 Months,97.4,95.4 to 98.7,459
PCV,≥3 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,94.2,90.8 to 96.7,459
PCV,≥4 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,87.5,82.7 to 91.5,459
Hep A,≥1 Dose,States/Local Areas,North Carolina,2020,Age,24 Months,84.4,79.0 to 89.1,459
Hep A,≥2 Doses,States/Local Areas,North Carolina,2020,Age,24 Months,36.3,30.3 to 43.1,459
PCV,≥1 Dose,States/Local Areas,North Carolina,2020,Age,3 Months,86.5,81.2 to 90.4,459
Combined 7 Series,,States/Local Areas,North Carolina,2020,Age,24 Months,66.5,60.1 to 72.8,459
Hep B,≥1 Dose,States/Local Areas,North Carolina,2020,Age,3 Months,96.3,92.8 to 98.2,459
Polio,≥2 Doses,States/Local Areas,North Carolina,2020,Age,5 Months,80.3,74.3 to 85.1,459
DTaP,≥2 Doses,States/Local Areas,North Carolina,2020,Age,5 Months,80.8,74.9 to 85.6,459
Hib,≥2 Doses,States/Local Areas,North Carolina,2020,Age,5 Months,76.2,69.9 to 81.6,459
Hep B,≥2 Doses,States/Local Areas,North Carolina,2020,Age,5 Months,90.4,86.0 to 93.5,459
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,90.4,87.1 to 93.8,656
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.2,87.6 to 98.8,109
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,93.5,88.2 to 98.9,194
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,83.1,66.5 to 99.7,30
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.2,94.2 to 98.1,640
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.4,85.8 to 93.1,640
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,92.6,89.2 to 96.0,379
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,83.1,66.5 to 99.7,30
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,96.7,94.7 to 98.7,656
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,79.7,62.3 to 97.1,30
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,82.6,77.5 to 87.8,379
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.7,85.0 to 92.4,640
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.1,71.5 to 90.6,109
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,86.4,79.5 to 93.4,194
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,82.9,66.3 to 99.5,30
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,92.8,89.2 to 96.3,379
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,94.0,86.0 to 100.0,30
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,79.4,73.6 to 85.1,379
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.4,84.8 to 97.9,109
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.2 to 97.6,656
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,93.7 to 97.8,640
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,86.8,79.6 to 93.9,194
Influenza,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.5,52.5 to 76.5,143
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,91.7,88.0 to 95.4,379
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.0,87.4 to 98.6,109
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,93.7 to 97.7,640
Influenza,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",55.7,43.9 to 67.5,109
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.4,89.7 to 100.0,143
Influenza,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.0,68.9 to 79.1,640
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.5,77.8 to 93.2,109
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,84.4,77.3 to 91.5,194
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,70.0,49.4 to 90.6,30
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.5,64.8 to 86.1,143
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,97.7,94.3 to 100.0,30
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.1,85.5 to 92.6,640
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,88.3,74.9 to 100.0,30
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,78.2,69.8 to 86.5,194
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.3,63.9 to 84.8,109
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.0,75.4 to 84.7,640
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,74.0,65.1 to 82.9,194
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,69.1,48.4 to 89.9,30
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.7,77.7 to 93.8,109
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,72.5,66.5 to 78.6,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,69.4 to 90.2,143
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,69.2,48.2 to 90.2,30
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.5,82.6 to 90.5,640
Influenza,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,58.6,51.9 to 65.2,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,79.1,71.0 to 87.1,194
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,92.0,86.3 to 97.7,194
Influenza,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,80.6,75.9 to 85.3,656
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.3,73.3 to 93.2,143
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,62.0,40.6 to 83.4,30
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,87.4,83.4 to 91.5,656
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.1 to 99.0,656
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.0 to 94.7,379
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,93.3,84.1 to 100.0,30
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,91.7 to 100.0,143
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,95.4,92.9 to 97.9,656
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,81.6,62.1 to 100.0,30
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.7,82.6 to 96.9,109
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,91.8,86.3 to 97.3,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,78.6,73.0 to 84.2,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.3,70.9 to 89.7,109
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,82.2,77.9 to 86.5,656
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.8,54.3 to 77.2,109
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,83.5,79.5 to 87.5,656
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.3,85.0 to 97.6,109
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,92.2 to 97.1,640
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,89.7 to 100.0,143
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.8,81.9 to 89.7,640
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,91.6 to 96.6,640
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,86.3 to 99.4,143
Hib,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,94.7,92.5 to 96.4,764
Hep B,≥2 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,94.1,89.7 to 96.7,305
PCV,≥4 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,88.0,84.3 to 91.2,764
Hib,≥2 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,90.3,83.8 to 94.4,305
≥1 Dose MMR,,States/Local Areas,North Carolina,2021,Age,35 Months,96.1,93.3 to 98.0,305
PCV,≥3 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,96.3,92.1 to 98.6,305
Hib,≥3 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,44.0,35.9 to 52.4,305
Hib,≥2 Doses,States/Local Areas,North Carolina,2020,Age,13 Months,94.9,91.2 to 97.0,459
Hib,≥2 Doses,States/Local Areas,North Carolina,2021,Age,5 Months,76.5,68.5 to 83.0,305
Hib,Primary Series,States/Local Areas,North Carolina,2020-2021,Age,24 Months,96.2,94.3 to 97.6,764
Hib,≥3 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,91.0,85.4 to 94.6,305
Combined 7 Series,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,72.4,66.2 to 78.7,379
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,93.0,89.6 to 96.3,379
Influenza,,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,90.5,86.8 to 94.2,403
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,78.8,72.4 to 85.1,256
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,94.0,91.0 to 97.1,403
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,83.0,76.9 to 89.0,256
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,84.5,79.3 to 89.7,427
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,91.2,87.4 to 95.0,403
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,92.6,88.8 to 96.4,256
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,90.8,86.4 to 95.2,256
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,93.5,90.4 to 96.7,403
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,89.4,84.5 to 94.2,256
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,92.3,88.5 to 96.2,427
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,97.5,95.6 to 99.4,403
Influenza,,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,54.1,46.2 to 62.0,256
Influenza,,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,66.6,59.7 to 73.5,427
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,94.2,92.1 to 96.3,1086
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Overall,Overall,95.0,93.0 to 97.0,1086
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,92.6,88.6 to 96.5,427
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,93.5,89.9 to 97.2,256
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,97.1,94.9 to 99.2,403
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,63.1,53.8 to 72.3,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,78.7,72.9 to 84.5,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,82.0,76.4 to 87.7,403
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,88.8,84.4 to 93.3,427
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,94.7,92.1 to 97.3,403
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,88.2 to 95.4,518
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Poverty,<133% FPL,69.7,62.5 to 76.9,256
Rotavirus,,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,79.0,72.7 to 85.3,427
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Urbanicity,Living In a Non-MSA,96.9,93.6 to 100.0,140
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.1,92.1 to 96.1,637
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,90.5 to 97.0,285
Hib,≥3 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,59.3,51.3 to 66.8,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,82.8,71.8 to 93.7,48
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.4,82.2 to 94.6,123
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.4,83.1 to 89.8,637
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,84.6 to 93.8,285
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.5,70.9 to 88.1,124
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Overall,Overall,86.2,83.4 to 89.0,830
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,86.0,82.3 to 89.6,421
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,92.6,87.9 to 95.5,230
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,92.4,89.4 to 94.7,447
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,84.0,67.7 to 92.9,237
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,88.4,82.4 to 92.6,467
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,94.6,90.5 to 97.0,293
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,91.8,88.3 to 94.3,556
Hib,≥3 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,74.3,67.2 to 80.3,217
Hib,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,72.2,67.0 to 76.8,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,92.9,90.9 to 94.5,294
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,89.3,79.7 to 94.7,237
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,91.7,88.3 to 94.2,467
DTaP,≥3 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,90.9,88.8 to 92.7,299
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,88.9,82.9 to 92.9,263
Polio,≥3 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,93.0,88.4 to 95.8,230
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,93.7,90.8 to 95.7,447
Polio,≥3 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,88.0,77.6 to 94.0,237
Polio,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,90.6,87.3 to 93.1,467
Hib,≥3 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,63.8,56.2 to 70.7,298
Hib,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,67.0,61.5 to 72.1,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,70.0,62.4 to 76.6,227
Hib,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,67.0,61.7 to 71.9,525
Hib,≥3 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,87.8,86.8 to 88.7,299
Hib,≥3 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,91.9,90.1 to 93.4,294
Hib,≥3 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,75.1,67.9 to 81.2,263
Polio,≥3 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,94.4,90.7 to 96.6,217
Polio,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,92.9,89.6 to 95.2,444
Polio,≥3 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,91.4,87.4 to 94.2,294
Hib,Full Series,States/Local Areas,North Carolina,2021,Age,24 Months,79.6,72.7 to 85.7,305
Hep A,≥2 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,76.2,65.3 to 85.7,305
Polio,≥3 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,89.6,84.2 to 93.3,298
Polio,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,92.0,88.7 to 94.4,591
Polio,≥3 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,91.3,86.2 to 94.7,227
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,90.5,87.0 to 93.1,525
Hib,≥3 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,70.4,62.4 to 77.4,293
Hib,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,72.8,67.4 to 77.5,556
DTaP,≥4 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,75.6,67.8 to 82.0,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2021,Age,35 Months,97.4,87.7 to 99.8,305
PCV,≥3 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,94.0,88.5 to 96.9,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2021,Age,24 Months,88.1,82.3 to 92.7,305
DTaP,≥3 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,95.3,90.8 to 97.7,305
Hep A,≥2 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,44.9,36.5 to 54.4,305
PCV,≥3 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,73.4,65.4 to 80.0,305
PCV,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,5 Months,80.4,75.7 to 84.3,764
Hib,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,64.2,59.0 to 69.2,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,92.8,87.4 to 96.0,305
Hep B,≥3 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,95.3,91.6 to 97.7,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2021,Age,19 Months,85.5,78.8 to 90.4,305
Polio,≥2 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,97.0,94.0 to 98.5,305
Hep A,≥2 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,28.2,21.5 to 36.2,305
DTaP,≥4 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,83.2,76.8 to 88.7,305
PCV,≥4 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,88.8,82.9 to 93.4,305
DTaP,≥1 Dose,States/Local Areas,North Carolina,2021,Age,3 Months,89.5,82.7 to 93.8,305
Hep B,≥3 Doses,States/Local Areas,North Carolina,2021,Age,7 Months,70.0,61.9 to 77.0,305
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,95.3,93.0 to 97.1,764
Polio,≥3 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,96.5,93.6 to 98.3,305
Hib,Primary Series,States/Local Areas,North Carolina,2021,Age,24 Months,96.4,93.5 to 98.2,305
≥1 Dose MMR,,States/Local Areas,North Carolina,2021,Age,24 Months,96.1,93.3 to 98.0,305
Hib,≥3 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,94.1,90.5 to 96.7,305
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2021,Age,0-1 Days,84.4,77.9 to 89.2,305
Hib,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,95.6,93.4 to 97.2,764
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2021,Age,0-2 Days,85.4,79.0 to 90.1,305
≥1 Dose Varicella,,States/Local Areas,North Carolina,2021,Age,24 Months,95.1,91.4 to 97.5,305
PCV,≥3 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,94.2,89.4 to 97.4,305
PCV,≥4 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,88.6,82.7 to 93.2,305
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,92.3,87.7 to 95.3,217
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,90.9,87.4 to 93.5,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,85.4,79.3 to 89.9,298
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,89.9,86.3 to 92.6,591
Hib,≥2 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,89.9,84.4 to 93.6,263
PCV,≥3 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,94.3,90.5 to 96.9,227
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,93.7,90.9 to 95.9,525
PCV,≥3 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,94.6,90.9 to 97.1,217
PCV,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,94.4,91.7 to 96.5,444
PCV,≥3 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,93.6,89.2 to 96.6,230
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,94.2,91.5 to 96.3,447
Hib,≥2 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,92.5,87.2 to 95.7,293
Hib,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,91.2,87.6 to 93.8,556
Polio,≥1 Dose,States/Local Areas,North Carolina,2021,Age,3 Months,88.2,81.1 to 92.8,305
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,81.5,74.9 to 88.1,155
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,86.2,81.9 to 90.4,408
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,89.9,86.0 to 93.9,267
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.4 to 97.0,562
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,91.0,86.8 to 95.2,209
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,87.5,75.4 to 99.7,48
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,88.4 to 98.8,123
Hib,≥3 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,51.0,42.7 to 59.2,293
Hib,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,55.1,49.3 to 60.7,556
Hib,≥3 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,45.1,37.9 to 52.5,298
Hib,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,47.9,42.4 to 53.5,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,95.6,91.7 to 98.1,294
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,86.9,74.5 to 99.2,48
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.6 to 98.1,123
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,93.1 to 96.7,637
PCV,≥3 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,88.6,82.2 to 93.5,237
PCV,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,91.1,87.4 to 94.1,467
PCV,≥3 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,93.4,88.6 to 96.7,299
PCV,≥3 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,93.1,88.1 to 96.5,263
Hib,≥2 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,93.2,88.1 to 96.2,217
Hib,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,93.3,90.0 to 95.5,444
PCV,≥3 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,96.8,93.3 to 98.8,293
PCV,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,95.0,92.1 to 97.1,556
Polio,≥1 Dose,States/Local Areas,North Dakota,2011,Age,3 Months,89.0,87.1 to 90.6,299
Polio,≥1 Dose,States/Local Areas,North Dakota,2012,Age,3 Months,87.3,82.1 to 91.1,294
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,94.0,92.1 to 95.8,830
PCV,≥1 Dose,States/Local Areas,North Dakota,2019,Age,3 Months,95.1,91.4 to 97.2,263
Polio,≥1 Dose,States/Local Areas,North Dakota,2013,Age,3 Months,84.8,66.4 to 94.0,237
Polio,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,3 Months,86.6,80.2 to 91.1,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2013,Age,0-3 Days,82.8,75.2 to 88.4,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2013-2014,Age,0-3 Days,83.7,79.0 to 87.5,467
DTaP,≥3 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,68.7,66.2 to 71.1,299
DTaP,≥3 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,72.7,68.5 to 76.6,294
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,70.9,62.1 to 78.4,237
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,71.8,67.5 to 75.8,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014,Age,0-3 Days,84.6,78.3 to 89.3,230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2015,Age,0-3 Days,86.4,82.2 to 89.7,447
PCV,≥1 Dose,States/Local Areas,North Dakota,2015,Age,3 Months,90.8,84.8 to 94.5,217
PCV,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,3 Months,90.5,86.6 to 93.4,444
PCV,≥1 Dose,States/Local Areas,North Dakota,2014,Age,3 Months,84.2,77.7 to 89.0,230
PCV,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,3 Months,87.5,83.3 to 90.7,447
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,73.0 to 88.9,123
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.6,85.8 to 91.5,637
PCV,≥3 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,93.1,88.5 to 96.3,298
PCV,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,94.9,92.1 to 96.9,591
Hib,≥2 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,88.7,83.6 to 92.3,294
PCV,≥3 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,94.3,90.5 to 96.9,227
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,93.7,90.9 to 95.9,525
Hib,≥2 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,89.0,87.4 to 90.4,299
Hib,≥2 Doses,States/Local Areas,North Dakota,2019,Age,5 Months,85.0,78.6 to 89.8,263
Hib,≥2 Doses,States/Local Areas,North Dakota,2018,Age,5 Months,83.3,76.6 to 88.3,293
Hib,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,5 Months,84.1,79.7 to 87.8,556
PCV,≥1 Dose,States/Local Areas,North Dakota,2017,Age,3 Months,85.0,78.7 to 89.7,298
PCV,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,3 Months,88.8,84.9 to 91.8,591
PCV,≥1 Dose,States/Local Areas,North Dakota,2016,Age,3 Months,90.3,84.8 to 93.9,227
PCV,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,3 Months,87.7,83.7 to 90.8,525
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,95.4,93.3 to 97.5,562
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,95.0,88.9 to 100.0,42
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,95.6,91.5 to 98.1,248
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,93.5,90.2 to 96.8,285
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.3,90.1 to 98.5,124
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,94.2,91.8 to 96.7,421
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,91.0,86.9 to 95.2,209
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,86.0,83.2 to 88.8,830
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,84.4,80.2 to 88.6,421
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.7,75.1 to 90.3,124
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,77.3,70.0 to 84.6,155
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,86.9,82.9 to 90.9,408
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,91.0,87.3 to 94.8,267
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,89.4,83.9 to 93.2,227
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,87.5,83.5 to 90.6,525
DTaP,≥3 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,86.5,83.0 to 89.3,299
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,68.8,61.5 to 75.2,298
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,72.5,67.3 to 77.2,591
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,78.2,71.4 to 83.8,263
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018,Age,7 Months,76.5,69.0 to 82.7,293
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,7 Months,77.4,72.4 to 81.7,556
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,82.1,76.5 to 87.6,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,89.4,86.1 to 92.6,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,72.7,56.5 to 88.8,42
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2019,Age,0-3 Days,86.2,79.1 to 91.2,263
Polio,≥1 Dose,States/Local Areas,North Dakota,2019,Age,3 Months,93.3,89.4 to 95.9,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2018,Age,0-3 Days,85.6,79.0 to 90.4,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2018-2019,Age,0-3 Days,85.9,81.2 to 89.6,556
PCV,≥3 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,95.0,90.1 to 98.0,263
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,95.0,88.9 to 100.0,42
Hib,≥2 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,92.6,87.2 to 95.8,263
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,93.4,91.4 to 95.3,830
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,89.6,84.4 to 94.8,155
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.9,84.1 to 95.7,124
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,94.3,91.7 to 96.9,421
Hib,≥2 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,93.6,89.4 to 96.2,298
Hib,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,94.5,91.7 to 96.4,591
Hib,≥2 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,95.4,91.1 to 97.7,293
Hib,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,94.0,90.8 to 96.1,556
DTaP,≥3 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,89.0,85.0 to 92.1,294
Hib,≥3 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,80.7,74.4 to 85.8,294
Hib,≥3 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,81.9,79.7 to 83.8,299
Hib,≥3 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,64.0,55.8 to 71.4,230
Hib,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,69.1,63.7 to 74.1,447
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,93.7,90.8 to 96.5,408
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,95.9,93.3 to 98.4,267
Polio,≥3 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,88.2,86.1 to 89.9,299
Hib,≥3 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,71.2,51.4 to 85.3,237
Hib,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,67.5,56.2 to 77.0,467
Hib,≥2 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,92.8,87.9 to 95.8,230
Hib,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,93.9,91.1 to 95.9,447
Hib,≥2 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,95.0,91.0 to 97.3,227
Hib,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,94.3,91.7 to 96.2,525
Hib,≥2 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,95.1,91.4 to 97.3,217
Hib,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,95.1,92.3 to 96.9,444
Polio,≥1 Dose,States/Local Areas,North Dakota,2018,Age,3 Months,90.2,84.2 to 94.1,293
Polio,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,3 Months,91.8,88.3 to 94.3,556
Polio,≥1 Dose,States/Local Areas,North Dakota,2017,Age,3 Months,85.7,79.7 to 90.2,298
Polio,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,3 Months,87.9,83.9 to 91.1,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,49.7,41.8 to 57.6,227
Hib,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,47.5,42.1 to 52.9,525
Hib,≥3 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,51.3,43.4 to 59.1,217
Hib,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,50.5,44.8 to 56.2,444
Hib,≥3 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,45.6,38.0 to 53.4,230
Hib,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,48.5,42.9 to 54.0,447
PCV,≥3 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,97.5,93.8 to 99.3,293
PCV,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,96.2,93.4 to 98.0,556
PCV,≥3 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,93.1,88.5 to 96.3,298
PCV,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,95.2,92.4 to 97.2,591
Hib,≥2 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,91.0,80.0 to 96.2,237
Hib,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,91.9,87.7 to 94.7,467
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,73.3,65.9 to 79.6,227
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,71.1,65.9 to 75.8,525
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2015,Age,0-3 Days,88.2,82.2 to 92.3,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2015-2016,Age,0-3 Days,87.2,83.2 to 90.4,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,72.6,64.7 to 79.4,230
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,72.4,67.0 to 77.2,447
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015,Age,7 Months,72.1,64.4 to 78.7,217
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,7 Months,72.7,67.4 to 77.4,444
Hib,≥2 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,94.9,93.2 to 96.1,299
Hib,≥2 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,93.3,90.9 to 95.1,294
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016,Age,0-3 Days,86.2,80.2 to 90.7,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2017,Age,0-3 Days,85.4,81.3 to 88.8,525
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2017,Age,0-3 Days,84.7,74.9 to 91.1,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2017-2018,Age,0-3 Days,85.1,80.8 to 88.6,591
Polio,≥1 Dose,States/Local Areas,North Dakota,2016,Age,3 Months,91.6,87.1 to 94.7,227
Polio,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,3 Months,88.8,85.1 to 91.6,525
Polio,≥1 Dose,States/Local Areas,North Dakota,2015,Age,3 Months,92.2,86.9 to 95.5,217
Polio,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,3 Months,91.9,88.5 to 94.4,444
Polio,≥1 Dose,States/Local Areas,North Dakota,2014,Age,3 Months,88.3,82.3 to 92.4,230
Polio,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,3 Months,90.2,86.4 to 93.0,447
Hib,≥3 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,52.3,39.1 to 65.3,237
Hib,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,48.9,41.7 to 56.1,467
Hib,≥3 Doses,States/Local Areas,North Dakota,2011,Age,7 Months,65.0,62.0 to 67.9,299
Hib,≥3 Doses,States/Local Areas,North Dakota,2012,Age,7 Months,65.6,59.4 to 71.3,294
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,93.8,91.0 to 96.6,408
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,95.9,93.5 to 98.2,267
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,92.0,87.5 to 96.5,155
Hib,≥2 Doses,States/Local Areas,North Dakota,2017,Age,7 Months,86.3,80.2 to 90.8,298
Hib,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,7 Months,89.3,85.5 to 92.2,591
Hib,≥2 Doses,States/Local Areas,North Dakota,2016,Age,7 Months,93.3,89.1 to 96.0,227
Hib,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,7 Months,89.9,86.4 to 92.6,525
Hib,≥2 Doses,States/Local Areas,North Dakota,2011,Age,5 Months,78.7,74.7 to 82.2,299
Hib,≥2 Doses,States/Local Areas,North Dakota,2012,Age,5 Months,78.6,73.7 to 82.8,294
PCV,≥3 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,90.2,84.5 to 93.9,298
PCV,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,93.0,89.7 to 95.3,591
Hib,≥2 Doses,States/Local Areas,North Dakota,2014,Age,5 Months,77.7,70.0 to 83.9,230
Hib,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,5 Months,79.5,77.1 to 81.7,447
Hib,≥2 Doses,States/Local Areas,North Dakota,2013,Age,5 Months,77.6,64.3 to 86.9,237
Hib,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,5 Months,77.6,71.1 to 83.0,467
PCV,≥3 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,93.4,88.6 to 96.7,299
PCV,≥3 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,92.0,85.9 to 95.5,263
PCV,≥3 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,96.0,91.9 to 98.1,293
PCV,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,93.1,89.7 to 95.4,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,89.1,84.9 to 93.4,285
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2012,Age,0-3 Days,84.2,77.6 to 89.1,294
Hib,≥2 Doses,States/Local Areas,North Dakota,2014,Age,7 Months,90.2,84.8 to 93.8,230
Hib,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,7 Months,91.7,88.3 to 94.2,447
Hib,≥2 Doses,States/Local Areas,North Dakota,2013,Age,7 Months,84.8,67.4 to 93.8,237
Hib,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,7 Months,87.6,81.4 to 92.0,467
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Overall,Overall,93.0,91.0 to 95.0,830
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,91.2,86.2 to 96.1,155
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.2,86.7 to 97.6,124
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,92.9,90.1 to 95.7,421
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,94.0,91.2 to 96.8,408
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,92.3,88.7 to 95.8,267
PCV,≥1 Dose,States/Local Areas,North Dakota,2011,Age,3 Months,87.7,85.1 to 89.9,299
Hib,≥2 Doses,States/Local Areas,North Dakota,2016,Age,5 Months,83.9,77.8 to 88.6,227
Hib,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,5 Months,81.5,77.1 to 85.2,525
Hib,≥2 Doses,States/Local Areas,North Dakota,2015,Age,5 Months,81.2,74.1 to 86.7,217
Hib,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,5 Months,82.5,77.9 to 86.4,444
PCV,≥4 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,88.0,82.0 to 92.7,263
Hib,Full Series,States/Local Areas,North Dakota,2020,Age,24 Months,80.9,72.9 to 87.8,248
PCV,≥4 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,94.7,89.6 to 97.8,293
PCV,≥4 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,91.4,87.4 to 94.6,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,80.7,73.9 to 86.7,298
PCV,≥4 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,87.9,83.4 to 91.6,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,87.9,81.5 to 92.9,237
PCV,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,90.2,86.4 to 93.3,467
Hib,≥2 Doses,States/Local Areas,North Dakota,2017,Age,5 Months,79.0,72.3 to 84.4,298
Hib,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,5 Months,81.1,76.5 to 84.9,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,94.5,90.2 to 97.4,294
PCV,≥3 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,92.3,87.9 to 95.6,230
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,93.4,90.7 to 95.6,447
PCV,≥3 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,94.6,90.9 to 97.1,217
PCV,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,94.4,91.7 to 96.5,444
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,78.8,72.5 to 85.2,209
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,81.8,68.7 to 94.8,42
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,82.7,69.7 to 95.7,48
PCV,≥1 Dose,States/Local Areas,North Dakota,2013,Age,3 Months,85.5,65.6 to 94.8,237
PCV,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,3 Months,84.8,76.2 to 90.7,467
PCV,≥1 Dose,States/Local Areas,North Dakota,2018,Age,3 Months,92.8,87.5 to 96.0,293
PCV,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,3 Months,93.9,90.9 to 96.0,556
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2011,Age,0-3 Days,88.2,82.7 to 92.2,299
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,90.6,87.7 to 93.5,562
PCV,≥3 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,91.5,86.4 to 94.7,230
PCV,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,93.0,90.0 to 95.2,447
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,96.4,93.4 to 98.3,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,96.7,92.6 to 98.9,293
Hep B,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,96.5,94.2 to 98.1,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,90.1,85.0 to 94.0,230
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,90.0,86.4 to 93.0,447
PCV,≥4 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,90.1,84.6 to 94.3,217
PCV,≥4 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,89.4,85.6 to 92.6,444
PCV,≥4 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,88.9,83.6 to 93.1,227
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,84.8,80.6 to 88.6,525
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,91.5,87.2 to 95.7,209
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,94.3,91.9 to 96.6,562
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,87.0,74.3 to 99.7,48
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.6 to 98.3,123
PCV,≥3 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,92.3,87.2 to 95.5,227
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,91.3,87.7 to 93.9,525
PCV,≥3 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,94.6,91.2 to 96.7,217
PCV,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,93.5,90.3 to 95.7,444
Hep B,≥2 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,97.7,94.8 to 99.0,263
Hep B,≥2 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,95.7,92.0 to 97.8,293
Hep B,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,96.7,94.5 to 98.0,556
Hep B,≥2 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,94.2,90.3 to 96.6,298
Hep B,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,94.9,92.4 to 96.6,591
Hib,≥1 Dose,States/Local Areas,North Dakota,2017,Age,3 Months,86.2,80.1 to 90.6,298
Hib,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,3 Months,88.6,84.7 to 91.7,591
Hib,≥1 Dose,States/Local Areas,North Dakota,2016,Age,3 Months,90.7,85.2 to 94.2,227
Hib,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,3 Months,88.5,84.6 to 91.5,525
Hib,≥1 Dose,States/Local Areas,North Dakota,2015,Age,3 Months,91.4,85.9 to 94.9,217
Hib,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,3 Months,91.1,87.3 to 93.8,444
≥1 Dose MMR,,States/Local Areas,North Dakota,2017,Age,35 Months,95.8,91.9 to 98.1,298
≥1 Dose MMR,,States/Local Areas,North Dakota,2017-2018,Age,35 Months,97.2,94.7 to 98.7,591
≥1 Dose MMR,,States/Local Areas,North Dakota,2018,Age,35 Months,98.5,95.2 to 99.7,293
≥1 Dose MMR,,States/Local Areas,North Dakota,2018-2019,Age,35 Months,96.2,93.2 to 98.1,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,83.7,76.9 to 89.4,237
PCV,≥4 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,86.9,82.7 to 90.5,467
≥1 Dose MMR,,States/Local Areas,North Dakota,2019,Age,35 Months,93.3,88.4 to 96.6,263
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,86.8 to 97.8,123
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,90.6,81.9 to 99.3,42
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.4,90.1 to 94.7,637
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,92.3,88.8 to 95.7,285
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,90.6,81.9 to 99.3,42
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,92.9,90.4 to 95.5,562
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,91.5,87.2 to 95.7,209
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019,Age,35 Months,91.5,86.4 to 95.3,263
≥1 Dose MMR,,States/Local Areas,North Dakota,2016,Age,35 Months,94.7,90.7 to 97.4,227
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2017,Age,35 Months,95.3,92.6 to 97.2,525
PCV,≥4 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,87.1,81.3 to 91.9,217
PCV,≥4 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,87.3,83.3 to 90.7,444
PCV,≥4 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,87.7,82.3 to 92.1,227
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,83.6,79.3 to 87.4,525
PCV,≥4 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,79.4,72.8 to 85.3,298
PCV,≥4 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,84.8,80.7 to 88.5,591
≥1 Dose MMR,,States/Local Areas,North Dakota,2015,Age,35 Months,94.0,90.0 to 96.8,217
≥1 Dose MMR,,States/Local Areas,North Dakota,2015-2016,Age,35 Months,94.4,91.6 to 96.5,444
≥1 Dose MMR,,States/Local Areas,North Dakota,2014,Age,35 Months,96.0,91.5 to 98.5,230
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2015,Age,35 Months,95.0,92.2 to 97.0,447
PCV,≥3 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,90.1,84.8 to 93.8,227
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,87.8,83.9 to 90.9,525
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,93.4,88.5 to 96.7,237
Hep B,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,94.0,90.9 to 96.3,467
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,94.4,90.3 to 97.2,230
Hep B,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,95.4,92.8 to 97.3,447
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,96.3,92.9 to 98.3,217
Hep B,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,96.4,93.7 to 98.1,444
Hep B,≥3 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,93.0,88.4 to 96.2,294
PCV,≥3 Doses,States/Local Areas,North Dakota,2018,Age,13 Months,95.6,91.6 to 97.8,293
PCV,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,13 Months,93.1,89.7 to 95.4,556
PCV,≥3 Doses,States/Local Areas,North Dakota,2017,Age,13 Months,85.4,79.1 to 90.1,298
PCV,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,13 Months,90.4,86.7 to 93.1,591
Hep B,≥2 Doses,States/Local Areas,North Dakota,2012,Age,13 Months,94.5,91.3 to 96.6,294
Hep B,≥2 Doses,States/Local Areas,North Dakota,2013,Age,13 Months,92.1,78.7 to 97.4,237
Hep B,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,13 Months,92.6,86.7 to 96.0,467
Hep B,≥2 Doses,States/Local Areas,North Dakota,2011,Age,13 Months,94.7,92.2 to 96.5,299
Hep B,≥2 Doses,States/Local Areas,North Dakota,2019,Age,7 Months,95.7,92.4 to 97.6,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,94.0,90.1 to 96.7,298
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,95.2,92.6 to 97.1,591
PCV,≥3 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,93.4,91.4 to 94.9,294
PCV,≥4 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,87.3,81.6 to 91.9,294
PCV,≥4 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,82.9,76.4 to 88.4,299
PCV,≥4 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,90.6,85.6 to 94.4,293
PCV,≥4 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,89.0,85.2 to 92.1,556
PCV,≥4 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,87.3,81.3 to 92.1,263
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,95.9,92.2 to 98.2,227
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,95.0,92.4 to 96.9,525
PCV,≥3 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,86.0,69.4 to 94.3,237
PCV,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,88.8,83.0 to 92.8,467
PCV,≥3 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,89.8,88.8 to 90.8,299
PCV,≥3 Doses,States/Local Areas,North Dakota,2019,Age,13 Months,90.5,84.5 to 94.4,263
Hep B,≥2 Doses,States/Local Areas,North Dakota,2016,Age,13 Months,95.0,91.2 to 97.2,227
Hep B,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,13 Months,94.6,92.1 to 96.3,525
Hep B,≥2 Doses,States/Local Areas,North Dakota,2015,Age,13 Months,96.7,93.7 to 98.3,217
Hep B,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,13 Months,95.9,93.5 to 97.4,444
Hep B,≥2 Doses,States/Local Areas,North Dakota,2014,Age,13 Months,93.0,88.2 to 95.9,230
Hep B,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,13 Months,94.8,92.2 to 96.6,447
Hib,≥1 Dose,States/Local Areas,North Dakota,2014,Age,3 Months,84.9,78.5 to 89.6,230
Hib,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,3 Months,88.2,84.1 to 91.3,447
Hib,≥1 Dose,States/Local Areas,North Dakota,2011,Age,3 Months,87.9,84.8 to 90.4,299
Hib,≥1 Dose,States/Local Areas,North Dakota,2012,Age,3 Months,86.7,81.7 to 90.5,294
Hib,≥1 Dose,States/Local Areas,North Dakota,2013,Age,3 Months,86.1,66.0 to 95.2,237
Hib,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,3 Months,85.5,77.0 to 91.2,467
Hib,≥1 Dose,States/Local Areas,North Dakota,2019,Age,3 Months,93.7,89.8 to 96.2,263
Hib,≥1 Dose,States/Local Areas,North Dakota,2018,Age,3 Months,91.2,85.5 to 94.8,293
Hib,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,3 Months,92.4,89.2 to 94.8,556
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,91.2 to 95.6,637
≥1 Dose MMR,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,93.5,90.1 to 96.8,285
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,92.7,89.3 to 96.0,267
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Overall,Overall,92.0,89.9 to 94.1,830
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,90.9,85.9 to 95.8,155
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.5,84.6 to 96.5,124
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,92.4,89.4 to 95.3,421
PCV,≥4 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,85.1,79.4 to 89.9,294
Hep B,≥3 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,91.2,86.3 to 94.8,299
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,93.8,90.0 to 96.5,298
Hep B,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,94.5,92.0 to 96.5,591
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,96.4,93.4 to 98.3,263
PCV,≥4 Doses,States/Local Areas,North Dakota,2013,Age,24 Months,82.8,76.0 to 88.5,237
PCV,≥4 Doses,States/Local Areas,North Dakota,2013-2014,Age,24 Months,85.6,81.3 to 89.3,467
PCV,≥4 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,88.2,82.9 to 92.5,230
PCV,≥4 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,87.7,83.8 to 91.0,447
≥1 Dose MMR,,States/Local Areas,North Dakota,2019,Age,24 Months,92.8,87.9 to 96.2,263
≥1 Dose MMR,,States/Local Areas,North Dakota,2012,Age,35 Months,96.2,92.2 to 98.4,294
≥1 Dose MMR,,States/Local Areas,North Dakota,2011,Age,35 Months,91.6,86.4 to 95.4,299
≥1 Dose MMR,,States/Local Areas,North Dakota,2013,Age,35 Months,93.1,87.7 to 96.7,237
≥1 Dose MMR,,States/Local Areas,North Dakota,2013-2014,Age,35 Months,94.6,91.4 to 96.9,467
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,92.0,88.8 to 95.1,408
PCV,≥1 Dose,States/Local Areas,North Dakota,2012,Age,3 Months,86.5,82.2 to 89.9,294
≥1 Dose Varicella,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,84.0,71.0 to 97.1,48
Combined 7 Series,,States/Local Areas,North Carolina,2011,Age,35 Months,79.3,70.6 to 86.8,252
Hep A,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,24 Months,87.6,86.9 to 88.4,34652
Hep A,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,79.4,78.2 to 80.6,34652
Hep A,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,35 Months,91.9,91.1 to 92.7,34652
Hib,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,91.3,90.7 to 91.9,34652
Influenza,,HHS Regions/National,United States,2019-2020,Age,24 Months,60.9,59.9 to 61.9,34652
Hib,Primary Series,HHS Regions/National,United States,2019-2020,Age,24 Months,92.8,92.2 to 93.3,34652
Hib,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,55.0,54.0 to 56.0,34652
Hib,Full Series,HHS Regions/National,United States,2019-2020,Age,24 Months,78.7,77.8 to 79.6,34652
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2019-2020,Age,0-1 Days,76.9,76.0 to 77.7,34652
Combined 7 Series,,HHS Regions/National,United States,2019-2020,Age,35 Months,74.6,73.5 to 75.7,34652
≥1 Dose Varicella,,HHS Regions/National,United States,2019-2020,Age,19 Months,87.7,87.0 to 88.4,34652
Hep B,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,90.8,90.1 to 91.4,34652
PCV,≥4 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,78.4,77.5 to 79.3,34652
Hep A,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,19 Months,83.7,82.9 to 84.5,34652
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2019-2020,Age,0-2 Days,79.8,79.0 to 80.7,34652
≥1 Dose Varicella,,HHS Regions/National,United States,2019-2020,Age,24 Months,90.4,89.7 to 91.1,34652
Hep B,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,91.8,91.2 to 92.4,34652
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2019-2020,Age,0-3 Days,80.8,80.0 to 81.6,34652
PCV,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,92.3,91.7 to 92.9,34652
PCV,≥4 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,81.9,81.0 to 82.8,34652
Hep A,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,28.6,27.7 to 29.5,34652
≥1 Dose MMR,,HHS Regions/National,United States,2019-2020,Age,19 Months,88.3,87.6 to 89.0,34652
Hib,Primary Series,HHS Regions/National,United States,2019-2020,Age,19 Months,91.9,91.3 to 92.5,34652
Hib,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,89.4,88.7 to 90.0,34652
Hib,Full Series,HHS Regions/National,United States,2019-2020,Age,19 Months,73.4,72.5 to 74.3,34652
Hib,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,92.8,92.1 to 93.3,34652
Hep B,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,93.5,92.9 to 94.1,34652
Hib,Full Series,HHS Regions/National,United States,2019-2020,Age,35 Months,82.9,82.0 to 83.8,34652
Hib,Primary Series,HHS Regions/National,United States,2019-2020,Age,35 Months,93.7,93.1 to 94.3,34652
≥1 Dose Varicella,,HHS Regions/National,United States,2019-2020,Age,35 Months,93.7,93.0 to 94.4,34652
PCV,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,93.2,92.6 to 93.8,34652
PCV,≥4 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,84.9,83.9 to 85.7,34652
DTaP,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,93.2,92.7 to 93.8,34652
DTaP,≥4 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,80.4,79.5 to 81.3,34652
Polio,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,92.5,91.9 to 93.0,34652
≥1 Dose MMR,,HHS Regions/National,United States,2019-2020,Age,24 Months,90.9,90.3 to 91.6,34652
Hep B,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,3 Months,95.5,95.1 to 95.9,34652
PCV,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,3 Months,86.8,86.0 to 87.5,34652
DTaP,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,5 Months,80.3,79.4 to 81.2,34652
Hib,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,5 Months,78.2,77.3 to 79.1,34652
Polio,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,5 Months,79.7,78.9 to 80.6,34652
Polio,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,93.5,93.0 to 94.0,34652
≥1 Dose MMR,,HHS Regions/National,United States,2019-2020,Age,13 Months,66.8,65.7 to 67.7,34652
Hib,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,93.3,92.8 to 93.8,34652
Hib,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,74.1,73.2 to 74.9,34652
Hep B,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,94.3,93.8 to 94.7,34652
Hib,Primary Series,HHS Regions/National,United States,2019-2020,Age,13 Months,86.7,86.0 to 87.4,34652
PCV,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,5 Months,78.6,77.7 to 79.5,34652
Hep B,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,5 Months,89.0,88.3 to 89.7,34652
DTaP,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,71.6,70.6 to 72.6,34652
Hib,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,89.4,88.7 to 90.0,34652
Polio,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,89.7,89.0 to 90.3,34652
≥1 Dose Varicella,,HHS Regions/National,United States,2019-2020,Age,13 Months,61.4,60.4 to 62.4,34652
Hep B,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,88.4,87.7 to 89.1,34652
PCV,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,88.2,87.5 to 88.9,34652
DTaP,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,92.4,91.8 to 92.9,34652
DTaP,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,94.7,94.1 to 95.3,34652
Combined 7 Series,,HHS Regions/National,United States,2019-2020,Age,24 Months,68.9,67.9 to 69.9,34652
Polio,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,93.9,93.3 to 94.5,34652
DTaP,≥4 Doses,HHS Regions/National,United States,2019-2020,Age,35 Months,87.7,86.7 to 88.6,34652
≥1 Dose MMR,,HHS Regions/National,United States,2019-2020,Age,35 Months,93.5,92.8 to 94.2,34652
Hib,Primary Series,HHS Regions/National,United States,2020,Age,13 Months,85.3,84.2 to 86.4,17387
PCV,≥4 Doses,HHS Regions/National,United States,2020,Age,35 Months,83.3,82.0 to 84.6,17387
Hep A,≥1 Dose,HHS Regions/National,United States,2020,Age,19 Months,82.9,81.7 to 84.0,17387
Hib,≥3 Doses,HHS Regions/National,United States,2020,Age,13 Months,72.8,71.5 to 74.0,17387
PCV,≥4 Doses,HHS Regions/National,United States,2020,Age,19 Months,76.9,75.5 to 78.2,17387
≥1 Dose MMR,,HHS Regions/National,United States,2020,Age,35 Months,92.7,91.7 to 93.7,17387
Polio,≥3 Doses,HHS Regions/National,United States,2020,Age,35 Months,93.3,92.4 to 94.2,17387
DTaP,≥4 Doses,HHS Regions/National,United States,2020,Age,35 Months,87.2,85.8 to 88.6,17387
≥1 Dose Varicella,,HHS Regions/National,United States,2020,Age,19 Months,86.9,85.8 to 87.9,17387
PCV,≥3 Doses,HHS Regions/National,United States,2020,Age,19 Months,90.3,89.3 to 91.3,17387
Hib,Full Series,HHS Regions/National,United States,2020,Age,19 Months,72.2,70.9 to 73.6,17387
Hep B,≥3 Doses,HHS Regions/National,United States,2020,Age,19 Months,90.0,88.9 to 90.9,17387
PCV,≥3 Doses,HHS Regions/National,United States,2020,Age,35 Months,92.3,91.4 to 93.2,17387
Hep B,≥3 Doses,HHS Regions/National,United States,2020,Age,35 Months,92.5,91.5 to 93.4,17387
≥1 Dose Varicella,,HHS Regions/National,United States,2020,Age,35 Months,92.9,91.8 to 94.0,17387
Hib,Primary Series,HHS Regions/National,United States,2020,Age,35 Months,92.7,91.7 to 93.5,17387
Hib,Full Series,HHS Regions/National,United States,2020,Age,35 Months,81.4,80.1 to 82.7,17387
Hib,≥3 Doses,HHS Regions/National,United States,2020,Age,35 Months,91.7,90.7 to 92.6,17387
Hib,Primary Series,HHS Regions/National,United States,2020,Age,24 Months,91.6,90.6 to 92.4,17387
Hib,≥3 Doses,HHS Regions/National,United States,2020,Age,24 Months,90.2,89.2 to 91.1,17387
≥1 Dose MMR,,HHS Regions/National,United States,2020,Age,24 Months,90.1,89.0 to 91.0,17387
DTaP,≥4 Doses,HHS Regions/National,United States,2020,Age,24 Months,79.6,78.2 to 80.9,17387
Polio,≥3 Doses,HHS Regions/National,United States,2020,Age,24 Months,91.9,91.0 to 92.7,17387
Hep B,≥2 Doses,HHS Regions/National,United States,2020,Age,7 Months,91.0,90.0 to 91.9,17387
DTaP,≥3 Doses,HHS Regions/National,United States,2020,Age,24 Months,92.5,91.6 to 93.3,17387
Hib,Primary Series,HHS Regions/National,United States,2020,Age,7 Months,71.2,69.8 to 72.5,17387
Hib,≥3 Doses,HHS Regions/National,United States,2020,Age,7 Months,54.4,52.9 to 55.9,17387
Hib,≥2 Doses,HHS Regions/National,United States,2020,Age,7 Months,87.9,86.8 to 88.8,17387
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2020,Age,0-2 Days,79.2,78.0 to 80.4,17387
DTaP,≥1 Dose,HHS Regions/National,United States,2020,Age,3 Months,86.1,84.9 to 87.1,17387
Hep A,≥2 Doses,HHS Regions/National,United States,2020,Age,19 Months,27.9,26.7 to 29.2,17387
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2020,Age,0-1 Days,76.7,75.5 to 78.0,17387
Combined 7 Series,,HHS Regions/National,United States,2020,Age,35 Months,73.4,71.8 to 75.0,17387
≥1 Dose MMR,,HHS Regions/National,United States,2020,Age,13 Months,66.2,64.8 to 67.7,17387
Hep B,≥2 Doses,HHS Regions/National,United States,2020,Age,13 Months,93.2,92.4 to 93.9,17387
DTaP,≥3 Doses,HHS Regions/National,United States,2020,Age,13 Months,88.7,87.6 to 89.6,17387
PCV,≥3 Doses,HHS Regions/National,United States,2020,Age,7 Months,68.2,66.7 to 69.6,17387
Rotavirus,,HHS Regions/National,United States,2019-2020,Age,8 Months,75.7,74.8 to 76.7,34652
Hep B,≥1 Dose,HHS Regions/National,United States,2020,Age,3 Months,94.7,94.0 to 95.3,17387
Hep B,≥3 Doses,HHS Regions/National,United States,2020,Age,7 Months,63.2,61.7 to 64.6,17387
Hib,≥1 Dose,HHS Regions/National,United States,2020,Age,3 Months,83.5,82.3 to 84.6,17387
Polio,≥1 Dose,HHS Regions/National,United States,2020,Age,3 Months,85.7,84.5 to 86.7,17387
Hep B,≥2 Doses,HHS Regions/National,United States,2020,Age,5 Months,87.6,86.4 to 88.6,17387
Hib,≥2 Doses,HHS Regions/National,United States,2020,Age,5 Months,76.2,74.9 to 77.5,17387
Polio,≥2 Doses,HHS Regions/National,United States,2020,Age,5 Months,78.1,76.8 to 79.4,17387
PCV,≥1 Dose,HHS Regions/National,United States,2020,Age,3 Months,84.5,83.3 to 85.6,17387
DTaP,≥2 Doses,HHS Regions/National,United States,2020,Age,5 Months,78.5,77.2 to 79.8,17387
Hep A,≥2 Doses,HHS Regions/National,United States,2020,Age,24 Months,47.5,46.0 to 49.0,17387
Combined 7 Series,,HHS Regions/National,United States,2020,Age,24 Months,67.8,66.3 to 69.2,17387
Hep A,≥1 Dose,HHS Regions/National,United States,2020,Age,24 Months,86.9,85.8 to 88.0,17387
PCV,≥4 Doses,HHS Regions/National,United States,2020,Age,24 Months,80.6,79.3 to 81.9,17387
DTaP,≥3 Doses,HHS Regions/National,United States,2020,Age,35 Months,93.8,92.9 to 94.6,17387
PCV,≥3 Doses,HHS Regions/National,United States,2020,Age,24 Months,91.3,90.3 to 92.2,17387
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2020,Age,0-3 Days,80.2,79.0 to 81.4,17387
Rotavirus,,HHS Regions/National,United States,2020,Age,8 Months,74.9,73.5 to 76.2,17387
Influenza,,HHS Regions/National,United States,2020,Age,24 Months,57.8,56.4 to 59.3,17387
Hib,Primary Series,HHS Regions/National,United States,2020,Age,19 Months,90.7,89.8 to 91.6,17387
Hib,≥3 Doses,HHS Regions/National,United States,2020,Age,19 Months,88.3,87.3 to 89.2,17387
≥1 Dose MMR,,HHS Regions/National,United States,2020,Age,19 Months,87.4,86.3 to 88.5,17387
Polio,≥3 Doses,HHS Regions/National,United States,2020,Age,19 Months,90.7,89.8 to 91.6,17387
DTaP,≥4 Doses,HHS Regions/National,United States,2020,Age,19 Months,70.3,68.9 to 71.7,17387
DTaP,≥3 Doses,HHS Regions/National,United States,2020,Age,19 Months,91.6,90.7 to 92.5,17387
Polio,≥2 Doses,HHS Regions/National,United States,2020,Age,7 Months,88.8,87.7 to 89.7,17387
PCV,≥2 Doses,HHS Regions/National,United States,2020,Age,5 Months,76.9,75.6 to 78.2,17387
DTaP,≥3 Doses,HHS Regions/National,United States,2020,Age,7 Months,70.9,69.5 to 72.3,17387
PCV,≥3 Doses,HHS Regions/National,United States,2020,Age,13 Months,87.1,86.0 to 88.1,17387
≥1 Dose Varicella,,HHS Regions/National,United States,2020,Age,13 Months,61.1,59.6 to 62.5,17387
Hep B,≥3 Doses,HHS Regions/National,United States,2020,Age,13 Months,87.6,86.5 to 88.6,17387
DTaP,≥4 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,71.3,70.4 to 72.3,34652
Polio,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,91.4,90.7 to 91.9,34652
PCV,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,68.9,67.9 to 69.9,34652
DTaP,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,13 Months,89.8,89.1 to 90.4,34652
Hib,Primary Series,HHS Regions/National,United States,2019-2020,Age,7 Months,71.7,70.7 to 72.6,34652
Hib,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,3 Months,86.1,85.4 to 86.9,34652
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,87.1,86.3 to 87.9,37121
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.3,89.9 to 92.8,4715
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.9,94.4 to 95.3,37179
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,93.2,92.3 to 94.2,12650
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,89.1,88.2 to 89.9,22343
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,87.8,85.6 to 90.1,2369
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,76.0,72.1 to 79.9,1616
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.7,82.9 to 84.5,37179
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,70.8,66.7 to 75.0,1616
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,90.7,89.9 to 91.5,22343
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,95.6,95.1 to 96.0,37121
Hib,Full Series,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,58.9,54.5 to 63.3,1616
Hib,Full Series,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,76.4,73.1 to 79.7,2369
Hib,Full Series,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,75.3,74.1 to 76.6,22343
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,85.1,82.6 to 87.5,2369
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,89.6,87.4 to 91.7,2369
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.0,86.2 to 87.7,37179
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.9,82.0 to 85.8,4715
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,77.3,74.1 to 80.6,2369
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,76.1,74.9 to 77.4,22343
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,63.0,58.7 to 67.4,1616
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,90.7,89.8 to 91.5,22343
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,93.7,93.2 to 94.3,37121
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,89.6,87.5 to 91.7,2369
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,81.4,78.1 to 84.7,1616
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.6,93.0 to 94.1,37179
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,90.0,88.8 to 91.1,12650
Influenza,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.8,60.7 to 65.0,8905
Polio,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,3 Months,87.8,87.0 to 88.5,34652
DTaP,≥1 Dose,HHS Regions/National,United States,2019-2020,Age,3 Months,88.5,87.8 to 89.2,34652
Polio,≥2 Doses,HHS Regions/National,United States,2020,Age,13 Months,92.6,91.7 to 93.3,17387
Hep A,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,24 Months,47.8,46.7 to 48.8,34652
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.3,88.7 to 91.9,4715
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.8,92.3 to 93.3,37179
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,90.5,89.7 to 91.3,22343
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.2,88.5 to 91.8,4715
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,62.7,58.3 to 67.0,1616
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.9,93.4 to 94.4,37179
Influenza,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",46.7,44.3 to 49.1,4715
Influenza,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.2,64.2 to 66.1,37179
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,83.5,80.3 to 86.6,1616
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.0,84.3 to 85.8,37179
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.8,73.7 to 78.0,4715
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,80.8,79.1 to 82.5,12650
Rotavirus,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,75.2,73.4 to 77.0,12650
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,79.8,76.4 to 83.3,1616
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.1,72.1 to 74.1,37179
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,67.9,65.9 to 69.8,12650
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.2,60.8 to 65.5,4715
Rotavirus,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,71.1,67.7 to 74.5,2369
Rotavirus,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,59.2,54.8 to 63.6,1616
Rotavirus,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,69.5,68.2 to 70.8,22343
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,47.8,42.3 to 53.2,1616
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,75.4,70.9 to 79.9,2369
Hib,Full Series,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.4,81.6 to 83.3,37179
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,79.6,78.0 to 81.3,12650
Influenza,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,50.4,49.0 to 51.7,22343
Influenza,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,52.7,48.9 to 56.5,2369
PCV,≥3 Doses,HHS Regions/National,United States,2021,Age,19 Months,90.9,89.7 to 92.0,11281
Hep B,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,93.1,92.4 to 93.8,28668
Hep B,≥3 Doses,HHS Regions/National,United States,2021,Age,24 Months,91.1,89.9 to 92.2,11281
DTaP,≥4 Doses,HHS Regions/National,United States,2021,Age,19 Months,69.5,67.6 to 71.3,11281
Hib,Full Series,HHS Regions/National,United States,2021,Age,24 Months,76.1,74.3 to 77.8,11281
Hib,≥1 Dose,HHS Regions/National,United States,2021,Age,3 Months,83.7,82.1 to 85.2,11281
Hib,≥3 Doses,HHS Regions/National,United States,2021,Age,24 Months,90.1,88.8 to 91.2,11281
≥1 Dose MMR,,HHS Regions/National,United States,2021,Age,24 Months,90.6,89.5 to 91.7,11281
Polio,≥3 Doses,HHS Regions/National,United States,2021,Age,24 Months,91.9,90.7 to 92.9,11281
Hib,Primary Series,HHS Regions/National,United States,2021,Age,24 Months,91.6,90.4 to 92.6,11281
Polio,≥1 Dose,HHS Regions/National,United States,2021,Age,3 Months,86.5,85.0 to 87.8,11281
PCV,≥4 Doses,HHS Regions/National,United States,2021,Age,35 Months,85.2,82.2 to 87.9,11281
Hep A,≥2 Doses,HHS Regions/National,United States,2021,Age,19 Months,27.7,26.0 to 29.4,11281
Hep A,≥1 Dose,HHS Regions/National,United States,2021,Age,19 Months,81.8,80.2 to 83.3,11281
DTaP,≥3 Doses,HHS Regions/National,United States,2021,Age,13 Months,88.7,87.4 to 89.9,11281
DTaP,≥1 Dose,HHS Regions/National,United States,2021,Age,3 Months,86.9,85.5 to 88.3,11281
DTaP,≥4 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,87.0,85.7 to 88.2,28668
Combined 7 Series,,HHS Regions/National,United States,2021,Age,24 Months,66.1,64.1 to 68.0,11281
PCV,≥3 Doses,HHS Regions/National,United States,2021,Age,7 Months,66.8,64.9 to 68.7,11281
Hep A,≥1 Dose,HHS Regions/National,United States,2021,Age,24 Months,86.2,84.6 to 87.6,11281
DTaP,≥3 Doses,HHS Regions/National,United States,2021,Age,19 Months,91.6,90.5 to 92.6,11281
Hep A,≥2 Doses,HHS Regions/National,United States,2021,Age,24 Months,44.3,42.3 to 46.3,11281
PCV,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,92.7,91.9 to 93.4,28668
PCV,≥4 Doses,HHS Regions/National,United States,2021,Age,24 Months,80.8,79.1 to 82.4,11281
PCV,≥3 Doses,HHS Regions/National,United States,2021,Age,24 Months,92.0,90.9 to 93.0,11281
Hib,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,72.6,71.5 to 73.6,28668
≥1 Dose Varicella,,HHS Regions/National,United States,2021,Age,24 Months,90.1,89.0 to 91.2,11281
Hep B,≥3 Doses,HHS Regions/National,United States,2021,Age,7 Months,63.0,61.1 to 64.9,11281
Polio,≥2 Doses,HHS Regions/National,United States,2021,Age,13 Months,92.3,91.2 to 93.4,11281
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2021,Age,0-2 Days,78.1,76.4 to 79.7,11281
Hep B,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,92.6,91.7 to 93.3,28668
Hib,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,92.1,91.4 to 92.8,28668
DTaP,≥3 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,88.0,86.4 to 89.5,2367
DTaP,≥3 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,88.1,84.9 to 90.7,2229
Hib,Primary Series,HHS Regions/National,Region 6,2020,Age,24 Months,90.3,87.2 to 93.0,2206
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,72.5,68.6 to 76.0,2266
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,69.9,67.0 to 72.6,2732
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,72.3,70.2 to 74.3,5265
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,74.7,71.7 to 77.6,2533
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,73.6,71.2 to 75.9,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,87.0,85.0 to 88.8,2855
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,86.7,85.2 to 88.1,5587
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,86.4,84.0 to 88.4,2732
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,88.1,86.5 to 89.6,5265
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,89.1,87.4 to 90.7,2707
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,88.1,86.8 to 89.3,5562
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,87.6,85.8 to 89.1,2273
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,87.5,86.5 to 88.4,4660
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,87.4,85.3 to 89.2,2387
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,88.3,86.9 to 89.5,5094
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2019,Age,0-3 Days,80.3,76.9 to 83.3,2266
Polio,≥1 Dose,HHS Regions/National,Region 6,2019,Age,3 Months,87.5,84.5 to 90.0,2266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2018,Age,0-3 Days,81.0,78.2 to 83.5,2533
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2018-2019,Age,0-3 Days,80.6,78.4 to 82.6,4799
PCV,≥3 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,93.5,91.1 to 95.4,2266
Hib,≥3 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,62.3,59.0 to 65.5,2533
Hib,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,61.5,58.9 to 64.1,4799
Hib,≥3 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,58.9,56.0 to 61.8,2732
Hib,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,60.6,58.4 to 62.8,5265
Hib,≥2 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,93.9,92.5 to 95.1,2707
Hib,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,93.1,92.0 to 94.0,5562
Hib,≥2 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,92.2,90.5 to 93.6,2855
Hib,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,91.4,90.1 to 92.5,5587
Hib,≥2 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,92.0,90.3 to 93.5,2387
Hib,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,93.0,91.9 to 93.9,5094
Polio,≥1 Dose,HHS Regions/National,Region 6,2018,Age,3 Months,87.4,84.8 to 89.6,2533
Polio,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,3 Months,87.5,85.5 to 89.2,4799
Polio,≥1 Dose,HHS Regions/National,Region 6,2017,Age,3 Months,84.8,82.4 to 86.9,2732
Polio,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,3 Months,86.1,84.4 to 87.6,5265
Hib,≥3 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,58.5,56.0 to 61.1,2707
Hib,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,57.1,55.3 to 58.9,5562
Hib,≥3 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,55.7,53.0 to 58.3,2855
Hib,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,57.3,55.3 to 59.2,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,94.6,92.4 to 96.3,2533
PCV,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,94.1,92.4 to 95.5,4799
Hib,≥3 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,55.7,52.9 to 58.4,2387
Hib,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,57.1,55.2 to 59.0,5094
Hib,≥2 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,91.8,90.2 to 93.1,2273
Hib,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,91.9,90.8 to 92.9,4660
PCV,≥3 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,90.2,88.0 to 92.1,2732
PCV,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,92.5,90.8 to 93.9,5265
Hib,≥3 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,60.7,56.7 to 64.7,2266
Hep A,≥2 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,83.0,75.2 to 89.5,1478
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,89.0,86.2 to 91.3,2266
DTaP,≥3 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,92.3,89.4 to 94.4,2229
DTaP,≥3 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,92.3,90.5 to 93.8,2367
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,89.9,87.5 to 91.8,2533
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,89.4,87.7 to 91.0,4799
Hib,≥2 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,93.6,91.5 to 95.3,2266
Hib,≥2 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,93.9,92.0 to 95.4,2533
Hib,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,93.8,92.4 to 94.9,4799
Hib,≥2 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,90.6,88.5 to 92.4,2732
Hib,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,92.3,90.9 to 93.5,5265
Hib,≥3 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,77.7,75.2 to 80.1,2273
Hib,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,77.4,75.2 to 79.4,4660
Polio,≥3 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,90.0,87.3 to 92.2,2229
Hib,≥3 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,77.0,74.6 to 79.2,2387
Hib,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,78.2,76.6 to 79.7,5094
Hib,≥3 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,84.0,79.1 to 87.8,2229
Hib,≥3 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,82.4,80.4 to 84.2,2367
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,69.6,67.1 to 71.9,2707
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,69.4,67.6 to 71.1,5562
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,66.8,64.1 to 69.4,2387
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,68.2,66.4 to 70.0,5094
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2015,Age,0-3 Days,79.7,77.5 to 81.7,2707
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2015-2016,Age,0-3 Days,78.6,77.0 to 80.1,5562
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,69.2,66.7 to 71.7,2855
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,69.5,67.6 to 71.4,5587
Hib,≥2 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,90.8,88.4 to 92.8,2266
Hib,≥2 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,93.7,92.7 to 94.6,2367
Hib,≥2 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,93.5,91.3 to 95.1,2229
Hib,≥2 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,87.1,85.1 to 88.9,2855
Hib,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,86.8,85.2 to 88.1,5587
Hib,≥2 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,86.4,84.1 to 88.4,2732
Hib,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,88.4,86.8 to 89.8,5265
Hib,≥2 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,90.3,88.0 to 92.2,2533
Hib,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,90.6,88.9 to 92.0,4799
PCV,≥3 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,92.5,90.7 to 94.1,2387
PCV,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,93.4,92.2 to 94.4,5094
PCV,≥3 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,94.3,92.8 to 95.5,2707
PCV,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,93.5,92.3 to 94.6,5562
PCV,≥3 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,92.7,90.7 to 94.4,2855
PCV,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,91.6,90.1 to 92.9,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,58.1,54.8 to 61.3,2367
Hib,≥3 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,61.2,55.8 to 66.3,2229
Hib,≥3 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,54.9,49.7 to 60.1,2273
Hib,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,55.3,51.5 to 59.0,4660
Polio,≥1 Dose,HHS Regions/National,Region 6,2014,Age,3 Months,83.8,81.6 to 85.8,2387
Polio,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,3 Months,85.4,84.0 to 86.7,5094
Polio,≥1 Dose,HHS Regions/National,Region 6,2015,Age,3 Months,87.0,85.1 to 88.7,2707
Polio,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,3 Months,86.7,85.3 to 88.0,5562
Polio,≥1 Dose,HHS Regions/National,Region 6,2016,Age,3 Months,86.3,84.3 to 88.1,2855
Polio,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,3 Months,85.6,84.1 to 87.0,5587
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2017,Age,0-3 Days,76.0,72.2 to 79.3,1774
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2017-2018,Age,0-3 Days,79.2,77.2 to 81.0,5265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2016,Age,0-3 Days,77.5,75.1 to 79.7,2855
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2016-2017,Age,0-3 Days,77.4,75.6 to 79.1,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,92.7,90.8 to 94.4,2533
PCV,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,92.2,90.7 to 93.5,4799
PCV,≥3 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,93.4,91.5 to 95.0,2367
PCV,≥1 Dose,HHS Regions/National,Region 6,2018,Age,3 Months,85.3,82.5 to 87.7,2533
PCV,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,3 Months,86.2,84.2 to 88.0,4799
PCV,≥1 Dose,HHS Regions/National,Region 6,2019,Age,3 Months,87.2,84.2 to 89.6,2266
Polio,≥1 Dose,HHS Regions/National,Region 6,2012,Age,3 Months,84.7,83.0 to 86.3,2367
Polio,≥1 Dose,HHS Regions/National,Region 6,2011,Age,3 Months,85.2,81.0 to 88.7,2229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2013,Age,0-3 Days,75.9,73.3 to 78.3,2273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2013-2014,Age,0-3 Days,75.7,74.0 to 77.4,4660
Polio,≥1 Dose,HHS Regions/National,Region 6,2013,Age,3 Months,85.3,82.2 to 88.0,2273
Polio,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,3 Months,84.6,82.4 to 86.5,4660
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2014,Age,0-3 Days,75.6,73.1 to 77.9,2387
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2014-2015,Age,0-3 Days,77.6,76.0 to 79.2,5094
Hib,≥2 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,89.4,87.7 to 90.9,2707
Hib,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,88.3,87.0 to 89.5,5562
PCV,≥3 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,91.6,89.3 to 93.6,2266
PCV,≥3 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,91.9,89.6 to 93.8,2229
PCV,≥3 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,92.3,90.4 to 94.0,2273
PCV,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,92.4,91.1 to 93.6,4660
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,66.0,62.0 to 69.9,2273
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,66.4,63.9 to 68.8,4660
DTaP,≥3 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,65.4,62.6 to 68.0,2367
DTaP,≥3 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,66.2,61.4 to 70.7,2229
PCV,≥1 Dose,HHS Regions/National,Region 6,2014,Age,3 Months,82.5,80.3 to 84.6,2387
PCV,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,3 Months,83.8,82.3 to 85.1,5094
PCV,≥1 Dose,HHS Regions/National,Region 6,2015,Age,3 Months,85.0,83.0 to 86.8,2707
PCV,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,3 Months,85.0,83.5 to 86.3,5562
PCV,≥3 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,89.1,87.0 to 91.1,2732
PCV,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,90.9,89.5 to 92.2,5265
PCV,≥3 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,90.0,88.1 to 91.7,2855
PCV,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,89.6,88.2 to 90.9,5587
Hib,≥2 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,87.8,86.2 to 89.2,2367
PCV,≥3 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,92.6,91.2 to 93.9,2707
PCV,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,91.3,90.1 to 92.4,5562
Hib,≥2 Doses,HHS Regions/National,Region 6,2019,Age,5 Months,80.6,77.3 to 83.6,2266
Hib,≥2 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,89.5,85.4 to 92.5,2229
Hib,≥2 Doses,HHS Regions/National,Region 6,2018,Age,5 Months,79.8,76.7 to 82.5,2533
Hib,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,5 Months,80.2,78.0 to 82.2,4799
Hib,≥3 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,79.3,77.2 to 81.3,2707
Hib,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,77.9,76.3 to 79.4,5562
Hib,≥3 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,76.5,74.1 to 78.8,2855
Hib,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,76.6,74.8 to 78.3,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,76.6,74.0 to 79.1,2732
Hib,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,77.8,75.9 to 79.6,5265
Polio,≥3 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,89.1,87.1 to 90.7,2387
Polio,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,90.2,88.9 to 91.3,5094
Polio,≥3 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,90.8,89.1 to 92.3,2367
Polio,≥3 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,91.2,89.4 to 92.8,2707
Polio,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,90.5,89.3 to 91.6,5562
Polio,≥3 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,89.2,87.1 to 90.9,2273
Polio,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,89.1,88.1 to 90.1,4660
Hib,≥3 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,78.4,74.9 to 81.5,2266
Hib,≥2 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,90.3,86.9 to 92.8,2206
Hib,≥3 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,90.6,89.4 to 91.6,2367
Hib,≥3 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,90.8,87.1 to 93.5,2229
Hib,≥3 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,79.0,76.1 to 81.7,2533
Hib,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,78.7,76.5 to 80.8,4799
Polio,≥3 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,89.8,87.9 to 91.3,2855
Polio,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,88.7,87.2 to 90.0,5587
Polio,≥3 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,87.6,85.3 to 89.6,2732
Polio,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,89.8,88.2 to 91.1,5265
PCV,≥4 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,79.4,75.1 to 83.4,2206
Hib,Primary Series,HHS Regions/National,Region 5,2021,Age,24 Months,91.6,89.4 to 93.5,1478
Polio,≥1 Dose,HHS Regions/National,Region 5,2021,Age,3 Months,85.1,82.1 to 87.6,1478
Hib,Full Series,HHS Regions/National,Region 5,2021,Age,24 Months,76.0,72.6 to 79.2,1478
≥1 Dose Varicella,,HHS Regions/National,Region 5,2021,Age,19 Months,87.7,84.9 to 90.0,1478
DTaP,≥4 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,70.8,67.3 to 74.1,1478
Hep A,≥1 Dose,HHS Regions/National,Region 5,2021,Age,35 Months,91.4,88.3 to 93.9,1478
PCV,≥3 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,90.4,87.9 to 92.4,1478
Hep B,≥3 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,64.1,60.6 to 67.5,1478
Hib,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,65.7,63.5 to 67.8,3717
PCV,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,5 Months,77.6,75.6 to 79.6,3717
Hep A,≥2 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,48.8,45.0 to 52.7,1478
PCV,≥3 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,67.8,64.2 to 71.2,1478
Hep B,≥3 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,92.2,90.0 to 94.0,1478
DTaP,≥3 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,88.2,85.5 to 90.5,1478
Hep A,≥1 Dose,HHS Regions/National,Region 5,2021,Age,19 Months,83.6,80.7 to 86.2,1478
Polio,≥2 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,92.1,89.8 to 93.9,1478
Hep A,≥2 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,30.6,27.6 to 33.9,1478
PCV,≥4 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,85.1,80.4 to 89.2,1478
DTaP,≥4 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,79.5,76.2 to 82.7,1478
Polio,≥3 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,92.3,90.1 to 94.2,1478
DTaP,≥1 Dose,HHS Regions/National,Region 5,2021,Age,3 Months,86.1,83.2 to 88.6,1478
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,93.0,91.6 to 94.2,3717
≥1 Dose MMR,,HHS Regions/National,Region 5,2021,Age,24 Months,92.1,89.7 to 94.2,1478
Hib,≥3 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,90.0,87.5 to 92.2,1478
Hib,≥2 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,85.2,82.9 to 87.3,2273
Hib,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,85.8,84.4 to 87.0,4660
Hib,≥2 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,86.3,84.2 to 88.2,2387
Hib,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,87.9,86.5 to 89.1,5094
PCV,≥1 Dose,HHS Regions/National,Region 6,2016,Age,3 Months,85.0,82.9 to 86.8,2855
PCV,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,3 Months,84.6,83.1 to 86.0,5587
PCV,≥1 Dose,HHS Regions/National,Region 6,2017,Age,3 Months,84.2,81.9 to 86.3,2732
PCV,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,3 Months,84.7,83.0 to 86.4,5265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2011,Age,0-3 Days,78.7,75.7 to 81.4,2229
PCV,≥3 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,91.0,88.5 to 92.9,2266
PCV,≥3 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,91.2,89.0 to 93.2,2229
PCV,≥3 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,92.0,89.9 to 93.7,2533
PCV,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,88.9,87.1 to 90.4,4799
Hep A,≥1 Dose,HHS Regions/National,Region 6,2020,Age,35 Months,92.0,88.8 to 94.6,2206
Hep B,≥2 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,94.3,92.3 to 95.9,2266
Hib,≥2 Doses,HHS Regions/National,Region 6,2012,Age,5 Months,74.0,71.7 to 76.3,2367
Hib,≥2 Doses,HHS Regions/National,Region 6,2011,Age,5 Months,74.9,69.2 to 79.8,2229
Hib,≥2 Doses,HHS Regions/National,Region 6,2013,Age,5 Months,72.6,69.0 to 75.9,2273
Hib,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,5 Months,73.5,71.3 to 75.6,4660
Hib,≥2 Doses,HHS Regions/National,Region 6,2014,Age,5 Months,74.4,71.9 to 76.7,2387
Hib,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,5 Months,76.0,73.7 to 78.3,5094
PCV,≥3 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,88.5,86.3 to 90.3,2732
PCV,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,90.2,88.7 to 91.5,5265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2012,Age,0-3 Days,77.5,74.7 to 80.1,2367
PCV,≥1 Dose,HHS Regions/National,Region 6,2012,Age,3 Months,84.0,82.1 to 85.8,2367
PCV,≥1 Dose,HHS Regions/National,Region 6,2011,Age,3 Months,82.5,78.7 to 85.7,2229
PCV,≥4 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,82.3,79.9 to 84.6,2855
PCV,≥4 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,81.6,79.8 to 83.3,5587
PCV,≥4 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,84.7,81.8 to 87.4,2533
PCV,≥4 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,85.2,83.0 to 87.2,4799
Hib,≥2 Doses,HHS Regions/National,Region 6,2015,Age,5 Months,77.7,75.4 to 79.8,2707
Hib,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,5 Months,76.0,74.3 to 77.6,5562
Hib,≥2 Doses,HHS Regions/National,Region 6,2016,Age,5 Months,74.2,71.8 to 76.6,2855
Hib,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,5 Months,74.6,72.8 to 76.4,5587
PCV,≥4 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,80.8,78.0 to 83.4,2732
PCV,≥4 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,82.8,80.8 to 84.7,5265
PCV,≥4 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,85.6,82.3 to 88.6,2266
PCV,≥3 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,91.3,89.6 to 92.8,2387
PCV,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,91.9,90.8 to 92.9,5094
PCV,≥3 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,92.6,90.7 to 94.2,2367
Hib,≥2 Doses,HHS Regions/National,Region 6,2017,Age,5 Months,75.0,72.2 to 77.6,2732
Hib,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,5 Months,77.4,75.3 to 79.3,5265
PCV,≥3 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,90.8,88.9 to 92.5,2273
PCV,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,91.0,89.8 to 92.2,4660
Hib,≥1 Dose,HHS Regions/National,Region 6,2019,Age,3 Months,87.1,84.1 to 89.5,2266
Hib,≥1 Dose,HHS Regions/National,Region 6,2018,Age,3 Months,86.6,83.9 to 88.9,2533
Hib,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,3 Months,86.8,84.9 to 88.6,4799
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,93.5,90.7 to 95.6,2266
PCV,≥3 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,89.7,87.8 to 91.3,2387
PCV,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,90.6,89.4 to 91.7,5094
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,91.9,89.7 to 93.7,2533
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,92.5,90.8 to 94.0,4799
PCV,≥1 Dose,HHS Regions/National,Region 6,2013,Age,3 Months,84.1,80.2 to 87.2,2273
PCV,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,3 Months,83.3,81.0 to 85.4,4660
PCV,≥4 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,81.8,79.2 to 84.3,2273
PCV,≥4 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,83.1,81.4 to 84.8,4660
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019,Age,35 Months,93.4,90.5 to 95.7,2266
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018,Age,35 Months,93.1,91.1 to 94.7,2533
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018-2019,Age,35 Months,93.1,91.5 to 94.6,4799
PCV,≥4 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,80.4,78.2 to 82.5,2707
PCV,≥4 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,80.0,78.4 to 81.6,5562
≥1 Dose MMR,,HHS Regions/National,Region 6,2016,Age,35 Months,92.2,90.6 to 93.7,2855
≥1 Dose MMR,,HHS Regions/National,Region 6,2016-2017,Age,35 Months,92.0,90.7 to 93.2,5587
≥1 Dose MMR,,HHS Regions/National,Region 6,2014,Age,35 Months,93.6,91.8 to 95.2,2387
≥1 Dose MMR,,HHS Regions/National,Region 6,2014-2015,Age,35 Months,93.4,92.2 to 94.5,5094
≥1 Dose MMR,,HHS Regions/National,Region 6,2015,Age,35 Months,93.2,91.4 to 94.6,2707
≥1 Dose MMR,,HHS Regions/National,Region 6,2015-2016,Age,35 Months,92.7,91.5 to 93.7,5562
PCV,≥4 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,78.6,76.0 to 81.1,2732
PCV,≥4 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,79.7,77.8 to 81.5,5265
PCV,≥4 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,79.7,77.3 to 81.9,2855
PCV,≥4 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,79.1,77.4 to 80.8,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,89.5,87.2 to 91.4,2533
PCV,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,88.9,87.1 to 90.4,4799
PCV,≥3 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,85.7,83.4 to 87.8,2732
PCV,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,87.6,86.0 to 89.0,5265
Hep B,≥2 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,91.9,89.5 to 93.8,2266
Hep B,≥2 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,93.6,91.5 to 95.3,2229
Hep B,≥2 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,94.9,93.8 to 95.9,2367
Hep B,≥3 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,92.6,90.5 to 94.3,2367
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,91.5,89.5 to 93.2,2387
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,92.1,90.8 to 93.2,5094
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,90.8,88.8 to 92.6,2273
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,91.1,89.8 to 92.4,4660
PCV,≥3 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,84.9,82.8 to 86.9,2855
PCV,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,85.3,83.8 to 86.8,5587
PCV,≥4 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,80.7,77.9 to 83.4,2533
PCV,≥4 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,81.2,79.1 to 83.3,4799
PCV,≥4 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,81.7,78.4 to 84.7,2266
PCV,≥4 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,84.3,80.7 to 87.5,2229
PCV,≥4 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,83.5,80.9 to 86.0,2367
PCV,≥3 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,91.4,89.6 to 92.9,2367
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,90.4,87.8 to 92.7,2732
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,91.1,89.4 to 92.5,5265
PCV,≥3 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,88.2,85.4 to 90.6,2266
PCV,≥3 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,89.7,85.9 to 92.6,2229
PCV,≥3 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,89.5,87.9 to 90.9,2273
PCV,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,89.6,88.6 to 90.5,4660
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,92.7,91.1 to 94.1,2707
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,91.5,90.3 to 92.7,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,90.4,88.5 to 92.0,2855
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,90.3,88.8 to 91.8,5587
PCV,≥4 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,85.1,82.9 to 87.1,2707
PCV,≥4 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,83.7,82.1 to 85.3,5562
PCV,≥4 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,84.5,82.2 to 86.6,2387
PCV,≥4 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,84.8,83.2 to 86.3,5094
Hep B,≥2 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,95.4,93.7 to 96.6,2533
Hep B,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,94.8,93.6 to 95.9,4799
Hep B,≥2 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,93.3,91.8 to 94.6,2855
Hep B,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,92.9,91.8 to 93.9,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,91.5,90.0 to 92.8,2707
PCV,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,90.3,89.0 to 91.4,5562
PCV,≥3 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,89.0,87.0 to 90.7,2855
PCV,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,88.7,87.3 to 90.0,5587
Hib,≥1 Dose,HHS Regions/National,Region 6,2015,Age,3 Months,86.6,84.8 to 88.3,2707
Hib,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,3 Months,85.5,84.1 to 86.8,5562
Hib,≥1 Dose,HHS Regions/National,Region 6,2016,Age,3 Months,84.3,82.1 to 86.2,2855
Hib,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,3 Months,84.4,82.9 to 85.9,5587
Hib,≥1 Dose,HHS Regions/National,Region 6,2017,Age,3 Months,84.6,82.3 to 86.6,2732
Hib,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,3 Months,85.6,83.8 to 87.2,5265
Hep B,≥2 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,92.5,90.7 to 94.0,2732
Hep B,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,93.9,92.7 to 94.9,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2018,Age,35 Months,93.3,91.3 to 94.9,2533
≥1 Dose MMR,,HHS Regions/National,Region 6,2018-2019,Age,35 Months,93.3,91.6 to 94.7,4799
≥1 Dose MMR,,HHS Regions/National,Region 6,2017,Age,35 Months,91.8,89.5 to 93.7,2732
≥1 Dose MMR,,HHS Regions/National,Region 6,2017-2018,Age,35 Months,92.5,91.1 to 93.8,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2019,Age,35 Months,93.5,90.4 to 95.8,2266
Hib,≥1 Dose,HHS Regions/National,Region 6,2013,Age,3 Months,83.5,80.0 to 86.6,2273
Hib,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,3 Months,83.3,81.3 to 85.1,4660
Hib,≥1 Dose,HHS Regions/National,Region 6,2012,Age,3 Months,85.1,83.2 to 86.7,2367
Hib,≥1 Dose,HHS Regions/National,Region 6,2011,Age,3 Months,85.2,81.2 to 88.5,2229
Hib,≥1 Dose,HHS Regions/National,Region 6,2014,Age,3 Months,83.0,80.8 to 85.1,2387
Hib,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,3 Months,84.8,83.4 to 86.2,5094
Hep B,≥2 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,94.0,92.6 to 95.2,2387
Hep B,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,94.1,93.2 to 94.9,5094
Hep B,≥2 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,94.3,93.0 to 95.3,2707
Hep B,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,93.8,92.8 to 94.6,5562
Hep B,≥2 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,93.8,92.8 to 94.7,2273
Hep B,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,93.9,93.2 to 94.6,4660
Combined 7 Series,,HHS Regions/National,Region 5,2019,Age,24 Months,69.2,66.2 to 72.2,2023
Polio,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,94.3,93.1 to 95.3,4262
DTaP,≥4 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,89.1,87.2 to 90.9,4262
Combined 7 Series,,HHS Regions/National,Region 5,2019-2020,Age,24 Months,69.5,67.4 to 71.4,4262
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,92.4,91.2 to 93.5,4262
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,95.0,93.9 to 96.0,4262
PCV,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,88.3,86.8 to 89.6,4262
Hib,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,88.8,87.3 to 90.1,4262
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,88.5,87.0 to 89.8,4262
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019-2020,Age,13 Months,60.2,58.1 to 62.2,4262
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,70.7,68.7 to 72.6,4262
Polio,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,89.0,87.5 to 90.3,4262
PCV,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,5 Months,78.1,76.2 to 79.8,4262
Hep B,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,5 Months,89.7,88.4 to 90.9,4262
Hib,Primary Series,HHS Regions/National,Region 5,2019-2020,Age,13 Months,86.0,84.5 to 87.4,4262
Hep B,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,94.4,93.3 to 95.2,4262
Hib,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,67.6,65.7 to 69.5,4262
Hib,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,93.3,92.2 to 94.3,4262
≥1 Dose MMR,,HHS Regions/National,Region 5,2019-2020,Age,13 Months,66.6,64.5 to 68.6,4262
Polio,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,93.4,92.2 to 94.4,4262
Polio,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,5 Months,79.2,77.4 to 80.9,4262
Hib,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,5 Months,77.4,75.6 to 79.2,4262
DTaP,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,5 Months,79.8,78.0 to 81.5,4262
PCV,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,3 Months,86.3,84.7 to 87.7,4262
Hep B,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,3 Months,95.5,94.5 to 96.2,4262
≥1 Dose MMR,,HHS Regions/National,Region 5,2019-2020,Age,24 Months,91.1,89.8 to 92.3,4262
DTaP,≥4 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,81.8,80.1 to 83.5,4262
Polio,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,92.9,91.7 to 94.0,4262
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,93.7,92.6 to 94.7,4262
PCV,≥4 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,85.5,83.8 to 87.2,4262
PCV,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,93.6,92.4 to 94.6,4262
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019-2020,Age,35 Months,94.2,92.8 to 95.4,4262
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,93.3,92.1 to 94.4,4262
Hib,Full Series,HHS Regions/National,Region 5,2019-2020,Age,35 Months,82.4,80.6 to 84.1,4262
Hib,Primary Series,HHS Regions/National,Region 5,2019-2020,Age,35 Months,93.8,92.7 to 94.9,4262
Hib,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,92.7,91.4 to 93.8,4262
≥1 Dose MMR,,HHS Regions/National,Region 5,2019-2020,Age,35 Months,94.2,93.0 to 95.3,4262
Hib,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,88.3,86.9 to 89.6,4262
Hib,Primary Series,HHS Regions/National,Region 5,2019-2020,Age,19 Months,91.7,90.5 to 92.8,4262
≥1 Dose MMR,,HHS Regions/National,Region 5,2019-2020,Age,19 Months,88.5,87.0 to 89.8,4262
Hep A,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,30.5,28.7 to 32.4,4262
PCV,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,92.8,91.6 to 93.8,4262
PCV,≥4 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,82.6,80.9 to 84.3,4262
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,91.9,90.7 to 93.0,4262
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019-2020,Age,24 Months,90.8,89.5 to 92.0,4262
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2019-2020,Age,0-3 Days,82.0,80.3 to 83.6,4262
Hib,Full Series,HHS Regions/National,Region 5,2019-2020,Age,24 Months,79.2,77.4 to 80.9,4262
PCV,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,68.1,66.0 to 70.0,4262
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2019-2020,Age,0-1 Days,77.0,75.2 to 78.7,4262
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2019-2020,Age,0-2 Days,80.9,79.1 to 82.5,4262
Hep A,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,19 Months,85.0,83.4 to 86.5,4262
PCV,≥4 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,78.8,77.0 to 80.6,4262
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,91.2,90.0 to 92.4,4262
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019-2020,Age,19 Months,87.6,86.1 to 89.0,4262
Combined 7 Series,,HHS Regions/National,Region 5,2019-2020,Age,35 Months,74.5,72.5 to 76.6,4262
Hib,Full Series,HHS Regions/National,Region 5,2019-2020,Age,19 Months,73.8,71.9 to 75.6,4262
Hib,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,49.6,47.6 to 51.6,4262
Hib,Primary Series,HHS Regions/National,Region 5,2019-2020,Age,24 Months,93.0,91.9 to 94.1,4262
Influenza,,HHS Regions/National,Region 5,2019-2020,Age,24 Months,64.8,62.7 to 66.8,4262
Hib,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,91.5,90.2 to 92.7,4262
Hep A,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,35 Months,92.6,91.3 to 93.8,4262
Hep A,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,35 Months,81.4,79.0 to 83.7,4262
Hep A,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,24 Months,88.8,87.4 to 90.2,4262
Polio,≥2 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,93.1,91.4 to 94.4,2239
Hep A,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,24 Months,50.2,48.1 to 52.3,4262
Combined 7 Series,,HHS Regions/National,Region 5,2020,Age,35 Months,75.0,72.2 to 77.6,2239
Hep A,≥2 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,79.8,76.6 to 82.9,2239
Hep A,≥2 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,32.4,29.9 to 35.0,2239
Hep A,≥1 Dose,HHS Regions/National,Region 5,2020,Age,19 Months,85.1,82.9 to 87.1,2239
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2020,Age,0-2 Days,80.2,77.9 to 82.4,2239
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2020,Age,0-1 Days,76.6,74.1 to 79.0,2239
DTaP,≥1 Dose,HHS Regions/National,Region 5,2020,Age,3 Months,85.9,83.7 to 87.8,2239
Polio,≥2 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,89.1,87.1 to 90.8,2239
Hib,≥2 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,88.3,86.3 to 90.1,2239
Hib,≥3 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,50.6,47.8 to 53.3,2239
Hib,Primary Series,HHS Regions/National,Region 5,2020,Age,7 Months,72.8,70.2 to 75.3,2239
Hep B,≥2 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,91.0,89.2 to 92.5,2239
PCV,≥2 Doses,HHS Regions/National,Region 5,2020,Age,5 Months,76.8,74.2 to 79.2,2239
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,93.3,91.8 to 94.7,2239
DTaP,≥4 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,81.9,79.5 to 84.1,2239
≥1 Dose MMR,,HHS Regions/National,Region 5,2020,Age,24 Months,91.7,90.0 to 93.2,2239
Polio,≥3 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,92.7,91.0 to 94.1,2239
Hib,Primary Series,HHS Regions/National,Region 5,2020,Age,24 Months,92.6,91.0 to 94.0,2239
≥1 Dose MMR,,HHS Regions/National,Region 5,2020,Age,35 Months,94.3,92.7 to 95.6,2239
Hib,≥3 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,91.0,89.2 to 92.6,2239
Hib,Primary Series,HHS Regions/National,Region 5,2020,Age,35 Months,93.4,91.9 to 94.8,2239
Hib,≥3 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,92.1,90.3 to 93.6,2239
Hib,Full Series,HHS Regions/National,Region 5,2020,Age,35 Months,81.4,79.0 to 83.7,2239
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,92.2,90.4 to 93.7,2239
Hib,Primary Series,HHS Regions/National,Region 5,2020,Age,19 Months,91.1,89.3 to 92.6,2239
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020,Age,35 Months,93.9,92.0 to 95.5,2239
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,90.2,88.3 to 91.8,2239
Hib,Full Series,HHS Regions/National,Region 5,2020,Age,19 Months,73.4,70.7 to 75.8,2239
PCV,≥3 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,91.0,89.1 to 92.5,2239
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020,Age,19 Months,87.6,85.5 to 89.5,2239
DTaP,≥4 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,88.9,86.5 to 91.1,2239
PCV,≥4 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,78.4,75.9 to 80.7,2239
Polio,≥3 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,93.7,92.1 to 95.0,2239
PCV,≥4 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,84.8,82.5 to 87.0,2239
PCV,≥3 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,93.1,91.5 to 94.5,2239
Hib,Primary Series,HHS Regions/National,Region 5,2020,Age,13 Months,84.7,82.4 to 86.6,2239
Hib,≥3 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,66.9,64.3 to 69.5,2239
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,87.6,85.6 to 89.4,2239
Hep B,≥2 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,93.4,91.8 to 94.7,2239
PCV,≥3 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,87.7,85.6 to 89.5,2239
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020,Age,13 Months,62.7,60.0 to 65.4,2239
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,71.9,69.2 to 74.4,2239
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,92.0,90.2 to 93.4,2239
DTaP,≥4 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,72.8,70.1 to 75.3,2239
Polio,≥3 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,91.0,89.1 to 92.6,2239
≥1 Dose MMR,,HHS Regions/National,Region 5,2020,Age,19 Months,88.9,86.9 to 90.6,2239
Hib,≥3 Doses,HHS Regions/National,Region 5,2020,Age,19 Months,88.1,86.0 to 90.0,2239
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2020,Age,0-3 Days,81.7,79.3 to 83.8,2239
Influenza,,HHS Regions/National,Region 5,2020,Age,24 Months,62.1,59.3 to 64.9,2239
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020,Age,35 Months,94.6,93.2 to 95.9,2239
Rotavirus,,HHS Regions/National,Region 5,2020,Age,8 Months,76.5,73.9 to 78.8,2239
PCV,≥4 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,82.4,80.0 to 84.6,2239
PCV,≥3 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,92.2,90.5 to 93.7,2239
Hep A,≥1 Dose,HHS Regions/National,Region 5,2020,Age,24 Months,89.0,87.2 to 90.7,2239
Hep A,≥2 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,51.3,48.5 to 54.1,2239
PCV,≥1 Dose,HHS Regions/National,Region 5,2020,Age,3 Months,84.5,82.3 to 86.5,2239
Combined 7 Series,,HHS Regions/National,Region 5,2020,Age,24 Months,69.8,67.1 to 72.4,2239
Hep B,≥1 Dose,HHS Regions/National,Region 5,2020,Age,3 Months,94.6,93.3 to 95.7,2239
DTaP,≥2 Doses,HHS Regions/National,Region 5,2020,Age,5 Months,78.4,75.8 to 80.7,2239
Polio,≥2 Doses,HHS Regions/National,Region 5,2020,Age,5 Months,77.9,75.4 to 80.3,2239
Hep B,≥2 Doses,HHS Regions/National,Region 5,2020,Age,5 Months,88.5,86.6 to 90.3,2239
Hib,≥2 Doses,HHS Regions/National,Region 5,2020,Age,5 Months,76.2,73.6 to 78.6,2239
Polio,≥1 Dose,HHS Regions/National,Region 5,2020,Age,3 Months,85.4,83.3 to 87.4,2239
Hib,≥1 Dose,HHS Regions/National,Region 5,2020,Age,3 Months,83.4,81.2 to 85.4,2239
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,65.1,62.4 to 67.7,2239
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020-2021,Age,35 Months,93.8,92.0 to 95.3,3717
PCV,≥3 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,87.4,84.6 to 89.7,1478
Hib,≥2 Doses,HHS Regions/National,Region 5,2021,Age,5 Months,76.4,73.1 to 79.5,1478
Hib,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,3 Months,85.5,83.9 to 86.9,4262
DTaP,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,3 Months,87.9,86.4 to 89.3,4262
Polio,≥1 Dose,HHS Regions/National,Region 5,2019-2020,Age,3 Months,87.3,85.8 to 88.7,4262
Hib,Primary Series,HHS Regions/National,Region 5,2019-2020,Age,7 Months,71.9,69.9 to 73.8,4262
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,13 Months,89.6,88.2 to 90.9,4262
Polio,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,91.4,90.1 to 92.6,4262
DTaP,≥4 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,72.5,70.6 to 74.4,4262
Rotavirus,,HHS Regions/National,Region 5,2019-2020,Age,8 Months,77.2,75.4 to 79.0,4262
PCV,≥3 Doses,HHS Regions/National,Region 5,2020,Age,7 Months,69.2,66.5 to 71.8,2239
Hep A,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,35 Months,92.7,91.0 to 94.1,3717
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2021,Age,0-1 Days,76.5,73.2 to 79.5,1478
Hib,Primary Series,HHS Regions/National,Region 5,2020-2021,Age,24 Months,92.1,90.7 to 93.3,3717
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2021,Age,0-2 Days,80.2,77.1 to 83.0,1478
≥1 Dose Varicella,,HHS Regions/National,Region 5,2021,Age,24 Months,91.3,88.9 to 93.4,1478
PCV,≥3 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,91.8,89.4 to 93.8,1478
PCV,≥4 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,82.0,78.9 to 84.9,1478
Hep A,≥1 Dose,HHS Regions/National,Region 5,2021,Age,24 Months,87.8,85.1 to 90.3,1478
Hib,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,92.2,90.8 to 93.4,3717
DTaP,≥3 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,91.0,88.6 to 92.9,1478
Hep A,≥1 Dose,HHS Regions/National,Region 5,2011,Age,19 Months,73.6,70.4 to 76.5,1771
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,95.1,93.6 to 96.4,1835
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,93.8,92.6 to 94.9,3854
DTaP,≥1 Dose,HHS Regions/National,Region 5,2019,Age,3 Months,90.2,88.1 to 91.9,2023
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,93.4,91.7 to 94.9,1726
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,93.1,91.9 to 94.1,3461
DTaP,≥1 Dose,HHS Regions/National,Region 5,2017,Age,3 Months,87.2,84.8 to 89.2,2019
DTaP,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,3 Months,87.8,86.2 to 89.2,4223
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,92.7,91.0 to 94.3,1735
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,93.9,92.8 to 94.9,3570
DTaP,≥1 Dose,HHS Regions/National,Region 5,2018,Age,3 Months,88.4,86.3 to 90.2,2204
DTaP,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,3 Months,89.3,87.9 to 90.6,4227
DTaP,≥4 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,88.4,85.9 to 90.6,3717
PCV,≥2 Doses,HHS Regions/National,Region 5,2021,Age,5 Months,78.5,75.2 to 81.5,1478
Hep A,≥1 Dose,HHS Regions/National,Region 5,2015,Age,19 Months,75.1,71.3 to 78.5,1735
Hep A,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,19 Months,79.2,77.2 to 81.0,3570
Hep A,≥1 Dose,HHS Regions/National,Region 5,2014,Age,19 Months,79.3,76.5 to 81.7,1726
Hep A,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,19 Months,77.2,75.2 to 79.1,3461
Hep B,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,93.6,92.4 to 94.7,3717
Polio,≥2 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,86.6,83.8 to 89.1,1478
Hib,≥2 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,86.3,83.4 to 88.7,1478
Hep A,≥1 Dose,HHS Regions/National,Region 5,2012,Age,19 Months,76.6,74.0 to 78.9,1752
Hep B,≥3 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,91.1,88.8 to 93.0,1478
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,91.5,90.0 to 92.7,3717
Hib,≥1 Dose,HHS Regions/National,Region 5,2021,Age,3 Months,83.9,81.0 to 86.5,1478
DTaP,≥3 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,68.7,65.0 to 72.1,1478
Hep B,≥2 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,91.1,88.7 to 93.0,1478
≥1 Dose MMR,,HHS Regions/National,Region 5,2021,Age,35 Months,92.6,90.1 to 94.6,1478
Hib,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,90.5,89.0 to 91.9,3717
PCV,≥4 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,82.2,80.2 to 84.1,3717
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,87.6,85.9 to 89.0,3717
PCV,≥3 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,92.5,90.1 to 94.5,1478
Hib,≥3 Doses,HHS Regions/National,Region 5,2021,Age,7 Months,47.6,44.1 to 51.1,1478
Hib,≥3 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,87.6,84.9 to 89.9,1478
Hib,Primary Series,HHS Regions/National,Region 5,2021,Age,19 Months,90.8,88.5 to 92.8,1478
Combined 7 Series,,HHS Regions/National,Region 5,2017,Age,24 Months,71.1,68.2 to 74.0,2019
Combined 7 Series,,HHS Regions/National,Region 5,2017-2018,Age,24 Months,69.9,67.9 to 71.9,4223
Combined 7 Series,,HHS Regions/National,Region 5,2018,Age,24 Months,68.7,65.9 to 71.4,2204
Combined 7 Series,,HHS Regions/National,Region 5,2018-2019,Age,24 Months,68.9,66.8 to 70.9,4227
Hib,Primary Series,HHS Regions/National,Region 5,2017,Age,35 Months,93.1,91.0 to 94.8,2019
Hib,Primary Series,HHS Regions/National,Region 5,2017-2018,Age,35 Months,93.8,92.5 to 94.9,4223
Combined 7 Series,,HHS Regions/National,Region 5,2016,Age,24 Months,71.7,68.8 to 74.6,1835
Combined 7 Series,,HHS Regions/National,Region 5,2016-2017,Age,24 Months,71.4,69.4 to 73.5,3854
Hib,Primary Series,HHS Regions/National,Region 5,2019,Age,35 Months,94.4,92.7 to 95.9,2023
Hib,≥3 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,93.6,91.7 to 95.3,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,91.4,89.2 to 93.3,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,95.5,94.1 to 96.7,1835
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,95.2,94.0 to 96.2,3854
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,94.9,93.3 to 96.3,1735
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,95.2,94.1 to 96.1,3570
PCV,≥2 Doses,HHS Regions/National,Region 5,2011,Age,5 Months,75.2,70.4 to 79.4,1771
PCV,≥2 Doses,HHS Regions/National,Region 5,2012,Age,5 Months,73.6,69.8 to 77.1,1752
PCV,≥2 Doses,HHS Regions/National,Region 5,2013,Age,5 Months,71.9,68.5 to 75.1,1730
PCV,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,5 Months,73.2,71.0 to 75.3,3456
DTaP,≥4 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,72.0,66.9 to 76.6,1752
Hep A,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,23.8,22.0 to 25.6,3461
DTaP,≥4 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,68.9,65.6 to 72.0,1771
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,94.9,93.0 to 96.4,2019
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,95.0,93.8 to 96.1,4223
Hep A,≥1 Dose,HHS Regions/National,Region 5,2013,Age,24 Months,82.3,79.6 to 84.8,1730
Hep A,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,24 Months,83.1,81.2 to 84.9,3456
Hep A,≥1 Dose,HHS Regions/National,Region 5,2011,Age,24 Months,78.6,75.9 to 81.2,1771
Hep A,≥1 Dose,HHS Regions/National,Region 5,2019,Age,19 Months,85.2,82.8 to 87.3,2023
Hep A,≥1 Dose,HHS Regions/National,Region 5,2012,Age,24 Months,81.6,78.9 to 84.2,1752
Hep A,≥1 Dose,HHS Regions/National,Region 5,2016,Age,19 Months,83.3,80.7 to 85.6,1835
Hep A,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,19 Months,83.1,81.2 to 84.8,3854
Hep A,≥1 Dose,HHS Regions/National,Region 5,2017,Age,19 Months,82.8,80.1 to 85.2,2019
Hep A,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,19 Months,83.4,81.6 to 85.0,4223
Hep A,≥1 Dose,HHS Regions/National,Region 5,2018,Age,19 Months,84.0,81.6 to 86.1,2204
Hep A,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,19 Months,84.2,82.3 to 86.0,3417
DTaP,≥3 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,95.1,93.2 to 96.6,1771
DTaP,≥3 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,93.8,91.9 to 95.3,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,95.1,93.5 to 96.5,1730
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,94.8,93.6 to 95.9,3456
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,94.6,92.9 to 96.0,1726
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,94.7,93.6 to 95.7,3461
Hep A,≥2 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,20.5,18.3 to 22.9,1771
DTaP,≥2 Doses,HHS Regions/National,Region 5,2019,Age,5 Months,81.4,78.8 to 83.8,2023
Hep A,≥2 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,23.9,21.6 to 26.4,1752
Hep A,≥2 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,23.9,21.5 to 26.6,1726
Hep A,≥2 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,28.1,26.4 to 29.8,1730
Hep A,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,26.0,24.1 to 28.0,3456
Hib,≥3 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,91.0,89.2 to 92.6,2204
Hib,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,91.5,90.3 to 92.7,4227
Hib,≥3 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,89.1,86.8 to 91.2,2019
Hib,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,90.1,88.6 to 91.4,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,92.0,90.2 to 93.6,2023
Hib,≥3 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,91.5,89.6 to 93.2,1726
Hib,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,91.0,89.6 to 92.3,3461
Hib,≥3 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,93.9,92.1 to 95.4,1730
Hib,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,92.7,91.4 to 93.9,3456
Hep A,≥2 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,27.1,24.5 to 29.9,1835
Hep A,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,27.2,25.3 to 29.1,3854
Hep A,≥2 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,23.6,21.0 to 26.3,1735
Hep A,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,25.3,23.5 to 27.2,3570
Hib,≥3 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,90.4,88.3 to 92.3,1735
Hib,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,91.9,90.6 to 93.2,3570
Combined 7 Series,,HHS Regions/National,Region 5,2014,Age,24 Months,69.2,66.2 to 72.2,1726
Combined 7 Series,,HHS Regions/National,Region 5,2014-2015,Age,24 Months,66.7,64.5 to 68.8,3461
Combined 7 Series,,HHS Regions/National,Region 5,2015,Age,24 Months,64.1,60.9 to 67.2,1735
Combined 7 Series,,HHS Regions/National,Region 5,2015-2016,Age,24 Months,67.9,65.7 to 70.0,3570
Hib,Primary Series,HHS Regions/National,Region 5,2018,Age,35 Months,94.5,92.9 to 95.8,2204
Hib,Primary Series,HHS Regions/National,Region 5,2018-2019,Age,35 Months,94.5,93.3 to 95.5,4227
Combined 7 Series,,HHS Regions/National,Region 5,2011,Age,35 Months,71.3,67.9 to 74.5,1771
Combined 7 Series,,HHS Regions/National,Region 5,2012,Age,35 Months,72.9,69.7 to 76.1,1752
Combined 7 Series,,HHS Regions/National,Region 5,2014,Age,35 Months,74.3,71.0 to 77.4,1726
Combined 7 Series,,HHS Regions/National,Region 5,2014-2015,Age,35 Months,72.3,69.9 to 74.6,3461
Hib,Primary Series,HHS Regions/National,Region 5,2016,Age,35 Months,94.8,93.3 to 96.2,1835
Hib,Primary Series,HHS Regions/National,Region 5,2016-2017,Age,35 Months,94.0,92.7 to 95.1,3854
Combined 7 Series,,HHS Regions/National,Region 5,2013,Age,35 Months,73.2,69.9 to 76.4,1730
Combined 7 Series,,HHS Regions/National,Region 5,2013-2014,Age,35 Months,73.7,71.4 to 76.0,3456
Combined 7 Series,,HHS Regions/National,Region 5,2016,Age,35 Months,75.6,72.7 to 78.5,1835
Combined 7 Series,,HHS Regions/National,Region 5,2016-2017,Age,35 Months,75.7,73.6 to 77.8,3854
Combined 7 Series,,HHS Regions/National,Region 5,2017,Age,35 Months,75.8,72.8 to 78.7,2019
Combined 7 Series,,HHS Regions/National,Region 5,2017-2018,Age,35 Months,76.0,73.9 to 78.0,4223
PCV,≥2 Doses,HHS Regions/National,Region 5,2014,Age,5 Months,74.5,71.6 to 77.2,1726
PCV,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,5 Months,73.7,71.4 to 76.0,3461
Hep A,≥1 Dose,HHS Regions/National,Region 5,2016,Age,24 Months,87.7,85.4 to 89.8,1835
Hep A,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,24 Months,86.7,85.1 to 88.3,3854
Hep A,≥1 Dose,HHS Regions/National,Region 5,2015,Age,24 Months,82.0,79.3 to 84.5,1735
Hep A,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,24 Months,84.8,83.1 to 86.5,3570
Hep A,≥1 Dose,HHS Regions/National,Region 5,2014,Age,24 Months,83.9,81.5 to 86.2,1726
Hep A,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,24 Months,82.9,81.1 to 84.7,3461
PCV,≥2 Doses,HHS Regions/National,Region 5,2016,Age,5 Months,78.9,76.2 to 81.4,1835
PCV,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,5 Months,78.3,76.3 to 80.1,3854
PCV,≥2 Doses,HHS Regions/National,Region 5,2015,Age,5 Months,73.0,69.9 to 75.8,1735
PCV,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,5 Months,75.9,73.9 to 77.9,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,95.0,93.4 to 96.4,2204
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,95.3,94.1 to 96.3,4227
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,95.5,93.8 to 96.9,2023
Hep A,≥1 Dose,HHS Regions/National,Region 5,2018,Age,24 Months,88.0,85.9 to 89.9,2204
Hep A,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,24 Months,88.3,86.8 to 89.7,4227
Hep A,≥1 Dose,HHS Regions/National,Region 5,2011,Age,35 Months,84.3,81.4 to 87.0,1771
Hep A,≥1 Dose,HHS Regions/National,Region 5,2019,Age,24 Months,88.5,86.3 to 90.5,2023
Hep A,≥1 Dose,HHS Regions/National,Region 5,2017,Age,24 Months,85.8,83.3 to 88.0,2019
Hep A,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,24 Months,86.9,85.3 to 88.4,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,93.3,91.4 to 94.9,2204
Hib,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,93.4,92.1 to 94.5,4227
Hep A,≥2 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,27.3,24.8 to 29.9,2019
Hep A,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,27.2,25.5 to 29.0,4223
DTaP,≥4 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,66.7,62.9 to 70.3,1735
DTaP,≥4 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,69.5,67.4 to 71.6,3570
DTaP,≥4 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,71.7,68.8 to 74.5,1726
DTaP,≥4 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,69.2,67.1 to 71.3,3461
DTaP,≥4 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,70.2,66.4 to 73.7,1730
DTaP,≥4 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,70.9,68.5 to 73.3,3456
Hib,≥3 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,91.5,89.3 to 93.5,2019
Hib,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,92.5,91.0 to 93.8,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,93.5,91.7 to 95.0,1835
Hib,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,92.5,91.1 to 93.7,3854
Hep A,≥2 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,27.2,24.9 to 29.7,2204
Hep A,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,28.0,25.9 to 30.3,3417
Hep A,≥2 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,39.5,36.3 to 43.0,1771
Hep A,≥2 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,28.7,26.1 to 31.4,2023
Hib,≥3 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,90.6,88.6 to 92.3,1726
Hib,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,89.7,88.3 to 91.1,3461
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,92.5,90.4 to 94.3,2019
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,93.2,91.9 to 94.3,4223
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,93.9,92.4 to 95.2,2204
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,94.0,92.9 to 95.0,4227
DTaP,≥2 Doses,HHS Regions/National,Region 5,2016,Age,5 Months,79.9,77.1 to 82.4,1835
DTaP,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,5 Months,79.8,77.8 to 81.6,3854
DTaP,≥2 Doses,HHS Regions/National,Region 5,2018,Age,5 Months,78.8,76.2 to 81.1,2204
DTaP,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,5 Months,80.1,78.3 to 81.8,4227
DTaP,≥2 Doses,HHS Regions/National,Region 5,2017,Age,5 Months,79.7,76.9 to 82.1,2019
DTaP,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,5 Months,79.2,77.4 to 81.0,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,92.6,90.9 to 94.2,1835
Hib,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,90.9,89.5 to 92.2,3854
Hib,≥3 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,88.8,86.7 to 90.8,1735
Hib,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,90.7,89.3 to 92.0,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,94.1,92.5 to 95.5,2023
Hep A,≥1 Dose,HHS Regions/National,Region 5,2013,Age,19 Months,77.4,74.6 to 80.0,1730
Hep A,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,19 Months,78.3,75.9 to 80.6,3456
Hib,Full Series,HHS Regions/National,Region 5,2021,Age,19 Months,71.0,67.5 to 74.2,1478
DTaP,≥1 Dose,HHS Regions/National,Region 5,2016,Age,3 Months,88.7,86.6 to 90.6,1835
DTaP,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,3 Months,88.0,86.4 to 89.4,3854
DTaP,≥1 Dose,HHS Regions/National,Region 5,2015,Age,3 Months,85.7,83.3 to 87.9,1735
DTaP,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,3 Months,87.2,85.6 to 88.7,3570
DTaP,≥1 Dose,HHS Regions/National,Region 5,2014,Age,3 Months,87.0,84.8 to 89.0,1726
DTaP,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,3 Months,86.4,84.7 to 87.9,3461
DTaP,≥1 Dose,HHS Regions/National,Region 5,2013,Age,3 Months,85.1,82.2 to 87.7,1730
DTaP,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,3 Months,86.1,83.8 to 88.1,3456
DTaP,≥1 Dose,HHS Regions/National,Region 5,2011,Age,3 Months,87.7,85.5 to 89.5,1771
DTaP,≥1 Dose,HHS Regions/National,Region 5,2012,Age,3 Months,85.8,82.6 to 88.5,1752
Combined 7 Series,,HHS Regions/National,Region 5,2021,Age,35 Months,71.4,67.5 to 75.2,1478
PCV,≥4 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,78.8,75.5 to 81.7,1478
Hib,Primary Series,HHS Regions/National,Region 5,2021,Age,7 Months,69.5,66.0 to 72.8,1478
Hib,Primary Series,HHS Regions/National,Region 5,2015,Age,35 Months,92.5,90.7 to 94.1,1735
Hib,Primary Series,HHS Regions/National,Region 5,2015-2016,Age,35 Months,93.7,92.5 to 94.7,3570
Combined 7 Series,,HHS Regions/National,Region 5,2011,Age,24 Months,64.8,61.7 to 68.0,1771
Combined 7 Series,,HHS Regions/National,Region 5,2012,Age,24 Months,67.8,64.7 to 71.0,1752
≥1 Dose MMR,,HHS Regions/National,Region 5,2020,Age,13 Months,69.5,66.8 to 72.1,2239
Hib,Primary Series,HHS Regions/National,Region 5,2013,Age,7 Months,68.0,63.8 to 72.0,1730
Hib,Primary Series,HHS Regions/National,Region 5,2013-2014,Age,7 Months,69.1,66.5 to 71.5,3456
Hib,Primary Series,HHS Regions/National,Region 5,2013,Age,35 Months,94.1,92.4 to 95.6,1730
Hib,Primary Series,HHS Regions/National,Region 5,2013-2014,Age,35 Months,93.7,92.4 to 94.8,3456
Hib,Primary Series,HHS Regions/National,Region 5,2011,Age,35 Months,94.0,92.1 to 95.5,1771
Hib,Primary Series,HHS Regions/National,Region 5,2019,Age,24 Months,93.5,91.8 to 94.9,2023
Hib,Primary Series,HHS Regions/National,Region 5,2012,Age,35 Months,92.4,90.4 to 94.1,1752
Hib,Primary Series,HHS Regions/National,Region 5,2014,Age,35 Months,93.3,91.5 to 94.7,1726
Hib,Primary Series,HHS Regions/National,Region 5,2014-2015,Age,35 Months,92.9,91.7 to 94.0,3461
Combined 7 Series,,HHS Regions/National,Region 5,2013,Age,24 Months,67.6,64.4 to 70.7,1730
Combined 7 Series,,HHS Regions/National,Region 5,2013-2014,Age,24 Months,68.4,66.2 to 70.6,3456
Hib,Primary Series,HHS Regions/National,Region 5,2013,Age,24 Months,93.1,91.3 to 94.6,1730
Hib,Primary Series,HHS Regions/National,Region 5,2013-2014,Age,24 Months,93.0,91.7 to 94.1,3456
Hib,Primary Series,HHS Regions/National,Region 5,2018,Age,24 Months,93.4,91.9 to 94.7,2204
Hib,Primary Series,HHS Regions/National,Region 5,2018-2019,Age,24 Months,93.4,92.3 to 94.4,4227
Hib,Primary Series,HHS Regions/National,Region 5,2016,Age,24 Months,94.4,92.8 to 95.7,1835
Hib,Primary Series,HHS Regions/National,Region 5,2016-2017,Age,24 Months,93.0,91.7 to 94.1,3854
Hib,Primary Series,HHS Regions/National,Region 5,2017,Age,24 Months,91.6,89.4 to 93.4,2019
Hib,Primary Series,HHS Regions/National,Region 5,2017-2018,Age,24 Months,92.5,91.2 to 93.6,4223
Hib,Primary Series,HHS Regions/National,Region 5,2019,Age,7 Months,71.3,68.4 to 74.0,2023
Hib,Primary Series,HHS Regions/National,Region 5,2015,Age,13 Months,83.8,81.2 to 86.1,1735
Hib,Primary Series,HHS Regions/National,Region 5,2015-2016,Age,13 Months,86.3,84.6 to 87.8,3570
Hib,Primary Series,HHS Regions/National,Region 5,2014,Age,13 Months,88.0,85.8 to 89.9,1726
Hib,Primary Series,HHS Regions/National,Region 5,2014-2015,Age,13 Months,85.9,84.2 to 87.4,3461
Hib,Primary Series,HHS Regions/National,Region 5,2015,Age,24 Months,91.7,89.9 to 93.3,1735
Hib,Primary Series,HHS Regions/National,Region 5,2015-2016,Age,24 Months,93.0,91.8 to 94.1,3570
Hib,Primary Series,HHS Regions/National,Region 5,2014,Age,24 Months,92.9,91.1 to 94.3,1726
Hib,Primary Series,HHS Regions/National,Region 5,2014-2015,Age,24 Months,92.3,91.0 to 93.4,3461
Hib,Primary Series,HHS Regions/National,Region 5,2018,Age,7 Months,73.0,70.3 to 75.5,2204
Hib,Primary Series,HHS Regions/National,Region 5,2018-2019,Age,7 Months,72.1,70.2 to 74.0,4227
Hib,Primary Series,HHS Regions/National,Region 5,2017,Age,7 Months,74.1,71.3 to 76.8,2019
Hib,Primary Series,HHS Regions/National,Region 5,2017-2018,Age,7 Months,73.5,71.6 to 75.4,4223
Hib,Primary Series,HHS Regions/National,Region 5,2016,Age,7 Months,72.3,69.3 to 75.1,1835
Hib,Primary Series,HHS Regions/National,Region 5,2016-2017,Age,7 Months,73.2,71.1 to 75.2,3854
Hib,Primary Series,HHS Regions/National,Region 5,2011,Age,13 Months,86.7,84.3 to 88.8,1771
Hib,Primary Series,HHS Regions/National,Region 5,2012,Age,13 Months,86.5,83.1 to 89.2,1752
Hib,Primary Series,HHS Regions/National,Region 5,2013,Age,13 Months,87.6,84.9 to 89.9,1730
Hib,Primary Series,HHS Regions/National,Region 5,2013-2014,Age,13 Months,87.8,86.0 to 89.4,3456
Hib,Primary Series,HHS Regions/National,Region 5,2016,Age,13 Months,88.8,86.6 to 90.7,1835
Hib,Primary Series,HHS Regions/National,Region 5,2016-2017,Age,13 Months,88.1,86.5 to 89.6,3854
Hib,Primary Series,HHS Regions/National,Region 5,2019,Age,13 Months,87.4,85.1 to 89.3,2023
Hib,Primary Series,HHS Regions/National,Region 5,2018,Age,19 Months,92.3,90.6 to 93.6,2204
Hib,Primary Series,HHS Regions/National,Region 5,2018-2019,Age,19 Months,87.3,85.8 to 88.7,4227
Hib,Primary Series,HHS Regions/National,Region 5,2011,Age,19 Months,91.5,89.4 to 93.1,1771
Hib,Primary Series,HHS Regions/National,Region 5,2013,Age,19 Months,91.7,89.3 to 93.6,1730
Hib,Primary Series,HHS Regions/National,Region 5,2013-2014,Age,19 Months,91.7,90.3 to 92.9,3456
Hib,Primary Series,HHS Regions/National,Region 5,2014,Age,19 Months,91.6,89.7 to 93.2,1726
Hib,Primary Series,HHS Regions/National,Region 5,2014-2015,Age,19 Months,90.7,89.3 to 92.0,3461
Hib,Primary Series,HHS Regions/National,Region 5,2015,Age,7 Months,67.3,64.2 to 70.2,1735
Hib,Primary Series,HHS Regions/National,Region 5,2015-2016,Age,7 Months,69.8,67.6 to 71.8,3570
Hib,Primary Series,HHS Regions/National,Region 5,2014,Age,7 Months,70.2,67.1 to 73.0,1726
Hib,Primary Series,HHS Regions/National,Region 5,2014-2015,Age,7 Months,68.7,66.6 to 70.8,3461
Hib,Primary Series,HHS Regions/National,Region 5,2017,Age,13 Months,87.4,85.0 to 89.5,2019
Hib,Primary Series,HHS Regions/National,Region 5,2017-2018,Age,13 Months,87.3,85.8 to 88.7,4223
Hib,Primary Series,HHS Regions/National,Region 5,2018,Age,13 Months,87.2,85.2 to 89.0,2204
Hib,Primary Series,HHS Regions/National,Region 5,2018-2019,Age,13 Months,87.3,85.8 to 88.7,4227
Hib,Primary Series,HHS Regions/National,Region 5,2012,Age,19 Months,91.0,88.2 to 93.2,1752
Hib,Primary Series,HHS Regions/National,Region 5,2015,Age,19 Months,89.9,87.2 to 92.0,1735
Hib,Primary Series,HHS Regions/National,Region 5,2015-2016,Age,19 Months,91.5,90.2 to 92.7,3570
Hib,Primary Series,HHS Regions/National,Region 5,2017,Age,19 Months,91.2,89.0 to 93.0,2019
Hib,Primary Series,HHS Regions/National,Region 5,2017-2018,Age,19 Months,91.7,90.4 to 92.9,4223
Hib,Primary Series,HHS Regions/National,Region 5,2019,Age,19 Months,92.4,90.6 to 93.9,2023
Hib,Primary Series,HHS Regions/National,Region 5,2016,Age,19 Months,93.2,91.5 to 94.7,1835
Hib,Primary Series,HHS Regions/National,Region 5,2016-2017,Age,19 Months,92.3,90.8 to 93.5,3854
Hib,Primary Series,HHS Regions/National,Region 5,2011,Age,24 Months,92.7,90.8 to 94.3,1771
Hib,Primary Series,HHS Regions/National,Region 5,2012,Age,24 Months,91.7,89.7 to 93.4,1752
Hib,Full Series,HHS Regions/National,Region 5,2013,Age,24 Months,80.3,77.5 to 82.9,1730
Hib,Full Series,HHS Regions/National,Region 5,2013-2014,Age,24 Months,79.8,77.8 to 81.7,3456
Hib,Full Series,HHS Regions/National,Region 5,2014,Age,24 Months,79.3,76.6 to 81.9,1726
Hib,Full Series,HHS Regions/National,Region 5,2014-2015,Age,24 Months,77.2,75.2 to 79.1,3461
Hib,Full Series,HHS Regions/National,Region 5,2016,Age,19 Months,76.4,73.5 to 79.0,1835
Hib,Full Series,HHS Regions/National,Region 5,2016-2017,Age,19 Months,75.8,73.8 to 77.7,3854
Hib,Full Series,HHS Regions/National,Region 5,2015,Age,19 Months,69.6,65.5 to 73.4,1735
Hib,Full Series,HHS Regions/National,Region 5,2015-2016,Age,19 Months,73.0,70.9 to 75.0,3570
Hib,Full Series,HHS Regions/National,Region 5,2014,Age,19 Months,74.5,71.6 to 77.2,1726
Hib,Full Series,HHS Regions/National,Region 5,2014-2015,Age,19 Months,72.1,70.0 to 74.1,3461
Hib,Full Series,HHS Regions/National,Region 5,2019,Age,19 Months,74.3,71.4 to 76.9,2023
Hib,Full Series,HHS Regions/National,Region 5,2012,Age,24 Months,78.5,75.6 to 81.2,1752
Hib,Full Series,HHS Regions/National,Region 5,2011,Age,24 Months,78.6,75.9 to 81.3,1771
Hib,Full Series,HHS Regions/National,Region 5,2018,Age,19 Months,72.6,69.9 to 75.1,2204
Hib,Full Series,HHS Regions/National,Region 5,2018-2019,Age,19 Months,95.6,94.7 to 96.3,4227
Hib,Full Series,HHS Regions/National,Region 5,2017,Age,19 Months,75.3,72.5 to 77.9,2019
Hib,Full Series,HHS Regions/National,Region 5,2017-2018,Age,19 Months,74.0,72.0 to 75.8,4223
Combined 7 Series,,HHS Regions/National,Region 5,2018,Age,35 Months,76.2,73.2 to 79.1,2204
Combined 7 Series,,HHS Regions/National,Region 5,2018-2019,Age,35 Months,75.3,73.1 to 77.5,4227
Combined 7 Series,,HHS Regions/National,Region 5,2019,Age,35 Months,74.2,71.1 to 77.2,2023
Combined 7 Series,,HHS Regions/National,Region 5,2015,Age,35 Months,70.4,66.9 to 73.8,1735
Combined 7 Series,,HHS Regions/National,Region 5,2015-2016,Age,35 Months,73.0,70.7 to 75.2,3570
Hib,Full Series,HHS Regions/National,Region 5,2011,Age,19 Months,71.2,68.0 to 74.2,1771
Hib,Full Series,HHS Regions/National,Region 5,2012,Age,19 Months,73.7,70.2 to 76.9,1752
Hib,Full Series,HHS Regions/National,Region 5,2013,Age,19 Months,73.9,70.0 to 77.4,1730
Hib,Full Series,HHS Regions/National,Region 5,2013-2014,Age,19 Months,74.2,71.9 to 76.3,3456
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,59.2,51.7 to 66.6,257
Hep B,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,96.0,92.2 to 98.0,436
Hep A,≥1 Dose,States/Local Areas,New Jersey,2021,Age,35 Months,83.6,72.8 to 91.9,168
PCV,≥3 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,90.6,81.7 to 95.4,168
Hib,Primary Series,States/Local Areas,New Jersey,2021,Age,7 Months,69.2,58.8 to 77.9,168
Hep B,≥3 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,91.5,83.6 to 96.6,168
PCV,≥4 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,72.5,61.6 to 81.2,168
Hep A,≥2 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,70.1,56.5 to 82.7,168
DTaP,≥4 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,67.0,56.2 to 76.2,168
Hib,Full Series,States/Local Areas,New Jersey,2021,Age,24 Months,77.4,66.9 to 86.6,168
Hib,≥1 Dose,States/Local Areas,New Jersey,2021,Age,3 Months,84.9,75.6 to 91.0,168
Hib,≥3 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,89.5,81.3 to 95.2,168
Hib,Primary Series,States/Local Areas,New Jersey,2021,Age,24 Months,90.8,82.8 to 96.0,168
≥1 Dose MMR,,States/Local Areas,New Jersey,2021,Age,24 Months,81.6,71.8 to 89.6,168
Polio,≥3 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,93.7,87.0 to 97.7,168
Polio,≥1 Dose,States/Local Areas,New Jersey,2021,Age,3 Months,89.8,81.9 to 94.4,168
DTaP,≥4 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,85.6,74.5 to 93.5,168
DTaP,≥1 Dose,States/Local Areas,New Jersey,2021,Age,3 Months,90.3,82.4 to 94.9,168
Hep A,≥2 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,19.7,13.0 to 28.7,168
Polio,≥2 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,91.7,82.1 to 96.4,168
DTaP,≥3 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,89.1,79.6 to 94.5,168
Hep A,≥1 Dose,States/Local Areas,New Jersey,2021,Age,19 Months,75.9,65.3 to 84.1,168
PCV,≥4 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,81.5,70.7 to 90.1,168
Combined 7 Series,,States/Local Areas,New Jersey,2021,Age,24 Months,60.3,49.8 to 71.0,168
PCV,≥3 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,59.2,48.7 to 69.0,168
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,92.9,88.5 to 96.1,436
Hep A,≥2 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,41.4,31.3 to 53.3,168
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,94.0,89.6 to 97.0,436
Combined 7 Series,,States/Local Areas,New Jersey,2015,Age,35 Months,79.6,72.0 to 86.3,315
Combined 7 Series,,States/Local Areas,New Jersey,2015-2016,Age,35 Months,77.1,71.3 to 82.5,613
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,66.7,59.9 to 73.5,328
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,77.1,72.1 to 82.1,529
Hib,Full Series,States/Local Areas,New Jersey,2011,Age,19 Months,73.1,68.0 to 77.6,264
Hib,Full Series,States/Local Areas,New Jersey,2012,Age,19 Months,72.3,64.7 to 78.9,288
Hib,Full Series,States/Local Areas,New Jersey,2013,Age,19 Months,75.1,70.1 to 79.5,252
Hib,Full Series,States/Local Areas,New Jersey,2013-2014,Age,19 Months,71.7,67.6 to 75.5,586
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.1,67.1 to 83.1,206
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.5,65.1 to 75.9,538
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.6,63.5 to 71.7,952
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,70.4,61.5 to 79.4,162
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Overall,Overall,68.2,64.5 to 71.9,1114
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,89.9,83.8 to 93.8,268
PCV,≥3 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,69.6,61.6 to 76.6,268
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.2,77.3 to 85.2,874
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,77.4,67.2 to 87.5,134
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.9,92.6 to 97.1,874
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,89.0 to 98.9,134
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.8,68.9 to 82.6,874
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020-2021,Age,35 Months,91.7,85.8 to 95.8,436
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2021,Age,0-1 Days,71.5,61.3 to 79.8,168
Hib,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,92.4,87.2 to 95.6,436
Rotavirus,,States/Local Areas,New Jersey,2019-2020,Age,8 Months,72.4,66.7 to 77.5,547
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.6,87.8 to 93.4,874
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.6,75.5 to 83.7,874
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,75.6,65.5 to 85.7,134
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.6,77.0 to 84.3,874
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,87.2,79.9 to 94.6,134
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,60.6,49.6 to 71.7,134
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.6,71.4 to 79.8,874
Influenza,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.3,64.9 to 73.6,874
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,67.6,63.1 to 72.1,874
Influenza,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,54.7,43.5 to 65.9,134
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.7,79.0 to 86.4,874
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,85.9 to 91.8,874
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.8 to 95.9,874
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,90.7,84.1 to 97.3,134
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,71.6,64.2 to 78.9,290
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,57.3,48.6 to 66.1,203
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,88.8,81.7 to 95.9,134
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,92.3,89.1 to 95.5,515
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,80.5,74.0 to 87.0,290
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,69.1,63.2 to 75.0,515
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,68.3,61.0 to 75.7,290
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,68.0,55.8 to 80.2,203
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,93.9,90.8 to 96.9,515
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,88.6,82.8 to 94.4,203
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,90.4,85.6 to 95.1,290
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,94.7,92.6 to 96.7,1008
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,91.3,88.7 to 93.8,1008
Influenza,,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,60.6,52.9 to 68.3,290
Influenza,,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,53.4,44.5 to 62.2,203
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,92.8,89.7 to 95.9,515
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,91.0,86.7 to 95.2,290
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,81.0,74.0 to 87.9,203
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,88.9,84.9 to 93.0,515
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,83.5,76.9 to 90.1,203
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,87.6,81.7 to 93.6,203
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,86.8,82.4 to 91.3,515
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,78.3,71.0 to 85.7,290
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,68.6,60.3 to 76.9,203
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,83.8,79.1 to 88.5,515
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,65.9,57.4 to 74.4,203
Influenza,,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,80.8,75.7 to 85.9,515
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,91.8,87.8 to 95.9,286
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,57.1,49.7 to 64.4,286
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.1,92.7 to 97.5,506
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,94.3,90.3 to 97.0,268
Hep B,≥1 Dose,States/Local Areas,New Jersey,2020,Age,3 Months,97.1,92.6 to 98.9,268
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,42.7,35.1 to 50.7,268
Hib,≥1 Dose,States/Local Areas,New Jersey,2020,Age,3 Months,78.0,70.0 to 84.3,268
Polio,≥1 Dose,States/Local Areas,New Jersey,2020,Age,3 Months,79.3,71.5 to 85.4,268
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,75.8,69.1 to 82.6,695
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,78.1,66.3 to 89.9,286
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.9,94.5 to 99.2,167
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,91.5,88.6 to 94.5,695
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.3,53.2 to 83.4,59
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,75.0,67.5 to 82.4,276
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,79.8 to 95.5,167
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,93.5,90.7 to 96.3,695
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,86.1,81.1 to 91.1,286
Influenza,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,56.1,48.3 to 64.0,276
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,80.5,76.7 to 84.2,1008
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,93.4,91.3 to 95.6,1008
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,84.2,79.5 to 89.0,515
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,92.8,90.4 to 95.3,1008
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,69.5,61.1 to 77.9,203
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Overall,Overall,89.8,87.1 to 92.5,1008
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,82.7,77.1 to 88.2,290
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,81.0,77.4 to 84.6,1008
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,78.5,71.4 to 85.6,203
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,75.3,67.2 to 83.4,515
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Overall,Overall,81.9,78.7 to 85.2,1008
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,83.7,73.3 to 94.1,290
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,94.0,90.0 to 97.9,290
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,84.7,78.3 to 91.2,203
Influenza,,States/Local Areas,New Jersey,2016-2019,Overall,Overall,66.4,62.3 to 70.6,1008
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Overall,Overall,72.0,68.1 to 75.9,1008
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,86.7,80.9 to 92.5,203
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Overall,Overall,76.5,70.2 to 82.8,1008
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Overall,Overall,72.7,68.6 to 76.7,1008
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Overall,Overall,88.8,86.1 to 91.6,1008
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,80.0,72.9 to 87.0,290
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,98.2,96.5 to 99.9,515
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,63.9,56.0 to 71.8,290
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,95.6,92.7 to 98.6,290
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,78.4,73.1 to 83.6,515
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,52.4,43.7 to 61.0,203
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,96.5,94.2 to 98.8,515
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Poverty,<133% FPL,80.4,73.6 to 87.2,203
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,89.1,84.1 to 94.1,290
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Overall,Overall,78.8,75.0 to 82.6,1008
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,71.2,60.8 to 81.7,134
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.2,68.1 to 76.3,874
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,97.0,94.8 to 99.2,515
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,133% to <400% FPL,94.2,91.0 to 97.4,290
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Overall,Overall,66.3,62.0 to 70.5,1008
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,60.8,49.7 to 71.9,134
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.8 to 95.7,874
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,89.1 to 99.0,134
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.8,89.3 to 94.4,874
PCV,≥3 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,85.0,75.1 to 91.4,168
PCV,≥3 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,91.7,84.1 to 96.5,168
Hib,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,81.8,75.9 to 86.5,436
Hep A,≥1 Dose,States/Local Areas,New Jersey,2021,Age,24 Months,81.0,70.7 to 89.4,168
≥1 Dose Varicella,,States/Local Areas,New Jersey,2021,Age,24 Months,82.4,72.5 to 90.4,168
PCV,≥4 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,77.1,67.0 to 86.0,168
PCV,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,96.1,92.1 to 98.4,436
Hep B,≥3 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,42.1,32.3 to 52.6,168
DTaP,≥3 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,92.1,83.3 to 96.5,168
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2021,Age,0-2 Days,77.9,68.5 to 85.1,168
PCV,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,5 Months,73.3,66.8 to 78.9,436
Hib,Full Series,States/Local Areas,New Jersey,2019,Age,19 Months,72.3,63.7 to 79.6,279
Hib,Full Series,States/Local Areas,New Jersey,2017,Age,19 Months,70.4,62.2 to 77.5,263
Hib,Full Series,States/Local Areas,New Jersey,2017-2018,Age,19 Months,74.6,69.2 to 79.4,532
Hib,Full Series,States/Local Areas,New Jersey,2014,Age,19 Months,68.2,61.1 to 74.6,334
Hib,Full Series,States/Local Areas,New Jersey,2014-2015,Age,19 Months,72.7,67.9 to 77.0,649
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,62.9,55.8 to 70.0,299
Hib,Full Series,States/Local Areas,New Jersey,2018,Age,19 Months,78.8,71.5 to 84.7,269
Hib,Full Series,States/Local Areas,New Jersey,2018-2019,Age,19 Months,96.2,92.8 to 98.1,548
Hib,Full Series,States/Local Areas,New Jersey,2015,Age,19 Months,77.2,70.4 to 82.8,315
Hib,Full Series,States/Local Areas,New Jersey,2015-2016,Age,19 Months,74.7,69.5 to 79.3,613
Hib,Full Series,States/Local Areas,New Jersey,2016,Age,19 Months,72.2,63.8 to 79.3,298
Hib,Full Series,States/Local Areas,New Jersey,2016-2017,Age,19 Months,71.3,65.5 to 76.5,561
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.4,50.9 to 79.8,71
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,73.8,69.6 to 78.1,756
Combined 7 Series,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,61.0,54.2 to 67.7,321
Combined 7 Series,,States/Local Areas,New Jersey,2019,Age,35 Months,69.4,60.5 to 78.0,279
Combined 7 Series,,States/Local Areas,New Jersey,2018,Age,35 Months,71.4,63.6 to 78.7,269
Combined 7 Series,,States/Local Areas,New Jersey,2018-2019,Age,35 Months,70.4,64.5 to 76.1,548
Hib,Primary Series,States/Local Areas,New Jersey,2019,Age,19 Months,92.6,85.5 to 96.3,279
Hib,Full Series,States/Local Areas,New Jersey,2012,Age,24 Months,80.3,74.1 to 85.9,288
Hib,Full Series,States/Local Areas,New Jersey,2011,Age,24 Months,81.2,73.9 to 87.5,264
Hib,Full Series,States/Local Areas,New Jersey,2013,Age,24 Months,85.2,78.9 to 90.4,252
Hib,Full Series,States/Local Areas,New Jersey,2013-2014,Age,24 Months,81.0,76.4 to 85.1,586
Hib,Full Series,States/Local Areas,New Jersey,2014,Age,24 Months,76.6,70.0 to 82.7,334
Hib,Full Series,States/Local Areas,New Jersey,2014-2015,Age,24 Months,79.4,75.0 to 83.5,649
Hib,Primary Series,States/Local Areas,New Jersey,2011,Age,24 Months,95.0,90.3 to 97.9,264
Hib,Primary Series,States/Local Areas,New Jersey,2012,Age,24 Months,94.3,90.4 to 97.0,288
Hib,Primary Series,States/Local Areas,New Jersey,2017,Age,19 Months,87.7,80.2 to 92.6,263
Hib,Primary Series,States/Local Areas,New Jersey,2017-2018,Age,19 Months,91.5,87.2 to 94.5,532
Hib,Primary Series,States/Local Areas,New Jersey,2016,Age,19 Months,92.9,87.3 to 96.2,298
Hib,Primary Series,States/Local Areas,New Jersey,2016-2017,Age,19 Months,90.3,85.9 to 93.5,561
Hib,Primary Series,States/Local Areas,New Jersey,2015,Age,19 Months,94.3,90.8 to 96.6,315
Hib,Primary Series,States/Local Areas,New Jersey,2015-2016,Age,19 Months,93.6,90.5 to 95.8,613
Hib,Primary Series,States/Local Areas,New Jersey,2014,Age,19 Months,90.8,85.2 to 94.4,334
Hib,Primary Series,States/Local Areas,New Jersey,2014-2015,Age,19 Months,92.6,89.4 to 94.8,649
Hib,Primary Series,States/Local Areas,New Jersey,2013,Age,19 Months,97.1,95.6 to 98.2,252
Hib,Primary Series,States/Local Areas,New Jersey,2013-2014,Age,19 Months,94.0,90.9 to 96.1,586
Hib,Primary Series,States/Local Areas,New Jersey,2018,Age,13 Months,91.6,86.4 to 95.0,269
Hib,Primary Series,States/Local Areas,New Jersey,2018-2019,Age,13 Months,90.6,86.4 to 93.6,548
Hib,Primary Series,States/Local Areas,New Jersey,2018,Age,19 Months,95.4,90.5 to 97.8,269
Hib,Primary Series,States/Local Areas,New Jersey,2018-2019,Age,19 Months,90.6,86.4 to 93.6,548
Hib,Primary Series,States/Local Areas,New Jersey,2012,Age,19 Months,93.2,89.7 to 95.6,288
Hib,Primary Series,States/Local Areas,New Jersey,2011,Age,19 Months,94.8,91.1 to 97.0,264
Hib,Primary Series,States/Local Areas,New Jersey,2019,Age,13 Months,89.6,82.3 to 94.1,279
Hib,Primary Series,States/Local Areas,New Jersey,2017,Age,13 Months,81.9,73.7 to 87.9,263
Hib,Primary Series,States/Local Areas,New Jersey,2017-2018,Age,13 Months,86.7,81.9 to 90.4,532
Hib,Primary Series,States/Local Areas,New Jersey,2016,Age,13 Months,89.7,83.5 to 93.7,298
Hib,Primary Series,States/Local Areas,New Jersey,2016-2017,Age,13 Months,85.8,80.8 to 89.6,561
Combined 7 Series,,States/Local Areas,New Jersey,2011,Age,24 Months,67.6,59.6 to 75.4,264
Hib,Primary Series,States/Local Areas,New Jersey,2013,Age,7 Months,61.4,51.0 to 70.8,252
Hib,Primary Series,States/Local Areas,New Jersey,2013-2014,Age,7 Months,63.3,57.1 to 69.0,586
Hib,Primary Series,States/Local Areas,New Jersey,2017,Age,7 Months,66.2,57.7 to 73.7,263
Hib,Primary Series,States/Local Areas,New Jersey,2017-2018,Age,7 Months,71.9,66.2 to 77.0,532
Hib,Primary Series,States/Local Areas,New Jersey,2016,Age,7 Months,64.7,56.2 to 72.4,298
Hib,Primary Series,States/Local Areas,New Jersey,2016-2017,Age,7 Months,65.4,59.5 to 70.9,561
Hib,Primary Series,States/Local Areas,New Jersey,2015,Age,7 Months,73.1,66.6 to 78.8,315
Hib,Primary Series,States/Local Areas,New Jersey,2015-2016,Age,7 Months,68.9,63.6 to 73.8,613
Hib,Primary Series,States/Local Areas,New Jersey,2014,Age,7 Months,65.2,57.8 to 71.9,334
Hib,Primary Series,States/Local Areas,New Jersey,2014-2015,Age,7 Months,69.1,64.2 to 73.7,649
Hib,Primary Series,States/Local Areas,New Jersey,2011,Age,13 Months,91.4,85.3 to 95.1,264
Hib,Primary Series,States/Local Areas,New Jersey,2012,Age,13 Months,91.2,86.4 to 94.4,288
Hib,Primary Series,States/Local Areas,New Jersey,2013,Age,13 Months,95.0,92.3 to 96.8,252
Hib,Primary Series,States/Local Areas,New Jersey,2013-2014,Age,13 Months,90.7,87.4 to 93.2,586
Hib,Primary Series,States/Local Areas,New Jersey,2018,Age,7 Months,77.7,70.0 to 83.8,269
Hib,Primary Series,States/Local Areas,New Jersey,2018-2019,Age,7 Months,73.1,67.3 to 78.2,548
Hib,Primary Series,States/Local Areas,New Jersey,2019,Age,7 Months,68.3,59.5 to 76.1,279
Hib,Primary Series,States/Local Areas,New Jersey,2015,Age,13 Months,92.7,88.9 to 95.3,315
Hib,Primary Series,States/Local Areas,New Jersey,2015-2016,Age,13 Months,91.2,87.8 to 93.8,613
Hib,Primary Series,States/Local Areas,New Jersey,2014,Age,13 Months,86.4,80.3 to 90.7,334
Hib,Primary Series,States/Local Areas,New Jersey,2014-2015,Age,13 Months,89.5,86.1 to 92.2,649
Hib,Primary Series,States/Local Areas,New Jersey,2017,Age,24 Months,89.6,83.0 to 94.5,263
Hib,Primary Series,States/Local Areas,New Jersey,2017-2018,Age,24 Months,92.5,88.7 to 95.5,532
Hib,Primary Series,States/Local Areas,New Jersey,2016,Age,24 Months,93.0,88.0 to 96.5,298
Hib,Primary Series,States/Local Areas,New Jersey,2016-2017,Age,24 Months,91.3,87.3 to 94.5,561
Combined 7 Series,,States/Local Areas,New Jersey,2013,Age,24 Months,68.0,60.1 to 75.8,252
Combined 7 Series,,States/Local Areas,New Jersey,2013-2014,Age,24 Months,66.2,60.9 to 71.4,586
Combined 7 Series,,States/Local Areas,New Jersey,2012,Age,24 Months,64.3,57.0 to 71.5,288
Hib,Primary Series,States/Local Areas,New Jersey,2018,Age,24 Months,95.4,91.2 to 98.0,269
Hib,Primary Series,States/Local Areas,New Jersey,2018-2019,Age,24 Months,94.8,91.4 to 97.2,548
Hib,Primary Series,States/Local Areas,New Jersey,2015,Age,24 Months,95.2,92.1 to 97.4,315
Hib,Primary Series,States/Local Areas,New Jersey,2015-2016,Age,24 Months,94.1,91.2 to 96.3,613
Hib,Primary Series,States/Local Areas,New Jersey,2014,Age,24 Months,90.9,85.9 to 94.8,334
Hib,Primary Series,States/Local Areas,New Jersey,2014-2015,Age,24 Months,93.1,90.1 to 95.4,649
Hib,Primary Series,States/Local Areas,New Jersey,2013,Age,24 Months,97.4,95.1 to 98.8,252
Hib,Primary Series,States/Local Areas,New Jersey,2013-2014,Age,24 Months,94.2,91.5 to 96.3,586
Hib,Primary Series,States/Local Areas,New Jersey,2012,Age,35 Months,94.3,90.4 to 97.0,288
Hib,Primary Series,States/Local Areas,New Jersey,2014,Age,35 Months,90.9,85.9 to 94.8,334
Hib,Primary Series,States/Local Areas,New Jersey,2014-2015,Age,35 Months,93.1,90.1 to 95.4,649
Hib,Primary Series,States/Local Areas,New Jersey,2011,Age,35 Months,95.9,91.0 to 98.6,264
Hib,Primary Series,States/Local Areas,New Jersey,2019,Age,24 Months,94.2,88.4 to 97.7,279
Hib,Primary Series,States/Local Areas,New Jersey,2013,Age,35 Months,98.8,97.2 to 99.6,252
Hib,Primary Series,States/Local Areas,New Jersey,2013-2014,Age,35 Months,95.2,92.5 to 97.2,586
Hib,Primary Series,States/Local Areas,New Jersey,2016,Age,35 Months,93.4,88.4 to 96.7,298
Hib,Primary Series,States/Local Areas,New Jersey,2016-2017,Age,35 Months,92.6,88.6 to 95.5,561
Combined 7 Series,,States/Local Areas,New Jersey,2019,Age,24 Months,64.2,55.6 to 72.7,279
Combined 7 Series,,States/Local Areas,New Jersey,2017,Age,24 Months,66.8,58.9 to 74.5,263
Combined 7 Series,,States/Local Areas,New Jersey,2017-2018,Age,24 Months,67.9,62.4 to 73.3,532
Combined 7 Series,,States/Local Areas,New Jersey,2018,Age,24 Months,68.9,61.2 to 76.3,269
Combined 7 Series,,States/Local Areas,New Jersey,2018-2019,Age,24 Months,66.6,60.8 to 72.3,548
Hib,Primary Series,States/Local Areas,New Jersey,2017,Age,35 Months,91.5,85.1 to 95.9,263
Hib,Primary Series,States/Local Areas,New Jersey,2017-2018,Age,35 Months,93.9,90.1 to 96.6,532
Hib,Primary Series,States/Local Areas,New Jersey,2015,Age,35 Months,95.2,92.1 to 97.4,315
Hib,Primary Series,States/Local Areas,New Jersey,2015-2016,Age,35 Months,94.3,91.4 to 96.4,613
Combined 7 Series,,States/Local Areas,New Jersey,2014,Age,35 Months,71.5,64.2 to 78.4,334
Combined 7 Series,,States/Local Areas,New Jersey,2014-2015,Age,35 Months,75.5,70.2 to 80.4,649
Combined 7 Series,,States/Local Areas,New Jersey,2011,Age,35 Months,74.6,65.9 to 82.6,264
Combined 7 Series,,States/Local Areas,New Jersey,2016,Age,35 Months,73.7,65.5 to 81.3,298
Combined 7 Series,,States/Local Areas,New Jersey,2016-2017,Age,35 Months,74.6,68.3 to 80.5,561
Combined 7 Series,,States/Local Areas,New Jersey,2017,Age,35 Months,75.0,65.9 to 83.2,263
Combined 7 Series,,States/Local Areas,New Jersey,2017-2018,Age,35 Months,74.0,67.6 to 79.9,532
Combined 7 Series,,States/Local Areas,New Jersey,2013,Age,35 Months,76.1,67.9 to 83.6,252
Combined 7 Series,,States/Local Areas,New Jersey,2013-2014,Age,35 Months,73.7,68.2 to 78.9,586
Combined 7 Series,,States/Local Areas,New Jersey,2012,Age,35 Months,78.5,70.2 to 85.8,288
Hep A,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,28.8,23.8 to 34.6,547
Polio,≥2 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,94.4,89.3 to 97.1,268
Hep A,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,24 Months,82.9,78.2 to 87.1,547
Hep A,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,77.2,68.3 to 85.1,547
Hep A,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,35 Months,90.3,84.5 to 94.6,547
Influenza,,States/Local Areas,New Jersey,2019-2020,Age,24 Months,68.3,62.7 to 73.8,547
Hib,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,94.5,91.1 to 96.8,547
Hib,Full Series,States/Local Areas,New Jersey,2019-2020,Age,24 Months,81.9,76.7 to 86.5,547
Hib,Primary Series,States/Local Areas,New Jersey,2019-2020,Age,24 Months,94.4,91.1 to 96.8,547
Hib,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,65.6,59.7 to 71.0,547
Combined 7 Series,,States/Local Areas,New Jersey,2019-2020,Age,35 Months,70.1,64.1 to 75.9,547
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2019-2020,Age,0-1 Days,77.9,72.7 to 82.3,547
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019-2020,Age,19 Months,84.8,79.6 to 88.9,547
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,89.5,85.1 to 92.7,547
PCV,≥4 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,73.8,67.9 to 78.9,547
Hep A,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,19 Months,75.5,70.0 to 80.2,547
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2019-2020,Age,0-2 Days,80.3,75.3 to 84.6,547
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019-2020,Age,24 Months,91.4,87.4 to 94.4,547
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,92.2,88.5 to 95.1,547
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2019-2020,Age,0-3 Days,82.6,77.7 to 86.6,547
PCV,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,64.4,58.4 to 69.9,547
PCV,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,93.5,89.8 to 96.2,547
PCV,≥4 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,77.8,72.2 to 82.9,547
≥1 Dose MMR,,States/Local Areas,New Jersey,2019-2020,Age,19 Months,86.6,81.7 to 90.4,547
Hep A,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,16.4,12.5 to 21.1,547
Hib,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,91.2,86.8 to 94.2,547
Hib,Primary Series,States/Local Areas,New Jersey,2019-2020,Age,19 Months,92.2,88.1 to 95.0,547
Hib,Full Series,States/Local Areas,New Jersey,2019-2020,Age,19 Months,71.4,65.6 to 76.6,547
Hib,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,96.7,92.0 to 99.0,547
Hib,Full Series,States/Local Areas,New Jersey,2019-2020,Age,35 Months,88.6,82.3 to 93.5,547
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,94.2,90.7 to 96.7,547
Hib,Primary Series,States/Local Areas,New Jersey,2019-2020,Age,35 Months,97.5,93.3 to 99.3,547
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019-2020,Age,35 Months,95.2,89.0 to 98.4,547
PCV,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,97.4,92.4 to 99.4,547
PCV,≥4 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,81.0,75.0 to 86.3,547
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,95.3,92.1 to 97.5,547
DTaP,≥4 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,81.3,75.9 to 86.1,547
Polio,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,24 Months,92.8,88.9 to 95.7,547
≥1 Dose MMR,,States/Local Areas,New Jersey,2019-2020,Age,24 Months,94.3,91.0 to 96.8,547
Hep B,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,3 Months,96.7,94.0 to 98.2,547
PCV,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,3 Months,79.1,73.6 to 83.8,547
DTaP,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,5 Months,74.9,68.9 to 80.0,547
Polio,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,5 Months,74.2,68.4 to 79.3,547
Polio,≥3 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,88.8,82.0 to 93.3,268
DTaP,≥4 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,69.2,61.2 to 76.3,268
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,92.6,86.7 to 96.0,268
Polio,≥2 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,88.0,81.0 to 92.6,268
PCV,≥2 Doses,States/Local Areas,New Jersey,2020,Age,5 Months,71.3,63.2 to 78.3,268
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020,Age,13 Months,56.8,48.8 to 64.4,268
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,73.8,65.8 to 80.4,268
PCV,≥3 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,86.0,79.0 to 90.9,268
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,89.5,83.3 to 93.6,268
Hep B,≥2 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,96.0,91.7 to 98.1,268
Hib,Primary Series,States/Local Areas,New Jersey,2020,Age,13 Months,86.4,80.1 to 91.0,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,82.2,75.4 to 87.4,268
Hep A,≥1 Dose,States/Local Areas,New Jersey,2020,Age,19 Months,74.5,66.9 to 80.9,268
PCV,≥4 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,84.7,76.4 to 91.2,268
≥1 Dose MMR,,States/Local Areas,New Jersey,2020,Age,35 Months,96.8,93.5 to 98.7,268
PCV,≥4 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,76.4,68.6 to 82.8,268
Polio,≥3 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,97.1,92.8 to 99.2,268
DTaP,≥4 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,85.6,77.5 to 91.9,268
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020,Age,19 Months,86.1,78.9 to 91.1,268
PCV,≥3 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,89.0,82.3 to 93.4,268
Hib,Full Series,States/Local Areas,New Jersey,2020,Age,19 Months,69.9,61.8 to 76.9,268
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,91.4,85.8 to 95.0,268
PCV,≥3 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,96.4,92.0 to 98.7,268
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020,Age,35 Months,95.6,91.7 to 98.0,268
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,95.9,92.5 to 98.0,268
Hib,Primary Series,States/Local Areas,New Jersey,2020,Age,35 Months,98.0,91.8 to 99.8,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,94.9,90.0 to 97.9,268
Hib,Full Series,States/Local Areas,New Jersey,2020,Age,35 Months,86.6,79.0 to 92.5,268
Hib,Primary Series,States/Local Areas,New Jersey,2020,Age,24 Months,94.0,89.3 to 97.1,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,94.0,89.3 to 97.1,268
≥1 Dose MMR,,States/Local Areas,New Jersey,2020,Age,24 Months,96.7,93.5 to 98.6,268
DTaP,≥4 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,81.3,73.8 to 87.8,268
Polio,≥3 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,93.0,87.5 to 96.7,268
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,95.4,91.1 to 98.0,268
Hep B,≥2 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,91.7,85.9 to 95.3,268
Hib,Primary Series,States/Local Areas,New Jersey,2020,Age,7 Months,70.0,62.1 to 76.9,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,65.8,57.8 to 73.0,268
Hib,≥2 Doses,States/Local Areas,New Jersey,2020,Age,7 Months,87.5,80.5 to 92.2,268
DTaP,≥1 Dose,States/Local Areas,New Jersey,2020,Age,3 Months,81.3,73.5 to 87.3,268
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2020,Age,0-2 Days,81.2,74.4 to 86.6,268
Hep A,≥2 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,15.0,10.5 to 20.9,268
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2020,Age,0-1 Days,79.2,72.1 to 84.8,268
Combined 7 Series,,States/Local Areas,New Jersey,2020,Age,35 Months,70.7,62.7 to 78.3,268
Hib,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,5 Months,73.8,67.9 to 78.9,547
Polio,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,94.4,90.5 to 96.7,547
≥1 Dose MMR,,States/Local Areas,New Jersey,2019-2020,Age,13 Months,59.0,53.0 to 64.7,547
Hib,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,85.2,80.5 to 88.9,547
Hib,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,94.3,90.5 to 96.7,547
Hep B,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,95.8,92.5 to 97.6,547
Hib,Primary Series,States/Local Areas,New Jersey,2019-2020,Age,13 Months,88.5,84.1 to 91.8,547
Hep B,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,5 Months,87.5,82.7 to 91.1,547
PCV,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,5 Months,70.0,64.1 to 75.3,547
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,71.3,65.4 to 76.5,547
Hib,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,88.9,84.2 to 92.3,547
Polio,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,88.9,84.2 to 92.4,547
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019-2020,Age,13 Months,51.1,45.3 to 56.9,547
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,85.9,80.9 to 89.8,547
PCV,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,85.0,79.8 to 89.1,547
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,91.6,87.1 to 94.6,547
Combined 7 Series,,States/Local Areas,New Jersey,2019-2020,Age,24 Months,65.7,59.9 to 71.5,547
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,97.2,93.1 to 99.2,547
DTaP,≥4 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,85.2,79.5 to 90.1,547
Polio,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,35 Months,97.3,93.2 to 99.2,547
≥1 Dose MMR,,States/Local Areas,New Jersey,2019-2020,Age,35 Months,97.6,92.2 to 99.6,547
DTaP,≥2 Doses,States/Local Areas,New Jersey,2020,Age,5 Months,75.7,67.5 to 82.3,268
Combined 7 Series,,States/Local Areas,New Jersey,2020,Age,24 Months,67.2,59.4 to 74.8,268
Hep A,≥2 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,27.2,20.9 to 34.9,268
Hep A,≥1 Dose,States/Local Areas,New Jersey,2020,Age,24 Months,86.2,80.5 to 90.9,268
PCV,≥4 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,81.6,74.3 to 87.8,268
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,96.1,91.7 to 98.6,268
PCV,≥3 Doses,States/Local Areas,New Jersey,2020,Age,24 Months,94.6,89.8 to 97.6,268
Rotavirus,,States/Local Areas,New Jersey,2020,Age,8 Months,75.5,67.8 to 81.8,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2020,Age,0-3 Days,83.6,76.9 to 88.7,268
Influenza,,States/Local Areas,New Jersey,2020,Age,24 Months,65.8,58.0 to 73.5,268
Hib,Primary Series,States/Local Areas,New Jersey,2020,Age,19 Months,91.3,85.0 to 95.1,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2020,Age,19 Months,89.3,82.6 to 93.7,268
≥1 Dose MMR,,States/Local Areas,New Jersey,2020,Age,19 Months,86.2,79.0 to 91.2,268
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,73.8,63.4 to 84.2,134
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,86.8,79.0 to 94.6,134
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,88.7,81.4 to 96.1,134
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,64.5 to 91.6,134
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,86.8,81.6 to 91.9,276
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.7,62.6 to 82.7,167
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,82.7 to 99.0,167
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,88.8 to 95.4,506
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.6,65.4 to 81.7,506
DTaP,≥4 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,70.2,64.5 to 75.4,547
Polio,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,88.8,84.0 to 92.3,547
Hib,Primary Series,States/Local Areas,New Jersey,2019-2020,Age,7 Months,69.2,63.3 to 74.5,547
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,13 Months,89.7,85.1 to 93.0,547
Polio,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,3 Months,82.2,76.9 to 86.5,547
DTaP,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,3 Months,85.5,80.4 to 89.4,547
Hep B,≥2 Doses,States/Local Areas,New Jersey,2020,Age,5 Months,88.7,82.3 to 92.9,268
Hib,≥2 Doses,States/Local Areas,New Jersey,2020,Age,5 Months,72.3,64.1 to 79.2,268
Polio,≥2 Doses,States/Local Areas,New Jersey,2020,Age,5 Months,74.8,66.7 to 81.4,268
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,90.9 to 100.0,167
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,71.3 to 82.5,506
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.9,86.4 to 93.5,506
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.9,75.4 to 96.4,59
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,75.2,70.5 to 80.0,695
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.0,43.3 to 74.7,59
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,72.0,67.1 to 76.9,695
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.5,76.8 to 86.3,506
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.6,81.5 to 97.6,59
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,71.9,65.4 to 78.4,286
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,85.9,79.9 to 91.8,276
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.9,72.5 to 95.3,59
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.7,91.1 to 100.0,167
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,85.5,80.4 to 90.6,286
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,97.8,96.2 to 99.3,695
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,81.9,77.6 to 86.2,695
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,84.4 to 95.5,167
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,90.7,86.1 to 95.4,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,76.1,69.6 to 82.6,276
Influenza,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,57.7,50.3 to 65.0,286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.0,64.9 to 85.1,167
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,60.3,53.1 to 67.6,286
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.0,52.6 to 83.4,59
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,60.5,52.6 to 68.4,276
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.7,66.9 to 78.5,506
Combined 7 Series,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",46.1,30.8 to 61.5,59
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,66.4,58.8 to 74.0,276
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.1,79.1 to 89.2,506
Rotavirus,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.0,74.8 to 91.2,167
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,77.6,70.9 to 84.4,276
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.1,50.1 to 80.2,59
Influenza,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.7,66.9 to 78.5,506
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,90.8 to 100.0,167
Influenza,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",56.9,40.6 to 73.2,59
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,93.4 to 98.1,506
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.6,78.4 to 98.7,59
Influenza,,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,75.1,70.4 to 79.8,695
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,89.1,84.3 to 93.9,286
Influenza,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.1,68.0 to 86.3,167
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,84.7,78.7 to 90.7,276
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,93.2 to 98.7,506
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,95.2,92.8 to 97.6,695
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.9,76.3 to 97.4,59
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,74.1,67.4 to 80.9,286
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,87.1,82.4 to 91.8,286
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,80.2,73.9 to 86.6,276
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.4,68.9 to 91.9,59
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.2,78.1 to 88.4,506
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,71.5,64.6 to 78.4,286
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,96.1,94.2 to 98.1,695
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.1 to 95.3,286
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.5,79.6 to 89.3,506
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.2,95.1 to 99.2,506
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,91.9,87.4 to 96.5,276
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.1,82.0 to 100.0,59
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,86.7,82.8 to 90.7,695
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.7,78.4 to 98.9,59
PCV,≥1 Dose,States/Local Areas,New Jersey,2020,Age,3 Months,77.7,69.8 to 84.0,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,65.1,54.5 to 74.4,168
Polio,≥2 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,90.9,81.4 to 95.8,168
≥1 Dose MMR,,States/Local Areas,New Jersey,2021,Age,35 Months,87.2,76.4 to 94.6,168
Hib,≥2 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,85.8,75.5 to 92.3,168
Hib,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,91.7,87.0 to 95.2,436
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,87.9,82.5 to 91.8,436
Hep B,≥2 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,91.6,83.6 to 95.9,168
PCV,≥4 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,79.2,73.0 to 84.8,436
DTaP,≥3 Doses,States/Local Areas,New Jersey,2021,Age,7 Months,71.4,61.0 to 80.0,168
Polio,≥3 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,90.9,82.4 to 95.5,168
Hib,≥1 Dose,States/Local Areas,New Jersey,2019-2020,Age,3 Months,82.4,77.2 to 86.7,547
Hib,Primary Series,States/Local Areas,New Jersey,2021,Age,19 Months,90.8,81.7 to 95.6,168
Hib,Primary Series,States/Local Areas,New Jersey,2020-2021,Age,24 Months,92.3,87.8 to 95.7,436
Hib,≥3 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,89.4,80.1 to 94.6,168
PCV,≥3 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,96.4,88.1 to 99.4,168
Combined 7 Series,,States/Local Areas,New Jersey,2021,Age,35 Months,62.5,51.6 to 73.5,168
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,92.4,87.5 to 95.4,436
DTaP,≥1 Dose,States/Local Areas,New Jersey,2016,Age,3 Months,87.7,80.6 to 92.4,298
DTaP,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,3 Months,85.2,80.0 to 89.2,561
DTaP,≥1 Dose,States/Local Areas,New Jersey,2015,Age,3 Months,91.9,86.9 to 95.1,315
DTaP,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,3 Months,89.8,85.7 to 92.8,613
DTaP,≥1 Dose,States/Local Areas,New Jersey,2014,Age,3 Months,91.7,86.8 to 94.9,334
DTaP,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,3 Months,91.8,88.5 to 94.2,649
DTaP,≥1 Dose,States/Local Areas,New Jersey,2013,Age,3 Months,85.8,76.0 to 92.0,252
DTaP,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,3 Months,88.7,85.7 to 91.1,586
DTaP,≥1 Dose,States/Local Areas,New Jersey,2011,Age,3 Months,92.5,88.3 to 95.2,264
DTaP,≥1 Dose,States/Local Areas,New Jersey,2012,Age,3 Months,85.0,76.7 to 90.6,288
PCV,≥2 Doses,States/Local Areas,New Jersey,2021,Age,5 Months,75.2,64.6 to 83.4,168
DTaP,≥4 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,88.1,81.8 to 93.1,436
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"White, Non-Hispanic",64.2,58.0 to 70.3,506
Hep A,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,24 Months,83.8,77.9 to 88.9,436
Hep B,≥3 Doses,States/Local Areas,New Jersey,2021,Age,19 Months,90.9,82.0 to 95.7,168
≥1 Dose Varicella,,States/Local Areas,New Jersey,2021,Age,19 Months,79.9,68.8 to 87.7,168
Hib,Full Series,States/Local Areas,New Jersey,2020-2021,Age,24 Months,78.5,72.2 to 84.3,436
Hib,Full Series,States/Local Areas,New Jersey,2021,Age,19 Months,63.5,52.7 to 73.1,168
DTaP,≥1 Dose,States/Local Areas,New Jersey,2018,Age,3 Months,93.9,89.1 to 96.7,269
DTaP,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,3 Months,91.2,86.8 to 94.2,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,97.0,94.1 to 98.7,315
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,95.5,92.7 to 97.4,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,93.2,88.6 to 96.4,334
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,95.1,92.4 to 97.0,649
DTaP,≥1 Dose,States/Local Areas,New Jersey,2017,Age,3 Months,82.7,74.7 to 88.5,263
DTaP,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,3 Months,88.3,83.6 to 91.8,532
Hep A,≥1 Dose,States/Local Areas,New Jersey,2011,Age,19 Months,68.8,59.3 to 76.9,264
DTaP,≥1 Dose,States/Local Areas,New Jersey,2019,Age,3 Months,88.4,80.6 to 93.3,279
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,94.1,89.1 to 97.3,298
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,92.4,88.4 to 95.4,561
Hep A,≥1 Dose,States/Local Areas,New Jersey,2012,Age,19 Months,70.0,61.9 to 77.1,288
Hep A,≥1 Dose,States/Local Areas,New Jersey,2015,Age,19 Months,69.5,66.0 to 72.8,315
Hep A,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,19 Months,71.3,66.1 to 75.9,613
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014,Age,19 Months,72.2,65.5 to 78.1,334
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,19 Months,70.9,66.2 to 75.2,649
Hep A,≥1 Dose,States/Local Areas,New Jersey,2013,Age,19 Months,72.1,64.1 to 78.9,252
Hep A,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,19 Months,72.2,66.7 to 77.1,586
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,96.3,92.2 to 98.6,269
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,95.4,92.0 to 97.7,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,90.7,84.2 to 95.4,263
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,93.5,89.7 to 96.3,532
DTaP,≥2 Doses,States/Local Areas,New Jersey,2018,Age,5 Months,85.2,78.6 to 90.1,269
DTaP,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,5 Months,80.1,74.5 to 84.7,548
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.3,91.1 to 95.5,952
DTaP,≥2 Doses,States/Local Areas,New Jersey,2017,Age,5 Months,77.8,69.5 to 84.4,263
DTaP,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,5 Months,81.5,76.3 to 85.8,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,89.6,83.0 to 94.5,263
Hib,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,92.5,88.7 to 95.5,532
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,94.5,88.5 to 98.0,279
Hib,≥3 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,92.7,87.7 to 96.2,298
Hib,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,91.2,87.2 to 94.4,561
Hib,≥3 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,92.9,88.6 to 96.1,315
Hib,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,92.8,89.6 to 95.3,613
Hib,≥3 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,91.0,86.9 to 94.0,447
Hib,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,73.8,69.5 to 77.6,821
Hib,≥3 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,87.8,82.5 to 91.6,429
Hib,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,89.4,86.2 to 91.9,876
Polio,≥3 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,93.5,90.2 to 96.0,395
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,92.5,89.8 to 94.7,824
Hib,≥3 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,91.9,87.8 to 94.7,395
Hib,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,89.9,86.8 to 92.4,824
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,92.9,88.7 to 95.6,247
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,94.1,91.2 to 96.1,500
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,95.3,92.3 to 97.2,253
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,94.7,92.0 to 96.6,648
Hib,≥3 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,91.2,85.7 to 94.8,253
Hib,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,91.5,88.1 to 94.0,648
Polio,≥3 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,95.1,90.8 to 97.8,253
Polio,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,94.3,91.7 to 96.3,648
Polio,≥3 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,92.3,88.2 to 95.4,247
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,93.7,90.9 to 95.9,500
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,94.1,90.5 to 96.4,395
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,92.3,89.4 to 94.4,824
Hib,≥2 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,92.3,87.6 to 95.3,357
Polio,≥3 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,95.6,92.4 to 97.5,374
Polio,≥3 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,91.6,87.5 to 94.8,268
Polio,≥3 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,93.6,89.0 to 96.8,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,90.0,84.7 to 93.6,247
Hib,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,90.6,86.9 to 93.4,500
Hib,≥3 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,86.5,79.2 to 91.6,250
Hib,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,88.3,85.7 to 90.4,497
Polio,≥3 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,92.4,87.9 to 95.6,250
Polio,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,92.4,89.4 to 94.7,497
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,97.9,91.4 to 99.8,298
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,94.4,90.4 to 97.1,561
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,97.0,94.1 to 98.7,315
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,97.7,93.9 to 99.4,613
PCV,≥2 Doses,States/Local Areas,New Jersey,2011,Age,5 Months,75.9,65.2 to 84.1,264
PCV,≥2 Doses,States/Local Areas,New Jersey,2012,Age,5 Months,67.8,64.7 to 70.7,288
PCV,≥2 Doses,States/Local Areas,New Jersey,2013,Age,5 Months,68.9,57.8 to 78.1,252
PCV,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,5 Months,69.4,63.9 to 74.4,586
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,92.5,86.3 to 96.6,263
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,95.0,91.2 to 97.5,532
Hep A,≥1 Dose,States/Local Areas,New Jersey,2017,Age,24 Months,76.9,69.7 to 83.5,263
Hep A,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,24 Months,83.3,78.8 to 87.3,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,95.9,91.0 to 98.6,264
≥1 Dose MMR,,States/Local Areas,New Jersey,2020,Age,13 Months,62.4,54.3 to 69.8,268
Hib,≥3 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,94.4,90.5 to 97.1,288
DTaP,≥4 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,66.5,61.2 to 71.4,288
DTaP,≥4 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,69.3,60.1 to 77.1,264
Hep A,≥2 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,30.3,23.2 to 39.0,264
Hep A,≥2 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,16.9,11.3 to 24.4,279
Hep A,≥2 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,20.6,14.9 to 27.8,269
Hep A,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,19.5,14.7 to 25.5,443
Hib,≥3 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,91.5,85.1 to 95.9,263
Hib,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,93.9,90.1 to 96.6,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,93.1,88.1 to 96.5,298
Hib,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,92.5,88.5 to 95.4,561
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,97.6,96.3 to 98.9,756
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,91.2,87.4 to 95.0,321
DTaP,≥4 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,71.3,67.3 to 75.1,315
DTaP,≥4 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,69.7,64.3 to 74.6,613
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,63.1,56.1 to 69.6,334
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,67.2,62.3 to 71.7,649
DTaP,≥4 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,69.8,61.9 to 76.7,252
DTaP,≥4 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,66.5,60.4 to 72.1,586
Hep A,≥2 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,24.6,18.6 to 32.1,288
Hib,≥3 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,96.1,91.7 to 98.5,269
Hib,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,96.7,92.7 to 98.8,548
PCV,≥2 Doses,States/Local Areas,New Jersey,2017,Age,5 Months,75.3,67.3 to 81.9,263
PCV,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,5 Months,78.0,72.7 to 82.5,532
Hep A,≥1 Dose,States/Local Areas,New Jersey,2011,Age,35 Months,82.3,75.6 to 88.0,264
Hep A,≥1 Dose,States/Local Areas,New Jersey,2019,Age,24 Months,78.2,70.3 to 85.1,279
Hep A,≥1 Dose,States/Local Areas,New Jersey,2018,Age,24 Months,90.1,84.8 to 94.1,269
Hep A,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,24 Months,84.1,79.3 to 88.4,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,97.1,89.6 to 99.6,279
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,97.2,92.5 to 99.3,269
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,97.6,92.8 to 99.5,548
PCV,≥2 Doses,States/Local Areas,New Jersey,2016,Age,5 Months,70.6,62.1 to 77.8,298
PCV,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,5 Months,72.9,67.2 to 78.0,561
PCV,≥2 Doses,States/Local Areas,New Jersey,2015,Age,5 Months,75.4,68.8 to 81.0,315
PCV,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,5 Months,73.0,67.7 to 77.7,613
PCV,≥2 Doses,States/Local Areas,New Jersey,2014,Age,5 Months,70.0,63.1 to 76.2,334
PCV,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,5 Months,72.7,70.4 to 74.9,649
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016,Age,24 Months,80.0,72.8 to 86.3,298
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,24 Months,78.4,73.3 to 83.0,561
Hep A,≥1 Dose,States/Local Areas,New Jersey,2015,Age,24 Months,75.7,69.5 to 81.6,315
Hep A,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,24 Months,77.9,73.2 to 82.3,613
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,93.7,91.8 to 95.6,1114
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,91.0,86.5 to 95.6,257
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,94.0,90.9 to 97.0,328
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,96.0,93.8 to 98.2,529
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,24 Months,76.6,72.2 to 80.8,649
Hep A,≥2 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,12.2,8.1 to 17.9,263
Hep A,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,16.4,12.8 to 20.8,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,93.5,89.1 to 96.5,315
Hib,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,93.4,90.2 to 95.8,613
Hib,≥3 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,90.7,85.7 to 94.6,334
Hib,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,92.1,88.9 to 94.7,649
Hib,≥3 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,97.7,95.2 to 99.1,252
Hib,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,94.6,91.8 to 96.7,586
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,15.6,10.7 to 22.1,298
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,13.9,10.6 to 18.0,561
Hep A,≥2 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,16.4,13.4 to 19.9,315
Hep A,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,16.0,12.5 to 20.2,613
Hib,≥3 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,94.2,88.4 to 97.7,279
Hib,≥3 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,95.4,91.2 to 98.0,269
Hib,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,94.8,91.4 to 97.2,548
Hep A,≥2 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,11.3,8.6 to 14.9,288
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,11.1,7.2 to 16.8,334
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,13.7,10.6 to 17.7,649
Hep A,≥2 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,20.4,13.1 to 30.3,252
Hep A,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,15.8,12.4 to 19.9,586
DTaP,≥2 Doses,States/Local Areas,New Jersey,2019,Age,5 Months,74.8,65.8 to 82.0,279
Hep A,≥2 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,14.4,9.0 to 22.3,264
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,93.2,88.6 to 96.4,334
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,95.1,92.4 to 97.0,649
DTaP,≥3 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,99.4,96.9 to 99.9,264
DTaP,≥3 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,96.2,92.2 to 98.5,288
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,99.2,98.1 to 99.8,252
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,96.7,94.3 to 98.3,586
Hep A,≥1 Dose,States/Local Areas,New Jersey,2018,Age,19 Months,80.6,73.0 to 86.4,269
Hep A,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,19 Months,78.0,71.7 to 83.2,443
Hep A,≥1 Dose,States/Local Areas,New Jersey,2017,Age,19 Months,72.5,64.6 to 79.2,263
Hep A,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,19 Months,76.5,71.2 to 81.1,532
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016,Age,19 Months,73.0,65.1 to 79.8,298
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,19 Months,72.8,67.3 to 77.6,561
Hep A,≥1 Dose,States/Local Areas,New Jersey,2012,Age,24 Months,76.5,70.3 to 82.3,288
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014,Age,24 Months,77.5,71.3 to 83.2,334
Hep A,≥1 Dose,States/Local Areas,New Jersey,2013,Age,24 Months,78.9,72.1 to 84.9,252
Hep A,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,24 Months,78.2,73.7 to 82.5,586
Hep A,≥1 Dose,States/Local Areas,New Jersey,2011,Age,24 Months,76.1,69.0 to 82.6,264
Hep A,≥1 Dose,States/Local Areas,New Jersey,2019,Age,19 Months,75.5,67.2 to 82.3,279
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,84.7,80.3 to 89.1,462
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,76.7,72.0 to 81.5,506
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Overall,Overall,80.5,77.4 to 83.6,1165
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,80.6,75.4 to 85.8,379
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.7,74.3 to 87.1,261
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,93.4,90.6 to 96.2,525
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,89.0 to 96.0,382
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.9,93.6 to 100.0,129
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,92.9,90.3 to 95.4,644
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,80.4,75.7 to 85.2,525
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.0,72.7 to 85.2,382
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.6,79.1 to 94.1,129
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,80.2,76.2 to 84.2,644
Hib,Primary Series,States/Local Areas,New Mexico,2012,Age,7 Months,70.0,64.3 to 75.2,263
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,83.6,75.4 to 91.8,197
Hib,Primary Series,States/Local Areas,New Mexico,2011,Age,7 Months,74.0,68.4 to 78.9,268
Hib,Full Series,States/Local Areas,New Mexico,2018,Age,35 Months,86.6,81.5 to 90.9,447
Hib,Full Series,States/Local Areas,New Mexico,2018-2019,Age,35 Months,89.2,85.8 to 92.1,821
Hib,Full Series,States/Local Areas,New Mexico,2019,Age,35 Months,91.6,87.1 to 95.1,374
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,79.9,76.0 to 83.7,707
Polio,≥3 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,96.9,93.9 to 98.6,374
Hib,Full Series,States/Local Areas,New Mexico,2016,Age,35 Months,89.0,82.6 to 93.8,395
Hib,Full Series,States/Local Areas,New Mexico,2016-2017,Age,35 Months,83.3,79.1 to 87.0,824
Hib,Full Series,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,84.6,79.5 to 89.6,418
Hep A,≥1 Dose,States/Local Areas,New Mexico,2015,Age,35 Months,90.1,83.7 to 94.8,253
Hep A,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,35 Months,92.2,88.1 to 95.3,648
Polio,≥2 Doses,States/Local Areas,New Mexico,2012,Age,5 Months,76.4,71.3 to 80.8,263
Polio,≥2 Doses,States/Local Areas,New Mexico,2011,Age,5 Months,77.4,72.2 to 81.8,268
Hep A,≥1 Dose,States/Local Areas,New Mexico,2012,Age,35 Months,93.6,86.3 to 97.8,263
Polio,≥2 Doses,States/Local Areas,New Mexico,2013,Age,5 Months,81.2,76.2 to 85.4,250
Polio,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,5 Months,80.9,78.3 to 83.2,497
Polio,≥2 Doses,States/Local Areas,New Mexico,2014,Age,5 Months,80.5,73.8 to 85.8,247
Polio,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,5 Months,80.6,79.2 to 82.1,500
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,91.7,88.7 to 94.7,506
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,96.2,92.7 to 99.8,197
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,95.8,93.5 to 98.1,462
Hep B,≥3 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,73.0,63.7 to 80.6,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,67.1,63.9 to 70.1,268
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,75.0,67.5 to 81.2,250
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,73.8,69.4 to 77.8,497
DTaP,≥4 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,74.5,67.9 to 80.2,374
DTaP,≥4 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,81.7,75.5 to 87.1,268
DTaP,≥4 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,84.5,77.2 to 90.5,263
Hep A,≥1 Dose,States/Local Areas,New Mexico,2013,Age,35 Months,91.2,85.2 to 95.5,250
Hep A,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,35 Months,91.6,87.9 to 94.5,497
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014,Age,35 Months,91.9,87.0 to 95.5,247
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,35 Months,91.0,87.3 to 94.0,500
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,93.8,92.0 to 95.6,1165
Hep A,≥2 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,53.2,45.3 to 61.7,253
Hep A,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,50.8,45.4 to 56.4,648
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,46.6,39.0 to 54.7,247
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,50.1,44.6 to 55.9,500
Hib,≥3 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,95.5,91.7 to 97.9,374
PCV,≥2 Doses,States/Local Areas,New Mexico,2018,Age,5 Months,81.1,75.1 to 85.9,447
PCV,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,5 Months,82.5,78.4 to 86.1,821
PCV,≥2 Doses,States/Local Areas,New Mexico,2019,Age,5 Months,84.0,77.8 to 88.8,374
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,94.5,91.9 to 97.1,525
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.1,91.2 to 97.1,382
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.0,86.5 to 95.5,261
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,94.6,91.8 to 97.4,379
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,92.4,88.2 to 95.5,357
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,94.3 to 100.0,129
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,93.2,90.7 to 95.7,644
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,74.1,67.5 to 79.7,395
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,70.9,66.4 to 75.1,824
DTaP,≥4 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,67.5,61.1 to 73.2,429
DTaP,≥4 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,69.9,65.6 to 73.9,876
DTaP,≥4 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,72.4,66.5 to 77.5,447
DTaP,≥4 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,95.5,93.0 to 97.2,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,39.3,32.2 to 47.4,250
Hep A,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,42.9,37.7 to 48.6,497
Polio,≥2 Doses,States/Local Areas,New Mexico,2016,Age,5 Months,79.6,72.9 to 85.1,395
Polio,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,5 Months,78.9,74.5 to 82.7,824
Polio,≥2 Doses,States/Local Areas,New Mexico,2017,Age,5 Months,78.0,72.1 to 83.0,429
Polio,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,5 Months,81.1,77.1 to 84.6,876
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,72.6,65.4 to 78.8,247
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,71.3,66.0 to 76.1,500
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,70.0,62.2 to 76.8,253
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,73.9,69.1 to 78.3,648
Polio,≥2 Doses,States/Local Areas,New Mexico,2019,Age,5 Months,86.3,80.1 to 90.8,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,88.9,85.6 to 92.1,644
Polio,≥2 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,90.7,84.9 to 94.3,263
Polio,≥2 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,88.4,86.1 to 90.4,268
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,69.2,63.0 to 74.8,429
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,72.1,67.8 to 76.0,876
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,75.0,68.9 to 80.3,447
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,76.0,71.6 to 80.0,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,79.5,72.2 to 86.0,395
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,79.0,74.0 to 83.5,824
Hep A,≥2 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,84.1,74.3 to 91.7,253
Hep A,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,81.8,75.7 to 87.1,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,77.1,70.4 to 82.7,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,77.5,67.9 to 85.9,247
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,80.6,74.0 to 86.5,500
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014,Age,13 Months,57.3,49.7 to 64.6,247
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2015,Age,13 Months,61.0,55.5 to 66.2,500
≥1 Dose Varicella,,States/Local Areas,New Mexico,2012,Age,13 Months,59.2,57.3 to 61.1,263
Hep A,≥1 Dose,States/Local Areas,New Mexico,2019,Age,35 Months,94.2,90.1 to 97.0,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,89.0,85.7 to 92.2,707
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,90.0,86.2 to 93.8,418
Polio,≥2 Doses,States/Local Areas,New Mexico,2018,Age,5 Months,84.2,78.3 to 88.7,447
Polio,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,5 Months,85.2,81.1 to 88.6,821
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013,Age,13 Months,58.2,47.5 to 68.2,250
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013-2014,Age,13 Months,57.8,50.8 to 64.5,497
≥1 Dose Varicella,,States/Local Areas,New Mexico,2011,Age,13 Months,56.7,50.5 to 62.8,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2014,Age,13 Months,61.6,54.1 to 68.6,247
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2015,Age,13 Months,64.3,58.9 to 69.4,500
≥1 Dose MMR,,States/Local Areas,New Mexico,2015,Age,13 Months,67.1,59.2 to 74.2,253
≥1 Dose MMR,,States/Local Areas,New Mexico,2015-2016,Age,13 Months,66.2,61.1 to 71.0,648
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019,Age,13 Months,68.6,61.9 to 74.6,374
≥1 Dose Varicella,,States/Local Areas,New Mexico,2011,Age,19 Months,80.9,77.7 to 83.8,268
≥1 Dose Varicella,,States/Local Areas,New Mexico,2012,Age,19 Months,88.3,80.5 to 93.2,263
≥1 Dose MMR,,States/Local Areas,New Mexico,2016,Age,13 Months,65.2,58.6 to 71.2,395
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2017,Age,13 Months,65.4,60.9 to 69.7,824
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018,Age,13 Months,69.5,63.1 to 75.2,447
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018-2019,Age,13 Months,69.0,64.4 to 73.3,821
DTaP,≥4 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,92.3,83.0 to 97.6,263
DTaP,≥4 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,92.0,84.8 to 96.6,253
DTaP,≥4 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,92.1,87.6 to 95.4,648
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,89.0,83.7 to 93.2,247
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,90.2,86.0 to 93.6,500
Hep A,≥2 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,85.2,78.2 to 90.9,374
Hep B,≥3 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,88.7,83.5 to 92.4,263
DTaP,≥4 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,91.3,84.9 to 95.7,250
DTaP,≥4 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,90.4,86.2 to 93.7,497
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,89.3,86.6 to 91.6,250
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,89.3,87.2 to 91.2,497
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,89.3,84.1 to 93.0,247
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,89.4,85.6 to 92.3,500
Hep A,≥2 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,84.4,75.6 to 91.3,447
Hep A,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,84.7,79.2 to 89.4,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,78.5,71.6 to 84.6,429
Hep A,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,80.6,75.3 to 85.4,876
Hib,Full Series,States/Local Areas,New Mexico,2014,Age,35 Months,81.5,75.1 to 87.0,247
Hib,Full Series,States/Local Areas,New Mexico,2014-2015,Age,35 Months,84.0,79.7 to 87.9,500
Hib,Full Series,States/Local Areas,New Mexico,2015,Age,35 Months,86.6,80.3 to 91.7,253
Hib,Full Series,States/Local Areas,New Mexico,2015-2016,Age,35 Months,87.9,83.4 to 91.6,648
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,93.2,90.8 to 95.6,707
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,93.8,90.6 to 97.0,418
Polio,≥3 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,96.4,93.1 to 98.4,447
Polio,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,96.6,94.5 to 98.1,821
Hib,Full Series,States/Local Areas,New Mexico,2017,Age,35 Months,77.7,71.8 to 83.1,429
Hib,Full Series,States/Local Areas,New Mexico,2017-2018,Age,35 Months,81.9,78.0 to 85.4,876
Hib,Full Series,States/Local Areas,New Mexico,2019,Age,24 Months,87.4,82.2 to 91.6,374
DTaP,≥2 Doses,States/Local Areas,New Mexico,2013,Age,5 Months,82.1,76.1 to 86.8,250
DTaP,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,5 Months,82.2,79.8 to 84.3,497
DTaP,≥2 Doses,States/Local Areas,New Mexico,2012,Age,5 Months,76.9,72.5 to 80.8,263
DTaP,≥2 Doses,States/Local Areas,New Mexico,2011,Age,5 Months,77.2,71.3 to 82.3,268
Hib,Full Series,States/Local Areas,New Mexico,2013,Age,35 Months,81.4,74.8 to 87.1,250
Hib,Full Series,States/Local Areas,New Mexico,2013-2014,Age,35 Months,81.5,77.0 to 85.7,497
Hib,Full Series,States/Local Areas,New Mexico,2011,Age,35 Months,83.1,76.7 to 88.6,268
Hib,Full Series,States/Local Areas,New Mexico,2012,Age,35 Months,94.1,86.3 to 98.2,263
Polio,≥3 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,92.3,88.2 to 95.4,247
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,94.4,91.6 to 96.5,500
Polio,≥3 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,94.6,90.2 to 97.5,250
Polio,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,93.5,90.6 to 95.7,497
Polio,≥3 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,95.2,90.2 to 98.1,263
DTaP,≥2 Doses,States/Local Areas,New Mexico,2014,Age,5 Months,82.2,76.0 to 87.1,247
DTaP,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,5 Months,81.5,79.8 to 83.1,500
DTaP,≥2 Doses,States/Local Areas,New Mexico,2015,Age,5 Months,80.8,74.3 to 86.0,253
DTaP,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,5 Months,80.4,75.8 to 84.3,648
Polio,≥3 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,95.4,91.2 to 98.0,429
Polio,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,95.9,93.3 to 97.8,876
Polio,≥3 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,94.2,90.8 to 96.7,395
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,95.1,92.1 to 97.2,824
Polio,≥3 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,94.5,89.1 to 97.7,268
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,95.1,91.4 to 97.2,447
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,92.6,89.7 to 94.7,821
Polio,≥3 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,96.8,92.5 to 99.0,253
Polio,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,95.4,92.8 to 97.3,648
Hib,≥3 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,88.4,82.6 to 93.0,250
Hib,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,90.2,86.7 to 93.1,497
Hib,≥3 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,93.0,87.3 to 96.8,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,91.2,86.1 to 95.0,268
Hib,≥3 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,91.9,87.7 to 95.1,247
Hib,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,92.6,89.4 to 95.1,500
Hib,Full Series,States/Local Areas,New Mexico,2016,Age,24 Months,80.9,75.0 to 86.2,395
Hib,Full Series,States/Local Areas,New Mexico,2016-2017,Age,24 Months,78.8,74.7 to 82.7,824
Hib,Full Series,States/Local Areas,New Mexico,2018,Age,24 Months,83.5,78.5 to 88.0,447
Hib,Full Series,States/Local Areas,New Mexico,2018-2019,Age,24 Months,85.4,81.9 to 88.6,821
Hib,Full Series,States/Local Areas,New Mexico,2017,Age,24 Months,76.5,70.7 to 82.0,429
Hib,Full Series,States/Local Areas,New Mexico,2017-2018,Age,24 Months,79.9,76.1 to 83.5,876
DTaP,≥3 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,96.0,92.5 to 98.2,263
Polio,≥3 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,95.7,92.6 to 97.7,447
Polio,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,95.6,93.6 to 97.2,821
Polio,≥3 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,95.6,92.7 to 97.7,374
Hib,≥3 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,91.5,86.6 to 94.7,374
Polio,≥3 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,91.3,86.8 to 94.7,429
Polio,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,93.4,90.7 to 95.5,876
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,95.2,91.6 to 97.6,250
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,94.2,91.7 to 96.2,497
Hib,Full Series,States/Local Areas,New Mexico,2015,Age,24 Months,85.8,79.5 to 90.9,253
Hib,Full Series,States/Local Areas,New Mexico,2015-2016,Age,24 Months,83.4,79.2 to 87.2,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,92.9,88.9 to 95.8,268
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,96.2,93.0 to 98.0,374
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,90.3,85.3 to 93.7,429
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,92.7,89.7 to 94.8,876
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,85.1,79.5 to 89.9,247
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,85.7,81.6 to 89.3,500
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,79.5,73.3 to 85.0,395
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,77.7,73.4 to 81.7,824
DTaP,≥4 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,86.2,80.0 to 91.3,253
DTaP,≥4 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,83.0,78.6 to 86.9,648
Polio,≥2 Doses,States/Local Areas,New Mexico,2015,Age,5 Months,80.8,74.3 to 86.0,253
Polio,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,5 Months,80.2,75.7 to 84.1,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,78.1,72.3 to 83.0,395
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,73.9,69.6 to 77.7,824
Hep A,≥2 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,57.7,50.5 to 65.0,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,72.5,61.1 to 82.9,268
Hep A,≥2 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,73.1,61.2 to 83.8,263
Hep A,≥2 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,78.4,69.4 to 86.2,250
Hep A,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,77.7,71.4 to 83.5,497
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016,Age,35 Months,93.9,88.9 to 97.2,395
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,35 Months,93.0,90.0 to 95.3,824
Hep A,≥2 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,53.2,46.6 to 60.1,447
Hep A,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,55.4,50.5 to 60.5,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,51.7,45.4 to 58.4,429
Hep A,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,52.4,47.7 to 57.2,876
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,47.9,41.1 to 55.2,395
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,49.7,45.0 to 54.7,824
DTaP,≥4 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,77.2,70.3 to 83.5,250
DTaP,≥4 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,81.2,76.7 to 85.3,497
≥1 Dose MMR,,States/Local Areas,New Mexico,2013,Age,13 Months,59.4,49.7 to 68.4,250
≥1 Dose MMR,,States/Local Areas,New Mexico,2013-2014,Age,13 Months,60.5,55.1 to 65.6,497
≥1 Dose MMR,,States/Local Areas,New Mexico,2012,Age,13 Months,58.5,55.7 to 61.2,263
≥1 Dose MMR,,States/Local Areas,New Mexico,2011,Age,13 Months,54.5,48.1 to 60.7,268
DTaP,≥4 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,83.2,77.3 to 88.3,374
DTaP,≥4 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,84.0,77.9 to 89.3,268
DTaP,≥4 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,82.8,77.3 to 87.6,447
DTaP,≥4 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,83.0,79.0 to 86.6,821
DTaP,≥4 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,75.7,69.6 to 81.3,429
DTaP,≥4 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,79.1,75.1 to 82.9,876
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016,Age,13 Months,63.3,56.7 to 69.5,395
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2017,Age,13 Months,61.8,57.2 to 66.2,824
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017,Age,13 Months,60.2,53.8 to 66.3,429
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017-2018,Age,13 Months,64.8,60.3 to 69.0,876
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015,Age,13 Months,64.7,56.6 to 72.0,253
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015-2016,Age,13 Months,64.0,58.8 to 68.9,648
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.7 to 100.0,129
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,87.7,83.6 to 91.8,525
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.5,80.1 to 90.8,382
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.0,81.6 to 92.5,261
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,91.2,87.4 to 94.9,379
Polio,≥2 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,89.5,84.5 to 93.1,247
Polio,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,90.9,87.5 to 93.4,500
Polio,≥2 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,90.2,87.7 to 92.3,250
Polio,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,89.9,87.8 to 91.6,497
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,86.1,82.0 to 90.1,506
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Overall,Overall,88.6,86.1 to 91.2,1165
Polio,≥2 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,92.3,87.3 to 95.4,253
Polio,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,92.4,89.4 to 94.6,648
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,91.4,88.0 to 94.8,462
Hep B,≥3 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,86.1,83.7 to 88.3,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2017,Age,13 Months,65.7,59.4 to 71.5,429
≥1 Dose MMR,,States/Local Areas,New Mexico,2017-2018,Age,13 Months,69.9,65.6 to 73.8,876
≥1 Dose MMR,,States/Local Areas,New Mexico,2018,Age,13 Months,74.1,68.1 to 79.3,447
≥1 Dose MMR,,States/Local Areas,New Mexico,2018-2019,Age,13 Months,73.3,68.9 to 77.2,821
≥1 Dose MMR,,States/Local Areas,New Mexico,2019,Age,13 Months,72.4,65.9 to 78.1,374
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014,Age,19 Months,88.3,83.2 to 92.1,247
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2015,Age,19 Months,86.5,82.2 to 89.8,500
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015,Age,19 Months,84.5,75.4 to 90.7,253
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015-2016,Age,19 Months,86.8,82.6 to 90.2,648
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013,Age,19 Months,79.2,73.0 to 84.3,250
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013-2014,Age,19 Months,83.7,80.1 to 86.8,497
Polio,≥2 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,94.4,89.1 to 97.2,263
Polio,≥2 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,95.0,93.5 to 96.2,268
Polio,≥2 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,92.6,90.1 to 94.5,250
Polio,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,93.2,91.8 to 94.4,497
Polio,≥2 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,93.8,89.8 to 96.3,247
Polio,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,94.9,92.2 to 96.7,500
Hep B,≥1 Dose,States/Local Areas,New Mexico,2015,Age,3 Months,96.8,93.0 to 98.6,253
Hep B,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,3 Months,96.5,94.4 to 97.8,648
Hep B,≥1 Dose,States/Local Areas,New Mexico,2016,Age,3 Months,96.1,93.6 to 97.6,395
Hep B,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,3 Months,95.7,93.9 to 97.1,824
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.5,66.0 to 98.9,129
Hep A,≥1 Dose,States/Local Areas,New Mexico,2017,Age,35 Months,92.4,88.2 to 95.5,429
Hep A,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,35 Months,92.8,90.0 to 95.0,876
Hep A,≥1 Dose,States/Local Areas,New Mexico,2018,Age,35 Months,93.2,89.1 to 96.1,447
Hep A,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,35 Months,93.8,91.0 to 95.9,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,79.7,74.7 to 84.7,644
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,73.0,66.4 to 79.6,525
Polio,≥2 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,95.9,92.8 to 97.7,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,79.0,74.6 to 83.3,1165
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,75.2,68.3 to 82.1,506
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.2,71.0 to 89.5,261
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,86.4,80.1 to 92.7,379
DTaP,≥4 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,85.1,78.9 to 90.3,429
DTaP,≥4 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,88.0,83.9 to 91.5,876
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,92.0,86.0 to 96.1,395
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,88.5,84.3 to 92.0,824
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,89.4,84.9 to 92.6,395
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,87.6,84.2 to 90.4,824
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,89.4,83.3 to 93.5,253
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,89.4,85.8 to 92.2,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,85.8,80.2 to 90.0,429
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,87.4,83.7 to 90.3,876
Hep B,≥1 Dose,States/Local Areas,New Mexico,2013,Age,3 Months,92.4,89.1 to 94.8,250
Hep B,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,3 Months,94.0,92.2 to 95.4,497
Hep B,≥1 Dose,States/Local Areas,New Mexico,2012,Age,3 Months,94.1,90.3 to 96.5,263
Hep B,≥1 Dose,States/Local Areas,New Mexico,2011,Age,3 Months,92.1,90.0 to 93.7,268
Hep B,≥1 Dose,States/Local Areas,New Mexico,2014,Age,3 Months,95.5,92.1 to 97.5,247
Hep B,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,3 Months,96.2,93.9 to 97.6,500
Polio,≥2 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,92.5,88.8 to 95.1,395
Polio,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,91.3,88.4 to 93.6,824
Polio,≥2 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,90.0,85.0 to 93.5,429
Polio,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,90.8,87.5 to 93.2,876
Polio,≥2 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,91.5,86.8 to 94.6,447
Polio,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,93.7,91.0 to 95.6,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,78.6,72.8 to 84.4,707
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,81.7,75.4 to 88.0,418
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.4,78.1 to 88.6,382
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.4,70.1 to 88.8,129
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,82.9,80.0 to 85.8,1165
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,82.7,77.7 to 87.7,379
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,85.5,81.4 to 89.6,525
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.1,70.4 to 83.8,261
≥1 Dose MMR,,States/Local Areas,New Mexico,2015,Age,19 Months,87.1,80.0 to 92.0,253
≥1 Dose MMR,,States/Local Areas,New Mexico,2015-2016,Age,19 Months,88.5,84.5 to 91.6,648
≥1 Dose MMR,,States/Local Areas,New Mexico,2016,Age,19 Months,90.0,85.4 to 93.2,395
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2017,Age,19 Months,90.3,87.3 to 92.7,824
≥1 Dose MMR,,States/Local Areas,New Mexico,2017,Age,19 Months,90.6,86.3 to 93.7,429
≥1 Dose MMR,,States/Local Areas,New Mexico,2017-2018,Age,19 Months,92.6,89.9 to 94.6,876
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,79.0,74.4 to 83.6,506
≥1 Dose Varicella,,States/Local Areas,New Mexico,2011,Age,24 Months,86.5,80.5 to 91.3,268
≥1 Dose Varicella,,States/Local Areas,New Mexico,2012,Age,24 Months,90.3,84.6 to 94.6,263
Hep B,≥1 Dose,States/Local Areas,New Mexico,2018,Age,3 Months,95.6,91.1 to 97.9,447
Hep B,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,3 Months,96.9,94.7 to 98.3,821
Hep B,≥1 Dose,States/Local Areas,New Mexico,2019,Age,3 Months,98.3,96.6 to 99.1,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,81.4,75.1 to 87.6,462
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2011,Age,0-1 Days,58.5,48.2 to 68.1,268
Hep B,≥2 Doses,States/Local Areas,New Mexico,2012,Age,5 Months,86.4,85.0 to 87.7,263
Hep B,≥2 Doses,States/Local Areas,New Mexico,2011,Age,5 Months,81.0,74.6 to 86.1,268
Hep B,≥2 Doses,States/Local Areas,New Mexico,2013,Age,5 Months,89.0,85.7 to 91.7,250
Hep B,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,5 Months,89.6,87.0 to 91.8,497
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,90.3,86.9 to 92.8,250
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,90.5,87.7 to 92.7,497
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,85.1,76.1 to 94.1,197
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,90.7,85.5 to 94.1,247
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,92.0,88.6 to 94.5,500
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,93.4,89.4 to 96.0,253
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,92.9,89.9 to 95.1,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,89.8,85.3 to 93.0,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,89.0,83.9 to 92.6,447
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,90.9,87.8 to 93.3,821
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,92.8,88.8 to 95.5,374
Hep B,≥3 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,88.0,85.7 to 89.9,268
DTaP,≥4 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,91.6,85.8 to 95.7,447
DTaP,≥4 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,91.7,87.6 to 94.9,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.5,68.4 to 84.7,382
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,90.9,85.1 to 96.7,197
Combined 7 Series,,States/Local Areas,Kansas,2021,Age,24 Months,68.9,60.1 to 77.4,266
Hib,Full Series,States/Local Areas,Kansas,2020-2021,Age,35 Months,81.3,75.6 to 86.3,634
Hep A,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,33.2,28.4 to 38.5,634
PCV,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,67.3,61.6 to 72.5,634
DTaP,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,86.8,81.9 to 90.6,634
Hep B,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,89.4,85.5 to 92.4,634
Hib,Primary Series,States/Local Areas,Kansas,2020-2021,Age,19 Months,90.7,87.0 to 93.5,634
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2020-2021,Age,0-1 Days,75.0,69.5 to 79.8,634
Hep A,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,19 Months,84.5,80.0 to 88.1,634
Hib,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,92.4,87.8 to 95.8,634
Hib,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,85.5,81.3 to 89.0,634
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,69.2,60.8 to 77.6,234
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,79.8 to 96.3,155
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,74.8,67.6 to 81.9,299
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,67.7,60.5 to 74.9,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2020-2021,Age,0-3 Days,77.5,72.1 to 82.1,634
Hib,Primary Series,States/Local Areas,Kansas,2020-2021,Age,35 Months,92.6,89.4 to 95.1,634
Influenza,,States/Local Areas,Kansas,2020-2021,Age,24 Months,55.0,49.5 to 60.7,634
Hep B,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,68.9,63.2 to 74.0,634
Hep B,≥3 Doses,States/Local Areas,Kansas,2021,Age,35 Months,91.8,86.6 to 95.6,266
PCV,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,90.6,86.7 to 93.4,634
Hib,Primary Series,States/Local Areas,Kansas,2021,Age,13 Months,81.3,73.0 to 87.5,266
DTaP,≥4 Doses,States/Local Areas,Kansas,2021,Age,35 Months,86.8,78.0 to 93.3,266
PCV,≥4 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,76.9,71.9 to 81.2,634
Polio,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,88.8,84.2 to 92.2,634
PCV,≥4 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,83.4,78.8 to 87.5,634
Polio,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,5 Months,75.8,70.3 to 80.6,634
Hib,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,3 Months,81.4,76.8 to 85.2,634
Combined 7 Series,,States/Local Areas,Kansas,2020-2021,Age,24 Months,66.4,60.9 to 71.9,634
≥1 Dose MMR,,States/Local Areas,Kansas,2020-2021,Age,35 Months,93.3,88.6 to 96.6,634
PCV,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,93.1,88.6 to 96.3,634
≥1 Dose Varicella,,States/Local Areas,Kansas,2020-2021,Age,19 Months,85.6,81.3 to 89.1,634
DTaP,≥3 Doses,States/Local Areas,Kansas,2021,Age,35 Months,98.0,89.8 to 99.9,266
Hib,Full Series,States/Local Areas,Kansas,2021,Age,35 Months,81.7,72.4 to 89.3,266
Polio,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,92.5,87.9 to 95.8,634
Hep B,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,90.9,87.1 to 93.6,634
Combined 7 Series,,States/Local Areas,Kansas,2020-2021,Age,35 Months,71.3,65.6 to 76.8,634
PCV,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,91.3,87.7 to 94.1,634
Hib,≥3 Doses,States/Local Areas,Kansas,2021,Age,13 Months,64.4,55.8 to 72.2,266
Polio,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,89.4,85.4 to 92.4,634
Hep B,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,5 Months,86.3,82.0 to 89.7,634
Hib,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,5 Months,74.0,68.5 to 78.8,634
DTaP,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,68.3,62.6 to 73.4,634
≥1 Dose Varicella,,States/Local Areas,Kansas,2020-2021,Age,24 Months,88.8,84.9 to 92.1,634
Hep A,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,54.2,48.5 to 60.1,634
Hib,Primary Series,States/Local Areas,Kansas,2021,Age,35 Months,92.5,87.8 to 95.9,266
Hib,Primary Series,States/Local Areas,Kansas,2020-2021,Age,7 Months,69.9,64.2 to 75.0,634
Rotavirus,,States/Local Areas,Kansas,2021,Age,8 Months,72.6,63.5 to 80.1,266
Hib,≥2 Doses,States/Local Areas,Kansas,2021,Age,13 Months,92.1,86.5 to 95.5,266
Hep B,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,90.7,87.2 to 93.7,634
PCV,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,88.0,83.8 to 91.2,634
Polio,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,90.4,86.7 to 93.4,634
≥1 Dose MMR,,States/Local Areas,Kansas,2020-2021,Age,19 Months,87.5,83.3 to 90.7,634
DTaP,≥4 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,66.8,61.2 to 72.0,634
Hep A,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,81.7,73.7 to 88.4,634
PCV,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,3 Months,84.6,80.2 to 88.1,634
Hib,≥3 Doses,States/Local Areas,Kansas,2021,Age,35 Months,91.5,86.1 to 95.4,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2021,Age,0-3 Days,72.2,63.2 to 79.7,266
DTaP,≥3 Doses,States/Local Areas,Kansas,2021,Age,24 Months,91.1,85.9 to 94.9,266
≥1 Dose MMR,,States/Local Areas,Kansas,2021,Age,13 Months,70.2,61.7 to 77.6,266
Hib,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,39.0,33.9 to 44.4,634
Polio,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,3 Months,84.1,79.7 to 87.7,634
Hep A,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,24 Months,87.8,83.7 to 91.3,634
DTaP,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,5 Months,76.9,71.4 to 81.6,634
Hib,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,62.7,57.3 to 67.9,634
Hib,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,7 Months,87.9,83.2 to 91.3,634
Hep B,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,3 Months,94.8,92.1 to 96.7,634
≥1 Dose Varicella,,States/Local Areas,Kansas,2020-2021,Age,13 Months,60.5,55.0 to 65.7,634
Polio,≥2 Doses,States/Local Areas,Kansas,2021,Age,13 Months,92.6,87.2 to 95.8,266
Influenza,,States/Local Areas,Kansas,2021,Age,24 Months,50.4,42.1 to 59.4,266
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,95.1,92.8 to 97.4,749
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,84.1,78.2 to 90.0,299
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,68.5,61.0 to 75.9,299
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,83.9,80.2 to 87.7,749
Influenza,,States/Local Areas,Kansas,2014-2017,Overall,Overall,55.7,51.4 to 60.0,905
Influenza,,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,44.5,36.7 to 52.4,256
Influenza,,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,52.8,46.3 to 59.2,413
Influenza,,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,75.3,68.4 to 82.3,236
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,74.6 to 91.7,155
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,88.8,85.4 to 92.2,749
Influenza,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,56.8,49.1 to 64.4,270
Influenza,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,48.9,41.5 to 56.3,315
Influenza,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",58.7,53.6 to 63.8,612
Influenza,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,59.9,52.9 to 66.9,320
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.6,72.5 to 90.6,155
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.0,53.2 to 61.3,155
Influenza,,States/Local Areas,Kansas,2017,Age,24 Months,66.3,59.8 to 72.7,354
Influenza,,States/Local Areas,Kansas,2017-2018,Age,24 Months,62.2,57.3 to 67.0,749
Influenza,,States/Local Areas,Kansas,2018,Age,24 Months,57.9,51.0 to 64.9,395
Influenza,,States/Local Areas,Kansas,2018-2019,Age,24 Months,59.9,54.9 to 64.9,753
Hep B,≥1 Dose,States/Local Areas,Kansas,2021,Age,3 Months,93.3,88.7 to 96.2,266
Hib,Full Series,States/Local Areas,Kansas,2020-2021,Age,24 Months,76.5,71.4 to 81.3,634
Influenza,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,35.7,15.3 to 56.1,35
Influenza,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",39.0,18.8 to 59.3,35
Influenza,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,49.3,39.3 to 59.3,174
Influenza,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",56.0,41.8 to 70.1,84
Influenza,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,43.9,32.5 to 55.3,134
Influenza,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,66.4,61.1 to 71.6,527
Influenza,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,44.1,35.5 to 52.8,209
Influenza,,States/Local Areas,Kansas,2019,Age,24 Months,61.9,54.7 to 69.1,358
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,74.9,64.0 to 85.8,234
DTaP,≥2 Doses,States/Local Areas,Kansas,2021,Age,5 Months,75.4,66.3 to 82.7,266
Hep B,≥3 Doses,States/Local Areas,Kansas,2021,Age,13 Months,86.3,80.2 to 90.8,266
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,91.3,88.2 to 94.4,749
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,80.6,74.5 to 86.7,299
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,84.7 to 98.0,155
PCV,≥1 Dose,States/Local Areas,Kansas,2021,Age,3 Months,87.9,81.8 to 92.1,266
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.4,66.0 to 96.9,48
Polio,≥2 Doses,States/Local Areas,Kansas,2021,Age,5 Months,74.6,65.5 to 82.0,266
Polio,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,92.1,88.6 to 94.6,634
≥1 Dose MMR,,States/Local Areas,Kansas,2021,Age,19 Months,90.1,84.6 to 93.8,266
≥1 Dose Varicella,,States/Local Areas,Kansas,2021,Age,13 Months,63.5,55.0 to 71.3,266
≥1 Dose MMR,,States/Local Areas,Kansas,2020-2021,Age,13 Months,67.9,62.4 to 72.9,634
Hib,Full Series,States/Local Areas,Kansas,2020-2021,Age,19 Months,71.1,65.7 to 76.0,634
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2020-2021,Age,0-2 Days,77.1,71.6 to 81.7,634
Polio,≥3 Doses,States/Local Areas,Kansas,2021,Age,19 Months,90.6,84.9 to 94.3,266
Rotavirus,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.4,73.1 to 85.7,270
Rotavirus,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,71.2,64.4 to 78.0,315
Rotavirus,,States/Local Areas,Kansas,2014-2017,Overall,Overall,77.4,73.8 to 80.9,905
Rotavirus,,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,63.9,56.3 to 71.6,256
Rotavirus,,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,79.1,74.2 to 84.0,413
Rotavirus,,States/Local Areas,Kansas,2019,Age,8 Months,77.6,71.0 to 83.1,358
Rotavirus,,States/Local Areas,Kansas,2017,Age,8 Months,79.7,73.6 to 84.7,354
Rotavirus,,States/Local Areas,Kansas,2017-2018,Age,8 Months,79.9,75.6 to 83.5,749
Rotavirus,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,72.5,62.2 to 82.7,134
Rotavirus,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,86.0,82.6 to 89.4,527
Rotavirus,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,58.5,36.1 to 80.8,35
Rotavirus,,States/Local Areas,Kansas,2018,Age,8 Months,80.0,73.8 to 85.1,395
Rotavirus,,States/Local Areas,Kansas,2018-2019,Age,8 Months,78.8,74.4 to 82.7,753
Rotavirus,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",51.4,30.1 to 72.7,35
Rotavirus,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,65.2,56.9 to 73.5,209
Rotavirus,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,75.2,66.8 to 83.6,174
Rotavirus,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,66.2 to 89.8,84
Rotavirus,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.7,75.7 to 83.7,612
Rotavirus,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,80.3,74.8 to 85.7,320
Rotavirus,,States/Local Areas,Kansas,2011,Age,8 Months,71.4,63.4 to 78.3,221
Rotavirus,,States/Local Areas,Kansas,2016,Age,8 Months,76.6,69.6 to 82.3,301
Rotavirus,,States/Local Areas,Kansas,2016-2017,Age,8 Months,78.1,73.6 to 82.0,655
Rotavirus,,States/Local Areas,Kansas,2014,Age,8 Months,76.0,68.0 to 82.6,208
Rotavirus,,States/Local Areas,Kansas,2014-2015,Age,8 Months,77.2,71.5 to 82.1,388
Rotavirus,,States/Local Areas,Kansas,2012,Age,8 Months,77.6,70.1 to 83.7,224
Rotavirus,,States/Local Areas,Kansas,2013,Age,8 Months,80.9,73.7 to 86.5,231
Rotavirus,,States/Local Areas,Kansas,2013-2014,Age,8 Months,78.5,73.3 to 82.9,439
Rotavirus,,States/Local Areas,Kansas,2015,Age,8 Months,78.4,69.7 to 85.2,180
Rotavirus,,States/Local Areas,Kansas,2015-2016,Age,8 Months,77.5,72.1 to 82.1,481
Rotavirus,,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,91.6,88.0 to 95.2,236
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,72.9,67.3 to 78.5,413
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,80.1,73.0 to 87.2,236
Hib,Full Series,States/Local Areas,Kansas,2011,Age,19 Months,69.9,64.1 to 75.2,221
Hib,Full Series,States/Local Areas,Kansas,2012,Age,19 Months,79.2,75.2 to 82.6,224
Hib,Full Series,States/Local Areas,Kansas,2013,Age,19 Months,79.6,73.6 to 84.5,231
Hib,Full Series,States/Local Areas,Kansas,2013-2014,Age,19 Months,79.7,77.2 to 82.0,439
Hib,Full Series,States/Local Areas,Kansas,2018,Age,19 Months,76.1,69.7 to 81.5,395
Hib,Full Series,States/Local Areas,Kansas,2018-2019,Age,19 Months,95.6,93.3 to 97.1,753
Hib,Full Series,States/Local Areas,Kansas,2015,Age,19 Months,76.5,69.1 to 82.6,180
Hib,Full Series,States/Local Areas,Kansas,2015-2016,Age,19 Months,74.5,68.7 to 79.6,481
Hib,Full Series,States/Local Areas,Kansas,2014,Age,19 Months,79.9,71.9 to 86.1,208
Hib,Full Series,States/Local Areas,Kansas,2014-2015,Age,19 Months,78.2,72.2 to 83.2,388
Hib,Full Series,States/Local Areas,Kansas,2016,Age,19 Months,72.4,64.9 to 78.8,301
Hib,Full Series,States/Local Areas,Kansas,2016-2017,Age,19 Months,74.3,69.3 to 78.7,655
Hib,Full Series,States/Local Areas,Kansas,2017,Age,19 Months,76.2,69.5 to 81.8,354
Hib,Full Series,States/Local Areas,Kansas,2017-2018,Age,19 Months,76.2,71.6 to 80.2,749
Hib,Full Series,States/Local Areas,Kansas,2013,Age,24 Months,82.5,75.9 to 88.2,231
Hib,Full Series,States/Local Areas,Kansas,2013-2014,Age,24 Months,83.4,78.9 to 87.5,439
Hib,Full Series,States/Local Areas,Kansas,2014,Age,24 Months,84.6,78.0 to 90.0,208
Hib,Full Series,States/Local Areas,Kansas,2014-2015,Age,24 Months,82.8,77.7 to 87.3,388
Hib,Full Series,States/Local Areas,Kansas,2012,Age,24 Months,83.1,76.4 to 88.9,224
Hib,Full Series,States/Local Areas,Kansas,2011,Age,24 Months,75.0,67.0 to 82.4,221
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,98.6,97.4 to 99.8,332
Hib,Primary Series,States/Local Areas,Kansas,2019-2020,Age,7 Months,75.6,71.1 to 79.6,726
Hep B,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,93.0,90.0 to 95.1,726
PCV,≥3 Doses,States/Local Areas,Kansas,2021,Age,19 Months,91.4,85.8 to 94.9,266
Hep A,≥1 Dose,States/Local Areas,Kansas,2021,Age,35 Months,87.4,81.2 to 92.4,266
≥1 Dose Varicella,,States/Local Areas,Kansas,2021,Age,19 Months,86.9,80.9 to 91.3,266
Combined 7 Series,,States/Local Areas,Kansas,2011,Age,35 Months,75.6,61.7 to 87.4,221
Combined 7 Series,,States/Local Areas,Kansas,2014,Age,35 Months,77.6,69.4 to 85.0,208
Combined 7 Series,,States/Local Areas,Kansas,2014-2015,Age,35 Months,77.9,71.8 to 83.4,388
Hib,Primary Series,States/Local Areas,Kansas,2017,Age,24 Months,93.2,88.9 to 96.3,354
Hib,Primary Series,States/Local Areas,Kansas,2017-2018,Age,24 Months,92.9,89.9 to 95.2,749
Hep B,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,91.1,87.5 to 94.0,634
Hib,Full Series,States/Local Areas,Kansas,2021,Age,24 Months,77.0,68.8 to 84.4,266
Hib,Primary Series,States/Local Areas,Kansas,2020-2021,Age,13 Months,83.9,79.0 to 87.9,634
Polio,≥1 Dose,States/Local Areas,Kansas,2021,Age,3 Months,87.2,81.1 to 91.6,266
Hib,≥3 Doses,States/Local Areas,Kansas,2021,Age,24 Months,91.4,86.0 to 95.3,266
Hib,Primary Series,States/Local Areas,Kansas,2021,Age,24 Months,92.5,87.8 to 95.9,266
≥1 Dose MMR,,States/Local Areas,Kansas,2021,Age,24 Months,92.7,87.5 to 96.2,266
Polio,≥3 Doses,States/Local Areas,Kansas,2021,Age,24 Months,90.9,85.7 to 94.8,266
DTaP,≥4 Doses,States/Local Areas,Kansas,2021,Age,24 Months,80.7,72.4 to 87.8,266
DTaP,≥1 Dose,States/Local Areas,Kansas,2021,Age,3 Months,85.6,77.4 to 91.1,266
DTaP,≥3 Doses,States/Local Areas,Kansas,2021,Age,19 Months,90.4,84.7 to 94.1,266
PCV,≥4 Doses,States/Local Areas,Kansas,2021,Age,35 Months,87.9,81.7 to 92.8,266
Hep A,≥1 Dose,States/Local Areas,Kansas,2021,Age,19 Months,84.1,77.4 to 89.2,266
PCV,≥4 Doses,States/Local Areas,Kansas,2021,Age,19 Months,81.8,74.6 to 87.3,266
Hep B,≥3 Doses,States/Local Areas,Kansas,2021,Age,24 Months,91.6,86.4 to 95.3,266
Hep A,≥2 Doses,States/Local Areas,Kansas,2021,Age,19 Months,37.6,29.8 to 46.0,266
PCV,≥3 Doses,States/Local Areas,Kansas,2021,Age,7 Months,64.5,55.5 to 72.5,266
DTaP,≥3 Doses,States/Local Areas,Kansas,2021,Age,13 Months,85.2,77.0 to 90.9,266
Hep A,≥2 Doses,States/Local Areas,Kansas,2021,Age,24 Months,60.0,51.0 to 69.1,266
PCV,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,5 Months,75.9,70.4 to 80.7,634
DTaP,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,94.1,89.7 to 97.0,634
PCV,≥4 Doses,States/Local Areas,Kansas,2021,Age,24 Months,87.6,81.4 to 92.5,266
PCV,≥3 Doses,States/Local Areas,Kansas,2021,Age,24 Months,91.7,86.6 to 95.4,266
Hep B,≥3 Doses,States/Local Areas,Kansas,2021,Age,7 Months,66.6,57.8 to 74.4,266
Hep A,≥1 Dose,States/Local Areas,Kansas,2021,Age,24 Months,87.4,81.2 to 92.4,266
DTaP,≥4 Doses,States/Local Areas,Kansas,2021,Age,19 Months,67.1,57.9 to 75.1,266
≥1 Dose Varicella,,States/Local Areas,Kansas,2021,Age,24 Months,90.8,85.4 to 94.8,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2021,Age,0-2 Days,71.9,62.9 to 79.4,266
Hib,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,91.9,88.3 to 94.4,634
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2021,Age,0-1 Days,70.4,61.3 to 78.1,266
≥1 Dose Varicella,,States/Local Areas,Kansas,2020-2021,Age,35 Months,93.6,88.8 to 96.8,634
PCV,≥3 Doses,States/Local Areas,Kansas,2021,Age,13 Months,88.9,82.8 to 93.0,266
DTaP,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,3 Months,83.9,78.9 to 87.9,634
DTaP,≥4 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,77.6,72.3 to 82.4,634
Hep B,≥2 Doses,States/Local Areas,Kansas,2021,Age,5 Months,85.4,78.6 to 90.2,266
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.5,75.9 to 87.1,370
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,75.4,68.6 to 82.3,366
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,87.6,82.3 to 92.8,366
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,92.7 to 99.0,370
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,90.4,86.4 to 94.3,528
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.8,77.8 to 91.7,370
Rotavirus,,States/Local Areas,Kansas,2019-2020,Age,8 Months,78.1,73.6 to 82.0,726
Hep A,≥1 Dose,States/Local Areas,Kansas,2020-2021,Age,35 Months,90.6,85.2 to 94.6,634
PCV,≥3 Doses,States/Local Areas,Kansas,2020,Age,7 Months,70.1,63.3 to 76.2,368
Hep B,≥3 Doses,States/Local Areas,Kansas,2020,Age,7 Months,71.1,64.3 to 77.1,368
Hib,≥1 Dose,States/Local Areas,Kansas,2020,Age,3 Months,79.4,72.8 to 84.7,368
Polio,≥1 Dose,States/Local Areas,Kansas,2020,Age,3 Months,81.0,74.3 to 86.2,368
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,95.9,94.0 to 97.7,749
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,87.0,81.9 to 92.0,749
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,67.1,58.1 to 76.2,299
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.0 to 96.2,749
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.7,77.6 to 93.9,155
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.2,51.8 to 84.6,48
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,93.4,88.0 to 98.9,177
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,75.0,66.9 to 83.0,234
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.1,62.0 to 82.2,155
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,93.9,91.3 to 96.4,749
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,73.8,51.6 to 96.0,39
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,83.2,77.3 to 89.0,299
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,95.4,90.7 to 100.0,177
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,89.6,83.2 to 96.0,234
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,82.9,73.8 to 92.1,177
Influenza,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,54.9,46.4 to 63.5,234
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,91.4,89.1 to 93.8,1264
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Overall,Overall,87.5,84.8 to 90.3,1264
Rotavirus,,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,91.2,87.5 to 95.0,332
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,90.7,88.2 to 93.2,1264
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Overall,Overall,90.0,87.5 to 92.5,1264
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,88.1,84.0 to 92.1,601
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,82.2,78.9 to 85.5,1264
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,79.4,73.3 to 85.5,331
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,92.8,88.4 to 97.2,332
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,84.7,77.6 to 91.8,601
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,92.2,88.9 to 95.5,601
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,82.5,76.5 to 88.5,331
Influenza,,States/Local Areas,Kansas,2016-2019,Overall,Overall,60.2,56.4 to 64.0,1264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Overall,Overall,79.5,76.4 to 82.7,1264
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,86.7,81.4 to 91.9,331
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,79.0,74.4 to 83.6,1264
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,82.4,76.8 to 88.1,332
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Overall,Overall,89.2,86.6 to 91.7,1264
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,99.2,98.4 to 100.0,332
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,68.3,63.1 to 73.6,601
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,93.9,91.1 to 96.6,601
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,56.9,49.5 to 64.3,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,79.5,73.5 to 85.4,331
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,98.2,97.0 to 99.4,332
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,94.5,92.2 to 96.7,601
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Overall,Overall,77.3,73.9 to 80.8,1264
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Overall,Overall,68.2,64.5 to 71.9,1264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.7,68.6 to 80.8,370
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,86.6,81.3 to 91.9,366
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,99.2,98.3 to 100.0,332
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,93.5,90.7 to 96.2,601
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,83.7,78.3 to 89.2,366
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,67.2,61.3 to 73.1,528
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,76.1 to 85.5,528
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,88.8,83.7 to 93.9,366
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,91.8 to 98.3,370
Influenza,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,52.3,45.0 to 59.7,366
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,86.3 to 94.2,528
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,91.8 to 98.3,370
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,74.9,68.3 to 81.5,366
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.9,90.2 to 97.7,370
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.1,75.2 to 86.9,370
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,75.9,70.4 to 81.3,528
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,84.1,78.5 to 89.7,366
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,87.4 to 95.9,370
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,86.4,82.0 to 90.9,528
Rotavirus,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,79.0,73.7 to 84.3,528
Rotavirus,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.0,75.6 to 86.4,370
Influenza,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.3,61.9 to 74.7,370
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,67.1,60.1 to 74.2,366
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.3,63.8 to 76.8,370
Influenza,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,58.5,52.4 to 64.5,528
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,79.0,72.6 to 85.4,366
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.4,78.9 to 89.9,370
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,75.4,69.8 to 81.0,528
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,87.7 to 96.2,370
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,90.8,86.6 to 95.0,366
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,82.4,77.1 to 87.6,528
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,88.4,84.3 to 92.5,528
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,88.8,83.8 to 93.9,366
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.3 to 95.7,528
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,66.0,57.2 to 74.9,366
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,87.9,82.7 to 93.1,366
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,89.0,84.7 to 93.3,528
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,91.7 to 98.4,370
Rotavirus,,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,68.0,60.8 to 75.2,331
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,88.4,84.4 to 92.5,528
Rotavirus,,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,79.5,75.1 to 84.0,601
Rotavirus,,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a Non-MSA,75.1,68.6 to 81.6,366
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Urbanicity,Living In a MSA Principal City,82.7,74.4 to 91.0,528
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.2,57.2 to 83.2,84
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.8,68.1 to 77.6,612
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.0,63.7 to 78.3,270
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,72.5,66.0 to 79.1,320
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,71.1,64.4 to 77.7,315
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Overall,Overall,71.6,67.7 to 75.6,905
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,63.1,55.4 to 70.9,256
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,70.6,61.7 to 79.6,174
Combined 7 Series,,States/Local Areas,Kansas,2015,Age,35 Months,78.2,69.0 to 86.1,180
Combined 7 Series,,States/Local Areas,Kansas,2015-2016,Age,35 Months,74.0,68.2 to 79.4,481
Hib,Full Series,States/Local Areas,Kansas,2019,Age,19 Months,73.7,66.8 to 79.7,358
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,72.7,62.5 to 82.9,134
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,39.3,18.7 to 59.9,35
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.1,39.4 to 80.7,35
Hib,Primary Series,States/Local Areas,Kansas,2015,Age,13 Months,89.1,81.3 to 93.9,180
Hib,Primary Series,States/Local Areas,Kansas,2015-2016,Age,13 Months,88.8,84.1 to 92.2,481
Hib,Primary Series,States/Local Areas,Kansas,2014,Age,13 Months,92.5,87.4 to 95.6,208
Hib,Primary Series,States/Local Areas,Kansas,2014-2015,Age,13 Months,90.8,86.4 to 93.8,388
Hib,Primary Series,States/Local Areas,Kansas,2016,Age,13 Months,88.5,82.3 to 92.7,301
Hib,Primary Series,States/Local Areas,Kansas,2016-2017,Age,13 Months,88.0,84.0 to 91.1,655
Hib,Primary Series,States/Local Areas,Kansas,2018,Age,7 Months,75.8,69.3 to 81.3,395
Hib,Primary Series,States/Local Areas,Kansas,2018-2019,Age,7 Months,76.4,71.9 to 80.4,753
Hib,Primary Series,States/Local Areas,Kansas,2015,Age,7 Months,77.7,68.8 to 84.6,180
Hib,Primary Series,States/Local Areas,Kansas,2015-2016,Age,7 Months,76.8,71.2 to 81.6,481
Hib,Primary Series,States/Local Areas,Kansas,2014,Age,7 Months,74.7,66.3 to 81.6,208
Hib,Primary Series,States/Local Areas,Kansas,2014-2015,Age,7 Months,76.2,70.3 to 81.3,388
Hib,Primary Series,States/Local Areas,Kansas,2011,Age,35 Months,92.4,86.8 to 96.3,221
Hib,Primary Series,States/Local Areas,Kansas,2019,Age,24 Months,93.8,89.9 to 96.6,358
Hib,Primary Series,States/Local Areas,Kansas,2015,Age,35 Months,92.6,87.0 to 96.4,180
Hib,Primary Series,States/Local Areas,Kansas,2015-2016,Age,35 Months,92.2,88.6 to 95.0,481
Combined 7 Series,,States/Local Areas,Kansas,2011,Age,24 Months,66.6,58.2 to 74.9,221
Hib,Primary Series,States/Local Areas,Kansas,2013,Age,7 Months,74.3,72.1 to 76.4,231
Hib,Primary Series,States/Local Areas,Kansas,2013-2014,Age,7 Months,74.5,73.2 to 75.9,439
Hib,Primary Series,States/Local Areas,Kansas,2019,Age,19 Months,93.8,89.5 to 96.5,358
DTaP,≥3 Doses,States/Local Areas,Kansas,2020,Age,13 Months,88.4,82.3 to 92.6,368
Combined 7 Series,,States/Local Areas,Kansas,2013,Age,24 Months,74.0,66.7 to 80.8,231
Combined 7 Series,,States/Local Areas,Kansas,2013-2014,Age,24 Months,73.5,68.1 to 78.6,439
Combined 7 Series,,States/Local Areas,Kansas,2012,Age,24 Months,72.7,65.1 to 79.8,224
Hib,Primary Series,States/Local Areas,Kansas,2013,Age,24 Months,94.7,90.0 to 97.7,231
Hib,Primary Series,States/Local Areas,Kansas,2013-2014,Age,24 Months,94.8,91.8 to 97.0,439
Hib,Primary Series,States/Local Areas,Kansas,2011,Age,24 Months,92.4,86.8 to 96.3,221
Hib,Primary Series,States/Local Areas,Kansas,2012,Age,24 Months,97.4,94.5 to 99.0,224
Hib,Primary Series,States/Local Areas,Kansas,2015,Age,19 Months,92.6,89.2 to 95.1,180
Hib,Primary Series,States/Local Areas,Kansas,2015-2016,Age,19 Months,91.1,87.0 to 94.0,481
Hib,Primary Series,States/Local Areas,Kansas,2018,Age,19 Months,91.6,86.5 to 94.8,395
Hib,Primary Series,States/Local Areas,Kansas,2018-2019,Age,19 Months,84.9,80.8 to 88.2,753
Hib,Primary Series,States/Local Areas,Kansas,2016,Age,19 Months,89.5,83.3 to 93.6,301
Hib,Primary Series,States/Local Areas,Kansas,2016-2017,Age,19 Months,90.2,86.3 to 93.0,655
Hib,Primary Series,States/Local Areas,Kansas,2013,Age,19 Months,93.9,91.3 to 95.8,231
Hib,Primary Series,States/Local Areas,Kansas,2013-2014,Age,19 Months,93.9,91.6 to 95.6,439
Hib,Primary Series,States/Local Areas,Kansas,2014,Age,19 Months,93.9,89.1 to 96.7,208
Hib,Primary Series,States/Local Areas,Kansas,2014-2015,Age,19 Months,93.3,89.6 to 95.7,388
Hib,Primary Series,States/Local Areas,Kansas,2017,Age,19 Months,90.9,85.6 to 94.3,354
Hib,Primary Series,States/Local Areas,Kansas,2017-2018,Age,19 Months,91.2,87.8 to 93.7,749
Hib,Primary Series,States/Local Areas,Kansas,2012,Age,19 Months,95.2,93.5 to 96.4,224
Hib,Primary Series,States/Local Areas,Kansas,2018,Age,13 Months,85.4,79.5 to 89.9,395
Hib,Primary Series,States/Local Areas,Kansas,2018-2019,Age,13 Months,84.9,80.8 to 88.2,753
Hib,Primary Series,States/Local Areas,Kansas,2011,Age,19 Months,90.7,81.0 to 95.7,221
Hib,Primary Series,States/Local Areas,Kansas,2011,Age,13 Months,87.1,79.2 to 92.3,221
Hib,Primary Series,States/Local Areas,Kansas,2012,Age,13 Months,93.2,91.8 to 94.5,224
Hib,Primary Series,States/Local Areas,Kansas,2013,Age,13 Months,89.0,84.6 to 92.3,231
Hib,Primary Series,States/Local Areas,Kansas,2013-2014,Age,13 Months,90.7,88.9 to 92.3,439
Hib,Primary Series,States/Local Areas,Kansas,2019,Age,13 Months,84.4,78.3 to 89.0,358
Hib,Primary Series,States/Local Areas,Kansas,2017,Age,13 Months,87.5,81.8 to 91.6,354
Hib,Primary Series,States/Local Areas,Kansas,2017-2018,Age,13 Months,86.5,82.5 to 89.6,749
Hib,Primary Series,States/Local Areas,Kansas,2019,Age,7 Months,77.1,70.6 to 82.5,358
Hib,Primary Series,States/Local Areas,Kansas,2017,Age,7 Months,77.2,70.9 to 82.4,354
Hib,Primary Series,States/Local Areas,Kansas,2017-2018,Age,7 Months,76.5,72.0 to 80.4,749
Hib,Primary Series,States/Local Areas,Kansas,2016,Age,7 Months,75.8,68.6 to 81.8,301
Hib,Primary Series,States/Local Areas,Kansas,2016-2017,Age,7 Months,76.5,71.8 to 80.6,655
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,76.7,72.0 to 81.4,527
Combined 7 Series,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,64.9,56.5 to 73.3,209
Combined 7 Series,,States/Local Areas,Kansas,2019,Age,35 Months,73.3,66.1 to 80.1,358
Combined 7 Series,,States/Local Areas,Kansas,2018,Age,35 Months,73.4,66.4 to 79.9,395
Combined 7 Series,,States/Local Areas,Kansas,2018-2019,Age,35 Months,73.2,68.3 to 78.0,753
Combined 7 Series,,States/Local Areas,Kansas,2013,Age,35 Months,78.6,70.7 to 85.6,231
Combined 7 Series,,States/Local Areas,Kansas,2013-2014,Age,35 Months,77.7,72.1 to 82.9,439
Combined 7 Series,,States/Local Areas,Kansas,2012,Age,35 Months,84.1,77.0 to 90.0,224
Combined 7 Series,,States/Local Areas,Kansas,2016,Age,35 Months,70.1,62.6 to 77.3,301
Combined 7 Series,,States/Local Areas,Kansas,2016-2017,Age,35 Months,75.1,69.9 to 79.9,655
Combined 7 Series,,States/Local Areas,Kansas,2017,Age,35 Months,81.5,74.2 to 87.8,354
Combined 7 Series,,States/Local Areas,Kansas,2017-2018,Age,35 Months,77.4,72.4 to 82.1,749
Combined 7 Series,,States/Local Areas,Kansas,2019,Age,24 Months,65.4,58.2 to 72.5,358
Hib,Primary Series,States/Local Areas,Kansas,2016,Age,24 Months,91.7,86.8 to 95.3,301
Hib,Primary Series,States/Local Areas,Kansas,2016-2017,Age,24 Months,92.4,89.3 to 94.9,655
Combined 7 Series,,States/Local Areas,Kansas,2015,Age,24 Months,73.2,64.6 to 81.1,180
Combined 7 Series,,States/Local Areas,Kansas,2015-2016,Age,24 Months,70.7,65.0 to 76.2,481
Hib,Primary Series,States/Local Areas,Kansas,2018,Age,35 Months,92.5,88.0 to 95.8,395
Hib,Primary Series,States/Local Areas,Kansas,2018-2019,Age,35 Months,94.0,91.3 to 96.2,753
Combined 7 Series,,States/Local Areas,Kansas,2016,Age,24 Months,67.9,60.4 to 75.1,301
Combined 7 Series,,States/Local Areas,Kansas,2016-2017,Age,24 Months,70.7,65.7 to 75.5,655
Hib,Primary Series,States/Local Areas,Kansas,2019,Age,35 Months,95.6,92.3 to 97.7,358
Combined 7 Series,,States/Local Areas,Kansas,2017,Age,24 Months,73.7,67.2 to 79.9,354
Combined 7 Series,,States/Local Areas,Kansas,2017-2018,Age,24 Months,70.8,66.2 to 75.4,749
Combined 7 Series,,States/Local Areas,Kansas,2018,Age,24 Months,68.0,61.3 to 74.5,395
Combined 7 Series,,States/Local Areas,Kansas,2018-2019,Age,24 Months,66.7,61.8 to 71.6,753
Combined 7 Series,,States/Local Areas,Kansas,2014,Age,24 Months,73.1,65.1 to 80.6,208
Combined 7 Series,,States/Local Areas,Kansas,2014-2015,Age,24 Months,73.1,67.3 to 78.7,388
Hib,Primary Series,States/Local Areas,Kansas,2018,Age,24 Months,92.5,88.0 to 95.8,395
Hib,Primary Series,States/Local Areas,Kansas,2018-2019,Age,24 Months,93.2,90.3 to 95.5,753
Hib,Primary Series,States/Local Areas,Kansas,2012,Age,35 Months,98.3,96.3 to 99.4,224
Hib,Primary Series,States/Local Areas,Kansas,2014,Age,35 Months,94.7,90.5 to 97.5,208
Hib,Primary Series,States/Local Areas,Kansas,2014-2015,Age,35 Months,93.7,90.3 to 96.2,388
Hib,Primary Series,States/Local Areas,Kansas,2013,Age,35 Months,96.6,93.0 to 98.6,231
Hib,Primary Series,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.0,93.2 to 97.9,439
Hib,Primary Series,States/Local Areas,Kansas,2016,Age,35 Months,91.7,86.8 to 95.3,301
Hib,Primary Series,States/Local Areas,Kansas,2016-2017,Age,35 Months,92.4,89.3 to 94.9,655
Hib,Primary Series,States/Local Areas,Kansas,2017,Age,35 Months,93.2,88.9 to 96.3,354
Hib,Primary Series,States/Local Areas,Kansas,2017-2018,Age,35 Months,92.9,89.9 to 95.2,749
Hib,Primary Series,States/Local Areas,Kansas,2015,Age,24 Months,92.6,87.0 to 96.4,180
Hib,Primary Series,States/Local Areas,Kansas,2015-2016,Age,24 Months,92.2,88.6 to 95.0,481
Hib,Primary Series,States/Local Areas,Kansas,2014,Age,24 Months,94.7,90.5 to 97.5,208
Hib,Primary Series,States/Local Areas,Kansas,2014-2015,Age,24 Months,93.7,90.3 to 96.2,388
DTaP,≥3 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,93.9,86.5 to 97.3,243
Hib,≥3 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,85.1,78.7 to 89.8,238
Hib,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,83.6,78.7 to 87.5,461
Hib,≥3 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,67.6,60.0 to 74.5,259
Hib,≥3 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,94.6,89.8 to 97.2,232
Hib,≥3 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,95.5,89.3 to 98.2,243
Hib,≥3 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,82.1,74.2 to 88.0,223
Hib,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,83.0,78.1 to 87.0,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,84.0,77.9 to 88.7,266
Hib,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,80.3,75.9 to 84.1,545
Polio,≥3 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,92.5,87.9 to 95.5,279
Polio,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,76.9,72.2 to 81.1,538
Hib,≥3 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,76.6,69.7 to 82.3,279
Hib,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,72.2,67.1 to 76.8,538
Polio,≥3 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,93.3,87.6 to 96.5,223
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,95.0,91.9 to 97.0,489
Polio,≥3 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,96.8,93.2 to 98.5,266
Polio,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,94.7,92.0 to 96.5,545
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,90.7,85.7 to 94.0,279
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,91.9,88.8 to 94.2,538
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,93.1,89.1 to 95.8,259
DTaP,≥3 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,95.4,89.7 to 98.0,243
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,96.9,90.1 to 99.1,225
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,93.0,87.7 to 96.1,476
DTaP,≥3 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,96.5,93.3 to 98.2,232
Polio,≥3 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,96.6,91.1 to 98.7,225
Polio,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,92.8,88.0 to 95.8,476
Polio,≥3 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,89.1,81.7 to 93.8,251
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,91.3,87.1 to 94.3,489
Polio,≥3 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,95.1,93.4 to 96.5,232
Polio,≥3 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,93.5,89.9 to 95.9,238
Polio,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,93.4,90.0 to 95.7,461
Hib,≥3 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,82.9,75.0 to 88.7,225
Hib,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,80.7,75.6 to 84.9,476
Polio,≥3 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,95.3,89.6 to 97.9,243
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,95.8,92.8 to 98.9,221
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,94.8,91.9 to 97.7,393
Hib,≥3 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,78.5,70.8 to 84.5,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,81.8,76.9 to 85.8,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,93.1,87.2 to 96.4,243
Hib,≥3 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,89.3,88.1 to 90.4,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,78.1,71.9 to 84.3,236
Hib,≥3 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,57.2,49.4 to 64.6,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,89.8 to 96.1,435
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.1,92.8 to 97.4,580
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,93.6,90.7 to 95.6,225
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,90.2,86.1 to 93.2,476
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,86.8,79.3 to 91.9,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,89.4,85.0 to 92.6,489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,82.5,76.8 to 88.1,259
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Overall,Overall,82.1,79.1 to 85.2,850
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,83.9,79.9 to 87.9,435
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.6,68.8 to 84.5,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.8,79.1 to 86.4,580
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,75.5 to 93.5,80
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,82.5,75.6 to 89.4,168
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,84.2,78.5 to 89.8,221
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,83.8,79.4 to 88.1,393
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,91.9,86.7 to 95.2,238
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,91.8,87.7 to 94.5,461
DTaP,≥3 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,94.8,91.7 to 96.7,232
Hib,≥2 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,95.3,91.5 to 97.4,279
Hib,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,96.0,93.8 to 97.4,538
Hib,≥2 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,96.6,93.0 to 98.3,266
Hib,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,95.9,93.6 to 97.4,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,91.0,86.5 to 95.5,236
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,93.9,91.8 to 96.0,850
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,92.9,89.4 to 96.4,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,98.0,95.3 to 100.0,156
Hib,≥2 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,96.8,93.9 to 98.3,259
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,91.6,84.6 to 95.5,223
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,92.6,88.7 to 95.3,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,93.7,88.8 to 96.5,266
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,92.2,89.0 to 94.5,545
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,95.7,92.5 to 98.9,168
Hib,≥2 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,94.4,90.2 to 96.8,259
Hib,≥3 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,65.2,57.9 to 71.9,266
Hib,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,61.4,56.2 to 66.4,545
Hib,≥3 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,57.5,49.9 to 64.9,279
Hib,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,57.4,51.9 to 62.6,538
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,83.2 to 97.5,80
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,95.4,92.1 to 98.7,168
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,91.5,86.9 to 96.1,284
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,96.1,94.1 to 98.0,527
PCV,≥3 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,97.1,94.5 to 98.7,259
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2018,Age,0-3 Days,88.9,83.5 to 92.7,279
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2018-2019,Age,0-3 Days,86.5,82.4 to 89.7,538
Polio,≥1 Dose,States/Local Areas,Nebraska,2019,Age,3 Months,95.7,91.7 to 97.8,259
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2019,Age,0-3 Days,84.0,77.4 to 88.9,259
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,83.2,79.3 to 87.0,527
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,80.6,75.1 to 86.0,284
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,76.0,69.1 to 81.7,279
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,78.9,74.3 to 82.8,538
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,81.9,75.4 to 86.9,259
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,77.4,70.4 to 83.1,266
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,76.7,72.0 to 80.8,545
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014,Age,0-3 Days,75.9,68.4 to 82.1,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2014-2015,Age,0-3 Days,80.5,75.6 to 84.7,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,75.3,69.0 to 80.7,225
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,74.1,69.7 to 78.1,476
DTaP,≥3 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,76.4,73.3 to 79.2,232
DTaP,≥3 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,76.3,69.6 to 82.0,243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2013,Age,0-3 Days,76.6,69.0 to 82.8,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2013-2014,Age,0-3 Days,76.3,71.0 to 80.8,476
Polio,≥1 Dose,States/Local Areas,Nebraska,2013,Age,3 Months,90.4,86.9 to 93.1,225
Polio,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,3 Months,88.2,86.7 to 89.6,476
PCV,≥1 Dose,States/Local Areas,Nebraska,2019,Age,3 Months,95.0,90.8 to 97.4,259
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,93.4,91.2 to 95.6,850
Polio,≥1 Dose,States/Local Areas,Nebraska,2012,Age,3 Months,89.1,86.0 to 91.5,232
Polio,≥1 Dose,States/Local Areas,Nebraska,2011,Age,3 Months,90.6,84.4 to 94.5,243
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.9,84.6 to 91.3,580
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,70.6 to 90.6,80
PCV,≥1 Dose,States/Local Areas,Nebraska,2014,Age,3 Months,85.0,77.7 to 90.3,251
PCV,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,3 Months,87.5,83.1 to 90.9,489
PCV,≥1 Dose,States/Local Areas,Nebraska,2015,Age,3 Months,90.0,84.4 to 93.7,238
PCV,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,3 Months,89.9,86.0 to 92.8,461
Hib,≥2 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,93.0,87.7 to 96.1,238
Hib,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,92.8,89.2 to 95.3,461
PCV,≥3 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,96.3,93.5 to 98.1,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,95.7,91.8 to 98.1,243
PCV,≥3 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,96.2,92.1 to 98.5,225
PCV,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,93.5,89.7 to 96.2,476
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,93.3,90.0 to 96.5,435
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.2,90.5 to 95.9,580
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,91.6,87.9 to 95.4,259
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.5,92.8 to 100.0,156
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,90.0 to 99.9,80
PCV,≥3 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,95.7,91.9 to 98.1,232
Hib,≥2 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,91.7,87.3 to 94.7,279
Hib,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,93.0,90.2 to 95.1,538
PCV,≥3 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,90.9,84.1 to 95.6,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,93.1,89.3 to 96.0,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,95.4,91.2 to 98.0,238
PCV,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,94.9,91.7 to 97.2,461
PCV,≥3 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,94.1,89.0 to 97.4,223
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,95.9,93.0 to 97.9,489
Hib,≥2 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,92.7,86.7 to 96.1,223
Hib,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,93.2,89.7 to 95.6,489
Hib,≥2 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,93.9,88.9 to 96.7,266
Hib,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,92.8,89.7 to 95.0,545
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,92.1,87.6 to 96.7,236
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,95.7,92.7 to 98.6,221
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,93.1,89.7 to 96.4,393
Hib,≥3 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,70.9,68.3 to 73.3,232
Hib,≥3 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,74.3,68.8 to 79.1,243
Hib,≥3 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,62.4,59.6 to 65.2,225
Hib,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,62.3,58.9 to 65.6,476
Polio,≥1 Dose,States/Local Areas,Nebraska,2014,Age,3 Months,86.0,78.7 to 91.1,251
Polio,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,3 Months,88.6,84.2 to 91.9,489
Polio,≥1 Dose,States/Local Areas,Nebraska,2015,Age,3 Months,91.2,85.7 to 94.7,238
Polio,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,3 Months,90.8,86.9 to 93.6,461
Polio,≥1 Dose,States/Local Areas,Nebraska,2016,Age,3 Months,90.3,84.2 to 94.3,223
Polio,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,3 Months,93.0,89.5 to 95.3,489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2017,Age,0-3 Days,85.2,76.9 to 90.9,138
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2017-2018,Age,0-3 Days,85.0,80.8 to 88.5,545
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016,Age,0-3 Days,82.7,75.6 to 88.1,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2017,Age,0-3 Days,82.0,77.2 to 86.0,489
Hib,≥2 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,97.9,96.1 to 98.9,232
Hib,≥2 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,96.0,90.7 to 98.3,243
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,81.1,74.5 to 86.4,238
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,80.8,76.0 to 84.9,461
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,72.9,65.0 to 79.5,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,77.0,71.9 to 81.4,489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2015,Age,0-3 Days,85.1,78.8 to 89.8,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2015-2016,Age,0-3 Days,83.9,79.4 to 87.7,461
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,80.5,73.0 to 86.3,223
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,78.9,74.0 to 83.2,489
Hib,≥2 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,96.3,92.2 to 98.3,225
Hib,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,93.6,89.6 to 96.2,476
PCV,≥3 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,97.3,94.0 to 99.0,266
PCV,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,95.8,93.4 to 97.5,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,93.8,90.0 to 96.6,279
PCV,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,95.5,93.2 to 97.2,538
Hib,≥3 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,62.2,54.3 to 69.6,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,64.9,59.4 to 70.0,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,67.5,59.9 to 74.3,238
Hib,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,67.6,62.1 to 72.7,461
Hib,≥3 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,67.7,59.4 to 75.0,223
Hib,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,66.5,61.0 to 71.6,489
Polio,≥1 Dose,States/Local Areas,Nebraska,2017,Age,3 Months,95.7,92.0 to 97.7,266
Polio,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,3 Months,93.7,90.8 to 95.7,545
Polio,≥1 Dose,States/Local Areas,Nebraska,2018,Age,3 Months,91.6,86.7 to 94.8,279
Polio,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,3 Months,93.6,90.7 to 95.7,538
Hib,≥2 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,95.7,91.2 to 98.0,238
Hib,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,95.4,92.2 to 97.4,461
Hib,≥2 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,95.1,89.5 to 97.8,223
Hib,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,95.8,92.8 to 97.6,489
Hib,≥2 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,91.0,83.9 to 95.1,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,93.4,89.4 to 95.9,489
Rotavirus,,States/Local Areas,Nebraska,2017,Age,8 Months,79.9,73.1 to 85.4,266
Rotavirus,,States/Local Areas,Nebraska,2017-2018,Age,8 Months,79.7,75.1 to 83.6,545
Rotavirus,,States/Local Areas,Nebraska,2019,Age,8 Months,81.5,74.9 to 86.7,259
Rotavirus,,States/Local Areas,Nebraska,2018,Age,8 Months,79.4,73.0 to 84.6,279
Rotavirus,,States/Local Areas,Nebraska,2018-2019,Age,8 Months,80.4,76.0 to 84.2,538
Hep B,≥3 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,82.6,74.0 to 88.7,171
Polio,≥2 Doses,States/Local Areas,Nebraska,2021,Age,5 Months,86.4,78.3 to 91.8,171
Polio,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,95.7,92.4 to 97.6,422
Combined 7 Series,,States/Local Areas,Nebraska,2021,Age,24 Months,59.1,48.9 to 69.5,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,91.3,86.9 to 94.3,422
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2020-2021,Age,0-3 Days,81.3,75.0 to 86.3,422
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,95.5,92.5 to 97.5,422
Hep A,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,19 Months,91.1,86.7 to 94.1,422
Hib,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,93.9,90.4 to 96.5,422
Hib,Primary Series,States/Local Areas,Nebraska,2020-2021,Age,35 Months,94.9,91.5 to 97.2,422
Hib,Primary Series,States/Local Areas,Nebraska,2020-2021,Age,19 Months,93.5,89.4 to 96.0,422
Hib,Full Series,States/Local Areas,Nebraska,2020-2021,Age,35 Months,67.3,60.6 to 73.8,422
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,94.8,91.4 to 96.9,422
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2020-2021,Age,0-1 Days,80.6,74.3 to 85.6,422
PCV,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,81.0,75.4 to 85.6,422
Polio,≥3 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,92.1,85.4 to 95.9,171
Hib,Full Series,States/Local Areas,Nebraska,2020-2021,Age,19 Months,62.6,55.7 to 68.9,422
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2020-2021,Age,0-2 Days,80.8,74.5 to 85.8,422
≥1 Dose MMR,,States/Local Areas,Nebraska,2021,Age,19 Months,90.5,82.3 to 95.2,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2021,Age,13 Months,71.0,60.7 to 79.6,171
PCV,≥1 Dose,States/Local Areas,Nebraska,2021,Age,3 Months,92.6,85.7 to 96.3,171
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,94.4,90.8 to 96.7,422
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,87.6,84.5 to 90.7,527
DTaP,≥2 Doses,States/Local Areas,Nebraska,2021,Age,5 Months,87.3,79.3 to 92.6,171
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.3,62.3 to 84.2,80
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,80.1,73.0 to 87.2,168
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,67.6,61.0 to 74.2,284
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,81.3,76.9 to 85.7,435
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.8,78.1 to 85.5,580
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,67.5,60.5 to 74.6,236
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Overall,Overall,79.4,76.2 to 82.7,850
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,68.2,61.7 to 74.8,259
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.4,81.3 to 93.5,156
Rotavirus,,States/Local Areas,Nebraska,2014,Age,8 Months,72.0,64.1 to 78.7,251
Rotavirus,,States/Local Areas,Nebraska,2014-2015,Age,8 Months,76.8,71.8 to 81.1,489
Rotavirus,,States/Local Areas,Nebraska,2012,Age,8 Months,75.9,68.1 to 82.3,232
Rotavirus,,States/Local Areas,Nebraska,2013,Age,8 Months,74.2,66.9 to 80.4,225
Rotavirus,,States/Local Areas,Nebraska,2013-2014,Age,8 Months,73.1,67.8 to 77.8,476
Rotavirus,,States/Local Areas,Nebraska,2015,Age,8 Months,81.6,75.4 to 86.6,238
Rotavirus,,States/Local Areas,Nebraska,2015-2016,Age,8 Months,81.1,76.4 to 85.0,461
Rotavirus,,States/Local Areas,Nebraska,2016,Age,8 Months,80.5,73.1 to 86.3,223
Rotavirus,,States/Local Areas,Nebraska,2016-2017,Age,8 Months,80.2,75.3 to 84.4,489
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,81.1,76.6 to 85.7,393
Rotavirus,,States/Local Areas,Nebraska,2011,Age,8 Months,79.6,72.4 to 85.3,243
Rotavirus,,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,91.2,86.9 to 95.4,221
Influenza,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,63.2,56.6 to 69.9,284
Influenza,,States/Local Areas,Nebraska,2013,Age,24 Months,70.8,63.2 to 78.1,225
Influenza,,States/Local Areas,Nebraska,2013-2014,Age,24 Months,67.1,61.7 to 72.4,476
Influenza,,States/Local Areas,Nebraska,2011,Age,24 Months,63.9,56.1 to 71.6,243
Influenza,,States/Local Areas,Nebraska,2012,Age,24 Months,69.9,62.4 to 77.2,232
Influenza,,States/Local Areas,Nebraska,2015,Age,24 Months,73.1,66.2 to 79.5,238
Influenza,,States/Local Areas,Nebraska,2015-2016,Age,24 Months,73.2,68.1 to 78.0,461
Influenza,,States/Local Areas,Nebraska,2014,Age,24 Months,63.4,55.9 to 70.9,251
Influenza,,States/Local Areas,Nebraska,2014-2015,Age,24 Months,68.2,63.1 to 73.3,489
Influenza,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.7,64.1 to 85.3,80
Influenza,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,75.2,68.0 to 82.3,168
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,77.8 to 93.8,90
Influenza,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,76.2,71.5 to 80.9,435
Influenza,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.4,66.1 to 74.8,580
Influenza,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,52.0,44.8 to 59.2,259
Influenza,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.2,67.3 to 83.1,156
Influenza,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,75.3,71.1 to 79.6,527
Influenza,,States/Local Areas,Nebraska,2016,Age,24 Months,73.2,65.6 to 80.4,223
Influenza,,States/Local Areas,Nebraska,2016-2017,Age,24 Months,72.9,67.8 to 77.8,489
Influenza,,States/Local Areas,Nebraska,2018,Age,24 Months,76.5,70.0 to 82.5,279
Influenza,,States/Local Areas,Nebraska,2018-2019,Age,24 Months,77.0,72.3 to 81.4,538
Influenza,,States/Local Areas,Nebraska,2017,Age,24 Months,72.5,65.6 to 79.0,266
Influenza,,States/Local Areas,Nebraska,2017-2018,Age,24 Months,74.5,69.7 to 79.0,545
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,91.0,88.2 to 93.8,597
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,88.7,84.5 to 92.9,300
Influenza,,States/Local Areas,Nebraska,2019,Age,24 Months,77.3,70.4 to 83.6,259
Polio,≥2 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,93.5,86.8 to 96.9,171
Influenza,,States/Local Areas,Nebraska,2021,Age,24 Months,64.8,54.1 to 75.3,171
Hib,Full Series,States/Local Areas,Nebraska,2020-2021,Age,24 Months,67.2,60.5 to 73.7,422
Hep B,≥1 Dose,States/Local Areas,Nebraska,2021,Age,3 Months,96.5,91.2 to 98.7,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020-2021,Age,13 Months,74.5,68.3 to 79.9,422
Influenza,,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,83.5,78.0 to 89.0,221
Influenza,,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,67.7,62.2 to 73.2,393
Influenza,,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,63.6,56.5 to 70.7,236
Influenza,,States/Local Areas,Nebraska,2014-2017,Overall,Overall,70.4,66.8 to 74.0,850
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,86.7,83.4 to 90.0,597
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,94.1,91.2 to 96.9,300
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,96.6,94.8 to 98.3,597
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.3,69.8 to 94.7,90
Hep B,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,3 Months,96.3,93.3 to 98.0,422
Hib,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,91.4,87.3 to 94.3,422
Hib,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,60.2,53.5 to 66.5,422
DTaP,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,5 Months,88.4,83.8 to 91.8,422
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,88.8,85.5 to 92.2,597
Hep A,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,24 Months,92.1,88.1 to 95.2,422
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2021,Age,0-3 Days,76.8,66.4 to 84.7,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,95.3,87.7 to 98.8,171
PCV,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,3 Months,93.7,89.9 to 96.1,422
Hib,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,49.3,42.6 to 56.1,422
≥1 Dose MMR,,States/Local Areas,Nebraska,2021,Age,13 Months,68.8,58.2 to 77.8,171
Polio,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,94.7,91.5 to 96.9,422
Hep A,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,81.9,74.5 to 88.1,422
≥1 Dose MMR,,States/Local Areas,Nebraska,2020-2021,Age,19 Months,92.7,88.3 to 95.5,422
PCV,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,93.6,90.2 to 95.9,422
Rotavirus,,States/Local Areas,Nebraska,2021,Age,8 Months,79.0,70.1 to 85.8,171
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,94.5,91.2 to 96.9,422
Hib,≥2 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,93.9,87.3 to 97.2,171
DTaP,≥3 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,93.5,87.8 to 97.1,171
Hep A,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,68.1,61.5 to 74.4,422
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020-2021,Age,24 Months,93.0,88.9 to 95.9,422
Hib,Primary Series,States/Local Areas,Nebraska,2021,Age,35 Months,95.6,88.2 to 99.0,171
Hib,Primary Series,States/Local Areas,Nebraska,2020-2021,Age,7 Months,68.4,61.7 to 74.5,422
Polio,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,3 Months,93.9,90.1 to 96.3,422
DTaP,≥4 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,82.1,76.6 to 86.5,422
Polio,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,94.7,91.3 to 96.8,422
Hib,≥3 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,53.5,43.1 to 63.6,171
PCV,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,95.6,92.7 to 97.6,422
Polio,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,94.7,91.5 to 96.9,422
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020-2021,Age,19 Months,91.7,87.4 to 94.7,422
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,82.1,76.6 to 86.6,422
Hep B,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,5 Months,94.0,90.6 to 96.3,422
Hib,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,5 Months,69.2,62.6 to 75.1,422
Combined 7 Series,,States/Local Areas,Nebraska,2020-2021,Age,35 Months,62.8,56.0 to 69.6,422
DTaP,≥3 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,93.5,87.8 to 97.1,171
Hib,Full Series,States/Local Areas,Nebraska,2021,Age,35 Months,64.4,54.1 to 74.6,171
Hep B,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,95.5,92.2 to 97.5,422
Combined 7 Series,,States/Local Areas,Nebraska,2020-2021,Age,24 Months,61.2,54.5 to 68.0,422
Hib,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,3 Months,74.8,68.2 to 80.5,422
PCV,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,95.9,93.0 to 97.9,422
≥1 Dose MMR,,States/Local Areas,Nebraska,2020-2021,Age,35 Months,95.9,91.6 to 98.4,422
Influenza,,States/Local Areas,Nebraska,2020-2021,Age,24 Months,70.5,63.9 to 76.9,422
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,77.7,72.0 to 82.5,422
PCV,≥4 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,90.0,85.6 to 93.5,422
Polio,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,7 Months,93.2,89.7 to 95.6,422
PCV,≥4 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,87.2,82.3 to 90.8,422
Hib,Primary Series,States/Local Areas,Nebraska,2021,Age,13 Months,70.5,59.6 to 79.4,171
PCV,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,95.5,92.2 to 97.4,422
DTaP,≥4 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,90.3,81.8 to 95.9,171
Hep B,≥3 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,95.2,86.5 to 99.0,171
Polio,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,5 Months,87.8,83.1 to 91.3,422
Rotavirus,,States/Local Areas,Nebraska,2020-2021,Age,8 Months,79.4,73.7 to 84.2,422
Hep B,≥2 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,97.1,92.0 to 99.0,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2021,Age,35 Months,93.7,83.0 to 98.7,171
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,91.1,85.1 to 94.8,560
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,92.4,89.0 to 94.9,1210
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,94.9,90.9 to 97.1,580
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,93.0,89.6 to 95.3,1140
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,78.1,71.7 to 83.4,650
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,79.3,75.1 to 82.9,1291
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,94.8,91.8 to 96.7,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,95.0,93.5 to 96.1,561
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,92.2,87.2 to 95.4,1117
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,95.8,93.6 to 97.2,626
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,94.3,90.9 to 96.4,641
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,80.5,72.6 to 86.5,517
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,84.4,79.8 to 88.2,1097
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,79.8,73.1 to 85.2,560
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,79.0,74.4 to 82.9,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,88.4,83.3 to 92.1,580
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,84.2,80.0 to 87.6,1140
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,92.8,89.0 to 95.4,561
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,90.9,86.7 to 93.8,1117
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,90.5,87.7 to 92.7,517
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,92.6,88.8 to 95.2,1097
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,93.8,89.9 to 96.2,611
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,89.0,82.9 to 93.1,556
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,89.7,85.4 to 92.9,1073
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,93.0,88.9 to 95.7,650
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,93.6,91.1 to 95.5,1291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,79.6,74.4 to 84.8,636
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,95.7,92.2 to 97.7,641
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,89.6,84.4 to 93.1,655
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,93.0,91.0 to 95.1,1975
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,87.7,82.9 to 92.5,636
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.5,91.8 to 97.2,945
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,89.8,80.0 to 99.6,48
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,93.3,87.9 to 96.4,560
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,93.9,90.8 to 96.1,1210
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,94.6,90.5 to 97.0,650
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,95.1,92.7 to 96.8,1291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,82.7,73.9 to 91.4,323
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,77.9 to 91.3,288
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.1,75.2 to 82.9,1044
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,78.3,73.7 to 82.9,982
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.2,78.3 to 86.2,945
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,80.5,77.6 to 83.5,1975
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,76.6,63.9 to 89.3,48
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,87.3,80.9 to 91.8,556
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,88.0,83.4 to 91.4,1073
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,94.0,92.1 to 95.5,561
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,90.7,85.1 to 94.4,1117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,81.1,75.7 to 86.5,551
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,80.8,76.2 to 85.4,788
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.1,90.3 to 95.9,1044
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,87.7 to 94.4,982
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,62.9,56.6 to 68.8,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,90.3 to 95.8,945
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,90.8,86.8 to 93.7,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,94.3,89.8 to 96.9,580
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,91.8,88.1 to 94.3,1140
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,88.7,81.5 to 93.3,517
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,91.5,87.4 to 94.3,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,89.2,83.1 to 93.3,560
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,91.1,87.6 to 93.7,1210
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,89.0,78.8 to 99.1,48
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,96.6,94.7 to 97.9,626
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,94.1,90.6 to 96.4,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,83.4,79.0 to 87.1,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,89.6,85.0 to 92.8,626
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,72.8,65.4 to 79.1,556
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,76.6,71.4 to 81.2,1073
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,94.0,90.7 to 97.3,551
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,97.2,95.6 to 98.7,788
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,94.2,91.6 to 96.0,626
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,84.6,79.6 to 88.5,561
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,78.7,72.7 to 83.7,1117
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.5 to 98.9,1077
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,92.0,88.8 to 95.2,741
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,94.5,90.7 to 98.3,323
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,89.3 to 97.6,288
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.4,83.9 to 96.9,320
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,51.0,27.1 to 74.8,42
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,58.7,52.2 to 65.0,650
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,60.8,56.2 to 65.2,1291
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,68.0,61.0 to 74.2,560
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,63.4,58.6 to 67.9,1210
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,91.9,86.6 to 95.3,556
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,92.5,88.6 to 95.1,1073
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,95.9,92.1 to 97.9,580
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,94.6,91.5 to 96.6,1140
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,93.0,86.3 to 96.6,517
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,94.4,90.9 to 96.7,1097
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,94.9,92.7 to 96.5,626
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,91.8,88.1 to 94.4,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,80.5,74.7 to 85.2,641
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2015,Age,0-2 Days,79.9,72.9 to 85.5,517
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2015-2016,Age,0-2 Days,80.7,76.2 to 84.4,1097
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2014,Age,0-2 Days,67.1,59.7 to 73.6,556
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2014-2015,Age,0-2 Days,73.5,68.4 to 78.0,1073
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013,Age,35 Months,92.0,86.6 to 95.8,561
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,91.5,87.9 to 94.4,1117
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018,Age,24 Months,93.5,89.5 to 96.3,650
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,94.4,92.0 to 96.3,1291
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,85.2,80.4 to 89.0,641
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014,Age,35 Months,90.8,85.7 to 94.7,556
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,90.1,86.1 to 93.3,1073
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015,Age,35 Months,90.7,84.3 to 95.3,517
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,93.5,89.6 to 96.3,1097
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,87.5,82.8 to 91.4,626
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,91.5,84.9 to 95.4,517
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,92.8,89.3 to 95.2,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,94.8,91.6 to 97.1,650
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,94.9,92.8 to 96.7,1291
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,86.2,79.0 to 91.2,517
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,89.3,85.1 to 92.4,1097
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,85.1,78.3 to 90.0,556
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,85.6,80.9 to 89.3,1073
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,92.8,87.6 to 96.0,560
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,92.7,89.6 to 95.0,1210
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,90.5,87.8 to 92.7,561
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,87.8,82.7 to 91.6,1117
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,94.1,90.7 to 96.3,580
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,93.5,90.6 to 95.5,1140
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2016,Age,0-2 Days,81.4,75.5 to 86.1,580
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2016-2017,Age,0-2 Days,82.5,78.5 to 85.9,1140
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016,Age,24 Months,93.2,88.9 to 96.3,580
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,93.4,90.5 to 95.7,1140
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015,Age,24 Months,88.2,81.9 to 93.1,517
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,90.8,87.0 to 93.8,1097
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2012,Age,24 Months,90.1,85.2 to 93.9,611
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2011,Age,24 Months,93.2,89.3 to 96.1,626
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019,Age,19 Months,92.6,88.8 to 95.2,641
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018,Age,19 Months,93.1,88.8 to 95.8,650
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,95.1,92.7 to 96.8,1291
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,84.2,81.2 to 86.9,626
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,79.8,70.6 to 86.6,611
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,83.1,79.4 to 86.3,561
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,82.0,78.9 to 84.7,1117
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,5 Months,91.3,86.8 to 94.4,650
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,5 Months,92.1,89.3 to 94.2,1291
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,5 Months,91.7,86.5 to 95.1,560
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,5 Months,91.5,88.3 to 93.9,1210
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,90.8,87.6 to 93.2,626
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,5 Months,92.9,89.1 to 95.5,641
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2017,Age,0-1 Days,76.8,70.7 to 82.0,560
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2017-2018,Age,0-1 Days,78.1,74.2 to 81.6,1210
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2016,Age,0-1 Days,75.8,69.6 to 81.0,580
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2016-2017,Age,0-1 Days,76.3,71.9 to 80.2,1140
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017,Age,35 Months,95.0,90.8 to 97.7,560
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,96.0,92.6 to 98.1,1210
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,92.6,88.3 to 95.4,650
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,93.5,90.9 to 95.4,1291
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2019,Age,0-2 Days,86.4,81.8 to 89.9,641
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2018,Age,0-2 Days,82.5,77.6 to 86.5,650
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2018-2019,Age,0-2 Days,84.4,81.2 to 87.2,1291
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2017,Age,0-2 Days,83.6,78.2 to 87.9,560
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2017-2018,Age,0-2 Days,83.0,79.5 to 86.1,1210
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,85.0,79.7 to 89.6,611
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,92.4,88.0 to 95.6,626
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,93.7,89.0 to 96.8,560
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,94.2,91.5 to 96.3,1210
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,95.1,91.8 to 97.3,641
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,87.9,82.6 to 92.2,561
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,86.1,82.1 to 89.6,1117
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,84.3,78.1 to 89.4,556
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,83.7,79.2 to 87.8,1073
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019,Age,24 Months,95.3,92.2 to 97.4,641
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2012,Age,35 Months,93.7,88.8 to 96.9,611
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2011,Age,35 Months,93.8,89.8 to 96.6,626
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013,Age,35 Months,96.0,93.3 to 97.8,561
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,93.8,91.0 to 96.0,1117
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.7,91.5 to 98.2,580
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,95.4,92.6 to 97.4,1140
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,3 Months,90.2,85.6 to 93.4,626
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,3 Months,88.8,84.1 to 92.3,611
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,3 Months,87.8,82.1 to 91.9,561
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,3 Months,87.4,83.6 to 90.5,1117
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,95.0,91.6 to 97.1,580
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,95.1,88.4 to 98.0,517
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,95.0,91.8 to 97.1,1097
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,90.2,84.3 to 94.0,556
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,92.6,88.6 to 95.3,1073
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,3 Months,87.1,81.2 to 91.3,556
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,3 Months,85.7,81.2 to 89.3,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,94.1,89.5 to 97.2,560
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,94.8,92.1 to 96.8,1210
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,92.9,89.1 to 95.5,611
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,87.4,81.9 to 91.9,611
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,89.0,84.4 to 92.8,626
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,83.0,77.6 to 87.7,650
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,85.3,81.9 to 88.4,1291
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,87.7,83.2 to 91.5,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,91.7,87.2 to 95.1,580
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,92.9,89.7 to 95.3,1140
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,93.7,88.2 to 97.2,517
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,92.7,89.3 to 95.3,1097
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,91.9,89.3 to 93.8,561
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,90.2,85.6 to 93.5,1117
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,94.5,92.4 to 96.0,626
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,93.7,90.1 to 96.0,641
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,90.7,82.3 to 99.1,115
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,63.2,39.0 to 87.4,42
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.4,84.6 to 96.2,320
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.5 to 97.0,1077
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,91.7,88.6 to 94.9,741
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.2,91.9 to 97.5,641
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.5,91.2 to 98.1,580
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,94.9,92.1 to 97.0,1140
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,83.5,76.6 to 89.3,517
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,85.8,81.6 to 89.5,1097
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,88.2,83.1 to 92.4,580
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,87.0,83.2 to 90.2,1140
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,85.7,79.9 to 90.4,560
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,84.4,80.5 to 87.8,1210
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015,Age,35 Months,93.4,88.2 to 96.9,517
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,94.8,91.3 to 97.2,1097
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014,Age,35 Months,92.2,87.4 to 95.7,556
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,92.3,88.7 to 95.1,1073
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,92.4,87.7 to 95.4,580
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,90.4,86.7 to 93.1,1140
Hib,Full Series,States/Local Areas,Pennsylvania,2020,Age,24 Months,72.5,66.3 to 78.3,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,94.2,90.2 to 97.0,561
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,91.3,87.7 to 94.2,1117
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,88.2,82.2 to 92.9,556
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,91.3,87.3 to 94.3,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,92.8,89.3 to 95.5,611
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,90.8,86.3 to 93.9,650
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,92.3,89.5 to 94.3,1291
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,88.3,82.2 to 92.6,560
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,89.6,85.9 to 92.3,1210
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,93.7,91.7 to 95.3,611
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,95.2,93.4 to 96.6,561
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,92.7,88.9 to 95.3,1117
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,95.3,94.2 to 96.1,626
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,94.5,91.0 to 96.7,641
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018,Age,35 Months,97.1,92.2 to 99.3,650
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,95.7,92.7 to 97.7,1291
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,94.7,91.5 to 97.9,323
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,92.3,90.2 to 94.4,1975
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,90.9,86.9 to 94.8,636
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,89.7 to 95.5,945
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,89.8,79.6 to 99.9,48
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017,Age,35 Months,94.3,90.0 to 97.1,560
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,95.7,92.2 to 97.9,1210
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018,Age,35 Months,97.3,92.7 to 99.3,650
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,96.3,93.2 to 98.2,1291
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,90.7,85.5 to 94.6,561
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,87.7,83.7 to 91.2,1117
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.8,92.7 to 97.8,641
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,89.4 to 97.7,288
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,94.4,89.0 to 99.8,115
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,88.8 to 94.9,1044
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,92.2,89.2 to 95.1,982
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,95.1,91.4 to 97.3,580
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,93.1,89.8 to 95.3,1140
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,90.2,84.1 to 94.1,517
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,92.7,89.0 to 95.2,1097
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,94.6,91.7 to 96.6,1140
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,95.8,92.1 to 97.8,650
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,95.6,93.2 to 97.1,1291
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,94.2,88.8 to 97.1,560
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,95.0,92.0 to 96.9,1210
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,3 Months,89.9,84.2 to 93.7,560
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,3 Months,89.6,86.0 to 92.3,1210
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,3 Months,92.2,88.2 to 94.9,580
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,3 Months,91.1,87.8 to 93.6,1140
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,3 Months,84.4,76.9 to 89.7,517
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,3 Months,88.3,84.1 to 91.5,1097
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,3 Months,89.1,84.4 to 92.4,641
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,3 Months,89.2,84.4 to 92.6,650
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,3 Months,89.1,85.9 to 91.7,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.9,90.1 to 95.7,1044
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,93.2,90.6 to 95.8,982
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,96.4,94.2 to 98.5,788
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,88.6,82.2 to 92.9,556
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,89.4,85.1 to 92.6,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.8,92.6 to 97.9,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,95.5,92.2 to 97.7,650
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,95.7,93.5 to 97.3,1291
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,84.9,78.7 to 90.1,556
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,86.1,81.5 to 90.1,1073
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,89.3,82.1 to 94.5,517
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,90.9,86.8 to 94.2,1097
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,92.4,89.3 to 95.5,741
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,95.4,93.5 to 97.3,1077
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,95.3,92.3 to 98.3,323
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,90.9 to 98.7,288
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.7,86.3 to 97.0,320
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,70.0,45.4 to 94.6,42
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,91.2,85.1 to 95.5,517
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,93.1,89.7 to 95.7,1097
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,89.8,84.2 to 94.1,556
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,90.5,86.5 to 93.7,1073
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,92.9,88.1 to 96.2,561
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,91.3,87.8 to 94.2,1117
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,5 Months,82.4,76.1 to 87.4,560
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,5 Months,81.3,77.1 to 84.8,1210
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,94.3,91.0 to 96.7,611
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,81.6,76.7 to 86.5,741
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,76.8,63.7 to 89.9,115
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,46.7,23.5 to 69.9,42
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,88.3,82.7 to 93.8,323
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.2,63.8 to 82.5,320
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,3 Months,86.0,79.4 to 90.7,561
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,3 Months,84.4,78.5 to 89.0,1117
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,5 Months,83.5,77.6 to 88.1,580
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,5 Months,83.0,78.8 to 86.5,1140
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,5 Months,76.7,69.0 to 82.9,517
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,5 Months,80.1,75.4 to 84.1,1097
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.8,74.7 to 92.9,288
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,89.6,85.4 to 93.7,551
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,94.5,90.9 to 97.0,626
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,94.5,90.9 to 96.7,641
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,93.0,88.5 to 95.8,650
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,92.3,89.5 to 94.3,1291
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,95.4,91.8 to 97.4,641
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,5 Months,83.0,75.3 to 88.7,626
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,5 Months,75.3,69.4 to 80.5,611
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,91.0,85.2 to 94.6,560
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,92.0,88.5 to 94.4,1210
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,5 Months,80.8,74.7 to 85.7,556
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,5 Months,78.7,73.1 to 83.5,1073
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,5 Months,79.8,75.5 to 83.4,561
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,5 Months,80.3,77.5 to 82.8,1117
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,88.9,83.4 to 93.2,560
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,88.0,83.7 to 91.7,1210
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,90.6,85.8 to 94.3,641
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,92.8,87.8 to 96.2,580
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,90.8,87.3 to 93.7,1140
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,87.8,79.3 to 94.0,650
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,88.8,84.5 to 92.4,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,93.3,91.4 to 95.3,1975
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,92.1,88.3 to 95.9,636
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.0,91.4 to 96.7,945
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,88.0,76.4 to 99.5,48
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,91.8,88.2 to 95.4,551
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,96.0,94.0 to 98.1,788
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,3 Months,89.8,85.2 to 93.0,626
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,85.7,82.9 to 88.5,1975
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,80.8,66.5 to 95.0,48
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.3,82.4 to 90.2,945
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,68.1,43.8 to 92.3,42
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,77.8,71.9 to 83.6,636
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,87.0,82.2 to 91.7,551
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,92.3,89.1 to 95.4,788
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,88.3,82.5 to 92.3,556
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,87.2,82.7 to 90.7,1073
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,93.4,90.6 to 95.5,561
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,90.8,87.7 to 93.2,1117
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,3 Months,87.7,82.2 to 91.7,611
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,92.7,90.2 to 95.2,1077
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2012,Age,0-3 Days,76.9,70.8 to 82.0,611
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,3 Months,88.9,84.0 to 92.4,650
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,3 Months,90.6,87.5 to 92.9,1291
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,3 Months,87.1,81.0 to 91.5,560
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,3 Months,88.0,84.3 to 90.9,1210
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,3 Months,91.7,87.7 to 94.5,580
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,3 Months,89.4,85.9 to 92.1,1140
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,95.1,93.1 to 97.1,1077
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,88.8,80.6 to 96.9,115
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.6,82.7 to 96.5,320
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,92.4,87.5 to 95.9,560
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,92.7,89.6 to 95.1,1210
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,90.1,84.6 to 93.8,611
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,95.2,91.8 to 97.5,580
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,93.8,90.9 to 96.0,1140
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,85.6,81.8 to 89.4,982
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2011,Age,0-3 Days,81.5,75.7 to 86.1,626
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,89.8,86.0 to 93.6,741
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,91.6,87.9 to 94.3,626
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,5 Months,81.7,76.4 to 86.1,641
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,5 Months,80.1,74.4 to 84.8,650
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,5 Months,80.9,77.2 to 84.2,1291
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.9,80.0 to 93.9,288
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.3,83.7 to 90.9,1044
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,3 Months,83.2,75.8 to 88.7,517
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,3 Months,87.4,83.3 to 90.7,1097
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,3 Months,82.9,76.4 to 87.8,556
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,3 Months,83.0,78.3 to 86.9,1073
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014,Age,0-3 Days,67.9,60.5 to 74.4,556
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2015,Age,0-3 Days,75.1,70.1 to 79.5,1073
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,71.9,66.5 to 76.7,626
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,71.8,65.5 to 77.4,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,73.8,67.7 to 79.1,561
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,69.9,64.0 to 75.2,1117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2013,Age,0-3 Days,78.2,71.4 to 83.8,561
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2013-2014,Age,0-3 Days,73.1,68.1 to 77.5,1117
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,3 Months,86.8,80.2 to 91.4,561
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,3 Months,86.2,82.2 to 89.3,1117
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,3 Months,90.2,86.0 to 93.2,626
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,3 Months,90.2,86.6 to 92.9,611
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,91.7,89.5 to 93.8,1975
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,3 Months,92.3,88.2 to 95.1,641
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,93.0,88.9 to 96.0,650
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,94.1,91.6 to 96.1,1291
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,86.2,78.6 to 91.4,517
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,90.5,86.4 to 93.5,1097
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,94.0,88.8 to 97.3,561
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,93.1,89.6 to 95.8,1117
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,94.8,91.3 to 97.3,626
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,95.2,92.1 to 97.4,641
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,94.9,91.6 to 97.2,611
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,94.0,89.6 to 98.4,323
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.5,81.9 to 95.1,288
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,89.4 to 95.0,1044
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,89.7,85.9 to 93.5,982
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,90.0,84.1 to 93.9,560
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,89.9,86.3 to 92.6,1210
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,94.8,91.2 to 97.0,580
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,92.4,89.1 to 94.8,1140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016,Age,0-3 Days,83.4,77.8 to 87.8,580
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2017,Age,0-3 Days,84.0,80.1 to 87.2,1140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2017,Age,0-3 Days,84.1,76.2 to 89.8,311
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2017-2018,Age,0-3 Days,84.3,80.8 to 87.2,1210
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,3 Months,93.2,89.4 to 95.7,580
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,3 Months,91.5,88.2 to 93.9,1140
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,3 Months,84.9,77.5 to 90.2,517
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,3 Months,89.0,84.9 to 92.1,1097
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,3 Months,85.6,79.5 to 90.0,556
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,3 Months,85.2,80.6 to 88.9,1073
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,65.6,60.7 to 70.3,561
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,59.9,56.1 to 63.5,1117
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,69.5,63.7 to 74.7,626
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,64.8,58.7 to 70.4,611
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,92.8,89.3 to 96.3,551
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,94.8,92.4 to 97.1,788
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,87.3,82.5 to 92.2,636
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020,Age,24 Months,89.0,84.4 to 92.8,655
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,93.0,89.0 to 95.6,641
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,82.7,76.9 to 87.3,580
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,78.7,74.2 to 82.5,1140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2015,Age,0-3 Days,82.4,75.6 to 87.6,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2015-2016,Age,0-3 Days,82.9,78.7 to 86.4,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,66.0,58.7 to 72.6,556
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,66.7,61.4 to 71.7,1073
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,67.5,59.5 to 74.5,517
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,75.0,70.1 to 79.4,1097
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,3 Months,89.7,84.9 to 93.1,650
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,3 Months,91.0,88.0 to 93.3,1291
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,3 Months,89.7,84.0 to 93.6,560
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,3 Months,89.7,86.1 to 92.4,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,73.6,67.2 to 79.1,580
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,70.8,66.1 to 75.1,1140
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,60.0,52.0 to 67.5,517
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,66.8,61.6 to 71.5,1097
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,54.1,46.8 to 61.1,556
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,57.0,51.6 to 62.2,1073
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,94.3,90.0 to 97.1,650
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,95.0,92.4 to 96.9,1291
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,94.9,90.3 to 97.7,560
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,94.6,91.7 to 96.8,1210
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,96.1,94.3 to 97.4,561
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,94.0,89.6 to 96.7,1117
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,89.7,85.1 to 93.0,650
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,91.3,88.4 to 93.6,1291
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,92.3,87.1 to 96.0,556
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,92.3,88.4 to 95.3,1073
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.6,92.2 to 97.8,580
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,95.3,92.6 to 97.2,1140
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,91.2,85.1 to 95.5,517
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,93.4,90.0 to 96.0,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,94.0,90.3 to 96.4,626
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,66.3,44.5 to 88.0,42
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,74.6,67.8 to 80.3,560
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,73.6,69.1 to 77.7,1210
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,75.9,70.3 to 80.7,641
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,72.7,66.5 to 78.0,650
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,74.3,70.2 to 78.0,1291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,82.1,77.8 to 86.3,741
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.1,74.2 to 87.9,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,81.3,77.2 to 85.4,1077
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,72.6,60.5 to 84.8,115
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2019,Age,0-3 Days,87.3,82.9 to 90.7,641
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,3 Months,92.3,88.2 to 95.1,641
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2018,Age,0-3 Days,83.9,79.2 to 87.7,650
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2018-2019,Age,0-3 Days,85.6,82.5 to 88.3,1291
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.5,92.3 to 97.7,641
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,85.8,75.5 to 96.0,115
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.2,80.2 to 88.1,945
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,35 Months,91.8,86.5 to 95.5,560
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,92.6,88.5 to 95.6,1210
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,35 Months,91.9,86.5 to 95.7,580
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,91.9,88.3 to 94.7,1140
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,84.5,78.8 to 89.4,561
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,84.0,79.9 to 87.7,1117
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,54.1,47.2 to 61.4,580
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,54.2,49.3 to 59.2,1140
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,54.4,47.6 to 61.4,560
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,55.0,50.4 to 59.8,1210
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,55.6,49.4 to 62.1,650
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,55.6,51.2 to 60.2,1291
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,84.7,79.0 to 89.5,611
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,85.8,80.9 to 89.9,626
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,75.3,69.5 to 80.4,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,62.1,54.5 to 69.3,561
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,58.2,53.5 to 62.9,1117
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,49.6,47.0 to 52.2,626
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,55.0,48.4 to 61.4,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,94.0,90.6 to 97.3,551
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,97.8,96.5 to 99.2,788
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013,Age,13 Months,60.4,55.0 to 65.5,561
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,61.0,56.2 to 65.6,1117
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,5 Months,80.6,74.9 to 85.3,650
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,5 Months,82.8,79.1 to 85.9,1291
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,79.3,66.1 to 92.6,115
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,49.0,25.6 to 72.4,42
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.3,75.4 to 91.1,320
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,91.6,89.0 to 94.2,1077
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,85.4,81.0 to 89.8,741
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,35 Months,94.6,90.9 to 97.2,641
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,35 Months,94.0,86.0 to 98.2,650
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,94.2,90.2 to 96.9,1291
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2012,Age,13 Months,59.9,51.5 to 67.8,611
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014,Age,13 Months,61.7,54.6 to 68.2,556
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,58.5,53.2 to 63.6,1073
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,70.6,62.0 to 78.7,556
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,77.9,71.0 to 84.2,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,66.3,60.2 to 72.0,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,87.6,77.9 to 94.4,517
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,82.6,76.2 to 88.1,1097
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,79.1,71.7 to 85.7,580
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,81.6,76.5 to 86.1,1140
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,61.6,55.3 to 67.5,650
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,63.9,59.6 to 68.1,1291
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,46.3,39.6 to 53.1,560
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,53.9,49.2 to 58.5,1210
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,91.8,88.4 to 94.3,626
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,91.7,88.5 to 94.1,611
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,89.9,84.4 to 95.5,323
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,5 Months,85.0,80.0 to 88.9,641
Hib,Primary Series,States/Local Areas,Pennsylvania,2011,Age,7 Months,73.4,68.2 to 78.1,626
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,88.8,85.1 to 92.5,788
Hib,Primary Series,States/Local Areas,Pennsylvania,2012,Age,7 Months,70.3,63.6 to 76.2,611
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,80.5,68.8 to 92.2,115
Hib,Full Series,States/Local Areas,Pennsylvania,2016,Age,35 Months,88.4,82.5 to 93.1,580
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,88.1,84.2 to 91.4,1140
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,81.7,73.6 to 89.7,323
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,80.9 to 93.3,288
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.0,79.0 to 86.9,1044
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,79.7,74.9 to 84.6,982
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,83.4,77.3 to 88.7,556
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,80.9,76.0 to 85.3,1073
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,78.7,71.0 to 85.4,517
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,82.6,77.8 to 86.8,1097
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,86.6,80.8 to 91.4,580
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,86.4,82.4 to 89.8,1140
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,75.2,66.5 to 83.1,561
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,72.6,66.6 to 78.4,1117
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,82.4,71.5 to 91.0,611
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,76.7,69.6 to 83.1,626
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,55.6,49.2 to 62.1,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,54.9,48.0 to 61.6,580
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,50.6,45.7 to 55.4,1140
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,5 Months,77.1,69.5 to 83.3,517
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,5 Months,81.0,76.4 to 84.9,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,53.4,45.6 to 61.0,517
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,54.1,48.9 to 59.2,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,54.3,47.2 to 61.2,556
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,53.9,48.5 to 59.1,1073
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,5 Months,82.3,75.8 to 87.3,560
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,5 Months,81.4,77.2 to 85.0,1210
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,5 Months,85.0,79.4 to 89.3,580
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,5 Months,83.6,79.5 to 87.1,1140
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,35 Months,91.4,85.0 to 95.8,517
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,90.9,86.6 to 94.3,1097
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,46.2,39.1 to 53.9,561
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,44.8,39.8 to 50.1,1117
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,76.0,69.9 to 81.1,650
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,95.4,92.9 to 97.0,1291
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,76.9,70.3 to 82.3,560
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,76.4,72.0 to 80.3,1210
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,79.1,72.6 to 84.4,580
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,78.0,73.4 to 81.9,1140
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.1,84.7 to 97.6,320
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,95.9,92.9 to 99.0,323
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,90.9 to 98.8,288
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.5,92.1 to 97.0,1044
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,90.7 to 96.6,982
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,92.5 to 97.4,945
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,92.3,84.2 to 100.0,48
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,5 Months,81.0,74.6 to 86.1,560
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,5 Months,80.7,76.5 to 84.3,1210
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,5 Months,84.1,79.0 to 88.2,641
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,5 Months,80.4,74.6 to 85.1,650
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,5 Months,82.2,78.5 to 85.4,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015,Age,13 Months,57.7,49.9 to 65.2,517
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,60.1,54.9 to 65.0,1097
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014,Age,13 Months,60.3,53.1 to 67.0,556
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,59.0,53.7 to 64.1,1073
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018,Age,13 Months,68.9,62.6 to 74.6,650
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,68.7,64.3 to 72.8,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013,Age,13 Months,56.6,51.4 to 61.8,561
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,58.5,53.2 to 63.6,1117
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2012,Age,19 Months,89.8,87.5 to 91.6,611
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2011,Age,19 Months,91.0,86.4 to 94.2,626
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019,Age,13 Months,68.5,62.4 to 74.1,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,83.8,76.9 to 89.6,560
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,83.4,78.4 to 87.7,1210
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,83.2,75.6 to 89.5,650
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,83.4,78.5 to 87.7,1291
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,80.7,73.8 to 86.1,556
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,85.1,80.5 to 88.8,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,93.2,91.0 to 94.8,561
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,87.0,78.8 to 92.3,1117
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,90.3,84.7 to 94.4,561
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,88.6,84.3 to 92.2,1117
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,88.0,83.6 to 91.3,611
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,84.0,77.3 to 89.5,641
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,87.0,80.0 to 92.5,556
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,86.0,80.7 to 90.5,1073
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,92.7,87.9 to 96.0,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.2,92.1 to 97.4,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,43.4,36.7 to 50.8,556
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,44.4,39.2 to 49.9,1073
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,45.4,37.7 to 53.9,517
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,49.7,44.5 to 55.3,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,94.3,92.5 to 96.2,1975
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,35 Months,86.8,80.5 to 91.8,556
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,88.0,83.3 to 91.8,1073
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,35 Months,87.5,80.8 to 92.7,561
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,87.1,82.6 to 90.9,1117
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,91.2,87.1 to 95.3,636
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,5 Months,79.9,73.7 to 84.9,556
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,5 Months,78.5,72.4 to 83.6,1073
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,5 Months,80.2,75.5 to 84.1,561
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,5 Months,80.0,77.4 to 82.4,1117
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,35 Months,88.2,81.8 to 93.2,611
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,5 Months,82.6,74.7 to 88.4,626
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,5 Months,77.3,72.6 to 81.4,611
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,90.2,85.8 to 93.8,626
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,82.9,77.5 to 87.6,641
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,86.1,80.6 to 90.8,560
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,84.8,81.0 to 88.2,1210
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,83.4,78.0 to 88.1,650
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,83.2,79.4 to 86.5,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2011,Age,13 Months,49.2,43.4 to 55.1,626
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2012,Age,13 Months,47.7,41.6 to 54.0,611
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,88.6,86.5 to 90.4,626
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,84.5,79.5 to 89.4,551
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,86.1,78.5 to 91.3,517
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,90.1,85.9 to 93.1,1097
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,86.9,84.2 to 89.6,1975
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,84.2,78.9 to 89.5,636
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,93.1,91.4 to 94.5,561
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,90.7,88.1 to 92.8,1117
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,88.3,82.5 to 92.3,556
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,87.2,82.7 to 90.7,1073
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.0,82.3 to 89.7,1044
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,86.4,82.2 to 90.6,982
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.8,83.2 to 90.5,945
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,90.2,80.6 to 99.9,48
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,84.7 to 96.1,288
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015,Age,13 Months,55.3,47.4 to 62.9,517
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,60.4,55.2 to 65.4,1097
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017,Age,13 Months,64.2,57.1 to 70.7,560
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,66.5,61.8 to 70.9,1210
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016,Age,13 Months,65.6,58.7 to 71.9,580
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,64.9,59.9 to 69.5,1140
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017,Age,13 Months,59.6,52.5 to 66.4,560
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,65.7,61.0 to 70.2,1210
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018,Age,13 Months,71.9,65.8 to 77.3,650
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,70.6,66.3 to 74.6,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016,Age,13 Months,62.4,55.5 to 68.9,580
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,61.0,56.1 to 65.8,1140
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,91.1,86.5 to 94.2,650
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,92.4,89.5 to 94.5,1291
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,90.4,84.5 to 94.2,560
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,90.8,87.2 to 93.4,1210
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,94.2,90.3 to 96.5,580
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,92.3,89.0 to 94.7,1140
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,3 Months,95.4,92.1 to 97.4,626
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,3 Months,92.9,90.0 to 95.0,611
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,3 Months,94.4,93.5 to 95.2,561
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,3 Months,92.4,87.1 to 95.6,1117
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,84.4,80.0 to 88.7,982
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.8,80.9 to 88.8,945
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,84.1,81.1 to 87.0,1975
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,75.2,60.4 to 90.1,48
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.1,83.0 to 95.2,288
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.5,80.6 to 88.4,1044
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,84.2,76.7 to 91.7,323
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2012,Age,24 Months,91.2,86.9 to 94.6,611
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2011,Age,24 Months,91.1,86.5 to 94.6,626
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,77.3,71.3 to 83.4,636
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017,Age,19 Months,89.6,84.3 to 93.2,560
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,91.3,88.1 to 93.7,1210
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016,Age,19 Months,90.7,85.4 to 94.1,580
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,90.1,86.6 to 92.8,1140
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015,Age,19 Months,88.9,85.8 to 91.4,517
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,89.8,85.8 to 92.8,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,93.3,89.7 to 95.7,517
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,92.4,88.7 to 94.9,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,84.9,78.3 to 89.7,556
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,89.1,84.8 to 92.3,1073
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,89.4,82.6 to 96.1,788
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,93.7,91.9 to 95.1,561
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,89.3,83.4 to 93.3,1117
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,5 Months,91.4,87.8 to 94.0,561
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,5 Months,86.6,80.4 to 91.0,1117
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,5 Months,88.8,85.9 to 91.1,626
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,5 Months,89.6,85.1 to 92.8,611
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2011,Age,0-1 Days,69.6,63.5 to 75.1,626
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,81.9,75.1 to 88.6,551
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,3 Months,97.6,95.5 to 98.8,641
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,13 Months,91.6,86.0 to 95.1,556
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,92.4,88.4 to 95.1,1073
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,3 Months,96.8,94.0 to 98.3,650
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,3 Months,97.2,95.6 to 98.2,1291
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,96.9,95.3 to 97.9,626
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,95.4,93.2 to 96.9,611
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013,Age,19 Months,87.2,81.6 to 91.3,561
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,88.1,84.6 to 90.9,1117
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015,Age,19 Months,85.8,78.9 to 90.7,517
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,88.1,83.9 to 91.4,1097
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014,Age,19 Months,89.1,83.5 to 92.9,556
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,87.4,83.1 to 90.7,1073
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,74.7,65.0 to 84.4,636
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,82.1,77.5 to 86.7,1975
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,93.7,89.9 to 96.1,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.6,78.4 to 90.9,945
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,94.7,90.9 to 97.3,650
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,94.9,92.4 to 96.7,1291
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2011,Age,13 Months,60.5,52.6 to 67.8,626
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,89.5,75.4 to 100.0,48
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.1,78.5 to 89.6,1044
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,3 Months,96.9,94.3 to 98.4,580
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,3 Months,97.5,95.7 to 98.6,1140
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,3 Months,95.6,90.9 to 97.9,517
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,3 Months,96.2,93.8 to 97.7,1097
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,3 Months,90.3,84.1 to 94.2,556
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,3 Months,92.9,89.2 to 95.4,1073
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,13 Months,95.5,93.6 to 96.8,561
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,93.6,90.0 to 95.9,1117
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,56.4,28.5 to 84.3,42
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,92.9,87.6 to 96.5,580
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,92.1,88.5 to 94.9,1140
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,91.3,86.0 to 95.2,560
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,89.1,85.4 to 92.2,1210
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,87.6,81.5 to 91.9,560
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,88.8,85.1 to 91.6,1210
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,85.4,77.4 to 91.8,517
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,89.1,84.4 to 92.9,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,89.6,83.0 to 93.8,517
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,89.9,86.0 to 92.8,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,90.3,85.3 to 93.7,580
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,88.9,85.2 to 91.8,1140
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,87.2,83.1 to 91.3,1077
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,74.4,66.0 to 82.8,741
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.9,66.9 to 94.9,320
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,77.2,70.4 to 84.1,982
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,77.1,63.7 to 90.6,323
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,97.9,94.3 to 100.0,115
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,92.0,88.8 to 95.2,788
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,91.5,88.5 to 93.7,611
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,90.6,88.5 to 92.3,626
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,92.4,88.6 to 95.0,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,90.0,85.4 to 93.3,650
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,91.2,88.3 to 93.4,1291
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,86.5,81.0 to 91.0,650
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,87.7,83.9 to 90.9,1291
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2011,Age,19 Months,90.0,84.6 to 93.7,626
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,79.3,66.1 to 92.5,115
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,63.3,38.7 to 87.9,42
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.2,65.8 to 84.7,320
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,90.0,87.0 to 92.9,1077
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,79.4,74.1 to 84.7,741
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,89.1,83.9 to 93.2,641
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,3 Months,98.1,94.9 to 99.3,560
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,3 Months,97.5,95.6 to 98.5,1210
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,13 Months,95.2,91.2 to 97.5,580
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,94.5,91.4 to 96.5,1140
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,13 Months,93.2,86.4 to 96.7,517
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,94.2,90.6 to 96.5,1097
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016,Age,19 Months,90.5,85.1 to 94.1,580
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,90.1,86.5 to 92.8,1140
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019,Age,13 Months,69.3,63.2 to 74.8,641
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018,Age,19 Months,92.6,88.2 to 95.4,650
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,68.7,64.3 to 72.8,1291
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017,Age,19 Months,89.6,84.3 to 93.3,560
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,91.1,87.8 to 93.6,1210
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2012,Age,19 Months,88.7,87.3 to 89.9,611
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014,Age,19 Months,91.0,86.0 to 94.3,556
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,89.9,86.0 to 92.9,1073
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013,Age,19 Months,88.6,83.5 to 92.2,561
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,89.8,86.8 to 92.1,1117
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2015,Age,0-1 Days,70.1,62.3 to 76.9,517
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2015-2016,Age,0-1 Days,72.9,68.0 to 77.3,1097
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,5 Months,87.3,79.8 to 92.2,517
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,5 Months,89.4,85.3 to 92.5,1097
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2014,Age,0-1 Days,62.7,55.5 to 69.4,556
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2014-2015,Age,0-1 Days,66.4,61.1 to 71.3,1073
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2013,Age,0-1 Days,67.5,59.9 to 74.3,561
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2013-2014,Age,0-1 Days,65.1,58.8 to 70.9,1117
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013,Age,24 Months,89.0,83.3 to 93.4,561
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,89.7,86.0 to 92.7,1117
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014,Age,24 Months,90.4,85.3 to 94.3,556
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,89.2,85.2 to 92.5,1073
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,13 Months,93.7,88.3 to 96.8,560
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,94.3,91.2 to 96.4,1210
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019,Age,19 Months,91.5,87.5 to 94.4,641
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,13 Months,95.8,92.3 to 97.8,641
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,13 Months,94.9,90.8 to 97.2,650
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,95.4,92.9 to 97.0,1291
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2012,Age,0-1 Days,68.0,58.4 to 76.3,611
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,5 Months,81.7,74.8 to 87.1,556
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,5 Months,84.5,80.2 to 88.0,1073
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,5 Months,91.6,87.2 to 94.6,580
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,5 Months,91.7,88.5 to 94.1,1140
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,94.8,91.2 to 96.9,650
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,91.2,88.3 to 93.4,1291
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,93.0,87.8 to 96.1,560
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,93.9,91.0 to 95.9,1210
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,68.3,58.3 to 77.0,611
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,85.3,80.4 to 90.3,551
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,89.3,85.5 to 93.0,788
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,59.2,51.9 to 66.2,556
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,60.8,55.4 to 66.0,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,91.4,86.5 to 94.6,580
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,92.2,88.9 to 94.6,1140
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,7 Months,69.3,61.9 to 75.9,626
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,70.8,66.3 to 74.9,561
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,65.0,59.9 to 69.9,1117
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2012,Age,35 Months,96.3,93.3 to 98.3,611
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2011,Age,35 Months,91.8,87.2 to 95.2,626
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019,Age,24 Months,93.9,90.4 to 96.4,641
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017,Age,24 Months,93.6,89.3 to 96.5,560
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,93.4,90.6 to 95.6,1210
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013,Age,24 Months,92.6,88.6 to 95.7,561
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,92.0,89.0 to 94.4,1117
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014,Age,24 Months,91.6,86.9 to 95.0,556
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,91.5,87.9 to 94.3,1073
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015,Age,24 Months,91.8,86.1 to 95.8,517
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,92.3,88.8 to 95.0,1097
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018,Age,24 Months,93.0,89.0 to 96.0,650
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,93.5,90.9 to 95.5,1291
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,91.3,87.0 to 94.7,626
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,94.0,90.2 to 96.4,641
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,94.0,90.0 to 96.7,561
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,90.1,86.5 to 93.0,1117
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,92.6,89.1 to 95.3,611
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,7 Months,79.7,73.8 to 84.6,580
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,75.2,70.6 to 79.2,1140
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,84.5,78.6 to 89.0,580
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,83.6,79.4 to 87.0,1140
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,77.2,75.5 to 78.7,517
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,80.8,76.0 to 84.9,1097
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,80.8,74.3 to 86.0,556
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,79.0,74.0 to 83.2,1073
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,7 Months,62.5,54.7 to 69.6,517
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,71.1,66.1 to 75.6,1097
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,7 Months,70.5,63.6 to 76.6,560
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,71.1,66.5 to 75.2,1210
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2018,Age,0-1 Days,79.4,74.3 to 83.6,650
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2018-2019,Age,0-1 Days,81.2,77.9 to 84.2,1291
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,35 Months,89.7,84.4 to 93.8,655
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2011,Age,0-2 Days,80.6,76.7 to 84.0,626
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2019,Age,0-1 Days,83.1,78.4 to 87.0,641
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,7 Months,94.5,92.8 to 95.8,561
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,89.9,84.0 to 93.8,1117
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2012,Age,0-2 Days,75.6,68.3 to 81.6,611
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2013,Age,0-2 Days,77.6,70.8 to 83.2,561
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2013-2014,Age,0-2 Days,72.3,65.6 to 78.2,1117
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,13 Months,92.8,89.1 to 95.3,626
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,7 Months,75.7,70.1 to 80.6,641
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,7 Months,71.6,65.5 to 77.0,650
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,73.7,69.6 to 77.4,1291
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,7 Months,91.9,89.2 to 94.1,611
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,7 Months,85.2,78.6 to 90.0,556
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,88.4,83.9 to 91.7,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,86.1,80.1 to 91.0,556
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,89.9,86.0 to 93.1,1073
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,93.6,88.1 to 97.1,517
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,92.5,89.1 to 95.1,1097
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,91.4,86.9 to 94.8,580
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,92.5,89.4 to 95.0,1140
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,13 Months,89.2,84.2 to 92.7,611
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016,Age,24 Months,92.9,88.5 to 96.0,580
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,93.0,90.1 to 95.3,1140
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017,Age,24 Months,93.1,88.8 to 96.2,560
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,93.3,90.5 to 95.6,1210
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,80.4,74.7 to 85.0,650
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,83.9,80.1 to 87.0,1060
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,82.6,76.4 to 87.4,560
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,81.5,77.4 to 85.0,1210
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,82.1,79.1 to 85.1,1975
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,75.9,61.4 to 90.4,48
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,72.3,65.9 to 78.7,636
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,85.0,80.3 to 89.8,551
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,52.0,28.2 to 75.8,42
Hib,Full Series,States/Local Areas,Pennsylvania,2017,Age,35 Months,87.7,82.3 to 92.2,560
Hib,Full Series,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,86.4,82.7 to 89.7,1210
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,97.1,95.6 to 98.6,1077
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.5 to 94.0,741
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,90.9,82.9 to 99.0,115
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,64.4,39.8 to 89.0,42
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,94.9,91.7 to 97.2,641
Hib,Full Series,States/Local Areas,Pennsylvania,2014,Age,35 Months,80.5,74.1 to 86.3,556
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,81.3,76.1 to 85.9,1073
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,88.7,85.7 to 91.6,1077
Hib,Full Series,States/Local Areas,Pennsylvania,2015,Age,35 Months,84.0,75.7 to 90.8,517
Hib,Full Series,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,85.9,80.9 to 90.1,1097
Hib,Full Series,States/Local Areas,Pennsylvania,2019,Age,35 Months,87.2,82.2 to 91.4,641
Hib,Full Series,States/Local Areas,Pennsylvania,2018,Age,35 Months,85.1,79.8 to 89.7,650
Hib,Full Series,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,86.1,82.4 to 89.3,1291
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,76.8,71.3 to 82.4,741
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.9,63.6 to 82.3,320
Hib,Full Series,States/Local Areas,Pennsylvania,2013,Age,35 Months,89.0,83.2 to 93.5,561
Hib,Full Series,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,84.5,80.1 to 88.3,1117
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.5,84.1 to 97.0,320
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,96.0,92.9 to 99.0,323
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,86.2 to 97.8,288
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.8,89.9 to 95.6,1044
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,89.7 to 95.8,982
Hib,Full Series,States/Local Areas,Pennsylvania,2019,Age,24 Months,81.8,76.8 to 86.4,641
Hib,Full Series,States/Local Areas,Pennsylvania,2012,Age,35 Months,84.6,78.5 to 89.8,611
Hib,Full Series,States/Local Areas,Pennsylvania,2011,Age,35 Months,88.7,84.1 to 92.4,626
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,95.7,92.9 to 97.7,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,88.7,83.0 to 93.1,556
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,90.3,86.3 to 93.5,1073
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,5 Months,83.4,75.2 to 89.2,626
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,5 Months,77.7,72.8 to 82.0,611
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,5 Months,83.1,79.0 to 86.6,561
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,5 Months,81.7,78.5 to 84.6,1117
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,96.6,93.6 to 98.5,561
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,93.5,90.2 to 96.0,1117
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,90.8,85.3 to 94.9,556
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,91.4,87.4 to 94.5,1073
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,5 Months,77.5,69.9 to 83.6,517
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,5 Months,81.7,77.1 to 85.6,1097
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,5 Months,80.3,74.1 to 85.4,556
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,5 Months,78.9,72.6 to 84.1,1073
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,91.5,85.3 to 95.8,517
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,93.7,90.3 to 96.2,1097
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.9,92.4 to 98.1,580
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,95.0,92.1 to 97.1,1140
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,94.2,89.2 to 97.3,560
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,94.4,91.4 to 96.6,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,95.2,92.0 to 97.4,626
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,94.2,90.7 to 96.7,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,95.8,92.2 to 98.0,561
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,92.2,88.9 to 94.9,1117
Hib,Full Series,States/Local Areas,Pennsylvania,2018,Age,24 Months,83.0,77.7 to 87.7,650
Hib,Full Series,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,82.4,78.8 to 85.7,1291
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,96.0,92.9 to 98.0,626
Hib,Full Series,States/Local Areas,Pennsylvania,2016,Age,24 Months,84.0,78.0 to 89.0,580
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,84.8,80.9 to 88.3,1140
Hib,Full Series,States/Local Areas,Pennsylvania,2017,Age,24 Months,85.6,80.2 to 90.2,560
Hib,Full Series,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,84.3,80.6 to 87.7,1210
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,96.1,93.1 to 98.0,611
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,92.4,87.3 to 96.0,560
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,93.3,90.2 to 95.7,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,94.8,91.4 to 96.9,641
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,94.6,91.4 to 96.9,641
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,94.2,90.5 to 96.9,650
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,94.4,92.0 to 96.3,1291
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,95.9,92.9 to 97.9,626
Hib,Full Series,States/Local Areas,Pennsylvania,2015,Age,24 Months,76.4,68.7 to 83.4,517
Hib,Full Series,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,80.1,75.3 to 84.5,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,96.2,92.6 to 98.3,561
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,93.4,90.2 to 95.9,1117
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,93.1,87.8 to 96.2,560
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,93.7,90.6 to 95.9,1210
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,95.3,91.9 to 97.4,641
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,94.4,90.3 to 96.8,650
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,93.6,91.1 to 95.5,1291
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,89.3,83.7 to 93.6,556
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,90.3,86.3 to 93.6,1073
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,91.5,85.3 to 95.8,517
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,93.6,90.1 to 96.1,1097
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,91.6,86.9 to 94.7,650
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,79.3,75.1 to 82.9,1291
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,94.9,91.2 to 97.1,580
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,93.7,90.7 to 95.8,1140
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,95.6,92.2 to 97.8,580
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,94.0,91.1 to 96.3,1140
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,92.4,87.2 to 95.7,560
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,92.0,88.7 to 94.4,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,88.8,85.2 to 91.7,517
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,91.8,87.8 to 94.6,1097
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,24 Months,93.9,89.4 to 96.9,561
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,91.6,88.1 to 94.4,1117
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,93.9,91.0 to 95.9,561
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,90.1,83.0 to 94.4,1117
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,86.2,79.8 to 90.8,556
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,87.5,82.9 to 91.0,1073
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,95.4,92.5 to 97.5,611
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,94.5,90.9 to 97.0,626
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,93.8,89.6 to 96.3,650
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,70.6,66.3 to 74.6,1291
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,94.4,90.9 to 96.6,641
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,95.7,92.0 to 97.8,580
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,94.4,91.4 to 96.4,1140
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,91.2,88.0 to 93.6,517
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,93.5,89.7 to 95.9,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,89.4,83.1 to 93.5,556
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,90.3,85.9 to 93.4,1073
PCV,≥4 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,75.9,69.6 to 81.7,351
DTaP,≥4 Doses,States/Local Areas,Oregon,2012,Age,19 Months,66.8,62.9 to 70.6,229
DTaP,≥4 Doses,States/Local Areas,Oregon,2011,Age,19 Months,63.3,57.0 to 69.1,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2019,Age,19 Months,85.7,79.4 to 90.3,264
Hep A,≥1 Dose,States/Local Areas,Oregon,2011,Age,24 Months,75.8,68.5 to 82.4,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2013,Age,24 Months,89.9,84.2 to 94.2,208
Hep A,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,24 Months,87.7,84.0 to 90.9,478
Hep A,≥1 Dose,States/Local Areas,Oregon,2012,Age,24 Months,83.7,76.7 to 89.5,229
≥1 Dose MMR,,States/Local Areas,Oregon,2020,Age,13 Months,70.4,62.0 to 77.6,220
Hib,≥3 Doses,States/Local Areas,Oregon,2011,Age,35 Months,86.0,79.3 to 91.5,266
Hib,≥3 Doses,States/Local Areas,Oregon,2012,Age,35 Months,93.3,88.0 to 96.8,229
PCV,≥2 Doses,States/Local Areas,Oregon,2013,Age,5 Months,78.9,75.2 to 82.2,208
PCV,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,5 Months,75.3,71.5 to 78.8,478
PCV,≥2 Doses,States/Local Areas,Oregon,2012,Age,5 Months,79.5,75.0 to 83.4,229
PCV,≥2 Doses,States/Local Areas,Oregon,2011,Age,5 Months,68.2,62.3 to 73.5,266
DTaP,≥3 Doses,States/Local Areas,Oregon,2015,Age,35 Months,94.6,88.2 to 98.1,243
DTaP,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,94.9,90.7 to 97.6,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2016,Age,35 Months,94.7,89.1 to 97.9,177
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,94.1,90.2 to 96.8,372
DTaP,≥3 Doses,States/Local Areas,Oregon,2017,Age,35 Months,92.6,86.9 to 96.5,195
DTaP,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,94.3,91.0 to 96.7,485
Polio,≥2 Doses,States/Local Areas,Oregon,2021,Age,7 Months,89.4,81.2 to 94.3,131
Hib,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,86.8,81.2 to 91.4,351
Hib,≥2 Doses,States/Local Areas,Oregon,2021,Age,7 Months,89.4,81.2 to 94.3,131
DTaP,≥3 Doses,States/Local Areas,Oregon,2021,Age,24 Months,92.2,84.7 to 96.9,131
Hib,≥3 Doses,States/Local Areas,Oregon,2021,Age,19 Months,84.5,74.5 to 91.1,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.1,73.6 to 82.7,556
DTaP,≥1 Dose,States/Local Areas,Oregon,2012,Age,3 Months,87.4,80.0 to 92.3,229
DTaP,≥1 Dose,States/Local Areas,Oregon,2011,Age,3 Months,84.8,80.3 to 88.4,266
DTaP,≥1 Dose,States/Local Areas,Oregon,2013,Age,3 Months,92.0,89.1 to 94.1,208
DTaP,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,3 Months,89.3,86.5 to 91.5,478
DTaP,≥1 Dose,States/Local Areas,Oregon,2014,Age,3 Months,86.6,80.8 to 90.8,270
DTaP,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,3 Months,89.1,85.4 to 92.0,513
DTaP,≥1 Dose,States/Local Areas,Oregon,2015,Age,3 Months,91.6,86.4 to 95.0,243
DTaP,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,3 Months,88.9,83.9 to 92.5,420
DTaP,≥1 Dose,States/Local Areas,Oregon,2016,Age,3 Months,86.1,77.0 to 92.0,177
DTaP,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,3 Months,86.4,80.8 to 90.5,372
DTaP,≥1 Dose,States/Local Areas,Oregon,2017,Age,3 Months,86.6,79.0 to 91.7,195
DTaP,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,3 Months,88.5,84.0 to 91.9,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2014,Age,24 Months,90.6,85.9 to 94.2,270
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,90.9,87.5 to 93.7,513
DTaP,≥3 Doses,States/Local Areas,Oregon,2015,Age,24 Months,91.2,85.9 to 95.0,243
DTaP,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,91.8,87.8 to 94.9,420
DTaP,≥1 Dose,States/Local Areas,Oregon,2018,Age,3 Months,90.6,85.0 to 94.2,290
DTaP,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,3 Months,91.4,87.7 to 94.0,554
DTaP,≥3 Doses,States/Local Areas,Oregon,2016,Age,24 Months,92.6,86.3 to 96.7,177
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,92.8,88.6 to 95.8,372
DTaP,≥1 Dose,States/Local Areas,Oregon,2019,Age,3 Months,92.2,86.7 to 95.6,264
Hep A,≥1 Dose,States/Local Areas,Oregon,2011,Age,19 Months,71.5,68.9 to 73.9,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2012,Age,19 Months,75.2,68.9 to 80.6,229
Hib,Primary Series,States/Local Areas,Oregon,2020-2021,Age,24 Months,90.1,85.3 to 93.8,351
Hib,Primary Series,States/Local Areas,Oregon,2021,Age,19 Months,90.8,82.7 to 95.4,131
Hep B,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,87.4,82.2 to 91.2,351
Hib,Full Series,States/Local Areas,Oregon,2021,Age,19 Months,72.1,61.7 to 80.6,131
Hep A,≥1 Dose,States/Local Areas,Oregon,2014,Age,19 Months,79.8,73.4 to 85.0,270
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,19 Months,81.5,76.9 to 85.3,513
Hep A,≥1 Dose,States/Local Areas,Oregon,2015,Age,19 Months,83.2,79.2 to 86.6,243
Hep A,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,19 Months,87.4,83.0 to 90.7,420
Hep A,≥1 Dose,States/Local Areas,Oregon,2013,Age,19 Months,81.9,79.5 to 84.1,208
Hep A,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,19 Months,80.9,77.7 to 83.6,478
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,92.9,88.2 to 97.5,251
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,91.6,88.1 to 95.1,308
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,85.1,79.7 to 90.6,221
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,89.6,86.9 to 92.3,780
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,79.6,71.1 to 88.2,138
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.8,86.5 to 95.1,217
DTaP,≥2 Doses,States/Local Areas,Oregon,2016,Age,5 Months,74.1,63.4 to 82.5,177
DTaP,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,5 Months,75.8,68.8 to 81.6,372
DTaP,≥2 Doses,States/Local Areas,Oregon,2018,Age,5 Months,84.5,78.2 to 89.2,290
DTaP,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,5 Months,83.2,78.4 to 87.1,554
DTaP,≥2 Doses,States/Local Areas,Oregon,2017,Age,5 Months,77.5,67.7 to 85.0,195
DTaP,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,5 Months,80.9,75.2 to 85.6,485
Hib,≥3 Doses,States/Local Areas,Oregon,2015,Age,24 Months,92.2,87.5 to 95.6,243
Hib,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,90.7,86.3 to 94.2,420
Hib,≥3 Doses,States/Local Areas,Oregon,2016,Age,24 Months,89.2,81.4 to 94.7,177
Hib,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,89.3,84.4 to 93.2,372
DTaP,≥3 Doses,States/Local Areas,Oregon,2019,Age,24 Months,94.0,89.1 to 97.2,264
Hib,≥3 Doses,States/Local Areas,Oregon,2018,Age,35 Months,94.3,90.2 to 97.0,290
Hib,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,94.3,91.3 to 96.6,554
Hep A,≥2 Doses,States/Local Areas,Oregon,2012,Age,24 Months,36.9,29.2 to 45.9,229
DTaP,≥4 Doses,States/Local Areas,Oregon,2013,Age,19 Months,71.2,66.5 to 75.5,208
DTaP,≥4 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,68.2,62.7 to 73.2,478
DTaP,≥4 Doses,States/Local Areas,Oregon,2014,Age,19 Months,65.0,57.8 to 71.7,270
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,64.6,59.2 to 69.7,513
DTaP,≥4 Doses,States/Local Areas,Oregon,2015,Age,19 Months,64.2,60.3 to 67.9,243
DTaP,≥4 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,64.0,57.4 to 70.1,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,87.8,83.6 to 91.9,314
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,96.2,93.6 to 98.8,428
Hep A,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,31.8,26.7 to 37.3,485
Hib,≥3 Doses,States/Local Areas,Oregon,2016,Age,35 Months,90.0,82.2 to 95.3,177
Hib,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,90.1,85.3 to 93.9,372
Hib,≥3 Doses,States/Local Areas,Oregon,2017,Age,35 Months,90.2,84.0 to 94.8,195
Hib,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,92.1,88.5 to 94.9,485
Hep A,≥2 Doses,States/Local Areas,Oregon,2018,Age,19 Months,32.8,26.3 to 40.0,290
Hep A,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,33.3,27.6 to 39.5,474
Hep A,≥2 Doses,States/Local Areas,Oregon,2019,Age,19 Months,32.3,25.3 to 40.2,264
Hep A,≥2 Doses,States/Local Areas,Oregon,2011,Age,24 Months,31.7,25.1 to 39.5,266
DTaP,≥3 Doses,States/Local Areas,Oregon,2013,Age,35 Months,94.8,91.2 to 97.2,208
DTaP,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,93.0,90.1 to 95.3,478
DTaP,≥3 Doses,States/Local Areas,Oregon,2012,Age,35 Months,95.8,91.3 to 98.4,229
DTaP,≥3 Doses,States/Local Areas,Oregon,2011,Age,35 Months,91.8,85.2 to 96.2,266
DTaP,≥3 Doses,States/Local Areas,Oregon,2014,Age,35 Months,91.2,86.5 to 94.8,270
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.5,88.9 to 95.3,513
Hep A,≥2 Doses,States/Local Areas,Oregon,2011,Age,19 Months,19.6,15.9 to 23.9,266
DTaP,≥2 Doses,States/Local Areas,Oregon,2019,Age,5 Months,81.9,74.1 to 87.7,264
Hep A,≥2 Doses,States/Local Areas,Oregon,2013,Age,19 Months,27.1,21.5 to 33.4,208
Hep A,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,23.6,18.2 to 30.1,478
Hep A,≥2 Doses,States/Local Areas,Oregon,2014,Age,19 Months,20.1,14.6 to 27.0,270
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,20.4,16.3 to 25.2,513
Hep A,≥2 Doses,States/Local Areas,Oregon,2012,Age,19 Months,19.1,14.0 to 25.6,229
Hib,≥3 Doses,States/Local Areas,Oregon,2018,Age,24 Months,94.3,90.2 to 97.0,290
Hib,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,92.8,89.6 to 95.3,554
Hib,≥3 Doses,States/Local Areas,Oregon,2019,Age,24 Months,91.3,86.0 to 95.2,264
Hib,≥3 Doses,States/Local Areas,Oregon,2017,Age,24 Months,89.3,83.1 to 94.0,195
Hib,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,91.7,88.0 to 94.5,485
Hep A,≥1 Dose,States/Local Areas,Oregon,2017,Age,19 Months,85.1,77.9 to 90.2,195
Hep A,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,19 Months,86.1,81.5 to 89.7,485
Hep A,≥1 Dose,States/Local Areas,Oregon,2018,Age,19 Months,87.2,80.8 to 91.6,290
Hep A,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,19 Months,88.4,84.0 to 91.7,474
Hep A,≥2 Doses,States/Local Areas,Oregon,2015,Age,19 Months,20.7,17.5 to 24.3,243
Hep A,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,24.6,19.4 to 30.7,420
Hep A,≥2 Doses,States/Local Areas,Oregon,2016,Age,19 Months,28.6,20.3 to 38.6,177
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,29.7,23.9 to 36.1,372
Hib,≥3 Doses,States/Local Areas,Oregon,2013,Age,35 Months,93.8,89.0 to 97.0,208
Hib,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,91.8,88.5 to 94.6,478
Hib,≥3 Doses,States/Local Areas,Oregon,2014,Age,35 Months,90.0,84.8 to 93.9,270
Hib,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.0,88.5 to 94.8,513
Hib,≥3 Doses,States/Local Areas,Oregon,2015,Age,35 Months,94.2,88.9 to 97.5,243
Hib,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,92.2,87.4 to 95.6,420
Hep A,≥2 Doses,States/Local Areas,Oregon,2017,Age,19 Months,30.8,23.3 to 39.4,195
DTaP,≥3 Doses,States/Local Areas,Oregon,2017,Age,24 Months,92.6,86.9 to 96.5,195
DTaP,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,94.3,91.0 to 96.7,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2018,Age,24 Months,96.2,92.3 to 98.5,290
DTaP,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,95.1,92.2 to 97.2,554
Hep B,≥3 Doses,States/Local Areas,Oregon,2021,Age,19 Months,89.8,81.7 to 94.5,131
Hep A,≥1 Dose,States/Local Areas,Oregon,2014,Age,24 Months,85.4,80.2 to 89.9,270
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,24 Months,85.7,81.8 to 89.2,513
Hep A,≥1 Dose,States/Local Areas,Oregon,2015,Age,24 Months,86.0,79.9 to 91.0,243
Hep A,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,24 Months,89.5,85.7 to 92.7,420
Hep A,≥1 Dose,States/Local Areas,Oregon,2016,Age,24 Months,93.1,88.4 to 96.4,177
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,24 Months,92.1,88.7 to 94.8,372
PCV,≥2 Doses,States/Local Areas,Oregon,2014,Age,5 Months,71.6,64.4 to 77.9,270
PCV,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,5 Months,74.5,71.3 to 77.5,513
PCV,≥2 Doses,States/Local Areas,Oregon,2015,Age,5 Months,77.4,70.0 to 83.4,243
PCV,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,5 Months,74.9,68.6 to 80.3,420
PCV,≥2 Doses,States/Local Areas,Oregon,2016,Age,5 Months,72.4,61.8 to 81.0,177
PCV,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,5 Months,73.5,66.5 to 79.5,372
DTaP,≥3 Doses,States/Local Areas,Oregon,2018,Age,35 Months,96.3,92.3 to 98.5,290
DTaP,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,96.0,93.3 to 97.8,554
DTaP,≥3 Doses,States/Local Areas,Oregon,2019,Age,35 Months,95.5,91.2 to 98.1,264
Hep A,≥1 Dose,States/Local Areas,Oregon,2018,Age,24 Months,92.5,87.5 to 96.0,290
Hep A,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,24 Months,89.5,85.7 to 92.6,554
Hep A,≥1 Dose,States/Local Areas,Oregon,2019,Age,24 Months,86.4,80.5 to 91.2,264
Hep A,≥1 Dose,States/Local Areas,Oregon,2011,Age,35 Months,84.4,76.1 to 91.0,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2017,Age,24 Months,91.2,86.0 to 95.0,195
Hep A,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,24 Months,91.9,88.4 to 94.6,485
Hep A,≥1 Dose,States/Local Areas,Oregon,2016,Age,19 Months,91.6,85.7 to 95.2,177
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,19 Months,88.3,83.9 to 91.7,372
DTaP,≥3 Doses,States/Local Areas,Indiana,2015,Age,19 Months,88.3,78.0 to 94.1,251
DTaP,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,90.7,86.8 to 93.6,536
DTaP,≥3 Doses,States/Local Areas,Indiana,2014,Age,19 Months,91.2,85.3 to 94.9,258
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,89.7,85.5 to 92.8,509
DTaP,≥3 Doses,States/Local Areas,Indiana,2018,Age,19 Months,89.5,83.7 to 93.4,272
DTaP,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,88.3,83.9 to 91.6,481
Polio,≥3 Doses,States/Local Areas,Indiana,2011,Age,35 Months,93.1,88.0 to 96.5,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2016,Age,19 Months,93.2,88.4 to 96.1,285
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,93.0,89.9 to 95.2,589
Hib,≥3 Doses,States/Local Areas,Indiana,2016,Age,19 Months,85.6,79.0 to 90.4,285
Hib,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,86.2,82.0 to 89.5,589
Hib,≥3 Doses,States/Local Areas,Indiana,2015,Age,19 Months,79.4,67.1 to 88.0,251
Hib,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,82.5,77.3 to 86.7,536
Polio,≥3 Doses,States/Local Areas,Indiana,2013,Age,24 Months,95.8,91.6 to 98.3,218
Polio,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,93.6,90.3 to 96.0,476
Hib,≥3 Doses,States/Local Areas,Indiana,2014,Age,19 Months,87.6,81.3 to 91.9,258
Hib,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,83.5,78.4 to 87.6,509
Polio,≥3 Doses,States/Local Areas,Indiana,2012,Age,24 Months,92.0,87.3 to 95.5,307
Polio,≥3 Doses,States/Local Areas,Indiana,2011,Age,24 Months,92.6,87.6 to 96.1,271
Polio,≥3 Doses,States/Local Areas,Indiana,2019,Age,19 Months,90.6,83.6 to 94.8,209
Polio,≥3 Doses,States/Local Areas,Indiana,2014,Age,24 Months,91.3,85.9 to 95.2,258
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,90.6,86.8 to 93.6,509
Polio,≥3 Doses,States/Local Areas,Indiana,2015,Age,24 Months,89.8,84.2 to 94.1,251
Polio,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,90.9,87.3 to 93.7,536
Polio,≥3 Doses,States/Local Areas,Indiana,2016,Age,24 Months,91.9,87.2 to 95.4,285
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,92.5,89.5 to 94.9,589
Hib,≥3 Doses,States/Local Areas,Indiana,2017,Age,19 Months,86.8,81.0 to 91.0,304
Hib,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,86.6,82.4 to 89.9,576
Hib,≥3 Doses,States/Local Areas,Indiana,2018,Age,19 Months,86.4,80.3 to 90.9,272
Hib,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,69.0,63.2 to 74.3,481
DTaP,≥3 Doses,States/Local Areas,Indiana,2019,Age,19 Months,92.4,86.0 to 96.0,209
DTaP,≥3 Doses,States/Local Areas,Indiana,2011,Age,24 Months,94.0,89.3 to 97.1,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2017,Age,19 Months,92.8,88.1 to 95.8,304
DTaP,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,91.2,87.6 to 93.8,576
Hib,Full Series,States/Local Areas,Indiana,2015,Age,24 Months,68.4,59.8 to 76.7,251
Hib,Full Series,States/Local Areas,Indiana,2015-2016,Age,24 Months,72.3,66.7 to 77.7,536
DTaP,≥3 Doses,States/Local Areas,Indiana,2013,Age,24 Months,96.0,91.7 to 98.4,218
DTaP,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,93.7,90.4 to 96.1,476
Polio,≥3 Doses,States/Local Areas,Indiana,2017,Age,24 Months,93.1,88.9 to 96.1,304
Polio,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,90.6,87.1 to 93.4,576
Hib,≥3 Doses,States/Local Areas,Indiana,2019,Age,19 Months,89.7,83.0 to 93.9,209
Polio,≥3 Doses,States/Local Areas,Indiana,2019,Age,24 Months,92.4,86.3 to 96.5,209
Polio,≥3 Doses,States/Local Areas,Indiana,2018,Age,24 Months,88.0,82.4 to 92.6,272
Polio,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,90.2,86.2 to 93.4,481
DTaP,≥3 Doses,States/Local Areas,Indiana,2012,Age,24 Months,91.9,87.1 to 95.4,307
Polio,≥3 Doses,States/Local Areas,Indiana,2018,Age,35 Months,91.6,85.3 to 96.0,272
Polio,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,92.8,88.1 to 96.1,481
Hib,Full Series,States/Local Areas,Indiana,2017,Age,24 Months,76.9,70.8 to 82.6,304
Hib,Full Series,States/Local Areas,Indiana,2017-2018,Age,24 Months,76.6,71.8 to 81.0,576
Hib,Full Series,States/Local Areas,Indiana,2018,Age,24 Months,76.2,69.2 to 82.6,272
Hib,Full Series,States/Local Areas,Indiana,2018-2019,Age,24 Months,77.7,72.6 to 82.5,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2020,Age,24 Months,91.6,86.2 to 95.5,232
Hib,≥3 Doses,States/Local Areas,Indiana,2014,Age,24 Months,89.2,83.4 to 93.6,258
Hib,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,87.3,83.0 to 91.0,509
Hib,≥3 Doses,States/Local Areas,Indiana,2011,Age,24 Months,92.1,86.9 to 95.8,271
Hib,≥3 Doses,States/Local Areas,Indiana,2012,Age,24 Months,88.0,82.5 to 92.4,307
Hib,≥3 Doses,States/Local Areas,Indiana,2013,Age,24 Months,95.1,90.6 to 97.9,218
Hib,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,92.1,88.5 to 94.9,476
Hib,Full Series,States/Local Areas,Indiana,2016,Age,24 Months,76.4,69.3 to 82.8,285
Hib,Full Series,States/Local Areas,Indiana,2016-2017,Age,24 Months,76.6,72.0 to 81.0,589
Polio,≥3 Doses,States/Local Areas,Indiana,2013,Age,35 Months,98.2,95.3 to 99.5,218
Polio,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,94.5,91.3 to 96.9,476
Polio,≥3 Doses,States/Local Areas,Indiana,2014,Age,35 Months,91.5,86.1 to 95.4,258
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,92.6,89.1 to 95.3,509
Polio,≥3 Doses,States/Local Areas,Indiana,2012,Age,35 Months,94.7,90.2 to 97.5,307
Hib,Full Series,States/Local Areas,Indiana,2012,Age,35 Months,82.4,75.5 to 88.3,307
Hib,Full Series,States/Local Areas,Indiana,2011,Age,35 Months,82.4,75.7 to 88.2,271
Hib,Full Series,States/Local Areas,Indiana,2013,Age,35 Months,87.3,80.8 to 92.4,218
Hib,Full Series,States/Local Areas,Indiana,2013-2014,Age,35 Months,81.5,76.6 to 86.0,476
Hib,Full Series,States/Local Areas,Indiana,2019,Age,24 Months,79.2,71.3 to 86.2,209
DTaP,≥2 Doses,States/Local Areas,Indiana,2015,Age,5 Months,71.8,63.3 to 79.0,251
DTaP,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,5 Months,73.2,67.5 to 78.2,536
DTaP,≥2 Doses,States/Local Areas,Indiana,2016,Age,5 Months,74.6,66.7 to 81.1,285
DTaP,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,5 Months,77.5,72.6 to 81.8,589
DTaP,≥2 Doses,States/Local Areas,Indiana,2011,Age,5 Months,74.6,70.2 to 78.5,271
DTaP,≥2 Doses,States/Local Areas,Indiana,2012,Age,5 Months,77.6,71.0 to 83.1,307
DTaP,≥2 Doses,States/Local Areas,Indiana,2013,Age,5 Months,70.2,68.4 to 71.9,218
DTaP,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,5 Months,72.8,68.7 to 76.4,476
DTaP,≥2 Doses,States/Local Areas,Indiana,2014,Age,5 Months,75.4,67.6 to 81.8,258
DTaP,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,5 Months,73.6,64.6 to 81.0,509
Polio,≥3 Doses,States/Local Areas,Indiana,2016,Age,35 Months,92.6,87.9 to 95.9,285
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,94.5,91.7 to 96.6,589
Polio,≥3 Doses,States/Local Areas,Indiana,2017,Age,35 Months,96.2,93.0 to 98.2,304
Polio,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,94.3,90.6 to 96.9,576
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.5,88.2 to 100.0,66
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.4 to 96.9,483
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,89.4,85.9 to 92.9,434
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,91.4,83.9 to 98.9,44
Polio,≥3 Doses,States/Local Areas,Indiana,2015,Age,35 Months,93.7,88.9 to 96.9,251
Polio,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,93.3,90.1 to 95.8,536
Hib,Full Series,States/Local Areas,Indiana,2017,Age,35 Months,82.8,76.0 to 88.5,304
Hib,Full Series,States/Local Areas,Indiana,2017-2018,Age,35 Months,81.9,76.0 to 87.1,576
Polio,≥3 Doses,States/Local Areas,Indiana,2019,Age,35 Months,92.4,86.3 to 96.5,209
Hib,Full Series,States/Local Areas,Indiana,2016,Age,35 Months,81.5,74.4 to 87.6,285
Hib,Full Series,States/Local Areas,Indiana,2016-2017,Age,35 Months,82.1,77.3 to 86.5,589
Hib,Full Series,States/Local Areas,Indiana,2015,Age,35 Months,72.6,63.4 to 81.1,251
Hib,Full Series,States/Local Areas,Indiana,2015-2016,Age,35 Months,77.0,71.0 to 82.5,536
Hib,Full Series,States/Local Areas,Indiana,2014,Age,35 Months,75.9,68.4 to 82.7,258
Hib,Full Series,States/Local Areas,Indiana,2014-2015,Age,35 Months,74.4,68.4 to 80.0,509
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.0,58.8 to 85.1,66
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,71.0,65.6 to 76.3,434
Hib,Full Series,States/Local Areas,Indiana,2019,Age,35 Months,87.5,78.6 to 93.9,209
Hib,Full Series,States/Local Areas,Indiana,2018,Age,35 Months,80.7,71.3 to 88.5,272
Hib,Full Series,States/Local Areas,Indiana,2018-2019,Age,35 Months,84.0,77.4 to 89.6,481
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,84.7,80.7 to 88.7,483
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,90.3,84.7 to 95.8,150
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.4,87.8 to 98.9,109
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.2,88.5 to 93.9,650
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,88.8 to 95.1,452
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.2,86.1 to 94.3,316
Hib,Primary Series,States/Local Areas,Indiana,2011,Age,7 Months,61.4,57.2 to 65.5,271
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,89.2,84.1 to 94.3,233
Hib,Primary Series,States/Local Areas,Indiana,2012,Age,7 Months,72.0,64.4 to 78.5,307
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,67.6,57.6 to 77.6,150
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,72.0 to 90.6,109
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.6,71.3 to 79.9,650
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,75.7,70.5 to 80.9,452
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.9,70.8 to 83.0,316
Hib,≥3 Doses,States/Local Areas,Indiana,2019,Age,35 Months,93.3,87.8 to 96.9,209
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,70.6,62.9 to 78.4,207
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Overall,Overall,75.0,71.5 to 78.5,975
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,69.9,63.8 to 76.1,337
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,73.3,67.7 to 78.8,405
Hib,Full Series,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,41.4,23.7 to 59.1,44
DTaP,≥4 Doses,States/Local Areas,Indiana,2013,Age,24 Months,83.3,76.4 to 89.1,218
DTaP,≥4 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,82.4,77.5 to 86.7,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2016,Age,24 Months,42.7,35.5 to 50.6,285
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,46.9,41.9 to 52.3,589
Hep A,≥2 Doses,States/Local Areas,Indiana,2017,Age,24 Months,51.3,44.3 to 58.6,304
Hep A,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,49.7,44.5 to 55.1,576
DTaP,≥4 Doses,States/Local Areas,Indiana,2014,Age,24 Months,81.4,74.4 to 87.5,258
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,76.4,71.1 to 81.3,509
Hep A,≥2 Doses,States/Local Areas,Indiana,2018,Age,24 Months,48.0,40.7 to 56.0,272
Hep A,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,50.3,44.5 to 56.4,481
≥1 Dose Varicella,,States/Local Areas,Indiana,2013,Age,13 Months,54.3,53.2 to 55.3,218
≥1 Dose Varicella,,States/Local Areas,Indiana,2013-2014,Age,13 Months,55.9,53.4 to 58.3,476
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.8,74.6 to 95.0,66
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,55.1,36.6 to 73.6,44
Polio,≥2 Doses,States/Local Areas,Indiana,2018,Age,5 Months,76.8,69.8 to 82.6,272
Polio,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,5 Months,78.3,73.2 to 82.7,481
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,92.4,89.6 to 95.2,483
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,84.7,80.5 to 88.9,434
Hep A,≥1 Dose,States/Local Areas,Indiana,2019,Age,35 Months,92.6,84.5 to 97.3,209
≥1 Dose Varicella,,States/Local Areas,Indiana,2012,Age,13 Months,51.2,45.2 to 57.2,307
≥1 Dose Varicella,,States/Local Areas,Indiana,2015,Age,13 Months,47.5,39.0 to 56.3,251
≥1 Dose Varicella,,States/Local Areas,Indiana,2015-2016,Age,13 Months,48.6,42.9 to 54.3,536
≥1 Dose Varicella,,States/Local Areas,Indiana,2014,Age,13 Months,57.5,49.7 to 64.9,258
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2015,Age,13 Months,52.5,46.6 to 58.3,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2015,Age,7 Months,57.3,48.5 to 65.6,251
Hep B,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,62.1,56.4 to 67.5,536
Hep B,≥3 Doses,States/Local Areas,Indiana,2014,Age,7 Months,66.0,58.3 to 72.9,258
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,61.6,55.8 to 67.1,509
Polio,≥2 Doses,States/Local Areas,Indiana,2017,Age,5 Months,80.9,74.9 to 85.7,304
Polio,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,5 Months,78.8,74.4 to 82.7,576
Polio,≥2 Doses,States/Local Areas,Indiana,2016,Age,5 Months,75.2,67.4 to 81.6,285
Polio,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,5 Months,78.0,73.2 to 82.2,589
Hep B,≥3 Doses,States/Local Areas,Indiana,2011,Age,13 Months,79.6,76.1 to 82.7,271
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,87.6,83.5 to 91.7,405
Polio,≥2 Doses,States/Local Areas,Indiana,2016,Age,7 Months,87.9,81.9 to 92.1,285
Polio,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,89.1,85.3 to 92.0,589
Polio,≥2 Doses,States/Local Areas,Indiana,2015,Age,7 Months,86.7,80.3 to 91.3,251
Polio,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,87.3,83.1 to 90.6,536
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Overall,Overall,86.2,83.5 to 89.0,975
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,81.9,76.8 to 86.9,337
Polio,≥2 Doses,States/Local Areas,Indiana,2014,Age,7 Months,87.7,81.4 to 92.1,258
Polio,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,87.2,82.9 to 90.5,509
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.5,78.1 to 88.9,316
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,86.2,81.1 to 91.3,207
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,82.9 to 89.6,650
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,88.1,84.1 to 92.1,452
≥1 Dose MMR,,States/Local Areas,Indiana,2011,Age,13 Months,47.7,43.5 to 52.1,271
≥1 Dose MMR,,States/Local Areas,Indiana,2012,Age,13 Months,48.1,40.4 to 55.8,307
≥1 Dose MMR,,States/Local Areas,Indiana,2013,Age,13 Months,51.8,48.8 to 54.7,218
≥1 Dose MMR,,States/Local Areas,Indiana,2013-2014,Age,13 Months,53.0,50.1 to 55.9,476
≥1 Dose Varicella,,States/Local Areas,Indiana,2011,Age,13 Months,45.2,39.5 to 51.0,271
Hep A,≥1 Dose,States/Local Areas,Indiana,2018,Age,35 Months,93.8,87.5 to 97.6,272
Hep A,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,35 Months,93.2,88.2 to 96.6,481
Hep A,≥1 Dose,States/Local Areas,Indiana,2017,Age,35 Months,92.9,88.1 to 96.3,304
Hep A,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,35 Months,93.5,89.4 to 96.4,576
Hep A,≥2 Doses,States/Local Areas,Indiana,2019,Age,24 Months,52.9,44.0 to 62.4,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2016,Age,7 Months,67.1,59.8 to 73.6,285
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,66.0,61.1 to 70.6,589
Polio,≥2 Doses,States/Local Areas,Indiana,2015,Age,5 Months,70.9,62.3 to 78.1,251
Polio,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,5 Months,73.0,67.3 to 78.0,536
DTaP,≥4 Doses,States/Local Areas,Indiana,2015,Age,24 Months,71.5,63.6 to 79.0,251
DTaP,≥4 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,74.2,68.9 to 79.2,536
DTaP,≥4 Doses,States/Local Areas,Indiana,2016,Age,24 Months,76.8,69.9 to 83.2,285
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,78.3,73.8 to 82.6,589
Hep A,≥1 Dose,States/Local Areas,Indiana,2016,Age,35 Months,89.9,83.8 to 94.5,285
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,35 Months,91.5,87.7 to 94.5,589
Hep A,≥2 Doses,States/Local Areas,Indiana,2013,Age,35 Months,79.7,69.3 to 88.4,218
Hep A,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,79.2,71.8 to 85.7,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2012,Age,35 Months,77.0,67.9 to 85.0,307
Hep A,≥2 Doses,States/Local Areas,Indiana,2011,Age,35 Months,73.3,62.6 to 83.0,271
Hep A,≥1 Dose,States/Local Areas,Indiana,2014,Age,35 Months,86.8,80.6 to 91.8,258
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,35 Months,87.8,83.3 to 91.6,509
Hep A,≥1 Dose,States/Local Areas,Indiana,2013,Age,35 Months,94.6,87.4 to 98.3,218
Hep A,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,35 Months,90.2,85.6 to 93.7,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2014,Age,24 Months,52.4,44.7 to 60.6,258
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,49.9,44.1 to 56.1,509
Hep A,≥2 Doses,States/Local Areas,Indiana,2015,Age,24 Months,47.2,38.7 to 56.6,251
Hep A,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,45.0,39.3 to 51.1,536
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,92.3,90.2 to 94.4,975
Hep A,≥2 Doses,States/Local Areas,Indiana,2013,Age,24 Months,50.3,41.9 to 59.2,218
Hep A,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,51.3,45.6 to 57.3,476
DTaP,≥4 Doses,States/Local Areas,Indiana,2018,Age,19 Months,69.8,62.5 to 76.2,272
DTaP,≥4 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,92.5,88.6 to 95.1,481
DTaP,≥4 Doses,States/Local Areas,Indiana,2017,Age,19 Months,68.6,61.7 to 74.8,304
DTaP,≥4 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,69.2,64.2 to 73.8,576
DTaP,≥4 Doses,States/Local Areas,Indiana,2016,Age,19 Months,68.9,61.4 to 75.5,285
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,68.7,63.7 to 73.3,589
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,88.7,82.1 to 95.3,150
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,85.0 to 98.6,109
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.2,87.2 to 95.2,316
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,93.4,90.0 to 96.7,207
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,89.9 to 95.0,650
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,92.6,89.4 to 95.8,452
PCV,≥2 Doses,States/Local Areas,Indiana,2019,Age,5 Months,78.7,70.4 to 85.1,209
PCV,≥2 Doses,States/Local Areas,Indiana,2018,Age,5 Months,73.6,66.4 to 79.8,272
PCV,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,5 Months,76.1,70.8 to 80.8,481
DTaP,≥4 Doses,States/Local Areas,Indiana,2012,Age,24 Months,77.9,71.3 to 83.9,307
DTaP,≥4 Doses,States/Local Areas,Indiana,2011,Age,24 Months,76.7,69.8 to 82.9,271
DTaP,≥4 Doses,States/Local Areas,Indiana,2019,Age,19 Months,66.9,58.2 to 74.6,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2013,Age,7 Months,65.3,62.4 to 68.2,218
Hep B,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,65.6,64.0 to 67.2,476
Hep B,≥3 Doses,States/Local Areas,Indiana,2011,Age,7 Months,52.0,43.1 to 60.8,271
Hep B,≥3 Doses,States/Local Areas,Indiana,2012,Age,7 Months,67.5,55.5 to 77.6,307
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,92.2,88.8 to 95.6,405
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,97.4,95.4 to 99.4,233
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,90.1,86.3 to 93.9,337
Polio,≥2 Doses,States/Local Areas,Indiana,2014,Age,5 Months,74.7,66.9 to 81.1,258
Polio,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,5 Months,72.8,63.7 to 80.3,509
Polio,≥2 Doses,States/Local Areas,Indiana,2013,Age,5 Months,70.6,68.4 to 72.8,218
Polio,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,5 Months,72.6,67.5 to 77.2,476
Polio,≥2 Doses,States/Local Areas,Indiana,2011,Age,5 Months,72.2,68.0 to 76.0,271
Polio,≥2 Doses,States/Local Areas,Indiana,2012,Age,5 Months,76.6,70.0 to 82.1,307
Hep A,≥1 Dose,States/Local Areas,Indiana,2015,Age,35 Months,88.6,82.1 to 93.5,251
Hep A,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,35 Months,89.5,85.1 to 93.0,536
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,91.8,88.9 to 94.8,483
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,85.7,81.7 to 89.8,434
≥1 Dose Varicella,,States/Local Areas,Indiana,2019,Age,35 Months,90.5,82.1 to 96.0,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2017,Age,35 Months,94.3,90.7 to 96.9,304
Hep B,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,93.1,90.1 to 95.5,576
PCV,≥3 Doses,States/Local Areas,Indiana,2012,Age,19 Months,88.8,83.0 to 92.8,307
Hib,Full Series,States/Local Areas,Indiana,2020,Age,24 Months,82.1,75.5 to 87.7,232
Hep B,≥3 Doses,States/Local Areas,Indiana,2018,Age,35 Months,91.7,86.7 to 95.4,272
Hep B,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,93.1,89.6 to 95.7,481
PCV,≥4 Doses,States/Local Areas,Indiana,2012,Age,35 Months,82.8,75.8 to 88.7,307
PCV,≥4 Doses,States/Local Areas,Indiana,2011,Age,35 Months,84.8,77.2 to 90.9,271
PCV,≥4 Doses,States/Local Areas,Indiana,2018,Age,24 Months,77.1,70.3 to 83.3,272
PCV,≥4 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,79.8,74.8 to 84.4,481
PCV,≥4 Doses,States/Local Areas,Indiana,2019,Age,24 Months,83.2,75.4 to 89.7,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2016,Age,35 Months,92.3,87.4 to 95.7,285
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,93.2,90.3 to 95.5,589
PCV,≥3 Doses,States/Local Areas,Indiana,2014,Age,19 Months,90.9,85.0 to 94.6,258
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,88.8,84.3 to 92.1,509
PCV,≥3 Doses,States/Local Areas,Indiana,2013,Age,19 Months,93.6,89.0 to 96.3,218
PCV,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,92.2,88.5 to 94.8,476
PCV,≥3 Doses,States/Local Areas,Indiana,2011,Age,19 Months,88.0,83.4 to 91.6,271
PCV,≥3 Doses,States/Local Areas,Indiana,2019,Age,13 Months,88.0,80.7 to 92.7,209
Hep B,≥2 Doses,States/Local Areas,Indiana,2014,Age,13 Months,93.9,89.1 to 96.7,258
Hep B,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,92.1,88.5 to 94.6,509
Hib,≥1 Dose,States/Local Areas,Indiana,2014,Age,3 Months,82.7,76.2 to 87.8,258
Hib,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,3 Months,82.8,78.0 to 86.8,509
Hep B,≥2 Doses,States/Local Areas,Indiana,2015,Age,13 Months,90.2,84.3 to 94.1,251
Hep B,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,90.9,87.0 to 93.7,536
Hep B,≥2 Doses,States/Local Areas,Indiana,2016,Age,13 Months,91.6,85.6 to 95.2,285
Hep B,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,93.6,90.4 to 95.8,589
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,74.0,68.9 to 79.1,434
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,52.5,34.1 to 70.9,44
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.5,63.8 to 89.1,66
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,76.4,67.3 to 85.5,150
PCV,≥1 Dose,States/Local Areas,Indiana,2013,Age,3 Months,81.3,78.9 to 83.6,218
PCV,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,3 Months,80.7,74.0 to 86.0,476
Hib,≥1 Dose,States/Local Areas,Indiana,2019,Age,3 Months,87.4,80.0 to 92.4,209
Hib,≥1 Dose,States/Local Areas,Indiana,2018,Age,3 Months,86.9,81.2 to 91.0,272
Hib,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,3 Months,87.1,82.7 to 90.6,481
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.6,80.5 to 90.6,316
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,84.8,79.2 to 90.5,207
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Overall,Overall,86.7,84.0 to 89.5,975
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,83.0,78.1 to 87.9,337
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,86.9,82.6 to 91.2,405
Hib,≥1 Dose,States/Local Areas,Indiana,2011,Age,3 Months,80.2,77.0 to 83.0,271
Hib,≥1 Dose,States/Local Areas,Indiana,2012,Age,3 Months,83.5,79.7 to 86.7,307
Hib,≥1 Dose,States/Local Areas,Indiana,2013,Age,3 Months,81.7,79.4 to 83.7,218
Hib,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,3 Months,82.2,77.3 to 86.2,476
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2019,Age,0-2 Days,87.0,80.1 to 91.8,209
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2018,Age,0-2 Days,79.3,72.9 to 84.5,272
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2018-2019,Age,0-2 Days,83.1,78.6 to 86.8,481
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2017,Age,0-2 Days,78.5,72.3 to 83.6,304
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2017-2018,Age,0-2 Days,78.9,74.5 to 82.6,576
PCV,≥4 Doses,States/Local Areas,Indiana,2012,Age,24 Months,76.9,70.4 to 82.9,307
Hep B,≥3 Doses,States/Local Areas,Indiana,2011,Age,35 Months,91.7,86.0 to 95.7,271
Hep B,≥3 Doses,States/Local Areas,Indiana,2017,Age,24 Months,92.9,89.1 to 95.8,304
Hep B,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,91.7,88.7 to 94.2,576
Hep B,≥3 Doses,States/Local Areas,Indiana,2019,Age,24 Months,93.6,88.6 to 97.0,209
PCV,≥4 Doses,States/Local Areas,Indiana,2013,Age,24 Months,80.8,73.3 to 87.4,218
PCV,≥4 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,81.8,76.8 to 86.2,476
PCV,≥4 Doses,States/Local Areas,Indiana,2014,Age,24 Months,82.4,75.8 to 88.0,258
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,78.6,73.3 to 83.5,509
PCV,≥4 Doses,States/Local Areas,Indiana,2015,Age,24 Months,74.8,66.4 to 82.4,251
PCV,≥4 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,73.0,67.5 to 78.3,536
≥1 Dose MMR,,States/Local Areas,Indiana,2019,Age,24 Months,87.0,79.4 to 92.9,209
≥1 Dose MMR,,States/Local Areas,Indiana,2012,Age,35 Months,94.4,89.8 to 97.3,307
≥1 Dose MMR,,States/Local Areas,Indiana,2011,Age,35 Months,91.9,86.4 to 95.9,271
≥1 Dose MMR,,States/Local Areas,Indiana,2013,Age,35 Months,97.5,92.4 to 99.5,218
≥1 Dose MMR,,States/Local Areas,Indiana,2013-2014,Age,35 Months,92.9,88.8 to 96.0,476
≥1 Dose Varicella,,States/Local Areas,Indiana,2016,Age,35 Months,89.5,83.5 to 94.1,285
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2017,Age,35 Months,92.2,88.7 to 95.0,589
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.8,76.4 to 87.2,316
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,88.4,84.9 to 91.9,483
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,81.4,72.9 to 90.0,150
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,80.8 to 96.6,109
≥1 Dose Varicella,,States/Local Areas,Indiana,2017,Age,35 Months,94.8,90.8 to 97.5,304
≥1 Dose Varicella,,States/Local Areas,Indiana,2017-2018,Age,35 Months,92.7,88.8 to 95.7,576
≥1 Dose Varicella,,States/Local Areas,Indiana,2018,Age,35 Months,90.5,83.9 to 95.2,272
≥1 Dose Varicella,,States/Local Areas,Indiana,2018-2019,Age,35 Months,90.5,85.4 to 94.4,481
PCV,≥3 Doses,States/Local Areas,Indiana,2016,Age,13 Months,82.8,75.9 to 88.0,285
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,86.7,82.6 to 89.9,589
Hep B,≥3 Doses,States/Local Areas,Indiana,2018,Age,24 Months,90.5,85.7 to 94.2,272
Hep B,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,92.1,88.7 to 94.7,481
PCV,≥3 Doses,States/Local Areas,Indiana,2015,Age,13 Months,81.7,73.3 to 87.9,251
PCV,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,82.2,77.0 to 86.5,536
PCV,≥3 Doses,States/Local Areas,Indiana,2014,Age,13 Months,86.4,79.8 to 91.1,258
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,84.1,79.0 to 88.1,509
Hep B,≥2 Doses,States/Local Areas,Indiana,2018,Age,7 Months,90.4,85.3 to 93.8,272
Hep B,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,93.0,89.8 to 95.2,481
Hep B,≥2 Doses,States/Local Areas,Indiana,2017,Age,7 Months,92.6,88.1 to 95.4,304
Hep B,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,91.5,88.3 to 93.8,576
Hep B,≥2 Doses,States/Local Areas,Indiana,2016,Age,7 Months,89.8,83.9 to 93.7,285
Hep B,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,91.2,87.7 to 93.7,589
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2016,Age,0-2 Days,80.0,72.9 to 85.6,285
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2016-2017,Age,0-2 Days,79.3,74.7 to 83.2,589
Hep B,≥3 Doses,States/Local Areas,Indiana,2015,Age,24 Months,86.0,79.3 to 91.4,251
Hep B,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,88.9,84.9 to 92.3,536
PCV,≥3 Doses,States/Local Areas,Indiana,2013,Age,13 Months,87.7,85.1 to 89.9,218
PCV,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,87.1,83.8 to 89.8,476
Hep B,≥3 Doses,States/Local Areas,Indiana,2016,Age,24 Months,91.9,87.1 to 95.5,285
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,92.4,89.5 to 94.8,589
PCV,≥3 Doses,States/Local Areas,Indiana,2012,Age,13 Months,84.5,78.8 to 88.8,307
≥1 Dose MMR,,States/Local Areas,Indiana,2016,Age,24 Months,87.8,82.0 to 92.4,285
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2017,Age,24 Months,88.7,85.0 to 91.8,589
≥1 Dose MMR,,States/Local Areas,Indiana,2017,Age,24 Months,89.6,84.7 to 93.5,304
≥1 Dose MMR,,States/Local Areas,Indiana,2017-2018,Age,24 Months,87.6,83.8 to 90.8,576
PCV,≥4 Doses,States/Local Areas,Indiana,2018,Age,19 Months,75.0,67.9 to 81.0,272
PCV,≥4 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,76.8,70.8 to 82.0,406
PCV,≥4 Doses,States/Local Areas,Indiana,2017,Age,19 Months,79.6,73.4 to 84.7,304
PCV,≥4 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,77.3,72.6 to 81.5,576
PCV,≥3 Doses,States/Local Areas,Indiana,2011,Age,13 Months,81.8,77.3 to 85.5,271
PCV,≥3 Doses,States/Local Areas,Indiana,2019,Age,7 Months,61.6,52.9 to 69.6,209
PCV,≥3 Doses,States/Local Areas,Indiana,2018,Age,7 Months,60.2,52.5 to 67.5,272
PCV,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,60.9,55.1 to 66.4,481
Hep B,≥2 Doses,States/Local Areas,Indiana,2012,Age,7 Months,90.0,85.0 to 93.4,307
Hep B,≥2 Doses,States/Local Areas,Indiana,2015,Age,7 Months,89.6,83.6 to 93.6,251
Hep B,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,89.7,85.7 to 92.7,536
Hep B,≥2 Doses,States/Local Areas,Indiana,2014,Age,7 Months,90.8,85.6 to 94.3,258
Hep B,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,90.2,86.5 to 93.0,509
Hep B,≥2 Doses,States/Local Areas,Indiana,2013,Age,7 Months,91.3,86.7 to 94.4,218
Hep B,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,91.1,87.3 to 93.8,476
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2012,Age,0-2 Days,85.4,81.0 to 88.9,307
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2013,Age,0-2 Days,73.0,66.2 to 79.0,218
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2013-2014,Age,0-2 Days,74.8,69.4 to 79.5,476
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2011,Age,0-2 Days,79.6,73.4 to 84.7,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2019,Age,0-1 Days,84.7,77.3 to 90.0,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2011,Age,24 Months,90.7,85.2 to 94.8,271
Hep B,≥3 Doses,States/Local Areas,Indiana,2019,Age,19 Months,93.6,87.9 to 96.7,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2013,Age,24 Months,92.1,86.1 to 96.1,218
Hep B,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,91.4,87.5 to 94.5,476
Hep B,≥3 Doses,States/Local Areas,Indiana,2014,Age,24 Months,90.7,85.2 to 94.7,258
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,88.3,84.1 to 91.8,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2012,Age,24 Months,91.0,85.8 to 94.9,307
PCV,≥3 Doses,States/Local Areas,Indiana,2016,Age,7 Months,60.0,52.2 to 67.2,285
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,61.5,56.3 to 66.5,589
PCV,≥4 Doses,States/Local Areas,Indiana,2016,Age,19 Months,69.8,62.3 to 76.4,285
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,74.7,69.9 to 79.0,589
PCV,≥4 Doses,States/Local Areas,Indiana,2015,Age,19 Months,66.2,58.2 to 73.4,251
PCV,≥4 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,68.0,62.2 to 73.3,536
PCV,≥3 Doses,States/Local Areas,Indiana,2015,Age,7 Months,56.0,47.7 to 64.0,251
PCV,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,58.0,52.3 to 63.5,536
PCV,≥3 Doses,States/Local Areas,Indiana,2017,Age,7 Months,63.0,56.0 to 69.6,304
PCV,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,61.6,56.4 to 66.6,576
≥1 Dose MMR,,States/Local Areas,Indiana,2013,Age,24 Months,93.0,87.2 to 96.9,218
≥1 Dose MMR,,States/Local Areas,Indiana,2013-2014,Age,24 Months,90.8,86.8 to 94.0,476
≥1 Dose MMR,,States/Local Areas,Indiana,2014,Age,24 Months,88.6,82.6 to 93.3,258
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2015,Age,24 Months,86.9,82.7 to 90.5,509
≥1 Dose MMR,,States/Local Areas,Indiana,2015,Age,24 Months,85.1,78.9 to 90.4,251
≥1 Dose MMR,,States/Local Areas,Indiana,2015-2016,Age,24 Months,86.5,82.3 to 90.1,536
≥1 Dose Varicella,,States/Local Areas,Indiana,2018,Age,24 Months,86.3,80.5 to 91.0,272
≥1 Dose Varicella,,States/Local Areas,Indiana,2018-2019,Age,24 Months,87.3,82.9 to 91.1,481
≥1 Dose Varicella,,States/Local Areas,Indiana,2012,Age,35 Months,94.3,88.7 to 97.7,307
≥1 Dose Varicella,,States/Local Areas,Indiana,2011,Age,35 Months,91.4,85.4 to 95.6,271
≥1 Dose Varicella,,States/Local Areas,Indiana,2019,Age,24 Months,88.7,81.3 to 94.1,209
≥1 Dose Varicella,,States/Local Areas,Indiana,2013,Age,35 Months,98.9,95.7 to 99.8,218
≥1 Dose Varicella,,States/Local Areas,Indiana,2013-2014,Age,35 Months,93.3,89.4 to 96.1,476
≥1 Dose MMR,,States/Local Areas,Indiana,2018,Age,24 Months,85.6,79.6 to 90.5,272
≥1 Dose MMR,,States/Local Areas,Indiana,2018-2019,Age,24 Months,86.3,81.7 to 90.2,481
PCV,≥4 Doses,States/Local Areas,Indiana,2019,Age,19 Months,76.5,68.0 to 83.2,209
≥1 Dose Varicella,,States/Local Areas,Indiana,2014,Age,35 Months,88.1,81.9 to 93.0,258
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2015,Age,35 Months,88.3,83.7 to 92.1,509
≥1 Dose Varicella,,States/Local Areas,Indiana,2015,Age,35 Months,88.4,81.4 to 93.7,251
≥1 Dose Varicella,,States/Local Areas,Indiana,2015-2016,Age,35 Months,89.4,84.7 to 93.1,536
Hep A,≥1 Dose,States/Local Areas,Indiana,2020,Age,35 Months,96.9,90.9 to 99.4,232
PCV,≥4 Doses,States/Local Areas,Indiana,2011,Age,24 Months,78.6,71.8 to 84.8,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2015,Age,0-2 Days,77.2,69.6 to 83.4,251
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2015-2016,Age,0-2 Days,78.6,73.6 to 82.9,536
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2014,Age,0-2 Days,76.5,69.4 to 82.4,258
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2014-2015,Age,0-2 Days,76.9,71.8 to 81.3,509
≥1 Dose Varicella,,States/Local Areas,Indiana,2015,Age,24 Months,84.7,78.2 to 90.1,251
≥1 Dose Varicella,,States/Local Areas,Indiana,2015-2016,Age,24 Months,85.6,81.3 to 89.4,536
≥1 Dose MMR,,States/Local Areas,Indiana,2012,Age,24 Months,89.7,84.8 to 93.6,307
≥1 Dose MMR,,States/Local Areas,Indiana,2011,Age,24 Months,89.6,84.4 to 93.7,271
≥1 Dose Varicella,,States/Local Areas,Indiana,2016,Age,24 Months,86.5,80.5 to 91.5,285
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2017,Age,24 Months,88.5,84.8 to 91.7,589
≥1 Dose Varicella,,States/Local Areas,Indiana,2017,Age,24 Months,90.6,85.7 to 94.3,304
≥1 Dose Varicella,,States/Local Areas,Indiana,2017-2018,Age,24 Months,88.4,84.7 to 91.5,576
≥1 Dose MMR,,States/Local Areas,Indiana,2019,Age,19 Months,84.4,76.1 to 90.2,209
PCV,≥4 Doses,States/Local Areas,Indiana,2014,Age,19 Months,74.3,66.6 to 80.7,258
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,70.3,64.4 to 75.5,509
≥1 Dose MMR,,States/Local Areas,Indiana,2018,Age,19 Months,83.6,77.2 to 88.5,272
≥1 Dose MMR,,States/Local Areas,Indiana,2018-2019,Age,19 Months,93.2,89.6 to 95.6,481
PCV,≥4 Doses,States/Local Areas,Indiana,2011,Age,19 Months,68.5,62.0 to 74.3,271
PCV,≥4 Doses,States/Local Areas,Indiana,2012,Age,19 Months,71.4,68.8 to 73.8,307
PCV,≥4 Doses,States/Local Areas,Indiana,2013,Age,19 Months,75.9,73.1 to 78.5,218
PCV,≥4 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,75.1,70.7 to 79.0,476
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2018,Age,0-1 Days,77.1,70.5 to 82.6,272
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2018-2019,Age,0-1 Days,80.9,76.2 to 84.8,481
Hep B,≥2 Doses,States/Local Areas,Indiana,2018,Age,5 Months,88.9,83.7 to 92.6,272
Hep B,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,5 Months,91.8,88.5 to 94.1,481
Hep B,≥2 Doses,States/Local Areas,Indiana,2017,Age,5 Months,89.6,84.7 to 93.1,304
Hep B,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,5 Months,89.3,85.9 to 91.9,576
Hep B,≥2 Doses,States/Local Areas,Indiana,2011,Age,7 Months,88.5,84.0 to 91.9,271
Hep B,≥2 Doses,States/Local Areas,Indiana,2019,Age,5 Months,94.7,90.1 to 97.2,209
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2017,Age,0-1 Days,75.2,68.8 to 80.6,304
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2017-2018,Age,0-1 Days,76.1,71.7 to 80.1,576
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2016,Age,0-1 Days,74.3,66.9 to 80.6,285
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2016-2017,Age,0-1 Days,74.7,69.9 to 79.0,589
≥1 Dose Varicella,,States/Local Areas,Indiana,2013,Age,24 Months,95.5,90.9 to 98.2,218
≥1 Dose Varicella,,States/Local Areas,Indiana,2013-2014,Age,24 Months,91.1,87.4 to 94.2,476
≥1 Dose Varicella,,States/Local Areas,Indiana,2014,Age,24 Months,86.9,80.8 to 91.9,258
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2015,Age,24 Months,85.8,81.5 to 89.6,509
≥1 Dose Varicella,,States/Local Areas,Indiana,2019,Age,19 Months,85.9,77.8 to 91.4,209
Polio,≥2 Doses,States/Local Areas,Indiana,2019,Age,13 Months,92.1,85.3 to 95.9,209
Polio,≥2 Doses,States/Local Areas,Indiana,2018,Age,13 Months,92.9,87.9 to 95.9,272
Polio,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,92.5,88.6 to 95.1,481
Hep B,≥2 Doses,States/Local Areas,Indiana,2015,Age,5 Months,85.2,78.9 to 89.9,251
Hep B,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,5 Months,86.3,82.0 to 89.7,536
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2015,Age,0-1 Days,66.7,58.1 to 74.2,251
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2015-2016,Age,0-1 Days,70.4,64.8 to 75.5,536
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2014,Age,0-1 Days,72.2,64.9 to 78.5,258
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2014-2015,Age,0-1 Days,69.4,63.9 to 74.5,509
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2013,Age,0-1 Days,67.3,60.2 to 73.7,218
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2013-2014,Age,0-1 Days,69.8,64.4 to 74.6,476
Hep B,≥2 Doses,States/Local Areas,Indiana,2016,Age,5 Months,87.5,81.1 to 91.9,285
Hep B,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,5 Months,88.5,84.7 to 91.5,589
Hep B,≥3 Doses,States/Local Areas,Indiana,2018,Age,19 Months,90.1,84.8 to 93.6,272
Hep B,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,88.8,84.7 to 91.9,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2017,Age,19 Months,92.8,88.6 to 95.5,304
Hep B,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,91.4,88.3 to 93.8,576
PCV,≥3 Doses,States/Local Areas,Indiana,2012,Age,7 Months,63.3,60.4 to 66.2,307
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,79.5,74.4 to 84.7,405
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,89.4,84.4 to 94.5,233
PCV,≥3 Doses,States/Local Areas,Indiana,2014,Age,7 Months,62.7,54.8 to 69.9,258
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,59.4,53.6 to 64.8,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2016,Age,19 Months,91.9,86.6 to 95.2,285
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,92.4,89.2 to 94.6,589
PCV,≥3 Doses,States/Local Areas,Indiana,2011,Age,7 Months,58.4,54.8 to 61.9,271
PCV,≥3 Doses,States/Local Areas,Indiana,2013,Age,7 Months,64.5,58.4 to 70.2,218
PCV,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,63.6,60.3 to 66.8,476
Polio,≥2 Doses,States/Local Areas,Indiana,2017,Age,13 Months,96.0,92.5 to 97.9,304
Polio,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,94.5,91.6 to 96.4,576
Polio,≥2 Doses,States/Local Areas,Indiana,2016,Age,13 Months,92.5,87.5 to 95.6,285
Polio,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,94.3,91.4 to 96.2,589
Polio,≥2 Doses,States/Local Areas,Indiana,2015,Age,13 Months,91.3,85.5 to 95.0,251
Polio,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,91.9,88.3 to 94.5,536
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,73.8,64.1 to 83.6,150
≥1 Dose Varicella,,States/Local Areas,Indiana,2018,Age,19 Months,85.1,79.0 to 89.7,272
≥1 Dose Varicella,,States/Local Areas,Indiana,2018-2019,Age,19 Months,58.0,52.1 to 63.7,481
≥1 Dose Varicella,,States/Local Areas,Indiana,2017,Age,19 Months,86.9,81.1 to 91.1,304
≥1 Dose Varicella,,States/Local Areas,Indiana,2017-2018,Age,19 Months,86.0,82.0 to 89.3,576
≥1 Dose MMR,,States/Local Areas,Indiana,2012,Age,19 Months,84.3,80.3 to 87.6,307
≥1 Dose MMR,,States/Local Areas,Indiana,2014,Age,19 Months,85.2,78.5 to 90.1,258
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2015,Age,19 Months,83.1,78.2 to 87.1,509
≥1 Dose MMR,,States/Local Areas,Indiana,2013,Age,19 Months,91.8,90.0 to 93.4,218
≥1 Dose MMR,,States/Local Areas,Indiana,2013-2014,Age,19 Months,88.5,83.7 to 92.1,476
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.2,59.4 to 85.0,66
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,43.7,25.7 to 61.6,44
≥1 Dose MMR,,States/Local Areas,Indiana,2011,Age,19 Months,86.3,79.6 to 91.1,271
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,85.8,82.0 to 89.5,483
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,73.4,68.2 to 78.7,434
DTaP,≥4 Doses,States/Local Areas,Indiana,2019,Age,35 Months,85.9,77.1 to 92.6,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2015,Age,19 Months,83.3,72.1 to 90.5,251
Hep B,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,87.5,82.9 to 91.0,536
Hep B,≥3 Doses,States/Local Areas,Indiana,2014,Age,19 Months,90.4,84.4 to 94.2,258
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,86.8,82.1 to 90.4,509
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,87.5,80.8 to 94.2,233
Hep B,≥2 Doses,States/Local Areas,Indiana,2014,Age,5 Months,88.6,83.0 to 92.6,258
Hep B,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,5 Months,86.9,82.5 to 90.4,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2013,Age,19 Months,92.1,86.4 to 95.5,218
Hep B,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,91.2,88.4 to 93.5,476
Hep B,≥2 Doses,States/Local Areas,Indiana,2013,Age,5 Months,85.5,80.7 to 89.3,218
Hep B,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,5 Months,87.1,83.4 to 90.0,476
Hep B,≥2 Doses,States/Local Areas,Indiana,2011,Age,5 Months,84.8,79.2 to 89.2,271
Hep B,≥2 Doses,States/Local Areas,Indiana,2012,Age,5 Months,86.6,82.4 to 90.0,307
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2011,Age,0-1 Days,72.3,67.5 to 76.6,271
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,75.7,68.0 to 83.4,405
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2012,Age,0-1 Days,79.2,74.5 to 83.3,307
Hep B,≥1 Dose,States/Local Areas,Indiana,2019,Age,3 Months,98.0,94.2 to 99.3,209
Hep B,≥1 Dose,States/Local Areas,Indiana,2018,Age,3 Months,96.3,92.7 to 98.1,272
Hep B,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,3 Months,97.1,94.9 to 98.4,481
≥1 Dose Varicella,,States/Local Areas,Indiana,2012,Age,24 Months,88.2,83.1 to 92.3,307
≥1 Dose Varicella,,States/Local Areas,Indiana,2011,Age,24 Months,88.6,83.3 to 92.8,271
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,68.9,62.7 to 75.1,337
≥1 Dose MMR,,States/Local Areas,Indiana,2017,Age,19 Months,86.6,80.8 to 90.8,304
≥1 Dose MMR,,States/Local Areas,Indiana,2017-2018,Age,19 Months,85.1,80.9 to 88.4,576
≥1 Dose MMR,,States/Local Areas,Indiana,2016,Age,19 Months,85.5,79.2 to 90.1,285
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2017,Age,19 Months,86.0,81.9 to 89.3,589
≥1 Dose MMR,,States/Local Areas,Indiana,2015,Age,19 Months,81.0,76.4 to 84.9,251
≥1 Dose MMR,,States/Local Areas,Indiana,2015-2016,Age,19 Months,83.2,78.4 to 87.1,536
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.9,74.0 to 85.9,316
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,78.3,73.2 to 83.3,452
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,70.3,62.7 to 78.0,207
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,77.1,73.7 to 80.6,975
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.8,74.9 to 92.8,109
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.2,73.0 to 81.4,650
Hep B,≥3 Doses,States/Local Areas,Indiana,2011,Age,19 Months,86.7,82.4 to 90.0,271
Hep B,≥3 Doses,States/Local Areas,Indiana,2019,Age,13 Months,90.2,83.4 to 94.4,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2018,Age,13 Months,87.4,81.8 to 91.5,272
Hep B,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,88.8,84.7 to 91.9,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2012,Age,19 Months,90.0,83.1 to 94.3,307
DTaP,≥4 Doses,States/Local Areas,Indiana,2016,Age,35 Months,85.2,78.1 to 91.0,285
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,86.4,81.6 to 90.4,589
DTaP,≥4 Doses,States/Local Areas,Indiana,2017,Age,35 Months,87.7,80.8 to 93.0,304
DTaP,≥4 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,84.2,79.6 to 88.3,576
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,78.5,62.5 to 94.4,150
Hep B,≥3 Doses,States/Local Areas,Indiana,2017,Age,13 Months,91.3,86.9 to 94.3,304
Hep B,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,89.4,85.9 to 92.0,576
Hep B,≥3 Doses,States/Local Areas,Indiana,2015,Age,13 Months,81.8,73.9 to 87.7,251
Hep B,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,85.2,80.4 to 89.0,536
Hep B,≥3 Doses,States/Local Areas,Indiana,2016,Age,13 Months,88.7,82.8 to 92.8,285
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,90.0,86.5 to 92.7,589
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.8,43.7 to 78.0,66
DTaP,≥4 Doses,States/Local Areas,Indiana,2018,Age,35 Months,81.4,74.7 to 87.3,272
DTaP,≥4 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,83.3,78.0 to 87.9,481
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,32.7,10.9 to 54.6,44
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,81.9,75.7 to 88.2,483
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,73.8,66.4 to 81.2,434
Hep B,≥1 Dose,States/Local Areas,Indiana,2017,Age,3 Months,95.8,92.4 to 97.7,304
Hep B,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,3 Months,96.0,93.8 to 97.5,576
Hep B,≥1 Dose,States/Local Areas,Indiana,2016,Age,3 Months,93.4,87.9 to 96.5,285
Hep B,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,3 Months,94.6,91.6 to 96.5,589
Hep B,≥1 Dose,States/Local Areas,Indiana,2015,Age,3 Months,92.2,86.5 to 95.6,251
Hep B,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,3 Months,92.8,89.1 to 95.3,536
Polio,≥2 Doses,States/Local Areas,Indiana,2014,Age,13 Months,92.0,86.0 to 95.5,258
Polio,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,91.7,87.8 to 94.4,509
Polio,≥2 Doses,States/Local Areas,Indiana,2013,Age,13 Months,96.1,92.6 to 98.0,218
Polio,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,94.0,88.9 to 96.9,476
Polio,≥2 Doses,States/Local Areas,Indiana,2011,Age,13 Months,90.4,85.0 to 93.9,271
Polio,≥2 Doses,States/Local Areas,Indiana,2012,Age,13 Months,90.9,84.1 to 95.0,307
≥1 Dose Varicella,,States/Local Areas,Indiana,2016,Age,19 Months,85.5,79.0 to 90.2,285
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2017,Age,19 Months,86.2,82.0 to 89.5,589
≥1 Dose Varicella,,States/Local Areas,Indiana,2015,Age,19 Months,82.6,77.5 to 86.7,251
≥1 Dose Varicella,,States/Local Areas,Indiana,2015-2016,Age,19 Months,84.0,79.2 to 87.9,536
≥1 Dose Varicella,,States/Local Areas,Indiana,2014,Age,19 Months,85.3,78.7 to 90.2,258
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2015,Age,19 Months,84.0,79.1 to 87.9,509
≥1 Dose MMR,,States/Local Areas,Indiana,2019,Age,13 Months,59.9,50.4 to 68.8,209
≥1 Dose MMR,,States/Local Areas,Indiana,2018,Age,13 Months,60.2,52.4 to 67.4,272
≥1 Dose MMR,,States/Local Areas,Indiana,2018-2019,Age,13 Months,60.0,53.9 to 65.9,481
≥1 Dose MMR,,States/Local Areas,Indiana,2017,Age,13 Months,58.0,51.0 to 64.7,304
≥1 Dose MMR,,States/Local Areas,Indiana,2017-2018,Age,13 Months,59.1,53.8 to 64.1,576
DTaP,≥4 Doses,States/Local Areas,Indiana,2011,Age,35 Months,86.5,79.0 to 92.3,271
DTaP,≥4 Doses,States/Local Areas,Indiana,2019,Age,24 Months,79.3,71.1 to 86.4,209
Polio,≥2 Doses,States/Local Areas,Indiana,2018,Age,7 Months,86.2,80.1 to 90.7,272
Polio,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,86.5,82.0 to 90.1,481
Polio,≥2 Doses,States/Local Areas,Indiana,2017,Age,7 Months,90.2,84.9 to 93.8,304
Polio,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,88.2,84.3 to 91.2,576
Hep B,≥1 Dose,States/Local Areas,Indiana,2014,Age,3 Months,92.5,87.3 to 95.7,258
Hep B,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,3 Months,92.4,88.8 to 94.9,509
Hep B,≥1 Dose,States/Local Areas,Indiana,2011,Age,3 Months,94.3,90.7 to 96.6,271
Hep B,≥1 Dose,States/Local Areas,Indiana,2012,Age,3 Months,94.1,90.8 to 96.2,307
Hep B,≥1 Dose,States/Local Areas,Indiana,2013,Age,3 Months,93.8,92.2 to 95.0,218
Hep B,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,3 Months,93.1,91.2 to 94.7,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.8,64.7 to 80.8,316
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,92.6,88.4 to 96.7,233
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,70.1,59.8 to 80.4,207
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,69.6,60.8 to 78.5,337
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,75.3,70.3 to 80.2,975
Polio,≥2 Doses,States/Local Areas,Indiana,2019,Age,7 Months,86.9,79.3 to 92.0,209
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.8,69.0 to 80.6,650
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,78.5,70.9 to 86.1,452
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,78.2 to 100.0,109
DTaP,≥4 Doses,States/Local Areas,Indiana,2017,Age,24 Months,79.9,73.9 to 85.2,304
DTaP,≥4 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,79.6,75.1 to 83.7,576
DTaP,≥4 Doses,States/Local Areas,Indiana,2018,Age,24 Months,79.4,72.8 to 85.3,272
DTaP,≥4 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,79.2,74.0 to 83.9,481
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,82.4 to 97.1,109
≥1 Dose Varicella,,States/Local Areas,Indiana,2017,Age,13 Months,59.4,52.4 to 66.0,304
≥1 Dose Varicella,,States/Local Areas,Indiana,2017-2018,Age,13 Months,58.4,53.2 to 63.4,576
≥1 Dose Varicella,,States/Local Areas,Indiana,2016,Age,13 Months,49.7,42.2 to 57.1,285
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2017,Age,13 Months,54.5,49.4 to 59.6,589
Hep A,≥2 Doses,States/Local Areas,Indiana,2017,Age,35 Months,79.0,70.6 to 86.3,304
Hep A,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,76.3,70.4 to 81.8,576
Hep A,≥2 Doses,States/Local Areas,Indiana,2018,Age,35 Months,74.1,65.7 to 81.8,272
Hep A,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,77.0,70.3 to 83.1,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2014,Age,13 Months,88.5,82.1 to 92.8,258
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,85.2,80.3 to 89.0,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2013,Age,13 Months,88.3,82.9 to 92.2,218
Hep B,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,88.4,85.1 to 91.1,476
DTaP,≥4 Doses,States/Local Areas,Indiana,2013,Age,35 Months,88.7,81.7 to 93.9,218
DTaP,≥4 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,86.2,81.4 to 90.3,476
Hep B,≥3 Doses,States/Local Areas,Indiana,2012,Age,13 Months,87.4,79.1 to 92.7,307
Hep A,≥2 Doses,States/Local Areas,Indiana,2019,Age,35 Months,80.5,69.7 to 89.4,209
DTaP,≥4 Doses,States/Local Areas,Indiana,2014,Age,35 Months,83.9,77.0 to 89.7,258
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,82.4,77.1 to 87.1,509
DTaP,≥4 Doses,States/Local Areas,Indiana,2015,Age,35 Months,80.4,72.4 to 87.3,251
DTaP,≥4 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,82.8,77.3 to 87.5,536
DTaP,≥4 Doses,States/Local Areas,Indiana,2012,Age,35 Months,89.7,82.6 to 94.8,307
≥1 Dose Varicella,,States/Local Areas,Indiana,2018,Age,13 Months,57.4,49.7 to 64.8,272
≥1 Dose Varicella,,States/Local Areas,Indiana,2018-2019,Age,13 Months,58.0,52.1 to 63.7,481
≥1 Dose MMR,,States/Local Areas,Indiana,2016,Age,13 Months,54.0,46.5 to 61.5,285
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2017,Age,13 Months,56.0,50.9 to 61.1,589
≥1 Dose Varicella,,States/Local Areas,Indiana,2012,Age,19 Months,83.6,80.2 to 86.5,307
≥1 Dose Varicella,,States/Local Areas,Indiana,2013,Age,19 Months,92.6,90.1 to 94.6,218
≥1 Dose Varicella,,States/Local Areas,Indiana,2013-2014,Age,19 Months,89.0,84.7 to 92.2,476
≥1 Dose Varicella,,States/Local Areas,Indiana,2011,Age,19 Months,87.0,82.5 to 90.4,271
≥1 Dose Varicella,,States/Local Areas,Indiana,2019,Age,13 Months,58.7,49.8 to 67.0,209
≥1 Dose MMR,,States/Local Areas,Indiana,2015,Age,13 Months,45.5,37.1 to 54.2,251
≥1 Dose MMR,,States/Local Areas,Indiana,2015-2016,Age,13 Months,49.7,44.0 to 55.5,536
≥1 Dose MMR,,States/Local Areas,Indiana,2014,Age,13 Months,54.3,46.5 to 61.9,258
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2015,Age,13 Months,49.9,44.1 to 55.7,509
Hep A,≥2 Doses,States/Local Areas,Indiana,2014,Age,35 Months,78.2,68.4 to 86.7,258
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,77.5,70.8 to 83.7,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2019,Age,7 Months,61.7,53.2 to 69.5,209
Polio,≥2 Doses,States/Local Areas,Indiana,2013,Age,7 Months,89.2,87.6 to 90.7,218
Polio,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,88.5,84.2 to 91.7,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2015,Age,35 Months,76.9,67.1 to 85.4,251
Hep A,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,75.4,68.3 to 82.0,536
Hep A,≥2 Doses,States/Local Areas,Indiana,2016,Age,35 Months,73.6,63.2 to 83.0,285
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,76.4,69.7 to 82.5,589
Hep B,≥3 Doses,States/Local Areas,Indiana,2018,Age,7 Months,62.0,54.4 to 69.1,272
Hep B,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,61.8,56.1 to 67.3,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2017,Age,7 Months,64.9,58.1 to 71.2,304
Hep B,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,63.5,58.4 to 68.3,576
Polio,≥2 Doses,States/Local Areas,Indiana,2011,Age,7 Months,86.5,82.6 to 89.6,271
Polio,≥2 Doses,States/Local Areas,Indiana,2012,Age,7 Months,87.9,80.6 to 92.7,307
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,84.2,76.2 to 92.2,150
Polio,≥2 Doses,States/Local Areas,Indiana,2019,Age,5 Months,79.9,71.8 to 86.1,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,81.9,77.0 to 86.8,337
Hib,≥2 Doses,States/Local Areas,Indiana,2014,Age,13 Months,91.1,84.9 to 94.9,258
Hib,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,90.7,86.6 to 93.7,509
Hib,≥2 Doses,States/Local Areas,Indiana,2016,Age,13 Months,93.0,88.0 to 96.0,285
Hib,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,94.4,91.6 to 96.4,589
Hib,≥2 Doses,States/Local Areas,Indiana,2015,Age,13 Months,90.4,84.0 to 94.4,251
Hib,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,91.7,87.9 to 94.4,536
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,81.3,72.7 to 89.9,150
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,77.3,63.8 to 90.8,44
DTaP,≥3 Doses,States/Local Areas,Indiana,2011,Age,13 Months,84.4,79.7 to 88.1,271
PCV,≥3 Doses,States/Local Areas,Indiana,2016,Age,35 Months,90.3,84.7 to 94.5,285
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,93.2,89.9 to 95.7,589
PCV,≥3 Doses,States/Local Areas,Indiana,2015,Age,35 Months,91.6,86.1 to 95.6,251
PCV,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,91.0,87.2 to 94.1,536
PCV,≥3 Doses,States/Local Areas,Indiana,2014,Age,35 Months,91.5,86.1 to 95.5,258
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,91.6,87.8 to 94.6,509
Hib,≥2 Doses,States/Local Areas,Indiana,2018,Age,7 Months,86.0,79.7 to 90.5,272
Hib,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,87.4,82.9 to 90.8,481
Hib,≥2 Doses,States/Local Areas,Indiana,2019,Age,7 Months,88.8,81.7 to 93.4,209
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.3,85.0 to 93.6,316
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,90.4,86.1 to 94.8,207
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016,Age,0-3 Days,80.6,73.5 to 86.2,285
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2017,Age,0-3 Days,79.9,75.4 to 83.8,589
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2017,Age,0-3 Days,81.2,72.8 to 87.4,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2017-2018,Age,0-3 Days,80.3,76.0 to 84.0,576
Polio,≥1 Dose,States/Local Areas,Indiana,2016,Age,3 Months,84.2,78.1 to 88.9,285
Polio,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,3 Months,85.9,82.0 to 89.0,589
Polio,≥1 Dose,States/Local Areas,Indiana,2015,Age,3 Months,80.9,72.9 to 87.0,251
Polio,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,3 Months,82.5,77.6 to 86.6,536
Polio,≥1 Dose,States/Local Areas,Indiana,2014,Age,3 Months,82.5,75.8 to 87.6,258
Polio,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,3 Months,81.7,76.6 to 85.8,509
Hib,≥3 Doses,States/Local Areas,Indiana,2013,Age,7 Months,52.6,47.3 to 57.8,218
Hib,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,51.0,47.0 to 55.0,476
Hib,≥3 Doses,States/Local Areas,Indiana,2011,Age,7 Months,53.8,47.3 to 60.1,271
Hib,≥3 Doses,States/Local Areas,Indiana,2012,Age,7 Months,57.2,51.9 to 62.3,307
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,91.5,88.3 to 94.7,405
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,93.9,90.3 to 97.5,233
DTaP,≥3 Doses,States/Local Areas,Indiana,2014,Age,7 Months,64.2,56.2 to 71.5,258
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,62.0,56.3 to 67.4,509
Hib,≥2 Doses,States/Local Areas,Indiana,2017,Age,7 Months,89.3,83.8 to 93.1,304
Hib,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,87.7,83.7 to 90.8,576
Hib,≥2 Doses,States/Local Areas,Indiana,2016,Age,7 Months,87.6,81.7 to 91.9,285
Hib,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,88.5,84.6 to 91.5,589
Hib,≥2 Doses,States/Local Areas,Indiana,2019,Age,13 Months,93.6,87.6 to 96.8,209
Hib,≥2 Doses,States/Local Areas,Indiana,2017,Age,13 Months,95.9,92.3 to 97.8,304
Hib,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,94.3,91.5 to 96.3,576
Hib,≥2 Doses,States/Local Areas,Indiana,2018,Age,13 Months,92.8,87.8 to 95.8,272
Hib,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,93.2,89.6 to 95.6,481
DTaP,≥3 Doses,States/Local Areas,Indiana,2012,Age,13 Months,87.4,80.9 to 91.9,307
DTaP,≥3 Doses,States/Local Areas,Indiana,2015,Age,13 Months,82.5,74.5 to 88.4,251
DTaP,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,84.3,79.3 to 88.2,536
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,94.6,92.2 to 97.0,483
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,88.7,85.0 to 92.3,434
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.5,88.2 to 100.0,66
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,88.1,77.2 to 99.0,44
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,88.0,81.0 to 95.0,150
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.9,81.3 to 96.6,109
Hib,≥3 Doses,States/Local Areas,Indiana,2018,Age,7 Months,48.9,41.4 to 56.5,272
Hib,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,48.2,42.5 to 54.0,481
Hib,≥3 Doses,States/Local Areas,Indiana,2017,Age,7 Months,46.4,39.6 to 53.4,304
Hib,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,47.7,42.5 to 52.8,576
DTaP,≥3 Doses,States/Local Areas,Indiana,2017,Age,7 Months,65.3,58.3 to 71.7,304
DTaP,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,7 Months,65.3,60.1 to 70.2,576
DTaP,≥3 Doses,States/Local Areas,Indiana,2019,Age,7 Months,65.3,56.6 to 73.0,209
DTaP,≥3 Doses,States/Local Areas,Indiana,2018,Age,7 Months,65.4,57.7 to 72.3,272
DTaP,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,7 Months,65.3,59.6 to 70.6,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.8,77.1 to 94.5,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,80.0,75.5 to 84.4,434
Hib,Primary Series,States/Local Areas,Indiana,2020,Age,24 Months,93.6,88.3 to 97.0,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,78.2,73.6 to 82.9,483
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2019,Age,0-3 Days,87.5,80.5 to 92.2,209
≥1 Dose Varicella,,States/Local Areas,Indiana,2020,Age,24 Months,91.4,86.0 to 95.4,232
Polio,≥1 Dose,States/Local Areas,Indiana,2019,Age,3 Months,86.2,78.4 to 91.5,209
PCV,≥3 Doses,States/Local Areas,Indiana,2019,Age,35 Months,94.4,88.7 to 97.8,209
Polio,≥1 Dose,States/Local Areas,Indiana,2018,Age,3 Months,87.4,81.8 to 91.4,272
Polio,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,3 Months,86.8,82.3 to 90.3,481
Polio,≥1 Dose,States/Local Areas,Indiana,2017,Age,3 Months,87.5,82.2 to 91.4,304
Polio,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,3 Months,87.4,83.8 to 90.4,576
Hib,≥3 Doses,States/Local Areas,Indiana,2016,Age,7 Months,48.0,40.6 to 55.4,285
Hib,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,47.2,42.1 to 52.3,589
Hib,≥3 Doses,States/Local Areas,Indiana,2015,Age,7 Months,46.0,37.6 to 54.7,251
Hib,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,47.0,41.3 to 52.7,536
Hib,≥3 Doses,States/Local Areas,Indiana,2014,Age,7 Months,49.4,41.8 to 57.1,258
Hib,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,47.7,42.0 to 53.5,509
PCV,≥3 Doses,States/Local Areas,Indiana,2018,Age,35 Months,91.6,85.9 to 95.7,272
PCV,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,93.3,89.4 to 96.1,481
PCV,≥3 Doses,States/Local Areas,Indiana,2017,Age,35 Months,95.8,92.3 to 98.0,304
PCV,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,94.0,90.6 to 96.5,576
Hib,≥2 Doses,States/Local Areas,Indiana,2013,Age,13 Months,95.6,90.4 to 98.0,218
Hib,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,93.3,87.5 to 96.5,476
DTaP,≥3 Doses,States/Local Areas,Indiana,2016,Age,7 Months,65.7,57.8 to 72.8,285
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,7 Months,65.5,60.3 to 70.4,589
DTaP,≥3 Doses,States/Local Areas,Indiana,2015,Age,7 Months,59.8,51.5 to 67.6,251
DTaP,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,62.7,57.0 to 68.1,536
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2018,Age,0-3 Days,81.4,75.1 to 86.3,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2018-2019,Age,0-3 Days,84.4,80.0 to 88.0,481
Hib,≥2 Doses,States/Local Areas,Indiana,2011,Age,13 Months,91.7,88.0 to 94.4,271
Hib,≥2 Doses,States/Local Areas,Indiana,2012,Age,13 Months,90.4,84.5 to 94.2,307
DTaP,≥3 Doses,States/Local Areas,Indiana,2017,Age,13 Months,88.8,83.6 to 92.6,304
DTaP,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,88.0,84.1 to 90.9,576
DTaP,≥3 Doses,States/Local Areas,Indiana,2016,Age,13 Months,86.1,79.4 to 90.8,285
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,87.5,83.4 to 90.6,589
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.9 to 94.2,650
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,91.6,88.2 to 95.0,452
Hib,≥3 Doses,States/Local Areas,Indiana,2019,Age,7 Months,47.5,39.1 to 56.1,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.3,70.3 to 82.2,316
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,81.2,76.9 to 85.4,452
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,78.5,71.6 to 85.4,207
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Overall,Overall,79.2,76.0 to 82.3,975
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.4,77.5 to 93.2,109
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.6,72.6 to 80.6,650
DTaP,≥3 Doses,States/Local Areas,Indiana,2014,Age,13 Months,87.8,81.2 to 92.2,258
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,85.1,80.2 to 89.0,509
DTaP,≥3 Doses,States/Local Areas,Indiana,2013,Age,13 Months,89.6,86.8 to 92.0,218
DTaP,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,88.7,84.9 to 91.7,476
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.7,86.7 to 94.8,316
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,90.2,85.9 to 94.6,207
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,91.1,88.8 to 93.3,975
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,88.3,84.2 to 92.4,337
DTaP,≥3 Doses,States/Local Areas,Indiana,2012,Age,19 Months,89.8,81.1 to 94.7,307
DTaP,≥3 Doses,States/Local Areas,Indiana,2013,Age,19 Months,96.0,94.6 to 97.0,218
DTaP,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,93.6,90.0 to 96.0,476
DTaP,≥3 Doses,States/Local Areas,Indiana,2011,Age,19 Months,90.5,87.1 to 93.0,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2019,Age,13 Months,89.6,82.4 to 94.1,209
DTaP,≥3 Doses,States/Local Areas,Indiana,2020,Age,13 Months,92.7,87.4 to 95.9,232
DTaP,≥3 Doses,States/Local Areas,Indiana,2018,Age,13 Months,87.1,81.0 to 91.4,272
DTaP,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,88.3,83.9 to 91.6,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,75.1,70.0 to 80.2,405
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,81.6,75.3 to 87.9,233
Polio,≥3 Doses,States/Local Areas,Indiana,2012,Age,19 Months,89.1,81.7 to 93.8,307
Hib,≥3 Doses,States/Local Areas,Indiana,2017,Age,13 Months,66.6,59.4 to 73.1,304
Hib,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,67.3,62.0 to 72.1,576
Hib,≥3 Doses,States/Local Areas,Indiana,2016,Age,13 Months,67.1,59.2 to 74.1,285
Hib,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,13 Months,66.8,61.6 to 71.7,589
Hib,≥3 Doses,States/Local Areas,Indiana,2015,Age,13 Months,70.8,62.2 to 78.1,251
Hib,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,13 Months,69.0,63.2 to 74.2,536
Hib,≥3 Doses,States/Local Areas,Indiana,2012,Age,13 Months,75.9,66.3 to 83.4,307
Hib,≥3 Doses,States/Local Areas,Indiana,2011,Age,13 Months,75.2,65.6 to 82.8,271
Hib,≥3 Doses,States/Local Areas,Indiana,2014,Age,13 Months,71.8,64.4 to 78.2,258
Hib,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,13 Months,71.3,65.8 to 76.3,509
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,91.0,87.4 to 94.6,405
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,97.1,95.0 to 99.2,233
Polio,≥3 Doses,States/Local Areas,Indiana,2011,Age,19 Months,88.8,83.5 to 92.6,271
Hib,≥3 Doses,States/Local Areas,Indiana,2013,Age,13 Months,78.7,74.4 to 82.4,218
Hib,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,75.3,71.1 to 79.0,476
Polio,≥3 Doses,States/Local Areas,Indiana,2015,Age,19 Months,85.9,77.2 to 91.7,251
Polio,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,88.6,84.2 to 91.9,536
Polio,≥3 Doses,States/Local Areas,Indiana,2014,Age,19 Months,91.3,85.4 to 95.0,258
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,88.6,84.1 to 92.0,509
Polio,≥3 Doses,States/Local Areas,Indiana,2013,Age,19 Months,95.8,94.4 to 96.9,218
Polio,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,93.6,89.9 to 96.0,476
Hib,≥3 Doses,States/Local Areas,Indiana,2011,Age,19 Months,88.8,83.9 to 92.4,271
Hib,≥3 Doses,States/Local Areas,Indiana,2012,Age,19 Months,87.3,80.3 to 92.1,307
Hib,≥2 Doses,States/Local Areas,Indiana,2020,Age,13 Months,94.8,89.6 to 97.5,232
Hib,≥3 Doses,States/Local Areas,Indiana,2019,Age,13 Months,70.1,61.3 to 77.6,209
Polio,≥3 Doses,States/Local Areas,Indiana,2017,Age,19 Months,92.9,88.3 to 95.8,304
Polio,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,90.2,86.5 to 92.9,576
Polio,≥3 Doses,States/Local Areas,Indiana,2016,Age,19 Months,91.4,86.2 to 94.7,285
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,92.1,88.9 to 94.5,589
Hib,≥3 Doses,States/Local Areas,Indiana,2018,Age,13 Months,68.0,60.3 to 74.8,272
Hib,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,69.0,63.2 to 74.3,481
Polio,≥3 Doses,States/Local Areas,Indiana,2018,Age,19 Months,87.5,81.4 to 91.8,272
Polio,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,60.0,53.9 to 65.9,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.3,86.3 to 92.3,650
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,87.6 to 94.3,452
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,90.1,84.5 to 95.7,150
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.8 to 98.6,109
PCV,≥3 Doses,States/Local Areas,Indiana,2012,Age,35 Months,91.6,86.5 to 95.3,307
PCV,≥3 Doses,States/Local Areas,Indiana,2013,Age,35 Months,97.4,92.2 to 99.4,218
PCV,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,93.9,90.1 to 96.5,476
PCV,≥3 Doses,States/Local Areas,Indiana,2011,Age,35 Months,95.0,89.4 to 98.2,271
PCV,≥3 Doses,States/Local Areas,Indiana,2019,Age,24 Months,94.4,88.7 to 97.8,209
Hib,≥2 Doses,States/Local Areas,Indiana,2015,Age,7 Months,86.3,79.6 to 91.1,251
Hib,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,7 Months,87.0,82.7 to 90.3,536
Polio,≥1 Dose,States/Local Areas,Indiana,2011,Age,3 Months,79.7,78.1 to 81.2,271
Polio,≥1 Dose,States/Local Areas,Indiana,2012,Age,3 Months,84.2,79.3 to 88.1,307
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,90.4,88.1 to 92.6,975
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,87.6,83.3 to 91.8,337
PCV,≥1 Dose,States/Local Areas,Indiana,2019,Age,3 Months,85.9,78.3 to 91.2,209
Polio,≥1 Dose,States/Local Areas,Indiana,2013,Age,3 Months,83.1,81.9 to 84.2,218
Polio,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,3 Months,82.8,76.7 to 87.5,476
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2013,Age,0-3 Days,75.2,66.9 to 81.9,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2013-2014,Age,0-3 Days,76.7,71.4 to 81.2,476
DTaP,≥3 Doses,States/Local Areas,Indiana,2011,Age,7 Months,63.0,59.4 to 66.4,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2012,Age,7 Months,68.6,64.0 to 72.9,307
DTaP,≥3 Doses,States/Local Areas,Indiana,2013,Age,7 Months,66.5,61.9 to 70.7,218
DTaP,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,65.3,62.6 to 67.9,476
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014,Age,0-3 Days,78.2,71.3 to 83.9,258
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2014-2015,Age,0-3 Days,77.8,72.8 to 82.1,509
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2015,Age,0-3 Days,77.3,69.7 to 83.5,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2015-2016,Age,0-3 Days,79.0,73.9 to 83.2,536
PCV,≥1 Dose,States/Local Areas,Indiana,2015,Age,3 Months,78.6,70.3 to 85.1,251
PCV,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,3 Months,80.3,75.1 to 84.6,536
PCV,≥1 Dose,States/Local Areas,Indiana,2014,Age,3 Months,80.1,73.1 to 85.6,258
PCV,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,3 Months,79.4,74.1 to 83.8,509
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.6,67.7 to 87.6,109
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.0,76.1 to 83.9,650
PCV,≥3 Doses,States/Local Areas,Indiana,2018,Age,24 Months,89.7,84.6 to 93.7,272
PCV,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,91.9,88.3 to 94.7,481
PCV,≥3 Doses,States/Local Areas,Indiana,2017,Age,24 Months,93.5,89.6 to 96.3,304
PCV,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,91.6,88.5 to 94.2,576
Hib,≥2 Doses,States/Local Areas,Indiana,2012,Age,7 Months,87.5,80.7 to 92.2,307
PCV,≥3 Doses,States/Local Areas,Indiana,2016,Age,24 Months,89.4,83.8 to 93.7,285
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,91.5,88.2 to 94.2,589
Hib,≥2 Doses,States/Local Areas,Indiana,2011,Age,7 Months,86.7,83.1 to 89.6,271
Hib,≥2 Doses,States/Local Areas,Indiana,2019,Age,5 Months,80.8,72.9 to 86.9,209
Hib,≥2 Doses,States/Local Areas,Indiana,2018,Age,5 Months,76.4,69.3 to 82.2,272
Hib,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,5 Months,78.6,73.5 to 83.0,481
PCV,≥1 Dose,States/Local Areas,Indiana,2017,Age,3 Months,84.8,79.1 to 89.2,304
PCV,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,3 Months,84.6,80.6 to 87.9,576
PCV,≥1 Dose,States/Local Areas,Indiana,2016,Age,3 Months,81.9,75.3 to 87.1,285
PCV,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,3 Months,83.4,79.2 to 86.9,589
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.4,88.0 to 100.0,66
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,93.5,91.0 to 95.9,483
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,87.8,84.0 to 91.6,434
PCV,≥1 Dose,States/Local Areas,Indiana,2018,Age,3 Months,84.4,78.3 to 89.0,272
PCV,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,3 Months,85.2,80.5 to 88.8,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2011,Age,0-3 Days,81.1,74.0 to 86.7,271
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,78.6,73.7 to 83.6,452
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2012,Age,0-3 Days,86.1,80.4 to 90.4,307
Hib,≥2 Doses,States/Local Areas,Indiana,2014,Age,7 Months,86.8,80.2 to 91.4,258
Hib,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,7 Months,86.6,82.1 to 90.1,509
Hib,≥2 Doses,States/Local Areas,Indiana,2013,Age,7 Months,87.7,85.1 to 89.9,218
Hib,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,7 Months,87.2,82.5 to 90.9,476
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,91.2,83.7 to 98.8,44
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,75.4,68.3 to 82.5,207
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,78.9,75.6 to 82.2,975
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,71.6,65.7 to 77.5,337
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,79.2,74.1 to 84.4,405
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,93.4,89.9 to 96.9,233
PCV,≥4 Doses,States/Local Areas,Indiana,2019,Age,35 Months,87.8,80.1 to 93.6,209
PCV,≥4 Doses,States/Local Areas,Indiana,2018,Age,35 Months,80.7,74.0 to 86.7,272
PCV,≥4 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,83.8,78.9 to 88.2,481
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,87.0,81.9 to 92.1,207
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Overall,Overall,87.4,84.7 to 90.0,975
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,83.1,78.3 to 88.0,337
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,88.8,84.9 to 92.7,405
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,93.5,89.1 to 97.8,233
PCV,≥1 Dose,States/Local Areas,Indiana,2011,Age,3 Months,78.5,76.9 to 80.0,271
PCV,≥1 Dose,States/Local Areas,Indiana,2012,Age,3 Months,82.1,77.3 to 86.0,307
Hib,≥2 Doses,States/Local Areas,Indiana,2014,Age,5 Months,75.1,67.6 to 81.4,258
Hib,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,5 Months,73.0,64.5 to 80.1,509
Hib,≥2 Doses,States/Local Areas,Indiana,2013,Age,5 Months,70.2,68.1 to 72.2,218
Hib,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,5 Months,72.6,68.6 to 76.4,476
PCV,≥3 Doses,States/Local Areas,Indiana,2011,Age,24 Months,91.6,86.2 to 95.5,271
PCV,≥3 Doses,States/Local Areas,Indiana,2019,Age,19 Months,91.6,85.2 to 95.4,209
PCV,≥3 Doses,States/Local Areas,Indiana,2018,Age,19 Months,89.5,83.9 to 93.3,272
PCV,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,86.9,82.4 to 90.3,481
Hib,≥2 Doses,States/Local Areas,Indiana,2016,Age,5 Months,74.2,66.4 to 80.6,285
Hib,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,5 Months,76.4,71.4 to 80.7,589
Hib,≥2 Doses,States/Local Areas,Indiana,2015,Age,5 Months,70.9,62.4 to 78.2,251
Hib,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,5 Months,72.5,66.8 to 77.5,536
PCV,≥4 Doses,States/Local Areas,Indiana,2017,Age,35 Months,89.2,83.2 to 93.8,304
PCV,≥4 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,84.7,80.4 to 88.5,576
Hib,≥2 Doses,States/Local Areas,Indiana,2011,Age,5 Months,71.7,66.7 to 76.2,271
Hib,≥2 Doses,States/Local Areas,Indiana,2012,Age,5 Months,76.7,71.1 to 81.5,307
PCV,≥3 Doses,States/Local Areas,Indiana,2013,Age,24 Months,94.6,89.3 to 97.8,218
PCV,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,24 Months,92.7,89.1 to 95.4,476
Hib,≥2 Doses,States/Local Areas,Indiana,2017,Age,5 Months,78.6,72.3 to 83.7,304
Hib,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,5 Months,77.5,72.9 to 81.5,576
PCV,≥3 Doses,States/Local Areas,Indiana,2012,Age,24 Months,91.1,86.1 to 94.9,307
PCV,≥3 Doses,States/Local Areas,Indiana,2014,Age,24 Months,90.9,85.5 to 94.9,258
PCV,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,90.3,86.4 to 93.5,509
PCV,≥3 Doses,States/Local Areas,Indiana,2015,Age,24 Months,89.7,83.6 to 94.3,251
PCV,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,89.6,85.6 to 92.9,536
PCV,≥4 Doses,States/Local Areas,Indiana,2014,Age,35 Months,83.6,77.1 to 89.2,258
PCV,≥4 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,81.1,75.6 to 86.0,509
PCV,≥4 Doses,States/Local Areas,Indiana,2015,Age,35 Months,78.4,69.5 to 86.2,251
PCV,≥4 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,76.9,71.1 to 82.3,536
PCV,≥4 Doses,States/Local Areas,Indiana,2016,Age,35 Months,74.9,67.4 to 81.7,285
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,81.8,77.0 to 86.1,589
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,86.1,82.1 to 90.0,434
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.5,73.0 to 94.0,66
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,63.4,45.0 to 81.8,44
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,85.5,77.6 to 93.3,150
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,85.7 to 98.3,109
Hep B,≥3 Doses,States/Local Areas,Indiana,2019,Age,35 Months,94.1,89.0 to 97.4,209
PCV,≥3 Doses,States/Local Areas,Indiana,2017,Age,19 Months,93.5,89.2 to 96.2,304
PCV,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,91.5,88.2 to 93.9,576
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.4,84.2 to 90.6,650
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,89.0,85.3 to 92.8,452
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.0,79.7 to 90.3,316
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,94.3,90.5 to 98.1,233
PCV,≥3 Doses,States/Local Areas,Indiana,2016,Age,19 Months,87.8,81.5 to 92.1,285
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,90.6,87.0 to 93.3,589
PCV,≥3 Doses,States/Local Areas,Indiana,2015,Age,19 Months,86.6,78.4 to 92.1,251
PCV,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,87.2,82.6 to 90.7,536
Hep B,≥2 Doses,States/Local Areas,Indiana,2019,Age,13 Months,97.3,93.5 to 98.9,209
Hep B,≥2 Doses,States/Local Areas,Indiana,2018,Age,13 Months,94.2,89.6 to 96.9,272
Hep B,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,95.7,93.0 to 97.4,481
Hep B,≥2 Doses,States/Local Areas,Indiana,2017,Age,13 Months,95.7,92.1 to 97.7,304
Hep B,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,94.9,92.3 to 96.7,576
Hib,≥1 Dose,States/Local Areas,Indiana,2017,Age,3 Months,85.7,80.1 to 89.9,304
Hib,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,3 Months,86.3,82.4 to 89.4,576
Hib,≥1 Dose,States/Local Areas,Indiana,2016,Age,3 Months,83.8,77.6 to 88.6,285
Hib,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,3 Months,84.8,80.8 to 88.1,589
Hib,≥1 Dose,States/Local Areas,Indiana,2015,Age,3 Months,82.9,75.3 to 88.5,251
Hib,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,3 Months,83.4,78.7 to 87.2,536
≥1 Dose MMR,,States/Local Areas,Indiana,2017,Age,35 Months,93.5,89.0 to 96.7,304
≥1 Dose MMR,,States/Local Areas,Indiana,2017-2018,Age,35 Months,92.0,87.7 to 95.2,576
≥1 Dose MMR,,States/Local Areas,Indiana,2018,Age,35 Months,90.3,83.3 to 95.2,272
≥1 Dose MMR,,States/Local Areas,Indiana,2018-2019,Age,35 Months,90.1,84.5 to 94.2,481
PCV,≥4 Doses,States/Local Areas,Indiana,2013,Age,35 Months,86.1,76.0 to 93.5,218
PCV,≥4 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,84.6,79.0 to 89.5,476
≥1 Dose MMR,,States/Local Areas,Indiana,2019,Age,35 Months,89.8,80.3 to 95.9,209
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,92.2,89.3 to 95.1,483
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.1,83.9 to 90.4,650
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,88.3,84.3 to 92.2,452
Hep B,≥3 Doses,States/Local Areas,Indiana,2013,Age,35 Months,94.2,88.5 to 97.6,218
Hep B,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,92.1,88.3 to 95.1,476
Hep B,≥3 Doses,States/Local Areas,Indiana,2014,Age,35 Months,90.9,85.4 to 94.9,258
Hep B,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,91.1,87.0 to 94.4,509
Hep B,≥3 Doses,States/Local Areas,Indiana,2015,Age,35 Months,91.2,84.9 to 95.6,251
Hep B,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,92.1,88.1 to 95.2,536
Hep B,≥3 Doses,States/Local Areas,Indiana,2012,Age,35 Months,93.1,88.3 to 96.5,307
PCV,≥3 Doses,States/Local Areas,Indiana,2018,Age,13 Months,85.8,79.9 to 90.2,272
PCV,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,13 Months,86.9,82.4 to 90.3,481
PCV,≥3 Doses,States/Local Areas,Indiana,2017,Age,13 Months,90.5,85.7 to 93.8,304
PCV,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,13 Months,88.2,84.5 to 91.1,576
Hep B,≥2 Doses,States/Local Areas,Indiana,2012,Age,13 Months,92.8,85.7 to 96.6,307
Hep B,≥2 Doses,States/Local Areas,Indiana,2013,Age,13 Months,97.4,94.7 to 98.7,218
Hep B,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,13 Months,95.6,92.4 to 97.6,476
Hep B,≥2 Doses,States/Local Areas,Indiana,2011,Age,13 Months,91.9,89.2 to 94.0,271
Hep B,≥2 Doses,States/Local Areas,Indiana,2019,Age,7 Months,95.6,91.0 to 97.9,209
PCV,≥4 Doses,States/Local Areas,Indiana,2016,Age,24 Months,71.1,63.8 to 77.9,285
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,77.3,72.6 to 81.6,589
PCV,≥4 Doses,States/Local Areas,Indiana,2017,Age,24 Months,83.4,77.8 to 88.3,304
PCV,≥4 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,80.3,75.8 to 84.4,576
≥1 Dose MMR,,States/Local Areas,Indiana,2015,Age,35 Months,91.0,84.2 to 95.7,251
≥1 Dose MMR,,States/Local Areas,Indiana,2015-2016,Age,35 Months,91.4,86.9 to 94.7,536
≥1 Dose MMR,,States/Local Areas,Indiana,2014,Age,35 Months,89.6,83.4 to 94.2,258
≥1 Dose MMR,,States/Local Areas,Indiana,2014-2015,Age,35 Months,90.3,85.8 to 93.9,509
≥1 Dose MMR,,States/Local Areas,Indiana,2016,Age,35 Months,90.4,84.8 to 94.6,285
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2017,Age,35 Months,91.9,88.4 to 94.7,589
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.7,78.3 to 97.1,66
≥1 Dose Varicella,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,59.3,40.9 to 77.6,44
Hib,≥3 Doses,States/Local Areas,Indiana,2013,Age,19 Months,91.6,86.4 to 95.0,218
Hib,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,89.6,86.0 to 92.4,476
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,66.7,58.2 to 74.3,262
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,75.6,61.2 to 87.8,262
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,19 Months,77.6,69.5 to 84.1,262
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,91.1,84.3 to 95.1,262
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,27.3,20.7 to 35.2,262
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,3 Months,86.3,78.9 to 91.4,262
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,79.1,71.0 to 86.1,262
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,74.4,66.2 to 82.0,262
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,93.6,87.7 to 97.3,262
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,92.3,88.0 to 95.4,638
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,3 Months,84.9,77.5 to 90.2,262
Hib,Primary Series,States/Local Areas,IL-Rest of state,2021,Age,24 Months,91.5,85.7 to 95.7,262
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2021,Age,24 Months,92.4,85.0 to 97.0,262
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,91.2,85.2 to 95.5,262
Hib,Full Series,States/Local Areas,IL-Rest of state,2021,Age,24 Months,74.5,66.3 to 82.0,262
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2021,Age,19 Months,83.7,75.9 to 89.4,262
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,35 Months,90.2,83.0 to 95.3,262
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,88.2,80.5 to 93.1,262
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2021,Age,0-2 Days,73.0,64.6 to 80.0,262
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,92.6,88.9 to 95.1,638
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,92.1,85.7 to 96.4,262
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,78.7,70.7 to 85.8,262
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,24 Months,83.9,76.4 to 90.0,262
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,5 Months,76.9,71.7 to 81.3,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,65.5,60.2 to 70.4,638
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,53.2,45.1 to 61.2,262
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2021,Age,24 Months,89.3,82.1 to 94.5,262
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,38.2,30.7 to 46.8,262
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,67.3,58.8 to 74.8,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,90.4,83.1 to 94.7,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,87.2,79.3 to 92.4,262
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,74.4,65.7 to 81.5,262
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,88.2,81.4 to 93.4,262
Rotavirus,,States/Local Areas,IL-Rest of state,2019-2020,Age,8 Months,78.7,74.5 to 82.3,750
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,77.7,71.8 to 83.6,279
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,57.5,50.2 to 64.8,279
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,68.5,63.1 to 73.9,464
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,95.4,92.7 to 98.0,464
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,98.3,97.0 to 99.5,539
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,91.4,89.4 to 93.5,1282
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,73.9,69.8 to 78.0,1282
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,84.7,80.9 to 88.5,539
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,90.7,86.4 to 95.0,279
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,78.3,75.3 to 81.2,1282
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,60.1,56.5 to 63.8,1282
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,88.0,83.0 to 92.9,279
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,93.4,90.2 to 96.5,464
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,71.2,64.4 to 78.0,464
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,87.5,82.4 to 92.7,539
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,81.7,76.1 to 87.4,279
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,80.3,75.4 to 85.1,464
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,84.1,81.4 to 86.8,1282
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,93.0,91.0 to 95.0,1282
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,91.3,89.2 to 93.4,1282
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,86.7,82.8 to 90.6,539
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,84.5,81.8 to 87.2,1282
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,93.9,92.1 to 95.7,1282
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,51.9,44.1 to 59.7,246
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,92.6,88.5 to 96.7,246
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,90.0,86.3 to 93.8,398
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.9 to 95.3,851
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.5,73.1 to 87.8,196
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,80.6,74.5 to 86.6,246
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.0,53.8 to 80.3,67
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,94.0,92.0 to 96.0,851
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.8 to 96.4,196
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,65.9,58.8 to 73.1,398
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,94.8,92.9 to 96.6,851
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,81.8,77.2 to 86.4,851
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,3 Months,87.7,82.7 to 91.4,376
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,3 Months,85.9,80.7 to 89.9,376
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,60.3,54.0 to 66.3,376
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,73.8,67.7 to 79.1,376
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,94.9,91.0 to 97.4,638
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2021,Age,0-1 Days,69.1,60.6 to 76.5,262
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,92.5,88.3 to 95.7,638
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,85.2,77.2 to 90.7,262
Influenza,,States/Local Areas,Kansas,2013,Age,24 Months,48.8,41.1 to 57.2,231
Influenza,,States/Local Areas,Kansas,2013-2014,Age,24 Months,51.5,45.6 to 57.6,439
Influenza,,States/Local Areas,Kansas,2012,Age,24 Months,48.6,40.7 to 57.2,224
Influenza,,States/Local Areas,Kansas,2011,Age,24 Months,50.8,42.7 to 59.4,221
Influenza,,States/Local Areas,Kansas,2014,Age,24 Months,54.2,45.6 to 63.2,208
Influenza,,States/Local Areas,Kansas,2014-2015,Age,24 Months,55.6,49.2 to 62.2,388
Influenza,,States/Local Areas,Kansas,2015,Age,24 Months,56.9,47.6 to 66.6,180
Influenza,,States/Local Areas,Kansas,2015-2016,Age,24 Months,53.6,47.6 to 59.9,481
Influenza,,States/Local Areas,Kansas,2016,Age,24 Months,50.2,42.9 to 58.0,301
Influenza,,States/Local Areas,Kansas,2016-2017,Age,24 Months,58.1,53.0 to 63.2,655
Hep B,≥2 Doses,States/Local Areas,Kansas,2021,Age,13 Months,92.8,87.4 to 96.0,266
≥1 Dose Varicella,,States/Local Areas,Kansas,2021,Age,35 Months,93.9,87.8 to 97.5,266
DTaP,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,91.1,87.5 to 93.9,634
Rotavirus,,States/Local Areas,Kansas,2020-2021,Age,8 Months,75.6,70.1 to 80.4,634
Hib,≥3 Doses,States/Local Areas,Kansas,2013,Age,19 Months,89.9,81.9 to 94.6,231
Hib,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,89.5,85.7 to 92.5,439
Hib,≥3 Doses,States/Local Areas,Kansas,2011,Age,19 Months,90.7,81.0 to 95.7,221
Hib,≥3 Doses,States/Local Areas,Kansas,2012,Age,19 Months,92.0,89.9 to 93.6,224
Hib,≥3 Doses,States/Local Areas,Kansas,2019,Age,13 Months,59.3,51.9 to 66.3,358
Polio,≥3 Doses,States/Local Areas,Kansas,2017,Age,19 Months,92.7,87.9 to 95.7,354
Polio,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,92.3,89.0 to 94.6,749
Polio,≥3 Doses,States/Local Areas,Kansas,2016,Age,19 Months,87.4,81.2 to 91.8,301
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,90.0,86.2 to 92.8,655
Hib,≥3 Doses,States/Local Areas,Kansas,2018,Age,13 Months,62.2,55.3 to 68.7,395
Hib,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,60.8,55.7 to 65.6,753
Polio,≥3 Doses,States/Local Areas,Kansas,2018,Age,19 Months,91.9,86.8 to 95.1,395
Polio,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,65.3,60.3 to 70.1,753
Hib,≥3 Doses,States/Local Areas,Kansas,2017,Age,13 Months,65.6,58.5 to 72.0,354
Hib,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,63.9,59.0 to 68.5,749
Hib,≥3 Doses,States/Local Areas,Kansas,2016,Age,13 Months,59.4,51.7 to 66.6,301
Hib,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,62.4,57.2 to 67.3,655
Hib,≥3 Doses,States/Local Areas,Kansas,2015,Age,13 Months,58.4,48.6 to 67.5,180
Hib,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,58.9,52.7 to 64.8,481
Polio,≥3 Doses,States/Local Areas,Kansas,2015,Age,19 Months,92.1,88.9 to 94.5,180
Polio,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,89.8,85.7 to 92.9,481
Polio,≥3 Doses,States/Local Areas,Kansas,2014,Age,19 Months,89.9,83.6 to 94.0,208
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,91.0,86.9 to 94.0,388
Polio,≥3 Doses,States/Local Areas,Kansas,2013,Age,19 Months,93.3,88.1 to 96.3,231
Polio,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,91.6,88.7 to 93.8,439
DTaP,≥3 Doses,States/Local Areas,Kansas,2017,Age,13 Months,89.3,83.6 to 93.1,354
DTaP,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,89.2,85.4 to 92.0,749
DTaP,≥3 Doses,States/Local Areas,Kansas,2016,Age,13 Months,87.2,80.8 to 91.6,301
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,88.2,84.2 to 91.3,655
DTaP,≥3 Doses,States/Local Areas,Kansas,2012,Age,19 Months,95.0,93.1 to 96.3,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2013,Age,19 Months,93.4,88.5 to 96.3,231
DTaP,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,92.9,91.0 to 94.5,439
DTaP,≥3 Doses,States/Local Areas,Kansas,2011,Age,19 Months,92.2,82.5 to 96.7,221
DTaP,≥3 Doses,States/Local Areas,Kansas,2019,Age,13 Months,90.1,84.6 to 93.8,358
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,89.2 to 94.7,612
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,86.8 to 95.2,320
Hib,≥3 Doses,States/Local Areas,Kansas,2019,Age,7 Months,43.5,36.5 to 50.8,358
DTaP,≥3 Doses,States/Local Areas,Kansas,2014,Age,13 Months,87.1,79.8 to 92.1,208
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,87.9,82.8 to 91.7,388
DTaP,≥3 Doses,States/Local Areas,Kansas,2013,Age,13 Months,90.8,82.5 to 95.4,231
DTaP,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,89.0,82.9 to 93.1,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.0,90.1 to 99.9,84
DTaP,≥3 Doses,States/Local Areas,Kansas,2018,Age,13 Months,89.1,83.5 to 92.9,395
DTaP,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,89.6,85.9 to 92.4,753
Hib,≥3 Doses,States/Local Areas,Kansas,2012,Age,13 Months,74.2,63.2 to 82.8,224
Hib,≥3 Doses,States/Local Areas,Kansas,2011,Age,13 Months,80.8,74.2 to 86.0,221
Hib,≥3 Doses,States/Local Areas,Kansas,2014,Age,13 Months,72.4,64.3 to 79.3,208
Hib,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,65.4,59.0 to 71.3,388
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,91.6,88.1 to 95.2,413
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,98.0,96.1 to 100.0,236
Polio,≥3 Doses,States/Local Areas,Kansas,2011,Age,19 Months,90.9,82.1 to 95.6,221
Hib,≥3 Doses,States/Local Areas,Kansas,2013,Age,13 Months,69.4,61.7 to 76.2,231
Hib,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,70.9,67.7 to 74.0,439
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,73.4,67.4 to 79.4,413
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,77.0,70.1 to 83.8,236
Polio,≥3 Doses,States/Local Areas,Kansas,2012,Age,19 Months,93.4,91.1 to 95.2,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2011,Age,7 Months,72.2,66.6 to 77.2,221
DTaP,≥3 Doses,States/Local Areas,Kansas,2012,Age,7 Months,69.2,61.6 to 76.0,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2013,Age,7 Months,71.5,68.4 to 74.4,231
DTaP,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,69.7,65.7 to 73.5,439
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2015,Age,0-3 Days,63.2,52.7 to 72.5,180
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2015-2016,Age,0-3 Days,69.5,62.9 to 75.3,481
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,98.4,96.8 to 99.9,134
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,92.3,89.5 to 95.1,527
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,91.1,87.3 to 94.9,315
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,89.1 to 94.5,612
PCV,≥3 Doses,States/Local Areas,Kansas,2012,Age,35 Months,95.5,90.7 to 98.2,224
PCV,≥3 Doses,States/Local Areas,Kansas,2013,Age,35 Months,95.5,91.5 to 98.0,231
PCV,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.1,92.4 to 98.3,439
PCV,≥3 Doses,States/Local Areas,Kansas,2011,Age,35 Months,91.5,85.8 to 95.6,221
PCV,≥3 Doses,States/Local Areas,Kansas,2019,Age,24 Months,92.3,87.6 to 95.7,358
Hib,≥2 Doses,States/Local Areas,Kansas,2015,Age,7 Months,90.0,82.9 to 94.4,180
Hib,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,88.7,84.2 to 92.0,481
Hib,≥2 Doses,States/Local Areas,Kansas,2017,Age,7 Months,87.8,81.9 to 91.9,354
Hib,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,89.5,85.9 to 92.3,749
Hib,≥2 Doses,States/Local Areas,Kansas,2016,Age,7 Months,87.3,80.9 to 91.7,301
Hib,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,87.5,83.4 to 90.7,655
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,94.1,91.6 to 96.5,527
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,87.0,81.3 to 92.7,209
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.0,71.8 to 98.1,35
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,72.6,51.4 to 93.8,35
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,91.5,85.8 to 97.2,174
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,74.1 to 96.5,84
Hib,≥3 Doses,States/Local Areas,Kansas,2018,Age,7 Months,38.5,32.3 to 45.2,395
Hib,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,41.0,36.2 to 45.9,753
Hib,≥3 Doses,States/Local Areas,Kansas,2017,Age,7 Months,42.2,35.7 to 49.0,354
Hib,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,40.4,35.8 to 45.1,749
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,90.8 to 96.8,320
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,94.6,90.3 to 98.8,174
Hib,≥2 Doses,States/Local Areas,Kansas,2014,Age,13 Months,95.1,90.6 to 97.5,208
Hib,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,94.6,91.1 to 96.8,388
Hib,≥2 Doses,States/Local Areas,Kansas,2016,Age,13 Months,91.6,86.0 to 95.1,301
Hib,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,92.0,88.6 to 94.5,655
Hib,≥2 Doses,States/Local Areas,Kansas,2015,Age,13 Months,94.1,87.8 to 97.3,180
Hib,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,92.9,89.1 to 95.5,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,76.6,67.3 to 85.8,174
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,69.2,46.1 to 92.2,35
DTaP,≥3 Doses,States/Local Areas,Kansas,2011,Age,13 Months,90.4,81.7 to 95.2,221
DTaP,≥3 Doses,States/Local Areas,Kansas,2017,Age,7 Months,73.5,67.0 to 79.2,354
DTaP,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,73.5,68.9 to 77.6,749
DTaP,≥3 Doses,States/Local Areas,Kansas,2019,Age,7 Months,78.5,71.7 to 84.0,358
DTaP,≥3 Doses,States/Local Areas,Kansas,2018,Age,7 Months,73.4,66.7 to 79.2,395
DTaP,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,75.9,71.2 to 80.0,753
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.3,71.4 to 97.2,35
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,79.9,72.6 to 87.2,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,78.0,68.1 to 87.9,134
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,73.4,68.4 to 78.5,527
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2019,Age,0-3 Days,81.7,75.3 to 86.7,358
Polio,≥1 Dose,States/Local Areas,Kansas,2019,Age,3 Months,88.6,82.9 to 92.6,358
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,91.3,84.0 to 98.6,134
PCV,≥3 Doses,States/Local Areas,Kansas,2019,Age,35 Months,92.7,88.0 to 96.1,358
Polio,≥1 Dose,States/Local Areas,Kansas,2018,Age,3 Months,88.6,83.3 to 92.4,395
Polio,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,3 Months,88.6,84.9 to 91.5,753
Polio,≥1 Dose,States/Local Areas,Kansas,2017,Age,3 Months,90.2,85.4 to 93.5,354
Polio,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,3 Months,89.4,86.0 to 92.1,749
Hib,≥3 Doses,States/Local Areas,Kansas,2016,Age,7 Months,38.1,31.3 to 45.5,301
Hib,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,40.1,35.3 to 45.1,655
Hib,≥3 Doses,States/Local Areas,Kansas,2015,Age,7 Months,38.1,29.1 to 48.0,180
Hib,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,38.1,32.3 to 44.3,481
Hib,≥3 Doses,States/Local Areas,Kansas,2014,Age,7 Months,44.8,36.2 to 53.7,208
Hib,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,41.4,35.1 to 48.1,388
PCV,≥3 Doses,States/Local Areas,Kansas,2018,Age,35 Months,91.8,87.2 to 95.3,395
PCV,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,92.3,89.1 to 94.8,753
PCV,≥3 Doses,States/Local Areas,Kansas,2017,Age,35 Months,91.9,87.1 to 95.3,354
PCV,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,91.9,88.7 to 94.4,749
Hib,≥2 Doses,States/Local Areas,Kansas,2013,Age,13 Months,95.1,90.8 to 97.5,231
Hib,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,95.1,93.2 to 96.4,439
DTaP,≥3 Doses,States/Local Areas,Kansas,2016,Age,7 Months,69.1,61.7 to 75.7,301
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,71.3,66.4 to 75.7,655
DTaP,≥3 Doses,States/Local Areas,Kansas,2015,Age,7 Months,68.8,59.2 to 77.0,180
DTaP,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,69.0,62.9 to 74.4,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2018,Age,0-3 Days,75.7,68.8 to 81.5,395
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2018-2019,Age,0-3 Days,78.7,74.1 to 82.7,753
Hib,≥2 Doses,States/Local Areas,Kansas,2011,Age,13 Months,92.8,82.8 to 97.2,221
Hib,≥2 Doses,States/Local Areas,Kansas,2012,Age,13 Months,95.0,93.2 to 96.4,224
Hib,≥2 Doses,States/Local Areas,Kansas,2019,Age,7 Months,92.0,87.2 to 95.2,358
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.7,90.1 to 97.4,270
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,87.6,82.6 to 92.6,315
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,90.9,88.4 to 93.4,905
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,84.4,78.6 to 90.1,256
Hib,≥2 Doses,States/Local Areas,Kansas,2019,Age,13 Months,93.5,89.1 to 96.2,358
Hib,≥2 Doses,States/Local Areas,Kansas,2017,Age,13 Months,92.4,87.7 to 95.4,354
Hib,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,93.5,90.5 to 95.5,749
Hib,≥2 Doses,States/Local Areas,Kansas,2018,Age,13 Months,94.5,90.3 to 96.9,395
Hib,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,94.0,91.2 to 96.0,753
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,78.0,71.3 to 84.8,256
DTaP,≥3 Doses,States/Local Areas,Kansas,2012,Age,13 Months,93.6,90.5 to 95.7,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2015,Age,13 Months,88.7,80.8 to 93.7,180
DTaP,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,88.0,83.2 to 91.5,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.4,61.0 to 75.9,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,79.2,73.3 to 85.2,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,79.1,73.1 to 85.1,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Overall,Overall,75.7,72.0 to 79.5,905
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,69.9 to 93.8,84
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.0,69.4 to 78.6,612
≥1 Dose MMR,,States/Local Areas,Kansas,2019,Age,19 Months,88.1,81.9 to 92.4,358
≥1 Dose MMR,,States/Local Areas,Kansas,2018,Age,19 Months,87.6,82.0 to 91.6,395
≥1 Dose MMR,,States/Local Areas,Kansas,2018-2019,Age,19 Months,94.0,91.2 to 96.0,753
PCV,≥4 Doses,States/Local Areas,Kansas,2011,Age,19 Months,76.9,68.0 to 83.9,221
PCV,≥4 Doses,States/Local Areas,Kansas,2012,Age,19 Months,83.1,78.5 to 86.8,224
PCV,≥4 Doses,States/Local Areas,Kansas,2013,Age,19 Months,81.0,75.7 to 85.4,231
PCV,≥4 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,82.2,78.6 to 85.3,439
Hep B,≥2 Doses,States/Local Areas,Kansas,2014,Age,13 Months,94.8,90.3 to 97.3,208
Hep B,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,94.0,90.4 to 96.3,388
Hib,≥1 Dose,States/Local Areas,Kansas,2014,Age,3 Months,87.0,80.4 to 91.7,208
Hib,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,3 Months,87.0,82.2 to 90.7,388
Hep B,≥2 Doses,States/Local Areas,Kansas,2015,Age,13 Months,93.3,86.7 to 96.7,180
Hep B,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,93.1,89.3 to 95.6,481
Hep B,≥2 Doses,States/Local Areas,Kansas,2016,Age,13 Months,93.0,87.9 to 96.0,301
Hep B,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,94.3,91.4 to 96.3,655
PCV,≥4 Doses,States/Local Areas,Kansas,2014,Age,35 Months,85.6,79.2 to 90.8,208
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,87.5,82.7 to 91.5,388
PCV,≥4 Doses,States/Local Areas,Kansas,2015,Age,35 Months,89.6,82.2 to 94.8,180
PCV,≥4 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,85.1,80.4 to 89.1,481
PCV,≥4 Doses,States/Local Areas,Kansas,2016,Age,35 Months,81.2,74.7 to 86.8,301
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,84.5,80.2 to 88.3,655
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,85.0,78.6 to 91.4,209
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.6,82.6 to 100.0,35
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,67.6,45.2 to 90.1,35
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,90.7,85.0 to 96.4,174
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.7,74.5 to 94.8,84
Hep B,≥3 Doses,States/Local Areas,Kansas,2019,Age,35 Months,95.7,92.5 to 97.9,358
PCV,≥3 Doses,States/Local Areas,Kansas,2017,Age,19 Months,91.5,86.3 to 94.8,354
PCV,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,90.8,87.3 to 93.5,749
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.0,86.8 to 93.2,612
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,90.2,86.2 to 94.3,320
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.8,85.8 to 95.8,270
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,96.1,93.4 to 98.8,236
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.9,84.8 to 95.1,270
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,85.5,80.4 to 90.5,315
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Overall,Overall,88.6,85.8 to 91.3,905
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,80.5,74.0 to 86.9,256
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,90.2,86.7 to 93.8,413
Hib,≥1 Dose,States/Local Areas,Kansas,2019,Age,3 Months,82.3,75.9 to 87.3,358
Hib,≥1 Dose,States/Local Areas,Kansas,2018,Age,3 Months,86.6,81.1 to 90.7,395
Hib,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,3 Months,84.5,80.4 to 87.9,753
PCV,≥3 Doses,States/Local Areas,Kansas,2013,Age,24 Months,93.4,88.5 to 96.7,231
PCV,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,92.6,89.3 to 95.2,439
Hib,≥2 Doses,States/Local Areas,Kansas,2017,Age,5 Months,80.1,73.9 to 85.2,354
Hib,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,5 Months,81.3,77.1 to 84.8,749
Hep B,≥3 Doses,States/Local Areas,Kansas,2020,Age,24 Months,89.9,84.6 to 94.0,368
PCV,≥3 Doses,States/Local Areas,Kansas,2012,Age,24 Months,95.5,90.7 to 98.2,224
PCV,≥3 Doses,States/Local Areas,Kansas,2014,Age,24 Months,91.8,86.9 to 95.5,208
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,91.9,88.3 to 94.8,388
PCV,≥3 Doses,States/Local Areas,Kansas,2015,Age,24 Months,92.0,86.2 to 96.0,180
PCV,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,91.3,87.6 to 94.2,481
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,77.9,70.4 to 85.3,209
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,78.7,69.2 to 88.2,134
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,64.8,42.4 to 87.2,35
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.9,58.4 to 93.4,35
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,84.0,76.7 to 91.2,174
PCV,≥1 Dose,States/Local Areas,Kansas,2013,Age,3 Months,86.9,81.3 to 91.0,231
PCV,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,3 Months,86.7,84.2 to 88.8,439
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,89.2,85.8 to 92.5,527
Hib,≥2 Doses,States/Local Areas,Kansas,2016,Age,5 Months,77.5,70.2 to 83.4,301
Hib,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,5 Months,78.8,74.1 to 82.8,655
Hib,≥2 Doses,States/Local Areas,Kansas,2015,Age,5 Months,79.7,71.4 to 86.0,180
Hib,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,5 Months,78.6,73.2 to 83.2,481
Hib,≥2 Doses,States/Local Areas,Kansas,2014,Age,5 Months,73.4,64.7 to 80.7,208
Hib,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,5 Months,76.6,69.2 to 82.6,388
Hib,≥2 Doses,States/Local Areas,Kansas,2013,Age,5 Months,78.7,75.7 to 81.4,231
Hib,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,5 Months,76.1,72.6 to 79.2,439
PCV,≥3 Doses,States/Local Areas,Kansas,2011,Age,24 Months,91.5,85.8 to 95.6,221
PCV,≥3 Doses,States/Local Areas,Kansas,2019,Age,19 Months,92.1,87.0 to 95.3,358
PCV,≥3 Doses,States/Local Areas,Kansas,2018,Age,19 Months,90.2,84.8 to 93.9,395
PCV,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,87.8,83.8 to 90.9,753
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",49.7,34.7 to 61.3,84
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,94.2,90.8 to 97.6,236
Hib,≥2 Doses,States/Local Areas,Kansas,2011,Age,5 Months,78.3,72.9 to 82.9,221
Hib,≥2 Doses,States/Local Areas,Kansas,2012,Age,5 Months,82.0,77.3 to 86.0,224
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,88.0,83.3 to 92.8,315
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Overall,Overall,89.8,87.1 to 92.4,905
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,83.7,77.5 to 89.8,256
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,91.3,87.9 to 94.7,413
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,94.9,91.4 to 98.3,236
PCV,≥1 Dose,States/Local Areas,Kansas,2011,Age,3 Months,87.9,78.7 to 93.4,221
PCV,≥1 Dose,States/Local Areas,Kansas,2012,Age,3 Months,90.5,86.7 to 93.3,224
Hib,Full Series,States/Local Areas,Kansas,2020,Age,24 Months,76.3,70.0 to 82.1,368
PCV,≥4 Doses,States/Local Areas,Kansas,2019,Age,35 Months,86.7,80.8 to 91.5,358
PCV,≥4 Doses,States/Local Areas,Kansas,2018,Age,35 Months,85.3,79.4 to 90.2,395
PCV,≥4 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,85.9,81.8 to 89.4,753
PCV,≥4 Doses,States/Local Areas,Kansas,2017,Age,35 Months,88.5,82.3 to 93.3,354
PCV,≥4 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,86.9,82.6 to 90.5,749
Hib,≥2 Doses,States/Local Areas,Kansas,2014,Age,7 Months,89.8,83.0 to 94.0,208
Hib,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,89.9,85.3 to 93.2,388
Hib,≥2 Doses,States/Local Areas,Kansas,2013,Age,7 Months,92.1,87.4 to 95.1,231
Hib,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,90.9,87.4 to 93.6,439
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.0,79.1 to 90.9,270
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,74.2,53.0 to 95.4,35
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,81.2,75.3 to 87.0,315
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,83.6,80.3 to 86.9,905
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,74.1,66.9 to 81.3,256
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,84.6,80.1 to 89.1,413
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,94.2,90.2 to 98.3,236
PCV,≥1 Dose,States/Local Areas,Kansas,2017,Age,3 Months,88.8,83.8 to 92.3,354
PCV,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,3 Months,88.5,85.0 to 91.2,749
PCV,≥1 Dose,States/Local Areas,Kansas,2016,Age,3 Months,82.7,75.8 to 87.9,301
PCV,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,3 Months,85.7,81.6 to 89.0,655
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.4,75.2 to 99.7,35
PCV,≥3 Doses,States/Local Areas,Kansas,2018,Age,24 Months,91.8,87.2 to 95.3,395
PCV,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,92.1,88.9 to 94.6,753
PCV,≥3 Doses,States/Local Areas,Kansas,2017,Age,24 Months,91.9,87.1 to 95.3,354
PCV,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,91.9,88.7 to 94.4,749
Hib,≥2 Doses,States/Local Areas,Kansas,2012,Age,7 Months,89.8,87.3 to 91.9,224
PCV,≥3 Doses,States/Local Areas,Kansas,2016,Age,24 Months,90.5,85.4 to 94.3,301
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,91.2,87.8 to 93.9,655
Hib,≥2 Doses,States/Local Areas,Kansas,2011,Age,7 Months,89.7,81.3 to 94.6,221
Hib,≥2 Doses,States/Local Areas,Kansas,2019,Age,5 Months,78.0,71.3 to 83.6,358
Hib,≥2 Doses,States/Local Areas,Kansas,2018,Age,5 Months,82.4,76.5 to 87.1,395
Hib,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,5 Months,80.2,75.9 to 84.0,753
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,84.3,79.0 to 89.5,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2012,Age,0-3 Days,84.1,77.9 to 88.8,224
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,91.5,87.1 to 95.9,209
PCV,≥1 Dose,States/Local Areas,Kansas,2018,Age,3 Months,88.2,82.8 to 92.0,395
PCV,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,3 Months,87.2,83.3 to 90.2,753
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2011,Age,0-3 Days,80.8,73.4 to 86.6,221
PCV,≥1 Dose,States/Local Areas,Kansas,2015,Age,3 Months,87.1,79.4 to 92.1,180
PCV,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,3 Months,84.9,80.0 to 88.8,481
PCV,≥1 Dose,States/Local Areas,Kansas,2014,Age,3 Months,86.4,79.7 to 91.2,208
PCV,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,3 Months,86.7,81.9 to 90.4,388
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.4,63.9 to 88.9,84
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.0,81.2 to 88.8,612
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014,Age,0-3 Days,75.3,67.5 to 81.7,208
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2014-2015,Age,0-3 Days,69.2,62.5 to 75.2,388
Polio,≥1 Dose,States/Local Areas,Kansas,2011,Age,3 Months,90.6,85.1 to 94.2,221
Polio,≥1 Dose,States/Local Areas,Kansas,2012,Age,3 Months,92.3,91.0 to 93.4,224
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,92.5,90.4 to 94.6,905
PCV,≥1 Dose,States/Local Areas,Kansas,2019,Age,3 Months,86.1,80.1 to 90.6,358
Polio,≥1 Dose,States/Local Areas,Kansas,2013,Age,3 Months,86.4,80.4 to 90.8,231
Polio,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,3 Months,87.0,84.7 to 88.9,439
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2013,Age,0-3 Days,79.7,72.5 to 85.4,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2013-2014,Age,0-3 Days,77.5,72.4 to 81.9,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.1,87.9 to 96.3,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016,Age,0-3 Days,76.1,69.2 to 81.8,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2017,Age,0-3 Days,80.6,76.3 to 84.3,655
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2017,Age,0-3 Days,89.8,84.2 to 93.5,216
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2017-2018,Age,0-3 Days,80.5,76.2 to 84.3,749
Polio,≥1 Dose,States/Local Areas,Kansas,2016,Age,3 Months,83.2,76.3 to 88.4,301
Polio,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,3 Months,86.6,82.6 to 89.9,655
Polio,≥1 Dose,States/Local Areas,Kansas,2015,Age,3 Months,87.8,80.2 to 92.8,180
Polio,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,3 Months,85.6,80.7 to 89.4,481
Polio,≥1 Dose,States/Local Areas,Kansas,2014,Age,3 Months,87.5,80.9 to 92.1,208
Polio,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,3 Months,87.7,82.9 to 91.3,388
Hib,≥3 Doses,States/Local Areas,Kansas,2013,Age,7 Months,40.2,36.3 to 44.2,231
Hib,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,42.5,39.8 to 45.2,439
Hib,≥3 Doses,States/Local Areas,Kansas,2011,Age,7 Months,59.2,52.4 to 65.6,221
Hib,≥3 Doses,States/Local Areas,Kansas,2012,Age,7 Months,48.6,40.2 to 57.2,224
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,93.3,90.5 to 96.2,413
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,96.2,93.5 to 98.9,236
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,88.4,83.5 to 93.2,256
DTaP,≥3 Doses,States/Local Areas,Kansas,2014,Age,7 Months,67.9,59.0 to 75.7,208
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,68.4,61.9 to 74.2,388
PCV,≥3 Doses,States/Local Areas,Kansas,2016,Age,35 Months,90.5,85.4 to 94.3,301
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,91.2,87.8 to 93.9,655
PCV,≥3 Doses,States/Local Areas,Kansas,2015,Age,35 Months,92.0,86.2 to 96.0,180
PCV,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,91.3,87.6 to 94.2,481
PCV,≥3 Doses,States/Local Areas,Kansas,2014,Age,35 Months,96.5,90.9 to 99.1,208
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,95.7,90.2 to 98.6,388
Hib,≥2 Doses,States/Local Areas,Kansas,2018,Age,7 Months,91.3,86.5 to 94.6,395
Hib,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,91.7,88.4 to 94.1,753
Hib,≥3 Doses,States/Local Areas,Kansas,2014,Age,24 Months,91.4,86.3 to 95.2,208
Hib,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,89.2,84.7 to 92.8,388
Hib,≥3 Doses,States/Local Areas,Kansas,2011,Age,24 Months,92.4,86.8 to 96.3,221
Hib,≥3 Doses,States/Local Areas,Kansas,2012,Age,24 Months,92.8,87.6 to 96.4,224
Hib,≥3 Doses,States/Local Areas,Kansas,2013,Age,24 Months,92.4,87.0 to 96.1,231
Hib,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,92.0,88.4 to 94.8,439
DTaP,≥4 Doses,States/Local Areas,Kansas,2012,Age,24 Months,82.4,75.4 to 88.4,224
DTaP,≥4 Doses,States/Local Areas,Kansas,2011,Age,24 Months,80.8,73.1 to 87.4,221
DTaP,≥4 Doses,States/Local Areas,Kansas,2019,Age,19 Months,71.0,63.8 to 77.2,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2013,Age,7 Months,74.1,68.0 to 79.4,231
Hep B,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,73.6,68.6 to 78.0,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2011,Age,7 Months,65.4,57.9 to 72.2,221
Hep B,≥3 Doses,States/Local Areas,Kansas,2012,Age,7 Months,68.9,65.6 to 72.1,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,93.7,90.9 to 96.5,413
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,98.6,96.8 to 100.0,236
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,84.8,79.1 to 90.6,256
Polio,≥2 Doses,States/Local Areas,Kansas,2014,Age,5 Months,73.2,64.4 to 80.4,208
Polio,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,5 Months,77.1,69.8 to 83.1,388
Polio,≥2 Doses,States/Local Areas,Kansas,2013,Age,5 Months,79.9,76.1 to 83.3,231
Polio,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,5 Months,76.6,72.2 to 80.5,439
Polio,≥2 Doses,States/Local Areas,Kansas,2011,Age,5 Months,78.0,72.3 to 82.8,221
Polio,≥2 Doses,States/Local Areas,Kansas,2012,Age,5 Months,84.1,79.9 to 87.5,224
Hep A,≥1 Dose,States/Local Areas,Kansas,2015,Age,35 Months,94.6,84.2 to 99.0,180
Hep A,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,35 Months,92.5,87.6 to 96.0,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2013,Age,24 Months,83.7,77.1 to 89.3,231
DTaP,≥4 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,82.6,77.7 to 86.9,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2016,Age,24 Months,58.4,50.9 to 66.0,301
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,54.5,49.4 to 59.8,655
Hep A,≥2 Doses,States/Local Areas,Kansas,2017,Age,24 Months,50.3,43.6 to 57.4,354
Hep A,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,50.6,45.7 to 55.6,749
DTaP,≥4 Doses,States/Local Areas,Kansas,2014,Age,24 Months,81.5,74.2 to 87.8,208
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,80.6,75.4 to 85.3,388
Hep A,≥2 Doses,States/Local Areas,Kansas,2018,Age,24 Months,50.9,43.8 to 58.4,395
Hep A,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,56.5,51.3 to 61.8,753
Polio,≥3 Doses,States/Local Areas,Kansas,2011,Age,35 Months,91.5,85.8 to 95.6,221
Hib,Full Series,States/Local Areas,Kansas,2017,Age,24 Months,80.4,74.3 to 85.9,354
Hib,Full Series,States/Local Areas,Kansas,2017-2018,Age,24 Months,80.1,75.9 to 83.9,749
Hib,Full Series,States/Local Areas,Kansas,2018,Age,24 Months,79.6,73.8 to 84.9,395
Hib,Full Series,States/Local Areas,Kansas,2018-2019,Age,24 Months,79.3,75.0 to 83.2,753
Polio,≥3 Doses,States/Local Areas,Kansas,2017,Age,24 Months,93.3,88.9 to 96.4,354
Polio,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,92.9,89.9 to 95.3,749
Hib,≥3 Doses,States/Local Areas,Kansas,2019,Age,19 Months,89.1,83.7 to 92.9,358
Polio,≥3 Doses,States/Local Areas,Kansas,2019,Age,24 Months,92.4,87.7 to 95.8,358
Polio,≥3 Doses,States/Local Areas,Kansas,2018,Age,24 Months,92.5,88.0 to 95.8,395
Polio,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,92.5,89.4 to 95.0,753
DTaP,≥3 Doses,States/Local Areas,Kansas,2012,Age,24 Months,96.0,91.4 to 98.6,224
Polio,≥2 Doses,States/Local Areas,Kansas,2020,Age,13 Months,91.6,86.4 to 94.9,368
DTaP,≥3 Doses,States/Local Areas,Kansas,2011,Age,24 Months,92.2,86.6 to 96.1,221
Hib,Full Series,States/Local Areas,Kansas,2015,Age,24 Months,81.1,72.9 to 88.0,180
Hib,Full Series,States/Local Areas,Kansas,2015-2016,Age,24 Months,79.1,73.8 to 84.0,481
DTaP,≥3 Doses,States/Local Areas,Kansas,2013,Age,24 Months,93.4,88.7 to 96.7,231
DTaP,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,93.4,90.2 to 95.9,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2013,Age,24 Months,58.4,50.3 to 66.8,231
Hep A,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,55.2,49.2 to 61.3,439
DTaP,≥4 Doses,States/Local Areas,Kansas,2018,Age,19 Months,70.2,63.4 to 76.3,395
DTaP,≥4 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,94.3,91.4 to 96.2,753
DTaP,≥4 Doses,States/Local Areas,Kansas,2017,Age,19 Months,68.3,61.3 to 74.6,354
DTaP,≥4 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,69.3,64.4 to 73.7,749
DTaP,≥4 Doses,States/Local Areas,Kansas,2016,Age,19 Months,65.4,57.6 to 72.4,301
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,66.8,61.6 to 71.6,655
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,93.2,88.4 to 98.0,174
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,80.7 to 98.2,84
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,89.7 to 97.3,270
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,90.0,85.6 to 94.4,315
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.7,90.0 to 95.4,612
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,92.5,88.8 to 96.2,320
PCV,≥2 Doses,States/Local Areas,Kansas,2019,Age,5 Months,81.9,75.4 to 87.0,358
PCV,≥2 Doses,States/Local Areas,Kansas,2018,Age,5 Months,82.9,77.0 to 87.6,395
PCV,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,5 Months,82.4,78.2 to 86.0,753
Hep A,≥2 Doses,States/Local Areas,Kansas,2014,Age,24 Months,52.2,43.6 to 61.3,208
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,51.1,44.6 to 58.0,388
Hep A,≥2 Doses,States/Local Areas,Kansas,2015,Age,24 Months,50.0,40.5 to 60.4,180
Hep A,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,54.1,48.0 to 60.5,481
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,92.1,89.8 to 94.4,905
Hep A,≥2 Doses,States/Local Areas,Kansas,2014,Age,35 Months,78.6,68.3 to 87.4,208
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,77.8,70.0 to 84.8,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2019,Age,7 Months,76.1,69.6 to 81.6,358
Polio,≥2 Doses,States/Local Areas,Kansas,2013,Age,7 Months,92.1,87.4 to 95.1,231
Polio,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,90.2,85.1 to 93.6,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2015,Age,35 Months,74.0,63.9 to 83.2,180
Hep A,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,78.0,71.7 to 83.7,481
Hep A,≥2 Doses,States/Local Areas,Kansas,2016,Age,35 Months,80.3,72.7 to 86.8,301
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,81.7,75.9 to 86.9,655
Hep B,≥3 Doses,States/Local Areas,Kansas,2018,Age,7 Months,70.8,64.0 to 76.7,395
Hep B,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,73.4,68.8 to 77.6,753
Hep B,≥3 Doses,States/Local Areas,Kansas,2017,Age,7 Months,70.1,63.4 to 76.0,354
Hep B,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,70.4,65.7 to 74.7,749
Polio,≥2 Doses,States/Local Areas,Kansas,2011,Age,7 Months,89.6,81.6 to 94.4,221
Polio,≥2 Doses,States/Local Areas,Kansas,2012,Age,7 Months,90.1,86.1 to 93.0,224
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,86.4,79.9 to 92.9,174
Polio,≥2 Doses,States/Local Areas,Kansas,2019,Age,5 Months,85.0,78.9 to 89.5,358
≥1 Dose Varicella,,States/Local Areas,Kansas,2013,Age,13 Months,66.6,62.1 to 70.8,231
≥1 Dose Varicella,,States/Local Areas,Kansas,2013-2014,Age,13 Months,64.5,59.5 to 69.3,439
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.6,82.6 to 100.0,35
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,92.8,87.4 to 98.3,134
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,64.6,42.1 to 87.1,35
Polio,≥2 Doses,States/Local Areas,Kansas,2018,Age,5 Months,83.9,78.2 to 88.4,395
Polio,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,5 Months,84.5,80.4 to 87.8,753
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,89.2,85.8 to 92.6,527
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,81.0,74.2 to 87.9,209
Hep A,≥1 Dose,States/Local Areas,Kansas,2019,Age,35 Months,93.1,87.4 to 96.8,358
≥1 Dose Varicella,,States/Local Areas,Kansas,2012,Age,13 Months,50.6,46.8 to 54.4,224
≥1 Dose Varicella,,States/Local Areas,Kansas,2015,Age,13 Months,58.9,49.0 to 68.0,180
≥1 Dose Varicella,,States/Local Areas,Kansas,2015-2016,Age,13 Months,59.6,53.4 to 65.5,481
≥1 Dose Varicella,,States/Local Areas,Kansas,2014,Age,13 Months,62.5,53.6 to 70.5,208
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2015,Age,13 Months,60.7,54.1 to 66.9,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2015,Age,7 Months,70.9,61.4 to 78.8,180
Hep B,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,69.3,63.3 to 74.6,481
Hep B,≥3 Doses,States/Local Areas,Kansas,2014,Age,7 Months,73.1,64.7 to 80.0,208
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,72.0,65.8 to 77.4,388
Polio,≥2 Doses,States/Local Areas,Kansas,2017,Age,5 Months,81.0,74.9 to 85.9,354
Polio,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,5 Months,82.5,78.4 to 85.9,749
Polio,≥2 Doses,States/Local Areas,Kansas,2016,Age,5 Months,77.9,70.7 to 83.8,301
Polio,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,5 Months,79.4,74.8 to 83.4,655
Hib,Primary Series,States/Local Areas,Kansas,2020,Age,24 Months,92.6,88.1 to 95.9,368
Hib,≥3 Doses,States/Local Areas,Kansas,2019,Age,35 Months,92.0,87.1 to 95.5,358
Hep A,≥1 Dose,States/Local Areas,Kansas,2014,Age,35 Months,97.6,93.1 to 99.5,208
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,35 Months,96.1,91.3 to 98.6,388
Hep A,≥1 Dose,States/Local Areas,Kansas,2013,Age,35 Months,93.1,87.7 to 96.7,231
Hep A,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.3,92.3 to 98.6,439
≥1 Dose Varicella,,States/Local Areas,Kansas,2011,Age,13 Months,54.9,47.0 to 62.7,221
Hep A,≥1 Dose,States/Local Areas,Kansas,2018,Age,35 Months,90.3,85.2 to 94.2,395
Hep A,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,35 Months,91.6,87.9 to 94.6,753
Hep A,≥1 Dose,States/Local Areas,Kansas,2017,Age,35 Months,95.4,89.2 to 98.6,354
Hep A,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,35 Months,92.2,88.7 to 95.0,749
Hep A,≥1 Dose,States/Local Areas,Kansas,2016,Age,35 Months,92.3,86.9 to 96.0,301
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,35 Months,93.5,89.8 to 96.2,655
Hep A,≥2 Doses,States/Local Areas,Kansas,2013,Age,35 Months,82.1,74.0 to 88.8,231
Hep A,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,80.8,73.8 to 86.9,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2012,Age,35 Months,79.3,70.5 to 86.9,224
Hep A,≥2 Doses,States/Local Areas,Kansas,2011,Age,35 Months,73.3,62.4 to 83.1,221
Polio,≥3 Doses,States/Local Areas,Kansas,2014,Age,24 Months,92.4,87.5 to 95.9,208
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,92.3,88.7 to 95.1,388
Polio,≥3 Doses,States/Local Areas,Kansas,2015,Age,24 Months,92.1,86.5 to 96.0,180
Polio,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,90.8,87.1 to 93.9,481
Polio,≥3 Doses,States/Local Areas,Kansas,2016,Age,24 Months,89.4,84.1 to 93.6,301
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,91.4,88.0 to 94.1,655
Hib,≥3 Doses,States/Local Areas,Kansas,2017,Age,19 Months,86.9,81.1 to 91.2,354
Hib,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,88.4,84.6 to 91.3,749
Hib,≥3 Doses,States/Local Areas,Kansas,2018,Age,19 Months,89.8,84.6 to 93.4,395
Hib,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,60.8,55.7 to 65.6,753
DTaP,≥3 Doses,States/Local Areas,Kansas,2018,Age,19 Months,92.1,87.0 to 95.3,395
DTaP,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,89.6,85.9 to 92.4,753
DTaP,≥3 Doses,States/Local Areas,Kansas,2019,Age,19 Months,92.2,87.1 to 95.4,358
DTaP,≥3 Doses,States/Local Areas,Kansas,2017,Age,19 Months,92.9,88.1 to 95.9,354
DTaP,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,92.5,89.2 to 94.9,749
Polio,≥3 Doses,States/Local Areas,Kansas,2013,Age,24 Months,93.5,88.7 to 96.8,231
Polio,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,93.0,89.7 to 95.5,439
Hib,≥3 Doses,States/Local Areas,Kansas,2014,Age,19 Months,89.1,82.9 to 93.3,208
Hib,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,88.0,83.1 to 91.6,388
Polio,≥3 Doses,States/Local Areas,Kansas,2012,Age,24 Months,95.1,90.4 to 97.9,224
Polio,≥3 Doses,States/Local Areas,Kansas,2011,Age,24 Months,90.9,85.1 to 95.1,221
Polio,≥3 Doses,States/Local Areas,Kansas,2019,Age,19 Months,92.2,87.1 to 95.4,358
Hib,≥3 Doses,States/Local Areas,Kansas,2016,Age,19 Months,82.4,75.6 to 87.6,301
Hib,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,84.6,80.3 to 88.2,655
Hib,≥3 Doses,States/Local Areas,Kansas,2015,Age,19 Months,86.9,82.3 to 90.4,180
Hib,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,84.7,79.6 to 88.7,481
DTaP,≥3 Doses,States/Local Areas,Kansas,2015,Age,19 Months,92.1,88.9 to 94.5,180
DTaP,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,90.8,86.7 to 93.7,481
DTaP,≥3 Doses,States/Local Areas,Kansas,2014,Age,19 Months,92.4,87.0 to 95.7,208
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,92.3,88.4 to 94.9,388
Polio,≥3 Doses,States/Local Areas,Kansas,2012,Age,35 Months,95.6,90.7 to 98.3,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2016,Age,19 Months,89.3,83.4 to 93.3,301
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,91.1,87.5 to 93.8,655
Polio,≥3 Doses,States/Local Areas,Kansas,2013,Age,35 Months,96.1,92.1 to 98.4,231
Polio,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.8,92.8 to 98.8,439
Polio,≥3 Doses,States/Local Areas,Kansas,2014,Age,35 Months,97.9,92.3 to 99.7,208
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,97.0,92.7 to 99.1,388
Hib,Full Series,States/Local Areas,Kansas,2012,Age,35 Months,91.5,85.1 to 95.9,224
Hib,Full Series,States/Local Areas,Kansas,2011,Age,35 Months,82.6,69.5 to 92.4,221
Hib,Full Series,States/Local Areas,Kansas,2013,Age,35 Months,83.0,76.3 to 88.6,231
Hib,Full Series,States/Local Areas,Kansas,2013-2014,Age,35 Months,88.0,82.3 to 92.5,439
Hib,Full Series,States/Local Areas,Kansas,2019,Age,24 Months,78.9,72.5 to 84.7,358
DTaP,≥2 Doses,States/Local Areas,Kansas,2011,Age,5 Months,79.0,73.7 to 83.5,221
DTaP,≥2 Doses,States/Local Areas,Kansas,2012,Age,5 Months,84.4,80.7 to 87.6,224
DTaP,≥2 Doses,States/Local Areas,Kansas,2013,Age,5 Months,80.0,74.6 to 84.5,231
DTaP,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,5 Months,77.4,72.9 to 81.4,439
DTaP,≥2 Doses,States/Local Areas,Kansas,2015,Age,5 Months,81.0,72.8 to 87.2,180
DTaP,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,5 Months,79.5,74.2 to 84.0,481
DTaP,≥2 Doses,States/Local Areas,Kansas,2016,Age,5 Months,78.0,70.8 to 83.9,301
DTaP,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,5 Months,79.6,74.9 to 83.5,655
Polio,≥3 Doses,States/Local Areas,Kansas,2016,Age,35 Months,90.3,85.2 to 94.3,301
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,91.9,88.6 to 94.6,655
Polio,≥3 Doses,States/Local Areas,Kansas,2017,Age,35 Months,93.5,89.1 to 96.6,354
Polio,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,93.1,90.1 to 95.5,749
DTaP,≥2 Doses,States/Local Areas,Kansas,2014,Age,5 Months,74.8,66.2 to 81.8,208
DTaP,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,5 Months,77.9,71.2 to 83.4,388
Polio,≥3 Doses,States/Local Areas,Kansas,2015,Age,35 Months,95.7,90.1 to 98.6,180
Polio,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,92.5,88.9 to 95.2,481
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.0,71.8 to 98.1,35
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,86.3,82.7 to 89.9,527
Polio,≥3 Doses,States/Local Areas,Kansas,2018,Age,35 Months,92.6,88.1 to 95.9,395
Polio,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,93.3,90.1 to 95.8,753
Polio,≥3 Doses,States/Local Areas,Kansas,2019,Age,35 Months,94.3,89.5 to 97.4,358
Hib,Full Series,States/Local Areas,Kansas,2017,Age,35 Months,85.7,78.9 to 91.1,354
Hib,Full Series,States/Local Areas,Kansas,2017-2018,Age,35 Months,83.2,78.8 to 87.2,749
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,94.2,91.8 to 96.6,527
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,87.0,81.3 to 92.7,209
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,94.5,89.7 to 99.3,134
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,74.2,53.0 to 95.4,35
Hib,Full Series,States/Local Areas,Kansas,2016,Age,35 Months,79.1,72.1 to 85.3,301
Hib,Full Series,States/Local Areas,Kansas,2016-2017,Age,35 Months,81.9,77.2 to 86.1,655
Hib,Full Series,States/Local Areas,Kansas,2019,Age,35 Months,80.0,73.6 to 85.7,358
Hib,Full Series,States/Local Areas,Kansas,2018,Age,35 Months,81.1,75.1 to 86.4,395
Hib,Full Series,States/Local Areas,Kansas,2018-2019,Age,35 Months,80.6,76.3 to 84.6,753
Hib,Full Series,States/Local Areas,Kansas,2015,Age,35 Months,84.4,75.8 to 91.2,180
Hib,Full Series,States/Local Areas,Kansas,2015-2016,Age,35 Months,81.7,76.4 to 86.4,481
Hib,Full Series,States/Local Areas,Kansas,2014,Age,35 Months,91.7,83.6 to 96.7,208
Hib,Full Series,States/Local Areas,Kansas,2014-2015,Age,35 Months,89.0,82.6 to 93.9,388
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.6,53.5 to 87.8,35
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,73.8,65.9 to 81.8,209
Hep A,≥2 Doses,States/Local Areas,Kansas,2017,Age,35 Months,85.6,74.5 to 93.6,354
Hep A,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,79.5,73.0 to 85.3,749
Hep A,≥2 Doses,States/Local Areas,Kansas,2018,Age,35 Months,74.3,66.1 to 81.9,395
Hep A,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,78.2,72.8 to 83.2,753
Hep B,≥3 Doses,States/Local Areas,Kansas,2014,Age,13 Months,92.4,87.4 to 95.5,208
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,90.4,86.3 to 93.4,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2013,Age,13 Months,91.1,86.9 to 94.0,231
Hep B,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,91.7,89.6 to 93.4,439
DTaP,≥4 Doses,States/Local Areas,Kansas,2013,Age,35 Months,87.7,81.2 to 92.7,231
DTaP,≥4 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,88.2,83.1 to 92.3,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2012,Age,13 Months,89.4,83.8 to 93.2,224
Hep A,≥2 Doses,States/Local Areas,Kansas,2019,Age,35 Months,82.2,75.0 to 88.4,358
DTaP,≥4 Doses,States/Local Areas,Kansas,2014,Age,35 Months,88.6,80.3 to 94.5,208
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,86.9,81.2 to 91.6,388
DTaP,≥4 Doses,States/Local Areas,Kansas,2015,Age,35 Months,84.5,76.7 to 90.8,180
DTaP,≥4 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,82.0,76.9 to 86.6,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2012,Age,35 Months,92.6,86.2 to 96.8,224
≥1 Dose Varicella,,States/Local Areas,Kansas,2018,Age,13 Months,56.0,49.0 to 62.8,395
≥1 Dose Varicella,,States/Local Areas,Kansas,2018-2019,Age,13 Months,58.2,53.1 to 63.1,753
≥1 Dose MMR,,States/Local Areas,Kansas,2016,Age,13 Months,67.3,59.9 to 74.0,301
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2017,Age,13 Months,69.1,64.3 to 73.6,655
≥1 Dose Varicella,,States/Local Areas,Kansas,2012,Age,19 Months,89.6,85.3 to 92.8,224
≥1 Dose Varicella,,States/Local Areas,Kansas,2013,Age,19 Months,88.9,83.1 to 92.9,231
≥1 Dose Varicella,,States/Local Areas,Kansas,2013-2014,Age,19 Months,89.9,87.2 to 92.0,439
≥1 Dose Varicella,,States/Local Areas,Kansas,2011,Age,19 Months,84.5,81.6 to 87.1,221
≥1 Dose Varicella,,States/Local Areas,Kansas,2019,Age,13 Months,60.4,53.1 to 67.3,358
≥1 Dose MMR,,States/Local Areas,Kansas,2015,Age,13 Months,63.7,53.7 to 72.6,180
≥1 Dose MMR,,States/Local Areas,Kansas,2015-2016,Age,13 Months,65.4,59.3 to 71.1,481
≥1 Dose MMR,,States/Local Areas,Kansas,2014,Age,13 Months,65.5,56.7 to 73.3,208
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2015,Age,13 Months,64.6,58.0 to 70.6,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2011,Age,13 Months,86.1,77.9 to 91.6,221
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,87.8,83.7 to 91.9,413
Polio,≥2 Doses,States/Local Areas,Kansas,2016,Age,7 Months,87.2,80.8 to 91.7,301
Polio,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,88.3,84.2 to 91.4,655
Polio,≥2 Doses,States/Local Areas,Kansas,2015,Age,7 Months,90.0,82.9 to 94.4,180
Polio,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,88.6,84.1 to 92.0,481
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Overall,Overall,86.8,83.9 to 89.7,905
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,79.5,73.1 to 86.0,256
Polio,≥2 Doses,States/Local Areas,Kansas,2014,Age,7 Months,88.2,81.0 to 92.9,208
Polio,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,89.1,84.4 to 92.6,388
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.0,81.5 to 92.4,270
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,84.1,78.8 to 89.4,315
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.8,84.3 to 91.3,612
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,88.6,84.1 to 93.0,320
Hep A,≥2 Doses,States/Local Areas,Kansas,2019,Age,24 Months,62.3,54.9 to 69.6,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2016,Age,7 Months,67.6,60.1 to 74.3,301
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,68.8,63.9 to 73.4,655
Polio,≥2 Doses,States/Local Areas,Kansas,2015,Age,5 Months,81.0,72.8 to 87.2,180
Polio,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,5 Months,79.5,74.1 to 84.0,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2015,Age,24 Months,79.6,72.1 to 86.2,180
DTaP,≥4 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,77.8,72.6 to 82.6,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2016,Age,24 Months,75.8,68.6 to 82.4,301
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,76.9,72.1 to 81.4,655
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.9,66.4 to 89.3,84
≥1 Dose Varicella,,States/Local Areas,Kansas,2017,Age,13 Months,63.6,56.9 to 69.9,354
≥1 Dose Varicella,,States/Local Areas,Kansas,2017-2018,Age,13 Months,59.9,55.0 to 64.6,749
≥1 Dose Varicella,,States/Local Areas,Kansas,2016,Age,13 Months,60.4,52.8 to 67.5,301
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2017,Age,13 Months,62.0,56.9 to 66.8,655
Hep B,≥1 Dose,States/Local Areas,Kansas,2017,Age,3 Months,97.8,96.0 to 98.8,354
Hep B,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,3 Months,96.8,95.0 to 98.0,749
Hep B,≥1 Dose,States/Local Areas,Kansas,2016,Age,3 Months,94.6,90.6 to 96.9,301
Hep B,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,3 Months,96.2,94.1 to 97.5,655
Hep B,≥1 Dose,States/Local Areas,Kansas,2015,Age,3 Months,93.8,87.2 to 97.1,180
Hep B,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,3 Months,94.2,90.7 to 96.4,481
Polio,≥2 Doses,States/Local Areas,Kansas,2014,Age,13 Months,95.1,90.6 to 97.5,208
Polio,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,95.3,92.2 to 97.2,388
Polio,≥2 Doses,States/Local Areas,Kansas,2013,Age,13 Months,94.6,90.6 to 97.0,231
Polio,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,94.9,93.1 to 96.2,439
Polio,≥2 Doses,States/Local Areas,Kansas,2011,Age,13 Months,92.3,82.6 to 96.8,221
Polio,≥2 Doses,States/Local Areas,Kansas,2012,Age,13 Months,95.6,93.4 to 97.1,224
≥1 Dose Varicella,,States/Local Areas,Kansas,2016,Age,19 Months,86.7,81.1 to 90.9,301
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2017,Age,19 Months,88.9,85.5 to 91.6,655
≥1 Dose Varicella,,States/Local Areas,Kansas,2015,Age,19 Months,83.3,74.7 to 89.5,180
≥1 Dose Varicella,,States/Local Areas,Kansas,2015-2016,Age,19 Months,85.0,80.0 to 88.9,481
≥1 Dose Varicella,,States/Local Areas,Kansas,2014,Age,19 Months,90.9,85.6 to 94.3,208
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2015,Age,19 Months,87.1,82.2 to 90.8,388
≥1 Dose MMR,,States/Local Areas,Kansas,2019,Age,13 Months,67.9,60.5 to 74.5,358
≥1 Dose MMR,,States/Local Areas,Kansas,2018,Age,13 Months,62.8,55.8 to 69.3,395
≥1 Dose MMR,,States/Local Areas,Kansas,2018-2019,Age,13 Months,65.3,60.3 to 70.1,753
≥1 Dose MMR,,States/Local Areas,Kansas,2017,Age,13 Months,71.0,64.5 to 76.8,354
≥1 Dose MMR,,States/Local Areas,Kansas,2017-2018,Age,13 Months,67.0,62.2 to 71.4,749
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.7,49.0 to 94.4,35
≥1 Dose MMR,,States/Local Areas,Kansas,2011,Age,13 Months,56.5,50.4 to 62.4,221
≥1 Dose MMR,,States/Local Areas,Kansas,2012,Age,13 Months,54.8,48.9 to 60.6,224
≥1 Dose MMR,,States/Local Areas,Kansas,2013,Age,13 Months,66.0,62.6 to 69.3,231
≥1 Dose MMR,,States/Local Areas,Kansas,2013-2014,Age,13 Months,65.7,62.5 to 68.8,439
DTaP,≥4 Doses,States/Local Areas,Kansas,2017,Age,24 Months,78.1,71.5 to 84.0,354
DTaP,≥4 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,78.4,73.9 to 82.6,749
DTaP,≥4 Doses,States/Local Areas,Kansas,2018,Age,24 Months,78.7,72.4 to 84.4,395
DTaP,≥4 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,79.1,74.5 to 83.3,753
DTaP,≥4 Doses,States/Local Areas,Kansas,2011,Age,35 Months,88.2,77.2 to 95.5,221
DTaP,≥4 Doses,States/Local Areas,Kansas,2019,Age,24 Months,79.5,72.7 to 85.5,358
Hib,Full Series,States/Local Areas,Kansas,2016,Age,24 Months,77.1,70.0 to 83.5,301
Hib,Full Series,States/Local Areas,Kansas,2016-2017,Age,24 Months,78.7,74.1 to 83.0,655
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.7,72.1 to 89.3,270
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,67.2,57.6 to 76.9,256
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,78.3,72.7 to 83.9,905
Polio,≥2 Doses,States/Local Areas,Kansas,2019,Age,7 Months,92.3,87.4 to 95.4,358
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.5,77.6 to 91.5,612
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,73.6,60.6 to 86.5,315
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,79.8,71.7 to 87.9,320
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,81.7,76.1 to 87.3,527
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,68.9,58.3 to 79.6,209
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,85.5,71.2 to 99.7,134
Hep B,≥3 Doses,States/Local Areas,Kansas,2015,Age,19 Months,89.8,83.7 to 93.8,180
Hep B,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,89.4,85.2 to 92.6,481
Hep B,≥3 Doses,States/Local Areas,Kansas,2014,Age,19 Months,93.9,89.3 to 96.5,208
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,91.8,87.9 to 94.6,388
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,85.8,78.9 to 92.7,236
Hep B,≥3 Doses,States/Local Areas,Kansas,2013,Age,19 Months,93.5,91.6 to 95.0,231
Hep B,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,93.7,92.4 to 94.8,439
Hep B,≥2 Doses,States/Local Areas,Kansas,2013,Age,5 Months,90.5,86.7 to 93.3,231
Hep B,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,5 Months,90.9,89.1 to 92.4,439
Hep B,≥2 Doses,States/Local Areas,Kansas,2011,Age,5 Months,90.8,83.8 to 94.9,221
Hep B,≥2 Doses,States/Local Areas,Kansas,2012,Age,5 Months,91.3,88.9 to 93.1,224
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2011,Age,0-1 Days,75.0,65.0 to 82.8,221
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,81.0,72.2 to 89.7,413
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2012,Age,0-1 Days,80.8,77.3 to 83.8,224
Hep B,≥1 Dose,States/Local Areas,Kansas,2019,Age,3 Months,96.6,92.0 to 98.6,358
Hep B,≥1 Dose,States/Local Areas,Kansas,2018,Age,3 Months,95.8,92.3 to 97.8,395
Hep B,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,3 Months,96.2,93.7 to 97.8,753
≥1 Dose Varicella,,States/Local Areas,Kansas,2012,Age,24 Months,92.5,87.2 to 96.2,224
≥1 Dose Varicella,,States/Local Areas,Kansas,2011,Age,24 Months,89.3,83.2 to 94.0,221
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,71.0,63.7 to 78.3,256
≥1 Dose MMR,,States/Local Areas,Kansas,2017,Age,19 Months,91.7,87.4 to 94.6,354
≥1 Dose MMR,,States/Local Areas,Kansas,2017-2018,Age,19 Months,89.6,86.3 to 92.3,749
≥1 Dose MMR,,States/Local Areas,Kansas,2016,Age,19 Months,87.6,82.0 to 91.7,301
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2017,Age,19 Months,89.6,86.2 to 92.2,655
≥1 Dose MMR,,States/Local Areas,Kansas,2015,Age,19 Months,87.3,79.6 to 92.4,180
≥1 Dose MMR,,States/Local Areas,Kansas,2015-2016,Age,19 Months,87.5,82.9 to 90.9,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.0,73.8 to 86.3,270
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,78.8,72.8 to 84.8,320
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,76.2,69.9 to 82.6,315
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,78.4,74.8 to 82.0,905
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.4,61.7 to 87.0,84
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.9,75.5 to 84.2,612
Polio,≥2 Doses,States/Local Areas,Kansas,2017,Age,13 Months,94.0,89.6 to 96.5,354
Polio,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,94.3,91.5 to 96.2,749
Polio,≥2 Doses,States/Local Areas,Kansas,2016,Age,13 Months,91.1,85.3 to 94.8,301
Polio,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,92.5,89.1 to 94.9,655
Polio,≥2 Doses,States/Local Areas,Kansas,2015,Age,13 Months,95.5,90.3 to 98.0,180
Polio,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,93.4,89.8 to 95.8,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,78.8,70.9 to 86.7,174
≥1 Dose Varicella,,States/Local Areas,Kansas,2018,Age,19 Months,86.9,81.3 to 91.0,395
≥1 Dose Varicella,,States/Local Areas,Kansas,2018-2019,Age,19 Months,58.2,53.1 to 63.1,753
≥1 Dose Varicella,,States/Local Areas,Kansas,2017,Age,19 Months,91.2,86.9 to 94.2,354
≥1 Dose Varicella,,States/Local Areas,Kansas,2017-2018,Age,19 Months,89.0,85.7 to 91.7,749
≥1 Dose MMR,,States/Local Areas,Kansas,2012,Age,19 Months,89.2,86.7 to 91.2,224
≥1 Dose MMR,,States/Local Areas,Kansas,2014,Age,19 Months,90.9,85.6 to 94.4,208
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2015,Age,19 Months,89.1,84.7 to 92.4,388
≥1 Dose MMR,,States/Local Areas,Kansas,2013,Age,19 Months,89.3,85.9 to 91.9,231
≥1 Dose MMR,,States/Local Areas,Kansas,2013-2014,Age,19 Months,90.1,88.6 to 91.4,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2011,Age,19 Months,88.7,80.4 to 93.7,221
Hep B,≥3 Doses,States/Local Areas,Kansas,2019,Age,13 Months,88.7,83.2 to 92.5,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2018,Age,13 Months,90.2,84.9 to 93.7,395
Hep B,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,89.4,85.8 to 92.2,753
Hep A,≥1 Dose,States/Local Areas,Kansas,2020,Age,35 Months,91.8,85.3 to 96.1,368
Hep B,≥3 Doses,States/Local Areas,Kansas,2012,Age,19 Months,92.6,88.7 to 95.2,224
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.7,45.0 to 84.4,35
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,76.6,66.8 to 86.4,134
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,52.2,29.3 to 75.2,35
≥1 Dose MMR,,States/Local Areas,Kansas,2011,Age,19 Months,85.6,81.0 to 89.2,221
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,83.1,78.8 to 87.4,527
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,73.6,66.0 to 81.2,209
DTaP,≥4 Doses,States/Local Areas,Kansas,2019,Age,35 Months,86.7,80.2 to 91.9,358
Polio,≥2 Doses,States/Local Areas,Kansas,2018,Age,7 Months,91.9,87.1 to 95.0,395
Polio,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,92.1,88.9 to 94.5,753
Polio,≥2 Doses,States/Local Areas,Kansas,2017,Age,7 Months,89.4,83.8 to 93.1,354
Polio,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,90.6,87.1 to 93.2,749
Hep B,≥1 Dose,States/Local Areas,Kansas,2014,Age,3 Months,95.4,90.8 to 97.7,208
Hep B,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,3 Months,94.6,90.9 to 96.8,388
Hep B,≥1 Dose,States/Local Areas,Kansas,2011,Age,3 Months,97.0,88.0 to 99.3,221
Hep B,≥1 Dose,States/Local Areas,Kansas,2012,Age,3 Months,95.1,90.9 to 97.4,224
Hep B,≥1 Dose,States/Local Areas,Kansas,2013,Age,3 Months,95.6,92.4 to 97.5,231
Hep B,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,3 Months,95.5,92.8 to 97.2,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,74.7,63.4 to 86.0,174
Hep B,≥3 Doses,States/Local Areas,Kansas,2017,Age,13 Months,90.2,85.0 to 93.7,354
Hep B,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,90.2,86.7 to 92.8,749
Hep B,≥3 Doses,States/Local Areas,Kansas,2015,Age,13 Months,88.5,81.4 to 93.1,180
Hep B,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,87.4,82.9 to 90.8,481
Hep B,≥3 Doses,States/Local Areas,Kansas,2016,Age,13 Months,86.2,79.9 to 90.8,301
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,88.2,84.2 to 91.2,655
DTaP,≥4 Doses,States/Local Areas,Kansas,2016,Age,35 Months,79.7,72.6 to 86.0,301
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,83.7,78.7 to 88.0,655
DTaP,≥4 Doses,States/Local Areas,Kansas,2017,Age,35 Months,90.1,82.2 to 95.4,354
DTaP,≥4 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,86.7,81.8 to 90.8,749
DTaP,≥4 Doses,States/Local Areas,Kansas,2018,Age,35 Months,84.0,77.5 to 89.4,395
DTaP,≥4 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,85.3,80.8 to 89.2,753
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,42.8,18.0 to 67.5,35
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2015,Age,0-1 Days,60.3,50.0 to 69.7,180
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2015-2016,Age,0-1 Days,66.1,59.6 to 72.1,481
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2014,Age,0-1 Days,72.1,64.0 to 79.0,208
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2014-2015,Age,0-1 Days,66.2,59.5 to 72.3,388
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2013,Age,0-1 Days,76.9,73.6 to 79.8,231
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2013-2014,Age,0-1 Days,74.5,70.9 to 77.8,439
Hep B,≥2 Doses,States/Local Areas,Kansas,2014,Age,5 Months,91.3,85.5 to 94.9,208
Hep B,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,5 Months,89.8,87.3 to 91.9,388
Hep B,≥2 Doses,States/Local Areas,Kansas,2016,Age,5 Months,87.9,81.9 to 92.1,301
Hep B,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,5 Months,90.8,87.3 to 93.4,655
Hep B,≥3 Doses,States/Local Areas,Kansas,2018,Age,19 Months,92.2,87.3 to 95.4,395
Hep B,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,89.4,85.8 to 92.2,753
Hep B,≥3 Doses,States/Local Areas,Kansas,2017,Age,19 Months,93.7,89.4 to 96.3,354
Hep B,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,93.0,89.9 to 95.2,749
PCV,≥3 Doses,States/Local Areas,Kansas,2012,Age,7 Months,69.4,64.3 to 74.1,224
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,78.6,73.4 to 83.8,413
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,87.6,81.4 to 93.9,236
PCV,≥3 Doses,States/Local Areas,Kansas,2014,Age,7 Months,65.6,56.8 to 73.5,208
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,67.1,60.7 to 72.9,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2016,Age,19 Months,89.0,83.3 to 93.0,301
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,91.3,87.9 to 93.9,655
PCV,≥3 Doses,States/Local Areas,Kansas,2011,Age,7 Months,68.3,62.8 to 73.3,221
PCV,≥3 Doses,States/Local Areas,Kansas,2013,Age,7 Months,69.2,66.7 to 71.6,231
PCV,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,67.4,64.4 to 70.3,439
≥1 Dose Varicella,,States/Local Areas,Kansas,2015,Age,24 Months,87.1,80.2 to 92.5,180
≥1 Dose Varicella,,States/Local Areas,Kansas,2015-2016,Age,24 Months,88.0,83.9 to 91.5,481
≥1 Dose MMR,,States/Local Areas,Kansas,2012,Age,24 Months,93.0,88.2 to 96.3,224
≥1 Dose MMR,,States/Local Areas,Kansas,2011,Age,24 Months,88.4,82.2 to 93.1,221
≥1 Dose Varicella,,States/Local Areas,Kansas,2016,Age,24 Months,89.0,84.2 to 92.8,301
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2017,Age,24 Months,91.0,88.0 to 93.6,655
≥1 Dose Varicella,,States/Local Areas,Kansas,2017,Age,24 Months,93.2,89.2 to 96.0,354
≥1 Dose Varicella,,States/Local Areas,Kansas,2017-2018,Age,24 Months,91.6,88.7 to 94.1,749
≥1 Dose Varicella,,States/Local Areas,Kansas,2013,Age,24 Months,91.2,86.0 to 95.0,231
≥1 Dose Varicella,,States/Local Areas,Kansas,2013-2014,Age,24 Months,90.7,87.3 to 93.6,439
≥1 Dose Varicella,,States/Local Areas,Kansas,2014,Age,24 Months,90.4,85.3 to 94.3,208
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2015,Age,24 Months,88.8,84.6 to 92.2,388
≥1 Dose Varicella,,States/Local Areas,Kansas,2019,Age,19 Months,86.1,79.7 to 90.8,358
Polio,≥2 Doses,States/Local Areas,Kansas,2019,Age,13 Months,93.8,89.4 to 96.5,358
Polio,≥2 Doses,States/Local Areas,Kansas,2018,Age,13 Months,94.7,90.5 to 97.1,395
Polio,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,94.3,91.4 to 96.2,753
Hep B,≥2 Doses,States/Local Areas,Kansas,2015,Age,5 Months,88.4,80.1 to 93.5,180
Hep B,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,5 Months,88.2,83.3 to 91.7,481
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2018,Age,0-1 Days,72.3,65.4 to 78.3,395
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2018-2019,Age,0-1 Days,75.0,70.2 to 79.2,753
Hep B,≥2 Doses,States/Local Areas,Kansas,2018,Age,5 Months,91.3,86.5 to 94.5,395
Hep B,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,5 Months,91.8,88.8 to 94.1,753
PCV,≥4 Doses,States/Local Areas,Kansas,2020,Age,35 Months,78.5,71.8 to 84.6,368
Hep B,≥2 Doses,States/Local Areas,Kansas,2017,Age,5 Months,93.9,89.7 to 96.4,354
Hep B,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,5 Months,92.6,89.6 to 94.8,749
Hep B,≥2 Doses,States/Local Areas,Kansas,2011,Age,7 Months,92.4,84.6 to 96.4,221
Hep B,≥2 Doses,States/Local Areas,Kansas,2019,Age,5 Months,92.4,88.0 to 95.3,358
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2017,Age,0-1 Days,81.4,75.4 to 86.2,354
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2017-2018,Age,0-1 Days,76.9,72.4 to 80.8,749
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2016,Age,0-1 Days,72.3,65.2 to 78.4,301
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2016-2017,Age,0-1 Days,76.8,72.2 to 80.8,655
Hep B,≥3 Doses,States/Local Areas,Kansas,2011,Age,24 Months,89.3,82.9 to 94.1,221
Hep B,≥3 Doses,States/Local Areas,Kansas,2019,Age,19 Months,92.7,88.1 to 95.6,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2013,Age,24 Months,94.9,91.4 to 97.3,231
Hep B,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,94.6,92.1 to 96.6,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2014,Age,24 Months,94.4,90.4 to 97.1,208
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,92.7,89.1 to 95.4,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2012,Age,24 Months,94.8,90.6 to 97.6,224
PCV,≥3 Doses,States/Local Areas,Kansas,2016,Age,7 Months,68.9,61.5 to 75.5,301
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,70.5,65.6 to 74.9,655
PCV,≥4 Doses,States/Local Areas,Kansas,2016,Age,19 Months,78.4,71.5 to 84.0,301
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,80.5,76.0 to 84.3,655
PCV,≥4 Doses,States/Local Areas,Kansas,2015,Age,19 Months,83.6,76.6 to 88.8,180
PCV,≥4 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,81.1,76.1 to 85.3,481
PCV,≥4 Doses,States/Local Areas,Kansas,2014,Age,19 Months,83.5,76.4 to 88.7,208
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,83.5,78.5 to 87.6,388
PCV,≥3 Doses,States/Local Areas,Kansas,2015,Age,7 Months,68.5,58.9 to 76.8,180
PCV,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,68.7,62.7 to 74.2,481
PCV,≥3 Doses,States/Local Areas,Kansas,2017,Age,7 Months,72.1,65.5 to 77.8,354
PCV,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,72.7,68.0 to 76.9,749
≥1 Dose MMR,,States/Local Areas,Kansas,2013,Age,24 Months,92.3,86.7 to 96.2,231
≥1 Dose MMR,,States/Local Areas,Kansas,2013-2014,Age,24 Months,92.0,88.5 to 94.8,439
≥1 Dose MMR,,States/Local Areas,Kansas,2014,Age,24 Months,91.8,87.0 to 95.3,208
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2015,Age,24 Months,90.5,86.6 to 93.6,388
≥1 Dose MMR,,States/Local Areas,Kansas,2015,Age,24 Months,89.2,82.8 to 94.0,180
≥1 Dose MMR,,States/Local Areas,Kansas,2015-2016,Age,24 Months,89.8,85.9 to 92.9,481
≥1 Dose Varicella,,States/Local Areas,Kansas,2018,Age,24 Months,90.1,85.4 to 93.7,395
≥1 Dose Varicella,,States/Local Areas,Kansas,2018-2019,Age,24 Months,89.7,86.2 to 92.7,753
≥1 Dose Varicella,,States/Local Areas,Kansas,2012,Age,35 Months,96.8,93.3 to 98.7,224
≥1 Dose Varicella,,States/Local Areas,Kansas,2011,Age,35 Months,97.6,88.7 to 99.8,221
≥1 Dose Varicella,,States/Local Areas,Kansas,2019,Age,24 Months,89.4,83.6 to 93.8,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2015,Age,24 Months,90.9,84.7 to 95.3,180
Hep B,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,90.2,86.3 to 93.4,481
PCV,≥3 Doses,States/Local Areas,Kansas,2013,Age,13 Months,88.7,80.5 to 93.7,231
PCV,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,87.9,83.2 to 91.4,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2016,Age,24 Months,89.5,84.2 to 93.6,301
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,92.4,89.3 to 94.9,655
PCV,≥3 Doses,States/Local Areas,Kansas,2012,Age,13 Months,93.9,92.7 to 94.9,224
≥1 Dose MMR,,States/Local Areas,Kansas,2016,Age,24 Months,90.3,85.7 to 93.9,301
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2017,Age,24 Months,92.5,89.7 to 94.7,655
≥1 Dose MMR,,States/Local Areas,Kansas,2017,Age,24 Months,94.8,91.6 to 97.0,354
≥1 Dose MMR,,States/Local Areas,Kansas,2017-2018,Age,24 Months,92.9,90.1 to 95.1,749
PCV,≥4 Doses,States/Local Areas,Kansas,2018,Age,19 Months,78.8,72.4 to 84.0,395
PCV,≥4 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,81.3,76.1 to 85.7,609
PCV,≥4 Doses,States/Local Areas,Kansas,2017,Age,19 Months,82.5,76.4 to 87.3,354
PCV,≥4 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,80.7,76.4 to 84.3,749
PCV,≥3 Doses,States/Local Areas,Kansas,2011,Age,13 Months,88.6,80.3 to 93.6,221
PCV,≥3 Doses,States/Local Areas,Kansas,2019,Age,7 Months,74.8,67.7 to 80.8,358
PCV,≥3 Doses,States/Local Areas,Kansas,2018,Age,7 Months,73.2,66.5 to 79.1,395
PCV,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,74.0,69.2 to 78.3,753
Hep B,≥2 Doses,States/Local Areas,Kansas,2012,Age,7 Months,94.4,92.3 to 96.0,224
Hep B,≥2 Doses,States/Local Areas,Kansas,2015,Age,7 Months,90.3,82.8 to 94.8,180
Hep B,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,7 Months,90.4,86.0 to 93.5,481
Hep B,≥2 Doses,States/Local Areas,Kansas,2014,Age,7 Months,94.0,89.2 to 96.8,208
Hep B,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,7 Months,92.2,88.0 to 95.0,388
Hep B,≥2 Doses,States/Local Areas,Kansas,2013,Age,7 Months,94.1,89.3 to 96.8,231
Hep B,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,7 Months,94.1,91.8 to 95.7,439
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2012,Age,0-2 Days,84.1,82.2 to 85.8,224
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2013,Age,0-2 Days,78.7,74.5 to 82.4,231
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2013-2014,Age,0-2 Days,77.0,73.1 to 80.5,439
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2011,Age,0-2 Days,80.2,72.4 to 86.2,221
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2019,Age,0-1 Days,77.7,70.9 to 83.3,358
PCV,≥3 Doses,States/Local Areas,Kansas,2016,Age,13 Months,85.9,79.2 to 90.6,301
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,13 Months,86.9,82.7 to 90.2,655
Hep B,≥3 Doses,States/Local Areas,Kansas,2018,Age,24 Months,93.1,88.8 to 96.1,395
Hep B,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,93.3,90.5 to 95.5,753
PCV,≥3 Doses,States/Local Areas,Kansas,2015,Age,13 Months,87.8,79.7 to 92.9,180
PCV,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,13 Months,86.8,81.9 to 90.6,481
PCV,≥3 Doses,States/Local Areas,Kansas,2014,Age,13 Months,87.0,80.2 to 91.7,208
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,13 Months,87.4,82.4 to 91.1,388
Hep B,≥2 Doses,States/Local Areas,Kansas,2017,Age,7 Months,94.6,90.3 to 97.0,354
Hep B,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,7 Months,93.6,90.7 to 95.7,749
Hep B,≥2 Doses,States/Local Areas,Kansas,2016,Age,7 Months,90.5,84.8 to 94.2,301
Hep B,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,7 Months,92.5,89.1 to 94.9,655
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2016,Age,0-2 Days,74.7,67.7 to 80.6,301
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2016-2017,Age,0-2 Days,79.3,74.8 to 83.1,655
≥1 Dose Varicella,,States/Local Areas,Kansas,2013,Age,35 Months,94.5,90.1 to 97.4,231
≥1 Dose Varicella,,States/Local Areas,Kansas,2013-2014,Age,35 Months,94.7,90.9 to 97.3,439
≥1 Dose MMR,,States/Local Areas,Kansas,2018,Age,24 Months,90.9,86.3 to 94.5,395
≥1 Dose MMR,,States/Local Areas,Kansas,2018-2019,Age,24 Months,90.1,86.5 to 93.0,753
PCV,≥4 Doses,States/Local Areas,Kansas,2019,Age,19 Months,82.7,76.3 to 87.7,358
≥1 Dose Varicella,,States/Local Areas,Kansas,2014,Age,35 Months,94.9,88.9 to 98.2,208
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2015,Age,35 Months,94.7,89.1 to 97.9,388
≥1 Dose Varicella,,States/Local Areas,Kansas,2015,Age,35 Months,92.6,84.8 to 97.2,180
≥1 Dose Varicella,,States/Local Areas,Kansas,2015-2016,Age,35 Months,92.0,87.7 to 95.3,481
PCV,≥4 Doses,States/Local Areas,Kansas,2011,Age,24 Months,82.6,75.3 to 88.7,221
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2015,Age,0-2 Days,62.0,51.6 to 71.4,180
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2015-2016,Age,0-2 Days,68.2,61.6 to 74.1,481
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2014,Age,0-2 Days,75.3,67.5 to 81.7,208
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2014-2015,Age,0-2 Days,68.6,61.9 to 74.6,388
PCV,≥4 Doses,States/Local Areas,Kansas,2012,Age,24 Months,85.7,79.1 to 91.1,224
Hep B,≥3 Doses,States/Local Areas,Kansas,2011,Age,35 Months,92.3,86.2 to 96.4,221
Hep B,≥3 Doses,States/Local Areas,Kansas,2017,Age,24 Months,95.4,92.2 to 97.6,354
Hep B,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,94.2,91.7 to 96.2,749
Hep B,≥3 Doses,States/Local Areas,Kansas,2019,Age,24 Months,93.6,89.6 to 96.4,358
PCV,≥4 Doses,States/Local Areas,Kansas,2013,Age,24 Months,84.7,78.1 to 90.2,231
PCV,≥4 Doses,States/Local Areas,Kansas,2013-2014,Age,24 Months,85.1,80.6 to 89.0,439
PCV,≥4 Doses,States/Local Areas,Kansas,2014,Age,24 Months,85.6,79.2 to 90.8,208
PCV,≥4 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,85.3,80.7 to 89.4,388
PCV,≥4 Doses,States/Local Areas,Kansas,2015,Age,24 Months,85.1,78.1 to 90.9,180
PCV,≥4 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,83.1,78.4 to 87.3,481
≥1 Dose MMR,,States/Local Areas,Kansas,2019,Age,24 Months,89.2,83.5 to 93.6,358
≥1 Dose MMR,,States/Local Areas,Kansas,2012,Age,35 Months,96.0,92.4 to 98.2,224
≥1 Dose MMR,,States/Local Areas,Kansas,2011,Age,35 Months,97.0,86.4 to 99.8,221
≥1 Dose MMR,,States/Local Areas,Kansas,2013,Age,35 Months,94.8,90.1 to 97.7,231
≥1 Dose MMR,,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.5,92.4 to 98.8,439
≥1 Dose Varicella,,States/Local Areas,Kansas,2016,Age,35 Months,91.4,86.3 to 95.1,301
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2017,Age,35 Months,93.9,90.7 to 96.3,655
Hep B,≥2 Doses,States/Local Areas,Kansas,2018,Age,7 Months,92.6,87.9 to 95.6,395
Hep B,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,7 Months,93.7,90.9 to 95.7,753
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2019,Age,0-2 Days,81.1,74.7 to 86.2,358
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2018,Age,0-2 Days,74.6,67.7 to 80.5,395
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2018-2019,Age,0-2 Days,77.8,73.2 to 81.9,753
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2017,Age,0-2 Days,84.1,78.3 to 88.5,354
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2017-2018,Age,0-2 Days,79.4,75.0 to 83.2,749
≥1 Dose Varicella,,States/Local Areas,Kansas,2017,Age,35 Months,97.3,93.1 to 99.3,354
≥1 Dose Varicella,,States/Local Areas,Kansas,2017-2018,Age,35 Months,93.7,90.5 to 96.0,749
≥1 Dose Varicella,,States/Local Areas,Kansas,2018,Age,35 Months,90.9,86.2 to 94.5,395
≥1 Dose Varicella,,States/Local Areas,Kansas,2018-2019,Age,35 Months,92.7,89.3 to 95.3,753
Hep B,≥3 Doses,States/Local Areas,Kansas,2013,Age,35 Months,96.3,93.0 to 98.3,231
Hep B,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.0,93.4 to 97.7,439
Hep B,≥3 Doses,States/Local Areas,Kansas,2014,Age,35 Months,95.7,91.4 to 98.2,208
Hep B,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,93.2,89.5 to 95.9,388
Hep B,≥3 Doses,States/Local Areas,Kansas,2015,Age,35 Months,90.9,84.7 to 95.3,180
Hep B,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,92.2,87.8 to 95.4,481
Hep B,≥3 Doses,States/Local Areas,Kansas,2012,Age,35 Months,95.2,90.9 to 97.8,224
PCV,≥3 Doses,States/Local Areas,Kansas,2018,Age,13 Months,87.7,81.9 to 91.9,395
PCV,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,87.8,83.8 to 90.9,753
PCV,≥3 Doses,States/Local Areas,Kansas,2017,Age,13 Months,88.0,82.3 to 92.0,354
PCV,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,87.8,84.0 to 90.9,749
Hep B,≥2 Doses,States/Local Areas,Kansas,2012,Age,13 Months,96.1,92.4 to 98.0,224
Hep B,≥2 Doses,States/Local Areas,Kansas,2013,Age,13 Months,97.3,96.0 to 98.2,231
Hep B,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,13 Months,96.1,93.3 to 97.7,439
Hep B,≥2 Doses,States/Local Areas,Kansas,2011,Age,13 Months,93.9,86.7 to 97.4,221
Hep B,≥2 Doses,States/Local Areas,Kansas,2019,Age,7 Months,94.8,91.2 to 97.0,358
PCV,≥4 Doses,States/Local Areas,Kansas,2016,Age,24 Months,81.0,74.6 to 86.7,301
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,83.0,78.7 to 86.8,655
PCV,≥4 Doses,States/Local Areas,Kansas,2017,Age,24 Months,85.0,79.4 to 89.8,354
PCV,≥4 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,84.4,80.5 to 87.9,749
≥1 Dose MMR,,States/Local Areas,Kansas,2015,Age,35 Months,93.1,86.7 to 97.1,180
≥1 Dose MMR,,States/Local Areas,Kansas,2015-2016,Age,35 Months,93.1,89.1 to 96.0,481
≥1 Dose MMR,,States/Local Areas,Kansas,2014,Age,35 Months,98.2,93.4 to 99.7,208
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2015,Age,35 Months,96.3,91.4 to 98.8,388
≥1 Dose MMR,,States/Local Areas,Kansas,2016,Age,35 Months,92.7,87.7 to 96.2,301
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2017,Age,35 Months,94.4,91.4 to 96.7,655
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.6,82.6 to 100.0,35
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,92.2,86.4 to 98.0,134
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,67.6,45.2 to 90.1,35
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,92.2,89.5 to 95.0,527
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,81.7,74.9 to 88.5,209
≥1 Dose Varicella,,States/Local Areas,Kansas,2019,Age,35 Months,94.4,89.6 to 97.4,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2017,Age,35 Months,95.5,92.2 to 97.7,354
Hep B,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,94.6,92.0 to 96.6,749
PCV,≥3 Doses,States/Local Areas,Kansas,2012,Age,19 Months,94.3,93.1 to 95.4,224
Hep B,≥3 Doses,States/Local Areas,Kansas,2018,Age,35 Months,93.6,89.2 to 96.6,395
Hep B,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,94.6,92.0 to 96.6,753
PCV,≥4 Doses,States/Local Areas,Kansas,2012,Age,35 Months,91.6,85.3 to 95.9,224
PCV,≥4 Doses,States/Local Areas,Kansas,2011,Age,35 Months,89.5,77.4 to 96.8,221
PCV,≥4 Doses,States/Local Areas,Kansas,2018,Age,24 Months,83.8,78.1 to 88.7,395
PCV,≥4 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,83.9,79.9 to 87.6,753
PCV,≥4 Doses,States/Local Areas,Kansas,2019,Age,24 Months,84.1,78.1 to 89.3,358
Hep B,≥3 Doses,States/Local Areas,Kansas,2016,Age,35 Months,91.9,86.2 to 95.9,301
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,93.8,90.4 to 96.3,655
PCV,≥3 Doses,States/Local Areas,Kansas,2014,Age,19 Months,91.7,86.3 to 95.1,208
PCV,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,91.9,88.0 to 94.6,388
PCV,≥3 Doses,States/Local Areas,Kansas,2013,Age,19 Months,92.6,87.7 to 95.6,231
PCV,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,92.2,90.1 to 93.8,439
PCV,≥3 Doses,States/Local Areas,Kansas,2011,Age,19 Months,91.5,82.3 to 96.1,221
PCV,≥3 Doses,States/Local Areas,Kansas,2019,Age,13 Months,87.9,81.9 to 92.1,358
Hib,≥1 Dose,States/Local Areas,Kansas,2011,Age,3 Months,90.8,85.2 to 94.4,221
Hib,≥1 Dose,States/Local Areas,Kansas,2012,Age,3 Months,92.1,89.9 to 93.9,224
Hib,≥1 Dose,States/Local Areas,Kansas,2013,Age,3 Months,85.7,80.1 to 89.9,231
Hib,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,3 Months,86.4,84.4 to 88.1,439
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,87.8,81.4 to 94.1,174
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.8,70.0 to 91.6,84
PCV,≥3 Doses,States/Local Areas,Kansas,2016,Age,19 Months,87.9,81.5 to 92.2,301
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,89.6,85.8 to 92.6,655
PCV,≥3 Doses,States/Local Areas,Kansas,2015,Age,19 Months,92.0,88.2 to 94.7,180
PCV,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,90.0,85.7 to 93.1,481
Hep B,≥2 Doses,States/Local Areas,Kansas,2019,Age,13 Months,94.9,91.3 to 97.0,358
Hep B,≥2 Doses,States/Local Areas,Kansas,2018,Age,13 Months,96.2,93.0 to 98.0,395
Hep B,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,13 Months,95.6,93.3 to 97.1,753
Hep B,≥2 Doses,States/Local Areas,Kansas,2017,Age,13 Months,95.7,92.1 to 97.6,354
Hep B,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,13 Months,95.9,93.7 to 97.4,749
Hib,≥1 Dose,States/Local Areas,Kansas,2017,Age,3 Months,88.3,83.1 to 92.1,354
Hib,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,3 Months,87.5,83.8 to 90.4,749
Hib,≥1 Dose,States/Local Areas,Kansas,2016,Age,3 Months,83.6,76.8 to 88.6,301
Hib,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,3 Months,85.9,81.8 to 89.2,655
Hib,≥1 Dose,States/Local Areas,Kansas,2015,Age,3 Months,87.0,79.4 to 92.1,180
Hib,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,3 Months,85.3,80.4 to 89.1,481
≥1 Dose MMR,,States/Local Areas,Kansas,2017,Age,35 Months,96.4,92.4 to 98.6,354
≥1 Dose MMR,,States/Local Areas,Kansas,2017-2018,Age,35 Months,93.6,90.7 to 95.8,749
≥1 Dose MMR,,States/Local Areas,Kansas,2018,Age,35 Months,91.1,86.4 to 94.6,395
≥1 Dose MMR,,States/Local Areas,Kansas,2018-2019,Age,35 Months,92.6,89.2 to 95.2,753
PCV,≥4 Doses,States/Local Areas,Kansas,2013,Age,35 Months,86.6,79.6 to 92.2,231
PCV,≥4 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,85.9,81.2 to 89.9,439
≥1 Dose MMR,,States/Local Areas,Kansas,2019,Age,35 Months,94.0,89.1 to 97.2,358
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,93.7,88.5 to 98.9,134
≥1 Dose MMR,,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,92.3,89.5 to 95.2,527
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.6,86.4 to 92.8,612
≥1 Dose Varicella,,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,85.7 to 93.9,320
Influenza,,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,51.6,44.5 to 58.8,238
Influenza,,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,47.3,41.3 to 53.4,378
Influenza,,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,36.1,28.9 to 43.3,222
Influenza,,States/Local Areas,Iowa,2014-2017,Overall,Overall,44.8,40.9 to 48.8,838
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,91.8,89.0 to 94.7,469
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,92.1,88.2 to 96.0,282
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,98.0,96.7 to 99.3,469
Influenza,,States/Local Areas,Iowa,2021,Age,24 Months,47.1,37.3 to 58.0,184
Hib,Full Series,States/Local Areas,Iowa,2020-2021,Age,24 Months,78.9,72.5 to 84.7,455
Hep B,≥1 Dose,States/Local Areas,Iowa,2021,Age,3 Months,92.7,84.2 to 96.8,184
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,80.0,67.7 to 92.4,91
Influenza,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",35.9,23.4 to 48.4,75
Influenza,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,48.8,36.8 to 60.8,84
Influenza,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",29.1,13.5 to 44.7,37
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,87.2 to 100.0,83
Influenza,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,38.2,31.6 to 44.7,297
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",100.0,,83
Influenza,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,52.5,47.2 to 57.8,472
Influenza,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,36.8,21.2 to 52.4,49
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,89.9,85.5 to 94.3,282
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,90.5,87.7 to 93.4,469
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.3,58.0 to 100.0,30
Influenza,,States/Local Areas,Iowa,2019,Age,24 Months,56.3,48.1 to 64.8,250
Influenza,,States/Local Areas,Iowa,2018,Age,24 Months,44.6,36.9 to 53.2,255
Influenza,,States/Local Areas,Iowa,2018-2019,Age,24 Months,50.4,44.7 to 56.4,505
Influenza,,States/Local Areas,Iowa,2017,Age,24 Months,42.9,35.2 to 51.4,228
Influenza,,States/Local Areas,Iowa,2017-2018,Age,24 Months,43.7,38.2 to 49.7,483
Influenza,,States/Local Areas,Iowa,2016,Age,24 Months,47.5,39.2 to 56.6,198
Influenza,,States/Local Areas,Iowa,2016-2017,Age,24 Months,45.1,39.4 to 51.4,426
Influenza,,States/Local Areas,Iowa,2015,Age,24 Months,46.2,39.1 to 54.0,238
Influenza,,States/Local Areas,Iowa,2015-2016,Age,24 Months,46.9,41.3 to 52.8,436
Influenza,,States/Local Areas,Iowa,2014,Age,24 Months,42.4,36.0 to 49.6,277
Influenza,,States/Local Areas,Iowa,2014-2015,Age,24 Months,44.4,39.5 to 49.5,515
Influenza,,States/Local Areas,Iowa,2011,Age,24 Months,42.9,34.7 to 52.1,220
Influenza,,States/Local Areas,Iowa,2012,Age,24 Months,39.5,32.3 to 47.6,247
Influenza,,States/Local Areas,Iowa,2013,Age,24 Months,40.3,33.6 to 47.8,265
Influenza,,States/Local Areas,Iowa,2013-2014,Age,24 Months,41.4,36.6 to 46.5,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,91.9,87.1 to 95.4,455
Hib,≥2 Doses,States/Local Areas,Iowa,2021,Age,13 Months,90.8,80.9 to 95.9,184
Hep A,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,47.4,40.7 to 54.5,455
≥1 Dose Varicella,,States/Local Areas,Iowa,2020-2021,Age,24 Months,90.3,85.7 to 93.9,455
Hib,Primary Series,States/Local Areas,Iowa,2020-2021,Age,7 Months,78.3,71.8 to 83.7,455
DTaP,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,77.4,70.8 to 82.9,455
Hib,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,5 Months,81.7,75.3 to 86.8,455
Hep B,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,5 Months,92.4,88.1 to 95.3,455
Hib,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,89.0,83.8 to 92.7,455
Polio,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,95.0,90.2 to 97.9,455
≥1 Dose MMR,,States/Local Areas,Iowa,2020-2021,Age,35 Months,93.7,88.5 to 97.1,455
Combined 7 Series,,States/Local Areas,Iowa,2020-2021,Age,24 Months,70.9,64.2 to 77.3,455
Hib,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,3 Months,87.2,81.3 to 91.4,455
Polio,≥2 Doses,States/Local Areas,Iowa,2021,Age,13 Months,94.7,88.3 to 97.7,184
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,81.9 to 99.9,83
Influenza,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,43.2,36.3 to 50.1,274
Influenza,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",46.7,42.2 to 51.2,642
Influenza,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,46.2,39.6 to 52.8,326
Influenza,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,45.1,38.2 to 52.1,238
≥1 Dose Varicella,,States/Local Areas,Iowa,2020-2021,Age,13 Months,48.1,41.4 to 55.0,455
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2021,Age,0-3 Days,80.0,70.3 to 87.1,184
Hib,≥3 Doses,States/Local Areas,Iowa,2021,Age,35 Months,89.7,81.0 to 95.5,184
PCV,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,3 Months,89.2,83.8 to 92.9,455
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,93.7,90.9 to 96.4,469
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,80.2 to 98.9,83
Hep B,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,3 Months,94.7,90.4 to 97.1,455
Hib,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,90.2,85.0 to 93.8,455
Hib,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,63.6,56.7 to 70.0,455
DTaP,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,5 Months,84.7,78.7 to 89.3,455
Hib,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,34.6,28.5 to 41.3,455
≥1 Dose MMR,,States/Local Areas,Iowa,2021,Age,13 Months,49.7,39.4 to 60.0,184
Hep A,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,24 Months,87.8,82.9 to 91.8,455
DTaP,≥3 Doses,States/Local Areas,Iowa,2021,Age,24 Months,93.2,85.9 to 97.5,184
PCV,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,88.9,83.5 to 92.7,455
Polio,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,92.7,88.4 to 95.8,455
Polio,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,3 Months,91.5,86.9 to 94.6,455
Hep A,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,81.3,71.4 to 89.3,455
≥1 Dose MMR,,States/Local Areas,Iowa,2020-2021,Age,19 Months,88.4,82.9 to 92.3,455
Rotavirus,,States/Local Areas,Iowa,2021,Age,8 Months,77.7,67.1 to 85.7,184
Hib,Primary Series,States/Local Areas,Iowa,2021,Age,35 Months,90.8,82.2 to 96.3,184
DTaP,≥4 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,74.7,67.8 to 80.5,455
Polio,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,92.4,87.8 to 95.3,455
Hib,≥3 Doses,States/Local Areas,Iowa,2021,Age,13 Months,64.9,54.2 to 74.3,184
PCV,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,91.1,86.3 to 94.7,455
≥1 Dose Varicella,,States/Local Areas,Iowa,2020-2021,Age,19 Months,89.3,84.3 to 92.8,455
Hib,Full Series,States/Local Areas,Iowa,2021,Age,35 Months,81.1,71.0 to 89.3,184
DTaP,≥3 Doses,States/Local Areas,Iowa,2021,Age,35 Months,93.2,85.9 to 97.5,184
Combined 7 Series,,States/Local Areas,Iowa,2020-2021,Age,35 Months,76.4,69.4 to 82.8,455
Hep B,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,93.9,89.6 to 96.5,455
DTaP,≥4 Doses,States/Local Areas,Iowa,2021,Age,35 Months,85.2,74.6 to 93.0,184
Hib,Primary Series,States/Local Areas,Iowa,2021,Age,13 Months,86.7,76.6 to 92.9,184
PCV,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,90.6,85.5 to 94.1,455
Hep B,≥3 Doses,States/Local Areas,Iowa,2021,Age,35 Months,89.8,81.3 to 95.5,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,78.6,72.7 to 83.5,455
Influenza,,States/Local Areas,Iowa,2020-2021,Age,24 Months,45.8,39.4 to 52.8,455
PCV,≥4 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,83.3,77.2 to 88.0,455
PCV,≥4 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,86.6,81.3 to 91.1,455
Polio,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,92.3,88.3 to 95.0,455
DTaP,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,93.2,89.1 to 96.1,455
Rotavirus,,States/Local Areas,Iowa,2020-2021,Age,8 Months,79.4,73.0 to 84.6,455
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,82.8,77.3 to 88.4,282
PCV,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,92.2,87.3 to 95.7,455
Hep B,≥2 Doses,States/Local Areas,Iowa,2021,Age,13 Months,92.5,84.1 to 96.6,184
≥1 Dose Varicella,,States/Local Areas,Iowa,2021,Age,35 Months,95.7,87.4 to 99.2,184
Combined 7 Series,,States/Local Areas,Iowa,2021,Age,24 Months,72.5,62.2 to 82.0,184
Hib,Primary Series,States/Local Areas,Iowa,2020-2021,Age,35 Months,92.2,87.5 to 95.7,455
Hib,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,91.1,86.1 to 94.9,455
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2020-2021,Age,0-3 Days,82.8,77.1 to 87.4,455
Polio,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,5 Months,85.5,79.8 to 89.8,455
Hep A,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,19 Months,85.2,79.5 to 89.6,455
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2020-2021,Age,0-1 Days,80.6,74.7 to 85.3,455
Hib,Primary Series,States/Local Areas,Iowa,2020-2021,Age,19 Months,92.2,87.0 to 95.4,455
PCV,≥1 Dose,States/Local Areas,Iowa,2021,Age,3 Months,86.7,77.0 to 92.7,184
Hib,Full Series,States/Local Areas,Iowa,2020-2021,Age,35 Months,80.7,74.2 to 86.5,455
Hep B,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,91.7,86.5 to 95.0,455
DTaP,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,89.5,84.1 to 93.2,455
PCV,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,7 Months,75.2,68.6 to 80.9,455
Hep A,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,35.4,29.2 to 42.1,455
Polio,≥3 Doses,States/Local Areas,Iowa,2021,Age,19 Months,92.2,83.5 to 96.5,184
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2020-2021,Age,0-2 Days,82.8,77.1 to 87.3,455
Hib,Full Series,States/Local Areas,Iowa,2020-2021,Age,19 Months,75.0,68.1 to 80.8,455
≥1 Dose MMR,,States/Local Areas,Iowa,2020-2021,Age,13 Months,51.9,45.0 to 58.7,455
≥1 Dose Varicella,,States/Local Areas,Iowa,2021,Age,13 Months,48.1,37.9 to 58.4,184
≥1 Dose MMR,,States/Local Areas,Iowa,2021,Age,19 Months,87.9,78.6 to 93.5,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2021,Age,13 Months,89.5,79.9 to 94.8,184
Polio,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,94.2,90.5 to 96.5,455
DTaP,≥2 Doses,States/Local Areas,Iowa,2021,Age,5 Months,83.0,72.7 to 90.0,184
Polio,≥2 Doses,States/Local Areas,Iowa,2021,Age,5 Months,85.0,75.4 to 91.3,184
Rotavirus,,States/Local Areas,Iowa,2018,Age,8 Months,81.5,73.8 to 87.3,255
Rotavirus,,States/Local Areas,Iowa,2018-2019,Age,8 Months,82.9,77.7 to 87.0,505
Rotavirus,,States/Local Areas,Iowa,2017,Age,8 Months,67.3,59.0 to 74.6,228
Rotavirus,,States/Local Areas,Iowa,2017-2018,Age,8 Months,74.3,68.7 to 79.1,483
Rotavirus,,States/Local Areas,Iowa,2019,Age,8 Months,84.3,76.7 to 89.8,250
Rotavirus,,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,85.8,81.0 to 90.7,238
Rotavirus,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.6,64.0 to 87.1,75
Rotavirus,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,72.5,61.4 to 83.5,84
Rotavirus,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,64.8,58.4 to 71.3,297
Rotavirus,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.9,59.4 to 90.3,37
Rotavirus,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,86.4,82.7 to 90.0,472
Rotavirus,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,79.6,67.3 to 91.9,49
Rotavirus,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,78.1,72.1 to 84.1,274
Rotavirus,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.9,71.7 to 80.0,642
Rotavirus,,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,59.2,51.7 to 66.7,222
Rotavirus,,States/Local Areas,Iowa,2014-2017,Overall,Overall,75.4,71.8 to 79.0,838
Rotavirus,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,71.7,65.9 to 77.5,326
Rotavirus,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.0,70.1 to 83.9,238
Rotavirus,,States/Local Areas,Iowa,2015,Age,8 Months,78.9,70.3 to 85.5,238
Rotavirus,,States/Local Areas,Iowa,2015-2016,Age,8 Months,80.8,75.2 to 85.4,436
Rotavirus,,States/Local Areas,Iowa,2016,Age,8 Months,82.7,75.1 to 88.4,198
Rotavirus,,States/Local Areas,Iowa,2016-2017,Age,8 Months,75.0,69.5 to 79.9,426
Rotavirus,,States/Local Areas,Iowa,2011,Age,8 Months,71.6,63.0 to 78.8,220
Rotavirus,,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,81.2,76.3 to 86.2,378
Rotavirus,,States/Local Areas,Iowa,2013,Age,8 Months,75.1,68.1 to 81.1,265
Rotavirus,,States/Local Areas,Iowa,2013-2014,Age,8 Months,74.3,69.5 to 78.5,542
Rotavirus,,States/Local Areas,Iowa,2012,Age,8 Months,68.7,60.3 to 76.0,247
Rotavirus,,States/Local Areas,Iowa,2014,Age,8 Months,73.4,66.8 to 79.0,277
Rotavirus,,States/Local Areas,Iowa,2014-2015,Age,8 Months,76.1,70.9 to 80.6,515
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,85.6,77.6 to 93.5,91
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.6,84.5 to 100.0,83
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,75.0,67.1 to 82.8,194
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,85.3,80.2 to 90.5,282
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,98.2,96.3 to 100.0,239
Hib,Primary Series,States/Local Areas,Iowa,2014,Age,7 Months,81.5,75.5 to 86.3,277
Hib,Primary Series,States/Local Areas,Iowa,2014-2015,Age,7 Months,80.0,75.5 to 83.9,515
Hib,Primary Series,States/Local Areas,Iowa,2015,Age,7 Months,78.6,71.5 to 84.3,238
Hib,Primary Series,States/Local Areas,Iowa,2015-2016,Age,7 Months,78.5,73.1 to 83.1,436
Hib,Primary Series,States/Local Areas,Iowa,2013,Age,7 Months,76.9,75.2 to 78.5,265
Hib,Primary Series,States/Local Areas,Iowa,2013-2014,Age,7 Months,79.2,77.0 to 81.3,542
Hib,Primary Series,States/Local Areas,Iowa,2018,Age,7 Months,88.5,82.0 to 92.8,255
Hib,Primary Series,States/Local Areas,Iowa,2018-2019,Age,7 Months,88.2,83.6 to 91.6,505
Hib,Primary Series,States/Local Areas,Iowa,2019,Age,7 Months,87.9,80.7 to 92.7,250
Hib,Primary Series,States/Local Areas,Iowa,2014,Age,13 Months,91.5,86.7 to 94.6,277
Hib,Primary Series,States/Local Areas,Iowa,2014-2015,Age,13 Months,91.2,87.7 to 93.7,515
Hib,Primary Series,States/Local Areas,Iowa,2015,Age,13 Months,90.8,85.3 to 94.4,238
Hib,Primary Series,States/Local Areas,Iowa,2015-2016,Age,13 Months,93.2,89.9 to 95.4,436
Hep B,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,94.6,91.1 to 96.7,521
Hib,Primary Series,States/Local Areas,Iowa,2019-2020,Age,7 Months,83.1,77.7 to 87.4,521
Hib,Primary Series,States/Local Areas,Iowa,2013,Age,13 Months,90.5,87.8 to 92.6,265
Hib,Primary Series,States/Local Areas,Iowa,2013-2014,Age,13 Months,91.0,89.6 to 92.2,542
Hib,Primary Series,States/Local Areas,Iowa,2012,Age,13 Months,89.6,81.7 to 94.3,247
Hib,Primary Series,States/Local Areas,Iowa,2011,Age,13 Months,88.1,80.3 to 93.1,220
Hib,Primary Series,States/Local Areas,Iowa,2016,Age,7 Months,78.5,70.1 to 85.0,198
Hib,Primary Series,States/Local Areas,Iowa,2016-2017,Age,7 Months,78.3,72.5 to 83.2,426
Hib,Primary Series,States/Local Areas,Iowa,2017,Age,7 Months,78.1,70.5 to 84.2,228
Hib,Primary Series,States/Local Areas,Iowa,2017-2018,Age,7 Months,83.2,78.4 to 87.1,483
Hib,Primary Series,States/Local Areas,Iowa,2013,Age,19 Months,94.4,90.6 to 96.7,265
Hib,Primary Series,States/Local Areas,Iowa,2013-2014,Age,19 Months,94.2,92.0 to 95.8,542
Hib,Primary Series,States/Local Areas,Iowa,2018,Age,19 Months,95.9,89.9 to 98.4,255
Hib,Primary Series,States/Local Areas,Iowa,2018-2019,Age,19 Months,94.4,90.8 to 96.7,505
Hib,Primary Series,States/Local Areas,Iowa,2014,Age,19 Months,94.0,89.8 to 96.5,277
Hib,Primary Series,States/Local Areas,Iowa,2014-2015,Age,19 Months,94.0,90.9 to 96.0,515
Hib,Primary Series,States/Local Areas,Iowa,2016,Age,19 Months,98.1,95.8 to 99.2,198
Hib,Primary Series,States/Local Areas,Iowa,2016-2017,Age,19 Months,96.0,93.2 to 97.6,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2020,Age,13 Months,89.6,83.0 to 93.9,271
Hib,Primary Series,States/Local Areas,Iowa,2019,Age,19 Months,94.9,88.7 to 97.8,250
Hib,Primary Series,States/Local Areas,Iowa,2015,Age,19 Months,93.9,92.8 to 94.9,238
Hib,Primary Series,States/Local Areas,Iowa,2015-2016,Age,19 Months,96.0,93.4 to 97.7,436
Hib,Primary Series,States/Local Areas,Iowa,2012,Age,24 Months,92.8,88.3 to 96.0,247
Hib,Primary Series,States/Local Areas,Iowa,2011,Age,24 Months,91.4,85.0 to 95.8,220
Hib,Primary Series,States/Local Areas,Iowa,2013,Age,24 Months,95.8,91.9 to 98.1,265
Hib,Primary Series,States/Local Areas,Iowa,2013-2014,Age,24 Months,94.8,92.3 to 96.7,542
Combined 7 Series,,States/Local Areas,Iowa,2012,Age,24 Months,77.2,70.0 to 83.7,247
Combined 7 Series,,States/Local Areas,Iowa,2013,Age,24 Months,70.2,63.2 to 77.0,265
Combined 7 Series,,States/Local Areas,Iowa,2013-2014,Age,24 Months,70.5,65.6 to 75.2,542
Hib,Primary Series,States/Local Areas,Iowa,2015,Age,35 Months,96.0,91.6 to 98.4,238
Hib,Primary Series,States/Local Areas,Iowa,2015-2016,Age,35 Months,97.1,94.8 to 98.6,436
Combined 7 Series,,States/Local Areas,Iowa,2011,Age,24 Months,71.4,63.0 to 79.4,220
Hib,Primary Series,States/Local Areas,Iowa,2017,Age,35 Months,94.8,90.1 to 97.8,228
Hib,Primary Series,States/Local Areas,Iowa,2017-2018,Age,35 Months,95.5,92.3 to 97.7,483
Hib,Primary Series,States/Local Areas,Iowa,2011,Age,35 Months,94.9,89.0 to 98.2,220
Hib,Primary Series,States/Local Areas,Iowa,2012,Age,19 Months,92.6,84.6 to 96.6,247
Hib,Primary Series,States/Local Areas,Iowa,2016,Age,35 Months,98.1,96.1 to 99.3,198
Hib,Primary Series,States/Local Areas,Iowa,2016-2017,Age,35 Months,96.5,94.0 to 98.2,426
Hib,Primary Series,States/Local Areas,Iowa,2013,Age,35 Months,95.8,91.9 to 98.1,265
Hib,Primary Series,States/Local Areas,Iowa,2013-2014,Age,35 Months,95.9,93.1 to 97.8,542
Hib,Primary Series,States/Local Areas,Iowa,2018,Age,24 Months,95.9,90.9 to 98.6,255
Hib,Primary Series,States/Local Areas,Iowa,2018-2019,Age,24 Months,95.6,92.2 to 97.8,505
Hib,Primary Series,States/Local Areas,Iowa,2019,Age,24 Months,95.3,89.9 to 98.3,250
Hib,Primary Series,States/Local Areas,Iowa,2014,Age,35 Months,96.5,90.9 to 99.1,277
Hib,Primary Series,States/Local Areas,Iowa,2014-2015,Age,35 Months,97.0,92.4 to 99.1,515
Hib,Primary Series,States/Local Areas,Iowa,2012,Age,35 Months,92.8,88.3 to 96.0,247
Hib,Primary Series,States/Local Areas,Iowa,2014,Age,24 Months,94.0,90.2 to 96.7,277
Hib,Primary Series,States/Local Areas,Iowa,2014-2015,Age,24 Months,94.9,92.3 to 96.9,515
Hib,Primary Series,States/Local Areas,Iowa,2015,Age,24 Months,96.0,91.6 to 98.4,238
Hib,Primary Series,States/Local Areas,Iowa,2015-2016,Age,24 Months,97.1,94.8 to 98.6,436
Hib,Primary Series,States/Local Areas,Iowa,2017,Age,24 Months,93.8,89.1 to 96.9,228
Hib,Primary Series,States/Local Areas,Iowa,2017-2018,Age,24 Months,94.8,91.6 to 97.1,483
Hib,Primary Series,States/Local Areas,Iowa,2019,Age,13 Months,94.5,88.4 to 97.5,250
Hib,Primary Series,States/Local Areas,Iowa,2017,Age,19 Months,93.8,88.5 to 96.7,228
Hib,Primary Series,States/Local Areas,Iowa,2017-2018,Age,19 Months,94.8,91.3 to 96.9,483
Hib,Primary Series,States/Local Areas,Iowa,2016,Age,24 Months,98.1,96.1 to 99.3,198
Hib,Primary Series,States/Local Areas,Iowa,2016-2017,Age,24 Months,96.0,93.4 to 97.7,426
Hib,Primary Series,States/Local Areas,Iowa,2016,Age,13 Months,95.5,91.7 to 97.6,198
Hib,Primary Series,States/Local Areas,Iowa,2016-2017,Age,13 Months,93.3,89.9 to 95.7,426
Hib,Primary Series,States/Local Areas,Iowa,2017,Age,13 Months,91.2,85.0 to 94.9,228
Hib,Primary Series,States/Local Areas,Iowa,2017-2018,Age,13 Months,92.7,88.9 to 95.3,483
Hib,Primary Series,States/Local Areas,Iowa,2011,Age,19 Months,91.4,81.6 to 96.2,220
Hib,Primary Series,States/Local Areas,Iowa,2018,Age,13 Months,94.3,88.8 to 97.2,255
Hib,Primary Series,States/Local Areas,Iowa,2018-2019,Age,13 Months,94.4,90.8 to 96.7,505
Combined 7 Series,,States/Local Areas,Iowa,2017,Age,35 Months,80.2,71.2 to 87.9,228
Combined 7 Series,,States/Local Areas,Iowa,2017-2018,Age,35 Months,84.1,78.1 to 89.1,483
Combined 7 Series,,States/Local Areas,Iowa,2016,Age,35 Months,83.5,75.4 to 90.1,198
Combined 7 Series,,States/Local Areas,Iowa,2016-2017,Age,35 Months,81.8,75.8 to 87.0,426
Combined 7 Series,,States/Local Areas,Iowa,2019,Age,24 Months,83.2,75.7 to 89.5,250
Combined 7 Series,,States/Local Areas,Iowa,2011,Age,35 Months,78.8,70.4 to 86.2,220
Combined 7 Series,,States/Local Areas,Iowa,2012,Age,35 Months,79.4,72.3 to 85.8,247
Combined 7 Series,,States/Local Areas,Iowa,2013,Age,35 Months,75.9,68.8 to 82.3,265
Combined 7 Series,,States/Local Areas,Iowa,2013-2014,Age,35 Months,75.2,70.3 to 79.9,542
Combined 7 Series,,States/Local Areas,Iowa,2014,Age,35 Months,74.9,67.9 to 81.4,277
Combined 7 Series,,States/Local Areas,Iowa,2014-2015,Age,35 Months,77.6,72.6 to 82.3,515
Combined 7 Series,,States/Local Areas,Iowa,2018,Age,24 Months,81.5,74.4 to 87.7,255
Combined 7 Series,,States/Local Areas,Iowa,2018-2019,Age,24 Months,82.4,77.3 to 86.9,505
Combined 7 Series,,States/Local Areas,Iowa,2017,Age,24 Months,69.5,61.8 to 76.9,228
Combined 7 Series,,States/Local Areas,Texas,2019,Age,35 Months,75.2,69.7 to 80.4,919
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,72.9,70.1 to 75.6,2524
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,64.1,61.1 to 67.1,2412
Combined 7 Series,,States/Local Areas,Texas,2018,Age,35 Months,72.9,67.9 to 77.7,1065
Combined 7 Series,,States/Local Areas,Texas,2018-2019,Age,35 Months,74.1,70.3 to 77.7,1984
Hib,Full Series,States/Local Areas,Texas,2017,Age,19 Months,71.3,67.5 to 74.9,1271
Hib,Full Series,States/Local Areas,Texas,2017-2018,Age,19 Months,71.5,68.5 to 74.2,2336
Hib,Full Series,States/Local Areas,Texas,2014,Age,19 Months,70.2,66.7 to 73.4,1413
Hib,Full Series,States/Local Areas,Texas,2014-2015,Age,19 Months,72.2,69.9 to 74.4,3053
Hib,Full Series,States/Local Areas,Texas,2015,Age,19 Months,74.3,72.2 to 76.2,1640
Hib,Full Series,States/Local Areas,Texas,2015-2016,Age,19 Months,73.5,71.3 to 75.6,3243
Hib,Full Series,States/Local Areas,Texas,2016,Age,19 Months,72.8,69.6 to 75.8,1603
Hib,Full Series,States/Local Areas,Texas,2016-2017,Age,19 Months,72.1,69.6 to 74.4,2874
Combined 7 Series,,States/Local Areas,Texas,2011,Age,35 Months,71.6,66.3 to 76.6,1195
Hib,Full Series,States/Local Areas,Texas,2014,Age,24 Months,78.6,75.5 to 81.5,1413
Hib,Full Series,States/Local Areas,Texas,2014-2015,Age,24 Months,79.1,77.1 to 81.1,3053
Hib,Full Series,States/Local Areas,Texas,2013,Age,24 Months,76.9,73.6 to 80.1,1375
Hib,Full Series,States/Local Areas,Texas,2013-2014,Age,24 Months,77.7,75.5 to 79.9,2788
Hib,Full Series,States/Local Areas,Texas,2013,Age,19 Months,71.9,68.5 to 75.0,1375
Hib,Full Series,States/Local Areas,Texas,2013-2014,Age,19 Months,71.0,68.9 to 73.0,2788
Hib,Full Series,States/Local Areas,Texas,2012,Age,19 Months,73.2,70.9 to 75.4,1359
Hib,Full Series,States/Local Areas,Texas,2011,Age,19 Months,68.6,63.8 to 73.1,1195
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,66.6,62.9 to 70.2,1676
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,77.3,74.0 to 80.6,1491
Hep A,≥2 Doses,States/Local Areas,Texas,2021,Age,35 Months,93.6,78.8 to 99.2,446
Hep A,≥1 Dose,States/Local Areas,Texas,2021,Age,35 Months,96.6,91.9 to 98.9,446
PCV,≥3 Doses,States/Local Areas,Texas,2021,Age,19 Months,95.7,92.2 to 97.7,446
Hep B,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,93.3,89.5 to 96.0,1241
DTaP,≥4 Doses,States/Local Areas,Texas,2021,Age,19 Months,78.2,70.1 to 84.6,446
≥1 Dose Varicella,,States/Local Areas,Texas,2021,Age,19 Months,94.6,91.1 to 96.7,446
Hib,Full Series,States/Local Areas,Texas,2021,Age,24 Months,78.2,69.9 to 85.5,446
Polio,≥1 Dose,States/Local Areas,Texas,2021,Age,3 Months,86.6,78.1 to 92.1,446
Hib,Primary Series,States/Local Areas,Texas,2021,Age,24 Months,92.3,85.8 to 96.5,446
≥1 Dose MMR,,States/Local Areas,Texas,2021,Age,24 Months,96.7,94.2 to 98.3,446
Polio,≥3 Doses,States/Local Areas,Texas,2021,Age,24 Months,93.9,89.1 to 97.1,446
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",57.1,49.7 to 64.5,363
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,63.0,54.9 to 71.2,266
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Overall,Overall,67.1,65.1 to 69.1,5548
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.9,63.3 to 74.5,546
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.0,65.6 to 72.4,1682
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,68.0,65.5 to 70.5,3481
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,66.6,63.3 to 70.0,1801
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,62.2,59.2 to 65.3,2381
Combined 7 Series,,States/Local Areas,Texas,2015,Age,35 Months,74.9,70.4 to 79.2,1640
Combined 7 Series,,States/Local Areas,Texas,2015-2016,Age,35 Months,73.7,70.9 to 76.4,3243
Hib,Full Series,States/Local Areas,Texas,2018,Age,19 Months,71.6,67.1 to 75.7,1065
Hib,Full Series,States/Local Areas,Texas,2018-2019,Age,19 Months,94.7,92.9 to 96.1,1984
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,67.8,65.0 to 70.6,2957
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,69.9,62.0 to 77.8,315
Combined 7 Series,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,46.7,38.1 to 55.3,297
PCV,≥3 Doses,States/Local Areas,Texas,2021,Age,13 Months,92.4,87.1 to 95.6,446
Hib,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,90.3,86.1 to 93.4,1241
DTaP,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,3 Months,85.1,80.3 to 88.9,1241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2021,Age,0-1 Days,81.1,72.9 to 87.2,446
Hep A,≥2 Doses,States/Local Areas,Texas,2021,Age,24 Months,43.3,34.6 to 53.2,446
PCV,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,5 Months,75.0,69.2 to 80.1,1241
PCV,≥3 Doses,States/Local Areas,Texas,2021,Age,24 Months,95.7,92.6 to 97.8,446
Hep A,≥1 Dose,States/Local Areas,Texas,2021,Age,19 Months,92.0,87.0 to 95.2,446
≥1 Dose Varicella,,States/Local Areas,Texas,2020-2021,Age,35 Months,94.8,91.7 to 97.1,1241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2021,Age,0-2 Days,81.9,73.7 to 88.0,446
PCV,≥4 Doses,States/Local Areas,Texas,2021,Age,24 Months,85.7,79.0 to 91.2,446
≥1 Dose Varicella,,States/Local Areas,Texas,2021,Age,24 Months,96.3,93.6 to 98.1,446
DTaP,≥4 Doses,States/Local Areas,Texas,2021,Age,24 Months,83.5,76.2 to 89.6,446
Hep A,≥2 Doses,States/Local Areas,Texas,2021,Age,19 Months,33.1,24.9 to 42.6,446
Hib,≥3 Doses,States/Local Areas,Texas,2021,Age,24 Months,91.9,85.5 to 96.2,446
≥1 Dose MMR,,States/Local Areas,Texas,2020-2021,Age,24 Months,92.8,90.2 to 95.0,1241
DTaP,≥1 Dose,States/Local Areas,Texas,2021,Age,3 Months,86.5,78.1 to 92.1,446
PCV,≥4 Doses,States/Local Areas,Texas,2021,Age,19 Months,84.2,76.8 to 89.5,446
Hep B,≥3 Doses,States/Local Areas,Texas,2021,Age,24 Months,93.0,88.2 to 96.4,446
PCV,≥4 Doses,States/Local Areas,Texas,2021,Age,35 Months,89.4,81.3 to 95.0,446
DTaP,≥3 Doses,States/Local Areas,Texas,2021,Age,13 Months,92.4,86.1 to 96.0,446
PCV,≥3 Doses,States/Local Areas,Texas,2021,Age,7 Months,71.1,61.8 to 78.8,446
Hep B,≥3 Doses,States/Local Areas,Texas,2021,Age,7 Months,69.5,60.0 to 77.5,446
DTaP,≥3 Doses,States/Local Areas,Texas,2021,Age,19 Months,94.2,88.8 to 97.1,446
Hep A,≥1 Dose,States/Local Areas,Texas,2021,Age,24 Months,94.1,89.6 to 97.0,446
Hib,Full Series,States/Local Areas,Texas,2011,Age,24 Months,78.8,74.3 to 83.0,1195
Hib,Full Series,States/Local Areas,Texas,2012,Age,24 Months,78.2,74.5 to 81.7,1359
Hib,Primary Series,States/Local Areas,Texas,2013,Age,24 Months,90.8,88.3 to 93.0,1375
Hib,Primary Series,States/Local Areas,Texas,2013-2014,Age,24 Months,90.9,89.2 to 92.4,2788
Hib,Primary Series,States/Local Areas,Texas,2017,Age,24 Months,89.5,86.7 to 92.0,1271
Hib,Primary Series,States/Local Areas,Texas,2017-2018,Age,24 Months,91.3,89.3 to 93.0,2336
Hib,Primary Series,States/Local Areas,Texas,2014,Age,24 Months,91.0,88.7 to 93.1,1413
Hib,Primary Series,States/Local Areas,Texas,2014-2015,Age,24 Months,92.0,90.5 to 93.3,3053
Hib,Primary Series,States/Local Areas,Texas,2015,Age,24 Months,92.9,91.0 to 94.5,1640
Hib,Primary Series,States/Local Areas,Texas,2015-2016,Age,24 Months,92.1,90.7 to 93.4,3243
Hib,Primary Series,States/Local Areas,Texas,2016,Age,24 Months,91.3,89.1 to 93.2,1603
Hib,Primary Series,States/Local Areas,Texas,2016-2017,Age,24 Months,90.4,88.7 to 92.0,2874
Hib,Primary Series,States/Local Areas,Texas,2018,Age,24 Months,93.0,90.2 to 95.2,1065
Hib,Primary Series,States/Local Areas,Texas,2018-2019,Age,24 Months,92.4,90.3 to 94.2,1984
Hib,Primary Series,States/Local Areas,Texas,2012,Age,35 Months,93.2,90.6 to 95.3,1359
Hib,Primary Series,States/Local Areas,Texas,2019,Age,24 Months,91.8,88.5 to 94.4,919
Hib,Primary Series,States/Local Areas,Texas,2011,Age,35 Months,93.7,90.8 to 96.0,1195
Hib,Primary Series,States/Local Areas,Texas,2013,Age,35 Months,92.6,90.0 to 94.7,1375
Hib,Primary Series,States/Local Areas,Texas,2013-2014,Age,35 Months,92.3,90.6 to 93.8,2788
Combined 7 Series,,States/Local Areas,Texas,2013,Age,24 Months,64.7,61.0 to 68.4,1375
Combined 7 Series,,States/Local Areas,Texas,2013-2014,Age,24 Months,66.4,63.9 to 68.9,2788
Combined 7 Series,,States/Local Areas,Texas,2011,Age,24 Months,66.3,61.4 to 71.2,1195
Combined 7 Series,,States/Local Areas,Texas,2012,Age,24 Months,69.4,65.5 to 73.3,1359
Hib,Primary Series,States/Local Areas,Texas,2015,Age,35 Months,94.4,92.3 to 96.0,1640
Hib,Primary Series,States/Local Areas,Texas,2015-2016,Age,35 Months,93.9,92.3 to 95.2,3243
Combined 7 Series,,States/Local Areas,Texas,2013,Age,35 Months,70.2,66.3 to 74.0,1375
Combined 7 Series,,States/Local Areas,Texas,2013-2014,Age,35 Months,72.5,69.8 to 75.1,2788
Hib,Primary Series,States/Local Areas,Texas,2016,Age,35 Months,93.3,90.9 to 95.3,1603
Hib,Primary Series,States/Local Areas,Texas,2016-2017,Age,35 Months,92.2,90.3 to 93.9,2874
Combined 7 Series,,States/Local Areas,Texas,2017,Age,35 Months,71.5,67.3 to 75.6,1271
Combined 7 Series,,States/Local Areas,Texas,2017-2018,Age,35 Months,72.3,69.0 to 75.5,2336
Combined 7 Series,,States/Local Areas,Texas,2016,Age,35 Months,72.9,69.5 to 76.2,1603
Combined 7 Series,,States/Local Areas,Texas,2016-2017,Age,35 Months,72.2,69.5 to 74.8,2874
Combined 7 Series,,States/Local Areas,Texas,2018,Age,24 Months,66.5,62.0 to 71.0,1065
Combined 7 Series,,States/Local Areas,Texas,2018-2019,Age,24 Months,68.3,64.8 to 71.7,1984
Combined 7 Series,,States/Local Areas,Texas,2017,Age,24 Months,67.1,63.2 to 70.9,1271
Combined 7 Series,,States/Local Areas,Texas,2017-2018,Age,24 Months,66.8,63.8 to 69.8,2336
Combined 7 Series,,States/Local Areas,Texas,2014,Age,35 Months,74.6,70.9 to 78.1,1413
Combined 7 Series,,States/Local Areas,Texas,2014-2015,Age,35 Months,74.5,71.7 to 77.2,3053
Combined 7 Series,,States/Local Areas,Texas,2012,Age,35 Months,74.1,70.0 to 77.9,1359
Hib,Primary Series,States/Local Areas,Texas,2014,Age,35 Months,92.1,89.6 to 94.1,1413
Hib,Primary Series,States/Local Areas,Texas,2014-2015,Age,35 Months,93.2,91.6 to 94.5,3053
Hib,Primary Series,States/Local Areas,Texas,2018,Age,35 Months,93.1,90.3 to 95.3,1065
Hib,Primary Series,States/Local Areas,Texas,2018-2019,Age,35 Months,93.8,91.8 to 95.4,1984
Combined 7 Series,,States/Local Areas,Texas,2015,Age,24 Months,66.0,62.7 to 69.2,1640
Combined 7 Series,,States/Local Areas,Texas,2015-2016,Age,24 Months,66.8,64.5 to 69.1,3243
Combined 7 Series,,States/Local Areas,Texas,2014,Age,24 Months,68.1,64.7 to 71.5,1413
Combined 7 Series,,States/Local Areas,Texas,2014-2015,Age,24 Months,67.1,64.7 to 69.4,3053
Combined 7 Series,,States/Local Areas,Texas,2019,Age,24 Months,70.1,64.9 to 75.2,919
Hib,Primary Series,States/Local Areas,Texas,2019,Age,35 Months,94.5,91.6 to 96.7,919
Combined 7 Series,,States/Local Areas,Texas,2016,Age,24 Months,67.7,64.4 to 71.0,1603
Combined 7 Series,,States/Local Areas,Texas,2016-2017,Age,24 Months,67.4,64.9 to 69.9,2874
Hib,Primary Series,States/Local Areas,Texas,2017,Age,35 Months,90.9,87.9 to 93.4,1271
Hib,Primary Series,States/Local Areas,Texas,2017-2018,Age,35 Months,91.9,89.9 to 93.6,2336
Hib,Primary Series,States/Local Areas,Texas,2013,Age,13 Months,85.6,83.3 to 87.6,1375
Hib,Primary Series,States/Local Areas,Texas,2013-2014,Age,13 Months,85.2,83.5 to 86.8,2788
Hib,Primary Series,States/Local Areas,Texas,2012,Age,13 Months,86.5,84.6 to 88.2,1359
Hib,Primary Series,States/Local Areas,Texas,2011,Age,13 Months,88.3,82.7 to 92.3,1195
Hib,Primary Series,States/Local Areas,Texas,2018,Age,7 Months,76.0,71.7 to 79.8,1065
Hib,Primary Series,States/Local Areas,Texas,2018-2019,Age,7 Months,74.9,71.6 to 78.0,1984
Hib,Primary Series,States/Local Areas,Texas,2014,Age,7 Months,67.5,64.1 to 70.8,1413
Hib,Primary Series,States/Local Areas,Texas,2014-2015,Age,7 Months,69.4,67.0 to 71.6,3053
Hib,Primary Series,States/Local Areas,Texas,2015,Age,7 Months,71.1,68.0 to 74.1,1640
Hib,Primary Series,States/Local Areas,Texas,2015-2016,Age,7 Months,70.1,67.9 to 72.3,3243
Hib,Primary Series,States/Local Areas,Texas,2013,Age,7 Months,66.4,61.5 to 70.9,1375
Hib,Primary Series,States/Local Areas,Texas,2013-2014,Age,7 Months,67.0,64.3 to 69.6,2788
Hib,Primary Series,States/Local Areas,Texas,2012,Age,7 Months,65.3,62.1 to 68.4,1359
Hib,Primary Series,States/Local Areas,Texas,2014,Age,13 Months,84.9,82.0 to 87.3,1413
Hib,Primary Series,States/Local Areas,Texas,2014-2015,Age,13 Months,86.1,84.3 to 87.8,3053
Hib,Primary Series,States/Local Areas,Texas,2015,Age,13 Months,87.4,85.0 to 89.4,1640
Hib,Primary Series,States/Local Areas,Texas,2015-2016,Age,13 Months,86.0,84.2 to 87.6,3243
Hib,Primary Series,States/Local Areas,Texas,2019,Age,7 Months,73.9,68.6 to 78.6,919
Hib,Primary Series,States/Local Areas,Texas,2012,Age,24 Months,92.3,89.8 to 94.4,1359
Hib,Primary Series,States/Local Areas,Texas,2011,Age,24 Months,93.4,90.5 to 95.6,1195
Hib,Primary Series,States/Local Areas,Texas,2019,Age,19 Months,91.3,87.8 to 93.8,919
Hib,Primary Series,States/Local Areas,Texas,2016,Age,19 Months,90.7,88.4 to 92.6,1603
Hib,Primary Series,States/Local Areas,Texas,2016-2017,Age,19 Months,90.0,88.2 to 91.6,2874
Hib,Primary Series,States/Local Areas,Texas,2016,Age,7 Months,69.1,65.8 to 72.2,1603
Hib,Primary Series,States/Local Areas,Texas,2016-2017,Age,7 Months,69.9,67.4 to 72.2,2874
Hib,Primary Series,States/Local Areas,Texas,2017,Age,7 Months,70.7,66.9 to 74.2,1271
Hib,Primary Series,States/Local Areas,Texas,2017-2018,Age,7 Months,73.3,70.5 to 75.9,2336
Hib,Primary Series,States/Local Areas,Texas,2018,Age,19 Months,92.1,89.1 to 94.4,1065
Hib,Primary Series,States/Local Areas,Texas,2018-2019,Age,19 Months,87.5,84.9 to 89.7,1984
Hib,Primary Series,States/Local Areas,Texas,2017,Age,19 Months,89.3,86.4 to 91.7,1271
Hib,Primary Series,States/Local Areas,Texas,2017-2018,Age,19 Months,90.7,88.7 to 92.4,2336
Hib,Primary Series,States/Local Areas,Texas,2015,Age,19 Months,92.0,89.6 to 93.9,1640
Hib,Primary Series,States/Local Areas,Texas,2015-2016,Age,19 Months,91.3,89.8 to 92.6,3243
Hib,Primary Series,States/Local Areas,Texas,2016,Age,13 Months,84.6,81.9 to 87.0,1603
Hib,Primary Series,States/Local Areas,Texas,2016-2017,Age,13 Months,84.6,82.4 to 86.4,2874
Hib,Primary Series,States/Local Areas,Texas,2018,Age,13 Months,87.5,83.9 to 90.5,1065
Hib,Primary Series,States/Local Areas,Texas,2018-2019,Age,13 Months,87.5,84.9 to 89.7,1984
Hib,Primary Series,States/Local Areas,Texas,2017,Age,13 Months,84.5,81.2 to 87.3,1271
Hib,Primary Series,States/Local Areas,Texas,2017-2018,Age,13 Months,86.0,83.6 to 88.1,2336
Hib,Primary Series,States/Local Areas,Texas,2019,Age,13 Months,87.4,83.5 to 90.5,919
Hib,Primary Series,States/Local Areas,Texas,2012,Age,19 Months,91.5,89.9 to 92.9,1359
Hep B,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,90.4,87.5 to 92.7,1714
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,95.1,93.4 to 96.8,1354
Hib,Full Series,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,79.3,76.5 to 82.1,2285
Hib,Primary Series,States/Local Areas,Texas,2014,Age,19 Months,88.9,86.3 to 91.1,1413
Hib,Primary Series,States/Local Areas,Texas,2014-2015,Age,19 Months,90.4,88.8 to 91.8,3053
Hib,Primary Series,States/Local Areas,Texas,2013,Age,19 Months,90.4,88.3 to 92.3,1375
Hib,Primary Series,States/Local Areas,Texas,2013-2014,Age,19 Months,89.7,87.8 to 91.2,2788
Hib,Primary Series,States/Local Areas,Texas,2011,Age,19 Months,92.5,88.3 to 95.3,1195
PCV,≥3 Doses,States/Local Areas,Texas,2020,Age,13 Months,84.1,78.3 to 88.7,795
≥1 Dose Varicella,,States/Local Areas,Texas,2020,Age,13 Months,70.3,63.8 to 76.1,795
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.6,86.0 to 91.3,1538
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,79.2,76.6 to 81.8,2786
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.7,76.5 to 83.0,1538
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,74.8,66.8 to 82.8,225
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,92.3,90.8 to 93.9,2786
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,88.8 to 93.6,1538
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,87.5,81.7 to 93.3,225
Rotavirus,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.0,71.6 to 78.5,1538
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,86.5,80.4 to 92.5,225
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,82.4,79.2 to 85.5,2786
PCV,≥3 Doses,States/Local Areas,Texas,2020,Age,7 Months,67.6,60.7 to 73.9,795
Hep B,≥3 Doses,States/Local Areas,Texas,2020,Age,7 Months,64.7,58.0 to 70.9,795
Polio,≥1 Dose,States/Local Areas,Texas,2020,Age,3 Months,83.1,77.1 to 87.8,795
Hib,≥1 Dose,States/Local Areas,Texas,2020,Age,3 Months,80.4,74.2 to 85.4,795
Rotavirus,,States/Local Areas,Texas,2019-2020,Age,8 Months,74.3,70.1 to 78.1,1714
Hep B,≥2 Doses,States/Local Areas,Texas,2020,Age,5 Months,84.9,79.2 to 89.2,795
DTaP,≥1 Dose,States/Local Areas,Texas,2020,Age,3 Months,83.7,77.7 to 88.3,795
Hib,≥2 Doses,States/Local Areas,Texas,2020,Age,5 Months,74.5,67.9 to 80.2,795
Polio,≥2 Doses,States/Local Areas,Texas,2020,Age,5 Months,76.6,70.0 to 82.0,795
DTaP,≥2 Doses,States/Local Areas,Texas,2020,Age,5 Months,77.1,70.7 to 82.6,795
Hib,≥2 Doses,States/Local Areas,Texas,2020,Age,13 Months,89.9,85.0 to 93.3,795
Hep B,≥1 Dose,States/Local Areas,Texas,2020,Age,3 Months,94.8,91.4 to 96.9,795
PCV,≥1 Dose,States/Local Areas,Texas,2020,Age,3 Months,81.6,75.2 to 86.6,795
Hep A,≥1 Dose,States/Local Areas,Texas,2020,Age,24 Months,89.5,85.1 to 93.0,795
Hep A,≥2 Doses,States/Local Areas,Texas,2020,Age,24 Months,51.5,44.7 to 58.8,795
PCV,≥3 Doses,States/Local Areas,Texas,2020,Age,24 Months,87.1,81.8 to 91.4,795
PCV,≥4 Doses,States/Local Areas,Texas,2020,Age,24 Months,78.7,72.7 to 84.2,795
≥1 Dose Varicella,,States/Local Areas,Texas,2020,Age,24 Months,88.1,83.4 to 92.0,795
Influenza,,States/Local Areas,Texas,2020,Age,24 Months,53.3,46.5 to 60.3,795
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2020,Age,0-3 Days,84.3,79.6 to 88.1,795
Rotavirus,,States/Local Areas,Texas,2020,Age,8 Months,73.8,67.2 to 79.5,795
Hib,≥3 Doses,States/Local Areas,Texas,2020,Age,19 Months,89.0,84.2 to 92.5,795
Combined 7 Series,,States/Local Areas,Texas,2020,Age,24 Months,64.9,58.3 to 71.5,795
≥1 Dose MMR,,States/Local Areas,Texas,2020,Age,19 Months,87.7,82.8 to 91.3,795
Polio,≥3 Doses,States/Local Areas,Texas,2020,Age,19 Months,89.8,84.9 to 93.2,795
DTaP,≥4 Doses,States/Local Areas,Texas,2020,Age,19 Months,68.7,61.9 to 74.8,795
DTaP,≥3 Doses,States/Local Areas,Texas,2020,Age,19 Months,90.1,85.2 to 93.4,795
DTaP,≥3 Doses,States/Local Areas,Texas,2020,Age,7 Months,71.3,64.5 to 77.2,795
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,68.4,59.7 to 77.2,252
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.3,79.7 to 90.8,331
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.9 to 92.8,1416
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.9,60.4 to 73.4,517
Rotavirus,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.9,74.2 to 81.5,1416
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,87.2 to 94.7,517
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,74.8,71.8 to 77.7,2267
Rotavirus,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.4,65.8 to 79.0,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.1,74.7 to 85.5,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.7,66.8 to 80.5,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,79.6,76.8 to 82.3,2267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,75.3,66.2 to 84.4,250
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.7,79.0 to 90.4,331
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.6,89.3 to 93.9,1416
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,80.0,72.0 to 88.0,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,81.4,78.5 to 84.3,1780
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,86.7 to 93.9,517
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,89.3,87.1 to 91.5,2285
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,94.0,92.3 to 95.6,2267
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,91.0,89.0 to 93.0,2267
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,80.2,72.4 to 87.9,250
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,89.3,83.4 to 95.2,252
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,45.3,35.6 to 55.0,250
Rotavirus,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,82.8,80.2 to 85.3,2267
Rotavirus,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.6,71.1 to 82.1,517
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.1,72.5 to 83.7,517
Influenza,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,47.0,43.2 to 50.7,1780
Influenza,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,64.9,61.6 to 68.2,2267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,84.5,81.9 to 87.0,2285
Influenza,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,42.8,32.8 to 52.8,252
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,45.6,34.0 to 57.2,250
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,81.6,72.8 to 90.5,252
Hib,Full Series,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.1,75.5 to 82.8,1416
Rotavirus,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,77.6,70.0 to 85.1,252
Rotavirus,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,72.7,69.5 to 75.9,1780
Rotavirus,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,56.2,46.1 to 66.3,250
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.8,50.2 to 65.4,331
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.3,66.4 to 74.3,1416
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,79.4,71.5 to 87.3,250
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,69.7,66.5 to 72.9,2285
Rotavirus,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,76.6,73.8 to 79.5,2285
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,82.8,80.2 to 85.4,2285
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.5,66.7 to 80.3,331
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.1,80.8 to 87.4,1416
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,80.7,73.1 to 88.3,250
Influenza,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",48.4,40.6 to 56.1,331
Influenza,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",59.8,55.6 to 64.0,1416
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,63.5,53.8 to 73.3,250
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.7,84.9 to 94.5,331
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,88.4 to 93.7,1416
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,90.3,88.1 to 92.5,1780
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,84.9,82.4 to 87.3,2267
Influenza,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,31.7,22.9 to 40.5,250
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,85.2 to 93.1,517
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,83.0,78.3 to 87.6,1780
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,83.8,80.8 to 86.9,2267
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,79.7,76.8 to 82.5,2285
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.1,63.1 to 77.2,331
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,91.1,85.5 to 96.7,252
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.1,73.7 to 84.6,517
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,80.7,73.1 to 88.4,250
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,78.9,75.8 to 82.0,1780
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.2,84.3 to 94.0,331
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,88.4,85.9 to 90.8,1780
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,91.7,89.7 to 93.6,2267
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,81.0,73.9 to 88.1,252
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,91.9,87.5 to 96.2,252
Influenza,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,51.3,47.9 to 54.7,2285
Rotavirus,,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,85.4,82.4 to 88.3,1354
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,90.9,89.5 to 92.3,4549
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,79.2,77.2 to 81.1,4549
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,87.2,84.4 to 90.0,1546
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,91.3,90.0 to 92.6,4549
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,73.8,70.2 to 77.3,1649
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Overall,Overall,89.5,88.0 to 91.0,4549
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,86.9,84.1 to 89.7,1649
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,91.7,89.6 to 93.8,1546
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,86.2,82.9 to 89.6,1354
Influenza,,States/Local Areas,Texas,2016-2019,Overall,Overall,53.7,51.3 to 56.1,4549
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,88.5,86.0 to 91.1,1649
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,86.0,83.1 to 88.9,1649
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Overall,Overall,88.3,86.7 to 89.9,4549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Overall,Overall,80.2,78.3 to 82.1,4549
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,81.1,78.4 to 83.9,4549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,80.4,77.2 to 83.6,1649
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Overall,Overall,68.2,66.0 to 70.5,4549
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,78.1,73.2 to 83.1,1649
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,95.2,93.5 to 96.9,1354
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Overall,Overall,89.2,87.7 to 90.7,4549
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,80.0,76.7 to 83.4,1354
Rotavirus,,States/Local Areas,Texas,2016-2019,Overall,Overall,76.5,74.5 to 78.5,4549
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,89.0,86.6 to 91.5,1546
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,91.6,89.2 to 94.0,1354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,80.4,77.2 to 83.5,1546
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,65.6,61.7 to 69.6,1546
Hib,Full Series,States/Local Areas,Texas,2016-2019,Overall,Overall,77.6,75.6 to 79.7,4549
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,63.0,59.2 to 66.8,1649
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,94.8,93.0 to 96.5,1354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,83.8,76.1 to 91.4,225
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.6,86.0 to 91.3,1538
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,80.6,78.0 to 83.1,2786
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,87.1,81.2 to 93.1,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.2,76.1 to 82.3,1538
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,89.9,84.8 to 95.0,225
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.1,87.5 to 92.6,1538
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,68.4,65.4 to 71.3,2786
Influenza,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,53.0,49.2 to 56.8,1538
Influenza,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,43.6,33.5 to 53.6,225
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,90.1 to 93.3,2786
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,91.7,87.0 to 96.4,225
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,89.3,87.3 to 91.2,2786
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,89.9,88.1 to 91.8,2786
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,89.5,87.1 to 92.0,1354
Rotavirus,,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,71.3,67.9 to 74.7,1649
Rotavirus,,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,76.0,72.5 to 79.5,1546
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,92.6,90.5 to 94.8,1354
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,81.6,76.9 to 86.2,1546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,79.6,76.0 to 83.1,1354
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,92.0,89.9 to 94.1,1546
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,91.8,90.5 to 93.1,4549
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,89.4,86.9 to 92.0,1649
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,92.1,90.0 to 94.3,1354
Influenza,,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,44.0,40.1 to 47.9,1649
Influenza,,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,51.7,47.6 to 55.9,1546
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,88.5,86.9 to 90.0,4549
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,86.8,84.0 to 89.6,1649
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,89.8,87.4 to 92.2,1546
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,90.9,88.6 to 93.2,1546
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,86.9,84.1 to 89.7,1649
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,90.2,87.8 to 92.6,1546
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,90.3,88.0 to 92.7,1354
Hib,Full Series,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,72.9,69.4 to 76.5,1649
Hib,Full Series,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,75.6,71.9 to 79.2,1546
Hib,Full Series,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,88.0,85.4 to 90.6,1354
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,88.4,85.8 to 91.0,1649
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Poverty,<133% FPL,76.8,73.5 to 80.1,1649
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,91.9,89.7 to 94.0,1354
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,81.3,78.0 to 84.5,1546
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Overall,Overall,81.6,79.7 to 83.4,4549
Influenza,,States/Local Areas,Texas,2016-2019,Poverty,>400% FPL,72.0,67.9 to 76.0,1354
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,64.7,61.1 to 68.3,1780
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,91.1,89.0 to 93.3,1780
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,83.2 to 92.3,517
Hib,Full Series,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.9,73.5 to 80.2,1538
Hib,Full Series,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,78.1,75.5 to 80.8,2786
Rotavirus,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,75.1,67.1 to 83.0,225
≥1 Dose MMR,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,90.7,88.9 to 92.4,2786
Hib,Full Series,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,79.1,71.8 to 86.5,225
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,89.4,87.5 to 91.3,2786
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.1,84.4 to 89.9,1538
Rotavirus,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,77.9,75.5 to 80.3,2786
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,65.0,56.1 to 73.9,225
Influenza,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,55.7,52.6 to 58.9,2786
Combined 7 Series,,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.5,64.8 to 72.1,1538
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,82.3,80.0 to 84.6,2786
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,80.1,72.7 to 87.5,225
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.9,77.7 to 84.1,1538
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Principal City,92.0,90.4 to 93.5,2786
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,91.3,86.6 to 96.1,225
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.5,88.1 to 92.9,1538
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,88.1,81.9 to 94.3,225
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,92.1,90.2 to 94.0,2285
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.5,85.8 to 95.1,331
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.4,83.5 to 93.4,331
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.6,84.9 to 90.2,1538
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.2,75.4 to 85.0,1538
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Urbanicity,Living In a Non-MSA,75.9,65.3 to 86.4,225
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,88.9,86.6 to 91.1,2285
Hib,≥3 Doses,States/Local Areas,Texas,2021,Age,19 Months,90.1,82.5 to 94.6,446
Hep B,≥2 Doses,States/Local Areas,Texas,2021,Age,7 Months,93.6,88.2 to 96.6,446
≥1 Dose MMR,,States/Local Areas,Texas,2021,Age,35 Months,97.3,94.2 to 99.0,446
Hib,≥2 Doses,States/Local Areas,Texas,2021,Age,7 Months,85.4,76.1 to 91.5,446
Hib,≥3 Doses,States/Local Areas,Texas,2021,Age,7 Months,56.3,46.7 to 65.3,446
Polio,≥2 Doses,States/Local Areas,Texas,2021,Age,7 Months,89.6,82.0 to 94.2,446
Polio,≥3 Doses,States/Local Areas,Texas,2021,Age,35 Months,98.7,94.4 to 99.8,446
DTaP,≥3 Doses,States/Local Areas,Texas,2021,Age,7 Months,71.7,62.3 to 79.6,446
PCV,≥2 Doses,States/Local Areas,Texas,2021,Age,5 Months,76.2,66.8 to 83.5,446
Hib,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,90.7,87.0 to 93.7,1241
Hep B,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,92.9,89.7 to 95.2,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,92.2,88.8 to 94.6,1241
PCV,≥3 Doses,States/Local Areas,Texas,2021,Age,35 Months,95.7,92.6 to 97.8,446
Hib,Primary Series,States/Local Areas,Texas,2021,Age,7 Months,65.6,55.9 to 74.1,446
Combined 7 Series,,States/Local Areas,Texas,2021,Age,35 Months,93.7,77.5 to 99.4,446
DTaP,≥1 Dose,States/Local Areas,Texas,2013,Age,3 Months,87.8,84.4 to 90.6,1375
DTaP,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,3 Months,86.5,84.3 to 88.4,2788
DTaP,≥1 Dose,States/Local Areas,Texas,2014,Age,3 Months,85.2,82.4 to 87.6,1413
DTaP,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,3 Months,86.8,85.0 to 88.4,3053
DTaP,≥1 Dose,States/Local Areas,Texas,2015,Age,3 Months,88.4,86.0 to 90.5,1640
DTaP,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,3 Months,88.3,86.6 to 89.8,3243
DTaP,≥1 Dose,States/Local Areas,Texas,2016,Age,3 Months,88.2,85.7 to 90.3,1603
DTaP,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,3 Months,87.2,85.3 to 88.9,2874
DTaP,≥1 Dose,States/Local Areas,Texas,2012,Age,3 Months,86.0,84.1 to 87.7,1359
DTaP,≥1 Dose,States/Local Areas,Texas,2011,Age,3 Months,87.2,81.8 to 91.2,1195
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,86.8 to 94.3,517
Hib,≥1 Dose,States/Local Areas,Texas,2021,Age,3 Months,81.1,71.8 to 87.8,446
Hep B,≥3 Doses,States/Local Areas,Texas,2021,Age,19 Months,92.8,87.4 to 96.0,446
DTaP,≥4 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,87.2,81.4 to 91.9,1241
PCV,≥4 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,82.2,77.8 to 86.2,1241
Hep B,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,88.6,84.5 to 91.7,1241
Hib,Primary Series,States/Local Areas,Texas,2021,Age,19 Months,91.8,84.6 to 95.8,446
Hib,≥2 Doses,States/Local Areas,Texas,2021,Age,5 Months,71.5,61.6 to 79.7,446
Hib,Full Series,States/Local Areas,Texas,2021,Age,19 Months,74.5,65.5 to 81.8,446
Hep B,≥3 Doses,States/Local Areas,Texas,2020,Age,13 Months,87.6,83.0 to 91.1,795
Hep B,≥2 Doses,States/Local Areas,Texas,2020,Age,13 Months,91.5,87.0 to 94.5,795
Hib,Primary Series,States/Local Areas,Texas,2020,Age,13 Months,84.4,78.9 to 88.7,795
Hib,≥3 Doses,States/Local Areas,Texas,2020,Age,13 Months,81.7,76.0 to 86.3,795
PCV,≥3 Doses,States/Local Areas,Texas,2020,Age,35 Months,88.3,83.0 to 92.6,795
PCV,≥4 Doses,States/Local Areas,Texas,2020,Age,19 Months,76.8,70.5 to 82.1,795
PCV,≥3 Doses,States/Local Areas,Texas,2020,Age,19 Months,86.7,81.1 to 90.9,795
DTaP,≥4 Doses,States/Local Areas,Texas,2020,Age,35 Months,84.0,76.7 to 90.0,795
Polio,≥3 Doses,States/Local Areas,Texas,2020,Age,35 Months,90.5,86.0 to 94.0,795
≥1 Dose Varicella,,States/Local Areas,Texas,2020,Age,19 Months,87.2,82.2 to 90.9,795
DTaP,≥3 Doses,States/Local Areas,Texas,2020,Age,35 Months,90.9,86.4 to 94.3,795
Hib,Full Series,States/Local Areas,Texas,2020,Age,19 Months,73.6,67.3 to 79.1,795
Hep B,≥3 Doses,States/Local Areas,Texas,2020,Age,19 Months,88.4,83.8 to 91.8,795
≥1 Dose Varicella,,States/Local Areas,Texas,2020,Age,35 Months,91.8,86.5 to 95.6,795
Hib,Primary Series,States/Local Areas,Texas,2020,Age,19 Months,89.3,84.5 to 92.8,795
Hib,Full Series,States/Local Areas,Texas,2020,Age,35 Months,79.9,73.9 to 85.2,795
Hep B,≥3 Doses,States/Local Areas,Texas,2020,Age,35 Months,92.1,87.4 to 95.5,795
Hib,≥3 Doses,States/Local Areas,Texas,2020,Age,35 Months,90.0,85.4 to 93.6,795
Hib,Primary Series,States/Local Areas,Texas,2020,Age,35 Months,90.2,85.6 to 93.8,795
Hib,≥3 Doses,States/Local Areas,Texas,2020,Age,24 Months,89.5,85.0 to 93.1,795
≥1 Dose MMR,,States/Local Areas,Texas,2020,Age,35 Months,91.4,86.2 to 95.2,795
Polio,≥3 Doses,States/Local Areas,Texas,2020,Age,24 Months,90.2,85.8 to 93.8,795
≥1 Dose MMR,,States/Local Areas,Texas,2020,Age,24 Months,88.7,84.2 to 92.5,795
DTaP,≥4 Doses,States/Local Areas,Texas,2020,Age,24 Months,76.3,69.9 to 82.2,795
PCV,≥2 Doses,States/Local Areas,Texas,2020,Age,5 Months,73.9,67.1 to 79.7,795
DTaP,≥3 Doses,States/Local Areas,Texas,2020,Age,24 Months,90.5,86.0 to 94.0,795
Hep B,≥2 Doses,States/Local Areas,Texas,2020,Age,7 Months,88.9,83.9 to 92.5,795
Hib,Primary Series,States/Local Areas,Texas,2020,Age,7 Months,70.1,63.4 to 76.1,795
Hib,≥3 Doses,States/Local Areas,Texas,2020,Age,7 Months,64.9,58.0 to 71.1,795
Polio,≥2 Doses,States/Local Areas,Texas,2020,Age,7 Months,85.3,79.5 to 89.7,795
Hib,≥2 Doses,States/Local Areas,Texas,2020,Age,7 Months,84.8,79.0 to 89.3,795
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2020,Age,0-1 Days,81.0,75.7 to 85.3,795
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2020,Age,0-2 Days,82.8,77.8 to 86.9,795
Hep A,≥2 Doses,States/Local Areas,Texas,2020,Age,19 Months,31.1,25.2 to 37.7,795
Hep A,≥1 Dose,States/Local Areas,Texas,2020,Age,19 Months,84.8,79.7 to 88.7,795
Hep A,≥2 Doses,States/Local Areas,Texas,2020,Age,35 Months,77.7,69.9 to 84.7,795
≥1 Dose MMR,,States/Local Areas,Texas,2020,Age,13 Months,71.9,65.5 to 77.6,795
Combined 7 Series,,States/Local Areas,Texas,2020,Age,35 Months,71.9,64.1 to 79.3,795
Hep A,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,24 Months,89.3,86.5 to 91.7,1714
Hep A,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,81.5,76.4 to 86.0,1714
Hep A,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,54.5,50.0 to 59.1,1714
Hep A,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,35 Months,93.6,90.6 to 95.9,1714
Hib,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,90.2,87.4 to 92.7,1714
Influenza,,States/Local Areas,Texas,2019-2020,Age,24 Months,54.4,50.0 to 58.9,1714
Hib,Primary Series,States/Local Areas,Texas,2019-2020,Age,24 Months,90.5,87.7 to 92.9,1714
Hib,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,88.1,84.7 to 90.8,1714
Combined 7 Series,,States/Local Areas,Texas,2019-2020,Age,35 Months,73.0,68.3 to 77.6,1714
Hib,Full Series,States/Local Areas,Texas,2019-2020,Age,19 Months,74.7,70.7 to 78.4,1714
Hep B,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,87.9,84.8 to 90.4,1714
≥1 Dose Varicella,,States/Local Areas,Texas,2019-2020,Age,19 Months,87.1,84.0 to 89.7,1714
PCV,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,88.8,85.5 to 91.4,1714
PCV,≥4 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,78.7,74.7 to 82.2,1714
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2019-2020,Age,0-1 Days,80.0,76.5 to 83.1,1714
Hep A,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,19 Months,85.2,82.0 to 87.9,1714
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2019-2020,Age,0-2 Days,81.9,78.6 to 84.9,1714
PCV,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,69.2,64.7 to 73.3,1714
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2019-2020,Age,0-3 Days,82.8,79.5 to 85.7,1714
Hib,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,64.5,60.1 to 68.7,1714
Hep B,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,89.1,86.2 to 91.6,1714
Hib,Full Series,States/Local Areas,Texas,2019-2020,Age,24 Months,78.5,74.8 to 82.1,1714
PCV,≥4 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,80.6,76.9 to 84.2,1714
PCV,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,89.2,86.1 to 91.9,1714
≥1 Dose Varicella,,States/Local Areas,Texas,2019-2020,Age,24 Months,89.0,86.1 to 91.5,1714
Hep A,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,32.7,28.7 to 36.9,1714
≥1 Dose MMR,,States/Local Areas,Texas,2019-2020,Age,19 Months,87.1,83.9 to 89.7,1714
Hib,Primary Series,States/Local Areas,Texas,2019-2020,Age,19 Months,90.1,87.1 to 92.4,1714
Hib,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,89.7,86.8 to 92.1,1714
≥1 Dose MMR,,States/Local Areas,Texas,2019-2020,Age,35 Months,92.5,89.2 to 95.1,1714
Hib,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,91.8,89.0 to 94.2,1714
Hib,Primary Series,States/Local Areas,Texas,2019-2020,Age,35 Months,92.0,89.2 to 94.3,1714
Hib,Full Series,States/Local Areas,Texas,2019-2020,Age,35 Months,81.3,77.5 to 84.8,1714
Hep B,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,92.9,89.9 to 95.3,1714
≥1 Dose Varicella,,States/Local Areas,Texas,2019-2020,Age,35 Months,92.8,89.6 to 95.3,1714
PCV,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,90.6,87.4 to 93.2,1714
PCV,≥4 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,82.6,78.8 to 86.1,1714
Polio,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,90.5,87.7 to 93.0,1714
DTaP,≥4 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,77.7,73.7 to 81.4,1714
DTaP,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,24 Months,91.2,88.4 to 93.5,1714
≥1 Dose MMR,,States/Local Areas,Texas,2019-2020,Age,24 Months,89.1,86.1 to 91.6,1714
PCV,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,3 Months,84.6,80.8 to 87.7,1714
Hep B,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,3 Months,95.3,93.2 to 96.8,1714
DTaP,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,5 Months,80.4,76.5 to 83.9,1714
Hib,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,5 Months,78.6,74.5 to 82.1,1714
Polio,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,5 Months,80.0,76.1 to 83.5,1714
≥1 Dose MMR,,States/Local Areas,Texas,2019-2020,Age,13 Months,70.2,65.9 to 74.2,1714
Polio,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,91.3,88.3 to 93.5,1714
Polio,≥2 Doses,States/Local Areas,Texas,2020,Age,13 Months,90.0,85.2 to 93.4,795
Hib,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,81.2,77.5 to 84.4,1714
Hib,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,91.4,88.6 to 93.6,1714
DTaP,≥3 Doses,States/Local Areas,Texas,2020,Age,13 Months,86.7,81.5 to 90.6,795
Hib,Primary Series,States/Local Areas,Texas,2019-2020,Age,13 Months,85.6,82.2 to 88.4,1714
Hep B,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,5 Months,87.4,84.1 to 90.0,1714
PCV,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,5 Months,78.0,73.9 to 81.7,1714
Polio,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,88.4,84.9 to 91.1,1714
DTaP,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,72.1,67.8 to 76.1,1714
Hep B,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,87.0,83.9 to 89.5,1714
Hep B,≥2 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,92.8,90.2 to 94.7,1714
PCV,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,86.0,82.5 to 89.0,1714
≥1 Dose Varicella,,States/Local Areas,Texas,2019-2020,Age,13 Months,68.5,64.2 to 72.5,1714
DTaP,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,93.8,91.1 to 96.0,1714
Combined 7 Series,,States/Local Areas,Texas,2019-2020,Age,24 Months,67.2,63.0 to 71.4,1714
DTaP,≥4 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,84.4,80.1 to 88.1,1714
Polio,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,35 Months,92.7,89.8 to 95.0,1714
DTaP,≥4 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,70.3,66.0 to 74.2,1714
DTaP,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,90.7,87.7 to 92.9,1714
Polio,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,19 Months,90.0,87.0 to 92.3,1714
Hep B,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,7 Months,64.0,59.5 to 68.2,1714
DTaP,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,3 Months,86.0,82.4 to 88.9,1714
DTaP,≥3 Doses,States/Local Areas,Texas,2019-2020,Age,13 Months,87.4,84.1 to 90.1,1714
Hib,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,3 Months,83.9,80.2 to 87.1,1714
Polio,≥1 Dose,States/Local Areas,Texas,2019-2020,Age,3 Months,85.4,81.8 to 88.4,1714
Hep A,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,35 Months,94.5,91.6 to 96.7,1241
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,89.4,87.2 to 91.6,2285
Influenza,,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",55.9,48.9 to 62.9,517
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,77.1,68.9 to 85.4,250
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,90.8,85.2 to 96.4,252
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,89.1 to 94.0,1416
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,87.4,84.8 to 89.9,1780
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,90.3,88.2 to 92.4,2267
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,59.7,50.0 to 69.5,250
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,78.5,70.8 to 86.1,252
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,76.1,72.8 to 79.4,1780
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.2,86.5 to 91.9,1416
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,90.9,85.6 to 96.2,252
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,89.9,84.5 to 95.4,252
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.3,78.6 to 90.0,331
Hib,Full Series,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,78.3,70.8 to 85.9,252
Hib,Full Series,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,74.9,71.6 to 78.2,1780
Hib,Full Series,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,55.3,45.2 to 65.3,250
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,89.9,87.6 to 92.2,1780
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,93.5,91.7 to 95.2,2267
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,76.6,68.3 to 85.0,250
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Other,88.6,82.1 to 95.0,252
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,89.1,86.7 to 91.5,1780
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2019,Insurance Coverage,Uninsured,75.9,67.1 to 84.8,250
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,89.7 to 94.5,1416
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.1,78.6 to 85.6,1416
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.0,85.1 to 90.8,1416
Hib,Full Series,States/Local Areas,Texas,2019,Age,19 Months,76.2,71.2 to 80.6,919
DTaP,≥3 Doses,States/Local Areas,Texas,2019,Age,24 Months,92.5,89.3 to 95.0,919
Hib,≥3 Doses,States/Local Areas,Texas,2012,Age,35 Months,92.8,90.1 to 94.9,1359
Hib,≥3 Doses,States/Local Areas,Texas,2011,Age,35 Months,93.6,90.7 to 95.9,1195
Hep A,≥1 Dose,States/Local Areas,Texas,2017,Age,24 Months,86.7,83.7 to 89.4,1271
Hep A,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,24 Months,88.8,86.8 to 90.7,2336
Hep A,≥1 Dose,States/Local Areas,Texas,2019,Age,24 Months,88.7,84.9 to 91.9,919
Hep A,≥1 Dose,States/Local Areas,Texas,2011,Age,35 Months,91.5,87.0 to 94.9,1195
Hep A,≥1 Dose,States/Local Areas,Texas,2018,Age,24 Months,91.1,88.3 to 93.4,1065
Hep A,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,24 Months,89.9,87.5 to 91.9,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,93.1,88.1 to 98.0,315
Hep A,≥1 Dose,States/Local Areas,Texas,2012,Age,24 Months,88.5,85.5 to 91.0,1359
Hep A,≥1 Dose,States/Local Areas,Texas,2019,Age,19 Months,85.9,81.6 to 89.2,919
Hep A,≥1 Dose,States/Local Areas,Texas,2011,Age,24 Months,85.8,81.9 to 89.1,1195
Hep A,≥1 Dose,States/Local Areas,Texas,2013,Age,24 Months,86.4,83.5 to 88.9,1375
Hep A,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,24 Months,87.4,85.5 to 89.1,2788
DTaP,≥3 Doses,States/Local Areas,Texas,2017,Age,35 Months,90.0,87.1 to 92.6,1271
DTaP,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,93.2,90.6 to 95.3,2336
DTaP,≥4 Doses,States/Local Areas,Texas,2011,Age,19 Months,63.7,60.4 to 66.8,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2014,Age,19 Months,24.2,21.4 to 27.3,1413
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,26.2,24.1 to 28.3,3053
DTaP,≥4 Doses,States/Local Areas,Texas,2012,Age,19 Months,72.4,69.4 to 75.1,1359
PCV,≥2 Doses,States/Local Areas,Texas,2013,Age,5 Months,75.2,71.9 to 78.2,1375
PCV,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,5 Months,75.5,72.9 to 77.9,2788
PCV,≥2 Doses,States/Local Areas,Texas,2012,Age,5 Months,74.3,72.0 to 76.4,1359
PCV,≥2 Doses,States/Local Areas,Texas,2011,Age,5 Months,73.7,65.2 to 80.7,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2015,Age,35 Months,95.8,93.9 to 97.3,1640
DTaP,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,94.8,93.4 to 96.0,3243
DTaP,≥3 Doses,States/Local Areas,Texas,2016,Age,35 Months,93.7,91.5 to 95.5,1603
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,92.0,90.1 to 93.6,2874
Hep A,≥1 Dose,States/Local Areas,Texas,2015,Age,24 Months,89.6,87.4 to 91.5,1640
Hep A,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,24 Months,88.8,87.2 to 90.3,3243
Hep A,≥1 Dose,States/Local Areas,Texas,2016,Age,24 Months,88.0,85.6 to 90.3,1603
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,24 Months,87.4,85.5 to 89.1,2874
PCV,≥2 Doses,States/Local Areas,Texas,2014,Age,5 Months,75.7,72.6 to 78.6,1413
PCV,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,5 Months,76.8,74.2 to 79.2,3053
Hib,≥3 Doses,States/Local Areas,Texas,2015,Age,35 Months,94.7,92.5 to 96.5,1640
Hib,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,94.0,92.3 to 95.4,3243
Hep A,≥2 Doses,States/Local Areas,Texas,2015,Age,19 Months,28.1,25.2 to 31.2,1640
Hep A,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,28.9,26.8 to 31.1,3243
Hep A,≥2 Doses,States/Local Areas,Texas,2016,Age,19 Months,29.7,26.7 to 32.8,1603
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,31.1,28.7 to 33.6,2874
Hib,≥3 Doses,States/Local Areas,Texas,2013,Age,35 Months,92.2,89.7 to 94.4,1375
Hib,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,92.3,90.5 to 93.8,2788
Hib,≥3 Doses,States/Local Areas,Texas,2014,Age,35 Months,92.3,89.8 to 94.4,1413
Hib,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,93.5,91.8 to 94.9,3053
Hib,≥3 Doses,States/Local Areas,Texas,2019,Age,24 Months,91.5,88.2 to 94.1,919
Hib,≥3 Doses,States/Local Areas,Texas,2017,Age,24 Months,88.7,85.9 to 91.2,1271
Hib,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,90.2,88.2 to 92.0,2336
Hib,≥3 Doses,States/Local Areas,Texas,2018,Age,24 Months,91.6,88.6 to 94.1,1065
Hib,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,91.5,89.4 to 93.4,1984
Hep A,≥2 Doses,States/Local Areas,Texas,2013,Age,19 Months,26.4,22.8 to 30.4,1375
Hep A,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,25.3,23.0 to 27.8,2788
Hep A,≥2 Doses,States/Local Areas,Texas,2012,Age,19 Months,25.5,21.9 to 29.4,1359
DTaP,≥2 Doses,States/Local Areas,Texas,2019,Age,5 Months,84.2,79.6 to 87.8,919
Hep A,≥2 Doses,States/Local Areas,Texas,2011,Age,19 Months,20.7,16.3 to 25.9,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2014,Age,35 Months,93.8,91.4 to 95.7,1413
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,94.8,93.3 to 96.1,3053
DTaP,≥3 Doses,States/Local Areas,Texas,2013,Age,35 Months,93.5,91.1 to 95.5,1375
DTaP,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,93.6,92.0 to 95.0,2788
DTaP,≥3 Doses,States/Local Areas,Texas,2012,Age,35 Months,93.7,91.3 to 95.7,1359
DTaP,≥3 Doses,States/Local Areas,Texas,2011,Age,35 Months,95.2,92.5 to 97.1,1195
Hep A,≥1 Dose,States/Local Areas,Texas,2018,Age,19 Months,85.6,82.1 to 88.4,1065
Hep A,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,19 Months,86.0,83.3 to 88.4,1672
Hep A,≥1 Dose,States/Local Areas,Texas,2017,Age,19 Months,83.5,80.3 to 86.3,1271
Hep A,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,19 Months,84.5,82.2 to 86.6,2336
Hep A,≥1 Dose,States/Local Areas,Texas,2016,Age,19 Months,84.7,82.0 to 87.0,1603
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,19 Months,84.1,82.0 to 85.9,2874
Hib,Primary Series,States/Local Areas,Texas,2020-2021,Age,24 Months,91.1,87.3 to 94.0,1241
DTaP,≥1 Dose,States/Local Areas,Texas,2018,Age,3 Months,88.8,85.2 to 91.5,1065
DTaP,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,3 Months,88.8,86.2 to 91.0,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2015,Age,24 Months,93.6,91.8 to 95.2,1640
DTaP,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,92.8,91.4 to 94.0,3243
DTaP,≥1 Dose,States/Local Areas,Texas,2017,Age,3 Months,86.2,83.1 to 88.7,1271
DTaP,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,3 Months,87.5,85.2 to 89.4,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2014,Age,24 Months,92.0,89.8 to 93.9,1413
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,92.8,91.4 to 94.1,3053
DTaP,≥1 Dose,States/Local Areas,Texas,2019,Age,3 Months,88.8,84.8 to 91.9,919
Hep A,≥1 Dose,States/Local Areas,Texas,2011,Age,19 Months,80.3,73.9 to 85.5,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2013,Age,24 Months,91.6,89.2 to 93.7,1375
DTaP,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,91.8,90.2 to 93.2,2788
Hep A,≥1 Dose,States/Local Areas,Texas,2014,Age,19 Months,82.8,80.0 to 85.4,1413
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,19 Months,84.3,82.4 to 86.0,3053
Hep A,≥1 Dose,States/Local Areas,Texas,2015,Age,19 Months,85.7,84.3 to 87.1,1640
Hep A,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,19 Months,85.2,83.4 to 86.9,3243
Hep A,≥1 Dose,States/Local Areas,Texas,2012,Age,19 Months,85.0,82.4 to 87.3,1359
Hep A,≥1 Dose,States/Local Areas,Texas,2013,Age,19 Months,81.8,79.4 to 83.9,1375
Hep A,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,19 Months,82.3,80.6 to 83.9,2788
DTaP,≥2 Doses,States/Local Areas,Texas,2017,Age,5 Months,76.8,73.2 to 80.1,1271
DTaP,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,5 Months,80.4,77.8 to 82.8,2336
DTaP,≥2 Doses,States/Local Areas,Texas,2018,Age,5 Months,84.1,80.2 to 87.3,1065
DTaP,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,5 Months,84.1,81.2 to 86.6,1984
DTaP,≥2 Doses,States/Local Areas,Texas,2016,Age,5 Months,77.9,74.9 to 80.6,1603
DTaP,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,5 Months,77.4,75.0 to 79.5,2874
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,86.0,80.2 to 91.8,266
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.1,88.0 to 92.2,1801
DTaP,≥3 Doses,States/Local Areas,Texas,2018,Age,24 Months,93.9,91.4 to 95.9,1065
DTaP,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,93.2,91.3 to 94.9,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2017,Age,24 Months,89.1,86.2 to 91.6,1271
DTaP,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,91.5,89.6 to 93.1,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2016,Age,24 Months,91.9,89.7 to 93.7,1603
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,90.5,88.7 to 92.1,2874
Hib,≥3 Doses,States/Local Areas,Texas,2015,Age,24 Months,92.4,90.5 to 94.1,1640
Hib,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,91.6,90.2 to 93.0,3243
Hib,≥3 Doses,States/Local Areas,Texas,2016,Age,24 Months,90.8,88.6 to 92.8,1603
Hib,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,89.8,88.0 to 91.4,2874
Hib,≥3 Doses,States/Local Areas,Texas,2014,Age,24 Months,90.3,87.9 to 92.4,1413
Hib,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,91.3,89.8 to 92.7,3053
Hep A,≥2 Doses,States/Local Areas,Texas,2019,Age,19 Months,34.9,29.7 to 40.5,919
Hep A,≥2 Doses,States/Local Areas,Texas,2011,Age,24 Months,47.8,42.6 to 53.2,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2018,Age,19 Months,27.3,23.4 to 31.7,1065
Hep A,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,32.3,28.7 to 36.2,1672
Hib,≥3 Doses,States/Local Areas,Texas,2016,Age,35 Months,93.1,90.6 to 95.1,1603
Hib,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,91.6,89.6 to 93.4,2874
Hib,≥3 Doses,States/Local Areas,Texas,2017,Age,35 Months,89.9,87.0 to 92.4,1271
Hib,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,91.0,89.0 to 92.8,2336
DTaP,≥4 Doses,States/Local Areas,Texas,2013,Age,19 Months,69.7,66.0 to 73.2,1375
DTaP,≥4 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,68.3,65.7 to 70.8,2788
DTaP,≥4 Doses,States/Local Areas,Texas,2014,Age,19 Months,66.9,63.4 to 70.2,1413
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,68.2,65.9 to 70.5,3053
DTaP,≥4 Doses,States/Local Areas,Texas,2015,Age,19 Months,69.6,67.1 to 71.9,1640
DTaP,≥4 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,70.9,68.7 to 73.1,3243
Hep A,≥2 Doses,States/Local Areas,Texas,2017,Age,19 Months,32.6,28.8 to 36.5,1271
Hep A,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,30.0,27.2 to 32.9,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,94.1,92.6 to 95.7,2524
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,89.8,87.7 to 91.8,2412
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,89.9,88.6 to 91.3,5548
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,88.2,86.0 to 90.4,2381
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,89.6,87.2 to 92.1,1676
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,93.8,91.9 to 95.6,1491
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,79.9,72.5 to 87.2,297
DTaP,≥3 Doses,States/Local Areas,Texas,2019,Age,35 Months,95.8,92.8 to 97.8,919
DTaP,≥3 Doses,States/Local Areas,Texas,2018,Age,35 Months,95.8,92.7 to 97.8,1065
DTaP,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,96.0,93.8 to 97.6,1984
PCV,≥2 Doses,States/Local Areas,Texas,2015,Age,5 Months,77.9,75.0 to 80.5,1640
PCV,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,5 Months,76.4,74.3 to 78.4,3243
PCV,≥2 Doses,States/Local Areas,Texas,2016,Age,5 Months,75.0,71.8 to 77.9,1603
PCV,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,5 Months,74.9,72.5 to 77.2,2874
Hep A,≥1 Dose,States/Local Areas,Texas,2014,Age,24 Months,88.3,85.9 to 90.5,1413
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,24 Months,89.0,87.3 to 90.5,3053
Hep A,≥2 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,22.5,19.1 to 26.4,1050
Hep A,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,21.4,18.9 to 24.2,2042
DTaP,≥4 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,67.6,63.5 to 71.6,977
DTaP,≥4 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,65.4,60.7 to 69.9,1041
Combined 7 Series,,HHS Regions/National,Region 10,2019,Age,35 Months,77.7,73.5 to 81.6,1312
Combined 7 Series,,HHS Regions/National,Region 10,2018,Age,35 Months,76.4,72.6 to 80.0,1500
Combined 7 Series,,HHS Regions/National,Region 10,2018-2019,Age,35 Months,77.0,74.3 to 79.7,2812
Hib,Full Series,HHS Regions/National,Region 10,2019,Age,19 Months,78.8,75.2 to 82.0,1312
Hib,≥3 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,92.6,89.4 to 95.2,1041
DTaP,≥2 Doses,HHS Regions/National,Region 10,2019,Age,5 Months,85.3,82.2 to 88.0,1312
Hep A,≥1 Dose,HHS Regions/National,Region 10,2019,Age,19 Months,86.3,83.4 to 88.8,1312
Hep A,≥1 Dose,HHS Regions/National,Region 10,2012,Age,24 Months,83.9,80.0 to 87.4,977
Hep A,≥1 Dose,HHS Regions/National,Region 10,2011,Age,24 Months,81.2,76.7 to 85.4,1041
Hep A,≥1 Dose,HHS Regions/National,Region 10,2013,Age,24 Months,85.0,81.6 to 88.1,1048
Hep A,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,24 Months,86.3,84.1 to 88.4,2098
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,93.6,91.2 to 95.5,1419
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,95.0,93.7 to 96.2,2919
PCV,≥2 Doses,HHS Regions/National,Region 10,2013,Age,5 Months,76.3,72.5 to 79.7,1048
PCV,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,5 Months,75.7,72.5 to 78.7,2098
PCV,≥2 Doses,HHS Regions/National,Region 10,2012,Age,5 Months,80.0,77.3 to 82.5,977
PCV,≥2 Doses,HHS Regions/National,Region 10,2011,Age,5 Months,73.0,68.1 to 77.5,1041
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,92.9,89.8 to 95.4,992
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,93.0,90.7 to 94.8,1867
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,92.9,89.4 to 95.5,875
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,93.2,91.2 to 94.9,2294
Hib,Full Series,HHS Regions/National,Region 10,2012,Age,19 Months,72.6,67.5 to 77.2,977
Hib,Full Series,HHS Regions/National,Region 10,2011,Age,19 Months,70.5,64.4 to 76.0,1041
Combined 7 Series,,HHS Regions/National,Region 10,2015,Age,35 Months,69.1,63.7 to 74.3,992
Combined 7 Series,,HHS Regions/National,Region 10,2015-2016,Age,35 Months,70.6,66.8 to 74.3,1867
Hib,≥3 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,92.3,89.4 to 94.7,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,91.3,87.6 to 94.3,992
Hib,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,89.6,86.7 to 92.0,1867
Hep A,≥2 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,20.3,18.0 to 22.7,992
Hep A,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,22.2,19.4 to 25.2,1867
Hep A,≥2 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,24.1,20.1 to 28.8,875
Hep A,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,26.0,23.2 to 28.9,2294
Hib,≥3 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,92.3,89.7 to 94.5,1048
Hib,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,91.7,89.8 to 93.5,2098
Hib,≥3 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,91.2,88.2 to 93.7,1050
Hib,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,91.1,88.8 to 93.1,2042
PCV,≥2 Doses,HHS Regions/National,Region 10,2015,Age,5 Months,75.1,70.2 to 79.5,992
PCV,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,5 Months,75.5,72.0 to 78.7,1867
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,96.2,94.5 to 97.4,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,96.5,94.9 to 97.6,1500
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,96.3,95.2 to 97.2,2812
Hep A,≥1 Dose,HHS Regions/National,Region 10,2015,Age,24 Months,85.3,81.7 to 88.5,992
Hep A,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,24 Months,86.5,83.9 to 88.9,1867
Hep A,≥1 Dose,HHS Regions/National,Region 10,2014,Age,24 Months,87.6,84.6 to 90.3,1050
Hep A,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,24 Months,86.5,84.2 to 88.6,2042
Hep A,≥1 Dose,HHS Regions/National,Region 10,2016,Age,24 Months,87.7,83.7 to 91.1,875
Hep A,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,24 Months,88.0,85.6 to 90.2,2294
PCV,≥2 Doses,HHS Regions/National,Region 10,2014,Age,5 Months,75.2,71.1 to 78.9,1050
PCV,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,5 Months,75.2,72.6 to 77.6,2042
Hep A,≥2 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,33.0,28.2 to 38.4,1041
Hep A,≥2 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,31.0,27.5 to 34.8,1500
Hep A,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,30.0,27.1 to 33.1,2358
Hib,≥3 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,87.7,83.3 to 91.4,875
Hib,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,89.1,86.6 to 91.4,2294
Hib,≥3 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,90.6,87.9 to 92.8,1419
Hib,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,92.7,91.1 to 94.1,2919
DTaP,≥4 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,68.7,65.7 to 71.6,1048
DTaP,≥4 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,70.2,67.4 to 72.9,2098
DTaP,≥4 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,71.7,67.4 to 75.7,1050
DTaP,≥4 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,66.8,63.3 to 70.1,2042
DTaP,≥4 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,61.9,59.4 to 64.3,992
DTaP,≥4 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,65.2,61.4 to 68.8,1867
Hep A,≥2 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,27.9,24.3 to 31.7,1419
Hep A,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,29.4,26.9 to 32.1,2919
Hep A,≥2 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,18.1,15.6 to 20.8,1041
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,93.2,90.6 to 95.3,1050
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,93.1,91.1 to 94.7,2042
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,94.2,91.9 to 96.1,1048
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,93.7,92.0 to 95.1,2098
DTaP,≥3 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,95.3,92.9 to 97.1,977
DTaP,≥3 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,94.9,91.5 to 97.2,1041
Hep A,≥2 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,21.8,17.8 to 26.4,1048
Hep A,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,22.2,19.1 to 25.5,2098
Hep A,≥2 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,18.9,16.6 to 21.4,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,93.2,91.1 to 94.9,1312
Hib,≥3 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,89.1,86.4 to 91.4,1419
Hib,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,91.7,90.1 to 93.1,2919
Hib,≥3 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,94.4,92.6 to 95.9,1500
Hib,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,93.8,92.4 to 95.0,2812
Hep A,≥1 Dose,HHS Regions/National,Region 10,2017,Age,19 Months,83.9,80.6 to 86.7,1419
Hep A,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,19 Months,85.6,83.4 to 87.6,2919
Hep A,≥1 Dose,HHS Regions/National,Region 10,2018,Age,19 Months,87.3,84.1 to 89.9,1500
Hep A,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,19 Months,88.1,85.8 to 90.0,2358
Hep A,≥1 Dose,HHS Regions/National,Region 10,2016,Age,19 Months,84.6,80.1 to 88.2,875
Hep A,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,19 Months,84.2,81.6 to 86.6,2294
Hep A,≥1 Dose,HHS Regions/National,Region 10,2017,Age,24 Months,88.4,85.6 to 90.8,1419
Hep A,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,24 Months,89.9,88.0 to 91.5,2919
PCV,≥2 Doses,HHS Regions/National,Region 10,2016,Age,5 Months,75.9,70.7 to 80.4,875
PCV,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,5 Months,76.0,72.8 to 79.0,2294
Hep A,≥2 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,29.7,26.1 to 33.5,1312
Hep A,≥1 Dose,HHS Regions/National,Region 10,2019,Age,24 Months,87.6,84.8 to 90.1,1312
Hep A,≥1 Dose,HHS Regions/National,Region 10,2011,Age,35 Months,86.9,82.0 to 91.0,1041
Hep A,≥1 Dose,HHS Regions/National,Region 10,2018,Age,24 Months,91.4,88.9 to 93.5,1500
Hep A,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,24 Months,89.5,87.7 to 91.2,2812
Hep A,≥1 Dose,HHS Regions/National,Region 10,2011,Age,19 Months,73.8,70.7 to 76.7,1041
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,92.7,90.2 to 94.7,1048
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,92.0,90.2 to 93.7,2098
DTaP,≥1 Dose,HHS Regions/National,Region 10,2018,Age,3 Months,92.0,89.4 to 94.0,1500
DTaP,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,3 Months,92.6,90.9 to 93.9,2812
DTaP,≥1 Dose,HHS Regions/National,Region 10,2019,Age,3 Months,93.2,91.0 to 94.9,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,91.5,88.7 to 93.8,992
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,91.8,89.6 to 93.7,1867
DTaP,≥1 Dose,HHS Regions/National,Region 10,2017,Age,3 Months,85.6,82.2 to 88.5,1419
DTaP,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,3 Months,88.8,86.6 to 90.6,2919
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,91.4,88.6 to 93.8,1050
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,91.5,89.6 to 93.2,2042
Hep A,≥1 Dose,HHS Regions/National,Region 10,2013,Age,19 Months,79.1,75.6 to 82.3,1048
Hep A,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,19 Months,80.7,78.7 to 82.6,2098
Combined 7 Series,,HHS Regions/National,Region 10,2021,Age,35 Months,80.3,71.9 to 87.4,754
Hep B,≥2 Doses,HHS Regions/National,Region 10,2021,Age,5 Months,89.9,86.3 to 92.6,754
Polio,≥3 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,92.1,88.3 to 95.0,754
Hib,Full Series,HHS Regions/National,Region 10,2021,Age,19 Months,73.1,67.8 to 77.7,754
Hep B,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,93.2,91.1 to 94.7,2007
DTaP,≥3 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,72.5,67.3 to 77.2,754
Hep A,≥2 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,78.2,66.3 to 88.2,754
Hib,Primary Series,HHS Regions/National,Region 10,2021,Age,7 Months,73.6,68.4 to 78.2,754
Hep B,≥3 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,90.2,86.5 to 93.0,754
DTaP,≥4 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,69.7,64.3 to 74.6,754
DTaP,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,3 Months,86.9,84.4 to 89.1,2007
Hep A,≥1 Dose,HHS Regions/National,Region 10,2012,Age,19 Months,76.6,72.4 to 80.2,977
Hep A,≥1 Dose,HHS Regions/National,Region 10,2015,Age,19 Months,80.9,79.0 to 82.6,992
Hep A,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,19 Months,82.7,79.7 to 85.4,1867
Hep A,≥1 Dose,HHS Regions/National,Region 10,2014,Age,19 Months,82.3,78.4 to 85.6,1050
Hep A,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,19 Months,81.6,78.8 to 84.1,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,89.1,86.1 to 91.8,1050
Hib,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,89.3,87.0 to 91.3,2042
DTaP,≥2 Doses,HHS Regions/National,Region 10,2018,Age,5 Months,84.8,81.6 to 87.4,1500
DTaP,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,5 Months,85.1,82.9 to 87.0,2812
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,95.2,93.4 to 96.6,1312
Hib,≥3 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,89.4,86.0 to 92.3,992
Hib,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,88.1,85.4 to 90.6,1867
Hib,≥3 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,86.8,82.4 to 90.6,875
Hib,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,87.9,85.4 to 90.2,2294
DTaP,≥2 Doses,HHS Regions/National,Region 10,2017,Age,5 Months,78.2,74.3 to 81.7,1419
DTaP,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,5 Months,81.5,79.0 to 83.7,2919
DTaP,≥2 Doses,HHS Regions/National,Region 10,2016,Age,5 Months,77.5,72.4 to 81.9,875
DTaP,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,5 Months,77.9,74.7 to 80.7,2294
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,92.6,90.2 to 94.6,1419
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,94.4,93.0 to 95.7,2919
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,96.3,94.8 to 97.5,1500
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,95.8,94.6 to 96.7,2812
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,92.1,88.6 to 94.8,875
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,92.3,90.3 to 94.1,2294
DTaP,≥1 Dose,HHS Regions/National,Region 10,2012,Age,3 Months,87.8,84.4 to 90.5,977
DTaP,≥1 Dose,HHS Regions/National,Region 10,2011,Age,3 Months,87.8,84.2 to 90.7,1041
DTaP,≥1 Dose,HHS Regions/National,Region 10,2013,Age,3 Months,88.5,86.4 to 90.3,1048
DTaP,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,3 Months,87.7,86.3 to 89.0,2098
DTaP,≥1 Dose,HHS Regions/National,Region 10,2014,Age,3 Months,87.0,83.6 to 89.7,1050
DTaP,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,3 Months,88.3,85.8 to 90.3,2042
DTaP,≥1 Dose,HHS Regions/National,Region 10,2015,Age,3 Months,89.6,85.8 to 92.4,992
DTaP,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,3 Months,88.2,85.4 to 90.5,1867
DTaP,≥1 Dose,HHS Regions/National,Region 10,2016,Age,3 Months,86.9,82.4 to 90.3,875
DTaP,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,3 Months,86.2,83.5 to 88.6,2294
Hib,Primary Series,HHS Regions/National,Region 10,2021,Age,19 Months,92.0,88.7 to 94.4,754
Hib,Primary Series,HHS Regions/National,Region 10,2020-2021,Age,24 Months,91.9,89.8 to 93.6,2007
Hib,≥1 Dose,HHS Regions/National,Region 10,2021,Age,3 Months,88.1,84.3 to 91.0,754
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,88.9,86.5 to 90.9,2007
PCV,≥4 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,80.1,77.1 to 83.0,2007
DTaP,≥4 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,85.9,82.6 to 88.8,2007
Hib,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,91.3,89.0 to 93.1,2007
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2021,Age,0-1 Days,83.7,79.7 to 87.1,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020-2021,Age,35 Months,92.0,89.6 to 94.0,2007
≥1 Dose Varicella,,HHS Regions/National,Region 10,2021,Age,24 Months,89.9,86.3 to 92.9,754
PCV,≥4 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,78.5,73.6 to 83.0,754
Polio,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,90.2,87.9 to 92.1,2007
Hep A,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,29.6,26.7 to 32.7,2007
Hep B,≥3 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,72.1,66.8 to 76.8,754
Hib,≥3 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,55.7,50.3 to 60.9,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2021,Age,19 Months,87.2,83.2 to 90.3,754
Hib,Primary Series,HHS Regions/National,Region 10,2020-2021,Age,13 Months,87.5,85.0 to 89.7,2007
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,91.7,89.5 to 93.5,2007
Hep A,≥1 Dose,HHS Regions/National,Region 10,2021,Age,35 Months,95.2,89.7 to 98.3,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,89.7,85.9 to 92.5,754
Polio,≥3 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,91.3,87.8 to 94.1,754
DTaP,≥1 Dose,HHS Regions/National,Region 10,2021,Age,3 Months,88.6,84.7 to 91.5,754
DTaP,≥4 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,76.7,71.6 to 81.5,754
≥1 Dose MMR,,HHS Regions/National,Region 10,2021,Age,24 Months,90.7,87.2 to 93.6,754
Hib,Primary Series,HHS Regions/National,Region 10,2021,Age,24 Months,92.1,88.9 to 94.6,754
Hep B,≥2 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,92.0,88.6 to 94.5,754
Polio,≥1 Dose,HHS Regions/National,Region 10,2021,Age,3 Months,88.5,84.7 to 91.4,754
Hib,≥3 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,87.8,83.8 to 91.1,754
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2021,Age,0-2 Days,83.9,79.8 to 87.2,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,87.6,83.7 to 90.6,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,90.3,86.7 to 93.2,754
PCV,≥4 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,76.7,71.6 to 81.1,754
PCV,≥2 Doses,HHS Regions/National,Region 10,2021,Age,5 Months,78.1,73.3 to 82.2,754
≥1 Dose MMR,,HHS Regions/National,Region 10,2020-2021,Age,24 Months,90.0,87.7 to 92.0,2007
DTaP,≥3 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,91.5,88.0 to 94.3,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,92.7,91.0 to 94.1,2565
DTaP,≥4 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,71.4,68.7 to 74.0,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,72.9,70.1 to 75.5,2565
DTaP,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,3 Months,89.3,87.2 to 91.1,2565
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2019-2020,Age,0-3 Days,82.9,80.6 to 84.9,2565
Hep A,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,19 Months,86.5,84.3 to 88.3,2565
Polio,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,3 Months,88.2,86.1 to 90.0,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,90.8,87.3 to 93.6,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,93.6,91.1 to 95.6,2007
Hep A,≥1 Dose,HHS Regions/National,Region 10,2021,Age,19 Months,85.3,81.2 to 88.7,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,90.3,86.7 to 93.2,754
PCV,≥4 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,87.0,79.1 to 93.0,754
Hib,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,89.0,86.6 to 91.1,2007
Hep A,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,35 Months,92.7,90.3 to 94.7,2007
Hep A,≥1 Dose,HHS Regions/National,Region 10,2021,Age,24 Months,89.0,85.3 to 92.1,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,90.2,86.5 to 92.9,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,70.8,65.5 to 75.5,754
Hep A,≥2 Doses,HHS Regions/National,Region 10,2021,Age,24 Months,46.0,40.4 to 52.0,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,91.0,87.4 to 93.7,754
Hib,Full Series,HHS Regions/National,Region 10,2021,Age,24 Months,78.5,73.7 to 82.9,754
Hib,≥2 Doses,HHS Regions/National,Region 10,2020,Age,5 Months,78.4,74.6 to 81.8,1253
Polio,≥2 Doses,HHS Regions/National,Region 10,2020,Age,5 Months,78.8,74.9 to 82.1,1253
DTaP,≥2 Doses,HHS Regions/National,Region 10,2020,Age,5 Months,80.0,76.2 to 83.2,1253
Hep B,≥1 Dose,HHS Regions/National,Region 10,2020,Age,3 Months,93.0,90.3 to 95.0,1253
PCV,≥1 Dose,HHS Regions/National,Region 10,2020,Age,3 Months,83.2,79.6 to 86.3,1253
Hep A,≥1 Dose,HHS Regions/National,Region 10,2020,Age,24 Months,89.5,86.5 to 92.0,1253
Hep A,≥2 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,51.0,46.8 to 55.4,1253
PCV,≥3 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,90.7,87.9 to 93.1,1253
PCV,≥4 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,81.7,78.2 to 85.0,1253
Rotavirus,,HHS Regions/National,Region 10,2020,Age,8 Months,74.3,70.3 to 77.9,1253
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020,Age,24 Months,89.7,86.8 to 92.2,1253
Influenza,,HHS Regions/National,Region 10,2020,Age,24 Months,67.1,63.1 to 71.0,1253
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2020,Age,0-3 Days,82.4,78.9 to 85.4,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2020,Age,19 Months,88.1,84.9 to 90.7,1253
Combined 7 Series,,HHS Regions/National,Region 10,2020,Age,24 Months,70.0,66.0 to 73.9,1253
Hib,≥3 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,88.5,85.4 to 90.9,1253
Polio,≥3 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,89.6,86.6 to 92.0,1253
DTaP,≥4 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,71.1,67.1 to 74.7,1253
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,91.4,88.6 to 93.6,1253
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,71.4,67.3 to 75.2,1253
PCV,≥3 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,86.6,83.2 to 89.4,1253
Hep B,≥2 Doses,HHS Regions/National,Region 10,2020,Age,5 Months,88.1,84.9 to 90.8,1253
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020,Age,13 Months,62.1,57.9 to 66.0,1253
PCV,≥2 Doses,HHS Regions/National,Region 10,2020,Age,5 Months,78.2,74.4 to 81.5,1253
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,88.7,85.5 to 91.3,1253
Hep B,≥2 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,93.2,90.5 to 95.2,1253
Hib,Primary Series,HHS Regions/National,Region 10,2020,Age,13 Months,87.5,84.2 to 90.2,1253
Hib,≥3 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,75.6,72.0 to 78.9,1253
PCV,≥3 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,91.7,89.0 to 94.0,1253
Hib,≥2 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,91.0,88.0 to 93.3,1253
PCV,≥4 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,79.5,75.7 to 82.8,1253
PCV,≥3 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,90.4,87.5 to 92.7,1253
Polio,≥3 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,92.2,89.1 to 94.7,1253
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,93.7,90.9 to 95.9,1253
DTaP,≥4 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,85.4,81.7 to 88.6,1253
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,90.8,87.8 to 93.0,1253
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020,Age,19 Months,87.5,84.4 to 90.1,1253
Hib,Full Series,HHS Regions/National,Region 10,2020,Age,19 Months,76.8,73.0 to 80.3,1253
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020,Age,35 Months,91.4,88.4 to 93.8,1253
Hib,Primary Series,HHS Regions/National,Region 10,2020,Age,19 Months,91.1,88.3 to 93.3,1253
Hib,Full Series,HHS Regions/National,Region 10,2020,Age,35 Months,84.1,80.6 to 87.3,1253
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,92.0,89.4 to 94.1,1253
Hib,≥3 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,91.4,88.4 to 93.9,1253
Hib,Primary Series,HHS Regions/National,Region 10,2020,Age,35 Months,92.5,89.7 to 94.9,1253
Hib,≥3 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,90.2,87.4 to 92.6,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2020,Age,35 Months,90.5,87.4 to 93.0,1253
Polio,≥3 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,90.7,87.9 to 93.0,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2020,Age,24 Months,89.4,86.4 to 92.0,1253
DTaP,≥4 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,80.1,76.5 to 83.5,1253
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,92.4,89.9 to 94.5,1253
Hib,Primary Series,HHS Regions/National,Region 10,2020,Age,7 Months,74.1,70.0 to 77.7,1253
Hib,≥3 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,53.3,49.3 to 57.4,1253
Hib,≥2 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,86.8,83.4 to 89.6,1253
Polio,≥2 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,87.9,84.7 to 90.5,1253
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2020,Age,0-1 Days,79.3,75.6 to 82.5,1253
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2020,Age,0-2 Days,81.3,77.7 to 84.3,1253
Hep A,≥2 Doses,HHS Regions/National,Region 10,2020,Age,19 Months,30.3,26.8 to 34.1,1253
Hep A,≥1 Dose,HHS Regions/National,Region 10,2020,Age,19 Months,86.8,83.6 to 89.5,1253
Hep A,≥2 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,80.8,76.2 to 85.0,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2020,Age,13 Months,70.9,66.9 to 74.6,1253
Combined 7 Series,,HHS Regions/National,Region 10,2020,Age,35 Months,74.0,69.8 to 78.0,1253
Hep A,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,24 Months,88.6,86.6 to 90.4,2565
Hep A,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,79.9,76.7 to 82.9,2565
Hep A,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,35 Months,91.7,89.8 to 93.3,2565
Hep A,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,49.6,46.6 to 52.7,2565
Influenza,,HHS Regions/National,Region 10,2019-2020,Age,24 Months,69.4,66.7 to 72.1,2565
Hib,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,91.7,90.0 to 93.2,2565
Hib,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,89.7,87.7 to 91.4,2565
Hib,Primary Series,HHS Regions/National,Region 10,2019-2020,Age,24 Months,93.1,91.5 to 94.5,2565
Combined 7 Series,,HHS Regions/National,Region 10,2019-2020,Age,35 Months,75.8,72.9 to 78.7,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,91.7,90.0 to 93.2,2565
Hib,Full Series,HHS Regions/National,Region 10,2019-2020,Age,19 Months,77.8,75.2 to 80.2,2565
PCV,≥4 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,79.9,77.4 to 82.3,2565
PCV,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,91.6,89.8 to 93.2,2565
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2019-2020,Age,0-1 Days,79.3,76.9 to 81.6,2565
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2019-2020,Age,0-2 Days,82.1,79.8 to 84.2,2565
PCV,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,71.9,69.2 to 74.6,2565
Hib,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,56.7,53.9 to 59.5,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,92.5,90.9 to 93.9,2565
Hib,Full Series,HHS Regions/National,Region 10,2019-2020,Age,24 Months,81.9,79.5 to 84.2,2565
PCV,≥4 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,82.2,79.8 to 84.5,2565
PCV,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,92.2,90.5 to 93.7,2565
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019-2020,Age,24 Months,89.4,87.5 to 91.2,2565
Hep A,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,29.8,27.3 to 32.5,2565
Polio,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,91.2,89.3 to 92.7,2565
Hib,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,19 Months,89.9,88.0 to 91.5,2565
≥1 Dose MMR,,HHS Regions/National,Region 10,2019-2020,Age,19 Months,88.4,86.4 to 90.2,2565
Hib,Primary Series,HHS Regions/National,Region 10,2019-2020,Age,19 Months,92.5,90.8 to 93.9,2565
≥1 Dose MMR,,HHS Regions/National,Region 10,2019-2020,Age,35 Months,91.8,89.8 to 93.5,2565
Hib,Primary Series,HHS Regions/National,Region 10,2019-2020,Age,35 Months,94.0,92.3 to 95.4,2565
Hib,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,93.3,91.6 to 94.8,2565
Hib,Full Series,HHS Regions/National,Region 10,2019-2020,Age,35 Months,85.4,83.0 to 87.7,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,92.9,91.3 to 94.3,2565
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019-2020,Age,35 Months,92.1,90.1 to 93.8,2565
PCV,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,93.5,91.8 to 95.0,2565
PCV,≥4 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,85.4,83.0 to 87.7,2565
DTaP,≥4 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,80.5,77.9 to 82.9,2565
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,93.8,92.3 to 95.1,2565
Polio,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,24 Months,92.2,90.5 to 93.7,2565
≥1 Dose MMR,,HHS Regions/National,Region 10,2019-2020,Age,24 Months,89.5,87.5 to 91.2,2565
Hib,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,3 Months,88.1,86.0 to 89.9,2565
Hep B,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,3 Months,94.4,92.8 to 95.6,2565
PCV,≥1 Dose,HHS Regions/National,Region 10,2019-2020,Age,3 Months,87.2,85.0 to 89.1,2565
Polio,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,5 Months,81.6,79.1 to 83.8,2565
DTaP,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,5 Months,82.7,80.3 to 84.9,2565
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,90.3,88.4 to 92.0,2565
Polio,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,93.4,91.8 to 94.7,2565
Hib,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,93.4,91.7 to 94.7,2565
≥1 Dose MMR,,HHS Regions/National,Region 10,2019-2020,Age,13 Months,70.0,67.2 to 72.6,2565
Hib,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,77.0,74.6 to 79.3,2565
Hib,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,5 Months,81.8,79.3 to 83.9,2565
Hib,Primary Series,HHS Regions/National,Region 10,2019-2020,Age,13 Months,89.3,87.2 to 91.0,2565
Hep B,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,5 Months,89.6,87.6 to 91.3,2565
PCV,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,5 Months,80.9,78.4 to 83.2,2565
Polio,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,89.7,87.8 to 91.4,2565
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,74.7,72.0 to 77.3,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,89.4,87.3 to 91.1,2565
Hep B,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,94.2,92.7 to 95.4,2565
PCV,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,13 Months,88.2,86.0 to 90.0,2565
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019-2020,Age,13 Months,62.1,59.2 to 64.8,2565
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,94.9,93.3 to 96.2,2565
Combined 7 Series,,HHS Regions/National,Region 10,2019-2020,Age,24 Months,70.2,67.4 to 72.9,2565
DTaP,≥4 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,87.0,84.5 to 89.2,2565
Polio,≥3 Doses,HHS Regions/National,Region 10,2019-2020,Age,35 Months,93.4,91.7 to 94.9,2565
Hib,≥3 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,87.1,83.0 to 90.4,754
Polio,≥2 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,90.3,86.8 to 93.0,754
Hib,≥2 Doses,HHS Regions/National,Region 10,2021,Age,7 Months,88.8,85.0 to 91.7,754
Hib,Full Series,States/Local Areas,Utah,2016,Age,35 Months,84.0,78.2 to 88.9,293
Hib,Full Series,States/Local Areas,Utah,2016-2017,Age,35 Months,86.3,81.9 to 90.1,520
Hib,Full Series,States/Local Areas,Utah,2018,Age,24 Months,83.1,77.0 to 88.4,298
Hib,Full Series,States/Local Areas,Utah,2018-2019,Age,24 Months,82.5,78.3 to 86.2,628
Hib,Full Series,States/Local Areas,Utah,2019,Age,24 Months,81.8,75.8 to 87.0,330
Hib,Full Series,States/Local Areas,Utah,2012,Age,35 Months,82.8,76.1 to 88.5,260
Hib,Full Series,States/Local Areas,Utah,2011,Age,35 Months,78.3,70.6 to 85.1,266
Polio,≥3 Doses,States/Local Areas,Utah,2016,Age,35 Months,92.4,88.0 to 95.6,293
Polio,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,93.3,90.1 to 95.7,520
Polio,≥3 Doses,States/Local Areas,Utah,2017,Age,35 Months,94.1,89.0 to 97.3,227
Polio,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,95.3,92.3 to 97.3,525
Polio,≥3 Doses,States/Local Areas,Utah,2015,Age,35 Months,89.7,83.7 to 94.2,241
Polio,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,91.0,87.4 to 94.0,534
DTaP,≥2 Doses,States/Local Areas,Utah,2014,Age,5 Months,80.5,73.8 to 85.9,258
DTaP,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,5 Months,82.2,77.6 to 86.0,499
DTaP,≥2 Doses,States/Local Areas,Utah,2015,Age,5 Months,83.9,76.8 to 89.1,241
DTaP,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,5 Months,82.7,78.1 to 86.5,534
Hib,Full Series,States/Local Areas,Utah,2014,Age,35 Months,83.8,77.3 to 89.3,258
Hib,Full Series,States/Local Areas,Utah,2014-2015,Age,35 Months,83.2,78.3 to 87.5,499
Hib,Full Series,States/Local Areas,Utah,2015,Age,35 Months,83.0,75.0 to 89.6,241
Hib,Full Series,States/Local Areas,Utah,2015-2016,Age,35 Months,83.2,78.5 to 87.3,534
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,93.7,91.5 to 95.8,651
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,75.0,61.6 to 88.4,45
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,91.6,87.3 to 95.9,222
Hib,Full Series,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.0,73.7 to 82.3,520
Polio,≥3 Doses,States/Local Areas,Utah,2019,Age,35 Months,97.5,94.2 to 99.1,330
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,82.2 to 99.7,74
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,92.7,87.9 to 97.4,134
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,89.5 to 94.2,729
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,89.6 to 96.3,337
Polio,≥3 Doses,States/Local Areas,Utah,2018,Age,35 Months,96.6,93.6 to 98.4,298
Polio,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,97.1,95.0 to 98.5,628
Hib,Full Series,States/Local Areas,Utah,2017,Age,35 Months,88.6,81.6 to 93.9,227
Hib,Full Series,States/Local Areas,Utah,2017-2018,Age,35 Months,86.9,82.4 to 90.7,525
Hib,Full Series,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,82.8,79.3 to 86.2,651
Hib,Full Series,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,76.8,70.2 to 83.3,222
Hib,Full Series,States/Local Areas,Utah,2019,Age,35 Months,86.0,80.0 to 91.0,330
≥1 Dose MMR,,States/Local Areas,Utah,2011,Age,13 Months,60.1,54.4 to 65.5,266
Hib,Full Series,States/Local Areas,Utah,2018,Age,35 Months,85.5,79.3 to 90.5,298
Hib,Full Series,States/Local Areas,Utah,2018-2019,Age,35 Months,85.6,81.4 to 89.3,628
Hib,Full Series,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,70.4,55.1 to 85.7,45
Hib,Full Series,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,66.6,54.3 to 78.9,88
Hib,Full Series,States/Local Areas,Utah,2014-2017,Overall,Overall,80.1,77.1 to 83.2,945
Hib,Full Series,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,75.1,68.2 to 81.9,224
Hib,Full Series,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,82.1,78.3 to 85.8,550
Hib,Primary Series,States/Local Areas,Utah,2011,Age,7 Months,76.9,67.0 to 84.5,266
Hib,Full Series,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,82.5,75.6 to 89.4,171
Hib,Full Series,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.6,72.1 to 93.1,74
Hib,Full Series,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,84.6,78.0 to 91.3,134
Hib,Full Series,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.9,75.3 to 82.5,729
Hib,Full Series,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,85.6,81.2 to 90.0,337
DTaP,≥4 Doses,States/Local Areas,Utah,2018,Age,19 Months,79.6,72.9 to 84.9,298
DTaP,≥4 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,96.4,94.0 to 97.8,628
Hep A,≥1 Dose,States/Local Areas,Utah,2018,Age,35 Months,96.2,91.2 to 98.7,298
Hep A,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,35 Months,95.2,92.1 to 97.3,628
≥1 Dose Varicella,,States/Local Areas,Utah,2012,Age,13 Months,53.7,48.3 to 59.1,260
≥1 Dose Varicella,,States/Local Areas,Utah,2014,Age,13 Months,59.9,52.4 to 67.0,258
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2015,Age,13 Months,59.4,53.9 to 64.6,499
Hep A,≥1 Dose,States/Local Areas,Utah,2019,Age,35 Months,94.3,89.8 to 97.3,330
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,89.5,86.7 to 92.4,651
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,86.6,81.2 to 92.0,222
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,76.7,63.4 to 90.0,45
Hep B,≥3 Doses,States/Local Areas,Utah,2017,Age,7 Months,72.2,63.6 to 79.5,227
Hep B,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,70.2,64.8 to 75.1,525
Polio,≥2 Doses,States/Local Areas,Utah,2018,Age,5 Months,84.5,77.9 to 89.3,298
Polio,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,5 Months,86.7,82.6 to 90.0,628
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,90.6,85.2 to 96.1,134
Polio,≥2 Doses,States/Local Areas,Utah,2011,Age,7 Months,87.7,76.2 to 94.1,266
Polio,≥2 Doses,States/Local Areas,Utah,2012,Age,7 Months,88.9,83.4 to 92.7,260
Hep A,≥2 Doses,States/Local Areas,Utah,2016,Age,35 Months,75.8,58.7 to 89.7,293
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,78.4,70.5 to 85.4,520
Hep A,≥2 Doses,States/Local Areas,Utah,2015,Age,35 Months,78.8,68.6 to 87.5,241
Hep A,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,76.7,66.9 to 85.3,534
Hep A,≥2 Doses,States/Local Areas,Utah,2014,Age,35 Months,81.5,69.5 to 90.9,258
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,79.1,71.7 to 85.7,499
Hep B,≥3 Doses,States/Local Areas,Utah,2016,Age,7 Months,63.4,56.0 to 70.3,293
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,67.8,62.2 to 72.9,520
PCV,≥2 Doses,States/Local Areas,Utah,2017,Age,5 Months,84.9,78.1 to 89.9,227
PCV,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,5 Months,84.2,79.6 to 87.9,525
PCV,≥2 Doses,States/Local Areas,Utah,2018,Age,5 Months,83.4,76.7 to 88.5,298
PCV,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,5 Months,85.9,81.6 to 89.3,628
PCV,≥2 Doses,States/Local Areas,Utah,2019,Age,5 Months,88.3,82.7 to 92.3,330
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,83.0 to 100.0,74
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,93.7,89.2 to 98.3,134
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,86.6,78.1 to 95.0,88
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.5,89.9 to 95.1,520
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,90.2 to 94.7,729
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,90.6 to 97.0,337
DTaP,≥4 Doses,States/Local Areas,Utah,2017,Age,19 Months,79.7,72.0 to 85.7,227
DTaP,≥4 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,79.6,74.7 to 83.8,525
DTaP,≥4 Doses,States/Local Areas,Utah,2016,Age,19 Months,73.1,65.8 to 79.3,293
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,76.4,71.2 to 80.8,520
Hep A,≥2 Doses,States/Local Areas,Utah,2013,Age,24 Months,45.7,37.6 to 54.6,250
Hep A,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,45.8,40.3 to 51.8,508
Hep A,≥1 Dose,States/Local Areas,Utah,2014,Age,35 Months,91.6,86.2 to 95.5,258
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,35 Months,89.6,85.3 to 93.1,499
Hep A,≥1 Dose,States/Local Areas,Utah,2013,Age,35 Months,88.8,81.6 to 94.1,250
Hep A,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,35 Months,90.2,85.9 to 93.7,508
Hep A,≥2 Doses,States/Local Areas,Utah,2012,Age,24 Months,37.8,29.9 to 46.9,260
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.5,75.5 to 89.5,520
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.1,73.9 to 84.3,729
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,83.3,74.6 to 92.1,337
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.1,52.4 to 89.8,74
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,87.6,74.0 to 100.0,134
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,85.3,59.8 to 100.0,45
Polio,≥2 Doses,States/Local Areas,Utah,2019,Age,5 Months,89.0,83.4 to 92.9,330
Hep B,≥3 Doses,States/Local Areas,Utah,2018,Age,7 Months,68.1,61.1 to 74.3,298
Hep B,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,68.7,63.9 to 73.1,628
≥1 Dose MMR,,States/Local Areas,Utah,2012,Age,13 Months,60.2,54.5 to 65.6,260
Hep A,≥1 Dose,States/Local Areas,Utah,2016,Age,35 Months,90.8,85.5 to 94.7,293
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,35 Months,92.3,88.8 to 95.1,520
Hib,≥3 Doses,States/Local Areas,Utah,2018,Age,35 Months,95.7,92.5 to 97.9,298
Hib,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,96.3,94.1 to 97.8,628
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,92.6,90.6 to 94.6,945
Hep A,≥2 Doses,States/Local Areas,Utah,2014,Age,24 Months,46.0,38.5 to 54.1,258
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,42.6,37.3 to 48.4,499
≥1 Dose Varicella,,States/Local Areas,Utah,2013,Age,13 Months,55.1,51.3 to 58.8,250
≥1 Dose Varicella,,States/Local Areas,Utah,2013-2014,Age,13 Months,57.5,55.7 to 59.3,508
≥1 Dose Varicella,,States/Local Areas,Utah,2011,Age,13 Months,54.9,47.2 to 62.3,266
Hib,≥3 Doses,States/Local Areas,Utah,2019,Age,35 Months,96.6,93.3 to 98.6,330
Polio,≥2 Doses,States/Local Areas,Utah,2014,Age,5 Months,80.1,73.3 to 85.5,258
Polio,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,5 Months,81.3,76.6 to 85.2,499
Polio,≥2 Doses,States/Local Areas,Utah,2013,Age,5 Months,78.0,68.4 to 85.3,250
Polio,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,5 Months,79.0,74.6 to 82.9,508
Hep A,≥1 Dose,States/Local Areas,Utah,2012,Age,35 Months,93.2,87.4 to 97.0,260
Polio,≥2 Doses,States/Local Areas,Utah,2011,Age,5 Months,80.6,74.5 to 85.5,266
Polio,≥2 Doses,States/Local Areas,Utah,2012,Age,5 Months,80.5,70.9 to 87.5,260
DTaP,≥4 Doses,States/Local Areas,Utah,2012,Age,24 Months,81.1,74.3 to 87.0,260
DTaP,≥4 Doses,States/Local Areas,Utah,2011,Age,24 Months,80.4,73.0 to 86.8,266
Hep B,≥3 Doses,States/Local Areas,Utah,2011,Age,7 Months,61.2,55.1 to 67.0,266
Hep B,≥3 Doses,States/Local Areas,Utah,2012,Age,7 Months,65.0,59.2 to 70.4,260
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,94.1,91.7 to 96.4,550
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,92.5,88.3 to 96.8,171
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,90.0,85.2 to 94.8,224
Hep A,≥2 Doses,States/Local Areas,Utah,2017,Age,24 Months,50.2,41.4 to 59.7,227
Hep A,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,49.4,43.7 to 55.5,525
Hep A,≥2 Doses,States/Local Areas,Utah,2015,Age,24 Months,39.1,31.8 to 47.2,241
Hep A,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,40.0,34.8 to 45.6,534
Hep A,≥2 Doses,States/Local Areas,Utah,2016,Age,24 Months,40.9,33.9 to 48.6,293
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,45.4,39.7 to 51.5,520
DTaP,≥4 Doses,States/Local Areas,Utah,2013,Age,24 Months,75.6,68.2 to 82.5,250
DTaP,≥4 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,80.0,75.2 to 84.3,508
Hep B,≥3 Doses,States/Local Areas,Utah,2014,Age,19 Months,87.7,81.6 to 91.9,258
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,88.7,84.6 to 91.8,499
Hep B,≥3 Doses,States/Local Areas,Utah,2015,Age,19 Months,89.7,85.3 to 93.0,241
Hep B,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,91.2,87.6 to 93.8,534
Hep B,≥3 Doses,States/Local Areas,Utah,2013,Age,19 Months,87.7,85.8 to 89.5,250
Hep B,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,87.7,85.5 to 89.6,508
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,79.2,70.8 to 87.5,171
Hep B,≥2 Doses,States/Local Areas,Utah,2013,Age,5 Months,81.9,76.4 to 86.4,250
Hep B,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,5 Months,83.6,80.0 to 86.6,508
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2011,Age,0-1 Days,77.7,74.6 to 80.5,266
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,79.5,74.2 to 84.8,550
Hep B,≥2 Doses,States/Local Areas,Utah,2011,Age,5 Months,83.3,75.4 to 89.0,266
Hep B,≥2 Doses,States/Local Areas,Utah,2012,Age,5 Months,87.3,85.0 to 89.3,260
Polio,≥2 Doses,States/Local Areas,Utah,2014,Age,13 Months,91.3,85.9 to 94.8,258
Polio,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,91.6,87.7 to 94.3,499
Hep B,≥1 Dose,States/Local Areas,Utah,2018,Age,3 Months,96.7,93.7 to 98.3,298
Hep B,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,3 Months,96.2,93.8 to 97.6,628
≥1 Dose MMR,,States/Local Areas,Utah,2016,Age,19 Months,86.0,80.0 to 90.4,293
≥1 Dose MMR,,States/Local Areas,Utah,2016-2017,Age,19 Months,87.5,83.2 to 90.8,520
≥1 Dose MMR,,States/Local Areas,Utah,2015,Age,19 Months,82.5,70.3 to 90.4,241
≥1 Dose MMR,,States/Local Areas,Utah,2015-2016,Age,19 Months,84.2,79.8 to 87.8,534
≥1 Dose Varicella,,States/Local Areas,Utah,2012,Age,24 Months,89.2,83.4 to 93.7,260
≥1 Dose Varicella,,States/Local Areas,Utah,2011,Age,24 Months,85.5,78.9 to 90.9,266
≥1 Dose MMR,,States/Local Areas,Utah,2014,Age,19 Months,87.9,82.1 to 92.0,258
≥1 Dose MMR,,States/Local Areas,Utah,2014-2015,Age,19 Months,85.2,80.8 to 88.7,499
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,78.7,72.1 to 85.3,224
Hep B,≥1 Dose,States/Local Areas,Utah,2019,Age,3 Months,95.7,91.5 to 97.8,330
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,83.9,76.7 to 91.2,134
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.6,69.8 to 93.4,74
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.0,77.5 to 84.6,729
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.2,77.0 to 85.3,520
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,83.1,78.0 to 88.2,337
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,77.4,67.0 to 87.7,88
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,81.6,78.6 to 84.7,945
≥1 Dose MMR,,States/Local Areas,Utah,2017,Age,13 Months,65.3,56.4 to 73.2,227
≥1 Dose MMR,,States/Local Areas,Utah,2017-2018,Age,13 Months,68.7,63.1 to 73.9,525
≥1 Dose MMR,,States/Local Areas,Utah,2016,Age,13 Months,68.9,61.8 to 75.2,293
≥1 Dose MMR,,States/Local Areas,Utah,2016-2017,Age,13 Months,67.1,61.5 to 72.3,520
≥1 Dose Varicella,,States/Local Areas,Utah,2014,Age,19 Months,85.4,79.3 to 90.0,258
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2015,Age,19 Months,84.8,80.4 to 88.3,499
≥1 Dose Varicella,,States/Local Areas,Utah,2015,Age,19 Months,84.1,70.8 to 92.0,241
≥1 Dose Varicella,,States/Local Areas,Utah,2015-2016,Age,19 Months,84.1,79.7 to 87.7,534
Polio,≥2 Doses,States/Local Areas,Utah,2011,Age,13 Months,92.2,83.5 to 96.5,266
Polio,≥2 Doses,States/Local Areas,Utah,2012,Age,13 Months,93.3,91.5 to 94.8,260
≥1 Dose Varicella,,States/Local Areas,Utah,2013,Age,19 Months,79.9,76.5 to 83.0,250
≥1 Dose Varicella,,States/Local Areas,Utah,2013-2014,Age,19 Months,82.7,79.3 to 85.6,508
Hep B,≥3 Doses,States/Local Areas,Utah,2017,Age,13 Months,93.2,87.5 to 96.4,227
Hep B,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,92.4,89.0 to 94.7,525
≥1 Dose MMR,,States/Local Areas,Utah,2018,Age,13 Months,72.4,65.3 to 78.5,298
≥1 Dose MMR,,States/Local Areas,Utah,2018-2019,Age,13 Months,72.1,67.3 to 76.4,628
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,90.4,78.3 to 100.0,224
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,80.7,74.9 to 86.6,945
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,49.0,33.7 to 64.3,88
≥1 Dose Varicella,,States/Local Areas,Utah,2017,Age,19 Months,89.6,82.7 to 94.0,227
≥1 Dose Varicella,,States/Local Areas,Utah,2017-2018,Age,19 Months,88.9,84.5 to 92.1,525
≥1 Dose MMR,,States/Local Areas,Utah,2012,Age,19 Months,84.1,80.9 to 86.9,260
≥1 Dose MMR,,States/Local Areas,Utah,2013,Age,19 Months,83.0,80.1 to 85.5,250
≥1 Dose MMR,,States/Local Areas,Utah,2013-2014,Age,19 Months,85.4,82.1 to 88.3,508
Hep B,≥1 Dose,States/Local Areas,Utah,2017,Age,3 Months,97.5,95.1 to 98.7,227
Hep B,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,3 Months,97.1,95.4 to 98.2,525
Polio,≥2 Doses,States/Local Areas,Utah,2016,Age,13 Months,92.6,87.9 to 95.6,293
Polio,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,93.4,90.0 to 95.7,520
≥1 Dose Varicella,,States/Local Areas,Utah,2018,Age,19 Months,88.0,81.8 to 92.3,298
≥1 Dose Varicella,,States/Local Areas,Utah,2018-2019,Age,19 Months,63.5,58.5 to 68.2,628
≥1 Dose MMR,,States/Local Areas,Utah,2019,Age,13 Months,71.7,65.1 to 77.6,330
≥1 Dose Varicella,,States/Local Areas,Utah,2016,Age,19 Months,84.2,78.0 to 88.9,293
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2017,Age,19 Months,86.9,82.5 to 90.3,520
Polio,≥2 Doses,States/Local Areas,Utah,2015,Age,13 Months,91.8,85.5 to 95.5,241
Polio,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,92.2,88.5 to 94.8,534
Hep B,≥3 Doses,States/Local Areas,Utah,2019,Age,13 Months,91.5,86.7 to 94.6,330
Hep B,≥3 Doses,States/Local Areas,Utah,2018,Age,13 Months,91.5,87.0 to 94.6,298
Hep B,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,91.5,88.4 to 93.8,628
Polio,≥2 Doses,States/Local Areas,Utah,2019,Age,7 Months,93.5,88.2 to 96.6,330
Hep B,≥3 Doses,States/Local Areas,Utah,2012,Age,19 Months,89.0,85.9 to 91.5,260
Hep B,≥3 Doses,States/Local Areas,Utah,2011,Age,19 Months,87.7,82.5 to 91.6,266
≥1 Dose MMR,,States/Local Areas,Utah,2011,Age,19 Months,84.5,74.1 to 91.3,266
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,69.5,54.0 to 85.1,45
DTaP,≥4 Doses,States/Local Areas,Utah,2019,Age,35 Months,91.9,86.8 to 95.5,330
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,84.0,80.5 to 87.4,651
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,79.2,72.7 to 85.7,222
DTaP,≥4 Doses,States/Local Areas,Utah,2018,Age,35 Months,90.8,85.2 to 95.0,298
DTaP,≥4 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,91.3,87.6 to 94.2,628
Hep B,≥1 Dose,States/Local Areas,Utah,2016,Age,3 Months,91.9,86.4 to 95.3,293
Hep B,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,3 Months,94.7,91.7 to 96.6,520
Hep B,≥1 Dose,States/Local Areas,Utah,2015,Age,3 Months,96.0,91.6 to 98.1,241
Hep B,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,3 Months,94.0,90.7 to 96.1,534
Hep B,≥1 Dose,States/Local Areas,Utah,2014,Age,3 Months,92.9,87.4 to 96.1,258
Hep B,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,3 Months,94.4,91.2 to 96.5,499
Polio,≥2 Doses,States/Local Areas,Utah,2013,Age,13 Months,91.2,88.9 to 93.0,250
Polio,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,91.3,89.6 to 92.7,508
Polio,≥2 Doses,States/Local Areas,Utah,2017,Age,7 Months,93.0,87.2 to 96.3,227
Polio,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,92.7,89.2 to 95.2,525
Polio,≥2 Doses,States/Local Areas,Utah,2016,Age,7 Months,89.6,84.5 to 93.1,293
Polio,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,91.3,87.7 to 93.9,520
Hep B,≥1 Dose,States/Local Areas,Utah,2011,Age,3 Months,94.4,91.7 to 96.3,266
Hep B,≥1 Dose,States/Local Areas,Utah,2012,Age,3 Months,94.2,90.6 to 96.5,260
Hep B,≥1 Dose,States/Local Areas,Utah,2013,Age,3 Months,93.1,89.4 to 95.5,250
Hep B,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,3 Months,93.0,91.4 to 94.3,508
Polio,≥2 Doses,States/Local Areas,Utah,2018,Age,7 Months,92.4,87.5 to 95.4,298
Polio,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,93.0,89.6 to 95.3,628
≥1 Dose Varicella,,States/Local Areas,Utah,2019,Age,13 Months,65.1,58.2 to 71.5,330
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,88.8,83.3 to 94.3,171
Hep A,≥2 Doses,States/Local Areas,Utah,2018,Age,35 Months,88.1,81.1 to 93.4,298
Hep A,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,84.9,79.5 to 89.6,628
Hep A,≥2 Doses,States/Local Areas,Utah,2017,Age,35 Months,84.7,76.8 to 91.0,227
Hep A,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,86.6,81.5 to 90.9,525
Hep B,≥3 Doses,States/Local Areas,Utah,2014,Age,13 Months,86.1,79.9 to 90.6,258
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,87.3,83.0 to 90.5,499
Hep B,≥3 Doses,States/Local Areas,Utah,2013,Age,13 Months,85.4,83.4 to 87.1,250
Hep B,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,85.7,83.9 to 87.4,508
DTaP,≥4 Doses,States/Local Areas,Utah,2013,Age,35 Months,80.6,72.8 to 87.2,250
DTaP,≥4 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,83.7,78.9 to 87.9,508
Hep B,≥3 Doses,States/Local Areas,Utah,2012,Age,13 Months,86.1,83.3 to 88.5,260
Hep A,≥2 Doses,States/Local Areas,Utah,2019,Age,35 Months,81.5,72.8 to 88.8,330
DTaP,≥4 Doses,States/Local Areas,Utah,2014,Age,35 Months,87.5,81.3 to 92.4,258
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,86.0,81.0 to 90.2,499
DTaP,≥4 Doses,States/Local Areas,Utah,2012,Age,35 Months,90.0,82.4 to 95.3,260
≥1 Dose MMR,,States/Local Areas,Utah,2014,Age,13 Months,61.3,53.8 to 68.3,258
≥1 Dose MMR,,States/Local Areas,Utah,2014-2015,Age,13 Months,60.9,55.5 to 66.1,499
≥1 Dose MMR,,States/Local Areas,Utah,2015,Age,13 Months,60.5,52.6 to 68.0,241
≥1 Dose MMR,,States/Local Areas,Utah,2015-2016,Age,13 Months,64.7,59.4 to 69.7,534
≥1 Dose Varicella,,States/Local Areas,Utah,2012,Age,19 Months,86.6,82.8 to 89.8,260
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,87.9,84.6 to 91.2,550
≥1 Dose Varicella,,States/Local Areas,Utah,2011,Age,19 Months,84.3,72.4 to 91.7,266
≥1 Dose MMR,,States/Local Areas,Utah,2013,Age,13 Months,56.6,50.8 to 62.1,250
≥1 Dose MMR,,States/Local Areas,Utah,2013-2014,Age,13 Months,58.9,56.3 to 61.5,508
≥1 Dose Varicella,,States/Local Areas,Utah,2018,Age,13 Months,61.8,54.5 to 68.6,298
≥1 Dose Varicella,,States/Local Areas,Utah,2018-2019,Age,13 Months,63.5,58.5 to 68.2,628
Polio,≥2 Doses,States/Local Areas,Utah,2014,Age,7 Months,88.4,82.6 to 92.5,258
Polio,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,88.3,84.0 to 91.6,499
Polio,≥2 Doses,States/Local Areas,Utah,2013,Age,7 Months,85.4,81.8 to 88.5,250
Polio,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,86.9,84.0 to 89.4,508
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Overall,Overall,87.8,85.3 to 90.4,945
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,86.9,81.6 to 92.3,224
Hep B,≥3 Doses,States/Local Areas,Utah,2019,Age,7 Months,69.3,62.4 to 75.4,330
Hep B,≥3 Doses,States/Local Areas,Utah,2011,Age,13 Months,82.7,76.6 to 87.5,266
Polio,≥2 Doses,States/Local Areas,Utah,2015,Age,7 Months,88.2,81.1 to 92.9,241
Polio,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,88.9,84.7 to 92.0,534
≥1 Dose Varicella,,States/Local Areas,Utah,2017,Age,13 Months,61.9,52.9 to 70.1,227
≥1 Dose Varicella,,States/Local Areas,Utah,2017-2018,Age,13 Months,61.8,56.1 to 67.3,525
≥1 Dose Varicella,,States/Local Areas,Utah,2016,Age,13 Months,62.9,55.5 to 69.9,293
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2017,Age,13 Months,62.4,56.6 to 67.9,520
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,72.5 to 94.3,74
≥1 Dose Varicella,,States/Local Areas,Utah,2015,Age,13 Months,58.8,50.8 to 66.3,241
≥1 Dose Varicella,,States/Local Areas,Utah,2015-2016,Age,13 Months,60.9,55.4 to 66.0,534
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,67.8,54.7 to 80.8,88
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.6,85.4 to 91.8,520
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.4,84.5 to 90.4,729
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,90.4,86.5 to 94.4,337
DTaP,≥4 Doses,States/Local Areas,Utah,2018,Age,24 Months,88.2,82.6 to 92.7,298
DTaP,≥4 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,87.0,83.2 to 90.2,628
DTaP,≥4 Doses,States/Local Areas,Utah,2017,Age,24 Months,85.5,78.5 to 91.2,227
DTaP,≥4 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,86.9,82.6 to 90.7,525
DTaP,≥4 Doses,States/Local Areas,Utah,2011,Age,35 Months,85.4,78.0 to 91.3,266
DTaP,≥4 Doses,States/Local Areas,Utah,2019,Age,24 Months,85.8,80.6 to 90.3,330
≥1 Dose MMR,,States/Local Areas,Utah,2019,Age,19 Months,93.0,88.9 to 95.7,330
PCV,≥4 Doses,States/Local Areas,Utah,2020,Age,35 Months,86.3,81.3 to 90.5,333
≥1 Dose Varicella,,States/Local Areas,Utah,2014,Age,24 Months,87.7,82.1 to 92.2,258
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2015,Age,24 Months,87.5,83.6 to 90.9,499
Hep B,≥2 Doses,States/Local Areas,Utah,2017,Age,5 Months,93.1,87.5 to 96.3,227
Hep B,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,5 Months,92.1,88.8 to 94.5,525
Hep B,≥3 Doses,States/Local Areas,Utah,2018,Age,19 Months,94.6,90.7 to 97.0,298
Hep B,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,91.5,88.4 to 93.8,628
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2015,Age,0-1 Days,79.3,72.6 to 84.7,241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2015-2016,Age,0-1 Days,76.9,72.1 to 81.0,534
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2017,Age,0-1 Days,78.5,69.7 to 85.2,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2017-2018,Age,0-1 Days,80.5,75.3 to 84.9,525
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2016,Age,0-1 Days,74.4,67.4 to 80.4,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2016-2017,Age,0-1 Days,76.4,71.0 to 81.1,520
Hep A,≥1 Dose,States/Local Areas,Utah,2020,Age,35 Months,92.5,88.2 to 95.6,333
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,81.1,76.6 to 85.7,651
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,84.2,69.5 to 98.8,222
Hep B,≥3 Doses,States/Local Areas,Utah,2016,Age,13 Months,90.0,84.6 to 93.6,293
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,91.6,87.9 to 94.2,520
Hep B,≥3 Doses,States/Local Areas,Utah,2015,Age,13 Months,88.4,81.9 to 92.8,241
Hep B,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,89.2,85.2 to 92.2,534
DTaP,≥4 Doses,States/Local Areas,Utah,2015,Age,35 Months,85.9,77.2 to 92.5,241
DTaP,≥4 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,83.9,78.9 to 88.4,534
DTaP,≥4 Doses,States/Local Areas,Utah,2016,Age,35 Months,83.7,77.2 to 89.2,293
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,88.1,83.4 to 92.0,520
DTaP,≥4 Doses,States/Local Areas,Utah,2017,Age,35 Months,93.9,87.1 to 97.8,227
DTaP,≥4 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,91.8,87.4 to 95.1,525
Hep A,≥1 Dose,States/Local Areas,Utah,2017,Age,35 Months,94.4,89.1 to 97.6,227
Hep A,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,35 Months,95.2,91.9 to 97.5,525
Hep A,≥1 Dose,States/Local Areas,Utah,2015,Age,35 Months,86.7,79.9 to 92.0,241
Hep A,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,35 Months,89.0,84.8 to 92.4,534
Hep B,≥3 Doses,States/Local Areas,Utah,2014,Age,7 Months,66.8,59.6 to 73.4,258
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,65.6,60.2 to 70.6,499
Hep B,≥3 Doses,States/Local Areas,Utah,2015,Age,7 Months,64.3,56.2 to 71.6,241
Hep B,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,63.9,58.4 to 69.0,534
Polio,≥2 Doses,States/Local Areas,Utah,2017,Age,5 Months,87.3,80.7 to 91.9,227
Polio,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,5 Months,85.9,81.5 to 89.4,525
Polio,≥2 Doses,States/Local Areas,Utah,2016,Age,5 Months,80.9,74.3 to 86.1,293
Polio,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,5 Months,84.1,79.6 to 87.7,520
Hep A,≥2 Doses,States/Local Areas,Utah,2018,Age,24 Months,48.4,41.3 to 56.1,298
Hep A,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,50.7,45.7 to 56.1,628
Hep B,≥3 Doses,States/Local Areas,Utah,2013,Age,7 Months,63.0,54.9 to 70.4,250
Hep B,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,64.9,60.3 to 69.3,508
Hep A,≥2 Doses,States/Local Areas,Utah,2019,Age,24 Months,53.1,46.0 to 60.5,330
Polio,≥2 Doses,States/Local Areas,Utah,2015,Age,5 Months,82.4,75.3 to 87.9,241
Polio,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,5 Months,81.7,77.0 to 85.6,534
Hep A,≥2 Doses,States/Local Areas,Utah,2013,Age,35 Months,79.3,69.5 to 87.6,250
Hep A,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,79.5,72.3 to 85.9,508
Hep A,≥2 Doses,States/Local Areas,Utah,2012,Age,35 Months,74.6,64.9 to 83.4,260
Hep A,≥2 Doses,States/Local Areas,Utah,2011,Age,35 Months,72.7,64.2 to 80.6,266
DTaP,≥4 Doses,States/Local Areas,Utah,2014,Age,24 Months,84.5,78.6 to 89.6,258
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,80.0,75.2 to 84.4,499
DTaP,≥4 Doses,States/Local Areas,Utah,2016,Age,24 Months,80.0,73.4 to 85.9,293
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,82.8,78.0 to 87.0,520
DTaP,≥4 Doses,States/Local Areas,Utah,2015,Age,24 Months,75.4,67.9 to 82.3,241
DTaP,≥4 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,77.7,72.8 to 82.4,534
DTaP,≥4 Doses,States/Local Areas,Utah,2019,Age,19 Months,80.7,74.5 to 85.8,330
DTaP,≥3 Doses,States/Local Areas,Utah,2015,Age,13 Months,88.9,82.4 to 93.2,241
DTaP,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,90.4,86.5 to 93.2,534
Hib,≥2 Doses,States/Local Areas,Utah,2016,Age,13 Months,93.3,88.5 to 96.1,293
Hib,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,93.8,90.3 to 96.0,520
Hib,≥2 Doses,States/Local Areas,Utah,2015,Age,13 Months,91.3,84.9 to 95.1,241
Hib,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,92.3,88.5 to 94.8,534
Hib,≥2 Doses,States/Local Areas,Utah,2014,Age,13 Months,90.1,84.2 to 94.0,258
Hib,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,90.7,86.7 to 93.6,499
DTaP,≥3 Doses,States/Local Areas,Utah,2016,Age,13 Months,91.9,87.1 to 95.0,293
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,91.9,88.2 to 94.5,520
DTaP,≥3 Doses,States/Local Areas,Utah,2017,Age,13 Months,91.9,85.4 to 95.6,227
DTaP,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,92.4,88.8 to 94.9,525
Hib,≥3 Doses,States/Local Areas,Utah,2017,Age,7 Months,75.4,67.3 to 82.1,227
Hib,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,71.7,66.3 to 76.6,525
Hib,≥2 Doses,States/Local Areas,Utah,2018,Age,7 Months,92.1,87.2 to 95.2,298
Hib,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,92.8,89.4 to 95.1,628
Hib,≥2 Doses,States/Local Areas,Utah,2011,Age,13 Months,92.7,83.8 to 96.9,266
Hib,≥2 Doses,States/Local Areas,Utah,2012,Age,13 Months,92.7,91.0 to 94.2,260
PCV,≥1 Dose,States/Local Areas,Utah,2019,Age,3 Months,90.6,85.0 to 94.3,330
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016,Age,0-3 Days,82.7,76.6 to 87.5,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2017,Age,0-3 Days,82.9,78.0 to 86.9,520
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2017,Age,0-3 Days,86.3,78.3 to 91.7,153
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2017-2018,Age,0-3 Days,83.6,78.7 to 87.5,525
Polio,≥1 Dose,States/Local Areas,Utah,2016,Age,3 Months,86.0,79.8 to 90.5,293
Polio,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,3 Months,88.7,84.5 to 91.9,520
Polio,≥1 Dose,States/Local Areas,Utah,2015,Age,3 Months,85.7,78.5 to 90.8,241
Polio,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,3 Months,85.9,81.3 to 89.5,534
Polio,≥1 Dose,States/Local Areas,Utah,2014,Age,3 Months,84.6,78.1 to 89.3,258
Polio,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,3 Months,85.1,80.5 to 88.8,499
Hib,≥3 Doses,States/Local Areas,Utah,2013,Age,7 Months,62.1,59.8 to 64.3,250
Hib,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,58.5,56.1 to 60.7,508
Hib,≥3 Doses,States/Local Areas,Utah,2012,Age,7 Months,63.8,57.2 to 70.0,260
Hib,≥3 Doses,States/Local Areas,Utah,2011,Age,7 Months,72.1,62.5 to 79.9,266
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,90.6,86.3 to 94.8,224
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,92.1,89.6 to 94.7,550
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,90.3,84.9 to 95.6,171
PCV,≥3 Doses,States/Local Areas,Utah,2016,Age,35 Months,93.7,89.9 to 96.4,293
PCV,≥3 Doses,States/Local Areas,Utah,2015,Age,35 Months,89.4,83.4 to 94.0,241
PCV,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,91.5,88.0 to 94.3,534
PCV,≥3 Doses,States/Local Areas,Utah,2014,Age,35 Months,91.2,86.5 to 94.8,258
PCV,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,90.3,86.6 to 93.3,499
Hib,≥2 Doses,States/Local Areas,Utah,2017,Age,7 Months,92.7,86.9 to 96.1,227
Hib,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,92.4,88.9 to 94.9,525
Hib,≥2 Doses,States/Local Areas,Utah,2016,Age,7 Months,88.7,83.5 to 92.4,293
Hib,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,90.7,87.1 to 93.4,520
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,93.9,91.9 to 96.0,651
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,91.6,87.4 to 95.9,222
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,78.4,65.6 to 91.1,45
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.0,86.4 to 100.0,74
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,94.9,90.7 to 99.1,134
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2018,Age,0-3 Days,84.2,78.3 to 88.7,298
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2018-2019,Age,0-3 Days,85.2,81.3 to 88.5,628
Polio,≥1 Dose,States/Local Areas,Utah,2018,Age,3 Months,92.3,88.0 to 95.1,298
Polio,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,3 Months,91.6,88.2 to 94.0,628
Polio,≥1 Dose,States/Local Areas,Utah,2019,Age,3 Months,90.8,85.2 to 94.4,330
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,83.2,77.5 to 88.9,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,82.0,78.5 to 85.5,651
Hib,≥2 Doses,States/Local Areas,Utah,2019,Age,7 Months,93.4,88.1 to 96.5,330
PCV,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,93.8,90.7 to 96.1,520
PCV,≥3 Doses,States/Local Areas,Utah,2019,Age,35 Months,96.0,92.1 to 98.3,330
DTaP,≥3 Doses,States/Local Areas,Utah,2017,Age,7 Months,83.5,75.5 to 89.3,227
DTaP,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,80.4,75.3 to 84.7,525
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2019,Age,0-3 Days,86.3,80.5 to 90.5,330
DTaP,≥3 Doses,States/Local Areas,Utah,2018,Age,7 Months,77.2,70.1 to 83.0,298
DTaP,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,80.6,76.0 to 84.5,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,69.1,54.5 to 83.7,45
PCV,≥3 Doses,States/Local Areas,Utah,2017,Age,35 Months,93.9,88.7 to 97.2,227
PCV,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,94.7,91.8 to 96.8,525
Hib,≥2 Doses,States/Local Areas,Utah,2013,Age,13 Months,91.2,88.9 to 93.0,250
Hib,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,90.7,88.6 to 92.4,508
PCV,≥3 Doses,States/Local Areas,Utah,2018,Age,35 Months,95.5,92.3 to 97.6,298
PCV,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,95.8,93.5 to 97.5,628
Hib,≥3 Doses,States/Local Areas,Utah,2014,Age,7 Months,54.9,47.3 to 62.2,258
Hib,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,56.6,51.1 to 61.9,499
Hib,≥3 Doses,States/Local Areas,Utah,2015,Age,7 Months,58.3,50.4 to 65.9,241
Hib,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,60.1,54.8 to 65.3,534
Polio,≥1 Dose,States/Local Areas,Utah,2017,Age,3 Months,91.5,85.1 to 95.3,227
Polio,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,3 Months,91.9,88.3 to 94.4,525
DTaP,≥3 Doses,States/Local Areas,Utah,2014,Age,7 Months,70.7,63.3 to 77.1,258
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,72.9,67.8 to 77.5,499
DTaP,≥3 Doses,States/Local Areas,Utah,2015,Age,7 Months,75.2,67.7 to 81.4,241
DTaP,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,74.7,69.7 to 79.1,534
DTaP,≥3 Doses,States/Local Areas,Utah,2016,Age,7 Months,74.1,67.2 to 80.0,293
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,78.8,73.7 to 83.1,520
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2015,Age,0-3 Days,83.9,77.9 to 88.5,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2015-2016,Age,0-3 Days,83.3,79.2 to 86.8,534
DTaP,≥3 Doses,States/Local Areas,Utah,2011,Age,13 Months,90.2,81.0 to 95.2,266
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.3,88.9 to 93.7,729
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,89.7 to 96.4,337
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,81.9,78.1 to 85.8,550
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,80.0,73.1 to 86.8,171
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,81.5,75.6 to 87.5,224
Polio,≥3 Doses,States/Local Areas,Utah,2011,Age,19 Months,91.6,81.5 to 96.4,266
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,93.4,91.1 to 95.8,550
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,92.6,88.3 to 96.9,171
Hib,≥3 Doses,States/Local Areas,Utah,2013,Age,13 Months,76.1,73.0 to 78.9,250
Hib,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,75.2,72.8 to 77.3,508
Hib,≥3 Doses,States/Local Areas,Utah,2014,Age,13 Months,74.2,67.0 to 80.3,258
Hib,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,75.6,70.6 to 80.0,499
Hib,≥3 Doses,States/Local Areas,Utah,2012,Age,13 Months,84.3,78.1 to 88.9,260
Hib,≥3 Doses,States/Local Areas,Utah,2011,Age,13 Months,86.0,75.3 to 92.6,266
Hib,≥2 Doses,States/Local Areas,Utah,2017,Age,13 Months,94.3,88.4 to 97.2,227
Hib,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,94.7,91.5 to 96.7,525
Hib,≥2 Doses,States/Local Areas,Utah,2018,Age,13 Months,95.2,91.3 to 97.4,298
Hib,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,95.6,93.1 to 97.3,628
Hib,≥2 Doses,States/Local Areas,Utah,2019,Age,13 Months,96.1,91.9 to 98.2,330
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,85.6,77.0 to 94.2,88
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,90.1 to 95.2,520
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,92.3,90.3 to 94.3,945
PCV,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,89.6,84.9 to 94.3,224
DTaP,≥3 Doses,States/Local Areas,Utah,2012,Age,13 Months,92.1,89.8 to 93.9,260
DTaP,≥3 Doses,States/Local Areas,Utah,2014,Age,13 Months,87.9,82.0 to 92.1,258
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,88.4,84.3 to 91.6,499
DTaP,≥3 Doses,States/Local Areas,Utah,2013,Age,13 Months,86.0,81.1 to 89.8,250
DTaP,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,87.0,84.3 to 89.3,508
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,83.1,76.3 to 90.0,134
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.6,72.7 to 94.4,74
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.0,77.7 to 84.3,729
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.1,78.2 to 86.0,520
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,81.1,76.2 to 86.0,337
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,79.1,69.3 to 88.9,88
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2017,Overall,Overall,81.5,78.6 to 84.4,945
Hib,≥3 Doses,States/Local Areas,Utah,2019,Age,7 Months,71.4,64.5 to 77.4,330
Hib,≥3 Doses,States/Local Areas,Utah,2018,Age,7 Months,67.8,60.4 to 74.5,298
Hib,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,69.6,64.6 to 74.2,628
Hib,≥3 Doses,States/Local Areas,Utah,2016,Age,7 Months,62.0,54.8 to 68.8,293
Hib,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,68.7,63.3 to 73.6,520
Polio,≥3 Doses,States/Local Areas,Utah,2017,Age,19 Months,94.1,88.3 to 97.1,227
Polio,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,94.8,91.7 to 96.8,525
Polio,≥3 Doses,States/Local Areas,Utah,2016,Age,19 Months,91.8,87.1 to 94.9,293
Polio,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,92.9,89.5 to 95.3,520
Polio,≥3 Doses,States/Local Areas,Utah,2015,Age,19 Months,89.2,81.0 to 94.1,241
Polio,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,90.5,86.6 to 93.3,534
Hib,≥3 Doses,States/Local Areas,Utah,2011,Age,19 Months,92.2,82.8 to 96.7,266
Hib,≥3 Doses,States/Local Areas,Utah,2012,Age,19 Months,90.3,88.3 to 92.0,260
Hib,≥3 Doses,States/Local Areas,Utah,2018,Age,13 Months,86.6,81.4 to 90.6,298
Hib,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,85.1,81.2 to 88.4,628
DTaP,≥3 Doses,States/Local Areas,Utah,2018,Age,13 Months,92.9,88.6 to 95.7,298
DTaP,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,94.2,91.4 to 96.1,628
DTaP,≥3 Doses,States/Local Areas,Utah,2019,Age,13 Months,95.5,91.1 to 97.7,330
Polio,≥3 Doses,States/Local Areas,Utah,2014,Age,19 Months,89.9,84.4 to 93.6,258
Polio,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,89.5,85.5 to 92.6,499
Polio,≥3 Doses,States/Local Areas,Utah,2012,Age,19 Months,92.0,89.0 to 94.2,260
Polio,≥3 Doses,States/Local Areas,Utah,2013,Age,19 Months,88.3,83.8 to 91.7,250
Polio,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,89.1,85.7 to 91.8,508
Hib,≥3 Doses,States/Local Areas,Utah,2017,Age,13 Months,83.7,76.1 to 89.2,227
Hib,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,85.1,80.7 to 88.7,525
Hib,≥3 Doses,States/Local Areas,Utah,2016,Age,13 Months,80.6,74.3 to 85.7,293
Hib,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,82.1,77.4 to 86.1,520
Hib,≥3 Doses,States/Local Areas,Utah,2015,Age,13 Months,77.0,69.7 to 83.1,241
Hib,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,78.8,74.1 to 82.9,534
DTaP,≥3 Doses,States/Local Areas,Utah,2012,Age,19 Months,93.2,91.3 to 94.7,260
DTaP,≥3 Doses,States/Local Areas,Utah,2011,Age,19 Months,93.3,85.8 to 97.0,266
Rotavirus,,HHS Regions/National,Region 10,2019-2020,Age,8 Months,76.7,74.1 to 79.1,2565
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,72.3,68.2 to 76.0,1253
PCV,≥3 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,69.4,65.2 to 73.2,1253
Hep B,≥2 Doses,HHS Regions/National,Region 10,2020,Age,7 Months,90.9,87.8 to 93.2,1253
Hib,≥1 Dose,HHS Regions/National,Region 10,2020,Age,3 Months,83.9,80.3 to 87.0,1253
DTaP,≥1 Dose,HHS Regions/National,Region 10,2020,Age,3 Months,85.2,81.6 to 88.2,1253
Polio,≥1 Dose,HHS Regions/National,Region 10,2020,Age,3 Months,84.2,80.6 to 87.3,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2020-2021,Age,13 Months,70.5,67.2 to 73.5,2007
PCV,≥3 Doses,States/Local Areas,Utah,2018,Age,24 Months,95.5,92.3 to 97.6,298
PCV,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,95.2,92.7 to 97.0,628
Hib,≥2 Doses,States/Local Areas,Utah,2015,Age,7 Months,88.8,81.7 to 93.3,241
Hib,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,88.7,84.6 to 91.9,534
PCV,≥3 Doses,States/Local Areas,Utah,2013,Age,35 Months,94.5,86.9 to 98.4,250
PCV,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,94.2,88.6 to 97.6,508
PCV,≥3 Doses,States/Local Areas,Utah,2011,Age,35 Months,92.8,87.8 to 96.3,266
PCV,≥3 Doses,States/Local Areas,Utah,2019,Age,24 Months,94.9,90.7 to 97.6,330
PCV,≥3 Doses,States/Local Areas,Utah,2012,Age,35 Months,93.4,88.6 to 96.7,260
DTaP,≥3 Doses,States/Local Areas,Utah,2011,Age,7 Months,78.2,69.8 to 84.8,266
DTaP,≥3 Doses,States/Local Areas,Utah,2012,Age,7 Months,74.9,64.8 to 82.9,260
DTaP,≥3 Doses,States/Local Areas,Utah,2013,Age,7 Months,72.2,64.9 to 78.4,250
DTaP,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,71.4,68.4 to 74.3,508
PCV,≥1 Dose,States/Local Areas,Utah,2018,Age,3 Months,90.0,85.0 to 93.5,298
PCV,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,3 Months,90.3,86.8 to 93.0,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014,Age,0-3 Days,78.5,71.7 to 84.0,258
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2014-2015,Age,0-3 Days,81.2,76.7 to 84.9,499
Polio,≥1 Dose,States/Local Areas,Utah,2011,Age,3 Months,89.6,83.7 to 93.6,266
Polio,≥1 Dose,States/Local Areas,Utah,2012,Age,3 Months,83.9,74.0 to 90.5,260
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,91.4,89.4 to 93.5,945
Polio,≥1 Dose,States/Local Areas,Utah,2013,Age,3 Months,84.7,77.9 to 89.7,250
Polio,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,3 Months,84.6,81.6 to 87.2,508
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2013,Age,0-3 Days,79.4,71.8 to 85.3,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2013-2014,Age,0-3 Days,78.9,74.0 to 83.1,508
PCV,≥1 Dose,States/Local Areas,Utah,2012,Age,3 Months,79.2,72.9 to 84.3,260
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,77.7 to 97.2,74
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.7,78.3 to 85.1,729
PCV,≥1 Dose,States/Local Areas,Utah,2014,Age,3 Months,84.6,78.1 to 89.3,258
PCV,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,3 Months,84.9,80.4 to 88.6,499
PCV,≥1 Dose,States/Local Areas,Utah,2015,Age,3 Months,85.3,78.1 to 90.4,241
DTaP,≥3 Doses,States/Local Areas,Utah,2019,Age,7 Months,84.0,78.0 to 88.6,330
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,86.2 to 100.0,74
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,94.2,90.3 to 98.1,134
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,86.2,77.8 to 94.6,88
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.9,90.4 to 95.4,520
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.3,87.8 to 92.8,729
PCV,≥3 Doses,States/Local Areas,Utah,2016,Age,24 Months,93.6,89.8 to 96.3,293
PCV,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,93.7,90.7 to 96.0,520
Hib,≥2 Doses,States/Local Areas,Utah,2018,Age,5 Months,82.5,75.7 to 87.7,298
Hib,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,5 Months,83.9,79.5 to 87.5,628
PCV,≥3 Doses,States/Local Areas,Utah,2015,Age,24 Months,89.4,83.4 to 94.0,241
PCV,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,91.5,88.0 to 94.3,534
Hib,≥2 Doses,States/Local Areas,Utah,2012,Age,7 Months,87.9,83.8 to 91.1,260
PCV,≥3 Doses,States/Local Areas,Utah,2017,Age,24 Months,93.9,88.7 to 97.2,227
PCV,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,94.7,91.8 to 96.8,525
Hib,≥2 Doses,States/Local Areas,Utah,2011,Age,7 Months,88.6,77.3 to 94.6,266
Hib,≥2 Doses,States/Local Areas,Utah,2017,Age,5 Months,87.2,80.6 to 91.8,227
Hib,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,5 Months,84.9,80.3 to 88.5,525
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,82.2,74.9 to 89.4,171
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,80.0,73.5 to 86.5,224
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,83.8,80.3 to 87.3,550
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,76.7,63.7 to 89.8,45
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.4,77.4 to 85.5,520
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,67.6,55.4 to 79.8,88
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,82.5,79.5 to 85.4,945
Hib,≥2 Doses,States/Local Areas,Utah,2014,Age,7 Months,87.7,81.5 to 92.0,258
Hib,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,88.2,83.8 to 91.5,499
Hib,≥2 Doses,States/Local Areas,Utah,2013,Age,7 Months,84.0,79.6 to 87.6,250
Hib,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,85.9,82.5 to 88.7,508
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,86.7,82.3 to 91.1,337
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2012,Age,0-3 Days,81.2,73.9 to 86.8,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2011,Age,0-3 Days,79.1,72.2 to 84.7,266
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,92.6,88.7 to 96.6,222
PCV,≥3 Doses,States/Local Areas,Utah,2018,Age,19 Months,94.8,90.9 to 97.1,298
PCV,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,93.4,90.2 to 95.6,628
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.9,85.8 to 92.1,520
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,85.8,77.5 to 94.1,88
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Overall,Overall,89.6,87.2 to 92.0,945
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,90.5,85.8 to 95.2,224
PCV,≥1 Dose,States/Local Areas,Utah,2011,Age,3 Months,88.5,83.4 to 92.1,266
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,89.2,86.0 to 92.3,550
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,89.6,84.1 to 95.2,171
PCV,≥1 Dose,States/Local Areas,Utah,2017,Age,3 Months,89.9,83.5 to 94.0,227
PCV,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,3 Months,89.9,86.1 to 92.8,525
PCV,≥1 Dose,States/Local Areas,Utah,2016,Age,3 Months,84.9,78.7 to 89.6,293
PCV,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,3 Months,87.4,83.2 to 90.7,520
Hib,≥2 Doses,States/Local Areas,Utah,2019,Age,5 Months,85.3,79.3 to 89.8,330
Hep B,≥3 Doses,States/Local Areas,Utah,2020,Age,24 Months,89.4,84.9 to 93.0,333
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,92.1,89.8 to 94.5,651
PCV,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,3 Months,85.1,80.6 to 88.8,534
PCV,≥4 Doses,States/Local Areas,Utah,2018,Age,35 Months,89.5,84.2 to 93.7,298
PCV,≥4 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,89.9,86.2 to 92.9,628
PCV,≥4 Doses,States/Local Areas,Utah,2016,Age,35 Months,86.6,81.5 to 90.9,293
PCV,≥4 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,86.3,82.0 to 90.1,520
Hep B,≥2 Doses,States/Local Areas,Utah,2019,Age,13 Months,95.4,91.3 to 97.6,330
Hib,Full Series,States/Local Areas,Utah,2020,Age,24 Months,82.4,77.3 to 86.9,333
PCV,≥4 Doses,States/Local Areas,Utah,2017,Age,35 Months,86.0,78.8 to 91.7,227
PCV,≥4 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,87.7,83.3 to 91.4,525
PCV,≥3 Doses,States/Local Areas,Utah,2017,Age,19 Months,93.2,87.5 to 96.5,227
PCV,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,94.0,90.8 to 96.1,525
Hib,≥2 Doses,States/Local Areas,Utah,2013,Age,5 Months,76.9,68.1 to 83.9,250
Hib,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,5 Months,77.2,73.5 to 80.5,508
Hib,≥2 Doses,States/Local Areas,Utah,2011,Age,5 Months,80.4,73.7 to 85.6,266
Hib,≥2 Doses,States/Local Areas,Utah,2012,Age,5 Months,77.0,68.9 to 83.5,260
Hib,≥1 Dose,States/Local Areas,Utah,2019,Age,3 Months,87.2,81.3 to 91.5,330
Hib,≥1 Dose,States/Local Areas,Utah,2018,Age,3 Months,89.4,84.2 to 93.0,298
Hib,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,3 Months,88.3,84.5 to 91.2,628
Hib,≥2 Doses,States/Local Areas,Utah,2016,Age,5 Months,80.2,73.6 to 85.5,293
Hib,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,5 Months,83.7,79.2 to 87.3,520
Hib,≥2 Doses,States/Local Areas,Utah,2015,Age,5 Months,82.1,74.9 to 87.6,241
Hib,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,5 Months,81.2,76.5 to 85.1,534
Hib,≥2 Doses,States/Local Areas,Utah,2014,Age,5 Months,77.4,70.4 to 83.2,258
Hib,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,5 Months,79.8,74.6 to 84.2,499
PCV,≥1 Dose,States/Local Areas,Utah,2013,Age,3 Months,83.7,76.3 to 89.1,250
PCV,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,3 Months,84.1,80.5 to 87.2,508
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,69.0,53.7 to 84.3,45
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,80.8,74.7 to 86.9,222
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,85.4,79.0 to 91.9,134
PCV,≥3 Doses,States/Local Areas,Utah,2016,Age,13 Months,93.0,88.9 to 95.7,293
PCV,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,92.2,88.7 to 94.7,520
Hep B,≥2 Doses,States/Local Areas,Utah,2019,Age,7 Months,94.5,90.4 to 96.9,330
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2019,Age,0-2 Days,85.9,80.1 to 90.2,330
PCV,≥3 Doses,States/Local Areas,Utah,2018,Age,13 Months,92.8,88.0 to 95.8,298
PCV,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,93.4,90.2 to 95.6,628
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2018,Age,0-2 Days,84.0,78.1 to 88.5,298
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2018-2019,Age,0-2 Days,84.9,81.0 to 88.2,628
Hep B,≥2 Doses,States/Local Areas,Utah,2018,Age,7 Months,92.2,87.8 to 95.1,298
Hep B,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,93.4,90.6 to 95.4,628
Hep B,≥3 Doses,States/Local Areas,Utah,2013,Age,35 Months,89.7,83.3 to 94.4,250
Hep B,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,88.6,84.5 to 92.0,508
Hep B,≥3 Doses,States/Local Areas,Utah,2014,Age,35 Months,87.8,82.2 to 92.3,258
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,90.8,85.9 to 94.5,499
Hep B,≥3 Doses,States/Local Areas,Utah,2012,Age,35 Months,91.9,85.9 to 96.0,260
PCV,≥3 Doses,States/Local Areas,Utah,2017,Age,13 Months,91.3,85.0 to 95.1,227
PCV,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,92.1,88.3 to 94.7,525
Hep B,≥2 Doses,States/Local Areas,Utah,2012,Age,13 Months,92.1,89.3 to 94.2,260
Hep B,≥2 Doses,States/Local Areas,Utah,2011,Age,13 Months,92.1,85.3 to 95.9,266
PCV,≥4 Doses,States/Local Areas,Utah,2016,Age,24 Months,86.1,81.0 to 90.5,293
PCV,≥4 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,84.4,80.1 to 88.2,520
PCV,≥4 Doses,States/Local Areas,Utah,2017,Age,24 Months,82.5,75.4 to 88.5,227
PCV,≥4 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,85.5,81.1 to 89.3,525
≥1 Dose MMR,,States/Local Areas,Utah,2014,Age,35 Months,94.0,87.5 to 97.8,258
≥1 Dose MMR,,States/Local Areas,Utah,2014-2015,Age,35 Months,91.6,87.1 to 95.0,499
≥1 Dose MMR,,States/Local Areas,Utah,2015,Age,35 Months,89.2,82.9 to 94.0,241
≥1 Dose MMR,,States/Local Areas,Utah,2015-2016,Age,35 Months,90.3,86.1 to 93.6,534
≥1 Dose Varicella,,States/Local Areas,Utah,2018,Age,35 Months,98.3,94.9 to 99.6,298
≥1 Dose Varicella,,States/Local Areas,Utah,2018-2019,Age,35 Months,96.6,94.0 to 98.2,628
PCV,≥4 Doses,States/Local Areas,Utah,2015,Age,24 Months,81.5,74.8 to 87.4,241
PCV,≥4 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,83.8,79.6 to 87.6,534
≥1 Dose MMR,,States/Local Areas,Utah,2016,Age,35 Months,91.1,85.3 to 95.3,293
≥1 Dose MMR,,States/Local Areas,Utah,2016-2017,Age,35 Months,92.4,88.7 to 95.2,520
≥1 Dose Varicella,,States/Local Areas,Utah,2019,Age,35 Months,95.4,91.6 to 97.9,330
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,89.6,86.7 to 92.4,651
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,87.9,82.9 to 92.8,222
PCV,≥3 Doses,States/Local Areas,Utah,2011,Age,24 Months,92.8,87.8 to 96.3,266
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,86.7 to 94.0,337
PCV,≥4 Doses,States/Local Areas,Utah,2019,Age,35 Months,90.2,84.9 to 94.2,330
PCV,≥3 Doses,States/Local Areas,Utah,2019,Age,19 Months,94.2,89.3 to 96.9,330
PCV,≥3 Doses,States/Local Areas,Utah,2012,Age,24 Months,93.0,88.2 to 96.4,260
PCV,≥3 Doses,States/Local Areas,Utah,2013,Age,24 Months,89.7,83.7 to 94.2,250
PCV,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,90.5,86.8 to 93.5,508
PCV,≥3 Doses,States/Local Areas,Utah,2014,Age,24 Months,91.2,86.5 to 94.8,258
PCV,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,90.3,86.6 to 93.3,499
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,78.6,65.6 to 91.6,45
Hep B,≥3 Doses,States/Local Areas,Utah,2016,Age,35 Months,92.7,88.8 to 95.7,293
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,94.2,91.7 to 96.2,520
Hep B,≥3 Doses,States/Local Areas,Utah,2015,Age,35 Months,92.6,85.8 to 96.9,241
Hep B,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,93.0,88.7 to 96.1,534
PCV,≥3 Doses,States/Local Areas,Utah,2013,Age,19 Months,89.1,86.8 to 91.1,250
PCV,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,89.9,87.2 to 92.1,508
PCV,≥3 Doses,States/Local Areas,Utah,2011,Age,19 Months,92.8,85.3 to 96.6,266
PCV,≥4 Doses,States/Local Areas,Utah,2018,Age,24 Months,88.6,83.3 to 92.8,298
PCV,≥4 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,88.8,85.2 to 91.9,628
PCV,≥4 Doses,States/Local Areas,Utah,2019,Age,24 Months,89.0,83.8 to 93.1,330
PCV,≥4 Doses,States/Local Areas,Utah,2012,Age,35 Months,85.0,78.7 to 90.3,260
PCV,≥4 Doses,States/Local Areas,Utah,2011,Age,35 Months,87.5,81.2 to 92.5,266
Hep B,≥3 Doses,States/Local Areas,Utah,2017,Age,35 Months,95.9,92.6 to 98.0,227
Hep B,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,95.8,93.5 to 97.5,525
PCV,≥3 Doses,States/Local Areas,Utah,2012,Age,19 Months,91.8,89.2 to 93.8,260
Hep B,≥2 Doses,States/Local Areas,Utah,2014,Age,13 Months,91.1,85.7 to 94.6,258
Hep B,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,91.2,87.3 to 94.0,499
Hib,≥1 Dose,States/Local Areas,Utah,2014,Age,3 Months,83.4,76.9 to 88.3,258
Hib,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,3 Months,84.1,79.4 to 87.9,499
Hep B,≥2 Doses,States/Local Areas,Utah,2013,Age,13 Months,92.1,90.1 to 93.8,250
Hep B,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,91.6,90.2 to 92.9,508
Hep B,≥2 Doses,States/Local Areas,Utah,2015,Age,13 Months,91.3,84.9 to 95.2,241
Hep B,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,92.3,88.7 to 94.8,534
Hib,≥1 Dose,States/Local Areas,Utah,2011,Age,3 Months,90.1,83.6 to 94.1,266
Hib,≥1 Dose,States/Local Areas,Utah,2012,Age,3 Months,82.2,72.3 to 89.0,260
Hib,≥1 Dose,States/Local Areas,Utah,2013,Age,3 Months,85.2,79.6 to 89.4,250
Hib,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,3 Months,84.3,82.4 to 86.0,508
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.7,85.8 to 91.6,729
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,87.4 to 95.1,337
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,89.4,83.9 to 94.8,171
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,88.2,84.9 to 91.4,550
Hib,≥1 Dose,States/Local Areas,Utah,2017,Age,3 Months,91.1,84.8 to 95.0,227
Hib,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,3 Months,90.3,86.5 to 93.1,525
PCV,≥4 Doses,States/Local Areas,Utah,2014,Age,35 Months,86.3,79.5 to 91.7,258
PCV,≥4 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,85.1,80.4 to 89.2,499
PCV,≥4 Doses,States/Local Areas,Utah,2015,Age,35 Months,83.9,77.0 to 89.7,241
PCV,≥4 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,85.1,80.9 to 88.8,534
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,79.9,67.2 to 92.7,45
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,83.2 to 99.4,74
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,92.8,88.1 to 97.5,134
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,91.1,86.7 to 95.6,222
≥1 Dose MMR,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,89.8,86.9 to 92.7,651
Hep B,≥3 Doses,States/Local Areas,Utah,2018,Age,35 Months,95.8,92.2 to 98.0,298
Hep B,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,95.6,93.2 to 97.3,628
PCV,≥3 Doses,States/Local Areas,Utah,2014,Age,19 Months,90.6,85.4 to 94.1,258
PCV,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,89.9,86.0 to 92.8,499
Hep B,≥3 Doses,States/Local Areas,Utah,2019,Age,35 Months,95.4,92.0 to 97.7,330
Hep B,≥2 Doses,States/Local Areas,Utah,2017,Age,13 Months,95.5,91.7 to 97.6,227
Hep B,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,95.8,93.5 to 97.3,525
Hib,≥1 Dose,States/Local Areas,Utah,2016,Age,3 Months,84.9,78.7 to 89.6,293
Hib,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,3 Months,88.0,83.8 to 91.2,520
Hib,≥1 Dose,States/Local Areas,Utah,2015,Age,3 Months,84.8,77.5 to 90.0,241
Hib,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,3 Months,84.9,80.2 to 88.6,534
PCV,≥3 Doses,States/Local Areas,Utah,2016,Age,19 Months,93.5,89.3 to 96.1,293
PCV,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,93.4,90.1 to 95.6,520
PCV,≥3 Doses,States/Local Areas,Utah,2015,Age,19 Months,89.2,80.7 to 94.2,241
PCV,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,91.3,87.6 to 94.0,534
Hep B,≥2 Doses,States/Local Areas,Utah,2016,Age,13 Months,93.3,89.1 to 96.0,293
Hep B,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,13 Months,94.4,91.7 to 96.2,520
Hep B,≥2 Doses,States/Local Areas,Utah,2018,Age,13 Months,96.2,92.8 to 98.0,298
Hep B,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,95.8,93.4 to 97.3,628
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,82.3,72.9 to 91.6,88
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.5,85.2 to 91.7,520
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Overall,Overall,88.3,85.8 to 90.8,945
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,87.8,82.7 to 93.0,224
≥1 Dose MMR,,States/Local Areas,Utah,2018,Age,24 Months,93.8,89.3 to 96.8,298
≥1 Dose MMR,,States/Local Areas,Utah,2018-2019,Age,24 Months,94.2,91.4 to 96.2,628
≥1 Dose MMR,,States/Local Areas,Utah,2019,Age,24 Months,94.5,91.0 to 97.0,330
≥1 Dose MMR,,States/Local Areas,Utah,2012,Age,35 Months,91.0,84.3 to 95.6,260
≥1 Dose MMR,,States/Local Areas,Utah,2011,Age,35 Months,89.9,83.6 to 94.6,266
≥1 Dose Varicella,,States/Local Areas,Utah,2016,Age,35 Months,91.0,85.8 to 94.8,293
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2017,Age,35 Months,93.0,89.6 to 95.6,520
≥1 Dose MMR,,States/Local Areas,Utah,2013,Age,35 Months,87.0,79.7 to 92.6,250
≥1 Dose MMR,,States/Local Areas,Utah,2013-2014,Age,35 Months,89.7,85.2 to 93.4,508
PCV,≥4 Doses,States/Local Areas,Utah,2014,Age,24 Months,81.5,75.2 to 87.0,258
PCV,≥4 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,81.5,77.0 to 85.6,499
PCV,≥4 Doses,States/Local Areas,Utah,2013,Age,24 Months,76.5,68.8 to 83.5,250
PCV,≥4 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,79.0,74.1 to 83.5,508
Hep B,≥3 Doses,States/Local Areas,Utah,2017,Age,24 Months,95.9,92.6 to 98.0,227
Hep B,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,95.3,92.9 to 97.1,525
Hep B,≥3 Doses,States/Local Areas,Utah,2019,Age,24 Months,94.0,90.3 to 96.6,330
PCV,≥4 Doses,States/Local Areas,Utah,2012,Age,24 Months,81.3,74.9 to 86.9,260
Hep B,≥3 Doses,States/Local Areas,Utah,2011,Age,35 Months,88.9,83.0 to 93.4,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2017,Age,0-2 Days,83.0,74.8 to 88.9,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2017-2018,Age,0-2 Days,83.5,78.6 to 87.4,525
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2016,Age,0-2 Days,82.0,75.8 to 86.8,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2016-2017,Age,0-2 Days,82.5,77.6 to 86.5,520
PCV,≥4 Doses,States/Local Areas,Utah,2011,Age,24 Months,86.5,80.2 to 91.6,266
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,91.1,86.0 to 96.2,134
PCV,≥4 Doses,States/Local Areas,Utah,2013,Age,35 Months,78.1,70.3 to 85.0,250
PCV,≥4 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,81.9,76.9 to 86.4,508
≥1 Dose MMR,,States/Local Areas,Utah,2018,Age,35 Months,97.2,93.5 to 99.0,298
≥1 Dose MMR,,States/Local Areas,Utah,2018-2019,Age,35 Months,96.7,94.3 to 98.3,628
≥1 Dose MMR,,States/Local Areas,Utah,2017,Age,35 Months,94.0,89.1 to 97.2,227
≥1 Dose MMR,,States/Local Areas,Utah,2017-2018,Age,35 Months,95.6,92.9 to 97.6,525
≥1 Dose MMR,,States/Local Areas,Utah,2019,Age,35 Months,96.3,92.6 to 98.5,330
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.8,74.8 to 94.9,74
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.2,85.3 to 91.0,729
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,85.1 to 93.4,337
≥1 Dose Varicella,,States/Local Areas,Utah,2017,Age,35 Months,95.6,90.6 to 98.4,227
≥1 Dose Varicella,,States/Local Areas,Utah,2017-2018,Age,35 Months,97.0,94.4 to 98.6,525
≥1 Dose Varicella,,States/Local Areas,Utah,2015,Age,35 Months,89.6,83.4 to 94.2,241
≥1 Dose Varicella,,States/Local Areas,Utah,2015-2016,Age,35 Months,90.5,86.6 to 93.7,534
Hep B,≥2 Doses,States/Local Areas,Utah,2017,Age,7 Months,95.4,91.6 to 97.5,227
Hep B,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,93.8,91.1 to 95.8,525
PCV,≥3 Doses,States/Local Areas,Utah,2013,Age,13 Months,85.7,80.6 to 89.6,250
PCV,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,13 Months,86.9,83.4 to 89.8,508
Hep B,≥2 Doses,States/Local Areas,Utah,2016,Age,7 Months,90.7,85.5 to 94.2,293
Hep B,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,93.0,90.0 to 95.2,520
Hep B,≥3 Doses,States/Local Areas,Utah,2018,Age,24 Months,94.7,91.2 to 97.2,298
Hep B,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,94.4,91.9 to 96.3,628
Hep B,≥2 Doses,States/Local Areas,Utah,2015,Age,7 Months,90.9,84.5 to 94.8,241
Hep B,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,90.8,87.0 to 93.6,534
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2013,Age,0-2 Days,79.4,75.3 to 82.9,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2013-2014,Age,0-2 Days,78.2,76.7 to 79.7,508
PCV,≥3 Doses,States/Local Areas,Utah,2014,Age,13 Months,88.2,82.6 to 92.1,258
PCV,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,13 Months,87.8,83.7 to 90.9,499
PCV,≥3 Doses,States/Local Areas,Utah,2015,Age,13 Months,87.4,80.8 to 91.9,241
PCV,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,13 Months,90.2,86.4 to 93.0,534
≥1 Dose Varicella,,States/Local Areas,Utah,2014,Age,35 Months,90.0,84.0 to 94.4,258
≥1 Dose Varicella,,States/Local Areas,Utah,2014-2015,Age,35 Months,90.2,85.9 to 93.6,499
≥1 Dose Varicella,,States/Local Areas,Utah,2012,Age,35 Months,90.9,84.8 to 95.3,260
PCV,≥3 Doses,States/Local Areas,Utah,2019,Age,7 Months,83.9,78.1 to 88.4,330
≥1 Dose Varicella,,States/Local Areas,Utah,2013,Age,35 Months,86.0,78.7 to 91.8,250
≥1 Dose Varicella,,States/Local Areas,Utah,2013-2014,Age,35 Months,87.8,83.3 to 91.6,508
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2014,Age,0-2 Days,77.1,70.2 to 82.8,258
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2014-2015,Age,0-2 Days,80.5,76.0 to 84.3,499
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2015,Age,0-2 Days,83.9,77.9 to 88.5,241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2015-2016,Age,0-2 Days,82.9,78.8 to 86.4,534
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2018,Age,0-1 Days,82.7,76.7 to 87.4,298
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2018-2019,Age,0-1 Days,83.9,79.9 to 87.3,628
Hep B,≥3 Doses,States/Local Areas,Utah,2019,Age,19 Months,94.0,89.9 to 96.5,330
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2011,Age,0-2 Days,79.1,76.9 to 81.2,266
Hep B,≥2 Doses,States/Local Areas,Utah,2013,Age,7 Months,86.4,82.7 to 89.5,250
Hep B,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,87.9,85.6 to 90.0,508
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2012,Age,0-2 Days,80.2,76.3 to 83.6,260
Hep B,≥2 Doses,States/Local Areas,Utah,2014,Age,7 Months,89.4,83.7 to 93.3,258
Hep B,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,90.2,86.2 to 93.1,499
Hep B,≥2 Doses,States/Local Areas,Utah,2012,Age,7 Months,89.7,84.8 to 93.2,260
PCV,≥3 Doses,States/Local Areas,Utah,2018,Age,7 Months,76.3,69.2 to 82.2,298
PCV,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,7 Months,80.1,75.6 to 84.0,628
PCV,≥3 Doses,States/Local Areas,Utah,2011,Age,13 Months,91.1,85.3 to 94.8,266
Hep B,≥3 Doses,States/Local Areas,Utah,2014,Age,24 Months,87.7,82.1 to 92.2,258
Hep B,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,88.8,85.0 to 92.1,499
Hep B,≥3 Doses,States/Local Areas,Utah,2015,Age,24 Months,89.9,84.2 to 94.2,241
Hep B,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,91.3,87.9 to 94.1,534
Hep B,≥3 Doses,States/Local Areas,Utah,2016,Age,24 Months,92.7,88.8 to 95.7,293
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,94.2,91.7 to 96.2,520
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2019,Age,0-1 Days,85.2,79.4 to 89.6,330
Hep B,≥2 Doses,States/Local Areas,Utah,2011,Age,7 Months,87.0,75.7 to 93.5,266
PCV,≥3 Doses,States/Local Areas,Utah,2012,Age,13 Months,90.4,88.5 to 92.0,260
≥1 Dose MMR,,States/Local Areas,Utah,2016,Age,24 Months,88.5,83.2 to 92.7,293
≥1 Dose MMR,,States/Local Areas,Utah,2016-2017,Age,24 Months,90.1,86.5 to 93.1,520
≥1 Dose MMR,,States/Local Areas,Utah,2017,Age,24 Months,92.0,86.6 to 95.8,227
≥1 Dose MMR,,States/Local Areas,Utah,2017-2018,Age,24 Months,92.8,89.5 to 95.4,525
PCV,≥4 Doses,States/Local Areas,Utah,2018,Age,19 Months,84.8,78.4 to 89.5,298
PCV,≥4 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,86.7,82.1 to 90.3,508
PCV,≥4 Doses,States/Local Areas,Utah,2017,Age,19 Months,80.8,73.2 to 86.7,227
PCV,≥4 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,82.8,78.0 to 86.7,525
PCV,≥4 Doses,States/Local Areas,Utah,2016,Age,19 Months,83.9,78.0 to 88.4,293
PCV,≥4 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,82.4,77.8 to 86.2,520
PCV,≥4 Doses,States/Local Areas,Utah,2015,Age,19 Months,78.5,65.7 to 87.5,241
PCV,≥4 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,81.2,76.6 to 85.1,534
PCV,≥3 Doses,States/Local Areas,Utah,2017,Age,7 Months,80.4,72.3 to 86.5,227
PCV,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,7 Months,78.4,73.1 to 82.8,525
PCV,≥4 Doses,States/Local Areas,Utah,2014,Age,19 Months,77.4,70.6 to 83.0,258
PCV,≥4 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,78.0,73.1 to 82.2,499
PCV,≥3 Doses,States/Local Areas,Utah,2015,Age,7 Months,73.0,65.4 to 79.4,241
PCV,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,7 Months,73.0,67.9 to 77.5,534
PCV,≥3 Doses,States/Local Areas,Utah,2016,Age,7 Months,73.0,66.0 to 78.9,293
PCV,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,7 Months,76.6,71.5 to 81.1,520
Hep B,≥3 Doses,States/Local Areas,Utah,2012,Age,24 Months,90.3,84.6 to 94.5,260
Hep B,≥2 Doses,States/Local Areas,Utah,2018,Age,5 Months,91.0,86.5 to 94.1,298
Hep B,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,5 Months,91.6,88.5 to 93.9,628
Hep B,≥2 Doses,States/Local Areas,Utah,2019,Age,5 Months,92.2,87.5 to 95.3,330
Hep B,≥3 Doses,States/Local Areas,Utah,2013,Age,24 Months,88.1,81.9 to 93.0,250
Hep B,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,87.9,83.9 to 91.4,508
Hep B,≥3 Doses,States/Local Areas,Utah,2011,Age,24 Months,87.8,82.0 to 92.4,266
≥1 Dose Varicella,,States/Local Areas,Utah,2018,Age,24 Months,92.2,87.1 to 95.8,298
≥1 Dose Varicella,,States/Local Areas,Utah,2018-2019,Age,24 Months,92.6,89.5 to 95.0,628
≥1 Dose MMR,,States/Local Areas,Utah,2015,Age,24 Months,86.6,80.3 to 91.6,241
≥1 Dose MMR,,States/Local Areas,Utah,2015-2016,Age,24 Months,87.5,83.5 to 90.9,534
≥1 Dose MMR,,States/Local Areas,Utah,2014,Age,24 Months,90.0,84.7 to 94.0,258
≥1 Dose MMR,,States/Local Areas,Utah,2014-2015,Age,24 Months,88.3,84.3 to 91.6,499
≥1 Dose MMR,,States/Local Areas,Utah,2013,Age,24 Months,86.1,79.0 to 91.8,250
≥1 Dose MMR,,States/Local Areas,Utah,2013-2014,Age,24 Months,88.0,83.7 to 91.6,508
≥1 Dose Varicella,,States/Local Areas,Utah,2017,Age,24 Months,93.0,87.7 to 96.6,227
≥1 Dose Varicella,,States/Local Areas,Utah,2017-2018,Age,24 Months,92.6,89.1 to 95.3,525
≥1 Dose Varicella,,States/Local Areas,Utah,2019,Age,24 Months,93.1,89.1 to 96.0,330
PCV,≥3 Doses,States/Local Areas,Utah,2014,Age,7 Months,68.5,61.1 to 75.0,258
PCV,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,7 Months,70.7,65.5 to 75.4,499
PCV,≥3 Doses,States/Local Areas,Utah,2012,Age,7 Months,69.1,60.0 to 76.8,260
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,81.7,77.7 to 85.7,550
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,86.7,80.5 to 92.9,171
Hep B,≥3 Doses,States/Local Areas,Utah,2016,Age,19 Months,92.6,88.3 to 95.4,293
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,93.0,89.8 to 95.3,520
PCV,≥3 Doses,States/Local Areas,Utah,2011,Age,7 Months,74.9,64.5 to 83.0,266
PCV,≥3 Doses,States/Local Areas,Utah,2013,Age,7 Months,70.3,62.3 to 77.2,250
PCV,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,7 Months,69.4,66.4 to 72.2,508
Hep B,≥2 Doses,States/Local Areas,Utah,2014,Age,5 Months,85.2,78.9 to 89.8,258
Hep B,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,5 Months,86.2,82.5 to 89.2,499
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2012,Age,0-1 Days,76.8,74.2 to 79.3,260
Hep B,≥2 Doses,States/Local Areas,Utah,2016,Age,5 Months,86.5,80.4 to 91.0,293
Hep B,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,5 Months,89.8,85.9 to 92.7,520
Hep B,≥3 Doses,States/Local Areas,Utah,2017,Age,19 Months,93.5,87.8 to 96.6,227
Hep B,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,94.1,90.9 to 96.2,525
Polio,≥2 Doses,States/Local Areas,Utah,2017,Age,13 Months,94.3,88.4 to 97.2,227
Polio,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,13 Months,95.3,92.2 to 97.2,525
≥1 Dose Varicella,,States/Local Areas,Utah,2013,Age,24 Months,84.5,77.3 to 90.4,250
≥1 Dose Varicella,,States/Local Areas,Utah,2013-2014,Age,24 Months,86.1,81.7 to 89.9,508
Polio,≥2 Doses,States/Local Areas,Utah,2018,Age,13 Months,96.4,93.2 to 98.1,298
Polio,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,13 Months,96.4,94.0 to 97.8,628
≥1 Dose Varicella,,States/Local Areas,Utah,2019,Age,19 Months,91.9,87.4 to 94.9,330
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2014,Age,0-1 Days,73.9,66.8 to 80.0,258
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2014-2015,Age,0-1 Days,76.6,71.8 to 80.8,499
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2013,Age,0-1 Days,76.8,72.9 to 80.3,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2013-2014,Age,0-1 Days,75.3,73.1 to 77.4,508
Hep B,≥2 Doses,States/Local Areas,Utah,2015,Age,5 Months,87.2,80.6 to 91.8,241
Hep B,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,5 Months,86.9,82.6 to 90.2,534
PCV,≥3 Doses,States/Local Areas,Utah,2019,Age,13 Months,94.0,89.2 to 96.7,330
PCV,≥4 Doses,States/Local Areas,Utah,2019,Age,19 Months,86.5,80.6 to 90.8,330
PCV,≥4 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,84.9,81.7 to 88.2,651
≥1 Dose Varicella,,States/Local Areas,Utah,2011,Age,35 Months,89.9,83.0 to 94.9,266
≥1 Dose MMR,,States/Local Areas,Utah,2012,Age,24 Months,87.5,81.2 to 92.5,260
Polio,≥2 Doses,States/Local Areas,Utah,2019,Age,13 Months,96.3,92.1 to 98.3,330
≥1 Dose MMR,,States/Local Areas,Utah,2017,Age,19 Months,89.0,82.1 to 93.5,227
≥1 Dose MMR,,States/Local Areas,Utah,2017-2018,Age,19 Months,89.8,85.6 to 92.9,525
PCV,≥4 Doses,States/Local Areas,Utah,2011,Age,19 Months,81.6,68.3 to 90.1,266
PCV,≥4 Doses,States/Local Areas,Utah,2012,Age,19 Months,80.3,76.1 to 83.9,260
PCV,≥4 Doses,States/Local Areas,Utah,2013,Age,19 Months,71.1,68.1 to 73.9,250
PCV,≥4 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,74.3,71.2 to 77.1,508
≥1 Dose Varicella,,States/Local Areas,Utah,2015,Age,24 Months,87.3,81.5 to 92.1,241
≥1 Dose Varicella,,States/Local Areas,Utah,2015-2016,Age,24 Months,87.0,83.1 to 90.5,534
≥1 Dose MMR,,States/Local Areas,Utah,2018,Age,19 Months,90.7,84.9 to 94.4,298
≥1 Dose MMR,,States/Local Areas,Utah,2018-2019,Age,19 Months,95.6,93.1 to 97.3,628
≥1 Dose MMR,,States/Local Areas,Utah,2011,Age,24 Months,87.5,81.3 to 92.5,266
≥1 Dose Varicella,,States/Local Areas,Utah,2016,Age,24 Months,86.7,81.1 to 91.3,293
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2017,Age,24 Months,89.6,85.9 to 92.7,520
Rotavirus,,States/Local Areas,Utah,2018,Age,8 Months,84.2,78.1 to 88.8,298
Rotavirus,,States/Local Areas,Utah,2018-2019,Age,8 Months,84.2,80.2 to 87.6,628
Rotavirus,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,81.5,78.2 to 84.9,651
Rotavirus,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.0,58.9 to 85.2,74
Rotavirus,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.5,75.1 to 82.0,729
Rotavirus,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,80.1,75.1 to 85.2,337
Rotavirus,,States/Local Areas,Utah,2017,Age,8 Months,80.0,71.4 to 86.4,227
Rotavirus,,States/Local Areas,Utah,2017-2018,Age,8 Months,82.0,76.9 to 86.2,525
Rotavirus,,States/Local Areas,Utah,2019,Age,8 Months,84.3,78.4 to 88.8,330
Rotavirus,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,63.9,48.5 to 79.3,45
Rotavirus,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,71.3,64.2 to 78.3,222
Rotavirus,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,77.1,69.2 to 85.0,134
Rotavirus,,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,81.0,77.2 to 84.8,550
Rotavirus,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,61.9,49.2 to 74.6,88
Rotavirus,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.4,73.1 to 81.7,520
Rotavirus,,States/Local Areas,Utah,2014-2017,Overall,Overall,77.3,74.1 to 80.5,945
Rotavirus,,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,67.9,60.6 to 75.2,224
Rotavirus,,States/Local Areas,Utah,2011,Age,8 Months,72.9,65.1 to 79.4,266
Rotavirus,,States/Local Areas,Utah,2015,Age,8 Months,75.0,67.5 to 81.3,241
Rotavirus,,States/Local Areas,Utah,2015-2016,Age,8 Months,76.5,71.5 to 80.8,534
Rotavirus,,States/Local Areas,Utah,2016,Age,8 Months,78.0,71.2 to 83.5,293
Rotavirus,,States/Local Areas,Utah,2016-2017,Age,8 Months,78.9,73.7 to 83.4,520
Rotavirus,,States/Local Areas,Utah,2014,Age,8 Months,74.7,67.7 to 80.7,258
Rotavirus,,States/Local Areas,Utah,2014-2015,Age,8 Months,74.9,69.8 to 79.3,499
Rotavirus,,States/Local Areas,Utah,2012,Age,8 Months,72.8,65.1 to 79.3,260
Rotavirus,,States/Local Areas,Utah,2013,Age,8 Months,76.2,68.4 to 82.5,250
Rotavirus,,States/Local Areas,Utah,2013-2014,Age,8 Months,75.5,70.4 to 79.9,508
Hib,Full Series,States/Local Areas,Utah,2015,Age,19 Months,73.2,60.5 to 82.9,241
Hib,Full Series,States/Local Areas,Utah,2015-2016,Age,19 Months,73.9,68.8 to 78.4,534
Hib,Full Series,States/Local Areas,Utah,2017,Age,19 Months,80.7,73.3 to 86.4,227
Hib,Full Series,States/Local Areas,Utah,2017-2018,Age,19 Months,78.7,73.8 to 82.9,525
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,64.2,48.1 to 80.3,45
Combined 7 Series,,States/Local Areas,Utah,2018,Age,35 Months,83.3,76.8 to 88.8,298
Combined 7 Series,,States/Local Areas,Utah,2018-2019,Age,35 Months,81.4,76.9 to 85.5,628
Combined 7 Series,,States/Local Areas,Utah,2019,Age,35 Months,79.7,73.3 to 85.4,330
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,74.6,70.6 to 78.6,651
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,69.0,61.7 to 76.3,222
Hib,Full Series,States/Local Areas,Utah,2011,Age,19 Months,68.3,58.6 to 76.6,266
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,73.1,68.6 to 77.6,550
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,76.1,68.3 to 83.9,171
Hib,Full Series,States/Local Areas,Utah,2012,Age,19 Months,73.0,67.6 to 77.9,260
Hib,Full Series,States/Local Areas,Utah,2018,Age,19 Months,76.7,69.8 to 82.4,298
Hib,Full Series,States/Local Areas,Utah,2018-2019,Age,19 Months,95.8,93.4 to 97.3,628
Hib,Full Series,States/Local Areas,Utah,2016,Age,19 Months,74.6,67.5 to 80.5,293
Hib,Full Series,States/Local Areas,Utah,2016-2017,Age,19 Months,77.6,72.6 to 81.9,520
Hib,Full Series,States/Local Areas,Utah,2013,Age,19 Months,69.4,66.3 to 72.3,250
Hib,Full Series,States/Local Areas,Utah,2013-2014,Age,19 Months,70.8,67.8 to 73.7,508
Hib,Full Series,States/Local Areas,Utah,2014,Age,19 Months,72.2,65.2 to 78.3,258
Hib,Full Series,States/Local Areas,Utah,2014-2015,Age,19 Months,72.7,67.6 to 77.2,499
Hib,Full Series,States/Local Areas,Utah,2013,Age,24 Months,76.7,69.4 to 83.3,250
Hib,Full Series,States/Local Areas,Utah,2013-2014,Age,24 Months,77.6,72.8 to 82.0,508
Hib,Full Series,States/Local Areas,Utah,2019,Age,19 Months,77.8,71.2 to 83.2,330
Hib,Full Series,States/Local Areas,Utah,2012,Age,24 Months,79.4,72.7 to 85.4,260
Hib,Full Series,States/Local Areas,Utah,2011,Age,24 Months,76.6,68.9 to 83.5,266
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.8,59.2 to 84.4,74
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.6,66.6 to 74.7,729
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.3,67.6 to 77.0,520
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,74.8,69.2 to 80.5,337
Hib,Primary Series,States/Local Areas,Utah,2017,Age,13 Months,91.8,86.0 to 95.3,227
Hib,Primary Series,States/Local Areas,Utah,2017-2018,Age,13 Months,91.7,88.3 to 94.2,525
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,56.2,43.1 to 69.3,88
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Overall,Overall,72.1,68.6 to 75.6,945
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,67.8,60.3 to 75.2,224
Combined 7 Series,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,79.2,71.3 to 87.0,134
Hib,Primary Series,States/Local Areas,Utah,2018,Age,19 Months,95.5,92.0 to 97.6,298
Hib,Primary Series,States/Local Areas,Utah,2018-2019,Age,19 Months,90.8,87.4 to 93.3,628
Hib,Primary Series,States/Local Areas,Utah,2011,Age,19 Months,92.7,83.7 to 96.9,266
Hib,Primary Series,States/Local Areas,Utah,2013,Age,19 Months,87.9,83.5 to 91.2,250
Hib,Primary Series,States/Local Areas,Utah,2013-2014,Age,19 Months,88.3,85.7 to 90.5,508
Hib,Primary Series,States/Local Areas,Utah,2019,Age,7 Months,78.9,72.5 to 84.1,330
Hib,Primary Series,States/Local Areas,Utah,2016,Age,13 Months,90.1,85.2 to 93.5,293
Hib,Primary Series,States/Local Areas,Utah,2016-2017,Age,13 Months,91.0,87.4 to 93.6,520
Hib,Primary Series,States/Local Areas,Utah,2014,Age,19 Months,88.8,82.7 to 92.8,258
Hib,Primary Series,States/Local Areas,Utah,2014-2015,Age,19 Months,88.7,84.4 to 91.9,499
Hib,Primary Series,States/Local Areas,Utah,2012,Age,19 Months,90.7,88.3 to 92.6,260
Hib,Primary Series,States/Local Areas,Utah,2018,Age,13 Months,91.6,87.2 to 94.6,298
Hib,Primary Series,States/Local Areas,Utah,2018-2019,Age,13 Months,90.8,87.4 to 93.3,628
DTaP,≥3 Doses,States/Local Areas,Utah,2020,Age,13 Months,91.9,87.8 to 94.8,333
Hib,Primary Series,States/Local Areas,Utah,2014,Age,13 Months,84.7,78.4 to 89.5,258
Hib,Primary Series,States/Local Areas,Utah,2014-2015,Age,13 Months,86.1,81.7 to 89.5,499
Hib,Primary Series,States/Local Areas,Utah,2015,Age,13 Months,87.4,80.6 to 92.0,241
Hib,Primary Series,States/Local Areas,Utah,2015-2016,Age,13 Months,88.7,84.8 to 91.8,534
Hib,Primary Series,States/Local Areas,Utah,2016,Age,19 Months,92.2,87.4 to 95.2,293
Hib,Primary Series,States/Local Areas,Utah,2016-2017,Age,19 Months,93.0,89.6 to 95.4,520
Hib,Primary Series,States/Local Areas,Utah,2018,Age,7 Months,76.0,68.9 to 82.0,298
Hib,Primary Series,States/Local Areas,Utah,2018-2019,Age,7 Months,77.4,72.7 to 81.5,628
Hib,Primary Series,States/Local Areas,Utah,2020,Age,24 Months,94.0,90.4 to 96.5,333
Hib,Primary Series,States/Local Areas,Utah,2011,Age,13 Months,89.3,79.1 to 94.9,266
Hib,Primary Series,States/Local Areas,Utah,2012,Age,13 Months,89.5,85.8 to 92.3,260
Hib,Primary Series,States/Local Areas,Utah,2013,Age,13 Months,85.4,81.6 to 88.5,250
Hib,Primary Series,States/Local Areas,Utah,2013-2014,Age,13 Months,85.1,83.1 to 86.9,508
Hib,Primary Series,States/Local Areas,Utah,2014,Age,7 Months,70.9,63.6 to 77.2,258
Hib,Primary Series,States/Local Areas,Utah,2014-2015,Age,7 Months,71.1,65.9 to 75.8,499
Hib,Primary Series,States/Local Areas,Utah,2015,Age,7 Months,71.4,63.6 to 78.1,241
Hib,Primary Series,States/Local Areas,Utah,2015-2016,Age,7 Months,73.1,68.0 to 77.6,534
Combined 7 Series,,States/Local Areas,Utah,2018,Age,24 Months,79.0,72.4 to 84.8,298
Combined 7 Series,,States/Local Areas,Utah,2018-2019,Age,24 Months,76.7,72.2 to 81.0,628
Combined 7 Series,,States/Local Areas,Utah,2017,Age,24 Months,77.1,69.8 to 83.7,227
Combined 7 Series,,States/Local Areas,Utah,2017-2018,Age,24 Months,78.1,73.2 to 82.6,525
Combined 7 Series,,States/Local Areas,Utah,2014,Age,24 Months,71.8,64.9 to 78.4,258
Combined 7 Series,,States/Local Areas,Utah,2014-2015,Age,24 Months,69.9,64.8 to 74.9,499
Combined 7 Series,,States/Local Areas,Utah,2013,Age,24 Months,63.9,55.9 to 71.8,250
Combined 7 Series,,States/Local Areas,Utah,2013-2014,Age,24 Months,67.8,62.5 to 73.0,508
Combined 7 Series,,States/Local Areas,Utah,2019,Age,24 Months,74.6,68.1 to 80.6,330
Combined 7 Series,,States/Local Areas,Utah,2016,Age,24 Months,72.9,66.1 to 79.4,293
Combined 7 Series,,States/Local Areas,Utah,2016-2017,Age,24 Months,75.1,70.1 to 79.8,520
Hib,Primary Series,States/Local Areas,Utah,2019,Age,35 Months,96.8,93.4 to 98.7,330
Hib,Primary Series,States/Local Areas,Utah,2018,Age,35 Months,96.1,92.9 to 98.1,298
Hib,Primary Series,States/Local Areas,Utah,2018-2019,Age,35 Months,96.5,94.3 to 98.0,628
Combined 7 Series,,States/Local Areas,Utah,2015,Age,24 Months,68.0,60.4 to 75.4,241
Combined 7 Series,,States/Local Areas,Utah,2015-2016,Age,24 Months,70.4,65.3 to 75.4,534
Hib,Primary Series,States/Local Areas,Utah,2017,Age,35 Months,93.9,88.8 to 97.2,227
Hib,Primary Series,States/Local Areas,Utah,2017-2018,Age,35 Months,95.0,92.1 to 97.1,525
Combined 7 Series,,States/Local Areas,Utah,2016,Age,35 Months,77.2,70.4 to 83.5,293
Combined 7 Series,,States/Local Areas,Utah,2016-2017,Age,35 Months,79.4,74.3 to 84.0,520
Combined 7 Series,,States/Local Areas,Utah,2017,Age,35 Months,81.3,73.7 to 87.9,227
Combined 7 Series,,States/Local Areas,Utah,2017-2018,Age,35 Months,82.3,77.4 to 86.7,525
Combined 7 Series,,States/Local Areas,Utah,2012,Age,35 Months,78.2,69.9 to 85.5,260
Combined 7 Series,,States/Local Areas,Utah,2014,Age,35 Months,76.8,69.8 to 83.3,258
Combined 7 Series,,States/Local Areas,Utah,2014-2015,Age,35 Months,76.1,70.3 to 81.5,499
Combined 7 Series,,States/Local Areas,Utah,2013,Age,35 Months,68.8,60.5 to 76.8,250
Combined 7 Series,,States/Local Areas,Utah,2013-2014,Age,35 Months,72.6,67.2 to 77.8,508
Hib,Primary Series,States/Local Areas,Utah,2017,Age,19 Months,93.9,88.1 to 97.0,227
Hib,Primary Series,States/Local Areas,Utah,2017-2018,Age,19 Months,94.7,91.5 to 96.7,525
Combined 7 Series,,States/Local Areas,Utah,2015,Age,35 Months,74.9,66.1 to 83.0,241
Combined 7 Series,,States/Local Areas,Utah,2015-2016,Age,35 Months,76.3,70.5 to 81.7,534
Hib,Primary Series,States/Local Areas,Utah,2013,Age,7 Months,73.1,66.0 to 79.1,250
Hib,Primary Series,States/Local Areas,Utah,2013-2014,Age,7 Months,72.0,68.8 to 74.9,508
Hib,Primary Series,States/Local Areas,Utah,2019,Age,19 Months,94.9,90.5 to 97.3,330
Hib,Primary Series,States/Local Areas,Utah,2017,Age,7 Months,86.4,79.5 to 91.3,227
Hib,Primary Series,States/Local Areas,Utah,2017-2018,Age,7 Months,81.3,76.5 to 85.4,525
Hib,Primary Series,States/Local Areas,Utah,2016,Age,7 Months,74.8,68.0 to 80.6,293
Hib,Primary Series,States/Local Areas,Utah,2016-2017,Age,7 Months,80.6,75.9 to 84.5,520
Hib,Primary Series,States/Local Areas,Utah,2012,Age,7 Months,73.5,64.7 to 80.7,260
Hib,Primary Series,States/Local Areas,Utah,2015,Age,19 Months,88.6,82.8 to 92.7,241
Hib,Primary Series,States/Local Areas,Utah,2015-2016,Age,19 Months,90.4,86.4 to 93.3,534
Hib,Primary Series,States/Local Areas,Utah,2011,Age,24 Months,92.7,87.6 to 96.3,266
Hib,Primary Series,States/Local Areas,Utah,2012,Age,24 Months,91.4,86.3 to 95.2,260
Hib,Primary Series,States/Local Areas,Utah,2019,Age,13 Months,89.9,84.4 to 93.6,330
Combined 7 Series,,States/Local Areas,Utah,2011,Age,35 Months,71.9,63.9 to 79.4,266
Hib,Primary Series,States/Local Areas,Utah,2020-2021,Age,19 Months,93.8,91.1 to 95.6,559
≥1 Dose MMR,,States/Local Areas,Utah,2020-2021,Age,13 Months,70.9,65.4 to 75.9,559
Rotavirus,,States/Local Areas,Utah,2019-2020,Age,8 Months,80.5,76.3 to 84.2,663
Polio,≥1 Dose,States/Local Areas,Utah,2020,Age,3 Months,92.3,88.0 to 95.1,333
DTaP,≥1 Dose,States/Local Areas,Utah,2020,Age,3 Months,92.8,88.5 to 95.5,333
Hib,≥1 Dose,States/Local Areas,Utah,2020,Age,3 Months,91.4,87.1 to 94.4,333
Hep B,≥2 Doses,States/Local Areas,Utah,2020,Age,7 Months,92.5,88.3 to 95.3,333
PCV,≥3 Doses,States/Local Areas,Utah,2020,Age,7 Months,76.4,69.9 to 81.8,333
Hep B,≥3 Doses,States/Local Areas,Utah,2020,Age,7 Months,69.5,63.1 to 75.3,333
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2021,Age,0-1 Days,84.9,77.9 to 89.9,226
PCV,≥3 Doses,States/Local Areas,Utah,2021,Age,13 Months,89.7,83.2 to 93.9,226
PCV,≥4 Doses,States/Local Areas,Utah,2021,Age,24 Months,82.0,74.1 to 88.6,226
PCV,≥3 Doses,States/Local Areas,Utah,2021,Age,24 Months,92.5,87.4 to 96.1,226
≥1 Dose Varicella,,States/Local Areas,Utah,2021,Age,24 Months,89.1,83.0 to 93.8,226
Hep A,≥1 Dose,States/Local Areas,Utah,2021,Age,24 Months,92.4,86.8 to 96.2,226
DTaP,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,94.4,92.0 to 96.3,559
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2021,Age,0-2 Days,85.3,78.3 to 90.3,226
Hep B,≥2 Doses,States/Local Areas,Utah,2021,Age,7 Months,94.3,90.2 to 96.7,226
Hib,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,94.7,92.2 to 96.5,559
Hib,Primary Series,States/Local Areas,Utah,2021,Age,24 Months,93.8,90.0 to 96.5,226
Polio,≥1 Dose,States/Local Areas,Utah,2021,Age,3 Months,90.4,83.9 to 94.4,226
Hib,≥3 Doses,States/Local Areas,Utah,2021,Age,24 Months,93.7,90.0 to 96.4,226
≥1 Dose MMR,,States/Local Areas,Utah,2021,Age,24 Months,89.8,83.2 to 94.6,226
DTaP,≥1 Dose,States/Local Areas,Utah,2021,Age,3 Months,90.7,84.2 to 94.7,226
Polio,≥3 Doses,States/Local Areas,Utah,2021,Age,24 Months,94.0,90.4 to 96.6,226
PCV,≥3 Doses,States/Local Areas,Utah,2021,Age,19 Months,90.7,84.3 to 94.7,226
Hep A,≥1 Dose,States/Local Areas,Utah,2021,Age,35 Months,94.8,89.7 to 97.8,226
Hep B,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,92.1,89.3 to 94.4,559
Hib,Primary Series,States/Local Areas,Utah,2015,Age,35 Months,90.6,84.2 to 95.2,241
Hib,Primary Series,States/Local Areas,Utah,2015-2016,Age,35 Months,91.5,87.8 to 94.4,534
Hib,Primary Series,States/Local Areas,Utah,2016,Age,35 Months,92.7,88.3 to 95.9,293
Hib,Primary Series,States/Local Areas,Utah,2016-2017,Age,35 Months,93.3,90.1 to 95.8,520
Hib,Primary Series,States/Local Areas,Utah,2012,Age,35 Months,93.0,87.9 to 96.5,260
Combined 7 Series,,States/Local Areas,Utah,2011,Age,24 Months,67.2,59.4 to 74.7,266
Hib,Primary Series,States/Local Areas,Utah,2013,Age,24 Months,89.9,83.8 to 94.5,250
Hib,Primary Series,States/Local Areas,Utah,2013-2014,Age,24 Months,89.3,85.3 to 92.6,508
Combined 7 Series,,States/Local Areas,Utah,2012,Age,24 Months,68.7,61.3 to 75.9,260
Hib,Primary Series,States/Local Areas,Utah,2013,Age,35 Months,94.1,85.0 to 98.5,250
Hib,Primary Series,States/Local Areas,Utah,2013-2014,Age,35 Months,93.1,86.0 to 97.3,508
Hib,Primary Series,States/Local Areas,Utah,2011,Age,35 Months,92.7,87.6 to 96.3,266
Hib,Primary Series,States/Local Areas,Utah,2019,Age,24 Months,95.6,91.9 to 97.9,330
Hib,Primary Series,States/Local Areas,Utah,2014,Age,24 Months,88.9,83.3 to 93.2,258
Hib,Primary Series,States/Local Areas,Utah,2014-2015,Age,24 Months,88.9,84.8 to 92.2,499
Hib,Primary Series,States/Local Areas,Utah,2015,Age,24 Months,88.8,82.6 to 93.6,241
Hib,Primary Series,States/Local Areas,Utah,2015-2016,Age,24 Months,90.7,87.0 to 93.7,534
Hib,Primary Series,States/Local Areas,Utah,2017,Age,24 Months,93.9,88.8 to 97.2,227
Hib,Primary Series,States/Local Areas,Utah,2017-2018,Age,24 Months,94.9,92.0 to 97.0,525
Hib,Primary Series,States/Local Areas,Utah,2018,Age,24 Months,96.0,92.8 to 98.1,298
Hib,Primary Series,States/Local Areas,Utah,2018-2019,Age,24 Months,95.8,93.5 to 97.5,628
Hib,Primary Series,States/Local Areas,Utah,2016,Age,24 Months,92.6,88.2 to 95.8,293
Hib,Primary Series,States/Local Areas,Utah,2016-2017,Age,24 Months,93.2,90.1 to 95.7,520
Hib,Primary Series,States/Local Areas,Utah,2014,Age,35 Months,89.4,83.8 to 93.7,258
Hib,Primary Series,States/Local Areas,Utah,2014-2015,Age,35 Months,89.9,85.9 to 93.2,499
Hep A,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,35 Months,93.6,90.6 to 95.9,663
Hep A,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,81.2,75.4 to 86.3,663
Hep A,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,24 Months,91.4,88.4 to 93.9,663
Combined 7 Series,,States/Local Areas,Utah,2020,Age,35 Months,77.7,71.8 to 83.2,333
≥1 Dose MMR,,States/Local Areas,Utah,2020,Age,13 Months,75.5,69.4 to 80.7,333
Hep A,≥2 Doses,States/Local Areas,Utah,2020,Age,35 Months,80.4,73.5 to 86.5,333
Hep A,≥1 Dose,States/Local Areas,Utah,2020,Age,19 Months,87.6,82.5 to 91.4,333
Hep A,≥2 Doses,States/Local Areas,Utah,2020,Age,19 Months,36.4,30.2 to 43.1,333
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2020,Age,0-2 Days,81.0,74.7 to 86.0,333
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2020,Age,0-1 Days,77.8,71.3 to 83.1,333
Polio,≥2 Doses,States/Local Areas,Utah,2020,Age,7 Months,92.2,87.8 to 95.1,333
Hib,≥2 Doses,States/Local Areas,Utah,2020,Age,7 Months,91.6,87.2 to 94.5,333
Hib,≥3 Doses,States/Local Areas,Utah,2020,Age,7 Months,69.5,62.9 to 75.5,333
Hib,Primary Series,States/Local Areas,Utah,2020,Age,7 Months,77.3,71.4 to 82.3,333
DTaP,≥3 Doses,States/Local Areas,Utah,2020,Age,24 Months,93.8,90.3 to 96.4,333
DTaP,≥4 Doses,States/Local Areas,Utah,2020,Age,24 Months,85.1,80.2 to 89.3,333
≥1 Dose MMR,,States/Local Areas,Utah,2020,Age,24 Months,93.7,90.3 to 96.2,333
Polio,≥3 Doses,States/Local Areas,Utah,2020,Age,24 Months,94.2,90.6 to 96.7,333
≥1 Dose MMR,,States/Local Areas,Utah,2020,Age,35 Months,94.3,90.8 to 96.8,333
Hib,≥3 Doses,States/Local Areas,Utah,2020,Age,24 Months,93.7,90.2 to 96.3,333
Hib,Primary Series,States/Local Areas,Utah,2020,Age,35 Months,94.3,90.8 to 96.8,333
Hib,≥3 Doses,States/Local Areas,Utah,2020,Age,35 Months,94.0,90.5 to 96.6,333
Hep B,≥3 Doses,States/Local Areas,Utah,2020,Age,35 Months,89.4,84.9 to 93.0,333
Hib,Full Series,States/Local Areas,Utah,2020,Age,35 Months,85.2,80.2 to 89.5,333
Hib,Primary Series,States/Local Areas,Utah,2020,Age,19 Months,94.0,90.1 to 96.4,333
≥1 Dose Varicella,,States/Local Areas,Utah,2020,Age,35 Months,93.0,88.7 to 96.1,333
Hep B,≥3 Doses,States/Local Areas,Utah,2020,Age,19 Months,89.4,84.6 to 92.8,333
Hib,Full Series,States/Local Areas,Utah,2020,Age,19 Months,76.6,70.8 to 81.7,333
≥1 Dose Varicella,,States/Local Areas,Utah,2020,Age,19 Months,88.7,83.6 to 92.4,333
DTaP,≥4 Doses,States/Local Areas,Utah,2020,Age,35 Months,90.0,85.1 to 93.8,333
DTaP,≥3 Doses,States/Local Areas,Utah,2020,Age,35 Months,93.8,90.3 to 96.4,333
Polio,≥3 Doses,States/Local Areas,Utah,2020,Age,35 Months,94.2,90.6 to 96.7,333
PCV,≥3 Doses,States/Local Areas,Utah,2020,Age,19 Months,91.9,87.4 to 95.0,333
PCV,≥4 Doses,States/Local Areas,Utah,2020,Age,19 Months,82.4,76.8 to 86.9,333
Hib,≥2 Doses,States/Local Areas,Utah,2020,Age,13 Months,94.8,91.0 to 97.0,333
PCV,≥3 Doses,States/Local Areas,Utah,2020,Age,35 Months,93.0,88.8 to 96.0,333
Hib,≥3 Doses,States/Local Areas,Utah,2020,Age,13 Months,84.8,79.7 to 88.8,333
Hib,Primary Series,States/Local Areas,Utah,2020,Age,13 Months,90.4,86.2 to 93.5,333
Hep B,≥2 Doses,States/Local Areas,Utah,2020,Age,13 Months,94.0,90.0 to 96.4,333
Hep B,≥3 Doses,States/Local Areas,Utah,2020,Age,13 Months,88.3,83.3 to 91.9,333
PCV,≥2 Doses,States/Local Areas,Utah,2020,Age,5 Months,85.0,79.8 to 89.0,333
≥1 Dose Varicella,,States/Local Areas,Utah,2020,Age,13 Months,62.8,56.1 to 69.0,333
PCV,≥3 Doses,States/Local Areas,Utah,2020,Age,13 Months,90.3,85.4 to 93.6,333
Polio,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,95.6,93.0 to 97.2,663
DTaP,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,93.7,91.0 to 95.7,663
DTaP,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,5 Months,87.4,83.8 to 90.3,663
Polio,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,5 Months,87.0,83.4 to 90.0,663
PCV,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,3 Months,90.5,87.1 to 93.2,663
Hep B,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,3 Months,95.6,93.2 to 97.2,663
Hib,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,3 Months,89.3,85.8 to 92.0,663
≥1 Dose MMR,,States/Local Areas,Utah,2019-2020,Age,24 Months,94.1,91.8 to 95.9,663
DTaP,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,95.1,92.7 to 96.9,663
DTaP,≥4 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,85.4,81.9 to 88.6,663
Polio,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,95.1,92.7 to 96.9,663
PCV,≥4 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,88.2,84.7 to 91.3,663
PCV,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,94.6,91.9 to 96.6,663
≥1 Dose Varicella,,States/Local Areas,Utah,2019-2020,Age,35 Months,94.4,91.6 to 96.5,663
Hep B,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,92.5,89.7 to 94.7,663
Hib,Full Series,States/Local Areas,Utah,2019-2020,Age,35 Months,85.6,81.8 to 89.0,663
Hib,Primary Series,States/Local Areas,Utah,2019-2020,Age,35 Months,95.5,93.2 to 97.2,663
≥1 Dose MMR,,States/Local Areas,Utah,2019-2020,Age,35 Months,95.4,93.0 to 97.2,663
Hib,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,95.3,93.0 to 97.0,663
≥1 Dose MMR,,States/Local Areas,Utah,2019-2020,Age,19 Months,92.0,89.1 to 94.2,663
Hib,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,93.7,91.0 to 95.7,663
Hib,Primary Series,States/Local Areas,Utah,2019-2020,Age,19 Months,94.4,91.8 to 96.3,663
Polio,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,94.7,92.0 to 96.5,663
Hep A,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,36.6,32.1 to 41.4,663
≥1 Dose Varicella,,States/Local Areas,Utah,2019-2020,Age,24 Months,92.1,89.3 to 94.4,663
PCV,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,93.9,91.2 to 96.1,663
PCV,≥4 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,87.1,83.6 to 90.2,663
Hib,Full Series,States/Local Areas,Utah,2019-2020,Age,24 Months,82.1,78.3 to 85.6,663
Hep B,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,91.7,88.9 to 94.0,663
Hib,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,70.5,65.8 to 74.8,663
PCV,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,80.1,75.9 to 83.8,663
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2019-2020,Age,0-2 Days,83.5,79.4 to 86.9,663
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2019-2020,Age,0-1 Days,81.6,77.4 to 85.2,663
Hep A,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,19 Months,88.4,84.8 to 91.3,663
PCV,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,93.1,90.0 to 95.2,663
PCV,≥4 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,84.5,80.6 to 87.7,663
Hep B,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,91.7,88.7 to 93.9,663
≥1 Dose Varicella,,States/Local Areas,Utah,2019-2020,Age,19 Months,90.3,87.1 to 92.8,663
Combined 7 Series,,States/Local Areas,Utah,2019-2020,Age,35 Months,78.7,74.4 to 82.8,663
Hib,Full Series,States/Local Areas,Utah,2019-2020,Age,19 Months,77.2,73.0 to 81.0,663
Hib,Primary Series,States/Local Areas,Utah,2019-2020,Age,24 Months,94.8,92.4 to 96.6,663
Hib,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,92.5,89.3 to 94.8,663
Hib,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,94.6,92.1 to 96.4,663
Influenza,,States/Local Areas,Utah,2019-2020,Age,24 Months,68.8,64.1 to 73.4,663
Hep A,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,24 Months,50.5,45.6 to 55.6,663
DTaP,≥3 Doses,States/Local Areas,Utah,2020,Age,7 Months,76.4,69.9 to 81.8,333
Hep B,≥2 Doses,States/Local Areas,Utah,2020,Age,5 Months,89.6,84.8 to 93.0,333
Hib,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,95.5,92.9 to 97.1,663
PCV,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,5 Months,86.7,83.0 to 89.6,663
Hep B,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,5 Months,90.9,87.7 to 93.3,663
Hib,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,5 Months,84.8,81.0 to 88.0,663
Hib,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,84.2,80.3 to 87.5,663
Hib,Primary Series,States/Local Areas,Utah,2019-2020,Age,13 Months,90.2,86.9 to 92.7,663
≥1 Dose MMR,,States/Local Areas,Utah,2019-2020,Age,13 Months,73.6,69.2 to 77.6,663
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,91.3 to 95.5,782
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,93.1,90.0 to 96.2,366
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,76.2,68.8 to 83.6,366
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,50.6,32.6 to 68.6,71
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,94.2 to 97.6,591
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,83.7,72.0 to 95.5,71
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,90.0 to 96.8,366
Rotavirus,,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,83.7,80.0 to 87.4,597
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,92.0,88.4 to 95.7,366
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,86.6,80.7 to 92.5,222
Rotavirus,,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,76.7,69.5 to 84.0,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,82.5,75.9 to 89.1,222
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,81.4,76.4 to 86.4,597
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,93.3,89.6 to 97.0,222
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,93.3,88.9 to 97.7,209
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,95.6,93.7 to 97.5,597
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,94.6,92.9 to 96.3,1028
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,94.1,92.4 to 95.7,1028
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,93.5,89.9 to 97.0,222
Influenza,,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,53.4,45.1 to 61.7,209
Influenza,,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,63.4,58.4 to 68.4,597
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,90.4,87.3 to 93.4,597
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,89.6,84.6 to 94.6,209
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,92.8,88.9 to 96.7,209
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,90.0,85.3 to 94.6,222
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,90.9,87.9 to 93.8,597
Hib,Full Series,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,83.8,77.8 to 89.8,222
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,92.0,87.3 to 96.6,209
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,95.5,93.6 to 97.4,597
Hib,Full Series,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,83.8,80.0 to 87.6,597
Hib,Full Series,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,79.2,72.5 to 85.9,209
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,85.8,82.3 to 89.3,597
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,85.6,82.8 to 88.4,1028
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,84.7,78.4 to 90.9,209
Influenza,,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,73.1,65.6 to 80.7,222
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,94.7,91.2 to 98.2,205
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,77.3,70.2 to 84.4,205
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,87.9 to 99.5,87
Polio,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,3 Months,91.5,88.2 to 94.0,663
DTaP,≥3 Doses,States/Local Areas,Utah,2020,Age,19 Months,93.6,89.7 to 96.1,333
Hib,≥3 Doses,States/Local Areas,Utah,2021,Age,19 Months,93.5,89.4 to 96.1,226
Polio,≥2 Doses,States/Local Areas,Utah,2021,Age,7 Months,92.3,86.8 to 95.6,226
≥1 Dose MMR,,States/Local Areas,Utah,2020-2021,Age,24 Months,91.8,88.2 to 94.7,559
PCV,≥2 Doses,States/Local Areas,Utah,2021,Age,5 Months,81.8,73.5 to 88.0,226
DTaP,≥3 Doses,States/Local Areas,Utah,2021,Age,7 Months,78.0,70.0 to 84.4,226
Hib,≥2 Doses,States/Local Areas,Utah,2021,Age,7 Months,91.6,86.1 to 95.1,226
DTaP,≥3 Doses,States/Local Areas,Utah,2021,Age,24 Months,94.9,91.4 to 97.3,226
PCV,≥3 Doses,States/Local Areas,Utah,2021,Age,35 Months,92.5,87.4 to 96.1,226
Hib,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,93.7,91.2 to 95.7,559
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2019-2020,Age,0-3 Days,84.1,80.0 to 87.4,663
DTaP,≥1 Dose,States/Local Areas,Utah,2019-2020,Age,3 Months,91.9,88.6 to 94.3,663
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,64.2 to 88.0,87
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,96.5,93.5 to 99.4,154
DTaP,≥4 Doses,States/Local Areas,Utah,2020,Age,19 Months,77.2,71.2 to 82.2,333
Polio,≥3 Doses,States/Local Areas,Utah,2020,Age,19 Months,93.9,90.1 to 96.3,333
≥1 Dose MMR,,States/Local Areas,Utah,2020,Age,19 Months,91.0,86.4 to 94.1,333
Combined 7 Series,,States/Local Areas,Utah,2020,Age,24 Months,73.9,68.0 to 79.5,333
Hib,≥3 Doses,States/Local Areas,Utah,2020,Age,19 Months,92.8,88.8 to 95.5,333
Influenza,,States/Local Areas,Utah,2020,Age,24 Months,65.5,58.9 to 72.0,333
Rotavirus,,States/Local Areas,Utah,2020,Age,8 Months,76.7,70.1 to 82.1,333
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2020,Age,0-3 Days,81.7,75.4 to 86.6,333
≥1 Dose Varicella,,States/Local Areas,Utah,2020,Age,24 Months,91.2,87.0 to 94.4,333
PCV,≥4 Doses,States/Local Areas,Utah,2020,Age,24 Months,85.3,80.2 to 89.6,333
PCV,≥3 Doses,States/Local Areas,Utah,2020,Age,24 Months,93.0,88.8 to 96.0,333
Hep A,≥2 Doses,States/Local Areas,Utah,2020,Age,24 Months,47.8,41.3 to 54.8,333
Hep A,≥1 Dose,States/Local Areas,Utah,2020,Age,24 Months,91.4,87.3 to 94.6,333
PCV,≥1 Dose,States/Local Areas,Utah,2020,Age,3 Months,90.5,85.7 to 93.8,333
Hep B,≥1 Dose,States/Local Areas,Utah,2020,Age,3 Months,95.6,92.1 to 97.6,333
DTaP,≥2 Doses,States/Local Areas,Utah,2020,Age,5 Months,85.4,80.3 to 89.4,333
Polio,≥2 Doses,States/Local Areas,Utah,2020,Age,5 Months,85.0,79.8 to 89.0,333
Hib,≥2 Doses,States/Local Areas,Utah,2020,Age,5 Months,84.3,79.1 to 88.4,333
Hep B,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,69.4,64.8 to 73.7,663
DTaP,≥4 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,79.0,74.7 to 82.6,663
DTaP,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,19 Months,94.6,92.0 to 96.4,663
≥1 Dose Varicella,,States/Local Areas,Utah,2021,Age,19 Months,89.4,82.7 to 93.7,226
Hib,≥3 Doses,States/Local Areas,Utah,2021,Age,7 Months,72.2,63.6 to 79.4,226
≥1 Dose Varicella,,States/Local Areas,Utah,2020-2021,Age,35 Months,92.5,88.7 to 95.4,559
Hib,Primary Series,States/Local Areas,Utah,2020-2021,Age,13 Months,90.6,87.5 to 93.0,559
Hib,Full Series,States/Local Areas,Utah,2021,Age,24 Months,83.8,76.2 to 90.0,226
Hep A,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,35.1,30.1 to 40.5,559
DTaP,≥3 Doses,States/Local Areas,Utah,2021,Age,13 Months,93.9,89.8 to 96.5,226
PCV,≥3 Doses,States/Local Areas,Utah,2021,Age,7 Months,71.9,62.9 to 79.4,226
Hep B,≥3 Doses,States/Local Areas,Utah,2021,Age,7 Months,72.7,64.1 to 79.9,226
Hep A,≥2 Doses,States/Local Areas,Utah,2021,Age,24 Months,50.0,40.6 to 60.4,226
PCV,≥4 Doses,States/Local Areas,Utah,2021,Age,35 Months,83.2,75.2 to 89.9,226
DTaP,≥3 Doses,States/Local Areas,Utah,2021,Age,19 Months,94.9,91.1 to 97.2,226
DTaP,≥4 Doses,States/Local Areas,Utah,2021,Age,24 Months,85.0,77.4 to 91.1,226
Hep A,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,35 Months,93.5,90.1 to 96.0,559
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,85.9,82.6 to 89.2,751
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,84.2 to 98.9,87
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,85.0,69.8 to 100.0,205
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,80.1,75.6 to 84.6,751
Influenza,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,37.4,18.6 to 56.2,44
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,92.5,84.8 to 100.0,44
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,72.9 to 93.6,87
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,83.9,76.2 to 91.5,154
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,91.6,87.4 to 95.7,205
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,92.5,90.1 to 94.9,751
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,87.1,81.4 to 92.8,205
Influenza,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,56.5,46.5 to 66.4,154
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,84.8,81.9 to 87.7,1028
Rotavirus,,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,84.2,78.4 to 90.1,222
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,94.1,92.3 to 95.9,1028
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,94.3,92.6 to 96.1,1028
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,83.5,77.0 to 89.9,209
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,89.5,86.3 to 92.7,597
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,93.1,89.5 to 96.8,222
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,83.8,76.0 to 91.6,222
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,90.9,86.4 to 95.4,209
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,92.8,88.5 to 97.2,209
Influenza,,States/Local Areas,Utah,2016-2019,Overall,Overall,62.5,58.6 to 66.3,1028
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,95.0,93.0 to 97.0,597
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,83.9,77.9 to 89.9,209
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Overall,Overall,75.2,71.8 to 78.7,1028
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,77.0,62.7 to 91.4,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Overall,Overall,83.2,80.2 to 86.1,1028
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,94.1,90.5 to 97.8,209
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Overall,Overall,90.6,88.3 to 92.8,1028
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Overall,Overall,91.8,89.8 to 93.9,1028
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,93.5,89.7 to 97.3,222
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Overall,Overall,90.7,88.4 to 93.0,1028
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Overall,Overall,80.1,75.3 to 84.9,1028
Rotavirus,,States/Local Areas,Utah,2016-2019,Overall,Overall,81.9,78.9 to 85.0,1028
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,76.1,71.7 to 80.5,597
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,77.5,70.6 to 84.4,222
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,93.8,90.2 to 97.5,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,83.0,79.0 to 86.9,597
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Poverty,<133% FPL,71.9,64.3 to 79.5,209
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,94.1,92.0 to 96.3,597
Hib,Full Series,States/Local Areas,Utah,2016-2019,Overall,Overall,82.5,79.6 to 85.5,1028
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,74.3,61.8 to 86.8,71
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,93.1,89.3 to 97.0,222
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,85.3,74.6 to 96.0,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.2,80.4 to 88.0,591
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,82.8,77.8 to 87.9,366
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,87.4 to 93.3,591
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,83.7,71.9 to 95.4,71
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.5,93.7 to 97.4,591
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,73.2,67.1 to 79.4,366
Influenza,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,42.6,27.9 to 57.4,71
Influenza,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,64.0,59.1 to 69.0,591
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,90.0 to 96.8,366
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,89.9,80.5 to 99.3,71
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.7,94.0 to 97.5,591
Influenza,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",45.5,31.7 to 59.4,87
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,93.0,88.0 to 98.0,154
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,91.7,83.8 to 99.6,44
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.3,92.3 to 96.2,782
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.5,86.8 to 92.3,782
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,71.8,54.5 to 89.1,44
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,94.9,91.5 to 98.4,205
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,93.9,92.0 to 95.9,751
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,84.8,78.8 to 90.9,205
Hib,Full Series,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,83.3,77.3 to 89.3,205
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,94.6,92.5 to 96.7,751
Hib,Full Series,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,78.7,65.4 to 92.0,44
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,84.8 to 99.4,87
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,93.8,90.0 to 97.6,205
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,83.3,70.6 to 95.9,44
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,78.4,61.5 to 95.3,44
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,90.2,85.7 to 94.7,205
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.1,81.9 to 88.3,782
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.9,93.0 to 96.7,782
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,94.1,89.4 to 98.8,154
Hep A,≥1 Dose,States/Local Areas,Utah,2021,Age,19 Months,85.4,77.5 to 90.9,226
DTaP,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,3 Months,91.7,88.1 to 94.3,559
Hep B,≥3 Doses,States/Local Areas,Utah,2021,Age,24 Months,94.7,91.2 to 97.2,226
PCV,≥4 Doses,States/Local Areas,Utah,2021,Age,19 Months,81.2,72.7 to 87.5,226
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.7,83.3 to 90.0,591
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,83.1,77.8 to 88.5,366
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.6,90.2 to 95.0,591
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.7,93.9 to 97.5,591
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,76.9,64.6 to 89.2,71
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,90.2 to 97.0,366
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,89.9,81.6 to 98.2,71
Rotavirus,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.2,80.6 to 87.9,591
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.0,79.2 to 90.8,591
Hib,Full Series,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,82.8,77.7 to 87.9,366
Hib,Full Series,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,69.3,54.8 to 83.7,71
Rotavirus,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,61.3,46.4 to 76.3,71
Hib,Full Series,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.6,79.9 to 87.3,591
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,87.0 to 94.7,366
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.0,88.3 to 93.7,591
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,79.9,65.4 to 94.3,71
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,91.5,87.8 to 95.2,366
Rotavirus,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,81.3,75.9 to 86.8,366
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.7,73.5 to 81.8,591
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,62.7,48.3 to 77.2,71
Influenza,,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,63.0,56.4 to 69.6,366
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,70.8,56.6 to 84.9,71
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.3,84.0 to 90.7,591
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a MSA Principal City,85.0,80.2 to 89.9,366
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Urbanicity,Living In a Non-MSA,82.4,70.5 to 94.3,71
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.1,87.5 to 92.8,782
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,85.8 to 100.0,87
Rotavirus,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.0,80.8 to 87.1,782
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,75.6,71.6 to 79.6,751
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,68.9 to 91.8,87
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,83.3,79.8 to 86.8,751
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,86.2,80.6 to 91.8,205
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.6,88.0 to 93.2,782
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,64.7,46.4 to 83.0,44
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,89.2 to 100.0,87
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,95.0,91.3 to 98.8,154
≥1 Dose Varicella,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,92.0,89.5 to 94.5,751
Rotavirus,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.0,62.6 to 87.4,87
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,94.8,92.7 to 96.9,751
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,90.5,81.9 to 99.0,44
Rotavirus,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,83.8,80.4 to 87.2,751
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,63.6,45.6 to 81.7,44
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,85.4 to 98.1,87
Influenza,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,67.2,62.7 to 71.6,751
Influenza,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,56.0,47.6 to 64.3,205
Hib,Full Series,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.9,78.5 to 85.2,782
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,82.4,74.9 to 89.9,154
Rotavirus,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,74.5,60.4 to 88.6,44
Rotavirus,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,79.0,72.0 to 86.1,205
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,65.0,36.6 to 93.3,44
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.0,70.1 to 77.9,782
Combined 7 Series,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,78.5,69.7 to 87.3,154
Rotavirus,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,77.1,68.5 to 85.7,154
≥1 Dose MMR,,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,85.1,72.8 to 97.4,44
Hep B,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,92.1,84.5 to 99.7,44
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.0,81.8 to 88.1,782
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,84.6,77.1 to 92.2,154
Influenza,,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",66.0,61.7 to 70.2,782
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Uninsured,75.5,61.4 to 89.5,44
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.5 to 96.4,782
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,94.6,91.2 to 98.1,205
Polio,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,95.9,93.6 to 97.5,663
DTaP,≥4 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,91.0,87.6 to 93.8,663
DTaP,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,35 Months,95.6,93.4 to 97.3,663
Combined 7 Series,,States/Local Areas,Utah,2019-2020,Age,24 Months,74.3,69.9 to 78.4,663
≥1 Dose Varicella,,States/Local Areas,Utah,2019-2020,Age,13 Months,64.0,59.2 to 68.5,663
PCV,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,92.1,89.0 to 94.4,663
Hep B,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,94.7,92.1 to 96.5,663
Hep B,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,13 Months,89.9,86.7 to 92.4,663
DTaP,≥3 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,80.2,75.9 to 83.9,663
Polio,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,92.9,89.7 to 95.1,663
Polio,≥3 Doses,States/Local Areas,Vermont,2019,Age,35 Months,95.9,92.8 to 98.0,334
Hib,Full Series,States/Local Areas,Vermont,2013,Age,35 Months,91.3,85.3 to 95.6,261
Hib,Full Series,States/Local Areas,Vermont,2013-2014,Age,35 Months,89.4,85.1 to 92.8,532
Polio,≥3 Doses,States/Local Areas,Vermont,2018,Age,35 Months,93.9,89.8 to 96.7,340
Polio,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,94.9,92.4 to 96.8,674
DTaP,≥3 Doses,States/Local Areas,Vermont,2012,Age,24 Months,95.8,91.5 to 98.3,261
Hib,Full Series,States/Local Areas,Vermont,2017,Age,35 Months,89.3,84.4 to 93.2,330
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,93.2,90.7 to 95.8,453
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,94.0,91.5 to 96.5,492
Hib,Full Series,States/Local Areas,Vermont,2015,Age,35 Months,86.0,80.3 to 90.7,252
Hib,Full Series,States/Local Areas,Vermont,2015-2016,Age,35 Months,87.2,83.2 to 90.7,500
Hib,Full Series,States/Local Areas,Vermont,2014,Age,35 Months,87.7,81.3 to 92.7,271
Hib,Full Series,States/Local Areas,Vermont,2014-2015,Age,35 Months,86.9,82.7 to 90.5,523
DTaP,≥2 Doses,States/Local Areas,Vermont,2015,Age,5 Months,88.3,81.8 to 92.6,252
DTaP,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,5 Months,87.7,83.2 to 91.1,500
DTaP,≥2 Doses,States/Local Areas,Vermont,2014,Age,5 Months,85.1,78.8 to 89.8,271
DTaP,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,5 Months,86.7,85.6 to 87.7,523
Hib,Full Series,States/Local Areas,Vermont,2016,Age,35 Months,88.5,82.5 to 93.2,248
Hib,Full Series,States/Local Areas,Vermont,2016-2017,Age,35 Months,89.0,85.3 to 92.2,578
Polio,≥3 Doses,States/Local Areas,Vermont,2017,Age,35 Months,94.4,90.3 to 97.2,330
Polio,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,94.2,91.4 to 96.3,670
Polio,≥3 Doses,States/Local Areas,Vermont,2016,Age,35 Months,93.6,89.7 to 96.4,248
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,94.0,91.3 to 96.1,578
Polio,≥3 Doses,States/Local Areas,Vermont,2012,Age,35 Months,96.8,93.4 to 98.8,261
Polio,≥3 Doses,States/Local Areas,Vermont,2015,Age,35 Months,94.8,90.1 to 97.7,252
Polio,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,94.2,91.3 to 96.4,500
Hib,Full Series,States/Local Areas,Vermont,2011,Age,35 Months,83.5,77.1 to 89.0,274
Hib,Full Series,States/Local Areas,Vermont,2012,Age,35 Months,86.7,80.7 to 91.6,261
Hib,Full Series,States/Local Areas,Vermont,2019,Age,24 Months,88.0,83.1 to 92.0,334
Hib,Full Series,States/Local Areas,Vermont,2018,Age,24 Months,88.4,83.5 to 92.5,340
Hib,Full Series,States/Local Areas,Vermont,2018-2019,Age,24 Months,88.2,84.8 to 91.1,674
Polio,≥3 Doses,States/Local Areas,Vermont,2013,Age,35 Months,96.3,92.5 to 98.5,261
Polio,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,95.5,92.8 to 97.5,532
Polio,≥3 Doses,States/Local Areas,Vermont,2014,Age,35 Months,94.8,90.3 to 97.7,271
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,94.9,91.9 to 97.1,523
DTaP,≥2 Doses,States/Local Areas,Vermont,2013,Age,5 Months,82.0,73.9 to 88.0,261
DTaP,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,5 Months,83.5,79.0 to 87.2,532
DTaP,≥2 Doses,States/Local Areas,Vermont,2012,Age,5 Months,83.8,79.4 to 87.4,261
DTaP,≥2 Doses,States/Local Areas,Vermont,2011,Age,5 Months,83.7,77.7 to 88.3,274
Polio,≥3 Doses,States/Local Areas,Vermont,2011,Age,35 Months,92.3,88.2 to 95.4,274
DTaP,≥3 Doses,States/Local Areas,Vermont,2019,Age,19 Months,96.4,92.9 to 98.2,334
DTaP,≥3 Doses,States/Local Areas,Vermont,2011,Age,24 Months,96.2,92.9 to 98.2,274
Hib,Full Series,States/Local Areas,Vermont,2015,Age,24 Months,85.2,79.5 to 90.0,252
Hib,Full Series,States/Local Areas,Vermont,2014,Age,24 Months,84.4,78.2 to 89.6,271
Hib,Full Series,States/Local Areas,Vermont,2014-2015,Age,24 Months,84.8,80.7 to 88.5,523
Polio,≥3 Doses,States/Local Areas,Vermont,2017,Age,24 Months,94.1,89.9 to 96.9,330
Polio,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,93.5,90.8 to 95.7,670
Polio,≥3 Doses,States/Local Areas,Vermont,2019,Age,24 Months,95.9,92.8 to 98.0,334
Polio,≥3 Doses,States/Local Areas,Vermont,2018,Age,24 Months,93.0,89.0 to 95.9,340
Polio,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,94.4,92.0 to 96.3,674
Hib,≥3 Doses,States/Local Areas,Vermont,2019,Age,19 Months,96.2,92.7 to 98.1,334
Polio,≥3 Doses,States/Local Areas,Vermont,2016,Age,24 Months,93.1,89.1 to 96.0,248
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,93.6,90.8 to 95.7,578
Hib,≥3 Doses,States/Local Areas,Vermont,2013,Age,24 Months,95.1,90.8 to 97.8,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,94.8,91.9 to 96.9,532
Hib,≥3 Doses,States/Local Areas,Vermont,2012,Age,24 Months,94.7,90.2 to 97.5,261
Hib,≥3 Doses,States/Local Areas,Vermont,2011,Age,24 Months,92.1,87.3 to 95.6,274
Hib,Full Series,States/Local Areas,Vermont,2015-2016,Age,24 Months,86.2,82.1 to 89.7,500
Hib,Full Series,States/Local Areas,Vermont,2016,Age,24 Months,87.1,81.2 to 91.9,248
Hib,Full Series,States/Local Areas,Vermont,2016-2017,Age,24 Months,87.8,84.0 to 91.0,578
Hib,≥3 Doses,States/Local Areas,Vermont,2019,Age,13 Months,93.9,89.7 to 96.4,334
Hib,Full Series,States/Local Areas,Vermont,2017,Age,24 Months,88.2,83.2 to 92.2,330
Hib,Full Series,States/Local Areas,Vermont,2017-2018,Age,24 Months,88.3,84.9 to 91.2,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2015,Age,19 Months,94.0,91.8 to 95.6,252
DTaP,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,95.2,92.3 to 97.0,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2014,Age,19 Months,93.7,88.7 to 96.6,271
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,93.9,90.5 to 96.1,523
DTaP,≥3 Doses,States/Local Areas,Vermont,2013,Age,19 Months,96.5,94.7 to 97.7,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,95.1,93.4 to 96.4,532
Polio,≥3 Doses,States/Local Areas,Vermont,2018,Age,19 Months,92.9,88.5 to 95.6,340
Polio,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,75.0,70.6 to 79.0,674
Hib,≥3 Doses,States/Local Areas,Vermont,2015,Age,19 Months,91.8,88.8 to 94.1,252
Hib,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,94.2,91.0 to 96.3,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2017,Age,19 Months,95.9,92.1 to 97.9,330
DTaP,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,95.5,93.2 to 97.1,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2016,Age,19 Months,96.4,92.8 to 98.2,248
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,96.1,93.8 to 97.6,578
Polio,≥3 Doses,States/Local Areas,Vermont,2011,Age,24 Months,92.3,88.2 to 95.4,274
Polio,≥3 Doses,States/Local Areas,Vermont,2012,Age,24 Months,92.2,87.5 to 95.6,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013,Age,19 Months,94.8,90.7 to 97.2,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,94.6,92.9 to 95.9,532
Hib,≥3 Doses,States/Local Areas,Vermont,2014,Age,19 Months,94.4,89.5 to 97.1,271
Hib,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,93.1,89.6 to 95.5,523
Polio,≥3 Doses,States/Local Areas,Vermont,2019,Age,19 Months,95.9,92.4 to 97.9,334
Hib,≥3 Doses,States/Local Areas,Vermont,2018,Age,19 Months,93.3,88.9 to 96.1,340
Hib,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,91.5,88.4 to 93.9,674
DTaP,≥3 Doses,States/Local Areas,Vermont,2018,Age,19 Months,95.2,91.7 to 97.3,340
DTaP,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,93.6,90.8 to 95.6,674
Polio,≥3 Doses,States/Local Areas,Vermont,2015,Age,24 Months,92.8,88.5 to 96.0,252
Polio,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,92.9,90.1 to 95.2,500
Polio,≥3 Doses,States/Local Areas,Vermont,2014,Age,24 Months,94.0,89.5 to 97.0,271
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,93.4,90.4 to 95.7,523
Hib,≥3 Doses,States/Local Areas,Vermont,2017,Age,19 Months,94.8,90.9 to 97.0,330
Hib,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,94.0,91.3 to 96.0,670
Hib,≥3 Doses,States/Local Areas,Vermont,2016,Age,19 Months,96.4,93.0 to 98.2,248
Hib,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,95.6,93.2 to 97.2,578
Polio,≥3 Doses,States/Local Areas,Vermont,2013,Age,24 Months,94.9,91.2 to 97.3,261
Polio,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,94.4,91.7 to 96.5,532
DTaP,≥4 Doses,States/Local Areas,Utah,2011,Age,19 Months,71.2,60.3 to 80.0,266
DTaP,≥4 Doses,States/Local Areas,Utah,2012,Age,19 Months,70.2,62.7 to 76.7,260
Hep A,≥2 Doses,States/Local Areas,Utah,2014,Age,19 Months,28.4,22.4 to 35.2,258
Hep A,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,27.4,22.9 to 32.4,499
DTaP,≥2 Doses,States/Local Areas,Utah,2019,Age,5 Months,89.3,83.6 to 93.1,330
Hib,≥3 Doses,States/Local Areas,Utah,2011,Age,35 Months,92.2,87.0 to 95.8,266
Hep A,≥1 Dose,States/Local Areas,Utah,2013,Age,24 Months,84.3,77.3 to 90.0,250
Hep A,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,24 Months,85.7,81.4 to 89.6,508
Hep A,≥1 Dose,States/Local Areas,Utah,2011,Age,24 Months,88.1,82.2 to 92.8,266
Hep A,≥1 Dose,States/Local Areas,Utah,2012,Age,24 Months,88.6,83.0 to 93.0,260
Hep A,≥1 Dose,States/Local Areas,Utah,2019,Age,19 Months,89.2,83.7 to 93.0,330
DTaP,≥3 Doses,States/Local Areas,Utah,2016,Age,35 Months,92.6,88.2 to 95.8,293
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,93.4,90.2 to 95.9,520
DTaP,≥3 Doses,States/Local Areas,Utah,2015,Age,35 Months,90.1,84.1 to 94.5,241
DTaP,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,91.3,87.7 to 94.2,534
PCV,≥2 Doses,States/Local Areas,Utah,2011,Age,5 Months,79.6,73.0 to 85.0,266
PCV,≥2 Doses,States/Local Areas,Utah,2012,Age,5 Months,76.7,66.7 to 84.3,260
PCV,≥2 Doses,States/Local Areas,Utah,2013,Age,5 Months,78.2,69.3 to 85.1,250
PCV,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,5 Months,78.6,74.8 to 82.0,508
DTaP,≥3 Doses,States/Local Areas,Utah,2017,Age,35 Months,94.3,89.1 to 97.5,227
DTaP,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,95.2,92.4 to 97.3,525
Hib,Primary Series,States/Local Areas,Utah,2021,Age,7 Months,77.8,70.0 to 84.0,226
DTaP,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,94.3,91.7 to 96.1,559
Hep B,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,94.9,92.4 to 96.6,559
Polio,≥3 Doses,States/Local Areas,Utah,2021,Age,35 Months,94.0,90.4 to 96.6,226
Hep B,≥2 Doses,States/Local Areas,Utah,2021,Age,5 Months,91.6,85.9 to 95.2,226
DTaP,≥4 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,84.7,80.4 to 88.5,559
Hep A,≥2 Doses,States/Local Areas,Utah,2021,Age,35 Months,85.8,76.3 to 93.0,226
Combined 7 Series,,States/Local Areas,Utah,2021,Age,35 Months,78.9,69.1 to 87.2,226
DTaP,≥4 Doses,States/Local Areas,Utah,2021,Age,19 Months,73.4,64.6 to 80.6,226
≥1 Dose MMR,,States/Local Areas,Utah,2021,Age,35 Months,91.1,84.1 to 95.9,226
Hep B,≥3 Doses,States/Local Areas,Utah,2021,Age,19 Months,94.7,90.8 to 97.0,226
Hib,Primary Series,States/Local Areas,Utah,2020-2021,Age,24 Months,93.9,91.4 to 95.8,559
Hib,Primary Series,States/Local Areas,Utah,2021,Age,19 Months,93.6,89.5 to 96.1,226
DTaP,≥1 Dose,States/Local Areas,Utah,2016,Age,3 Months,86.4,80.2 to 90.9,293
DTaP,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,3 Months,89.0,84.8 to 92.1,520
DTaP,≥1 Dose,States/Local Areas,Utah,2015,Age,3 Months,86.0,78.8 to 91.0,241
DTaP,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,3 Months,86.2,81.6 to 89.7,534
DTaP,≥1 Dose,States/Local Areas,Utah,2014,Age,3 Months,85.7,79.4 to 90.3,258
DTaP,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,3 Months,85.8,81.3 to 89.4,499
DTaP,≥1 Dose,States/Local Areas,Utah,2013,Age,3 Months,86.4,81.6 to 90.0,250
DTaP,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,3 Months,86.0,83.9 to 87.9,508
Hib,≥1 Dose,States/Local Areas,Utah,2021,Age,3 Months,88.5,82.0 to 92.9,226
DTaP,≥1 Dose,States/Local Areas,Utah,2011,Age,3 Months,91.1,85.7 to 94.6,266
DTaP,≥1 Dose,States/Local Areas,Utah,2012,Age,3 Months,84.2,74.3 to 90.8,260
DTaP,≥4 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,90.8,86.9 to 94.0,559
PCV,≥4 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,83.7,79.1 to 87.8,559
Hib,Full Series,States/Local Areas,Utah,2021,Age,19 Months,74.9,66.3 to 81.9,226
Hep B,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,90.8,87.7 to 93.2,559
DTaP,≥3 Doses,States/Local Areas,Utah,2016,Age,24 Months,92.6,88.2 to 95.7,293
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,93.4,90.2 to 95.8,520
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Overall,Overall,91.9,89.9 to 94.0,945
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,89.3,84.4 to 94.1,224
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,93.2,90.8 to 95.6,550
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,92.5,88.2 to 96.7,171
DTaP,≥3 Doses,States/Local Areas,Utah,2018,Age,24 Months,96.2,93.2 to 98.1,298
DTaP,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,96.3,94.1 to 97.9,628
DTaP,≥3 Doses,States/Local Areas,Utah,2017,Age,24 Months,94.3,89.1 to 97.5,227
DTaP,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,95.2,92.4 to 97.3,525
DTaP,≥2 Doses,States/Local Areas,Utah,2016,Age,5 Months,81.5,75.0 to 86.6,293
DTaP,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,5 Months,84.5,80.0 to 88.1,520
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,85.7,77.1 to 94.3,88
Polio,≥3 Doses,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.0,89.3 to 94.7,520
DTaP,≥2 Doses,States/Local Areas,Utah,2017,Age,5 Months,87.5,80.9 to 92.1,227
DTaP,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,5 Months,86.2,81.8 to 89.7,525
Hib,≥3 Doses,States/Local Areas,Utah,2016,Age,24 Months,92.0,87.6 to 95.3,293
Hib,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,91.8,88.2 to 94.7,520
Hib,≥3 Doses,States/Local Areas,Utah,2015,Age,24 Months,87.2,80.8 to 92.2,241
Hib,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,89.6,85.8 to 92.7,534
DTaP,≥3 Doses,States/Local Areas,Utah,2019,Age,24 Months,96.3,92.6 to 98.5,330
Hib,≥3 Doses,States/Local Areas,Utah,2014,Age,24 Months,88.3,82.8 to 92.8,258
Hib,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,87.8,83.7 to 91.2,499
DTaP,≥2 Doses,States/Local Areas,Utah,2018,Age,5 Months,84.8,78.3 to 89.6,298
DTaP,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,5 Months,87.0,82.9 to 90.3,628
Hep A,≥1 Dose,States/Local Areas,Utah,2013,Age,19 Months,79.6,71.5 to 85.8,250
Hep A,≥1 Dose,States/Local Areas,Utah,2013-2014,Age,19 Months,81.3,76.0 to 85.6,508
Hep A,≥1 Dose,States/Local Areas,Utah,2014,Age,19 Months,83.0,76.4 to 88.0,258
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,19 Months,81.6,76.9 to 85.6,499
Hep A,≥1 Dose,States/Local Areas,Utah,2015,Age,19 Months,80.2,66.5 to 89.2,241
Hep A,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,19 Months,82.5,77.9 to 86.3,534
DTaP,≥3 Doses,States/Local Areas,Utah,2014,Age,24 Months,92.5,87.6 to 96.0,258
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,91.1,87.4 to 94.1,499
DTaP,≥1 Dose,States/Local Areas,Utah,2017,Age,3 Months,91.7,85.3 to 95.4,227
DTaP,≥3 Doses,States/Local Areas,Utah,2015,Age,24 Months,89.8,83.8 to 94.3,241
DTaP,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,91.1,87.5 to 94.1,534
DTaP,≥1 Dose,States/Local Areas,Utah,2019,Age,3 Months,91.0,85.4 to 94.6,330
DTaP,≥1 Dose,States/Local Areas,Utah,2018,Age,3 Months,92.3,88.0 to 95.1,298
DTaP,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,3 Months,91.7,88.3 to 94.1,628
DTaP,≥3 Doses,States/Local Areas,Utah,2013,Age,24 Months,89.5,83.4 to 94.0,250
DTaP,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,91.0,87.2 to 94.0,508
Hep A,≥1 Dose,States/Local Areas,Utah,2011,Age,19 Months,86.3,73.4 to 93.4,266
DTaP,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,3 Months,92.0,88.4 to 94.5,525
Hep A,≥1 Dose,States/Local Areas,Utah,2018,Age,24 Months,92.7,88.0 to 96.1,298
Hep A,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,24 Months,92.1,88.8 to 94.7,628
Hep A,≥1 Dose,States/Local Areas,Utah,2011,Age,35 Months,91.2,85.1 to 95.5,266
Hep A,≥1 Dose,States/Local Areas,Utah,2019,Age,24 Months,91.4,86.6 to 95.0,330
Hep A,≥2 Doses,States/Local Areas,Utah,2019,Age,19 Months,36.8,30.4 to 43.8,330
PCV,≥2 Doses,States/Local Areas,Utah,2016,Age,5 Months,80.3,73.8 to 85.6,293
PCV,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,5 Months,82.6,78.0 to 86.4,520
Hep A,≥1 Dose,States/Local Areas,Utah,2017,Age,24 Months,92.2,86.2 to 96.2,227
Hep A,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,24 Months,92.2,88.6 to 95.0,525
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,80.3,67.9 to 92.7,45
Hep A,≥2 Doses,States/Local Areas,Utah,2017,Age,19 Months,32.5,24.6 to 41.4,227
Hep A,≥2 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,33.3,28.1 to 39.0,525
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,94.2,92.1 to 96.2,651
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,91.8,87.6 to 96.1,222
DTaP,≥4 Doses,States/Local Areas,Utah,2015,Age,19 Months,66.8,54.5 to 77.1,241
DTaP,≥4 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,69.9,64.6 to 74.7,534
DTaP,≥4 Doses,States/Local Areas,Utah,2014,Age,19 Months,71.9,64.9 to 78.0,258
DTaP,≥4 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,69.3,64.1 to 74.1,499
DTaP,≥4 Doses,States/Local Areas,Utah,2013,Age,19 Months,65.4,59.0 to 71.3,250
DTaP,≥4 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,68.7,64.4 to 72.7,508
Hib,≥3 Doses,States/Local Areas,Utah,2017,Age,35 Months,92.2,85.9 to 96.4,227
Hib,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,35 Months,94.0,90.5 to 96.5,525
Hib,≥3 Doses,States/Local Areas,Utah,2016,Age,35 Months,92.2,87.8 to 95.4,293
Hib,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,35 Months,92.2,88.6 to 95.0,520
Hep A,≥2 Doses,States/Local Areas,Utah,2018,Age,19 Months,34.2,27.8 to 41.3,298
Hep A,≥2 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,34.9,29.6 to 40.6,508
Hep A,≥2 Doses,States/Local Areas,Utah,2011,Age,24 Months,44.4,36.8 to 52.8,266
PCV,≥2 Doses,States/Local Areas,Utah,2014,Age,5 Months,79.0,72.2 to 84.5,258
PCV,≥2 Doses,States/Local Areas,Utah,2014-2015,Age,5 Months,80.9,75.3 to 85.5,499
Hep A,≥1 Dose,States/Local Areas,Utah,2016,Age,24 Months,86.8,81.1 to 91.5,293
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,24 Months,89.1,85.2 to 92.4,520
Hep A,≥1 Dose,States/Local Areas,Utah,2014,Age,24 Months,87.5,81.8 to 92.1,258
Hep A,≥1 Dose,States/Local Areas,Utah,2014-2015,Age,24 Months,85.9,81.7 to 89.6,499
Hep A,≥1 Dose,States/Local Areas,Utah,2015,Age,24 Months,84.3,77.8 to 89.8,241
Hep A,≥1 Dose,States/Local Areas,Utah,2015-2016,Age,24 Months,85.6,81.3 to 89.3,534
DTaP,≥3 Doses,States/Local Areas,Utah,2018,Age,35 Months,96.2,93.3 to 98.1,298
DTaP,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,35 Months,97.0,94.9 to 98.4,628
DTaP,≥3 Doses,States/Local Areas,Utah,2019,Age,35 Months,97.4,94.2 to 99.1,330
PCV,≥2 Doses,States/Local Areas,Utah,2015,Age,5 Months,82.8,75.7 to 88.2,241
PCV,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,5 Months,81.6,76.9 to 85.5,534
Hib,≥3 Doses,States/Local Areas,Utah,2014,Age,35 Months,89.0,83.4 to 93.4,258
Hib,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,88.9,84.8 to 92.3,499
Hib,≥3 Doses,States/Local Areas,Utah,2013,Age,35 Months,94.4,85.1 to 98.7,250
Hib,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,93.6,86.5 to 97.7,508
Hep A,≥2 Doses,States/Local Areas,Utah,2016,Age,19 Months,29.0,22.9 to 35.9,293
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,30.7,25.6 to 36.3,520
Hep A,≥2 Doses,States/Local Areas,Utah,2015,Age,19 Months,26.4,16.3 to 39.9,241
Hep A,≥2 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,27.7,23.2 to 32.7,534
Hib,≥3 Doses,States/Local Areas,Utah,2015,Age,35 Months,88.9,82.5 to 93.8,241
Hib,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,35 Months,90.4,86.6 to 93.4,534
Hib,≥3 Doses,States/Local Areas,Utah,2012,Age,35 Months,92.3,87.2 to 95.9,260
PCV,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,5 Months,83.4,78.6 to 87.3,559
Hep A,≥1 Dose,States/Local Areas,Utah,2012,Age,19 Months,84.8,81.6 to 87.5,260
Hep A,≥1 Dose,States/Local Areas,Utah,2016,Age,19 Months,84.7,78.6 to 89.3,293
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2017,Age,19 Months,86.6,82.2 to 90.1,520
Hep A,≥1 Dose,States/Local Areas,Utah,2018,Age,19 Months,90.5,84.7 to 94.2,298
Hep A,≥1 Dose,States/Local Areas,Utah,2018-2019,Age,19 Months,89.9,85.4 to 93.1,508
Hep A,≥1 Dose,States/Local Areas,Utah,2017,Age,19 Months,88.6,81.4 to 93.2,227
Hep A,≥1 Dose,States/Local Areas,Utah,2017-2018,Age,19 Months,89.5,85.1 to 92.7,525
Hib,≥3 Doses,States/Local Areas,Utah,2018,Age,24 Months,95.7,92.5 to 97.8,298
Hib,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,95.6,93.2 to 97.3,628
Hib,≥3 Doses,States/Local Areas,Utah,2017,Age,24 Months,91.5,85.3 to 95.9,227
Hib,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,93.6,90.2 to 96.2,525
Hib,≥3 Doses,States/Local Areas,Utah,2019,Age,24 Months,95.4,91.7 to 97.8,330
Hep A,≥2 Doses,States/Local Areas,Utah,2012,Age,19 Months,20.1,15.1 to 26.4,260
Hep A,≥2 Doses,States/Local Areas,Utah,2013,Age,19 Months,25.7,20.6 to 31.5,250
Hep A,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,27.0,21.8 to 33.0,508
DTaP,≥3 Doses,States/Local Areas,Utah,2011,Age,35 Months,93.3,88.2 to 96.7,266
DTaP,≥3 Doses,States/Local Areas,Utah,2012,Age,35 Months,94.3,89.4 to 97.5,260
DTaP,≥3 Doses,States/Local Areas,Utah,2013,Age,35 Months,95.3,87.1 to 99.0,250
DTaP,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,95.1,89.4 to 98.2,508
DTaP,≥3 Doses,States/Local Areas,Utah,2014,Age,35 Months,92.5,87.6 to 96.0,258
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,91.2,87.5 to 94.2,499
Hep A,≥2 Doses,States/Local Areas,Utah,2011,Age,19 Months,26.3,23.8 to 29.0,266
Polio,≥3 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,91.7,89.8 to 93.2,977
Polio,≥3 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,89.1,85.8 to 91.7,1050
Polio,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,88.8,86.4 to 90.8,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,74.6,69.6 to 79.1,875
Hib,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,75.2,72.1 to 78.0,2294
Hib,≥3 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,75.8,72.2 to 79.0,1419
Hib,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,76.9,74.6 to 79.2,2919
Hib,≥3 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,75.2,70.5 to 79.4,992
Hib,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,74.9,71.5 to 78.0,1867
Polio,≥3 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,89.8,87.9 to 91.4,1048
Polio,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,89.5,87.4 to 91.2,2098
DTaP,≥3 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,91.4,86.0 to 94.8,1041
DTaP,≥3 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,92.9,90.9 to 94.4,977
Polio,≥3 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,88.5,87.7 to 89.3,992
Polio,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,87.8,84.9 to 90.2,1867
Polio,≥3 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,87.1,82.4 to 90.6,875
Polio,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,88.5,85.9 to 90.7,2294
Polio,≥3 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,90.0,87.2 to 92.2,1419
Polio,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,92.1,90.4 to 93.5,2919
PCV,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,5 Months,78.1,75.1 to 80.9,2007
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,91.5,88.8 to 93.6,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,93.9,92.0 to 95.3,1500
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,92.7,91.1 to 94.0,2812
Hib,≥3 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,54.3,48.9 to 59.5,875
Hib,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,53.4,50.0 to 56.8,2294
Hib,≥3 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,56.3,52.5 to 60.1,1500
Hib,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,58.0,55.2 to 60.7,2812
DTaP,≥3 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,87.9,83.2 to 91.4,1041
DTaP,≥3 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,90.5,88.0 to 92.6,977
Hib,≥2 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,95.8,94.1 to 97.0,1312
Hib,≥2 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,95.4,93.6 to 96.7,1500
Hib,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,95.6,94.4 to 96.5,2812
Hib,≥2 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,91.3,88.6 to 93.4,1419
Hib,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,93.3,91.7 to 94.6,2919
Hib,≥3 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,78.1,74.9 to 81.1,1500
Hib,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,78.0,75.7 to 80.2,2812
Hib,≥3 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,89.3,85.8 to 92.0,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,89.1,82.6 to 93.4,1041
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,88.3,85.3 to 90.7,1419
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,91.1,89.3 to 92.5,2919
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,87.1,82.5 to 90.7,875
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,87.7,85.0 to 90.0,2294
Hib,≥3 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,59.6,55.7 to 63.5,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,89.6,87.2 to 91.6,1048
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,89.0,86.5 to 91.1,2098
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,88.5,85.1 to 91.1,1050
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,87.3,84.7 to 89.6,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,81.9,74.4 to 87.6,1041
Hib,≥3 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,81.3,77.5 to 84.5,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,78.3,74.5 to 81.7,1050
Hib,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,76.8,73.8 to 79.5,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,79.7,75.3 to 83.5,1048
Hib,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,79.0,73.6 to 83.5,2098
Polio,≥3 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,88.8,83.8 to 92.4,1041
Hib,≥2 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,91.8,89.0 to 93.9,1050
Hib,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,92.1,90.1 to 93.7,2042
Hib,≥2 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,92.4,89.3 to 94.7,992
Hib,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,91.2,88.6 to 93.2,1867
Hib,≥2 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,89.9,85.6 to 93.0,875
Hib,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,90.6,88.1 to 92.6,2294
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,76.8,73.3 to 79.9,1500
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,77.3,74.8 to 79.7,2812
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2019,Age,0-3 Days,83.5,80.4 to 86.2,1312
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2018,Age,0-3 Days,79.9,76.7 to 82.8,1500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2018-2019,Age,0-3 Days,81.7,79.5 to 83.7,2812
Hib,≥3 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,52.6,48.4 to 56.7,1419
Hib,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,54.4,51.6 to 57.2,2919
PCV,≥1 Dose,HHS Regions/National,Region 10,2019,Age,3 Months,91.1,88.6 to 93.1,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,86.2,81.9 to 89.6,992
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,86.7,83.6 to 89.2,1867
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,69.8,65.7 to 73.7,1419
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,73.3,70.6 to 75.8,2919
PCV,≥3 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,95.2,92.9 to 96.9,1312
Hib,≥2 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,92.5,90.2 to 94.3,1312
Polio,≥1 Dose,HHS Regions/National,Region 10,2019,Age,3 Months,92.0,89.7 to 93.9,1312
Polio,≥1 Dose,HHS Regions/National,Region 10,2018,Age,3 Months,89.8,86.9 to 92.1,1500
Polio,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,3 Months,90.9,89.1 to 92.4,2812
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,77.9,74.3 to 81.2,1312
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2015,Age,0-3 Days,74.8,70.2 to 78.9,992
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2015-2016,Age,0-3 Days,74.9,71.5 to 78.0,1867
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,72.0,66.9 to 76.7,875
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,70.9,67.7 to 74.0,2294
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,70.8,66.0 to 75.3,992
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,71.4,67.9 to 74.7,1867
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,68.2,63.6 to 72.3,1050
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,69.5,66.2 to 72.6,2042
Polio,≥1 Dose,HHS Regions/National,Region 10,2017,Age,3 Months,84.4,80.9 to 87.4,1419
Polio,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,3 Months,87.1,84.8 to 89.0,2919
Hib,≥3 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,52.2,47.2 to 57.3,992
Hib,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,53.2,49.6 to 56.9,1867
Hib,≥3 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,52.6,48.1 to 57.1,1050
Hib,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,52.4,49.0 to 55.8,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,95.2,93.4 to 96.7,1500
PCV,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,95.2,93.8 to 96.4,2812
Hib,≥2 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,92.8,90.0 to 94.9,1048
Hib,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,92.3,90.2 to 94.0,2098
PCV,≥3 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,92.7,90.3 to 94.8,1419
PCV,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,94.0,92.5 to 95.3,2919
Hib,≥3 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,57.8,50.9 to 64.4,1041
Hib,≥3 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,57.8,49.8 to 65.4,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,53.7,46.0 to 61.2,1048
Hib,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,53.1,44.9 to 61.3,2098
Polio,≥1 Dose,HHS Regions/National,Region 10,2014,Age,3 Months,85.1,81.6 to 88.1,1050
Polio,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,3 Months,86.7,84.1 to 88.9,2042
Polio,≥1 Dose,HHS Regions/National,Region 10,2015,Age,3 Months,88.3,84.3 to 91.4,992
Polio,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,3 Months,86.9,84.0 to 89.4,1867
Polio,≥1 Dose,HHS Regions/National,Region 10,2016,Age,3 Months,85.5,81.0 to 89.1,875
Polio,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,3 Months,85.0,82.2 to 87.4,2294
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2017,Age,0-3 Days,74.6,68.8 to 79.6,587
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2017-2018,Age,0-3 Days,78.4,76.1 to 80.6,2919
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2016,Age,0-3 Days,75.0,69.9 to 79.4,875
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2016-2017,Age,0-3 Days,75.9,72.9 to 78.8,2294
PCV,≥1 Dose,HHS Regions/National,Region 10,2015,Age,3 Months,86.1,81.7 to 89.6,992
PCV,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,3 Months,85.3,82.2 to 87.9,1867
PCV,≥1 Dose,HHS Regions/National,Region 10,2014,Age,3 Months,84.8,81.3 to 87.8,1050
PCV,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,3 Months,85.5,82.7 to 87.8,2042
PCV,≥1 Dose,HHS Regions/National,Region 10,2012,Age,3 Months,85.9,83.7 to 87.9,977
Hib,≥2 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,91.9,89.7 to 93.6,977
Hib,≥2 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,92.6,87.8 to 95.6,1041
Hib,≥2 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,91.8,89.1 to 93.8,1500
Hib,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,92.1,90.4 to 93.5,2812
Hib,≥2 Doses,HHS Regions/National,Region 10,2018,Age,5 Months,82.3,78.9 to 85.2,1500
Hib,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,5 Months,83.6,81.3 to 85.6,2812
PCV,≥3 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,88.6,84.4 to 92.1,875
PCV,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,89.8,87.4 to 91.9,2294
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2013,Age,0-3 Days,72.3,68.2 to 76.1,1048
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2013-2014,Age,0-3 Days,71.7,68.8 to 74.5,2098
Polio,≥1 Dose,HHS Regions/National,Region 10,2013,Age,3 Months,86.3,84.9 to 87.5,1048
Polio,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,3 Months,85.7,84.4 to 86.8,2098
Polio,≥1 Dose,HHS Regions/National,Region 10,2012,Age,3 Months,86.1,83.8 to 88.1,977
Polio,≥1 Dose,HHS Regions/National,Region 10,2011,Age,3 Months,86.9,82.5 to 90.4,1041
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2014,Age,0-3 Days,71.1,66.9 to 75.0,1050
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2014-2015,Age,0-3 Days,72.9,69.8 to 75.8,2042
PCV,≥1 Dose,HHS Regions/National,Region 10,2018,Age,3 Months,88.0,84.9 to 90.5,1500
PCV,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,3 Months,89.5,87.6 to 91.2,2812
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,68.3,64.8 to 71.5,1048
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,68.2,65.2 to 71.1,2098
DTaP,≥3 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,73.4,70.3 to 76.2,977
DTaP,≥3 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,68.7,65.2 to 72.1,1041
PCV,≥3 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,94.3,91.1 to 96.6,977
PCV,≥3 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,93.7,91.5 to 95.5,1312
PCV,≥3 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,91.5,88.2 to 94.1,1041
PCV,≥3 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,92.8,90.2 to 94.9,1048
PCV,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,92.7,90.9 to 94.3,2098
Hib,≥2 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,86.9,82.8 to 90.2,992
Hib,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,87.0,84.1 to 89.4,1867
PCV,≥3 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,94.5,92.6 to 96.0,1500
PCV,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,94.1,92.7 to 95.3,2812
Hib,≥2 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,87.1,82.6 to 90.5,875
Hib,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,86.9,84.3 to 89.2,2294
Hib,≥2 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,86.8,83.7 to 89.4,1419
Hib,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,89.3,87.3 to 91.0,2919
PCV,≥3 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,92.8,90.0 to 95.0,1050
PCV,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,91.7,89.5 to 93.7,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,90.8,87.2 to 93.8,992
PCV,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,89.9,87.2 to 92.3,1867
PCV,≥3 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,89.0,84.8 to 92.5,875
PCV,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,90.9,88.5 to 93.0,2294
Hep B,≥2 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,88.2,83.7 to 91.5,875
Hep B,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,88.5,85.9 to 90.7,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,86.2,83.7 to 88.4,1048
PCV,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,86.2,83.6 to 88.5,2098
Hep B,≥2 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,88.9,85.9 to 91.3,1419
Hep B,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,90.3,88.4 to 91.9,2919
Hep B,≥2 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,94.1,92.0 to 95.6,1500
Hep B,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,94.7,93.4 to 95.7,2812
Hep B,≥2 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,91.0,86.8 to 93.9,875
Hep B,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,91.6,89.3 to 93.5,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,88.3,85.6 to 90.6,992
PCV,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,88.3,85.6 to 90.6,1867
PCV,≥3 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,88.3,83.9 to 91.7,875
PCV,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,88.8,86.2 to 90.9,2294
Hib,≥1 Dose,HHS Regions/National,Region 10,2015,Age,3 Months,88.0,84.0 to 91.1,992
Hib,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,3 Months,86.5,83.6 to 89.0,1867
Hib,≥1 Dose,HHS Regions/National,Region 10,2016,Age,3 Months,85.0,80.5 to 88.7,875
Hib,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,3 Months,84.7,81.9 to 87.1,2294
Hep B,≥2 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,92.4,89.9 to 94.3,1419
Hep B,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,93.2,91.7 to 94.5,2919
≥1 Dose MMR,,HHS Regions/National,Region 10,2019,Age,35 Months,93.3,90.6 to 95.4,1312
≥1 Dose MMR,,HHS Regions/National,Region 10,2017,Age,35 Months,94.0,91.8 to 95.8,1419
≥1 Dose MMR,,HHS Regions/National,Region 10,2017-2018,Age,35 Months,94.8,93.3 to 96.0,2919
≥1 Dose MMR,,HHS Regions/National,Region 10,2018,Age,35 Months,95.5,93.5 to 97.0,1500
≥1 Dose MMR,,HHS Regions/National,Region 10,2018-2019,Age,35 Months,94.3,92.7 to 95.7,2812
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015,Age,35 Months,91.3,87.9 to 94.0,992
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015-2016,Age,35 Months,92.2,89.8 to 94.2,1867
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017,Age,35 Months,93.6,91.5 to 95.3,1419
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017-2018,Age,35 Months,93.9,92.4 to 95.2,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,85.4,81.6 to 88.8,1048
PCV,≥4 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,84.3,81.7 to 86.8,2098
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,93.9,91.9 to 95.5,1312
PCV,≥3 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,89.3,86.0 to 92.0,1050
PCV,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,88.8,86.4 to 90.9,2042
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,92.1,89.7 to 94.1,1500
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,93.0,91.5 to 94.3,2812
PCV,≥4 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,79.6,74.8 to 83.9,992
PCV,≥4 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,81.0,77.6 to 84.1,1867
PCV,≥4 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,83.3,79.5 to 86.7,1050
PCV,≥4 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,81.4,78.4 to 84.2,2042
Hib,≥1 Dose,HHS Regions/National,Region 10,2017,Age,3 Months,84.4,80.9 to 87.3,1419
Hib,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,3 Months,86.7,84.5 to 88.7,2919
Hib,≥1 Dose,HHS Regions/National,Region 10,2013,Age,3 Months,86.8,84.9 to 88.6,1048
Hib,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,3 Months,86.3,85.0 to 87.6,2098
Hib,≥1 Dose,HHS Regions/National,Region 10,2012,Age,3 Months,85.8,82.5 to 88.6,977
Hib,≥1 Dose,HHS Regions/National,Region 10,2011,Age,3 Months,87.0,82.8 to 90.3,1041
Hep B,≥2 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,91.1,87.5 to 93.8,992
Hep B,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,91.0,88.4 to 93.1,1867
Hep B,≥2 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,92.8,90.8 to 94.4,1048
Hep B,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,91.7,90.0 to 93.2,2098
Hib,≥1 Dose,HHS Regions/National,Region 10,2014,Age,3 Months,85.8,82.4 to 88.7,1050
Hib,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,3 Months,86.9,84.4 to 89.1,2042
Hep B,≥2 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,90.6,87.7 to 92.9,1050
Hep B,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,90.9,88.6 to 92.7,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019,Age,35 Months,93.1,90.3 to 95.3,1312
≥1 Dose MMR,,HHS Regions/National,Region 10,2016,Age,35 Months,94.4,91.9 to 96.3,875
≥1 Dose MMR,,HHS Regions/National,Region 10,2016-2017,Age,35 Months,94.2,92.6 to 95.6,2294
PCV,≥4 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,77.4,72.7 to 81.8,992
PCV,≥4 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,77.7,74.3 to 80.9,1867
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018,Age,35 Months,94.1,91.9 to 95.9,1500
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018-2019,Age,35 Months,93.6,91.9 to 95.1,2812
≥1 Dose MMR,,HHS Regions/National,Region 10,2015,Age,35 Months,90.9,87.6 to 93.6,992
≥1 Dose MMR,,HHS Regions/National,Region 10,2015-2016,Age,35 Months,92.8,90.8 to 94.6,1867
≥1 Dose MMR,,HHS Regions/National,Region 10,2014,Age,35 Months,90.9,87.7 to 93.6,1050
≥1 Dose MMR,,HHS Regions/National,Region 10,2014-2015,Age,35 Months,90.9,88.6 to 92.9,2042
PCV,≥4 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,82.6,79.2 to 85.6,1419
PCV,≥4 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,83.1,80.8 to 85.2,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,78.0,73.1 to 82.6,875
PCV,≥4 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,80.3,77.3 to 83.1,2294
Hep B,≥2 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,90.5,86.2 to 93.5,1041
Hep B,≥2 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,91.3,87.6 to 94.0,977
PCV,≥3 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,86.6,83.5 to 89.2,1419
PCV,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,88.1,86.0 to 89.9,2919
Hep B,≥3 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,89.4,85.8 to 92.4,977
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,88.4,84.9 to 91.4,1050
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,89.9,87.6 to 92.0,2042
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,91.3,88.6 to 93.6,1048
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,89.8,87.7 to 91.8,2098
Hep B,≥2 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,91.7,89.3 to 93.6,1500
Hep B,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,92.7,91.2 to 94.0,2812
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2018,Age,0-2 Days,79.1,75.9 to 82.1,1500
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2018-2019,Age,0-2 Days,81.1,78.9 to 83.1,2812
PCV,≥3 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,89.6,86.8 to 91.9,1500
PCV,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,89.6,87.7 to 91.3,2812
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2019,Age,0-2 Days,83.1,79.9 to 85.8,1312
Hep B,≥2 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,93.7,91.6 to 95.3,1312
PCV,≥3 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,85.5,80.8 to 89.2,875
PCV,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,86.0,83.3 to 88.4,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,91.5,90.0 to 92.9,977
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,91.2,88.6 to 93.5,1419
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,91.6,89.9 to 93.2,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,81.7,77.0 to 85.9,1041
PCV,≥4 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,84.8,80.4 to 88.7,977
PCV,≥4 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,82.4,79.1 to 85.5,1312
PCV,≥4 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,83.5,80.3 to 86.5,1500
PCV,≥4 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,83.0,80.7 to 85.2,2812
PCV,≥3 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,89.8,83.7 to 93.7,1041
PCV,≥3 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,89.1,86.2 to 91.5,1048
PCV,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,89.2,86.8 to 91.3,2098
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,91.4,88.1 to 94.2,992
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,90.2,87.6 to 92.4,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,88.7,84.7 to 92.1,875
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,90.0,87.6 to 92.1,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,90.1,86.9 to 92.7,1050
PCV,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,89.8,87.5 to 91.8,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,91.0,88.2 to 93.4,1048
PCV,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,90.6,88.5 to 92.4,2098
PCV,≥3 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,91.8,88.8 to 94.2,977
PCV,≥3 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,92.9,90.4 to 94.7,1312
PCV,≥4 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,87.0,83.6 to 90.1,1312
PCV,≥1 Dose,HHS Regions/National,Region 10,2013,Age,3 Months,84.9,83.3 to 86.4,1048
PCV,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,3 Months,84.9,83.5 to 86.1,2098
Hib,≥2 Doses,HHS Regions/National,Region 10,2014,Age,5 Months,76.4,72.4 to 80.0,1050
Hib,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,5 Months,76.4,73.4 to 79.2,2042
Hib,≥2 Doses,HHS Regions/National,Region 10,2015,Age,5 Months,76.5,71.7 to 80.7,992
Hib,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,5 Months,76.4,73.0 to 79.6,1867
Hib,≥2 Doses,HHS Regions/National,Region 10,2016,Age,5 Months,76.3,71.2 to 80.8,875
Hib,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,5 Months,76.7,73.5 to 79.7,2294
Hib,≥1 Dose,HHS Regions/National,Region 10,2019,Age,3 Months,92.0,89.7 to 93.8,1312
Hib,≥2 Doses,HHS Regions/National,Region 10,2012,Age,5 Months,80.6,76.7 to 84.0,977
Hib,≥2 Doses,HHS Regions/National,Region 10,2011,Age,5 Months,75.4,70.8 to 79.5,1041
Hib,≥2 Doses,HHS Regions/National,Region 10,2013,Age,5 Months,78.9,75.2 to 82.2,1048
Hib,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,5 Months,77.6,74.0 to 80.9,2098
PCV,≥3 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,89.2,86.3 to 91.6,1419
PCV,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,91.6,89.8 to 93.0,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,84.1,80.7 to 87.1,1419
PCV,≥4 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,84.6,82.2 to 86.7,2919
Hep B,≥2 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,95.4,93.7 to 96.6,1312
PCV,≥4 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,82.3,77.4 to 86.6,875
PCV,≥4 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,83.2,80.2 to 85.9,2294
PCV,≥4 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,85.1,81.8 to 88.0,1500
PCV,≥4 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,86.0,83.7 to 88.2,2812
Hib,≥1 Dose,HHS Regions/National,Region 10,2018,Age,3 Months,89.2,86.2 to 91.5,1500
Hib,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,3 Months,90.6,88.8 to 92.1,2812
PCV,≥3 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,89.6,86.7 to 91.9,1312
PCV,≥3 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,90.5,87.5 to 93.1,1041
PCV,≥1 Dose,HHS Regions/National,Region 10,2011,Age,3 Months,85.0,80.2 to 88.8,1041
PCV,≥3 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,94.0,92.1 to 95.5,1500
PCV,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,89.6,87.7 to 91.3,2812
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2011,Age,0-3 Days,71.4,66.8 to 75.6,1041
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2012,Age,0-3 Days,68.8,64.0 to 73.2,977
Hib,≥2 Doses,HHS Regions/National,Region 10,2019,Age,5 Months,85.0,81.8 to 87.7,1312
PCV,≥1 Dose,HHS Regions/National,Region 10,2016,Age,3 Months,84.4,79.9 to 88.1,875
PCV,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,3 Months,84.0,81.2 to 86.5,2294
PCV,≥1 Dose,HHS Regions/National,Region 10,2017,Age,3 Months,83.6,80.1 to 86.6,1419
PCV,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,3 Months,85.8,83.5 to 87.8,2919
Hib,≥2 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,88.0,85.6 to 90.0,1048
Hib,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,88.0,85.4 to 90.2,2098
Hib,≥2 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,88.0,85.0 to 90.5,1050
Hib,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,87.5,85.0 to 89.6,2042
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020,Age,24 Months,91.8,89.2 to 93.9,1253
Hib,≥2 Doses,HHS Regions/National,Region 10,2017,Age,5 Months,77.2,73.2 to 80.7,1419
Hib,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,5 Months,79.7,77.1 to 82.0,2919
Hib,≥2 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,86.9,80.8 to 91.2,1041
PCV,≥3 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,91.0,88.4 to 93.2,1419
PCV,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,92.7,91.2 to 94.1,2919
Hib,≥2 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,90.4,88.2 to 92.1,977
PCV,≥3 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,89.5,86.1 to 92.4,992
PCV,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,89.0,86.4 to 91.4,1867
Hib,Primary Series,HHS Regions/National,Region 10,2011,Age,7 Months,69.2,64.9 to 73.2,1041
DTaP,≥4 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,81.6,77.8 to 85.1,1048
DTaP,≥4 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,81.1,78.4 to 83.6,2098
Hep A,≥2 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,42.4,37.1 to 48.2,875
Hep A,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,44.4,41.0 to 47.9,2294
Hep A,≥2 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,40.2,35.3 to 45.5,992
Hep A,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,41.4,37.7 to 45.2,1867
Hep A,≥2 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,46.3,42.2 to 50.6,1419
Hep A,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,48.3,45.4 to 51.2,2919
Hep B,≥3 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,65.2,60.6 to 69.6,977
Hep B,≥3 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,57.8,55.0 to 60.5,1041
DTaP,≥4 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,77.5,73.0 to 81.8,1041
DTaP,≥4 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,80.6,76.3 to 84.6,977
Polio,≥2 Doses,HHS Regions/National,Region 10,2012,Age,5 Months,80.3,76.6 to 83.6,977
Polio,≥2 Doses,HHS Regions/National,Region 10,2011,Age,5 Months,75.6,70.7 to 80.0,1041
Hep A,≥1 Dose,HHS Regions/National,Region 10,2012,Age,35 Months,89.0,85.0 to 92.4,977
Polio,≥2 Doses,HHS Regions/National,Region 10,2013,Age,5 Months,78.3,74.4 to 81.8,1048
Polio,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,5 Months,77.1,73.4 to 80.4,2098
Polio,≥2 Doses,HHS Regions/National,Region 10,2014,Age,5 Months,75.9,71.9 to 79.6,1050
Polio,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,5 Months,75.6,72.4 to 78.6,2042
Hep A,≥2 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,40.6,36.1 to 45.4,1050
Hep A,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,40.4,37.1 to 44.0,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,94.8,93.1 to 96.3,1500
Hib,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,95.0,93.7 to 96.1,2812
DTaP,≥4 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,74.3,70.5 to 77.8,1500
DTaP,≥4 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,94.9,93.6 to 96.0,2812
Hib,≥3 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,95.0,93.0 to 96.6,1312
Hep A,≥2 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,35.0,30.3 to 40.2,977
Hep A,≥1 Dose,HHS Regions/National,Region 10,2013,Age,35 Months,88.4,85.0 to 91.3,1048
Hep A,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,35 Months,89.9,87.7 to 91.9,2098
Hep A,≥1 Dose,HHS Regions/National,Region 10,2014,Age,35 Months,91.3,88.3 to 93.8,1050
Hep A,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,35 Months,90.4,88.1 to 92.4,2042
Hep A,≥2 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,38.3,33.9 to 43.1,1048
Hep A,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,39.5,36.3 to 42.9,2098
DTaP,≥4 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,68.5,63.1 to 73.4,875
DTaP,≥4 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,70.2,66.9 to 73.3,2294
DTaP,≥4 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,72.0,68.2 to 75.5,1419
DTaP,≥4 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,73.1,70.5 to 75.6,2919
PCV,≥2 Doses,HHS Regions/National,Region 10,2019,Age,5 Months,83.7,80.4 to 86.6,1312
PCV,≥2 Doses,HHS Regions/National,Region 10,2018,Age,5 Months,81.1,77.7 to 84.2,1500
PCV,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,5 Months,82.4,80.1 to 84.5,2812
PCV,≥2 Doses,HHS Regions/National,Region 10,2017,Age,5 Months,76.2,72.2 to 79.8,1419
PCV,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,5 Months,78.7,76.0 to 81.1,2919
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,64.6,59.1 to 69.8,875
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,66.3,62.9 to 69.5,2294
Hep A,≥2 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,78.0,72.9 to 82.7,1050
Hep A,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,75.5,71.6 to 79.2,2042
Hep A,≥2 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,72.7,66.9 to 78.3,992
Hep A,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,74.7,70.4 to 78.9,1867
Hep A,≥2 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,76.8,70.4 to 82.8,875
Hep A,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,77.3,73.5 to 80.9,2294
Polio,≥2 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,88.8,86.5 to 90.7,977
Polio,≥2 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,87.0,80.5 to 91.5,1041
Polio,≥2 Doses,HHS Regions/National,Region 10,2018,Age,5 Months,83.2,79.9 to 86.0,1500
Polio,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,5 Months,83.7,81.5 to 85.8,2812
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,68.0,64.0 to 71.7,1419
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,69.2,66.4 to 71.8,2919
Hep A,≥1 Dose,HHS Regions/National,Region 10,2019,Age,35 Months,91.2,88.5 to 93.5,1312
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014,Age,13 Months,56.7,52.0 to 61.2,1050
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014-2015,Age,13 Months,56.8,53.4 to 60.2,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2012,Age,13 Months,52.6,48.6 to 56.5,977
Hep A,≥1 Dose,HHS Regions/National,Region 10,2018,Age,35 Months,93.1,90.6 to 95.0,1500
Hep A,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,35 Months,92.2,90.4 to 93.7,2812
Hep A,≥2 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,70.8,64.2 to 77.1,1041
Hep A,≥2 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,74.8,69.1 to 80.2,977
Hep A,≥2 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,72.4,67.4 to 77.2,1048
Hep A,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,75.4,71.8 to 78.8,2098
Polio,≥2 Doses,HHS Regions/National,Region 10,2015,Age,5 Months,75.3,70.3 to 79.8,992
Polio,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,5 Months,75.8,72.2 to 79.0,1867
Hep A,≥2 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,48.4,44.2 to 52.8,1312
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,68.2,64.2 to 71.9,1048
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,65.5,61.6 to 69.2,2098
Hep A,≥2 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,50.2,46.2 to 54.4,1500
Hep A,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,49.3,46.4 to 52.3,2812
Polio,≥2 Doses,HHS Regions/National,Region 10,2016,Age,5 Months,76.2,71.0 to 80.7,875
Polio,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,5 Months,76.4,73.2 to 79.3,2294
Polio,≥2 Doses,HHS Regions/National,Region 10,2017,Age,5 Months,76.6,72.6 to 80.2,1419
Polio,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,5 Months,79.9,77.3 to 82.2,2919
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,68.5,63.6 to 73.1,992
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,66.6,62.9 to 70.0,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,62.9,58.2 to 67.3,1050
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,65.7,62.3 to 68.9,2042
Hep A,≥1 Dose,HHS Regions/National,Region 10,2015,Age,35 Months,89.4,85.8 to 92.4,992
Hep A,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,35 Months,90.3,87.7 to 92.6,1867
≥1 Dose Varicella,,HHS Regions/National,Region 10,2011,Age,13 Months,52.3,46.2 to 58.3,1041
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013,Age,13 Months,55.0,48.7 to 61.1,1048
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013-2014,Age,13 Months,55.8,51.5 to 60.1,2098
DTaP,≥4 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,71.6,67.7 to 75.3,1312
DTaP,≥4 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,73.7,68.8 to 78.4,992
DTaP,≥4 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,75.0,71.5 to 78.4,1867
DTaP,≥4 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,76.2,71.2 to 80.9,875
DTaP,≥4 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,79.6,76.7 to 82.5,2294
DTaP,≥4 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,80.6,76.7 to 84.1,1050
DTaP,≥4 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,77.2,74.1 to 80.1,2042
Hep A,≥1 Dose,HHS Regions/National,Region 10,2017,Age,35 Months,92.5,89.8 to 94.6,1419
Hep A,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,35 Months,92.8,91.1 to 94.4,2919
Hep A,≥1 Dose,HHS Regions/National,Region 10,2016,Age,35 Months,91.2,87.3 to 94.2,875
Hep A,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,35 Months,91.9,89.7 to 93.9,2294
≥1 Dose MMR,,HHS Regions/National,Region 10,2012,Age,13 Months,58.9,50.9 to 66.4,977
≥1 Dose MMR,,HHS Regions/National,Region 10,2011,Age,13 Months,58.1,50.9 to 65.0,1041
Hib,Full Series,HHS Regions/National,Region 10,2020,Age,24 Months,81.4,77.8 to 84.6,1253
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,70.4,66.6 to 73.9,1500
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,72.1,69.5 to 74.7,2812
Polio,≥2 Doses,HHS Regions/National,Region 10,2019,Age,5 Months,84.3,81.0 to 87.1,1312
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016,Age,13 Months,56.2,50.7 to 61.6,875
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016-2017,Age,13 Months,59.6,56.2 to 62.9,2294
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017,Age,13 Months,63.1,59.2 to 66.9,1419
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017-2018,Age,13 Months,64.2,61.5 to 66.9,2919
Polio,≥2 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,86.8,82.6 to 90.1,992
Polio,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,86.7,83.7 to 89.2,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,81.3,78.2 to 84.1,1041
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,73.9,70.1 to 77.4,1312
Polio,≥2 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,86.9,84.5 to 88.9,1048
Polio,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,87.1,84.4 to 89.3,2098
Polio,≥2 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,87.2,84.1 to 89.8,1050
Polio,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,87.0,84.5 to 89.2,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018,Age,13 Months,65.4,61.6 to 69.1,1500
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018-2019,Age,13 Months,63.9,61.1 to 66.5,2812
≥1 Dose MMR,,HHS Regions/National,Region 10,2013,Age,13 Months,58.5,54.3 to 62.6,1048
≥1 Dose MMR,,HHS Regions/National,Region 10,2013-2014,Age,13 Months,60.7,56.9 to 64.4,2098
≥1 Dose Varicella,,HHS Regions/National,Region 10,2011,Age,19 Months,80.9,77.9 to 83.6,1041
≥1 Dose Varicella,,HHS Regions/National,Region 10,2012,Age,19 Months,80.2,75.0 to 84.5,977
≥1 Dose MMR,,HHS Regions/National,Region 10,2015,Age,13 Months,61.0,55.9 to 65.8,992
≥1 Dose MMR,,HHS Regions/National,Region 10,2015-2016,Age,13 Months,62.4,58.6 to 65.9,1867
≥1 Dose MMR,,HHS Regions/National,Region 10,2014,Age,13 Months,62.9,58.3 to 67.3,1050
≥1 Dose MMR,,HHS Regions/National,Region 10,2014-2015,Age,13 Months,61.9,58.5 to 65.2,2042
DTaP,≥4 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,88.0,83.4 to 91.8,977
DTaP,≥4 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,85.4,81.4 to 88.8,1050
DTaP,≥4 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,84.4,81.5 to 87.2,2042
Hep A,≥2 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,78.2,73.5 to 82.5,1312
Hep B,≥3 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,83.1,79.7 to 86.0,977
DTaP,≥4 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,88.3,85.0 to 91.2,1048
DTaP,≥4 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,86.8,84.2 to 89.1,2098
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,85.9,83.5 to 87.9,1048
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,84.8,82.8 to 86.5,2098
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,83.7,79.9 to 86.9,1050
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,84.5,81.8 to 86.9,2042
Hep A,≥2 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,77.9,73.6 to 81.9,1419
Hep A,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,79.0,76.0 to 81.9,2919
Hep A,≥2 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,80.3,76.0 to 84.2,1500
Hep A,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,79.2,76.1 to 82.1,2812
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019,Age,13 Months,62.3,58.3 to 66.1,1312
Polio,≥2 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,91.7,89.0 to 93.7,1500
Polio,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,91.5,89.8 to 93.0,2812
Hep B,≥1 Dose,HHS Regions/National,Region 10,2013,Age,3 Months,93.1,92.3 to 93.7,1048
Hep B,≥1 Dose,HHS Regions/National,Region 10,2013-2014,Age,3 Months,92.1,91.1 to 93.0,2098
Hep B,≥1 Dose,HHS Regions/National,Region 10,2012,Age,3 Months,92.4,89.9 to 94.3,977
Hep B,≥1 Dose,HHS Regions/National,Region 10,2011,Age,3 Months,91.5,88.6 to 93.7,1041
Polio,≥2 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,86.5,82.0 to 90.0,875
Polio,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,86.6,83.9 to 88.9,2294
Polio,≥2 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,86.7,83.5 to 89.3,1419
Polio,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,89.1,87.1 to 90.9,2919
Polio,≥2 Doses,HHS Regions/National,Region 10,2013,Age,13 Months,91.9,89.6 to 93.7,1048
Polio,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,13 Months,91.7,89.9 to 93.3,2098
Hep B,≥1 Dose,HHS Regions/National,Region 10,2014,Age,3 Months,91.2,88.2 to 93.5,1050
Hep B,≥1 Dose,HHS Regions/National,Region 10,2014-2015,Age,3 Months,91.8,89.6 to 93.5,2042
Hep B,≥1 Dose,HHS Regions/National,Region 10,2015,Age,3 Months,92.4,88.9 to 94.8,992
Hep B,≥1 Dose,HHS Regions/National,Region 10,2015-2016,Age,3 Months,92.4,89.9 to 94.3,1867
Hep B,≥1 Dose,HHS Regions/National,Region 10,2016,Age,3 Months,92.4,88.4 to 95.1,875
Hep B,≥1 Dose,HHS Regions/National,Region 10,2016-2017,Age,3 Months,93.0,90.8 to 94.7,2294
Hep A,≥1 Dose,HHS Regions/National,Region 10,2020,Age,35 Months,92.1,89.3 to 94.4,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2018,Age,13 Months,77.3,73.8 to 80.6,1500
≥1 Dose MMR,,HHS Regions/National,Region 10,2018-2019,Age,13 Months,73.3,70.6 to 75.7,2812
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,85.4,82.1 to 88.1,1419
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,86.8,84.7 to 88.6,2919
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013,Age,19 Months,85.6,82.0 to 88.6,1048
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013-2014,Age,19 Months,85.0,81.9 to 87.6,2098
Polio,≥2 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,92.0,90.5 to 93.3,977
Polio,≥2 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,92.0,86.1 to 95.5,1041
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015,Age,19 Months,84.7,82.6 to 86.7,992
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015-2016,Age,19 Months,84.2,81.2 to 86.8,1867
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014,Age,19 Months,84.4,80.9 to 87.3,1050
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014-2015,Age,19 Months,84.5,81.9 to 86.8,2042
≥1 Dose MMR,,HHS Regions/National,Region 10,2016,Age,13 Months,63.8,58.3 to 68.9,875
≥1 Dose MMR,,HHS Regions/National,Region 10,2016-2017,Age,13 Months,66.0,62.6 to 69.2,2294
≥1 Dose MMR,,HHS Regions/National,Region 10,2017,Age,13 Months,68.3,64.4 to 71.9,1419
≥1 Dose MMR,,HHS Regions/National,Region 10,2017-2018,Age,13 Months,72.8,70.1 to 75.2,2919
Hep B,≥1 Dose,HHS Regions/National,Region 10,2019,Age,3 Months,95.7,93.9 to 97.0,1312
≥1 Dose MMR,,HHS Regions/National,Region 10,2014,Age,19 Months,85.6,82.1 to 88.6,1050
≥1 Dose MMR,,HHS Regions/National,Region 10,2014-2015,Age,19 Months,85.7,83.1 to 87.9,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2011,Age,24 Months,84.7,80.5 to 88.5,1041
≥1 Dose Varicella,,HHS Regions/National,Region 10,2012,Age,24 Months,86.7,83.0 to 90.0,977
≥1 Dose MMR,,HHS Regions/National,Region 10,2015,Age,19 Months,85.7,83.0 to 88.0,992
≥1 Dose MMR,,HHS Regions/National,Region 10,2015-2016,Age,19 Months,86.3,83.5 to 88.7,1867
≥1 Dose MMR,,HHS Regions/National,Region 10,2016,Age,19 Months,86.9,82.6 to 90.2,875
≥1 Dose MMR,,HHS Regions/National,Region 10,2016-2017,Age,19 Months,87.5,85.0 to 89.6,2294
Hep B,≥1 Dose,HHS Regions/National,Region 10,2018,Age,3 Months,94.1,92.0 to 95.6,1500
Hep B,≥1 Dose,HHS Regions/National,Region 10,2018-2019,Age,3 Months,94.9,93.6 to 95.9,2812
Polio,≥2 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,91.6,88.8 to 93.7,1050
Polio,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,91.8,89.8 to 93.5,2042
Hep B,≥2 Doses,HHS Regions/National,Region 10,2012,Age,5 Months,82.8,79.8 to 85.4,977
Hep B,≥2 Doses,HHS Regions/National,Region 10,2011,Age,5 Months,82.2,78.7 to 85.2,1041
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2011,Age,0-1 Days,60.8,54.2 to 67.0,1041
Hep B,≥2 Doses,HHS Regions/National,Region 10,2013,Age,5 Months,84.6,81.2 to 87.5,1048
Hep B,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,5 Months,83.5,81.5 to 85.3,2098
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,89.2,86.9 to 91.1,1048
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,87.8,86.0 to 89.3,2098
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,88.8,87.0 to 90.4,992
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,88.0,85.2 to 90.3,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,86.3,82.7 to 89.3,1050
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,87.6,85.1 to 89.7,2042
DTaP,≥4 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,87.0,83.9 to 89.8,1419
DTaP,≥4 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,88.1,86.0 to 90.0,2919
DTaP,≥4 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,82.1,77.2 to 86.4,875
DTaP,≥4 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,84.6,81.7 to 87.2,2294
DTaP,≥4 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,83.4,78.9 to 87.4,992
DTaP,≥4 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,82.8,79.6 to 85.8,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,85.4,81.3 to 88.7,992
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,84.5,81.4 to 87.1,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,83.6,78.8 to 87.5,875
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,84.5,81.6 to 87.0,2294
DTaP,≥4 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,89.3,86.4 to 91.8,1500
DTaP,≥4 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,88.8,86.5 to 90.9,2812
DTaP,≥4 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,88.4,84.6 to 91.5,1312
≥1 Dose MMR,,HHS Regions/National,Region 10,2011,Age,19 Months,83.0,79.1 to 86.2,1041
Hep B,≥3 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,85.5,82.6 to 88.0,1041
Hep B,≥3 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,86.6,82.7 to 89.7,977
Polio,≥2 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,91.4,89.0 to 93.4,1312
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,88.2,85.3 to 90.5,1500
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,89.2,87.3 to 90.9,2812
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,90.2,87.4 to 92.5,1312
Polio,≥2 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,92.1,88.8 to 94.4,992
Polio,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,90.7,88.1 to 92.8,1867
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016,Age,19 Months,83.7,79.1 to 87.4,875
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016-2017,Age,19 Months,85.1,82.4 to 87.4,2294
≥1 Dose MMR,,HHS Regions/National,Region 10,2019,Age,13 Months,69.2,65.2 to 72.8,1312
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018,Age,19 Months,90.4,87.9 to 92.4,1500
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018-2019,Age,19 Months,63.9,61.1 to 66.5,2812
Polio,≥2 Doses,HHS Regions/National,Region 10,2016,Age,13 Months,89.4,85.0 to 92.6,875
Polio,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,13 Months,90.2,87.8 to 92.2,2294
Hep B,≥1 Dose,HHS Regions/National,Region 10,2017,Age,3 Months,93.6,91.4 to 95.3,1419
Hep B,≥1 Dose,HHS Regions/National,Region 10,2017-2018,Age,3 Months,93.8,92.4 to 95.0,2919
≥1 Dose MMR,,HHS Regions/National,Region 10,2013,Age,19 Months,88.3,85.9 to 90.3,1048
≥1 Dose MMR,,HHS Regions/National,Region 10,2013-2014,Age,19 Months,87.0,84.9 to 88.8,2098
≥1 Dose MMR,,HHS Regions/National,Region 10,2012,Age,19 Months,83.7,74.6 to 89.9,977
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017,Age,19 Months,86.5,83.5 to 89.0,1419
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017-2018,Age,19 Months,88.4,86.5 to 90.1,2919
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2016,Age,0-1 Days,69.0,63.7 to 73.8,875
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2016-2017,Age,0-1 Days,70.1,66.9 to 73.1,2294
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2017,Age,0-1 Days,71.3,67.5 to 74.8,1419
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2017-2018,Age,0-1 Days,73.9,71.4 to 76.3,2919
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2015,Age,0-1 Days,69.3,64.4 to 73.7,992
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2015-2016,Age,0-1 Days,69.1,65.6 to 72.4,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,91.1,88.6 to 93.2,1500
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,89.2,87.3 to 90.9,2812
Hep B,≥2 Doses,HHS Regions/National,Region 10,2017,Age,5 Months,85.1,81.9 to 87.8,1419
Hep B,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,5 Months,87.4,85.4 to 89.2,2919
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014,Age,24 Months,87.4,84.3 to 90.1,1050
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014-2015,Age,24 Months,87.9,85.6 to 89.9,2042
PCV,≥4 Doses,HHS Regions/National,Region 10,2020,Age,35 Months,83.9,80.3 to 87.2,1253
≥1 Dose MMR,,HHS Regions/National,Region 10,2019,Age,19 Months,88.8,86.0 to 91.1,1312
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019,Age,24 Months,89.3,86.6 to 91.6,1312
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017,Age,24 Months,90.4,87.9 to 92.6,1419
≥1 Dose Varicella,,HHS Regions/National,Region 10,2017-2018,Age,24 Months,91.4,89.8 to 92.9,2919
≥1 Dose MMR,,HHS Regions/National,Region 10,2013,Age,24 Months,90.8,88.0 to 93.2,1048
≥1 Dose MMR,,HHS Regions/National,Region 10,2013-2014,Age,24 Months,89.6,87.5 to 91.5,2098
≥1 Dose MMR,,HHS Regions/National,Region 10,2014,Age,24 Months,88.5,85.3 to 91.3,1050
≥1 Dose MMR,,HHS Regions/National,Region 10,2014-2015,Age,24 Months,88.7,86.5 to 90.8,2042
≥1 Dose MMR,,HHS Regions/National,Region 10,2015,Age,24 Months,88.9,85.6 to 91.8,992
≥1 Dose MMR,,HHS Regions/National,Region 10,2015-2016,Age,24 Months,89.8,87.4 to 91.8,1867
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018,Age,24 Months,92.5,90.3 to 94.3,1500
≥1 Dose Varicella,,HHS Regions/National,Region 10,2018-2019,Age,24 Months,90.9,89.2 to 92.4,2812
Hep B,≥3 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,86.7,82.8 to 90.1,1041
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,90.3,87.6 to 92.6,1048
Hep B,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,88.6,86.5 to 90.6,2098
Hep B,≥2 Doses,HHS Regions/National,Region 10,2019,Age,5 Months,91.3,88.9 to 93.2,1312
Hep B,≥2 Doses,HHS Regions/National,Region 10,2018,Age,5 Months,89.8,87.3 to 91.9,1500
Hep B,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,5 Months,90.5,88.8 to 92.0,2812
Hep B,≥3 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,87.9,84.3 to 91.0,977
PCV,≥3 Doses,HHS Regions/National,Region 10,2016,Age,7 Months,69.6,64.4 to 74.4,875
PCV,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,7 Months,68.4,65.1 to 71.6,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,67.6,62.6 to 72.3,992
PCV,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,68.6,65.0 to 72.0,1867
PCV,≥4 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,79.7,75.8 to 83.1,1050
PCV,≥4 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,76.5,73.4 to 79.4,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2017,Age,7 Months,67.2,63.0 to 71.1,1419
PCV,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,7 Months,69.3,66.5 to 72.0,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,73.4,69.3 to 77.2,992
PCV,≥4 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,74.9,71.4 to 78.1,1867
PCV,≥4 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,76.3,71.2 to 80.8,875
PCV,≥4 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,77.7,74.6 to 80.5,2294
PCV,≥4 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,79.1,75.5 to 82.3,1419
PCV,≥4 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,80.0,77.5 to 82.2,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,80.9,77.5 to 84.0,1500
PCV,≥4 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,81.6,78.8 to 84.1,2358
≥1 Dose MMR,,HHS Regions/National,Region 10,2017,Age,24 Months,92.1,89.7 to 94.1,1419
≥1 Dose MMR,,HHS Regions/National,Region 10,2017-2018,Age,24 Months,93.1,91.6 to 94.5,2919
≥1 Dose MMR,,HHS Regions/National,Region 10,2016,Age,24 Months,90.5,87.1 to 93.4,875
≥1 Dose MMR,,HHS Regions/National,Region 10,2016-2017,Age,24 Months,91.3,89.3 to 93.1,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2012,Age,13 Months,87.7,85.0 to 90.0,977
Hep B,≥2 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,87.4,83.5 to 90.5,1041
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2019,Age,0-1 Days,79.4,76.0 to 82.5,1312
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,88.0,84.0 to 91.5,875
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,89.2,86.9 to 91.4,2294
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,90.2,87.1 to 92.9,992
Hep B,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,89.1,86.6 to 91.4,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,87.0,83.5 to 90.0,1050
Hep B,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,88.6,86.3 to 90.7,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2011,Age,13 Months,85.9,79.7 to 90.4,1041
PCV,≥3 Doses,HHS Regions/National,Region 10,2018,Age,7 Months,71.5,67.8 to 75.0,1500
PCV,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,7 Months,73.1,70.5 to 75.6,2812
Hep B,≥2 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,87.1,83.6 to 90.0,977
Hep B,≥2 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,86.5,82.9 to 89.5,1050
Hep B,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,87.7,85.1 to 89.9,2042
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2012,Age,0-2 Days,67.6,62.1 to 72.6,977
Hep B,≥2 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,89.4,86.9 to 91.5,1048
Hep B,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,87.9,85.7 to 89.9,2098
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2011,Age,0-2 Days,69.1,62.4 to 75.1,1041
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,92.8,90.6 to 94.5,1312
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2018,Age,0-1 Days,76.6,73.3 to 79.7,1500
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2018-2019,Age,0-1 Days,78.0,75.7 to 80.2,2812
Hep B,≥2 Doses,HHS Regions/National,Region 10,2015,Age,5 Months,84.2,79.9 to 87.7,992
Hep B,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,5 Months,84.0,80.9 to 86.7,1867
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2013,Age,0-1 Days,65.8,62.8 to 68.7,1048
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2013-2014,Age,0-1 Days,64.9,62.5 to 67.3,2098
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2014,Age,0-1 Days,64.0,59.6 to 68.2,1050
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2014-2015,Age,0-1 Days,66.6,63.4 to 69.8,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019,Age,19 Months,88.2,85.3 to 90.5,1312
Polio,≥2 Doses,HHS Regions/National,Region 10,2018,Age,13 Months,94.8,92.8 to 96.2,1500
Polio,≥2 Doses,HHS Regions/National,Region 10,2018-2019,Age,13 Months,94.9,93.6 to 96.0,2812
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013,Age,24 Months,88.6,85.7 to 91.2,1048
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013-2014,Age,24 Months,88.0,85.9 to 89.9,2098
Polio,≥2 Doses,HHS Regions/National,Region 10,2017,Age,13 Months,91.1,88.4 to 93.2,1419
Polio,≥2 Doses,HHS Regions/National,Region 10,2017-2018,Age,13 Months,92.9,91.3 to 94.3,2919
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,89.3,86.4 to 91.6,1419
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,90.2,88.3 to 91.8,2919
Hep B,≥2 Doses,HHS Regions/National,Region 10,2016,Age,5 Months,83.8,79.1 to 87.7,875
Hep B,≥2 Doses,HHS Regions/National,Region 10,2016-2017,Age,5 Months,84.4,81.7 to 86.9,2294
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2012,Age,0-1 Days,61.9,55.0 to 68.4,977
Hep B,≥2 Doses,HHS Regions/National,Region 10,2014,Age,5 Months,82.3,78.4 to 85.6,1050
Hep B,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,5 Months,83.3,81.5 to 84.9,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2013,Age,7 Months,65.1,60.7 to 69.3,1048
PCV,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,7 Months,65.8,62.2 to 69.2,2098
PCV,≥3 Doses,HHS Regions/National,Region 10,2011,Age,7 Months,65.0,61.0 to 68.8,1041
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,87.1,82.6 to 90.5,875
Hep B,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,88.2,85.6 to 90.3,2294
PCV,≥3 Doses,HHS Regions/National,Region 10,2012,Age,7 Months,68.7,65.4 to 71.8,977
PCV,≥3 Doses,HHS Regions/National,Region 10,2014,Age,7 Months,66.4,61.8 to 70.7,1050
PCV,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,7 Months,67.0,63.6 to 70.2,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016,Age,24 Months,87.0,82.9 to 90.5,875
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016-2017,Age,24 Months,88.7,86.3 to 90.8,2294
≥1 Dose MMR,,HHS Regions/National,Region 10,2011,Age,24 Months,86.4,82.4 to 89.8,1041
≥1 Dose MMR,,HHS Regions/National,Region 10,2018,Age,19 Months,93.0,90.7 to 94.8,1500
≥1 Dose MMR,,HHS Regions/National,Region 10,2018-2019,Age,19 Months,95.6,94.4 to 96.5,2812
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015,Age,24 Months,88.3,84.9 to 91.3,992
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015-2016,Age,24 Months,87.7,85.0 to 90.0,1867
PCV,≥4 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,79.1,76.3 to 81.6,1048
PCV,≥4 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,79.4,76.6 to 81.9,2098
PCV,≥4 Doses,HHS Regions/National,Region 10,2012,Age,19 Months,76.6,72.1 to 80.5,977
PCV,≥4 Doses,HHS Regions/National,Region 10,2011,Age,19 Months,72.0,68.4 to 75.2,1041
≥1 Dose MMR,,HHS Regions/National,Region 10,2017,Age,19 Months,88.1,85.2 to 90.5,1419
≥1 Dose MMR,,HHS Regions/National,Region 10,2017-2018,Age,19 Months,90.5,88.7 to 92.1,2919
Polio,≥2 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,95.0,93.2 to 96.4,1312
DTaP,≥4 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,81.0,77.4 to 84.3,1312
DTaP,≥4 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,84.9,80.1 to 89.0,1041
DTaP,≥4 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,83.1,79.9 to 86.0,1419
DTaP,≥4 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,83.8,81.6 to 85.8,2919
DTaP,≥4 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,84.5,81.5 to 87.3,1500
DTaP,≥4 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,82.7,80.4 to 84.9,2812
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015,Age,13 Months,57.0,51.9 to 62.0,992
≥1 Dose Varicella,,HHS Regions/National,Region 10,2015-2016,Age,13 Months,56.6,52.9 to 60.3,1867
≥1 Dose MMR,,HHS Regions/National,Region 10,2012,Age,24 Months,89.2,85.9 to 92.0,977
≥1 Dose Varicella,,HHS Regions/National,Region 10,2011,Age,35 Months,90.3,85.9 to 93.8,1041
PCV,≥4 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,80.4,76.8 to 83.5,1312
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2015,Age,0-2 Days,74.0,69.3 to 78.1,992
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2015-2016,Age,0-2 Days,74.2,70.8 to 77.3,1867
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2014,Age,0-2 Days,69.5,65.2 to 73.5,1050
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2014-2015,Age,0-2 Days,71.7,68.6 to 74.7,2042
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013,Age,35 Months,90.5,87.6 to 93.1,1048
≥1 Dose Varicella,,HHS Regions/National,Region 10,2013-2014,Age,35 Months,90.0,87.9 to 91.9,2098
Hib,Primary Series,HHS Regions/National,Region 10,2020,Age,24 Months,91.6,88.9 to 93.9,1253
PCV,≥3 Doses,HHS Regions/National,Region 10,2019,Age,7 Months,74.8,71.0 to 78.2,1312
≥1 Dose Varicella,,HHS Regions/National,Region 10,2012,Age,35 Months,90.7,87.1 to 93.6,977
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014,Age,35 Months,89.5,86.3 to 92.2,1050
≥1 Dose Varicella,,HHS Regions/National,Region 10,2014-2015,Age,35 Months,90.4,88.2 to 92.4,2042
PCV,≥3 Doses,HHS Regions/National,Region 10,2015,Age,13 Months,83.8,79.3 to 87.5,992
PCV,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,13 Months,84.7,81.5 to 87.4,1867
PCV,≥3 Doses,HHS Regions/National,Region 10,2014,Age,13 Months,86.2,82.6 to 89.2,1050
PCV,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,13 Months,85.0,82.2 to 87.5,2042
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2013,Age,0-2 Days,71.1,68.1 to 73.9,1048
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2013-2014,Age,0-2 Days,70.3,68.0 to 72.5,2098
Hep B,≥2 Doses,HHS Regions/National,Region 10,2015,Age,7 Months,88.8,84.9 to 91.8,992
Hep B,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,7 Months,88.5,85.7 to 90.8,1867
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,91.3,88.9 to 93.4,1500
Hep B,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,92.3,90.8 to 93.7,2812
PCV,≥4 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,76.8,72.2 to 81.0,1041
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2016,Age,0-2 Days,74.4,69.3 to 78.9,875
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2016-2017,Age,0-2 Days,75.1,72.0 to 77.9,2294
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2017,Age,0-2 Days,75.8,72.2 to 79.1,1419
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2017-2018,Age,0-2 Days,77.4,75.0 to 79.7,2919
Hep B,≥3 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,89.4,85.3 to 92.7,1041
PCV,≥4 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,82.0,77.8 to 85.8,977
Hep B,≥3 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,93.3,91.3 to 95.0,1312
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,90.5,87.8 to 92.8,1419
Hep B,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,90.9,89.1 to 92.5,2919
PCV,≥4 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,82.7,79.0 to 86.0,1048
PCV,≥4 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,82.0,79.4 to 84.4,2098
PCV,≥4 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,81.3,77.5 to 84.7,1050
PCV,≥4 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,79.3,76.3 to 82.1,2042
≥1 Dose MMR,,HHS Regions/National,Region 10,2013,Age,35 Months,93.0,90.4 to 95.2,1048
≥1 Dose MMR,,HHS Regions/National,Region 10,2013-2014,Age,35 Months,91.9,89.9 to 93.7,2098
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016,Age,35 Months,92.9,89.6 to 95.4,875
≥1 Dose Varicella,,HHS Regions/National,Region 10,2016-2017,Age,35 Months,93.3,91.3 to 94.9,2294
≥1 Dose MMR,,HHS Regions/National,Region 10,2011,Age,35 Months,91.0,87.2 to 94.1,1041
≥1 Dose MMR,,HHS Regions/National,Region 10,2012,Age,35 Months,91.7,88.5 to 94.4,977
≥1 Dose MMR,,HHS Regions/National,Region 10,2019,Age,24 Months,89.4,86.8 to 91.8,1312
≥1 Dose MMR,,HHS Regions/National,Region 10,2018,Age,24 Months,94.2,92.1 to 95.9,1500
≥1 Dose MMR,,HHS Regions/National,Region 10,2018-2019,Age,24 Months,91.8,90.2 to 93.3,2812
Hib,Full Series,HHS Regions/National,Region 10,2018,Age,35 Months,86.5,83.4 to 89.2,1500
Hib,Full Series,HHS Regions/National,Region 10,2018-2019,Age,35 Months,86.5,84.2 to 88.6,2812
Hib,Full Series,HHS Regions/National,Region 10,2013,Age,35 Months,84.7,81.1 to 87.8,1048
Hib,Full Series,HHS Regions/National,Region 10,2013-2014,Age,35 Months,84.3,81.8 to 86.7,2098
Polio,≥3 Doses,HHS Regions/National,Region 10,2018,Age,35 Months,95.3,93.4 to 96.7,1500
Polio,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,35 Months,95.0,93.7 to 96.2,2812
Hib,Full Series,HHS Regions/National,Region 10,2019,Age,35 Months,86.6,83.1 to 89.6,1312
Hib,Full Series,HHS Regions/National,Region 10,2017,Age,35 Months,82.4,78.8 to 85.8,1419
Hib,Full Series,HHS Regions/National,Region 10,2017-2018,Age,35 Months,84.4,82.1 to 86.7,2919
Polio,≥3 Doses,HHS Regions/National,Region 10,2019,Age,35 Months,94.8,92.7 to 96.4,1312
Hib,Full Series,HHS Regions/National,Region 10,2015,Age,35 Months,79.7,75.3 to 83.8,992
Hib,Full Series,HHS Regions/National,Region 10,2015-2016,Age,35 Months,79.7,76.5 to 82.7,1867
Hib,Full Series,HHS Regions/National,Region 10,2014,Age,35 Months,84.0,80.3 to 87.3,1050
Hib,Full Series,HHS Regions/National,Region 10,2014-2015,Age,35 Months,81.8,79.0 to 84.5,2042
Polio,≥3 Doses,HHS Regions/National,Region 10,2015,Age,35 Months,91.9,88.2 to 94.8,992
Polio,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,35 Months,91.6,88.8 to 93.9,1867
Hib,Full Series,HHS Regions/National,Region 10,2016,Age,35 Months,79.7,74.9 to 84.1,875
Hib,Full Series,HHS Regions/National,Region 10,2016-2017,Age,35 Months,81.1,78.1 to 83.9,2294
DTaP,≥2 Doses,HHS Regions/National,Region 10,2015,Age,5 Months,77.6,72.7 to 81.8,992
DTaP,≥2 Doses,HHS Regions/National,Region 10,2015-2016,Age,5 Months,77.5,74.1 to 80.6,1867
DTaP,≥2 Doses,HHS Regions/National,Region 10,2014,Age,5 Months,77.5,73.5 to 81.0,1050
DTaP,≥2 Doses,HHS Regions/National,Region 10,2014-2015,Age,5 Months,77.5,74.7 to 80.1,2042
Polio,≥3 Doses,HHS Regions/National,Region 10,2017,Age,35 Months,92.5,90.0 to 94.6,1419
Polio,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,35 Months,93.9,92.4 to 95.2,2919
Polio,≥3 Doses,HHS Regions/National,Region 10,2016,Age,35 Months,91.3,86.8 to 94.7,875
Polio,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,35 Months,91.7,89.3 to 93.7,2294
Hib,Full Series,HHS Regions/National,Region 10,2011,Age,35 Months,81.8,77.3 to 86.0,1041
Hib,Full Series,HHS Regions/National,Region 10,2012,Age,35 Months,83.4,79.0 to 87.2,977
Hib,Full Series,HHS Regions/National,Region 10,2019,Age,24 Months,82.3,79.0 to 85.4,1312
Hib,Full Series,HHS Regions/National,Region 10,2018,Age,24 Months,83.9,80.9 to 86.8,1500
Hib,Full Series,HHS Regions/National,Region 10,2018-2019,Age,24 Months,83.1,80.9 to 85.3,2812
Polio,≥3 Doses,HHS Regions/National,Region 10,2013,Age,35 Months,92.3,89.6 to 94.5,1048
Polio,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,35 Months,92.0,90.1 to 93.7,2098
Polio,≥3 Doses,HHS Regions/National,Region 10,2014,Age,35 Months,91.8,88.8 to 94.3,1050
Polio,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,35 Months,91.8,89.5 to 93.7,2042
DTaP,≥2 Doses,HHS Regions/National,Region 10,2013,Age,5 Months,80.3,77.1 to 83.2,1048
DTaP,≥2 Doses,HHS Regions/National,Region 10,2013-2014,Age,5 Months,78.9,75.7 to 81.8,2098
DTaP,≥2 Doses,HHS Regions/National,Region 10,2012,Age,5 Months,82.1,78.1 to 85.4,977
DTaP,≥2 Doses,HHS Regions/National,Region 10,2011,Age,5 Months,76.9,72.7 to 80.7,1041
Polio,≥3 Doses,HHS Regions/National,Region 10,2012,Age,35 Months,94.0,91.2 to 96.2,977
Hib,Full Series,HHS Regions/National,Region 10,2015,Age,24 Months,77.4,73.1 to 81.5,992
Hib,Full Series,HHS Regions/National,Region 10,2015-2016,Age,24 Months,77.5,74.3 to 80.6,1867
Hib,Full Series,HHS Regions/National,Region 10,2014,Age,24 Months,80.9,77.2 to 84.3,1050
Hib,Full Series,HHS Regions/National,Region 10,2014-2015,Age,24 Months,79.2,76.3 to 81.8,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2019,Age,13 Months,77.9,74.5 to 81.0,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,93.3,90.7 to 95.3,977
DTaP,≥3 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,94.1,92.0 to 95.7,1312
DTaP,≥3 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,92.4,89.4 to 94.8,1041
Polio,≥3 Doses,HHS Regions/National,Region 10,2017,Age,24 Months,91.4,88.9 to 93.6,1419
Polio,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,24 Months,93.1,91.5 to 94.4,2919
Polio,≥3 Doses,HHS Regions/National,Region 10,2019,Age,24 Months,93.7,91.6 to 95.4,1312
Polio,≥3 Doses,HHS Regions/National,Region 10,2018,Age,24 Months,94.8,92.9 to 96.3,1500
Polio,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,24 Months,94.2,92.9 to 95.4,2812
Hib,≥3 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,91.3,88.8 to 93.2,1312
Polio,≥3 Doses,HHS Regions/National,Region 10,2016,Age,24 Months,89.0,84.9 to 92.4,875
Polio,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,24 Months,90.2,87.8 to 92.3,2294
Hib,≥3 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,91.7,89.1 to 93.9,1048
Hib,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,90.4,88.4 to 92.2,2098
Hib,≥3 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,90.8,87.8 to 93.4,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,90.7,87.7 to 93.3,1041
Hib,Full Series,HHS Regions/National,Region 10,2016,Age,24 Months,77.6,72.7 to 82.1,875
Hib,Full Series,HHS Regions/National,Region 10,2016-2017,Age,24 Months,78.6,75.6 to 81.5,2294
Polio,≥3 Doses,HHS Regions/National,Region 10,2011,Age,35 Months,93.3,89.8 to 96.0,1041
Hib,Full Series,HHS Regions/National,Region 10,2017,Age,24 Months,79.6,76.0 to 83.0,1419
Hib,Full Series,HHS Regions/National,Region 10,2017-2018,Age,24 Months,81.8,79.4 to 84.0,2919
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,90.9,90.1 to 91.8,992
DTaP,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,90.5,88.1 to 92.5,1867
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,90.2,87.0 to 92.7,1050
DTaP,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,90.6,88.5 to 92.4,2042
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,92.0,89.8 to 93.8,1048
DTaP,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,91.1,89.1 to 92.8,2098
DTaP,≥4 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,78.5,75.4 to 81.4,2007
Polio,≥3 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,94.3,92.3 to 95.8,1500
Polio,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,73.3,70.6 to 75.7,2812
Hib,≥3 Doses,HHS Regions/National,Region 10,2015,Age,19 Months,87.8,86.1 to 89.4,992
Hib,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,19 Months,86.3,83.4 to 88.8,1867
Polio,≥3 Doses,HHS Regions/National,Region 10,2011,Age,24 Months,90.0,86.7 to 92.8,1041
Polio,≥3 Doses,HHS Regions/National,Region 10,2012,Age,24 Months,91.9,89.0 to 94.3,977
Hib,≥3 Doses,HHS Regions/National,Region 10,2013,Age,19 Months,90.4,87.2 to 92.9,1048
Hib,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,19 Months,89.3,86.6 to 91.5,2098
Hib,≥3 Doses,HHS Regions/National,Region 10,2014,Age,19 Months,88.1,84.8 to 90.7,1050
Hib,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,19 Months,88.0,85.6 to 90.0,2042
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,91.3,88.7 to 93.4,1419
DTaP,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,93.6,92.1 to 94.8,2919
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,90.1,86.0 to 93.2,875
DTaP,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,90.7,88.4 to 92.7,2294
Polio,≥3 Doses,HHS Regions/National,Region 10,2019,Age,19 Months,92.8,90.4 to 94.5,1312
Polio,≥2 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,91.8,88.9 to 94.0,1253
Hib,≥3 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,92.6,90.4 to 94.3,1500
Hib,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,78.0,75.7 to 80.2,2812
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018,Age,19 Months,95.9,94.2 to 97.1,1500
DTaP,≥3 Doses,HHS Regions/National,Region 10,2018-2019,Age,19 Months,92.7,91.1 to 94.0,2812
Polio,≥3 Doses,HHS Regions/National,Region 10,2015,Age,24 Months,89.2,85.7 to 92.2,992
Polio,≥3 Doses,HHS Regions/National,Region 10,2015-2016,Age,24 Months,89.1,86.4 to 91.4,1867
Polio,≥3 Doses,HHS Regions/National,Region 10,2014,Age,24 Months,89.7,86.6 to 92.4,1050
Polio,≥3 Doses,HHS Regions/National,Region 10,2014-2015,Age,24 Months,89.5,87.2 to 91.5,2042
Hib,≥3 Doses,HHS Regions/National,Region 10,2017,Age,19 Months,86.8,83.7 to 89.3,1419
Hib,≥3 Doses,HHS Regions/National,Region 10,2017-2018,Age,19 Months,89.7,87.8 to 91.3,2919
Hib,≥3 Doses,HHS Regions/National,Region 10,2016,Age,19 Months,84.8,80.1 to 88.6,875
Hib,≥3 Doses,HHS Regions/National,Region 10,2016-2017,Age,19 Months,85.8,83.0 to 88.2,2294
Polio,≥3 Doses,HHS Regions/National,Region 10,2013,Age,24 Months,90.5,87.5 to 93.0,1048
Polio,≥3 Doses,HHS Regions/National,Region 10,2013-2014,Age,24 Months,90.1,88.0 to 92.0,2098
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,82.1,63.8 to 92.3,35
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,86.5,69.5 to 94.7,35
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,80.9,64.4 to 93.0,58
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,81.4,64.9 to 91.2,58
DTaP,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,3 Months,92.1,83.1 to 96.5,58
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,83.2,64.4 to 95.4,35
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,65.1,41.1 to 83.3,35
Hep B,"≥1 Dose, 2 Day",States/Local Areas,U.S. Virgin Islands,2021,Age,0-2 Days,38.7,19.8 to 61.7,35
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,51.9,30.2 to 72.8,35
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,82.1,68.9 to 92.0,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,86.5,69.5 to 94.7,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,78.7,57.4 to 94.0,35
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,81.8,67.2 to 90.8,93
PCV,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,5 Months,41.4,22.4 to 63.4,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,74.4,50.6 to 89.2,35
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,85.9,72.5 to 94.9,58
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,77.1,61.3 to 89.9,58
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,89.2,75.1 to 95.8,58
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,82.5,62.7 to 95.4,35
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,5 Months,79.3,53.7 to 92.7,35
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,73.2,53.5 to 86.6,35
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,76.1,54.7 to 92.5,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,79.3,53.7 to 92.7,35
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,55.4,38.5 to 73.8,58
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,63.6,41.0 to 81.5,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,78.6,61.7 to 89.3,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,82.1,68.9 to 92.0,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,82.6,64.2 to 92.6,35
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,84.6,70.3 to 92.8,93
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,68.7,52.3 to 81.4,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,73.9,58.2 to 85.1,93
Combined 7 Series,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,40.4,26.3 to 58.5,93
Hep A,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,51.8,30.6 to 76.7,93
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,74.9,56.6 to 89.9,93
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,84.2,70.7 to 93.7,93
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,75.8,58.5 to 89.9,93
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,79.2,64.5 to 90.8,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,78.4,63.6 to 90.3,93
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,52.4,32.3 to 75.7,35
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,87.2,73.3 to 94.4,58
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,76.6,61.5 to 87.0,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,79.7,65.2 to 89.2,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,83.2,64.4 to 95.4,35
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,76.1,54.7 to 92.5,35
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,89.0,72.0 to 96.2,35
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,35.6,22.0 to 52.0,58
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,67.3,51.1 to 82.5,58
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,76.7,61.8 to 89.0,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,81.1,68.0 to 91.2,93
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,55.1,38.7 to 73.0,93
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,75.8,58.3 to 89.9,93
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,58.0,42.6 to 74.3,93
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,80.3,66.3 to 91.1,93
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,79.3,57.8 to 94.3,35
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,78.1,62.3 to 90.6,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,82.6,66.9 to 93.7,35
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,69.7,52.7 to 85.0,93
PCV,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,5 Months,53.8,37.2 to 69.6,93
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,5 Months,77.5,62.1 to 87.9,93
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,83.7,69.1 to 93.9,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,5 Months,51.6,35.2 to 67.7,93
Polio,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,3 Months,86.0,69.6 to 94.3,35
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,5 Months,59.6,42.2 to 74.8,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,82.7,66.9 to 93.8,35
Combined 7 Series,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,37.2,23.6 to 55.3,58
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,75.6,54.4 to 92.1,35
DTaP,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,3 Months,88.4,71.8 to 95.8,35
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,37.8,21.0 to 61.6,35
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,75.4,54.5 to 91.7,35
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,70.0,48.2 to 89.0,35
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,83.2,60.6 to 94.1,35
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,87.2,73.4 to 94.4,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,64.8,44.3 to 81.0,35
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,64.7,42.2 to 86.1,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,84.6,69.8 to 94.6,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,66.2,47.8 to 80.8,93
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,79.8,64.7 to 89.4,58
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,67.5,48.8 to 82.0,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,65.1,46.9 to 79.8,93
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,41.7,26.9 to 58.2,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,31.9,19.7 to 47.1,93
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,75.6,51.4 to 90.1,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,63.9,40.9 to 81.9,35
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,69.1,53.2 to 81.4,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,59.5,42.0 to 74.9,93
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,56.0,39.6 to 71.1,93
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,87.1,72.8 to 94.4,93
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,32.8,20.7 to 47.7,93
Combined 7 Series,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,40.3,26.2 to 58.3,93
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2019-2020,Age,0-3 Days,62.8,47.0 to 76.3,93
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,8 Months,45.6,30.1 to 62.1,93
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,35 Months,83.6,70.3 to 93.2,93
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,51.2,34.8 to 67.3,93
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,42.0,27.2 to 58.3,93
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,74.8,59.1 to 85.9,93
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,66.8,51.6 to 79.2,93
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,69.5,54.5 to 83.3,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,81.1,68.0 to 91.2,93
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,51.5,36.1 to 69.0,93
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,69.7,55.7 to 82.7,93
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,76.1,51.1 to 90.6,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,82.7,69.7 to 92.4,93
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,83.3,70.2 to 92.9,93
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,69.6,54.6 to 83.4,93
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,74.9,60.8 to 87.1,93
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,76.6,62.3 to 88.5,93
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,66.4,45.7 to 85.7,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,78.7,53.5 to 92.3,35
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,7 Months,59.3,37.3 to 78.0,35
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,90.0,75.4 to 96.4,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,40.5,25.5 to 57.4,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,76.6,54.8 to 89.9,35
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,24 Months,70.0,48.2 to 89.0,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,72.3,56.6 to 84.0,93
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,32.6,20.5 to 47.5,93
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,81.4,66.8 to 90.5,93
DTaP,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,5 Months,61.0,43.4 to 76.1,93
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,7 Months,49.8,33.6 to 66.0,93
DTaP,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,3 Months,88.3,79.1 to 93.8,93
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,13 Months,68.5,49.8 to 82.7,93
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,85.2,73.9 to 96.5,41
Influenza,,States/Local Areas,Tennessee,2012,Age,24 Months,53.5,45.1 to 62.4,256
Influenza,,States/Local Areas,Tennessee,2011,Age,24 Months,46.6,39.0 to 54.8,256
Influenza,,States/Local Areas,Tennessee,2014,Age,24 Months,41.3,33.7 to 50.0,243
Influenza,,States/Local Areas,Tennessee,2014-2015,Age,24 Months,46.1,40.4 to 52.2,484
Influenza,,States/Local Areas,Tennessee,2015,Age,24 Months,50.7,42.5 to 59.6,241
Influenza,,States/Local Areas,Tennessee,2015-2016,Age,24 Months,53.7,47.6 to 60.1,459
Influenza,,States/Local Areas,Tennessee,2013,Age,24 Months,53.7,45.5 to 62.3,227
Influenza,,States/Local Areas,Tennessee,2013-2014,Age,24 Months,47.5,41.8 to 53.6,470
PCV,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,92.9,89.6 to 95.2,759
Polio,≥3 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,87.8,81.1 to 92.3,243
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,92.0,88.4 to 94.5,484
Hib,≥3 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,66.1,58.3 to 73.1,305
Hib,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,65.2,59.7 to 70.2,715
Hib,≥3 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,69.1,60.5 to 76.6,218
Hib,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,67.6,61.9 to 72.8,523
Hib,≥3 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,72.1,64.2 to 78.9,241
Hib,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,70.7,65.0 to 75.8,459
Hib,≥3 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,74.4,69.5 to 78.7,256
Polio,≥3 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,94.1,89.8 to 96.7,227
Polio,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,90.9,89.0 to 92.6,470
Polio,≥3 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,93.2,87.7 to 96.3,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,93.3,90.2 to 96.4,413
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.0,90.2 to 95.8,564
Hib,≥3 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,46.9,40.2 to 53.7,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,91.2,86.4 to 94.4,410
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,89.2,85.6 to 92.0,806
DTaP,≥3 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,94.4,91.1 to 96.6,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,93.2,90.9 to 94.9,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,87.3,81.3 to 91.5,396
Polio,≥3 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,88.1,80.8 to 92.9,305
Polio,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,91.8,87.5 to 94.7,715
Polio,≥3 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,93.3,88.1 to 96.3,218
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,90.7,86.4 to 93.7,523
Hib,≥3 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,64.2,57.1 to 70.7,410
Hib,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,62.8,57.8 to 67.5,806
Polio,≥3 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,96.2,93.9 to 97.7,241
Polio,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,94.8,92.0 to 96.6,459
Hib,≥3 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,89.0,85.7 to 91.6,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,91.8,86.5 to 95.2,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,61.4,54.5 to 67.8,396
Hib,≥2 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,94.9,90.1 to 97.4,363
PCV,≥3 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,97.3,93.9 to 99.1,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.3,83.8 to 98.8,61
DTaP,≥3 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,89.9,84.8 to 93.5,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Overall,Overall,70.4,66.4 to 74.4,829
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,76.2,67.7 to 84.6,148
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.5,62.2 to 76.8,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,68.8,63.1 to 74.6,413
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.2,65.3 to 75.0,564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.3,48.1 to 76.4,70
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,69.5,59.2 to 79.9,134
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,86.4,79.3 to 91.3,243
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,90.6,86.7 to 93.4,484
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,94.1,87.7 to 97.2,227
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,90.2,86.0 to 93.2,470
Hib,≥3 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,79.4,76.1 to 82.4,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,58.3,49.8 to 66.3,243
Hib,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,65.2,59.4 to 70.6,484
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,96.0,91.8 to 100.0,189
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,93.5,90.0 to 97.0,342
Polio,≥3 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,90.8,87.9 to 93.1,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,75.4,67.5 to 81.9,227
Hib,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,66.8,56.7 to 75.5,470
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,67.7,59.4 to 76.0,189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,69.4,62.9 to 75.9,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,72.5,66.2 to 78.8,298
Hib,≥2 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,92.6,86.3 to 96.2,305
Hib,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,94.5,91.3 to 96.6,715
Hib,≥2 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,96.4,93.7 to 98.0,410
Hib,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,93.9,91.0 to 96.0,806
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.5,86.9 to 96.1,268
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,92.2,86.1 to 98.2,148
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,90.1,85.9 to 94.4,298
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,92.5,90.1 to 94.9,829
Hib,≥2 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,91.4,85.9 to 94.9,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,94.8,91.1 to 97.0,241
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,92.4,88.7 to 94.9,459
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,88.2,81.1 to 92.9,305
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,89.7,85.3 to 92.9,715
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,89.9,83.1 to 94.2,218
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,89.1,84.4 to 92.4,523
Hib,≥2 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,96.1,91.6 to 98.2,256
Hib,≥2 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,96.1,94.8 to 97.0,256
Hib,≥2 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,88.1,82.4 to 92.1,396
Hib,≥2 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,92.8,88.1 to 95.7,410
Hib,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,90.5,87.0 to 93.1,806
Hib,≥2 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,90.0,83.1 to 94.2,243
Hib,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,93.3,89.7 to 95.8,484
Hib,≥2 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,95.8,92.0 to 97.9,218
Hib,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,94.2,90.7 to 96.4,523
Hib,≥2 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,96.7,93.6 to 98.3,241
Hib,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,96.3,94.0 to 97.7,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,80.8 to 96.4,70
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,89.3,81.2 to 97.4,134
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.8,90.2 to 100.0,61
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,88.8,84.5 to 93.1,331
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,97.3,95.5 to 99.2,430
Hib,≥3 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,49.4,41.5 to 57.4,305
Hib,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,47.8,42.4 to 53.2,715
Hib,≥3 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,46.1,39.3 to 53.0,410
Hib,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,46.5,41.7 to 51.4,806
PCV,≥3 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,93.7,88.4 to 97.1,396
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,87.1,76.0 to 98.2,41
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2018,Age,0-3 Days,75.0,68.3 to 80.7,410
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2018-2019,Age,0-3 Days,74.8,70.3 to 78.8,806
Polio,≥1 Dose,States/Local Areas,Tennessee,2019,Age,3 Months,87.3,81.5 to 91.5,396
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,69.9,64.2 to 75.6,430
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,59.0,39.9 to 78.1,41
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020,Age,24 Months,92.3,87.8 to 95.6,363
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,71.7,65.8 to 77.7,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.8,66.6 to 89.1,61
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2019,Age,0-3 Days,74.6,68.5 to 79.8,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,73.9,67.1 to 79.6,410
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,73.0,68.2 to 77.3,806
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,70.8,62.8 to 77.7,305
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,72.3,67.0 to 77.0,715
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,72.1,65.3 to 78.1,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,88.2,86.3 to 89.9,256
PCV,≥1 Dose,States/Local Areas,Tennessee,2015,Age,3 Months,81.8,72.9 to 88.3,241
PCV,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,3 Months,86.3,81.0 to 90.3,459
PCV,≥1 Dose,States/Local Areas,Tennessee,2014,Age,3 Months,86.8,79.8 to 91.6,243
PCV,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,3 Months,84.3,78.8 to 88.6,484
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.1,76.7 to 85.6,564
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.4,63.3 to 87.4,70
Hib,≥2 Doses,States/Local Areas,Tennessee,2017,Age,5 Months,75.5,67.7 to 81.9,305
Hib,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,5 Months,77.1,72.0 to 81.5,715
PCV,≥1 Dose,States/Local Areas,Tennessee,2012,Age,3 Months,84.9,79.4 to 89.1,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014,Age,0-3 Days,61.4,53.1 to 69.2,243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2014-2015,Age,0-3 Days,67.0,61.2 to 72.2,484
Polio,≥1 Dose,States/Local Areas,Tennessee,2013,Age,3 Months,91.5,85.9 to 95.0,227
Polio,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,3 Months,89.3,87.6 to 90.8,470
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2013,Age,0-3 Days,66.3,58.0 to 73.8,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2013-2014,Age,0-3 Days,63.9,58.0 to 69.4,470
Polio,≥1 Dose,States/Local Areas,Tennessee,2011,Age,3 Months,92.7,87.7 to 95.7,256
Polio,≥1 Dose,States/Local Areas,Tennessee,2012,Age,3 Months,86.7,80.4 to 91.2,256
PCV,≥1 Dose,States/Local Areas,Tennessee,2019,Age,3 Months,87.6,81.9 to 91.7,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,92.3,90.0 to 94.6,829
PCV,≥1 Dose,States/Local Areas,Tennessee,2018,Age,3 Months,90.6,85.4 to 94.0,410
PCV,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,3 Months,89.1,85.4 to 91.9,806
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.2,88.0 to 96.4,268
PCV,≥3 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,96.5,94.0 to 98.2,410
PCV,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,94.7,92.0 to 96.6,806
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016,Age,0-3 Days,72.5,64.5 to 79.3,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2017,Age,0-3 Days,73.2,68.0 to 77.9,523
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2017,Age,0-3 Days,79.0,67.9 to 87.0,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2017-2018,Age,0-3 Days,74.5,69.6 to 78.8,715
Polio,≥1 Dose,States/Local Areas,Tennessee,2016,Age,3 Months,89.5,83.6 to 93.5,218
Polio,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,3 Months,89.7,85.7 to 92.7,523
Polio,≥1 Dose,States/Local Areas,Tennessee,2015,Age,3 Months,83.0,73.9 to 89.3,241
Polio,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,3 Months,86.2,80.8 to 90.2,459
Polio,≥1 Dose,States/Local Areas,Tennessee,2014,Age,3 Months,87.2,80.3 to 91.9,243
Polio,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,3 Months,85.1,79.6 to 89.3,484
Hib,≥3 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,48.4,36.4 to 60.5,227
Hib,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,45.3,36.5 to 54.3,470
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,92.0,88.4 to 95.6,298
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,94.9,90.4 to 99.4,189
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,91.5,87.6 to 95.5,342
Hib,≥3 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,53.4,49.4 to 57.3,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,59.0,54.4 to 63.5,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,93.3,88.6 to 96.5,218
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,92.7,89.0 to 95.5,523
PCV,≥3 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,95.8,92.7 to 97.8,241
PCV,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,94.5,91.9 to 96.6,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,87.6,81.0 to 92.7,243
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,91.7,88.0 to 94.6,484
DTaP,≥3 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,71.3,66.5 to 75.7,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,70.2,65.4 to 74.5,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,70.4,62.0 to 77.6,227
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,69.8,65.1 to 74.1,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2011,Age,35 Months,95.4,90.3 to 98.3,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,93.7,88.3 to 99.0,148
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,91.8,88.5 to 95.1,413
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.2,90.5 to 96.0,564
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,84.4 to 97.7,70
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,90.0,83.1 to 97.0,134
PCV,≥3 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,96.5,92.7 to 98.6,227
PCV,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,92.0,88.2 to 95.0,470
PCV,≥3 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,95.9,91.4 to 98.5,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,92.7,87.8 to 96.1,396
Hib,≥2 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,91.9,84.9 to 95.8,241
Hib,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,92.3,88.3 to 95.0,459
Hib,≥2 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,86.9,79.5 to 91.9,305
Hib,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,89.9,85.4 to 93.1,715
Hib,≥2 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,92.7,87.6 to 95.8,218
Hib,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,89.8,85.4 to 92.9,523
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,70.7,61.8 to 78.2,218
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,70.7,64.9 to 76.0,523
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2015,Age,0-3 Days,72.4,64.6 to 79.1,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2015-2016,Age,0-3 Days,72.5,67.0 to 77.4,459
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,69.2,60.9 to 76.4,243
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,68.3,62.2 to 73.7,484
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,67.3,58.4 to 75.2,241
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,69.0,62.8 to 74.6,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,91.7,85.7 to 95.8,305
PCV,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,94.5,91.2 to 96.8,715
Hib,≥2 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,97.3,95.9 to 98.2,227
Hib,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,93.6,90.3 to 95.9,470
Hib,≥3 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,42.2,34.3 to 50.5,243
Hib,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,43.8,38.1 to 49.7,484
PCV,≥3 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,97.2,94.7 to 98.7,410
PCV,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,95.4,92.7 to 97.4,806
Hib,≥3 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,44.0,35.6 to 52.8,218
Hib,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,46.8,40.9 to 52.7,523
Hib,≥3 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,45.5,37.3 to 53.9,241
Hib,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,44.8,38.8 to 50.9,459
Polio,≥1 Dose,States/Local Areas,Tennessee,2017,Age,3 Months,89.9,83.8 to 93.8,305
Polio,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,3 Months,91.3,87.7 to 93.9,715
Polio,≥1 Dose,States/Local Areas,Tennessee,2018,Age,3 Months,92.7,87.9 to 95.7,410
Polio,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,3 Months,90.0,86.4 to 92.7,806
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014,Age,35 Months,90.7,83.1 to 95.8,243
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2015,Age,35 Months,93.1,89.0 to 96.1,484
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015,Age,35 Months,95.9,92.2 to 98.2,241
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015-2016,Age,35 Months,95.4,92.2 to 97.6,459
≥1 Dose Varicella,,States/Local Areas,Tennessee,2012,Age,35 Months,94.4,89.2 to 97.6,256
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013,Age,35 Months,91.4,84.2 to 96.2,227
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013-2014,Age,35 Months,91.6,86.2 to 95.4,470
PCV,≥4 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,80.2,73.9 to 85.3,396
Hep B,≥2 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,92.1,86.3 to 95.6,305
Hep B,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,94.8,91.7 to 96.8,715
PCV,≥3 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,94.9,92.0 to 96.8,227
PCV,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,89.0,83.5 to 92.9,470
Hep B,≥2 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,91.5,85.7 to 95.2,218
Hep B,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,91.8,88.0 to 94.5,523
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2016,Age,0-2 Days,70.6,62.4 to 77.6,218
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2016-2017,Age,0-2 Days,71.1,65.7 to 75.9,523
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,81.0,65.2 to 96.8,41
≥1 Dose MMR,,States/Local Areas,Tennessee,2012,Age,24 Months,94.4,90.4 to 97.1,256
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2017,Age,0-2 Days,71.6,64.2 to 78.0,305
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2017-2018,Age,0-2 Days,72.9,68.0 to 77.4,715
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2018,Age,0-2 Days,74.2,67.5 to 80.0,410
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2018-2019,Age,0-2 Days,73.8,69.4 to 77.9,806
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2019,Age,0-2 Days,73.4,67.3 to 78.8,396
Hep B,≥2 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,97.5,94.6 to 98.9,410
Hep B,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,94.8,92.0 to 96.7,806
PCV,≥4 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,85.7,79.3 to 91.0,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,97.0,95.4 to 98.1,227
Hep B,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,93.4,89.7 to 95.8,470
Hep B,≥2 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,97.7,95.1 to 98.9,241
Hep B,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,95.4,92.4 to 97.2,459
Hep B,≥2 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,89.8,83.4 to 94.0,243
Hep B,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,93.8,90.3 to 96.0,484
Hib,≥1 Dose,States/Local Areas,Tennessee,2014,Age,3 Months,87.0,80.1 to 91.7,243
Hib,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,3 Months,84.9,79.5 to 89.2,484
Hib,≥1 Dose,States/Local Areas,Tennessee,2011,Age,3 Months,91.9,83.7 to 96.1,256
Hib,≥1 Dose,States/Local Areas,Tennessee,2012,Age,3 Months,86.6,82.2 to 90.0,256
Hib,≥1 Dose,States/Local Areas,Tennessee,2013,Age,3 Months,91.2,83.3 to 95.5,227
Hib,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,3 Months,89.1,87.5 to 90.5,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,87.2,78.7 to 95.7,134
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,84.8,72.8 to 96.9,41
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.4,81.2 to 97.5,61
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.7,84.8 to 94.5,268
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,92.0,86.7 to 97.2,148
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,89.0,84.5 to 93.5,298
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Overall,Overall,89.9,87.3 to 92.6,829
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,89.5,85.7 to 93.3,413
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.3,88.4 to 94.2,564
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,78.3 to 95.7,70
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,85.4,73.7 to 97.2,41
≥1 Dose MMR,,States/Local Areas,Tennessee,2019,Age,35 Months,91.8,86.3 to 95.8,396
≥1 Dose MMR,,States/Local Areas,Tennessee,2017,Age,35 Months,90.0,83.6 to 94.6,305
≥1 Dose MMR,,States/Local Areas,Tennessee,2017-2018,Age,35 Months,93.4,90.0 to 96.0,715
≥1 Dose MMR,,States/Local Areas,Tennessee,2018,Age,35 Months,96.9,94.1 to 98.5,410
≥1 Dose MMR,,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.4,91.4 to 96.6,806
Hep B,≥2 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,96.0,91.4 to 98.2,305
Hep B,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,97.4,95.1 to 98.6,715
Hib,≥1 Dose,States/Local Areas,Tennessee,2017,Age,3 Months,88.0,81.7 to 92.4,305
Hib,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,3 Months,89.5,85.7 to 92.4,715
Hib,≥1 Dose,States/Local Areas,Tennessee,2016,Age,3 Months,90.6,84.9 to 94.2,218
Hib,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,3 Months,89.3,85.2 to 92.3,523
Hib,≥1 Dose,States/Local Areas,Tennessee,2015,Age,3 Months,82.9,73.9 to 89.3,241
Hib,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,3 Months,86.7,81.4 to 90.6,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,93.3,88.0 to 96.3,218
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,90.6,86.4 to 93.6,523
PCV,≥3 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,95.7,94.7 to 96.5,241
PCV,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,94.5,91.6 to 96.4,459
Hep B,≥2 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,93.0,87.2 to 96.3,218
Hep B,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,94.5,91.2 to 96.7,523
Hep B,≥2 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,98.7,97.3 to 99.3,410
Hep B,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,96.2,93.8 to 97.7,806
PCV,≥4 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,85.3,76.1 to 92.3,243
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,86.0,80.7 to 90.4,484
PCV,≥4 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,88.1,81.7 to 93.0,241
PCV,≥4 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,85.7,79.3 to 91.0,459
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,94.6,91.7 to 97.5,430
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,84.4,79.2 to 89.6,331
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,78.8 to 96.1,70
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,82.6,73.0 to 92.2,134
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.2,74.8 to 95.6,61
PCV,≥4 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,86.5,79.1 to 92.2,227
PCV,≥4 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,85.2,79.7 to 89.9,470
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,96.5,93.8 to 98.2,410
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.8,92.3 to 96.7,806
PCV,≥3 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,87.6,80.4 to 92.4,243
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,91.6,87.8 to 94.4,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,93.4,88.8 to 96.5,396
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,89.0,84.9 to 93.0,342
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,94.1,89.4 to 98.9,189
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,88.6,84.6 to 92.7,413
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.5 to 94.6,564
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017,Age,35 Months,91.9,86.1 to 95.9,305
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017-2018,Age,35 Months,94.1,91.0 to 96.5,715
Hib,≥1 Dose,States/Local Areas,Tennessee,2018,Age,3 Months,91.0,85.8 to 94.4,410
Hib,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,3 Months,89.1,85.4 to 91.9,806
Hib,≥1 Dose,States/Local Areas,Tennessee,2019,Age,3 Months,87.2,81.5 to 91.3,396
PCV,≥3 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,96.5,92.7 to 98.6,227
PCV,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,92.0,88.2 to 95.0,470
PCV,≥3 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,95.7,92.5 to 97.8,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,87.6,81.0 to 92.7,243
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,91.7,88.0 to 94.6,484
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,88.2,83.9 to 92.4,430
PCV,≥4 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,85.2,79.5 to 90.1,396
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,77.5,67.2 to 87.8,134
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.1,56.2 to 84.0,61
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,70.8,64.0 to 77.5,331
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,69.9,52.2 to 87.6,41
PCV,≥1 Dose,States/Local Areas,Tennessee,2013,Age,3 Months,93.2,87.6 to 96.4,227
PCV,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,3 Months,90.0,88.6 to 91.2,470
Hib,≥2 Doses,States/Local Areas,Tennessee,2016,Age,5 Months,79.6,71.8 to 85.6,218
Hib,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,5 Months,77.5,72.2 to 82.1,523
Hib,≥2 Doses,States/Local Areas,Tennessee,2015,Age,5 Months,75.2,66.1 to 82.5,241
Hib,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,5 Months,77.4,71.5 to 82.3,459
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,87.4,82.4 to 92.3,298
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Overall,Overall,88.9,86.0 to 91.9,829
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.5,81.5 to 93.5,268
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,91.9,86.5 to 97.3,148
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,93.7,87.9 to 99.4,189
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,88.4,83.9 to 92.8,342
PCV,≥1 Dose,States/Local Areas,Tennessee,2011,Age,3 Months,90.6,81.8 to 95.4,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,85.7,80.6 to 90.0,410
PCV,≥4 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,85.5,81.7 to 88.8,806
PCV,≥4 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,85.0,72.9 to 93.6,218
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,82.0,75.8 to 87.5,523
PCV,≥4 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,81.8,74.0 to 88.4,305
PCV,≥4 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,83.8,79.0 to 88.0,715
PCV,≥3 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,88.0,80.9 to 92.7,305
PCV,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,91.5,87.2 to 94.4,715
Hib,≥2 Doses,States/Local Areas,Tennessee,2014,Age,5 Months,78.6,71.2 to 84.6,243
Hib,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,5 Months,76.9,75.1 to 78.6,484
Hib,≥2 Doses,States/Local Areas,Tennessee,2013,Age,5 Months,79.2,64.4 to 88.9,227
Hib,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,5 Months,78.9,71.1 to 85.1,470
Hib,≥2 Doses,States/Local Areas,Tennessee,2011,Age,5 Months,77.5,69.9 to 83.5,256
Hib,≥2 Doses,States/Local Areas,Tennessee,2012,Age,5 Months,74.0,70.4 to 77.2,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,93.8,89.0 to 96.6,396
PCV,≥3 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,94.9,91.3 to 97.1,410
PCV,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,87.8,84.0 to 90.8,806
PCV,≥3 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,93.2,88.0 to 96.7,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,90.4,84.8 to 94.1,396
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,78.4,74.4 to 82.4,829
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,74.6,64.8 to 84.5,148
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.7,75.3 to 88.1,268
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,75.0,68.2 to 81.9,342
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,74.7,68.3 to 81.1,298
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,93.4,88.7 to 98.2,189
Hib,≥2 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,87.5,80.6 to 92.2,243
Hib,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,89.7,85.2 to 93.0,484
Hib,≥2 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,95.1,93.5 to 96.3,227
Hib,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,91.3,88.3 to 93.6,470
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2012,Age,0-3 Days,79.2,71.9 to 85.0,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,72.1 to 83.4,413
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2011,Age,0-3 Days,74.0,66.8 to 80.2,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,90.6,86.7 to 94.4,331
PCV,≥1 Dose,States/Local Areas,Tennessee,2017,Age,3 Months,87.0,80.6 to 91.5,305
PCV,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,3 Months,88.8,84.9 to 91.8,715
PCV,≥1 Dose,States/Local Areas,Tennessee,2016,Age,3 Months,90.9,85.3 to 94.5,218
PCV,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,3 Months,88.9,84.9 to 92.0,523
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,84.6,72.4 to 96.8,41
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,95.3,92.6 to 98.0,430
Hib,≥2 Doses,States/Local Areas,Tennessee,2018,Age,5 Months,78.7,72.4 to 83.9,410
Hib,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,5 Months,78.9,74.6 to 82.7,806
Hib,≥2 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,89.4,86.9 to 91.4,256
Hib,≥2 Doses,States/Local Areas,Tennessee,2019,Age,5 Months,79.1,72.7 to 84.4,396
PCV,≥3 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,95.8,92.7 to 97.8,241
PCV,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,94.5,91.9 to 96.6,459
Hib,≥2 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,85.6,80.7 to 89.4,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,93.3,88.6 to 96.5,218
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,91.8,87.9 to 94.8,523
PCV,≥3 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,90.2,83.9 to 94.8,305
PCV,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,93.4,90.1 to 95.9,715
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,68.0,59.6 to 75.4,241
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,67.8,61.8 to 73.3,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,65.0,56.9 to 72.4,243
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,66.5,60.7 to 71.8,484
Polio,≥2 Doses,States/Local Areas,Tennessee,2017,Age,5 Months,77.9,70.2 to 84.1,305
Polio,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,5 Months,79.3,74.4 to 83.6,715
Polio,≥2 Doses,States/Local Areas,Tennessee,2016,Age,5 Months,79.5,71.7 to 85.6,218
Polio,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,5 Months,78.7,73.4 to 83.2,523
Hep A,≥1 Dose,States/Local Areas,Tennessee,2017,Age,35 Months,92.1,86.6 to 96.0,305
Hep A,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,35 Months,94.2,91.1 to 96.5,715
Hep A,≥1 Dose,States/Local Areas,Tennessee,2015,Age,35 Months,89.5,83.5 to 94.0,241
Hep A,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,35 Months,89.7,85.6 to 93.1,459
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,73.6,67.7 to 79.5,413
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.1,75.6 to 84.7,564
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.0,58.7 to 85.3,70
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,66.4,55.7 to 77.2,134
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.8,69.4 to 84.2,268
Hep A,≥2 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,75.2,64.9 to 84.5,227
Hep A,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,76.5,69.7 to 82.8,470
Hep A,≥2 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,69.8,58.8 to 80.2,256
Hep A,≥2 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,80.4,70.1 to 88.9,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,67.6,58.8 to 75.4,218
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,64.4,58.4 to 69.9,523
Polio,≥2 Doses,States/Local Areas,Tennessee,2015,Age,5 Months,75.5,66.4 to 82.8,241
Polio,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,5 Months,77.5,71.6 to 82.5,459
Hep A,≥2 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,43.9,37.4 to 51.0,396
Hep A,≥2 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,51.0,44.1 to 58.3,410
Hep A,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,47.8,42.9 to 52.9,806
Polio,≥2 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,88.5,86.4 to 90.4,256
Polio,≥2 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,88.0,82.6 to 91.9,256
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,84.0,75.1 to 92.9,134
Polio,≥2 Doses,States/Local Areas,Tennessee,2019,Age,5 Months,79.5,72.9 to 84.8,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,61.2,53.0 to 68.9,305
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,68.5,63.1 to 73.4,715
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,75.7,69.5 to 81.0,410
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,72.4,67.9 to 76.5,806
Hep A,≥2 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,78.3,68.1 to 87.0,241
Hep A,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,78.7,70.5 to 85.9,459
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,80.0,67.2 to 90.3,218
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,83.3,75.0 to 90.0,523
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,78.0,69.3 to 85.6,243
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,78.2,71.6 to 84.2,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,69.1,62.3 to 75.1,396
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014,Age,13 Months,48.1,39.9 to 56.4,243
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2015,Age,13 Months,54.2,48.3 to 60.0,484
≥1 Dose Varicella,,States/Local Areas,Tennessee,2012,Age,13 Months,60.7,54.9 to 66.2,256
Hep A,≥1 Dose,States/Local Areas,Tennessee,2018,Age,35 Months,96.2,92.7 to 98.4,410
Hep A,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.6,91.5 to 96.9,806
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,84.8,79.9 to 89.8,331
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,93.6,91.0 to 96.2,430
Hep A,≥1 Dose,States/Local Areas,Tennessee,2019,Age,35 Months,92.7,87.0 to 96.5,396
Polio,≥2 Doses,States/Local Areas,Tennessee,2018,Age,5 Months,80.7,74.6 to 85.7,410
Polio,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,5 Months,80.1,75.8 to 83.8,806
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,80.1,66.2 to 94.0,41
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.5,81.3 to 97.7,61
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013,Age,13 Months,56.4,53.1 to 59.7,227
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013-2014,Age,13 Months,52.2,49.1 to 55.3,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2011,Age,13 Months,56.6,51.9 to 61.2,256
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,84.9,78.2 to 91.6,189
Hib,Primary Series,States/Local Areas,Tennessee,2011,Age,7 Months,72.9,67.7 to 77.5,256
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.3,82.6 to 99.9,61
Hib,Full Series,States/Local Areas,Tennessee,2018,Age,35 Months,86.8,82.0 to 90.9,410
Hib,Full Series,States/Local Areas,Tennessee,2018-2019,Age,35 Months,81.6,77.6 to 85.4,806
Hib,Full Series,States/Local Areas,Tennessee,2019,Age,35 Months,76.0,69.5 to 82.0,396
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,93.1,90.1 to 96.1,413
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,90.8 to 96.1,564
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,79.8 to 96.6,70
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,88.9,80.2 to 97.6,134
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,66.2,59.3 to 73.0,331
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.8,50.9 to 80.7,61
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,86.0,81.6 to 90.4,430
Polio,≥3 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,92.0,86.2 to 96.0,396
Polio,≥3 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,96.9,94.2 to 98.6,410
Polio,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.4,91.4 to 96.6,806
Hib,Full Series,States/Local Areas,Tennessee,2016,Age,35 Months,86.8,76.8 to 93.9,218
Hib,Full Series,States/Local Areas,Tennessee,2016-2017,Age,35 Months,82.3,76.3 to 87.6,523
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,88.6,83.9 to 93.3,331
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,87.9,77.2 to 98.6,41
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,96.6,94.6 to 98.7,430
Hib,Full Series,States/Local Areas,Tennessee,2014,Age,35 Months,81.4,73.7 to 88.0,243
Hib,Full Series,States/Local Areas,Tennessee,2014-2015,Age,35 Months,84.5,79.5 to 88.8,484
Hib,Full Series,States/Local Areas,Tennessee,2017,Age,35 Months,80.0,72.3 to 86.7,305
Hib,Full Series,States/Local Areas,Tennessee,2017-2018,Age,35 Months,83.6,79.2 to 87.6,715
Hib,Full Series,States/Local Areas,Tennessee,2015,Age,35 Months,87.4,81.2 to 92.4,241
Hib,Full Series,States/Local Areas,Tennessee,2015-2016,Age,35 Months,87.5,81.3 to 92.4,459
Polio,≥3 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,95.9,92.5 to 98.0,256
DTaP,≥2 Doses,States/Local Areas,Tennessee,2011,Age,5 Months,78.5,71.7 to 84.0,256
DTaP,≥2 Doses,States/Local Areas,Tennessee,2012,Age,5 Months,75.8,70.7 to 80.3,256
DTaP,≥2 Doses,States/Local Areas,Tennessee,2013,Age,5 Months,79.0,61.9 to 89.7,227
DTaP,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,5 Months,78.5,69.9 to 85.2,470
Hib,Full Series,States/Local Areas,Tennessee,2013,Age,35 Months,86.6,79.5 to 92.3,227
Hib,Full Series,States/Local Areas,Tennessee,2013-2014,Age,35 Months,83.9,78.7 to 88.4,470
Hib,Full Series,States/Local Areas,Tennessee,2012,Age,35 Months,81.9,72.8 to 89.4,256
Hib,Full Series,States/Local Areas,Tennessee,2011,Age,35 Months,86.3,78.5 to 92.4,256
Hib,Full Series,States/Local Areas,Tennessee,2018,Age,24 Months,83.8,78.5 to 88.4,410
Hib,Full Series,States/Local Areas,Tennessee,2018-2019,Age,24 Months,78.4,74.2 to 82.3,806
Hib,Full Series,States/Local Areas,Tennessee,2019,Age,24 Months,72.8,66.3 to 78.9,396
Polio,≥3 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,97.1,93.4 to 99.0,227
Polio,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,92.9,89.4 to 95.6,470
Polio,≥3 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,88.3,82.3 to 93.1,243
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,92.3,89.0 to 94.9,484
Polio,≥3 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,96.2,93.4 to 98.1,241
Polio,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,94.8,92.2 to 96.7,459
DTaP,≥2 Doses,States/Local Areas,Tennessee,2015,Age,5 Months,75.6,66.5 to 82.9,241
DTaP,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,5 Months,77.1,71.1 to 82.1,459
Polio,≥3 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,93.3,88.6 to 96.5,218
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,92.8,88.6 to 95.8,523
Polio,≥3 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,91.5,84.9 to 96.0,305
Polio,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,94.2,90.7 to 96.8,715
DTaP,≥2 Doses,States/Local Areas,Tennessee,2014,Age,5 Months,78.0,70.2 to 84.3,243
DTaP,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,5 Months,76.8,75.2 to 78.4,484
Hib,≥3 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,92.1,86.6 to 96.0,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,96.0,92.9 to 98.0,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,94.9,90.4 to 97.8,227
Hib,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,91.0,87.1 to 94.1,470
Hib,Full Series,States/Local Areas,Tennessee,2015,Age,24 Months,82.0,75.4 to 87.7,241
Hib,Full Series,States/Local Areas,Tennessee,2015-2016,Age,24 Months,78.4,73.2 to 83.3,459
Polio,≥3 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,95.5,91.6 to 97.9,256
Hib,Full Series,States/Local Areas,Tennessee,2016,Age,24 Months,74.8,66.5 to 82.4,218
Hib,Full Series,States/Local Areas,Tennessee,2016-2017,Age,24 Months,75.0,69.3 to 80.2,523
Hib,Full Series,States/Local Areas,Tennessee,2017,Age,24 Months,75.1,67.4 to 82.2,305
Hib,Full Series,States/Local Areas,Tennessee,2017-2018,Age,24 Months,79.7,75.1 to 83.9,715
Polio,≥3 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,88.6,81.9 to 93.7,305
Polio,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,92.7,89.1 to 95.4,715
Polio,≥3 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,96.7,94.0 to 98.4,410
Polio,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,93.1,90.1 to 95.5,806
Polio,≥3 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,89.3,83.9 to 93.5,396
Hib,≥3 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,87.6,81.8 to 91.7,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,95.7,92.5 to 97.9,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,93.6,88.5 to 97.0,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,90.1,84.3 to 93.9,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,95.5,91.8 to 97.5,410
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,89.2,85.6 to 92.0,806
Hib,≥3 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,89.3,83.9 to 93.0,410
Hib,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,62.8,57.8 to 67.5,806
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,92.3,86.2 to 95.9,218
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,91.2,86.9 to 94.2,523
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,90.1,83.1 to 94.4,305
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,92.8,88.6 to 95.5,715
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,96.7,95.5 to 97.6,241
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,94.6,91.4 to 96.6,459
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,88.7,82.0 to 93.2,243
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,92.7,89.1 to 95.2,484
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,96.0,91.4 to 98.2,227
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,92.3,89.3 to 94.6,470
Polio,≥3 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,97.0,93.3 to 98.9,227
Polio,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,92.8,89.3 to 95.5,470
Hib,≥3 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,93.1,90.7 to 94.9,227
Hib,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,88.0,83.4 to 91.4,470
Hib,≥3 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,82.9,75.5 to 88.4,243
Hib,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,87.4,83.1 to 90.7,484
Polio,≥3 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,95.1,91.8 to 97.3,256
Polio,≥3 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,91.8,86.4 to 95.7,256
Polio,≥3 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,88.4,82.4 to 92.5,396
Polio,≥3 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,95.5,91.8 to 97.5,410
Polio,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,67.9,63.2 to 72.2,806
Polio,≥3 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,88.3,82.3 to 93.1,243
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,92.3,89.0 to 94.9,484
Polio,≥3 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,96.2,93.4 to 98.1,241
Polio,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,94.8,92.2 to 96.7,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,93.7,89.4 to 96.7,363
Hib,≥3 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,91.9,87.1 to 95.0,241
Hib,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,90.1,86.2 to 93.0,459
Hib,≥3 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,88.3,81.4 to 92.9,218
Hib,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,85.6,80.9 to 89.4,523
Polio,≥3 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,93.3,88.6 to 96.5,218
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,90.9,86.9 to 94.1,523
Hib,≥3 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,83.0,75.8 to 88.4,305
Hib,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,86.2,81.6 to 89.7,715
Hib,≥3 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,92.6,87.0 to 96.4,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,89.2 to 97.8,268
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,93.4,87.8 to 99.0,148
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,93.2,90.0 to 96.3,413
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.4,91.8 to 96.9,564
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,82.7 to 97.3,70
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,91.0,83.1 to 99.0,134
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.0,86.3 to 99.7,61
PCV,≥2 Doses,States/Local Areas,Tennessee,2018,Age,5 Months,78.2,71.8 to 83.4,410
PCV,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,5 Months,78.3,73.9 to 82.2,806
PCV,≥2 Doses,States/Local Areas,Tennessee,2017,Age,5 Months,77.5,69.7 to 83.7,305
PCV,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,5 Months,77.8,72.8 to 82.2,715
PCV,≥2 Doses,States/Local Areas,Tennessee,2019,Age,5 Months,78.4,71.8 to 83.8,396
DTaP,≥4 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,68.2,60.2 to 75.3,305
DTaP,≥4 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,69.1,63.7 to 74.0,715
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,64.1,55.0 to 72.2,218
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,66.2,60.2 to 71.7,523
Hep A,≥2 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,45.9,37.7 to 55.0,227
Hep A,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,43.4,37.5 to 49.8,470
DTaP,≥4 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,69.9,62.9 to 76.1,410
DTaP,≥4 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,94.2,91.3 to 96.1,806
Polio,≥2 Doses,States/Local Areas,Tennessee,2014,Age,5 Months,77.3,69.5 to 83.7,243
Polio,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,5 Months,76.4,74.5 to 78.3,484
Polio,≥2 Doses,States/Local Areas,Tennessee,2013,Age,5 Months,79.1,61.7 to 89.8,227
Polio,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,5 Months,78.2,69.8 to 84.8,470
Hep A,≥1 Dose,States/Local Areas,Tennessee,2012,Age,35 Months,93.8,89.8 to 96.6,256
Polio,≥2 Doses,States/Local Areas,Tennessee,2011,Age,5 Months,77.7,70.5 to 83.5,256
Polio,≥2 Doses,States/Local Areas,Tennessee,2012,Age,5 Months,74.8,68.3 to 80.3,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,96.0,91.8 to 100.0,189
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,94.4,91.2 to 97.5,342
Hep B,≥3 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,64.8,60.2 to 69.1,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,73.1,67.3 to 78.3,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,74.5,65.8 to 82.4,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,80.5,73.7 to 86.5,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,74.7,65.1 to 82.4,227
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,69.9,65.4 to 73.9,470
DTaP,≥4 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,72.9,66.2 to 78.7,396
DTaP,≥4 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,82.8,75.6 to 88.9,227
DTaP,≥4 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,80.5,75.4 to 85.0,470
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,44.6,35.9 to 54.4,218
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,44.6,38.6 to 51.0,523
Hep A,≥2 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,44.5,36.7 to 53.2,305
Hep A,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,47.8,42.6 to 53.4,715
Hep A,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,42.8,36.8 to 49.3,459
≥1 Dose MMR,,States/Local Areas,Tennessee,2015,Age,13 Months,55.0,46.5 to 63.1,241
≥1 Dose MMR,,States/Local Areas,Tennessee,2015-2016,Age,13 Months,56.2,50.2 to 62.1,459
≥1 Dose MMR,,States/Local Areas,Tennessee,2014,Age,13 Months,47.5,39.4 to 55.7,243
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2015,Age,13 Months,51.2,45.3 to 57.1,484
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,87.3,82.9 to 91.7,342
≥1 Dose Varicella,,States/Local Areas,Tennessee,2012,Age,19 Months,89.4,84.3 to 93.0,256
≥1 Dose Varicella,,States/Local Areas,Tennessee,2011,Age,19 Months,87.3,85.1 to 89.3,256
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019,Age,13 Months,59.1,52.3 to 65.6,396
≥1 Dose MMR,,States/Local Areas,Tennessee,2013,Age,13 Months,47.2,40.1 to 54.4,227
≥1 Dose MMR,,States/Local Areas,Tennessee,2013-2014,Age,13 Months,47.3,41.9 to 52.9,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018,Age,13 Months,56.8,49.8 to 63.5,410
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018-2019,Age,13 Months,58.0,53.1 to 62.7,806
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,85.1,77.8 to 90.9,243
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,88.3,84.0 to 92.0,484
DTaP,≥4 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,84.0,73.6 to 92.0,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,86.9,79.4 to 92.7,227
DTaP,≥4 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,85.9,80.8 to 90.2,470
Hep B,≥3 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,92.7,90.7 to 94.3,256
Hep A,≥2 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,78.2,70.2 to 85.2,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,82.3,75.0 to 87.8,243
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,87.6,83.4 to 90.9,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,87.9,83.6 to 91.2,227
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,85.1,80.3 to 88.8,470
Hep A,≥2 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,85.5,76.1 to 92.7,305
Hep A,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,86.5,80.3 to 91.5,715
Hep A,≥2 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,87.3,80.7 to 92.5,410
Hep A,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,82.9,77.7 to 87.5,806
Hep B,≥3 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,83.5,80.6 to 85.9,256
Polio,≥2 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,91.4,84.5 to 95.3,241
Polio,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,91.5,87.4 to 94.3,459
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,86.5,81.6 to 91.3,298
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Overall,Overall,88.3,85.5 to 91.1,829
Polio,≥2 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,94.3,91.7 to 96.1,227
Polio,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,91.1,88.3 to 93.3,470
Polio,≥2 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,88.0,81.1 to 92.6,243
Polio,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,89.7,85.1 to 92.9,484
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.7,81.4 to 92.0,268
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,89.6,83.4 to 95.8,148
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,85.1 to 92.7,413
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.5,85.2 to 91.9,564
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,82.6 to 97.8,70
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016,Age,35 Months,90.0,83.8 to 94.5,218
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,35 Months,91.2,87.2 to 94.3,523
DTaP,≥4 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,85.5,79.6 to 90.3,241
DTaP,≥4 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,82.0,76.9 to 86.5,459
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,78.5,70.0 to 86.0,218
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,78.2,72.5 to 83.3,523
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,78.1,70.8 to 84.6,243
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,81.9,77.3 to 86.1,484
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,77.7,71.2 to 84.2,342
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,68.6,61.6 to 75.6,298
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Overall,Overall,75.2,71.1 to 79.3,829
Hib,Full Series,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,77.0,68.1 to 86.0,148
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014,Age,35 Months,92.8,81.8 to 98.3,243
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,35 Months,89.4,84.0 to 93.6,484
Hep A,≥1 Dose,States/Local Areas,Tennessee,2013,Age,35 Months,90.5,83.2 to 95.5,227
Hep A,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,35 Months,90.5,84.5 to 94.9,470
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,41.0,32.9 to 50.4,243
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,41.2,35.4 to 47.5,484
Hep A,≥2 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,41.4,33.6 to 50.1,241
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,93.3,91.0 to 95.6,829
Hib,≥3 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,96.6,94.1 to 98.2,410
Hib,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.7,91.8 to 96.8,806
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015,Age,13 Months,60.3,51.9 to 68.2,241
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015-2016,Age,13 Months,58.7,52.7 to 64.5,459
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017,Age,13 Months,57.8,49.7 to 65.5,305
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017-2018,Age,13 Months,57.3,51.9 to 62.6,715
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016,Age,13 Months,57.1,48.3 to 65.4,218
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2017,Age,13 Months,57.5,51.5 to 63.2,523
DTaP,≥4 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,89.7,80.5 to 95.8,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,77.8,71.4 to 83.5,396
Polio,≥2 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,95.7,90.3 to 98.1,256
Polio,≥2 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,95.8,94.6 to 96.8,256
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013,Age,19 Months,86.7,80.2 to 91.4,227
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013-2014,Age,19 Months,84.0,81.6 to 86.2,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015,Age,19 Months,92.8,89.9 to 94.9,241
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015-2016,Age,19 Months,90.4,86.6 to 93.2,459
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014,Age,19 Months,81.3,73.8 to 87.1,243
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2015,Age,19 Months,87.1,82.8 to 90.4,484
≥1 Dose MMR,,States/Local Areas,Tennessee,2017,Age,13 Months,53.4,45.5 to 61.0,305
≥1 Dose MMR,,States/Local Areas,Tennessee,2017-2018,Age,13 Months,60.4,55.1 to 65.5,715
≥1 Dose MMR,,States/Local Areas,Tennessee,2016,Age,13 Months,57.6,48.8 to 65.9,218
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2017,Age,13 Months,55.4,49.6 to 61.2,523
≥1 Dose MMR,,States/Local Areas,Tennessee,2018,Age,13 Months,67.4,60.8 to 73.4,410
≥1 Dose MMR,,States/Local Areas,Tennessee,2018-2019,Age,13 Months,67.9,63.2 to 72.2,806
Hep B,≥1 Dose,States/Local Areas,Tennessee,2016,Age,3 Months,95.6,91.2 to 97.8,218
Hep B,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,3 Months,96.7,94.3 to 98.1,523
Hep B,≥1 Dose,States/Local Areas,Tennessee,2015,Age,3 Months,96.0,92.6 to 97.9,241
Hep B,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,3 Months,95.8,93.3 to 97.4,459
Hep B,≥1 Dose,States/Local Areas,Tennessee,2014,Age,3 Months,92.8,88.0 to 95.8,243
Hep B,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,3 Months,94.4,91.7 to 96.3,484
Polio,≥2 Doses,States/Local Areas,Tennessee,2013,Age,13 Months,97.2,95.9 to 98.1,227
Polio,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,13 Months,93.5,89.7 to 96.0,470
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.3,82.8 to 100.0,70
Hep A,≥2 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,38.4,30.5 to 47.5,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2011,Age,13 Months,47.5,46.1 to 48.9,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2012,Age,13 Months,58.3,52.1 to 64.2,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,78.0,70.4 to 84.7,305
DTaP,≥4 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,79.9,75.0 to 84.4,715
DTaP,≥4 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,81.6,75.6 to 86.9,410
DTaP,≥4 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,79.9,75.6 to 83.9,806
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,84.0,74.9 to 93.1,298
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,81.7,76.2 to 87.2,829
Polio,≥2 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,89.4,84.0 to 93.2,396
Polio,≥2 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,88.1,80.7 to 92.9,305
Polio,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,90.5,86.0 to 93.6,715
Polio,≥2 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,91.6,86.3 to 94.9,218
Polio,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,89.8,85.5 to 93.0,523
Hep B,≥1 Dose,States/Local Areas,Tennessee,2011,Age,3 Months,94.7,90.6 to 97.1,256
Hep B,≥1 Dose,States/Local Areas,Tennessee,2012,Age,3 Months,97.3,95.2 to 98.5,256
Hep B,≥1 Dose,States/Local Areas,Tennessee,2013,Age,3 Months,97.3,94.4 to 98.7,227
Hep B,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,3 Months,95.0,93.6 to 96.1,470
Polio,≥2 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,92.9,88.2 to 95.8,410
Polio,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,91.1,87.8 to 93.6,806
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,94.8,90.5 to 99.1,189
Hep A,≥1 Dose,States/Local Areas,Tennessee,2020,Age,35 Months,92.2,87.0 to 95.8,363
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,84.6,77.6 to 89.8,305
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,89.1,85.3 to 92.1,715
DTaP,≥4 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,91.7,86.5 to 95.4,241
DTaP,≥4 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,91.8,86.5 to 95.6,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,92.9,88.3 to 95.8,241
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,90.6,86.5 to 93.5,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,88.1,80.9 to 92.9,218
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,86.4,81.6 to 90.1,523
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,93.0,83.1 to 98.1,218
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,89.1,81.7 to 94.4,523
DTaP,≥4 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,87.3,76.8 to 94.6,305
DTaP,≥4 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,88.2,82.3 to 92.9,715
≥1 Dose MMR,,States/Local Areas,Tennessee,2014,Age,19 Months,78.6,70.6 to 84.8,243
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2015,Age,19 Months,83.9,79.3 to 87.7,484
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,75.5,68.9 to 82.1,298
≥1 Dose Varicella,,States/Local Areas,Tennessee,2012,Age,24 Months,91.5,86.6 to 95.2,256
≥1 Dose Varicella,,States/Local Areas,Tennessee,2011,Age,24 Months,91.3,86.7 to 94.7,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2016,Age,19 Months,86.9,79.9 to 91.7,218
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2017,Age,19 Months,85.8,81.0 to 89.6,523
≥1 Dose MMR,,States/Local Areas,Tennessee,2015,Age,19 Months,89.3,86.6 to 91.5,241
≥1 Dose MMR,,States/Local Areas,Tennessee,2015-2016,Age,19 Months,88.1,84.0 to 91.2,459
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,72.6,62.1 to 83.2,134
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.4,78.0 to 86.8,564
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,66.1 to 89.9,70
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,78.9,74.9 to 82.9,829
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,71.8,61.9 to 81.6,148
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.4,74.3 to 88.6,268
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,79.9,74.5 to 85.3,413
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,96.8,95.5 to 97.7,241
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,94.0,90.5 to 96.2,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,85.1,78.3 to 90.1,243
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,91.0,87.3 to 93.7,484
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,83.9,74.4 to 93.4,189
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,93.3,91.5 to 94.7,227
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,89.2,86.1 to 91.6,470
Hep B,≥2 Doses,States/Local Areas,Tennessee,2013,Age,5 Months,89.9,83.7 to 93.9,227
Hep B,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,5 Months,86.1,83.7 to 88.1,470
Hep B,≥2 Doses,States/Local Areas,Tennessee,2011,Age,5 Months,89.0,84.6 to 92.3,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2012,Age,5 Months,88.3,85.5 to 90.5,256
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,78.8,71.2 to 86.5,342
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2011,Age,0-1 Days,67.0,63.5 to 70.4,256
Hep B,≥1 Dose,States/Local Areas,Tennessee,2018,Age,3 Months,98.9,97.4 to 99.6,410
Hep B,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,3 Months,98.0,96.4 to 98.9,806
Polio,≥2 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,89.9,83.0 to 94.2,243
Polio,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,93.3,89.6 to 95.7,484
Hep B,≥1 Dose,States/Local Areas,Tennessee,2019,Age,3 Months,97.0,94.0 to 98.6,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,94.6,93.3 to 95.6,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,93.6,90.3 to 95.8,410
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,90.5,87.4 to 93.0,806
Hep B,≥3 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,87.8,85.0 to 90.2,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,87.5,81.8 to 91.5,396
≥1 Dose MMR,,States/Local Areas,Tennessee,2011,Age,19 Months,85.2,79.1 to 89.8,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,78.1,62.3 to 93.9,41
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.4,55.7 to 85.1,61
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,73.3,66.5 to 80.1,331
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,85.8,81.2 to 90.4,430
DTaP,≥4 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,83.4,77.0 to 88.9,396
DTaP,≥4 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,88.6,83.0 to 93.0,410
DTaP,≥4 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,86.0,81.8 to 89.7,806
≥1 Dose MMR,,States/Local Areas,Tennessee,2012,Age,19 Months,88.5,82.4 to 92.7,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2013,Age,19 Months,87.0,81.6 to 91.1,227
≥1 Dose MMR,,States/Local Areas,Tennessee,2013-2014,Age,19 Months,82.8,80.5 to 84.8,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017,Age,19 Months,85.4,78.3 to 90.4,305
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017-2018,Age,19 Months,88.3,84.3 to 91.4,715
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018,Age,19 Months,91.2,86.8 to 94.3,410
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018-2019,Age,19 Months,58.0,53.1 to 62.7,806
Hep B,≥1 Dose,States/Local Areas,Tennessee,2017,Age,3 Months,97.8,95.1 to 99.0,305
Hep B,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,3 Months,98.4,97.0 to 99.1,715
Polio,≥2 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,94.7,90.4 to 97.1,218
Polio,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,94.1,90.7 to 96.3,523
Polio,≥2 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,96.7,93.6 to 98.3,241
Polio,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,95.7,93.3 to 97.3,459
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016,Age,19 Months,88.0,81.3 to 92.5,218
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2017,Age,19 Months,86.7,82.0 to 90.2,523
≥1 Dose MMR,,States/Local Areas,Tennessee,2019,Age,13 Months,68.4,61.6 to 74.4,396
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,88.1,81.9 to 94.4,189
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,78.3,71.7 to 84.9,342
PCV,≥3 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,69.9,62.7 to 76.3,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,68.0,59.7 to 75.3,243
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,65.9,59.8 to 71.4,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,91.0,84.3 to 95.0,218
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,90.9,86.5 to 93.9,523
PCV,≥3 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,68.4,62.1 to 74.1,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,69.8,63.2 to 75.7,227
PCV,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,68.9,62.8 to 74.4,470
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2012,Age,0-1 Days,77.5,75.6 to 79.3,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2014,Age,5 Months,82.3,74.7 to 87.9,243
Hep B,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,5 Months,86.7,80.3 to 91.3,484
Hep B,≥2 Doses,States/Local Areas,Tennessee,2016,Age,5 Months,89.7,83.6 to 93.7,218
Hep B,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,5 Months,89.1,84.9 to 92.2,523
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,90.7,84.3 to 94.7,305
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,93.5,90.1 to 95.7,715
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,96.2,93.3 to 97.9,410
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,90.5,87.4 to 93.0,806
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,91.1,86.9 to 95.4,298
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,76.3,61.7 to 91.0,134
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,82.4,74.2 to 90.6,413
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.0,77.1 to 88.9,564
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.4,66.5 to 84.3,268
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,88.8,79.8 to 97.7,148
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,77.3,67.2 to 87.5,331
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,88.2,82.7 to 93.8,430
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.7,56.1 to 95.4,61
Hep B,≥2 Doses,States/Local Areas,Tennessee,2015,Age,5 Months,91.2,85.7 to 94.7,241
Hep B,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,5 Months,90.5,86.6 to 93.3,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2014,Age,0-1 Days,58.5,50.1 to 66.4,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2014-2015,Age,0-1 Days,63.7,57.9 to 69.2,484
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2013,Age,0-1 Days,63.8,58.0 to 69.3,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2013-2014,Age,0-1 Days,61.1,56.6 to 65.5,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013,Age,24 Months,89.8,83.4 to 94.5,227
≥1 Dose Varicella,,States/Local Areas,Tennessee,2013-2014,Age,24 Months,87.1,82.7 to 90.8,470
Polio,≥2 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,93.6,87.5 to 96.8,305
Polio,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,95.0,91.9 to 97.0,715
Polio,≥2 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,96.5,93.8 to 98.0,410
Polio,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,94.2,91.3 to 96.1,806
Polio,≥2 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,91.8,86.6 to 95.2,396
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019,Age,19 Months,85.8,79.8 to 90.2,396
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017,Age,24 Months,88.7,82.6 to 93.4,305
≥1 Dose Varicella,,States/Local Areas,Tennessee,2017-2018,Age,24 Months,92.1,88.8 to 94.7,715
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019,Age,24 Months,90.8,85.8 to 94.6,396
≥1 Dose MMR,,States/Local Areas,Tennessee,2013,Age,24 Months,89.4,83.0 to 94.1,227
≥1 Dose MMR,,States/Local Areas,Tennessee,2013-2014,Age,24 Months,85.8,81.1 to 89.9,470
≥1 Dose MMR,,States/Local Areas,Tennessee,2014,Age,24 Months,82.3,75.0 to 88.5,243
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2015,Age,24 Months,87.4,83.1 to 91.0,484
≥1 Dose MMR,,States/Local Areas,Tennessee,2015,Age,24 Months,92.4,88.2 to 95.5,241
≥1 Dose MMR,,States/Local Areas,Tennessee,2015-2016,Age,24 Months,92.0,88.6 to 94.7,459
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018,Age,24 Months,95.5,92.7 to 97.4,410
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018-2019,Age,24 Months,93.2,90.5 to 95.4,806
PCV,≥4 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,72.6,63.7 to 80.0,218
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,74.0,68.1 to 79.1,523
PCV,≥4 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,79.7,74.2 to 84.2,241
PCV,≥4 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,76.2,70.7 to 81.0,459
PCV,≥4 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,75.8,68.1 to 82.1,243
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,77.7,72.7 to 82.1,484
PCV,≥3 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,63.7,54.8 to 71.8,241
PCV,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,67.6,61.4 to 73.2,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2017,Age,7 Months,68.4,60.4 to 75.5,305
PCV,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,7 Months,69.2,63.9 to 74.1,715
Hep B,≥3 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,95.9,92.5 to 98.0,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2016,Age,7 Months,71.6,62.9 to 78.9,218
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,7 Months,70.0,64.2 to 75.2,523
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,94.2,89.9 to 97.1,227
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,90.4,86.6 to 93.5,470
Hep B,≥3 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,90.4,84.6 to 94.6,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,90.8,85.5 to 94.3,396
Hep B,≥2 Doses,States/Local Areas,Tennessee,2013,Age,7 Months,95.5,93.8 to 96.7,227
Hep B,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,7 Months,91.4,87.4 to 94.2,470
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2012,Age,0-2 Days,78.8,76.6 to 80.8,256
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2013,Age,0-2 Days,65.7,60.0 to 71.1,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2013-2014,Age,0-2 Days,63.3,59.5 to 67.0,470
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2018,Age,0-1 Days,72.2,65.5 to 78.1,410
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2018-2019,Age,0-1 Days,71.1,66.5 to 75.3,806
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2011,Age,0-2 Days,71.2,66.4 to 75.5,256
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2019,Age,0-1 Days,69.9,63.5 to 75.6,396
Hep B,≥2 Doses,States/Local Areas,Tennessee,2012,Age,7 Months,93.9,90.3 to 96.3,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2014,Age,7 Months,87.3,80.3 to 92.1,243
Hep B,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,7 Months,91.9,88.1 to 94.5,484
PCV,≥3 Doses,States/Local Areas,Tennessee,2018,Age,7 Months,69.9,63.1 to 76.0,410
PCV,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,7 Months,70.4,65.6 to 74.7,806
PCV,≥3 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,90.1,87.6 to 92.1,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,70.8,63.9 to 76.8,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,86.5,80.3 to 91.6,243
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,91.7,88.2 to 94.4,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,96.8,94.1 to 98.5,241
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,94.6,91.5 to 96.8,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,92.3,86.5 to 96.3,218
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,92.4,88.6 to 95.3,523
PCV,≥3 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,89.2,83.3 to 93.2,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2011,Age,7 Months,91.8,88.5 to 94.2,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2016,Age,24 Months,91.6,85.8 to 95.6,218
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2017,Age,24 Months,89.7,85.5 to 93.2,523
≥1 Dose MMR,,States/Local Areas,Tennessee,2017,Age,24 Months,88.0,81.4 to 93.1,305
≥1 Dose MMR,,States/Local Areas,Tennessee,2017-2018,Age,24 Months,92.0,88.4 to 94.8,715
PCV,≥4 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,75.3,67.2 to 81.9,305
PCV,≥4 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,78.3,73.2 to 82.6,715
PCV,≥4 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,81.2,75.4 to 86.0,410
PCV,≥4 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,82.2,77.5 to 86.1,651
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2015,Age,0-2 Days,71.9,64.1 to 78.7,241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2015-2016,Age,0-2 Days,71.3,65.7 to 76.2,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2014,Age,0-2 Days,60.9,52.5 to 68.7,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2014-2015,Age,0-2 Days,66.4,60.6 to 71.7,484
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016,Age,24 Months,90.9,85.2 to 95.0,218
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2017,Age,24 Months,89.8,85.8 to 93.1,523
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015,Age,24 Months,94.2,90.4 to 96.9,241
≥1 Dose Varicella,,States/Local Areas,Tennessee,2015-2016,Age,24 Months,92.6,89.3 to 95.1,459
≥1 Dose MMR,,States/Local Areas,Tennessee,2011,Age,24 Months,91.2,86.3 to 94.9,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,76.9,71.5 to 81.6,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,80.1,77.5 to 82.5,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,79.7,72.4 to 85.5,227
PCV,≥4 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,77.7,72.0 to 82.6,470
≥1 Dose MMR,,States/Local Areas,Tennessee,2018,Age,19 Months,91.4,87.0 to 94.4,410
≥1 Dose MMR,,States/Local Areas,Tennessee,2018-2019,Age,19 Months,93.9,91.0 to 96.0,806
≥1 Dose MMR,,States/Local Areas,Tennessee,2019,Age,19 Months,84.6,78.4 to 89.2,396
≥1 Dose MMR,,States/Local Areas,Tennessee,2017,Age,19 Months,84.8,77.4 to 90.1,305
≥1 Dose MMR,,States/Local Areas,Tennessee,2017-2018,Age,19 Months,88.1,83.9 to 91.3,715
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2017,Age,0-1 Days,70.5,63.1 to 76.9,305
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2017-2018,Age,0-1 Days,71.3,66.4 to 75.8,715
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2016,Age,0-1 Days,67.3,58.9 to 74.7,218
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2016-2017,Age,0-1 Days,68.9,63.4 to 73.9,523
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014,Age,24 Months,84.3,77.8 to 89.7,243
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2015,Age,24 Months,89.2,85.5 to 92.3,484
Hep B,≥2 Doses,States/Local Areas,Tennessee,2017,Age,5 Months,88.5,82.0 to 92.8,305
Hep B,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,5 Months,91.0,87.4 to 93.7,715
Hep B,≥2 Doses,States/Local Areas,Tennessee,2019,Age,5 Months,87.5,81.8 to 91.6,396
Hep B,≥2 Doses,States/Local Areas,Tennessee,2018,Age,5 Months,93.6,89.7 to 96.1,410
Hep B,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,5 Months,90.6,87.2 to 93.1,806
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2015,Age,0-1 Days,69.0,61.0 to 76.0,241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2015-2016,Age,0-1 Days,68.2,62.5 to 73.4,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2015,Age,13 Months,91.7,86.4 to 95.0,241
PCV,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,13 Months,91.3,87.5 to 94.0,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2014,Age,13 Months,83.2,75.6 to 88.8,243
PCV,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,13 Months,87.4,83.0 to 90.9,484
Hep B,≥2 Doses,States/Local Areas,Tennessee,2015,Age,7 Months,96.4,93.3 to 98.1,241
Hep B,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,7 Months,94.0,90.9 to 96.1,459
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,96.5,93.8 to 98.2,410
Hep B,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,94.3,91.7 to 96.3,806
≥1 Dose MMR,,States/Local Areas,Tennessee,2013,Age,35 Months,90.7,84.1 to 95.3,227
≥1 Dose MMR,,States/Local Areas,Tennessee,2013-2014,Age,35 Months,89.5,84.6 to 93.4,470
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016,Age,35 Months,95.2,89.9 to 98.2,218
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2017,Age,35 Months,93.3,89.5 to 96.0,523
≥1 Dose MMR,,States/Local Areas,Tennessee,2012,Age,35 Months,97.0,92.9 to 99.1,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2011,Age,35 Months,95.0,89.8 to 98.0,256
≥1 Dose MMR,,States/Local Areas,Tennessee,2018,Age,24 Months,95.9,93.1 to 97.7,410
≥1 Dose MMR,,States/Local Areas,Tennessee,2018-2019,Age,24 Months,92.8,89.9 to 95.1,806
≥1 Dose MMR,,States/Local Areas,Tennessee,2019,Age,24 Months,89.5,84.3 to 93.5,396
PCV,≥4 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,84.1,77.0 to 90.0,227
PCV,≥4 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,82.0,77.0 to 86.4,470
PCV,≥4 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,79.7,72.5 to 86.0,243
PCV,≥4 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,81.3,76.6 to 85.6,484
PCV,≥4 Doses,States/Local Areas,Tennessee,2012,Age,24 Months,83.2,76.3 to 89.0,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,92.4,87.7 to 95.8,256
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,92.5,87.2 to 96.2,305
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,94.5,91.6 to 96.6,715
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,92.2,87.5 to 95.6,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,92.3,86.5 to 96.3,218
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,94.3,90.7 to 96.9,523
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,96.8,94.1 to 98.5,241
Hep B,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,94.6,91.5 to 96.8,459
PCV,≥3 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,96.5,95.4 to 97.4,227
PCV,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,92.0,89.7 to 93.9,470
PCV,≥3 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,92.8,90.2 to 94.7,256
PCV,≥3 Doses,States/Local Areas,Tennessee,2019,Age,13 Months,86.7,80.7 to 91.0,396
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,95.3,90.2 to 98.2,305
Hep B,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,95.8,93.1 to 97.7,715
PCV,≥3 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,94.8,91.7 to 96.8,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,87.5,80.4 to 92.9,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,87.3,80.7 to 92.4,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,83.5,77.8 to 88.5,396
PCV,≥4 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,85.2,80.1 to 89.6,410
PCV,≥4 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,84.4,80.7 to 87.8,806
PCV,≥3 Doses,States/Local Areas,Tennessee,2016,Age,13 Months,90.9,84.8 to 94.7,218
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,13 Months,88.9,84.4 to 92.2,523
Hib,Full Series,States/Local Areas,Tennessee,2020,Age,24 Months,76.5,69.7 to 82.7,363
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,94.5,90.1 to 97.4,227
Hep B,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,91.3,87.4 to 94.4,470
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,88.0,81.4 to 93.0,243
Hep B,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,92.4,88.8 to 95.1,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,95.9,92.5 to 98.0,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2012,Age,13 Months,97.7,95.9 to 98.7,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2011,Age,13 Months,95.5,91.6 to 97.6,256
Hep B,≥2 Doses,States/Local Areas,Tennessee,2019,Age,7 Months,92.1,87.0 to 95.3,396
PCV,≥3 Doses,States/Local Areas,Tennessee,2017,Age,13 Months,86.9,79.7 to 91.7,305
PCV,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,13 Months,87.9,83.4 to 91.3,715
PCV,≥3 Doses,States/Local Areas,Tennessee,2018,Age,13 Months,88.9,83.7 to 92.6,410
PCV,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,13 Months,87.8,84.0 to 90.8,806
PCV,≥4 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,76.7,68.4 to 84.1,218
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,77.4,71.9 to 82.6,523
PCV,≥4 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,78.1,70.5 to 84.9,305
PCV,≥4 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,81.7,76.9 to 86.0,715
≥1 Dose MMR,,States/Local Areas,Tennessee,2015,Age,35 Months,93.6,89.4 to 96.5,241
≥1 Dose MMR,,States/Local Areas,Tennessee,2015-2016,Age,35 Months,94.4,90.9 to 96.8,459
≥1 Dose MMR,,States/Local Areas,Tennessee,2014,Age,35 Months,87.9,80.2 to 93.6,243
≥1 Dose MMR,,States/Local Areas,Tennessee,2014-2015,Age,35 Months,90.5,86.3 to 93.8,484
≥1 Dose MMR,,States/Local Areas,Tennessee,2016,Age,35 Months,95.3,89.9 to 98.3,218
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2017,Age,35 Months,92.2,88.1 to 95.2,523
PCV,≥4 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,82.9,76.7 to 88.2,241
PCV,≥4 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,79.8,74.7 to 84.5,459
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018,Age,35 Months,96.4,93.6 to 98.2,410
≥1 Dose Varicella,,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.8,92.0 to 96.9,806
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,87.6,83.0 to 92.2,331
≥1 Dose Varicella,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,93.9,91.3 to 96.4,430
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019,Age,35 Months,93.1,87.8 to 96.7,396
Hep B,≥3 Doses,States/Local Areas,Alaska,2017,Age,13 Months,85.4,79.5 to 89.8,258
Hep B,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,86.7,82.8 to 89.7,533
Hep B,≥3 Doses,States/Local Areas,Alaska,2016,Age,13 Months,85.7,78.7 to 90.7,228
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,85.6,81.1 to 89.1,486
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,69.2,61.6 to 76.7,357
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,79.8,73.6 to 86.0,458
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,64.0,44.8 to 83.3,61
Polio,≥2 Doses,States/Local Areas,Alaska,2019,Age,7 Months,84.8,77.9 to 89.8,287
DTaP,≥4 Doses,States/Local Areas,Alaska,2017,Age,24 Months,71.3,63.9 to 78.3,258
DTaP,≥4 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,74.1,69.2 to 78.7,533
Hep A,≥2 Doses,States/Local Areas,Alaska,2014,Age,35 Months,77.9,70.3 to 84.6,275
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,73.8,68.0 to 79.4,532
DTaP,≥4 Doses,States/Local Areas,Alaska,2016,Age,24 Months,77.0,69.6 to 83.6,228
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,74.4,69.2 to 79.3,486
DTaP,≥4 Doses,States/Local Areas,Alaska,2015,Age,24 Months,71.6,64.6 to 78.2,257
DTaP,≥4 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,74.3,69.3 to 79.1,485
Hep A,≥2 Doses,States/Local Areas,Alaska,2013,Age,35 Months,64.6,55.5 to 73.5,303
Hep A,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,71.9,65.9 to 77.6,578
Hep A,≥2 Doses,States/Local Areas,Alaska,2012,Age,35 Months,85.6,76.5 to 92.6,273
Hep A,≥2 Doses,States/Local Areas,Alaska,2011,Age,35 Months,84.8,74.3 to 92.6,288
Hep A,≥2 Doses,States/Local Areas,Alaska,2019,Age,24 Months,34.1,27.1 to 42.2,287
Polio,≥2 Doses,States/Local Areas,Alaska,2018,Age,5 Months,68.8,61.7 to 75.2,275
Polio,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,5 Months,71.8,66.8 to 76.4,562
Hep B,≥3 Doses,States/Local Areas,Alaska,2016,Age,7 Months,72.5,64.6 to 79.2,228
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,73.8,68.5 to 78.5,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2015,Age,7 Months,78.4,72.2 to 83.5,257
Hep B,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,75.4,70.4 to 79.7,485
Hep B,≥3 Doses,States/Local Areas,Alaska,2014,Age,7 Months,72.6,65.7 to 78.5,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,75.4,70.9 to 79.5,532
Polio,≥2 Doses,States/Local Areas,Alaska,2017,Age,5 Months,70.9,63.4 to 77.5,258
Polio,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,5 Months,69.9,64.8 to 74.6,533
Polio,≥2 Doses,States/Local Areas,Alaska,2016,Age,5 Months,68.8,60.7 to 75.9,228
Polio,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,5 Months,69.8,64.3 to 74.8,486
Hep A,≥1 Dose,States/Local Areas,Alaska,2018,Age,35 Months,90.3,85.0 to 94.2,275
Hep A,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,35 Months,87.8,83.1 to 91.7,562
≥1 Dose Varicella,,States/Local Areas,Alaska,2011,Age,13 Months,34.0,26.0 to 43.1,288
Hep A,≥2 Doses,States/Local Areas,Alaska,2018,Age,24 Months,40.3,33.2 to 48.2,275
Hep A,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,37.3,32.2 to 42.9,562
DTaP,≥4 Doses,States/Local Areas,Alaska,2014,Age,24 Months,75.2,68.9 to 81.0,275
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,73.3,68.7 to 77.7,532
Hep A,≥2 Doses,States/Local Areas,Alaska,2017,Age,24 Months,27.2,21.0 to 34.8,258
Hep A,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,33.5,28.6 to 38.9,533
Hep A,≥2 Doses,States/Local Areas,Alaska,2016,Age,24 Months,42.6,34.3 to 51.9,228
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,35.4,29.9 to 41.6,486
DTaP,≥4 Doses,States/Local Areas,Alaska,2013,Age,24 Months,70.6,63.7 to 77.3,303
DTaP,≥4 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,72.9,68.2 to 77.4,578
DTaP,≥4 Doses,States/Local Areas,Alaska,2012,Age,24 Months,78.4,71.8 to 84.5,273
DTaP,≥4 Doses,States/Local Areas,Alaska,2011,Age,24 Months,77.9,71.1 to 84.0,288
DTaP,≥4 Doses,States/Local Areas,Alaska,2019,Age,19 Months,64.3,56.6 to 71.4,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2013,Age,7 Months,75.3,69.5 to 80.3,303
Hep B,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,73.9,70.7 to 76.9,578
Hep B,≥3 Doses,States/Local Areas,Alaska,2012,Age,7 Months,76.9,71.9 to 81.2,273
Hep B,≥3 Doses,States/Local Areas,Alaska,2011,Age,7 Months,73.1,70.2 to 75.9,288
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,92.9,89.6 to 96.2,283
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,91.7,88.7 to 94.7,404
Polio,≥2 Doses,States/Local Areas,Alaska,2015,Age,5 Months,73.0,66.3 to 78.8,257
Polio,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,5 Months,70.9,65.6 to 75.6,485
Polio,≥2 Doses,States/Local Areas,Alaska,2014,Age,5 Months,66.6,59.6 to 73.0,275
Polio,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,5 Months,69.8,65.4 to 73.9,532
Polio,≥2 Doses,States/Local Areas,Alaska,2013,Age,5 Months,73.0,68.0 to 77.5,303
Polio,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,5 Months,69.8,66.2 to 73.1,578
Polio,≥2 Doses,States/Local Areas,Alaska,2012,Age,5 Months,73.6,67.7 to 78.8,273
Hep A,≥1 Dose,States/Local Areas,Alaska,2015,Age,35 Months,88.0,81.7 to 92.9,257
Hep A,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,35 Months,88.1,83.9 to 91.7,485
Hep A,≥1 Dose,States/Local Areas,Alaska,2017,Age,35 Months,85.6,79.1 to 90.9,258
Hep A,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,35 Months,88.1,84.0 to 91.5,533
Hep A,≥1 Dose,States/Local Areas,Alaska,2016,Age,35 Months,88.6,82.6 to 93.2,228
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,35 Months,87.1,82.9 to 90.7,486
Hep A,≥1 Dose,States/Local Areas,Alaska,2014,Age,35 Months,88.4,83.3 to 92.5,275
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,35 Months,88.3,84.3 to 91.7,532
Hep A,≥1 Dose,States/Local Areas,Alaska,2013,Age,35 Months,90.0,82.5 to 95.2,303
Hep A,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,35 Months,89.0,84.6 to 92.6,578
Hib,≥3 Doses,States/Local Areas,Alaska,2019,Age,35 Months,86.8,79.1 to 92.8,287
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,89.6,87.2 to 92.0,905
Hep A,≥2 Doses,States/Local Areas,Alaska,2015,Age,24 Months,34.1,27.1 to 42.3,257
Hep A,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,38.3,32.8 to 44.5,485
Hep A,≥2 Doses,States/Local Areas,Alaska,2014,Age,24 Months,35.2,28.8 to 42.5,275
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,34.7,29.9 to 40.1,532
Hep A,≥2 Doses,States/Local Areas,Alaska,2013,Age,24 Months,32.6,26.5 to 39.7,303
Hep A,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,34.0,29.4 to 39.0,578
DTaP,≥4 Doses,States/Local Areas,Alaska,2018,Age,19 Months,66.0,59.0 to 72.4,275
DTaP,≥4 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,90.9,87.2 to 93.6,562
DTaP,≥4 Doses,States/Local Areas,Alaska,2017,Age,19 Months,56.9,49.4 to 64.1,258
DTaP,≥4 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,61.4,56.3 to 66.3,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,83.7,77.6 to 89.8,218
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,86.0,81.3 to 90.7,255
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.1,85.6 to 94.6,187
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,87.7 to 94.7,463
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.7,85.4 to 91.9,481
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.7,85.3 to 94.0,306
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,94.2,89.4 to 99.1,97
Polio,≥2 Doses,States/Local Areas,Alaska,2011,Age,5 Months,73.5,69.7 to 76.9,288
PCV,≥2 Doses,States/Local Areas,Alaska,2019,Age,5 Months,74.3,67.0 to 80.5,287
PCV,≥2 Doses,States/Local Areas,Alaska,2018,Age,5 Months,68.3,61.2 to 74.7,275
PCV,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,5 Months,71.3,66.2 to 75.9,562
Hep B,≥2 Doses,States/Local Areas,Alaska,2016,Age,5 Months,83.7,76.4 to 89.0,228
Hep B,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,5 Months,84.2,79.4 to 88.0,486
Hep B,≥2 Doses,States/Local Areas,Alaska,2015,Age,5 Months,83.2,77.6 to 87.7,257
Hep B,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,5 Months,83.4,79.0 to 87.1,485
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2015,Age,0-1 Days,66.0,58.5 to 72.8,257
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2015-2016,Age,0-1 Days,64.4,59.0 to 69.5,485
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2014,Age,0-1 Days,61.6,54.5 to 68.2,275
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2014-2015,Age,0-1 Days,63.8,58.7 to 68.6,532
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2013,Age,0-1 Days,61.3,54.4 to 67.7,303
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2013-2014,Age,0-1 Days,61.4,57.1 to 65.5,578
Polio,≥2 Doses,States/Local Areas,Alaska,2019,Age,13 Months,89.9,83.7 to 93.9,287
Polio,≥2 Doses,States/Local Areas,Alaska,2018,Age,13 Months,91.9,87.1 to 95.0,275
Polio,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,90.9,87.2 to 93.6,562
≥1 Dose Varicella,,States/Local Areas,Alaska,2014,Age,24 Months,86.4,81.3 to 90.7,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2015,Age,24 Months,83.8,79.9 to 87.2,532
≥1 Dose Varicella,,States/Local Areas,Alaska,2013,Age,24 Months,79.7,73.3 to 85.4,303
≥1 Dose Varicella,,States/Local Areas,Alaska,2013-2014,Age,24 Months,83.1,79.0 to 86.8,578
≥1 Dose Varicella,,States/Local Areas,Alaska,2012,Age,24 Months,85.6,80.1 to 90.3,273
≥1 Dose Varicella,,States/Local Areas,Alaska,2011,Age,24 Months,87.5,81.9 to 92.1,288
≥1 Dose MMR,,States/Local Areas,Alaska,2017,Age,19 Months,83.7,77.6 to 88.4,258
≥1 Dose MMR,,States/Local Areas,Alaska,2017-2018,Age,19 Months,84.8,80.7 to 88.2,533
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,67.2,59.9 to 74.6,218
≥1 Dose MMR,,States/Local Areas,Alaska,2016,Age,19 Months,82.5,75.5 to 87.8,228
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2017,Age,19 Months,83.1,78.6 to 86.8,486
≥1 Dose MMR,,States/Local Areas,Alaska,2015,Age,19 Months,79.1,74.5 to 83.0,257
≥1 Dose MMR,,States/Local Areas,Alaska,2015-2016,Age,19 Months,80.8,76.2 to 84.7,485
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,73.2,69.6 to 76.8,905
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,68.2,61.4 to 75.1,255
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,64.6,56.3 to 72.9,187
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,79.6,74.8 to 84.3,463
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.8,69.0 to 78.6,481
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,63.2 to 75.8,306
PCV,≥3 Doses,States/Local Areas,Alaska,2011,Age,7 Months,51.7,48.3 to 55.2,288
Hep B,≥3 Doses,States/Local Areas,Alaska,2016,Age,19 Months,88.1,81.5 to 92.6,228
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,88.6,84.5 to 91.7,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2015,Age,19 Months,88.0,83.1 to 91.7,257
Hep B,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,88.1,84.2 to 91.1,485
Hep B,≥3 Doses,States/Local Areas,Alaska,2014,Age,19 Months,89.8,85.0 to 93.1,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,88.9,85.7 to 91.5,532
Hep B,≥2 Doses,States/Local Areas,Alaska,2014,Age,5 Months,83.9,78.1 to 88.4,275
Hep B,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,5 Months,83.6,81.6 to 85.4,532
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,82.3,75.7 to 89.0,283
Hep B,≥2 Doses,States/Local Areas,Alaska,2013,Age,5 Months,84.6,78.0 to 89.5,303
Hep B,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,5 Months,84.3,80.4 to 87.5,578
Hep B,≥2 Doses,States/Local Areas,Alaska,2012,Age,5 Months,82.6,78.5 to 86.1,273
Hep B,≥2 Doses,States/Local Areas,Alaska,2011,Age,5 Months,86.5,83.9 to 88.7,288
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,72.2,64.0 to 80.3,404
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2012,Age,0-1 Days,53.0,44.9 to 60.9,273
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2011,Age,0-1 Days,54.4,50.8 to 58.0,288
Hep B,≥1 Dose,States/Local Areas,Alaska,2019,Age,3 Months,95.9,91.7 to 98.0,287
≥1 Dose Varicella,,States/Local Areas,Alaska,2019,Age,19 Months,75.9,68.6 to 82.0,287
Hep B,≥1 Dose,States/Local Areas,Alaska,2018,Age,3 Months,91.5,86.6 to 94.8,275
Hep B,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,3 Months,93.7,90.6 to 95.7,562
Polio,≥2 Doses,States/Local Areas,Alaska,2017,Age,13 Months,87.1,81.6 to 91.2,258
Polio,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,89.5,86.0 to 92.2,533
Polio,≥2 Doses,States/Local Areas,Alaska,2016,Age,13 Months,88.5,81.9 to 92.9,228
Polio,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,87.9,83.7 to 91.1,486
Polio,≥2 Doses,States/Local Areas,Alaska,2015,Age,13 Months,89.5,85.0 to 92.8,257
Polio,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,89.0,85.2 to 91.9,485
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,83.0,74.6 to 91.4,97
≥1 Dose Varicella,,States/Local Areas,Alaska,2018,Age,19 Months,77.0,70.1 to 82.7,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2018-2019,Age,19 Months,38.0,33.0 to 43.1,562
≥1 Dose Varicella,,States/Local Areas,Alaska,2017,Age,19 Months,73.4,66.0 to 79.6,258
≥1 Dose Varicella,,States/Local Areas,Alaska,2017-2018,Age,19 Months,75.2,70.2 to 79.5,533
≥1 Dose MMR,,States/Local Areas,Alaska,2014,Age,19 Months,84.2,78.7 to 88.6,275
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2015,Age,19 Months,81.7,77.5 to 85.2,532
≥1 Dose MMR,,States/Local Areas,Alaska,2012,Age,19 Months,83.0,79.0 to 86.3,273
≥1 Dose MMR,,States/Local Areas,Alaska,2013,Age,19 Months,79.6,75.4 to 83.2,303
≥1 Dose MMR,,States/Local Areas,Alaska,2013-2014,Age,19 Months,81.9,78.1 to 85.2,578
≥1 Dose MMR,,States/Local Areas,Alaska,2011,Age,19 Months,80.2,75.4 to 84.3,288
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,62.7,47.6 to 77.8,61
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,67.4,61.5 to 73.3,357
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,81.6,77.4 to 85.7,458
DTaP,≥4 Doses,States/Local Areas,Alaska,2019,Age,35 Months,81.7,74.1 to 88.2,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2015,Age,0-2 Days,66.7,59.1 to 73.4,257
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2015-2016,Age,0-2 Days,67.3,62.0 to 72.2,485
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2014,Age,0-2 Days,65.3,58.2 to 71.7,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2014-2015,Age,0-2 Days,66.0,60.9 to 70.7,532
Hib,Primary Series,States/Local Areas,Alaska,2020,Age,24 Months,87.9,82.4 to 92.3,302
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2017,Age,0-1 Days,69.0,61.6 to 75.6,258
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2017-2018,Age,0-1 Days,66.7,61.6 to 71.4,533
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2016,Age,0-1 Days,62.9,54.9 to 70.3,228
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2016-2017,Age,0-1 Days,65.7,60.3 to 70.8,486
PCV,≥4 Doses,States/Local Areas,Alaska,2017,Age,19 Months,75.2,68.0 to 81.2,258
PCV,≥4 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,73.4,68.4 to 77.8,533
Hep B,≥3 Doses,States/Local Areas,Alaska,2013,Age,19 Months,87.4,82.3 to 91.1,303
Hep B,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,88.6,84.8 to 91.5,578
Hep A,≥1 Dose,States/Local Areas,Alaska,2020,Age,35 Months,89.9,81.8 to 95.4,302
Hep B,≥3 Doses,States/Local Areas,Alaska,2012,Age,19 Months,91.3,88.9 to 93.3,273
Hep B,≥3 Doses,States/Local Areas,Alaska,2011,Age,19 Months,93.1,88.3 to 96.0,288
Hep B,≥3 Doses,States/Local Areas,Alaska,2019,Age,13 Months,86.9,80.4 to 91.5,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2018,Age,13 Months,88.0,82.7 to 91.8,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,87.5,83.5 to 90.6,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,67.0,57.4 to 76.7,218
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,73.2,68.4 to 78.1,905
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,68.1,59.8 to 76.4,255
Hep B,≥1 Dose,States/Local Areas,Alaska,2017,Age,3 Months,92.7,88.1 to 95.6,258
Hep B,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,3 Months,92.1,88.9 to 94.4,533
Hep B,≥1 Dose,States/Local Areas,Alaska,2016,Age,3 Months,92.7,87.4 to 95.9,228
Hep B,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,3 Months,92.7,89.3 to 95.1,486
Hep B,≥1 Dose,States/Local Areas,Alaska,2015,Age,3 Months,92.6,88.6 to 95.3,257
Hep B,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,3 Months,92.7,89.5 to 94.9,485
Polio,≥2 Doses,States/Local Areas,Alaska,2014,Age,13 Months,92.1,88.2 to 94.8,275
Polio,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,90.8,87.9 to 93.0,532
Polio,≥2 Doses,States/Local Areas,Alaska,2013,Age,13 Months,89.2,84.2 to 92.7,303
Polio,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,90.6,87.3 to 93.2,578
Polio,≥2 Doses,States/Local Areas,Alaska,2012,Age,13 Months,92.5,89.1 to 95.0,273
Polio,≥2 Doses,States/Local Areas,Alaska,2011,Age,13 Months,94.6,89.1 to 97.4,288
≥1 Dose Varicella,,States/Local Areas,Alaska,2016,Age,19 Months,78.3,70.8 to 84.3,228
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2017,Age,19 Months,76.0,70.9 to 80.5,486
≥1 Dose Varicella,,States/Local Areas,Alaska,2015,Age,19 Months,72.0,68.1 to 75.6,257
≥1 Dose Varicella,,States/Local Areas,Alaska,2015-2016,Age,19 Months,75.2,70.2 to 79.6,485
≥1 Dose Varicella,,States/Local Areas,Alaska,2014,Age,19 Months,80.3,74.4 to 85.1,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2015,Age,19 Months,76.2,71.7 to 80.1,532
≥1 Dose MMR,,States/Local Areas,Alaska,2019,Age,13 Months,57.0,49.4 to 64.3,287
≥1 Dose MMR,,States/Local Areas,Alaska,2018,Age,13 Months,59.8,52.5 to 66.6,275
≥1 Dose MMR,,States/Local Areas,Alaska,2018-2019,Age,13 Months,58.4,53.2 to 63.5,562
≥1 Dose MMR,,States/Local Areas,Alaska,2017,Age,13 Months,60.0,52.5 to 67.0,258
≥1 Dose MMR,,States/Local Areas,Alaska,2017-2018,Age,13 Months,59.9,54.7 to 64.9,533
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,87.7,83.5 to 91.8,283
Polio,≥2 Doses,States/Local Areas,Alaska,2018,Age,7 Months,81.8,75.3 to 86.9,275
Polio,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,83.3,78.7 to 87.0,562
Polio,≥2 Doses,States/Local Areas,Alaska,2017,Age,7 Months,80.4,73.4 to 86.0,258
Polio,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,81.1,76.5 to 85.0,533
Hep B,≥1 Dose,States/Local Areas,Alaska,2014,Age,3 Months,92.3,87.9 to 95.2,275
Hep B,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,3 Months,92.5,89.6 to 94.6,532
Hep B,≥1 Dose,States/Local Areas,Alaska,2013,Age,3 Months,92.5,87.1 to 95.8,303
Hep B,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,3 Months,92.4,88.8 to 95.0,578
Hep B,≥1 Dose,States/Local Areas,Alaska,2012,Age,3 Months,89.8,86.5 to 92.4,273
Hep B,≥1 Dose,States/Local Areas,Alaska,2011,Age,3 Months,92.9,90.6 to 94.8,288
≥1 Dose Varicella,,States/Local Areas,Alaska,2013,Age,19 Months,73.3,66.2 to 79.3,303
≥1 Dose Varicella,,States/Local Areas,Alaska,2013-2014,Age,19 Months,76.8,70.6 to 82.0,578
≥1 Dose Varicella,,States/Local Areas,Alaska,2012,Age,19 Months,77.7,70.3 to 83.7,273
≥1 Dose Varicella,,States/Local Areas,Alaska,2011,Age,19 Months,77.5,73.0 to 81.5,288
≥1 Dose Varicella,,States/Local Areas,Alaska,2019,Age,13 Months,39.2,31.9 to 46.9,287
≥1 Dose MMR,,States/Local Areas,Alaska,2016,Age,13 Months,52.9,45.1 to 60.5,228
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2017,Age,13 Months,56.2,50.7 to 61.4,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2015,Age,13 Months,84.9,79.3 to 89.2,257
Hep B,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,85.3,81.0 to 88.8,485
≥1 Dose MMR,,States/Local Areas,Alaska,2015,Age,13 Months,42.4,35.2 to 49.9,257
≥1 Dose MMR,,States/Local Areas,Alaska,2015-2016,Age,13 Months,47.7,42.4 to 53.1,485
≥1 Dose MMR,,States/Local Areas,Alaska,2014,Age,13 Months,39.3,32.6 to 46.3,275
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2015,Age,13 Months,40.8,35.9 to 46.0,532
DTaP,≥4 Doses,States/Local Areas,Alaska,2015,Age,35 Months,77.0,69.9 to 83.5,257
DTaP,≥4 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,78.7,73.6 to 83.4,485
DTaP,≥4 Doses,States/Local Areas,Alaska,2012,Age,35 Months,87.5,80.5 to 92.8,273
DTaP,≥4 Doses,States/Local Areas,Alaska,2014,Age,35 Months,82.7,76.2 to 88.2,275
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,79.8,75.0 to 84.1,532
DTaP,≥4 Doses,States/Local Areas,Alaska,2013,Age,35 Months,83.2,76.2 to 89.0,303
DTaP,≥4 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,82.9,78.2 to 87.1,578
Hep A,≥2 Doses,States/Local Areas,Alaska,2019,Age,35 Months,68.7,58.8 to 78.2,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2012,Age,13 Months,88.9,86.7 to 90.8,273
Hep A,≥2 Doses,States/Local Areas,Alaska,2018,Age,35 Months,69.5,61.0 to 77.7,275
Hep A,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,69.3,62.8 to 75.7,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2017,Age,35 Months,70.9,61.9 to 79.3,258
Hep A,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,70.4,64.1 to 76.4,533
Hep B,≥3 Doses,States/Local Areas,Alaska,2014,Age,13 Months,87.9,82.9 to 91.6,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,86.4,82.8 to 89.4,532
Hep B,≥3 Doses,States/Local Areas,Alaska,2013,Age,13 Months,86.3,80.8 to 90.4,303
Hep B,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,87.1,83.4 to 90.1,578
Hep B,≥3 Doses,States/Local Areas,Alaska,2011,Age,13 Months,89.7,87.1 to 91.8,288
Polio,≥2 Doses,States/Local Areas,Alaska,2016,Age,7 Months,80.5,72.9 to 86.5,228
Polio,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,80.5,75.4 to 84.7,486
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,84.0,79.6 to 88.3,404
Polio,≥2 Doses,States/Local Areas,Alaska,2015,Age,7 Months,85.0,79.5 to 89.3,257
Polio,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,82.7,78.1 to 86.6,485
Polio,≥2 Doses,States/Local Areas,Alaska,2014,Age,7 Months,81.7,75.6 to 86.6,275
Polio,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,83.4,79.3 to 86.7,532
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,79.2,72.6 to 85.7,218
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Overall,Overall,83.6,80.6 to 86.5,905
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,78.6,73.0 to 84.2,255
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.4,72.5 to 86.4,187
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,88.1,84.1 to 92.2,463
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.2,79.2 to 87.1,481
≥1 Dose Varicella,,States/Local Areas,Alaska,2018,Age,13 Months,36.8,30.4 to 43.8,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2018-2019,Age,13 Months,38.0,33.0 to 43.1,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,60.8,50.5 to 71.1,187
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,83.6,76.4 to 90.7,463
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.5,67.7 to 81.2,481
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.8,58.5 to 75.1,306
DTaP,≥4 Doses,States/Local Areas,Alaska,2018,Age,35 Months,84.2,77.9 to 89.6,275
DTaP,≥4 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,83.1,78.3 to 87.4,562
DTaP,≥4 Doses,States/Local Areas,Alaska,2017,Age,35 Months,77.8,69.9 to 84.8,258
DTaP,≥4 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,81.1,76.1 to 85.7,533
DTaP,≥4 Doses,States/Local Areas,Alaska,2016,Age,35 Months,80.5,73.1 to 87.0,228
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,79.2,73.9 to 84.0,486
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,89.7,80.9 to 98.6,97
≥1 Dose Varicella,,States/Local Areas,Alaska,2017,Age,13 Months,33.1,26.6 to 40.2,258
≥1 Dose Varicella,,States/Local Areas,Alaska,2017-2018,Age,13 Months,34.9,30.3 to 39.9,533
≥1 Dose Varicella,,States/Local Areas,Alaska,2016,Age,13 Months,39.8,32.4 to 47.6,228
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2017,Age,13 Months,36.7,31.6 to 42.0,486
≥1 Dose MMR,,States/Local Areas,Alaska,2013,Age,13 Months,39.8,36.1 to 43.5,303
≥1 Dose MMR,,States/Local Areas,Alaska,2013-2014,Age,13 Months,39.5,36.6 to 42.5,578
≥1 Dose MMR,,States/Local Areas,Alaska,2012,Age,13 Months,44.0,40.8 to 47.2,273
≥1 Dose MMR,,States/Local Areas,Alaska,2011,Age,13 Months,41.3,34.0 to 49.1,288
DTaP,≥4 Doses,States/Local Areas,Alaska,2011,Age,35 Months,89.0,78.0 to 96.0,288
DTaP,≥4 Doses,States/Local Areas,Alaska,2019,Age,24 Months,75.8,68.4 to 82.6,287
DTaP,≥4 Doses,States/Local Areas,Alaska,2018,Age,24 Months,76.9,70.6 to 82.7,275
DTaP,≥4 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,76.4,71.6 to 80.9,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2016,Age,35 Months,77.3,67.5 to 85.8,228
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,74.3,67.7 to 80.4,486
Hep A,≥2 Doses,States/Local Areas,Alaska,2015,Age,35 Months,69.1,60.2 to 77.7,257
Hep A,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,73.3,66.7 to 79.5,485
Hep B,≥3 Doses,States/Local Areas,Alaska,2019,Age,7 Months,76.8,69.4 to 82.9,287
Polio,≥2 Doses,States/Local Areas,Alaska,2013,Age,7 Months,84.5,80.2 to 88.0,303
Polio,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,83.1,79.8 to 85.9,578
Hep B,≥3 Doses,States/Local Areas,Alaska,2018,Age,7 Months,69.7,62.6 to 76.0,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,73.2,68.1 to 77.7,562
Hep B,≥3 Doses,States/Local Areas,Alaska,2017,Age,7 Months,75.3,68.1 to 81.3,258
Hep B,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,72.5,67.6 to 77.0,533
Polio,≥2 Doses,States/Local Areas,Alaska,2012,Age,7 Months,90.4,85.0 to 94.0,273
Polio,≥2 Doses,States/Local Areas,Alaska,2011,Age,7 Months,89.0,84.9 to 92.1,288
Polio,≥2 Doses,States/Local Areas,Alaska,2019,Age,5 Months,75.0,67.7 to 81.0,287
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.5,78.3 to 88.7,306
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,89.5,83.1 to 95.9,97
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,79.9,67.4 to 92.4,61
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,82.8,78.1 to 87.5,357
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,86.2,82.4 to 89.9,458
Hep A,≥1 Dose,States/Local Areas,Alaska,2019,Age,35 Months,84.9,77.0 to 91.3,287
≥1 Dose Varicella,,States/Local Areas,Alaska,2015,Age,13 Months,29.7,23.1 to 37.2,257
≥1 Dose Varicella,,States/Local Areas,Alaska,2015-2016,Age,13 Months,34.8,29.7 to 40.3,485
≥1 Dose Varicella,,States/Local Areas,Alaska,2012,Age,13 Months,35.3,28.8 to 42.4,273
≥1 Dose Varicella,,States/Local Areas,Alaska,2014,Age,13 Months,30.6,24.4 to 37.5,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2015,Age,13 Months,30.1,25.5 to 35.2,532
≥1 Dose Varicella,,States/Local Areas,Alaska,2013,Age,13 Months,31.3,27.2 to 35.8,303
≥1 Dose Varicella,,States/Local Areas,Alaska,2013-2014,Age,13 Months,31.0,28.7 to 33.4,578
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,83.0,78.6 to 87.5,463
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.7,72.2 to 81.2,481
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.9,70.1 to 81.8,306
PCV,≥1 Dose,States/Local Areas,Alaska,2015,Age,3 Months,84.7,79.1 to 89.0,257
PCV,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,3 Months,84.3,80.0 to 87.9,485
PCV,≥1 Dose,States/Local Areas,Alaska,2014,Age,3 Months,80.9,74.8 to 85.8,275
PCV,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,3 Months,82.8,78.8 to 86.2,532
PCV,≥1 Dose,States/Local Areas,Alaska,2013,Age,3 Months,84.0,77.6 to 88.8,303
PCV,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,3 Months,82.4,78.1 to 86.0,578
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,82.4,72.4 to 92.4,97
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,76.7,62.9 to 90.4,61
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,70.5,64.8 to 76.1,357
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,84.1,80.3 to 87.8,458
PCV,≥3 Doses,States/Local Areas,Alaska,2015,Age,24 Months,89.8,85.6 to 93.2,257
PCV,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,87.7,83.9 to 91.0,485
PCV,≥3 Doses,States/Local Areas,Alaska,2014,Age,24 Months,90.5,86.1 to 93.9,275
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,90.1,87.2 to 92.6,532
PCV,≥3 Doses,States/Local Areas,Alaska,2013,Age,24 Months,85.7,80.1 to 90.4,303
PCV,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,88.1,84.6 to 91.2,578
Hib,≥2 Doses,States/Local Areas,Alaska,2017,Age,5 Months,69.4,61.8 to 76.1,258
Hib,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,5 Months,68.6,63.4 to 73.3,533
Hib,≥2 Doses,States/Local Areas,Alaska,2016,Age,5 Months,70.4,62.4 to 77.4,228
Hib,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,5 Months,70.0,64.5 to 74.9,486
Hib,≥2 Doses,States/Local Areas,Alaska,2015,Age,5 Months,73.6,66.9 to 79.3,257
Hib,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,5 Months,72.0,66.8 to 76.6,485
PCV,≥1 Dose,States/Local Areas,Alaska,2012,Age,3 Months,85.5,82.9 to 87.8,273
PCV,≥1 Dose,States/Local Areas,Alaska,2011,Age,3 Months,87.2,82.6 to 90.7,288
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,88.9,84.9 to 93.0,283
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,86.0,82.0 to 90.0,404
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,81.3,75.0 to 87.5,218
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Overall,Overall,85.3,82.5 to 88.1,905
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,82.3,77.1 to 87.5,255
PCV,≥4 Doses,States/Local Areas,Alaska,2019,Age,35 Months,75.5,67.9 to 82.5,287
PCV,≥4 Doses,States/Local Areas,Alaska,2018,Age,35 Months,76.4,69.6 to 82.6,275
PCV,≥4 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,76.1,71.1 to 80.8,562
PCV,≥4 Doses,States/Local Areas,Alaska,2017,Age,35 Months,76.2,69.3 to 82.5,258
PCV,≥4 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,76.5,71.7 to 81.0,533
PCV,≥3 Doses,States/Local Areas,Alaska,2012,Age,24 Months,91.4,86.7 to 94.9,273
PCV,≥3 Doses,States/Local Areas,Alaska,2011,Age,24 Months,90.7,85.5 to 94.7,288
PCV,≥3 Doses,States/Local Areas,Alaska,2019,Age,19 Months,85.7,78.9 to 90.6,287
PCV,≥3 Doses,States/Local Areas,Alaska,2018,Age,19 Months,86.4,80.5 to 90.7,275
PCV,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,80.4,75.6 to 84.5,562
Hib,≥2 Doses,States/Local Areas,Alaska,2014,Age,5 Months,68.6,61.5 to 74.9,275
Hib,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,5 Months,71.1,66.9 to 74.9,532
Hib,≥2 Doses,States/Local Areas,Alaska,2013,Age,5 Months,71.8,66.7 to 76.4,303
Hib,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,5 Months,70.2,67.0 to 73.2,578
Hib,≥2 Doses,States/Local Areas,Alaska,2012,Age,5 Months,74.8,68.9 to 80.0,273
Hib,≥2 Doses,States/Local Areas,Alaska,2011,Age,5 Months,73.1,68.2 to 77.5,288
Hib,≥1 Dose,States/Local Areas,Alaska,2019,Age,3 Months,85.3,78.5 to 90.1,287
Hib,≥1 Dose,States/Local Areas,Alaska,2018,Age,3 Months,82.1,75.8 to 87.1,275
Hib,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,3 Months,83.7,79.2 to 87.3,562
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,86.4,81.9 to 90.9,283
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.2,72.4 to 86.0,187
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,89.7,85.9 to 93.4,463
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.5,80.7 to 88.3,481
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,80.3 to 90.2,306
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,90.0,83.9 to 96.1,97
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,83.6,79.0 to 88.3,357
PCV,≥4 Doses,States/Local Areas,Alaska,2016,Age,35 Months,79.6,72.5 to 85.8,228
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,78.1,73.2 to 82.6,486
PCV,≥4 Doses,States/Local Areas,Alaska,2015,Age,35 Months,77.6,71.0 to 83.6,257
PCV,≥4 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,78.5,73.7 to 82.9,485
PCV,≥4 Doses,States/Local Areas,Alaska,2014,Age,35 Months,82.7,77.0 to 87.7,275
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,80.2,75.9 to 84.1,532
DTaP,≥3 Doses,States/Local Areas,Alaska,2017,Age,7 Months,62.1,54.6 to 69.1,258
DTaP,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,59.7,54.5 to 64.7,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2016,Age,7 Months,58.4,50.1 to 66.2,228
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,60.1,54.5 to 65.5,486
DTaP,≥3 Doses,States/Local Areas,Alaska,2015,Age,7 Months,64.4,57.1 to 71.0,257
DTaP,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,61.3,55.8 to 66.6,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2018,Age,0-3 Days,67.4,60.3 to 73.7,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2018-2019,Age,0-3 Days,71.9,67.0 to 76.3,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2017,Age,0-3 Days,66.9,56.2 to 76.1,145
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2017-2018,Age,0-3 Days,69.2,64.2 to 73.8,533
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016,Age,0-3 Days,68.8,61.2 to 75.5,228
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2017,Age,0-3 Days,69.8,64.6 to 74.6,486
Polio,≥1 Dose,States/Local Areas,Alaska,2016,Age,3 Months,84.1,76.8 to 89.3,228
Polio,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,3 Months,83.3,78.6 to 87.2,486
Polio,≥1 Dose,States/Local Areas,Alaska,2015,Age,3 Months,85.8,80.5 to 89.8,257
Polio,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,3 Months,84.9,80.6 to 88.4,485
Hib,≥3 Doses,States/Local Areas,Alaska,2013,Age,7 Months,8.9,5.3 to 14.6,303
Hib,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,6.5,5.3 to 8.0,578
Hib,≥3 Doses,States/Local Areas,Alaska,2012,Age,7 Months,8.9,6.1 to 12.8,273
Hib,≥3 Doses,States/Local Areas,Alaska,2011,Age,7 Months,8.8,6.5 to 11.9,288
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,90.7,87.0 to 94.4,283
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,88.8,85.0 to 92.5,404
DTaP,≥3 Doses,States/Local Areas,Alaska,2014,Age,7 Months,59.2,52.1 to 66.0,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,61.8,56.7 to 66.6,532
PCV,≥3 Doses,States/Local Areas,Alaska,2016,Age,35 Months,87.3,80.8 to 92.4,228
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,87.2,83.0 to 90.8,486
PCV,≥3 Doses,States/Local Areas,Alaska,2015,Age,35 Months,90.7,86.3 to 94.1,257
PCV,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,89.0,85.2 to 92.3,485
PCV,≥3 Doses,States/Local Areas,Alaska,2014,Age,35 Months,91.3,87.1 to 94.6,275
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,91.1,88.1 to 93.6,532
Hib,≥2 Doses,States/Local Areas,Alaska,2018,Age,7 Months,80.7,74.1 to 85.9,275
Hib,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,82.4,77.8 to 86.2,562
DTaP,≥3 Doses,States/Local Areas,Alaska,2013,Age,7 Months,60.2,54.9 to 65.2,303
DTaP,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,59.7,56.0 to 63.3,578
DTaP,≥3 Doses,States/Local Areas,Alaska,2012,Age,7 Months,64.3,61.7 to 66.9,273
DTaP,≥3 Doses,States/Local Areas,Alaska,2011,Age,7 Months,54.7,49.4 to 59.9,288
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2015,Age,0-3 Days,68.0,60.6 to 74.7,257
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2015-2016,Age,0-3 Days,68.4,63.2 to 73.3,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014,Age,0-3 Days,67.3,60.2 to 73.6,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2015,Age,0-3 Days,67.7,62.6 to 72.3,532
Polio,≥1 Dose,States/Local Areas,Alaska,2014,Age,3 Months,80.6,74.4 to 85.5,275
Polio,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,3 Months,83.2,79.2 to 86.5,532
Polio,≥1 Dose,States/Local Areas,Alaska,2013,Age,3 Months,84.3,77.8 to 89.2,303
Polio,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,3 Months,82.4,78.5 to 85.8,578
Polio,≥1 Dose,States/Local Areas,Alaska,2012,Age,3 Months,85.8,80.2 to 90.0,273
Polio,≥1 Dose,States/Local Areas,Alaska,2011,Age,3 Months,88.9,83.7 to 92.5,288
PCV,≥1 Dose,States/Local Areas,Alaska,2019,Age,3 Months,84.8,77.9 to 89.9,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,85.9,80.1 to 91.7,218
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,88.4,85.8 to 91.0,905
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,84.4,79.4 to 89.4,255
Hib,≥2 Doses,States/Local Areas,Alaska,2017,Age,7 Months,80.8,73.7 to 86.3,258
Hib,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,80.7,76.0 to 84.6,533
Hib,≥2 Doses,States/Local Areas,Alaska,2019,Age,7 Months,84.3,77.4 to 89.3,287
DTaP,≥3 Doses,States/Local Areas,Alaska,2018,Age,13 Months,87.9,82.5 to 91.9,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,85.6,81.2 to 89.0,562
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.1,82.8 to 93.4,187
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,86.9 to 94.4,463
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.4,82.7 to 90.1,481
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,85.6 to 94.3,306
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,91.5,84.2 to 98.7,97
PCV,≥3 Doses,States/Local Areas,Alaska,2012,Age,35 Months,92.6,87.5 to 96.2,273
PCV,≥3 Doses,States/Local Areas,Alaska,2013,Age,35 Months,94.1,87.8 to 97.8,303
PCV,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,92.3,88.3 to 95.3,578
PCV,≥3 Doses,States/Local Areas,Alaska,2011,Age,35 Months,92.3,87.5 to 95.8,288
PCV,≥3 Doses,States/Local Areas,Alaska,2019,Age,24 Months,86.1,79.8 to 91.3,287
Hib,≥2 Doses,States/Local Areas,Alaska,2016,Age,7 Months,81.7,74.1 to 87.4,228
Hib,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,81.3,76.2 to 85.4,486
Hib,≥2 Doses,States/Local Areas,Alaska,2015,Age,7 Months,84.3,78.8 to 88.6,257
Hib,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,83.0,78.4 to 86.7,485
Hib,≥2 Doses,States/Local Areas,Alaska,2014,Age,7 Months,80.6,74.4 to 85.6,275
Hib,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,82.5,78.4 to 85.9,532
Hib,≥2 Doses,States/Local Areas,Alaska,2013,Age,7 Months,84.3,80.0 to 87.8,303
Hib,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,82.5,79.3 to 85.2,578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2012,Age,0-3 Days,55.3,48.0 to 62.5,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2011,Age,0-3 Days,56.9,49.2 to 64.2,288
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,87.0,82.6 to 91.4,357
PCV,≥1 Dose,States/Local Areas,Alaska,2018,Age,3 Months,81.5,75.1 to 86.6,275
PCV,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,3 Months,83.1,78.6 to 86.9,562
PCV,≥1 Dose,States/Local Areas,Alaska,2017,Age,3 Months,80.1,73.1 to 85.6,258
PCV,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,3 Months,80.8,76.2 to 84.7,533
PCV,≥1 Dose,States/Local Areas,Alaska,2016,Age,3 Months,84.0,76.9 to 89.2,228
PCV,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,3 Months,82.2,77.3 to 86.2,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,90.5,87.5 to 93.5,458
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,85.2,74.0 to 96.4,61
Hep B,≥3 Doses,States/Local Areas,Alaska,2020,Age,24 Months,88.7,82.8 to 93.2,302
PCV,≥3 Doses,States/Local Areas,Alaska,2018,Age,24 Months,87.9,82.6 to 92.1,275
PCV,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,87.0,83.0 to 90.5,562
PCV,≥3 Doses,States/Local Areas,Alaska,2017,Age,24 Months,86.9,81.4 to 91.4,258
PCV,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,87.3,83.6 to 90.5,533
PCV,≥3 Doses,States/Local Areas,Alaska,2016,Age,24 Months,85.7,79.3 to 91.0,228
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,86.2,82.0 to 89.8,486
Hib,≥2 Doses,States/Local Areas,Alaska,2012,Age,7 Months,89.8,82.3 to 94.3,273
Hib,≥2 Doses,States/Local Areas,Alaska,2011,Age,7 Months,88.1,85.1 to 90.6,288
Hib,≥2 Doses,States/Local Areas,Alaska,2019,Age,5 Months,75.3,68.1 to 81.4,287
Hib,≥2 Doses,States/Local Areas,Alaska,2018,Age,5 Months,67.7,60.6 to 74.1,275
Hib,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,5 Months,71.4,66.4 to 76.0,562
Hep B,≥3 Doses,States/Local Areas,Alaska,2019,Age,35 Months,87.9,81.8 to 92.7,287
PCV,≥3 Doses,States/Local Areas,Alaska,2017,Age,19 Months,84.4,78.3 to 89.0,258
PCV,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,85.4,81.3 to 88.7,533
PCV,≥3 Doses,States/Local Areas,Alaska,2016,Age,19 Months,85.7,78.7 to 90.6,228
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,85.1,80.6 to 88.7,486
PCV,≥3 Doses,States/Local Areas,Alaska,2015,Age,19 Months,87.1,82.8 to 90.5,257
PCV,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,86.4,82.3 to 89.7,485
Hep B,≥2 Doses,States/Local Areas,Alaska,2019,Age,13 Months,91.5,85.7 to 95.1,287
Hep B,≥2 Doses,States/Local Areas,Alaska,2018,Age,13 Months,92.9,88.3 to 95.8,275
Hep B,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,92.2,88.8 to 94.7,562
Hep B,≥2 Doses,States/Local Areas,Alaska,2017,Age,13 Months,89.5,84.3 to 93.2,258
Hep B,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,91.2,87.9 to 93.7,533
Hib,≥1 Dose,States/Local Areas,Alaska,2017,Age,3 Months,80.3,73.3 to 85.8,258
Hib,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,3 Months,81.2,76.6 to 85.1,533
Hib,≥1 Dose,States/Local Areas,Alaska,2016,Age,3 Months,84.2,77.1 to 89.4,228
Hib,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,3 Months,82.4,77.6 to 86.4,486
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,84.0,79.8 to 88.3,404
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,77.4,70.5 to 84.2,218
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Overall,Overall,82.7,79.7 to 85.7,905
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,77.4,71.6 to 83.3,255
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.8,67.3 to 82.4,187
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,89.1,85.3 to 92.9,463
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.5,78.4 to 86.6,481
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,87.9,84.6 to 91.2,458
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,82.3,70.5 to 94.0,61
≥1 Dose MMR,,States/Local Areas,Alaska,2019,Age,35 Months,89.4,82.7 to 94.3,287
PCV,≥4 Doses,States/Local Areas,Alaska,2013,Age,35 Months,77.6,71.1 to 83.6,303
PCV,≥4 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,80.3,76.0 to 84.3,578
≥1 Dose MMR,,States/Local Areas,Alaska,2018,Age,35 Months,90.7,85.5 to 94.6,275
≥1 Dose MMR,,States/Local Areas,Alaska,2018-2019,Age,35 Months,90.0,86.0 to 93.2,562
PCV,≥4 Doses,States/Local Areas,Alaska,2012,Age,35 Months,82.7,76.7 to 88.0,273
PCV,≥4 Doses,States/Local Areas,Alaska,2011,Age,35 Months,81.1,74.3 to 87.0,288
PCV,≥4 Doses,States/Local Areas,Alaska,2019,Age,24 Months,73.6,66.2 to 80.5,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2018,Age,35 Months,92.7,88.1 to 96.0,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,90.4,86.7 to 93.4,562
PCV,≥3 Doses,States/Local Areas,Alaska,2012,Age,19 Months,89.7,85.9 to 92.6,273
Hep B,≥3 Doses,States/Local Areas,Alaska,2017,Age,35 Months,90.2,85.3 to 94.0,258
Hep B,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,91.4,88.2 to 94.1,533
Hep B,≥3 Doses,States/Local Areas,Alaska,2016,Age,35 Months,89.1,82.9 to 93.7,228
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,89.6,85.7 to 92.8,486
PCV,≥3 Doses,States/Local Areas,Alaska,2014,Age,19 Months,88.4,83.4 to 92.0,275
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,87.8,84.4 to 90.5,532
PCV,≥3 Doses,States/Local Areas,Alaska,2013,Age,19 Months,84.8,81.4 to 87.7,303
PCV,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,86.6,83.1 to 89.5,578
PCV,≥3 Doses,States/Local Areas,Alaska,2011,Age,19 Months,88.7,84.6 to 91.7,288
PCV,≥3 Doses,States/Local Areas,Alaska,2019,Age,13 Months,80.0,72.6 to 85.8,287
Hep B,≥2 Doses,States/Local Areas,Alaska,2016,Age,13 Months,92.1,86.9 to 95.4,228
Hep B,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,90.9,87.5 to 93.5,486
Hib,≥1 Dose,States/Local Areas,Alaska,2015,Age,3 Months,83.7,77.8 to 88.3,257
Hib,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,3 Months,83.9,79.5 to 87.6,485
Hep B,≥2 Doses,States/Local Areas,Alaska,2015,Age,13 Months,90.1,85.5 to 93.3,257
Hep B,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,91.1,87.9 to 93.5,485
Hep B,≥2 Doses,States/Local Areas,Alaska,2014,Age,13 Months,93.3,89.6 to 95.7,275
Hep B,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,91.7,88.9 to 93.8,532
Hib,≥1 Dose,States/Local Areas,Alaska,2014,Age,3 Months,80.3,74.2 to 85.2,275
Hib,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,3 Months,82.0,77.8 to 85.5,532
Hib,≥1 Dose,States/Local Areas,Alaska,2013,Age,3 Months,83.6,77.2 to 88.5,303
Hib,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,3 Months,81.9,77.5 to 85.7,578
Hib,≥1 Dose,States/Local Areas,Alaska,2012,Age,3 Months,87.0,83.3 to 90.1,273
Hib,≥1 Dose,States/Local Areas,Alaska,2011,Age,3 Months,88.3,85.1 to 91.0,288
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.8,76.4 to 87.3,306
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,87.8,81.1 to 94.5,97
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,78.8,66.2 to 91.5,61
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,79.6,74.5 to 84.7,357
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,87.2,83.8 to 90.5,458
≥1 Dose Varicella,,States/Local Areas,Alaska,2019,Age,35 Months,85.0,77.6 to 91.0,287
≥1 Dose MMR,,States/Local Areas,Alaska,2017,Age,35 Months,86.1,80.3 to 90.8,258
≥1 Dose MMR,,States/Local Areas,Alaska,2017-2018,Age,35 Months,88.5,84.7 to 91.8,533
≥1 Dose MMR,,States/Local Areas,Alaska,2016,Age,35 Months,87.3,81.1 to 92.3,228
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2017,Age,35 Months,86.8,82.6 to 90.4,486
≥1 Dose MMR,,States/Local Areas,Alaska,2015,Age,35 Months,88.1,82.2 to 92.7,257
≥1 Dose MMR,,States/Local Areas,Alaska,2015-2016,Age,35 Months,87.6,83.4 to 91.2,485
PCV,≥4 Doses,States/Local Areas,Alaska,2018,Age,24 Months,74.1,67.3 to 80.4,275
PCV,≥4 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,73.8,68.8 to 78.5,562
PCV,≥4 Doses,States/Local Areas,Alaska,2017,Age,24 Months,76.2,69.3 to 82.5,258
PCV,≥4 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,75.2,70.4 to 79.7,533
PCV,≥4 Doses,States/Local Areas,Alaska,2016,Age,24 Months,78.3,71.3 to 84.7,228
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,77.4,72.5 to 81.9,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2015,Age,35 Months,94.4,89.0 to 97.7,257
Hep B,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,91.4,87.4 to 94.6,485
Hep B,≥3 Doses,States/Local Areas,Alaska,2014,Age,35 Months,92.2,88.2 to 95.2,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,93.2,89.9 to 95.8,532
Hep B,≥3 Doses,States/Local Areas,Alaska,2013,Age,35 Months,87.7,82.3 to 92.1,303
Hep B,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,90.1,86.8 to 92.9,578
PCV,≥3 Doses,States/Local Areas,Alaska,2018,Age,13 Months,80.9,74.2 to 86.1,275
PCV,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,80.4,75.6 to 84.5,562
PCV,≥3 Doses,States/Local Areas,Alaska,2017,Age,13 Months,79.7,72.8 to 85.2,258
PCV,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,80.3,75.6 to 84.2,533
Hep B,≥2 Doses,States/Local Areas,Alaska,2013,Age,13 Months,89.8,84.7 to 93.4,303
Hep B,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,91.5,88.3 to 93.9,578
Hep B,≥2 Doses,States/Local Areas,Alaska,2012,Age,13 Months,92.0,89.0 to 94.2,273
Hep B,≥2 Doses,States/Local Areas,Alaska,2011,Age,13 Months,94.1,89.7 to 96.7,288
Hep B,≥2 Doses,States/Local Areas,Alaska,2019,Age,7 Months,91.4,85.7 to 95.0,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2019,Age,0-2 Days,76.1,69.3 to 81.8,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2012,Age,35 Months,96.8,92.8 to 98.9,273
≥1 Dose MMR,,States/Local Areas,Alaska,2014,Age,35 Months,88.6,83.8 to 92.5,275
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2015,Age,35 Months,88.4,84.6 to 91.7,532
≥1 Dose Varicella,,States/Local Areas,Alaska,2018,Age,35 Months,89.1,83.7 to 93.4,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2018-2019,Age,35 Months,87.1,82.6 to 90.9,562
≥1 Dose Varicella,,States/Local Areas,Alaska,2017,Age,35 Months,85.2,78.4 to 90.8,258
≥1 Dose Varicella,,States/Local Areas,Alaska,2017-2018,Age,35 Months,87.3,83.1 to 90.9,533
≥1 Dose Varicella,,States/Local Areas,Alaska,2016,Age,35 Months,86.9,80.6 to 91.9,228
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2017,Age,35 Months,86.0,81.5 to 89.9,486
≥1 Dose MMR,,States/Local Areas,Alaska,2013,Age,35 Months,92.0,83.7 to 97.0,303
≥1 Dose MMR,,States/Local Areas,Alaska,2013-2014,Age,35 Months,89.8,85.5 to 93.2,578
≥1 Dose MMR,,States/Local Areas,Alaska,2012,Age,35 Months,96.6,92.4 to 98.8,273
≥1 Dose MMR,,States/Local Areas,Alaska,2011,Age,35 Months,91.6,86.5 to 95.3,288
≥1 Dose MMR,,States/Local Areas,Alaska,2019,Age,24 Months,85.9,79.7 to 91.0,287
PCV,≥4 Doses,States/Local Areas,Alaska,2015,Age,24 Months,75.2,68.6 to 81.3,257
PCV,≥4 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,76.8,72.0 to 81.3,485
PCV,≥4 Doses,States/Local Areas,Alaska,2014,Age,24 Months,80.1,74.3 to 85.2,275
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,77.7,73.4 to 81.7,532
PCV,≥4 Doses,States/Local Areas,Alaska,2013,Age,24 Months,75.7,69.2 to 81.7,303
PCV,≥4 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,77.9,73.6 to 81.9,578
PCV,≥4 Doses,States/Local Areas,Alaska,2012,Age,24 Months,82.1,76.1 to 87.4,273
Hep B,≥3 Doses,States/Local Areas,Alaska,2011,Age,35 Months,94.0,89.9 to 96.9,288
Hep B,≥3 Doses,States/Local Areas,Alaska,2019,Age,24 Months,87.9,81.8 to 92.7,287
Hep B,≥3 Doses,States/Local Areas,Alaska,2018,Age,24 Months,92.0,87.7 to 95.3,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,90.0,86.4 to 93.0,562
PCV,≥3 Doses,States/Local Areas,Alaska,2016,Age,13 Months,82.3,75.1 to 87.9,228
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,81.1,76.2 to 85.2,486
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,83.6,78.3 to 88.9,283
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,76.6,71.6 to 81.7,404
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,71.7,64.8 to 78.6,218
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,77.0,73.6 to 80.3,905
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,72.1,65.8 to 78.4,255
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.7,60.9 to 76.6,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2013,Age,0-3 Days,64.6,57.7 to 71.1,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2013-2014,Age,0-3 Days,66.0,61.1 to 70.6,578
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2018,Age,0-2 Days,65.7,58.6 to 72.1,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2018-2019,Age,0-2 Days,70.8,65.9 to 75.2,562
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2017,Age,0-2 Days,70.1,62.7 to 76.6,258
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2017-2018,Age,0-2 Days,68.0,62.9 to 72.6,533
PCV,≥3 Doses,States/Local Areas,Alaska,2015,Age,13 Months,82.2,76.6 to 86.8,257
PCV,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,82.3,77.8 to 86.0,485
PCV,≥3 Doses,States/Local Areas,Alaska,2014,Age,13 Months,85.6,80.3 to 89.6,275
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,83.9,80.1 to 87.1,532
Hep B,≥2 Doses,States/Local Areas,Alaska,2018,Age,7 Months,88.5,83.1 to 92.3,275
Hep B,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,89.9,86.2 to 92.7,562
Hep B,≥2 Doses,States/Local Areas,Alaska,2017,Age,7 Months,88.8,83.5 to 92.6,258
Hep B,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,88.7,85.0 to 91.5,533
Hep B,≥2 Doses,States/Local Areas,Alaska,2016,Age,7 Months,88.8,82.2 to 93.2,228
Hep B,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,88.8,84.7 to 91.9,486
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2016,Age,0-2 Days,68.0,60.4 to 74.8,228
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2016-2017,Age,0-2 Days,69.0,63.7 to 73.8,486
≥1 Dose Varicella,,States/Local Areas,Alaska,2015,Age,35 Months,84.3,78.2 to 89.5,257
≥1 Dose Varicella,,States/Local Areas,Alaska,2015-2016,Age,35 Months,85.6,81.3 to 89.4,485
PCV,≥4 Doses,States/Local Areas,Alaska,2011,Age,24 Months,78.7,72.0 to 84.6,288
≥1 Dose Varicella,,States/Local Areas,Alaska,2014,Age,35 Months,87.3,82.3 to 91.5,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2014-2015,Age,35 Months,85.9,81.9 to 89.3,532
≥1 Dose Varicella,,States/Local Areas,Alaska,2013,Age,35 Months,88.2,80.1 to 94.0,303
≥1 Dose Varicella,,States/Local Areas,Alaska,2013-2014,Age,35 Months,87.3,82.9 to 91.0,578
≥1 Dose MMR,,States/Local Areas,Alaska,2018,Age,24 Months,89.0,83.9 to 93.1,275
≥1 Dose MMR,,States/Local Areas,Alaska,2018-2019,Age,24 Months,87.5,83.6 to 90.9,562
PCV,≥4 Doses,States/Local Areas,Alaska,2019,Age,19 Months,69.0,61.3 to 75.7,287
≥1 Dose MMR,,States/Local Areas,Alaska,2017,Age,24 Months,86.1,80.3 to 90.8,258
≥1 Dose MMR,,States/Local Areas,Alaska,2017-2018,Age,24 Months,87.5,83.7 to 90.8,533
≥1 Dose MMR,,States/Local Areas,Alaska,2016,Age,24 Months,86.5,80.3 to 91.6,228
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2017,Age,24 Months,86.3,82.2 to 89.9,486
PCV,≥4 Doses,States/Local Areas,Alaska,2018,Age,19 Months,71.6,64.5 to 77.7,275
PCV,≥4 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,67.4,61.3 to 73.0,446
Hep B,≥3 Doses,States/Local Areas,Alaska,2017,Age,24 Months,89.6,84.8 to 93.4,258
Hep B,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,90.8,87.6 to 93.4,533
PCV,≥3 Doses,States/Local Areas,Alaska,2012,Age,13 Months,86.0,81.7 to 89.4,273
Hep B,≥3 Doses,States/Local Areas,Alaska,2016,Age,24 Months,88.1,82.0 to 92.9,228
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,88.8,85.0 to 92.0,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2015,Age,24 Months,90.1,85.9 to 93.5,257
Hep B,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,89.1,85.4 to 92.1,485
PCV,≥3 Doses,States/Local Areas,Alaska,2013,Age,13 Months,81.7,77.8 to 85.1,303
PCV,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,83.7,80.2 to 86.6,578
PCV,≥3 Doses,States/Local Areas,Alaska,2011,Age,13 Months,81.1,76.4 to 85.1,288
PCV,≥3 Doses,States/Local Areas,Alaska,2019,Age,7 Months,59.9,52.1 to 67.3,287
PCV,≥3 Doses,States/Local Areas,Alaska,2018,Age,7 Months,53.8,46.6 to 60.8,275
PCV,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,56.8,51.5 to 61.9,562
Hep B,≥2 Doses,States/Local Areas,Alaska,2015,Age,7 Months,87.2,81.9 to 91.0,257
Hep B,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,88.0,84.0 to 91.1,485
Hep B,≥2 Doses,States/Local Areas,Alaska,2012,Age,7 Months,90.9,88.8 to 92.6,273
Hep B,≥2 Doses,States/Local Areas,Alaska,2014,Age,7 Months,89.3,84.5 to 92.8,275
Hep B,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,88.3,84.8 to 91.0,532
Hep B,≥2 Doses,States/Local Areas,Alaska,2013,Age,7 Months,88.1,82.5 to 92.1,303
Hep B,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,88.7,84.8 to 91.7,578
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2013,Age,0-2 Days,63.5,55.8 to 70.7,303
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2013-2014,Age,0-2 Days,64.4,60.9 to 67.8,578
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2012,Age,0-2 Days,54.6,46.6 to 62.3,273
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2011,Age,0-2 Days,56.8,53.7 to 59.9,288
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2019,Age,0-1 Days,75.1,68.2 to 80.9,287
≥1 Dose Varicella,,States/Local Areas,Alaska,2012,Age,35 Months,90.8,85.4 to 94.8,273
≥1 Dose Varicella,,States/Local Areas,Alaska,2011,Age,35 Months,97.1,90.5 to 99.5,288
≥1 Dose Varicella,,States/Local Areas,Alaska,2019,Age,24 Months,79.8,72.8 to 85.9,287
≥1 Dose Varicella,,States/Local Areas,Alaska,2018,Age,24 Months,84.0,78.5 to 88.8,275
≥1 Dose Varicella,,States/Local Areas,Alaska,2018-2019,Age,24 Months,81.9,77.5 to 85.9,562
≥1 Dose MMR,,States/Local Areas,Alaska,2015,Age,24 Months,84.1,78.5 to 88.9,257
≥1 Dose MMR,,States/Local Areas,Alaska,2015-2016,Age,24 Months,85.3,81.2 to 88.9,485
≥1 Dose MMR,,States/Local Areas,Alaska,2014,Age,24 Months,87.9,83.0 to 91.9,275
≥1 Dose MMR,,States/Local Areas,Alaska,2014-2015,Age,24 Months,86.0,82.4 to 89.2,532
≥1 Dose MMR,,States/Local Areas,Alaska,2013,Age,24 Months,84.1,78.1 to 89.3,303
≥1 Dose MMR,,States/Local Areas,Alaska,2013-2014,Age,24 Months,86.0,82.2 to 89.4,578
PCV,≥4 Doses,States/Local Areas,Alaska,2016,Age,19 Months,76.5,69.0 to 82.6,228
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,75.9,70.8 to 80.3,486
PCV,≥4 Doses,States/Local Areas,Alaska,2015,Age,19 Months,72.4,68.1 to 76.3,257
PCV,≥4 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,74.5,69.5 to 78.9,485
PCV,≥3 Doses,States/Local Areas,Alaska,2017,Age,7 Months,59.2,51.7 to 66.3,258
PCV,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,56.6,51.4 to 61.6,533
PCV,≥3 Doses,States/Local Areas,Alaska,2016,Age,7 Months,57.7,49.5 to 65.5,228
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,58.4,52.8 to 63.8,486
Hep B,≥3 Doses,States/Local Areas,Alaska,2014,Age,24 Months,91.4,87.3 to 94.6,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,90.8,88.0 to 93.2,532
PCV,≥4 Doses,States/Local Areas,Alaska,2020,Age,35 Months,74.5,67.5 to 81.0,302
Hep B,≥3 Doses,States/Local Areas,Alaska,2012,Age,24 Months,93.4,89.0 to 96.5,273
Hep B,≥3 Doses,States/Local Areas,Alaska,2013,Age,24 Months,87.4,82.0 to 91.7,303
Hep B,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,89.5,86.1 to 92.3,578
Hep B,≥3 Doses,States/Local Areas,Alaska,2011,Age,24 Months,93.7,89.6 to 96.6,288
Hep B,≥3 Doses,States/Local Areas,Alaska,2019,Age,19 Months,87.4,80.9 to 92.0,287
Hep B,≥2 Doses,States/Local Areas,Alaska,2011,Age,7 Months,90.9,85.7 to 94.4,288
Hep B,≥2 Doses,States/Local Areas,Alaska,2019,Age,5 Months,88.2,82.1 to 92.4,287
Hep B,≥2 Doses,States/Local Areas,Alaska,2018,Age,5 Months,83.7,77.9 to 88.2,275
Hep B,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,5 Months,85.9,81.8 to 89.1,562
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2018,Age,0-1 Days,64.2,57.2 to 70.7,275
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2018-2019,Age,0-1 Days,69.5,64.6 to 74.0,562
≥1 Dose Varicella,,States/Local Areas,Alaska,2017,Age,24 Months,80.5,74.0 to 86.3,258
≥1 Dose Varicella,,States/Local Areas,Alaska,2017-2018,Age,24 Months,82.2,78.0 to 86.1,533
≥1 Dose Varicella,,States/Local Areas,Alaska,2016,Age,24 Months,85.2,79.1 to 90.4,228
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2017,Age,24 Months,83.1,78.7 to 87.1,486
≥1 Dose Varicella,,States/Local Areas,Alaska,2015,Age,24 Months,81.2,75.2 to 86.5,257
≥1 Dose Varicella,,States/Local Areas,Alaska,2015-2016,Age,24 Months,83.2,79.0 to 87.0,485
≥1 Dose MMR,,States/Local Areas,Alaska,2012,Age,24 Months,90.0,84.8 to 94.0,273
PCV,≥3 Doses,States/Local Areas,Alaska,2015,Age,7 Months,61.0,53.6 to 67.9,257
PCV,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,59.3,53.8 to 64.6,485
≥1 Dose MMR,,States/Local Areas,Alaska,2011,Age,24 Months,86.8,81.1 to 91.5,288
≥1 Dose MMR,,States/Local Areas,Alaska,2019,Age,19 Months,82.8,76.2 to 87.9,287
PCV,≥4 Doses,States/Local Areas,Alaska,2014,Age,19 Months,76.0,69.7 to 81.4,275
PCV,≥4 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,74.2,69.6 to 78.3,532
≥1 Dose MMR,,States/Local Areas,Alaska,2018,Age,19 Months,86.0,79.8 to 90.5,275
≥1 Dose MMR,,States/Local Areas,Alaska,2018-2019,Age,19 Months,90.0,86.2 to 92.8,562
PCV,≥4 Doses,States/Local Areas,Alaska,2013,Age,19 Months,73.8,70.2 to 77.2,303
PCV,≥4 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,74.9,71.9 to 77.8,578
PCV,≥4 Doses,States/Local Areas,Alaska,2012,Age,19 Months,80.0,77.0 to 82.8,273
PCV,≥4 Doses,States/Local Areas,Alaska,2011,Age,19 Months,67.6,63.6 to 71.3,288
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,83.8,78.7 to 88.9,283
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,70.9,65.3 to 76.5,404
PCV,≥3 Doses,States/Local Areas,Alaska,2012,Age,7 Months,64.1,60.8 to 67.2,273
PCV,≥3 Doses,States/Local Areas,Alaska,2014,Age,7 Months,59.6,52.5 to 66.4,275
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,60.3,55.2 to 65.2,532
PCV,≥3 Doses,States/Local Areas,Alaska,2013,Age,7 Months,57.8,53.6 to 61.9,303
PCV,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,7 Months,58.7,55.3 to 62.0,578
Hep B,≥3 Doses,States/Local Areas,Alaska,2018,Age,19 Months,91.6,86.9 to 94.8,275
Hep B,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,87.5,83.5 to 90.6,562
Hep B,≥3 Doses,States/Local Areas,Alaska,2017,Age,19 Months,89.2,84.0 to 92.8,258
Hep B,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,90.4,87.0 to 92.9,533
Hep B,≥2 Doses,States/Local Areas,Alaska,2017,Age,5 Months,84.8,78.4 to 89.6,258
Hep B,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,5 Months,84.3,80.1 to 87.7,533
Hib,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,3 Months,89.7,85.4 to 92.8,467
Rotavirus,,States/Local Areas,Alabama,2019-2020,Age,8 Months,78.0,72.7 to 82.5,467
Hep A,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,35 Months,90.4,85.5 to 94.2,400
PCV,≥3 Doses,States/Local Areas,Alabama,2021,Age,13 Months,81.0,70.5 to 88.3,160
Hib,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,88.9,83.0 to 92.9,400
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2021,Age,0-1 Days,69.8,59.0 to 78.8,160
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2021,Age,0-2 Days,72.8,62.1 to 81.3,160
PCV,≥3 Doses,States/Local Areas,Alabama,2021,Age,24 Months,88.1,79.2 to 94.4,160
PCV,≥4 Doses,States/Local Areas,Alabama,2021,Age,24 Months,76.5,66.5 to 85.4,160
Hep A,≥1 Dose,States/Local Areas,Alabama,2021,Age,24 Months,87.6,78.9 to 93.9,160
≥1 Dose Varicella,,States/Local Areas,Alabama,2021,Age,24 Months,86.1,76.8 to 93.1,160
DTaP,≥3 Doses,States/Local Areas,Alabama,2021,Age,19 Months,85.2,75.1 to 91.6,160
Hib,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,71.9,65.0 to 77.9,400
PCV,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,5 Months,76.0,69.2 to 81.7,400
Hep B,≥3 Doses,States/Local Areas,Alabama,2021,Age,7 Months,49.7,38.8 to 60.7,160
Hep A,≥2 Doses,States/Local Areas,Alabama,2021,Age,24 Months,38.8,27.7 to 52.5,160
PCV,≥3 Doses,States/Local Areas,Alabama,2021,Age,7 Months,59.9,48.5 to 70.3,160
DTaP,≥3 Doses,States/Local Areas,Alabama,2021,Age,13 Months,81.2,70.7 to 88.5,160
PCV,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,91.8,86.9 to 95.4,400
Polio,≥2 Doses,States/Local Areas,Alabama,2021,Age,13 Months,85.2,74.4 to 92.0,160
Hep A,≥1 Dose,States/Local Areas,Alabama,2021,Age,19 Months,78.4,67.7 to 86.2,160
PCV,≥4 Doses,States/Local Areas,Alabama,2021,Age,35 Months,78.9,68.6 to 87.6,160
Hep B,≥3 Doses,States/Local Areas,Alabama,2021,Age,24 Months,80.1,70.3 to 88.3,160
Hep A,≥2 Doses,States/Local Areas,Alabama,2021,Age,19 Months,21.7,14.2 to 31.7,160
DTaP,≥1 Dose,States/Local Areas,Alabama,2021,Age,3 Months,83.2,72.5 to 90.3,160
Hep B,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,87.1,81.5 to 91.7,400
DTaP,≥4 Doses,States/Local Areas,Alabama,2021,Age,24 Months,81.7,71.4 to 90.0,160
Polio,≥3 Doses,States/Local Areas,Alabama,2021,Age,24 Months,85.3,75.7 to 92.6,160
Polio,≥1 Dose,States/Local Areas,Alabama,2021,Age,3 Months,80.8,69.7 to 88.5,160
≥1 Dose MMR,,States/Local Areas,Alabama,2021,Age,24 Months,86.2,76.9 to 93.1,160
Hib,Primary Series,States/Local Areas,Alabama,2021,Age,24 Months,86.4,76.7 to 93.5,160
Hib,≥3 Doses,States/Local Areas,Alabama,2021,Age,24 Months,85.4,75.6 to 92.7,160
Hib,Full Series,States/Local Areas,Alabama,2021,Age,24 Months,72.1,61.4 to 81.9,160
DTaP,≥4 Doses,States/Local Areas,Alabama,2021,Age,19 Months,63.0,51.6 to 73.2,160
Hep A,≥2 Doses,States/Local Areas,Alabama,2021,Age,35 Months,71.4,55.9 to 85.3,160
Combined 7 Series,,States/Local Areas,Alabama,2021,Age,35 Months,65.5,54.1 to 76.6,160
PCV,≥4 Doses,States/Local Areas,Alabama,2021,Age,19 Months,70.4,59.3 to 79.5,160
Hib,Primary Series,States/Local Areas,Alabama,2021,Age,7 Months,61.3,49.9 to 71.5,160
Polio,≥2 Doses,States/Local Areas,Alabama,2021,Age,7 Months,81.2,70.1 to 88.8,160
≥1 Dose Varicella,,States/Local Areas,Alabama,2020-2021,Age,35 Months,91.8,86.7 to 95.6,400
Polio,≥1 Dose,States/Local Areas,Alabama,2020,Age,3 Months,90.7,84.4 to 94.6,240
Hib,≥1 Dose,States/Local Areas,Alabama,2020,Age,3 Months,87.4,80.4 to 92.1,240
Hep B,≥1 Dose,States/Local Areas,Alabama,2020,Age,3 Months,96.9,93.6 to 98.6,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2020,Age,24 Months,90.9,85.8 to 94.8,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2020,Age,7 Months,61.0,52.8 to 68.7,240
PCV,≥3 Doses,States/Local Areas,Alabama,2020,Age,7 Months,72.2,63.6 to 79.3,240
DTaP,≥3 Doses,States/Local Areas,Alabama,2020,Age,13 Months,88.0,81.0 to 92.6,240
≥1 Dose Varicella,,States/Local Areas,Alabama,2020,Age,19 Months,90.3,84.7 to 94.0,240
PCV,≥3 Doses,States/Local Areas,Alabama,2020,Age,19 Months,92.3,86.3 to 95.7,240
DTaP,≥4 Doses,States/Local Areas,Alabama,2020,Age,35 Months,87.8,80.8 to 93.1,240
Polio,≥3 Doses,States/Local Areas,Alabama,2020,Age,35 Months,93.1,88.0 to 96.6,240
PCV,≥4 Doses,States/Local Areas,Alabama,2020,Age,19 Months,72.4,63.7 to 79.7,240
PCV,≥4 Doses,States/Local Areas,Alabama,2020,Age,35 Months,81.8,73.9 to 88.5,240
Hib,≥3 Doses,States/Local Areas,Alabama,2020,Age,13 Months,72.7,64.4 to 79.7,240
Hib,Primary Series,States/Local Areas,Alabama,2020,Age,13 Months,83.1,75.4 to 88.8,240
Hep B,≥2 Doses,States/Local Areas,Alabama,2020,Age,13 Months,95.5,91.9 to 97.6,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2020,Age,13 Months,86.9,80.0 to 91.6,240
≥1 Dose Varicella,,States/Local Areas,Alabama,2020,Age,13 Months,68.3,60.0 to 75.6,240
PCV,≥3 Doses,States/Local Areas,Alabama,2020,Age,13 Months,88.2,81.2 to 92.8,240
DTaP,≥3 Doses,States/Local Areas,Alabama,2020,Age,7 Months,74.8,66.6 to 81.5,240
PCV,≥2 Doses,States/Local Areas,Alabama,2020,Age,5 Months,82.4,74.6 to 88.1,240
DTaP,≥3 Doses,States/Local Areas,Alabama,2020,Age,19 Months,92.3,86.4 to 95.8,240
DTaP,≥4 Doses,States/Local Areas,Alabama,2020,Age,19 Months,67.0,58.4 to 74.6,240
Polio,≥3 Doses,States/Local Areas,Alabama,2020,Age,19 Months,90.4,83.8 to 94.5,240
≥1 Dose MMR,,States/Local Areas,Alabama,2020,Age,19 Months,88.6,81.8 to 93.1,240
Hib,≥3 Doses,States/Local Areas,Alabama,2020,Age,19 Months,87.5,80.5 to 92.2,240
Influenza,,States/Local Areas,Alabama,2020,Age,24 Months,32.3,25.5 to 40.4,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2020,Age,0-3 Days,79.5,71.9 to 85.4,240
Rotavirus,,States/Local Areas,Alabama,2020,Age,8 Months,76.9,68.8 to 83.4,240
DTaP,≥3 Doses,States/Local Areas,Alabama,2020,Age,35 Months,94.5,90.4 to 97.3,240
PCV,≥3 Doses,States/Local Areas,Alabama,2020,Age,24 Months,94.4,90.3 to 97.2,240
PCV,≥4 Doses,States/Local Areas,Alabama,2020,Age,24 Months,77.6,69.6 to 84.7,240
Hep A,≥1 Dose,States/Local Areas,Alabama,2020,Age,24 Months,89.0,83.8 to 93.2,240
Hep A,≥2 Doses,States/Local Areas,Alabama,2020,Age,24 Months,41.1,33.1 to 50.2,240
Combined 7 Series,,States/Local Areas,Alabama,2020,Age,24 Months,61.8,53.5 to 70.2,240
PCV,≥1 Dose,States/Local Areas,Alabama,2020,Age,3 Months,89.0,82.3 to 93.4,240
DTaP,≥2 Doses,States/Local Areas,Alabama,2020,Age,5 Months,83.6,76.2 to 89.1,240
Polio,≥2 Doses,States/Local Areas,Alabama,2020,Age,5 Months,83.6,76.2 to 89.1,240
Hib,≥2 Doses,States/Local Areas,Alabama,2020,Age,5 Months,79.7,71.7 to 85.9,240
Hep B,≥2 Doses,States/Local Areas,Alabama,2020,Age,5 Months,86.4,79.5 to 91.2,240
PCV,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,5 Months,83.5,78.6 to 87.5,467
Hep B,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,5 Months,87.0,82.6 to 90.5,467
Hep B,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,95.0,92.0 to 96.9,467
Hib,Primary Series,States/Local Areas,Alabama,2019-2020,Age,13 Months,86.6,81.9 to 90.3,467
Hib,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,76.2,70.7 to 80.9,467
Hib,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,94.3,91.0 to 96.5,467
≥1 Dose MMR,,States/Local Areas,Alabama,2019-2020,Age,13 Months,67.0,61.1 to 72.3,467
Polio,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,94.7,91.6 to 96.7,467
Hib,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,5 Months,80.9,75.8 to 85.2,467
Polio,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,5 Months,83.6,78.8 to 87.5,467
DTaP,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,5 Months,84.0,79.2 to 87.9,467
PCV,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,3 Months,91.2,87.3 to 94.0,467
Hep B,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,3 Months,96.6,94.4 to 98.0,467
≥1 Dose MMR,,States/Local Areas,Alabama,2019-2020,Age,24 Months,94.6,91.5 to 96.8,467
Polio,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,95.4,92.6 to 97.3,467
DTaP,≥4 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,79.7,74.4 to 84.5,467
DTaP,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,96.2,93.9 to 97.8,467
PCV,≥4 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,85.1,80.1 to 89.4,467
PCV,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,96.0,93.7 to 97.6,467
≥1 Dose Varicella,,States/Local Areas,Alabama,2019-2020,Age,35 Months,95.8,93.2 to 97.7,467
Hep B,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,93.4,90.0 to 95.9,467
Hib,Full Series,States/Local Areas,Alabama,2019-2020,Age,35 Months,80.3,74.6 to 85.4,467
Hib,Primary Series,States/Local Areas,Alabama,2019-2020,Age,35 Months,96.3,94.1 to 97.9,467
Hib,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,95.0,92.2 to 97.1,467
≥1 Dose MMR,,States/Local Areas,Alabama,2019-2020,Age,35 Months,95.1,92.0 to 97.3,467
Hib,Full Series,States/Local Areas,Alabama,2019-2020,Age,19 Months,68.4,62.5 to 73.9,467
Hib,Primary Series,States/Local Areas,Alabama,2019-2020,Age,19 Months,93.5,90.0 to 95.9,467
Hib,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,89.8,85.6 to 92.9,467
≥1 Dose MMR,,States/Local Areas,Alabama,2019-2020,Age,19 Months,91.4,87.4 to 94.3,467
Hep A,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,25.8,21.1 to 31.2,467
PCV,≥4 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,81.7,76.6 to 86.3,467
PCV,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,96.0,93.7 to 97.6,467
≥1 Dose Varicella,,States/Local Areas,Alabama,2019-2020,Age,24 Months,95.2,92.5 to 97.1,467
Hep B,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,91.8,88.4 to 94.6,467
Hib,Full Series,States/Local Areas,Alabama,2019-2020,Age,24 Months,75.3,69.7 to 80.5,467
PCV,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,71.9,66.1 to 77.1,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2019-2020,Age,0-3 Days,81.8,76.7 to 86.0,467
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2019-2020,Age,0-2 Days,81.3,76.2 to 85.5,467
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2019-2020,Age,0-1 Days,78.7,73.5 to 83.1,467
Hep A,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,19 Months,84.8,80.0 to 88.6,467
PCV,≥4 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,77.5,71.9 to 82.2,467
≥1 Dose Varicella,,States/Local Areas,Alabama,2019-2020,Age,19 Months,91.8,88.3 to 94.4,467
Hep B,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,90.6,86.7 to 93.4,467
Combined 7 Series,,States/Local Areas,Alabama,2019-2020,Age,35 Months,70.7,64.3 to 76.7,467
Hib,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,60.2,54.2 to 65.8,467
Hib,Primary Series,States/Local Areas,Alabama,2019-2020,Age,24 Months,95.9,93.6 to 97.6,467
Hib,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,93.0,89.7 to 95.5,467
Influenza,,States/Local Areas,Alabama,2019-2020,Age,24 Months,37.1,31.9 to 42.9,467
Hep A,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,35 Months,91.1,87.3 to 94.2,467
Hep A,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,75.6,68.6 to 82.1,467
Hep A,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,24 Months,88.5,84.4 to 91.9,467
Hep A,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,24 Months,40.1,34.4 to 46.3,467
Polio,≥2 Doses,States/Local Areas,Alabama,2020,Age,13 Months,93.9,88.7 to 96.8,240
Hep A,≥2 Doses,States/Local Areas,Alabama,2020,Age,35 Months,77.3,68.2 to 85.4,240
Combined 7 Series,,States/Local Areas,Alabama,2020,Age,35 Months,70.1,61.0 to 78.6,240
Hep A,≥1 Dose,States/Local Areas,Alabama,2020,Age,19 Months,85.2,78.8 to 90.0,240
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2020,Age,0-1 Days,75.2,67.3 to 81.6,240
Hep A,≥2 Doses,States/Local Areas,Alabama,2020,Age,19 Months,24.6,18.3 to 32.2,240
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2020,Age,0-2 Days,78.7,71.0 to 84.8,240
DTaP,≥1 Dose,States/Local Areas,Alabama,2020,Age,3 Months,90.7,84.4 to 94.6,240
Polio,≥2 Doses,States/Local Areas,Alabama,2020,Age,7 Months,91.0,84.7 to 94.9,240
Hib,≥2 Doses,States/Local Areas,Alabama,2020,Age,7 Months,89.4,82.7 to 93.7,240
Hib,≥3 Doses,States/Local Areas,Alabama,2020,Age,7 Months,59.3,50.8 to 67.3,240
Hib,Primary Series,States/Local Areas,Alabama,2020,Age,7 Months,73.3,65.0 to 80.3,240
Hep B,≥2 Doses,States/Local Areas,Alabama,2020,Age,7 Months,93.3,88.4 to 96.3,240
DTaP,≥3 Doses,States/Local Areas,Alabama,2020,Age,24 Months,94.5,90.4 to 97.3,240
DTaP,≥4 Doses,States/Local Areas,Alabama,2020,Age,24 Months,78.4,70.6 to 85.3,240
Polio,≥3 Doses,States/Local Areas,Alabama,2020,Age,24 Months,93.1,88.0 to 96.6,240
≥1 Dose MMR,,States/Local Areas,Alabama,2020,Age,24 Months,93.3,88.4 to 96.6,240
Hib,≥3 Doses,States/Local Areas,Alabama,2020,Age,24 Months,90.7,85.3 to 94.7,240
Hib,Primary Series,States/Local Areas,Alabama,2020,Age,24 Months,94.0,89.8 to 96.9,240
≥1 Dose MMR,,States/Local Areas,Alabama,2020,Age,35 Months,94.4,89.6 to 97.4,240
Hib,≥3 Doses,States/Local Areas,Alabama,2020,Age,35 Months,93.4,88.6 to 96.7,240
Hib,Primary Series,States/Local Areas,Alabama,2020,Age,35 Months,94.9,90.8 to 97.5,240
Hib,Full Series,States/Local Areas,Alabama,2020,Age,35 Months,77.6,68.8 to 85.3,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2020,Age,35 Months,92.2,87.0 to 95.9,240
≥1 Dose Varicella,,States/Local Areas,Alabama,2020,Age,35 Months,95.8,92.4 to 98.0,240
PCV,≥3 Doses,States/Local Areas,Alabama,2020,Age,35 Months,94.4,90.3 to 97.2,240
Hib,Primary Series,States/Local Areas,Alabama,2020,Age,19 Months,91.2,84.8 to 95.0,240
Hib,Full Series,States/Local Areas,Alabama,2020,Age,19 Months,63.9,55.2 to 71.8,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2020,Age,19 Months,90.9,85.3 to 94.5,240
DTaP,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,74.3,68.6 to 79.2,467
Polio,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,3 Months,92.1,88.4 to 94.7,467
DTaP,≥1 Dose,States/Local Areas,Alabama,2019-2020,Age,3 Months,92.4,88.8 to 94.9,467
DTaP,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,90.1,85.9 to 93.2,467
Hib,Primary Series,States/Local Areas,Alabama,2019-2020,Age,7 Months,73.7,68.2 to 78.6,467
Polio,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,92.7,89.0 to 95.3,467
DTaP,≥4 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,68.8,62.8 to 74.2,467
Polio,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,95.7,93.0 to 97.6,467
DTaP,≥4 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,92.2,86.6 to 96.1,467
DTaP,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,35 Months,96.2,93.9 to 97.8,467
Combined 7 Series,,States/Local Areas,Alabama,2019-2020,Age,24 Months,63.5,57.6 to 69.4,467
DTaP,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,93.9,90.5 to 96.2,467
PCV,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,90.0,85.8 to 93.1,467
≥1 Dose Varicella,,States/Local Areas,Alabama,2019-2020,Age,13 Months,68.8,63.0 to 74.0,467
Hep B,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,13 Months,86.8,82.3 to 90.3,467
Hib,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,89.3,84.9 to 92.6,467
Polio,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,90.7,86.7 to 93.6,467
DTaP,≥3 Doses,States/Local Areas,Alaska,2017,Age,13 Months,80.7,73.5 to 86.3,258
DTaP,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,84.3,79.8 to 87.9,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2016,Age,13 Months,81.6,74.1 to 87.3,228
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,81.2,76.1 to 85.3,486
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,64.9,58.4 to 71.5,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,66.1,60.5 to 71.6,404
Polio,≥3 Doses,States/Local Areas,Alaska,2012,Age,19 Months,91.6,88.5 to 93.9,273
Hib,≥3 Doses,States/Local Areas,Alaska,2015,Age,13 Months,58.7,51.2 to 65.8,257
Hib,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,58.1,52.7 to 63.3,485
Hib,≥3 Doses,States/Local Areas,Alaska,2012,Age,13 Months,60.1,56.5 to 63.5,273
Hib,≥3 Doses,States/Local Areas,Alaska,2014,Age,13 Months,63.2,56.2 to 69.6,275
Hib,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,60.9,55.9 to 65.8,532
Hib,≥3 Doses,States/Local Areas,Alaska,2013,Age,13 Months,65.1,60.2 to 69.8,303
Hib,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,64.2,61.0 to 67.2,578
Polio,≥3 Doses,States/Local Areas,Alaska,2011,Age,19 Months,91.1,86.4 to 94.2,288
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,89.3,85.1 to 93.5,283
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,87.6,83.5 to 91.7,404
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,84.0,78.0 to 90.0,218
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,87.0,84.2 to 89.8,905
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,84.2,79.1 to 89.3,255
DTaP,≥3 Doses,States/Local Areas,Alaska,2015,Age,13 Months,82.9,77.1 to 87.5,257
DTaP,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,82.2,77.6 to 86.1,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2012,Age,13 Months,87.5,82.9 to 91.1,273
DTaP,≥3 Doses,States/Local Areas,Alaska,2014,Age,13 Months,84.8,79.5 to 89.0,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,83.9,80.0 to 87.1,532
DTaP,≥3 Doses,States/Local Areas,Alaska,2013,Age,13 Months,84.8,81.0 to 87.9,303
DTaP,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,84.8,81.9 to 87.3,578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Overall,Overall,68.8,65.2 to 72.4,905
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,64.9,58.3 to 71.5,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,63.3,54.6 to 71.9,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,73.1,68.3 to 77.8,463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",60.7,55.5 to 65.8,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,70.8 to 81.7,306
Hib,≥3 Doses,States/Local Areas,Alaska,2011,Age,13 Months,58.1,51.8 to 64.2,288
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.9,77.4 to 90.4,187
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,89.6,85.8 to 93.5,463
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.0,81.1 to 88.9,481
Hib,≥3 Doses,States/Local Areas,Alaska,2018,Age,7 Months,7.0,4.4 to 11.0,275
Hib,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,6.4,4.2 to 9.5,562
Hib,≥3 Doses,States/Local Areas,Alaska,2017,Age,7 Months,6.3,3.6 to 10.6,258
Hib,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,7 Months,6.6,4.6 to 9.4,533
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,84.2 to 93.3,306
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,88.7,81.0 to 96.4,97
Hib,≥2 Doses,States/Local Areas,Alaska,2017,Age,13 Months,86.6,81.0 to 90.8,258
Hib,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,88.9,85.3 to 91.7,533
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,83.7,78.9 to 88.5,357
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,90.7,87.7 to 93.7,458
Hib,≥2 Doses,States/Local Areas,Alaska,2019,Age,13 Months,88.7,82.3 to 93.0,287
Hib,≥2 Doses,States/Local Areas,Alaska,2018,Age,13 Months,91.2,86.5 to 94.4,275
Hib,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,90.0,86.2 to 92.8,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,76.1,69.7 to 82.4,218
Hib,≥2 Doses,States/Local Areas,Alaska,2016,Age,13 Months,87.4,80.5 to 92.1,228
Hib,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,87.0,82.8 to 90.4,486
Hib,≥2 Doses,States/Local Areas,Alaska,2015,Age,13 Months,89.4,84.2 to 93.0,257
Hib,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,13 Months,88.4,84.3 to 91.5,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2011,Age,13 Months,86.3,80.9 to 90.4,288
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,74.2,63.7 to 84.7,97
DTaP,≥3 Doses,States/Local Areas,Alaska,2019,Age,7 Months,61.4,53.6 to 68.7,287
DTaP,≥3 Doses,States/Local Areas,Alaska,2018,Age,7 Months,57.2,50.0 to 64.1,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,7 Months,59.3,54.0 to 64.3,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,71.9,66.5 to 77.3,357
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,65.3,60.2 to 70.5,458
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,73.1,60.1 to 86.1,61
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2019,Age,0-3 Days,76.7,69.8 to 82.3,287
Hib,Full Series,States/Local Areas,Alaska,2020,Age,24 Months,71.8,64.8 to 78.4,302
Polio,≥1 Dose,States/Local Areas,Alaska,2019,Age,3 Months,85.4,78.7 to 90.3,287
PCV,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,83.9,72.6 to 95.3,61
Hib,≥2 Doses,States/Local Areas,Alaska,2014,Age,13 Months,91.8,87.9 to 94.5,275
Hib,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,13 Months,90.6,87.5 to 93.0,532
PCV,≥3 Doses,States/Local Areas,Alaska,2019,Age,35 Months,89.2,81.9 to 94.5,287
Polio,≥1 Dose,States/Local Areas,Alaska,2018,Age,3 Months,82.6,76.0 to 87.6,275
Polio,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,3 Months,84.0,79.4 to 87.7,562
Polio,≥1 Dose,States/Local Areas,Alaska,2017,Age,3 Months,82.5,75.9 to 87.6,258
Polio,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,3 Months,82.5,78.0 to 86.3,533
Hib,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,7 Months,5.0,3.2 to 7.7,486
Hib,≥3 Doses,States/Local Areas,Alaska,2015,Age,7 Months,8.6,4.9 to 14.7,257
Hib,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,7 Months,6.2,4.0 to 9.6,485
Hib,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,7 Months,6.4,4.1 to 9.9,532
PCV,≥3 Doses,States/Local Areas,Alaska,2018,Age,35 Months,88.9,83.7 to 93.1,275
PCV,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,89.0,84.7 to 92.5,562
PCV,≥3 Doses,States/Local Areas,Alaska,2017,Age,35 Months,86.9,81.4 to 91.4,258
PCV,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,87.9,84.2 to 91.1,533
Hib,≥2 Doses,States/Local Areas,Alaska,2013,Age,13 Months,88.7,83.5 to 92.4,303
Hib,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,13 Months,90.2,86.3 to 93.1,578
Hib,≥2 Doses,States/Local Areas,Alaska,2012,Age,13 Months,91.0,84.5 to 94.9,273
Hib,≥2 Doses,States/Local Areas,Alaska,2011,Age,13 Months,93.4,89.1 to 96.0,288
DTaP,≥3 Doses,States/Local Areas,Alaska,2013,Age,19 Months,87.8,83.1 to 91.3,303
DTaP,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,88.1,84.8 to 90.7,578
DTaP,≥3 Doses,States/Local Areas,Alaska,2012,Age,19 Months,91.6,88.5 to 93.9,273
DTaP,≥3 Doses,States/Local Areas,Alaska,2011,Age,19 Months,91.9,88.0 to 94.6,288
DTaP,≥3 Doses,States/Local Areas,Alaska,2019,Age,13 Months,83.1,75.8 to 88.5,287
Hib,≥3 Doses,States/Local Areas,Alaska,2017,Age,13 Months,62.1,54.5 to 69.2,258
Hib,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,13 Months,62.4,57.2 to 67.3,533
Hib,≥3 Doses,States/Local Areas,Alaska,2016,Age,13 Months,57.5,49.6 to 65.0,228
Hib,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,13 Months,59.6,54.2 to 64.9,486
Polio,≥3 Doses,States/Local Areas,Alaska,2015,Age,19 Months,86.3,82.9 to 89.1,257
Polio,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,86.0,81.9 to 89.3,485
Polio,≥3 Doses,States/Local Areas,Alaska,2014,Age,19 Months,87.0,81.9 to 90.8,275
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,86.6,83.2 to 89.5,532
Polio,≥3 Doses,States/Local Areas,Alaska,2013,Age,19 Months,86.4,82.7 to 89.5,303
Polio,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,86.7,83.7 to 89.3,578
Polio,≥3 Doses,States/Local Areas,Alaska,2017,Age,19 Months,85.8,79.2 to 90.5,258
Polio,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,88.4,84.4 to 91.4,533
Polio,≥3 Doses,States/Local Areas,Alaska,2016,Age,19 Months,85.8,78.9 to 90.7,228
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,85.8,81.2 to 89.4,486
Hib,≥3 Doses,States/Local Areas,Alaska,2013,Age,19 Months,80.2,75.8 to 84.0,303
Hib,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,82.4,77.2 to 86.6,578
Hib,≥3 Doses,States/Local Areas,Alaska,2012,Age,19 Months,84.4,79.5 to 88.4,273
Hib,≥3 Doses,States/Local Areas,Alaska,2011,Age,19 Months,81.2,76.3 to 85.4,288
Hib,≥3 Doses,States/Local Areas,Alaska,2019,Age,13 Months,57.8,50.1 to 65.1,287
PCV,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,5 Months,71.4,65.6 to 76.5,492
Hib,≥3 Doses,States/Local Areas,Alaska,2018,Age,13 Months,62.7,55.6 to 69.4,275
Hib,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,13 Months,60.3,55.1 to 65.3,562
Polio,≥3 Doses,States/Local Areas,Alaska,2018,Age,19 Months,91.1,86.2 to 94.3,275
Polio,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,58.4,53.2 to 63.5,562
Hib,Primary Series,States/Local Areas,Alaska,2012,Age,7 Months,86.7,81.4 to 90.7,273
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,85.8,80.9 to 90.7,283
Hib,Primary Series,States/Local Areas,Alaska,2011,Age,7 Months,77.1,72.2 to 81.5,288
DTaP,≥4 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,72.6,66.5 to 78.3,492
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.0,65.0 to 80.9,187
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,82.3,77.8 to 86.7,463
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.1,72.4 to 81.7,481
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.0,74.7 to 85.4,306
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,82.4,73.1 to 91.7,97
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,78.0,73.1 to 83.0,404
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,74.1,67.2 to 80.9,218
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Overall,Overall,78.8,75.6 to 82.1,905
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,77.0,71.1 to 82.9,255
DTaP,≥3 Doses,States/Local Areas,Alaska,2015,Age,19 Months,88.0,83.1 to 91.6,257
DTaP,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,87.2,83.2 to 90.4,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2014,Age,19 Months,88.3,83.3 to 92.0,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,88.2,84.9 to 90.8,532
DTaP,≥3 Doses,States/Local Areas,Alaska,2016,Age,19 Months,86.5,79.6 to 91.3,228
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,85.6,80.9 to 89.3,486
DTaP,≥3 Doses,States/Local Areas,Alaska,2018,Age,19 Months,91.7,87.0 to 94.9,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,85.6,81.2 to 89.0,562
DTaP,≥3 Doses,States/Local Areas,Alaska,2017,Age,19 Months,84.6,77.7 to 89.7,258
DTaP,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,88.1,84.0 to 91.3,533
Hib,≥3 Doses,States/Local Areas,Alaska,2016,Age,19 Months,82.1,74.8 to 87.7,228
Hib,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,81.0,76.2 to 85.1,486
Hib,≥3 Doses,States/Local Areas,Alaska,2015,Age,19 Months,80.9,76.3 to 84.8,257
Hib,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,81.5,76.8 to 85.4,485
Hib,≥3 Doses,States/Local Areas,Alaska,2014,Age,19 Months,84.6,79.2 to 88.8,275
Hib,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,82.8,78.7 to 86.2,532
Polio,≥3 Doses,States/Local Areas,Alaska,2013,Age,24 Months,86.9,81.4 to 91.5,303
Polio,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,88.2,84.7 to 91.2,578
Polio,≥3 Doses,States/Local Areas,Alaska,2012,Age,24 Months,92.8,88.4 to 96.0,273
Polio,≥3 Doses,States/Local Areas,Alaska,2011,Age,24 Months,91.7,86.6 to 95.5,288
Polio,≥3 Doses,States/Local Areas,Alaska,2019,Age,19 Months,85.7,78.8 to 90.7,287
DTaP,≥3 Doses,States/Local Areas,Alaska,2019,Age,19 Months,87.3,80.6 to 91.9,287
Hib,≥3 Doses,States/Local Areas,Alaska,2018,Age,19 Months,86.1,80.7 to 90.2,275
Hib,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,60.3,55.1 to 65.3,562
Hib,≥3 Doses,States/Local Areas,Alaska,2017,Age,19 Months,79.8,73.1 to 85.1,258
Hib,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,82.9,78.7 to 86.4,533
Polio,≥3 Doses,States/Local Areas,Alaska,2016,Age,24 Months,87.2,80.9 to 92.2,228
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,88.1,84.1 to 91.6,486
Polio,≥3 Doses,States/Local Areas,Alaska,2015,Age,24 Months,89.3,85.0 to 92.8,257
Polio,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,88.2,84.5 to 91.5,485
Polio,≥3 Doses,States/Local Areas,Alaska,2014,Age,24 Months,89.4,84.9 to 93.0,275
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,89.4,86.3 to 92.0,532
Polio,≥2 Doses,States/Local Areas,Alaska,2020,Age,13 Months,86.3,80.0 to 90.8,302
Hib,Full Series,States/Local Areas,Alaska,2017,Age,35 Months,79.4,72.7 to 85.3,258
Hib,Full Series,States/Local Areas,Alaska,2017-2018,Age,35 Months,80.6,76.2 to 84.6,533
DTaP,≥2 Doses,States/Local Areas,Alaska,2016,Age,5 Months,70.1,62.0 to 77.1,228
DTaP,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,5 Months,70.7,65.2 to 75.6,486
DTaP,≥2 Doses,States/Local Areas,Alaska,2015,Age,5 Months,74.0,67.4 to 79.6,257
DTaP,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,5 Months,72.0,66.8 to 76.6,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2012,Age,24 Months,93.2,88.8 to 96.4,273
Hib,Full Series,States/Local Areas,Alaska,2015,Age,24 Months,75.7,69.0 to 81.9,257
Hib,Full Series,States/Local Areas,Alaska,2015-2016,Age,24 Months,76.5,71.5 to 81.1,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2013,Age,24 Months,88.3,83.0 to 92.5,303
DTaP,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,89.6,86.2 to 92.4,578
DTaP,≥3 Doses,States/Local Areas,Alaska,2011,Age,24 Months,92.8,87.7 to 96.3,288
Polio,≥3 Doses,States/Local Areas,Alaska,2011,Age,35 Months,93.3,88.6 to 96.6,288
Hib,≥3 Doses,States/Local Areas,Alaska,2014,Age,24 Months,88.4,83.6 to 92.2,275
Hib,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,85.7,82.0 to 89.0,532
Hib,≥3 Doses,States/Local Areas,Alaska,2013,Age,24 Months,81.8,75.7 to 87.1,303
Hib,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,24 Months,85.2,81.3 to 88.6,578
Hib,≥3 Doses,States/Local Areas,Alaska,2012,Age,24 Months,86.5,80.8 to 91.2,273
Hib,≥3 Doses,States/Local Areas,Alaska,2011,Age,24 Months,87.0,80.8 to 91.9,288
Hib,≥3 Doses,States/Local Areas,Alaska,2019,Age,19 Months,79.3,72.2 to 85.0,287
Polio,≥3 Doses,States/Local Areas,Alaska,2019,Age,24 Months,86.0,79.6 to 91.3,287
Polio,≥3 Doses,States/Local Areas,Alaska,2018,Age,24 Months,91.2,86.7 to 94.6,275
Polio,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,88.7,84.9 to 91.9,562
Polio,≥3 Doses,States/Local Areas,Alaska,2017,Age,24 Months,89.2,83.9 to 93.3,258
Polio,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,90.2,86.8 to 93.1,533
Hib,Full Series,States/Local Areas,Alaska,2018,Age,24 Months,80.8,74.9 to 86.0,275
Hib,Full Series,States/Local Areas,Alaska,2018-2019,Age,24 Months,77.7,73.2 to 82.0,562
Hib,Full Series,States/Local Areas,Alaska,2017,Age,24 Months,77.5,71.1 to 83.4,258
Hib,Full Series,States/Local Areas,Alaska,2017-2018,Age,24 Months,79.1,74.8 to 83.1,533
Hib,Full Series,States/Local Areas,Alaska,2016,Age,24 Months,77.2,69.9 to 83.9,228
Hib,Full Series,States/Local Areas,Alaska,2016-2017,Age,24 Months,77.4,72.5 to 82.0,486
Polio,≥3 Doses,States/Local Areas,Alaska,2015,Age,35 Months,92.7,87.1 to 96.4,257
Polio,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,89.7,85.5 to 93.1,485
Polio,≥3 Doses,States/Local Areas,Alaska,2012,Age,35 Months,97.4,93.6 to 99.2,273
Polio,≥3 Doses,States/Local Areas,Alaska,2014,Age,35 Months,91.4,87.2 to 94.7,275
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,92.2,88.6 to 95.0,532
Polio,≥3 Doses,States/Local Areas,Alaska,2013,Age,35 Months,93.7,86.4 to 97.8,303
Polio,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,92.0,87.7 to 95.2,578
DTaP,≥2 Doses,States/Local Areas,Alaska,2014,Age,5 Months,67.7,60.6 to 74.0,275
DTaP,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,5 Months,70.8,65.4 to 75.7,532
DTaP,≥2 Doses,States/Local Areas,Alaska,2013,Age,5 Months,74.6,68.6 to 79.8,303
DTaP,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,5 Months,71.1,67.4 to 74.6,578
DTaP,≥2 Doses,States/Local Areas,Alaska,2012,Age,5 Months,74.7,69.1 to 79.5,273
DTaP,≥2 Doses,States/Local Areas,Alaska,2011,Age,5 Months,74.1,70.0 to 77.9,288
Hib,Full Series,States/Local Areas,Alaska,2014,Age,35 Months,85.5,80.5 to 89.8,275
Hib,Full Series,States/Local Areas,Alaska,2014-2015,Age,35 Months,82.6,78.2 to 86.5,532
Hib,Full Series,States/Local Areas,Alaska,2013,Age,35 Months,81.3,74.3 to 87.3,303
Hib,Full Series,States/Local Areas,Alaska,2013-2014,Age,35 Months,83.4,79.1 to 87.2,578
Hib,Full Series,States/Local Areas,Alaska,2012,Age,35 Months,86.3,80.0 to 91.4,273
Hib,Full Series,States/Local Areas,Alaska,2011,Age,35 Months,83.4,76.6 to 89.2,288
Hib,Full Series,States/Local Areas,Alaska,2019,Age,24 Months,74.5,67.5 to 81.1,287
Polio,≥3 Doses,States/Local Areas,Alaska,2017,Age,35 Months,90.4,85.2 to 94.4,258
Polio,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,90.9,87.5 to 93.6,533
Polio,≥3 Doses,States/Local Areas,Alaska,2016,Age,35 Months,87.2,80.9 to 92.2,228
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,88.7,84.7 to 92.1,486
Hib,Full Series,States/Local Areas,Alaska,2016,Age,35 Months,77.6,70.3 to 84.2,228
Hib,Full Series,States/Local Areas,Alaska,2016-2017,Age,35 Months,78.4,73.4 to 82.9,486
Hib,Full Series,States/Local Areas,Alaska,2015,Age,35 Months,79.5,72.3 to 85.9,257
Hib,Full Series,States/Local Areas,Alaska,2015-2016,Age,35 Months,78.2,73.2 to 82.9,485
Polio,≥3 Doses,States/Local Areas,Alaska,2018,Age,35 Months,91.2,86.7 to 94.6,275
Polio,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,90.6,86.5 to 94.0,562
Hib,Full Series,States/Local Areas,Alaska,2019,Age,35 Months,80.3,71.7 to 87.7,287
Hib,Full Series,States/Local Areas,Alaska,2018,Age,35 Months,81.9,76.1 to 87.0,275
Hib,Full Series,States/Local Areas,Alaska,2018-2019,Age,35 Months,81.0,75.9 to 85.6,562
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,74.3,68.9 to 79.8,357
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,74.4,60.3 to 88.6,61
Polio,≥3 Doses,States/Local Areas,Alaska,2019,Age,35 Months,90.2,82.9 to 95.2,287
Hib,Full Series,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,83.7,79.8 to 87.6,458
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,83.9,72.6 to 95.3,61
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,85.5,80.9 to 90.0,357
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,91.5,88.8 to 94.2,458
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.6,85.0 to 94.1,187
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,85.3 to 93.1,463
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.4,82.8 to 89.9,481
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,83.6 to 92.6,306
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,96.0,91.1 to 100.0,97
PCV,≥2 Doses,States/Local Areas,Alabama,2011,Age,5 Months,79.9,74.0 to 84.8,218
PCV,≥2 Doses,States/Local Areas,Alabama,2012,Age,5 Months,83.6,78.4 to 87.8,233
PCV,≥2 Doses,States/Local Areas,Alabama,2013,Age,5 Months,76.0,68.6 to 82.0,260
PCV,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,5 Months,77.1,73.5 to 80.3,536
DTaP,≥3 Doses,States/Local Areas,Alabama,2016,Age,35 Months,93.6,89.1 to 96.7,309
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,95.6,93.0 to 97.5,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2017,Age,35 Months,97.7,94.7 to 99.2,259
DTaP,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,97.6,93.2 to 99.4,491
Hep A,≥1 Dose,States/Local Areas,Alabama,2018,Age,24 Months,88.0,82.1 to 92.7,232
Hep A,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,24 Months,88.0,83.8 to 91.5,459
Hep A,≥1 Dose,States/Local Areas,Alabama,2019,Age,24 Months,87.8,81.4 to 92.8,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2011,Age,35 Months,87.2,79.7 to 92.9,218
Hep A,≥1 Dose,States/Local Areas,Alabama,2012,Age,35 Months,87.7,79.9 to 93.5,233
PCV,≥2 Doses,States/Local Areas,Alabama,2017,Age,5 Months,78.4,70.2 to 84.9,259
PCV,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,5 Months,72.7,66.5 to 78.1,491
DTaP,≥2 Doses,States/Local Areas,Alabama,2019,Age,5 Months,84.5,77.8 to 89.4,227
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,93.6,89.8 to 97.4,209
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,93.9,92.0 to 95.7,1042
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,93.1,90.2 to 96.0,370
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,93.4,90.0 to 96.7,415
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,97.2,94.7 to 99.8,257
Hep A,≥1 Dose,States/Local Areas,Alabama,2019,Age,19 Months,84.2,76.6 to 89.6,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2011,Age,24 Months,82.7,75.4 to 88.9,218
Hep A,≥1 Dose,States/Local Areas,Alabama,2013,Age,24 Months,88.9,83.2 to 93.3,260
Hep A,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,24 Months,88.1,84.2 to 91.5,536
Hep A,≥1 Dose,States/Local Areas,Alabama,2012,Age,24 Months,84.9,77.3 to 91.0,233
Hep A,≥1 Dose,States/Local Areas,Alabama,2014,Age,24 Months,87.3,81.5 to 92.0,276
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,24 Months,88.1,84.4 to 91.4,563
Hep A,≥1 Dose,States/Local Areas,Alabama,2015,Age,24 Months,88.9,84.1 to 92.8,287
Hep A,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,24 Months,88.4,85.0 to 91.4,596
Hep A,≥1 Dose,States/Local Areas,Alabama,2016,Age,24 Months,87.9,82.9 to 92.0,309
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,24 Months,87.3,83.4 to 90.7,568
PCV,≥2 Doses,States/Local Areas,Alabama,2014,Age,5 Months,78.2,71.0 to 84.0,276
PCV,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,5 Months,77.3,74.6 to 79.9,563
PCV,≥2 Doses,States/Local Areas,Alabama,2015,Age,5 Months,76.4,68.9 to 82.6,287
PCV,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,5 Months,75.3,70.1 to 79.8,596
PCV,≥2 Doses,States/Local Areas,Alabama,2016,Age,5 Months,74.1,66.7 to 80.3,309
PCV,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,5 Months,76.3,70.9 to 80.9,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2018,Age,35 Months,97.0,89.4 to 99.6,232
DTaP,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,97.6,93.8 to 99.4,459
DTaP,≥3 Doses,States/Local Areas,Alabama,2019,Age,35 Months,97.8,95.3 to 99.2,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2017,Age,24 Months,86.7,80.4 to 91.8,259
Hep A,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,24 Months,87.4,83.1 to 91.0,491
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,97.2,92.6 to 100.0,67
DTaP,≥4 Doses,States/Local Areas,Alabama,2014,Age,19 Months,70.3,62.7 to 76.9,276
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,71.4,66.2 to 76.1,563
DTaP,≥4 Doses,States/Local Areas,Alabama,2015,Age,19 Months,72.6,69.8 to 75.1,287
DTaP,≥4 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,69.6,64.5 to 74.4,596
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,96.3,93.6 to 99.0,500
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,95.2,93.2 to 97.2,453
DTaP,≥4 Doses,States/Local Areas,Alabama,2016,Age,19 Months,66.7,59.3 to 73.3,309
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,67.5,62.0 to 72.6,568
Hep A,≥2 Doses,States/Local Areas,Alabama,2018,Age,19 Months,19.3,13.7 to 26.6,232
Hep A,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,25.3,19.7 to 31.9,372
Hep A,≥2 Doses,States/Local Areas,Alabama,2019,Age,19 Months,26.6,20.0 to 34.6,227
Hep A,≥2 Doses,States/Local Areas,Alabama,2011,Age,24 Months,45.2,36.2 to 55.2,218
Hib,≥3 Doses,States/Local Areas,Alabama,2016,Age,35 Months,92.8,88.4 to 96.0,309
Hib,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,93.9,90.6 to 96.3,568
Hib,≥3 Doses,States/Local Areas,Alabama,2017,Age,35 Months,94.7,89.5 to 97.9,259
Hib,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,95.4,90.6 to 98.2,491
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.2,92.7 to 99.7,132
Hep A,≥2 Doses,States/Local Areas,Alabama,2012,Age,24 Months,49.2,39.9 to 59.3,233
Hib,≥3 Doses,States/Local Areas,Alabama,2018,Age,35 Months,95.3,87.8 to 98.8,232
Hib,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.3,91.9 to 98.6,459
PCV,≥3 Doses,States/Local Areas,Alabama,2021,Age,19 Months,84.5,74.5 to 91.0,160
Hep A,≥1 Dose,States/Local Areas,Alabama,2021,Age,35 Months,88.5,79.6 to 94.7,160
PCV,≥2 Doses,States/Local Areas,Alabama,2021,Age,5 Months,69.7,58.2 to 79.2,160
DTaP,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,88.7,83.1 to 92.6,400
Hep B,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,93.7,89.3 to 96.4,400
DTaP,≥3 Doses,States/Local Areas,Alabama,2021,Age,7 Months,62.8,51.3 to 72.9,160
PCV,≥4 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,77.1,70.9 to 82.9,400
Polio,≥3 Doses,States/Local Areas,Alabama,2021,Age,19 Months,82.3,71.7 to 89.5,160
Hib,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,87.8,82.4 to 92.2,400
Hep B,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,80.4,73.9 to 85.7,400
Hib,≥2 Doses,States/Local Areas,Alabama,2021,Age,7 Months,78.6,67.5 to 86.7,160
PCV,≥3 Doses,States/Local Areas,Alabama,2021,Age,35 Months,89.4,80.2 to 95.5,160
≥1 Dose MMR,,States/Local Areas,Alabama,2021,Age,35 Months,87.9,78.2 to 94.7,160
Hib,≥3 Doses,States/Local Areas,Alabama,2021,Age,19 Months,82.3,71.7 to 89.5,160
Hib,≥2 Doses,States/Local Areas,Alabama,2021,Age,5 Months,70.9,59.7 to 80.0,160
Hib,Primary Series,States/Local Areas,Alabama,2020-2021,Age,24 Months,90.1,84.8 to 94.1,400
Hib,Primary Series,States/Local Areas,Alabama,2021,Age,19 Months,83.3,72.7 to 90.4,160
Hib,Full Series,States/Local Areas,Alabama,2021,Age,19 Months,62.0,50.7 to 72.1,160
Hib,≥3 Doses,States/Local Areas,Alabama,2021,Age,7 Months,56.3,45.0 to 66.9,160
Hep B,≥2 Doses,States/Local Areas,Alabama,2021,Age,7 Months,86.3,75.9 to 92.6,160
Hep B,≥3 Doses,States/Local Areas,Alabama,2021,Age,19 Months,79.4,68.8 to 87.1,160
DTaP,≥4 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,85.8,79.8 to 90.8,400
Hib,≥1 Dose,States/Local Areas,Alabama,2021,Age,3 Months,80.1,69.4 to 87.7,160
DTaP,≥1 Dose,States/Local Areas,Alabama,2011,Age,3 Months,87.6,81.6 to 91.8,218
DTaP,≥1 Dose,States/Local Areas,Alabama,2012,Age,3 Months,91.3,89.8 to 92.5,233
DTaP,≥1 Dose,States/Local Areas,Alabama,2013,Age,3 Months,88.7,82.3 to 93.0,260
DTaP,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,3 Months,89.0,85.0 to 92.1,536
DTaP,≥1 Dose,States/Local Areas,Alabama,2014,Age,3 Months,89.3,83.5 to 93.3,276
DTaP,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,3 Months,87.5,83.3 to 90.8,563
DTaP,≥1 Dose,States/Local Areas,Alabama,2015,Age,3 Months,85.8,79.1 to 90.6,287
DTaP,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,3 Months,86.4,82.2 to 89.8,596
DTaP,≥1 Dose,States/Local Areas,Alabama,2016,Age,3 Months,87.1,81.3 to 91.3,309
DTaP,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,3 Months,86.2,81.3 to 89.9,568
DTaP,≥1 Dose,States/Local Areas,Alabama,2017,Age,3 Months,85.2,76.9 to 90.9,259
DTaP,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,3 Months,86.5,80.8 to 90.7,491
DTaP,≥3 Doses,States/Local Areas,Alabama,2014,Age,24 Months,96.9,93.3 to 98.8,276
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,96.1,93.7 to 97.7,563
DTaP,≥3 Doses,States/Local Areas,Alabama,2015,Age,24 Months,95.3,91.5 to 97.8,287
DTaP,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,93.6,90.7 to 95.9,596
DTaP,≥1 Dose,States/Local Areas,Alabama,2018,Age,3 Months,87.8,80.4 to 92.7,232
DTaP,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,3 Months,91.2,87.0 to 94.1,459
DTaP,≥3 Doses,States/Local Areas,Alabama,2016,Age,24 Months,91.9,87.1 to 95.4,309
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,94.0,91.2 to 96.2,568
DTaP,≥1 Dose,States/Local Areas,Alabama,2019,Age,3 Months,94.5,90.1 to 97.0,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2011,Age,19 Months,79.7,70.4 to 86.6,218
Hep A,≥1 Dose,States/Local Areas,Alabama,2012,Age,19 Months,81.5,77.0 to 85.3,233
≥1 Dose Varicella,,States/Local Areas,Alabama,2021,Age,19 Months,82.5,72.2 to 89.5,160
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.7,75.3 to 84.0,632
Hep A,≥1 Dose,States/Local Areas,Alabama,2013,Age,19 Months,87.0,80.2 to 91.6,260
Hep A,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,19 Months,85.7,80.8 to 89.5,536
Hep A,≥1 Dose,States/Local Areas,Alabama,2016,Age,19 Months,81.4,75.4 to 86.3,309
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,19 Months,80.5,75.7 to 84.6,568
Hep A,≥1 Dose,States/Local Areas,Alabama,2014,Age,19 Months,84.4,77.9 to 89.2,276
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,19 Months,85.2,81.0 to 88.6,563
Hep A,≥1 Dose,States/Local Areas,Alabama,2015,Age,19 Months,86.0,80.6 to 90.1,287
Hep A,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,19 Months,83.8,79.7 to 87.1,596
DTaP,≥2 Doses,States/Local Areas,Alabama,2017,Age,5 Months,78.5,70.4 to 84.9,259
DTaP,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,5 Months,73.4,67.3 to 78.8,491
DTaP,≥2 Doses,States/Local Areas,Alabama,2018,Age,5 Months,68.2,58.8 to 76.4,232
DTaP,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,5 Months,76.4,70.5 to 81.4,459
DTaP,≥3 Doses,States/Local Areas,Alabama,2017,Age,24 Months,96.2,93.0 to 98.2,259
DTaP,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,94.7,91.6 to 96.9,491
DTaP,≥3 Doses,States/Local Areas,Alabama,2018,Age,24 Months,93.2,87.7 to 96.8,232
DTaP,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,95.6,92.7 to 97.6,459
Hib,≥3 Doses,States/Local Areas,Alabama,2015,Age,24 Months,93.5,89.3 to 96.5,287
Hib,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,91.9,88.7 to 94.5,596
Hib,≥3 Doses,States/Local Areas,Alabama,2016,Age,24 Months,90.2,85.1 to 94.2,309
Hib,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,91.7,88.2 to 94.5,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2019,Age,24 Months,97.8,95.3 to 99.2,227
Hib,≥3 Doses,States/Local Areas,Alabama,2017,Age,24 Months,93.1,87.9 to 96.6,259
Hib,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,91.8,87.3 to 95.2,491
Hep A,≥1 Dose,States/Local Areas,Alabama,2017,Age,19 Months,79.6,71.7 to 85.8,259
Hep A,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,19 Months,80.4,74.9 to 84.9,491
Hep A,≥1 Dose,States/Local Areas,Alabama,2018,Age,19 Months,81.1,73.0 to 87.2,232
Hep A,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,19 Months,84.8,78.9 to 89.2,372
DTaP,≥3 Doses,States/Local Areas,Alabama,2011,Age,35 Months,92.3,85.0 to 96.8,218
DTaP,≥3 Doses,States/Local Areas,Alabama,2012,Age,35 Months,96.1,90.4 to 98.9,233
DTaP,≥3 Doses,States/Local Areas,Alabama,2013,Age,35 Months,95.8,91.0 to 98.5,260
DTaP,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,96.4,93.5 to 98.2,536
DTaP,≥3 Doses,States/Local Areas,Alabama,2014,Age,35 Months,96.9,93.3 to 98.8,276
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,96.1,93.7 to 97.7,563
DTaP,≥3 Doses,States/Local Areas,Alabama,2015,Age,35 Months,95.3,91.5 to 97.8,287
DTaP,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,94.7,91.8 to 96.8,596
Hep A,≥2 Doses,States/Local Areas,Alabama,2011,Age,19 Months,31.3,26.6 to 36.3,218
Hep A,≥2 Doses,States/Local Areas,Alabama,2013,Age,19 Months,24.5,16.7 to 34.4,260
Hep A,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,25.7,20.9 to 31.2,536
Hep A,≥2 Doses,States/Local Areas,Alabama,2012,Age,19 Months,25.5,22.0 to 29.4,233
Hep A,≥2 Doses,States/Local Areas,Alabama,2014,Age,19 Months,27.0,20.6 to 34.5,276
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,29.1,24.2 to 34.5,563
Hib,≥3 Doses,States/Local Areas,Alabama,2018,Age,24 Months,90.2,83.4 to 95.1,232
Hib,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,92.8,89.0 to 95.7,459
Hib,≥3 Doses,States/Local Areas,Alabama,2019,Age,24 Months,95.4,91.5 to 97.9,227
Hib,≥3 Doses,States/Local Areas,Alabama,2011,Age,35 Months,91.9,84.7 to 96.5,218
Hib,≥3 Doses,States/Local Areas,Alabama,2012,Age,35 Months,96.7,91.3 to 99.1,233
DTaP,≥4 Doses,States/Local Areas,Alabama,2011,Age,19 Months,77.6,73.4 to 81.3,218
DTaP,≥4 Doses,States/Local Areas,Alabama,2012,Age,19 Months,74.0,70.8 to 77.0,233
DTaP,≥4 Doses,States/Local Areas,Alabama,2013,Age,19 Months,68.0,61.0 to 74.3,260
DTaP,≥4 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,69.2,66.4 to 71.8,536
Hep A,≥2 Doses,States/Local Areas,Alabama,2015,Age,19 Months,31.2,28.7 to 33.8,287
Hep A,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,28.7,24.0 to 34.0,596
Hep A,≥2 Doses,States/Local Areas,Alabama,2016,Age,19 Months,26.2,20.2 to 33.3,309
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,25.1,20.6 to 30.3,568
Hib,≥3 Doses,States/Local Areas,Alabama,2013,Age,35 Months,94.8,90.3 to 97.6,260
Hib,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,95.5,92.7 to 97.5,536
Hib,≥3 Doses,States/Local Areas,Alabama,2014,Age,35 Months,96.4,92.3 to 98.6,276
Hib,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,95.9,93.1 to 97.9,563
Hib,≥3 Doses,States/Local Areas,Alabama,2015,Age,35 Months,95.2,90.7 to 97.9,287
Hib,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,93.9,91.0 to 96.2,596
Hep A,≥2 Doses,States/Local Areas,Alabama,2017,Age,19 Months,24.0,17.7 to 31.8,259
Hep A,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,21.7,17.2 to 27.0,491
Polio,≥3 Doses,States/Local Areas,Iowa,2019,Age,35 Months,95.0,89.7 to 98.1,250
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,86.8,82.9 to 90.8,378
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,76.5,69.7 to 83.2,222
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Overall,Overall,84.4,81.4 to 87.3,838
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,79.4,74.1 to 84.8,326
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.9,78.1 to 89.6,238
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,89.9,85.9 to 93.8,274
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.1,80.7 to 87.5,642
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.3,72.4 to 94.2,75
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,86.6,78.5 to 94.6,84
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,91.5 to 98.5,238
Hib,Primary Series,States/Local Areas,Iowa,2012,Age,7 Months,72.3,67.8 to 76.5,247
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,90.3,86.2 to 94.4,238
Hib,Primary Series,States/Local Areas,Iowa,2011,Age,7 Months,69.9,63.7 to 75.4,220
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,88.9,80.0 to 97.9,49
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,95.7,93.1 to 98.3,274
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.2,93.4 to 97.1,642
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.5,89.7 to 100.0,75
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,98.1,95.5 to 100.0,84
Hib,Full Series,States/Local Areas,Iowa,2016,Age,35 Months,92.4,85.8 to 96.7,198
Hib,Full Series,States/Local Areas,Iowa,2016-2017,Age,35 Months,88.5,83.5 to 92.5,426
Hib,Full Series,States/Local Areas,Iowa,2018,Age,35 Months,93.7,89.1 to 96.8,255
Hib,Full Series,States/Local Areas,Iowa,2018-2019,Age,35 Months,92.6,88.8 to 95.4,505
Hib,Full Series,States/Local Areas,Iowa,2019,Age,35 Months,91.5,85.4 to 95.7,250
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,78.0,72.3 to 83.7,297
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.5,70.0 to 97.0,37
Hib,Full Series,States/Local Areas,Iowa,2014,Age,35 Months,86.7,80.9 to 91.4,277
Hib,Full Series,States/Local Areas,Iowa,2014-2015,Age,35 Months,87.0,82.5 to 90.9,515
Hib,Full Series,States/Local Areas,Iowa,2015,Age,35 Months,88.0,80.0 to 93.8,238
Hib,Full Series,States/Local Areas,Iowa,2015-2016,Age,35 Months,90.3,85.1 to 94.3,436
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,97.8,93.6 to 100.0,49
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,91.9,88.2 to 95.6,297
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,97.9,96.5 to 99.2,472
Polio,≥3 Doses,States/Local Areas,Iowa,2018,Age,35 Months,98.5,96.3 to 99.5,255
Polio,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,96.9,94.1 to 98.6,505
Hib,Full Series,States/Local Areas,Iowa,2017,Age,35 Months,85.0,77.6 to 91.0,228
Hib,Full Series,States/Local Areas,Iowa,2017-2018,Age,35 Months,89.4,85.0 to 92.9,483
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.0,74.3 to 99.6,37
Hib,Full Series,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,91.4,88.8 to 93.9,472
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,80.7,74.4 to 86.9,378
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2011,Age,0-1 Days,61.3,54.3 to 67.8,220
Hep B,≥2 Doses,States/Local Areas,Iowa,2012,Age,5 Months,83.6,78.6 to 87.6,247
Hep B,≥2 Doses,States/Local Areas,Iowa,2011,Age,5 Months,88.5,83.1 to 92.3,220
Hep B,≥2 Doses,States/Local Areas,Iowa,2013,Age,5 Months,89.1,87.2 to 90.7,265
Hep B,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,5 Months,89.6,83.7 to 93.5,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2013,Age,19 Months,96.1,89.7 to 98.6,265
Hep B,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,94.4,91.1 to 96.6,542
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,80.4,73.3 to 87.4,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2014,Age,19 Months,92.8,88.1 to 95.7,277
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,93.9,90.7 to 96.0,515
Hep B,≥3 Doses,States/Local Areas,Iowa,2015,Age,19 Months,95.0,93.1 to 96.4,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,95.9,93.0 to 97.6,436
DTaP,≥4 Doses,States/Local Areas,Iowa,2018,Age,35 Months,93.2,87.4 to 96.9,255
DTaP,≥4 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,93.5,89.1 to 96.6,505
DTaP,≥4 Doses,States/Local Areas,Iowa,2017,Age,35 Months,85.0,76.6 to 91.7,228
DTaP,≥4 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,89.3,83.8 to 93.6,483
DTaP,≥4 Doses,States/Local Areas,Iowa,2016,Age,35 Months,93.2,86.9 to 97.1,198
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,88.8,83.7 to 92.9,426
Hep B,≥3 Doses,States/Local Areas,Iowa,2016,Age,13 Months,95.5,91.4 to 97.6,198
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,93.4,90.1 to 95.7,426
Hep B,≥3 Doses,States/Local Areas,Iowa,2015,Age,13 Months,93.2,88.0 to 96.3,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,94.4,91.2 to 96.4,436
Hep B,≥3 Doses,States/Local Areas,Iowa,2017,Age,13 Months,91.4,85.6 to 95.0,228
Hep B,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,93.7,90.3 to 96.0,483
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,78.5,66.3 to 90.7,84
Hep B,≥1 Dose,States/Local Areas,Iowa,2013,Age,3 Months,96.1,94.6 to 97.2,265
Hep B,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,3 Months,96.3,94.8 to 97.4,542
Hep B,≥1 Dose,States/Local Areas,Iowa,2012,Age,3 Months,92.8,90.3 to 94.6,247
Hep B,≥1 Dose,States/Local Areas,Iowa,2011,Age,3 Months,96.0,94.6 to 97.1,220
Hep B,≥1 Dose,States/Local Areas,Iowa,2014,Age,3 Months,96.5,93.9 to 98.1,277
Hep B,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,3 Months,96.6,94.3 to 98.0,515
Polio,≥2 Doses,States/Local Areas,Iowa,2017,Age,7 Months,89.6,83.0 to 93.9,228
Polio,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,91.8,87.8 to 94.6,483
Polio,≥2 Doses,States/Local Areas,Iowa,2018,Age,7 Months,94.0,88.6 to 96.9,255
Polio,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,93.9,90.2 to 96.3,505
≥1 Dose Varicella,,States/Local Areas,Iowa,2014,Age,19 Months,88.9,83.8 to 92.5,277
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2015,Age,19 Months,88.4,84.4 to 91.4,515
≥1 Dose Varicella,,States/Local Areas,Iowa,2015,Age,19 Months,87.9,86.1 to 89.5,238
≥1 Dose Varicella,,States/Local Areas,Iowa,2015-2016,Age,19 Months,87.5,82.7 to 91.1,436
≥1 Dose Varicella,,States/Local Areas,Iowa,2016,Age,19 Months,87.1,79.8 to 92.0,198
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2017,Age,19 Months,88.9,84.6 to 92.1,426
Polio,≥2 Doses,States/Local Areas,Iowa,2012,Age,13 Months,93.1,88.6 to 95.9,247
Polio,≥2 Doses,States/Local Areas,Iowa,2011,Age,13 Months,95.4,90.4 to 97.8,220
Polio,≥2 Doses,States/Local Areas,Iowa,2013,Age,13 Months,95.3,91.2 to 97.6,265
Polio,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,95.6,93.2 to 97.2,542
Polio,≥2 Doses,States/Local Areas,Iowa,2014,Age,13 Months,95.9,92.4 to 97.9,277
Polio,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,95.5,92.6 to 97.2,515
Hep B,≥1 Dose,States/Local Areas,Iowa,2015,Age,3 Months,96.6,92.0 to 98.6,238
Hep B,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,3 Months,97.3,94.9 to 98.6,436
Hep B,≥1 Dose,States/Local Areas,Iowa,2016,Age,3 Months,97.9,95.2 to 99.1,198
Hep B,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,3 Months,97.3,95.1 to 98.5,426
Hep B,≥1 Dose,States/Local Areas,Iowa,2017,Age,3 Months,96.6,92.6 to 98.5,228
Hep B,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,3 Months,97.1,94.4 to 98.5,483
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.0,50.6 to 81.5,75
Hep B,≥2 Doses,States/Local Areas,Iowa,2015,Age,5 Months,91.6,85.7 to 95.2,238
Hep B,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,5 Months,93.5,90.1 to 95.8,436
Polio,≥2 Doses,States/Local Areas,Iowa,2018,Age,13 Months,97.0,92.5 to 98.9,255
Polio,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,96.2,92.7 to 98.0,505
Polio,≥2 Doses,States/Local Areas,Iowa,2019,Age,13 Months,95.3,88.9 to 98.1,250
≥1 Dose Varicella,,States/Local Areas,Iowa,2019,Age,19 Months,91.3,85.2 to 95.1,250
≥1 Dose Varicella,,States/Local Areas,Iowa,2014,Age,24 Months,90.1,85.5 to 93.6,277
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2015,Age,24 Months,90.0,86.4 to 93.0,515
≥1 Dose Varicella,,States/Local Areas,Iowa,2013,Age,24 Months,91.3,86.2 to 95.0,265
≥1 Dose Varicella,,States/Local Areas,Iowa,2013-2014,Age,24 Months,90.5,87.3 to 93.3,542
PCV,≥4 Doses,States/Local Areas,Iowa,2013,Age,19 Months,81.3,78.5 to 83.9,265
PCV,≥4 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,80.5,78.2 to 82.6,542
PCV,≥4 Doses,States/Local Areas,Iowa,2012,Age,19 Months,82.5,74.0 to 88.7,247
PCV,≥4 Doses,States/Local Areas,Iowa,2011,Age,19 Months,76.6,69.6 to 82.4,220
≥1 Dose MMR,,States/Local Areas,Iowa,2018,Age,19 Months,95.5,90.7 to 97.9,255
≥1 Dose MMR,,States/Local Areas,Iowa,2018-2019,Age,19 Months,95.5,91.7 to 97.6,505
PCV,≥4 Doses,States/Local Areas,Iowa,2014,Age,19 Months,79.6,73.2 to 84.8,277
≥1 Dose MMR,,States/Local Areas,Iowa,2019,Age,19 Months,92.2,86.1 to 95.7,250
DTaP,≥4 Doses,States/Local Areas,Iowa,2019,Age,35 Months,93.4,86.9 to 97.3,250
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,74.2,68.0 to 80.4,297
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,89.2,86.0 to 92.4,472
≥1 Dose MMR,,States/Local Areas,Iowa,2011,Age,19 Months,84.8,79.4 to 88.9,220
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,91.6,80.9 to 100.0,49
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.4,55.9 to 91.0,37
Hep B,≥3 Doses,States/Local Areas,Iowa,2012,Age,19 Months,93.1,87.0 to 96.4,247
Hep A,≥1 Dose,States/Local Areas,Iowa,2020,Age,35 Months,90.7,84.0 to 95.4,271
Hep B,≥3 Doses,States/Local Areas,Iowa,2018,Age,13 Months,96.1,91.7 to 98.2,255
Hep B,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,94.6,90.9 to 96.9,505
Hep B,≥3 Doses,States/Local Areas,Iowa,2019,Age,13 Months,93.1,86.3 to 96.6,250
Hep B,≥3 Doses,States/Local Areas,Iowa,2011,Age,19 Months,95.3,89.7 to 97.9,220
≥1 Dose MMR,,States/Local Areas,Iowa,2013,Age,19 Months,91.2,88.9 to 93.0,265
≥1 Dose MMR,,States/Local Areas,Iowa,2013-2014,Age,19 Months,91.5,90.6 to 92.4,542
≥1 Dose MMR,,States/Local Areas,Iowa,2014,Age,19 Months,91.9,87.3 to 94.9,277
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2015,Age,19 Months,90.4,86.6 to 93.2,515
≥1 Dose MMR,,States/Local Areas,Iowa,2012,Age,19 Months,89.9,83.3 to 94.1,247
≥1 Dose Varicella,,States/Local Areas,Iowa,2017,Age,19 Months,90.7,85.4 to 94.2,228
≥1 Dose Varicella,,States/Local Areas,Iowa,2017-2018,Age,19 Months,92.0,88.3 to 94.5,483
≥1 Dose Varicella,,States/Local Areas,Iowa,2018,Age,19 Months,93.3,87.4 to 96.5,255
≥1 Dose Varicella,,States/Local Areas,Iowa,2018-2019,Age,19 Months,54.3,48.3 to 60.1,505
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,85.1,76.1 to 94.1,84
Polio,≥2 Doses,States/Local Areas,Iowa,2015,Age,13 Months,95.0,89.8 to 97.6,238
Polio,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,96.2,93.4 to 97.9,436
Polio,≥2 Doses,States/Local Areas,Iowa,2016,Age,13 Months,97.5,94.7 to 98.9,198
Polio,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,95.8,93.1 to 97.5,426
Polio,≥2 Doses,States/Local Areas,Iowa,2017,Age,13 Months,94.1,89.1 to 96.9,228
Polio,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,95.6,92.5 to 97.4,483
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.6,79.0 to 86.2,642
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,65.9 to 90.9,75
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,82.0,78.7 to 85.2,838
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,77.9,72.0 to 83.7,326
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,86.1,81.2 to 91.0,274
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.3,76.2 to 88.4,238
≥1 Dose MMR,,States/Local Areas,Iowa,2015,Age,19 Months,88.8,86.5 to 90.8,238
≥1 Dose MMR,,States/Local Areas,Iowa,2015-2016,Age,19 Months,88.2,83.5 to 91.7,436
≥1 Dose MMR,,States/Local Areas,Iowa,2016,Age,19 Months,87.7,80.4 to 92.5,198
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2017,Age,19 Months,88.9,84.6 to 92.1,426
≥1 Dose MMR,,States/Local Areas,Iowa,2017,Age,19 Months,90.2,84.6 to 93.9,228
≥1 Dose MMR,,States/Local Areas,Iowa,2017-2018,Age,19 Months,92.8,89.4 to 95.2,483
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,71.6,64.2 to 79.1,222
≥1 Dose Varicella,,States/Local Areas,Iowa,2011,Age,24 Months,84.8,77.6 to 90.7,220
≥1 Dose Varicella,,States/Local Areas,Iowa,2012,Age,24 Months,89.6,84.2 to 93.8,247
Hep B,≥1 Dose,States/Local Areas,Iowa,2018,Age,3 Months,97.5,92.5 to 99.2,255
Hep B,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,3 Months,96.4,93.0 to 98.2,505
Hep B,≥1 Dose,States/Local Areas,Iowa,2019,Age,3 Months,95.4,89.2 to 98.1,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2012,Age,0-1 Days,61.4,56.2 to 66.3,247
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2019,Age,0-1 Days,79.8,72.4 to 85.6,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2011,Age,0-2 Days,70.3,61.8 to 77.6,220
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2013,Age,0-2 Days,72.3,68.8 to 75.5,265
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2013-2014,Age,0-2 Days,72.7,68.7 to 76.3,542
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2012,Age,0-2 Days,68.0,65.4 to 70.5,247
Hep B,≥2 Doses,States/Local Areas,Iowa,2013,Age,7 Months,95.0,92.9 to 96.5,265
Hep B,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,93.7,90.7 to 95.8,542
Hep B,≥2 Doses,States/Local Areas,Iowa,2014,Age,7 Months,92.5,87.7 to 95.5,277
Hep B,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,93.2,89.8 to 95.5,515
Hep B,≥2 Doses,States/Local Areas,Iowa,2015,Age,7 Months,93.9,88.1 to 97.0,238
Hep B,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,94.7,91.4 to 96.7,436
Hep B,≥2 Doses,States/Local Areas,Iowa,2012,Age,7 Months,89.1,80.7 to 94.1,247
PCV,≥3 Doses,States/Local Areas,Iowa,2018,Age,7 Months,80.2,72.4 to 86.2,255
PCV,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,78.6,73.0 to 83.4,505
PCV,≥3 Doses,States/Local Areas,Iowa,2019,Age,7 Months,77.0,68.4 to 83.9,250
PCV,≥3 Doses,States/Local Areas,Iowa,2011,Age,13 Months,88.9,83.4 to 92.8,220
PCV,≥4 Doses,States/Local Areas,Iowa,2017,Age,19 Months,78.6,70.7 to 84.8,228
PCV,≥4 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,83.9,79.0 to 87.9,483
PCV,≥4 Doses,States/Local Areas,Iowa,2018,Age,19 Months,89.4,83.0 to 93.6,255
PCV,≥4 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,89.6,84.4 to 93.2,396
≥1 Dose MMR,,States/Local Areas,Iowa,2017,Age,24 Months,92.0,87.2 to 95.6,228
≥1 Dose MMR,,States/Local Areas,Iowa,2017-2018,Age,24 Months,94.6,91.6 to 96.7,483
≥1 Dose MMR,,States/Local Areas,Iowa,2016,Age,24 Months,91.0,84.4 to 95.5,198
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2017,Age,24 Months,91.5,87.6 to 94.6,426
PCV,≥3 Doses,States/Local Areas,Iowa,2012,Age,13 Months,90.2,83.4 to 94.4,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2016,Age,24 Months,96.8,93.6 to 98.6,198
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,95.3,92.6 to 97.3,426
PCV,≥3 Doses,States/Local Areas,Iowa,2013,Age,13 Months,90.2,85.6 to 93.4,265
PCV,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,89.4,85.9 to 92.2,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2015,Age,24 Months,96.6,92.3 to 98.9,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,96.7,94.2 to 98.3,436
≥1 Dose Varicella,,States/Local Areas,Iowa,2019,Age,24 Months,93.4,87.8 to 97.0,250
≥1 Dose Varicella,,States/Local Areas,Iowa,2011,Age,35 Months,93.9,86.7 to 98.0,220
≥1 Dose Varicella,,States/Local Areas,Iowa,2012,Age,35 Months,91.6,86.4 to 95.4,247
≥1 Dose Varicella,,States/Local Areas,Iowa,2018,Age,24 Months,94.9,89.8 to 97.9,255
≥1 Dose Varicella,,States/Local Areas,Iowa,2018-2019,Age,24 Months,94.1,90.6 to 96.7,505
≥1 Dose MMR,,States/Local Areas,Iowa,2015,Age,24 Months,91.3,85.4 to 95.5,238
≥1 Dose MMR,,States/Local Areas,Iowa,2015-2016,Age,24 Months,91.2,86.9 to 94.5,436
≥1 Dose MMR,,States/Local Areas,Iowa,2014,Age,24 Months,93.2,89.4 to 96.1,277
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2015,Age,24 Months,92.2,88.8 to 94.8,515
≥1 Dose MMR,,States/Local Areas,Iowa,2013,Age,24 Months,95.9,92.7 to 98.0,265
≥1 Dose MMR,,States/Local Areas,Iowa,2013-2014,Age,24 Months,94.5,92.1 to 96.3,542
PCV,≥3 Doses,States/Local Areas,Iowa,2017,Age,7 Months,68.1,59.9 to 75.3,228
PCV,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,74.1,68.5 to 79.0,483
PCV,≥3 Doses,States/Local Areas,Iowa,2015,Age,7 Months,75.0,67.7 to 81.1,238
PCV,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,76.6,71.0 to 81.3,436
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,82.3,78.0 to 86.0,515
PCV,≥4 Doses,States/Local Areas,Iowa,2015,Age,19 Months,85.1,81.8 to 87.9,238
PCV,≥4 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,84.1,78.9 to 88.2,436
PCV,≥4 Doses,States/Local Areas,Iowa,2016,Age,19 Months,83.0,74.7 to 89.0,198
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,80.8,75.4 to 85.3,426
PCV,≥3 Doses,States/Local Areas,Iowa,2016,Age,7 Months,78.2,69.5 to 84.9,198
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,73.1,67.0 to 78.5,426
Hep B,≥3 Doses,States/Local Areas,Iowa,2012,Age,24 Months,93.1,88.7 to 96.2,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2014,Age,24 Months,92.8,88.5 to 95.9,277
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,94.7,91.9 to 96.8,515
Hep B,≥3 Doses,States/Local Areas,Iowa,2013,Age,24 Months,96.7,93.7 to 98.5,265
Hep B,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,94.7,92.2 to 96.7,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2019,Age,19 Months,94.5,88.2 to 97.5,250
Hep B,≥3 Doses,States/Local Areas,Iowa,2011,Age,24 Months,95.3,90.3 to 98.2,220
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2016,Age,0-2 Days,85.5,78.4 to 90.5,198
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2016-2017,Age,0-2 Days,83.8,79.1 to 87.7,426
Hep B,≥2 Doses,States/Local Areas,Iowa,2016,Age,7 Months,95.4,91.5 to 97.6,198
Hep B,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,95.0,92.1 to 96.9,426
Hep B,≥2 Doses,States/Local Areas,Iowa,2017,Age,7 Months,94.7,89.7 to 97.3,228
Hep B,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,95.6,92.5 to 97.4,483
Hep B,≥2 Doses,States/Local Areas,Iowa,2018,Age,7 Months,96.5,92.0 to 98.5,255
PCV,≥3 Doses,States/Local Areas,Iowa,2014,Age,13 Months,88.7,83.3 to 92.4,277
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,90.8,87.2 to 93.5,515
PCV,≥3 Doses,States/Local Areas,Iowa,2015,Age,13 Months,93.0,87.3 to 96.3,238
PCV,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,93.3,89.5 to 95.8,436
Hep B,≥3 Doses,States/Local Areas,Iowa,2018,Age,24 Months,98.1,96.0 to 99.2,255
Hep B,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,96.3,93.5 to 98.1,505
PCV,≥3 Doses,States/Local Areas,Iowa,2016,Age,13 Months,93.6,88.4 to 96.5,198
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,91.3,87.2 to 94.2,426
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2016,Age,0-1 Days,79.1,71.2 to 85.3,198
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2016-2017,Age,0-1 Days,78.4,73.2 to 82.8,426
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2017,Age,0-1 Days,77.7,70.3 to 83.7,228
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2017-2018,Age,0-1 Days,79.2,74.2 to 83.5,483
Hep B,≥2 Doses,States/Local Areas,Iowa,2019,Age,5 Months,92.3,85.5 to 96.1,250
Hep B,≥2 Doses,States/Local Areas,Iowa,2011,Age,7 Months,93.3,90.7 to 95.2,220
Hep B,≥2 Doses,States/Local Areas,Iowa,2017,Age,5 Months,91.3,85.1 to 95.1,228
Hep B,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,5 Months,93.8,90.2 to 96.1,483
PCV,≥4 Doses,States/Local Areas,Iowa,2020,Age,35 Months,86.4,79.8 to 91.7,271
Hep B,≥2 Doses,States/Local Areas,Iowa,2018,Age,5 Months,96.3,91.9 to 98.4,255
Hep B,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,5 Months,94.3,90.6 to 96.6,505
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2018,Age,0-1 Days,80.8,73.4 to 86.5,255
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2018-2019,Age,0-1 Days,80.3,75.3 to 84.5,505
≥1 Dose Varicella,,States/Local Areas,Iowa,2017,Age,24 Months,91.9,87.2 to 95.4,228
≥1 Dose Varicella,,States/Local Areas,Iowa,2017-2018,Age,24 Months,93.4,90.1 to 95.9,483
≥1 Dose Varicella,,States/Local Areas,Iowa,2016,Age,24 Months,90.3,83.7 to 95.0,198
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2017,Age,24 Months,91.1,87.2 to 94.2,426
≥1 Dose MMR,,States/Local Areas,Iowa,2011,Age,24 Months,89.9,83.4 to 94.6,220
≥1 Dose MMR,,States/Local Areas,Iowa,2012,Age,24 Months,91.9,87.2 to 95.4,247
≥1 Dose Varicella,,States/Local Areas,Iowa,2015,Age,24 Months,90.0,83.9 to 94.5,238
≥1 Dose Varicella,,States/Local Areas,Iowa,2015-2016,Age,24 Months,90.1,85.8 to 93.6,436
PCV,≥3 Doses,States/Local Areas,Iowa,2013,Age,7 Months,71.3,68.0 to 74.3,265
PCV,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,70.6,68.5 to 72.7,542
PCV,≥3 Doses,States/Local Areas,Iowa,2011,Age,7 Months,66.4,62.4 to 70.2,220
Hep B,≥3 Doses,States/Local Areas,Iowa,2016,Age,19 Months,96.8,93.1 to 98.5,198
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,95.1,92.1 to 97.0,426
PCV,≥3 Doses,States/Local Areas,Iowa,2014,Age,7 Months,70.0,63.2 to 76.1,277
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,72.5,67.6 to 77.0,515
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,88.8,84.2 to 93.5,238
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,85.5,81.3 to 89.8,378
PCV,≥3 Doses,States/Local Areas,Iowa,2012,Age,7 Months,68.3,65.3 to 71.1,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2017,Age,19 Months,93.4,88.1 to 96.4,228
Hep B,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,95.6,92.8 to 97.3,483
Hep B,≥3 Doses,States/Local Areas,Iowa,2018,Age,19 Months,97.9,95.5 to 99.0,255
Hep B,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,94.6,90.9 to 96.9,505
Hep B,≥2 Doses,States/Local Areas,Iowa,2016,Age,5 Months,95.4,91.5 to 97.6,198
Hep B,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,5 Months,93.4,89.9 to 95.7,426
Hep B,≥2 Doses,States/Local Areas,Iowa,2014,Age,5 Months,90.0,84.8 to 93.6,277
Hep B,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,5 Months,90.8,86.1 to 94.1,515
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2013,Age,0-1 Days,62.8,59.4 to 66.1,265
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2013-2014,Age,0-1 Days,65.6,61.3 to 69.6,542
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2014,Age,0-1 Days,68.3,61.5 to 74.3,277
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2014-2015,Age,0-1 Days,71.4,66.2 to 76.1,515
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2015,Age,0-1 Days,74.5,66.0 to 81.5,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2015-2016,Age,0-1 Days,76.8,71.1 to 81.7,436
Hib,≥2 Doses,States/Local Areas,Iowa,2015,Age,5 Months,80.7,73.5 to 86.3,238
Hib,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,5 Months,82.8,77.5 to 87.1,436
Hib,≥2 Doses,States/Local Areas,Iowa,2016,Age,5 Months,84.9,76.6 to 90.7,198
Hib,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,5 Months,82.8,77.6 to 87.1,426
PCV,≥3 Doses,States/Local Areas,Iowa,2015,Age,24 Months,95.0,90.5 to 97.8,238
PCV,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,96.0,93.1 to 97.9,436
PCV,≥3 Doses,States/Local Areas,Iowa,2014,Age,24 Months,91.9,87.5 to 95.3,277
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,93.5,90.5 to 95.8,515
PCV,≥3 Doses,States/Local Areas,Iowa,2012,Age,24 Months,93.4,89.0 to 96.5,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2020,Age,24 Months,94.0,89.4 to 97.0,271
Hib,≥2 Doses,States/Local Areas,Iowa,2017,Age,5 Months,80.7,73.3 to 86.4,228
Hib,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,5 Months,84.7,80.0 to 88.4,483
PCV,≥3 Doses,States/Local Areas,Iowa,2013,Age,24 Months,94.3,90.2 to 97.0,265
PCV,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,93.1,90.2 to 95.4,542
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,93.7,91.3 to 96.0,472
PCV,≥1 Dose,States/Local Areas,Iowa,2013,Age,3 Months,88.3,86.3 to 90.0,265
PCV,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,3 Months,88.2,85.6 to 90.4,542
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,92.0,85.5 to 98.5,84
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.6,72.7 to 98.6,37
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,86.7,75.8 to 97.6,49
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,80.0,74.2 to 85.8,297
Hib,≥2 Doses,States/Local Areas,Iowa,2012,Age,5 Months,75.4,72.2 to 78.4,247
Hib,≥2 Doses,States/Local Areas,Iowa,2011,Age,5 Months,74.5,69.5 to 79.0,220
Hib,≥1 Dose,States/Local Areas,Iowa,2018,Age,3 Months,92.8,87.2 to 96.0,255
Hib,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,3 Months,93.0,89.1 to 95.5,505
Hib,≥1 Dose,States/Local Areas,Iowa,2019,Age,3 Months,93.2,86.8 to 96.6,250
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,90.2 to 100.0,75
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,97.2,94.0 to 100.0,84
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.3,66.4 to 96.2,37
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,89.3,85.2 to 93.4,297
PCV,≥4 Doses,States/Local Areas,Iowa,2016,Age,35 Months,90.8,83.7 to 95.7,198
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,89.1,84.1 to 93.1,426
PCV,≥4 Doses,States/Local Areas,Iowa,2015,Age,35 Months,92.3,84.5 to 97.1,238
PCV,≥4 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,90.9,86.5 to 94.4,436
PCV,≥4 Doses,States/Local Areas,Iowa,2014,Age,35 Months,86.3,80.5 to 91.1,277
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,89.0,84.7 to 92.5,515
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,95.7,92.9 to 98.5,238
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,88.4 to 96.7,238
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,89.2 to 96.2,274
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,89.3 to 94.4,642
PCV,≥3 Doses,States/Local Areas,Iowa,2017,Age,19 Months,92.6,87.1 to 95.8,228
PCV,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,93.2,89.4 to 95.7,483
Hep B,≥3 Doses,States/Local Areas,Iowa,2019,Age,35 Months,95.1,89.8 to 98.2,250
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,92.3,89.2 to 95.4,378
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,83.9,78.2 to 89.6,222
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Overall,Overall,90.5,88.1 to 92.9,838
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,89.4,85.1 to 93.7,326
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,86.0 to 94.9,238
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,91.5,87.9 to 95.1,274
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.0,87.2 to 92.8,642
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,95.1,92.8 to 97.4,472
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,97.8,93.6 to 100.0,49
≥1 Dose MMR,,States/Local Areas,Iowa,2019,Age,35 Months,95.6,91.0 to 98.3,250
PCV,≥4 Doses,States/Local Areas,Iowa,2013,Age,35 Months,88.5,83.2 to 92.7,265
PCV,≥4 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,87.3,83.5 to 90.6,542
≥1 Dose MMR,,States/Local Areas,Iowa,2018,Age,35 Months,99.2,97.5 to 99.8,255
≥1 Dose MMR,,States/Local Areas,Iowa,2018-2019,Age,35 Months,97.4,94.9 to 98.8,505
≥1 Dose MMR,,States/Local Areas,Iowa,2017,Age,35 Months,94.1,89.5 to 97.2,228
≥1 Dose MMR,,States/Local Areas,Iowa,2017-2018,Age,35 Months,96.9,94.4 to 98.4,483
Hib,≥1 Dose,States/Local Areas,Iowa,2015,Age,3 Months,90.9,84.8 to 94.6,238
Hib,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,3 Months,92.9,89.2 to 95.3,436
Hib,≥1 Dose,States/Local Areas,Iowa,2016,Age,3 Months,94.9,90.1 to 97.4,198
Hib,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,3 Months,91.4,87.7 to 94.1,426
Hib,≥1 Dose,States/Local Areas,Iowa,2017,Age,3 Months,88.0,82.1 to 92.1,228
Hib,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,3 Months,90.3,86.5 to 93.2,483
Hep B,≥2 Doses,States/Local Areas,Iowa,2017,Age,13 Months,95.0,90.0 to 97.6,228
Hep B,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,95.9,92.9 to 97.7,483
Hep B,≥2 Doses,States/Local Areas,Iowa,2018,Age,13 Months,96.8,92.1 to 98.7,255
Hep B,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,95.4,91.6 to 97.5,505
Hep B,≥2 Doses,States/Local Areas,Iowa,2019,Age,13 Months,93.9,87.1 to 97.3,250
PCV,≥3 Doses,States/Local Areas,Iowa,2015,Age,19 Months,94.5,92.5 to 96.0,238
PCV,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,94.5,91.0 to 96.7,436
PCV,≥3 Doses,States/Local Areas,Iowa,2016,Age,19 Months,94.5,89.4 to 97.2,198
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,93.6,90.1 to 95.9,426
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.4,91.1 to 100.0,75
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,94.4,89.5 to 99.4,84
Hib,≥1 Dose,States/Local Areas,Iowa,2013,Age,3 Months,88.1,86.0 to 90.0,265
Hib,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,3 Months,88.8,86.0 to 91.1,542
Hib,≥1 Dose,States/Local Areas,Iowa,2012,Age,3 Months,83.7,79.8 to 86.9,247
Hib,≥1 Dose,States/Local Areas,Iowa,2011,Age,3 Months,86.0,80.9 to 89.9,220
PCV,≥3 Doses,States/Local Areas,Iowa,2019,Age,13 Months,92.7,86.0 to 96.3,250
PCV,≥3 Doses,States/Local Areas,Iowa,2011,Age,19 Months,91.2,81.3 to 96.1,220
PCV,≥3 Doses,States/Local Areas,Iowa,2013,Age,19 Months,93.9,90.3 to 96.2,265
PCV,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,92.9,91.2 to 94.3,542
PCV,≥3 Doses,States/Local Areas,Iowa,2014,Age,19 Months,91.9,87.1 to 95.1,277
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,93.2,90.0 to 95.5,515
Hep B,≥3 Doses,States/Local Areas,Iowa,2016,Age,35 Months,96.8,93.6 to 98.6,198
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,95.9,93.2 to 97.7,426
PCV,≥4 Doses,States/Local Areas,Iowa,2019,Age,24 Months,90.9,84.5 to 95.4,250
PCV,≥4 Doses,States/Local Areas,Iowa,2018,Age,24 Months,91.0,85.3 to 95.2,255
PCV,≥4 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,91.0,86.9 to 94.2,505
PCV,≥4 Doses,States/Local Areas,Iowa,2011,Age,35 Months,86.0,78.0 to 92.2,220
PCV,≥4 Doses,States/Local Areas,Iowa,2012,Age,35 Months,90.4,84.7 to 94.6,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2018,Age,35 Months,98.1,96.0 to 99.2,255
Hep B,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,96.6,93.8 to 98.4,505
PCV,≥3 Doses,States/Local Areas,Iowa,2012,Age,19 Months,93.3,86.5 to 96.8,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2017,Age,35 Months,95.2,90.4 to 98.1,228
Hep B,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,96.5,94.0 to 98.1,483
≥1 Dose Varicella,,States/Local Areas,Iowa,2019,Age,35 Months,94.1,88.4 to 97.6,250
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,88.5,84.3 to 92.7,297
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,93.5,90.8 to 96.1,472
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,95.0,89.0 to 100.0,49
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.3,66.4 to 96.2,37
≥1 Dose MMR,,States/Local Areas,Iowa,2016,Age,35 Months,99.7,98.2 to 100.0,198
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2017,Age,35 Months,96.9,93.8 to 98.7,426
≥1 Dose MMR,,States/Local Areas,Iowa,2014,Age,35 Months,95.8,92.1 to 98.1,277
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2015,Age,35 Months,94.7,91.4 to 97.0,515
≥1 Dose MMR,,States/Local Areas,Iowa,2015,Age,35 Months,93.0,86.7 to 97.0,238
≥1 Dose MMR,,States/Local Areas,Iowa,2015-2016,Age,35 Months,97.1,93.6 to 98.9,436
PCV,≥4 Doses,States/Local Areas,Iowa,2017,Age,24 Months,82.2,74.8 to 88.4,228
PCV,≥4 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,86.6,81.9 to 90.6,483
PCV,≥4 Doses,States/Local Areas,Iowa,2016,Age,24 Months,87.2,80.3 to 92.6,198
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,84.7,79.7 to 89.0,426
Hep B,≥2 Doses,States/Local Areas,Iowa,2019,Age,7 Months,93.6,86.8 to 97.0,250
Hep B,≥2 Doses,States/Local Areas,Iowa,2011,Age,13 Months,95.6,90.0 to 98.2,220
Hep B,≥2 Doses,States/Local Areas,Iowa,2013,Age,13 Months,96.0,94.0 to 97.4,265
Hep B,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,95.0,91.5 to 97.1,542
Hep B,≥2 Doses,States/Local Areas,Iowa,2012,Age,13 Months,93.4,87.0 to 96.7,247
PCV,≥3 Doses,States/Local Areas,Iowa,2017,Age,13 Months,89.0,82.1 to 93.5,228
PCV,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,90.9,86.6 to 93.9,483
PCV,≥3 Doses,States/Local Areas,Iowa,2018,Age,13 Months,92.8,86.7 to 96.2,255
PCV,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,92.7,88.6 to 95.5,505
Hep B,≥3 Doses,States/Local Areas,Iowa,2012,Age,35 Months,95.1,90.4 to 97.9,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2015,Age,35 Months,98.0,94.1 to 99.6,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,97.3,94.9 to 98.7,436
Hep B,≥3 Doses,States/Local Areas,Iowa,2014,Age,35 Months,95.5,90.6 to 98.3,277
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,96.9,93.7 to 98.7,515
Hep B,≥3 Doses,States/Local Areas,Iowa,2013,Age,35 Months,96.7,93.7 to 98.5,265
Hep B,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,96.2,93.5 to 98.1,542
Hep B,≥2 Doses,States/Local Areas,Iowa,2016,Age,13 Months,96.8,93.1 to 98.5,198
Hep B,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,95.9,93.1 to 97.6,426
Hep B,≥2 Doses,States/Local Areas,Iowa,2015,Age,13 Months,97.2,92.3 to 99.0,238
Hep B,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,97.0,94.3 to 98.4,436
Hib,≥1 Dose,States/Local Areas,Iowa,2014,Age,3 Months,89.4,84.5 to 92.9,277
Hib,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,3 Months,90.1,86.5 to 92.8,515
Hep B,≥2 Doses,States/Local Areas,Iowa,2014,Age,13 Months,94.0,89.6 to 96.6,277
Hep B,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,95.6,92.7 to 97.3,515
≥1 Dose Varicella,,States/Local Areas,Iowa,2018,Age,35 Months,98.4,95.5 to 99.6,255
≥1 Dose Varicella,,States/Local Areas,Iowa,2018-2019,Age,35 Months,96.1,92.8 to 98.2,505
≥1 Dose Varicella,,States/Local Areas,Iowa,2017,Age,35 Months,93.6,89.1 to 96.7,228
≥1 Dose Varicella,,States/Local Areas,Iowa,2017-2018,Age,35 Months,96.0,93.3 to 97.9,483
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2017,Age,0-2 Days,82.2,75.1 to 87.5,228
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2017-2018,Age,0-2 Days,82.6,77.7 to 86.6,483
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2018,Age,0-2 Days,83.0,75.7 to 88.5,255
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2018-2019,Age,0-2 Days,84.2,79.5 to 88.1,505
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2019,Age,0-2 Days,85.5,78.9 to 90.3,250
Hep B,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,95.0,91.3 to 97.2,505
≥1 Dose Varicella,,States/Local Areas,Iowa,2016,Age,35 Months,95.7,89.8 to 98.7,198
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2017,Age,35 Months,94.6,91.1 to 97.0,426
≥1 Dose MMR,,States/Local Areas,Iowa,2013,Age,35 Months,95.9,92.7 to 98.0,265
≥1 Dose MMR,,States/Local Areas,Iowa,2013-2014,Age,35 Months,95.8,93.6 to 97.5,542
≥1 Dose MMR,,States/Local Areas,Iowa,2011,Age,35 Months,96.0,90.0 to 98.8,220
≥1 Dose MMR,,States/Local Areas,Iowa,2012,Age,35 Months,93.7,89.2 to 96.8,247
≥1 Dose MMR,,States/Local Areas,Iowa,2019,Age,24 Months,94.9,90.2 to 97.7,250
PCV,≥4 Doses,States/Local Areas,Iowa,2015,Age,24 Months,88.8,82.9 to 93.4,238
PCV,≥4 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,88.0,83.4 to 91.8,436
PCV,≥4 Doses,States/Local Areas,Iowa,2014,Age,24 Months,83.8,78.2 to 88.7,277
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,86.3,82.4 to 89.8,515
PCV,≥4 Doses,States/Local Areas,Iowa,2013,Age,24 Months,86.4,80.9 to 91.0,265
PCV,≥4 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,85.1,81.3 to 88.6,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2019,Age,24 Months,94.5,89.1 to 97.8,250
Hep B,≥3 Doses,States/Local Areas,Iowa,2017,Age,24 Months,93.9,89.2 to 97.0,228
Hep B,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,95.9,93.4 to 97.7,483
Hep B,≥3 Doses,States/Local Areas,Iowa,2011,Age,35 Months,96.9,91.6 to 99.2,220
PCV,≥4 Doses,States/Local Areas,Iowa,2012,Age,24 Months,89.1,83.5 to 93.5,247
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2014,Age,0-2 Days,73.0,66.3 to 78.8,277
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2014-2015,Age,0-2 Days,78.9,73.9 to 83.2,515
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2015,Age,0-2 Days,84.8,76.4 to 90.6,238
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2015-2016,Age,0-2 Days,85.1,79.9 to 89.2,436
PCV,≥4 Doses,States/Local Areas,Iowa,2011,Age,24 Months,83.0,75.3 to 89.4,220
≥1 Dose Varicella,,States/Local Areas,Iowa,2015,Age,35 Months,91.5,85.2 to 95.8,238
≥1 Dose Varicella,,States/Local Areas,Iowa,2015-2016,Age,35 Months,93.8,89.7 to 96.7,436
≥1 Dose Varicella,,States/Local Areas,Iowa,2014,Age,35 Months,92.7,87.8 to 96.1,277
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2015,Age,35 Months,92.0,88.4 to 94.9,515
PCV,≥4 Doses,States/Local Areas,Iowa,2019,Age,19 Months,88.9,81.4 to 93.6,250
≥1 Dose MMR,,States/Local Areas,Iowa,2018,Age,24 Months,97.1,93.2 to 99.0,255
≥1 Dose MMR,,States/Local Areas,Iowa,2018-2019,Age,24 Months,96.0,93.2 to 97.9,505
≥1 Dose Varicella,,States/Local Areas,Iowa,2013,Age,35 Months,91.3,86.2 to 95.0,265
≥1 Dose Varicella,,States/Local Areas,Iowa,2013-2014,Age,35 Months,91.8,88.5 to 94.5,542
Hib,Full Series,States/Local Areas,Iowa,2019,Age,24 Months,91.3,85.2 to 95.6,250
Polio,≥3 Doses,States/Local Areas,Iowa,2015,Age,35 Months,96.0,91.7 to 98.5,238
Polio,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,97.3,94.8 to 98.8,436
DTaP,≥2 Doses,States/Local Areas,Iowa,2014,Age,5 Months,79.9,73.6 to 85.0,277
DTaP,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,5 Months,80.6,75.4 to 85.0,515
Polio,≥3 Doses,States/Local Areas,Iowa,2017,Age,35 Months,97.0,93.1 to 98.9,228
Polio,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,97.7,95.7 to 98.9,483
Polio,≥3 Doses,States/Local Areas,Iowa,2016,Age,35 Months,99.0,96.1 to 99.9,198
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,97.7,95.5 to 99.0,426
DTaP,≥2 Doses,States/Local Areas,Iowa,2016,Age,5 Months,84.9,76.6 to 90.6,198
DTaP,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,5 Months,82.7,77.4 to 87.0,426
DTaP,≥2 Doses,States/Local Areas,Iowa,2015,Age,5 Months,81.3,74.1 to 86.9,238
DTaP,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,5 Months,83.1,77.8 to 87.4,436
DTaP,≥2 Doses,States/Local Areas,Iowa,2013,Age,5 Months,82.2,80.0 to 84.2,265
DTaP,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,5 Months,81.0,76.3 to 85.0,542
DTaP,≥2 Doses,States/Local Areas,Iowa,2012,Age,5 Months,78.2,75.1 to 80.9,247
DTaP,≥2 Doses,States/Local Areas,Iowa,2011,Age,5 Months,77.8,73.5 to 81.6,220
Polio,≥3 Doses,States/Local Areas,Iowa,2014,Age,35 Months,95.9,92.6 to 98.0,277
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,96.1,93.5 to 97.8,515
Polio,≥3 Doses,States/Local Areas,Iowa,2013,Age,35 Months,96.1,92.3 to 98.3,265
Polio,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,97.9,93.6 to 99.6,542
Hib,Full Series,States/Local Areas,Iowa,2013,Age,35 Months,88.0,82.6 to 92.3,265
Hib,Full Series,States/Local Areas,Iowa,2013-2014,Age,35 Months,87.2,83.4 to 90.5,542
Hib,Full Series,States/Local Areas,Iowa,2011,Age,35 Months,84.5,76.5 to 91.0,220
Hib,Full Series,States/Local Areas,Iowa,2012,Age,35 Months,87.8,82.4 to 92.2,247
Polio,≥3 Doses,States/Local Areas,Iowa,2012,Age,35 Months,95.7,90.7 to 98.4,247
Hib,≥3 Doses,States/Local Areas,Iowa,2015,Age,19 Months,90.1,88.3 to 91.6,238
Hib,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,90.5,86.1 to 93.6,436
Hib,≥3 Doses,States/Local Areas,Iowa,2016,Age,19 Months,91.0,84.3 to 95.0,198
Hib,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,88.5,83.9 to 91.9,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2016,Age,19 Months,95.5,90.9 to 97.8,198
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,94.8,91.8 to 96.7,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2014,Age,19 Months,95.6,91.8 to 97.6,277
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,95.1,92.3 to 97.0,515
DTaP,≥3 Doses,States/Local Areas,Iowa,2015,Age,19 Months,94.7,93.0 to 96.0,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,95.1,91.7 to 97.2,436
DTaP,≥3 Doses,States/Local Areas,Iowa,2017,Age,19 Months,94.1,89.5 to 96.8,228
DTaP,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,95.4,92.5 to 97.2,483
DTaP,≥3 Doses,States/Local Areas,Iowa,2019,Age,19 Months,94.2,87.9 to 97.3,250
Polio,≥2 Doses,States/Local Areas,Iowa,2020,Age,13 Months,93.6,88.4 to 96.6,271
Polio,≥3 Doses,States/Local Areas,Iowa,2019,Age,19 Months,94.2,87.9 to 97.3,250
Polio,≥3 Doses,States/Local Areas,Iowa,2011,Age,24 Months,93.1,87.3 to 96.8,220
Polio,≥3 Doses,States/Local Areas,Iowa,2012,Age,24 Months,93.1,88.6 to 96.2,247
Hib,≥3 Doses,States/Local Areas,Iowa,2014,Age,19 Months,90.8,86.1 to 94.1,277
Hib,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,90.5,86.8 to 93.2,515
Polio,≥3 Doses,States/Local Areas,Iowa,2013,Age,24 Months,95.7,92.0 to 98.0,265
Polio,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,95.1,92.7 to 96.9,542
Polio,≥3 Doses,States/Local Areas,Iowa,2011,Age,35 Months,96.8,91.6 to 99.2,220
DTaP,≥3 Doses,States/Local Areas,Iowa,2018,Age,19 Months,96.8,92.2 to 98.7,255
DTaP,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,94.3,90.6 to 96.6,505
Polio,≥3 Doses,States/Local Areas,Iowa,2015,Age,24 Months,95.5,91.1 to 98.1,238
Polio,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,96.5,93.9 to 98.2,436
Polio,≥3 Doses,States/Local Areas,Iowa,2014,Age,24 Months,94.6,91.0 to 97.1,277
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,95.0,92.4 to 97.0,515
DTaP,≥3 Doses,States/Local Areas,Iowa,2011,Age,24 Months,93.1,87.3 to 96.8,220
Hib,≥3 Doses,States/Local Areas,Iowa,2018,Age,19 Months,91.2,84.6 to 95.1,255
Hib,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,60.4,54.3 to 66.1,505
Hib,≥3 Doses,States/Local Areas,Iowa,2017,Age,19 Months,86.1,79.0 to 91.0,228
Hib,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,88.6,84.1 to 92.0,483
Polio,≥3 Doses,States/Local Areas,Iowa,2016,Age,24 Months,97.8,95.1 to 99.2,198
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,96.2,93.8 to 97.8,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2013,Age,24 Months,97.9,94.4 to 99.4,265
DTaP,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,96.5,94.4 to 97.9,542
Hib,Full Series,States/Local Areas,Iowa,2015,Age,24 Months,84.0,77.4 to 89.5,238
Hib,Full Series,States/Local Areas,Iowa,2015-2016,Age,24 Months,84.2,79.4 to 88.5,436
Hib,Full Series,States/Local Areas,Iowa,2016,Age,24 Months,84.6,77.4 to 90.4,198
Hib,Full Series,States/Local Areas,Iowa,2016-2017,Age,24 Months,83.9,78.9 to 88.3,426
Polio,≥3 Doses,States/Local Areas,Iowa,2017,Age,24 Months,94.8,90.6 to 97.5,228
Polio,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,95.8,93.2 to 97.7,483
DTaP,≥3 Doses,States/Local Areas,Iowa,2012,Age,24 Months,94.5,90.1 to 97.3,247
Polio,≥3 Doses,States/Local Areas,Iowa,2018,Age,24 Months,97.0,93.0 to 99.0,255
Polio,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,95.7,92.6 to 97.8,505
Polio,≥3 Doses,States/Local Areas,Iowa,2019,Age,24 Months,94.5,89.0 to 97.8,250
Hib,≥3 Doses,States/Local Areas,Iowa,2019,Age,19 Months,89.2,82.1 to 93.7,250
Hib,Full Series,States/Local Areas,Iowa,2018,Age,24 Months,88.8,82.9 to 93.4,255
Hib,Full Series,States/Local Areas,Iowa,2018-2019,Age,24 Months,90.1,86.0 to 93.3,505
Hib,Full Series,States/Local Areas,Iowa,2017,Age,24 Months,83.3,76.1 to 89.4,228
Hib,Full Series,States/Local Areas,Iowa,2017-2018,Age,24 Months,86.1,81.5 to 90.0,483
Hib,≥3 Doses,States/Local Areas,Iowa,2013,Age,24 Months,93.6,89.2 to 96.6,265
Hib,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,92.8,89.9 to 95.2,542
Hib,≥3 Doses,States/Local Areas,Iowa,2012,Age,24 Months,92.4,87.8 to 95.8,247
Hib,≥3 Doses,States/Local Areas,Iowa,2011,Age,24 Months,90.5,83.9 to 95.2,220
Hib,≥3 Doses,States/Local Areas,Iowa,2014,Age,24 Months,92.1,87.8 to 95.4,277
Hib,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,92.6,89.4 to 95.1,515
≥1 Dose MMR,,States/Local Areas,Iowa,2017,Age,13 Months,57.1,48.9 to 65.0,228
≥1 Dose MMR,,States/Local Areas,Iowa,2017-2018,Age,13 Months,61.2,55.3 to 66.7,483
≥1 Dose MMR,,States/Local Areas,Iowa,2018,Age,13 Months,65.3,56.8 to 72.9,255
≥1 Dose MMR,,States/Local Areas,Iowa,2018-2019,Age,13 Months,62.7,56.7 to 68.3,505
≥1 Dose MMR,,States/Local Areas,Iowa,2019,Age,13 Months,60.0,51.5 to 67.9,250
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,86.1,72.0 to 100.0,49
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,66.5,58.0 to 75.1,297
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,81.2,76.3 to 86.1,472
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.1,52.5 to 93.6,37
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,88.3,83.6 to 93.1,238
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,78.6,70.8 to 86.4,274
Polio,≥2 Doses,States/Local Areas,Iowa,2019,Age,7 Months,93.9,87.6 to 97.1,250
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,74.4,69.8 to 79.0,838
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,61.2,51.6 to 70.8,222
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,67.8,60.4 to 75.3,326
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.7,69.5 to 86.0,238
DTaP,≥4 Doses,States/Local Areas,Iowa,2019,Age,24 Months,88.5,81.7 to 93.6,250
DTaP,≥4 Doses,States/Local Areas,Iowa,2011,Age,35 Months,91.4,83.9 to 96.3,220
DTaP,≥4 Doses,States/Local Areas,Iowa,2018,Age,24 Months,88.3,82.1 to 93.2,255
DTaP,≥4 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,88.5,84.0 to 92.1,505
DTaP,≥4 Doses,States/Local Areas,Iowa,2017,Age,24 Months,76.7,69.2 to 83.5,228
DTaP,≥4 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,82.5,77.6 to 86.8,483
≥1 Dose MMR,,States/Local Areas,Iowa,2014,Age,13 Months,62.1,55.2 to 68.6,277
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2015,Age,13 Months,59.2,54.0 to 64.2,515
≥1 Dose MMR,,States/Local Areas,Iowa,2015,Age,13 Months,56.3,48.2 to 64.0,238
≥1 Dose MMR,,States/Local Areas,Iowa,2015-2016,Age,13 Months,57.1,51.1 to 63.0,436
≥1 Dose Varicella,,States/Local Areas,Iowa,2019,Age,13 Months,51.6,43.2 to 59.9,250
≥1 Dose Varicella,,States/Local Areas,Iowa,2011,Age,19 Months,81.5,75.5 to 86.3,220
≥1 Dose Varicella,,States/Local Areas,Iowa,2013,Age,19 Months,88.6,84.7 to 91.6,265
≥1 Dose Varicella,,States/Local Areas,Iowa,2013-2014,Age,19 Months,88.8,86.8 to 90.4,542
≥1 Dose Varicella,,States/Local Areas,Iowa,2012,Age,19 Months,85.2,81.1 to 88.5,247
≥1 Dose MMR,,States/Local Areas,Iowa,2016,Age,13 Months,58.0,49.1 to 66.5,198
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2017,Age,13 Months,57.6,51.6 to 63.3,426
≥1 Dose Varicella,,States/Local Areas,Iowa,2018,Age,13 Months,56.9,48.4 to 65.0,255
≥1 Dose Varicella,,States/Local Areas,Iowa,2018-2019,Age,13 Months,54.3,48.3 to 60.1,505
DTaP,≥4 Doses,States/Local Areas,Iowa,2012,Age,35 Months,90.9,84.8 to 95.3,247
DTaP,≥4 Doses,States/Local Areas,Iowa,2015,Age,35 Months,91.1,83.9 to 95.9,238
DTaP,≥4 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,92.0,87.5 to 95.4,436
DTaP,≥4 Doses,States/Local Areas,Iowa,2014,Age,35 Months,88.4,81.0 to 93.9,277
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,89.8,84.9 to 93.7,515
Hep A,≥2 Doses,States/Local Areas,Iowa,2019,Age,35 Months,81.8,73.5 to 88.8,250
Hep B,≥3 Doses,States/Local Areas,Iowa,2012,Age,13 Months,91.2,84.5 to 95.1,247
DTaP,≥4 Doses,States/Local Areas,Iowa,2013,Age,35 Months,91.2,85.6 to 95.2,265
DTaP,≥4 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,89.7,85.3 to 93.2,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2013,Age,13 Months,94.1,89.3 to 96.8,265
Hep B,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,93.1,89.7 to 95.5,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2014,Age,13 Months,92.2,87.5 to 95.2,277
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,92.7,89.4 to 95.0,515
Hep A,≥2 Doses,States/Local Areas,Iowa,2018,Age,35 Months,83.2,74.0 to 90.6,255
Hep A,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,82.8,76.8 to 88.0,505
Hep A,≥2 Doses,States/Local Areas,Iowa,2017,Age,35 Months,77.0,65.7 to 86.7,228
Hep A,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,80.5,73.1 to 86.9,483
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,84.9 to 93.5,274
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.5,80.0 to 86.9,642
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,78.0,72.6 to 83.5,326
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,80.4 to 91.5,238
Polio,≥2 Doses,States/Local Areas,Iowa,2014,Age,7 Months,93.2,89.0 to 95.8,277
Polio,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,92.8,89.5 to 95.1,515
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,75.2,68.4 to 82.0,222
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Overall,Overall,84.1,81.1 to 87.1,838
Polio,≥2 Doses,States/Local Areas,Iowa,2015,Age,7 Months,92.4,86.5 to 95.9,238
Polio,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,90.9,86.5 to 93.9,436
Polio,≥2 Doses,States/Local Areas,Iowa,2016,Age,7 Months,89.4,82.5 to 93.7,198
Polio,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,89.5,85.0 to 92.8,426
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,88.2,84.6 to 91.8,378
Hep B,≥3 Doses,States/Local Areas,Iowa,2011,Age,13 Months,92.1,90.4 to 93.5,220
≥1 Dose Varicella,,States/Local Areas,Iowa,2016,Age,13 Months,51.7,42.9 to 60.5,198
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2017,Age,13 Months,50.4,44.5 to 56.4,426
≥1 Dose Varicella,,States/Local Areas,Iowa,2017,Age,13 Months,49.1,41.0 to 57.2,228
≥1 Dose Varicella,,States/Local Areas,Iowa,2017-2018,Age,13 Months,52.9,47.1 to 58.7,483
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,73.7 to 95.3,75
DTaP,≥4 Doses,States/Local Areas,Iowa,2016,Age,24 Months,84.1,76.7 to 90.2,198
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,80.4,75.2 to 85.2,426
DTaP,≥4 Doses,States/Local Areas,Iowa,2015,Age,24 Months,85.1,78.4 to 90.5,238
DTaP,≥4 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,84.5,79.6 to 88.8,436
Polio,≥2 Doses,States/Local Areas,Iowa,2015,Age,5 Months,80.9,73.7 to 86.5,238
Polio,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,5 Months,82.4,77.0 to 86.7,436
Hep B,≥3 Doses,States/Local Areas,Iowa,2016,Age,7 Months,77.7,69.2 to 84.4,198
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,75.8,70.0 to 80.9,426
Hep A,≥2 Doses,States/Local Areas,Iowa,2019,Age,24 Months,62.6,54.2 to 71.1,250
Polio,≥2 Doses,States/Local Areas,Iowa,2016,Age,5 Months,83.9,75.5 to 89.8,198
Polio,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,5 Months,82.2,76.8 to 86.5,426
Polio,≥2 Doses,States/Local Areas,Iowa,2017,Age,5 Months,80.5,72.9 to 86.3,228
Polio,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,5 Months,85.7,81.1 to 89.3,483
Hep B,≥3 Doses,States/Local Areas,Iowa,2014,Age,7 Months,79.9,73.6 to 85.0,277
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,81.5,77.2 to 85.2,515
Hep B,≥3 Doses,States/Local Areas,Iowa,2015,Age,7 Months,83.1,76.7 to 88.1,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,80.4,75.1 to 84.8,436
≥1 Dose Varicella,,States/Local Areas,Iowa,2014,Age,13 Months,52.8,45.8 to 59.7,277
≥1 Dose Varicella,,States/Local Areas,Iowa,2014-2015,Age,13 Months,49.3,44.1 to 54.5,515
≥1 Dose Varicella,,States/Local Areas,Iowa,2015,Age,13 Months,45.8,38.0 to 53.8,238
≥1 Dose Varicella,,States/Local Areas,Iowa,2015-2016,Age,13 Months,48.8,42.8 to 54.8,436
≥1 Dose Varicella,,States/Local Areas,Iowa,2012,Age,13 Months,47.8,38.5 to 57.2,247
Hep A,≥1 Dose,States/Local Areas,Iowa,2019,Age,35 Months,94.3,89.8 to 97.2,250
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,79.8,74.2 to 85.4,297
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,89.6,86.6 to 92.6,472
Polio,≥2 Doses,States/Local Areas,Iowa,2018,Age,5 Months,91.1,85.5 to 94.6,255
Polio,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,5 Months,89.2,84.7 to 92.5,505
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,84.8,74.2 to 95.4,49
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.5,73.4 to 99.4,37
≥1 Dose Varicella,,States/Local Areas,Iowa,2013,Age,13 Months,45.8,35.8 to 56.2,265
≥1 Dose Varicella,,States/Local Areas,Iowa,2013-2014,Age,13 Months,49.3,45.0 to 53.7,542
Polio,≥2 Doses,States/Local Areas,Iowa,2019,Age,5 Months,87.3,79.7 to 92.4,250
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,86.9,79.2 to 94.7,84
Polio,≥2 Doses,States/Local Areas,Iowa,2012,Age,7 Months,90.4,86.4 to 93.3,247
Polio,≥2 Doses,States/Local Areas,Iowa,2011,Age,7 Months,89.5,86.5 to 91.8,220
Hep B,≥3 Doses,States/Local Areas,Iowa,2017,Age,7 Months,74.0,66.1 to 80.5,228
Hep B,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,82.0,77.2 to 86.0,483
Hep B,≥3 Doses,States/Local Areas,Iowa,2018,Age,7 Months,90.3,84.9 to 94.0,255
Hep B,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,86.2,81.6 to 89.8,505
Hep A,≥2 Doses,States/Local Areas,Iowa,2016,Age,35 Months,77.8,68.2 to 86.2,198
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,77.5,70.1 to 84.2,426
Hep A,≥2 Doses,States/Local Areas,Iowa,2015,Age,35 Months,79.8,71.7 to 86.8,238
Hep A,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,78.8,72.6 to 84.4,436
Polio,≥2 Doses,States/Local Areas,Iowa,2013,Age,7 Months,90.5,85.2 to 94.1,265
Polio,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,91.9,87.9 to 94.6,542
Hep B,≥3 Doses,States/Local Areas,Iowa,2019,Age,7 Months,82.0,74.2 to 87.8,250
Hep A,≥2 Doses,States/Local Areas,Iowa,2014,Age,35 Months,68.1,60.1 to 75.9,277
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,74.3,68.5 to 79.8,515
Hep A,≥2 Doses,States/Local Areas,Iowa,2011,Age,35 Months,64.2,54.4 to 74.0,220
Hep A,≥2 Doses,States/Local Areas,Iowa,2012,Age,35 Months,77.6,68.4 to 85.7,247
Hep A,≥2 Doses,States/Local Areas,Iowa,2013,Age,35 Months,73.8,65.6 to 81.5,265
Hep A,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,71.6,65.7 to 77.3,542
Hep A,≥1 Dose,States/Local Areas,Iowa,2016,Age,35 Months,91.7,85.2 to 96.2,198
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,35 Months,91.2,87.2 to 94.3,426
Hep A,≥1 Dose,States/Local Areas,Iowa,2017,Age,35 Months,90.6,85.6 to 94.5,228
Hep A,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,35 Months,92.2,88.7 to 95.0,483
Hep A,≥1 Dose,States/Local Areas,Iowa,2018,Age,35 Months,93.8,88.5 to 97.3,255
Hep A,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,35 Months,94.0,90.6 to 96.4,505
≥1 Dose Varicella,,States/Local Areas,Iowa,2011,Age,13 Months,47.7,36.9 to 58.7,220
Hep A,≥1 Dose,States/Local Areas,Iowa,2013,Age,35 Months,87.6,81.6 to 92.4,265
Hep A,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,35 Months,86.2,82.0 to 89.8,542
Hep A,≥1 Dose,States/Local Areas,Iowa,2014,Age,35 Months,84.7,78.4 to 89.9,277
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,35 Months,84.8,80.3 to 88.7,515
≥1 Dose MMR,,States/Local Areas,Iowa,2013,Age,13 Months,49.5,43.8 to 55.2,265
≥1 Dose MMR,,States/Local Areas,Iowa,2013-2014,Age,13 Months,55.8,53.2 to 58.4,542
≥1 Dose MMR,,States/Local Areas,Iowa,2012,Age,13 Months,53.4,42.6 to 64.0,247
≥1 Dose MMR,,States/Local Areas,Iowa,2011,Age,13 Months,49.4,41.7 to 57.2,220
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.2,69.9 to 80.5,642
Hib,≥3 Doses,States/Local Areas,Iowa,2019,Age,35 Months,94.5,88.8 to 97.9,250
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,95.7,94.0 to 97.3,838
Hep A,≥2 Doses,States/Local Areas,Iowa,2015,Age,24 Months,55.7,47.8 to 64.0,238
Hep A,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,54.6,48.5 to 60.9,436
Hep A,≥2 Doses,States/Local Areas,Iowa,2014,Age,24 Months,45.9,39.1 to 53.3,277
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,50.8,45.5 to 56.4,515
PCV,≥2 Doses,States/Local Areas,Iowa,2018,Age,5 Months,88.8,82.7 to 93.0,255
PCV,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,5 Months,87.6,82.9 to 91.2,505
PCV,≥2 Doses,States/Local Areas,Iowa,2019,Age,5 Months,86.4,78.5 to 91.7,250
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,96.9,94.7 to 99.1,274
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.9,94.2 to 97.6,642
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,95.1,92.2 to 97.9,326
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,91.5 to 98.5,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.5,89.7 to 100.0,75
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,98.1,95.5 to 100.0,84
DTaP,≥4 Doses,States/Local Areas,Iowa,2016,Age,19 Months,76.3,67.7 to 83.1,198
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,70.8,65.0 to 75.9,426
DTaP,≥4 Doses,States/Local Areas,Iowa,2017,Age,19 Months,65.2,57.0 to 72.5,228
DTaP,≥4 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,74.3,68.9 to 79.1,483
DTaP,≥4 Doses,States/Local Areas,Iowa,2018,Age,19 Months,83.7,76.8 to 88.9,255
DTaP,≥4 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,96.2,92.7 to 98.0,505
Hep A,≥2 Doses,States/Local Areas,Iowa,2013,Age,24 Months,43.3,36.5 to 50.9,265
Hep A,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,44.6,39.7 to 49.8,542
Hep A,≥2 Doses,States/Local Areas,Iowa,2018,Age,24 Months,56.4,48.1 to 65.0,255
Hep A,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,59.6,53.6 to 65.6,505
DTaP,≥4 Doses,States/Local Areas,Iowa,2014,Age,24 Months,81.9,75.9 to 87.1,277
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,83.5,79.2 to 87.4,515
Hep A,≥2 Doses,States/Local Areas,Iowa,2017,Age,24 Months,49.3,40.9 to 58.5,228
Hep A,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,52.9,46.9 to 59.1,483
Hep A,≥2 Doses,States/Local Areas,Iowa,2016,Age,24 Months,53.5,44.6 to 62.8,198
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,51.4,45.2 to 57.8,426
DTaP,≥4 Doses,States/Local Areas,Iowa,2013,Age,24 Months,85.1,79.2 to 90.0,265
DTaP,≥4 Doses,States/Local Areas,Iowa,2013-2014,Age,24 Months,83.4,79.3 to 87.1,542
Hep A,≥1 Dose,States/Local Areas,Iowa,2015,Age,35 Months,85.3,78.1 to 91.1,238
Hep A,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,35 Months,88.9,84.1 to 92.7,436
Polio,≥2 Doses,States/Local Areas,Iowa,2012,Age,5 Months,77.0,73.7 to 79.9,247
Polio,≥2 Doses,States/Local Areas,Iowa,2011,Age,5 Months,77.1,72.4 to 81.3,220
Polio,≥2 Doses,States/Local Areas,Iowa,2013,Age,5 Months,82.7,76.0 to 87.9,265
Polio,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,5 Months,81.1,74.5 to 86.3,542
Polio,≥2 Doses,States/Local Areas,Iowa,2014,Age,5 Months,79.5,73.2 to 84.6,277
Polio,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,5 Months,80.2,75.1 to 84.5,515
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,90.4,85.8 to 95.0,222
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,99.0,97.9 to 100.0,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,97.6,96.1 to 99.1,378
Hep B,≥3 Doses,States/Local Areas,Iowa,2012,Age,7 Months,75.2,66.9 to 81.9,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2011,Age,7 Months,70.3,65.4 to 74.8,220
Hep B,≥3 Doses,States/Local Areas,Iowa,2013,Age,7 Months,76.0,73.9 to 78.0,265
Hep B,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,78.0,75.2 to 80.5,542
DTaP,≥4 Doses,States/Local Areas,Iowa,2019,Age,19 Months,77.9,69.8 to 84.3,250
DTaP,≥4 Doses,States/Local Areas,Iowa,2011,Age,24 Months,85.1,77.7 to 91.1,220
DTaP,≥4 Doses,States/Local Areas,Iowa,2012,Age,24 Months,86.5,80.1 to 91.7,247
Rotavirus,,States/Local Areas,Indiana,2019-2020,Age,8 Months,74.5,68.9 to 79.3,441
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.3,79.3 to 89.3,336
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,66.1,57.1 to 75.1,178
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,85.4,78.9 to 91.8,178
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,89.9 to 96.9,336
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,89.8 to 96.1,481
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.4,68.9 to 86.0,336
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2021,Age,0-1 Days,77.4,66.5 to 85.5,137
Hep A,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,35 Months,96.7,90.7 to 99.3,369
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,91.5,86.9 to 96.2,178
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,88.5 to 95.2,481
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.5 to 96.0,336
Rotavirus,,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,67.5,61.1 to 73.9,318
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,88.6,84.7 to 92.4,481
Rotavirus,,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,73.6,68.2 to 79.0,437
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,95.2,92.6 to 97.9,240
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,79.4,74.1 to 84.7,437
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,86.0,80.9 to 91.1,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,77.8,72.9 to 82.7,437
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,63.4,54.3 to 72.4,318
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,98.3,96.9 to 99.7,240
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,88.5,84.6 to 92.4,437
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,90.3,86.3 to 94.2,318
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,93.2,91.1 to 95.3,995
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,92.5,90.4 to 94.5,995
Influenza,,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,58.3,52.1 to 64.4,437
Influenza,,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,47.6,40.7 to 54.5,318
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,97.9,96.2 to 99.5,240
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,88.9,85.0 to 92.8,437
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,84.1,79.0 to 89.2,318
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,94.2,90.6 to 97.8,240
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,81.0,76.1 to 86.0,437
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,82.8,77.5 to 88.1,318
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,79.2,75.8 to 82.5,995
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,88.7,84.5 to 92.8,318
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,93.8,90.8 to 96.9,240
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,70.1,63.9 to 76.3,318
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,76.6,71.3 to 81.9,437
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,95.9,93.0 to 98.8,240
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,71.6,65.5 to 77.6,318
Influenza,,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,76.1,69.2 to 83.0,240
Rotavirus,,States/Local Areas,Indiana,2016-2019,Overall,Overall,74.6,71.1 to 78.2,995
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,92.6 to 96.8,652
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,64.1,58.5 to 69.8,440
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,91.2 to 95.6,652
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,66.4,57.3 to 75.6,178
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.0,83.2 to 92.8,336
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.5,76.1 to 87.0,336
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,78.7,73.9 to 83.5,481
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,86.9,80.9 to 92.8,178
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.9,80.7 to 91.0,336
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,89.8,86.0 to 93.6,481
Rotavirus,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,70.0 to 80.1,481
Rotavirus,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.8,71.8 to 83.7,336
Influenza,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,62.0,55.1 to 68.9,336
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,51.3,41.5 to 61.2,178
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.9,70.1 to 81.7,336
Influenza,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,57.8,52.1 to 63.5,481
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,70.1,61.0 to 79.2,178
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.7,78.7 to 88.6,336
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,80.5,75.7 to 85.3,481
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.5,85.2 to 93.9,336
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,93.5,89.5 to 97.4,178
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,79.9,75.0 to 84.7,481
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,89.1,85.3 to 92.8,481
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,93.6,89.5 to 97.6,178
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,89.4 to 95.4,481
Rotavirus,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,67.8,58.9 to 76.7,178
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,78.8,71.8 to 85.9,481
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,63.1,52.6 to 73.6,178
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,88.1 to 99.4,115
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,80.9,76.6 to 85.2,519
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.4,71.6 to 83.2,652
≥1 Dose Varicella,,States/Local Areas,Indiana,2020-2021,Age,35 Months,93.2,88.7 to 96.4,369
PCV,≥3 Doses,States/Local Areas,Indiana,2020,Age,7 Months,61.9,53.3 to 69.8,232
Hep B,≥3 Doses,States/Local Areas,Indiana,2020,Age,7 Months,64.0,55.9 to 71.5,232
Hib,≥1 Dose,States/Local Areas,Indiana,2020,Age,3 Months,83.1,76.1 to 88.4,232
Polio,≥1 Dose,States/Local Areas,Indiana,2020,Age,3 Months,83.2,76.2 to 88.5,232
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,94.3,92.0 to 96.7,519
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,84.8,79.2 to 90.4,519
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,70.3,63.2 to 77.5,440
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.6 to 95.5,519
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,82.2 to 98.7,115
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.7,61.2 to 86.2,78
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,79.6,71.0 to 88.3,150
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.9,68.7 to 89.1,115
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,93.8,91.4 to 96.2,519
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,85.9,81.7 to 90.1,440
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,89.7,83.7 to 95.7,150
Influenza,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,49.2,38.5 to 59.9,150
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,92.0,89.8 to 94.2,995
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Overall,Overall,88.0,85.3 to 90.7,995
Rotavirus,,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,92.4,88.3 to 96.4,240
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,91.9,89.7 to 94.1,995
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Overall,Overall,88.1,85.4 to 90.8,995
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,88.4,84.3 to 92.5,437
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,79.3,75.9 to 82.6,995
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,83.9,78.7 to 89.1,318
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,92.6,87.3 to 97.8,240
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,78.6,71.8 to 85.5,437
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,92.5,89.2 to 95.9,437
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,88.2,83.9 to 92.5,318
Influenza,,States/Local Areas,Indiana,2016-2019,Overall,Overall,57.4,53.3 to 61.4,995
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Overall,Overall,82.2,79.2 to 85.1,995
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,89.4,85.4 to 93.4,318
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Overall,Overall,75.5,70.6 to 80.3,995
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,87.5,82.7 to 92.3,240
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Overall,Overall,88.7,86.1 to 91.3,995
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,98.7,97.4 to 100.0,240
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,66.5,60.5 to 72.5,437
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,93.5,90.3 to 96.7,437
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,59.9,53.2 to 66.5,318
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,85.0,80.4 to 89.7,318
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,97.0,95.0 to 99.0,240
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,93.3,90.4 to 96.2,437
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Overall,Overall,77.3,73.9 to 80.8,995
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Overall,Overall,67.8,64.0 to 71.6,995
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.1,70.1 to 82.0,336
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,84.0,77.4 to 90.6,178
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,87.6,81.8 to 93.4,178
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,97.2,95.1 to 99.4,240
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,133% to <400% FPL,92.7,89.5 to 96.0,437
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,85.2,81.4 to 88.9,481
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,91.4,86.3 to 96.6,178
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,68.7,63.3 to 74.0,481
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.3 to 95.7,336
Influenza,,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a Non-MSA,48.4,38.5 to 58.3,178
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,89.0 to 95.2,481
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.4 to 95.6,336
Hep A,≥1 Dose,States/Local Areas,Indiana,2021,Age,24 Months,91.7,85.7 to 95.9,137
PCV,≥4 Doses,States/Local Areas,Indiana,2021,Age,24 Months,82.4,73.0 to 90.0,137
≥1 Dose Varicella,,States/Local Areas,Indiana,2021,Age,24 Months,91.7,84.6 to 96.4,137
PCV,≥3 Doses,States/Local Areas,Indiana,2021,Age,24 Months,93.1,86.0 to 97.4,137
Hib,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,94.1,89.7 to 96.7,369
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2021,Age,0-2 Days,81.4,71.1 to 88.6,137
PCV,≥3 Doses,States/Local Areas,Indiana,2021,Age,13 Months,88.2,78.9 to 93.7,137
DTaP,≥4 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,68.8,62.9 to 74.2,441
Polio,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,91.0,86.4 to 94.1,441
DTaP,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,91.0,86.7 to 94.0,441
Hep B,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,62.8,56.8 to 68.3,441
Hib,Primary Series,States/Local Areas,Indiana,2019-2020,Age,7 Months,70.3,64.4 to 75.6,441
DTaP,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,3 Months,85.4,80.5 to 89.2,441
Hib,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,3 Months,85.3,80.4 to 89.1,441
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.4,86.3 to 92.4,652
Rotavirus,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.9,74.8 to 82.9,652
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.9,69.4 to 92.5,78
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.6 to 93.2,652
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.2,80.1 to 96.3,78
Rotavirus,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",56.9,43.6 to 70.2,78
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,76.5,72.0 to 81.1,519
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,85.7 to 91.9,652
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,83.3,79.2 to 87.5,440
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.3,64.2 to 88.3,78
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,87.4,80.5 to 94.3,150
≥1 Dose MMR,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.3,90.9 to 100.0,115
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,87.9,83.9 to 91.9,440
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.2 to 98.9,519
Rotavirus,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,84.0,79.9 to 88.0,519
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,91.3,87.9 to 94.6,440
Influenza,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,51.6,45.7 to 57.5,440
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,68.6 to 88.7,115
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,91.1,86.1 to 96.2,150
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,86.2,79.7 to 92.8,150
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,71.8 to 88.9,115
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.1,51.9 to 78.3,78
Rotavirus,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,69.4,64.0 to 74.8,440
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,65.2,54.6 to 75.8,150
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",54.9,41.6 to 68.2,78
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.9,66.3 to 75.5,652
Combined 7 Series,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.0,56.3 to 77.6,115
Rotavirus,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,74.0,64.8 to 83.2,150
Rotavirus,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,60.4 to 81.3,115
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.3,77.3 to 85.2,652
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.6,54.4 to 80.7,78
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,80.6,72.6 to 88.5,150
Influenza,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",61.1,56.1 to 66.1,652
Influenza,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",55.5,44.1 to 66.9,115
Influenza,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",48.8,35.5 to 62.0,78
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.7,74.5 to 94.8,78
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.3,90.9 to 95.8,652
≥1 Dose Varicella,,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,86.9,79.9 to 93.9,150
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,91.4 to 95.9,652
Influenza,,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,68.5,63.4 to 73.6,519
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.4,77.6 to 97.1,78
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,75.4,70.2 to 80.6,440
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,91.2,88.0 to 94.5,440
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.5,72.0 to 94.9,78
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,86.6,79.5 to 93.8,150
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.6,75.6 to 83.6,652
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.2 to 97.6,519
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,90.3,86.8 to 93.8,440
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.1,76.1 to 84.1,652
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,85.5 to 98.7,115
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.7,79.4 to 98.1,78
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,91.1,85.2 to 96.9,150
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.4,78.8 to 98.0,78
Hep B,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,90.0,84.7 to 95.3,150
Hep B,≥2 Doses,States/Local Areas,Indiana,2020,Age,5 Months,86.7,79.7 to 91.5,232
Hib,≥2 Doses,States/Local Areas,Indiana,2020,Age,5 Months,71.9,63.2 to 79.1,232
Polio,≥2 Doses,States/Local Areas,Indiana,2020,Age,5 Months,72.3,63.6 to 79.6,232
DTaP,≥2 Doses,States/Local Areas,Indiana,2020,Age,5 Months,72.3,63.6 to 79.6,232
PCV,≥1 Dose,States/Local Areas,Indiana,2020,Age,3 Months,83.0,76.0 to 88.3,232
Hep B,≥1 Dose,States/Local Areas,Indiana,2020,Age,3 Months,95.9,92.6 to 97.8,232
Hep A,≥1 Dose,States/Local Areas,Indiana,2020,Age,24 Months,92.5,87.6 to 95.9,232
Hep A,≥2 Doses,States/Local Areas,Indiana,2020,Age,24 Months,59.7,51.4 to 68.1,232
PCV,≥4 Doses,States/Local Areas,Indiana,2020,Age,24 Months,86.3,79.7 to 91.6,232
PCV,≥3 Doses,States/Local Areas,Indiana,2020,Age,24 Months,93.5,88.2 to 96.9,232
DTaP,≥3 Doses,States/Local Areas,Indiana,2020,Age,35 Months,94.6,90.0 to 97.5,232
Influenza,,States/Local Areas,Indiana,2020,Age,24 Months,52.7,44.7 to 61.2,232
Rotavirus,,States/Local Areas,Indiana,2020,Age,8 Months,74.0,66.0 to 80.6,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2020,Age,0-3 Days,80.3,72.2 to 86.4,232
Combined 7 Series,,States/Local Areas,Indiana,2020,Age,24 Months,72.4,64.9 to 79.6,232
Hib,≥3 Doses,States/Local Areas,Indiana,2020,Age,19 Months,89.2,81.2 to 94.1,232
Polio,≥3 Doses,States/Local Areas,Indiana,2020,Age,19 Months,91.7,84.9 to 95.6,232
≥1 Dose MMR,,States/Local Areas,Indiana,2020,Age,19 Months,87.5,80.6 to 92.1,232
DTaP,≥4 Doses,States/Local Areas,Indiana,2020,Age,19 Months,71.2,63.0 to 78.2,232
DTaP,≥3 Doses,States/Local Areas,Indiana,2020,Age,19 Months,94.3,89.2 to 97.1,232
DTaP,≥3 Doses,States/Local Areas,Indiana,2020,Age,7 Months,65.1,56.5 to 72.9,232
PCV,≥3 Doses,States/Local Areas,Indiana,2020,Age,13 Months,89.0,82.8 to 93.2,232
≥1 Dose Varicella,,States/Local Areas,Indiana,2020,Age,13 Months,60.8,52.5 to 68.6,232
Hep B,≥3 Doses,States/Local Areas,Indiana,2020,Age,13 Months,88.7,82.5 to 92.9,232
Hep B,≥2 Doses,States/Local Areas,Indiana,2020,Age,13 Months,93.0,87.0 to 96.3,232
Hib,≥3 Doses,States/Local Areas,Indiana,2020,Age,13 Months,72.7,64.5 to 79.6,232
Hib,Primary Series,States/Local Areas,Indiana,2020,Age,13 Months,89.9,83.9 to 93.8,232
PCV,≥3 Doses,States/Local Areas,Indiana,2020,Age,35 Months,93.5,88.2 to 96.9,232
PCV,≥4 Doses,States/Local Areas,Indiana,2020,Age,35 Months,86.9,80.3 to 92.2,232
PCV,≥4 Doses,States/Local Areas,Indiana,2020,Age,19 Months,78.9,70.7 to 85.3,232
Polio,≥3 Doses,States/Local Areas,Indiana,2020,Age,35 Months,93.4,88.1 to 96.9,232
DTaP,≥4 Doses,States/Local Areas,Indiana,2020,Age,35 Months,88.8,82.8 to 93.4,232
≥1 Dose Varicella,,States/Local Areas,Indiana,2020,Age,19 Months,86.1,78.7 to 91.2,232
PCV,≥3 Doses,States/Local Areas,Indiana,2020,Age,19 Months,92.8,86.9 to 96.2,232
Hep B,≥3 Doses,States/Local Areas,Indiana,2020,Age,19 Months,91.0,84.9 to 94.7,232
Hib,Full Series,States/Local Areas,Indiana,2020,Age,19 Months,73.5,65.3 to 80.3,232
Hib,Primary Series,States/Local Areas,Indiana,2020,Age,19 Months,93.5,87.5 to 96.7,232
≥1 Dose Varicella,,States/Local Areas,Indiana,2020,Age,35 Months,93.1,87.3 to 96.8,232
Hep B,≥3 Doses,States/Local Areas,Indiana,2020,Age,35 Months,91.6,86.2 to 95.5,232
Hib,Full Series,States/Local Areas,Indiana,2020,Age,35 Months,86.2,80.2 to 91.2,232
Hib,Primary Series,States/Local Areas,Indiana,2020,Age,35 Months,93.6,88.3 to 97.0,232
Hib,≥3 Doses,States/Local Areas,Indiana,2020,Age,35 Months,93.1,87.7 to 96.7,232
≥1 Dose MMR,,States/Local Areas,Indiana,2020,Age,35 Months,93.3,87.5 to 96.9,232
Hib,≥3 Doses,States/Local Areas,Indiana,2020,Age,24 Months,93.1,87.7 to 96.7,232
≥1 Dose MMR,,States/Local Areas,Indiana,2020,Age,24 Months,91.7,86.2 to 95.6,232
DTaP,≥4 Doses,States/Local Areas,Indiana,2020,Age,24 Months,82.3,75.7 to 88.0,232
Polio,≥3 Doses,States/Local Areas,Indiana,2020,Age,24 Months,93.4,88.1 to 96.9,232
PCV,≥2 Doses,States/Local Areas,Indiana,2020,Age,5 Months,70.2,61.5 to 77.8,232
DTaP,≥3 Doses,States/Local Areas,Indiana,2020,Age,24 Months,94.6,90.0 to 97.5,232
Hep B,≥2 Doses,States/Local Areas,Indiana,2020,Age,7 Months,90.0,83.7 to 94.0,232
Hib,Primary Series,States/Local Areas,Indiana,2020,Age,7 Months,71.5,63.4 to 78.5,232
Hib,≥3 Doses,States/Local Areas,Indiana,2020,Age,7 Months,50.6,42.4 to 58.7,232
DTaP,≥1 Dose,States/Local Areas,Indiana,2020,Age,3 Months,83.2,76.2 to 88.5,232
Polio,≥2 Doses,States/Local Areas,Indiana,2020,Age,7 Months,88.4,81.9 to 92.8,232
Hib,≥2 Doses,States/Local Areas,Indiana,2020,Age,7 Months,88.3,81.8 to 92.7,232
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2020,Age,0-1 Days,78.0,69.8 to 84.6,232
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2020,Age,0-2 Days,80.1,72.0 to 86.2,232
Hep A,≥2 Doses,States/Local Areas,Indiana,2020,Age,19 Months,36.6,29.1 to 44.7,232
Hep A,≥1 Dose,States/Local Areas,Indiana,2020,Age,19 Months,84.1,76.1 to 89.8,232
Combined 7 Series,,States/Local Areas,Indiana,2020,Age,35 Months,75.7,68.2 to 82.7,232
Hep A,≥2 Doses,States/Local Areas,Indiana,2020,Age,35 Months,80.8,70.4 to 89.3,232
Polio,≥2 Doses,States/Local Areas,Indiana,2020,Age,13 Months,93.4,87.4 to 96.6,232
Hep A,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,55.8,49.8 to 62.0,441
Hep A,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,24 Months,91.7,87.5 to 94.9,441
Hep A,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,35 Months,95.2,90.4 to 98.0,441
Hep A,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,80.1,72.5 to 86.7,441
Influenza,,States/Local Areas,Indiana,2019-2020,Age,24 Months,56.0,49.9 to 62.4,441
Hib,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,93.2,89.4 to 96.0,441
Hib,Primary Series,States/Local Areas,Indiana,2019-2020,Age,24 Months,93.8,90.1 to 96.4,441
Hib,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,48.9,43.0 to 54.9,441
Combined 7 Series,,States/Local Areas,Indiana,2019-2020,Age,35 Months,74.8,68.5 to 80.6,441
Hib,Full Series,States/Local Areas,Indiana,2019-2020,Age,19 Months,72.9,67.1 to 78.0,441
Hep B,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,92.3,88.4 to 94.9,441
≥1 Dose Varicella,,States/Local Areas,Indiana,2019-2020,Age,19 Months,85.8,80.5 to 89.8,441
PCV,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,92.1,88.0 to 94.9,441
PCV,≥4 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,77.4,71.7 to 82.3,441
Hep A,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,19 Months,84.4,78.9 to 88.7,441
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2019-2020,Age,0-1 Days,81.4,76.1 to 85.8,441
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2019-2020,Age,0-2 Days,83.6,78.5 to 87.7,441
Hep B,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,92.6,89.0 to 95.4,441
Hib,Full Series,States/Local Areas,Indiana,2019-2020,Age,24 Months,80.8,75.6 to 85.5,441
≥1 Dose Varicella,,States/Local Areas,Indiana,2019-2020,Age,24 Months,90.1,85.5 to 93.6,441
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2019-2020,Age,0-3 Days,83.9,78.8 to 88.0,441
PCV,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,61.7,55.5 to 67.5,441
PCV,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,93.7,90.0 to 96.4,441
PCV,≥4 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,84.7,79.6 to 89.1,441
Hep A,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,30.6,25.4 to 36.3,441
≥1 Dose MMR,,States/Local Areas,Indiana,2019-2020,Age,19 Months,85.7,80.5 to 89.7,441
Hib,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,89.3,84.4 to 92.8,441
Hib,Primary Series,States/Local Areas,Indiana,2019-2020,Age,19 Months,93.1,89.1 to 95.7,441
Hib,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,93.2,89.4 to 96.0,441
≥1 Dose MMR,,States/Local Areas,Indiana,2019-2020,Age,35 Months,91.6,86.3 to 95.3,441
Hib,Full Series,States/Local Areas,Indiana,2019-2020,Age,35 Months,86.5,81.5 to 90.7,441
Hib,Primary Series,States/Local Areas,Indiana,2019-2020,Age,35 Months,93.8,90.1 to 96.4,441
Hep B,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,92.9,89.3 to 95.6,441
≥1 Dose Varicella,,States/Local Areas,Indiana,2019-2020,Age,35 Months,91.9,87.0 to 95.5,441
PCV,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,93.7,90.0 to 96.4,441
DTaP,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,94.3,90.8 to 96.7,441
PCV,≥4 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,87.1,82.1 to 91.3,441
DTaP,≥4 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,80.6,75.3 to 85.4,441
Polio,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,24 Months,92.7,88.8 to 95.6,441
≥1 Dose MMR,,States/Local Areas,Indiana,2019-2020,Age,24 Months,89.3,84.6 to 93.1,441
Hep B,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,3 Months,96.9,94.8 to 98.2,441
PCV,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,3 Months,84.4,79.5 to 88.4,441
DTaP,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,5 Months,76.7,70.9 to 81.7,441
Polio,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,5 Months,75.9,70.1 to 80.9,441
Hib,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,5 Months,76.3,70.5 to 81.2,441
Polio,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,92.6,88.3 to 95.3,441
≥1 Dose MMR,,States/Local Areas,Indiana,2019-2020,Age,13 Months,63.8,57.6 to 69.7,441
Hib,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,71.1,65.1 to 76.4,441
Hib,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,94.1,90.3 to 96.4,441
Hep B,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,95.1,91.8 to 97.1,441
Hib,Primary Series,States/Local Areas,Indiana,2019-2020,Age,13 Months,88.9,84.4 to 92.2,441
Hep B,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,5 Months,90.7,86.7 to 93.6,441
PCV,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,5 Months,74.4,68.4 to 79.6,441
DTaP,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,65.0,58.9 to 70.7,441
Polio,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,87.4,82.6 to 91.0,441
Hib,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,88.4,83.8 to 91.8,441
Hep B,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,89.3,84.9 to 92.5,441
≥1 Dose Varicella,,States/Local Areas,Indiana,2019-2020,Age,13 Months,59.6,53.6 to 65.3,441
PCV,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,13 Months,88.3,83.7 to 91.7,441
DTaP,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,94.3,90.8 to 96.7,441
Combined 7 Series,,States/Local Areas,Indiana,2019-2020,Age,24 Months,70.1,63.9 to 76.1,441
DTaP,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,19 Months,93.2,89.4 to 95.8,441
DTaP,≥4 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,87.3,82.2 to 91.6,441
Polio,≥3 Doses,States/Local Areas,Indiana,2019-2020,Age,35 Months,92.7,88.8 to 95.6,441
DTaP,≥3 Doses,States/Local Areas,Iowa,2018,Age,13 Months,94.7,89.1 to 97.5,255
DTaP,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,94.3,90.6 to 96.6,505
DTaP,≥3 Doses,States/Local Areas,Iowa,2016,Age,13 Months,95.1,90.6 to 97.5,198
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,92.4,88.7 to 95.0,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2017,Age,13 Months,89.7,83.1 to 93.8,228
DTaP,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,92.1,88.1 to 94.9,483
Polio,≥3 Doses,States/Local Areas,Iowa,2012,Age,19 Months,93.0,86.9 to 96.4,247
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,83.9,78.8 to 89.0,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,81.4,76.6 to 86.2,378
Hib,≥3 Doses,States/Local Areas,Iowa,2013,Age,13 Months,68.2,62.5 to 73.4,265
Hib,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,69.9,64.3 to 75.0,542
Polio,≥3 Doses,States/Local Areas,Iowa,2011,Age,19 Months,91.8,82.4 to 96.4,220
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,98.1,96.3 to 99.8,238
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,96.9,95.2 to 98.7,378
Hib,≥3 Doses,States/Local Areas,Iowa,2014,Age,13 Months,71.6,65.2 to 77.2,277
Hib,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,72.1,66.8 to 76.9,515
Hib,≥3 Doses,States/Local Areas,Iowa,2011,Age,13 Months,78.2,72.9 to 82.7,220
Hib,≥3 Doses,States/Local Areas,Iowa,2012,Age,13 Months,72.9,63.0 to 80.9,247
Hib,≥3 Doses,States/Local Areas,Iowa,2019,Age,7 Months,38.6,30.7 to 47.1,250
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,95.0,91.9 to 98.1,274
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.2,92.0 to 96.4,642
DTaP,≥3 Doses,States/Local Areas,Iowa,2013,Age,13 Months,92.9,89.8 to 95.1,265
DTaP,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,92.4,90.3 to 94.0,542
DTaP,≥3 Doses,States/Local Areas,Iowa,2014,Age,13 Months,91.8,87.0 to 95.0,277
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,93.1,89.8 to 95.3,515
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.6,77.0 to 84.2,642
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,80.6 to 99.3,75
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Overall,Overall,81.9,78.9 to 85.0,838
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,80.8,75.8 to 85.8,326
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,83.2,78.1 to 88.2,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.8,76.0 to 87.7,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2015,Age,13 Months,94.3,89.2 to 97.1,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,94.7,91.3 to 96.8,436
DTaP,≥3 Doses,States/Local Areas,Iowa,2012,Age,13 Months,91.7,85.9 to 95.3,247
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,81.0,75.3 to 86.8,222
Hib,≥2 Doses,States/Local Areas,Iowa,2018,Age,13 Months,95.7,89.8 to 98.2,255
Hib,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,95.5,91.7 to 97.6,505
Hib,≥2 Doses,States/Local Areas,Iowa,2017,Age,13 Months,94.1,89.1 to 96.9,228
Hib,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,94.9,91.5 to 97.0,483
Hib,≥2 Doses,States/Local Areas,Iowa,2019,Age,13 Months,95.3,88.9 to 98.1,250
DTaP,≥3 Doses,States/Local Areas,Iowa,2019,Age,13 Months,94.0,87.8 to 97.1,250
DTaP,≥3 Doses,States/Local Areas,Iowa,2011,Age,19 Months,93.1,85.6 to 96.8,220
DTaP,≥3 Doses,States/Local Areas,Iowa,2013,Age,19 Months,96.7,89.8 to 99.0,265
DTaP,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,96.1,94.0 to 97.5,542
DTaP,≥3 Doses,States/Local Areas,Iowa,2012,Age,19 Months,94.5,88.4 to 97.4,247
Hib,≥3 Doses,States/Local Areas,Iowa,2015,Age,13 Months,72.7,64.2 to 79.8,238
Hib,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,70.7,64.8 to 76.0,436
Hib,≥3 Doses,States/Local Areas,Iowa,2016,Age,13 Months,68.7,60.1 to 76.1,198
Hib,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,68.8,62.9 to 74.2,426
Hib,≥3 Doses,States/Local Areas,Iowa,2017,Age,13 Months,68.9,60.7 to 76.1,228
Hib,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,13 Months,64.1,58.2 to 69.7,483
Polio,≥3 Doses,States/Local Areas,Iowa,2013,Age,19 Months,94.7,89.3 to 97.5,265
Polio,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,94.4,92.9 to 95.7,542
Polio,≥3 Doses,States/Local Areas,Iowa,2014,Age,19 Months,94.1,90.2 to 96.6,277
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,94.2,91.2 to 96.2,515
Polio,≥3 Doses,States/Local Areas,Iowa,2015,Age,19 Months,94.3,93.0 to 95.4,238
Polio,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,94.8,91.4 to 96.9,436
Polio,≥3 Doses,States/Local Areas,Iowa,2018,Age,19 Months,96.8,92.2 to 98.7,255
Polio,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,62.7,56.7 to 68.3,505
Hib,≥3 Doses,States/Local Areas,Iowa,2018,Age,13 Months,59.2,50.6 to 67.3,255
Hib,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,13 Months,60.4,54.3 to 66.1,505
Polio,≥3 Doses,States/Local Areas,Iowa,2016,Age,19 Months,95.3,90.7 to 97.6,198
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,94.6,91.6 to 96.6,426
Polio,≥3 Doses,States/Local Areas,Iowa,2017,Age,19 Months,93.9,89.3 to 96.6,228
Polio,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,95.3,92.4 to 97.1,483
Hib,≥3 Doses,States/Local Areas,Iowa,2019,Age,13 Months,61.5,53.1 to 69.3,250
Hib,≥3 Doses,States/Local Areas,Iowa,2012,Age,19 Months,90.8,82.6 to 95.4,247
Hib,≥3 Doses,States/Local Areas,Iowa,2011,Age,19 Months,87.6,80.6 to 92.3,220
Hib,≥3 Doses,States/Local Areas,Iowa,2013,Age,19 Months,90.7,86.3 to 93.8,265
Hib,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,90.8,88.7 to 92.5,542
Hep A,≥1 Dose,States/Local Areas,Indiana,2012,Age,35 Months,92.6,85.4 to 97.1,307
DTaP,≥4 Doses,States/Local Areas,Indiana,2012,Age,19 Months,66.7,61.2 to 71.8,307
DTaP,≥4 Doses,States/Local Areas,Indiana,2011,Age,19 Months,62.4,57.5 to 67.1,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2016,Age,35 Months,94.1,89.9 to 97.0,285
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,95.7,93.2 to 97.5,589
DTaP,≥3 Doses,States/Local Areas,Indiana,2015,Age,35 Months,95.1,90.7 to 97.8,251
DTaP,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,94.8,91.9 to 96.9,536
PCV,≥2 Doses,States/Local Areas,Indiana,2011,Age,5 Months,71.6,66.7 to 76.0,271
PCV,≥2 Doses,States/Local Areas,Indiana,2012,Age,5 Months,73.9,67.8 to 79.1,307
PCV,≥2 Doses,States/Local Areas,Indiana,2013,Age,5 Months,69.1,67.4 to 70.8,218
PCV,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,5 Months,71.0,67.4 to 74.2,476
DTaP,≥3 Doses,States/Local Areas,Indiana,2017,Age,35 Months,97.1,93.8 to 98.9,304
DTaP,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,96.2,93.0 to 98.2,576
Hep A,≥1 Dose,States/Local Areas,Indiana,2012,Age,24 Months,82.1,76.2 to 87.3,307
Hep A,≥1 Dose,States/Local Areas,Indiana,2014,Age,24 Months,86.3,80.1 to 91.4,258
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,24 Months,86.4,82.1 to 90.1,509
Hep A,≥1 Dose,States/Local Areas,Indiana,2013,Age,24 Months,88.4,81.9 to 93.3,218
Hep A,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,24 Months,87.3,83.0 to 91.0,476
Hep A,≥1 Dose,States/Local Areas,Indiana,2011,Age,24 Months,79.5,73.0 to 85.3,271
Hep A,≥1 Dose,States/Local Areas,Indiana,2019,Age,19 Months,85.1,76.8 to 90.8,209
DTaP,≥2 Doses,States/Local Areas,Indiana,2018,Age,5 Months,77.6,70.6 to 83.3,272
DTaP,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,5 Months,79.5,74.4 to 83.8,481
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,93.1,89.7 to 96.5,207
DTaP,≥2 Doses,States/Local Areas,Indiana,2019,Age,5 Months,81.4,73.4 to 87.4,209
Hep A,≥1 Dose,States/Local Areas,Indiana,2016,Age,19 Months,81.3,74.4 to 86.7,285
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,19 Months,82.0,77.5 to 85.8,589
Hib,≥3 Doses,States/Local Areas,Indiana,2011,Age,35 Months,93.2,87.7 to 96.8,271
Hib,≥3 Doses,States/Local Areas,Indiana,2012,Age,35 Months,91.8,86.1 to 95.8,307
Hib,≥2 Doses,States/Local Areas,Iowa,2012,Age,13 Months,93.2,86.2 to 96.7,247
Hib,≥2 Doses,States/Local Areas,Iowa,2011,Age,13 Months,93.7,84.8 to 97.6,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2018,Age,0-3 Days,84.2,76.9 to 89.5,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2018-2019,Age,0-3 Days,85.1,80.4 to 88.8,505
DTaP,≥3 Doses,States/Local Areas,Iowa,2015,Age,7 Months,77.9,70.8 to 83.6,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,78.0,72.5 to 82.7,436
DTaP,≥3 Doses,States/Local Areas,Iowa,2016,Age,7 Months,78.2,69.5 to 84.9,198
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,72.6,66.4 to 78.0,426
Hib,≥2 Doses,States/Local Areas,Iowa,2013,Age,13 Months,94.1,91.1 to 96.1,265
Hib,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,13 Months,94.6,93.0 to 95.9,542
PCV,≥3 Doses,States/Local Areas,Iowa,2017,Age,35 Months,93.1,88.2 to 96.5,228
PCV,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,96.3,92.3 to 98.6,483
PCV,≥3 Doses,States/Local Areas,Iowa,2018,Age,35 Months,99.0,95.0 to 99.9,255
PCV,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,97.1,93.8 to 98.9,505
Hib,≥3 Doses,States/Local Areas,Iowa,2014,Age,7 Months,45.9,39.1 to 52.8,277
Hib,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,43.0,37.9 to 48.3,515
Hib,≥3 Doses,States/Local Areas,Iowa,2015,Age,7 Months,40.1,32.8 to 47.9,238
Hib,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,39.4,33.8 to 45.3,436
Hib,≥3 Doses,States/Local Areas,Iowa,2016,Age,7 Months,38.7,30.5 to 47.7,198
Hib,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,38.5,32.7 to 44.6,426
Polio,≥1 Dose,States/Local Areas,Iowa,2017,Age,3 Months,87.7,81.5 to 92.0,228
Polio,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,3 Months,91.2,87.5 to 93.9,483
Polio,≥1 Dose,States/Local Areas,Iowa,2018,Age,3 Months,94.7,90.3 to 97.2,255
Polio,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,3 Months,94.0,90.4 to 96.3,505
PCV,≥3 Doses,States/Local Areas,Iowa,2019,Age,35 Months,94.6,89.0 to 97.9,250
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,96.7,92.1 to 100.0,49
Polio,≥1 Dose,States/Local Areas,Iowa,2019,Age,3 Months,93.2,86.8 to 96.6,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2019,Age,0-3 Days,85.9,79.3 to 90.7,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,83.6,79.6 to 87.5,472
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,76.0,62.1 to 89.9,49
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,82.0,77.0 to 87.0,297
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.0,74.4 to 97.6,37
DTaP,≥3 Doses,States/Local Areas,Iowa,2018,Age,7 Months,82.7,75.1 to 88.3,255
DTaP,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,80.6,75.1 to 85.1,505
DTaP,≥3 Doses,States/Local Areas,Iowa,2019,Age,7 Months,78.4,69.8 to 85.1,250
DTaP,≥3 Doses,States/Local Areas,Iowa,2017,Age,7 Months,66.9,58.7 to 74.3,228
DTaP,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,74.7,69.2 to 79.6,483
Hib,Primary Series,States/Local Areas,Iowa,2020,Age,24 Months,93.7,89.0 to 96.8,271
Hib,≥3 Doses,States/Local Areas,Iowa,2017,Age,7 Months,38.2,30.6 to 46.5,228
Hib,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,36.9,31.5 to 42.5,483
Hib,≥3 Doses,States/Local Areas,Iowa,2018,Age,7 Months,35.5,28.3 to 43.4,255
Hib,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,37.0,31.6 to 42.8,505
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,83.5 to 99.7,75
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,97.6,94.7 to 100.0,84
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.7,76.4 to 100.0,37
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,89.2,84.8 to 93.5,297
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.4 to 99.1,472
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,86.5,81.1 to 91.9,222
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,93.9,91.9 to 95.9,838
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,94.2,91.0 to 97.4,326
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.2,88.0 to 96.4,238
Hib,≥2 Doses,States/Local Areas,Iowa,2015,Age,13 Months,94.3,89.2 to 97.1,238
Hib,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,13 Months,95.9,93.1 to 97.6,436
Hib,≥2 Doses,States/Local Areas,Iowa,2016,Age,13 Months,97.5,94.7 to 98.9,198
Hib,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,13 Months,95.8,93.1 to 97.5,426
Hib,≥2 Doses,States/Local Areas,Iowa,2018,Age,7 Months,93.3,87.0 to 96.7,255
Hib,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,7 Months,93.6,89.6 to 96.1,505
PCV,≥3 Doses,States/Local Areas,Iowa,2014,Age,35 Months,92.7,88.5 to 95.9,277
PCV,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,94.8,91.9 to 96.9,515
PCV,≥3 Doses,States/Local Areas,Iowa,2015,Age,35 Months,96.9,92.3 to 99.1,238
PCV,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,97.6,94.6 to 99.1,436
PCV,≥3 Doses,States/Local Areas,Iowa,2016,Age,35 Months,98.7,94.8 to 99.8,198
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,95.3,92.3 to 97.4,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2014,Age,7 Months,73.3,66.5 to 79.2,277
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,75.6,70.8 to 79.8,515
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,91.4,87.3 to 95.5,222
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,97.5,95.4 to 99.6,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,96.1,94.0 to 98.2,378
Hib,≥3 Doses,States/Local Areas,Iowa,2012,Age,7 Months,44.8,36.9 to 52.9,247
Hib,≥3 Doses,States/Local Areas,Iowa,2011,Age,7 Months,47.1,38.7 to 55.6,220
Hib,≥3 Doses,States/Local Areas,Iowa,2013,Age,7 Months,43.3,40.6 to 46.0,265
Hib,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,44.6,41.1 to 48.1,542
Polio,≥1 Dose,States/Local Areas,Iowa,2014,Age,3 Months,89.0,84.1 to 92.5,277
Polio,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,3 Months,90.0,86.4 to 92.7,515
Polio,≥1 Dose,States/Local Areas,Iowa,2015,Age,3 Months,91.0,85.0 to 94.8,238
Polio,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,3 Months,92.4,88.6 to 95.0,436
Polio,≥1 Dose,States/Local Areas,Iowa,2016,Age,3 Months,93.8,88.5 to 96.8,198
Polio,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,3 Months,90.8,86.8 to 93.6,426
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2017,Age,0-3 Days,79.9,69.1 to 87.6,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2017-2018,Age,0-3 Days,83.4,78.5 to 87.3,483
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016,Age,0-3 Days,85.6,78.5 to 90.6,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2017,Age,0-3 Days,84.1,79.3 to 87.9,426
Hib,≥2 Doses,States/Local Areas,Iowa,2014,Age,13 Months,95.1,91.0 to 97.4,277
Hib,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,13 Months,94.7,91.7 to 96.7,515
DTaP,≥3 Doses,States/Local Areas,Iowa,2011,Age,13 Months,91.0,86.9 to 93.9,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,81.3,72.6 to 89.9,84
Hib,≥2 Doses,States/Local Areas,Iowa,2016,Age,7 Months,90.4,83.8 to 94.4,198
Hib,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,7 Months,90.1,85.8 to 93.2,426
Hib,≥2 Doses,States/Local Areas,Iowa,2017,Age,7 Months,89.9,83.5 to 93.9,228
Hib,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,7 Months,91.6,87.5 to 94.4,483
Hib,≥2 Doses,States/Local Areas,Iowa,2015,Age,7 Months,91.4,85.5 to 95.0,238
Hib,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,7 Months,90.9,86.6 to 93.9,436
PCV,≥3 Doses,States/Local Areas,Iowa,2019,Age,24 Months,94.6,89.0 to 97.9,250
PCV,≥3 Doses,States/Local Areas,Iowa,2011,Age,35 Months,93.1,86.9 to 97.0,220
PCV,≥3 Doses,States/Local Areas,Iowa,2013,Age,35 Months,97.2,92.0 to 99.4,265
PCV,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,95.4,91.6 to 97.8,542
PCV,≥3 Doses,States/Local Areas,Iowa,2012,Age,35 Months,93.4,89.0 to 96.5,247
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",99.3,97.9 to 100.0,75
Hib,≥2 Doses,States/Local Areas,Iowa,2019,Age,7 Months,93.9,87.6 to 97.1,250
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,98.1,95.5 to 100.0,84
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,95.1,92.5 to 97.8,274
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.5,92.5 to 96.5,642
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2013,Age,0-3 Days,77.1,70.6 to 82.6,265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2013-2014,Age,0-3 Days,75.8,71.0 to 79.9,542
Polio,≥1 Dose,States/Local Areas,Iowa,2013,Age,3 Months,90.4,85.7 to 93.6,265
Polio,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,3 Months,89.7,86.8 to 92.0,542
PCV,≥1 Dose,States/Local Areas,Iowa,2019,Age,3 Months,92.4,85.5 to 96.2,250
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,95.0,93.3 to 96.7,838
Polio,≥1 Dose,States/Local Areas,Iowa,2012,Age,3 Months,84.0,79.6 to 87.5,247
Polio,≥1 Dose,States/Local Areas,Iowa,2011,Age,3 Months,87.8,83.6 to 91.1,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014,Age,0-3 Days,74.4,67.8 to 80.1,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2014-2015,Age,0-3 Days,80.0,75.0 to 84.2,515
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.3 to 90.1,642
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.5,67.0 to 90.0,75
PCV,≥1 Dose,States/Local Areas,Iowa,2014,Age,3 Months,88.1,82.8 to 92.0,277
PCV,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,3 Months,88.8,84.9 to 91.8,515
PCV,≥1 Dose,States/Local Areas,Iowa,2015,Age,3 Months,89.5,83.0 to 93.7,238
PCV,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,3 Months,91.7,87.7 to 94.4,436
Hib,≥2 Doses,States/Local Areas,Iowa,2018,Age,5 Months,88.8,82.5 to 93.0,255
Hib,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,5 Months,88.0,83.3 to 91.5,505
Hib,≥2 Doses,States/Local Areas,Iowa,2019,Age,5 Months,87.2,79.6 to 92.2,250
Hib,≥2 Doses,States/Local Areas,Iowa,2011,Age,7 Months,87.6,84.3 to 90.2,220
PCV,≥3 Doses,States/Local Areas,Iowa,2016,Age,24 Months,97.6,94.0 to 99.3,198
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,95.1,92.1 to 97.2,426
Hib,≥2 Doses,States/Local Areas,Iowa,2012,Age,7 Months,90.6,84.6 to 94.5,247
PCV,≥3 Doses,States/Local Areas,Iowa,2017,Age,24 Months,93.1,88.2 to 96.5,228
PCV,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,93.6,90.1 to 96.1,483
PCV,≥3 Doses,States/Local Areas,Iowa,2018,Age,24 Months,94.0,88.6 to 97.4,255
PCV,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,94.3,90.6 to 96.8,505
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2015,Age,0-3 Days,85.6,77.1 to 91.3,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2015-2016,Age,0-3 Days,85.6,80.3 to 89.6,436
DTaP,≥3 Doses,States/Local Areas,Iowa,2013,Age,7 Months,74.8,71.9 to 77.5,265
DTaP,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,74.1,71.9 to 76.1,542
DTaP,≥3 Doses,States/Local Areas,Iowa,2012,Age,7 Months,71.5,68.9 to 74.0,247
DTaP,≥3 Doses,States/Local Areas,Iowa,2011,Age,7 Months,71.1,66.4 to 75.4,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2011,Age,0-3 Days,72.7,64.2 to 79.9,220
PCV,≥1 Dose,States/Local Areas,Iowa,2018,Age,3 Months,92.7,87.4 to 95.9,255
PCV,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,3 Months,92.6,88.6 to 95.2,505
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,92.4,89.0 to 95.8,297
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2012,Age,0-3 Days,69.3,61.5 to 76.2,247
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,88.3,83.4 to 93.2,274
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,95.2,92.4 to 98.1,326
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,91.0 to 97.7,238
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,97.1,95.6 to 98.7,472
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,97.8,93.6 to 100.0,49
Hep B,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.7,76.4 to 100.0,37
PCV,≥1 Dose,States/Local Areas,Iowa,2016,Age,3 Months,93.9,88.5 to 96.8,198
PCV,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,3 Months,91.3,87.5 to 94.1,426
PCV,≥1 Dose,States/Local Areas,Iowa,2017,Age,3 Months,88.8,83.0 to 92.8,228
PCV,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,3 Months,90.7,87.0 to 93.5,483
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,94.5,91.2 to 97.8,238
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,88.0,84.0 to 92.1,378
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,77.9,71.2 to 84.5,222
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,86.4,83.4 to 89.3,838
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,86.0,81.2 to 90.8,326
PCV,≥4 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.9,79.1 to 90.6,238
Hib,≥2 Doses,States/Local Areas,Iowa,2013,Age,7 Months,89.6,86.4 to 92.1,265
Hib,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,7 Months,90.8,87.6 to 93.3,542
Hib,≥2 Doses,States/Local Areas,Iowa,2014,Age,7 Months,92.0,87.4 to 95.0,277
Hib,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,7 Months,91.7,88.2 to 94.2,515
PCV,≥1 Dose,States/Local Areas,Iowa,2012,Age,3 Months,80.6,75.5 to 84.9,247
PCV,≥1 Dose,States/Local Areas,Iowa,2011,Age,3 Months,86.0,80.9 to 89.9,220
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,95.8,92.8 to 98.7,238
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,93.8,91.0 to 96.6,378
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,87.0,81.8 to 92.3,222
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Overall,Overall,92.1,89.9 to 94.3,838
≥1 Dose MMR,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,91.2,87.4 to 95.1,326
PCV,≥4 Doses,States/Local Areas,Iowa,2017,Age,35 Months,87.5,79.9 to 93.3,228
PCV,≥4 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,90.9,86.1 to 94.6,483
PCV,≥4 Doses,States/Local Areas,Iowa,2018,Age,35 Months,94.4,87.7 to 98.1,255
PCV,≥4 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,92.9,88.6 to 96.0,505
PCV,≥4 Doses,States/Local Areas,Iowa,2019,Age,35 Months,91.4,85.0 to 95.8,250
Hib,Full Series,States/Local Areas,Iowa,2020,Age,24 Months,76.8,68.6 to 84.3,271
PCV,≥3 Doses,States/Local Areas,Iowa,2018,Age,19 Months,93.8,87.6 to 97.0,255
PCV,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,92.7,88.6 to 95.5,505
PCV,≥3 Doses,States/Local Areas,Iowa,2019,Age,19 Months,94.2,87.9 to 97.3,250
PCV,≥3 Doses,States/Local Areas,Iowa,2011,Age,24 Months,91.2,84.7 to 95.6,220
Hib,≥2 Doses,States/Local Areas,Iowa,2013,Age,5 Months,81.2,79.1 to 83.1,265
Hib,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,5 Months,81.1,76.5 to 84.9,542
Hib,≥2 Doses,States/Local Areas,Iowa,2014,Age,5 Months,81.0,75.0 to 85.8,277
Hib,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,5 Months,80.8,75.5 to 85.2,515
Hib,Full Series,States/Local Areas,Indiana,2021,Age,19 Months,77.6,67.3 to 85.3,137
DTaP,≥1 Dose,States/Local Areas,Indiana,2018,Age,3 Months,87.8,82.2 to 91.7,272
DTaP,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,3 Months,87.8,83.4 to 91.1,481
DTaP,≥3 Doses,States/Local Areas,Indiana,2015,Age,24 Months,91.4,86.1 to 95.3,251
DTaP,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,92.5,89.2 to 95.1,536
DTaP,≥3 Doses,States/Local Areas,Indiana,2014,Age,24 Months,91.3,86.0 to 95.2,258
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,24 Months,91.4,87.7 to 94.4,509
DTaP,≥1 Dose,States/Local Areas,Indiana,2017,Age,3 Months,87.1,81.7 to 91.0,304
DTaP,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,3 Months,87.4,83.7 to 90.4,576
Hep A,≥1 Dose,States/Local Areas,Indiana,2011,Age,19 Months,76.6,72.1 to 80.5,271
DTaP,≥1 Dose,States/Local Areas,Indiana,2019,Age,3 Months,87.7,80.2 to 92.7,209
DTaP,≥3 Doses,States/Local Areas,Indiana,2016,Age,24 Months,93.7,89.4 to 96.6,285
DTaP,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,93.3,90.4 to 95.6,589
Hep A,≥1 Dose,States/Local Areas,Indiana,2012,Age,19 Months,79.3,78.0 to 80.6,307
Hep A,≥1 Dose,States/Local Areas,Indiana,2015,Age,19 Months,78.2,71.7 to 83.5,251
Hep A,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,19 Months,79.7,74.5 to 84.1,536
Hep A,≥1 Dose,States/Local Areas,Indiana,2014,Age,19 Months,83.8,77.0 to 88.8,258
Hep A,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,19 Months,81.0,75.9 to 85.2,509
Hep A,≥1 Dose,States/Local Areas,Indiana,2013,Age,19 Months,84.8,79.3 to 89.0,218
Hep A,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,19 Months,84.3,79.1 to 88.4,476
PCV,≥2 Doses,States/Local Areas,Indiana,2021,Age,5 Months,81.3,71.1 to 88.5,137
Combined 7 Series,,States/Local Areas,Indiana,2021,Age,35 Months,75.8,64.3 to 85.9,137
DTaP,≥1 Dose,States/Local Areas,Indiana,2016,Age,3 Months,83.5,77.1 to 88.4,285
DTaP,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,3 Months,85.3,81.2 to 88.6,589
DTaP,≥1 Dose,States/Local Areas,Indiana,2015,Age,3 Months,83.1,75.5 to 88.7,251
DTaP,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,3 Months,83.3,78.5 to 87.2,536
DTaP,≥1 Dose,States/Local Areas,Indiana,2014,Age,3 Months,83.4,76.7 to 88.5,258
DTaP,≥1 Dose,States/Local Areas,Indiana,2014-2015,Age,3 Months,83.3,78.4 to 87.2,509
DTaP,≥1 Dose,States/Local Areas,Indiana,2013,Age,3 Months,82.9,81.7 to 84.1,218
DTaP,≥1 Dose,States/Local Areas,Indiana,2013-2014,Age,3 Months,83.2,77.9 to 87.3,476
DTaP,≥1 Dose,States/Local Areas,Indiana,2011,Age,3 Months,80.7,78.4 to 82.9,271
DTaP,≥1 Dose,States/Local Areas,Indiana,2012,Age,3 Months,84.4,79.6 to 88.3,307
Hib,≥1 Dose,States/Local Areas,Indiana,2021,Age,3 Months,85.4,76.3 to 91.4,137
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.6,76.7 to 84.4,652
Hep B,≥3 Doses,States/Local Areas,Indiana,2021,Age,19 Months,91.4,81.6 to 96.2,137
Hib,Primary Series,States/Local Areas,Indiana,2021,Age,7 Months,73.8,63.0 to 82.3,137
PCV,≥4 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,84.6,78.9 to 89.4,369
DTaP,≥4 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,87.4,81.6 to 92.0,369
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Overall,Overall,91.7,89.6 to 93.8,975
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,88.7,84.8 to 92.7,337
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,92.9,89.9 to 95.9,405
Polio,≥3 Doses,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,95.5,92.2 to 98.8,233
DTaP,≥3 Doses,States/Local Areas,Indiana,2018,Age,24 Months,92.0,87.0 to 95.7,272
DTaP,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,93.2,89.6 to 95.8,481
DTaP,≥3 Doses,States/Local Areas,Indiana,2017,Age,24 Months,93.0,88.7 to 96.1,304
DTaP,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,92.4,89.2 to 95.0,576
DTaP,≥2 Doses,States/Local Areas,Indiana,2017,Age,5 Months,80.4,74.3 to 85.4,304
DTaP,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,5 Months,79.0,74.5 to 82.9,576
Hib,≥3 Doses,States/Local Areas,Indiana,2017,Age,24 Months,87.5,82.1 to 91.9,304
Hib,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,24 Months,87.4,83.4 to 90.8,576
DTaP,≥3 Doses,States/Local Areas,Indiana,2019,Age,24 Months,94.3,88.8 to 97.7,209
Hib,≥3 Doses,States/Local Areas,Indiana,2016,Age,24 Months,87.6,81.7 to 92.3,285
Hib,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,24 Months,87.5,83.7 to 90.9,589
Hib,≥3 Doses,States/Local Areas,Indiana,2015,Age,24 Months,85.4,78.6 to 90.9,251
Hib,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,24 Months,86.4,82.1 to 90.2,536
Hep A,≥2 Doses,States/Local Areas,Indiana,2011,Age,24 Months,41.5,34.0 to 50.0,271
Hep A,≥2 Doses,States/Local Areas,Indiana,2019,Age,19 Months,25.0,18.4 to 33.1,209
Hep A,≥2 Doses,States/Local Areas,Indiana,2018,Age,19 Months,26.9,20.9 to 33.9,272
Hep A,≥2 Doses,States/Local Areas,Indiana,2018-2019,Age,19 Months,27.6,21.8 to 34.3,406
Hib,≥3 Doses,States/Local Areas,Indiana,2017,Age,35 Months,95.7,90.8 to 98.5,304
Hib,≥3 Doses,States/Local Areas,Indiana,2017-2018,Age,35 Months,94.6,90.5 to 97.3,576
Hib,≥3 Doses,States/Local Areas,Indiana,2016,Age,35 Months,89.6,83.7 to 94.0,285
Hib,≥3 Doses,States/Local Areas,Indiana,2016-2017,Age,35 Months,92.5,88.8 to 95.3,589
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,95.5,93.4 to 97.6,483
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.8 to 93.7,434
DTaP,≥4 Doses,States/Local Areas,Indiana,2015,Age,19 Months,58.8,41.5 to 74.2,251
DTaP,≥4 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,63.8,58.0 to 69.2,536
DTaP,≥4 Doses,States/Local Areas,Indiana,2014,Age,19 Months,67.2,59.5 to 74.1,258
DTaP,≥4 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,63.0,57.2 to 68.5,509
DTaP,≥4 Doses,States/Local Areas,Indiana,2013,Age,19 Months,71.5,64.7 to 77.4,218
DTaP,≥4 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,69.4,62.5 to 75.5,476
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.6,91.5 to 100.0,66
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,88.1,77.2 to 99.0,44
Hep A,≥2 Doses,States/Local Areas,Indiana,2012,Age,24 Months,44.3,37.1 to 52.2,307
Hib,≥3 Doses,States/Local Areas,Indiana,2018,Age,35 Months,92.6,85.8 to 96.9,272
Hib,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,93.5,88.9 to 96.6,481
PCV,≥2 Doses,States/Local Areas,Indiana,2017,Age,5 Months,77.4,71.0 to 82.8,304
PCV,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,5 Months,75.5,70.9 to 79.7,576
Hep A,≥1 Dose,States/Local Areas,Indiana,2011,Age,35 Months,86.0,79.2 to 91.5,271
Hep A,≥1 Dose,States/Local Areas,Indiana,2019,Age,24 Months,90.9,83.6 to 95.9,209
Hep A,≥1 Dose,States/Local Areas,Indiana,2018,Age,24 Months,87.0,81.5 to 91.6,272
Hep A,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,24 Months,88.8,84.5 to 92.3,481
Hep A,≥1 Dose,States/Local Areas,Indiana,2017,Age,24 Months,88.1,82.8 to 92.4,304
Hep A,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,24 Months,87.5,83.8 to 90.8,576
DTaP,≥3 Doses,States/Local Areas,Indiana,2019,Age,35 Months,94.3,88.8 to 97.7,209
DTaP,≥3 Doses,States/Local Areas,Indiana,2018,Age,35 Months,94.8,89.4 to 97.9,272
DTaP,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,35 Months,95.3,91.2 to 97.8,481
PCV,≥2 Doses,States/Local Areas,Indiana,2016,Age,5 Months,72.6,64.7 to 79.3,285
PCV,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,5 Months,75.0,70.0 to 79.5,589
PCV,≥2 Doses,States/Local Areas,Indiana,2015,Age,5 Months,67.5,58.7 to 75.2,251
PCV,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,5 Months,70.0,64.2 to 75.3,536
PCV,≥2 Doses,States/Local Areas,Indiana,2014,Age,5 Months,72.8,65.0 to 79.4,258
PCV,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,5 Months,70.2,62.0 to 77.2,509
Hep A,≥1 Dose,States/Local Areas,Indiana,2016,Age,24 Months,85.7,79.5 to 90.8,285
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2017,Age,24 Months,86.9,82.9 to 90.3,589
Hep A,≥1 Dose,States/Local Areas,Indiana,2015,Age,24 Months,86.5,80.3 to 91.5,251
Hep A,≥1 Dose,States/Local Areas,Indiana,2015-2016,Age,24 Months,86.1,81.8 to 89.8,536
Hep A,≥2 Doses,States/Local Areas,Indiana,2017,Age,19 Months,30.0,24.1 to 36.6,304
Hep A,≥2 Doses,States/Local Areas,Indiana,2017-2018,Age,19 Months,28.5,24.1 to 33.2,576
Hib,≥3 Doses,States/Local Areas,Indiana,2015,Age,35 Months,86.4,79.7 to 91.8,251
Hib,≥3 Doses,States/Local Areas,Indiana,2015-2016,Age,35 Months,87.9,83.6 to 91.6,536
Hib,≥3 Doses,States/Local Areas,Indiana,2014,Age,35 Months,89.4,83.6 to 93.8,258
Hib,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,88.0,83.6 to 91.6,509
Hib,≥3 Doses,States/Local Areas,Indiana,2013,Age,35 Months,96.5,92.3 to 98.8,218
Hib,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,92.7,89.1 to 95.5,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2016,Age,19 Months,25.6,19.9 to 32.1,285
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2017,Age,19 Months,27.8,23.6 to 32.4,589
Hep A,≥2 Doses,States/Local Areas,Indiana,2015,Age,19 Months,25.7,18.1 to 35.2,251
Hep A,≥2 Doses,States/Local Areas,Indiana,2015-2016,Age,19 Months,25.6,20.9 to 31.0,536
Hib,≥3 Doses,States/Local Areas,Indiana,2019,Age,24 Months,93.3,87.8 to 96.9,209
Hib,≥3 Doses,States/Local Areas,Indiana,2018,Age,24 Months,87.2,81.6 to 91.9,272
Hib,≥3 Doses,States/Local Areas,Indiana,2018-2019,Age,24 Months,90.2,86.4 to 93.3,481
Hep A,≥2 Doses,States/Local Areas,Indiana,2012,Age,19 Months,23.0,21.6 to 24.4,307
Hep A,≥2 Doses,States/Local Areas,Indiana,2014,Age,19 Months,26.7,20.5 to 34.0,258
Hep A,≥2 Doses,States/Local Areas,Indiana,2014-2015,Age,19 Months,26.2,21.3 to 31.8,509
Hep A,≥2 Doses,States/Local Areas,Indiana,2013,Age,19 Months,31.1,28.2 to 34.1,218
Hep A,≥2 Doses,States/Local Areas,Indiana,2013-2014,Age,19 Months,28.9,27.3 to 30.6,476
Hep A,≥2 Doses,States/Local Areas,Indiana,2011,Age,19 Months,19.0,15.1 to 23.7,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2014,Age,35 Months,92.4,87.0 to 96.2,258
DTaP,≥3 Doses,States/Local Areas,Indiana,2014-2015,Age,35 Months,93.9,90.4 to 96.4,509
DTaP,≥3 Doses,States/Local Areas,Indiana,2011,Age,35 Months,95.1,90.1 to 98.0,271
DTaP,≥3 Doses,States/Local Areas,Indiana,2012,Age,35 Months,94.6,90.1 to 97.5,307
DTaP,≥3 Doses,States/Local Areas,Indiana,2013,Age,35 Months,97.4,93.6 to 99.2,218
DTaP,≥3 Doses,States/Local Areas,Indiana,2013-2014,Age,35 Months,94.8,91.5 to 97.1,476
Hep A,≥1 Dose,States/Local Areas,Indiana,2018,Age,19 Months,84.0,77.6 to 88.8,272
Hep A,≥1 Dose,States/Local Areas,Indiana,2018-2019,Age,19 Months,85.1,79.4 to 89.4,406
Hep A,≥1 Dose,States/Local Areas,Indiana,2017,Age,19 Months,82.8,76.4 to 87.6,304
Hep A,≥1 Dose,States/Local Areas,Indiana,2017-2018,Age,19 Months,83.4,79.0 to 86.9,576
Polio,≥1 Dose,States/Local Areas,Indiana,2019-2020,Age,3 Months,84.6,79.6 to 88.6,441
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,86.9,83.2 to 90.6,519
Hib,Primary Series,States/Local Areas,Indiana,2021,Age,19 Months,93.3,84.9 to 97.1,137
Hib,≥3 Doses,States/Local Areas,Indiana,2021,Age,19 Months,90.8,81.9 to 95.5,137
Hib,Primary Series,States/Local Areas,Indiana,2020-2021,Age,24 Months,93.5,89.3 to 96.5,369
≥1 Dose MMR,,States/Local Areas,Indiana,2021,Age,35 Months,92.7,85.3 to 97.2,137
Hib,≥2 Doses,States/Local Areas,Indiana,2021,Age,7 Months,88.5,79.1 to 94.0,137
Hep B,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,87.0,81.2 to 91.3,369
Hib,≥3 Doses,States/Local Areas,Indiana,2021,Age,7 Months,50.9,40.2 to 61.4,137
Hib,≥2 Doses,States/Local Areas,Indiana,2021,Age,5 Months,80.2,69.9 to 87.6,137
PCV,≥3 Doses,States/Local Areas,Indiana,2021,Age,35 Months,93.1,86.0 to 97.4,137
Polio,≥2 Doses,States/Local Areas,Indiana,2021,Age,7 Months,88.5,79.1 to 94.0,137
Hib,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,92.3,87.7 to 95.6,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,93.8,89.4 to 96.5,369
Hep B,≥2 Doses,States/Local Areas,Indiana,2021,Age,7 Months,91.0,81.7 to 95.8,137
Hep B,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,93.5,88.5 to 96.4,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2021,Age,7 Months,64.3,52.8 to 74.4,137
Combined 7 Series,,States/Local Areas,Oklahoma,2015,Age,35 Months,71.5,64.3 to 78.4,275
Combined 7 Series,,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,71.1,66.1 to 76.0,594
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,68.8,63.4 to 74.2,439
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,66.0,60.8 to 71.2,498
Combined 7 Series,,States/Local Areas,Oklahoma,2019,Age,35 Months,74.1,64.5 to 82.9,205
Combined 7 Series,,States/Local Areas,Oklahoma,2018,Age,35 Months,68.2,59.2 to 76.9,194
Combined 7 Series,,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,71.1,64.5 to 77.4,399
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,78.4,61.7 to 95.1,32
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,63.2,57.2 to 69.2,370
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.3,41.8 to 78.7,36
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.6,57.6 to 71.6,289
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.3,63.2 to 73.5,519
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,67.6,61.2 to 73.9,313
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.3,62.2 to 74.3,355
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,66.5,62.8 to 70.3,996
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,63.0,56.1 to 69.8,328
Hib,Full Series,States/Local Areas,Oklahoma,2016,Age,19 Months,71.5,65.3 to 77.0,319
Hib,Full Series,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,73.2,68.3 to 77.6,562
Hib,Full Series,States/Local Areas,Oklahoma,2015,Age,19 Months,73.6,69.2 to 77.5,275
Hib,Full Series,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,72.6,68.0 to 76.7,594
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,67.7,61.8 to 73.7,404
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,72.6,65.6 to 79.6,222
Hib,Full Series,States/Local Areas,Oklahoma,2011,Age,19 Months,75.7,69.0 to 81.3,279
Hib,Full Series,States/Local Areas,Oklahoma,2012,Age,19 Months,74.8,59.7 to 85.6,260
Hib,Full Series,States/Local Areas,Oklahoma,2013,Age,19 Months,78.0,67.2 to 86.0,198
Hib,Full Series,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,74.1,65.2 to 81.3,425
Hib,Full Series,States/Local Areas,Oklahoma,2014,Age,19 Months,70.1,61.6 to 77.5,227
Hib,Full Series,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,71.9,66.5 to 76.7,502
Hib,Full Series,States/Local Areas,Oklahoma,2019,Age,19 Months,77.0,68.4 to 83.8,205
Hib,Full Series,States/Local Areas,Oklahoma,2018,Age,19 Months,76.4,68.3 to 82.9,194
Hib,Full Series,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,94.3,90.9 to 96.4,399
Hib,Full Series,States/Local Areas,Oklahoma,2013,Age,24 Months,82.3,75.2 to 88.3,198
Hib,Full Series,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,78.5,73.2 to 83.4,425
Hib,Full Series,States/Local Areas,Oklahoma,2014,Age,24 Months,74.8,66.8 to 82.1,227
Hib,Full Series,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,76.4,71.4 to 81.2,502
Hib,Full Series,States/Local Areas,Oklahoma,2017,Age,19 Months,75.0,67.1 to 81.6,243
Hib,Full Series,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,75.7,70.1 to 80.5,437
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,68.0,59.1 to 75.6,279
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,67.9,55.4 to 78.3,260
Hib,Primary Series,States/Local Areas,Oklahoma,2011,Age,24 Months,92.7,88.0 to 96.0,279
Hib,Primary Series,States/Local Areas,Oklahoma,2012,Age,24 Months,94.8,90.6 to 97.5,260
Hib,Primary Series,States/Local Areas,Oklahoma,2015,Age,19 Months,91.8,89.7 to 93.4,275
Hib,Primary Series,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,90.2,86.8 to 92.7,594
Hib,Full Series,States/Local Areas,Oklahoma,2012,Age,24 Months,76.8,69.5 to 83.5,260
Hib,Full Series,States/Local Areas,Oklahoma,2011,Age,24 Months,79.4,73.3 to 84.9,279
Hib,Primary Series,States/Local Areas,Oklahoma,2018,Age,19 Months,93.8,88.9 to 96.6,194
Hib,Primary Series,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,89.6,85.1 to 92.9,399
Hib,Primary Series,States/Local Areas,Oklahoma,2019,Age,19 Months,92.6,85.9 to 96.3,205
Hib,Primary Series,States/Local Areas,Oklahoma,2016,Age,19 Months,88.5,83.5 to 92.2,319
Hib,Primary Series,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,87.8,83.7 to 91.0,562
Hib,Primary Series,States/Local Areas,Oklahoma,2017,Age,19 Months,87.1,80.0 to 91.9,243
Hib,Primary Series,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,90.4,86.3 to 93.4,437
Hib,Primary Series,States/Local Areas,Oklahoma,2014,Age,19 Months,90.8,84.0 to 94.9,227
Hib,Primary Series,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,91.3,87.4 to 94.1,502
Hib,Primary Series,States/Local Areas,Oklahoma,2011,Age,19 Months,91.8,89.3 to 93.8,279
Hib,Primary Series,States/Local Areas,Oklahoma,2013,Age,19 Months,89.6,84.5 to 93.2,198
Hib,Primary Series,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,90.2,85.2 to 93.6,425
Hib,Primary Series,States/Local Areas,Oklahoma,2019,Age,13 Months,90.8,84.2 to 94.9,205
Hib,Primary Series,States/Local Areas,Oklahoma,2018,Age,13 Months,88.4,81.4 to 93.0,194
Hib,Primary Series,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,89.6,85.1 to 92.9,399
Hib,Primary Series,States/Local Areas,Oklahoma,2012,Age,19 Months,94.8,90.8 to 97.1,260
Hib,Primary Series,States/Local Areas,Oklahoma,2017,Age,13 Months,83.0,75.7 to 88.5,243
Hib,Primary Series,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,85.7,80.9 to 89.5,437
Hib,Primary Series,States/Local Areas,Oklahoma,2013,Age,7 Months,63.5,58.7 to 68.0,198
Hib,Primary Series,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,66.1,61.8 to 70.2,425
Hib,Primary Series,States/Local Areas,Oklahoma,2017,Age,24 Months,88.8,82.4 to 93.8,243
Hib,Primary Series,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,91.3,87.4 to 94.3,437
Hib,Primary Series,States/Local Areas,Oklahoma,2016,Age,13 Months,84.6,79.2 to 88.8,319
Hib,Primary Series,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,83.8,79.5 to 87.4,562
Hib,Primary Series,States/Local Areas,Oklahoma,2015,Age,7 Months,72.5,65.6 to 78.5,275
Hib,Primary Series,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,69.4,64.8 to 73.7,594
Hib,Primary Series,States/Local Areas,Oklahoma,2014,Age,7 Months,68.8,60.3 to 76.2,227
Hib,Primary Series,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,70.6,65.2 to 75.5,502
Hib,Primary Series,States/Local Areas,Oklahoma,2017,Age,7 Months,75.1,67.2 to 81.6,243
Hib,Primary Series,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,75.8,70.3 to 80.5,437
Hib,Primary Series,States/Local Areas,Oklahoma,2016,Age,7 Months,66.4,59.9 to 72.3,319
Hib,Primary Series,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,70.6,65.6 to 75.1,562
Hib,Primary Series,States/Local Areas,Oklahoma,2018,Age,7 Months,76.5,68.6 to 82.9,194
Hib,Primary Series,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,77.1,71.4 to 82.0,399
Hib,Primary Series,States/Local Areas,Oklahoma,2019,Age,7 Months,77.8,68.9 to 84.7,205
Hib,Primary Series,States/Local Areas,Oklahoma,2011,Age,13 Months,89.3,85.8 to 92.0,279
Hib,Primary Series,States/Local Areas,Oklahoma,2012,Age,13 Months,89.1,85.6 to 91.9,260
Hib,Primary Series,States/Local Areas,Oklahoma,2013,Age,13 Months,86.8,80.3 to 91.4,198
Hib,Primary Series,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,86.7,80.2 to 91.3,425
Hib,Primary Series,States/Local Areas,Oklahoma,2015,Age,13 Months,89.1,83.7 to 92.8,275
Hib,Primary Series,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,86.9,83.2 to 89.8,594
Hib,Primary Series,States/Local Areas,Oklahoma,2014,Age,13 Months,86.6,79.4 to 91.6,227
Hib,Primary Series,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,87.9,83.5 to 91.2,502
Hib,Primary Series,States/Local Areas,Oklahoma,2018,Age,24 Months,93.8,89.4 to 96.8,194
Hib,Primary Series,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,93.2,89.7 to 95.9,399
Combined 7 Series,,States/Local Areas,Oklahoma,2012,Age,24 Months,61.8,54.0 to 69.7,260
Hib,Primary Series,States/Local Areas,Oklahoma,2013,Age,24 Months,90.1,84.4 to 94.4,198
Hib,Primary Series,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,90.5,86.4 to 93.7,425
Combined 7 Series,,States/Local Areas,Oklahoma,2011,Age,24 Months,68.2,61.5 to 74.7,279
Combined 7 Series,,States/Local Areas,Oklahoma,2013,Age,24 Months,68.8,60.6 to 76.7,198
Combined 7 Series,,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,67.2,61.3 to 72.9,425
Hib,Primary Series,States/Local Areas,Oklahoma,2016,Age,24 Months,89.3,84.8 to 93.0,319
Hib,Primary Series,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,89.1,85.3 to 92.2,562
Hib,Primary Series,States/Local Areas,Oklahoma,2015,Age,24 Months,92.3,87.8 to 95.6,275
Hib,Primary Series,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,90.9,87.8 to 93.4,594
Hib,Primary Series,States/Local Areas,Oklahoma,2014,Age,24 Months,90.8,84.7 to 95.2,227
Hib,Primary Series,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,91.6,87.9 to 94.5,502
Hib,Primary Series,States/Local Areas,Oklahoma,2012,Age,35 Months,94.8,90.6 to 97.5,260
Hib,Primary Series,States/Local Areas,Oklahoma,2014,Age,35 Months,90.8,84.7 to 95.2,227
Hib,Primary Series,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,92.4,88.9 to 95.2,502
Hib,Primary Series,States/Local Areas,Oklahoma,2011,Age,35 Months,94.0,89.6 to 96.9,279
Hib,Primary Series,States/Local Areas,Oklahoma,2019,Age,24 Months,92.6,86.7 to 96.6,205
Hib,Primary Series,States/Local Areas,Oklahoma,2013,Age,35 Months,92.4,86.5 to 96.3,198
Hib,Primary Series,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,91.9,87.8 to 95.0,425
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,66.7,57.8 to 75.5,152
Hib,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,93.0,87.9 to 96.5,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,92.1,87.3 to 95.6,279
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,24 Months,87.0,80.6 to 92.1,260
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,24 Months,87.1,80.4 to 92.4,198
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,86.0,81.3 to 90.1,425
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,24 Months,86.3,81.2 to 90.7,279
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,19 Months,85.2,77.3 to 90.6,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,91.9,85.5 to 96.1,243
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,94.2,90.8 to 96.7,437
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,91.2,86.6 to 94.7,319
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,91.4,87.7 to 94.3,562
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,94.9,90.8 to 97.6,275
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,93.0,90.1 to 95.4,594
PCV,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,5 Months,71.4,63.4 to 78.2,279
PCV,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,5 Months,74.1,63.1 to 82.7,260
PCV,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,5 Months,69.5,65.0 to 73.6,198
PCV,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,5 Months,71.0,68.5 to 73.5,425
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,19 Months,87.3,81.2 to 91.6,194
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,87.3,81.6 to 91.4,309
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,19 Months,80.9,73.3 to 86.7,243
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,84.1,79.3 to 87.9,437
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,90.8,84.3 to 95.4,205
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,87.1,80.5 to 92.3,194
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,88.9,84.5 to 92.5,399
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,20.6,18.2 to 23.3,260
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,24.4,18.0 to 32.0,227
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,25.2,20.7 to 30.2,502
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,21.7,17.3 to 27.0,198
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,23.0,20.6 to 25.7,425
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,5 Months,80.7,71.8 to 87.2,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,19.8,13.6 to 27.9,279
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,95.5,89.9 to 98.5,227
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,95.3,91.9 to 97.5,502
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,94.5,90.9 to 97.0,279
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,94.5,90.1 to 97.4,260
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,93.3,87.5 to 97.0,198
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,94.1,90.2 to 96.8,425
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,38.4,31.2 to 46.5,279
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,27.4,20.0 to 36.3,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,25.8,18.7 to 34.4,194
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,29.8,23.3 to 37.3,309
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,86.5,79.5 to 92.0,243
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,89.5,84.9 to 93.3,437
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,88.5,83.8 to 92.3,319
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,87.6,83.5 to 91.0,562
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,96.5,94.9 to 98.0,439
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,90.0,86.7 to 93.3,498
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,65.2,63.3 to 67.2,275
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,67.4,62.6 to 71.9,594
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,68.0,59.4 to 75.5,227
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,66.6,61.1 to 71.7,502
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,70.8,60.4 to 79.4,198
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,69.4,62.0 to 75.9,425
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,34.2,27.2 to 42.4,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,92.6,86.7 to 96.5,194
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,92.5,88.2 to 95.7,399
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,19 Months,81.1,75.4 to 85.8,319
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,81.0,76.5 to 84.9,562
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,24 Months,85.0,77.9 to 90.8,227
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,85.1,80.8 to 88.8,502
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,35 Months,94.9,91.0 to 97.4,279
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,24 Months,90.0,84.0 to 94.5,205
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,24 Months,87.3,81.7 to 91.8,194
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,88.6,84.7 to 92.0,399
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,94.1,88.0 to 97.7,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,93.5,82.9 to 100.0,32
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,96.5,93.0 to 98.5,194
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,95.7,92.5 to 97.8,399
PCV,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,5 Months,69.3,62.9 to 75.1,319
PCV,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,5 Months,74.0,69.3 to 78.2,562
PCV,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,5 Months,74.7,67.8 to 80.6,275
PCV,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,5 Months,72.1,67.3 to 76.3,594
PCV,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,5 Months,72.6,64.5 to 79.5,227
PCV,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,5 Months,73.7,71.0 to 76.2,502
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,24 Months,83.6,78.4 to 88.2,319
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,83.3,79.0 to 87.1,562
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,24 Months,85.2,80.1 to 89.6,275
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,84.4,80.7 to 87.7,594
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,24.9,18.8 to 32.1,243
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,25.3,20.5 to 30.8,437
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,90.8,85.2 to 94.9,275
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,89.7,86.2 to 92.7,594
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,91.9,85.2 to 96.3,227
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,91.3,87.1 to 94.5,502
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,90.8,84.9 to 95.0,198
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,91.1,86.8 to 94.4,425
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,25.3,20.1 to 31.4,319
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,25.1,21.0 to 29.7,562
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,26.0,22.9 to 29.4,275
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,25.6,21.6 to 30.2,594
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,5 Months,79.3,72.2 to 84.9,243
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,5 Months,79.4,74.2 to 83.7,437
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,5 Months,79.5,71.6 to 85.6,194
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,5 Months,80.1,74.3 to 84.8,399
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,5 Months,70.7,64.3 to 76.4,319
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,5 Months,74.9,70.2 to 79.0,562
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.1,87.4 to 94.8,355
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,90.6,86.3 to 94.9,328
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,90.5,88.2 to 92.8,996
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,87.5,83.4 to 91.6,370
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,92.6,89.5 to 95.7,404
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,93.8,89.3 to 98.4,222
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,86.1,79.1 to 91.7,243
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,86.6,81.9 to 90.6,437
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,92.6,86.5 to 96.6,205
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,87.1,82.2 to 91.2,319
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,86.6,82.5 to 90.2,562
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,87.8,82.3 to 92.2,275
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,87.4,83.9 to 90.5,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,93.2,88.6 to 96.4,194
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,92.9,89.2 to 95.7,399
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,88.8,82.3 to 93.7,243
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,91.0,87.1 to 94.1,437
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,19 Months,83.6,70.7 to 91.5,198
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,82.4,75.8 to 87.5,425
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,19 Months,81.4,79.2 to 83.4,275
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,81.3,77.1 to 84.8,594
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,19 Months,81.2,73.5 to 87.0,227
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,81.3,76.6 to 85.2,502
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,19 Months,82.9,80.9 to 84.8,260
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,19 Months,77.8,69.2 to 84.5,279
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,3 Months,88.3,79.8 to 93.5,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,89.7,85.2 to 93.2,319
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,89.2,85.5 to 92.3,562
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,3 Months,89.2,83.3 to 93.2,194
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,3 Months,88.7,83.9 to 92.2,399
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,92.5,88.2 to 95.7,275
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,91.1,88.1 to 93.6,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,92.2,86.5 to 96.2,227
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,92.4,89.0 to 95.1,502
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,3 Months,85.6,78.7 to 90.5,243
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,3 Months,87.4,83.1 to 90.7,437
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,3 Months,82.7,76.9 to 87.3,319
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,3 Months,84.1,79.8 to 87.6,562
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,3 Months,87.6,82.0 to 91.7,275
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,3 Months,85.2,81.3 to 88.4,594
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,3 Months,84.1,76.3 to 89.7,227
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,3 Months,85.9,81.2 to 89.5,502
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,3 Months,81.6,76.7 to 85.7,198
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,3 Months,82.8,79.0 to 86.1,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,87.6,83.2 to 91.0,446
Hib,Primary Series,States/Local Areas,Oklahoma,2021,Age,19 Months,91.8,85.4 to 95.5,148
PCV,≥4 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,78.4,72.9 to 83.5,446
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,87.1,79.9 to 92.6,446
Hib,Primary Series,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,91.8,88.3 to 94.7,446
Hib,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,84.7,75.3 to 90.9,148
Hib,Full Series,States/Local Areas,Oklahoma,2021,Age,19 Months,71.6,61.5 to 79.9,148
PCV,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,94.5,88.8 to 97.8,148
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.4,69.5 to 79.2,456
Hib,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,3 Months,89.0,81.7 to 93.6,148
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,24 Months,83.1,76.0 to 89.0,243
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,85.1,80.7 to 89.1,437
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,3 Months,83.5,77.6 to 88.1,279
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,3 Months,85.7,74.0 to 92.7,260
Hib,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,5 Months,79.7,71.2 to 86.2,148
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,91.5,85.0 to 95.3,148
≥1 Dose MMR,,States/Local Areas,Oklahoma,2021,Age,35 Months,88.3,80.5 to 94.0,148
Hib,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,90.7,84.3 to 94.7,148
Hib,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,50.3,40.2 to 60.3,148
Polio,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,90.3,83.2 to 94.6,148
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,92.2,84.6 to 96.2,148
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,89.6,85.4 to 93.0,446
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,91.5,87.4 to 94.3,446
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,78.8,69.9 to 85.6,148
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,94.0,90.2 to 96.4,446
PCV,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,5 Months,77.9,68.5 to 85.0,148
Hib,Primary Series,States/Local Areas,Oklahoma,2021,Age,7 Months,77.5,68.7 to 84.4,148
Combined 7 Series,,States/Local Areas,Oklahoma,2021,Age,35 Months,70.5,60.7 to 79.7,148
Polio,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,93.2,87.4 to 96.9,148
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,93.8,77.3 to 99.5,148
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,35 Months,87.8,80.0 to 93.7,148
PCV,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,93.7,87.5 to 96.9,148
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,88.0,83.2 to 92.0,446
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,91.1,87.1 to 94.2,446
Hib,Full Series,States/Local Areas,Oklahoma,2021,Age,24 Months,81.4,72.9 to 88.6,148
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,69.6,59.1 to 78.4,148
Hib,Primary Series,States/Local Areas,Oklahoma,2021,Age,24 Months,91.8,86.0 to 95.8,148
Polio,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,3 Months,89.9,82.6 to 94.3,148
Polio,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,93.2,87.4 to 96.9,148
Hib,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,90.3,83.7 to 95.0,148
≥1 Dose MMR,,States/Local Areas,Oklahoma,2021,Age,24 Months,88.3,80.5 to 94.0,148
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,82.5,73.5 to 89.9,148
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,92.5,86.1 to 96.1,148
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,78.6,70.2 to 85.2,148
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2021,Age,0-1 Days,75.3,65.2 to 83.1,148
PCV,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,94.5,88.8 to 97.8,148
PCV,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,5 Months,74.6,68.7 to 79.6,446
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,3 Months,84.9,79.9 to 88.8,446
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,94.8,86.0 to 98.8,446
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2021,Age,0-2 Days,79.1,69.6 to 86.2,148
PCV,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,90.2,81.7 to 94.9,148
Hib,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,91.8,87.9 to 94.6,446
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2021,Age,19 Months,87.5,78.8 to 92.9,148
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,3 Months,89.9,82.6 to 94.3,148
PCV,≥4 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,84.4,74.0 to 92.3,148
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,35.5,26.5 to 45.7,148
PCV,≥4 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,76.4,65.9 to 84.5,148
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,92.1,86.3 to 96.1,148
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,92.3,86.0 to 95.9,148
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,19 Months,86.3,77.7 to 92.0,148
PCV,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,7 Months,74.7,65.1 to 82.4,148
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,54.1,43.9 to 65.1,148
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,24 Months,87.8,80.0 to 93.7,148
PCV,≥4 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,82.3,73.4 to 89.6,148
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2021,Age,24 Months,86.1,77.9 to 92.4,148
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,82.4,77.2 to 87.6,261
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,89.1,84.6 to 93.6,271
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,89.7 to 96.0,261
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,79.4,73.8 to 84.9,261
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.4,72.5 to 84.4,339
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,76.3,69.8 to 82.8,271
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,92.0,88.5 to 95.6,261
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,87.6 to 95.5,339
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,78.1,70.8 to 85.4,261
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,67.2,60.2 to 74.1,271
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,84.1,78.6 to 89.6,271
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.9,65.4 to 80.4,339
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,74.1 to 85.4,261
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,72.1,64.4 to 79.9,271
Rotavirus,,States/Local Areas,Oklahoma,2019-2020,Age,8 Months,73.7,68.0 to 78.7,503
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,74.8,68.8 to 80.8,354
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,68.9,62.9 to 74.9,312
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,87.6,83.1 to 92.0,261
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,87.3,82.3 to 92.4,205
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,82.4,77.3 to 87.5,354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,68.3,60.8 to 75.8,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,78.4,73.1 to 83.6,354
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,72.0,65.1 to 78.9,312
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,94.1,90.3 to 98.0,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,87.3,83.2 to 91.5,312
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,89.8,86.0 to 93.7,354
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,91.1,88.8 to 93.4,871
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,89.4,87.1 to 91.8,871
Influenza,,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,47.8,41.0 to 54.5,354
Influenza,,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,42.6,36.1 to 49.1,312
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,93.6,89.8 to 97.4,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,88.4,84.4 to 92.4,354
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,82.8,77.9 to 87.6,312
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,87.9,83.0 to 92.8,205
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,84.3,79.7 to 88.9,312
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,86.6,82.2 to 90.9,312
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,86.5,81.1 to 91.8,205
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,79.2,73.7 to 84.7,354
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,72.5,66.6 to 78.4,312
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,89.0,83.9 to 94.0,205
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,74.0,68.2 to 79.8,312
Influenza,,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,76.0,69.3 to 82.7,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,89.2,85.8 to 92.6,453
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,65.3,59.9 to 70.7,453
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.3,87.2 to 93.3,456
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,3 Months,79.8,72.5 to 85.6,298
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,5 Months,84.1,77.4 to 89.1,298
Hib,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,5 Months,70.2,62.6 to 76.8,298
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,5 Months,74.0,66.5 to 80.3,298
Polio,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,5 Months,74.6,67.2 to 80.9,298
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,3 Months,92.8,87.7 to 95.9,298
PCV,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,3 Months,79.9,72.9 to 85.5,298
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,24 Months,87.7,81.7 to 92.4,298
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,43.6,36.5 to 51.4,298
PCV,≥4 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,74.5,67.4 to 81.1,298
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,90.5,85.0 to 94.6,298
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020,Age,24 Months,88.2,82.3 to 92.8,298
Rotavirus,,States/Local Areas,Oklahoma,2020,Age,8 Months,72.0,64.6 to 78.4,298
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2020,Age,0-3 Days,75.4,68.2 to 81.4,298
Influenza,,States/Local Areas,Oklahoma,2020,Age,24 Months,47.8,40.5 to 55.7,298
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,86.1,79.2 to 91.0,298
Combined 7 Series,,States/Local Areas,Oklahoma,2020,Age,24 Months,59.4,51.9 to 67.0,298
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020,Age,19 Months,82.5,75.1 to 88.1,298
Polio,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,90.0,84.0 to 93.9,298
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,68.7,61.1 to 75.4,298
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,90.5,84.5 to 94.3,298
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,66.1,58.5 to 72.9,298
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,81.7,74.8 to 87.0,298
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020,Age,13 Months,59.9,52.2 to 67.2,298
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,84.7,78.0 to 89.6,298
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,91.6,85.7 to 95.2,298
Hib,Primary Series,States/Local Areas,Oklahoma,2020,Age,13 Months,78.5,71.4 to 84.2,298
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,58.3,50.6 to 65.6,298
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,95.8,90.1 to 98.7,446
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,62.4,54.8 to 69.4,298
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,67.8,60.3 to 74.6,298
Hib,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,3 Months,78.8,71.6 to 84.5,298
Polio,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,3 Months,80.6,73.3 to 86.2,298
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,75.8,68.8 to 82.8,368
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,75.0,69.1 to 80.9,453
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,78.8 to 89.9,247
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,81.8,74.4 to 89.3,140
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.6,65.4 to 79.8,247
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.9,80.7 to 91.1,247
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,92.6,89.5 to 95.7,368
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,86.4,82.7 to 90.1,453
Influenza,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,48.3,38.4 to 58.3,140
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,78.2,74.7 to 81.7,871
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,90.4,88.0 to 92.8,871
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,83.2,77.2 to 89.2,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,89.5,87.0 to 92.0,871
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,73.0,67.1 to 79.0,312
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,88.0,85.4 to 90.7,871
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,87.5,83.4 to 91.6,354
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,79.4,76.0 to 82.8,871
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,84.5,80.0 to 89.0,312
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,80.3,72.1 to 88.4,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,75.6,68.2 to 82.9,354
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,91.7,88.2 to 95.2,354
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,86.0,81.6 to 90.4,312
Influenza,,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,50.2,46.0 to 54.4,871
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Overall,Overall,77.3,74.0 to 80.6,871
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,86.4,83.7 to 89.1,871
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,85.5,81.1 to 89.8,312
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,74.7,70.2 to 79.1,871
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,66.6,62.6 to 70.6,871
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,86.7,84.0 to 89.5,871
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,95.8,92.4 to 99.2,205
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,73.5,69.8 to 77.2,871
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,68.1,61.7 to 74.4,354
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,78.0,71.8 to 84.2,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,93.3,90.1 to 96.5,354
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,61.0,54.6 to 67.5,312
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,93.7,90.1 to 97.4,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Poverty,<133% FPL,79.8,74.7 to 84.9,312
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,92.4,89.6 to 95.1,354
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Overall,Overall,77.4,73.9 to 80.9,871
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,95.2,91.7 to 98.6,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,82.2,76.9 to 87.5,271
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,92.9,89.6 to 96.1,354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.2,70.8 to 81.5,339
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,85.8,80.7 to 90.9,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,68.9 to 81.2,261
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,68.8,62.2 to 75.4,261
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,87.2,82.0 to 92.3,271
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,92.2,88.7 to 95.7,261
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.0,87.0 to 95.0,339
Influenza,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,38.0,30.8 to 45.2,271
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.6,85.8 to 93.3,339
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.9,85.3 to 92.4,456
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.3,74.9 to 83.8,456
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,82.6 to 92.5,247
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.4,85.1 to 91.8,456
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,69.9,63.9 to 75.9,368
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,75.4,70.1 to 80.6,368
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,79.4,75.0 to 83.7,453
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,90.1,84.2 to 96.0,140
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,90.6,86.9 to 94.4,368
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.8,79.4 to 90.3,247
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,95.1,92.5 to 97.6,368
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,79.1,73.5 to 84.7,368
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.4,60.1 to 74.8,247
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.7,62.2 to 77.1,247
Influenza,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,63.5,57.3 to 69.7,368
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,88.6,82.1 to 95.1,140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,77.3,69.1 to 85.5,140
Influenza,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,44.3,38.7 to 49.9,453
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.2,77.0 to 85.5,456
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,74.7 to 85.9,247
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,70.8,65.7 to 75.8,453
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,68.6,59.4 to 77.8,140
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",71.2,66.2 to 76.3,456
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,72.2,63.1 to 81.2,140
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.1,80.3 to 88.0,456
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,81.6,73.8 to 89.5,140
Influenza,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",56.3,50.7 to 61.9,456
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.5,82.5 to 92.5,247
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,90.5 to 95.7,456
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,88.8,85.4 to 92.2,453
Influenza,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",44.4,36.6 to 52.2,247
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,86.8,80.0 to 93.7,140
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,89.3 to 94.9,456
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,91.9,88.9 to 94.9,368
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,75.9,71.1 to 80.8,453
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,88.8,85.5 to 92.1,453
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,90.3,84.7 to 95.8,140
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.7,84.3 to 91.1,456
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,75.6,70.8 to 80.5,453
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,94.4,91.8 to 97.1,368
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,88.5,84.9 to 92.1,453
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.3,76.9 to 85.7,456
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,91.0 to 96.1,456
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,85.7,81.9 to 89.5,453
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,90.6,84.8 to 96.5,140
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,83.4,79.0 to 87.9,368
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,93.0,89.2 to 95.6,503
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,19 Months,81.4,74.1 to 87.0,298
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,34.8,28.0 to 42.2,298
Combined 7 Series,,States/Local Areas,Oklahoma,2020,Age,35 Months,69.3,59.7 to 78.5,298
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020,Age,13 Months,63.7,55.9 to 70.8,298
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,73.6,65.3 to 81.3,298
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.4,69.3 to 81.5,339
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,77.2,70.9 to 83.5,271
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,88.5,84.2 to 92.8,261
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.2,86.0 to 94.4,339
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,88.1,84.0 to 92.3,261
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.4,81.8 to 91.0,339
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,84.0,78.7 to 89.3,271
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.6,72.9 to 84.4,339
Rotavirus,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,72.3,65.7 to 78.9,261
Influenza,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,54.2,47.5 to 60.8,339
Influenza,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,54.7,47.2 to 62.2,261
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,66.2,59.0 to 73.4,271
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,64.9,58.2 to 71.5,339
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.7,71.7 to 83.7,339
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,78.0,71.9 to 84.1,271
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Principal City,90.4,86.5 to 94.3,261
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.0,85.6 to 94.3,339
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,87.7,83.1 to 92.3,271
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.6,81.9 to 91.3,339
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Urbanicity,Living In a Non-MSA,84.5,79.1 to 90.0,271
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,90.6,85.0 to 94.7,298
PCV,≥4 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,71.8,64.2 to 78.3,298
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,88.0,81.6 to 92.3,298
Polio,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,92.1,87.0 to 95.7,298
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,84.8,76.0 to 91.7,298
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020,Age,19 Months,83.3,76.0 to 88.7,298
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,92.5,87.4 to 96.1,298
Hib,Full Series,States/Local Areas,Oklahoma,2020,Age,19 Months,65.0,57.2 to 72.0,298
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,19 Months,87.6,81.1 to 92.1,298
Hib,Primary Series,States/Local Areas,Oklahoma,2020,Age,19 Months,90.4,84.6 to 94.1,298
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020,Age,35 Months,97.2,89.1 to 99.7,298
Hib,Full Series,States/Local Areas,Oklahoma,2020,Age,35 Months,80.7,71.2 to 88.7,298
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,90.0,84.2 to 94.3,298
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,90.1,84.6 to 94.3,298
Hib,Primary Series,States/Local Areas,Oklahoma,2020,Age,35 Months,93.7,89.7 to 96.6,298
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020,Age,35 Months,97.1,88.7 to 99.7,298
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,88.9,83.1 to 93.4,298
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020,Age,24 Months,87.7,81.5 to 92.5,298
Polio,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,92.1,87.0 to 95.7,298
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,74.0,66.8 to 80.8,298
PCV,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,5 Months,71.2,63.7 to 77.8,298
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,92.5,87.4 to 96.1,298
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,89.2,83.2 to 93.3,298
Hib,Primary Series,States/Local Areas,Oklahoma,2020,Age,7 Months,63.5,55.9 to 70.5,298
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,36.0,29.2 to 43.5,298
Polio,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,86.2,79.6 to 90.9,298
Hib,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,7 Months,84.4,77.8 to 89.4,298
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2020,Age,0-1 Days,73.8,66.6 to 79.9,298
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2020,Age,0-2 Days,74.1,66.8 to 80.2,298
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,88.8,84.7 to 92.3,503
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,74.6,67.7 to 81.0,503
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,95.1,91.1 to 97.6,503
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,42.4,36.7 to 48.6,503
Influenza,,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,49.2,43.3 to 55.4,503
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,89.8,85.6 to 93.2,503
Hib,Primary Series,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,92.3,88.6 to 95.1,503
Hib,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,85.8,80.8 to 89.6,503
Combined 7 Series,,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,71.3,64.6 to 77.6,503
Hib,Full Series,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,70.8,65.0 to 75.9,503
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,84.5,79.4 to 88.5,503
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,88.8,84.3 to 92.2,503
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,89.9,85.7 to 93.0,503
PCV,≥4 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,74.4,68.7 to 79.4,503
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,83.4,78.3 to 87.5,503
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2019-2020,Age,0-1 Days,74.3,68.5 to 79.4,503
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2019-2020,Age,0-2 Days,74.8,69.0 to 79.8,503
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,87.3,82.8 to 91.2,503
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,91.2,87.4 to 94.3,503
Hib,Full Series,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,75.4,70.0 to 80.5,503
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,39.7,33.9 to 45.8,503
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2019-2020,Age,0-3 Days,75.7,69.9 to 80.6,503
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,67.3,61.4 to 72.6,503
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,90.2,86.0 to 93.5,503
PCV,≥4 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,76.8,71.5 to 81.9,503
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,84.8,79.6 to 88.8,503
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,30.6,25.5 to 36.2,503
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,87.2,82.4 to 90.9,503
Hib,Primary Series,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,91.5,87.4 to 94.3,503
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,94.8,89.9 to 97.8,503
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,90.6,86.5 to 93.9,503
Hib,Full Series,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,83.0,76.9 to 88.2,503
Hib,Primary Series,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,93.4,90.0 to 96.0,503
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,91.2,87.4 to 94.3,503
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,93.3,88.2 to 96.7,503
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,90.7,86.6 to 94.0,503
PCV,≥4 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,82.2,75.9 to 87.7,503
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,75.6,70.0 to 80.8,503
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,92.6,88.8 to 95.4,503
Polio,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,92.3,88.5 to 95.3,503
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,88.2,83.8 to 91.9,503
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,3 Months,94.5,91.2 to 96.6,503
PCV,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,3 Months,83.7,78.5 to 87.8,503
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,5 Months,77.2,71.6 to 82.0,503
Polio,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,5 Months,77.5,72.0 to 82.3,503
Hib,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,5 Months,73.9,68.2 to 78.9,503
Polio,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,91.5,87.4 to 94.4,503
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,64.5,58.4 to 70.2,503
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,60.9,54.7 to 66.7,503
Polio,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,90.5,84.6 to 94.3,298
Hib,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,91.1,86.9 to 94.0,503
Hib,Primary Series,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,84.5,79.8 to 88.3,503
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,84.1,77.4 to 89.1,298
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,5 Months,86.3,81.4 to 90.0,503
PCV,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,5 Months,74.3,68.6 to 79.3,503
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,69.8,64.0 to 75.0,503
Polio,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,87.5,82.8 to 91.1,503
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,87.3,82.7 to 90.9,503
Hib,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,3 Months,82.6,77.3 to 86.8,503
Polio,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,3 Months,84.3,79.0 to 88.4,503
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,68.4,62.5 to 73.7,503
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,90.5,86.1 to 93.6,503
Polio,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,19 Months,90.2,85.8 to 93.4,503
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,69.8,64.0 to 74.9,503
DTaP,≥1 Dose,States/Local Areas,Oklahoma,2019-2020,Age,3 Months,83.9,78.7 to 88.1,503
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,87.2,82.5 to 90.7,503
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,83.9,78.7 to 88.0,503
Combined 7 Series,,States/Local Areas,Oklahoma,2019-2020,Age,24 Months,63.5,57.7 to 69.4,503
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,93.2,89.4 to 96.0,503
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,83.3,77.2 to 88.5,503
Polio,≥3 Doses,States/Local Areas,Oklahoma,2019-2020,Age,35 Months,93.0,89.2 to 95.8,503
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019-2020,Age,13 Months,58.4,52.3 to 64.2,503
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,89.2,83.4 to 95.1,140
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",58.1,50.2 to 66.0,247
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,83.5 to 92.6,247
DTaP,≥3 Doses,States/Local Areas,Oregon,2017,Age,13 Months,86.8,79.5 to 91.8,195
DTaP,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,89.8,85.5 to 92.9,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2015,Age,13 Months,88.5,82.5 to 92.6,243
DTaP,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,87.8,82.4 to 91.7,420
Hib,≥2 Doses,States/Local Areas,Oregon,2012,Age,13 Months,92.5,89.3 to 94.8,229
Hib,≥2 Doses,States/Local Areas,Oregon,2011,Age,13 Months,86.1,81.5 to 89.7,266
PCV,≥3 Doses,States/Local Areas,Oregon,2015,Age,35 Months,94.0,87.4 to 97.8,243
PCV,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,91.5,86.4 to 95.2,420
PCV,≥3 Doses,States/Local Areas,Oregon,2016,Age,35 Months,89.5,81.4 to 95.2,177
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,90.7,85.9 to 94.4,372
PCV,≥3 Doses,States/Local Areas,Oregon,2014,Age,35 Months,91.5,86.9 to 94.9,270
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.3,88.7 to 95.1,513
Hib,≥2 Doses,States/Local Areas,Oregon,2018,Age,7 Months,92.1,87.3 to 95.2,290
Hib,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,92.1,88.6 to 94.5,554
PCV,≥3 Doses,States/Local Areas,Oregon,2019,Age,35 Months,94.0,87.5 to 97.8,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2018,Age,0-3 Days,82.6,76.3 to 87.5,290
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2018-2019,Age,0-3 Days,85.3,81.3 to 88.6,554
Polio,≥1 Dose,States/Local Areas,Oregon,2019,Age,3 Months,91.4,85.9 to 94.9,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2019,Age,0-3 Days,88.2,82.8 to 92.0,264
Hib,Full Series,States/Local Areas,Oregon,2020,Age,24 Months,76.8,69.1 to 83.8,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,73.3,67.9 to 78.6,428
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,76.9,71.5 to 82.3,314
DTaP,≥3 Doses,States/Local Areas,Oregon,2018,Age,7 Months,76.9,69.8 to 82.7,290
DTaP,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,76.3,70.9 to 80.9,554
DTaP,≥3 Doses,States/Local Areas,Oregon,2019,Age,7 Months,75.6,67.5 to 82.3,264
DTaP,≥3 Doses,States/Local Areas,Oregon,2017,Age,7 Months,73.0,63.2 to 80.9,195
DTaP,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,74.9,68.9 to 80.0,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2011,Age,13 Months,85.0,74.4 to 91.7,266
DTaP,≥3 Doses,States/Local Areas,Oregon,2016,Age,13 Months,87.1,77.2 to 93.1,177
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,87.0,81.2 to 91.2,372
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,81.3,73.3 to 89.2,138
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.4,82.0 to 92.8,217
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,89.0,84.9 to 93.0,425
PCV,≥3 Doses,States/Local Areas,Oregon,2012,Age,35 Months,94.1,89.1 to 97.3,229
PCV,≥3 Doses,States/Local Areas,Oregon,2019,Age,24 Months,92.3,86.0 to 96.5,264
PCV,≥3 Doses,States/Local Areas,Oregon,2011,Age,35 Months,84.5,78.1 to 89.9,266
PCV,≥3 Doses,States/Local Areas,Oregon,2013,Age,35 Months,93.3,89.1 to 96.3,208
PCV,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,92.3,89.4 to 94.7,478
Hib,≥2 Doses,States/Local Areas,Oregon,2015,Age,7 Months,87.8,81.5 to 92.2,243
Hib,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,89.1,84.1 to 92.7,420
PCV,≥3 Doses,States/Local Areas,Oregon,2018,Age,24 Months,93.5,89.2 to 96.5,290
PCV,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,92.9,89.3 to 95.7,554
PCV,≥1 Dose,States/Local Areas,Oregon,2019,Age,3 Months,91.4,85.9 to 94.9,264
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,87.3,84.3 to 90.4,780
Polio,≥1 Dose,States/Local Areas,Oregon,2012,Age,3 Months,85.4,81.2 to 88.7,229
Polio,≥1 Dose,States/Local Areas,Oregon,2011,Age,3 Months,82.1,74.7 to 87.7,266
Polio,≥1 Dose,States/Local Areas,Oregon,2013,Age,3 Months,86.5,84.9 to 88.0,208
Polio,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,3 Months,86.1,84.7 to 87.4,478
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2013,Age,0-3 Days,71.9,63.7 to 78.8,208
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2013-2014,Age,0-3 Days,71.6,66.3 to 76.4,478
DTaP,≥3 Doses,States/Local Areas,Oregon,2013,Age,7 Months,68.8,63.1 to 74.0,208
DTaP,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,66.8,63.3 to 70.1,478
DTaP,≥3 Doses,States/Local Areas,Oregon,2012,Age,7 Months,74.5,67.1 to 80.7,229
DTaP,≥3 Doses,States/Local Areas,Oregon,2011,Age,7 Months,67.0,60.7 to 72.8,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014,Age,0-3 Days,71.4,64.5 to 77.4,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2015,Age,0-3 Days,75.3,70.6 to 79.6,513
PCV,≥1 Dose,States/Local Areas,Oregon,2014,Age,3 Months,83.3,77.2 to 88.0,270
PCV,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,3 Months,85.9,81.8 to 89.2,513
PCV,≥1 Dose,States/Local Areas,Oregon,2015,Age,3 Months,88.6,82.6 to 92.7,243
PCV,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,3 Months,85.7,80.4 to 89.7,420
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.6,69.5 to 79.8,520
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.8,69.5 to 88.0,118
PCV,≥3 Doses,States/Local Areas,Oregon,2016,Age,24 Months,88.7,80.6 to 94.5,177
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,89.2,84.2 to 93.1,372
Hib,≥2 Doses,States/Local Areas,Oregon,2012,Age,7 Months,89.6,86.1 to 92.3,229
PCV,≥3 Doses,States/Local Areas,Oregon,2017,Age,24 Months,89.6,83.4 to 94.2,195
PCV,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,91.6,87.9 to 94.5,485
Hib,≥2 Doses,States/Local Areas,Oregon,2018,Age,5 Months,81.9,75.2 to 87.2,290
Hib,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,5 Months,81.5,76.6 to 85.6,554
Hib,≥2 Doses,States/Local Areas,Oregon,2019,Age,5 Months,81.1,73.4 to 87.0,264
Hib,≥2 Doses,States/Local Areas,Oregon,2011,Age,7 Months,82.4,77.2 to 86.5,266
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,89.3,85.0 to 93.7,428
PCV,≥1 Dose,States/Local Areas,Oregon,2016,Age,3 Months,82.7,73.5 to 89.2,177
PCV,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,3 Months,83.4,77.6 to 87.9,372
PCV,≥1 Dose,States/Local Areas,Oregon,2017,Age,3 Months,84.0,76.3 to 89.5,195
PCV,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,3 Months,85.7,81.0 to 89.4,485
PCV,≥1 Dose,States/Local Areas,Oregon,2018,Age,3 Months,87.5,81.6 to 91.7,290
PCV,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,3 Months,89.4,85.6 to 92.3,554
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.5,81.5 to 89.4,520
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.7,84.1 to 97.2,118
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,86.1,81.7 to 90.5,314
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2011,Age,0-3 Days,62.8,55.1 to 69.8,266
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,82.2,77.4 to 87.0,425
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2012,Age,0-3 Days,62.7,54.4 to 70.3,229
Hib,≥2 Doses,States/Local Areas,Oregon,2013,Age,7 Months,89.2,85.2 to 92.1,208
Hib,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,86.3,82.9 to 89.2,478
Hib,≥2 Doses,States/Local Areas,Oregon,2014,Age,7 Months,83.5,77.1 to 88.4,270
Hib,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,85.7,81.4 to 89.1,513
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,90.4,85.4 to 95.4,251
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,77.7,71.7 to 83.6,308
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,68.3,60.9 to 75.6,221
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.5,68.1 to 83.0,217
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,64.7,54.4 to 74.9,138
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,77.4,73.6 to 81.2,780
PCV,≥4 Doses,States/Local Areas,Oregon,2018,Age,35 Months,82.6,76.5 to 88.0,290
PCV,≥4 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,83.7,79.0 to 87.8,554
PCV,≥4 Doses,States/Local Areas,Oregon,2019,Age,35 Months,84.6,77.2 to 90.7,264
PCV,≥4 Doses,States/Local Areas,Oregon,2017,Age,35 Months,83.2,75.8 to 89.3,195
PCV,≥4 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,82.9,78.2 to 87.1,485
PCV,≥1 Dose,States/Local Areas,Oregon,2011,Age,3 Months,80.5,75.3 to 84.9,266
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,91.3,86.7 to 96.0,251
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,93.4,90.4 to 96.5,308
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,84.2,76.9 to 91.4,138
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.0,83.3 to 92.8,217
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,85.7,80.6 to 90.7,221
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Overall,Overall,90.0,87.6 to 92.5,780
Hib,≥2 Doses,States/Local Areas,Oregon,2013,Age,5 Months,81.0,73.9 to 86.5,208
Hib,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,5 Months,76.6,72.8 to 80.0,478
Hib,≥2 Doses,States/Local Areas,Oregon,2014,Age,5 Months,72.2,64.9 to 78.5,270
Hib,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,5 Months,75.8,72.7 to 78.6,513
PCV,≥3 Doses,States/Local Areas,Oregon,2017,Age,19 Months,87.8,80.6 to 92.6,195
PCV,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,90.0,85.8 to 93.0,485
Hib,≥2 Doses,States/Local Areas,Oregon,2012,Age,5 Months,80.3,76.7 to 83.4,229
Hib,≥2 Doses,States/Local Areas,Oregon,2011,Age,5 Months,72.3,67.6 to 76.5,266
PCV,≥3 Doses,States/Local Areas,Oregon,2018,Age,19 Months,92.1,87.3 to 95.2,290
PCV,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,87.7,83.2 to 91.1,554
PCV,≥3 Doses,States/Local Areas,Oregon,2019,Age,19 Months,92.3,85.1 to 96.2,264
PCV,≥3 Doses,States/Local Areas,Oregon,2011,Age,24 Months,84.0,77.6 to 89.4,266
Hib,≥2 Doses,States/Local Areas,Oregon,2015,Age,5 Months,79.4,72.1 to 85.1,243
Hib,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,5 Months,76.7,70.4 to 81.9,420
Hib,≥2 Doses,States/Local Areas,Oregon,2016,Age,5 Months,73.9,63.3 to 82.3,177
Hib,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,5 Months,75.1,68.1 to 81.0,372
PCV,≥3 Doses,States/Local Areas,Oregon,2012,Age,24 Months,91.7,86.5 to 95.5,229
Hib,≥2 Doses,States/Local Areas,Oregon,2017,Age,5 Months,76.4,66.6 to 84.0,195
Hib,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,5 Months,79.1,73.2 to 84.0,485
PCV,≥3 Doses,States/Local Areas,Oregon,2013,Age,24 Months,91.5,87.2 to 94.8,208
PCV,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,91.2,88.2 to 93.7,478
PCV,≥3 Doses,States/Local Areas,Oregon,2014,Age,24 Months,90.9,86.3 to 94.4,270
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,90.6,87.2 to 93.4,513
PCV,≥3 Doses,States/Local Areas,Oregon,2015,Age,24 Months,90.1,84.8 to 94.2,243
PCV,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,89.4,84.8 to 93.2,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,90.5,84.3 to 96.8,133
PCV,≥1 Dose,States/Local Areas,Oregon,2012,Age,3 Months,85.7,78.1 to 90.9,229
PCV,≥1 Dose,States/Local Areas,Oregon,2013,Age,3 Months,87.4,86.2 to 88.5,208
PCV,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,3 Months,85.4,83.1 to 87.4,478
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,84.4,77.2 to 91.5,133
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,72.8,66.8 to 78.7,314
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.1 to 97.0,118
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,93.1,88.9 to 97.3,133
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,92.9,89.8 to 96.0,428
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,87.8,83.9 to 91.7,314
PCV,≥4 Doses,States/Local Areas,Oregon,2016,Age,35 Months,79.4,70.3 to 87.2,177
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,81.3,75.5 to 86.4,372
PCV,≥4 Doses,States/Local Areas,Oregon,2015,Age,35 Months,85.4,79.0 to 90.8,243
PCV,≥4 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,82.3,76.8 to 87.2,420
PCV,≥4 Doses,States/Local Areas,Oregon,2014,Age,35 Months,79.0,72.6 to 84.9,270
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,82.2,77.7 to 86.3,513
Hep B,≥3 Doses,States/Local Areas,Oregon,2018,Age,35 Months,92.5,87.8 to 95.8,290
Hep B,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,93.2,90.3 to 95.5,554
Hep B,≥3 Doses,States/Local Areas,Oregon,2019,Age,35 Months,94.0,90.3 to 96.6,264
PCV,≥3 Doses,States/Local Areas,Oregon,2014,Age,19 Months,88.9,83.6 to 92.6,270
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,89.2,85.5 to 92.1,513
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,91.0,86.1 to 95.9,251
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,89.9 to 96.0,425
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.4,85.0 to 91.8,520
Hib,≥1 Dose,States/Local Areas,Oregon,2018,Age,3 Months,89.6,83.9 to 93.4,290
Hib,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,3 Months,90.0,86.2 to 92.9,554
Hib,≥1 Dose,States/Local Areas,Oregon,2019,Age,3 Months,90.5,84.7 to 94.3,264
Hib,≥1 Dose,States/Local Areas,Oregon,2015,Age,3 Months,90.3,84.9 to 93.9,243
Hib,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,3 Months,87.6,82.5 to 91.3,420
Hib,≥1 Dose,States/Local Areas,Oregon,2016,Age,3 Months,84.8,75.6 to 90.9,177
Hib,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,3 Months,84.9,79.3 to 89.2,372
Hib,≥1 Dose,States/Local Areas,Oregon,2017,Age,3 Months,85.1,77.5 to 90.4,195
Hib,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,3 Months,87.3,82.7 to 90.8,485
Hep B,≥2 Doses,States/Local Areas,Oregon,2017,Age,13 Months,91.0,84.6 to 94.9,195
Hep B,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,92.4,88.9 to 94.9,485
Hep B,≥2 Doses,States/Local Areas,Oregon,2018,Age,13 Months,94.0,90.0 to 96.4,290
Hep B,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,94.9,92.7 to 96.5,554
Hep B,≥2 Doses,States/Local Areas,Oregon,2019,Age,13 Months,96.0,93.2 to 97.6,264
PCV,≥3 Doses,States/Local Areas,Oregon,2015,Age,19 Months,89.6,87.9 to 91.0,243
PCV,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,89.2,84.1 to 92.7,420
PCV,≥3 Doses,States/Local Areas,Oregon,2016,Age,19 Months,88.7,79.5 to 94.1,177
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,88.3,82.8 to 92.2,372
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,87.9 to 94.7,425
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.6,81.7 to 89.5,520
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.9,80.9 to 94.8,118
≥1 Dose MMR,,States/Local Areas,Oregon,2019,Age,35 Months,92.9,86.9 to 96.8,264
PCV,≥4 Doses,States/Local Areas,Oregon,2013,Age,35 Months,85.5,79.2 to 90.6,208
PCV,≥4 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,82.3,77.8 to 86.3,478
≥1 Dose MMR,,States/Local Areas,Oregon,2018,Age,35 Months,94.7,90.4 to 97.4,290
≥1 Dose MMR,,States/Local Areas,Oregon,2018-2019,Age,35 Months,93.7,90.2 to 96.3,554
≥1 Dose MMR,,States/Local Areas,Oregon,2017,Age,35 Months,96.9,91.6 to 99.3,195
≥1 Dose MMR,,States/Local Areas,Oregon,2017-2018,Age,35 Months,95.5,92.5 to 97.5,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2012,Age,13 Months,90.0,85.8 to 93.1,229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,73.5,66.6 to 80.5,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,78.0,72.6 to 83.5,308
Hib,≥2 Doses,States/Local Areas,Oregon,2015,Age,13 Months,93.7,89.5 to 96.3,243
Hib,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,93.4,89.4 to 95.9,420
Hib,≥2 Doses,States/Local Areas,Oregon,2016,Age,13 Months,93.0,85.3 to 96.8,177
Hib,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,91.5,86.8 to 94.6,372
Hib,≥2 Doses,States/Local Areas,Oregon,2014,Age,13 Months,89.4,83.9 to 93.1,270
Hib,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,91.5,88.3 to 94.0,513
Hib,≥3 Doses,States/Local Areas,Oregon,2017,Age,7 Months,52.3,43.1 to 61.4,195
Hib,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,55.4,49.3 to 61.3,485
Hib,≥3 Doses,States/Local Areas,Oregon,2018,Age,7 Months,58.5,50.9 to 65.7,290
Hib,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,59.2,53.6 to 64.6,554
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,80.1 to 95.9,118
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,95.2,91.2 to 99.2,133
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,84.7,80.1 to 89.4,314
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,95.7,92.9 to 98.4,428
DTaP,≥3 Doses,States/Local Areas,Oregon,2018,Age,13 Months,92.8,88.2 to 95.7,290
DTaP,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,91.4,87.4 to 94.3,554
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,75.2,68.5 to 81.9,221
Hib,≥3 Doses,States/Local Areas,Oregon,2019,Age,7 Months,60.0,51.7 to 67.8,264
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,89.8 to 96.3,425
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.6,83.9 to 91.3,520
Hib,≥3 Doses,States/Local Areas,Oregon,2013,Age,13 Months,78.3,74.8 to 81.5,208
Hib,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,76.8,74.7 to 78.7,478
Polio,≥3 Doses,States/Local Areas,Oregon,2011,Age,19 Months,83.0,76.4 to 88.0,266
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,94.3,89.9 to 98.7,251
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,92.8,89.4 to 96.1,308
Hib,≥3 Doses,States/Local Areas,Oregon,2014,Age,13 Months,75.2,68.5 to 80.9,270
Hib,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,76.0,71.2 to 80.3,513
Hib,≥3 Doses,States/Local Areas,Oregon,2011,Age,13 Months,75.5,67.5 to 82.0,266
Hib,≥3 Doses,States/Local Areas,Oregon,2012,Age,13 Months,79.1,71.5 to 85.1,229
Hib,≥2 Doses,States/Local Areas,Oregon,2013,Age,13 Months,94.7,89.8 to 97.3,208
Hib,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,92.1,88.5 to 94.6,478
PCV,≥3 Doses,States/Local Areas,Oregon,2017,Age,35 Months,92.0,86.0 to 96.1,195
PCV,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,93.4,90.0 to 96.0,485
PCV,≥3 Doses,States/Local Areas,Oregon,2018,Age,35 Months,95.0,91.0 to 97.6,290
PCV,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,94.5,90.8 to 97.1,554
Hib,≥3 Doses,States/Local Areas,Oregon,2014,Age,7 Months,48.7,41.4 to 56.0,270
Hib,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,52.1,46.7 to 57.5,513
Hib,≥3 Doses,States/Local Areas,Oregon,2015,Age,7 Months,55.5,47.4 to 63.2,243
Hib,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,53.1,46.6 to 59.5,420
Hib,≥3 Doses,States/Local Areas,Oregon,2016,Age,7 Months,50.7,40.6 to 60.8,177
Hib,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,51.5,44.6 to 58.3,372
Polio,≥1 Dose,States/Local Areas,Oregon,2017,Age,3 Months,85.0,77.3 to 90.5,195
Polio,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,3 Months,86.9,82.2 to 90.4,485
Polio,≥1 Dose,States/Local Areas,Oregon,2018,Age,3 Months,88.7,82.9 to 92.7,290
Polio,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,3 Months,90.0,86.3 to 92.8,554
DTaP,≥3 Doses,States/Local Areas,Oregon,2015,Age,7 Months,68.0,60.0 to 75.1,243
DTaP,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,68.1,61.5 to 74.1,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2014,Age,7 Months,64.7,57.3 to 71.5,270
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,66.4,61.0 to 71.4,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2015,Age,0-3 Days,79.3,72.4 to 84.9,243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2015-2016,Age,0-3 Days,78.7,73.0 to 83.4,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2016,Age,7 Months,68.2,57.5 to 77.3,177
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,70.6,63.5 to 76.8,372
Hib,≥2 Doses,States/Local Areas,Oregon,2019,Age,7 Months,92.0,86.5 to 95.3,264
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,84.9,79.7 to 90.2,221
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,87.4,80.9 to 93.9,251
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,89.4,85.1 to 93.8,308
Hib,≥3 Doses,States/Local Areas,Oregon,2012,Age,7 Months,55.2,42.3 to 67.4,229
Hib,≥3 Doses,States/Local Areas,Oregon,2011,Age,7 Months,54.5,50.3 to 58.7,266
Hib,≥3 Doses,States/Local Areas,Oregon,2013,Age,7 Months,53.4,47.4 to 59.4,208
Hib,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,51.1,46.9 to 55.3,478
Polio,≥1 Dose,States/Local Areas,Oregon,2014,Age,3 Months,85.8,80.0 to 90.1,270
Polio,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,3 Months,88.2,84.4 to 91.1,513
Polio,≥1 Dose,States/Local Areas,Oregon,2015,Age,3 Months,90.6,85.3 to 94.1,243
Polio,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,3 Months,87.5,82.4 to 91.3,420
Polio,≥1 Dose,States/Local Areas,Oregon,2016,Age,3 Months,84.4,75.2 to 90.6,177
Polio,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,3 Months,84.7,79.0 to 89.1,372
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2017,Age,0-3 Days,80.8,69.0 to 88.8,88
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2017-2018,Age,0-3 Days,82.9,78.3 to 86.8,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016,Age,0-3 Days,78.0,68.5 to 85.2,177
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2017,Age,0-3 Days,80.6,74.8 to 85.4,372
Hib,≥2 Doses,States/Local Areas,Oregon,2016,Age,7 Months,90.3,81.2 to 95.3,177
Hib,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,88.9,83.6 to 92.6,372
Hib,≥2 Doses,States/Local Areas,Oregon,2017,Age,7 Months,87.4,80.4 to 92.2,195
Hib,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,89.7,85.6 to 92.8,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2019,Age,13 Months,90.0,82.6 to 94.4,264
DTaP,≥3 Doses,States/Local Areas,Oregon,2011,Age,19 Months,86.5,77.5 to 92.2,266
DTaP,≥3 Doses,States/Local Areas,Oregon,2013,Age,19 Months,93.6,92.0 to 94.9,208
DTaP,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,91.6,87.9 to 94.2,478
DTaP,≥3 Doses,States/Local Areas,Oregon,2012,Age,19 Months,92.1,85.7 to 95.7,229
Hib,≥3 Doses,States/Local Areas,Oregon,2016,Age,13 Months,74.9,64.6 to 83.0,177
Hib,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,72.7,66.2 to 78.3,372
Hib,≥3 Doses,States/Local Areas,Oregon,2017,Age,13 Months,70.4,61.9 to 77.7,195
Hib,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,74.1,68.7 to 78.8,485
Polio,≥3 Doses,States/Local Areas,Oregon,2014,Age,19 Months,88.2,82.9 to 92.0,270
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,88.7,84.9 to 91.6,513
Hib,≥3 Doses,States/Local Areas,Oregon,2015,Age,13 Months,76.9,69.5 to 83.0,243
Hib,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,75.9,69.7 to 81.2,420
Hib,≥2 Doses,States/Local Areas,Oregon,2018,Age,13 Months,95.3,90.8 to 97.7,290
Hib,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,95.1,92.2 to 97.0,554
Hib,≥2 Doses,States/Local Areas,Oregon,2017,Age,13 Months,90.0,83.1 to 94.2,195
Hib,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,92.6,88.7 to 95.2,485
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,78.4,69.7 to 87.1,138
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.6,83.4 to 93.8,217
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,82.1,76.1 to 88.0,221
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,89.3,86.6 to 92.1,780
Hib,≥2 Doses,States/Local Areas,Oregon,2019,Age,13 Months,94.9,90.3 to 97.4,264
DTaP,≥3 Doses,States/Local Areas,Oregon,2013,Age,13 Months,90.4,85.1 to 93.9,208
DTaP,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,88.3,85.1 to 90.9,478
DTaP,≥3 Doses,States/Local Areas,Oregon,2014,Age,13 Months,86.2,80.5 to 90.5,270
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,87.4,83.4 to 90.5,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,72.6,62.9 to 82.3,138
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Overall,Overall,76.0,72.3 to 79.6,780
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.1,66.3 to 79.9,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,78.6,73.7 to 83.4,425
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.6,68.9 to 78.3,520
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.7,62.7 to 82.6,118
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,85.7,79.0 to 92.3,133
Polio,≥3 Doses,States/Local Areas,Oregon,2012,Age,19 Months,90.5,85.6 to 93.9,229
Polio,≥3 Doses,States/Local Areas,Oregon,2015,Age,19 Months,89.2,87.3 to 90.8,243
Polio,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,88.2,83.0 to 91.9,420
Polio,≥3 Doses,States/Local Areas,Oregon,2013,Age,19 Months,90.6,89.3 to 91.7,208
Polio,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,89.4,86.2 to 92.0,478
Hib,≥3 Doses,States/Local Areas,Oregon,2018,Age,13 Months,77.8,71.0 to 83.5,290
Hib,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,77.5,72.3 to 82.0,554
Polio,≥3 Doses,States/Local Areas,Oregon,2016,Age,19 Months,87.2,77.9 to 92.9,177
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,88.8,83.5 to 92.6,372
Polio,≥3 Doses,States/Local Areas,Oregon,2017,Age,19 Months,90.5,84.0 to 94.5,195
Polio,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,92.3,88.6 to 94.9,485
Hib,≥3 Doses,States/Local Areas,Oregon,2019,Age,13 Months,77.1,68.9 to 83.7,264
Hib,≥3 Doses,States/Local Areas,Oregon,2012,Age,19 Months,86.5,76.9 to 92.4,229
Hib,≥3 Doses,States/Local Areas,Oregon,2011,Age,19 Months,82.0,73.7 to 88.2,266
Hep B,≥2 Doses,States/Local Areas,Oregon,2019,Age,7 Months,93.1,88.5 to 95.9,264
Hep B,≥2 Doses,States/Local Areas,Oregon,2011,Age,13 Months,87.3,80.9 to 91.8,266
Hep B,≥2 Doses,States/Local Areas,Oregon,2013,Age,13 Months,92.0,86.6 to 95.4,208
Hep B,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,91.3,87.5 to 94.0,478
Hep B,≥2 Doses,States/Local Areas,Oregon,2012,Age,13 Months,91.6,89.6 to 93.3,229
PCV,≥3 Doses,States/Local Areas,Oregon,2017,Age,13 Months,84.5,76.8 to 90.0,195
PCV,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,85.8,81.2 to 89.4,485
PCV,≥3 Doses,States/Local Areas,Oregon,2018,Age,13 Months,87.1,81.5 to 91.2,290
PCV,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,87.7,83.2 to 91.1,554
Hep B,≥3 Doses,States/Local Areas,Oregon,2012,Age,35 Months,87.5,81.1 to 92.6,229
Hep B,≥3 Doses,States/Local Areas,Oregon,2014,Age,35 Months,89.0,83.7 to 93.2,270
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,90.5,86.6 to 93.6,513
Hep B,≥3 Doses,States/Local Areas,Oregon,2013,Age,35 Months,91.6,85.8 to 95.6,208
Hep B,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,90.2,86.5 to 93.3,478
PCV,≥3 Doses,States/Local Areas,Oregon,2016,Age,13 Months,87.7,78.7 to 93.2,177
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,86.1,80.5 to 90.3,372
≥1 Dose MMR,,States/Local Areas,Oregon,2014,Age,35 Months,90.3,84.0 to 94.9,270
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.0,88.1 to 94.9,513
≥1 Dose MMR,,States/Local Areas,Oregon,2015,Age,35 Months,93.7,88.9 to 96.9,243
≥1 Dose MMR,,States/Local Areas,Oregon,2015-2016,Age,35 Months,95.3,92.3 to 97.4,420
PCV,≥4 Doses,States/Local Areas,Oregon,2017,Age,24 Months,81.7,74.3 to 88.0,195
PCV,≥4 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,81.9,77.2 to 86.2,485
PCV,≥4 Doses,States/Local Areas,Oregon,2016,Age,24 Months,79.1,70.0 to 86.9,177
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,80.4,74.6 to 85.5,372
PCV,≥4 Doses,States/Local Areas,Oregon,2015,Age,24 Months,81.6,75.0 to 87.4,243
PCV,≥4 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,80.4,74.8 to 85.4,420
≥1 Dose MMR,,States/Local Areas,Oregon,2016,Age,35 Months,96.3,92.3 to 98.5,177
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2017,Age,35 Months,96.5,93.7 to 98.3,372
≥1 Dose Varicella,,States/Local Areas,Oregon,2019,Age,35 Months,93.6,85.9 to 97.9,264
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,87.6,83.7 to 91.4,314
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,89.7,85.6 to 93.7,428
PCV,≥3 Doses,States/Local Areas,Oregon,2019,Age,13 Months,88.3,80.6 to 93.2,264
PCV,≥3 Doses,States/Local Areas,Oregon,2011,Age,19 Months,82.8,76.0 to 87.9,266
PCV,≥3 Doses,States/Local Areas,Oregon,2013,Age,19 Months,91.5,89.4 to 93.3,208
PCV,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,90.2,86.2 to 93.1,478
Hep B,≥3 Doses,States/Local Areas,Oregon,2015,Age,35 Months,92.0,85.7 to 96.2,243
Hep B,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,91.9,87.8 to 95.0,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2016,Age,35 Months,91.8,86.0 to 95.9,177
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,91.8,87.6 to 95.0,372
PCV,≥4 Doses,States/Local Areas,Oregon,2019,Age,24 Months,81.4,74.2 to 87.7,264
PCV,≥4 Doses,States/Local Areas,Oregon,2018,Age,24 Months,82.3,76.1 to 87.6,290
PCV,≥4 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,81.9,77.2 to 86.1,554
PCV,≥4 Doses,States/Local Areas,Oregon,2011,Age,35 Months,75.9,67.6 to 83.4,266
PCV,≥4 Doses,States/Local Areas,Oregon,2012,Age,35 Months,83.4,75.1 to 90.1,229
PCV,≥3 Doses,States/Local Areas,Oregon,2012,Age,19 Months,91.4,87.2 to 94.3,229
Hep B,≥3 Doses,States/Local Areas,Oregon,2017,Age,35 Months,91.8,85.4 to 96.2,195
Hep B,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,92.0,88.2 to 95.0,485
Hib,≥1 Dose,States/Local Areas,Oregon,2014,Age,3 Months,84.9,79.0 to 89.3,270
Hib,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,3 Months,87.6,83.8 to 90.6,513
Hep B,≥2 Doses,States/Local Areas,Oregon,2014,Age,13 Months,90.5,85.5 to 93.9,270
Hep B,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,91.2,87.6 to 93.8,513
Hep B,≥2 Doses,States/Local Areas,Oregon,2015,Age,13 Months,91.8,86.1 to 95.4,243
Hep B,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,93.1,89.4 to 95.5,420
Hep B,≥2 Doses,States/Local Areas,Oregon,2016,Age,13 Months,94.3,88.9 to 97.2,177
Hep B,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,92.7,88.7 to 95.3,372
Hib,≥1 Dose,States/Local Areas,Oregon,2013,Age,3 Months,88.9,86.1 to 91.2,208
Hib,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,3 Months,86.9,84.3 to 89.2,478
Hib,≥1 Dose,States/Local Areas,Oregon,2012,Age,3 Months,86.4,79.3 to 91.4,229
Hib,≥1 Dose,States/Local Areas,Oregon,2011,Age,3 Months,83.6,79.2 to 87.2,266
≥1 Dose Varicella,,States/Local Areas,Oregon,2016,Age,35 Months,94.2,87.3 to 98.1,177
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2017,Age,35 Months,95.1,90.6 to 97.9,372
≥1 Dose MMR,,States/Local Areas,Oregon,2013,Age,35 Months,92.0,86.4 to 95.9,208
≥1 Dose MMR,,States/Local Areas,Oregon,2013-2014,Age,35 Months,91.1,87.1 to 94.2,478
≥1 Dose MMR,,States/Local Areas,Oregon,2011,Age,35 Months,84.4,77.5 to 90.1,266
≥1 Dose MMR,,States/Local Areas,Oregon,2012,Age,35 Months,89.6,82.9 to 94.5,229
≥1 Dose MMR,,States/Local Areas,Oregon,2019,Age,24 Months,86.3,80.0 to 91.4,264
PCV,≥4 Doses,States/Local Areas,Oregon,2014,Age,24 Months,75.9,69.5 to 81.8,270
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,78.7,74.2 to 82.9,513
PCV,≥4 Doses,States/Local Areas,Oregon,2013,Age,24 Months,84.6,78.3 to 89.8,208
PCV,≥4 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,80.2,75.8 to 84.3,478
Hep B,≥3 Doses,States/Local Areas,Oregon,2019,Age,24 Months,93.6,90.0 to 96.3,264
Hep B,≥3 Doses,States/Local Areas,Oregon,2017,Age,24 Months,91.1,84.8 to 95.6,195
Hep B,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,91.3,87.5 to 94.3,485
Hep B,≥3 Doses,States/Local Areas,Oregon,2011,Age,35 Months,85.6,79.0 to 91.0,266
PCV,≥4 Doses,States/Local Areas,Oregon,2012,Age,24 Months,78.4,70.9 to 85.0,229
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2017,Age,0-2 Days,82.2,74.8 to 87.8,195
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2017-2018,Age,0-2 Days,82.0,77.3 to 85.9,485
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2018,Age,0-2 Days,81.8,75.5 to 86.7,290
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2018-2019,Age,0-2 Days,84.3,80.3 to 87.7,554
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2019,Age,0-2 Days,87.0,81.5 to 91.0,264
Hep B,≥2 Doses,States/Local Areas,Oregon,2018,Age,7 Months,91.5,86.5 to 94.8,290
Hep B,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,92.3,89.1 to 94.6,554
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2016,Age,0-2 Days,76.9,67.4 to 84.3,177
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2016-2017,Age,0-2 Days,79.6,73.7 to 84.4,372
Hep B,≥2 Doses,States/Local Areas,Oregon,2016,Age,7 Months,89.2,80.2 to 94.4,177
Hep B,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,88.2,82.9 to 92.1,372
PCV,≥3 Doses,States/Local Areas,Oregon,2013,Age,13 Months,88.9,85.3 to 91.8,208
PCV,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,86.1,83.0 to 88.7,478
Hep B,≥2 Doses,States/Local Areas,Oregon,2017,Age,7 Months,87.3,80.1 to 92.1,195
Hep B,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,89.4,85.2 to 92.5,485
PCV,≥3 Doses,States/Local Areas,Oregon,2014,Age,13 Months,83.2,77.1 to 87.9,270
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,84.7,80.5 to 88.2,513
PCV,≥3 Doses,States/Local Areas,Oregon,2015,Age,13 Months,86.2,79.7 to 90.9,243
PCV,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,87.0,81.8 to 90.8,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2018,Age,24 Months,91.7,87.0 to 95.2,290
Hep B,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,92.6,89.7 to 95.0,554
Hep B,≥2 Doses,States/Local Areas,Oregon,2015,Age,7 Months,90.6,84.8 to 94.4,243
Hep B,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,89.9,85.0 to 93.4,420
PCV,≥4 Doses,States/Local Areas,Oregon,2011,Age,24 Months,69.9,62.3 to 77.1,266
≥1 Dose Varicella,,States/Local Areas,Oregon,2015,Age,35 Months,91.9,86.3 to 95.9,243
≥1 Dose Varicella,,States/Local Areas,Oregon,2015-2016,Age,35 Months,93.5,89.2 to 96.6,420
≥1 Dose Varicella,,States/Local Areas,Oregon,2014,Age,35 Months,89.4,83.4 to 93.9,270
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2015,Age,35 Months,90.8,86.9 to 93.9,513
PCV,≥4 Doses,States/Local Areas,Oregon,2019,Age,19 Months,80.9,73.1 to 86.8,264
≥1 Dose MMR,,States/Local Areas,Oregon,2018,Age,24 Months,94.4,90.1 to 97.2,290
≥1 Dose MMR,,States/Local Areas,Oregon,2018-2019,Age,24 Months,90.4,86.7 to 93.4,554
≥1 Dose Varicella,,States/Local Areas,Oregon,2013,Age,35 Months,90.8,84.9 to 95.0,208
≥1 Dose Varicella,,States/Local Areas,Oregon,2013-2014,Age,35 Months,90.0,86.1 to 93.3,478
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2014,Age,0-2 Days,70.2,63.3 to 76.4,270
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2014-2015,Age,0-2 Days,74.4,69.6 to 78.7,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2015,Age,0-2 Days,78.6,71.7 to 84.2,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2015-2016,Age,0-2 Days,77.8,72.1 to 82.6,420
PCV,≥4 Doses,States/Local Areas,Oregon,2017,Age,19 Months,77.9,69.8 to 84.3,195
PCV,≥4 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,79.1,74.0 to 83.4,485
PCV,≥4 Doses,States/Local Areas,Oregon,2018,Age,19 Months,80.4,73.6 to 85.8,290
PCV,≥4 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,83.0,78.1 to 87.0,474
≥1 Dose MMR,,States/Local Areas,Oregon,2017,Age,24 Months,94.7,90.0 to 97.6,195
≥1 Dose MMR,,States/Local Areas,Oregon,2017-2018,Age,24 Months,94.5,91.5 to 96.7,485
≥1 Dose MMR,,States/Local Areas,Oregon,2016,Age,24 Months,92.3,87.0 to 96.0,177
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2017,Age,24 Months,93.4,90.1 to 96.0,372
PCV,≥3 Doses,States/Local Areas,Oregon,2012,Age,13 Months,89.1,86.7 to 91.1,229
Hep B,≥3 Doses,States/Local Areas,Oregon,2016,Age,24 Months,90.7,84.7 to 95.0,177
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,90.8,86.6 to 94.1,372
Hep B,≥3 Doses,States/Local Areas,Oregon,2015,Age,24 Months,89.3,83.6 to 93.6,243
Hep B,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,90.0,86.0 to 93.2,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2014,Age,24 Months,87.4,82.4 to 91.5,270
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,88.3,84.7 to 91.4,513
Hep B,≥2 Doses,States/Local Areas,Oregon,2014,Age,7 Months,87.1,81.8 to 91.1,270
Hep B,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,88.9,85.2 to 91.8,513
Hep B,≥2 Doses,States/Local Areas,Oregon,2012,Age,7 Months,86.4,83.6 to 88.8,229
PCV,≥3 Doses,States/Local Areas,Oregon,2018,Age,7 Months,71.8,64.4 to 78.2,290
PCV,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,73.6,68.2 to 78.4,554
PCV,≥3 Doses,States/Local Areas,Oregon,2019,Age,7 Months,75.4,67.4 to 81.9,264
PCV,≥3 Doses,States/Local Areas,Oregon,2011,Age,13 Months,79.5,73.6 to 84.3,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2013,Age,0-2 Days,68.6,61.9 to 74.6,208
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2013-2014,Age,0-2 Days,69.4,65.8 to 72.8,478
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2012,Age,0-2 Days,60.2,54.7 to 65.4,229
Hep B,≥2 Doses,States/Local Areas,Oregon,2013,Age,7 Months,86.4,81.8 to 90.0,208
Hep B,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,86.8,83.5 to 89.5,478
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2019,Age,0-1 Days,83.7,77.5 to 88.5,264
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2011,Age,0-2 Days,60.1,53.4 to 66.5,266
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2018,Age,0-1 Days,81.3,75.1 to 86.3,290
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2018-2019,Age,0-1 Days,82.5,78.3 to 86.1,554
PCV,≥3 Doses,States/Local Areas,Oregon,2017,Age,7 Months,69.3,59.6 to 77.6,195
PCV,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,70.6,64.5 to 75.9,485
PCV,≥3 Doses,States/Local Areas,Oregon,2015,Age,7 Months,65.1,57.1 to 72.3,243
PCV,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,66.4,59.9 to 72.4,420
PCV,≥4 Doses,States/Local Areas,Oregon,2014,Age,19 Months,72.8,65.8 to 78.8,270
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,73.6,68.5 to 78.1,513
PCV,≥4 Doses,States/Local Areas,Oregon,2015,Age,19 Months,74.3,70.1 to 78.2,243
PCV,≥4 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,76.0,69.9 to 81.2,420
PCV,≥4 Doses,States/Local Areas,Oregon,2016,Age,19 Months,77.7,67.7 to 85.2,177
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,77.8,71.6 to 82.9,372
PCV,≥3 Doses,States/Local Areas,Oregon,2016,Age,7 Months,67.8,57.3 to 76.8,177
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,68.6,61.5 to 74.8,372
Hep B,≥3 Doses,States/Local Areas,Oregon,2012,Age,24 Months,84.3,77.8 to 89.7,229
PCV,≥4 Doses,States/Local Areas,Oregon,2020,Age,35 Months,78.7,70.8 to 85.7,220
Hep B,≥3 Doses,States/Local Areas,Oregon,2013,Age,24 Months,89.7,84.0 to 94.0,208
Hep B,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,88.4,84.8 to 91.5,478
Hep B,≥3 Doses,States/Local Areas,Oregon,2019,Age,19 Months,93.6,89.6 to 96.1,264
Hep B,≥3 Doses,States/Local Areas,Oregon,2011,Age,24 Months,81.7,75.2 to 87.3,266
≥1 Dose Varicella,,States/Local Areas,Oregon,2018,Age,24 Months,91.5,86.7 to 95.1,290
≥1 Dose Varicella,,States/Local Areas,Oregon,2018-2019,Age,24 Months,89.5,85.5 to 92.8,554
≥1 Dose MMR,,States/Local Areas,Oregon,2015,Age,24 Months,91.0,86.1 to 94.7,243
≥1 Dose MMR,,States/Local Areas,Oregon,2015-2016,Age,24 Months,91.7,88.2 to 94.5,420
≥1 Dose MMR,,States/Local Areas,Oregon,2014,Age,24 Months,86.2,80.6 to 90.8,270
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2015,Age,24 Months,88.6,85.0 to 91.7,513
≥1 Dose MMR,,States/Local Areas,Oregon,2013,Age,24 Months,91.4,86.0 to 95.3,208
≥1 Dose MMR,,States/Local Areas,Oregon,2013-2014,Age,24 Months,88.8,85.0 to 92.0,478
≥1 Dose Varicella,,States/Local Areas,Oregon,2017,Age,24 Months,93.9,89.0 to 97.1,195
≥1 Dose Varicella,,States/Local Areas,Oregon,2017-2018,Age,24 Months,92.6,89.3 to 95.1,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2019,Age,24 Months,87.4,80.7 to 92.6,264
≥1 Dose Varicella,,States/Local Areas,Oregon,2011,Age,35 Months,82.0,75.1 to 87.9,266
≥1 Dose Varicella,,States/Local Areas,Oregon,2012,Age,35 Months,86.2,79.2 to 91.8,229
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,83.2,75.8 to 90.7,138
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.8,79.2 to 90.4,217
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,86.0,81.0 to 91.0,221
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Overall,Overall,88.0,85.3 to 90.8,780
PCV,≥4 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,84.6,79.5 to 89.7,428
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,88.4,84.0 to 92.8,308
≥1 Dose Varicella,,States/Local Areas,Oregon,2017,Age,35 Months,94.9,90.0 to 97.8,195
≥1 Dose Varicella,,States/Local Areas,Oregon,2017-2018,Age,35 Months,94.0,90.8 to 96.4,485
PCV,≥3 Doses,States/Local Areas,Oregon,2013,Age,7 Months,65.6,57.8 to 72.6,208
PCV,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,64.5,59.0 to 69.6,478
PCV,≥3 Doses,States/Local Areas,Oregon,2011,Age,7 Months,61.0,55.8 to 65.9,266
Hep B,≥3 Doses,States/Local Areas,Oregon,2016,Age,19 Months,90.7,84.1 to 94.7,177
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,89.0,84.4 to 92.4,372
PCV,≥3 Doses,States/Local Areas,Oregon,2014,Age,7 Months,63.4,55.9 to 70.2,270
PCV,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,64.2,58.8 to 69.3,513
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,86.0,79.3 to 92.7,251
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,75.2,68.7 to 81.6,308
PCV,≥3 Doses,States/Local Areas,Oregon,2012,Age,7 Months,70.3,62.2 to 77.3,229
Hep B,≥3 Doses,States/Local Areas,Oregon,2017,Age,19 Months,87.4,80.1 to 92.2,195
Hep B,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,89.3,85.1 to 92.5,485
Hep B,≥3 Doses,States/Local Areas,Oregon,2018,Age,19 Months,91.4,86.2 to 94.7,290
Hep B,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,88.3,84.1 to 91.5,554
Hep B,≥2 Doses,States/Local Areas,Oregon,2016,Age,5 Months,80.5,70.0 to 87.9,177
Hep B,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,5 Months,83.3,77.2 to 88.0,372
Hep B,≥2 Doses,States/Local Areas,Oregon,2014,Age,5 Months,83.4,77.5 to 87.9,270
Hep B,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,5 Months,84.8,82.5 to 86.9,513
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2012,Age,0-1 Days,50.3,43.0 to 57.4,229
Polio,≥2 Doses,States/Local Areas,Oregon,2018,Age,13 Months,95.0,90.5 to 97.4,290
Hib,Primary Series,States/Local Areas,Oregon,2020,Age,24 Months,89.3,82.5 to 94.3,220
≥1 Dose Varicella,,States/Local Areas,Oregon,2018,Age,35 Months,93.3,88.5 to 96.5,290
≥1 Dose Varicella,,States/Local Areas,Oregon,2018-2019,Age,35 Months,93.5,89.3 to 96.4,554
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,93.9,89.8 to 98.0,133
Rotavirus,,States/Local Areas,Georgia,2018,Age,8 Months,71.4,62.5 to 78.8,282
Rotavirus,,States/Local Areas,Georgia,2018-2019,Age,8 Months,73.0,66.8 to 78.3,555
Rotavirus,,States/Local Areas,Georgia,2019,Age,8 Months,74.5,65.6 to 81.8,273
Rotavirus,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,82.5,77.9 to 87.1,576
Rotavirus,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,76.2,63.6 to 88.9,68
Rotavirus,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,72.1,66.4 to 77.8,396
Rotavirus,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.6,59.5 to 75.7,192
Rotavirus,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,83.3,77.0 to 89.6,215
Rotavirus,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.1,64.3 to 83.9,148
Rotavirus,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,63.7,47.3 to 80.2,50
Rotavirus,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.1,75.3 to 84.9,535
Rotavirus,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,75.5,69.3 to 81.6,418
Rotavirus,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,70.7,59.2 to 82.3,108
Rotavirus,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.6,72.9 to 82.3,564
Rotavirus,,States/Local Areas,Georgia,2014-2017,Overall,Overall,76.1,72.5 to 79.7,1090
Rotavirus,,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,71.0,65.1 to 76.9,372
Rotavirus,,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,76.1,70.0 to 82.3,376
Rotavirus,,States/Local Areas,Georgia,2015,Age,8 Months,76.0,69.0 to 81.9,306
Rotavirus,,States/Local Areas,Georgia,2015-2016,Age,8 Months,75.3,70.2 to 79.8,640
Rotavirus,,States/Local Areas,Georgia,2016,Age,8 Months,74.5,66.9 to 80.9,334
Rotavirus,,States/Local Areas,Georgia,2016-2017,Age,8 Months,74.2,68.7 to 79.1,626
Rotavirus,,States/Local Areas,Georgia,2017,Age,8 Months,73.9,65.7 to 80.8,292
Rotavirus,,States/Local Areas,Georgia,2017-2018,Age,8 Months,72.7,66.5 to 78.1,574
Rotavirus,,States/Local Areas,Georgia,2013,Age,8 Months,74.0,66.0 to 80.6,276
Rotavirus,,States/Local Areas,Georgia,2013-2014,Age,8 Months,73.9,68.4 to 78.8,560
Rotavirus,,States/Local Areas,Georgia,2014,Age,8 Months,73.8,66.5 to 80.0,284
Rotavirus,,States/Local Areas,Georgia,2014-2015,Age,8 Months,74.9,70.0 to 79.3,590
Rotavirus,,States/Local Areas,Georgia,2012,Age,8 Months,75.4,67.7 to 81.7,270
Hep B,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,93.7,90.1 to 96.0,611
Rotavirus,,States/Local Areas,Georgia,2011,Age,8 Months,69.9,60.4 to 77.9,219
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,97.3,94.9 to 99.7,367
Hep B,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,73.2,67.8 to 78.0,611
Hib,Primary Series,States/Local Areas,Georgia,2014,Age,13 Months,88.7,83.4 to 92.5,284
Hib,Primary Series,States/Local Areas,Georgia,2014-2015,Age,13 Months,86.6,82.5 to 89.8,590
Hib,Primary Series,States/Local Areas,Georgia,2015,Age,13 Months,84.4,77.9 to 89.3,306
Hib,Primary Series,States/Local Areas,Georgia,2015-2016,Age,13 Months,87.3,83.1 to 90.6,640
Hib,Primary Series,States/Local Areas,Georgia,2016,Age,13 Months,90.2,84.2 to 94.1,334
Hib,Primary Series,States/Local Areas,Georgia,2016-2017,Age,13 Months,87.5,82.9 to 91.0,626
Hib,Primary Series,States/Local Areas,Georgia,2019,Age,7 Months,72.0,62.9 to 79.7,273
Hib,Primary Series,States/Local Areas,Georgia,2011,Age,13 Months,90.6,85.8 to 93.9,219
Hib,Primary Series,States/Local Areas,Georgia,2012,Age,13 Months,89.7,87.8 to 91.3,270
Hib,Primary Series,States/Local Areas,Georgia,2013,Age,13 Months,92.9,88.1 to 95.9,276
Hib,Primary Series,States/Local Areas,Georgia,2013-2014,Age,13 Months,90.8,84.4 to 94.7,560
Hib,Primary Series,States/Local Areas,Georgia,2016,Age,7 Months,72.8,65.1 to 79.3,334
Hib,Primary Series,States/Local Areas,Georgia,2016-2017,Age,7 Months,72.0,66.3 to 77.0,626
Hib,Primary Series,States/Local Areas,Georgia,2017,Age,7 Months,71.1,62.5 to 78.5,292
Hib,Primary Series,States/Local Areas,Georgia,2017-2018,Age,7 Months,69.6,63.4 to 75.3,574
Hib,Primary Series,States/Local Areas,Georgia,2018,Age,7 Months,68.1,59.1 to 75.9,282
Hib,Primary Series,States/Local Areas,Georgia,2018-2019,Age,7 Months,70.1,63.8 to 75.7,555
Combined 7 Series,,States/Local Areas,Georgia,2011,Age,24 Months,69.3,60.4 to 77.8,219
Combined 7 Series,,States/Local Areas,Georgia,2013,Age,24 Months,72.6,64.7 to 80.1,276
Combined 7 Series,,States/Local Areas,Georgia,2013-2014,Age,24 Months,71.2,66.0 to 76.2,560
Combined 7 Series,,States/Local Areas,Georgia,2012,Age,24 Months,68.2,59.8 to 76.3,270
Hib,Primary Series,States/Local Areas,Georgia,2019,Age,24 Months,91.1,84.4 to 95.8,273
Hib,Primary Series,States/Local Areas,Georgia,2011,Age,24 Months,93.0,87.0 to 96.9,219
Hib,Primary Series,States/Local Areas,Georgia,2012,Age,24 Months,93.2,87.8 to 96.8,270
Hib,Primary Series,States/Local Areas,Georgia,2013,Age,24 Months,97.4,93.9 to 99.1,276
Hib,Primary Series,States/Local Areas,Georgia,2013-2014,Age,24 Months,94.7,91.9 to 96.8,560
Hib,Primary Series,States/Local Areas,Georgia,2019,Age,13 Months,85.1,76.7 to 90.8,273
Hib,Primary Series,States/Local Areas,Georgia,2011,Age,19 Months,92.6,87.8 to 95.6,219
Hib,Primary Series,States/Local Areas,Georgia,2015,Age,19 Months,91.0,89.2 to 92.5,306
Hib,Primary Series,States/Local Areas,Georgia,2015-2016,Age,19 Months,91.1,87.3 to 93.8,640
Hib,Primary Series,States/Local Areas,Georgia,2018,Age,19 Months,89.4,82.1 to 94.0,282
Hib,Primary Series,States/Local Areas,Georgia,2018-2019,Age,19 Months,84.5,79.0 to 88.8,555
Hib,Primary Series,States/Local Areas,Georgia,2019,Age,19 Months,91.1,83.5 to 95.4,273
Hib,Primary Series,States/Local Areas,Georgia,2016,Age,19 Months,91.2,85.2 to 94.9,334
Hib,Primary Series,States/Local Areas,Georgia,2016-2017,Age,19 Months,91.0,86.8 to 93.9,626
Hib,Primary Series,States/Local Areas,Georgia,2017,Age,19 Months,90.7,84.1 to 94.7,292
Hib,Primary Series,States/Local Areas,Georgia,2017-2018,Age,19 Months,90.1,85.1 to 93.5,574
Hib,Primary Series,States/Local Areas,Georgia,2014,Age,19 Months,92.0,86.8 to 95.3,284
Hib,Primary Series,States/Local Areas,Georgia,2014-2015,Age,19 Months,91.5,88.0 to 94.1,590
Hib,Primary Series,States/Local Areas,Georgia,2012,Age,19 Months,92.0,89.4 to 94.1,270
Hib,Primary Series,States/Local Areas,Georgia,2013,Age,19 Months,96.8,92.6 to 98.6,276
Hib,Primary Series,States/Local Areas,Georgia,2013-2014,Age,19 Months,94.4,87.3 to 97.6,560
Hib,Primary Series,States/Local Areas,Georgia,2018,Age,13 Months,84.0,76.0 to 89.7,282
Hib,Primary Series,States/Local Areas,Georgia,2018-2019,Age,13 Months,84.5,79.0 to 88.8,555
Hib,Primary Series,States/Local Areas,Georgia,2014,Age,7 Months,72.3,65.1 to 78.4,284
Hib,Primary Series,States/Local Areas,Georgia,2014-2015,Age,7 Months,69.4,64.3 to 74.0,590
Hib,Primary Series,States/Local Areas,Georgia,2015,Age,7 Months,66.5,59.0 to 73.3,306
Hib,Primary Series,States/Local Areas,Georgia,2015-2016,Age,7 Months,69.6,64.3 to 74.4,640
Hib,Primary Series,States/Local Areas,Georgia,2017,Age,13 Months,84.9,77.3 to 90.3,292
Hib,Primary Series,States/Local Areas,Georgia,2017-2018,Age,13 Months,84.5,78.9 to 88.8,574
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,72.2,64.3 to 80.1,215
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,67.6,61.1 to 74.2,376
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,80.1,74.1 to 86.1,342
Hib,Full Series,States/Local Areas,Georgia,2011,Age,19 Months,71.5,64.6 to 77.5,219
Hib,Full Series,States/Local Areas,Georgia,2012,Age,19 Months,66.9,62.5 to 71.1,270
Hib,Full Series,States/Local Areas,Georgia,2013,Age,19 Months,76.8,73.9 to 79.5,276
Hib,Full Series,States/Local Areas,Georgia,2013-2014,Age,19 Months,76.5,74.8 to 78.1,560
Hep A,≥1 Dose,States/Local Areas,Georgia,2012,Age,19 Months,76.7,73.5 to 79.6,270
Hep A,≥1 Dose,States/Local Areas,Georgia,2014,Age,19 Months,80.5,74.0 to 85.6,284
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,19 Months,81.0,76.6 to 84.8,590
Hep A,≥1 Dose,States/Local Areas,Georgia,2015,Age,19 Months,81.6,79.6 to 83.3,306
Hep A,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,19 Months,84.1,79.7 to 87.7,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2016,Age,24 Months,94.1,89.4 to 97.2,334
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,93.2,89.6 to 95.9,626
DTaP,≥1 Dose,States/Local Areas,Georgia,2019,Age,3 Months,89.2,81.8 to 93.9,273
Hep A,≥1 Dose,States/Local Areas,Georgia,2011,Age,19 Months,82.0,76.8 to 86.3,219
DTaP,≥1 Dose,States/Local Areas,Georgia,2017,Age,3 Months,88.7,81.6 to 93.3,292
DTaP,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,3 Months,89.0,84.3 to 92.4,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2014,Age,24 Months,92.5,87.7 to 96.0,284
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,93.3,90.2 to 95.7,590
DTaP,≥3 Doses,States/Local Areas,Georgia,2015,Age,24 Months,94.0,89.8 to 96.9,306
DTaP,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,94.1,91.1 to 96.4,640
DTaP,≥1 Dose,States/Local Areas,Georgia,2018,Age,3 Months,89.3,82.0 to 93.9,282
DTaP,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,3 Months,89.3,84.4 to 92.8,555
Combined 7 Series,,States/Local Areas,Georgia,2017,Age,24 Months,68.9,60.8 to 76.7,292
Combined 7 Series,,States/Local Areas,Georgia,2017-2018,Age,24 Months,64.5,58.5 to 70.5,574
Combined 7 Series,,States/Local Areas,Georgia,2018,Age,24 Months,60.1,51.5 to 68.9,282
Combined 7 Series,,States/Local Areas,Georgia,2018-2019,Age,24 Months,64.5,58.2 to 70.7,555
Combined 7 Series,,States/Local Areas,Georgia,2014,Age,24 Months,69.8,62.7 to 76.6,284
Combined 7 Series,,States/Local Areas,Georgia,2014-2015,Age,24 Months,66.8,61.6 to 72.0,590
Combined 7 Series,,States/Local Areas,Georgia,2015,Age,24 Months,64.0,56.6 to 71.4,306
Combined 7 Series,,States/Local Areas,Georgia,2015-2016,Age,24 Months,67.0,61.8 to 72.1,640
Hib,Primary Series,States/Local Areas,Georgia,2018,Age,35 Months,90.4,83.7 to 95.1,282
Hib,Primary Series,States/Local Areas,Georgia,2018-2019,Age,35 Months,90.9,86.4 to 94.4,555
Combined 7 Series,,States/Local Areas,Georgia,2016,Age,24 Months,70.0,62.7 to 77.0,334
Combined 7 Series,,States/Local Areas,Georgia,2016-2017,Age,24 Months,69.4,64.0 to 74.6,626
Hib,Primary Series,States/Local Areas,Georgia,2019,Age,35 Months,91.3,84.6 to 95.9,273
Hib,Primary Series,States/Local Areas,Georgia,2013,Age,7 Months,70.3,63.6 to 76.3,276
Hib,Primary Series,States/Local Areas,Georgia,2013-2014,Age,7 Months,71.3,68.2 to 74.2,560
Hib,Primary Series,States/Local Areas,Georgia,2017,Age,35 Months,91.5,85.5 to 95.7,292
Hib,Primary Series,States/Local Areas,Georgia,2017-2018,Age,35 Months,91.0,86.3 to 94.5,574
Hib,Primary Series,States/Local Areas,Georgia,2014,Age,24 Months,92.0,87.3 to 95.5,284
Hib,Primary Series,States/Local Areas,Georgia,2014-2015,Age,24 Months,91.6,88.3 to 94.3,590
Hib,Primary Series,States/Local Areas,Georgia,2015,Age,24 Months,91.2,86.2 to 94.9,306
Hib,Primary Series,States/Local Areas,Georgia,2015-2016,Age,24 Months,91.5,87.9 to 94.3,640
Hib,Primary Series,States/Local Areas,Georgia,2016,Age,24 Months,91.7,86.2 to 95.6,334
Hib,Primary Series,States/Local Areas,Georgia,2016-2017,Age,24 Months,91.5,87.6 to 94.6,626
Hib,Primary Series,States/Local Areas,Georgia,2015,Age,35 Months,96.1,92.2 to 98.4,306
Hib,Primary Series,States/Local Areas,Georgia,2015-2016,Age,35 Months,93.9,90.5 to 96.3,640
Hib,Primary Series,States/Local Areas,Georgia,2016,Age,35 Months,92.9,87.7 to 96.4,334
Hib,Primary Series,States/Local Areas,Georgia,2016-2017,Age,35 Months,92.2,88.4 to 95.2,626
Hib,Primary Series,States/Local Areas,Georgia,2011,Age,35 Months,93.0,87.0 to 96.9,219
Hib,Primary Series,States/Local Areas,Georgia,2013,Age,35 Months,97.4,93.9 to 99.1,276
Hib,Primary Series,States/Local Areas,Georgia,2013-2014,Age,35 Months,94.7,91.9 to 96.8,560
Hib,Primary Series,States/Local Areas,Georgia,2012,Age,35 Months,94.1,88.6 to 97.5,270
Hib,Primary Series,States/Local Areas,Georgia,2014,Age,35 Months,92.0,87.3 to 95.5,284
Hib,Primary Series,States/Local Areas,Georgia,2014-2015,Age,35 Months,93.3,90.1 to 95.8,590
Hib,Primary Series,States/Local Areas,Georgia,2017,Age,24 Months,91.4,85.4 to 95.6,292
Hib,Primary Series,States/Local Areas,Georgia,2017-2018,Age,24 Months,90.5,85.9 to 94.2,574
Hib,Primary Series,States/Local Areas,Georgia,2018,Age,24 Months,89.7,83.1 to 94.6,282
Hib,Primary Series,States/Local Areas,Georgia,2018-2019,Age,24 Months,90.4,85.9 to 94.0,555
Combined 7 Series,,States/Local Areas,Georgia,2018,Age,35 Months,70.3,60.3 to 79.8,282
Combined 7 Series,,States/Local Areas,Georgia,2018-2019,Age,35 Months,71.9,65.0 to 78.5,555
Combined 7 Series,,States/Local Areas,Georgia,2019,Age,35 Months,73.3,64.0 to 81.9,273
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,73.3,68.1 to 78.5,576
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,66.4,60.5 to 72.3,396
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.2,57.1 to 73.3,192
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,52.4,34.5 to 70.3,50
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,70.4,56.6 to 84.2,68
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,64.1,57.9 to 70.2,372
Hib,Full Series,States/Local Areas,Georgia,2011,Age,24 Months,78.7,70.2 to 86.1,219
Hib,Full Series,States/Local Areas,Georgia,2012,Age,24 Months,79.3,71.7 to 86.0,270
Hib,Full Series,States/Local Areas,Georgia,2013,Age,24 Months,84.0,76.6 to 90.1,276
Hib,Full Series,States/Local Areas,Georgia,2013-2014,Age,24 Months,82.5,77.9 to 86.6,560
Hib,Full Series,States/Local Areas,Georgia,2014,Age,24 Months,81.0,74.8 to 86.4,284
Hib,Full Series,States/Local Areas,Georgia,2014-2015,Age,24 Months,78.5,73.9 to 82.8,590
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.1,59.4 to 78.8,148
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.1,64.7 to 75.4,535
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.4,63.2 to 73.6,564
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,69.0,62.8 to 75.2,418
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,69.6,58.0 to 81.1,108
Combined 7 Series,,States/Local Areas,Georgia,2014-2017,Overall,Overall,68.8,65.0 to 72.5,1090
Rotavirus,,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,86.6,81.3 to 91.8,342
Combined 7 Series,,States/Local Areas,Georgia,2019,Age,24 Months,68.9,59.8 to 77.6,273
≥1 Dose MMR,,States/Local Areas,Georgia,2020,Age,13 Months,55.2,46.7 to 63.4,338
Hib,Full Series,States/Local Areas,Georgia,2019,Age,19 Months,69.6,60.1 to 77.8,273
Hib,Full Series,States/Local Areas,Georgia,2016,Age,19 Months,74.6,67.4 to 80.7,334
Hib,Full Series,States/Local Areas,Georgia,2016-2017,Age,19 Months,72.3,66.8 to 77.2,626
Hib,Full Series,States/Local Areas,Georgia,2014,Age,19 Months,76.1,69.2 to 81.9,284
Hib,Full Series,States/Local Areas,Georgia,2014-2015,Age,19 Months,72.5,67.5 to 77.0,590
Hib,Full Series,States/Local Areas,Georgia,2015,Age,19 Months,68.9,66.3 to 71.3,306
Hib,Full Series,States/Local Areas,Georgia,2015-2016,Age,19 Months,71.7,66.6 to 76.3,640
Hib,Full Series,States/Local Areas,Georgia,2017,Age,19 Months,70.0,61.5 to 77.2,292
Hib,Full Series,States/Local Areas,Georgia,2017-2018,Age,19 Months,66.0,59.7 to 71.8,574
Hib,Full Series,States/Local Areas,Georgia,2018,Age,19 Months,62.0,52.9 to 70.3,282
Hib,Full Series,States/Local Areas,Georgia,2018-2019,Age,19 Months,94.8,91.0 to 97.1,555
Combined 7 Series,,States/Local Areas,Georgia,2011,Age,35 Months,82.4,68.2 to 92.7,219
Combined 7 Series,,States/Local Areas,Georgia,2016,Age,35 Months,79.9,71.9 to 86.9,334
Combined 7 Series,,States/Local Areas,Georgia,2016-2017,Age,35 Months,76.0,70.2 to 81.4,626
Combined 7 Series,,States/Local Areas,Georgia,2017,Age,35 Months,71.8,63.5 to 79.6,292
Combined 7 Series,,States/Local Areas,Georgia,2017-2018,Age,35 Months,71.1,64.5 to 77.5,574
Combined 7 Series,,States/Local Areas,Georgia,2012,Age,35 Months,80.3,72.6 to 87.0,270
Combined 7 Series,,States/Local Areas,Georgia,2013,Age,35 Months,79.9,71.8 to 87.0,276
Combined 7 Series,,States/Local Areas,Georgia,2013-2014,Age,35 Months,78.3,73.0 to 83.2,560
Combined 7 Series,,States/Local Areas,Georgia,2015,Age,35 Months,70.8,62.9 to 78.3,306
Combined 7 Series,,States/Local Areas,Georgia,2015-2016,Age,35 Months,75.5,69.9 to 80.7,640
Combined 7 Series,,States/Local Areas,Georgia,2014,Age,35 Months,76.6,69.4 to 83.1,284
Combined 7 Series,,States/Local Areas,Georgia,2014-2015,Age,35 Months,73.7,68.4 to 78.9,590
PCV,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,69.5,63.6 to 74.9,611
≥1 Dose Varicella,,States/Local Areas,Georgia,2019-2020,Age,24 Months,89.6,85.3 to 93.0,611
Hep B,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,92.7,89.1 to 95.4,611
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2019-2020,Age,0-1 Days,72.3,66.4 to 77.6,611
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2019-2020,Age,0-2 Days,79.5,74.2 to 84.0,611
Hep A,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,19 Months,85.4,80.3 to 89.3,611
PCV,≥4 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,77.4,71.6 to 82.4,611
≥1 Dose Varicella,,States/Local Areas,Georgia,2019-2020,Age,19 Months,88.0,83.3 to 91.5,611
Hep B,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,92.4,88.5 to 95.0,611
Combined 7 Series,,States/Local Areas,Georgia,2019-2020,Age,35 Months,72.0,65.9 to 77.8,611
Hib,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,47.2,41.0 to 53.4,611
Hib,Primary Series,States/Local Areas,Georgia,2019-2020,Age,24 Months,91.0,86.9 to 94.2,611
Hib,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,87.5,82.8 to 91.4,611
Influenza,,States/Local Areas,Georgia,2019-2020,Age,24 Months,42.9,37.1 to 49.3,611
Hep A,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,80.0,73.2 to 86.0,611
Hep A,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,35 Months,92.1,88.0 to 95.2,611
Hep A,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,24 Months,89.6,85.3 to 93.1,611
Polio,≥2 Doses,States/Local Areas,Georgia,2020,Age,13 Months,92.4,87.1 to 95.7,338
Hep A,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,51.1,44.9 to 57.6,611
Hep A,≥2 Doses,States/Local Areas,Georgia,2020,Age,35 Months,78.7,69.2 to 86.8,338
Combined 7 Series,,States/Local Areas,Georgia,2020,Age,35 Months,70.3,62.4 to 77.9,338
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2020,Age,0-1 Days,77.5,70.5 to 83.2,338
Hep A,≥1 Dose,States/Local Areas,Georgia,2020,Age,19 Months,82.4,75.0 to 88.0,338
Hep A,≥2 Doses,States/Local Areas,Georgia,2020,Age,19 Months,25.4,19.2 to 32.8,338
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2020,Age,0-2 Days,81.1,74.6 to 86.2,338
Polio,≥2 Doses,States/Local Areas,Georgia,2020,Age,7 Months,85.5,78.5 to 90.5,338
DTaP,≥1 Dose,States/Local Areas,Georgia,2020,Age,3 Months,84.3,76.3 to 89.9,338
Hib,≥2 Doses,States/Local Areas,Georgia,2020,Age,7 Months,85.3,78.3 to 90.3,338
Hib,≥3 Doses,States/Local Areas,Georgia,2020,Age,7 Months,46.7,38.6 to 55.0,338
Hib,Primary Series,States/Local Areas,Georgia,2020,Age,7 Months,67.2,58.9 to 74.5,338
Hep B,≥2 Doses,States/Local Areas,Georgia,2020,Age,7 Months,93.5,88.9 to 96.2,338
DTaP,≥3 Doses,States/Local Areas,Georgia,2020,Age,24 Months,91.5,86.4 to 95.3,338
Polio,≥3 Doses,States/Local Areas,Georgia,2020,Age,24 Months,90.4,84.8 to 94.5,338
DTaP,≥4 Doses,States/Local Areas,Georgia,2020,Age,24 Months,81.9,75.0 to 87.9,338
≥1 Dose MMR,,States/Local Areas,Georgia,2020,Age,24 Months,85.4,78.8 to 90.8,338
Hib,≥3 Doses,States/Local Areas,Georgia,2020,Age,24 Months,87.1,80.8 to 92.1,338
Hib,Primary Series,States/Local Areas,Georgia,2020,Age,24 Months,90.3,84.7 to 94.5,338
≥1 Dose MMR,,States/Local Areas,Georgia,2020,Age,35 Months,88.8,81.9 to 94.0,338
Hib,≥3 Doses,States/Local Areas,Georgia,2020,Age,35 Months,91.2,85.2 to 95.4,338
Hib,Primary Series,States/Local Areas,Georgia,2020,Age,35 Months,91.9,86.7 to 95.7,338
Hib,Full Series,States/Local Areas,Georgia,2020,Age,35 Months,74.9,66.7 to 82.4,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2020,Age,35 Months,92.5,87.6 to 96.0,338
≥1 Dose Varicella,,States/Local Areas,Georgia,2020,Age,35 Months,87.8,81.5 to 92.8,338
Hib,Primary Series,States/Local Areas,Georgia,2020,Age,19 Months,89.1,82.6 to 93.4,338
Hib,Full Series,States/Local Areas,Georgia,2020,Age,19 Months,66.4,58.0 to 73.9,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2020,Age,19 Months,92.1,86.8 to 95.4,338
PCV,≥3 Doses,States/Local Areas,Georgia,2020,Age,19 Months,89.7,83.4 to 93.8,338
≥1 Dose Varicella,,States/Local Areas,Georgia,2020,Age,19 Months,84.9,78.0 to 90.0,338
DTaP,≥4 Doses,States/Local Areas,Georgia,2020,Age,35 Months,87.9,81.1 to 93.1,338
Polio,≥3 Doses,States/Local Areas,Georgia,2020,Age,35 Months,92.3,87.1 to 96.0,338
PCV,≥4 Doses,States/Local Areas,Georgia,2020,Age,19 Months,78.7,71.0 to 84.8,338
PCV,≥4 Doses,States/Local Areas,Georgia,2020,Age,35 Months,80.0,72.8 to 86.4,338
PCV,≥3 Doses,States/Local Areas,Georgia,2020,Age,35 Months,90.1,84.3 to 94.4,338
Hib,Primary Series,States/Local Areas,Georgia,2020,Age,13 Months,82.8,75.5 to 88.2,338
Hib,≥3 Doses,States/Local Areas,Georgia,2020,Age,13 Months,62.0,53.7 to 69.7,338
Hep B,≥2 Doses,States/Local Areas,Georgia,2020,Age,13 Months,93.8,89.3 to 96.5,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2020,Age,13 Months,90.7,85.3 to 94.3,338
≥1 Dose Varicella,,States/Local Areas,Georgia,2020,Age,13 Months,51.5,43.2 to 59.7,338
PCV,≥3 Doses,States/Local Areas,Georgia,2020,Age,13 Months,83.7,76.3 to 89.1,338
DTaP,≥3 Doses,States/Local Areas,Georgia,2020,Age,7 Months,69.7,61.5 to 76.8,338
PCV,≥2 Doses,States/Local Areas,Georgia,2020,Age,5 Months,74.8,66.8 to 81.4,338
DTaP,≥3 Doses,States/Local Areas,Georgia,2020,Age,19 Months,91.5,85.9 to 95.0,338
DTaP,≥4 Doses,States/Local Areas,Georgia,2020,Age,19 Months,70.8,62.6 to 77.8,338
≥1 Dose MMR,,States/Local Areas,Georgia,2020,Age,19 Months,83.6,76.2 to 89.0,338
Polio,≥3 Doses,States/Local Areas,Georgia,2020,Age,19 Months,90.4,84.2 to 94.3,338
Hib,≥3 Doses,States/Local Areas,Georgia,2020,Age,19 Months,83.4,75.8 to 89.0,338
Influenza,,States/Local Areas,Georgia,2020,Age,24 Months,39.1,31.6 to 47.7,338
Rotavirus,,States/Local Areas,Georgia,2020,Age,8 Months,69.6,61.5 to 76.7,338
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2020,Age,0-3 Days,81.6,75.2 to 86.7,338
PCV,≥3 Doses,States/Local Areas,Georgia,2020,Age,24 Months,90.0,84.2 to 94.3,338
DTaP,≥3 Doses,States/Local Areas,Georgia,2020,Age,35 Months,91.9,86.8 to 95.6,338
PCV,≥4 Doses,States/Local Areas,Georgia,2020,Age,24 Months,79.5,72.3 to 85.9,338
Hep A,≥1 Dose,States/Local Areas,Georgia,2020,Age,24 Months,86.1,79.4 to 91.4,338
Hep A,≥2 Doses,States/Local Areas,Georgia,2020,Age,24 Months,48.7,40.9 to 57.1,338
Combined 7 Series,,States/Local Areas,Georgia,2020,Age,24 Months,69.1,61.3 to 76.7,338
PCV,≥1 Dose,States/Local Areas,Georgia,2020,Age,3 Months,81.5,73.3 to 87.7,338
DTaP,≥2 Doses,States/Local Areas,Georgia,2020,Age,5 Months,77.7,69.9 to 84.0,338
Polio,≥2 Doses,States/Local Areas,Georgia,2020,Age,5 Months,78.9,71.3 to 84.9,338
Hib,≥2 Doses,States/Local Areas,Georgia,2020,Age,5 Months,77.3,69.5 to 83.6,338
Hep B,≥2 Doses,States/Local Areas,Georgia,2020,Age,5 Months,89.8,84.3 to 93.5,338
Polio,≥1 Dose,States/Local Areas,Georgia,2020,Age,3 Months,83.3,75.3 to 89.1,338
Hib,≥1 Dose,States/Local Areas,Georgia,2020,Age,3 Months,83.1,75.1 to 89.0,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2020,Age,7 Months,72.9,65.6 to 79.1,338
Hep B,≥1 Dose,States/Local Areas,Georgia,2020,Age,3 Months,96.3,93.8 to 97.9,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2020,Age,24 Months,92.5,87.6 to 96.0,338
DTaP,≥3 Doses,States/Local Areas,Georgia,2020,Age,13 Months,86.7,79.8 to 91.5,338
PCV,≥3 Doses,States/Local Areas,Georgia,2020,Age,7 Months,66.8,58.5 to 74.1,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,93.9,89.1 to 98.7,171
Polio,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,93.1,89.4 to 95.9,611
DTaP,≥4 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,85.2,79.6 to 89.8,611
DTaP,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,93.4,89.7 to 96.1,611
Combined 7 Series,,States/Local Areas,Georgia,2019-2020,Age,24 Months,69.2,63.2 to 75.1,611
≥1 Dose Varicella,,States/Local Areas,Georgia,2019-2020,Age,13 Months,56.1,49.8 to 62.3,611
DTaP,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,92.5,88.6 to 95.2,611
PCV,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,88.0,83.3 to 91.5,611
Hep B,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,91.6,87.7 to 94.3,611
Hib,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,87.6,82.9 to 91.2,611
Polio,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,89.0,84.5 to 92.3,611
DTaP,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,7 Months,71.3,65.4 to 76.6,611
PCV,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,5 Months,76.6,70.8 to 81.5,611
Hep B,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,5 Months,90.6,86.7 to 93.4,611
Hep B,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,94.2,90.6 to 96.4,611
Hib,Primary Series,States/Local Areas,Georgia,2019-2020,Age,13 Months,84.2,79.0 to 88.4,611
Hib,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,92.9,89.0 to 95.5,611
Hib,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,64.1,57.8 to 69.9,611
≥1 Dose MMR,,States/Local Areas,Georgia,2019-2020,Age,13 Months,61.7,55.3 to 67.7,611
Polio,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,93.5,89.7 to 95.9,611
Hib,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,5 Months,78.2,72.5 to 83.0,611
Polio,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,5 Months,78.8,73.1 to 83.6,611
DTaP,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,5 Months,78.7,73.0 to 83.5,611
PCV,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,3 Months,84.8,79.5 to 89.0,611
Hep B,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,3 Months,96.3,94.0 to 97.8,611
≥1 Dose MMR,,States/Local Areas,Georgia,2019-2020,Age,24 Months,88.9,84.5 to 92.5,611
Polio,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,91.5,87.6 to 94.5,611
DTaP,≥4 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,80.0,74.6 to 85.0,611
DTaP,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,92.5,88.8 to 95.3,611
PCV,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,92.3,88.4 to 95.2,611
PCV,≥4 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,82.2,76.9 to 86.9,611
≥1 Dose Varicella,,States/Local Areas,Georgia,2019-2020,Age,35 Months,91.4,87.2 to 94.6,611
Hep B,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,92.9,89.4 to 95.6,611
Hib,Primary Series,States/Local Areas,Georgia,2019-2020,Age,35 Months,91.9,87.9 to 95.0,611
Hib,Full Series,States/Local Areas,Georgia,2019-2020,Age,35 Months,76.8,70.8 to 82.4,611
Hib,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,35 Months,90.4,85.7 to 94.0,611
≥1 Dose MMR,,States/Local Areas,Georgia,2019-2020,Age,35 Months,91.9,87.5 to 95.2,611
Hib,Full Series,States/Local Areas,Georgia,2019-2020,Age,19 Months,68.2,61.9 to 73.9,611
Hib,Primary Series,States/Local Areas,Georgia,2019-2020,Age,19 Months,90.4,85.8 to 93.5,611
Hib,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,85.4,80.1 to 89.4,611
≥1 Dose MMR,,States/Local Areas,Georgia,2019-2020,Age,19 Months,87.4,82.5 to 91.0,611
Hep A,≥2 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,29.6,24.2 to 35.5,611
PCV,≥4 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,80.8,75.4 to 85.7,611
PCV,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,24 Months,91.6,87.7 to 94.6,611
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2019-2020,Age,0-3 Days,81.4,76.3 to 85.6,611
Hep A,≥1 Dose,States/Local Areas,Georgia,2013,Age,19 Months,89.0,83.2 to 93.0,276
Hep A,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,19 Months,84.7,79.6 to 88.8,560
Hep A,≥1 Dose,States/Local Areas,Georgia,2016,Age,19 Months,86.7,80.6 to 91.1,334
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,19 Months,84.5,79.8 to 88.3,626
DTaP,≥2 Doses,States/Local Areas,Georgia,2017,Age,5 Months,76.4,68.2 to 83.0,292
DTaP,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,5 Months,73.2,66.9 to 78.7,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2017,Age,24 Months,92.2,86.4 to 96.2,292
DTaP,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,91.9,87.4 to 95.2,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2018,Age,24 Months,91.4,85.3 to 95.7,282
DTaP,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,92.2,88.1 to 95.3,555
Hib,≥3 Doses,States/Local Areas,Georgia,2015,Age,24 Months,88.0,82.1 to 92.6,306
Hib,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,89.3,85.4 to 92.5,640
Hib,≥3 Doses,States/Local Areas,Georgia,2016,Age,24 Months,90.6,85.2 to 94.7,334
Hib,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,89.4,85.3 to 92.8,626
DTaP,≥3 Doses,States/Local Areas,Georgia,2019,Age,24 Months,93.0,86.9 to 96.9,273
Hib,≥3 Doses,States/Local Areas,Georgia,2017,Age,24 Months,88.2,81.7 to 93.2,292
Hib,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,88.1,83.3 to 92.1,574
Hib,Full Series,States/Local Areas,Georgia,2021,Age,19 Months,64.6,55.2 to 72.9,255
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,96.7,94.3 to 99.1,108
DTaP,≥2 Doses,States/Local Areas,Georgia,2019,Age,5 Months,79.6,70.8 to 86.3,273
DTaP,≥2 Doses,States/Local Areas,Georgia,2018,Age,5 Months,70.0,60.9 to 77.7,282
DTaP,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,5 Months,74.8,68.6 to 80.1,555
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,93.0,91.0 to 95.0,1090
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,92.1,88.9 to 95.4,372
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,92.1,88.5 to 95.7,376
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,96.1,93.5 to 98.6,342
DTaP,≥4 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,82.8,76.3 to 88.3,593
DTaP,≥1 Dose,States/Local Areas,Georgia,2013,Age,3 Months,92.0,90.8 to 93.1,276
DTaP,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,3 Months,89.0,84.3 to 92.4,560
DTaP,≥1 Dose,States/Local Areas,Georgia,2014,Age,3 Months,86.0,79.7 to 90.6,284
DTaP,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,3 Months,87.6,83.6 to 90.8,590
DTaP,≥1 Dose,States/Local Areas,Georgia,2015,Age,3 Months,89.3,83.6 to 93.1,306
DTaP,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,3 Months,90.3,86.7 to 93.0,640
DTaP,≥1 Dose,States/Local Areas,Georgia,2016,Age,3 Months,91.3,86.1 to 94.7,334
DTaP,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,3 Months,90.0,85.8 to 93.0,626
Combined 7 Series,,States/Local Areas,Georgia,2021,Age,35 Months,62.0,52.7 to 71.4,255
≥1 Dose Varicella,,States/Local Areas,Georgia,2021,Age,19 Months,82.1,73.6 to 88.3,255
Hib,≥1 Dose,States/Local Areas,Georgia,2021,Age,3 Months,85.7,77.6 to 91.1,255
PCV,≥4 Doses,States/Local Areas,Georgia,2021,Age,19 Months,73.9,64.7 to 81.4,255
Hib,Primary Series,States/Local Areas,Georgia,2021,Age,7 Months,65.8,56.6 to 74.0,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.2,75.7 to 84.6,537
DTaP,≥1 Dose,States/Local Areas,Georgia,2011,Age,3 Months,84.5,73.8 to 91.3,219
DTaP,≥1 Dose,States/Local Areas,Georgia,2012,Age,3 Months,86.4,80.2 to 90.9,270
PCV,≥2 Doses,States/Local Areas,Georgia,2021,Age,5 Months,75.5,66.1 to 82.9,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,91.6,87.7 to 94.4,593
Hep B,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,93.9,90.5 to 96.1,593
Hep B,≥3 Doses,States/Local Areas,Georgia,2021,Age,19 Months,88.1,81.2 to 92.7,255
Hep B,≥2 Doses,States/Local Areas,Georgia,2021,Age,7 Months,90.5,83.4 to 94.8,255
Polio,≥2 Doses,States/Local Areas,Georgia,2021,Age,7 Months,85.8,77.8 to 91.3,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2021,Age,7 Months,68.8,59.7 to 76.7,255
Polio,≥3 Doses,States/Local Areas,Georgia,2021,Age,19 Months,90.6,84.3 to 94.6,255
Hib,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,88.4,84.2 to 92.0,593
PCV,≥4 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,77.5,71.9 to 82.6,593
Hep B,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,87.4,82.9 to 90.9,593
Hib,≥2 Doses,States/Local Areas,Georgia,2021,Age,7 Months,85.8,77.8 to 91.2,255
≥1 Dose MMR,,States/Local Areas,Georgia,2021,Age,35 Months,91.7,76.8 to 98.5,255
PCV,≥3 Doses,States/Local Areas,Georgia,2021,Age,35 Months,93.8,88.2 to 97.3,255
Hib,Primary Series,States/Local Areas,Georgia,2020-2021,Age,24 Months,91.5,87.7 to 94.4,593
Hib,≥2 Doses,States/Local Areas,Georgia,2021,Age,5 Months,76.7,67.5 to 83.9,255
Hib,≥3 Doses,States/Local Areas,Georgia,2021,Age,19 Months,87.8,80.9 to 92.4,255
Hep A,≥1 Dose,States/Local Areas,Georgia,2017,Age,19 Months,82.3,74.8 to 88.0,292
Hep A,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,19 Months,79.3,73.4 to 84.2,574
Hep A,≥1 Dose,States/Local Areas,Georgia,2018,Age,19 Months,76.2,67.3 to 83.3,282
Hep A,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,19 Months,78.8,71.4 to 84.6,441
DTaP,≥3 Doses,States/Local Areas,Georgia,2011,Age,35 Months,91.0,84.3 to 95.6,219
DTaP,≥3 Doses,States/Local Areas,Georgia,2012,Age,35 Months,93.1,87.7 to 96.8,270
DTaP,≥3 Doses,States/Local Areas,Georgia,2013,Age,35 Months,98.3,96.1 to 99.4,276
DTaP,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,95.8,92.9 to 97.8,560
DTaP,≥3 Doses,States/Local Areas,Georgia,2014,Age,35 Months,93.3,88.1 to 96.8,284
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,95.6,92.5 to 97.7,590
Hep A,≥2 Doses,States/Local Areas,Georgia,2011,Age,19 Months,24.8,20.7 to 29.3,219
Hep A,≥2 Doses,States/Local Areas,Georgia,2013,Age,19 Months,29.6,26.4 to 33.1,276
Hep A,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,28.2,25.5 to 31.0,560
Hep A,≥2 Doses,States/Local Areas,Georgia,2012,Age,19 Months,22.4,17.9 to 27.7,270
Hep A,≥2 Doses,States/Local Areas,Georgia,2014,Age,19 Months,26.7,20.5 to 34.1,284
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,25.9,21.6 to 30.8,590
Hib,≥3 Doses,States/Local Areas,Georgia,2018,Age,24 Months,88.1,81.4 to 93.2,282
Hib,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,87.9,83.0 to 91.9,555
Hib,≥3 Doses,States/Local Areas,Georgia,2019,Age,24 Months,87.6,80.2 to 93.3,273
Hib,≥3 Doses,States/Local Areas,Georgia,2011,Age,35 Months,92.5,86.4 to 96.5,219
Hib,≥3 Doses,States/Local Areas,Georgia,2012,Age,35 Months,92.9,87.2 to 96.6,270
Hep A,≥1 Dose,States/Local Areas,Georgia,2019,Age,19 Months,87.4,79.4 to 92.5,273
Hep A,≥1 Dose,States/Local Areas,Georgia,2011,Age,24 Months,83.3,75.6 to 89.7,219
Hep A,≥1 Dose,States/Local Areas,Georgia,2013,Age,24 Months,91.7,86.2 to 95.6,276
Hep A,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,24 Months,88.2,84.4 to 91.5,560
Hep A,≥1 Dose,States/Local Areas,Georgia,2012,Age,24 Months,85.4,78.8 to 90.9,270
Hep A,≥1 Dose,States/Local Areas,Georgia,2014,Age,24 Months,84.9,79.1 to 89.8,284
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,24 Months,84.9,80.8 to 88.6,590
DTaP,≥3 Doses,States/Local Areas,Georgia,2017,Age,35 Months,92.7,86.8 to 96.6,292
DTaP,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,92.6,88.1 to 95.8,574
DTaP,≥4 Doses,States/Local Areas,Georgia,2011,Age,19 Months,67.7,57.9 to 76.2,219
DTaP,≥4 Doses,States/Local Areas,Georgia,2012,Age,19 Months,62.5,59.3 to 65.6,270
PCV,≥2 Doses,States/Local Areas,Georgia,2011,Age,5 Months,71.5,61.1 to 80.1,219
PCV,≥2 Doses,States/Local Areas,Georgia,2012,Age,5 Months,78.2,72.4 to 83.1,270
PCV,≥2 Doses,States/Local Areas,Georgia,2013,Age,5 Months,78.1,74.1 to 81.6,276
PCV,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,5 Months,76.1,69.1 to 82.0,560
DTaP,≥3 Doses,States/Local Areas,Georgia,2015,Age,35 Months,98.2,95.7 to 99.4,306
DTaP,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,97.8,95.5 to 99.1,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2016,Age,35 Months,97.5,93.1 to 99.4,334
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,95.3,91.5 to 97.7,626
Hep A,≥2 Doses,States/Local Areas,Georgia,2015,Age,19 Months,25.2,21.6 to 29.1,306
Hep A,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,24.8,20.7 to 29.4,640
Hep A,≥2 Doses,States/Local Areas,Georgia,2016,Age,19 Months,24.4,18.7 to 31.1,334
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,22.2,18.1 to 26.9,626
Hib,≥3 Doses,States/Local Areas,Georgia,2013,Age,35 Months,94.9,89.4 to 98.1,276
Hib,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,92.2,88.6 to 95.0,560
Hib,≥3 Doses,States/Local Areas,Georgia,2014,Age,35 Months,89.4,84.1 to 93.6,284
Hib,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,89.5,85.6 to 92.7,590
Hib,≥3 Doses,States/Local Areas,Georgia,2015,Age,35 Months,90.0,83.6 to 94.6,306
Hib,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,91.1,87.2 to 94.1,640
Hep A,≥2 Doses,States/Local Areas,Georgia,2017,Age,19 Months,20.1,14.6 to 26.9,292
Hep A,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,21.1,16.9 to 26.0,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,91.2,82.9 to 99.5,68
Hep A,≥1 Dose,States/Local Areas,Georgia,2017,Age,24 Months,88.2,81.9 to 93.1,292
Hep A,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,24 Months,85.9,80.7 to 90.2,574
DTaP,≥4 Doses,States/Local Areas,Georgia,2013,Age,19 Months,75.4,68.0 to 81.5,276
DTaP,≥4 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,72.2,66.3 to 77.4,560
DTaP,≥4 Doses,States/Local Areas,Georgia,2014,Age,19 Months,69.0,61.5 to 75.6,284
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,68.6,63.2 to 73.5,590
DTaP,≥4 Doses,States/Local Areas,Georgia,2015,Age,19 Months,68.1,63.6 to 72.2,306
DTaP,≥4 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,67.6,62.3 to 72.5,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,95.4,93.3 to 97.6,576
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,93.1,89.7 to 96.5,396
Hep A,≥2 Doses,States/Local Areas,Georgia,2018,Age,19 Months,22.1,16.1 to 29.6,282
Hep A,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,27.1,21.1 to 34.2,441
Hep A,≥2 Doses,States/Local Areas,Georgia,2019,Age,19 Months,33.0,25.0 to 42.2,273
Hep A,≥2 Doses,States/Local Areas,Georgia,2011,Age,24 Months,46.5,37.1 to 56.9,219
Hib,≥3 Doses,States/Local Areas,Georgia,2016,Age,35 Months,92.3,87.2 to 95.9,334
Hib,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,91.0,87.0 to 94.3,626
Hib,≥3 Doses,States/Local Areas,Georgia,2017,Age,35 Months,89.7,83.0 to 94.5,292
Hib,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,89.5,84.6 to 93.4,574
Hep A,≥2 Doses,States/Local Areas,Georgia,2012,Age,24 Months,38.5,30.8 to 47.3,270
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,96.3,91.6 to 100.0,50
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.6,87.0 to 96.2,192
Hib,≥3 Doses,States/Local Areas,Georgia,2018,Age,35 Months,89.3,82.5 to 94.3,282
Hib,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,89.1,84.3 to 93.0,555
Hep A,≥1 Dose,States/Local Areas,Georgia,2012,Age,35 Months,93.4,88.9 to 96.6,270
PCV,≥2 Doses,States/Local Areas,Georgia,2017,Age,5 Months,73.9,65.6 to 80.7,292
PCV,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,5 Months,72.2,66.0 to 77.7,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,94.3,91.9 to 96.7,629
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,83.2,76.6 to 89.8,629
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,75.7,66.5 to 85.0,344
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,93.5,90.4 to 96.5,629
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.8,59.1 to 76.5,212
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,81.3,72.7 to 89.9,171
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,63.4 to 85.1,147
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,93.0,84.6 to 100.0,37
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,94.2,91.5 to 97.0,629
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,86.9,81.8 to 92.0,344
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,85.8,72.1 to 99.6,37
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,91.3,85.5 to 97.0,171
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,81.8,67.1 to 96.5,57
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.2,80.3 to 90.2,537
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,71.1,53.8 to 88.4,57
Influenza,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,48.4,37.7 to 59.1,171
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,92.3,89.8 to 94.8,1067
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Overall,Overall,88.2,85.1 to 91.3,1067
Rotavirus,,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,87.4,81.5 to 93.3,367
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Overall,Overall,89.5,86.5 to 92.5,1067
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,92.2,89.6 to 94.7,1067
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,80.2,76.4 to 84.1,1067
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,85.1,79.8 to 90.4,419
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,85.9,80.1 to 91.6,281
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,94.6,91.0 to 98.2,367
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,72.6,63.5 to 81.7,419
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,93.3,90.1 to 96.6,419
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,88.3,83.0 to 93.5,281
Influenza,,States/Local Areas,Georgia,2016-2019,Overall,Overall,46.5,42.1 to 50.9,1067
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Overall,Overall,78.5,75.0 to 82.0,1067
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,90.9,86.8 to 95.1,281
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,81.6,75.2 to 88.0,367
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,77.8,72.2 to 83.4,1067
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Overall,Overall,89.8,86.9 to 92.8,1067
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,97.6,95.2 to 99.9,367
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,95.0,92.2 to 97.8,419
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,66.6,59.8 to 73.4,419
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,57.7,50.2 to 65.3,281
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,75.4,68.9 to 81.8,281
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,93.2,89.4 to 97.0,367
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,95.8,93.6 to 98.0,419
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Overall,Overall,75.7,71.6 to 79.7,1067
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,93.1,87.0 to 99.1,99
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,81.3,72.0 to 90.6,99
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.9,74.2 to 83.6,575
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Overall,Overall,66.5,62.2 to 70.8,1067
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,97.3,94.8 to 99.7,367
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,94.2,91.2 to 97.1,419
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,77.2,71.1 to 83.3,393
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,66.0,58.9 to 73.0,393
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,94.6,89.6 to 99.6,99
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.5,87.7 to 95.3,575
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,89.1 to 96.6,393
Influenza,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,33.1,20.3 to 45.9,99
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,90.5 to 96.4,575
Hep A,≥1 Dose,States/Local Areas,Georgia,2015,Age,24 Months,85.0,78.9 to 90.1,306
Hep A,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,24 Months,88.6,84.8 to 91.9,640
Hep A,≥1 Dose,States/Local Areas,Georgia,2016,Age,24 Months,92.4,87.5 to 95.9,334
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,24 Months,90.3,86.4 to 93.4,626
PCV,≥2 Doses,States/Local Areas,Georgia,2014,Age,5 Months,74.2,66.9 to 80.4,284
PCV,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,5 Months,74.2,67.9 to 79.7,590
PCV,≥2 Doses,States/Local Areas,Georgia,2015,Age,5 Months,74.3,66.9 to 80.5,306
PCV,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,5 Months,75.3,70.1 to 79.8,640
PCV,≥2 Doses,States/Local Areas,Georgia,2016,Age,5 Months,76.3,68.7 to 82.4,334
PCV,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,5 Months,75.1,69.6 to 79.8,626
DTaP,≥3 Doses,States/Local Areas,Georgia,2018,Age,35 Months,92.4,86.2 to 96.5,282
DTaP,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,93.4,89.2 to 96.4,555
DTaP,≥3 Doses,States/Local Areas,Georgia,2019,Age,35 Months,94.4,88.1 to 98.0,273
Hep A,≥1 Dose,States/Local Areas,Georgia,2018,Age,24 Months,83.5,75.8 to 89.8,282
Hep A,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,24 Months,87.8,82.9 to 91.8,555
Hep A,≥1 Dose,States/Local Areas,Georgia,2019,Age,24 Months,92.1,85.8 to 96.4,273
Hep A,≥1 Dose,States/Local Areas,Georgia,2011,Age,35 Months,97.1,88.9 to 99.7,219
Hib,≥2 Doses,States/Local Areas,Georgia,2020,Age,13 Months,92.4,87.0 to 95.6,338
Hib,Primary Series,States/Local Areas,Georgia,2021,Age,19 Months,91.5,85.1 to 95.3,255
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,82.2,76.3 to 88.1,393
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,91.2,86.9 to 95.4,393
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,88.2 to 95.4,393
Rotavirus,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,67.4,52.2 to 82.5,99
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.7,83.1 to 92.3,575
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,84.5,74.9 to 94.1,99
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.4,68.8 to 80.1,575
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,74.9,68.2 to 81.7,393
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.0,82.3 to 91.6,575
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,85.9 to 94.5,393
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,88.4,80.2 to 96.6,99
Rotavirus,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.2,69.6 to 80.8,575
Rotavirus,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,74.0,67.0 to 81.0,393
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,79.7,69.7 to 89.6,393
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,93.5,87.5 to 99.4,99
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,81.8,70.9 to 92.7,99
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.8,69.1 to 80.5,575
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.7,89.0 to 96.4,575
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,94.9,89.9 to 99.9,99
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,92.3,88.3 to 96.3,393
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.7,69.7 to 83.7,575
Influenza,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,46.1,40.2 to 52.1,575
Influenza,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,51.0,43.6 to 58.4,393
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,73.1,61.3 to 84.8,99
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.7,59.8 to 71.7,575
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,84.7,74.6 to 94.8,99
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.2,72.7 to 83.7,575
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,76.3,69.8 to 82.8,393
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.8,84.3 to 93.2,575
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,96.7,94.0 to 99.5,99
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,80.0,75.5 to 84.6,629
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,88.9 to 96.1,537
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,90.1 to 96.8,537
Rotavirus,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.8,75.6 to 85.9,537
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.1,78.6 to 91.7,212
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,75.4,70.2 to 80.7,629
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,61.5,54.7 to 68.3,344
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.6,70.4 to 84.8,212
Rotavirus,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.8,50.6 to 68.9,212
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.6,85.3 to 93.9,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,77.5,71.9 to 83.1,344
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,71.6,54.1 to 89.2,37
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,81.9,68.7 to 95.0,57
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,92.3,86.1 to 98.4,171
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.5,77.7 to 91.2,212
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.9,80.5 to 97.3,147
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,88.3,83.4 to 93.2,344
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,96.4,94.5 to 98.3,629
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,93.0,84.6 to 100.0,37
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,90.9,86.6 to 95.3,344
Rotavirus,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,83.4,78.6 to 88.2,629
Influenza,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,34.2,27.6 to 40.8,344
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.5,68.5 to 90.4,147
Influenza,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,56.1,32.8 to 79.5,37
Influenza,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,35.7,20.1 to 51.2,57
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,93.6,88.7 to 98.5,171
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,75.5,66.0 to 85.0,171
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.9,70.8 to 89.0,147
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,65.8,45.9 to 85.7,57
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,58.4,31.8 to 85.1,37
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.3,59.7 to 76.9,212
Rotavirus,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,73.8,56.6 to 91.0,37
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.9,67.0 to 78.7,537
Rotavirus,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,63.6,45.6 to 81.6,57
Rotavirus,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,67.5,60.6 to 74.4,344
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,69.7,59.9 to 79.6,171
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.0,55.4 to 78.6,147
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",56.5,47.8 to 65.3,212
Rotavirus,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,87.1,80.4 to 93.9,171
Rotavirus,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.6,58.4 to 82.8,147
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,85.3,77.6 to 92.9,171
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,77.4,61.0 to 93.8,37
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.9,90.9 to 96.8,537
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.5,63.3 to 79.6,212
Influenza,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",54.6,48.2 to 60.9,537
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,82.5,68.0 to 97.0,57
Influenza,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",34.1,25.5 to 42.7,212
Influenza,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",49.7,37.9 to 61.4,147
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.4,83.4 to 95.4,212
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,81.7,67.1 to 96.3,57
Influenza,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,62.3,56.4 to 68.1,629
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,90.9,84.3 to 97.5,171
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,79.3 to 97.2,147
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,89.7 to 96.4,537
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,87.6,74.9 to 100.0,37
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.0,85.3 to 96.6,212
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,65.5,46.8 to 84.3,37
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,61.1,43.7 to 78.6,57
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,93.7,90.6 to 96.8,344
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,92.0,83.3 to 100.0,37
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,83.4,68.9 to 97.9,57
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.5,80.1 to 92.8,212
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,90.1,83.5 to 96.6,171
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,89.9,79.3 to 100.0,57
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,71.4,53.9 to 88.8,37
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,63.0,45.8 to 80.3,57
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,85.1,70.7 to 99.5,37
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.4,76.1 to 86.7,537
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.9 to 98.0,629
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,90.6,86.3 to 94.9,344
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,85.6,70.9 to 100.0,37
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,80.6,65.8 to 95.3,57
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.9,75.4 to 86.4,537
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,93.8,88.9 to 98.6,171
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.4,88.9 to 99.9,147
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,82.8,78.0 to 87.6,629
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.0,82.8 to 95.1,212
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,73.0,66.4 to 79.5,344
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.7,87.2 to 96.3,212
Hib,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,3 Months,86.0,80.8 to 90.0,611
≥1 Dose Varicella,,States/Local Areas,Georgia,2020-2021,Age,35 Months,87.9,82.6 to 92.2,593
Rotavirus,,States/Local Areas,Georgia,2019-2020,Age,8 Months,72.4,66.5 to 77.6,611
Hep A,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,35 Months,85.9,80.5 to 90.4,593
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2021,Age,0-1 Days,72.7,64.0 to 79.9,255
Hib,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,92.6,88.6 to 95.2,593
PCV,≥3 Doses,States/Local Areas,Georgia,2021,Age,13 Months,84.8,76.3 to 90.6,255
Hib,Full Series,States/Local Areas,Georgia,2019-2020,Age,24 Months,73.2,67.3 to 78.8,611
Hib,Primary Series,States/Local Areas,Georgia,2019-2020,Age,7 Months,69.8,63.7 to 75.2,611
DTaP,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,13 Months,89.2,84.7 to 92.5,611
Polio,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,90.8,86.5 to 93.8,611
DTaP,≥4 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,71.4,65.4 to 76.8,611
Polio,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,3 Months,85.8,80.5 to 89.8,611
DTaP,≥1 Dose,States/Local Areas,Georgia,2019-2020,Age,3 Months,86.8,81.7 to 90.7,611
Hib,≥3 Doses,States/Local Areas,Georgia,2021,Age,7 Months,48.1,39.2 to 57.2,255
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,79.1,62.9 to 95.3,99
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.2,90.5 to 99.8,147
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.7,71.4 to 85.9,537
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.3,88.6 to 96.1,575
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,87.7 to 95.6,393
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a Non-MSA,93.1,87.3 to 98.9,99
Rotavirus,,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,63.2,55.5 to 71.0,281
Rotavirus,,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,77.3,71.1 to 83.5,419
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,86.2 to 94.9,393
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,93.1,88.7 to 97.5,367
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,79.4,73.3 to 85.4,419
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,80.8,75.1 to 86.5,367
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,80.6,75.5 to 85.7,419
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,74.2,63.8 to 84.6,281
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,97.3,95.0 to 99.7,367
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,90.3,86.0 to 94.7,419
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,88.1,82.7 to 93.5,281
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,92.8,90.3 to 95.3,1067
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,93.2,91.2 to 95.3,1067
Influenza,,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,42.6,35.7 to 49.6,419
Influenza,,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,36.7,29.3 to 44.2,281
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,97.3,94.9 to 99.7,367
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,89.7,85.4 to 94.1,419
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,85.7,79.8 to 91.6,281
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,89.4,84.2 to 94.7,367
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,76.8,70.6 to 83.0,419
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,84.4,78.4 to 90.4,281
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Overall,Overall,76.1,72.0 to 80.1,1067
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,87.8,82.5 to 93.1,281
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,89.4,84.0 to 94.9,367
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Poverty,133% to <400% FPL,72.8,66.2 to 79.3,419
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,70.5,63.2 to 77.8,281
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,97.4,95.3 to 99.6,367
Rotavirus,,States/Local Areas,Georgia,2016-2019,Overall,Overall,73.9,69.7 to 78.2,1067
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,73.8,66.8 to 80.8,281
Influenza,,States/Local Areas,Georgia,2016-2019,Poverty,>400% FPL,69.9,62.4 to 77.4,367
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.9,92.2 to 97.7,537
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,83.5,69.1 to 97.9,57
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Other,48.8,31.7 to 66.0,57
Combined 7 Series,,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Uninsured,61.7,42.5 to 80.9,37
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.6,90.8 to 96.4,537
PCV,≥4 Doses,States/Local Areas,Georgia,2021,Age,24 Months,75.6,66.9 to 83.5,255
Hep A,≥1 Dose,States/Local Areas,Georgia,2021,Age,24 Months,81.9,73.8 to 88.7,255
≥1 Dose Varicella,,States/Local Areas,Georgia,2021,Age,24 Months,83.5,75.7 to 89.9,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2021,Age,19 Months,91.7,85.5 to 95.4,255
Hib,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,63.1,56.9 to 68.9,593
PCV,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,5 Months,75.1,69.2 to 80.3,593
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2021,Age,0-2 Days,73.8,65.1 to 81.0,255
PCV,≥3 Doses,States/Local Areas,Georgia,2021,Age,24 Months,93.8,88.2 to 97.3,255
Hep A,≥2 Doses,States/Local Areas,Georgia,2021,Age,24 Months,40.4,32.0 to 50.2,255
PCV,≥3 Doses,States/Local Areas,Georgia,2021,Age,7 Months,65.9,56.6 to 74.2,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2021,Age,13 Months,84.4,76.0 to 90.2,255
Hep B,≥3 Doses,States/Local Areas,Georgia,2021,Age,24 Months,89.8,83.7 to 94.3,255
Hep B,≥3 Doses,States/Local Areas,Georgia,2021,Age,7 Months,55.2,46.1 to 64.0,255
Hep A,≥1 Dose,States/Local Areas,Georgia,2021,Age,19 Months,79.8,71.0 to 86.4,255
Polio,≥2 Doses,States/Local Areas,Georgia,2021,Age,13 Months,92.7,85.8 to 96.4,255
Hep A,≥2 Doses,States/Local Areas,Georgia,2021,Age,19 Months,28.1,20.7 to 37.0,255
DTaP,≥1 Dose,States/Local Areas,Georgia,2021,Age,3 Months,87.2,79.2 to 92.4,255
PCV,≥4 Doses,States/Local Areas,Georgia,2021,Age,35 Months,77.7,68.5 to 85.7,255
DTaP,≥4 Doses,States/Local Areas,Georgia,2021,Age,24 Months,70.4,61.8 to 78.6,255
Hep B,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,91.1,87.3 to 94.1,593
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,85.4,78.9 to 90.2,271
Rotavirus,,States/Local Areas,West Virginia,2019-2020,Age,8 Months,69.0,63.6 to 74.0,472
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020-2021,Age,35 Months,90.5,84.6 to 94.9,428
Hib,≥1 Dose,States/Local Areas,West Virginia,2020,Age,3 Months,80.9,74.0 to 86.3,271
Polio,≥1 Dose,States/Local Areas,West Virginia,2020,Age,3 Months,85.5,79.3 to 90.1,271
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,87.4,81.5 to 92.2,271
Hep B,≥1 Dose,States/Local Areas,West Virginia,2020,Age,3 Months,94.6,89.3 to 97.3,271
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,61.6,54.1 to 68.5,271
PCV,≥3 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,66.3,58.8 to 73.1,271
PCV,≥4 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,68.9,58.4 to 77.8,157
Combined 7 Series,,States/Local Areas,West Virginia,2021,Age,35 Months,74.6,59.5 to 87.5,157
Hib,Primary Series,States/Local Areas,West Virginia,2021,Age,7 Months,67.2,56.8 to 76.1,157
Hib,Primary Series,States/Local Areas,West Virginia,2021,Age,19 Months,89.1,79.8 to 94.4,157
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,83.6,78.1 to 88.0,428
DTaP,≥3 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,68.4,58.1 to 77.2,157
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,88.6,83.4 to 92.3,428
Hep B,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,91.7,87.0 to 94.8,428
Hib,Full Series,States/Local Areas,West Virginia,2021,Age,19 Months,64.8,54.4 to 74.0,157
DTaP,≥1 Dose,States/Local Areas,West Virginia,2016,Age,3 Months,87.5,81.9 to 91.5,296
DTaP,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,3 Months,86.2,82.2 to 89.4,555
DTaP,≥1 Dose,States/Local Areas,West Virginia,2015,Age,3 Months,88.1,82.8 to 92.0,281
DTaP,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,3 Months,87.8,84.1 to 90.7,577
DTaP,≥1 Dose,States/Local Areas,West Virginia,2014,Age,3 Months,85.0,78.9 to 89.6,268
DTaP,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,3 Months,86.6,82.7 to 89.7,549
DTaP,≥1 Dose,States/Local Areas,West Virginia,2013,Age,3 Months,87.3,82.6 to 90.9,243
DTaP,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,3 Months,86.2,83.3 to 88.6,511
DTaP,≥1 Dose,States/Local Areas,West Virginia,2011,Age,3 Months,86.6,82.5 to 89.9,231
DTaP,≥1 Dose,States/Local Areas,West Virginia,2012,Age,3 Months,82.7,78.9 to 85.9,254
Hib,≥2 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,86.4,76.5 to 92.5,157
Hib,≥3 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,57.4,47.2 to 67.1,157
PCV,≥4 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,76.9,70.9 to 82.4,428
≥1 Dose MMR,,States/Local Areas,West Virginia,2021,Age,35 Months,88.7,78.6 to 95.5,157
PCV,≥3 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,88.8,80.6 to 94.6,157
Hib,Full Series,States/Local Areas,West Virginia,2020-2021,Age,24 Months,73.7,67.7 to 79.4,428
Hib,≥2 Doses,States/Local Areas,West Virginia,2021,Age,5 Months,73.5,63.0 to 81.9,157
Hib,≥3 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,88.0,78.9 to 93.6,157
Hib,Primary Series,States/Local Areas,West Virginia,2020-2021,Age,24 Months,87.9,83.0 to 91.9,428
Polio,≥2 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,86.1,76.3 to 92.3,157
Hib,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,86.7,81.8 to 90.9,428
Polio,≥3 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,89.3,80.0 to 94.6,157
PCV,≥2 Doses,States/Local Areas,West Virginia,2021,Age,5 Months,73.0,62.4 to 81.4,157
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,93.8,89.9 to 96.6,296
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,94.3,91.0 to 96.7,555
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,94.2,90.2 to 96.9,281
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,94.0,91.3 to 96.1,577
PCV,≥2 Doses,States/Local Areas,West Virginia,2011,Age,5 Months,71.1,66.0 to 75.7,231
PCV,≥2 Doses,States/Local Areas,West Virginia,2012,Age,5 Months,75.3,70.6 to 79.4,254
Hep A,≥1 Dose,States/Local Areas,West Virginia,2017,Age,19 Months,84.6,78.4 to 89.2,259
Hep A,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,19 Months,84.7,80.5 to 88.2,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,92.0,87.7 to 95.2,252
Hib,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,91.2,87.9 to 94.0,453
Hib,≥3 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,91.0,85.8 to 94.8,259
Hib,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,91.5,88.3 to 94.2,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,90.4,84.9 to 94.6,201
Hep A,≥2 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,20.1,14.3 to 27.4,254
Hep A,≥2 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,26.3,21.3 to 32.1,243
Hep A,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,23.2,19.1 to 27.9,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,95.4,91.1 to 98.0,231
DTaP,≥3 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,94.6,89.5 to 97.7,254
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,96.9,91.2 to 99.3,243
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,96.1,93.3 to 98.0,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,95.7,92.7 to 97.8,268
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,94.9,92.5 to 96.7,549
Hep A,≥2 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,24.5,16.8 to 34.3,231
DTaP,≥2 Doses,States/Local Areas,West Virginia,2019,Age,5 Months,78.6,70.7 to 84.8,201
Hib,≥3 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,95.1,90.0 to 98.1,231
Hep A,≥1 Dose,States/Local Areas,West Virginia,2013,Age,24 Months,81.8,74.8 to 87.8,243
Hep A,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,24 Months,84.9,80.8 to 88.6,511
Hep A,≥1 Dose,States/Local Areas,West Virginia,2011,Age,24 Months,86.1,79.4 to 91.4,231
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,20.0,15.1 to 26.1,268
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,21.4,17.8 to 25.6,549
DTaP,≥4 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,63.7,57.2 to 69.7,254
DTaP,≥4 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,59.3,50.1 to 67.8,231
Hep A,≥1 Dose,States/Local Areas,West Virginia,2012,Age,24 Months,83.4,76.5 to 89.2,254
Hep A,≥1 Dose,States/Local Areas,West Virginia,2019,Age,19 Months,82.0,74.2 to 87.8,201
Hep A,≥1 Dose,States/Local Areas,West Virginia,2018,Age,19 Months,84.9,78.8 to 89.6,252
Hep A,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,19 Months,84.2,78.5 to 88.6,362
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016,Age,19 Months,82.3,76.3 to 87.1,296
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,19 Months,83.4,79.3 to 86.9,555
Hib,≥3 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,95.9,90.5 to 98.7,281
Hib,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,93.5,90.2 to 96.0,577
Hib,≥3 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,96.1,90.8 to 98.8,254
Hep A,≥1 Dose,States/Local Areas,West Virginia,2015,Age,24 Months,85.7,80.2 to 90.4,281
Hep A,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,24 Months,85.7,81.9 to 89.1,577
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,95.8,92.4 to 98.0,252
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,95.1,92.2 to 97.1,453
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,94.4,89.4 to 97.5,201
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,91.5,84.1 to 98.8,67
PCV,≥2 Doses,States/Local Areas,West Virginia,2013,Age,5 Months,73.2,68.1 to 77.7,243
PCV,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,5 Months,71.1,66.3 to 75.4,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,95.1,88.3 to 98.6,259
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,95.4,92.1 to 97.6,511
PCV,≥2 Doses,States/Local Areas,West Virginia,2015,Age,5 Months,75.3,68.9 to 80.8,281
PCV,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,5 Months,73.9,69.3 to 78.1,577
Hep A,≥1 Dose,States/Local Areas,West Virginia,2018,Age,24 Months,88.2,82.8 to 92.6,252
Hep A,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,24 Months,88.9,84.9 to 92.3,453
Hep A,≥1 Dose,States/Local Areas,West Virginia,2011,Age,35 Months,95.5,90.4 to 98.4,231
Hep A,≥1 Dose,States/Local Areas,West Virginia,2019,Age,24 Months,89.8,83.7 to 94.3,201
Hep A,≥2 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,33.4,26.2 to 41.5,201
PCV,≥2 Doses,States/Local Areas,West Virginia,2016,Age,5 Months,72.5,65.8 to 78.2,296
PCV,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,5 Months,73.2,68.3 to 77.5,555
Hep A,≥1 Dose,States/Local Areas,West Virginia,2017,Age,24 Months,91.2,86.6 to 94.7,259
Hep A,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,24 Months,89.8,86.3 to 92.7,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,94.3,89.9 to 97.2,268
Hib,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,94.9,91.4 to 97.2,549
Hib,≥3 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,95.7,89.7 to 98.7,243
Hib,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,94.9,91.5 to 97.3,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,27.6,21.9 to 34.0,296
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,30.4,26.0 to 35.2,555
Hep A,≥2 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,22.9,18.0 to 28.7,281
Hep A,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,25.1,21.3 to 29.5,577
PCV,≥2 Doses,States/Local Areas,West Virginia,2014,Age,5 Months,68.9,61.5 to 75.4,268
PCV,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,5 Months,72.1,64.2 to 78.8,549
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016,Age,24 Months,85.7,80.3 to 90.3,296
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,24 Months,88.5,85.0 to 91.5,555
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014,Age,24 Months,87.9,83.0 to 91.9,268
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,24 Months,86.9,83.2 to 90.0,549
Hep A,≥2 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,33.3,26.7 to 40.6,259
Hep A,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,31.7,27.1 to 36.7,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,95.3,92.7 to 97.8,432
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,93.6,91.2 to 95.9,500
DTaP,≥4 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,71.4,68.0 to 74.6,281
DTaP,≥4 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,70.5,65.8 to 74.8,577
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,55.8,48.5 to 62.9,268
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,63.6,58.6 to 68.3,549
DTaP,≥4 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,64.5,57.7 to 70.7,243
DTaP,≥4 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,60.2,56.3 to 64.0,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,91.0,85.8 to 94.8,259
Hib,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,92.9,89.6 to 95.5,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,92.4,88.0 to 95.7,296
Hib,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,91.8,88.5 to 94.4,555
Hep A,≥2 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,30.0,23.9 to 37.0,252
Hep A,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,33.6,27.5 to 40.3,362
Hep A,≥2 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,47.2,38.6 to 56.7,231
DTaP,≥1 Dose,States/Local Areas,West Virginia,2019,Age,3 Months,87.7,80.3 to 92.5,201
DTaP,≥1 Dose,States/Local Areas,West Virginia,2018,Age,3 Months,91.0,85.7 to 94.5,252
DTaP,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,3 Months,89.3,85.0 to 92.5,453
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,92.1,86.8 to 95.9,243
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,93.9,91.0 to 96.2,511
Hep A,≥1 Dose,States/Local Areas,West Virginia,2011,Age,19 Months,75.9,69.9 to 81.1,231
DTaP,≥1 Dose,States/Local Areas,West Virginia,2017,Age,3 Months,84.9,78.6 to 89.6,259
DTaP,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,3 Months,87.9,84.0 to 91.0,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,95.7,92.7 to 97.8,268
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,94.9,92.5 to 96.7,549
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,94.2,90.2 to 96.9,281
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,93.7,91.0 to 95.8,577
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014,Age,19 Months,80.2,73.8 to 85.3,268
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,19 Months,81.3,77.1 to 85.0,549
Hep A,≥1 Dose,States/Local Areas,West Virginia,2015,Age,19 Months,82.5,79.7 to 85.0,281
Hep A,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,19 Months,82.4,78.3 to 86.0,577
Hep A,≥1 Dose,States/Local Areas,West Virginia,2013,Age,19 Months,78.6,75.2 to 81.6,243
Hep A,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,19 Months,79.4,75.0 to 83.1,511
DTaP,≥2 Doses,States/Local Areas,West Virginia,2018,Age,5 Months,82.3,75.9 to 87.3,252
DTaP,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,5 Months,80.5,75.6 to 84.6,453
Hib,≥3 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,91.9,87.5 to 95.2,296
Hib,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,91.5,88.2 to 94.1,555
Hib,≥3 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,91.0,86.2 to 94.7,281
Hib,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,91.5,88.3 to 94.1,577
Hib,≥3 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,91.7,87.1 to 95.1,268
Hib,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,91.3,88.1 to 94.0,549
Hep A,≥1 Dose,States/Local Areas,West Virginia,2012,Age,19 Months,77.8,75.5 to 79.9,254
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,94.4,89.4 to 97.5,201
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,93.0,91.2 to 94.8,1023
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,92.1,89.3 to 94.8,410
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,93.0,90.1 to 96.0,418
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,95.6,92.4 to 98.8,195
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,95.0,91.7 to 97.3,252
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,94.7,91.8 to 96.8,453
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,93.2,88.3 to 96.6,259
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,94.1,91.3 to 96.3,511
DTaP,≥2 Doses,States/Local Areas,West Virginia,2016,Age,5 Months,73.4,66.7 to 79.2,296
DTaP,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,5 Months,74.6,69.7 to 78.9,555
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,91.6,88.7 to 94.6,386
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.8,92.0 to 97.7,335
DTaP,≥2 Doses,States/Local Areas,West Virginia,2017,Age,5 Months,75.7,68.5 to 81.8,259
DTaP,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,5 Months,79.0,74.3 to 83.1,511
Hib,≥1 Dose,States/Local Areas,West Virginia,2021,Age,3 Months,81.6,71.7 to 88.6,157
≥1 Dose Varicella,,States/Local Areas,West Virginia,2021,Age,19 Months,77.9,68.0 to 85.4,157
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,93.3,89.4 to 96.1,296
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,93.2,90.2 to 95.6,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,87.7,78.4 to 93.3,157
DTaP,≥4 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,84.9,77.9 to 90.7,428
Hib,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,89.8,85.0 to 93.2,428
Hep B,≥2 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,92.9,84.2 to 96.9,157
PCV,≥3 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,78.9,68.2 to 86.7,157
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2021,Age,0-1 Days,76.7,66.8 to 84.3,157
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2021,Age,0-2 Days,78.5,68.8 to 85.9,157
PCV,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,89.0,84.1 to 93.0,428
PCV,≥4 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,73.2,63.2 to 82.3,157
Hep B,≥2 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,86.1,79.3 to 90.9,271
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,88.3,82.4 to 92.9,271
DTaP,≥4 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,75.2,68.0 to 81.8,271
Polio,≥3 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,86.9,80.7 to 91.9,271
Hib,≥3 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,84.9,78.5 to 90.2,271
≥1 Dose MMR,,States/Local Areas,West Virginia,2020,Age,24 Months,89.4,83.9 to 93.7,271
Hib,≥3 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,85.7,79.3 to 90.9,271
≥1 Dose MMR,,States/Local Areas,West Virginia,2020,Age,35 Months,92.1,85.7 to 96.3,271
Hib,Primary Series,States/Local Areas,West Virginia,2020,Age,24 Months,86.8,80.7 to 91.7,271
Hib,Primary Series,States/Local Areas,West Virginia,2020,Age,35 Months,87.6,81.4 to 92.4,271
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,90.3,83.5 to 95.1,271
Hib,Full Series,States/Local Areas,West Virginia,2020,Age,35 Months,78.5,71.1 to 85.1,271
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020,Age,35 Months,90.6,84.3 to 95.1,271
Hib,Primary Series,States/Local Areas,West Virginia,2020,Age,19 Months,86.6,80.0 to 91.3,271
PCV,≥3 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,89.0,83.0 to 93.5,271
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,87.0,80.5 to 91.5,271
Hib,Full Series,States/Local Areas,West Virginia,2020,Age,19 Months,65.4,57.8 to 72.2,271
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020,Age,19 Months,80.6,73.4 to 86.2,271
PCV,≥3 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,87.4,81.2 to 91.8,271
Polio,≥3 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,90.3,83.7 to 95.1,271
DTaP,≥4 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,84.8,77.5 to 90.8,271
PCV,≥4 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,72.0,64.5 to 78.4,271
Hib,≥3 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,68.0,60.6 to 74.7,271
PCV,≥4 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,80.7,73.9 to 86.7,271
Hib,Primary Series,States/Local Areas,West Virginia,2020,Age,13 Months,80.8,73.7 to 86.4,271
Hep B,≥2 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,90.5,84.5 to 94.4,271
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,80.7,73.6 to 86.3,271
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,68.5,61.1 to 75.2,271
PCV,≥3 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,84.6,78.2 to 89.4,271
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020,Age,13 Months,43.2,36.2 to 50.4,271
PCV,≥2 Doses,States/Local Areas,West Virginia,2020,Age,5 Months,74.9,67.7 to 81.0,271
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,87.6,81.2 to 92.0,271
DTaP,≥4 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,64.8,57.4 to 71.6,271
Polio,≥3 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,86.3,79.6 to 91.0,271
≥1 Dose MMR,,States/Local Areas,West Virginia,2020,Age,19 Months,85.9,79.5 to 90.6,271
Hib,≥3 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,84.5,77.7 to 89.5,271
Rotavirus,,States/Local Areas,West Virginia,2020,Age,8 Months,74.2,67.0 to 80.3,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2020,Age,0-3 Days,81.1,74.4 to 86.4,271
Influenza,,States/Local Areas,West Virginia,2020,Age,24 Months,47.0,39.8 to 54.7,271
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,89.6,83.1 to 94.3,271
PCV,≥3 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,87.8,82.0 to 92.4,271
Hep A,≥1 Dose,States/Local Areas,West Virginia,2020,Age,24 Months,87.1,81.2 to 91.8,271
PCV,≥4 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,80.4,73.6 to 86.4,271
Combined 7 Series,,States/Local Areas,West Virginia,2020,Age,24 Months,63.0,55.6 to 70.4,271
Hep A,≥2 Doses,States/Local Areas,West Virginia,2020,Age,24 Months,46.9,39.7 to 54.7,271
PCV,≥1 Dose,States/Local Areas,West Virginia,2020,Age,3 Months,85.1,79.0 to 89.7,271
DTaP,≥2 Doses,States/Local Areas,West Virginia,2020,Age,5 Months,75.2,67.9 to 81.3,271
Polio,≥2 Doses,States/Local Areas,West Virginia,2020,Age,5 Months,75.2,67.9 to 81.3,271
Hib,≥2 Doses,States/Local Areas,West Virginia,2020,Age,5 Months,71.8,64.3 to 78.3,271
Hep B,≥2 Doses,States/Local Areas,West Virginia,2020,Age,5 Months,83.9,77.1 to 88.9,271
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,88.0,83.5 to 92.4,284
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.6,89.1 to 96.2,307
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,89.5,85.4 to 93.5,284
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,73.6,68.3 to 79.0,387
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,88.4,82.6 to 94.2,188
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,71.6,66.0 to 77.1,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,83.4,77.7 to 89.2,188
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,83.3,76.8 to 89.8,387
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,92.7,88.4 to 96.9,188
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,92.9,90.0 to 95.7,345
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,93.5,90.6 to 96.4,387
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,93.7,91.9 to 95.5,920
Influenza,,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,62.7,54.3 to 71.1,188
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,91.9,89.9 to 93.9,920
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,93.4,89.2 to 97.5,188
Influenza,,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,43.5,37.4 to 49.6,345
Influenza,,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,54.1,48.3 to 60.0,387
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,88.7,84.8 to 92.6,387
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,89.0,85.5 to 92.5,345
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,88.6,84.8 to 92.4,345
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,91.6,86.9 to 96.2,188
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,88.1,84.2 to 91.9,387
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,90.3,85.7 to 94.9,188
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,92.6,89.8 to 95.5,345
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,92.5,89.4 to 95.6,387
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,76.7,71.6 to 81.9,387
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,70.7,65.2 to 76.2,345
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,81.6,76.9 to 86.2,387
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,79.9,76.9 to 83.0,920
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,75.2,70.2 to 80.2,345
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,93.2,90.7 to 95.7,444
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,60.4,55.2 to 65.7,444
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,79.2 to 95.6,65
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,75.6,69.8 to 81.4,284
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,72.5,66.8 to 78.3,329
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.2,75.9 to 86.6,307
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,89.5,85.3 to 93.7,284
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,69.8,63.9 to 75.6,329
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,86.8 to 94.6,307
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,90.6,86.5 to 94.6,284
Influenza,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,51.5,44.6 to 58.3,284
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,74.6,68.5 to 80.8,284
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,71.0,64.9 to 77.1,307
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,58.4,52.2 to 64.6,329
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,76.5,71.2 to 81.8,329
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.6,80.9 to 90.3,307
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,77.5,71.8 to 83.3,284
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,91.8,88.6 to 95.0,329
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,91.1,87.6 to 94.7,329
PCV,≥4 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,75.7,65.2 to 85.0,157
Hep A,≥1 Dose,States/Local Areas,West Virginia,2021,Age,19 Months,80.7,71.2 to 87.6,157
Polio,≥2 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,92.4,83.9 to 96.6,157
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,90.1,84.5 to 94.4,428
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,90.5 to 94.6,794
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,74.7,67.5 to 81.9,284
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,79.0,71.6 to 86.4,329
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,52.0,38.0 to 66.0,63
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.6,55.4 to 81.9,65
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,93.5,86.1 to 100.0,34
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.6,88.2 to 93.0,794
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,80.8 to 96.6,65
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.7,70.0 to 77.5,794
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,74.9,69.9 to 80.0,399
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,67.7 to 89.0,65
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,81.5,77.1 to 86.0,399
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,79.9,75.9 to 84.0,444
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.3,87.8 to 92.8,794
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,77.3,65.3 to 89.2,63
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.1,78.0 to 94.2,65
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,84.0,71.7 to 96.2,34
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,94.0,91.1 to 96.9,399
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.5,65.4 to 87.6,65
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,89.1,80.9 to 97.3,63
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.4 to 98.3,399
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,80.0,75.3 to 84.7,399
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.8,74.6 to 93.0,65
Influenza,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,64.3,58.8 to 69.8,399
Influenza,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,42.6,37.3 to 48.0,444
Influenza,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,49.9,35.8 to 63.9,63
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.0,72.5 to 79.6,794
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,80.5,57.5 to 100.0,63
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,90.4,81.5 to 99.2,34
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,70.0,65.0 to 75.0,444
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,75.7,63.7 to 87.7,63
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",64.9,61.0 to 68.9,794
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,60.5,42.0 to 79.1,34
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,69.0,51.4 to 86.5,34
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.5,77.2 to 83.8,794
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,66.5,48.4 to 84.6,34
Influenza,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",52.1,48.0 to 56.2,794
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.6,91.6 to 95.6,794
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,90.7,87.7 to 93.6,444
Polio,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,91.3,87.2 to 94.6,472
DTaP,≥4 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,84.4,79.1 to 89.0,472
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,91.9,88.1 to 94.9,472
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,90.0,86.0 to 92.9,472
Combined 7 Series,,States/Local Areas,West Virginia,2019-2020,Age,24 Months,60.0,54.4 to 65.7,472
PCV,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,83.5,78.7 to 87.4,472
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019-2020,Age,13 Months,43.4,38.1 to 48.8,472
Hib,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,84.6,80.0 to 88.3,472
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,83.2,78.3 to 87.2,472
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,67.7,62.1 to 72.8,472
Polio,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,86.0,81.6 to 89.5,472
PCV,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,5 Months,74.2,68.8 to 78.9,472
Hep B,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,5 Months,85.7,81.0 to 89.4,472
Hep B,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,92.7,89.1 to 95.2,472
Hib,Primary Series,States/Local Areas,West Virginia,2019-2020,Age,13 Months,79.1,73.9 to 83.5,472
Hib,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,89.5,85.3 to 92.6,472
Hib,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,68.2,62.7 to 73.3,472
≥1 Dose MMR,,States/Local Areas,West Virginia,2019-2020,Age,13 Months,56.1,50.4 to 61.5,472
Polio,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,90.9,87.0 to 93.8,472
Polio,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,5 Months,75.8,70.5 to 80.4,472
Hib,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,5 Months,72.1,66.7 to 76.9,472
DTaP,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,5 Months,76.9,71.7 to 81.4,472
PCV,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,3 Months,84.8,80.0 to 88.5,472
Hep B,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,3 Months,94.6,90.7 to 96.9,472
≥1 Dose MMR,,States/Local Areas,West Virginia,2019-2020,Age,24 Months,88.6,84.5 to 92.0,472
DTaP,≥4 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,75.9,70.6 to 80.8,472
Polio,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,89.7,85.6 to 93.0,472
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,91.4,87.7 to 94.3,472
PCV,≥4 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,81.4,76.4 to 85.9,472
PCV,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,89.6,85.6 to 92.9,472
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019-2020,Age,35 Months,91.0,86.5 to 94.4,472
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,93.1,88.8 to 96.2,472
Hib,Full Series,States/Local Areas,West Virginia,2019-2020,Age,35 Months,77.2,71.6 to 82.5,472
Hib,Primary Series,States/Local Areas,West Virginia,2019-2020,Age,35 Months,89.4,85.4 to 92.7,472
Hib,Full Series,States/Local Areas,West Virginia,2019-2020,Age,19 Months,64.5,58.9 to 69.8,472
≥1 Dose MMR,,States/Local Areas,West Virginia,2019-2020,Age,35 Months,91.4,86.9 to 94.8,472
Hib,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,88.0,83.9 to 91.5,472
Hib,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,86.8,82.4 to 90.3,472
Hib,Primary Series,States/Local Areas,West Virginia,2019-2020,Age,19 Months,88.3,84.0 to 91.6,472
≥1 Dose MMR,,States/Local Areas,West Virginia,2019-2020,Age,19 Months,84.5,79.8 to 88.2,472
Hep A,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,29.8,25.1 to 35.0,472
PCV,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,88.8,84.9 to 92.1,472
PCV,≥4 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,79.9,75.0 to 84.4,472
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,89.9,86.2 to 93.0,472
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019-2020,Age,24 Months,88.9,84.8 to 92.3,472
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2019-2020,Age,0-3 Days,80.0,74.9 to 84.3,472
Hib,Full Series,States/Local Areas,West Virginia,2019-2020,Age,24 Months,70.8,65.4 to 76.1,472
PCV,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,63.0,57.4 to 68.3,472
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2019-2020,Age,0-2 Days,78.9,73.8 to 83.3,472
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2019-2020,Age,0-1 Days,75.7,70.5 to 80.3,472
PCV,≥4 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,72.7,67.4 to 77.5,472
Hep A,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,19 Months,81.8,76.8 to 85.9,472
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,88.9,84.8 to 91.9,472
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019-2020,Age,19 Months,82.1,77.3 to 86.2,472
Combined 7 Series,,States/Local Areas,West Virginia,2019-2020,Age,35 Months,66.1,60.0 to 72.2,472
Hib,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,51.0,45.5 to 56.5,472
Hib,Primary Series,States/Local Areas,West Virginia,2019-2020,Age,24 Months,89.1,85.0 to 92.4,472
Influenza,,States/Local Areas,West Virginia,2019-2020,Age,24 Months,49.6,44.2 to 55.2,472
Hib,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,87.7,83.5 to 91.2,472
Hep A,≥1 Dose,States/Local Areas,West Virginia,2021,Age,24 Months,87.0,78.4 to 93.3,157
PCV,≥3 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,88.8,80.6 to 94.6,157
≥1 Dose Varicella,,States/Local Areas,West Virginia,2021,Age,24 Months,85.2,76.0 to 92.2,157
Hib,Full Series,States/Local Areas,West Virginia,2021,Age,24 Months,75.2,65.1 to 84.2,157
Hib,Primary Series,States/Local Areas,West Virginia,2021,Age,24 Months,89.1,80.9 to 94.8,157
Hib,≥3 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,88.6,80.3 to 94.5,157
≥1 Dose MMR,,States/Local Areas,West Virginia,2021,Age,24 Months,86.0,76.7 to 92.9,157
Polio,≥1 Dose,States/Local Areas,West Virginia,2021,Age,3 Months,82.5,72.6 to 89.4,157
Polio,≥3 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,89.7,81.5 to 95.4,157
Hep A,≥2 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,76.4,63.1 to 87.7,157
Hep A,≥1 Dose,States/Local Areas,West Virginia,2021,Age,35 Months,88.2,79.3 to 94.5,157
DTaP,≥4 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,59.3,48.8 to 69.0,157
Hep B,≥3 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,87.7,79.4 to 93.8,157
DTaP,≥3 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,82.2,71.8 to 89.4,157
PCV,≥3 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,87.5,78.2 to 93.1,157
PCV,≥3 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,65.3,55.0 to 74.4,157
PCV,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,5 Months,74.0,67.8 to 79.3,428
Hib,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,70.0,63.8 to 75.5,428
Hep B,≥3 Doses,States/Local Areas,West Virginia,2021,Age,7 Months,63.7,53.2 to 73.0,157
Hep A,≥2 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,47.2,37.5 to 58.0,157
DTaP,≥4 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,73.2,63.2 to 82.3,157
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,86.6,82.6 to 90.6,399
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,77.0 to 93.6,65
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,73.4,67.2 to 79.6,444
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,88.9,84.3 to 93.6,399
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.2,70.8 to 91.6,65
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,74.6,57.7 to 91.4,34
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,89.1,80.9 to 97.3,63
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,87.4,83.9 to 90.9,444
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,83.1,72.3 to 93.9,63
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.2 to 96.0,399
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,75.6,71.1 to 80.1,444
Influenza,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,38.5,18.8 to 58.2,34
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,71.6,59.3 to 84.0,63
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,81.0,74.4 to 87.7,188
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,93.2,91.4 to 95.1,920
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,78.2,75.0 to 81.3,920
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,91.4,89.4 to 93.5,920
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,72.8,67.5 to 78.1,345
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,87.5,83.4 to 91.7,387
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,94.4,90.9 to 97.9,188
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,93.0,89.0 to 97.1,188
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,83.3,73.5 to 93.0,188
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,86.1,82.0 to 90.2,345
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,91.1,88.0 to 94.3,345
Influenza,,States/Local Areas,West Virginia,2016-2019,Overall,Overall,50.9,47.1 to 54.7,920
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,91.1,87.5 to 94.6,387
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,79.9,75.3 to 84.5,345
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Overall,Overall,64.8,61.2 to 68.5,920
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,72.3,65.5 to 79.1,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Overall,Overall,80.3,77.4 to 83.2,920
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,89.6,86.1 to 93.1,345
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Overall,Overall,88.1,85.6 to 90.6,920
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Overall,Overall,89.2,86.8 to 91.5,920
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,96.1,93.2 to 99.1,188
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Overall,Overall,89.7,87.4 to 92.0,920
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Overall,Overall,78.3,74.1 to 82.5,920
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Overall,Overall,74.0,70.5 to 77.4,920
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,67.0,61.4 to 72.7,387
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,78.9,71.9 to 86.0,188
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,95.3,92.2 to 98.4,188
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,79.3,74.6 to 84.1,387
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Poverty,<133% FPL,57.6,51.7 to 63.5,345
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,93.1,90.1 to 96.1,387
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Overall,Overall,76.4,73.1 to 79.7,920
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,80.7,75.9 to 85.6,329
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,>400% FPL,96.1,93.1 to 99.0,188
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.2,77.5 to 87.0,307
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,89.5,85.8 to 93.2,329
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,77.5,71.8 to 83.1,284
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.3,87.4 to 95.1,307
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,93.0,90.0 to 96.0,329
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,92.2 to 97.7,307
Combined 7 Series,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,65.6,59.2 to 71.9,284
Influenza,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,43.7,37.6 to 49.9,329
Influenza,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,58.0,51.3 to 64.7,307
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,91.3,87.4 to 95.2,284
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,93.8,90.9 to 96.7,329
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,86.3 to 94.7,284
Influenza,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",45.5,31.7 to 59.3,65
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,88.8,78.3 to 99.3,34
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,89.1 to 93.7,794
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,86.3,77.3 to 95.4,63
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.3,86.7 to 92.0,794
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,84.4,74.3 to 94.5,63
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,91.1,88.3 to 93.9,444
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,94.7,91.9 to 97.5,399
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,74.4,69.7 to 79.0,444
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,70.1,56.2 to 84.0,63
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,72.8,68.0 to 77.5,444
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,61.7,47.5 to 75.8,63
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,81.9,70.9 to 92.8,63
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,95.4,92.9 to 97.9,399
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,80.8 to 96.6,65
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,92.5,89.9 to 95.1,444
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,88.8,85.6 to 92.1,444
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Other,77.4,65.7 to 89.2,63
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.2,74.8 to 81.7,794
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,92.3 to 96.0,794
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,92.0,83.3 to 100.0,34
DTaP,≥3 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,89.6,80.3 to 94.8,157
DTaP,≥1 Dose,States/Local Areas,West Virginia,2021,Age,3 Months,82.1,72.1 to 89.0,157
Hep A,≥2 Doses,States/Local Areas,West Virginia,2021,Age,19 Months,23.9,16.5 to 33.3,157
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,74.9,68.9 to 81.0,284
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.9,80.4 to 89.5,307
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.8,88.2 to 95.3,307
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.2,92.4 to 97.9,307
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,91.9,88.2 to 95.5,284
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,74.3,68.6 to 80.0,329
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,86.6,82.3 to 91.0,329
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a Non-MSA,83.9,79.2 to 88.6,329
Rotavirus,,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.0,72.3 to 83.8,307
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.2,73.1 to 87.3,307
Hib,Primary Series,States/Local Areas,West Virginia,2019-2020,Age,7 Months,63.3,57.6 to 68.6,472
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,13 Months,85.1,80.5 to 88.8,472
Polio,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,87.8,83.4 to 91.1,472
DTaP,≥4 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,63.5,57.9 to 68.8,472
Polio,≥2 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,88.2,81.9 to 92.5,271
Hep A,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,35 Months,78.8,73.1 to 84.0,472
Hep A,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,35 Months,93.0,88.8 to 96.1,472
Hep A,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,24 Months,88.4,84.3 to 91.9,472
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2020,Age,0-1 Days,74.3,67.1 to 80.4,271
Combined 7 Series,,States/Local Areas,West Virginia,2020,Age,35 Months,65.9,58.3 to 73.4,271
Hep A,≥2 Doses,States/Local Areas,West Virginia,2020,Age,35 Months,77.1,69.4 to 84.1,271
Hep A,≥1 Dose,States/Local Areas,West Virginia,2020,Age,19 Months,81.7,74.7 to 87.0,271
Hep A,≥2 Doses,States/Local Areas,West Virginia,2020,Age,19 Months,26.4,20.6 to 33.0,271
DTaP,≥1 Dose,States/Local Areas,West Virginia,2020,Age,3 Months,84.9,78.5 to 89.6,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2020,Age,0-2 Days,79.3,72.4 to 84.9,271
Hib,≥2 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,83.0,75.9 to 88.3,271
Polio,≥2 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,85.6,78.9 to 90.4,271
Hib,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,3 Months,82.6,77.7 to 86.6,472
DTaP,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,3 Months,86.2,81.6 to 89.8,472
Polio,≥1 Dose,States/Local Areas,West Virginia,2019-2020,Age,3 Months,86.5,82.0 to 90.1,472
Hib,≥3 Doses,States/Local Areas,West Virginia,2020,Age,7 Months,53.2,45.9 to 60.4,271
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.0,91.3 to 96.8,307
Hib,Primary Series,States/Local Areas,West Virginia,2020,Age,7 Months,66.6,59.0 to 73.4,271
Hep A,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,24 Months,50.4,44.9 to 56.2,472
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,93.7,89.4 to 96.7,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,42.8,34.9 to 51.2,224
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.7,77.4 to 88.0,307
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,92.5,89.2 to 95.8,303
Hib,Primary Series,States/Local Areas,Wisconsin,2011,Age,7 Months,75.5,70.6 to 79.8,225
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,82.0,77.2 to 86.9,404
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.6,81.0 to 88.2,661
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,82.1,73.9 to 90.3,125
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,68.6 to 88.2,92
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,82.2,77.3 to 87.2,384
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,71.9,64.9 to 78.9,236
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,81.9,78.6 to 85.1,923
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,79.9,72.6 to 87.2,212
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,63.5,43.7 to 83.3,34
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,94.8,88.6 to 97.7,238
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,92.0,87.9 to 94.8,479
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,92.2,87.3 to 95.4,275
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,93.5,89.8 to 95.9,513
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,91.4,88.4 to 93.7,262
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,90.5,87.1 to 93.1,537
Polio,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,88.6,81.8 to 93.1,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,92.2,87.2 to 95.8,235
Polio,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,89.3,84.9 to 92.9,459
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,80.5,72.9 to 86.4,241
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,88.0,80.6 to 92.9,238
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,84.3,79.2 to 88.3,479
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,89.5,84.1 to 93.3,275
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,88.8,84.4 to 92.1,513
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,89.2,82.6 to 93.6,241
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,86.2,81.4 to 89.9,465
Polio,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,95.0,91.8 to 97.2,262
Polio,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,94.0,91.4 to 96.0,537
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,86.4,79.1 to 92.1,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,90.6,86.7 to 93.8,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,93.8,89.5 to 96.4,262
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,93.0,90.1 to 95.2,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,87.5,79.5 to 92.7,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,90.7,86.4 to 93.7,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,93.1,88.2 to 96.1,235
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,90.3,87.0 to 92.9,459
Polio,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,93.7,88.9 to 96.9,225
Polio,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,90.6,85.2 to 94.6,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,87.8,80.3 to 92.6,235
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,85.4,82.4 to 87.9,459
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,82.9,74.6 to 88.9,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,87.2,82.5 to 90.7,486
Polio,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,89.1,82.4 to 93.4,241
Polio,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,70.6,64.9 to 75.6,465
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,83.5,76.2 to 89.0,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,44.3,38.6 to 50.1,465
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,93.0,88.6 to 96.2,275
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,91.9,88.2 to 94.9,513
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,91.3,86.2 to 95.0,235
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,87.8,83.2 to 91.6,459
Hib,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,88.3,81.8 to 93.3,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,91.4,85.2 to 95.6,225
Hib,Full Series,States/Local Areas,Wisconsin,2015,Age,24 Months,79.4,73.2 to 85.0,262
Hib,Full Series,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,82.0,77.8 to 85.9,537
Hib,Full Series,States/Local Areas,Wisconsin,2016,Age,24 Months,84.5,78.6 to 89.5,275
Hib,Full Series,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,83.0,78.4 to 87.2,513
Polio,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,96.7,91.3 to 99.2,225
Hib,Full Series,States/Local Areas,Wisconsin,2017,Age,24 Months,81.4,74.2 to 87.6,238
Hib,Full Series,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,81.4,76.4 to 85.8,479
Polio,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,90.8,84.5 to 95.2,238
Polio,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,90.7,86.7 to 94.0,479
Polio,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,88.9,82.6 to 93.6,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,90.6,84.9 to 94.9,241
Polio,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,89.8,85.7 to 93.1,465
Hib,Full Series,States/Local Areas,Wisconsin,2014,Age,24 Months,80.2,72.5 to 86.9,224
Hib,Full Series,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,79.9,74.8 to 84.5,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,88.6,81.7 to 93.1,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,95.4,90.5 to 98.2,225
Hib,Full Series,States/Local Areas,Wisconsin,2019,Age,35 Months,81.3,73.6 to 88.0,224
Hib,Full Series,States/Local Areas,Wisconsin,2018,Age,35 Months,82.8,75.8 to 88.8,241
Hib,Full Series,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,82.1,77.0 to 86.7,465
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,92.4,89.1 to 95.8,404
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,88.2 to 94.1,661
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,91.1,84.6 to 97.6,125
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,91.6 to 99.4,92
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.5,74.0 to 98.9,45
Polio,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,90.6,85.2 to 94.6,226
Polio,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,91.1,85.3 to 95.3,241
Polio,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,91.4,87.3 to 94.6,465
Polio,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,90.8,84.5 to 95.2,238
Polio,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,91.0,86.9 to 94.2,479
Hib,Full Series,States/Local Areas,Wisconsin,2017,Age,35 Months,87.9,78.0 to 94.7,238
Hib,Full Series,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,85.0,79.2 to 89.9,479
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,75.1,69.2 to 81.0,332
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",63.7,47.5 to 79.9,45
Hib,Full Series,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,88.9,85.8 to 92.1,548
Polio,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,91.5,85.4 to 95.8,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,62.3,41.9 to 82.6,34
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,88.2,83.7 to 92.7,332
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,96.3,94.4 to 98.2,548
Hib,Full Series,States/Local Areas,Wisconsin,2015,Age,35 Months,84.5,78.2 to 89.7,262
Hib,Full Series,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,85.3,81.1 to 89.0,537
Hib,Full Series,States/Local Areas,Wisconsin,2014,Age,35 Months,83.2,75.2 to 89.8,224
Hib,Full Series,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,83.8,78.7 to 88.3,486
Hib,Full Series,States/Local Areas,Wisconsin,2011,Age,35 Months,85.4,76.6 to 92.1,225
Hib,Full Series,States/Local Areas,Wisconsin,2012,Age,35 Months,76.5,68.7 to 83.5,226
Hib,Full Series,States/Local Areas,Wisconsin,2019,Age,24 Months,79.9,72.3 to 86.4,224
Hib,Full Series,States/Local Areas,Wisconsin,2018,Age,24 Months,81.1,74.1 to 87.1,241
Hib,Full Series,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,80.5,75.4 to 85.0,465
Hib,Full Series,States/Local Areas,Wisconsin,2016,Age,35 Months,86.1,80.3 to 90.9,275
Hib,Full Series,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,86.2,81.1 to 90.6,513
Hib,Full Series,States/Local Areas,Wisconsin,2013,Age,35 Months,82.2,75.5 to 88.0,235
Hib,Full Series,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,82.7,77.4 to 87.3,459
Polio,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,92.2,87.2 to 95.8,235
Polio,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,89.4,84.9 to 93.0,459
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,86.5,79.2 to 92.2,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,90.7,86.7 to 93.9,486
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,5 Months,75.9,68.3 to 82.2,235
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,5 Months,73.4,69.9 to 76.7,459
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,5 Months,77.9,70.9 to 83.6,226
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,5 Months,81.7,75.1 to 86.8,225
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,5 Months,82.8,76.7 to 87.5,262
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,5 Months,83.2,79.1 to 86.7,537
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,5 Months,70.9,61.9 to 78.6,224
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,5 Months,76.8,72.6 to 80.6,486
≥1 Dose MMR,,States/Local Areas,Wisconsin,2012,Age,13 Months,57.4,44.6 to 69.3,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,89.3,82.8 to 94.1,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,95.0,91.8 to 97.2,262
Polio,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,94.5,92.1 to 96.4,537
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,94.0,90.0 to 96.8,275
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,92.6,88.9 to 95.4,513
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,35 Months,89.8,84.1 to 94.2,262
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,91.4,87.5 to 94.4,537
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,35 Months,94.4,85.4 to 98.7,238
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,90.3,85.2 to 94.3,479
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,35 Months,93.0,87.8 to 96.5,275
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,93.0,88.5 to 96.2,513
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,73.2,65.0 to 80.2,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019,Age,24 Months,87.8,81.2 to 93.0,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017,Age,24 Months,90.5,84.3 to 95.0,238
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,89.5,85.4 to 92.9,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013,Age,24 Months,92.3,86.3 to 96.3,235
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,90.3,85.9 to 93.8,459
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014,Age,24 Months,88.3,81.5 to 93.5,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,90.1,86.1 to 93.3,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018,Age,24 Months,88.7,82.9 to 93.3,241
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,88.3,84.0 to 91.9,465
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,92.4,87.2 to 96.0,225
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,90.2,85.2 to 94.1,235
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,91.2,87.5 to 94.1,459
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,5 Months,92.1,86.5 to 95.6,224
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,5 Months,92.1,87.0 to 95.3,241
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,5 Months,92.1,88.6 to 94.6,465
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,89.4,84.3 to 93.4,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,71.8,64.6 to 78.0,275
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,72.5,67.2 to 77.3,513
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,71.7,64.6 to 77.8,262
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,71.7,66.8 to 76.2,537
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,77.1,68.7 to 83.8,224
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,77.4,72.0 to 81.9,486
PCV,≥4 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,77.6,70.2 to 83.6,262
PCV,≥4 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,79.2,74.8 to 83.1,537
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,80.9,74.4 to 86.0,275
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,80.0,75.0 to 84.2,513
PCV,≥4 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,79.2,71.3 to 85.3,238
PCV,≥4 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,79.7,74.4 to 84.1,479
PCV,≥4 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,80.2,72.7 to 86.0,241
PCV,≥4 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,81.4,75.3 to 86.3,369
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017,Age,24 Months,93.0,87.2 to 96.8,238
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,91.0,87.1 to 94.2,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016,Age,24 Months,93.4,89.6 to 96.1,275
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,93.2,89.8 to 95.7,513
PCV,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,86.0,81.7 to 89.4,226
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,95.2,93.4 to 96.5,225
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2019,Age,0-1 Days,81.3,73.5 to 87.2,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,91.4,86.4 to 95.1,275
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,90.2,86.0 to 93.5,513
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,91.2,87.1 to 94.5,262
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,91.3,88.2 to 93.9,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,92.0,86.9 to 95.7,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,91.6,88.4 to 94.2,486
PCV,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,91.9,88.8 to 94.3,225
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,72.1,64.3 to 78.8,241
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,69.0,63.2 to 74.3,465
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,73.3,65.2 to 80.1,238
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,72.7,67.2 to 77.6,479
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,89.9,84.0 to 93.8,226
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,90.9,85.1 to 94.5,224
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,90.2,86.6 to 92.9,486
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2012,Age,0-2 Days,75.5,71.4 to 79.1,226
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,88.8,84.0 to 92.3,235
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,89.8,86.5 to 92.4,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2011,Age,0-2 Days,78.6,70.4 to 85.0,225
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,93.1,87.3 to 96.4,224
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2018,Age,0-1 Days,79.6,72.5 to 85.2,241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2018-2019,Age,0-1 Days,80.4,75.3 to 84.7,465
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015,Age,35 Months,93.4,88.3 to 96.8,262
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,94.1,90.4 to 96.8,537
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017,Age,35 Months,94.5,87.0 to 98.3,238
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,93.6,87.8 to 97.2,479
PCV,≥4 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,79.4,71.5 to 85.6,224
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,90.8,85.3 to 94.4,275
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,91.4,87.6 to 94.1,513
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,87.2,80.7 to 91.8,235
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,85.5,80.3 to 89.6,459
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,91.9,86.2 to 95.4,238
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,93.0,89.6 to 95.3,479
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2016,Age,0-1 Days,70.1,62.9 to 76.4,275
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2016-2017,Age,0-1 Days,68.3,62.9 to 73.2,513
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2017,Age,0-1 Days,66.4,58.3 to 73.6,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2017-2018,Age,0-1 Days,73.0,67.6 to 77.7,479
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2015,Age,0-1 Days,61.1,54.0 to 67.7,262
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2015-2016,Age,0-1 Days,65.6,60.5 to 70.2,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,92.4,87.2 to 95.7,241
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,91.4,87.5 to 94.1,465
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,5 Months,90.1,83.8 to 94.1,238
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,5 Months,91.1,87.3 to 93.9,479
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014,Age,24 Months,87.1,80.3 to 92.4,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,87.6,83.4 to 91.1,486
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019,Age,19 Months,86.6,79.4 to 91.5,224
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,5 Months,87.8,82.6 to 91.6,262
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,5 Months,88.8,85.2 to 91.6,537
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2013,Age,0-1 Days,57.5,54.5 to 60.4,235
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2013-2014,Age,0-1 Days,60.5,56.0 to 64.8,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2014,Age,0-1 Days,63.5,55.6 to 70.8,224
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2014-2015,Age,0-1 Days,62.3,56.9 to 67.4,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019,Age,19 Months,83.3,75.5 to 89.0,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,88.3,82.3 to 92.5,287
Polio,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,92.1,86.6 to 95.4,241
Polio,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,92.1,88.3 to 94.8,465
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013,Age,24 Months,90.0,84.4 to 94.3,235
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,88.7,84.3 to 92.3,459
Polio,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,93.2,86.7 to 96.7,238
Polio,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,92.7,88.8 to 95.3,479
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,88.9,81.4 to 93.6,238
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,90.7,86.3 to 93.7,479
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,5 Months,89.8,84.2 to 93.6,275
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,5 Months,90.0,85.9 to 92.9,513
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2012,Age,0-1 Days,62.3,54.6 to 69.4,226
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,5 Months,88.2,81.6 to 92.6,224
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,5 Months,88.0,85.6 to 90.0,486
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,65.4,58.6 to 71.6,235
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,63.7,59.7 to 67.6,459
PCV,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,76.5,70.8 to 81.3,225
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,90.6,85.1 to 94.2,275
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,89.8,85.3 to 93.0,513
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,90.0,86.0 to 94.0,303
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,83.2,78.2 to 88.2,384
PCV,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,65.8,57.5 to 73.2,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,62.0,53.2 to 70.1,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,66.8,61.0 to 72.2,486
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,83.9,76.4 to 90.1,241
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,85.2,79.9 to 89.8,465
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,78.8,73.1 to 84.5,332
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,87.7,84.2 to 91.2,548
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,86.3,78.4 to 92.3,224
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,59.3,39.1 to 79.5,34
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.9,58.5 to 89.3,45
≥1 Dose MMR,,States/Local Areas,Wisconsin,2011,Age,19 Months,89.1,85.6 to 91.8,225
Polio,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,94.6,90.8 to 96.9,262
Polio,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,93.4,90.4 to 95.4,537
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016,Age,19 Months,87.0,81.2 to 91.2,275
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,86.1,81.5 to 89.7,513
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019,Age,13 Months,66.6,58.1 to 74.2,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018,Age,19 Months,86.2,79.8 to 90.8,241
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,59.7,53.9 to 65.2,465
Polio,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,92.1,87.1 to 95.3,275
Polio,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,92.7,88.8 to 95.3,513
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,3 Months,92.6,86.8 to 95.9,238
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,3 Months,94.7,91.6 to 96.7,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013,Age,19 Months,88.9,86.9 to 90.6,235
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,87.6,86.7 to 88.5,459
≥1 Dose MMR,,States/Local Areas,Wisconsin,2012,Age,19 Months,91.6,87.3 to 94.5,226
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017,Age,19 Months,85.2,77.7 to 90.5,238
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,85.7,81.0 to 89.4,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014,Age,19 Months,86.3,78.6 to 91.5,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,88.6,84.2 to 91.8,486
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,74.9,68.1 to 81.8,236
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2011,Age,24 Months,92.2,86.9 to 95.9,225
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2012,Age,24 Months,90.6,85.9 to 94.2,226
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015,Age,19 Months,90.9,84.6 to 94.7,262
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,90.2,86.9 to 92.7,537
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016,Age,19 Months,89.5,84.4 to 93.0,275
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,88.9,84.6 to 92.1,513
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,3 Months,95.9,90.8 to 98.2,224
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,81.1,72.1 to 90.1,125
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.9,80.2 to 87.6,661
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,72.2 to 91.6,92
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,82.6,79.4 to 85.8,923
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,78.2,70.6 to 85.7,212
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,84.8,80.2 to 89.3,404
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.0,76.4 to 87.6,307
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,3 Months,96.8,93.9 to 98.4,241
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,3 Months,96.4,93.7 to 97.9,465
Polio,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,88.5,80.9 to 93.3,224
Polio,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,91.5,87.5 to 94.3,486
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,5 Months,86.0,80.4 to 90.2,226
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,5 Months,93.0,90.4 to 95.0,225
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,75.9,68.1 to 83.7,384
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2011,Age,0-1 Days,60.7,52.9 to 68.0,225
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,5 Months,86.2,80.7 to 90.3,235
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,5 Months,87.1,83.5 to 90.1,459
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,85.1,78.5 to 91.7,303
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,89.7,83.3 to 93.8,235
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,89.9,85.5 to 93.0,459
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,90.3,85.4 to 93.7,262
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,90.4,87.0 to 93.0,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,90.0,83.9 to 94.0,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,90.2,86.5 to 92.9,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016,Age,24 Months,89.4,84.1 to 93.5,275
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,89.9,85.9 to 93.2,513
≥1 Dose MMR,,States/Local Areas,Wisconsin,2011,Age,24 Months,92.4,86.3 to 96.5,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018,Age,19 Months,88.8,82.5 to 93.0,241
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,92.1,88.4 to 94.7,465
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015,Age,24 Months,88.0,82.8 to 92.2,262
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,88.7,85.1 to 91.8,537
PCV,≥4 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,77.8,70.5 to 83.7,235
PCV,≥4 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,77.5,72.5 to 81.7,459
PCV,≥4 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,76.4,68.3 to 83.0,226
PCV,≥4 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,85.0,79.3 to 89.2,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017,Age,19 Months,88.3,81.0 to 93.0,238
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,88.5,84.0 to 91.9,479
Polio,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,92.2,85.9 to 95.8,224
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,19.7,3.8 to 35.5,34
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,89.9,82.1 to 95.3,238
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,86.7,81.4 to 91.1,479
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,88.2,82.6 to 92.7,275
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,88.8,84.2 to 92.5,513
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,90.1,83.4 to 94.9,262
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,88.5,84.3 to 92.0,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,88.8,83.8 to 92.3,262
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,88.4,84.8 to 91.3,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,88.1,82.3 to 92.2,275
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,88.1,83.6 to 91.5,513
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,70.6,62.9 to 78.3,332
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,82.7,77.5 to 87.8,548
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.4,46.6 to 86.2,45
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,92.9,89.3 to 96.6,303
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019,Age,13 Months,53.7,45.3 to 61.9,224
Polio,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,87.9,81.1 to 92.5,241
Polio,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,86.0,81.0 to 89.9,465
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,3 Months,94.5,86.9 to 97.8,235
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,3 Months,93.8,91.2 to 95.7,459
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,3 Months,92.0,85.7 to 95.7,226
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,3 Months,97.1,93.8 to 98.6,225
Polio,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,90.7,85.7 to 94.1,275
Polio,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,89.6,85.3 to 92.8,513
Polio,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,88.5,81.0 to 93.3,238
Polio,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,88.2,83.4 to 91.7,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017,Age,13 Months,63.9,55.3 to 71.6,238
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,69.1,63.4 to 74.3,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016,Age,13 Months,69.4,62.2 to 75.8,275
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,66.7,61.1 to 71.8,513
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013,Age,19 Months,86.7,79.5 to 91.7,235
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,85.6,81.7 to 88.7,459
Polio,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,89.9,86.8 to 92.4,226
Polio,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,97.4,96.0 to 98.3,225
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015,Age,19 Months,86.6,83.8 to 89.0,262
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,86.8,83.0 to 89.9,537
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014,Age,19 Months,84.4,76.6 to 89.9,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,85.5,80.9 to 89.1,486
Polio,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,91.4,86.2 to 94.7,235
Polio,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,89.9,87.1 to 92.2,459
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,3 Months,93.1,88.4 to 96.0,224
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,3 Months,92.3,89.1 to 94.6,486
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,3 Months,91.5,86.6 to 94.7,262
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,3 Months,92.5,89.2 to 94.8,537
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,3 Months,93.5,88.3 to 96.5,275
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,3 Months,93.0,89.4 to 95.5,513
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,84.4,70.1 to 98.7,125
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.9,89.1 to 98.7,92
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016,Age,13 Months,54.6,47.1 to 61.9,275
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,52.2,46.6 to 57.8,513
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017,Age,13 Months,49.8,41.5 to 58.1,238
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,57.7,51.9 to 63.3,479
Polio,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,87.0,81.3 to 91.1,262
Polio,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,88.8,85.2 to 91.6,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,86.0,82.5 to 88.9,225
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,73.6,65.2 to 80.6,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,73.1,66.1 to 80.1,236
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,83.4,80.2 to 86.6,923
Polio,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,87.7,82.3 to 91.6,235
Polio,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,84.9,81.3 to 88.0,459
Polio,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,82.1,73.7 to 88.3,224
Polio,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,84.6,79.4 to 88.6,486
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,84.1,76.2 to 90.6,226
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,84.6,76.4 to 91.2,224
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,86.6,81.1 to 91.2,486
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,80.4,71.1 to 88.3,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,84.1,78.6 to 88.4,226
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,89.3,82.1 to 94.5,235
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,86.8,81.2 to 91.3,459
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,84.0,76.6 to 89.4,235
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,84.7,81.8 to 87.3,459
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,85.5,78.0 to 90.7,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,87.1,82.9 to 90.4,486
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,71.6,61.4 to 81.1,238
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,75.5,68.6 to 81.9,479
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,79.1,69.2 to 87.5,241
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,79.3,72.7 to 85.1,465
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,90.2,83.6 to 94.9,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015,Age,13 Months,67.3,60.2 to 73.7,262
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,68.3,63.4 to 72.9,537
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014,Age,13 Months,58.3,49.6 to 66.5,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,62.8,57.0 to 68.2,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018,Age,13 Months,65.6,57.8 to 72.7,241
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,59.7,53.9 to 65.2,465
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013,Age,13 Months,47.0,43.3 to 50.8,235
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,52.6,47.4 to 57.8,459
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2011,Age,19 Months,89.8,82.5 to 94.3,225
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,84.9,80.3 to 89.5,384
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2012,Age,19 Months,88.9,84.7 to 92.0,226
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,89.2,84.5 to 92.7,226
Polio,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,84.1,76.0 to 89.8,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,91.4,86.0 to 94.9,241
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,91.4,87.5 to 94.1,465
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,91.3,85.0 to 95.1,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,91.1,87.5 to 93.7,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2012,Age,24 Months,92.6,88.2 to 95.8,226
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2011,Age,35 Months,93.3,88.1 to 96.8,225
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,85.2,77.5 to 90.5,224
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.0,70.8 to 93.2,92
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,78.1,71.7 to 84.5,404
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.2,67.9 to 78.6,661
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.2,67.1 to 83.3,307
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,67.4,56.1 to 78.8,212
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,74.9,70.2 to 79.5,923
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,64.8,56.1 to 73.4,236
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018,Age,13 Months,74.4,66.8 to 80.8,241
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,70.6,64.9 to 75.6,465
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,88.0,80.6 to 92.9,238
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,89.7,85.4 to 92.9,479
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,80.0,72.8 to 85.7,241
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,76.8,71.4 to 81.5,465
Polio,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,5 Months,79.6,71.4 to 86.0,224
Hib,Full Series,States/Local Areas,Wisconsin,2020,Age,24 Months,80.7,74.3 to 86.4,287
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,80.7,73.4 to 87.1,224
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,84.4,77.2 to 90.3,238
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,82.7,77.8 to 87.1,479
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,81.0,74.0 to 87.0,241
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,80.9,75.9 to 85.4,465
≥1 Dose MMR,,States/Local Areas,Wisconsin,2011,Age,13 Months,57.8,54.4 to 61.2,225
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,86.2,81.9 to 90.4,404
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.9,79.0 to 86.8,661
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.7,80.7 to 90.7,307
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,73.0,64.6 to 81.5,212
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015,Age,13 Months,56.2,49.0 to 63.2,262
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,55.4,50.3 to 60.5,537
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,69.5,61.6 to 76.5,241
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,92.1,88.3 to 94.8,465
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,83.3,76.4 to 89.1,235
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,81.5,76.3 to 86.2,459
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,46.3,39.1 to 54.1,275
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,46.8,41.3 to 52.7,513
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,37.7,31.0 to 45.3,262
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,41.9,36.9 to 47.3,537
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,47.9,39.5 to 57.0,238
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,47.5,41.8 to 53.7,479
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,87.2,81.8 to 92.6,236
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,97.9,96.0 to 99.8,303
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,94.7,92.1 to 97.3,384
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,67.7,66.0 to 69.3,226
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,66.7,62.3 to 70.9,225
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,84.0,76.8 to 89.9,225
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,78.5,71.1 to 85.0,226
Polio,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,5 Months,76.9,70.0 to 82.6,226
Polio,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,5 Months,80.6,73.1 to 86.3,225
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,35 Months,83.1,76.6 to 88.6,226
Polio,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,5 Months,75.5,68.3 to 81.4,235
Polio,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,5 Months,72.5,69.3 to 75.4,459
Polio,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,5 Months,69.4,60.4 to 77.1,224
Polio,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,5 Months,75.9,71.3 to 80.0,486
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,44.6,36.7 to 53.4,224
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,41.2,35.9 to 47.0,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,93.2,91.1 to 95.3,923
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,89.4,83.0 to 94.2,241
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,89.5,85.0 to 93.1,465
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,44.5,36.1 to 53.8,226
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,35 Months,85.9,78.2 to 92.0,235
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,82.5,76.7 to 87.7,459
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,35 Months,79.2,70.8 to 86.6,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,84.0,78.5 to 88.8,486
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,39.8,32.7 to 47.8,235
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,42.2,36.7 to 48.1,459
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,73.4,66.2 to 79.5,275
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,73.4,68.1 to 78.1,513
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,73.4,65.3 to 80.2,238
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,71.5,65.9 to 76.5,479
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,93.3,90.1 to 96.5,404
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,91.5 to 96.4,661
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.9,91.4 to 98.4,307
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,90.2,85.4 to 95.0,212
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,91.1,84.6 to 97.6,125
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,91.6 to 99.3,92
PCV,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,5 Months,79.6,71.3 to 86.0,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,92.0,87.4 to 95.4,287
PCV,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,5 Months,79.1,71.6 to 85.0,241
PCV,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,5 Months,79.4,74.0 to 83.9,465
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.5,74.0 to 98.9,45
PCV,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,5 Months,77.6,69.5 to 84.0,238
PCV,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,5 Months,78.3,73.0 to 82.9,479
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,79.9,72.1 to 86.7,224
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,80.3,75.3 to 85.0,486
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,80.7,74.6 to 86.2,262
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,82.6,78.3 to 86.4,537
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,84.5,78.6 to 89.5,275
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,84.4,79.8 to 88.5,513
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,78.4,70.1 to 85.7,225
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,80.9,69.3 to 90.2,226
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,70.9,60.2 to 80.9,235
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,68.4,61.3 to 75.2,459
Polio,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,5 Months,82.4,76.3 to 87.2,262
Polio,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,5 Months,82.9,78.8 to 86.4,537
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,45.4,37.5 to 54.2,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,62.3,54.5 to 69.5,235
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,65.2,61.4 to 68.8,459
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,47.4,39.6 to 55.8,241
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,46.4,40.7 to 52.5,465
Polio,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,5 Months,83.5,77.4 to 88.2,275
Polio,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,5 Months,81.4,76.6 to 85.5,513
Polio,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,5 Months,79.3,71.4 to 85.5,238
Polio,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,5 Months,78.7,73.4 to 83.2,479
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,66.5,59.4 to 72.9,262
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,69.7,64.8 to 74.3,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,68.2,59.8 to 75.5,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,67.3,61.8 to 72.4,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2011,Age,13 Months,57.4,53.8 to 60.8,225
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013,Age,13 Months,46.5,41.4 to 51.7,235
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,48.8,44.1 to 53.5,459
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,36.8,17.5 to 56.1,34
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.7,59.6 to 89.7,45
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,78.5,72.8 to 84.2,332
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,91.0,88.2 to 93.9,548
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,35 Months,87.5,80.6 to 92.9,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014,Age,13 Months,51.2,42.8 to 59.4,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,53.7,48.1 to 59.2,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2012,Age,13 Months,54.3,42.4 to 65.8,226
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,35 Months,87.4,81.0 to 92.4,241
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,87.5,83.0 to 91.4,465
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,73.0,65.8 to 79.1,275
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,74.5,69.1 to 79.1,513
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,66.9,57.5 to 76.0,224
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,72.8,66.0 to 79.3,486
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,79.8,70.8 to 87.5,262
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,78.3,72.3 to 83.7,537
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,77.6,69.4 to 84.8,275
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,75.1,68.6 to 81.1,513
Polio,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,87.7,86.4 to 88.8,226
Polio,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,89.9,88.1 to 91.5,225
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,81.3,72.6 to 90.0,125
Polio,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,5 Months,78.1,70.6 to 84.2,241
Polio,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,5 Months,78.9,73.5 to 83.4,465
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,75.9,67.7 to 82.6,238
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,78.0,72.6 to 82.5,479
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,91.3,86.3 to 94.6,275
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,92.7,89.0 to 95.2,513
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,88.7,83.3 to 92.5,262
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,90.0,86.5 to 92.7,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,94.1,88.1 to 97.2,238
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,90.2,86.0 to 93.3,479
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,86.0,81.2 to 90.8,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,79.1,73.5 to 84.7,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,75.7,70.4 to 80.9,384
Hib,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,73.6,67.3 to 79.1,225
Hib,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,70.2,60.4 to 78.5,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,57.1,48.8 to 65.1,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,60.3,54.7 to 65.7,486
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,62.8,57.4 to 67.8,235
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,60.0,55.7 to 64.2,459
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,97.9,96.0 to 99.8,303
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,93.0,89.9 to 96.2,384
Polio,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,92.3,88.8 to 94.8,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2015,Age,0-3 Days,77.6,71.3 to 82.8,262
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2015-2016,Age,0-3 Days,80.3,76.1 to 84.0,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,74.2,67.1 to 80.3,275
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,75.2,69.9 to 79.8,513
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,75.2,68.3 to 81.0,262
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,74.7,69.9 to 79.0,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,66.0,57.2 to 73.9,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,70.6,64.9 to 75.8,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,91.4,89.0 to 93.3,225
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,93.9,89.5 to 96.6,225
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,92.6,89.1 to 95.1,226
PCV,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,3 Months,86.9,79.5 to 91.9,224
Hib,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,89.2,85.3 to 92.2,226
Hib,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,96.8,93.7 to 98.4,225
Hib,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,87.7,80.8 to 92.3,241
Hib,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,85.8,80.9 to 89.7,465
Polio,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,3 Months,88.1,80.9 to 92.9,238
Polio,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,3 Months,88.8,84.2 to 92.1,479
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,43.8,36.8 to 51.0,262
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,40.6,35.7 to 45.7,537
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,36.5,29.2 to 44.4,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,40.1,35.0 to 45.6,486
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,90.9,85.0 to 95.2,241
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,91.0,86.9 to 94.2,465
Hib,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,92.6,87.3 to 95.8,235
Hib,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,90.7,87.5 to 93.2,459
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,94.2,88.8 to 97.5,238
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,92.6,88.8 to 95.5,479
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,72.0,64.2 to 78.7,241
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,69.4,63.5 to 74.6,465
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2019,Age,0-3 Days,84.0,76.1 to 89.7,224
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,30.2,12.7 to 47.8,34
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,76.1,68.1 to 82.6,238
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,74.1,68.6 to 78.9,479
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,91.0,84.9 to 95.4,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,92.6,88.2 to 95.9,275
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,93.5,90.0 to 96.0,513
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,47.4,41.1 to 53.7,235
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,42.0,37.5 to 46.6,459
Hib,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,84.0,76.2 to 89.6,224
Hib,Primary Series,States/Local Areas,Wisconsin,2020,Age,24 Months,93.1,88.8 to 96.2,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,80.0,76.0 to 83.9,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,84.4,80.0 to 88.7,332
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.8,64.4 to 91.1,45
Polio,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,3 Months,87.3,79.9 to 92.2,224
Polio,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,3 Months,89.4,83.1 to 93.6,241
Polio,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,3 Months,88.4,83.8 to 91.8,465
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2018,Age,0-3 Days,84.7,77.9 to 89.7,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2018-2019,Age,0-3 Days,84.4,79.4 to 88.3,465
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,89.3,82.3 to 96.2,125
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,88.3 to 97.7,92
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.2,69.9 to 96.5,45
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,67.1,48.5 to 85.8,34
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,86.9,82.3 to 91.5,332
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,97.8,96.6 to 99.1,548
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,90.7,86.2 to 95.1,236
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,95.3,92.3 to 98.2,303
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,88.1,83.9 to 92.4,384
Hib,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,54.6,49.0 to 60.2,225
Hib,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,50.4,39.6 to 61.2,226
Polio,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,3 Months,86.2,79.0 to 91.1,224
Polio,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,3 Months,86.8,82.4 to 90.2,486
Polio,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,3 Months,87.4,81.6 to 91.6,262
Polio,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,3 Months,86.9,82.9 to 90.1,537
Polio,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,3 Months,86.5,80.5 to 90.8,275
Polio,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,3 Months,87.3,82.8 to 90.7,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2017,Age,0-3 Days,87.4,80.2 to 92.3,161
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2017-2018,Age,0-3 Days,84.8,80.4 to 88.4,479
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016,Age,0-3 Days,83.2,77.2 to 87.9,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2017,Age,0-3 Days,84.0,79.8 to 87.5,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014,Age,0-3 Days,77.9,70.9 to 83.6,224
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2015,Age,0-3 Days,77.7,73.1 to 81.8,486
PCV,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,3 Months,88.8,82.4 to 93.1,241
PCV,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,3 Months,87.9,83.2 to 91.4,465
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,68.2,59.7 to 75.6,235
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,67.1,63.7 to 70.3,459
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,69.1,59.4 to 77.3,226
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,77.4,74.5 to 80.2,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2013,Age,0-3 Days,75.9,68.8 to 81.7,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2013-2014,Age,0-3 Days,76.9,72.0 to 81.1,459
Polio,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,3 Months,83.2,78.8 to 86.8,235
Polio,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,3 Months,84.6,82.2 to 86.8,459
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,91.0,88.6 to 93.3,923
Polio,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,3 Months,86.5,79.9 to 91.2,226
Polio,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,3 Months,90.9,85.9 to 94.3,225
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,93.1,90.0 to 96.1,404
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,66.7,57.9 to 74.5,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,37.2,29.6 to 45.6,238
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,33.0,27.8 to 38.6,479
Hib,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,88.7,81.2 to 93.5,224
Hib,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,91.2,87.1 to 94.1,486
Hib,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,93.6,89.4 to 96.3,262
Hib,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,93.0,90.0 to 95.2,537
Hib,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,92.3,87.4 to 95.4,275
Hib,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,93.7,90.0 to 96.1,513
Hib,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,90.3,85.2 to 93.8,275
Hib,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,90.7,86.6 to 93.7,513
Hib,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,7 Months,91.1,83.9 to 95.3,238
Hib,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,89.4,84.8 to 92.7,479
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,86.4,78.8 to 92.4,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,90.3,86.1 to 93.6,486
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,89.4,84.8 to 93.1,459
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,94.2,90.8 to 96.7,262
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,93.4,90.7 to 95.5,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.4,86.3 to 92.5,661
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.9,90.4 to 97.3,307
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,81.3,74.2 to 88.4,212
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,93.3,88.0 to 98.5,125
PCV,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,3 Months,86.6,80.7 to 90.8,226
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.6,82.1 to 89.1,661
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,72.4 to 90.5,92
PCV,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,3 Months,85.1,77.5 to 90.4,224
PCV,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,3 Months,85.3,80.7 to 88.9,486
PCV,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,91.1,85.8 to 95.0,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,89.6,83.4 to 94.3,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,94.5,89.6 to 97.5,225
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,92.4,87.4 to 95.9,235
Hib,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,85.4,79.4 to 89.8,262
Hib,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,87.8,84.1 to 90.8,537
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,90.5,84.7 to 94.7,241
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,90.1,86.0 to 93.4,465
Hib,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,5 Months,78.2,70.6 to 84.2,241
Hib,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,5 Months,78.5,73.2 to 83.1,465
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,93.1,89.3 to 95.9,262
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,92.9,90.1 to 95.1,537
Hib,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,7 Months,86.2,83.2 to 88.7,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,92.6,88.2 to 95.9,275
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,93.5,90.0 to 96.0,513
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,89.4 to 98.7,92
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,94.2,88.8 to 97.5,238
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,92.4,88.6 to 95.3,479
Hib,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,5 Months,78.6,70.4 to 85.0,238
Hib,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,5 Months,78.4,73.0 to 82.9,479
Hib,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,7 Months,89.3,86.9 to 91.4,225
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,83.6,80.5 to 86.7,923
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,79.5,72.1 to 86.8,212
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.5,79.4 to 89.6,307
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,48.0,27.3 to 68.7,34
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,84.9,80.4 to 89.4,384
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,74.2,67.3 to 81.0,236
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,92.3,88.6 to 96.0,303
Hib,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,7 Months,88.5,83.3 to 92.2,235
Hib,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,85.4,81.6 to 88.6,459
Hib,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,7 Months,82.3,73.9 to 88.5,224
Hib,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,83.9,78.6 to 88.0,486
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2012,Age,0-3 Days,77.5,70.3 to 83.4,226
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,84.4,79.9 to 88.9,404
PCV,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,3 Months,85.4,79.5 to 89.9,262
PCV,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,3 Months,85.9,81.8 to 89.1,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,94.2,91.9 to 96.5,548
Hib,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,5 Months,78.9,70.8 to 85.3,224
PCV,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,3 Months,86.3,80.3 to 90.6,275
PCV,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,3 Months,85.5,80.7 to 89.3,513
PCV,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,3 Months,84.7,76.8 to 90.3,238
PCV,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,3 Months,86.7,81.9 to 90.4,479
Hib,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,3 Months,87.9,81.4 to 92.3,241
Hib,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,3 Months,86.8,82.1 to 90.4,465
Hib,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,3 Months,85.7,78.4 to 90.9,224
Hib,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,5 Months,76.4,69.9 to 82.0,226
Hib,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,5 Months,80.2,75.2 to 84.4,225
Hib,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,5 Months,74.1,68.8 to 78.8,235
Hib,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,5 Months,71.3,69.1 to 73.4,459
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,94.2,88.0 to 97.3,238
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,91.6,87.4 to 94.5,479
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2011,Age,0-3 Days,80.0,72.6 to 85.8,225
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,91.3,87.5 to 95.1,332
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.1,85.2 to 100.0,45
PCV,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,92.5,87.1 to 96.2,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,96.9,94.7 to 99.1,303
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,92.1,88.7 to 95.5,384
PCV,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,3 Months,89.0,86.1 to 91.4,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,83.5,77.6 to 89.4,236
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,90.7,88.2 to 93.2,923
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,86.3,80.0 to 92.5,212
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.4,88.4 to 96.4,307
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,89.1,82.4 to 93.4,241
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,85.8,80.9 to 89.6,465
Hib,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,5 Months,68.4,59.4 to 76.2,224
Hib,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,5 Months,74.8,70.0 to 79.0,486
Hib,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,5 Months,81.2,74.9 to 86.1,262
Hib,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,5 Months,82.2,77.9 to 85.7,537
Hib,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,5 Months,83.2,77.1 to 87.9,275
Hib,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,5 Months,80.9,75.9 to 85.1,513
PCV,≥4 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,84.2,76.8 to 90.3,238
PCV,≥4 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,84.7,79.6 to 89.1,479
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,95.4,90.2 to 97.9,224
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,87.5,82.2 to 91.9,275
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,86.0,81.5 to 89.8,513
PCV,≥4 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,85.0,77.9 to 90.7,241
PCV,≥4 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,85.0,80.0 to 89.3,465
PCV,≥4 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,84.8,77.4 to 90.8,224
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,90.5,87.5 to 93.5,548
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,83.2,75.0 to 91.4,125
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.8,53.9 to 85.6,45
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,55.1,34.7 to 75.5,34
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,78.2,72.5 to 83.8,332
PCV,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,3 Months,83.1,79.1 to 86.4,235
PCV,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,3 Months,84.1,81.4 to 86.5,459
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,86.0,78.1 to 93.8,125
Hib,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,3 Months,82.5,78.6 to 85.8,235
Hib,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,3 Months,83.6,81.8 to 85.3,459
Hib,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,3 Months,86.3,79.7 to 91.0,226
Hib,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,3 Months,91.4,87.5 to 94.1,225
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,92.4,87.9 to 95.3,262
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,92.6,89.4 to 94.9,537
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,91.9,86.5 to 95.3,235
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,92.9,90.1 to 94.9,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2019,Age,0-2 Days,83.7,75.9 to 89.4,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,85.8,80.9 to 89.6,465
Hib,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,3 Months,84.8,77.6 to 90.1,224
Hib,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,3 Months,85.5,81.0 to 89.0,486
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,93.8,89.4 to 96.5,224
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,93.1,90.2 to 95.2,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,84.9,79.9 to 89.8,332
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,93.8,91.4 to 96.2,548
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019,Age,35 Months,92.7,85.0 to 97.3,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016,Age,35 Months,95.9,91.9 to 98.3,275
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,95.4,91.5 to 97.9,513
PCV,≥4 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,80.2,74.1 to 85.6,262
PCV,≥4 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,83.8,79.8 to 87.3,537
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018,Age,35 Months,92.4,84.8 to 97.1,241
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,92.9,87.4 to 96.6,465
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015,Age,35 Months,94.3,88.7 to 97.7,262
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,95.3,91.8 to 97.6,537
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014,Age,35 Months,90.4,83.4 to 95.3,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,91.9,87.7 to 95.1,486
PCV,≥4 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,83.0,75.8 to 89.0,238
PCV,≥4 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,83.2,78.3 to 87.5,479
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,87.1,81.8 to 91.5,275
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,85.3,80.9 to 89.2,513
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,13 Months,96.5,94.4 to 97.8,225
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,90.5,85.3 to 94.0,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,89.9,83.1 to 94.2,238
PCV,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,88.2,83.6 to 91.6,479
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,89.4,84.3 to 93.4,226
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,92.7,87.3 to 96.4,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,92.4,89.2 to 95.0,486
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,91.9,86.9 to 95.5,235
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,92.4,88.7 to 95.3,459
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,94.1,89.6 to 96.7,241
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,93.8,90.5 to 96.0,465
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2018,Age,0-2 Days,84.0,77.2 to 89.1,241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2018-2019,Age,0-2 Days,83.9,78.9 to 87.9,465
PCV,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,86.4,79.5 to 91.3,241
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,93.5,87.8 to 96.6,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,90.4,85.3 to 93.9,275
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,90.2,86.1 to 93.2,513
PCV,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,90.0,86.2 to 92.9,226
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,91.3,84.0 to 96.1,238
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,96.1,89.7 to 99.0,479
PCV,≥4 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,92.0,86.4 to 95.9,225
PCV,≥4 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,78.1,70.4 to 84.9,226
PCV,≥4 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,81.5,74.2 to 87.8,224
PCV,≥4 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,83.2,76.4 to 89.0,241
PCV,≥4 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,82.4,77.5 to 86.7,465
PCV,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,92.4,89.3 to 94.6,225
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,89.9,82.5 to 94.4,235
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,87.6,82.6 to 91.3,459
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,92.1,88.2 to 95.1,262
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,92.4,89.4 to 94.9,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,92.5,87.8 to 95.9,275
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,91.9,87.8 to 95.1,513
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,47.4,26.7 to 68.2,34
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.9,70.8 to 97.0,45
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,88.9,82.1 to 93.4,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,91.1,85.8 to 95.0,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,91.6,86.5 to 95.3,235
PCV,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,88.6,84.0 to 92.4,459
Hib,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,3 Months,88.2,80.9 to 92.9,238
Hib,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,3 Months,88.0,83.4 to 91.5,479
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,87.1,82.7 to 91.6,384
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,96.5,94.2 to 98.7,303
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,87.9 to 94.9,404
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.6,88.7 to 94.4,661
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,85.6,78.0 to 91.6,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,89.4,85.1 to 92.8,486
PCV,≥4 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,85.1,78.7 to 90.4,235
PCV,≥4 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,84.2,79.1 to 88.7,459
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,94.4,89.3 to 97.6,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,85.3,77.0 to 90.9,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,89.2,84.7 to 92.5,486
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,99.5,97.0 to 100.0,241
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,96.9,91.9 to 99.1,465
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,95.4,93.3 to 97.4,548
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,86.6,81.8 to 91.4,332
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,87.0,79.2 to 94.7,125
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,87.2 to 97.5,92
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.0,74.5 to 99.4,45
≥1 Dose MMR,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,75.4,58.2 to 92.6,34
PCV,≥4 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,83.6,77.6 to 88.8,262
PCV,≥4 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,85.5,81.5 to 89.0,537
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,83.5,75.6 to 90.0,224
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,83.6,78.5 to 88.1,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,81.4,75.3 to 87.5,236
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,87.9,85.2 to 90.7,923
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.4,85.0 to 93.8,307
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,79.3,71.8 to 86.7,212
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,86.9 to 94.3,404
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.4,84.0 to 90.8,661
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.2,91.3 to 99.1,92
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019,Age,35 Months,93.9,86.9 to 97.8,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017,Age,35 Months,94.0,87.8 to 97.7,238
≥1 Dose MMR,,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,97.4,92.4 to 99.4,479
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018,Age,35 Months,97.6,91.4 to 99.7,241
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,96.1,90.9 to 98.8,465
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,35 Months,89.9,84.2 to 94.2,287
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,96.3,93.2 to 98.1,241
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,95.9,93.2 to 97.5,465
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,92.8,87.5 to 96.0,275
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,93.1,89.4 to 95.5,513
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,93.1,89.0 to 95.7,262
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,92.5,89.4 to 94.7,537
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,91.8,86.9 to 95.0,275
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,93.0,89.3 to 95.5,513
Hib,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,3 Months,86.1,80.1 to 90.6,262
Hib,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,3 Months,86.4,82.4 to 89.7,537
Hib,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,3 Months,86.7,80.8 to 91.0,275
Hib,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,3 Months,87.4,83.0 to 90.9,513
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,93.3,87.8 to 96.4,238
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,94.8,91.8 to 96.7,479
PCV,≥4 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,87.1,80.7 to 92.2,225
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2016,Age,0-2 Days,78.2,71.4 to 83.7,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2016-2017,Age,0-2 Days,80.3,75.6 to 84.3,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2017,Age,0-2 Days,82.4,75.7 to 87.6,238
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2017-2018,Age,0-2 Days,83.2,78.6 to 87.0,479
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,93.9,89.1 to 97.1,225
PCV,≥4 Doses,States/Local Areas,Wisconsin,2012,Age,24 Months,78.1,70.4 to 84.9,226
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,93.7,88.6 to 97.0,224
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,88.9,82.1 to 93.9,238
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,90.7,86.6 to 93.9,479
PCV,≥4 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,82.6,76.2 to 88.1,235
PCV,≥4 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,82.0,76.9 to 86.5,459
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,81.4,73.6 to 88.0,224
PCV,≥4 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,80.8,75.8 to 85.4,486
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013,Age,35 Months,92.5,86.5 to 96.5,235
≥1 Dose MMR,,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,91.6,87.1 to 95.0,459
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016,Age,35 Months,94.4,89.4 to 97.5,275
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,94.3,90.0 to 97.2,513
≥1 Dose MMR,,States/Local Areas,Wisconsin,2011,Age,35 Months,93.5,87.3 to 97.3,225
≥1 Dose MMR,,States/Local Areas,Wisconsin,2012,Age,35 Months,93.6,89.3 to 96.6,226
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019,Age,24 Months,89.6,83.4 to 94.3,224
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018,Age,24 Months,89.1,83.3 to 93.6,241
≥1 Dose MMR,,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,89.4,85.3 to 92.8,465
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2015,Age,0-2 Days,75.4,68.9 to 80.9,262
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2015-2016,Age,0-2 Days,76.8,72.2 to 80.8,537
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2014,Age,0-2 Days,72.4,65.1 to 78.8,224
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2014-2015,Age,0-2 Days,73.9,69.0 to 78.3,486
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013,Age,35 Months,91.7,85.9 to 95.8,235
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,90.4,86.0 to 93.9,459
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,65.9,57.0 to 73.8,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2012,Age,35 Months,91.9,87.3 to 95.3,226
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015,Age,24 Months,91.7,87.4 to 95.0,262
≥1 Dose MMR,,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,92.6,89.8 to 94.8,537
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014,Age,35 Months,88.9,82.0 to 94.0,224
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,90.6,86.4 to 94.0,486
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,86.5,80.8 to 90.7,262
PCV,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,88.4,84.8 to 91.3,537
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,83.8,75.5 to 89.7,224
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,85.2,80.1 to 89.1,486
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2013,Age,0-2 Days,70.9,67.4 to 74.2,235
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2013-2014,Age,0-2 Days,71.7,67.3 to 75.7,459
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,7 Months,89.5,84.5 to 93.0,262
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,90.1,86.6 to 92.8,537
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,92.4,87.7 to 95.9,241
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,93.1,89.7 to 95.6,465
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,86.2,78.7 to 91.3,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,86.3,79.4 to 91.1,241
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,86.2,81.4 to 89.9,465
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,92.3,88.9 to 95.7,404
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.1,90.5 to 95.7,661
PCV,≥4 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,86.9,80.7 to 91.9,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,45.7,37.8 to 53.7,241
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,44.3,38.6 to 50.1,465
Hib,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,91.6,86.1 to 95.1,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,86.8,82.3 to 90.3,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,88.4,82.1 to 92.7,225
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,7 Months,37.3,30.6 to 44.5,275
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,37.3,32.1 to 42.7,513
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,7 Months,28.7,22.1 to 36.4,241
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,27.9,23.1 to 33.2,465
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,7 Months,27.0,20.5 to 34.7,224
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Overall,Overall,80.0,76.9 to 83.0,923
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,72.1,64.2 to 79.9,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,82.7,78.5 to 86.9,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.9,75.8 to 85.9,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.5,72.5 to 80.4,661
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,82.7 to 95.6,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,90.4,85.4 to 95.4,125
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,13 Months,87.6,81.8 to 91.8,235
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,86.6,83.0 to 89.5,459
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,13 Months,85.6,77.5 to 91.1,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,87.1,82.2 to 90.9,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,13 Months,87.3,82.0 to 91.2,226
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,85.0,79.4 to 90.6,236
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,91.8,89.5 to 94.1,923
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.7,90.0 to 97.4,307
PCV,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,87.7,82.0 to 93.4,212
Hib,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,13 Months,92.3,86.5 to 95.7,224
Hib,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,13 Months,91.9,86.3 to 95.3,241
Hib,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,92.1,88.4 to 94.7,465
Hib,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,95.0,88.8 to 97.9,238
Hib,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,93.5,89.7 to 95.9,479
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,13 Months,59.8,51.4 to 67.7,238
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,52.8,47.0 to 58.5,479
Polio,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,93.5,88.7 to 96.3,262
Polio,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,92.6,89.6 to 94.8,537
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,91.8,86.8 to 95.0,275
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,91.0,86.9 to 93.9,513
Polio,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,90.2,83.2 to 94.4,238
Polio,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,89.6,85.1 to 92.9,479
Polio,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,91.6,84.1 to 95.8,235
Polio,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,88.9,85.0 to 91.9,459
Polio,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,90.5,87.5 to 92.9,226
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,86.1,78.2 to 91.5,224
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,89.8,85.5 to 92.9,486
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,13 Months,63.5,56.2 to 70.2,262
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,60.5,55.3 to 65.5,537
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,13 Months,57.5,50.0 to 64.7,275
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,58.6,53.0 to 64.0,513
DTaP,≥3 Doses,States/Local Areas,Ohio,2012,Age,13 Months,92.4,87.0 to 95.7,239
Hib,≥3 Doses,States/Local Areas,Ohio,2019,Age,13 Months,80.0,73.0 to 85.5,384
PCV,≥4 Doses,States/Local Areas,Ohio,2020,Age,35 Months,82.3,77.0 to 87.0,484
Hib,≥2 Doses,States/Local Areas,Ohio,2020,Age,13 Months,91.7,87.5 to 94.6,484
Hib,≥3 Doses,States/Local Areas,Ohio,2012,Age,19 Months,95.6,88.7 to 98.4,239
Hib,≥3 Doses,States/Local Areas,Ohio,2011,Age,19 Months,90.5,86.2 to 93.5,229
Hib,≥3 Doses,States/Local Areas,Ohio,2018,Age,13 Months,80.1,74.2 to 84.8,406
Hib,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,80.0,75.6 to 83.8,790
Polio,≥3 Doses,States/Local Areas,Ohio,2016,Age,19 Months,92.2,86.5 to 95.6,283
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,89.2,84.5 to 92.5,566
Polio,≥3 Doses,States/Local Areas,Ohio,2017,Age,19 Months,86.2,78.3 to 91.5,283
Polio,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,89.1,84.7 to 92.3,689
Hib,≥3 Doses,States/Local Areas,Ohio,2015,Age,13 Months,74.3,67.6 to 80.1,292
Hib,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,76.0,71.0 to 80.4,575
Polio,≥3 Doses,States/Local Areas,Ohio,2013,Age,19 Months,88.3,86.3 to 90.1,207
Polio,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,87.9,86.6 to 89.1,439
Polio,≥3 Doses,States/Local Areas,Ohio,2014,Age,19 Months,87.4,81.7 to 91.6,232
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,85.5,81.5 to 88.8,524
Polio,≥3 Doses,States/Local Areas,Ohio,2012,Age,19 Months,93.6,85.0 to 97.4,239
Polio,≥3 Doses,States/Local Areas,Ohio,2015,Age,19 Months,83.6,80.6 to 86.3,292
Polio,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,87.9,84.0 to 90.9,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2018,Age,13 Months,87.3,82.2 to 91.1,406
DTaP,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,88.4,84.6 to 91.4,790
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,74.6,68.3 to 80.9,337
Hib,≥3 Doses,States/Local Areas,Ohio,2016,Age,13 Months,77.7,69.9 to 83.9,283
Hib,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,77.0,71.5 to 81.7,566
Hib,≥3 Doses,States/Local Areas,Ohio,2017,Age,13 Months,76.2,68.2 to 82.8,283
Hib,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,78.1,73.2 to 82.3,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2019,Age,13 Months,89.5,83.2 to 93.6,384
DTaP,≥3 Doses,States/Local Areas,Ohio,2011,Age,19 Months,91.7,88.9 to 93.8,229
DTaP,≥3 Doses,States/Local Areas,Ohio,2013,Age,19 Months,91.7,90.0 to 93.1,207
DTaP,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,90.3,88.5 to 91.8,439
DTaP,≥3 Doses,States/Local Areas,Ohio,2012,Age,19 Months,95.9,90.1 to 98.4,239
DTaP,≥3 Doses,States/Local Areas,Ohio,2013,Age,13 Months,88.8,83.7 to 92.4,207
DTaP,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,88.2,86.8 to 89.4,439
DTaP,≥3 Doses,States/Local Areas,Ohio,2014,Age,13 Months,87.5,81.5 to 91.8,232
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,85.1,81.0 to 88.5,524
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,69.4,58.9 to 79.9,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Overall,Overall,75.8,71.9 to 79.6,973
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.8,70.0 to 81.7,423
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,78.5,73.0 to 84.0,391
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.6,70.0 to 79.2,669
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.3,61.9 to 84.6,111
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,74.5,57.6 to 91.4,89
Hib,≥2 Doses,States/Local Areas,Ohio,2018,Age,13 Months,93.7,89.7 to 96.2,406
Hib,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,93.9,91.2 to 95.8,790
Hib,≥2 Doses,States/Local Areas,Ohio,2017,Age,13 Months,88.5,80.8 to 93.4,283
Hib,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,91.1,86.9 to 94.0,689
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,90.2,85.1 to 95.3,159
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.8,80.4 to 91.2,423
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,84.6,79.9 to 89.3,337
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,88.0,85.1 to 91.0,973
Hib,≥2 Doses,States/Local Areas,Ohio,2019,Age,13 Months,94.2,89.8 to 96.8,384
Hib,≥3 Doses,States/Local Areas,Ohio,2019,Age,7 Months,56.0,48.8 to 63.0,384
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,85.1 to 93.4,391
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.4,87.0 to 93.7,669
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,72.7,64.2 to 81.2,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,79.1,73.7 to 84.5,353
Hib,≥3 Doses,States/Local Areas,Ohio,2013,Age,13 Months,81.3,78.2 to 84.1,207
Hib,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,82.3,80.2 to 84.2,439
Polio,≥3 Doses,States/Local Areas,Ohio,2011,Age,19 Months,92.0,90.4 to 93.3,229
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,92.9,86.2 to 99.6,283
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,89.2,84.6 to 93.8,353
Hib,≥3 Doses,States/Local Areas,Ohio,2014,Age,13 Months,83.2,76.5 to 88.3,232
Hib,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,78.8,74.1 to 82.9,524
Hib,≥3 Doses,States/Local Areas,Ohio,2011,Age,13 Months,82.8,78.6 to 86.3,229
Hib,≥3 Doses,States/Local Areas,Ohio,2012,Age,13 Months,84.0,77.3 to 89.0,239
DTaP,≥3 Doses,States/Local Areas,Ohio,2017,Age,13 Months,85.2,77.2 to 90.7,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,86.3,81.7 to 89.8,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2015,Age,13 Months,82.7,76.6 to 87.5,292
DTaP,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,86.5,82.4 to 89.7,575
Hib,≥2 Doses,States/Local Areas,Ohio,2019,Age,7 Months,89.9,84.5 to 93.6,384
DTaP,≥3 Doses,States/Local Areas,Ohio,2016,Age,13 Months,90.2,84.2 to 94.1,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,87.7,82.9 to 91.3,566
Hib,≥3 Doses,States/Local Areas,Ohio,2017,Age,7 Months,58.9,50.8 to 66.6,283
Hib,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,59.3,53.9 to 64.4,689
Hib,≥3 Doses,States/Local Areas,Ohio,2018,Age,7 Months,59.7,52.7 to 66.3,406
Hib,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,57.9,52.9 to 62.7,790
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,78.8 to 96.6,111
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,82.6,71.0 to 94.2,89
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.1,73.2 to 91.0,104
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,86.4,82.2 to 90.6,386
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,90.8,86.4 to 95.1,554
Hib,≥2 Doses,States/Local Areas,Ohio,2018,Age,7 Months,87.7,82.6 to 91.4,406
Hib,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,88.8,85.3 to 91.5,790
PCV,≥3 Doses,States/Local Areas,Ohio,2014,Age,35 Months,91.4,86.8 to 94.9,232
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,90.1,86.8 to 92.9,524
PCV,≥3 Doses,States/Local Areas,Ohio,2015,Age,35 Months,89.0,84.0 to 92.9,292
PCV,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,91.0,87.5 to 93.8,575
PCV,≥3 Doses,States/Local Areas,Ohio,2016,Age,35 Months,93.2,88.1 to 96.7,283
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,90.5,86.1 to 94.0,566
Polio,≥2 Doses,States/Local Areas,Ohio,2012,Age,5 Months,79.4,75.4 to 83.0,239
Polio,≥2 Doses,States/Local Areas,Ohio,2011,Age,5 Months,73.0,63.6 to 80.8,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2012,Age,35 Months,88.1,81.7 to 93.1,239
Polio,≥2 Doses,States/Local Areas,Ohio,2013,Age,5 Months,68.3,66.0 to 70.5,207
Polio,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,5 Months,73.7,69.1 to 77.8,439
Polio,≥2 Doses,States/Local Areas,Ohio,2014,Age,5 Months,79.0,71.8 to 84.8,232
Polio,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,5 Months,74.5,69.7 to 78.8,524
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,85.1,80.4 to 89.7,337
Hep A,≥2 Doses,States/Local Areas,Ohio,2018,Age,24 Months,44.9,38.4 to 52.0,406
Hep A,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,47.2,42.1 to 52.5,790
Hep A,≥2 Doses,States/Local Areas,Ohio,2017,Age,24 Months,43.8,36.4 to 51.9,283
Hep A,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,44.4,39.4 to 49.8,689
Hep A,≥2 Doses,States/Local Areas,Ohio,2016,Age,24 Months,43.1,35.3 to 51.9,283
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,43.4,38.0 to 49.3,566
DTaP,≥4 Doses,States/Local Areas,Ohio,2013,Age,24 Months,78.1,70.5 to 85.0,207
DTaP,≥4 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,78.2,73.0 to 83.0,439
Hep A,≥1 Dose,States/Local Areas,Ohio,2015,Age,35 Months,83.4,74.1 to 90.8,292
Hep A,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,35 Months,84.8,79.4 to 89.4,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,92.9,86.2 to 99.6,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,90.9,86.7 to 95.2,353
Hep B,≥3 Doses,States/Local Areas,Ohio,2012,Age,7 Months,58.5,55.8 to 61.1,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2011,Age,7 Months,46.4,42.0 to 51.0,229
Hep B,≥3 Doses,States/Local Areas,Ohio,2013,Age,7 Months,55.9,48.6 to 62.9,207
Hep B,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,56.2,50.9 to 61.3,439
DTaP,≥4 Doses,States/Local Areas,Ohio,2019,Age,19 Months,73.6,66.3 to 79.7,384
DTaP,≥4 Doses,States/Local Areas,Ohio,2011,Age,24 Months,71.7,63.8 to 79.3,229
DTaP,≥4 Doses,States/Local Areas,Ohio,2012,Age,24 Months,90.0,84.7 to 94.0,239
Hep A,≥1 Dose,States/Local Areas,Ohio,2013,Age,35 Months,82.7,74.7 to 89.3,207
Hep A,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,35 Months,84.0,78.8 to 88.4,439
Hep A,≥1 Dose,States/Local Areas,Ohio,2014,Age,35 Months,85.3,79.2 to 90.4,232
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,35 Months,83.9,78.6 to 88.5,524
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,88.8,86.0 to 91.7,973
Hep A,≥2 Doses,States/Local Areas,Ohio,2015,Age,24 Months,36.2,29.6 to 43.8,292
Hep A,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,39.5,34.3 to 45.2,575
Hep A,≥2 Doses,States/Local Areas,Ohio,2014,Age,24 Months,37.1,29.2 to 46.4,232
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,36.7,31.4 to 42.5,524
Hib,≥3 Doses,States/Local Areas,Ohio,2019,Age,35 Months,93.9,89.8 to 96.8,384
PCV,≥2 Doses,States/Local Areas,Ohio,2018,Age,5 Months,72.7,65.6 to 78.7,406
PCV,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,5 Months,75.2,70.4 to 79.5,790
PCV,≥2 Doses,States/Local Areas,Ohio,2019,Age,5 Months,77.8,70.7 to 83.6,384
PCV,≥2 Doses,States/Local Areas,Ohio,2017,Age,5 Months,73.9,65.8 to 80.7,283
PCV,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,5 Months,73.3,68.0 to 78.0,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,90.2,85.1 to 95.3,159
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.0,81.7 to 92.3,423
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,90.0,86.0 to 94.0,391
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.0,87.7 to 94.3,669
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,78.1 to 96.0,111
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,85.9,75.7 to 96.1,89
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.2,74.7 to 91.8,104
Hep B,≥3 Doses,States/Local Areas,Ohio,2020,Age,24 Months,90.0,85.9 to 93.3,484
DTaP,≥4 Doses,States/Local Areas,Ohio,2016,Age,19 Months,71.6,63.7 to 78.3,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,70.3,64.7 to 75.4,566
DTaP,≥4 Doses,States/Local Areas,Ohio,2017,Age,19 Months,69.1,60.9 to 76.3,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,67.6,62.2 to 72.6,689
DTaP,≥4 Doses,States/Local Areas,Ohio,2018,Age,19 Months,66.1,58.9 to 72.7,406
DTaP,≥4 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,94.0,91.2 to 96.0,790
Hep A,≥2 Doses,States/Local Areas,Ohio,2013,Age,24 Months,42.4,34.2 to 51.7,207
Hep A,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,39.8,33.9 to 46.3,439
≥1 Dose MMR,,States/Local Areas,Ohio,2014,Age,13 Months,50.9,42.5 to 59.2,232
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2015,Age,13 Months,50.6,45.0 to 56.2,524
≥1 Dose MMR,,States/Local Areas,Ohio,2015,Age,13 Months,50.4,43.0 to 57.8,292
≥1 Dose MMR,,States/Local Areas,Ohio,2015-2016,Age,13 Months,52.6,47.1 to 58.0,575
≥1 Dose Varicella,,States/Local Areas,Ohio,2019,Age,13 Months,54.2,47.1 to 61.2,384
≥1 Dose Varicella,,States/Local Areas,Ohio,2011,Age,19 Months,75.6,72.4 to 78.5,229
≥1 Dose Varicella,,States/Local Areas,Ohio,2012,Age,19 Months,88.0,84.6 to 90.7,239
≥1 Dose MMR,,States/Local Areas,Ohio,2016,Age,13 Months,54.8,46.7 to 62.7,283
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2017,Age,13 Months,54.4,48.7 to 60.0,566
≥1 Dose Varicella,,States/Local Areas,Ohio,2018,Age,13 Months,52.0,45.1 to 58.7,406
≥1 Dose Varicella,,States/Local Areas,Ohio,2018-2019,Age,13 Months,53.1,48.1 to 58.0,790
DTaP,≥4 Doses,States/Local Areas,Ohio,2012,Age,35 Months,91.6,86.4 to 95.4,239
DTaP,≥4 Doses,States/Local Areas,Ohio,2014,Age,35 Months,83.5,76.5 to 89.3,232
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,85.1,79.8 to 89.7,524
Hep A,≥2 Doses,States/Local Areas,Ohio,2019,Age,35 Months,85.9,78.1 to 92.1,384
Hep B,≥3 Doses,States/Local Areas,Ohio,2012,Age,13 Months,88.4,80.9 to 93.3,239
DTaP,≥4 Doses,States/Local Areas,Ohio,2013,Age,35 Months,84.7,76.8 to 91.1,207
DTaP,≥4 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,84.1,79.0 to 88.5,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2013,Age,13 Months,87.5,84.5 to 90.0,207
Hep B,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,87.0,85.2 to 88.6,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2014,Age,13 Months,86.5,80.6 to 90.9,232
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,83.5,79.3 to 87.0,524
Hep A,≥2 Doses,States/Local Areas,Ohio,2018,Age,35 Months,80.2,72.1 to 87.2,406
Hep A,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,83.0,77.2 to 88.0,790
Hep A,≥2 Doses,States/Local Areas,Ohio,2017,Age,35 Months,78.7,69.7 to 86.5,283
Hep A,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,79.5,73.5 to 84.8,689
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,79.3,73.5 to 85.2,353
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,66.0,59.6 to 72.5,337
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,72.2,63.0 to 81.4,159
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Overall,Overall,75.2,71.3 to 79.0,973
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,77.0,71.4 to 82.6,391
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,74.9 to 83.6,669
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.4,58.6 to 82.2,111
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,73.3,59.9 to 86.7,89
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.2,74.7 to 91.8,104
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.6,68.4 to 80.8,423
Hib,Primary Series,States/Local Areas,Ohio,2012,Age,7 Months,72.2,67.6 to 76.4,239
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,86.5,79.2 to 93.8,283
Hib,Primary Series,States/Local Areas,Ohio,2011,Age,7 Months,64.6,57.1 to 71.4,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2018,Age,35 Months,93.5,88.0 to 97.1,406
Hep A,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,35 Months,93.2,89.3 to 96.0,790
Polio,≥2 Doses,States/Local Areas,Ohio,2016,Age,5 Months,74.8,67.1 to 81.2,283
Polio,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,5 Months,74.7,69.2 to 79.5,566
Polio,≥2 Doses,States/Local Areas,Ohio,2017,Age,5 Months,74.6,66.4 to 81.3,283
Polio,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,5 Months,74.0,68.8 to 78.7,689
Hep B,≥3 Doses,States/Local Areas,Ohio,2014,Age,7 Months,56.5,48.3 to 64.3,232
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,56.0,50.4 to 61.4,524
Hep B,≥3 Doses,States/Local Areas,Ohio,2015,Age,7 Months,55.5,48.0 to 62.7,292
Hep B,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,52.5,47.1 to 57.9,575
Polio,≥2 Doses,States/Local Areas,Ohio,2019,Age,5 Months,77.4,70.3 to 83.3,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,73.0,59.2 to 86.8,89
Polio,≥2 Doses,States/Local Areas,Ohio,2012,Age,7 Months,92.1,86.7 to 95.5,239
Polio,≥2 Doses,States/Local Areas,Ohio,2011,Age,7 Months,86.0,84.0 to 87.8,229
Hep B,≥3 Doses,States/Local Areas,Ohio,2017,Age,7 Months,58.3,50.3 to 65.9,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,56.6,51.4 to 61.6,689
Hep B,≥3 Doses,States/Local Areas,Ohio,2018,Age,7 Months,54.9,48.2 to 61.3,406
Hep B,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,55.9,51.0 to 60.7,790
Hep A,≥2 Doses,States/Local Areas,Ohio,2016,Age,35 Months,73.5,63.7 to 82.4,283
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,76.3,69.7 to 82.4,566
Hep A,≥2 Doses,States/Local Areas,Ohio,2015,Age,35 Months,62.7,53.9 to 71.6,292
Hep A,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,68.0,61.4 to 74.5,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2019,Age,7 Months,57.0,49.7 to 64.0,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2014,Age,35 Months,66.1,55.5 to 76.3,232
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,64.1,57.3 to 70.9,524
≥1 Dose Varicella,,States/Local Areas,Ohio,2014,Age,13 Months,46.7,38.5 to 55.1,232
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2015,Age,13 Months,47.2,41.7 to 52.7,524
≥1 Dose Varicella,,States/Local Areas,Ohio,2012,Age,13 Months,59.1,54.8 to 63.4,239
Hep A,≥1 Dose,States/Local Areas,Ohio,2019,Age,35 Months,92.2,87.0 to 95.8,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,78.3,73.1 to 83.5,386
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,82.0,76.7 to 87.2,554
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.3,68.7 to 87.9,104
Polio,≥2 Doses,States/Local Areas,Ohio,2018,Age,5 Months,73.5,66.4 to 79.5,406
Polio,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,5 Months,75.5,70.6 to 79.8,790
≥1 Dose Varicella,,States/Local Areas,Ohio,2013,Age,13 Months,54.5,48.4 to 60.5,207
≥1 Dose Varicella,,States/Local Areas,Ohio,2013-2014,Age,13 Months,50.6,44.8 to 56.4,439
DTaP,≥4 Doses,States/Local Areas,Ohio,2014,Age,24 Months,78.4,71.3 to 84.7,232
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,77.1,72.3 to 81.7,524
DTaP,≥4 Doses,States/Local Areas,Ohio,2016,Age,24 Months,79.9,72.8 to 86.2,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,77.9,72.7 to 82.8,566
DTaP,≥4 Doses,States/Local Areas,Ohio,2015,Age,24 Months,75.8,69.2 to 82.0,292
DTaP,≥4 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,77.9,73.0 to 82.4,575
Polio,≥2 Doses,States/Local Areas,Ohio,2015,Age,5 Months,69.9,62.8 to 76.2,292
Polio,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,5 Months,72.4,67.2 to 77.0,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2016,Age,7 Months,49.6,41.7 to 57.4,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,53.9,48.3 to 59.5,566
Hep A,≥2 Doses,States/Local Areas,Ohio,2019,Age,24 Months,49.7,42.1 to 57.9,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2011,Age,35 Months,63.4,53.2 to 73.6,229
Hep A,≥2 Doses,States/Local Areas,Ohio,2012,Age,35 Months,81.6,74.0 to 88.1,239
Hep A,≥2 Doses,States/Local Areas,Ohio,2013,Age,35 Months,61.8,51.7 to 71.9,207
Hep A,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,64.0,56.6 to 71.4,439
Hep A,≥1 Dose,States/Local Areas,Ohio,2016,Age,35 Months,87.4,80.8 to 92.6,283
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,35 Months,86.2,81.2 to 90.5,566
≥1 Dose Varicella,,States/Local Areas,Ohio,2011,Age,13 Months,47.7,41.3 to 54.2,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,65.4 to 88.4,111
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,76.1,67.6 to 84.6,159
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.6,72.7 to 84.5,423
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,81.3,75.8 to 86.7,391
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.8,76.5 to 85.1,669
Polio,≥2 Doses,States/Local Areas,Ohio,2014,Age,7 Months,85.6,79.2 to 90.2,232
Polio,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,84.7,80.5 to 88.2,524
Polio,≥2 Doses,States/Local Areas,Ohio,2013,Age,7 Months,85.6,77.7 to 91.0,207
Polio,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,85.6,82.3 to 88.3,439
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,74.5,68.6 to 80.5,337
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Overall,Overall,79.3,75.6 to 82.9,973
Polio,≥2 Doses,States/Local Areas,Ohio,2015,Age,7 Months,83.9,77.9 to 88.5,292
Polio,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,84.9,80.5 to 88.4,575
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,83.5,78.2 to 88.9,353
Hep B,≥3 Doses,States/Local Areas,Ohio,2011,Age,13 Months,80.0,75.1 to 84.1,229
≥1 Dose MMR,,States/Local Areas,Ohio,2017,Age,13 Months,54.0,46.0 to 61.8,283
≥1 Dose MMR,,States/Local Areas,Ohio,2017-2018,Age,13 Months,58.0,52.6 to 63.2,689
≥1 Dose MMR,,States/Local Areas,Ohio,2018,Age,13 Months,62.0,54.8 to 68.7,406
≥1 Dose MMR,,States/Local Areas,Ohio,2018-2019,Age,13 Months,60.8,55.7 to 65.6,790
≥1 Dose Varicella,,States/Local Areas,Ohio,2014,Age,19 Months,83.9,77.3 to 88.9,232
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2015,Age,19 Months,80.4,75.6 to 84.5,524
≥1 Dose Varicella,,States/Local Areas,Ohio,2015,Age,19 Months,76.9,69.3 to 83.1,292
≥1 Dose Varicella,,States/Local Areas,Ohio,2015-2016,Age,19 Months,82.8,78.0 to 86.7,575
≥1 Dose Varicella,,States/Local Areas,Ohio,2013,Age,19 Months,83.5,78.3 to 87.7,207
≥1 Dose Varicella,,States/Local Areas,Ohio,2013-2014,Age,19 Months,83.7,80.3 to 86.7,439
Polio,≥2 Doses,States/Local Areas,Ohio,2012,Age,13 Months,95.7,89.0 to 98.4,239
Polio,≥2 Doses,States/Local Areas,Ohio,2011,Age,13 Months,92.8,91.5 to 93.9,229
Polio,≥2 Doses,States/Local Areas,Ohio,2013,Age,13 Months,93.1,89.1 to 95.7,207
Polio,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,91.9,90.7 to 93.0,439
Polio,≥2 Doses,States/Local Areas,Ohio,2014,Age,13 Months,90.7,85.6 to 94.1,232
Polio,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,88.9,85.2 to 91.7,524
Hep B,≥1 Dose,States/Local Areas,Ohio,2014,Age,3 Months,94.1,90.0 to 96.6,232
Hep B,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,3 Months,93.9,91.0 to 95.9,524
Hep B,≥1 Dose,States/Local Areas,Ohio,2015,Age,3 Months,93.7,89.4 to 96.3,292
Hep B,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,3 Months,95.7,93.3 to 97.3,575
Hep B,≥1 Dose,States/Local Areas,Ohio,2016,Age,3 Months,97.8,94.8 to 99.1,283
Hep B,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,3 Months,97.1,95.0 to 98.3,566
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.8,49.5 to 78.1,111
Hib,Full Series,States/Local Areas,Ohio,2020,Age,24 Months,76.7,71.4 to 81.7,484
DTaP,≥4 Doses,States/Local Areas,Ohio,2019,Age,24 Months,84.8,78.4 to 90.2,384
DTaP,≥4 Doses,States/Local Areas,Ohio,2011,Age,35 Months,78.5,69.9 to 86.0,229
DTaP,≥4 Doses,States/Local Areas,Ohio,2018,Age,24 Months,77.2,70.2 to 83.5,406
DTaP,≥4 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,80.8,76.1 to 85.1,790
DTaP,≥4 Doses,States/Local Areas,Ohio,2017,Age,24 Months,75.8,68.0 to 82.8,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,76.7,71.5 to 81.6,689
Hep A,≥1 Dose,States/Local Areas,Ohio,2017,Age,35 Months,85.3,77.3 to 91.6,283
Hep A,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,35 Months,89.4,84.5 to 93.3,689
≥1 Dose MMR,,States/Local Areas,Ohio,2013,Age,13 Months,53.7,47.4 to 60.0,207
≥1 Dose MMR,,States/Local Areas,Ohio,2013-2014,Age,13 Months,52.3,47.2 to 57.4,439
≥1 Dose MMR,,States/Local Areas,Ohio,2012,Age,13 Months,58.4,49.7 to 66.5,239
≥1 Dose MMR,,States/Local Areas,Ohio,2011,Age,13 Months,48.1,45.4 to 50.8,229
≥1 Dose Varicella,,States/Local Areas,Ohio,2016,Age,13 Months,56.0,47.8 to 63.8,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2017,Age,13 Months,56.6,50.9 to 62.2,566
≥1 Dose Varicella,,States/Local Areas,Ohio,2017,Age,13 Months,57.3,49.2 to 65.0,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2017-2018,Age,13 Months,54.6,49.3 to 59.8,689
≥1 Dose Varicella,,States/Local Areas,Ohio,2015,Age,13 Months,47.7,40.6 to 54.8,292
≥1 Dose Varicella,,States/Local Areas,Ohio,2015-2016,Age,13 Months,51.8,46.4 to 57.2,575
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,78.2,61.1 to 95.3,89
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,76.4,64.5 to 88.2,391
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.9,64.1 to 75.7,669
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,65.0,52.2 to 77.8,159
DTaP,≥4 Doses,States/Local Areas,Ohio,2017,Age,35 Months,82.3,74.0 to 89.2,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,88.9,83.5 to 93.1,689
DTaP,≥4 Doses,States/Local Areas,Ohio,2016,Age,35 Months,85.3,78.3 to 91.0,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,83.8,78.5 to 88.4,566
Hep B,≥3 Doses,States/Local Areas,Ohio,2016,Age,13 Months,90.2,84.6 to 93.9,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,87.4,82.8 to 91.0,566
Hep B,≥3 Doses,States/Local Areas,Ohio,2015,Age,13 Months,80.5,74.3 to 85.6,292
Hep B,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,85.4,81.3 to 88.7,575
DTaP,≥4 Doses,States/Local Areas,Ohio,2015,Age,35 Months,87.0,79.1 to 93.0,292
DTaP,≥4 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,85.7,80.5 to 90.1,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2017,Age,13 Months,84.6,76.7 to 90.2,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,85.0,80.4 to 88.6,689
Hep B,≥1 Dose,States/Local Areas,Ohio,2013,Age,3 Months,93.7,88.8 to 96.6,207
Hep B,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,3 Months,93.9,91.4 to 95.7,439
Hep B,≥1 Dose,States/Local Areas,Ohio,2012,Age,3 Months,97.1,95.2 to 98.2,239
Hep B,≥1 Dose,States/Local Areas,Ohio,2011,Age,3 Months,92.9,88.7 to 95.6,229
Polio,≥2 Doses,States/Local Areas,Ohio,2016,Age,7 Months,85.9,79.0 to 90.8,283
Polio,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,85.3,80.3 to 89.2,566
Polio,≥2 Doses,States/Local Areas,Ohio,2017,Age,7 Months,84.6,76.9 to 90.1,283
Polio,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,86.7,82.2 to 90.1,689
Polio,≥2 Doses,States/Local Areas,Ohio,2018,Age,7 Months,88.7,83.7 to 92.3,406
Polio,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,89.6,86.1 to 92.2,790
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,73.8,60.1 to 87.5,89
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.7,76.6 to 84.8,669
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.4,60.6 to 84.1,111
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,72.3,63.3 to 81.3,159
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,77.0,73.2 to 80.7,973
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.7,72.9 to 84.6,423
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,77.3,71.6 to 83.0,391
≥1 Dose MMR,,States/Local Areas,Ohio,2015,Age,19 Months,79.6,73.7 to 84.4,292
≥1 Dose MMR,,States/Local Areas,Ohio,2015-2016,Age,19 Months,84.1,79.6 to 87.8,575
≥1 Dose MMR,,States/Local Areas,Ohio,2016,Age,19 Months,88.7,82.1 to 93.1,283
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2017,Age,19 Months,84.7,79.4 to 88.7,566
≥1 Dose MMR,,States/Local Areas,Ohio,2017,Age,19 Months,80.5,72.1 to 86.9,283
≥1 Dose MMR,,States/Local Areas,Ohio,2017-2018,Age,19 Months,82.6,77.2 to 86.8,689
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,68.1,61.8 to 74.5,337
≥1 Dose Varicella,,States/Local Areas,Ohio,2011,Age,24 Months,79.5,72.0 to 86.1,229
≥1 Dose Varicella,,States/Local Areas,Ohio,2012,Age,24 Months,93.0,88.8 to 96.1,239
Hep B,≥1 Dose,States/Local Areas,Ohio,2018,Age,3 Months,95.8,92.2 to 97.8,406
Hep B,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,3 Months,95.4,92.8 to 97.1,790
Hep B,≥1 Dose,States/Local Areas,Ohio,2019,Age,3 Months,95.0,90.6 to 97.4,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,74.0,63.8 to 84.2,353
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2011,Age,0-1 Days,65.4,60.7 to 69.8,229
Hep B,≥2 Doses,States/Local Areas,Ohio,2012,Age,5 Months,88.0,86.7 to 89.2,239
Hep B,≥2 Doses,States/Local Areas,Ohio,2011,Age,5 Months,88.1,85.3 to 90.5,229
Hep B,≥2 Doses,States/Local Areas,Ohio,2013,Age,5 Months,85.1,76.4 to 90.9,207
Hep B,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,5 Months,86.5,82.4 to 89.7,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2013,Age,19 Months,90.3,86.1 to 93.3,207
Hep B,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,89.8,88.1 to 91.3,439
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,78.0,68.5 to 87.6,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2014,Age,19 Months,89.3,83.8 to 93.1,232
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,86.8,82.8 to 89.9,524
Hep B,≥3 Doses,States/Local Areas,Ohio,2015,Age,19 Months,84.2,82.0 to 86.1,292
Hep B,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,88.6,84.9 to 91.5,575
DTaP,≥4 Doses,States/Local Areas,Ohio,2019,Age,35 Months,91.8,84.4 to 96.6,384
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,70.6,64.8 to 76.4,386
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,85.2,80.4 to 89.9,554
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.9,55.6 to 78.2,104
≥1 Dose MMR,,States/Local Areas,Ohio,2011,Age,19 Months,80.7,72.8 to 86.8,229
≥1 Dose MMR,,States/Local Areas,Ohio,2013,Age,19 Months,84.8,79.6 to 88.9,207
≥1 Dose MMR,,States/Local Areas,Ohio,2013-2014,Age,19 Months,85.2,82.2 to 87.8,439
≥1 Dose MMR,,States/Local Areas,Ohio,2014,Age,19 Months,85.6,79.4 to 90.2,232
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2015,Age,19 Months,82.6,78.1 to 86.3,524
≥1 Dose MMR,,States/Local Areas,Ohio,2012,Age,19 Months,90.0,86.0 to 93.0,239
≥1 Dose Varicella,,States/Local Areas,Ohio,2017,Age,19 Months,80.7,72.3 to 87.0,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2017-2018,Age,19 Months,81.9,76.5 to 86.2,689
≥1 Dose Varicella,,States/Local Areas,Ohio,2018,Age,19 Months,83.0,75.9 to 88.3,406
≥1 Dose Varicella,,States/Local Areas,Ohio,2018-2019,Age,19 Months,53.1,48.1 to 58.0,790
≥1 Dose MMR,,States/Local Areas,Ohio,2019,Age,13 Months,59.6,52.3 to 66.5,384
≥1 Dose Varicella,,States/Local Areas,Ohio,2016,Age,19 Months,88.7,82.1 to 93.1,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2017,Age,19 Months,84.7,79.5 to 88.8,566
Polio,≥2 Doses,States/Local Areas,Ohio,2015,Age,13 Months,87.1,81.5 to 91.2,292
Polio,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,89.4,85.7 to 92.2,575
Polio,≥2 Doses,States/Local Areas,Ohio,2016,Age,13 Months,91.7,86.3 to 95.1,283
Polio,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,90.0,85.6 to 93.2,566
Hep B,≥1 Dose,States/Local Areas,Ohio,2017,Age,3 Months,96.4,92.8 to 98.2,283
Hep B,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,3 Months,96.1,93.8 to 97.6,689
Polio,≥2 Doses,States/Local Areas,Ohio,2019,Age,7 Months,90.4,85.0 to 94.0,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,72.2,65.4 to 79.0,973
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,65.6,56.6 to 74.7,337
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.7,63.1 to 78.3,423
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,81.7,73.6 to 89.8,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2012,Age,19 Months,93.5,88.3 to 96.5,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2018,Age,13 Months,85.3,80.0 to 89.4,406
Hep B,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,85.8,81.8 to 89.0,790
Hep B,≥3 Doses,States/Local Areas,Ohio,2019,Age,13 Months,86.2,79.7 to 90.8,384
Hep B,≥3 Doses,States/Local Areas,Ohio,2011,Age,19 Months,86.9,85.1 to 88.5,229
DTaP,≥4 Doses,States/Local Areas,Ohio,2018,Age,35 Months,93.5,87.4 to 97.3,406
DTaP,≥4 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,92.7,88.3 to 96.0,790
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2016,Age,0-1 Days,69.5,61.6 to 76.4,283
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2016-2017,Age,0-1 Days,71.0,65.5 to 76.0,566
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2017,Age,0-1 Days,72.5,64.4 to 79.4,283
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2017-2018,Age,0-1 Days,73.8,68.7 to 78.3,689
Hep B,≥2 Doses,States/Local Areas,Ohio,2019,Age,5 Months,89.5,84.2 to 93.2,384
Hep B,≥2 Doses,States/Local Areas,Ohio,2011,Age,7 Months,92.2,90.6 to 93.5,229
Hep B,≥2 Doses,States/Local Areas,Ohio,2017,Age,5 Months,87.7,80.3 to 92.6,283
Hep B,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,5 Months,88.6,84.3 to 91.9,689
Hep B,≥2 Doses,States/Local Areas,Ohio,2018,Age,5 Months,89.5,84.4 to 93.1,406
Hep B,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,5 Months,89.5,86.0 to 92.2,790
PCV,≥3 Doses,States/Local Areas,Ohio,2013,Age,7 Months,53.7,47.6 to 59.7,207
PCV,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,57.6,53.0 to 62.1,439
PCV,≥3 Doses,States/Local Areas,Ohio,2011,Age,7 Months,60.8,53.3 to 67.8,229
Hep B,≥3 Doses,States/Local Areas,Ohio,2016,Age,19 Months,93.1,88.0 to 96.1,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,90.3,85.8 to 93.4,566
PCV,≥3 Doses,States/Local Areas,Ohio,2014,Age,7 Months,61.6,53.2 to 69.3,232
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,60.7,55.2 to 65.9,524
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,87.3,80.3 to 94.3,283
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,81.5,75.9 to 87.1,353
PCV,≥3 Doses,States/Local Areas,Ohio,2012,Age,7 Months,68.0,64.9 to 70.9,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2017,Age,19 Months,87.4,79.5 to 92.5,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,88.4,84.0 to 91.7,689
Hep B,≥3 Doses,States/Local Areas,Ohio,2018,Age,19 Months,89.4,84.4 to 93.0,406
Hep B,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,85.8,81.8 to 89.0,790
Hep B,≥2 Doses,States/Local Areas,Ohio,2016,Age,5 Months,89.2,83.0 to 93.3,283
Hep B,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,5 Months,88.4,83.9 to 91.8,566
Hep B,≥2 Doses,States/Local Areas,Ohio,2014,Age,5 Months,87.9,82.4 to 91.8,232
Hep B,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,5 Months,86.3,84.9 to 87.7,524
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2012,Age,0-1 Days,56.0,51.0 to 60.8,239
Polio,≥2 Doses,States/Local Areas,Ohio,2018,Age,13 Months,94.6,91.0 to 96.8,406
Polio,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,94.0,91.2 to 96.0,790
Polio,≥2 Doses,States/Local Areas,Ohio,2019,Age,13 Months,93.4,88.6 to 96.3,384
≥1 Dose Varicella,,States/Local Areas,Ohio,2019,Age,19 Months,88.2,82.5 to 92.2,384
DTaP,≥3 Doses,States/Local Areas,Ohio,2020,Age,13 Months,88.1,83.2 to 91.7,484
Polio,≥2 Doses,States/Local Areas,Ohio,2017,Age,13 Months,88.3,80.6 to 93.2,283
Polio,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,91.5,87.3 to 94.3,689
≥1 Dose Varicella,,States/Local Areas,Ohio,2014,Age,24 Months,87.1,81.3 to 91.8,232
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2015,Age,24 Months,84.3,79.9 to 88.2,524
≥1 Dose Varicella,,States/Local Areas,Ohio,2013,Age,24 Months,85.4,78.2 to 91.2,207
≥1 Dose Varicella,,States/Local Areas,Ohio,2013-2014,Age,24 Months,86.3,81.8 to 90.1,439
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2013,Age,0-1 Days,69.8,65.7 to 73.7,207
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2013-2014,Age,0-1 Days,65.1,63.7 to 66.5,439
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2014,Age,0-1 Days,60.3,51.8 to 68.3,232
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2014-2015,Age,0-1 Days,61.1,55.4 to 66.5,524
Hep B,≥2 Doses,States/Local Areas,Ohio,2015,Age,5 Months,84.8,79.1 to 89.1,292
Hep B,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,5 Months,87.0,83.0 to 90.1,575
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2015,Age,0-1 Days,61.9,54.3 to 69.0,292
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2015-2016,Age,0-1 Days,65.7,60.3 to 70.8,575
≥1 Dose Varicella,,States/Local Areas,Ohio,2017,Age,24 Months,81.6,73.9 to 88.2,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2017-2018,Age,24 Months,84.6,79.6 to 88.9,689
≥1 Dose Varicella,,States/Local Areas,Ohio,2019,Age,24 Months,93.0,88.1 to 96.4,384
≥1 Dose Varicella,,States/Local Areas,Ohio,2011,Age,35 Months,89.4,82.1 to 94.7,229
≥1 Dose Varicella,,States/Local Areas,Ohio,2012,Age,35 Months,95.2,91.2 to 97.7,239
≥1 Dose Varicella,,States/Local Areas,Ohio,2018,Age,24 Months,87.1,80.4 to 92.4,406
≥1 Dose Varicella,,States/Local Areas,Ohio,2018-2019,Age,24 Months,89.9,85.8 to 93.3,790
≥1 Dose MMR,,States/Local Areas,Ohio,2015,Age,24 Months,85.7,80.3 to 90.3,292
≥1 Dose MMR,,States/Local Areas,Ohio,2015-2016,Age,24 Months,87.5,83.5 to 90.9,575
≥1 Dose MMR,,States/Local Areas,Ohio,2014,Age,24 Months,88.0,82.5 to 92.5,232
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2015,Age,24 Months,86.9,83.1 to 90.2,524
≥1 Dose MMR,,States/Local Areas,Ohio,2013,Age,24 Months,86.6,79.7 to 92.2,207
≥1 Dose MMR,,States/Local Areas,Ohio,2013-2014,Age,24 Months,87.3,82.9 to 91.0,439
PCV,≥3 Doses,States/Local Areas,Ohio,2017,Age,7 Months,66.7,58.5 to 74.0,283
PCV,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,65.5,60.1 to 70.5,689
PCV,≥3 Doses,States/Local Areas,Ohio,2015,Age,7 Months,59.8,52.6 to 66.6,292
PCV,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,59.9,54.4 to 65.1,575
PCV,≥4 Doses,States/Local Areas,Ohio,2014,Age,19 Months,73.9,65.9 to 80.6,232
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,71.5,66.2 to 76.3,524
PCV,≥4 Doses,States/Local Areas,Ohio,2015,Age,19 Months,69.2,66.0 to 72.1,292
PCV,≥4 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,76.0,71.0 to 80.3,575
PCV,≥4 Doses,States/Local Areas,Ohio,2016,Age,19 Months,82.8,75.7 to 88.2,283
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,79.7,74.3 to 84.1,566
PCV,≥3 Doses,States/Local Areas,Ohio,2016,Age,7 Months,59.9,51.7 to 67.7,283
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,63.3,57.5 to 68.7,566
Hep B,≥3 Doses,States/Local Areas,Ohio,2012,Age,24 Months,93.5,89.6 to 96.4,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2013,Age,24 Months,90.9,85.2 to 95.1,207
Hep B,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,90.9,87.4 to 93.8,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2019,Age,19 Months,89.9,84.7 to 93.5,384
Hep B,≥3 Doses,States/Local Areas,Ohio,2011,Age,24 Months,89.3,82.9 to 94.2,229
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2018,Age,0-1 Days,75.1,68.6 to 80.7,406
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2018-2019,Age,0-1 Days,76.4,71.9 to 80.4,790
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2019,Age,0-1 Days,77.7,71.2 to 83.0,384
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2011,Age,0-2 Days,76.0,71.0 to 80.3,229
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2013,Age,0-2 Days,78.5,75.4 to 81.3,207
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2013-2014,Age,0-2 Days,73.0,69.4 to 76.3,439
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2012,Age,0-2 Days,71.0,69.1 to 72.9,239
Hep B,≥2 Doses,States/Local Areas,Ohio,2013,Age,7 Months,88.3,82.1 to 92.5,207
Hep B,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,89.7,86.2 to 92.3,439
Hep B,≥2 Doses,States/Local Areas,Ohio,2014,Age,7 Months,91.1,86.2 to 94.3,232
Hep B,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,89.4,85.9 to 92.1,524
Hep B,≥2 Doses,States/Local Areas,Ohio,2012,Age,7 Months,92.8,89.8 to 95.0,239
PCV,≥3 Doses,States/Local Areas,Ohio,2018,Age,7 Months,64.2,57.2 to 70.7,406
PCV,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,64.2,59.1 to 68.9,790
PCV,≥3 Doses,States/Local Areas,Ohio,2019,Age,7 Months,64.1,56.7 to 70.8,384
PCV,≥3 Doses,States/Local Areas,Ohio,2011,Age,13 Months,82.7,78.6 to 86.1,229
PCV,≥4 Doses,States/Local Areas,Ohio,2017,Age,19 Months,76.5,68.2 to 83.1,283
PCV,≥4 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,74.9,69.6 to 79.6,689
PCV,≥4 Doses,States/Local Areas,Ohio,2018,Age,19 Months,73.4,66.3 to 79.4,406
PCV,≥4 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,76.3,70.6 to 81.3,644
≥1 Dose MMR,,States/Local Areas,Ohio,2017,Age,24 Months,81.8,74.0 to 88.4,283
≥1 Dose MMR,,States/Local Areas,Ohio,2017-2018,Age,24 Months,85.0,80.0 to 89.3,689
≥1 Dose MMR,,States/Local Areas,Ohio,2016,Age,24 Months,89.2,83.1 to 93.8,283
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2017,Age,24 Months,85.5,80.6 to 89.7,566
PCV,≥3 Doses,States/Local Areas,Ohio,2012,Age,13 Months,89.8,84.1 to 93.5,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2016,Age,24 Months,93.6,89.0 to 96.7,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,90.5,86.4 to 93.9,566
Hep B,≥3 Doses,States/Local Areas,Ohio,2015,Age,24 Months,86.2,81.0 to 90.5,292
Hep B,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,89.9,86.5 to 92.7,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2014,Age,24 Months,91.0,86.4 to 94.5,232
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,88.7,85.2 to 91.7,524
PCV,≥4 Doses,States/Local Areas,Ohio,2013,Age,19 Months,74.8,68.2 to 80.5,207
PCV,≥4 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,74.4,67.8 to 80.0,439
PCV,≥4 Doses,States/Local Areas,Ohio,2012,Age,19 Months,83.7,80.3 to 86.5,239
PCV,≥4 Doses,States/Local Areas,Ohio,2011,Age,19 Months,69.1,61.8 to 75.5,229
≥1 Dose MMR,,States/Local Areas,Ohio,2018,Age,19 Months,84.6,77.5 to 89.7,406
≥1 Dose MMR,,States/Local Areas,Ohio,2018-2019,Age,19 Months,93.9,91.2 to 95.8,790
≥1 Dose MMR,,States/Local Areas,Ohio,2019,Age,19 Months,88.4,82.9 to 92.2,384
≥1 Dose MMR,,States/Local Areas,Ohio,2011,Age,24 Months,84.7,78.0 to 90.3,229
≥1 Dose MMR,,States/Local Areas,Ohio,2012,Age,24 Months,94.1,90.1 to 96.8,239
≥1 Dose Varicella,,States/Local Areas,Ohio,2015,Age,24 Months,81.4,74.9 to 87.2,292
≥1 Dose Varicella,,States/Local Areas,Ohio,2015-2016,Age,24 Months,85.1,80.7 to 88.9,575
≥1 Dose Varicella,,States/Local Areas,Ohio,2016,Age,24 Months,88.7,82.7 to 93.4,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2017,Age,24 Months,85.2,80.4 to 89.4,566
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2014,Age,0-2 Days,67.5,59.0 to 74.9,232
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2014-2015,Age,0-2 Days,69.5,63.9 to 74.5,524
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2015,Age,0-2 Days,71.5,64.0 to 78.0,292
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2015-2016,Age,0-2 Days,75.8,70.7 to 80.3,575
PCV,≥4 Doses,States/Local Areas,Ohio,2011,Age,24 Months,73.3,65.4 to 80.6,229
≥1 Dose Varicella,,States/Local Areas,Ohio,2015,Age,35 Months,84.4,77.7 to 89.9,292
≥1 Dose Varicella,,States/Local Areas,Ohio,2015-2016,Age,35 Months,87.8,83.4 to 91.5,575
≥1 Dose Varicella,,States/Local Areas,Ohio,2014,Age,35 Months,88.1,82.3 to 92.7,232
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2015,Age,35 Months,86.3,81.9 to 90.1,524
PCV,≥4 Doses,States/Local Areas,Ohio,2019,Age,19 Months,78.9,71.6 to 84.8,384
≥1 Dose MMR,,States/Local Areas,Ohio,2018,Age,24 Months,88.0,81.3 to 93.2,406
≥1 Dose MMR,,States/Local Areas,Ohio,2018-2019,Age,24 Months,89.8,85.8 to 93.1,790
≥1 Dose Varicella,,States/Local Areas,Ohio,2013,Age,35 Months,87.7,80.3 to 93.3,207
≥1 Dose Varicella,,States/Local Areas,Ohio,2013-2014,Age,35 Months,88.0,83.5 to 91.8,439
Hib,≥1 Dose,States/Local Areas,Ohio,2013,Age,3 Months,79.3,70.0 to 86.3,207
Hib,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,3 Months,80.8,75.2 to 85.3,439
Hib,≥1 Dose,States/Local Areas,Ohio,2012,Age,3 Months,88.9,85.5 to 91.5,239
Hib,≥1 Dose,States/Local Areas,Ohio,2011,Age,3 Months,86.8,85.2 to 88.3,229
Hib,≥1 Dose,States/Local Areas,Ohio,2014,Age,3 Months,82.2,75.4 to 87.4,232
Hib,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,3 Months,82.9,78.4 to 86.7,524
Hep B,≥2 Doses,States/Local Areas,Ohio,2014,Age,13 Months,93.3,88.9 to 96.0,232
Hep B,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,92.4,89.5 to 94.6,524
Hep B,≥2 Doses,States/Local Areas,Ohio,2015,Age,13 Months,91.6,87.3 to 94.5,292
Hep B,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,93.6,90.7 to 95.6,575
Hep B,≥2 Doses,States/Local Areas,Ohio,2016,Age,13 Months,95.5,91.0 to 97.8,283
Hep B,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,92.6,88.4 to 95.4,566
PCV,≥3 Doses,States/Local Areas,Ohio,2019,Age,13 Months,87.5,81.0 to 92.0,384
PCV,≥3 Doses,States/Local Areas,Ohio,2011,Age,19 Months,87.9,83.7 to 91.1,229
PCV,≥3 Doses,States/Local Areas,Ohio,2013,Age,19 Months,92.4,89.6 to 94.5,207
PCV,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,90.6,89.1 to 91.9,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2016,Age,35 Months,93.8,89.2 to 96.9,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,90.7,86.6 to 94.0,566
PCV,≥4 Doses,States/Local Areas,Ohio,2019,Age,24 Months,82.3,75.4 to 88.2,384
PCV,≥4 Doses,States/Local Areas,Ohio,2018,Age,24 Months,79.1,72.6 to 85.0,406
PCV,≥4 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,80.6,75.9 to 84.8,790
PCV,≥4 Doses,States/Local Areas,Ohio,2011,Age,35 Months,76.7,68.5 to 84.1,229
PCV,≥4 Doses,States/Local Areas,Ohio,2012,Age,35 Months,89.5,83.0 to 94.3,239
PCV,≥3 Doses,States/Local Areas,Ohio,2012,Age,19 Months,94.2,87.9 to 97.3,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2017,Age,35 Months,87.4,80.3 to 92.9,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,91.1,87.1 to 94.3,689
Hep B,≥2 Doses,States/Local Areas,Ohio,2019,Age,7 Months,92.7,87.9 to 95.7,384
Hep B,≥2 Doses,States/Local Areas,Ohio,2011,Age,13 Months,93.2,91.6 to 94.4,229
Hep B,≥2 Doses,States/Local Areas,Ohio,2013,Age,13 Months,92.6,88.7 to 95.3,207
Hep B,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,93.0,91.0 to 94.5,439
Hep B,≥2 Doses,States/Local Areas,Ohio,2012,Age,13 Months,96.0,92.1 to 98.0,239
PCV,≥3 Doses,States/Local Areas,Ohio,2017,Age,13 Months,84.0,75.9 to 89.7,283
PCV,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,84.6,79.9 to 88.4,689
PCV,≥3 Doses,States/Local Areas,Ohio,2018,Age,13 Months,85.2,79.6 to 89.5,406
PCV,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,86.4,82.3 to 89.6,790
Hep B,≥3 Doses,States/Local Areas,Ohio,2012,Age,35 Months,95.7,91.9 to 98.0,239
Hep B,≥3 Doses,States/Local Areas,Ohio,2015,Age,35 Months,88.1,83.0 to 92.3,292
Hep B,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,90.8,87.4 to 93.6,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2014,Age,35 Months,92.0,87.6 to 95.3,232
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,90.1,86.7 to 93.0,524
Hep B,≥3 Doses,States/Local Areas,Ohio,2013,Age,35 Months,91.5,85.6 to 95.7,207
Hep B,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,91.8,88.2 to 94.6,439
PCV,≥3 Doses,States/Local Areas,Ohio,2016,Age,13 Months,87.7,81.2 to 92.2,283
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,85.9,80.9 to 89.7,566
≥1 Dose MMR,,States/Local Areas,Ohio,2014,Age,35 Months,91.7,85.3 to 96.1,232
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2015,Age,35 Months,92.1,87.2 to 95.6,524
≥1 Dose MMR,,States/Local Areas,Ohio,2015,Age,35 Months,91.6,84.5 to 96.3,292
≥1 Dose MMR,,States/Local Areas,Ohio,2015-2016,Age,35 Months,90.5,86.5 to 93.8,575
PCV,≥4 Doses,States/Local Areas,Ohio,2017,Age,24 Months,78.3,70.5 to 85.2,283
PCV,≥4 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,78.7,73.7 to 83.4,689
PCV,≥4 Doses,States/Local Areas,Ohio,2016,Age,24 Months,83.4,76.7 to 89.0,283
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,80.8,75.7 to 85.4,566
PCV,≥4 Doses,States/Local Areas,Ohio,2015,Age,24 Months,74.2,67.6 to 80.5,292
PCV,≥4 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,78.8,74.1 to 83.1,575
≥1 Dose MMR,,States/Local Areas,Ohio,2016,Age,35 Months,90.8,84.8 to 95.1,283
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2017,Age,35 Months,88.6,83.7 to 92.5,566
≥1 Dose Varicella,,States/Local Areas,Ohio,2019,Age,35 Months,96.2,92.1 to 98.6,384
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,82.7,77.8 to 87.5,386
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,87.1,82.2 to 92.0,554
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.6,72.6 to 90.6,104
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2016,Age,0-2 Days,80.2,73.1 to 85.8,283
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2016-2017,Age,0-2 Days,79.3,74.0 to 83.7,566
Hep B,≥2 Doses,States/Local Areas,Ohio,2016,Age,7 Months,93.7,88.3 to 96.7,283
Hep B,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,91.2,86.8 to 94.2,566
PCV,≥3 Doses,States/Local Areas,Ohio,2013,Age,13 Months,89.1,82.1 to 93.6,207
PCV,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,87.8,85.8 to 89.5,439
Hep B,≥2 Doses,States/Local Areas,Ohio,2017,Age,7 Months,88.7,81.1 to 93.5,283
Hep B,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,90.5,86.3 to 93.5,689
PCV,≥3 Doses,States/Local Areas,Ohio,2014,Age,13 Months,86.5,80.3 to 91.0,232
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,83.5,79.1 to 87.1,524
PCV,≥3 Doses,States/Local Areas,Ohio,2015,Age,13 Months,80.4,74.1 to 85.5,292
PCV,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,84.1,79.7 to 87.6,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2018,Age,24 Months,92.8,88.4 to 96.0,406
Hep B,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,92.1,88.9 to 94.6,790
Hep B,≥2 Doses,States/Local Areas,Ohio,2015,Age,7 Months,87.8,82.5 to 91.6,292
Hep B,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,90.7,87.3 to 93.3,575
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,71.4,60.3 to 82.6,386
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,74.8,68.2 to 81.4,554
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.0,56.3 to 99.7,104
≥1 Dose Varicella,,States/Local Areas,Ohio,2018,Age,35 Months,95.3,91.2 to 97.8,406
≥1 Dose Varicella,,States/Local Areas,Ohio,2018-2019,Age,35 Months,95.8,93.0 to 97.7,790
≥1 Dose Varicella,,States/Local Areas,Ohio,2017,Age,35 Months,85.9,77.2 to 92.6,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2017-2018,Age,35 Months,91.6,87.0 to 95.1,689
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2017,Age,0-2 Days,78.3,70.2 to 84.7,283
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2017-2018,Age,0-2 Days,79.2,74.2 to 83.5,689
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2018,Age,0-2 Days,80.1,73.9 to 85.2,406
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2018-2019,Age,0-2 Days,80.7,76.4 to 84.3,790
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2019,Age,0-2 Days,81.2,75.1 to 86.1,384
Hep B,≥2 Doses,States/Local Areas,Ohio,2018,Age,7 Months,92.4,87.9 to 95.3,406
Hep B,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,92.5,89.5 to 94.8,790
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,85.3,80.2 to 90.3,391
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.2,81.2 to 89.2,669
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.2,68.9 to 91.5,111
≥1 Dose MMR,,States/Local Areas,Ohio,2019,Age,35 Months,95.7,92.0 to 98.0,384
PCV,≥4 Doses,States/Local Areas,Ohio,2013,Age,35 Months,80.7,73.2 to 87.3,207
PCV,≥4 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,81.4,76.2 to 86.2,439
≥1 Dose MMR,,States/Local Areas,Ohio,2018,Age,35 Months,95.1,90.2 to 98.1,406
≥1 Dose MMR,,States/Local Areas,Ohio,2018-2019,Age,35 Months,95.4,92.4 to 97.4,790
≥1 Dose MMR,,States/Local Areas,Ohio,2017,Age,35 Months,86.6,78.4 to 92.8,283
≥1 Dose MMR,,States/Local Areas,Ohio,2017-2018,Age,35 Months,91.2,86.5 to 94.8,689
Hib,≥1 Dose,States/Local Areas,Ohio,2015,Age,3 Months,83.6,77.2 to 88.5,292
Hib,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,3 Months,86.4,82.3 to 89.6,575
Hib,≥1 Dose,States/Local Areas,Ohio,2016,Age,3 Months,89.1,83.6 to 93.0,283
Hib,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,3 Months,85.0,80.2 to 88.7,566
Hib,≥1 Dose,States/Local Areas,Ohio,2017,Age,3 Months,80.7,72.7 to 86.8,283
Hib,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,3 Months,82.4,77.5 to 86.5,689
Hep B,≥2 Doses,States/Local Areas,Ohio,2017,Age,13 Months,89.7,82.2 to 94.2,283
Hep B,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,13 Months,92.9,89.0 to 95.5,689
Hep B,≥2 Doses,States/Local Areas,Ohio,2018,Age,13 Months,96.2,93.4 to 97.9,406
Hep B,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,13 Months,95.2,92.7 to 96.8,790
Hep B,≥2 Doses,States/Local Areas,Ohio,2019,Age,13 Months,94.1,89.7 to 96.7,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2020,Age,35 Months,89.9,85.6 to 93.3,484
PCV,≥3 Doses,States/Local Areas,Ohio,2015,Age,19 Months,85.4,82.7 to 87.7,292
PCV,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,88.7,84.8 to 91.7,575
PCV,≥3 Doses,States/Local Areas,Ohio,2016,Age,19 Months,92.0,86.3 to 95.5,283
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,88.8,84.0 to 92.2,566
≥1 Dose Varicella,,States/Local Areas,Ohio,2016,Age,35 Months,90.7,84.7 to 95.0,283
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2017,Age,35 Months,88.1,83.2 to 92.2,566
≥1 Dose MMR,,States/Local Areas,Ohio,2013,Age,35 Months,88.5,81.4 to 93.8,207
≥1 Dose MMR,,States/Local Areas,Ohio,2013-2014,Age,35 Months,90.2,85.3 to 94.0,439
≥1 Dose MMR,,States/Local Areas,Ohio,2011,Age,35 Months,89.7,82.8 to 94.7,229
≥1 Dose MMR,,States/Local Areas,Ohio,2012,Age,35 Months,96.0,92.3 to 98.2,239
≥1 Dose MMR,,States/Local Areas,Ohio,2019,Age,24 Months,91.7,87.0 to 95.2,384
PCV,≥4 Doses,States/Local Areas,Ohio,2014,Age,24 Months,77.8,70.4 to 84.5,232
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,76.0,71.0 to 80.7,524
PCV,≥4 Doses,States/Local Areas,Ohio,2013,Age,24 Months,79.6,72.1 to 86.1,207
PCV,≥4 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,78.7,73.5 to 83.4,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2019,Age,24 Months,90.9,86.1 to 94.6,384
Hep B,≥3 Doses,States/Local Areas,Ohio,2017,Age,24 Months,87.4,80.3 to 92.9,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,90.3,86.2 to 93.5,689
Hep B,≥3 Doses,States/Local Areas,Ohio,2011,Age,35 Months,89.6,83.1 to 94.4,229
PCV,≥4 Doses,States/Local Areas,Ohio,2012,Age,24 Months,87.2,81.1 to 92.0,239
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,85.5,78.5 to 92.5,159
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.1,76.3 to 87.9,423
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,79.2,73.5 to 84.9,337
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Overall,Overall,84.1,80.7 to 87.5,973
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,85.3,73.8 to 96.9,89
Hib,≥1 Dose,States/Local Areas,Ohio,2018,Age,3 Months,84.1,77.8 to 89.0,406
Hib,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,3 Months,85.0,80.9 to 88.4,790
Hib,≥1 Dose,States/Local Areas,Ohio,2019,Age,3 Months,85.9,80.0 to 90.3,384
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.2,65.5 to 88.8,111
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,89.0,79.0 to 99.1,89
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.5,73.7 to 91.4,104
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,88.8,84.3 to 93.3,554
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,85.2,80.7 to 89.7,386
PCV,≥4 Doses,States/Local Areas,Ohio,2016,Age,35 Months,85.9,79.5 to 91.1,283
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,83.6,78.5 to 88.0,566
PCV,≥4 Doses,States/Local Areas,Ohio,2015,Age,35 Months,79.0,72.2 to 85.1,292
PCV,≥4 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,82.3,77.7 to 86.5,575
PCV,≥4 Doses,States/Local Areas,Ohio,2014,Age,35 Months,82.0,74.4 to 88.5,232
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,80.4,75.4 to 84.9,524
Hep B,≥3 Doses,States/Local Areas,Ohio,2018,Age,35 Months,94.1,89.7 to 97.0,406
Hep B,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,93.8,90.7 to 96.2,790
Hep B,≥3 Doses,States/Local Areas,Ohio,2019,Age,35 Months,93.9,88.7 to 97.3,384
PCV,≥3 Doses,States/Local Areas,Ohio,2014,Age,19 Months,88.8,83.2 to 92.6,232
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,87.1,83.2 to 90.2,524
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,90.6,83.9 to 97.4,283
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,87.1,82.5 to 91.7,391
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.4,84.8 to 91.9,669
PCV,≥1 Dose,States/Local Areas,Ohio,2013,Age,3 Months,78.0,72.7 to 82.5,207
PCV,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,3 Months,78.8,75.6 to 81.7,439
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,76.7,63.7 to 89.7,89
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.9,55.5 to 78.3,104
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,74.1,68.5 to 79.7,386
PCV,≥3 Doses,States/Local Areas,Ohio,2015,Age,24 Months,86.7,81.6 to 90.9,292
PCV,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,89.4,85.9 to 92.4,575
PCV,≥3 Doses,States/Local Areas,Ohio,2014,Age,24 Months,90.4,85.7 to 94.0,232
PCV,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,88.5,85.1 to 91.4,524
PCV,≥3 Doses,States/Local Areas,Ohio,2012,Age,24 Months,94.2,90.2 to 97.0,239
Hib,≥2 Doses,States/Local Areas,Ohio,2017,Age,5 Months,74.6,66.5 to 81.4,283
Hib,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,5 Months,73.5,68.3 to 78.2,689
PCV,≥3 Doses,States/Local Areas,Ohio,2013,Age,24 Months,93.3,88.7 to 96.5,207
PCV,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,91.8,88.6 to 94.4,439
PCV,≥3 Doses,States/Local Areas,Ohio,2018,Age,19 Months,88.9,83.7 to 92.6,406
PCV,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,86.4,82.3 to 89.6,790
PCV,≥3 Doses,States/Local Areas,Ohio,2019,Age,19 Months,92.5,87.7 to 95.6,384
PCV,≥3 Doses,States/Local Areas,Ohio,2011,Age,24 Months,88.6,82.0 to 93.6,229
Hib,≥2 Doses,States/Local Areas,Ohio,2013,Age,5 Months,70.7,68.1 to 73.1,207
Hib,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,5 Months,74.9,71.0 to 78.4,439
Hib,≥2 Doses,States/Local Areas,Ohio,2014,Age,5 Months,79.1,71.8 to 84.8,232
Hib,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,5 Months,74.2,69.2 to 78.7,524
PCV,≥3 Doses,States/Local Areas,Ohio,2017,Age,19 Months,85.5,77.5 to 91.0,283
PCV,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,87.2,82.6 to 90.7,689
Hib,≥2 Doses,States/Local Areas,Ohio,2012,Age,5 Months,79.2,74.1 to 83.5,239
Hib,≥2 Doses,States/Local Areas,Ohio,2011,Age,5 Months,70.7,63.3 to 77.2,229
Hib,≥2 Doses,States/Local Areas,Ohio,2015,Age,5 Months,69.4,62.2 to 75.7,292
Hib,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,5 Months,72.1,67.0 to 76.7,575
Hib,≥2 Doses,States/Local Areas,Ohio,2016,Age,5 Months,74.8,67.2 to 81.2,283
Hib,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,5 Months,74.7,69.3 to 79.5,566
≥1 Dose Varicella,,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,86.4,81.3 to 91.4,353
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,83.8,79.0 to 88.6,554
PCV,≥1 Dose,States/Local Areas,Ohio,2012,Age,3 Months,87.7,83.5 to 91.0,239
PCV,≥1 Dose,States/Local Areas,Ohio,2011,Age,3 Months,82.3,78.8 to 85.3,229
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,90.6,83.7 to 97.5,283
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,89.5,85.1 to 93.9,353
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,84.8,77.7 to 91.9,159
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.0,80.6 to 91.4,423
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,81.5,76.2 to 86.8,337
≥1 Dose MMR,,States/Local Areas,Ohio,2014-2017,Overall,Overall,86.2,83.1 to 89.4,973
PCV,≥4 Doses,States/Local Areas,Ohio,2017,Age,35 Months,81.4,73.3 to 88.2,283
PCV,≥4 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,84.9,79.5 to 89.5,689
PCV,≥4 Doses,States/Local Areas,Ohio,2018,Age,35 Months,87.7,80.8 to 93.1,406
PCV,≥4 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,87.1,82.1 to 91.2,790
PCV,≥4 Doses,States/Local Areas,Ohio,2019,Age,35 Months,85.6,78.8 to 91.2,384
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,87.7,80.5 to 95.0,283
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,82.6,77.4 to 87.9,353
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,69.4,63.1 to 75.8,337
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.1,72.2 to 84.1,423
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,76.5,68.1 to 85.0,159
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,78.0,74.4 to 81.7,973
Hib,≥2 Doses,States/Local Areas,Ohio,2013,Age,7 Months,87.9,76.8 to 94.1,207
Hib,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,87.0,82.1 to 90.7,439
Hib,≥2 Doses,States/Local Areas,Ohio,2014,Age,7 Months,86.1,79.8 to 90.7,232
Hib,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,84.8,80.6 to 88.3,524
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2012,Age,0-3 Days,71.8,62.5 to 79.5,239
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,78.6,73.0 to 84.3,391
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2011,Age,0-3 Days,79.2,71.6 to 85.2,229
PCV,≥1 Dose,States/Local Areas,Ohio,2018,Age,3 Months,84.4,77.8 to 89.3,406
PCV,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,3 Months,87.2,83.1 to 90.4,790
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,89.4,85.7 to 93.1,386
PCV,≥1 Dose,States/Local Areas,Ohio,2016,Age,3 Months,90.3,85.2 to 93.8,283
PCV,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,3 Months,85.1,80.4 to 88.8,566
PCV,≥1 Dose,States/Local Areas,Ohio,2017,Age,3 Months,79.8,71.9 to 86.0,283
PCV,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,3 Months,82.1,77.1 to 86.2,689
Hib,≥2 Doses,States/Local Areas,Ohio,2018,Age,5 Months,72.4,65.4 to 78.5,406
Hib,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,5 Months,72.9,68.0 to 77.3,790
Hib,≥2 Doses,States/Local Areas,Ohio,2019,Age,5 Months,73.4,66.2 to 79.5,384
Hib,≥2 Doses,States/Local Areas,Ohio,2011,Age,7 Months,84.1,82.2 to 85.8,229
PCV,≥3 Doses,States/Local Areas,Ohio,2016,Age,24 Months,92.2,87.1 to 95.9,283
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,88.9,84.5 to 92.5,566
Hib,≥2 Doses,States/Local Areas,Ohio,2012,Age,7 Months,93.2,85.9 to 96.9,239
PCV,≥3 Doses,States/Local Areas,Ohio,2017,Age,24 Months,85.5,78.2 to 91.4,283
PCV,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,88.6,84.4 to 92.1,689
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014,Age,0-3 Days,71.0,62.8 to 78.1,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2015,Age,0-3 Days,72.6,67.1 to 77.5,524
DTaP,≥3 Doses,States/Local Areas,Ohio,2013,Age,7 Months,57.0,49.7 to 64.1,207
DTaP,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,61.4,57.7 to 65.1,439
DTaP,≥3 Doses,States/Local Areas,Ohio,2012,Age,7 Months,72.7,68.9 to 76.3,239
DTaP,≥3 Doses,States/Local Areas,Ohio,2011,Age,7 Months,65.8,60.1 to 71.1,229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2013,Age,0-3 Days,79.9,72.2 to 85.8,207
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2013-2014,Age,0-3 Days,75.5,69.9 to 80.3,439
Polio,≥1 Dose,States/Local Areas,Ohio,2013,Age,3 Months,81.3,73.9 to 87.0,207
Polio,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,3 Months,81.2,77.9 to 84.2,439
PCV,≥1 Dose,States/Local Areas,Ohio,2019,Age,3 Months,90.0,84.6 to 93.6,384
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,89.2,86.4 to 92.0,973
Polio,≥1 Dose,States/Local Areas,Ohio,2012,Age,3 Months,89.9,84.9 to 93.4,239
Polio,≥1 Dose,States/Local Areas,Ohio,2011,Age,3 Months,86.8,85.2 to 88.3,229
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,89.5,85.1 to 94.0,554
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.8,80.1 to 95.4,104
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.3,78.3 to 86.3,669
PCV,≥4 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.4,59.5 to 83.3,111
PCV,≥3 Doses,States/Local Areas,Ohio,2018,Age,24 Months,91.7,87.2 to 95.1,406
PCV,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,93.1,90.2 to 95.4,790
Hib,≥2 Doses,States/Local Areas,Ohio,2015,Age,7 Months,83.5,77.4 to 88.2,292
Hib,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,84.9,80.5 to 88.4,575
PCV,≥3 Doses,States/Local Areas,Ohio,2019,Age,24 Months,94.5,90.6 to 97.2,384
PCV,≥3 Doses,States/Local Areas,Ohio,2011,Age,35 Months,88.6,82.0 to 93.6,229
PCV,≥3 Doses,States/Local Areas,Ohio,2013,Age,35 Months,94.2,89.7 to 97.2,207
PCV,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,92.8,89.7 to 95.2,439
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,87.6,80.8 to 94.4,159
PCV,≥1 Dose,States/Local Areas,Ohio,2014,Age,3 Months,79.6,72.5 to 85.3,232
PCV,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,3 Months,80.7,75.9 to 84.7,524
PCV,≥1 Dose,States/Local Areas,Ohio,2015,Age,3 Months,81.7,75.1 to 86.9,292
PCV,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,3 Months,86.0,81.9 to 89.3,575
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.2,82.1 to 92.3,423
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,88.5 to 95.5,391
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.3,85.9 to 92.7,669
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.2,75.3 to 95.2,111
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,95.9,92.2 to 99.7,89
PCV,≥3 Doses,States/Local Areas,Ohio,2012,Age,35 Months,94.2,90.2 to 97.0,239
Hib,≥2 Doses,States/Local Areas,Ohio,2016,Age,7 Months,86.3,79.5 to 91.2,283
Hib,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,85.7,80.7 to 89.5,566
Hib,≥2 Doses,States/Local Areas,Ohio,2017,Age,7 Months,85.0,77.2 to 90.4,283
Hib,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,86.3,81.9 to 89.8,689
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,87.8,83.5 to 92.0,337
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,89.4,82.3 to 96.6,283
Hep B,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,90.7,86.6 to 94.8,353
Hib,≥3 Doses,States/Local Areas,Ohio,2012,Age,7 Months,64.9,59.6 to 69.8,239
Hib,≥3 Doses,States/Local Areas,Ohio,2011,Age,7 Months,61.7,51.9 to 70.7,229
Hib,≥3 Doses,States/Local Areas,Ohio,2013,Age,7 Months,51.0,44.3 to 57.7,207
Hib,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,7 Months,56.8,53.5 to 60.0,439
Polio,≥1 Dose,States/Local Areas,Ohio,2014,Age,3 Months,81.2,74.2 to 86.6,232
Polio,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,3 Months,82.7,78.1 to 86.5,524
Polio,≥1 Dose,States/Local Areas,Ohio,2015,Age,3 Months,84.2,77.9 to 89.0,292
Polio,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,3 Months,86.8,82.8 to 90.0,575
Polio,≥1 Dose,States/Local Areas,Ohio,2016,Age,3 Months,89.4,83.7 to 93.3,283
Polio,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,3 Months,85.0,80.2 to 88.8,566
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2017,Age,0-3 Days,77.0,64.2 to 86.1,166
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2017-2018,Age,0-3 Days,81.4,76.5 to 85.5,689
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016,Age,0-3 Days,82.7,75.8 to 87.9,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2017,Age,0-3 Days,81.8,76.8 to 86.0,566
Hib,≥2 Doses,States/Local Areas,Ohio,2012,Age,13 Months,95.7,89.0 to 98.4,239
Hib,≥2 Doses,States/Local Areas,Ohio,2011,Age,13 Months,91.2,88.2 to 93.4,229
DTaP,≥3 Doses,States/Local Areas,Ohio,2015,Age,7 Months,63.9,56.7 to 70.5,292
DTaP,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,62.4,56.9 to 67.5,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2014,Age,7 Months,65.9,57.6 to 73.3,232
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,64.9,59.4 to 70.0,524
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2015,Age,0-3 Days,74.2,66.6 to 80.5,292
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2015-2016,Age,0-3 Days,78.4,73.4 to 82.7,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2016,Age,7 Months,60.9,52.6 to 68.6,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,64.3,58.5 to 69.7,566
Hib,≥2 Doses,States/Local Areas,Ohio,2013,Age,13 Months,93.1,89.1 to 95.7,207
Hib,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,13 Months,92.2,90.8 to 93.4,439
PCV,≥3 Doses,States/Local Areas,Ohio,2017,Age,35 Months,88.4,80.7 to 94.0,283
PCV,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,90.8,86.5 to 94.2,689
PCV,≥3 Doses,States/Local Areas,Ohio,2018,Age,35 Months,93.4,88.7 to 96.6,406
PCV,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,94.0,91.1 to 96.3,790
Hib,≥3 Doses,States/Local Areas,Ohio,2014,Age,7 Months,62.7,54.3 to 70.3,232
Hib,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,7 Months,57.0,51.5 to 62.3,524
Hib,≥3 Doses,States/Local Areas,Ohio,2015,Age,7 Months,51.3,44.2 to 58.4,292
Hib,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,7 Months,51.8,46.4 to 57.1,575
Hib,≥3 Doses,States/Local Areas,Ohio,2016,Age,7 Months,52.2,44.2 to 60.1,283
Hib,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,7 Months,55.6,49.8 to 61.1,566
Polio,≥1 Dose,States/Local Areas,Ohio,2017,Age,3 Months,80.6,72.6 to 86.7,283
Polio,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,3 Months,83.8,78.9 to 87.8,689
Polio,≥1 Dose,States/Local Areas,Ohio,2018,Age,3 Months,87.1,80.9 to 91.5,406
Polio,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,3 Months,88.5,84.6 to 91.6,790
Hib,≥2 Doses,States/Local Areas,Ohio,2015,Age,13 Months,87.2,81.6 to 91.3,292
Hib,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,13 Months,90.2,86.6 to 92.9,575
Hib,≥2 Doses,States/Local Areas,Ohio,2016,Age,13 Months,93.1,88.0 to 96.1,283
Hib,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,13 Months,90.8,86.4 to 93.9,566
Hib,≥2 Doses,States/Local Areas,Ohio,2014,Age,13 Months,91.3,86.3 to 94.6,232
Hib,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,13 Months,89.2,85.7 to 92.0,524
PCV,≥3 Doses,States/Local Areas,Ohio,2019,Age,35 Months,94.5,90.6 to 97.2,384
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2018,Age,0-3 Days,81.8,75.6 to 86.7,406
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2018-2019,Age,0-3 Days,81.7,77.5 to 85.3,790
Polio,≥1 Dose,States/Local Areas,Ohio,2019,Age,3 Months,90.0,84.4 to 93.7,384
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2019,Age,0-3 Days,81.7,75.6 to 86.6,384
Hib,Primary Series,States/Local Areas,Ohio,2020,Age,24 Months,92.6,88.9 to 95.3,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,73.5,67.9 to 79.1,554
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,78.0,72.5 to 83.4,386
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.6,74.2 to 90.9,104
DTaP,≥3 Doses,States/Local Areas,Ohio,2018,Age,7 Months,66.2,59.1 to 72.6,406
DTaP,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,7 Months,65.8,60.8 to 70.5,790
DTaP,≥3 Doses,States/Local Areas,Ohio,2019,Age,7 Months,65.4,58.0 to 72.1,384
DTaP,≥3 Doses,States/Local Areas,Ohio,2017,Age,7 Months,67.6,59.4 to 74.9,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,7 Months,66.9,61.6 to 71.9,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2011,Age,13 Months,86.6,82.9 to 89.7,229
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,88.8,84.6 to 93.1,391
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,86.5 to 93.3,669
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.5,72.3 to 92.8,111
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,85.2,74.9 to 95.5,89
Hib,Full Series,States/Local Areas,Ohio,2018,Age,35 Months,85.4,77.8 to 91.4,406
Hib,Full Series,States/Local Areas,Ohio,2018-2019,Age,35 Months,84.5,79.2 to 89.0,790
Hib,Full Series,States/Local Areas,Ohio,2019,Age,35 Months,82.5,75.7 to 88.4,384
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,69.3,63.4 to 75.1,386
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",63.4,52.0 to 74.7,104
Hib,Full Series,States/Local Areas,Ohio,2015,Age,35 Months,77.7,70.5 to 84.2,292
Hib,Full Series,States/Local Areas,Ohio,2015-2016,Age,35 Months,79.3,74.3 to 84.0,575
Hib,Full Series,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,82.7,77.8 to 87.7,554
Hib,Full Series,States/Local Areas,Ohio,2014,Age,35 Months,85.4,78.4 to 91.1,232
Hib,Full Series,States/Local Areas,Ohio,2014-2015,Age,35 Months,81.5,76.5 to 86.0,524
Polio,≥3 Doses,States/Local Areas,Ohio,2019,Age,35 Months,97.0,92.8 to 99.1,384
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,85.9,81.7 to 90.1,386
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,90.4,86.0 to 94.8,554
Hib,Full Series,States/Local Areas,Ohio,2016,Age,35 Months,81.2,73.9 to 87.6,283
Hib,Full Series,States/Local Areas,Ohio,2016-2017,Age,35 Months,82.9,76.5 to 88.5,566
Hib,Full Series,States/Local Areas,Ohio,2011,Age,35 Months,80.6,71.4 to 88.4,229
Hib,Full Series,States/Local Areas,Ohio,2012,Age,35 Months,85.9,79.1 to 91.3,239
Hib,Full Series,States/Local Areas,Ohio,2019,Age,24 Months,79.8,73.0 to 85.8,384
DTaP,≥2 Doses,States/Local Areas,Ohio,2013,Age,5 Months,70.8,68.0 to 73.4,207
DTaP,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,5 Months,74.8,71.3 to 78.1,439
DTaP,≥2 Doses,States/Local Areas,Ohio,2012,Age,5 Months,81.2,78.1 to 83.9,239
DTaP,≥2 Doses,States/Local Areas,Ohio,2011,Age,5 Months,72.9,63.7 to 80.5,229
Hib,Full Series,States/Local Areas,Ohio,2017,Age,35 Months,87.0,74.3 to 95.4,283
Hib,Full Series,States/Local Areas,Ohio,2017-2018,Age,35 Months,86.0,79.3 to 91.4,689
Polio,≥3 Doses,States/Local Areas,Ohio,2018,Age,35 Months,94.1,90.3 to 96.8,406
Polio,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,95.3,92.4 to 97.4,790
Polio,≥3 Doses,States/Local Areas,Ohio,2014,Age,35 Months,90.5,85.7 to 94.3,232
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,89.0,85.5 to 92.0,524
Polio,≥3 Doses,States/Local Areas,Ohio,2013,Age,35 Months,91.4,85.6 to 95.5,207
Polio,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,90.9,87.3 to 93.9,439
Hib,Full Series,States/Local Areas,Ohio,2013,Age,35 Months,82.2,74.4 to 88.9,207
Hib,Full Series,States/Local Areas,Ohio,2013-2014,Age,35 Months,83.9,78.7 to 88.4,439
Polio,≥3 Doses,States/Local Areas,Ohio,2012,Age,35 Months,95.4,91.6 to 97.8,239
Hib,≥3 Doses,States/Local Areas,Ohio,2014,Age,24 Months,89.8,85.0 to 93.6,232
Hib,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,88.2,84.8 to 91.1,524
DTaP,≥2 Doses,States/Local Areas,Ohio,2014,Age,5 Months,78.9,71.7 to 84.7,232
DTaP,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,5 Months,75.3,70.8 to 79.3,524
Polio,≥3 Doses,States/Local Areas,Ohio,2015,Age,35 Months,87.5,82.4 to 91.7,292
Polio,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,89.8,86.4 to 92.8,575
Polio,≥3 Doses,States/Local Areas,Ohio,2017,Age,35 Months,89.8,82.0 to 95.2,283
Polio,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,92.0,87.6 to 95.3,689
Polio,≥3 Doses,States/Local Areas,Ohio,2016,Age,35 Months,92.5,87.4 to 96.1,283
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,90.6,86.3 to 94.1,566
DTaP,≥2 Doses,States/Local Areas,Ohio,2015,Age,5 Months,71.6,64.5 to 77.8,292
DTaP,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,5 Months,73.3,68.2 to 77.9,575
Hib,≥3 Doses,States/Local Areas,Ohio,2013,Age,24 Months,92.0,87.1 to 95.5,207
Hib,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,90.9,87.6 to 93.6,439
Hib,≥3 Doses,States/Local Areas,Ohio,2012,Age,24 Months,95.6,92.0 to 97.9,239
Hib,≥3 Doses,States/Local Areas,Ohio,2011,Age,24 Months,90.7,84.6 to 95.1,229
Hib,Full Series,States/Local Areas,Ohio,2017,Age,24 Months,78.9,71.2 to 85.6,283
Hib,Full Series,States/Local Areas,Ohio,2017-2018,Age,24 Months,76.9,71.9 to 81.6,689
Hib,Full Series,States/Local Areas,Ohio,2016,Age,24 Months,77.9,70.5 to 84.5,283
Hib,Full Series,States/Local Areas,Ohio,2016-2017,Age,24 Months,78.4,73.2 to 83.3,566
DTaP,≥3 Doses,States/Local Areas,Ohio,2012,Age,24 Months,96.0,92.3 to 98.2,239
Polio,≥3 Doses,States/Local Areas,Ohio,2011,Age,35 Months,92.0,86.5 to 95.8,229
Hib,Full Series,States/Local Areas,Ohio,2018,Age,24 Months,74.6,68.0 to 80.9,406
Hib,Full Series,States/Local Areas,Ohio,2018-2019,Age,24 Months,77.1,72.4 to 81.5,790
Polio,≥3 Doses,States/Local Areas,Ohio,2018,Age,24 Months,93.3,89.5 to 96.1,406
Polio,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,93.3,90.6 to 95.5,790
Polio,≥3 Doses,States/Local Areas,Ohio,2019,Age,24 Months,93.4,89.1 to 96.5,384
Hib,≥3 Doses,States/Local Areas,Ohio,2019,Age,19 Months,90.8,85.2 to 94.4,384
Polio,≥3 Doses,States/Local Areas,Ohio,2017,Age,24 Months,86.2,79.0 to 91.9,283
Polio,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,89.7,85.7 to 93.1,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2013,Age,24 Months,93.3,88.7 to 96.5,207
DTaP,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,91.8,88.7 to 94.4,439
Hib,Full Series,States/Local Areas,Ohio,2015,Age,24 Months,71.1,64.2 to 77.7,292
Hib,Full Series,States/Local Areas,Ohio,2015-2016,Age,24 Months,74.5,69.5 to 79.3,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2011,Age,24 Months,91.7,85.5 to 95.9,229
DTaP,≥3 Doses,States/Local Areas,Ohio,2018,Age,19 Months,91.6,87.1 to 94.6,406
DTaP,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,88.4,84.6 to 91.4,790
DTaP,≥3 Doses,States/Local Areas,Ohio,2019,Age,19 Months,93.6,89.2 to 96.3,384
Hib,≥3 Doses,States/Local Areas,Ohio,2018,Age,19 Months,89.6,84.9 to 93.0,406
Hib,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,80.0,75.6 to 83.8,790
Hib,≥3 Doses,States/Local Areas,Ohio,2017,Age,19 Months,84.5,76.4 to 90.2,283
Hib,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,87.0,82.5 to 90.5,689
Polio,≥3 Doses,States/Local Areas,Ohio,2016,Age,24 Months,92.5,87.4 to 96.0,283
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,89.4,85.0 to 92.9,566
Hib,≥3 Doses,States/Local Areas,Ohio,2016,Age,19 Months,92.2,86.7 to 95.6,283
Hib,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,88.4,83.6 to 91.9,566
DTaP,≥3 Doses,States/Local Areas,Ohio,2017,Age,19 Months,86.7,78.8 to 92.0,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,89.2,84.7 to 92.4,689
Hib,≥3 Doses,States/Local Areas,Ohio,2015,Age,19 Months,85.2,83.7 to 86.7,292
Hib,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,88.7,84.9 to 91.7,575
Polio,≥3 Doses,States/Local Areas,Ohio,2015,Age,24 Months,85.2,80.0 to 89.6,292
Polio,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,88.8,85.3 to 91.8,575
Polio,≥3 Doses,States/Local Areas,Ohio,2014,Age,24 Months,89.2,84.3 to 93.1,232
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,87.2,83.6 to 90.3,524
DTaP,≥3 Doses,States/Local Areas,Ohio,2014,Age,19 Months,88.9,83.4 to 92.7,232
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,87.5,83.7 to 90.5,524
DTaP,≥3 Doses,States/Local Areas,Ohio,2015,Age,19 Months,86.2,83.1 to 88.8,292
DTaP,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,89.5,85.8 to 92.4,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2016,Age,19 Months,92.9,87.3 to 96.2,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,89.8,85.2 to 93.1,566
Polio,≥3 Doses,States/Local Areas,Ohio,2019,Age,19 Months,92.3,87.5 to 95.4,384
Polio,≥3 Doses,States/Local Areas,Ohio,2018,Age,19 Months,92.0,87.7 to 94.9,406
Polio,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,60.8,55.7 to 65.6,790
Polio,≥3 Doses,States/Local Areas,Ohio,2011,Age,24 Months,92.0,86.5 to 95.8,229
Polio,≥3 Doses,States/Local Areas,Ohio,2012,Age,24 Months,95.0,91.2 to 97.5,239
Hib,≥3 Doses,States/Local Areas,Ohio,2014,Age,19 Months,88.3,82.7 to 92.3,232
Hib,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,86.8,82.9 to 89.9,524
Hib,≥3 Doses,States/Local Areas,Ohio,2013,Age,19 Months,90.8,87.4 to 93.4,207
Hib,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,89.6,88.2 to 90.8,439
Polio,≥3 Doses,States/Local Areas,Ohio,2013,Age,24 Months,90.1,84.3 to 94.5,207
Polio,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,24 Months,89.6,86.0 to 92.7,439
Hib,Primary Series,States/Local Areas,North Dakota,2020-2021,Age,24 Months,91.5,87.4 to 94.7,391
Hib,≥3 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,93.2,88.4 to 96.6,299
Hib,≥3 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,95.3,91.0 to 98.0,294
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,90.7,86.3 to 93.8,391
Hep A,≥1 Dose,States/Local Areas,North Dakota,2017,Age,24 Months,90.1,85.2 to 94.0,298
Hep A,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,24 Months,90.4,86.9 to 93.2,591
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014,Age,24 Months,87.8,82.2 to 92.3,230
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,24 Months,89.6,86.1 to 92.6,447
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016,Age,19 Months,84.7,78.2 to 89.5,227
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,19 Months,84.8,80.5 to 88.3,525
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,94.4,90.6 to 97.0,227
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,93.7,91.0 to 95.9,525
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,95.0,91.4 to 97.4,217
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,94.7,92.0 to 96.7,444
PCV,≥2 Doses,States/Local Areas,North Dakota,2011,Age,5 Months,78.3,74.7 to 81.5,299
PCV,≥2 Doses,States/Local Areas,North Dakota,2012,Age,5 Months,78.2,74.6 to 81.4,294
PCV,≥2 Doses,States/Local Areas,North Dakota,2013,Age,5 Months,77.5,64.7 to 86.6,237
PCV,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,5 Months,77.8,71.4 to 83.1,467
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,93.1,88.8 to 96.2,298
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,94.8,92.0 to 96.9,591
Hep A,≥1 Dose,States/Local Areas,North Dakota,2012,Age,24 Months,86.5,81.0 to 91.1,294
Hep A,≥1 Dose,States/Local Areas,North Dakota,2013,Age,24 Months,90.5,85.2 to 94.5,237
Hep A,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,24 Months,89.1,85.3 to 92.3,467
Hep A,≥1 Dose,States/Local Areas,North Dakota,2011,Age,24 Months,84.8,78.8 to 89.8,299
Hep A,≥1 Dose,States/Local Areas,North Dakota,2019,Age,19 Months,91.5,86.1 to 94.9,263
DTaP,≥4 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,68.2,63.1 to 72.9,294
DTaP,≥4 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,68.7,60.6 to 75.8,299
Polio,≥3 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,93.4,85.5 to 97.8,143
Hep B,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,93.8,90.2 to 96.1,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,90.3,85.7 to 93.6,391
DTaP,≥3 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,75.2,64.4 to 83.5,143
≥1 Dose MMR,,States/Local Areas,North Dakota,2020-2021,Age,24 Months,87.0,81.6 to 91.5,391
Hib,Primary Series,States/Local Areas,North Dakota,2021,Age,7 Months,75.9,65.2 to 84.2,143
PCV,≥2 Doses,States/Local Areas,North Dakota,2021,Age,5 Months,79.1,68.8 to 86.7,143
PCV,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,5 Months,77.3,70.9 to 82.7,391
Hep A,≥2 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,69.5,54.5 to 83.3,143
DTaP,≥1 Dose,States/Local Areas,North Dakota,2016,Age,3 Months,91.9,87.3 to 94.9,227
DTaP,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,3 Months,89.1,85.4 to 91.9,525
DTaP,≥1 Dose,States/Local Areas,North Dakota,2015,Age,3 Months,92.9,87.7 to 96.0,217
DTaP,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,3 Months,92.4,89.1 to 94.7,444
DTaP,≥1 Dose,States/Local Areas,North Dakota,2014,Age,3 Months,88.3,82.3 to 92.4,230
DTaP,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,3 Months,90.6,86.8 to 93.3,447
DTaP,≥1 Dose,States/Local Areas,North Dakota,2013,Age,3 Months,86.0,68.3 to 94.6,237
DTaP,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,3 Months,87.2,80.8 to 91.7,467
Combined 7 Series,,States/Local Areas,North Dakota,2021,Age,35 Months,72.1,61.3 to 82.1,143
DTaP,≥1 Dose,States/Local Areas,North Dakota,2011,Age,3 Months,89.0,87.1 to 90.6,299
DTaP,≥1 Dose,States/Local Areas,North Dakota,2012,Age,3 Months,87.5,82.4 to 91.2,294
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.0,81.4 to 88.6,795
Hib,≥1 Dose,States/Local Areas,North Dakota,2021,Age,3 Months,88.5,81.0 to 93.3,143
≥1 Dose MMR,,States/Local Areas,North Dakota,2021,Age,35 Months,89.9,79.6 to 96.4,143
Polio,≥2 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,87.3,78.5 to 92.8,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,89.1,81.5 to 93.8,143
Hib,Full Series,States/Local Areas,North Dakota,2021,Age,19 Months,68.6,57.4 to 77.9,143
PCV,≥4 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,80.4,74.2 to 85.9,391
DTaP,≥4 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,87.5,72.8 to 96.4,391
Hib,Primary Series,States/Local Areas,North Dakota,2021,Age,19 Months,89.8,82.2 to 94.3,143
DTaP,≥1 Dose,States/Local Areas,North Dakota,2018,Age,3 Months,91.0,85.3 to 94.7,293
DTaP,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,3 Months,92.4,89.2 to 94.8,556
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,95.0,91.4 to 97.4,217
DTaP,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,94.7,92.0 to 96.7,444
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014,Age,24 Months,95.1,91.4 to 97.5,230
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,24 Months,95.0,92.6 to 96.8,447
DTaP,≥1 Dose,States/Local Areas,North Dakota,2017,Age,3 Months,86.1,80.0 to 90.6,298
DTaP,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,3 Months,88.5,84.5 to 91.6,591
Hep A,≥1 Dose,States/Local Areas,North Dakota,2011,Age,19 Months,77.5,74.1 to 80.5,299
DTaP,≥1 Dose,States/Local Areas,North Dakota,2019,Age,3 Months,93.9,90.1 to 96.3,263
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,94.4,90.6 to 97.0,227
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,93.6,90.9 to 95.8,525
Hep A,≥1 Dose,States/Local Areas,North Dakota,2012,Age,19 Months,82.8,79.5 to 85.7,294
Hep A,≥1 Dose,States/Local Areas,North Dakota,2015,Age,19 Months,86.9,84.8 to 88.8,217
Hep A,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,19 Months,85.8,81.5 to 89.3,444
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014,Age,19 Months,85.2,78.9 to 89.9,230
Hep A,≥1 Dose,States/Local Areas,North Dakota,2014-2015,Age,19 Months,86.1,81.8 to 89.5,447
Hep A,≥1 Dose,States/Local Areas,North Dakota,2013,Age,19 Months,82.0,68.5 to 90.5,237
Hep A,≥1 Dose,States/Local Areas,North Dakota,2013-2014,Age,19 Months,83.6,77.2 to 88.5,467
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Overall,Overall,93.7,91.8 to 95.7,830
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,89.0,83.7 to 94.4,155
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,94.8,92.2 to 97.4,408
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,95.7,93.1 to 98.3,267
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,95.6,91.8 to 97.9,293
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,95.7,93.0 to 97.5,556
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,92.9,88.6 to 96.0,298
DTaP,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,94.2,91.4 to 96.2,591
DTaP,≥2 Doses,States/Local Areas,North Dakota,2018,Age,5 Months,86.2,79.9 to 90.7,293
DTaP,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,5 Months,85.9,81.6 to 89.3,556
DTaP,≥2 Doses,States/Local Areas,North Dakota,2016,Age,5 Months,83.8,77.6 to 88.5,227
DTaP,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,5 Months,81.1,76.7 to 84.9,525
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.0,86.8 to 97.3,124
Polio,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,93.5,90.8 to 96.2,421
DTaP,≥2 Doses,States/Local Areas,North Dakota,2017,Age,5 Months,78.3,71.5 to 83.8,298
DTaP,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,5 Months,82.1,77.6 to 85.8,591
Hep A,≥2 Doses,States/Local Areas,North Dakota,2011,Age,24 Months,49.3,42.0 to 57.0,299
Hep A,≥2 Doses,States/Local Areas,North Dakota,2019,Age,19 Months,40.4,32.7 to 48.5,263
Hep A,≥2 Doses,States/Local Areas,North Dakota,2018,Age,19 Months,21.4,15.7 to 28.4,293
Hep A,≥2 Doses,States/Local Areas,North Dakota,2018-2019,Age,19 Months,29.4,23.8 to 35.7,462
Hib,≥3 Doses,States/Local Areas,North Dakota,2017,Age,35 Months,92.2,87.5 to 95.6,298
Hib,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,35 Months,93.9,90.4 to 96.5,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2016,Age,35 Months,93.9,90.0 to 96.6,227
Hib,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,35 Months,93.0,90.1 to 95.3,525
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,95.7,93.6 to 97.8,562
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,91.5,87.4 to 95.5,209
DTaP,≥4 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,73.4,67.1 to 78.9,217
DTaP,≥4 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,72.2,66.9 to 76.9,444
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,78.1,70.5 to 84.2,230
DTaP,≥4 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,75.8,70.6 to 80.3,447
DTaP,≥4 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,69.7,58.9 to 78.7,237
DTaP,≥4 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,74.1,68.9 to 78.6,467
Hep A,≥2 Doses,States/Local Areas,North Dakota,2012,Age,24 Months,44.2,36.8 to 52.3,294
Hib,≥3 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,96.0,90.2 to 98.8,293
Hib,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,93.9,90.1 to 96.7,556
Hib,≥3 Doses,States/Local Areas,North Dakota,2017,Age,24 Months,91.3,86.7 to 94.7,298
Hib,≥3 Doses,States/Local Areas,North Dakota,2017-2018,Age,24 Months,91.9,88.7 to 94.5,591
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,95.7,91.6 to 98.2,263
Hib,≥3 Doses,States/Local Areas,North Dakota,2016,Age,24 Months,93.5,89.6 to 96.3,227
Hib,≥3 Doses,States/Local Areas,North Dakota,2016-2017,Age,24 Months,92.4,89.5 to 94.7,525
Hib,≥3 Doses,States/Local Areas,North Dakota,2015,Age,24 Months,94.4,90.5 to 97.0,217
Hib,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,24 Months,93.9,91.1 to 96.1,444
Hep A,≥1 Dose,States/Local Areas,North Dakota,2011,Age,35 Months,89.4,82.0 to 94.7,299
Hep A,≥1 Dose,States/Local Areas,North Dakota,2019,Age,24 Months,92.2,87.4 to 95.7,263
Hep A,≥1 Dose,States/Local Areas,North Dakota,2018,Age,24 Months,90.7,85.4 to 94.6,293
Hep A,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,24 Months,91.4,88.0 to 94.2,556
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019,Age,35 Months,96.2,92.1 to 98.6,263
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,95.0,88.9 to 100.0,42
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018,Age,35 Months,96.7,92.6 to 98.9,293
DTaP,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,35 Months,96.4,93.7 to 98.1,556
PCV,≥2 Doses,States/Local Areas,North Dakota,2016,Age,5 Months,83.2,77.0 to 87.9,227
PCV,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,5 Months,80.3,75.8 to 84.1,525
PCV,≥2 Doses,States/Local Areas,North Dakota,2015,Age,5 Months,81.6,74.4 to 87.2,217
PCV,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,5 Months,82.4,77.7 to 86.3,444
PCV,≥2 Doses,States/Local Areas,North Dakota,2014,Age,5 Months,78.1,70.4 to 84.3,230
PCV,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,5 Months,79.9,77.3 to 82.3,447
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016,Age,24 Months,89.1,83.9 to 93.2,227
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2017,Age,24 Months,89.6,86.1 to 92.5,525
Hep A,≥1 Dose,States/Local Areas,North Dakota,2015,Age,24 Months,91.3,86.8 to 94.8,217
Hep A,≥1 Dose,States/Local Areas,North Dakota,2015-2016,Age,24 Months,90.3,86.8 to 93.2,444
Hep A,≥2 Doses,States/Local Areas,North Dakota,2017,Age,19 Months,33.6,27.1 to 40.8,298
Hep A,≥2 Doses,States/Local Areas,North Dakota,2017-2018,Age,19 Months,27.7,23.2 to 32.7,591
Hib,≥3 Doses,States/Local Areas,North Dakota,2015,Age,35 Months,94.4,90.5 to 97.0,217
Hib,≥3 Doses,States/Local Areas,North Dakota,2015-2016,Age,35 Months,94.1,91.4 to 96.2,444
Hib,≥3 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,91.5,86.5 to 95.2,230
Hib,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,93.0,89.9 to 95.4,447
Hib,≥3 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,88.8,82.2 to 93.8,237
Hib,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,90.3,86.3 to 93.6,467
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016,Age,19 Months,28.2,21.7 to 35.7,227
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2017,Age,19 Months,30.8,26.1 to 36.0,525
Hep A,≥2 Doses,States/Local Areas,North Dakota,2015,Age,19 Months,25.4,22.6 to 28.5,217
Hep A,≥2 Doses,States/Local Areas,North Dakota,2015-2016,Age,19 Months,26.8,22.2 to 31.9,444
Hib,≥3 Doses,States/Local Areas,North Dakota,2019,Age,24 Months,91.3,86.3 to 95.1,263
Hib,≥3 Doses,States/Local Areas,North Dakota,2018,Age,24 Months,92.7,87.6 to 96.2,293
Hib,≥3 Doses,States/Local Areas,North Dakota,2018-2019,Age,24 Months,91.9,88.5 to 94.6,556
Hep A,≥2 Doses,States/Local Areas,North Dakota,2012,Age,19 Months,23.3,20.8 to 26.0,294
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014,Age,19 Months,31.6,24.8 to 39.4,230
Hep A,≥2 Doses,States/Local Areas,North Dakota,2014-2015,Age,19 Months,28.5,23.8 to 33.8,447
Hep A,≥2 Doses,States/Local Areas,North Dakota,2013,Age,19 Months,27.8,22.9 to 33.2,237
Hep A,≥2 Doses,States/Local Areas,North Dakota,2013-2014,Age,19 Months,29.8,27.6 to 32.0,467
DTaP,≥2 Doses,States/Local Areas,North Dakota,2019,Age,5 Months,85.7,79.3 to 90.3,263
Hep A,≥2 Doses,States/Local Areas,North Dakota,2011,Age,19 Months,29.8,25.8 to 34.0,299
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014,Age,35 Months,95.6,91.9 to 97.9,230
DTaP,≥3 Doses,States/Local Areas,North Dakota,2014-2015,Age,35 Months,95.3,92.9 to 97.1,447
DTaP,≥3 Doses,States/Local Areas,North Dakota,2011,Age,35 Months,94.6,90.3 to 97.4,299
DTaP,≥3 Doses,States/Local Areas,North Dakota,2012,Age,35 Months,97.2,93.2 to 99.2,294
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013,Age,35 Months,96.0,91.0 to 98.7,237
DTaP,≥3 Doses,States/Local Areas,North Dakota,2013-2014,Age,35 Months,95.9,92.9 to 97.9,467
Hep A,≥1 Dose,States/Local Areas,North Dakota,2018,Age,19 Months,87.5,81.5 to 91.8,293
Hep A,≥1 Dose,States/Local Areas,North Dakota,2018-2019,Age,19 Months,88.8,83.8 to 92.4,462
Hep A,≥1 Dose,States/Local Areas,North Dakota,2017,Age,19 Months,84.9,78.8 to 89.5,298
Hep A,≥1 Dose,States/Local Areas,North Dakota,2017-2018,Age,19 Months,86.2,82.0 to 89.5,591
Hep A,≥1 Dose,States/Local Areas,Delaware,2014,Age,35 Months,94.1,87.9 to 97.8,234
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,35 Months,93.5,89.0 to 96.6,461
Hep A,≥1 Dose,States/Local Areas,Delaware,2013,Age,35 Months,96.1,92.2 to 98.4,222
Hep A,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,35 Months,95.1,91.7 to 97.5,456
≥1 Dose Varicella,,States/Local Areas,Delaware,2013,Age,13 Months,63.1,54.2 to 71.1,222
≥1 Dose Varicella,,States/Local Areas,Delaware,2013-2014,Age,13 Months,62.2,56.3 to 67.7,456
Influenza,,States/Local Areas,Delaware,2012,Age,24 Months,68.7,61.4 to 75.8,251
Influenza,,States/Local Areas,Delaware,2011,Age,24 Months,66.5,58.9 to 74.0,264
Influenza,,States/Local Areas,Delaware,2015,Age,24 Months,62.8,55.0 to 70.5,227
Influenza,,States/Local Areas,Delaware,2015-2016,Age,24 Months,64.4,58.8 to 69.9,460
Influenza,,States/Local Areas,Delaware,2014,Age,24 Months,55.4,47.3 to 63.8,234
Influenza,,States/Local Areas,Delaware,2014-2015,Age,24 Months,59.1,53.3 to 64.9,461
Influenza,,States/Local Areas,Delaware,2016,Age,24 Months,66.1,58.2 to 73.8,233
Influenza,,States/Local Areas,Delaware,2016-2017,Age,24 Months,63.5,58.2 to 68.8,541
Influenza,,States/Local Areas,Delaware,2013,Age,24 Months,74.2,67.0 to 81.0,222
Influenza,,States/Local Areas,Delaware,2013-2014,Age,24 Months,64.8,59.2 to 70.3,456
DTaP,≥4 Doses,States/Local Areas,Delaware,2017,Age,24 Months,87.4,82.2 to 91.7,308
DTaP,≥4 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,84.0,80.1 to 87.5,556
Hep A,≥2 Doses,States/Local Areas,Delaware,2014,Age,35 Months,76.1,66.4 to 84.8,234
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,76.4,69.0 to 83.1,461
DTaP,≥4 Doses,States/Local Areas,Delaware,2016,Age,24 Months,77.6,69.9 to 84.4,233
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,82.4,77.8 to 86.6,541
DTaP,≥4 Doses,States/Local Areas,Delaware,2015,Age,24 Months,84.0,77.0 to 89.9,227
DTaP,≥4 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,80.9,75.7 to 85.5,460
Hep A,≥2 Doses,States/Local Areas,Delaware,2013,Age,35 Months,82.3,74.1 to 89.1,222
Hep A,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,79.2,72.9 to 84.9,456
Hep A,≥2 Doses,States/Local Areas,Delaware,2012,Age,35 Months,80.8,71.9 to 88.3,251
Hep A,≥2 Doses,States/Local Areas,Delaware,2011,Age,35 Months,75.8,66.7 to 84.0,264
Hep A,≥2 Doses,States/Local Areas,Delaware,2019,Age,24 Months,59.4,50.6 to 68.3,205
Hib,≥3 Doses,States/Local Areas,Delaware,2019,Age,35 Months,96.0,92.0 to 98.3,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,95.8,94.1 to 97.4,873
Hep A,≥2 Doses,States/Local Areas,Delaware,2015,Age,24 Months,48.1,40.3 to 56.4,227
Hep A,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,52.4,46.8 to 58.2,460
Hep A,≥2 Doses,States/Local Areas,Delaware,2014,Age,24 Months,45.5,37.5 to 54.3,234
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,46.8,41.2 to 52.8,461
Hep A,≥2 Doses,States/Local Areas,Delaware,2013,Age,24 Months,55.3,47.4 to 63.6,222
Hep A,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,50.4,44.7 to 56.4,456
DTaP,≥4 Doses,States/Local Areas,Delaware,2018,Age,19 Months,73.2,66.5 to 78.9,248
DTaP,≥4 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,96.2,94.0 to 97.7,453
DTaP,≥4 Doses,States/Local Areas,Delaware,2017,Age,19 Months,77.2,70.7 to 82.6,308
DTaP,≥4 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,75.2,70.7 to 79.2,556
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.2,93.1 to 97.2,581
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,96.8,94.1 to 99.6,292
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.3,95.4 to 99.2,420
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.0,88.7 to 99.3,114
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,97.2,95.0 to 99.5,214
Polio,≥2 Doses,States/Local Areas,Delaware,2011,Age,5 Months,82.9,73.5 to 89.4,264
PCV,≥2 Doses,States/Local Areas,Delaware,2019,Age,5 Months,86.6,79.5 to 91.5,205
PCV,≥2 Doses,States/Local Areas,Delaware,2018,Age,5 Months,82.8,76.5 to 87.7,248
PCV,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,5 Months,84.7,80.1 to 88.3,453
Hep A,≥2 Doses,States/Local Areas,Delaware,2018,Age,24 Months,50.4,43.3 to 58.0,248
Hep A,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,54.7,49.1 to 60.6,453
DTaP,≥4 Doses,States/Local Areas,Delaware,2014,Age,24 Months,87.2,80.7 to 92.3,234
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,85.5,80.8 to 89.5,461
Hep A,≥2 Doses,States/Local Areas,Delaware,2017,Age,24 Months,55.8,48.9 to 63.0,308
Hep A,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,53.2,48.2 to 58.4,556
Hep A,≥2 Doses,States/Local Areas,Delaware,2016,Age,24 Months,56.8,48.9 to 65.0,233
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,56.3,51.0 to 61.7,541
DTaP,≥4 Doses,States/Local Areas,Delaware,2013,Age,24 Months,84.9,78.3 to 90.4,222
DTaP,≥4 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,85.8,81.4 to 89.7,456
DTaP,≥4 Doses,States/Local Areas,Delaware,2012,Age,24 Months,86.4,80.6 to 91.2,251
DTaP,≥4 Doses,States/Local Areas,Delaware,2011,Age,24 Months,87.0,80.8 to 92.0,264
DTaP,≥4 Doses,States/Local Areas,Delaware,2019,Age,19 Months,76.9,68.3 to 83.7,205
Hep B,≥3 Doses,States/Local Areas,Delaware,2013,Age,7 Months,57.0,49.9 to 63.8,222
Hep B,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,52.7,49.0 to 56.4,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2012,Age,7 Months,53.6,49.2 to 58.0,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2011,Age,7 Months,49.9,43.2 to 56.7,264
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,98.3,96.7 to 99.9,270
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,93.9,90.3 to 97.4,284
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,95.7,93.1 to 98.3,319
Polio,≥2 Doses,States/Local Areas,Delaware,2015,Age,5 Months,81.9,74.2 to 87.6,227
Polio,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,5 Months,82.4,77.3 to 86.6,460
Polio,≥2 Doses,States/Local Areas,Delaware,2014,Age,5 Months,79.6,71.8 to 85.6,234
Polio,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,5 Months,80.7,76.5 to 84.3,461
Polio,≥2 Doses,States/Local Areas,Delaware,2013,Age,5 Months,87.6,86.0 to 89.1,222
Polio,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,5 Months,83.6,80.5 to 86.2,456
Polio,≥2 Doses,States/Local Areas,Delaware,2012,Age,5 Months,76.9,70.5 to 82.3,251
Hep A,≥1 Dose,States/Local Areas,Delaware,2015,Age,35 Months,92.7,85.9 to 96.9,227
Hep A,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,35 Months,91.3,86.0 to 95.1,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2013,Age,19 Months,93.6,91.0 to 95.5,222
Hep B,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,91.1,88.2 to 93.2,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2012,Age,19 Months,97.1,94.1 to 98.6,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2011,Age,19 Months,91.0,84.6 to 94.9,264
Hep B,≥3 Doses,States/Local Areas,Delaware,2019,Age,13 Months,93.1,88.1 to 96.0,205
Hep B,≥3 Doses,States/Local Areas,Delaware,2018,Age,13 Months,89.6,84.6 to 93.1,248
Hep B,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,91.3,88.0 to 93.7,453
Polio,≥2 Doses,States/Local Areas,Delaware,2017,Age,13 Months,95.6,91.3 to 97.9,308
Polio,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,95.2,92.6 to 97.0,556
Polio,≥2 Doses,States/Local Areas,Delaware,2016,Age,13 Months,93.7,88.1 to 96.7,233
Polio,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,94.6,91.4 to 96.7,541
Polio,≥2 Doses,States/Local Areas,Delaware,2015,Age,13 Months,92.5,85.8 to 96.1,227
Polio,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,93.1,89.1 to 95.7,460
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,78.5,71.6 to 85.4,214
≥1 Dose Varicella,,States/Local Areas,Delaware,2018,Age,19 Months,89.0,83.8 to 92.7,248
≥1 Dose Varicella,,States/Local Areas,Delaware,2018-2019,Age,19 Months,58.1,52.5 to 63.4,453
≥1 Dose Varicella,,States/Local Areas,Delaware,2017,Age,19 Months,86.4,80.6 to 90.6,308
≥1 Dose Varicella,,States/Local Areas,Delaware,2017-2018,Age,19 Months,87.7,84.0 to 90.6,556
≥1 Dose MMR,,States/Local Areas,Delaware,2014,Age,19 Months,87.6,80.6 to 92.3,234
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2015,Age,19 Months,87.1,82.3 to 90.7,461
≥1 Dose MMR,,States/Local Areas,Delaware,2012,Age,19 Months,91.2,86.1 to 94.6,251
≥1 Dose MMR,,States/Local Areas,Delaware,2013,Age,19 Months,91.4,88.0 to 93.9,222
≥1 Dose MMR,,States/Local Areas,Delaware,2013-2014,Age,19 Months,89.5,86.3 to 92.0,456
≥1 Dose MMR,,States/Local Areas,Delaware,2011,Age,19 Months,91.8,88.3 to 94.3,264
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.0,71.7 to 88.2,125
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,80.6,75.7 to 85.6,384
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,91.3,88.1 to 94.5,445
DTaP,≥4 Doses,States/Local Areas,Delaware,2019,Age,35 Months,90.7,83.4 to 95.7,205
DTaP,≥4 Doses,States/Local Areas,Delaware,2017,Age,35 Months,94.8,91.0 to 97.3,308
DTaP,≥4 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,92.0,88.4 to 94.8,556
DTaP,≥4 Doses,States/Local Areas,Delaware,2016,Age,35 Months,86.6,77.1 to 93.5,233
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,91.0,86.0 to 94.7,541
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,82.5,74.1 to 91.0,214
Hep B,≥3 Doses,States/Local Areas,Delaware,2017,Age,13 Months,87.9,82.0 to 92.0,308
Hep B,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,88.7,85.0 to 91.6,556
Hep B,≥3 Doses,States/Local Areas,Delaware,2015,Age,13 Months,82.6,75.2 to 88.1,227
Hep B,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,83.4,78.6 to 87.4,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2016,Age,13 Months,84.3,77.3 to 89.5,233
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,86.1,81.7 to 89.6,541
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.4,54.9 to 83.8,125
DTaP,≥4 Doses,States/Local Areas,Delaware,2018,Age,35 Months,88.7,82.3 to 93.6,248
DTaP,≥4 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,89.6,85.0 to 93.3,453
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,78.3,70.8 to 85.8,384
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,83.9,78.4 to 89.3,445
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,92.4,88.8 to 96.0,270
Polio,≥2 Doses,States/Local Areas,Delaware,2018,Age,7 Months,92.6,88.1 to 95.5,248
Polio,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,92.7,89.2 to 95.2,453
Polio,≥2 Doses,States/Local Areas,Delaware,2017,Age,7 Months,93.0,88.3 to 95.9,308
Polio,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,92.8,89.8 to 95.0,556
Hep B,≥1 Dose,States/Local Areas,Delaware,2014,Age,3 Months,93.9,87.9 to 97.1,234
Hep B,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,3 Months,95.3,91.8 to 97.3,461
Hep B,≥1 Dose,States/Local Areas,Delaware,2013,Age,3 Months,95.9,93.1 to 97.6,222
Hep B,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,3 Months,94.9,93.0 to 96.3,456
Hep B,≥1 Dose,States/Local Areas,Delaware,2012,Age,3 Months,98.9,95.9 to 99.7,251
Hep B,≥1 Dose,States/Local Areas,Delaware,2011,Age,3 Months,99.5,98.6 to 99.8,264
≥1 Dose MMR,,States/Local Areas,Delaware,2017,Age,13 Months,54.6,47.5 to 61.5,308
≥1 Dose MMR,,States/Local Areas,Delaware,2017-2018,Age,13 Months,57.8,52.7 to 62.8,556
≥1 Dose MMR,,States/Local Areas,Delaware,2019,Age,13 Months,66.8,58.6 to 74.1,205
≥1 Dose MMR,,States/Local Areas,Delaware,2018,Age,13 Months,61.3,54.0 to 68.1,248
≥1 Dose MMR,,States/Local Areas,Delaware,2018-2019,Age,13 Months,64.0,58.5 to 69.1,453
Polio,≥2 Doses,States/Local Areas,Delaware,2012,Age,13 Months,98.2,94.1 to 99.5,251
Polio,≥2 Doses,States/Local Areas,Delaware,2011,Age,13 Months,96.4,93.4 to 98.1,264
≥1 Dose Varicella,,States/Local Areas,Delaware,2016,Age,19 Months,86.8,79.7 to 91.7,233
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2017,Age,19 Months,86.6,82.3 to 90.0,541
≥1 Dose Varicella,,States/Local Areas,Delaware,2015,Age,19 Months,85.5,78.2 to 90.6,227
≥1 Dose Varicella,,States/Local Areas,Delaware,2015-2016,Age,19 Months,86.2,81.3 to 89.9,460
≥1 Dose Varicella,,States/Local Areas,Delaware,2014,Age,19 Months,86.6,79.3 to 91.6,234
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2015,Age,19 Months,86.0,81.1 to 89.8,461
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,78.2,69.4 to 87.0,319
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,79.8,75.0 to 84.6,873
Polio,≥2 Doses,States/Local Areas,Delaware,2019,Age,7 Months,92.8,86.4 to 96.3,205
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.7,74.5 to 84.9,581
Hep B,≥1 Dose,States/Local Areas,Delaware,2017,Age,3 Months,99.2,97.8 to 99.7,308
Hep B,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,3 Months,97.6,95.8 to 98.7,556
Hep B,≥1 Dose,States/Local Areas,Delaware,2016,Age,3 Months,97.3,93.1 to 98.9,233
Hep B,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,3 Months,98.2,96.2 to 99.2,541
Hep B,≥1 Dose,States/Local Areas,Delaware,2015,Age,3 Months,96.7,92.0 to 98.7,227
Hep B,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,3 Months,97.0,94.2 to 98.4,460
Polio,≥2 Doses,States/Local Areas,Delaware,2014,Age,13 Months,94.1,88.6 to 97.0,234
Polio,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,93.3,89.4 to 95.8,461
Polio,≥2 Doses,States/Local Areas,Delaware,2013,Age,13 Months,96.8,93.1 to 98.6,222
Polio,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,95.5,92.6 to 97.2,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,90.7 to 96.1,420
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,80.1,70.7 to 89.5,292
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.9,78.6 to 89.2,420
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.6,66.2 to 89.0,114
≥1 Dose MMR,,States/Local Areas,Delaware,2013,Age,13 Months,62.5,54.7 to 69.8,222
≥1 Dose MMR,,States/Local Areas,Delaware,2013-2014,Age,13 Months,62.5,57.1 to 67.5,456
≥1 Dose MMR,,States/Local Areas,Delaware,2012,Age,13 Months,59.5,51.9 to 66.6,251
≥1 Dose MMR,,States/Local Areas,Delaware,2011,Age,13 Months,63.4,59.3 to 67.3,264
DTaP,≥4 Doses,States/Local Areas,Delaware,2011,Age,35 Months,95.6,88.9 to 98.8,264
DTaP,≥4 Doses,States/Local Areas,Delaware,2019,Age,24 Months,86.5,79.3 to 92.1,205
DTaP,≥4 Doses,States/Local Areas,Delaware,2018,Age,24 Months,80.5,74.5 to 86.0,248
DTaP,≥4 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,83.5,78.9 to 87.5,453
Hep B,≥3 Doses,States/Local Areas,Delaware,2011,Age,13 Months,88.1,84.4 to 91.0,264
Polio,≥2 Doses,States/Local Areas,Delaware,2016,Age,7 Months,91.2,85.1 to 95.0,233
Polio,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,92.1,88.5 to 94.7,541
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,89.5,85.4 to 93.7,284
Polio,≥2 Doses,States/Local Areas,Delaware,2015,Age,7 Months,89.2,82.0 to 93.7,227
Polio,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,90.2,85.8 to 93.3,460
Polio,≥2 Doses,States/Local Areas,Delaware,2014,Age,7 Months,92.1,85.6 to 95.8,234
Polio,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,90.6,86.2 to 93.8,461
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,88.8,84.3 to 93.2,319
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Overall,Overall,90.0,87.5 to 92.5,873
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.2,87.2 to 93.2,581
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,89.6,85.3 to 93.9,292
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.6,84.9 to 92.3,420
≥1 Dose Varicella,,States/Local Areas,Delaware,2018,Age,13 Months,56.3,49.0 to 63.3,248
≥1 Dose Varicella,,States/Local Areas,Delaware,2017,Age,13 Months,51.5,44.5 to 58.4,308
≥1 Dose Varicella,,States/Local Areas,Delaware,2017-2018,Age,13 Months,53.9,48.8 to 58.9,556
≥1 Dose Varicella,,States/Local Areas,Delaware,2016,Age,13 Months,56.8,48.7 to 64.5,233
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2017,Age,13 Months,54.2,48.8 to 59.4,541
≥1 Dose MMR,,States/Local Areas,Delaware,2015,Age,13 Months,55.9,47.8 to 63.7,227
≥1 Dose MMR,,States/Local Areas,Delaware,2015-2016,Age,13 Months,56.9,51.1 to 62.4,460
≥1 Dose MMR,,States/Local Areas,Delaware,2014,Age,13 Months,62.4,54.2 to 69.9,234
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2015,Age,13 Months,59.1,53.4 to 64.6,461
≥1 Dose Varicella,,States/Local Areas,Delaware,2013,Age,19 Months,90.4,86.8 to 93.1,222
≥1 Dose Varicella,,States/Local Areas,Delaware,2013-2014,Age,19 Months,88.5,84.5 to 91.6,456
≥1 Dose Varicella,,States/Local Areas,Delaware,2012,Age,19 Months,88.7,84.8 to 91.7,251
≥1 Dose Varicella,,States/Local Areas,Delaware,2011,Age,19 Months,90.7,87.5 to 93.1,264
≥1 Dose Varicella,,States/Local Areas,Delaware,2019,Age,13 Months,59.9,51.4 to 67.9,205
≥1 Dose Varicella,,States/Local Areas,Delaware,2018-2019,Age,13 Months,58.1,52.5 to 63.4,453
≥1 Dose MMR,,States/Local Areas,Delaware,2016,Age,13 Months,57.8,49.7 to 65.5,233
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2017,Age,13 Months,56.2,50.8 to 61.4,541
DTaP,≥4 Doses,States/Local Areas,Delaware,2015,Age,35 Months,93.1,83.7 to 98.1,227
DTaP,≥4 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,90.1,83.1 to 95.1,460
DTaP,≥4 Doses,States/Local Areas,Delaware,2012,Age,35 Months,90.8,85.2 to 94.9,251
DTaP,≥4 Doses,States/Local Areas,Delaware,2014,Age,35 Months,88.2,81.7 to 93.3,234
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,91.5,85.3 to 95.9,461
DTaP,≥4 Doses,States/Local Areas,Delaware,2013,Age,35 Months,91.4,86.1 to 95.2,222
DTaP,≥4 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,90.3,86.3 to 93.6,456
Hep A,≥2 Doses,States/Local Areas,Delaware,2019,Age,35 Months,92.7,83.4 to 97.8,205
Hep B,≥3 Doses,States/Local Areas,Delaware,2012,Age,13 Months,95.1,91.7 to 97.2,251
Hep A,≥2 Doses,States/Local Areas,Delaware,2018,Age,35 Months,77.1,68.7 to 84.5,248
Hep A,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,85.0,78.2 to 90.5,453
Hep A,≥2 Doses,States/Local Areas,Delaware,2017,Age,35 Months,83.3,76.0 to 89.5,308
Hep A,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,80.8,75.2 to 85.9,556
Hep B,≥3 Doses,States/Local Areas,Delaware,2014,Age,13 Months,87.3,80.2 to 92.1,234
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,85.0,80.1 to 88.8,461
Hep B,≥3 Doses,States/Local Areas,Delaware,2013,Age,13 Months,90.8,88.3 to 92.9,222
Hep B,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,89.1,86.4 to 91.3,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2016,Age,7 Months,48.1,40.2 to 56.0,233
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,50.1,44.8 to 55.4,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2015,Age,7 Months,48.6,40.6 to 56.6,227
Hep B,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,48.3,42.7 to 54.0,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2014,Age,7 Months,48.5,40.4 to 56.7,234
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,48.5,42.8 to 54.3,461
Polio,≥2 Doses,States/Local Areas,Delaware,2017,Age,5 Months,83.5,76.8 to 88.5,308
Polio,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,5 Months,83.7,79.3 to 87.3,556
Polio,≥2 Doses,States/Local Areas,Delaware,2016,Age,5 Months,83.0,75.6 to 88.5,233
Polio,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,5 Months,83.2,78.4 to 87.1,541
Hep A,≥1 Dose,States/Local Areas,Delaware,2018,Age,35 Months,93.1,88.5 to 96.4,248
Hep A,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,35 Months,95.6,92.7 to 97.6,453
≥1 Dose Varicella,,States/Local Areas,Delaware,2011,Age,13 Months,62.5,56.1 to 68.5,264
Hep A,≥1 Dose,States/Local Areas,Delaware,2017,Age,35 Months,94.7,89.9 to 97.7,308
Hep A,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,35 Months,94.0,90.7 to 96.3,556
Hep A,≥1 Dose,States/Local Areas,Delaware,2016,Age,35 Months,88.4,81.9 to 93.4,233
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,35 Months,91.5,87.5 to 94.7,541
Polio,≥2 Doses,States/Local Areas,Delaware,2018,Age,5 Months,83.9,77.7 to 88.6,248
Polio,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,5 Months,86.5,82.1 to 90.0,453
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.7,81.2 to 94.2,125
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,90.6,86.8 to 94.4,384
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,90.9,87.9 to 94.0,445
Hep A,≥1 Dose,States/Local Areas,Delaware,2019,Age,35 Months,97.6,93.8 to 99.3,205
≥1 Dose Varicella,,States/Local Areas,Delaware,2015,Age,13 Months,54.1,46.0 to 61.9,227
≥1 Dose Varicella,,States/Local Areas,Delaware,2015-2016,Age,13 Months,55.4,49.7 to 61.0,460
≥1 Dose Varicella,,States/Local Areas,Delaware,2012,Age,13 Months,57.6,50.9 to 64.1,251
≥1 Dose Varicella,,States/Local Areas,Delaware,2014,Age,13 Months,61.3,53.0 to 69.0,234
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2015,Age,13 Months,57.7,51.9 to 63.2,461
Hep A,≥2 Doses,States/Local Areas,Delaware,2016,Age,35 Months,78.1,68.2 to 86.7,233
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,80.4,74.4 to 85.8,541
Hep A,≥2 Doses,States/Local Areas,Delaware,2015,Age,35 Months,76.9,65.5 to 86.8,227
Hep A,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,77.5,69.7 to 84.6,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2019,Age,7 Months,47.7,39.3 to 56.3,205
Polio,≥2 Doses,States/Local Areas,Delaware,2013,Age,7 Months,93.4,91.3 to 95.0,222
Polio,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,92.7,91.2 to 94.0,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2018,Age,7 Months,51.5,44.1 to 58.7,248
Hep B,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,49.6,44.0 to 55.3,453
Hep B,≥3 Doses,States/Local Areas,Delaware,2017,Age,7 Months,52.2,45.2 to 59.1,308
Hep B,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,51.8,46.8 to 56.9,556
Polio,≥2 Doses,States/Local Areas,Delaware,2012,Age,7 Months,91.1,84.1 to 95.2,251
Polio,≥2 Doses,States/Local Areas,Delaware,2011,Age,7 Months,93.7,89.3 to 96.4,264
Polio,≥2 Doses,States/Local Areas,Delaware,2019,Age,5 Months,89.3,82.4 to 93.7,205
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,85.1 to 98.0,114
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,93.6,90.3 to 96.9,214
PCV,≥3 Doses,States/Local Areas,Delaware,2012,Age,24 Months,97.5,94.8 to 98.9,251
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,87.4,82.5 to 92.3,292
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.3,86.7 to 93.9,420
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.9,76.3 to 93.4,114
PCV,≥1 Dose,States/Local Areas,Delaware,2015,Age,3 Months,87.5,80.5 to 92.2,227
PCV,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,3 Months,88.1,83.6 to 91.5,460
PCV,≥1 Dose,States/Local Areas,Delaware,2014,Age,3 Months,85.9,77.8 to 91.4,234
PCV,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,3 Months,86.7,81.6 to 90.5,461
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.6,86.7 to 92.6,581
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,93.4,89.6 to 97.2,292
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2013,Age,0-3 Days,73.3,65.2 to 80.0,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2013-2014,Age,0-3 Days,70.4,64.6 to 75.7,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.8 to 96.0,445
Hib,≥2 Doses,States/Local Areas,Delaware,2011,Age,7 Months,94.2,89.5 to 96.8,264
Hib,≥2 Doses,States/Local Areas,Delaware,2019,Age,5 Months,88.0,81.2 to 92.6,205
Hib,≥2 Doses,States/Local Areas,Delaware,2018,Age,5 Months,84.2,78.0 to 88.9,248
Hib,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,5 Months,86.1,81.7 to 89.6,453
PCV,≥3 Doses,States/Local Areas,Delaware,2018,Age,24 Months,92.8,88.7 to 95.8,248
PCV,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,93.9,91.0 to 96.1,453
PCV,≥3 Doses,States/Local Areas,Delaware,2017,Age,24 Months,96.5,93.3 to 98.5,308
PCV,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,94.7,92.2 to 96.5,556
PCV,≥3 Doses,States/Local Areas,Delaware,2016,Age,24 Months,93.9,89.0 to 97.1,233
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,95.3,92.5 to 97.3,541
Hib,≥2 Doses,States/Local Areas,Delaware,2012,Age,7 Months,90.0,81.1 to 95.0,251
Hib,≥2 Doses,States/Local Areas,Delaware,2012,Age,5 Months,77.7,70.1 to 83.8,251
Hib,≥2 Doses,States/Local Areas,Delaware,2011,Age,5 Months,83.9,75.1 to 90.0,264
Hib,≥2 Doses,States/Local Areas,Delaware,2014,Age,5 Months,80.1,72.4 to 86.1,234
Hib,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,5 Months,81.1,77.5 to 84.2,461
Hib,≥2 Doses,States/Local Areas,Delaware,2013,Age,5 Months,86.7,84.2 to 88.9,222
Hib,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,5 Months,83.4,81.2 to 85.4,456
PCV,≥4 Doses,States/Local Areas,Delaware,2017,Age,35 Months,94.6,91.0 to 97.1,308
PCV,≥4 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,92.1,88.8 to 94.7,556
PCV,≥4 Doses,States/Local Areas,Delaware,2019,Age,35 Months,88.7,81.7 to 93.9,205
PCV,≥4 Doses,States/Local Areas,Delaware,2018,Age,35 Months,89.5,83.6 to 94.0,248
PCV,≥4 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,89.0,84.6 to 92.6,453
PCV,≥3 Doses,States/Local Areas,Delaware,2011,Age,24 Months,97.2,93.8 to 99.0,264
PCV,≥3 Doses,States/Local Areas,Delaware,2019,Age,19 Months,95.1,90.0 to 97.6,205
PCV,≥3 Doses,States/Local Areas,Delaware,2018,Age,19 Months,92.8,88.3 to 95.6,248
PCV,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,92.1,88.8 to 94.5,453
PCV,≥1 Dose,States/Local Areas,Delaware,2012,Age,3 Months,87.3,82.2 to 91.1,251
PCV,≥1 Dose,States/Local Areas,Delaware,2011,Age,3 Months,87.9,81.4 to 92.4,264
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,93.6,89.9 to 97.2,270
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,91.9,88.1 to 95.6,284
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,90.4,86.4 to 94.3,319
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Overall,Overall,91.7,89.5 to 93.9,873
PCV,≥3 Doses,States/Local Areas,Delaware,2015,Age,24 Months,94.8,89.8 to 97.9,227
PCV,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,94.3,91.0 to 96.7,460
PCV,≥3 Doses,States/Local Areas,Delaware,2014,Age,24 Months,93.7,88.4 to 97.2,234
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,94.4,90.9 to 96.8,461
PCV,≥3 Doses,States/Local Areas,Delaware,2013,Age,24 Months,94.6,89.7 to 97.7,222
PCV,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,94.2,90.8 to 96.7,456
Hib,≥2 Doses,States/Local Areas,Delaware,2017,Age,5 Months,83.2,76.6 to 88.3,308
Hib,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,5 Months,83.7,79.4 to 87.3,556
Hib,≥2 Doses,States/Local Areas,Delaware,2016,Age,5 Months,82.7,75.3 to 88.3,233
Hib,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,5 Months,83.0,78.2 to 86.9,541
Hib,≥2 Doses,States/Local Areas,Delaware,2015,Age,5 Months,82.0,74.3 to 87.8,227
Hib,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,5 Months,82.4,77.2 to 86.5,460
PCV,≥1 Dose,States/Local Areas,Delaware,2013,Age,3 Months,89.0,86.1 to 91.4,222
PCV,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,3 Months,87.4,86.0 to 88.8,456
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.8,75.1 to 90.6,125
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,82.1,76.0 to 88.2,214
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,84.3,79.7 to 88.9,384
Hib,≥1 Dose,States/Local Areas,Delaware,2019,Age,3 Months,93.4,87.8 to 96.5,205
Hib,≥1 Dose,States/Local Areas,Delaware,2018,Age,3 Months,92.5,88.2 to 95.4,248
Hib,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,3 Months,93.0,89.7 to 95.2,453
Hep B,≥3 Doses,States/Local Areas,Delaware,2019,Age,35 Months,95.6,91.5 to 98.0,205
PCV,≥3 Doses,States/Local Areas,Delaware,2017,Age,19 Months,94.4,89.9 to 97.0,308
PCV,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,93.6,90.7 to 95.7,556
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.9,80.4 to 93.3,125
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,86.5 to 98.2,114
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,94.4,91.1 to 97.8,214
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,91.5,88.1 to 94.9,384
PCV,≥4 Doses,States/Local Areas,Delaware,2016,Age,35 Months,84.3,76.7 to 90.5,233
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,89.8,85.4 to 93.3,541
PCV,≥4 Doses,States/Local Areas,Delaware,2015,Age,35 Months,93.8,84.1 to 98.5,227
PCV,≥4 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,90.4,83.1 to 95.4,460
PCV,≥4 Doses,States/Local Areas,Delaware,2014,Age,35 Months,92.5,85.5 to 96.9,234
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,92.8,87.3 to 96.6,461
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,90.4,86.1 to 94.7,292
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.5,87.0 to 93.9,420
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,93.0,90.2 to 95.9,445
≥1 Dose MMR,,States/Local Areas,Delaware,2019,Age,35 Months,96.7,92.7 to 98.9,205
PCV,≥4 Doses,States/Local Areas,Delaware,2013,Age,35 Months,93.2,87.8 to 96.7,222
PCV,≥4 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,92.8,88.8 to 95.8,456
≥1 Dose MMR,,States/Local Areas,Delaware,2017,Age,35 Months,97.0,93.7 to 98.8,308
≥1 Dose MMR,,States/Local Areas,Delaware,2017-2018,Age,35 Months,94.3,91.3 to 96.5,556
≥1 Dose MMR,,States/Local Areas,Delaware,2018,Age,35 Months,91.3,86.3 to 94.9,248
≥1 Dose MMR,,States/Local Areas,Delaware,2018-2019,Age,35 Months,93.9,90.9 to 96.2,453
PCV,≥3 Doses,States/Local Areas,Delaware,2016,Age,19 Months,92.1,86.0 to 95.7,233
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,93.3,89.7 to 95.6,541
PCV,≥3 Doses,States/Local Areas,Delaware,2015,Age,19 Months,93.7,91.8 to 95.2,227
PCV,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,92.9,89.0 to 95.5,460
Hep B,≥2 Doses,States/Local Areas,Delaware,2019,Age,13 Months,97.1,93.8 to 98.7,205
Hep B,≥2 Doses,States/Local Areas,Delaware,2018,Age,13 Months,96.3,92.6 to 98.1,248
Hep B,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,96.7,94.5 to 98.0,453
Hep B,≥2 Doses,States/Local Areas,Delaware,2017,Age,13 Months,96.4,92.6 to 98.2,308
Hep B,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,96.3,94.0 to 97.8,556
Hib,≥1 Dose,States/Local Areas,Delaware,2017,Age,3 Months,91.4,86.8 to 94.6,308
Hib,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,3 Months,92.0,89.0 to 94.2,556
Hib,≥1 Dose,States/Local Areas,Delaware,2016,Age,3 Months,89.0,82.5 to 93.3,233
Hib,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,3 Months,90.2,86.4 to 93.1,541
Hib,≥1 Dose,States/Local Areas,Delaware,2015,Age,3 Months,88.4,81.5 to 92.9,227
Hib,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,3 Months,88.7,84.2 to 92.0,460
Hep B,≥2 Doses,States/Local Areas,Delaware,2016,Age,13 Months,92.9,87.2 to 96.2,233
Hep B,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,94.6,91.4 to 96.7,541
Hep B,≥2 Doses,States/Local Areas,Delaware,2015,Age,13 Months,92.9,87.2 to 96.2,227
Hep B,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,92.9,89.2 to 95.4,460
Hep B,≥2 Doses,States/Local Areas,Delaware,2014,Age,13 Months,94.7,89.5 to 97.4,234
Hep B,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,93.8,90.3 to 96.1,461
Hib,≥1 Dose,States/Local Areas,Delaware,2014,Age,3 Months,89.2,81.8 to 93.8,234
Hib,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,3 Months,88.8,84.1 to 92.2,461
Hep B,≥3 Doses,States/Local Areas,Delaware,2016,Age,35 Months,89.7,83.9 to 94.1,233
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,91.3,87.9 to 94.1,541
PCV,≥3 Doses,States/Local Areas,Delaware,2014,Age,19 Months,93.7,87.7 to 96.9,234
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,93.7,89.8 to 96.2,461
PCV,≥3 Doses,States/Local Areas,Delaware,2013,Age,19 Months,94.6,91.4 to 96.7,222
PCV,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,94.2,91.3 to 96.2,456
PCV,≥3 Doses,States/Local Areas,Delaware,2011,Age,19 Months,95.3,89.6 to 97.9,264
PCV,≥3 Doses,States/Local Areas,Delaware,2019,Age,13 Months,93.5,88.1 to 96.6,205
PCV,≥4 Doses,States/Local Areas,Delaware,2012,Age,35 Months,92.6,88.2 to 95.8,251
PCV,≥4 Doses,States/Local Areas,Delaware,2011,Age,35 Months,89.4,83.2 to 94.1,264
PCV,≥4 Doses,States/Local Areas,Delaware,2019,Age,24 Months,87.1,80.3 to 92.5,205
Hep B,≥3 Doses,States/Local Areas,Delaware,2017,Age,35 Months,92.9,88.8 to 95.9,308
Hep B,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,93.0,90.1 to 95.3,556
PCV,≥3 Doses,States/Local Areas,Delaware,2012,Age,19 Months,97.3,94.7 to 98.6,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2018,Age,35 Months,93.0,88.6 to 96.1,248
Hep B,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,94.2,91.4 to 96.4,453
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.7,81.5 to 94.0,125
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.6 to 93.8,384
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,92.4,89.3 to 95.4,445
≥1 Dose Varicella,,States/Local Areas,Delaware,2019,Age,35 Months,95.3,90.1 to 98.2,205
≥1 Dose MMR,,States/Local Areas,Delaware,2016,Age,35 Months,90.8,84.4 to 95.3,233
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2017,Age,35 Months,93.7,90.0 to 96.4,541
≥1 Dose MMR,,States/Local Areas,Delaware,2015,Age,35 Months,94.3,87.6 to 98.0,227
≥1 Dose MMR,,States/Local Areas,Delaware,2015-2016,Age,35 Months,92.9,88.1 to 96.2,460
PCV,≥4 Doses,States/Local Areas,Delaware,2018,Age,24 Months,83.1,77.4 to 88.0,248
PCV,≥4 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,85.1,80.8 to 88.9,453
PCV,≥4 Doses,States/Local Areas,Delaware,2017,Age,24 Months,87.8,82.9 to 91.8,308
PCV,≥4 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,85.5,81.8 to 88.7,556
PCV,≥4 Doses,States/Local Areas,Delaware,2016,Age,24 Months,81.5,74.1 to 87.9,233
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,84.6,80.2 to 88.5,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2012,Age,35 Months,97.9,95.4 to 99.2,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2015,Age,35 Months,87.5,81.3 to 92.4,227
Hep B,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,88.6,84.5 to 92.0,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2014,Age,35 Months,94.6,88.4 to 98.1,234
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,91.1,86.7 to 94.5,461
Hib,Full Series,States/Local Areas,Delaware,2020,Age,24 Months,79.1,71.1 to 86.1,183
Hep B,≥3 Doses,States/Local Areas,Delaware,2013,Age,35 Months,95.1,90.4 to 98.0,222
Hep B,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,94.9,91.1 to 97.4,456
PCV,≥3 Doses,States/Local Areas,Delaware,2018,Age,13 Months,90.8,86.0 to 94.0,248
PCV,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,92.1,88.8 to 94.5,453
PCV,≥3 Doses,States/Local Areas,Delaware,2017,Age,13 Months,91.3,86.1 to 94.7,308
PCV,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,91.1,87.7 to 93.6,556
Hep B,≥2 Doses,States/Local Areas,Delaware,2013,Age,13 Months,95.0,92.4 to 96.7,222
Hep B,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,94.8,93.6 to 95.9,456
Hep B,≥2 Doses,States/Local Areas,Delaware,2012,Age,13 Months,98.2,94.1 to 99.5,251
Hep B,≥2 Doses,States/Local Areas,Delaware,2011,Age,13 Months,97.2,94.9 to 98.5,264
Hep B,≥2 Doses,States/Local Areas,Delaware,2019,Age,7 Months,96.5,93.2 to 98.2,205
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,93.3,89.6 to 97.1,270
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.1,88.3 to 93.9,581
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,89.1 to 96.5,292
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.7,89.6 to 95.8,420
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,91.1,87.2 to 95.0,284
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,88.1,83.8 to 92.3,319
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Overall,Overall,90.5,88.1 to 92.9,873
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.6,87.7 to 93.4,581
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.0 to 98.8,114
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,91.6,87.4 to 95.7,214
Hib,≥1 Dose,States/Local Areas,Delaware,2013,Age,3 Months,90.0,87.8 to 91.9,222
Hib,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,3 Months,89.6,86.8 to 91.9,456
Hib,≥1 Dose,States/Local Areas,Delaware,2012,Age,3 Months,89.7,84.4 to 93.3,251
Hib,≥1 Dose,States/Local Areas,Delaware,2011,Age,3 Months,92.4,87.3 to 95.6,264
≥1 Dose MMR,,States/Local Areas,Delaware,2014,Age,35 Months,93.0,87.7 to 96.6,234
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2015,Age,35 Months,93.9,89.6 to 96.8,461
≥1 Dose Varicella,,States/Local Areas,Delaware,2018,Age,35 Months,94.2,89.6 to 97.3,248
≥1 Dose Varicella,,States/Local Areas,Delaware,2018-2019,Age,35 Months,94.7,91.4 to 97.1,453
≥1 Dose Varicella,,States/Local Areas,Delaware,2017,Age,35 Months,95.5,92.1 to 97.8,308
≥1 Dose Varicella,,States/Local Areas,Delaware,2017-2018,Age,35 Months,95.0,92.2 to 97.0,556
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2019,Age,0-2 Days,78.9,70.8 to 85.3,205
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2018,Age,0-2 Days,80.7,74.2 to 85.9,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2018-2019,Age,0-2 Days,79.9,74.8 to 84.1,453
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2017,Age,0-2 Days,78.7,72.3 to 83.9,308
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2017-2018,Age,0-2 Days,79.7,75.3 to 83.5,556
≥1 Dose Varicella,,States/Local Areas,Delaware,2016,Age,35 Months,90.5,84.1 to 95.0,233
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2017,Age,35 Months,92.9,89.1 to 95.7,541
≥1 Dose MMR,,States/Local Areas,Delaware,2013,Age,35 Months,97.4,93.7 to 99.2,222
≥1 Dose MMR,,States/Local Areas,Delaware,2013-2014,Age,35 Months,95.4,92.1 to 97.6,456
≥1 Dose MMR,,States/Local Areas,Delaware,2012,Age,35 Months,96.1,92.6 to 98.3,251
≥1 Dose MMR,,States/Local Areas,Delaware,2011,Age,35 Months,95.6,90.4 to 98.5,264
≥1 Dose MMR,,States/Local Areas,Delaware,2019,Age,24 Months,95.8,91.9 to 98.1,205
PCV,≥4 Doses,States/Local Areas,Delaware,2015,Age,24 Months,85.4,78.7 to 90.8,227
PCV,≥4 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,83.5,78.6 to 87.8,460
PCV,≥4 Doses,States/Local Areas,Delaware,2014,Age,24 Months,88.3,82.1 to 93.1,234
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,86.7,82.2 to 90.5,461
PCV,≥4 Doses,States/Local Areas,Delaware,2013,Age,24 Months,84.7,77.9 to 90.4,222
PCV,≥4 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,86.3,81.9 to 90.2,456
PCV,≥4 Doses,States/Local Areas,Delaware,2012,Age,24 Months,90.2,85.5 to 93.9,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2011,Age,35 Months,93.9,89.7 to 96.8,264
Hep B,≥3 Doses,States/Local Areas,Delaware,2019,Age,24 Months,94.2,89.9 to 97.1,205
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2015,Age,0-2 Days,74.4,66.9 to 80.7,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2015-2016,Age,0-2 Days,78.0,73.0 to 82.2,460
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2014,Age,0-2 Days,66.0,57.3 to 73.7,234
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2014-2015,Age,0-2 Days,70.2,64.5 to 75.3,461
≥1 Dose Varicella,,States/Local Areas,Delaware,2015,Age,35 Months,94.0,87.5 to 97.8,227
≥1 Dose Varicella,,States/Local Areas,Delaware,2015-2016,Age,35 Months,93.1,88.1 to 96.5,460
PCV,≥4 Doses,States/Local Areas,Delaware,2011,Age,24 Months,87.0,80.7 to 92.0,264
≥1 Dose Varicella,,States/Local Areas,Delaware,2014,Age,35 Months,92.7,87.3 to 96.4,234
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2015,Age,35 Months,93.7,89.5 to 96.6,461
≥1 Dose Varicella,,States/Local Areas,Delaware,2013,Age,35 Months,95.4,91.3 to 97.9,222
≥1 Dose Varicella,,States/Local Areas,Delaware,2013-2014,Age,35 Months,94.1,90.8 to 96.5,456
≥1 Dose MMR,,States/Local Areas,Delaware,2018,Age,24 Months,90.1,85.3 to 93.9,248
≥1 Dose MMR,,States/Local Areas,Delaware,2018-2019,Age,24 Months,92.9,89.9 to 95.2,453
PCV,≥4 Doses,States/Local Areas,Delaware,2019,Age,19 Months,82.4,74.3 to 88.3,205
PCV,≥3 Doses,States/Local Areas,Delaware,2016,Age,13 Months,91.4,85.4 to 95.1,233
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,91.4,87.6 to 94.1,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2018,Age,24 Months,90.7,86.2 to 94.1,248
Hep B,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,92.4,89.4 to 94.8,453
PCV,≥3 Doses,States/Local Areas,Delaware,2015,Age,13 Months,89.6,82.5 to 94.1,227
PCV,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,90.5,86.1 to 93.6,460
PCV,≥3 Doses,States/Local Areas,Delaware,2014,Age,13 Months,91.1,84.0 to 95.2,234
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,90.3,85.7 to 93.6,461
Hep B,≥2 Doses,States/Local Areas,Delaware,2018,Age,7 Months,95.7,92.1 to 97.7,248
Hep B,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,96.1,93.8 to 97.5,453
Hep B,≥2 Doses,States/Local Areas,Delaware,2017,Age,7 Months,94.8,90.8 to 97.1,308
Hep B,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,95.2,92.8 to 96.9,556
Hep B,≥2 Doses,States/Local Areas,Delaware,2016,Age,7 Months,92.7,86.9 to 96.0,233
Hep B,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,93.7,90.5 to 95.9,541
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2016,Age,0-2 Days,81.5,74.7 to 86.8,233
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2016-2017,Age,0-2 Days,80.1,75.6 to 84.0,541
Hep A,≥1 Dose,States/Local Areas,Delaware,2020,Age,35 Months,93.5,87.5 to 97.2,183
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2011,Age,0-2 Days,82.6,74.0 to 88.8,264
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2019,Age,0-1 Days,71.8,63.4 to 78.8,205
Hep B,≥2 Doses,States/Local Areas,Delaware,2013,Age,7 Months,91.9,89.4 to 93.8,222
Hep B,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,91.1,89.8 to 92.3,456
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2013,Age,0-2 Days,71.1,62.7 to 78.2,222
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2013-2014,Age,0-2 Days,68.5,65.8 to 71.1,456
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2012,Age,0-2 Days,80.9,73.7 to 86.4,251
PCV,≥3 Doses,States/Local Areas,Delaware,2011,Age,13 Months,93.7,86.6 to 97.1,264
PCV,≥3 Doses,States/Local Areas,Delaware,2019,Age,7 Months,69.2,60.5 to 76.8,205
PCV,≥3 Doses,States/Local Areas,Delaware,2018,Age,7 Months,71.3,64.3 to 77.4,248
PCV,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,70.3,64.8 to 75.2,453
Hep B,≥2 Doses,States/Local Areas,Delaware,2015,Age,7 Months,89.1,82.4 to 93.5,227
Hep B,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,90.9,86.8 to 93.8,460
Hep B,≥2 Doses,States/Local Areas,Delaware,2012,Age,7 Months,92.0,85.5 to 95.7,251
Hep B,≥2 Doses,States/Local Areas,Delaware,2014,Age,7 Months,90.3,84.0 to 94.3,234
Hep B,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,89.7,85.4 to 92.9,461
≥1 Dose MMR,,States/Local Areas,Delaware,2017,Age,24 Months,93.0,88.7 to 96.1,308
≥1 Dose MMR,,States/Local Areas,Delaware,2017-2018,Age,24 Months,91.5,88.4 to 94.1,556
≥1 Dose MMR,,States/Local Areas,Delaware,2016,Age,24 Months,89.9,83.6 to 94.5,233
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2017,Age,24 Months,91.4,87.7 to 94.3,541
PCV,≥4 Doses,States/Local Areas,Delaware,2018,Age,19 Months,76.2,69.9 to 81.6,248
PCV,≥4 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,79.7,73.9 to 84.5,375
Hep B,≥3 Doses,States/Local Areas,Delaware,2017,Age,24 Months,92.9,88.8 to 95.9,308
Hep B,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,91.8,88.9 to 94.2,556
PCV,≥3 Doses,States/Local Areas,Delaware,2012,Age,13 Months,94.0,91.7 to 95.7,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2016,Age,24 Months,89.7,83.9 to 94.1,233
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,91.3,87.9 to 94.1,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2015,Age,24 Months,87.5,81.3 to 92.4,227
Hep B,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,88.6,84.5 to 92.0,460
PCV,≥3 Doses,States/Local Areas,Delaware,2013,Age,13 Months,93.9,90.6 to 96.0,222
PCV,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,92.5,89.3 to 94.8,456
PCV,≥4 Doses,States/Local Areas,Delaware,2017,Age,19 Months,83.8,78.1 to 88.3,308
PCV,≥4 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,80.1,76.0 to 83.7,556
≥1 Dose Varicella,,States/Local Areas,Delaware,2012,Age,35 Months,95.4,91.7 to 97.8,251
≥1 Dose Varicella,,States/Local Areas,Delaware,2011,Age,35 Months,97.0,91.4 to 99.3,264
≥1 Dose Varicella,,States/Local Areas,Delaware,2019,Age,24 Months,95.3,90.1 to 98.2,205
≥1 Dose Varicella,,States/Local Areas,Delaware,2018,Age,24 Months,91.8,87.4 to 95.1,248
≥1 Dose Varicella,,States/Local Areas,Delaware,2018-2019,Age,24 Months,93.5,90.3 to 95.9,453
≥1 Dose MMR,,States/Local Areas,Delaware,2015,Age,24 Months,89.7,83.4 to 94.3,227
≥1 Dose MMR,,States/Local Areas,Delaware,2015-2016,Age,24 Months,89.8,85.5 to 93.2,460
≥1 Dose MMR,,States/Local Areas,Delaware,2014,Age,24 Months,90.5,84.8 to 94.7,234
≥1 Dose MMR,,States/Local Areas,Delaware,2014-2015,Age,24 Months,90.1,86.0 to 93.4,461
≥1 Dose MMR,,States/Local Areas,Delaware,2013,Age,24 Months,93.1,87.8 to 96.6,222
≥1 Dose MMR,,States/Local Areas,Delaware,2013-2014,Age,24 Months,91.8,88.1 to 94.7,456
PCV,≥4 Doses,States/Local Areas,Delaware,2016,Age,19 Months,76.3,68.3 to 82.8,233
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,80.1,75.2 to 84.2,541
PCV,≥4 Doses,States/Local Areas,Delaware,2015,Age,19 Months,79.9,74.5 to 84.3,227
PCV,≥4 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,78.1,72.7 to 82.7,460
PCV,≥3 Doses,States/Local Areas,Delaware,2017,Age,7 Months,72.5,65.5 to 78.6,308
PCV,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,71.9,67.0 to 76.3,556
PCV,≥3 Doses,States/Local Areas,Delaware,2016,Age,7 Months,71.5,63.7 to 78.2,233
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,72.0,66.8 to 76.7,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2014,Age,24 Months,90.4,84.3 to 94.9,234
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,88.9,84.7 to 92.4,461
Hep B,≥3 Doses,States/Local Areas,Delaware,2012,Age,24 Months,97.8,95.3 to 99.1,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2013,Age,24 Months,93.6,88.7 to 96.9,222
Hep B,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,92.0,88.2 to 94.9,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2011,Age,24 Months,93.9,89.7 to 96.8,264
Hep B,≥3 Doses,States/Local Areas,Delaware,2019,Age,19 Months,94.0,89.3 to 96.7,205
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,90.6,87.3 to 93.8,445
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2017,Age,0-1 Days,72.1,65.4 to 77.9,308
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2017-2018,Age,0-1 Days,72.1,67.4 to 76.4,556
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2016,Age,0-1 Days,73.5,65.8 to 80.0,233
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2016-2017,Age,0-1 Days,72.8,67.8 to 77.2,541
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2018,Age,0-1 Days,72.2,65.3 to 78.1,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2018-2019,Age,0-1 Days,72.0,66.7 to 76.7,453
Hep B,≥2 Doses,States/Local Areas,Delaware,2018,Age,5 Months,94.2,90.3 to 96.6,248
Hep B,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,5 Months,94.7,92.1 to 96.4,453
Hep B,≥2 Doses,States/Local Areas,Delaware,2011,Age,7 Months,95.9,91.8 to 98.0,264
Hep B,≥2 Doses,States/Local Areas,Delaware,2019,Age,5 Months,95.2,91.4 to 97.3,205
≥1 Dose Varicella,,States/Local Areas,Delaware,2017,Age,24 Months,90.9,86.4 to 94.3,308
≥1 Dose Varicella,,States/Local Areas,Delaware,2017-2018,Age,24 Months,91.3,88.3 to 93.8,556
≥1 Dose Varicella,,States/Local Areas,Delaware,2016,Age,24 Months,89.6,83.4 to 94.2,233
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2017,Age,24 Months,90.2,86.4 to 93.2,541
≥1 Dose Varicella,,States/Local Areas,Delaware,2015,Age,24 Months,87.2,80.6 to 92.4,227
≥1 Dose Varicella,,States/Local Areas,Delaware,2015-2016,Age,24 Months,88.4,84.0 to 92.1,460
≥1 Dose MMR,,States/Local Areas,Delaware,2012,Age,24 Months,95.2,91.7 to 97.6,251
PCV,≥3 Doses,States/Local Areas,Delaware,2015,Age,7 Months,69.8,61.7 to 76.8,227
PCV,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,70.7,65.1 to 75.7,460
≥1 Dose MMR,,States/Local Areas,Delaware,2011,Age,24 Months,93.8,88.7 to 97.1,264
≥1 Dose MMR,,States/Local Areas,Delaware,2019,Age,19 Months,94.5,89.8 to 97.0,205
PCV,≥4 Doses,States/Local Areas,Delaware,2014,Age,19 Months,80.5,73.0 to 86.4,234
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,80.2,75.0 to 84.5,461
≥1 Dose MMR,,States/Local Areas,Delaware,2018,Age,19 Months,87.5,81.9 to 91.5,248
≥1 Dose MMR,,States/Local Areas,Delaware,2018-2019,Age,19 Months,95.8,93.5 to 97.4,453
PCV,≥4 Doses,States/Local Areas,Delaware,2013,Age,19 Months,81.0,77.0 to 84.4,222
PCV,≥4 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,80.7,76.3 to 84.5,456
PCV,≥4 Doses,States/Local Areas,Delaware,2012,Age,19 Months,83.3,77.2 to 87.9,251
PCV,≥4 Doses,States/Local Areas,Delaware,2011,Age,19 Months,83.8,76.9 to 89.0,264
Hep B,≥2 Doses,States/Local Areas,Delaware,2017,Age,5 Months,93.2,88.9 to 95.9,308
Hep B,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,5 Months,93.7,91.0 to 95.6,556
Hep B,≥2 Doses,States/Local Areas,Delaware,2016,Age,5 Months,91.1,85.3 to 94.8,233
Hep B,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,5 Months,92.2,88.8 to 94.6,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2018,Age,19 Months,90.7,85.9 to 93.9,248
Hep B,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,91.3,88.0 to 93.7,453
Hep B,≥3 Doses,States/Local Areas,Delaware,2017,Age,19 Months,90.3,84.8 to 93.9,308
Hep B,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,90.5,87.0 to 93.1,556
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,90.1,86.0 to 94.2,270
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,88.1,83.3 to 92.8,284
PCV,≥3 Doses,States/Local Areas,Delaware,2012,Age,7 Months,68.6,60.1 to 76.0,251
PCV,≥3 Doses,States/Local Areas,Delaware,2014,Age,7 Months,68.0,59.5 to 75.5,234
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,68.9,63.1 to 74.2,461
PCV,≥3 Doses,States/Local Areas,Delaware,2011,Age,7 Months,73.6,66.0 to 80.0,264
PCV,≥3 Doses,States/Local Areas,Delaware,2013,Age,7 Months,73.4,66.8 to 79.1,222
PCV,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,70.7,68.5 to 72.8,456
Hep B,≥2 Doses,States/Local Areas,Delaware,2015,Age,5 Months,84.3,77.0 to 89.6,227
Hep B,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,5 Months,87.7,83.2 to 91.1,460
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2015,Age,0-1 Days,66.6,58.6 to 73.8,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2015-2016,Age,0-1 Days,70.0,64.6 to 75.0,460
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2014,Age,0-1 Days,63.5,55.0 to 71.4,234
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2014-2015,Age,0-1 Days,65.1,59.2 to 70.5,461
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2013,Age,0-1 Days,63.9,56.7 to 70.5,222
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2013-2014,Age,0-1 Days,63.7,60.1 to 67.2,456
Polio,≥2 Doses,States/Local Areas,Delaware,2019,Age,13 Months,97.7,94.6 to 99.0,205
Polio,≥2 Doses,States/Local Areas,Delaware,2018,Age,13 Months,94.8,91.1 to 97.1,248
Polio,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,96.2,94.0 to 97.7,453
≥1 Dose Varicella,,States/Local Areas,Delaware,2014,Age,24 Months,90.4,84.6 to 94.8,234
≥1 Dose Varicella,,States/Local Areas,Delaware,2014-2015,Age,24 Months,88.8,84.5 to 92.3,461
≥1 Dose Varicella,,States/Local Areas,Delaware,2013,Age,24 Months,92.7,87.5 to 96.3,222
≥1 Dose Varicella,,States/Local Areas,Delaware,2013-2014,Age,24 Months,91.5,87.8 to 94.5,456
Hep B,≥3 Doses,States/Local Areas,Delaware,2016,Age,19 Months,88.8,82.4 to 93.0,233
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,89.5,85.6 to 92.5,541
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,84.9,81.8 to 87.9,873
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.7,81.1 to 88.3,581
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,85.0,79.5 to 90.4,292
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.7,87.2 to 94.2,420
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,72.8 to 91.0,114
≥1 Dose Varicella,,States/Local Areas,Delaware,2012,Age,24 Months,94.0,90.4 to 96.6,251
≥1 Dose Varicella,,States/Local Areas,Delaware,2011,Age,24 Months,92.0,86.7 to 95.8,264
≥1 Dose MMR,,States/Local Areas,Delaware,2017,Age,19 Months,89.0,83.4 to 92.9,308
≥1 Dose MMR,,States/Local Areas,Delaware,2017-2018,Age,19 Months,88.3,84.5 to 91.2,556
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,78.5,72.8 to 84.1,319
≥1 Dose MMR,,States/Local Areas,Delaware,2016,Age,19 Months,86.8,79.6 to 91.7,233
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2017,Age,19 Months,87.9,83.6 to 91.2,541
≥1 Dose MMR,,States/Local Areas,Delaware,2015,Age,19 Months,86.5,79.9 to 91.2,227
≥1 Dose MMR,,States/Local Areas,Delaware,2015-2016,Age,19 Months,86.7,81.8 to 90.4,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2015,Age,19 Months,85.2,82.4 to 87.6,227
Hep B,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,87.0,82.4 to 90.5,460
Hep B,≥3 Doses,States/Local Areas,Delaware,2014,Age,19 Months,88.5,81.3 to 93.1,234
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,86.8,82.0 to 90.5,461
Hep B,≥2 Doses,States/Local Areas,Delaware,2014,Age,5 Months,85.1,77.3 to 90.5,234
Hep B,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,5 Months,84.7,83.4 to 86.0,461
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,88.5,81.5 to 95.5,270
Hep B,≥2 Doses,States/Local Areas,Delaware,2013,Age,5 Months,88.9,86.4 to 91.0,222
Hep B,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,5 Months,87.0,84.8 to 89.0,456
Hep B,≥2 Doses,States/Local Areas,Delaware,2012,Age,5 Months,87.4,79.1 to 92.7,251
Hep B,≥2 Doses,States/Local Areas,Delaware,2011,Age,5 Months,91.2,85.2 to 95.0,264
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,75.1,67.6 to 82.6,284
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2012,Age,0-1 Days,73.1,63.6 to 80.9,251
Hep A,≥2 Doses,States/Local Areas,Delaware,2020,Age,35 Months,89.2,79.2 to 95.7,183
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2011,Age,0-1 Days,78.6,72.6 to 83.5,264
Hep B,≥1 Dose,States/Local Areas,Delaware,2019,Age,3 Months,97.6,94.3 to 99.0,205
≥1 Dose Varicella,,States/Local Areas,Delaware,2019,Age,19 Months,95.7,91.3 to 97.9,205
Hep B,≥1 Dose,States/Local Areas,Delaware,2018,Age,3 Months,96.0,92.3 to 97.9,248
Hep B,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,3 Months,96.8,94.6 to 98.1,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2017,Age,13 Months,91.4,86.1 to 94.8,308
DTaP,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,92.2,89.0 to 94.5,556
Polio,≥3 Doses,States/Local Areas,Delaware,2012,Age,19 Months,96.5,92.8 to 98.3,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,76.8,70.4 to 83.1,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,78.5,72.9 to 84.1,284
DTaP,≥3 Doses,States/Local Areas,Delaware,2016,Age,13 Months,91.7,85.6 to 95.4,233
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,91.6,87.8 to 94.2,541
DTaP,≥3 Doses,States/Local Areas,Delaware,2018,Age,13 Months,93.0,88.7 to 95.8,248
DTaP,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,93.6,90.5 to 95.8,453
Polio,≥3 Doses,States/Local Areas,Delaware,2013,Age,19 Months,95.0,91.5 to 97.1,222
Polio,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,93.0,89.4 to 95.4,456
Polio,≥3 Doses,States/Local Areas,Delaware,2015,Age,19 Months,92.0,90.7 to 93.1,227
Polio,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,92.0,87.8 to 94.8,460
Polio,≥3 Doses,States/Local Areas,Delaware,2014,Age,19 Months,91.0,83.9 to 95.1,234
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,91.5,87.0 to 94.5,461
Hib,≥3 Doses,States/Local Areas,Delaware,2015,Age,13 Months,79.0,71.3 to 85.0,227
Hib,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,81.0,76.0 to 85.2,460
Hib,≥3 Doses,States/Local Areas,Delaware,2012,Age,13 Months,90.6,88.2 to 92.6,251
Hib,≥3 Doses,States/Local Areas,Delaware,2014,Age,13 Months,77.6,69.6 to 83.9,234
Hib,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,78.3,73.0 to 82.8,461
Hib,≥3 Doses,States/Local Areas,Delaware,2013,Age,13 Months,85.5,80.5 to 89.4,222
Hib,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,81.5,77.2 to 85.2,456
Polio,≥3 Doses,States/Local Areas,Delaware,2011,Age,19 Months,94.6,93.0 to 95.9,264
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,97.5,95.5 to 99.4,270
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,93.9,90.3 to 97.4,284
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.0,72.2 to 81.7,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.2,59.2 to 79.3,114
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Overall,Overall,77.4,74.1 to 80.8,873
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.9,75.0 to 82.7,581
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,74.8,68.6 to 80.9,292
DTaP,≥3 Doses,States/Local Areas,Delaware,2014,Age,13 Months,92.2,85.8 to 95.8,234
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,91.3,86.9 to 94.3,461
DTaP,≥3 Doses,States/Local Areas,Delaware,2013,Age,13 Months,95.4,90.9 to 97.7,222
DTaP,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,93.8,90.4 to 96.0,456
Hib,≥3 Doses,States/Local Areas,Delaware,2011,Age,13 Months,93.1,90.2 to 95.2,264
Hib,≥3 Doses,States/Local Areas,Delaware,2019,Age,7 Months,62.6,53.9 to 70.6,205
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,95.9,92.8 to 98.9,292
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.1,95.1 to 99.0,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,77.0,71.6 to 82.4,319
Hib,≥2 Doses,States/Local Areas,Delaware,2020,Age,13 Months,88.9,81.8 to 93.4,183
Hib,≥2 Doses,States/Local Areas,Delaware,2019,Age,13 Months,97.2,94.1 to 98.7,205
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,95.3,92.6 to 98.1,319
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,95.4,93.7 to 97.1,873
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.1,93.0 to 97.2,581
Hib,≥2 Doses,States/Local Areas,Delaware,2018,Age,13 Months,94.6,90.7 to 96.9,248
Hib,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,95.8,93.5 to 97.4,453
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,96.1,93.6 to 98.6,384
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,96.6,94.8 to 98.4,445
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.7 to 98.7,114
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,96.1,93.1 to 99.2,214
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.7,87.8 to 97.6,125
Hib,≥2 Doses,States/Local Areas,Delaware,2017,Age,13 Months,96.4,92.8 to 98.3,308
Hib,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,95.5,93.1 to 97.1,556
Hib,≥3 Doses,States/Local Areas,Delaware,2018,Age,7 Months,65.6,58.4 to 72.2,248
Hib,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,64.1,58.5 to 69.4,453
Hib,≥3 Doses,States/Local Areas,Delaware,2017,Age,7 Months,66.7,59.7 to 73.1,308
Hib,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,66.2,61.2 to 70.8,556
≥1 Dose Varicella,,States/Local Areas,Delaware,2020,Age,24 Months,89.8,83.7 to 94.3,183
Hib,≥2 Doses,States/Local Areas,Delaware,2019,Age,7 Months,92.3,86.0 to 95.9,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2017,Age,7 Months,74.1,67.1 to 80.0,308
DTaP,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,73.9,69.0 to 78.2,556
DTaP,≥3 Doses,States/Local Areas,Delaware,2016,Age,7 Months,72.5,64.6 to 79.1,233
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,73.3,68.1 to 77.9,541
DTaP,≥3 Doses,States/Local Areas,Delaware,2015,Age,7 Months,72.4,64.2 to 79.2,227
DTaP,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,72.4,66.9 to 77.4,460
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2018,Age,0-3 Days,81.7,75.2 to 86.8,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2018-2019,Age,0-3 Days,81.2,76.3 to 85.3,453
Polio,≥1 Dose,States/Local Areas,Delaware,2018,Age,3 Months,92.6,88.4 to 95.3,248
Polio,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,3 Months,93.4,90.2 to 95.6,453
Polio,≥1 Dose,States/Local Areas,Delaware,2017,Age,3 Months,91.1,86.4 to 94.2,308
Polio,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,3 Months,91.8,88.8 to 94.0,556
Hib,≥3 Doses,States/Local Areas,Delaware,2016,Age,7 Months,62.1,54.1 to 69.5,233
Hib,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,64.4,59.1 to 69.4,541
Hib,≥3 Doses,States/Local Areas,Delaware,2015,Age,7 Months,60.3,52.0 to 67.9,227
Hib,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,61.2,55.4 to 66.6,460
Hib,≥3 Doses,States/Local Areas,Delaware,2014,Age,7 Months,59.0,50.6 to 67.0,234
Hib,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,59.6,53.8 to 65.3,461
PCV,≥3 Doses,States/Local Areas,Delaware,2018,Age,35 Months,94.5,90.7 to 97.1,248
PCV,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,96.1,93.7 to 97.8,453
PCV,≥3 Doses,States/Local Areas,Delaware,2017,Age,35 Months,96.5,93.3 to 98.5,308
PCV,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,95.6,93.3 to 97.3,556
Hib,≥2 Doses,States/Local Areas,Delaware,2013,Age,13 Months,96.4,92.2 to 98.4,222
Hib,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,13 Months,95.1,91.6 to 97.2,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2011,Age,13 Months,95.1,91.5 to 97.2,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,84.0,78.2 to 89.7,214
DTaP,≥3 Doses,States/Local Areas,Delaware,2019,Age,7 Months,73.0,64.3 to 80.3,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2018,Age,7 Months,73.6,66.7 to 79.6,248
DTaP,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,73.3,67.9 to 78.1,453
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.5,70.3 to 86.6,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,78.3,73.5 to 83.1,384
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,78.0,73.2 to 82.7,445
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2019,Age,0-3 Days,80.7,72.7 to 86.8,205
Polio,≥1 Dose,States/Local Areas,Delaware,2019,Age,3 Months,94.2,88.4 to 97.1,205
Hib,≥2 Doses,States/Local Areas,Delaware,2014,Age,13 Months,93.8,87.7 to 97.0,234
Hib,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,13 Months,93.8,90.0 to 96.3,461
PCV,≥3 Doses,States/Local Areas,Delaware,2019,Age,35 Months,97.5,94.3 to 99.2,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2015,Age,13 Months,90.3,83.4 to 94.6,227
DTaP,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,91.0,86.7 to 94.0,460
DTaP,≥3 Doses,States/Local Areas,Delaware,2012,Age,13 Months,96.9,93.2 to 98.6,251
Hib,≥2 Doses,States/Local Areas,Delaware,2016,Age,13 Months,93.1,87.5 to 96.3,233
Hib,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,94.8,91.7 to 96.8,541
Hib,≥2 Doses,States/Local Areas,Delaware,2015,Age,13 Months,93.9,87.8 to 97.0,227
Hib,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,13 Months,93.5,89.7 to 95.9,460
Hib,≥2 Doses,States/Local Areas,Delaware,2012,Age,13 Months,97.8,95.0 to 99.1,251
Hib,≥2 Doses,States/Local Areas,Delaware,2011,Age,13 Months,96.6,93.6 to 98.2,264
Hib,≥2 Doses,States/Local Areas,Delaware,2017,Age,7 Months,93.7,89.6 to 96.3,308
Hib,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,7 Months,93.1,90.2 to 95.2,556
Hib,≥2 Doses,States/Local Areas,Delaware,2016,Age,7 Months,91.0,84.8 to 94.8,233
Hib,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,7 Months,92.3,88.9 to 94.8,541
Hib,≥2 Doses,States/Local Areas,Delaware,2018,Age,7 Months,92.4,87.7 to 95.3,248
Hib,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,7 Months,92.3,88.7 to 94.8,453
PCV,≥3 Doses,States/Local Areas,Delaware,2014,Age,35 Months,94.1,88.7 to 97.5,234
PCV,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,94.5,91.0 to 97.0,461
PCV,≥3 Doses,States/Local Areas,Delaware,2016,Age,35 Months,93.9,89.0 to 97.1,233
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,95.3,92.5 to 97.3,541
PCV,≥3 Doses,States/Local Areas,Delaware,2015,Age,35 Months,94.8,89.8 to 97.9,227
PCV,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,94.3,91.0 to 96.7,460
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2017,Age,0-3 Days,81.1,72.0 to 87.8,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2017-2018,Age,0-3 Days,82.4,78.2 to 85.9,556
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016,Age,0-3 Days,86.6,80.9 to 90.8,233
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2017,Age,0-3 Days,84.8,80.9 to 88.0,541
Polio,≥1 Dose,States/Local Areas,Delaware,2016,Age,3 Months,89.5,83.0 to 93.8,233
Polio,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,3 Months,90.3,86.5 to 93.1,541
Polio,≥1 Dose,States/Local Areas,Delaware,2015,Age,3 Months,88.3,81.4 to 92.9,227
Polio,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,3 Months,88.9,84.5 to 92.2,460
Polio,≥1 Dose,States/Local Areas,Delaware,2014,Age,3 Months,87.2,79.4 to 92.3,234
Polio,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,3 Months,87.8,82.9 to 91.4,461
Hib,≥3 Doses,States/Local Areas,Delaware,2013,Age,7 Months,68.4,67.1 to 69.7,222
Hib,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,63.7,59.0 to 68.1,456
Hib,≥3 Doses,States/Local Areas,Delaware,2012,Age,7 Months,65.6,58.4 to 72.2,251
Hib,≥3 Doses,States/Local Areas,Delaware,2011,Age,7 Months,78.6,72.5 to 83.7,264
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,93.3,90.0 to 96.5,270
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,91.6,87.7 to 95.4,284
DTaP,≥3 Doses,States/Local Areas,Delaware,2014,Age,7 Months,69.9,61.4 to 77.3,234
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,71.1,65.3 to 76.3,461
Hib,≥2 Doses,States/Local Areas,Delaware,2015,Age,7 Months,89.5,82.4 to 94.0,227
Hib,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,7 Months,90.2,85.8 to 93.4,460
PCV,≥3 Doses,States/Local Areas,Delaware,2013,Age,35 Months,94.6,89.7 to 97.7,222
PCV,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,94.4,90.9 to 96.8,456
PCV,≥3 Doses,States/Local Areas,Delaware,2011,Age,35 Months,98.1,94.6 to 99.5,264
PCV,≥3 Doses,States/Local Areas,Delaware,2019,Age,24 Months,95.1,90.6 to 97.8,205
PCV,≥3 Doses,States/Local Areas,Delaware,2012,Age,35 Months,97.5,94.8 to 98.9,251
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,83.7 to 97.0,114
Hib,Full Series,States/Local Areas,Delaware,2017,Age,35 Months,93.5,89.4 to 96.4,308
Hib,Full Series,States/Local Areas,Delaware,2017-2018,Age,35 Months,91.4,87.9 to 94.2,556
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,93.1,89.1 to 97.0,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014,Age,0-3 Days,67.6,59.0 to 75.2,234
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2014-2015,Age,0-3 Days,71.9,66.3 to 77.0,461
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2015,Age,0-3 Days,76.2,68.8 to 82.4,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2015-2016,Age,0-3 Days,81.4,76.8 to 85.3,460
DTaP,≥3 Doses,States/Local Areas,Delaware,2013,Age,7 Months,77.6,75.0 to 79.9,222
DTaP,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,73.7,70.3 to 76.9,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2012,Age,7 Months,69.8,60.4 to 77.8,251
DTaP,≥3 Doses,States/Local Areas,Delaware,2011,Age,7 Months,79.2,73.1 to 84.2,264
Polio,≥1 Dose,States/Local Areas,Delaware,2013,Age,3 Months,91.4,89.3 to 93.1,222
Polio,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,3 Months,89.3,86.9 to 91.3,456
Polio,≥1 Dose,States/Local Areas,Delaware,2012,Age,3 Months,89.7,85.4 to 92.9,251
Polio,≥1 Dose,States/Local Areas,Delaware,2011,Age,3 Months,91.9,85.9 to 95.5,264
PCV,≥1 Dose,States/Local Areas,Delaware,2019,Age,3 Months,91.3,85.0 to 95.1,205
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,89.0,84.7 to 93.3,319
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,91.0,88.6 to 93.3,873
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,90.7,86.7 to 94.7,270
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,89.4,84.9 to 93.9,284
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,81.2,75.9 to 86.6,319
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,86.4,83.6 to 89.3,873
PCV,≥4 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,82.4 to 89.5,581
Hib,≥2 Doses,States/Local Areas,Delaware,2014,Age,7 Months,91.8,84.8 to 95.7,234
Hib,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,7 Months,90.6,86.0 to 93.8,461
Hib,≥2 Doses,States/Local Areas,Delaware,2013,Age,7 Months,92.9,91.1 to 94.4,222
Hib,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,7 Months,92.3,89.9 to 94.2,456
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2012,Age,0-3 Days,83.9,77.4 to 88.7,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2011,Age,0-3 Days,84.1,77.7 to 88.9,264
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,90.4,86.7 to 94.0,384
PCV,≥1 Dose,States/Local Areas,Delaware,2018,Age,3 Months,92.0,87.6 to 94.9,248
PCV,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,3 Months,91.6,88.1 to 94.2,453
PCV,≥1 Dose,States/Local Areas,Delaware,2017,Age,3 Months,91.3,86.7 to 94.4,308
PCV,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,3 Months,91.6,88.6 to 93.9,556
PCV,≥1 Dose,States/Local Areas,Delaware,2016,Age,3 Months,88.8,82.3 to 93.1,233
PCV,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,3 Months,90.0,86.3 to 92.9,541
Hep B,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.6,77.4 to 91.7,125
DTaP,≥3 Doses,States/Local Areas,Delaware,2013,Age,19 Months,96.1,91.1 to 98.3,222
DTaP,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,94.6,90.4 to 97.0,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2012,Age,19 Months,98.0,93.4 to 99.4,251
DTaP,≥3 Doses,States/Local Areas,Delaware,2011,Age,19 Months,97.2,94.0 to 98.7,264
DTaP,≥3 Doses,States/Local Areas,Delaware,2019,Age,13 Months,94.3,88.9 to 97.1,205
Hib,≥3 Doses,States/Local Areas,Delaware,2017,Age,13 Months,83.0,77.2 to 87.6,308
Hib,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,13 Months,83.7,79.7 to 87.1,556
Hib,≥3 Doses,States/Local Areas,Delaware,2016,Age,13 Months,83.0,76.2 to 88.2,233
Hib,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,13 Months,83.0,78.6 to 86.7,541
Hib,≥3 Doses,States/Local Areas,Delaware,2012,Age,19 Months,95.8,93.6 to 97.3,251
Hib,≥3 Doses,States/Local Areas,Delaware,2011,Age,19 Months,96.1,93.1 to 97.8,264
Hib,≥3 Doses,States/Local Areas,Delaware,2019,Age,13 Months,81.9,74.6 to 87.4,205
Polio,≥3 Doses,States/Local Areas,Delaware,2018,Age,19 Months,94.0,90.0 to 96.5,248
Polio,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,64.0,58.5 to 69.1,453
Hib,≥3 Doses,States/Local Areas,Delaware,2018,Age,13 Months,84.5,78.4 to 89.1,248
Hib,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,13 Months,83.2,78.7 to 86.9,453
Polio,≥3 Doses,States/Local Areas,Delaware,2017,Age,19 Months,93.6,88.6 to 96.5,308
Polio,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,93.8,90.8 to 95.9,556
Polio,≥3 Doses,States/Local Areas,Delaware,2016,Age,19 Months,92.0,85.9 to 95.6,233
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,92.8,89.1 to 95.3,541
Hib,≥3 Doses,States/Local Areas,Delaware,2013,Age,19 Months,94.8,88.2 to 97.8,222
Hib,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,92.9,87.7 to 96.0,456
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.2,92.0 to 96.5,581
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,89.3,86.0 to 92.6,445
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.0,68.5 to 85.5,125
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,80.2,75.2 to 85.2,384
Hib,Full Series,States/Local Areas,Delaware,2019,Age,35 Months,84.4,76.6 to 90.7,205
Hib,Full Series,States/Local Areas,Delaware,2018,Age,35 Months,89.3,83.3 to 93.8,248
Hib,Full Series,States/Local Areas,Delaware,2018-2019,Age,35 Months,86.9,82.1 to 90.9,453
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,95.5,92.2 to 98.8,292
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.1,92.5 to 97.8,420
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,88.7 to 99.4,114
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,96.8,94.3 to 99.3,214
Hib,Full Series,States/Local Areas,Delaware,2016,Age,35 Months,83.0,74.3 to 90.0,233
Hib,Full Series,States/Local Areas,Delaware,2016-2017,Age,35 Months,88.0,83.1 to 92.0,541
Hib,Full Series,States/Local Areas,Delaware,2015,Age,35 Months,88.1,81.6 to 93.1,227
Hib,Full Series,States/Local Areas,Delaware,2015-2016,Age,35 Months,85.3,80.0 to 89.8,460
Polio,≥3 Doses,States/Local Areas,Delaware,2018,Age,35 Months,96.7,93.5 to 98.6,248
Polio,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,97.1,95.0 to 98.5,453
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.1,87.0 to 97.1,125
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,95.6,92.9 to 98.3,384
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,95.3,93.0 to 97.6,445
Polio,≥3 Doses,States/Local Areas,Delaware,2019,Age,35 Months,97.5,94.2 to 99.2,205
DTaP,≥2 Doses,States/Local Areas,Delaware,2016,Age,5 Months,83.2,75.8 to 88.7,233
DTaP,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,5 Months,83.2,78.4 to 87.1,541
DTaP,≥2 Doses,States/Local Areas,Delaware,2015,Age,5 Months,82.8,75.1 to 88.5,227
DTaP,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,5 Months,83.0,77.9 to 87.1,460
Polio,≥3 Doses,States/Local Areas,Delaware,2017,Age,35 Months,97.0,93.5 to 98.9,308
Polio,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,96.9,94.8 to 98.4,556
Polio,≥3 Doses,States/Local Areas,Delaware,2016,Age,35 Months,94.9,90.5 to 97.7,233
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,96.6,93.6 to 98.4,541
DTaP,≥2 Doses,States/Local Areas,Delaware,2014,Age,5 Months,80.7,73.1 to 86.6,234
DTaP,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,5 Months,81.8,78.2 to 84.9,461
DTaP,≥2 Doses,States/Local Areas,Delaware,2013,Age,5 Months,87.5,85.9 to 88.9,222
DTaP,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,5 Months,84.1,80.9 to 86.8,456
DTaP,≥2 Doses,States/Local Areas,Delaware,2012,Age,5 Months,78.2,71.1 to 84.1,251
DTaP,≥2 Doses,States/Local Areas,Delaware,2011,Age,5 Months,85.7,79.1 to 90.5,264
Hib,Full Series,States/Local Areas,Delaware,2014,Age,35 Months,89.3,83.2 to 93.9,234
Hib,Full Series,States/Local Areas,Delaware,2014-2015,Age,35 Months,88.7,84.3 to 92.2,461
Hib,Full Series,States/Local Areas,Delaware,2013,Age,35 Months,87.4,81.3 to 92.2,222
Hib,Full Series,States/Local Areas,Delaware,2013-2014,Age,35 Months,88.6,84.4 to 92.0,456
Hib,Full Series,States/Local Areas,Delaware,2012,Age,35 Months,88.5,83.0 to 92.8,251
Hib,Full Series,States/Local Areas,Delaware,2011,Age,35 Months,88.3,82.0 to 93.2,264
Hib,Full Series,States/Local Areas,Delaware,2019,Age,24 Months,82.2,74.5 to 88.7,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2015,Age,19 Months,94.4,93.6 to 95.0,227
DTaP,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,93.4,89.5 to 95.9,460
DTaP,≥3 Doses,States/Local Areas,Delaware,2014,Age,19 Months,93.1,86.9 to 96.5,234
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,93.7,89.9 to 96.2,461
Polio,≥3 Doses,States/Local Areas,Delaware,2015,Age,35 Months,95.3,89.0 to 98.6,227
Polio,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,95.7,91.4 to 98.2,460
Polio,≥3 Doses,States/Local Areas,Delaware,2012,Age,35 Months,97.7,95.0 to 99.1,251
Polio,≥3 Doses,States/Local Areas,Delaware,2014,Age,35 Months,95.0,88.8 to 98.3,234
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,95.2,90.9 to 97.9,461
Polio,≥3 Doses,States/Local Areas,Delaware,2013,Age,35 Months,96.4,92.5 to 98.6,222
Polio,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,95.6,92.3 to 97.8,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2016,Age,19 Months,92.4,86.3 to 95.9,233
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,93.2,89.5 to 95.6,541
Hib,≥3 Doses,States/Local Areas,Delaware,2016,Age,19 Months,91.4,85.3 to 95.1,233
Hib,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,92.8,89.2 to 95.2,541
Hib,≥3 Doses,States/Local Areas,Delaware,2015,Age,19 Months,91.2,87.2 to 94.1,227
Hib,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,91.3,87.2 to 94.2,460
Polio,≥3 Doses,States/Local Areas,Delaware,2011,Age,35 Months,99.2,97.1 to 99.9,264
DTaP,≥3 Doses,States/Local Areas,Delaware,2018,Age,19 Months,95.2,91.5 to 97.3,248
DTaP,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,93.6,90.5 to 95.8,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2017,Age,19 Months,94.0,88.9 to 96.8,308
DTaP,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,94.6,91.7 to 96.5,556
Polio,≥3 Doses,States/Local Areas,Delaware,2019,Age,19 Months,95.1,90.0 to 97.6,205
Polio,≥3 Doses,States/Local Areas,Delaware,2012,Age,24 Months,97.7,95.0 to 99.1,251
Polio,≥3 Doses,States/Local Areas,Delaware,2011,Age,24 Months,97.1,93.7 to 99.0,264
Hib,≥3 Doses,States/Local Areas,Delaware,2014,Age,19 Months,91.0,84.7 to 94.9,234
Hib,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,91.1,86.9 to 94.1,461
Polio,≥3 Doses,States/Local Areas,Delaware,2013,Age,24 Months,95.8,91.8 to 98.1,222
Polio,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,94.3,90.9 to 96.7,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2019,Age,19 Months,95.1,90.0 to 97.6,205
Polio,≥3 Doses,States/Local Areas,Delaware,2015,Age,24 Months,92.8,87.1 to 96.6,227
Polio,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,93.9,90.4 to 96.4,460
Polio,≥3 Doses,States/Local Areas,Delaware,2014,Age,24 Months,92.7,86.9 to 96.6,234
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,92.7,88.8 to 95.6,461
Hib,Full Series,States/Local Areas,Delaware,2015,Age,24 Months,86.1,79.9 to 91.2,227
Hib,Full Series,States/Local Areas,Delaware,2015-2016,Age,24 Months,81.8,76.8 to 86.2,460
DTaP,≥3 Doses,States/Local Areas,Delaware,2013,Age,24 Months,96.1,92.2 to 98.4,222
DTaP,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,94.6,91.4 to 96.9,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2011,Age,24 Months,99.1,97.2 to 99.8,264
Hib,≥3 Doses,States/Local Areas,Delaware,2018,Age,19 Months,94.0,89.9 to 96.5,248
Hib,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,83.2,78.7 to 86.9,453
Hib,≥3 Doses,States/Local Areas,Delaware,2017,Age,19 Months,94.2,89.6 to 96.8,308
Hib,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,94.1,91.2 to 96.0,556
Polio,≥3 Doses,States/Local Areas,Delaware,2016,Age,24 Months,94.9,90.5 to 97.7,233
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,95.3,92.4 to 97.3,541
Polio,≥3 Doses,States/Local Areas,Delaware,2017,Age,24 Months,95.3,91.4 to 97.8,308
Polio,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,95.0,92.5 to 96.9,556
Hib,≥3 Doses,States/Local Areas,Delaware,2019,Age,19 Months,90.6,84.1 to 94.6,205
Polio,≥3 Doses,States/Local Areas,Delaware,2019,Age,24 Months,96.2,92.0 to 98.5,205
Polio,≥3 Doses,States/Local Areas,Delaware,2018,Age,24 Months,94.6,91.1 to 97.1,248
Polio,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,95.4,92.9 to 97.3,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2012,Age,24 Months,98.2,95.6 to 99.4,251
Hib,Full Series,States/Local Areas,Delaware,2018,Age,24 Months,82.3,76.4 to 87.4,248
Hib,Full Series,States/Local Areas,Delaware,2018-2019,Age,24 Months,82.3,77.6 to 86.5,453
Hib,Full Series,States/Local Areas,Delaware,2017,Age,24 Months,85.9,80.7 to 90.3,308
Hib,Full Series,States/Local Areas,Delaware,2017-2018,Age,24 Months,84.0,80.2 to 87.5,556
Hib,Full Series,States/Local Areas,Delaware,2016,Age,24 Months,77.2,69.7 to 84.1,233
Hib,Full Series,States/Local Areas,Delaware,2016-2017,Age,24 Months,81.4,76.7 to 85.7,541
Hib,≥3 Doses,States/Local Areas,Delaware,2014,Age,24 Months,92.6,87.0 to 96.4,234
Hib,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,92.5,88.7 to 95.4,461
Hib,≥3 Doses,States/Local Areas,Delaware,2013,Age,24 Months,94.8,90.7 to 97.5,222
Hib,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,24 Months,93.7,90.4 to 96.1,456
Hib,≥3 Doses,States/Local Areas,Delaware,2012,Age,24 Months,96.6,93.7 to 98.4,251
Hib,≥3 Doses,States/Local Areas,Delaware,2011,Age,24 Months,97.4,94.0 to 99.1,264
Hib,Primary Series,States/Local Areas,Delaware,2012,Age,7 Months,73.0,63.5 to 80.7,251
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,89.8,85.7 to 93.9,270
Hib,Primary Series,States/Local Areas,Delaware,2011,Age,7 Months,79.7,73.8 to 84.6,264
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.2,80.5 to 87.8,581
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,82.2,76.5 to 88.0,292
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,86.4 to 93.4,420
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.2,72.0 to 90.4,114
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,76.7,69.6 to 83.9,214
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,86.7,81.9 to 91.5,284
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,76.8,71.0 to 82.5,319
Hib,Full Series,States/Local Areas,Delaware,2014-2017,Overall,Overall,83.5,80.4 to 86.6,873
Hep A,≥1 Dose,States/Local Areas,Connecticut,2015,Age,35 Months,96.3,91.5 to 98.8,216
Hep A,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,35 Months,96.4,91.8 to 98.8,398
Polio,≥2 Doses,States/Local Areas,Connecticut,2012,Age,5 Months,85.3,75.0 to 91.8,245
Polio,≥2 Doses,States/Local Areas,Connecticut,2013,Age,5 Months,78.5,71.2 to 84.3,255
Polio,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,5 Months,83.4,77.8 to 87.8,518
Polio,≥2 Doses,States/Local Areas,Connecticut,2014,Age,5 Months,88.5,82.1 to 92.8,263
Polio,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,5 Months,86.9,83.3 to 89.8,479
Polio,≥2 Doses,States/Local Areas,Connecticut,2015,Age,5 Months,85.2,77.9 to 90.4,216
Polio,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,5 Months,86.5,81.3 to 90.5,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,94.6,90.9 to 98.2,178
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,92.8,88.4 to 97.2,246
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,99.2,97.8 to 100.0,338
Hep B,≥3 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,46.8,43.5 to 50.1,243
Hep B,≥3 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,60.9,45.3 to 74.5,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,68.7,56.6 to 78.7,255
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,63.7,58.9 to 68.3,518
DTaP,≥4 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,75.2,68.7 to 80.8,311
DTaP,≥4 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,89.7,84.3 to 93.8,243
DTaP,≥4 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,85.9,78.9 to 91.5,245
DTaP,≥4 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,85.9,79.2 to 91.3,255
DTaP,≥4 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,85.6,81.0 to 89.6,518
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,56.8,47.3 to 66.8,182
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,57.4,50.6 to 64.3,366
Hep A,≥2 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,58.0,48.4 to 67.8,184
Hep A,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,58.0,52.0 to 64.2,492
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,85.4,78.8 to 90.9,263
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,84.3,79.2 to 88.7,479
Hep A,≥2 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,58.1,51.0 to 65.3,308
Hep A,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,57.1,52.0 to 62.3,619
DTaP,≥4 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,91.4,87.1 to 94.8,308
DTaP,≥4 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,90.6,87.4 to 93.2,619
DTaP,≥4 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,89.7,84.9 to 93.5,311
DTaP,≥4 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,92.6,87.0 to 96.3,243
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013,Age,13 Months,58.8,53.4 to 64.0,255
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013-2014,Age,13 Months,55.1,52.8 to 57.5,518
Hep B,≥1 Dose,States/Local Areas,Connecticut,2011,Age,3 Months,95.2,92.8 to 96.9,243
Hep B,≥1 Dose,States/Local Areas,Connecticut,2012,Age,3 Months,95.9,94.2 to 97.1,245
Hep B,≥1 Dose,States/Local Areas,Connecticut,2013,Age,3 Months,98.2,95.2 to 99.3,255
Hep B,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,3 Months,96.5,93.4 to 98.2,518
Hep B,≥1 Dose,States/Local Areas,Connecticut,2014,Age,3 Months,94.8,90.6 to 97.2,263
Hep B,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,3 Months,95.1,91.8 to 97.1,479
Polio,≥2 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,89.0,80.1 to 94.2,184
Polio,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,92.7,88.0 to 95.7,492
Polio,≥2 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,96.4,92.3 to 98.4,308
Polio,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,95.7,93.2 to 97.3,619
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,93.4,90.1 to 96.7,338
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,93.0,85.6 to 96.7,182
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,90.0,84.8 to 93.6,366
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,88.6,81.2 to 93.3,216
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,90.7,85.9 to 94.0,398
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,87.0,78.4 to 92.5,184
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,89.5,84.8 to 92.9,492
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,84.3,76.7 to 91.8,182
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,87.7,76.2 to 99.3,92
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,85.9,80.8 to 91.1,474
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,78.1,69.8 to 86.5,186
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.5,45.2 to 83.8,44
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,89.4,81.0 to 95.2,182
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,88.9,83.0 to 93.5,366
DTaP,≥4 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,87.6,79.2 to 93.7,184
DTaP,≥4 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,91.4,86.8 to 94.8,492
Polio,≥2 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,97.2,94.5 to 98.6,255
Polio,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,96.2,94.1 to 97.6,518
Polio,≥2 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,95.2,91.1 to 97.5,263
Polio,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,94.9,91.6 to 96.9,479
Hep B,≥1 Dose,States/Local Areas,Connecticut,2015,Age,3 Months,95.4,89.2 to 98.1,216
Hep B,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,3 Months,95.3,91.0 to 97.6,398
Hep B,≥1 Dose,States/Local Areas,Connecticut,2016,Age,3 Months,95.2,87.3 to 98.3,182
Hep B,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,3 Months,95.1,90.6 to 97.5,366
Hep B,≥1 Dose,States/Local Areas,Connecticut,2017,Age,3 Months,95.0,88.4 to 97.9,184
Hep B,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,3 Months,97.4,94.1 to 98.9,492
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.3,68.1 to 88.5,115
Polio,≥2 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,95.0,91.1 to 97.2,311
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,83.9,79.6 to 88.2,762
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,79.3,70.7 to 87.9,178
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014,Age,19 Months,90.4,85.2 to 93.9,263
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2015,Age,19 Months,89.6,85.6 to 92.6,479
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015,Age,19 Months,88.8,84.7 to 91.9,216
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015-2016,Age,19 Months,89.1,83.9 to 92.7,398
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016,Age,19 Months,89.4,80.6 to 94.4,182
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2017,Age,19 Months,88.0,82.0 to 92.2,366
Polio,≥2 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,97.3,96.4 to 98.1,243
Polio,≥2 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,94.3,85.3 to 97.9,245
≥1 Dose MMR,,States/Local Areas,Connecticut,2018,Age,13 Months,80.0,73.9 to 85.0,308
≥1 Dose MMR,,States/Local Areas,Connecticut,2018-2019,Age,13 Months,76.3,71.9 to 80.3,619
≥1 Dose MMR,,States/Local Areas,Connecticut,2019,Age,13 Months,72.6,65.8 to 78.4,311
≥1 Dose MMR,,States/Local Areas,Connecticut,2017,Age,13 Months,65.7,55.8 to 74.4,184
≥1 Dose MMR,,States/Local Areas,Connecticut,2017-2018,Age,13 Months,72.9,66.9 to 78.1,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016,Age,13 Months,57.7,47.6 to 67.2,182
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2017,Age,13 Months,57.1,50.1 to 63.9,366
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017,Age,13 Months,56.5,46.7 to 65.8,184
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017-2018,Age,13 Months,60.5,54.4 to 66.3,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018,Age,13 Months,64.5,57.4 to 71.0,308
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018-2019,Age,13 Months,63.8,58.9 to 68.4,619
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.2,87.6 to 94.8,421
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,88.7,83.6 to 93.8,261
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.2,87.0 to 93.5,478
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Overall,Overall,89.8,87.0 to 92.5,762
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,90.6,86.1 to 95.1,178
Polio,≥2 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,92.2,86.6 to 95.6,263
Polio,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,92.6,88.9 to 95.2,479
Polio,≥2 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,93.0,87.2 to 96.3,216
Polio,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,93.7,89.6 to 96.2,398
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,84.0,77.5 to 90.5,246
Polio,≥2 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,94.3,87.2 to 97.6,182
Polio,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,91.7,86.5 to 95.0,366
Hep B,≥3 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,91.8,88.2 to 94.4,243
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,94.1,92.2 to 95.5,255
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,91.1,87.8 to 93.6,518
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,88.1,82.5 to 92.1,263
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,88.3,84.0 to 91.6,479
Hep A,≥2 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,85.4,74.7 to 93.2,184
Hep A,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,86.2,80.5 to 90.9,492
Hep A,≥2 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,86.5,80.0 to 91.7,308
Hep A,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,87.2,82.6 to 91.2,619
Hep B,≥3 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,91.2,83.2 to 95.6,245
Hep A,≥2 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,88.1,80.9 to 93.5,311
DTaP,≥4 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,87.3,80.5 to 92.5,255
DTaP,≥4 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,88.7,84.2 to 92.4,518
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,89.7,83.6 to 94.3,263
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,90.0,84.8 to 93.9,479
DTaP,≥4 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,89.1,81.5 to 94.6,245
DTaP,≥4 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,91.5,81.2 to 97.3,216
DTaP,≥4 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,90.0,83.9 to 94.5,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2016,Age,13 Months,65.3,55.3 to 74.1,182
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2017,Age,13 Months,65.5,58.6 to 71.8,366
Hep A,≥1 Dose,States/Local Areas,Connecticut,2020,Age,35 Months,96.6,90.5 to 99.2,248
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019,Age,13 Months,63.0,56.0 to 69.4,311
≥1 Dose Varicella,,States/Local Areas,Connecticut,2011,Age,19 Months,91.6,87.5 to 94.4,243
≥1 Dose Varicella,,States/Local Areas,Connecticut,2012,Age,19 Months,91.5,89.3 to 93.4,245
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013,Age,19 Months,93.9,89.4 to 96.6,255
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013-2014,Age,19 Months,92.2,90.9 to 93.3,518
≥1 Dose MMR,,States/Local Areas,Connecticut,2014,Age,13 Months,60.8,52.7 to 68.4,263
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2015,Age,13 Months,61.3,55.4 to 66.8,479
≥1 Dose MMR,,States/Local Areas,Connecticut,2015,Age,13 Months,61.7,53.1 to 69.7,216
≥1 Dose MMR,,States/Local Areas,Connecticut,2015-2016,Age,13 Months,63.5,56.9 to 69.6,398
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,92.7,88.4 to 97.0,182
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,78.9 to 93.5,115
Polio,≥2 Doses,States/Local Areas,Connecticut,2019,Age,5 Months,88.2,82.6 to 92.2,311
Polio,≥2 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,96.3,94.8 to 97.4,243
Polio,≥2 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,92.1,84.4 to 96.2,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,51.6,42.0 to 61.0,184
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,54.9,48.9 to 60.8,492
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,58.2,51.1 to 65.0,308
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,58.2,53.2 to 63.1,619
Polio,≥2 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,90.4,83.1 to 94.8,255
Polio,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,91.3,88.1 to 93.7,518
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,58.2,51.2 to 65.0,311
Hep A,≥2 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,85.6,77.0 to 92.3,216
Hep A,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,83.8,77.3 to 89.4,398
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,82.2,72.0 to 90.4,182
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,83.6,76.5 to 89.5,366
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014,Age,13 Months,51.4,43.5 to 59.2,263
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2015,Age,13 Months,52.9,47.2 to 58.7,479
≥1 Dose Varicella,,States/Local Areas,Connecticut,2012,Age,13 Months,58.4,46.6 to 69.3,245
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015,Age,13 Months,54.5,46.0 to 62.7,216
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015-2016,Age,13 Months,56.1,49.5 to 62.5,398
Hep A,≥1 Dose,States/Local Areas,Connecticut,2019,Age,35 Months,94.7,90.6 to 97.4,311
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,90.3,86.7 to 93.8,474
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,91.2,86.8 to 95.6,186
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,85.7,75.6 to 95.7,92
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.5,66.7 to 94.3,44
Polio,≥2 Doses,States/Local Areas,Connecticut,2018,Age,5 Months,88.1,82.8 to 91.9,308
Polio,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,5 Months,88.2,84.5 to 91.1,619
DTaP,≥4 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,94.1,89.7 to 97.1,308
DTaP,≥4 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,94.4,91.4 to 96.6,619
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.6,82.3 to 93.0,421
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,77.9,70.5 to 85.4,261
≥1 Dose MMR,,States/Local Areas,Connecticut,2011,Age,13 Months,62.6,60.0 to 65.2,243
≥1 Dose MMR,,States/Local Areas,Connecticut,2012,Age,13 Months,57.1,49.4 to 64.5,245
≥1 Dose MMR,,States/Local Areas,Connecticut,2013,Age,13 Months,60.2,56.3 to 64.0,255
≥1 Dose MMR,,States/Local Areas,Connecticut,2013-2014,Age,13 Months,60.5,59.0 to 62.0,518
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016,Age,35 Months,95.3,87.6 to 98.9,182
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,35 Months,95.2,89.4 to 98.3,366
Hep A,≥1 Dose,States/Local Areas,Connecticut,2017,Age,35 Months,90.9,82.9 to 96.2,184
Hep A,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,35 Months,93.0,88.6 to 96.1,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2011,Age,13 Months,60.3,55.5 to 64.9,243
Hep A,≥1 Dose,States/Local Areas,Connecticut,2018,Age,35 Months,95.0,90.9 to 97.7,308
Hep A,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,35 Months,94.9,92.1 to 96.9,619
Polio,≥2 Doses,States/Local Areas,Connecticut,2016,Age,5 Months,87.9,79.4 to 93.2,182
Polio,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,5 Months,84.5,78.3 to 89.1,366
Polio,≥2 Doses,States/Local Areas,Connecticut,2017,Age,5 Months,81.0,71.3 to 87.9,184
Polio,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,5 Months,84.5,79.2 to 88.7,492
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,58.7,50.8 to 66.2,263
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,57.0,51.2 to 62.6,479
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,55.3,46.9 to 63.5,216
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,61.2,54.7 to 67.4,398
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,67.3,57.4 to 75.8,182
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,59.5,52.6 to 66.1,366
PCV,≥2 Doses,States/Local Areas,Connecticut,2018,Age,5 Months,87.1,81.3 to 91.3,308
PCV,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,5 Months,87.9,84.0 to 90.9,619
PCV,≥2 Doses,States/Local Areas,Connecticut,2019,Age,5 Months,88.6,83.0 to 92.5,311
Polio,≥2 Doses,States/Local Areas,Connecticut,2011,Age,5 Months,94.1,91.0 to 96.2,243
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,94.9,91.4 to 98.4,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,88.3 to 99.2,115
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",98.3,96.7 to 99.9,421
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,95.8,92.6 to 99.0,261
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.9,93.6 to 98.2,478
DTaP,≥4 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,73.2,63.1 to 81.3,184
DTaP,≥4 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,75.5,69.6 to 80.6,492
DTaP,≥4 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,77.8,71.5 to 83.1,308
DTaP,≥4 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,96.7,94.2 to 98.1,619
Hep A,≥2 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,53.0,45.1 to 61.2,255
Hep A,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,53.0,47.4 to 58.8,518
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,53.2,45.3 to 61.4,263
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,52.5,46.7 to 58.6,479
Hep A,≥2 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,51.9,43.5 to 60.8,216
Hep A,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,54.3,47.8 to 61.0,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,95.9,94.0 to 97.7,762
Hib,≥3 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,95.8,92.3 to 98.1,311
Hep A,≥2 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,56.1,48.9 to 63.4,311
Hep A,≥2 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,85.4,74.5 to 93.4,243
Hep A,≥2 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,83.9,75.5 to 90.6,245
Hep A,≥2 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,84.6,75.6 to 91.6,255
Hep A,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,81.4,75.5 to 86.7,518
DTaP,≥4 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,83.1,75.2 to 89.6,216
DTaP,≥4 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,82.5,76.8 to 87.4,398
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,82.4,74.0 to 89.4,182
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,83.4,77.6 to 88.4,366
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,78.2,70.3 to 85.3,263
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,81.8,76.0 to 86.8,479
DTaP,≥4 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,84.4,75.9 to 91.1,184
DTaP,≥4 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,87.9,83.1 to 91.9,492
Hep A,≥1 Dose,States/Local Areas,Connecticut,2013,Age,35 Months,95.7,91.7 to 98.1,255
Hep A,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,35 Months,96.0,92.8 to 98.1,518
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014,Age,35 Months,97.7,93.1 to 99.5,263
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,35 Months,97.4,94.0 to 99.1,479
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.7,81.6 to 91.8,478
≥1 Dose MMR,,States/Local Areas,Connecticut,2020-2021,Age,19 Months,92.4,87.4 to 95.6,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,81.6,75.1 to 88.0,178
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,95.6,91.4 to 97.8,308
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,95.0,92.2 to 96.8,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,94.5,87.3 to 97.7,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,91.3,85.7 to 94.8,366
DTaP,≥3 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,92.3,81.6 to 97.0,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,93.4,87.3 to 96.7,216
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,93.9,89.7 to 96.5,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,94.9,91.9 to 96.8,255
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,94.1,92.3 to 95.5,518
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,93.3,88.0 to 96.4,263
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,93.3,89.6 to 95.8,479
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,76.2,69.6 to 82.8,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.7,73.8 to 83.7,478
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Overall,Overall,77.7,73.7 to 81.6,762
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.0,74.0 to 90.0,115
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.2,69.5 to 80.9,421
Hib,≥2 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,96.5,92.5 to 98.5,308
Hib,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,96.1,93.6 to 97.7,619
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,91.8 to 97.0,478
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,93.8,91.7 to 96.0,762
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,91.1,86.6 to 95.6,178
Hib,≥2 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,95.7,91.7 to 97.8,311
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,88.0,78.4 to 93.7,184
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,91.8,86.7 to 95.1,492
Polio,≥3 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,92.9,89.2 to 95.4,255
Polio,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,92.7,92.0 to 93.4,518
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.4,94.1 to 98.6,421
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,88.7 to 96.7,261
Hib,≥3 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,66.9,60.0 to 73.2,311
Hib,≥3 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,94.1,91.4 to 96.0,243
Hib,≥2 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,93.7,87.4 to 96.9,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,79.5,73.3 to 85.6,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,73.2,66.2 to 80.2,338
Polio,≥3 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,91.6,82.1 to 96.2,245
Hib,≥3 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,66.6,56.9 to 75.1,184
Hib,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,68.1,62.2 to 73.4,492
Hib,≥3 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,69.5,62.7 to 75.5,308
Hib,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,68.2,63.4 to 72.7,619
Hib,≥2 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,93.0,84.6 to 97.0,184
Hib,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,94.8,90.5 to 97.2,492
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.4,76.4 to 98.4,44
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,93.5,89.5 to 97.5,182
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,84.6 to 97.5,115
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,97.0,95.1 to 98.9,474
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,91.6,87.3 to 96.0,186
PCV,≥3 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,96.5,93.2 to 98.5,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,89.5,81.5 to 97.6,92
Hib,≥2 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,97.2,93.6 to 98.8,263
Hib,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,96.6,93.7 to 98.2,479
Polio,≥1 Dose,States/Local Areas,Connecticut,2019,Age,3 Months,92.3,87.7 to 95.2,311
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2019,Age,0-3 Days,86.1,80.3 to 90.4,311
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,80.9,71.6 to 90.1,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,74.5,68.7 to 80.2,474
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,81.3,74.8 to 87.8,186
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.9,65.5 to 92.2,44
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,84.5,78.7 to 89.0,308
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,82.8,78.6 to 86.3,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,81.0,74.7 to 86.1,311
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,78.8,71.1 to 86.5,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,97.0,95.9 to 97.8,243
Hib,≥2 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,99.3,98.0 to 99.7,255
Hib,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,98.2,96.9 to 99.0,518
PCV,≥3 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,90.1,82.1 to 95.6,184
PCV,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,93.3,88.9 to 96.4,492
PCV,≥3 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,96.6,92.8 to 98.7,308
PCV,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,96.5,94.2 to 98.1,619
Hib,≥3 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,65.8,58.0 to 72.8,263
Hib,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,66.0,60.4 to 71.2,479
Hib,≥3 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,66.3,57.9 to 73.8,216
Hib,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,68.2,61.8 to 74.0,398
Hib,≥3 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,70.1,60.2 to 78.4,182
Hib,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,68.4,61.6 to 74.5,366
Polio,≥1 Dose,States/Local Areas,Connecticut,2017,Age,3 Months,90.0,81.8 to 94.7,184
Polio,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,3 Months,91.7,87.3 to 94.7,492
Polio,≥1 Dose,States/Local Areas,Connecticut,2018,Age,3 Months,93.5,88.9 to 96.3,308
Polio,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,3 Months,92.9,89.9 to 95.1,619
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2018,Age,0-3 Days,83.3,77.1 to 88.0,308
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2018-2019,Age,0-3 Days,84.7,80.6 to 88.0,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,78.1,70.2 to 84.4,216
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,82.9,77.5 to 87.2,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,87.7,80.0 to 92.7,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,82.6,76.6 to 87.3,366
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,77.4,67.8 to 84.8,184
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,81.0,75.5 to 85.5,492
Hib,≥2 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,95.6,91.6 to 97.7,311
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,75.7,68.0 to 82.1,263
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,76.9,71.6 to 81.5,479
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,90.0,85.1 to 94.9,246
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,93.5,89.5 to 97.5,338
Hib,≥3 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,82.4,77.2 to 86.6,243
Hib,≥3 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,71.4,55.1 to 83.5,245
Hib,≥3 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,66.8,59.2 to 73.6,255
Hib,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,66.3,58.5 to 73.3,518
Polio,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,3 Months,89.6,85.2 to 92.7,479
Polio,≥1 Dose,States/Local Areas,Connecticut,2015,Age,3 Months,89.6,83.1 to 93.9,216
Polio,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,3 Months,90.1,85.2 to 93.5,398
Polio,≥1 Dose,States/Local Areas,Connecticut,2016,Age,3 Months,90.5,82.1 to 95.2,182
Polio,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,3 Months,90.2,84.9 to 93.9,366
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016,Age,0-3 Days,76.8,65.6 to 85.2,182
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2017,Age,0-3 Days,78.9,72.0 to 84.5,366
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2017,Age,0-3 Days,82.3,68.3 to 90.9,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2017-2018,Age,0-3 Days,82.1,77.0 to 86.3,492
Hib,≥2 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,94.4,87.2 to 97.6,182
Hib,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,91.8,86.6 to 95.1,366
Hib,≥2 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,89.2,80.3 to 94.4,184
Hib,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,92.4,87.7 to 95.4,492
Hib,≥2 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,95.9,90.6 to 98.3,216
Hib,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,96.0,92.1 to 98.0,398
Hib,≥2 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,96.1,88.5 to 98.7,182
Hib,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,94.5,89.6 to 97.2,366
PCV,≥3 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,97.2,90.8 to 99.5,216
PCV,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,95.6,91.6 to 98.1,398
PCV,≥3 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,95.4,89.2 to 98.6,182
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,92.8,87.9 to 96.2,366
PCV,≥3 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,93.7,88.7 to 97.0,263
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,95.2,91.6 to 97.6,479
Hib,≥2 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,95.6,91.5 to 97.8,308
Hib,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,95.6,93.0 to 97.3,619
Hib,≥2 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,97.5,96.6 to 98.1,243
Hib,≥2 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,95.2,88.2 to 98.2,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,91.0 to 96.7,421
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,92.2,88.1 to 96.3,261
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.4,89.3 to 95.6,478
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,92.6,87.5 to 97.7,182
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,85.0 to 97.3,115
PCV,≥3 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,91.9,85.6 to 96.1,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,92.3,89.9 to 94.8,762
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,93.1,89.2 to 97.0,178
PCV,≥1 Dose,States/Local Areas,Connecticut,2019,Age,3 Months,93.1,89.0 to 95.8,311
Polio,≥1 Dose,States/Local Areas,Connecticut,2011,Age,3 Months,95.1,90.6 to 97.5,243
Polio,≥1 Dose,States/Local Areas,Connecticut,2012,Age,3 Months,88.5,82.8 to 92.5,245
Polio,≥1 Dose,States/Local Areas,Connecticut,2013,Age,3 Months,89.3,87.0 to 91.2,255
Polio,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,3 Months,89.4,87.2 to 91.3,518
Polio,≥1 Dose,States/Local Areas,Connecticut,2014,Age,3 Months,89.5,83.0 to 93.7,263
DTaP,≥3 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,86.0,80.7 to 90.0,243
DTaP,≥3 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,74.8,58.3 to 86.3,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,74.1,64.5 to 81.8,255
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,74.9,68.7 to 80.2,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2015,Age,0-3 Days,77.2,69.1 to 83.7,216
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2015-2016,Age,0-3 Days,77.0,70.3 to 82.6,398
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020,Age,24 Months,95.6,90.2 to 98.5,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014,Age,0-3 Days,73.5,66.0 to 79.8,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2014-2015,Age,0-3 Days,75.3,69.9 to 80.0,479
Hib,≥2 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,94.1,83.1 to 98.1,255
Hib,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,93.4,89.9 to 95.8,518
Hib,≥2 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,92.7,87.1 to 96.0,263
Hib,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,93.1,89.4 to 95.6,479
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.7,84.9 to 92.5,478
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,86.8,83.6 to 90.0,762
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,84.3,78.4 to 90.1,178
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,80.5,73.2 to 87.8,246
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,93.6,90.2 to 96.9,338
PCV,≥3 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,96.5,93.2 to 98.5,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,95.1,91.4 to 97.5,243
PCV,≥3 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,99.7,98.8 to 99.9,255
PCV,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,96.8,94.2 to 98.4,518
Hib,≥2 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,93.5,87.7 to 96.7,216
Hib,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,93.9,89.8 to 96.4,398
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,90.7,83.3 to 98.2,92
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,92.3,88.8 to 95.7,474
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.4,74.9 to 97.9,44
PCV,≥1 Dose,States/Local Areas,Connecticut,2016,Age,3 Months,89.7,81.4 to 94.6,182
PCV,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,3 Months,88.6,83.0 to 92.5,366
PCV,≥1 Dose,States/Local Areas,Connecticut,2017,Age,3 Months,87.4,78.8 to 92.8,184
PCV,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,3 Months,89.9,85.1 to 93.3,492
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2013,Age,0-3 Days,82.2,75.9 to 87.2,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2013-2014,Age,0-3 Days,77.9,73.1 to 82.1,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2012,Age,0-3 Days,78.0,69.9 to 84.4,245
PCV,≥1 Dose,States/Local Areas,Connecticut,2018,Age,3 Months,92.4,87.1 to 95.6,308
PCV,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,3 Months,92.8,89.6 to 95.0,619
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,92.8,88.7 to 96.8,186
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2011,Age,0-3 Days,81.9,75.5 to 86.9,243
Hib,≥2 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,93.7,87.0 to 97.0,245
PCV,≥3 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,95.4,89.2 to 98.6,182
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,92.7,87.9 to 96.1,366
PCV,≥3 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,90.0,82.0 to 95.5,184
PCV,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,93.1,88.7 to 96.2,492
PCV,≥3 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,96.2,92.5 to 98.4,308
PCV,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,96.3,94.0 to 97.9,619
Polio,≥3 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,92.6,87.5 to 95.7,263
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,92.2,88.4 to 94.9,479
Polio,≥3 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,91.9,87.7 to 94.8,216
Polio,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,93.2,88.9 to 96.0,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,94.4,89.9 to 96.9,311
DTaP,≥3 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,97.5,96.6 to 98.1,243
DTaP,≥3 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,94.7,89.2 to 97.5,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,97.0,94.8 to 98.3,255
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,96.3,95.6 to 97.0,518
Hib,≥3 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,81.8,72.4 to 88.5,182
Hib,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,79.9,73.5 to 85.1,366
Hib,≥3 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,78.0,68.4 to 85.3,184
Hib,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,80.6,75.1 to 85.1,492
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,90.2,85.3 to 95.2,246
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,98.8,97.2 to 100.0,338
Polio,≥3 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,95.4,92.8 to 97.1,243
Hib,≥3 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,86.9,84.3 to 89.1,255
Hib,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,85.3,83.1 to 87.2,518
Hib,≥3 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,83.7,77.4 to 88.5,263
Hib,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,82.1,77.2 to 86.1,479
Hib,≥3 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,87.9,76.7 to 94.1,245
Hib,≥3 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,80.5,72.6 to 86.5,216
Hib,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,81.1,75.3 to 85.9,398
Polio,≥3 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,94.6,87.5 to 97.8,182
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,92.5,87.3 to 95.7,366
Polio,≥3 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,90.4,81.4 to 95.3,184
Polio,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,93.2,88.4 to 96.0,492
Hib,≥3 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,83.2,77.3 to 87.7,308
Hib,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,83.2,79.2 to 86.5,619
Polio,≥3 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,95.9,91.7 to 98.0,308
Polio,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,76.3,71.9 to 80.3,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,96.1,92.2 to 98.1,311
Hib,≥3 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,96.4,95.3 to 97.3,255
Hib,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,95.5,94.6 to 96.2,518
Hib,≥3 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,83.2,77.4 to 87.7,311
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,93.6,87.8 to 97.2,248
Hib,≥3 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,97.4,96.5 to 98.1,243
Hib,≥3 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,91.9,81.5 to 96.7,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,95.7,88.2 to 98.5,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,93.5,88.2 to 96.5,366
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,95.7,91.4 to 97.9,263
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,95.1,91.7 to 97.1,479
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,94.5,91.8 to 96.3,216
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,95.1,90.9 to 97.4,398
Hib,≥3 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,93.0,89.3 to 95.5,216
Hib,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,94.3,89.9 to 96.8,398
Hib,≥3 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,95.7,88.0 to 98.5,182
Hib,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,93.3,88.0 to 96.3,366
Polio,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,3 Months,92.1,87.3 to 95.2,412
Hep A,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,91.2,83.6 to 96.2,412
Polio,≥3 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,94.3,90.2 to 97.1,263
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,93.4,90.0 to 96.0,479
Polio,≥3 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,92.2,86.3 to 96.2,216
Polio,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,94.2,90.2 to 96.9,398
Polio,≥3 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,95.4,91.9 to 97.7,255
Polio,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,94.8,92.3 to 96.8,518
Hib,≥3 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,94.5,90.2 to 96.9,263
Hib,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,93.7,90.1 to 96.1,479
Polio,≥3 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,97.3,94.4 to 99.0,243
Polio,≥3 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,93.4,87.9 to 97.0,245
Polio,≥3 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,93.7,89.6 to 96.3,311
Polio,≥3 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,96.2,90.0 to 99.0,182
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,93.7,89.0 to 96.9,366
Hib,≥3 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,90.9,81.9 to 95.6,184
Hib,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,92.7,88.0 to 95.6,492
Hib,≥3 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,94.5,90.2 to 97.0,308
Hib,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,83.2,79.2 to 86.5,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,91.1,82.0 to 95.9,184
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,93.9,89.1 to 96.7,492
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,96.7,92.3 to 98.6,308
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,95.0,92.2 to 96.8,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,97.9,95.1 to 99.3,243
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,98.9,96.8 to 99.8,255
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,97.6,95.6 to 98.8,518
Hib,Full Series,States/Local Areas,Connecticut,2015,Age,24 Months,83.8,76.3 to 90.0,216
Hib,Full Series,States/Local Areas,Connecticut,2015-2016,Age,24 Months,84.0,78.4 to 88.9,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,95.1,89.7 to 98.2,245
Polio,≥3 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,96.7,92.9 to 98.8,308
Polio,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,95.9,93.5 to 97.6,619
Polio,≥3 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,95.1,91.6 to 97.5,311
Hib,≥3 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,95.8,91.8 to 97.9,311
Polio,≥3 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,91.1,83.2 to 96.3,184
Polio,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,93.9,89.6 to 96.9,492
Hib,Full Series,States/Local Areas,Connecticut,2016,Age,24 Months,84.3,75.5 to 91.3,182
Hib,Full Series,States/Local Areas,Connecticut,2016-2017,Age,24 Months,83.8,77.7 to 89.0,366
Hib,Full Series,States/Local Areas,Connecticut,2017,Age,24 Months,83.3,74.4 to 90.4,184
Hib,Full Series,States/Local Areas,Connecticut,2017-2018,Age,24 Months,87.2,82.2 to 91.4,492
Hib,Full Series,States/Local Areas,Connecticut,2018,Age,24 Months,91.2,87.0 to 94.6,308
Hib,Full Series,States/Local Areas,Connecticut,2018-2019,Age,24 Months,91.3,88.3 to 93.8,619
Hib,≥3 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,97.6,94.6 to 99.1,243
Hib,≥3 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,93.7,88.1 to 97.3,245
Hib,≥3 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,98.0,95.5 to 99.3,255
Hib,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,96.8,94.7 to 98.3,518
Hib,≥3 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,95.5,91.8 to 97.9,263
Hib,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,94.6,91.3 to 96.9,479
Polio,≥3 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,97.3,94.4 to 99.0,243
Hib,≥2 Doses,States/Local Areas,Connecticut,2018,Age,5 Months,86.3,80.9 to 90.4,308
Hib,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,5 Months,87.6,83.9 to 90.5,619
Hib,≥2 Doses,States/Local Areas,Connecticut,2019,Age,5 Months,88.9,83.4 to 92.7,311
Hib,≥2 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,96.9,95.6 to 97.8,243
PCV,≥1 Dose,States/Local Areas,Connecticut,2014,Age,3 Months,86.5,79.5 to 91.4,263
PCV,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,3 Months,88.2,83.7 to 91.6,479
PCV,≥1 Dose,States/Local Areas,Connecticut,2015,Age,3 Months,90.0,83.5 to 94.1,216
PCV,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,3 Months,89.9,85.0 to 93.3,398
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,81.2 to 95.3,115
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,87.5 to 94.7,421
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,82.9,77.0 to 88.9,261
Hib,≥2 Doses,States/Local Areas,Connecticut,2013,Age,5 Months,79.7,73.7 to 84.7,255
Hib,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,5 Months,83.9,79.4 to 87.6,518
Hib,≥2 Doses,States/Local Areas,Connecticut,2014,Age,5 Months,88.2,81.7 to 92.6,263
Hib,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,5 Months,86.7,83.3 to 89.5,479
Hib,≥2 Doses,States/Local Areas,Connecticut,2011,Age,5 Months,94.3,92.2 to 95.8,243
Hib,≥2 Doses,States/Local Areas,Connecticut,2012,Age,5 Months,86.2,75.9 to 92.5,245
PCV,≥3 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,96.2,92.0 to 98.2,308
PCV,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,94.8,92.1 to 96.7,619
PCV,≥3 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,95.7,91.6 to 97.9,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,95.1,91.4 to 97.5,243
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Overall,Overall,92.5,90.1 to 94.9,762
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,91.4,87.0 to 95.8,178
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,88.5,82.8 to 94.2,246
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,96.4,94.1 to 98.8,338
PCV,≥1 Dose,States/Local Areas,Connecticut,2011,Age,3 Months,92.4,88.9 to 94.9,243
PCV,≥4 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,95.0,91.1 to 97.6,308
PCV,≥4 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,94.6,91.8 to 96.6,619
PCV,≥4 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,94.0,89.7 to 97.0,311
PCV,≥4 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,87.9,79.3 to 94.2,184
PCV,≥4 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,91.5,86.7 to 95.0,492
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,78.7,67.4 to 90.1,92
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,86.1,80.5 to 91.7,186
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,84.2,77.4 to 91.0,182
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.5,56.6 to 86.5,44
PCV,≥1 Dose,States/Local Areas,Connecticut,2013,Age,3 Months,87.9,86.3 to 89.4,255
PCV,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,3 Months,87.2,86.1 to 88.2,518
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,91.8,88.5 to 95.0,474
Hib,≥2 Doses,States/Local Areas,Connecticut,2015,Age,5 Months,85.2,77.9 to 90.4,216
Hib,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,5 Months,86.0,80.7 to 90.0,398
Hib,≥2 Doses,States/Local Areas,Connecticut,2016,Age,5 Months,86.8,78.3 to 92.3,182
Hib,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,5 Months,83.3,77.1 to 88.0,366
Hib,≥2 Doses,States/Local Areas,Connecticut,2017,Age,5 Months,79.6,69.9 to 86.8,184
Hib,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,5 Months,83.0,77.5 to 87.3,492
PCV,≥3 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,99.4,98.4 to 99.8,255
PCV,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,95.8,93.3 to 97.6,518
PCV,≥3 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,92.1,87.2 to 95.7,263
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,93.0,89.5 to 95.7,479
PCV,≥3 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,93.8,88.1 to 97.3,216
PCV,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,94.6,90.7 to 97.2,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.8,92.1 to 97.4,421
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,84.5 to 94.3,261
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.3,91.8 to 96.9,478
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,96.4,93.9 to 98.9,338
Hib,≥1 Dose,States/Local Areas,Connecticut,2015,Age,3 Months,90.0,83.5 to 94.2,216
Hib,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,3 Months,91.2,86.5 to 94.4,398
Hib,≥1 Dose,States/Local Areas,Connecticut,2016,Age,3 Months,92.5,84.2 to 96.6,182
Hib,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,3 Months,91.3,86.0 to 94.7,366
Hib,≥1 Dose,States/Local Areas,Connecticut,2017,Age,3 Months,90.2,82.0 to 94.9,184
Hib,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,3 Months,91.6,87.2 to 94.6,492
Hep B,≥2 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,93.0,85.1 to 96.9,184
Hep B,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,95.1,91.0 to 97.4,492
Hep B,≥2 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,97.2,92.9 to 98.9,308
Hep B,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,96.6,94.1 to 98.1,619
Hep B,≥2 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,96.0,92.1 to 98.0,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,93.6,90.4 to 95.8,216
PCV,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,94.5,90.2 to 96.9,398
PCV,≥3 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,95.4,87.9 to 98.3,182
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,92.7,87.4 to 95.9,366
≥1 Dose MMR,,States/Local Areas,Connecticut,2018,Age,35 Months,97.4,93.8 to 99.2,308
≥1 Dose MMR,,States/Local Areas,Connecticut,2018-2019,Age,35 Months,96.0,93.5 to 97.7,619
≥1 Dose MMR,,States/Local Areas,Connecticut,2017-2018,Age,35 Months,95.2,91.2 to 97.7,492
PCV,≥4 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,92.4,86.8 to 96.2,255
PCV,≥4 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,89.5,85.4 to 92.8,518
≥1 Dose MMR,,States/Local Areas,Connecticut,2019,Age,35 Months,94.3,90.4 to 97.0,311
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,84.1,73.9 to 94.4,92
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,95.8,93.7 to 98.0,474
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,90.9 to 96.7,421
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,84.3 to 94.3,261
PCV,≥4 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,86.6,80.4 to 91.6,263
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,89.2,84.8 to 92.8,479
PCV,≥4 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,92.4,84.8 to 97.0,216
PCV,≥4 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,89.9,84.1 to 94.2,398
PCV,≥4 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,87.8,78.7 to 94.3,182
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,88.6,82.1 to 93.5,366
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,92.1,87.8 to 96.4,186
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,91.9,87.0 to 96.8,182
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,85.3 to 97.2,115
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.7,74.0 to 97.3,44
PCV,≥3 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,90.0,80.9 to 95.0,184
PCV,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,93.1,88.3 to 96.0,492
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,95.6,92.2 to 97.9,311
Hib,≥1 Dose,States/Local Areas,Connecticut,2018,Age,3 Months,93.0,88.4 to 95.9,308
Hib,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,3 Months,92.9,90.0 to 95.1,619
Hib,≥1 Dose,States/Local Areas,Connecticut,2019,Age,3 Months,92.8,88.5 to 95.6,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,91.4,85.2 to 95.8,245
PCV,≥1 Dose,States/Local Areas,Connecticut,2012,Age,3 Months,85.2,78.7 to 89.9,245
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.1,90.4 to 95.9,478
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Overall,Overall,91.8,89.3 to 94.3,762
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,91.7,87.6 to 95.8,178
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,85.9,79.7 to 92.2,246
Hep B,≥2 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,95.6,91.8 to 97.7,311
Hep B,≥2 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,95.5,92.9 to 97.2,243
Hep B,≥2 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,92.4,84.0 to 96.6,245
Hep B,≥2 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,98.4,97.6 to 98.9,255
Hep B,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,95.4,92.6 to 97.2,518
PCV,≥3 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,87.7,78.2 to 93.4,184
PCV,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,91.5,86.4 to 94.8,492
PCV,≥3 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,95.3,90.9 to 97.6,308
PCV,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,94.8,92.1 to 96.7,619
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,98.0,95.2 to 99.3,255
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,95.6,93.1 to 97.4,518
Hib,Full Series,States/Local Areas,Connecticut,2020,Age,24 Months,83.6,75.9 to 89.9,248
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,93.3,88.9 to 96.4,263
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,92.4,88.6 to 95.4,479
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,91.0,83.9 to 95.8,216
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,92.5,88.0 to 95.8,398
Hep B,≥3 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,91.9,86.3 to 95.9,245
PCV,≥4 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,83.6,74.8 to 90.7,182
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,84.7,78.6 to 89.8,366
PCV,≥4 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,85.8,76.9 to 92.6,184
PCV,≥4 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,89.5,84.5 to 93.4,492
PCV,≥4 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,93.2,89.1 to 96.2,308
PCV,≥4 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,92.6,89.7 to 94.9,619
≥1 Dose MMR,,States/Local Areas,Connecticut,2015,Age,35 Months,98.1,93.2 to 99.7,216
≥1 Dose MMR,,States/Local Areas,Connecticut,2015-2016,Age,35 Months,98.1,95.1 to 99.4,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2016,Age,35 Months,97.3,93.1 to 99.2,182
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2017,Age,35 Months,96.1,91.4 to 98.7,366
≥1 Dose MMR,,States/Local Areas,Connecticut,2017,Age,35 Months,92.5,85.0 to 97.1,184
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019,Age,35 Months,95.3,91.6 to 97.8,311
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,93.8,91.0 to 96.7,474
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,92.6,88.7 to 96.6,186
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,84.7,74.4 to 95.0,92
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.1,67.9 to 94.3,44
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,95.3,91.0 to 98.0,308
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,95.5,92.9 to 97.4,619
PCV,≥3 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,91.4,87.6 to 94.2,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,90.3,82.6 to 95.5,184
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,92.8,88.5 to 96.0,492
PCV,≥4 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,91.9,87.6 to 95.2,311
PCV,≥4 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,92.5,86.9 to 96.3,243
PCV,≥4 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,86.8,80.3 to 92.0,245
PCV,≥3 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,94.4,90.3 to 96.9,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,95.1,92.9 to 96.7,243
PCV,≥3 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,98.2,96.3 to 99.1,255
PCV,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,94.6,91.7 to 96.6,518
PCV,≥3 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,91.1,85.5 to 94.6,263
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,92.3,88.5 to 95.0,479
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,94.4,88.0 to 98.1,182
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,92.4,87.6 to 95.8,366
Hib,≥1 Dose,States/Local Areas,Connecticut,2011,Age,3 Months,95.8,92.6 to 97.6,243
Hib,≥1 Dose,States/Local Areas,Connecticut,2012,Age,3 Months,89.8,83.0 to 94.1,245
Hib,≥1 Dose,States/Local Areas,Connecticut,2013,Age,3 Months,92.3,89.7 to 94.3,255
Hib,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,3 Months,90.8,88.9 to 92.4,518
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,94.9,91.4 to 97.3,311
Hep B,≥3 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,95.3,92.1 to 97.5,243
PCV,≥4 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,86.0,79.4 to 91.3,245
PCV,≥4 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,91.5,85.9 to 95.5,255
PCV,≥4 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,88.2,83.9 to 91.7,518
PCV,≥4 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,84.7,78.0 to 90.2,263
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,86.6,81.9 to 90.5,479
PCV,≥4 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,88.3,81.4 to 93.5,216
PCV,≥4 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,85.8,80.4 to 90.4,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2019,Age,24 Months,93.1,88.8 to 96.1,311
≥1 Dose MMR,,States/Local Areas,Connecticut,2011,Age,35 Months,94.3,89.7 to 97.3,243
≥1 Dose MMR,,States/Local Areas,Connecticut,2012,Age,35 Months,93.1,87.0 to 97.1,245
≥1 Dose MMR,,States/Local Areas,Connecticut,2013,Age,35 Months,97.7,94.5 to 99.3,255
≥1 Dose MMR,,States/Local Areas,Connecticut,2013-2014,Age,35 Months,95.9,92.9 to 97.9,518
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016,Age,35 Months,95.4,88.0 to 98.8,182
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2017,Age,35 Months,94.9,89.7 to 98.0,366
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017,Age,35 Months,92.5,84.9 to 97.1,184
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017-2018,Age,35 Months,94.5,90.5 to 97.2,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018,Age,35 Months,96.5,92.9 to 98.6,308
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018-2019,Age,35 Months,96.0,93.5 to 97.7,619
≥1 Dose MMR,,States/Local Areas,Connecticut,2014,Age,35 Months,93.6,88.0 to 97.1,263
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2015,Age,35 Months,95.5,91.9 to 97.9,479
Hib,≥1 Dose,States/Local Areas,Connecticut,2014,Age,3 Months,89.3,82.8 to 93.5,263
Hib,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,3 Months,89.7,85.4 to 92.8,479
Hep B,≥2 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,92.4,87.2 to 95.6,263
Hep B,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,93.6,90.1 to 96.0,479
Hep B,≥2 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,94.8,88.8 to 97.7,216
Hep B,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,94.9,90.6 to 97.3,398
Hep B,≥2 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,95.0,87.3 to 98.2,182
Hep B,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,94.0,89.2 to 96.8,366
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2017,Age,0-2 Days,78.2,69.3 to 85.1,184
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2017-2018,Age,0-2 Days,80.4,75.1 to 84.8,492
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2018,Age,0-2 Days,82.5,76.4 to 87.4,308
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2018-2019,Age,0-2 Days,83.8,79.7 to 87.2,619
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2019,Age,0-2 Days,85.0,79.2 to 89.4,311
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2016,Age,0-2 Days,76.0,64.9 to 84.4,182
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2016-2017,Age,0-2 Days,77.1,70.2 to 82.8,366
Hep B,≥2 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,93.7,86.2 to 97.3,182
Hep B,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,92.0,86.8 to 95.3,366
Hep B,≥2 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,90.3,81.6 to 95.1,184
Hep B,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,92.9,88.4 to 95.7,492
Hep B,≥2 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,95.5,91.4 to 97.7,308
Hep B,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,95.5,93.0 to 97.2,619
PCV,≥3 Doses,States/Local Areas,Connecticut,2014,Age,13 Months,88.2,81.9 to 92.5,263
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,13 Months,90.7,86.6 to 93.7,479
PCV,≥3 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,93.3,87.0 to 96.6,216
PCV,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,93.8,89.6 to 96.4,398
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,95.2,90.8 to 97.9,308
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,95.1,92.4 to 97.0,619
PCV,≥3 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,94.4,87.3 to 97.6,182
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,91.1,85.5 to 94.6,366
PCV,≥3 Doses,States/Local Areas,Connecticut,2013,Age,13 Months,95.4,89.9 to 98.0,255
PCV,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,13 Months,91.8,85.4 to 95.6,518
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,89.7,83.0 to 94.6,216
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,92.1,87.7 to 95.4,398
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,94.4,88.0 to 98.1,182
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,92.0,87.3 to 95.5,366
PCV,≥3 Doses,States/Local Areas,Connecticut,2012,Age,13 Months,90.7,87.4 to 93.2,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,89.6,81.9 to 95.0,184
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,92.4,88.1 to 95.6,492
PCV,≥4 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,86.8,81.1 to 91.0,308
PCV,≥4 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,89.2,85.3 to 92.1,520
≥1 Dose MMR,,States/Local Areas,Connecticut,2016,Age,24 Months,90.6,83.2 to 95.7,182
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2017,Age,24 Months,90.5,85.3 to 94.4,366
≥1 Dose MMR,,States/Local Areas,Connecticut,2017,Age,24 Months,90.3,82.4 to 95.7,184
≥1 Dose MMR,,States/Local Areas,Connecticut,2017-2018,Age,24 Months,93.7,89.4 to 96.7,492
Hep B,≥2 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,91.1,85.8 to 94.5,263
Hep B,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,92.7,89.1 to 95.2,479
Hep B,≥2 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,91.3,83.8 to 95.5,245
Hep B,≥2 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,94.4,88.4 to 97.3,216
Hep B,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,94.0,89.7 to 96.6,398
PCV,≥3 Doses,States/Local Areas,Connecticut,2018,Age,7 Months,83.4,77.2 to 88.1,308
PCV,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,7 Months,81.2,76.9 to 84.8,619
PCV,≥3 Doses,States/Local Areas,Connecticut,2019,Age,7 Months,78.9,72.6 to 84.1,311
PCV,≥3 Doses,States/Local Areas,Connecticut,2011,Age,13 Months,94.0,92.4 to 95.4,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2012,Age,0-2 Days,76.5,72.9 to 79.8,245
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2013,Age,0-2 Days,77.2,68.8 to 83.9,255
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2013-2014,Age,0-2 Days,74.0,66.3 to 80.5,518
Hep B,≥2 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,96.6,94.7 to 97.8,255
Hep B,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,93.8,91.6 to 95.5,518
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2019,Age,0-1 Days,81.3,75.2 to 86.2,311
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2011,Age,0-2 Days,81.2,77.3 to 84.6,243
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,94.8,91.0 to 97.1,311
Hep B,≥3 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,95.3,92.1 to 97.5,243
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013,Age,24 Months,96.6,93.8 to 98.4,255
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,24 Months,94.1,91.4 to 96.2,518
Hep B,≥3 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,91.9,86.3 to 95.8,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,91.5,86.8 to 95.1,263
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,90.7,86.8 to 93.9,479
PCV,≥3 Doses,States/Local Areas,Connecticut,2016,Age,7 Months,82.8,74.6 to 88.7,182
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,7 Months,78.1,71.8 to 83.3,366
PCV,≥3 Doses,States/Local Areas,Connecticut,2017,Age,7 Months,73.3,63.6 to 81.1,184
PCV,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,7 Months,78.3,72.6 to 83.1,492
PCV,≥4 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,80.5,78.7 to 82.2,216
PCV,≥4 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,82.1,76.0 to 86.9,398
PCV,≥4 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,83.6,73.9 to 90.2,182
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,84.1,77.6 to 89.0,366
≥1 Dose MMR,,States/Local Areas,Connecticut,2013,Age,24 Months,95.7,91.2 to 98.3,255
≥1 Dose MMR,,States/Local Areas,Connecticut,2013-2014,Age,24 Months,94.1,90.8 to 96.6,518
≥1 Dose MMR,,States/Local Areas,Connecticut,2014,Age,24 Months,92.2,86.8 to 96.0,263
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2015,Age,24 Months,92.5,88.8 to 95.4,479
≥1 Dose MMR,,States/Local Areas,Connecticut,2015,Age,24 Months,92.9,87.2 to 96.6,216
≥1 Dose MMR,,States/Local Areas,Connecticut,2015-2016,Age,24 Months,91.7,87.3 to 95.1,398
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018,Age,24 Months,96.2,92.6 to 98.3,308
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018-2019,Age,24 Months,95.6,93.2 to 97.4,619
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019,Age,24 Months,95.0,91.2 to 97.5,311
≥1 Dose Varicella,,States/Local Areas,Connecticut,2011,Age,35 Months,95.7,92.0 to 98.1,243
≥1 Dose Varicella,,States/Local Areas,Connecticut,2012,Age,35 Months,95.1,89.5 to 98.3,245
PCV,≥4 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,88.2,82.8 to 92.1,311
≥1 Dose MMR,,States/Local Areas,Connecticut,2018,Age,24 Months,97.0,93.5 to 98.9,308
≥1 Dose MMR,,States/Local Areas,Connecticut,2018-2019,Age,24 Months,95.1,92.5 to 97.0,619
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013,Age,35 Months,98.5,95.7 to 99.6,255
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013-2014,Age,35 Months,97.6,95.2 to 99.0,518
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014,Age,35 Months,96.8,92.8 to 98.9,263
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2015,Age,35 Months,98.0,95.4 to 99.3,479
PCV,≥4 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,88.6,82.8 to 93.2,243
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015,Age,35 Months,99.4,96.8 to 100.0,216
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015-2016,Age,35 Months,97.2,92.7 to 99.2,398
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2014,Age,0-2 Days,70.8,63.2 to 77.5,263
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2014-2015,Age,0-2 Days,73.9,68.4 to 78.7,479
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2015,Age,0-2 Days,77.0,68.9 to 83.5,216
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2015-2016,Age,0-2 Days,76.5,69.8 to 82.1,398
PCV,≥4 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,86.3,80.8 to 90.4,243
PCV,≥4 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,83.8,80.7 to 86.5,245
PCV,≥4 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,89.1,85.3 to 91.9,255
PCV,≥4 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,84.7,80.2 to 88.3,518
≥1 Dose MMR,,States/Local Areas,Connecticut,2018,Age,19 Months,95.5,91.1 to 97.8,308
≥1 Dose MMR,,States/Local Areas,Connecticut,2018-2019,Age,19 Months,96.1,93.6 to 97.7,619
PCV,≥4 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,80.3,72.7 to 86.2,263
PCV,≥4 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,80.4,75.0 to 84.9,479
≥1 Dose MMR,,States/Local Areas,Connecticut,2019,Age,19 Months,92.8,88.1 to 95.7,311
≥1 Dose MMR,,States/Local Areas,Connecticut,2011,Age,24 Months,93.7,89.2 to 96.8,243
PCV,≥3 Doses,States/Local Areas,Connecticut,2015,Age,7 Months,77.5,69.7 to 83.7,216
PCV,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,7 Months,80.1,74.6 to 84.7,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2012,Age,24 Months,92.5,86.5 to 96.5,245
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015,Age,24 Months,93.4,88.0 to 96.9,216
≥1 Dose Varicella,,States/Local Areas,Connecticut,2015-2016,Age,24 Months,91.3,86.7 to 94.7,398
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016,Age,24 Months,89.2,81.4 to 94.7,182
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2017,Age,24 Months,88.7,83.2 to 93.1,366
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017,Age,24 Months,88.1,79.7 to 94.2,184
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017-2018,Age,24 Months,92.2,87.6 to 95.6,492
Hep B,≥1 Dose,States/Local Areas,Connecticut,2018,Age,3 Months,99.8,98.9 to 100.0,308
Hep B,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,3 Months,99.1,97.9 to 99.6,619
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019,Age,19 Months,94.4,90.1 to 96.9,311
Hep B,≥1 Dose,States/Local Areas,Connecticut,2019,Age,3 Months,98.3,96.0 to 99.3,311
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2011,Age,0-1 Days,67.5,61.4 to 73.1,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2012,Age,0-1 Days,63.5,58.8 to 67.9,245
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,79.9,71.2 to 88.7,246
Hep B,≥2 Doses,States/Local Areas,Connecticut,2011,Age,5 Months,93.2,90.7 to 95.1,243
Hep B,≥2 Doses,States/Local Areas,Connecticut,2012,Age,5 Months,88.5,78.5 to 94.2,245
Hep B,≥2 Doses,States/Local Areas,Connecticut,2013,Age,5 Months,92.3,90.0 to 94.1,255
Hep B,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,5 Months,90.2,88.3 to 91.8,518
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,89.5,84.4 to 94.6,338
Hep B,≥2 Doses,States/Local Areas,Connecticut,2014,Age,5 Months,88.0,82.0 to 92.2,263
Hep B,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,5 Months,90.7,87.2 to 93.3,479
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,91.0,85.7 to 94.5,263
Hep B,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,90.0,85.8 to 93.1,479
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,89.1,83.3 to 93.0,216
Hep B,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,91.6,86.8 to 94.7,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2015,Age,19 Months,89.8,85.5 to 92.9,216
≥1 Dose MMR,,States/Local Areas,Connecticut,2015-2016,Age,19 Months,90.1,85.1 to 93.5,398
≥1 Dose MMR,,States/Local Areas,Connecticut,2016,Age,19 Months,90.5,82.1 to 95.1,182
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2017,Age,19 Months,89.1,83.2 to 93.1,366
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,80.4,73.7 to 87.1,178
≥1 Dose MMR,,States/Local Areas,Connecticut,2017,Age,19 Months,87.8,78.3 to 93.4,184
≥1 Dose MMR,,States/Local Areas,Connecticut,2017-2018,Age,19 Months,91.6,86.5 to 94.9,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2011,Age,24 Months,94.4,90.6 to 97.0,243
≥1 Dose Varicella,,States/Local Areas,Connecticut,2012,Age,24 Months,93.8,88.5 to 97.2,245
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.6,74.7 to 92.6,115
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.4,85.6 to 93.2,421
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,82.6,76.5 to 88.7,261
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.3,83.5 to 91.1,478
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,85.6,82.3 to 88.8,762
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,94.2,86.7 to 97.6,182
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,91.6,86.5 to 94.9,366
≥1 Dose MMR,,States/Local Areas,Connecticut,2013,Age,19 Months,94.4,91.7 to 96.3,255
≥1 Dose MMR,,States/Local Areas,Connecticut,2013-2014,Age,19 Months,93.1,90.5 to 95.0,518
≥1 Dose MMR,,States/Local Areas,Connecticut,2012,Age,19 Months,91.0,89.6 to 92.3,245
≥1 Dose MMR,,States/Local Areas,Connecticut,2014,Age,19 Months,91.8,85.8 to 95.4,263
≥1 Dose MMR,,States/Local Areas,Connecticut,2014-2015,Age,19 Months,90.8,86.5 to 93.8,479
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017,Age,19 Months,86.7,77.2 to 92.6,184
≥1 Dose Varicella,,States/Local Areas,Connecticut,2017-2018,Age,19 Months,90.1,84.9 to 93.6,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018,Age,19 Months,93.5,88.3 to 96.5,308
≥1 Dose Varicella,,States/Local Areas,Connecticut,2018-2019,Age,19 Months,63.8,58.9 to 68.4,619
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,84.6,78.3 to 90.8,182
Polio,≥2 Doses,States/Local Areas,Connecticut,2015,Age,13 Months,94.5,88.7 to 97.4,216
Polio,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,13 Months,95.1,91.1 to 97.4,398
Polio,≥2 Doses,States/Local Areas,Connecticut,2016,Age,13 Months,95.8,88.5 to 98.5,182
Polio,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,13 Months,94.3,89.4 to 97.0,366
Polio,≥2 Doses,States/Local Areas,Connecticut,2017,Age,13 Months,92.8,84.5 to 96.8,184
Polio,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,13 Months,95.1,90.8 to 97.4,492
DTaP,≥4 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,94.6,90.2 to 97.5,311
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,90.8,87.2 to 94.4,474
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,80.9,74.4 to 87.4,186
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,79.5,68.7 to 90.3,92
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.0,59.0 to 89.0,44
≥1 Dose MMR,,States/Local Areas,Connecticut,2011,Age,19 Months,92.6,87.6 to 95.6,243
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013,Age,24 Months,96.2,91.5 to 98.7,255
≥1 Dose Varicella,,States/Local Areas,Connecticut,2013-2014,Age,24 Months,94.2,91.2 to 96.5,518
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014,Age,24 Months,92.2,87.5 to 95.6,263
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2015,Age,24 Months,92.8,89.4 to 95.4,479
Polio,≥2 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,97.4,93.1 to 99.1,308
Polio,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,96.7,94.2 to 98.1,619
Polio,≥2 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,95.9,92.1 to 97.9,311
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2013,Age,0-1 Days,68.8,60.1 to 76.4,255
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2013-2014,Age,0-1 Days,64.4,56.9 to 71.4,518
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2014,Age,0-1 Days,60.0,52.0 to 67.5,263
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2014-2015,Age,0-1 Days,65.4,59.6 to 70.7,479
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2015,Age,0-1 Days,70.8,62.6 to 77.9,216
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2015-2016,Age,0-1 Days,70.0,63.3 to 76.0,398
Hep B,≥2 Doses,States/Local Areas,Connecticut,2015,Age,5 Months,93.3,87.6 to 96.5,216
Hep B,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,5 Months,93.4,89.2 to 96.0,398
PCV,≥3 Doses,States/Local Areas,Connecticut,2013,Age,7 Months,67.2,57.6 to 75.6,255
PCV,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,7 Months,69.0,61.7 to 75.5,518
PCV,≥3 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,78.4,71.9 to 83.7,243
PCV,≥3 Doses,States/Local Areas,Connecticut,2014,Age,7 Months,70.9,63.0 to 77.7,263
PCV,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,7 Months,74.1,68.7 to 78.9,479
PCV,≥3 Doses,States/Local Areas,Connecticut,2012,Age,7 Months,68.2,58.6 to 76.4,245
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,80.8,74.0 to 87.6,246
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,93.3,89.9 to 96.7,338
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,89.0,80.5 to 94.1,184
Hep B,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,91.5,86.8 to 94.6,492
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,94.0,89.1 to 96.8,308
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,92.1,89.1 to 94.3,619
Hep B,≥2 Doses,States/Local Areas,Connecticut,2016,Age,5 Months,93.4,86.0 to 97.1,182
Hep B,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,5 Months,91.2,86.0 to 94.6,366
Hep B,≥2 Doses,States/Local Areas,Connecticut,2017,Age,5 Months,88.9,80.4 to 94.0,184
Hep B,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,5 Months,90.8,86.1 to 94.0,492
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,93.2,88.8 to 97.5,182
≥1 Dose Varicella,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,83.7 to 96.7,115
PCV,≥4 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,84.6,74.7 to 91.1,184
PCV,≥4 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,85.7,80.3 to 89.8,492
Hep B,≥2 Doses,States/Local Areas,Connecticut,2019,Age,5 Months,95.1,91.2 to 97.3,311
Hep B,≥2 Doses,States/Local Areas,Connecticut,2011,Age,7 Months,94.7,91.9 to 96.6,243
Hep B,≥2 Doses,States/Local Areas,Connecticut,2018,Age,5 Months,92.6,87.5 to 95.7,308
Hep B,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,5 Months,93.8,90.8 to 95.9,619
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2018,Age,0-1 Days,77.3,70.6 to 82.8,308
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2018-2019,Age,0-1 Days,79.3,74.8 to 83.1,619
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2016,Age,0-1 Days,69.2,58.3 to 78.2,182
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2016-2017,Age,0-1 Days,70.6,63.7 to 76.7,366
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2017,Age,0-1 Days,72.1,63.1 to 79.7,184
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2017-2018,Age,0-1 Days,74.7,69.2 to 79.5,492
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018,Age,13 Months,92.0,87.1 to 95.2,308
Hep B,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,13 Months,92.1,89.1 to 94.3,619
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019,Age,13 Months,92.2,88.0 to 95.0,311
Hep B,≥3 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,94.9,92.5 to 96.5,243
Hep B,≥3 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,91.8,83.1 to 96.2,245
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,96.5,93.8 to 98.0,255
Hep B,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,93.7,91.5 to 95.4,518
Hep A,≥2 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,87.5,78.0 to 94.3,248
Hep B,≥2 Doses,States/Local Areas,Colorado,2021,Age,5 Months,83.9,74.4 to 90.4,171
Hep A,≥2 Doses,States/Local Areas,Colorado,2021,Age,19 Months,23.7,16.7 to 32.4,171
DTaP,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,3 Months,84.2,78.4 to 88.6,482
PCV,≥3 Doses,States/Local Areas,Colorado,2021,Age,13 Months,84.1,74.8 to 90.4,171
PCV,≥3 Doses,States/Local Areas,Colorado,2021,Age,24 Months,86.4,77.9 to 92.9,171
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2021,Age,0-2 Days,81.0,71.5 to 87.9,171
Hib,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,89.0,83.7 to 92.7,482
≥1 Dose Varicella,,States/Local Areas,Colorado,2020-2021,Age,35 Months,88.6,83.4 to 92.8,482
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2021,Age,0-1 Days,79.2,69.7 to 86.3,171
Hep A,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,35 Months,88.8,82.7 to 93.5,482
Hib,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,61.4,56.0 to 66.5,576
Hib,Full Series,States/Local Areas,Colorado,2019-2020,Age,24 Months,79.9,75.4 to 84.0,576
Hep B,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,93.0,90.2 to 95.3,576
≥1 Dose Varicella,,States/Local Areas,Colorado,2019-2020,Age,24 Months,90.1,86.6 to 93.0,576
PCV,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,93.1,90.3 to 95.4,576
PCV,≥4 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,83.1,78.8 to 87.0,576
Polio,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,92.7,89.7 to 94.9,576
Hep A,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,26.9,22.2 to 32.1,576
≥1 Dose MMR,,States/Local Areas,Colorado,2019-2020,Age,19 Months,89.3,85.6 to 92.2,576
Hib,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,90.2,86.7 to 92.8,576
Hib,Primary Series,States/Local Areas,Colorado,2019-2020,Age,19 Months,93.2,90.4 to 95.3,576
≥1 Dose MMR,,States/Local Areas,Colorado,2019-2020,Age,35 Months,93.7,90.3 to 96.2,576
Hib,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,93.1,89.7 to 95.7,576
Hib,Primary Series,States/Local Areas,Colorado,2019-2020,Age,35 Months,94.4,91.8 to 96.4,576
Hib,Full Series,States/Local Areas,Colorado,2019-2020,Age,35 Months,84.4,79.9 to 88.3,576
Hep B,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,94.6,91.7 to 96.7,576
≥1 Dose Varicella,,States/Local Areas,Colorado,2019-2020,Age,35 Months,93.4,90.1 to 95.9,576
PCV,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,94.6,91.8 to 96.8,576
PCV,≥4 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,85.4,81.1 to 89.1,576
DTaP,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,95.1,92.7 to 96.9,576
DTaP,≥4 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,81.1,76.7 to 85.1,576
Polio,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,93.9,91.2 to 96.0,576
≥1 Dose MMR,,States/Local Areas,Colorado,2019-2020,Age,24 Months,91.2,87.8 to 93.9,576
Hib,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,3 Months,88.4,84.4 to 91.4,576
Hep B,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,3 Months,95.4,92.6 to 97.2,576
PCV,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,3 Months,89.2,85.4 to 92.2,576
DTaP,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,5 Months,84.6,80.3 to 88.0,576
Polio,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,5 Months,83.5,79.1 to 87.1,576
DTaP,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,91.7,88.5 to 94.0,576
Polio,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,94.4,91.7 to 96.3,576
≥1 Dose MMR,,States/Local Areas,Colorado,2019-2020,Age,13 Months,69.8,64.4 to 74.6,576
Hib,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,94.1,91.3 to 96.1,576
Hib,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,79.1,74.6 to 83.1,576
Hib,Primary Series,States/Local Areas,Colorado,2019-2020,Age,13 Months,89.1,85.6 to 91.9,576
Hib,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,5 Months,82.6,78.2 to 86.3,576
Hep B,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,5 Months,89.3,85.6 to 92.2,576
PCV,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,5 Months,83.8,79.4 to 87.4,576
DTaP,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,76.2,71.3 to 80.5,576
Polio,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,91.3,87.9 to 93.8,576
Hep B,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,94.8,92.3 to 96.5,576
Hep B,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,90.5,87.0 to 93.1,576
≥1 Dose Varicella,,States/Local Areas,Colorado,2019-2020,Age,13 Months,60.1,54.7 to 65.4,576
PCV,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,13 Months,90.4,87.0 to 93.0,576
Combined 7 Series,,States/Local Areas,Colorado,2019-2020,Age,24 Months,69.7,64.8 to 74.6,576
DTaP,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,95.8,93.5 to 97.5,576
DTaP,≥4 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,87.7,83.3 to 91.3,576
Polio,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,94.6,92.0 to 96.6,576
≥1 Dose MMR,,States/Local Areas,Colorado,2020-2021,Age,13 Months,66.9,60.6 to 72.7,482
Hib,Primary Series,States/Local Areas,Colorado,2020-2021,Age,19 Months,87.5,82.2 to 91.4,482
Rotavirus,,States/Local Areas,Colorado,2019-2020,Age,8 Months,78.4,73.8 to 82.3,576
DTaP,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,93.9,91.1 to 95.8,576
DTaP,≥4 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,73.4,68.5 to 77.7,576
Hep B,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,67.3,62.0 to 72.2,576
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2019-2020,Age,0-3 Days,80.7,75.9 to 84.7,576
PCV,≥3 Doses,States/Local Areas,Colorado,2020,Age,7 Months,70.4,63.4 to 76.5,311
Hep B,≥3 Doses,States/Local Areas,Colorado,2020,Age,7 Months,64.9,57.8 to 71.4,311
Hib,≥1 Dose,States/Local Areas,Colorado,2020,Age,3 Months,87.7,82.1 to 91.8,311
Hep B,≥2 Doses,States/Local Areas,Colorado,2020,Age,7 Months,91.3,86.4 to 94.6,311
Polio,≥1 Dose,States/Local Areas,Colorado,2020,Age,3 Months,87.6,81.8 to 91.7,311
DTaP,≥1 Dose,States/Local Areas,Colorado,2020,Age,3 Months,89.5,84.1 to 93.2,311
Hib,≥2 Doses,States/Local Areas,Colorado,2020,Age,5 Months,80.0,73.5 to 85.1,311
Polio,≥2 Doses,States/Local Areas,Colorado,2020,Age,5 Months,79.4,72.8 to 84.7,311
DTaP,≥2 Doses,States/Local Areas,Colorado,2020,Age,5 Months,81.3,74.9 to 86.3,311
PCV,≥1 Dose,States/Local Areas,Colorado,2020,Age,3 Months,87.5,81.8 to 91.6,311
Hep B,≥1 Dose,States/Local Areas,Colorado,2020,Age,3 Months,92.7,87.6 to 95.8,311
Hep A,≥1 Dose,States/Local Areas,Colorado,2020,Age,24 Months,85.7,79.9 to 90.5,311
Hep A,≥2 Doses,States/Local Areas,Colorado,2020,Age,24 Months,46.2,39.3 to 53.7,311
PCV,≥4 Doses,States/Local Areas,Colorado,2020,Age,24 Months,80.7,74.4 to 86.2,311
PCV,≥3 Doses,States/Local Areas,Colorado,2020,Age,24 Months,92.0,87.6 to 95.3,311
≥1 Dose Varicella,,States/Local Areas,Colorado,2020,Age,24 Months,87.4,81.9 to 91.9,311
Influenza,,States/Local Areas,Colorado,2020,Age,24 Months,68.4,61.8 to 74.9,311
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2020,Age,0-3 Days,80.0,73.7 to 85.0,311
Hib,≥3 Doses,States/Local Areas,Colorado,2020,Age,19 Months,88.9,83.6 to 92.7,311
Combined 7 Series,,States/Local Areas,Colorado,2020,Age,24 Months,66.0,59.2 to 72.8,311
Polio,≥3 Doses,States/Local Areas,Colorado,2020,Age,19 Months,90.7,85.5 to 94.1,311
≥1 Dose MMR,,States/Local Areas,Colorado,2020,Age,19 Months,87.1,81.3 to 91.3,311
DTaP,≥4 Doses,States/Local Areas,Colorado,2020,Age,19 Months,70.0,63.2 to 76.1,311
DTaP,≥3 Doses,States/Local Areas,Colorado,2020,Age,19 Months,92.6,88.1 to 95.5,311
PCV,≥3 Doses,States/Local Areas,Colorado,2020,Age,13 Months,87.7,82.2 to 91.7,311
DTaP,≥3 Doses,States/Local Areas,Colorado,2020,Age,7 Months,73.4,66.6 to 79.2,311
Hep B,≥2 Doses,States/Local Areas,Colorado,2020,Age,5 Months,87.0,81.2 to 91.2,311
PCV,≥2 Doses,States/Local Areas,Colorado,2020,Age,5 Months,80.8,74.4 to 85.9,311
≥1 Dose Varicella,,States/Local Areas,Colorado,2020,Age,13 Months,57.5,50.5 to 64.3,311
Hep B,≥3 Doses,States/Local Areas,Colorado,2020,Age,13 Months,88.8,83.4 to 92.7,311
Hep B,≥2 Doses,States/Local Areas,Colorado,2020,Age,13 Months,92.8,88.4 to 95.6,311
Hib,Primary Series,States/Local Areas,Colorado,2020,Age,13 Months,89.3,84.3 to 92.9,311
Hib,≥3 Doses,States/Local Areas,Colorado,2020,Age,13 Months,77.4,71.0 to 82.7,311
Hib,≥2 Doses,States/Local Areas,Colorado,2020,Age,13 Months,93.2,88.7 to 96.0,311
PCV,≥3 Doses,States/Local Areas,Colorado,2020,Age,35 Months,94.0,89.6 to 97.0,311
PCV,≥4 Doses,States/Local Areas,Colorado,2020,Age,19 Months,78.3,71.7 to 83.7,311
Polio,≥3 Doses,States/Local Areas,Colorado,2020,Age,35 Months,93.2,88.7 to 96.3,311
PCV,≥3 Doses,States/Local Areas,Colorado,2020,Age,19 Months,91.1,86.2 to 94.4,311
DTaP,≥4 Doses,States/Local Areas,Colorado,2020,Age,35 Months,86.6,80.3 to 91.6,311
DTaP,≥3 Doses,States/Local Areas,Colorado,2020,Age,35 Months,95.3,91.5 to 97.8,311
≥1 Dose Varicella,,States/Local Areas,Colorado,2020,Age,19 Months,85.3,79.4 to 89.8,311
Hep B,≥3 Doses,States/Local Areas,Colorado,2020,Age,19 Months,88.8,83.4 to 92.7,311
Hib,Full Series,States/Local Areas,Colorado,2020,Age,19 Months,75.1,68.4 to 80.8,311
Hib,Primary Series,States/Local Areas,Colorado,2020,Age,19 Months,92.2,87.6 to 95.2,311
≥1 Dose Varicella,,States/Local Areas,Colorado,2020,Age,35 Months,91.9,86.8 to 95.6,311
Hep B,≥3 Doses,States/Local Areas,Colorado,2020,Age,35 Months,93.4,88.5 to 96.8,311
Hib,Full Series,States/Local Areas,Colorado,2020,Age,35 Months,83.0,76.8 to 88.4,311
Hib,Primary Series,States/Local Areas,Colorado,2020,Age,35 Months,93.6,89.4 to 96.5,311
Hib,≥3 Doses,States/Local Areas,Colorado,2020,Age,35 Months,92.5,87.2 to 96.1,311
≥1 Dose MMR,,States/Local Areas,Colorado,2020,Age,35 Months,92.5,87.1 to 96.2,311
Hib,≥3 Doses,States/Local Areas,Colorado,2020,Age,24 Months,90.9,86.1 to 94.6,311
≥1 Dose MMR,,States/Local Areas,Colorado,2020,Age,24 Months,88.6,83.3 to 92.9,311
Polio,≥3 Doses,States/Local Areas,Colorado,2020,Age,24 Months,92.5,88.0 to 95.8,311
DTaP,≥3 Doses,States/Local Areas,Colorado,2020,Age,24 Months,94.6,90.9 to 97.2,311
DTaP,≥4 Doses,States/Local Areas,Colorado,2020,Age,24 Months,79.2,73.0 to 84.8,311
Hib,Primary Series,States/Local Areas,Colorado,2020,Age,7 Months,77.2,70.8 to 82.6,311
Hib,≥3 Doses,States/Local Areas,Colorado,2020,Age,7 Months,58.0,51.0 to 64.7,311
Polio,≥2 Doses,States/Local Areas,Colorado,2020,Age,7 Months,89.4,83.9 to 93.2,311
Hib,≥2 Doses,States/Local Areas,Colorado,2020,Age,7 Months,89.6,84.3 to 93.3,311
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2020,Age,0-1 Days,79.0,72.5 to 84.2,311
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2020,Age,0-2 Days,80.0,73.7 to 85.0,311
Rotavirus,,States/Local Areas,Colorado,2020,Age,8 Months,73.3,66.7 to 79.1,311
Hep A,≥2 Doses,States/Local Areas,Colorado,2020,Age,19 Months,27.9,22.3 to 34.3,311
Hep A,≥1 Dose,States/Local Areas,Colorado,2020,Age,19 Months,83.3,77.0 to 88.1,311
Combined 7 Series,,States/Local Areas,Colorado,2020,Age,35 Months,73.2,65.8 to 80.1,311
Hep A,≥2 Doses,States/Local Areas,Colorado,2020,Age,35 Months,80.2,71.9 to 87.3,311
≥1 Dose MMR,,States/Local Areas,Colorado,2020,Age,13 Months,69.1,62.1 to 75.3,311
Hep A,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,24 Months,86.2,82.2 to 89.7,576
Hep A,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,35 Months,91.2,87.4 to 94.2,576
Hep A,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,35 Months,78.1,72.2 to 83.5,576
Influenza,,States/Local Areas,Colorado,2019-2020,Age,24 Months,73.2,68.4 to 77.8,576
Hep A,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,40.6,35.3 to 46.2,576
Hib,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,24 Months,91.6,88.3 to 94.2,576
Hib,Primary Series,States/Local Areas,Colorado,2019-2020,Age,24 Months,94.1,91.5 to 96.2,576
Hib,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,91.1,87.7 to 93.7,576
Hib,Full Series,States/Local Areas,Colorado,2019-2020,Age,19 Months,76.4,71.6 to 80.6,576
Combined 7 Series,,States/Local Areas,Colorado,2019-2020,Age,35 Months,76.7,71.5 to 81.6,576
Hep B,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,91.6,88.3 to 94.0,576
≥1 Dose Varicella,,States/Local Areas,Colorado,2019-2020,Age,19 Months,88.0,84.1 to 91.1,576
PCV,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,92.4,89.2 to 94.6,576
PCV,≥4 Doses,States/Local Areas,Colorado,2019-2020,Age,19 Months,81.0,76.4 to 84.8,576
Hep A,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,19 Months,84.0,79.8 to 87.5,576
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2019-2020,Age,0-1 Days,79.3,74.5 to 83.5,576
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2019-2020,Age,0-2 Days,80.2,75.4 to 84.2,576
PCV,≥3 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,74.6,69.6 to 79.0,576
Hib,≥2 Doses,States/Local Areas,Colorado,2021,Age,7 Months,81.4,71.5 to 88.4,171
Polio,≥2 Doses,States/Local Areas,Colorado,2021,Age,7 Months,82.7,73.1 to 89.4,171
Hep B,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,91.6,87.4 to 94.6,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,87.7,82.4 to 91.5,482
Polio,≥3 Doses,States/Local Areas,Colorado,2021,Age,35 Months,85.6,77.1 to 92.1,171
DTaP,≥3 Doses,States/Local Areas,Colorado,2021,Age,7 Months,68.9,58.6 to 77.7,171
≥1 Dose MMR,,States/Local Areas,Colorado,2020-2021,Age,24 Months,86.0,80.8 to 90.3,482
Hib,Primary Series,States/Local Areas,Colorado,2021,Age,7 Months,69.1,59.0 to 77.6,171
PCV,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,5 Months,77.3,71.3 to 82.3,482
Combined 7 Series,,States/Local Areas,Colorado,2021,Age,35 Months,68.5,58.1 to 78.4,171
Hep B,≥2 Doses,States/Local Areas,Colorado,2021,Age,7 Months,88.4,80.4 to 93.4,171
PCV,≥3 Doses,States/Local Areas,Colorado,2021,Age,35 Months,86.4,77.9 to 92.9,171
Hib,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,87.4,82.4 to 91.6,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2021,Age,19 Months,85.9,76.5 to 91.9,171
DTaP,≥4 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,83.3,77.3 to 88.5,482
Hib,Full Series,States/Local Areas,Colorado,2021,Age,19 Months,68.4,58.4 to 77.0,171
PCV,≥4 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,80.0,74.6 to 85.0,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,84.7,79.1 to 89.0,482
Hib,Primary Series,States/Local Areas,Colorado,2021,Age,19 Months,82.9,73.2 to 89.5,171
Hib,Primary Series,States/Local Areas,Colorado,2020-2021,Age,24 Months,88.9,83.9 to 92.9,482
Hib,≥3 Doses,States/Local Areas,Colorado,2021,Age,19 Months,81.5,71.8 to 88.4,171
Hib,≥3 Doses,States/Local Areas,Colorado,2019,Age,24 Months,92.5,88.1 to 95.7,265
Hib,≥3 Doses,States/Local Areas,Colorado,2018,Age,24 Months,93.7,88.4 to 97.1,296
Hib,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,93.1,89.9 to 95.6,561
Hep A,≥2 Doses,States/Local Areas,Colorado,2014,Age,19 Months,24.9,18.4 to 32.8,232
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,22.0,17.7 to 27.1,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2012,Age,19 Months,19.3,15.6 to 23.6,297
Hep A,≥2 Doses,States/Local Areas,Colorado,2013,Age,19 Months,22.7,18.6 to 27.5,250
Hep A,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,23.8,20.5 to 27.6,482
Hep A,≥2 Doses,States/Local Areas,Colorado,2011,Age,19 Months,17.8,14.2 to 21.9,277
DTaP,≥3 Doses,States/Local Areas,Colorado,2015,Age,35 Months,92.6,88.4 to 95.8,272
DTaP,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,94.0,91.1 to 96.1,519
Hep A,≥1 Dose,States/Local Areas,Colorado,2018,Age,19 Months,83.0,75.8 to 88.5,296
Hep A,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,19 Months,84.6,78.8 to 89.0,446
Hep A,≥1 Dose,States/Local Areas,Colorado,2017,Age,19 Months,85.3,78.3 to 90.3,231
Hep A,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,19 Months,84.2,79.4 to 88.0,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2014,Age,35 Months,97.3,93.8 to 99.1,232
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,95.4,92.7 to 97.3,504
DTaP,≥3 Doses,States/Local Areas,Colorado,2013,Age,35 Months,94.0,89.5 to 97.0,250
DTaP,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,95.7,93.1 to 97.6,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2012,Age,35 Months,94.7,89.9 to 97.6,297
DTaP,≥3 Doses,States/Local Areas,Colorado,2011,Age,35 Months,93.2,88.2 to 96.5,277
Hib,≥3 Doses,States/Local Areas,Colorado,2012,Age,35 Months,90.8,85.6 to 94.6,297
Hib,≥3 Doses,States/Local Areas,Colorado,2011,Age,35 Months,90.9,85.7 to 94.8,277
Hep A,≥1 Dose,States/Local Areas,Colorado,2014,Age,24 Months,84.0,77.2 to 89.6,232
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,24 Months,82.6,78.0 to 86.8,504
Hep A,≥1 Dose,States/Local Areas,Colorado,2012,Age,24 Months,78.4,72.0 to 84.3,297
Hep A,≥1 Dose,States/Local Areas,Colorado,2013,Age,24 Months,82.2,75.7 to 87.9,250
Hep A,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,24 Months,83.0,78.4 to 87.1,482
Hep A,≥1 Dose,States/Local Areas,Colorado,2011,Age,24 Months,75.0,68.2 to 81.3,277
Hep A,≥1 Dose,States/Local Areas,Colorado,2019,Age,19 Months,84.6,78.2 to 89.4,265
DTaP,≥3 Doses,States/Local Areas,Colorado,2017,Age,35 Months,95.3,89.8 to 98.3,231
DTaP,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,96.1,92.7 to 98.2,527
DTaP,≥4 Doses,States/Local Areas,Colorado,2011,Age,19 Months,73.9,70.6 to 77.0,277
DTaP,≥4 Doses,States/Local Areas,Colorado,2013,Age,19 Months,70.6,64.9 to 75.7,250
DTaP,≥4 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,75.2,73.0 to 77.3,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2012,Age,19 Months,66.1,60.3 to 71.5,297
DTaP,≥3 Doses,States/Local Areas,Colorado,2016,Age,35 Months,95.3,91.1 to 97.9,247
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,95.3,92.1 to 97.5,478
PCV,≥2 Doses,States/Local Areas,Colorado,2013,Age,5 Months,79.9,76.3 to 83.0,250
PCV,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,5 Months,78.7,74.7 to 82.2,482
PCV,≥2 Doses,States/Local Areas,Colorado,2012,Age,5 Months,77.4,69.4 to 83.8,297
PCV,≥2 Doses,States/Local Areas,Colorado,2011,Age,5 Months,76.4,69.7 to 82.0,277
PCV,≥2 Doses,States/Local Areas,Colorado,2017,Age,5 Months,88.3,81.3 to 92.9,231
PCV,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,5 Months,89.4,85.1 to 92.5,527
Hep A,≥1 Dose,States/Local Areas,Colorado,2012,Age,35 Months,85.5,78.8 to 90.9,297
Hib,≥3 Doses,States/Local Areas,Colorado,2018,Age,35 Months,93.7,88.4 to 97.1,296
Hib,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,93.8,90.5 to 96.2,561
Hep A,≥2 Doses,States/Local Areas,Colorado,2012,Age,24 Months,38.1,31.0 to 46.3,297
Hib,≥3 Doses,States/Local Areas,Colorado,2017,Age,35 Months,95.2,89.7 to 98.3,231
Hib,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,94.4,90.8 to 96.9,527
Hib,≥3 Doses,States/Local Areas,Colorado,2016,Age,35 Months,95.3,90.8 to 98.0,247
Hib,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,95.6,92.3 to 97.7,478
Hep A,≥2 Doses,States/Local Areas,Colorado,2011,Age,24 Months,32.5,25.6 to 40.8,277
Hep A,≥2 Doses,States/Local Areas,Colorado,2019,Age,19 Months,26.6,19.3 to 35.5,265
Hep A,≥2 Doses,States/Local Areas,Colorado,2018,Age,19 Months,28.0,21.3 to 35.9,296
Hep A,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,25.4,19.5 to 32.5,446
DTaP,≥4 Doses,States/Local Areas,Colorado,2016,Age,19 Months,69.6,60.9 to 77.1,247
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,70.4,64.2 to 76.0,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,91.6,87.9 to 95.3,268
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,97.9,96.2 to 99.6,564
DTaP,≥4 Doses,States/Local Areas,Colorado,2015,Age,19 Months,71.0,66.5 to 75.1,272
DTaP,≥4 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,70.3,64.6 to 75.5,519
DTaP,≥4 Doses,States/Local Areas,Colorado,2014,Age,19 Months,79.9,72.6 to 85.6,232
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,75.4,70.1 to 80.1,504
Hep A,≥1 Dose,States/Local Areas,Colorado,2017,Age,24 Months,86.7,80.3 to 91.8,231
Hep A,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,24 Months,87.2,82.9 to 90.8,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,97.0,92.8 to 100.0,39
DTaP,≥3 Doses,States/Local Areas,Colorado,2019,Age,35 Months,96.5,93.3 to 98.4,265
DTaP,≥3 Doses,States/Local Areas,Colorado,2018,Age,35 Months,96.7,92.0 to 99.0,296
DTaP,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,96.6,94.0 to 98.3,561
PCV,≥2 Doses,States/Local Areas,Colorado,2016,Age,5 Months,77.3,68.9 to 83.9,247
PCV,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,5 Months,82.7,77.3 to 87.0,478
PCV,≥2 Doses,States/Local Areas,Colorado,2015,Age,5 Months,79.6,72.4 to 85.3,272
PCV,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,5 Months,78.4,73.0 to 83.0,519
PCV,≥2 Doses,States/Local Areas,Colorado,2014,Age,5 Months,77.6,69.6 to 83.9,232
PCV,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,5 Months,78.6,76.4 to 80.6,504
Hep A,≥1 Dose,States/Local Areas,Colorado,2016,Age,24 Months,86.9,80.3 to 92.2,247
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,24 Months,86.8,82.3 to 90.6,478
Hep A,≥1 Dose,States/Local Areas,Colorado,2015,Age,24 Months,81.3,74.6 to 87.1,272
Hep A,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,24 Months,84.1,79.5 to 88.2,519
Hep A,≥1 Dose,States/Local Areas,Colorado,2011,Age,35 Months,81.9,75.2 to 87.8,277
Hep A,≥1 Dose,States/Local Areas,Colorado,2019,Age,24 Months,86.6,80.8 to 91.4,265
Hep A,≥1 Dose,States/Local Areas,Colorado,2018,Age,24 Months,87.6,81.6 to 92.4,296
Hep A,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,24 Months,87.1,83.0 to 90.6,561
Hep A,≥2 Doses,States/Local Areas,Colorado,2017,Age,19 Months,24.2,17.4 to 32.5,231
Hep A,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,26.1,21.1 to 31.7,527
Hib,≥3 Doses,States/Local Areas,Colorado,2015,Age,35 Months,90.5,85.9 to 94.2,272
Hib,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,93.0,89.9 to 95.4,519
Hib,≥3 Doses,States/Local Areas,Colorado,2014,Age,35 Months,94.0,88.5 to 97.4,232
Hib,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,92.6,88.9 to 95.4,504
Hib,≥3 Doses,States/Local Areas,Colorado,2013,Age,35 Months,93.0,87.8 to 96.5,250
Hib,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,93.5,89.8 to 96.1,482
Hep A,≥2 Doses,States/Local Areas,Colorado,2016,Age,19 Months,24.0,17.4 to 32.3,247
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,24.1,19.2 to 29.8,478
Hep A,≥2 Doses,States/Local Areas,Colorado,2015,Age,19 Months,19.1,12.0 to 29.1,272
Hep A,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,21.6,17.1 to 26.8,519
Hep A,≥2 Doses,States/Local Areas,Colorado,2021,Age,35 Months,71.3,58.2 to 83.1,171
PCV,≥3 Doses,States/Local Areas,Colorado,2021,Age,19 Months,85.0,75.7 to 91.2,171
Hep A,≥1 Dose,States/Local Areas,Colorado,2021,Age,35 Months,79.7,70.5 to 87.6,171
Hep B,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,91.5,86.0 to 95.4,482
Hib,≥3 Doses,States/Local Areas,Colorado,2021,Age,7 Months,53.9,44.0 to 63.5,171
≥1 Dose Varicella,,States/Local Areas,Colorado,2021,Age,19 Months,82.9,73.6 to 89.4,171
PCV,≥2 Doses,States/Local Areas,Colorado,2021,Age,5 Months,73.8,63.6 to 82.0,171
DTaP,≥4 Doses,States/Local Areas,Colorado,2021,Age,19 Months,66.6,56.4 to 75.5,171
Hib,Full Series,States/Local Areas,Colorado,2021,Age,24 Months,70.9,61.4 to 79.8,171
Hib,Primary Series,States/Local Areas,Colorado,2020-2021,Age,13 Months,84.9,79.6 to 89.0,482
≥1 Dose MMR,,States/Local Areas,Colorado,2021,Age,24 Months,83.4,74.5 to 90.5,171
Hib,Primary Series,States/Local Areas,Colorado,2021,Age,24 Months,84.3,75.4 to 91.3,171
Polio,≥1 Dose,States/Local Areas,Colorado,2021,Age,3 Months,80.3,70.3 to 87.5,171
Polio,≥3 Doses,States/Local Areas,Colorado,2021,Age,24 Months,85.3,76.9 to 91.9,171
DTaP,≥4 Doses,States/Local Areas,Colorado,2021,Age,24 Months,74.5,65.2 to 82.9,171
DTaP,≥1 Dose,States/Local Areas,Colorado,2021,Age,3 Months,78.9,68.7 to 86.5,171
Hib,≥3 Doses,States/Local Areas,Colorado,2021,Age,24 Months,83.9,75.1 to 91.0,171
PCV,≥4 Doses,States/Local Areas,Colorado,2021,Age,35 Months,79.4,70.4 to 87.2,171
Hep A,≥1 Dose,States/Local Areas,Colorado,2021,Age,19 Months,78.4,68.5 to 85.9,171
Hep A,≥2 Doses,States/Local Areas,Colorado,2021,Age,24 Months,44.0,34.4 to 54.9,171
Hep A,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,25.8,21.1 to 31.1,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2021,Age,7 Months,64.9,54.6 to 74.1,171
PCV,≥4 Doses,States/Local Areas,Colorado,2021,Age,19 Months,79.2,69.5 to 86.5,171
Hep B,≥3 Doses,States/Local Areas,Colorado,2021,Age,24 Months,85.9,77.4 to 92.4,171
DTaP,≥3 Doses,States/Local Areas,Colorado,2021,Age,13 Months,82.6,73.0 to 89.3,171
PCV,≥3 Doses,States/Local Areas,Colorado,2021,Age,7 Months,65.3,55.0 to 74.3,171
DTaP,≥3 Doses,States/Local Areas,Colorado,2021,Age,19 Months,82.8,73.2 to 89.5,171
Hep A,≥1 Dose,States/Local Areas,Colorado,2021,Age,24 Months,79.7,70.5 to 87.6,171
DTaP,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,90.1,85.1 to 93.9,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,77.0,71.4 to 82.2,482
PCV,≥4 Doses,States/Local Areas,Colorado,2021,Age,24 Months,79.4,70.4 to 87.2,171
≥1 Dose Varicella,,States/Local Areas,Colorado,2021,Age,24 Months,83.3,74.6 to 90.3,171
Polio,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,3 Months,89.4,85.5 to 92.3,576
DTaP,≥1 Dose,States/Local Areas,Colorado,2019-2020,Age,3 Months,90.5,86.8 to 93.2,576
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.2,82.6 to 93.7,327
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,94.3,91.5 to 97.1,503
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.2,89.1 to 97.3,327
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,93.1,87.4 to 98.8,94
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,81.1,76.0 to 86.2,503
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.5,81.0 to 92.1,327
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,74.4,61.1 to 87.7,94
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.6,65.3 to 79.9,327
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,56.7,42.8 to 70.7,94
Influenza,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,70.7,65.0 to 76.5,503
Influenza,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.2,67.2 to 81.3,327
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,79.4,73.0 to 85.8,503
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,93.3,89.4 to 97.2,200
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.6,76.2 to 97.1,96
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,90.0 to 95.7,610
Rotavirus,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,75.8 to 85.8,503
Rotavirus,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.9,76.8 to 89.0,327
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.2,76.9 to 89.6,327
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,85.2,75.9 to 94.5,94
Rotavirus,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,82.6,74.0 to 91.3,94
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.1,68.8 to 85.5,327
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,83.2,78.4 to 87.9,503
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.6,76.1 to 89.0,327
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,65.1,51.3 to 78.9,94
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.9,85.9 to 95.9,327
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,88.6,84.8 to 92.3,503
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.9,73.2 to 86.6,327
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,89.2,80.6 to 97.7,94
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,65.9,52.0 to 79.8,94
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,93.4 to 98.3,503
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,89.3 to 97.5,327
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,94.4,89.3 to 99.5,94
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,90.0 to 96.1,503
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,85.0,80.4 to 89.6,503
Influenza,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,55.7,42.0 to 69.3,94
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,95.1,92.5 to 97.7,503
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.4,88.2 to 96.6,327
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,94.4,89.3 to 99.5,94
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,71.0,65.2 to 76.7,503
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,81.0,76.4 to 85.6,503
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.5,73.4 to 85.6,327
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,86.3,76.9 to 95.7,94
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,67.2,53.5 to 80.9,94
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,88.6 to 95.5,503
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,92.4,88.4 to 96.4,341
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,98.4,97.1 to 99.7,427
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Overall,Overall,70.2,65.9 to 74.5,924
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Overall,Overall,81.3,77.5 to 85.1,924
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,89.5,84.9 to 94.1,341
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,97.4,95.8 to 99.1,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,84.2,77.5 to 90.8,156
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,55.1,45.3 to 64.8,156
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,71.4,64.5 to 78.3,341
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,93.1,89.2 to 97.1,341
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,99.2,98.3 to 100.0,427
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Overall,Overall,90.2,87.3 to 93.1,924
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,78.2,73.1 to 83.2,924
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,81.3,75.9 to 86.6,427
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,89.8,84.7 to 95.0,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Overall,Overall,79.2,75.6 to 82.8,924
Influenza,,States/Local Areas,Colorado,2016-2019,Overall,Overall,70.5,66.2 to 74.8,924
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,89.7,84.5 to 94.9,156
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,92.9,89.0 to 96.9,341
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,98.4,96.9 to 99.9,427
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,76.2,68.2 to 84.3,341
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,86.6,81.4 to 91.7,427
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,81.5,73.9 to 89.1,156
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,84.3,78.8 to 89.8,341
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,84.5,81.0 to 88.0,924
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,93.8,91.6 to 96.0,924
Rotavirus,,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,79.8,73.9 to 85.6,341
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Overall,Overall,91.6,88.9 to 94.3,924
Rotavirus,,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,93.0,90.0 to 96.1,427
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Overall,Overall,86.4,83.2 to 89.6,924
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,94.1,92.0 to 96.2,924
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.1,79.5 to 88.7,610
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,87.1,71.3 to 100.0,38
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,93.4,89.5 to 97.3,200
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,95.3,88.2 to 100.0,38
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,86.9,81.7 to 92.0,244
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,96.0,93.5 to 98.6,624
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.1,64.4 to 89.8,96
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,76.7,69.1 to 84.2,200
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,93.9,90.7 to 97.0,624
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,73.8,51.8 to 95.8,38
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,73.3,64.4 to 82.3,244
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,81.8,76.3 to 87.4,624
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,81.0 to 89.5,610
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,94.4,91.4 to 97.3,624
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,76.0,57.3 to 94.6,38
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.6,93.1 to 98.2,610
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,96.6,91.3 to 100.0,38
Influenza,,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,86.7,82.3 to 91.1,427
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,70.8,61.8 to 79.8,156
Rotavirus,,States/Local Areas,Colorado,2016-2019,Overall,Overall,81.7,78.1 to 85.3,924
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,93.2,90.5 to 95.9,427
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,67.9,58.8 to 76.9,156
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,82.5,76.5 to 88.5,341
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,91.1,87.4 to 94.9,427
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,91.5,86.6 to 96.4,156
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,79.2,75.3 to 83.1,924
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,85.1,78.1 to 92.1,156
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,83.3,77.5 to 89.1,341
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,86.5,81.6 to 91.4,427
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,83.9,76.7 to 91.0,156
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,89.0,84.1 to 93.9,341
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,97.0,95.4 to 98.6,427
Influenza,,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,56.7,47.0 to 66.5,156
Influenza,,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,66.6,59.7 to 73.6,341
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,92.3,89.9 to 94.6,924
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Overall,Overall,94.9,92.8 to 96.9,924
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,92.3,87.6 to 96.9,156
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,90.7,86.3 to 95.1,341
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,98.1,96.7 to 99.5,427
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,69.9,57.6 to 82.2,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,75.3,69.0 to 81.5,341
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,79.7,74.1 to 85.3,427
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Poverty,133% to <400% FPL,85.9,80.8 to 91.1,341
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Poverty,>400% FPL,94.4,91.8 to 97.1,427
Rotavirus,,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,71.2,62.4 to 80.1,156
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,89.4,80.5 to 98.2,94
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,72.8,65.8 to 79.7,244
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,84.4,79.7 to 89.1,624
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,85.6 to 100.0,96
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,93.6,89.7 to 97.4,200
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.1,76.2 to 86.0,610
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,94.2,86.7 to 100.0,38
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,93.1,84.8 to 100.0,38
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,91.6,87.7 to 95.6,244
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,96.3,93.9 to 98.8,624
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,82.8,68.7 to 97.0,38
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.5,78.8 to 88.2,610
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,87.8,82.3 to 93.3,200
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,88.6,75.8 to 100.0,38
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,92.7,84.3 to 100.0,38
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,89.8,85.6 to 94.0,244
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,85.1,71.0 to 99.3,38
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.3,91.5 to 97.1,610
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,80.1 to 99.7,96
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,91.0,85.9 to 96.0,200
Influenza,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,79.1,74.2 to 84.0,624
Influenza,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,70.6,62.7 to 78.5,200
Influenza,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,55.1 to 84.0,96
Influenza,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",71.5,66.1 to 76.8,610
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,93.3,84.9 to 100.0,38
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,91.5 to 97.0,610
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.2,67.2 to 91.3,96
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,87.5,81.7 to 93.3,200
Rotavirus,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.8,69.4 to 92.2,96
Rotavirus,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,80.1,73.1 to 87.1,200
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.5,59.5 to 85.6,96
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,71.0,62.9 to 79.0,200
Rotavirus,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,74.8,68.1 to 81.5,244
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.4,64.8 to 76.0,610
Rotavirus,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,75.7,57.3 to 94.2,38
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,73.1 to 93.3,96
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,93.5,89.6 to 97.4,200
Influenza,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,58.9,36.3 to 81.5,38
Influenza,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,61.9,54.3 to 69.5,244
Rotavirus,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,88.3,84.5 to 92.2,624
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,92.0,88.2 to 95.8,244
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,97.2,94.9 to 99.6,624
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,86.1,80.9 to 91.3,244
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,80.7 to 100.0,96
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,91.9,87.2 to 96.7,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Insurance Coverage,Other,80.0,64.3 to 95.7,38
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,81.1,75.1 to 87.0,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,85.3,79.8 to 90.8,200
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,61.9,54.2 to 69.6,244
Combined 7 Series,,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,76.7,71.5 to 82.0,624
Rotavirus,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.6,79.1 to 88.0,610
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.2,85.3 to 93.1,610
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,87.5 to 94.8,610
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,78.4,73.7 to 83.2,624
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.2,74.0 to 86.5,610
Polio,≥3 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,96.9,93.9 to 98.7,255
Polio,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,96.3,93.7 to 98.0,518
Polio,≥3 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,95.8,91.5 to 98.3,263
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,95.9,92.1 to 98.2,479
Polio,≥3 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,93.4,87.9 to 97.0,245
Polio,≥3 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,95.8,89.1 to 99.0,216
Polio,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,95.3,91.2 to 97.8,398
Hib,Full Series,States/Local Areas,Connecticut,2019,Age,24 Months,91.3,86.8 to 94.7,311
Hib,Full Series,States/Local Areas,Connecticut,2011,Age,35 Months,95.4,91.3 to 98.0,243
Hib,Full Series,States/Local Areas,Connecticut,2012,Age,35 Months,85.5,78.3 to 91.4,245
Hib,Full Series,States/Local Areas,Connecticut,2013,Age,35 Months,89.3,82.8 to 94.1,255
Hib,Full Series,States/Local Areas,Connecticut,2013-2014,Age,35 Months,89.1,84.9 to 92.6,518
Hib,Full Series,States/Local Areas,Connecticut,2014,Age,35 Months,88.9,83.1 to 93.4,263
Hib,Full Series,States/Local Areas,Connecticut,2014-2015,Age,35 Months,88.6,83.9 to 92.4,479
DTaP,≥2 Doses,States/Local Areas,Connecticut,2011,Age,5 Months,94.8,92.5 to 96.5,243
DTaP,≥2 Doses,States/Local Areas,Connecticut,2012,Age,5 Months,86.5,76.2 to 92.7,245
DTaP,≥2 Doses,States/Local Areas,Connecticut,2013,Age,5 Months,81.1,73.6 to 86.9,255
DTaP,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,5 Months,85.0,80.0 to 88.9,518
DTaP,≥2 Doses,States/Local Areas,Connecticut,2014,Age,5 Months,88.9,82.6 to 93.2,263
DTaP,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,5 Months,87.9,84.6 to 90.5,479
DTaP,≥2 Doses,States/Local Areas,Connecticut,2015,Age,5 Months,86.8,79.5 to 91.8,216
DTaP,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,5 Months,87.0,81.7 to 90.9,398
DTaP,≥2 Doses,States/Local Areas,Connecticut,2016,Age,5 Months,87.2,78.7 to 92.6,182
DTaP,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,5 Months,84.2,78.1 to 88.9,366
Polio,≥3 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,95.9,92.4 to 98.1,311
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,96.7,94.8 to 98.7,474
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,89.8,81.5 to 98.2,92
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,93.9,90.1 to 97.7,186
Polio,≥3 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,96.2,90.0 to 99.0,182
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,94.7,90.2 to 97.5,366
Polio,≥3 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,93.1,85.8 to 97.4,184
Polio,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,94.9,91.0 to 97.5,492
Hib,Full Series,States/Local Areas,Connecticut,2017-2018,Age,35 Months,89.4,84.5 to 93.3,492
Hib,Full Series,States/Local Areas,Connecticut,2017,Age,35 Months,86.0,77.1 to 92.8,184
Polio,≥3 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,96.8,93.0 to 98.8,308
Polio,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,96.4,94.0 to 98.0,619
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.5,76.1 to 98.8,44
Hib,Full Series,States/Local Areas,Connecticut,2015,Age,35 Months,88.5,80.1 to 94.5,216
Hib,Full Series,States/Local Areas,Connecticut,2015-2016,Age,35 Months,88.4,82.3 to 93.1,398
Hib,Full Series,States/Local Areas,Connecticut,2016,Age,35 Months,88.4,79.4 to 94.6,182
Hib,Full Series,States/Local Areas,Connecticut,2016-2017,Age,35 Months,87.8,81.4 to 92.8,366
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,91.0,87.6 to 94.3,474
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,75.4,63.8 to 87.0,92
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,82.7,76.6 to 88.7,186
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.1,58.6 to 89.7,44
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,94.4,90.8 to 98.0,182
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.4,87.9 to 98.8,115
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.8,94.7 to 98.9,421
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,94.4,90.8 to 98.0,261
Hib,Full Series,States/Local Areas,Connecticut,2018,Age,35 Months,92.9,88.7 to 95.9,308
Hib,Full Series,States/Local Areas,Connecticut,2018-2019,Age,35 Months,92.7,89.7 to 95.0,619
Hib,Full Series,States/Local Areas,Connecticut,2019,Age,35 Months,92.5,88.0 to 95.8,311
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.1,92.7 to 97.5,478
Hib,Primary Series,States/Local Areas,Connecticut,2011,Age,7 Months,86.1,81.3 to 89.9,243
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,92.7,89.1 to 96.3,338
Hib,Primary Series,States/Local Areas,Connecticut,2012,Age,7 Months,73.9,58.6 to 85.0,245
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Overall,Overall,85.2,81.8 to 88.5,762
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,82.6,76.5 to 88.6,178
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,77.9,70.4 to 85.4,246
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,82.9,75.8 to 89.9,182
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,82.0 to 95.4,115
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.8,83.8 to 91.8,421
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,82.6,76.4 to 88.8,261
Hib,Full Series,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.1,83.2 to 91.1,478
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a Non-MSA,78.8,58.7 to 98.9,94
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,89.0 to 95.8,503
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.8,87.6 to 95.9,327
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,90.6,78.8 to 100.0,32
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,67.9,60.8 to 74.3,275
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,65.1,60.2 to 69.7,594
Hib,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,88.3,84.4 to 91.3,279
Hib,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,91.9,90.1 to 93.3,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,64.2,54.6 to 72.9,205
Polio,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,88.0,81.0 to 92.6,243
Polio,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,90.2,86.1 to 93.2,437
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,87.9,82.9 to 91.6,319
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,88.0,83.9 to 91.1,562
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,66.5,57.7 to 74.3,194
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,65.4,58.9 to 71.3,399
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,90.3,84.1 to 94.2,194
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,90.2,85.7 to 93.4,399
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,60.1,52.0 to 67.8,243
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,63.3,57.4 to 68.9,437
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,62.3,55.8 to 68.4,319
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,61.2,56.1 to 66.2,562
Polio,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,89.5,83.0 to 93.7,198
Polio,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,89.6,84.5 to 93.2,425
Polio,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,90.2,87.3 to 92.5,275
Polio,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,89.1,85.7 to 91.7,594
Polio,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,93.2,90.5 to 95.1,260
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,89.7,82.9 to 94.1,227
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,90.0,86.0 to 92.9,502
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,92.8,90.0 to 94.9,260
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,89.5,83.0 to 93.7,198
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,90.8,87.3 to 93.4,425
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,90.9,88.1 to 93.1,279
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,90.1,82.7 to 94.5,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.3,85.3 to 93.3,355
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,88.3,81.8 to 92.7,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,78.5,73.2 to 83.7,370
Hib,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,92.3,85.6 to 96.0,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,90.1,87.7 to 92.4,996
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,86.0,81.7 to 90.4,370
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.4,87.7 to 95.1,355
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,89.8,85.0 to 94.6,328
Hib,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,89.8,83.8 to 93.7,243
Hib,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,90.9,86.8 to 93.8,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,92.0,85.7 to 95.7,194
Hib,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,92.1,87.9 to 95.0,399
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,88.8,83.9 to 92.3,319
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,87.2,83.1 to 90.4,562
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.0,86.4 to 93.6,519
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,89.0,85.0 to 93.0,313
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,44.3,35.3 to 53.8,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,76.5,71.2 to 81.8,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,68.9,61.6 to 76.1,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,79.3,71.4 to 87.2,152
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.8,73.1 to 84.4,289
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.7,70.0 to 79.4,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,69.6,63.2 to 76.1,313
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.3,69.0 to 79.7,355
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Overall,Overall,76.1,72.7 to 79.4,996
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,86.8,82.5 to 91.0,328
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,89.7,82.7 to 94.1,227
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,88.4,84.2 to 91.7,502
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,88.0,79.2 to 93.3,198
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,88.8,83.8 to 92.4,425
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,87.2,81.3 to 91.4,275
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,88.0,84.2 to 90.9,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,85.5,78.4 to 90.5,243
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,87.9,83.4 to 91.3,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,92.7,89.5 to 95.0,279
Hib,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,94.6,93.6 to 95.5,260
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.5,87.4 to 93.7,519
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,85.1 to 93.4,313
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,91.0,87.1 to 94.9,328
Hib,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,77.9,75.4 to 80.2,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,72.6,69.9 to 75.1,279
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,63.4,54.8 to 71.1,227
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,65.6,60.1 to 70.7,502
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,92.3,89.0 to 95.5,404
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,95.8,93.3 to 98.2,222
Polio,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,89.1,86.0 to 91.6,279
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,71.4,62.1 to 79.1,198
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,67.4,60.8 to 73.3,425
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,92.6,89.4 to 95.7,439
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,90.1,86.8 to 93.4,498
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.3,80.6 to 100.0,36
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,88.8,83.3 to 94.3,152
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.6,86.4 to 94.9,289
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,39.8,31.4 to 48.8,194
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,42.0,35.8 to 48.5,399
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,44.5,36.8 to 52.4,243
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,42.1,36.4 to 48.1,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,92.6,86.2 to 96.1,227
Hib,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,92.6,89.0 to 95.1,502
Hib,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,88.3,83.2 to 92.0,319
Hib,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,89.0,85.3 to 91.9,562
Hib,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,92.6,87.9 to 95.5,275
Hib,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,90.4,87.2 to 92.9,594
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2020,Age,35 Months,97.2,92.3 to 99.3,298
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014,Age,0-3 Days,73.2,64.6 to 80.3,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2015,Age,0-3 Days,77.2,72.0 to 81.7,502
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,58.1,51.7 to 64.3,279
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,64.3,50.0 to 76.4,260
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,59.7,54.2 to 65.0,198
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,63.4,58.9 to 67.8,425
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2013,Age,0-3 Days,80.2,72.8 to 85.9,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2013-2014,Age,0-3 Days,76.7,71.1 to 81.4,425
Polio,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,3 Months,80.8,76.8 to 84.3,198
Polio,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,3 Months,81.6,78.7 to 84.1,425
Polio,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,3 Months,82.9,77.7 to 87.2,279
Polio,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,3 Months,85.7,74.0 to 92.7,260
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,89.8,87.4 to 92.1,996
PCV,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,3 Months,87.8,79.3 to 93.1,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,91.8,87.1 to 95.3,194
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,90.8,86.8 to 94.0,399
Hib,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,85.8,79.6 to 90.3,275
Hib,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,85.4,81.4 to 88.6,594
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,91.4,85.7 to 95.5,198
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,90.6,86.5 to 93.9,425
PCV,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,92.5,88.2 to 95.6,279
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,89.8,83.1 to 94.6,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,91.7,86.4 to 95.5,260
PCV,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,3 Months,87.4,81.8 to 91.5,275
PCV,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,3 Months,84.0,80.1 to 87.3,594
PCV,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,3 Months,79.3,71.2 to 85.6,227
PCV,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,3 Months,83.3,78.5 to 87.3,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,88.5,83.1 to 94.0,152
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,85.9 to 94.2,289
Hib,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,85.6,78.8 to 90.5,243
Hib,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,87.5,83.0 to 91.0,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,85.0,79.5 to 89.2,319
Hib,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,85.3,81.1 to 88.7,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016,Age,0-3 Days,76.0,69.9 to 81.2,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2016-2017,Age,0-3 Days,76.4,71.7 to 80.6,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2017,Age,0-3 Days,76.4,67.2 to 83.6,175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2017-2018,Age,0-3 Days,76.5,71.2 to 81.2,437
Polio,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,3 Months,82.1,76.3 to 86.7,319
Polio,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,3 Months,83.8,79.5 to 87.3,562
Polio,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,3 Months,87.3,81.6 to 91.4,275
Polio,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,3 Months,84.7,80.8 to 87.9,594
Polio,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,3 Months,82.3,74.3 to 88.2,227
Polio,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,3 Months,84.8,80.1 to 88.6,502
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,42.0,36.4 to 47.9,198
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,39.7,35.5 to 44.1,425
Hib,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,42.7,38.5 to 47.0,279
Hib,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,46.7,38.6 to 55.0,260
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,91.1,87.6 to 94.7,404
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,93.4,90.2 to 96.7,222
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,87.2,83.1 to 91.3,370
Hib,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,87.2,79.1 to 92.4,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,63.0,56.5 to 69.2,319
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,66.3,61.3 to 71.0,562
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2015,Age,0-3 Days,81.2,75.1 to 86.1,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2015-2016,Age,0-3 Days,78.6,74.3 to 82.4,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,67.2,58.8 to 74.6,227
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,66.4,60.9 to 71.4,502
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,65.5,58.3 to 72.1,275
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,64.3,59.4 to 68.9,594
Polio,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,3 Months,89.1,83.2 to 93.1,194
Polio,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,3 Months,88.7,83.9 to 92.2,399
Polio,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,3 Months,85.6,78.7 to 90.5,243
Polio,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,3 Months,87.3,83.0 to 90.7,437
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,31.4,25.6 to 37.8,319
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,37.7,32.9 to 42.8,562
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,42.8,35.9 to 50.0,275
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,37.1,32.6 to 42.0,594
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,37.4,29.4 to 46.1,227
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,40.1,34.7 to 45.7,502
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,93.5,89.0 to 96.6,194
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,92.3,88.4 to 95.3,399
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,89.0,82.3 to 94.0,243
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,91.2,87.3 to 94.3,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,89.4,80.4 to 94.5,198
Hib,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,91.0,85.7 to 94.4,425
Hib,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,89.4,83.1 to 93.6,194
Hib,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,88.3,83.5 to 91.9,399
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,89.7,83.4 to 94.3,227
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,91.6,87.6 to 94.6,502
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,88.4,83.8 to 92.2,319
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,88.6,84.8 to 91.9,562
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,93.3,88.2 to 96.8,275
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,90.8,87.5 to 93.5,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,87.4,82.9 to 90.8,279
Hib,Primary Series,States/Local Areas,Oklahoma,2020,Age,24 Months,92.0,87.3 to 95.4,298
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,69.7,61.8 to 76.7,243
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,71.3,65.7 to 76.4,437
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,73.8,64.5 to 81.4,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,72.9,64.6 to 79.9,194
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,73.4,67.3 to 78.7,399
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.2,45.3 to 83.1,36
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,79.7,75.1 to 84.2,498
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,73.0,67.9 to 78.0,439
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,64.7,45.3 to 84.1,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2019,Age,0-3 Days,76.5,67.2 to 83.8,205
Polio,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,3 Months,88.3,79.8 to 93.5,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2018,Age,0-3 Days,76.2,68.3 to 82.7,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2018-2019,Age,0-3 Days,76.3,70.4 to 81.4,399
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,90.9,84.1 to 95.6,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,93.5,82.9 to 100.0,32
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.2,81.7 to 100.0,36
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,86.7,74.3 to 99.1,32
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,88.4,84.4 to 92.4,439
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,89.8,86.7 to 92.9,498
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019,Age,35 Months,91.7,84.1 to 96.6,205
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016,Age,35 Months,91.3,86.9 to 94.7,319
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,91.0,87.2 to 94.0,562
PCV,≥4 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,75.8,69.3 to 81.8,275
PCV,≥4 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,77.5,73.2 to 81.5,594
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,79.2,73.6 to 84.3,319
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,80.1,75.6 to 84.2,562
PCV,≥4 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,80.9,73.7 to 87.2,243
PCV,≥4 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,78.2,72.8 to 83.1,437
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015,Age,35 Months,90.8,86.2 to 94.3,275
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,90.9,87.9 to 93.5,594
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014,Age,35 Months,97.1,92.8 to 99.2,227
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,93.7,90.5 to 96.1,502
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,86.0,80.8 to 90.0,319
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,84.9,80.6 to 88.4,562
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,92.9,87.2 to 96.7,198
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,92.2,88.3 to 95.2,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,91.6,85.5 to 95.8,227
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,92.3,88.8 to 95.0,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,92.9,88.8 to 95.8,275
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,95.5,90.9 to 98.2,260
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,87.6,81.1 to 92.0,194
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,86.7,81.6 to 90.6,399
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,83.6,76.2 to 89.1,243
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,85.6,80.9 to 89.3,437
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,95.5,91.6 to 97.7,260
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,93.7,89.1 to 96.4,198
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,94.1,91.4 to 96.0,425
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,95.5,92.8 to 97.2,279
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,92.1,85.1 to 96.0,205
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,5 Months,89.1,83.3 to 93.0,194
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,5 Months,89.0,84.6 to 92.2,399
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,5 Months,84.6,77.6 to 89.7,243
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,5 Months,86.8,82.5 to 90.2,437
PCV,≥4 Doses,States/Local Areas,Oklahoma,2020,Age,35 Months,83.3,72.9 to 91.4,298
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,90.8,88.2 to 92.8,279
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,5 Months,88.9,81.5 to 93.6,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017,Age,35 Months,88.6,81.3 to 93.9,243
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,89.7,85.4 to 93.2,437
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018,Age,35 Months,90.6,85.4 to 94.6,194
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,91.2,86.8 to 94.5,399
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,86.8,81.1 to 92.6,152
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.3,67.7 to 86.8,289
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,87.7,84.0 to 91.3,404
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,88.3,85.8 to 90.7,996
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,86.4,82.1 to 90.7,370
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.5,84.7 to 92.4,355
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,84.8,79.4 to 90.3,328
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017,Age,35 Months,90.7,84.3 to 95.3,243
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,92.0,87.8 to 95.1,437
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018,Age,35 Months,93.1,87.8 to 96.6,194
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,93.6,89.6 to 96.5,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,82.2,74.9 to 88.4,198
PCV,≥4 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,82.9,77.5 to 87.7,425
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019,Age,35 Months,94.2,87.7 to 98.0,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,85.7 to 94.4,289
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,96.1,90.1 to 100.0,32
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.0,83.3 to 90.7,519
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,90.5,86.9 to 94.1,313
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,88.1,83.2 to 91.8,319
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,87.3,83.2 to 90.6,562
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,90.4,86.1 to 93.5,275
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,89.3,85.9 to 91.9,594
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,94.5,88.8 to 97.4,205
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,94.0,89.2 to 96.8,194
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,94.3,90.9 to 96.4,399
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,91.4,85.7 to 95.0,243
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,92.7,89.2 to 95.2,437
Hib,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,3 Months,84.8,77.8 to 89.9,243
Hib,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,3 Months,84.9,80.0 to 88.7,437
Hib,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,3 Months,80.9,75.1 to 85.6,319
Hib,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,3 Months,82.8,78.5 to 86.5,562
Hib,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,3 Months,85.8,79.9 to 90.2,275
Hib,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,3 Months,83.4,79.4 to 86.7,594
Hib,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,3 Months,86.6,78.2 to 92.1,205
Hib,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,3 Months,84.9,77.4 to 90.2,194
Hib,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,3 Months,85.8,80.5 to 89.8,399
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.1,85.7 to 92.5,519
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,91.8,88.6 to 94.9,313
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,93.9,90.9 to 96.9,222
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,88.7,81.8 to 93.2,227
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,89.5,85.5 to 92.5,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,92.4,86.9 to 96.1,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,93.8,89.3 to 96.8,194
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,93.3,90.0 to 95.8,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,83.4,75.1 to 90.2,227
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,81.4,76.3 to 85.9,502
PCV,≥4 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,79.9,73.4 to 85.7,275
PCV,≥4 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,81.1,76.8 to 85.0,594
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,82.2,76.8 to 87.0,319
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,81.8,77.3 to 85.8,562
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,90.9,88.0 to 93.7,498
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,90.4,86.7 to 94.0,439
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.4,90.1 to 100.0,36
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,88.9,83.6 to 94.2,152
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,86.1 to 94.5,289
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,91.7,87.3 to 95.1,275
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,90.1,87.0 to 92.7,594
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,89.7,83.4 to 94.3,227
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,90.7,87.0 to 93.7,502
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,90.7,85.1 to 94.9,198
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,90.1,86.1 to 93.4,425
Hib,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,5 Months,77.7,70.4 to 83.6,243
Hib,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,5 Months,76.9,71.5 to 81.6,437
PCV,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,91.7,86.4 to 95.5,260
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,78.3,73.8 to 82.8,498
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,84.1,69.9 to 98.4,32
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.7,71.9 to 97.5,36
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,79.2,71.9 to 86.5,152
PCV,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,3 Months,79.8,75.6 to 83.5,198
PCV,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,3 Months,79.6,76.9 to 82.0,425
Hib,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,5 Months,68.5,62.0 to 74.3,319
Hib,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,5 Months,72.9,68.2 to 77.2,562
Hib,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,5 Months,74.4,67.5 to 80.3,275
Hib,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,5 Months,71.5,66.8 to 75.8,594
Hib,Full Series,States/Local Areas,Oklahoma,2020,Age,24 Months,69.8,62.4 to 76.9,298
Hib,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,5 Months,73.9,66.8 to 79.9,279
Hib,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,5 Months,76.3,63.4 to 85.8,260
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,86.5,79.1 to 91.6,243
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,89.2,84.8 to 92.4,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,5 Months,74.9,66.8 to 81.6,227
Hib,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,5 Months,74.7,71.6 to 77.5,502
Hib,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,5 Months,68.7,61.5 to 75.0,198
Hib,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,5 Months,71.8,68.8 to 74.6,425
PCV,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,90.3,85.7 to 93.9,279
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,89.7,82.2 to 94.2,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,91.8,86.7 to 95.1,194
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,86.7,81.6 to 90.6,399
PCV,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,3 Months,80.9,69.0 to 89.0,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,89.9,87.7 to 92.2,996
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,87.9,83.8 to 91.9,370
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.6,88.3 to 95.0,355
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,85.2,79.8 to 90.6,328
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,90.3,87.2 to 93.5,404
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,94.0,90.9 to 97.1,222
PCV,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,3 Months,79.3,72.3 to 84.9,279
PCV,≥4 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,81.1,73.9 to 87.3,243
PCV,≥4 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,80.2,74.8 to 85.2,437
PCV,≥4 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,82.0,73.1 to 89.3,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020,Age,24 Months,90.0,84.2 to 94.3,298
PCV,≥4 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,79.5,71.2 to 86.7,194
PCV,≥4 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,80.8,74.8 to 86.1,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,78.9,75.7 to 82.1,996
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,72.8,66.3 to 79.3,328
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.4,76.3 to 86.6,355
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,72.5,66.9 to 78.1,370
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,83.6,79.0 to 88.1,404
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,85.6,80.8 to 90.4,222
Hib,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,85.6,78.2 to 90.7,227
Hib,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,85.7,81.1 to 89.3,502
Hib,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,83.2,76.9 to 88.1,198
Hib,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,84.4,81.1 to 87.2,425
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,82.3,77.8 to 86.8,439
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2012,Age,0-3 Days,80.3,74.0 to 85.4,260
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,81.1,76.0 to 86.1,313
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2011,Age,0-3 Days,71.4,63.9 to 77.9,279
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,89.1,85.6 to 92.6,498
PCV,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,3 Months,83.2,75.9 to 88.7,194
PCV,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,3 Months,85.5,80.2 to 89.5,399
PCV,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,3 Months,85.1,78.2 to 90.1,243
PCV,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,3 Months,84.2,79.4 to 88.0,437
PCV,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,3 Months,80.5,74.6 to 85.3,319
PCV,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,3 Months,82.8,78.4 to 86.4,562
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.7,69.3 to 100.0,36
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,87.0,80.1 to 92.4,243
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,89.4,85.3 to 92.7,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,88.1,83.6 to 91.6,260
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,88.4,83.7 to 92.2,319
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,87.7,83.7 to 91.1,562
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,92.3,89.7 to 94.9,439
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,99.1,97.2 to 100.0,32
Hib,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,85.7,81.0 to 89.4,279
Hib,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,5 Months,77.8,68.6 to 84.8,205
Hib,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,5 Months,76.2,67.7 to 83.0,194
Hib,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,5 Months,77.0,70.9 to 82.1,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.0,69.6 to 82.4,289
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.8,75.3 to 84.3,519
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,35 Months,91.6,86.6 to 95.2,275
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,91.2,87.7 to 94.0,594
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,48.5,38.6 to 59.6,198
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,45.7,39.2 to 52.7,425
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,70.9,62.4 to 78.1,194
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,93.2,89.4 to 95.7,399
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,69.9,61.7 to 77.0,243
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,70.4,64.6 to 75.6,437
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,69.7,63.4 to 75.3,319
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,69.8,64.7 to 74.4,562
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.3,80.6 to 100.0,36
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,90.2,85.0 to 95.4,152
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,87.0 to 95.1,289
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,89.0 to 95.3,519
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,87.6 to 94.8,313
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.3,88.7 to 95.9,355
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,90.8,86.5 to 95.0,328
PCV,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,5 Months,78.9,71.8 to 84.5,243
PCV,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,5 Months,77.0,71.6 to 81.6,437
PCV,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,5 Months,77.8,68.7 to 84.8,205
PCV,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,5 Months,75.2,66.8 to 82.0,194
PCV,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,5 Months,76.5,70.4 to 81.6,399
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,35 Months,90.9,86.2 to 94.5,319
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,89.2,84.9 to 92.7,562
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,87.3,83.2 to 91.4,370
Polio,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,5 Months,76.2,68.1 to 82.7,227
Polio,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,5 Months,75.5,72.2 to 78.6,502
Polio,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,5 Months,69.1,65.6 to 72.5,198
Polio,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,5 Months,72.6,70.4 to 74.8,425
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,35 Months,95.4,89.7 to 98.5,260
Polio,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,5 Months,75.1,68.9 to 80.3,279
Polio,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,5 Months,77.5,63.6 to 87.2,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,90.8,84.3 to 95.4,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,43.4,35.3 to 52.6,227
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,45.2,39.7 to 51.1,502
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,47.1,39.9 to 54.8,275
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,45.1,40.1 to 50.3,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,91.5,89.3 to 93.6,996
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,35 Months,90.6,83.8 to 95.4,227
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,91.2,87.1 to 94.4,502
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,35 Months,90.8,84.2 to 95.4,198
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,90.4,85.9 to 94.0,425
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015,Age,13 Months,55.3,48.0 to 62.3,275
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,57.9,53.0 to 62.6,594
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014,Age,13 Months,57.4,48.7 to 65.6,227
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,56.3,50.7 to 61.8,502
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018,Age,13 Months,61.7,52.7 to 69.9,194
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,59.4,52.9 to 65.7,399
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016,Age,13 Months,60.6,53.9 to 66.8,319
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,60.3,55.1 to 65.3,562
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2012,Age,19 Months,85.2,78.6 to 90.1,260
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2011,Age,19 Months,83.1,80.0 to 85.8,279
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019,Age,13 Months,57.2,47.6 to 66.2,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,69.0,59.5 to 78.1,243
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,71.9,65.1 to 78.3,437
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,74.7,65.3 to 83.2,194
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,75.2,68.1 to 81.8,399
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,89.7,83.0 to 93.9,227
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,88.1,84.1 to 91.2,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,89.7,84.0 to 93.6,198
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,89.7,85.7 to 92.7,425
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,83.3,75.3 to 89.8,198
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,86.9,81.6 to 91.3,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,89.4,84.8 to 92.8,260
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,75.9,64.9 to 85.5,205
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,90.9,83.8 to 95.7,227
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,87.9,82.7 to 92.1,502
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,82.4,74.6 to 89.0,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2011,Age,13 Months,50.1,47.0 to 53.2,279
≥1 Dose MMR,,States/Local Areas,Oklahoma,2012,Age,13 Months,53.8,44.8 to 62.6,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013,Age,13 Months,49.4,38.3 to 60.5,198
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,53.4,45.9 to 60.7,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,85.8,82.5 to 88.6,279
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,85.4,81.1 to 89.6,404
Polio,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,86.1,80.0 to 90.6,275
Polio,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,85.9,82.0 to 89.1,594
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,85.9,83.3 to 88.6,996
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,85.0,80.5 to 89.5,370
Polio,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,85.6,81.3 to 89.1,198
Polio,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,86.1,83.3 to 88.5,425
Polio,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,86.7,79.3 to 91.7,227
Polio,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,86.4,81.8 to 89.9,502
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,82.6 to 89.9,519
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,85.9,81.2 to 90.5,313
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.8,83.9 to 91.7,355
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,83.8,78.4 to 89.1,328
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,79.8 to 90.7,289
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015,Age,13 Months,53.4,46.2 to 60.5,275
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,54.7,49.8 to 59.5,594
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017,Age,13 Months,54.8,46.7 to 62.6,243
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,58.2,52.2 to 64.0,437
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016,Age,13 Months,56.1,49.5 to 62.5,319
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,55.4,50.3 to 60.5,562
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017,Age,13 Months,60.0,51.9 to 67.6,243
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,63.3,57.4 to 68.9,437
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018,Age,13 Months,66.7,57.8 to 74.5,194
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,66.2,59.7 to 72.2,399
Polio,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,93.8,92.5 to 94.9,279
Polio,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,94.5,92.5 to 95.9,260
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013,Age,19 Months,85.9,73.7 to 92.9,198
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,84.9,78.2 to 89.8,425
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015,Age,19 Months,85.5,84.3 to 86.6,275
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,84.7,80.9 to 87.9,594
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014,Age,19 Months,83.9,76.8 to 89.1,227
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,84.7,80.3 to 88.2,502
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,75.2,67.4 to 82.9,370
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,78.9,74.2 to 83.5,996
Polio,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,89.1,81.6 to 93.8,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.4,75.1 to 89.7,355
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,87.6,81.8 to 92.2,279
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,77.2,68.5 to 84.8,205
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,77.0,69.3 to 84.0,243
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,75.6,70.2 to 80.7,437
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,74.3,66.5 to 81.6,194
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,75.7,69.9 to 81.1,399
Polio,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,95.9,92.1 to 98.3,194
Polio,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,95.3,92.0 to 97.6,399
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2011,Age,13 Months,52.1,48.3 to 55.9,279
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,77.3,69.5 to 85.1,328
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.0,75.0 to 87.0,519
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,84.5,79.0 to 89.1,319
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,84.4,79.6 to 88.6,562
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,84.2,76.0 to 90.8,243
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,84.7,79.1 to 89.4,437
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,84.2,77.0 to 89.4,243
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,87.4,83.0 to 90.8,437
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,84.9,77.4 to 91.0,275
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,84.6,80.1 to 88.6,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,86.6,81.2 to 90.6,275
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,85.9,82.2 to 88.9,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,85.1,79.7 to 89.2,319
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,84.6,80.4 to 88.1,562
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.0,45.9 to 86.0,36
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2016,Age,3 Months,94.8,91.7 to 96.8,319
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2016-2017,Age,3 Months,94.5,91.8 to 96.3,562
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2015,Age,3 Months,97.0,93.3 to 98.7,275
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2015-2016,Age,3 Months,95.9,93.8 to 97.3,594
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,3 Months,93.9,88.4 to 96.9,227
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,3 Months,95.5,92.4 to 97.3,502
Polio,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,91.0,86.1 to 94.3,198
Polio,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,92.0,88.6 to 94.4,425
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,76.6,68.2 to 85.0,313
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,81.9,72.1 to 91.7,152
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,82.3,77.0 to 87.5,439
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,80.4,73.3 to 87.5,498
Polio,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,91.4,86.1 to 94.7,194
Polio,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,90.2,85.9 to 93.3,399
Polio,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,86.4,79.7 to 91.1,243
Polio,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,88.9,84.8 to 92.0,437
Polio,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,85.6,80.3 to 89.7,319
Polio,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,86.0,81.9 to 89.3,562
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,3 Months,96.1,94.8 to 97.1,279
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,3 Months,95.3,89.4 to 97.9,260
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,3 Months,96.9,95.4 to 97.9,198
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,3 Months,95.4,93.3 to 96.9,425
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,78.7,73.2 to 84.2,313
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.2,77.0 to 87.5,355
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,79.1,75.8 to 82.4,996
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,75.9,69.6 to 82.3,328
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,74.3 to 86.3,289
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.1,75.5 to 84.7,519
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,78.8,71.4 to 86.2,152
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2012,Age,24 Months,88.3,81.7 to 93.3,260
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2011,Age,24 Months,88.9,84.0 to 92.7,279
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,72.7,67.0 to 78.4,370
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017,Age,19 Months,85.6,78.5 to 90.6,243
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,86.4,81.9 to 90.0,437
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016,Age,19 Months,86.3,81.2 to 90.3,319
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,86.0,81.8 to 89.3,562
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015,Age,19 Months,86.5,84.8 to 88.2,275
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,86.4,82.8 to 89.4,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,89.8,87.2 to 91.9,275
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,88.1,84.7 to 90.9,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,90.5,83.8 to 94.6,227
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,90.2,86.3 to 93.0,502
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,81.6,74.5 to 88.8,222
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,91.5,84.1 to 95.6,198
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,91.0,85.9 to 94.4,425
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,5 Months,87.6,80.8 to 92.2,198
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,5 Months,88.1,84.6 to 90.8,425
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,5 Months,84.7,81.1 to 87.7,279
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,5 Months,88.3,82.0 to 92.6,260
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2011,Age,0-1 Days,67.1,57.8 to 75.3,279
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,81.2,74.1 to 88.3,404
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,3 Months,96.4,91.8 to 98.5,205
Polio,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,93.0,86.7 to 96.5,227
Polio,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,93.1,89.5 to 95.5,502
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,3 Months,95.0,90.6 to 97.3,194
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,3 Months,95.7,92.9 to 97.4,399
≥1 Dose MMR,,States/Local Areas,Oklahoma,2011,Age,19 Months,82.8,78.4 to 86.5,279
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.7,46.5 to 83.0,36
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,89.0,75.7 to 100.0,32
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,82.8,78.3 to 87.2,439
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,78.1,73.4 to 82.8,498
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,81.4,72.3 to 89.0,205
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,3 Months,94.2,89.2 to 97.0,243
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,3 Months,94.6,91.5 to 96.6,437
Polio,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,89.4,84.7 to 92.8,319
Polio,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,90.0,86.5 to 92.6,562
Polio,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,93.2,88.6 to 96.0,275
Polio,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,91.3,88.2 to 93.7,594
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016,Age,19 Months,83.9,78.4 to 88.2,319
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,84.1,79.6 to 87.7,562
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019,Age,13 Months,65.8,56.0 to 74.4,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018,Age,19 Months,87.2,81.2 to 91.5,194
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,59.4,52.9 to 65.7,399
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017,Age,19 Months,84.3,76.6 to 89.7,243
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,85.7,81.0 to 89.4,437
≥1 Dose MMR,,States/Local Areas,Oklahoma,2012,Age,19 Months,85.4,77.7 to 90.8,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014,Age,19 Months,86.3,79.6 to 91.0,227
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,86.4,82.3 to 89.7,502
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013,Age,19 Months,86.0,76.4 to 92.1,198
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,86.2,81.8 to 89.6,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,93.3,88.7 to 96.1,260
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,89.9,86.9 to 92.3,279
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,90.0,83.0 to 94.3,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,90.7,85.1 to 94.3,194
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,90.3,86.2 to 93.3,399
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2018,Age,35 Months,85.1,77.5 to 91.2,194
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,83.4,77.5 to 88.5,399
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,76.0,44.5 to 100.0,32
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,89.6,85.5 to 93.7,222
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2017,Age,0-1 Days,76.4,68.8 to 82.7,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2017-2018,Age,0-1 Days,76.2,70.8 to 80.8,437
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2016,Age,0-1 Days,75.0,68.8 to 80.2,319
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2016-2017,Age,0-1 Days,75.7,70.9 to 79.9,562
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016,Age,24 Months,85.4,80.3 to 89.7,319
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,85.1,80.9 to 88.8,562
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015,Age,24 Months,89.6,85.0 to 93.3,275
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,87.4,84.1 to 90.4,594
≥1 Dose MMR,,States/Local Areas,Oklahoma,2012,Age,24 Months,88.3,81.6 to 93.4,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2011,Age,24 Months,88.9,84.2 to 92.8,279
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019,Age,19 Months,87.0,79.1 to 92.2,205
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018,Age,19 Months,87.3,80.9 to 91.8,194
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,92.1,87.9 to 95.0,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,72.4,64.9 to 78.9,279
PCV,≥4 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,74.1,62.1 to 83.3,260
PCV,≥4 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,78.8,71.0 to 85.0,198
PCV,≥4 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,75.3,68.5 to 81.0,425
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2015,Age,0-1 Days,78.4,71.9 to 83.7,275
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2015-2016,Age,0-1 Days,76.7,72.3 to 80.6,594
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,5 Months,86.1,80.5 to 90.3,275
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,5 Months,85.8,82.1 to 88.8,594
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2014,Age,0-1 Days,69.6,60.9 to 77.1,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2014-2015,Age,0-1 Days,74.0,68.6 to 78.8,502
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2013,Age,0-1 Days,75.1,73.0 to 77.2,198
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2013-2014,Age,0-1 Days,72.4,69.2 to 75.3,425
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013,Age,24 Months,88.0,81.3 to 93.2,198
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,88.8,84.5 to 92.3,425
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014,Age,24 Months,89.3,83.7 to 93.7,227
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,89.5,86.0 to 92.5,502
Polio,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,13 Months,90.5,84.8 to 94.3,243
Polio,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,13 Months,92.2,88.7 to 94.7,437
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019,Age,19 Months,85.5,77.6 to 91.0,205
Polio,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,92.5,85.8 to 96.2,205
Polio,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,13 Months,93.9,89.0 to 96.7,194
Polio,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,13 Months,93.2,89.4 to 95.7,399
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2012,Age,0-1 Days,72.4,62.9 to 80.2,260
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,5 Months,88.5,82.2 to 92.8,227
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,5 Months,87.3,82.8 to 90.8,502
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,5 Months,85.5,80.2 to 89.5,319
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,5 Months,85.0,80.9 to 88.4,562
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,91.5,86.2 to 94.9,194
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,90.3,86.2 to 93.3,399
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,86.9,79.9 to 91.7,243
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,89.2,85.0 to 92.3,437
PCV,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,63.7,54.3 to 72.2,260
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,84.1,79.5 to 88.8,404
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,85.1,79.8 to 90.3,222
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,64.5,56.1 to 72.2,227
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,64.7,59.2 to 69.9,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,86.4,81.2 to 90.4,319
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,86.7,82.6 to 89.9,562
PCV,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,55.8,48.6 to 62.9,279
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,56.5,50.9 to 61.8,198
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,60.5,56.3 to 64.5,425
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2012,Age,35 Months,94.7,89.0 to 98.0,260
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2011,Age,35 Months,93.3,89.4 to 96.2,279
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2019,Age,24 Months,86.3,79.1 to 92.0,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017,Age,24 Months,84.7,77.6 to 90.5,243
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,86.7,82.3 to 90.5,437
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013,Age,24 Months,88.6,81.9 to 93.6,198
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,90.5,86.4 to 93.7,425
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014,Age,24 Months,92.1,87.0 to 95.7,227
≥1 Dose MMR,,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,90.9,87.6 to 93.6,502
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015,Age,24 Months,89.6,84.9 to 93.3,275
≥1 Dose MMR,,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,88.3,85.1 to 91.2,594
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018,Age,24 Months,88.7,83.2 to 93.0,194
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,87.6,83.2 to 91.3,399
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,91.7,87.6 to 94.9,279
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,92.2,86.2 to 95.7,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,91.6,86.1 to 95.6,198
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,91.1,87.1 to 94.2,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,94.6,89.9 to 97.6,260
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,61.1,54.6 to 67.3,319
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,64.4,59.3 to 69.2,562
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,75.2,69.1 to 80.4,319
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,77.2,72.5 to 81.3,562
PCV,≥4 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,70.7,66.6 to 74.5,275
PCV,≥4 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,72.9,68.3 to 77.1,594
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,71.7,63.3 to 78.7,227
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,71.2,65.8 to 76.0,502
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,64.9,57.7 to 71.5,275
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,63.0,58.2 to 67.7,594
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,67.8,59.7 to 75.0,243
PCV,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,68.1,62.3 to 73.5,437
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2018,Age,0-1 Days,76.0,68.0 to 82.4,194
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2018-2019,Age,0-1 Days,75.7,69.7 to 80.9,399
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2011,Age,0-2 Days,70.3,59.8 to 79.1,279
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2019,Age,0-1 Days,75.5,66.2 to 82.9,205
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,92.3,88.8 to 94.8,198
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,92.0,89.0 to 94.2,425
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2012,Age,0-2 Days,78.4,73.5 to 82.6,260
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2013,Age,0-2 Days,78.8,75.5 to 81.7,198
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2013-2014,Age,0-2 Days,75.4,70.7 to 79.5,425
PCV,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,13 Months,85.4,80.3 to 89.3,279
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,72.5,63.3 to 80.2,205
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,68.5,59.8 to 76.0,194
PCV,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,70.5,64.3 to 76.0,399
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,92.0,87.1 to 95.1,260
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,91.7,85.6 to 95.3,227
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,91.1,87.4 to 93.8,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,90.5,84.5 to 94.9,227
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,90.9,87.3 to 93.8,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,91.2,86.8 to 94.6,275
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,89.0,85.8 to 91.8,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,86.8,81.9 to 90.9,319
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,87.0,83.1 to 90.4,562
PCV,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,13 Months,85.6,80.6 to 89.5,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016,Age,24 Months,87.3,82.6 to 91.2,319
≥1 Dose MMR,,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,86.9,83.0 to 90.3,562
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017,Age,24 Months,86.6,80.0 to 91.8,243
≥1 Dose MMR,,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,87.6,83.3 to 91.3,437
PCV,≥4 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,74.7,66.2 to 81.7,194
PCV,≥4 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,75.3,68.0 to 81.4,309
PCV,≥4 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,79.4,71.8 to 85.4,243
PCV,≥4 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,77.1,71.5 to 81.8,437
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2015,Age,0-2 Days,79.7,73.3 to 84.9,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2015-2016,Age,0-2 Days,77.4,73.0 to 81.3,594
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2014,Age,0-2 Days,72.0,63.4 to 79.2,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2014-2015,Age,0-2 Days,75.8,70.5 to 80.5,502
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013,Age,35 Months,90.2,83.5 to 95.0,198
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,92.6,88.5 to 95.7,425
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018,Age,24 Months,88.7,82.9 to 93.2,194
≥1 Dose MMR,,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,88.8,84.4 to 92.4,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,77.2,68.2 to 84.3,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014,Age,35 Months,95.9,91.0 to 98.5,227
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,94.0,90.5 to 96.5,502
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015,Age,35 Months,92.2,87.3 to 95.7,275
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,91.1,87.8 to 93.8,594
PCV,≥4 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,76.7,70.3 to 82.5,279
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,90.5,85.4 to 93.9,275
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,90.4,87.1 to 92.8,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,91.5,86.6 to 95.1,194
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,91.9,88.5 to 94.7,399
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,85.1,78.9 to 89.7,275
PCV,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,85.6,81.6 to 88.8,594
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,84.1,76.5 to 89.5,227
PCV,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,84.6,79.9 to 88.3,502
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,88.9,82.4 to 93.2,243
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,90.9,87.0 to 93.7,437
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,13 Months,86.8,79.4 to 91.8,198
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,85.4,78.7 to 90.3,425
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,90.2,85.6 to 93.5,319
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,89.6,85.8 to 92.4,562
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2016,Age,0-2 Days,75.2,69.0 to 80.4,319
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2016-2017,Age,0-2 Days,75.9,71.1 to 80.1,562
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,92.9,88.0 to 95.9,194
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,92.5,88.6 to 95.2,399
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2019,Age,0-2 Days,76.1,66.8 to 83.4,205
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2018,Age,0-2 Days,76.0,68.0 to 82.4,194
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2018-2019,Age,0-2 Days,76.0,70.1 to 81.1,399
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2017,Age,0-2 Days,76.7,69.0 to 82.9,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2017-2018,Age,0-2 Days,76.3,71.0 to 81.0,437
PCV,≥4 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,76.0,68.6 to 82.9,260
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,93.0,89.2 to 95.8,279
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,87.2,80.8 to 92.3,243
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,89.4,85.4 to 92.6,437
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,92.4,86.9 to 96.1,205
PCV,≥4 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,81.0,73.7 to 87.3,198
PCV,≥4 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,78.3,73.0 to 83.2,425
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,75.5,67.7 to 82.6,227
PCV,≥4 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,75.6,70.6 to 80.4,502
≥1 Dose MMR,,States/Local Areas,Oklahoma,2019,Age,24 Months,88.9,82.2 to 93.9,205
≥1 Dose MMR,,States/Local Areas,Oklahoma,2012,Age,35 Months,92.8,86.3 to 97.0,260
≥1 Dose MMR,,States/Local Areas,Oklahoma,2011,Age,35 Months,95.2,91.6 to 97.6,279
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013,Age,35 Months,90.3,83.7 to 95.0,198
≥1 Dose MMR,,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,93.4,89.5 to 96.2,425
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016,Age,35 Months,90.3,85.5 to 94.0,319
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,89.5,85.3 to 92.9,562
Hib,≥1 Dose,States/Local Areas,Oklahoma,2011,Age,3 Months,80.9,75.4 to 85.3,279
Hib,≥1 Dose,States/Local Areas,Oklahoma,2012,Age,3 Months,85.3,74.0 to 92.2,260
Hib,≥1 Dose,States/Local Areas,Oklahoma,2013,Age,3 Months,79.2,75.2 to 82.8,198
Hib,≥1 Dose,States/Local Areas,Oklahoma,2013-2014,Age,3 Months,79.9,77.4 to 82.3,425
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,13 Months,91.3,86.9 to 94.4,319
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,13 Months,91.4,88.0 to 93.9,562
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,13 Months,92.8,88.3 to 95.7,275
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,13 Months,92.1,89.1 to 94.3,594
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,13 Months,94.4,88.9 to 97.3,227
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,93.6,90.4 to 95.8,502
Hib,≥1 Dose,States/Local Areas,Oklahoma,2014,Age,3 Months,80.7,72.7 to 86.8,227
Hib,≥1 Dose,States/Local Areas,Oklahoma,2014-2015,Age,3 Months,83.2,78.4 to 87.1,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,90.3,83.9 to 94.8,243
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,92.1,88.4 to 95.0,437
PCV,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,19 Months,89.5,83.7 to 93.4,260
PCV,≥4 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,80.3,72.8 to 86.9,260
PCV,≥4 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,78.9,72.6 to 84.6,279
PCV,≥4 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,75.4,67.4 to 82.8,194
PCV,≥4 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,77.4,71.7 to 82.7,399
PCV,≥4 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,79.5,71.1 to 86.7,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,87.8,82.9 to 91.9,319
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,89.0,85.2 to 92.2,562
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,90.4,87.3 to 93.0,594
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,88.3,81.6 to 92.7,198
PCV,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,88.5,83.4 to 92.2,425
PCV,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,19 Months,88.2,83.6 to 91.7,279
PCV,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,13 Months,85.9,77.3 to 91.6,205
Hib,≥3 Doses,States/Local Areas,Ohio,2020,Age,13 Months,78.7,72.9 to 83.5,484
Hib,Primary Series,States/Local Areas,Ohio,2020,Age,13 Months,84.1,79.0 to 88.1,484
Hep B,≥2 Doses,States/Local Areas,Ohio,2020,Age,13 Months,92.7,88.8 to 95.3,484
Hep B,≥3 Doses,States/Local Areas,Ohio,2020,Age,13 Months,87.5,82.8 to 91.0,484
PCV,≥3 Doses,States/Local Areas,Ohio,2020,Age,13 Months,87.5,82.6 to 91.2,484
≥1 Dose Varicella,,States/Local Areas,Ohio,2020,Age,13 Months,59.5,53.5 to 65.1,484
DTaP,≥3 Doses,States/Local Areas,Ohio,2020,Age,7 Months,71.1,65.2 to 76.4,484
DTaP,≥3 Doses,States/Local Areas,Ohio,2020,Age,19 Months,92.7,88.8 to 95.3,484
DTaP,≥4 Doses,States/Local Areas,Ohio,2020,Age,19 Months,75.0,69.3 to 79.9,484
Polio,≥3 Doses,States/Local Areas,Ohio,2020,Age,19 Months,92.2,88.3 to 94.9,484
≥1 Dose MMR,,States/Local Areas,Ohio,2020,Age,19 Months,87.5,82.9 to 91.0,484
Combined 7 Series,,States/Local Areas,Ohio,2020,Age,24 Months,68.8,63.1 to 74.4,484
Hib,≥3 Doses,States/Local Areas,Ohio,2020,Age,19 Months,91.5,87.4 to 94.3,484
Influenza,,States/Local Areas,Ohio,2020,Age,24 Months,61.3,55.4 to 67.3,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2020,Age,0-3 Days,84.1,79.0 to 88.1,484
Rotavirus,,States/Local Areas,Ohio,2020,Age,8 Months,74.6,68.8 to 79.6,484
≥1 Dose Varicella,,States/Local Areas,Ohio,2020,Age,24 Months,87.6,83.0 to 91.4,484
DTaP,≥3 Doses,States/Local Areas,Ohio,2020,Age,35 Months,93.2,89.5 to 95.9,484
PCV,≥3 Doses,States/Local Areas,Ohio,2020,Age,24 Months,92.1,88.3 to 95.0,484
PCV,≥4 Doses,States/Local Areas,Ohio,2020,Age,24 Months,81.3,76.1 to 86.0,484
Hep A,≥2 Doses,States/Local Areas,Ohio,2020,Age,24 Months,48.0,42.2 to 54.1,484
Hep A,≥1 Dose,States/Local Areas,Ohio,2020,Age,24 Months,87.1,82.9 to 90.8,484
PCV,≥1 Dose,States/Local Areas,Ohio,2020,Age,3 Months,82.2,76.7 to 86.6,484
Hep B,≥1 Dose,States/Local Areas,Ohio,2020,Age,3 Months,94.8,91.2 to 96.9,484
Polio,≥2 Doses,States/Local Areas,Ohio,2020,Age,5 Months,78.5,72.9 to 83.2,484
DTaP,≥2 Doses,States/Local Areas,Ohio,2020,Age,5 Months,78.6,73.0 to 83.3,484
Hib,≥2 Doses,States/Local Areas,Ohio,2020,Age,5 Months,74.3,68.5 to 79.3,484
Hep B,≥2 Doses,States/Local Areas,Ohio,2020,Age,5 Months,89.0,84.4 to 92.3,484
DTaP,≥1 Dose,States/Local Areas,Ohio,2020,Age,3 Months,84.3,79.0 to 88.5,484
Hep A,≥2 Doses,States/Local Areas,Ohio,2020,Age,35 Months,81.5,75.1 to 87.0,484
≥1 Dose MMR,,States/Local Areas,Ohio,2020,Age,13 Months,68.7,63.0 to 74.0,484
Combined 7 Series,,States/Local Areas,Ohio,2020,Age,35 Months,72.7,66.6 to 78.6,484
Hep A,≥2 Doses,States/Local Areas,Ohio,2020,Age,19 Months,31.4,26.3 to 36.8,484
Hep A,≥1 Dose,States/Local Areas,Ohio,2020,Age,19 Months,84.3,79.5 to 88.1,484
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2020,Age,0-2 Days,82.7,77.6 to 86.9,484
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2020,Age,0-1 Days,78.6,73.1 to 83.2,484
Hib,≥2 Doses,States/Local Areas,Ohio,2020,Age,7 Months,87.2,82.2 to 91.0,484
Polio,≥2 Doses,States/Local Areas,Ohio,2020,Age,7 Months,88.5,83.7 to 92.1,484
Hib,≥3 Doses,States/Local Areas,Ohio,2020,Age,7 Months,60.9,54.7 to 66.6,484
Hib,Primary Series,States/Local Areas,Ohio,2020,Age,7 Months,69.2,63.2 to 74.6,484
Hep B,≥2 Doses,States/Local Areas,Ohio,2020,Age,7 Months,90.7,86.3 to 93.7,484
DTaP,≥3 Doses,States/Local Areas,Ohio,2020,Age,24 Months,92.7,89.1 to 95.5,484
PCV,≥2 Doses,States/Local Areas,Ohio,2020,Age,5 Months,76.8,71.1 to 81.7,484
DTaP,≥4 Doses,States/Local Areas,Ohio,2020,Age,24 Months,83.1,78.1 to 87.6,484
Polio,≥3 Doses,States/Local Areas,Ohio,2020,Age,24 Months,92.4,88.7 to 95.2,484
≥1 Dose MMR,,States/Local Areas,Ohio,2020,Age,24 Months,89.0,84.9 to 92.4,484
Hib,≥3 Doses,States/Local Areas,Ohio,2020,Age,24 Months,91.7,87.9 to 94.7,484
≥1 Dose MMR,,States/Local Areas,Ohio,2020,Age,35 Months,91.4,87.2 to 94.7,484
Hib,Primary Series,States/Local Areas,Ohio,2020,Age,35 Months,92.9,89.2 to 95.6,484
Hib,≥3 Doses,States/Local Areas,Ohio,2020,Age,35 Months,91.7,87.9 to 94.7,484
Hep B,≥3 Doses,States/Local Areas,Ohio,2020,Age,35 Months,90.3,86.1 to 93.6,484
Hib,Full Series,States/Local Areas,Ohio,2020,Age,35 Months,77.9,72.4 to 82.9,484
≥1 Dose Varicella,,States/Local Areas,Ohio,2020,Age,35 Months,91.2,85.9 to 95.1,484
Hib,Primary Series,States/Local Areas,Ohio,2020,Age,19 Months,92.6,88.7 to 95.2,484
Hep B,≥3 Doses,States/Local Areas,Ohio,2020,Age,19 Months,89.5,85.0 to 92.7,484
Hib,Full Series,States/Local Areas,Ohio,2020,Age,19 Months,73.2,67.5 to 78.2,484
PCV,≥3 Doses,States/Local Areas,Ohio,2020,Age,19 Months,92.0,87.9 to 94.8,484
≥1 Dose Varicella,,States/Local Areas,Ohio,2020,Age,19 Months,86.1,81.1 to 89.9,484
DTaP,≥4 Doses,States/Local Areas,Ohio,2020,Age,35 Months,85.6,80.3 to 90.1,484
Polio,≥3 Doses,States/Local Areas,Ohio,2020,Age,35 Months,92.6,88.9 to 95.4,484
PCV,≥4 Doses,States/Local Areas,Ohio,2020,Age,19 Months,78.5,72.9 to 83.2,484
PCV,≥3 Doses,States/Local Areas,Ohio,2020,Age,35 Months,93.2,89.5 to 95.9,484
Hep A,≥1 Dose,States/Local Areas,Ohio,2014,Age,24 Months,80.4,73.6 to 86.4,232
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,24 Months,76.8,71.9 to 81.5,524
Hib,≥1 Dose,States/Local Areas,Ohio,2021,Age,3 Months,84.0,76.9 to 89.3,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.4,76.4 to 84.4,891
DTaP,≥1 Dose,States/Local Areas,Ohio,2012,Age,3 Months,90.5,86.1 to 93.6,239
DTaP,≥1 Dose,States/Local Areas,Ohio,2011,Age,3 Months,86.9,85.2 to 88.4,229
PCV,≥2 Doses,States/Local Areas,Ohio,2021,Age,5 Months,78.6,70.5 to 84.9,275
Hep B,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,93.4,90.7 to 95.4,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,91.3,87.8 to 93.8,759
Hib,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,91.4,88.2 to 94.0,759
Hib,≥2 Doses,States/Local Areas,Ohio,2021,Age,7 Months,85.9,78.7 to 90.9,275
≥1 Dose MMR,,States/Local Areas,Ohio,2021,Age,35 Months,91.5,85.7 to 95.5,275
Hep B,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,87.6,83.8 to 90.5,759
Polio,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,94.5,91.7 to 96.6,868
DTaP,≥4 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,89.3,84.4 to 93.2,868
DTaP,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,94.6,91.8 to 96.7,868
Combined 7 Series,,States/Local Areas,Ohio,2019-2020,Age,24 Months,68.0,63.3 to 72.5,868
DTaP,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,92.9,90.0 to 95.0,868
PCV,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,87.4,83.4 to 90.5,868
≥1 Dose Varicella,,States/Local Areas,Ohio,2019-2020,Age,13 Months,57.0,52.3 to 61.5,868
Hib,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,88.1,84.4 to 91.0,868
Hep B,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,86.6,82.7 to 89.7,868
Polio,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,89.0,85.4 to 91.8,868
DTaP,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,67.9,63.2 to 72.3,868
PCV,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,5 Months,76.7,72.2 to 80.7,868
Hep B,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,5 Months,89.1,85.7 to 91.7,868
Hep B,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,93.2,90.3 to 95.2,868
Hib,Primary Series,States/Local Areas,Ohio,2019-2020,Age,13 Months,84.5,80.6 to 87.8,868
Hib,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,92.7,89.8 to 94.9,868
Hib,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,79.2,74.8 to 83.0,868
≥1 Dose MMR,,States/Local Areas,Ohio,2019-2020,Age,13 Months,64.2,59.6 to 68.7,868
Polio,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,92.8,89.8 to 95.0,868
Hib,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,5 Months,73.4,68.8 to 77.5,868
Polio,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,5 Months,77.5,73.0 to 81.5,868
DTaP,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,5 Months,78.1,73.6 to 82.0,868
PCV,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,3 Months,85.6,81.7 to 88.7,868
Hep B,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,3 Months,94.6,91.9 to 96.5,868
≥1 Dose MMR,,States/Local Areas,Ohio,2019-2020,Age,24 Months,90.5,87.5 to 93.0,868
Polio,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,92.6,89.8 to 94.9,868
DTaP,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,93.3,90.6 to 95.4,868
DTaP,≥4 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,83.7,79.7 to 87.4,868
PCV,≥4 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,83.3,78.9 to 87.2,868
PCV,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,93.6,90.9 to 95.7,868
≥1 Dose Varicella,,States/Local Areas,Ohio,2019-2020,Age,35 Months,93.7,90.3 to 96.2,868
Hep B,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,91.9,88.6 to 94.5,868
Hib,Primary Series,States/Local Areas,Ohio,2019-2020,Age,35 Months,93.0,90.2 to 95.2,868
Hib,Full Series,States/Local Areas,Ohio,2019-2020,Age,35 Months,79.7,75.3 to 83.7,868
Hib,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,92.5,89.7 to 94.8,868
≥1 Dose MMR,,States/Local Areas,Ohio,2019-2020,Age,35 Months,93.8,91.1 to 95.9,868
Hib,Primary Series,States/Local Areas,Ohio,2019-2020,Age,19 Months,92.2,89.3 to 94.4,868
Hib,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,91.0,87.8 to 93.5,868
Hep A,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,30.3,26.4 to 34.5,868
≥1 Dose MMR,,States/Local Areas,Ohio,2019-2020,Age,19 Months,87.7,84.2 to 90.5,868
PCV,≥4 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,81.2,76.9 to 85.1,868
PCV,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,93.0,90.2 to 95.2,868
PCV,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,65.4,60.7 to 69.9,868
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2019-2020,Age,0-3 Days,82.7,78.9 to 86.0,868
Hib,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,58.3,53.5 to 62.9,868
Hib,Full Series,States/Local Areas,Ohio,2019-2020,Age,24 Months,77.8,73.5 to 81.8,868
Hep B,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,90.1,87.0 to 92.8,868
≥1 Dose Varicella,,States/Local Areas,Ohio,2019-2020,Age,24 Months,90.3,87.1 to 93.0,868
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2019-2020,Age,0-2 Days,81.8,77.9 to 85.2,868
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2019-2020,Age,0-1 Days,78.0,73.9 to 81.6,868
Hep A,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,19 Months,84.2,80.3 to 87.4,868
PCV,≥4 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,78.3,73.8 to 82.3,868
Hep B,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,89.5,86.2 to 92.1,868
≥1 Dose Varicella,,States/Local Areas,Ohio,2019-2020,Age,19 Months,86.8,83.1 to 89.8,868
Hib,Full Series,States/Local Areas,Ohio,2019-2020,Age,19 Months,73.4,68.9 to 77.5,868
Combined 7 Series,,States/Local Areas,Ohio,2019-2020,Age,35 Months,72.3,67.4 to 76.9,868
Hib,Primary Series,States/Local Areas,Ohio,2019-2020,Age,24 Months,92.8,90.1 to 95.0,868
Hib,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,92.5,89.7 to 94.8,868
Influenza,,States/Local Areas,Ohio,2019-2020,Age,24 Months,63.9,59.2 to 68.5,868
Hep A,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,35 Months,91.0,87.8 to 93.7,868
Hep A,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,35 Months,84.0,78.8 to 88.6,868
Hep A,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,24 Months,87.4,83.9 to 90.5,868
Polio,≥2 Doses,States/Local Areas,Ohio,2020,Age,13 Months,92.6,88.6 to 95.3,484
Hep A,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,24 Months,48.3,43.6 to 53.3,868
DTaP,≥3 Doses,States/Local Areas,Ohio,2011,Age,35 Months,94.8,89.1 to 98.1,229
DTaP,≥3 Doses,States/Local Areas,Ohio,2014,Age,35 Months,92.0,87.6 to 95.3,232
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,90.9,87.7 to 93.5,524
Hep A,≥2 Doses,States/Local Areas,Ohio,2011,Age,19 Months,19.3,16.2 to 22.9,229
DTaP,≥2 Doses,States/Local Areas,Ohio,2019,Age,5 Months,78.3,71.3 to 84.1,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2013,Age,19 Months,27.0,23.4 to 31.0,207
Hep A,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,23.4,18.4 to 29.3,439
Hep A,≥2 Doses,States/Local Areas,Ohio,2014,Age,19 Months,19.7,14.2 to 26.7,232
Hep A,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,21.8,17.7 to 26.4,524
Hep A,≥2 Doses,States/Local Areas,Ohio,2012,Age,19 Months,27.8,23.3 to 32.8,239
Hib,≥3 Doses,States/Local Areas,Ohio,2018,Age,24 Months,91.3,87.2 to 94.6,406
Hib,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,92.6,89.8 to 94.9,790
Hib,≥3 Doses,States/Local Areas,Ohio,2019,Age,24 Months,93.9,89.8 to 96.8,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2015,Age,19 Months,23.8,21.7 to 26.1,292
Hep A,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,21.6,17.8 to 26.0,575
Hep A,≥2 Doses,States/Local Areas,Ohio,2016,Age,19 Months,19.4,14.5 to 25.6,283
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,19 Months,23.6,19.5 to 28.3,566
Hib,≥3 Doses,States/Local Areas,Ohio,2013,Age,35 Months,94.0,89.5 to 97.1,207
Hib,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,92.2,88.9 to 94.7,439
Hib,≥3 Doses,States/Local Areas,Ohio,2014,Age,35 Months,90.1,85.3 to 93.9,232
Hib,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,35 Months,89.6,86.2 to 92.4,524
Hib,≥3 Doses,States/Local Areas,Ohio,2015,Age,35 Months,89.1,84.2 to 92.9,292
Hib,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,91.0,87.7 to 93.8,575
Hep A,≥2 Doses,States/Local Areas,Ohio,2017,Age,19 Months,27.8,21.6 to 35.1,283
Hep A,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,19 Months,27.1,23.0 to 31.7,689
Hib,≥3 Doses,States/Local Areas,Ohio,2018,Age,35 Months,92.4,88.3 to 95.5,406
Hib,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,93.2,90.4 to 95.4,790
Hep A,≥2 Doses,States/Local Areas,Ohio,2012,Age,24 Months,42.9,34.4 to 52.6,239
DTaP,≥4 Doses,States/Local Areas,Ohio,2013,Age,19 Months,64.4,56.8 to 71.2,207
DTaP,≥4 Doses,States/Local Areas,Ohio,2013-2014,Age,19 Months,67.0,61.1 to 72.5,439
DTaP,≥4 Doses,States/Local Areas,Ohio,2014,Age,19 Months,69.7,61.7 to 76.6,232
DTaP,≥4 Doses,States/Local Areas,Ohio,2014-2015,Age,19 Months,67.4,62.0 to 72.3,524
DTaP,≥4 Doses,States/Local Areas,Ohio,2015,Age,19 Months,65.1,62.4 to 67.6,292
DTaP,≥4 Doses,States/Local Areas,Ohio,2015-2016,Age,19 Months,68.3,63.0 to 73.2,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,87.2,83.1 to 91.2,386
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,91.6,87.4 to 95.8,554
Hib,≥3 Doses,States/Local Areas,Ohio,2016,Age,35 Months,93.2,88.1 to 96.6,283
Hib,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,90.1,85.6 to 93.7,566
Hib,≥3 Doses,States/Local Areas,Ohio,2017,Age,35 Months,88.0,79.5 to 94.1,283
Hib,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,90.2,85.7 to 93.7,689
Hep A,≥2 Doses,States/Local Areas,Ohio,2018,Age,19 Months,26.4,21.3 to 32.1,406
Hep A,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,19 Months,27.7,23.2 to 32.8,644
Hep A,≥2 Doses,States/Local Areas,Ohio,2019,Age,19 Months,29.6,23.8 to 36.1,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2011,Age,24 Months,36.7,29.1 to 45.7,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2015,Age,24 Months,73.3,66.2 to 79.9,292
Hep A,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,24 Months,78.3,73.4 to 82.8,575
Hep A,≥1 Dose,States/Local Areas,Ohio,2016,Age,24 Months,83.3,76.5 to 89.0,283
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,24 Months,81.8,76.7 to 86.4,566
PCV,≥2 Doses,States/Local Areas,Ohio,2014,Age,5 Months,75.0,67.0 to 81.6,232
PCV,≥2 Doses,States/Local Areas,Ohio,2014-2015,Age,5 Months,71.8,65.1 to 77.6,524
PCV,≥2 Doses,States/Local Areas,Ohio,2015,Age,5 Months,68.6,61.4 to 74.9,292
PCV,≥2 Doses,States/Local Areas,Ohio,2015-2016,Age,5 Months,71.7,66.5 to 76.3,575
PCV,≥2 Doses,States/Local Areas,Ohio,2016,Age,5 Months,74.8,67.1 to 81.2,283
PCV,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,5 Months,74.3,68.9 to 79.1,566
DTaP,≥3 Doses,States/Local Areas,Ohio,2018,Age,35 Months,95.3,91.6 to 97.7,406
DTaP,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,35 Months,95.7,93.0 to 97.6,790
DTaP,≥3 Doses,States/Local Areas,Ohio,2019,Age,35 Months,96.6,92.0 to 98.9,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2018,Age,24 Months,86.5,80.6 to 91.4,406
Hep A,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,24 Months,87.0,83.0 to 90.5,790
Hep A,≥1 Dose,States/Local Areas,Ohio,2019,Age,24 Months,87.4,81.6 to 92.0,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2011,Age,35 Months,80.8,72.2 to 88.1,229
Hib,≥3 Doses,States/Local Areas,Ohio,2015,Age,24 Months,86.5,81.5 to 90.7,292
Hib,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,89.6,86.2 to 92.5,575
Hib,≥3 Doses,States/Local Areas,Ohio,2016,Age,24 Months,92.7,87.7 to 96.2,283
Hib,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,88.9,84.4 to 92.5,566
DTaP,≥3 Doses,States/Local Areas,Ohio,2019,Age,24 Months,94.4,90.5 to 97.1,384
Hib,≥3 Doses,States/Local Areas,Ohio,2017,Age,24 Months,84.9,77.5 to 91.0,283
Hib,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,88.2,84.0 to 91.7,689
DTaP,≥2 Doses,States/Local Areas,Ohio,2017,Age,5 Months,74.7,66.6 to 81.5,283
DTaP,≥2 Doses,States/Local Areas,Ohio,2017-2018,Age,5 Months,74.4,69.1 to 79.0,689
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,87.6,81.8 to 93.4,159
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.3,81.0 to 91.6,423
DTaP,≥2 Doses,States/Local Areas,Ohio,2016,Age,5 Months,75.1,67.4 to 81.5,283
DTaP,≥2 Doses,States/Local Areas,Ohio,2016-2017,Age,5 Months,74.9,69.4 to 79.7,566
DTaP,≥2 Doses,States/Local Areas,Ohio,2018,Age,5 Months,74.0,66.9 to 80.0,406
DTaP,≥2 Doses,States/Local Areas,Ohio,2018-2019,Age,5 Months,76.2,71.3 to 80.4,790
DTaP,≥3 Doses,States/Local Areas,Ohio,2017,Age,24 Months,86.7,79.5 to 92.4,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,24 Months,90.3,86.3 to 93.6,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2018,Age,24 Months,94.0,90.2 to 96.6,406
DTaP,≥3 Doses,States/Local Areas,Ohio,2018-2019,Age,24 Months,94.2,91.7 to 96.2,790
Hep A,≥1 Dose,States/Local Areas,Ohio,2017,Age,24 Months,80.4,72.7 to 87.1,283
Hep A,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,24 Months,83.5,78.7 to 87.8,689
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,90.3,83.1 to 97.4,283
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,90.7,86.5 to 95.0,353
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,83.6,78.9 to 88.4,337
Polio,≥3 Doses,States/Local Areas,Ohio,2014-2017,Overall,Overall,87.6,84.6 to 90.5,973
Hep A,≥1 Dose,States/Local Areas,Ohio,2012,Age,19 Months,78.6,73.8 to 82.6,239
DTaP,≥3 Doses,States/Local Areas,Ohio,2016,Age,24 Months,93.2,88.2 to 96.7,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,24 Months,90.0,85.7 to 93.5,566
DTaP,≥1 Dose,States/Local Areas,Ohio,2019,Age,3 Months,90.9,85.6 to 94.4,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2011,Age,19 Months,67.6,65.3 to 69.8,229
DTaP,≥1 Dose,States/Local Areas,Ohio,2017,Age,3 Months,80.7,72.7 to 86.8,283
DTaP,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,3 Months,83.9,79.0 to 87.9,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2014,Age,24 Months,90.4,85.8 to 94.1,232
DTaP,≥3 Doses,States/Local Areas,Ohio,2014-2015,Age,24 Months,89.0,85.7 to 91.8,524
DTaP,≥3 Doses,States/Local Areas,Ohio,2015,Age,24 Months,87.5,82.6 to 91.6,292
DTaP,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,24 Months,90.4,87.0 to 93.2,575
DTaP,≥1 Dose,States/Local Areas,Ohio,2018,Age,3 Months,87.1,81.0 to 91.5,406
DTaP,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,3 Months,89.0,85.1 to 92.0,790
Hib,Full Series,States/Local Areas,Ohio,2021,Age,19 Months,71.8,63.8 to 78.7,275
Hep A,≥1 Dose,States/Local Areas,Ohio,2013,Age,19 Months,74.3,71.2 to 77.2,207
Hep A,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,19 Months,73.9,71.2 to 76.5,439
Hep A,≥1 Dose,States/Local Areas,Ohio,2014,Age,19 Months,73.6,65.7 to 80.2,232
Hep A,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,19 Months,70.7,65.3 to 75.6,524
Hep A,≥1 Dose,States/Local Areas,Ohio,2015,Age,19 Months,67.8,62.0 to 73.1,292
Hep A,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,19 Months,74.0,68.7 to 78.6,575
DTaP,≥4 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,86.8,81.9 to 90.9,759
PCV,≥4 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,82.1,77.8 to 86.0,759
Hep B,≥3 Doses,States/Local Areas,Ohio,2021,Age,19 Months,92.3,87.6 to 95.3,275
Hib,≥2 Doses,States/Local Areas,Ohio,2021,Age,5 Months,75.9,67.8 to 82.4,275
DTaP,≥1 Dose,States/Local Areas,Ohio,2013,Age,3 Months,82.8,76.2 to 87.9,207
DTaP,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,3 Months,82.9,79.6 to 85.8,439
DTaP,≥1 Dose,States/Local Areas,Ohio,2014,Age,3 Months,83.0,76.3 to 88.2,232
DTaP,≥1 Dose,States/Local Areas,Ohio,2014-2015,Age,3 Months,84.4,80.0 to 87.9,524
DTaP,≥1 Dose,States/Local Areas,Ohio,2015,Age,3 Months,85.7,79.5 to 90.3,292
DTaP,≥1 Dose,States/Local Areas,Ohio,2015-2016,Age,3 Months,87.9,83.9 to 91.0,575
DTaP,≥1 Dose,States/Local Areas,Ohio,2016,Age,3 Months,90.2,84.6 to 93.9,283
DTaP,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,3 Months,85.5,80.7 to 89.2,566
Combined 7 Series,,States/Local Areas,Ohio,2021,Age,35 Months,75.3,66.9 to 82.9,275
Hib,Primary Series,States/Local Areas,Ohio,2021,Age,7 Months,69.2,61.0 to 76.4,275
Polio,≥2 Doses,States/Local Areas,Ohio,2021,Age,7 Months,86.1,79.0 to 91.0,275
PCV,≥3 Doses,States/Local Areas,Ohio,2020,Age,7 Months,67.7,61.7 to 73.2,484
Rotavirus,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,74.2,65.8 to 82.5,187
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,87.1,80.2 to 94.1,187
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,70.7 to 85.3,455
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,92.7,88.5 to 96.9,187
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,79.3,73.9 to 84.7,455
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.4,84.7 to 94.1,568
Rotavirus,,States/Local Areas,Ohio,2019-2020,Age,8 Months,75.7,71.2 to 79.6,868
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.9,82.9 to 92.9,568
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,89.0,83.4 to 94.6,187
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.1,85.5 to 94.7,568
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,88.1 to 95.4,455
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,73.3,64.5 to 82.1,187
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.9,78.6 to 89.2,568
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.8,64.8 to 76.8,568
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,63.2,53.2 to 73.2,187
Influenza,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,62.2,56.0 to 68.4,455
Influenza,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,64.3,58.2 to 70.3,568
Rotavirus,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,70.4,64.3 to 76.5,455
Rotavirus,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.1,70.4 to 81.8,568
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,79.8,71.5 to 88.1,187
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.8,79.8 to 89.9,568
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,86.4,81.7 to 91.1,455
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.8,82.8 to 92.9,568
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,89.6,85.5 to 93.8,455
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,76.4,67.8 to 85.0,187
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.3,71.6 to 83.0,568
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,68.0,56.0 to 80.0,187
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.1,55.2 to 77.0,138
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,95.0,90.8 to 99.2,90
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,78.8,73.5 to 84.1,455
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.4,79.1 to 91.7,568
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.5,85.9 to 95.1,568
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,89.4 to 96.5,455
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,75.2,66.0 to 84.4,187
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.1,74.5 to 85.8,568
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,79.9,74.6 to 85.1,455
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,93.2,90.0 to 96.5,455
Influenza,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,46.2,35.9 to 56.6,187
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.0,85.4 to 94.6,568
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,88.1 to 95.6,455
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,91.5,86.8 to 96.2,187
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,70.7,64.9 to 76.5,455
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,70.9,65.7 to 76.1,455
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,86.1,79.0 to 93.3,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.0,79.2 to 88.8,568
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,91.4,87.7 to 95.1,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,69.3,58.9 to 79.7,187
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,95.4,89.7 to 100.0,420
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Overall,Overall,77.8,74.3 to 81.4,1210
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,90.1,86.3 to 93.9,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,79.4,73.0 to 85.7,323
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,95.1,89.4 to 100.0,420
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,60.4,53.4 to 67.4,323
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,91.8,88.2 to 95.5,467
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,84.5,78.1 to 90.9,420
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,68.4,62.3 to 74.6,467
Rotavirus,,States/Local Areas,Ohio,2016-2019,Overall,Overall,73.5,69.8 to 77.3,1210
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,96.2,90.5 to 100.0,420
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Overall,Overall,88.4,85.5 to 91.4,1210
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Overall,Overall,69.4,65.5 to 73.2,1210
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,79.1,74.5 to 83.7,1210
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,91.0,86.8 to 95.2,323
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Overall,Overall,84.7,81.5 to 87.9,1210
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Overall,Overall,80.2,76.7 to 83.7,1210
Influenza,,States/Local Areas,Ohio,2016-2019,Overall,Overall,60.3,56.3 to 64.2,1210
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,87.5,82.9 to 92.2,323
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,89.9,85.9 to 93.8,467
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,78.7,71.7 to 85.8,467
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,89.3,82.3 to 96.2,420
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,79.7,73.9 to 85.6,323
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,80.2,76.7 to 83.7,1210
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,85.1,80.5 to 89.8,467
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Overall,Overall,88.5,85.6 to 91.5,1210
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,71.8,65.3 to 78.4,323
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,90.5,87.8 to 93.1,1210
Rotavirus,,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,87.5,81.0 to 93.9,420
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,91.0,88.4 to 93.6,1210
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,79.2,75.7 to 82.8,1210
Influenza,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,63.8,47.6 to 80.1,90
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,85.7,80.9 to 90.4,412
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,91.4,87.5 to 95.3,757
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,82.5 to 97.9,138
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.6,65.4 to 85.9,138
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,77.9,65.4 to 90.3,90
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.7,52.7 to 78.7,91
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,78.9 to 97.0,138
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,78.5,71.2 to 85.9,412
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,81.7,76.2 to 87.2,757
Polio,≥1 Dose,States/Local Areas,Ohio,2020,Age,3 Months,84.0,78.7 to 88.2,484
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,87.6,77.3 to 97.9,90
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.2,81.2 to 97.2,91
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,85.8,81.1 to 90.6,412
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,90.0 to 95.8,891
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.9,79.0 to 86.8,891
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,90.2,86.3 to 94.0,412
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,92.1,88.4 to 95.9,757
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,71.6,65.7 to 77.4,412
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.2,82.6 to 89.8,891
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,74.9,60.5 to 89.2,90
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.3,70.1 to 90.4,91
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,92.3,88.8 to 95.7,412
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,73.4,67.5 to 79.3,412
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,91.2,87.4 to 95.0,757
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.8,80.6 to 97.0,91
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,88.1 to 94.3,891
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,86.1,75.5 to 96.6,90
Influenza,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.0,52.0 to 73.9,138
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,89.0,85.1 to 93.0,412
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.8,88.8 to 94.8,891
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.0,79.5 to 96.6,91
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,85.0 to 99.0,138
Influenza,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",44.5,31.9 to 57.0,91
Influenza,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",62.5,57.9 to 67.1,891
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,77.7,65.1 to 90.2,90
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.5,60.7 to 84.2,91
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.8,78.8 to 86.7,891
Rotavirus,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,74.7,62.1 to 87.2,90
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.4,68.0 to 76.8,891
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",58.1,45.2 to 71.0,91
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,68.8,54.7 to 82.9,90
Rotavirus,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,68.8,63.0 to 74.7,412
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.8,50.6 to 75.1,91
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.9,74.8 to 91.0,138
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.5,77.5 to 85.4,891
Influenza,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,49.2,42.8 to 55.6,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,76.6,58.3 to 94.8,90
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,88.0,77.7 to 98.2,90
Influenza,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,71.7,66.6 to 76.8,757
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,65.6 to 86.5,138
Rotavirus,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.8,69.3 to 88.4,138
Rotavirus,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,80.2,75.3 to 85.1,757
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,92.8,89.1 to 96.5,757
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.7,76.5 to 94.9,138
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,91.3,87.5 to 95.2,757
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,83.4,71.5 to 95.3,90
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.1,73.8 to 94.3,91
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,80.6,75.0 to 86.1,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,80.6,75.9 to 85.2,757
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.0,68.7 to 89.3,91
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,77.2,72.5 to 82.0,757
Rotavirus,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",55.5,42.7 to 68.3,91
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.0,86.8 to 93.3,891
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.9,72.1 to 93.8,91
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.2,85.2 to 99.2,138
Rotavirus,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.0,71.7 to 80.4,891
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.6,87.3 to 93.8,891
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,82.4 to 97.6,138
Hep B,≥2 Doses,States/Local Areas,Ohio,2021,Age,7 Months,90.1,83.9 to 94.1,275
Hib,≥3 Doses,States/Local Areas,Ohio,2021,Age,7 Months,61.9,53.6 to 69.6,275
DTaP,≥3 Doses,States/Local Areas,Ohio,2021,Age,7 Months,69.0,60.5 to 76.3,275
PCV,≥3 Doses,States/Local Areas,Ohio,2021,Age,35 Months,89.4,83.4 to 94.0,275
Hib,≥3 Doses,States/Local Areas,Ohio,2021,Age,19 Months,88.2,81.6 to 92.7,275
Polio,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,3 Months,86.6,82.9 to 89.7,868
Hib,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,3 Months,82.1,78.1 to 85.5,868
DTaP,≥1 Dose,States/Local Areas,Ohio,2019-2020,Age,3 Months,87.2,83.6 to 90.2,868
Hib,Primary Series,States/Local Areas,Ohio,2019-2020,Age,7 Months,65.5,60.8 to 69.9,868
DTaP,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,13 Months,88.6,84.8 to 91.5,868
Polio,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,92.0,89.0 to 94.2,868
DTaP,≥4 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,74.0,69.5 to 78.1,868
Hib,Primary Series,States/Local Areas,Ohio,2020-2021,Age,24 Months,92.3,89.4 to 94.7,759
Hib,Primary Series,States/Local Areas,Ohio,2021,Age,19 Months,90.8,85.0 to 94.5,275
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,84.9,80.5 to 89.4,757
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.1,78.4 to 95.8,91
Combined 7 Series,,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,62.5,56.2 to 68.7,412
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,91.4,87.8 to 95.0,412
Influenza,,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,84.4,78.1 to 90.6,420
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,71.1,64.6 to 77.6,323
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,91.4,84.9 to 97.9,420
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,69.9,63.3 to 76.6,323
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,77.4,72.0 to 82.9,467
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,90.4,84.4 to 96.4,420
Polio,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,87.6,82.9 to 92.3,323
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,84.3,78.9 to 89.8,323
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,91.2,85.2 to 97.3,420
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,84.4,79.0 to 89.9,323
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,88.2,83.9 to 92.6,467
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,94.8,89.1 to 100.0,420
Influenza,,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,46.2,39.2 to 53.2,323
Influenza,,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,58.9,52.6 to 65.2,467
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,91.7,89.3 to 94.2,1210
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Overall,Overall,91.9,89.3 to 94.4,1210
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,88.1,83.7 to 92.5,467
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,89.0,84.6 to 93.5,323
≥1 Dose MMR,,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,95.5,89.8 to 100.0,420
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,74.1,65.7 to 82.6,323
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,78.3,73.1 to 83.6,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,84.3,77.6 to 90.9,420
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,80.8,75.5 to 86.0,467
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,93.6,87.8 to 99.3,420
≥1 Dose Varicella,,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a MSA Principal City,89.8,85.7 to 93.9,455
Rotavirus,,States/Local Areas,Ohio,2016-2019,Poverty,<133% FPL,62.3,55.5 to 69.1,323
Rotavirus,,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,75.7,69.8 to 81.6,467
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Urbanicity,Living In a Non-MSA,93.7,89.6 to 97.7,187
Hib,≥1 Dose,States/Local Areas,Ohio,2020,Age,3 Months,78.9,73.4 to 83.6,484
Hep B,≥3 Doses,States/Local Areas,Ohio,2020,Age,7 Months,59.9,54.1 to 65.5,484
Hep A,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,35 Months,88.0,83.8 to 91.6,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2020-2021,Age,35 Months,91.7,86.9 to 95.3,759
Hep B,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.7,89.7 to 95.6,891
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2021,Age,0-1 Days,79.9,72.5 to 85.6,275
DTaP,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,3 Months,85.2,81.0 to 88.6,759
Hib,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,91.5,88.1 to 93.9,759
PCV,≥3 Doses,States/Local Areas,Ohio,2021,Age,13 Months,88.6,81.9 to 93.1,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2021,Age,0-2 Days,85.2,78.8 to 89.9,275
Hep A,≥2 Doses,States/Local Areas,Ohio,2021,Age,35 Months,73.4,61.7 to 83.9,275
≥1 Dose Varicella,,States/Local Areas,Ohio,2021,Age,19 Months,87.5,80.6 to 92.2,275
≥1 Dose MMR,,States/Local Areas,Ohio,2020-2021,Age,24 Months,90.2,86.9 to 93.0,759
Hep B,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,92.7,89.7 to 95.0,759
PCV,≥3 Doses,States/Local Areas,Ohio,2021,Age,19 Months,89.3,82.7 to 93.6,275
Hep A,≥1 Dose,States/Local Areas,Ohio,2021,Age,35 Months,85.1,78.0 to 90.9,275
DTaP,≥3 Doses,States/Local Areas,Ohio,2021,Age,13 Months,87.6,80.8 to 92.2,275
PCV,≥4 Doses,States/Local Areas,Ohio,2021,Age,19 Months,80.2,72.4 to 86.2,275
Hep B,≥3 Doses,States/Local Areas,Ohio,2021,Age,24 Months,92.8,88.6 to 96.0,275
Hep A,≥2 Doses,States/Local Areas,Ohio,2021,Age,19 Months,31.3,24.6 to 38.9,275
PCV,≥4 Doses,States/Local Areas,Ohio,2021,Age,35 Months,83.3,76.1 to 89.2,275
DTaP,≥1 Dose,States/Local Areas,Ohio,2021,Age,3 Months,86.1,78.9 to 91.1,275
DTaP,≥4 Doses,States/Local Areas,Ohio,2021,Age,24 Months,81.0,73.5 to 87.5,275
Polio,≥3 Doses,States/Local Areas,Ohio,2021,Age,24 Months,90.7,85.3 to 94.7,275
Polio,≥1 Dose,States/Local Areas,Ohio,2021,Age,3 Months,84.4,77.0 to 89.8,275
≥1 Dose MMR,,States/Local Areas,Ohio,2021,Age,24 Months,91.5,85.7 to 95.5,275
Hib,Primary Series,States/Local Areas,Ohio,2021,Age,24 Months,92.1,87.2 to 95.6,275
Hib,Full Series,States/Local Areas,Ohio,2021,Age,24 Months,78.1,70.6 to 84.8,275
Hib,≥3 Doses,States/Local Areas,Ohio,2021,Age,24 Months,91.0,85.7 to 95.0,275
DTaP,≥4 Doses,States/Local Areas,Ohio,2021,Age,19 Months,69.4,61.1 to 76.6,275
PCV,≥3 Doses,States/Local Areas,Ohio,2021,Age,24 Months,89.4,83.4 to 94.0,275
PCV,≥4 Doses,States/Local Areas,Ohio,2021,Age,24 Months,82.8,75.7 to 88.8,275
Hep A,≥1 Dose,States/Local Areas,Ohio,2021,Age,24 Months,85.1,78.0 to 90.9,275
DTaP,≥3 Doses,States/Local Areas,Ohio,2021,Age,19 Months,89.9,83.6 to 93.9,275
PCV,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,5 Months,77.7,72.9 to 81.8,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2021,Age,24 Months,90.2,84.1 to 94.7,275
Hep B,≥3 Doses,States/Local Areas,Ohio,2021,Age,7 Months,55.5,47.3 to 63.3,275
Hib,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,79.3,74.7 to 83.2,759
Hep A,≥2 Doses,States/Local Areas,Ohio,2021,Age,24 Months,50.3,41.0 to 60.3,275
PCV,≥3 Doses,States/Local Areas,Ohio,2021,Age,7 Months,68.6,60.1 to 75.9,275
Hep A,≥1 Dose,States/Local Areas,Ohio,2021,Age,19 Months,79.6,71.6 to 85.8,275
Polio,≥2 Doses,States/Local Areas,Ohio,2021,Age,13 Months,90.9,85.0 to 94.6,275
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.5,72.1 to 83.0,355
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2017,Age,35 Months,87.2,79.8 to 92.9,243
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,89.5,85.1 to 93.1,437
Hib,Primary Series,States/Local Areas,Oklahoma,2011,Age,7 Months,65.5,60.8 to 69.9,279
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,83.4,77.2 to 89.6,222
Hib,Primary Series,States/Local Areas,Oklahoma,2012,Age,7 Months,67.0,53.8 to 77.9,260
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,75.3,67.4 to 82.5,198
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,77.2,71.7 to 82.4,425
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,43.0,36.5 to 50.1,319
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,42.8,37.8 to 48.3,562
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,42.5,34.9 to 51.0,243
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,41.6,35.9 to 47.9,437
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,40.8,32.4 to 50.5,194
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,41.2,35.0 to 48.0,399
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,72.9,65.0 to 80.2,260
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,79.7,73.6 to 85.1,279
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,68.3,59.2 to 76.3,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,7 Months,72.9,69.5 to 76.1,198
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,7 Months,69.5,65.9 to 72.8,425
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,62.7,58.1 to 67.1,279
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,68.7,54.8 to 79.9,260
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,93.9,90.9 to 96.8,404
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,97.1,95.3 to 99.0,222
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013,Age,13 Months,49.7,36.1 to 63.3,198
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2013-2014,Age,13 Months,52.8,46.4 to 59.1,425
Polio,≥2 Doses,States/Local Areas,Oklahoma,2018,Age,5 Months,79.4,71.5 to 85.5,194
Polio,≥2 Doses,States/Local Areas,Oklahoma,2018-2019,Age,5 Months,80.0,74.3 to 84.7,399
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.8,79.1 to 100.0,36
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,92.6,83.5 to 100.0,32
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,86.4,82.2 to 90.5,439
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,86.6,82.9 to 90.2,498
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2019,Age,35 Months,93.3,87.6 to 97.0,205
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2012,Age,13 Months,52.4,43.0 to 61.7,260
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014,Age,13 Months,56.0,47.3 to 64.3,227
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2014-2015,Age,13 Months,54.7,49.0 to 60.2,502
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,79.1,69.6 to 87.3,227
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,77.7,71.0 to 83.8,502
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,7 Months,71.8,63.1 to 79.2,205
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,75.8,66.8 to 83.9,275
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,74.7,68.8 to 80.3,594
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,73.5,66.0 to 80.5,319
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,71.4,65.3 to 77.2,562
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,7 Months,78.1,70.6 to 84.1,194
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,7 Months,75.0,69.3 to 79.9,399
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,7 Months,74.4,66.6 to 80.9,243
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,7 Months,76.2,70.9 to 80.8,437
Polio,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,7 Months,86.6,83.4 to 89.3,279
Polio,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,7 Months,89.0,83.8 to 92.7,260
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,84.9,78.4 to 91.3,152
Polio,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,5 Months,80.7,71.8 to 87.2,205
Polio,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,35 Months,95.0,90.8 to 97.7,275
Polio,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,92.4,89.4 to 94.8,594
Hib,Full Series,States/Local Areas,Oklahoma,2016,Age,35 Months,79.8,73.8 to 85.1,319
Hib,Full Series,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,79.4,74.5 to 83.9,562
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,78.1,70.1 to 86.1,152
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,71.7 to 84.3,289
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.4,70.6 to 80.2,519
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,78.7,72.9 to 84.4,313
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,79.1,71.3 to 85.9,227
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,77.2,72.2 to 81.9,502
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,75.4,68.8 to 81.5,275
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,77.5,73.1 to 81.6,594
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,79.5,73.9 to 84.6,319
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,78.3,73.7 to 82.7,562
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,77.7,68.2 to 86.0,198
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,78.0,71.3 to 84.1,425
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,78.4,69.0 to 86.5,260
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,70.5,61.9 to 78.6,279
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,41.5,32.8 to 51.5,205
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,7 Months,70.9,64.6 to 76.5,319
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,7 Months,72.6,67.7 to 77.0,562
Polio,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,5 Months,74.9,67.9 to 80.7,275
Polio,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,5 Months,72.2,67.5 to 76.4,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,7 Months,68.4,61.4 to 74.6,275
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,7 Months,69.6,65.0 to 73.8,594
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,7 Months,66.0,57.3 to 73.7,227
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,7 Months,67.2,61.6 to 72.2,502
Polio,≥2 Doses,States/Local Areas,Oklahoma,2017,Age,5 Months,79.3,72.2 to 84.9,243
Polio,≥2 Doses,States/Local Areas,Oklahoma,2017-2018,Age,5 Months,79.3,74.2 to 83.7,437
Polio,≥2 Doses,States/Local Areas,Oklahoma,2016,Age,5 Months,69.4,62.9 to 75.2,319
Polio,≥2 Doses,States/Local Areas,Oklahoma,2016-2017,Age,5 Months,74.2,69.5 to 78.4,562
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2018,Age,35 Months,91.5,86.4 to 95.3,194
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,92.4,88.8 to 95.2,399
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,76.7,73.3 to 80.1,996
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,72.9,66.3 to 79.5,328
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,74.9,69.4 to 80.4,370
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,75.8,70.3 to 81.3,404
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,93.7,90.9 to 96.5,439
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,90.0,86.7 to 93.3,498
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,93.5,82.9 to 100.0,32
Polio,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,35 Months,94.1,88.0 to 97.7,205
Hib,Full Series,States/Local Areas,Oklahoma,2014,Age,35 Months,85.1,77.0 to 91.5,227
Hib,Full Series,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,83.6,78.4 to 88.3,502
Hib,Full Series,States/Local Areas,Oklahoma,2017,Age,35 Months,78.9,71.1 to 85.8,243
Hib,Full Series,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,81.5,76.0 to 86.5,437
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,79.6,74.8 to 84.5,439
Hib,Full Series,States/Local Areas,Oklahoma,2015,Age,35 Months,82.5,75.8 to 88.3,275
Hib,Full Series,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,81.3,76.9 to 85.3,594
Hib,Full Series,States/Local Areas,Oklahoma,2019,Age,35 Months,85.9,78.0 to 92.0,205
Hib,Full Series,States/Local Areas,Oklahoma,2018,Age,35 Months,84.4,76.7 to 90.7,194
Hib,Full Series,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,85.2,79.8 to 89.7,399
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,89.9,84.7 to 95.2,152
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,86.7 to 94.9,289
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.4,87.0 to 93.9,519
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,85.8 to 93.9,313
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.3,80.6 to 100.0,36
Hib,Full Series,States/Local Areas,Oklahoma,2013,Age,35 Months,83.7,76.6 to 89.6,198
Hib,Full Series,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,84.0,78.6 to 88.7,425
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.6,58.6 to 92.7,36
Hib,Full Series,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,76.1,71.3 to 80.9,498
Hib,Full Series,States/Local Areas,Oklahoma,2019,Age,24 Months,81.7,74.0 to 88.3,205
Hib,Full Series,States/Local Areas,Oklahoma,2012,Age,35 Months,80.2,72.8 to 86.7,260
Hib,Full Series,States/Local Areas,Oklahoma,2011,Age,35 Months,81.7,75.5 to 87.1,279
Polio,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,35 Months,94.9,90.7 to 97.6,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,87.3,80.9 to 92.4,227
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,87.6,83.5 to 91.1,502
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2011,Age,5 Months,75.1,68.9 to 80.3,279
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2012,Age,5 Months,77.4,63.4 to 87.1,260
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2013,Age,5 Months,70.4,66.6 to 74.0,198
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2013-2014,Age,5 Months,74.0,70.9 to 76.8,425
Polio,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,35 Months,93.3,87.5 to 97.0,198
Polio,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,93.2,89.1 to 96.2,425
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,35 Months,94.1,87.5 to 97.9,227
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,94.6,90.9 to 97.2,502
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2015,Age,5 Months,74.9,67.9 to 80.7,275
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2015-2016,Age,5 Months,72.8,68.1 to 77.0,594
Hib,Full Series,States/Local Areas,Oklahoma,2018,Age,24 Months,77.2,69.6 to 84.0,194
Hib,Full Series,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,79.4,74.0 to 84.3,399
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,35 Months,89.8,85.1 to 93.5,319
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,90.7,87.0 to 93.7,562
Polio,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,35 Months,91.9,85.5 to 96.1,243
Polio,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,93.9,90.4 to 96.5,437
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2014,Age,5 Months,77.6,69.7 to 83.9,227
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2014-2015,Age,5 Months,76.2,72.0 to 80.0,502
Polio,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,35 Months,93.7,89.7 to 96.5,279
Hib,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,91.6,86.9 to 95.2,279
Hib,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,92.5,87.4 to 96.1,260
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,88.7,82.9 to 93.2,198
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,88.0,83.8 to 91.6,425
Hib,Full Series,States/Local Areas,Oklahoma,2016,Age,24 Months,75.3,69.4 to 80.8,319
Hib,Full Series,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,76.3,71.6 to 80.8,562
Hib,Full Series,States/Local Areas,Oklahoma,2017,Age,24 Months,77.4,69.9 to 84.2,243
Hib,Full Series,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,77.3,72.0 to 82.2,437
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,94.5,90.1 to 97.4,260
Polio,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,24 Months,88.8,82.3 to 93.7,243
Polio,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,90.6,86.7 to 93.7,437
Hib,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,88.2,80.6 to 93.1,205
Polio,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,24 Months,92.6,86.5 to 96.6,205
Polio,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,24 Months,92.5,87.7 to 95.9,194
Polio,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,92.5,88.8 to 95.3,399
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,93.1,89.1 to 96.0,279
Hib,Full Series,States/Local Areas,Oklahoma,2015,Age,24 Months,78.1,71.8 to 83.8,275
Hib,Full Series,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,76.7,72.4 to 80.7,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,92.0,86.4 to 95.9,198
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,92.1,88.2 to 95.0,425
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,88.0,81.0 to 92.6,243
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,90.2,86.1 to 93.2,437
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,90.4,83.0 to 94.8,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,92.5,87.2 to 95.7,194
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,90.2,85.7 to 93.4,399
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,24 Months,90.0,83.7 to 94.6,227
Polio,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,90.9,87.2 to 93.9,502
Polio,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,24 Months,91.9,87.5 to 95.2,275
Polio,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,90.2,87.2 to 92.8,594
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,62.6,56.3 to 68.6,446
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,86.7,79.4 to 91.6,194
Hib,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,65.4,58.9 to 71.3,399
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,84.7,79.3 to 89.0,319
Hib,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,84.5,80.1 to 88.1,562
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,24 Months,88.6,84.0 to 92.3,319
Polio,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,88.7,84.9 to 91.9,562
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017,Age,19 Months,84.2,76.7 to 89.7,243
Hib,≥3 Doses,States/Local Areas,Oklahoma,2017-2018,Age,19 Months,85.5,80.5 to 89.4,437
Hib,≥2 Doses,States/Local Areas,Oklahoma,2020,Age,13 Months,89.8,83.9 to 93.8,298
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,86.0,83.1 to 88.5,275
Hib,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,85.4,81.5 to 88.6,594
Polio,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,24 Months,92.0,86.4 to 95.9,198
Polio,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,90.9,86.9 to 94.1,425
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013,Age,19 Months,85.4,78.3 to 90.4,198
Hib,≥3 Doses,States/Local Areas,Oklahoma,2013-2014,Age,19 Months,86.1,81.7 to 89.6,425
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,86.9,79.9 to 91.7,227
Hib,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,86.5,82.1 to 89.9,502
Polio,≥3 Doses,States/Local Areas,Oklahoma,2012,Age,24 Months,94.9,90.7 to 97.6,260
Polio,≥3 Doses,States/Local Areas,Oklahoma,2011,Age,24 Months,91.3,87.0 to 94.6,279
Polio,≥3 Doses,States/Local Areas,Oklahoma,2018,Age,19 Months,92.5,87.2 to 95.7,194
Polio,≥3 Doses,States/Local Areas,Oklahoma,2018-2019,Age,19 Months,66.2,59.7 to 72.2,399
Polio,≥3 Doses,States/Local Areas,Oklahoma,2019,Age,19 Months,90.4,83.0 to 94.8,205
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016,Age,19 Months,89.7,84.9 to 93.1,319
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2016-2017,Age,19 Months,88.9,84.9 to 91.9,562
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015,Age,19 Months,90.8,86.9 to 93.6,275
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2015-2016,Age,19 Months,90.2,87.0 to 92.7,594
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014,Age,19 Months,92.0,85.6 to 95.7,227
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2014-2015,Age,19 Months,91.4,87.7 to 94.1,502
Hib,Primary Series,States/Local Areas,South Dakota,2018,Age,13 Months,89.5,84.8 to 92.8,390
Hib,Primary Series,States/Local Areas,South Dakota,2018-2019,Age,13 Months,88.3,85.0 to 91.0,708
Hib,Primary Series,States/Local Areas,South Dakota,2017,Age,13 Months,90.7,85.1 to 94.3,335
Hib,Primary Series,States/Local Areas,South Dakota,2017-2018,Age,13 Months,90.1,86.7 to 92.7,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,83.5,75.2 to 89.5,289
Hib,Primary Series,States/Local Areas,South Dakota,2014,Age,19 Months,91.8,86.8 to 95.0,274
Hib,Primary Series,States/Local Areas,South Dakota,2014-2015,Age,19 Months,92.7,89.6 to 95.0,493
Hib,Primary Series,States/Local Areas,South Dakota,2013,Age,19 Months,89.0,87.2 to 90.6,222
Hib,Primary Series,States/Local Areas,South Dakota,2013-2014,Age,19 Months,90.4,89.0 to 91.6,496
Hib,Primary Series,States/Local Areas,South Dakota,2011,Age,19 Months,96.1,94.6 to 97.2,194
Hib,Primary Series,States/Local Areas,South Dakota,2016,Age,13 Months,84.0,76.8 to 89.3,235
Hib,Primary Series,States/Local Areas,South Dakota,2016-2017,Age,13 Months,87.4,83.0 to 90.7,570
Hib,Primary Series,States/Local Areas,South Dakota,2012,Age,24 Months,97.6,93.5 to 99.4,211
Hib,Primary Series,States/Local Areas,South Dakota,2011,Age,24 Months,96.8,93.6 to 98.7,194
Hib,Primary Series,States/Local Areas,South Dakota,2019,Age,19 Months,93.1,88.1 to 96.1,318
Hib,Primary Series,States/Local Areas,South Dakota,2016,Age,19 Months,86.9,80.2 to 91.6,235
Hib,Primary Series,States/Local Areas,South Dakota,2016-2017,Age,19 Months,90.2,86.3 to 93.2,570
Hib,Primary Series,States/Local Areas,South Dakota,2019,Age,13 Months,87.1,81.8 to 91.0,318
Hib,Primary Series,States/Local Areas,South Dakota,2018,Age,19 Months,96.0,93.2 to 97.7,390
Hib,Primary Series,States/Local Areas,South Dakota,2018-2019,Age,19 Months,88.3,85.0 to 91.0,708
Hib,Primary Series,States/Local Areas,South Dakota,2017,Age,19 Months,93.5,88.8 to 96.3,335
Hib,Primary Series,States/Local Areas,South Dakota,2017-2018,Age,19 Months,94.7,92.1 to 96.5,725
Hib,Primary Series,States/Local Areas,South Dakota,2015,Age,19 Months,93.7,91.9 to 95.1,219
Hib,Primary Series,States/Local Areas,South Dakota,2015-2016,Age,19 Months,90.4,86.4 to 93.3,454
Hib,Primary Series,States/Local Areas,South Dakota,2013,Age,13 Months,86.0,82.7 to 88.8,222
Hib,Primary Series,States/Local Areas,South Dakota,2013-2014,Age,13 Months,87.7,86.4 to 88.8,496
Hib,Primary Series,States/Local Areas,South Dakota,2012,Age,13 Months,89.6,85.0 to 93.0,211
Hib,Primary Series,States/Local Areas,South Dakota,2011,Age,13 Months,93.8,90.2 to 96.1,194
Hib,Primary Series,States/Local Areas,South Dakota,2018,Age,7 Months,70.2,63.4 to 76.2,390
Hib,Primary Series,States/Local Areas,South Dakota,2018-2019,Age,7 Months,70.5,65.6 to 75.0,708
Hib,Primary Series,States/Local Areas,South Dakota,2020,Age,24 Months,93.3,87.8 to 96.8,289
Hib,Primary Series,States/Local Areas,South Dakota,2014,Age,7 Months,71.1,63.9 to 77.4,274
Hib,Primary Series,States/Local Areas,South Dakota,2014-2015,Age,7 Months,71.2,65.9 to 75.9,493
Hib,Primary Series,States/Local Areas,South Dakota,2015,Age,7 Months,71.2,63.5 to 77.8,219
Hib,Primary Series,States/Local Areas,South Dakota,2015-2016,Age,7 Months,69.3,64.0 to 74.3,454
Combined 7 Series,,States/Local Areas,South Dakota,2018,Age,24 Months,75.3,69.4 to 80.8,390
Combined 7 Series,,States/Local Areas,South Dakota,2018-2019,Age,24 Months,70.6,66.0 to 75.1,708
Combined 7 Series,,States/Local Areas,South Dakota,2017,Age,24 Months,69.7,62.8 to 76.4,335
Combined 7 Series,,States/Local Areas,South Dakota,2017-2018,Age,24 Months,72.4,67.8 to 76.9,725
Combined 7 Series,,States/Local Areas,South Dakota,2011,Age,35 Months,76.8,66.1 to 86.1,194
Hib,Primary Series,States/Local Areas,South Dakota,2012,Age,7 Months,63.2,61.2 to 65.3,211
Hib,Primary Series,States/Local Areas,South Dakota,2014,Age,13 Months,89.3,84.0 to 93.0,274
Hib,Primary Series,States/Local Areas,South Dakota,2014-2015,Age,13 Months,90.4,86.9 to 93.0,493
Hib,Primary Series,States/Local Areas,South Dakota,2015,Age,13 Months,91.4,86.3 to 94.7,219
Hib,Primary Series,States/Local Areas,South Dakota,2015-2016,Age,13 Months,87.8,83.4 to 91.1,454
PCV,≥3 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,87.6,77.0 to 93.7,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2021,Age,35 Months,90.9,80.9 to 96.9,194
Hib,Primary Series,States/Local Areas,South Dakota,2012,Age,19 Months,95.8,92.5 to 97.7,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,91.2,86.0 to 95.0,483
DTaP,≥4 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,72.1,60.6 to 81.3,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2021,Age,19 Months,88.2,78.9 to 93.8,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,48.0,36.9 to 59.2,194
Hib,Full Series,States/Local Areas,South Dakota,2021,Age,24 Months,75.4,64.5 to 85.0,194
Hib,Primary Series,States/Local Areas,South Dakota,2020-2021,Age,13 Months,84.2,77.3 to 89.2,483
Hib,Primary Series,States/Local Areas,South Dakota,2021,Age,24 Months,87.5,78.2 to 94.2,194
Polio,≥1 Dose,States/Local Areas,South Dakota,2021,Age,3 Months,79.3,67.6 to 87.6,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,85.5,75.7 to 92.9,194
Polio,≥3 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,85.5,75.7 to 92.8,194
DTaP,≥1 Dose,States/Local Areas,South Dakota,2021,Age,3 Months,79.5,67.7 to 87.7,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2021,Age,24 Months,88.4,80.0 to 94.4,194
DTaP,≥4 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,75.7,65.2 to 85.0,194
PCV,≥4 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,82.2,72.2 to 90.2,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,85.6,74.6 to 92.3,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2021,Age,19 Months,86.4,77.0 to 92.4,194
PCV,≥4 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,81.7,70.8 to 89.1,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,89.7,81.2 to 95.5,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,30.7,24.5 to 37.8,483
DTaP,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,3 Months,82.0,75.0 to 87.4,483
Hep A,≥2 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,47.5,36.4 to 60.0,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,80.0,68.4 to 88.1,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,62.5,50.4 to 73.2,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2021,Age,24 Months,86.4,78.0 to 92.8,194
Combined 7 Series,,States/Local Areas,South Dakota,2013,Age,35 Months,76.9,68.7 to 84.2,222
Combined 7 Series,,States/Local Areas,South Dakota,2013-2014,Age,35 Months,78.5,73.1 to 83.5,496
Combined 7 Series,,States/Local Areas,South Dakota,2019,Age,24 Months,65.6,58.5 to 72.6,318
Combined 7 Series,,States/Local Areas,South Dakota,2017,Age,35 Months,76.8,69.8 to 83.1,335
Combined 7 Series,,States/Local Areas,South Dakota,2017-2018,Age,35 Months,78.5,73.8 to 82.9,725
Combined 7 Series,,States/Local Areas,South Dakota,2016,Age,35 Months,75.1,67.8 to 81.8,235
Combined 7 Series,,States/Local Areas,South Dakota,2016-2017,Age,35 Months,76.2,71.1 to 80.9,570
Hib,Primary Series,States/Local Areas,South Dakota,2016,Age,7 Months,67.5,59.7 to 74.4,235
Hib,Primary Series,States/Local Areas,South Dakota,2016-2017,Age,7 Months,67.9,62.5 to 72.9,570
Hib,Primary Series,States/Local Areas,South Dakota,2017,Age,7 Months,68.4,60.7 to 75.1,335
Hib,Primary Series,States/Local Areas,South Dakota,2017-2018,Age,7 Months,69.3,64.1 to 73.9,725
Hib,Primary Series,States/Local Areas,South Dakota,2019,Age,7 Months,70.9,63.5 to 77.3,318
Hib,Primary Series,States/Local Areas,South Dakota,2013,Age,7 Months,64.9,60.6 to 69.1,222
Hib,Primary Series,States/Local Areas,South Dakota,2013-2014,Age,7 Months,68.0,64.9 to 71.0,496
Hib,Primary Series,States/Local Areas,South Dakota,2019,Age,35 Months,94.7,90.4 to 97.6,318
Combined 7 Series,,States/Local Areas,South Dakota,2016,Age,24 Months,68.9,61.5 to 76.0,235
Combined 7 Series,,States/Local Areas,South Dakota,2016-2017,Age,24 Months,69.4,64.3 to 74.3,570
Hib,Primary Series,States/Local Areas,South Dakota,2017,Age,35 Months,94.8,91.0 to 97.4,335
Hib,Primary Series,States/Local Areas,South Dakota,2017-2018,Age,35 Months,95.8,93.7 to 97.4,725
Hib,Primary Series,States/Local Areas,South Dakota,2018,Age,35 Months,96.8,94.6 to 98.3,390
Hib,Primary Series,States/Local Areas,South Dakota,2018-2019,Age,35 Months,95.7,93.5 to 97.4,708
Combined 7 Series,,States/Local Areas,South Dakota,2015,Age,24 Months,72.2,64.5 to 79.5,219
Combined 7 Series,,States/Local Areas,South Dakota,2015-2016,Age,24 Months,70.4,65.0 to 75.7,454
Combined 7 Series,,States/Local Areas,South Dakota,2014,Age,24 Months,73.4,66.7 to 79.7,274
Combined 7 Series,,States/Local Areas,South Dakota,2014-2015,Age,24 Months,72.6,67.6 to 77.5,493
Hib,Primary Series,States/Local Areas,South Dakota,2013,Age,24 Months,91.1,85.2 to 95.3,222
Hib,Primary Series,States/Local Areas,South Dakota,2013-2014,Age,24 Months,91.9,88.3 to 94.7,496
Combined 7 Series,,States/Local Areas,South Dakota,2014,Age,35 Months,80.0,73.0 to 86.2,274
Combined 7 Series,,States/Local Areas,South Dakota,2014-2015,Age,35 Months,80.2,74.7 to 85.2,493
Combined 7 Series,,States/Local Areas,South Dakota,2012,Age,35 Months,76.1,67.5 to 83.9,211
Hib,Primary Series,States/Local Areas,South Dakota,2017,Age,24 Months,94.8,91.0 to 97.4,335
Hib,Primary Series,States/Local Areas,South Dakota,2017-2018,Age,24 Months,95.8,93.6 to 97.3,725
Hib,Primary Series,States/Local Areas,South Dakota,2014,Age,24 Months,92.8,88.3 to 96.0,274
Hib,Primary Series,States/Local Areas,South Dakota,2014-2015,Age,24 Months,93.3,90.4 to 95.5,493
Hib,Primary Series,States/Local Areas,South Dakota,2015,Age,24 Months,93.7,89.7 to 96.5,219
Hib,Primary Series,States/Local Areas,South Dakota,2015-2016,Age,24 Months,91.0,87.3 to 94.0,454
Combined 7 Series,,States/Local Areas,South Dakota,2013,Age,24 Months,64.7,56.8 to 72.6,222
Combined 7 Series,,States/Local Areas,South Dakota,2013-2014,Age,24 Months,69.0,63.8 to 74.2,496
Combined 7 Series,,States/Local Areas,South Dakota,2011,Age,24 Months,68.7,59.2 to 77.7,194
Combined 7 Series,,States/Local Areas,South Dakota,2012,Age,24 Months,73.6,65.1 to 81.4,211
Hib,Primary Series,States/Local Areas,South Dakota,2015,Age,35 Months,95.1,91.3 to 97.6,219
Hib,Primary Series,States/Local Areas,South Dakota,2015-2016,Age,35 Months,91.9,88.2 to 94.8,454
Hib,Primary Series,States/Local Areas,South Dakota,2016,Age,35 Months,88.6,82.4 to 93.4,235
Hib,Primary Series,States/Local Areas,South Dakota,2016-2017,Age,35 Months,91.8,88.2 to 94.6,570
Hib,Primary Series,States/Local Areas,South Dakota,2016,Age,24 Months,88.3,82.1 to 93.2,235
Hib,Primary Series,States/Local Areas,South Dakota,2016-2017,Age,24 Months,91.7,88.1 to 94.5,570
Hib,Primary Series,States/Local Areas,South Dakota,2018,Age,24 Months,96.7,94.5 to 98.2,390
Hib,Primary Series,States/Local Areas,South Dakota,2018-2019,Age,24 Months,95.6,93.4 to 97.3,708
Hib,Primary Series,States/Local Areas,South Dakota,2014,Age,35 Months,93.7,89.2 to 96.8,274
Hib,Primary Series,States/Local Areas,South Dakota,2014-2015,Age,35 Months,94.4,91.6 to 96.5,493
Hib,Primary Series,States/Local Areas,South Dakota,2012,Age,35 Months,97.6,93.5 to 99.4,211
Hib,Primary Series,States/Local Areas,South Dakota,2019,Age,24 Months,94.7,90.4 to 97.6,318
Hib,Primary Series,States/Local Areas,South Dakota,2011,Age,35 Months,96.8,93.6 to 98.7,194
Hib,Primary Series,States/Local Areas,South Dakota,2013,Age,35 Months,94.3,88.2 to 97.8,222
Hib,Primary Series,States/Local Areas,South Dakota,2013-2014,Age,35 Months,94.3,90.5 to 97.0,496
Hib,≥2 Doses,States/Local Areas,South Dakota,2020,Age,5 Months,76.2,67.4 to 83.3,289
Polio,≥2 Doses,States/Local Areas,South Dakota,2020,Age,5 Months,75.2,66.3 to 82.3,289
DTaP,≥2 Doses,States/Local Areas,South Dakota,2020,Age,5 Months,76.4,67.6 to 83.5,289
Hep B,≥1 Dose,States/Local Areas,South Dakota,2020,Age,3 Months,96.8,92.6 to 98.6,289
PCV,≥1 Dose,States/Local Areas,South Dakota,2020,Age,3 Months,83.2,75.1 to 89.1,289
Hep A,≥1 Dose,States/Local Areas,South Dakota,2020,Age,24 Months,85.2,78.1 to 90.9,289
Hep A,≥2 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,47.7,39.0 to 57.2,289
PCV,≥3 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,89.7,83.3 to 94.4,289
PCV,≥4 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,74.3,66.1 to 81.9,289
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020,Age,24 Months,89.0,82.7 to 93.8,289
Influenza,,States/Local Areas,South Dakota,2020,Age,24 Months,64.9,56.3 to 73.3,289
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2020,Age,0-3 Days,83.0,75.2 to 88.7,289
Rotavirus,,States/Local Areas,South Dakota,2020,Age,8 Months,76.7,68.1 to 83.5,289
Hib,≥3 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,88.1,81.0 to 92.8,289
Combined 7 Series,,States/Local Areas,South Dakota,2020,Age,24 Months,59.4,50.9 to 68.1,289
≥1 Dose MMR,,States/Local Areas,South Dakota,2020,Age,19 Months,87.2,80.3 to 91.9,289
Polio,≥3 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,89.0,81.7 to 93.6,289
DTaP,≥4 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,57.6,48.8 to 66.1,289
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,91.2,84.5 to 95.2,289
PCV,≥3 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,83.5,75.2 to 89.5,289
Hep B,≥2 Doses,States/Local Areas,South Dakota,2020,Age,5 Months,88.4,80.7 to 93.3,289
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,72.4,63.6 to 79.8,289
PCV,≥2 Doses,States/Local Areas,South Dakota,2020,Age,5 Months,75.0,66.2 to 82.1,289
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020,Age,13 Months,59.0,50.1 to 67.3,289
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,88.4,80.9 to 93.2,289
Hep B,≥2 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,96.0,92.1 to 98.1,289
Hib,Primary Series,States/Local Areas,South Dakota,2020,Age,13 Months,87.1,79.7 to 92.0,289
Hib,≥3 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,72.1,63.4 to 79.4,289
Hib,≥2 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,91.0,84.0 to 95.1,289
PCV,≥3 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,89.7,83.3 to 94.4,289
PCV,≥4 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,67.7,58.9 to 75.4,289
Polio,≥3 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,92.1,86.2 to 96.2,289
PCV,≥3 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,87.0,79.2 to 92.1,289
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,94.2,89.1 to 97.5,289
DTaP,≥4 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,84.0,73.6 to 92.0,289
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020,Age,19 Months,86.3,79.4 to 91.2,289
Hib,Full Series,States/Local Areas,South Dakota,2020,Age,19 Months,61.1,52.2 to 69.3,289
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,91.0,84.3 to 95.0,289
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020,Age,35 Months,90.2,83.6 to 94.9,289
Hib,Primary Series,States/Local Areas,South Dakota,2020,Age,19 Months,93.3,87.1 to 96.6,289
Hib,Full Series,States/Local Areas,South Dakota,2020,Age,35 Months,82.0,70.7 to 90.9,289
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,92.9,87.3 to 96.6,289
Hib,≥3 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,88.6,82.1 to 93.5,289
Hib,Primary Series,States/Local Areas,South Dakota,2020,Age,35 Months,93.3,87.8 to 96.8,289
Hib,≥3 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,88.3,81.8 to 93.3,289
≥1 Dose MMR,,States/Local Areas,South Dakota,2020,Age,35 Months,91.6,85.9 to 95.6,289
Polio,≥3 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,90.2,83.9 to 94.8,289
≥1 Dose MMR,,States/Local Areas,South Dakota,2020,Age,24 Months,91.2,85.6 to 95.3,289
DTaP,≥4 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,67.6,58.9 to 76.0,289
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,92.4,86.8 to 96.3,289
Hib,Primary Series,States/Local Areas,South Dakota,2020,Age,7 Months,72.2,63.4 to 79.6,289
Hib,≥3 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,60.4,51.6 to 68.6,289
Polio,≥2 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,86.3,78.2 to 91.6,289
Hib,≥2 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,85.7,77.6 to 91.2,289
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2020,Age,0-1 Days,80.4,72.4 to 86.5,289
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2020,Age,0-2 Days,82.7,74.9 to 88.4,289
Hep A,≥2 Doses,States/Local Areas,South Dakota,2020,Age,19 Months,23.9,17.9 to 31.3,289
Hep A,≥1 Dose,States/Local Areas,South Dakota,2020,Age,19 Months,82.9,75.2 to 88.5,289
Hep A,≥2 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,80.7,68.5 to 90.4,289
≥1 Dose MMR,,States/Local Areas,South Dakota,2020,Age,13 Months,61.1,52.2 to 69.3,289
Combined 7 Series,,States/Local Areas,South Dakota,2020,Age,35 Months,74.1,61.9 to 85.0,289
Hep A,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,24 Months,87.4,83.0 to 91.2,607
Hep A,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,81.8,73.6 to 88.6,607
Hep A,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,35 Months,88.5,84.0 to 92.1,607
Hep A,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,50.2,44.4 to 56.3,607
Influenza,,States/Local Areas,South Dakota,2019-2020,Age,24 Months,68.4,62.9 to 73.8,607
Hib,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,91.1,87.3 to 94.1,607
Hib,Primary Series,States/Local Areas,South Dakota,2019-2020,Age,24 Months,93.9,90.5 to 96.3,607
Hib,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,87.7,83.1 to 91.2,607
Hib,Full Series,States/Local Areas,South Dakota,2019-2020,Age,19 Months,63.5,57.8 to 68.8,607
Combined 7 Series,,States/Local Areas,South Dakota,2019-2020,Age,35 Months,75.1,66.7 to 82.7,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,91.9,88.0 to 94.6,607
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019-2020,Age,19 Months,86.9,82.5 to 90.3,607
PCV,≥4 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,73.1,67.5 to 78.1,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,89.5,84.9 to 92.8,607
Hep A,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,19 Months,84.1,79.3 to 88.0,607
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2019-2020,Age,0-1 Days,81.7,76.8 to 85.7,607
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2019-2020,Age,0-2 Days,84.1,79.4 to 87.9,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,68.8,63.1 to 74.0,607
Hib,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,60.7,54.9 to 66.2,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,93.5,90.1 to 96.1,607
Hib,Full Series,States/Local Areas,South Dakota,2019-2020,Age,24 Months,71.8,66.4 to 77.0,607
PCV,≥4 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,78.8,73.5 to 83.7,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,92.2,88.3 to 95.2,607
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019-2020,Age,24 Months,91.5,87.7 to 94.6,607
Hep A,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,28.7,24.2 to 33.6,607
Polio,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,90.4,86.1 to 93.5,607
Hib,Primary Series,States/Local Areas,South Dakota,2019-2020,Age,19 Months,93.2,89.6 to 95.6,607
Hib,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,89.3,85.0 to 92.4,607
≥1 Dose MMR,,States/Local Areas,South Dakota,2019-2020,Age,19 Months,87.9,83.6 to 91.2,607
Hib,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,91.4,87.6 to 94.4,607
≥1 Dose MMR,,States/Local Areas,South Dakota,2019-2020,Age,35 Months,93.6,90.1 to 96.2,607
Hib,Primary Series,States/Local Areas,South Dakota,2019-2020,Age,35 Months,93.9,90.5 to 96.3,607
Hib,Full Series,States/Local Areas,South Dakota,2019-2020,Age,35 Months,82.0,74.5 to 88.5,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,93.5,90.1 to 96.1,607
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019-2020,Age,35 Months,92.8,88.8 to 95.7,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,92.2,88.3 to 95.2,607
PCV,≥4 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,82.8,77.3 to 87.7,607
Polio,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,92.5,88.6 to 95.4,607
DTaP,≥4 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,71.2,65.5 to 76.7,607
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,24 Months,93.6,90.1 to 96.2,607
≥1 Dose MMR,,States/Local Areas,South Dakota,2019-2020,Age,24 Months,93.2,89.7 to 95.8,607
Hib,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,3 Months,83.2,78.3 to 87.2,607
Hep B,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,3 Months,96.6,94.2 to 98.1,607
PCV,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,3 Months,85.2,80.3 to 89.0,607
Polio,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,5 Months,76.0,70.4 to 80.8,607
DTaP,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,5 Months,76.7,71.2 to 81.5,607
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,86.6,81.8 to 90.4,607
Polio,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,92.1,88.1 to 94.9,607
Hib,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,92.3,88.4 to 95.0,607
≥1 Dose MMR,,States/Local Areas,South Dakota,2019-2020,Age,13 Months,65.3,59.7 to 70.6,607
Hib,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,74.8,69.4 to 79.6,607
Hib,Primary Series,States/Local Areas,South Dakota,2019-2020,Age,13 Months,86.8,82.4 to 90.2,607
Hib,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,5 Months,73.8,68.2 to 78.7,607
Hep B,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,5 Months,89.5,85.1 to 92.7,607
PCV,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,5 Months,75.9,70.4 to 80.7,607
Polio,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,88.3,83.7 to 91.7,607
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,71.3,65.6 to 76.4,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,89.7,85.5 to 92.8,607
Hep B,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,95.3,92.5 to 97.1,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,13 Months,86.7,81.8 to 90.4,607
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019-2020,Age,13 Months,63.0,57.3 to 68.3,607
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,94.7,91.4 to 97.1,607
Combined 7 Series,,States/Local Areas,South Dakota,2019-2020,Age,24 Months,62.6,56.9 to 68.2,607
DTaP,≥4 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,86.5,79.3 to 92.1,607
Polio,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,35 Months,93.6,89.9 to 96.3,607
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,91.6,87.5 to 94.4,607
DTaP,≥4 Doses,States/Local Areas,South Dakota,2019-2020,Age,19 Months,61.6,55.8 to 67.0,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,79.1,73.8 to 83.5,607
DTaP,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,3 Months,86.2,81.4 to 89.9,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2019-2020,Age,0-3 Days,84.9,80.3 to 88.6,607
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,83.4,78.8 to 88.1,790
Influenza,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,62.6,40.5 to 84.6,32
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,72.0,63.3 to 80.7,324
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,83.2 to 95.6,190
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,75.1,62.4 to 87.7,75
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.2,63.2 to 81.1,190
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,82.0,65.7 to 98.4,32
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,91.9,89.1 to 94.7,790
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,90.3,86.0 to 94.6,324
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,87.7 to 98.8,190
Influenza,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,79.4,68.4 to 90.4,75
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,77.0,73.5 to 80.4,1175
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,93.6,91.5 to 95.6,1175
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,85.6,80.8 to 90.3,332
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,93.0,90.8 to 95.1,1175
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,70.3,62.6 to 78.1,236
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Overall,Overall,91.0,88.6 to 93.4,1175
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,85.5,81.6 to 89.4,607
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,86.8,81.3 to 92.4,236
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,86.5,80.3 to 92.8,332
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,78.2,71.9 to 84.4,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,91.2,88.0 to 94.5,607
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,93.7,89.3 to 98.2,236
Influenza,,States/Local Areas,South Dakota,2016-2019,Overall,Overall,72.2,68.6 to 75.8,1175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Overall,Overall,82.8,79.9 to 85.6,1175
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Overall,Overall,87.3,84.7 to 89.9,1175
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,94.9,91.0 to 98.9,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,81.3,75.0 to 87.5,236
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,78.1,73.6 to 82.6,1175
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Overall,Overall,68.9,65.2 to 72.5,1175
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Overall,Overall,90.3,87.9 to 92.7,1175
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,95.9,93.0 to 98.7,332
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,69.0,64.0 to 74.0,607
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Overall,Overall,76.4,73.0 to 79.8,1175
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,76.8,70.6 to 83.0,332
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,93.0,90.0 to 95.9,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,94.9,91.9 to 98.0,332
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,62.2,54.2 to 70.3,236
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,90.8,87.5 to 94.1,607
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Overall,Overall,75.3,71.9 to 78.8,1175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,80.7,76.5 to 84.9,632
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,95.6,92.7 to 98.5,332
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,91.4,88.3 to 94.6,632
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,85.2,80.7 to 89.7,378
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.8,78.1 to 91.5,165
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,94.1,91.4 to 96.9,632
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.3,84.6 to 98.1,165
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,68.9,62.7 to 75.1,378
Influenza,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,68.9,63.7 to 74.1,632
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,90.1 to 96.8,378
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,94.9,92.3 to 97.5,632
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,88.1 to 95.3,378
Polio,≥1 Dose,States/Local Areas,South Dakota,2019-2020,Age,3 Months,86.1,81.2 to 89.8,607
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,79.0,70.7 to 85.5,289
PCV,≥3 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,70.6,61.8 to 78.0,289
Hep B,≥2 Doses,States/Local Areas,South Dakota,2020,Age,7 Months,90.9,83.9 to 95.0,289
Hib,≥1 Dose,States/Local Areas,South Dakota,2020,Age,3 Months,84.5,76.5 to 90.2,289
DTaP,≥1 Dose,States/Local Areas,South Dakota,2020,Age,3 Months,84.8,76.7 to 90.4,289
Polio,≥1 Dose,States/Local Areas,South Dakota,2020,Age,3 Months,84.7,76.7 to 90.4,289
Hib,Primary Series,States/Local Areas,South Dakota,2020-2021,Age,19 Months,90.1,84.2 to 94.0,483
≥1 Dose MMR,,States/Local Areas,South Dakota,2020-2021,Age,13 Months,66.2,59.0 to 72.6,483
Rotavirus,,States/Local Areas,South Dakota,2019-2020,Age,8 Months,78.4,73.1 to 82.8,607
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.2,80.9 to 95.5,165
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,76.5,70.6 to 82.3,378
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.0,68.1 to 85.9,165
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,77.3,72.5 to 82.2,632
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,91.6 to 97.5,378
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,85.4 to 98.7,165
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,93.3,90.5 to 96.1,632
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,73.9,69.0 to 78.9,632
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,81.6,74.3 to 88.9,378
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,81.5 to 96.2,165
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.1,63.9 to 88.2,165
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.3,78.6 to 94.0,165
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,77.5,73.0 to 82.0,607
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,67.0,59.2 to 74.7,236
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,89.9,85.8 to 94.0,378
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,89.6,85.1 to 94.1,332
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,82.1,77.7 to 86.4,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,86.4,81.4 to 91.4,332
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,82.0,78.0 to 85.9,607
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,71.9,61.7 to 82.1,236
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,91.1,86.9 to 95.3,332
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,95.5,91.6 to 99.4,236
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,94.5,92.5 to 96.4,1175
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,92.9,90.8 to 95.0,1175
Influenza,,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,70.2,65.3 to 75.2,607
Influenza,,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,64.4,56.4 to 72.5,236
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,91.8,87.8 to 95.9,332
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,88.2,84.5 to 91.8,607
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,92.2,87.8 to 96.5,236
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,91.4,86.5 to 96.2,236
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,91.8,88.6 to 94.9,607
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,84.2,78.7 to 89.6,332
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,90.6,87.2 to 94.0,607
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,94.8,90.6 to 99.0,236
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,79.0,73.2 to 84.9,332
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,76.3,71.7 to 81.0,607
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,70.6,62.8 to 78.3,236
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,91.1,87.4 to 94.8,332
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,<133% FPL,75.4,68.1 to 82.7,236
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Overall,Overall,81.9,78.7 to 85.1,1175
Influenza,,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,86.2,81.4 to 91.0,332
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,94.5,91.1 to 98.0,324
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,63.0,56.2 to 69.9,324
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,95.5,88.8 to 100.0,75
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.5,54.2 to 72.7,190
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,87.8 to 98.9,190
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.1,87.4 to 92.8,882
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.7,89.2 to 94.2,882
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,74.8,70.6 to 78.9,790
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.5,77.1 to 83.9,882
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,74.3 to 89.6,190
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,84.0,80.6 to 87.4,790
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,83.9,78.9 to 88.8,324
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,64.7,43.0 to 86.4,32
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,90.8,87.9 to 93.7,790
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,95.4,90.9 to 100.0,75
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.5,83.2 to 95.8,190
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.3 to 97.6,790
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,71.5,49.7 to 93.3,32
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.5,53.3 to 71.6,190
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,82.9,79.3 to 86.5,790
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,51.5,29.8 to 73.2,32
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,64.8 to 82.3,190
Influenza,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,80.7,77.0 to 84.4,790
Influenza,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,63.3,56.4 to 70.2,324
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,95.4,88.4 to 100.0,75
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,84.0,74.0 to 94.0,75
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.5,72.6 to 80.3,882
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,56.5,32.2 to 80.9,32
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,69.8,63.4 to 76.2,324
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,68.7,49.2 to 88.1,32
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,62.6,48.8 to 76.3,75
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.1,68.1 to 76.1,882
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,80.7,69.7 to 91.7,75
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,85.6,71.2 to 100.0,32
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,89.0,77.8 to 100.0,32
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,80.6,69.3 to 91.9,75
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,61.4,39.3 to 83.4,32
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.6,82.4 to 88.7,882
Influenza,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.5,71.6 to 79.3,882
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.6,91.4 to 95.8,882
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,93.7,90.1 to 97.3,324
Polio,≥2 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,83.7,72.5 to 90.9,194
Hep B,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,94.0,89.4 to 96.7,483
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,88.3,82.1 to 92.5,483
Polio,≥3 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,89.5,78.5 to 96.3,194
PCV,≥2 Doses,States/Local Areas,South Dakota,2021,Age,5 Months,66.5,54.8 to 76.4,194
PCV,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,5 Months,70.5,63.2 to 76.9,483
Combined 7 Series,,States/Local Areas,South Dakota,2021,Age,35 Months,67.9,56.7 to 78.6,194
Hib,≥1 Dose,States/Local Areas,South Dakota,2021,Age,3 Months,78.6,67.4 to 86.7,194
DTaP,≥1 Dose,States/Local Areas,South Dakota,2013,Age,3 Months,85.4,74.3 to 92.2,222
DTaP,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,3 Months,85.8,80.1 to 90.0,496
DTaP,≥1 Dose,States/Local Areas,South Dakota,2014,Age,3 Months,86.2,80.2 to 90.6,274
DTaP,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,3 Months,87.6,83.6 to 90.7,493
DTaP,≥1 Dose,States/Local Areas,South Dakota,2015,Age,3 Months,89.0,83.0 to 93.0,219
DTaP,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,3 Months,87.6,83.3 to 91.0,454
DTaP,≥1 Dose,States/Local Areas,South Dakota,2016,Age,3 Months,86.2,79.3 to 91.1,235
DTaP,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,3 Months,87.6,83.5 to 90.8,570
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,74.7,68.9 to 80.5,378
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,88.7,84.1 to 93.3,378
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,75.4,70.6 to 80.3,632
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.4,67.4 to 85.4,165
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,88.7,84.4 to 93.0,378
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.1,71.6 to 88.7,165
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,87.0,83.3 to 90.8,632
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,76.9 to 92.3,165
Rotavirus,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,78.7,73.5 to 83.9,378
Influenza,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.6,64.4 to 82.9,165
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,68.4,63.3 to 73.6,632
Influenza,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,76.4,70.8 to 82.1,378
Combined 7 Series,,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.3,60.8 to 79.8,165
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,83.1,78.0 to 88.2,378
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,81.5,76.9 to 86.0,632
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.5,71.9 to 89.1,165
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,92.2,88.5 to 95.8,378
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,93.6,90.8 to 96.4,632
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.1,85.4 to 98.7,165
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,94.6,92.0 to 97.1,632
Hib,≥3 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,84.7,73.9 to 91.6,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Urbanicity,Living In a Non-MSA,75.8,69.6 to 82.0,632
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.2,86.6 to 97.8,190
PCV,≥3 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,92.5,80.9 to 98.2,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,85.6,75.8 to 92.9,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,82.2,71.2 to 89.6,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,86.8,81.0 to 91.5,483
Influenza,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.9,51.6 to 70.3,190
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,86.2 to 98.4,190
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,96.0,91.2 to 100.0,75
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.3,89.7 to 94.8,882
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,93.5,91.0 to 96.0,790
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,82.0,65.7 to 98.4,32
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,93.4,89.7 to 97.1,324
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,70.3,63.7 to 76.9,324
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,54.8,33.0 to 76.7,32
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.8,84.9 to 90.7,882
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,70.1,63.5 to 76.6,324
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,65.5,45.8 to 85.2,32
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,94.8,92.6 to 97.1,790
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.2 to 95.2,324
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,70.0,49.4 to 90.6,32
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,93.9,90.3 to 97.6,324
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.5,75.8 to 83.3,882
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Uninsured,81.2,65.0 to 97.3,32
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,98.9,97.4 to 100.0,75
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,92.1 to 96.4,882
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,83.6,79.9 to 87.2,790
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.6,90.3 to 95.0,882
DTaP,≥4 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,71.9,64.8 to 78.6,483
PCV,≥4 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,82.2,72.2 to 90.2,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2021,Age,24 Months,87.6,78.3 to 94.2,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,91.8,85.9 to 95.9,483
≥1 Dose Varicella,,States/Local Areas,South Dakota,2021,Age,24 Months,88.2,79.9 to 94.2,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,80.6,69.4 to 88.4,194
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2021,Age,0-2 Days,79.0,67.9 to 87.0,194
Hep B,≥2 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,92.0,83.3 to 96.4,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,89.2,83.1 to 93.2,483
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020-2021,Age,35 Months,91.3,86.0 to 95.2,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,83.4,72.4 to 90.7,194
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2021,Age,0-1 Days,76.1,65.0 to 84.6,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,35 Months,88.4,83.0 to 92.8,483
Hep B,≥2 Doses,States/Local Areas,South Dakota,2021,Age,5 Months,83.7,72.7 to 90.8,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,97.4,93.4 to 99.3,211
Hib,≥3 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,96.8,93.6 to 98.7,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2021,Age,7 Months,63.5,51.6 to 73.9,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2020-2021,Age,24 Months,89.9,84.9 to 93.8,483
Hep A,≥2 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,74.3,57.4 to 88.5,194
DTaP,≥1 Dose,States/Local Areas,South Dakota,2012,Age,3 Months,84.6,81.1 to 87.6,211
DTaP,≥1 Dose,States/Local Areas,South Dakota,2011,Age,3 Months,90.6,84.2 to 94.6,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2021,Age,35 Months,92.3,83.0 to 97.6,194
DTaP,≥4 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,85.4,76.5 to 92.2,483
Hib,Full Series,States/Local Areas,South Dakota,2021,Age,19 Months,74.3,62.6 to 83.3,194
PCV,≥4 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,78.5,72.2 to 84.3,483
Hep B,≥3 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,89.7,80.0 to 95.0,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,88.0,81.8 to 92.2,483
DTaP,≥1 Dose,States/Local Areas,South Dakota,2018,Age,3 Months,90.9,86.3 to 94.0,390
DTaP,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,3 Months,89.3,85.7 to 92.1,708
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,93.7,89.7 to 96.5,219
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,92.0,88.4 to 94.8,454
DTaP,≥1 Dose,States/Local Areas,South Dakota,2017,Age,3 Months,88.9,83.9 to 92.5,335
DTaP,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,3 Months,89.9,86.5 to 92.5,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,92.8,88.2 to 96.0,274
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,93.2,90.3 to 95.5,493
DTaP,≥1 Dose,States/Local Areas,South Dakota,2019,Age,3 Months,87.6,81.5 to 91.9,318
Hep A,≥1 Dose,States/Local Areas,South Dakota,2011,Age,19 Months,70.1,65.5 to 74.3,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,92.5,87.0 to 96.2,222
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,92.6,89.2 to 95.2,496
Hib,Primary Series,States/Local Areas,South Dakota,2021,Age,19 Months,87.2,76.7 to 93.4,194
Hib,Primary Series,States/Local Areas,South Dakota,2020-2021,Age,24 Months,90.3,84.8 to 94.4,483
Hep A,≥1 Dose,States/Local Areas,South Dakota,2012,Age,19 Months,74.2,68.3 to 79.3,211
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014,Age,19 Months,76.0,69.2 to 81.7,274
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,19 Months,79.7,75.1 to 83.7,493
Hep A,≥1 Dose,States/Local Areas,South Dakota,2015,Age,19 Months,83.5,76.9 to 88.5,219
Hep A,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,19 Months,82.0,77.2 to 85.9,454
DTaP,≥2 Doses,States/Local Areas,South Dakota,2017,Age,5 Months,80.2,73.6 to 85.4,335
DTaP,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,5 Months,81.6,77.3 to 85.3,725
DTaP,≥2 Doses,States/Local Areas,South Dakota,2018,Age,5 Months,83.1,77.3 to 87.6,390
DTaP,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,5 Months,80.1,75.6 to 83.9,708
DTaP,≥2 Doses,States/Local Areas,South Dakota,2016,Age,5 Months,77.5,70.1 to 83.5,235
DTaP,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,5 Months,78.9,74.0 to 83.0,570
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,92.1,88.9 to 95.3,483
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.1,84.6 to 97.6,125
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,96.5,93.7 to 98.3,390
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,96.0,93.6 to 97.7,708
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,95.1,91.4 to 97.6,335
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,95.8,93.6 to 97.5,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,90.4,84.3 to 94.9,235
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,92.8,89.3 to 95.5,570
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,92.1,89.8 to 94.4,873
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,89.5,84.6 to 94.5,208
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,91.5,88.2 to 94.9,456
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,97.0,94.5 to 99.4,209
Hep A,≥1 Dose,States/Local Areas,South Dakota,2013,Age,19 Months,73.9,70.6 to 76.9,222
Hep A,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,19 Months,74.9,72.4 to 77.3,496
Hib,Primary Series,States/Local Areas,South Dakota,2021,Age,7 Months,66.7,54.6 to 76.9,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,95.8,91.2 to 98.4,318
Hib,≥3 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,92.0,87.4 to 95.4,274
Hib,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,92.6,89.7 to 95.0,493
Hep A,≥2 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,33.4,27.2 to 40.3,318
Hep A,≥2 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,37.0,28.5 to 47.1,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,36.0,29.8 to 42.8,390
Hep A,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,33.1,28.2 to 38.3,604
Hib,≥3 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,89.2,82.9 to 94.0,235
Hib,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,91.9,88.3 to 94.8,570
Hib,≥3 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,94.6,90.7 to 97.2,335
Hib,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,94.8,92.3 to 96.7,725
DTaP,≥4 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,60.1,59.4 to 60.9,222
DTaP,≥4 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,66.0,60.2 to 71.4,496
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,71.9,64.7 to 78.2,274
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,70.4,65.2 to 75.2,493
DTaP,≥4 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,68.9,66.7 to 71.0,219
DTaP,≥4 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,66.4,61.0 to 71.5,454
Hep A,≥2 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,30.7,24.4 to 37.8,335
Hep A,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,33.3,28.8 to 38.2,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,96.7,94.8 to 98.5,553
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,89.9,85.6 to 94.3,264
Hib,≥3 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,93.2,89.2 to 96.1,219
Hib,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,90.3,86.6 to 93.4,454
Hib,≥3 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,87.4,81.2 to 92.4,235
Hib,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,91.1,87.5 to 94.0,570
Hep A,≥1 Dose,States/Local Areas,South Dakota,2017,Age,24 Months,85.5,79.6 to 90.4,335
Hep A,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,24 Months,87.9,84.3 to 91.1,725
Hep A,≥1 Dose,States/Local Areas,South Dakota,2019,Age,24 Months,89.7,84.1 to 93.9,318
Hep A,≥1 Dose,States/Local Areas,South Dakota,2011,Age,35 Months,77.1,68.2 to 85.0,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2018,Age,24 Months,90.5,86.1 to 94.0,390
Hep A,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,24 Months,89.8,86.4 to 92.7,708
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,95.8,91.2 to 98.4,318
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,96.7,93.8 to 98.5,390
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,96.1,93.7 to 97.8,708
PCV,≥2 Doses,States/Local Areas,South Dakota,2015,Age,5 Months,74.9,67.4 to 81.1,219
PCV,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,5 Months,75.8,70.6 to 80.3,454
PCV,≥2 Doses,States/Local Areas,South Dakota,2016,Age,5 Months,76.7,69.3 to 82.8,235
PCV,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,5 Months,78.0,73.2 to 82.2,570
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014,Age,24 Months,82.5,76.7 to 87.5,274
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,24 Months,85.7,82.0 to 89.0,493
Hep A,≥1 Dose,States/Local Areas,South Dakota,2015,Age,24 Months,88.9,84.1 to 92.8,219
Hep A,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,24 Months,86.3,82.1 to 89.9,454
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016,Age,24 Months,83.5,76.7 to 89.2,235
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,24 Months,84.5,80.1 to 88.4,570
PCV,≥2 Doses,States/Local Areas,South Dakota,2014,Age,5 Months,75.8,68.8 to 81.6,274
PCV,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,5 Months,75.3,72.1 to 78.3,493
Hib,≥3 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,93.2,89.2 to 96.1,219
Hib,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,91.3,87.5 to 94.2,454
Hep A,≥2 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,27.4,21.7 to 33.9,219
Hep A,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,27.7,23.1 to 32.9,454
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,28.1,22.0 to 35.1,235
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,29.4,24.9 to 34.3,570
Hib,≥3 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,93.9,87.5 to 97.7,222
Hib,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,93.8,89.8 to 96.6,496
Hib,≥3 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,93.0,88.4 to 96.2,274
Hib,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,93.2,90.2 to 95.5,493
Hib,≥3 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,94.1,89.8 to 97.0,318
Hib,≥3 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,94.6,90.7 to 97.2,335
Hib,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,94.7,92.3 to 96.6,725
Hib,≥3 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,95.0,91.6 to 97.3,390
Hib,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,94.4,91.8 to 96.4,708
Hep A,≥2 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,24.2,22.0 to 26.5,222
Hep A,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,25.2,23.2 to 27.3,496
Hep A,≥2 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,14.4,10.7 to 19.0,211
DTaP,≥2 Doses,States/Local Areas,South Dakota,2019,Age,5 Months,76.9,69.7 to 82.8,318
Hep A,≥2 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,15.3,9.6 to 23.5,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,93.2,88.6 to 96.4,274
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,93.5,90.6 to 95.7,493
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,96.0,89.9 to 98.9,222
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,95.0,91.2 to 97.5,496
DTaP,≥3 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,97.8,93.5 to 99.5,211
DTaP,≥3 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,97.1,93.7 to 98.9,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2018,Age,19 Months,89.4,84.3 to 92.9,390
Hep A,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,19 Months,85.5,80.7 to 89.3,604
Hep A,≥1 Dose,States/Local Areas,South Dakota,2017,Age,19 Months,81.6,75.1 to 86.7,335
Hep A,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,19 Months,85.4,81.4 to 88.6,725
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016,Age,19 Months,80.5,73.2 to 86.1,235
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,19 Months,81.0,76.3 to 85.0,570
Hep A,≥1 Dose,States/Local Areas,South Dakota,2012,Age,24 Months,77.2,69.3 to 84.2,211
Hep A,≥1 Dose,States/Local Areas,South Dakota,2019,Age,19 Months,85.1,78.6 to 89.9,318
Hep A,≥1 Dose,States/Local Areas,South Dakota,2011,Age,24 Months,72.8,64.1 to 80.8,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2013,Age,24 Months,78.0,71.0 to 84.4,222
Hep A,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,24 Months,80.3,75.8 to 84.4,496
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,95.3,91.5 to 97.7,335
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,96.0,93.8 to 97.6,725
DTaP,≥4 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,69.0,57.8 to 78.4,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,26.2,20.2 to 33.2,274
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,26.8,22.2 to 31.9,493
DTaP,≥4 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,74.9,69.7 to 79.4,211
PCV,≥2 Doses,States/Local Areas,South Dakota,2013,Age,5 Months,70.0,63.9 to 75.4,222
PCV,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,5 Months,72.9,68.3 to 77.0,496
PCV,≥2 Doses,States/Local Areas,South Dakota,2012,Age,5 Months,70.9,61.8 to 78.7,211
PCV,≥2 Doses,States/Local Areas,South Dakota,2011,Age,5 Months,80.0,72.1 to 86.1,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,93.7,89.7 to 96.5,219
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,92.0,88.4 to 94.8,454
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,90.4,84.3 to 94.9,235
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,92.9,89.4 to 95.6,570
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.3,87.6 to 94.9,469
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,79.1 to 94.9,157
PCV,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,90.6,86.8 to 93.3,723
Hib,≥3 Doses,States/Local Areas,Florida,2013,Age,19 Months,94.8,88.9 to 97.6,272
Hib,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,91.1,85.3 to 94.8,546
Hib,≥3 Doses,States/Local Areas,Florida,2012,Age,19 Months,92.1,91.1 to 92.9,240
Hib,≥3 Doses,States/Local Areas,Florida,2011,Age,19 Months,89.5,80.9 to 94.4,236
Hib,≥3 Doses,States/Local Areas,Florida,2019,Age,13 Months,78.8,71.1 to 84.9,333
Polio,≥3 Doses,States/Local Areas,Florida,2018,Age,19 Months,88.2,80.5 to 93.1,324
Polio,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,69.9,63.8 to 75.4,657
Hib,≥3 Doses,States/Local Areas,Florida,2018,Age,13 Months,75.7,66.6 to 82.9,324
Hib,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,77.3,71.5 to 82.2,657
Polio,≥3 Doses,States/Local Areas,Florida,2017,Age,19 Months,86.8,80.4 to 91.3,374
Polio,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,87.5,82.8 to 91.0,698
Polio,≥3 Doses,States/Local Areas,Florida,2016,Age,19 Months,89.0,82.8 to 93.2,349
Polio,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,87.9,83.7 to 91.2,723
DTaP,≥3 Doses,States/Local Areas,Florida,2013,Age,19 Months,95.2,88.6 to 98.0,272
DTaP,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,92.4,87.1 to 95.7,546
DTaP,≥3 Doses,States/Local Areas,Florida,2012,Age,19 Months,95.0,92.3 to 96.7,240
DTaP,≥3 Doses,States/Local Areas,Florida,2011,Age,19 Months,91.5,80.4 to 96.5,236
DTaP,≥3 Doses,States/Local Areas,Florida,2019,Age,13 Months,89.2,83.1 to 93.3,333
Polio,≥3 Doses,States/Local Areas,Florida,2015,Age,19 Months,92.2,91.0 to 93.3,309
Polio,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,90.6,87.0 to 93.4,658
Polio,≥3 Doses,States/Local Areas,Florida,2014,Age,19 Months,84.9,77.3 to 90.2,274
Polio,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,88.6,84.3 to 91.8,583
DTaP,≥3 Doses,States/Local Areas,Florida,2016,Age,13 Months,86.2,79.5 to 91.0,349
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,86.5,82.1 to 89.9,723
DTaP,≥3 Doses,States/Local Areas,Florida,2018,Age,13 Months,86.8,78.8 to 92.1,324
DTaP,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,88.0,83.2 to 91.6,657
Polio,≥3 Doses,States/Local Areas,Florida,2013,Age,19 Months,90.2,86.9 to 92.8,272
Polio,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,87.5,82.8 to 91.1,546
Hib,≥3 Doses,States/Local Areas,Florida,2017,Age,13 Months,80.5,73.8 to 85.8,374
Hib,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,78.1,72.7 to 82.7,698
Hib,≥3 Doses,States/Local Areas,Florida,2016,Age,13 Months,75.9,68.2 to 82.2,349
Hib,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,78.2,73.3 to 82.4,723
DTaP,≥3 Doses,States/Local Areas,Florida,2017,Age,13 Months,86.7,80.3 to 91.3,374
DTaP,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,86.8,81.9 to 90.4,698
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,66.4,59.8 to 72.9,340
DTaP,≥3 Doses,States/Local Areas,Florida,2015,Age,13 Months,91.7,86.6 to 95.0,309
DTaP,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,89.0,85.0 to 92.0,658
DTaP,≥3 Doses,States/Local Areas,Florida,2012,Age,13 Months,89.6,86.8 to 92.0,240
Hib,≥3 Doses,States/Local Areas,Florida,2019,Age,7 Months,50.9,42.5 to 59.2,333
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,88.3 to 94.3,672
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,88.7 to 95.8,568
Polio,≥3 Doses,States/Local Areas,Florida,2012,Age,19 Months,93.2,87.9 to 96.3,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,57.4,49.7 to 65.2,364
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,66.0,59.8 to 72.2,467
Hib,≥3 Doses,States/Local Areas,Florida,2011,Age,13 Months,82.0,77.3 to 86.0,236
Hib,≥3 Doses,States/Local Areas,Florida,2015,Age,13 Months,84.0,77.6 to 88.9,309
Hib,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,80.0,75.1 to 84.1,658
Hib,≥3 Doses,States/Local Areas,Florida,2012,Age,13 Months,83.1,78.0 to 87.2,240
Hib,≥3 Doses,States/Local Areas,Florida,2014,Age,13 Months,75.1,66.5 to 82.0,274
Hib,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,79.6,74.3 to 84.0,583
Hib,≥3 Doses,States/Local Areas,Florida,2013,Age,13 Months,87.0,81.4 to 91.1,272
Hib,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,80.9,76.4 to 84.8,546
Polio,≥3 Doses,States/Local Areas,Florida,2011,Age,19 Months,87.4,75.6 to 93.9,236
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,95.9,93.5 to 98.3,364
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,93.2,90.3 to 96.1,467
Hib,≥2 Doses,States/Local Areas,Florida,2019,Age,7 Months,89.9,84.3 to 93.7,333
DTaP,≥3 Doses,States/Local Areas,Florida,2017,Age,7 Months,68.7,60.9 to 75.6,374
DTaP,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,69.6,63.5 to 75.1,698
DTaP,≥3 Doses,States/Local Areas,Florida,2016,Age,7 Months,71.5,63.3 to 78.4,349
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,70.1,64.4 to 75.2,723
DTaP,≥3 Doses,States/Local Areas,Florida,2015,Age,7 Months,68.4,60.1 to 75.6,309
DTaP,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,69.9,64.2 to 75.0,658
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2018,Age,0-3 Days,66.9,57.3 to 75.2,324
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2018-2019,Age,0-3 Days,69.9,63.8 to 75.4,657
Polio,≥1 Dose,States/Local Areas,Florida,2018,Age,3 Months,87.0,79.2 to 92.2,324
Polio,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,3 Months,86.3,81.3 to 90.1,657
Polio,≥1 Dose,States/Local Areas,Florida,2017,Age,3 Months,81.7,74.8 to 87.0,374
Polio,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,3 Months,84.3,79.3 to 88.3,698
Hib,≥3 Doses,States/Local Areas,Florida,2016,Age,7 Months,60.5,52.3 to 68.2,349
Hib,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,59.4,53.6 to 64.8,723
Hib,≥3 Doses,States/Local Areas,Florida,2015,Age,7 Months,55.7,47.5 to 63.7,309
Hib,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,58.1,52.3 to 63.7,658
Hib,≥3 Doses,States/Local Areas,Florida,2014,Age,7 Months,51.7,43.0 to 60.3,274
Hib,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,53.7,47.7 to 59.7,583
PCV,≥3 Doses,States/Local Areas,Florida,2018,Age,35 Months,90.9,84.6 to 95.3,324
PCV,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,91.7,87.7 to 94.8,657
PCV,≥3 Doses,States/Local Areas,Florida,2017,Age,35 Months,91.0,85.4 to 95.1,374
PCV,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,90.9,86.9 to 94.1,698
Hib,≥2 Doses,States/Local Areas,Florida,2013,Age,13 Months,97.1,91.2 to 99.1,272
Hib,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,93.0,86.5 to 96.5,546
Hib,≥2 Doses,States/Local Areas,Florida,2018,Age,7 Months,87.1,79.3 to 92.3,324
Hib,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,88.5,84.0 to 91.9,657
PCV,≥3 Doses,States/Local Areas,Florida,2014,Age,35 Months,89.1,82.6 to 93.9,274
PCV,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,90.0,85.9 to 93.3,583
PCV,≥3 Doses,States/Local Areas,Florida,2016,Age,35 Months,92.6,87.8 to 96.0,349
PCV,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,91.8,88.3 to 94.7,723
PCV,≥3 Doses,States/Local Areas,Florida,2015,Age,35 Months,90.8,85.6 to 94.8,309
PCV,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,91.8,88.4 to 94.5,658
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,90.2,87.0 to 93.5,672
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.4,89.2 to 95.6,568
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,100.0,,30
Hib,≥2 Doses,States/Local Areas,Florida,2012,Age,13 Months,95.2,90.7 to 97.5,240
Hib,≥2 Doses,States/Local Areas,Florida,2011,Age,13 Months,90.8,87.5 to 93.3,236
Hib,≥2 Doses,States/Local Areas,Florida,2016,Age,13 Months,93.9,89.6 to 96.5,349
Hib,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,93.3,90.2 to 95.5,723
Hib,≥2 Doses,States/Local Areas,Florida,2015,Age,13 Months,92.1,86.9 to 95.3,309
Hib,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,93.0,89.9 to 95.2,658
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,89.7,86.4 to 93.1,490
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,94.2,91.0 to 97.4,628
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,81.0 to 96.2,157
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,90.1,86.1 to 94.1,340
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.8,85.6 to 98.0,106
Hib,≥2 Doses,States/Local Areas,Florida,2017,Age,13 Months,92.8,87.7 to 95.8,374
Hib,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,93.1,89.5 to 95.5,698
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,75.9,60.0 to 91.9,39
Hib,≥3 Doses,States/Local Areas,Florida,2018,Age,7 Months,52.1,42.7 to 61.4,324
Hib,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,51.5,45.2 to 57.7,657
Hib,≥3 Doses,States/Local Areas,Florida,2017,Age,7 Months,58.2,50.4 to 65.7,374
Hib,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,55.2,49.1 to 61.2,698
DTaP,≥3 Doses,States/Local Areas,Florida,2011,Age,13 Months,85.2,78.3 to 90.3,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,68.2,61.7 to 74.7,340
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,59.2,39.0 to 79.4,39
DTaP,≥3 Doses,States/Local Areas,Florida,2019,Age,7 Months,68.3,59.6 to 75.9,333
DTaP,≥3 Doses,States/Local Areas,Florida,2018,Age,7 Months,70.6,61.0 to 78.6,324
DTaP,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,69.4,63.1 to 75.1,657
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.0,65.1 to 85.0,106
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,68.5,63.0 to 73.9,490
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,58.9,52.9 to 64.8,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2019,Age,0-3 Days,72.9,65.1 to 79.6,333
≥1 Dose Varicella,,States/Local Areas,Florida,2020,Age,24 Months,89.8,84.9 to 93.6,390
Polio,≥1 Dose,States/Local Areas,Florida,2019,Age,3 Months,85.6,78.4 to 90.7,333
Hib,≥2 Doses,States/Local Areas,Florida,2014,Age,13 Months,89.0,82.3 to 93.3,274
Hib,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,90.5,86.6 to 93.4,583
PCV,≥3 Doses,States/Local Areas,Florida,2019,Age,35 Months,92.5,87.1 to 96.2,333
Hib,≥2 Doses,States/Local Areas,Florida,2019,Age,13 Months,93.6,88.9 to 96.4,333
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,87.1,82.5 to 91.7,340
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,91.1,88.7 to 93.4,1171
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.9,85.9 to 93.8,469
PCV,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,100.0,,30
Hib,≥2 Doses,States/Local Areas,Florida,2018,Age,13 Months,93.5,87.5 to 96.7,324
Hib,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,93.5,90.1 to 95.8,657
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",56.8,50.4 to 63.2,568
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.3,49.1 to 71.5,157
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Overall,Overall,64.4,60.5 to 68.4,1171
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,55.1,32.6 to 77.7,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,63.3,58.0 to 68.6,672
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.0,60.9 to 73.0,469
DTaP,≥3 Doses,States/Local Areas,Florida,2014,Age,13 Months,84.4,76.8 to 89.8,274
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,88.1,83.7 to 91.4,583
DTaP,≥3 Doses,States/Local Areas,Florida,2013,Age,13 Months,93.2,82.2 to 97.6,272
DTaP,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,88.7,80.1 to 93.9,546
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,90.5,86.7 to 94.4,340
Hib,≥2 Doses,States/Local Areas,Florida,2011,Age,7 Months,81.6,76.3 to 86.0,236
Hib,≥2 Doses,States/Local Areas,Florida,2019,Age,5 Months,72.9,64.2 to 80.1,333
Hib,≥2 Doses,States/Local Areas,Florida,2018,Age,5 Months,77.7,68.8 to 84.6,324
Hib,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,5 Months,75.3,69.2 to 80.5,657
Hib,≥2 Doses,States/Local Areas,Florida,2015,Age,7 Months,88.2,81.7 to 92.6,309
Hib,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,89.1,85.0 to 92.2,658
PCV,≥3 Doses,States/Local Areas,Florida,2013,Age,35 Months,95.3,91.0 to 98.0,272
PCV,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,92.2,88.4 to 95.1,546
PCV,≥3 Doses,States/Local Areas,Florida,2011,Age,35 Months,90.7,84.2 to 95.2,236
PCV,≥3 Doses,States/Local Areas,Florida,2019,Age,24 Months,92.5,87.1 to 96.2,333
PCV,≥3 Doses,States/Local Areas,Florida,2012,Age,35 Months,93.2,88.0 to 96.7,240
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.5,78.2 to 94.9,157
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2015,Age,0-3 Days,64.4,56.2 to 71.8,309
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2015-2016,Age,0-3 Days,63.6,58.0 to 69.0,658
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014,Age,0-3 Days,63.7,55.1 to 71.6,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2014-2015,Age,0-3 Days,64.1,58.1 to 69.6,583
DTaP,≥3 Doses,States/Local Areas,Florida,2013,Age,7 Months,67.6,62.9 to 72.0,272
DTaP,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,64.8,58.3 to 70.8,546
DTaP,≥3 Doses,States/Local Areas,Florida,2012,Age,7 Months,62.9,56.6 to 68.8,240
DTaP,≥3 Doses,States/Local Areas,Florida,2011,Age,7 Months,65.1,57.1 to 72.4,236
Polio,≥1 Dose,States/Local Areas,Florida,2013,Age,3 Months,87.7,83.7 to 90.8,272
Polio,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,3 Months,85.2,80.3 to 89.1,546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2013-2014,Age,0-3 Days,61.3,55.3 to 66.9,546
Polio,≥1 Dose,States/Local Areas,Florida,2012,Age,3 Months,87.7,86.3 to 89.0,240
Polio,≥1 Dose,States/Local Areas,Florida,2011,Age,3 Months,83.1,76.5 to 88.2,236
PCV,≥1 Dose,States/Local Areas,Florida,2019,Age,3 Months,84.9,77.8 to 89.9,333
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,88.6,84.0 to 93.1,340
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,91.0,88.6 to 93.3,1171
Hib,≥2 Doses,States/Local Areas,Florida,2017,Age,7 Months,84.1,77.2 to 89.2,374
Hib,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,85.6,80.5 to 89.5,698
Hib,≥2 Doses,States/Local Areas,Florida,2016,Age,7 Months,90.0,84.1 to 93.9,349
Hib,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,87.0,82.7 to 90.4,723
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2017,Age,0-3 Days,59.3,49.1 to 68.7,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2017-2018,Age,0-3 Days,62.5,56.4 to 68.2,698
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016,Age,0-3 Days,62.9,54.8 to 70.3,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2017,Age,0-3 Days,60.5,54.9 to 65.9,723
Polio,≥1 Dose,States/Local Areas,Florida,2016,Age,3 Months,88.9,83.0 to 93.0,349
Polio,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,3 Months,85.3,80.9 to 88.8,723
Polio,≥1 Dose,States/Local Areas,Florida,2015,Age,3 Months,83.2,76.1 to 88.5,309
Polio,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,3 Months,86.0,81.6 to 89.6,658
Polio,≥1 Dose,States/Local Areas,Florida,2014,Age,3 Months,82.8,75.1 to 88.5,274
Polio,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,3 Months,83.0,78.0 to 87.0,583
Hib,≥3 Doses,States/Local Areas,Florida,2013,Age,7 Months,58.8,52.8 to 64.5,272
Hib,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,55.2,49.5 to 60.8,546
Hib,≥3 Doses,States/Local Areas,Florida,2012,Age,7 Months,52.7,46.6 to 58.6,240
Hib,≥3 Doses,States/Local Areas,Florida,2011,Age,7 Months,61.2,56.2 to 66.1,236
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,91.8,88.2 to 95.4,364
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,93.6,90.8 to 96.4,467
DTaP,≥3 Doses,States/Local Areas,Florida,2014,Age,7 Months,62.1,53.3 to 70.2,274
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,65.3,59.3 to 70.8,583
PCV,≥3 Doses,States/Local Areas,Florida,2018,Age,24 Months,90.9,84.6 to 95.3,324
PCV,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,91.7,87.7 to 94.8,657
PCV,≥3 Doses,States/Local Areas,Florida,2017,Age,24 Months,90.3,84.8 to 94.4,374
PCV,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,90.6,86.6 to 93.8,698
PCV,≥3 Doses,States/Local Areas,Florida,2016,Age,24 Months,91.6,86.6 to 95.2,349
PCV,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,90.9,87.4 to 93.8,723
Hib,≥2 Doses,States/Local Areas,Florida,2012,Age,7 Months,92.1,91.4 to 92.8,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2011,Age,0-3 Days,52.0,42.6 to 61.3,236
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,91.1,87.9 to 94.3,490
PCV,≥1 Dose,States/Local Areas,Florida,2018,Age,3 Months,85.1,77.3 to 90.6,324
PCV,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,3 Months,85.0,80.0 to 88.9,657
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2012,Age,0-3 Days,53.8,45.2 to 62.2,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2013,Age,0-3 Days,58.8,50.6 to 66.5,272
PCV,≥1 Dose,States/Local Areas,Florida,2017,Age,3 Months,78.8,71.5 to 84.6,374
PCV,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,3 Months,81.9,76.7 to 86.2,698
PCV,≥1 Dose,States/Local Areas,Florida,2016,Age,3 Months,86.3,79.8 to 91.0,349
PCV,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,3 Months,82.5,77.8 to 86.4,723
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.6,84.8 to 98.5,106
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,91.9,88.4 to 95.4,628
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,89.1,84.7 to 93.4,364
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,81.2,76.1 to 86.4,467
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,75.3,69.3 to 81.4,340
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,80.2,76.9 to 83.6,1171
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,76.3,54.4 to 98.1,30
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.3,75.0 to 85.6,469
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,75.8,59.8 to 91.8,39
Hib,≥2 Doses,States/Local Areas,Florida,2014,Age,7 Months,86.2,79.1 to 91.2,274
Hib,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,87.2,82.7 to 90.7,583
Hib,≥2 Doses,States/Local Areas,Florida,2013,Age,7 Months,92.7,89.8 to 94.8,272
Hib,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,89.4,83.7 to 93.3,546
PCV,≥3 Doses,States/Local Areas,Florida,2012,Age,24 Months,92.8,87.7 to 96.3,240
Hib,≥2 Doses,States/Local Areas,Florida,2012,Age,5 Months,74.3,68.8 to 79.1,240
Hib,≥2 Doses,States/Local Areas,Florida,2011,Age,5 Months,70.7,60.7 to 78.9,236
Hib,≥2 Doses,States/Local Areas,Florida,2014,Age,5 Months,73.5,65.0 to 80.6,274
Hib,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,5 Months,75.9,72.9 to 78.6,583
Hib,≥2 Doses,States/Local Areas,Florida,2013,Age,5 Months,77.2,69.5 to 83.4,272
Hib,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,5 Months,75.3,70.9 to 79.3,546
PCV,≥3 Doses,States/Local Areas,Florida,2015,Age,24 Months,90.2,84.9 to 94.3,309
PCV,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,90.9,87.4 to 93.8,658
PCV,≥3 Doses,States/Local Areas,Florida,2014,Age,24 Months,88.5,82.1 to 93.4,274
PCV,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,89.4,85.4 to 92.7,583
PCV,≥3 Doses,States/Local Areas,Florida,2013,Age,24 Months,93.7,88.9 to 96.9,272
PCV,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,91.1,87.1 to 94.2,546
Hib,≥2 Doses,States/Local Areas,Florida,2017,Age,5 Months,72.9,65.1 to 79.5,374
Hib,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,5 Months,75.3,69.5 to 80.3,698
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,85.9,81.6 to 90.1,628
PCV,≥1 Dose,States/Local Areas,Florida,2013,Age,3 Months,85.4,81.9 to 88.4,272
PCV,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,3 Months,84.1,78.9 to 88.2,546
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.6,68.7 to 88.5,106
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,80.5,75.0 to 86.0,340
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,77.5,72.5 to 82.5,490
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,59.7,37.8 to 81.5,39
PCV,≥4 Doses,States/Local Areas,Florida,2017,Age,35 Months,79.6,72.5 to 86.0,374
PCV,≥4 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,81.0,75.8 to 85.7,698
PCV,≥4 Doses,States/Local Areas,Florida,2019,Age,35 Months,85.5,77.1 to 92.0,333
PCV,≥4 Doses,States/Local Areas,Florida,2018,Age,35 Months,82.6,74.7 to 89.2,324
PCV,≥4 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,84.0,78.4 to 88.9,657
PCV,≥3 Doses,States/Local Areas,Florida,2011,Age,24 Months,90.6,84.1 to 95.2,236
PCV,≥3 Doses,States/Local Areas,Florida,2019,Age,19 Months,90.1,83.6 to 94.2,333
PCV,≥3 Doses,States/Local Areas,Florida,2018,Age,19 Months,90.9,83.9 to 95.0,324
PCV,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,85.1,79.9 to 89.1,657
PCV,≥1 Dose,States/Local Areas,Florida,2012,Age,3 Months,81.1,78.5 to 83.5,240
PCV,≥1 Dose,States/Local Areas,Florida,2011,Age,3 Months,77.7,75.3 to 80.0,236
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,94.0,91.0 to 97.0,364
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,92.8,90.1 to 95.5,467
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,88.1,83.7 to 92.6,340
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Overall,Overall,91.0,88.7 to 93.3,1171
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,94.7,84.8 to 100.0,30
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,80.4,76.0 to 84.9,672
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.3,76.2 to 86.3,568
PCV,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,69.0 to 88.3,157
PCV,≥1 Dose,States/Local Areas,Florida,2015,Age,3 Months,82.4,75.4 to 87.8,309
PCV,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,3 Months,84.4,79.8 to 88.1,658
PCV,≥1 Dose,States/Local Areas,Florida,2014,Age,3 Months,82.8,75.0 to 88.5,274
PCV,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,3 Months,82.6,77.7 to 86.6,583
Hib,≥2 Doses,States/Local Areas,Florida,2016,Age,5 Months,77.4,69.8 to 83.5,349
Hib,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,5 Months,75.1,69.9 to 79.7,723
Hib,≥2 Doses,States/Local Areas,Florida,2015,Age,5 Months,78.2,70.8 to 84.1,309
Hib,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,5 Months,77.8,72.6 to 82.2,658
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,94.1,91.1 to 97.0,364
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,86.5 to 94.2,469
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,88.2 to 94.1,672
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.2,86.3 to 94.0,568
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,94.1,91.5 to 96.6,467
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,87.9,83.4 to 92.3,340
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Overall,Overall,91.3,89.1 to 93.6,1171
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,86.5 to 94.3,469
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,94.7,84.8 to 100.0,30
Hib,≥1 Dose,States/Local Areas,Florida,2019,Age,3 Months,86.5,79.8 to 91.2,333
Hib,≥1 Dose,States/Local Areas,Florida,2018,Age,3 Months,85.7,77.4 to 91.2,324
Hib,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,3 Months,86.1,81.1 to 89.9,657
Hep B,≥3 Doses,States/Local Areas,Florida,2019,Age,35 Months,93.1,88.6 to 96.4,333
PCV,≥3 Doses,States/Local Areas,Florida,2017,Age,19 Months,88.9,82.6 to 93.1,374
PCV,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,89.9,85.5 to 93.1,698
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.4,90.0 to 100.0,106
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,88.5,76.5 to 100.0,39
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.9,76.7 to 93.1,157
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,91.8,88.3 to 95.4,340
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,90.0,86.8 to 93.3,490
PCV,≥4 Doses,States/Local Areas,Florida,2016,Age,35 Months,83.9,77.2 to 89.5,349
PCV,≥4 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,81.7,76.9 to 86.1,723
PCV,≥4 Doses,States/Local Areas,Florida,2015,Age,35 Months,82.0,75.4 to 87.8,309
PCV,≥4 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,82.9,78.3 to 87.1,658
PCV,≥4 Doses,States/Local Areas,Florida,2014,Age,35 Months,81.9,74.6 to 88.1,274
PCV,≥4 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,82.0,77.2 to 86.3,583
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,90.7,86.9 to 94.6,340
PCV,≥4 Doses,States/Local Areas,Florida,2017,Age,19 Months,74.3,66.7 to 80.7,374
PCV,≥4 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,76.6,71.1 to 81.3,698
Hep B,≥2 Doses,States/Local Areas,Florida,2016,Age,13 Months,94.2,90.0 to 96.6,349
Hep B,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,93.5,90.5 to 95.5,723
Hep B,≥2 Doses,States/Local Areas,Florida,2015,Age,13 Months,90.0,84.2 to 93.8,309
Hep B,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,92.1,88.7 to 94.5,658
Hep B,≥2 Doses,States/Local Areas,Florida,2014,Age,13 Months,92.6,86.3 to 96.1,274
Hep B,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,91.3,87.3 to 94.1,583
Hib,≥1 Dose,States/Local Areas,Florida,2014,Age,3 Months,84.8,77.5 to 90.1,274
Hib,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,3 Months,84.8,80.0 to 88.6,583
Hib,≥1 Dose,States/Local Areas,Florida,2013,Age,3 Months,87.3,82.4 to 91.0,272
Hib,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,3 Months,86.1,81.2 to 89.8,546
Hib,≥1 Dose,States/Local Areas,Florida,2012,Age,3 Months,87.5,85.3 to 89.3,240
Hib,≥1 Dose,States/Local Areas,Florida,2011,Age,3 Months,82.7,77.1 to 87.2,236
Hep B,≥3 Doses,States/Local Areas,Florida,2016,Age,35 Months,97.6,91.2 to 99.7,349
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,93.9,90.1 to 96.6,723
PCV,≥3 Doses,States/Local Areas,Florida,2014,Age,19 Months,88.2,81.2 to 92.8,274
PCV,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,89.2,84.9 to 92.4,583
PCV,≥3 Doses,States/Local Areas,Florida,2013,Age,19 Months,92.9,85.7 to 96.6,272
PCV,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,90.5,85.3 to 94.0,546
PCV,≥3 Doses,States/Local Areas,Florida,2011,Age,19 Months,89.1,81.3 to 94.0,236
PCV,≥3 Doses,States/Local Areas,Florida,2019,Age,13 Months,85.2,77.9 to 90.4,333
PCV,≥4 Doses,States/Local Areas,Florida,2012,Age,35 Months,80.5,72.9 to 87.0,240
PCV,≥4 Doses,States/Local Areas,Florida,2011,Age,35 Months,80.2,71.4 to 87.6,236
PCV,≥4 Doses,States/Local Areas,Florida,2019,Age,24 Months,81.7,74.5 to 87.9,333
Hep B,≥3 Doses,States/Local Areas,Florida,2017,Age,35 Months,92.6,87.8 to 96.0,374
Hep B,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,92.0,88.3 to 94.9,698
PCV,≥3 Doses,States/Local Areas,Florida,2012,Age,19 Months,91.1,86.2 to 94.4,240
Hep B,≥3 Doses,States/Local Areas,Florida,2018,Age,35 Months,91.3,85.1 to 95.6,324
Hep B,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,92.0,88.3 to 94.9,657
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2019,Age,0-2 Days,72.2,64.4 to 78.9,333
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2018,Age,0-2 Days,64.2,54.7 to 72.8,324
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2018-2019,Age,0-2 Days,68.2,62.1 to 73.8,657
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2017,Age,0-2 Days,57.2,49.4 to 64.7,374
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2017-2018,Age,0-2 Days,60.7,54.6 to 66.5,698
≥1 Dose Varicella,,States/Local Areas,Florida,2016,Age,35 Months,94.4,90.4 to 97.1,349
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2017,Age,35 Months,93.7,90.5 to 96.1,723
≥1 Dose MMR,,States/Local Areas,Florida,2013,Age,35 Months,90.4,84.1 to 94.9,272
≥1 Dose MMR,,States/Local Areas,Florida,2013-2014,Age,35 Months,93.3,88.9 to 96.4,546
≥1 Dose MMR,,States/Local Areas,Florida,2012,Age,35 Months,95.9,91.8 to 98.3,240
≥1 Dose MMR,,States/Local Areas,Florida,2011,Age,35 Months,93.3,86.9 to 97.2,236
≥1 Dose MMR,,States/Local Areas,Florida,2019,Age,24 Months,95.4,91.5 to 97.9,333
PCV,≥4 Doses,States/Local Areas,Florida,2015,Age,24 Months,80.0,73.4 to 85.9,309
PCV,≥4 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,80.6,75.9 to 84.8,658
PCV,≥4 Doses,States/Local Areas,Florida,2014,Age,24 Months,79.8,72.5 to 86.2,274
PCV,≥4 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,79.9,75.1 to 84.4,583
PCV,≥4 Doses,States/Local Areas,Florida,2013,Age,24 Months,84.0,77.8 to 89.4,272
PCV,≥4 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,81.9,77.0 to 86.2,546
PCV,≥4 Doses,States/Local Areas,Florida,2012,Age,24 Months,80.1,72.5 to 86.7,240
Hep B,≥3 Doses,States/Local Areas,Florida,2011,Age,35 Months,91.4,85.4 to 95.7,236
Hep B,≥3 Doses,States/Local Areas,Florida,2019,Age,24 Months,92.5,88.0 to 95.8,333
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.7,88.0 to 99.4,106
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,71.3,51.1 to 91.5,39
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,91.0,88.0 to 94.1,490
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,93.6,90.4 to 96.8,628
≥1 Dose Varicella,,States/Local Areas,Florida,2019,Age,35 Months,97.5,93.5 to 99.3,333
≥1 Dose MMR,,States/Local Areas,Florida,2016,Age,35 Months,93.6,89.2 to 96.7,349
≥1 Dose MMR,,States/Local Areas,Florida,2016-2017,Age,35 Months,93.4,90.5 to 95.7,723
≥1 Dose MMR,,States/Local Areas,Florida,2015,Age,35 Months,93.0,88.5 to 96.2,309
≥1 Dose MMR,,States/Local Areas,Florida,2015-2016,Age,35 Months,93.4,90.4 to 95.7,658
PCV,≥4 Doses,States/Local Areas,Florida,2018,Age,24 Months,80.7,72.9 to 87.3,324
PCV,≥4 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,81.2,76.0 to 85.8,657
PCV,≥4 Doses,States/Local Areas,Florida,2017,Age,24 Months,78.9,71.7 to 85.2,374
PCV,≥4 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,79.7,74.5 to 84.4,698
PCV,≥4 Doses,States/Local Areas,Florida,2016,Age,24 Months,81.1,74.4 to 87.0,349
PCV,≥4 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,80.0,75.2 to 84.4,723
Hep B,≥3 Doses,States/Local Areas,Florida,2012,Age,35 Months,93.1,87.6 to 96.8,240
Hep B,≥3 Doses,States/Local Areas,Florida,2015,Age,35 Months,90.2,84.8 to 94.3,309
Hep B,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,95.5,90.0 to 98.4,658
Hep B,≥3 Doses,States/Local Areas,Florida,2014,Age,35 Months,94.2,88.0 to 97.9,274
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,93.0,88.5 to 96.2,583
Hib,Full Series,States/Local Areas,Florida,2020,Age,24 Months,78.3,71.9 to 84.1,390
Hep B,≥3 Doses,States/Local Areas,Florida,2013,Age,35 Months,91.0,85.3 to 95.1,272
Hep B,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,93.1,88.9 to 96.2,546
PCV,≥3 Doses,States/Local Areas,Florida,2018,Age,13 Months,84.9,76.8 to 90.5,324
PCV,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,85.1,79.9 to 89.1,657
PCV,≥3 Doses,States/Local Areas,Florida,2017,Age,13 Months,82.4,75.2 to 87.9,374
PCV,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,83.7,78.5 to 87.8,698
Hep B,≥2 Doses,States/Local Areas,Florida,2013,Age,13 Months,94.0,92.4 to 95.3,272
Hep B,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,93.3,90.9 to 95.1,546
Hep B,≥2 Doses,States/Local Areas,Florida,2012,Age,13 Months,94.2,90.4 to 96.5,240
Hep B,≥2 Doses,States/Local Areas,Florida,2011,Age,13 Months,91.5,85.2 to 95.2,236
Hep B,≥2 Doses,States/Local Areas,Florida,2019,Age,7 Months,88.5,81.9 to 92.9,333
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,88.8 to 94.5,672
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,88.7 to 95.6,568
≥1 Dose MMR,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,92.8,89.5 to 96.1,628
≥1 Dose MMR,,States/Local Areas,Florida,2019,Age,35 Months,95.4,91.5 to 97.9,333
PCV,≥4 Doses,States/Local Areas,Florida,2013,Age,35 Months,85.1,78.8 to 90.4,272
PCV,≥4 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,83.5,78.6 to 87.8,546
≥1 Dose MMR,,States/Local Areas,Florida,2017,Age,35 Months,93.3,89.0 to 96.3,374
≥1 Dose MMR,,States/Local Areas,Florida,2017-2018,Age,35 Months,92.9,89.4 to 95.6,698
≥1 Dose MMR,,States/Local Areas,Florida,2018,Age,35 Months,92.4,86.4 to 96.5,324
≥1 Dose MMR,,States/Local Areas,Florida,2018-2019,Age,35 Months,94.1,90.6 to 96.6,657
PCV,≥3 Doses,States/Local Areas,Florida,2016,Age,19 Months,90.4,84.6 to 94.1,349
PCV,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,89.6,85.6 to 92.6,723
PCV,≥3 Doses,States/Local Areas,Florida,2015,Age,19 Months,90.2,87.9 to 92.1,309
PCV,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,90.3,86.4 to 93.1,658
Hep B,≥2 Doses,States/Local Areas,Florida,2019,Age,13 Months,93.2,88.2 to 96.1,333
Hep B,≥2 Doses,States/Local Areas,Florida,2018,Age,13 Months,93.8,87.9 to 96.9,324
Hep B,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,93.5,89.9 to 95.8,657
Hep B,≥2 Doses,States/Local Areas,Florida,2017,Age,13 Months,92.8,87.9 to 95.8,374
Hep B,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,93.3,89.8 to 95.6,698
Hib,≥1 Dose,States/Local Areas,Florida,2017,Age,3 Months,81.7,74.8 to 87.1,374
Hib,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,3 Months,83.7,78.4 to 87.8,698
Hib,≥1 Dose,States/Local Areas,Florida,2016,Age,3 Months,88.1,82.0 to 92.3,349
Hib,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,3 Months,84.9,80.5 to 88.5,723
Hib,≥1 Dose,States/Local Areas,Florida,2015,Age,3 Months,84.8,77.9 to 89.8,309
Hib,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,3 Months,86.4,82.0 to 89.9,658
≥1 Dose Varicella,,States/Local Areas,Florida,2012,Age,35 Months,95.2,91.1 to 97.8,240
≥1 Dose Varicella,,States/Local Areas,Florida,2011,Age,35 Months,93.1,86.3 to 97.3,236
≥1 Dose Varicella,,States/Local Areas,Florida,2019,Age,24 Months,91.2,85.5 to 95.3,333
≥1 Dose Varicella,,States/Local Areas,Florida,2018,Age,24 Months,92.2,86.4 to 96.2,324
≥1 Dose Varicella,,States/Local Areas,Florida,2018-2019,Age,24 Months,91.7,87.8 to 94.8,657
≥1 Dose MMR,,States/Local Areas,Florida,2015,Age,24 Months,92.1,87.5 to 95.5,309
≥1 Dose MMR,,States/Local Areas,Florida,2015-2016,Age,24 Months,92.4,89.3 to 94.9,658
≥1 Dose MMR,,States/Local Areas,Florida,2014,Age,24 Months,87.2,80.8 to 92.2,274
≥1 Dose MMR,,States/Local Areas,Florida,2014-2015,Age,24 Months,89.6,85.8 to 92.8,583
≥1 Dose MMR,,States/Local Areas,Florida,2013,Age,24 Months,86.9,80.7 to 91.9,272
≥1 Dose MMR,,States/Local Areas,Florida,2013-2014,Age,24 Months,87.0,82.6 to 90.7,546
PCV,≥4 Doses,States/Local Areas,Florida,2016,Age,19 Months,73.6,65.7 to 80.3,349
PCV,≥4 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,74.0,68.7 to 78.7,723
PCV,≥4 Doses,States/Local Areas,Florida,2015,Age,19 Months,77.2,63.1 to 87.0,309
PCV,≥4 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,75.5,70.2 to 80.1,658
PCV,≥3 Doses,States/Local Areas,Florida,2017,Age,7 Months,64.4,56.5 to 71.7,374
PCV,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,66.1,59.9 to 71.8,698
PCV,≥3 Doses,States/Local Areas,Florida,2016,Age,7 Months,66.2,57.8 to 73.6,349
PCV,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,65.3,59.5 to 70.7,723
Hep B,≥3 Doses,States/Local Areas,Florida,2014,Age,24 Months,90.4,84.3 to 94.8,274
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,89.7,85.8 to 93.0,583
Hep B,≥3 Doses,States/Local Areas,Florida,2012,Age,24 Months,91.0,85.8 to 94.9,240
Hep B,≥3 Doses,States/Local Areas,Florida,2013,Age,24 Months,89.2,83.7 to 93.5,272
Hep B,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,89.8,85.7 to 93.2,546
Hep B,≥3 Doses,States/Local Areas,Florida,2011,Age,24 Months,88.7,82.7 to 93.4,236
Hep B,≥3 Doses,States/Local Areas,Florida,2019,Age,19 Months,91.0,85.4 to 94.6,333
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2011,Age,0-2 Days,49.4,45.0 to 53.8,236
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2019,Age,0-1 Days,67.6,59.5 to 74.8,333
Hep B,≥2 Doses,States/Local Areas,Florida,2013,Age,7 Months,89.1,87.8 to 90.2,272
Hep B,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,89.4,87.5 to 91.0,546
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2013,Age,0-2 Days,56.7,51.8 to 61.5,272
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2013-2014,Age,0-2 Days,59.7,55.9 to 63.4,546
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2012,Age,0-2 Days,52.5,49.0 to 56.0,240
PCV,≥3 Doses,States/Local Areas,Florida,2011,Age,13 Months,82.6,78.8 to 85.9,236
PCV,≥3 Doses,States/Local Areas,Florida,2019,Age,7 Months,64.0,55.3 to 71.9,333
PCV,≥3 Doses,States/Local Areas,Florida,2018,Age,7 Months,67.7,58.1 to 76.0,324
PCV,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,65.9,59.5 to 71.7,657
Hep B,≥2 Doses,States/Local Areas,Florida,2015,Age,7 Months,86.1,79.3 to 91.0,309
Hep B,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,89.0,84.9 to 92.0,658
Hep B,≥2 Doses,States/Local Areas,Florida,2012,Age,7 Months,90.6,88.4 to 92.3,240
Hep B,≥2 Doses,States/Local Areas,Florida,2014,Age,7 Months,89.7,83.3 to 93.8,274
Hep B,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,87.9,83.5 to 91.3,583
≥1 Dose MMR,,States/Local Areas,Florida,2017,Age,24 Months,92.1,87.8 to 95.3,374
≥1 Dose MMR,,States/Local Areas,Florida,2017-2018,Age,24 Months,91.4,87.8 to 94.3,698
≥1 Dose MMR,,States/Local Areas,Florida,2016,Age,24 Months,92.8,88.3 to 96.0,349
≥1 Dose MMR,,States/Local Areas,Florida,2016-2017,Age,24 Months,92.4,89.4 to 94.8,723
PCV,≥4 Doses,States/Local Areas,Florida,2018,Age,19 Months,78.9,70.5 to 85.5,324
PCV,≥4 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,79.0,72.1 to 84.6,505
Hep B,≥3 Doses,States/Local Areas,Florida,2017,Age,24 Months,92.0,87.3 to 95.5,374
Hep B,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,91.7,88.0 to 94.6,698
Hep A,≥1 Dose,States/Local Areas,Florida,2020,Age,35 Months,87.0,81.0 to 91.8,390
PCV,≥3 Doses,States/Local Areas,Florida,2012,Age,13 Months,84.4,83.3 to 85.5,240
Hep B,≥3 Doses,States/Local Areas,Florida,2016,Age,24 Months,91.3,86.1 to 95.1,349
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,91.6,88.2 to 94.3,723
Hep B,≥3 Doses,States/Local Areas,Florida,2015,Age,24 Months,89.0,83.6 to 93.3,309
Hep B,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,90.1,86.5 to 93.1,658
PCV,≥3 Doses,States/Local Areas,Florida,2013,Age,13 Months,91.7,83.5 to 96.0,272
PCV,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,87.0,79.0 to 92.3,546
≥1 Dose Varicella,,States/Local Areas,Florida,2017,Age,24 Months,90.6,85.4 to 94.5,374
≥1 Dose Varicella,,States/Local Areas,Florida,2017-2018,Age,24 Months,91.4,87.7 to 94.3,698
≥1 Dose Varicella,,States/Local Areas,Florida,2016,Age,24 Months,93.2,88.9 to 96.3,349
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2017,Age,24 Months,91.9,88.7 to 94.6,723
≥1 Dose Varicella,,States/Local Areas,Florida,2015,Age,24 Months,91.0,85.6 to 95.0,309
≥1 Dose Varicella,,States/Local Areas,Florida,2015-2016,Age,24 Months,92.1,88.8 to 94.8,658
≥1 Dose MMR,,States/Local Areas,Florida,2012,Age,24 Months,88.9,82.8 to 93.6,240
PCV,≥3 Doses,States/Local Areas,Florida,2015,Age,7 Months,63.2,54.9 to 70.8,309
PCV,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,64.7,58.8 to 70.1,658
≥1 Dose MMR,,States/Local Areas,Florida,2011,Age,24 Months,92.2,86.0 to 96.3,236
≥1 Dose MMR,,States/Local Areas,Florida,2019,Age,19 Months,92.5,87.2 to 95.7,333
PCV,≥4 Doses,States/Local Areas,Florida,2014,Age,19 Months,76.9,69.1 to 83.3,274
PCV,≥4 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,77.1,71.9 to 81.6,583
≥1 Dose MMR,,States/Local Areas,Florida,2018,Age,19 Months,90.6,83.7 to 94.8,324
≥1 Dose MMR,,States/Local Areas,Florida,2018-2019,Age,19 Months,93.5,90.1 to 95.8,657
PCV,≥4 Doses,States/Local Areas,Florida,2013,Age,19 Months,81.3,71.6 to 88.2,272
PCV,≥4 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,79.1,72.1 to 84.7,546
PCV,≥4 Doses,States/Local Areas,Florida,2012,Age,19 Months,76.5,74.1 to 78.8,240
PCV,≥4 Doses,States/Local Areas,Florida,2011,Age,19 Months,73.3,66.7 to 79.0,236
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2015,Age,0-2 Days,61.6,53.4 to 69.2,309
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2015-2016,Age,0-2 Days,60.8,55.1 to 66.2,658
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2014,Age,0-2 Days,62.7,54.0 to 70.6,274
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2014-2015,Age,0-2 Days,62.1,56.2 to 67.7,583
≥1 Dose Varicella,,States/Local Areas,Florida,2015,Age,35 Months,93.0,87.6 to 96.5,309
≥1 Dose Varicella,,States/Local Areas,Florida,2015-2016,Age,35 Months,93.7,90.5 to 96.1,658
PCV,≥4 Doses,States/Local Areas,Florida,2011,Age,24 Months,76.8,68.4 to 84.3,236
≥1 Dose Varicella,,States/Local Areas,Florida,2014,Age,35 Months,95.6,90.9 to 98.2,274
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2015,Age,35 Months,95.6,91.5 to 98.1,583
≥1 Dose Varicella,,States/Local Areas,Florida,2013,Age,35 Months,94.2,89.3 to 97.3,272
≥1 Dose Varicella,,States/Local Areas,Florida,2013-2014,Age,35 Months,95.3,91.7 to 97.6,546
≥1 Dose MMR,,States/Local Areas,Florida,2018,Age,24 Months,90.6,84.4 to 95.1,324
≥1 Dose MMR,,States/Local Areas,Florida,2018-2019,Age,24 Months,93.1,89.5 to 95.8,657
PCV,≥4 Doses,States/Local Areas,Florida,2019,Age,19 Months,79.2,71.5 to 85.2,333
PCV,≥3 Doses,States/Local Areas,Florida,2016,Age,13 Months,87.0,80.7 to 91.5,349
PCV,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,84.7,80.1 to 88.4,723
Hep B,≥3 Doses,States/Local Areas,Florida,2018,Age,24 Months,91.3,85.1 to 95.6,324
Hep B,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,91.9,88.2 to 94.8,657
PCV,≥3 Doses,States/Local Areas,Florida,2015,Age,13 Months,88.1,81.7 to 92.5,309
PCV,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,87.6,83.3 to 90.9,658
PCV,≥3 Doses,States/Local Areas,Florida,2014,Age,13 Months,82.6,75.0 to 88.2,274
PCV,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,85.4,80.6 to 89.1,583
Hep B,≥2 Doses,States/Local Areas,Florida,2018,Age,7 Months,90.6,83.8 to 94.7,324
Hep B,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,89.5,85.1 to 92.7,657
Hep B,≥2 Doses,States/Local Areas,Florida,2017,Age,7 Months,85.7,79.2 to 90.4,374
Hep B,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,88.1,83.8 to 91.4,698
Hep B,≥2 Doses,States/Local Areas,Florida,2016,Age,7 Months,91.8,87.1 to 94.9,349
Hep B,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,88.7,84.9 to 91.7,723
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2016,Age,0-2 Days,60.0,51.9 to 67.6,349
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2016-2017,Age,0-2 Days,58.6,53.0 to 64.0,723
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2018,Age,0-1 Days,60.5,51.0 to 69.2,324
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2018-2019,Age,0-1 Days,64.1,57.8 to 69.8,657
Hep B,≥2 Doses,States/Local Areas,Florida,2018,Age,5 Months,84.3,76.1 to 90.0,324
Hep B,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,5 Months,84.0,78.8 to 88.2,657
Hep B,≥2 Doses,States/Local Areas,Florida,2011,Age,7 Months,85.5,81.3 to 88.9,236
Hep B,≥2 Doses,States/Local Areas,Florida,2019,Age,5 Months,83.7,76.4 to 89.1,333
≥1 Dose MMR,,States/Local Areas,Florida,2014,Age,35 Months,95.1,90.2 to 98.0,274
≥1 Dose MMR,,States/Local Areas,Florida,2014-2015,Age,35 Months,95.2,91.3 to 97.7,583
≥1 Dose Varicella,,States/Local Areas,Florida,2018,Age,35 Months,92.8,86.9 to 96.7,324
≥1 Dose Varicella,,States/Local Areas,Florida,2018-2019,Age,35 Months,94.5,90.3 to 97.3,657
≥1 Dose Varicella,,States/Local Areas,Florida,2017,Age,35 Months,92.6,87.5 to 96.1,374
≥1 Dose Varicella,,States/Local Areas,Florida,2017-2018,Age,35 Months,92.7,89.0 to 95.6,698
≥1 Dose MMR,,States/Local Areas,Florida,2015,Age,13 Months,62.7,54.5 to 70.3,309
≥1 Dose MMR,,States/Local Areas,Florida,2015-2016,Age,13 Months,62.0,56.2 to 67.5,658
≥1 Dose MMR,,States/Local Areas,Florida,2014,Age,13 Months,60.8,52.2 to 68.7,274
≥1 Dose MMR,,States/Local Areas,Florida,2014-2015,Age,13 Months,61.7,55.9 to 67.3,583
≥1 Dose Varicella,,States/Local Areas,Florida,2013,Age,19 Months,87.9,80.9 to 92.6,272
≥1 Dose Varicella,,States/Local Areas,Florida,2013-2014,Age,19 Months,87.4,82.3 to 91.2,546
≥1 Dose Varicella,,States/Local Areas,Florida,2012,Age,19 Months,84.3,75.2 to 90.4,240
≥1 Dose Varicella,,States/Local Areas,Florida,2011,Age,19 Months,85.7,80.2 to 89.9,236
≥1 Dose Varicella,,States/Local Areas,Florida,2019,Age,13 Months,67.5,59.3 to 74.8,333
≥1 Dose Varicella,,States/Local Areas,Florida,2018,Age,13 Months,65.7,56.2 to 74.1,324
≥1 Dose Varicella,,States/Local Areas,Florida,2018-2019,Age,13 Months,66.6,60.4 to 72.3,657
≥1 Dose MMR,,States/Local Areas,Florida,2016,Age,13 Months,61.3,53.1 to 69.0,349
≥1 Dose MMR,,States/Local Areas,Florida,2016-2017,Age,13 Months,60.8,55.2 to 66.2,723
DTaP,≥4 Doses,States/Local Areas,Florida,2015,Age,35 Months,86.8,80.2 to 92.1,309
DTaP,≥4 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,89.4,84.1 to 93.5,658
DTaP,≥4 Doses,States/Local Areas,Florida,2012,Age,35 Months,85.8,78.1 to 91.9,240
DTaP,≥4 Doses,States/Local Areas,Florida,2014,Age,35 Months,87.1,79.9 to 92.7,274
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,87.2,82.4 to 91.2,583
DTaP,≥4 Doses,States/Local Areas,Florida,2013,Age,35 Months,91.2,85.2 to 95.4,272
DTaP,≥4 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,88.9,84.1 to 92.8,546
Hep A,≥2 Doses,States/Local Areas,Florida,2019,Age,35 Months,77.3,67.7 to 85.7,333
Hep B,≥3 Doses,States/Local Areas,Florida,2012,Age,13 Months,85.3,78.6 to 90.1,240
Hep A,≥2 Doses,States/Local Areas,Florida,2018,Age,35 Months,65.8,54.3 to 77.0,324
Hep A,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,71.5,63.9 to 78.7,657
Hep A,≥2 Doses,States/Local Areas,Florida,2017,Age,35 Months,68.8,59.5 to 77.7,374
Hep A,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,67.4,59.9 to 74.7,698
Hep B,≥3 Doses,States/Local Areas,Florida,2014,Age,13 Months,83.8,76.5 to 89.1,274
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,83.2,78.3 to 87.2,583
Hep B,≥3 Doses,States/Local Areas,Florida,2013,Age,13 Months,84.2,78.8 to 88.5,272
Hep B,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,84.0,80.6 to 86.9,546
DTaP,≥4 Doses,States/Local Areas,Florida,2011,Age,35 Months,88.2,79.9 to 94.2,236
DTaP,≥4 Doses,States/Local Areas,Florida,2019,Age,24 Months,82.6,75.5 to 88.7,333
DTaP,≥4 Doses,States/Local Areas,Florida,2018,Age,24 Months,83.0,75.3 to 89.5,324
DTaP,≥4 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,82.9,77.7 to 87.5,657
Hep B,≥3 Doses,States/Local Areas,Florida,2011,Age,13 Months,79.3,74.2 to 83.6,236
Polio,≥2 Doses,States/Local Areas,Florida,2016,Age,7 Months,89.1,83.1 to 93.1,349
Polio,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,86.8,82.5 to 90.2,723
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,82.6,78.1 to 87.1,467
Polio,≥2 Doses,States/Local Areas,Florida,2015,Age,7 Months,87.9,81.3 to 92.4,309
Polio,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,88.5,84.3 to 91.7,658
Polio,≥2 Doses,States/Local Areas,Florida,2014,Age,7 Months,84.8,77.4 to 90.1,274
Polio,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,86.3,81.6 to 90.0,583
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,71.7,65.2 to 78.1,340
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Overall,Overall,77.2,73.7 to 80.8,1171
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,78.4,73.9 to 83.0,672
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.3,68.5 to 80.1,568
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.4,70.7 to 82.2,469
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,64.9,42.4 to 87.4,30
≥1 Dose Varicella,,States/Local Areas,Florida,2017,Age,13 Months,58.5,50.7 to 65.9,374
≥1 Dose Varicella,,States/Local Areas,Florida,2017-2018,Age,13 Months,62.0,56.0 to 67.7,698
≥1 Dose Varicella,,States/Local Areas,Florida,2016,Age,13 Months,62.1,53.9 to 69.8,349
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2017,Age,13 Months,60.3,54.6 to 65.8,723
≥1 Dose MMR,,States/Local Areas,Florida,2017,Age,13 Months,60.3,52.7 to 67.5,374
≥1 Dose MMR,,States/Local Areas,Florida,2017-2018,Age,13 Months,64.4,58.4 to 69.9,698
≥1 Dose MMR,,States/Local Areas,Florida,2019,Age,13 Months,71.3,63.4 to 78.1,333
≥1 Dose MMR,,States/Local Areas,Florida,2018,Age,13 Months,68.5,58.9 to 76.8,324
≥1 Dose MMR,,States/Local Areas,Florida,2018-2019,Age,13 Months,69.9,63.8 to 75.4,657
Polio,≥2 Doses,States/Local Areas,Florida,2012,Age,13 Months,95.4,91.3 to 97.6,240
Polio,≥2 Doses,States/Local Areas,Florida,2011,Age,13 Months,91.7,86.0 to 95.2,236
≥1 Dose Varicella,,States/Local Areas,Florida,2016,Age,19 Months,84.7,77.3 to 90.0,349
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2017,Age,19 Months,85.7,81.1 to 89.3,723
≥1 Dose Varicella,,States/Local Areas,Florida,2015,Age,19 Months,88.2,81.6 to 92.6,309
≥1 Dose Varicella,,States/Local Areas,Florida,2015-2016,Age,19 Months,86.5,81.8 to 90.1,658
≥1 Dose Varicella,,States/Local Areas,Florida,2014,Age,19 Months,86.9,80.0 to 91.7,274
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2015,Age,19 Months,87.6,83.1 to 91.0,583
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,62.5,53.3 to 71.7,340
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,68.6,63.3 to 73.9,1171
Polio,≥2 Doses,States/Local Areas,Florida,2019,Age,7 Months,86.1,79.1 to 91.0,333
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.9,62.0 to 77.7,469
Hep A,≥1 Dose,States/Local Areas,Florida,2014,Age,35 Months,81.8,73.7 to 88.7,274
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,35 Months,82.4,77.0 to 87.2,583
Hep A,≥1 Dose,States/Local Areas,Florida,2013,Age,35 Months,81.1,73.4 to 87.6,272
Hep A,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,35 Months,81.4,75.9 to 86.3,546
≥1 Dose MMR,,States/Local Areas,Florida,2013,Age,13 Months,52.0,43.7 to 60.1,272
≥1 Dose MMR,,States/Local Areas,Florida,2013-2014,Age,13 Months,56.4,52.0 to 60.7,546
≥1 Dose MMR,,States/Local Areas,Florida,2012,Age,13 Months,50.1,45.7 to 54.5,240
≥1 Dose MMR,,States/Local Areas,Florida,2011,Age,13 Months,45.7,39.2 to 52.4,236
Hep B,≥1 Dose,States/Local Areas,Florida,2017,Age,3 Months,88.8,82.9 to 92.9,374
Hep B,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,3 Months,91.9,88.3 to 94.5,698
Hep B,≥1 Dose,States/Local Areas,Florida,2016,Age,3 Months,93.1,88.6 to 95.9,349
Hep B,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,3 Months,91.0,87.4 to 93.6,723
Hep B,≥1 Dose,States/Local Areas,Florida,2015,Age,3 Months,90.5,84.3 to 94.4,309
Hep B,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,3 Months,91.8,88.2 to 94.4,658
Polio,≥2 Doses,States/Local Areas,Florida,2014,Age,13 Months,88.9,82.3 to 93.3,274
Polio,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,13 Months,89.7,85.5 to 92.7,583
Polio,≥2 Doses,States/Local Areas,Florida,2013,Age,13 Months,96.8,94.7 to 98.1,272
Polio,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,13 Months,92.8,87.3 to 96.0,546
≥1 Dose Varicella,,States/Local Areas,Florida,2013,Age,13 Months,63.6,52.3 to 73.5,272
≥1 Dose Varicella,,States/Local Areas,Florida,2013-2014,Age,13 Months,63.0,56.4 to 69.1,546
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,75.1,34.6 to 100.0,30
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,67.4,60.4 to 74.4,672
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.9,62.0 to 75.8,568
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.2,54.6 to 79.9,157
DTaP,≥4 Doses,States/Local Areas,Florida,2018,Age,35 Months,88.7,80.7 to 94.4,324
DTaP,≥4 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,88.5,83.4 to 92.7,657
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,41.6,18.2 to 64.9,39
DTaP,≥4 Doses,States/Local Areas,Florida,2017,Age,35 Months,92.9,87.2 to 96.7,374
DTaP,≥4 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,90.6,85.8 to 94.4,698
DTaP,≥4 Doses,States/Local Areas,Florida,2016,Age,35 Months,92.1,83.8 to 97.1,349
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,92.1,87.5 to 95.5,723
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,67.2,58.3 to 76.2,340
Hep B,≥3 Doses,States/Local Areas,Florida,2017,Age,13 Months,86.1,79.9 to 90.6,374
Hep B,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,84.5,79.4 to 88.5,698
Hep B,≥3 Doses,States/Local Areas,Florida,2015,Age,13 Months,82.6,75.3 to 88.1,309
Hep B,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,82.1,77.0 to 86.2,658
Hep B,≥3 Doses,States/Local Areas,Florida,2016,Age,13 Months,81.6,74.1 to 87.3,349
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,83.9,79.1 to 87.7,723
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.9,54.1 to 87.7,106
≥1 Dose MMR,,States/Local Areas,Florida,2011,Age,19 Months,87.0,81.1 to 91.3,236
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.2,68.1 to 88.2,106
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,65.6,44.0 to 87.2,39
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,79.5,74.6 to 84.4,490
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,86.4,82.3 to 90.6,628
DTaP,≥4 Doses,States/Local Areas,Florida,2019,Age,35 Months,87.9,81.2 to 93.1,333
Polio,≥2 Doses,States/Local Areas,Florida,2017,Age,13 Months,93.1,88.2 to 96.1,374
Polio,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,13 Months,93.4,89.8 to 95.7,698
Polio,≥2 Doses,States/Local Areas,Florida,2016,Age,13 Months,93.8,89.6 to 96.4,349
Polio,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,13 Months,93.5,90.5 to 95.6,723
Polio,≥2 Doses,States/Local Areas,Florida,2015,Age,13 Months,90.4,84.4 to 94.2,309
Polio,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,13 Months,92.1,88.6 to 94.6,658
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,82.5,77.0 to 87.9,340
≥1 Dose Varicella,,States/Local Areas,Florida,2018,Age,19 Months,90.3,83.4 to 94.5,324
≥1 Dose Varicella,,States/Local Areas,Florida,2018-2019,Age,19 Months,66.6,60.4 to 72.3,657
≥1 Dose Varicella,,States/Local Areas,Florida,2017,Age,19 Months,86.7,80.4 to 91.2,374
≥1 Dose Varicella,,States/Local Areas,Florida,2017-2018,Age,19 Months,88.5,84.1 to 91.7,698
≥1 Dose MMR,,States/Local Areas,Florida,2014,Age,19 Months,85.6,78.7 to 90.6,274
≥1 Dose MMR,,States/Local Areas,Florida,2014-2015,Age,19 Months,87.5,83.1 to 90.8,583
≥1 Dose MMR,,States/Local Areas,Florida,2012,Age,19 Months,85.9,84.2 to 87.4,240
≥1 Dose MMR,,States/Local Areas,Florida,2013,Age,19 Months,82.9,79.7 to 85.7,272
≥1 Dose MMR,,States/Local Areas,Florida,2013-2014,Age,19 Months,84.3,81.1 to 87.1,546
Hep B,≥3 Doses,States/Local Areas,Florida,2016,Age,19 Months,88.5,82.0 to 92.9,349
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,89.6,85.5 to 92.6,723
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,81.9,78.6 to 85.2,1171
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,79.8,57.7 to 100.0,30
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,81.6,77.2 to 86.0,672
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.5,77.3 to 87.6,469
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.5,78.8 to 88.2,568
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,71.2 to 90.1,157
≥1 Dose Varicella,,States/Local Areas,Florida,2012,Age,24 Months,90.2,84.6 to 94.4,240
≥1 Dose Varicella,,States/Local Areas,Florida,2011,Age,24 Months,92.3,85.7 to 96.6,236
≥1 Dose MMR,,States/Local Areas,Florida,2017,Age,19 Months,89.1,83.5 to 92.9,374
≥1 Dose MMR,,States/Local Areas,Florida,2017-2018,Age,19 Months,89.8,85.7 to 92.9,698
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,78.6,72.7 to 84.5,340
≥1 Dose MMR,,States/Local Areas,Florida,2016,Age,19 Months,86.5,79.6 to 91.3,349
≥1 Dose MMR,,States/Local Areas,Florida,2016-2017,Age,19 Months,87.8,83.5 to 91.0,723
≥1 Dose MMR,,States/Local Areas,Florida,2015,Age,19 Months,89.3,86.3 to 91.7,309
≥1 Dose MMR,,States/Local Areas,Florida,2015-2016,Age,19 Months,87.9,83.5 to 91.2,658
Hep B,≥3 Doses,States/Local Areas,Florida,2015,Age,19 Months,88.2,86.4 to 89.7,309
Hep B,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,88.3,84.2 to 91.5,658
Hep B,≥3 Doses,States/Local Areas,Florida,2014,Age,19 Months,89.4,82.8 to 93.7,274
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,88.8,84.6 to 91.9,583
Hep B,≥2 Doses,States/Local Areas,Florida,2014,Age,5 Months,83.8,76.3 to 89.3,274
Hep B,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,5 Months,84.0,82.3 to 85.7,583
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,68.3,59.1 to 77.5,364
Hep B,≥2 Doses,States/Local Areas,Florida,2013,Age,5 Months,82.2,79.5 to 84.6,272
Hep B,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,5 Months,83.0,80.9 to 84.9,546
Hep B,≥2 Doses,States/Local Areas,Florida,2012,Age,5 Months,82.9,81.0 to 84.6,240
Hep B,≥2 Doses,States/Local Areas,Florida,2011,Age,5 Months,77.0,70.8 to 82.2,236
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,76.0,68.5 to 83.5,467
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2012,Age,0-1 Days,46.5,41.3 to 51.8,240
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2011,Age,0-1 Days,43.1,37.8 to 48.6,236
Hep B,≥1 Dose,States/Local Areas,Florida,2019,Age,3 Months,93.4,87.7 to 96.6,333
≥1 Dose Varicella,,States/Local Areas,Florida,2019,Age,19 Months,89.5,83.1 to 93.7,333
Hep B,≥1 Dose,States/Local Areas,Florida,2018,Age,3 Months,95.1,90.2 to 97.6,324
Hep B,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,3 Months,94.2,90.8 to 96.4,657
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,79.7,73.4 to 86.1,364
Polio,≥2 Doses,States/Local Areas,Florida,2018,Age,7 Months,88.0,80.2 to 92.9,324
Polio,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,87.0,82.1 to 90.8,657
Polio,≥2 Doses,States/Local Areas,Florida,2017,Age,7 Months,84.6,77.7 to 89.6,374
Polio,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,86.3,81.2 to 90.1,698
Hep B,≥1 Dose,States/Local Areas,Florida,2014,Age,3 Months,95.4,91.1 to 97.7,274
Hep B,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,3 Months,92.9,89.4 to 95.4,583
Hep B,≥1 Dose,States/Local Areas,Florida,2013,Age,3 Months,93.0,91.1 to 94.5,272
Hep B,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,3 Months,94.2,92.8 to 95.4,546
Hep B,≥1 Dose,States/Local Areas,Florida,2012,Age,3 Months,93.2,91.2 to 94.7,240
Hep B,≥1 Dose,States/Local Areas,Florida,2011,Age,3 Months,88.6,82.0 to 93.0,236
Hep B,≥3 Doses,States/Local Areas,Florida,2013,Age,19 Months,87.5,82.1 to 91.5,272
Hep B,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,88.5,86.3 to 90.4,546
Hep B,≥3 Doses,States/Local Areas,Florida,2012,Age,19 Months,89.2,78.2 to 95.0,240
Hep B,≥3 Doses,States/Local Areas,Florida,2011,Age,19 Months,87.1,79.9 to 92.0,236
Hep B,≥3 Doses,States/Local Areas,Florida,2019,Age,13 Months,89.2,83.1 to 93.3,333
Hep B,≥3 Doses,States/Local Areas,Florida,2018,Age,13 Months,82.9,74.1 to 89.1,324
Hep B,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,86.0,80.9 to 90.0,657
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,66.9,59.7 to 74.2,490
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,74.7,66.6 to 82.8,628
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2017,Age,0-1 Days,48.0,40.5 to 55.7,374
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2017-2018,Age,0-1 Days,54.2,48.2 to 60.1,698
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2016,Age,0-1 Days,50.5,42.3 to 58.6,349
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2016-2017,Age,0-1 Days,49.2,43.6 to 54.9,723
Hep B,≥2 Doses,States/Local Areas,Florida,2017,Age,5 Months,80.6,73.6 to 86.1,374
Hep B,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,5 Months,82.4,77.2 to 86.7,698
Hep B,≥2 Doses,States/Local Areas,Florida,2016,Age,5 Months,88.8,83.3 to 92.6,349
Hep B,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,5 Months,84.7,80.3 to 88.2,723
Hep B,≥3 Doses,States/Local Areas,Florida,2018,Age,19 Months,90.4,83.5 to 94.6,324
Hep B,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,86.0,80.9 to 90.0,657
Hep B,≥3 Doses,States/Local Areas,Florida,2017,Age,19 Months,90.6,85.1 to 94.3,374
Hep B,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,90.5,86.4 to 93.5,698
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,88.0,82.9 to 93.1,364
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,82.4,77.4 to 87.4,467
PCV,≥3 Doses,States/Local Areas,Florida,2012,Age,7 Months,57.0,47.7 to 65.9,240
PCV,≥3 Doses,States/Local Areas,Florida,2014,Age,7 Months,60.1,51.3 to 68.3,274
PCV,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,61.6,55.6 to 67.3,583
PCV,≥3 Doses,States/Local Areas,Florida,2011,Age,7 Months,58.1,55.0 to 61.1,236
PCV,≥3 Doses,States/Local Areas,Florida,2013,Age,7 Months,64.4,58.6 to 69.8,272
PCV,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,62.2,58.0 to 66.3,546
Hep B,≥2 Doses,States/Local Areas,Florida,2015,Age,5 Months,84.3,77.4 to 89.4,309
Hep B,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,5 Months,86.5,82.3 to 89.9,658
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2015,Age,0-1 Days,49.7,41.5 to 57.8,309
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2015-2016,Age,0-1 Days,50.1,44.3 to 55.9,658
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2014,Age,0-1 Days,55.0,46.3 to 63.5,274
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2014-2015,Age,0-1 Days,52.3,46.3 to 58.3,583
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2013,Age,0-1 Days,49.7,40.6 to 58.9,272
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2013-2014,Age,0-1 Days,52.4,46.8 to 57.9,546
Polio,≥2 Doses,States/Local Areas,Florida,2019,Age,13 Months,92.1,86.4 to 95.5,333
Polio,≥2 Doses,States/Local Areas,Florida,2018,Age,13 Months,93.6,87.6 to 96.8,324
Polio,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,13 Months,92.8,89.0 to 95.4,657
≥1 Dose Varicella,,States/Local Areas,Florida,2014,Age,24 Months,87.4,81.1 to 92.4,274
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2015,Age,24 Months,89.2,85.2 to 92.6,583
≥1 Dose Varicella,,States/Local Areas,Florida,2013,Age,24 Months,91.5,86.6 to 95.1,272
≥1 Dose Varicella,,States/Local Areas,Florida,2013-2014,Age,24 Months,89.3,85.4 to 92.6,546
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.1,86.3 to 94.0,469
Hib,Full Series,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,85.3,81.0 to 89.5,628
DTaP,≥4 Doses,States/Local Areas,Florida,2017,Age,24 Months,80.3,73.6 to 86.2,374
DTaP,≥4 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,81.7,76.7 to 86.2,698
DTaP,≥4 Doses,States/Local Areas,Florida,2016,Age,24 Months,81.0,74.1 to 87.0,349
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,80.7,75.9 to 85.0,723
DTaP,≥4 Doses,States/Local Areas,Florida,2015,Age,24 Months,83.2,76.6 to 88.9,309
DTaP,≥4 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,82.2,77.5 to 86.5,658
Hep A,≥2 Doses,States/Local Areas,Florida,2013,Age,35 Months,68.5,58.3 to 78.3,272
Hep A,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,66.1,58.8 to 73.3,546
Hep A,≥2 Doses,States/Local Areas,Florida,2012,Age,35 Months,66.4,56.5 to 76.0,240
Hep A,≥2 Doses,States/Local Areas,Florida,2011,Age,35 Months,63.5,47.8 to 79.1,236
Hep A,≥2 Doses,States/Local Areas,Florida,2019,Age,24 Months,49.2,40.9 to 58.3,333
Hib,≥3 Doses,States/Local Areas,Florida,2019,Age,35 Months,94.1,89.8 to 97.0,333
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,92.6,90.5 to 94.7,1171
Hep A,≥2 Doses,States/Local Areas,Florida,2015,Age,24 Months,35.3,28.0 to 43.9,309
Hep A,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,36.1,30.8 to 42.1,658
Hep A,≥2 Doses,States/Local Areas,Florida,2014,Age,24 Months,38.4,30.2 to 47.9,274
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,36.8,31.1 to 43.2,583
Hep A,≥2 Doses,States/Local Areas,Florida,2013,Age,24 Months,40.5,32.8 to 49.2,272
Hep A,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,39.4,33.7 to 45.7,546
DTaP,≥4 Doses,States/Local Areas,Florida,2018,Age,19 Months,70.3,60.7 to 78.3,324
DTaP,≥4 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,92.8,89.0 to 95.4,657
DTaP,≥4 Doses,States/Local Areas,Florida,2017,Age,19 Months,72.8,65.3 to 79.1,374
DTaP,≥4 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,71.5,65.6 to 76.8,698
DTaP,≥4 Doses,States/Local Areas,Florida,2016,Age,19 Months,68.2,60.0 to 75.4,349
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,70.5,65.1 to 75.4,723
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,90.0 to 95.4,672
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,90.7 to 96.8,568
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,88.1 to 95.3,469
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,100.0,,30
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,81.2 to 96.4,157
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,92.7,89.4 to 95.9,340
PCV,≥2 Doses,States/Local Areas,Florida,2019,Age,5 Months,72.0,63.2 to 79.4,333
PCV,≥2 Doses,States/Local Areas,Florida,2018,Age,5 Months,77.3,68.7 to 84.1,324
PCV,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,5 Months,74.7,68.6 to 79.9,657
Hep B,≥3 Doses,States/Local Areas,Florida,2016,Age,7 Months,48.8,40.7 to 57.0,349
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,7 Months,49.3,43.7 to 55.0,723
Hep B,≥3 Doses,States/Local Areas,Florida,2015,Age,7 Months,49.1,41.0 to 57.3,309
Hep B,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,7 Months,49.0,43.2 to 54.8,658
Hep B,≥3 Doses,States/Local Areas,Florida,2014,Age,7 Months,47.4,38.9 to 56.0,274
Hep B,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,7 Months,48.3,42.3 to 54.2,583
Polio,≥2 Doses,States/Local Areas,Florida,2017,Age,5 Months,75.0,67.5 to 81.3,374
Polio,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,5 Months,77.3,71.7 to 82.1,698
Polio,≥2 Doses,States/Local Areas,Florida,2016,Age,5 Months,76.6,68.9 to 82.9,349
Polio,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,5 Months,75.8,70.6 to 80.4,723
Hep A,≥1 Dose,States/Local Areas,Florida,2018,Age,35 Months,81.4,72.7 to 88.6,324
Hep A,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,35 Months,87.5,81.9 to 92.1,657
≥1 Dose Varicella,,States/Local Areas,Florida,2011,Age,13 Months,52.4,46.4 to 58.3,236
Hep A,≥1 Dose,States/Local Areas,Florida,2017,Age,35 Months,83.4,76.2 to 89.5,374
Hep A,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,35 Months,82.2,76.6 to 87.1,698
Hep A,≥1 Dose,States/Local Areas,Florida,2016,Age,35 Months,85.2,77.4 to 91.5,349
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,35 Months,84.1,79.0 to 88.6,723
Polio,≥2 Doses,States/Local Areas,Florida,2018,Age,5 Months,79.7,71.0 to 86.2,324
Polio,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,5 Months,77.6,71.7 to 82.6,657
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.0,69.5 to 88.5,106
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,58.1,36.3 to 79.8,39
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,74.6,69.4 to 79.9,490
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,82.7,78.2 to 87.2,628
Hep A,≥1 Dose,States/Local Areas,Florida,2019,Age,35 Months,94.6,89.6 to 97.7,333
≥1 Dose Varicella,,States/Local Areas,Florida,2015,Age,13 Months,63.2,54.9 to 70.7,309
≥1 Dose Varicella,,States/Local Areas,Florida,2015-2016,Age,13 Months,62.7,56.9 to 68.1,658
≥1 Dose Varicella,,States/Local Areas,Florida,2012,Age,13 Months,58.1,53.7 to 62.4,240
≥1 Dose Varicella,,States/Local Areas,Florida,2014,Age,13 Months,62.4,53.8 to 70.3,274
≥1 Dose Varicella,,States/Local Areas,Florida,2014-2015,Age,13 Months,62.8,56.9 to 68.3,583
Hep A,≥2 Doses,States/Local Areas,Florida,2016,Age,35 Months,67.9,57.4 to 77.9,349
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,68.2,61.2 to 75.0,723
Hep A,≥2 Doses,States/Local Areas,Florida,2015,Age,35 Months,65.4,55.5 to 75.1,309
Hep A,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,66.6,59.4 to 73.7,658
Hep A,≥2 Doses,States/Local Areas,Florida,2014,Age,35 Months,64.3,53.7 to 74.7,274
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,64.6,57.3 to 71.9,583
Hep B,≥3 Doses,States/Local Areas,Florida,2019,Age,7 Months,49.7,41.4 to 58.1,333
Polio,≥2 Doses,States/Local Areas,Florida,2013,Age,7 Months,91.9,89.5 to 93.8,272
Polio,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,88.3,82.8 to 92.2,546
Hep B,≥3 Doses,States/Local Areas,Florida,2018,Age,7 Months,48.3,39.1 to 57.6,324
Hep B,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,7 Months,49.0,42.8 to 55.3,657
Hep B,≥3 Doses,States/Local Areas,Florida,2017,Age,7 Months,49.8,42.1 to 57.5,374
Hep B,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,7 Months,49.1,43.0 to 55.1,698
Polio,≥2 Doses,States/Local Areas,Florida,2012,Age,7 Months,91.2,89.9 to 92.4,240
Polio,≥2 Doses,States/Local Areas,Florida,2011,Age,7 Months,83.9,77.2 to 88.9,236
Polio,≥2 Doses,States/Local Areas,Florida,2019,Age,5 Months,75.5,66.9 to 82.5,333
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.3,68.7 to 88.0,157
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,79.1,73.2 to 84.9,340
Hib,Full Series,States/Local Areas,Florida,2019,Age,35 Months,89.5,82.9 to 94.4,333
Hib,Full Series,States/Local Areas,Florida,2018,Age,35 Months,80.3,71.7 to 87.6,324
Hib,Full Series,States/Local Areas,Florida,2018-2019,Age,35 Months,84.8,79.3 to 89.5,657
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,87.5 to 93.7,672
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.3,89.0 to 95.5,568
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,79.7 to 95.6,157
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,89.2,85.0 to 93.4,340
Hib,Full Series,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.8,68.8 to 88.8,106
Hib,Full Series,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,76.3,71.2 to 81.4,490
Hib,Full Series,States/Local Areas,Florida,2016,Age,35 Months,82.4,74.5 to 89.0,349
Hib,Full Series,States/Local Areas,Florida,2016-2017,Age,35 Months,82.7,77.5 to 87.3,723
Hib,Full Series,States/Local Areas,Florida,2015,Age,35 Months,80.2,73.1 to 86.4,309
Hib,Full Series,States/Local Areas,Florida,2015-2016,Age,35 Months,81.1,76.0 to 85.8,658
Hib,Full Series,States/Local Areas,Florida,2020-2021,Age,24 Months,77.4,72.0 to 82.4,666
Hib,Full Series,States/Local Areas,Florida,2017,Age,35 Months,82.9,75.6 to 89.1,374
Hib,Full Series,States/Local Areas,Florida,2017-2018,Age,35 Months,81.5,76.0 to 86.4,698
Polio,≥3 Doses,States/Local Areas,Florida,2018,Age,35 Months,89.5,83.0 to 94.4,324
Polio,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,90.3,86.1 to 93.6,657
Hep A,≥2 Doses,States/Local Areas,Florida,2018,Age,24 Months,42.4,33.6 to 52.4,324
Hep A,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,45.8,39.5 to 52.6,657
DTaP,≥4 Doses,States/Local Areas,Florida,2014,Age,24 Months,79.8,72.2 to 86.5,274
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,81.6,76.6 to 86.0,583
Hep A,≥2 Doses,States/Local Areas,Florida,2017,Age,24 Months,40.9,33.6 to 49.2,374
Hep A,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,41.8,35.9 to 48.2,698
Hep A,≥2 Doses,States/Local Areas,Florida,2016,Age,24 Months,37.1,29.6 to 45.7,349
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,39.1,33.7 to 45.0,723
DTaP,≥4 Doses,States/Local Areas,Florida,2013,Age,24 Months,82.4,76.2 to 87.8,272
DTaP,≥4 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,81.1,76.1 to 85.6,546
DTaP,≥4 Doses,States/Local Areas,Florida,2012,Age,24 Months,83.0,75.7 to 89.2,240
DTaP,≥4 Doses,States/Local Areas,Florida,2011,Age,24 Months,81.2,73.1 to 88.1,236
DTaP,≥4 Doses,States/Local Areas,Florida,2019,Age,19 Months,72.0,63.9 to 78.8,333
Hep B,≥3 Doses,States/Local Areas,Florida,2013,Age,7 Months,47.2,41.8 to 52.6,272
Hep B,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,7 Months,47.3,44.1 to 50.5,546
Hep B,≥3 Doses,States/Local Areas,Florida,2012,Age,7 Months,46.4,38.7 to 54.2,240
Hep B,≥3 Doses,States/Local Areas,Florida,2011,Age,7 Months,38.9,31.8 to 46.4,236
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,95.9,93.5 to 98.3,364
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,94.3,91.9 to 96.7,467
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,89.7,85.5 to 93.8,340
Polio,≥2 Doses,States/Local Areas,Florida,2015,Age,5 Months,79.6,72.4 to 85.3,309
Polio,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,5 Months,78.1,73.0 to 82.5,658
Polio,≥2 Doses,States/Local Areas,Florida,2014,Age,5 Months,72.1,63.4 to 79.4,274
Polio,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,5 Months,75.9,72.9 to 78.7,583
Polio,≥2 Doses,States/Local Areas,Florida,2013,Age,5 Months,78.3,70.4 to 84.5,272
Polio,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,5 Months,75.1,69.4 to 80.1,546
Polio,≥2 Doses,States/Local Areas,Florida,2012,Age,5 Months,75.7,70.7 to 80.1,240
Polio,≥2 Doses,States/Local Areas,Florida,2011,Age,5 Months,70.4,57.6 to 80.7,236
Hep A,≥1 Dose,States/Local Areas,Florida,2015,Age,35 Months,83.4,76.0 to 89.5,309
Hep A,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,35 Months,84.3,79.0 to 88.9,658
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,89.7,86.3 to 93.0,490
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,75.9,60.0 to 91.9,39
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,93.3,89.9 to 96.6,628
Polio,≥3 Doses,States/Local Areas,Florida,2019,Age,35 Months,90.9,85.3 to 95.0,333
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.3,86.2 to 98.5,106
Polio,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,96.4,92.1 to 98.7,658
DTaP,≥2 Doses,States/Local Areas,Florida,2016,Age,5 Months,79.4,72.0 to 85.3,349
DTaP,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,5 Months,77.2,72.1 to 81.6,723
DTaP,≥2 Doses,States/Local Areas,Florida,2015,Age,5 Months,80.3,73.1 to 86.0,309
DTaP,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,5 Months,79.9,74.9 to 84.1,658
Hib,Full Series,States/Local Areas,Florida,2014,Age,35 Months,82.7,75.7 to 88.6,274
Hib,Full Series,States/Local Areas,Florida,2014-2015,Age,35 Months,81.4,76.5 to 85.8,583
Hib,Full Series,States/Local Areas,Florida,2013,Age,35 Months,82.6,75.9 to 88.4,272
Hib,Full Series,States/Local Areas,Florida,2013-2014,Age,35 Months,82.6,77.8 to 86.9,546
Hib,Full Series,States/Local Areas,Florida,2012,Age,35 Months,87.7,80.3 to 93.3,240
Hib,Full Series,States/Local Areas,Florida,2011,Age,35 Months,85.4,76.5 to 92.2,236
Hib,Full Series,States/Local Areas,Florida,2019,Age,24 Months,84.1,77.7 to 89.5,333
Polio,≥3 Doses,States/Local Areas,Florida,2017,Age,35 Months,92.6,87.3 to 96.3,374
Polio,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,91.1,87.0 to 94.3,698
Polio,≥3 Doses,States/Local Areas,Florida,2016,Age,35 Months,96.7,90.5 to 99.3,349
Polio,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,94.1,89.8 to 97.0,723
DTaP,≥2 Doses,States/Local Areas,Florida,2014,Age,5 Months,74.3,65.6 to 81.5,274
DTaP,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,5 Months,77.4,74.6 to 79.9,583
DTaP,≥2 Doses,States/Local Areas,Florida,2013,Age,5 Months,78.2,71.0 to 84.0,272
DTaP,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,5 Months,76.2,71.0 to 80.8,546
DTaP,≥2 Doses,States/Local Areas,Florida,2012,Age,5 Months,75.5,70.0 to 80.3,240
DTaP,≥2 Doses,States/Local Areas,Florida,2011,Age,5 Months,72.3,59.3 to 82.5,236
Polio,≥3 Doses,States/Local Areas,Florida,2015,Age,35 Months,95.3,91.3 to 97.8,309
Polio,≥3 Doses,States/Local Areas,Florida,2012,Age,35 Months,95.1,90.5 to 97.9,240
Polio,≥3 Doses,States/Local Areas,Florida,2014,Age,35 Months,92.1,85.4 to 96.4,274
Polio,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,93.8,89.8 to 96.5,583
Polio,≥3 Doses,States/Local Areas,Florida,2013,Age,35 Months,94.5,89.9 to 97.4,272
Polio,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,93.5,89.5 to 96.4,546
Polio,≥3 Doses,States/Local Areas,Florida,2011,Age,35 Months,92.3,84.2 to 97.1,236
Hib,≥3 Doses,States/Local Areas,Florida,2014,Age,24 Months,88.1,81.7 to 93.1,274
Hib,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,89.8,86.0 to 93.0,583
Hib,≥3 Doses,States/Local Areas,Florida,2013,Age,24 Months,95.9,92.1 to 98.2,272
Hib,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,92.0,88.2 to 94.9,546
Hib,≥3 Doses,States/Local Areas,Florida,2012,Age,24 Months,92.8,87.2 to 96.5,240
Hib,≥3 Doses,States/Local Areas,Florida,2011,Age,24 Months,89.9,83.6 to 94.6,236
Hib,Full Series,States/Local Areas,Florida,2018,Age,24 Months,77.1,68.8 to 84.6,324
Hib,Full Series,States/Local Areas,Florida,2018-2019,Age,24 Months,80.6,75.3 to 85.3,657
Hib,Full Series,States/Local Areas,Florida,2017,Age,24 Months,78.5,71.5 to 84.8,374
Hib,Full Series,States/Local Areas,Florida,2017-2018,Age,24 Months,77.8,72.4 to 82.7,698
Hib,Full Series,States/Local Areas,Florida,2016,Age,24 Months,77.3,69.9 to 83.9,349
Hib,Full Series,States/Local Areas,Florida,2016-2017,Age,24 Months,77.9,72.9 to 82.6,723
DTaP,≥3 Doses,States/Local Areas,Florida,2012,Age,24 Months,95.6,90.9 to 98.2,240
Polio,≥3 Doses,States/Local Areas,Florida,2017,Age,24 Months,91.7,86.6 to 95.4,374
Polio,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,90.7,86.7 to 93.9,698
Hib,≥3 Doses,States/Local Areas,Florida,2019,Age,19 Months,90.4,84.4 to 94.2,333
Polio,≥3 Doses,States/Local Areas,Florida,2019,Age,24 Months,90.9,85.3 to 95.0,333
Polio,≥3 Doses,States/Local Areas,Florida,2018,Age,24 Months,89.5,83.0 to 94.4,324
Polio,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,90.3,86.1 to 93.6,657
DTaP,≥3 Doses,States/Local Areas,Florida,2011,Age,24 Months,93.1,87.2 to 97.0,236
DTaP,≥3 Doses,States/Local Areas,Florida,2018,Age,19 Months,89.6,82.1 to 94.2,324
DTaP,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,88.0,83.2 to 91.6,657
DTaP,≥3 Doses,States/Local Areas,Florida,2017,Age,19 Months,92.2,87.0 to 95.4,374
DTaP,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,90.9,86.7 to 93.9,698
Hib,Full Series,States/Local Areas,Florida,2015,Age,24 Months,78.7,71.6 to 85.0,309
Hib,Full Series,States/Local Areas,Florida,2015-2016,Age,24 Months,78.0,73.0 to 82.7,658
DTaP,≥3 Doses,States/Local Areas,Florida,2013,Age,24 Months,96.9,93.5 to 98.7,272
DTaP,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,93.5,89.9 to 96.1,546
DTaP,≥3 Doses,States/Local Areas,Florida,2019,Age,19 Months,91.8,85.8 to 95.4,333
Polio,≥3 Doses,States/Local Areas,Florida,2015,Age,24 Months,92.2,88.0 to 95.4,309
Polio,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,91.8,88.7 to 94.4,658
Polio,≥3 Doses,States/Local Areas,Florida,2014,Age,24 Months,87.9,81.6 to 92.9,274
Polio,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,90.2,86.4 to 93.2,583
Hib,≥3 Doses,States/Local Areas,Florida,2018,Age,19 Months,89.0,81.5 to 93.7,324
Hib,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,77.3,71.5 to 82.2,657
Hib,≥3 Doses,States/Local Areas,Florida,2017,Age,19 Months,90.5,85.0 to 94.1,374
Hib,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,89.7,85.4 to 92.9,698
Polio,≥3 Doses,States/Local Areas,Florida,2016,Age,24 Months,91.5,86.6 to 95.2,349
Polio,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,91.6,88.1 to 94.3,723
DTaP,≥3 Doses,States/Local Areas,Florida,2016,Age,19 Months,91.0,85.3 to 94.7,349
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,91.6,88.0 to 94.2,723
Hib,≥3 Doses,States/Local Areas,Florida,2016,Age,19 Months,87.3,80.6 to 91.9,349
Hib,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,88.9,84.8 to 92.0,723
Hib,≥3 Doses,States/Local Areas,Florida,2015,Age,19 Months,91.0,89.8 to 92.1,309
Hib,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,89.2,85.1 to 92.2,658
Polio,≥3 Doses,States/Local Areas,Florida,2019,Age,19 Months,89.9,83.7 to 93.9,333
Polio,≥3 Doses,States/Local Areas,Florida,2012,Age,24 Months,94.6,89.9 to 97.5,240
Polio,≥3 Doses,States/Local Areas,Florida,2011,Age,24 Months,90.7,82.5 to 96.1,236
Hib,≥3 Doses,States/Local Areas,Florida,2014,Age,19 Months,87.5,80.6 to 92.2,274
Hib,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,89.3,85.2 to 92.4,583
Polio,≥3 Doses,States/Local Areas,Florida,2013,Age,24 Months,93.1,88.6 to 96.2,272
Polio,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,24 Months,90.5,86.5 to 93.6,546
DTaP,≥3 Doses,States/Local Areas,Florida,2015,Age,19 Months,93.5,92.0 to 94.8,309
DTaP,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,92.3,88.9 to 94.7,658
DTaP,≥3 Doses,States/Local Areas,Florida,2014,Age,19 Months,89.8,83.2 to 94.0,274
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,91.7,88.0 to 94.3,583
Hib,Full Series,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,69.1,47.8 to 90.3,39
Hib,Full Series,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.1,74.8 to 85.3,469
Hib,Full Series,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,78.8,74.1 to 83.5,672
Hib,Full Series,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.0,74.9 to 85.1,568
Hib,Full Series,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.7,61.3 to 84.0,157
Hib,Full Series,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,81.8,76.5 to 87.2,340
Hib,Full Series,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,80.8,75.6 to 86.0,467
Hib,Full Series,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,73.8,67.6 to 80.1,340
Hib,Full Series,States/Local Areas,Florida,2014-2017,Overall,Overall,79.7,76.2 to 83.1,1171
Hib,Full Series,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,88.5,73.6 to 100.0,30
Hib,Primary Series,States/Local Areas,Florida,2012,Age,7 Months,64.3,54.4 to 73.2,240
Hib,Full Series,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,90.1,86.5 to 93.8,364
Hib,Primary Series,States/Local Areas,Florida,2011,Age,7 Months,66.4,60.2 to 72.1,236
Hib,Full Series,States/Local Areas,Kentucky,2013,Age,19 Months,71.2,64.7 to 76.9,236
Hib,Full Series,States/Local Areas,Kentucky,2013-2014,Age,19 Months,70.5,65.4 to 75.2,482
Hib,Full Series,States/Local Areas,Kentucky,2012,Age,19 Months,74.2,62.9 to 83.1,236
Hib,Full Series,States/Local Areas,Kentucky,2011,Age,19 Months,66.5,60.1 to 72.5,217
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,79.0,70.2 to 87.8,185
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,72.3,65.7 to 78.8,300
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014,Age,19 Months,69.2,60.9 to 76.4,246
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,19 Months,74.4,68.8 to 79.3,456
Hep A,≥1 Dose,States/Local Areas,Kentucky,2015,Age,19 Months,79.6,76.1 to 82.8,210
Hep A,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,19 Months,78.3,72.2 to 83.3,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,96.4,90.8 to 99.0,181
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,95.3,91.9 to 97.6,419
DTaP,≥1 Dose,States/Local Areas,Kentucky,2019,Age,3 Months,91.7,85.3 to 95.4,271
Hep A,≥1 Dose,States/Local Areas,Kentucky,2011,Age,19 Months,65.5,62.6 to 68.3,217
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,85.7,78.6 to 90.7,324
DTaP,≥1 Dose,States/Local Areas,Kentucky,2017,Age,3 Months,88.7,82.4 to 92.9,238
DTaP,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,3 Months,87.9,83.7 to 91.2,516
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,93.2,88.1 to 96.7,246
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,95.0,91.7 to 97.3,456
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,96.7,91.9 to 99.1,210
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,96.6,93.2 to 98.6,391
DTaP,≥1 Dose,States/Local Areas,Kentucky,2018,Age,3 Months,87.1,80.8 to 91.6,278
DTaP,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,3 Months,89.4,85.2 to 92.5,549
DTaP,≥2 Doses,States/Local Areas,Kentucky,2017,Age,5 Months,78.9,71.8 to 84.7,238
DTaP,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,5 Months,76.9,71.9 to 81.3,516
DTaP,≥2 Doses,States/Local Areas,Kentucky,2019,Age,5 Months,81.5,73.6 to 87.4,271
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,94.8,92.0 to 97.6,248
DTaP,≥2 Doses,States/Local Areas,Kentucky,2018,Age,5 Months,74.9,67.9 to 80.8,278
DTaP,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,5 Months,78.2,73.1 to 82.6,549
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,94.1,89.2 to 97.3,238
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,93.6,90.4 to 96.1,516
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,93.2,88.5 to 96.4,278
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,93.6,90.3 to 96.1,549
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,97.2,94.2 to 100.0,185
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,94.7,91.3 to 98.0,300
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,93.5,89.7 to 97.3,263
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,94.7,92.6 to 96.8,748
Hib,≥3 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,96.0,91.0 to 98.6,210
Hib,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,96.3,93.0 to 98.4,391
Hib,≥3 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,96.7,91.4 to 99.1,181
Hib,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,94.7,91.2 to 97.1,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,94.1,88.9 to 97.4,271
Hib,≥3 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,92.6,87.2 to 96.2,238
Hib,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,91.7,88.2 to 94.5,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2013,Age,19 Months,70.1,63.4 to 76.0,236
Hep A,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,19 Months,69.7,65.5 to 73.5,482
Hib,Full Series,States/Local Areas,Kentucky,2021,Age,19 Months,63.1,53.9 to 71.4,216
Hib,≥1 Dose,States/Local Areas,Kentucky,2021,Age,3 Months,83.3,75.4 to 89.0,216
Hep A,≥1 Dose,States/Local Areas,Kentucky,2012,Age,19 Months,68.8,60.9 to 75.8,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.8,77.9 to 85.7,627
DTaP,≥1 Dose,States/Local Areas,Kentucky,2012,Age,3 Months,83.7,76.2 to 89.1,236
DTaP,≥1 Dose,States/Local Areas,Kentucky,2011,Age,3 Months,89.5,85.0 to 92.7,217
Combined 7 Series,,States/Local Areas,Kentucky,2021,Age,35 Months,70.0,60.8 to 78.6,216
PCV,≥2 Doses,States/Local Areas,Kentucky,2021,Age,5 Months,80.3,72.1 to 86.5,216
Polio,≥2 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,90.9,84.4 to 94.9,216
Hep B,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,93.1,89.3 to 95.6,540
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,91.2,87.0 to 94.2,540
Hep B,≥2 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,91.5,85.1 to 95.3,216
DTaP,≥3 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,77.4,69.2 to 83.9,216
Hep B,≥3 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,91.5,85.2 to 95.3,216
Polio,≥3 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,92.4,86.0 to 96.0,216
Hib,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,88.1,83.6 to 91.9,540
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,88.0,83.5 to 91.4,540
Hib,≥2 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,90.9,84.4 to 94.9,216
PCV,≥4 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,80.3,75.2 to 85.0,540
PCV,≥3 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,94.7,89.7 to 97.7,216
≥1 Dose MMR,,States/Local Areas,Kentucky,2021,Age,35 Months,92.3,86.2 to 96.3,216
Hib,≥3 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,53.8,44.9 to 62.4,216
Hib,≥3 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,86.4,78.6 to 91.7,216
Hib,≥2 Doses,States/Local Areas,Kentucky,2021,Age,5 Months,76.3,67.5 to 83.3,216
Hib,Primary Series,States/Local Areas,Kentucky,2020-2021,Age,24 Months,90.4,86.3 to 93.7,540
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016,Age,19 Months,76.9,67.2 to 84.4,181
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,19 Months,79.6,73.8 to 84.4,419
Hep A,≥1 Dose,States/Local Areas,Kentucky,2017,Age,19 Months,82.4,75.5 to 87.7,238
Hep A,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,19 Months,84.1,79.6 to 87.7,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2018,Age,19 Months,85.7,79.8 to 90.1,278
Hep A,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,19 Months,87.9,83.2 to 91.4,425
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,96.1,91.2 to 98.7,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,95.2,91.8 to 97.5,482
DTaP,≥3 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,92.8,87.1 to 96.6,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,92.3,86.0 to 96.5,217
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,94.2,89.0 to 97.4,246
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,96.5,93.5 to 98.4,456
Hep A,≥2 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,17.6,12.0 to 25.0,217
Hep A,≥2 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,17.5,13.0 to 23.3,236
Hep A,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,20.1,16.6 to 24.1,482
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,22.7,16.9 to 29.8,246
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,24.4,19.8 to 29.8,456
Hep A,≥2 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,23.6,19.0 to 29.0,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,91.0,86.0 to 94.8,278
Hib,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,92.3,88.9 to 95.0,549
Hib,≥3 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,93.6,88.6 to 97.0,271
Hib,≥3 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,91.1,84.9 to 95.5,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,91.0,84.4 to 95.6,217
Hep A,≥1 Dose,States/Local Areas,Kentucky,2019,Age,19 Months,91.2,86.1 to 94.5,271
Hep A,≥1 Dose,States/Local Areas,Kentucky,2011,Age,24 Months,68.0,59.4 to 76.2,217
Hep A,≥1 Dose,States/Local Areas,Kentucky,2013,Age,24 Months,73.6,66.3 to 80.5,236
Hep A,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,24 Months,75.8,70.6 to 80.7,482
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014,Age,24 Months,77.9,70.2 to 84.8,246
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,24 Months,80.8,75.6 to 85.4,456
Hep A,≥1 Dose,States/Local Areas,Kentucky,2012,Age,24 Months,74.4,67.2 to 81.1,236
DTaP,≥4 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,83.9,78.3 to 88.7,540
≥1 Dose Varicella,,States/Local Areas,Kentucky,2021,Age,19 Months,82.2,73.4 to 88.5,216
DTaP,≥1 Dose,States/Local Areas,Kentucky,2013,Age,3 Months,89.4,82.6 to 93.8,236
DTaP,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,3 Months,87.8,81.8 to 92.0,482
DTaP,≥1 Dose,States/Local Areas,Kentucky,2014,Age,3 Months,86.1,79.7 to 90.8,246
DTaP,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,3 Months,86.9,82.5 to 90.4,456
DTaP,≥1 Dose,States/Local Areas,Kentucky,2015,Age,3 Months,87.7,80.9 to 92.3,210
DTaP,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,3 Months,88.5,83.5 to 92.1,391
DTaP,≥1 Dose,States/Local Areas,Kentucky,2016,Age,3 Months,89.2,81.0 to 94.2,181
DTaP,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,3 Months,89.0,84.1 to 92.5,419
Hib,Primary Series,States/Local Areas,Kentucky,2021,Age,7 Months,71.0,62.5 to 78.3,216
PCV,≥4 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,77.6,69.0 to 84.3,216
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,67.3,59.8 to 74.8,267
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.8,66.3 to 81.3,233
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.3,67.5 to 77.1,566
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.2,52.4 to 80.0,71
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Overall,Overall,70.8,66.5 to 75.1,748
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,71.3,64.1 to 78.5,248
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,65.3,58.1 to 72.6,263
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,92.8,88.5 to 97.0,242
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,93.1,89.8 to 96.4,340
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,86.2,81.2 to 91.3,340
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.8,87.5 to 96.1,262
Hib,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,92.6,88.6 to 95.2,540
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.8,84.8 to 94.8,262
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,86.0,80.7 to 91.4,340
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.9,75.7 to 88.1,262
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,80.7,74.0 to 87.4,242
Influenza,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,61.5,54.5 to 68.4,340
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.7,65.6 to 79.8,262
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,65.2,56.7 to 73.7,242
Influenza,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,58.5,51.0 to 66.0,262
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.8,68.1 to 81.6,262
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,78.6,72.3 to 85.0,340
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,89.6,85.3 to 93.8,340
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,80.9,73.5 to 88.3,242
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.0,81.2 to 92.8,262
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,83.0,77.2 to 88.9,340
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.1,75.9 to 88.2,262
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,64.0,53.9 to 74.1,242
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.8,85.1 to 94.5,262
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,78.5,71.3 to 85.8,242
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,83.5,76.6 to 90.5,340
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,69.5,61.2 to 77.8,242
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.0,67.6 to 86.3,262
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,96.0,92.7 to 99.2,340
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,89.3 to 97.5,262
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,86.3,79.8 to 92.9,242
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,79.3,72.1 to 86.4,242
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.8,76.6 to 89.0,262
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,93.7,89.9 to 97.5,340
Hep A,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,35 Months,92.0,87.4 to 95.4,540
PCV,≥3 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,88.9,81.7 to 93.5,216
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,96.0,92.7 to 99.2,340
Influenza,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,36.7,29.0 to 44.4,242
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.9,89.9 to 97.9,262
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,92.8,88.5 to 97.0,242
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,81.9,75.8 to 87.9,340
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,77.3,71.1 to 83.5,340
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,76.8,69.7 to 83.9,242
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,96.2,93.4 to 98.9,361
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,97.6,95.4 to 99.8,232
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,86.8,80.3 to 93.2,242
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.1,80.0 to 90.1,262
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Overall,Overall,72.5,68.3 to 76.6,844
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Overall,Overall,81.5,77.8 to 85.2,844
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,94.7,91.6 to 97.9,361
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,95.0,91.9 to 98.2,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,79.9,73.4 to 86.4,251
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,64.4,56.7 to 72.1,251
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,96.2,93.4 to 98.9,361
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,75.5,69.5 to 81.6,361
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,97.6,95.4 to 99.8,232
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Overall,Overall,90.4,87.7 to 93.2,844
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,80.8,73.8 to 87.8,232
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Overall,Overall,74.9,70.8 to 78.9,844
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,76.2,71.0 to 81.4,844
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,88.2,82.9 to 93.4,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Overall,Overall,81.6,78.1 to 85.1,844
Influenza,,States/Local Areas,Kentucky,2016-2019,Overall,Overall,53.8,49.3 to 58.2,844
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,87.2,81.7 to 92.7,251
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,95.1,91.9 to 98.3,361
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,71.4,63.1 to 79.7,361
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,90.7,84.8 to 96.6,232
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,84.0,78.1 to 89.9,251
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,83.3,79.9 to 86.7,844
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,84.9,79.6 to 90.3,361
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Overall,Overall,90.2,87.4 to 92.9,844
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,92.7,90.1 to 95.2,844
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,86.2,79.8 to 92.6,232
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Overall,Overall,86.4,83.1 to 89.6,844
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,94.4,92.2 to 96.6,844
Influenza,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,51.2,35.9 to 66.5,75
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,83.7,70.0 to 97.4,75
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.4 to 95.1,335
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,91.9,88.7 to 95.1,467
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,69.8 to 93.3,91
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,71.0,56.4 to 85.6,75
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.8,70.4 to 99.2,51
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.7,75.7 to 95.7,91
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,92.3,89.0 to 95.5,467
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,75.6,67.6 to 83.5,335
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,83.3,77.1 to 89.5,467
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,94.9,92.3 to 97.5,467
Hib,≥1 Dose,States/Local Areas,Kentucky,2020,Age,3 Months,78.4,70.8 to 84.5,324
Polio,≥1 Dose,States/Local Areas,Kentucky,2020,Age,3 Months,81.4,74.0 to 87.1,324
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,90.4,84.4 to 94.7,324
Hep B,≥1 Dose,States/Local Areas,Kentucky,2020,Age,3 Months,94.9,90.8 to 97.3,324
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,59.8,52.0 to 67.1,324
PCV,≥3 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,66.0,58.1 to 73.1,324
Hib,Primary Series,States/Local Areas,Kentucky,2020,Age,19 Months,88.8,82.1 to 93.1,324
Hib,Full Series,States/Local Areas,Kentucky,2020,Age,19 Months,63.4,55.4 to 70.7,324
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,89.0,82.3 to 93.3,324
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020,Age,19 Months,81.6,74.1 to 87.3,324
PCV,≥3 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,89.6,83.2 to 93.7,324
DTaP,≥4 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,79.3,72.0 to 85.8,324
Polio,≥3 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,93.1,87.1 to 97.0,324
PCV,≥4 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,72.3,64.4 to 79.0,324
PCV,≥4 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,79.0,71.3 to 85.8,324
PCV,≥3 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,91.8,86.0 to 95.9,324
Hib,Primary Series,States/Local Areas,Kentucky,2020,Age,13 Months,79.8,72.4 to 85.6,324
Hib,≥3 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,61.2,53.5 to 68.4,324
Hep B,≥2 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,92.9,87.0 to 96.2,324
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,85.7,78.8 to 90.6,324
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020,Age,13 Months,57.5,49.8 to 64.8,324
PCV,≥3 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,86.1,79.1 to 91.0,324
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,67.1,59.2 to 74.1,324
PCV,≥2 Doses,States/Local Areas,Kentucky,2020,Age,5 Months,74.0,66.1 to 80.6,324
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,89.7,83.1 to 93.9,324
DTaP,≥4 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,66.0,58.0 to 73.2,324
≥1 Dose MMR,,States/Local Areas,Kentucky,2020,Age,19 Months,83.5,76.3 to 88.9,324
Polio,≥3 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,89.5,82.9 to 93.7,324
Hib,≥3 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,85.1,78.2 to 90.1,324
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2020,Age,0-3 Days,83.5,77.2 to 88.3,324
Rotavirus,,States/Local Areas,Kentucky,2020,Age,8 Months,61.6,53.7 to 68.9,324
Influenza,,States/Local Areas,Kentucky,2020,Age,24 Months,44.2,37.1 to 52.0,324
PCV,≥3 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,89.9,84.1 to 94.3,324
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,93.0,86.9 to 96.9,324
PCV,≥4 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,76.3,69.0 to 83.0,324
Hep A,≥1 Dose,States/Local Areas,Kentucky,2020,Age,24 Months,85.0,78.5 to 90.4,324
Hep A,≥2 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,57.4,49.9 to 65.1,324
Combined 7 Series,,States/Local Areas,Kentucky,2020,Age,24 Months,61.5,53.9 to 69.1,324
PCV,≥1 Dose,States/Local Areas,Kentucky,2020,Age,3 Months,80.1,72.5 to 86.0,324
DTaP,≥2 Doses,States/Local Areas,Kentucky,2020,Age,5 Months,75.0,67.2 to 81.5,324
Polio,≥2 Doses,States/Local Areas,Kentucky,2020,Age,5 Months,74.6,66.8 to 81.1,324
Hib,≥2 Doses,States/Local Areas,Kentucky,2020,Age,5 Months,72.5,64.6 to 79.3,324
Hep B,≥2 Doses,States/Local Areas,Kentucky,2020,Age,5 Months,88.0,81.2 to 92.6,324
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,89.7,80.1 to 99.3,75
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.6,82.1 to 100.0,51
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.3,78.7 to 97.9,91
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.5,80.7 to 88.3,627
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,93.1,89.4 to 96.8,335
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,97.5,95.7 to 99.3,467
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.9,78.8 to 87.0,627
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,79.2,73.2 to 85.1,335
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,83.4,71.8 to 95.0,75
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",98.2,94.8 to 100.0,51
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,91.7,87.8 to 95.6,335
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,80.4,74.7 to 86.1,335
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.1,80.2 to 100.0,51
Influenza,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,68.2,62.8 to 73.7,467
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.0,92.8 to 97.2,627
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,87.0,76.1 to 98.0,75
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.3,94.4 to 98.1,627
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.6,82.1 to 100.0,51
Influenza,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",52.6,35.2 to 70.0,51
Influenza,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.9,46.9 to 73.0,91
Influenza,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",53.1,47.9 to 58.2,627
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,68.0,52.9 to 83.1,75
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.4,64.7 to 94.1,51
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.1,82.6 to 89.5,627
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.0,70.3 to 91.6,91
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,64.4,48.7 to 80.1,75
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.6,56.9 to 84.3,91
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.8,69.2 to 78.5,627
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.3,64.1 to 94.5,51
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,57.5,42.4 to 72.6,75
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,70.5,64.1 to 77.0,335
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.4,64.6 to 94.2,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,76.5 to 95.6,91
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,71.7,56.8 to 86.7,75
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,89.7,80.1 to 99.3,75
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.3,67.4 to 91.2,91
Influenza,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,43.0,36.4 to 49.7,335
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,93.1,89.4 to 96.8,335
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,83.3,78.7 to 88.0,467
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,97.1,95.2 to 99.1,467
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,91.3,87.4 to 95.2,335
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.5,79.5 to 97.5,91
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,82.5,70.7 to 94.4,75
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",98.2,94.7 to 100.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,82.3,77.1 to 87.4,335
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.8,81.9 to 89.7,627
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,78.2,73.2 to 83.3,467
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.9,45.8 to 82.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.2,66.4 to 98.0,51
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.8,87.6 to 93.9,627
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.3,93.5 to 100.0,51
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.0,71.5 to 80.6,627
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.2 to 93.5,627
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.6,72.6 to 84.5,627
Hep A,≥1 Dose,States/Local Areas,Kentucky,2012,Age,35 Months,77.6,70.4 to 84.1,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,92.8,87.0 to 96.1,324
Hib,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,3 Months,84.0,79.0 to 87.9,595
Polio,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,3 Months,86.7,82.0 to 90.3,595
DTaP,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,3 Months,86.6,81.9 to 90.2,595
Hib,Primary Series,States/Local Areas,Kentucky,2019-2020,Age,7 Months,69.2,63.5 to 74.4,595
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,88.7,84.1 to 92.1,595
Polio,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,91.8,87.8 to 94.6,595
DTaP,≥4 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,68.9,63.1 to 74.1,595
Hib,Primary Series,States/Local Areas,Kentucky,2021,Age,19 Months,90.4,83.5 to 94.6,216
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,86.9,82.6 to 91.2,467
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",99.0,97.0 to 100.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,83.0,78.4 to 87.7,467
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,80.1 to 98.2,91
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,79.6,65.1 to 94.1,75
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,91.2 to 96.1,627
Combined 7 Series,,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,69.5,63.1 to 76.0,335
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,94.1 to 97.9,627
Influenza,,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,73.8,66.4 to 81.3,232
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,75.9,69.2 to 82.6,251
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,93.9,90.3 to 97.4,232
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,84.7,79.6 to 89.8,361
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,74.0,66.9 to 81.2,251
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,88.5,82.7 to 94.3,232
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,90.6,85.9 to 95.3,251
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,83.1,79.5 to 86.6,844
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,87.0,81.8 to 92.2,251
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,86.9,82.2 to 91.5,361
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,91.3,86.0 to 96.7,232
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,87.9,82.9 to 93.0,251
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,90.6,86.3 to 94.9,361
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,94.6,90.5 to 98.7,232
Influenza,,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,37.9,30.6 to 45.2,251
Influenza,,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,58.1,51.3 to 64.8,361
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,92.4,89.9 to 94.8,844
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Overall,Overall,94.2,92.0 to 96.4,844
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,90.1,85.3 to 94.9,251
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,90.5,86.3 to 94.8,361
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,95.3,92.3 to 98.3,232
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,74.8,65.4 to 84.3,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,83.2,78.1 to 88.3,361
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,81.3,74.6 to 88.1,232
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,84.4,79.4 to 89.5,361
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,94.6,91.2 to 98.0,232
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Poverty,133% to <400% FPL,74.5,68.3 to 80.8,361
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,93.5,90.3 to 96.7,340
Rotavirus,,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,69.1,61.7 to 76.5,251
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Principal City,94.2,90.3 to 98.2,340
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,92.2,87.8 to 96.5,242
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.3,86.5 to 96.1,262
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Urbanicity,Living In a Non-MSA,91.1,86.1 to 96.0,242
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,94.1,89.2 to 97.3,238
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,93.9,90.6 to 96.3,516
DTaP,≥4 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,69.0,64.8 to 73.0,217
DTaP,≥4 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,69.9,62.8 to 76.2,236
PCV,≥2 Doses,States/Local Areas,Kentucky,2013,Age,5 Months,73.7,63.3 to 82.0,236
PCV,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,5 Months,74.1,70.5 to 77.5,482
PCV,≥2 Doses,States/Local Areas,Kentucky,2012,Age,5 Months,74.4,68.6 to 79.5,236
PCV,≥2 Doses,States/Local Areas,Kentucky,2011,Age,5 Months,74.4,61.9 to 83.8,217
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,98.5,94.7 to 99.8,210
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,97.6,94.3 to 99.2,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,96.6,90.9 to 99.1,181
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,95.4,91.9 to 97.6,419
Hep A,≥2 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,26.2,16.6 to 38.7,210
Hep A,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,25.5,19.9 to 32.1,391
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,24.9,16.6 to 35.6,181
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,25.2,19.8 to 31.5,419
Hib,≥3 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,94.1,89.1 to 97.3,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,93.2,89.7 to 95.9,482
Hib,≥3 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,92.2,86.9 to 95.9,246
Hib,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,95.4,92.1 to 97.6,456
Hib,≥3 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,98.3,94.0 to 99.7,210
Hib,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,97.4,94.2 to 99.1,391
Hep A,≥2 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,25.5,19.4 to 32.7,238
Hep A,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,27.6,23.2 to 32.4,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2015,Age,24 Months,83.7,76.6 to 89.7,210
Hep A,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,24 Months,84.2,78.9 to 88.9,391
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016,Age,24 Months,84.9,76.5 to 91.6,181
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,24 Months,85.9,80.7 to 90.2,419
PCV,≥2 Doses,States/Local Areas,Kentucky,2014,Age,5 Months,74.6,66.6 to 81.2,246
PCV,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,5 Months,75.0,72.7 to 77.2,456
PCV,≥2 Doses,States/Local Areas,Kentucky,2015,Age,5 Months,75.4,67.1 to 82.1,210
PCV,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,5 Months,77.1,70.9 to 82.3,391
PCV,≥2 Doses,States/Local Areas,Kentucky,2016,Age,5 Months,78.8,68.9 to 86.1,181
PCV,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,5 Months,78.0,72.1 to 83.0,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,93.9,89.0 to 97.1,278
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,94.8,91.3 to 97.3,549
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,95.4,90.1 to 98.3,271
Hep A,≥1 Dose,States/Local Areas,Kentucky,2017,Age,24 Months,86.9,80.6 to 91.9,238
Hep A,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,24 Months,87.2,83.1 to 90.7,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2018,Age,24 Months,87.3,81.9 to 91.8,278
Hep A,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,24 Months,90.8,87.4 to 93.6,549
Hep A,≥1 Dose,States/Local Areas,Kentucky,2019,Age,24 Months,94.3,90.0 to 97.1,271
Hep A,≥1 Dose,States/Local Areas,Kentucky,2011,Age,35 Months,72.7,64.1 to 80.8,217
PCV,≥2 Doses,States/Local Areas,Kentucky,2017,Age,5 Months,77.2,70.0 to 83.1,238
PCV,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,5 Months,74.3,69.2 to 78.9,516
Hib,≥3 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,92.5,87.2 to 96.2,278
Hib,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,94.1,90.6 to 96.7,549
Hep A,≥2 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,30.8,23.8 to 39.3,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.7,78.1 to 100.0,38
DTaP,≥4 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,70.1,61.8 to 77.3,236
DTaP,≥4 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,68.2,63.1 to 72.9,482
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,66.3,58.2 to 73.6,246
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,69.7,64.0 to 74.8,456
DTaP,≥4 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,73.1,62.9 to 81.3,210
DTaP,≥4 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,75.3,69.4 to 80.3,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,94.2,90.5 to 97.9,307
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,96.5,94.2 to 98.8,397
Hib,≥3 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,96.8,91.5 to 99.2,181
Hib,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,94.8,91.3 to 97.2,419
Hib,≥3 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,92.6,87.2 to 96.2,238
Hib,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,92.3,88.7 to 95.1,516
Hep A,≥2 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,29.6,23.7 to 36.4,278
Hep A,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,30.1,24.5 to 36.3,425
Hep A,≥2 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,32.4,25.1 to 40.6,271
Hep A,≥2 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,32.4,24.5 to 42.0,217
Polio,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,94.4,90.5 to 97.1,595
DTaP,≥4 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,85.1,80.3 to 89.3,595
Combined 7 Series,,States/Local Areas,Kentucky,2019-2020,Age,24 Months,68.4,62.8 to 73.8,595
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,91.9,87.9 to 94.7,595
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,94.3,90.4 to 97.0,595
PCV,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,88.6,84.1 to 92.0,595
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019-2020,Age,13 Months,57.7,52.0 to 63.3,595
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,87.6,83.0 to 91.1,595
Hib,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,87.1,82.3 to 90.7,595
Polio,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,88.0,83.2 to 91.5,595
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,71.2,65.6 to 76.3,595
PCV,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,5 Months,77.2,71.7 to 81.9,595
Hep B,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,5 Months,90.8,86.5 to 93.8,595
Hib,Primary Series,States/Local Areas,Kentucky,2019-2020,Age,13 Months,82.8,77.7 to 86.8,595
Hep B,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,94.4,90.7 to 96.7,595
Hib,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,93.8,90.1 to 96.2,595
Hib,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,66.0,60.3 to 71.3,595
≥1 Dose MMR,,States/Local Areas,Kentucky,2019-2020,Age,13 Months,59.1,53.3 to 64.7,595
Polio,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,13 Months,93.5,89.7 to 96.0,595
Hib,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,5 Months,75.7,70.2 to 80.6,595
Polio,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,5 Months,78.0,72.5 to 82.6,595
DTaP,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,5 Months,78.1,72.7 to 82.8,595
PCV,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,3 Months,85.9,81.2 to 89.6,595
≥1 Dose MMR,,States/Local Areas,Kentucky,2019-2020,Age,24 Months,88.3,84.1 to 91.9,595
Hep B,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,3 Months,94.7,91.4 to 96.8,595
Polio,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,92.0,88.3 to 95.0,595
DTaP,≥4 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,82.4,77.5 to 86.8,595
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,92.1,88.4 to 95.1,595
PCV,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,93.5,89.7 to 96.2,595
PCV,≥4 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,84.8,79.8 to 89.0,595
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019-2020,Age,35 Months,92.2,87.8 to 95.5,595
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,93.0,89.2 to 95.9,595
Hib,Primary Series,States/Local Areas,Kentucky,2019-2020,Age,35 Months,94.0,90.2 to 96.7,595
Hib,Full Series,States/Local Areas,Kentucky,2019-2020,Age,35 Months,78.1,72.8 to 82.9,595
≥1 Dose MMR,,States/Local Areas,Kentucky,2019-2020,Age,35 Months,92.1,88.0 to 95.3,595
Hib,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,93.4,89.5 to 96.3,595
Hib,Primary Series,States/Local Areas,Kentucky,2019-2020,Age,19 Months,91.3,87.2 to 94.1,595
Hib,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,88.1,83.6 to 91.4,595
≥1 Dose MMR,,States/Local Areas,Kentucky,2019-2020,Age,19 Months,86.2,81.6 to 89.8,595
Hep A,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,32.7,27.7 to 38.2,595
PCV,≥4 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,82.5,77.8 to 86.8,595
PCV,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,91.8,88.1 to 94.7,595
Hib,Full Series,States/Local Areas,Kentucky,2019-2020,Age,24 Months,75.9,70.7 to 80.9,595
PCV,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,69.5,63.8 to 74.6,595
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2019-2020,Age,0-3 Days,83.4,78.7 to 87.3,595
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,91.5,87.7 to 94.6,595
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019-2020,Age,24 Months,88.5,84.2 to 92.1,595
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2019-2020,Age,0-2 Days,82.8,78.0 to 86.7,595
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2019-2020,Age,0-1 Days,80.2,75.3 to 84.4,595
Hep A,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,19 Months,87.2,83.0 to 90.5,595
PCV,≥4 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,78.6,73.4 to 83.0,595
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019-2020,Age,19 Months,85.7,81.0 to 89.5,595
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,90.4,86.2 to 93.5,595
Hib,Full Series,States/Local Areas,Kentucky,2019-2020,Age,19 Months,68.1,62.4 to 73.4,595
Combined 7 Series,,States/Local Areas,Kentucky,2019-2020,Age,35 Months,72.1,66.5 to 77.4,595
Hib,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,52.4,46.7 to 58.1,595
Hib,Primary Series,States/Local Areas,Kentucky,2019-2020,Age,24 Months,91.7,87.9 to 94.6,595
Hib,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,90.6,86.7 to 93.7,595
Influenza,,States/Local Areas,Kentucky,2019-2020,Age,24 Months,51.8,46.2 to 57.6,595
Hep A,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,35 Months,80.7,74.7 to 86.1,595
Hep A,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,35 Months,92.2,88.4 to 95.2,595
Hep A,≥1 Dose,States/Local Areas,Kentucky,2019-2020,Age,24 Months,89.9,86.0 to 93.0,595
Hep A,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,24 Months,55.1,49.4 to 61.1,595
Polio,≥2 Doses,States/Local Areas,Kentucky,2020,Age,13 Months,92.1,86.1 to 95.7,324
Combined 7 Series,,States/Local Areas,Kentucky,2020,Age,35 Months,63.9,56.2 to 71.5,324
Hep A,≥2 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,78.2,70.2 to 85.3,324
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2020,Age,0-1 Days,78.8,72.0 to 84.3,324
Hep A,≥1 Dose,States/Local Areas,Kentucky,2020,Age,19 Months,82.9,75.9 to 88.2,324
Hep A,≥2 Doses,States/Local Areas,Kentucky,2020,Age,19 Months,34.0,27.2 to 41.5,324
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2020,Age,0-2 Days,82.1,75.7 to 87.2,324
Hib,≥2 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,83.9,76.6 to 89.3,324
Polio,≥2 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,84.8,77.5 to 90.1,324
DTaP,≥1 Dose,States/Local Areas,Kentucky,2020,Age,3 Months,81.4,74.0 to 87.1,324
Hib,≥3 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,44.5,37.2 to 52.1,324
Hib,Primary Series,States/Local Areas,Kentucky,2020,Age,7 Months,63.2,55.3 to 70.4,324
Hep B,≥2 Doses,States/Local Areas,Kentucky,2020,Age,7 Months,89.4,83.0 to 93.6,324
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,90.1,84.1 to 94.5,324
Polio,≥3 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,89.8,83.9 to 94.3,324
DTaP,≥4 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,77.3,70.0 to 83.8,324
≥1 Dose MMR,,States/Local Areas,Kentucky,2020,Age,24 Months,85.2,78.5 to 90.7,324
Hib,≥3 Doses,States/Local Areas,Kentucky,2020,Age,24 Months,87.6,81.4 to 92.5,324
≥1 Dose MMR,,States/Local Areas,Kentucky,2020,Age,35 Months,89.0,82.3 to 94.0,324
Hib,Primary Series,States/Local Areas,Kentucky,2020,Age,24 Months,89.2,83.2 to 93.8,324
Hib,≥3 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,91.3,85.1 to 95.7,324
Hib,Primary Series,States/Local Areas,Kentucky,2020,Age,35 Months,92.4,86.5 to 96.4,324
Hib,Full Series,States/Local Areas,Kentucky,2020,Age,35 Months,71.3,63.7 to 78.5,324
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020,Age,35 Months,91.2,85.4 to 95.3,324
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020,Age,35 Months,88.0,81.0 to 93.3,324
≥1 Dose MMR,,States/Local Areas,Kentucky,2021,Age,24 Months,92.1,86.1 to 96.2,216
Hib,Primary Series,States/Local Areas,Kentucky,2021,Age,24 Months,91.6,85.7 to 95.7,216
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,92.0,88.2 to 94.9,540
Polio,≥1 Dose,States/Local Areas,Kentucky,2021,Age,3 Months,88.2,81.4 to 92.7,216
Hib,Full Series,States/Local Areas,Kentucky,2021,Age,24 Months,75.1,66.3 to 83.0,216
Hep A,≥1 Dose,States/Local Areas,Kentucky,2021,Age,35 Months,96.3,90.0 to 99.1,216
PCV,≥3 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,93.0,87.2 to 96.3,216
DTaP,≥4 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,69.1,59.9 to 77.0,216
Hep A,≥2 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,77.4,65.4 to 87.5,216
Rotavirus,,States/Local Areas,Kentucky,2019-2020,Age,8 Months,71.0,65.5 to 76.0,595
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020-2021,Age,35 Months,89.2,84.5 to 93.0,540
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2021,Age,0-1 Days,74.1,65.9 to 80.9,216
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2021,Age,0-2 Days,75.7,67.5 to 82.4,216
PCV,≥3 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,94.7,89.7 to 97.7,216
PCV,≥4 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,85.0,77.8 to 90.9,216
≥1 Dose Varicella,,States/Local Areas,Kentucky,2021,Age,24 Months,89.7,82.8 to 94.7,216
Hep A,≥1 Dose,States/Local Areas,Kentucky,2021,Age,24 Months,92.8,87.1 to 96.6,216
DTaP,≥3 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,92.7,86.3 to 96.3,216
Hib,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,63.9,58.0 to 69.4,540
PCV,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,5 Months,77.1,71.6 to 81.9,540
Hep A,≥2 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,46.4,37.7 to 56.0,216
Hep B,≥3 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,57.0,48.2 to 65.4,216
PCV,≥3 Doses,States/Local Areas,Kentucky,2021,Age,7 Months,75.6,67.3 to 82.3,216
DTaP,≥3 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,90.6,83.4 to 94.8,216
Hep B,≥3 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,92.6,87.4 to 96.3,216
Hep A,≥1 Dose,States/Local Areas,Kentucky,2021,Age,19 Months,84.4,76.1 to 90.2,216
Polio,≥2 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,92.4,86.0 to 96.0,216
Hep A,≥2 Doses,States/Local Areas,Kentucky,2021,Age,19 Months,28.4,21.4 to 36.5,216
PCV,≥4 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,87.0,79.8 to 92.6,216
DTaP,≥4 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,81.7,73.5 to 88.6,216
DTaP,≥1 Dose,States/Local Areas,Kentucky,2021,Age,3 Months,88.2,81.4 to 92.7,216
Polio,≥3 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,94.0,88.4 to 97.5,216
Hib,≥3 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,88.6,81.6 to 93.9,216
Influenza,,States/Local Areas,Vermont,2013,Age,24 Months,71.9,65.1 to 78.4,261
Influenza,,States/Local Areas,Vermont,2013-2014,Age,24 Months,71.2,66.3 to 75.9,532
Influenza,,States/Local Areas,Vermont,2015,Age,24 Months,59.7,51.7 to 67.8,252
Influenza,,States/Local Areas,Vermont,2015-2016,Age,24 Months,65.7,60.2 to 71.3,500
Influenza,,States/Local Areas,Vermont,2014,Age,24 Months,70.4,63.6 to 77.0,271
Influenza,,States/Local Areas,Vermont,2014-2015,Age,24 Months,65.1,59.8 to 70.4,523
Influenza,,States/Local Areas,Vermont,2011,Age,24 Months,67.7,60.7 to 74.5,274
Influenza,,States/Local Areas,Vermont,2012,Age,24 Months,65.9,58.8 to 72.9,261
Influenza,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,81.1,77.2 to 85.1,492
Influenza,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,76.8,67.6 to 86.0,120
Influenza,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.5,65.6 to 73.4,835
Influenza,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.3,62.6 to 75.9,286
Influenza,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,66.3,61.3 to 71.2,565
Influenza,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,58.9,53.3 to 64.5,453
Influenza,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,61.3,44.9 to 77.7,48
Influenza,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.7,52.0 to 77.4,80
Influenza,,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,65.5,60.0 to 71.0,421
Influenza,,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,60.1,52.3 to 67.9,236
Influenza,,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,82.6,77.8 to 87.4,314
Hib,Primary Series,States/Local Areas,Vermont,2021,Age,35 Months,95.1,89.2 to 98.3,193
Polio,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,5 Months,88.0,83.0 to 91.6,500
Hib,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,94.4,90.6 to 96.7,500
≥1 Dose MMR,,States/Local Areas,Vermont,2021,Age,13 Months,70.6,60.8 to 78.7,193
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,94.4,92.2 to 96.7,597
Hib,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,95.5,92.0 to 97.5,500
Hib,≥3 Doses,States/Local Areas,Vermont,2021,Age,35 Months,95.1,89.2 to 98.3,193
DTaP,≥3 Doses,States/Local Areas,Vermont,2021,Age,24 Months,95.4,89.6 to 98.5,193
PCV,≥1 Dose,States/Local Areas,Vermont,2021,Age,3 Months,93.2,86.2 to 96.8,193
Influenza,,States/Local Areas,Vermont,2014-2017,Overall,Overall,68.5,64.8 to 72.1,971
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,93.5,91.1 to 95.9,597
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,91.7,84.5 to 98.8,56
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.1,75.6 to 94.6,78
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,97.4,95.9 to 98.8,597
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,83.0 to 99.9,78
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.6,56.5 to 84.7,78
DTaP,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,80.2,74.7 to 84.7,500
PCV,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,92.3,88.1 to 95.1,500
Hib,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,77.8,72.2 to 82.5,500
Hep B,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,93.5,89.3 to 96.1,500
Combined 7 Series,,States/Local Areas,Vermont,2020-2021,Age,24 Months,75.6,69.9 to 81.0,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2021,Age,35 Months,95.4,89.6 to 98.5,193
Polio,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,95.6,92.0 to 97.8,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,84.9,76.6 to 91.5,500
PCV,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,3 Months,93.6,89.7 to 96.1,500
DTaP,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,5 Months,88.8,84.1 to 92.2,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2021,Age,0-3 Days,77.2,68.5 to 84.1,193
Hib,≥2 Doses,States/Local Areas,Vermont,2021,Age,13 Months,95.8,88.9 to 98.5,193
PCV,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,96.4,94.1 to 97.8,641
Rotavirus,,States/Local Areas,Vermont,2020-2021,Age,8 Months,82.0,76.9 to 86.2,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,94.6,90.6 to 96.9,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2020-2021,Age,0-3 Days,78.6,73.1 to 83.2,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,97.1,94.1 to 98.8,500
DTaP,≥4 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,86.4,81.6 to 90.5,500
Hep A,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,19 Months,84.4,79.4 to 88.4,500
Polio,≥3 Doses,States/Local Areas,Vermont,2021,Age,35 Months,93.5,86.9 to 97.5,193
≥1 Dose Varicella,,States/Local Areas,Vermont,2021,Age,35 Months,94.7,88.7 to 98.1,193
Hep A,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,35 Months,91.9,87.4 to 95.3,500
Hib,Full Series,States/Local Areas,Vermont,2020-2021,Age,19 Months,83.0,77.8 to 87.2,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,96.8,93.8 to 98.5,500
Hep B,≥2 Doses,States/Local Areas,Vermont,2021,Age,13 Months,93.8,86.0 to 97.4,193
Hib,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,96.5,93.4 to 98.4,500
PCV,≥4 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,86.1,81.2 to 89.8,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,79.1,73.7 to 83.7,500
DTaP,≥4 Doses,States/Local Areas,Vermont,2021,Age,35 Months,88.8,80.6 to 94.6,193
≥1 Dose MMR,,States/Local Areas,Vermont,2020-2021,Age,35 Months,96.9,93.5 to 98.8,500
PCV,≥4 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,90.9,86.5 to 94.4,500
Influenza,,States/Local Areas,Vermont,2020-2021,Age,24 Months,75.7,70.0 to 81.0,500
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2020-2021,Age,0-1 Days,76.3,70.9 to 81.1,500
Hib,Primary Series,States/Local Areas,Vermont,2021,Age,13 Months,91.0,83.7 to 95.3,193
Hib,Primary Series,States/Local Areas,Vermont,2020-2021,Age,13 Months,92.5,88.4 to 95.2,500
Hib,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,3 Months,91.9,87.7 to 94.8,500
≥1 Dose MMR,,States/Local Areas,Vermont,2020-2021,Age,24 Months,95.2,91.7 to 97.6,500
Combined 7 Series,,States/Local Areas,Vermont,2020-2021,Age,35 Months,78.2,72.1 to 83.8,500
PCV,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,5 Months,88.9,84.4 to 92.2,500
Hep B,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,5 Months,91.8,87.4 to 94.8,500
Polio,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,94.6,90.6 to 96.9,500
Polio,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,92.0,87.4 to 95.1,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2021,Age,35 Months,94.3,88.3 to 97.9,193
PCV,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,95.5,92.1 to 97.4,500
Hib,Full Series,States/Local Areas,Vermont,2021,Age,35 Months,86.1,78.3 to 92.2,193
Polio,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,95.8,92.2 to 98.1,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,34.2,28.7 to 40.4,500
Hib,Primary Series,States/Local Areas,Vermont,2020-2021,Age,7 Months,78.5,72.9 to 83.1,500
Hib,≥3 Doses,States/Local Areas,Vermont,2021,Age,13 Months,91.0,83.7 to 95.3,193
≥1 Dose Varicella,,States/Local Areas,Vermont,2020-2021,Age,24 Months,92.5,88.6 to 95.4,500
PCV,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,96.2,93.2 to 98.1,500
Rotavirus,,States/Local Areas,Vermont,2021,Age,8 Months,80.1,71.6 to 86.5,193
Hib,Full Series,States/Local Areas,Vermont,2017-2018,Age,35 Months,89.5,86.2 to 92.4,670
≥1 Dose MMR,,States/Local Areas,Vermont,2020-2021,Age,19 Months,94.0,90.1 to 96.4,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2011,Age,19 Months,95.4,92.1 to 97.4,274
DTaP,≥3 Doses,States/Local Areas,Vermont,2012,Age,19 Months,95.1,93.8 to 96.1,261
Polio,≥3 Doses,States/Local Areas,Vermont,2015,Age,19 Months,92.8,90.7 to 94.5,252
Polio,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,92.9,89.9 to 95.0,500
Polio,≥3 Doses,States/Local Areas,Vermont,2016,Age,19 Months,92.9,88.6 to 95.7,248
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,93.2,90.3 to 95.3,578
Polio,≥3 Doses,States/Local Areas,Vermont,2017,Age,19 Months,93.6,89.0 to 96.3,330
Polio,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,93.2,90.3 to 95.3,670
PCV,≥1 Dose,States/Local Areas,Vermont,2019,Age,3 Months,94.1,90.0 to 96.6,334
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,91.9,85.8 to 98.0,120
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.2,94.8 to 97.6,835
Hib,≥2 Doses,States/Local Areas,Vermont,2020,Age,13 Months,97.8,95.0 to 99.1,307
DTaP,≥3 Doses,States/Local Areas,Vermont,2011,Age,13 Months,94.4,91.6 to 96.2,274
DTaP,≥3 Doses,States/Local Areas,Vermont,2019,Age,13 Months,95.2,91.1 to 97.4,334
DTaP,≥3 Doses,States/Local Areas,Vermont,2018,Age,13 Months,92.1,87.7 to 95.0,340
DTaP,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,93.6,90.8 to 95.6,674
Hib,≥3 Doses,States/Local Areas,Vermont,2016,Age,13 Months,94.6,89.6 to 97.2,248
Hib,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,92.6,89.4 to 94.9,578
Hib,≥3 Doses,States/Local Areas,Vermont,2017,Age,13 Months,90.7,85.8 to 94.0,330
Hib,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,90.0,86.7 to 92.6,670
Hib,≥3 Doses,States/Local Areas,Vermont,2015,Age,13 Months,90.7,84.9 to 94.5,252
Hib,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,92.7,89.1 to 95.1,500
Polio,≥3 Doses,States/Local Areas,Vermont,2013,Age,19 Months,94.9,93.1 to 96.2,261
Polio,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,94.2,92.3 to 95.6,532
Polio,≥3 Doses,States/Local Areas,Vermont,2012,Age,19 Months,91.3,89.3 to 92.9,261
Polio,≥3 Doses,States/Local Areas,Vermont,2014,Age,19 Months,93.5,88.5 to 96.4,271
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,93.2,90.0 to 95.4,523
Hib,≥3 Doses,States/Local Areas,Vermont,2011,Age,13 Months,88.2,84.9 to 90.9,274
Hib,≥3 Doses,States/Local Areas,Vermont,2012,Age,13 Months,90.3,84.0 to 94.3,261
Hib,≥3 Doses,States/Local Areas,Vermont,2014,Age,13 Months,90.0,84.3 to 93.8,271
Hib,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,90.4,86.5 to 93.2,523
Hib,≥3 Doses,States/Local Areas,Vermont,2013,Age,13 Months,93.4,88.8 to 96.2,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,91.7,89.1 to 93.8,532
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,96.5,94.1 to 98.9,314
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,96.5,94.5 to 98.5,421
Polio,≥3 Doses,States/Local Areas,Vermont,2011,Age,19 Months,91.7,87.1 to 94.8,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,56.5,48.9 to 64.0,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,59.4,53.2 to 65.6,314
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,55.1,49.5 to 60.7,421
Hib,≥3 Doses,States/Local Areas,Vermont,2016,Age,7 Months,79.9,72.8 to 85.5,248
Hib,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,78.7,74.1 to 82.6,578
Hib,≥3 Doses,States/Local Areas,Vermont,2018,Age,7 Months,74.5,68.3 to 79.9,340
Hib,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,76.0,71.7 to 79.8,674
Hib,≥3 Doses,States/Local Areas,Vermont,2019,Age,7 Months,77.5,71.4 to 82.6,334
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Overall,Overall,56.7,53.0 to 60.4,971
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,59.1,54.2 to 64.0,565
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,56.4,46.5 to 66.4,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,51.4,44.6 to 58.1,286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",55.4,51.4 to 59.4,835
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.2,50.2 to 74.3,80
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,56.7,40.6 to 72.7,48
DTaP,≥3 Doses,States/Local Areas,Vermont,2013,Age,13 Months,95.1,93.3 to 96.5,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,93.7,91.6 to 95.3,532
DTaP,≥3 Doses,States/Local Areas,Vermont,2014,Age,13 Months,92.2,86.6 to 95.6,271
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,92.3,88.7 to 94.8,523
DTaP,≥3 Doses,States/Local Areas,Vermont,2012,Age,13 Months,91.7,89.8 to 93.3,261
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,92.5,88.8 to 96.2,236
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,95.3,93.7 to 96.8,971
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.4,93.4 to 99.3,286
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,95.5,93.7 to 97.3,565
Hib,≥2 Doses,States/Local Areas,Vermont,2019,Age,13 Months,96.2,92.7 to 98.1,334
Hib,≥2 Doses,States/Local Areas,Vermont,2018,Age,13 Months,93.9,89.5 to 96.6,340
Hib,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,95.0,92.4 to 96.8,674
Hib,≥2 Doses,States/Local Areas,Vermont,2017,Age,13 Months,94.9,91.1 to 97.2,330
Hib,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,94.4,91.7 to 96.3,670
Hib,≥3 Doses,States/Local Areas,Vermont,2018,Age,13 Months,89.3,84.3 to 92.9,340
Hib,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,91.5,88.4 to 93.9,674
Hib,≥3 Doses,States/Local Areas,Vermont,2012,Age,19 Months,93.9,90.0 to 96.3,261
Hib,≥3 Doses,States/Local Areas,Vermont,2011,Age,19 Months,91.1,89.1 to 92.9,274
PCV,≥3 Doses,States/Local Areas,Vermont,2012,Age,35 Months,93.3,89.0 to 96.3,261
PCV,≥3 Doses,States/Local Areas,Vermont,2019,Age,24 Months,96.5,93.4 to 98.4,334
PCV,≥3 Doses,States/Local Areas,Vermont,2011,Age,35 Months,91.8,86.9 to 95.4,274
PCV,≥3 Doses,States/Local Areas,Vermont,2013,Age,35 Months,94.3,90.0 to 97.2,261
PCV,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,94.8,91.9 to 97.0,532
Hib,≥2 Doses,States/Local Areas,Vermont,2015,Age,7 Months,90.0,83.7 to 94.0,252
Hib,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,92.2,88.4 to 94.8,500
PCV,≥3 Doses,States/Local Areas,Vermont,2018,Age,24 Months,93.1,89.0 to 96.0,340
PCV,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,94.7,92.3 to 96.6,674
Hib,≥2 Doses,States/Local Areas,Vermont,2016,Age,7 Months,94.4,89.4 to 97.1,248
Hib,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,93.7,90.7 to 95.7,578
Hib,≥2 Doses,States/Local Areas,Vermont,2017,Age,7 Months,92.9,88.9 to 95.6,330
Hib,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,92.0,89.1 to 94.2,670
PCV,≥3 Doses,States/Local Areas,Vermont,2014,Age,35 Months,95.2,90.7 to 97.9,271
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,94.6,91.6 to 96.8,523
PCV,≥3 Doses,States/Local Areas,Vermont,2015,Age,35 Months,94.0,89.5 to 97.0,252
PCV,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,95.0,92.4 to 96.9,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,93.8,91.0 to 96.7,314
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,92.7,89.8 to 95.6,421
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,93.0,89.6 to 96.4,236
Hib,≥3 Doses,States/Local Areas,Vermont,2011,Age,7 Months,66.0,61.0 to 70.7,274
Hib,≥3 Doses,States/Local Areas,Vermont,2012,Age,7 Months,71.6,67.8 to 75.1,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013,Age,7 Months,73.7,64.5 to 81.2,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,73.5,69.2 to 77.4,532
Polio,≥1 Dose,States/Local Areas,Vermont,2014,Age,3 Months,87.7,81.9 to 91.8,271
Polio,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,3 Months,88.5,84.7 to 91.5,523
Polio,≥1 Dose,States/Local Areas,Vermont,2015,Age,3 Months,89.4,83.9 to 93.2,252
Polio,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,3 Months,91.2,87.9 to 93.6,500
Polio,≥1 Dose,States/Local Areas,Vermont,2016,Age,3 Months,92.9,88.7 to 95.6,248
Polio,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,3 Months,91.2,87.8 to 93.7,578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2017,Age,0-3 Days,64.1,55.4 to 72.0,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2017-2018,Age,0-3 Days,66.4,61.7 to 70.8,670
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016,Age,0-3 Days,58.6,50.6 to 66.2,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2017,Age,0-3 Days,60.9,55.7 to 65.9,578
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,92.7,90.5 to 95.0,565
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,93.8,85.9 to 100.0,48
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,84.4 to 99.6,80
Hib,≥2 Doses,States/Local Areas,Vermont,2012,Age,13 Months,96.7,91.6 to 98.7,261
Hib,≥2 Doses,States/Local Areas,Vermont,2011,Age,13 Months,92.5,88.9 to 95.0,274
Hib,≥2 Doses,States/Local Areas,Vermont,2018,Age,7 Months,91.1,86.4 to 94.4,340
Hib,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,92.6,89.5 to 94.8,674
≥1 Dose Varicella,,States/Local Areas,Vermont,2020,Age,24 Months,91.6,86.0 to 95.6,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2015,Age,0-3 Days,55.8,47.6 to 63.6,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2015-2016,Age,0-3 Days,57.2,51.5 to 62.7,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2016,Age,7 Months,83.3,76.3 to 88.6,248
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,80.9,76.3 to 84.8,578
DTaP,≥3 Doses,States/Local Areas,Vermont,2015,Age,7 Months,74.3,66.1 to 81.2,252
DTaP,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,78.9,73.5 to 83.4,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2014,Age,7 Months,74.9,67.9 to 80.8,271
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,74.6,69.3 to 79.3,523
Polio,≥1 Dose,States/Local Areas,Vermont,2017,Age,3 Months,89.5,83.8 to 93.3,330
Polio,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,3 Months,89.4,85.7 to 92.2,670
Hib,≥3 Doses,States/Local Areas,Vermont,2015,Age,7 Months,66.4,58.0 to 74.0,252
Hib,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,73.2,67.7 to 78.1,500
Hib,≥3 Doses,States/Local Areas,Vermont,2014,Age,7 Months,73.3,66.4 to 79.3,271
Hib,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,69.9,64.5 to 74.8,523
PCV,≥3 Doses,States/Local Areas,Vermont,2018,Age,35 Months,93.1,89.0 to 96.0,340
PCV,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,94.7,92.3 to 96.6,674
Hib,≥2 Doses,States/Local Areas,Vermont,2013,Age,13 Months,95.0,91.2 to 97.2,261
Hib,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,95.3,93.3 to 96.7,532
PCV,≥3 Doses,States/Local Areas,Vermont,2017,Age,35 Months,94.6,90.6 to 97.3,330
PCV,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,93.9,91.1 to 96.0,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2018,Age,7 Months,76.5,70.4 to 81.7,340
DTaP,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,77.9,73.6 to 81.6,674
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2019,Age,0-3 Days,79.4,73.8 to 84.1,334
DTaP,≥3 Doses,States/Local Areas,Vermont,2017,Age,7 Months,78.4,72.1 to 83.6,330
DTaP,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,77.5,73.2 to 81.3,670
PCV,≥3 Doses,States/Local Areas,Vermont,2019,Age,35 Months,96.5,93.4 to 98.4,334
PCV,≥3 Doses,States/Local Areas,Vermont,2016,Age,35 Months,96.1,92.9 to 98.1,248
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,95.3,92.9 to 97.1,578
Hib,≥2 Doses,States/Local Areas,Vermont,2019,Age,7 Months,94.0,89.7 to 96.6,334
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,56.1,50.9 to 61.2,492
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,57.7,52.3 to 63.1,453
Polio,≥1 Dose,States/Local Areas,Vermont,2019,Age,3 Months,93.7,89.6 to 96.2,334
Polio,≥1 Dose,States/Local Areas,Vermont,2018,Age,3 Months,89.2,84.0 to 92.9,340
Polio,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,3 Months,91.4,88.2 to 93.8,674
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2018,Age,0-3 Days,69.6,63.1 to 75.5,340
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2018-2019,Age,0-3 Days,74.4,70.1 to 78.3,674
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,93.8,85.9 to 100.0,48
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.9,78.8 to 97.0,80
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,93.4,90.8 to 96.0,453
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.3 to 99.2,492
Hib,≥2 Doses,States/Local Areas,Vermont,2014,Age,13 Months,95.7,91.0 to 98.0,271
Hib,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,94.7,91.4 to 96.7,523
Hib,≥2 Doses,States/Local Areas,Vermont,2015,Age,13 Months,93.6,88.3 to 96.7,252
Hib,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,94.4,91.0 to 96.5,500
Hib,≥2 Doses,States/Local Areas,Vermont,2016,Age,13 Months,95.1,90.0 to 97.6,248
Hib,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,95.0,92.1 to 96.9,578
DTaP,≥3 Doses,States/Local Areas,Vermont,2019,Age,7 Months,79.3,73.2 to 84.3,334
Hib,≥3 Doses,States/Local Areas,Vermont,2017,Age,7 Months,77.4,71.4 to 82.5,330
Hib,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,76.0,71.7 to 79.8,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2015,Age,13 Months,92.3,87.1 to 95.6,252
DTaP,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,93.2,89.8 to 95.6,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2017,Age,13 Months,92.3,87.5 to 95.4,330
DTaP,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,92.2,89.1 to 94.5,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2016,Age,13 Months,94.1,88.6 to 97.0,248
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,93.2,89.9 to 95.5,578
Hib,≥3 Doses,States/Local Areas,Vermont,2019,Age,35 Months,96.2,93.1 to 98.2,334
Hep A,≥1 Dose,States/Local Areas,Vermont,2017,Age,35 Months,91.3,86.8 to 94.8,330
Hep A,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,35 Months,91.1,87.6 to 93.9,670
Hep A,≥1 Dose,States/Local Areas,Vermont,2016,Age,35 Months,91.4,85.9 to 95.4,248
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,35 Months,91.4,87.9 to 94.1,578
Hep A,≥2 Doses,States/Local Areas,Vermont,2012,Age,24 Months,32.1,25.5 to 39.8,261
≥1 Dose MMR,,States/Local Areas,Vermont,2012,Age,13 Months,58.2,51.9 to 64.2,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2011,Age,13 Months,44.5,41.3 to 47.7,274
≥1 Dose Varicella,,States/Local Areas,Vermont,2013,Age,13 Months,55.5,49.4 to 61.4,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2013-2014,Age,13 Months,56.3,53.5 to 59.0,532
DTaP,≥4 Doses,States/Local Areas,Vermont,2019,Age,19 Months,77.0,70.8 to 82.2,334
DTaP,≥4 Doses,States/Local Areas,Vermont,2015,Age,24 Months,82.5,75.3 to 88.6,252
DTaP,≥4 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,84.0,79.3 to 88.2,500
DTaP,≥4 Doses,States/Local Areas,Vermont,2016,Age,24 Months,85.4,79.1 to 90.6,248
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,87.0,83.1 to 90.4,578
DTaP,≥4 Doses,States/Local Areas,Vermont,2014,Age,24 Months,82.1,75.8 to 87.5,271
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,82.3,77.6 to 86.5,523
DTaP,≥4 Doses,States/Local Areas,Vermont,2019,Age,24 Months,88.0,83.1 to 92.0,334
DTaP,≥4 Doses,States/Local Areas,Vermont,2011,Age,35 Months,87.0,80.9 to 91.8,274
DTaP,≥4 Doses,States/Local Areas,Vermont,2017,Age,24 Months,88.5,83.7 to 92.4,330
DTaP,≥4 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,87.8,84.5 to 90.7,670
DTaP,≥4 Doses,States/Local Areas,Vermont,2018,Age,24 Months,87.2,82.3 to 91.3,340
DTaP,≥4 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,87.6,84.2 to 90.5,674
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,86.3,79.2 to 93.5,120
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.1,81.2 to 87.0,835
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.0,83.3 to 92.8,286
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,83.5,80.0 to 87.0,565
≥1 Dose Varicella,,States/Local Areas,Vermont,2015,Age,13 Months,54.0,46.0 to 61.9,252
≥1 Dose Varicella,,States/Local Areas,Vermont,2015-2016,Age,13 Months,56.1,50.4 to 61.6,500
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.3,78.5 to 96.1,80
≥1 Dose Varicella,,States/Local Areas,Vermont,2016,Age,13 Months,58.1,50.1 to 65.7,248
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2017,Age,13 Months,59.5,54.3 to 64.5,578
≥1 Dose Varicella,,States/Local Areas,Vermont,2017,Age,13 Months,60.9,54.2 to 67.2,330
≥1 Dose Varicella,,States/Local Areas,Vermont,2017-2018,Age,13 Months,58.7,53.9 to 63.3,670
Polio,≥2 Doses,States/Local Areas,Vermont,2015,Age,7 Months,89.7,84.1 to 93.5,252
Polio,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,90.7,87.1 to 93.4,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2011,Age,13 Months,88.4,84.4 to 91.5,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2019,Age,7 Months,72.6,66.2 to 78.2,334
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,86.4,81.6 to 91.3,236
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Overall,Overall,85.0,82.4 to 87.7,971
Polio,≥2 Doses,States/Local Areas,Vermont,2013,Age,7 Months,93.2,90.3 to 95.3,261
Polio,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,92.3,89.3 to 94.5,532
Polio,≥2 Doses,States/Local Areas,Vermont,2014,Age,7 Months,91.2,85.6 to 94.8,271
Polio,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,90.5,86.7 to 93.2,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2018,Age,13 Months,56.5,49.8 to 62.9,340
≥1 Dose Varicella,,States/Local Areas,Vermont,2018-2019,Age,13 Months,60.0,55.4 to 64.5,674
≥1 Dose MMR,,States/Local Areas,Vermont,2013,Age,13 Months,58.4,52.2 to 64.3,261
≥1 Dose MMR,,States/Local Areas,Vermont,2013-2014,Age,13 Months,63.3,61.5 to 65.0,532
≥1 Dose Varicella,,States/Local Areas,Vermont,2011,Age,19 Months,77.1,74.8 to 79.2,274
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,82.0,77.5 to 86.4,421
≥1 Dose Varicella,,States/Local Areas,Vermont,2012,Age,19 Months,85.8,82.1 to 88.9,261
≥1 Dose MMR,,States/Local Areas,Vermont,2015,Age,13 Months,70.3,62.7 to 76.9,252
≥1 Dose MMR,,States/Local Areas,Vermont,2015-2016,Age,13 Months,68.7,63.3 to 73.7,500
≥1 Dose MMR,,States/Local Areas,Vermont,2014,Age,13 Months,68.4,61.1 to 74.8,271
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2015,Age,13 Months,69.3,64.2 to 74.0,523
DTaP,≥4 Doses,States/Local Areas,Vermont,2012,Age,35 Months,94.4,88.1 to 98.0,261
DTaP,≥4 Doses,States/Local Areas,Vermont,2014,Age,35 Months,89.2,81.5 to 94.7,271
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,87.8,83.4 to 91.5,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2019,Age,35 Months,80.2,72.1 to 87.2,334
Hep B,≥3 Doses,States/Local Areas,Vermont,2012,Age,13 Months,86.8,84.2 to 89.1,261
DTaP,≥4 Doses,States/Local Areas,Vermont,2013,Age,35 Months,92.9,86.6 to 96.9,261
DTaP,≥4 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,91.1,86.4 to 94.7,532
Hep B,≥3 Doses,States/Local Areas,Vermont,2013,Age,13 Months,91.6,89.0 to 93.6,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,90.8,88.0 to 93.0,532
Hep B,≥3 Doses,States/Local Areas,Vermont,2014,Age,13 Months,90.1,84.3 to 93.8,271
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,89.7,86.1 to 92.5,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2017,Age,35 Months,80.3,73.6 to 86.3,330
Hep A,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,77.6,72.5 to 82.4,670
Hep A,≥2 Doses,States/Local Areas,Vermont,2018,Age,35 Months,74.8,67.0 to 81.9,340
Hep A,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,76.9,71.4 to 82.1,674
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,88.4,84.6 to 92.1,314
≥1 Dose Varicella,,States/Local Areas,Vermont,2019,Age,13 Months,63.8,57.2 to 69.8,334
Polio,≥2 Doses,States/Local Areas,Vermont,2018,Age,7 Months,90.3,85.4 to 93.6,340
Polio,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,91.8,88.7 to 94.1,674
Hep B,≥1 Dose,States/Local Areas,Vermont,2013,Age,3 Months,93.1,87.5 to 96.3,261
Hep B,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,3 Months,92.1,88.4 to 94.7,532
Hep B,≥1 Dose,States/Local Areas,Vermont,2012,Age,3 Months,91.0,85.0 to 94.7,261
Hep B,≥1 Dose,States/Local Areas,Vermont,2011,Age,3 Months,89.3,82.5 to 93.6,274
Polio,≥2 Doses,States/Local Areas,Vermont,2016,Age,7 Months,91.7,86.5 to 95.1,248
Polio,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,91.6,88.3 to 94.0,578
Polio,≥2 Doses,States/Local Areas,Vermont,2017,Age,7 Months,91.4,86.7 to 94.6,330
Polio,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,90.8,87.6 to 93.3,670
Polio,≥2 Doses,States/Local Areas,Vermont,2013,Age,13 Months,95.5,93.6 to 96.9,261
Polio,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,95.1,93.4 to 96.4,532
Hep B,≥1 Dose,States/Local Areas,Vermont,2014,Age,3 Months,91.1,85.6 to 94.6,271
Hep B,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,3 Months,90.7,87.2 to 93.3,523
Hep B,≥1 Dose,States/Local Areas,Vermont,2015,Age,3 Months,90.3,85.1 to 93.8,252
Hep B,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,3 Months,92.7,89.7 to 94.9,500
Hep B,≥1 Dose,States/Local Areas,Vermont,2016,Age,3 Months,95.1,91.3 to 97.3,248
Hep B,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,3 Months,94.4,91.4 to 96.3,578
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,85.6,70.6 to 100.0,48
DTaP,≥4 Doses,States/Local Areas,Vermont,2017,Age,35 Months,91.6,86.9 to 95.1,330
DTaP,≥4 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,92.5,89.2 to 95.0,670
DTaP,≥4 Doses,States/Local Areas,Vermont,2016,Age,35 Months,87.8,81.4 to 92.8,248
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,89.8,86.0 to 93.0,578
DTaP,≥4 Doses,States/Local Areas,Vermont,2015,Age,35 Months,87.4,81.4 to 92.2,252
DTaP,≥4 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,87.8,83.5 to 91.4,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2015,Age,13 Months,89.4,84.1 to 93.0,252
Hep B,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,91.1,87.7 to 93.6,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2016,Age,13 Months,92.8,87.7 to 95.9,248
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,91.6,88.1 to 94.1,578
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,70.5,63.4 to 77.5,453
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,84.4,79.5 to 89.4,492
Hep B,≥3 Doses,States/Local Areas,Vermont,2018,Age,7 Months,81.5,76.0 to 85.9,340
Hep B,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,77.1,73.0 to 80.8,674
Polio,≥2 Doses,States/Local Areas,Vermont,2019,Age,5 Months,89.4,84.7 to 92.8,334
≥1 Dose MMR,,States/Local Areas,Vermont,2011,Age,13 Months,56.2,50.7 to 61.5,274
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.6,60.3 to 88.9,80
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,77.6,67.6 to 87.6,120
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.9,70.4 to 79.3,835
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.6,71.2 to 86.1,286
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,75.4,68.2 to 82.5,565
≥1 Dose MMR,,States/Local Areas,Vermont,2017,Age,13 Months,71.9,65.4 to 77.6,330
≥1 Dose MMR,,States/Local Areas,Vermont,2017-2018,Age,13 Months,72.0,67.4 to 76.2,670
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,83.8,80.8 to 86.8,971
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,82.8,78.6 to 87.0,565
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,83.1,75.4 to 90.8,120
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.3,81.5 to 91.2,286
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.2,80.9 to 87.5,835
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.1,69.6 to 90.7,80
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,79.1,66.6 to 91.6,48
Hep B,≥1 Dose,States/Local Areas,Vermont,2019,Age,3 Months,97.8,95.1 to 99.0,334
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,77.7,70.8 to 84.6,236
≥1 Dose MMR,,States/Local Areas,Vermont,2014,Age,19 Months,90.7,85.3 to 94.2,271
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2015,Age,19 Months,91.6,88.1 to 94.2,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2011,Age,24 Months,79.5,73.6 to 84.9,274
≥1 Dose Varicella,,States/Local Areas,Vermont,2012,Age,24 Months,88.1,82.7 to 92.4,261
≥1 Dose MMR,,States/Local Areas,Vermont,2015,Age,19 Months,92.6,90.3 to 94.3,252
≥1 Dose MMR,,States/Local Areas,Vermont,2015-2016,Age,19 Months,92.7,89.4 to 95.0,500
≥1 Dose MMR,,States/Local Areas,Vermont,2016,Age,19 Months,92.8,88.2 to 95.7,248
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2017,Age,19 Months,93.0,90.0 to 95.1,578
Hep B,≥1 Dose,States/Local Areas,Vermont,2018,Age,3 Months,92.7,88.1 to 95.6,340
Hep B,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,3 Months,95.2,92.6 to 96.9,674
Polio,≥2 Doses,States/Local Areas,Vermont,2014,Age,13 Months,94.7,89.6 to 97.4,271
Polio,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,94.0,90.9 to 96.1,523
Hep B,≥2 Doses,States/Local Areas,Vermont,2012,Age,5 Months,84.5,77.2 to 89.8,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2011,Age,5 Months,85.2,78.4 to 90.0,274
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,71.1,64.7 to 77.4,421
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2011,Age,0-1 Days,24.3,22.3 to 26.5,274
Hep B,≥2 Doses,States/Local Areas,Vermont,2013,Age,5 Months,84.2,79.4 to 88.0,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,5 Months,85.5,82.4 to 88.2,532
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,82.7,75.9 to 89.5,314
Hep B,≥3 Doses,States/Local Areas,Vermont,2013,Age,19 Months,93.0,89.2 to 95.5,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,92.6,89.7 to 94.8,532
Hep B,≥3 Doses,States/Local Areas,Vermont,2015,Age,19 Months,91.4,89.5 to 92.9,252
Hep B,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,92.8,89.8 to 94.9,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2014,Age,19 Months,92.3,87.1 to 95.5,271
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,91.8,88.5 to 94.2,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,76.2,71.5 to 80.9,971
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,76.0,66.8 to 85.2,236
≥1 Dose MMR,,States/Local Areas,Vermont,2018,Age,13 Months,72.1,65.4 to 77.9,340
≥1 Dose MMR,,States/Local Areas,Vermont,2018-2019,Age,13 Months,75.0,70.6 to 79.0,674
Hep B,≥3 Doses,States/Local Areas,Vermont,2017,Age,13 Months,90.3,85.0 to 93.9,330
Hep B,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,90.4,87.0 to 92.9,670
≥1 Dose Varicella,,States/Local Areas,Vermont,2013,Age,19 Months,84.8,80.6 to 88.3,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2013-2014,Age,19 Months,85.9,83.6 to 88.0,532
Polio,≥2 Doses,States/Local Areas,Vermont,2012,Age,13 Months,95.3,92.7 to 97.1,261
Polio,≥2 Doses,States/Local Areas,Vermont,2011,Age,13 Months,94.2,91.8 to 95.9,274
≥1 Dose Varicella,,States/Local Areas,Vermont,2015,Age,19 Months,85.5,79.2 to 90.2,252
≥1 Dose Varicella,,States/Local Areas,Vermont,2015-2016,Age,19 Months,88.0,83.7 to 91.3,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2014,Age,19 Months,87.1,81.6 to 91.1,271
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2015,Age,19 Months,86.3,81.9 to 89.8,523
≥1 Dose MMR,,States/Local Areas,Vermont,2016,Age,13 Months,67.3,59.2 to 74.4,248
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2017,Age,13 Months,69.6,64.5 to 74.2,578
DTaP,≥4 Doses,States/Local Areas,Vermont,2018,Age,35 Months,93.1,88.5 to 96.3,340
DTaP,≥4 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,92.8,89.6 to 95.3,674
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,80.7,76.0 to 85.4,453
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,88.7,85.4 to 92.0,492
DTaP,≥4 Doses,States/Local Areas,Vermont,2019,Age,35 Months,92.6,87.8 to 96.0,334
≥1 Dose MMR,,States/Local Areas,Vermont,2011,Age,19 Months,85.8,82.4 to 88.6,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2011,Age,19 Months,90.0,85.3 to 93.3,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2012,Age,19 Months,88.7,84.4 to 92.0,261
Polio,≥2 Doses,States/Local Areas,Vermont,2019,Age,7 Months,93.4,89.1 to 96.1,334
Hep B,≥3 Doses,States/Local Areas,Vermont,2018,Age,13 Months,90.4,85.8 to 93.7,340
Hep B,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,91.8,88.9 to 94.0,674
Hep B,≥3 Doses,States/Local Areas,Vermont,2019,Age,13 Months,93.3,89.3 to 95.9,334
Polio,≥2 Doses,States/Local Areas,Vermont,2015,Age,13 Months,93.3,88.7 to 96.2,252
Polio,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,93.1,89.9 to 95.3,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2016,Age,19 Months,90.5,85.4 to 93.9,248
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2017,Age,19 Months,90.1,86.9 to 92.7,578
≥1 Dose MMR,,States/Local Areas,Vermont,2019,Age,13 Months,78.1,72.1 to 83.0,334
Hep A,≥2 Doses,States/Local Areas,Vermont,2020,Age,35 Months,84.6,74.2 to 92.5,307
≥1 Dose Varicella,,States/Local Areas,Vermont,2018,Age,19 Months,88.7,83.7 to 92.3,340
≥1 Dose Varicella,,States/Local Areas,Vermont,2018-2019,Age,19 Months,60.0,55.4 to 64.5,674
Polio,≥2 Doses,States/Local Areas,Vermont,2016,Age,13 Months,92.8,87.7 to 95.9,248
Polio,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,93.2,90.0 to 95.4,578
Hep B,≥1 Dose,States/Local Areas,Vermont,2017,Age,3 Months,93.6,88.5 to 96.6,330
Hep B,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,3 Months,93.2,90.0 to 95.4,670
≥1 Dose MMR,,States/Local Areas,Vermont,2013,Age,19 Months,90.8,87.5 to 93.3,261
≥1 Dose MMR,,States/Local Areas,Vermont,2013-2014,Age,19 Months,90.7,88.3 to 92.7,532
≥1 Dose MMR,,States/Local Areas,Vermont,2012,Age,19 Months,92.5,87.5 to 95.6,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2017,Age,19 Months,89.8,85.1 to 93.2,330
≥1 Dose Varicella,,States/Local Areas,Vermont,2017-2018,Age,19 Months,89.3,86.0 to 91.8,670
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2016,Age,0-1 Days,47.0,39.0 to 55.1,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2016-2017,Age,0-1 Days,48.8,43.5 to 54.0,578
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2017,Age,0-1 Days,50.6,43.8 to 57.3,330
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2017-2018,Age,0-1 Days,55.1,50.4 to 59.8,670
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2015,Age,0-1 Days,42.5,34.8 to 50.5,252
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2015-2016,Age,0-1 Days,44.7,39.2 to 50.4,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2018,Age,19 Months,90.7,86.1 to 93.9,340
Hep B,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,91.8,88.9 to 94.0,674
Hep B,≥2 Doses,States/Local Areas,Vermont,2017,Age,5 Months,88.6,82.9 to 92.5,330
Hep B,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,5 Months,90.1,86.6 to 92.8,670
≥1 Dose Varicella,,States/Local Areas,Vermont,2014,Age,24 Months,87.9,82.8 to 92.0,271
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2015,Age,24 Months,88.2,84.7 to 91.2,523
≥1 Dose MMR,,States/Local Areas,Vermont,2019,Age,19 Months,91.5,87.0 to 94.6,334
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.0,83.2 to 92.7,286
DTaP,≥4 Doses,States/Local Areas,Vermont,2018,Age,19 Months,77.7,71.5 to 82.9,340
DTaP,≥4 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,94.5,91.9 to 96.3,674
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,91.6,88.3 to 94.9,314
Hib,Primary Series,States/Local Areas,Vermont,2011,Age,7 Months,67.5,63.1 to 71.7,274
Hib,Full Series,States/Local Areas,Vermont,2018,Age,35 Months,89.9,84.9 to 93.8,340
Hib,Full Series,States/Local Areas,Vermont,2018-2019,Age,35 Months,90.8,87.4 to 93.7,674
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,84.2,76.5 to 91.9,120
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.1,84.3 to 89.9,835
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,80.9,68.5 to 93.2,48
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.0,71.6 to 92.5,80
Hib,Full Series,States/Local Areas,Vermont,2019,Age,35 Months,91.9,86.8 to 95.6,334
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,86.1,82.1 to 90.1,421
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,82.4,76.5 to 88.2,236
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Overall,Overall,86.4,83.8 to 89.1,971
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,86.3,82.8 to 89.7,565
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,90.7,84.2 to 97.2,120
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.6,91.8 to 95.5,835
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,93.8,85.9 to 100.0,48
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,84.4 to 99.6,80
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,83.7,79.6 to 87.9,453
Hib,Full Series,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,90.6,87.7 to 93.5,492
Hep A,≥1 Dose,States/Local Areas,Vermont,2013,Age,35 Months,89.0,81.8 to 94.2,261
Hep A,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,35 Months,86.8,81.7 to 91.0,532
Hep A,≥1 Dose,States/Local Areas,Vermont,2014,Age,35 Months,84.1,77.9 to 89.4,271
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,35 Months,86.1,81.7 to 89.9,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2013,Age,24 Months,32.8,26.5 to 40.2,261
Hep A,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,36.8,32.0 to 42.2,532
DTaP,≥4 Doses,States/Local Areas,Vermont,2016,Age,19 Months,74.1,66.7 to 80.3,248
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,74.6,69.8 to 78.9,578
DTaP,≥4 Doses,States/Local Areas,Vermont,2017,Age,19 Months,75.1,68.6 to 80.7,330
DTaP,≥4 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,76.4,72.0 to 80.4,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,93.2,87.4 to 98.9,120
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,95.1 to 97.9,835
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.1,93.3 to 99.0,286
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,96.1,94.4 to 97.8,565
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,93.8,85.9 to 100.0,48
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,81.4 to 98.3,80
PCV,≥2 Doses,States/Local Areas,Vermont,2019,Age,5 Months,86.7,81.4 to 90.7,334
PCV,≥2 Doses,States/Local Areas,Vermont,2018,Age,5 Months,82.7,76.7 to 87.5,340
PCV,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,5 Months,84.7,80.8 to 87.9,674
PCV,≥2 Doses,States/Local Areas,Vermont,2017,Age,5 Months,81.8,75.4 to 86.8,330
PCV,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,5 Months,82.3,78.0 to 85.8,670
Hep B,≥3 Doses,States/Local Areas,Vermont,2016,Age,7 Months,79.5,72.4 to 85.1,248
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,76.4,71.8 to 80.6,578
Hep A,≥2 Doses,States/Local Areas,Vermont,2014,Age,35 Months,70.0,62.2 to 77.5,271
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,71.0,65.0 to 76.7,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2015,Age,35 Months,72.0,62.9 to 80.4,252
Hep A,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,79.3,73.2 to 84.8,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2016,Age,35 Months,85.6,77.7 to 91.9,248
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,83.1,77.9 to 87.6,578
Polio,≥2 Doses,States/Local Areas,Vermont,2012,Age,7 Months,91.8,89.7 to 93.6,261
Polio,≥2 Doses,States/Local Areas,Vermont,2011,Age,7 Months,89.4,86.3 to 91.9,274
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,91.2,82.4 to 100.0,48
Polio,≥2 Doses,States/Local Areas,Vermont,2018,Age,5 Months,84.1,78.2 to 88.6,340
Polio,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,5 Months,86.7,83.0 to 89.7,674
Hep B,≥3 Doses,States/Local Areas,Vermont,2017,Age,7 Months,73.4,66.9 to 79.0,330
Hep B,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,77.4,73.2 to 81.1,670
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,81.8,77.6 to 85.9,453
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,88.9,85.9 to 91.9,492
Hep A,≥1 Dose,States/Local Areas,Vermont,2019,Age,35 Months,93.5,88.4 to 96.9,334
≥1 Dose Varicella,,States/Local Areas,Vermont,2014,Age,13 Months,57.1,49.8 to 64.1,271
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2015,Age,13 Months,55.6,50.2 to 60.9,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2012,Age,13 Months,54.4,47.1 to 61.5,261
Hep A,≥1 Dose,States/Local Areas,Vermont,2018,Age,35 Months,90.7,85.3 to 94.7,340
Hep A,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,35 Months,92.0,88.5 to 94.8,674
DTaP,≥4 Doses,States/Local Areas,Vermont,2013,Age,24 Months,84.0,78.2 to 89.0,261
DTaP,≥4 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,83.1,78.9 to 86.9,532
Hep A,≥2 Doses,States/Local Areas,Vermont,2016,Age,24 Months,43.6,35.9 to 52.2,248
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,40.2,35.1 to 45.7,578
Hep A,≥2 Doses,States/Local Areas,Vermont,2015,Age,24 Months,40.9,33.0 to 49.8,252
Hep A,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,42.2,36.6 to 48.3,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2017,Age,24 Months,36.8,30.5 to 43.9,330
Hep A,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,37.6,33.1 to 42.5,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,93.4,89.9 to 96.8,236
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,98.0,96.3 to 99.7,314
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,96.0,93.7 to 98.3,421
Hep B,≥3 Doses,States/Local Areas,Vermont,2012,Age,7 Months,74.6,68.7 to 79.7,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2011,Age,7 Months,68.9,63.4 to 73.8,274
DTaP,≥4 Doses,States/Local Areas,Vermont,2011,Age,24 Months,84.8,78.9 to 89.8,274
DTaP,≥4 Doses,States/Local Areas,Vermont,2012,Age,24 Months,88.6,83.0 to 93.0,261
Polio,≥2 Doses,States/Local Areas,Vermont,2012,Age,5 Months,82.1,76.7 to 86.5,261
Polio,≥2 Doses,States/Local Areas,Vermont,2011,Age,5 Months,81.9,75.3 to 87.0,274
Hep A,≥1 Dose,States/Local Areas,Vermont,2012,Age,35 Months,84.5,78.4 to 89.6,261
Polio,≥2 Doses,States/Local Areas,Vermont,2013,Age,5 Months,80.1,73.3 to 85.5,261
Polio,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,5 Months,81.9,77.3 to 85.6,532
Polio,≥2 Doses,States/Local Areas,Vermont,2014,Age,5 Months,83.7,77.3 to 88.6,271
Polio,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,5 Months,84.8,82.7 to 86.7,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2014,Age,24 Months,41.0,34.0 to 48.9,271
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,41.0,35.6 to 46.8,523
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,95.7,94.2 to 97.2,971
Hib,≥3 Doses,States/Local Areas,Vermont,2018,Age,35 Months,93.5,89.4 to 96.4,340
Hib,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,94.8,92.3 to 96.7,674
Hep A,≥2 Doses,States/Local Areas,Vermont,2011,Age,35 Months,67.4,57.9 to 76.7,274
Hep A,≥2 Doses,States/Local Areas,Vermont,2012,Age,35 Months,71.2,63.0 to 78.9,261
Hep A,≥2 Doses,States/Local Areas,Vermont,2013,Age,35 Months,73.4,65.0 to 81.2,261
Hep A,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,71.7,66.0 to 77.2,532
Polio,≥2 Doses,States/Local Areas,Vermont,2015,Age,5 Months,85.9,79.6 to 90.5,252
Polio,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,5 Months,84.8,80.3 to 88.4,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2019,Age,24 Months,33.6,27.7 to 40.4,334
Hep B,≥3 Doses,States/Local Areas,Vermont,2013,Age,7 Months,75.1,69.0 to 80.3,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,76.9,73.2 to 80.1,532
Hep A,≥2 Doses,States/Local Areas,Vermont,2018,Age,24 Months,38.4,32.2 to 45.4,340
Hep A,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,36.1,31.7 to 40.9,674
Polio,≥2 Doses,States/Local Areas,Vermont,2016,Age,5 Months,83.8,76.8 to 88.9,248
Polio,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,5 Months,83.4,78.9 to 87.0,578
Polio,≥2 Doses,States/Local Areas,Vermont,2017,Age,5 Months,83.0,76.8 to 87.8,330
Polio,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,5 Months,83.5,79.4 to 87.0,670
Hep B,≥3 Doses,States/Local Areas,Vermont,2015,Age,7 Months,72.4,64.4 to 79.2,252
Hep B,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,76.0,70.7 to 80.5,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2014,Age,7 Months,78.7,71.9 to 84.3,271
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,75.6,70.4 to 80.1,523
Hep A,≥1 Dose,States/Local Areas,Vermont,2015,Age,35 Months,88.3,81.7 to 93.3,252
Hep A,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,35 Months,90.1,85.8 to 93.5,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2019,Age,24 Months,93.7,89.9 to 96.4,334
≥1 Dose Varicella,,States/Local Areas,Vermont,2017,Age,24 Months,91.9,87.7 to 95.1,330
≥1 Dose Varicella,,States/Local Areas,Vermont,2017-2018,Age,24 Months,91.5,88.6 to 93.8,670
≥1 Dose MMR,,States/Local Areas,Vermont,2013,Age,24 Months,93.2,88.7 to 96.4,261
≥1 Dose MMR,,States/Local Areas,Vermont,2013-2014,Age,24 Months,92.8,89.7 to 95.2,532
≥1 Dose MMR,,States/Local Areas,Vermont,2014,Age,24 Months,92.5,87.8 to 95.8,271
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2015,Age,24 Months,92.8,89.8 to 95.2,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2018,Age,24 Months,91.0,86.9 to 94.3,340
≥1 Dose Varicella,,States/Local Areas,Vermont,2018-2019,Age,24 Months,92.3,89.6 to 94.5,674
Hep B,≥3 Doses,States/Local Areas,Vermont,2011,Age,24 Months,90.7,86.3 to 94.1,274
Hep A,≥1 Dose,States/Local Areas,Vermont,2020,Age,35 Months,89.6,83.2 to 94.4,307
Hep B,≥3 Doses,States/Local Areas,Vermont,2013,Age,24 Months,93.8,90.0 to 96.6,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,93.2,90.4 to 95.5,532
Hep B,≥2 Doses,States/Local Areas,Vermont,2019,Age,5 Months,93.4,89.3 to 96.0,334
Hep B,≥2 Doses,States/Local Areas,Vermont,2018,Age,5 Months,91.8,87.1 to 94.9,340
Hep B,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,5 Months,92.6,89.6 to 94.7,674
Hep B,≥3 Doses,States/Local Areas,Vermont,2012,Age,24 Months,88.9,83.8 to 93.0,261
PCV,≥3 Doses,States/Local Areas,Vermont,2016,Age,7 Months,78.3,71.2 to 84.0,248
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,77.1,72.4 to 81.1,578
PCV,≥3 Doses,States/Local Areas,Vermont,2015,Age,7 Months,69.9,61.7 to 77.1,252
PCV,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,74.1,68.8 to 78.9,500
PCV,≥4 Doses,States/Local Areas,Vermont,2014,Age,19 Months,81.2,74.7 to 86.4,271
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,84.9,80.8 to 88.3,523
PCV,≥3 Doses,States/Local Areas,Vermont,2017,Age,7 Months,75.8,69.5 to 81.2,330
PCV,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,75.5,71.1 to 79.4,670
PCV,≥4 Doses,States/Local Areas,Vermont,2015,Age,19 Months,88.7,81.1 to 93.5,252
PCV,≥4 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,87.5,83.4 to 90.7,500
PCV,≥4 Doses,States/Local Areas,Vermont,2016,Age,19 Months,86.4,79.7 to 91.1,248
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,86.3,82.2 to 89.6,578
PCV,≥4 Doses,States/Local Areas,Vermont,2017,Age,19 Months,86.3,80.8 to 90.4,330
PCV,≥4 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,85.8,82.1 to 88.9,670
PCV,≥4 Doses,States/Local Areas,Vermont,2018,Age,19 Months,85.4,79.9 to 89.6,340
PCV,≥4 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,84.6,79.9 to 88.4,545
≥1 Dose MMR,,States/Local Areas,Vermont,2017,Age,24 Months,95.6,91.8 to 97.9,330
≥1 Dose MMR,,States/Local Areas,Vermont,2017-2018,Age,24 Months,94.3,91.7 to 96.4,670
≥1 Dose MMR,,States/Local Areas,Vermont,2016,Age,24 Months,94.1,90.3 to 96.8,248
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2017,Age,24 Months,95.0,92.5 to 96.9,578
PCV,≥3 Doses,States/Local Areas,Vermont,2012,Age,13 Months,91.1,85.6 to 94.6,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2011,Age,7 Months,89.0,83.9 to 92.7,274
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2019,Age,0-1 Days,70.6,64.3 to 76.2,334
Hep B,≥3 Doses,States/Local Areas,Vermont,2016,Age,24 Months,94.2,90.6 to 96.8,248
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,93.6,90.9 to 95.8,578
Hep B,≥3 Doses,States/Local Areas,Vermont,2015,Age,24 Months,91.4,86.8 to 94.8,252
Hep B,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,92.8,90.0 to 95.0,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2014,Age,24 Months,92.6,88.0 to 96.0,271
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,92.0,88.9 to 94.5,523
PCV,≥3 Doses,States/Local Areas,Vermont,2011,Age,13 Months,88.6,85.9 to 90.9,274
PCV,≥3 Doses,States/Local Areas,Vermont,2018,Age,7 Months,75.1,68.9 to 80.5,340
PCV,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,76.5,72.2 to 80.3,674
Hep B,≥2 Doses,States/Local Areas,Vermont,2012,Age,7 Months,89.8,86.4 to 92.5,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2014,Age,7 Months,91.1,85.4 to 94.7,271
Hep B,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,90.2,86.6 to 92.9,523
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2012,Age,0-2 Days,41.2,35.5 to 47.2,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2013,Age,7 Months,93.3,90.8 to 95.2,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,92.2,88.9 to 94.7,532
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2011,Age,0-2 Days,37.7,32.1 to 43.7,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2019,Age,19 Months,94.6,91.0 to 96.8,334
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2018,Age,0-1 Days,59.8,53.1 to 66.1,340
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2018-2019,Age,0-1 Days,65.1,60.5 to 69.4,674
Hep B,≥2 Doses,States/Local Areas,Vermont,2015,Age,5 Months,86.5,80.5 to 90.8,252
Hep B,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,5 Months,89.2,85.6 to 92.0,500
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2013,Age,0-1 Days,30.5,25.8 to 35.7,261
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2013-2014,Age,0-1 Days,28.4,24.2 to 33.0,532
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2014,Age,0-1 Days,26.2,20.5 to 33.0,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2014-2015,Age,0-1 Days,34.3,29.4 to 39.5,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2019,Age,19 Months,90.7,86.1 to 93.8,334
Polio,≥2 Doses,States/Local Areas,Vermont,2018,Age,13 Months,93.4,89.1 to 96.1,340
Polio,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,94.5,91.9 to 96.3,674
≥1 Dose Varicella,,States/Local Areas,Vermont,2013,Age,24 Months,89.2,84.1 to 93.2,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2013-2014,Age,24 Months,88.5,85.1 to 91.5,532
Polio,≥2 Doses,States/Local Areas,Vermont,2017,Age,13 Months,93.6,89.0 to 96.3,330
Polio,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,93.5,90.6 to 95.5,670
Hep B,≥3 Doses,States/Local Areas,Vermont,2017,Age,19 Months,92.8,87.9 to 95.8,330
Hep B,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,91.7,88.6 to 94.1,670
Hep B,≥2 Doses,States/Local Areas,Vermont,2016,Age,5 Months,92.0,87.3 to 95.0,248
Hep B,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,5 Months,90.3,86.8 to 92.9,578
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2012,Age,0-1 Days,24.4,19.7 to 29.8,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2014,Age,5 Months,86.9,80.7 to 91.4,271
Hep B,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,5 Months,86.7,84.9 to 88.3,523
PCV,≥3 Doses,States/Local Areas,Vermont,2013,Age,7 Months,72.9,64.0 to 80.2,261
PCV,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,71.9,68.1 to 75.5,532
PCV,≥3 Doses,States/Local Areas,Vermont,2011,Age,7 Months,63.5,58.1 to 68.5,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2016,Age,19 Months,94.2,90.2 to 96.6,248
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,93.5,90.5 to 95.6,578
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,87.6,83.2 to 91.9,314
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,85.8,81.7 to 89.9,421
PCV,≥3 Doses,States/Local Areas,Vermont,2012,Age,7 Months,73.7,66.9 to 79.5,261
PCV,≥3 Doses,States/Local Areas,Vermont,2014,Age,7 Months,71.0,64.0 to 77.1,271
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,70.5,65.1 to 75.3,523
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2015,Age,0-2 Days,53.1,45.1 to 61.1,252
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2015-2016,Age,0-2 Days,54.4,48.6 to 60.0,500
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2014,Age,0-2 Days,45.2,38.2 to 52.4,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2014-2015,Age,0-2 Days,49.2,43.8 to 54.5,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2013,Age,35 Months,94.1,89.1 to 97.3,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2013-2014,Age,35 Months,93.6,90.2 to 96.1,532
PCV,≥3 Doses,States/Local Areas,Vermont,2019,Age,7 Months,77.8,71.8 to 82.9,334
≥1 Dose Varicella,,States/Local Areas,Vermont,2012,Age,35 Months,93.2,88.3 to 96.6,261
≥1 Dose MMR,,States/Local Areas,Vermont,2015,Age,24 Months,93.1,88.9 to 96.2,252
≥1 Dose MMR,,States/Local Areas,Vermont,2015-2016,Age,24 Months,93.6,90.9 to 95.8,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2014,Age,35 Months,92.9,88.0 to 96.3,271
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2015,Age,35 Months,91.8,88.3 to 94.6,523
PCV,≥3 Doses,States/Local Areas,Vermont,2015,Age,13 Months,92.9,87.9 to 96.0,252
PCV,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,93.3,90.0 to 95.5,500
PCV,≥3 Doses,States/Local Areas,Vermont,2014,Age,13 Months,90.6,85.5 to 94.1,271
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,91.8,88.4 to 94.2,523
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2013,Age,0-2 Days,43.6,39.8 to 47.6,261
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2013-2014,Age,0-2 Days,44.4,42.0 to 46.8,532
Hep B,≥2 Doses,States/Local Areas,Vermont,2015,Age,7 Months,89.3,84.2 to 92.9,252
Hep B,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,7 Months,91.7,88.7 to 94.0,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2018,Age,24 Months,91.6,87.4 to 94.8,340
Hep B,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,93.0,90.5 to 95.1,674
≥1 Dose Varicella,,States/Local Areas,Vermont,2016,Age,24 Months,91.5,87.0 to 94.9,248
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2017,Age,24 Months,91.8,88.8 to 94.2,578
≥1 Dose MMR,,States/Local Areas,Vermont,2011,Age,24 Months,88.3,83.2 to 92.5,274
≥1 Dose MMR,,States/Local Areas,Vermont,2018,Age,19 Months,92.7,88.2 to 95.5,340
≥1 Dose MMR,,States/Local Areas,Vermont,2018-2019,Age,19 Months,95.0,92.4 to 96.8,674
≥1 Dose Varicella,,States/Local Areas,Vermont,2015,Age,24 Months,88.5,83.5 to 92.5,252
≥1 Dose Varicella,,States/Local Areas,Vermont,2015-2016,Age,24 Months,90.0,86.7 to 92.7,500
PCV,≥4 Doses,States/Local Areas,Vermont,2013,Age,19 Months,81.7,72.2 to 88.5,261
PCV,≥4 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,81.5,77.9 to 84.6,532
PCV,≥4 Doses,States/Local Areas,Vermont,2012,Age,19 Months,81.9,77.1 to 85.9,261
PCV,≥4 Doses,States/Local Areas,Vermont,2011,Age,19 Months,75.6,70.6 to 80.0,274
≥1 Dose MMR,,States/Local Areas,Vermont,2017,Age,19 Months,93.1,88.8 to 95.8,330
≥1 Dose MMR,,States/Local Areas,Vermont,2017-2018,Age,19 Months,92.9,90.0 to 95.0,670
Polio,≥2 Doses,States/Local Areas,Vermont,2019,Age,13 Months,95.6,92.1 to 97.6,334
Hep B,≥2 Doses,States/Local Areas,Vermont,2016,Age,7 Months,94.1,90.1 to 96.5,248
Hep B,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,7 Months,92.6,89.6 to 94.8,578
PCV,≥3 Doses,States/Local Areas,Vermont,2013,Age,13 Months,92.7,88.4 to 95.5,261
PCV,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,91.7,87.9 to 94.4,532
Hep B,≥2 Doses,States/Local Areas,Vermont,2017,Age,7 Months,91.1,86.2 to 94.4,330
Hep B,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,7 Months,92.1,89.0 to 94.4,670
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2016,Age,0-2 Days,55.5,47.5 to 63.3,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2016-2017,Age,0-2 Days,57.8,52.5 to 62.9,578
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2017,Age,0-2 Days,60.1,53.2 to 66.5,330
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2017-2018,Age,0-2 Days,64.0,59.3 to 68.4,670
Hep B,≥3 Doses,States/Local Areas,Vermont,2011,Age,35 Months,90.9,86.5 to 94.3,274
PCV,≥4 Doses,States/Local Areas,Vermont,2012,Age,24 Months,85.8,79.8 to 90.7,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2019,Age,24 Months,94.6,91.3 to 96.9,334
Hep B,≥3 Doses,States/Local Areas,Vermont,2017,Age,24 Months,93.1,88.6 to 96.2,330
Hep B,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,92.3,89.4 to 94.7,670
PCV,≥4 Doses,States/Local Areas,Vermont,2013,Age,24 Months,86.5,80.6 to 91.4,261
PCV,≥4 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,86.2,82.0 to 89.8,532
PCV,≥4 Doses,States/Local Areas,Vermont,2014,Age,24 Months,85.8,79.8 to 90.7,271
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,87.9,84.1 to 91.1,523
≥1 Dose MMR,,States/Local Areas,Vermont,2013,Age,35 Months,96.3,92.6 to 98.5,261
≥1 Dose MMR,,States/Local Areas,Vermont,2013-2014,Age,35 Months,95.3,92.4 to 97.4,532
≥1 Dose Varicella,,States/Local Areas,Vermont,2016,Age,35 Months,93.6,89.1 to 96.6,248
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2017,Age,35 Months,93.0,90.1 to 95.3,578
≥1 Dose MMR,,States/Local Areas,Vermont,2011,Age,35 Months,93.8,88.6 to 97.1,274
≥1 Dose MMR,,States/Local Areas,Vermont,2012,Age,35 Months,97.9,95.3 to 99.2,261
≥1 Dose MMR,,States/Local Areas,Vermont,2019,Age,24 Months,93.7,89.8 to 96.4,334
≥1 Dose MMR,,States/Local Areas,Vermont,2018,Age,24 Months,93.0,88.9 to 96.0,340
≥1 Dose MMR,,States/Local Areas,Vermont,2018-2019,Age,24 Months,93.3,90.6 to 95.5,674
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,90.1,85.9 to 94.2,236
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Overall,Overall,89.3,87.0 to 91.5,971
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.7,85.7 to 93.8,286
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,89.2,86.4 to 92.1,565
≥1 Dose MMR,,States/Local Areas,Vermont,2012,Age,24 Months,92.8,89.0 to 95.7,261
≥1 Dose Varicella,,States/Local Areas,Vermont,2011,Age,35 Months,86.0,80.0 to 90.9,274
PCV,≥4 Doses,States/Local Areas,Vermont,2019,Age,19 Months,87.6,82.4 to 91.5,334
≥1 Dose Varicella,,States/Local Areas,Vermont,2015,Age,35 Months,90.4,85.4 to 94.3,252
≥1 Dose Varicella,,States/Local Areas,Vermont,2015-2016,Age,35 Months,92.0,88.7 to 94.6,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2017,Age,35 Months,92.5,88.2 to 95.6,330
≥1 Dose Varicella,,States/Local Areas,Vermont,2017-2018,Age,35 Months,93.3,90.4 to 95.6,670
PCV,≥4 Doses,States/Local Areas,Vermont,2011,Age,24 Months,80.1,73.8 to 85.7,274
PCV,≥3 Doses,States/Local Areas,Vermont,2019,Age,13 Months,93.6,89.1 to 96.3,334
Hep B,≥2 Doses,States/Local Areas,Vermont,2018,Age,13 Months,93.3,88.9 to 96.0,340
Hep B,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,94.6,92.1 to 96.4,674
Hep B,≥2 Doses,States/Local Areas,Vermont,2016,Age,13 Months,94.4,90.4 to 96.8,248
Hep B,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,93.7,90.8 to 95.8,578
PCV,≥3 Doses,States/Local Areas,Vermont,2015,Age,19 Months,94.0,88.3 to 97.0,252
PCV,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,94.9,92.1 to 96.7,500
PCV,≥3 Doses,States/Local Areas,Vermont,2016,Age,19 Months,95.8,92.2 to 97.7,248
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,94.7,92.0 to 96.5,578
Hib,≥1 Dose,States/Local Areas,Vermont,2015,Age,3 Months,87.3,80.9 to 91.7,252
Hib,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,3 Months,90.2,86.6 to 92.9,500
Hib,≥1 Dose,States/Local Areas,Vermont,2016,Age,3 Months,93.1,89.0 to 95.8,248
Hib,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,3 Months,91.3,88.1 to 93.7,578
Hep B,≥2 Doses,States/Local Areas,Vermont,2017,Age,13 Months,93.1,88.2 to 96.1,330
Hep B,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,93.2,90.1 to 95.4,670
Hep B,≥3 Doses,States/Local Areas,Vermont,2019,Age,35 Months,96.1,91.9 to 98.4,334
PCV,≥3 Doses,States/Local Areas,Vermont,2014,Age,19 Months,94.3,89.5 to 97.0,271
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,94.2,91.0 to 96.3,523
Hep B,≥3 Doses,States/Local Areas,Vermont,2018,Age,35 Months,91.6,87.4 to 94.8,340
Hep B,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,93.5,90.8 to 95.6,674
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,96.0,94.1 to 97.9,492
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,91.3,88.3 to 94.3,453
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,90.0,80.0 to 100.0,48
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,81.6 to 98.2,80
PCV,≥4 Doses,States/Local Areas,Vermont,2015,Age,35 Months,91.0,86.1 to 94.6,252
PCV,≥4 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,90.2,86.6 to 93.3,500
PCV,≥4 Doses,States/Local Areas,Vermont,2014,Age,35 Months,88.0,81.8 to 92.9,271
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,89.4,85.6 to 92.6,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,88.5,81.3 to 95.8,120
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.5,87.1 to 91.9,835
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.8,74.3 to 93.3,80
≥1 Dose MMR,,States/Local Areas,Vermont,2019,Age,35 Months,95.4,91.7 to 97.8,334
≥1 Dose MMR,,States/Local Areas,Vermont,2017,Age,35 Months,96.8,93.0 to 98.8,330
≥1 Dose MMR,,States/Local Areas,Vermont,2017-2018,Age,35 Months,95.2,92.5 to 97.1,670
≥1 Dose MMR,,States/Local Areas,Vermont,2018,Age,35 Months,93.6,89.5 to 96.5,340
≥1 Dose MMR,,States/Local Areas,Vermont,2018-2019,Age,35 Months,94.5,91.8 to 96.5,674
Hib,≥1 Dose,States/Local Areas,Vermont,2017,Age,3 Months,89.5,84.1 to 93.2,330
Hib,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,3 Months,89.5,86.0 to 92.3,670
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,88.0,84.2 to 91.8,421
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,90.4,87.0 to 93.8,314
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,86.9 to 99.0,120
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.1,92.2 to 95.9,835
PCV,≥4 Doses,States/Local Areas,Vermont,2013,Age,35 Months,90.3,84.0 to 94.8,261
PCV,≥4 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,89.1,84.8 to 92.7,532
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,93.1,84.7 to 100.0,48
Hib,≥1 Dose,States/Local Areas,Vermont,2013,Age,3 Months,90.6,85.9 to 93.9,261
Hib,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,3 Months,88.6,85.6 to 91.0,532
Hib,≥1 Dose,States/Local Areas,Vermont,2012,Age,3 Months,90.3,84.8 to 94.0,261
Hib,≥1 Dose,States/Local Areas,Vermont,2011,Age,3 Months,88.2,83.2 to 91.8,274
Hep B,≥2 Doses,States/Local Areas,Vermont,2015,Age,13 Months,92.8,88.1 to 95.8,252
Hep B,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,13 Months,93.6,90.7 to 95.6,500
Hep B,≥2 Doses,States/Local Areas,Vermont,2013,Age,13 Months,94.6,92.3 to 96.2,261
Hep B,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,13 Months,94.0,91.1 to 96.0,532
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2019,Age,0-2 Days,77.4,71.6 to 82.3,334
Hib,≥1 Dose,States/Local Areas,Vermont,2014,Age,3 Months,86.5,80.7 to 90.8,271
Hib,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,3 Months,86.9,82.8 to 90.1,523
Hep B,≥2 Doses,States/Local Areas,Vermont,2014,Age,13 Months,93.5,88.3 to 96.5,271
Hep B,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,13 Months,93.2,89.9 to 95.4,523
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,87.7,84.2 to 91.2,453
≥1 Dose Varicella,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,91.1,88.3 to 93.8,492
≥1 Dose Varicella,,States/Local Areas,Vermont,2019,Age,35 Months,94.0,90.2 to 96.7,334
≥1 Dose MMR,,States/Local Areas,Vermont,2016,Age,35 Months,95.0,91.1 to 97.6,248
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2017,Age,35 Months,96.2,93.5 to 98.0,578
PCV,≥4 Doses,States/Local Areas,Vermont,2015,Age,24 Months,90.1,85.3 to 93.9,252
PCV,≥4 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,89.3,85.6 to 92.4,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2018,Age,35 Months,94.0,89.7 to 97.0,340
≥1 Dose Varicella,,States/Local Areas,Vermont,2018-2019,Age,35 Months,94.3,91.4 to 96.5,674
≥1 Dose MMR,,States/Local Areas,Vermont,2015,Age,35 Months,93.5,89.2 to 96.5,252
≥1 Dose MMR,,States/Local Areas,Vermont,2015-2016,Age,35 Months,94.2,91.4 to 96.3,500
≥1 Dose MMR,,States/Local Areas,Vermont,2014,Age,35 Months,94.8,90.1 to 97.7,271
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2015,Age,35 Months,94.2,91.1 to 96.4,523
PCV,≥4 Doses,States/Local Areas,Vermont,2017,Age,24 Months,89.0,84.1 to 93.0,330
PCV,≥4 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,89.2,85.9 to 92.0,670
PCV,≥4 Doses,States/Local Areas,Vermont,2016,Age,24 Months,88.7,82.8 to 93.2,248
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,88.9,85.2 to 92.0,578
Hep B,≥2 Doses,States/Local Areas,Vermont,2011,Age,13 Months,91.8,86.5 to 95.1,274
Hep B,≥2 Doses,States/Local Areas,Vermont,2012,Age,13 Months,90.8,87.9 to 93.1,261
PCV,≥3 Doses,States/Local Areas,Vermont,2017,Age,13 Months,90.2,85.0 to 93.7,330
PCV,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,13 Months,90.3,86.9 to 92.9,670
Hep B,≥3 Doses,States/Local Areas,Vermont,2012,Age,35 Months,93.0,86.4 to 97.1,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2014,Age,35 Months,93.4,88.7 to 96.6,271
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,92.8,89.7 to 95.2,523
Hep B,≥3 Doses,States/Local Areas,Vermont,2013,Age,35 Months,94.0,90.2 to 96.8,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,93.7,90.9 to 96.0,532
Hep B,≥2 Doses,States/Local Areas,Vermont,2018,Age,7 Months,93.0,88.7 to 95.8,340
Hep B,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,7 Months,94.3,91.7 to 96.2,674
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2018,Age,0-2 Days,68.0,61.4 to 73.9,340
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2018-2019,Age,0-2 Days,72.6,68.2 to 76.6,674
PCV,≥3 Doses,States/Local Areas,Vermont,2018,Age,13 Months,90.4,85.5 to 93.8,340
PCV,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,13 Months,91.9,88.8 to 94.3,674
Hib,Full Series,States/Local Areas,Vermont,2020,Age,24 Months,86.7,81.0 to 91.3,307
Hep B,≥2 Doses,States/Local Areas,Vermont,2019,Age,7 Months,95.7,92.3 to 97.6,334
PCV,≥3 Doses,States/Local Areas,Vermont,2016,Age,13 Months,93.7,88.7 to 96.5,248
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,13 Months,92.0,88.6 to 94.4,578
PCV,≥3 Doses,States/Local Areas,Vermont,2012,Age,19 Months,92.5,88.5 to 95.2,261
Hep B,≥3 Doses,States/Local Areas,Vermont,2017,Age,35 Months,93.1,88.6 to 96.2,330
Hep B,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,92.3,89.4 to 94.7,670
PCV,≥4 Doses,States/Local Areas,Vermont,2011,Age,35 Months,84.0,77.7 to 89.4,274
PCV,≥4 Doses,States/Local Areas,Vermont,2012,Age,35 Months,90.4,84.4 to 94.8,261
PCV,≥4 Doses,States/Local Areas,Vermont,2019,Age,24 Months,89.4,84.7 to 93.2,334
PCV,≥4 Doses,States/Local Areas,Vermont,2018,Age,24 Months,89.4,84.8 to 93.1,340
PCV,≥4 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,89.4,86.2 to 92.2,674
PCV,≥3 Doses,States/Local Areas,Vermont,2011,Age,19 Months,91.2,89.1 to 93.0,274
PCV,≥3 Doses,States/Local Areas,Vermont,2013,Age,19 Months,94.3,89.5 to 97.0,261
PCV,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,94.3,90.7 to 96.6,532
Hep B,≥3 Doses,States/Local Areas,Vermont,2015,Age,35 Months,92.1,87.5 to 95.5,252
Hep B,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,93.6,90.8 to 95.8,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2016,Age,35 Months,94.9,91.3 to 97.4,248
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,94.0,91.2 to 96.1,578
PCV,≥3 Doses,States/Local Areas,Vermont,2014,Age,24 Months,94.4,90.1 to 97.3,271
PCV,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,94.2,91.2 to 96.4,523
PCV,≥3 Doses,States/Local Areas,Vermont,2013,Age,24 Months,94.3,90.0 to 97.2,261
PCV,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,94.4,91.5 to 96.6,532
PCV,≥3 Doses,States/Local Areas,Vermont,2012,Age,24 Months,93.3,89.0 to 96.3,261
PCV,≥3 Doses,States/Local Areas,Vermont,2019,Age,19 Months,96.5,93.0 to 98.3,334
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,80.2,67.5 to 92.9,48
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,85.5,81.6 to 89.4,453
PCV,≥1 Dose,States/Local Areas,Vermont,2013,Age,3 Months,90.2,83.6 to 94.3,261
PCV,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,3 Months,89.4,85.3 to 92.4,532
Hib,≥2 Doses,States/Local Areas,Vermont,2014,Age,5 Months,81.6,75.1 to 86.6,271
Hib,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,5 Months,82.3,80.0 to 84.5,523
Hib,≥2 Doses,States/Local Areas,Vermont,2015,Age,5 Months,83.2,76.0 to 88.5,252
Hib,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,5 Months,84.2,79.5 to 88.0,500
Hib,≥2 Doses,States/Local Areas,Vermont,2016,Age,5 Months,85.3,78.6 to 90.1,248
Hib,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,5 Months,84.0,79.6 to 87.5,578
Hib,≥1 Dose,States/Local Areas,Vermont,2018,Age,3 Months,89.6,84.4 to 93.2,340
Hib,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,3 Months,91.4,88.2 to 93.8,674
Hib,≥1 Dose,States/Local Areas,Vermont,2019,Age,3 Months,93.4,89.2 to 96.0,334
Hib,≥2 Doses,States/Local Areas,Vermont,2012,Age,5 Months,81.5,75.1 to 86.6,261
Hib,≥2 Doses,States/Local Areas,Vermont,2011,Age,5 Months,82.2,75.8 to 87.2,274
Hib,≥2 Doses,States/Local Areas,Vermont,2013,Age,5 Months,80.0,69.5 to 87.6,261
Hib,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,5 Months,80.8,75.3 to 85.2,532
PCV,≥3 Doses,States/Local Areas,Vermont,2017,Age,19 Months,93.6,89.1 to 96.3,330
PCV,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,93.3,90.3 to 95.4,670
PCV,≥4 Doses,States/Local Areas,Vermont,2017,Age,35 Months,91.0,86.4 to 94.5,330
PCV,≥4 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,91.0,87.8 to 93.6,670
Hep B,≥2 Doses,States/Local Areas,Vermont,2019,Age,13 Months,96.1,92.6 to 97.9,334
PCV,≥4 Doses,States/Local Areas,Vermont,2016,Age,35 Months,89.7,83.8 to 94.1,248
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,90.4,86.8 to 93.4,578
PCV,≥4 Doses,States/Local Areas,Vermont,2018,Age,35 Months,91.1,86.4 to 94.6,340
PCV,≥4 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,91.7,88.3 to 94.4,674
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,95.8,93.5 to 98.1,314
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,94.1,91.3 to 96.9,421
PCV,≥1 Dose,States/Local Areas,Vermont,2011,Age,3 Months,86.3,79.6 to 91.0,274
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,90.7,86.6 to 94.7,236
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Overall,Overall,93.5,91.6 to 95.3,971
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,93.8,91.5 to 96.0,565
≥1 Dose MMR,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.1,89.5 to 96.8,286
PCV,≥3 Doses,States/Local Areas,Vermont,2018,Age,19 Months,93.0,88.5 to 95.8,340
PCV,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,91.9,88.8 to 94.3,674
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,92.9,90.3 to 95.5,453
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2011,Age,0-3 Days,45.2,38.1 to 52.5,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2012,Age,0-3 Days,46.5,39.2 to 54.0,261
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,84.6,76.5 to 92.7,120
PCV,≥1 Dose,States/Local Areas,Vermont,2015,Age,3 Months,88.8,83.0 to 92.7,252
PCV,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,3 Months,90.8,87.4 to 93.3,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,93.3,90.8 to 95.9,492
Hib,≥2 Doses,States/Local Areas,Vermont,2019,Age,5 Months,88.8,84.0 to 92.3,334
PCV,≥1 Dose,States/Local Areas,Vermont,2016,Age,3 Months,92.8,88.7 to 95.5,248
PCV,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,3 Months,90.4,86.9 to 93.0,578
PCV,≥1 Dose,States/Local Areas,Vermont,2017,Age,3 Months,87.9,82.0 to 92.0,330
PCV,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,3 Months,88.7,84.9 to 91.6,670
PCV,≥4 Doses,States/Local Areas,Vermont,2019,Age,35 Months,94.3,86.3 to 98.4,334
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,92.8,90.2 to 95.5,492
PCV,≥3 Doses,States/Local Areas,Vermont,2011,Age,24 Months,91.8,86.9 to 95.4,274
Hib,≥2 Doses,States/Local Areas,Vermont,2013,Age,7 Months,93.6,87.4 to 96.8,261
Hib,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,92.6,90.2 to 94.5,532
Hib,≥2 Doses,States/Local Areas,Vermont,2014,Age,7 Months,91.7,86.1 to 95.1,271
Hib,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,7 Months,90.8,86.9 to 93.7,523
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,88.5,86.0 to 91.0,971
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,87.3,84.0 to 90.6,565
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,89.3 to 96.6,286
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,88.1,84.4 to 91.9,421
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,84.6,79.1 to 90.1,236
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,93.6,90.5 to 96.7,314
PCV,≥3 Doses,States/Local Areas,Vermont,2017,Age,24 Months,94.1,90.1 to 96.9,330
PCV,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,93.6,90.8 to 95.8,670
Hib,≥2 Doses,States/Local Areas,Vermont,2012,Age,7 Months,94.3,90.6 to 96.6,261
PCV,≥3 Doses,States/Local Areas,Vermont,2015,Age,24 Months,94.0,89.5 to 97.0,252
PCV,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,95.0,92.4 to 96.9,500
Hib,≥2 Doses,States/Local Areas,Vermont,2018,Age,5 Months,84.2,78.3 to 88.7,340
Hib,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,5 Months,86.4,82.8 to 89.4,674
PCV,≥3 Doses,States/Local Areas,Vermont,2016,Age,24 Months,96.1,92.9 to 98.1,248
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,95.1,92.6 to 96.9,578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2013,Age,0-3 Days,47.2,40.1 to 54.4,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2013-2014,Age,0-3 Days,47.0,41.9 to 52.1,532
Polio,≥1 Dose,States/Local Areas,Vermont,2013,Age,3 Months,91.5,87.1 to 94.5,261
Polio,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,3 Months,89.6,85.3 to 92.8,532
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,93.1,91.3 to 94.9,971
Polio,≥1 Dose,States/Local Areas,Vermont,2012,Age,3 Months,92.3,86.9 to 95.6,261
Polio,≥1 Dose,States/Local Areas,Vermont,2011,Age,3 Months,87.9,83.0 to 91.6,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014,Age,0-3 Days,46.8,39.7 to 53.9,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2014-2015,Age,0-3 Days,51.2,45.9 to 56.6,523
PCV,≥1 Dose,States/Local Areas,Vermont,2018,Age,3 Months,89.4,84.2 to 93.0,340
PCV,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,3 Months,91.7,88.6 to 94.0,674
DTaP,≥3 Doses,States/Local Areas,Vermont,2013,Age,7 Months,76.8,68.2 to 83.7,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,7 Months,75.9,72.9 to 78.7,532
DTaP,≥3 Doses,States/Local Areas,Vermont,2012,Age,7 Months,75.6,70.0 to 80.4,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2011,Age,7 Months,71.7,66.1 to 76.7,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,88.6,81.8 to 95.4,120
PCV,≥1 Dose,States/Local Areas,Vermont,2014,Age,3 Months,88.5,83.3 to 92.3,271
PCV,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,3 Months,88.6,84.9 to 91.5,523
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.6,87.1 to 92.1,835
PCV,≥4 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,74.6 to 94.7,80
PCV,≥1 Dose,States/Local Areas,Vermont,2012,Age,3 Months,87.1,78.4 to 92.6,261
Hib,≥2 Doses,States/Local Areas,Vermont,2017,Age,5 Months,82.6,76.6 to 87.4,330
Hib,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,5 Months,83.4,79.3 to 86.8,670
Hib,≥2 Doses,States/Local Areas,Vermont,2011,Age,7 Months,89.5,85.9 to 92.2,274
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.1,91.2 to 95.0,835
Hep B,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.2,93.6 to 98.8,286
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,83.5,78.0 to 89.0,300
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,74.9,68.2 to 81.6,263
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Overall,Overall,80.7,76.8 to 84.5,748
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,82.9,77.3 to 88.6,248
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.8,73.7 to 87.8,233
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,78.1,71.2 to 85.1,267
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.6,76.2 to 84.9,566
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.0,68.4 to 91.6,71
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,79.8,66.6 to 93.0,73
Hib,Primary Series,States/Local Areas,Kentucky,2012,Age,7 Months,74.3,69.2 to 78.8,236
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,87.0,78.7 to 95.4,185
Hib,Primary Series,States/Local Areas,Kentucky,2011,Age,7 Months,67.7,58.5 to 75.8,217
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.6,90.4 to 98.7,233
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,94.7,90.7 to 98.6,267
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.3,93.3 to 97.4,566
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,81.8 to 100.0,71
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,96.1,89.7 to 100.0,73
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,83.8,78.6 to 88.9,397
Polio,≥3 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,91.7,85.5 to 96.0,217
Polio,≥3 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,95.4,90.1 to 98.3,271
Hib,Full Series,States/Local Areas,Kentucky,2016,Age,35 Months,91.7,84.6 to 96.4,181
Hib,Full Series,States/Local Areas,Kentucky,2016-2017,Age,35 Months,90.3,85.6 to 94.0,419
Hib,Full Series,States/Local Areas,Kentucky,2018,Age,35 Months,84.7,78.1 to 90.2,278
Hib,Full Series,States/Local Areas,Kentucky,2018-2019,Age,35 Months,84.5,79.6 to 88.8,549
Hib,Full Series,States/Local Areas,Kentucky,2019,Age,35 Months,84.4,76.9 to 90.5,271
Hib,Full Series,States/Local Areas,Kentucky,2014,Age,35 Months,80.3,72.3 to 87.2,246
Hib,Full Series,States/Local Areas,Kentucky,2014-2015,Age,35 Months,82.5,77.0 to 87.3,456
Hib,Full Series,States/Local Areas,Kentucky,2015,Age,35 Months,84.6,77.0 to 90.7,210
Hib,Full Series,States/Local Areas,Kentucky,2015-2016,Age,35 Months,88.0,82.9 to 92.2,391
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,79.6,73.6 to 85.5,307
Hib,Full Series,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.5,68.7 to 100.0,38
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,93.9,90.2 to 97.6,307
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,96.4,94.1 to 98.7,397
Hib,Full Series,States/Local Areas,Kentucky,2017,Age,35 Months,89.3,82.5 to 94.3,238
Hib,Full Series,States/Local Areas,Kentucky,2017-2018,Age,35 Months,87.1,82.4 to 91.0,516
Polio,≥3 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,93.9,89.0 to 97.1,278
Polio,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,94.8,91.3 to 97.3,549
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.7,78.1 to 100.0,38
Hib,Full Series,States/Local Areas,Kentucky,2019,Age,24 Months,80.9,73.4 to 87.3,271
Polio,≥3 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,98.1,93.7 to 99.7,210
Polio,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,97.6,94.3 to 99.2,391
DTaP,≥2 Doses,States/Local Areas,Kentucky,2014,Age,5 Months,74.1,65.9 to 80.9,246
DTaP,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,5 Months,76.2,72.8 to 79.3,456
DTaP,≥2 Doses,States/Local Areas,Kentucky,2016,Age,5 Months,80.8,71.2 to 87.7,181
DTaP,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,5 Months,79.9,74.1 to 84.6,419
DTaP,≥2 Doses,States/Local Areas,Kentucky,2015,Age,5 Months,78.3,70.3 to 84.7,210
DTaP,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,5 Months,79.6,73.6 to 84.5,391
Polio,≥3 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,94.1,89.2 to 97.3,238
Polio,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,93.9,90.6 to 96.3,516
Polio,≥3 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,97.4,91.8 to 99.5,181
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,95.8,92.5 to 98.0,419
DTaP,≥2 Doses,States/Local Areas,Kentucky,2013,Age,5 Months,76.7,69.2 to 82.8,236
DTaP,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,5 Months,75.4,71.7 to 78.7,482
DTaP,≥2 Doses,States/Local Areas,Kentucky,2012,Age,5 Months,77.2,67.9 to 84.4,236
DTaP,≥2 Doses,States/Local Areas,Kentucky,2011,Age,5 Months,76.6,63.1 to 86.3,217
Polio,≥3 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,93.2,88.1 to 96.6,246
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,95.8,92.6 to 97.9,456
Polio,≥3 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,94.9,90.2 to 97.8,236
Polio,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,94.2,90.9 to 96.6,482
Hib,Full Series,States/Local Areas,Kentucky,2013,Age,35 Months,80.3,72.7 to 86.9,236
Hib,Full Series,States/Local Areas,Kentucky,2013-2014,Age,35 Months,80.2,74.8 to 85.1,482
Hib,Full Series,States/Local Areas,Kentucky,2011,Age,35 Months,81.0,72.0 to 88.5,217
Hib,Full Series,States/Local Areas,Kentucky,2012,Age,35 Months,87.2,77.8 to 93.9,236
Polio,≥3 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,90.5,84.7 to 94.8,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,93.5,88.2 to 96.5,210
Hib,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,93.7,89.9 to 96.2,391
Hib,≥3 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,93.9,87.8 to 97.0,181
Hib,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,92.0,88.0 to 94.7,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,95.4,88.9 to 98.2,181
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,94.7,90.9 to 96.9,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,89.0,82.1 to 93.4,246
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,92.3,88.1 to 95.0,456
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,95.5,91.7 to 97.6,210
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,95.5,91.7 to 97.6,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,93.9,88.3 to 96.9,238
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,93.0,89.3 to 95.5,516
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,94.1,88.1 to 97.1,271
Polio,≥3 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,94.1,88.1 to 97.1,271
Polio,≥3 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,90.8,84.6 to 95.2,217
Polio,≥3 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,90.0,84.2 to 94.3,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,87.0,80.2 to 91.7,246
Hib,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,90.3,86.1 to 93.3,456
Polio,≥3 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,92.4,87.9 to 95.7,236
Polio,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,92.7,89.4 to 95.2,482
Polio,≥3 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,95.9,91.1 to 98.5,210
Polio,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,96.6,93.3 to 98.5,391
Polio,≥3 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,92.8,87.7 to 96.3,246
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,94.4,91.1 to 96.7,456
Hib,≥3 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,95.5,90.7 to 98.3,271
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,92.1,86.4 to 95.5,278
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,90.4,86.1 to 93.4,549
DTaP,≥3 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,91.3,85.2 to 95.6,217
Hib,≥3 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,89.3,83.4 to 93.3,278
Hib,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,71.9,66.5 to 76.8,549
Hib,≥3 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,90.0,84.0 to 93.9,238
Hib,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,89.7,85.7 to 92.6,516
Polio,≥3 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,97.3,91.8 to 99.4,181
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,95.7,92.4 to 97.9,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,93.5,89.1 to 96.5,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,93.4,90.2 to 95.9,482
Hib,Full Series,States/Local Areas,Kentucky,2015,Age,24 Months,81.0,73.5 to 87.5,210
Hib,Full Series,States/Local Areas,Kentucky,2015-2016,Age,24 Months,84.3,79.2 to 88.8,391
Hib,Full Series,States/Local Areas,Kentucky,2016,Age,24 Months,87.6,80.1 to 93.2,181
Hib,Full Series,States/Local Areas,Kentucky,2016-2017,Age,24 Months,86.0,81.2 to 90.1,419
Polio,≥3 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,94.1,89.2 to 97.3,238
Polio,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,93.6,90.4 to 96.1,516
DTaP,≥3 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,92.2,86.6 to 96.1,236
Polio,≥3 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,93.2,88.5 to 96.4,278
Polio,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,93.6,90.3 to 96.1,549
Polio,≥3 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,94.1,88.9 to 97.4,271
Hib,≥3 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,91.1,85.0 to 94.8,271
Hib,Full Series,States/Local Areas,Kentucky,2018,Age,24 Months,79.6,73.1 to 85.4,278
Hib,Full Series,States/Local Areas,Kentucky,2018-2019,Age,24 Months,80.2,75.4 to 84.7,549
Hib,Full Series,States/Local Areas,Kentucky,2017,Age,24 Months,84.4,78.0 to 89.8,238
Hib,Full Series,States/Local Areas,Kentucky,2017-2018,Age,24 Months,82.0,77.5 to 86.1,516
Hib,≥3 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,91.5,86.7 to 95.0,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,91.5,87.9 to 94.3,482
Hib,≥3 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,89.1,82.6 to 93.9,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,90.1,83.6 to 94.8,217
Hib,≥3 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,91.4,86.1 to 95.2,246
Hib,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,93.7,90.3 to 96.2,456
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,94.9,92.7 to 97.0,748
Hep A,≥2 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,38.7,31.0 to 47.5,210
Hep A,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,37.5,31.4 to 44.3,391
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,37.4,30.1 to 45.8,246
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,38.0,32.6 to 44.0,456
PCV,≥2 Doses,States/Local Areas,Kentucky,2018,Age,5 Months,71.4,64.1 to 77.7,278
PCV,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,5 Months,76.0,70.8 to 80.6,549
PCV,≥2 Doses,States/Local Areas,Kentucky,2019,Age,5 Months,80.8,72.8 to 86.8,271
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,94.7,90.7 to 98.6,267
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.5,93.5 to 97.6,566
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,95.8,93.1 to 98.4,248
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.2,89.9 to 98.4,233
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,81.8 to 100.0,71
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,96.7,90.3 to 100.0,73
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,77.4,68.6 to 84.4,181
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,76.8,71.2 to 81.5,419
DTaP,≥4 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,76.1,68.8 to 82.1,238
DTaP,≥4 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,70.6,65.4 to 75.3,516
DTaP,≥4 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,65.0,57.5 to 71.7,278
DTaP,≥4 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,94.6,91.1 to 96.8,549
Hep A,≥2 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,33.3,25.9 to 42.0,236
Hep A,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,35.3,30.0 to 41.2,482
≥1 Dose MMR,,States/Local Areas,Kentucky,2013,Age,13 Months,42.6,31.5 to 54.5,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2013-2014,Age,13 Months,45.2,35.8 to 55.1,482
≥1 Dose MMR,,States/Local Areas,Kentucky,2012,Age,13 Months,34.9,30.6 to 39.5,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2011,Age,13 Months,46.0,37.2 to 55.0,217
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020,Age,24 Months,84.1,77.2 to 89.8,324
Hep A,≥2 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,53.5,46.2 to 61.3,278
Hep A,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,53.2,47.6 to 59.1,549
Hep A,≥2 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,47.6,39.9 to 55.9,238
Hep A,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,50.4,45.0 to 56.1,516
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,36.3,27.2 to 47.2,181
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,42.0,35.9 to 48.6,419
DTaP,≥4 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,81.9,75.1 to 87.8,236
DTaP,≥4 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,81.2,76.3 to 85.6,482
Hep A,≥1 Dose,States/Local Areas,Kentucky,2015,Age,35 Months,92.9,86.3 to 97.0,210
Hep A,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,35 Months,91.5,86.2 to 95.3,391
Polio,≥2 Doses,States/Local Areas,Kentucky,2012,Age,5 Months,74.2,68.8 to 79.0,236
Polio,≥2 Doses,States/Local Areas,Kentucky,2011,Age,5 Months,76.6,63.1 to 86.3,217
Polio,≥2 Doses,States/Local Areas,Kentucky,2013,Age,5 Months,74.3,68.7 to 79.2,236
Polio,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,5 Months,74.0,70.4 to 77.3,482
Polio,≥2 Doses,States/Local Areas,Kentucky,2014,Age,5 Months,73.7,65.6 to 80.5,246
Polio,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,5 Months,76.0,71.9 to 79.6,456
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,93.5,89.6 to 97.3,263
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,97.6,94.7 to 100.0,185
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,95.0,91.7 to 98.3,300
Hep B,≥3 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,56.9,49.1 to 64.4,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,61.3,54.1 to 67.9,217
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,61.0,54.7 to 67.0,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,60.1,55.4 to 64.7,482
DTaP,≥4 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,71.4,62.8 to 78.6,271
DTaP,≥4 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,78.8,70.8 to 85.8,217
DTaP,≥4 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,78.5,71.1 to 85.2,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016,Age,35 Months,93.0,86.5 to 97.0,181
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2017,Age,35 Months,93.5,88.9 to 96.7,419
≥1 Dose MMR,,States/Local Areas,Kentucky,2013,Age,35 Months,95.8,90.8 to 98.6,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2013-2014,Age,35 Months,93.3,89.2 to 96.2,482
≥1 Dose MMR,,States/Local Areas,Kentucky,2011,Age,35 Months,91.7,85.5 to 96.0,217
≥1 Dose MMR,,States/Local Areas,Kentucky,2012,Age,35 Months,87.7,81.1 to 92.9,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2019,Age,24 Months,91.4,85.9 to 95.4,271
PCV,≥4 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,84.7,77.7 to 90.5,210
PCV,≥4 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,86.0,81.0 to 90.3,391
PCV,≥4 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,82.9,76.2 to 88.7,246
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,83.8,79.0 to 88.1,456
PCV,≥4 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,84.6,78.7 to 89.5,236
PCV,≥4 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,83.8,79.3 to 87.7,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,92.6,87.1 to 96.4,271
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,90.8,85.2 to 94.9,238
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,91.6,88.0 to 94.5,516
Hep B,≥3 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,90.1,83.8 to 94.7,217
PCV,≥4 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,81.2,74.1 to 87.4,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018,Age,35 Months,94.6,89.5 to 97.7,278
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018-2019,Age,35 Months,95.7,92.4 to 97.9,549
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017,Age,35 Months,93.9,87.8 to 97.6,238
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017-2018,Age,35 Months,94.0,89.9 to 96.8,516
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2017,Age,0-2 Days,80.2,73.1 to 85.8,238
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2017-2018,Age,0-2 Days,80.9,76.3 to 84.8,516
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2018,Age,0-2 Days,81.6,75.1 to 86.7,278
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2018-2019,Age,0-2 Days,82.5,77.6 to 86.4,549
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2019,Age,0-2 Days,83.3,75.6 to 88.9,271
Hep B,≥2 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,91.4,85.9 to 94.9,278
Hep B,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,93.0,89.2 to 95.5,549
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2014,Age,0-2 Days,78.9,71.4 to 84.8,246
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2014-2015,Age,0-2 Days,80.5,75.4 to 84.7,456
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2015,Age,0-2 Days,82.1,74.7 to 87.6,210
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2015-2016,Age,0-2 Days,79.2,72.8 to 84.4,391
PCV,≥4 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,80.5,72.8 to 87.2,217
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015,Age,35 Months,93.8,87.9 to 97.4,210
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015-2016,Age,35 Months,93.4,89.2 to 96.4,391
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014,Age,35 Months,92.0,86.3 to 95.9,246
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2015,Age,35 Months,92.9,89.1 to 95.8,456
PCV,≥4 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,84.5,77.3 to 89.7,271
≥1 Dose MMR,,States/Local Areas,Kentucky,2018,Age,24 Months,91.0,86.2 to 94.7,278
≥1 Dose MMR,,States/Local Areas,Kentucky,2018-2019,Age,24 Months,91.1,87.6 to 94.0,549
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013,Age,35 Months,95.6,91.1 to 98.2,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013-2014,Age,35 Months,93.9,90.5 to 96.4,482
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2019,Age,0-1 Days,81.5,73.8 to 87.3,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2011,Age,0-2 Days,85.8,79.7 to 90.3,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2013,Age,0-2 Days,80.3,76.7 to 83.5,236
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2013-2014,Age,0-2 Days,79.6,77.4 to 81.6,482
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2012,Age,0-2 Days,77.5,75.0 to 79.9,236
Hep B,≥2 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,89.5,86.5 to 91.8,236
Hep B,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,91.3,88.9 to 93.2,482
Hep B,≥2 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,93.2,88.1 to 96.2,246
Hep B,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,93.7,90.2 to 96.0,456
Hep B,≥2 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,94.3,88.3 to 97.3,210
Hep B,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,95.0,91.0 to 97.2,391
Hep B,≥2 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,91.2,86.5 to 94.4,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,66.3,58.7 to 73.1,278
PCV,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,69.6,64.0 to 74.6,549
PCV,≥3 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,73.0,64.6 to 80.0,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,87.3,84.2 to 89.9,217
PCV,≥4 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,80.7,73.7 to 86.1,238
PCV,≥4 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,77.0,71.9 to 81.4,516
PCV,≥4 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,73.2,65.6 to 79.7,278
PCV,≥4 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,77.6,71.2 to 82.9,425
≥1 Dose MMR,,States/Local Areas,Kentucky,2017,Age,24 Months,91.0,85.5 to 95.0,238
≥1 Dose MMR,,States/Local Areas,Kentucky,2017-2018,Age,24 Months,91.0,87.5 to 93.9,516
≥1 Dose MMR,,States/Local Areas,Kentucky,2016,Age,24 Months,92.0,85.5 to 96.3,181
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2017,Age,24 Months,91.5,87.4 to 94.7,419
PCV,≥3 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,87.1,76.9 to 93.2,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,96.8,91.5 to 99.2,181
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,93.9,90.3 to 96.5,419
PCV,≥3 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,90.3,84.1 to 94.3,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,88.4,84.4 to 91.5,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,92.8,86.8 to 96.7,210
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,94.9,91.2 to 97.4,391
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019,Age,24 Months,93.0,87.8 to 96.6,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2011,Age,35 Months,93.0,87.0 to 96.8,217
≥1 Dose Varicella,,States/Local Areas,Kentucky,2012,Age,35 Months,91.4,85.8 to 95.5,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018,Age,24 Months,90.3,85.2 to 94.2,278
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018-2019,Age,24 Months,91.5,87.9 to 94.3,549
≥1 Dose MMR,,States/Local Areas,Kentucky,2015,Age,24 Months,88.6,81.7 to 93.7,210
≥1 Dose MMR,,States/Local Areas,Kentucky,2015-2016,Age,24 Months,90.3,85.7 to 93.9,391
≥1 Dose MMR,,States/Local Areas,Kentucky,2014,Age,24 Months,89.2,83.0 to 93.8,246
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2015,Age,24 Months,88.9,84.4 to 92.5,456
≥1 Dose MMR,,States/Local Areas,Kentucky,2013,Age,24 Months,90.9,85.4 to 95.0,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2013-2014,Age,24 Months,90.1,86.1 to 93.3,482
PCV,≥3 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,65.3,57.4 to 72.4,238
PCV,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,65.8,60.3 to 70.8,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,66.0,57.5 to 73.6,210
PCV,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,67.9,61.4 to 73.8,391
PCV,≥4 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,79.2,71.6 to 85.2,246
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,80.3,75.0 to 84.7,456
PCV,≥4 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,81.5,76.1 to 85.9,210
PCV,≥4 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,81.6,75.9 to 86.2,391
PCV,≥4 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,81.7,72.7 to 88.2,181
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,81.2,75.7 to 85.7,419
PCV,≥3 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,69.8,59.7 to 78.3,181
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,67.6,61.2 to 73.3,419
Hep B,≥3 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,90.8,85.5 to 94.8,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,90.9,85.3 to 95.1,246
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,91.8,87.9 to 94.9,456
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,92.2,87.2 to 95.8,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,91.6,88.0 to 94.5,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,92.1,85.8 to 95.7,271
Hep B,≥3 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,89.5,83.2 to 94.1,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2016,Age,0-2 Days,76.4,65.5 to 84.6,181
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2016-2017,Age,0-2 Days,78.3,71.9 to 83.5,419
Hep B,≥2 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,95.7,89.0 to 98.4,181
Hep B,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,93.9,90.1 to 96.3,419
Hep B,≥2 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,92.2,86.6 to 95.5,238
Hep B,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,91.8,88.1 to 94.4,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,86.5,79.5 to 91.3,246
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,88.1,83.4 to 91.6,456
PCV,≥3 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,89.8,82.4 to 94.3,210
PCV,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,89.6,84.4 to 93.3,391
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,92.4,87.5 to 95.9,278
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,92.5,89.0 to 95.2,549
PCV,≥3 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,89.5,80.9 to 94.4,181
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,90.1,85.2 to 93.4,419
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2016,Age,0-1 Days,73.3,62.6 to 81.8,181
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2016-2017,Age,0-1 Days,75.0,68.6 to 80.4,419
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2017,Age,0-1 Days,76.7,69.2 to 82.8,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2017-2018,Age,0-1 Days,78.6,73.7 to 82.7,516
Hep B,≥2 Doses,States/Local Areas,Kentucky,2019,Age,5 Months,93.6,87.4 to 96.8,271
Hep B,≥2 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,91.7,85.9 to 95.3,217
Hep B,≥2 Doses,States/Local Areas,Kentucky,2017,Age,5 Months,89.8,83.7 to 93.8,238
Hep B,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,5 Months,90.0,85.9 to 92.9,516
Hep B,≥2 Doses,States/Local Areas,Kentucky,2018,Age,5 Months,90.1,84.1 to 94.0,278
Hep B,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,5 Months,91.8,87.9 to 94.6,549
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2018,Age,0-1 Days,80.4,73.8 to 85.7,278
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2018-2019,Age,0-1 Days,81.0,76.1 to 85.1,549
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017,Age,24 Months,91.1,85.5 to 95.1,238
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017-2018,Age,24 Months,90.7,87.0 to 93.6,516
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016,Age,24 Months,92.7,86.3 to 96.8,181
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2017,Age,24 Months,92.0,87.9 to 95.1,419
≥1 Dose MMR,,States/Local Areas,Kentucky,2011,Age,24 Months,86.4,79.8 to 91.7,217
≥1 Dose MMR,,States/Local Areas,Kentucky,2012,Age,24 Months,83.0,76.0 to 88.9,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015,Age,24 Months,88.7,81.7 to 93.9,210
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015-2016,Age,24 Months,90.7,86.1 to 94.3,391
PCV,≥3 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,59.4,55.5 to 63.2,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,64.1,61.5 to 66.5,482
PCV,≥3 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,67.3,56.0 to 76.8,217
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,94.0,85.9 to 97.6,181
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,92.1,87.6 to 95.1,419
PCV,≥3 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,68.7,60.7 to 75.7,246
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,67.4,61.7 to 72.6,456
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,93.0,87.6 to 98.4,185
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,86.4,81.5 to 91.3,300
PCV,≥3 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,68.5,60.3 to 75.7,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,90.2,84.1 to 94.1,238
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,91.3,87.5 to 94.0,516
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,92.4,87.0 to 95.6,278
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,90.1,86.0 to 93.1,549
Hep B,≥2 Doses,States/Local Areas,Kentucky,2016,Age,5 Months,91.0,82.7 to 95.5,181
Hep B,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,5 Months,90.4,85.7 to 93.7,419
Hep B,≥2 Doses,States/Local Areas,Kentucky,2014,Age,5 Months,90.5,85.1 to 94.1,246
Hep B,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,5 Months,88.7,84.6 to 91.8,456
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2013,Age,0-1 Days,77.1,74.2 to 79.8,236
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2013-2014,Age,0-1 Days,76.6,74.6 to 78.5,482
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2014,Age,0-1 Days,76.2,68.6 to 82.3,246
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2014-2015,Age,0-1 Days,78.3,73.1 to 82.7,456
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2015,Age,0-1 Days,80.4,73.0 to 86.2,210
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2015-2016,Age,0-1 Days,76.8,70.4 to 82.2,391
DTaP,≥4 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,90.6,83.7 to 95.4,271
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,82.1,76.3 to 87.8,307
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,86.3,81.9 to 90.8,397
≥1 Dose MMR,,States/Local Areas,Kentucky,2011,Age,19 Months,83.8,80.4 to 86.8,217
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.2,53.1 to 91.2,38
Hep B,≥3 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,90.1,85.5 to 93.4,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,90.5,85.1 to 94.1,278
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,90.1,86.0 to 93.1,549
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,89.8,82.9 to 94.1,271
Hep B,≥3 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,87.5,82.4 to 91.3,217
≥1 Dose MMR,,States/Local Areas,Kentucky,2013,Age,19 Months,87.4,82.3 to 91.2,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2013-2014,Age,19 Months,84.6,77.7 to 89.7,482
≥1 Dose MMR,,States/Local Areas,Kentucky,2014,Age,19 Months,81.8,74.3 to 87.5,246
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2015,Age,19 Months,82.2,77.0 to 86.5,456
≥1 Dose MMR,,States/Local Areas,Kentucky,2012,Age,19 Months,81.3,72.9 to 87.6,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017,Age,19 Months,88.9,82.6 to 93.1,238
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017-2018,Age,19 Months,88.5,84.5 to 91.6,516
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018,Age,19 Months,88.0,82.4 to 92.0,278
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018-2019,Age,19 Months,59.3,53.6 to 64.7,549
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,85.0,72.2 to 97.9,73
Polio,≥2 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,97.9,93.9 to 99.3,210
Polio,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,97.2,93.9 to 98.8,391
Polio,≥2 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,96.7,90.0 to 98.9,181
Polio,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,95.7,92.0 to 97.7,419
Polio,≥2 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,94.7,89.3 to 97.4,238
Polio,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,94.5,91.2 to 96.6,516
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.9,81.1 to 88.6,566
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.9,66.3 to 91.5,71
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,83.4,79.8 to 87.0,748
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,84.3,78.8 to 89.7,248
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,82.6,76.2 to 89.0,267
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.3,76.8 to 89.8,233
≥1 Dose MMR,,States/Local Areas,Kentucky,2015,Age,19 Months,82.6,76.2 to 87.6,210
≥1 Dose MMR,,States/Local Areas,Kentucky,2015-2016,Age,19 Months,84.4,78.8 to 88.6,391
≥1 Dose MMR,,States/Local Areas,Kentucky,2016,Age,19 Months,86.1,77.5 to 91.7,181
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2017,Age,19 Months,87.4,82.4 to 91.1,419
≥1 Dose MMR,,States/Local Areas,Kentucky,2017,Age,19 Months,88.8,82.7 to 92.9,238
≥1 Dose MMR,,States/Local Areas,Kentucky,2017-2018,Age,19 Months,88.5,84.5 to 91.6,516
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,76.0,69.4 to 82.6,263
≥1 Dose Varicella,,States/Local Areas,Kentucky,2011,Age,24 Months,90.0,84.0 to 94.5,217
≥1 Dose Varicella,,States/Local Areas,Kentucky,2012,Age,24 Months,90.1,84.2 to 94.4,236
Hep B,≥1 Dose,States/Local Areas,Kentucky,2018,Age,3 Months,96.1,92.1 to 98.1,278
Hep B,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,3 Months,95.2,91.9 to 97.2,549
Hep B,≥1 Dose,States/Local Areas,Kentucky,2019,Age,3 Months,94.4,88.2 to 97.4,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2012,Age,0-1 Days,71.9,69.3 to 74.3,236
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,69.9,61.8 to 78.1,300
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2011,Age,0-1 Days,80.6,72.9 to 86.5,217
Hep B,≥2 Doses,States/Local Areas,Kentucky,2012,Age,5 Months,88.3,84.1 to 91.5,236
Hep B,≥2 Doses,States/Local Areas,Kentucky,2011,Age,5 Months,90.1,84.2 to 94.0,217
Hep B,≥2 Doses,States/Local Areas,Kentucky,2013,Age,5 Months,87.7,83.9 to 90.7,236
Hep B,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,5 Months,89.1,86.2 to 91.5,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,91.1,86.1 to 94.4,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,89.2,86.7 to 91.2,482
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,80.1,68.8 to 91.4,185
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,87.3,80.7 to 91.8,246
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,89.7,85.4 to 92.9,456
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,92.2,89.5 to 94.2,210
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,93.1,88.4 to 96.0,391
Hep B,≥2 Doses,States/Local Areas,Kentucky,2015,Age,5 Months,86.9,79.8 to 91.8,210
Hep B,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,5 Months,89.0,83.9 to 92.6,391
Polio,≥2 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,94.3,89.5 to 97.0,278
Polio,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,94.6,91.1 to 96.8,549
Polio,≥2 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,94.9,88.8 to 97.7,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019,Age,19 Months,89.9,83.7 to 93.9,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014,Age,24 Months,89.3,83.5 to 93.8,246
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2015,Age,24 Months,89.0,84.6 to 92.6,456
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013,Age,24 Months,92.6,88.1 to 95.9,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013-2014,Age,24 Months,91.0,87.4 to 93.9,482
DTaP,≥4 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,87.3,80.5 to 92.6,278
DTaP,≥4 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,88.9,84.2 to 92.7,549
DTaP,≥4 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,90.3,83.7 to 95.0,238
DTaP,≥4 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,89.0,84.3 to 92.9,516
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,91.2,83.2 to 96.3,181
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,90.7,85.7 to 94.4,419
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,90.6,82.2 to 95.2,181
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,88.9,84.0 to 92.5,419
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,87.5,80.2 to 92.3,210
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,89.0,83.9 to 92.7,391
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,87.2,80.6 to 91.9,238
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,88.9,84.7 to 92.0,516
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,75.1,59.7 to 90.5,73
Hep B,≥1 Dose,States/Local Areas,Kentucky,2013,Age,3 Months,96.2,93.8 to 97.7,236
Hep B,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,3 Months,95.8,94.3 to 96.9,482
Hep B,≥1 Dose,States/Local Areas,Kentucky,2012,Age,3 Months,94.6,92.1 to 96.3,236
Hep B,≥1 Dose,States/Local Areas,Kentucky,2011,Age,3 Months,97.0,95.3 to 98.1,217
Hep B,≥1 Dose,States/Local Areas,Kentucky,2014,Age,3 Months,95.3,91.8 to 97.4,246
Hep B,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,3 Months,96.0,93.5 to 97.5,456
Polio,≥2 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,90.4,84.5 to 94.2,238
Polio,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,88.8,84.8 to 91.9,516
Polio,≥2 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,87.3,81.0 to 91.7,278
Polio,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,89.2,84.8 to 92.4,549
PCV,≥4 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,80.6,75.8 to 84.6,236
PCV,≥4 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,79.9,75.7 to 83.5,482
PCV,≥4 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,77.2,62.3 to 87.4,236
PCV,≥4 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,77.9,71.7 to 83.0,217
≥1 Dose MMR,,States/Local Areas,Kentucky,2018,Age,19 Months,88.3,82.5 to 92.3,278
≥1 Dose MMR,,States/Local Areas,Kentucky,2018-2019,Age,19 Months,94.6,91.1 to 96.8,549
≥1 Dose MMR,,States/Local Areas,Kentucky,2019,Age,19 Months,88.7,82.4 to 92.9,271
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,93.9,90.9 to 96.9,397
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.5,94.1 to 100.0,38
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,87.1,79.9 to 94.4,185
Hep A,≥1 Dose,States/Local Areas,Kentucky,2020,Age,35 Months,88.0,81.5 to 93.1,324
≥1 Dose MMR,,States/Local Areas,Kentucky,2017,Age,13 Months,55.2,47.5 to 62.6,238
≥1 Dose MMR,,States/Local Areas,Kentucky,2017-2018,Age,13 Months,59.7,54.4 to 64.7,516
≥1 Dose MMR,,States/Local Areas,Kentucky,2018,Age,13 Months,64.2,57.1 to 70.8,278
≥1 Dose MMR,,States/Local Areas,Kentucky,2018-2019,Age,13 Months,60.9,55.2 to 66.3,549
≥1 Dose MMR,,States/Local Areas,Kentucky,2019,Age,13 Months,57.5,48.8 to 65.8,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014,Age,19 Months,83.3,76.2 to 88.6,246
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2015,Age,19 Months,83.8,78.8 to 87.8,456
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015,Age,19 Months,84.4,75.5 to 90.5,210
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015-2016,Age,19 Months,86.0,80.5 to 90.1,391
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016,Age,19 Months,87.6,79.0 to 93.0,181
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2017,Age,19 Months,88.3,83.3 to 91.9,419
Polio,≥2 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,94.3,91.6 to 96.2,236
Polio,≥2 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,93.1,86.5 to 96.6,217
Polio,≥2 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,93.1,89.5 to 95.6,236
Polio,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,93.4,91.1 to 95.2,482
Polio,≥2 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,93.7,88.6 to 96.6,246
Polio,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,95.8,92.8 to 97.5,456
Hep B,≥1 Dose,States/Local Areas,Kentucky,2015,Age,3 Months,96.7,92.4 to 98.6,210
Hep B,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,3 Months,97.8,95.7 to 98.9,391
Hep B,≥1 Dose,States/Local Areas,Kentucky,2016,Age,3 Months,99.0,97.0 to 99.6,181
Hep B,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,3 Months,96.9,94.5 to 98.2,419
Hep B,≥1 Dose,States/Local Areas,Kentucky,2017,Age,3 Months,94.8,90.2 to 97.3,238
Hep B,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,3 Months,95.4,92.7 to 97.2,516
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.5,54.3 to 88.7,71
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,70.0,62.0 to 77.9,307
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,76.3,69.0 to 83.5,397
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.5,60.4 to 100.0,38
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,80.4,71.8 to 88.9,267
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.7,63.4 to 75.9,566
Polio,≥2 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,91.1,84.2 to 95.1,271
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,70.8,65.4 to 76.2,748
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,67.5,58.5 to 76.5,263
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,62.3,53.5 to 71.0,248
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.8,59.9 to 79.7,233
DTaP,≥4 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,87.1,80.2 to 92.5,271
DTaP,≥4 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,89.4,81.2 to 95.0,217
DTaP,≥4 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,80.2,73.5 to 86.2,278
DTaP,≥4 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,83.6,78.9 to 87.8,549
DTaP,≥4 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,84.2,77.6 to 89.7,238
DTaP,≥4 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,82.2,77.6 to 86.4,516
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016,Age,13 Months,55.6,45.4 to 65.3,181
≥1 Dose Varicella,,States/Local Areas,Kentucky,2016-2017,Age,13 Months,58.8,52.3 to 64.9,419
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017,Age,13 Months,62.0,54.2 to 69.2,238
≥1 Dose Varicella,,States/Local Areas,Kentucky,2017-2018,Age,13 Months,61.3,56.0 to 66.4,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.1,65.9 to 90.2,71
≥1 Dose MMR,,States/Local Areas,Kentucky,2014,Age,13 Months,47.9,40.0 to 55.9,246
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2015,Age,13 Months,48.6,42.9 to 54.3,456
≥1 Dose MMR,,States/Local Areas,Kentucky,2015,Age,13 Months,49.3,41.0 to 57.6,210
≥1 Dose MMR,,States/Local Areas,Kentucky,2015-2016,Age,13 Months,43.9,37.7 to 50.3,391
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019,Age,13 Months,57.9,49.2 to 66.1,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2011,Age,19 Months,88.3,84.0 to 91.6,217
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013,Age,19 Months,91.5,86.9 to 94.6,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013-2014,Age,19 Months,87.4,80.9 to 91.9,482
≥1 Dose Varicella,,States/Local Areas,Kentucky,2012,Age,19 Months,86.7,80.8 to 91.0,236
≥1 Dose MMR,,States/Local Areas,Kentucky,2016,Age,13 Months,38.6,29.9 to 48.1,181
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2017,Age,13 Months,46.8,40.7 to 53.1,419
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018,Age,13 Months,60.6,53.3 to 67.5,278
≥1 Dose Varicella,,States/Local Areas,Kentucky,2018-2019,Age,13 Months,59.3,53.6 to 64.7,549
DTaP,≥4 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,92.0,80.0 to 98.1,236
DTaP,≥4 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,89.3,81.8 to 94.7,210
DTaP,≥4 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,90.1,84.7 to 94.1,391
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,84.7,77.7 to 90.4,246
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,87.0,82.0 to 91.1,456
Hep A,≥2 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,84.1,74.4 to 91.7,271
Hep B,≥3 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,86.6,81.2 to 90.7,236
DTaP,≥4 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,85.4,77.8 to 91.4,236
DTaP,≥4 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,84.8,79.8 to 89.1,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,86.9,83.6 to 89.7,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,86.4,84.7 to 88.0,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,85.9,79.1 to 90.7,246
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,86.7,82.0 to 90.3,456
Hep A,≥2 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,78.3,69.7 to 85.8,278
Hep A,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,80.9,74.6 to 86.5,549
Hep A,≥2 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,77.0,68.4 to 84.7,238
Hep A,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,77.6,71.6 to 83.1,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,87.5,82.5 to 92.5,267
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.2,76.9 to 85.6,566
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,78.0,71.3 to 84.7,248
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.3,73.0 to 87.6,233
Polio,≥2 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,88.3,82.0 to 92.6,246
Polio,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,90.9,87.0 to 93.8,456
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,80.5,74.3 to 86.6,263
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Overall,Overall,81.9,78.2 to 85.7,748
Polio,≥2 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,93.6,87.9 to 96.7,210
Polio,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,91.1,86.4 to 94.3,391
Polio,≥2 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,88.7,80.2 to 93.8,181
Polio,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,89.5,84.7 to 93.0,419
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,81.0,75.0 to 87.0,300
Hep B,≥3 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,86.1,82.6 to 88.9,217
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,80.5,73.3 to 86.7,246
DTaP,≥4 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,81.6,76.5 to 86.1,456
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,86.6,79.0 to 92.4,181
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,85.4,80.5 to 89.6,419
DTaP,≥4 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,82.7,75.3 to 88.9,210
DTaP,≥4 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,84.6,79.5 to 89.1,391
Polio,≥2 Doses,States/Local Areas,Kentucky,2015,Age,5 Months,78.2,70.1 to 84.5,210
Polio,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,5 Months,79.4,73.5 to 84.4,391
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,55.0,45.0 to 64.6,181
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,55.2,48.9 to 61.4,419
Hep A,≥2 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,52.8,44.3 to 61.9,271
Hep A,≥2 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,52.0,41.9 to 63.1,217
Hep A,≥2 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,65.4,53.9 to 76.6,236
Hep A,≥2 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,60.1,51.1 to 69.3,236
Hep A,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,63.0,56.2 to 69.8,482
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016,Age,35 Months,89.6,80.8 to 95.5,181
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,35 Months,91.2,85.3 to 95.4,419
Polio,≥2 Doses,States/Local Areas,Kentucky,2016,Age,5 Months,80.7,71.2 to 87.6,181
Polio,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,5 Months,79.5,73.8 to 84.3,419
Polio,≥2 Doses,States/Local Areas,Kentucky,2017,Age,5 Months,78.4,71.2 to 84.1,238
Polio,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,5 Months,76.6,71.6 to 81.0,516
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,59.2,51.1 to 66.8,246
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,56.8,51.0 to 62.5,456
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,54.4,46.0 to 62.6,210
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,54.7,48.2 to 61.1,391
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014,Age,13 Months,63.3,55.2 to 70.7,246
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2015,Age,13 Months,60.8,55.0 to 66.3,456
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015,Age,13 Months,58.3,49.7 to 66.4,210
≥1 Dose Varicella,,States/Local Areas,Kentucky,2015-2016,Age,13 Months,56.9,50.3 to 63.4,391
≥1 Dose Varicella,,States/Local Areas,Kentucky,2012,Age,13 Months,61.1,56.3 to 65.6,236
Hep A,≥1 Dose,States/Local Areas,Kentucky,2019,Age,35 Months,96.2,91.5 to 98.7,271
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,81.6,76.0 to 87.2,307
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,85.6,80.8 to 90.3,397
Polio,≥2 Doses,States/Local Areas,Kentucky,2018,Age,5 Months,74.9,67.9 to 80.8,278
Polio,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,5 Months,78.2,73.1 to 82.6,549
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.6,80.3 to 100.0,38
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013,Age,13 Months,62.4,53.9 to 70.3,236
≥1 Dose Varicella,,States/Local Areas,Kentucky,2013-2014,Age,13 Months,62.9,57.1 to 68.3,482
Polio,≥2 Doses,States/Local Areas,Kentucky,2019,Age,5 Months,81.6,73.7 to 87.5,271
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,86.4,74.8 to 98.1,73
Polio,≥2 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,87.2,84.4 to 89.6,236
Polio,≥2 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,91.2,87.5 to 93.9,217
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,55.5,47.6 to 63.0,238
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,59.4,54.0 to 64.5,516
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,63.3,56.1 to 70.0,278
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,62.7,57.2 to 67.9,549
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,74.1,62.4 to 84.6,181
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,75.9,68.7 to 82.4,419
Hep A,≥2 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,73.0,62.2 to 82.9,210
Hep A,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,73.7,65.6 to 81.2,391
Polio,≥2 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,86.1,78.8 to 91.2,236
Polio,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,87.2,83.3 to 90.3,482
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,62.0,53.6 to 69.8,271
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,65.6,55.8 to 75.3,246
Hep A,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,69.3,61.9 to 76.4,456
Hep A,≥1 Dose,States/Local Areas,Kentucky,2017,Age,35 Months,92.7,85.5 to 97.1,238
Hep A,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,35 Months,91.9,87.2 to 95.3,516
Hep A,≥1 Dose,States/Local Areas,Kentucky,2018,Age,35 Months,90.6,84.9 to 94.8,278
Hep A,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,35 Months,93.6,90.0 to 96.2,549
≥1 Dose Varicella,,States/Local Areas,Kentucky,2011,Age,13 Months,62.1,55.1 to 68.6,217
Hep A,≥1 Dose,States/Local Areas,Kentucky,2013,Age,35 Months,78.3,69.6 to 85.9,236
Hep A,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,35 Months,80.0,74.7 to 84.8,482
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014,Age,35 Months,82.8,75.7 to 88.9,246
Hep A,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,35 Months,88.1,83.4 to 92.0,456
Hib,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,3 Months,80.9,76.5 to 84.7,726
Polio,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,3 Months,84.7,80.4 to 88.2,726
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,31.1,12.9 to 49.3,39
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,88.7 to 99.4,155
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,78.9,74.8 to 83.1,749
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.0,77.6 to 88.3,827
Hep A,≥1 Dose,States/Local Areas,Kansas,2012,Age,24 Months,89.1,84.0 to 93.2,224
Hep A,≥1 Dose,States/Local Areas,Kansas,2014,Age,24 Months,87.5,81.6 to 92.3,208
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,24 Months,86.1,81.5 to 90.0,388
Hep A,≥1 Dose,States/Local Areas,Kansas,2013,Age,24 Months,89.2,83.1 to 93.9,231
Hep A,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,24 Months,88.3,84.2 to 91.8,439
Hep A,≥1 Dose,States/Local Areas,Kansas,2011,Age,24 Months,85.6,78.7 to 91.2,221
Hep A,≥1 Dose,States/Local Areas,Kansas,2019,Age,19 Months,85.3,79.0 to 90.0,358
Hib,≥3 Doses,States/Local Areas,Kansas,2019,Age,24 Months,91.3,86.5 to 95.0,358
Hib,≥3 Doses,States/Local Areas,Kansas,2018,Age,24 Months,91.1,86.4 to 94.7,395
Hib,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,91.2,88.0 to 93.9,753
Hep A,≥2 Doses,States/Local Areas,Kansas,2012,Age,19 Months,25.9,20.7 to 31.8,224
Hep A,≥2 Doses,States/Local Areas,Kansas,2014,Age,19 Months,32.5,25.0 to 41.0,208
Hep A,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,31.4,25.8 to 37.6,388
Hep A,≥2 Doses,States/Local Areas,Kansas,2013,Age,19 Months,36.0,31.5 to 40.7,231
Hep A,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,34.2,27.3 to 41.8,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2011,Age,19 Months,24.8,16.4 to 35.6,221
DTaP,≥3 Doses,States/Local Areas,Kansas,2014,Age,35 Months,98.2,93.4 to 99.8,208
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,97.2,93.2 to 99.2,388
DTaP,≥3 Doses,States/Local Areas,Kansas,2011,Age,35 Months,92.2,86.6 to 96.1,221
DTaP,≥3 Doses,States/Local Areas,Kansas,2012,Age,35 Months,96.0,91.4 to 98.6,224
DTaP,≥3 Doses,States/Local Areas,Kansas,2013,Age,35 Months,96.1,92.0 to 98.4,231
DTaP,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,97.0,93.4 to 99.0,439
Hep A,≥1 Dose,States/Local Areas,Kansas,2018,Age,19 Months,83.1,76.9 to 88.0,395
Hep A,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,19 Months,84.3,79.2 to 88.3,609
Hep A,≥1 Dose,States/Local Areas,Kansas,2017,Age,19 Months,86.1,80.7 to 90.2,354
Hep A,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,19 Months,84.6,80.6 to 87.9,749
Hep A,≥1 Dose,States/Local Areas,Kansas,2016,Age,19 Months,85.8,80.0 to 90.2,301
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,19 Months,86.0,82.2 to 89.1,655
Hib,≥3 Doses,States/Local Areas,Kansas,2021,Age,19 Months,87.1,80.5 to 91.6,266
PCV,≥2 Doses,States/Local Areas,Kansas,2017,Age,5 Months,79.8,73.7 to 84.8,354
PCV,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,5 Months,81.3,77.2 to 84.9,749
Hep A,≥1 Dose,States/Local Areas,Kansas,2011,Age,35 Months,89.0,82.5 to 93.9,221
Hep A,≥1 Dose,States/Local Areas,Kansas,2019,Age,24 Months,89.2,83.4 to 93.6,358
Hep A,≥1 Dose,States/Local Areas,Kansas,2018,Age,24 Months,86.4,80.8 to 91.0,395
Hep A,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,24 Months,87.7,83.8 to 91.0,753
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,95.2,90.6 to 99.9,134
Hep A,≥1 Dose,States/Local Areas,Kansas,2017,Age,24 Months,90.9,86.5 to 94.4,354
Hep A,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,24 Months,88.7,85.2 to 91.7,749
DTaP,≥3 Doses,States/Local Areas,Kansas,2019,Age,35 Months,93.1,88.3 to 96.4,358
DTaP,≥3 Doses,States/Local Areas,Kansas,2018,Age,35 Months,92.8,88.3 to 96.0,395
DTaP,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,92.9,89.8 to 95.4,753
PCV,≥2 Doses,States/Local Areas,Kansas,2016,Age,5 Months,77.6,70.4 to 83.5,301
PCV,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,5 Months,78.7,74.0 to 82.7,655
PCV,≥2 Doses,States/Local Areas,Kansas,2015,Age,5 Months,79.5,71.2 to 85.9,180
PCV,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,5 Months,78.6,73.2 to 83.1,481
PCV,≥2 Doses,States/Local Areas,Kansas,2014,Age,5 Months,74.0,65.5 to 81.1,208
PCV,≥2 Doses,States/Local Areas,Kansas,2014-2015,Age,5 Months,76.8,69.8 to 82.5,388
Hep A,≥1 Dose,States/Local Areas,Kansas,2016,Age,24 Months,89.2,84.3 to 93.2,301
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,24 Months,90.1,86.8 to 92.8,655
Hep A,≥1 Dose,States/Local Areas,Kansas,2015,Age,24 Months,84.7,77.6 to 90.5,180
Hep A,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,24 Months,86.9,82.6 to 90.5,481
Hep A,≥2 Doses,States/Local Areas,Kansas,2017,Age,19 Months,33.7,27.7 to 40.1,354
Hep A,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,19 Months,33.5,29.2 to 38.0,749
Hib,≥3 Doses,States/Local Areas,Kansas,2015,Age,35 Months,87.9,80.1 to 93.6,180
Hib,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,87.7,83.1 to 91.5,481
Hib,≥3 Doses,States/Local Areas,Kansas,2014,Age,35 Months,98.0,92.4 to 99.7,208
Hib,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,35 Months,94.4,87.4 to 98.2,388
Hib,≥3 Doses,States/Local Areas,Kansas,2013,Age,35 Months,94.3,89.9 to 97.3,231
Hib,≥3 Doses,States/Local Areas,Kansas,2013-2014,Age,35 Months,96.1,91.6 to 98.6,439
Hep A,≥2 Doses,States/Local Areas,Kansas,2016,Age,19 Months,36.3,29.3 to 43.9,301
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2017,Age,19 Months,35.0,30.3 to 40.0,655
Hep A,≥2 Doses,States/Local Areas,Kansas,2015,Age,19 Months,30.3,29.2 to 31.3,180
Hep A,≥2 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,33.2,27.7 to 39.2,481
DTaP,≥3 Doses,States/Local Areas,Kansas,2016,Age,35 Months,91.9,86.6 to 95.7,301
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,92.9,89.4 to 95.5,655
DTaP,≥3 Doses,States/Local Areas,Kansas,2015,Age,35 Months,95.7,90.1 to 98.6,180
DTaP,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,35 Months,93.4,89.7 to 96.1,481
PCV,≥2 Doses,States/Local Areas,Kansas,2011,Age,5 Months,75.8,70.0 to 80.7,221
PCV,≥2 Doses,States/Local Areas,Kansas,2012,Age,5 Months,83.0,79.6 to 85.9,224
PCV,≥2 Doses,States/Local Areas,Kansas,2013,Age,5 Months,79.8,75.7 to 83.3,231
PCV,≥2 Doses,States/Local Areas,Kansas,2013-2014,Age,5 Months,76.9,72.9 to 80.6,439
DTaP,≥4 Doses,States/Local Areas,Kansas,2012,Age,19 Months,76.5,70.7 to 81.5,224
DTaP,≥4 Doses,States/Local Areas,Kansas,2011,Age,19 Months,71.0,63.7 to 77.3,221
DTaP,≥3 Doses,States/Local Areas,Kansas,2017,Age,35 Months,93.6,89.2 to 96.6,354
DTaP,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,93.2,90.2 to 95.6,749
Hep A,≥2 Doses,States/Local Areas,Kansas,2011,Age,24 Months,45.0,36.6 to 54.3,221
Hep A,≥2 Doses,States/Local Areas,Kansas,2019,Age,19 Months,43.9,36.9 to 51.2,358
Hep A,≥2 Doses,States/Local Areas,Kansas,2018,Age,19 Months,33.3,27.4 to 39.8,395
Hep A,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,19 Months,39.3,33.6 to 45.4,609
Hib,≥3 Doses,States/Local Areas,Kansas,2017,Age,35 Months,89.8,84.6 to 93.8,354
Hib,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,35 Months,91.1,87.5 to 93.9,749
Hib,≥3 Doses,States/Local Areas,Kansas,2016,Age,35 Months,87.5,82.0 to 92.0,301
Hib,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,35 Months,88.7,85.0 to 91.8,655
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Private Insurance Only,94.6,92.2 to 97.0,527
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Any Medicaid,87.4,81.8 to 93.1,209
DTaP,≥4 Doses,States/Local Areas,Kansas,2015,Age,19 Months,72.3,64.9 to 78.7,180
DTaP,≥4 Doses,States/Local Areas,Kansas,2015-2016,Age,19 Months,68.9,62.9 to 74.4,481
DTaP,≥4 Doses,States/Local Areas,Kansas,2014,Age,19 Months,74.4,65.7 to 81.5,208
DTaP,≥4 Doses,States/Local Areas,Kansas,2014-2015,Age,19 Months,73.4,67.1 to 78.8,388
DTaP,≥4 Doses,States/Local Areas,Kansas,2013,Age,19 Months,77.5,70.8 to 83.0,231
DTaP,≥4 Doses,States/Local Areas,Kansas,2013-2014,Age,19 Months,75.9,72.0 to 79.5,439
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.0,71.8 to 98.1,35
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,74.2,53.0 to 95.4,35
Hep A,≥2 Doses,States/Local Areas,Kansas,2012,Age,24 Months,50.9,42.7 to 59.7,224
Hib,≥3 Doses,States/Local Areas,Kansas,2018,Age,35 Months,92.0,87.1 to 95.6,395
Hib,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,35 Months,92.0,88.7 to 94.7,753
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,94.6,90.6 to 98.5,332
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,83.6,79.1 to 88.0,601
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,80.6,74.5 to 86.7,332
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,79.0,74.4 to 83.6,601
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,62.7,53.9 to 71.5,331
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,95.4,92.3 to 98.6,332
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,92.1,88.8 to 95.3,601
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,83.0,77.1 to 89.0,331
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,91.8,89.4 to 94.1,1264
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,92.9,90.9 to 94.9,1264
Influenza,,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,61.1,55.7 to 66.5,601
Influenza,,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,46.2,38.9 to 53.4,331
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,97.5,95.6 to 99.4,332
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,89.7,86.0 to 93.4,601
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,82.1,76.2 to 87.9,331
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,91.1,86.9 to 95.4,332
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,76.8,71.8 to 81.9,601
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,83.0,77.2 to 88.8,331
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Overall,Overall,77.4,73.9 to 80.9,1264
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,82.6,76.7 to 88.6,331
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,88.6,84.1 to 93.1,332
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,65.5,58.2 to 72.8,331
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Poverty,133% to <400% FPL,79.5,74.8 to 84.3,601
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,97.4,95.5 to 99.2,332
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Poverty,<133% FPL,71.3,64.2 to 78.4,331
Influenza,,States/Local Areas,Kansas,2016-2019,Poverty,>400% FPL,76.8,70.3 to 83.2,332
Rotavirus,,States/Local Areas,Kansas,2016-2019,Overall,Overall,78.7,75.4 to 82.0,1264
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.8,90.2 to 95.5,827
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,69.9,59.7 to 80.2,177
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,58.5,50.8 to 66.2,299
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.2,90.9 to 95.5,827
DTaP,≥1 Dose,States/Local Areas,Kansas,2020,Age,3 Months,82.1,75.6 to 87.2,368
Hep B,≥2 Doses,States/Local Areas,Kansas,2020,Age,5 Months,87.2,81.3 to 91.5,368
Hib,≥2 Doses,States/Local Areas,Kansas,2020,Age,5 Months,75.9,69.2 to 81.5,368
Polio,≥2 Doses,States/Local Areas,Kansas,2020,Age,5 Months,77.0,70.3 to 82.5,368
DTaP,≥2 Doses,States/Local Areas,Kansas,2020,Age,5 Months,78.4,71.7 to 83.8,368
PCV,≥1 Dose,States/Local Areas,Kansas,2020,Age,3 Months,81.2,74.7 to 86.4,368
Hep B,≥1 Dose,States/Local Areas,Kansas,2020,Age,3 Months,96.4,93.1 to 98.1,368
Hep A,≥1 Dose,States/Local Areas,Kansas,2020,Age,24 Months,88.1,82.4 to 92.6,368
Hep A,≥2 Doses,States/Local Areas,Kansas,2020,Age,24 Months,48.6,41.8 to 56.0,368
PCV,≥4 Doses,States/Local Areas,Kansas,2020,Age,24 Months,75.4,68.8 to 81.5,368
PCV,≥3 Doses,States/Local Areas,Kansas,2020,Age,24 Months,90.9,85.6 to 94.8,368
≥1 Dose Varicella,,States/Local Areas,Kansas,2020,Age,24 Months,86.7,80.8 to 91.5,368
Influenza,,States/Local Areas,Kansas,2020,Age,24 Months,59.5,52.7 to 66.4,368
Rotavirus,,States/Local Areas,Kansas,2020,Age,8 Months,78.7,72.1 to 84.0,368
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2020,Age,0-3 Days,82.9,77.0 to 87.5,368
Combined 7 Series,,States/Local Areas,Kansas,2020,Age,24 Months,64.3,57.5 to 71.0,368
Hib,≥3 Doses,States/Local Areas,Kansas,2020,Age,19 Months,84.0,77.9 to 88.7,368
Polio,≥3 Doses,States/Local Areas,Kansas,2020,Age,19 Months,88.2,82.1 to 92.4,368
≥1 Dose MMR,,States/Local Areas,Kansas,2020,Age,19 Months,84.9,78.3 to 89.7,368
DTaP,≥4 Doses,States/Local Areas,Kansas,2020,Age,19 Months,66.5,59.8 to 72.6,368
DTaP,≥3 Doses,States/Local Areas,Kansas,2020,Age,19 Months,89.9,83.8 to 93.8,368
PCV,≥3 Doses,States/Local Areas,Kansas,2020,Age,13 Months,87.1,80.9 to 91.5,368
DTaP,≥3 Doses,States/Local Areas,Kansas,2020,Age,7 Months,72.4,65.6 to 78.2,368
≥1 Dose Varicella,,States/Local Areas,Kansas,2020,Age,13 Months,57.4,50.5 to 64.1,368
Hep B,≥3 Doses,States/Local Areas,Kansas,2020,Age,13 Months,87.8,81.8 to 92.0,368
Hep B,≥2 Doses,States/Local Areas,Kansas,2020,Age,13 Months,93.4,88.7 to 96.3,368
Hib,≥3 Doses,States/Local Areas,Kansas,2020,Age,13 Months,61.0,54.2 to 67.5,368
Hib,Primary Series,States/Local Areas,Kansas,2020,Age,13 Months,86.6,81.0 to 90.7,368
PCV,≥3 Doses,States/Local Areas,Kansas,2020,Age,35 Months,92.8,87.2 to 96.5,368
Hib,≥2 Doses,States/Local Areas,Kansas,2020,Age,13 Months,91.7,86.4 to 95.0,368
PCV,≥3 Doses,States/Local Areas,Kansas,2020,Age,19 Months,89.8,83.7 to 93.7,368
Polio,≥3 Doses,States/Local Areas,Kansas,2020,Age,35 Months,92.2,86.4 to 96.1,368
PCV,≥4 Doses,States/Local Areas,Kansas,2020,Age,19 Months,71.9,64.9 to 77.9,368
DTaP,≥4 Doses,States/Local Areas,Kansas,2020,Age,35 Months,83.6,76.2 to 89.7,368
DTaP,≥3 Doses,States/Local Areas,Kansas,2020,Age,35 Months,93.2,87.6 to 96.9,368
≥1 Dose Varicella,,States/Local Areas,Kansas,2020,Age,19 Months,84.3,77.8 to 89.2,368
Hep B,≥3 Doses,States/Local Areas,Kansas,2020,Age,19 Months,88.7,82.7 to 92.8,368
Hib,Full Series,States/Local Areas,Kansas,2020,Age,19 Months,72.4,65.8 to 78.2,368
Hib,Primary Series,States/Local Areas,Kansas,2020,Age,19 Months,90.8,85.5 to 94.3,368
PCV,≥3 Doses,States/Local Areas,Kansas,2021,Age,35 Months,91.7,86.6 to 95.4,266
Hib,≥3 Doses,States/Local Areas,Kansas,2011,Age,35 Months,92.4,86.8 to 96.3,221
Hib,≥3 Doses,States/Local Areas,Kansas,2012,Age,35 Months,95.5,89.8 to 98.5,224
Hib,≥3 Doses,States/Local Areas,Kansas,2021,Age,7 Months,38.3,30.7 to 46.6,266
Hib,≥2 Doses,States/Local Areas,Kansas,2021,Age,7 Months,87.1,79.0 to 92.4,266
Hep B,≥2 Doses,States/Local Areas,Kansas,2021,Age,7 Months,90.7,84.7 to 94.5,266
Hib,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,89.2,85.5 to 92.3,634
Hib,Primary Series,States/Local Areas,Kansas,2021,Age,7 Months,65.5,56.5 to 73.5,266
Hep A,≥1 Dose,States/Local Areas,Kansas,2012,Age,35 Months,95.7,92.3 to 97.9,224
≥1 Dose MMR,,States/Local Areas,Kansas,2021,Age,35 Months,93.7,88.5 to 97.1,266
Polio,≥2 Doses,States/Local Areas,Kansas,2021,Age,7 Months,89.2,81.0 to 94.1,266
Hep B,≥2 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,93.1,89.7 to 95.4,634
DTaP,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,19 Months,90.1,86.2 to 93.0,634
Polio,≥3 Doses,States/Local Areas,Kansas,2021,Age,35 Months,90.9,85.7 to 94.8,266
DTaP,≥3 Doses,States/Local Areas,Kansas,2021,Age,7 Months,64.2,55.3 to 72.3,266
≥1 Dose MMR,,States/Local Areas,Kansas,2020-2021,Age,24 Months,90.1,86.2 to 93.2,634
PCV,≥2 Doses,States/Local Areas,Kansas,2021,Age,5 Months,74.9,65.8 to 82.3,266
Combined 7 Series,,States/Local Areas,Kansas,2021,Age,35 Months,75.8,66.1 to 84.4,266
DTaP,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,91.1,87.1 to 93.9,726
DTaP,≥4 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,68.8,63.9 to 73.3,726
Hep B,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,73.3,68.6 to 77.5,726
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2019-2020,Age,0-3 Days,82.2,78.0 to 85.8,726
DTaP,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,3 Months,86.0,81.9 to 89.3,726
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.1,87.1 to 93.1,827
Rotavirus,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.3,76.3 to 84.4,827
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.9,83.2 to 100.0,48
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.5,86.4 to 92.6,827
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.7,63.3 to 94.1,48
Rotavirus,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.5,47.8 to 83.1,48
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,74.9,70.6 to 79.2,749
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.6,84.2 to 91.0,827
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,78.6,72.3 to 85.0,299
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,82.3,74.2 to 90.4,177
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,85.4,69.5 to 100.0,39
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.9,83.2 to 100.0,48
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,91.5,85.8 to 97.2,234
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,78.2 to 94.5,155
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,81.6,75.6 to 87.5,299
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,96.0,93.9 to 98.2,749
Rotavirus,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,85.8,82.4 to 89.1,749
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,84.6,78.8 to 90.5,299
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,73.8,51.6 to 96.0,39
Influenza,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,49.8,42.1 to 57.5,299
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.6,70.2 to 89.0,155
Influenza,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,49.0,38.6 to 59.4,177
Influenza,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,28.4,11.3 to 45.6,39
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,89.3,82.9 to 95.7,234
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,82.2,75.3 to 89.2,234
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,87.3,75.1 to 99.5,177
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.4,77.1 to 91.7,155
Hep A,≥2 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,29.9,10.2 to 49.6,39
Rotavirus,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,75.7,66.4 to 85.1,177
Rotavirus,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,64.4,41.8 to 86.9,39
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.5,54.6 to 86.4,48
Rotavirus,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,68.5,61.1 to 75.9,299
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,62.2,53.6 to 70.7,234
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.9,39.0 to 76.7,48
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",71.2,66.6 to 75.8,827
Combined 7 Series,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.1,58.0 to 78.3,155
≥1 Dose MMR,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,63.0,37.7 to 88.2,39
Rotavirus,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,77.8,70.3 to 85.3,234
Rotavirus,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.7,68.6 to 86.7,155
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.7,79.7 to 87.7,827
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.8,72.4 to 97.2,48
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,79.4,71.6 to 87.2,234
PCV,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,38.2,18.1 to 58.3,39
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,91.1,84.0 to 98.2,177
Influenza,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.9,61.2 to 70.6,827
Influenza,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",52.5,41.7 to 63.3,155
Influenza,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",39.6,22.4 to 56.7,48
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,93.4,88.0 to 98.9,177
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.3,77.5 to 99.2,48
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.4,89.7 to 95.1,827
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,89.7,83.6 to 95.7,234
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.9,89.1 to 94.7,827
Influenza,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,70.5,66.0 to 75.0,749
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.3,77.5 to 99.2,48
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,68.1,60.7 to 75.5,299
PCV,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,73.5,51.3 to 95.7,39
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,78.7,69.2 to 88.1,177
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,45.2,21.7 to 68.6,39
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,87.3,82.1 to 92.6,299
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,96.4,94.0 to 98.9,177
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,75.2,53.0 to 97.5,39
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,94.8,89.8 to 99.8,177
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.6,84.2 to 100.0,48
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,89.3,83.1 to 95.4,234
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,77.2,67.7 to 86.6,177
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,42.4,19.6 to 65.2,39
Hib,Full Series,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.6,75.4 to 83.8,827
Hep A,≥1 Dose,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,56.1,31.5 to 80.6,39
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.5 to 97.8,749
Polio,≥3 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Any Medicaid,84.2,78.3 to 90.1,299
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Other,93.6,87.7 to 99.4,177
≥1 Dose Varicella,,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Uninsured,63.0,37.7 to 88.2,39
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.2,76.1 to 84.4,827
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,84.7 to 98.0,155
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.3,77.5 to 99.2,48
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,89.6,83.2 to 96.0,234
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.0,78.6 to 99.3,48
DTaP,≥4 Doses,States/Local Areas,Kansas,2016-2019,Insurance Coverage,Private Insurance Only,83.9,80.0 to 87.8,749
Hep B,≥3 Doses,States/Local Areas,Kansas,2016-2019,Race and Ethnicity,Hispanic,92.2,86.7 to 97.7,234
≥1 Dose Varicella,,States/Local Areas,Kansas,2020,Age,35 Months,92.0,85.2 to 96.5,368
Hep B,≥3 Doses,States/Local Areas,Kansas,2020,Age,35 Months,90.1,84.8 to 94.2,368
Hib,Full Series,States/Local Areas,Kansas,2020,Age,35 Months,80.8,74.2 to 86.7,368
Hib,Primary Series,States/Local Areas,Kansas,2020,Age,35 Months,92.6,88.1 to 95.9,368
Hib,≥3 Doses,States/Local Areas,Kansas,2020,Age,35 Months,91.5,85.5 to 95.8,368
Hib,≥3 Doses,States/Local Areas,Kansas,2020,Age,24 Months,87.1,81.5 to 91.6,368
≥1 Dose MMR,,States/Local Areas,Kansas,2020,Age,35 Months,91.5,84.6 to 96.1,368
≥1 Dose MMR,,States/Local Areas,Kansas,2020,Age,24 Months,87.3,81.4 to 92.1,368
Polio,≥3 Doses,States/Local Areas,Kansas,2020,Age,24 Months,89.8,84.5 to 94.0,368
DTaP,≥3 Doses,States/Local Areas,Kansas,2020,Age,24 Months,91.0,85.7 to 94.9,368
DTaP,≥4 Doses,States/Local Areas,Kansas,2020,Age,24 Months,74.8,68.4 to 80.8,368
PCV,≥2 Doses,States/Local Areas,Kansas,2020,Age,5 Months,76.9,70.3 to 82.4,368
Hep B,≥2 Doses,States/Local Areas,Kansas,2020,Age,7 Months,91.1,85.9 to 94.5,368
Hib,Primary Series,States/Local Areas,Kansas,2020,Age,7 Months,74.3,67.7 to 80.0,368
Hib,≥3 Doses,States/Local Areas,Kansas,2020,Age,7 Months,39.7,33.2 to 46.6,368
Polio,≥2 Doses,States/Local Areas,Kansas,2020,Age,7 Months,88.5,82.9 to 92.4,368
Hib,≥2 Doses,States/Local Areas,Kansas,2020,Age,7 Months,88.6,83.1 to 92.4,368
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2020,Age,0-1 Days,79.8,73.7 to 84.7,368
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2020,Age,0-2 Days,82.3,76.4 to 87.0,368
Hep A,≥2 Doses,States/Local Areas,Kansas,2020,Age,19 Months,28.8,23.4 to 34.9,368
Hep A,≥1 Dose,States/Local Areas,Kansas,2020,Age,19 Months,84.8,78.5 to 89.6,368
Combined 7 Series,,States/Local Areas,Kansas,2020,Age,35 Months,68.4,61.5 to 75.1,368
≥1 Dose MMR,,States/Local Areas,Kansas,2020,Age,13 Months,65.5,58.5 to 71.9,368
Hep A,≥2 Doses,States/Local Areas,Kansas,2020,Age,35 Months,78.4,68.3 to 87.1,368
Hep A,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,24 Months,88.4,84.4 to 91.8,726
Hep A,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,35 Months,92.2,88.0 to 95.3,726
Hep A,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,79.7,73.8 to 85.0,726
Influenza,,States/Local Areas,Kansas,2019-2020,Age,24 Months,60.5,55.5 to 65.5,726
Hib,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,89.2,85.4 to 92.3,726
Hep A,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,55.2,50.1 to 60.5,726
Hib,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,90.2,86.7 to 92.9,726
Hib,Primary Series,States/Local Areas,Kansas,2019-2020,Age,24 Months,93.2,90.3 to 95.5,726
Combined 7 Series,,States/Local Areas,Kansas,2019-2020,Age,35 Months,70.9,65.8 to 75.8,726
Hib,Full Series,States/Local Areas,Kansas,2019-2020,Age,19 Months,73.0,68.2 to 77.3,726
Hep B,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,90.7,87.1 to 93.3,726
≥1 Dose Varicella,,States/Local Areas,Kansas,2019-2020,Age,19 Months,85.3,80.8 to 88.8,726
PCV,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,90.9,87.0 to 93.7,726
PCV,≥4 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,77.1,72.3 to 81.2,726
Hep A,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,19 Months,84.8,80.5 to 88.4,726
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kansas,2019-2020,Age,0-1 Days,78.9,74.5 to 82.7,726
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kansas,2019-2020,Age,0-2 Days,81.6,77.4 to 85.2,726
Hep B,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,91.8,88.5 to 94.4,726
Hib,Full Series,States/Local Areas,Kansas,2019-2020,Age,24 Months,77.5,72.9 to 81.7,726
Hib,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,41.5,36.7 to 46.5,726
PCV,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,72.2,67.2 to 76.6,726
PCV,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,91.6,88.0 to 94.4,726
≥1 Dose Varicella,,States/Local Areas,Kansas,2019-2020,Age,24 Months,88.2,84.1 to 91.7,726
PCV,≥4 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,79.5,75.0 to 83.7,726
Hep A,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,36.2,31.6 to 41.0,726
≥1 Dose MMR,,States/Local Areas,Kansas,2019-2020,Age,19 Months,86.6,82.2 to 90.1,726
Polio,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,90.2,86.2 to 93.1,726
Hib,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,19 Months,86.5,82.4 to 89.8,726
Hib,Primary Series,States/Local Areas,Kansas,2019-2020,Age,19 Months,92.3,89.1 to 94.7,726
Hib,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,91.3,87.6 to 94.3,726
≥1 Dose MMR,,States/Local Areas,Kansas,2019-2020,Age,35 Months,92.9,89.1 to 95.7,726
Hib,Full Series,States/Local Areas,Kansas,2019-2020,Age,35 Months,80.1,75.5 to 84.4,726
Hib,Primary Series,States/Local Areas,Kansas,2019-2020,Age,35 Months,94.3,91.5 to 96.5,726
Hep B,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,93.2,90.1 to 95.6,726
≥1 Dose Varicella,,States/Local Areas,Kansas,2019-2020,Age,35 Months,93.4,89.6 to 96.2,726
PCV,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,92.6,89.0 to 95.3,726
PCV,≥4 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,82.5,77.9 to 86.6,726
DTaP,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,91.8,88.2 to 94.6,726
DTaP,≥4 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,77.2,72.5 to 81.6,726
Polio,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,24 Months,91.1,87.5 to 94.0,726
≥1 Dose MMR,,States/Local Areas,Kansas,2019-2020,Age,24 Months,88.4,84.3 to 91.8,726
Hep B,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,3 Months,96.5,94.0 to 98.0,726
PCV,≥1 Dose,States/Local Areas,Kansas,2019-2020,Age,3 Months,83.7,79.3 to 87.2,726
DTaP,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,5 Months,81.8,77.4 to 85.5,726
Polio,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,5 Months,81.0,76.6 to 84.7,726
DTaP,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,89.3,85.2 to 92.3,726
Polio,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,92.7,89.5 to 95.0,726
Hib,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,60.0,54.9 to 64.9,726
Hib,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,92.6,89.4 to 94.9,726
≥1 Dose MMR,,States/Local Areas,Kansas,2019-2020,Age,13 Months,66.8,61.7 to 71.5,726
Hib,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,5 Months,77.1,72.5 to 81.1,726
Hib,Primary Series,States/Local Areas,Kansas,2019-2020,Age,13 Months,85.5,81.5 to 88.7,726
Hep B,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,5 Months,89.8,86.2 to 92.5,726
PCV,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,5 Months,79.5,75.0 to 83.4,726
DTaP,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,75.1,70.3 to 79.3,726
Polio,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,7 Months,90.3,86.8 to 93.0,726
Hep B,≥2 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,94.2,91.4 to 96.1,726
Hep B,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,88.2,84.4 to 91.2,726
≥1 Dose Varicella,,States/Local Areas,Kansas,2019-2020,Age,13 Months,59.0,53.9 to 63.9,726
PCV,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,13 Months,87.5,83.3 to 90.8,726
DTaP,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,93.0,89.3 to 95.7,726
Combined 7 Series,,States/Local Areas,Kansas,2019-2020,Age,24 Months,64.7,59.7 to 69.7,726
DTaP,≥4 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,85.1,80.2 to 89.3,726
Polio,≥3 Doses,States/Local Areas,Kansas,2019-2020,Age,35 Months,93.0,89.6 to 95.6,726
Hib,≥2 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,90.3,83.4 to 94.5,271
Hib,≥2 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,88.7,80.3 to 93.9,181
Hib,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,89.6,84.7 to 93.0,419
Hib,≥2 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,90.4,84.5 to 94.2,238
Hib,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,88.7,84.6 to 91.8,516
DTaP,≥3 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,89.9,84.3 to 93.6,217
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,87.7,74.7 to 100.0,73
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,86.4 to 95.6,267
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.0,90.4 to 95.6,566
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2013,Age,0-3 Days,80.3,72.1 to 86.6,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2013-2014,Age,0-3 Days,79.8,74.4 to 84.3,482
Polio,≥1 Dose,States/Local Areas,Kentucky,2013,Age,3 Months,88.6,79.8 to 93.8,236
Polio,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,3 Months,87.1,79.7 to 92.1,482
PCV,≥1 Dose,States/Local Areas,Kentucky,2019,Age,3 Months,91.6,85.3 to 95.4,271
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,92.3,89.8 to 94.8,748
Polio,≥1 Dose,States/Local Areas,Kentucky,2012,Age,3 Months,83.2,76.1 to 88.5,236
Polio,≥1 Dose,States/Local Areas,Kentucky,2011,Age,3 Months,89.5,85.0 to 92.7,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014,Age,0-3 Days,79.3,71.8 to 85.2,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2015,Age,0-3 Days,80.7,75.6 to 85.0,456
Hib,≥2 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,87.0,80.8 to 91.4,278
Hib,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,88.6,84.3 to 91.9,549
PCV,≥3 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,92.5,87.2 to 96.2,246
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,94.4,90.7 to 96.9,456
PCV,≥3 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,95.8,90.3 to 98.7,210
PCV,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,96.0,92.0 to 98.4,391
PCV,≥3 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,96.3,89.4 to 99.2,181
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,94.7,90.7 to 97.3,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,68.3,60.2 to 75.5,246
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,69.4,63.7 to 74.5,456
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,91.4,87.0 to 95.8,263
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,93.5,89.2 to 97.7,185
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,92.6,88.7 to 96.5,300
Hib,≥3 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,51.5,36.7 to 66.1,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,61.3,57.1 to 65.3,217
Hib,≥3 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,44.5,39.8 to 49.2,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,47.8,43.8 to 51.9,482
Polio,≥1 Dose,States/Local Areas,Kentucky,2014,Age,3 Months,85.6,79.1 to 90.3,246
Polio,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,3 Months,86.6,82.1 to 90.0,456
Polio,≥1 Dose,States/Local Areas,Kentucky,2015,Age,3 Months,87.5,80.8 to 92.1,210
Polio,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,3 Months,88.3,83.3 to 91.9,391
Polio,≥1 Dose,States/Local Areas,Kentucky,2016,Age,3 Months,89.0,80.8 to 94.0,181
Polio,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,3 Months,88.6,83.7 to 92.1,419
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2017,Age,0-3 Days,83.8,71.9 to 91.3,111
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2017-2018,Age,0-3 Days,81.4,76.7 to 85.3,516
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016,Age,0-3 Days,79.5,70.4 to 86.4,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2016-2017,Age,0-3 Days,80.0,74.4 to 84.6,419
Hib,≥2 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,92.9,87.1 to 96.2,210
Hib,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,90.8,86.0 to 94.1,391
PCV,≥3 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,93.5,88.3 to 96.9,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,90.6,84.0 to 95.2,217
PCV,≥3 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,94.2,89.6 to 97.2,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,93.5,90.0 to 96.1,482
PCV,≥3 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,91.3,85.6 to 95.4,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.3,78.3 to 98.3,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2015,Age,0-3 Days,82.2,74.8 to 87.8,210
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2015-2016,Age,0-3 Days,80.9,75.2 to 85.5,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,63.0,57.4 to 68.3,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,65.7,62.8 to 68.5,482
DTaP,≥3 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,69.0,60.5 to 76.4,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,69.3,59.0 to 78.0,217
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,92.9,89.0 to 96.7,248
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.1,88.5 to 97.7,233
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.2 to 90.1,566
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,67.9 to 91.7,71
PCV,≥1 Dose,States/Local Areas,Kentucky,2014,Age,3 Months,85.4,78.9 to 90.1,246
PCV,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,3 Months,85.5,80.8 to 89.1,456
PCV,≥1 Dose,States/Local Areas,Kentucky,2015,Age,3 Months,85.5,78.2 to 90.6,210
PCV,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,3 Months,84.7,79.1 to 89.1,391
Hib,≥2 Doses,States/Local Areas,Kentucky,2018,Age,5 Months,73.1,66.1 to 79.2,278
Hib,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,5 Months,76.2,71.0 to 80.7,549
Hib,≥2 Doses,States/Local Areas,Kentucky,2019,Age,5 Months,79.3,71.2 to 85.5,271
Hib,≥2 Doses,States/Local Areas,Kentucky,2011,Age,7 Months,88.4,85.6 to 90.8,217
PCV,≥3 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,93.3,85.7 to 97.7,181
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,93.2,88.9 to 96.3,419
Hib,≥2 Doses,States/Local Areas,Kentucky,2012,Age,7 Months,89.0,84.0 to 92.6,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,93.1,87.8 to 96.6,238
PCV,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,92.4,88.9 to 95.1,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,91.7,86.7 to 95.4,278
PCV,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,92.6,89.2 to 95.3,549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2011,Age,0-3 Days,86.1,79.1 to 91.0,217
PCV,≥1 Dose,States/Local Areas,Kentucky,2018,Age,3 Months,83.4,76.6 to 88.6,278
PCV,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,3 Months,87.5,83.1 to 90.9,549
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,92.0,88.2 to 95.9,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2012,Age,0-3 Days,77.9,70.1 to 84.1,236
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,82.1,75.8 to 88.3,267
PCV,≥1 Dose,States/Local Areas,Kentucky,2016,Age,3 Months,84.0,74.6 to 90.3,181
PCV,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,3 Months,86.1,80.7 to 90.2,419
PCV,≥1 Dose,States/Local Areas,Kentucky,2017,Age,3 Months,88.3,82.0 to 92.6,238
PCV,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,3 Months,85.9,81.4 to 89.4,516
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,89.0,82.9 to 93.1,278
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,90.4,86.1 to 93.4,549
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,90.4,82.5 to 94.9,181
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,91.1,86.6 to 94.2,419
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,91.9,86.1 to 95.4,238
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,90.5,86.5 to 93.4,516
Hib,≥3 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,89.0,83.5 to 92.8,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,88.0,84.1 to 91.1,482
Polio,≥3 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,89.2,82.7 to 93.4,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,78.9,70.5 to 87.3,185
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,82.4,77.1 to 87.6,300
Hib,≥3 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,70.5,65.0 to 75.6,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,73.0,68.3 to 77.3,482
Polio,≥3 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,90.6,83.6 to 94.8,217
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,97.3,94.3 to 100.0,185
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,93.9,90.2 to 97.7,300
Hib,≥3 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,75.5,68.0 to 81.7,246
Hib,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,75.5,70.2 to 80.2,456
Hib,≥3 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,80.3,74.9 to 84.7,217
Hib,≥3 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,74.8,60.6 to 85.2,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,60.6,52.0 to 68.6,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,86.3 to 96.2,267
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.2,91.8 to 96.6,566
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,89.1,83.7 to 92.9,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,87.7,84.5 to 90.4,482
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,86.4,79.4 to 91.2,246
DTaP,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,89.4,85.0 to 92.6,456
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,73.4,58.7 to 88.0,73
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.0,76.9 to 85.0,566
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,69.1 to 92.1,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Overall,Overall,80.4,76.7 to 84.0,748
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,78.3,71.9 to 84.7,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,76.3,69.4 to 83.1,267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.7,81.4 to 92.0,233
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,92.4,86.1 to 96.0,210
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,91.4,86.7 to 94.5,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,87.9,77.6 to 93.8,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,79.1,73.0 to 85.2,263
Hib,≥2 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,94.3,89.5 to 97.0,278
Hib,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,94.6,91.1 to 96.8,549
Hib,≥2 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,93.8,88.1 to 96.9,238
Hib,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,94.0,90.6 to 96.3,516
Hib,≥2 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,94.9,88.8 to 97.7,271
Hib,≥2 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,94.6,91.5 to 96.6,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,92.0,87.8 to 94.9,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2018,Age,0-3 Days,82.3,75.8 to 87.4,278
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2018-2019,Age,0-3 Days,82.8,78.0 to 86.8,549
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,70.4,62.2 to 77.5,210
DTaP,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,72.2,65.9 to 77.7,391
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,73.9,64.0 to 81.9,181
DTaP,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,71.1,64.9 to 76.5,419
Hib,≥2 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,92.0,87.2 to 95.1,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,92.7,90.2 to 94.6,482
PCV,≥3 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,93.1,87.8 to 96.6,238
PCV,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,92.8,89.3 to 95.6,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,93.1,87.7 to 96.7,278
PCV,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,94.3,90.6 to 96.9,549
Hib,≥3 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,51.2,43.1 to 59.1,246
Hib,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,52.6,46.8 to 58.3,456
Hib,≥3 Doses,States/Local Areas,Kentucky,2015,Age,7 Months,54.0,45.7 to 62.1,210
Hib,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,7 Months,55.2,48.6 to 61.6,391
Hib,≥3 Doses,States/Local Areas,Kentucky,2016,Age,7 Months,56.4,46.2 to 66.1,181
Hib,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,7 Months,57.4,51.0 to 63.6,419
Polio,≥1 Dose,States/Local Areas,Kentucky,2017,Age,3 Months,88.1,81.8 to 92.4,238
Polio,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,3 Months,87.6,83.4 to 90.9,516
Polio,≥1 Dose,States/Local Areas,Kentucky,2018,Age,3 Months,87.1,80.8 to 91.6,278
Polio,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,3 Months,89.5,85.3 to 92.6,549
PCV,≥3 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,95.0,89.9 to 98.0,271
Polio,≥1 Dose,States/Local Areas,Kentucky,2019,Age,3 Months,91.8,85.4 to 95.5,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2019,Age,0-3 Days,83.4,75.7 to 89.0,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,81.4,76.2 to 86.6,397
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,81.6,76.5 to 86.8,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.9,65.7 to 98.1,38
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,72.9,65.6 to 79.1,278
DTaP,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,74.2,68.8 to 79.0,549
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,75.6,67.3 to 82.3,271
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,68.2,60.3 to 75.1,238
DTaP,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,70.5,65.2 to 75.3,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,90.3,85.7 to 95.0,263
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,93.1,90.6 to 95.6,748
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,95.1,92.3 to 97.9,248
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.7,87.9 to 97.5,233
Hib,≥3 Doses,States/Local Areas,Kentucky,2017,Age,7 Months,58.4,50.5 to 65.9,238
Hib,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,7 Months,57.1,51.7 to 62.3,516
Hib,≥3 Doses,States/Local Areas,Kentucky,2018,Age,7 Months,55.7,48.3 to 62.8,278
Hib,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,7 Months,58.1,52.5 to 63.6,549
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,77.7 to 97.8,71
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,90.9,78.8 to 100.0,73
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.7,78.1 to 100.0,38
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,91.2,86.8 to 95.6,307
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,96.6,94.3 to 98.8,397
Hib,≥2 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,97.2,92.9 to 98.9,210
Hib,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,96.7,93.3 to 98.4,391
Hib,≥2 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,96.2,89.8 to 98.6,181
Hib,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,95.0,91.3 to 97.2,419
Hib,≥2 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,93.5,88.3 to 96.4,246
Hib,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,95.3,92.3 to 97.2,456
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,94.6,90.8 to 98.4,185
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,86.3,81.1 to 91.4,300
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,78.4,72.3 to 84.5,263
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Overall,Overall,84.7,81.3 to 88.1,748
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,87.5,82.7 to 92.3,248
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.5,78.5 to 90.5,233
Hib,≥2 Doses,States/Local Areas,Kentucky,2013,Age,7 Months,86.6,81.0 to 90.7,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,7 Months,87.3,84.2 to 89.8,482
Hib,≥2 Doses,States/Local Areas,Kentucky,2014,Age,7 Months,88.0,81.7 to 92.3,246
Hib,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,7 Months,90.4,86.4 to 93.3,456
PCV,≥1 Dose,States/Local Areas,Kentucky,2012,Age,3 Months,81.1,76.4 to 85.1,236
PCV,≥1 Dose,States/Local Areas,Kentucky,2011,Age,3 Months,87.5,83.8 to 90.5,217
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,93.3,89.2 to 97.5,185
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,88.9,83.9 to 93.9,300
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,89.1,84.3 to 93.9,263
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Overall,Overall,89.7,86.8 to 92.7,748
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,87.3,81.6 to 93.0,248
PCV,≥4 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,86.0,79.6 to 91.1,238
PCV,≥4 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,85.0,80.3 to 89.1,516
PCV,≥4 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,84.4,77.2 to 90.3,278
PCV,≥4 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,87.4,82.8 to 91.3,549
PCV,≥4 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,90.9,84.5 to 95.4,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,90.6,84.7 to 94.4,278
PCV,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,88.6,84.2 to 91.9,549
PCV,≥3 Doses,States/Local Areas,Kentucky,2019,Age,19 Months,93.5,87.6 to 96.6,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2011,Age,24 Months,90.0,83.5 to 94.7,217
Hib,≥2 Doses,States/Local Areas,Kentucky,2013,Age,5 Months,72.7,66.6 to 78.0,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,5 Months,71.8,67.7 to 75.7,482
Hib,≥2 Doses,States/Local Areas,Kentucky,2014,Age,5 Months,71.0,62.4 to 78.4,246
Hib,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,5 Months,74.6,69.1 to 79.4,456
Hib,≥2 Doses,States/Local Areas,Kentucky,2015,Age,5 Months,78.2,70.1 to 84.5,210
Hib,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,5 Months,79.8,73.9 to 84.7,391
Hib,≥2 Doses,States/Local Areas,Kentucky,2016,Age,5 Months,81.4,72.0 to 88.2,181
Hib,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,5 Months,79.7,74.0 to 84.4,419
PCV,≥3 Doses,States/Local Areas,Kentucky,2015,Age,24 Months,94.0,88.1 to 97.6,210
PCV,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,24 Months,93.7,89.2 to 96.8,391
PCV,≥3 Doses,States/Local Areas,Kentucky,2014,Age,24 Months,92.1,86.8 to 95.8,246
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,24 Months,93.0,89.3 to 95.8,456
PCV,≥3 Doses,States/Local Areas,Kentucky,2012,Age,24 Months,90.9,85.3 to 95.0,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2017,Age,5 Months,77.9,70.7 to 83.7,238
Hib,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,5 Months,75.5,70.5 to 79.9,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2013,Age,24 Months,93.0,88.3 to 96.2,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,24 Months,92.6,89.0 to 95.3,482
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,90.5,86.8 to 94.2,397
PCV,≥1 Dose,States/Local Areas,Kentucky,2013,Age,3 Months,88.1,81.3 to 92.7,236
PCV,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,3 Months,86.8,81.2 to 90.9,482
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,79.9,66.4 to 93.4,73
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.1,56.5 to 93.7,38
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,80.5,74.9 to 86.2,307
Hib,≥2 Doses,States/Local Areas,Kentucky,2012,Age,5 Months,76.3,68.4 to 82.6,236
Hib,≥2 Doses,States/Local Areas,Kentucky,2011,Age,5 Months,75.1,64.0 to 83.6,217
Hib,≥1 Dose,States/Local Areas,Kentucky,2018,Age,3 Months,86.0,79.7 to 90.5,278
Hib,≥1 Dose,States/Local Areas,Kentucky,2018-2019,Age,3 Months,87.7,83.3 to 91.0,549
Hib,≥1 Dose,States/Local Areas,Kentucky,2019,Age,3 Months,89.4,82.7 to 93.7,271
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,74.5 to 96.1,71
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,87.0,74.9 to 99.0,73
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.2,83.5 to 100.0,38
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,89.5,85.1 to 94.0,307
PCV,≥4 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,88.5,81.0 to 94.1,181
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,87.4,82.6 to 91.4,419
PCV,≥4 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,86.0,78.9 to 91.6,210
PCV,≥4 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,87.3,82.2 to 91.4,391
PCV,≥4 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,85.9,79.4 to 91.3,246
PCV,≥4 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,85.9,81.2 to 89.9,456
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,91.5,87.4 to 95.5,267
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,88.0 to 94.2,566
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,93.0,89.8 to 96.2,397
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.4,76.1 to 96.7,71
≥1 Dose MMR,,States/Local Areas,Kentucky,2019,Age,35 Months,96.0,91.6 to 98.5,271
PCV,≥4 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,85.0,79.2 to 90.0,236
PCV,≥4 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,85.5,81.1 to 89.3,482
≥1 Dose MMR,,States/Local Areas,Kentucky,2018,Age,35 Months,95.3,91.0 to 98.0,278
≥1 Dose MMR,,States/Local Areas,Kentucky,2018-2019,Age,35 Months,95.6,92.6 to 97.6,549
≥1 Dose MMR,,States/Local Areas,Kentucky,2017,Age,35 Months,94.7,88.5 to 98.2,238
≥1 Dose MMR,,States/Local Areas,Kentucky,2017-2018,Age,35 Months,94.9,91.0 to 97.4,516
Hib,≥1 Dose,States/Local Areas,Kentucky,2015,Age,3 Months,87.0,80.1 to 91.8,210
Hib,≥1 Dose,States/Local Areas,Kentucky,2015-2016,Age,3 Months,87.9,82.9 to 91.6,391
Hib,≥1 Dose,States/Local Areas,Kentucky,2016,Age,3 Months,88.8,80.7 to 93.8,181
Hib,≥1 Dose,States/Local Areas,Kentucky,2016-2017,Age,3 Months,88.5,83.6 to 92.0,419
Hib,≥1 Dose,States/Local Areas,Kentucky,2017,Age,3 Months,88.1,81.8 to 92.4,238
Hib,≥1 Dose,States/Local Areas,Kentucky,2017-2018,Age,3 Months,87.1,82.8 to 90.4,516
Hep B,≥2 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,96.1,91.2 to 98.3,238
Hep B,≥2 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,95.2,92.1 to 97.1,516
Hep B,≥2 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,94.3,89.6 to 97.0,278
Hep B,≥2 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,95.0,91.6 to 97.0,549
Hep B,≥2 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,95.6,89.5 to 98.3,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,93.1,90.8 to 94.9,210
PCV,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,92.5,87.5 to 95.6,391
PCV,≥3 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,91.9,83.2 to 96.3,181
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,92.2,87.5 to 95.3,419
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,92.8,87.8 to 97.7,185
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.8,85.7 to 95.8,233
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,90.8,86.5 to 95.2,267
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.3,87.1 to 93.5,566
PCV,≥3 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,92.6,86.8 to 96.0,238
PCV,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,91.6,87.8 to 94.4,516
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019,Age,35 Months,95.7,89.6 to 98.7,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,88.7,83.8 to 93.6,300
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,90.6,86.1 to 95.1,263
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Overall,Overall,90.1,87.3 to 93.0,748
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,87.3,81.6 to 93.0,248
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.5,86.5 to 96.4,233
Hep B,≥2 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,96.4,89.3 to 98.9,181
Hep B,≥2 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,96.3,92.6 to 98.1,419
Hep B,≥2 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,97.2,91.8 to 99.1,210
Hep B,≥2 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,96.8,93.0 to 98.6,391
Hib,≥1 Dose,States/Local Areas,Kentucky,2014,Age,3 Months,83.7,75.9 to 89.3,246
Hib,≥1 Dose,States/Local Areas,Kentucky,2014-2015,Age,3 Months,85.3,80.4 to 89.2,456
Hep B,≥2 Doses,States/Local Areas,Kentucky,2014,Age,13 Months,93.6,88.5 to 96.5,246
Hep B,≥2 Doses,States/Local Areas,Kentucky,2014-2015,Age,13 Months,95.4,92.2 to 97.3,456
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,84.9,72.4 to 97.4,73
Hib,≥1 Dose,States/Local Areas,Kentucky,2013,Age,3 Months,87.4,78.8 to 92.8,236
Hib,≥1 Dose,States/Local Areas,Kentucky,2013-2014,Age,3 Months,85.5,77.7 to 90.9,482
Hib,≥1 Dose,States/Local Areas,Kentucky,2012,Age,3 Months,82.9,75.9 to 88.2,236
Hib,≥1 Dose,States/Local Areas,Kentucky,2011,Age,3 Months,88.3,85.3 to 90.8,217
PCV,≥3 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,91.1,84.5 to 95.0,271
PCV,≥3 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,89.8,84.3 to 93.5,217
PCV,≥3 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,91.9,85.7 to 95.5,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,90.1,86.5 to 92.9,482
PCV,≥3 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,88.4,81.5 to 92.9,246
PCV,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,90.8,86.3 to 93.8,456
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016,Age,35 Months,96.8,91.5 to 99.2,181
Hep B,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,35 Months,95.9,91.8 to 98.3,419
PCV,≥4 Doses,States/Local Areas,Kentucky,2019,Age,24 Months,88.4,82.4 to 93.1,271
PCV,≥4 Doses,States/Local Areas,Kentucky,2018,Age,24 Months,79.1,72.1 to 85.3,278
PCV,≥4 Doses,States/Local Areas,Kentucky,2018-2019,Age,24 Months,83.7,79.1 to 87.8,549
PCV,≥4 Doses,States/Local Areas,Kentucky,2011,Age,35 Months,86.3,78.3 to 92.5,217
PCV,≥4 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,90.2,80.8 to 96.2,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018,Age,35 Months,92.4,87.5 to 95.9,278
Hep B,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,35 Months,94.1,90.3 to 96.7,549
Hib,Full Series,States/Local Areas,Kentucky,2020,Age,24 Months,70.3,62.8 to 77.6,324
PCV,≥3 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,90.4,85.1 to 93.9,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017,Age,35 Months,94.4,87.7 to 98.1,238
Hep B,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,35 Months,94.2,89.4 to 97.3,516
≥1 Dose Varicella,,States/Local Areas,Kentucky,2019,Age,35 Months,97.1,92.6 to 99.2,271
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,91.6,87.7 to 95.5,307
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,91.4,87.7 to 95.1,397
≥1 Dose Varicella,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.9,82.0 to 100.0,38
≥1 Dose MMR,,States/Local Areas,Kentucky,2016,Age,35 Months,92.4,85.8 to 96.6,181
≥1 Dose MMR,,States/Local Areas,Kentucky,2016-2017,Age,35 Months,93.6,88.8 to 96.8,419
≥1 Dose MMR,,States/Local Areas,Kentucky,2014,Age,35 Months,90.8,84.6 to 95.2,246
≥1 Dose MMR,,States/Local Areas,Kentucky,2014-2015,Age,35 Months,92.9,88.6 to 96.0,456
≥1 Dose MMR,,States/Local Areas,Kentucky,2015,Age,35 Months,94.5,88.3 to 98.0,210
≥1 Dose MMR,,States/Local Areas,Kentucky,2015-2016,Age,35 Months,93.6,89.1 to 96.7,391
PCV,≥4 Doses,States/Local Areas,Kentucky,2017,Age,24 Months,84.0,77.8 to 89.3,238
PCV,≥4 Doses,States/Local Areas,Kentucky,2017-2018,Age,24 Months,81.5,76.8 to 85.7,516
PCV,≥4 Doses,States/Local Areas,Kentucky,2016,Age,24 Months,87.4,79.7 to 93.2,181
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2017,Age,24 Months,85.7,80.8 to 89.8,419
Hep B,≥2 Doses,States/Local Areas,Kentucky,2019,Age,7 Months,94.5,88.4 to 97.5,271
Hep B,≥2 Doses,States/Local Areas,Kentucky,2011,Age,13 Months,93.2,87.8 to 96.3,217
Hep B,≥2 Doses,States/Local Areas,Kentucky,2013,Age,13 Months,94.7,92.7 to 96.2,236
Hep B,≥2 Doses,States/Local Areas,Kentucky,2013-2014,Age,13 Months,94.2,93.2 to 95.0,482
Hep B,≥2 Doses,States/Local Areas,Kentucky,2012,Age,13 Months,95.1,90.1 to 97.7,236
PCV,≥3 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,90.7,84.8 to 94.4,238
PCV,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,88.4,84.2 to 91.7,516
PCV,≥3 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,86.2,79.5 to 90.9,278
PCV,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,88.6,84.2 to 91.9,549
Hep B,≥3 Doses,States/Local Areas,Kentucky,2012,Age,35 Months,91.7,86.2 to 95.6,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015,Age,35 Months,92.8,86.8 to 96.7,210
Hep B,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,35 Months,94.9,91.2 to 97.4,391
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014,Age,35 Months,92.9,87.6 to 96.5,246
Hep B,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,35 Months,92.9,89.1 to 95.7,456
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013,Age,35 Months,96.4,89.9 to 99.2,236
Hep B,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,35 Months,94.4,90.7 to 97.0,482
DTaP,≥3 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,91.7,85.0 to 95.5,271
DTaP,≥3 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,91.1,82.8 to 95.6,217
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,91.4,86.5 to 94.7,236
DTaP,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,90.2,87.1 to 92.6,482
DTaP,≥3 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,91.7,85.4 to 95.5,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2015,Age,13 Months,75.5,67.6 to 82.1,210
Hib,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,13 Months,75.6,69.3 to 81.0,391
Hib,≥3 Doses,States/Local Areas,Kentucky,2016,Age,13 Months,75.7,65.4 to 83.6,181
Hib,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,13 Months,78.6,72.6 to 83.6,419
Hib,≥3 Doses,States/Local Areas,Kentucky,2017,Age,13 Months,81.6,74.8 to 86.9,238
Hib,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,13 Months,77.0,72.2 to 81.1,516
Polio,≥3 Doses,States/Local Areas,Kentucky,2013,Age,19 Months,90.3,85.5 to 93.7,236
Polio,≥3 Doses,States/Local Areas,Kentucky,2013-2014,Age,19 Months,89.3,86.4 to 91.7,482
Polio,≥3 Doses,States/Local Areas,Kentucky,2014,Age,19 Months,88.3,81.5 to 92.9,246
Polio,≥3 Doses,States/Local Areas,Kentucky,2014-2015,Age,19 Months,91.7,87.6 to 94.5,456
Polio,≥3 Doses,States/Local Areas,Kentucky,2015,Age,19 Months,95.0,91.8 to 97.0,210
Polio,≥3 Doses,States/Local Areas,Kentucky,2015-2016,Age,19 Months,95.6,92.0 to 97.7,391
Polio,≥3 Doses,States/Local Areas,Kentucky,2018,Age,19 Months,92.1,86.4 to 95.5,278
Polio,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,19 Months,60.9,55.2 to 66.3,549
Hib,≥3 Doses,States/Local Areas,Kentucky,2018,Age,13 Months,72.3,65.2 to 78.4,278
Hib,≥3 Doses,States/Local Areas,Kentucky,2018-2019,Age,13 Months,71.9,66.5 to 76.8,549
Polio,≥3 Doses,States/Local Areas,Kentucky,2016,Age,19 Months,96.3,89.9 to 98.7,181
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2017,Age,19 Months,95.1,91.4 to 97.3,419
Polio,≥3 Doses,States/Local Areas,Kentucky,2017,Age,19 Months,93.9,88.3 to 96.9,238
Polio,≥3 Doses,States/Local Areas,Kentucky,2017-2018,Age,19 Months,93.0,89.3 to 95.5,516
Hib,≥3 Doses,States/Local Areas,Kentucky,2019,Age,13 Months,71.6,63.1 to 78.8,271
Hib,≥3 Doses,States/Local Areas,Kentucky,2012,Age,19 Months,88.1,78.6 to 93.7,236
Hib,≥3 Doses,States/Local Areas,Kentucky,2011,Age,19 Months,89.6,83.3 to 93.7,217
Hib,Primary Series,States/Local Areas,Kansas,2020-2021,Age,24 Months,92.6,89.4 to 95.1,634
Hep A,≥1 Dose,States/Local Areas,Kansas,2012,Age,19 Months,84.3,80.3 to 87.6,224
Hep A,≥1 Dose,States/Local Areas,Kansas,2015,Age,19 Months,83.9,77.9 to 88.6,180
Hep A,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,19 Months,84.9,80.2 to 88.6,481
Hep A,≥1 Dose,States/Local Areas,Kansas,2014,Age,19 Months,85.2,78.3 to 90.2,208
Hep A,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,19 Months,84.6,79.6 to 88.5,388
DTaP,≥1 Dose,States/Local Areas,Kansas,2018,Age,3 Months,88.7,83.3 to 92.5,395
DTaP,≥1 Dose,States/Local Areas,Kansas,2018-2019,Age,3 Months,89.4,85.8 to 92.1,753
DTaP,≥3 Doses,States/Local Areas,Kansas,2015,Age,24 Months,92.1,86.5 to 96.0,180
DTaP,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,91.5,87.9 to 94.4,481
DTaP,≥3 Doses,States/Local Areas,Kansas,2014,Age,24 Months,93.4,88.6 to 96.6,208
DTaP,≥3 Doses,States/Local Areas,Kansas,2014-2015,Age,24 Months,92.7,89.2 to 95.5,388
DTaP,≥1 Dose,States/Local Areas,Kansas,2017,Age,3 Months,90.4,85.6 to 93.7,354
DTaP,≥1 Dose,States/Local Areas,Kansas,2017-2018,Age,3 Months,89.5,86.1 to 92.2,749
Hep A,≥1 Dose,States/Local Areas,Kansas,2011,Age,19 Months,80.5,77.3 to 83.4,221
DTaP,≥1 Dose,States/Local Areas,Kansas,2019,Age,3 Months,90.1,84.8 to 93.6,358
DTaP,≥3 Doses,States/Local Areas,Kansas,2016,Age,24 Months,90.9,85.8 to 94.7,301
DTaP,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,92.2,88.9 to 94.8,655
DTaP,≥3 Doses,States/Local Areas,Kansas,2018,Age,24 Months,92.8,88.3 to 96.0,395
DTaP,≥3 Doses,States/Local Areas,Kansas,2018-2019,Age,24 Months,92.7,89.6 to 95.2,753
DTaP,≥3 Doses,States/Local Areas,Kansas,2017,Age,24 Months,93.6,89.2 to 96.6,354
DTaP,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,93.2,90.2 to 95.5,749
DTaP,≥2 Doses,States/Local Areas,Kansas,2018,Age,5 Months,84.2,78.5 to 88.7,395
DTaP,≥2 Doses,States/Local Areas,Kansas,2018-2019,Age,5 Months,84.7,80.6 to 88.0,753
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,89.7,85.2 to 94.1,315
DTaP,≥2 Doses,States/Local Areas,Kansas,2019,Age,5 Months,85.1,79.0 to 89.6,358
DTaP,≥2 Doses,States/Local Areas,Kansas,2017,Age,5 Months,81.2,75.1 to 86.1,354
DTaP,≥2 Doses,States/Local Areas,Kansas,2017-2018,Age,5 Months,82.7,78.6 to 86.2,749
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Overall,Overall,91.7,89.3 to 94.0,905
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,84.5,78.8 to 90.2,256
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,93.3,90.4 to 96.1,413
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,98.1,96.0 to 100.0,236
Hep A,≥1 Dose,States/Local Areas,Kansas,2013,Age,19 Months,85.8,79.5 to 90.3,231
Hep A,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,19 Months,85.5,82.3 to 88.2,439
DTaP,≥1 Dose,States/Local Areas,Kansas,2016,Age,3 Months,83.2,76.3 to 88.4,301
DTaP,≥1 Dose,States/Local Areas,Kansas,2016-2017,Age,3 Months,86.7,82.6 to 90.0,655
DTaP,≥1 Dose,States/Local Areas,Kansas,2015,Age,3 Months,87.8,80.2 to 92.8,180
DTaP,≥1 Dose,States/Local Areas,Kansas,2015-2016,Age,3 Months,85.6,80.7 to 89.4,481
DTaP,≥1 Dose,States/Local Areas,Kansas,2014,Age,3 Months,88.4,81.8 to 92.8,208
DTaP,≥1 Dose,States/Local Areas,Kansas,2014-2015,Age,3 Months,88.1,83.3 to 91.6,388
DTaP,≥1 Dose,States/Local Areas,Kansas,2013,Age,3 Months,86.1,78.1 to 91.5,231
DTaP,≥1 Dose,States/Local Areas,Kansas,2013-2014,Age,3 Months,87.2,84.8 to 89.3,439
DTaP,≥1 Dose,States/Local Areas,Kansas,2011,Age,3 Months,91.1,85.9 to 94.5,221
DTaP,≥1 Dose,States/Local Areas,Kansas,2012,Age,3 Months,93.6,91.0 to 95.5,224
Hib,≥1 Dose,States/Local Areas,Kansas,2021,Age,3 Months,83.3,76.8 to 88.3,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.5,73.3 to 81.6,827
Hib,≥2 Doses,States/Local Areas,Kansas,2021,Age,5 Months,72.2,63.1 to 79.7,266
Hep A,≥2 Doses,States/Local Areas,Kansas,2021,Age,35 Months,89.6,74.5 to 97.7,266
Hep B,≥3 Doses,States/Local Areas,Kansas,2021,Age,19 Months,90.2,84.6 to 93.9,266
PCV,≥4 Doses,States/Local Areas,Kansas,2020-2021,Age,24 Months,81.5,76.9 to 85.6,634
Hib,Full Series,States/Local Areas,Kansas,2021,Age,19 Months,69.9,61.2 to 77.3,266
DTaP,≥4 Doses,States/Local Areas,Kansas,2020-2021,Age,35 Months,85.7,79.7 to 90.7,634
Hep B,≥3 Doses,States/Local Areas,Kansas,2020-2021,Age,13 Months,87.0,82.9 to 90.3,634
Hib,Primary Series,States/Local Areas,Kansas,2021,Age,19 Months,90.7,84.7 to 94.5,266
Hib,≥3 Doses,States/Local Areas,Kansas,2017,Age,24 Months,89.2,84.0 to 93.3,354
Hib,≥3 Doses,States/Local Areas,Kansas,2017-2018,Age,24 Months,90.2,86.8 to 93.0,749
DTaP,≥3 Doses,States/Local Areas,Kansas,2019,Age,24 Months,92.7,88.0 to 96.0,358
Hib,≥3 Doses,States/Local Areas,Kansas,2016,Age,24 Months,87.4,81.9 to 91.9,301
Hib,≥3 Doses,States/Local Areas,Kansas,2016-2017,Age,24 Months,88.3,84.6 to 91.5,655
Hib,≥3 Doses,States/Local Areas,Kansas,2015,Age,24 Months,86.9,79.3 to 92.7,180
Hib,≥3 Doses,States/Local Areas,Kansas,2015-2016,Age,24 Months,87.2,82.6 to 91.1,481
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,93.3,90.7 to 95.9,504
Hib,≥3 Doses,States/Local Areas,Colorado,2012,Age,19 Months,90.8,85.5 to 94.2,297
Hib,≥3 Doses,States/Local Areas,Colorado,2011,Age,19 Months,88.2,83.5 to 91.8,277
Hib,≥3 Doses,States/Local Areas,Colorado,2019,Age,13 Months,81.1,74.0 to 86.5,265
Influenza,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,75.6,70.4 to 80.8,564
Influenza,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,56.2,48.6 to 63.7,268
Hib,Full Series,States/Local Areas,Colorado,2020-2021,Age,24 Months,74.8,69.1 to 80.2,482
Influenza,,States/Local Areas,Colorado,2021,Age,24 Months,67.0,57.3 to 76.5,171
Hep B,≥1 Dose,States/Local Areas,Colorado,2021,Age,3 Months,94.4,87.8 to 97.5,171
Influenza,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,63.1,45.1 to 81.1,39
Influenza,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,64.6,56.9 to 72.3,303
Influenza,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,61.5,48.5 to 74.5,87
Influenza,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,67.8,62.1 to 73.6,504
Influenza,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.1,63.7 to 74.4,570
Influenza,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.9,56.9 to 82.9,96
Influenza,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,61.4,52.9 to 69.9,203
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,74.5,65.0 to 84.0,200
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,90.3,86.7 to 94.0,624
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,83.6,71.2 to 96.0,39
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,82.7,77.1 to 88.4,244
Influenza,,States/Local Areas,Colorado,2019,Age,24 Months,77.8,70.9 to 84.0,265
Influenza,,States/Local Areas,Colorado,2018,Age,24 Months,67.8,59.6 to 75.7,296
Influenza,,States/Local Areas,Colorado,2018-2019,Age,24 Months,72.9,67.4 to 78.1,561
Influenza,,States/Local Areas,Colorado,2017,Age,24 Months,71.1,62.6 to 79.2,231
Influenza,,States/Local Areas,Colorado,2017-2018,Age,24 Months,69.4,63.5 to 75.2,527
Polio,≥2 Doses,States/Local Areas,Colorado,2021,Age,13 Months,86.2,76.8 to 92.2,171
Hib,≥3 Doses,States/Local Areas,Colorado,2013,Age,19 Months,89.5,86.4 to 92.0,250
Hib,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,90.4,88.4 to 92.1,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2013,Age,19 Months,92.1,87.1 to 95.2,250
DTaP,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,93.9,92.4 to 95.1,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2012,Age,19 Months,93.4,90.5 to 95.4,297
DTaP,≥3 Doses,States/Local Areas,Colorado,2011,Age,19 Months,89.8,87.7 to 91.6,277
DTaP,≥3 Doses,States/Local Areas,Colorado,2019,Age,13 Months,93.6,89.3 to 96.2,265
Polio,≥3 Doses,States/Local Areas,Colorado,2018,Age,19 Months,95.9,91.0 to 98.2,296
Polio,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,71.4,65.7 to 76.6,561
Hib,≥3 Doses,States/Local Areas,Colorado,2018,Age,13 Months,75.6,67.3 to 82.3,296
Hib,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,78.3,73.0 to 82.8,561
Polio,≥3 Doses,States/Local Areas,Colorado,2017,Age,19 Months,94.4,88.1 to 97.5,231
Polio,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,95.1,91.5 to 97.3,527
Polio,≥3 Doses,States/Local Areas,Colorado,2016,Age,19 Months,92.3,87.0 to 95.5,247
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,93.3,89.6 to 95.7,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2016,Age,13 Months,92.3,86.2 to 95.9,247
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,93.1,89.1 to 95.7,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2018,Age,13 Months,93.2,88.0 to 96.3,296
DTaP,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,93.4,90.3 to 95.6,561
Polio,≥3 Doses,States/Local Areas,Colorado,2013,Age,19 Months,89.7,87.5 to 91.5,250
Polio,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,91.0,89.5 to 92.3,482
Polio,≥3 Doses,States/Local Areas,Colorado,2015,Age,19 Months,90.6,88.4 to 92.4,272
Polio,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,91.4,87.9 to 94.0,519
Polio,≥3 Doses,States/Local Areas,Colorado,2014,Age,19 Months,92.3,86.1 to 95.9,232
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,91.5,87.5 to 94.2,504
DTaP,≥3 Doses,States/Local Areas,Colorado,2015,Age,13 Months,90.6,85.3 to 94.2,272
DTaP,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,91.5,87.7 to 94.2,519
DTaP,≥3 Doses,States/Local Areas,Colorado,2012,Age,13 Months,91.0,88.1 to 93.3,297
Polio,≥3 Doses,States/Local Areas,Colorado,2012,Age,19 Months,91.3,88.2 to 93.7,297
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,74.1,67.8 to 80.5,367
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,74.8,68.9 to 80.6,345
Hib,≥3 Doses,States/Local Areas,Colorado,2017,Age,13 Months,87.5,80.9 to 92.0,231
Hib,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,81.6,76.4 to 85.9,527
Hib,≥3 Doses,States/Local Areas,Colorado,2016,Age,13 Months,77.1,68.6 to 83.9,247
Hib,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,82.3,76.9 to 86.6,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2017,Age,13 Months,93.8,87.6 to 97.0,231
DTaP,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,93.5,89.8 to 95.9,527
Hib,≥3 Doses,States/Local Areas,Colorado,2015,Age,13 Months,81.1,74.4 to 86.4,272
Hib,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,79.1,73.8 to 83.6,519
Hib,≥3 Doses,States/Local Areas,Colorado,2012,Age,13 Months,84.8,82.0 to 87.3,297
Hib,≥3 Doses,States/Local Areas,Colorado,2014,Age,13 Months,81.6,74.3 to 87.2,232
Hib,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,81.4,76.5 to 85.4,504
Hib,≥3 Doses,States/Local Areas,Colorado,2013,Age,13 Months,81.9,74.8 to 87.4,250
Hib,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,81.8,75.6 to 86.7,482
Polio,≥3 Doses,States/Local Areas,Colorado,2011,Age,19 Months,85.5,82.1 to 88.4,277
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,96.1,93.1 to 99.2,367
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,91.7,87.6 to 95.9,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.1,64.6 to 75.5,570
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,63.9 to 86.8,96
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Overall,Overall,74.3,70.4 to 78.1,894
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,64.4,51.2 to 77.6,87
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.2,68.3 to 82.1,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,75.3,70.4 to 80.2,504
DTaP,≥3 Doses,States/Local Areas,Colorado,2014,Age,13 Months,91.9,85.7 to 95.5,232
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,91.2,87.3 to 94.0,504
DTaP,≥3 Doses,States/Local Areas,Colorado,2013,Age,13 Months,88.8,82.0 to 93.2,250
DTaP,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,90.3,87.1 to 92.8,482
Hib,≥3 Doses,States/Local Areas,Colorado,2011,Age,13 Months,85.8,80.3 to 89.9,277
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.2,85.2 to 95.3,303
Hib,≥3 Doses,States/Local Areas,Colorado,2019,Age,7 Months,64.8,56.5 to 72.4,265
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,93.9,91.3 to 96.5,504
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,89.0 to 95.4,570
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.7,60.7 to 92.8,96
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,93.8,90.3 to 97.4,203
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.9,85.2 to 94.5,303
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,87.5,78.4 to 96.6,87
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.0,87.9 to 94.1,570
Hib,≥2 Doses,States/Local Areas,Colorado,2012,Age,13 Months,94.6,91.3 to 96.8,297
Hib,≥2 Doses,States/Local Areas,Colorado,2011,Age,13 Months,93.1,88.4 to 95.9,277
DTaP,≥3 Doses,States/Local Areas,Colorado,2011,Age,13 Months,88.9,85.8 to 91.3,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,81.3,75.2 to 87.4,203
DTaP,≥3 Doses,States/Local Areas,Colorado,2019,Age,7 Months,79.4,72.1 to 85.1,265
DTaP,≥3 Doses,States/Local Areas,Colorado,2018,Age,7 Months,81.0,73.3 to 86.9,296
DTaP,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,80.2,75.0 to 84.5,561
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,77.3,71.2 to 83.3,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,72.6,67.3 to 77.9,564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,72.5,56.8 to 88.2,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2019,Age,0-3 Days,80.7,72.9 to 86.6,265
Polio,≥1 Dose,States/Local Areas,Colorado,2019,Age,3 Months,91.7,86.1 to 95.2,265
Hib,≥2 Doses,States/Local Areas,Colorado,2014,Age,13 Months,95.3,89.0 to 98.0,232
Hib,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,93.7,90.3 to 96.0,504
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,94.7,88.4 to 100.0,39
PCV,≥3 Doses,States/Local Areas,Colorado,2019,Age,35 Months,95.3,91.6 to 97.7,265
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,88.5,84.1 to 93.0,268
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,97.0,94.8 to 99.1,564
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,84.8 to 100.0,96
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,92.9,89.0 to 96.8,203
Hib,≥2 Doses,States/Local Areas,Colorado,2017,Age,13 Months,94.9,88.6 to 97.8,231
Hib,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,95.5,91.9 to 97.5,527
Hib,≥3 Doses,States/Local Areas,Colorado,2018,Age,7 Months,61.3,52.7 to 69.1,296
Hib,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,63.0,57.1 to 68.6,561
Hib,≥3 Doses,States/Local Areas,Colorado,2017,Age,7 Months,67.2,58.0 to 75.2,231
Hib,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,64.2,58.1 to 70.0,527
Hib,≥2 Doses,States/Local Areas,Colorado,2016,Age,13 Months,95.1,90.3 to 97.5,247
Hib,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,95.0,91.5 to 97.1,478
Hib,≥2 Doses,States/Local Areas,Colorado,2015,Age,13 Months,92.2,87.4 to 95.3,272
Hib,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,93.6,90.5 to 95.8,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,73.8,65.8 to 81.7,182
Hib,≥2 Doses,States/Local Areas,Colorado,2019,Age,13 Months,95.6,92.2 to 97.6,265
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,89.9,85.5 to 94.4,182
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,92.5,90.1 to 94.8,894
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,91.2,85.1 to 97.3,87
Hib,≥2 Doses,States/Local Areas,Colorado,2018,Age,13 Months,96.0,90.9 to 98.3,296
Hib,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,95.8,93.1 to 97.5,561
Hib,≥2 Doses,States/Local Areas,Colorado,2012,Age,5 Months,76.3,66.5 to 84.0,297
Hib,≥2 Doses,States/Local Areas,Colorado,2011,Age,5 Months,80.7,74.8 to 85.5,277
Hib,≥2 Doses,States/Local Areas,Colorado,2014,Age,5 Months,80.5,72.8 to 86.4,232
Hib,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,5 Months,80.3,78.1 to 82.4,504
Hib,≥2 Doses,States/Local Areas,Colorado,2013,Age,5 Months,79.2,73.8 to 83.8,250
Hib,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,5 Months,79.9,77.7 to 81.9,482
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,84.6,80.1 to 89.1,504
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.2,80.9 to 89.5,570
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.7,69.0 to 92.3,96
PCV,≥1 Dose,States/Local Areas,Colorado,2015,Age,3 Months,85.8,79.7 to 90.3,272
PCV,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,3 Months,87.4,83.0 to 90.7,519
PCV,≥1 Dose,States/Local Areas,Colorado,2014,Age,3 Months,88.2,81.5 to 92.7,232
PCV,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,3 Months,87.0,82.7 to 90.3,504
PCV,≥3 Doses,States/Local Areas,Colorado,2018,Age,24 Months,96.4,92.0 to 98.7,296
PCV,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,95.4,92.7 to 97.3,561
PCV,≥3 Doses,States/Local Areas,Colorado,2017,Age,24 Months,94.4,89.1 to 97.7,231
PCV,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,95.4,92.1 to 97.6,527
PCV,≥3 Doses,States/Local Areas,Colorado,2016,Age,24 Months,93.9,89.6 to 96.9,247
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,94.2,90.9 to 96.5,478
Hib,≥2 Doses,States/Local Areas,Colorado,2012,Age,7 Months,88.6,84.9 to 91.5,297
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2011,Age,0-3 Days,62.4,54.4 to 69.8,277
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,89.6,85.4 to 93.8,268
PCV,≥1 Dose,States/Local Areas,Colorado,2018,Age,3 Months,92.1,86.3 to 95.5,296
PCV,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,3 Months,91.8,88.1 to 94.5,561
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2012,Age,0-3 Days,71.5,64.4 to 77.7,297
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2013,Age,0-3 Days,73.3,66.0 to 79.6,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2013-2014,Age,0-3 Days,72.4,67.1 to 77.2,482
PCV,≥1 Dose,States/Local Areas,Colorado,2017,Age,3 Months,90.6,83.2 to 94.9,231
PCV,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,3 Months,91.3,87.0 to 94.3,527
PCV,≥1 Dose,States/Local Areas,Colorado,2016,Age,3 Months,89.0,82.1 to 93.4,247
PCV,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,3 Months,89.8,85.1 to 93.1,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,94.6,92.1 to 97.1,564
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,90.4,81.6 to 99.1,39
PCV,≥3 Doses,States/Local Areas,Colorado,2015,Age,24 Months,91.7,87.1 to 95.1,272
PCV,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,92.8,89.8 to 95.2,519
PCV,≥3 Doses,States/Local Areas,Colorado,2014,Age,24 Months,92.9,87.0 to 96.7,232
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,92.2,88.7 to 95.0,504
PCV,≥3 Doses,States/Local Areas,Colorado,2013,Age,24 Months,93.4,89.0 to 96.5,250
PCV,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,93.0,89.5 to 95.7,482
Hib,≥2 Doses,States/Local Areas,Colorado,2017,Age,5 Months,88.5,81.6 to 93.0,231
Hib,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,5 Months,89.3,85.1 to 92.4,527
Hep B,≥3 Doses,States/Local Areas,Colorado,2020,Age,24 Months,90.4,85.6 to 94.2,311
Hib,≥1 Dose,States/Local Areas,Colorado,2019,Age,3 Months,89.6,83.6 to 93.7,265
Hib,≥1 Dose,States/Local Areas,Colorado,2018,Age,3 Months,91.7,85.9 to 95.2,296
Hib,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,3 Months,90.7,86.8 to 93.5,561
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,91.6,88.4 to 94.9,564
PCV,≥1 Dose,States/Local Areas,Colorado,2013,Age,3 Months,84.0,81.3 to 86.5,250
PCV,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,3 Months,86.1,83.4 to 88.5,482
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,86.2,80.5 to 91.9,203
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,77.2,70.9 to 83.6,268
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,91.1,81.1 to 100.0,39
PCV,≥4 Doses,States/Local Areas,Colorado,2017,Age,35 Months,88.7,80.9 to 94.4,231
PCV,≥4 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,88.7,83.2 to 93.0,527
PCV,≥4 Doses,States/Local Areas,Colorado,2019,Age,35 Months,89.2,83.2 to 93.7,265
Hib,Full Series,States/Local Areas,Colorado,2020,Age,24 Months,78.7,72.5 to 84.4,311
PCV,≥4 Doses,States/Local Areas,Colorado,2018,Age,35 Months,88.0,81.0 to 93.4,296
PCV,≥4 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,88.6,84.0 to 92.3,561
Hib,≥2 Doses,States/Local Areas,Colorado,2016,Age,5 Months,79.4,71.2 to 85.8,247
Hib,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,5 Months,83.9,78.7 to 88.0,478
Hib,≥2 Doses,States/Local Areas,Colorado,2015,Age,5 Months,80.2,73.0 to 85.8,272
Hib,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,5 Months,79.8,74.5 to 84.2,519
PCV,≥1 Dose,States/Local Areas,Colorado,2012,Age,3 Months,89.1,84.1 to 92.7,297
PCV,≥1 Dose,States/Local Areas,Colorado,2011,Age,3 Months,80.4,78.8 to 81.9,277
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,96.0,93.5 to 98.5,367
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,90.1,86.1 to 94.1,345
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,86.6,81.1 to 92.2,182
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Overall,Overall,90.9,88.4 to 93.3,894
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,90.9,84.8 to 97.1,87
PCV,≥3 Doses,States/Local Areas,Colorado,2012,Age,24 Months,93.6,88.9 to 96.8,297
PCV,≥3 Doses,States/Local Areas,Colorado,2011,Age,24 Months,92.0,86.6 to 95.8,277
PCV,≥3 Doses,States/Local Areas,Colorado,2019,Age,19 Months,93.9,89.7 to 96.5,265
PCV,≥3 Doses,States/Local Areas,Colorado,2018,Age,19 Months,96.3,91.2 to 98.5,296
PCV,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,93.2,90.0 to 95.4,561
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,93.8,90.3 to 97.3,367
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,85.0,79.9 to 90.0,345
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,75.5,67.7 to 83.2,182
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,84.8,81.5 to 88.1,894
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,83.2,73.3 to 93.1,87
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.7,80.1 to 91.3,303
Hib,≥2 Doses,States/Local Areas,Colorado,2014,Age,7 Months,93.3,87.1 to 96.6,232
Hib,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,90.8,86.7 to 93.8,504
Hib,≥2 Doses,States/Local Areas,Colorado,2013,Age,7 Months,88.3,84.9 to 91.0,250
Hib,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,90.8,88.8 to 92.4,482
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014,Age,0-3 Days,71.5,63.4 to 78.4,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2014-2015,Age,0-3 Days,73.0,67.7 to 77.7,504
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2015,Age,0-3 Days,74.5,67.3 to 80.7,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2015-2016,Age,0-3 Days,74.6,69.2 to 79.4,519
DTaP,≥3 Doses,States/Local Areas,Colorado,2013,Age,7 Months,70.0,60.6 to 78.0,250
DTaP,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,73.7,69.8 to 77.3,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2012,Age,7 Months,71.0,58.9 to 80.7,297
DTaP,≥3 Doses,States/Local Areas,Colorado,2011,Age,7 Months,77.7,75.4 to 79.8,277
Polio,≥1 Dose,States/Local Areas,Colorado,2014,Age,3 Months,89.8,83.6 to 93.9,232
Polio,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,3 Months,88.8,84.9 to 91.8,504
Polio,≥1 Dose,States/Local Areas,Colorado,2013,Age,3 Months,84.5,82.5 to 86.3,250
Polio,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,3 Months,87.2,85.4 to 88.8,482
Polio,≥1 Dose,States/Local Areas,Colorado,2012,Age,3 Months,88.9,84.2 to 92.3,297
Polio,≥1 Dose,States/Local Areas,Colorado,2011,Age,3 Months,83.8,80.9 to 86.3,277
PCV,≥1 Dose,States/Local Areas,Colorado,2019,Age,3 Months,91.6,85.9 to 95.1,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,88.7,83.8 to 93.6,182
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,91.6,89.3 to 94.0,894
Hib,≥2 Doses,States/Local Areas,Colorado,2015,Age,7 Months,88.4,82.3 to 92.6,272
Hib,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,90.6,86.7 to 93.5,519
PCV,≥3 Doses,States/Local Areas,Colorado,2013,Age,35 Months,94.1,89.6 to 97.1,250
PCV,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,93.9,90.4 to 96.5,482
PCV,≥3 Doses,States/Local Areas,Colorado,2011,Age,35 Months,92.0,86.6 to 95.8,277
PCV,≥3 Doses,States/Local Areas,Colorado,2019,Age,24 Months,94.4,90.6 to 97.0,265
Hib,≥2 Doses,States/Local Areas,Colorado,2011,Age,7 Months,88.8,84.4 to 92.1,277
Hib,≥2 Doses,States/Local Areas,Colorado,2019,Age,5 Months,85.9,79.6 to 90.5,265
Hib,≥2 Doses,States/Local Areas,Colorado,2018,Age,5 Months,90.1,84.3 to 93.9,296
Hib,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,5 Months,88.0,84.0 to 91.1,561
PCV,≥3 Doses,States/Local Areas,Colorado,2012,Age,35 Months,93.7,89.0 to 96.9,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.5,81.4 to 97.6,96
Hib,≥2 Doses,States/Local Areas,Colorado,2018,Age,7 Months,93.6,88.7 to 96.5,296
Hib,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,93.4,90.3 to 95.6,561
PCV,≥3 Doses,States/Local Areas,Colorado,2014,Age,35 Months,93.7,87.9 to 97.3,232
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,92.9,89.3 to 95.6,504
PCV,≥3 Doses,States/Local Areas,Colorado,2016,Age,35 Months,93.9,89.6 to 96.9,247
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,94.2,90.9 to 96.5,478
PCV,≥3 Doses,States/Local Areas,Colorado,2015,Age,35 Months,91.9,87.3 to 95.3,272
PCV,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,92.9,89.9 to 95.3,519
Hib,≥2 Doses,States/Local Areas,Colorado,2017,Age,7 Months,93.1,86.6 to 96.6,231
Hib,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,93.4,89.6 to 95.8,527
Hib,≥2 Doses,States/Local Areas,Colorado,2016,Age,7 Months,92.8,86.9 to 96.2,247
Hib,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,93.0,89.0 to 95.6,478
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2017,Age,0-3 Days,70.0,56.3 to 80.9,143
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2017-2018,Age,0-3 Days,80.1,74.9 to 84.5,527
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016,Age,0-3 Days,74.7,66.2 to 81.6,247
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2017,Age,0-3 Days,75.5,69.6 to 80.5,478
Polio,≥1 Dose,States/Local Areas,Colorado,2016,Age,3 Months,90.6,83.7 to 94.7,247
Polio,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,3 Months,91.1,86.5 to 94.2,478
Polio,≥1 Dose,States/Local Areas,Colorado,2015,Age,3 Months,87.8,82.3 to 91.7,272
Polio,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,3 Months,89.2,85.1 to 92.2,519
Hib,≥3 Doses,States/Local Areas,Colorado,2013,Age,7 Months,57.0,45.2 to 68.1,250
Hib,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,61.2,54.7 to 67.2,482
Hib,≥3 Doses,States/Local Areas,Colorado,2012,Age,7 Months,62.8,52.2 to 72.2,297
Hib,≥3 Doses,States/Local Areas,Colorado,2011,Age,7 Months,69.3,65.6 to 72.7,277
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,95.1,92.4 to 97.8,367
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,91.1,87.2 to 95.1,345
DTaP,≥3 Doses,States/Local Areas,Colorado,2014,Age,7 Months,77.4,69.5 to 83.8,232
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,77.3,71.9 to 81.8,504
Hib,≥2 Doses,States/Local Areas,Colorado,2019,Age,7 Months,93.1,88.6 to 96.0,265
DTaP,≥3 Doses,States/Local Areas,Colorado,2017,Age,7 Months,82.6,74.4 to 88.6,231
DTaP,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,81.8,76.4 to 86.2,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2016,Age,7 Months,74.5,65.7 to 81.7,247
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,78.5,72.6 to 83.4,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2015,Age,7 Months,77.1,69.7 to 83.1,272
DTaP,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,75.8,70.2 to 80.6,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2018,Age,0-3 Days,84.0,77.9 to 88.7,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2018-2019,Age,0-3 Days,82.3,77.6 to 86.3,561
Polio,≥1 Dose,States/Local Areas,Colorado,2018,Age,3 Months,92.0,86.3 to 95.5,296
Polio,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,3 Months,91.9,88.2 to 94.5,561
Polio,≥1 Dose,States/Local Areas,Colorado,2017,Age,3 Months,91.6,84.3 to 95.7,231
Polio,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,3 Months,91.8,87.5 to 94.7,527
Hib,≥3 Doses,States/Local Areas,Colorado,2016,Age,7 Months,55.4,46.5 to 64.0,247
Hib,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,61.2,54.8 to 67.2,478
Hib,≥3 Doses,States/Local Areas,Colorado,2015,Age,7 Months,64.7,56.6 to 72.0,272
Hib,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,60.0,54.0 to 65.8,519
Hib,≥3 Doses,States/Local Areas,Colorado,2014,Age,7 Months,65.3,57.0 to 72.8,232
Hib,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,65.0,59.2 to 70.3,504
PCV,≥3 Doses,States/Local Areas,Colorado,2018,Age,35 Months,96.4,92.0 to 98.7,296
PCV,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,95.8,93.1 to 97.7,561
PCV,≥3 Doses,States/Local Areas,Colorado,2017,Age,35 Months,94.4,89.1 to 97.7,231
PCV,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,95.4,92.2 to 97.6,527
Hib,≥2 Doses,States/Local Areas,Colorado,2013,Age,13 Months,92.6,88.3 to 95.4,250
Hib,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,93.9,91.4 to 95.8,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2011,Age,13 Months,79.9,74.3 to 84.6,277
Polio,≥2 Doses,States/Local Areas,Colorado,2016,Age,7 Months,90.9,84.7 to 94.8,247
Polio,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,92.5,88.5 to 95.2,478
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,83.7,78.6 to 88.7,345
Polio,≥2 Doses,States/Local Areas,Colorado,2015,Age,7 Months,89.1,83.2 to 93.1,272
Polio,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,90.0,86.0 to 93.0,519
Polio,≥2 Doses,States/Local Areas,Colorado,2014,Age,7 Months,92.1,85.8 to 95.7,232
Polio,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,90.6,86.5 to 93.6,504
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,79.2,71.8 to 86.5,182
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Overall,Overall,84.6,81.3 to 87.8,894
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.9,76.4 to 89.4,303
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,81.5,72.5 to 90.5,87
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,86.1,82.1 to 90.0,504
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.9,77.1 to 86.7,570
≥1 Dose Varicella,,States/Local Areas,Colorado,2018,Age,13 Months,62.7,54.4 to 70.4,296
≥1 Dose Varicella,,States/Local Areas,Colorado,2018-2019,Age,13 Months,62.8,56.9 to 68.3,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2013,Age,13 Months,47.3,38.6 to 56.2,250
≥1 Dose Varicella,,States/Local Areas,Colorado,2013-2014,Age,13 Months,54.7,50.3 to 59.0,482
≥1 Dose MMR,,States/Local Areas,Colorado,2013,Age,13 Months,48.0,39.4 to 56.7,250
≥1 Dose MMR,,States/Local Areas,Colorado,2013-2014,Age,13 Months,56.8,53.8 to 59.7,482
≥1 Dose MMR,,States/Local Areas,Colorado,2012,Age,13 Months,52.5,49.2 to 55.7,297
≥1 Dose MMR,,States/Local Areas,Colorado,2011,Age,13 Months,51.4,44.7 to 57.9,277
Hib,Full Series,States/Local Areas,Colorado,2017,Age,35 Months,93.0,85.5 to 97.5,231
Hib,Full Series,States/Local Areas,Colorado,2017-2018,Age,35 Months,88.4,82.3 to 93.1,527
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,69.6,54.5 to 84.7,87
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,75.3,68.4 to 82.3,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.9,67.0 to 80.7,570
Hep B,≥1 Dose,States/Local Areas,Colorado,2017,Age,3 Months,96.8,91.6 to 98.8,231
Hep B,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,3 Months,96.1,93.5 to 97.7,527
Hep B,≥1 Dose,States/Local Areas,Colorado,2016,Age,3 Months,92.9,86.0 to 96.6,247
Hep B,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,3 Months,94.8,90.9 to 97.1,478
Hep B,≥1 Dose,States/Local Areas,Colorado,2015,Age,3 Months,94.3,90.3 to 96.7,272
Hep B,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,3 Months,93.6,90.0 to 96.0,519
Polio,≥2 Doses,States/Local Areas,Colorado,2014,Age,13 Months,95.3,89.0 to 98.0,232
Polio,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,93.6,90.1 to 95.9,504
Polio,≥2 Doses,States/Local Areas,Colorado,2013,Age,13 Months,93.2,89.4 to 95.7,250
Polio,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,94.2,91.7 to 96.0,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2017,Age,13 Months,89.1,81.0 to 93.9,231
Hep B,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,89.1,84.4 to 92.5,527
Hep B,≥3 Doses,States/Local Areas,Colorado,2015,Age,13 Months,85.4,79.5 to 89.8,272
Hep B,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,87.3,83.0 to 90.6,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2016,Age,13 Months,89.2,82.3 to 93.6,247
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,89.1,84.2 to 92.6,478
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,73.3,63.8 to 82.8,268
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,80.1,74.1 to 86.2,564
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,69.2,48.8 to 89.6,39
≥1 Dose MMR,,States/Local Areas,Colorado,2011,Age,19 Months,83.7,80.4 to 86.6,277
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,85.9,74.6 to 97.3,39
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,77.1,70.9 to 83.4,268
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,84.7,80.0 to 89.4,564
DTaP,≥4 Doses,States/Local Areas,Colorado,2019,Age,35 Months,89.3,82.8 to 94.2,265
Polio,≥2 Doses,States/Local Areas,Colorado,2017,Age,13 Months,95.0,88.7 to 97.9,231
Polio,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,95.4,91.8 to 97.5,527
Polio,≥2 Doses,States/Local Areas,Colorado,2016,Age,13 Months,94.4,89.5 to 97.1,247
Polio,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,94.7,91.2 to 96.9,478
Polio,≥2 Doses,States/Local Areas,Colorado,2015,Age,13 Months,91.9,87.1 to 95.0,272
Polio,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,93.1,90.0 to 95.4,519
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,84.4,78.6 to 90.1,203
≥1 Dose Varicella,,States/Local Areas,Colorado,2018,Age,19 Months,90.1,83.4 to 94.2,296
≥1 Dose Varicella,,States/Local Areas,Colorado,2018-2019,Age,19 Months,62.8,56.9 to 68.3,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2017,Age,19 Months,87.1,79.7 to 92.0,231
≥1 Dose Varicella,,States/Local Areas,Colorado,2017-2018,Age,19 Months,88.5,83.9 to 92.0,527
≥1 Dose MMR,,States/Local Areas,Colorado,2014,Age,19 Months,90.8,85.5 to 94.3,232
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2015,Age,19 Months,88.5,84.7 to 91.5,504
≥1 Dose MMR,,States/Local Areas,Colorado,2012,Age,19 Months,83.4,80.1 to 86.3,297
≥1 Dose MMR,,States/Local Areas,Colorado,2013,Age,19 Months,88.2,85.0 to 90.8,250
≥1 Dose MMR,,States/Local Areas,Colorado,2013-2014,Age,19 Months,89.5,87.0 to 91.5,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2016,Age,19 Months,92.6,86.6 to 96.0,247
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,91.7,87.3 to 94.7,478
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,81.0,77.3 to 84.6,894
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,77.2,65.4 to 89.0,87
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.5,74.0 to 87.0,303
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,81.9,77.1 to 86.7,504
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.7,74.6 to 84.8,570
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.2,66.0 to 90.3,96
PCV,≥3 Doses,States/Local Areas,Colorado,2011,Age,7 Months,69.7,66.9 to 72.5,277
≥1 Dose Varicella,,States/Local Areas,Colorado,2012,Age,24 Months,86.3,80.5 to 91.1,297
≥1 Dose Varicella,,States/Local Areas,Colorado,2011,Age,24 Months,85.8,80.0 to 90.5,277
≥1 Dose MMR,,States/Local Areas,Colorado,2017,Age,19 Months,91.6,85.1 to 95.4,231
≥1 Dose MMR,,States/Local Areas,Colorado,2017-2018,Age,19 Months,91.1,86.8 to 94.1,527
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,75.8,68.2 to 83.4,182
≥1 Dose MMR,,States/Local Areas,Colorado,2016,Age,19 Months,90.7,84.1 to 94.7,247
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2017,Age,19 Months,91.1,86.8 to 94.1,478
≥1 Dose MMR,,States/Local Areas,Colorado,2015,Age,19 Months,86.3,85.6 to 87.1,272
≥1 Dose MMR,,States/Local Areas,Colorado,2015-2016,Age,19 Months,88.5,84.3 to 91.7,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2015,Age,19 Months,87.6,85.4 to 89.5,272
Hep B,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,90.1,86.3 to 92.9,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2014,Age,19 Months,94.0,89.2 to 96.7,232
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,90.8,87.4 to 93.4,504
Hep B,≥2 Doses,States/Local Areas,Colorado,2014,Age,5 Months,90.0,84.3 to 93.7,232
Hep B,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,5 Months,86.7,84.2 to 88.8,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,84.4,77.5 to 91.4,367
Hep B,≥2 Doses,States/Local Areas,Colorado,2013,Age,5 Months,86.6,82.7 to 89.7,250
Hep B,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,5 Months,88.3,86.1 to 90.1,482
Hep B,≥2 Doses,States/Local Areas,Colorado,2012,Age,5 Months,87.1,83.4 to 90.1,297
Hep B,≥2 Doses,States/Local Areas,Colorado,2011,Age,5 Months,79.7,76.8 to 82.3,277
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,71.7,63.2 to 80.1,345
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2012,Age,0-1 Days,67.2,64.2 to 70.1,297
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2011,Age,0-1 Days,58.8,55.0 to 62.5,277
Hep B,≥1 Dose,States/Local Areas,Colorado,2019,Age,3 Months,97.9,94.2 to 99.3,265
≥1 Dose Varicella,,States/Local Areas,Colorado,2019,Age,19 Months,91.1,85.5 to 94.7,265
Hep B,≥1 Dose,States/Local Areas,Colorado,2018,Age,3 Months,95.4,92.2 to 97.4,296
Hep B,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,3 Months,96.7,94.6 to 98.0,561
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,91.3,87.3 to 95.2,367
Hep A,≥1 Dose,States/Local Areas,Colorado,2020,Age,35 Months,92.6,87.2 to 96.2,311
Polio,≥2 Doses,States/Local Areas,Colorado,2018,Age,7 Months,93.5,88.6 to 96.4,296
Polio,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,93.6,90.6 to 95.7,561
Polio,≥2 Doses,States/Local Areas,Colorado,2017,Age,7 Months,94.2,88.0 to 97.2,231
Polio,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,93.8,90.3 to 96.1,527
Hep B,≥1 Dose,States/Local Areas,Colorado,2014,Age,3 Months,95.2,91.0 to 97.5,232
Hep B,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,3 Months,94.7,92.1 to 96.5,504
Hep B,≥1 Dose,States/Local Areas,Colorado,2013,Age,3 Months,93.7,89.6 to 96.3,250
Hep B,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,3 Months,94.4,92.3 to 96.0,482
Hep B,≥1 Dose,States/Local Areas,Colorado,2012,Age,3 Months,93.7,90.9 to 95.7,297
Hep B,≥1 Dose,States/Local Areas,Colorado,2011,Age,3 Months,90.0,86.1 to 92.8,277
DTaP,≥4 Doses,States/Local Areas,Colorado,2017,Age,35 Months,93.2,86.0 to 97.4,231
DTaP,≥4 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,90.2,84.8 to 94.3,527
DTaP,≥4 Doses,States/Local Areas,Colorado,2016,Age,35 Months,89.1,82.3 to 94.2,247
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,91.4,86.1 to 95.2,478
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,77.6,68.4 to 86.8,203
Hep B,≥3 Doses,States/Local Areas,Colorado,2013,Age,19 Months,89.8,87.2 to 91.9,250
Hep B,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,91.9,90.9 to 92.8,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2012,Age,19 Months,89.0,87.0 to 90.7,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2011,Age,19 Months,82.0,78.8 to 84.8,277
Hep B,≥3 Doses,States/Local Areas,Colorado,2019,Age,13 Months,92.4,87.6 to 95.5,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2018,Age,13 Months,89.1,83.1 to 93.1,296
Hep B,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,90.8,87.1 to 93.4,561
Hep B,≥2 Doses,States/Local Areas,Colorado,2017,Age,5 Months,84.0,75.4 to 90.0,231
Hep B,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,5 Months,85.4,80.2 to 89.3,527
Hep B,≥2 Doses,States/Local Areas,Colorado,2016,Age,5 Months,87.1,79.7 to 92.1,247
Hep B,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,5 Months,85.6,80.2 to 89.7,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2018,Age,19 Months,91.0,85.1 to 94.7,296
Hep B,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,90.8,87.1 to 93.4,561
Hep B,≥3 Doses,States/Local Areas,Colorado,2017,Age,19 Months,90.8,83.2 to 95.2,231
Hep B,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,90.9,86.4 to 94.0,527
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,88.2,83.1 to 93.3,367
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,79.4,73.4 to 85.4,345
PCV,≥3 Doses,States/Local Areas,Colorado,2012,Age,7 Months,69.5,57.8 to 79.1,297
PCV,≥3 Doses,States/Local Areas,Colorado,2014,Age,7 Months,74.1,65.9 to 80.9,232
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,74.5,69.0 to 79.3,504
PCV,≥3 Doses,States/Local Areas,Colorado,2013,Age,7 Months,65.3,57.1 to 72.6,250
PCV,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,69.7,65.5 to 73.5,482
Hep B,≥2 Doses,States/Local Areas,Colorado,2015,Age,5 Months,83.5,77.2 to 88.2,272
Hep B,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,5 Months,85.3,80.7 to 88.9,519
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2015,Age,0-1 Days,70.7,63.1 to 77.2,272
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2015-2016,Age,0-1 Days,71.4,65.8 to 76.4,519
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2014,Age,0-1 Days,68.2,59.8 to 75.5,232
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2014-2015,Age,0-1 Days,69.4,63.9 to 74.4,504
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2013,Age,0-1 Days,72.5,68.2 to 76.5,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2013-2014,Age,0-1 Days,70.3,67.2 to 73.3,482
Polio,≥2 Doses,States/Local Areas,Colorado,2019,Age,13 Months,96.2,93.0 to 97.9,265
Polio,≥2 Doses,States/Local Areas,Colorado,2018,Age,13 Months,95.9,90.9 to 98.2,296
Polio,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,96.0,93.4 to 97.6,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2014,Age,24 Months,91.7,86.9 to 95.2,232
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2015,Age,24 Months,89.4,85.8 to 92.4,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2013,Age,24 Months,88.8,83.2 to 93.2,250
≥1 Dose Varicella,,States/Local Areas,Colorado,2013-2014,Age,24 Months,90.1,86.5 to 93.1,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2018,Age,35 Months,86.6,79.9 to 92.0,296
DTaP,≥4 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,88.1,83.4 to 91.9,561
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2017,Age,0-1 Days,71.5,62.7 to 79.0,231
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2017-2018,Age,0-1 Days,77.1,71.6 to 81.7,527
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2016,Age,0-1 Days,72.2,63.5 to 79.5,247
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2016-2017,Age,0-1 Days,71.9,65.8 to 77.2,478
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2018,Age,0-1 Days,82.7,76.5 to 87.6,296
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2018-2019,Age,0-1 Days,81.0,76.2 to 85.1,561
Hep B,≥2 Doses,States/Local Areas,Colorado,2018,Age,5 Months,86.8,80.5 to 91.2,296
Hep B,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,5 Months,89.2,85.4 to 92.1,561
Hep B,≥2 Doses,States/Local Areas,Colorado,2011,Age,7 Months,84.1,79.9 to 87.6,277
Hep B,≥2 Doses,States/Local Areas,Colorado,2019,Age,5 Months,91.7,86.5 to 95.0,265
≥1 Dose Varicella,,States/Local Areas,Colorado,2017,Age,24 Months,88.7,82.1 to 93.6,231
≥1 Dose Varicella,,States/Local Areas,Colorado,2017-2018,Age,24 Months,89.5,85.1 to 93.1,527
≥1 Dose Varicella,,States/Local Areas,Colorado,2016,Age,24 Months,90.6,85.2 to 94.7,247
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2017,Age,24 Months,89.7,85.5 to 93.0,478
≥1 Dose Varicella,,States/Local Areas,Colorado,2015,Age,24 Months,87.1,81.5 to 91.6,272
≥1 Dose Varicella,,States/Local Areas,Colorado,2015-2016,Age,24 Months,88.8,85.1 to 92.0,519
≥1 Dose MMR,,States/Local Areas,Colorado,2012,Age,24 Months,86.0,80.1 to 90.9,297
PCV,≥3 Doses,States/Local Areas,Colorado,2015,Age,7 Months,74.8,67.3 to 81.1,272
PCV,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,72.4,66.8 to 77.5,519
≥1 Dose MMR,,States/Local Areas,Colorado,2011,Age,24 Months,87.1,81.2 to 91.9,277
≥1 Dose MMR,,States/Local Areas,Colorado,2019,Age,19 Months,91.5,85.9 to 95.0,265
PCV,≥4 Doses,States/Local Areas,Colorado,2014,Age,19 Months,83.3,76.0 to 88.7,232
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,81.7,76.9 to 85.7,504
≥1 Dose MMR,,States/Local Areas,Colorado,2018,Age,19 Months,90.6,83.9 to 94.7,296
≥1 Dose MMR,,States/Local Areas,Colorado,2018-2019,Age,19 Months,95.8,93.1 to 97.5,561
PCV,≥4 Doses,States/Local Areas,Colorado,2013,Age,19 Months,79.2,75.0 to 82.9,250
PCV,≥4 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,81.2,78.9 to 83.4,482
PCV,≥4 Doses,States/Local Areas,Colorado,2012,Age,19 Months,77.9,71.8 to 82.9,297
PCV,≥4 Doses,States/Local Areas,Colorado,2011,Age,19 Months,77.7,75.6 to 79.7,277
≥1 Dose Varicella,,States/Local Areas,Colorado,2012,Age,35 Months,92.5,87.2 to 96.2,297
≥1 Dose Varicella,,States/Local Areas,Colorado,2011,Age,35 Months,86.6,80.8 to 91.4,277
≥1 Dose Varicella,,States/Local Areas,Colorado,2019,Age,24 Months,93.1,88.4 to 96.3,265
≥1 Dose Varicella,,States/Local Areas,Colorado,2018,Age,24 Months,90.4,84.0 to 95.0,296
≥1 Dose Varicella,,States/Local Areas,Colorado,2018-2019,Age,24 Months,91.7,87.9 to 94.7,561
≥1 Dose MMR,,States/Local Areas,Colorado,2015,Age,24 Months,87.9,82.6 to 92.1,272
≥1 Dose MMR,,States/Local Areas,Colorado,2015-2016,Age,24 Months,90.3,86.8 to 93.2,519
≥1 Dose MMR,,States/Local Areas,Colorado,2014,Age,24 Months,91.3,86.5 to 94.9,232
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2015,Age,24 Months,89.6,86.1 to 92.5,504
≥1 Dose MMR,,States/Local Areas,Colorado,2013,Age,24 Months,91.8,87.0 to 95.3,250
≥1 Dose MMR,,States/Local Areas,Colorado,2013-2014,Age,24 Months,91.4,88.1 to 94.1,482
PCV,≥4 Doses,States/Local Areas,Colorado,2016,Age,19 Months,80.0,71.9 to 86.2,247
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,80.9,75.2 to 85.5,478
PCV,≥4 Doses,States/Local Areas,Colorado,2015,Age,19 Months,80.2,77.5 to 82.7,272
PCV,≥4 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,80.1,75.0 to 84.4,519
PCV,≥3 Doses,States/Local Areas,Colorado,2017,Age,7 Months,81.2,73.0 to 87.3,231
PCV,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,80.4,75.0 to 84.9,527
PCV,≥3 Doses,States/Local Areas,Colorado,2016,Age,7 Months,70.0,61.3 to 77.6,247
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,75.5,69.6 to 80.6,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2014,Age,24 Months,94.0,89.7 to 96.9,232
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,91.1,88.0 to 93.8,504
Hep B,≥3 Doses,States/Local Areas,Colorado,2012,Age,24 Months,89.4,83.6 to 93.8,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2013,Age,24 Months,91.1,86.3 to 94.7,250
Hep B,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,92.5,89.4 to 95.0,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2011,Age,24 Months,83.8,77.6 to 89.0,277
Hep B,≥3 Doses,States/Local Areas,Colorado,2019,Age,19 Months,94.3,90.3 to 96.8,265
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2011,Age,0-2 Days,61.9,57.6 to 66.0,277
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2019,Age,0-1 Days,79.3,71.5 to 85.4,265
Hep B,≥2 Doses,States/Local Areas,Colorado,2013,Age,7 Months,91.0,88.0 to 93.3,250
Hep B,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,92.6,91.4 to 93.7,482
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2013,Age,0-2 Days,73.2,68.9 to 77.0,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2013-2014,Age,0-2 Days,72.3,69.7 to 74.7,482
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2012,Age,0-2 Days,69.6,66.7 to 72.4,297
PCV,≥3 Doses,States/Local Areas,Colorado,2011,Age,13 Months,85.6,81.8 to 88.8,277
PCV,≥3 Doses,States/Local Areas,Colorado,2019,Age,7 Months,79.1,71.6 to 84.9,265
PCV,≥3 Doses,States/Local Areas,Colorado,2018,Age,7 Months,79.7,72.0 to 85.7,296
PCV,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,79.4,74.1 to 83.8,561
Hep B,≥2 Doses,States/Local Areas,Colorado,2015,Age,7 Months,87.7,82.1 to 91.7,272
Hep B,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,89.0,84.7 to 92.2,519
Hep B,≥2 Doses,States/Local Areas,Colorado,2012,Age,7 Months,91.3,88.7 to 93.4,297
Hep B,≥2 Doses,States/Local Areas,Colorado,2014,Age,7 Months,94.3,89.6 to 96.9,232
Hep B,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,91.0,87.5 to 93.5,504
≥1 Dose MMR,,States/Local Areas,Colorado,2017,Age,24 Months,93.0,87.2 to 96.8,231
≥1 Dose MMR,,States/Local Areas,Colorado,2017-2018,Age,24 Months,92.1,88.1 to 95.2,527
≥1 Dose MMR,,States/Local Areas,Colorado,2016,Age,24 Months,92.8,87.7 to 96.3,247
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2017,Age,24 Months,92.9,89.2 to 95.6,478
PCV,≥4 Doses,States/Local Areas,Colorado,2018,Age,19 Months,84.2,76.9 to 89.6,296
PCV,≥4 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,83.6,77.2 to 88.4,446
Hep B,≥3 Doses,States/Local Areas,Colorado,2017,Age,24 Months,91.3,84.5 to 96.0,231
Hep B,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,91.4,87.2 to 94.6,527
PCV,≥3 Doses,States/Local Areas,Colorado,2012,Age,13 Months,89.3,87.3 to 91.0,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2016,Age,24 Months,92.7,87.3 to 96.3,247
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,92.0,87.9 to 95.1,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2015,Age,24 Months,88.3,83.3 to 92.5,272
Hep B,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,90.5,87.0 to 93.4,519
PCV,≥3 Doses,States/Local Areas,Colorado,2013,Age,13 Months,88.7,82.4 to 93.0,250
PCV,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,89.3,85.3 to 92.3,482
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2015,Age,0-2 Days,74.0,66.7 to 80.2,272
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2015-2016,Age,0-2 Days,74.1,68.7 to 78.9,519
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2014,Age,0-2 Days,71.4,63.3 to 78.3,232
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2014-2015,Age,0-2 Days,72.7,67.4 to 77.4,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2015,Age,35 Months,90.1,84.3 to 94.5,272
≥1 Dose Varicella,,States/Local Areas,Colorado,2015-2016,Age,35 Months,92.2,88.4 to 95.0,519
PCV,≥4 Doses,States/Local Areas,Colorado,2011,Age,24 Months,83.0,76.4 to 88.5,277
≥1 Dose Varicella,,States/Local Areas,Colorado,2014,Age,35 Months,92.7,87.8 to 96.1,232
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2015,Age,35 Months,91.4,87.7 to 94.3,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2013,Age,35 Months,91.3,85.8 to 95.2,250
≥1 Dose Varicella,,States/Local Areas,Colorado,2013-2014,Age,35 Months,91.9,88.3 to 94.7,482
≥1 Dose MMR,,States/Local Areas,Colorado,2018,Age,24 Months,91.3,85.2 to 95.6,296
≥1 Dose MMR,,States/Local Areas,Colorado,2018-2019,Age,24 Months,92.4,88.7 to 95.2,561
PCV,≥4 Doses,States/Local Areas,Colorado,2019,Age,19 Months,83.9,77.2 to 88.9,265
PCV,≥3 Doses,States/Local Areas,Colorado,2016,Age,13 Months,89.5,83.2 to 93.6,247
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,91.2,87.1 to 94.0,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2018,Age,24 Months,91.4,86.1 to 95.3,296
Hep B,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,93.5,90.5 to 95.9,561
PCV,≥3 Doses,States/Local Areas,Colorado,2015,Age,13 Months,88.8,82.9 to 92.9,272
PCV,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,89.2,85.1 to 92.2,519
PCV,≥3 Doses,States/Local Areas,Colorado,2014,Age,13 Months,89.8,83.0 to 94.1,232
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,89.3,85.0 to 92.5,504
Hep B,≥2 Doses,States/Local Areas,Colorado,2018,Age,7 Months,90.8,85.2 to 94.5,296
Hep B,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,93.3,90.1 to 95.5,561
Hep B,≥2 Doses,States/Local Areas,Colorado,2017,Age,7 Months,90.1,82.1 to 94.7,231
Hep B,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,90.5,85.9 to 93.6,527
Hep B,≥2 Doses,States/Local Areas,Colorado,2016,Age,7 Months,90.3,82.9 to 94.7,247
Hep B,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,90.2,85.1 to 93.6,478
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2016,Age,0-2 Days,74.3,65.8 to 81.2,247
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2016-2017,Age,0-2 Days,74.0,68.1 to 79.2,478
Hib,≥1 Dose,States/Local Areas,Colorado,2013,Age,3 Months,83.2,80.2 to 85.9,250
Hib,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,3 Months,86.5,84.0 to 88.6,482
Hib,≥1 Dose,States/Local Areas,Colorado,2012,Age,3 Months,88.4,83.0 to 92.2,297
Hib,≥1 Dose,States/Local Areas,Colorado,2011,Age,3 Months,85.0,81.2 to 88.1,277
Hep B,≥3 Doses,States/Local Areas,Colorado,2016,Age,35 Months,93.9,87.5 to 97.7,247
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,92.8,88.4 to 95.9,478
PCV,≥3 Doses,States/Local Areas,Colorado,2014,Age,19 Months,91.4,84.7 to 95.4,232
PCV,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,91.3,87.2 to 94.1,504
PCV,≥3 Doses,States/Local Areas,Colorado,2013,Age,19 Months,91.1,87.4 to 93.8,250
PCV,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,19 Months,91.3,88.2 to 93.6,482
PCV,≥3 Doses,States/Local Areas,Colorado,2011,Age,19 Months,88.2,84.0 to 91.4,277
PCV,≥3 Doses,States/Local Areas,Colorado,2019,Age,13 Months,93.4,89.1 to 96.0,265
PCV,≥4 Doses,States/Local Areas,Colorado,2012,Age,35 Months,86.9,80.6 to 91.9,297
PCV,≥4 Doses,States/Local Areas,Colorado,2011,Age,35 Months,84.9,78.5 to 90.3,277
PCV,≥4 Doses,States/Local Areas,Colorado,2019,Age,24 Months,86.0,79.8 to 91.0,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2017,Age,35 Months,91.8,84.9 to 96.3,231
Hep B,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,92.0,87.9 to 95.2,527
PCV,≥3 Doses,States/Local Areas,Colorado,2012,Age,19 Months,92.3,89.3 to 94.5,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2018,Age,35 Months,92.3,86.9 to 96.0,296
Hep B,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,93.9,90.9 to 96.2,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,92.7,85.6 to 99.7,39
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,86.6,82.0 to 91.3,268
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,94.1,91.4 to 96.8,564
≥1 Dose Varicella,,States/Local Areas,Colorado,2019,Age,35 Months,94.9,90.5 to 97.7,265
≥1 Dose MMR,,States/Local Areas,Colorado,2017,Age,35 Months,93.2,87.4 to 96.9,231
≥1 Dose MMR,,States/Local Areas,Colorado,2017-2018,Age,35 Months,92.2,88.2 to 95.2,527
≥1 Dose MMR,,States/Local Areas,Colorado,2016,Age,35 Months,96.6,91.8 to 99.0,247
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2017,Age,35 Months,94.9,91.3 to 97.3,478
≥1 Dose MMR,,States/Local Areas,Colorado,2015,Age,35 Months,90.6,84.6 to 95.0,272
≥1 Dose MMR,,States/Local Areas,Colorado,2015-2016,Age,35 Months,93.5,89.8 to 96.3,519
PCV,≥4 Doses,States/Local Areas,Colorado,2018,Age,24 Months,85.3,78.5 to 90.9,296
PCV,≥4 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,85.7,81.1 to 89.6,561
PCV,≥4 Doses,States/Local Areas,Colorado,2017,Age,24 Months,83.6,75.7 to 90.1,231
PCV,≥4 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,84.4,79.3 to 88.9,527
PCV,≥4 Doses,States/Local Areas,Colorado,2016,Age,24 Months,84.5,77.1 to 90.5,247
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,84.0,78.8 to 88.6,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2015,Age,35 Months,89.3,84.3 to 93.3,272
Hep B,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,91.5,87.9 to 94.4,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2014,Age,35 Months,94.3,90.0 to 97.1,232
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,91.8,88.6 to 94.3,504
Hep B,≥3 Doses,States/Local Areas,Colorado,2013,Age,35 Months,91.8,86.9 to 95.4,250
Hep B,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,93.0,89.9 to 95.4,482
PCV,≥3 Doses,States/Local Areas,Colorado,2018,Age,13 Months,93.1,87.6 to 96.2,296
PCV,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,93.2,90.0 to 95.4,561
PCV,≥3 Doses,States/Local Areas,Colorado,2017,Age,13 Months,92.9,86.9 to 96.3,231
PCV,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,93.0,89.2 to 95.5,527
Hep B,≥2 Doses,States/Local Areas,Colorado,2013,Age,13 Months,93.5,91.2 to 95.2,250
Hep B,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,94.4,93.2 to 95.3,482
Hep B,≥2 Doses,States/Local Areas,Colorado,2012,Age,13 Months,93.7,91.9 to 95.2,297
Hep B,≥2 Doses,States/Local Areas,Colorado,2011,Age,13 Months,88.8,84.1 to 92.2,277
Hep B,≥2 Doses,States/Local Areas,Colorado,2019,Age,7 Months,95.8,92.0 to 97.8,265
≥1 Dose MMR,,States/Local Areas,Colorado,2014,Age,35 Months,92.3,87.4 to 95.8,232
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2015,Age,35 Months,91.4,87.7 to 94.3,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2018,Age,35 Months,90.4,84.0 to 95.0,296
≥1 Dose Varicella,,States/Local Areas,Colorado,2018-2019,Age,35 Months,92.6,88.8 to 95.5,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2017,Age,35 Months,91.7,85.7 to 95.9,231
≥1 Dose Varicella,,States/Local Areas,Colorado,2017-2018,Age,35 Months,91.0,86.7 to 94.4,527
≥1 Dose Varicella,,States/Local Areas,Colorado,2016,Age,35 Months,94.0,89.0 to 97.2,247
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2017,Age,35 Months,93.0,89.2 to 95.9,478
≥1 Dose MMR,,States/Local Areas,Colorado,2013,Age,35 Months,93.8,89.3 to 96.8,250
≥1 Dose MMR,,States/Local Areas,Colorado,2013-2014,Age,35 Months,93.0,89.7 to 95.5,482
≥1 Dose MMR,,States/Local Areas,Colorado,2012,Age,35 Months,91.8,86.3 to 95.7,297
≥1 Dose MMR,,States/Local Areas,Colorado,2011,Age,35 Months,88.5,82.2 to 93.4,277
≥1 Dose MMR,,States/Local Areas,Colorado,2019,Age,24 Months,93.5,88.8 to 96.7,265
PCV,≥4 Doses,States/Local Areas,Colorado,2015,Age,24 Months,82.9,76.7 to 88.2,272
PCV,≥4 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,83.7,79.0 to 87.8,519
PCV,≥4 Doses,States/Local Areas,Colorado,2014,Age,24 Months,86.1,79.7 to 91.4,232
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,84.5,80.1 to 88.4,504
PCV,≥4 Doses,States/Local Areas,Colorado,2013,Age,24 Months,87.0,80.4 to 92.2,250
PCV,≥4 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,86.3,81.9 to 90.2,482
PCV,≥4 Doses,States/Local Areas,Colorado,2012,Age,24 Months,82.4,76.2 to 87.8,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2011,Age,35 Months,85.4,79.2 to 90.5,277
Hep B,≥3 Doses,States/Local Areas,Colorado,2019,Age,24 Months,95.6,92.3 to 97.7,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2012,Age,35 Months,90.6,84.7 to 94.9,297
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2019,Age,0-2 Days,79.8,72.0 to 85.9,265
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2018,Age,0-2 Days,83.4,77.2 to 88.2,296
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2018-2019,Age,0-2 Days,81.6,76.8 to 85.6,561
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2017,Age,0-2 Days,73.7,65.1 to 80.9,231
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2017-2018,Age,0-2 Days,78.5,73.2 to 83.0,527
Hep B,≥2 Doses,States/Local Areas,Colorado,2016,Age,13 Months,94.4,88.2 to 97.4,247
Hep B,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,13 Months,93.6,89.2 to 96.3,478
Hep B,≥2 Doses,States/Local Areas,Colorado,2015,Age,13 Months,91.7,87.0 to 94.8,272
Hep B,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,13 Months,93.0,89.6 to 95.4,519
Hep B,≥2 Doses,States/Local Areas,Colorado,2014,Age,13 Months,95.3,90.6 to 97.7,232
Hep B,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,93.5,90.5 to 95.6,504
Hib,≥1 Dose,States/Local Areas,Colorado,2014,Age,3 Months,89.7,83.5 to 93.8,232
Hib,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,3 Months,89.1,85.3 to 92.1,504
PCV,≥4 Doses,States/Local Areas,Colorado,2017,Age,19 Months,81.8,73.1 to 88.1,231
PCV,≥4 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,83.0,77.5 to 87.4,527
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,79.0 to 96.4,96
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,92.5,88.6 to 96.5,203
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,90.6,86.6 to 94.6,345
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,85.1,79.4 to 90.9,182
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Overall,Overall,90.2,87.7 to 92.7,894
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.6,83.8 to 93.4,303
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,86.2,78.3 to 94.0,87
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,88.5 to 94.8,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.0,85.3 to 92.6,570
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,95.0,92.6 to 97.4,564
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,93.1,86.2 to 100.0,39
≥1 Dose MMR,,States/Local Areas,Colorado,2019,Age,35 Months,94.4,89.9 to 97.4,265
PCV,≥4 Doses,States/Local Areas,Colorado,2013,Age,35 Months,89.4,82.9 to 94.2,250
PCV,≥4 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,88.2,83.8 to 91.8,482
≥1 Dose MMR,,States/Local Areas,Colorado,2018,Age,35 Months,91.3,85.2 to 95.6,296
≥1 Dose MMR,,States/Local Areas,Colorado,2018-2019,Age,35 Months,92.9,89.3 to 95.6,561
PCV,≥3 Doses,States/Local Areas,Colorado,2016,Age,19 Months,93.1,88.2 to 96.1,247
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,93.7,90.2 to 96.1,478
PCV,≥3 Doses,States/Local Areas,Colorado,2015,Age,19 Months,91.1,87.7 to 93.6,272
PCV,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,92.1,88.8 to 94.5,519
Hep B,≥2 Doses,States/Local Areas,Colorado,2019,Age,13 Months,96.6,93.3 to 98.3,265
Hep B,≥2 Doses,States/Local Areas,Colorado,2018,Age,13 Months,93.4,88.1 to 96.5,296
Hep B,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,13 Months,95.0,92.1 to 96.9,561
Hep B,≥2 Doses,States/Local Areas,Colorado,2017,Age,13 Months,92.8,85.3 to 96.7,231
Hep B,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,13 Months,93.1,88.9 to 95.8,527
Hib,≥1 Dose,States/Local Areas,Colorado,2017,Age,3 Months,90.6,83.2 to 95.0,231
Hib,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,3 Months,91.2,86.8 to 94.2,527
Hib,≥1 Dose,States/Local Areas,Colorado,2016,Age,3 Months,91.3,84.6 to 95.3,247
Hib,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,3 Months,91.0,86.4 to 94.1,478
Hib,≥1 Dose,States/Local Areas,Colorado,2015,Age,3 Months,88.6,83.4 to 92.3,272
Hib,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,3 Months,89.9,86.0 to 92.8,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2019,Age,35 Months,95.6,92.3 to 97.7,265
PCV,≥3 Doses,States/Local Areas,Colorado,2017,Age,19 Months,94.4,88.3 to 97.4,231
PCV,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,95.3,91.8 to 97.4,527
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,79.4 to 96.8,96
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,93.2,89.4 to 96.9,203
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,87.1,82.5 to 91.8,268
PCV,≥4 Doses,States/Local Areas,Colorado,2016,Age,35 Months,87.1,79.8 to 92.7,247
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,88.2,82.6 to 92.6,478
PCV,≥4 Doses,States/Local Areas,Colorado,2015,Age,35 Months,83.6,77.4 to 88.9,272
PCV,≥4 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,85.4,80.7 to 89.4,519
PCV,≥4 Doses,States/Local Areas,Colorado,2014,Age,35 Months,87.6,81.2 to 92.7,232
PCV,≥4 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,85.8,81.3 to 89.7,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,94.7,91.8 to 97.7,367
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.0,85.6 to 94.4,303
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,88.1 to 94.6,504
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.8,86.3 to 93.3,570
Hib,Primary Series,States/Local Areas,Colorado,2020,Age,24 Months,93.5,89.3 to 96.4,311
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.0,86.3 to 95.7,303
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,86.6,82.4 to 90.8,564
Hib,Full Series,States/Local Areas,Colorado,2019,Age,35 Months,85.4,78.9 to 90.8,265
Hib,Full Series,States/Local Areas,Colorado,2018,Age,35 Months,83.0,75.5 to 89.3,296
Hib,Full Series,States/Local Areas,Colorado,2018-2019,Age,35 Months,84.1,79.1 to 88.4,561
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,94.3,91.5 to 97.0,504
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,88.9 to 95.4,570
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,84.8 to 100.0,96
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,93.5,89.8 to 97.2,203
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,77.3,71.1 to 83.4,268
Hib,Full Series,States/Local Areas,Colorado,2016,Age,35 Months,82.1,74.5 to 88.6,247
Hib,Full Series,States/Local Areas,Colorado,2016-2017,Age,35 Months,87.1,81.6 to 91.7,478
Hib,Full Series,States/Local Areas,Colorado,2015,Age,35 Months,88.0,81.1 to 93.3,272
Hib,Full Series,States/Local Areas,Colorado,2015-2016,Age,35 Months,84.7,79.8 to 89.0,519
Hep A,≥2 Doses,States/Local Areas,Colorado,2018,Age,24 Months,42.3,34.3 to 51.3,296
Hep A,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,39.2,33.6 to 45.5,561
DTaP,≥4 Doses,States/Local Areas,Colorado,2014,Age,24 Months,85.5,79.1 to 90.7,232
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,83.8,79.2 to 87.8,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2017,Age,24 Months,37.9,29.5 to 47.8,231
Hep A,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,40.0,34.1 to 46.6,527
Hep A,≥2 Doses,States/Local Areas,Colorado,2016,Age,24 Months,38.8,30.7 to 48.2,247
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,38.4,32.4 to 45.1,478
DTaP,≥4 Doses,States/Local Areas,Colorado,2013,Age,24 Months,85.8,79.7 to 90.8,250
DTaP,≥4 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,85.5,81.2 to 89.2,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2012,Age,24 Months,79.9,73.2 to 85.8,297
DTaP,≥4 Doses,States/Local Areas,Colorado,2011,Age,24 Months,81.4,74.8 to 87.2,277
DTaP,≥4 Doses,States/Local Areas,Colorado,2019,Age,19 Months,76.9,69.6 to 82.8,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2013,Age,7 Months,61.3,58.2 to 64.2,250
Hep B,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,66.6,62.5 to 70.4,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2012,Age,7 Months,61.9,55.6 to 67.9,297
Hep B,≥3 Doses,States/Local Areas,Colorado,2011,Age,7 Months,61.0,55.2 to 66.4,277
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,98.0,96.1 to 100.0,367
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,93.7,90.3 to 97.1,345
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,91.8,87.8 to 95.9,182
Polio,≥2 Doses,States/Local Areas,Colorado,2015,Age,5 Months,81.4,74.4 to 86.9,272
Polio,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,5 Months,80.2,74.9 to 84.6,519
Polio,≥2 Doses,States/Local Areas,Colorado,2014,Age,5 Months,80.9,73.3 to 86.8,232
Polio,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,5 Months,81.2,79.0 to 83.2,504
Polio,≥2 Doses,States/Local Areas,Colorado,2013,Age,5 Months,79.8,74.9 to 83.9,250
Polio,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,5 Months,80.4,78.2 to 82.3,482
Polio,≥2 Doses,States/Local Areas,Colorado,2012,Age,5 Months,76.1,67.6 to 82.9,297
Hep A,≥1 Dose,States/Local Areas,Colorado,2015,Age,35 Months,85.3,78.3 to 91.0,272
Hep A,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,35 Months,87.7,83.1 to 91.6,519
Hib,≥3 Doses,States/Local Areas,Colorado,2019,Age,35 Months,93.8,89.5 to 96.8,265
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,94.4,92.4 to 96.3,894
Hep A,≥2 Doses,States/Local Areas,Colorado,2015,Age,24 Months,39.7,32.0 to 48.5,272
Hep A,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,39.3,33.5 to 45.6,519
Hep A,≥2 Doses,States/Local Areas,Colorado,2014,Age,24 Months,44.7,36.4 to 53.9,232
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,42.2,36.4 to 48.4,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2013,Age,24 Months,37.8,30.0 to 46.7,250
Hep A,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,41.2,35.4 to 47.5,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2018,Age,19 Months,74.0,66.2 to 80.6,296
DTaP,≥4 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,96.0,93.4 to 97.6,561
DTaP,≥4 Doses,States/Local Areas,Colorado,2017,Age,19 Months,71.2,61.9 to 79.0,231
DTaP,≥4 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,72.6,66.6 to 77.9,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.7,88.7 to 96.7,303
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,92.5,86.9 to 98.1,87
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,95.6,93.3 to 97.9,504
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.8,92.5 to 97.2,570
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,84.8 to 100.0,96
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,93.6,89.8 to 97.3,203
Polio,≥2 Doses,States/Local Areas,Colorado,2011,Age,5 Months,79.6,73.8 to 84.4,277
PCV,≥2 Doses,States/Local Areas,Colorado,2019,Age,5 Months,87.4,81.2 to 91.7,265
PCV,≥2 Doses,States/Local Areas,Colorado,2018,Age,5 Months,90.5,84.7 to 94.2,296
PCV,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,5 Months,88.9,85.0 to 91.9,561
DTaP,≥4 Doses,States/Local Areas,Colorado,2017,Age,24 Months,80.1,71.4 to 87.5,231
DTaP,≥4 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,80.4,75.0 to 85.3,527
Hep A,≥2 Doses,States/Local Areas,Colorado,2014,Age,35 Months,74.3,65.2 to 82.6,232
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,71.7,64.8 to 78.3,504
DTaP,≥4 Doses,States/Local Areas,Colorado,2016,Age,24 Months,78.9,71.1 to 85.7,247
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,79.5,73.7 to 84.6,478
DTaP,≥4 Doses,States/Local Areas,Colorado,2015,Age,24 Months,82.0,75.4 to 87.7,272
DTaP,≥4 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,80.4,75.4 to 85.0,519
Hep A,≥2 Doses,States/Local Areas,Colorado,2013,Age,35 Months,70.9,61.3 to 79.9,250
Hep A,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,72.5,66.0 to 78.7,482
Hep A,≥2 Doses,States/Local Areas,Colorado,2012,Age,35 Months,70.4,61.7 to 78.7,297
Hep A,≥2 Doses,States/Local Areas,Colorado,2011,Age,35 Months,62.8,53.4 to 72.2,277
Hep A,≥2 Doses,States/Local Areas,Colorado,2019,Age,24 Months,36.2,28.5 to 45.3,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2016,Age,7 Months,71.1,62.5 to 78.4,247
Hep B,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,7 Months,70.4,64.3 to 75.8,478
Hep B,≥3 Doses,States/Local Areas,Colorado,2015,Age,7 Months,69.6,62.1 to 76.1,272
Hep B,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,7 Months,70.3,64.8 to 75.4,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2014,Age,7 Months,72.0,63.9 to 78.8,232
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,7 Months,70.8,65.3 to 75.6,504
Polio,≥2 Doses,States/Local Areas,Colorado,2017,Age,5 Months,88.8,82.1 to 93.2,231
Polio,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,5 Months,89.6,85.4 to 92.7,527
Polio,≥2 Doses,States/Local Areas,Colorado,2016,Age,5 Months,79.0,70.6 to 85.5,247
Polio,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,5 Months,83.8,78.6 to 88.0,478
Hep A,≥1 Dose,States/Local Areas,Colorado,2018,Age,35 Months,89.2,83.0 to 93.9,296
Hep A,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,35 Months,89.6,85.4 to 93.0,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2011,Age,13 Months,52.7,47.4 to 57.9,277
Polio,≥2 Doses,States/Local Areas,Colorado,2018,Age,5 Months,90.4,84.7 to 94.2,296
Polio,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,5 Months,89.3,85.5 to 92.2,561
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,76.4,61.4 to 91.4,39
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,82.1,76.6 to 87.6,268
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,88.6,84.5 to 92.7,564
Hep A,≥1 Dose,States/Local Areas,Colorado,2019,Age,35 Months,89.8,83.9 to 94.2,265
≥1 Dose Varicella,,States/Local Areas,Colorado,2015,Age,13 Months,58.1,50.0 to 65.8,272
≥1 Dose Varicella,,States/Local Areas,Colorado,2015-2016,Age,13 Months,55.8,49.9 to 61.6,519
≥1 Dose Varicella,,States/Local Areas,Colorado,2012,Age,13 Months,55.3,53.4 to 57.2,297
≥1 Dose Varicella,,States/Local Areas,Colorado,2014,Age,13 Months,62.1,53.6 to 69.9,232
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2015,Age,13 Months,60.1,54.3 to 65.6,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2016,Age,35 Months,78.9,69.5 to 87.0,247
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,78.9,72.3 to 84.8,478
Hep A,≥2 Doses,States/Local Areas,Colorado,2015,Age,35 Months,69.7,58.8 to 79.9,272
Hep A,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,74.2,67.0 to 80.9,519
Hep B,≥3 Doses,States/Local Areas,Colorado,2019,Age,7 Months,69.7,61.6 to 76.7,265
Polio,≥2 Doses,States/Local Areas,Colorado,2013,Age,7 Months,88.2,85.4 to 90.5,250
Polio,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,7 Months,90.2,88.5 to 91.6,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2018,Age,7 Months,69.1,61.1 to 76.2,296
Hep B,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,7 Months,69.4,63.7 to 74.5,561
Hep B,≥3 Doses,States/Local Areas,Colorado,2017,Age,7 Months,69.6,60.6 to 77.3,231
Hep B,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,7 Months,69.4,63.4 to 74.7,527
Polio,≥2 Doses,States/Local Areas,Colorado,2012,Age,7 Months,87.8,85.0 to 90.1,297
Polio,≥2 Doses,States/Local Areas,Colorado,2011,Age,7 Months,85.5,82.6 to 87.9,277
Polio,≥2 Doses,States/Local Areas,Colorado,2019,Age,5 Months,88.2,82.4 to 92.3,265
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.2,78.4 to 96.0,96
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,86.6,81.3 to 91.9,203
≥1 Dose MMR,,States/Local Areas,Colorado,2015,Age,13 Months,62.0,53.9 to 69.4,272
≥1 Dose MMR,,States/Local Areas,Colorado,2015-2016,Age,13 Months,61.9,55.9 to 67.5,519
≥1 Dose MMR,,States/Local Areas,Colorado,2014,Age,13 Months,65.7,57.2 to 73.2,232
≥1 Dose MMR,,States/Local Areas,Colorado,2014-2015,Age,13 Months,63.8,58.1 to 69.2,504
≥1 Dose Varicella,,States/Local Areas,Colorado,2013,Age,19 Months,86.2,84.4 to 87.8,250
≥1 Dose Varicella,,States/Local Areas,Colorado,2013-2014,Age,19 Months,89.2,87.4 to 90.8,482
≥1 Dose Varicella,,States/Local Areas,Colorado,2012,Age,19 Months,83.4,82.2 to 84.6,297
≥1 Dose Varicella,,States/Local Areas,Colorado,2011,Age,19 Months,84.1,80.7 to 87.0,277
≥1 Dose Varicella,,States/Local Areas,Colorado,2019,Age,13 Months,62.8,54.3 to 70.5,265
≥1 Dose MMR,,States/Local Areas,Colorado,2016,Age,13 Months,61.8,52.9 to 70.1,247
≥1 Dose MMR,,States/Local Areas,Colorado,2016-2017,Age,13 Months,64.8,58.4 to 70.6,478
PCV,≥4 Doses,States/Local Areas,Colorado,2020,Age,35 Months,81.8,75.6 to 87.2,311
DTaP,≥4 Doses,States/Local Areas,Colorado,2015,Age,35 Months,91.0,84.0 to 95.8,272
DTaP,≥4 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,90.0,85.0 to 93.9,519
DTaP,≥4 Doses,States/Local Areas,Colorado,2012,Age,35 Months,85.5,79.1 to 90.7,297
DTaP,≥4 Doses,States/Local Areas,Colorado,2014,Age,35 Months,88.5,82.3 to 93.3,232
DTaP,≥4 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,89.2,84.7 to 92.8,504
DTaP,≥4 Doses,States/Local Areas,Colorado,2013,Age,35 Months,88.6,82.8 to 93.1,250
DTaP,≥4 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,88.4,84.3 to 91.9,482
Hep A,≥2 Doses,States/Local Areas,Colorado,2019,Age,35 Months,76.2,67.6 to 84.0,265
Hep B,≥3 Doses,States/Local Areas,Colorado,2012,Age,13 Months,84.4,82.4 to 86.3,297
Hep A,≥2 Doses,States/Local Areas,Colorado,2018,Age,35 Months,78.1,68.7 to 86.2,296
Hep A,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,77.1,70.7 to 82.9,561
Hep A,≥2 Doses,States/Local Areas,Colorado,2017,Age,35 Months,79.0,69.5 to 87.0,231
Hep A,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,78.5,72.0 to 84.3,527
Hep B,≥3 Doses,States/Local Areas,Colorado,2014,Age,13 Months,89.5,83.3 to 93.6,232
Hep B,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,13 Months,87.4,83.4 to 90.6,504
Hep B,≥3 Doses,States/Local Areas,Colorado,2013,Age,13 Months,88.0,84.4 to 90.9,250
Hep B,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,13 Months,88.8,85.7 to 91.3,482
Hep A,≥1 Dose,States/Local Areas,Colorado,2017,Age,35 Months,87.3,81.0 to 92.3,231
Hep A,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,35 Months,88.3,84.0 to 91.8,527
Hep A,≥1 Dose,States/Local Areas,Colorado,2016,Age,35 Months,90.1,83.6 to 94.8,247
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,35 Months,88.9,84.5 to 92.5,478
Hep A,≥1 Dose,States/Local Areas,Colorado,2014,Age,35 Months,87.4,80.8 to 92.6,232
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,35 Months,86.3,81.6 to 90.3,504
Hep A,≥1 Dose,States/Local Areas,Colorado,2013,Age,35 Months,91.9,86.8 to 95.6,250
Hep A,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,35 Months,89.7,85.6 to 93.1,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2011,Age,35 Months,85.8,78.5 to 91.6,277
DTaP,≥4 Doses,States/Local Areas,Colorado,2019,Age,24 Months,83.3,76.9 to 88.8,265
DTaP,≥4 Doses,States/Local Areas,Colorado,2018,Age,24 Months,80.9,74.1 to 86.9,296
DTaP,≥4 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,82.1,77.5 to 86.3,561
≥1 Dose Varicella,,States/Local Areas,Colorado,2017,Age,13 Months,62.1,53.0 to 70.5,231
≥1 Dose Varicella,,States/Local Areas,Colorado,2017-2018,Age,13 Months,62.4,56.3 to 68.2,527
≥1 Dose Varicella,,States/Local Areas,Colorado,2016,Age,13 Months,53.5,44.8 to 62.1,247
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2017,Age,13 Months,57.8,51.4 to 63.9,478
≥1 Dose MMR,,States/Local Areas,Colorado,2017,Age,13 Months,67.8,58.7 to 75.8,231
≥1 Dose MMR,,States/Local Areas,Colorado,2017-2018,Age,13 Months,70.1,64.1 to 75.6,527
≥1 Dose MMR,,States/Local Areas,Colorado,2019,Age,13 Months,70.3,62.0 to 77.5,265
≥1 Dose MMR,,States/Local Areas,Colorado,2018,Age,13 Months,72.5,64.2 to 79.5,296
≥1 Dose MMR,,States/Local Areas,Colorado,2018-2019,Age,13 Months,71.4,65.7 to 76.6,561
Polio,≥2 Doses,States/Local Areas,Colorado,2012,Age,13 Months,93.7,91.1 to 95.5,297
Polio,≥2 Doses,States/Local Areas,Colorado,2011,Age,13 Months,90.8,88.4 to 92.8,277
≥1 Dose Varicella,,States/Local Areas,Colorado,2016,Age,19 Months,89.1,82.3 to 93.5,247
≥1 Dose Varicella,,States/Local Areas,Colorado,2016-2017,Age,19 Months,88.1,83.4 to 91.6,478
≥1 Dose Varicella,,States/Local Areas,Colorado,2015,Age,19 Months,86.0,84.7 to 87.3,272
≥1 Dose Varicella,,States/Local Areas,Colorado,2015-2016,Age,19 Months,87.5,83.2 to 90.9,519
≥1 Dose Varicella,,States/Local Areas,Colorado,2014,Age,19 Months,92.2,87.2 to 95.4,232
≥1 Dose Varicella,,States/Local Areas,Colorado,2014-2015,Age,19 Months,89.1,85.3 to 92.0,504
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,71.4,60.6 to 82.3,182
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,75.7,70.6 to 80.8,894
Polio,≥2 Doses,States/Local Areas,Colorado,2019,Age,7 Months,93.7,89.3 to 96.4,265
Hep A,≥2 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.4,69.8 to 87.0,303
DTaP,≥2 Doses,States/Local Areas,Colorado,2016,Age,5 Months,81.7,73.4 to 87.9,247
DTaP,≥2 Doses,States/Local Areas,Colorado,2016-2017,Age,5 Months,85.5,80.3 to 89.5,478
DTaP,≥2 Doses,States/Local Areas,Colorado,2015,Age,5 Months,80.9,73.8 to 86.4,272
DTaP,≥2 Doses,States/Local Areas,Colorado,2015-2016,Age,5 Months,81.3,76.0 to 85.6,519
Polio,≥3 Doses,States/Local Areas,Colorado,2018,Age,35 Months,95.9,91.6 to 98.4,296
Polio,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,35 Months,96.1,93.6 to 97.8,561
Polio,≥3 Doses,States/Local Areas,Colorado,2017,Age,35 Months,94.4,88.9 to 97.7,231
Polio,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,35 Months,95.2,91.9 to 97.4,527
Polio,≥3 Doses,States/Local Areas,Colorado,2016,Age,35 Months,94.5,89.8 to 97.4,247
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,35 Months,94.6,91.3 to 96.9,478
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,90.9,86.8 to 95.0,268
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,94.7,88.4 to 100.0,39
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,95.9,93.4 to 98.4,564
Polio,≥3 Doses,States/Local Areas,Colorado,2019,Age,35 Months,96.2,93.0 to 98.2,265
DTaP,≥2 Doses,States/Local Areas,Colorado,2014,Age,5 Months,81.1,73.5 to 87.0,232
DTaP,≥2 Doses,States/Local Areas,Colorado,2014-2015,Age,5 Months,81.0,78.4 to 83.4,504
DTaP,≥2 Doses,States/Local Areas,Colorado,2013,Age,5 Months,81.8,77.7 to 85.3,250
DTaP,≥2 Doses,States/Local Areas,Colorado,2013-2014,Age,5 Months,81.5,78.7 to 84.0,482
DTaP,≥2 Doses,States/Local Areas,Colorado,2012,Age,5 Months,77.6,69.3 to 84.1,297
DTaP,≥2 Doses,States/Local Areas,Colorado,2011,Age,5 Months,83.5,78.0 to 87.9,277
Hib,Full Series,States/Local Areas,Colorado,2014,Age,35 Months,82.5,75.6 to 88.4,232
Hib,Full Series,States/Local Areas,Colorado,2014-2015,Age,35 Months,84.7,80.2 to 88.7,504
Hib,Full Series,States/Local Areas,Colorado,2013,Age,35 Months,86.8,80.9 to 91.6,250
Hib,Full Series,States/Local Areas,Colorado,2013-2014,Age,35 Months,84.5,80.0 to 88.4,482
Hib,Full Series,States/Local Areas,Colorado,2012,Age,35 Months,83.6,76.9 to 89.3,297
Hib,Full Series,States/Local Areas,Colorado,2011,Age,35 Months,85.5,78.7 to 91.0,277
Hib,Full Series,States/Local Areas,Colorado,2019,Age,24 Months,81.0,74.3 to 86.9,265
Polio,≥3 Doses,States/Local Areas,Colorado,2015,Age,35 Months,91.7,86.9 to 95.2,272
Polio,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,35 Months,93.0,89.8 to 95.5,519
Polio,≥3 Doses,States/Local Areas,Colorado,2012,Age,35 Months,94.0,88.7 to 97.4,297
Polio,≥3 Doses,States/Local Areas,Colorado,2014,Age,35 Months,96.5,92.1 to 98.8,232
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,35 Months,94.5,91.2 to 96.8,504
Polio,≥3 Doses,States/Local Areas,Colorado,2013,Age,35 Months,91.6,86.3 to 95.5,250
Polio,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,35 Months,94.4,91.0 to 96.8,482
Polio,≥3 Doses,States/Local Areas,Colorado,2011,Age,35 Months,91.3,85.6 to 95.4,277
Hib,≥3 Doses,States/Local Areas,Colorado,2014,Age,24 Months,91.7,85.9 to 95.8,232
Hib,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,91.1,87.5 to 94.1,504
Hib,≥3 Doses,States/Local Areas,Colorado,2013,Age,24 Months,92.2,87.0 to 95.8,250
Hib,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,91.8,88.1 to 94.7,482
Hib,≥3 Doses,States/Local Areas,Colorado,2012,Age,24 Months,90.8,85.6 to 94.6,297
Hib,≥3 Doses,States/Local Areas,Colorado,2011,Age,24 Months,90.6,85.5 to 94.5,277
Polio,≥3 Doses,States/Local Areas,Colorado,2017,Age,24 Months,94.4,88.9 to 97.7,231
Polio,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,95.2,91.9 to 97.4,527
Hib,≥3 Doses,States/Local Areas,Colorado,2019,Age,19 Months,91.9,87.1 to 95.1,265
Polio,≥3 Doses,States/Local Areas,Colorado,2019,Age,24 Months,95.3,92.0 to 97.6,265
Polio,≥3 Doses,States/Local Areas,Colorado,2018,Age,24 Months,95.9,91.6 to 98.4,296
Polio,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,95.7,93.1 to 97.5,561
Hib,Full Series,States/Local Areas,Colorado,2018,Age,24 Months,81.5,74.1 to 87.8,296
Hib,Full Series,States/Local Areas,Colorado,2018-2019,Age,24 Months,81.2,76.3 to 85.7,561
Hib,Full Series,States/Local Areas,Colorado,2017,Age,24 Months,83.6,75.6 to 90.2,231
Hib,Full Series,States/Local Areas,Colorado,2017-2018,Age,24 Months,82.5,77.2 to 87.2,527
Hib,Full Series,States/Local Areas,Colorado,2016,Age,24 Months,79.6,71.9 to 86.4,247
Hib,Full Series,States/Local Areas,Colorado,2016-2017,Age,24 Months,81.5,76.1 to 86.4,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2012,Age,24 Months,93.4,88.7 to 96.6,297
Hib,Full Series,States/Local Areas,Colorado,2015,Age,24 Months,84.4,78.7 to 89.3,272
Hib,Full Series,States/Local Areas,Colorado,2015-2016,Age,24 Months,82.0,77.2 to 86.3,519
DTaP,≥3 Doses,States/Local Areas,Colorado,2013,Age,24 Months,93.3,88.8 to 96.4,250
DTaP,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,94.8,92.1 to 96.8,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2011,Age,24 Months,92.9,88.0 to 96.3,277
DTaP,≥3 Doses,States/Local Areas,Colorado,2018,Age,19 Months,95.5,90.4 to 97.9,296
DTaP,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,93.4,90.3 to 95.6,561
DTaP,≥3 Doses,States/Local Areas,Colorado,2017,Age,19 Months,95.2,88.8 to 98.0,231
DTaP,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,95.3,91.7 to 97.4,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2016,Age,19 Months,95.0,90.3 to 97.5,247
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,95.1,91.6 to 97.2,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2019,Age,19 Months,95.2,91.5 to 97.4,265
Polio,≥3 Doses,States/Local Areas,Colorado,2015,Age,24 Months,91.3,86.5 to 94.9,272
Polio,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,92.3,89.1 to 94.8,519
Polio,≥3 Doses,States/Local Areas,Colorado,2014,Age,24 Months,94.8,90.0 to 97.8,232
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,92.9,89.7 to 95.5,504
Hib,≥3 Doses,States/Local Areas,Colorado,2018,Age,19 Months,92.2,86.4 to 95.7,296
Hib,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,19 Months,78.3,73.0 to 82.8,561
Hib,≥3 Doses,States/Local Areas,Colorado,2017,Age,19 Months,93.5,87.3 to 96.8,231
Hib,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,19 Months,92.9,89.0 to 95.4,527
Polio,≥3 Doses,States/Local Areas,Colorado,2016,Age,24 Months,93.5,88.8 to 96.6,247
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,94.0,90.7 to 96.4,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2015,Age,19 Months,92.6,87.3 to 95.8,272
DTaP,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,93.8,90.8 to 95.9,519
DTaP,≥3 Doses,States/Local Areas,Colorado,2014,Age,19 Months,95.7,91.3 to 97.9,232
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,94.2,91.0 to 96.2,504
Hib,≥3 Doses,States/Local Areas,Colorado,2016,Age,19 Months,90.0,83.9 to 94.0,247
Hib,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,19 Months,91.7,87.7 to 94.5,478
Polio,≥2 Doses,States/Local Areas,Colorado,2020,Age,13 Months,93.2,88.7 to 96.0,311
Hib,≥3 Doses,States/Local Areas,Colorado,2015,Age,19 Months,89.7,87.1 to 91.8,272
Hib,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,19 Months,89.9,86.1 to 92.7,519
Polio,≥3 Doses,States/Local Areas,Colorado,2019,Age,19 Months,94.9,91.3 to 97.1,265
Polio,≥3 Doses,States/Local Areas,Colorado,2012,Age,24 Months,92.1,87.0 to 95.8,297
Polio,≥3 Doses,States/Local Areas,Colorado,2011,Age,24 Months,88.3,82.7 to 92.8,277
Hib,≥3 Doses,States/Local Areas,Colorado,2014,Age,19 Months,91.3,84.7 to 95.1,232
Hib,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,19 Months,90.5,86.5 to 93.4,504
Polio,≥3 Doses,States/Local Areas,Colorado,2013,Age,24 Months,90.3,85.0 to 94.3,250
Polio,≥3 Doses,States/Local Areas,Colorado,2013-2014,Age,24 Months,92.6,89.1 to 95.3,482
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.6,74.0 to 87.1,303
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,83.8,79.5 to 88.1,504
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.2,75.2 to 85.2,570
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,69.1 to 91.4,96
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,86.1,81.0 to 91.1,203
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,78.5,72.5 to 84.5,345
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,79.0,72.0 to 85.9,182
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Overall,Overall,81.9,78.4 to 85.4,894
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,74.3,62.0 to 86.5,87
Hib,Primary Series,States/Local Areas,Colorado,2012,Age,7 Months,72.0,61.5 to 80.6,297
Hib,Full Series,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,89.6,85.2 to 94.1,367
Hib,Primary Series,States/Local Areas,Colorado,2011,Age,7 Months,75.6,72.6 to 78.5,277
Hib,≥1 Dose,States/Local Areas,Virginia,2020,Age,3 Months,82.0,76.0 to 86.8,494
Polio,≥1 Dose,States/Local Areas,Virginia,2020,Age,3 Months,86.0,80.3 to 90.2,494
Hib,Primary Series,States/Local Areas,Virginia,2016,Age,35 Months,96.2,91.8 to 98.6,389
Hib,Primary Series,States/Local Areas,Virginia,2016-2017,Age,35 Months,94.2,90.9 to 96.6,808
Hib,Primary Series,States/Local Areas,Virginia,2012,Age,35 Months,90.8,84.2 to 95.4,342
Combined 7 Series,,States/Local Areas,Virginia,2011,Age,24 Months,65.8,55.7 to 75.8,277
Combined 7 Series,,States/Local Areas,Virginia,2012,Age,24 Months,62.1,53.0 to 71.2,342
Hib,Primary Series,States/Local Areas,Virginia,2013,Age,35 Months,93.3,88.5 to 96.7,357
Hib,Primary Series,States/Local Areas,Virginia,2013-2014,Age,35 Months,94.5,91.3 to 96.8,708
Hib,Primary Series,States/Local Areas,Virginia,2011,Age,35 Months,94.2,87.4 to 98.0,277
Hib,Primary Series,States/Local Areas,Virginia,2019,Age,24 Months,97.4,93.7 to 99.2,452
Hep B,≥1 Dose,States/Local Areas,Virginia,2020,Age,3 Months,94.5,90.7 to 96.8,494
Hep B,≥3 Doses,States/Local Areas,Virginia,2020,Age,24 Months,90.6,86.3 to 93.9,494
Hep B,≥3 Doses,States/Local Areas,Virginia,2020,Age,7 Months,45.6,39.2 to 52.2,494
PCV,≥3 Doses,States/Local Areas,Virginia,2020,Age,7 Months,69.7,63.0 to 75.6,494
DTaP,≥3 Doses,States/Local Areas,Virginia,2020,Age,13 Months,87.2,81.6 to 91.2,494
Rotavirus,,States/Local Areas,Virginia,2019-2020,Age,8 Months,76.8,72.0 to 81.0,946
≥1 Dose Varicella,,States/Local Areas,Virginia,2020-2021,Age,35 Months,93.6,89.4 to 96.5,804
Hib,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,91.9,88.3 to 94.5,804
Hib,Primary Series,States/Local Areas,Virginia,2015,Age,35 Months,94.2,89.3 to 97.4,374
Hib,Primary Series,States/Local Areas,Virginia,2015-2016,Age,35 Months,95.1,92.0 to 97.3,763
PCV,≥3 Doses,States/Local Areas,Virginia,2021,Age,13 Months,86.8,79.7 to 91.7,310
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2021,Age,0-1 Days,74.0,65.9 to 80.7,310
Hib,Primary Series,States/Local Areas,Virginia,2013,Age,24 Months,92.5,87.6 to 95.9,357
Hib,Primary Series,States/Local Areas,Virginia,2013-2014,Age,24 Months,94.1,90.8 to 96.4,708
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2021,Age,0-2 Days,74.9,66.7 to 81.6,310
PCV,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,91.6,88.0 to 94.5,804
PCV,≥4 Doses,States/Local Areas,Virginia,2021,Age,24 Months,79.9,72.9 to 86.1,310
≥1 Dose Varicella,,States/Local Areas,Virginia,2021,Age,24 Months,88.9,82.7 to 93.7,310
Hep A,≥1 Dose,States/Local Areas,Virginia,2021,Age,24 Months,84.8,78.0 to 90.4,310
PCV,≥3 Doses,States/Local Areas,Virginia,2021,Age,24 Months,90.5,84.3 to 94.9,310
Hib,Full Series,States/Local Areas,Virginia,2021,Age,24 Months,75.0,67.6 to 81.8,310
Hib,Primary Series,States/Local Areas,Virginia,2021,Age,24 Months,89.9,83.8 to 94.5,310
Hib,≥3 Doses,States/Local Areas,Virginia,2021,Age,24 Months,88.6,82.2 to 93.5,310
≥1 Dose MMR,,States/Local Areas,Virginia,2021,Age,24 Months,86.7,80.1 to 91.9,310
Polio,≥1 Dose,States/Local Areas,Virginia,2021,Age,3 Months,89.4,82.7 to 93.7,310
Polio,≥3 Doses,States/Local Areas,Virginia,2021,Age,24 Months,90.8,84.6 to 95.2,310
Hep A,≥2 Doses,States/Local Areas,Virginia,2021,Age,35 Months,68.0,57.8 to 77.7,310
Hep A,≥1 Dose,States/Local Areas,Virginia,2021,Age,35 Months,89.9,82.7 to 95.0,310
PCV,≥3 Doses,States/Local Areas,Virginia,2021,Age,19 Months,88.1,81.0 to 92.8,310
DTaP,≥4 Doses,States/Local Areas,Virginia,2021,Age,19 Months,73.8,66.0 to 80.3,310
Hep B,≥3 Doses,States/Local Areas,Virginia,2021,Age,24 Months,90.1,84.2 to 94.5,310
DTaP,≥3 Doses,States/Local Areas,Virginia,2021,Age,13 Months,87.8,80.6 to 92.5,310
PCV,≥3 Doses,States/Local Areas,Virginia,2021,Age,7 Months,68.5,59.8 to 76.0,310
PCV,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,5 Months,78.9,73.6 to 83.4,804
Hep A,≥2 Doses,States/Local Areas,Virginia,2021,Age,24 Months,39.5,32.0 to 48.1,310
Influenza,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,59.8 to 81.7,300
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,86.2,79.2 to 93.2,244
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.2,92.7 to 97.7,974
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,84.3,64.7 to 100.0,34
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.3,85.5 to 93.2,974
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,82.3,60.4 to 100.0,34
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.6,79.4 to 93.8,120
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,92.7,88.3 to 97.2,213
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,94.3,92.1 to 96.5,1368
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,79.7,72.5 to 86.8,213
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,69.2,43.8 to 94.6,34
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,76.1,68.6 to 83.7,213
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,80.0,59.6 to 100.0,34
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,83.3,63.7 to 100.0,34
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,96.1,94.1 to 98.1,1368
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.2 to 100.0,300
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,90.3,84.9 to 95.7,213
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,89.7,84.2 to 95.2,213
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,92.7,79.6 to 100.0,34
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.4,85.8 to 92.9,974
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,93.7 to 98.3,974
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.8,91.3 to 100.0,120
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,91.6,85.5 to 97.8,244
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,92.1,89.7 to 94.4,1368
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,83.9 to 97.8,300
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.9,79.3 to 94.6,120
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,71.8,61.6 to 81.9,213
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,84.2,79.3 to 89.1,1368
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,80.4 to 95.5,300
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,79.2,70.7 to 87.7,244
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,92.7,79.6 to 100.0,34
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,89.6,84.0 to 95.2,213
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,92.7,79.6 to 100.0,34
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.8 to 97.5,1368
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,84.6,78.4 to 90.8,213
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.4,87.7 to 99.0,120
Influenza,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,68.5,58.6 to 78.4,244
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,63.5,37.5 to 89.6,34
Rotavirus,,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,87.5,83.5 to 91.5,1086
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,93.8,91.5 to 96.0,1638
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,86.7,83.7 to 89.7,1638
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,93.7,91.5 to 95.9,1638
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,75.4,66.7 to 84.1,155
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,84.2,78.6 to 89.9,397
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,93.7,90.8 to 96.6,1086
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,97.7,96.1 to 99.4,1086
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,86.7,80.8 to 92.5,1086
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,81.2,73.4 to 88.9,155
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,86.7,79.8 to 93.7,155
Influenza,,States/Local Areas,Virginia,2016-2019,Overall,Overall,70.3,66.2 to 74.4,1638
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,93.2,89.5 to 96.8,397
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,79.3,71.6 to 87.1,155
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Overall,Overall,74.8,71.0 to 78.7,1638
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,69.3,57.7 to 80.9,155
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Overall,Overall,78.5,74.9 to 82.0,1638
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,89.5,83.4 to 95.6,155
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Overall,Overall,87.8,84.9 to 90.7,1638
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Overall,Overall,93.6,91.4 to 95.7,1638
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,98.7,97.5 to 99.8,1086
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Overall,Overall,92.2,90.0 to 94.5,1638
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,79.8,75.1 to 84.5,1638
Rotavirus,,States/Local Areas,Virginia,2016-2019,Overall,Overall,81.6,78.2 to 85.0,1638
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,71.7,64.7 to 78.8,397
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,83.5,79.2 to 87.7,1086
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,94.5,91.9 to 97.2,1086
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,71.0,63.9 to 78.1,397
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,62.6,52.9 to 72.3,155
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,93.7,90.6 to 96.9,397
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Overall,Overall,83.2,79.9 to 86.6,1638
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,73.5,57.2 to 89.7,51
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,97.2,95.0 to 99.4,1086
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.3,77.9 to 86.8,847
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,94.7,89.3 to 100.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,74.6,68.8 to 80.3,740
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.9 to 95.5,847
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,91.4,83.1 to 99.8,51
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.7,90.4 to 97.1,847
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,74.8,69.0 to 80.6,740
Influenza,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,51.1,31.6 to 70.5,51
Influenza,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.0,64.3 to 75.6,847
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,91.0 to 97.3,740
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,96.9,93.7 to 100.0,51
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,91.4,87.8 to 95.0,740
DTaP,≥3 Doses,States/Local Areas,Virginia,2021,Age,19 Months,88.2,81.1 to 92.9,310
Hib,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,78.9,74.0 to 83.0,804
Hep B,≥3 Doses,States/Local Areas,Virginia,2021,Age,7 Months,49.4,41.2 to 57.6,310
DTaP,≥1 Dose,States/Local Areas,Virginia,2021,Age,3 Months,89.3,82.6 to 93.7,310
DTaP,≥4 Doses,States/Local Areas,Virginia,2021,Age,24 Months,78.2,70.9 to 84.8,310
Hep A,≥2 Doses,States/Local Areas,Virginia,2021,Age,19 Months,28.4,21.7 to 36.2,310
Hep A,≥1 Dose,States/Local Areas,Virginia,2021,Age,19 Months,82.7,75.2 to 88.2,310
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,86.0,81.4 to 90.6,740
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.2,84.2 to 92.3,847
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.3 to 97.3,847
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,92.1 to 98.0,847
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,91.5 to 97.7,740
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,80.7,67.1 to 94.2,51
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,90.8,81.9 to 99.8,51
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,81.9,68.3 to 95.5,51
Rotavirus,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.1,80.7 to 89.5,847
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.8,72.3 to 85.2,847
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,82.5,77.3 to 87.7,740
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,73.9,58.1 to 89.7,51
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.1,80.6 to 89.6,847
Rotavirus,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,61.7,43.5 to 79.9,51
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,93.2,89.8 to 96.5,740
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.9,82.6 to 91.3,847
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,89.9,86.1 to 93.7,740
Rotavirus,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,80.7,75.6 to 85.9,740
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.1,70.8 to 81.4,847
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,66.1,48.5 to 83.8,51
Influenza,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,74.0,67.9 to 80.0,740
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,88.7,79.4 to 98.0,51
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.7,84.8 to 92.5,847
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,87.9,83.7 to 92.2,740
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,96.9,93.7 to 100.0,51
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,90.3,81.6 to 98.9,51
DTaP,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,3 Months,90.6,87.0 to 93.3,946
Polio,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,3 Months,89.6,85.9 to 92.4,946
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.8,91.9 to 97.6,847
PCV,≥3 Doses,States/Local Areas,Virginia,2021,Age,35 Months,91.1,84.8 to 95.5,310
≥1 Dose MMR,,States/Local Areas,Virginia,2021,Age,35 Months,90.2,81.7 to 95.9,310
PCV,≥4 Doses,States/Local Areas,Virginia,2021,Age,35 Months,83.1,75.6 to 89.4,310
Polio,≥2 Doses,States/Local Areas,Virginia,2021,Age,13 Months,90.9,84.5 to 94.8,310
Hep B,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,92.8,89.4 to 95.5,804
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.7,91.7 to 99.6,120
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,90.6 to 96.3,974
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,81.9,74.9 to 88.9,740
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a Non-MSA,77.3,51.8 to 100.0,51
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,52.4,25.7 to 79.2,34
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.3,64.0 to 84.6,300
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,90.7,84.5 to 96.8,244
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.2,89.9 to 96.5,847
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,90.3 to 96.9,740
Rotavirus,,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,81.0,75.2 to 86.8,397
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Urbanicity,Living In a MSA Principal City,92.0,88.6 to 95.3,740
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,94.7,92.5 to 97.0,1086
Rotavirus,,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,71.3,62.2 to 80.3,155
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,82.9,78.5 to 87.3,1086
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,78.2,69.5 to 86.8,397
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,98.0,97.0 to 99.0,1086
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,88.8,82.2 to 95.3,155
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,94.6,91.3 to 97.8,397
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,95.0,93.0 to 97.0,1638
Influenza,,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,83.6,79.1 to 88.1,1086
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,93.0,90.9 to 95.2,1638
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,95.9,93.9 to 97.8,1086
Influenza,,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,50.8,40.9 to 60.7,155
Influenza,,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,66.0,58.5 to 73.5,397
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,91.9,88.2 to 95.6,397
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,86.0,79.2 to 92.8,155
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,85.6,78.6 to 92.7,155
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,93.3,90.6 to 95.9,1086
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,93.1,89.4 to 96.7,397
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Poverty,>400% FPL,90.2,86.7 to 93.8,1086
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,86.4,79.5 to 93.3,155
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,94.6,91.4 to 97.8,397
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,79.8,73.5 to 86.2,397
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,74.2,65.5 to 82.9,155
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,87.1,82.3 to 91.9,397
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Overall,Overall,88.3,85.6 to 91.0,1638
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Poverty,<133% FPL,77.9,69.8 to 86.1,155
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,91.7,86.5 to 96.9,213
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,69.0,60.7 to 77.2,213
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,84.8 to 97.7,300
Hib,Primary Series,States/Local Areas,Virginia,2019-2020,Age,7 Months,73.0,68.1 to 77.4,946
DTaP,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,90.0,86.3 to 92.8,946
Polio,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,91.1,87.5 to 93.7,946
DTaP,≥4 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,74.3,69.6 to 78.5,946
PCV,≥4 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,80.1,75.5 to 84.4,804
Hib,≥3 Doses,States/Local Areas,Virginia,2021,Age,7 Months,61.2,52.7 to 69.1,310
Hib,Primary Series,States/Local Areas,Virginia,2020-2021,Age,24 Months,90.6,87.0 to 93.5,804
Hib,≥3 Doses,States/Local Areas,Virginia,2021,Age,19 Months,87.1,79.8 to 92.0,310
Hib,≥2 Doses,States/Local Areas,Virginia,2021,Age,5 Months,79.0,70.3 to 85.6,310
Hib,Primary Series,States/Local Areas,Virginia,2021,Age,19 Months,88.6,81.5 to 93.1,310
Hep B,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,86.9,82.9 to 90.1,804
Hib,≥2 Doses,States/Local Areas,Virginia,2021,Age,7 Months,89.2,82.5 to 93.6,310
DTaP,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,89.6,85.3 to 92.7,804
DTaP,≥3 Doses,States/Local Areas,Virginia,2021,Age,7 Months,71.6,63.0 to 78.9,310
PCV,≥2 Doses,States/Local Areas,Virginia,2021,Age,5 Months,80.0,71.2 to 86.6,310
Hib,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,89.8,86.0 to 92.8,804
Polio,≥3 Doses,States/Local Areas,Virginia,2021,Age,19 Months,88.0,80.8 to 92.7,310
Polio,≥2 Doses,States/Local Areas,Virginia,2021,Age,7 Months,89.4,82.7 to 93.7,310
Hib,Primary Series,States/Local Areas,Virginia,2021,Age,7 Months,67.3,58.7 to 74.9,310
Polio,≥2 Doses,States/Local Areas,Virginia,2020,Age,7 Months,85.6,79.8 to 90.0,494
Hib,≥2 Doses,States/Local Areas,Virginia,2020,Age,7 Months,85.1,79.3 to 89.5,494
Hib,Primary Series,States/Local Areas,Virginia,2020,Age,7 Months,66.2,59.3 to 72.4,494
Hib,≥3 Doses,States/Local Areas,Virginia,2020,Age,7 Months,59.9,53.2 to 66.3,494
DTaP,≥3 Doses,States/Local Areas,Virginia,2020,Age,24 Months,93.1,88.9 to 96.2,494
Hep B,≥2 Doses,States/Local Areas,Virginia,2020,Age,7 Months,91.1,86.5 to 94.3,494
DTaP,≥4 Doses,States/Local Areas,Virginia,2020,Age,24 Months,81.2,75.3 to 86.3,494
Polio,≥3 Doses,States/Local Areas,Virginia,2020,Age,24 Months,92.2,87.8 to 95.5,494
Hib,≥3 Doses,States/Local Areas,Virginia,2020,Age,24 Months,90.7,86.3 to 94.1,494
≥1 Dose MMR,,States/Local Areas,Virginia,2020,Age,24 Months,89.5,84.6 to 93.4,494
Hib,≥3 Doses,States/Local Areas,Virginia,2020,Age,35 Months,91.4,86.9 to 94.8,494
≥1 Dose MMR,,States/Local Areas,Virginia,2020,Age,35 Months,91.2,86.2 to 95.0,494
Hib,Primary Series,States/Local Areas,Virginia,2020,Age,24 Months,91.0,86.6 to 94.3,494
Hib,Primary Series,States/Local Areas,Virginia,2020,Age,35 Months,91.8,87.2 to 95.2,494
Hep B,≥3 Doses,States/Local Areas,Virginia,2020,Age,35 Months,93.2,89.0 to 96.2,494
Hib,Full Series,States/Local Areas,Virginia,2020,Age,35 Months,79.1,72.6 to 84.9,494
PCV,≥3 Doses,States/Local Areas,Virginia,2020,Age,35 Months,92.1,87.5 to 95.6,494
Hib,Primary Series,States/Local Areas,Virginia,2020,Age,19 Months,89.0,84.0 to 92.6,494
≥1 Dose Varicella,,States/Local Areas,Virginia,2020,Age,35 Months,94.4,89.3 to 97.6,494
Hep B,≥3 Doses,States/Local Areas,Virginia,2020,Age,19 Months,88.3,83.2 to 92.0,494
Hib,Full Series,States/Local Areas,Virginia,2020,Age,19 Months,71.0,64.6 to 76.7,494
≥1 Dose Varicella,,States/Local Areas,Virginia,2020,Age,19 Months,85.8,80.2 to 90.0,494
PCV,≥3 Doses,States/Local Areas,Virginia,2020,Age,19 Months,90.1,85.0 to 93.6,494
Polio,≥3 Doses,States/Local Areas,Virginia,2020,Age,35 Months,93.1,88.6 to 96.3,494
DTaP,≥4 Doses,States/Local Areas,Virginia,2020,Age,35 Months,87.9,81.3 to 93.0,494
PCV,≥4 Doses,States/Local Areas,Virginia,2020,Age,19 Months,76.0,69.6 to 81.4,494
Hib,≥3 Doses,States/Local Areas,Virginia,2020,Age,13 Months,78.7,72.6 to 83.8,494
PCV,≥4 Doses,States/Local Areas,Virginia,2020,Age,35 Months,82.0,76.0 to 87.3,494
Hib,Primary Series,States/Local Areas,Virginia,2020,Age,13 Months,82.6,76.8 to 87.2,494
Hep B,≥2 Doses,States/Local Areas,Virginia,2020,Age,13 Months,94.3,90.3 to 96.7,494
Hep B,≥3 Doses,States/Local Areas,Virginia,2020,Age,13 Months,86.4,81.2 to 90.4,494
DTaP,≥3 Doses,States/Local Areas,Virginia,2020,Age,7 Months,70.4,63.5 to 76.4,494
PCV,≥3 Doses,States/Local Areas,Virginia,2020,Age,13 Months,86.7,81.1 to 90.8,494
≥1 Dose Varicella,,States/Local Areas,Virginia,2020,Age,13 Months,58.8,52.2 to 65.1,494
PCV,≥2 Doses,States/Local Areas,Virginia,2020,Age,5 Months,77.7,71.4 to 83.0,494
DTaP,≥3 Doses,States/Local Areas,Virginia,2020,Age,19 Months,90.9,86.0 to 94.2,494
DTaP,≥4 Doses,States/Local Areas,Virginia,2020,Age,19 Months,71.2,64.8 to 77.0,494
Polio,≥3 Doses,States/Local Areas,Virginia,2020,Age,19 Months,90.0,84.9 to 93.5,494
≥1 Dose MMR,,States/Local Areas,Virginia,2020,Age,19 Months,85.6,79.8 to 89.9,494
Hib,≥3 Doses,States/Local Areas,Virginia,2020,Age,19 Months,88.0,82.7 to 91.8,494
Rotavirus,,States/Local Areas,Virginia,2020,Age,8 Months,71.9,65.2 to 77.8,494
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2020,Age,0-3 Days,74.0,67.8 to 79.4,494
Influenza,,States/Local Areas,Virginia,2020,Age,24 Months,61.7,55.2 to 68.3,494
DTaP,≥3 Doses,States/Local Areas,Virginia,2020,Age,35 Months,94.1,89.7 to 97.0,494
PCV,≥3 Doses,States/Local Areas,Virginia,2020,Age,24 Months,90.7,86.0 to 94.3,494
Hep A,≥1 Dose,States/Local Areas,Virginia,2020,Age,24 Months,85.9,80.8 to 90.3,494
PCV,≥4 Doses,States/Local Areas,Virginia,2020,Age,24 Months,80.2,74.2 to 85.5,494
Combined 7 Series,,States/Local Areas,Virginia,2020,Age,24 Months,67.5,61.1 to 73.8,494
Hep A,≥2 Doses,States/Local Areas,Virginia,2020,Age,24 Months,40.5,34.2 to 47.5,494
PCV,≥1 Dose,States/Local Areas,Virginia,2020,Age,3 Months,85.5,79.8 to 89.8,494
DTaP,≥2 Doses,States/Local Areas,Virginia,2020,Age,5 Months,79.3,72.9 to 84.5,494
Polio,≥2 Doses,States/Local Areas,Virginia,2020,Age,5 Months,78.6,72.2 to 83.8,494
Hep B,≥2 Doses,States/Local Areas,Virginia,2020,Age,5 Months,87.6,82.3 to 91.4,494
Hib,≥2 Doses,States/Local Areas,Virginia,2020,Age,5 Months,74.6,68.0 to 80.1,494
Hib,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,3 Months,87.2,83.3 to 90.3,946
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,90.8 to 96.1,974
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.1,89.5 to 100.0,300
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",96.2,92.7 to 99.7,120
Rotavirus,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.2,77.6 to 86.8,974
Rotavirus,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.8,70.7 to 88.9,120
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,80.5,76.6 to 84.3,1368
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.5,62.6 to 82.4,300
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.9,69.8 to 88.0,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,78.8,74.8 to 82.9,1368
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,79.6,72.6 to 86.5,213
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.2,92.8 to 97.7,974
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,70.6,46.2 to 95.0,34
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,87.0 to 99.3,300
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",96.8,93.5 to 100.0,120
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,86.3,79.0 to 93.7,244
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,94.1,92.1 to 96.1,1368
Rotavirus,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.1,73.2 to 91.1,300
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,92.7,79.6 to 100.0,34
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,97.4,96.0 to 98.9,1368
Rotavirus,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,87.4,84.2 to 90.6,1368
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.6,77.5 to 93.8,300
Influenza,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,77.7,73.5 to 81.9,1368
Influenza,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,57.4,48.6 to 66.2,213
Influenza,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,61.1,33.2 to 88.9,34
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.9,79.2 to 88.5,974
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,93.3,80.4 to 100.0,34
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,83.9,76.8 to 90.9,244
Rotavirus,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,73.4,65.8 to 81.0,213
Rotavirus,,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Other,58.1,31.3 to 84.8,34
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.9,70.8 to 81.1,974
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,67.4,57.7 to 77.2,244
Combined 7 Series,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.7,72.0 to 89.5,120
Rotavirus,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,81.3,73.6 to 89.1,244
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.9,87.6 to 94.2,974
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,82.3,74.8 to 89.8,244
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,82.5 to 95.7,120
Influenza,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.3,67.9 to 78.8,974
Influenza,,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.7,52.9 to 74.4,120
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,91.8 to 97.5,974
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,90.1,84.7 to 95.6,213
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.9,88.7 to 99.2,120
Polio,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,96.3,91.4 to 98.8,946
DTaP,≥4 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,89.3,85.0 to 92.8,946
DTaP,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,96.9,92.5 to 99.0,946
Combined 7 Series,,States/Local Areas,Virginia,2019-2020,Age,24 Months,72.7,68.1 to 77.2,946
DTaP,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,92.5,89.0 to 94.9,946
≥1 Dose Varicella,,States/Local Areas,Virginia,2019-2020,Age,13 Months,61.7,56.8 to 66.5,946
PCV,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,89.4,85.7 to 92.3,946
Hib,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,89.1,85.4 to 92.0,946
Hep B,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,88.1,84.3 to 91.1,946
DTaP,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,76.1,71.3 to 80.3,946
Polio,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,88.4,84.6 to 91.4,946
PCV,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,5 Months,81.0,76.4 to 84.8,946
Hep B,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,5 Months,89.6,86.0 to 92.4,946
Hep B,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,95.5,92.9 to 97.2,946
Hib,Primary Series,States/Local Areas,Virginia,2019-2020,Age,13 Months,87.4,83.7 to 90.4,946
Hib,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,94.2,91.3 to 96.2,946
Hib,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,81.4,76.9 to 85.3,946
≥1 Dose MMR,,States/Local Areas,Virginia,2019-2020,Age,13 Months,69.3,64.5 to 73.7,946
Polio,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,13 Months,93.9,90.7 to 96.0,946
Polio,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,5 Months,81.2,76.6 to 85.0,946
Hib,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,5 Months,78.9,74.2 to 82.8,946
DTaP,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,5 Months,82.1,77.6 to 85.9,946
PCV,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,3 Months,88.8,85.0 to 91.7,946
Hep B,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,3 Months,95.9,93.3 to 97.5,946
≥1 Dose MMR,,States/Local Areas,Virginia,2019-2020,Age,24 Months,92.5,89.4 to 95.0,946
DTaP,≥4 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,83.3,79.1 to 87.1,946
Polio,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,92.6,89.3 to 95.2,946
DTaP,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,93.6,90.5 to 96.0,946
PCV,≥4 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,88.2,82.6 to 92.7,946
PCV,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,94.5,91.6 to 96.7,946
≥1 Dose Varicella,,States/Local Areas,Virginia,2019-2020,Age,35 Months,95.6,92.2 to 97.8,946
Hep B,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,96.0,91.8 to 98.5,946
Hib,Full Series,States/Local Areas,Virginia,2019-2020,Age,35 Months,86.4,80.3 to 91.4,946
Hib,Primary Series,States/Local Areas,Virginia,2019-2020,Age,35 Months,94.9,92.4 to 96.8,946
Hib,Full Series,States/Local Areas,Virginia,2019-2020,Age,19 Months,75.3,70.7 to 79.4,946
≥1 Dose MMR,,States/Local Areas,Virginia,2019-2020,Age,35 Months,94.1,91.0 to 96.4,946
Hib,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,93.8,91.0 to 96.0,946
Hib,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,91.9,88.7 to 94.3,946
Hib,Primary Series,States/Local Areas,Virginia,2019-2020,Age,19 Months,93.2,90.3 to 95.3,946
≥1 Dose MMR,,States/Local Areas,Virginia,2019-2020,Age,19 Months,88.6,84.9 to 91.5,946
Hep A,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,26.8,22.6 to 31.5,946
PCV,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,93.6,90.7 to 95.9,946
PCV,≥4 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,83.9,79.8 to 87.6,946
Hep B,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,91.6,88.3 to 94.2,946
≥1 Dose Varicella,,States/Local Areas,Virginia,2019-2020,Age,24 Months,90.6,87.1 to 93.4,946
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2019-2020,Age,0-3 Days,78.6,74.1 to 82.5,946
PCV,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,74.0,69.1 to 78.3,946
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2019-2020,Age,0-2 Days,78.0,73.5 to 81.9,946
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2019-2020,Age,0-1 Days,73.9,69.2 to 78.1,946
PCV,≥4 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,81.2,76.8 to 84.9,946
Hep A,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,19 Months,83.3,79.0 to 86.8,946
Hep B,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,90.3,86.7 to 93.0,946
≥1 Dose Varicella,,States/Local Areas,Virginia,2019-2020,Age,19 Months,87.6,83.8 to 90.6,946
Hib,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,65.1,60.0 to 69.9,946
Combined 7 Series,,States/Local Areas,Virginia,2019-2020,Age,35 Months,78.0,73.2 to 82.5,946
Hib,Full Series,States/Local Areas,Virginia,2019-2020,Age,24 Months,80.1,75.8 to 84.1,946
Hib,Primary Series,States/Local Areas,Virginia,2019-2020,Age,24 Months,94.5,92.1 to 96.5,946
Influenza,,States/Local Areas,Virginia,2019-2020,Age,24 Months,69.2,64.5 to 73.8,946
Hib,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,93.4,90.6 to 95.6,946
Hep A,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,24 Months,42.5,37.7 to 47.7,946
Polio,≥2 Doses,States/Local Areas,Virginia,2020,Age,13 Months,92.5,87.9 to 95.4,494
Hep A,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,35 Months,92.9,88.8 to 95.9,946
Hep A,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,35 Months,83.2,76.6 to 88.8,946
Hep A,≥1 Dose,States/Local Areas,Virginia,2019-2020,Age,24 Months,88.4,84.7 to 91.6,946
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2020,Age,0-1 Days,68.5,62.1 to 74.3,494
Combined 7 Series,,States/Local Areas,Virginia,2020,Age,35 Months,73.7,66.6 to 80.4,494
Hep A,≥2 Doses,States/Local Areas,Virginia,2020,Age,35 Months,77.3,69.5 to 84.3,494
Hep A,≥1 Dose,States/Local Areas,Virginia,2020,Age,19 Months,80.9,75.0 to 85.6,494
Hep A,≥2 Doses,States/Local Areas,Virginia,2020,Age,19 Months,23.6,18.5 to 29.6,494
DTaP,≥1 Dose,States/Local Areas,Virginia,2020,Age,3 Months,86.6,81.0 to 90.8,494
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2020,Age,0-2 Days,73.2,67.0 to 78.7,494
Hep A,≥1 Dose,States/Local Areas,Virginia,2018,Age,19 Months,76.6,69.3 to 82.5,551
Hep A,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,19 Months,79.5,73.8 to 84.2,829
DTaP,≥4 Doses,States/Local Areas,Virginia,2011,Age,19 Months,67.7,59.9 to 74.7,277
DTaP,≥4 Doses,States/Local Areas,Virginia,2012,Age,19 Months,64.0,55.1 to 71.9,342
Hep A,≥2 Doses,States/Local Areas,Virginia,2014,Age,19 Months,22.4,16.0 to 30.5,351
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,22.3,17.6 to 27.8,725
Hep A,≥1 Dose,States/Local Areas,Virginia,2013,Age,24 Months,80.0,72.5 to 86.5,357
Hep A,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,24 Months,83.4,78.3 to 87.8,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2011,Age,24 Months,78.3,69.1 to 86.3,277
Hep A,≥1 Dose,States/Local Areas,Virginia,2012,Age,24 Months,76.4,68.0 to 83.9,342
Hep A,≥1 Dose,States/Local Areas,Virginia,2019,Age,19 Months,85.5,78.9 to 90.2,452
DTaP,≥3 Doses,States/Local Areas,Virginia,2016,Age,35 Months,96.8,92.3 to 99.0,389
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,94.6,91.4 to 96.9,808
DTaP,≥3 Doses,States/Local Areas,Virginia,2015,Age,35 Months,97.1,93.8 to 98.9,374
DTaP,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,97.0,94.4 to 98.5,763
PCV,≥2 Doses,States/Local Areas,Virginia,2011,Age,5 Months,78.3,70.2 to 84.6,277
PCV,≥2 Doses,States/Local Areas,Virginia,2012,Age,5 Months,68.4,59.1 to 76.4,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2017,Age,35 Months,92.2,86.9 to 95.9,419
DTaP,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,93.9,90.1 to 96.5,970
Hep A,≥2 Doses,States/Local Areas,Virginia,2017,Age,19 Months,27.2,20.5 to 35.2,419
Hep A,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,27.7,23.0 to 32.9,970
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.8 to 99.0,1104
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,94.3,89.7 to 98.9,149
DTaP,≥4 Doses,States/Local Areas,Virginia,2015,Age,19 Months,73.1,63.3 to 81.0,374
DTaP,≥4 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,76.7,71.2 to 81.5,763
DTaP,≥4 Doses,States/Local Areas,Virginia,2014,Age,19 Months,71.5,62.3 to 79.2,351
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,72.3,66.2 to 77.7,725
DTaP,≥4 Doses,States/Local Areas,Virginia,2013,Age,19 Months,69.6,57.4 to 79.5,357
DTaP,≥4 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,70.5,65.0 to 75.5,708
Hib,≥3 Doses,States/Local Areas,Virginia,2017,Age,35 Months,91.3,85.7 to 95.3,419
Hib,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,92.8,88.8 to 95.8,970
Hib,≥3 Doses,States/Local Areas,Virginia,2016,Age,35 Months,95.2,90.5 to 98.0,389
Hib,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,93.4,89.9 to 96.0,808
Hep A,≥2 Doses,States/Local Areas,Virginia,2018,Age,19 Months,28.1,22.1 to 35.1,551
Hep A,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,29.7,24.4 to 35.7,829
Hep A,≥2 Doses,States/Local Areas,Virginia,2011,Age,24 Months,35.4,26.0 to 47.0,277
PCV,≥2 Doses,States/Local Areas,Virginia,2014,Age,5 Months,78.3,69.2 to 85.3,351
PCV,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,5 Months,79.7,77.5 to 81.8,725
Hep A,≥1 Dose,States/Local Areas,Virginia,2016,Age,24 Months,90.5,85.0 to 94.6,389
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,24 Months,86.6,82.0 to 90.5,808
Hep A,≥1 Dose,States/Local Areas,Virginia,2014,Age,24 Months,87.0,79.8 to 92.5,351
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,24 Months,87.9,83.4 to 91.6,725
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,94.5,84.5 to 100.0,40
PCV,≥2 Doses,States/Local Areas,Virginia,2013,Age,5 Months,74.1,66.6 to 80.4,357
PCV,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,5 Months,76.2,72.5 to 79.5,708
PCV,≥2 Doses,States/Local Areas,Virginia,2015,Age,5 Months,81.2,73.1 to 87.3,374
PCV,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,5 Months,83.2,78.0 to 87.3,763
Hib,≥3 Doses,States/Local Areas,Virginia,2014,Age,35 Months,96.1,91.5 to 98.6,351
Hib,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,95.0,91.7 to 97.2,725
Hib,≥3 Doses,States/Local Areas,Virginia,2013,Age,35 Months,92.1,87.1 to 95.7,357
Hib,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,94.2,90.9 to 96.6,708
Hep A,≥2 Doses,States/Local Areas,Virginia,2016,Age,19 Months,22.0,15.9 to 29.6,389
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,24.6,19.9 to 29.9,808
Hep A,≥2 Doses,States/Local Areas,Virginia,2015,Age,19 Months,22.2,20.2 to 24.2,374
Hep A,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,22.1,17.5 to 27.4,763
Hib,≥3 Doses,States/Local Areas,Virginia,2015,Age,35 Months,94.1,89.2 to 97.3,374
Hib,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,94.6,91.4 to 96.9,763
Hib,≥3 Doses,States/Local Areas,Virginia,2012,Age,35 Months,87.5,79.9 to 93.2,342
Hep A,≥1 Dose,States/Local Areas,Virginia,2018,Age,24 Months,83.9,77.5 to 89.3,551
Hep A,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,24 Months,87.5,83.5 to 91.0,1003
Hep A,≥1 Dose,States/Local Areas,Virginia,2011,Age,35 Months,85.2,76.2 to 92.1,277
Hep A,≥1 Dose,States/Local Areas,Virginia,2019,Age,24 Months,91.3,86.0 to 95.1,452
Hep A,≥2 Doses,States/Local Areas,Virginia,2019,Age,19 Months,29.0,22.9 to 36.0,452
PCV,≥2 Doses,States/Local Areas,Virginia,2016,Age,5 Months,85.1,78.1 to 90.2,389
PCV,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,5 Months,82.6,77.7 to 86.7,808
Hep A,≥1 Dose,States/Local Areas,Virginia,2017,Age,24 Months,82.4,75.0 to 88.7,419
Hep A,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,24 Months,83.1,78.2 to 87.5,970
Hep A,≥1 Dose,States/Local Areas,Virginia,2015,Age,24 Months,88.8,83.1 to 93.2,374
Hep A,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,24 Months,89.7,85.7 to 92.9,763
DTaP,≥3 Doses,States/Local Areas,Virginia,2018,Age,35 Months,96.6,91.8 to 99.0,551
DTaP,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,97.8,94.0 to 99.5,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2019,Age,35 Months,99.0,95.6 to 99.9,452
Hib,Full Series,States/Local Areas,Virginia,2021,Age,19 Months,73.6,65.8 to 80.1,310
Hep A,≥1 Dose,States/Local Areas,Virginia,2012,Age,19 Months,70.1,62.1 to 77.0,342
Hep A,≥1 Dose,States/Local Areas,Virginia,2016,Age,19 Months,88.2,81.9 to 92.6,389
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,19 Months,83.4,78.3 to 87.5,808
Hib,≥3 Doses,States/Local Areas,Virginia,2018,Age,24 Months,91.0,85.9 to 94.9,551
Hib,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,93.3,90.1 to 95.8,1003
Hib,≥3 Doses,States/Local Areas,Virginia,2017,Age,24 Months,90.4,84.8 to 94.6,419
Hib,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,90.7,86.8 to 93.9,970
Hib,≥3 Doses,States/Local Areas,Virginia,2019,Age,24 Months,95.6,91.2 to 98.2,452
Hep A,≥2 Doses,States/Local Areas,Virginia,2012,Age,19 Months,15.7,11.2 to 21.6,342
Hep A,≥2 Doses,States/Local Areas,Virginia,2013,Age,19 Months,25.2,21.2 to 29.5,357
Hep A,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,23.8,21.3 to 26.5,708
DTaP,≥3 Doses,States/Local Areas,Virginia,2011,Age,35 Months,94.4,87.6 to 98.2,277
DTaP,≥3 Doses,States/Local Areas,Virginia,2012,Age,35 Months,90.4,83.6 to 95.2,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2013,Age,35 Months,93.5,88.5 to 96.8,357
DTaP,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,94.9,91.7 to 97.2,708
DTaP,≥3 Doses,States/Local Areas,Virginia,2014,Age,35 Months,96.4,91.5 to 98.8,351
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,96.7,93.9 to 98.4,725
Hep A,≥2 Doses,States/Local Areas,Virginia,2011,Age,19 Months,23.0,16.4 to 31.1,277
Hep A,≥1 Dose,States/Local Areas,Virginia,2017,Age,19 Months,78.4,70.1 to 84.9,419
Hep A,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,19 Months,77.5,72.0 to 82.2,970
DTaP,≥2 Doses,States/Local Areas,Virginia,2019,Age,5 Months,84.3,77.2 to 89.4,452
Hib,≥3 Doses,States/Local Areas,Virginia,2011,Age,35 Months,95.2,87.6 to 98.8,277
Combined 7 Series,,States/Local Areas,Virginia,2021,Age,35 Months,71.4,63.1 to 79.3,310
PCV,≥4 Doses,States/Local Areas,Virginia,2021,Age,19 Months,79.1,71.6 to 85.0,310
Hep B,≥2 Doses,States/Local Areas,Virginia,2021,Age,7 Months,90.2,83.7 to 94.3,310
Hep B,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,92.9,89.3 to 95.4,804
≥1 Dose Varicella,,States/Local Areas,Virginia,2021,Age,19 Months,85.6,78.6 to 90.6,310
Hep B,≥3 Doses,States/Local Areas,Virginia,2021,Age,19 Months,90.1,83.6 to 94.2,310
DTaP,≥1 Dose,States/Local Areas,Virginia,2016,Age,3 Months,91.9,85.4 to 95.6,389
DTaP,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,3 Months,91.4,87.2 to 94.3,808
DTaP,≥1 Dose,States/Local Areas,Virginia,2015,Age,3 Months,89.2,81.2 to 94.0,374
DTaP,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,3 Months,90.5,85.7 to 93.8,763
DTaP,≥1 Dose,States/Local Areas,Virginia,2014,Age,3 Months,89.1,81.6 to 93.8,351
DTaP,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,3 Months,89.1,84.0 to 92.8,725
DTaP,≥1 Dose,States/Local Areas,Virginia,2013,Age,3 Months,83.3,77.1 to 88.1,357
DTaP,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,3 Months,86.2,80.8 to 90.2,708
DTaP,≥1 Dose,States/Local Areas,Virginia,2011,Age,3 Months,91.1,81.2 to 96.0,277
DTaP,≥1 Dose,States/Local Areas,Virginia,2012,Age,3 Months,85.9,80.1 to 90.2,342
Hib,≥1 Dose,States/Local Areas,Virginia,2021,Age,3 Months,87.4,80.7 to 92.1,310
Hib,Full Series,States/Local Areas,Virginia,2020-2021,Age,24 Months,75.9,71.1 to 80.5,804
DTaP,≥4 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,86.2,80.6 to 90.9,804
DTaP,≥3 Doses,States/Local Areas,Virginia,2016,Age,24 Months,96.8,92.3 to 99.0,389
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,94.6,91.4 to 96.9,808
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,94.0,91.7 to 96.3,1316
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,89.7,83.3 to 96.1,127
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,93.3,89.2 to 97.4,345
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,96.9,94.5 to 99.2,844
DTaP,≥3 Doses,States/Local Areas,Virginia,2018,Age,24 Months,93.2,88.5 to 96.5,551
DTaP,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,93.5,90.1 to 96.0,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2017,Age,24 Months,92.2,86.9 to 95.9,419
DTaP,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,92.7,89.0 to 95.5,970
DTaP,≥2 Doses,States/Local Areas,Virginia,2016,Age,5 Months,88.2,81.7 to 92.7,389
DTaP,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,5 Months,86.8,82.3 to 90.3,808
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,96.4,90.9 to 100.0,39
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.1,92.2 to 98.0,673
DTaP,≥2 Doses,States/Local Areas,Virginia,2017,Age,5 Months,85.4,78.4 to 90.3,419
DTaP,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,5 Months,83.4,78.5 to 87.4,970
Hib,≥3 Doses,States/Local Areas,Virginia,2016,Age,24 Months,95.2,90.5 to 98.0,389
Hib,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,92.8,89.4 to 95.5,808
Hib,≥3 Doses,States/Local Areas,Virginia,2015,Age,24 Months,94.1,89.2 to 97.2,374
Hib,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,94.6,91.4 to 96.9,763
DTaP,≥3 Doses,States/Local Areas,Virginia,2019,Age,24 Months,93.7,88.5 to 97.1,452
Hib,≥3 Doses,States/Local Areas,Virginia,2014,Age,24 Months,96.1,91.5 to 98.6,351
Hib,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,95.0,91.7 to 97.2,725
DTaP,≥2 Doses,States/Local Areas,Virginia,2018,Age,5 Months,81.5,74.5 to 87.0,551
DTaP,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,5 Months,82.9,78.1 to 86.8,1003
Hep A,≥1 Dose,States/Local Areas,Virginia,2013,Age,19 Months,78.8,76.0 to 81.3,357
Hep A,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,19 Months,79.8,76.6 to 82.6,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2014,Age,19 Months,80.9,72.3 to 87.3,351
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,19 Months,81.7,76.2 to 86.1,725
Hep A,≥1 Dose,States/Local Areas,Virginia,2015,Age,19 Months,82.5,74.2 to 88.5,374
Hep A,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,19 Months,85.4,80.6 to 89.1,763
DTaP,≥3 Doses,States/Local Areas,Virginia,2014,Age,24 Months,95.1,90.1 to 98.1,351
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,96.1,93.3 to 98.0,725
DTaP,≥3 Doses,States/Local Areas,Virginia,2015,Age,24 Months,97.1,93.8 to 98.9,374
DTaP,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,96.9,94.4 to 98.5,763
DTaP,≥1 Dose,States/Local Areas,Virginia,2019,Age,3 Months,93.9,88.2 to 96.9,452
DTaP,≥1 Dose,States/Local Areas,Virginia,2018,Age,3 Months,86.8,80.5 to 91.3,551
DTaP,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,3 Months,90.3,86.3 to 93.2,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2013,Age,24 Months,92.5,87.6 to 95.9,357
DTaP,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,93.8,90.5 to 96.2,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2011,Age,19 Months,73.9,60.4 to 84.1,277
DTaP,≥1 Dose,States/Local Areas,Virginia,2017,Age,3 Months,90.9,84.7 to 94.7,419
DTaP,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,3 Months,88.8,84.7 to 92.0,970
Hib,≥3 Doses,States/Local Areas,Washington,2019,Age,35 Months,96.9,94.4 to 98.5,455
Hep A,≥1 Dose,States/Local Areas,Washington,2016,Age,35 Months,88.5,81.4 to 93.8,280
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,35 Months,90.4,86.4 to 93.7,747
≥1 Dose MMR,,States/Local Areas,Washington,2012,Age,13 Months,64.9,54.2 to 74.3,252
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.1,76.3 to 95.8,211
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,75.1,68.5 to 81.7,593
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.6,64.1 to 77.1,651
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2016,Age,0-1 Days,68.8,60.4 to 76.1,280
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2016-2017,Age,0-1 Days,70.3,65.3 to 74.9,747
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2017,Age,0-1 Days,71.9,66.2 to 76.9,467
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2017-2018,Age,0-1 Days,73.8,70.0 to 77.4,959
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2015,Age,0-1 Days,67.8,59.6 to 75.0,278
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2015-2016,Age,0-1 Days,68.3,62.5 to 73.5,558
Hep B,≥3 Doses,States/Local Areas,Washington,2018,Age,19 Months,89.6,85.3 to 92.7,492
Hep B,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,88.8,85.8 to 91.2,947
Hep B,≥2 Doses,States/Local Areas,Washington,2017,Age,5 Months,84.0,79.0 to 88.0,467
Hep B,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,5 Months,86.6,83.4 to 89.2,959
≥1 Dose Varicella,,States/Local Areas,Washington,2014,Age,24 Months,88.8,83.6 to 92.9,304
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2015,Age,24 Months,88.8,85.0 to 92.0,582
≥1 Dose MMR,,States/Local Areas,Washington,2019,Age,19 Months,90.9,86.7 to 93.8,455
≥1 Dose Varicella,,States/Local Areas,Washington,2016,Age,24 Months,85.3,78.4 to 90.9,280
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2017,Age,24 Months,87.9,84.0 to 91.2,747
≥1 Dose MMR,,States/Local Areas,Washington,2011,Age,24 Months,88.6,81.7 to 93.7,241
≥1 Dose MMR,,States/Local Areas,Washington,2018,Age,19 Months,94.2,90.4 to 96.5,492
≥1 Dose MMR,,States/Local Areas,Washington,2018-2019,Age,19 Months,96.8,95.0 to 97.9,947
≥1 Dose Varicella,,States/Local Areas,Washington,2015,Age,24 Months,88.8,83.0 to 93.4,278
≥1 Dose Varicella,,States/Local Areas,Washington,2015-2016,Age,24 Months,87.0,82.6 to 90.8,558
PCV,≥4 Doses,States/Local Areas,Washington,2013,Age,19 Months,79.1,74.3 to 83.3,313
PCV,≥4 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,80.9,77.3 to 84.0,617
PCV,≥4 Doses,States/Local Areas,Washington,2012,Age,19 Months,76.8,71.3 to 81.6,252
PCV,≥4 Doses,States/Local Areas,Washington,2011,Age,19 Months,74.0,69.8 to 77.8,241
≥1 Dose MMR,,States/Local Areas,Washington,2017,Age,19 Months,88.6,84.1 to 91.9,467
≥1 Dose MMR,,States/Local Areas,Washington,2017-2018,Age,19 Months,91.3,88.6 to 93.5,959
Polio,≥2 Doses,States/Local Areas,Washington,2019,Age,13 Months,96.7,93.7 to 98.3,455
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,76.4,71.5 to 81.3,1097
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,75.3,65.9 to 84.6,237
≥1 Dose MMR,,States/Local Areas,Washington,2018,Age,13 Months,79.0,73.2 to 83.7,492
≥1 Dose MMR,,States/Local Areas,Washington,2018-2019,Age,13 Months,76.2,72.2 to 79.7,947
Hep B,≥3 Doses,States/Local Areas,Washington,2017,Age,13 Months,85.7,80.9 to 89.4,467
Hep B,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,86.3,83.1 to 89.0,959
Hep B,≥3 Doses,States/Local Areas,Washington,2012,Age,19 Months,86.7,80.0 to 91.4,252
Polio,≥2 Doses,States/Local Areas,Washington,2019,Age,7 Months,93.0,89.3 to 95.6,455
Hep A,≥1 Dose,States/Local Areas,Washington,2020,Age,35 Months,93.0,89.0 to 96.0,445
Hep B,≥3 Doses,States/Local Areas,Washington,2018,Age,13 Months,86.9,82.3 to 90.4,492
Hep B,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,88.8,85.8 to 91.2,947
Hep B,≥3 Doses,States/Local Areas,Washington,2019,Age,13 Months,90.7,86.4 to 93.7,455
Hep B,≥3 Doses,States/Local Areas,Washington,2011,Age,19 Months,85.6,82.3 to 88.3,241
≥1 Dose Varicella,,States/Local Areas,Washington,2019,Age,24 Months,91.2,87.6 to 94.0,455
≥1 Dose Varicella,,States/Local Areas,Washington,2017,Age,24 Months,90.5,86.5 to 93.7,467
≥1 Dose Varicella,,States/Local Areas,Washington,2017-2018,Age,24 Months,92.2,89.6 to 94.3,959
≥1 Dose MMR,,States/Local Areas,Washington,2013,Age,24 Months,91.6,87.0 to 95.0,313
≥1 Dose MMR,,States/Local Areas,Washington,2013-2014,Age,24 Months,90.7,87.3 to 93.5,617
≥1 Dose MMR,,States/Local Areas,Washington,2014,Age,24 Months,89.8,84.5 to 94.0,304
≥1 Dose MMR,,States/Local Areas,Washington,2014-2015,Age,24 Months,89.4,85.6 to 92.5,582
≥1 Dose Varicella,,States/Local Areas,Washington,2018,Age,24 Months,93.9,90.5 to 96.4,492
≥1 Dose Varicella,,States/Local Areas,Washington,2018-2019,Age,24 Months,92.5,90.2 to 94.5,947
Hep B,≥3 Doses,States/Local Areas,Washington,2011,Age,24 Months,87.0,80.4 to 92.2,241
Hep B,≥3 Doses,States/Local Areas,Washington,2013,Age,24 Months,91.1,86.8 to 94.4,313
Hep B,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,88.1,84.5 to 91.2,617
Hep B,≥2 Doses,States/Local Areas,Washington,2019,Age,5 Months,92.7,89.0 to 95.3,455
PCV,≥4 Doses,States/Local Areas,Washington,2020,Age,35 Months,87.0,81.9 to 91.2,445
Hep B,≥2 Doses,States/Local Areas,Washington,2018,Age,5 Months,89.2,85.0 to 92.4,492
Hep B,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,5 Months,91.0,88.3 to 93.1,947
Hep B,≥3 Doses,States/Local Areas,Washington,2012,Age,24 Months,88.2,82.2 to 93.0,252
PCV,≥3 Doses,States/Local Areas,Washington,2016,Age,7 Months,72.0,63.8 to 78.9,280
PCV,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,69.8,64.8 to 74.4,747
PCV,≥3 Doses,States/Local Areas,Washington,2015,Age,7 Months,69.8,61.3 to 77.1,278
PCV,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,70.9,65.1 to 76.0,558
PCV,≥4 Doses,States/Local Areas,Washington,2014,Age,19 Months,82.6,76.0 to 87.7,304
PCV,≥4 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,77.8,72.6 to 82.3,582
PCV,≥3 Doses,States/Local Areas,Washington,2017,Age,7 Months,67.6,61.5 to 73.2,467
PCV,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,70.3,66.2 to 74.2,959
PCV,≥4 Doses,States/Local Areas,Washington,2015,Age,19 Months,73.1,65.6 to 79.4,278
PCV,≥4 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,73.3,67.5 to 78.3,558
PCV,≥4 Doses,States/Local Areas,Washington,2016,Age,19 Months,73.4,65.1 to 80.4,280
PCV,≥4 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,76.6,71.7 to 80.9,747
PCV,≥4 Doses,States/Local Areas,Washington,2017,Age,19 Months,79.9,74.4 to 84.4,467
PCV,≥4 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,80.7,76.9 to 84.0,959
PCV,≥4 Doses,States/Local Areas,Washington,2018,Age,19 Months,81.5,75.9 to 86.0,492
PCV,≥4 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,82.0,77.6 to 85.8,797
≥1 Dose MMR,,States/Local Areas,Washington,2017,Age,24 Months,92.0,88.1 to 94.9,467
≥1 Dose MMR,,States/Local Areas,Washington,2017-2018,Age,24 Months,93.3,90.8 to 95.3,959
≥1 Dose MMR,,States/Local Areas,Washington,2016,Age,24 Months,89.3,83.3 to 93.9,280
≥1 Dose MMR,,States/Local Areas,Washington,2016-2017,Age,24 Months,90.6,87.2 to 93.5,747
PCV,≥3 Doses,States/Local Areas,Washington,2012,Age,13 Months,87.1,82.7 to 90.6,252
Hep B,≥2 Doses,States/Local Areas,Washington,2011,Age,7 Months,88.6,82.9 to 92.6,241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2019,Age,0-1 Days,79.5,74.0 to 84.1,455
Hep B,≥3 Doses,States/Local Areas,Washington,2016,Age,24 Months,85.5,78.4 to 91.1,280
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,87.7,83.8 to 91.1,747
Hep B,≥3 Doses,States/Local Areas,Washington,2015,Age,24 Months,90.8,85.6 to 94.7,278
Hep B,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,88.1,83.9 to 91.7,558
Hep B,≥3 Doses,States/Local Areas,Washington,2014,Age,24 Months,85.2,79.3 to 90.2,304
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,88.0,84.2 to 91.3,582
PCV,≥3 Doses,States/Local Areas,Washington,2011,Age,13 Months,89.7,83.7 to 93.7,241
PCV,≥3 Doses,States/Local Areas,Washington,2018,Age,7 Months,73.1,67.2 to 78.3,492
PCV,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,74.4,70.4 to 78.1,947
Hep B,≥2 Doses,States/Local Areas,Washington,2012,Age,7 Months,86.0,79.9 to 90.5,252
Hep B,≥2 Doses,States/Local Areas,Washington,2014,Age,7 Months,84.5,78.2 to 89.3,304
Hep B,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,86.0,81.5 to 89.6,582
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2012,Age,0-2 Days,73.3,66.2 to 79.5,252
Hep B,≥2 Doses,States/Local Areas,Washington,2013,Age,7 Months,91.7,90.3 to 92.9,313
Hep B,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,88.1,84.0 to 91.2,617
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2011,Age,0-2 Days,73.8,65.2 to 80.9,241
Hep B,≥3 Doses,States/Local Areas,Washington,2019,Age,19 Months,92.9,89.3 to 95.4,455
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2018,Age,0-1 Days,75.8,70.5 to 80.5,492
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2018-2019,Age,0-1 Days,77.7,73.9 to 81.0,947
DTaP,≥4 Doses,States/Local Areas,Washington,2018,Age,35 Months,90.0,85.6 to 93.4,492
DTaP,≥4 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,90.4,87.0 to 93.2,947
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,71.5,65.3 to 77.7,352
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,86.6,83.1 to 90.2,679
DTaP,≥4 Doses,States/Local Areas,Washington,2019,Age,35 Months,91.1,85.7 to 95.1,455
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,86.6,75.4 to 97.7,52
≥1 Dose MMR,,States/Local Areas,Washington,2011,Age,19 Months,85.6,81.5 to 88.9,241
Polio,≥2 Doses,States/Local Areas,Washington,2015,Age,13 Months,92.3,86.3 to 95.8,278
Polio,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,90.0,85.4 to 93.2,558
≥1 Dose Varicella,,States/Local Areas,Washington,2016,Age,19 Months,82.7,75.0 to 88.5,280
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2017,Age,19 Months,85.2,80.9 to 88.8,747
≥1 Dose MMR,,States/Local Areas,Washington,2019,Age,13 Months,73.3,67.5 to 78.4,455
≥1 Dose Varicella,,States/Local Areas,Washington,2018,Age,19 Months,92.7,88.8 to 95.3,492
≥1 Dose Varicella,,States/Local Areas,Washington,2018-2019,Age,19 Months,69.5,65.3 to 73.3,947
Polio,≥2 Doses,States/Local Areas,Washington,2016,Age,13 Months,87.6,80.0 to 92.5,280
Polio,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,89.6,85.4 to 92.6,747
Hep B,≥1 Dose,States/Local Areas,Washington,2017,Age,3 Months,93.7,90.2 to 96.1,467
Hep B,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,3 Months,93.6,91.3 to 95.4,959
≥1 Dose MMR,,States/Local Areas,Washington,2013,Age,19 Months,90.6,89.2 to 91.7,313
≥1 Dose MMR,,States/Local Areas,Washington,2013-2014,Age,19 Months,89.0,86.8 to 90.9,617
≥1 Dose MMR,,States/Local Areas,Washington,2012,Age,19 Months,85.5,66.7 to 94.6,252
≥1 Dose Varicella,,States/Local Areas,Washington,2017,Age,19 Months,87.8,83.2 to 91.3,467
≥1 Dose Varicella,,States/Local Areas,Washington,2017-2018,Age,19 Months,90.2,87.4 to 92.5,959
PCV,≥4 Doses,States/Local Areas,Washington,2011,Age,24 Months,79.2,71.7 to 85.7,241
Hib,Primary Series,States/Local Areas,Washington,2020,Age,24 Months,92.7,88.9 to 95.6,445
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2016,Age,0-2 Days,73.6,65.4 to 80.4,280
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2016-2017,Age,0-2 Days,74.5,69.6 to 78.8,747
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2017,Age,0-2 Days,75.4,69.9 to 80.2,467
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2017-2018,Age,0-2 Days,77.4,73.7 to 80.8,959
Hep B,≥3 Doses,States/Local Areas,Washington,2011,Age,35 Months,89.4,82.4 to 94.4,241
PCV,≥4 Doses,States/Local Areas,Washington,2012,Age,24 Months,82.9,76.1 to 88.7,252
Hep B,≥3 Doses,States/Local Areas,Washington,2019,Age,24 Months,93.9,90.7 to 96.3,455
Hep B,≥3 Doses,States/Local Areas,Washington,2017,Age,24 Months,90.1,86.2 to 93.3,467
Hep B,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,89.9,87.2 to 92.3,959
PCV,≥4 Doses,States/Local Areas,Washington,2013,Age,24 Months,82.9,76.9 to 88.1,313
PCV,≥4 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,83.2,79.0 to 87.0,617
PCV,≥4 Doses,States/Local Areas,Washington,2014,Age,24 Months,83.4,77.2 to 88.7,304
PCV,≥4 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,79.5,74.5 to 84.1,582
≥1 Dose MMR,,States/Local Areas,Washington,2013,Age,35 Months,94.4,90.3 to 97.2,313
≥1 Dose MMR,,States/Local Areas,Washington,2013-2014,Age,35 Months,92.6,89.4 to 95.2,617
≥1 Dose Varicella,,States/Local Areas,Washington,2016,Age,35 Months,92.4,86.9 to 96.1,280
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2017,Age,35 Months,93.4,90.4 to 95.7,747
≥1 Dose MMR,,States/Local Areas,Washington,2011,Age,35 Months,93.3,86.7 to 97.3,241
≥1 Dose MMR,,States/Local Areas,Washington,2012,Age,35 Months,93.2,88.2 to 96.6,252
≥1 Dose MMR,,States/Local Areas,Washington,2019,Age,24 Months,91.6,87.8 to 94.5,455
≥1 Dose MMR,,States/Local Areas,Washington,2018,Age,24 Months,94.7,91.4 to 97.0,492
≥1 Dose MMR,,States/Local Areas,Washington,2018-2019,Age,24 Months,93.1,90.7 to 95.1,947
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2015,Age,0-2 Days,73.4,65.4 to 80.0,278
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2015-2016,Age,0-2 Days,73.5,67.9 to 78.4,558
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2014,Age,0-2 Days,69.1,62.1 to 75.4,304
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2014-2015,Age,0-2 Days,71.3,66.1 to 76.0,582
≥1 Dose Varicella,,States/Local Areas,Washington,2013,Age,35 Months,91.7,87.0 to 95.2,313
≥1 Dose Varicella,,States/Local Areas,Washington,2013-2014,Age,35 Months,90.6,87.2 to 93.4,617
PCV,≥3 Doses,States/Local Areas,Washington,2019,Age,7 Months,75.7,70.0 to 80.7,455
≥1 Dose Varicella,,States/Local Areas,Washington,2012,Age,35 Months,93.6,88.3 to 97.1,252
≥1 Dose MMR,,States/Local Areas,Washington,2015,Age,24 Months,88.9,83.2 to 93.3,278
≥1 Dose MMR,,States/Local Areas,Washington,2015-2016,Age,24 Months,89.1,85.1 to 92.4,558
≥1 Dose Varicella,,States/Local Areas,Washington,2014,Age,35 Months,89.3,84.2 to 93.4,304
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2015,Age,35 Months,90.7,87.0 to 93.7,582
PCV,≥3 Doses,States/Local Areas,Washington,2015,Age,13 Months,82.6,74.7 to 88.4,278
PCV,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,83.0,77.7 to 87.3,558
PCV,≥3 Doses,States/Local Areas,Washington,2014,Age,13 Months,86.8,80.4 to 91.3,304
PCV,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,84.7,79.8 to 88.6,582
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2013,Age,0-2 Days,73.4,69.2 to 77.2,313
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2013-2014,Age,0-2 Days,71.2,67.3 to 74.9,617
Hep B,≥2 Doses,States/Local Areas,Washington,2015,Age,7 Months,87.5,80.5 to 92.2,278
Hep B,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,87.0,82.1 to 90.7,558
Hep B,≥3 Doses,States/Local Areas,Washington,2018,Age,24 Months,89.7,85.8 to 93.0,492
Hep B,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,91.8,89.3 to 93.9,947
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.7,67.2 to 84.3,391
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,86.7,71.4 to 100.0,113
≥1 Dose MMR,,States/Local Areas,Washington,2012,Age,24 Months,91.8,86.8 to 95.4,252
≥1 Dose Varicella,,States/Local Areas,Washington,2011,Age,35 Months,92.6,84.9 to 97.2,241
Hep B,≥2 Doses,States/Local Areas,Washington,2016,Age,7 Months,86.4,78.9 to 91.6,280
Hep B,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,87.7,83.5 to 91.0,747
PCV,≥3 Doses,States/Local Areas,Washington,2013,Age,13 Months,85.1,79.7 to 89.2,313
PCV,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,85.9,80.9 to 89.8,617
Hep B,≥2 Doses,States/Local Areas,Washington,2017,Age,7 Months,89.0,84.5 to 92.4,467
Hep B,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,90.2,87.4 to 92.5,959
Hib,≥1 Dose,States/Local Areas,Washington,2017,Age,3 Months,83.7,78.3 to 88.0,467
Hib,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,3 Months,86.6,83.1 to 89.5,959
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,86.5,81.2 to 91.7,412
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,90.6,86.4 to 94.8,448
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,87.3 to 93.8,593
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.0,85.5 to 92.6,651
Hep B,≥3 Doses,States/Local Areas,Washington,2019,Age,35 Months,94.8,91.6 to 97.0,455
PCV,≥3 Doses,States/Local Areas,Washington,2014,Age,19 Months,89.1,83.1 to 93.1,304
PCV,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,88.4,84.2 to 91.6,582
Hep B,≥3 Doses,States/Local Areas,Washington,2018,Age,35 Months,90.6,86.8 to 93.8,492
Hep B,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,92.7,90.2 to 94.7,947
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,92.9,90.3 to 95.5,679
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,88.0,83.7 to 92.2,352
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,88.9,83.4 to 94.4,210
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,91.0 to 98.2,211
PCV,≥4 Doses,States/Local Areas,Washington,2015,Age,35 Months,77.0,69.1 to 84.2,278
PCV,≥4 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,80.0,74.4 to 85.1,558
PCV,≥4 Doses,States/Local Areas,Washington,2014,Age,35 Months,84.4,78.2 to 89.6,304
PCV,≥4 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,80.7,75.7 to 85.2,582
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,85.9,80.3 to 91.5,237
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Overall,Overall,87.7,84.8 to 90.6,1097
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.7,83.0 to 92.3,391
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,84.7,75.3 to 94.2,113
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,88.4,84.3 to 92.4,593
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.3,81.0 to 89.6,651
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,89.1,79.0 to 99.2,52
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,87.3 to 97.7,211
≥1 Dose MMR,,States/Local Areas,Washington,2019,Age,35 Months,94.4,90.2 to 97.2,455
≥1 Dose MMR,,States/Local Areas,Washington,2017,Age,35 Months,93.9,90.4 to 96.4,467
≥1 Dose MMR,,States/Local Areas,Washington,2017-2018,Age,35 Months,94.9,92.7 to 96.7,959
≥1 Dose MMR,,States/Local Areas,Washington,2018,Age,35 Months,96.0,93.0 to 98.0,492
≥1 Dose MMR,,States/Local Areas,Washington,2018-2019,Age,35 Months,95.1,92.7 to 96.9,947
Hep B,≥2 Doses,States/Local Areas,Washington,2018,Age,13 Months,93.5,90.0 to 95.8,492
Hep B,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,94.7,92.6 to 96.3,947
Hep B,≥2 Doses,States/Local Areas,Washington,2016,Age,13 Months,88.2,80.7 to 93.1,280
Hep B,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,90.6,86.6 to 93.6,747
PCV,≥3 Doses,States/Local Areas,Washington,2015,Age,19 Months,87.7,82.6 to 91.5,278
PCV,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,87.6,82.9 to 91.1,558
PCV,≥3 Doses,States/Local Areas,Washington,2016,Age,19 Months,87.4,79.8 to 92.4,280
PCV,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,88.7,84.5 to 91.9,747
Hib,≥1 Dose,States/Local Areas,Washington,2015,Age,3 Months,87.4,80.2 to 92.3,278
Hib,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,3 Months,86.1,81.2 to 90.0,558
Hib,≥1 Dose,States/Local Areas,Washington,2016,Age,3 Months,84.8,77.3 to 90.2,280
Hib,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,3 Months,84.3,79.8 to 87.9,747
Hep B,≥2 Doses,States/Local Areas,Washington,2017,Age,13 Months,93.1,89.4 to 95.6,467
Hep B,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,93.3,90.9 to 95.1,959
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,89.0,83.3 to 94.6,210
Hib,≥1 Dose,States/Local Areas,Washington,2013,Age,3 Months,87.2,84.5 to 89.5,313
Hib,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,3 Months,86.9,85.2 to 88.4,617
Hib,≥1 Dose,States/Local Areas,Washington,2012,Age,3 Months,85.1,79.6 to 89.3,252
Hib,≥1 Dose,States/Local Areas,Washington,2011,Age,3 Months,88.4,81.5 to 93.0,241
Hep B,≥2 Doses,States/Local Areas,Washington,2015,Age,13 Months,90.6,84.0 to 94.7,278
Hep B,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,89.4,84.7 to 92.8,558
Hep B,≥2 Doses,States/Local Areas,Washington,2013,Age,13 Months,94.3,92.6 to 95.7,313
Hep B,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,91.8,88.9 to 94.0,617
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2019,Age,0-2 Days,83.7,78.7 to 87.7,455
Hib,≥1 Dose,States/Local Areas,Washington,2014,Age,3 Months,86.5,80.6 to 90.8,304
Hib,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,3 Months,87.0,82.6 to 90.4,582
Hep B,≥2 Doses,States/Local Areas,Washington,2014,Age,13 Months,89.3,84.1 to 92.9,304
Hep B,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,90.0,86.0 to 92.9,582
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,85.6,80.7 to 90.5,352
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,91.1,87.8 to 94.3,679
≥1 Dose Varicella,,States/Local Areas,Washington,2019,Age,35 Months,93.9,90.2 to 96.6,455
≥1 Dose MMR,,States/Local Areas,Washington,2016,Age,35 Months,94.0,89.6 to 96.9,280
≥1 Dose MMR,,States/Local Areas,Washington,2016-2017,Age,35 Months,93.9,91.2 to 96.0,747
PCV,≥4 Doses,States/Local Areas,Washington,2015,Age,24 Months,75.6,67.7 to 82.8,278
PCV,≥4 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,75.6,70.1 to 80.8,558
≥1 Dose Varicella,,States/Local Areas,Washington,2018,Age,35 Months,94.7,91.3 to 97.1,492
≥1 Dose Varicella,,States/Local Areas,Washington,2018-2019,Age,35 Months,94.2,91.8 to 96.1,947
≥1 Dose MMR,,States/Local Areas,Washington,2015,Age,35 Months,89.8,84.0 to 94.1,278
≥1 Dose MMR,,States/Local Areas,Washington,2015-2016,Age,35 Months,92.2,88.6 to 95.1,558
≥1 Dose MMR,,States/Local Areas,Washington,2014,Age,35 Months,90.8,85.6 to 94.7,304
≥1 Dose MMR,,States/Local Areas,Washington,2014-2015,Age,35 Months,90.3,86.6 to 93.4,582
PCV,≥4 Doses,States/Local Areas,Washington,2017,Age,24 Months,83.7,78.7 to 88.0,467
PCV,≥4 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,84.1,80.6 to 87.2,959
PCV,≥4 Doses,States/Local Areas,Washington,2016,Age,24 Months,75.6,67.7 to 82.8,280
PCV,≥4 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,79.6,75.0 to 83.9,747
Hep B,≥2 Doses,States/Local Areas,Washington,2011,Age,13 Months,90.4,83.7 to 94.5,241
Hep B,≥2 Doses,States/Local Areas,Washington,2012,Age,13 Months,90.4,83.2 to 94.7,252
PCV,≥3 Doses,States/Local Areas,Washington,2017,Age,13 Months,88.2,83.7 to 91.6,467
PCV,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,89.6,86.5 to 92.1,959
Hep B,≥3 Doses,States/Local Areas,Washington,2012,Age,35 Months,88.5,82.5 to 93.2,252
Hep B,≥3 Doses,States/Local Areas,Washington,2014,Age,35 Months,86.8,80.8 to 91.6,304
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,89.0,85.1 to 92.3,582
Hep B,≥3 Doses,States/Local Areas,Washington,2013,Age,35 Months,91.8,87.6 to 95.0,313
Hep B,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,89.3,85.7 to 92.3,617
Hep B,≥2 Doses,States/Local Areas,Washington,2018,Age,7 Months,91.5,87.6 to 94.2,492
Hep B,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,93.1,90.6 to 94.9,947
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2018,Age,0-2 Days,79.5,74.3 to 83.9,492
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2018-2019,Age,0-2 Days,81.6,78.1 to 84.6,947
PCV,≥3 Doses,States/Local Areas,Washington,2018,Age,13 Months,91.1,86.4 to 94.3,492
PCV,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,91.3,88.4 to 93.6,947
Hep B,≥2 Doses,States/Local Areas,Washington,2019,Age,7 Months,94.6,91.3 to 96.7,455
PCV,≥3 Doses,States/Local Areas,Washington,2016,Age,13 Months,83.5,75.5 to 89.2,280
PCV,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,85.8,81.4 to 89.4,747
PCV,≥3 Doses,States/Local Areas,Washington,2012,Age,19 Months,92.1,90.0 to 93.9,252
Hep B,≥3 Doses,States/Local Areas,Washington,2017,Age,35 Months,90.8,86.9 to 93.9,467
Hep B,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,90.7,88.1 to 93.0,959
PCV,≥4 Doses,States/Local Areas,Washington,2011,Age,35 Months,83.4,75.8 to 89.7,241
PCV,≥4 Doses,States/Local Areas,Washington,2012,Age,35 Months,85.1,78.2 to 90.7,252
PCV,≥4 Doses,States/Local Areas,Washington,2019,Age,24 Months,83.0,78.0 to 87.4,455
PCV,≥4 Doses,States/Local Areas,Washington,2018,Age,24 Months,84.4,79.3 to 88.8,492
PCV,≥4 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,83.7,80.2 to 86.9,947
PCV,≥3 Doses,States/Local Areas,Washington,2011,Age,19 Months,93.1,87.1 to 96.4,241
PCV,≥3 Doses,States/Local Areas,Washington,2013,Age,19 Months,87.9,81.3 to 92.4,313
PCV,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,88.5,83.8 to 92.0,617
Hep B,≥3 Doses,States/Local Areas,Washington,2015,Age,35 Months,91.3,86.0 to 95.2,278
Hep B,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,88.5,84.2 to 92.1,558
Hep B,≥3 Doses,States/Local Areas,Washington,2016,Age,35 Months,85.5,78.4 to 91.1,280
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,88.1,84.2 to 91.5,747
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,87.6,77.2 to 98.1,52
≥1 Dose Varicella,,States/Local Areas,Washington,2015,Age,35 Months,91.7,86.1 to 95.7,278
≥1 Dose Varicella,,States/Local Areas,Washington,2015-2016,Age,35 Months,92.1,88.1 to 95.1,558
≥1 Dose Varicella,,States/Local Areas,Washington,2017,Age,35 Months,94.4,91.4 to 96.6,467
≥1 Dose Varicella,,States/Local Areas,Washington,2017-2018,Age,35 Months,94.6,92.4 to 96.3,959
PCV,≥4 Doses,States/Local Areas,Washington,2013,Age,35 Months,87.2,80.7 to 92.4,313
PCV,≥4 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,85.5,81.2 to 89.3,617
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,93.5,90.4 to 96.6,448
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,89.3,85.0 to 93.6,412
PCV,≥1 Dose,States/Local Areas,Washington,2011,Age,3 Months,86.8,79.6 to 91.7,241
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,86.7,81.3 to 92.1,237
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Overall,Overall,90.0,87.4 to 92.5,1097
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,84.8,75.4 to 94.1,113
≥1 Dose MMR,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,86.3 to 94.6,391
PCV,≥3 Doses,States/Local Areas,Washington,2018,Age,19 Months,95.3,92.3 to 97.2,492
PCV,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,91.3,88.4 to 93.6,947
PCV,≥4 Doses,States/Local Areas,Washington,2017,Age,35 Months,85.2,80.3 to 89.4,467
PCV,≥4 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,85.5,82.1 to 88.7,959
Hep B,≥2 Doses,States/Local Areas,Washington,2019,Age,13 Months,95.9,93.0 to 97.7,455
PCV,≥4 Doses,States/Local Areas,Washington,2016,Age,35 Months,83.1,75.4 to 89.6,280
PCV,≥4 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,83.9,79.5 to 87.9,747
PCV,≥4 Doses,States/Local Areas,Washington,2018,Age,35 Months,85.9,80.8 to 90.3,492
PCV,≥4 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,87.5,84.0 to 90.6,947
Hib,≥1 Dose,States/Local Areas,Washington,2018,Age,3 Months,89.6,84.6 to 93.1,492
Hib,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,3 Months,92.2,89.3 to 94.3,947
Hib,≥1 Dose,States/Local Areas,Washington,2019,Age,3 Months,94.8,91.5 to 96.8,455
Hib,≥2 Doses,States/Local Areas,Washington,2012,Age,5 Months,82.4,75.1 to 87.9,252
Hib,≥2 Doses,States/Local Areas,Washington,2011,Age,5 Months,76.6,69.7 to 82.4,241
Hib,≥2 Doses,States/Local Areas,Washington,2013,Age,5 Months,80.2,75.3 to 84.3,313
Hib,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,5 Months,80.1,75.8 to 83.7,617
PCV,≥3 Doses,States/Local Areas,Washington,2017,Age,19 Months,90.0,85.6 to 93.2,467
PCV,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,92.6,90.1 to 94.6,959
Hib,≥2 Doses,States/Local Areas,Washington,2014,Age,5 Months,80.0,73.5 to 85.2,304
Hib,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,5 Months,78.1,73.0 to 82.5,582
Hib,≥2 Doses,States/Local Areas,Washington,2015,Age,5 Months,76.2,68.0 to 82.9,278
Hib,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,5 Months,76.7,71.0 to 81.5,558
Hib,≥2 Doses,States/Local Areas,Washington,2016,Age,5 Months,77.1,68.9 to 83.6,280
Hib,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,5 Months,78.1,73.2 to 82.3,747
PCV,≥4 Doses,States/Local Areas,Washington,2019,Age,19 Months,80.6,75.3 to 85.0,455
PCV,≥3 Doses,States/Local Areas,Washington,2019,Age,13 Months,91.6,87.6 to 94.4,455
PCV,≥3 Doses,States/Local Areas,Washington,2014,Age,24 Months,89.1,83.6 to 93.4,304
PCV,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,89.1,85.2 to 92.3,582
PCV,≥3 Doses,States/Local Areas,Washington,2019,Age,19 Months,94.2,90.8 to 96.4,455
PCV,≥3 Doses,States/Local Areas,Washington,2012,Age,24 Months,92.2,87.2 to 95.8,252
PCV,≥3 Doses,States/Local Areas,Washington,2013,Age,24 Months,91.4,86.5 to 95.0,313
PCV,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,90.3,86.7 to 93.2,617
PCV,≥4 Doses,States/Local Areas,Washington,2019,Age,35 Months,89.4,84.4 to 93.3,455
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,89.0,85.6 to 92.4,679
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,78.6,71.1 to 86.1,210
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,84.7,73.6 to 95.9,52
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,71.8,65.7 to 78.0,352
PCV,≥1 Dose,States/Local Areas,Washington,2013,Age,3 Months,84.9,82.9 to 86.8,313
PCV,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,3 Months,85.2,83.3 to 87.0,617
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2011,Age,0-3 Days,76.5,68.8 to 82.8,241
PCV,≥3 Doses,States/Local Areas,Washington,2011,Age,24 Months,93.1,88.1 to 96.5,241
Hib,Full Series,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.1,74.4 to 85.7,391
DTaP,≥4 Doses,States/Local Areas,Washington,2018,Age,19 Months,75.0,69.0 to 80.2,492
DTaP,≥4 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,95.7,93.6 to 97.1,947
Hib,Full Series,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,83.8,78.6 to 89.1,448
Hib,Primary Series,States/Local Areas,Washington,2011,Age,7 Months,68.6,60.7 to 75.5,241
Hib,Full Series,States/Local Areas,Washington,2018,Age,35 Months,89.7,85.2 to 93.3,492
Hib,Full Series,States/Local Areas,Washington,2018-2019,Age,35 Months,89.0,85.7 to 91.8,947
Hib,Full Series,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,80.4,75.9 to 85.0,593
Hib,Full Series,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.9,73.2 to 82.6,651
Hib,Full Series,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,77.4,69.8 to 85.0,210
Hib,Full Series,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,80.0 to 92.6,211
Hib,Full Series,States/Local Areas,Washington,2019,Age,35 Months,88.4,83.5 to 92.4,455
DTaP,≥4 Doses,States/Local Areas,Washington,2013,Age,24 Months,81.8,75.6 to 87.2,313
DTaP,≥4 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,81.9,77.5 to 85.9,617
Hep A,≥2 Doses,States/Local Areas,Washington,2016,Age,24 Months,37.8,30.1 to 46.7,280
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,42.0,37.0 to 47.4,747
Hep A,≥2 Doses,States/Local Areas,Washington,2015,Age,24 Months,37.7,30.1 to 46.5,278
Hep A,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,37.9,32.3 to 44.0,558
Hep A,≥2 Doses,States/Local Areas,Washington,2017,Age,24 Months,46.1,40.2 to 52.5,467
Hep A,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,47.8,43.5 to 52.2,959
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,91.2,86.9 to 95.5,237
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,95.0,92.1 to 97.9,448
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,89.8,85.5 to 94.1,412
Hep B,≥3 Doses,States/Local Areas,Washington,2012,Age,7 Months,65.2,58.9 to 70.9,252
Hep B,≥3 Doses,States/Local Areas,Washington,2011,Age,7 Months,55.8,53.5 to 58.1,241
DTaP,≥4 Doses,States/Local Areas,Washington,2011,Age,24 Months,80.0,72.4 to 86.6,241
DTaP,≥4 Doses,States/Local Areas,Washington,2012,Age,24 Months,84.2,77.1 to 90.1,252
Polio,≥2 Doses,States/Local Areas,Washington,2012,Age,5 Months,83.1,76.5 to 88.1,252
Polio,≥2 Doses,States/Local Areas,Washington,2011,Age,5 Months,77.4,71.2 to 82.7,241
Hep A,≥1 Dose,States/Local Areas,Washington,2012,Age,35 Months,88.3,81.6 to 93.4,252
Polio,≥2 Doses,States/Local Areas,Washington,2013,Age,5 Months,80.1,74.4 to 84.7,313
Polio,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,5 Months,79.4,74.6 to 83.4,617
Polio,≥2 Doses,States/Local Areas,Washington,2014,Age,5 Months,78.7,72.1 to 84.1,304
Polio,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,5 Months,75.8,69.9 to 80.9,582
Hep A,≥2 Doses,States/Local Areas,Washington,2014,Age,24 Months,40.5,33.5 to 48.4,304
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,39.2,33.8 to 45.0,582
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,92.0,89.7 to 94.2,1097
Hib,≥3 Doses,States/Local Areas,Washington,2018,Age,35 Months,95.8,93.2 to 97.6,492
Hib,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,96.3,94.6 to 97.6,947
Hep A,≥2 Doses,States/Local Areas,Washington,2012,Age,24 Months,32.2,25.1 to 40.8,252
Hep A,≥1 Dose,States/Local Areas,Washington,2013,Age,35 Months,85.5,79.7 to 90.3,313
Hep A,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,35 Months,89.0,85.3 to 92.1,617
Hep A,≥1 Dose,States/Local Areas,Washington,2014,Age,35 Months,92.2,87.4 to 95.6,304
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,35 Months,90.0,86.3 to 93.1,582
Hep A,≥2 Doses,States/Local Areas,Washington,2013,Age,24 Months,37.8,31.1 to 45.5,313
Hep A,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,39.2,34.2 to 44.6,617
DTaP,≥4 Doses,States/Local Areas,Washington,2016,Age,19 Months,70.3,61.8 to 77.6,280
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,72.9,67.9 to 77.4,747
DTaP,≥4 Doses,States/Local Areas,Washington,2017,Age,19 Months,75.5,69.9 to 80.4,467
DTaP,≥4 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,75.3,71.2 to 79.0,959
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,94.2,91.8 to 96.5,593
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.3,88.0 to 94.5,651
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.3,84.7 to 93.8,391
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,90.4,82.3 to 98.4,113
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,91.8,87.0 to 96.7,210
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.5,90.6 to 98.4,211
PCV,≥2 Doses,States/Local Areas,Washington,2019,Age,5 Months,86.5,81.6 to 90.2,455
Hep B,≥3 Doses,States/Local Areas,Washington,2020,Age,24 Months,93.8,90.4 to 96.3,445
PCV,≥2 Doses,States/Local Areas,Washington,2018,Age,5 Months,81.1,75.5 to 85.7,492
PCV,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,5 Months,83.8,80.1 to 86.8,947
PCV,≥2 Doses,States/Local Areas,Washington,2017,Age,5 Months,78.5,72.9 to 83.3,467
PCV,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,5 Months,79.8,75.9 to 83.2,959
DTaP,≥4 Doses,States/Local Areas,Washington,2019,Age,19 Months,72.2,66.2 to 77.5,455
Hib,Full Series,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,78.8,73.3 to 84.4,412
Hib,Full Series,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,76.8,69.9 to 83.6,237
Hib,Full Series,States/Local Areas,Washington,2014-2017,Overall,Overall,79.9,76.6 to 83.3,1097
Hib,Full Series,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,76.7,66.1 to 87.4,113
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,85.9 to 93.6,593
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.1,84.1 to 92.2,651
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,88.9,82.8 to 94.9,210
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,90.2 to 98.2,211
Hib,Full Series,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,86.1,75.1 to 97.0,52
Hib,Full Series,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,75.2,69.5 to 81.0,352
Hib,Full Series,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,84.7,80.7 to 88.7,679
Hib,Full Series,States/Local Areas,Washington,2017,Age,35 Months,82.7,77.2 to 87.5,467
Hib,Full Series,States/Local Areas,Washington,2017-2018,Age,35 Months,86.1,82.6 to 89.2,959
Polio,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,94.1,91.8 to 95.9,959
Polio,≥3 Doses,States/Local Areas,Washington,2018,Age,35 Months,95.6,92.7 to 97.6,492
Polio,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,95.7,93.7 to 97.2,947
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,91.7,82.2 to 100.0,52
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,87.9,83.4 to 92.4,352
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,91.9,88.6 to 95.2,679
Polio,≥3 Doses,States/Local Areas,Washington,2019,Age,35 Months,95.8,92.8 to 97.8,455
DTaP,≥2 Doses,States/Local Areas,Washington,2015,Age,5 Months,76.3,67.9 to 83.0,278
DTaP,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,5 Months,77.6,72.0 to 82.4,558
DTaP,≥2 Doses,States/Local Areas,Washington,2014,Age,5 Months,80.9,74.4 to 86.0,304
DTaP,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,5 Months,78.6,73.5 to 82.9,582
Polio,≥3 Doses,States/Local Areas,Washington,2015,Age,35 Months,91.0,85.2 to 95.2,278
Polio,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,89.2,84.8 to 92.8,558
Hib,Full Series,States/Local Areas,Washington,2015,Age,35 Months,78.5,71.3 to 85.0,278
Hib,Full Series,States/Local Areas,Washington,2015-2016,Age,35 Months,78.4,73.3 to 83.2,558
Hib,Full Series,States/Local Areas,Washington,2014,Age,35 Months,85.6,79.6 to 90.5,304
Hib,Full Series,States/Local Areas,Washington,2014-2015,Age,35 Months,82.1,77.5 to 86.3,582
Hib,Full Series,States/Local Areas,Washington,2016,Age,35 Months,78.4,70.8 to 85.2,280
Hib,Full Series,States/Local Areas,Washington,2016-2017,Age,35 Months,80.8,76.2 to 85.0,747
≥1 Dose Varicella,,States/Local Areas,Washington,2011,Age,13 Months,57.4,50.9 to 63.6,241
≥1 Dose Varicella,,States/Local Areas,Washington,2013,Age,13 Months,58.8,50.4 to 66.7,313
≥1 Dose Varicella,,States/Local Areas,Washington,2013-2014,Age,13 Months,59.7,55.1 to 64.0,617
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,87.9,77.7 to 98.1,52
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,84.4,79.5 to 89.3,352
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,88.2,84.5 to 91.9,679
Hep A,≥1 Dose,States/Local Areas,Washington,2019,Age,35 Months,92.0,88.0 to 95.1,455
≥1 Dose Varicella,,States/Local Areas,Washington,2014,Age,13 Months,60.5,52.8 to 67.7,304
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2015,Age,13 Months,60.1,54.4 to 65.5,582
≥1 Dose Varicella,,States/Local Areas,Washington,2012,Age,13 Months,55.8,50.6 to 60.9,252
Hep A,≥1 Dose,States/Local Areas,Washington,2018,Age,35 Months,92.6,88.9 to 95.4,492
Hep A,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,35 Months,92.3,89.7 to 94.5,947
Hep B,≥3 Doses,States/Local Areas,Washington,2016,Age,7 Months,62.8,54.3 to 70.7,280
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,63.7,58.5 to 68.6,747
Hep A,≥2 Doses,States/Local Areas,Washington,2014,Age,35 Months,78.7,70.2 to 86.2,304
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,75.6,69.2 to 81.5,582
Hep A,≥2 Doses,States/Local Areas,Washington,2015,Age,35 Months,72.2,62.7 to 81.1,278
Hep A,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,72.1,65.3 to 78.5,558
Hep A,≥2 Doses,States/Local Areas,Washington,2016,Age,35 Months,72.2,62.6 to 81.0,280
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,74.4,68.7 to 79.7,747
Polio,≥2 Doses,States/Local Areas,Washington,2012,Age,7 Months,87.9,84.1 to 91.0,252
Polio,≥2 Doses,States/Local Areas,Washington,2011,Age,7 Months,89.9,80.7 to 95.0,241
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,84.4,77.7 to 91.1,210
Polio,≥2 Doses,States/Local Areas,Washington,2018,Age,5 Months,83.9,78.7 to 88.1,492
Polio,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,5 Months,85.9,82.5 to 88.8,947
Hep B,≥3 Doses,States/Local Areas,Washington,2017,Age,7 Months,64.6,58.6 to 70.2,467
Hep B,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,65.8,61.6 to 69.8,959
DTaP,≥4 Doses,States/Local Areas,Washington,2014,Age,24 Months,82.0,75.6 to 87.5,304
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,77.7,72.6 to 82.5,582
DTaP,≥4 Doses,States/Local Areas,Washington,2015,Age,24 Months,73.4,65.3 to 81.0,278
DTaP,≥4 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,75.2,69.6 to 80.5,558
DTaP,≥4 Doses,States/Local Areas,Washington,2016,Age,24 Months,76.7,68.9 to 83.8,280
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,80.6,76.0 to 84.8,747
Hep A,≥2 Doses,States/Local Areas,Washington,2011,Age,35 Months,70.6,59.8 to 80.7,241
Hep A,≥2 Doses,States/Local Areas,Washington,2012,Age,35 Months,73.9,64.9 to 82.1,252
Hep A,≥2 Doses,States/Local Areas,Washington,2013,Age,35 Months,70.6,62.5 to 78.3,313
Hep A,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,75.0,69.0 to 80.6,617
Polio,≥2 Doses,States/Local Areas,Washington,2015,Age,5 Months,72.9,64.2 to 80.2,278
Polio,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,5 Months,74.9,69.1 to 80.0,558
Hep A,≥2 Doses,States/Local Areas,Washington,2019,Age,24 Months,48.5,42.2 to 55.1,455
Hep B,≥3 Doses,States/Local Areas,Washington,2013,Age,7 Months,68.8,65.2 to 72.1,313
Hep B,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,66.0,62.4 to 69.4,617
Hep A,≥2 Doses,States/Local Areas,Washington,2018,Age,24 Months,49.4,43.4 to 55.7,492
Hep A,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,48.8,44.4 to 53.3,947
Polio,≥2 Doses,States/Local Areas,Washington,2016,Age,5 Months,76.9,68.7 to 83.5,280
Polio,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,5 Months,77.5,72.6 to 81.8,747
Polio,≥2 Doses,States/Local Areas,Washington,2017,Age,5 Months,78.1,72.3 to 83.0,467
Polio,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,5 Months,81.0,77.2 to 84.3,959
Hep B,≥3 Doses,States/Local Areas,Washington,2015,Age,7 Months,67.3,59.1 to 74.6,278
Hep B,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,65.1,59.2 to 70.5,558
Hep B,≥3 Doses,States/Local Areas,Washington,2014,Age,7 Months,63.2,55.6 to 70.2,304
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,65.3,59.7 to 70.4,582
Hep A,≥1 Dose,States/Local Areas,Washington,2015,Age,35 Months,87.6,81.6 to 92.4,278
Hep A,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,35 Months,88.1,83.5 to 91.9,558
Hep A,≥1 Dose,States/Local Areas,Washington,2017,Age,35 Months,91.8,87.5 to 95.0,467
Hep A,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,35 Months,92.2,89.5 to 94.5,959
≥1 Dose MMR,,States/Local Areas,Washington,2011,Age,13 Months,65.2,57.3 to 72.4,241
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,86.2,82.1 to 90.4,593
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.1,78.6 to 87.5,651
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.2,80.2 to 90.1,391
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,84.3,74.9 to 93.6,113
≥1 Dose Varicella,,States/Local Areas,Washington,2015,Age,13 Months,59.7,51.2 to 67.6,278
≥1 Dose Varicella,,States/Local Areas,Washington,2015-2016,Age,13 Months,56.9,50.9 to 62.7,558
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,88.5 to 97.0,211
≥1 Dose Varicella,,States/Local Areas,Washington,2016,Age,13 Months,54.2,45.6 to 62.5,280
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2017,Age,13 Months,60.8,55.5 to 65.8,747
≥1 Dose Varicella,,States/Local Areas,Washington,2017,Age,13 Months,67.6,61.7 to 72.9,467
≥1 Dose Varicella,,States/Local Areas,Washington,2017-2018,Age,13 Months,68.5,64.4 to 72.3,959
Polio,≥2 Doses,States/Local Areas,Washington,2015,Age,7 Months,85.0,77.4 to 90.4,278
Polio,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,85.1,80.0 to 89.1,558
Hep B,≥3 Doses,States/Local Areas,Washington,2011,Age,13 Months,81.9,79.1 to 84.5,241
Hep B,≥3 Doses,States/Local Areas,Washington,2019,Age,7 Months,72.7,66.9 to 77.9,455
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,85.3,79.5 to 91.0,237
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Overall,Overall,85.7,82.6 to 88.7,1097
Polio,≥2 Doses,States/Local Areas,Washington,2013,Age,7 Months,86.9,82.4 to 90.4,313
Polio,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,87.9,83.4 to 91.3,617
Polio,≥2 Doses,States/Local Areas,Washington,2014,Age,7 Months,88.9,83.7 to 92.5,304
Polio,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,86.9,82.5 to 90.4,582
DTaP,≥4 Doses,States/Local Areas,Washington,2012,Age,35 Months,90.2,84.0 to 94.7,252
DTaP,≥4 Doses,States/Local Areas,Washington,2014,Age,35 Months,85.3,78.9 to 90.6,304
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,84.8,80.0 to 89.0,582
Hep A,≥2 Doses,States/Local Areas,Washington,2019,Age,35 Months,81.0,74.2 to 86.9,455
Hep B,≥3 Doses,States/Local Areas,Washington,2012,Age,13 Months,82.6,77.2 to 86.9,252
DTaP,≥4 Doses,States/Local Areas,Washington,2013,Age,35 Months,88.4,82.8 to 92.8,313
DTaP,≥4 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,86.7,82.4 to 90.3,617
Hep B,≥3 Doses,States/Local Areas,Washington,2013,Age,13 Months,87.0,84.3 to 89.4,313
Hep B,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,84.9,82.0 to 87.4,617
Hep B,≥3 Doses,States/Local Areas,Washington,2014,Age,13 Months,82.8,76.2 to 87.8,304
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,84.2,79.5 to 87.9,582
Hep A,≥2 Doses,States/Local Areas,Washington,2017,Age,35 Months,76.8,70.4 to 82.6,467
Hep A,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,78.4,73.9 to 82.7,959
Hep A,≥2 Doses,States/Local Areas,Washington,2018,Age,35 Months,80.4,73.9 to 86.1,492
Hep A,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,80.6,75.9 to 84.8,947
≥1 Dose Varicella,,States/Local Areas,Washington,2018,Age,13 Months,69.4,63.4 to 74.8,492
≥1 Dose Varicella,,States/Local Areas,Washington,2018-2019,Age,13 Months,69.5,65.3 to 73.3,947
≥1 Dose MMR,,States/Local Areas,Washington,2013,Age,13 Months,60.1,54.0 to 65.9,313
≥1 Dose MMR,,States/Local Areas,Washington,2013-2014,Age,13 Months,64.4,60.8 to 67.9,617
≥1 Dose Varicella,,States/Local Areas,Washington,2011,Age,19 Months,82.7,78.4 to 86.2,241
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,83.7,78.5 to 89.0,412
≥1 Dose Varicella,,States/Local Areas,Washington,2012,Age,19 Months,81.8,73.1 to 88.2,252
DTaP,≥4 Doses,States/Local Areas,Washington,2011,Age,35 Months,86.1,78.2 to 92.2,241
≥1 Dose MMR,,States/Local Areas,Washington,2015,Age,13 Months,62.9,54.5 to 70.7,278
≥1 Dose MMR,,States/Local Areas,Washington,2015-2016,Age,13 Months,62.5,56.4 to 68.1,558
≥1 Dose MMR,,States/Local Areas,Washington,2014,Age,13 Months,68.7,60.9 to 75.5,304
≥1 Dose MMR,,States/Local Areas,Washington,2014-2015,Age,13 Months,65.8,60.1 to 71.1,582
Hep B,≥3 Doses,States/Local Areas,Washington,2018,Age,7 Months,67.1,61.1 to 72.6,492
Hep B,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,69.9,65.8 to 73.8,947
Polio,≥2 Doses,States/Local Areas,Washington,2019,Age,5 Months,88.0,83.2 to 91.5,455
DTaP,≥4 Doses,States/Local Areas,Washington,2019,Age,24 Months,81.9,76.6 to 86.7,455
DTaP,≥4 Doses,States/Local Areas,Washington,2017,Age,24 Months,84.4,79.8 to 88.5,467
DTaP,≥4 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,85.3,82.1 to 88.3,959
DTaP,≥4 Doses,States/Local Areas,Washington,2018,Age,24 Months,86.2,81.5 to 90.2,492
DTaP,≥4 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,84.0,80.5 to 87.2,947
DTaP,≥4 Doses,States/Local Areas,Washington,2017,Age,35 Months,87.3,82.8 to 91.1,467
DTaP,≥4 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,88.6,85.6 to 91.3,959
DTaP,≥4 Doses,States/Local Areas,Washington,2016,Age,35 Months,86.3,78.7 to 92.2,280
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,86.5,82.2 to 90.2,747
DTaP,≥4 Doses,States/Local Areas,Washington,2015,Age,35 Months,84.3,77.0 to 90.3,278
DTaP,≥4 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,85.4,80.2 to 89.8,558
Hep B,≥3 Doses,States/Local Areas,Washington,2015,Age,13 Months,85.6,78.5 to 90.6,278
Hep B,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,83.7,78.5 to 87.8,558
Hep B,≥3 Doses,States/Local Areas,Washington,2016,Age,13 Months,81.8,73.7 to 87.8,280
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,83.7,79.2 to 87.5,747
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,73.5,65.4 to 81.6,352
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,81.6,75.6 to 87.6,679
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,80.9,66.8 to 95.0,52
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,87.8,83.0 to 92.6,448
≥1 Dose Varicella,,States/Local Areas,Washington,2019,Age,13 Months,69.5,63.7 to 74.8,455
Polio,≥2 Doses,States/Local Areas,Washington,2018,Age,7 Months,92.4,87.7 to 95.4,492
Polio,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,92.7,89.9 to 94.8,947
Hep B,≥1 Dose,States/Local Areas,Washington,2013,Age,3 Months,93.2,92.3 to 94.1,313
Hep B,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,3 Months,91.7,89.9 to 93.3,617
Hep B,≥1 Dose,States/Local Areas,Washington,2012,Age,3 Months,92.3,87.5 to 95.3,252
Hep B,≥1 Dose,States/Local Areas,Washington,2011,Age,3 Months,92.5,88.2 to 95.3,241
Polio,≥2 Doses,States/Local Areas,Washington,2016,Age,7 Months,85.2,77.7 to 90.5,280
Polio,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,86.1,81.8 to 89.5,747
Polio,≥2 Doses,States/Local Areas,Washington,2017,Age,7 Months,87.0,82.1 to 90.7,467
Polio,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,89.7,86.5 to 92.2,959
≥1 Dose MMR,,States/Local Areas,Washington,2017,Age,13 Months,71.4,65.7 to 76.5,467
≥1 Dose MMR,,States/Local Areas,Washington,2017-2018,Age,13 Months,75.2,71.2 to 78.7,959
≥1 Dose MMR,,States/Local Areas,Washington,2016,Age,13 Months,62.0,53.3 to 70.0,280
≥1 Dose MMR,,States/Local Areas,Washington,2016-2017,Age,13 Months,66.7,61.4 to 71.5,747
≥1 Dose Varicella,,States/Local Areas,Washington,2013,Age,19 Months,88.4,84.5 to 91.4,313
≥1 Dose Varicella,,States/Local Areas,Washington,2013-2014,Age,19 Months,87.9,85.2 to 90.1,617
Polio,≥2 Doses,States/Local Areas,Washington,2012,Age,13 Months,91.6,89.4 to 93.4,252
Polio,≥2 Doses,States/Local Areas,Washington,2011,Age,13 Months,94.8,89.9 to 97.4,241
≥1 Dose Varicella,,States/Local Areas,Washington,2015,Age,19 Months,85.3,81.9 to 88.1,278
≥1 Dose Varicella,,States/Local Areas,Washington,2015-2016,Age,19 Months,84.0,78.9 to 88.0,558
≥1 Dose Varicella,,States/Local Areas,Washington,2014,Age,19 Months,87.4,81.7 to 91.5,304
≥1 Dose Varicella,,States/Local Areas,Washington,2014-2015,Age,19 Months,86.3,81.9 to 89.8,582
Polio,≥2 Doses,States/Local Areas,Washington,2013,Age,13 Months,93.1,88.9 to 95.8,313
Polio,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,92.1,88.8 to 94.5,617
Hep B,≥1 Dose,States/Local Areas,Washington,2014,Age,3 Months,90.3,84.9 to 93.9,304
Hep B,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,3 Months,90.5,86.5 to 93.3,582
Hep B,≥1 Dose,States/Local Areas,Washington,2015,Age,3 Months,90.6,84.1 to 94.6,278
Hep B,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,3 Months,90.2,85.6 to 93.4,558
Hep B,≥1 Dose,States/Local Areas,Washington,2016,Age,3 Months,89.7,82.4 to 94.2,280
Hep B,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,3 Months,91.7,87.8 to 94.4,747
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,91.7,80.7 to 100.0,210
Hep B,≥2 Doses,States/Local Areas,Washington,2015,Age,5 Months,82.8,75.3 to 88.5,278
Hep B,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,5 Months,83.3,78.2 to 87.4,558
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2013,Age,0-1 Days,69.3,65.7 to 72.7,313
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2013-2014,Age,0-1 Days,66.6,62.9 to 70.0,617
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2014,Age,0-1 Days,63.9,56.6 to 70.5,304
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2014-2015,Age,0-1 Days,65.8,60.4 to 70.8,582
≥1 Dose Varicella,,States/Local Areas,Washington,2019,Age,19 Months,89.8,85.8 to 92.8,455
Polio,≥2 Doses,States/Local Areas,Washington,2018,Age,13 Months,94.7,91.3 to 96.7,492
Polio,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,95.7,93.6 to 97.1,947
≥1 Dose Varicella,,States/Local Areas,Washington,2013,Age,24 Months,89.9,85.2 to 93.6,313
≥1 Dose Varicella,,States/Local Areas,Washington,2013-2014,Age,24 Months,89.3,86.0 to 92.2,617
Polio,≥2 Doses,States/Local Areas,Washington,2017,Age,13 Months,91.6,87.5 to 94.5,467
Polio,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,93.1,90.6 to 95.0,959
Hep B,≥3 Doses,States/Local Areas,Washington,2017,Age,19 Months,89.9,85.7 to 92.9,467
Hep B,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,89.7,86.9 to 92.0,959
Hep B,≥2 Doses,States/Local Areas,Washington,2016,Age,5 Months,83.8,76.3 to 89.3,280
Hep B,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,5 Months,83.9,79.6 to 87.5,747
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2012,Age,0-1 Days,68.4,60.5 to 75.3,252
Hep B,≥2 Doses,States/Local Areas,Washington,2014,Age,5 Months,80.8,74.1 to 86.1,304
Hep B,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,5 Months,81.8,79.8 to 83.7,582
PCV,≥3 Doses,States/Local Areas,Washington,2013,Age,7 Months,64.7,57.3 to 71.4,313
PCV,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,66.6,61.0 to 71.7,617
PCV,≥3 Doses,States/Local Areas,Washington,2011,Age,7 Months,67.8,62.6 to 72.6,241
Hep B,≥3 Doses,States/Local Areas,Washington,2016,Age,19 Months,83.8,76.0 to 89.5,280
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,86.8,82.5 to 90.2,747
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,87.4,83.0 to 91.9,448
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,79.7,74.3 to 85.2,412
PCV,≥3 Doses,States/Local Areas,Washington,2012,Age,7 Months,69.2,64.9 to 73.2,252
PCV,≥3 Doses,States/Local Areas,Washington,2014,Age,7 Months,68.4,60.9 to 75.1,304
PCV,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,69.1,63.5 to 74.2,582
Hep B,≥1 Dose,States/Local Areas,Washington,2019,Age,3 Months,96.0,93.2 to 97.7,455
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,78.3,70.7 to 85.8,210
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.8,74.1 to 83.5,651
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,77.4 to 91.2,211
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,79.3,75.8 to 82.7,1097
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,75.1,64.2 to 85.9,113
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,81.9,77.6 to 86.2,593
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.6,70.2 to 83.0,391
≥1 Dose MMR,,States/Local Areas,Washington,2014,Age,19 Months,87.5,81.5 to 91.8,304
≥1 Dose MMR,,States/Local Areas,Washington,2014-2015,Age,19 Months,86.5,82.1 to 90.0,582
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,69.5,61.9 to 77.2,237
≥1 Dose Varicella,,States/Local Areas,Washington,2011,Age,24 Months,86.6,79.3 to 92.3,241
≥1 Dose Varicella,,States/Local Areas,Washington,2012,Age,24 Months,89.4,83.4 to 93.9,252
≥1 Dose MMR,,States/Local Areas,Washington,2015,Age,19 Months,85.5,80.8 to 89.3,278
≥1 Dose MMR,,States/Local Areas,Washington,2015-2016,Age,19 Months,85.6,80.7 to 89.4,558
≥1 Dose MMR,,States/Local Areas,Washington,2016,Age,19 Months,85.6,78.1 to 90.9,280
≥1 Dose MMR,,States/Local Areas,Washington,2016-2017,Age,19 Months,87.1,82.9 to 90.4,747
Hep B,≥1 Dose,States/Local Areas,Washington,2018,Age,3 Months,93.5,90.0 to 95.9,492
Hep B,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,3 Months,94.8,92.7 to 96.3,947
Polio,≥2 Doses,States/Local Areas,Washington,2014,Age,13 Months,91.1,86.4 to 94.3,304
Polio,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,91.7,88.2 to 94.3,582
Hep B,≥2 Doses,States/Local Areas,Washington,2012,Age,5 Months,82.2,77.3 to 86.2,252
Hep B,≥2 Doses,States/Local Areas,Washington,2011,Age,5 Months,83.6,79.0 to 87.3,241
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,69.8,61.5 to 78.1,412
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2011,Age,0-1 Days,64.6,57.2 to 71.4,241
Hep B,≥2 Doses,States/Local Areas,Washington,2013,Age,5 Months,87.9,85.5 to 89.9,313
Hep B,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,5 Months,84.3,80.9 to 87.2,617
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,85.9,78.2 to 93.6,448
Hep B,≥3 Doses,States/Local Areas,Washington,2013,Age,19 Months,90.3,86.8 to 92.9,313
Hep B,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,87.7,85.1 to 90.0,617
Hep B,≥3 Doses,States/Local Areas,Washington,2015,Age,19 Months,89.3,87.2 to 91.1,278
Hep B,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,86.6,81.8 to 90.3,558
Hep B,≥3 Doses,States/Local Areas,Washington,2014,Age,19 Months,85.2,78.9 to 89.9,304
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,87.3,83.1 to 90.6,582
Polio,≥3 Doses,States/Local Areas,Washington,2017,Age,35 Months,92.6,88.9 to 95.4,467
Polio,≥3 Doses,States/Local Areas,Washington,2016,Age,35 Months,87.4,80.5 to 92.8,280
Polio,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,90.0,86.1 to 93.2,747
Hib,Full Series,States/Local Areas,Washington,2011,Age,35 Months,83.1,75.8 to 89.3,241
Hib,Full Series,States/Local Areas,Washington,2012,Age,35 Months,86.7,79.8 to 92.2,252
Hib,Full Series,States/Local Areas,Washington,2019,Age,24 Months,83.8,79.0 to 88.1,455
Hib,Full Series,States/Local Areas,Washington,2018,Age,24 Months,86.6,82.1 to 90.5,492
Hib,Full Series,States/Local Areas,Washington,2018-2019,Age,24 Months,85.2,81.9 to 88.1,947
Hib,Full Series,States/Local Areas,Washington,2013,Age,35 Months,86.1,80.5 to 90.7,313
Hib,Full Series,States/Local Areas,Washington,2013-2014,Age,35 Months,85.8,81.8 to 89.3,617
Polio,≥3 Doses,States/Local Areas,Washington,2012,Age,35 Months,94.6,89.9 to 97.6,252
Hib,≥3 Doses,States/Local Areas,Washington,2019,Age,13 Months,86.7,82.0 to 90.3,455
DTaP,≥3 Doses,States/Local Areas,Washington,2012,Age,24 Months,94.6,90.4 to 97.4,252
Polio,≥3 Doses,States/Local Areas,Washington,2013,Age,35 Months,93.1,88.8 to 96.2,313
Polio,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,92.4,89.2 to 95.0,617
Polio,≥3 Doses,States/Local Areas,Washington,2014,Age,35 Months,91.8,86.5 to 95.6,304
Polio,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,91.4,87.6 to 94.4,582
DTaP,≥2 Doses,States/Local Areas,Washington,2013,Age,5 Months,80.5,75.2 to 84.8,313
DTaP,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,5 Months,80.7,76.6 to 84.3,617
DTaP,≥2 Doses,States/Local Areas,Washington,2012,Age,5 Months,85.7,79.7 to 90.1,252
DTaP,≥2 Doses,States/Local Areas,Washington,2011,Age,5 Months,77.7,71.2 to 83.1,241
Polio,≥2 Doses,States/Local Areas,Washington,2020,Age,13 Months,92.1,87.5 to 95.1,445
DTaP,≥3 Doses,States/Local Areas,Washington,2019,Age,19 Months,96.2,93.2 to 97.9,455
DTaP,≥3 Doses,States/Local Areas,Washington,2011,Age,24 Months,94.1,89.1 to 97.3,241
Hib,Full Series,States/Local Areas,Washington,2014,Age,24 Months,83.5,77.5 to 88.6,304
Hib,Full Series,States/Local Areas,Washington,2014-2015,Age,24 Months,80.5,75.9 to 84.8,582
Polio,≥3 Doses,States/Local Areas,Washington,2017,Age,24 Months,91.5,87.7 to 94.5,467
Polio,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,93.3,90.9 to 95.2,959
Polio,≥3 Doses,States/Local Areas,Washington,2019,Age,24 Months,95.7,92.7 to 97.7,455
Polio,≥3 Doses,States/Local Areas,Washington,2018,Age,24 Months,95.1,92.2 to 97.2,492
Polio,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,95.3,93.4 to 96.9,947
Hib,≥3 Doses,States/Local Areas,Washington,2019,Age,19 Months,94.3,90.7 to 96.6,455
Polio,≥3 Doses,States/Local Areas,Washington,2016,Age,24 Months,87.4,80.5 to 92.8,280
Polio,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,89.4,85.5 to 92.7,747
Hib,Full Series,States/Local Areas,Washington,2015,Age,24 Months,77.6,70.4 to 84.1,278
Hib,Full Series,States/Local Areas,Washington,2015-2016,Age,24 Months,76.7,71.5 to 81.6,558
Hib,Full Series,States/Local Areas,Washington,2016,Age,24 Months,75.9,68.2 to 82.9,280
Hib,Full Series,States/Local Areas,Washington,2016-2017,Age,24 Months,78.1,73.4 to 82.5,747
Polio,≥3 Doses,States/Local Areas,Washington,2011,Age,35 Months,93.8,88.0 to 97.4,241
Hib,Full Series,States/Local Areas,Washington,2017,Age,24 Months,80.3,74.9 to 85.3,467
Hib,Full Series,States/Local Areas,Washington,2017-2018,Age,24 Months,83.5,79.9 to 86.7,959
Hib,≥3 Doses,States/Local Areas,Washington,2013,Age,24 Months,92.9,88.4 to 96.1,313
Hib,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,91.4,88.1 to 94.1,617
Hib,≥3 Doses,States/Local Areas,Washington,2012,Age,24 Months,91.6,86.6 to 95.3,252
Hib,≥3 Doses,States/Local Areas,Washington,2011,Age,24 Months,94.1,89.4 to 97.2,241
DTaP,≥3 Doses,States/Local Areas,Washington,2015,Age,19 Months,91.8,90.3 to 93.0,278
DTaP,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,90.9,86.8 to 93.8,558
DTaP,≥3 Doses,States/Local Areas,Washington,2014,Age,19 Months,90.0,84.1 to 93.8,304
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,90.9,87.3 to 93.5,582
DTaP,≥3 Doses,States/Local Areas,Washington,2013,Age,19 Months,91.8,87.8 to 94.6,313
DTaP,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,90.9,87.2 to 93.6,617
Polio,≥3 Doses,States/Local Areas,Washington,2018,Age,19 Months,94.5,91.2 to 96.6,492
Polio,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,76.2,72.2 to 79.7,947
Hib,≥3 Doses,States/Local Areas,Washington,2015,Age,19 Months,89.0,86.6 to 90.9,278
Hib,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,86.5,81.6 to 90.2,558
Polio,≥3 Doses,States/Local Areas,Washington,2011,Age,24 Months,90.8,85.2 to 94.9,241
Polio,≥3 Doses,States/Local Areas,Washington,2012,Age,24 Months,92.9,88.0 to 96.3,252
Hib,≥3 Doses,States/Local Areas,Washington,2013,Age,19 Months,92.1,88.2 to 94.8,313
Hib,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,91.0,87.9 to 93.4,617
Hib,≥3 Doses,States/Local Areas,Washington,2014,Age,19 Months,90.0,84.3 to 93.8,304
Hib,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,89.5,85.4 to 92.5,582
DTaP,≥3 Doses,States/Local Areas,Washington,2017,Age,19 Months,92.1,88.1 to 94.9,467
DTaP,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,94.2,91.8 to 95.8,959
DTaP,≥3 Doses,States/Local Areas,Washington,2016,Age,19 Months,90.0,82.8 to 94.3,280
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,91.0,87.2 to 93.8,747
Polio,≥3 Doses,States/Local Areas,Washington,2019,Age,19 Months,94.4,90.9 to 96.6,455
Polio,≥3 Doses,States/Local Areas,Washington,2013,Age,24 Months,90.7,85.8 to 94.4,313
Polio,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,89.8,86.3 to 92.8,617
Hib,≥3 Doses,States/Local Areas,Washington,2018,Age,19 Months,93.7,90.2 to 96.0,492
Hib,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,86.3,82.9 to 89.0,947
Hib,≥3 Doses,States/Local Areas,Washington,2017,Age,19 Months,88.6,84.1 to 91.9,467
Hib,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,91.1,88.4 to 93.3,959
Hib,≥3 Doses,States/Local Areas,Washington,2016,Age,19 Months,84.0,76.2 to 89.6,280
Hib,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,86.3,81.9 to 89.7,747
DTaP,≥3 Doses,States/Local Areas,Washington,2018,Age,19 Months,96.2,93.5 to 97.8,492
DTaP,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,94.6,92.3 to 96.2,947
Polio,≥3 Doses,States/Local Areas,Washington,2015,Age,24 Months,88.9,82.8 to 93.5,278
Polio,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,88.1,83.7 to 91.9,558
Polio,≥3 Doses,States/Local Areas,Washington,2014,Age,24 Months,89.0,83.6 to 93.3,304
Polio,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,88.9,85.0 to 92.2,582
Hib,Full Series,States/Local Areas,Alaska,2016,Age,19 Months,75.8,68.0 to 82.2,228
Hib,Full Series,States/Local Areas,Alaska,2016-2017,Age,19 Months,75.9,70.8 to 80.4,486
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,59.0,51.4 to 66.6,218
Hib,Full Series,States/Local Areas,Alaska,2018,Age,19 Months,78.8,72.5 to 84.0,275
Hib,Full Series,States/Local Areas,Alaska,2018-2019,Age,19 Months,92.2,88.8 to 94.7,562
Hib,Full Series,States/Local Areas,Alaska,2017,Age,19 Months,76.1,69.3 to 81.7,258
Hib,Full Series,States/Local Areas,Alaska,2017-2018,Age,19 Months,77.4,72.9 to 81.4,533
Hib,≥3 Doses,States/Local Areas,Alaska,2018,Age,35 Months,89.5,84.5 to 93.4,275
Hib,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,88.0,83.6 to 91.7,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2012,Age,24 Months,38.2,31.0 to 46.3,273
Hib,≥3 Doses,States/Local Areas,Alaska,2017,Age,35 Months,82.8,76.2 to 88.5,258
Hib,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,86.1,82.0 to 89.6,533
Hib,≥3 Doses,States/Local Areas,Alaska,2016,Age,35 Months,84.0,77.2 to 89.7,228
Hib,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,83.4,78.8 to 87.5,486
Hep A,≥2 Doses,States/Local Areas,Alaska,2011,Age,24 Months,29.6,22.8 to 37.8,288
Hep A,≥2 Doses,States/Local Areas,Alaska,2019,Age,19 Months,15.8,11.2 to 22.0,287
Hep A,≥2 Doses,States/Local Areas,Alaska,2018,Age,19 Months,17.5,12.9 to 23.4,275
Hep A,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,19 Months,15.9,12.2 to 20.5,446
DTaP,≥4 Doses,States/Local Areas,Alaska,2016,Age,19 Months,65.8,57.8 to 72.9,228
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,61.7,56.2 to 66.9,486
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,87.7,83.6 to 91.8,357
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,92.6,90.1 to 95.0,458
DTaP,≥4 Doses,States/Local Areas,Alaska,2015,Age,19 Months,56.9,50.7 to 62.9,257
DTaP,≥4 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,61.4,56.0 to 66.6,485
DTaP,≥4 Doses,States/Local Areas,Alaska,2014,Age,19 Months,67.5,60.7 to 73.5,275
DTaP,≥4 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,62.2,57.2 to 67.0,532
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,83.9,72.6 to 95.3,61
Hep A,≥1 Dose,States/Local Areas,Alaska,2017,Age,24 Months,81.5,75.1 to 87.1,258
Hep A,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,24 Months,83.4,79.3 to 87.1,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2019,Age,35 Months,90.5,83.6 to 95.4,287
DTaP,≥3 Doses,States/Local Areas,Alaska,2018,Age,35 Months,91.8,87.5 to 95.1,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,35 Months,91.2,87.2 to 94.3,562
PCV,≥2 Doses,States/Local Areas,Alaska,2016,Age,5 Months,70.3,62.3 to 77.3,228
PCV,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,5 Months,69.6,64.1 to 74.6,486
PCV,≥2 Doses,States/Local Areas,Alaska,2015,Age,5 Months,73.2,66.6 to 79.0,257
PCV,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,5 Months,71.8,66.6 to 76.4,485
PCV,≥2 Doses,States/Local Areas,Alaska,2014,Age,5 Months,67.1,60.0 to 73.4,275
PCV,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,5 Months,70.1,64.0 to 75.6,532
Hep A,≥1 Dose,States/Local Areas,Alaska,2016,Age,24 Months,86.9,81.1 to 91.7,228
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,24 Months,84.4,80.2 to 88.2,486
Hep A,≥1 Dose,States/Local Areas,Alaska,2015,Age,24 Months,83.4,77.5 to 88.4,257
Hep A,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,24 Months,85.2,81.1 to 88.8,485
PCV,≥2 Doses,States/Local Areas,Alaska,2017,Age,5 Months,68.8,61.1 to 75.5,258
PCV,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,5 Months,68.6,63.4 to 73.3,533
Hep A,≥1 Dose,States/Local Areas,Alaska,2012,Age,35 Months,89.8,84.4 to 94.0,273
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,59.7,44.5 to 75.0,61
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,57.7,51.6 to 63.7,357
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,73.5,68.8 to 78.2,458
Combined 7 Series,,States/Local Areas,Alaska,2019,Age,35 Months,67.8,59.9 to 75.6,287
Combined 7 Series,,States/Local Areas,Alaska,2018,Age,35 Months,63.5,56.4 to 70.6,275
Combined 7 Series,,States/Local Areas,Alaska,2018-2019,Age,35 Months,65.5,60.2 to 70.7,562
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,70.5,59.4 to 81.6,97
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,55.4,47.0 to 63.8,187
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,73.3,68.3 to 78.4,463
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.0,60.9 to 71.1,481
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.0,55.5 to 68.6,306
Hib,Full Series,States/Local Areas,Alaska,2013,Age,19 Months,76.6,72.0 to 80.6,303
Hib,Full Series,States/Local Areas,Alaska,2013-2014,Age,19 Months,78.4,74.0 to 82.3,578
Hib,Full Series,States/Local Areas,Alaska,2012,Age,19 Months,81.8,77.4 to 85.4,273
Hib,Full Series,States/Local Areas,Alaska,2011,Age,19 Months,73.5,66.0 to 79.9,288
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,75.9,70.0 to 81.8,283
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,62.6,56.9 to 68.3,404
Hib,Full Series,States/Local Areas,Alaska,2019,Age,19 Months,71.5,64.1 to 77.9,287
Hib,Full Series,States/Local Areas,Alaska,2014,Age,24 Months,84.8,79.7 to 89.1,275
Hib,Full Series,States/Local Areas,Alaska,2014-2015,Age,24 Months,80.3,76.1 to 84.2,532
Hib,Full Series,States/Local Areas,Alaska,2013,Age,24 Months,78.1,71.9 to 83.8,303
Hib,Full Series,States/Local Areas,Alaska,2013-2014,Age,24 Months,81.5,77.5 to 85.2,578
Hib,Full Series,States/Local Areas,Alaska,2012,Age,24 Months,83.9,78.1 to 88.8,273
Hib,Full Series,States/Local Areas,Alaska,2011,Age,24 Months,80.7,73.8 to 86.7,288
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Overall,Overall,65.0,61.2 to 68.8,905
Combined 7 Series,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,56.9,49.7 to 64.1,255
Hib,Primary Series,States/Local Areas,Alaska,2016,Age,24 Months,89.7,84.1 to 94.0,228
Hib,Primary Series,States/Local Areas,Alaska,2016-2017,Age,24 Months,88.6,84.8 to 91.8,486
Hib,Primary Series,States/Local Areas,Alaska,2015,Age,24 Months,91.2,86.8 to 94.6,257
Hib,Primary Series,States/Local Areas,Alaska,2015-2016,Age,24 Months,90.4,87.0 to 93.3,485
Hib,Primary Series,States/Local Areas,Alaska,2014,Age,24 Months,92.6,89.2 to 95.2,275
Hib,Primary Series,States/Local Areas,Alaska,2014-2015,Age,24 Months,91.9,89.2 to 94.1,532
Hib,Primary Series,States/Local Areas,Alaska,2018,Age,24 Months,93.5,89.6 to 96.3,275
Hib,Primary Series,States/Local Areas,Alaska,2018-2019,Age,24 Months,91.2,87.8 to 94.0,562
Hib,Primary Series,States/Local Areas,Alaska,2017,Age,24 Months,87.2,82.0 to 91.5,258
Hib,Primary Series,States/Local Areas,Alaska,2017-2018,Age,24 Months,90.3,87.1 to 93.0,533
Hib,Primary Series,States/Local Areas,Alaska,2019,Age,24 Months,88.8,83.0 to 93.4,287
Hib,Primary Series,States/Local Areas,Alaska,2014,Age,35 Months,93.1,89.8 to 95.7,275
Hib,Primary Series,States/Local Areas,Alaska,2014-2015,Age,35 Months,92.7,89.9 to 95.0,532
Hib,Primary Series,States/Local Areas,Alaska,2012,Age,35 Months,94.1,90.1 to 96.8,273
Hib,Primary Series,States/Local Areas,Alaska,2013,Age,35 Months,92.3,84.5 to 97.1,303
Hib,Primary Series,States/Local Areas,Alaska,2013-2014,Age,35 Months,92.0,88.3 to 94.8,578
Hib,Primary Series,States/Local Areas,Alaska,2011,Age,35 Months,94.9,90.3 to 97.7,288
PCV,≥3 Doses,States/Local Areas,Alaska,2020,Age,7 Months,64.8,57.5 to 71.4,302
Hep B,≥3 Doses,States/Local Areas,Alaska,2020,Age,7 Months,76.4,69.6 to 82.1,302
Hep B,≥2 Doses,States/Local Areas,Alaska,2020,Age,7 Months,85.8,79.7 to 90.3,302
Hib,≥1 Dose,States/Local Areas,Alaska,2020,Age,3 Months,79.0,72.3 to 84.5,302
Polio,≥1 Dose,States/Local Areas,Alaska,2020,Age,3 Months,78.7,71.9 to 84.2,302
DTaP,≥1 Dose,States/Local Areas,Alaska,2020,Age,3 Months,79.4,72.6 to 84.8,302
Rotavirus,,States/Local Areas,Alaska,2019-2020,Age,8 Months,67.7,62.4 to 72.5,589
≥1 Dose MMR,,States/Local Areas,Alaska,2020-2021,Age,13 Months,58.3,52.2 to 64.2,492
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2021,Age,0-1 Days,72.2,62.9 to 80.0,190
Hep A,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,16.6,12.6 to 21.7,492
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2021,Age,0-2 Days,73.3,63.9 to 81.0,190
Hep B,≥2 Doses,States/Local Areas,Alaska,2021,Age,7 Months,90.0,82.5 to 94.5,190
Hib,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,85.3,80.3 to 89.2,492
PCV,≥3 Doses,States/Local Areas,Alaska,2021,Age,13 Months,81.1,72.1 to 87.7,190
≥1 Dose Varicella,,States/Local Areas,Alaska,2020-2021,Age,35 Months,86.3,80.7 to 90.9,492
Hep B,≥3 Doses,States/Local Areas,Alaska,2021,Age,7 Months,77.2,67.8 to 84.5,190
PCV,≥3 Doses,States/Local Areas,Alaska,2021,Age,24 Months,85.7,77.4 to 92.2,190
≥1 Dose Varicella,,States/Local Areas,Alaska,2021,Age,24 Months,84.4,75.7 to 91.3,190
PCV,≥4 Doses,States/Local Areas,Alaska,2021,Age,19 Months,76.1,66.7 to 83.5,190
Hep B,≥3 Doses,States/Local Areas,Alaska,2021,Age,24 Months,87.6,80.1 to 93.3,190
DTaP,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,90.1,84.5 to 94.3,492
DTaP,≥3 Doses,States/Local Areas,Alaska,2021,Age,13 Months,83.7,74.7 to 89.9,190
PCV,≥3 Doses,States/Local Areas,Alaska,2021,Age,7 Months,64.9,55.1 to 73.6,190
Hep A,≥2 Doses,States/Local Areas,Alaska,2021,Age,24 Months,31.7,22.8 to 42.9,190
Hep A,≥1 Dose,States/Local Areas,Alaska,2021,Age,24 Months,79.5,70.5 to 87.2,190
PCV,≥4 Doses,States/Local Areas,Alaska,2021,Age,24 Months,77.1,68.3 to 84.9,190
Polio,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,85.4,80.3 to 89.3,492
PCV,≥2 Doses,States/Local Areas,Alaska,2021,Age,5 Months,72.9,63.5 to 80.7,190
Hep B,≥2 Doses,States/Local Areas,Alaska,2021,Age,5 Months,88.1,80.6 to 92.9,190
Hib,Primary Series,States/Local Areas,Alaska,2021,Age,7 Months,73.8,64.8 to 81.2,190
Combined 7 Series,,States/Local Areas,Alaska,2021,Age,35 Months,67.0,56.0 to 77.6,190
DTaP,≥4 Doses,States/Local Areas,Alaska,2021,Age,19 Months,63.9,54.0 to 72.8,190
Hep A,≥2 Doses,States/Local Areas,Alaska,2021,Age,35 Months,63.0,49.5 to 76.5,190
DTaP,≥3 Doses,States/Local Areas,Alaska,2021,Age,7 Months,65.0,55.2 to 73.6,190
Hep A,≥1 Dose,States/Local Areas,Alaska,2021,Age,35 Months,87.5,75.7 to 95.3,190
PCV,≥3 Doses,States/Local Areas,Alaska,2021,Age,19 Months,84.6,75.7 to 90.6,190
DTaP,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,3 Months,82.3,77.1 to 86.5,492
Hep B,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,88.9,84.3 to 92.7,492
Hib,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,4.9,2.9 to 8.2,589
≥1 Dose Varicella,,States/Local Areas,Alaska,2021,Age,19 Months,79.3,70.2 to 86.1,190
Hib,Full Series,States/Local Areas,Alaska,2021,Age,24 Months,76.2,67.7 to 83.8,190
DTaP,≥3 Doses,States/Local Areas,Alaska,2021,Age,19 Months,85.9,77.1 to 91.7,190
Hib,Primary Series,States/Local Areas,Alaska,2021,Age,24 Months,87.9,80.5 to 93.4,190
Hib,≥3 Doses,States/Local Areas,Alaska,2021,Age,24 Months,84.7,76.8 to 91.1,190
≥1 Dose MMR,,States/Local Areas,Alaska,2021,Age,24 Months,83.4,75.1 to 90.2,190
Polio,≥1 Dose,States/Local Areas,Alaska,2021,Age,3 Months,84.6,76.2 to 90.5,190
Polio,≥3 Doses,States/Local Areas,Alaska,2021,Age,24 Months,87.1,78.8 to 93.2,190
DTaP,≥1 Dose,States/Local Areas,Alaska,2021,Age,3 Months,85.2,76.7 to 90.9,190
DTaP,≥4 Doses,States/Local Areas,Alaska,2021,Age,24 Months,70.1,60.3 to 79.3,190
PCV,≥4 Doses,States/Local Areas,Alaska,2021,Age,35 Months,78.6,69.8 to 86.4,190
Hep A,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,35 Months,90.3,83.1 to 95.3,492
PCV,≥3 Doses,States/Local Areas,Alaska,2021,Age,35 Months,85.7,77.4 to 92.2,190
Hib,Primary Series,States/Local Areas,Alaska,2020-2021,Age,13 Months,83.2,78.1 to 87.3,492
Hep A,≥1 Dose,States/Local Areas,Alaska,2021,Age,19 Months,77.1,67.5 to 84.5,190
Polio,≥3 Doses,States/Local Areas,Alaska,2021,Age,35 Months,87.1,78.8 to 93.2,190
PCV,≥4 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,75.4,69.8 to 80.6,492
Hib,≥2 Doses,States/Local Areas,Alaska,2021,Age,7 Months,82.1,73.7 to 88.3,190
≥1 Dose MMR,,States/Local Areas,Alaska,2020-2021,Age,24 Months,83.9,78.9 to 88.3,492
Hep B,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,89.6,85.1 to 92.9,492
Polio,≥2 Doses,States/Local Areas,Alaska,2021,Age,7 Months,82.0,73.0 to 88.4,190
Hib,Primary Series,States/Local Areas,Alaska,2020-2021,Age,24 Months,87.9,83.4 to 91.6,492
Hib,Primary Series,States/Local Areas,Alaska,2021,Age,19 Months,87.4,79.4 to 92.6,190
Hib,≥3 Doses,States/Local Areas,Alaska,2021,Age,19 Months,84.0,75.4 to 90.0,190
Hep B,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,84.9,79.6 to 88.9,492
DTaP,≥3 Doses,States/Local Areas,Alaska,2021,Age,24 Months,87.1,78.8 to 93.2,190
Hib,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,83.2,78.2 to 87.5,492
Hep A,≥1 Dose,States/Local Areas,Alaska,2012,Age,19 Months,82.3,79.6 to 84.7,273
Hep A,≥1 Dose,States/Local Areas,Alaska,2011,Age,19 Months,70.6,64.6 to 76.0,288
DTaP,≥1 Dose,States/Local Areas,Alaska,2019,Age,3 Months,86.2,79.5 to 90.9,287
DTaP,≥3 Doses,States/Local Areas,Alaska,2016,Age,24 Months,88.8,83.1 to 93.3,228
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,89.3,85.5 to 92.5,486
DTaP,≥1 Dose,States/Local Areas,Alaska,2018,Age,3 Months,84.1,77.8 to 88.9,275
DTaP,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,3 Months,85.1,80.7 to 88.7,562
DTaP,≥3 Doses,States/Local Areas,Alaska,2015,Age,24 Months,91.0,87.2 to 94.1,257
DTaP,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,89.9,86.5 to 92.8,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2014,Age,24 Months,90.8,86.5 to 94.2,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,24 Months,90.9,88.1 to 93.3,532
DTaP,≥1 Dose,States/Local Areas,Alaska,2017,Age,3 Months,83.2,76.5 to 88.2,258
DTaP,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,3 Months,83.6,79.2 to 87.3,533
DTaP,≥1 Dose,States/Local Areas,Alaska,2016,Age,3 Months,84.5,77.2 to 89.7,228
DTaP,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,3 Months,83.9,79.1 to 87.7,486
DTaP,≥1 Dose,States/Local Areas,Alaska,2015,Age,3 Months,87.1,82.2 to 90.8,257
DTaP,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,3 Months,85.8,81.5 to 89.2,485
DTaP,≥1 Dose,States/Local Areas,Alaska,2014,Age,3 Months,81.6,75.5 to 86.5,275
DTaP,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,3 Months,84.3,80.5 to 87.5,532
DTaP,≥1 Dose,States/Local Areas,Alaska,2013,Age,3 Months,86.0,78.7 to 91.2,303
DTaP,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,3 Months,83.8,79.1 to 87.6,578
DTaP,≥1 Dose,States/Local Areas,Alaska,2012,Age,3 Months,87.1,83.0 to 90.3,273
DTaP,≥1 Dose,States/Local Areas,Alaska,2011,Age,3 Months,87.9,85.5 to 89.9,288
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",61.5,56.2 to 66.7,471
DTaP,≥2 Doses,States/Local Areas,Alaska,2018,Age,5 Months,69.3,62.2 to 75.7,275
DTaP,≥2 Doses,States/Local Areas,Alaska,2018-2019,Age,5 Months,72.0,66.9 to 76.6,562
DTaP,≥2 Doses,States/Local Areas,Alaska,2017,Age,5 Months,71.3,63.8 to 77.8,258
DTaP,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,5 Months,70.3,65.2 to 75.0,533
Hep A,≥1 Dose,States/Local Areas,Alaska,2015,Age,19 Months,74.0,69.6 to 78.0,257
Hep A,≥1 Dose,States/Local Areas,Alaska,2015-2016,Age,19 Months,76.9,71.9 to 81.2,485
Hep A,≥1 Dose,States/Local Areas,Alaska,2014,Age,19 Months,81.4,75.4 to 86.2,275
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,19 Months,77.7,73.1 to 81.7,532
Hep A,≥1 Dose,States/Local Areas,Alaska,2016,Age,19 Months,79.6,72.2 to 85.4,228
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2017,Age,19 Months,76.0,70.9 to 80.4,486
Hep A,≥1 Dose,States/Local Areas,Alaska,2013,Age,19 Months,69.7,64.2 to 74.7,303
Hep A,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,19 Months,75.6,68.4 to 81.6,578
Hep B,≥3 Doses,States/Local Areas,Alaska,2021,Age,19 Months,87.6,79.3 to 92.9,190
Hib,Full Series,States/Local Areas,Alaska,2021,Age,19 Months,75.8,66.7 to 83.0,190
Hib,Full Series,States/Local Areas,Alaska,2015,Age,19 Months,73.5,71.3 to 75.6,257
Hib,Full Series,States/Local Areas,Alaska,2015-2016,Age,19 Months,74.7,69.5 to 79.2,485
Hib,Full Series,States/Local Areas,Alaska,2014,Age,19 Months,80.2,74.4 to 85.1,275
Hib,Full Series,States/Local Areas,Alaska,2014-2015,Age,19 Months,76.9,72.4 to 80.9,532
Hep A,≥1 Dose,States/Local Areas,Alaska,2011,Age,35 Months,91.5,84.4 to 96.2,288
Hep A,≥1 Dose,States/Local Areas,Alaska,2019,Age,24 Months,79.8,72.7 to 86.1,287
Hep A,≥1 Dose,States/Local Areas,Alaska,2018,Age,24 Months,85.2,80.0 to 89.6,275
Hep A,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,24 Months,82.6,78.2 to 86.5,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2017,Age,19 Months,11.3,7.5 to 16.9,258
Hep A,≥2 Doses,States/Local Areas,Alaska,2017-2018,Age,19 Months,14.4,11.2 to 18.3,533
Hib,≥3 Doses,States/Local Areas,Alaska,2015,Age,35 Months,85.5,79.4 to 90.6,257
Hib,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,84.7,80.2 to 88.6,485
Hib,≥3 Doses,States/Local Areas,Alaska,2014,Age,35 Months,89.7,85.1 to 93.4,275
Hib,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,87.7,83.9 to 90.9,532
Hib,≥3 Doses,States/Local Areas,Alaska,2013,Age,35 Months,88.6,80.2 to 94.5,303
Hib,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,88.7,84.3 to 92.4,578
Hep A,≥2 Doses,States/Local Areas,Alaska,2016,Age,19 Months,19.1,13.6 to 26.2,228
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2017,Age,19 Months,15.5,11.9 to 19.9,486
Hep A,≥2 Doses,States/Local Areas,Alaska,2015,Age,19 Months,15.0,12.2 to 18.1,257
Hep A,≥2 Doses,States/Local Areas,Alaska,2015-2016,Age,19 Months,17.1,13.2 to 21.8,485
DTaP,≥4 Doses,States/Local Areas,Alaska,2013,Age,19 Months,55.7,51.3 to 60.0,303
DTaP,≥4 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,61.6,54.5 to 68.3,578
DTaP,≥4 Doses,States/Local Areas,Alaska,2012,Age,19 Months,69.4,66.5 to 72.2,273
DTaP,≥4 Doses,States/Local Areas,Alaska,2011,Age,19 Months,56.4,52.3 to 60.4,288
Hib,≥3 Doses,States/Local Areas,Alaska,2012,Age,35 Months,89.2,82.8 to 94.0,273
Hib,≥3 Doses,States/Local Areas,Alaska,2011,Age,35 Months,89.6,83.7 to 94.1,288
Hib,≥3 Doses,States/Local Areas,Alaska,2019,Age,24 Months,81.9,75.1 to 87.8,287
Hib,≥3 Doses,States/Local Areas,Alaska,2018,Age,24 Months,88.2,83.3 to 92.2,275
Hib,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,85.1,81.0 to 88.8,562
Hep A,≥2 Doses,States/Local Areas,Alaska,2014,Age,19 Months,17.4,12.7 to 23.5,275
Hep A,≥2 Doses,States/Local Areas,Alaska,2014-2015,Age,19 Months,16.2,12.6 to 20.6,532
Hep A,≥2 Doses,States/Local Areas,Alaska,2012,Age,19 Months,15.7,14.2 to 17.3,273
Hep A,≥2 Doses,States/Local Areas,Alaska,2013,Age,19 Months,14.4,10.4 to 19.7,303
Hep A,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,19 Months,15.9,13.2 to 19.1,578
Hep A,≥2 Doses,States/Local Areas,Alaska,2011,Age,19 Months,9.8,7.9 to 12.2,288
DTaP,≥3 Doses,States/Local Areas,Alaska,2015,Age,35 Months,93.9,88.8 to 97.1,257
DTaP,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,35 Months,91.2,87.4 to 94.2,485
Hib,≥1 Dose,States/Local Areas,Alaska,2021,Age,3 Months,82.9,74.3 to 89.0,190
DTaP,≥3 Doses,States/Local Areas,Alaska,2014,Age,35 Months,92.2,88.1 to 95.4,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2014-2015,Age,35 Months,93.2,89.8 to 95.7,532
DTaP,≥3 Doses,States/Local Areas,Alaska,2013,Age,35 Months,95.0,88.6 to 98.4,303
DTaP,≥3 Doses,States/Local Areas,Alaska,2013-2014,Age,35 Months,93.1,89.2 to 96.0,578
DTaP,≥3 Doses,States/Local Areas,Alaska,2012,Age,35 Months,97.9,94.0 to 99.5,273
DTaP,≥3 Doses,States/Local Areas,Alaska,2011,Age,35 Months,94.3,89.7 to 97.3,288
Hep A,≥1 Dose,States/Local Areas,Alaska,2014,Age,24 Months,87.0,81.9 to 91.3,275
Hep A,≥1 Dose,States/Local Areas,Alaska,2014-2015,Age,24 Months,85.2,81.4 to 88.6,532
Hep A,≥1 Dose,States/Local Areas,Alaska,2012,Age,24 Months,87.6,82.3 to 91.8,273
Hep A,≥1 Dose,States/Local Areas,Alaska,2013,Age,24 Months,75.7,69.1 to 81.8,303
Hep A,≥1 Dose,States/Local Areas,Alaska,2013-2014,Age,24 Months,81.4,77.2 to 85.3,578
Hep A,≥1 Dose,States/Local Areas,Alaska,2011,Age,24 Months,83.2,76.9 to 88.6,288
Hep A,≥1 Dose,States/Local Areas,Alaska,2019,Age,19 Months,74.4,66.9 to 80.7,287
Hep A,≥1 Dose,States/Local Areas,Alaska,2018,Age,19 Months,81.8,75.9 to 86.4,275
Hep A,≥1 Dose,States/Local Areas,Alaska,2018-2019,Age,19 Months,76.4,70.8 to 81.3,446
Hep A,≥1 Dose,States/Local Areas,Alaska,2017,Age,19 Months,71.7,64.5 to 78.0,258
Hep A,≥1 Dose,States/Local Areas,Alaska,2017-2018,Age,19 Months,76.7,72.0 to 80.7,533
Hib,≥3 Doses,States/Local Areas,Alaska,2017,Age,24 Months,80.9,74.6 to 86.4,258
Hib,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,84.5,80.5 to 88.0,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2019,Age,24 Months,87.7,81.5 to 92.6,287
Hib,≥3 Doses,States/Local Areas,Alaska,2016,Age,24 Months,83.6,76.9 to 89.3,228
Hib,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,24 Months,82.4,77.8 to 86.5,486
Hib,≥3 Doses,States/Local Areas,Alaska,2015,Age,24 Months,82.9,77.0 to 88.1,257
Hib,≥3 Doses,States/Local Areas,Alaska,2015-2016,Age,24 Months,83.3,78.8 to 87.2,485
DTaP,≥3 Doses,States/Local Areas,Alaska,2018,Age,24 Months,91.8,87.5 to 95.1,275
DTaP,≥3 Doses,States/Local Areas,Alaska,2018-2019,Age,24 Months,89.8,86.1 to 92.9,562
DTaP,≥3 Doses,States/Local Areas,Alaska,2017,Age,24 Months,89.7,84.3 to 93.8,258
DTaP,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,24 Months,90.8,87.4 to 93.6,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2017,Age,35 Months,90.9,85.6 to 94.8,258
DTaP,≥3 Doses,States/Local Areas,Alaska,2017-2018,Age,35 Months,91.4,88.0 to 94.2,533
DTaP,≥3 Doses,States/Local Areas,Alaska,2016,Age,35 Months,88.8,83.1 to 93.3,228
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2017,Age,35 Months,89.9,86.1 to 93.0,486
PCV,≥2 Doses,States/Local Areas,Alaska,2013,Age,5 Months,73.1,67.5 to 78.1,303
PCV,≥2 Doses,States/Local Areas,Alaska,2013-2014,Age,5 Months,70.1,67.1 to 72.9,578
PCV,≥2 Doses,States/Local Areas,Alaska,2012,Age,5 Months,73.6,69.4 to 77.4,273
PCV,≥2 Doses,States/Local Areas,Alaska,2011,Age,5 Months,69.8,64.2 to 74.8,288
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,91.1,87.4 to 94.7,283
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,89.9,86.4 to 93.5,404
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,82.5,76.3 to 88.7,218
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Overall,Overall,88.1,85.5 to 90.7,905
Polio,≥3 Doses,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,84.5,79.6 to 89.5,255
DTaP,≥2 Doses,States/Local Areas,Alaska,2019,Age,5 Months,74.8,67.6 to 80.9,287
PCV,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,5 Months,72.3,67.2 to 76.8,589
DTaP,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,63.2,57.9 to 68.3,589
Polio,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,82.7,78.2 to 86.5,589
Hep B,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,90.3,86.4 to 93.2,589
Hep B,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,86.4,82.1 to 89.8,589
≥1 Dose Varicella,,States/Local Areas,Alaska,2019-2020,Age,13 Months,41.5,36.3 to 46.8,589
PCV,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,80.8,75.9 to 84.8,589
Combined 7 Series,,States/Local Areas,Alaska,2019-2020,Age,24 Months,60.8,55.4 to 66.1,589
DTaP,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,90.8,86.1 to 94.4,589
DTaP,≥4 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,82.0,76.9 to 86.6,589
Polio,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,89.8,85.1 to 93.5,589
DTaP,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,87.2,82.9 to 90.6,589
DTaP,≥4 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,62.3,57.0 to 67.4,589
PCV,≥4 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,73.8,68.8 to 78.6,589
Hep B,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,76.9,72.0 to 81.2,589
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2019-2020,Age,0-3 Days,75.2,70.4 to 79.4,589
DTaP,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,3 Months,82.8,78.2 to 86.6,589
Hib,≥2 Doses,States/Local Areas,Alaska,2020,Age,5 Months,70.1,62.9 to 76.4,302
Polio,≥2 Doses,States/Local Areas,Alaska,2020,Age,5 Months,70.4,63.3 to 76.6,302
DTaP,≥2 Doses,States/Local Areas,Alaska,2020,Age,5 Months,71.2,64.1 to 77.4,302
PCV,≥1 Dose,States/Local Areas,Alaska,2020,Age,3 Months,78.7,71.9 to 84.2,302
Hep B,≥1 Dose,States/Local Areas,Alaska,2020,Age,3 Months,90.2,84.7 to 93.8,302
Hep A,≥1 Dose,States/Local Areas,Alaska,2020,Age,24 Months,79.1,72.4 to 85.1,302
Hep A,≥2 Doses,States/Local Areas,Alaska,2020,Age,24 Months,31.5,24.9 to 39.3,302
PCV,≥4 Doses,States/Local Areas,Alaska,2020,Age,24 Months,73.5,66.6 to 80.0,302
PCV,≥3 Doses,States/Local Areas,Alaska,2020,Age,24 Months,86.4,80.4 to 91.3,302
≥1 Dose Varicella,,States/Local Areas,Alaska,2020,Age,24 Months,79.2,72.7 to 85.0,302
Influenza,,States/Local Areas,Alaska,2020,Age,24 Months,63.5,56.5 to 70.6,302
Rotavirus,,States/Local Areas,Alaska,2020,Age,8 Months,69.2,62.1 to 75.5,302
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2020,Age,0-3 Days,72.8,65.9 to 78.8,302
≥1 Dose MMR,,States/Local Areas,Alaska,2020,Age,19 Months,81.3,74.5 to 86.6,302
Hib,≥3 Doses,States/Local Areas,Alaska,2020,Age,19 Months,79.4,72.4 to 85.0,302
Combined 7 Series,,States/Local Areas,Alaska,2020,Age,24 Months,58.1,50.8 to 65.6,302
Polio,≥3 Doses,States/Local Areas,Alaska,2020,Age,19 Months,84.9,78.6 to 89.6,302
DTaP,≥4 Doses,States/Local Areas,Alaska,2020,Age,19 Months,59.9,52.4 to 67.0,302
DTaP,≥3 Doses,States/Local Areas,Alaska,2020,Age,19 Months,86.9,80.7 to 91.3,302
PCV,≥3 Doses,States/Local Areas,Alaska,2020,Age,13 Months,81.4,74.8 to 86.6,302
Hep B,≥2 Doses,States/Local Areas,Alaska,2020,Age,5 Months,82.1,75.7 to 87.1,302
DTaP,≥3 Doses,States/Local Areas,Alaska,2020,Age,7 Months,65.3,58.1 to 72.0,302
PCV,≥2 Doses,States/Local Areas,Alaska,2020,Age,5 Months,69.9,62.7 to 76.1,302
≥1 Dose Varicella,,States/Local Areas,Alaska,2020,Age,13 Months,43.7,36.6 to 51.0,302
Hep B,≥3 Doses,States/Local Areas,Alaska,2020,Age,13 Months,85.5,79.2 to 90.1,302
Hep B,≥2 Doses,States/Local Areas,Alaska,2020,Age,13 Months,88.8,82.6 to 92.9,302
Hib,Primary Series,States/Local Areas,Alaska,2020,Age,13 Months,83.2,76.5 to 88.3,302
Hib,≥3 Doses,States/Local Areas,Alaska,2020,Age,13 Months,54.0,46.6 to 61.2,302
Hib,≥2 Doses,States/Local Areas,Alaska,2020,Age,13 Months,85.3,78.9 to 90.1,302
PCV,≥3 Doses,States/Local Areas,Alaska,2020,Age,35 Months,87.6,81.6 to 92.3,302
PCV,≥4 Doses,States/Local Areas,Alaska,2020,Age,19 Months,70.3,63.0 to 76.7,302
Polio,≥3 Doses,States/Local Areas,Alaska,2020,Age,35 Months,89.3,83.2 to 93.9,302
Hep B,≥3 Doses,States/Local Areas,Alaska,2020,Age,19 Months,86.6,80.4 to 91.1,302
Hib,Full Series,States/Local Areas,Alaska,2020,Age,19 Months,69.7,62.2 to 76.2,302
Hib,Primary Series,States/Local Areas,Alaska,2020,Age,19 Months,87.6,81.6 to 91.8,302
≥1 Dose Varicella,,States/Local Areas,Alaska,2020,Age,35 Months,85.0,78.0 to 90.7,302
Hep B,≥3 Doses,States/Local Areas,Alaska,2020,Age,35 Months,89.4,83.6 to 93.9,302
Hib,Full Series,States/Local Areas,Alaska,2020,Age,35 Months,72.4,65.4 to 79.0,302
Hib,Primary Series,States/Local Areas,Alaska,2020,Age,35 Months,89.6,84.0 to 93.9,302
Hib,≥3 Doses,States/Local Areas,Alaska,2020,Age,35 Months,82.4,76.1 to 87.9,302
≥1 Dose MMR,,States/Local Areas,Alaska,2020,Age,35 Months,87.4,80.8 to 92.5,302
Hib,≥3 Doses,States/Local Areas,Alaska,2020,Age,24 Months,81.8,75.5 to 87.3,302
≥1 Dose MMR,,States/Local Areas,Alaska,2020,Age,24 Months,84.2,78.2 to 89.3,302
Polio,≥3 Doses,States/Local Areas,Alaska,2020,Age,24 Months,86.8,81.0 to 91.6,302
DTaP,≥4 Doses,States/Local Areas,Alaska,2020,Age,24 Months,73.9,66.7 to 80.6,302
DTaP,≥3 Doses,States/Local Areas,Alaska,2020,Age,24 Months,88.9,83.2 to 93.4,302
Hib,Primary Series,States/Local Areas,Alaska,2020,Age,7 Months,70.4,63.2 to 76.7,302
Hib,≥2 Doses,States/Local Areas,Alaska,2020,Age,7 Months,78.7,71.9 to 84.2,302
Polio,≥2 Doses,States/Local Areas,Alaska,2020,Age,7 Months,80.2,73.5 to 85.5,302
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2020,Age,0-1 Days,69.9,62.8 to 76.1,302
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2020,Age,0-2 Days,72.5,65.5 to 78.5,302
Hep A,≥2 Doses,States/Local Areas,Alaska,2020,Age,19 Months,13.0,9.0 to 18.3,302
Hep A,≥1 Dose,States/Local Areas,Alaska,2020,Age,19 Months,74.1,66.9 to 80.2,302
Combined 7 Series,,States/Local Areas,Alaska,2020,Age,35 Months,61.1,53.6 to 68.7,302
Hep A,≥2 Doses,States/Local Areas,Alaska,2020,Age,35 Months,76.5,64.9 to 86.5,302
≥1 Dose MMR,,States/Local Areas,Alaska,2020,Age,13 Months,59.3,51.8 to 66.3,302
DTaP,≥3 Doses,States/Local Areas,Alaska,2020,Age,13 Months,84.1,77.6 to 88.9,302
Hep A,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,24 Months,79.6,74.8 to 84.1,589
Hep A,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,72.9,65.4 to 80.1,589
Hep A,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,35 Months,87.6,82.1 to 92.0,589
Influenza,,States/Local Areas,Alaska,2019-2020,Age,24 Months,64.1,58.9 to 69.3,589
Hep A,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,33.1,28.1 to 38.7,589
Hib,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,82.0,77.5 to 86.1,589
Hib,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,81.8,77.1 to 85.6,589
Hib,Primary Series,States/Local Areas,Alaska,2019-2020,Age,24 Months,88.5,84.6 to 91.8,589
Hib,Full Series,States/Local Areas,Alaska,2019-2020,Age,19 Months,70.7,65.5 to 75.3,589
Combined 7 Series,,States/Local Areas,Alaska,2019-2020,Age,35 Months,64.7,59.2 to 70.2,589
Hep B,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,87.2,83.0 to 90.6,589
PCV,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,85.3,80.8 to 88.9,589
PCV,≥4 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,69.6,64.4 to 74.4,589
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2019-2020,Age,0-1 Days,72.9,68.1 to 77.3,589
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2019-2020,Age,0-2 Days,74.7,69.9 to 79.0,589
PCV,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,62.1,56.8 to 67.2,589
Hib,Full Series,States/Local Areas,Alaska,2019-2020,Age,24 Months,73.4,68.5 to 78.1,589
Hep B,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,88.4,84.3 to 91.8,589
≥1 Dose Varicella,,States/Local Areas,Alaska,2019-2020,Age,24 Months,79.7,74.9 to 84.0,589
PCV,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,86.4,82.1 to 90.1,589
Hep A,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,14.7,11.4 to 18.7,589
Polio,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,85.4,81.0 to 89.0,589
≥1 Dose MMR,,States/Local Areas,Alaska,2019-2020,Age,19 Months,81.9,77.3 to 85.8,589
Hib,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,19 Months,79.3,74.5 to 83.5,589
Hib,Primary Series,States/Local Areas,Alaska,2019-2020,Age,19 Months,88.2,84.1 to 91.4,589
≥1 Dose MMR,,States/Local Areas,Alaska,2019-2020,Age,35 Months,88.5,83.7 to 92.3,589
Hib,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,85.0,80.0 to 89.3,589
Hib,Primary Series,States/Local Areas,Alaska,2019-2020,Age,35 Months,89.4,85.5 to 92.7,589
Hib,Full Series,States/Local Areas,Alaska,2019-2020,Age,35 Months,76.4,71.1 to 81.4,589
Hep B,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,88.8,84.7 to 92.2,589
≥1 Dose Varicella,,States/Local Areas,Alaska,2019-2020,Age,35 Months,85.3,80.1 to 89.8,589
PCV,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,88.8,83.9 to 92.7,589
PCV,≥4 Doses,States/Local Areas,Alaska,2019-2020,Age,35 Months,75.2,70.1 to 80.1,589
DTaP,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,88.3,84.2 to 91.8,589
DTaP,≥4 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,75.2,70.1 to 80.1,589
Polio,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,24 Months,86.5,82.3 to 90.2,589
Hib,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,3 Months,82.3,77.6 to 86.1,589
≥1 Dose MMR,,States/Local Areas,Alaska,2019-2020,Age,24 Months,85.1,80.8 to 88.8,589
Hep B,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,3 Months,93.2,90.0 to 95.4,589
PCV,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,3 Months,81.8,77.1 to 85.7,589
DTaP,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,5 Months,73.2,68.2 to 77.7,589
Polio,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,5 Months,72.9,67.9 to 77.4,589
DTaP,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,83.7,79.0 to 87.5,589
Polio,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,88.3,84.1 to 91.5,589
≥1 Dose MMR,,States/Local Areas,Alaska,2019-2020,Age,13 Months,58.3,53.0 to 63.5,589
Hib,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,87.2,83.0 to 90.6,589
Hib,≥3 Doses,States/Local Areas,Alaska,2019-2020,Age,13 Months,56.0,50.7 to 61.2,589
Hib,Primary Series,States/Local Areas,Alaska,2019-2020,Age,13 Months,84.0,79.4 to 87.7,589
Hib,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,5 Months,72.9,67.9 to 77.4,589
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,68.2,62.4 to 74.1,401
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,84.5,80.4 to 88.6,450
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.8,83.0 to 92.7,341
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,93.5,88.9 to 98.2,106
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.4,71.5 to 81.4,471
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,73.7,59.4 to 87.9,59
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,85.4,78.4 to 92.5,106
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,87.8,76.4 to 99.2,59
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,85.7,81.2 to 90.3,401
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,93.8,91.1 to 96.5,450
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,73.9,60.2 to 87.6,59
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.1,73.3 to 83.0,471
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,84.7,77.2 to 92.2,106
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,87.8,76.4 to 99.2,59
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,85.9,81.2 to 90.6,401
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,74.1,60.3 to 87.9,59
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.3,82.2 to 90.5,471
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,78.0 to 88.5,341
Influenza,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,70.2,65.0 to 75.4,450
Influenza,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,63.3,52.1 to 74.5,106
Influenza,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",64.4,59.1 to 69.6,471
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,84.8,73.0 to 96.6,59
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.7,85.0 to 92.3,471
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.6,65.5 to 77.7,341
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,76.6,65.9 to 87.2,106
Rotavirus,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",56.9,50.4 to 63.4,341
Rotavirus,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,69.4,58.9 to 79.8,106
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",58.9,52.5 to 65.3,341
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,65.9,54.6 to 77.3,106
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",66.2,60.9 to 71.5,471
Rotavirus,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,53.4,37.9 to 68.9,59
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.4,72.0 to 82.7,341
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,95.3,90.6 to 100.0,106
Influenza,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,51.9,36.7 to 67.1,59
Influenza,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,50.1,44.2 to 55.9,401
Rotavirus,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,55.4,49.5 to 61.4,401
Rotavirus,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,80.6,76.2 to 85.1,450
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,87.3,83.1 to 91.6,401
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,94.2,91.8 to 96.6,450
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,79.8,74.9 to 84.8,401
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,80.9 to 91.0,341
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,92.7,87.7 to 97.7,106
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,73.2,60.0 to 86.4,59
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,70.6,65.2 to 76.0,401
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,73.5,63.1 to 83.9,106
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,53.4,47.6 to 59.3,401
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,75.3,70.5 to 80.2,450
Rotavirus,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.9,68.8 to 78.9,471
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.4,79.1 to 87.6,471
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.0,83.2 to 90.7,471
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,67.9,62.6 to 73.2,450
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.0,68.4 to 81.6,471
Polio,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,3 Months,82.2,77.5 to 86.0,589
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,91.1,83.9 to 98.3,106
Rotavirus,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,70.5,65.1 to 75.9,490
Rotavirus,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,60.6,51.6 to 69.6,173
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.3,70.8 to 85.9,173
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,81.7,76.3 to 87.1,269
Rotavirus,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,60.5,53.4 to 67.6,269
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.0,53.6 to 76.5,173
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,80.3,75.6 to 85.0,490
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.0,63.5 to 80.4,173
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,76.5,70.3 to 82.7,269
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,85.8,81.6 to 90.1,490
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.4,77.0 to 89.9,173
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,86.4,81.3 to 91.5,269
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,64.9,56.0 to 73.7,173
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,71.9,65.3 to 78.6,269
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,87.1 to 94.7,490
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.3,82.9 to 93.8,173
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,89.4,85.0 to 93.8,269
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,88.5,84.5 to 92.5,490
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,86.2 to 94.3,490
Hep B,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,5 Months,85.4,81.2 to 88.8,589
PCV,≥3 Doses,States/Local Areas,Alaska,2020,Age,19 Months,84.5,78.0 to 89.3,302
DTaP,≥4 Doses,States/Local Areas,Alaska,2020,Age,35 Months,81.4,74.1 to 87.7,302
DTaP,≥3 Doses,States/Local Areas,Alaska,2020,Age,35 Months,90.8,84.7 to 95.2,302
≥1 Dose Varicella,,States/Local Areas,Alaska,2020,Age,19 Months,75.9,68.9 to 81.8,302
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,88.5,84.3 to 92.6,490
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.8,73.4 to 88.2,173
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,85.4,80.2 to 90.5,269
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,80.9,76.2 to 85.6,490
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.4,60.0 to 76.7,173
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,73.0,66.6 to 79.5,269
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,56.9,49.6 to 64.1,269
Influenza,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,64.2,58.8 to 69.7,490
Influenza,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,57.2,48.4 to 66.1,173
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,75.4,68.8 to 81.9,490
Hep A,≥1 Dose,States/Local Areas,Alaska,2019-2020,Age,19 Months,74.3,69.2 to 78.8,589
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,56.3,40.8 to 71.7,59
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,88.2 to 94.6,471
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,88.9,77.6 to 100.0,59
Influenza,,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,78.0,72.4 to 83.7,289
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,63.7,56.0 to 71.4,212
Rotavirus,,States/Local Areas,Alaska,2016-2019,Overall,Overall,65.8,61.9 to 69.6,932
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,90.4,86.4 to 94.4,289
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,69.7,62.1 to 77.4,212
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,78.1,73.0 to 83.1,431
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,85.6,80.9 to 90.3,289
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,80.1,73.2 to 86.9,212
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,75.3,71.7 to 78.9,932
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,81.2,74.6 to 87.9,212
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,73.0,67.6 to 78.5,431
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,87.3,82.9 to 91.8,289
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,76.0,68.8 to 83.2,212
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,83.6,79.2 to 87.9,431
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,91.1,87.2 to 95.0,289
Influenza,,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,47.2,39.3 to 55.1,212
Influenza,,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,53.8,48.1 to 59.6,431
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,88.5,85.6 to 91.3,932
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,90.0,87.4 to 92.6,932
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,80.6,73.7 to 87.5,212
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,88.1,84.2 to 91.9,431
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,91.5,87.6 to 95.5,289
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,65.3,55.9 to 74.8,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,63.3,57.6 to 68.9,431
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,74.3,68.5 to 80.2,289
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,76.3,71.1 to 81.5,431
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,87.9,83.4 to 92.3,289
Rotavirus,,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,45.8,37.7 to 53.9,212
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.3,67.3 to 83.2,173
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,87.6,82.8 to 92.5,269
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,84.4 to 94.0,341
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.5,83.6 to 91.3,471
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,71.8,63.5 to 80.2,269
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.0,78.5 to 91.6,173
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,79.7,74.8 to 84.6,490
Influenza,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,47.3,39.9 to 54.6,269
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,89.3,85.2 to 93.4,490
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.5,81.6 to 93.4,173
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,89.0,84.4 to 93.6,269
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,69.8,64.7 to 75.0,490
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,53.5,44.8 to 62.2,173
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,73.4,68.6 to 78.2,490
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,61.7,52.8 to 70.6,173
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,81.9,76.2 to 87.6,269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a Non-MSA,67.4,60.8 to 74.0,269
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Urbanicity,Living In a MSA Principal City,87.4,83.5 to 91.3,490
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,90.9,87.3 to 94.5,431
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,94.6,91.5 to 97.7,289
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Overall,Overall,63.0,59.2 to 66.9,932
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Overall,Overall,77.6,74.1 to 81.1,932
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,89.2,85.3 to 93.2,431
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,94.3,91.0 to 97.5,289
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,74.6,68.1 to 81.1,212
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,51.8,44.0 to 59.6,212
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,61.6,55.9 to 67.4,431
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,92.6,89.6 to 95.6,431
DTaP,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,95.2,92.2 to 98.2,289
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Overall,Overall,83.4,80.4 to 86.5,932
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,72.5,67.7 to 77.3,932
Combined 7 Series,,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,78.1,72.5 to 83.7,289
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,81.9,75.1 to 88.7,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2016-2019,Overall,Overall,69.4,65.8 to 73.0,932
Influenza,,States/Local Areas,Alaska,2016-2019,Overall,Overall,58.1,54.3 to 62.0,932
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,79.3,72.4 to 86.3,212
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,87.2,82.9 to 91.5,431
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,91.5,87.7 to 95.4,289
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,70.0,62.2 to 77.9,431
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,84.8,78.3 to 91.4,289
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,75.9,68.6 to 83.1,212
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,83.5,79.1 to 87.9,431
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,75.6,72.0 to 79.2,932
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,86.1,83.1 to 89.1,932
Rotavirus,,States/Local Areas,Alaska,2016-2019,Poverty,133% to <400% FPL,68.6,63.0 to 74.1,431
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Overall,Overall,87.0,84.2 to 89.8,932
Rotavirus,,States/Local Areas,Alaska,2016-2019,Poverty,>400% FPL,83.5,78.4 to 88.6,289
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Overall,Overall,83.2,80.1 to 86.3,932
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Overall,Overall,88.9,86.1 to 91.6,932
Influenza,,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",51.1,44.6 to 57.7,341
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.8,74.1 to 83.5,471
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,79.1,66.4 to 91.8,59
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,87.1,79.1 to 95.1,106
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,82.1,70.0 to 94.2,59
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,85.8,81.4 to 90.3,401
≥1 Dose MMR,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,90.2,86.7 to 93.7,450
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.0,65.9 to 78.1,341
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,81.1,72.4 to 89.9,106
≥1 Dose Varicella,,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,90.4,87.1 to 93.7,450
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,80.7,64.3 to 97.1,59
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,63.5,56.1 to 70.8,401
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,83.3,77.3 to 89.4,450
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.1,81.1 to 89.1,471
Hep B,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,92.7,89.6 to 95.8,450
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,88.2,69.3 to 100.0,48
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2016,Age,0-1 Days,79.5,73.0 to 84.8,257
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2016-2017,Age,0-1 Days,80.4,76.0 to 84.1,535
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2017,Age,0-1 Days,81.2,75.3 to 86.0,278
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2017-2018,Age,0-1 Days,83.7,79.5 to 87.2,562
DTaP,≥4 Doses,States/Local Areas,Arizona,2019,Age,35 Months,86.4,77.6 to 93.0,235
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,81.5,77.1 to 85.9,493
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,75.9,70.4 to 81.3,356
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,71.2,55.3 to 87.1,47
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,71.9,51.8 to 92.0,34
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.6,58.1 to 91.2,35
≥1 Dose MMR,,States/Local Areas,Arizona,2011,Age,19 Months,81.8,76.5 to 86.2,266
Hep B,≥3 Doses,States/Local Areas,Arizona,2018,Age,13 Months,94.0,88.8 to 96.9,284
Hep B,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,88.4,84.0 to 91.7,519
Hep B,≥3 Doses,States/Local Areas,Arizona,2019,Age,13 Months,82.7,75.2 to 88.2,235
Hep B,≥3 Doses,States/Local Areas,Arizona,2011,Age,19 Months,82.7,76.3 to 87.6,266
Hep B,≥3 Doses,States/Local Areas,Arizona,2012,Age,19 Months,83.7,78.8 to 87.6,277
Hep B,≥3 Doses,States/Local Areas,Arizona,2013,Age,19 Months,86.1,83.3 to 88.5,264
Hep B,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,87.3,85.1 to 89.3,523
≥1 Dose MMR,,States/Local Areas,Arizona,2013,Age,19 Months,79.7,72.3 to 85.5,264
≥1 Dose MMR,,States/Local Areas,Arizona,2013-2014,Age,19 Months,83.0,77.6 to 87.3,523
≥1 Dose MMR,,States/Local Areas,Arizona,2012,Age,19 Months,81.7,73.3 to 87.8,277
≥1 Dose MMR,,States/Local Areas,Arizona,2014,Age,19 Months,86.3,80.1 to 90.8,259
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2015,Age,19 Months,84.2,79.6 to 87.9,507
≥1 Dose Varicella,,States/Local Areas,Arizona,2017,Age,19 Months,83.6,77.1 to 88.6,278
≥1 Dose Varicella,,States/Local Areas,Arizona,2017-2018,Age,19 Months,88.9,84.8 to 92.0,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2018,Age,19 Months,94.2,88.6 to 97.2,284
≥1 Dose Varicella,,States/Local Areas,Arizona,2018-2019,Age,19 Months,70.4,64.8 to 75.4,519
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,76.5,70.9 to 82.1,329
Polio,≥2 Doses,States/Local Areas,Arizona,2015,Age,13 Months,91.4,86.1 to 94.8,248
DTaP,≥3 Doses,States/Local Areas,Arizona,2019,Age,19 Months,91.0,84.7 to 94.8,235
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.5,68.9 to 82.0,441
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,77.0,71.0 to 82.9,537
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.7,60.9 to 76.5,345
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,75.6,70.6 to 80.6,930
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,78.5,70.5 to 86.4,326
Hep A,≥1 Dose,States/Local Areas,Arizona,2020,Age,35 Months,90.8,84.3 to 95.3,271
Polio,≥2 Doses,States/Local Areas,Arizona,2019,Age,7 Months,88.9,81.7 to 93.5,235
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,56.0,33.3 to 78.6,47
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,79.8,73.9 to 85.8,493
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,75.7,68.1 to 83.4,356
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.8,75.4 to 100.0,35
DTaP,≥4 Doses,States/Local Areas,Arizona,2018,Age,35 Months,93.4,87.8 to 97.0,284
DTaP,≥4 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,89.8,84.9 to 93.6,519
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,69.7,27.0 to 100.0,34
≥1 Dose MMR,,States/Local Areas,Arizona,2017,Age,13 Months,61.7,54.1 to 68.8,278
≥1 Dose MMR,,States/Local Areas,Arizona,2017-2018,Age,13 Months,70.3,65.1 to 75.1,562
≥1 Dose MMR,,States/Local Areas,Arizona,2019,Age,13 Months,71.6,63.4 to 78.6,235
≥1 Dose MMR,,States/Local Areas,Arizona,2018,Age,13 Months,79.1,71.8 to 84.9,284
≥1 Dose MMR,,States/Local Areas,Arizona,2018-2019,Age,13 Months,75.4,70.0 to 80.1,519
≥1 Dose Varicella,,States/Local Areas,Arizona,2014,Age,19 Months,87.2,81.0 to 91.5,259
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2015,Age,19 Months,85.8,81.5 to 89.3,507
≥1 Dose Varicella,,States/Local Areas,Arizona,2015,Age,19 Months,84.5,81.8 to 86.9,248
≥1 Dose Varicella,,States/Local Areas,Arizona,2015-2016,Age,19 Months,87.3,83.1 to 90.6,505
≥1 Dose Varicella,,States/Local Areas,Arizona,2016,Age,19 Months,90.1,84.5 to 93.9,257
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2017,Age,19 Months,86.9,82.8 to 90.2,535
Polio,≥2 Doses,States/Local Areas,Arizona,2011,Age,13 Months,88.3,82.3 to 92.4,266
Polio,≥2 Doses,States/Local Areas,Arizona,2012,Age,13 Months,90.2,89.2 to 91.0,277
Polio,≥2 Doses,States/Local Areas,Arizona,2013,Age,13 Months,90.9,88.0 to 93.1,264
Polio,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,91.9,88.9 to 94.1,523
Polio,≥2 Doses,States/Local Areas,Arizona,2014,Age,13 Months,92.9,87.6 to 96.1,259
Polio,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,92.2,88.7 to 94.6,507
Hep B,≥1 Dose,States/Local Areas,Arizona,2015,Age,3 Months,91.8,87.4 to 94.8,248
Hep B,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,3 Months,94.6,92.2 to 96.3,505
Hep B,≥1 Dose,States/Local Areas,Arizona,2016,Age,3 Months,97.4,94.9 to 98.7,257
Hep B,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,3 Months,97.0,95.2 to 98.2,535
Hep B,≥1 Dose,States/Local Areas,Arizona,2017,Age,3 Months,96.6,93.5 to 98.3,278
Hep B,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,3 Months,97.8,96.3 to 98.7,562
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.7,71.9 to 91.5,125
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2018,Age,0-1 Days,86.2,79.9 to 90.7,284
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2018-2019,Age,0-1 Days,81.3,76.3 to 85.5,519
Hep B,≥2 Doses,States/Local Areas,Arizona,2018,Age,5 Months,91.4,85.2 to 95.2,284
Hep B,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,5 Months,89.6,85.2 to 92.8,519
Hep B,≥2 Doses,States/Local Areas,Arizona,2019,Age,5 Months,87.7,80.7 to 92.4,235
Hep B,≥2 Doses,States/Local Areas,Arizona,2011,Age,7 Months,86.8,81.6 to 90.8,266
PCV,≥4 Doses,States/Local Areas,Arizona,2020,Age,35 Months,78.1,70.5 to 84.8,271
PCV,≥4 Doses,States/Local Areas,Arizona,2011,Age,19 Months,73.5,64.2 to 81.1,266
PCV,≥4 Doses,States/Local Areas,Arizona,2012,Age,19 Months,72.1,68.3 to 75.5,277
PCV,≥4 Doses,States/Local Areas,Arizona,2013,Age,19 Months,74.0,71.3 to 76.5,264
PCV,≥4 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,74.4,71.5 to 77.0,523
≥1 Dose MMR,,States/Local Areas,Arizona,2018,Age,19 Months,95.2,90.0 to 97.8,284
≥1 Dose MMR,,States/Local Areas,Arizona,2018-2019,Age,19 Months,95.1,91.8 to 97.2,519
PCV,≥4 Doses,States/Local Areas,Arizona,2014,Age,19 Months,74.8,66.7 to 81.4,259
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,72.8,67.3 to 77.7,507
≥1 Dose MMR,,States/Local Areas,Arizona,2019,Age,19 Months,91.3,85.6 to 94.9,235
≥1 Dose MMR,,States/Local Areas,Arizona,2011,Age,24 Months,86.6,80.2 to 91.8,266
PCV,≥3 Doses,States/Local Areas,Arizona,2015,Age,7 Months,59.7,51.4 to 67.4,248
PCV,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,66.4,60.8 to 71.6,505
≥1 Dose MMR,,States/Local Areas,Arizona,2012,Age,24 Months,82.5,75.4 to 88.5,277
≥1 Dose Varicella,,States/Local Areas,Arizona,2015,Age,24 Months,90.0,84.4 to 94.2,248
≥1 Dose Varicella,,States/Local Areas,Arizona,2015-2016,Age,24 Months,90.9,87.3 to 93.9,505
≥1 Dose Varicella,,States/Local Areas,Arizona,2016,Age,24 Months,91.4,86.4 to 95.2,257
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2017,Age,24 Months,90.2,86.5 to 93.3,535
≥1 Dose Varicella,,States/Local Areas,Arizona,2017,Age,24 Months,88.9,83.2 to 93.3,278
≥1 Dose Varicella,,States/Local Areas,Arizona,2017-2018,Age,24 Months,93.1,89.9 to 95.6,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2013,Age,24 Months,88.3,81.8 to 93.2,264
≥1 Dose Varicella,,States/Local Areas,Arizona,2013-2014,Age,24 Months,87.9,83.7 to 91.4,523
≥1 Dose Varicella,,States/Local Areas,Arizona,2014,Age,24 Months,87.6,81.9 to 92.2,259
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2015,Age,24 Months,88.8,84.9 to 92.0,507
Polio,≥2 Doses,States/Local Areas,Arizona,2018,Age,13 Months,98.9,96.1 to 99.7,284
Polio,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,95.8,92.5 to 97.7,519
Polio,≥2 Doses,States/Local Areas,Arizona,2019,Age,13 Months,92.6,86.3 to 96.1,235
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2013,Age,0-1 Days,71.7,69.5 to 73.9,264
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2013-2014,Age,0-1 Days,71.6,65.9 to 76.7,523
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2014,Age,0-1 Days,71.5,63.9 to 78.0,259
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2014-2015,Age,0-1 Days,72.0,66.7 to 76.8,507
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2015,Age,0-1 Days,72.6,64.8 to 79.2,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2015-2016,Age,0-1 Days,76.0,71.0 to 80.4,505
Hep B,≥2 Doses,States/Local Areas,Arizona,2015,Age,5 Months,83.3,76.4 to 88.4,248
Hep B,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,5 Months,84.6,80.3 to 88.2,505
Hep B,≥2 Doses,States/Local Areas,Arizona,2016,Age,5 Months,86.1,80.3 to 90.3,257
Hep B,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,5 Months,87.4,83.5 to 90.4,535
Hep B,≥2 Doses,States/Local Areas,Arizona,2017,Age,5 Months,88.7,83.0 to 92.6,278
Hep B,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,5 Months,90.0,86.1 to 92.9,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2017,Age,19 Months,88.8,83.4 to 92.6,278
Hep B,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,92.5,89.4 to 94.8,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2018,Age,19 Months,96.4,92.8 to 98.2,284
Hep B,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,88.4,84.0 to 91.7,519
PCV,≥3 Doses,States/Local Areas,Arizona,2013,Age,7 Months,64.2,55.3 to 72.3,264
PCV,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,63.2,57.8 to 68.2,523
PCV,≥3 Doses,States/Local Areas,Arizona,2014,Age,7 Months,62.1,53.8 to 69.7,259
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,60.9,55.1 to 66.4,507
PCV,≥3 Doses,States/Local Areas,Arizona,2012,Age,7 Months,66.8,63.9 to 69.6,277
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,75.7,70.5 to 81.0,379
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,85.3,77.8 to 92.7,225
Polio,≥2 Doses,States/Local Areas,Arizona,2020,Age,13 Months,89.1,82.7 to 93.3,271
≥1 Dose MMR,,States/Local Areas,Arizona,2011,Age,13 Months,59.8,53.3 to 66.0,266
≥1 Dose MMR,,States/Local Areas,Arizona,2012,Age,13 Months,54.0,48.0 to 59.8,277
≥1 Dose MMR,,States/Local Areas,Arizona,2013,Age,13 Months,57.6,53.6 to 61.5,264
≥1 Dose MMR,,States/Local Areas,Arizona,2013-2014,Age,13 Months,61.6,58.2 to 64.9,523
Hep A,≥2 Doses,States/Local Areas,Arizona,2019,Age,24 Months,46.4,37.9 to 55.8,235
Hep A,≥2 Doses,States/Local Areas,Arizona,2011,Age,35 Months,75.7,61.3 to 87.9,266
Hep A,≥2 Doses,States/Local Areas,Arizona,2012,Age,35 Months,75.5,64.8 to 84.9,277
Hep A,≥2 Doses,States/Local Areas,Arizona,2013,Age,35 Months,63.7,53.8 to 73.5,264
Hep A,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,71.1,63.0 to 78.7,523
Hep A,≥1 Dose,States/Local Areas,Arizona,2016,Age,35 Months,92.1,86.7 to 95.9,257
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,35 Months,92.8,89.1 to 95.6,535
Hep A,≥1 Dose,States/Local Areas,Arizona,2017,Age,35 Months,93.2,87.6 to 96.9,278
Hep A,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,35 Months,95.6,91.9 to 97.9,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2011,Age,13 Months,60.8,55.1 to 66.3,266
Hep A,≥1 Dose,States/Local Areas,Arizona,2018,Age,35 Months,97.3,92.4 to 99.4,284
Hep A,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,35 Months,94.8,91.1 to 97.3,519
Polio,≥2 Doses,States/Local Areas,Arizona,2016,Age,5 Months,81.4,74.9 to 86.6,257
Polio,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,5 Months,78.4,73.5 to 82.6,535
Polio,≥2 Doses,States/Local Areas,Arizona,2017,Age,5 Months,75.3,68.0 to 81.4,278
Polio,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,5 Months,81.3,76.6 to 85.2,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2014,Age,7 Months,63.2,55.2 to 70.5,259
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,61.1,55.4 to 66.5,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2015,Age,7 Months,59.0,50.7 to 66.7,248
Hep B,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,59.0,53.3 to 64.5,505
Hib,Full Series,States/Local Areas,Arizona,2020,Age,24 Months,72.6,64.9 to 79.7,271
DTaP,≥4 Doses,States/Local Areas,Arizona,2019,Age,24 Months,81.7,74.7 to 87.8,235
DTaP,≥4 Doses,States/Local Areas,Arizona,2011,Age,35 Months,90.5,77.0 to 97.7,266
DTaP,≥4 Doses,States/Local Areas,Arizona,2018,Age,24 Months,90.0,84.6 to 94.2,284
DTaP,≥4 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,86.2,81.9 to 90.0,519
≥1 Dose Varicella,,States/Local Areas,Arizona,2016,Age,13 Months,67.9,60.1 to 74.8,257
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2017,Age,13 Months,64.1,58.7 to 69.3,535
≥1 Dose Varicella,,States/Local Areas,Arizona,2017,Age,13 Months,60.3,52.6 to 67.5,278
≥1 Dose Varicella,,States/Local Areas,Arizona,2017-2018,Age,13 Months,67.2,61.8 to 72.1,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2018,Age,13 Months,74.1,66.6 to 80.4,284
≥1 Dose Varicella,,States/Local Areas,Arizona,2018-2019,Age,13 Months,70.4,64.8 to 75.4,519
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.1,83.0 to 91.3,441
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,87.3,83.6 to 91.0,537
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.1,80.3 to 89.9,345
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,86.4,75.3 to 97.5,48
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Overall,Overall,86.4,83.6 to 89.3,930
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,86.0,81.5 to 90.5,326
Polio,≥2 Doses,States/Local Areas,Arizona,2014,Age,7 Months,90.1,84.4 to 93.8,259
Polio,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,86.5,82.2 to 89.9,507
Polio,≥2 Doses,States/Local Areas,Arizona,2015,Age,7 Months,82.9,76.0 to 88.1,248
Polio,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,87.5,83.4 to 90.7,505
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,85.3,80.9 to 89.6,379
Polio,≥2 Doses,States/Local Areas,Arizona,2016,Age,7 Months,92.1,87.3 to 95.3,257
Polio,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,89.2,85.4 to 92.1,535
Hep B,≥3 Doses,States/Local Areas,Arizona,2011,Age,13 Months,78.6,72.6 to 83.5,266
≥1 Dose MMR,,States/Local Areas,Arizona,2014,Age,13 Months,65.6,57.3 to 73.1,259
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2015,Age,13 Months,65.0,59.2 to 70.4,507
≥1 Dose MMR,,States/Local Areas,Arizona,2015,Age,13 Months,64.4,56.1 to 71.9,248
≥1 Dose MMR,,States/Local Areas,Arizona,2015-2016,Age,13 Months,66.4,60.7 to 71.6,505
Hep B,≥3 Doses,States/Local Areas,Arizona,2015,Age,13 Months,80.3,72.8 to 86.1,248
≥1 Dose MMR,,States/Local Areas,Arizona,2016,Age,13 Months,68.4,60.5 to 75.4,257
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2017,Age,13 Months,65.1,59.6 to 70.2,535
≥1 Dose Varicella,,States/Local Areas,Arizona,2019,Age,13 Months,66.6,58.3 to 74.0,235
≥1 Dose Varicella,,States/Local Areas,Arizona,2011,Age,19 Months,81.4,78.8 to 83.7,266
≥1 Dose Varicella,,States/Local Areas,Arizona,2012,Age,19 Months,83.8,74.8 to 90.1,277
≥1 Dose Varicella,,States/Local Areas,Arizona,2013,Age,19 Months,80.8,74.3 to 86.0,264
≥1 Dose Varicella,,States/Local Areas,Arizona,2013-2014,Age,19 Months,84.0,78.0 to 88.6,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2013,Age,13 Months,81.7,77.3 to 85.5,264
Hep B,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,83.5,81.2 to 85.6,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2014,Age,13 Months,85.4,79.4 to 89.9,259
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,82.9,78.2 to 86.7,507
Hep A,≥2 Doses,States/Local Areas,Arizona,2017,Age,35 Months,81.3,73.1 to 88.3,278
Hep A,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,79.8,73.2 to 85.7,562
Hep A,≥2 Doses,States/Local Areas,Arizona,2018,Age,35 Months,78.2,67.5 to 87.3,284
Hep A,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,82.4,73.1 to 89.9,519
Hep B,≥3 Doses,States/Local Areas,Arizona,2012,Age,13 Months,80.5,76.5 to 83.9,277
Hep A,≥2 Doses,States/Local Areas,Arizona,2019,Age,35 Months,88.2,73.1 to 96.9,235
DTaP,≥4 Doses,States/Local Areas,Arizona,2013,Age,35 Months,84.0,76.0 to 90.5,264
DTaP,≥4 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,86.0,80.8 to 90.4,523
DTaP,≥4 Doses,States/Local Areas,Arizona,2014,Age,35 Months,88.4,81.3 to 93.7,259
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,85.9,80.7 to 90.3,507
DTaP,≥4 Doses,States/Local Areas,Arizona,2012,Age,35 Months,80.3,72.6 to 87.0,277
DTaP,≥4 Doses,States/Local Areas,Arizona,2015,Age,35 Months,83.8,75.9 to 90.2,248
DTaP,≥4 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,86.9,81.7 to 91.2,505
DTaP,≥4 Doses,States/Local Areas,Arizona,2016,Age,35 Months,90.7,83.5 to 95.6,257
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,87.4,82.4 to 91.5,535
DTaP,≥4 Doses,States/Local Areas,Arizona,2017,Age,35 Months,84.1,77.5 to 89.6,278
DTaP,≥4 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,89.5,84.7 to 93.2,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2016,Age,13 Months,87.3,81.7 to 91.4,257
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,85.8,81.9 to 89.0,535
Hep B,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,83.8,79.2 to 87.5,505
Hep B,≥3 Doses,States/Local Areas,Arizona,2017,Age,13 Months,84.3,78.4 to 88.9,278
Hep B,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,89.1,85.4 to 92.0,562
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,72.6,64.3 to 80.8,329
Hep B,≥1 Dose,States/Local Areas,Arizona,2011,Age,3 Months,93.1,90.8 to 94.9,266
Hep B,≥1 Dose,States/Local Areas,Arizona,2012,Age,3 Months,93.1,90.0 to 95.3,277
Hep B,≥1 Dose,States/Local Areas,Arizona,2013,Age,3 Months,97.3,96.3 to 98.1,264
Hep B,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,3 Months,95.1,92.2 to 96.9,523
Hep B,≥1 Dose,States/Local Areas,Arizona,2014,Age,3 Months,92.8,87.6 to 95.9,259
Hep B,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,3 Months,92.3,89.2 to 94.6,507
Polio,≥2 Doses,States/Local Areas,Arizona,2017,Age,7 Months,86.2,79.8 to 90.8,278
Polio,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,90.1,86.2 to 93.0,562
Polio,≥2 Doses,States/Local Areas,Arizona,2018,Age,7 Months,94.0,88.8 to 96.9,284
Polio,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,91.5,87.3 to 94.4,519
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,90.0,83.9 to 96.2,225
PCV,≥2 Doses,States/Local Areas,Arizona,2018,Age,5 Months,84.0,77.5 to 88.9,284
PCV,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,5 Months,81.4,76.2 to 85.6,519
PCV,≥2 Doses,States/Local Areas,Arizona,2019,Age,5 Months,78.7,70.5 to 85.2,235
Polio,≥2 Doses,States/Local Areas,Arizona,2011,Age,5 Months,72.7,66.5 to 78.0,266
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,92.4,89.1 to 95.6,329
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.7 to 98.8,125
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.6,89.7 to 95.6,441
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,94.1,91.5 to 96.7,537
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.0,87.5 to 94.5,345
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,94.0,85.4 to 100.0,48
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,93.1,89.9 to 96.2,326
DTaP,≥4 Doses,States/Local Areas,Arizona,2017,Age,19 Months,71.7,64.5 to 77.9,278
DTaP,≥4 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,75.9,71.0 to 80.3,562
DTaP,≥4 Doses,States/Local Areas,Arizona,2018,Age,19 Months,80.2,73.1 to 85.9,284
DTaP,≥4 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,95.8,92.5 to 97.7,519
Hep A,≥2 Doses,States/Local Areas,Arizona,2013,Age,24 Months,43.1,34.7 to 52.6,264
Hep A,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,42.4,36.5 to 48.8,523
Hep A,≥1 Dose,States/Local Areas,Arizona,2013,Age,35 Months,88.1,80.7 to 93.6,264
Hep A,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,35 Months,92.0,87.8 to 95.2,523
Hep A,≥1 Dose,States/Local Areas,Arizona,2014,Age,35 Months,95.3,90.9 to 98.0,259
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,35 Months,91.6,87.2 to 95.0,507
Hep A,≥2 Doses,States/Local Areas,Arizona,2014,Age,24 Months,41.8,33.8 to 50.7,259
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,42.6,37.0 to 48.7,507
Hep A,≥2 Doses,States/Local Areas,Arizona,2015,Age,24 Months,43.4,35.7 to 52.0,248
Hep A,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,42.3,36.8 to 48.2,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,92.9,90.9 to 95.0,930
Hib,≥3 Doses,States/Local Areas,Arizona,2019,Age,35 Months,90.1,84.1 to 94.6,235
DTaP,≥4 Doses,States/Local Areas,Arizona,2013,Age,24 Months,78.1,70.4 to 85.0,264
DTaP,≥4 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,78.3,73.1 to 83.2,523
Hep A,≥2 Doses,States/Local Areas,Arizona,2016,Age,24 Months,41.1,33.6 to 49.6,257
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,45.6,40.3 to 51.4,535
Hep A,≥2 Doses,States/Local Areas,Arizona,2017,Age,24 Months,50.2,42.6 to 58.3,278
Hep A,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,49.9,44.3 to 55.7,562
DTaP,≥4 Doses,States/Local Areas,Arizona,2014,Age,24 Months,78.5,71.2 to 84.9,259
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,77.6,72.3 to 82.4,507
Hep A,≥2 Doses,States/Local Areas,Arizona,2018,Age,24 Months,49.6,41.7 to 58.1,284
Hep A,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,48.0,42.1 to 54.2,519
Hep A,≥1 Dose,States/Local Areas,Arizona,2015,Age,35 Months,87.0,79.4 to 92.8,248
Hep A,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,35 Months,89.8,85.2 to 93.5,505
Polio,≥2 Doses,States/Local Areas,Arizona,2012,Age,5 Months,76.8,70.3 to 82.3,277
Polio,≥2 Doses,States/Local Areas,Arizona,2013,Age,5 Months,65.0,59.3 to 70.2,264
Polio,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,5 Months,72.2,64.2 to 78.9,523
Polio,≥2 Doses,States/Local Areas,Arizona,2014,Age,5 Months,79.3,71.9 to 85.2,259
Polio,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,5 Months,75.0,72.7 to 77.1,507
Polio,≥2 Doses,States/Local Areas,Arizona,2015,Age,5 Months,70.6,62.3 to 77.6,248
Polio,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,5 Months,76.0,70.7 to 80.5,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,91.8,88.5 to 95.1,379
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,94.9,90.6 to 99.2,225
Hep B,≥3 Doses,States/Local Areas,Arizona,2011,Age,7 Months,56.6,53.8 to 59.3,266
Hep B,≥3 Doses,States/Local Areas,Arizona,2012,Age,7 Months,64.2,59.0 to 69.1,277
Hep B,≥3 Doses,States/Local Areas,Arizona,2013,Age,7 Months,58.0,51.9 to 63.9,264
Hep B,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,60.6,57.0 to 64.1,523
DTaP,≥4 Doses,States/Local Areas,Arizona,2019,Age,19 Months,73.7,65.8 to 80.3,235
DTaP,≥4 Doses,States/Local Areas,Arizona,2011,Age,24 Months,72.2,64.3 to 79.6,266
DTaP,≥4 Doses,States/Local Areas,Arizona,2012,Age,24 Months,75.3,67.6 to 82.3,277
Hep A,≥2 Doses,States/Local Areas,Arizona,2014,Age,35 Months,77.3,64.3 to 88.2,259
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,77.3,68.5 to 85.1,507
DTaP,≥4 Doses,States/Local Areas,Arizona,2017,Age,24 Months,81.7,75.3 to 87.3,278
DTaP,≥4 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,86.0,81.8 to 89.6,562
DTaP,≥4 Doses,States/Local Areas,Arizona,2015,Age,24 Months,76.5,68.8 to 83.5,248
DTaP,≥4 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,78.5,73.5 to 83.2,505
DTaP,≥4 Doses,States/Local Areas,Arizona,2016,Age,24 Months,80.4,73.8 to 86.2,257
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,81.0,76.4 to 85.2,535
Hep B,≥3 Doses,States/Local Areas,Arizona,2016,Age,7 Months,59.0,51.0 to 66.5,257
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,59.7,54.2 to 65.0,535
≥1 Dose Varicella,,States/Local Areas,Arizona,2013,Age,13 Months,56.5,52.1 to 60.8,264
≥1 Dose Varicella,,States/Local Areas,Arizona,2013-2014,Age,13 Months,60.7,56.7 to 64.7,523
≥1 Dose Varicella,,States/Local Areas,Arizona,2014,Age,13 Months,65.0,56.6 to 72.5,259
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2015,Age,13 Months,64.6,58.8 to 70.0,507
≥1 Dose Varicella,,States/Local Areas,Arizona,2012,Age,13 Months,53.5,46.1 to 60.8,277
≥1 Dose Varicella,,States/Local Areas,Arizona,2015,Age,13 Months,64.2,56.1 to 71.7,248
≥1 Dose Varicella,,States/Local Areas,Arizona,2015-2016,Age,13 Months,66.0,60.5 to 71.2,505
Hep A,≥1 Dose,States/Local Areas,Arizona,2019,Age,35 Months,91.9,86.0 to 96.0,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,89.6,86.2 to 93.1,493
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,85.2,80.8 to 89.6,356
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,75.6,60.1 to 91.1,47
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,81.4,63.4 to 99.5,34
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.8,78.0 to 100.0,35
Polio,≥2 Doses,States/Local Areas,Arizona,2018,Age,5 Months,87.4,81.3 to 91.7,284
Polio,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,5 Months,83.8,78.9 to 87.8,519
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,84.9,80.2 to 89.6,329
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,83.1 to 95.6,125
Polio,≥2 Doses,States/Local Areas,Arizona,2019,Age,5 Months,80.3,72.1 to 86.5,235
Polio,≥2 Doses,States/Local Areas,Arizona,2011,Age,7 Months,86.5,81.5 to 90.3,266
Polio,≥2 Doses,States/Local Areas,Arizona,2012,Age,7 Months,88.6,87.9 to 89.4,277
Hep B,≥3 Doses,States/Local Areas,Arizona,2017,Age,7 Months,60.4,52.8 to 67.5,278
Hep B,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,62.5,57.0 to 67.7,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2018,Age,7 Months,64.6,56.6 to 71.9,284
Hep B,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,60.4,54.5 to 66.0,519
Polio,≥2 Doses,States/Local Areas,Arizona,2013,Age,7 Months,83.3,79.8 to 86.3,264
Polio,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,86.7,82.0 to 90.3,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2019,Age,7 Months,56.1,47.4 to 64.4,235
Hep A,≥2 Doses,States/Local Areas,Arizona,2015,Age,35 Months,75.7,65.9 to 84.4,248
Hep A,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,73.6,67.2 to 79.6,505
Hep A,≥2 Doses,States/Local Areas,Arizona,2016,Age,35 Months,72.2,63.9 to 80.1,257
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,76.1,70.3 to 81.5,535
Hib,Full Series,States/Local Areas,Arizona,2016,Age,24 Months,81.5,75.1 to 87.0,257
Hib,Full Series,States/Local Areas,Arizona,2016-2017,Age,24 Months,78.8,74.1 to 83.1,535
Hib,Full Series,States/Local Areas,Arizona,2017,Age,24 Months,76.1,69.1 to 82.5,278
Hib,Full Series,States/Local Areas,Arizona,2017-2018,Age,24 Months,80.3,75.6 to 84.5,562
Hib,Full Series,States/Local Areas,Arizona,2018,Age,24 Months,84.3,78.0 to 89.6,284
Hib,Full Series,States/Local Areas,Arizona,2018-2019,Age,24 Months,81.5,76.7 to 85.8,519
DTaP,≥3 Doses,States/Local Areas,Arizona,2017,Age,19 Months,90.7,84.7 to 94.5,278
DTaP,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,94.5,91.2 to 96.6,562
DTaP,≥3 Doses,States/Local Areas,Arizona,2018,Age,19 Months,98.2,94.7 to 99.4,284
DTaP,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,92.9,89.2 to 95.4,519
Polio,≥3 Doses,States/Local Areas,Arizona,2017,Age,24 Months,90.3,84.8 to 94.4,278
Polio,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,94.2,91.2 to 96.5,562
Polio,≥3 Doses,States/Local Areas,Arizona,2018,Age,24 Months,98.3,95.4 to 99.5,284
Polio,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,94.6,91.5 to 96.9,519
Polio,≥3 Doses,States/Local Areas,Arizona,2019,Age,24 Months,90.9,85.3 to 95.1,235
Hib,≥3 Doses,States/Local Areas,Arizona,2019,Age,19 Months,88.9,82.2 to 93.3,235
Hib,≥3 Doses,States/Local Areas,Arizona,2011,Age,24 Months,89.5,83.8 to 93.8,266
Hib,≥3 Doses,States/Local Areas,Arizona,2012,Age,24 Months,85.2,78.7 to 90.5,277
Hib,≥3 Doses,States/Local Areas,Arizona,2013,Age,24 Months,89.4,83.2 to 94.1,264
Hib,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,90.6,86.7 to 93.6,523
Hib,≥3 Doses,States/Local Areas,Arizona,2014,Age,24 Months,91.7,86.8 to 95.3,259
Hib,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,90.6,87.2 to 93.5,507
Polio,≥3 Doses,States/Local Areas,Arizona,2011,Age,35 Months,91.1,84.2 to 95.7,266
DTaP,≥3 Doses,States/Local Areas,Arizona,2011,Age,24 Months,91.7,86.1 to 95.6,266
DTaP,≥3 Doses,States/Local Areas,Arizona,2013,Age,24 Months,92.1,86.3 to 96.1,264
DTaP,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,93.4,90.0 to 95.9,523
Hib,Full Series,States/Local Areas,Arizona,2015,Age,24 Months,73.2,65.2 to 80.6,248
Hib,Full Series,States/Local Areas,Arizona,2015-2016,Age,24 Months,77.4,72.2 to 82.1,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2012,Age,24 Months,87.0,80.7 to 92.0,277
Polio,≥3 Doses,States/Local Areas,Arizona,2014,Age,24 Months,94.2,90.0 to 97.0,259
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,92.0,88.7 to 94.6,507
Polio,≥3 Doses,States/Local Areas,Arizona,2015,Age,24 Months,90.0,84.7 to 94.1,248
Polio,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,91.7,88.5 to 94.3,505
Hib,≥3 Doses,States/Local Areas,Arizona,2018,Age,19 Months,95.9,91.6 to 98.1,284
Hib,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,79.3,74.2 to 83.6,519
Polio,≥3 Doses,States/Local Areas,Arizona,2016,Age,24 Months,93.4,89.4 to 96.3,257
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,91.8,88.6 to 94.5,535
Hib,≥3 Doses,States/Local Areas,Arizona,2017,Age,19 Months,89.1,83.2 to 93.2,278
Hib,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,92.5,89.0 to 94.9,562
DTaP,≥3 Doses,States/Local Areas,Arizona,2016,Age,19 Months,94.8,90.6 to 97.2,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,92.8,89.3 to 95.2,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2014,Age,19 Months,93.0,87.7 to 96.1,259
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,91.6,88.0 to 94.2,507
DTaP,≥3 Doses,States/Local Areas,Arizona,2015,Age,19 Months,90.1,85.6 to 93.4,248
DTaP,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,92.5,89.1 to 94.8,505
Hib,≥3 Doses,States/Local Areas,Arizona,2015,Age,19 Months,86.4,82.3 to 89.6,248
Hib,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,89.0,85.3 to 91.8,505
Hib,≥3 Doses,States/Local Areas,Arizona,2016,Age,19 Months,91.6,86.9 to 94.7,257
Hib,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,90.4,86.8 to 93.1,535
Polio,≥3 Doses,States/Local Areas,Arizona,2019,Age,19 Months,90.1,83.8 to 94.1,235
Polio,≥3 Doses,States/Local Areas,Arizona,2011,Age,24 Months,88.7,82.5 to 93.5,266
Polio,≥3 Doses,States/Local Areas,Arizona,2012,Age,24 Months,85.9,79.6 to 91.1,277
Polio,≥3 Doses,States/Local Areas,Arizona,2013,Age,24 Months,89.3,83.7 to 93.7,264
Polio,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,91.6,88.2 to 94.3,523
Hib,≥3 Doses,States/Local Areas,Arizona,2014,Age,19 Months,91.1,85.7 to 94.6,259
Hib,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,88.7,84.9 to 91.7,507
Hib,Full Series,States/Local Areas,Arizona,2019,Age,24 Months,78.3,71.0 to 84.8,235
Hib,Full Series,States/Local Areas,Arizona,2011,Age,35 Months,88.2,76.9 to 95.5,266
Hib,Full Series,States/Local Areas,Arizona,2012,Age,35 Months,77.8,70.1 to 84.7,277
Hib,Full Series,States/Local Areas,Arizona,2013,Age,35 Months,85.5,78.7 to 91.1,264
Hib,Full Series,States/Local Areas,Arizona,2013-2014,Age,35 Months,86.6,82.0 to 90.5,523
Hib,Full Series,States/Local Areas,Arizona,2014,Age,35 Months,88.0,81.7 to 92.9,259
Hib,Full Series,States/Local Areas,Arizona,2014-2015,Age,35 Months,81.3,76.1 to 86.0,507
DTaP,≥2 Doses,States/Local Areas,Arizona,2011,Age,5 Months,74.4,68.2 to 79.8,266
DTaP,≥2 Doses,States/Local Areas,Arizona,2012,Age,5 Months,77.2,70.5 to 82.8,277
DTaP,≥2 Doses,States/Local Areas,Arizona,2013,Age,5 Months,67.3,60.7 to 73.3,264
DTaP,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,5 Months,73.9,66.6 to 80.1,523
DTaP,≥2 Doses,States/Local Areas,Arizona,2014,Age,5 Months,80.4,73.1 to 86.2,259
DTaP,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,5 Months,76.6,73.5 to 79.5,507
Polio,≥3 Doses,States/Local Areas,Arizona,2013,Age,35 Months,90.6,85.0 to 94.8,264
Polio,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,93.1,89.8 to 95.7,523
Polio,≥3 Doses,States/Local Areas,Arizona,2014,Age,35 Months,96.0,92.6 to 98.1,259
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,93.2,90.0 to 95.6,507
Polio,≥3 Doses,States/Local Areas,Arizona,2012,Age,35 Months,91.5,84.5 to 96.2,277
Polio,≥3 Doses,States/Local Areas,Arizona,2015,Age,35 Months,90.7,85.4 to 94.7,248
Polio,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,92.9,89.7 to 95.4,505
Polio,≥3 Doses,States/Local Areas,Arizona,2019,Age,35 Months,91.3,85.6 to 95.4,235
Polio,≥3 Doses,States/Local Areas,Arizona,2016,Age,35 Months,95.3,91.2 to 97.8,257
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,94.1,90.9 to 96.4,535
Polio,≥3 Doses,States/Local Areas,Arizona,2017,Age,35 Months,92.6,87.4 to 96.2,278
Polio,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.2,93.2 to 98.2,562
DTaP,≥2 Doses,States/Local Areas,Arizona,2015,Age,5 Months,72.7,64.7 to 79.5,248
DTaP,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,5 Months,77.3,72.2 to 81.8,505
DTaP,≥2 Doses,States/Local Areas,Arizona,2016,Age,5 Months,82.0,75.5 to 87.1,257
DTaP,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,5 Months,79.1,74.3 to 83.3,535
Polio,≥3 Doses,States/Local Areas,Arizona,2018,Age,35 Months,99.6,98.5 to 99.9,284
Polio,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,97.2,93.1 to 99.1,519
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,90.8,87.7 to 93.9,493
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,92.8,89.7 to 96.0,356
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,84.1,71.5 to 96.7,47
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,85.9,71.6 to 100.0,34
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.5,88.0 to 100.0,35
Hib,Full Series,States/Local Areas,Arizona,2017,Age,35 Months,78.0,70.9 to 84.4,278
Hib,Full Series,States/Local Areas,Arizona,2017-2018,Age,35 Months,83.2,78.2 to 87.6,562
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,81.6,77.1 to 86.0,493
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,60.1,42.7 to 77.5,47
Hib,Full Series,States/Local Areas,Arizona,2015,Age,35 Months,74.6,66.6 to 82.0,248
Hib,Full Series,States/Local Areas,Arizona,2015-2016,Age,35 Months,79.5,74.2 to 84.3,505
Hib,Full Series,States/Local Areas,Arizona,2016,Age,35 Months,85.3,77.6 to 91.4,257
Hib,Full Series,States/Local Areas,Arizona,2016-2017,Age,35 Months,81.4,76.4 to 85.9,535
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.8,86.2 to 93.5,345
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,91.6,88.1 to 95.0,329
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,85.7 to 97.6,125
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.3,87.0 to 93.7,441
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,92.4,89.6 to 95.2,537
Hib,Full Series,States/Local Areas,Arizona,2018,Age,35 Months,87.6,81.0 to 92.8,284
Hib,Full Series,States/Local Areas,Arizona,2018-2019,Age,35 Months,84.9,79.6 to 89.5,519
Hib,Full Series,States/Local Areas,Arizona,2019,Age,35 Months,80.4,72.9 to 86.8,235
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,78.0,72.8 to 83.3,356
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.1,60.9 to 93.3,35
Hib,Primary Series,States/Local Areas,Arizona,2011,Age,7 Months,72.4,62.3 to 80.7,266
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,86.2,79.1 to 93.3,225
Hib,Primary Series,States/Local Areas,Arizona,2012,Age,7 Months,69.2,66.4 to 71.9,277
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,65.4,44.3 to 86.4,34
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,77.7,72.2 to 83.3,329
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,76.3 to 92.8,125
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.1,72.1 to 82.1,441
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,80.7,76.3 to 85.0,537
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.1,67.1 to 79.2,345
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,85.0,72.9 to 97.1,48
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Overall,Overall,78.2,74.7 to 81.6,930
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,76.5,70.9 to 82.1,326
Hib,Full Series,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,76.1,71.0 to 81.2,379
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,91.1,85.5 to 94.7,274
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,92.4,89.1 to 94.8,493
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,93.7,91.9 to 95.1,219
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,90.9,87.0 to 93.7,454
Hib,≥3 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,93.2,91.8 to 94.4,219
Hib,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,89.4,85.4 to 92.4,454
Polio,≥2 Doses,States/Local Areas,South Dakota,2020,Age,13 Months,90.7,83.5 to 94.9,289
Hib,≥3 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,94.3,90.3 to 96.6,390
Hib,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,80.2,76.0 to 83.8,708
Hib,≥3 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,91.6,86.7 to 94.8,335
Hib,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,92.9,89.9 to 95.0,725
Polio,≥3 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,88.2,81.9 to 93.1,235
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,91.1,87.4 to 94.1,570
Hib,≥3 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,85.5,78.8 to 90.4,235
Hib,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,88.6,84.5 to 91.7,570
Polio,≥3 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,93.3,89.1 to 96.3,219
Polio,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,90.8,87.0 to 93.8,454
Polio,≥3 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,92.8,88.2 to 96.0,274
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,93.0,90.1 to 95.4,493
Polio,≥3 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,95.0,91.2 to 97.2,390
Polio,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,70.1,65.2 to 74.5,708
Polio,≥3 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,91.6,86.0 to 95.1,318
Polio,≥3 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,94.0,89.4 to 97.1,194
Polio,≥3 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,96.2,91.7 to 98.7,211
Hib,≥3 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,88.8,83.1 to 92.8,274
Hib,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,91.0,87.6 to 93.6,493
Hib,≥3 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,85.8,81.3 to 89.4,222
Hib,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,87.3,85.7 to 88.8,496
Polio,≥3 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,91.6,86.0 to 95.6,222
Polio,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,92.2,88.7 to 94.9,496
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,93.6,89.3 to 96.2,335
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,94.3,91.6 to 96.1,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,88.0,81.3 to 92.5,235
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,90.8,87.0 to 93.6,570
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,95.0,91.2 to 97.2,390
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,91.0,87.5 to 93.6,708
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.2,74.9 to 91.5,125
DTaP,≥3 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,97.8,93.5 to 99.5,211
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,91.8,86.2 to 95.3,318
DTaP,≥3 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,96.7,93.5 to 98.6,194
Hib,Full Series,States/Local Areas,South Dakota,2015,Age,24 Months,82.5,75.6 to 88.4,219
Hib,Full Series,States/Local Areas,South Dakota,2015-2016,Age,24 Months,78.5,73.4 to 83.2,454
Polio,≥3 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,96.2,91.7 to 98.7,211
Polio,≥3 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,94.7,89.9 to 97.7,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,90.2,84.5 to 94.0,318
Polio,≥3 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,95.7,91.1 to 98.3,318
Polio,≥3 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,96.5,93.7 to 98.3,390
Polio,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,95.9,93.5 to 97.7,708
Polio,≥3 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,94.0,89.8 to 96.8,335
Polio,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,95.3,92.8 to 97.1,725
Hib,Full Series,States/Local Areas,South Dakota,2017,Age,24 Months,77.7,71.2 to 83.7,335
Hib,Full Series,States/Local Areas,South Dakota,2017-2018,Age,24 Months,79.0,74.8 to 82.9,725
Hib,Full Series,States/Local Areas,South Dakota,2016,Age,24 Months,74.8,67.5 to 81.5,235
Hib,Full Series,States/Local Areas,South Dakota,2016-2017,Age,24 Months,76.3,71.5 to 80.9,570
Hib,≥3 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,89.3,83.0 to 94.0,222
Hib,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,90.6,86.9 to 93.7,496
Hib,≥3 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,97.4,93.4 to 99.3,211
Hib,≥3 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,96.8,93.6 to 98.7,194
DTaP,≥2 Doses,States/Local Areas,South Dakota,2014,Age,5 Months,76.4,69.4 to 82.2,274
DTaP,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,5 Months,76.3,72.1 to 80.0,493
Polio,≥3 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,94.2,90.1 to 97.1,219
Polio,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,91.3,87.6 to 94.3,454
Polio,≥3 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,94.2,89.9 to 97.0,335
Polio,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,95.4,93.0 to 97.2,725
Polio,≥3 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,88.2,81.9 to 93.1,235
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,91.2,87.5 to 94.2,570
DTaP,≥2 Doses,States/Local Areas,South Dakota,2015,Age,5 Months,76.2,68.7 to 82.3,219
DTaP,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,5 Months,76.8,71.7 to 81.3,454
DTaP,≥2 Doses,States/Local Areas,South Dakota,2013,Age,5 Months,72.2,66.2 to 77.5,222
DTaP,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,5 Months,74.3,70.0 to 78.2,496
DTaP,≥2 Doses,States/Local Areas,South Dakota,2012,Age,5 Months,72.2,67.7 to 76.3,211
DTaP,≥2 Doses,States/Local Areas,South Dakota,2011,Age,5 Months,80.1,70.3 to 87.3,194
Polio,≥3 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,93.2,88.6 to 96.4,274
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,93.7,90.8 to 95.9,493
Polio,≥3 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,94.6,88.8 to 98.0,222
Polio,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,94.3,90.6 to 96.9,496
Hib,Full Series,States/Local Areas,South Dakota,2019,Age,24 Months,74.5,67.8 to 80.8,318
Hib,Full Series,States/Local Areas,South Dakota,2018,Age,24 Months,80.2,74.9 to 85.1,390
Hib,Full Series,States/Local Areas,South Dakota,2018-2019,Age,24 Months,77.4,73.2 to 81.4,708
Hib,Full Series,States/Local Areas,South Dakota,2011,Age,35 Months,89.6,82.5 to 94.7,194
Hib,Full Series,States/Local Areas,South Dakota,2012,Age,35 Months,87.1,79.5 to 92.9,211
Hib,Full Series,States/Local Areas,South Dakota,2013,Age,35 Months,82.6,74.7 to 89.2,222
Hib,Full Series,States/Local Areas,South Dakota,2013-2014,Age,35 Months,83.8,78.9 to 88.2,496
Hib,Full Series,States/Local Areas,South Dakota,2015,Age,35 Months,87.2,79.9 to 92.8,219
Hib,Full Series,States/Local Areas,South Dakota,2015-2016,Age,35 Months,83.8,78.8 to 88.3,454
Hib,Full Series,States/Local Areas,South Dakota,2017,Age,35 Months,82.9,76.4 to 88.5,335
Hib,Full Series,States/Local Areas,South Dakota,2017-2018,Age,35 Months,83.6,79.4 to 87.4,725
Polio,≥3 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,96.7,93.8 to 98.5,390
Polio,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,96.0,93.6 to 97.7,708
Hib,Full Series,States/Local Areas,South Dakota,2014,Age,35 Months,85.0,78.8 to 90.2,274
Hib,Full Series,States/Local Areas,South Dakota,2014-2015,Age,35 Months,86.1,81.4 to 90.2,493
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,95.8,93.8 to 97.8,553
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,89.4,84.9 to 93.9,264
Hib,Full Series,States/Local Areas,South Dakota,2016,Age,35 Months,80.3,73.3 to 86.4,235
Hib,Full Series,States/Local Areas,South Dakota,2016-2017,Age,35 Months,81.7,77.0 to 86.0,570
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,85.3,81.4 to 89.1,553
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,68.4,61.5 to 75.3,264
Hib,Full Series,States/Local Areas,South Dakota,2018,Age,35 Months,84.5,78.9 to 89.3,390
Hib,Full Series,States/Local Areas,South Dakota,2018-2019,Age,35 Months,82.6,78.2 to 86.6,708
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,89.3,78.8 to 99.9,56
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,84.1 to 95.9,141
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.9,90.4 to 95.4,655
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,92.2,88.4 to 96.0,265
Hib,Full Series,States/Local Areas,South Dakota,2019,Age,35 Months,80.6,73.6 to 86.7,318
Polio,≥3 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,95.7,91.1 to 98.3,318
Hib,Primary Series,States/Local Areas,South Dakota,2011,Age,7 Months,77.8,70.6 to 83.6,194
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,86.1,80.8 to 91.4,209
Hep A,≥2 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,34.1,25.6 to 44.5,211
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,80.0,66.3 to 93.6,56
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.6,64.5 to 82.7,141
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.7,74.7 to 82.7,655
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,78.0,71.9 to 84.1,265
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,75.2,69.9 to 80.4,483
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Overall,Overall,77.3,73.7 to 80.9,873
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,67.0,59.1 to 74.9,208
Hib,Full Series,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,80.2,75.5 to 84.9,456
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,81.3,75.0 to 86.7,274
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,81.6,77.1 to 85.7,493
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,72.9,65.6 to 79.8,235
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,75.7,70.8 to 80.4,570
DTaP,≥4 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,82.2,75.3 to 88.0,219
DTaP,≥4 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,77.5,72.4 to 82.2,454
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016,Age,35 Months,93.8,86.0 to 98.0,235
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,35 Months,90.9,86.2 to 94.5,570
Hep A,≥1 Dose,States/Local Areas,South Dakota,2015,Age,35 Months,92.4,87.9 to 95.7,219
Hep A,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,35 Months,92.9,88.5 to 96.1,454
Hep A,≥1 Dose,States/Local Areas,South Dakota,2017,Age,35 Months,88.8,83.0 to 93.4,335
Hep A,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,35 Months,91.6,88.1 to 94.4,725
Polio,≥2 Doses,States/Local Areas,South Dakota,2016,Age,5 Months,76.4,68.9 to 82.5,235
Polio,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,5 Months,77.9,73.1 to 82.1,570
Polio,≥2 Doses,States/Local Areas,South Dakota,2017,Age,5 Months,79.5,72.9 to 84.8,335
Polio,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,5 Months,81.2,76.8 to 84.8,725
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,68.3,60.8 to 75.0,274
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,73.0,68.0 to 77.5,493
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,77.8,71.0 to 83.3,219
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,75.5,70.5 to 79.9,454
≥1 Dose MMR,,States/Local Areas,South Dakota,2014,Age,13 Months,60.8,53.5 to 67.7,274
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2015,Age,13 Months,61.5,56.2 to 66.6,493
≥1 Dose MMR,,States/Local Areas,South Dakota,2015,Age,13 Months,62.2,54.3 to 69.5,219
≥1 Dose MMR,,States/Local Areas,South Dakota,2015-2016,Age,13 Months,60.9,55.3 to 66.2,454
≥1 Dose MMR,,States/Local Areas,South Dakota,2012,Age,13 Months,65.4,60.5 to 70.0,211
≥1 Dose MMR,,States/Local Areas,South Dakota,2011,Age,13 Months,59.5,53.1 to 65.6,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,90.2,85.5 to 94.9,208
Hib,≥3 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,95.1,91.7 to 97.4,390
Hib,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,94.7,92.1 to 96.6,708
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,93.0,90.9 to 95.2,873
Hep A,≥2 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,50.9,42.7 to 59.7,219
Hep A,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,49.6,43.9 to 55.6,454
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,44.3,37.1 to 52.3,274
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,47.6,42.0 to 53.5,493
Hep A,≥1 Dose,States/Local Areas,South Dakota,2013,Age,35 Months,86.8,78.2 to 93.2,222
Hep A,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,35 Months,85.2,80.3 to 89.4,496
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014,Age,35 Months,83.8,78.1 to 88.7,274
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,35 Months,88.1,84.5 to 91.2,493
≥1 Dose Varicella,,States/Local Areas,South Dakota,2011,Age,13 Months,60.1,52.9 to 66.9,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013,Age,13 Months,57.0,50.4 to 63.4,222
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013-2014,Age,13 Months,55.6,52.0 to 59.2,496
Polio,≥2 Doses,States/Local Areas,South Dakota,2018,Age,5 Months,82.9,77.1 to 87.4,390
Polio,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,5 Months,79.9,75.4 to 83.7,708
Hep A,≥1 Dose,States/Local Areas,South Dakota,2019,Age,35 Months,90.8,85.3 to 94.9,318
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,85.6,82.0 to 89.1,553
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,84.7,79.5 to 89.8,264
Hep A,≥1 Dose,States/Local Areas,South Dakota,2018,Age,35 Months,95.1,91.4 to 97.5,390
Hep A,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,35 Months,93.4,90.1 to 95.9,708
≥1 Dose Varicella,,States/Local Areas,South Dakota,2012,Age,13 Months,68.7,62.9 to 74.1,211
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014,Age,13 Months,54.3,46.8 to 61.6,274
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2015,Age,13 Months,62.1,56.7 to 67.3,493
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,78.6,71.4 to 84.4,318
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,77.2,68.6 to 84.8,274
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,76.5,69.8 to 82.6,493
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,80.9,70.3 to 89.5,235
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,76.5,70.2 to 82.2,570
Hep A,≥2 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,74.5,64.4 to 83.5,219
Hep A,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,77.8,70.5 to 84.4,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,78.6,71.8 to 84.1,390
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,78.6,73.8 to 82.7,708
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,78.2,71.2 to 83.8,335
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,78.4,73.6 to 82.5,725
Polio,≥2 Doses,States/Local Areas,South Dakota,2019,Age,5 Months,76.6,69.4 to 82.6,318
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,89.2,79.6 to 98.7,56
Polio,≥2 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,89.8,84.3 to 93.5,211
Polio,≥2 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,94.6,92.6 to 96.1,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,59.9,53.2 to 66.7,390
Hep A,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,56.3,51.3 to 61.4,708
Hep A,≥2 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,51.8,44.6 to 59.3,318
Polio,≥2 Doses,States/Local Areas,South Dakota,2015,Age,5 Months,76.2,68.7 to 82.3,219
Polio,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,5 Months,76.3,71.1 to 80.8,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,73.2,65.7 to 79.6,235
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,75.7,70.7 to 80.1,570
Hep A,≥2 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,64.0,52.2 to 75.6,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,61.1,50.6 to 71.8,211
Hep A,≥2 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,65.1,55.5 to 74.5,222
Hep A,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,71.0,64.4 to 77.3,496
Polio,≥2 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,92.9,89.1 to 95.5,222
Polio,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,93.3,90.1 to 95.6,496
Hep B,≥1 Dose,States/Local Areas,South Dakota,2014,Age,3 Months,94.5,90.1 to 97.0,274
Hep B,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,3 Months,94.7,91.9 to 96.6,493
Hep B,≥1 Dose,States/Local Areas,South Dakota,2015,Age,3 Months,95.0,90.7 to 97.4,219
Hep B,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,3 Months,93.9,90.7 to 96.0,454
Hep B,≥1 Dose,States/Local Areas,South Dakota,2016,Age,3 Months,92.7,87.4 to 95.9,235
Hep B,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,3 Months,93.4,90.4 to 95.5,570
≥1 Dose MMR,,States/Local Areas,South Dakota,2018,Age,13 Months,71.2,64.6 to 76.9,390
≥1 Dose MMR,,States/Local Areas,South Dakota,2018-2019,Age,13 Months,70.1,65.2 to 74.5,708
≥1 Dose MMR,,States/Local Areas,South Dakota,2016,Age,13 Months,59.5,51.6 to 66.9,235
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2017,Age,13 Months,64.0,58.7 to 68.9,570
≥1 Dose MMR,,States/Local Areas,South Dakota,2017,Age,13 Months,68.4,61.3 to 74.7,335
≥1 Dose MMR,,States/Local Areas,South Dakota,2017-2018,Age,13 Months,69.8,65.0 to 74.2,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014,Age,19 Months,86.4,80.6 to 90.7,274
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2015,Age,19 Months,88.8,85.2 to 91.7,493
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015,Age,19 Months,91.2,85.4 to 94.9,219
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015-2016,Age,19 Months,86.0,81.6 to 89.5,454
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013,Age,19 Months,84.3,81.9 to 86.4,222
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013-2014,Age,19 Months,85.3,83.6 to 86.9,496
Polio,≥2 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,95.1,91.1 to 97.4,211
Polio,≥2 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,96.6,94.9 to 97.8,194
DTaP,≥4 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,74.8,67.5 to 81.6,318
DTaP,≥4 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,90.2,82.9 to 95.3,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.7,77.8 to 91.5,141
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.5,81.2 to 87.9,655
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,88.0,83.3 to 92.7,265
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,83.6,79.6 to 87.7,483
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.0,74.8 to 91.2,125
Polio,≥2 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,88.9,83.1 to 92.9,274
Polio,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,89.0,85.1 to 91.9,493
Polio,≥2 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,82.4,81.7 to 83.1,222
Polio,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,85.6,83.3 to 87.7,496
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Overall,Overall,85.0,82.1 to 87.9,873
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,87.2,82.0 to 92.4,208
Polio,≥2 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,89.1,83.5 to 92.9,219
Polio,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,86.3,81.8 to 89.7,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,87.1,80.9 to 91.4,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,82.1,74.5 to 88.6,390
Hep A,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,82.1,76.3 to 87.2,708
Hep A,≥2 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,73.9,66.0 to 81.3,335
Hep A,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,77.9,72.3 to 83.0,725
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,90.2,86.7 to 92.8,222
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,88.9,86.1 to 91.1,496
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,87.5,81.5 to 91.8,274
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,89.1,85.2 to 92.0,493
Hep A,≥2 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,82.0,72.9 to 89.5,318
Hep B,≥3 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,90.3,80.6 to 95.4,211
DTaP,≥4 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,83.5,75.2 to 90.3,222
DTaP,≥4 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,85.6,80.4 to 90.1,496
DTaP,≥4 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,91.9,85.7 to 96.2,211
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,88.3,81.5 to 93.5,274
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,88.3,83.2 to 92.5,493
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018,Age,13 Months,64.8,58.1 to 70.9,390
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018-2019,Age,13 Months,65.5,60.5 to 70.1,708
≥1 Dose MMR,,States/Local Areas,South Dakota,2013,Age,13 Months,53.3,51.1 to 55.4,222
≥1 Dose MMR,,States/Local Areas,South Dakota,2013-2014,Age,13 Months,57.1,53.1 to 60.9,496
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019,Age,13 Months,66.3,58.7 to 73.1,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2011,Age,19 Months,90.0,86.9 to 92.5,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2012,Age,19 Months,90.8,86.6 to 93.8,211
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,81.7,77.3 to 86.2,456
DTaP,≥4 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,83.5,78.2 to 88.2,390
DTaP,≥4 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,79.2,74.8 to 83.4,708
DTaP,≥4 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,78.2,71.6 to 84.2,335
DTaP,≥4 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,80.9,76.6 to 84.9,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016,Age,13 Months,56.0,48.2 to 63.4,235
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2017,Age,13 Months,58.6,53.3 to 63.7,570
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017,Age,13 Months,61.2,53.9 to 68.1,335
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017-2018,Age,13 Months,63.0,58.0 to 67.7,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015,Age,13 Months,69.9,62.3 to 76.6,219
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015-2016,Age,13 Months,63.0,57.5 to 68.2,454
Hep A,≥2 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,51.0,43.6 to 58.8,335
Hep A,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,55.4,50.3 to 60.7,725
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,48.2,40.6 to 56.5,235
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,49.7,44.3 to 55.4,570
DTaP,≥4 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,71.8,63.9 to 79.2,222
DTaP,≥4 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,76.5,71.4 to 81.3,496
DTaP,≥4 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,65.4,57.9 to 72.3,318
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,66.4,62.6 to 70.0,222
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,67.4,65.4 to 69.2,496
DTaP,≥4 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,81.2,73.1 to 88.1,194
DTaP,≥4 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,85.0,78.2 to 90.5,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,71.4,66.2 to 76.1,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,71.9,65.3 to 77.7,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,92.9,89.9 to 96.0,456
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,97.2,94.9 to 99.5,209
Polio,≥2 Doses,States/Local Areas,South Dakota,2012,Age,5 Months,71.8,66.7 to 76.4,211
Polio,≥2 Doses,States/Local Areas,South Dakota,2011,Age,5 Months,79.8,69.6 to 87.2,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2012,Age,35 Months,79.5,71.6 to 86.4,211
Polio,≥2 Doses,States/Local Areas,South Dakota,2013,Age,5 Months,72.2,66.2 to 77.5,222
Polio,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,5 Months,74.1,70.0 to 77.9,496
Polio,≥2 Doses,States/Local Areas,South Dakota,2014,Age,5 Months,76.1,69.1 to 81.9,274
Polio,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,5 Months,76.1,72.0 to 79.8,493
DTaP,≥4 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,75.9,69.7 to 81.1,390
DTaP,≥4 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,95.0,92.4 to 96.7,708
Hep A,≥2 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,40.6,33.1 to 49.0,222
Hep A,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,42.5,37.1 to 48.2,496
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,63.9,56.2 to 71.0,235
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,67.2,62.0 to 72.0,570
DTaP,≥4 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,70.5,63.3 to 76.8,335
DTaP,≥4 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,73.1,68.4 to 77.4,725
PCV,≥2 Doses,States/Local Areas,South Dakota,2019,Age,5 Months,76.6,69.4 to 82.5,318
PCV,≥2 Doses,States/Local Areas,South Dakota,2017,Age,5 Months,79.3,72.7 to 84.7,335
PCV,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,5 Months,80.9,76.6 to 84.6,725
PCV,≥2 Doses,States/Local Areas,South Dakota,2018,Age,5 Months,82.6,76.8 to 87.1,390
PCV,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,5 Months,79.7,75.2 to 83.5,708
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,92.7,83.9 to 100.0,56
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,85.8 to 96.8,141
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.6,91.2 to 96.0,655
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,93.9,90.6 to 97.3,265
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,92.7,89.6 to 95.8,483
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,85.3 to 98.1,125
Hib,≥3 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,94.6,90.3 to 97.4,318
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2014,Age,0-2 Days,76.5,69.3 to 82.5,274
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2014-2015,Age,0-2 Days,76.8,71.8 to 81.1,493
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2015,Age,0-2 Days,77.0,69.9 to 82.9,219
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2015-2016,Age,0-2 Days,77.2,72.3 to 81.4,454
PCV,≥4 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,83.1,77.4 to 87.7,390
PCV,≥4 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,78.7,73.5 to 83.1,604
PCV,≥4 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,80.3,73.9 to 85.5,335
PCV,≥4 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,81.7,77.4 to 85.3,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2017,Age,24 Months,91.2,86.5 to 94.8,335
≥1 Dose MMR,,States/Local Areas,South Dakota,2017-2018,Age,24 Months,92.7,89.9 to 95.0,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2016,Age,24 Months,86.6,79.9 to 91.9,235
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2017,Age,24 Months,88.8,84.9 to 92.2,570
Hep B,≥2 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,93.5,87.7 to 96.7,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,87.5,80.0 to 92.4,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,89.1,83.0 to 93.7,235
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,90.9,87.4 to 93.8,570
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,90.6,85.5 to 94.5,219
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,89.9,86.0 to 93.0,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,93.0,88.7 to 96.2,274
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,91.9,88.6 to 94.5,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,67.1,59.4 to 74.0,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,91.5,87.1 to 94.5,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,73.4,66.6 to 79.3,390
PCV,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,70.4,65.3 to 75.0,708
Hep B,≥2 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,91.6,86.4 to 94.9,274
Hep B,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,91.4,88.1 to 93.9,493
Hep B,≥2 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,93.7,85.2 to 97.4,211
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2019,Age,0-1 Days,82.0,75.4 to 87.1,318
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2011,Age,0-2 Days,72.0,64.3 to 78.6,194
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2018,Age,0-1 Days,78.4,72.6 to 83.2,390
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2018-2019,Age,0-1 Days,80.1,75.9 to 83.8,708
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2013,Age,0-2 Days,67.2,60.2 to 73.6,222
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2013-2014,Age,0-2 Days,71.9,65.5 to 77.5,496
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2012,Age,0-2 Days,80.2,75.9 to 84.0,211
Hep B,≥2 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,92.5,87.3 to 95.7,222
Hep B,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,92.0,89.8 to 93.8,496
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,92.7,87.6 to 95.7,318
Hep B,≥3 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,90.9,84.5 to 95.4,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,91.8,86.2 to 95.8,222
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,92.4,89.0 to 95.1,496
PCV,≥3 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,63.8,55.9 to 71.1,235
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,65.8,60.3 to 70.8,570
Hep B,≥3 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,95.5,90.3 to 98.4,211
PCV,≥3 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,67.7,60.1 to 74.5,335
PCV,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,70.5,65.4 to 75.1,725
PCV,≥3 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,70.6,62.9 to 77.3,219
PCV,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,67.3,61.8 to 72.3,454
PCV,≥4 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,82.6,76.3 to 87.5,274
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,81.4,77.0 to 85.1,493
PCV,≥4 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,80.2,73.6 to 85.5,219
PCV,≥4 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,77.6,72.6 to 81.8,454
PCV,≥4 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,74.9,67.3 to 81.2,235
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,77.6,72.7 to 81.8,570
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018,Age,24 Months,92.8,89.0 to 95.7,390
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018-2019,Age,24 Months,93.4,90.6 to 95.5,708
≥1 Dose MMR,,States/Local Areas,South Dakota,2015,Age,24 Months,91.8,87.4 to 95.2,219
≥1 Dose MMR,,States/Local Areas,South Dakota,2015-2016,Age,24 Months,89.2,85.2 to 92.5,454
≥1 Dose MMR,,States/Local Areas,South Dakota,2014,Age,24 Months,92.8,88.9 to 95.7,274
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2015,Age,24 Months,92.3,89.4 to 94.6,493
≥1 Dose MMR,,States/Local Areas,South Dakota,2013,Age,24 Months,88.8,82.7 to 93.5,222
≥1 Dose MMR,,States/Local Areas,South Dakota,2013-2014,Age,24 Months,90.9,87.3 to 93.8,496
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019,Age,24 Months,94.6,90.5 to 97.3,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017,Age,24 Months,91.1,86.6 to 94.5,335
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017-2018,Age,24 Months,91.9,89.1 to 94.3,725
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,94.2,89.9 to 97.0,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,91.1,85.5 to 94.7,274
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,92.0,88.6 to 94.4,493
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,96.8,94.1 to 98.5,390
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,95.6,93.2 to 97.3,708
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Overall,Overall,90.1,87.6 to 92.5,873
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,90.0,85.3 to 94.8,208
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,90.5,87.2 to 93.7,483
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.2,79.5 to 94.9,125
≥1 Dose Varicella,,States/Local Areas,South Dakota,2011,Age,35 Months,95.7,90.4 to 98.6,194
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2015,Age,0-1 Days,72.6,65.1 to 79.0,219
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2015-2016,Age,0-1 Days,71.9,66.7 to 76.5,454
Hep B,≥2 Doses,States/Local Areas,South Dakota,2018,Age,5 Months,94.0,90.4 to 96.2,390
Hep B,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,5 Months,92.3,89.3 to 94.5,708
Hep B,≥2 Doses,States/Local Areas,South Dakota,2019,Age,5 Months,90.6,85.3 to 94.1,318
Hep B,≥2 Doses,States/Local Areas,South Dakota,2017,Age,5 Months,90.7,85.9 to 94.1,335
Hep B,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,5 Months,92.3,89.5 to 94.4,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014,Age,24 Months,92.0,88.0 to 95.0,274
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2015,Age,24 Months,92.7,90.0 to 94.9,493
PCV,≥4 Doses,States/Local Areas,South Dakota,2020,Age,35 Months,78.2,69.5 to 85.8,289
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2016,Age,0-1 Days,71.2,63.9 to 77.5,235
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2016-2017,Age,0-1 Days,75.3,70.4 to 79.7,570
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2017,Age,0-1 Days,79.4,72.4 to 85.0,335
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2017-2018,Age,0-1 Days,78.9,74.5 to 82.7,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2017,Age,19 Months,87.7,82.4 to 91.6,335
≥1 Dose MMR,,States/Local Areas,South Dakota,2017-2018,Age,19 Months,89.8,86.4 to 92.4,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2019,Age,19 Months,88.7,82.8 to 92.7,318
≥1 Dose MMR,,States/Local Areas,South Dakota,2018,Age,19 Months,92.0,87.3 to 95.0,390
≥1 Dose MMR,,States/Local Areas,South Dakota,2018-2019,Age,19 Months,94.9,92.3 to 96.7,708
PCV,≥4 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,73.9,68.5 to 78.7,222
PCV,≥4 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,78.2,74.9 to 81.2,496
PCV,≥4 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,81.6,72.6 to 88.1,211
PCV,≥4 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,79.3,72.8 to 84.6,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2011,Age,24 Months,89.1,82.4 to 94.1,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015,Age,24 Months,93.3,89.4 to 96.2,219
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015-2016,Age,24 Months,88.8,84.8 to 92.1,454
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016,Age,24 Months,84.1,77.3 to 89.7,235
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2017,Age,24 Months,87.5,83.5 to 91.0,570
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019,Age,19 Months,87.5,81.6 to 91.7,318
Polio,≥2 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,93.6,88.9 to 96.4,318
Polio,≥2 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,96.3,93.2 to 98.0,390
Polio,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,95.0,92.4 to 96.7,708
Polio,≥2 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,94.6,91.1 to 96.8,335
Polio,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,95.4,93.3 to 96.9,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013,Age,24 Months,87.5,81.6 to 92.3,222
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013-2014,Age,24 Months,89.9,86.4 to 92.8,496
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2013,Age,0-1 Days,62.9,56.0 to 69.3,222
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2013-2014,Age,0-1 Days,68.3,61.7 to 74.2,496
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2014,Age,0-1 Days,73.7,66.4 to 79.9,274
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2014-2015,Age,0-1 Days,73.2,68.0 to 77.8,493
Hep B,≥2 Doses,States/Local Areas,South Dakota,2015,Age,5 Months,88.4,83.0 to 92.3,219
Hep B,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,5 Months,87.2,82.9 to 90.5,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,95.9,92.5 to 97.8,390
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,92.4,89.3 to 94.6,708
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,91.0,86.3 to 94.2,335
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,93.4,90.6 to 95.4,725
Hep B,≥2 Doses,States/Local Areas,South Dakota,2016,Age,5 Months,85.9,78.8 to 90.8,235
Hep B,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,5 Months,88.3,84.2 to 91.5,570
Hep B,≥2 Doses,States/Local Areas,South Dakota,2014,Age,5 Months,88.4,82.5 to 92.4,274
Hep B,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,5 Months,88.4,85.2 to 91.0,493
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2012,Age,0-1 Days,75.9,71.1 to 80.0,211
PCV,≥3 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,62.5,56.9 to 67.8,222
PCV,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,64.1,60.8 to 67.3,496
PCV,≥3 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,72.9,65.0 to 79.6,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,87.2,80.7 to 91.8,235
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,89.1,85.2 to 92.1,570
PCV,≥3 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,65.7,58.2 to 72.6,274
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,68.2,62.8 to 73.1,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,61.8,58.4 to 65.0,211
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,78.6,73.8 to 83.4,456
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,87.1,81.7 to 92.5,209
≥1 Dose MMR,,States/Local Areas,South Dakota,2019,Age,13 Months,68.9,61.4 to 75.5,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016,Age,19 Months,80.6,73.3 to 86.3,235
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2017,Age,19 Months,84.3,79.9 to 87.9,570
Polio,≥2 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,93.5,89.0 to 96.2,219
Polio,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,90.6,86.7 to 93.5,454
Polio,≥2 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,87.7,81.0 to 92.3,235
Polio,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,91.2,87.5 to 93.8,570
Hep B,≥1 Dose,States/Local Areas,South Dakota,2017,Age,3 Months,94.1,90.4 to 96.4,335
Hep B,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,3 Months,95.2,93.1 to 96.7,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018,Age,19 Months,90.6,85.7 to 93.9,390
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018-2019,Age,19 Months,65.5,60.5 to 70.1,708
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017,Age,19 Months,88.0,82.9 to 91.7,335
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017-2018,Age,19 Months,89.3,85.9 to 91.9,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2013,Age,19 Months,85.0,82.8 to 87.0,222
≥1 Dose MMR,,States/Local Areas,South Dakota,2013-2014,Age,19 Months,86.5,85.0 to 87.9,496
≥1 Dose MMR,,States/Local Areas,South Dakota,2014,Age,19 Months,88.0,82.4 to 92.0,274
≥1 Dose MMR,,States/Local Areas,South Dakota,2012,Age,19 Months,90.7,85.8 to 94.0,211
DTaP,≥4 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,92.2,86.6 to 96.1,390
DTaP,≥4 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,89.8,85.1 to 93.5,708
Hep B,≥1 Dose,States/Local Areas,South Dakota,2019,Age,3 Months,96.3,92.5 to 98.2,318
Polio,≥2 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,93.8,89.0 to 96.5,274
Polio,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,93.6,90.6 to 95.7,493
Hep B,≥1 Dose,States/Local Areas,South Dakota,2018,Age,3 Months,96.5,93.8 to 98.0,390
Hep B,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,3 Months,96.4,94.3 to 97.7,708
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2011,Age,0-1 Days,64.0,59.3 to 68.4,194
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,76.6,69.6 to 83.5,456
Hep B,≥2 Doses,States/Local Areas,South Dakota,2012,Age,5 Months,88.1,77.6 to 94.0,211
Hep B,≥2 Doses,States/Local Areas,South Dakota,2011,Age,5 Months,88.1,82.2 to 92.2,194
Hep B,≥2 Doses,States/Local Areas,South Dakota,2013,Age,5 Months,90.0,85.3 to 93.3,222
Hep B,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,5 Months,89.2,85.7 to 91.9,496
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,91.6,88.7 to 93.8,222
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,91.4,89.6 to 92.9,496
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,88.5,78.3 to 98.6,209
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,91.3,85.7 to 94.8,274
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,90.9,87.3 to 93.6,493
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,90.6,89.8 to 91.4,219
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,88.9,84.8 to 92.1,454
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,75.7,69.2 to 82.3,265
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,78.5 to 93.3,125
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,76.0,70.9 to 81.1,483
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,77.3,73.7 to 81.0,873
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.3,59.9 to 78.7,141
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.5,76.7 to 84.4,655
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,76.8,63.2 to 90.5,56
DTaP,≥4 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,86.8,78.9 to 92.8,318
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,86.5,82.9 to 90.1,553
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,68.8,61.9 to 75.7,264
≥1 Dose MMR,,States/Local Areas,South Dakota,2011,Age,19 Months,88.2,83.0 to 92.0,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,91.1,86.1 to 94.4,318
Hep B,≥3 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,90.9,86.3 to 94.0,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,93.5,89.4 to 96.1,390
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,92.4,89.3 to 94.6,708
Hep B,≥3 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,93.5,88.7 to 96.4,211
≥1 Dose MMR,,States/Local Areas,South Dakota,2015,Age,19 Months,87.5,82.2 to 91.4,219
≥1 Dose MMR,,States/Local Areas,South Dakota,2015-2016,Age,19 Months,84.9,80.4 to 88.6,454
≥1 Dose MMR,,States/Local Areas,South Dakota,2016,Age,19 Months,82.4,75.1 to 87.8,235
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2017,Age,19 Months,85.0,80.7 to 88.6,570
≥1 Dose Varicella,,States/Local Areas,South Dakota,2011,Age,24 Months,90.7,84.9 to 94.9,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2012,Age,24 Months,94.0,89.5 to 97.0,211
DTaP,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,69.0,61.1 to 76.8,208
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2015,Age,19 Months,87.7,83.9 to 90.7,493
DTaP,≥4 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,84.0,77.7 to 89.4,335
DTaP,≥4 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,87.6,83.3 to 91.1,725
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,82.3,75.0 to 88.4,235
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,83.1,78.4 to 87.3,570
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,83.1,75.9 to 88.5,235
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,86.7,82.5 to 90.0,570
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,90.6,85.0 to 94.3,219
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,86.9,82.4 to 90.4,454
DTaP,≥4 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,88.1,80.3 to 93.9,219
DTaP,≥4 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,85.5,80.1 to 90.2,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,90.3,85.5 to 93.6,335
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,91.9,88.9 to 94.1,725
Hep A,≥1 Dose,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,88.4,83.8 to 92.9,209
Polio,≥2 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,92.6,88.2 to 95.4,390
Polio,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,91.5,88.3 to 93.9,708
Hep B,≥1 Dose,States/Local Areas,South Dakota,2013,Age,3 Months,96.2,88.8 to 98.8,222
Hep B,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,3 Months,95.4,93.0 to 96.9,496
Hep B,≥1 Dose,States/Local Areas,South Dakota,2012,Age,3 Months,95.1,89.7 to 97.7,211
Hep B,≥1 Dose,States/Local Areas,South Dakota,2011,Age,3 Months,95.9,92.1 to 97.9,194
Polio,≥2 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,83.4,76.3 to 88.7,235
Polio,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,86.4,82.2 to 89.8,570
Polio,≥2 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,89.4,84.2 to 93.1,335
Polio,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,91.0,87.6 to 93.5,725
Polio,≥2 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,90.4,85.2 to 94.0,318
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,77.9,72.2 to 83.6,873
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,71.6,60.1 to 83.1,208
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,76.6,69.1 to 84.1,483
Hep A,≥1 Dose,States/Local Areas,South Dakota,2020,Age,35 Months,86.4,79.2 to 92.0,289
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,80.1,74.2 to 86.0,553
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,81.3,68.5 to 94.2,264
≥1 Dose MMR,,States/Local Areas,South Dakota,2012,Age,24 Months,94.4,90.1 to 97.3,211
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.7,55.6 to 79.8,125
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.0,72.2 to 83.7,655
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,85.2,74.5 to 95.8,265
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,74.5,57.1 to 91.9,56
Hep A,≥2 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.2,62.4 to 51.4,141
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,90.2,88.3 to 91.9,222
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,90.7,89.4 to 91.8,496
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,87.4 to 98.6,141
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.7,87.9 to 93.5,655
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,64.5,58.7 to 70.0,222
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,66.0,63.0 to 68.8,496
DTaP,≥3 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,63.2,60.4 to 65.9,211
DTaP,≥3 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,73.0,63.2 to 81.0,194
PCV,≥1 Dose,States/Local Areas,South Dakota,2018,Age,3 Months,90.4,85.8 to 93.6,390
PCV,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,3 Months,88.8,85.1 to 91.6,708
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,91.4,89.0 to 93.7,873
PCV,≥1 Dose,States/Local Areas,South Dakota,2019,Age,3 Months,87.1,80.8 to 91.5,318
Polio,≥1 Dose,States/Local Areas,South Dakota,2012,Age,3 Months,84.2,81.0 to 87.0,211
Polio,≥1 Dose,States/Local Areas,South Dakota,2011,Age,3 Months,90.3,83.6 to 94.4,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2013,Age,0-3 Days,69.7,61.8 to 76.5,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2013-2014,Age,0-3 Days,74.1,68.9 to 78.7,496
Polio,≥1 Dose,States/Local Areas,South Dakota,2013,Age,3 Months,85.4,74.3 to 92.2,222
Polio,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,3 Months,85.7,80.0 to 89.9,496
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014,Age,0-3 Days,78.5,71.5 to 84.2,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2015,Age,0-3 Days,78.0,73.2 to 82.2,493
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.9,62.9 to 81.0,141
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.4,81.0 to 87.9,655
PCV,≥1 Dose,States/Local Areas,South Dakota,2014,Age,3 Months,84.6,78.4 to 89.2,274
PCV,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,3 Months,85.9,81.7 to 89.2,493
PCV,≥1 Dose,States/Local Areas,South Dakota,2015,Age,3 Months,87.2,81.1 to 91.5,219
PCV,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,3 Months,85.4,80.9 to 89.0,454
PCV,≥3 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,93.7,89.8 to 96.5,335
PCV,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,95.1,92.8 to 96.9,725
PCV,≥3 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,88.7,82.5 to 93.5,235
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,91.1,87.5 to 94.0,570
Hib,≥2 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,88.4,82.1 to 92.7,211
PCV,≥3 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,92.8,88.7 to 95.9,219
PCV,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,90.7,87.0 to 93.7,454
Hib,≥2 Doses,States/Local Areas,South Dakota,2019,Age,5 Months,71.8,64.5 to 78.0,318
Hib,≥2 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,94.8,92.6 to 96.3,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2018,Age,5 Months,78.9,73.0 to 83.8,390
Hib,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,5 Months,75.4,70.9 to 79.5,708
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,89.5,85.1 to 93.9,265
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,92.8,89.8 to 95.8,483
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.1,83.3 to 97.0,125
PCV,≥1 Dose,States/Local Areas,South Dakota,2012,Age,3 Months,83.6,80.0 to 86.7,211
Hib,≥2 Doses,States/Local Areas,South Dakota,2017,Age,5 Months,78.4,71.7 to 83.9,335
Hib,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,5 Months,78.7,74.2 to 82.5,725
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,93.6,91.0 to 96.1,553
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020,Age,24 Months,92.9,87.3 to 96.6,289
PCV,≥1 Dose,States/Local Areas,South Dakota,2016,Age,3 Months,83.6,76.4 to 88.8,235
PCV,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,3 Months,85.1,80.7 to 88.6,570
PCV,≥1 Dose,States/Local Areas,South Dakota,2017,Age,3 Months,86.6,81.1 to 90.7,335
PCV,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,3 Months,88.4,84.9 to 91.2,725
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,83.6,78.3 to 88.9,265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2012,Age,0-3 Days,80.5,72.3 to 86.8,211
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,89.0,84.1 to 93.9,209
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,72.1,64.6 to 79.5,208
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,83.2,78.9 to 87.5,456
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.8,76.7 to 92.9,125
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,78.1,73.2 to 83.0,483
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,80.9,77.6 to 84.3,873
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,90.4,86.1 to 94.7,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2011,Age,0-3 Days,73.0,63.7 to 80.6,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,81.7,81.0 to 82.3,222
Hib,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,85.3,82.8 to 87.4,496
Hib,≥2 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,88.8,83.0 to 92.8,274
Hib,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,89.2,85.4 to 92.1,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,91.8,86.2 to 95.3,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,95.4,91.4 to 97.9,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2018,Age,19 Months,95.0,91.2 to 97.2,390
PCV,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,19 Months,90.8,87.3 to 93.4,708
Hep B,≥2 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,94.7,90.3 to 97.1,318
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,71.9,64.1 to 78.5,219
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,67.9,62.4 to 72.9,454
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,67.4,59.9 to 74.1,274
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,69.6,64.3 to 74.5,493
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2015,Age,0-3 Days,77.5,70.4 to 83.3,219
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2015-2016,Age,0-3 Days,78.0,73.1 to 82.2,454
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,63.9,55.9 to 71.1,235
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,66.4,60.9 to 71.4,570
Hib,≥2 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,83.6,76.5 to 88.9,235
Hib,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,86.8,82.5 to 90.1,570
Hib,≥2 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,89.9,84.8 to 93.5,335
Hib,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,90.5,87.0 to 93.1,725
Hib,≥2 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,91.0,86.4 to 94.2,390
Hib,≥2 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,89.6,84.1 to 93.3,219
Hib,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,86.6,82.2 to 90.1,454
PCV,≥3 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,95.2,90.6 to 98.0,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,95.4,91.4 to 97.9,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,94.3,88.1 to 97.9,222
PCV,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,94.0,90.1 to 96.8,496
PCV,≥3 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,93.2,87.4 to 97.0,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,92.9,84.2 to 100.0,56
PCV,≥3 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,93.0,88.5 to 96.2,274
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,93.0,90.0 to 95.3,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,92.8,88.7 to 95.9,219
PCV,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,91.0,87.3 to 94.0,454
PCV,≥3 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,89.3,83.1 to 94.0,235
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,91.5,87.9 to 94.4,570
Hib,≥3 Doses,States/Local Areas,South Dakota,2011,Age,7 Months,63.8,56.8 to 70.2,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2012,Age,7 Months,59.4,56.1 to 62.7,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,89.5,85.9 to 93.1,456
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,95.9,93.2 to 98.6,209
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,91.1,86.3 to 95.9,208
Hib,≥3 Doses,States/Local Areas,South Dakota,2013,Age,7 Months,54.1,50.6 to 57.6,222
Hib,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,7 Months,56.8,54.7 to 59.0,496
Polio,≥1 Dose,States/Local Areas,South Dakota,2014,Age,3 Months,86.0,80.0 to 90.4,274
Polio,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,3 Months,87.2,83.1 to 90.4,493
Polio,≥1 Dose,States/Local Areas,South Dakota,2015,Age,3 Months,88.4,82.4 to 92.6,219
Polio,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,3 Months,86.4,82.0 to 89.9,454
Polio,≥1 Dose,States/Local Areas,South Dakota,2016,Age,3 Months,84.4,77.3 to 89.6,235
Polio,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,3 Months,86.3,82.1 to 89.6,570
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2017,Age,0-3 Days,81.3,70.0 to 89.0,144
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2017-2018,Age,0-3 Days,84.9,81.1 to 88.1,725
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016,Age,0-3 Days,78.4,71.5 to 84.1,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2017,Age,0-3 Days,82.0,77.5 to 85.8,570
PCV,≥3 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,96.5,93.7 to 98.3,390
PCV,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,95.8,93.3 to 97.5,708
DTaP,≥3 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,91.8,84.7 to 95.8,211
Hib,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,90.4,87.1 to 93.0,708
Hib,≥2 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,89.8,84.3 to 93.5,318
Hib,≥2 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,95.9,92.7 to 97.8,211
Hib,≥2 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,97.0,94.8 to 98.2,194
Polio,≥1 Dose,States/Local Areas,South Dakota,2018,Age,3 Months,90.7,86.1 to 93.9,390
Polio,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,3 Months,89.1,85.5 to 91.9,708
Polio,≥1 Dose,States/Local Areas,South Dakota,2017,Age,3 Months,88.1,83.1 to 91.8,335
Polio,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,3 Months,89.4,86.0 to 92.0,725
Hib,≥3 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,62.5,54.5 to 69.8,219
Hib,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,61.4,55.8 to 66.6,454
Hib,≥3 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,60.2,52.3 to 67.6,235
Hib,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,59.5,54.0 to 64.7,570
PCV,≥3 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,96.7,93.8 to 98.5,390
PCV,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,95.9,93.4 to 97.6,708
Hib,≥3 Doses,States/Local Areas,South Dakota,2014,Age,7 Months,59.5,52.0 to 66.7,274
Hib,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,7 Months,61.0,55.5 to 66.3,493
Hib,≥2 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,92.9,89.1 to 95.5,222
Hib,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,93.1,89.7 to 95.4,496
PCV,≥3 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,93.9,89.9 to 96.6,335
PCV,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,95.3,92.9 to 97.0,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,91.7,84.6 to 95.7,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,70.2,62.6 to 76.9,318
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,68.9,61.3 to 75.5,335
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,71.2,66.1 to 75.8,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,73.7,66.9 to 79.5,390
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,72.0,67.0 to 76.5,708
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2019,Age,0-3 Days,86.1,79.8 to 90.7,318
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,82.6,77.4 to 87.8,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,79.3,75.3 to 83.3,553
Polio,≥1 Dose,States/Local Areas,South Dakota,2019,Age,3 Months,87.4,81.3 to 91.7,318
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2018,Age,0-3 Days,84.2,79.1 to 88.3,390
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2018-2019,Age,0-3 Days,85.2,81.3 to 88.3,708
PCV,≥3 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,95.2,90.6 to 98.0,318
Hib,≥3 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,60.5,53.7 to 67.0,390
Hib,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,60.9,55.9 to 65.8,708
Hib,≥3 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,58.8,51.2 to 66.0,335
Hib,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,59.7,54.5 to 64.6,725
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,94.6,92.1 to 97.1,553
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,89.2,84.8 to 93.6,264
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,92.7,83.9 to 100.0,56
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,85.8 to 96.8,141
Hib,≥2 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,93.7,89.4 to 96.4,219
Hib,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,91.3,87.5 to 94.1,454
Hib,≥2 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,88.9,82.2 to 93.2,235
Hib,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,92.1,88.4 to 94.6,570
Hib,≥2 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,93.3,88.6 to 96.2,274
Hib,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,93.5,90.5 to 95.6,493
Hib,≥2 Doses,States/Local Areas,South Dakota,2012,Age,5 Months,73.1,65.5 to 79.5,211
Hib,≥2 Doses,States/Local Areas,South Dakota,2011,Age,5 Months,79.3,67.2 to 87.8,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2013,Age,5 Months,70.8,65.9 to 75.2,222
Hib,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,5 Months,73.1,69.4 to 76.4,496
Hib,≥2 Doses,States/Local Areas,South Dakota,2014,Age,5 Months,75.4,68.3 to 81.3,274
Hib,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,5 Months,75.2,71.8 to 78.3,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,92.3,87.9 to 95.3,335
PCV,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,93.6,90.9 to 95.6,725
PCV,≥1 Dose,States/Local Areas,South Dakota,2011,Age,3 Months,89.4,84.6 to 92.8,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,89.7,86.2 to 93.2,456
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,91.5,87.1 to 95.8,209
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,91.9,88.9 to 94.9,483
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.1,79.3 to 94.9,125
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Overall,Overall,90.1,87.6 to 92.6,873
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,89.3,84.2 to 94.3,208
PCV,≥4 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,85.0,79.1 to 90.0,335
PCV,≥4 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,87.6,83.7 to 91.0,725
PCV,≥4 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,83.1,76.3 to 88.9,235
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,84.0,79.6 to 87.9,570
Hib,Full Series,States/Local Areas,South Dakota,2020,Age,24 Months,69.5,61.1 to 77.5,289
PCV,≥4 Doses,States/Local Areas,South Dakota,2018,Age,35 Months,90.6,85.4 to 94.5,390
PCV,≥4 Doses,States/Local Areas,South Dakota,2018-2019,Age,35 Months,89.1,84.9 to 92.6,708
Hib,≥2 Doses,States/Local Areas,South Dakota,2015,Age,5 Months,75.0,67.5 to 81.2,219
Hib,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,5 Months,75.8,70.6 to 80.3,454
Hib,≥2 Doses,States/Local Areas,South Dakota,2016,Age,5 Months,76.6,69.1 to 82.7,235
Hib,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,5 Months,77.5,72.6 to 81.8,570
PCV,≥4 Doses,States/Local Areas,South Dakota,2019,Age,35 Months,87.8,80.6 to 93.2,318
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,88.0,84.7 to 91.4,553
PCV,≥1 Dose,States/Local Areas,South Dakota,2013,Age,3 Months,84.0,72.3 to 91.3,222
PCV,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,3 Months,84.3,78.0 to 89.0,496
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,74.8,68.5 to 81.1,264
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,81.6,69.5 to 93.6,56
PCV,≥3 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,92.6,88.1 to 95.9,274
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,92.7,89.7 to 95.1,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,92.7,86.9 to 96.6,211
PCV,≥3 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,92.2,86.6 to 96.0,222
PCV,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,92.4,89.0 to 95.0,496
Hib,≥1 Dose,States/Local Areas,South Dakota,2019,Age,3 Months,82.6,76.3 to 87.5,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2019,Age,35 Months,95.6,91.8 to 98.0,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,91.6,88.7 to 94.4,553
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,89.9,85.6 to 94.2,264
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018,Age,35 Months,95.4,91.9 to 97.7,390
≥1 Dose Varicella,,States/Local Areas,South Dakota,2018-2019,Age,35 Months,95.3,92.8 to 97.2,708
PCV,≥4 Doses,States/Local Areas,South Dakota,2015,Age,24 Months,83.8,78.1 to 88.8,219
PCV,≥4 Doses,States/Local Areas,South Dakota,2015-2016,Age,24 Months,81.4,76.9 to 85.6,454
≥1 Dose MMR,,States/Local Areas,South Dakota,2016,Age,35 Months,94.4,87.2 to 98.2,235
≥1 Dose MMR,,States/Local Areas,South Dakota,2016-2017,Age,35 Months,93.4,89.3 to 96.3,570
≥1 Dose MMR,,States/Local Areas,South Dakota,2014,Age,35 Months,94.3,90.5 to 97.0,274
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2015,Age,35 Months,93.9,91.1 to 96.1,493
≥1 Dose MMR,,States/Local Areas,South Dakota,2015,Age,35 Months,93.7,89.1 to 96.9,219
≥1 Dose MMR,,States/Local Areas,South Dakota,2015-2016,Age,35 Months,94.0,89.7 to 97.0,454
PCV,≥4 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,82.6,76.6 to 87.8,335
PCV,≥4 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,84.7,80.8 to 88.2,725
PCV,≥4 Doses,States/Local Areas,South Dakota,2016,Age,24 Months,78.9,71.9 to 85.2,235
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2017,Age,24 Months,80.8,76.2 to 85.0,570
PCV,≥3 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,91.5,86.6 to 94.7,390
PCV,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,90.8,87.3 to 93.4,708
PCV,≥3 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,89.3,83.7 to 93.1,335
PCV,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,90.4,86.7 to 93.1,725
Hep B,≥2 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,93.2,88.6 to 96.1,318
Hep B,≥2 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,94.9,89.1 to 97.7,194
Hep B,≥2 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,96.7,93.0 to 98.4,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,95.5,90.3 to 98.4,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,93.0,88.7 to 96.2,274
Hep B,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,93.0,89.9 to 95.4,493
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,92.2,86.5 to 96.2,222
Hep B,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,92.7,89.2 to 95.4,496
PCV,≥3 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,83.3,76.1 to 88.6,235
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,86.3,81.9 to 89.7,570
PCV,≥4 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,87.0,82.0 to 91.1,390
PCV,≥4 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,85.2,81.2 to 88.8,708
PCV,≥4 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,83.6,77.0 to 89.2,318
PCV,≥4 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,86.9,78.4 to 93.3,194
PCV,≥4 Doses,States/Local Areas,South Dakota,2012,Age,35 Months,86.7,79.2 to 92.5,211
PCV,≥3 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,91.0,83.4 to 95.4,211
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017,Age,35 Months,94.4,90.4 to 97.1,335
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,35 Months,95.6,93.3 to 97.3,725
PCV,≥3 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,89.9,84.3 to 93.7,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,94.7,92.2 to 96.5,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,90.1,87.5 to 92.2,222
PCV,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,90.6,89.0 to 92.0,496
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,93.2,88.4 to 96.5,219
Hep B,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,91.1,87.3 to 94.2,454
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016,Age,35 Months,89.1,83.0 to 93.7,235
Hep B,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,35 Months,91.9,88.4 to 94.7,570
PCV,≥4 Doses,States/Local Areas,South Dakota,2013,Age,35 Months,81.8,74.3 to 88.2,222
PCV,≥4 Doses,States/Local Areas,South Dakota,2013-2014,Age,35 Months,84.9,80.2 to 88.9,496
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,91.8,82.6 to 100.0,56
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,80.1 to 93.2,141
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,87.8,83.1 to 92.6,264
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,92.4,89.7 to 95.2,553
PCV,≥4 Doses,States/Local Areas,South Dakota,2015,Age,35 Months,90.1,83.5 to 94.8,219
PCV,≥4 Doses,States/Local Areas,South Dakota,2015-2016,Age,35 Months,87.0,82.2 to 91.1,454
PCV,≥4 Doses,States/Local Areas,South Dakota,2014,Age,35 Months,87.9,82.3 to 92.5,274
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2015,Age,35 Months,89.6,85.0 to 93.2,493
Hep B,≥2 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,97.4,95.3 to 98.5,390
Hep B,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,96.1,93.9 to 97.5,708
Hep B,≥2 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,90.8,84.6 to 94.6,235
Hep B,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,92.7,89.4 to 95.1,570
PCV,≥3 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,92.8,90.8 to 94.5,219
PCV,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,89.7,85.7 to 92.7,454
PCV,≥3 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,86.5,79.8 to 91.3,235
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,89.4,85.5 to 92.4,570
Hib,≥1 Dose,States/Local Areas,South Dakota,2015,Age,3 Months,87.6,81.6 to 91.9,219
Hib,≥1 Dose,States/Local Areas,South Dakota,2015-2016,Age,3 Months,86.1,81.6 to 89.6,454
Hib,≥1 Dose,States/Local Areas,South Dakota,2016,Age,3 Months,84.4,77.4 to 89.6,235
Hib,≥1 Dose,States/Local Areas,South Dakota,2016-2017,Age,3 Months,86.2,82.0 to 89.6,570
Hib,≥1 Dose,States/Local Areas,South Dakota,2017,Age,3 Months,88.0,83.0 to 91.7,335
Hib,≥1 Dose,States/Local Areas,South Dakota,2017-2018,Age,3 Months,87.7,84.3 to 90.5,725
Hep B,≥2 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,94.7,91.2 to 96.8,335
Hep B,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,96.0,94.0 to 97.3,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2018,Age,35 Months,96.7,93.8 to 98.5,390
≥1 Dose MMR,,States/Local Areas,South Dakota,2018-2019,Age,35 Months,96.2,93.9 to 97.9,708
≥1 Dose MMR,,States/Local Areas,South Dakota,2017,Age,35 Months,93.4,88.5 to 96.7,335
≥1 Dose MMR,,States/Local Areas,South Dakota,2017-2018,Age,35 Months,95.0,92.1 to 97.1,725
≥1 Dose MMR,,States/Local Areas,South Dakota,2019,Age,35 Months,96.1,92.4 to 98.3,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,80.5 to 93.5,141
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,88.6 to 93.7,655
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,86.4 to 94.8,265
Hib,≥1 Dose,States/Local Areas,South Dakota,2018,Age,3 Months,87.4,82.7 to 91.1,390
Hib,≥1 Dose,States/Local Areas,South Dakota,2018-2019,Age,3 Months,85.1,81.3 to 88.2,708
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,89.3 to 94.3,655
≥1 Dose MMR,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,88.4,83.6 to 93.2,265
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,93.0,88.9 to 97.2,209
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,88.5,84.9 to 92.1,456
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,91.7,82.7 to 100.0,56
Hib,≥1 Dose,States/Local Areas,South Dakota,2013,Age,3 Months,83.8,77.3 to 88.7,222
Hib,≥1 Dose,States/Local Areas,South Dakota,2013-2014,Age,3 Months,84.8,80.8 to 88.2,496
Hib,≥1 Dose,States/Local Areas,South Dakota,2012,Age,3 Months,84.6,81.6 to 87.1,211
Hib,≥1 Dose,States/Local Areas,South Dakota,2011,Age,3 Months,90.3,83.6 to 94.4,194
Hib,≥1 Dose,States/Local Areas,South Dakota,2014,Age,3 Months,85.9,79.9 to 90.3,274
Hib,≥1 Dose,States/Local Areas,South Dakota,2014-2015,Age,3 Months,86.8,82.7 to 90.0,493
Hep B,≥2 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,95.6,91.6 to 97.7,274
Hep B,≥2 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,94.4,91.6 to 96.3,493
Hep B,≥2 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,93.2,88.7 to 96.0,219
Hep B,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,92.0,88.4 to 94.5,454
Hep B,≥2 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,94.0,88.8 to 96.9,222
Hep B,≥2 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,94.8,92.0 to 96.7,496
PCV,≥4 Doses,States/Local Areas,South Dakota,2011,Age,24 Months,82.8,75.1 to 89.2,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2019,Age,24 Months,94.2,89.9 to 97.0,318
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017,Age,24 Months,92.8,88.7 to 95.9,335
Hep B,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,24 Months,94.4,91.9 to 96.3,725
Hep B,≥3 Doses,States/Local Areas,South Dakota,2011,Age,35 Months,90.9,84.5 to 95.4,194
PCV,≥4 Doses,States/Local Areas,South Dakota,2012,Age,24 Months,85.1,77.6 to 91.1,211
PCV,≥4 Doses,States/Local Areas,South Dakota,2014,Age,24 Months,85.7,80.0 to 90.4,274
PCV,≥4 Doses,States/Local Areas,South Dakota,2014-2015,Age,24 Months,84.7,80.8 to 88.3,493
PCV,≥4 Doses,States/Local Areas,South Dakota,2013,Age,24 Months,78.5,71.1 to 85.1,222
PCV,≥4 Doses,States/Local Areas,South Dakota,2013-2014,Age,24 Months,82.1,77.5 to 86.3,496
≥1 Dose MMR,,States/Local Areas,South Dakota,2019,Age,24 Months,95.7,92.0 to 98.1,318
≥1 Dose MMR,,States/Local Areas,South Dakota,2018,Age,24 Months,94.3,90.9 to 96.7,390
≥1 Dose MMR,,States/Local Areas,South Dakota,2018-2019,Age,24 Months,94.5,91.9 to 96.5,708
≥1 Dose MMR,,States/Local Areas,South Dakota,2011,Age,35 Months,94.4,86.8 to 98.4,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2012,Age,35 Months,95.8,91.2 to 98.4,211
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016,Age,35 Months,92.8,83.9 to 97.8,235
≥1 Dose Varicella,,States/Local Areas,South Dakota,2016-2017,Age,35 Months,92.2,88.1 to 95.3,570
≥1 Dose MMR,,States/Local Areas,South Dakota,2013,Age,35 Months,93.4,85.0 to 98.0,222
≥1 Dose MMR,,States/Local Areas,South Dakota,2013-2014,Age,35 Months,93.9,89.5 to 96.9,496
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018,Age,24 Months,95.9,92.8 to 97.9,390
Hep B,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,24 Months,95.1,92.6 to 96.9,708
Hep B,≥2 Doses,States/Local Areas,South Dakota,2015,Age,7 Months,91.3,86.3 to 94.6,219
Hep B,≥2 Doses,States/Local Areas,South Dakota,2015-2016,Age,7 Months,88.8,84.6 to 92.0,454
PCV,≥3 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,88.4,82.6 to 92.5,274
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,89.7,86.0 to 92.5,493
PCV,≥3 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,91.0,86.0 to 94.3,219
PCV,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,87.2,82.9 to 90.5,454
Hep B,≥2 Doses,States/Local Areas,South Dakota,2018,Age,7 Months,95.8,93.2 to 97.4,390
Hep B,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,7 Months,94.5,92.1 to 96.3,708
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2019,Age,0-2 Days,84.8,78.3 to 89.6,318
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2018,Age,0-2 Days,82.3,76.9 to 86.6,390
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2018-2019,Age,0-2 Days,83.5,79.5 to 86.8,708
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2017,Age,0-2 Days,85.3,79.1 to 89.8,335
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2017-2018,Age,0-2 Days,83.8,79.9 to 87.1,725
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017,Age,35 Months,93.4,89.2 to 96.4,335
≥1 Dose Varicella,,States/Local Areas,South Dakota,2017-2018,Age,35 Months,94.3,91.6 to 96.3,725
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2016,Age,0-2 Days,77.3,70.3 to 83.1,235
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2016-2017,Age,0-2 Days,81.3,76.8 to 85.1,570
Hep B,≥2 Doses,States/Local Areas,South Dakota,2016,Age,7 Months,86.2,79.2 to 91.2,235
Hep B,≥2 Doses,States/Local Areas,South Dakota,2016-2017,Age,7 Months,89.3,85.3 to 92.4,570
PCV,≥3 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,85.7,81.9 to 88.9,222
PCV,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,87.1,85.3 to 88.6,496
Hep B,≥2 Doses,States/Local Areas,South Dakota,2017,Age,7 Months,92.5,88.1 to 95.3,335
Hep B,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,7 Months,94.1,91.7 to 95.8,725
PCV,≥4 Doses,States/Local Areas,South Dakota,2019,Age,19 Months,78.6,71.6 to 84.2,318
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013,Age,35 Months,92.9,85.8 to 97.3,222
≥1 Dose Varicella,,States/Local Areas,South Dakota,2013-2014,Age,35 Months,93.8,89.8 to 96.6,496
≥1 Dose Varicella,,States/Local Areas,South Dakota,2012,Age,35 Months,94.7,90.0 to 97.6,211
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015,Age,35 Months,94.6,90.5 to 97.3,219
≥1 Dose Varicella,,States/Local Areas,South Dakota,2015-2016,Age,35 Months,93.4,88.7 to 96.7,454
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014,Age,35 Months,94.1,90.2 to 96.8,274
≥1 Dose Varicella,,States/Local Areas,South Dakota,2014-2015,Age,35 Months,94.3,91.7 to 96.4,493
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,84.8,77.6 to 90.0,235
DTaP,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,87.6,83.4 to 90.9,570
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,90.5,85.2 to 94.0,335
DTaP,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,91.3,87.8 to 93.8,725
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,91.9,87.0 to 95.1,219
DTaP,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,88.4,84.1 to 91.7,454
Hib,≥3 Doses,States/Local Areas,South Dakota,2012,Age,13 Months,87.0,80.5 to 91.5,211
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,80.6,74.3 to 86.8,208
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,77.8,73.2 to 82.3,456
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,82.4,76.4 to 88.5,209
Hib,≥3 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,79.2,69.8 to 86.3,222
Hib,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,80.2,76.0 to 83.7,496
Polio,≥3 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,93.6,89.1 to 96.3,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,91.2,87.8 to 94.6,456
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,96.7,94.3 to 99.1,209
Hib,≥3 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,81.1,74.7 to 86.2,274
Hib,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,83.5,79.1 to 87.1,493
Hib,≥3 Doses,States/Local Areas,South Dakota,2011,Age,13 Months,86.3,83.4 to 88.8,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013,Age,13 Months,86.2,83.8 to 88.4,222
DTaP,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,13 Months,87.3,86.1 to 88.4,496
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014,Age,13 Months,88.4,82.5 to 92.5,274
DTaP,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,13 Months,90.2,86.5 to 92.9,493
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,88.5,80.4 to 96.6,56
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.5,67.9 to 85.1,141
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.9,75.3 to 82.5,655
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,81.1,75.8 to 86.4,265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.1,80.4 to 93.8,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,76.6,71.9 to 81.3,483
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2014-2017,Overall,Overall,79.6,76.4 to 82.8,873
Hib,≥2 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,93.7,89.0 to 96.5,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Overall,Overall,91.5,89.2 to 93.9,873
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,88.5,83.4 to 93.6,208
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,91.6,88.4 to 94.9,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,85.3 to 98.1,125
Hib,≥2 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,96.0,93.0 to 97.8,390
Hib,≥2 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,94.9,92.3 to 96.7,708
Hib,≥2 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,95.2,91.8 to 97.3,335
Hib,≥2 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,95.6,93.5 to 97.1,725
Hib,≥3 Doses,States/Local Areas,South Dakota,2019,Age,7 Months,61.3,53.8 to 68.4,318
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.8 to 94.3,655
PCV,≥3 Doses,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,91.1,87.1 to 95.2,265
Polio,≥3 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,94.5,89.9 to 97.1,211
Polio,≥3 Doses,States/Local Areas,South Dakota,2013,Age,19 Months,89.4,86.7 to 91.5,222
Polio,≥3 Doses,States/Local Areas,South Dakota,2013-2014,Age,19 Months,90.3,88.8 to 91.6,496
DTaP,≥3 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,89.8,84.2 to 93.6,318
DTaP,≥3 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,96.0,94.3 to 97.2,194
DTaP,≥3 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,96.0,92.6 to 97.9,211
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,92.1,87.3 to 95.2,390
DTaP,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,91.0,87.5 to 93.6,708
Polio,≥1 Dose,States/Local Areas,South Carolina,2021,Age,3 Months,86.5,77.5 to 92.3,188
Hep A,≥2 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,71.8,58.3 to 84.0,188
Hib,≥3 Doses,States/Local Areas,South Dakota,2015,Age,13 Months,85.9,79.3 to 90.6,219
Hib,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,13 Months,81.1,76.2 to 85.3,454
Hib,≥3 Doses,States/Local Areas,South Dakota,2016,Age,13 Months,76.3,68.6 to 82.6,235
Hib,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,13 Months,79.3,74.4 to 83.5,570
Hib,≥3 Doses,States/Local Areas,South Dakota,2017,Age,13 Months,82.3,75.8 to 87.3,335
Hib,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,13 Months,82.3,78.0 to 85.8,725
Polio,≥3 Doses,States/Local Areas,South Dakota,2014,Age,19 Months,91.1,85.5 to 94.7,274
Polio,≥3 Doses,States/Local Areas,South Dakota,2014-2015,Age,19 Months,91.7,88.2 to 94.2,493
Hib,≥3 Doses,States/Local Areas,South Dakota,2019,Age,13 Months,78.0,71.4 to 83.5,318
Hib,≥3 Doses,States/Local Areas,South Dakota,2012,Age,19 Months,95.7,92.5 to 97.6,211
Hib,≥3 Doses,States/Local Areas,South Dakota,2011,Age,19 Months,96.1,94.6 to 97.2,194
Polio,≥3 Doses,States/Local Areas,South Dakota,2015,Age,19 Months,92.2,89.2 to 94.5,219
Polio,≥3 Doses,States/Local Areas,South Dakota,2015-2016,Age,19 Months,89.1,85.0 to 92.1,454
Hib,≥3 Doses,States/Local Areas,South Dakota,2018,Age,13 Months,82.2,76.7 to 86.7,390
Hib,≥3 Doses,States/Local Areas,South Dakota,2018-2019,Age,13 Months,80.2,76.0 to 83.8,708
Polio,≥3 Doses,States/Local Areas,South Dakota,2016,Age,19 Months,85.8,79.1 to 90.7,235
Polio,≥3 Doses,States/Local Areas,South Dakota,2016-2017,Age,19 Months,88.9,84.9 to 91.9,570
Polio,≥3 Doses,States/Local Areas,South Dakota,2017,Age,19 Months,91.9,87.0 to 95.1,335
Polio,≥3 Doses,States/Local Areas,South Dakota,2017-2018,Age,19 Months,93.4,90.5 to 95.5,725
Hib,Full Series,States/Local Areas,South Carolina,2021,Age,24 Months,69.6,60.6 to 78.2,188
≥1 Dose Varicella,,States/Local Areas,South Carolina,2021,Age,19 Months,85.7,77.3 to 91.3,188
≥1 Dose MMR,,States/Local Areas,South Carolina,2021,Age,24 Months,87.6,79.7 to 93.5,188
DTaP,≥4 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,70.7,61.5 to 78.4,188
Hep A,≥1 Dose,States/Local Areas,South Carolina,2021,Age,35 Months,84.9,76.3 to 91.6,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,88.9,80.4 to 94.0,188
DTaP,≥3 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,88.8,81.1 to 93.6,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,91.5,84.6 to 96.1,188
Hep A,≥1 Dose,States/Local Areas,South Carolina,2021,Age,19 Months,78.2,68.8 to 85.3,188
Polio,≥2 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,91.6,83.8 to 95.9,188
Hep A,≥2 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,36.3,28.0 to 45.5,188
DTaP,≥1 Dose,States/Local Areas,South Carolina,2021,Age,3 Months,86.5,77.5 to 92.3,188
DTaP,≥4 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,80.5,71.8 to 87.9,188
PCV,≥4 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,82.0,73.1 to 89.3,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,93.0,88.3 to 96.3,431
Polio,≥3 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,89.9,83.0 to 94.9,188
Hib,≥3 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,85.0,77.0 to 91.3,188
Hib,Primary Series,States/Local Areas,South Carolina,2021,Age,24 Months,89.5,82.5 to 94.5,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.8,89.2 to 98.4,124
Hib,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,92.7,88.3 to 95.6,431
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2021,Age,0-2 Days,75.0,66.0 to 82.2,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,88.9,81.3 to 94.4,188
PCV,≥4 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,79.9,71.5 to 87.2,188
Hep A,≥1 Dose,States/Local Areas,South Carolina,2021,Age,24 Months,83.3,75.0 to 90.1,188
≥1 Dose Varicella,,States/Local Areas,South Carolina,2021,Age,24 Months,87.7,80.5 to 93.2,188
DTaP,≥3 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,90.9,83.3 to 95.2,188
Hep A,≥2 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,46.9,37.9 to 56.8,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,70.0,60.6 to 77.9,188
PCV,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,5 Months,81.6,75.8 to 86.2,431
Hib,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,58.4,52.1 to 64.5,431
PCV,≥3 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,71.7,62.4 to 79.4,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,92.6 to 97.7,508
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,89.1,81.7 to 96.5,80
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,88.6 to 95.7,374
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.9,79.4 to 88.3,508
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,71.8,58.4 to 85.1,80
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,85.8,81.0 to 90.5,374
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,67.2,61.9 to 72.5,508
Influenza,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,46.0,39.5 to 52.6,374
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,60.5,45.9 to 75.2,80
Influenza,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,46.7,40.8 to 52.6,508
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,76.0,70.1 to 82.0,374
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.2,86.7 to 93.7,508
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,76.4,63.1 to 89.7,80
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.3,76.7 to 85.9,508
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,86.3 to 93.9,374
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.2,71.3 to 81.2,508
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,62.8,48.2 to 77.4,80
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,90.3,86.4 to 94.2,374
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,81.3,75.6 to 87.0,374
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,68.0,52.5 to 83.4,80
Hib,≥3 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,46.0,37.1 to 55.2,188
Hib,Primary Series,States/Local Areas,South Carolina,2020-2021,Age,24 Months,89.8,85.1 to 93.6,431
Hib,≥2 Doses,States/Local Areas,South Carolina,2021,Age,5 Months,75.4,66.2 to 82.8,188
Hib,Primary Series,States/Local Areas,South Carolina,2021,Age,19 Months,89.4,81.6 to 94.1,188
Hib,≥3 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,84.9,76.2 to 90.8,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.0 to 97.0,610
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,89.0,81.9 to 96.1,138
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.4,81.5 to 93.2,508
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,85.1,81.0 to 89.2,507
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.0,89.4 to 98.5,124
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.5,93.1 to 97.9,610
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,89.1,82.0 to 96.2,138
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.6,76.4 to 84.9,610
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,91.3,87.8 to 94.8,415
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,88.4,84.4 to 92.5,415
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.5 to 98.5,507
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,72.6,67.0 to 78.2,415
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.8,84.2 to 91.4,610
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.7,89.0 to 98.3,124
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,77.8,72.4 to 83.1,415
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,91.6,88.1 to 95.0,415
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.9 to 98.0,507
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.5,91.6 to 99.4,124
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.9,91.3 to 96.5,610
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,88.1,80.4 to 95.8,138
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,86.5 to 98.1,90
Influenza,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",39.5,27.2 to 51.9,90
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,77.8,66.6 to 89.1,80
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,81.4,69.4 to 93.3,80
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.7,93.2 to 98.2,508
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,90.3 to 97.0,374
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,70.3,56.8 to 83.9,80
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.2,75.4 to 85.0,508
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,82.5,77.4 to 87.6,374
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.5,88.0 to 94.9,508
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.0,91.2 to 96.9,508
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,83.9,75.2 to 92.6,374
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,93.1,89.8 to 96.3,374
PCV,≥3 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,86.3,78.0 to 91.8,188
Hep A,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,35 Months,87.9,82.4 to 92.4,431
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2021,Age,0-1 Days,71.8,62.6 to 79.5,188
Hib,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,3 Months,90.3,86.4 to 93.2,488
Polio,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,3 Months,91.2,87.3 to 93.9,488
DTaP,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,3 Months,91.8,88.0 to 94.5,488
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,89.7,84.7 to 93.2,488
Hib,Primary Series,States/Local Areas,South Carolina,2019-2020,Age,7 Months,72.3,66.3 to 77.6,488
Polio,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,90.7,85.7 to 94.1,488
DTaP,≥4 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,72.6,66.8 to 77.7,488
Polio,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,92.7,88.2 to 96.0,488
DTaP,≥4 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,88.3,83.0 to 92.6,488
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,90.7,85.7 to 94.1,488
Combined 7 Series,,States/Local Areas,South Carolina,2019-2020,Age,24 Months,67.8,62.1 to 73.4,488
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,92.8,88.3 to 96.0,488
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019-2020,Age,13 Months,56.9,50.8 to 62.8,488
PCV,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,90.7,85.9 to 94.0,488
Hib,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,92.0,87.6 to 95.0,488
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,89.0,84.1 to 92.5,488
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,74.1,68.0 to 79.5,488
Polio,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,93.0,88.8 to 95.7,488
PCV,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,5 Months,81.8,76.4 to 86.2,488
Hep B,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,5 Months,92.0,87.6 to 95.0,488
Hep B,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,96.3,92.5 to 98.2,488
Hib,Primary Series,States/Local Areas,South Carolina,2019-2020,Age,13 Months,83.3,78.0 to 87.5,488
Hib,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,94.0,89.9 to 96.5,488
Hib,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,62.3,56.2 to 67.9,488
≥1 Dose MMR,,States/Local Areas,South Carolina,2019-2020,Age,13 Months,64.0,57.9 to 69.6,488
Polio,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,13 Months,94.9,91.1 to 97.1,488
Polio,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,5 Months,81.7,76.3 to 86.1,488
Hib,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,5 Months,80.8,75.4 to 85.2,488
DTaP,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,5 Months,82.2,76.8 to 86.6,488
PCV,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,3 Months,91.8,88.0 to 94.5,488
Hep B,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,3 Months,96.5,93.4 to 98.2,488
≥1 Dose MMR,,States/Local Areas,South Carolina,2019-2020,Age,24 Months,91.8,88.1 to 94.7,488
DTaP,≥4 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,79.2,73.8 to 84.2,488
Polio,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,92.3,87.9 to 95.6,488
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,92.3,87.9 to 95.6,488
PCV,≥4 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,87.4,82.0 to 91.9,488
PCV,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,93.5,89.2 to 96.5,488
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019-2020,Age,35 Months,92.0,88.0 to 95.1,488
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,94.2,89.8 to 97.1,488
Hib,Full Series,States/Local Areas,South Carolina,2019-2020,Age,35 Months,78.4,72.3 to 83.9,488
Hib,Primary Series,States/Local Areas,South Carolina,2019-2020,Age,35 Months,94.6,91.2 to 97.1,488
Hib,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,90.9,86.2 to 94.5,488
≥1 Dose MMR,,States/Local Areas,South Carolina,2019-2020,Age,35 Months,94.6,91.1 to 97.0,488
Hib,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,85.1,79.7 to 89.3,488
Hib,Primary Series,States/Local Areas,South Carolina,2019-2020,Age,19 Months,91.6,86.9 to 94.7,488
≥1 Dose MMR,,States/Local Areas,South Carolina,2019-2020,Age,19 Months,88.3,83.4 to 91.9,488
Hep A,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,34.0,28.6 to 39.9,488
PCV,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,93.5,89.2 to 96.5,488
PCV,≥4 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,83.6,78.4 to 88.1,488
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,92.2,87.9 to 95.4,488
Hib,Full Series,States/Local Areas,South Carolina,2019-2020,Age,24 Months,73.9,68.3 to 79.2,488
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019-2020,Age,24 Months,89.8,85.6 to 93.2,488
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2019-2020,Age,0-3 Days,82.7,77.5 to 87.0,488
PCV,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,73.2,67.1 to 78.5,488
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2019-2020,Age,0-2 Days,82.1,76.9 to 86.4,488
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2019-2020,Age,0-1 Days,80.0,74.5 to 84.6,488
PCV,≥4 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,81.3,75.7 to 85.9,488
Hep A,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,19 Months,84.6,79.4 to 88.6,488
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019-2020,Age,19 Months,86.6,81.5 to 90.5,488
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,90.8,85.9 to 94.1,488
Hib,Full Series,States/Local Areas,South Carolina,2019-2020,Age,19 Months,69.2,63.3 to 74.5,488
Hib,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,49.5,43.5 to 55.5,488
Combined 7 Series,,States/Local Areas,South Carolina,2019-2020,Age,35 Months,75.4,69.3 to 81.1,488
Hib,Primary Series,States/Local Areas,South Carolina,2019-2020,Age,24 Months,93.1,89.5 to 95.9,488
Influenza,,States/Local Areas,South Carolina,2019-2020,Age,24 Months,45.4,39.8 to 51.5,488
Hib,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,88.1,83.3 to 92.0,488
Hep A,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,35 Months,92.1,87.9 to 95.2,488
Hep A,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,35 Months,83.4,76.9 to 88.9,488
Hep A,≥1 Dose,States/Local Areas,South Carolina,2019-2020,Age,24 Months,89.0,84.6 to 92.6,488
Polio,≥2 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,94.6,88.9 to 97.4,243
Hep A,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,24 Months,50.1,44.1 to 56.3,488
Hep A,≥2 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,87.1,75.1 to 95.1,243
Combined 7 Series,,States/Local Areas,South Carolina,2020,Age,35 Months,77.2,66.8 to 86.2,243
Hep A,≥1 Dose,States/Local Areas,South Carolina,2020,Age,19 Months,79.6,71.2 to 86.0,243
Hep A,≥2 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,32.0,24.7 to 40.2,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2020,Age,0-1 Days,80.4,72.4 to 86.5,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2020,Age,0-2 Days,82.4,75.2 to 87.9,243
Hib,≥2 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,94.5,88.8 to 97.3,243
Polio,≥2 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,94.3,88.7 to 97.3,243
DTaP,≥1 Dose,States/Local Areas,South Carolina,2020,Age,3 Months,91.8,85.6 to 95.5,243
Hib,Primary Series,States/Local Areas,South Carolina,2020,Age,7 Months,72.4,63.4 to 79.8,243
Hib,≥3 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,47.0,38.7 to 55.4,243
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,90.5,83.4 to 95.4,243
Hep B,≥2 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,94.6,89.3 to 97.3,243
DTaP,≥4 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,75.1,66.8 to 82.7,243
Polio,≥3 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,90.5,83.4 to 95.4,243
Hib,≥3 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,87.3,80.0 to 92.9,243
≥1 Dose MMR,,States/Local Areas,South Carolina,2020,Age,24 Months,90.0,83.4 to 94.7,243
≥1 Dose MMR,,States/Local Areas,South Carolina,2020,Age,35 Months,93.6,87.0 to 97.6,243
Hib,Primary Series,States/Local Areas,South Carolina,2020,Age,24 Months,90.1,83.4 to 94.9,243
Hib,Primary Series,States/Local Areas,South Carolina,2020,Age,35 Months,92.7,86.1 to 96.9,243
Hib,≥3 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,90.7,83.5 to 95.6,243
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,94.5,87.1 to 98.3,243
Hib,Full Series,States/Local Areas,South Carolina,2020,Age,35 Months,78.8,68.5 to 87.6,243
Hib,Primary Series,States/Local Areas,South Carolina,2020,Age,19 Months,88.5,80.5 to 93.4,243
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020,Age,35 Months,90.7,83.7 to 95.6,243
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,88.2,80.6 to 93.1,243
Hib,Full Series,States/Local Areas,South Carolina,2020,Age,19 Months,66.5,57.8 to 74.2,243
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020,Age,19 Months,83.6,75.3 to 89.5,243
PCV,≥3 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,88.8,80.6 to 93.8,243
Polio,≥3 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,91.3,84.1 to 96.1,243
DTaP,≥4 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,86.7,78.1 to 93.2,243
PCV,≥4 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,77.4,68.5 to 84.3,243
PCV,≥3 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,90.9,83.8 to 95.7,243
PCV,≥4 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,88.1,77.6 to 95.1,243
Hib,≥3 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,59.5,50.8 to 67.6,243
Hib,Primary Series,States/Local Areas,South Carolina,2020,Age,13 Months,82.1,74.0 to 88.0,243
Hep B,≥2 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,96.2,90.8 to 98.5,243
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,85.9,78.4 to 91.1,243
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020,Age,13 Months,50.9,42.5 to 59.4,243
PCV,≥3 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,88.4,80.2 to 93.4,243
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,73.0,63.9 to 80.6,243
PCV,≥2 Doses,States/Local Areas,South Carolina,2020,Age,5 Months,83.1,75.3 to 88.8,243
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,88.2,80.0 to 93.3,243
DTaP,≥4 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,68.2,59.5 to 75.8,243
Polio,≥3 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,88.2,80.0 to 93.3,243
≥1 Dose MMR,,States/Local Areas,South Carolina,2020,Age,19 Months,84.9,76.8 to 90.5,243
Hib,≥3 Doses,States/Local Areas,South Carolina,2020,Age,19 Months,83.1,74.7 to 89.1,243
Rotavirus,,States/Local Areas,South Carolina,2020,Age,8 Months,78.4,69.6 to 85.2,243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2020,Age,0-3 Days,83.5,76.3 to 88.9,243
Influenza,,States/Local Areas,South Carolina,2020,Age,24 Months,40.6,33.2 to 48.9,243
PCV,≥3 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,90.9,83.8 to 95.7,243
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020,Age,35 Months,91.3,84.1 to 96.1,243
Hep A,≥1 Dose,States/Local Areas,South Carolina,2020,Age,24 Months,85.4,78.3 to 91.1,243
PCV,≥4 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,80.9,72.9 to 87.7,243
Hep A,≥2 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,49.7,41.4 to 58.5,243
PCV,≥1 Dose,States/Local Areas,South Carolina,2020,Age,3 Months,90.9,84.8 to 94.8,243
Hep B,≥1 Dose,States/Local Areas,South Carolina,2020,Age,3 Months,96.5,91.1 to 98.6,243
Combined 7 Series,,States/Local Areas,South Carolina,2020,Age,24 Months,65.3,57.0 to 73.6,243
DTaP,≥2 Doses,States/Local Areas,South Carolina,2020,Age,5 Months,83.0,75.1 to 88.8,243
Polio,≥2 Doses,States/Local Areas,South Carolina,2020,Age,5 Months,82.1,74.2 to 87.9,243
Hep B,≥2 Doses,States/Local Areas,South Carolina,2020,Age,5 Months,93.5,88.1 to 96.5,243
Hib,≥2 Doses,States/Local Areas,South Carolina,2020,Age,5 Months,81.8,74.0 to 87.6,243
Rotavirus,,States/Local Areas,South Carolina,2019-2020,Age,8 Months,80.0,74.2 to 84.7,488
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020-2021,Age,35 Months,89.8,84.8 to 93.7,431
Hib,≥1 Dose,States/Local Areas,South Carolina,2020,Age,3 Months,90.1,83.9 to 94.0,243
Polio,≥1 Dose,States/Local Areas,South Carolina,2020,Age,3 Months,90.9,84.7 to 94.7,243
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,54.9,46.3 to 63.3,243
PCV,≥3 Doses,States/Local Areas,South Carolina,2020,Age,7 Months,73.1,64.0 to 80.6,243
Hep A,≥1 Dose,States/Local Areas,South Carolina,2012,Age,19 Months,73.0,67.2 to 78.1,255
PCV,≥2 Doses,States/Local Areas,South Carolina,2021,Age,5 Months,80.1,71.0 to 86.9,188
Combined 7 Series,,States/Local Areas,South Carolina,2021,Age,35 Months,66.9,57.3 to 76.2,188
Hep A,≥1 Dose,States/Local Areas,South Carolina,2013,Age,19 Months,81.1,78.3 to 83.6,261
Hep A,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,19 Months,82.4,78.6 to 85.6,512
Hep A,≥1 Dose,States/Local Areas,South Carolina,2015,Age,19 Months,82.1,79.0 to 84.9,273
Hep A,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,19 Months,83.6,78.9 to 87.3,564
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014,Age,19 Months,83.6,76.9 to 88.6,251
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,19 Months,82.9,78.2 to 86.7,524
DTaP,≥4 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,86.6,80.3 to 91.7,431
Hep B,≥3 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,91.5,83.7 to 95.8,188
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,95.2,92.3 to 98.1,247
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,94.1,91.4 to 96.8,423
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,92.8,89.4 to 96.3,327
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,93.8,91.9 to 95.6,997
Hib,Primary Series,States/Local Areas,South Carolina,2021,Age,7 Months,67.2,57.6 to 75.5,188
PCV,≥4 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,75.9,66.8 to 83.1,188
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,94.0,89.2 to 97.2,261
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,95.5,92.9 to 97.4,512
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,87.3,79.1 to 92.5,243
Hep A,≥1 Dose,States/Local Areas,South Carolina,2011,Age,19 Months,78.3,71.5 to 83.8,252
DTaP,≥1 Dose,States/Local Areas,South Carolina,2019,Age,3 Months,91.6,86.0 to 95.0,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,97.2,94.9 to 98.6,251
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,96.1,93.9 to 97.7,524
DTaP,≥1 Dose,States/Local Areas,South Carolina,2017,Age,3 Months,87.4,81.3 to 91.8,288
DTaP,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,3 Months,88.5,84.3 to 91.7,532
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,95.2,91.1 to 97.8,273
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,94.7,91.8 to 96.9,564
DTaP,≥1 Dose,States/Local Areas,South Carolina,2018,Age,3 Months,89.7,83.2 to 93.8,244
DTaP,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,3 Months,90.6,86.6 to 93.5,489
Hib,Full Series,States/Local Areas,South Carolina,2021,Age,19 Months,63.4,54.0 to 71.9,188
Hib,≥1 Dose,States/Local Areas,South Carolina,2021,Age,3 Months,82.8,73.8 to 89.2,188
DTaP,≥1 Dose,States/Local Areas,South Carolina,2016,Age,3 Months,92.6,87.1 to 95.8,291
DTaP,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,3 Months,90.0,86.1 to 92.9,579
DTaP,≥1 Dose,States/Local Areas,South Carolina,2015,Age,3 Months,85.7,77.6 to 91.2,273
DTaP,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,3 Months,89.1,84.4 to 92.5,564
DTaP,≥1 Dose,States/Local Areas,South Carolina,2014,Age,3 Months,92.0,87.3 to 95.0,251
DTaP,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,3 Months,88.8,84.3 to 92.2,524
DTaP,≥1 Dose,States/Local Areas,South Carolina,2013,Age,3 Months,87.5,83.3 to 90.8,261
DTaP,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,3 Months,89.8,86.3 to 92.5,512
DTaP,≥1 Dose,States/Local Areas,South Carolina,2011,Age,3 Months,87.1,84.9 to 89.0,252
DTaP,≥1 Dose,States/Local Areas,South Carolina,2012,Age,3 Months,86.3,78.9 to 91.3,255
DTaP,≥2 Doses,States/Local Areas,South Carolina,2019,Age,5 Months,80.5,72.8 to 86.4,245
Hep A,≥2 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,26.9,21.4 to 33.2,255
Hep A,≥2 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,20.3,15.7 to 25.8,261
Hep A,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,22.4,19.9 to 25.2,512
Hib,≥3 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,91.5,86.3 to 95.3,244
Hib,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,89.9,86.0 to 93.2,489
Hib,≥3 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,85.6,79.5 to 90.7,288
Hib,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,88.5,84.6 to 91.8,532
Hib,≥3 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,88.3,82.1 to 93.1,245
Hib,≥3 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,93.9,90.1 to 96.6,251
Hib,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,91.5,87.2 to 94.7,524
Hib,≥3 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,90.4,84.4 to 94.7,261
Hib,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,92.0,88.6 to 94.7,512
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,28.6,22.0 to 36.1,291
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,24.8,20.5 to 29.7,579
Hep A,≥2 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,25.4,20.1 to 31.5,273
Hep A,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,26.9,22.4 to 32.0,564
Hib,≥3 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,89.5,82.1 to 94.8,273
Hib,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,92.2,87.6 to 95.5,564
Hep A,≥1 Dose,States/Local Areas,South Carolina,2018,Age,19 Months,88.1,81.5 to 92.5,244
Hep A,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,19 Months,87.7,82.8 to 91.4,382
DTaP,≥3 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,95.9,90.2 to 98.8,252
DTaP,≥3 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,93.0,84.9 to 97.6,255
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,94.2,89.3 to 97.3,261
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,95.8,93.2 to 97.6,512
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,97.5,95.4 to 98.9,251
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,97.6,96.0 to 98.7,524
Hep A,≥2 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,24.0,15.8 to 34.6,252
PCV,≥2 Doses,States/Local Areas,South Carolina,2014,Age,5 Months,76.2,68.5 to 82.5,251
PCV,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,5 Months,74.8,68.9 to 80.0,524
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016,Age,24 Months,87.2,81.3 to 92.0,291
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,24 Months,87.0,83.1 to 90.4,579
Hep A,≥1 Dose,States/Local Areas,South Carolina,2015,Age,24 Months,88.1,82.9 to 92.4,273
Hep A,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,24 Months,87.7,83.8 to 91.0,564
Hep A,≥1 Dose,States/Local Areas,South Carolina,2018,Age,24 Months,90.3,84.5 to 94.7,244
Hep A,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,24 Months,91.2,87.6 to 94.1,489
Hep A,≥1 Dose,States/Local Areas,South Carolina,2011,Age,35 Months,85.4,77.6 to 91.5,252
Hep A,≥1 Dose,States/Local Areas,South Carolina,2019,Age,24 Months,92.0,87.3 to 95.4,245
Hib,≥2 Doses,States/Local Areas,South Carolina,2020,Age,13 Months,94.5,88.9 to 97.3,243
Hep A,≥1 Dose,States/Local Areas,South Carolina,2017,Age,24 Months,86.9,81.3 to 91.4,288
Hep A,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,24 Months,88.6,84.7 to 91.9,532
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,88.9,78.1 to 99.7,47
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,93.6,90.7 to 96.5,440
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,96.9,95.4 to 98.5,501
Hep A,≥2 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,21.0,15.7 to 27.5,288
Hep A,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,23.1,18.9 to 27.8,532
DTaP,≥4 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,64.5,56.8 to 71.4,273
DTaP,≥4 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,67.8,62.3 to 72.8,564
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,64.0,55.6 to 71.5,251
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,64.2,58.5 to 69.6,524
DTaP,≥4 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,64.9,58.9 to 70.5,261
DTaP,≥4 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,64.4,58.6 to 69.9,512
Hib,≥3 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,88.2,82.2 to 92.8,288
Hib,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,91.0,87.1 to 94.1,532
Hib,≥3 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,94.7,88.0 to 98.2,291
Hib,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,91.5,87.3 to 94.7,579
Hep A,≥2 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,25.1,19.0 to 32.4,244
Hep A,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,34.2,27.5 to 41.6,382
Hep A,≥2 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,38.2,30.0 to 47.7,252
Hep A,≥2 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,36.2,28.6 to 44.5,245
Hib,≥3 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,92.7,88.8 to 95.6,251
Hib,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,88.9,84.6 to 92.5,524
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014,Age,24 Months,85.2,79.0 to 90.4,251
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,24 Months,86.7,82.7 to 90.1,524
PCV,≥2 Doses,States/Local Areas,South Carolina,2016,Age,5 Months,78.0,70.4 to 84.1,291
PCV,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,5 Months,76.2,71.0 to 80.7,579
PCV,≥2 Doses,States/Local Areas,South Carolina,2015,Age,5 Months,73.5,65.5 to 80.2,273
PCV,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,5 Months,75.7,70.4 to 80.4,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,97.0,92.1 to 99.2,244
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,95.2,91.9 to 97.5,489
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,93.7,88.3 to 97.1,245
Hib,≥3 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,92.6,87.7 to 96.0,291
Hib,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,88.9,85.1 to 92.2,579
Hib,≥3 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,85.1,77.5 to 91.2,273
Hib,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,88.7,84.2 to 92.5,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,93.6,88.3 to 97.0,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,94.4,89.7 to 97.4,291
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,93.5,90.5 to 95.8,579
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,92.7,88.4 to 95.8,288
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,93.6,90.7 to 95.8,532
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,94.4,90.1 to 97.3,244
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,94.0,90.7 to 96.4,489
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,90.1 to 95.9,508
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,93.7,88.3 to 99.1,94
DTaP,≥2 Doses,States/Local Areas,South Carolina,2016,Age,5 Months,80.4,72.8 to 86.3,291
DTaP,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,5 Months,79.0,73.9 to 83.3,579
DTaP,≥2 Doses,States/Local Areas,South Carolina,2018,Age,5 Months,79.6,71.5 to 85.8,244
DTaP,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,5 Months,80.0,74.7 to 84.5,489
DTaP,≥2 Doses,States/Local Areas,South Carolina,2017,Age,5 Months,77.5,70.3 to 83.4,288
DTaP,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,5 Months,78.5,73.1 to 83.1,532
Hep B,≥2 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,89.6,81.0 to 94.5,188
Hib,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,86.3,81.0 to 90.8,431
Polio,≥2 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,87.7,79.2 to 93.0,188
Hep B,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,94.0,89.5 to 96.6,431
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,89.6,84.4 to 93.1,431
DTaP,≥3 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,71.9,62.5 to 79.7,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,88.4,83.3 to 92.0,431
PCV,≥4 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,80.3,74.6 to 85.4,431
Hib,≥2 Doses,States/Local Areas,South Carolina,2021,Age,7 Months,86.6,78.2 to 92.1,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,88.9,81.3 to 94.4,188
≥1 Dose MMR,,States/Local Areas,South Carolina,2021,Age,35 Months,88.9,80.8 to 94.6,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,91.9,88.7 to 95.1,415
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.0,89.4 to 98.5,124
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.4,91.9 to 96.9,610
Influenza,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",38.9,28.7 to 49.1,124
Influenza,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",49.4,44.2 to 54.5,610
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.8,76.5 to 91.1,124
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.9,82.2 to 89.6,610
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,80.5,70.7 to 90.2,138
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,76.0,67.1 to 84.8,138
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.7,64.9 to 74.5,610
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.5,58.1 to 76.9,124
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,65.1,54.5 to 75.8,138
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.9,68.2 to 85.5,124
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,72.5,67.0 to 78.0,415
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.2,74.8 to 83.6,610
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,81.5,73.9 to 89.1,138
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,88.9,81.7 to 96.0,138
Influenza,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,39.4,33.3 to 45.5,415
Influenza,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,54.0,48.1 to 59.9,507
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.4,63.9 to 86.9,90
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,88.0,84.5 to 91.5,507
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.6,59.5 to 83.8,90
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.5 to 99.2,507
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,75.9 to 96.1,90
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,88.6,81.0 to 96.3,138
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,94.0,91.5 to 96.6,507
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.6,86.2 to 97.0,124
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,77.9,72.9 to 82.9,415
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,76.2,70.7 to 81.7,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.6,57.8 to 77.3,124
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,68.0 to 88.1,90
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.4,68.6 to 86.2,124
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.9,77.9 to 85.9,610
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,74.5,69.5 to 79.6,507
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.6,87.4 to 93.8,610
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.6,86.2 to 92.9,610
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.3,88.8 to 97.9,124
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,86.5 to 98.1,90
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.9,48.0 to 73.8,90
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,87.9 to 97.7,90
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,63.4,57.5 to 69.3,415
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,91.3,87.8 to 94.8,415
Influenza,,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,60.9,53.0 to 68.8,262
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,83.6,80.4 to 86.9,962
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,76.8,70.3 to 83.4,265
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,92.5,88.2 to 96.7,262
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,70.2,63.0 to 77.4,265
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,80.0,75.1 to 84.9,435
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,81.5,74.4 to 88.6,262
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,90.3,86.3 to 94.4,265
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,92.7,89.2 to 96.2,435
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,81.1,74.3 to 88.0,262
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,94.7,91.9 to 97.5,435
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,86.2,81.1 to 91.4,265
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,85.5,80.4 to 90.7,265
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,92.0,88.6 to 95.4,435
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,93.6,89.4 to 97.8,262
Influenza,,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,36.5,29.0 to 44.0,265
Influenza,,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,43.9,37.6 to 50.1,435
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,93.4,91.4 to 95.5,962
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,94.0,92.0 to 96.0,962
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,90.6,86.5 to 94.7,265
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,91.5,86.7 to 96.3,262
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,82.9,73.6 to 92.1,265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,77.0,71.7 to 82.3,435
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,74.5,66.5 to 82.5,262
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,85.7,81.1 to 90.2,435
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,90.7,85.7 to 95.8,262
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,90.7,87.0 to 94.5,374
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,73.2,66.4 to 80.0,265
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,79.9,74.9 to 85.0,435
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,87.9 to 94.6,508
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,91.2,84.4 to 98.0,80
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,84.8,75.3 to 94.2,80
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,92.5 to 97.6,508
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,89.6 to 96.4,374
Influenza,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,30.3,15.3 to 45.3,80
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,70.4,63.9 to 76.8,374
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,84.8,75.3 to 94.2,80
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.2,73.2 to 83.2,508
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a MSA Principal City,74.4,68.4 to 80.4,374
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,81.4,69.4 to 93.3,80
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,95.3,91.4 to 99.1,262
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Urbanicity,Living In a Non-MSA,74.9,63.1 to 86.7,80
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Overall,Overall,76.9,73.2 to 80.5,962
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,94.2,91.2 to 97.2,435
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,63.6,56.1 to 71.1,265
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,95.6,92.0 to 99.2,262
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,95.3,92.6 to 98.1,435
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,68.8,60.8 to 76.8,262
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Overall,Overall,78.9,75.5 to 82.4,962
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,70.6,65.0 to 76.1,435
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,96.3,92.7 to 100.0,262
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Overall,Overall,90.1,87.6 to 92.7,962
Combined 7 Series,,States/Local Areas,South Carolina,2016-2019,Overall,Overall,67.7,63.8 to 71.7,962
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,84.6,79.7 to 89.4,962
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,77.0,70.6 to 83.4,265
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,91.2,87.3 to 95.1,265
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Overall,Overall,89.0,86.3 to 91.6,962
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Overall,Overall,76.5,72.8 to 80.1,962
Influenza,,States/Local Areas,South Carolina,2016-2019,Overall,Overall,45.1,40.8 to 49.3,962
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,90.2,86.2 to 94.2,265
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,93.5,90.3 to 96.7,435
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,84.3,76.8 to 91.8,435
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,88.3,81.5 to 95.1,262
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,86.3,81.1 to 91.5,265
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,89.3,85.3 to 93.2,435
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Overall,Overall,90.2,87.6 to 92.7,962
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,<133% FPL,80.4,74.1 to 86.7,265
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,93.5,91.4 to 95.5,962
Rotavirus,,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,85.9,80.1 to 91.8,262
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,93.4,91.3 to 95.5,962
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Overall,Overall,80.2,76.8 to 83.7,962
Influenza,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,44.5,33.1 to 55.9,138
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.8 to 98.6,90
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,87.4,83.1 to 91.7,415
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,94.9,92.6 to 97.2,507
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.9,63.8 to 88.0,90
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,76.4,65.9 to 86.9,138
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.0,75.5 to 90.6,124
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,77.1 to 96.3,90
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,82.6,75.6 to 89.7,415
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,86.4,81.6 to 91.2,507
Hib,Primary Series,States/Local Areas,Louisiana,2013,Age,24 Months,91.6,86.9 to 95.2,238
Hib,Primary Series,States/Local Areas,Louisiana,2013-2014,Age,24 Months,92.9,89.9 to 95.3,499
Hib,Primary Series,States/Local Areas,Louisiana,2011,Age,24 Months,90.6,84.9 to 94.8,257
Hib,Primary Series,States/Local Areas,Louisiana,2012,Age,24 Months,93.6,88.9 to 96.8,249
Hib,Primary Series,States/Local Areas,Louisiana,2018,Age,19 Months,89.3,84.1 to 93.0,401
Hib,Primary Series,States/Local Areas,Louisiana,2018-2019,Age,19 Months,85.8,81.7 to 89.2,812
Hep A,≥1 Dose,States/Local Areas,Louisiana,2018,Age,19 Months,77.1,70.2 to 82.9,401
Hep A,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,19 Months,77.9,72.0 to 82.8,633
Hep A,≥1 Dose,States/Local Areas,Louisiana,2017,Age,19 Months,83.0,76.4 to 88.0,399
Hep A,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,19 Months,80.1,75.3 to 84.2,800
Hib,≥3 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,92.0,86.6 to 95.8,411
Hib,≥3 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,87.3,81.7 to 91.9,401
Hib,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,89.6,85.9 to 92.7,812
Hep A,≥2 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,18.8,17.7 to 19.8,249
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,14.5,10.2 to 20.3,261
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,18.1,14.2 to 22.8,535
Hep A,≥2 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,20.8,15.3 to 27.8,238
Hep A,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,17.7,12.9 to 23.8,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,19.2,15.5 to 23.5,257
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,93.2,87.7 to 96.8,261
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,95.5,92.6 to 97.6,535
DTaP,≥3 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,92.6,86.9 to 96.5,257
DTaP,≥3 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,98.7,94.8 to 99.8,249
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,94.3,88.4 to 97.8,238
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,94.3,90.1 to 97.2,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,39.7,32.3 to 48.2,257
Hep A,≥2 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,24.3,18.7 to 31.0,411
Hep A,≥2 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,19.4,14.5 to 25.5,401
Hep A,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,20.0,15.4 to 25.5,633
Hib,≥3 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,90.8,85.4 to 94.8,399
Hib,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,91.0,87.4 to 94.0,800
Hib,≥3 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,88.8,81.1 to 94.4,266
Hib,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,89.9,85.3 to 93.6,665
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,96.3,93.8 to 98.7,447
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,92.4,89.2 to 95.5,535
DTaP,≥4 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,66.8,63.6 to 69.8,274
DTaP,≥4 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,65.2,59.2 to 70.8,540
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,63.5,55.5 to 70.8,261
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,65.1,59.4 to 70.5,535
DTaP,≥4 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,68.2,53.5 to 80.0,238
DTaP,≥4 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,65.8,53.5 to 76.4,499
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.5,89.3 to 97.8,162
Hep A,≥2 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,41.0,33.1 to 50.1,249
Hib,≥3 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,90.9,85.5 to 95.0,401
Hib,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,93.4,89.9 to 96.0,812
DTaP,≥4 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,67.2,61.8 to 72.2,257
DTaP,≥4 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,69.6,66.3 to 72.8,249
Hib,Primary Series,States/Local Areas,Louisiana,2019,Age,19 Months,90.5,84.6 to 94.3,411
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016,Age,19 Months,81.6,73.8 to 87.4,266
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,19 Months,82.3,77.3 to 86.3,665
Hib,≥3 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,91.6,85.7 to 95.7,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,96.5,88.9 to 99.4,249
Hep A,≥2 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,24.9,19.0 to 31.9,399
Hep A,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,22.2,18.2 to 26.8,800
Hib,≥3 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,96.8,94.2 to 98.4,274
Hib,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,93.0,88.9 to 96.1,540
Hib,≥3 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,91.4,85.6 to 95.5,261
Hib,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,94.2,91.2 to 96.5,535
Hib,≥3 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,90.1,84.3 to 94.4,238
Hib,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,91.0,86.6 to 94.4,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,23.4,16.7 to 31.8,266
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,24.1,19.5 to 29.5,665
Hep A,≥2 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,21.7,17.6 to 26.4,274
Hep A,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,22.5,17.9 to 28.0,540
DTaP,≥2 Doses,States/Local Areas,Louisiana,2017,Age,5 Months,72.1,64.5 to 78.6,399
DTaP,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,5 Months,72.6,67.3 to 77.3,800
DTaP,≥2 Doses,States/Local Areas,Louisiana,2018,Age,5 Months,73.1,65.8 to 79.3,401
DTaP,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,5 Months,72.9,67.8 to 77.6,812
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,89.6,81.4 to 97.8,152
DTaP,≥2 Doses,States/Local Areas,Louisiana,2019,Age,5 Months,72.8,65.3 to 79.3,411
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,92.0,89.6 to 94.4,1012
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,90.9,87.3 to 94.5,410
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,94.4,90.5 to 98.2,346
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,91.4,85.3 to 97.6,256
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,91.4,86.6 to 95.1,401
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,92.9,89.7 to 95.4,812
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,89.9,84.2 to 94.2,399
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,90.6,86.7 to 93.8,800
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,93.2,87.4 to 96.9,399
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,94.6,91.1 to 97.0,800
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,91.8,85.0 to 96.3,266
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,92.5,88.1 to 95.7,665
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,97.4,94.8 to 98.9,274
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,94.8,91.1 to 97.3,540
PCV,≥2 Doses,States/Local Areas,Louisiana,2011,Age,5 Months,67.1,62.0 to 71.8,257
PCV,≥2 Doses,States/Local Areas,Louisiana,2012,Age,5 Months,70.4,63.0 to 76.8,249
PCV,≥2 Doses,States/Local Areas,Louisiana,2013,Age,5 Months,69.0,63.9 to 73.6,238
PCV,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,5 Months,67.9,62.6 to 72.8,499
Hib,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,77.7,72.6 to 82.1,697
Hep A,≥1 Dose,States/Local Areas,Louisiana,2012,Age,24 Months,81.8,75.0 to 87.6,249
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014,Age,24 Months,80.6,73.8 to 86.5,261
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,24 Months,83.1,78.7 to 87.0,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2013,Age,24 Months,83.7,77.8 to 88.8,238
Hep A,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,24 Months,82.2,77.8 to 86.2,499
Hep A,≥1 Dose,States/Local Areas,Louisiana,2011,Age,24 Months,82.1,75.5 to 87.8,257
Hep A,≥1 Dose,States/Local Areas,Louisiana,2019,Age,19 Months,78.9,71.8 to 84.6,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,96.9,92.9 to 99.0,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,95.8,91.1 to 98.4,401
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,96.1,93.1 to 98.0,812
PCV,≥2 Doses,States/Local Areas,Louisiana,2016,Age,5 Months,73.0,64.2 to 80.3,266
PCV,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,5 Months,71.5,65.8 to 76.5,665
PCV,≥2 Doses,States/Local Areas,Louisiana,2015,Age,5 Months,70.0,62.1 to 76.8,274
PCV,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,5 Months,71.5,65.7 to 76.6,540
PCV,≥2 Doses,States/Local Areas,Louisiana,2014,Age,5 Months,66.8,58.5 to 74.2,261
PCV,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,5 Months,68.4,62.9 to 73.4,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016,Age,24 Months,85.6,79.2 to 90.9,266
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,24 Months,86.7,82.5 to 90.3,665
Hep A,≥1 Dose,States/Local Areas,Louisiana,2015,Age,24 Months,85.6,79.5 to 90.6,274
Hep A,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,24 Months,85.6,81.2 to 89.4,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,89.2,85.3 to 92.1,697
Hib,Primary Series,States/Local Areas,Louisiana,2021,Age,19 Months,92.3,85.5 to 96.1,264
Hib,Full Series,States/Local Areas,Louisiana,2021,Age,19 Months,70.5,61.6 to 78.1,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,91.7,85.1 to 96.2,264
Hep A,≥1 Dose,States/Local Areas,Louisiana,2015,Age,19 Months,79.2,74.4 to 83.3,274
Hep A,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,19 Months,80.4,75.2 to 84.7,540
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014,Age,19 Months,72.2,64.3 to 78.9,261
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,19 Months,75.7,70.3 to 80.4,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2012,Age,35 Months,83.7,77.1 to 89.4,249
Hep A,≥1 Dose,States/Local Areas,Louisiana,2012,Age,19 Months,79.9,69.8 to 87.2,249
DTaP,≥1 Dose,States/Local Areas,Louisiana,2011,Age,3 Months,83.0,79.8 to 85.8,257
DTaP,≥1 Dose,States/Local Areas,Louisiana,2012,Age,3 Months,84.9,77.2 to 90.4,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.3,69.3 to 79.4,750
Hib,≥1 Dose,States/Local Areas,Louisiana,2021,Age,3 Months,85.6,77.6 to 91.0,264
Hep B,≥3 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,94.8,90.2 to 97.3,264
Hib,≥2 Doses,States/Local Areas,Louisiana,2021,Age,5 Months,77.0,68.3 to 83.9,264
PCV,≥4 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,79.0,73.9 to 83.8,697
DTaP,≥4 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,86.3,81.2 to 90.5,697
Hib,≥3 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,89.6,83.9 to 93.9,399
Hib,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,88.5,84.3 to 91.9,800
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,94.4,89.8 to 97.4,411
Hib,≥3 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,88.8,81.1 to 94.4,266
Hib,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,89.3,84.6 to 93.0,665
Hib,≥3 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,94.2,90.1 to 97.0,274
Hib,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,91.5,87.2 to 94.8,540
PCV,≥2 Doses,States/Local Areas,Louisiana,2017,Age,5 Months,69.9,62.3 to 76.4,399
PCV,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,5 Months,69.9,64.6 to 74.7,800
Hep A,≥1 Dose,States/Local Areas,Louisiana,2011,Age,35 Months,87.0,80.6 to 92.1,257
Hep A,≥1 Dose,States/Local Areas,Louisiana,2019,Age,24 Months,86.2,80.2 to 91.2,411
Hep A,≥1 Dose,States/Local Areas,Louisiana,2018,Age,24 Months,81.2,74.8 to 86.8,401
Hep A,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,24 Months,83.7,79.3 to 87.5,812
Hep A,≥1 Dose,States/Local Areas,Louisiana,2017,Age,24 Months,87.8,82.1 to 92.4,399
Hep A,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,24 Months,84.6,80.1 to 88.5,800
Hep A,≥1 Dose,States/Local Areas,Louisiana,2013,Age,19 Months,81.5,75.5 to 86.3,238
Hep A,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,19 Months,76.9,69.2 to 83.1,499
Hep A,≥1 Dose,States/Local Areas,Louisiana,2011,Age,19 Months,77.5,75.4 to 79.4,257
DTaP,≥1 Dose,States/Local Areas,Louisiana,2019,Age,3 Months,81.1,74.1 to 86.6,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,91.8,85.0 to 96.3,266
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,91.0,86.7 to 94.3,665
DTaP,≥1 Dose,States/Local Areas,Louisiana,2018,Age,3 Months,83.6,77.2 to 88.5,401
DTaP,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,3 Months,82.4,77.8 to 86.2,812
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,96.7,93.8 to 98.4,274
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,94.2,90.5 to 96.8,540
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,91.9,86.6 to 95.7,261
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,94.4,91.5 to 96.6,535
DTaP,≥1 Dose,States/Local Areas,Louisiana,2017,Age,3 Months,85.3,78.7 to 90.1,399
DTaP,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,3 Months,84.5,80.1 to 88.0,800
DTaP,≥1 Dose,States/Local Areas,Louisiana,2016,Age,3 Months,83.9,75.6 to 89.7,266
DTaP,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,3 Months,84.6,79.5 to 88.6,665
DTaP,≥1 Dose,States/Local Areas,Louisiana,2015,Age,3 Months,85.1,78.4 to 90.1,274
DTaP,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,3 Months,84.5,79.4 to 88.5,540
DTaP,≥1 Dose,States/Local Areas,Louisiana,2014,Age,3 Months,81.4,73.5 to 87.4,261
DTaP,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,3 Months,83.3,78.3 to 87.3,535
DTaP,≥1 Dose,States/Local Areas,Louisiana,2013,Age,3 Months,85.4,78.1 to 90.5,238
DTaP,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,3 Months,83.4,77.5 to 88.0,499
Hib,≥2 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,88.9,81.5 to 93.6,264
Hib,≥3 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,62.9,53.9 to 71.1,264
Hib,Primary Series,States/Local Areas,Louisiana,2020-2021,Age,24 Months,92.4,88.8 to 95.2,697
Hib,≥3 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,91.8,85.1 to 95.6,264
≥1 Dose MMR,,States/Local Areas,Louisiana,2021,Age,35 Months,95.6,90.8 to 98.3,264
Polio,≥2 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,88.6,81.3 to 93.3,264
Hep B,≥2 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,92.0,86.0 to 95.6,264
DTaP,≥3 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,74.7,66.0 to 81.8,264
Hep B,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,94.1,90.9 to 96.3,697
PCV,≥2 Doses,States/Local Areas,Louisiana,2021,Age,5 Months,75.7,66.6 to 82.9,264
Hib,Primary Series,States/Local Areas,Louisiana,2021,Age,7 Months,73.1,64.3 to 80.4,264
Combined 7 Series,,States/Local Areas,Louisiana,2021,Age,35 Months,74.9,65.5 to 83.4,264
Hep A,≥2 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,88.7,69.1 to 98.3,264
Hib,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,91.2,87.5 to 94.2,697
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,92.9,89.1 to 95.4,697
Hep A,≥1 Dose,States/Local Areas,Louisiana,2021,Age,35 Months,95.0,91.0 to 97.6,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,91.4,84.1 to 95.5,264
Polio,≥3 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,94.0,88.5 to 97.4,264
≥1 Dose MMR,,States/Local Areas,Louisiana,2020-2021,Age,24 Months,90.7,87.1 to 93.7,697
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,94.3,91.7 to 96.3,697
≥1 Dose Varicella,,States/Local Areas,Louisiana,2021,Age,19 Months,88.4,81.3 to 93.0,264
DTaP,≥4 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,71.3,62.5 to 78.8,264
Hib,Full Series,States/Local Areas,Louisiana,2021,Age,24 Months,81.9,73.9 to 88.7,264
Polio,≥3 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,94.0,88.5 to 97.4,264
DTaP,≥4 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,85.1,77.3 to 91.3,264
Polio,≥1 Dose,States/Local Areas,Louisiana,2021,Age,3 Months,85.6,77.6 to 91.0,264
Hib,≥3 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,91.9,85.9 to 96.0,264
Hib,Primary Series,States/Local Areas,Louisiana,2021,Age,24 Months,92.3,86.3 to 96.3,264
≥1 Dose MMR,,States/Local Areas,Louisiana,2021,Age,24 Months,94.8,90.3 to 97.6,264
DTaP,≥1 Dose,States/Local Areas,Louisiana,2021,Age,3 Months,87.3,79.3 to 92.5,264
Hep A,≥2 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,24.7,18.0 to 32.9,264
Hep A,≥1 Dose,States/Local Areas,Louisiana,2021,Age,19 Months,80.8,72.4 to 87.1,264
PCV,≥4 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,77.8,68.9 to 84.7,264
Hep B,≥3 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,96.6,94.0 to 98.2,264
PCV,≥4 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,85.0,76.7 to 91.6,264
DTaP,≥3 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,91.3,84.5 to 95.3,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,69.2,60.1 to 77.0,264
Hep A,≥2 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,46.7,37.3 to 57.0,264
Hep B,≥3 Doses,States/Local Areas,Louisiana,2021,Age,7 Months,71.7,63.0 to 79.0,264
PCV,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,5 Months,75.9,70.4 to 80.7,697
DTaP,≥3 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,93.5,86.7 to 96.9,264
Hep A,≥1 Dose,States/Local Areas,Louisiana,2021,Age,24 Months,93.2,88.3 to 96.5,264
PCV,≥4 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,84.2,76.0 to 90.9,264
≥1 Dose Varicella,,States/Local Areas,Louisiana,2021,Age,24 Months,92.6,87.2 to 96.3,264
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2021,Age,0-1 Days,74.1,65.6 to 81.1,264
Polio,≥2 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,92.5,85.7 to 96.2,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,91.5,85.0 to 96.0,264
Hep A,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,35 Months,90.5,86.5 to 93.6,697
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,72.5 to 83.5,541
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,89.7,85.3 to 94.1,541
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,87.0,77.2 to 96.7,172
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,87.6 to 94.4,541
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.6,75.4 to 85.8,587
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,58.7,47.0 to 70.4,172
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,90.1,83.1 to 97.1,172
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.0,91.1 to 97.0,587
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,87.0 to 94.9,541
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,71.1,63.9 to 78.2,587
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.4 to 97.2,587
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,82.4,71.8 to 93.0,172
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,88.8,84.3 to 93.2,541
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,62.0,55.7 to 68.3,439
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,85.7 to 94.5,541
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,75.7,69.7 to 81.6,518
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,79.7,71.8 to 87.6,343
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,78.6,72.5 to 84.7,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,73.3,65.5 to 81.0,343
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,75.3,69.5 to 81.1,518
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,68.9,61.9 to 75.8,439
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,91.0,85.1 to 97.0,343
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,92.3,88.5 to 96.2,518
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,89.7,85.4 to 94.0,439
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,91.7,89.1 to 94.3,1300
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,92.2,90.0 to 94.4,1300
Influenza,,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,45.7,38.9 to 52.6,518
Influenza,,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,37.1,30.8 to 43.3,439
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,91.7,86.5 to 96.8,343
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,93.1,89.4 to 96.9,518
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,89.4,85.1 to 93.6,439
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,75.8,67.5 to 84.1,343
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,76.8,70.5 to 83.1,518
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,90.6,86.4 to 94.8,439
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,75.1,71.2 to 78.9,1300
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,89.6,85.3 to 93.9,439
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,78.2,70.2 to 86.1,343
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,74.4,68.7 to 80.1,439
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,76.8,70.5 to 83.0,518
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,89.0,83.8 to 94.2,343
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,74.7,69.1 to 80.4,439
Influenza,,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,61.5,52.5 to 70.6,343
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.0,89.5 to 96.6,750
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,62.8,57.4 to 68.3,654
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.0,88.6 to 95.4,750
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,67.6,60.7 to 73.8,433
Polio,≥1 Dose,States/Local Areas,Louisiana,2020,Age,3 Months,82.6,76.4 to 87.4,433
Hib,≥1 Dose,States/Local Areas,Louisiana,2020,Age,3 Months,81.4,75.0 to 86.5,433
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,94.0,90.7 to 97.4,609
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,79.1,71.6 to 86.6,609
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,66.5,60.4 to 72.6,654
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,93.9,90.4 to 97.3,609
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,74.2 to 92.2,126
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.7,60.7 to 76.8,236
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,78.3,68.9 to 87.6,188
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,67.4 to 86.4,126
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,93.3,89.7 to 97.0,609
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,90.5,87.0 to 94.0,654
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,91.1,84.0 to 98.2,188
Influenza,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,44.0,33.1 to 55.0,188
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,91.4,88.7 to 94.0,1300
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Overall,Overall,85.2,82.1 to 88.2,1300
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,78.2,70.6 to 85.9,343
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,90.1,87.3 to 93.0,1300
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Overall,Overall,91.4,88.8 to 94.0,1300
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,87.6,83.4 to 91.8,518
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,77.0,73.3 to 80.7,1300
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,81.9,76.6 to 87.2,439
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,78.1,67.0 to 89.2,343
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,67.0,59.0 to 75.0,518
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,90.8,86.2 to 95.3,518
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,88.1,83.5 to 92.6,439
Influenza,,States/Local Areas,Louisiana,2016-2019,Overall,Overall,44.5,40.3 to 48.7,1300
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Overall,Overall,74.9,71.3 to 78.5,1300
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,90.8,87.4 to 94.2,439
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Overall,Overall,69.8,64.9 to 74.6,1300
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Overall,Overall,69.8,65.9 to 73.7,1300
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,63.9,54.8 to 73.0,343
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Overall,Overall,91.1,88.6 to 93.7,1300
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,93.9,88.5 to 99.4,343
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,68.8,62.1 to 75.4,518
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,93.3,89.4 to 97.1,518
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,65.0,58.7 to 71.2,439
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,75.2,69.5 to 80.9,439
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,94.2,89.9 to 98.4,343
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,93.4,90.0 to 96.9,518
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Overall,Overall,75.9,72.2 to 79.7,1300
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Overall,Overall,66.2,62.1 to 70.3,1300
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.2,74.4 to 84.0,587
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,89.3,82.4 to 96.3,172
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,93.8,88.4 to 99.3,343
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,133% to <400% FPL,92.4,88.4 to 96.3,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,75.1,65.0 to 85.1,172
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,67.1,61.0 to 73.2,541
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,70.6,64.6 to 76.6,541
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,86.5,76.7 to 96.4,172
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.1,91.2 to 97.0,587
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,90.3,86.2 to 94.3,541
Influenza,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,33.0,22.3 to 43.6,172
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.9,90.9 to 96.8,587
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,87.5 to 94.8,750
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.5,71.6 to 81.4,750
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.3,87.6 to 96.9,236
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,87.3 to 94.7,750
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.3,72.0 to 84.6,236
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.4,55.4 to 71.4,236
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,75.1,69.5 to 80.6,609
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.7,80.7 to 88.8,750
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,76.8,72.2 to 81.4,654
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.6,86.5 to 96.6,236
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,95.9,93.2 to 98.6,188
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.5,78.0 to 95.0,126
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,90.1,86.6 to 93.6,654
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,96.9,94.6 to 99.1,609
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,85.7,81.6 to 89.8,609
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,89.1,85.3 to 93.0,654
Influenza,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,35.8,30.6 to 40.9,654
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.8,66.2 to 85.5,126
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,92.1,86.3 to 97.9,188
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,71.5,60.6 to 82.4,188
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.6,56.8 to 82.3,126
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.0,61.2 to 76.8,236
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,63.1,57.8 to 68.4,654
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,69.1,58.9 to 79.3,188
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",58.4,50.1 to 66.7,236
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.8,65.4 to 76.3,750
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.0,58.6 to 79.3,126
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,64.9,53.8 to 76.1,188
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.5,56.9 to 78.2,126
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.4,76.7 to 86.1,750
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.5,62.8 to 78.2,236
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,81.2,72.4 to 90.0,188
Influenza,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",52.2,46.4 to 58.0,750
Influenza,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",41.2,28.9 to 53.5,126
Influenza,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",35.8,28.0 to 43.6,236
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.3,85.0 to 95.5,236
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.6,89.0 to 96.2,750
Influenza,,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,62.5,55.9 to 69.0,609
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,94.3,90.3 to 98.3,188
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,88.5 to 95.7,750
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.4,81.5 to 93.4,236
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,70.7,65.5 to 76.0,654
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,91.4,88.5 to 94.4,654
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.3,79.2 to 91.3,236
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,90.5,83.6 to 97.5,188
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,71.6,66.5 to 76.8,654
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.1,76.3 to 85.9,750
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,96.3,93.9 to 98.7,609
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,89.0,85.2 to 92.8,654
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.7,73.7 to 83.7,750
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,83.8 to 97.8,126
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.1,84.9 to 95.4,236
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,93.4,87.8 to 99.0,188
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.7,89.0 to 96.4,236
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,85.0,80.5 to 89.4,609
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,90.9,83.8 to 98.0,188
Rotavirus,,States/Local Areas,Louisiana,2019-2020,Age,8 Months,70.4,65.2 to 75.1,844
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020-2021,Age,35 Months,92.9,88.9 to 95.9,697
DTaP,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,3 Months,84.7,79.9 to 88.6,697
PCV,≥3 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,86.7,78.5 to 92.1,264
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2021,Age,0-2 Days,78.6,70.8 to 84.8,264
Hib,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,92.3,88.4 to 94.9,697
Hib,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,3 Months,80.2,75.4 to 84.2,844
Polio,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,3 Months,81.1,76.4 to 85.1,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,63.6,56.4 to 70.3,433
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.0,74.7 to 85.3,587
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,69.5 to 80.8,541
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.8,82.5 to 91.0,587
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,82.0,74.3 to 89.7,172
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,84.8,79.7 to 89.8,541
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,68.6,62.5 to 74.7,541
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.8,67.3 to 78.3,587
Influenza,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,47.3,41.1 to 53.5,587
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,52.2,40.7 to 63.6,172
Combined 7 Series,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.6,64.7 to 76.5,587
Influenza,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,45.9,39.3 to 52.4,541
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,65.4,54.0 to 76.8,172
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.4,75.3 to 85.4,587
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,75.7,69.9 to 81.4,541
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,89.5 to 96.1,587
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,90.6,83.5 to 97.7,172
Rotavirus,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,65.0,53.7 to 76.3,172
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Principal City,71.5,64.3 to 78.8,541
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,67.6,56.2 to 79.1,172
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.7,90.4 to 96.9,587
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Urbanicity,Living In a Non-MSA,62.1,47.5 to 76.6,172
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.7 to 98.1,126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,72.6,66.8 to 78.5,609
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",71.4,64.8 to 78.0,750
Hep B,≥2 Doses,States/Local Areas,Louisiana,2020,Age,5 Months,88.2,82.6 to 92.1,433
DTaP,≥1 Dose,States/Local Areas,Louisiana,2020,Age,3 Months,82.1,75.7 to 87.1,433
Hib,≥2 Doses,States/Local Areas,Louisiana,2020,Age,5 Months,78.3,71.8 to 83.7,433
Polio,≥2 Doses,States/Local Areas,Louisiana,2020,Age,5 Months,78.3,71.7 to 83.7,433
DTaP,≥2 Doses,States/Local Areas,Louisiana,2020,Age,5 Months,79.7,73.2 to 85.0,433
PCV,≥1 Dose,States/Local Areas,Louisiana,2020,Age,3 Months,79.8,73.2 to 85.1,433
Hep B,≥1 Dose,States/Local Areas,Louisiana,2020,Age,3 Months,94.8,90.8 to 97.1,433
Hep A,≥1 Dose,States/Local Areas,Louisiana,2020,Age,24 Months,81.1,74.8 to 86.6,433
Hep A,≥2 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,43.0,36.2 to 50.5,433
PCV,≥4 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,74.1,67.3 to 80.4,433
PCV,≥3 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,92.2,87.4 to 95.6,433
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020,Age,24 Months,87.8,82.2 to 92.3,433
Influenza,,States/Local Areas,Louisiana,2020,Age,24 Months,44.7,37.9 to 52.1,433
Rotavirus,,States/Local Areas,Louisiana,2020,Age,8 Months,74.0,67.1 to 79.8,433
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2020,Age,0-3 Days,72.8,65.8 to 78.8,433
Hib,≥3 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,87.3,81.3 to 91.5,433
Combined 7 Series,,States/Local Areas,Louisiana,2020,Age,24 Months,64.5,57.5 to 71.5,433
Polio,≥3 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,90.1,84.9 to 93.6,433
≥1 Dose MMR,,States/Local Areas,Louisiana,2020,Age,19 Months,82.9,76.6 to 87.7,433
DTaP,≥4 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,65.4,58.2 to 71.9,433
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,92.3,87.5 to 95.4,433
PCV,≥3 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,83.8,77.5 to 88.5,433
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,68.6,61.4 to 74.9,433
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020,Age,13 Months,61.1,54.0 to 67.8,433
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,87.2,81.6 to 91.3,433
Hep B,≥2 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,94.4,90.3 to 96.8,433
Hib,≥3 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,75.7,69.0 to 81.4,433
Hib,Primary Series,States/Local Areas,Louisiana,2020,Age,13 Months,85.7,80.0 to 90.0,433
PCV,≥3 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,93.3,88.7 to 96.4,433
PCV,≥4 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,67.0,59.8 to 73.5,433
Polio,≥3 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,92.1,87.5 to 95.4,433
DTaP,≥4 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,81.5,74.9 to 87.2,433
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,93.9,89.8 to 96.8,433
PCV,≥3 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,90.0,84.5 to 93.7,433
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020,Age,19 Months,84.1,78.0 to 88.8,433
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,90.9,85.8 to 94.3,433
Hib,Full Series,States/Local Areas,Louisiana,2020,Age,19 Months,63.5,56.3 to 70.2,433
Hib,Primary Series,States/Local Areas,Louisiana,2020,Age,19 Months,91.4,86.3 to 94.7,433
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020,Age,35 Months,91.6,86.0 to 95.6,433
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,91.5,86.7 to 95.0,433
Hib,Full Series,States/Local Areas,Louisiana,2020,Age,35 Months,76.9,69.7 to 83.4,433
Hib,Primary Series,States/Local Areas,Louisiana,2020,Age,35 Months,92.6,88.0 to 95.8,433
Hib,≥3 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,90.5,85.5 to 94.4,433
Hib,≥3 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,90.5,85.5 to 94.3,433
≥1 Dose MMR,,States/Local Areas,Louisiana,2020,Age,35 Months,90.4,84.7 to 94.6,433
≥1 Dose MMR,,States/Local Areas,Louisiana,2020,Age,24 Months,86.5,80.8 to 91.2,433
Polio,≥3 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,91.9,87.4 to 95.3,433
DTaP,≥4 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,77.7,71.1 to 83.7,433
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,93.9,89.7 to 96.8,433
PCV,≥2 Doses,States/Local Areas,Louisiana,2020,Age,5 Months,76.2,69.4 to 81.8,433
Hep B,≥2 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,90.5,85.3 to 93.9,433
Hib,Primary Series,States/Local Areas,Louisiana,2020,Age,7 Months,69.5,62.4 to 75.8,433
Hib,≥3 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,57.2,50.0 to 64.2,433
Polio,≥2 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,85.6,79.5 to 90.0,433
Hib,≥2 Doses,States/Local Areas,Louisiana,2020,Age,7 Months,86.8,81.0 to 91.1,433
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2020,Age,0-1 Days,70.2,63.1 to 76.4,433
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2020,Age,0-2 Days,71.3,64.3 to 77.5,433
Hep A,≥2 Doses,States/Local Areas,Louisiana,2020,Age,19 Months,25.0,19.3 to 31.7,433
Hep A,≥1 Dose,States/Local Areas,Louisiana,2020,Age,19 Months,79.3,72.6 to 84.6,433
Combined 7 Series,,States/Local Areas,Louisiana,2020,Age,35 Months,66.7,59.7 to 73.7,433
≥1 Dose MMR,,States/Local Areas,Louisiana,2020,Age,13 Months,59.7,52.6 to 66.4,433
Hep A,≥2 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,68.5,60.6 to 76.1,433
Polio,≥2 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,91.7,86.7 to 94.9,433
Hep A,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,43.0,37.8 to 48.5,844
Hep A,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,24 Months,83.9,79.6 to 87.7,844
Hep A,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,35 Months,88.1,83.8 to 91.7,844
Hep A,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,68.8,62.8 to 74.6,844
Influenza,,States/Local Areas,Louisiana,2019-2020,Age,24 Months,45.8,40.8 to 51.1,844
Hib,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,91.5,88.0 to 94.2,844
Hib,Primary Series,States/Local Areas,Louisiana,2019-2020,Age,24 Months,93.1,90.0 to 95.6,844
Hib,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,86.0,81.6 to 89.5,844
Combined 7 Series,,States/Local Areas,Louisiana,2019-2020,Age,35 Months,68.2,62.9 to 73.4,844
Hib,Full Series,States/Local Areas,Louisiana,2019-2020,Age,19 Months,65.4,60.1 to 70.3,844
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,91.0,87.4 to 93.7,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,89.0,84.9 to 92.2,844
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019-2020,Age,19 Months,83.8,79.2 to 87.5,844
PCV,≥4 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,68.1,62.8 to 72.9,844
Hep A,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,19 Months,79.0,74.2 to 83.1,844
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2019-2020,Age,0-1 Days,71.0,66.0 to 75.6,844
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2019-2020,Age,0-2 Days,72.7,67.7 to 77.1,844
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019-2020,Age,24 Months,89.5,85.7 to 92.7,844
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,92.0,88.7 to 94.6,844
Hib,Full Series,States/Local Areas,Louisiana,2019-2020,Age,24 Months,73.4,68.4 to 78.1,844
Hib,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,52.9,47.7 to 58.1,844
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2019-2020,Age,0-3 Days,73.8,68.9 to 78.3,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,61.6,56.3 to 66.7,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,91.8,88.3 to 94.6,844
PCV,≥4 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,74.4,69.4 to 79.1,844
Hep A,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,24.4,20.3 to 29.1,844
≥1 Dose MMR,,States/Local Areas,Louisiana,2019-2020,Age,19 Months,83.2,78.6 to 86.9,844
Hib,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,87.2,83.0 to 90.5,844
Hib,Primary Series,States/Local Areas,Louisiana,2019-2020,Age,19 Months,90.9,87.1 to 93.6,844
Hib,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,93.4,90.1 to 95.9,844
≥1 Dose MMR,,States/Local Areas,Louisiana,2019-2020,Age,35 Months,91.7,87.9 to 94.8,844
Hib,Full Series,States/Local Areas,Louisiana,2019-2020,Age,35 Months,77.9,72.8 to 82.6,844
Hib,Primary Series,States/Local Areas,Louisiana,2019-2020,Age,35 Months,94.5,91.3 to 96.8,844
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,93.7,90.3 to 96.2,844
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019-2020,Age,35 Months,92.8,88.9 to 95.7,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,94.4,91.0 to 96.8,844
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,94.3,91.4 to 96.5,844
PCV,≥4 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,76.9,71.9 to 81.6,844
DTaP,≥4 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,76.2,71.3 to 80.7,844
Polio,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,24 Months,93.4,90.3 to 95.7,844
Hep B,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,3 Months,94.6,91.6 to 96.6,844
≥1 Dose MMR,,States/Local Areas,Louisiana,2019-2020,Age,24 Months,88.6,84.8 to 91.9,844
PCV,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,3 Months,78.9,74.0 to 83.1,844
DTaP,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,5 Months,76.1,71.0 to 80.5,844
Polio,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,5 Months,75.2,70.1 to 79.7,844
Hib,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,5 Months,75.1,70.1 to 79.5,844
Polio,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,93.5,90.3 to 95.7,844
≥1 Dose MMR,,States/Local Areas,Louisiana,2019-2020,Age,13 Months,57.0,51.8 to 62.2,844
Hib,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,75.6,70.7 to 79.9,844
Hib,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,93.4,90.1 to 95.6,844
Hib,Primary Series,States/Local Areas,Louisiana,2019-2020,Age,13 Months,85.9,81.8 to 89.3,844
Hep B,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,5 Months,88.0,84.0 to 91.2,844
PCV,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,5 Months,73.6,68.4 to 78.2,844
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,65.2,59.9 to 70.1,844
Polio,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,85.4,80.9 to 89.0,844
Hep B,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,94.3,91.3 to 96.4,844
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,88.6,84.8 to 91.6,844
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019-2020,Age,13 Months,58.7,53.4 to 63.8,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,84.0,79.4 to 87.7,844
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,95.4,92.5 to 97.5,844
Combined 7 Series,,States/Local Areas,Louisiana,2019-2020,Age,24 Months,64.7,59.5 to 69.8,844
DTaP,≥4 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,82.3,77.3 to 86.7,844
Polio,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,35 Months,94.3,91.3 to 96.5,844
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,91.4,87.6 to 94.0,844
DTaP,≥4 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,65.7,60.5 to 70.5,844
Polio,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,19 Months,90.2,86.4 to 93.0,844
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,65.5,60.3 to 70.4,844
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019-2020,Age,13 Months,87.9,83.9 to 91.1,844
DTaP,≥1 Dose,States/Local Areas,Louisiana,2019-2020,Age,3 Months,80.9,76.2 to 84.9,844
Hep A,≥2 Doses,States/Local Areas,Maine,2018,Age,24 Months,59.0,51.7 to 66.6,251
Hep A,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,58.8,53.4 to 64.2,495
Hep A,≥2 Doses,States/Local Areas,Maine,2017,Age,24 Months,45.5,38.3 to 53.3,259
Hep A,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,52.3,47.1 to 57.8,510
Hep A,≥2 Doses,States/Local Areas,Maine,2016,Age,24 Months,52.2,44.6 to 60.1,243
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,48.9,43.6 to 54.4,502
DTaP,≥4 Doses,States/Local Areas,Maine,2013,Age,24 Months,90.0,84.2 to 94.4,244
DTaP,≥4 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,87.4,83.5 to 90.8,519
Hib,Full Series,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,70.5,54.2 to 86.8,38
Hib,Full Series,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.6,79.0 to 88.2,395
Hib,Full Series,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,86.6,82.6 to 90.6,430
Hib,Full Series,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,74.8,68.8 to 80.9,275
Hib,Full Series,States/Local Areas,Maine,2014-2017,Overall,Overall,83.7,80.7 to 86.7,950
Hib,Full Series,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,86.1,82.2 to 90.1,371
Hep A,≥1 Dose,States/Local Areas,Maine,2015,Age,35 Months,89.2,84.5 to 92.9,278
Hep A,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,35 Months,90.0,86.7 to 92.7,521
Polio,≥2 Doses,States/Local Areas,Maine,2012,Age,5 Months,83.7,82.0 to 85.2,233
Polio,≥2 Doses,States/Local Areas,Maine,2011,Age,5 Months,81.0,76.8 to 84.6,203
Polio,≥2 Doses,States/Local Areas,Maine,2013,Age,5 Months,85.3,80.2 to 89.2,244
Polio,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,5 Months,81.6,77.8 to 84.8,519
Polio,≥2 Doses,States/Local Areas,Maine,2014,Age,5 Months,77.7,71.1 to 83.2,275
Polio,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,5 Months,80.7,77.8 to 83.2,553
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,91.8,88.3 to 95.2,275
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,98.6,97.2 to 100.0,245
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,94.6,92.0 to 97.2,430
Hep B,≥3 Doses,States/Local Areas,Maine,2012,Age,7 Months,54.2,49.8 to 58.4,233
Hep B,≥3 Doses,States/Local Areas,Maine,2011,Age,7 Months,42.0,35.3 to 49.0,203
Hep B,≥3 Doses,States/Local Areas,Maine,2013,Age,7 Months,59.8,53.7 to 65.7,244
Hep B,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,54.7,51.5 to 57.8,519
DTaP,≥4 Doses,States/Local Areas,Maine,2019,Age,19 Months,80.1,73.3 to 85.5,244
DTaP,≥4 Doses,States/Local Areas,Maine,2011,Age,24 Months,87.6,80.7 to 93.0,203
DTaP,≥4 Doses,States/Local Areas,Maine,2012,Age,24 Months,88.9,82.8 to 93.6,233
PCV,≥2 Doses,States/Local Areas,Maine,2018,Age,5 Months,85.8,79.6 to 90.4,251
PCV,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,5 Months,85.7,81.6 to 89.0,495
PCV,≥2 Doses,States/Local Areas,Maine,2019,Age,5 Months,85.5,79.9 to 89.8,244
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,87.1 to 97.1,184
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.6,92.8 to 96.4,821
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,94.6,92.2 to 97.0,371
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.6,93.4 to 97.8,395
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.0,92.2 to 99.9,66
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,94.1,87.5 to 100.0,40
DTaP,≥4 Doses,States/Local Areas,Maine,2016,Age,19 Months,74.0,66.7 to 80.2,243
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,75.4,70.5 to 79.7,502
DTaP,≥4 Doses,States/Local Areas,Maine,2017,Age,19 Months,76.8,70.1 to 82.5,259
DTaP,≥4 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,78.5,74.0 to 82.5,510
DTaP,≥4 Doses,States/Local Areas,Maine,2018,Age,19 Months,80.2,73.7 to 85.4,251
DTaP,≥4 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,96.0,93.1 to 97.7,495
Hep A,≥2 Doses,States/Local Areas,Maine,2013,Age,24 Months,48.1,39.8 to 57.1,244
Hep A,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,46.3,40.8 to 52.1,519
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,94.5,92.8 to 96.1,950
Hep A,≥2 Doses,States/Local Areas,Maine,2015,Age,24 Months,49.1,42.1 to 56.5,278
Hep A,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,50.7,45.5 to 56.0,521
Hep A,≥2 Doses,States/Local Areas,Maine,2014,Age,24 Months,44.5,37.6 to 52.0,275
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,46.8,41.8 to 52.0,553
Hep A,≥1 Dose,States/Local Areas,Maine,2013,Age,35 Months,83.9,77.1 to 89.6,244
Hep A,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,35 Months,85.4,81.0 to 89.2,519
Hep A,≥1 Dose,States/Local Areas,Maine,2014,Age,35 Months,86.7,80.9 to 91.5,275
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,35 Months,88.1,84.5 to 91.3,553
DTaP,≥4 Doses,States/Local Areas,Maine,2016,Age,24 Months,86.2,80.2 to 91.1,243
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,85.3,81.2 to 88.9,502
DTaP,≥4 Doses,States/Local Areas,Maine,2015,Age,24 Months,90.3,85.7 to 93.9,278
DTaP,≥4 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,88.3,84.6 to 91.4,521
Polio,≥2 Doses,States/Local Areas,Maine,2015,Age,5 Months,83.6,77.8 to 88.1,278
Polio,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,5 Months,83.1,78.9 to 86.6,521
Hep B,≥3 Doses,States/Local Areas,Maine,2016,Age,7 Months,59.1,51.2 to 66.5,243
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,59.7,54.4 to 64.9,502
Hep A,≥2 Doses,States/Local Areas,Maine,2019,Age,24 Months,58.5,50.8 to 66.5,244
Hep A,≥2 Doses,States/Local Areas,Maine,2011,Age,35 Months,72.7,63.5 to 81.2,203
Hep A,≥2 Doses,States/Local Areas,Maine,2012,Age,35 Months,67.9,57.8 to 77.6,233
Hep A,≥2 Doses,States/Local Areas,Maine,2013,Age,35 Months,63.5,54.6 to 72.2,244
Hep A,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,67.6,61.5 to 73.7,519
Hep A,≥1 Dose,States/Local Areas,Maine,2016,Age,35 Months,90.6,85.7 to 94.4,243
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,35 Months,88.4,84.7 to 91.6,502
Polio,≥2 Doses,States/Local Areas,Maine,2016,Age,5 Months,82.6,76.1 to 87.6,243
Polio,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,5 Months,81.5,77.1 to 85.3,502
Polio,≥2 Doses,States/Local Areas,Maine,2017,Age,5 Months,80.4,73.9 to 85.6,259
Polio,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,5 Months,83.2,78.9 to 86.8,510
Hep B,≥3 Doses,States/Local Areas,Maine,2014,Age,7 Months,49.4,42.3 to 56.5,275
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,48.6,43.6 to 53.7,553
Hep B,≥3 Doses,States/Local Areas,Maine,2015,Age,7 Months,47.9,40.8 to 55.1,278
Hep B,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,53.5,48.2 to 58.7,521
≥1 Dose Varicella,,States/Local Areas,Maine,2014,Age,13 Months,41.0,34.2 to 48.1,275
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2015,Age,13 Months,40.7,35.8 to 45.7,553
≥1 Dose Varicella,,States/Local Areas,Maine,2012,Age,13 Months,49.2,41.9 to 56.5,233
Hep A,≥1 Dose,States/Local Areas,Maine,2019,Age,35 Months,94.9,86.6 to 98.8,244
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,83.1,78.5 to 87.8,365
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,88.0,85.0 to 91.0,530
Polio,≥2 Doses,States/Local Areas,Maine,2018,Age,5 Months,85.9,79.7 to 90.5,251
Polio,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,5 Months,85.2,81.0 to 88.5,495
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,66.5,49.0 to 84.1,38
≥1 Dose Varicella,,States/Local Areas,Maine,2013,Age,13 Months,44.3,40.8 to 47.9,244
≥1 Dose Varicella,,States/Local Areas,Maine,2013-2014,Age,13 Months,42.7,39.2 to 46.2,519
≥1 Dose MMR,,States/Local Areas,Maine,2014,Age,13 Months,56.6,49.4 to 63.4,275
≥1 Dose MMR,,States/Local Areas,Maine,2014-2015,Age,13 Months,55.3,50.2 to 60.3,553
≥1 Dose MMR,,States/Local Areas,Maine,2015,Age,13 Months,54.0,46.8 to 61.1,278
≥1 Dose MMR,,States/Local Areas,Maine,2015-2016,Age,13 Months,55.2,49.9 to 60.5,521
≥1 Dose Varicella,,States/Local Areas,Maine,2019,Age,13 Months,58.2,50.7 to 65.4,244
≥1 Dose Varicella,,States/Local Areas,Maine,2011,Age,19 Months,86.4,79.5 to 91.3,203
≥1 Dose Varicella,,States/Local Areas,Maine,2013,Age,19 Months,87.9,86.1 to 89.5,244
≥1 Dose Varicella,,States/Local Areas,Maine,2013-2014,Age,19 Months,85.0,80.4 to 88.6,519
≥1 Dose Varicella,,States/Local Areas,Maine,2012,Age,19 Months,89.0,85.1 to 91.9,233
≥1 Dose MMR,,States/Local Areas,Maine,2016,Age,13 Months,56.5,48.6 to 64.0,243
≥1 Dose MMR,,States/Local Areas,Maine,2016-2017,Age,13 Months,59.2,53.8 to 64.4,502
≥1 Dose Varicella,,States/Local Areas,Maine,2018,Age,13 Months,58.2,50.9 to 65.3,251
≥1 Dose Varicella,,States/Local Areas,Maine,2018-2019,Age,13 Months,58.2,53.0 to 63.3,495
Hep A,≥1 Dose,States/Local Areas,Maine,2020,Age,35 Months,93.6,88.2 to 97.1,223
DTaP,≥4 Doses,States/Local Areas,Maine,2012,Age,35 Months,93.0,87.0 to 96.9,233
DTaP,≥4 Doses,States/Local Areas,Maine,2015,Age,35 Months,94.8,89.4 to 98.0,278
DTaP,≥4 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,94.2,90.7 to 96.7,521
DTaP,≥4 Doses,States/Local Areas,Maine,2014,Age,35 Months,89.5,83.8 to 93.9,275
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,91.9,88.2 to 94.9,553
Hep A,≥2 Doses,States/Local Areas,Maine,2019,Age,35 Months,90.7,81.7 to 96.4,244
Hep B,≥3 Doses,States/Local Areas,Maine,2012,Age,13 Months,88.1,83.5 to 91.6,233
DTaP,≥4 Doses,States/Local Areas,Maine,2013,Age,35 Months,91.9,86.1 to 95.9,244
DTaP,≥4 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,90.5,86.6 to 93.6,519
Hep B,≥3 Doses,States/Local Areas,Maine,2013,Age,13 Months,85.4,77.1 to 91.0,244
Hep B,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,83.9,79.8 to 87.3,519
Hep B,≥3 Doses,States/Local Areas,Maine,2014,Age,13 Months,82.5,76.8 to 87.0,275
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,84.1,80.3 to 87.3,553
Hep A,≥2 Doses,States/Local Areas,Maine,2018,Age,35 Months,81.4,73.9 to 87.8,251
Hep A,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,86.5,80.3 to 91.5,495
Hep A,≥2 Doses,States/Local Areas,Maine,2017,Age,35 Months,73.9,65.5 to 81.7,259
Hep A,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,77.8,72.1 to 83.0,510
≥1 Dose Varicella,,States/Local Areas,Maine,2016,Age,13 Months,43.7,36.4 to 51.3,243
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2017,Age,13 Months,48.5,43.2 to 53.7,502
≥1 Dose Varicella,,States/Local Areas,Maine,2017,Age,13 Months,53.4,46.0 to 60.7,259
≥1 Dose Varicella,,States/Local Areas,Maine,2017-2018,Age,13 Months,55.9,50.6 to 60.9,510
≥1 Dose Varicella,,States/Local Areas,Maine,2015,Age,13 Months,40.4,33.7 to 47.5,278
≥1 Dose Varicella,,States/Local Areas,Maine,2015-2016,Age,13 Months,42.1,37.0 to 47.2,521
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,78.6 to 94.8,66
Polio,≥2 Doses,States/Local Areas,Maine,2019,Age,5 Months,84.3,78.2 to 89.0,244
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,93.7,87.8 to 99.7,40
Polio,≥2 Doses,States/Local Areas,Maine,2012,Age,7 Months,93.7,91.4 to 95.4,233
Polio,≥2 Doses,States/Local Areas,Maine,2011,Age,7 Months,92.6,83.7 to 96.9,203
Hep B,≥3 Doses,States/Local Areas,Maine,2017,Age,7 Months,60.4,53.1 to 67.3,259
Hep B,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,63.0,57.9 to 67.8,510
Hep B,≥3 Doses,States/Local Areas,Maine,2018,Age,7 Months,65.5,58.3 to 72.0,251
Hep B,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,57.4,52.1 to 62.5,495
Hep A,≥2 Doses,States/Local Areas,Maine,2016,Age,35 Months,83.8,72.1 to 92.5,243
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,78.3,71.6 to 84.4,502
Hep A,≥2 Doses,States/Local Areas,Maine,2015,Age,35 Months,77.3,69.1 to 84.6,278
Hep A,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,80.5,73.3 to 86.7,521
Polio,≥2 Doses,States/Local Areas,Maine,2013,Age,7 Months,90.1,82.7 to 94.5,244
Polio,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,89.7,85.9 to 92.5,519
Hep B,≥3 Doses,States/Local Areas,Maine,2019,Age,7 Months,49.0,41.5 to 56.5,244
Hep A,≥2 Doses,States/Local Areas,Maine,2014,Age,35 Months,72.3,63.7 to 80.3,275
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,74.5,68.5 to 80.0,553
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,86.6,80.1 to 93.0,184
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.7,80.6 to 86.7,821
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,82.6,77.9 to 87.2,371
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.4,81.6 to 89.3,395
Polio,≥2 Doses,States/Local Areas,Maine,2014,Age,7 Months,89.2,84.4 to 92.7,275
Polio,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,90.4,87.3 to 92.9,553
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,81.6,76.3 to 86.9,275
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Overall,Overall,84.6,81.9 to 87.4,950
Polio,≥2 Doses,States/Local Areas,Maine,2015,Age,7 Months,91.7,87.0 to 94.8,278
Polio,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,91.2,87.8 to 93.7,521
Polio,≥2 Doses,States/Local Areas,Maine,2016,Age,7 Months,90.6,85.2 to 94.2,243
Polio,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,90.6,87.2 to 93.2,502
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,83.9,79.7 to 88.1,430
Hep B,≥3 Doses,States/Local Areas,Maine,2011,Age,13 Months,82.7,73.9 to 88.9,203
DTaP,≥4 Doses,States/Local Areas,Maine,2018,Age,24 Months,91.3,86.8 to 94.8,251
DTaP,≥4 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,87.8,83.8 to 91.2,495
DTaP,≥4 Doses,States/Local Areas,Maine,2017,Age,24 Months,84.3,78.5 to 89.2,259
DTaP,≥4 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,87.7,84.0 to 90.8,510
DTaP,≥4 Doses,States/Local Areas,Maine,2019,Age,24 Months,83.2,76.8 to 88.6,244
DTaP,≥4 Doses,States/Local Areas,Maine,2011,Age,35 Months,91.6,84.7 to 96.3,203
Hep A,≥1 Dose,States/Local Areas,Maine,2017,Age,35 Months,86.1,80.3 to 90.8,259
Hep A,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,35 Months,90.2,86.4 to 93.2,510
Hep A,≥1 Dose,States/Local Areas,Maine,2018,Age,35 Months,96.4,89.9 to 99.2,251
Hep A,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,35 Months,95.4,90.2 to 98.3,495
≥1 Dose Varicella,,States/Local Areas,Maine,2011,Age,13 Months,56.2,51.4 to 60.9,203
≥1 Dose MMR,,States/Local Areas,Maine,2013,Age,13 Months,44.0,38.5 to 49.7,244
≥1 Dose MMR,,States/Local Areas,Maine,2013-2014,Age,13 Months,50.2,45.8 to 54.6,519
≥1 Dose MMR,,States/Local Areas,Maine,2012,Age,13 Months,43.9,35.4 to 52.8,233
≥1 Dose MMR,,States/Local Areas,Maine,2011,Age,13 Months,52.2,50.0 to 54.4,203
≥1 Dose Varicella,,States/Local Areas,Maine,2014,Age,19 Months,81.9,75.9 to 86.7,275
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2015,Age,19 Months,83.9,79.7 to 87.4,553
≥1 Dose Varicella,,States/Local Areas,Maine,2015,Age,19 Months,85.9,81.2 to 89.6,278
≥1 Dose Varicella,,States/Local Areas,Maine,2015-2016,Age,19 Months,85.4,81.1 to 88.9,521
≥1 Dose Varicella,,States/Local Areas,Maine,2016,Age,19 Months,84.9,78.6 to 89.6,243
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2017,Age,19 Months,86.2,82.1 to 89.5,502
Polio,≥2 Doses,States/Local Areas,Maine,2012,Age,13 Months,96.4,94.8 to 97.6,233
Polio,≥2 Doses,States/Local Areas,Maine,2011,Age,13 Months,96.2,92.1 to 98.2,203
Polio,≥2 Doses,States/Local Areas,Maine,2013,Age,13 Months,94.7,93.4 to 95.8,244
Polio,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,92.9,91.8 to 93.9,519
Polio,≥2 Doses,States/Local Areas,Maine,2014,Age,13 Months,91.1,86.5 to 94.2,275
Polio,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,92.9,90.1 to 94.9,553
Hep B,≥1 Dose,States/Local Areas,Maine,2015,Age,3 Months,89.5,84.5 to 93.0,278
Hep B,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,3 Months,90.9,87.7 to 93.3,521
Hep B,≥1 Dose,States/Local Areas,Maine,2016,Age,3 Months,92.3,87.7 to 95.3,243
Hep B,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,3 Months,92.9,90.1 to 94.9,502
Hep B,≥1 Dose,States/Local Areas,Maine,2017,Age,3 Months,93.5,89.8 to 95.9,259
Hep B,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,3 Months,94.2,91.7 to 96.0,510
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.1,59.9 to 88.3,66
≥1 Dose MMR,,States/Local Areas,Maine,2017,Age,13 Months,62.1,54.6 to 69.1,259
≥1 Dose MMR,,States/Local Areas,Maine,2017-2018,Age,13 Months,64.6,59.4 to 69.6,510
≥1 Dose MMR,,States/Local Areas,Maine,2018,Age,13 Months,67.1,59.6 to 73.9,251
≥1 Dose MMR,,States/Local Areas,Maine,2018-2019,Age,13 Months,68.3,63.0 to 73.1,495
≥1 Dose MMR,,States/Local Areas,Maine,2019,Age,13 Months,69.5,62.0 to 76.1,244
DTaP,≥4 Doses,States/Local Areas,Maine,2014,Age,24 Months,84.9,79.3 to 89.6,275
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,87.5,84.0 to 90.6,553
Hib,≥3 Doses,States/Local Areas,Maine,2019,Age,35 Months,93.9,89.3 to 97.0,244
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,74.2,62.0 to 86.3,184
Hep B,≥1 Dose,States/Local Areas,Maine,2013,Age,3 Months,93.3,89.9 to 95.6,244
Hep B,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,3 Months,92.4,89.5 to 94.6,519
Hep B,≥1 Dose,States/Local Areas,Maine,2012,Age,3 Months,93.8,91.7 to 95.3,233
Hep B,≥1 Dose,States/Local Areas,Maine,2011,Age,3 Months,92.0,85.5 to 95.8,203
Hep B,≥1 Dose,States/Local Areas,Maine,2014,Age,3 Months,91.5,87.4 to 94.4,275
Hep B,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,3 Months,90.5,87.5 to 92.9,553
Polio,≥2 Doses,States/Local Areas,Maine,2017,Age,7 Months,90.6,85.7 to 93.9,259
Polio,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,92.5,89.4 to 94.7,510
Polio,≥2 Doses,States/Local Areas,Maine,2018,Age,7 Months,94.4,89.9 to 96.9,251
Polio,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,93.5,90.3 to 95.7,495
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.3,84.5 to 90.1,821
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,85.6 to 97.9,66
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,86.6,83.9 to 89.3,950
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,87.8,84.1 to 91.6,371
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,84.7,78.2 to 91.1,184
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.5,82.2 to 90.8,395
≥1 Dose MMR,,States/Local Areas,Maine,2015,Age,19 Months,92.2,89.3 to 94.4,278
≥1 Dose MMR,,States/Local Areas,Maine,2015-2016,Age,19 Months,90.4,86.9 to 93.0,521
≥1 Dose MMR,,States/Local Areas,Maine,2016,Age,19 Months,88.5,82.5 to 92.7,243
≥1 Dose MMR,,States/Local Areas,Maine,2016-2017,Age,19 Months,88.6,84.5 to 91.7,502
≥1 Dose MMR,,States/Local Areas,Maine,2017,Age,19 Months,88.6,82.7 to 92.7,259
≥1 Dose MMR,,States/Local Areas,Maine,2017-2018,Age,19 Months,90.8,87.1 to 93.5,510
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,80.4,75.2 to 85.6,275
≥1 Dose Varicella,,States/Local Areas,Maine,2011,Age,24 Months,91.9,86.7 to 95.6,203
≥1 Dose Varicella,,States/Local Areas,Maine,2012,Age,24 Months,93.8,89.8 to 96.6,233
Hep B,≥1 Dose,States/Local Areas,Maine,2018,Age,3 Months,95.0,90.8 to 97.3,251
Hep B,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,3 Months,94.3,91.0 to 96.5,495
Hep B,≥1 Dose,States/Local Areas,Maine,2019,Age,3 Months,93.7,87.7 to 96.8,244
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,71.9,63.6 to 80.2,430
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2011,Age,0-1 Days,47.2,44.0 to 50.5,203
Hep B,≥2 Doses,States/Local Areas,Maine,2012,Age,5 Months,85.2,81.2 to 88.5,233
Hep B,≥2 Doses,States/Local Areas,Maine,2011,Age,5 Months,82.5,71.3 to 90.0,203
Hep B,≥2 Doses,States/Local Areas,Maine,2013,Age,5 Months,86.9,80.8 to 91.3,244
Hep B,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,5 Months,85.4,83.0 to 87.6,519
Hep B,≥3 Doses,States/Local Areas,Maine,2013,Age,19 Months,87.6,82.1 to 91.6,244
Hep B,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,86.4,83.8 to 88.6,519
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,87.2,81.2 to 93.2,245
Hep B,≥3 Doses,States/Local Areas,Maine,2014,Age,19 Months,85.2,80.0 to 89.2,275
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,87.1,83.7 to 89.9,553
Hep B,≥3 Doses,States/Local Areas,Maine,2015,Age,19 Months,89.1,87.6 to 90.4,278
Hep B,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,89.7,86.3 to 92.3,521
Polio,≥2 Doses,States/Local Areas,Maine,2019,Age,7 Months,92.6,87.4 to 95.8,244
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,76.0,71.2 to 80.8,950
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,75.1,66.4 to 83.9,275
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,83.4,75.7 to 91.0,371
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.8,70.1 to 79.5,821
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.4,63.8 to 77.0,395
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,77.3,67.2 to 87.4,365
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,79.6,74.6 to 84.7,530
Hep B,≥3 Doses,States/Local Areas,Maine,2016,Age,13 Months,88.1,82.5 to 92.0,243
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,88.2,84.7 to 90.9,502
Hep B,≥3 Doses,States/Local Areas,Maine,2015,Age,13 Months,85.7,80.2 to 89.9,278
Hep B,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,86.9,83.2 to 89.9,521
Hep B,≥3 Doses,States/Local Areas,Maine,2017,Age,13 Months,88.2,83.5 to 91.7,259
Hep B,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,88.9,85.4 to 91.6,510
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,85.3,71.1 to 99.5,40
Hep B,≥3 Doses,States/Local Areas,Maine,2012,Age,19 Months,90.3,85.5 to 93.6,233
Hep A,≥2 Doses,States/Local Areas,Maine,2020,Age,35 Months,87.1,79.5 to 93.0,223
Hep B,≥3 Doses,States/Local Areas,Maine,2018,Age,13 Months,89.5,83.9 to 93.3,251
Hep B,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,88.2,84.2 to 91.3,495
Hep B,≥3 Doses,States/Local Areas,Maine,2019,Age,13 Months,86.8,80.4 to 91.4,244
Hep B,≥3 Doses,States/Local Areas,Maine,2011,Age,19 Months,85.9,75.7 to 92.2,203
DTaP,≥4 Doses,States/Local Areas,Maine,2019,Age,35 Months,94.4,83.3 to 99.0,244
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,83.5,79.0 to 88.0,365
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,90.9,87.8 to 94.0,530
≥1 Dose MMR,,States/Local Areas,Maine,2011,Age,19 Months,87.8,85.8 to 89.4,203
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,74.9,59.7 to 90.1,38
≥1 Dose MMR,,States/Local Areas,Maine,2013,Age,19 Months,91.5,88.1 to 94.0,244
≥1 Dose MMR,,States/Local Areas,Maine,2013-2014,Age,19 Months,89.6,85.9 to 92.4,519
≥1 Dose MMR,,States/Local Areas,Maine,2014,Age,19 Months,87.6,82.6 to 91.3,275
≥1 Dose MMR,,States/Local Areas,Maine,2014-2015,Age,19 Months,89.9,86.7 to 92.4,553
≥1 Dose MMR,,States/Local Areas,Maine,2012,Age,19 Months,91.5,86.3 to 94.9,233
≥1 Dose Varicella,,States/Local Areas,Maine,2017,Age,19 Months,87.6,81.9 to 91.7,259
≥1 Dose Varicella,,States/Local Areas,Maine,2017-2018,Age,19 Months,90.6,87.2 to 93.1,510
≥1 Dose Varicella,,States/Local Areas,Maine,2018,Age,19 Months,93.5,89.4 to 96.1,251
≥1 Dose Varicella,,States/Local Areas,Maine,2018-2019,Age,19 Months,58.2,53.0 to 63.3,495
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,91.5,83.5 to 99.5,40
Polio,≥2 Doses,States/Local Areas,Maine,2015,Age,13 Months,94.6,90.9 to 96.9,278
Polio,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,94.1,91.4 to 95.9,521
Polio,≥2 Doses,States/Local Areas,Maine,2016,Age,13 Months,93.5,89.2 to 96.1,243
Polio,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,93.7,91.0 to 95.6,502
Polio,≥2 Doses,States/Local Areas,Maine,2017,Age,13 Months,93.9,90.2 to 96.3,259
Polio,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,95.3,92.9 to 97.0,510
PCV,≥3 Doses,States/Local Areas,Maine,2013,Age,7 Months,71.6,67.0 to 75.8,244
PCV,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,70.3,67.2 to 73.1,519
PCV,≥3 Doses,States/Local Areas,Maine,2011,Age,7 Months,67.8,62.0 to 73.2,203
Hep B,≥3 Doses,States/Local Areas,Maine,2016,Age,19 Months,90.3,85.2 to 93.8,243
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,90.2,87.0 to 92.7,502
PCV,≥3 Doses,States/Local Areas,Maine,2014,Age,7 Months,68.9,61.9 to 75.1,275
PCV,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,68.8,64.0 to 73.2,553
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,93.7,89.7 to 97.6,245
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,88.3,84.4 to 92.2,430
PCV,≥3 Doses,States/Local Areas,Maine,2012,Age,7 Months,72.6,69.0 to 75.9,233
Hep B,≥3 Doses,States/Local Areas,Maine,2017,Age,19 Months,90.1,85.7 to 93.3,259
Hep B,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,91.2,88.2 to 93.5,510
Hep B,≥3 Doses,States/Local Areas,Maine,2018,Age,19 Months,92.3,87.5 to 95.3,251
Hep B,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,88.2,84.2 to 91.3,495
Hep B,≥2 Doses,States/Local Areas,Maine,2016,Age,5 Months,88.7,82.8 to 92.7,243
Hep B,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,5 Months,88.9,85.4 to 91.7,502
Hep B,≥2 Doses,States/Local Areas,Maine,2014,Age,5 Months,83.9,78.2 to 88.3,275
Hep B,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,5 Months,83.3,81.3 to 85.1,553
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2012,Age,0-1 Days,59.1,50.4 to 67.4,233
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2013,Age,0-1 Days,53.2,50.5 to 55.9,244
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2013-2014,Age,0-1 Days,49.5,47.4 to 51.6,519
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2014,Age,0-1 Days,45.6,38.7 to 52.7,275
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2014-2015,Age,0-1 Days,49.3,44.2 to 54.3,553
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2015,Age,0-1 Days,52.9,45.8 to 60.0,278
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2015-2016,Age,0-1 Days,56.6,51.3 to 61.8,521
Hep B,≥2 Doses,States/Local Areas,Maine,2015,Age,5 Months,82.7,76.9 to 87.2,278
Hep B,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,5 Months,85.7,81.8 to 88.9,521
Polio,≥2 Doses,States/Local Areas,Maine,2018,Age,13 Months,96.7,92.7 to 98.6,251
Polio,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,96.0,93.1 to 97.7,495
Polio,≥2 Doses,States/Local Areas,Maine,2019,Age,13 Months,95.2,90.2 to 97.8,244
≥1 Dose Varicella,,States/Local Areas,Maine,2019,Age,19 Months,92.3,87.2 to 95.5,244
≥1 Dose Varicella,,States/Local Areas,Maine,2014,Age,24 Months,85.1,79.7 to 89.6,275
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2015,Age,24 Months,87.6,84.0 to 90.7,553
≥1 Dose Varicella,,States/Local Areas,Maine,2013,Age,24 Months,88.9,83.3 to 93.3,244
≥1 Dose Varicella,,States/Local Areas,Maine,2013-2014,Age,24 Months,87.0,83.3 to 90.3,519
PCV,≥4 Doses,States/Local Areas,Maine,2013,Age,19 Months,82.8,75.6 to 88.3,244
PCV,≥4 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,80.0,74.3 to 84.8,519
PCV,≥4 Doses,States/Local Areas,Maine,2012,Age,19 Months,83.0,74.9 to 88.9,233
PCV,≥4 Doses,States/Local Areas,Maine,2011,Age,19 Months,80.2,64.7 to 90.0,203
≥1 Dose MMR,,States/Local Areas,Maine,2018,Age,19 Months,92.9,87.9 to 96.0,251
≥1 Dose MMR,,States/Local Areas,Maine,2018-2019,Age,19 Months,96.0,93.1 to 97.7,495
≥1 Dose MMR,,States/Local Areas,Maine,2019,Age,19 Months,91.0,85.6 to 94.5,244
≥1 Dose Varicella,,States/Local Areas,Maine,2017,Age,24 Months,91.5,87.0 to 94.9,259
≥1 Dose Varicella,,States/Local Areas,Maine,2017-2018,Age,24 Months,92.6,89.8 to 94.9,510
≥1 Dose Varicella,,States/Local Areas,Maine,2016,Age,24 Months,92.1,87.8 to 95.4,243
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2017,Age,24 Months,91.8,88.8 to 94.3,502
≥1 Dose MMR,,States/Local Areas,Maine,2011,Age,24 Months,93.7,88.9 to 97.0,203
≥1 Dose MMR,,States/Local Areas,Maine,2012,Age,24 Months,95.6,91.9 to 98.0,233
≥1 Dose Varicella,,States/Local Areas,Maine,2015,Age,24 Months,90.2,85.2 to 94.1,278
≥1 Dose Varicella,,States/Local Areas,Maine,2015-2016,Age,24 Months,91.4,88.2 to 94.0,521
Hep B,≥2 Doses,States/Local Areas,Maine,2019,Age,5 Months,89.9,83.7 to 93.9,244
Hep B,≥2 Doses,States/Local Areas,Maine,2011,Age,7 Months,85.4,75.0 to 91.9,203
Hep B,≥2 Doses,States/Local Areas,Maine,2017,Age,5 Months,89.2,84.6 to 92.6,259
Hep B,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,5 Months,89.4,86.0 to 92.1,510
Hep B,≥2 Doses,States/Local Areas,Maine,2018,Age,5 Months,89.7,84.2 to 93.4,251
Hep B,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,5 Months,89.8,85.9 to 92.7,495
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2018,Age,0-1 Days,66.1,58.6 to 72.9,251
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2018-2019,Age,0-1 Days,69.8,64.5 to 74.5,495
≥1 Dose Varicella,,States/Local Areas,Maine,2019,Age,24 Months,93.9,90.1 to 96.6,244
≥1 Dose Varicella,,States/Local Areas,Maine,2011,Age,35 Months,93.3,87.8 to 96.9,203
≥1 Dose Varicella,,States/Local Areas,Maine,2012,Age,35 Months,94.2,90.1 to 97.0,233
≥1 Dose Varicella,,States/Local Areas,Maine,2018,Age,24 Months,93.5,89.6 to 96.3,251
≥1 Dose Varicella,,States/Local Areas,Maine,2018-2019,Age,24 Months,93.7,91.1 to 95.8,495
≥1 Dose MMR,,States/Local Areas,Maine,2015,Age,24 Months,94.0,90.6 to 96.5,278
≥1 Dose MMR,,States/Local Areas,Maine,2015-2016,Age,24 Months,93.8,91.2 to 95.9,521
≥1 Dose MMR,,States/Local Areas,Maine,2014,Age,24 Months,91.2,87.2 to 94.4,275
≥1 Dose MMR,,States/Local Areas,Maine,2014-2015,Age,24 Months,92.6,90.0 to 94.7,553
≥1 Dose MMR,,States/Local Areas,Maine,2013,Age,24 Months,95.0,91.6 to 97.3,244
≥1 Dose MMR,,States/Local Areas,Maine,2013-2014,Age,24 Months,93.1,90.6 to 95.2,519
PCV,≥3 Doses,States/Local Areas,Maine,2017,Age,7 Months,66.1,58.8 to 72.7,259
PCV,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,68.3,63.3 to 73.0,510
PCV,≥3 Doses,States/Local Areas,Maine,2015,Age,7 Months,68.7,61.8 to 74.8,278
PCV,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,68.4,63.4 to 73.0,521
PCV,≥4 Doses,States/Local Areas,Maine,2014,Age,19 Months,77.1,70.8 to 82.4,275
PCV,≥4 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,77.5,72.9 to 81.5,553
PCV,≥4 Doses,States/Local Areas,Maine,2015,Age,19 Months,77.9,75.0 to 80.5,278
PCV,≥4 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,78.1,73.1 to 82.3,521
PCV,≥4 Doses,States/Local Areas,Maine,2016,Age,19 Months,78.2,70.9 to 84.1,243
PCV,≥4 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,77.5,72.5 to 81.9,502
PCV,≥3 Doses,States/Local Areas,Maine,2016,Age,7 Months,68.2,60.7 to 74.8,243
PCV,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,67.1,62.0 to 71.9,502
Hep B,≥3 Doses,States/Local Areas,Maine,2012,Age,24 Months,91.0,86.2 to 94.6,233
Hep B,≥3 Doses,States/Local Areas,Maine,2014,Age,24 Months,86.3,81.5 to 90.4,275
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,88.3,85.1 to 91.0,553
Hep B,≥3 Doses,States/Local Areas,Maine,2013,Age,24 Months,89.5,83.7 to 94.0,244
Hep B,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,87.9,84.3 to 91.1,519
Hep B,≥3 Doses,States/Local Areas,Maine,2019,Age,19 Months,90.1,83.8 to 94.1,244
Hep B,≥3 Doses,States/Local Areas,Maine,2011,Age,24 Months,86.1,80.0 to 91.1,203
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2019,Age,0-1 Days,73.5,66.1 to 79.8,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2011,Age,0-2 Days,60.1,56.2 to 63.9,203
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2013,Age,0-2 Days,64.9,61.3 to 68.3,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2013-2014,Age,0-2 Days,62.1,59.6 to 64.5,519
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2012,Age,0-2 Days,71.5,69.0 to 73.9,233
Hep B,≥2 Doses,States/Local Areas,Maine,2013,Age,7 Months,91.8,90.3 to 93.2,244
Hep B,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,90.4,88.0 to 92.3,519
Hep B,≥2 Doses,States/Local Areas,Maine,2014,Age,7 Months,88.8,84.2 to 92.2,275
Hep B,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,88.8,85.5 to 91.4,553
Hep B,≥2 Doses,States/Local Areas,Maine,2015,Age,7 Months,88.7,83.7 to 92.3,278
Hep B,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,90.3,87.1 to 92.8,521
Hep B,≥2 Doses,States/Local Areas,Maine,2012,Age,7 Months,89.9,86.5 to 92.4,233
PCV,≥3 Doses,States/Local Areas,Maine,2018,Age,7 Months,70.5,63.4 to 76.8,251
PCV,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,72.3,67.3 to 76.8,495
PCV,≥3 Doses,States/Local Areas,Maine,2019,Age,7 Months,74.1,67.0 to 80.1,244
PCV,≥3 Doses,States/Local Areas,Maine,2011,Age,13 Months,89.4,78.1 to 95.2,203
PCV,≥4 Doses,States/Local Areas,Maine,2017,Age,19 Months,76.8,69.5 to 82.7,259
PCV,≥4 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,83.0,78.7 to 86.7,510
PCV,≥4 Doses,States/Local Areas,Maine,2018,Age,19 Months,89.2,84.0 to 92.8,251
PCV,≥4 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,83.8,78.4 to 88.1,411
≥1 Dose MMR,,States/Local Areas,Maine,2017,Age,24 Months,91.5,86.7 to 95.1,259
≥1 Dose MMR,,States/Local Areas,Maine,2017-2018,Age,24 Months,92.9,89.8 to 95.3,510
≥1 Dose MMR,,States/Local Areas,Maine,2016,Age,24 Months,93.6,89.4 to 96.6,243
≥1 Dose MMR,,States/Local Areas,Maine,2016-2017,Age,24 Months,92.6,89.5 to 95.0,502
PCV,≥3 Doses,States/Local Areas,Maine,2012,Age,13 Months,94.2,92.0 to 95.8,233
Hep B,≥3 Doses,States/Local Areas,Maine,2016,Age,24 Months,90.3,85.6 to 94.0,243
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,90.5,87.5 to 93.1,502
Hep B,≥3 Doses,States/Local Areas,Maine,2015,Age,24 Months,90.2,85.8 to 93.7,278
Hep B,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,90.3,87.1 to 93.0,521
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2016,Age,0-1 Days,60.2,52.2 to 67.8,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2016-2017,Age,0-1 Days,61.0,55.5 to 66.2,502
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2017,Age,0-1 Days,61.7,54.3 to 68.6,259
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2017-2018,Age,0-1 Days,63.9,58.7 to 68.9,510
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2014,Age,0-2 Days,59.2,52.1 to 65.9,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2014-2015,Age,0-2 Days,62.2,57.2 to 66.9,553
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2015,Age,0-2 Days,65.2,58.2 to 71.6,278
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2015-2016,Age,0-2 Days,66.8,61.5 to 71.7,521
PCV,≥4 Doses,States/Local Areas,Maine,2011,Age,24 Months,84.8,77.8 to 90.6,203
≥1 Dose Varicella,,States/Local Areas,Maine,2015,Age,35 Months,93.2,88.6 to 96.4,278
≥1 Dose Varicella,,States/Local Areas,Maine,2015-2016,Age,35 Months,95.0,91.4 to 97.4,521
≥1 Dose Varicella,,States/Local Areas,Maine,2014,Age,35 Months,90.7,85.5 to 94.7,275
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2015,Age,35 Months,92.1,88.7 to 94.8,553
PCV,≥4 Doses,States/Local Areas,Maine,2019,Age,19 Months,83.2,77.0 to 88.0,244
≥1 Dose MMR,,States/Local Areas,Maine,2018,Age,24 Months,94.2,89.9 to 97.1,251
≥1 Dose MMR,,States/Local Areas,Maine,2018-2019,Age,24 Months,93.9,90.8 to 96.2,495
≥1 Dose Varicella,,States/Local Areas,Maine,2013,Age,35 Months,91.2,85.7 to 95.2,244
≥1 Dose Varicella,,States/Local Areas,Maine,2013-2014,Age,35 Months,91.0,87.3 to 93.9,519
≥1 Dose Varicella,,States/Local Areas,Maine,2016,Age,35 Months,95.5,91.2 to 98.1,243
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2017,Age,35 Months,94.2,91.0 to 96.6,502
≥1 Dose MMR,,States/Local Areas,Maine,2013,Age,35 Months,96.9,93.8 to 98.7,244
≥1 Dose MMR,,States/Local Areas,Maine,2013-2014,Age,35 Months,95.6,93.0 to 97.4,519
≥1 Dose MMR,,States/Local Areas,Maine,2011,Age,35 Months,95.2,89.9 to 98.2,203
≥1 Dose MMR,,States/Local Areas,Maine,2012,Age,35 Months,95.8,92.0 to 98.1,233
≥1 Dose MMR,,States/Local Areas,Maine,2019,Age,24 Months,93.5,88.6 to 96.8,244
PCV,≥4 Doses,States/Local Areas,Maine,2015,Age,24 Months,83.8,77.8 to 89.0,278
PCV,≥4 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,84.3,80.0 to 88.1,521
PCV,≥4 Doses,States/Local Areas,Maine,2014,Age,24 Months,80.4,74.6 to 85.6,275
PCV,≥4 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,82.1,77.9 to 85.9,553
PCV,≥4 Doses,States/Local Areas,Maine,2013,Age,24 Months,85.0,78.3 to 90.5,244
PCV,≥4 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,82.7,78.4 to 86.6,519
Hep B,≥3 Doses,States/Local Areas,Maine,2019,Age,24 Months,90.1,84.4 to 94.4,244
Hep B,≥3 Doses,States/Local Areas,Maine,2017,Age,24 Months,90.7,86.8 to 93.9,259
Hep B,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,91.8,89.0 to 94.1,510
Hep B,≥3 Doses,States/Local Areas,Maine,2011,Age,35 Months,88.6,82.2 to 93.5,203
PCV,≥4 Doses,States/Local Areas,Maine,2012,Age,24 Months,86.8,80.2 to 92.0,233
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2017,Age,0-2 Days,71.1,64.0 to 77.4,259
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2017-2018,Age,0-2 Days,70.9,65.9 to 75.5,510
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2018,Age,0-2 Days,70.7,63.4 to 77.1,251
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2018-2019,Age,0-2 Days,76.0,71.1 to 80.3,495
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2019,Age,0-2 Days,81.4,74.8 to 86.7,244
Hep B,≥2 Doses,States/Local Areas,Maine,2018,Age,7 Months,91.7,86.8 to 94.9,251
Hep B,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,90.9,87.2 to 93.7,495
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2016,Age,0-2 Days,68.3,60.2 to 75.5,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2016-2017,Age,0-2 Days,69.7,64.3 to 74.6,502
Hep B,≥2 Doses,States/Local Areas,Maine,2016,Age,7 Months,91.9,87.3 to 94.9,243
Hep B,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,91.0,88.0 to 93.3,502
PCV,≥3 Doses,States/Local Areas,Maine,2013,Age,13 Months,93.2,91.8 to 94.3,244
PCV,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,89.6,87.5 to 91.5,519
Hep B,≥2 Doses,States/Local Areas,Maine,2017,Age,7 Months,90.2,85.8 to 93.3,259
Hep B,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,91.0,87.9 to 93.3,510
PCV,≥3 Doses,States/Local Areas,Maine,2014,Age,13 Months,86.0,80.4 to 90.2,275
PCV,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,86.8,83.0 to 89.8,553
PCV,≥3 Doses,States/Local Areas,Maine,2015,Age,13 Months,87.6,82.1 to 91.6,278
PCV,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,88.1,84.3 to 91.1,521
Hep B,≥3 Doses,States/Local Areas,Maine,2018,Age,24 Months,92.8,88.5 to 95.9,251
Hep B,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,91.5,88.0 to 94.2,495
DTaP,≥4 Doses,States/Local Areas,Maine,2017,Age,35 Months,88.5,83.2 to 92.6,259
DTaP,≥4 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,91.7,88.3 to 94.4,510
DTaP,≥4 Doses,States/Local Areas,Maine,2016,Age,35 Months,94.6,89.4 to 97.7,243
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,91.0,87.4 to 94.0,502
DTaP,≥4 Doses,States/Local Areas,Maine,2018,Age,35 Months,95.7,90.4 to 98.5,251
DTaP,≥4 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,94.4,88.9 to 97.7,495
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,50.0,29.8 to 70.2,38
≥1 Dose Varicella,,States/Local Areas,Maine,2018,Age,35 Months,94.8,91.1 to 97.4,251
≥1 Dose Varicella,,States/Local Areas,Maine,2018-2019,Age,35 Months,95.3,92.6 to 97.2,495
≥1 Dose Varicella,,States/Local Areas,Maine,2017,Age,35 Months,92.6,88.3 to 95.8,259
≥1 Dose Varicella,,States/Local Areas,Maine,2017-2018,Age,35 Months,93.8,91.0 to 95.9,510
Hep B,≥2 Doses,States/Local Areas,Maine,2016,Age,13 Months,92.1,87.5 to 95.1,243
Hep B,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,92.3,89.4 to 94.4,502
Hep B,≥2 Doses,States/Local Areas,Maine,2015,Age,13 Months,90.6,85.8 to 93.9,278
Hep B,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,91.4,88.3 to 93.7,521
Hib,≥1 Dose,States/Local Areas,Maine,2014,Age,3 Months,88.7,83.6 to 92.4,275
Hib,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,3 Months,89.6,86.2 to 92.2,553
Hep B,≥2 Doses,States/Local Areas,Maine,2014,Age,13 Months,90.7,86.5 to 93.7,275
Hep B,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,90.7,87.6 to 93.0,553
PCV,≥3 Doses,States/Local Areas,Maine,2019,Age,13 Months,90.9,85.2 to 94.5,244
PCV,≥3 Doses,States/Local Areas,Maine,2011,Age,19 Months,94.4,89.0 to 97.2,203
PCV,≥3 Doses,States/Local Areas,Maine,2013,Age,19 Months,95.1,94.4 to 95.7,244
PCV,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,92.5,91.3 to 93.6,519
PCV,≥3 Doses,States/Local Areas,Maine,2014,Age,19 Months,89.9,84.9 to 93.4,275
PCV,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,90.2,86.8 to 92.8,553
Hep B,≥3 Doses,States/Local Areas,Maine,2016,Age,35 Months,90.3,85.6 to 94.0,243
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,92.2,89.1 to 94.6,502
PCV,≥4 Doses,States/Local Areas,Maine,2019,Age,24 Months,86.3,81.0 to 90.7,244
PCV,≥4 Doses,States/Local Areas,Maine,2018,Age,24 Months,90.4,85.8 to 94.1,251
PCV,≥4 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,88.4,85.0 to 91.4,495
PCV,≥4 Doses,States/Local Areas,Maine,2011,Age,35 Months,87.1,80.0 to 92.7,203
PCV,≥4 Doses,States/Local Areas,Maine,2012,Age,35 Months,89.2,82.8 to 94.0,233
Hep B,≥3 Doses,States/Local Areas,Maine,2018,Age,35 Months,95.7,90.9 to 98.4,251
Hep B,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,93.5,89.6 to 96.3,495
PCV,≥3 Doses,States/Local Areas,Maine,2012,Age,19 Months,96.7,94.7 to 97.9,233
Hep B,≥3 Doses,States/Local Areas,Maine,2017,Age,35 Months,93.5,89.8 to 96.2,259
Hep B,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,94.5,91.8 to 96.5,510
≥1 Dose Varicella,,States/Local Areas,Maine,2019,Age,35 Months,95.9,91.4 to 98.4,244
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,88.3,84.6 to 92.0,365
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,92.2,89.5 to 94.8,530
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,72.7,57.1 to 88.4,38
≥1 Dose MMR,,States/Local Areas,Maine,2016,Age,35 Months,93.6,89.4 to 96.6,243
≥1 Dose MMR,,States/Local Areas,Maine,2016-2017,Age,35 Months,94.2,91.4 to 96.3,502
≥1 Dose MMR,,States/Local Areas,Maine,2014,Age,35 Months,94.3,89.9 to 97.2,275
≥1 Dose MMR,,States/Local Areas,Maine,2014-2015,Age,35 Months,94.7,92.0 to 96.8,553
≥1 Dose MMR,,States/Local Areas,Maine,2015,Age,35 Months,94.6,91.2 to 97.0,278
≥1 Dose MMR,,States/Local Areas,Maine,2015-2016,Age,35 Months,94.1,91.5 to 96.1,521
PCV,≥4 Doses,States/Local Areas,Maine,2017,Age,24 Months,81.7,75.3 to 87.2,259
PCV,≥4 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,86.1,82.2 to 89.5,510
PCV,≥4 Doses,States/Local Areas,Maine,2016,Age,24 Months,84.8,78.4 to 90.1,243
PCV,≥4 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,83.3,78.8 to 87.2,502
Hep B,≥2 Doses,States/Local Areas,Maine,2019,Age,7 Months,90.1,83.9 to 94.1,244
Hep B,≥2 Doses,States/Local Areas,Maine,2011,Age,13 Months,90.9,82.7 to 95.4,203
Hep B,≥2 Doses,States/Local Areas,Maine,2013,Age,13 Months,94.1,91.4 to 96.1,244
Hep B,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,92.4,88.8 to 95.0,519
Hep B,≥2 Doses,States/Local Areas,Maine,2012,Age,13 Months,93.3,90.8 to 95.1,233
PCV,≥3 Doses,States/Local Areas,Maine,2017,Age,13 Months,88.3,82.8 to 92.3,259
PCV,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,91.5,88.2 to 93.9,510
PCV,≥3 Doses,States/Local Areas,Maine,2018,Age,13 Months,94.5,90.3 to 97.0,251
PCV,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,92.7,89.4 to 95.1,495
Hep B,≥3 Doses,States/Local Areas,Maine,2012,Age,35 Months,94.3,90.1 to 97.1,233
Hep B,≥3 Doses,States/Local Areas,Maine,2015,Age,35 Months,90.8,86.3 to 94.3,278
Hep B,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,90.6,87.4 to 93.3,521
Hep B,≥3 Doses,States/Local Areas,Maine,2014,Age,35 Months,86.8,81.9 to 90.8,275
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,88.8,85.6 to 91.5,553
Hep B,≥3 Doses,States/Local Areas,Maine,2013,Age,35 Months,90.5,84.8 to 94.8,244
Hep B,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,88.6,85.0 to 91.7,519
Hib,Full Series,States/Local Areas,Maine,2020,Age,24 Months,88.3,82.7 to 92.7,223
PCV,≥3 Doses,States/Local Areas,Maine,2016,Age,13 Months,88.6,82.8 to 92.6,243
PCV,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,88.5,84.6 to 91.4,502
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,86.2,79.6 to 92.8,184
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.2,87.9 to 92.5,821
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,96.0,94.4 to 97.6,530
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.6,84.4 to 96.8,66
≥1 Dose MMR,,States/Local Areas,Maine,2019,Age,35 Months,96.7,91.5 to 99.1,244
PCV,≥4 Doses,States/Local Areas,Maine,2013,Age,35 Months,87.5,81.3 to 92.5,244
PCV,≥4 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,86.6,82.5 to 90.2,519
≥1 Dose MMR,,States/Local Areas,Maine,2018,Age,35 Months,97.5,93.9 to 99.2,251
≥1 Dose MMR,,States/Local Areas,Maine,2018-2019,Age,35 Months,97.3,94.3 to 98.9,495
≥1 Dose MMR,,States/Local Areas,Maine,2017,Age,35 Months,94.4,90.4 to 97.1,259
≥1 Dose MMR,,States/Local Areas,Maine,2017-2018,Age,35 Months,95.8,93.3 to 97.6,510
Hib,≥1 Dose,States/Local Areas,Maine,2015,Age,3 Months,90.4,85.5 to 93.8,278
Hib,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,3 Months,89.5,86.0 to 92.2,521
Hib,≥1 Dose,States/Local Areas,Maine,2016,Age,3 Months,88.6,83.1 to 92.5,243
Hib,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,3 Months,88.7,85.2 to 91.4,502
Hib,≥1 Dose,States/Local Areas,Maine,2017,Age,3 Months,88.8,84.2 to 92.2,259
Hib,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,3 Months,90.2,87.0 to 92.7,510
Hep B,≥2 Doses,States/Local Areas,Maine,2017,Age,13 Months,92.5,88.5 to 95.1,259
Hep B,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,93.7,91.1 to 95.6,510
Hep B,≥2 Doses,States/Local Areas,Maine,2018,Age,13 Months,94.9,90.8 to 97.3,251
Hep B,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,93.7,90.3 to 96.0,495
Hep B,≥2 Doses,States/Local Areas,Maine,2019,Age,13 Months,92.5,86.4 to 96.0,244
PCV,≥3 Doses,States/Local Areas,Maine,2015,Age,19 Months,90.5,87.7 to 92.7,278
PCV,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,90.5,86.9 to 93.1,521
PCV,≥3 Doses,States/Local Areas,Maine,2016,Age,19 Months,90.4,85.0 to 94.0,243
PCV,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,90.0,86.4 to 92.8,502
PCV,≥3 Doses,States/Local Areas,Maine,2017,Age,19 Months,89.6,84.2 to 93.3,259
PCV,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,92.7,89.5 to 95.0,510
Hep B,≥3 Doses,States/Local Areas,Maine,2019,Age,35 Months,91.0,85.1 to 95.3,244
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,92.4,85.3 to 99.5,40
Hib,≥1 Dose,States/Local Areas,Maine,2013,Age,3 Months,90.2,87.8 to 92.2,244
Hib,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,3 Months,89.5,87.8 to 91.0,519
Hib,≥1 Dose,States/Local Areas,Maine,2012,Age,3 Months,90.0,87.2 to 92.2,233
Hib,≥1 Dose,States/Local Areas,Maine,2011,Age,3 Months,90.1,84.2 to 94.0,203
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,90.0,86.8 to 93.2,430
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,85.6,80.8 to 90.4,275
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Overall,Overall,89.4,87.2 to 91.7,950
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,90.3,87.0 to 93.5,371
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,87.3 to 93.6,395
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.5,85.4 to 97.6,66
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,93.5,86.9 to 100.0,40
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,74.6,59.4 to 89.8,38
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,90.5,87.1 to 93.9,365
PCV,≥4 Doses,States/Local Areas,Maine,2016,Age,35 Months,90.8,84.0 to 95.6,243
PCV,≥4 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,87.1,82.7 to 90.8,502
PCV,≥4 Doses,States/Local Areas,Maine,2015,Age,35 Months,86.8,80.7 to 91.8,278
PCV,≥4 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,88.4,84.1 to 92.0,521
PCV,≥4 Doses,States/Local Areas,Maine,2014,Age,35 Months,85.9,80.2 to 90.7,275
PCV,≥4 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,86.2,82.1 to 89.8,553
≥1 Dose Varicella,,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,94.5,91.8 to 97.3,245
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.9 to 96.1,395
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,90.9,85.6 to 96.2,184
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,90.4 to 94.5,821
Hib,≥1 Dose,States/Local Areas,Maine,2018,Age,3 Months,91.6,86.5 to 94.9,251
Hib,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,3 Months,92.8,89.5 to 95.0,495
Hib,≥1 Dose,States/Local Areas,Maine,2019,Age,3 Months,93.9,89.4 to 96.6,244
PCV,≥3 Doses,States/Local Areas,Maine,2015,Age,24 Months,91.1,86.5 to 94.7,278
PCV,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,91.3,88.2 to 93.9,521
PCV,≥3 Doses,States/Local Areas,Maine,2014,Age,24 Months,90.6,86.1 to 94.2,275
PCV,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,90.9,87.7 to 93.5,553
PCV,≥3 Doses,States/Local Areas,Maine,2012,Age,24 Months,97.8,95.4 to 99.1,233
Hib,≥2 Doses,States/Local Areas,Maine,2017,Age,5 Months,80.0,73.4 to 85.3,259
Hib,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,5 Months,83.2,78.9 to 86.8,510
PCV,≥3 Doses,States/Local Areas,Maine,2013,Age,24 Months,96.7,94.1 to 98.4,244
PCV,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,93.8,91.2 to 95.9,519
PCV,≥1 Dose,States/Local Areas,Maine,2013,Age,3 Months,89.9,87.2 to 92.0,244
PCV,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,3 Months,87.1,84.2 to 89.5,519
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,84.8,73.1 to 96.5,40
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,78.3,73.2 to 83.4,365
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,64.2,45.9 to 82.6,38
Hib,≥2 Doses,States/Local Areas,Maine,2015,Age,5 Months,83.6,77.8 to 88.1,278
Hib,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,5 Months,82.0,77.7 to 85.7,521
Hib,≥2 Doses,States/Local Areas,Maine,2016,Age,5 Months,80.5,73.7 to 85.9,243
Hib,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,5 Months,80.2,75.6 to 84.2,502
Hib,≥2 Doses,States/Local Areas,Maine,2012,Age,5 Months,82.5,80.2 to 84.5,233
Hib,≥2 Doses,States/Local Areas,Maine,2011,Age,5 Months,80.6,77.1 to 83.7,203
PCV,≥3 Doses,States/Local Areas,Maine,2018,Age,19 Months,95.8,91.7 to 97.9,251
PCV,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,92.7,89.4 to 95.1,495
PCV,≥3 Doses,States/Local Areas,Maine,2019,Age,19 Months,93.4,88.8 to 96.2,244
PCV,≥3 Doses,States/Local Areas,Maine,2011,Age,24 Months,94.4,90.1 to 97.2,203
PCV,≥1 Dose,States/Local Areas,Maine,2012,Age,3 Months,91.2,88.4 to 93.4,233
PCV,≥1 Dose,States/Local Areas,Maine,2011,Age,3 Months,88.2,83.4 to 91.7,203
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,97.2,95.3 to 99.2,245
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,93.8,91.2 to 96.3,430
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,87.7,83.5 to 91.9,275
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Overall,Overall,92.4,90.5 to 94.3,950
≥1 Dose MMR,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,92.1,89.1 to 95.0,371
PCV,≥4 Doses,States/Local Areas,Maine,2018,Age,35 Months,92.1,87.2 to 95.6,251
PCV,≥4 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,90.4,86.7 to 93.4,495
PCV,≥4 Doses,States/Local Areas,Maine,2019,Age,35 Months,88.8,82.9 to 93.4,244
PCV,≥4 Doses,States/Local Areas,Maine,2017,Age,35 Months,84.0,77.9 to 89.2,259
PCV,≥4 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,87.9,84.2 to 91.2,510
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,91.1,87.6 to 94.6,245
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,87.8,84.2 to 91.3,530
Hib,≥2 Doses,States/Local Areas,Maine,2013,Age,5 Months,85.4,82.3 to 88.1,244
Hib,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,5 Months,81.8,79.6 to 83.9,519
Hib,≥2 Doses,States/Local Areas,Maine,2014,Age,5 Months,78.1,71.6 to 83.5,275
Hib,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,5 Months,80.9,77.8 to 83.5,553
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,91.7,87.4 to 96.1,245
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,85.2,80.9 to 89.4,430
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,72.1,65.9 to 78.4,275
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,82.0,78.9 to 85.1,950
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,83.0,78.5 to 87.6,371
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.0,78.3 to 87.6,395
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,81.0,67.8 to 94.2,38
Hib,≥2 Doses,States/Local Areas,Maine,2013,Age,7 Months,90.8,85.6 to 94.2,244
Hib,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,90.7,86.9 to 93.4,519
Hib,≥2 Doses,States/Local Areas,Maine,2014,Age,7 Months,90.6,86.1 to 93.7,275
Hib,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,91.5,88.5 to 93.8,553
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2012,Age,0-3 Days,75.5,67.9 to 81.8,233
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,78.3,70.2 to 86.4,184
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2011,Age,0-3 Days,65.2,56.5 to 72.9,203
PCV,≥1 Dose,States/Local Areas,Maine,2018,Age,3 Months,91.0,85.7 to 94.5,251
PCV,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,3 Months,92.1,88.8 to 94.5,495
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,88.8,85.0 to 92.5,365
Hib,≥2 Doses,States/Local Areas,Maine,2018,Age,5 Months,86.3,80.1 to 90.8,251
Hib,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,5 Months,85.3,81.1 to 88.7,495
Hib,≥2 Doses,States/Local Areas,Maine,2019,Age,5 Months,84.3,78.1 to 88.9,244
Hib,≥2 Doses,States/Local Areas,Maine,2011,Age,7 Months,93.2,86.0 to 96.8,203
PCV,≥3 Doses,States/Local Areas,Maine,2016,Age,24 Months,91.7,87.0 to 95.2,243
PCV,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,91.7,88.6 to 94.2,502
Hib,≥2 Doses,States/Local Areas,Maine,2012,Age,7 Months,93.6,91.0 to 95.4,233
PCV,≥3 Doses,States/Local Areas,Maine,2017,Age,24 Months,91.6,87.2 to 94.9,259
PCV,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,93.7,91.1 to 95.8,510
PCV,≥3 Doses,States/Local Areas,Maine,2018,Age,24 Months,95.8,92.2 to 98.0,251
PCV,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,94.7,92.1 to 96.7,495
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,91.3,88.8 to 93.8,530
PCV,≥1 Dose,States/Local Areas,Maine,2016,Age,3 Months,89.8,84.4 to 93.4,243
PCV,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,3 Months,87.5,83.9 to 90.4,502
PCV,≥1 Dose,States/Local Areas,Maine,2017,Age,3 Months,85.2,79.7 to 89.4,259
PCV,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,3 Months,88.1,84.6 to 91.0,510
Polio,≥3 Doses,States/Local Areas,Maine,2019,Age,35 Months,95.3,90.9 to 98.0,244
Hib,Full Series,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,79.5,71.7 to 87.4,184
Hib,Full Series,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.7,81.6 to 87.7,821
Hib,Full Series,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.4,76.6 to 94.3,66
Hib,Full Series,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,87.4,77.8 to 96.9,40
Hib,Primary Series,States/Local Areas,Maine,2012,Age,7 Months,73.9,70.2 to 77.3,233
Hib,Full Series,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,92.3,88.0 to 96.5,245
Hib,Primary Series,States/Local Areas,Maine,2011,Age,7 Months,72.3,67.9 to 76.4,203
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,92.0 to 96.9,395
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,83.3 to 95.5,184
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.4,90.2 to 94.6,821
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.4,91.3 to 99.5,66
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,94.1,87.5 to 100.0,40
Hib,Full Series,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,88.4,84.9 to 92.0,530
Polio,≥3 Doses,States/Local Areas,Maine,2015,Age,35 Months,93.7,89.8 to 96.5,278
Polio,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,93.9,91.3 to 95.9,521
Hib,Full Series,States/Local Areas,Maine,2016,Age,35 Months,87.3,81.1 to 92.3,243
Hib,Full Series,States/Local Areas,Maine,2016-2017,Age,35 Months,85.8,81.7 to 89.4,502
Hib,Full Series,States/Local Areas,Maine,2018,Age,35 Months,89.7,83.7 to 94.2,251
Hib,Full Series,States/Local Areas,Maine,2018-2019,Age,35 Months,88.8,84.6 to 92.3,495
Hib,Full Series,States/Local Areas,Maine,2019,Age,35 Months,87.9,81.5 to 92.9,244
Hib,Full Series,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,79.9,74.9 to 84.9,365
Hib,Full Series,States/Local Areas,Maine,2014,Age,35 Months,85.5,80.0 to 90.1,275
Hib,Full Series,States/Local Areas,Maine,2014-2015,Age,35 Months,85.5,81.7 to 89.0,553
Hib,Full Series,States/Local Areas,Maine,2015,Age,35 Months,85.1,79.4 to 90.0,278
Hib,Full Series,States/Local Areas,Maine,2015-2016,Age,35 Months,86.2,82.1 to 89.8,521
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,90.8,87.2 to 94.4,365
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,82.5,69.6 to 95.3,38
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,95.4,93.6 to 97.2,530
Polio,≥3 Doses,States/Local Areas,Maine,2018,Age,35 Months,96.2,92.6 to 98.3,251
Polio,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,95.7,93.1 to 97.6,495
Hib,Full Series,States/Local Areas,Maine,2017,Age,35 Months,84.3,78.5 to 89.2,259
Hib,Full Series,States/Local Areas,Maine,2017-2018,Age,35 Months,87.0,83.1 to 90.5,510
DTaP,≥2 Doses,States/Local Areas,Maine,2014,Age,5 Months,80.7,74.3 to 85.9,275
DTaP,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,5 Months,82.6,78.5 to 86.1,553
Polio,≥3 Doses,States/Local Areas,Maine,2017,Age,35 Months,95.7,92.6 to 97.8,259
Polio,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,96.3,94.1 to 97.8,510
Polio,≥3 Doses,States/Local Areas,Maine,2016,Age,35 Months,94.2,90.3 to 96.9,243
Polio,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,95.2,92.8 to 96.9,502
DTaP,≥2 Doses,States/Local Areas,Maine,2016,Age,5 Months,82.5,75.9 to 87.6,243
DTaP,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,5 Months,82.0,77.5 to 85.7,502
DTaP,≥2 Doses,States/Local Areas,Maine,2015,Age,5 Months,84.5,78.8 to 88.9,278
DTaP,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,5 Months,83.5,79.3 to 87.0,521
DTaP,≥2 Doses,States/Local Areas,Maine,2013,Age,5 Months,87.8,85.4 to 89.9,244
DTaP,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,5 Months,84.3,80.8 to 87.3,519
DTaP,≥2 Doses,States/Local Areas,Maine,2012,Age,5 Months,85.5,83.8 to 87.2,233
DTaP,≥2 Doses,States/Local Areas,Maine,2011,Age,5 Months,81.4,77.0 to 85.1,203
Hib,Full Series,States/Local Areas,Maine,2019,Age,24 Months,84.0,78.0 to 89.2,244
Polio,≥3 Doses,States/Local Areas,Maine,2011,Age,35 Months,95.7,91.4 to 98.2,203
Polio,≥3 Doses,States/Local Areas,Maine,2014,Age,35 Months,89.8,85.4 to 93.4,275
Polio,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,91.7,88.9 to 94.1,553
Polio,≥3 Doses,States/Local Areas,Maine,2013,Age,35 Months,95.5,92.0 to 97.8,244
Polio,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,92.8,90.0 to 95.0,519
Hib,Full Series,States/Local Areas,Maine,2013,Age,35 Months,87.2,80.9 to 92.2,244
Hib,Full Series,States/Local Areas,Maine,2013-2014,Age,35 Months,86.4,82.4 to 90.0,519
Hib,Full Series,States/Local Areas,Maine,2011,Age,35 Months,82.5,74.9 to 88.9,203
Hib,Full Series,States/Local Areas,Maine,2012,Age,35 Months,89.6,83.3 to 94.3,233
Polio,≥3 Doses,States/Local Areas,Maine,2012,Age,35 Months,97.7,95.0 to 99.2,233
Hib,Full Series,States/Local Areas,Maine,2018,Age,24 Months,87.3,81.9 to 91.8,251
Hib,Full Series,States/Local Areas,Maine,2018-2019,Age,24 Months,85.9,81.9 to 89.5,495
Hib,Full Series,States/Local Areas,Maine,2017,Age,24 Months,83.9,78.1 to 88.9,259
Hib,Full Series,States/Local Areas,Maine,2017-2018,Age,24 Months,85.7,81.8 to 89.1,510
Hib,Full Series,States/Local Areas,Maine,2016,Age,24 Months,86.5,80.4 to 91.5,243
Hib,Full Series,States/Local Areas,Maine,2016-2017,Age,24 Months,85.3,81.2 to 88.9,502
Hib,≥3 Doses,States/Local Areas,Maine,2013,Age,24 Months,96.8,94.3 to 98.5,244
Hib,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,94.0,91.6 to 95.9,519
Hib,≥3 Doses,States/Local Areas,Maine,2012,Age,24 Months,96.0,92.1 to 98.3,233
Hib,≥3 Doses,States/Local Areas,Maine,2011,Age,24 Months,94.0,89.2 to 97.1,203
Hib,≥3 Doses,States/Local Areas,Maine,2014,Age,24 Months,91.1,86.8 to 94.4,275
Hib,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,92.3,89.6 to 94.6,553
Polio,≥3 Doses,States/Local Areas,Maine,2017,Age,24 Months,93.7,90.2 to 96.2,259
Polio,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,95.0,92.7 to 96.7,510
DTaP,≥3 Doses,States/Local Areas,Maine,2012,Age,24 Months,98.4,96.8 to 99.3,233
Polio,≥3 Doses,States/Local Areas,Maine,2018,Age,24 Months,96.2,92.6 to 98.3,251
Polio,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,95.7,93.1 to 97.6,495
Polio,≥3 Doses,States/Local Areas,Maine,2019,Age,24 Months,95.3,90.9 to 98.0,244
Hib,≥3 Doses,States/Local Areas,Maine,2019,Age,19 Months,92.9,87.7 to 96.0,244
DTaP,≥3 Doses,States/Local Areas,Maine,2013,Age,24 Months,97.1,94.4 to 98.7,244
DTaP,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,95.2,93.0 to 96.9,519
Hib,Full Series,States/Local Areas,Maine,2015,Age,24 Months,84.7,79.0 to 89.6,278
Hib,Full Series,States/Local Areas,Maine,2015-2016,Age,24 Months,85.6,81.6 to 89.2,521
DTaP,≥3 Doses,States/Local Areas,Maine,2011,Age,24 Months,97.2,93.6 to 99.1,203
DTaP,≥3 Doses,States/Local Areas,Maine,2017,Age,19 Months,92.5,87.8 to 95.5,259
DTaP,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,94.2,91.4 to 96.2,510
DTaP,≥3 Doses,States/Local Areas,Maine,2019,Age,19 Months,94.2,88.9 to 97.0,244
DTaP,≥3 Doses,States/Local Areas,Maine,2018,Age,19 Months,95.9,91.9 to 98.0,251
DTaP,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,93.8,90.7 to 95.9,495
Polio,≥3 Doses,States/Local Areas,Maine,2015,Age,24 Months,93.7,89.8 to 96.5,278
Polio,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,93.7,91.1 to 95.8,521
Polio,≥3 Doses,States/Local Areas,Maine,2014,Age,24 Months,89.8,85.4 to 93.4,275
Polio,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,91.7,88.9 to 94.1,553
Hep A,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,80.2,72.6 to 86.8,366
Hib,≥3 Doses,States/Local Areas,Maine,2015,Age,19 Months,93.2,88.7 to 96.0,278
Hib,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,92.0,88.8 to 94.3,521
Polio,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,3 Months,89.2,84.1 to 92.9,366
Hib,≥3 Doses,States/Local Areas,Maine,2018,Age,19 Months,93.9,89.6 to 96.5,251
Hib,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,77.4,72.8 to 81.4,495
Hib,≥3 Doses,States/Local Areas,Maine,2017,Age,19 Months,90.5,85.1 to 94.1,259
Hib,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,92.2,89.0 to 94.6,510
Polio,≥3 Doses,States/Local Areas,Maine,2016,Age,24 Months,94.0,90.1 to 96.7,243
Polio,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,93.8,91.3 to 95.8,502
Hib,≥3 Doses,States/Local Areas,Maine,2016,Age,19 Months,90.8,85.6 to 94.2,243
Hib,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,90.6,87.1 to 93.3,502
DTaP,≥3 Doses,States/Local Areas,Maine,2014,Age,19 Months,92.4,88.1 to 95.2,275
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,93.3,90.5 to 95.3,553
DTaP,≥3 Doses,States/Local Areas,Maine,2015,Age,19 Months,94.3,90.8 to 96.5,278
DTaP,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,93.4,90.5 to 95.5,521
Polio,≥3 Doses,States/Local Areas,Maine,2019,Age,19 Months,94.0,88.8 to 96.9,244
Polio,≥3 Doses,States/Local Areas,Maine,2011,Age,24 Months,94.9,90.5 to 97.6,203
Polio,≥3 Doses,States/Local Areas,Maine,2012,Age,24 Months,95.5,91.9 to 97.9,233
Hib,≥3 Doses,States/Local Areas,Maine,2014,Age,19 Months,89.0,84.1 to 92.5,275
Hib,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,91.1,88.0 to 93.4,553
Hib,≥3 Doses,States/Local Areas,Maine,2013,Age,19 Months,94.8,93.1 to 96.0,244
Hib,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,91.9,89.9 to 93.6,519
Polio,≥3 Doses,States/Local Areas,Maine,2013,Age,24 Months,95.2,91.7 to 97.6,244
Polio,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,24 Months,92.6,89.9 to 94.8,519
DTaP,≥3 Doses,States/Local Areas,Maine,2016,Age,19 Months,92.5,87.8 to 95.5,243
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,92.5,89.4 to 94.8,502
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,77.2,70.2 to 84.3,293
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,68.0,57.8 to 78.2,137
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,80.6,72.3 to 88.9,175
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Overall,Overall,79.0,75.1 to 82.9,833
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.2,63.7 to 78.8,315
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,83.6,78.5 to 88.7,343
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.7,77.3 to 86.2,605
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.9,67.4 to 88.4,111
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,79.6,68.5 to 90.7,66
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,97.0,92.6 to 98.8,269
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,94.2,90.5 to 96.6,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,91.5,88.7 to 93.6,227
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,94.3,90.6 to 96.6,444
Hib,Primary Series,States/Local Areas,Minnesota,2012,Age,7 Months,70.7,63.9 to 76.8,225
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,86.1,81.6 to 90.6,403
Hib,Primary Series,States/Local Areas,Minnesota,2011,Age,7 Months,71.4,63.2 to 78.4,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,97.2,92.5 to 99.0,217
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,96.1,93.2 to 97.7,507
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,94.5,88.4 to 97.4,283
Hib,≥3 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,87.4,79.5 to 92.5,227
Hib,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,90.5,85.9 to 93.7,444
Polio,≥3 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,93.2,86.9 to 96.6,283
Polio,≥3 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,92.2,86.2 to 96.2,208
Polio,≥3 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,94.6,90.1 to 97.4,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,91.9,86.0 to 95.4,269
Hib,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,89.6,85.1 to 92.9,496
Hib,≥3 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,92.1,88.4 to 94.7,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,92.0,89.6 to 93.9,562
Polio,≥3 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,93.6,89.4 to 96.5,293
Polio,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,94.7,92.0 to 96.7,562
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,94.9,90.4 to 97.4,290
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,93.9,90.8 to 96.1,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,92.9,87.6 to 96.5,227
Polio,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,94.3,91.0 to 96.7,444
Polio,≥3 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,95.8,92.0 to 98.1,269
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,94.3,91.2 to 96.6,496
Hib,≥3 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,87.0,80.8 to 91.4,328
Hib,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,52.4,46.9 to 57.8,611
Hib,≥3 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,89.4,83.2 to 93.5,290
Hib,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,88.2,84.1 to 91.4,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,95.7,91.1 to 98.3,217
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,94.9,92.0 to 97.0,507
Hib,≥3 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,93.7,87.1 to 97.0,217
Hib,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,91.6,87.4 to 94.4,507
DTaP,≥3 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,94.0,88.4 to 97.4,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,95.5,91.6 to 98.0,293
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,96.9,94.6 to 98.4,562
Hib,Full Series,States/Local Areas,Minnesota,2015,Age,24 Months,69.7,60.3 to 78.6,227
Hib,Full Series,States/Local Areas,Minnesota,2015-2016,Age,24 Months,77.7,71.7 to 83.3,444
Hib,≥3 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,92.3,87.9 to 95.6,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,93.1,89.9 to 95.5,562
Hib,≥3 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,92.7,87.0 to 96.5,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,93.5,87.9 to 97.1,208
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,90.8,84.4 to 95.3,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,94.0,88.9 to 97.2,269
Hib,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,91.0,87.0 to 94.3,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,96.2,92.1 to 98.5,225
Polio,≥3 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,92.0,87.3 to 95.5,328
Polio,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,93.1,89.6 to 95.7,611
Polio,≥3 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,94.1,88.4 to 97.5,283
Hib,≥3 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,87.8,80.9 to 92.5,283
Polio,≥3 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,94.2,90.0 to 97.0,290
Polio,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,93.1,90.1 to 95.5,618
Hib,Full Series,States/Local Areas,Minnesota,2016,Age,24 Months,86.0,78.9 to 91.6,217
Hib,Full Series,States/Local Areas,Minnesota,2016-2017,Age,24 Months,84.0,79.2 to 88.2,507
Hib,Full Series,States/Local Areas,Minnesota,2018,Age,24 Months,80.6,74.2 to 86.3,328
Hib,Full Series,States/Local Areas,Minnesota,2018-2019,Age,24 Months,79.8,75.1 to 84.2,611
Hib,Full Series,States/Local Areas,Minnesota,2017,Age,24 Months,82.2,75.4 to 88.0,290
Hib,Full Series,States/Local Areas,Minnesota,2017-2018,Age,24 Months,81.4,76.8 to 85.5,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,93.3,87.6 to 97.0,208
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,83.1,78.9 to 87.3,582
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.9,86.3 to 95.5,315
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,95.5,92.5 to 98.4,343
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.1,91.5 to 96.7,605
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.4,88.8 to 100.0,111
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,93.0,85.6 to 100.0,66
Hib,Full Series,States/Local Areas,Minnesota,2016,Age,35 Months,87.0,80.0 to 92.5,217
Hib,Full Series,States/Local Areas,Minnesota,2016-2017,Age,35 Months,86.8,82.2 to 90.7,507
Hib,Full Series,States/Local Areas,Minnesota,2018,Age,35 Months,86.2,79.8 to 91.4,328
Hib,Full Series,States/Local Areas,Minnesota,2018-2019,Age,35 Months,84.8,80.1 to 89.0,611
Hib,Full Series,States/Local Areas,Minnesota,2019,Age,35 Months,83.2,76.0 to 89.2,283
Hib,Full Series,States/Local Areas,Minnesota,2014,Age,35 Months,86.3,80.3 to 91.2,269
Hib,Full Series,States/Local Areas,Minnesota,2014-2015,Age,35 Months,82.9,77.1 to 88.0,496
Hib,Full Series,States/Local Areas,Minnesota,2015,Age,35 Months,79.6,69.1 to 88.4,227
Hib,Full Series,States/Local Areas,Minnesota,2015-2016,Age,35 Months,82.9,76.6 to 88.4,444
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.0,45.7 to 78.3,51
Hib,Full Series,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,72.4,64.5 to 80.4,221
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,90.4,85.7 to 95.2,221
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,95.6,93.2 to 98.0,582
Hib,Full Series,States/Local Areas,Minnesota,2017,Age,35 Months,86.8,80.6 to 91.7,290
Hib,Full Series,States/Local Areas,Minnesota,2017-2018,Age,35 Months,86.5,82.2 to 90.2,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,94.2,89.4 to 97.3,328
Polio,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,94.1,90.6 to 96.6,611
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.1,85.9 to 100.0,51
Polio,≥3 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,96.3,92.4 to 98.5,269
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,94.6,91.4 to 96.9,496
Polio,≥3 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,97.4,93.4 to 99.2,293
Polio,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,96.8,94.1 to 98.5,562
Polio,≥3 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,95.0,90.6 to 97.8,225
DTaP,≥2 Doses,States/Local Areas,Minnesota,2013,Age,5 Months,83.5,79.4 to 86.9,293
DTaP,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,5 Months,84.2,81.3 to 86.7,562
DTaP,≥2 Doses,States/Local Areas,Minnesota,2012,Age,5 Months,84.2,80.3 to 87.4,225
DTaP,≥2 Doses,States/Local Areas,Minnesota,2011,Age,5 Months,82.1,73.7 to 88.3,208
Hib,Full Series,States/Local Areas,Minnesota,2019,Age,24 Months,79.2,71.9 to 85.6,283
Polio,≥3 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,92.9,87.6 to 96.5,227
Polio,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,95.0,91.7 to 97.3,444
DTaP,≥2 Doses,States/Local Areas,Minnesota,2014,Age,5 Months,84.9,78.4 to 89.7,269
DTaP,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,5 Months,80.7,77.2 to 83.8,496
Hib,Full Series,States/Local Areas,Minnesota,2013,Age,35 Months,86.2,79.8 to 91.3,293
Hib,Full Series,States/Local Areas,Minnesota,2013-2014,Age,35 Months,86.2,81.9 to 89.9,562
Hib,Full Series,States/Local Areas,Minnesota,2011,Age,35 Months,83.6,75.7 to 90.1,208
Hib,Full Series,States/Local Areas,Minnesota,2012,Age,35 Months,85.0,77.6 to 90.9,225
DTaP,≥2 Doses,States/Local Areas,Minnesota,2016,Age,5 Months,87.2,79.0 to 92.5,217
DTaP,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,5 Months,85.6,80.5 to 89.5,507
DTaP,≥2 Doses,States/Local Areas,Minnesota,2015,Age,5 Months,76.6,67.2 to 84.0,227
DTaP,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,5 Months,81.9,75.9 to 86.6,444
Polio,≥3 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,94.2,90.0 to 97.0,290
Polio,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,94.3,91.3 to 96.5,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,97.2,92.7 to 99.2,217
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,95.8,93.0 to 97.7,507
Hep A,≥2 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,48.6,41.1 to 56.6,328
Hep A,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,47.9,42.4 to 53.7,611
Hep A,≥2 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,44.9,37.3 to 53.2,290
Hep A,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,46.7,41.3 to 52.4,618
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,53.2,43.3 to 63.7,217
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,49.1,42.8 to 55.8,507
DTaP,≥4 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,83.0,76.6 to 88.5,293
DTaP,≥4 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,82.8,78.2 to 87.0,562
Hib,Full Series,States/Local Areas,Minnesota,2020,Age,24 Months,76.1,68.5 to 83.0,239
≥1 Dose MMR,,States/Local Areas,Minnesota,2013,Age,13 Months,73.4,70.0 to 76.6,293
≥1 Dose MMR,,States/Local Areas,Minnesota,2013-2014,Age,13 Months,66.7,60.8 to 72.1,562
≥1 Dose MMR,,States/Local Areas,Minnesota,2012,Age,13 Months,65.5,59.1 to 71.3,225
≥1 Dose MMR,,States/Local Areas,Minnesota,2011,Age,13 Months,62.9,60.1 to 65.6,208
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,91.9,87.9 to 95.9,403
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.6,54.3 to 98.8,51
Hep A,≥1 Dose,States/Local Areas,Minnesota,2017,Age,35 Months,92.0,86.8 to 95.7,290
Hep A,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,35 Months,92.0,88.2 to 94.9,618
Hep A,≥1 Dose,States/Local Areas,Minnesota,2018,Age,35 Months,92.0,86.3 to 95.9,328
Hep A,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,35 Months,92.6,88.7 to 95.5,611
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,96.3,94.6 to 98.0,833
Hep A,≥2 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,32.3,24.0 to 42.4,227
Hep A,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,42.9,36.1 to 50.4,444
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,41.5,33.7 to 50.4,269
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,37.0,31.0 to 43.7,496
Hib,≥3 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,93.9,88.1 to 97.4,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2011,Age,13 Months,55.8,48.0 to 63.3,208
Polio,≥2 Doses,States/Local Areas,Minnesota,2016,Age,5 Months,86.9,78.7 to 92.2,217
Polio,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,5 Months,85.4,80.3 to 89.4,507
Polio,≥2 Doses,States/Local Areas,Minnesota,2017,Age,5 Months,83.9,76.8 to 89.1,290
Polio,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,5 Months,82.7,77.9 to 86.6,618
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,71.2,63.3 to 77.9,269
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,68.3,61.9 to 74.0,496
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,65.3,55.1 to 74.3,227
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,69.2,62.2 to 75.3,444
Polio,≥2 Doses,States/Local Areas,Minnesota,2019,Age,5 Months,83.6,75.9 to 89.1,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,91.8,83.2 to 100.0,66
Polio,≥2 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,91.9,83.0 to 96.4,225
Polio,≥2 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,90.7,87.3 to 93.2,208
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,73.0,65.7 to 79.3,290
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,75.7,70.7 to 80.0,618
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,78.3,71.4 to 84.0,328
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,78.7,73.7 to 82.9,611
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,82.1,71.5 to 90.5,217
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,82.5,76.1 to 88.1,507
Hep A,≥2 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,62.4,47.2 to 77.6,227
Hep A,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,72.9,63.7 to 81.3,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,79.0,71.5 to 85.0,283
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,82.8,71.6 to 91.4,269
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,73.5,63.3 to 82.8,496
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014,Age,13 Months,58.6,50.6 to 66.2,269
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2015,Age,13 Months,57.0,50.5 to 63.3,496
≥1 Dose Varicella,,States/Local Areas,Minnesota,2012,Age,13 Months,61.7,50.3 to 71.9,225
Hep A,≥1 Dose,States/Local Areas,Minnesota,2019,Age,35 Months,93.1,87.4 to 96.8,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,85.4,79.0 to 91.8,221
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,91.4,88.2 to 94.5,582
Polio,≥2 Doses,States/Local Areas,Minnesota,2018,Age,5 Months,81.4,74.5 to 86.8,328
Polio,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,5 Months,82.5,77.6 to 86.5,611
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.3,64.5 to 94.1,51
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013,Age,13 Months,66.1,62.5 to 69.5,293
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013-2014,Age,13 Months,62.4,56.5 to 67.9,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2015,Age,35 Months,90.4,83.2 to 95.3,227
Hep A,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,35 Months,91.6,86.8 to 95.1,444
Polio,≥2 Doses,States/Local Areas,Minnesota,2012,Age,5 Months,82.3,77.8 to 86.0,225
Polio,≥2 Doses,States/Local Areas,Minnesota,2011,Age,5 Months,78.2,70.4 to 84.4,208
Polio,≥2 Doses,States/Local Areas,Minnesota,2013,Age,5 Months,82.5,77.8 to 86.4,293
Polio,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,5 Months,83.6,80.6 to 86.2,562
Polio,≥2 Doses,States/Local Areas,Minnesota,2014,Age,5 Months,84.7,78.3 to 89.5,269
Polio,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,5 Months,80.7,77.2 to 83.7,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,96.3,93.3 to 99.4,137
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,98.9,97.8 to 99.9,403
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,93.3,89.0 to 97.6,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,63.2,56.1 to 69.8,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,60.0,52.1 to 67.5,208
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,75.8,69.6 to 81.0,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,73.5,69.1 to 77.5,562
DTaP,≥4 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,75.3,67.5 to 81.7,283
DTaP,≥4 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,87.8,81.3 to 92.8,208
DTaP,≥4 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,86.4,79.9 to 91.6,225
PCV,≥2 Doses,States/Local Areas,Minnesota,2018,Age,5 Months,81.3,74.4 to 86.7,328
PCV,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,5 Months,82.1,77.1 to 86.2,611
PCV,≥2 Doses,States/Local Areas,Minnesota,2019,Age,5 Months,82.9,75.2 to 88.6,283
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,98.6,97.4 to 99.7,343
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.4,94.4 to 98.4,605
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,96.4,93.5 to 99.3,175
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.8,88.4 to 97.2,315
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.6,96.4 to 100.0,111
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,95.9,91.0 to 100.0,66
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.1,85.9 to 100.0,51
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,82.9,74.9 to 88.7,217
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,79.2,73.8 to 83.8,507
DTaP,≥4 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,75.5,67.7 to 81.9,290
DTaP,≥4 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,73.0,67.7 to 77.7,618
DTaP,≥4 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,70.5,62.9 to 77.1,328
DTaP,≥4 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,95.4,92.0 to 97.4,611
Hep A,≥2 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,46.4,38.9 to 54.5,293
Hep A,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,43.9,38.4 to 49.8,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2013,Age,35 Months,90.4,84.6 to 94.7,293
Hep A,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,35 Months,91.5,87.9 to 94.4,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014,Age,35 Months,92.7,87.8 to 96.1,269
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,35 Months,91.4,87.3 to 94.6,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,93.0,87.8 to 96.0,328
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,91.0,86.9 to 93.9,611
Polio,≥3 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,94.1,88.5 to 97.6,283
Hep A,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,19 Months,90.3,86.9 to 92.8,823
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2019-2020,Age,0-2 Days,79.0,74.4 to 83.0,823
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2019-2020,Age,0-1 Days,74.4,69.6 to 78.7,823
≥1 Dose Varicella,,States/Local Areas,Michigan,2019-2020,Age,24 Months,93.5,90.8 to 95.6,823
Hep B,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,92.8,90.1 to 94.9,823
Hib,Full Series,States/Local Areas,Michigan,2019-2020,Age,24 Months,81.6,77.5 to 85.3,823
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2019-2020,Age,0-3 Days,80.6,76.0 to 84.4,823
PCV,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,69.5,64.6 to 74.0,823
PCV,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,94.3,91.8 to 96.3,823
PCV,≥4 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,83.6,79.7 to 87.2,823
Hep A,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,32.9,28.5 to 37.7,823
≥1 Dose MMR,,States/Local Areas,Michigan,2019-2020,Age,19 Months,91.0,87.6 to 93.5,823
Hib,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,88.1,84.3 to 91.1,823
Hib,Primary Series,States/Local Areas,Michigan,2019-2020,Age,19 Months,91.6,88.3 to 94.0,823
Hib,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,93.7,90.8 to 96.0,823
≥1 Dose MMR,,States/Local Areas,Michigan,2019-2020,Age,35 Months,96.8,94.6 to 98.3,823
Hib,Full Series,States/Local Areas,Michigan,2019-2020,Age,35 Months,84.5,80.5 to 88.1,823
Hib,Primary Series,States/Local Areas,Michigan,2019-2020,Age,35 Months,95.4,92.9 to 97.3,823
Hep B,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,94.8,92.1 to 96.8,823
≥1 Dose Varicella,,States/Local Areas,Michigan,2019-2020,Age,35 Months,96.7,94.4 to 98.3,823
PCV,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,95.2,92.8 to 97.0,823
DTaP,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,94.7,92.1 to 96.6,823
PCV,≥4 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,86.4,82.5 to 89.7,823
DTaP,≥4 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,80.7,76.2 to 84.8,823
Polio,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,94.6,92.0 to 96.5,823
Hep B,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,3 Months,96.5,94.5 to 97.7,823
≥1 Dose MMR,,States/Local Areas,Michigan,2019-2020,Age,24 Months,94.1,91.6 to 96.1,823
PCV,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,3 Months,86.4,82.6 to 89.5,823
DTaP,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,5 Months,82.7,78.4 to 86.2,823
Polio,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,5 Months,82.3,78.1 to 85.9,823
Hib,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,5 Months,81.2,77.0 to 84.9,823
Polio,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,94.6,92.0 to 96.4,823
≥1 Dose MMR,,States/Local Areas,Michigan,2019-2020,Age,13 Months,69.4,64.5 to 73.9,823
Hib,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,72.2,67.5 to 76.4,823
Hib,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,94.5,92.0 to 96.3,823
Hep B,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,95.4,93.1 to 96.9,823
Hib,Primary Series,States/Local Areas,Michigan,2019-2020,Age,13 Months,87.4,83.8 to 90.4,823
Hep B,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,5 Months,91.4,88.4 to 93.7,823
PCV,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,5 Months,80.0,75.5 to 83.8,823
DTaP,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,72.8,68.0 to 77.1,823
Polio,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,90.6,87.2 to 93.2,823
Hep B,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,90.1,86.9 to 92.6,823
Hib,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,90.6,87.3 to 93.1,823
≥1 Dose Varicella,,States/Local Areas,Michigan,2019-2020,Age,13 Months,65.6,60.6 to 70.3,823
PCV,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,89.4,85.9 to 92.1,823
DTaP,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,96.2,94.0 to 97.8,823
DTaP,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,92.1,88.8 to 94.5,823
Combined 7 Series,,States/Local Areas,Michigan,2019-2020,Age,24 Months,70.7,65.9 to 75.4,823
DTaP,≥4 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,87.9,83.5 to 91.6,823
Polio,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,95.6,93.1 to 97.4,823
Hib,Full Series,States/Local Areas,Michigan,2020,Age,19 Months,74.5,67.9 to 80.2,448
Hib,Primary Series,States/Local Areas,Michigan,2020,Age,19 Months,89.6,84.1 to 93.3,448
≥1 Dose Varicella,,States/Local Areas,Michigan,2020,Age,35 Months,95.7,92.5 to 97.8,448
Hep B,≥3 Doses,States/Local Areas,Michigan,2020,Age,35 Months,90.8,86.3 to 94.3,448
Hib,Full Series,States/Local Areas,Michigan,2020,Age,35 Months,82.7,76.7 to 87.9,448
Hib,≥3 Doses,States/Local Areas,Michigan,2020,Age,35 Months,91.4,86.8 to 94.9,448
Hib,Primary Series,States/Local Areas,Michigan,2020,Age,35 Months,93.1,88.9 to 96.1,448
≥1 Dose MMR,,States/Local Areas,Michigan,2020,Age,35 Months,95.9,92.7 to 98.0,448
Hib,≥3 Doses,States/Local Areas,Michigan,2020,Age,24 Months,90.4,85.6 to 94.1,448
≥1 Dose MMR,,States/Local Areas,Michigan,2020,Age,24 Months,94.0,90.0 to 96.7,448
DTaP,≥4 Doses,States/Local Areas,Michigan,2020,Age,24 Months,78.6,72.1 to 84.4,448
Polio,≥3 Doses,States/Local Areas,Michigan,2020,Age,24 Months,92.6,88.2 to 95.8,448
PCV,≥2 Doses,States/Local Areas,Michigan,2020,Age,5 Months,77.4,71.0 to 82.7,448
DTaP,≥3 Doses,States/Local Areas,Michigan,2020,Age,24 Months,92.8,88.4 to 95.9,448
Hep B,≥2 Doses,States/Local Areas,Michigan,2020,Age,7 Months,93.3,89.1 to 95.9,448
Hib,Primary Series,States/Local Areas,Michigan,2020,Age,7 Months,74.2,67.7 to 79.7,448
Hib,≥3 Doses,States/Local Areas,Michigan,2020,Age,7 Months,55.1,48.3 to 61.7,448
Hib,≥2 Doses,States/Local Areas,Michigan,2020,Age,7 Months,89.0,83.5 to 92.8,448
DTaP,≥1 Dose,States/Local Areas,Michigan,2020,Age,3 Months,86.4,80.8 to 90.5,448
Polio,≥2 Doses,States/Local Areas,Michigan,2020,Age,7 Months,88.8,83.1 to 92.7,448
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2020,Age,0-1 Days,72.2,65.7 to 77.9,448
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2020,Age,0-2 Days,76.5,70.3 to 81.8,448
Hep A,≥1 Dose,States/Local Areas,Michigan,2020,Age,19 Months,90.8,85.9 to 94.1,448
Hep A,≥2 Doses,States/Local Areas,Michigan,2020,Age,19 Months,33.3,27.6 to 39.6,448
Combined 7 Series,,States/Local Areas,Michigan,2020,Age,35 Months,76.9,70.1 to 83.0,448
≥1 Dose MMR,,States/Local Areas,Michigan,2020,Age,13 Months,70.9,64.2 to 76.9,448
Hep A,≥2 Doses,States/Local Areas,Michigan,2020,Age,35 Months,77.7,69.7 to 84.7,448
Hep A,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,55.7,50.6 to 61.0,823
Polio,≥2 Doses,States/Local Areas,Michigan,2020,Age,13 Months,93.1,88.1 to 96.1,448
Hep A,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,24 Months,92.7,89.8 to 95.0,823
Hep A,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,35 Months,94.9,92.2 to 96.9,823
Hep A,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,35 Months,82.5,77.1 to 87.3,823
Influenza,,States/Local Areas,Michigan,2019-2020,Age,24 Months,70.8,66.0 to 75.4,823
Hib,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,24 Months,92.2,89.1 to 94.6,823
Hib,Primary Series,States/Local Areas,Michigan,2019-2020,Age,24 Months,93.8,91.1 to 95.9,823
Hib,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,52.7,47.6 to 57.7,823
Combined 7 Series,,States/Local Areas,Michigan,2019-2020,Age,35 Months,77.6,72.7 to 82.2,823
Hib,Full Series,States/Local Areas,Michigan,2019-2020,Age,19 Months,76.9,72.4 to 80.9,823
Hep B,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,92.1,89.1 to 94.3,823
≥1 Dose Varicella,,States/Local Areas,Michigan,2019-2020,Age,19 Months,90.8,87.4 to 93.3,823
PCV,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,91.7,88.4 to 94.1,823
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,91.2 to 95.6,944
Rotavirus,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.1,75.4 to 82.8,944
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,91.5 to 95.9,944
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.1,78.6 to 95.6,106
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,78.8,74.6 to 82.9,808
Rotavirus,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.0,47.5 to 70.6,106
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.2,71.3 to 89.1,106
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.6,89.0 to 94.1,944
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,82.4,78.1 to 86.7,482
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,95.7,90.5 to 100.0,120
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.0,76.9 to 95.0,106
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.3,92.1 to 98.5,147
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,90.0,86.3 to 93.8,482
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.3 to 98.1,808
Rotavirus,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,86.4,83.1 to 89.6,808
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,93.4,90.4 to 96.3,482
Influenza,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,50.7,44.7 to 56.7,482
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,73.8 to 90.0,147
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,95.9,90.8 to 100.0,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,82.1,72.6 to 91.5,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,72.3 to 89.0,147
Rotavirus,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,63.6,58.0 to 69.3,482
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",64.9,53.8 to 76.0,106
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,69.2,57.6 to 80.9,120
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.1,74.3 to 82.0,944
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",44.9,33.8 to 56.1,106
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,61.2 to 80.3,147
Rotavirus,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,75.0,64.9 to 85.2,120
Rotavirus,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.7,65.7 to 83.7,147
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,85.9 to 91.8,944
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,81.5,71.5 to 91.4,120
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.9,61.3 to 82.5,106
Influenza,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.6,65.1 to 74.1,944
Influenza,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.5,55.3 to 75.6,147
Influenza,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",34.6,24.0 to 45.2,106
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,92.7 to 96.5,944
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.6,81.6 to 95.7,106
Influenza,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,75.4,71.1 to 79.7,808
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,91.8,84.5 to 99.1,120
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.3,92.3 to 96.3,944
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.2 to 96.0,808
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.1,80.8 to 95.3,106
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,76.5,71.2 to 81.9,482
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,92.5,89.0 to 95.9,482
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,91.8,84.5 to 99.1,120
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.9,81.8 to 96.1,106
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,75.3,70.0 to 80.6,482
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.1,83.0 to 89.3,944
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,95.3,93.2 to 97.3,808
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,91.7,88.4 to 94.9,482
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.9,83.8 to 90.1,944
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.0,93.1 to 96.9,944
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.2,92.0 to 100.0,147
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,96.5,91.8 to 100.0,120
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.7,86.7 to 98.6,106
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,88.5,85.2 to 91.8,808
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.7,80.5 to 96.9,106
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,91.2,83.0 to 99.5,120
Hep B,≥3 Doses,States/Local Areas,Michigan,2020,Age,7 Months,63.0,56.2 to 69.3,448
Polio,≥1 Dose,States/Local Areas,Michigan,2020,Age,3 Months,85.9,80.3 to 90.0,448
Hib,≥1 Dose,States/Local Areas,Michigan,2020,Age,3 Months,85.2,79.8 to 89.4,448
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,88.4,84.5 to 92.3,808
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,81.2,74.0 to 88.4,482
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,94.9,92.9 to 97.0,808
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,90.5 to 97.8,147
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,81.6,72.2 to 91.1,120
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.2,54.0 to 76.5,106
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,75.2 to 91.2,147
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,94.4,92.2 to 96.6,808
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.0 to 94.5,482
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,94.5,89.2 to 99.9,120
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,82.2,79.1 to 85.4,1317
Influenza,,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,65.8,54.7 to 77.0,120
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,93.3,91.4 to 95.2,1317
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Overall,Overall,91.2,89.0 to 93.4,1317
Rotavirus,,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,87.4,83.0 to 91.8,431
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,93.0,91.0 to 94.9,1317
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,72.8,65.9 to 79.7,304
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Overall,Overall,92.4,90.2 to 94.6,1317
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,90.5,87.3 to 93.7,582
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,84.3,81.4 to 87.3,1317
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,88.0,83.0 to 93.0,304
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,87.2,81.2 to 93.1,431
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,90.5,84.2 to 96.7,582
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,92.6,89.7 to 95.4,582
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,90.1,85.7 to 94.5,304
Influenza,,States/Local Areas,Michigan,2016-2019,Overall,Overall,62.8,59.0 to 66.7,1317
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Overall,Overall,81.1,78.2 to 84.1,1317
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,91.9,87.3 to 96.5,304
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,85.3,80.9 to 89.8,1317
Rotavirus,,States/Local Areas,Michigan,2016-2019,Overall,Overall,74.9,71.5 to 78.3,1317
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,81.9,76.4 to 87.3,431
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Overall,Overall,92.3,90.2 to 94.5,1317
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,98.6,97.4 to 99.9,431
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,72.2,67.0 to 77.4,582
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,93.6,90.9 to 96.3,582
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,60.7,53.2 to 68.1,304
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,86.5,82.1 to 90.9,304
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,97.2,95.2 to 99.1,431
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,91.5,88.4 to 94.6,582
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Overall,Overall,81.6,78.5 to 84.8,1317
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Overall,Overall,70.8,67.1 to 74.4,1317
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.2,75.9 to 84.5,669
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,87.4,81.3 to 93.5,219
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,98.0,96.5 to 99.5,431
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,93.0,90.2 to 95.8,582
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,87.3,81.9 to 92.6,219
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,70.8,64.6 to 77.1,429
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,80.4,75.3 to 85.4,429
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,90.5,85.4 to 95.7,219
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.9,91.2 to 96.5,669
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,90.5 to 96.8,429
Influenza,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,58.9,49.5 to 68.2,219
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.6,91.1 to 96.1,669
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,80.6 to 88.6,669
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,81.0,73.4 to 88.6,219
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,79.6,73.8 to 85.5,429
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,88.1,82.1 to 94.1,219
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.7,92.3 to 97.1,669
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,96.1,93.3 to 98.8,429
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.8,80.7 to 90.9,669
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,83.4,78.1 to 88.7,429
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,88.7 to 97.0,429
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,91.2,86.2 to 96.3,219
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,92.6,88.5 to 96.7,429
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,84.2,76.5 to 91.9,429
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.3,88.2 to 94.5,669
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,86.6,80.2 to 92.9,219
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,89.5 to 96.3,429
Rotavirus,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,71.7,65.5 to 77.8,429
Rotavirus,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.7,73.2 to 82.2,669
Influenza,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,67.5,62.3 to 72.7,669
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.3,65.2 to 75.3,669
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,72.7,63.8 to 81.6,219
Influenza,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,58.2,51.5 to 64.9,429
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.8,80.8 to 88.9,669
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,85.2,78.8 to 91.6,219
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,90.8 to 96.1,669
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,91.7,86.7 to 96.7,219
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.9,91.4 to 96.5,669
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,90.5,85.4 to 95.7,219
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.0 to 96.0,429
Rotavirus,,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,60.0,52.7 to 67.3,304
Rotavirus,,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,79.2,74.8 to 83.6,582
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,88.7 to 96.7,429
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,93.9,90.5 to 97.3,431
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,86.0,82.3 to 89.8,582
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,79.6,74.0 to 85.2,431
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,77.8,72.7 to 82.9,582
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,77.2,68.1 to 86.4,304
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,98.0,96.6 to 99.4,431
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,92.1,89.3 to 94.8,582
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,93.0,89.1 to 96.8,304
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,94.6,92.9 to 96.4,1317
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Overall,Overall,93.0,90.9 to 95.1,1317
Influenza,,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,61.7,56.0 to 67.4,582
Influenza,,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,49.2,41.8 to 56.6,304
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,98.2,96.9 to 99.5,431
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,90.5,87.4 to 93.5,582
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,90.1,85.2 to 95.1,304
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,90.5,86.0 to 95.0,431
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,84.9,80.8 to 89.0,582
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,88.6,83.2 to 93.9,304
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,90.3,85.9 to 94.6,304
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,89.1,84.6 to 93.7,431
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,73.9,67.1 to 80.7,304
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Poverty,133% to <400% FPL,83.3,79.1 to 87.5,582
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,97.3,95.8 to 98.9,431
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Poverty,<133% FPL,74.9,68.2 to 81.7,304
Influenza,,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,83.2,77.8 to 88.7,431
Combined 7 Series,,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,63.0,57.1 to 68.9,482
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.0,92.0 to 96.0,944
Rotavirus,,States/Local Areas,Michigan,2019-2020,Age,8 Months,78.7,74.3 to 82.6,823
PCV,≥3 Doses,States/Local Areas,Michigan,2020,Age,7 Months,69.0,62.3 to 75.0,448
≥1 Dose Varicella,,States/Local Areas,Michigan,2020-2021,Age,35 Months,95.4,92.4 to 97.5,771
Polio,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,3 Months,89.1,85.6 to 91.7,823
Hib,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,3 Months,87.4,83.8 to 90.4,823
PCV,≥4 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,80.7,76.4 to 84.4,823
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,79.7,75.6 to 83.7,808
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.5,79.1 to 87.8,944
Rotavirus,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,74.1,65.9 to 82.4,219
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.6 to 95.9,669
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,80.0,72.0 to 88.0,219
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.7,77.5 to 86.0,669
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a MSA Principal City,82.0,76.5 to 87.5,429
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Urbanicity,Living In a Non-MSA,84.6,72.6 to 96.5,219
DTaP,≥1 Dose,States/Local Areas,Michigan,2019-2020,Age,3 Months,89.4,86.0 to 92.1,823
Hep B,≥2 Doses,States/Local Areas,Michigan,2020,Age,5 Months,89.4,84.3 to 92.9,448
Hib,≥2 Doses,States/Local Areas,Michigan,2020,Age,5 Months,79.0,72.8 to 84.1,448
Polio,≥2 Doses,States/Local Areas,Michigan,2020,Age,5 Months,79.2,72.8 to 84.4,448
DTaP,≥2 Doses,States/Local Areas,Michigan,2020,Age,5 Months,79.8,73.4 to 85.0,448
Hep B,≥1 Dose,States/Local Areas,Michigan,2020,Age,3 Months,95.4,92.0 to 97.5,448
PCV,≥1 Dose,States/Local Areas,Michigan,2020,Age,3 Months,83.6,77.8 to 88.0,448
Hep A,≥1 Dose,States/Local Areas,Michigan,2020,Age,24 Months,92.1,87.8 to 95.4,448
Hep A,≥2 Doses,States/Local Areas,Michigan,2020,Age,24 Months,54.1,47.4 to 61.2,448
PCV,≥4 Doses,States/Local Areas,Michigan,2020,Age,24 Months,81.0,75.0 to 86.3,448
PCV,≥3 Doses,States/Local Areas,Michigan,2020,Age,24 Months,92.9,88.5 to 96.1,448
DTaP,≥3 Doses,States/Local Areas,Michigan,2020,Age,35 Months,94.0,89.9 to 96.8,448
≥1 Dose Varicella,,States/Local Areas,Michigan,2020,Age,24 Months,93.3,89.3 to 96.1,448
Rotavirus,,States/Local Areas,Michigan,2020,Age,8 Months,79.1,72.8 to 84.3,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2020,Age,0-3 Days,78.7,72.7 to 83.8,448
Influenza,,States/Local Areas,Michigan,2020,Age,24 Months,67.9,61.2 to 74.4,448
Combined 7 Series,,States/Local Areas,Michigan,2020,Age,24 Months,68.5,61.8 to 75.0,448
Hib,≥3 Doses,States/Local Areas,Michigan,2020,Age,19 Months,86.9,81.1 to 91.1,448
Polio,≥3 Doses,States/Local Areas,Michigan,2020,Age,19 Months,89.9,84.5 to 93.6,448
≥1 Dose MMR,,States/Local Areas,Michigan,2020,Age,19 Months,90.2,84.9 to 93.7,448
DTaP,≥4 Doses,States/Local Areas,Michigan,2020,Age,19 Months,70.2,63.3 to 76.4,448
DTaP,≥3 Doses,States/Local Areas,Michigan,2020,Age,19 Months,90.1,84.6 to 93.8,448
DTaP,≥3 Doses,States/Local Areas,Michigan,2020,Age,7 Months,72.0,65.3 to 77.9,448
PCV,≥3 Doses,States/Local Areas,Michigan,2020,Age,13 Months,87.5,81.7 to 91.6,448
≥1 Dose Varicella,,States/Local Areas,Michigan,2020,Age,13 Months,69.9,63.3 to 75.8,448
Hep B,≥3 Doses,States/Local Areas,Michigan,2020,Age,13 Months,88.4,83.2 to 92.2,448
Hep B,≥2 Doses,States/Local Areas,Michigan,2020,Age,13 Months,94.7,90.7 to 97.1,448
Hib,Primary Series,States/Local Areas,Michigan,2020,Age,13 Months,85.3,79.4 to 89.7,448
Hib,≥3 Doses,States/Local Areas,Michigan,2020,Age,13 Months,72.4,65.9 to 78.1,448
PCV,≥3 Doses,States/Local Areas,Michigan,2020,Age,35 Months,93.8,89.7 to 96.7,448
PCV,≥4 Doses,States/Local Areas,Michigan,2020,Age,35 Months,84.0,78.3 to 89.0,448
PCV,≥4 Doses,States/Local Areas,Michigan,2020,Age,19 Months,78.4,71.9 to 83.7,448
Polio,≥3 Doses,States/Local Areas,Michigan,2020,Age,35 Months,92.9,88.5 to 96.0,448
DTaP,≥4 Doses,States/Local Areas,Michigan,2020,Age,35 Months,86.8,80.7 to 91.8,448
PCV,≥3 Doses,States/Local Areas,Michigan,2020,Age,19 Months,90.2,84.7 to 93.8,448
≥1 Dose Varicella,,States/Local Areas,Michigan,2020,Age,19 Months,90.8,85.7 to 94.1,448
Hep B,≥3 Doses,States/Local Areas,Michigan,2020,Age,19 Months,90.6,85.7 to 93.9,448
DTaP,≥4 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,72.6,67.7 to 76.9,823
Polio,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,19 Months,92.0,88.8 to 94.4,823
DTaP,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,13 Months,89.6,86.0 to 92.3,823
Hep B,≥3 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,65.2,60.2 to 69.8,823
Hib,Primary Series,States/Local Areas,Michigan,2019-2020,Age,7 Months,74.4,69.8 to 78.6,823
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.7,92.7 to 98.8,147
Hib,≥2 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,92.0,85.2 to 95.9,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,77.6,68.1 to 87.1,137
Hib,≥3 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,45.7,38.0 to 53.5,290
Hib,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,42.9,37.7 to 48.3,618
Hib,≥3 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,40.1,33.2 to 47.6,328
Hib,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,40.2,35.1 to 45.6,611
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,87.3 to 100.0,111
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,92.3,84.3 to 100.0,66
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.3,78.7 to 97.9,51
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,92.0,87.4 to 96.5,221
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,95.1,92.6 to 97.7,582
PCV,≥3 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,94.5,89.3 to 97.7,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2018,Age,0-3 Days,78.2,70.9 to 84.0,328
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2018-2019,Age,0-3 Days,78.9,73.9 to 83.3,611
Polio,≥1 Dose,States/Local Areas,Minnesota,2019,Age,3 Months,90.3,83.4 to 94.6,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2019,Age,0-3 Days,79.8,72.2 to 85.7,283
Hib,Primary Series,States/Local Areas,Minnesota,2020,Age,24 Months,90.8,84.9 to 95.2,239
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,70.5,65.1 to 75.8,582
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.3,62.0 to 92.6,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,72.2,63.7 to 80.7,221
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,75.1,67.8 to 81.2,328
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,76.7,71.4 to 81.2,611
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,78.3,70.3 to 84.6,283
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,77.9,70.4 to 83.9,290
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,76.5,71.4 to 80.9,618
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,95.3,91.6 to 98.9,137
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,95.2,92.1 to 98.3,403
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,86.4,80.6 to 92.1,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,60.1,50.2 to 69.2,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,64.7,57.7 to 71.1,208
Hib,≥3 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,64.9,55.9 to 72.9,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,58.5,50.5 to 66.1,562
Polio,≥1 Dose,States/Local Areas,Minnesota,2014,Age,3 Months,90.5,84.6 to 94.3,269
Polio,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,3 Months,86.9,81.7 to 90.7,496
Polio,≥1 Dose,States/Local Areas,Minnesota,2015,Age,3 Months,83.3,74.5 to 89.4,227
Polio,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,3 Months,88.1,82.8 to 91.9,444
Polio,≥1 Dose,States/Local Areas,Minnesota,2016,Age,3 Months,93.1,86.3 to 96.6,217
Polio,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,3 Months,93.5,89.8 to 96.0,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2017,Age,0-3 Days,74.6,61.0 to 84.6,117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2017-2018,Age,0-3 Days,77.4,72.3 to 81.9,618
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016,Age,0-3 Days,70.4,60.5 to 78.7,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2017,Age,0-3 Days,73.6,67.4 to 78.9,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2013,Age,0-3 Days,64.1,56.2 to 71.3,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2013-2014,Age,0-3 Days,68.6,63.2 to 73.7,562
Polio,≥1 Dose,States/Local Areas,Minnesota,2013,Age,3 Months,88.6,84.2 to 91.8,293
Polio,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,3 Months,89.5,86.7 to 91.8,562
PCV,≥1 Dose,States/Local Areas,Minnesota,2019,Age,3 Months,89.1,81.8 to 93.6,283
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,92.1,89.5 to 94.7,833
Polio,≥1 Dose,States/Local Areas,Minnesota,2012,Age,3 Months,89.2,86.8 to 91.2,225
Polio,≥1 Dose,States/Local Areas,Minnesota,2011,Age,3 Months,87.1,78.6 to 92.6,208
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014,Age,0-3 Days,73.2,65.5 to 79.6,269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2015,Age,0-3 Days,70.5,64.1 to 76.1,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,95.5,89.2 to 98.2,217
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,95.0,91.6 to 97.1,507
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,94.5,90.0 to 97.1,290
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,91.5,87.8 to 94.2,618
Hib,≥3 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,40.3,33.0 to 48.0,283
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,95.9,93.3 to 98.5,343
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.3,93.0 to 97.5,605
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,86.9,78.8 to 92.2,227
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,91.1,86.4 to 94.3,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,95.0,86.9 to 98.2,225
Hib,≥2 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,95.2,90.6 to 97.6,328
Hib,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,95.2,91.8 to 97.3,611
Hib,≥2 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,96.2,92.6 to 98.1,290
Hib,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,95.7,93.0 to 97.4,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,95.5,92.1 to 98.9,137
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,94.0,91.8 to 96.2,833
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,97.0,94.3 to 99.7,175
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.6,84.5 to 94.8,315
Hib,≥2 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,95.3,89.1 to 98.0,283
Hib,≥2 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,95.7,87.4 to 98.6,225
Hib,≥2 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,93.2,88.9 to 95.8,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,62.5,52.3 to 71.6,227
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,71.0,64.0 to 77.0,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,72.5,64.4 to 79.4,269
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,67.5,61.1 to 73.3,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,79.6,69.8 to 86.8,217
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,78.7,72.8 to 83.7,507
Hib,≥2 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,96.9,94.8 to 98.1,293
Hib,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,96.5,94.7 to 97.7,562
PCV,≥3 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,94.6,90.4 to 97.3,290
PCV,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,94.7,91.8 to 96.8,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,94.6,90.1 to 97.5,328
PCV,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,94.5,91.3 to 96.8,611
Hib,≥3 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,52.2,44.0 to 60.2,269
Hib,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,45.6,39.4 to 51.9,496
Hib,≥3 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,39.0,29.9 to 48.8,227
Hib,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,41.4,34.8 to 48.4,444
Hib,≥3 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,44.0,34.4 to 53.9,217
Hib,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,44.8,38.6 to 51.2,507
Polio,≥1 Dose,States/Local Areas,Minnesota,2017,Age,3 Months,94.0,89.5 to 96.6,290
Polio,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,3 Months,92.3,88.9 to 94.7,618
Polio,≥1 Dose,States/Local Areas,Minnesota,2018,Age,3 Months,90.5,84.9 to 94.2,328
Polio,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,3 Months,90.4,86.3 to 93.4,611
Hib,≥2 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,93.9,89.1 to 96.6,227
Hib,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,95.8,93.0 to 97.6,444
Hib,≥2 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,97.8,93.0 to 99.4,217
Hib,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,97.0,94.5 to 98.4,507
Hib,≥2 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,96.1,91.6 to 98.2,269
Hib,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,95.0,92.0 to 96.9,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,88.6,82.1 to 92.9,328
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,91.0,86.9 to 93.9,611
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,93.6,87.7 to 96.8,283
DTaP,≥3 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,92.6,88.3 to 95.4,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,95.2,91.6 to 97.3,293
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,96.1,95.0 to 96.9,562
DTaP,≥3 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,96.2,89.9 to 98.6,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,61.0,51.0 to 70.3,227
Hib,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,62.2,55.2 to 68.6,444
Hib,≥3 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,63.3,53.6 to 72.0,217
Hib,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,63.2,57.1 to 69.0,507
Hib,≥3 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,63.2,55.5 to 70.3,290
Hib,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,58.3,52.9 to 63.5,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,95.8,91.5 to 98.0,269
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,93.6,90.0 to 96.0,496
Polio,≥3 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,91.5,85.9 to 94.9,227
Polio,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,93.6,89.8 to 96.0,444
Polio,≥3 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,93.6,90.3 to 95.8,293
Polio,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,94.7,93.4 to 95.7,562
Polio,≥3 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,94.6,89.9 to 97.1,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,73.4,67.2 to 79.5,403
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,63.9,55.6 to 72.3,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,84.3,77.9 to 89.1,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,78.2,71.7 to 83.5,562
Polio,≥3 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,90.8,87.2 to 93.4,208
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,97.9,96.2 to 99.6,403
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,88.1,82.8 to 93.4,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,72.1,64.4 to 78.7,269
Hib,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,66.6,60.3 to 72.3,496
Hib,≥3 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,82.4,75.6 to 87.6,208
Hib,≥3 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,86.7,81.1 to 90.8,225
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,92.4,88.0 to 95.3,293
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,93.1,90.8 to 94.8,562
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,93.7,88.8 to 96.6,269
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,90.3,85.8 to 93.5,496
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,70.9,59.6 to 82.2,175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Overall,Overall,71.0,66.4 to 75.5,833
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,68.6,62.1 to 75.2,343
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.1,66.8 to 81.5,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.1,61.5 to 72.8,605
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,65.6 to 86.6,111
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,78.5,64.9 to 92.1,66
Hib,≥2 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,89.2,82.0 to 93.7,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,51.3,43.5 to 59.1,283
Hib,≥3 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,92.7,90.2 to 94.6,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,92.1,87.1 to 95.3,208
Polio,≥3 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,91.8,86.6 to 95.1,328
Polio,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,68.0,62.5 to 73.1,611
Hib,≥3 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,53.4,45.9 to 60.8,328
Hib,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,52.4,46.9 to 57.8,611
Polio,≥3 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,95.7,90.4 to 98.2,217
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,94.8,91.6 to 96.8,507
Polio,≥3 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,93.8,89.2 to 96.5,290
Polio,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,92.8,89.6 to 95.1,618
Hib,≥2 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,91.5,85.9 to 95.0,328
Hib,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,91.8,87.7 to 94.6,611
PCV,≥3 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,95.9,91.1 to 98.6,269
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,92.5,88.2 to 95.6,496
PCV,≥3 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,88.9,81.6 to 94.3,227
PCV,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,92.7,88.6 to 95.8,444
PCV,≥3 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,96.7,92.8 to 98.8,217
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,95.6,93.0 to 97.5,507
Hib,≥2 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,96.1,90.7 to 98.4,217
Hib,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,94.4,91.0 to 96.5,507
Hib,≥2 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,92.7,87.4 to 95.9,290
Hib,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,92.1,88.5 to 94.6,618
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2015,Age,0-3 Days,67.7,57.3 to 76.7,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2015-2016,Age,0-3 Days,69.1,62.0 to 75.4,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,80.8,73.5 to 86.5,293
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,76.7,70.1 to 82.1,562
DTaP,≥3 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,75.8,70.0 to 80.7,225
DTaP,≥3 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,76.2,69.3 to 82.0,208
PCV,≥3 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,94.5,89.3 to 97.7,283
PCV,≥3 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,93.9,88.4 to 97.3,208
PCV,≥3 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,97.1,93.2 to 99.0,293
PCV,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,96.4,93.5 to 98.2,562
Hib,≥2 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,85.3,76.7 to 91.0,227
Hib,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,90.6,85.8 to 93.9,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,90.8,87.0 to 93.6,208
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,94.2,90.8 to 97.6,343
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,88.6 to 95.0,605
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,90.9,84.8 to 97.0,175
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.0,85.1 to 94.8,315
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,84.1 to 97.8,111
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,92.7,84.5 to 100.0,66
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.0,83.1 to 90.9,605
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.7,62.4 to 85.0,111
PCV,≥1 Dose,States/Local Areas,Minnesota,2014,Age,3 Months,85.7,78.3 to 90.8,269
PCV,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,3 Months,82.2,76.2 to 86.9,496
PCV,≥1 Dose,States/Local Areas,Minnesota,2015,Age,3 Months,78.7,68.7 to 86.1,227
PCV,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,3 Months,85.7,79.8 to 90.1,444
Hib,≥2 Doses,States/Local Areas,Minnesota,2018,Age,5 Months,82.0,75.1 to 87.4,328
Hib,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,5 Months,82.5,77.5 to 86.5,611
Hib,≥2 Doses,States/Local Areas,Minnesota,2019,Age,5 Months,82.9,75.4 to 88.6,283
Hib,≥2 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,91.0,87.3 to 93.7,208
PCV,≥3 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,96.7,92.8 to 98.8,217
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,95.6,93.0 to 97.5,507
Hib,≥2 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,93.1,82.5 to 97.5,225
PCV,≥3 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,94.6,90.4 to 97.3,290
PCV,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,93.8,90.8 to 96.0,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,92.9,88.3 to 96.2,328
PCV,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,93.7,90.5 to 96.2,611
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2011,Age,0-3 Days,62.0,52.2 to 70.9,208
PCV,≥1 Dose,States/Local Areas,Minnesota,2018,Age,3 Months,91.0,85.4 to 94.6,328
PCV,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,3 Months,90.0,85.8 to 93.1,611
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,90.5,85.4 to 95.6,221
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2012,Age,0-3 Days,70.3,62.6 to 77.0,225
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,87.3,82.4 to 92.2,343
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,92.9,89.8 to 96.0,582
PCV,≥1 Dose,States/Local Areas,Minnesota,2016,Age,3 Months,92.8,85.9 to 96.4,217
PCV,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,3 Months,93.2,89.4 to 95.7,507
PCV,≥1 Dose,States/Local Areas,Minnesota,2017,Age,3 Months,93.7,89.2 to 96.4,290
PCV,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,3 Months,92.3,89.0 to 94.7,618
Hib,≥2 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,94.1,90.8 to 96.3,293
Hib,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,91.5,87.8 to 94.2,562
Hib,≥2 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,88.9,82.3 to 93.2,269
Hib,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,87.1,82.0 to 90.9,496
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,91.6,87.7 to 95.5,403
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,78.8,71.9 to 85.7,293
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,65.6,55.4 to 75.9,137
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,77.9,68.6 to 87.1,175
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,81.5,77.6 to 85.3,833
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.5,68.3 to 82.7,315
Hib,≥2 Doses,States/Local Areas,Minnesota,2015,Age,5 Months,75.5,66.2 to 82.9,227
Hib,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,5 Months,81.3,75.3 to 86.1,444
Hib,≥2 Doses,States/Local Areas,Minnesota,2016,Age,5 Months,87.2,79.0 to 92.5,217
Hib,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,5 Months,85.7,80.6 to 89.6,507
PCV,≥3 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,88.9,81.6 to 94.3,227
PCV,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,92.7,88.6 to 95.8,444
PCV,≥3 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,95.4,90.5 to 98.2,269
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,92.2,87.9 to 95.4,496
PCV,≥3 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,95.6,91.5 to 98.1,225
Hib,≥2 Doses,States/Local Areas,Minnesota,2017,Age,5 Months,84.2,77.1 to 89.4,290
Hib,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,5 Months,83.1,78.4 to 87.0,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,95.3,91.8 to 97.6,293
PCV,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,95.3,92.5 to 97.3,562
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,87.3,83.2 to 91.3,582
PCV,≥1 Dose,States/Local Areas,Minnesota,2013,Age,3 Months,89.7,86.3 to 92.3,293
PCV,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,3 Months,87.7,82.7 to 91.4,562
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.5,45.3 to 77.7,51
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,80.3,69.0 to 91.7,66
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,73.1,65.3 to 80.9,221
PCV,≥3 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,92.8,87.7 to 95.9,328
PCV,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,91.3,87.4 to 94.1,611
PCV,≥3 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,94.0,88.1 to 97.1,283
PCV,≥3 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,92.0,85.5 to 96.4,208
Hib,≥2 Doses,States/Local Areas,Minnesota,2013,Age,5 Months,82.2,76.5 to 86.8,293
Hib,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,5 Months,81.8,77.8 to 85.2,562
Hib,≥2 Doses,States/Local Areas,Minnesota,2014,Age,5 Months,81.3,74.2 to 86.9,269
Hib,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,5 Months,78.4,75.3 to 81.2,496
Hib,≥2 Doses,States/Local Areas,Minnesota,2012,Age,5 Months,82.5,78.1 to 86.2,225
Hib,≥2 Doses,States/Local Areas,Minnesota,2011,Age,5 Months,77.3,69.9 to 83.3,208
PCV,≥4 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,83.6,77.0 to 89.2,328
PCV,≥4 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,86.4,82.0 to 90.2,611
PCV,≥4 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,89.3,83.1 to 94.1,283
PCV,≥4 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,87.9,81.7 to 92.7,290
PCV,≥4 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,85.7,81.2 to 89.5,618
PCV,≥1 Dose,States/Local Areas,Minnesota,2011,Age,3 Months,88.4,73.2 to 95.5,208
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,96.3,93.2 to 99.4,403
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,89.0,83.7 to 94.3,293
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,92.9,88.1 to 97.8,175
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,86.2,78.8 to 93.6,137
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Overall,Overall,91.5,88.7 to 94.4,833
PCV,≥1 Dose,States/Local Areas,Minnesota,2012,Age,3 Months,90.3,88.1 to 92.2,225
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.2 to 98.6,343
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.1 to 94.8,605
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,95.2,92.6 to 97.8,582
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,85.3 to 99.4,111
≥1 Dose MMR,,States/Local Areas,Minnesota,2019,Age,35 Months,92.8,87.1 to 96.6,283
PCV,≥4 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,88.6,82.1 to 93.6,293
PCV,≥4 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,88.4,83.1 to 92.7,562
≥1 Dose MMR,,States/Local Areas,Minnesota,2018,Age,35 Months,93.3,87.7 to 96.9,328
≥1 Dose MMR,,States/Local Areas,Minnesota,2018-2019,Age,35 Months,92.9,89.1 to 95.7,611
≥1 Dose MMR,,States/Local Areas,Minnesota,2017,Age,35 Months,96.1,92.4 to 98.3,290
≥1 Dose MMR,,States/Local Areas,Minnesota,2017-2018,Age,35 Months,94.6,91.6 to 96.9,618
Hib,≥1 Dose,States/Local Areas,Minnesota,2015,Age,3 Months,84.6,76.1 to 90.5,227
Hib,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,3 Months,89.3,84.2 to 92.9,444
Hib,≥1 Dose,States/Local Areas,Minnesota,2016,Age,3 Months,94.0,87.2 to 97.3,217
Hib,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,3 Months,94.0,90.3 to 96.3,507
Hib,≥1 Dose,States/Local Areas,Minnesota,2017,Age,3 Months,94.0,89.5 to 96.7,290
Hib,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,3 Months,92.6,89.1 to 95.0,618
Hep B,≥2 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,96.2,93.1 to 97.9,290
Hep B,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,95.4,92.9 to 97.1,618
Hep B,≥2 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,94.7,90.2 to 97.2,328
Hep B,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,95.1,92.1 to 97.1,611
Hep B,≥2 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,95.6,90.5 to 98.0,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2020,Age,35 Months,95.7,90.6 to 98.5,239
PCV,≥3 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,85.3,81.9 to 88.2,227
PCV,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,90.7,85.8 to 94.0,444
PCV,≥3 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,96.1,91.5 to 98.3,217
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,95.3,92.3 to 97.1,507
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,88.7,83.6 to 93.8,293
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,90.5,84.2 to 96.8,137
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Overall,Overall,91.4,88.6 to 94.2,833
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,91.9,86.8 to 97.0,175
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.6,79.5 to 91.7,315
PCV,≥3 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,96.0,91.9 to 98.4,225
Hib,≥1 Dose,States/Local Areas,Minnesota,2018,Age,3 Months,91.1,85.4 to 94.7,328
Hib,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,3 Months,90.4,86.2 to 93.4,611
Hib,≥1 Dose,States/Local Areas,Minnesota,2019,Age,3 Months,89.8,82.9 to 94.1,283
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,83.9 to 99.4,111
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,98.5,96.8 to 100.0,66
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.7,52.2 to 85.1,51
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,85.4,79.0 to 91.8,221
PCV,≥4 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,89.5,82.6 to 94.5,217
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,88.6,84.1 to 92.3,507
PCV,≥4 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,79.8,69.1 to 88.7,227
PCV,≥4 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,84.9,78.4 to 90.3,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,88.0,79.6 to 94.1,269
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,84.9,77.7 to 90.8,496
PCV,≥3 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,94.4,89.8 to 97.0,290
PCV,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,93.6,90.4 to 95.8,618
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,92.6,86.9 to 96.4,283
Hib,≥1 Dose,States/Local Areas,Minnesota,2013,Age,3 Months,88.4,84.2 to 91.7,293
Hib,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,3 Months,87.4,83.0 to 90.7,562
Hib,≥1 Dose,States/Local Areas,Minnesota,2012,Age,3 Months,89.9,87.9 to 91.6,225
Hib,≥1 Dose,States/Local Areas,Minnesota,2011,Age,3 Months,87.4,76.4 to 93.7,208
PCV,≥3 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,93.5,87.6 to 96.7,283
PCV,≥3 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,89.3,82.3 to 93.7,208
PCV,≥3 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,95.3,94.2 to 96.2,293
PCV,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,94.3,93.3 to 95.2,562
PCV,≥3 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,93.3,87.4 to 96.6,269
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,89.3,84.3 to 92.9,496
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,92.5,86.0 to 96.7,217
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,93.7,90.2 to 96.3,507
PCV,≥4 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,87.8,81.6 to 92.8,283
PCV,≥4 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,81.4,74.8 to 87.1,328
PCV,≥4 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,84.5,80.1 to 88.4,611
PCV,≥4 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,87.4,80.1 to 93.0,208
PCV,≥4 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,92.8,87.4 to 96.5,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,98.4,92.7 to 99.8,328
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,96.8,91.7 to 99.1,611
PCV,≥3 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,95.3,86.7 to 98.5,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,95.1,91.7 to 97.4,290
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,97.2,93.6 to 99.1,618
Hep B,≥2 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,93.0,87.8 to 96.1,283
Hep B,≥2 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,90.8,86.5 to 93.9,208
Hep B,≥2 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,94.0,92.8 to 95.0,293
Hep B,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,94.8,92.7 to 96.3,562
Hep B,≥2 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,94.4,89.1 to 97.2,225
PCV,≥3 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,93.8,89.2 to 96.5,290
PCV,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,91.5,87.9 to 94.1,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,89.2,83.1 to 93.2,328
PCV,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,91.3,87.4 to 94.1,611
Hep B,≥3 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,94.4,89.7 to 97.4,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,89.9,82.3 to 95.2,227
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,91.2,86.4 to 94.8,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,95.7,91.7 to 98.1,269
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,92.8,88.7 to 95.8,496
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,96.4,92.9 to 98.4,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,96.0,93.5 to 97.8,562
PCV,≥3 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,94.1,88.0 to 97.2,217
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,94.0,90.5 to 96.2,507
≥1 Dose MMR,,States/Local Areas,Minnesota,2014,Age,35 Months,94.0,89.5 to 97.0,269
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2015,Age,35 Months,94.0,90.0 to 96.8,496
≥1 Dose MMR,,States/Local Areas,Minnesota,2015,Age,35 Months,93.3,86.2 to 97.5,227
≥1 Dose MMR,,States/Local Areas,Minnesota,2015-2016,Age,35 Months,94.3,89.9 to 97.2,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,84.7,78.2 to 90.2,290
PCV,≥4 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,83.0,78.5 to 87.1,618
PCV,≥4 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,87.8,80.9 to 93.1,217
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,86.2,81.6 to 90.2,507
≥1 Dose MMR,,States/Local Areas,Minnesota,2016,Age,35 Months,95.2,89.2 to 98.4,217
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2017,Age,35 Months,95.6,92.3 to 97.8,507
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019,Age,35 Months,95.2,90.7 to 98.0,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,87.2,81.0 to 93.4,221
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.5 to 96.4,582
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.0,71.2 to 96.8,51
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,94.0,90.3 to 97.8,403
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.9,83.5 to 94.2,315
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,88.7 to 97.1,343
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,91.2 to 96.7,605
Hep B,≥2 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,96.1,91.1 to 98.3,217
Hep B,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,96.1,93.5 to 97.7,507
Hep B,≥2 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,90.9,83.3 to 95.2,227
Hep B,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,93.5,89.3 to 96.1,444
Hib,≥1 Dose,States/Local Areas,Minnesota,2014,Age,3 Months,86.3,79.3 to 91.1,269
Hib,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,3 Months,85.4,80.2 to 89.5,496
Hep B,≥2 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,95.6,91.3 to 97.8,269
Hep B,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,93.2,89.2 to 95.8,496
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2014,Age,0-2 Days,69.5,61.4 to 76.6,269
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2014-2015,Age,0-2 Days,68.6,62.1 to 74.4,496
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2015,Age,0-2 Days,67.6,57.2 to 76.5,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2015-2016,Age,0-2 Days,67.8,60.6 to 74.2,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,85.9,78.7 to 91.7,208
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015,Age,35 Months,92.0,86.4 to 95.9,227
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015-2016,Age,35 Months,93.3,89.3 to 96.2,444
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014,Age,35 Months,93.7,89.5 to 96.6,269
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2015,Age,35 Months,92.8,89.5 to 95.4,496
PCV,≥4 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,83.1,75.8 to 88.5,283
≥1 Dose MMR,,States/Local Areas,Minnesota,2018,Age,24 Months,91.6,86.2 to 95.5,328
≥1 Dose MMR,,States/Local Areas,Minnesota,2018-2019,Age,24 Months,92.0,88.3 to 94.9,611
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013,Age,35 Months,93.7,88.0 to 97.2,293
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013-2014,Age,35 Months,93.4,90.2 to 95.9,562
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016,Age,35 Months,96.0,89.7 to 99.0,217
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2017,Age,35 Months,95.1,91.5 to 97.5,507
≥1 Dose MMR,,States/Local Areas,Minnesota,2013,Age,35 Months,94.4,88.7 to 97.8,293
≥1 Dose MMR,,States/Local Areas,Minnesota,2013-2014,Age,35 Months,94.2,90.8 to 96.7,562
≥1 Dose MMR,,States/Local Areas,Minnesota,2011,Age,35 Months,93.1,87.7 to 96.7,208
≥1 Dose MMR,,States/Local Areas,Minnesota,2012,Age,35 Months,94.5,89.6 to 97.6,225
≥1 Dose MMR,,States/Local Areas,Minnesota,2019,Age,24 Months,92.7,86.9 to 96.5,283
PCV,≥4 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,73.7,64.3 to 82.4,227
PCV,≥4 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,80.7,74.8 to 86.1,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,78.0,70.5 to 84.7,269
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,75.8,69.8 to 81.4,496
PCV,≥4 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,83.1,76.4 to 88.8,293
PCV,≥4 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,80.5,75.6 to 85.0,562
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,92.6,86.9 to 96.4,283
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,94.8,91.4 to 97.1,290
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,94.3,91.7 to 96.3,618
Hep B,≥3 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,89.7,83.5 to 94.3,208
PCV,≥4 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,90.1,84.2 to 94.5,225
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018,Age,35 Months,90.8,85.3 to 94.9,328
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018-2019,Age,35 Months,93.0,89.3 to 95.7,611
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017,Age,35 Months,95.4,91.4 to 97.9,290
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017-2018,Age,35 Months,93.1,89.9 to 95.7,618
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2019,Age,0-1 Days,73.3,65.3 to 80.1,283
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2011,Age,0-2 Days,60.2,52.3 to 67.7,208
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2013,Age,0-2 Days,62.1,59.5 to 64.7,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2013-2014,Age,0-2 Days,65.8,63.6 to 68.0,562
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2012,Age,0-2 Days,70.3,64.1 to 75.9,225
Hep B,≥2 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,91.2,90.1 to 92.2,293
Hep B,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,92.5,90.4 to 94.2,562
Hep B,≥2 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,93.8,89.3 to 96.5,269
Hep B,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,88.4,83.4 to 92.0,496
Hep B,≥2 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,83.0,73.9 to 89.3,227
Hep B,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,87.1,81.7 to 91.0,444
Hep B,≥2 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,91.6,87.9 to 94.2,225
PCV,≥3 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,72.7,65.4 to 78.9,328
PCV,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,74.3,68.9 to 78.9,611
PCV,≥3 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,75.9,67.7 to 82.5,283
PCV,≥3 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,89.3,82.3 to 93.7,208
PCV,≥4 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,81.7,74.5 to 87.2,290
PCV,≥4 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,80.1,75.2 to 84.3,618
PCV,≥4 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,78.6,71.4 to 84.4,328
PCV,≥4 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,80.5,74.3 to 85.4,495
≥1 Dose MMR,,States/Local Areas,Minnesota,2017,Age,24 Months,93.6,88.6 to 96.9,290
≥1 Dose MMR,,States/Local Areas,Minnesota,2017-2018,Age,24 Months,92.4,88.8 to 95.1,618
≥1 Dose MMR,,States/Local Areas,Minnesota,2016,Age,24 Months,93.9,88.2 to 97.4,217
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2017,Age,24 Months,93.7,90.1 to 96.4,507
PCV,≥3 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,95.0,86.9 to 98.2,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,92.4,85.9 to 96.7,217
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,93.6,90.0 to 96.2,507
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,88.9,81.4 to 94.3,227
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,90.6,85.9 to 94.3,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,95.2,91.3 to 97.7,269
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,92.0,87.9 to 95.1,496
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019,Age,24 Months,93.3,88.1 to 96.8,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2011,Age,35 Months,90.8,85.2 to 94.9,208
≥1 Dose Varicella,,States/Local Areas,Minnesota,2012,Age,35 Months,93.9,88.6 to 97.3,225
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018,Age,24 Months,89.5,84.0 to 93.8,328
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018-2019,Age,24 Months,91.3,87.6 to 94.3,611
≥1 Dose MMR,,States/Local Areas,Minnesota,2015,Age,24 Months,85.6,77.1 to 92.2,227
≥1 Dose MMR,,States/Local Areas,Minnesota,2015-2016,Age,24 Months,89.7,84.7 to 93.7,444
≥1 Dose MMR,,States/Local Areas,Minnesota,2014,Age,24 Months,92.9,88.4 to 96.2,269
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2015,Age,24 Months,89.3,84.6 to 93.1,496
≥1 Dose MMR,,States/Local Areas,Minnesota,2013,Age,24 Months,91.6,86.0 to 95.6,293
≥1 Dose MMR,,States/Local Areas,Minnesota,2013-2014,Age,24 Months,92.3,88.8 to 95.0,562
PCV,≥3 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,77.1,69.6 to 83.1,290
PCV,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,74.9,69.8 to 79.4,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,59.9,49.7 to 69.4,227
PCV,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,68.9,61.9 to 75.1,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,76.1,68.2 to 82.6,269
PCV,≥4 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,73.5,67.2 to 78.9,496
PCV,≥4 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,70.8,68.9 to 72.6,227
PCV,≥4 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,78.7,72.4 to 84.0,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,86.8,79.3 to 91.9,217
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,84.2,79.2 to 88.2,507
PCV,≥3 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,77.9,68.2 to 85.4,217
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,77.5,71.6 to 82.5,507
Hep B,≥3 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,93.3,88.4 to 96.6,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013,Age,24 Months,93.6,89.3 to 96.6,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,24 Months,94.4,91.6 to 96.5,562
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,92.3,86.0 to 95.9,283
Hep B,≥3 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,89.6,83.4 to 94.3,208
≥1 Dose MMR,,States/Local Areas,Minnesota,2013,Age,19 Months,88.0,85.4 to 90.3,293
≥1 Dose MMR,,States/Local Areas,Minnesota,2013-2014,Age,19 Months,89.8,87.2 to 91.9,562
≥1 Dose MMR,,States/Local Areas,Minnesota,2014,Age,19 Months,91.5,86.1 to 95.0,269
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2015,Age,19 Months,87.1,81.8 to 91.0,496
≥1 Dose MMR,,States/Local Areas,Minnesota,2012,Age,19 Months,90.6,82.6 to 95.2,225
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017,Age,19 Months,91.6,85.7 to 95.2,290
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017-2018,Age,19 Months,89.8,85.8 to 92.8,618
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018,Age,19 Months,88.1,81.9 to 92.4,328
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018-2019,Age,19 Months,66.7,61.1 to 71.8,611
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,86.4,73.7 to 99.1,66
Polio,≥2 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,94.0,88.2 to 97.1,227
Polio,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,95.6,92.3 to 97.5,444
Polio,≥2 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,97.2,92.6 to 98.9,217
Polio,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,96.4,93.8 to 97.9,507
Polio,≥2 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,95.7,91.9 to 97.7,290
Polio,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,95.8,93.2 to 97.4,618
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.4,81.3 to 89.6,605
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.5,64.6 to 86.5,111
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,77.5,68.8 to 86.1,175
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,81.9,78.0 to 85.8,833
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,88.5,83.3 to 93.7,343
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.5,68.1 to 83.0,315
≥1 Dose MMR,,States/Local Areas,Minnesota,2015,Age,19 Months,82.7,78.4 to 86.2,227
≥1 Dose MMR,,States/Local Areas,Minnesota,2015-2016,Age,19 Months,87.1,81.4 to 91.3,444
≥1 Dose MMR,,States/Local Areas,Minnesota,2016,Age,19 Months,91.7,84.9 to 95.5,217
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2017,Age,19 Months,91.5,87.3 to 94.5,507
≥1 Dose MMR,,States/Local Areas,Minnesota,2017,Age,19 Months,91.4,85.2 to 95.2,290
≥1 Dose MMR,,States/Local Areas,Minnesota,2017-2018,Age,19 Months,89.7,85.5 to 92.8,618
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,68.4,58.1 to 78.8,137
≥1 Dose Varicella,,States/Local Areas,Minnesota,2011,Age,24 Months,90.0,84.4 to 94.3,208
≥1 Dose Varicella,,States/Local Areas,Minnesota,2012,Age,24 Months,90.1,84.1 to 94.6,225
Hep B,≥1 Dose,States/Local Areas,Minnesota,2018,Age,3 Months,96.8,93.1 to 98.6,328
Hep B,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,3 Months,96.5,93.7 to 98.1,611
Hep B,≥1 Dose,States/Local Areas,Minnesota,2019,Age,3 Months,96.2,91.0 to 98.4,283
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,68.6,58.8 to 78.3,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2011,Age,0-1 Days,54.1,45.7 to 62.3,208
Hep B,≥2 Doses,States/Local Areas,Minnesota,2012,Age,5 Months,87.6,82.1 to 91.6,225
Hep B,≥2 Doses,States/Local Areas,Minnesota,2011,Age,5 Months,84.3,78.3 to 88.9,208
Hep B,≥2 Doses,States/Local Areas,Minnesota,2013,Age,5 Months,85.8,84.0 to 87.4,293
Hep B,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,5 Months,86.7,84.6 to 88.6,562
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,92.5,91.0 to 93.8,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,93.8,91.4 to 95.6,562
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,89.8,84.2 to 95.4,403
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,95.2,90.8 to 97.5,269
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,91.9,87.5 to 94.8,496
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,88.6,82.7 to 92.7,227
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,90.5,85.4 to 94.0,444
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2016,Age,0-1 Days,61.7,51.6 to 70.9,217
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2016-2017,Age,0-1 Days,66.3,59.9 to 72.2,507
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2017,Age,0-1 Days,70.9,63.0 to 77.7,290
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2017-2018,Age,0-1 Days,72.5,67.1 to 77.2,618
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2016,Age,0-2 Days,67.9,57.8 to 76.6,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2016-2017,Age,0-2 Days,70.9,64.6 to 76.5,507
Hep B,≥2 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,91.3,84.8 to 95.1,217
Hep B,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,91.1,87.2 to 93.9,507
PCV,≥3 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,92.1,89.1 to 94.3,293
PCV,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,89.8,85.9 to 92.7,562
Hep B,≥2 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,91.0,85.7 to 94.4,290
Hep B,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,91.2,87.7 to 93.7,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,87.4,80.1 to 92.3,269
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,84.9,79.4 to 89.1,496
PCV,≥3 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,82.4,73.5 to 88.8,227
PCV,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,88.3,83.0 to 92.0,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,93.8,89.5 to 96.8,328
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,93.2,89.8 to 95.7,611
Hep B,≥3 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,92.6,88.0 to 95.5,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,91.8,86.8 to 95.1,328
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,91.2,87.4 to 94.0,611
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,90.6,84.2 to 94.6,283
Hep B,≥3 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,89.6,85.4 to 92.8,208
DTaP,≥4 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,87.0,80.0 to 92.5,283
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,76.7,68.9 to 84.5,221
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,85.8,81.4 to 90.1,582
≥1 Dose MMR,,States/Local Areas,Minnesota,2011,Age,19 Months,87.6,82.1 to 91.6,208
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.7,48.9 to 82.6,51
DTaP,≥4 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,87.5,80.4 to 92.9,328
DTaP,≥4 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,87.5,82.6 to 91.6,611
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2017,Age,0-2 Days,73.8,66.0 to 80.4,290
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2017-2018,Age,0-2 Days,75.5,70.3 to 80.1,618
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2018,Age,0-2 Days,77.1,69.9 to 83.1,328
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2018-2019,Age,0-2 Days,77.7,72.6 to 82.1,611
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2019,Age,0-2 Days,78.2,70.5 to 84.4,283
Hep B,≥2 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,91.4,86.2 to 94.7,328
Hep B,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,92.2,88.7 to 94.6,611
Hep B,≥2 Doses,States/Local Areas,Minnesota,2019,Age,5 Months,86.5,79.3 to 91.4,283
Hep B,≥2 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,88.3,85.6 to 90.6,208
Hep B,≥2 Doses,States/Local Areas,Minnesota,2017,Age,5 Months,84.9,78.8 to 89.4,290
Hep B,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,5 Months,87.0,82.9 to 90.1,618
Hep B,≥2 Doses,States/Local Areas,Minnesota,2018,Age,5 Months,89.1,83.3 to 93.0,328
Hep B,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,5 Months,87.8,83.4 to 91.1,611
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2018,Age,0-1 Days,74.0,66.5 to 80.4,328
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2018-2019,Age,0-1 Days,73.7,68.3 to 78.4,611
PCV,≥4 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,79.0,75.1 to 82.5,293
PCV,≥4 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,77.6,73.5 to 81.2,562
PCV,≥4 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,88.6,83.3 to 92.4,225
PCV,≥4 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,82.8,77.0 to 87.3,208
≥1 Dose MMR,,States/Local Areas,Minnesota,2018,Age,19 Months,87.9,81.5 to 92.3,328
≥1 Dose MMR,,States/Local Areas,Minnesota,2018-2019,Age,19 Months,95.2,91.8 to 97.3,611
≥1 Dose MMR,,States/Local Areas,Minnesota,2019,Age,19 Months,91.6,85.3 to 95.3,283
≥1 Dose MMR,,States/Local Areas,Minnesota,2011,Age,24 Months,91.4,86.0 to 95.3,208
≥1 Dose MMR,,States/Local Areas,Minnesota,2012,Age,24 Months,91.4,85.6 to 95.5,225
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015,Age,24 Months,89.5,83.4 to 94.1,227
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015-2016,Age,24 Months,91.1,86.9 to 94.3,444
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016,Age,24 Months,92.5,86.3 to 96.6,217
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2017,Age,24 Months,93.1,89.4 to 95.9,507
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017,Age,24 Months,93.8,89.2 to 96.9,290
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017-2018,Age,24 Months,91.6,88.2 to 94.4,618
PCV,≥3 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,76.5,72.1 to 80.4,293
PCV,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,71.9,66.1 to 77.1,562
PCV,≥3 Doses,States/Local Areas,Minnesota,2011,Age,7 Months,71.8,64.3 to 78.3,208
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,92.4,85.0 to 96.3,217
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,93.4,89.6 to 95.9,507
PCV,≥3 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,67.3,58.9 to 74.7,269
PCV,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,63.6,57.1 to 69.7,496
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,90.1,85.9 to 94.3,403
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,80.3,73.1 to 87.5,293
PCV,≥3 Doses,States/Local Areas,Minnesota,2012,Age,7 Months,74.3,67.2 to 80.4,225
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,94.3,90.5 to 96.6,290
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,93.6,90.7 to 95.6,618
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,92.8,87.9 to 95.8,328
Hep B,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,91.2,87.4 to 94.0,611
Hep B,≥2 Doses,States/Local Areas,Minnesota,2016,Age,5 Months,84.6,76.0 to 90.5,217
Hep B,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,5 Months,84.7,79.7 to 88.7,507
Hep B,≥2 Doses,States/Local Areas,Minnesota,2014,Age,5 Months,87.6,81.6 to 91.9,269
Hep B,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,5 Months,83.9,80.7 to 86.7,496
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2012,Age,0-1 Days,61.5,56.0 to 66.7,225
Polio,≥2 Doses,States/Local Areas,Minnesota,2018,Age,13 Months,95.9,91.5 to 98.0,328
Polio,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,13 Months,95.4,92.0 to 97.4,611
Polio,≥2 Doses,States/Local Areas,Minnesota,2019,Age,13 Months,94.9,88.8 to 97.8,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019,Age,19 Months,92.2,86.4 to 95.7,283
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,89.6,83.0 to 93.8,239
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014,Age,24 Months,92.9,88.6 to 96.0,269
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2015,Age,24 Months,91.2,87.5 to 94.1,496
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013,Age,24 Months,92.1,86.9 to 95.8,293
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013-2014,Age,24 Months,92.4,89.2 to 95.0,562
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2013,Age,0-1 Days,60.3,57.6 to 62.9,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2013-2014,Age,0-1 Days,60.2,57.0 to 63.2,562
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2014,Age,0-1 Days,60.0,51.7 to 67.8,269
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2014-2015,Age,0-1 Days,63.4,56.9 to 69.4,496
Hep B,≥2 Doses,States/Local Areas,Minnesota,2015,Age,5 Months,80.2,71.1 to 87.0,227
Hep B,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,5 Months,82.4,76.4 to 87.1,444
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2015,Age,0-1 Days,66.7,56.4 to 75.7,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2015-2016,Age,0-1 Days,64.3,57.1 to 70.8,444
≥1 Dose MMR,,States/Local Areas,Minnesota,2017,Age,13 Months,69.4,61.3 to 76.5,290
≥1 Dose MMR,,States/Local Areas,Minnesota,2017-2018,Age,13 Months,70.9,65.4 to 75.8,618
≥1 Dose MMR,,States/Local Areas,Minnesota,2018,Age,13 Months,72.4,64.9 to 78.8,328
≥1 Dose MMR,,States/Local Areas,Minnesota,2018-2019,Age,13 Months,68.0,62.5 to 73.1,611
≥1 Dose MMR,,States/Local Areas,Minnesota,2019,Age,13 Months,63.6,55.4 to 71.1,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014,Age,19 Months,90.6,85.1 to 94.1,269
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2015,Age,19 Months,87.6,82.8 to 91.2,496
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015,Age,19 Months,84.6,81.2 to 87.6,227
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015-2016,Age,19 Months,87.6,82.4 to 91.4,444
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016,Age,19 Months,90.6,83.6 to 94.8,217
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2017,Age,19 Months,91.1,86.8 to 94.0,507
Polio,≥2 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,95.7,89.5 to 98.3,225
Polio,≥2 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,92.2,88.9 to 94.6,208
Polio,≥2 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,95.5,94.0 to 96.7,293
Polio,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,95.6,93.9 to 96.8,562
Polio,≥2 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,95.7,91.3 to 97.9,269
Polio,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,94.8,91.5 to 96.9,496
Hep B,≥1 Dose,States/Local Areas,Minnesota,2015,Age,3 Months,91.4,85.1 to 95.2,227
Hep B,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,3 Months,92.6,88.6 to 95.2,444
Hep B,≥1 Dose,States/Local Areas,Minnesota,2016,Age,3 Months,93.8,88.0 to 96.9,217
Hep B,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,3 Months,94.5,91.2 to 96.6,507
Hep B,≥1 Dose,States/Local Areas,Minnesota,2017,Age,3 Months,95.2,91.1 to 97.5,290
Hep B,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,3 Months,96.0,93.5 to 97.6,618
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,67.9 to 98.9,111
≥1 Dose Varicella,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,96.2,91.4 to 100.0,66
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.4,88.9 to 100.0,51
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,84.8,77.0 to 92.5,343
Polio,≥2 Doses,States/Local Areas,Minnesota,2019,Age,7 Months,91.0,84.2 to 95.0,283
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,79.9,73.2 to 86.7,833
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,88.8,72.7 to 100.0,137
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,73.9,60.6 to 87.3,175
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.7,72.8 to 86.5,605
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.7,64.5 to 90.8,315
Hep B,≥1 Dose,States/Local Areas,Minnesota,2013,Age,3 Months,95.2,94.6 to 95.7,293
Hep B,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,3 Months,95.3,93.8 to 96.5,562
Hep B,≥1 Dose,States/Local Areas,Minnesota,2012,Age,3 Months,94.4,92.7 to 95.7,225
Hep B,≥1 Dose,States/Local Areas,Minnesota,2011,Age,3 Months,93.3,91.4 to 94.8,208
Hep B,≥1 Dose,States/Local Areas,Minnesota,2014,Age,3 Months,95.4,91.1 to 97.7,269
Hep B,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,3 Months,93.4,89.8 to 95.8,496
Polio,≥2 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,95.4,89.8 to 98.0,217
Polio,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,94.0,90.5 to 96.2,507
Polio,≥2 Doses,States/Local Areas,Minnesota,2017,Age,7 Months,92.6,87.3 to 95.7,290
Polio,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,7 Months,91.9,88.3 to 94.5,618
Polio,≥2 Doses,States/Local Areas,Minnesota,2018,Age,7 Months,91.3,85.7 to 94.8,328
Polio,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,7 Months,91.1,87.0 to 94.0,611
≥1 Dose MMR,,States/Local Areas,Minnesota,2014,Age,13 Months,60.0,51.9 to 67.6,269
≥1 Dose MMR,,States/Local Areas,Minnesota,2014-2015,Age,13 Months,58.0,51.5 to 64.3,496
≥1 Dose MMR,,States/Local Areas,Minnesota,2015,Age,13 Months,56.1,45.8 to 65.9,227
≥1 Dose MMR,,States/Local Areas,Minnesota,2015-2016,Age,13 Months,63.3,56.1 to 69.9,444
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019,Age,13 Months,63.6,55.4 to 71.0,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2011,Age,19 Months,87.0,84.3 to 89.3,208
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013,Age,19 Months,87.8,85.4 to 89.9,293
≥1 Dose Varicella,,States/Local Areas,Minnesota,2013-2014,Age,19 Months,89.2,87.1 to 90.9,562
≥1 Dose Varicella,,States/Local Areas,Minnesota,2012,Age,19 Months,89.5,79.6 to 94.9,225
≥1 Dose MMR,,States/Local Areas,Minnesota,2016,Age,13 Months,70.5,60.6 to 78.8,217
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2017,Age,13 Months,70.0,63.7 to 75.6,507
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018,Age,13 Months,69.7,62.2 to 76.4,328
≥1 Dose Varicella,,States/Local Areas,Minnesota,2018-2019,Age,13 Months,66.7,61.1 to 71.8,611
DTaP,≥4 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,91.7,85.7 to 95.9,225
DTaP,≥4 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,75.2,64.3 to 84.8,227
DTaP,≥4 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,84.6,77.8 to 90.2,444
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,95.2,88.9 to 98.5,269
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,87.6,79.4 to 93.6,496
Hep A,≥2 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,77.3,68.0 to 85.4,283
Hep B,≥3 Doses,States/Local Areas,Minnesota,2012,Age,13 Months,91.4,85.2 to 95.1,225
DTaP,≥4 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,90.0,83.6 to 94.6,293
DTaP,≥4 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,92.6,88.3 to 95.8,562
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013,Age,13 Months,90.6,88.8 to 92.2,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,13 Months,91.7,88.5 to 94.1,562
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014,Age,13 Months,92.8,88.3 to 95.6,269
Hep B,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,13 Months,89.0,84.4 to 92.3,496
Hep A,≥2 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,86.4,77.0 to 93.3,328
Hep A,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,83.4,75.8 to 89.7,611
Hep A,≥2 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,82.9,75.1 to 89.3,290
Hep A,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,84.5,78.7 to 89.4,618
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016,Age,13 Months,69.1,59.2 to 77.6,217
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2017,Age,13 Months,67.9,61.5 to 73.6,507
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017,Age,13 Months,66.6,58.4 to 73.8,290
≥1 Dose Varicella,,States/Local Areas,Minnesota,2017-2018,Age,13 Months,68.1,62.7 to 73.2,618
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015,Age,13 Months,55.5,45.2 to 65.3,227
≥1 Dose Varicella,,States/Local Areas,Minnesota,2015-2016,Age,13 Months,62.3,55.0 to 69.0,444
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.7,81.9 to 97.5,111
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,85.9 to 94.6,343
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.2,85.7 to 92.7,605
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,88.4,81.8 to 95.1,175
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.2,80.4 to 92.0,315
Polio,≥2 Doses,States/Local Areas,Minnesota,2014,Age,7 Months,93.0,88.1 to 96.0,269
Polio,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,7 Months,90.1,85.6 to 93.4,496
Polio,≥2 Doses,States/Local Areas,Minnesota,2013,Age,7 Months,92.6,88.6 to 95.3,293
Polio,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,7 Months,92.8,91.0 to 94.3,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,84.0,75.9 to 92.1,137
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Overall,Overall,88.5,85.4 to 91.7,833
Polio,≥2 Doses,States/Local Areas,Minnesota,2015,Age,7 Months,87.2,79.0 to 92.5,227
Polio,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,7 Months,91.3,86.6 to 94.4,444
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,87.2,81.8 to 92.6,293
Hep B,≥3 Doses,States/Local Areas,Minnesota,2011,Age,13 Months,85.6,83.3 to 87.7,208
DTaP,≥4 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,77.1,70.1 to 83.5,328
DTaP,≥4 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,79.7,74.9 to 84.2,611
DTaP,≥4 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,84.1,77.4 to 89.8,290
DTaP,≥4 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,80.6,75.8 to 84.9,618
DTaP,≥4 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,82.6,75.5 to 88.6,283
DTaP,≥4 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,89.5,83.0 to 94.3,208
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,74.4,60.7 to 88.1,221
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,84.0,78.2 to 89.8,582
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016,Age,13 Months,88.0,79.7 to 93.2,217
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,13 Months,90.7,86.2 to 93.8,507
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015,Age,13 Months,85.1,76.7 to 90.9,227
Hep B,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,13 Months,86.6,81.0 to 90.7,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017,Age,13 Months,93.3,89.3 to 95.9,290
Hep B,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,13 Months,92.6,89.5 to 94.8,618
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,74.6,55.3 to 93.8,66
DTaP,≥4 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,92.3,86.8 to 96.1,290
DTaP,≥4 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,89.8,85.5 to 93.3,618
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,94.3,85.7 to 98.5,217
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,93.0,88.6 to 96.1,507
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,82.6,75.9 to 88.5,269
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,75.9,69.8 to 81.5,496
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,89.6,82.8 to 94.6,217
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,86.9,82.2 to 90.8,507
DTaP,≥4 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,69.0,59.1 to 78.4,227
DTaP,≥4 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,79.4,73.2 to 85.0,444
Polio,≥2 Doses,States/Local Areas,Minnesota,2015,Age,5 Months,76.6,67.2 to 84.0,227
Polio,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,5 Months,81.7,75.7 to 86.5,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016,Age,7 Months,73.0,63.2 to 81.0,217
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,7 Months,73.0,67.0 to 78.3,507
Hep A,≥2 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,47.2,39.4 to 55.6,283
Hep A,≥2 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,68.8,56.2 to 80.6,208
Hep A,≥2 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,74.8,65.4 to 83.3,225
Hep A,≥2 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,79.8,71.9 to 86.8,293
Hep A,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,80.7,74.1 to 86.5,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016,Age,35 Months,92.7,85.8 to 97.1,217
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,35 Months,92.5,88.4 to 95.5,507
Rotavirus,,States/Local Areas,Vermont,2011,Age,8 Months,75.7,69.1 to 81.2,274
Rotavirus,,States/Local Areas,Vermont,2018,Age,8 Months,76.3,69.9 to 81.6,340
Rotavirus,,States/Local Areas,Vermont,2018-2019,Age,8 Months,78.4,74.1 to 82.1,674
Rotavirus,,States/Local Areas,Vermont,2019,Age,8 Months,80.6,74.4 to 85.5,334
Rotavirus,,States/Local Areas,Vermont,2017,Age,8 Months,78.5,72.3 to 83.6,330
Rotavirus,,States/Local Areas,Vermont,2017-2018,Age,8 Months,77.4,73.0 to 81.2,670
Rotavirus,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,84.7,80.7 to 88.7,492
Rotavirus,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,77.1,62.2 to 92.1,48
Rotavirus,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,75.0,70.1 to 79.9,453
Rotavirus,,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,70.0,62.9 to 77.1,236
Rotavirus,,States/Local Areas,Vermont,2014-2017,Overall,Overall,79.2,75.9 to 82.4,971
Rotavirus,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.1,75.4 to 86.8,286
Rotavirus,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,78.7,74.5 to 83.0,565
Rotavirus,,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,81.9,77.1 to 86.7,421
Rotavirus,,States/Local Areas,Vermont,2014,Age,8 Months,79.2,72.3 to 84.6,271
Rotavirus,,States/Local Areas,Vermont,2014-2015,Age,8 Months,75.5,70.5 to 79.8,523
Rotavirus,,States/Local Areas,Vermont,2016,Age,8 Months,78.5,70.9 to 84.6,248
Rotavirus,,States/Local Areas,Vermont,2016-2017,Age,8 Months,78.5,73.7 to 82.6,578
Rotavirus,,States/Local Areas,Vermont,2015,Age,8 Months,71.7,64.2 to 78.2,252
Rotavirus,,States/Local Areas,Vermont,2015-2016,Age,8 Months,75.2,69.9 to 79.7,500
Rotavirus,,States/Local Areas,Vermont,2013,Age,8 Months,71.9,64.8 to 78.1,261
Rotavirus,,States/Local Areas,Vermont,2013-2014,Age,8 Months,75.5,70.6 to 79.7,532
Rotavirus,,States/Local Areas,Vermont,2012,Age,8 Months,76.5,69.6 to 82.2,261
Hib,Full Series,States/Local Areas,Vermont,2013,Age,19 Months,80.6,67.9 to 89.1,261
Hib,Full Series,States/Local Areas,Vermont,2013-2014,Age,19 Months,80.2,74.8 to 84.6,532
Hib,Full Series,States/Local Areas,Vermont,2015,Age,19 Months,83.7,80.8 to 86.1,252
Hib,Full Series,States/Local Areas,Vermont,2015-2016,Age,19 Months,83.6,79.3 to 87.2,500
Hib,Full Series,States/Local Areas,Vermont,2017,Age,19 Months,84.4,78.7 to 88.8,330
Hib,Full Series,States/Local Areas,Vermont,2017-2018,Age,19 Months,83.9,80.1 to 87.2,670
Hib,Full Series,States/Local Areas,Vermont,2016,Age,19 Months,83.6,77.1 to 88.6,248
Hib,Full Series,States/Local Areas,Vermont,2016-2017,Age,19 Months,84.0,79.9 to 87.4,578
Hib,Full Series,States/Local Areas,Vermont,2018,Age,19 Months,83.4,77.8 to 87.9,340
Hib,Full Series,States/Local Areas,Vermont,2018-2019,Age,19 Months,94.6,92.1 to 96.4,674
Hib,Full Series,States/Local Areas,Vermont,2013,Age,24 Months,86.1,80.5 to 90.8,261
Hib,Full Series,States/Local Areas,Vermont,2013-2014,Age,24 Months,85.3,81.2 to 88.9,532
Hib,Full Series,States/Local Areas,Vermont,2011,Age,24 Months,79.3,72.9 to 85.0,274
Hib,Full Series,States/Local Areas,Vermont,2012,Age,24 Months,85.0,79.0 to 90.0,261
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,Hispanic,73.9,60.2 to 87.6,48
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,72.7,67.6 to 77.8,453
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,76.4,72.1 to 80.7,492
Combined 7 Series,,States/Local Areas,Vermont,2019,Age,35 Months,84.1,77.6 to 89.6,334
Combined 7 Series,,States/Local Areas,Vermont,2018,Age,35 Months,86.7,81.5 to 91.0,340
Combined 7 Series,,States/Local Areas,Vermont,2018-2019,Age,35 Months,85.2,81.2 to 88.7,674
Hib,Full Series,States/Local Areas,Vermont,2012,Age,19 Months,80.4,74.5 to 85.2,261
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,75.5,70.1 to 80.9,314
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,74.7,69.8 to 79.6,421
Hib,Full Series,States/Local Areas,Vermont,2011,Age,19 Months,71.7,64.8 to 77.6,274
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,71.8,64.5 to 79.1,236
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Overall,Overall,74.0,70.6 to 77.4,971
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,72.9,68.3 to 77.5,565
Hib,Full Series,States/Local Areas,Vermont,2014,Age,19 Months,79.7,72.9 to 85.1,271
Hib,Full Series,States/Local Areas,Vermont,2014-2015,Age,19 Months,81.6,77.2 to 85.4,523
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,73.8,64.7 to 82.8,120
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.4,70.7 to 82.2,286
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.3,70.7 to 78.0,835
Combined 7 Series,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.3,57.6 to 81.0,80
Combined 7 Series,,States/Local Areas,Vermont,2015,Age,35 Months,80.2,73.7 to 86.1,252
Combined 7 Series,,States/Local Areas,Vermont,2015-2016,Age,35 Months,80.3,75.5 to 84.7,500
Hib,Primary Series,States/Local Areas,Vermont,2016,Age,13 Months,94.8,89.8 to 97.4,248
Hib,Primary Series,States/Local Areas,Vermont,2016-2017,Age,13 Months,92.9,89.7 to 95.1,578
Hib,Full Series,States/Local Areas,Vermont,2019,Age,19 Months,82.7,77.0 to 87.1,334
Hib,Primary Series,States/Local Areas,Vermont,2019,Age,7 Months,78.0,71.9 to 83.0,334
Hib,Primary Series,States/Local Areas,Vermont,2017,Age,13 Months,91.0,86.1 to 94.2,330
Hib,Primary Series,States/Local Areas,Vermont,2017-2018,Age,13 Months,90.6,87.3 to 93.1,670
Polio,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,3 Months,91.0,86.5 to 94.2,500
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,92.2,85.2 to 99.2,56
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.2,61.6 to 68.8,973
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,89.0,85.6 to 92.4,522
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,79.1 to 96.2,78
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,96.4,92.1 to 100.0,56
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,81.1,66.9 to 95.3,56
Hep B,≥1 Dose,States/Local Areas,Vermont,2021,Age,3 Months,91.5,83.4 to 95.9,193
Rotavirus,,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,85.1,80.5 to 89.7,314
Rotavirus,,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Principal City,76.5,67.3 to 85.7,120
Rotavirus,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.4,75.9 to 82.8,835
Rotavirus,,States/Local Areas,Vermont,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.7,69.0 to 90.4,80
Hep B,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,95.0,92.3 to 96.8,641
Hep B,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,78.1,73.8 to 81.9,641
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,89.9,81.9 to 98.0,56
Polio,≥2 Doses,States/Local Areas,Vermont,2021,Age,5 Months,84.7,75.9 to 90.7,193
≥1 Dose MMR,,States/Local Areas,Vermont,2021,Age,19 Months,94.4,88.1 to 97.4,193
Influenza,,States/Local Areas,Vermont,2017,Age,24 Months,73.4,67.2 to 79.3,330
Influenza,,States/Local Areas,Vermont,2017-2018,Age,24 Months,73.5,69.1 to 77.6,670
Influenza,,States/Local Areas,Vermont,2018,Age,24 Months,73.4,67.3 to 79.1,340
Influenza,,States/Local Areas,Vermont,2018-2019,Age,24 Months,76.3,72.1 to 80.3,674
Influenza,,States/Local Areas,Vermont,2019,Age,24 Months,79.4,73.4 to 84.7,334
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.4,76.3 to 84.6,973
Influenza,,States/Local Areas,Vermont,2016,Age,24 Months,71.7,64.1 to 79.0,248
Influenza,,States/Local Areas,Vermont,2016-2017,Age,24 Months,72.6,67.7 to 77.3,578
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,85.0,81.2 to 88.8,497
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,92.0,89.6 to 94.4,597
≥1 Dose Varicella,,States/Local Areas,Vermont,2020-2021,Age,19 Months,90.8,86.6 to 93.8,500
Hep B,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,3 Months,93.3,88.8 to 96.1,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,20.1,16.0 to 25.0,500
PCV,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,7 Months,78.6,73.1 to 83.3,500
Hib,Primary Series,States/Local Areas,Vermont,2020-2021,Age,19 Months,95.5,92.0 to 97.5,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2021,Age,13 Months,87.9,79.2 to 93.2,193
≥1 Dose Varicella,,States/Local Areas,Vermont,2021,Age,13 Months,63.6,54.0 to 72.3,193
Influenza,,States/Local Areas,Vermont,2021,Age,24 Months,73.5,64.7 to 81.6,193
DTaP,≥4 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,76.0,70.3 to 80.9,500
Hib,≥2 Doses,States/Local Areas,Vermont,2021,Age,5 Months,87.5,79.7 to 92.6,193
Polio,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,95.8,91.8 to 97.9,500
Hib,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,5 Months,89.3,84.8 to 92.5,500
Hib,Full Series,States/Local Areas,Vermont,2020-2021,Age,35 Months,86.5,81.8 to 90.6,500
Hib,Primary Series,States/Local Areas,Vermont,2020-2021,Age,35 Months,96.5,93.4 to 98.4,500
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2020-2021,Age,0-2 Days,78.2,72.8 to 82.9,500
Hep B,≥2 Doses,States/Local Areas,Vermont,2021,Age,5 Months,90.6,82.9 to 95.1,193
DTaP,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,3 Months,92.3,88.2 to 95.0,500
≥1 Dose MMR,,States/Local Areas,Vermont,2020-2021,Age,13 Months,72.4,66.3 to 77.7,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,92.2,88.0 to 95.0,500
DTaP,≥2 Doses,States/Local Areas,Vermont,2021,Age,5 Months,86.3,78.0 to 91.8,193
Hib,Primary Series,States/Local Areas,Vermont,2019,Age,19 Months,96.2,92.7 to 98.1,334
Hib,Primary Series,States/Local Areas,Vermont,2018,Age,19 Months,93.3,88.9 to 96.1,340
Hib,Primary Series,States/Local Areas,Vermont,2018-2019,Age,19 Months,92.1,89.1 to 94.4,674
Combined 7 Series,,States/Local Areas,Vermont,2014,Age,35 Months,76.4,68.8 to 83.2,271
Combined 7 Series,,States/Local Areas,Vermont,2014-2015,Age,35 Months,78.2,73.2 to 82.8,523
Combined 7 Series,,States/Local Areas,Vermont,2012,Age,35 Months,78.0,70.0 to 85.2,261
Combined 7 Series,,States/Local Areas,Vermont,2017,Age,35 Months,82.2,76.4 to 87.2,330
Combined 7 Series,,States/Local Areas,Vermont,2017-2018,Age,35 Months,84.3,80.4 to 87.7,670
Combined 7 Series,,States/Local Areas,Vermont,2016,Age,35 Months,80.2,73.1 to 86.4,248
Combined 7 Series,,States/Local Areas,Vermont,2016-2017,Age,35 Months,81.1,76.6 to 85.2,578
Combined 7 Series,,States/Local Areas,Vermont,2011,Age,35 Months,71.6,64.1 to 78.7,274
Hib,Primary Series,States/Local Areas,Vermont,2012,Age,35 Months,96.2,91.6 to 98.6,261
Combined 7 Series,,States/Local Areas,Vermont,2011,Age,24 Months,62.3,55.2 to 69.5,274
Hib,Primary Series,States/Local Areas,Vermont,2012,Age,7 Months,72.3,68.7 to 75.7,261
Hib,Primary Series,States/Local Areas,Vermont,2017,Age,35 Months,95.8,92.4 to 97.9,330
Hib,Primary Series,States/Local Areas,Vermont,2017-2018,Age,35 Months,94.7,92.1 to 96.6,670
Hib,Primary Series,States/Local Areas,Vermont,2016,Age,35 Months,96.4,93.4 to 98.4,248
Hib,Primary Series,States/Local Areas,Vermont,2016-2017,Age,35 Months,96.1,94.0 to 97.7,578
Hib,Primary Series,States/Local Areas,Vermont,2015,Age,35 Months,91.8,86.6 to 95.6,252
Hib,Primary Series,States/Local Areas,Vermont,2015-2016,Age,35 Months,94.2,91.2 to 96.4,500
Combined 7 Series,,States/Local Areas,Vermont,2015,Age,24 Months,74.4,67.1 to 81.1,252
Combined 7 Series,,States/Local Areas,Vermont,2015-2016,Age,24 Months,75.1,70.0 to 79.9,500
Hib,Primary Series,States/Local Areas,Vermont,2018,Age,35 Months,93.5,89.4 to 96.4,340
Hib,Primary Series,States/Local Areas,Vermont,2018-2019,Age,35 Months,94.8,92.3 to 96.7,674
Hib,Primary Series,States/Local Areas,Vermont,2019,Age,35 Months,96.2,93.1 to 98.2,334
Combined 7 Series,,States/Local Areas,Vermont,2013,Age,24 Months,70.9,63.9 to 77.6,261
Combined 7 Series,,States/Local Areas,Vermont,2013-2014,Age,24 Months,70.2,65.4 to 74.9,532
Combined 7 Series,,States/Local Areas,Vermont,2017,Age,24 Months,80.1,74.3 to 85.3,330
Combined 7 Series,,States/Local Areas,Vermont,2017-2018,Age,24 Months,81.1,77.2 to 84.7,670
Combined 7 Series,,States/Local Areas,Vermont,2018,Age,24 Months,82.2,76.9 to 87.0,340
Combined 7 Series,,States/Local Areas,Vermont,2018-2019,Age,24 Months,80.8,77.0 to 84.3,674
Combined 7 Series,,States/Local Areas,Vermont,2013,Age,35 Months,79.8,72.1 to 86.6,261
Combined 7 Series,,States/Local Areas,Vermont,2013-2014,Age,35 Months,78.1,72.7 to 83.1,532
Combined 7 Series,,States/Local Areas,Vermont,2016,Age,24 Months,75.8,68.7 to 82.3,248
Combined 7 Series,,States/Local Areas,Vermont,2016-2017,Age,24 Months,78.0,73.5 to 82.2,578
Combined 7 Series,,States/Local Areas,Vermont,2019,Age,24 Months,79.3,73.8 to 84.3,334
Combined 7 Series,,States/Local Areas,Vermont,2014,Age,24 Months,69.5,62.7 to 76.2,271
Combined 7 Series,,States/Local Areas,Vermont,2014-2015,Age,24 Months,72.0,67.0 to 76.8,523
Hib,Primary Series,States/Local Areas,Vermont,2014,Age,35 Months,95.5,91.2 to 98.1,271
Hib,Primary Series,States/Local Areas,Vermont,2014-2015,Age,35 Months,93.6,90.4 to 96.0,523
Hib,Primary Series,States/Local Areas,Vermont,2013,Age,13 Months,93.4,88.8 to 96.2,261
Hib,Primary Series,States/Local Areas,Vermont,2013-2014,Age,13 Months,91.7,89.1 to 93.8,532
Hib,Primary Series,States/Local Areas,Vermont,2012,Age,13 Months,90.3,84.0 to 94.3,261
Hib,Primary Series,States/Local Areas,Vermont,2011,Age,13 Months,88.2,84.9 to 90.9,274
Hib,Primary Series,States/Local Areas,Vermont,2018,Age,7 Months,75.9,69.7 to 81.1,340
Hib,Primary Series,States/Local Areas,Vermont,2018-2019,Age,7 Months,76.9,72.7 to 80.6,674
Hib,Primary Series,States/Local Areas,Vermont,2015,Age,13 Months,91.3,85.5 to 94.9,252
Hib,Primary Series,States/Local Areas,Vermont,2015-2016,Age,13 Months,93.0,89.5 to 95.4,500
Hib,Primary Series,States/Local Areas,Vermont,2014,Age,13 Months,90.0,84.3 to 93.8,271
Hib,Primary Series,States/Local Areas,Vermont,2014-2015,Age,13 Months,90.6,86.8 to 93.4,523
Hib,Primary Series,States/Local Areas,Vermont,2015,Age,7 Months,67.7,59.3 to 75.1,252
Hib,Primary Series,States/Local Areas,Vermont,2015-2016,Age,7 Months,74.6,69.2 to 79.4,500
Hib,Primary Series,States/Local Areas,Vermont,2013,Age,7 Months,73.7,64.5 to 81.2,261
Hib,Primary Series,States/Local Areas,Vermont,2013-2014,Age,7 Months,73.5,69.2 to 77.4,532
Hib,Primary Series,States/Local Areas,Vermont,2016,Age,19 Months,96.4,93.0 to 98.2,248
Hib,Primary Series,States/Local Areas,Vermont,2016-2017,Age,19 Months,95.6,93.2 to 97.2,578
Hib,Primary Series,States/Local Areas,Vermont,2015,Age,19 Months,91.8,88.8 to 94.1,252
Hib,Primary Series,States/Local Areas,Vermont,2015-2016,Age,19 Months,94.2,91.0 to 96.3,500
Hib,Primary Series,States/Local Areas,Vermont,2012,Age,19 Months,93.9,90.0 to 96.3,261
Hib,Primary Series,States/Local Areas,Vermont,2014,Age,19 Months,94.4,89.5 to 97.1,271
Hib,Primary Series,States/Local Areas,Vermont,2014-2015,Age,19 Months,93.1,89.6 to 95.5,523
Hib,Primary Series,States/Local Areas,Vermont,2019,Age,13 Months,94.1,90.0 to 96.6,334
Hib,Primary Series,States/Local Areas,Vermont,2013,Age,19 Months,94.8,90.7 to 97.2,261
Hib,Primary Series,States/Local Areas,Vermont,2013-2014,Age,19 Months,94.6,92.9 to 95.9,532
Hib,Primary Series,States/Local Areas,Vermont,2011,Age,19 Months,91.1,89.1 to 92.9,274
Hib,Primary Series,States/Local Areas,Vermont,2014,Age,7 Months,73.3,66.4 to 79.3,271
Hib,Primary Series,States/Local Areas,Vermont,2014-2015,Age,7 Months,70.5,65.1 to 75.4,523
Hib,Primary Series,States/Local Areas,Vermont,2016,Age,7 Months,81.5,74.7 to 86.8,248
Hib,Primary Series,States/Local Areas,Vermont,2016-2017,Age,7 Months,80.3,75.9 to 84.1,578
Hib,Primary Series,States/Local Areas,Vermont,2017,Age,7 Months,79.2,73.2 to 84.1,330
Hib,Primary Series,States/Local Areas,Vermont,2017-2018,Age,7 Months,77.5,73.3 to 81.2,670
Hib,Primary Series,States/Local Areas,Vermont,2012,Age,24 Months,94.7,90.2 to 97.5,261
Hib,Primary Series,States/Local Areas,Vermont,2011,Age,24 Months,92.1,87.3 to 95.6,274
Hib,Primary Series,States/Local Areas,Vermont,2017,Age,19 Months,94.8,90.9 to 97.0,330
Hib,Primary Series,States/Local Areas,Vermont,2017-2018,Age,19 Months,94.0,91.3 to 96.0,670
Hib,Primary Series,States/Local Areas,Vermont,2018,Age,13 Months,90.2,85.3 to 93.6,340
Hib,Primary Series,States/Local Areas,Vermont,2018-2019,Age,13 Months,92.1,89.1 to 94.4,674
DTaP,≥1 Dose,States/Local Areas,Vermont,2012,Age,3 Months,93.8,91.5 to 95.6,261
DTaP,≥1 Dose,States/Local Areas,Vermont,2011,Age,3 Months,90.3,87.5 to 92.5,274
DTaP,≥1 Dose,States/Local Areas,Vermont,2013,Age,3 Months,94.3,89.2 to 97.0,261
DTaP,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,3 Months,91.8,88.3 to 94.3,532
DTaP,≥1 Dose,States/Local Areas,Vermont,2014,Age,3 Months,89.3,83.5 to 93.2,271
DTaP,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,3 Months,90.3,86.4 to 93.1,523
DTaP,≥1 Dose,States/Local Areas,Vermont,2015,Age,3 Months,91.3,85.5 to 94.9,252
DTaP,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,3 Months,93.7,90.5 to 95.9,500
DTaP,≥1 Dose,States/Local Areas,Vermont,2016,Age,3 Months,96.2,92.6 to 98.0,248
DTaP,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,3 Months,93.4,90.3 to 95.6,578
Hib,Full Series,States/Local Areas,Vermont,2021,Age,19 Months,81.9,73.1 to 88.2,193
Hib,Full Series,States/Local Areas,Vermont,2020-2021,Age,24 Months,86.0,81.3 to 90.1,500
Hep A,≥1 Dose,States/Local Areas,Vermont,2017,Age,24 Months,88.8,84.2 to 92.5,330
Hep A,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,24 Months,87.0,83.5 to 90.1,670
PCV,≥2 Doses,States/Local Areas,Vermont,2016,Age,5 Months,84.3,77.7 to 89.3,248
PCV,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,5 Months,83.1,78.6 to 86.7,578
Hep A,≥2 Doses,States/Local Areas,Vermont,2019,Age,19 Months,21.2,16.2 to 27.2,334
Hep A,≥1 Dose,States/Local Areas,Vermont,2019,Age,24 Months,88.7,84.1 to 92.5,334
Hep A,≥1 Dose,States/Local Areas,Vermont,2011,Age,35 Months,79.9,73.4 to 85.7,274
Hep A,≥1 Dose,States/Local Areas,Vermont,2018,Age,24 Months,85.3,79.8 to 89.9,340
Hep A,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,24 Months,87.0,83.5 to 90.1,674
Hep A,≥1 Dose,States/Local Areas,Vermont,2013,Age,19 Months,74.9,69.0 to 80.0,261
Hep A,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,19 Months,75.6,72.6 to 78.3,532
Hep A,≥1 Dose,States/Local Areas,Vermont,2015,Age,19 Months,78.2,75.3 to 80.9,252
Hep A,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,19 Months,80.4,75.8 to 84.3,500
Hep A,≥1 Dose,States/Local Areas,Vermont,2014,Age,19 Months,76.3,69.8 to 81.8,271
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,19 Months,77.3,72.7 to 81.3,523
Hib,≥3 Doses,States/Local Areas,Vermont,2014,Age,24 Months,94.5,90.1 to 97.3,271
Hib,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,93.2,89.9 to 95.7,523
DTaP,≥2 Doses,States/Local Areas,Vermont,2018,Age,5 Months,84.7,78.9 to 89.2,340
DTaP,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,5 Months,87.4,83.8 to 90.4,674
DTaP,≥2 Doses,States/Local Areas,Vermont,2017,Age,5 Months,84.5,78.6 to 89.1,330
DTaP,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,5 Months,84.6,80.6 to 88.0,670
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.4,93.8 to 98.9,286
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Urbanicity,Living In a Non-MSA,93.0,90.7 to 95.3,565
DTaP,≥2 Doses,States/Local Areas,Vermont,2016,Age,5 Months,87.1,80.3 to 91.8,248
DTaP,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,5 Months,85.8,81.5 to 89.3,578
DTaP,≥3 Doses,States/Local Areas,Vermont,2017,Age,24 Months,96.3,92.9 to 98.3,330
DTaP,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,95.8,93.6 to 97.4,670
DTaP,≥3 Doses,States/Local Areas,Vermont,2018,Age,24 Months,95.3,92.1 to 97.5,340
DTaP,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,95.8,93.7 to 97.4,674
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,>400% FPL,94.2,91.3 to 97.1,314
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,133% to <400% FPL,93.7,90.9 to 96.5,421
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Poverty,<133% FPL,92.9,89.5 to 96.3,236
Polio,≥3 Doses,States/Local Areas,Vermont,2014-2017,Overall,Overall,93.6,91.8 to 95.3,971
DTaP,≥3 Doses,States/Local Areas,Vermont,2019,Age,24 Months,96.4,93.3 to 98.3,334
Hib,≥3 Doses,States/Local Areas,Vermont,2015,Age,24 Months,91.8,86.6 to 95.6,252
Hib,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,94.2,91.2 to 96.4,500
Hib,≥3 Doses,States/Local Areas,Vermont,2016,Age,24 Months,96.4,93.4 to 98.4,248
Hib,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,95.9,93.8 to 97.5,578
DTaP,≥3 Doses,States/Local Areas,Vermont,2016,Age,24 Months,96.4,93.2 to 98.4,248
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,24 Months,96.3,94.2 to 97.9,578
≥1 Dose Varicella,,States/Local Areas,Vermont,2020-2021,Age,13 Months,63.9,57.8 to 69.6,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2021,Age,19 Months,91.4,84.7 to 95.3,193
Combined 7 Series,,States/Local Areas,Vermont,2021,Age,35 Months,76.8,67.4 to 85.1,193
DTaP,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,19 Months,96.1,92.7 to 98.0,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2021,Age,19 Months,94.3,87.3 to 97.6,193
Hep A,≥1 Dose,States/Local Areas,Vermont,2020-2021,Age,24 Months,88.4,84.0 to 92.1,500
Polio,≥3 Doses,States/Local Areas,Vermont,2021,Age,19 Months,93.5,85.8 to 97.2,193
Hep B,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,90.8,85.9 to 94.1,500
Hib,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,96.5,93.4 to 98.4,500
PCV,≥4 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,88.6,84.2 to 92.2,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2021,Age,7 Months,76.4,67.3 to 83.6,193
Hep A,≥2 Doses,States/Local Areas,Vermont,2014,Age,19 Months,24.4,18.7 to 31.1,271
Hep A,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,22.4,18.1 to 27.3,523
DTaP,≥4 Doses,States/Local Areas,Vermont,2012,Age,19 Months,76.6,72.2 to 80.5,261
DTaP,≥4 Doses,States/Local Areas,Vermont,2011,Age,19 Months,74.5,69.1 to 79.3,274
Hib,Primary Series,States/Local Areas,Vermont,2015,Age,24 Months,91.8,86.6 to 95.6,252
Hib,Primary Series,States/Local Areas,Vermont,2015-2016,Age,24 Months,94.2,91.2 to 96.4,500
Hib,Primary Series,States/Local Areas,Vermont,2014,Age,24 Months,94.5,90.1 to 97.3,271
Hib,Primary Series,States/Local Areas,Vermont,2014-2015,Age,24 Months,93.2,89.9 to 95.7,523
Hib,Primary Series,States/Local Areas,Vermont,2019,Age,24 Months,96.2,93.1 to 98.2,334
Hib,Primary Series,States/Local Areas,Vermont,2011,Age,35 Months,92.1,87.3 to 95.6,274
Hib,Primary Series,States/Local Areas,Vermont,2013,Age,35 Months,95.1,90.8 to 97.8,261
Hib,Primary Series,States/Local Areas,Vermont,2013-2014,Age,35 Months,95.3,92.5 to 97.4,532
Combined 7 Series,,States/Local Areas,Vermont,2012,Age,24 Months,69.7,62.6 to 76.6,261
Hib,Primary Series,States/Local Areas,Vermont,2016,Age,24 Months,96.4,93.4 to 98.4,248
Hib,Primary Series,States/Local Areas,Vermont,2016-2017,Age,24 Months,95.9,93.8 to 97.5,578
Hib,Primary Series,States/Local Areas,Vermont,2018,Age,24 Months,93.5,89.4 to 96.4,340
Hib,Primary Series,States/Local Areas,Vermont,2018-2019,Age,24 Months,94.8,92.3 to 96.7,674
Hib,Primary Series,States/Local Areas,Vermont,2017,Age,24 Months,95.4,92.0 to 97.7,330
Hib,Primary Series,States/Local Areas,Vermont,2017-2018,Age,24 Months,94.5,91.9 to 96.4,670
Hib,Primary Series,States/Local Areas,Vermont,2013,Age,24 Months,95.1,90.8 to 97.8,261
Hib,Primary Series,States/Local Areas,Vermont,2013-2014,Age,24 Months,94.8,91.9 to 96.9,532
DTaP,≥3 Doses,States/Local Areas,Vermont,2017,Age,35 Months,96.7,93.4 to 98.6,330
DTaP,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,96.5,94.4 to 98.0,670
PCV,≥2 Doses,States/Local Areas,Vermont,2013,Age,5 Months,79.1,69.4 to 86.3,261
PCV,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,5 Months,80.7,75.3 to 85.1,532
PCV,≥2 Doses,States/Local Areas,Vermont,2012,Age,5 Months,81.6,74.0 to 87.4,261
PCV,≥2 Doses,States/Local Areas,Vermont,2011,Age,5 Months,78.1,70.9 to 83.9,274
DTaP,≥3 Doses,States/Local Areas,Vermont,2015,Age,35 Months,94.0,89.4 to 97.1,252
DTaP,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,95.2,92.5 to 97.1,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2016,Age,35 Months,96.4,93.2 to 98.4,248
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,96.5,94.4 to 98.0,578
Hep A,≥1 Dose,States/Local Areas,Vermont,2011,Age,24 Months,73.7,67.4 to 79.7,274
Hep A,≥1 Dose,States/Local Areas,Vermont,2013,Age,24 Months,78.6,72.0 to 84.4,261
Hep A,≥1 Dose,States/Local Areas,Vermont,2013-2014,Age,24 Months,79.8,75.3 to 83.8,532
Hep A,≥1 Dose,States/Local Areas,Vermont,2019,Age,19 Months,86.0,80.8 to 89.9,334
Hep A,≥1 Dose,States/Local Areas,Vermont,2012,Age,24 Months,79.0,72.7 to 84.6,261
Hib,≥3 Doses,States/Local Areas,Vermont,2011,Age,35 Months,92.1,87.3 to 95.6,274
DTaP,≥2 Doses,States/Local Areas,Vermont,2019,Age,5 Months,90.2,85.6 to 93.5,334
≥1 Dose MMR,,States/Local Areas,Vermont,2020,Age,13 Months,74.4,66.9 to 80.7,307
Hep A,≥2 Doses,States/Local Areas,Vermont,2011,Age,19 Months,17.1,14.5 to 20.1,274
DTaP,≥3 Doses,States/Local Areas,Vermont,2014,Age,35 Months,95.1,90.5 to 97.9,271
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,94.6,91.5 to 96.8,523
DTaP,≥3 Doses,States/Local Areas,Vermont,2013,Age,35 Months,97.6,93.8 to 99.3,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,96.3,93.6 to 98.1,532
DTaP,≥3 Doses,States/Local Areas,Vermont,2012,Age,35 Months,98.8,96.8 to 99.6,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2011,Age,35 Months,96.2,92.9 to 98.2,274
Hep A,≥2 Doses,States/Local Areas,Vermont,2013,Age,19 Months,20.8,18.2 to 23.8,261
Hep A,≥2 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,22.6,18.4 to 27.3,532
Hep A,≥2 Doses,States/Local Areas,Vermont,2012,Age,19 Months,19.7,15.3 to 24.9,261
Hib,≥3 Doses,States/Local Areas,Vermont,2019,Age,24 Months,96.2,93.1 to 98.2,334
Hib,≥3 Doses,States/Local Areas,Vermont,2017,Age,24 Months,95.4,92.0 to 97.7,330
Hib,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,24 Months,94.5,91.9 to 96.4,670
Hib,≥3 Doses,States/Local Areas,Vermont,2018,Age,24 Months,93.5,89.4 to 96.4,340
Hib,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,24 Months,94.8,92.3 to 96.7,674
Hep A,≥1 Dose,States/Local Areas,Vermont,2017,Age,19 Months,87.6,82.7 to 91.2,330
Hep A,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,19 Months,84.5,80.6 to 87.7,670
Hep A,≥1 Dose,States/Local Areas,Vermont,2018,Age,19 Months,81.3,75.1 to 86.3,340
Hep A,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,19 Months,82.2,77.4 to 86.2,545
Hep A,≥1 Dose,States/Local Areas,Vermont,2016,Age,19 Months,82.5,75.8 to 87.7,248
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,19 Months,85.0,81.0 to 88.3,578
Hep A,≥1 Dose,States/Local Areas,Vermont,2014,Age,24 Months,81.0,75.0 to 86.3,271
Hep A,≥1 Dose,States/Local Areas,Vermont,2014-2015,Age,24 Months,81.3,77.0 to 85.2,523
Hep A,≥1 Dose,States/Local Areas,Vermont,2016,Age,24 Months,88.6,83.1 to 93.0,248
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2017,Age,24 Months,88.7,85.2 to 91.7,578
PCV,≥2 Doses,States/Local Areas,Vermont,2014,Age,5 Months,82.3,75.9 to 87.3,271
PCV,≥2 Doses,States/Local Areas,Vermont,2014-2015,Age,5 Months,84.0,82.5 to 85.4,523
Hep A,≥2 Doses,States/Local Areas,Vermont,2011,Age,24 Months,25.8,20.0 to 32.7,274
Hep A,≥2 Doses,States/Local Areas,Vermont,2018,Age,19 Months,23.9,18.9 to 29.9,340
Hep A,≥2 Doses,States/Local Areas,Vermont,2018-2019,Age,19 Months,21.1,17.0 to 25.8,545
Hib,≥3 Doses,States/Local Areas,Vermont,2016,Age,35 Months,96.4,93.4 to 98.4,248
Hib,≥3 Doses,States/Local Areas,Vermont,2016-2017,Age,35 Months,96.1,94.0 to 97.7,578
Hib,≥3 Doses,States/Local Areas,Vermont,2017,Age,35 Months,95.8,92.4 to 97.9,330
Hib,≥3 Doses,States/Local Areas,Vermont,2017-2018,Age,35 Months,94.7,92.1 to 96.6,670
DTaP,≥4 Doses,States/Local Areas,Vermont,2013,Age,19 Months,75.5,72.1 to 78.7,261
DTaP,≥4 Doses,States/Local Areas,Vermont,2013-2014,Age,19 Months,75.0,72.6 to 77.3,532
DTaP,≥4 Doses,States/Local Areas,Vermont,2014,Age,19 Months,74.5,67.6 to 80.4,271
DTaP,≥4 Doses,States/Local Areas,Vermont,2014-2015,Age,19 Months,73.4,68.2 to 78.0,523
DTaP,≥4 Doses,States/Local Areas,Vermont,2015,Age,19 Months,72.2,67.5 to 76.5,252
DTaP,≥4 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,73.1,67.8 to 77.9,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Any Medicaid,94.3,91.9 to 96.7,453
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2017,Insurance Coverage,Private Insurance Only,98.1,96.7 to 99.5,492
Hep A,≥2 Doses,States/Local Areas,Vermont,2017,Age,19 Months,19.8,14.9 to 25.7,330
Hep A,≥2 Doses,States/Local Areas,Vermont,2017-2018,Age,19 Months,21.8,18.2 to 25.9,670
Hib,≥3 Doses,States/Local Areas,Vermont,2012,Age,35 Months,96.2,91.6 to 98.6,261
Hib,≥3 Doses,States/Local Areas,Vermont,2015,Age,35 Months,91.8,86.6 to 95.6,252
Hib,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,35 Months,94.2,91.2 to 96.4,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2015,Age,19 Months,20.3,15.6 to 26.0,252
Hep A,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,19 Months,24.0,19.3 to 29.4,500
Hep A,≥2 Doses,States/Local Areas,Vermont,2016,Age,19 Months,27.6,20.8 to 35.5,248
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2017,Age,19 Months,23.7,19.4 to 28.6,578
Hib,≥3 Doses,States/Local Areas,Vermont,2013,Age,35 Months,95.1,90.8 to 97.8,261
Hib,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,35 Months,95.3,92.5 to 97.4,532
Hib,≥3 Doses,States/Local Areas,Vermont,2014,Age,35 Months,95.5,91.2 to 98.1,271
Hib,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,35 Months,93.6,90.4 to 96.0,523
PCV,≥2 Doses,States/Local Areas,Vermont,2015,Age,5 Months,85.8,79.4 to 90.4,252
PCV,≥2 Doses,States/Local Areas,Vermont,2015-2016,Age,5 Months,85.1,80.6 to 88.6,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2019,Age,35 Months,96.9,93.5 to 98.8,334
DTaP,≥3 Doses,States/Local Areas,Vermont,2018,Age,35 Months,96.3,93.1 to 98.3,340
DTaP,≥3 Doses,States/Local Areas,Vermont,2018-2019,Age,35 Months,96.7,94.5 to 98.2,674
Hep A,≥1 Dose,States/Local Areas,Vermont,2015,Age,24 Months,81.6,75.4 to 87.0,252
Hep A,≥1 Dose,States/Local Areas,Vermont,2015-2016,Age,24 Months,85.1,81.0 to 88.7,500
DTaP,≥1 Dose,States/Local Areas,Vermont,2017,Age,3 Months,90.6,85.1 to 94.2,330
DTaP,≥1 Dose,States/Local Areas,Vermont,2017-2018,Age,3 Months,90.6,87.1 to 93.3,670
Hep A,≥1 Dose,States/Local Areas,Vermont,2011,Age,19 Months,69.9,65.3 to 74.1,274
DTaP,≥3 Doses,States/Local Areas,Vermont,2013,Age,24 Months,96.5,93.0 to 98.5,261
DTaP,≥3 Doses,States/Local Areas,Vermont,2013-2014,Age,24 Months,95.4,92.7 to 97.3,532
DTaP,≥1 Dose,States/Local Areas,Vermont,2018,Age,3 Months,90.7,85.5 to 94.1,340
DTaP,≥1 Dose,States/Local Areas,Vermont,2018-2019,Age,3 Months,92.6,89.4 to 94.8,674
DTaP,≥1 Dose,States/Local Areas,Vermont,2019,Age,3 Months,94.6,90.5 to 96.9,334
DTaP,≥3 Doses,States/Local Areas,Vermont,2015,Age,24 Months,94.0,89.4 to 97.1,252
DTaP,≥3 Doses,States/Local Areas,Vermont,2015-2016,Age,24 Months,95.2,92.5 to 97.1,500
DTaP,≥3 Doses,States/Local Areas,Vermont,2014,Age,24 Months,94.2,89.7 to 97.2,271
DTaP,≥3 Doses,States/Local Areas,Vermont,2014-2015,Age,24 Months,94.1,91.0 to 96.4,523
DTaP,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,5 Months,91.1,88.0 to 93.5,641
Hib,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,5 Months,89.9,86.6 to 92.5,641
Polio,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,5 Months,90.6,87.5 to 93.0,641
Polio,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,96.5,94.5 to 97.8,641
≥1 Dose MMR,,States/Local Areas,Vermont,2019-2020,Age,13 Months,76.1,71.4 to 80.2,641
Hib,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,93.6,90.7 to 95.6,641
Hib,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,3 Months,92.8,89.6 to 95.1,641
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2020,Age,0-2 Days,79.7,72.8 to 85.2,307
DTaP,≥1 Dose,States/Local Areas,Vermont,2020,Age,3 Months,93.5,88.6 to 96.4,307
Hep A,≥2 Doses,States/Local Areas,Vermont,2020,Age,19 Months,22.6,17.2 to 29.1,307
Combined 7 Series,,States/Local Areas,Vermont,2020,Age,35 Months,79.0,71.2 to 85.8,307
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2020,Age,0-1 Days,76.4,69.4 to 82.2,307
Hep A,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,24 Months,88.1,84.4 to 91.3,641
Hep A,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,81.7,75.4 to 87.2,641
Hep A,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,35 Months,92.0,87.8 to 95.1,641
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,76.6,71.9 to 81.3,497
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,94.8,92.4 to 97.2,497
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,80.1,73.5 to 86.7,215
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,88.8,86.4 to 91.2,1123
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,89.7,86.4 to 93.0,522
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,78.6,71.5 to 85.8,215
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,89.6,86.4 to 92.9,522
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,94.3,92.0 to 96.6,522
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,90.9,86.2 to 95.5,215
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,93.8,91.0 to 96.7,386
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,93.8,91.2 to 96.4,522
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,90.6,86.9 to 94.3,386
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,91.4,87.2 to 95.7,215
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,91.2,87.0 to 95.5,215
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,90.4,87.4 to 93.5,522
Influenza,,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,72.6,67.7 to 77.4,522
Influenza,,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,63.4,55.6 to 71.2,215
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,92.8,89.9 to 95.7,386
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,92.9,91.0 to 94.7,1123
Influenza,,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,85.2,81.1 to 89.4,386
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,96.0,94.6 to 97.4,1123
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,96.6,94.8 to 98.3,522
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,92.8,88.5 to 97.1,215
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,96.4,94.3 to 98.5,386
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,78.3,72.4 to 84.1,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,64.6,58.9 to 70.3,386
Rotavirus,,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,66.1,58.3 to 73.9,215
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,94.5,91.8 to 97.2,386
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,88.1,81.0 to 95.3,115
Rotavirus,,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,80.3,75.8 to 84.9,522
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,84.4 to 97.2,115
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,94.5,92.3 to 96.7,673
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.2,93.7 to 98.7,335
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,92.4,89.9 to 94.9,673
Hib,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,97.0,95.0 to 98.2,641
Hib,Primary Series,States/Local Areas,Vermont,2019-2020,Age,13 Months,93.9,91.0 to 95.9,641
Hep B,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,95.8,93.0 to 97.5,641
Hep B,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,5 Months,93.4,90.3 to 95.5,641
PCV,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,5 Months,88.0,84.4 to 90.9,641
Polio,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,94.9,92.5 to 96.5,641
DTaP,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,82.0,77.8 to 85.5,641
≥1 Dose Varicella,,States/Local Areas,Vermont,2019-2020,Age,13 Months,63.8,58.8 to 68.5,641
Hep B,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,93.6,90.7 to 95.7,641
Hib,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,95.5,93.1 to 97.0,641
DTaP,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,96.7,94.6 to 98.0,641
PCV,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,94.7,92.1 to 96.5,641
Combined 7 Series,,States/Local Areas,Vermont,2019-2020,Age,24 Months,77.8,73.3 to 82.0,641
DTaP,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,97.6,95.7 to 98.8,641
DTaP,≥4 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,91.8,87.7 to 94.9,641
≥1 Dose MMR,,States/Local Areas,Vermont,2019-2020,Age,35 Months,96.0,93.3 to 97.8,641
Polio,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,96.9,95.0 to 98.2,641
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,93.3,90.6 to 96.0,497
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,91.9 to 95.6,973
Influenza,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.6,73.3 to 79.9,973
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,84.9,74.3 to 95.4,56
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.3,86.8 to 91.9,973
Rotavirus,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,78.7,66.0 to 91.3,56
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,82.2,70.7 to 93.7,56
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.3,76.0 to 82.5,973
Rotavirus,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,73.9,69.0 to 78.8,497
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,72.0,58.6 to 85.4,56
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.6,85.9 to 91.3,973
Influenza,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,66.3,61.2 to 71.5,497
Influenza,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,83.4,79.8 to 87.0,597
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.1,74.1 to 94.1,78
Rotavirus,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,86.7,83.1 to 90.3,597
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.6 to 99.1,597
Rotavirus,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.3,55.7 to 81.0,78
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,93.2,90.9 to 95.5,597
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,95.2,88.7 to 100.0,56
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,83.3 to 98.5,78
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,92.3 to 96.0,973
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,68.0,63.2 to 72.8,497
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,65.2,60.5 to 69.9,597
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.0,61.9 to 84.0,78
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,81.6,77.8 to 85.4,597
Rotavirus,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.5,77.2 to 83.8,973
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,82.7 to 99.6,78
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,89.0 to 93.2,973
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,94.4,88.8 to 100.0,56
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,97.0,95.4 to 98.5,673
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,89.4,82.5 to 96.2,115
Influenza,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.6,72.1 to 83.1,335
Influenza,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,72.3,68.0 to 76.5,673
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,81.0,72.6 to 89.5,115
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.9,92.2 to 97.7,335
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,93.8,91.6 to 96.0,673
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.7,89.3 to 96.0,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,61.9,51.4 to 72.4,115
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,91.4,88.9 to 93.8,673
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,66.2,60.0 to 72.5,335
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,94.8,92.3 to 97.4,386
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,67.0,62.8 to 71.3,673
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Overall,Overall,88.2,85.7 to 90.7,1123
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,92.9,90.1 to 95.6,522
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,69.4,61.7 to 77.1,215
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,67.2,62.3 to 72.1,522
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,95.0,92.7 to 97.3,386
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,80.6,75.7 to 85.4,386
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,82.1,78.0 to 86.1,522
Rotavirus,,States/Local Areas,Vermont,2016-2019,Overall,Overall,79.1,76.0 to 82.2,1123
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,79.4,75.6 to 83.2,1123
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Overall,Overall,91.4,89.4 to 93.3,1123
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,97.7,96.2 to 99.2,386
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Overall,Overall,94.0,92.3 to 95.7,1123
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Overall,Overall,87.9,85.5 to 90.2,1123
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,90.3,85.6 to 95.0,215
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Overall,Overall,66.2,62.9 to 69.6,1123
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,72.4,63.5 to 81.3,215
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Overall,Overall,78.6,75.5 to 81.6,1123
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,66.3,59.0 to 73.6,215
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,95.0,92.6 to 97.3,522
Influenza,,States/Local Areas,Vermont,2016-2019,Overall,Overall,74.1,70.9 to 77.3,1123
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,91.6,87.2 to 96.1,215
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,85.0,79.5 to 90.6,215
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,87.9,82.7 to 93.0,386
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,96.4,94.1 to 98.6,386
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,90.9,87.8 to 94.1,386
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Poverty,133% to <400% FPL,87.3,83.8 to 90.8,522
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Poverty,<133% FPL,77.3,70.3 to 84.2,215
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,94.6,92.9 to 96.2,1123
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,86.7,84.1 to 89.3,1123
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Overall,Overall,93.6,91.9 to 95.4,1123
Rotavirus,,States/Local Areas,Vermont,2016-2019,Poverty,>400% FPL,87.7,83.9 to 91.6,386
Influenza,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,46.8,31.1 to 62.5,56
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,84.8,80.8 to 88.8,497
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,96.0,94.2 to 97.9,597
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,92.9,90.1 to 95.7,497
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,91.0,83.2 to 98.7,56
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,74.5 to 94.4,78
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,88.3,84.1 to 92.5,597
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,73.0,66.8 to 79.1,497
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,80.1 to 97.0,78
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,91.3,88.5 to 94.2,597
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,91.1 to 95.1,973
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,96.4,92.1 to 100.0,56
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.3,94.9 to 97.7,973
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.4,83.6 to 89.3,973
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,91.2,88.3 to 94.2,497
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,92.7,90.1 to 95.4,497
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,80.4 to 98.2,78
Polio,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.3 to 97.5,597
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,84.5,80.4 to 88.7,497
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,83.5,79.4 to 87.7,497
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Private Insurance Only,94.7,92.6 to 96.8,597
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Insurance Coverage,Any Medicaid,92.4,89.6 to 95.2,497
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.3,84.7 to 89.9,973
PCV,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.9,93.1 to 96.6,973
≥1 Dose Varicella,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,Hispanic,95.7,91.0 to 100.0,56
Influenza,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.4,53.4 to 79.4,78
Hep A,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,33.5,29.0 to 38.4,641
Polio,≥2 Doses,States/Local Areas,Vermont,2020,Age,13 Months,97.4,94.7 to 98.7,307
Hib,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,97.1,95.2 to 98.3,641
Influenza,,States/Local Areas,Vermont,2019-2020,Age,24 Months,78.8,74.1 to 83.1,641
Hib,Primary Series,States/Local Areas,Vermont,2019-2020,Age,24 Months,97.0,95.2 to 98.3,641
Hib,Full Series,States/Local Areas,Vermont,2019-2020,Age,24 Months,87.2,83.5 to 90.4,641
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2019-2020,Age,0-1 Days,73.4,68.8 to 77.5,641
Combined 7 Series,,States/Local Areas,Vermont,2019-2020,Age,35 Months,81.5,76.4 to 86.0,641
Hib,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,78.9,74.5 to 82.7,641
≥1 Dose Varicella,,States/Local Areas,Vermont,2019-2020,Age,19 Months,90.3,86.7 to 93.0,641
Hep B,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,94.7,91.9 to 96.6,641
Hep A,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,19 Months,84.7,80.6 to 88.1,641
PCV,≥4 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,88.5,84.7 to 91.4,641
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2019-2020,Age,0-2 Days,78.3,73.9 to 82.2,641
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2019-2020,Age,0-3 Days,79.6,75.2 to 83.3,641
≥1 Dose Varicella,,States/Local Areas,Vermont,2019-2020,Age,24 Months,92.7,89.6 to 95.2,641
Hep B,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,94.9,92.3 to 96.8,641
PCV,≥4 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,90.1,86.8 to 93.0,641
PCV,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,97.1,95.2 to 98.3,641
Hep A,≥2 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,21.7,17.9 to 26.0,641
≥1 Dose MMR,,States/Local Areas,Vermont,2019-2020,Age,19 Months,92.5,89.1 to 94.9,641
Hib,Primary Series,States/Local Areas,Vermont,2019-2020,Age,19 Months,96.1,93.8 to 97.6,641
Hib,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,96.1,93.8 to 97.6,641
Hib,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,97.1,95.2 to 98.3,641
Hib,Full Series,States/Local Areas,Vermont,2019-2020,Age,19 Months,83.2,79.0 to 86.7,641
Hib,Primary Series,States/Local Areas,Vermont,2019-2020,Age,35 Months,97.0,95.2 to 98.3,641
Hep B,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,96.0,93.3 to 97.9,641
Hib,Full Series,States/Local Areas,Vermont,2019-2020,Age,35 Months,89.6,85.6 to 92.8,641
≥1 Dose Varicella,,States/Local Areas,Vermont,2019-2020,Age,35 Months,93.9,90.9 to 96.2,641
PCV,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,97.4,95.4 to 98.7,641
PCV,≥4 Doses,States/Local Areas,Vermont,2019-2020,Age,35 Months,93.0,89.2 to 95.8,641
DTaP,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,97.1,95.3 to 98.4,641
Polio,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,96.7,94.8 to 98.0,641
DTaP,≥4 Doses,States/Local Areas,Vermont,2019-2020,Age,24 Months,87.2,83.5 to 90.4,641
≥1 Dose MMR,,States/Local Areas,Vermont,2019-2020,Age,24 Months,94.1,91.2 to 96.3,641
Hep B,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,3 Months,96.6,94.0 to 98.1,641
PCV,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,3 Months,94.2,91.3 to 96.1,641
DTaP,≥3 Doses,States/Local Areas,Vermont,2020,Age,19 Months,96.8,93.6 to 98.4,307
Polio,≥2 Doses,States/Local Areas,Vermont,2020,Age,7 Months,96.3,93.4 to 97.9,307
PCV,≥2 Doses,States/Local Areas,Vermont,2020,Age,5 Months,89.6,84.0 to 93.4,307
PCV,≥3 Doses,States/Local Areas,Vermont,2020,Age,13 Months,95.7,92.0 to 97.7,307
DTaP,≥3 Doses,States/Local Areas,Vermont,2020,Age,7 Months,84.2,77.8 to 89.0,307
≥1 Dose Varicella,,States/Local Areas,Vermont,2020,Age,13 Months,64.2,56.6 to 71.2,307
Hep B,≥3 Doses,States/Local Areas,Vermont,2020,Age,13 Months,93.8,88.7 to 96.7,307
Hep B,≥2 Doses,States/Local Areas,Vermont,2020,Age,13 Months,95.5,90.1 to 98.0,307
Hib,Primary Series,States/Local Areas,Vermont,2020,Age,13 Months,94.0,89.4 to 96.7,307
PCV,≥4 Doses,States/Local Areas,Vermont,2020,Age,35 Months,93.0,88.0 to 96.4,307
Hep A,≥1 Dose,States/Local Areas,Vermont,2020,Age,19 Months,83.7,76.8 to 88.9,307
Hib,≥3 Doses,States/Local Areas,Vermont,2020,Age,13 Months,93.6,89.1 to 96.4,307
PCV,≥4 Doses,States/Local Areas,Vermont,2020,Age,19 Months,89.4,83.4 to 93.4,307
≥1 Dose MMR,,States/Local Areas,Vermont,2020,Age,35 Months,97.0,92.6 to 99.1,307
DTaP,≥4 Doses,States/Local Areas,Vermont,2020,Age,35 Months,90.7,83.5 to 95.6,307
Polio,≥3 Doses,States/Local Areas,Vermont,2020,Age,35 Months,97.9,95.4 to 99.2,307
PCV,≥3 Doses,States/Local Areas,Vermont,2020,Age,19 Months,96.2,92.5 to 98.1,307
≥1 Dose Varicella,,States/Local Areas,Vermont,2020,Age,19 Months,90.2,84.0 to 94.1,307
Hib,Full Series,States/Local Areas,Vermont,2020,Age,19 Months,84.3,77.7 to 89.1,307
Hep B,≥3 Doses,States/Local Areas,Vermont,2020,Age,19 Months,94.8,89.6 to 97.5,307
PCV,≥3 Doses,States/Local Areas,Vermont,2020,Age,35 Months,98.2,95.5 to 99.4,307
Hep B,≥3 Doses,States/Local Areas,Vermont,2020,Age,35 Months,95.9,91.5 to 98.5,307
≥1 Dose Varicella,,States/Local Areas,Vermont,2020,Age,35 Months,93.8,88.6 to 97.1,307
Hib,Primary Series,States/Local Areas,Vermont,2020,Age,35 Months,97.9,95.4 to 99.2,307
Hib,Full Series,States/Local Areas,Vermont,2020,Age,35 Months,87.2,81.4 to 91.8,307
Hib,Primary Series,States/Local Areas,Vermont,2020,Age,24 Months,97.9,95.4 to 99.2,307
Hib,≥3 Doses,States/Local Areas,Vermont,2020,Age,35 Months,97.9,95.5 to 99.2,307
≥1 Dose MMR,,States/Local Areas,Vermont,2020,Age,24 Months,94.6,89.5 to 97.7,307
Hib,≥3 Doses,States/Local Areas,Vermont,2020,Age,24 Months,97.9,95.5 to 99.2,307
Polio,≥3 Doses,States/Local Areas,Vermont,2020,Age,24 Months,97.5,95.0 to 98.9,307
DTaP,≥4 Doses,States/Local Areas,Vermont,2020,Age,24 Months,85.8,79.8 to 90.9,307
Hep B,≥2 Doses,States/Local Areas,Vermont,2020,Age,7 Months,94.3,89.2 to 97.1,307
DTaP,≥3 Doses,States/Local Areas,Vermont,2020,Age,24 Months,97.9,95.4 to 99.2,307
Hib,≥3 Doses,States/Local Areas,Vermont,2020,Age,7 Months,80.3,73.4 to 85.7,307
Hib,Primary Series,States/Local Areas,Vermont,2020,Age,7 Months,81.6,75.0 to 86.8,307
Hib,≥2 Doses,States/Local Areas,Vermont,2020,Age,7 Months,96.7,93.8 to 98.3,307
DTaP,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,3 Months,94.2,91.3 to 96.2,641
Polio,≥1 Dose,States/Local Areas,Vermont,2019-2020,Age,3 Months,93.2,90.1 to 95.4,641
Hib,Primary Series,States/Local Areas,Vermont,2020-2021,Age,24 Months,96.5,93.4 to 98.4,500
DTaP,≥4 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,77.3,72.7 to 81.3,641
Polio,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,19 Months,95.9,93.6 to 97.4,641
PCV,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,7 Months,79.7,75.3 to 83.4,641
DTaP,≥3 Doses,States/Local Areas,Vermont,2019-2020,Age,13 Months,95.3,92.9 to 96.9,641
Hib,Primary Series,States/Local Areas,Vermont,2019-2020,Age,7 Months,79.8,75.4 to 83.5,641
Hib,Primary Series,States/Local Areas,Vermont,2021,Age,19 Months,95.1,88.1 to 98.0,193
Hep A,≥1 Dose,States/Local Areas,Vermont,2012,Age,19 Months,74.3,66.5 to 80.8,261
Hib,≥3 Doses,States/Local Areas,Vermont,2021,Age,19 Months,95.1,88.1 to 98.0,193
Hib,≥3 Doses,States/Local Areas,Vermont,2021,Age,7 Months,75.5,66.3 to 82.8,193
Hep B,≥2 Doses,States/Local Areas,Vermont,2020,Age,5 Months,93.1,87.6 to 96.2,307
Hib,≥2 Doses,States/Local Areas,Vermont,2020,Age,5 Months,91.2,86.1 to 94.5,307
Polio,≥2 Doses,States/Local Areas,Vermont,2020,Age,5 Months,91.5,86.5 to 94.7,307
PCV,≥1 Dose,States/Local Areas,Vermont,2020,Age,3 Months,94.0,89.1 to 96.8,307
DTaP,≥2 Doses,States/Local Areas,Vermont,2020,Age,5 Months,91.5,86.5 to 94.7,307
Hep A,≥2 Doses,States/Local Areas,Vermont,2020,Age,24 Months,33.8,27.3 to 41.4,307
Combined 7 Series,,States/Local Areas,Vermont,2020,Age,24 Months,76.6,69.4 to 83.2,307
PCV,≥4 Doses,States/Local Areas,Vermont,2020,Age,24 Months,91.1,85.9 to 94.9,307
Hep A,≥1 Dose,States/Local Areas,Vermont,2020,Age,24 Months,87.2,80.9 to 92.2,307
PCV,≥3 Doses,States/Local Areas,Vermont,2020,Age,24 Months,97.6,95.1 to 99.0,307
DTaP,≥3 Doses,States/Local Areas,Vermont,2020,Age,35 Months,98.3,95.7 to 99.5,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Vermont,2020,Age,0-3 Days,80.1,73.1 to 85.6,307
Rotavirus,,States/Local Areas,Vermont,2020,Age,8 Months,84.1,77.9 to 88.8,307
Hib,≥3 Doses,States/Local Areas,Vermont,2020,Age,19 Months,95.9,92.2 to 97.9,307
Influenza,,States/Local Areas,Vermont,2020,Age,24 Months,77.7,70.4 to 84.2,307
Hib,Primary Series,States/Local Areas,Vermont,2020,Age,19 Months,95.9,92.2 to 97.9,307
≥1 Dose MMR,,States/Local Areas,Vermont,2020,Age,19 Months,93.6,87.7 to 96.7,307
Polio,≥3 Doses,States/Local Areas,Vermont,2020,Age,19 Months,95.7,92.0 to 97.7,307
DTaP,≥4 Doses,States/Local Areas,Vermont,2020,Age,19 Months,77.4,70.3 to 83.3,307
PCV,≥2 Doses,States/Local Areas,Vermont,2021,Age,5 Months,88.3,80.7 to 93.1,193
Polio,≥2 Doses,States/Local Areas,Vermont,2021,Age,7 Months,88.0,79.4 to 93.4,193
Hep B,≥2 Doses,States/Local Areas,Vermont,2021,Age,7 Months,92.7,85.1 to 96.6,193
≥1 Dose MMR,,States/Local Areas,Vermont,2021,Age,35 Months,96.6,90.4 to 99.2,193
Hib,≥2 Doses,States/Local Areas,Vermont,2021,Age,7 Months,92.2,84.8 to 96.2,193
PCV,≥3 Doses,States/Local Areas,Vermont,2021,Age,35 Months,94.8,89.3 to 98.0,193
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,86.9,79.4 to 94.4,115
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.7 to 95.6,335
PCV,≥4 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,87.6,84.4 to 90.9,673
Influenza,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,75.3,65.3 to 85.3,115
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,77.8,73.8 to 81.8,673
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.1,73.9 to 84.3,335
Rotavirus,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,73.7,63.6 to 83.8,115
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,87.2,79.8 to 94.6,115
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,87.6,84.6 to 90.5,673
Hep A,≥1 Dose,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.7,84.4 to 93.0,335
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,89.3,82.3 to 96.3,115
Rotavirus,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,79.0,74.9 to 83.0,673
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.3,85.1 to 93.4,335
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,88.2,84.9 to 91.4,673
Hib,Full Series,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,86.2,78.7 to 93.7,115
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,77.8,72.8 to 82.8,673
Combined 7 Series,,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.9,58.1 to 81.8,78
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,80.2 to 97.8,78
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,77.1,65.0 to 89.2,115
Hep A,≥2 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.6,76.9 to 90.4,335
Rotavirus,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.6,76.3 to 86.9,335
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,94.7,92.6 to 96.7,673
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,84.4 to 97.2,115
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a Non-MSA,86.9,83.6 to 90.3,673
DTaP,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.0,93.4 to 98.5,335
≥1 Dose MMR,,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.5,91.6 to 97.4,335
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,82.2,74.0 to 90.4,115
DTaP,≥4 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.1,83.9 to 92.3,335
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Principal City,89.4,82.5 to 96.2,115
Hep B,≥3 Doses,States/Local Areas,Vermont,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,92.8 to 97.9,335
Influenza,,States/Local Areas,Hawaii,2013,Age,24 Months,62.1,54.8 to 69.4,261
Influenza,,States/Local Areas,Hawaii,2013-2014,Age,24 Months,61.1,55.8 to 66.3,509
Influenza,,States/Local Areas,Hawaii,2016,Age,24 Months,51.8,44.0 to 60.0,230
Influenza,,States/Local Areas,Hawaii,2016-2017,Age,24 Months,54.1,48.5 to 59.9,459
Influenza,,States/Local Areas,Hawaii,2012,Age,24 Months,61.0,53.8 to 68.3,270
Influenza,,States/Local Areas,Hawaii,2011,Age,24 Months,58.4,50.3 to 66.7,244
Influenza,,States/Local Areas,Hawaii,2014,Age,24 Months,60.1,52.7 to 67.6,248
Influenza,,States/Local Areas,Hawaii,2014-2015,Age,24 Months,59.4,54.1 to 64.8,488
Influenza,,States/Local Areas,Hawaii,2015,Age,24 Months,58.7,51.2 to 66.5,240
Influenza,,States/Local Areas,Hawaii,2015-2016,Age,24 Months,55.2,49.7 to 60.8,470
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019-2020,Age,19 Months,85.0,80.4 to 88.7,447
Hib,≥3 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,70.3,63.5 to 76.3,246
PCV,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,5 Months,81.5,75.9 to 86.0,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,91.1,82.2 to 95.8,270
Hib,≥3 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,91.8,88.7 to 94.2,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,90.4,84.9 to 94.0,261
Hib,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,90.5,87.8 to 92.7,509
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,91.2,86.7 to 94.2,246
DTaP,≥3 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,90.7,89.0 to 92.1,244
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,92.5,87.8 to 95.5,261
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,91.6,88.3 to 94.0,509
DTaP,≥3 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,94.6,89.1 to 97.4,270
Polio,≥3 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,90.9,84.3 to 94.9,261
Polio,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,90.7,87.1 to 93.3,509
Polio,≥3 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,90.5,85.2 to 94.0,248
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,89.4,85.3 to 92.4,488
Polio,≥3 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,88.3,85.0 to 90.9,240
Polio,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,89.5,85.4 to 92.5,470
Polio,≥3 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,89.3,83.0 to 93.5,268
Polio,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,73.6,68.6 to 78.1,514
Hib,≥3 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,77.6,70.4 to 83.5,268
Hib,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,74.0,69.1 to 78.3,514
Polio,≥3 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,90.6,85.3 to 94.1,230
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,91.7,88.4 to 94.1,459
Polio,≥3 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,92.9,88.6 to 95.7,229
Polio,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,91.1,87.5 to 93.8,497
Hib,≥2 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,89.4,84.4 to 93.0,246
Hib,≥3 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,76.5,69.0 to 82.7,240
Hib,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,76.3,71.1 to 80.7,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,88.0,82.0 to 92.3,230
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,88.2,84.2 to 91.2,459
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,88.3,82.8 to 92.3,229
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,89.5,85.7 to 92.3,497
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,90.7,84.9 to 94.4,268
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,90.9,87.5 to 93.5,514
Hib,≥3 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,76.0,68.7 to 82.1,230
Hib,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,72.2,67.0 to 77.0,459
Hib,≥3 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,68.0,60.2 to 74.9,229
Hib,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,72.8,67.5 to 77.5,497
Hib,≥2 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,92.3,87.0 to 95.6,268
Hib,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,92.9,89.9 to 95.1,514
Hib,≥2 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,92.3,87.8 to 95.3,229
Hib,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,92.3,89.1 to 94.7,497
Hib,≥2 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,93.5,89.9 to 95.9,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,84.8,78.7 to 90.9,174
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,88.9,86.3 to 91.5,843
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.9,84.9 to 92.8,393
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,90.9,86.4 to 95.5,177
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,88.3,81.7 to 92.8,240
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,88.2,84.0 to 91.4,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,93.0,84.9 to 96.9,270
Polio,≥3 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,93.0,86.8 to 96.4,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,82.7,77.2 to 88.2,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,73.5,68.2 to 78.7,376
Hib,≥3 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,81.2,78.3 to 83.7,261
Hib,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,82.1,78.5 to 85.2,509
Polio,≥3 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,89.0,86.6 to 91.0,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,92.7,89.3 to 96.0,293
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,88.8,84.7 to 92.9,376
Hib,≥3 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,83.0,76.0 to 88.3,248
Hib,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,79.8,74.8 to 84.0,488
Hib,≥3 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,89.1,86.4 to 91.3,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,85.9,76.8 to 91.7,270
Hib,≥2 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,95.3,90.5 to 97.8,270
Hib,≥2 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,94.2,92.7 to 95.4,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2018,Age,0-3 Days,82.5,75.8 to 87.6,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2018-2019,Age,0-3 Days,83.4,79.2 to 86.9,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,73.4,66.0 to 79.7,240
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,70.0,64.6 to 75.0,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,66.8,58.6 to 74.0,230
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,66.1,60.4 to 71.3,459
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,65.3,57.3 to 72.6,229
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,69.8,64.3 to 74.8,497
Hib,≥2 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,92.9,89.5 to 95.2,261
Hib,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,91.5,87.8 to 94.2,509
PCV,≥3 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,94.6,89.2 to 97.9,229
PCV,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,93.5,90.1 to 96.0,497
PCV,≥3 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,92.5,88.0 to 95.8,268
PCV,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,93.0,90.0 to 95.3,514
Hib,≥3 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,64.6,56.8 to 71.7,248
Hib,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,63.3,57.9 to 68.5,488
Hib,≥3 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,62.0,54.1 to 69.3,240
Hib,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,58.9,53.3 to 64.3,470
Hib,≥3 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,55.9,47.9 to 63.6,230
Hib,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,52.1,46.5 to 57.6,459
Polio,≥1 Dose,States/Local Areas,Hawaii,2017,Age,3 Months,90.1,85.2 to 93.6,229
Polio,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,3 Months,90.1,86.5 to 92.9,497
Polio,≥1 Dose,States/Local Areas,Hawaii,2018,Age,3 Months,90.1,84.4 to 93.9,268
Polio,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,3 Months,89.1,85.4 to 91.9,514
Hib,≥3 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,61.1,54.0 to 67.8,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,87.5,82.6 to 92.4,273
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.4,83.9 to 94.8,185
Hib,≥2 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,88.2,82.0 to 92.4,230
Hib,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,88.7,84.8 to 91.8,459
Hib,≥2 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,89.4,84.0 to 93.1,229
Hib,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,90.0,86.4 to 92.7,497
Hib,≥3 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,47.7,39.9 to 55.6,229
Hib,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,51.1,45.4 to 56.8,497
Hib,≥3 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,54.6,46.4 to 62.5,268
Hib,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,57.8,52.4 to 63.1,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,89.9,88.3 to 91.3,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,74.5,66.2 to 82.8,145
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.1,60.9 to 77.2,185
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.7,79.9 to 87.4,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Overall,Overall,78.5,75.2 to 81.8,843
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,77.3,70.3 to 84.3,177
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,81.3,75.9 to 86.7,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.3,72.2 to 82.4,393
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,89.7,86.6 to 92.1,261
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,89.0,84.7 to 92.1,509
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,88.3,81.9 to 92.6,248
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,88.3,84.0 to 91.6,488
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,82.2,75.8 to 88.7,174
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,83.5,79.7 to 87.4,522
PCV,≥1 Dose,States/Local Areas,Hawaii,2013,Age,3 Months,78.3,72.5 to 83.2,261
PCV,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,3 Months,81.4,76.8 to 85.3,509
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,81.4,74.4 to 88.3,145
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,72.4,66.2 to 78.6,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2011,Age,0-3 Days,80.9,73.8 to 86.4,244
PCV,≥1 Dose,States/Local Areas,Hawaii,2018,Age,3 Months,89.5,84.3 to 93.2,268
PCV,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,3 Months,88.6,85.1 to 91.4,514
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,88.0,83.9 to 92.2,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2012,Age,0-3 Days,78.1,71.2 to 83.7,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,89.5,86.3 to 92.7,522
PCV,≥1 Dose,States/Local Areas,Hawaii,2016,Age,3 Months,84.0,77.4 to 89.0,230
PCV,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,3 Months,86.3,82.2 to 89.6,459
PCV,≥1 Dose,States/Local Areas,Hawaii,2017,Age,3 Months,88.9,83.7 to 92.5,229
PCV,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,3 Months,89.2,85.7 to 91.9,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,86.2,81.7 to 90.7,293
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,79.4,74.3 to 84.5,376
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,68.2,60.0 to 76.3,174
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,78.5,75.1 to 81.9,843
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,78.4,70.8 to 86.0,177
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.7,74.9 to 84.6,393
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,85.1,78.4 to 90.7,201
Hib,≥2 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,88.9,83.1 to 92.8,261
Hib,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,88.3,83.5 to 91.8,509
Hib,≥2 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,87.7,81.5 to 92.0,248
Hib,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,87.4,83.1 to 90.8,488
Hib,≥2 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,87.2,80.6 to 91.8,240
Hib,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,87.7,83.4 to 91.0,470
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.6,67.2 to 85.9,185
PCV,≥3 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,93.0,88.6 to 96.1,270
PCV,≥3 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,91.8,87.8 to 94.9,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,91.3,85.9 to 95.2,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,93.9,89.4 to 96.9,261
PCV,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,92.6,89.3 to 95.1,509
PCV,≥3 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,93.9,89.6 to 96.9,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,85.3 to 91.9,507
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,85.8,79.3 to 92.3,145
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,89.1,84.6 to 93.6,273
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.2,85.3 to 95.1,185
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.5,83.5 to 91.5,393
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,88.6,83.7 to 93.6,177
Hib,≥2 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,90.6,85.1 to 94.2,268
Hib,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,90.0,86.5 to 92.7,514
PCV,≥3 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,91.8,86.5 to 95.6,248
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,90.9,87.2 to 93.9,488
PCV,≥3 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,90.3,84.5 to 94.6,240
PCV,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,90.4,86.6 to 93.5,470
PCV,≥3 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,90.1,84.8 to 94.2,230
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,92.5,88.5 to 95.5,459
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,70.2,62.5 to 76.8,248
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,71.8,66.5 to 76.5,488
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,92.2,88.7 to 95.6,293
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,87.6,83.7 to 91.6,376
Hib,≥3 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,61.3,50.5 to 71.1,270
Hib,≥3 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,69.1,64.4 to 73.5,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,65.1,58.5 to 71.2,261
Hib,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,64.9,62.5 to 67.2,509
Polio,≥1 Dose,States/Local Areas,Hawaii,2014,Age,3 Months,86.6,80.8 to 90.9,248
Polio,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,3 Months,86.0,81.7 to 89.4,488
Polio,≥1 Dose,States/Local Areas,Hawaii,2015,Age,3 Months,85.4,78.5 to 90.3,240
Polio,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,3 Months,85.2,80.7 to 88.7,470
Polio,≥1 Dose,States/Local Areas,Hawaii,2016,Age,3 Months,85.0,78.5 to 89.7,230
Polio,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,3 Months,87.4,83.4 to 90.5,459
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016,Age,0-3 Days,79.5,72.7 to 84.9,230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2017,Age,0-3 Days,81.3,76.6 to 85.2,459
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2017,Age,0-3 Days,85.2,73.7 to 92.2,124
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2017-2018,Age,0-3 Days,82.9,78.2 to 86.7,497
Hib,≥2 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,90.7,84.2 to 94.7,240
Hib,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,90.6,86.6 to 93.5,470
Hib,≥2 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,90.5,84.8 to 94.3,230
Hib,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,91.4,87.9 to 93.9,459
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2015,Age,0-3 Days,76.2,68.6 to 82.5,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2015-2016,Age,0-3 Days,77.9,72.9 to 82.2,470
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014,Age,0-3 Days,75.1,67.8 to 81.1,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2015,Age,0-3 Days,75.6,70.5 to 80.1,488
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,70.7,66.9 to 74.1,261
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,70.4,67.3 to 73.4,509
DTaP,≥3 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,69.2,60.2 to 77.0,270
DTaP,≥3 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,72.4,66.4 to 77.7,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2013,Age,0-3 Days,75.0,67.8 to 81.1,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2013-2014,Age,0-3 Days,75.0,70.0 to 79.5,509
Polio,≥1 Dose,States/Local Areas,Hawaii,2013,Age,3 Months,79.4,74.5 to 83.5,261
Polio,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,3 Months,83.0,78.7 to 86.6,509
PCV,≥1 Dose,States/Local Areas,Hawaii,2019,Age,3 Months,87.7,82.6 to 91.5,246
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,84.7,78.5 to 90.8,174
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,88.2,85.6 to 90.8,843
Polio,≥1 Dose,States/Local Areas,Hawaii,2012,Age,3 Months,86.7,83.4 to 89.5,270
Polio,≥1 Dose,States/Local Areas,Hawaii,2011,Age,3 Months,85.5,82.1 to 88.4,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,88.6,84.4 to 92.9,293
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,89.7,86.4 to 93.0,522
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.5,86.2 to 92.9,507
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,87.0,80.8 to 93.2,145
PCV,≥3 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,93.2,89.0 to 96.2,246
Hib,≥2 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,90.2,84.6 to 93.9,248
Hib,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,90.5,86.4 to 93.4,488
Polio,≥1 Dose,States/Local Areas,Hawaii,2019,Age,3 Months,88.0,82.9 to 91.8,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2019,Age,0-3 Days,84.4,78.7 to 88.8,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,75.3,70.6 to 80.0,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,85.5,81.1 to 89.8,293
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,74.4,66.6 to 80.8,268
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,77.0,72.2 to 81.2,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,79.6,73.5 to 84.6,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013,Age,24 Months,89.4,84.3 to 93.4,261
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013-2014,Age,24 Months,89.8,86.4 to 92.6,509
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014,Age,24 Months,90.1,85.6 to 93.7,248
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2015,Age,24 Months,89.9,86.6 to 92.7,488
Polio,≥2 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,92.8,87.5 to 96.0,268
Polio,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,92.7,89.7 to 94.9,514
Polio,≥2 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,92.7,89.0 to 95.2,246
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2013,Age,0-1 Days,73.3,63.5 to 81.3,261
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2013-2014,Age,0-1 Days,71.0,65.0 to 76.4,509
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2014,Age,0-1 Days,68.7,61.1 to 75.4,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2014-2015,Age,0-1 Days,71.7,66.4 to 76.5,488
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2015,Age,0-1 Days,74.8,67.1 to 81.2,240
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2015-2016,Age,0-1 Days,74.7,69.5 to 79.3,470
Hep B,≥2 Doses,States/Local Areas,Hawaii,2015,Age,5 Months,87.3,80.7 to 91.9,240
Hep B,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,5 Months,86.2,82.1 to 89.5,470
PCV,≥3 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,63.9,58.8 to 68.6,261
PCV,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,64.3,61.0 to 67.6,509
PCV,≥3 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,68.5,61.1 to 75.0,244
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,89.8,86.4 to 92.4,459
PCV,≥3 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,64.8,57.1 to 71.8,248
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,66.2,60.8 to 71.2,488
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,87.2,82.8 to 91.6,293
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,80.8,76.0 to 85.7,376
PCV,≥3 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,60.9,54.8 to 66.7,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,91.1,86.4 to 94.2,229
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,90.3,86.8 to 92.9,497
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,89.5,83.9 to 93.3,268
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,88.6,85.0 to 91.3,514
Hep B,≥2 Doses,States/Local Areas,Hawaii,2016,Age,5 Months,85.1,79.4 to 89.4,230
Hep B,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,5 Months,87.9,84.2 to 90.8,459
Hep B,≥2 Doses,States/Local Areas,Hawaii,2017,Age,5 Months,91.0,85.8 to 94.4,229
Hep B,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,5 Months,90.1,86.5 to 92.9,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,71.8,69.8 to 73.7,261
PCV,≥4 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,72.9,67.8 to 77.4,509
PCV,≥4 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,74.9,62.0 to 84.6,270
PCV,≥4 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,75.9,72.1 to 79.4,244
≥1 Dose MMR,,States/Local Areas,Hawaii,2018,Age,19 Months,89.1,83.3 to 93.1,268
≥1 Dose MMR,,States/Local Areas,Hawaii,2018-2019,Age,19 Months,92.9,89.9 to 95.1,514
PCV,≥4 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,74.0,66.6 to 80.2,248
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,75.4,70.3 to 79.8,488
≥1 Dose MMR,,States/Local Areas,Hawaii,2019,Age,19 Months,86.2,80.5 to 90.5,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015,Age,24 Months,89.6,84.7 to 93.5,240
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015-2016,Age,24 Months,87.9,83.8 to 91.4,470
≥1 Dose MMR,,States/Local Areas,Hawaii,2012,Age,24 Months,94.8,91.3 to 97.2,270
≥1 Dose MMR,,States/Local Areas,Hawaii,2011,Age,24 Months,88.4,82.6 to 92.9,244
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016,Age,24 Months,86.6,80.0 to 91.9,230
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2017,Age,24 Months,86.6,82.2 to 90.4,459
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017,Age,24 Months,87.1,80.9 to 92.0,229
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017-2018,Age,24 Months,87.7,83.7 to 91.1,497
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,64.2,51.1 to 77.4,177
DTaP,≥4 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,80.3,73.3 to 86.4,246
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,75.1,69.1 to 81.2,293
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,84.8,81.2 to 88.4,522
≥1 Dose MMR,,States/Local Areas,Hawaii,2011,Age,19 Months,86.5,83.6 to 88.9,244
Hep B,≥3 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,90.9,87.0 to 93.7,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,87.9,82.1 to 92.1,268
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,88.6,85.0 to 91.3,514
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,89.2,84.7 to 92.5,246
Hep B,≥3 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,85.3,79.8 to 89.5,244
≥1 Dose MMR,,States/Local Areas,Hawaii,2013,Age,19 Months,90.4,85.2 to 93.9,261
≥1 Dose MMR,,States/Local Areas,Hawaii,2013-2014,Age,19 Months,88.6,83.5 to 92.3,509
≥1 Dose MMR,,States/Local Areas,Hawaii,2014,Age,19 Months,86.8,80.8 to 91.2,248
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2015,Age,19 Months,88.8,84.9 to 91.7,488
≥1 Dose MMR,,States/Local Areas,Hawaii,2012,Age,19 Months,90.9,87.1 to 93.7,270
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017,Age,19 Months,85.8,79.1 to 90.7,229
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017-2018,Age,19 Months,87.0,82.7 to 90.3,497
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018,Age,19 Months,88.1,82.2 to 92.2,268
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018-2019,Age,19 Months,68.8,63.6 to 73.6,514
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,80.8,73.8 to 87.8,145
Polio,≥2 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,91.7,85.5 to 95.4,240
Polio,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,90.9,87.0 to 93.7,470
Polio,≥2 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,90.1,84.4 to 93.9,230
Polio,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,92.0,88.6 to 94.4,459
Polio,≥2 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,94.0,90.0 to 96.5,229
Polio,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,93.4,90.3 to 95.6,497
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,88.7,83.3 to 92.5,230
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.6,78.8 to 90.4,185
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,73.8 to 83.0,507
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,79.9,76.6 to 83.3,843
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,81.2,74.2 to 88.2,177
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,80.1,74.2 to 86.0,273
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.2,74.2 to 84.2,393
≥1 Dose MMR,,States/Local Areas,Hawaii,2015,Age,19 Months,90.7,81.4 to 95.6,240
≥1 Dose MMR,,States/Local Areas,Hawaii,2015-2016,Age,19 Months,87.5,83.3 to 90.7,470
≥1 Dose MMR,,States/Local Areas,Hawaii,2016,Age,19 Months,84.3,77.4 to 89.4,230
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2017,Age,19 Months,86.1,81.6 to 89.6,459
≥1 Dose MMR,,States/Local Areas,Hawaii,2017,Age,19 Months,88.0,82.0 to 92.2,229
≥1 Dose MMR,,States/Local Areas,Hawaii,2017-2018,Age,19 Months,88.6,84.6 to 91.6,497
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,70.1,62.0 to 78.2,174
≥1 Dose Varicella,,States/Local Areas,Hawaii,2012,Age,24 Months,88.5,83.2 to 92.8,270
≥1 Dose Varicella,,States/Local Areas,Hawaii,2011,Age,24 Months,85.9,79.7 to 91.0,244
Hep B,≥1 Dose,States/Local Areas,Hawaii,2018,Age,3 Months,94.2,89.4 to 96.9,268
Hep B,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,3 Months,93.6,90.6 to 95.7,514
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019,Age,19 Months,87.8,82.4 to 91.8,246
Hep B,≥1 Dose,States/Local Areas,Hawaii,2019,Age,3 Months,93.0,88.6 to 95.8,246
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2012,Age,0-1 Days,73.9,70.2 to 77.4,270
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,79.1,71.4 to 86.8,376
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2011,Age,0-1 Days,77.5,72.3 to 81.9,244
Hep B,≥2 Doses,States/Local Areas,Hawaii,2012,Age,5 Months,88.3,83.3 to 91.9,270
Hep B,≥2 Doses,States/Local Areas,Hawaii,2011,Age,5 Months,80.4,74.8 to 85.0,244
Hep B,≥2 Doses,States/Local Areas,Hawaii,2013,Age,5 Months,86.5,80.4 to 90.9,261
Hep B,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,5 Months,84.7,81.3 to 87.6,509
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,89.3,84.0 to 93.0,261
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,88.1,84.2 to 91.1,509
Hep B,≥2 Doses,States/Local Areas,Hawaii,2014,Age,5 Months,82.9,76.6 to 87.8,248
Hep B,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,5 Months,85.1,83.2 to 86.9,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,74.3,65.8 to 82.7,293
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,86.9,80.9 to 91.2,248
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,88.8,84.9 to 91.8,488
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,90.7,88.3 to 92.7,240
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,89.7,86.0 to 92.5,470
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2019,Age,0-1 Days,81.0,74.9 to 85.9,246
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2011,Age,0-2 Days,80.6,75.0 to 85.3,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2013,Age,0-2 Days,74.8,66.2 to 81.9,261
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2013-2014,Age,0-2 Days,73.6,68.1 to 78.3,509
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2012,Age,0-2 Days,77.7,74.8 to 80.4,270
Hep B,≥2 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,88.9,82.8 to 93.1,261
Hep B,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,88.6,84.1 to 91.9,509
Hep B,≥2 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,88.2,82.7 to 92.2,248
Hep B,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,89.2,85.2 to 92.2,488
Hep B,≥2 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,90.1,83.8 to 94.1,240
Hep B,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,89.0,85.3 to 91.9,470
Hep B,≥2 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,92.5,88.0 to 95.4,270
PCV,≥3 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,72.7,64.9 to 79.3,268
PCV,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,75.5,70.7 to 79.7,514
PCV,≥3 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,78.3,72.3 to 83.3,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,86.2,83.3 to 88.6,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,87.7,85.2 to 89.8,261
PCV,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,87.1,83.8 to 89.8,509
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,90.9,85.7 to 94.8,240
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,90.6,87.2 to 93.4,470
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,90.3,85.5 to 94.0,230
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,91.2,88.1 to 93.7,459
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,92.1,88.0 to 95.2,229
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,90.8,87.6 to 93.5,497
PCV,≥3 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,88.8,78.7 to 94.4,270
PCV,≥4 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,74.3,66.9 to 80.6,229
PCV,≥4 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,75.2,70.0 to 79.8,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,76.1,68.5 to 82.4,268
PCV,≥4 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,73.5,67.2 to 78.9,428
≥1 Dose MMR,,States/Local Areas,Hawaii,2016,Age,24 Months,87.7,81.4 to 92.7,230
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2017,Age,24 Months,88.0,83.8 to 91.5,459
≥1 Dose MMR,,States/Local Areas,Hawaii,2017,Age,24 Months,88.6,83.0 to 93.0,229
≥1 Dose MMR,,States/Local Areas,Hawaii,2017-2018,Age,24 Months,89.0,85.3 to 92.1,497
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017,Age,35 Months,88.5,82.3 to 93.3,229
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017-2018,Age,35 Months,88.6,84.6 to 92.0,497
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018,Age,35 Months,88.5,83.0 to 92.8,268
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018-2019,Age,35 Months,90.5,87.1 to 93.3,514
≥1 Dose MMR,,States/Local Areas,Hawaii,2014,Age,35 Months,90.1,84.9 to 94.1,248
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2015,Age,35 Months,93.3,89.3 to 96.2,488
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019,Age,24 Months,91.8,87.3 to 95.2,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2012,Age,35 Months,92.2,87.4 to 95.6,270
≥1 Dose Varicella,,States/Local Areas,Hawaii,2011,Age,35 Months,89.6,82.7 to 94.6,244
≥1 Dose MMR,,States/Local Areas,Hawaii,2013,Age,24 Months,91.7,86.9 to 95.3,261
≥1 Dose MMR,,States/Local Areas,Hawaii,2013-2014,Age,24 Months,90.2,86.8 to 93.1,509
≥1 Dose MMR,,States/Local Areas,Hawaii,2014,Age,24 Months,88.8,83.5 to 93.0,248
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2015,Age,24 Months,90.6,87.1 to 93.4,488
≥1 Dose MMR,,States/Local Areas,Hawaii,2015,Age,24 Months,92.4,87.7 to 95.8,240
≥1 Dose MMR,,States/Local Areas,Hawaii,2015-2016,Age,24 Months,89.9,86.1 to 93.1,470
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018,Age,24 Months,88.4,82.9 to 92.7,268
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018-2019,Age,24 Months,90.0,86.6 to 92.8,514
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,90.8,86.6 to 93.8,246
Hep B,≥3 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,86.1,80.1 to 91.1,244
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,90.2,85.4 to 93.9,261
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,88.6,85.0 to 91.7,509
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,87.0,81.5 to 91.6,248
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,89.0,85.3 to 92.1,488
Hep B,≥3 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,92.1,88.1 to 95.2,270
PCV,≥3 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,64.4,56.3 to 71.7,230
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,63.4,57.8 to 68.8,459
PCV,≥3 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,62.4,54.3 to 69.9,229
PCV,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,67.5,62.0 to 72.7,497
PCV,≥3 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,67.6,59.8 to 74.5,240
PCV,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,65.9,60.4 to 71.1,470
PCV,≥4 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,76.8,70.6 to 82.0,240
PCV,≥4 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,74.5,69.2 to 79.1,470
PCV,≥4 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,72.3,64.6 to 78.9,230
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,73.3,68.0 to 78.0,459
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,91.2,87.4 to 94.3,246
PCV,≥4 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,85.6,80.3 to 90.2,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,87.5,81.5 to 92.3,244
PCV,≥4 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,76.2,68.8 to 82.8,261
PCV,≥4 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,76.0,71.0 to 80.7,509
PCV,≥4 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,76.0,69.1 to 82.4,248
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,78.8,74.0 to 83.1,488
PCV,≥4 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,81.5,75.1 to 87.2,240
PCV,≥4 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,81.7,77.0 to 85.9,470
≥1 Dose MMR,,States/Local Areas,Hawaii,2019,Age,24 Months,88.1,83.1 to 92.1,246
≥1 Dose MMR,,States/Local Areas,Hawaii,2012,Age,35 Months,95.7,92.2 to 97.9,270
≥1 Dose MMR,,States/Local Areas,Hawaii,2011,Age,35 Months,91.3,84.7 to 95.8,244
≥1 Dose MMR,,States/Local Areas,Hawaii,2013,Age,35 Months,95.4,91.6 to 97.8,261
≥1 Dose MMR,,States/Local Areas,Hawaii,2013-2014,Age,35 Months,92.7,89.5 to 95.2,509
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016,Age,35 Months,88.5,81.5 to 93.7,230
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2017,Age,35 Months,88.6,83.9 to 92.4,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2014,Age,0-2 Days,72.3,64.8 to 78.7,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2014-2015,Age,0-2 Days,74.2,69.0 to 78.9,488
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2015,Age,0-2 Days,76.2,68.6 to 82.5,240
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2015-2016,Age,0-2 Days,77.0,71.9 to 81.4,470
PCV,≥4 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,77.5,70.8 to 83.0,246
≥1 Dose MMR,,States/Local Areas,Hawaii,2018,Age,24 Months,89.4,84.1 to 93.5,268
≥1 Dose MMR,,States/Local Areas,Hawaii,2018-2019,Age,24 Months,88.8,85.2 to 91.8,514
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013,Age,35 Months,93.5,88.9 to 96.7,261
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013-2014,Age,35 Months,93.1,90.0 to 95.4,509
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014,Age,35 Months,92.6,88.4 to 95.8,248
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2015,Age,35 Months,91.4,88.2 to 94.0,488
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015,Age,35 Months,90.2,85.2 to 94.1,240
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015-2016,Age,35 Months,89.0,84.8 to 92.4,470
PCV,≥4 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,81.6,74.6 to 87.6,244
Hib,Primary Series,States/Local Areas,Hawaii,2020,Age,24 Months,87.0,80.2 to 92.3,201
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,84.4 to 91.5,507
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,87.2,81.2 to 93.3,145
Hib,≥1 Dose,States/Local Areas,Hawaii,2013,Age,3 Months,82.7,76.1 to 87.7,261
Hib,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,3 Months,84.6,80.2 to 88.2,509
Hib,≥1 Dose,States/Local Areas,Hawaii,2012,Age,3 Months,85.1,80.3 to 89.0,270
Hib,≥1 Dose,States/Local Areas,Hawaii,2011,Age,3 Months,87.4,81.9 to 91.4,244
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,90.3,85.3 to 94.2,268
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,92.0,89.0 to 94.4,514
PCV,≥3 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,91.8,85.4 to 95.6,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,92.9,88.8 to 96.0,229
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,91.7,88.5 to 94.3,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,81.0,74.8 to 86.5,246
PCV,≥4 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,89.5,83.9 to 93.8,270
PCV,≥4 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,86.1,78.6 to 92.0,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,89.4,84.7 to 92.8,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,89.8,88.6 to 90.8,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,90.5,85.3 to 93.9,261
PCV,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,90.1,87.0 to 92.6,509
PCV,≥3 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,89.8,84.2 to 93.6,248
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,88.9,84.8 to 92.0,488
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,93.1,87.8 to 96.7,230
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,93.3,89.8 to 95.9,459
Hep B,≥2 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,90.7,86.5 to 93.7,246
Hep B,≥2 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,89.0,86.2 to 91.3,244
Hep B,≥2 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,93.6,88.5 to 96.5,261
Hep B,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,91.6,86.7 to 94.7,509
Hep B,≥2 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,95.6,91.4 to 97.7,270
PCV,≥3 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,86.7,81.0 to 90.9,229
PCV,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,88.3,84.5 to 91.3,497
PCV,≥3 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,89.9,84.1 to 93.8,268
PCV,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,89.7,86.1 to 92.4,514
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,91.0,86.1 to 94.7,261
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,90.1,86.4 to 93.2,509
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,89.3,83.4 to 93.8,248
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,90.3,86.4 to 93.4,488
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,90.9,85.7 to 94.8,240
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,92.0,88.3 to 94.8,470
Hep B,≥3 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,93.6,89.6 to 96.4,270
PCV,≥4 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,82.2,75.3 to 88.2,230
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,80.0,75.2 to 84.4,459
PCV,≥4 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,78.1,71.2 to 84.3,229
PCV,≥4 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,80.6,75.9 to 84.9,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,83.6,77.0 to 89.1,268
PCV,≥4 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,82.3,77.8 to 86.4,514
≥1 Dose MMR,,States/Local Areas,Hawaii,2015,Age,35 Months,95.7,90.2 to 98.6,240
≥1 Dose MMR,,States/Local Areas,Hawaii,2015-2016,Age,35 Months,92.9,88.6 to 96.1,470
≥1 Dose MMR,,States/Local Areas,Hawaii,2016,Age,35 Months,89.3,83.0 to 94.1,230
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2017,Age,35 Months,89.6,85.5 to 93.0,459
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019,Age,35 Months,92.8,88.3 to 96.0,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,85.7,81.0 to 90.5,293
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,89.1,85.9 to 92.4,522
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2016,Age,0-2 Days,77.7,70.7 to 83.5,230
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2016-2017,Age,0-2 Days,79.6,74.7 to 83.7,459
Hep B,≥2 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,88.0,82.9 to 91.7,230
Hep B,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,90.8,87.8 to 93.1,459
Hep B,≥2 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,93.9,90.4 to 96.2,229
Hep B,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,92.1,89.0 to 94.4,497
Hep B,≥2 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,90.4,84.8 to 94.0,268
Hep B,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,90.5,87.2 to 93.0,514
PCV,≥3 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,86.5,80.1 to 91.2,248
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,86.3,81.8 to 89.7,488
PCV,≥3 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,86.0,79.3 to 90.8,240
PCV,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,85.9,81.5 to 89.4,470
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,89.5,84.3 to 93.5,268
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,90.4,87.2 to 93.0,514
PCV,≥3 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,85.8,79.4 to 90.4,230
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,86.2,82.1 to 89.5,459
Hep B,≥2 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,91.2,86.7 to 94.3,230
Hep B,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,93.2,90.6 to 95.2,459
Hep B,≥2 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,91.7,86.0 to 95.3,240
Hep B,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,91.5,88.1 to 94.0,470
Hib,≥1 Dose,States/Local Areas,Hawaii,2014,Age,3 Months,86.6,80.7 to 90.9,248
Hib,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,3 Months,85.5,81.2 to 89.0,488
Hep B,≥2 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,89.5,84.0 to 93.3,248
Hep B,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,90.6,86.9 to 93.4,488
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2017,Age,0-2 Days,81.7,74.4 to 87.2,229
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2017-2018,Age,0-2 Days,81.5,76.7 to 85.5,497
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2018,Age,0-2 Days,81.3,74.4 to 86.6,268
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2018-2019,Age,0-2 Days,82.1,77.8 to 85.7,514
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2019,Age,0-2 Days,83.0,77.2 to 87.5,246
Hib,≥1 Dose,States/Local Areas,Hawaii,2018,Age,3 Months,89.8,84.2 to 93.5,268
Hib,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,3 Months,89.2,85.7 to 92.0,514
Hib,≥1 Dose,States/Local Areas,Hawaii,2019,Age,3 Months,88.7,83.6 to 92.3,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,93.1,90.1 to 96.0,293
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.9,85.1 to 92.7,393
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,87.9,82.9 to 92.9,273
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,86.6 to 95.6,185
PCV,≥4 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,79.8,72.8 to 85.9,248
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,84.0,78.6 to 88.6,488
PCV,≥4 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,87.5,80.2 to 93.2,240
PCV,≥4 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,85.7,80.4 to 90.2,470
PCV,≥4 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,83.5,76.6 to 89.4,230
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,82.0,77.1 to 86.4,459
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,87.3,82.8 to 91.9,293
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,85.7 to 92.7,507
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,86.4,80.1 to 92.6,145
PCV,≥3 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,90.8,86.0 to 94.1,229
PCV,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,90.7,87.2 to 93.4,497
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,93.5,89.9 to 96.2,246
≥1 Dose MMR,,States/Local Areas,Hawaii,2018,Age,35 Months,90.0,84.7 to 94.1,268
≥1 Dose MMR,,States/Local Areas,Hawaii,2018-2019,Age,35 Months,89.5,85.9 to 92.5,514
≥1 Dose MMR,,States/Local Areas,Hawaii,2017,Age,35 Months,90.1,84.6 to 94.3,229
≥1 Dose MMR,,States/Local Areas,Hawaii,2017-2018,Age,35 Months,90.2,86.4 to 93.3,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,85.8,79.0 to 91.3,261
PCV,≥4 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,82.6,77.8 to 87.0,509
≥1 Dose MMR,,States/Local Areas,Hawaii,2019,Age,35 Months,89.1,84.0 to 93.1,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,86.9,82.0 to 91.9,273
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.4,81.9 to 93.0,185
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,89.5,86.2 to 92.8,522
Hib,≥1 Dose,States/Local Areas,Hawaii,2015,Age,3 Months,84.4,77.6 to 89.4,240
Hib,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,3 Months,84.9,80.3 to 88.5,470
Hib,≥1 Dose,States/Local Areas,Hawaii,2016,Age,3 Months,85.3,78.6 to 90.2,230
Hib,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,3 Months,87.3,83.2 to 90.5,459
Hib,≥1 Dose,States/Local Areas,Hawaii,2017,Age,3 Months,89.6,84.6 to 93.1,229
Hib,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,3 Months,89.7,86.1 to 92.4,497
Hep B,≥2 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,95.5,92.5 to 97.3,229
Hep B,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,94.7,92.2 to 96.4,497
Hep B,≥2 Doses,States/Local Areas,Hawaii,2018,Age,13 Months,93.9,89.3 to 96.6,268
Hep B,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,13 Months,92.9,90.1 to 95.0,514
Hep B,≥2 Doses,States/Local Areas,Hawaii,2019,Age,13 Months,91.9,88.0 to 94.7,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,88.0,84.4 to 90.9,240
PCV,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,88.3,84.2 to 91.5,470
PCV,≥3 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,88.7,82.8 to 92.7,230
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,89.7,86.0 to 92.5,459
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,87.5,83.5 to 91.5,376
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,81.7,74.9 to 88.5,174
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Overall,Overall,87.6,85.0 to 90.3,843
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.3,83.2 to 91.3,393
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,89.3,84.3 to 94.3,177
PCV,≥4 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,80.7,73.7 to 86.9,229
PCV,≥4 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,83.0,78.3 to 87.3,497
PCV,≥4 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,85.8,79.0 to 91.3,268
PCV,≥4 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,83.3,78.7 to 87.4,514
PCV,≥4 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,81.0,74.8 to 86.5,246
PCV,≥1 Dose,States/Local Areas,Hawaii,2012,Age,3 Months,82.7,79.2 to 85.8,270
PCV,≥1 Dose,States/Local Areas,Hawaii,2011,Age,3 Months,85.2,76.8 to 90.9,244
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,91.8,88.4 to 95.2,293
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,89.5,85.7 to 93.3,376
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,83.6,76.9 to 90.3,174
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Overall,Overall,88.7,86.0 to 91.3,843
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,88.9,83.4 to 94.4,177
PCV,≥3 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,90.6,84.9 to 94.3,268
PCV,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,89.7,86.1 to 92.4,514
PCV,≥3 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,91.1,86.8 to 94.2,246
PCV,≥3 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,91.0,85.6 to 94.9,244
Hib,≥2 Doses,States/Local Areas,Hawaii,2013,Age,5 Months,78.6,75.6 to 81.2,261
Hib,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,5 Months,78.7,75.7 to 81.4,509
Hib,≥2 Doses,States/Local Areas,Hawaii,2014,Age,5 Months,78.8,71.8 to 84.4,248
Hib,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,5 Months,79.4,74.8 to 83.4,488
Hib,≥2 Doses,States/Local Areas,Hawaii,2015,Age,5 Months,80.1,73.0 to 85.7,240
Hib,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,5 Months,75.3,70.0 to 79.9,470
Hib,≥2 Doses,States/Local Areas,Hawaii,2016,Age,5 Months,70.7,62.6 to 77.6,230
Hib,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,5 Months,72.5,67.0 to 77.4,459
Hib,≥2 Doses,States/Local Areas,Hawaii,2012,Age,5 Months,75.1,69.2 to 80.2,270
Hib,≥2 Doses,States/Local Areas,Hawaii,2011,Age,5 Months,75.4,71.9 to 78.6,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,89.4,83.8 to 93.7,240
PCV,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,89.6,85.9 to 92.7,470
PCV,≥3 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,91.1,86.3 to 94.8,248
PCV,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,90.3,86.7 to 93.2,488
Hib,≥2 Doses,States/Local Areas,Hawaii,2017,Age,5 Months,74.5,67.0 to 80.8,229
Hib,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,5 Months,79.5,74.6 to 83.7,497
PCV,≥3 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,90.5,85.5 to 94.3,261
PCV,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,90.8,87.4 to 93.6,509
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,76.5,70.2 to 82.7,273
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.5,74.9 to 88.2,185
PCV,≥4 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.1,72.4 to 81.8,507
PCV,≥1 Dose,States/Local Areas,Hawaii,2014,Age,3 Months,84.5,78.5 to 89.1,248
PCV,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,3 Months,82.9,78.4 to 86.6,488
PCV,≥1 Dose,States/Local Areas,Hawaii,2015,Age,3 Months,81.3,74.3 to 86.7,240
PCV,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,3 Months,82.7,78.1 to 86.5,470
Hib,≥2 Doses,States/Local Areas,Hawaii,2018,Age,5 Months,84.6,78.0 to 89.4,268
Hib,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,5 Months,84.1,79.9 to 87.5,514
Hib,≥2 Doses,States/Local Areas,Hawaii,2019,Age,5 Months,83.6,77.8 to 88.1,246
Hib,≥2 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,89.8,85.2 to 93.2,244
PCV,≥3 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,89.5,84.3 to 93.6,230
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,90.8,87.4 to 93.6,459
Hib,≥2 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,90.4,85.8 to 93.6,270
PCV,≥3 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,92.0,87.6 to 95.3,229
PCV,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,91.4,88.1 to 94.0,497
PCV,≥3 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,90.6,85.4 to 94.6,268
PCV,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,91.2,88.0 to 93.8,514
Hep A,≥1 Dose,States/Local Areas,Hawaii,2013,Age,35 Months,90.9,85.5 to 94.9,261
Hep A,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,35 Months,89.1,84.6 to 92.8,509
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014,Age,35 Months,87.4,79.8 to 93.1,248
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,35 Months,88.8,84.3 to 92.4,488
Hib,Primary Series,States/Local Areas,Hawaii,2012,Age,7 Months,65.1,54.8 to 74.1,270
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,87.3,83.0 to 91.5,293
Hib,Primary Series,States/Local Areas,Hawaii,2011,Age,7 Months,71.8,66.6 to 76.4,244
Polio,≥3 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,95.5,91.9 to 97.9,270
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.5,72.4 to 82.5,393
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,78.6,72.5 to 84.6,273
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.4,74.5 to 88.2,185
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,71.6 to 81.1,507
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,81.1,74.2 to 88.1,145
PCV,≥2 Doses,States/Local Areas,Hawaii,2018,Age,5 Months,85.3,78.9 to 90.0,268
PCV,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,5 Months,84.6,80.6 to 87.9,514
PCV,≥2 Doses,States/Local Areas,Hawaii,2019,Age,5 Months,84.0,78.4 to 88.3,246
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,90.1,85.7 to 94.5,273
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,88.4 to 96.7,185
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.3,87.8 to 94.8,393
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,91.0,86.4 to 95.6,177
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,88.1 to 94.3,507
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,89.0,83.2 to 94.8,145
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,71.4,63.6 to 78.0,230
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,69.7,64.2 to 74.7,459
DTaP,≥4 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,67.8,59.7 to 74.9,229
DTaP,≥4 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,70.0,64.4 to 75.0,497
DTaP,≥4 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,72.2,64.2 to 79.0,268
DTaP,≥4 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,92.7,89.7 to 94.9,514
Hep A,≥2 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,29.6,23.0 to 37.5,261
Hep A,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,34.9,29.9 to 40.4,509
DTaP,≥4 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,76.7,69.3 to 83.4,261
DTaP,≥4 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,77.9,73.0 to 82.5,509
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,45.7,38.0 to 54.2,230
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,46.6,41.0 to 52.5,459
Hep A,≥2 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,47.7,39.9 to 56.1,229
Hep A,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,48.9,43.1 to 54.9,497
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,79.3,72.7 to 85.1,248
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,82.0,77.5 to 86.1,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,50.1,41.9 to 59.0,268
Hep A,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,49.3,43.8 to 55.2,514
Hep A,≥1 Dose,States/Local Areas,Hawaii,2015,Age,35 Months,90.6,85.4 to 94.5,240
Hep A,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,35 Months,88.6,84.5 to 92.1,470
Polio,≥2 Doses,States/Local Areas,Hawaii,2012,Age,5 Months,77.9,72.4 to 82.6,270
Polio,≥2 Doses,States/Local Areas,Hawaii,2011,Age,5 Months,75.4,71.9 to 78.6,244
Polio,≥2 Doses,States/Local Areas,Hawaii,2013,Age,5 Months,75.1,69.6 to 79.9,261
Polio,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,5 Months,76.4,73.0 to 79.4,509
Polio,≥2 Doses,States/Local Areas,Hawaii,2014,Age,5 Months,77.7,70.7 to 83.4,248
Polio,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,5 Months,78.8,74.6 to 82.4,488
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,86.4,80.6 to 92.2,174
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,95.0,92.4 to 97.6,293
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,90.8,87.1 to 94.4,376
Hep B,≥3 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,56.4,51.9 to 60.7,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,57.5,51.4 to 63.4,244
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,62.3,58.9 to 65.5,261
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,60.2,54.8 to 65.3,509
DTaP,≥4 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,69.8,62.4 to 76.2,246
DTaP,≥4 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,86.6,81.3 to 91.1,270
DTaP,≥4 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,78.2,70.5 to 85.0,244
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,78.7,73.5 to 83.9,376
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,66.9,58.7 to 75.1,174
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Overall,Overall,78.2,74.7 to 81.7,843
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,79.1,71.5 to 86.7,177
Polio,≥3 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,93.4,89.1 to 96.5,261
Polio,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,92.7,89.6 to 95.2,509
Polio,≥3 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,92.1,87.2 to 95.6,248
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,92.5,88.4 to 95.6,488
Hib,Full Series,States/Local Areas,Hawaii,2012,Age,35 Months,89.3,83.2 to 93.9,270
Hib,Full Series,States/Local Areas,Hawaii,2011,Age,35 Months,82.1,74.7 to 88.4,244
Hib,Full Series,States/Local Areas,Hawaii,2013,Age,35 Months,86.1,79.3 to 91.5,261
Hib,Full Series,States/Local Areas,Hawaii,2013-2014,Age,35 Months,83.6,78.8 to 87.8,509
Hib,Full Series,States/Local Areas,Hawaii,2014,Age,35 Months,81.7,75.1 to 87.5,248
Hib,Full Series,States/Local Areas,Hawaii,2014-2015,Age,35 Months,80.7,75.8 to 85.1,488
Hib,Full Series,States/Local Areas,Hawaii,2019,Age,24 Months,76.5,69.9 to 82.6,246
DTaP,≥2 Doses,States/Local Areas,Hawaii,2013,Age,5 Months,77.9,74.8 to 80.7,261
DTaP,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,5 Months,78.4,75.3 to 81.2,509
DTaP,≥2 Doses,States/Local Areas,Hawaii,2012,Age,5 Months,79.3,73.7 to 83.9,270
DTaP,≥2 Doses,States/Local Areas,Hawaii,2011,Age,5 Months,76.4,72.5 to 79.8,244
DTaP,≥2 Doses,States/Local Areas,Hawaii,2014,Age,5 Months,78.9,72.0 to 84.5,248
DTaP,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,5 Months,79.7,75.4 to 83.5,488
Polio,≥3 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,90.7,85.2 to 94.8,244
Polio,≥3 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,91.4,87.2 to 94.7,246
Polio,≥3 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,92.7,87.9 to 96.0,230
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,93.8,90.6 to 96.2,459
Polio,≥3 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,95.3,90.4 to 98.1,229
Polio,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,93.5,90.1 to 96.1,497
DTaP,≥2 Doses,States/Local Areas,Hawaii,2015,Age,5 Months,80.5,73.4 to 86.1,240
DTaP,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,5 Months,76.0,70.7 to 80.5,470
DTaP,≥2 Doses,States/Local Areas,Hawaii,2016,Age,5 Months,71.5,63.6 to 78.4,230
DTaP,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,5 Months,73.2,67.8 to 78.0,459
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,88.9,84.6 to 93.1,293
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,91.6,88.7 to 94.5,522
Polio,≥3 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,92.8,85.9 to 97.0,240
Polio,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,92.9,88.8 to 95.9,470
≥1 Dose Varicella,,States/Local Areas,Hawaii,2011,Age,13 Months,55.1,50.3 to 59.9,244
Polio,≥2 Doses,States/Local Areas,Hawaii,2016,Age,5 Months,71.0,63.0 to 77.8,230
Polio,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,5 Months,72.9,67.5 to 77.7,459
Polio,≥2 Doses,States/Local Areas,Hawaii,2017,Age,5 Months,75.1,67.6 to 81.3,229
Polio,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,5 Months,80.5,75.6 to 84.6,497
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,58.0,50.4 to 65.4,248
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,58.9,53.4 to 64.2,488
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,59.8,52.0 to 67.1,240
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,60.9,55.5 to 66.1,470
Polio,≥2 Doses,States/Local Areas,Hawaii,2019,Age,5 Months,83.3,77.7 to 87.8,246
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.9,82.0 to 89.8,507
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,81.4,74.0 to 88.7,145
Polio,≥2 Doses,States/Local Areas,Hawaii,2012,Age,7 Months,92.6,89.5 to 94.9,270
Polio,≥2 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,88.0,84.7 to 90.7,244
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,58.3,50.3 to 66.0,229
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,58.4,52.6 to 63.9,497
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,58.4,50.1 to 66.2,268
Hep B,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,62.6,57.2 to 67.7,514
Polio,≥2 Doses,States/Local Areas,Hawaii,2013,Age,7 Months,88.0,83.3 to 91.5,261
Polio,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,7 Months,87.7,83.4 to 91.0,509
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,66.9,59.8 to 73.2,246
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,72.9,63.5 to 81.6,248
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,76.1,69.0 to 82.6,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,79.8,69.4 to 88.5,240
Hep A,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,77.8,70.6 to 84.3,470
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,75.1,65.8 to 83.4,230
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,76.7,69.9 to 82.9,459
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014,Age,13 Months,60.1,52.4 to 67.3,248
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2015,Age,13 Months,62.4,56.9 to 67.5,488
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015,Age,13 Months,64.7,56.9 to 71.8,240
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015-2016,Age,13 Months,64.2,58.7 to 69.4,470
≥1 Dose Varicella,,States/Local Areas,Hawaii,2012,Age,13 Months,57.4,45.6 to 68.4,270
Hep A,≥1 Dose,States/Local Areas,Hawaii,2019,Age,35 Months,91.1,86.3 to 94.7,246
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,82.6,77.3 to 87.9,293
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,86.0,82.3 to 89.7,522
Polio,≥2 Doses,States/Local Areas,Hawaii,2018,Age,5 Months,85.9,79.3 to 90.7,268
Polio,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,5 Months,84.6,80.5 to 88.0,514
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013,Age,13 Months,60.9,49.5 to 71.3,261
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013-2014,Age,13 Months,60.5,56.2 to 64.7,509
DTaP,≥4 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,73.6,65.8 to 80.8,229
DTaP,≥4 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,84.7,78.5 to 89.8,240
DTaP,≥4 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,83.5,79.0 to 87.5,470
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,82.3,75.5 to 88.1,230
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,78.0,72.9 to 82.8,459
Polio,≥2 Doses,States/Local Areas,Hawaii,2015,Age,5 Months,79.8,72.7 to 85.5,240
Polio,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,5 Months,75.3,70.1 to 79.9,470
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,62.1,54.2 to 69.4,230
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,60.3,54.7 to 65.7,459
Hep A,≥2 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,48.6,41.4 to 56.3,246
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,40.2,33.1 to 48.2,248
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,41.2,35.9 to 47.0,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,42.3,34.8 to 50.7,240
Hep A,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,44.1,38.6 to 50.0,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,90.9,88.5 to 93.3,843
Hib,≥3 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,90.2,85.4 to 93.9,246
Hep A,≥2 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,64.4,55.0 to 73.8,261
Hep A,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,68.7,62.0 to 75.1,509
Hep A,≥2 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,68.7,60.2 to 76.8,270
Hep A,≥2 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,65.7,53.9 to 77.2,244
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016,Age,35 Months,86.7,79.8 to 92.1,230
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,35 Months,88.9,84.6 to 92.4,459
Hep A,≥1 Dose,States/Local Areas,Hawaii,2017,Age,35 Months,91.2,85.6 to 95.2,229
Hep A,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,35 Months,89.4,85.6 to 92.7,497
Hep A,≥1 Dose,States/Local Areas,Hawaii,2018,Age,35 Months,87.5,81.6 to 92.2,268
Hep A,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,35 Months,89.4,85.7 to 92.5,514
DTaP,≥4 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,77.7,70.9 to 83.9,246
DTaP,≥4 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,79.5,71.7 to 86.3,244
Hib,Full Series,States/Local Areas,Hawaii,2020,Age,24 Months,76.9,69.2 to 83.9,201
DTaP,≥4 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,83.4,76.5 to 89.2,268
DTaP,≥4 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,80.6,75.8 to 85.0,514
DTaP,≥4 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,78.3,73.2 to 83.1,497
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,83.1,77.6 to 88.6,273
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.0,80.5 to 91.5,185
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.7,82.5 to 90.9,393
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,81.8,74.7 to 88.9,177
Polio,≥2 Doses,States/Local Areas,Hawaii,2014,Age,7 Months,87.3,81.2 to 91.7,248
Polio,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,7 Months,87.7,83.4 to 91.0,488
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,79.6,72.3 to 86.9,174
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Overall,Overall,84.5,81.5 to 87.6,843
Polio,≥2 Doses,States/Local Areas,Hawaii,2015,Age,7 Months,88.0,81.6 to 92.4,240
Polio,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,7 Months,87.9,83.7 to 91.1,470
Polio,≥2 Doses,States/Local Areas,Hawaii,2016,Age,7 Months,87.7,81.6 to 92.0,230
Polio,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,7 Months,89.1,85.3 to 92.1,459
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,83.9,79.3 to 88.5,376
Hep B,≥3 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,83.6,78.2 to 87.8,244
≥1 Dose MMR,,States/Local Areas,Hawaii,2014,Age,13 Months,64.4,56.8 to 71.4,248
≥1 Dose MMR,,States/Local Areas,Hawaii,2014-2015,Age,13 Months,65.3,59.9 to 70.3,488
≥1 Dose MMR,,States/Local Areas,Hawaii,2015,Age,13 Months,66.2,58.4 to 73.2,240
≥1 Dose MMR,,States/Local Areas,Hawaii,2015-2016,Age,13 Months,67.5,62.1 to 72.5,470
≥1 Dose MMR,,States/Local Areas,Hawaii,2016,Age,13 Months,68.8,60.9 to 75.7,230
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2017,Age,13 Months,68.8,63.3 to 73.9,459
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018,Age,13 Months,68.1,60.3 to 75.0,268
≥1 Dose Varicella,,States/Local Areas,Hawaii,2018-2019,Age,13 Months,68.8,63.6 to 73.6,514
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019,Age,13 Months,69.5,62.4 to 75.9,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2011,Age,19 Months,85.9,82.7 to 88.5,244
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013,Age,19 Months,88.1,82.0 to 92.4,261
≥1 Dose Varicella,,States/Local Areas,Hawaii,2013-2014,Age,19 Months,87.9,85.4 to 90.0,509
≥1 Dose Varicella,,States/Local Areas,Hawaii,2012,Age,19 Months,84.0,75.8 to 89.9,270
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,87.1,83.6 to 90.0,261
Hep B,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,85.4,80.9 to 89.0,509
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,83.7,76.8 to 88.8,248
Hep B,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,86.3,81.8 to 89.8,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,78.9,69.2 to 87.2,229
Hep A,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,78.7,71.9 to 84.8,497
Hep A,≥2 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,77.6,69.1 to 85.1,268
Hep A,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,74.3,68.3 to 79.9,514
Hep A,≥2 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,71.1,62.8 to 79.1,246
Hep B,≥3 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,89.4,85.2 to 92.5,270
DTaP,≥4 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,86.6,79.1 to 92.5,261
DTaP,≥4 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,85.2,80.5 to 89.3,509
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,84.4,78.2 to 89.7,248
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,87.4,82.8 to 91.3,488
DTaP,≥4 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,90.5,83.4 to 95.4,240
DTaP,≥4 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,89.4,84.5 to 93.3,470
DTaP,≥4 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,90.0,84.3 to 94.2,270
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,88.3,81.1 to 93.7,230
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,87.7,82.1 to 92.2,459
DTaP,≥4 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,87.8,78.3 to 94.5,229
DTaP,≥4 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,88.1,81.9 to 92.9,497
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016,Age,13 Months,85.7,79.9 to 90.0,230
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,13 Months,87.1,83.4 to 90.1,459
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015,Age,13 Months,88.8,82.5 to 93.1,240
Hep B,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,13 Months,87.2,83.1 to 90.4,470
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017,Age,13 Months,88.8,83.8 to 92.4,229
Hep B,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,13 Months,88.4,84.7 to 91.2,497
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,64.7,54.1 to 75.2,145
Hep B,≥1 Dose,States/Local Areas,Hawaii,2013,Age,3 Months,92.7,89.0 to 95.2,261
Hep B,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,3 Months,92.7,89.4 to 95.0,509
Hep B,≥1 Dose,States/Local Areas,Hawaii,2012,Age,3 Months,96.1,93.9 to 97.5,270
Hep B,≥1 Dose,States/Local Areas,Hawaii,2011,Age,3 Months,89.9,87.4 to 92.0,244
Hep B,≥1 Dose,States/Local Areas,Hawaii,2014,Age,3 Months,92.6,87.9 to 95.6,248
Hep B,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,3 Months,92.7,89.4 to 95.1,488
Polio,≥2 Doses,States/Local Areas,Hawaii,2017,Age,7 Months,90.7,85.6 to 94.1,229
Polio,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,7 Months,90.2,86.5 to 93.0,497
Polio,≥2 Doses,States/Local Areas,Hawaii,2018,Age,7 Months,89.7,83.6 to 93.7,268
Polio,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,7 Months,89.5,85.9 to 92.3,514
≥1 Dose MMR,,States/Local Areas,Hawaii,2013,Age,13 Months,65.1,55.1 to 74.0,261
≥1 Dose MMR,,States/Local Areas,Hawaii,2013-2014,Age,13 Months,64.8,60.4 to 68.9,509
≥1 Dose MMR,,States/Local Areas,Hawaii,2012,Age,13 Months,66.0,56.9 to 74.0,270
≥1 Dose MMR,,States/Local Areas,Hawaii,2011,Age,13 Months,60.3,54.4 to 65.9,244
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016,Age,13 Months,63.8,55.8 to 71.1,230
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2017,Age,13 Months,63.3,57.7 to 68.6,459
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017,Age,13 Months,62.8,54.7 to 70.3,229
≥1 Dose Varicella,,States/Local Areas,Hawaii,2017-2018,Age,13 Months,65.5,59.9 to 70.6,497
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,69.8,60.1 to 79.5,293
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,76.1,69.7 to 82.6,522
≥1 Dose MMR,,States/Local Areas,Hawaii,2017,Age,13 Months,68.9,60.8 to 75.9,229
≥1 Dose MMR,,States/Local Areas,Hawaii,2017-2018,Age,13 Months,71.7,66.3 to 76.6,497
≥1 Dose MMR,,States/Local Areas,Hawaii,2018,Age,13 Months,74.6,67.1 to 80.9,268
≥1 Dose MMR,,States/Local Areas,Hawaii,2018-2019,Age,13 Months,73.6,68.6 to 78.1,514
≥1 Dose MMR,,States/Local Areas,Hawaii,2019,Age,13 Months,72.6,65.6 to 78.7,246
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014,Age,19 Months,87.7,82.3 to 91.6,248
≥1 Dose Varicella,,States/Local Areas,Hawaii,2014-2015,Age,19 Months,88.2,84.5 to 91.1,488
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015,Age,19 Months,88.7,83.0 to 92.6,240
≥1 Dose Varicella,,States/Local Areas,Hawaii,2015-2016,Age,19 Months,85.7,81.3 to 89.2,470
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016,Age,19 Months,82.8,75.6 to 88.2,230
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2017,Age,19 Months,84.2,79.5 to 88.1,459
Polio,≥2 Doses,States/Local Areas,Hawaii,2012,Age,13 Months,96.0,93.4 to 97.6,270
Polio,≥2 Doses,States/Local Areas,Hawaii,2011,Age,13 Months,91.6,90.4 to 92.6,244
Polio,≥2 Doses,States/Local Areas,Hawaii,2013,Age,13 Months,93.6,89.7 to 96.1,261
Polio,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,13 Months,91.8,87.5 to 94.7,509
Polio,≥2 Doses,States/Local Areas,Hawaii,2014,Age,13 Months,89.9,84.3 to 93.7,248
Polio,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,13 Months,90.8,86.9 to 93.6,488
Hep B,≥1 Dose,States/Local Areas,Hawaii,2015,Age,3 Months,92.9,87.4 to 96.1,240
Hep B,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,3 Months,92.4,89.2 to 94.7,470
Hep B,≥1 Dose,States/Local Areas,Hawaii,2016,Age,3 Months,91.9,87.5 to 94.9,230
Hep B,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,3 Months,94.1,91.6 to 95.9,459
Hep B,≥1 Dose,States/Local Areas,Hawaii,2017,Age,3 Months,96.5,93.8 to 98.1,229
Hep B,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,3 Months,95.4,92.8 to 97.0,497
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.1,69.5 to 84.7,507
DTaP,≥4 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,87.6,80.8 to 92.8,268
DTaP,≥4 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,83.8,79.0 to 88.1,514
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,90.0,86.2 to 93.8,293
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,75.3,66.3 to 84.2,273
Polio,≥2 Doses,States/Local Areas,Hawaii,2019,Age,7 Months,89.4,84.6 to 92.8,246
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,73.4,68.0 to 78.7,843
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,62.3,50.4 to 74.2,174
Hep A,≥1 Dose,States/Local Areas,Hawaii,2020,Age,35 Months,85.3,78.4 to 90.9,201
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.9,69.0 to 82.8,393
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2016,Age,0-1 Days,74.7,67.3 to 80.9,230
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2016-2017,Age,0-1 Days,77.8,72.7 to 82.1,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2017,Age,0-1 Days,81.3,74.0 to 86.8,229
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2017-2018,Age,0-1 Days,80.1,75.3 to 84.2,497
Hep B,≥2 Doses,States/Local Areas,Hawaii,2019,Age,5 Months,90.0,85.6 to 93.1,246
Hep B,≥2 Doses,States/Local Areas,Hawaii,2011,Age,7 Months,85.5,82.9 to 87.8,244
PCV,≥4 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,81.8,73.8 to 88.6,201
Hep B,≥2 Doses,States/Local Areas,Hawaii,2018,Age,5 Months,89.3,83.6 to 93.1,268
Hep B,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,5 Months,89.6,86.2 to 92.3,514
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2018,Age,0-1 Days,79.0,71.9 to 84.6,268
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2018-2019,Age,0-1 Days,80.0,75.5 to 83.8,514
Hib,Full Series,States/Local Areas,Hawaii,2017,Age,35 Months,78.9,71.7 to 85.3,229
Hib,Full Series,States/Local Areas,Hawaii,2017-2018,Age,35 Months,82.3,77.5 to 86.6,497
Polio,≥3 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,91.9,86.7 to 95.6,268
Polio,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,91.7,88.3 to 94.3,514
Hib,Full Series,States/Local Areas,Hawaii,2016,Age,35 Months,86.5,79.2 to 92.2,230
Hib,Full Series,States/Local Areas,Hawaii,2016-2017,Age,35 Months,82.5,77.5 to 87.0,459
Hib,Full Series,States/Local Areas,Hawaii,2018,Age,35 Months,86.5,79.9 to 91.9,268
Hib,Full Series,States/Local Areas,Hawaii,2018-2019,Age,35 Months,81.9,77.2 to 86.2,514
Hib,Full Series,States/Local Areas,Hawaii,2019,Age,35 Months,77.5,70.9 to 83.6,246
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,82.9,79.0 to 86.8,522
Hib,Full Series,States/Local Areas,Hawaii,2016,Age,24 Months,81.6,74.8 to 87.6,230
Hib,Full Series,States/Local Areas,Hawaii,2016-2017,Age,24 Months,79.1,74.2 to 83.7,459
Hib,Full Series,States/Local Areas,Hawaii,2015,Age,35 Months,79.7,72.4 to 86.1,240
Hib,Full Series,States/Local Areas,Hawaii,2015-2016,Age,35 Months,82.9,77.8 to 87.4,470
Hib,Full Series,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,72.2,66.0 to 78.4,293
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.8,86.0 to 93.6,393
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,89.9,85.5 to 94.4,273
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.3,88.2 to 96.5,185
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,86.7 to 93.3,507
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,88.4,82.6 to 94.3,145
Hib,Full Series,States/Local Areas,Hawaii,2017,Age,24 Months,76.7,69.5 to 83.3,229
Hib,Full Series,States/Local Areas,Hawaii,2017-2018,Age,24 Months,80.2,75.4 to 84.6,497
Hib,Full Series,States/Local Areas,Hawaii,2018,Age,24 Months,84.0,77.6 to 89.4,268
Hib,Full Series,States/Local Areas,Hawaii,2018-2019,Age,24 Months,80.3,75.6 to 84.5,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,92.1,86.8 to 95.9,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,92.0,87.4 to 95.4,261
Hib,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,91.4,88.2 to 94.1,509
Hib,≥3 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,92.6,88.2 to 95.8,270
Hib,≥3 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,93.0,88.3 to 96.3,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,90.8,86.0 to 94.5,248
Hib,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,89.7,85.9 to 92.8,488
DTaP,≥3 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,95.5,92.1 to 97.7,270
Polio,≥3 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,89.3,83.5 to 93.8,268
Polio,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,90.4,86.9 to 93.2,514
Polio,≥3 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,91.4,87.2 to 94.7,246
Hib,≥3 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,88.1,82.9 to 91.8,246
Polio,≥3 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,92.9,89.0 to 95.9,229
Polio,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,91.1,87.7 to 93.9,497
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,92.5,87.9 to 95.8,261
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,91.7,88.4 to 94.3,509
Hib,Full Series,States/Local Areas,Hawaii,2015,Age,24 Months,76.5,69.5 to 83.0,240
Hib,Full Series,States/Local Areas,Hawaii,2015-2016,Age,24 Months,78.9,74.1 to 83.4,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,91.0,85.2 to 94.6,268
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,90.9,87.5 to 93.5,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,92.0,87.7 to 94.9,246
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,92.9,88.6 to 95.7,229
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,92.0,88.6 to 94.4,497
Polio,≥2 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,88.1,81.0 to 92.8,201
Hib,≥3 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,89.1,83.1 to 93.1,268
Hib,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,74.0,69.1 to 78.3,514
Polio,≥3 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,92.3,87.6 to 95.7,230
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,92.6,89.6 to 95.0,459
Hib,≥3 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,89.9,84.9 to 93.4,229
Hib,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,89.5,85.8 to 92.3,497
Polio,≥3 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,90.9,86.0 to 94.6,248
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,90.3,86.6 to 93.3,488
Polio,≥3 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,89.7,83.8 to 94.1,240
Polio,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,91.0,87.4 to 94.0,470
Polio,≥3 Doses,States/Local Areas,Hawaii,2013,Age,24 Months,91.3,86.6 to 94.9,261
Polio,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,24 Months,91.1,87.8 to 93.8,509
Hib,≥3 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,90.7,85.4 to 94.2,248
Hib,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,89.5,85.5 to 92.5,488
Polio,≥3 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,90.2,85.6 to 93.5,246
Polio,≥3 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,94.4,90.9 to 96.9,270
Polio,≥3 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,90.4,84.9 to 94.5,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,88.3,83.6 to 91.8,240
Hib,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,86.6,82.2 to 90.0,470
Hib,≥3 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,84.9,78.4 to 89.7,230
Hib,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,87.2,83.2 to 90.4,459
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,90.7,85.4 to 94.2,248
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,90.8,86.9 to 93.6,488
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,90.9,87.3 to 93.5,240
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,91.2,87.3 to 93.9,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,91.4,86.1 to 94.8,230
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,92.1,88.9 to 94.5,459
Hib,≥3 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,86.4,80.8 to 90.6,238
DTaP,≥3 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,87.5,81.4 to 91.8,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,89.5,81.1 to 94.5,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,89.2,82.2 to 93.6,249
Hib,≥3 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,76.3,69.2 to 82.2,411
Hib,≥3 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,74.1,66.7 to 80.3,399
Hib,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,72.7,67.5 to 77.3,800
Hib,≥3 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,72.5,63.1 to 80.2,266
Hib,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,73.3,67.3 to 78.5,665
Polio,≥3 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,89.3,83.8 to 93.1,401
Polio,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,57.2,52.0 to 62.3,812
Hib,≥3 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,71.2,64.0 to 77.6,401
Hib,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,73.8,68.8 to 78.2,812
Polio,≥3 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,88.5,82.2 to 92.8,399
Polio,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,88.9,84.6 to 92.1,800
Polio,≥3 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,89.2,81.2 to 94.0,266
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,88.9,84.1 to 92.3,665
DTaP,≥3 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,93.7,82.8 to 97.8,249
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,89.9,84.1 to 93.7,238
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,90.9,88.8 to 92.6,499
DTaP,≥3 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,91.4,84.4 to 95.4,257
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,88.5,82.5 to 92.7,411
Hib,≥3 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,82.3,75.8 to 87.4,274
Hib,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,77.4,71.7 to 82.2,540
Polio,≥3 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,86.8,75.7 to 93.3,238
Polio,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,88.7,84.8 to 91.7,499
Polio,≥3 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,91.1,86.8 to 94.1,274
Polio,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,90.1,85.6 to 93.3,540
Polio,≥3 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,90.5,84.5 to 94.3,261
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,90.8,87.0 to 93.6,535
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,84.1,75.3 to 90.2,266
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,85.2,79.9 to 89.3,665
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,88.7,83.0 to 92.6,401
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,88.6,84.7 to 91.6,812
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,76.2,69.4 to 82.9,346
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,69.6,60.8 to 78.3,256
Polio,≥3 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,92.2,83.1 to 96.6,249
Hib,≥3 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,83.7,73.9 to 90.3,249
Hib,≥3 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,85.2,80.3 to 89.1,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,71.7,64.0 to 78.4,261
Hib,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,77.0,72.0 to 81.4,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,92.5,87.9 to 97.1,346
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,91.0,84.8 to 97.2,256
Polio,≥3 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,91.0,84.0 to 95.1,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,71.1,68.5 to 73.6,238
Hib,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,71.4,68.7 to 74.0,499
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,86.3,79.7 to 91.0,399
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,87.5,83.1 to 90.9,800
Hib,≥2 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,94.8,89.7 to 97.5,411
Hib,≥2 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,91.6,86.2 to 95.0,399
Hib,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,93.3,90.1 to 95.5,800
Hib,≥2 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,95.0,91.0 to 97.3,401
Hib,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,94.9,92.0 to 96.8,812
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,78.2,72.9 to 83.4,410
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,88.0,81.8 to 92.3,261
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,90.0,86.2 to 92.8,535
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,85.5,80.8 to 89.2,238
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,86.7,84.8 to 88.5,499
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.0 to 97.5,447
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,90.8,87.3 to 94.3,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.2,86.1 to 96.3,162
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,94.1,88.3 to 99.8,162
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,84.9 to 99.4,92
Hib,≥3 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,44.0,37.1 to 51.1,401
Hib,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,46.9,41.8 to 52.1,812
Hib,≥3 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,47.6,40.2 to 55.0,399
Hib,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,45.8,40.7 to 51.0,800
DTaP,≥3 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,90.7,81.9 to 95.5,249
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,91.9,87.1 to 95.1,274
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,88.0,83.1 to 91.6,540
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.6,90.8 to 96.4,448
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,87.0,77.8 to 96.1,152
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,91.2,88.6 to 93.8,1012
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,90.6,86.9 to 94.2,410
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.7,87.1 to 94.2,596
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,90.7,86.7 to 94.6,412
Hib,≥3 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,49.8,42.4 to 57.3,411
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.7,78.1 to 87.2,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,72.3,66.0 to 78.7,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,69.4,58.8 to 80.0,152
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Overall,Overall,76.1,72.4 to 79.9,1012
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,59.7 to 87.3,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.3,70.4 to 80.1,596
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,73.5,62.5 to 84.5,162
Hib,≥2 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,86.6,80.1 to 91.2,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,68.1,59.2 to 75.9,266
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,65.1,59.3 to 70.5,665
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,61.0,53.0 to 68.4,274
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,64.6,58.7 to 70.1,540
Polio,≥1 Dose,States/Local Areas,Louisiana,2018,Age,3 Months,82.7,76.2 to 87.7,401
Polio,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,3 Months,81.9,77.3 to 85.8,812
Polio,≥1 Dose,States/Local Areas,Louisiana,2017,Age,3 Months,84.9,78.4 to 89.7,399
Polio,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,3 Months,83.8,79.4 to 87.4,800
Hib,≥3 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,54.3,45.5 to 62.9,266
Hib,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,51.0,45.2 to 56.8,665
Hib,≥3 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,53.5,45.4 to 61.3,274
Hib,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,53.9,47.9 to 59.8,540
Hib,≥3 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,45.1,37.5 to 52.9,261
Hib,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,49.3,43.8 to 54.8,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,93.3,88.4 to 96.6,401
PCV,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,94.5,91.2 to 96.9,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,91.7,85.7 to 95.9,399
PCV,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,92.7,89.0 to 95.5,800
Hib,≥2 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,91.2,86.1 to 94.5,238
Hib,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,92.0,89.2 to 94.1,499
Hib,≥2 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,92.7,87.5 to 95.9,261
Hib,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,94.7,91.9 to 96.5,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,96.2,93.1 to 99.2,162
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.0,96.1 to 99.9,92
Hib,≥2 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,86.1,79.6 to 90.7,399
Hib,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,85.6,81.1 to 89.2,800
Hib,≥2 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,84.2,75.6 to 90.2,266
Hib,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,85.1,79.9 to 89.1,665
Hib,≥2 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,93.9,85.8 to 97.5,257
Hib,≥2 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,95.1,90.0 to 97.7,249
Hib,≥2 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,93.5,86.1 to 97.1,266
Hib,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,92.6,88.5 to 95.3,665
Hib,≥2 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,96.6,93.8 to 98.1,274
Hib,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,95.0,91.4 to 97.2,540
Hib,Primary Series,States/Local Areas,Louisiana,2020,Age,24 Months,92.5,88.0 to 95.8,433
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,61.9,54.1 to 69.1,399
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,61.4,56.0 to 66.6,800
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,63.1,55.4 to 70.1,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,61.0,53.5 to 68.0,401
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,62.0,56.7 to 67.1,812
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.8,71.5 to 86.0,162
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,78.8,74.1 to 83.4,535
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,73.4,67.1 to 79.7,447
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2019,Age,0-3 Days,75.3,68.3 to 81.3,411
Polio,≥1 Dose,States/Local Areas,Louisiana,2019,Age,3 Months,81.1,74.1 to 86.6,411
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2018,Age,0-3 Days,76.0,69.4 to 81.6,401
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2018-2019,Age,0-3 Days,75.7,71.0 to 79.9,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,96.8,92.2 to 99.0,411
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017,Age,35 Months,95.6,91.2 to 98.2,399
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017-2018,Age,35 Months,94.5,91.5 to 96.8,800
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018,Age,35 Months,93.5,88.4 to 96.8,401
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018-2019,Age,35 Months,93.8,90.2 to 96.5,812
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,91.8,88.2 to 95.3,447
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,91.2,88.0 to 94.4,535
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019,Age,35 Months,94.4,88.2 to 98.0,411
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,91.7,87.3 to 96.0,346
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.9,87.4 to 94.4,448
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,93.1,86.8 to 99.5,152
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Overall,Overall,90.6,88.1 to 93.1,1012
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,90.1,86.5 to 93.8,410
Hib,≥1 Dose,States/Local Areas,Louisiana,2019,Age,3 Months,80.4,73.4 to 86.0,411
Hib,≥1 Dose,States/Local Areas,Louisiana,2018,Age,3 Months,82.0,75.4 to 87.1,401
Hib,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,3 Months,81.2,76.5 to 85.1,812
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.6,85.9 to 93.3,596
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,89.7,85.5 to 93.9,412
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.1,88.7 to 95.5,448
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,90.5,85.3 to 95.8,256
PCV,≥4 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,81.1,73.7 to 87.5,261
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,83.1,78.3 to 87.4,535
PCV,≥4 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,85.0,78.7 to 90.3,274
PCV,≥4 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,83.1,77.7 to 87.8,540
PCV,≥4 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,80.9,72.1 to 88.3,266
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,81.2,75.6 to 86.2,665
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,91.7,88.6 to 94.9,535
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.4,87.6 to 97.2,162
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,92.8,88.7 to 97.0,162
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,88.8 to 100.0,92
PCV,≥4 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,81.6,74.5 to 87.8,399
PCV,≥4 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,79.8,74.6 to 84.5,800
PCV,≥4 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,79.8,72.4 to 86.4,411
PCV,≥4 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,77.9,70.6 to 84.4,401
PCV,≥4 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,78.9,73.7 to 83.7,812
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,92.5,86.0 to 99.1,152
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Overall,Overall,91.2,88.7 to 93.7,1012
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,91.6,88.1 to 95.0,410
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,92.1,87.7 to 96.5,346
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,88.5,82.0 to 95.0,256
PCV,≥1 Dose,States/Local Areas,Louisiana,2011,Age,3 Months,79.7,76.0 to 83.0,257
PCV,≥1 Dose,States/Local Areas,Louisiana,2012,Age,3 Months,81.3,75.1 to 86.2,249
PCV,≥3 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,89.8,84.0 to 94.2,257
PCV,≥3 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,89.4,83.3 to 93.5,411
PCV,≥3 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,89.2,83.5 to 93.0,401
PCV,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,85.2,80.8 to 88.7,812
Hib,≥2 Doses,States/Local Areas,Louisiana,2011,Age,5 Months,71.2,63.5 to 77.9,257
Hib,≥2 Doses,States/Local Areas,Louisiana,2012,Age,5 Months,70.8,62.9 to 77.7,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,97.6,93.6 to 99.4,411
PCV,≥3 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,87.1,80.6 to 91.7,399
PCV,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,88.1,83.7 to 91.5,800
Hib,≥2 Doses,States/Local Areas,Louisiana,2014,Age,5 Months,67.3,59.0 to 74.7,261
Hib,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,5 Months,70.5,63.9 to 76.4,535
Hib,≥2 Doses,States/Local Areas,Louisiana,2013,Age,5 Months,65.6,62.0 to 69.0,238
Hib,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,5 Months,66.4,62.5 to 70.2,499
PCV,≥3 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,95.3,92.4 to 97.4,274
PCV,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,92.6,88.7 to 95.6,540
PCV,≥3 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,91.3,86.0 to 95.2,261
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,93.4,90.4 to 95.7,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,89.1,83.6 to 93.5,238
PCV,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,90.2,86.2 to 93.4,499
Hib,≥2 Doses,States/Local Areas,Louisiana,2017,Age,5 Months,71.7,64.2 to 78.2,399
Hib,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,5 Months,70.9,65.6 to 75.6,800
PCV,≥3 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,93.8,89.2 to 96.9,249
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,78.5,73.8 to 83.2,535
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.1,71.8 to 86.4,162
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,82.1,74.1 to 90.0,162
PCV,≥1 Dose,States/Local Areas,Louisiana,2013,Age,3 Months,81.0,72.7 to 87.3,238
PCV,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,3 Months,80.0,74.3 to 84.7,499
Hib,≥2 Doses,States/Local Areas,Louisiana,2016,Age,5 Months,72.4,63.5 to 79.9,266
Hib,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,5 Months,72.1,66.3 to 77.2,665
Hib,≥2 Doses,States/Local Areas,Louisiana,2015,Age,5 Months,73.7,66.1 to 80.1,274
Hib,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,5 Months,73.1,67.4 to 78.1,540
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.2,76.2 to 86.1,448
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,73.7,63.1 to 84.3,152
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,79.7,76.1 to 83.2,1012
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,80.8,76.0 to 85.7,410
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,77.0,70.0 to 84.0,346
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,81.0,73.2 to 88.8,256
Hib,≥2 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,84.8,78.2 to 89.7,261
Hib,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,88.6,84.7 to 91.6,535
Hib,≥2 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,80.9,73.4 to 86.6,238
Hib,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,82.8,79.4 to 85.8,499
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,80.9,75.5 to 86.3,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2011,Age,0-3 Days,81.9,75.1 to 87.2,257
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,95.1,92.8 to 97.3,535
PCV,≥1 Dose,States/Local Areas,Louisiana,2018,Age,3 Months,82.1,75.6 to 87.2,401
PCV,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,3 Months,80.7,76.0 to 84.7,812
PCV,≥1 Dose,States/Local Areas,Louisiana,2017,Age,3 Months,83.6,77.1 to 88.5,399
PCV,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,3 Months,82.8,78.4 to 86.5,800
PCV,≥1 Dose,States/Local Areas,Louisiana,2016,Age,3 Months,82.9,74.6 to 88.8,266
PCV,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,3 Months,83.2,78.1 to 87.3,665
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.9,94.5 to 99.3,162
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,93.0,89.4 to 96.5,447
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,85.1,80.4 to 89.8,447
Hib,≥2 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,88.4,85.3 to 90.9,257
Hib,≥2 Doses,States/Local Areas,Louisiana,2019,Age,5 Months,72.3,64.8 to 78.8,411
Hib,≥2 Doses,States/Local Areas,Louisiana,2018,Age,5 Months,70.0,62.7 to 76.5,401
Hib,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,5 Months,71.2,66.0 to 75.9,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,89.8,84.6 to 93.9,401
PCV,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,90.7,87.0 to 93.6,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,88.9,83.0 to 93.5,399
PCV,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,89.4,85.2 to 92.7,800
Hib,≥2 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,90.9,84.9 to 94.7,249
PCV,≥3 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,90.1,82.8 to 95.2,266
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,89.6,85.0 to 93.2,665
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2015,Age,0-3 Days,77.5,69.4 to 83.9,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2015-2016,Age,0-3 Days,78.0,72.4 to 82.7,540
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014,Age,0-3 Days,71.3,63.4 to 78.1,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2014-2015,Age,0-3 Days,74.4,68.9 to 79.2,535
DTaP,≥3 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,67.1,58.2 to 75.0,257
DTaP,≥3 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,68.8,63.9 to 73.3,249
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,57.9,52.5 to 63.1,238
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,59.1,55.4 to 62.6,499
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2013,Age,0-3 Days,72.2,64.7 to 78.6,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2013-2014,Age,0-3 Days,71.7,66.4 to 76.5,499
Polio,≥1 Dose,States/Local Areas,Louisiana,2013,Age,3 Months,82.2,76.3 to 86.8,238
Polio,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,3 Months,80.8,75.4 to 85.2,499
Polio,≥1 Dose,States/Local Areas,Louisiana,2011,Age,3 Months,81.5,78.8 to 83.9,257
Polio,≥1 Dose,States/Local Areas,Louisiana,2012,Age,3 Months,84.3,76.3 to 90.0,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,94.4,92.5 to 96.2,1012
PCV,≥1 Dose,States/Local Areas,Louisiana,2019,Age,3 Months,79.4,72.2 to 85.1,411
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.9,77.6 to 94.1,92
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.3,73.4 to 83.2,596
PCV,≥1 Dose,States/Local Areas,Louisiana,2015,Age,3 Months,79.1,71.7 to 84.9,274
PCV,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,3 Months,81.0,75.7 to 85.3,540
PCV,≥1 Dose,States/Local Areas,Louisiana,2014,Age,3 Months,78.9,71.1 to 85.1,261
PCV,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,3 Months,79.0,73.7 to 83.4,535
Hib,≥2 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,92.4,87.8 to 95.3,274
Hib,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,88.3,83.5 to 91.8,540
PCV,≥3 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,89.6,84.0 to 93.8,238
PCV,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,91.4,87.4 to 94.6,499
PCV,≥3 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,90.5,84.6 to 94.8,257
PCV,≥3 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,91.6,86.2 to 95.5,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,91.8 to 97.0,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2012,Age,0-3 Days,79.5,72.2 to 85.2,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,94.8,88.7 to 100.0,152
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.6,88.4 to 94.8,596
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,94.1,91.4 to 96.8,412
PCV,≥3 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,95.2,90.5 to 98.0,249
Hib,≥2 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,85.2,79.0 to 89.8,401
Hib,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,85.9,81.6 to 89.3,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,93.5,87.7 to 97.1,261
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,94.9,91.9 to 97.0,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,93.9,87.7 to 97.6,266
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,93.1,88.9 to 96.1,665
PCV,≥3 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,96.2,93.4 to 98.1,274
PCV,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,95.1,91.8 to 97.3,540
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016,Age,0-3 Days,78.6,70.4 to 84.9,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2016-2017,Age,0-3 Days,77.0,71.7 to 81.5,665
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2017,Age,0-3 Days,71.7,59.2 to 81.5,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2017-2018,Age,0-3 Days,75.7,71.0 to 79.9,800
Polio,≥1 Dose,States/Local Areas,Louisiana,2016,Age,3 Months,83.6,75.3 to 89.5,266
Polio,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,3 Months,84.2,79.1 to 88.3,665
Polio,≥1 Dose,States/Local Areas,Louisiana,2015,Age,3 Months,82.7,75.5 to 88.1,274
Polio,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,3 Months,83.1,77.9 to 87.3,540
Polio,≥1 Dose,States/Local Areas,Louisiana,2014,Age,3 Months,79.4,71.5 to 85.5,261
Polio,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,3 Months,81.0,75.8 to 85.3,535
Hib,≥3 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,46.1,41.6 to 50.7,238
Hib,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,45.6,41.7 to 49.6,499
Hib,≥3 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,62.9,55.2 to 70.1,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,56.8,48.8 to 64.5,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,94.8,91.3 to 98.3,346
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,91.7,86.4 to 97.0,256
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,95.0,92.8 to 97.3,410
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,60.3,52.2 to 67.9,261
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,60.7,55.1 to 66.0,535
Hep B,≥1 Dose,States/Local Areas,Louisiana,2019,Age,3 Months,94.7,89.9 to 97.3,411
Hep B,≥1 Dose,States/Local Areas,Louisiana,2018,Age,3 Months,94.9,90.0 to 97.5,401
Hep B,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,3 Months,94.8,91.7 to 96.8,812
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.9,67.8 to 83.9,162
≥1 Dose MMR,,States/Local Areas,Louisiana,2011,Age,19 Months,82.6,77.8 to 86.6,257
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,83.2,78.4 to 88.1,447
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,77.5,72.4 to 82.5,535
DTaP,≥4 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,84.6,77.0 to 90.8,411
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2018,Age,0-1 Days,71.9,65.1 to 77.9,401
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2018-2019,Age,0-1 Days,72.0,67.2 to 76.4,812
Hep B,≥2 Doses,States/Local Areas,Louisiana,2018,Age,5 Months,89.1,84.0 to 92.7,401
Hep B,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,5 Months,89.0,85.3 to 91.9,812
Hep B,≥2 Doses,States/Local Areas,Louisiana,2017,Age,5 Months,89.7,84.3 to 93.3,399
Hep B,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,5 Months,89.4,85.9 to 92.1,800
PCV,≥4 Doses,States/Local Areas,Louisiana,2020,Age,35 Months,75.4,68.6 to 81.7,433
Hep B,≥2 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,92.8,86.1 to 96.4,257
Hep B,≥2 Doses,States/Local Areas,Louisiana,2019,Age,5 Months,89.0,83.2 to 92.9,411
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015,Age,24 Months,89.9,84.6 to 94.0,274
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015-2016,Age,24 Months,91.0,87.3 to 94.0,540
≥1 Dose MMR,,States/Local Areas,Louisiana,2012,Age,24 Months,92.4,87.6 to 95.8,249
≥1 Dose MMR,,States/Local Areas,Louisiana,2011,Age,24 Months,88.9,83.3 to 93.3,257
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016,Age,24 Months,92.2,86.5 to 96.1,266
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2017,Age,24 Months,92.8,89.2 to 95.5,665
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017,Age,24 Months,93.5,88.5 to 96.8,399
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017-2018,Age,24 Months,91.6,87.7 to 94.6,800
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2015,Age,0-1 Days,70.3,61.9 to 77.5,274
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2015-2016,Age,0-1 Days,72.0,66.2 to 77.1,540
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2014,Age,0-1 Days,62.0,54.0 to 69.4,261
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2014-2015,Age,0-1 Days,66.1,60.5 to 71.4,535
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2013,Age,0-1 Days,64.9,59.2 to 70.3,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2013-2014,Age,0-1 Days,63.5,58.1 to 68.5,499
Hep B,≥2 Doses,States/Local Areas,Louisiana,2014,Age,5 Months,85.1,78.8 to 89.8,261
Hep B,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,5 Months,87.2,86.1 to 88.3,535
Hep B,≥2 Doses,States/Local Areas,Louisiana,2016,Age,5 Months,88.9,81.3 to 93.6,266
Hep B,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,5 Months,89.3,84.9 to 92.5,665
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,90.6,85.6 to 93.9,401
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,88.6,84.9 to 91.5,812
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,90.0,84.1 to 93.9,399
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,90.3,86.6 to 93.0,800
PCV,≥3 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,61.4,52.2 to 69.8,249
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,78.7,72.1 to 85.2,346
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,75.8,66.9 to 84.7,256
PCV,≥3 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,57.3,49.3 to 65.0,261
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,56.1,50.6 to 61.6,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,91.9,84.8 to 95.9,266
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,91.0,86.7 to 94.0,665
PCV,≥3 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,62.9,54.5 to 70.5,257
PCV,≥3 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,55.0,51.7 to 58.3,238
PCV,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,56.2,53.5 to 58.8,499
≥1 Dose Varicella,,States/Local Areas,Louisiana,2012,Age,24 Months,91.5,86.7 to 95.1,249
≥1 Dose Varicella,,States/Local Areas,Louisiana,2011,Age,24 Months,92.3,86.8 to 96.1,257
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,78.8,73.4 to 84.2,410
≥1 Dose MMR,,States/Local Areas,Louisiana,2017,Age,19 Months,89.0,83.3 to 92.9,399
≥1 Dose MMR,,States/Local Areas,Louisiana,2017-2018,Age,19 Months,88.1,83.9 to 91.3,800
≥1 Dose MMR,,States/Local Areas,Louisiana,2016,Age,19 Months,84.1,76.0 to 89.8,266
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2017,Age,19 Months,86.5,81.7 to 90.2,665
≥1 Dose MMR,,States/Local Areas,Louisiana,2015,Age,19 Months,84.3,81.0 to 87.1,274
≥1 Dose MMR,,States/Local Areas,Louisiana,2015-2016,Age,19 Months,84.2,79.2 to 88.2,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,92.3,91.2 to 93.3,274
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,92.1,88.2 to 94.8,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,94.8,90.6 to 97.1,261
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,93.5,90.6 to 95.6,535
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,73.5,62.5 to 84.5,256
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,90.5,86.2 to 93.5,238
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,92.6,90.9 to 94.0,499
Hep B,≥2 Doses,States/Local Areas,Louisiana,2013,Age,5 Months,87.5,84.3 to 90.1,238
Hep B,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,5 Months,86.3,83.7 to 88.5,499
Hep B,≥2 Doses,States/Local Areas,Louisiana,2011,Age,5 Months,88.8,84.9 to 91.8,257
Hep B,≥2 Doses,States/Local Areas,Louisiana,2012,Age,5 Months,89.3,82.4 to 93.7,249
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2011,Age,0-1 Days,73.3,67.7 to 78.3,257
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,75.5,65.9 to 85.2,346
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2012,Age,0-1 Days,68.0,57.5 to 77.0,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,95.2,89.1 to 98.0,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,94.1,83.7 to 98.0,257
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,90.2,84.7 to 93.9,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,87.0,81.5 to 91.0,401
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,88.6,84.9 to 91.5,812
Polio,≥2 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,92.1,86.7 to 95.4,399
Polio,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,94.0,90.9 to 96.1,800
Polio,≥2 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,95.0,88.3 to 98.0,266
Polio,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,93.6,89.8 to 96.0,665
Polio,≥2 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,96.5,93.7 to 98.0,274
Polio,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,95.7,92.5 to 97.6,540
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,83.1,75.1 to 91.1,162
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018,Age,19 Months,85.7,79.6 to 90.2,401
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018-2019,Age,19 Months,56.0,50.8 to 61.1,812
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017,Age,19 Months,88.7,82.6 to 92.8,399
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017-2018,Age,19 Months,87.2,82.9 to 90.6,800
≥1 Dose MMR,,States/Local Areas,Louisiana,2012,Age,19 Months,88.6,80.0 to 93.7,249
≥1 Dose MMR,,States/Local Areas,Louisiana,2014,Age,19 Months,82.3,74.7 to 88.0,261
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2015,Age,19 Months,83.3,78.2 to 87.5,535
≥1 Dose MMR,,States/Local Areas,Louisiana,2013,Age,19 Months,86.5,83.0 to 89.3,238
≥1 Dose MMR,,States/Local Areas,Louisiana,2013-2014,Age,19 Months,84.4,79.3 to 88.5,499
≥1 Dose MMR,,States/Local Areas,Louisiana,2015,Age,13 Months,50.5,42.4 to 58.6,274
≥1 Dose MMR,,States/Local Areas,Louisiana,2015-2016,Age,13 Months,50.7,44.7 to 56.6,540
≥1 Dose MMR,,States/Local Areas,Louisiana,2014,Age,13 Months,57.0,48.7 to 64.8,261
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2015,Age,13 Months,53.7,47.9 to 59.5,535
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018,Age,13 Months,54.3,47.2 to 61.3,401
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018-2019,Age,13 Months,56.0,50.8 to 61.1,812
≥1 Dose MMR,,States/Local Areas,Louisiana,2016,Age,13 Months,50.8,42.1 to 59.5,266
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2017,Age,13 Months,55.7,49.9 to 61.4,665
≥1 Dose Varicella,,States/Local Areas,Louisiana,2012,Age,19 Months,88.3,80.8 to 93.1,249
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013,Age,19 Months,87.5,82.6 to 91.2,238
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013-2014,Age,19 Months,83.8,77.1 to 88.9,499
≥1 Dose Varicella,,States/Local Areas,Louisiana,2011,Age,19 Months,85.0,80.8 to 88.4,257
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019,Age,13 Months,57.7,50.2 to 64.9,411
Hep A,≥2 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,73.2,65.1 to 80.8,399
Hep A,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,69.9,64.0 to 75.7,800
Hep A,≥2 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,66.0,57.4 to 74.5,401
Hep A,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,67.9,61.6 to 74.0,812
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,90.2,84.7 to 93.9,261
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,90.8,87.2 to 93.4,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,87.3,82.9 to 90.8,238
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,88.8,85.8 to 91.2,499
DTaP,≥4 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,90.1,81.9 to 95.6,238
DTaP,≥4 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,87.4,81.9 to 92.0,499
Hep B,≥3 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,92.4,88.1 to 95.2,249
Hep A,≥2 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,69.7,60.6 to 78.4,411
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,84.9,77.4 to 91.0,261
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,83.7,78.7 to 88.1,535
DTaP,≥4 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,82.5,75.4 to 88.6,274
DTaP,≥4 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,84.3,78.6 to 89.2,540
DTaP,≥4 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,90.0,83.2 to 94.9,249
Hib,≥3 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,96.8,92.5 to 99.0,411
≥1 Dose MMR,,States/Local Areas,Louisiana,2011,Age,13 Months,44.8,37.4 to 52.6,257
≥1 Dose MMR,,States/Local Areas,Louisiana,2012,Age,13 Months,49.9,46.7 to 53.0,249
≥1 Dose MMR,,States/Local Areas,Louisiana,2013,Age,13 Months,45.7,37.8 to 53.9,238
≥1 Dose MMR,,States/Local Areas,Louisiana,2013-2014,Age,13 Months,51.3,48.1 to 54.5,499
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,74.1 to 92.2,92
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015,Age,13 Months,56.1,47.8 to 64.0,274
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015-2016,Age,13 Months,53.7,47.6 to 59.7,540
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017,Age,13 Months,64.9,57.5 to 71.6,399
≥1 Dose Varicella,,States/Local Areas,Louisiana,2017-2018,Age,13 Months,59.6,54.4 to 64.7,800
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016,Age,13 Months,51.3,42.6 to 60.0,266
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2017,Age,13 Months,57.9,52.1 to 63.6,665
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,86.1,76.5 to 93.3,266
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,84.8,79.2 to 89.6,665
DTaP,≥4 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,83.7,76.9 to 89.4,399
DTaP,≥4 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,81.7,76.6 to 86.3,800
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,84.3,73.7 to 94.9,162
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,86.2,79.9 to 90.7,399
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,86.6,82.6 to 89.8,800
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,91.3,86.3 to 94.6,274
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,89.7,85.4 to 92.9,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,88.2,80.4 to 93.1,266
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,87.2,82.5 to 90.8,665
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.9,62.6 to 83.2,162
Polio,≥2 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,86.9,80.9 to 91.2,401
Polio,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,86.7,82.5 to 90.1,812
Polio,≥2 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,86.2,79.7 to 90.8,399
Polio,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,86.5,82.1 to 90.0,800
Hep B,≥1 Dose,States/Local Areas,Louisiana,2014,Age,3 Months,94.7,90.0 to 97.3,261
Hep B,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,3 Months,96.1,93.8 to 97.6,535
Hep B,≥1 Dose,States/Local Areas,Louisiana,2011,Age,3 Months,94.2,90.1 to 96.7,257
Hep B,≥1 Dose,States/Local Areas,Louisiana,2012,Age,3 Months,98.3,95.1 to 99.4,249
Hep B,≥1 Dose,States/Local Areas,Louisiana,2013,Age,3 Months,93.0,88.3 to 95.9,238
Hep B,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,3 Months,93.8,91.2 to 95.7,499
≥1 Dose MMR,,States/Local Areas,Louisiana,2017,Age,13 Months,60.9,53.6 to 67.8,399
≥1 Dose MMR,,States/Local Areas,Louisiana,2017-2018,Age,13 Months,59.8,54.6 to 64.8,800
≥1 Dose MMR,,States/Local Areas,Louisiana,2019,Age,13 Months,55.8,48.2 to 63.1,411
≥1 Dose MMR,,States/Local Areas,Louisiana,2018,Age,13 Months,58.7,51.5 to 65.5,401
≥1 Dose MMR,,States/Local Areas,Louisiana,2018-2019,Age,13 Months,57.2,52.0 to 62.3,812
Polio,≥2 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,94.5,87.7 to 97.7,257
Polio,≥2 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,96.9,91.0 to 99.0,249
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016,Age,19 Months,86.4,79.0 to 91.5,266
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2017,Age,19 Months,87.5,83.0 to 91.0,665
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015,Age,19 Months,84.1,81.4 to 86.4,274
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015-2016,Age,19 Months,85.2,80.5 to 89.0,540
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014,Age,19 Months,80.1,72.2 to 86.2,261
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2015,Age,19 Months,82.1,76.8 to 86.4,535
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.3,65.4 to 85.3,448
DTaP,≥4 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,79.8,72.3 to 86.4,401
DTaP,≥4 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,81.9,76.7 to 86.6,812
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,69.4,61.6 to 77.2,447
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,78.0,70.3 to 85.8,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,82.0,75.3 to 88.6,256
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,79.4,61.5 to 97.2,152
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,74.5,64.8 to 84.2,410
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,73.7,68.0 to 79.5,1012
Polio,≥2 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,86.6,80.1 to 91.2,411
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.6,64.5 to 80.8,596
Hep B,≥1 Dose,States/Local Areas,Louisiana,2017,Age,3 Months,96.9,93.2 to 98.6,399
Hep B,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,3 Months,95.9,93.1 to 97.6,800
Hep B,≥1 Dose,States/Local Areas,Louisiana,2016,Age,3 Months,96.6,90.3 to 98.9,266
Hep B,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,3 Months,96.8,93.6 to 98.4,665
Hep B,≥1 Dose,States/Local Areas,Louisiana,2015,Age,3 Months,97.6,95.8 to 98.6,274
Hep B,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,3 Months,97.1,94.4 to 98.5,540
Polio,≥2 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,93.6,88.9 to 96.4,261
Polio,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,95.0,92.5 to 96.7,535
Polio,≥2 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,90.9,85.2 to 94.6,238
Polio,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,92.2,89.9 to 94.1,499
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.3,77.3 to 87.3,448
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,78.8,73.1 to 84.5,412
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,67.4,56.2 to 78.7,152
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,78.2,74.4 to 82.0,1012
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.7,76.8 to 94.5,92
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.4,72.4 to 82.4,596
≥1 Dose Varicella,,States/Local Areas,Louisiana,2012,Age,35 Months,94.6,90.0 to 97.5,249
≥1 Dose Varicella,,States/Local Areas,Louisiana,2011,Age,35 Months,94.9,89.5 to 98.1,257
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019,Age,24 Months,91.0,85.6 to 95.0,411
≥1 Dose MMR,,States/Local Areas,Louisiana,2013,Age,24 Months,88.7,83.4 to 93.0,238
≥1 Dose MMR,,States/Local Areas,Louisiana,2013-2014,Age,24 Months,89.2,85.2 to 92.5,499
≥1 Dose MMR,,States/Local Areas,Louisiana,2014,Age,24 Months,89.7,83.4 to 94.4,261
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2015,Age,24 Months,90.6,86.6 to 93.7,535
≥1 Dose MMR,,States/Local Areas,Louisiana,2015,Age,24 Months,91.2,86.0 to 95.1,274
≥1 Dose MMR,,States/Local Areas,Louisiana,2015-2016,Age,24 Months,91.2,87.3 to 94.2,540
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018,Age,24 Months,89.6,84.3 to 93.7,401
≥1 Dose Varicella,,States/Local Areas,Louisiana,2018-2019,Age,24 Months,90.3,86.6 to 93.3,812
Hep B,≥3 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,94.5,89.9 to 97.5,257
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,91.4,85.9 to 94.9,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,91.6,86.7 to 95.2,238
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,94.1,91.4 to 96.2,499
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,96.7,94.3 to 98.3,261
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,95.7,93.8 to 97.2,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,95.8,92.1 to 98.1,249
PCV,≥3 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,67.0,58.2 to 74.8,266
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,64.0,58.2 to 69.4,665
PCV,≥4 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,71.4,62.5 to 78.9,266
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,73.7,68.1 to 78.7,665
PCV,≥4 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,69.7,67.7 to 71.5,274
PCV,≥4 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,70.5,64.7 to 75.8,540
PCV,≥4 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,70.3,62.3 to 77.3,261
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,70.0,64.3 to 75.1,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,55.0,46.9 to 62.8,274
PCV,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,61.0,55.1 to 66.6,540
PCV,≥3 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,60.8,53.1 to 68.0,399
PCV,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,58.5,53.1 to 63.7,800
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2011,Age,0-2 Days,78.9,73.4 to 83.5,257
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2019,Age,0-1 Days,72.2,65.0 to 78.4,411
Hep B,≥2 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,88.8,86.6 to 90.6,238
Hep B,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,89.7,88.2 to 91.1,499
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2012,Age,0-2 Days,77.5,68.4 to 84.6,249
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2013,Age,0-2 Days,71.9,63.1 to 79.2,238
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2013-2014,Age,0-2 Days,70.6,64.7 to 75.9,499
PCV,≥3 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,85.7,80.3 to 89.8,257
PCV,≥3 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,61.3,53.7 to 68.4,411
PCV,≥3 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,56.2,48.8 to 63.3,401
PCV,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,58.7,53.4 to 63.8,812
Hep B,≥2 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,95.8,90.9 to 98.1,249
Hep B,≥2 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,95.5,92.6 to 97.3,274
Hep B,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,92.9,89.0 to 95.5,540
Hep B,≥2 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,90.7,85.3 to 94.3,261
Hep B,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,93.1,90.2 to 95.2,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,94.7,91.6 to 97.0,274
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,94.2,91.2 to 96.5,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,93.7,88.1 to 97.2,266
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,92.4,88.8 to 95.2,665
PCV,≥3 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,88.3,80.8 to 93.1,249
≥1 Dose MMR,,States/Local Areas,Louisiana,2016,Age,24 Months,91.1,85.1 to 95.3,266
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2017,Age,24 Months,92.8,89.2 to 95.5,665
≥1 Dose MMR,,States/Local Areas,Louisiana,2017,Age,24 Months,94.6,90.1 to 97.4,399
≥1 Dose MMR,,States/Local Areas,Louisiana,2017-2018,Age,24 Months,92.7,88.9 to 95.5,800
PCV,≥4 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,68.7,61.5 to 75.1,401
PCV,≥4 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,67.7,61.3 to 73.5,633
PCV,≥4 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,76.2,68.9 to 82.3,399
PCV,≥4 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,72.5,67.4 to 77.1,800
≥1 Dose MMR,,States/Local Areas,Louisiana,2019,Age,19 Months,84.0,77.2 to 89.1,411
≥1 Dose MMR,,States/Local Areas,Louisiana,2018,Age,19 Months,87.2,81.2 to 91.4,401
≥1 Dose MMR,,States/Local Areas,Louisiana,2018-2019,Age,19 Months,94.9,92.0 to 96.8,812
PCV,≥4 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,75.9,68.6 to 82.0,257
PCV,≥4 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,77.6,69.4 to 84.0,249
PCV,≥4 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,76.5,70.0 to 82.0,238
PCV,≥4 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,73.5,66.0 to 79.8,499
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013,Age,24 Months,88.6,83.4 to 92.8,238
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013-2014,Age,24 Months,88.7,84.8 to 92.1,499
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014,Age,24 Months,88.8,82.5 to 93.6,261
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2015,Age,24 Months,89.4,85.5 to 92.7,535
≥1 Dose Varicella,,States/Local Areas,Louisiana,2019,Age,19 Months,83.9,77.0 to 89.1,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,88.0,82.6 to 91.9,433
Polio,≥2 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,95.7,91.0 to 97.9,411
Polio,≥2 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,95.8,92.0 to 97.9,401
Polio,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,95.7,93.0 to 97.4,812
Hep B,≥2 Doses,States/Local Areas,Louisiana,2015,Age,5 Months,89.4,83.3 to 93.4,274
Hep B,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,5 Months,89.1,84.6 to 92.5,540
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2015,Age,0-2 Days,77.1,69.1 to 83.6,274
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2015-2016,Age,0-2 Days,77.4,71.8 to 82.1,540
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2014,Age,0-2 Days,69.4,61.5 to 76.3,261
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2014-2015,Age,0-2 Days,73.3,67.8 to 78.2,535
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013,Age,35 Months,90.9,85.3 to 95.0,238
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013-2014,Age,35 Months,94.0,89.3 to 97.1,499
≥1 Dose MMR,,States/Local Areas,Louisiana,2018,Age,24 Months,90.6,85.4 to 94.5,401
≥1 Dose MMR,,States/Local Areas,Louisiana,2018-2019,Age,24 Months,90.5,86.9 to 93.5,812
PCV,≥4 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,69.6,62.0 to 76.2,411
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014,Age,35 Months,97.5,92.1 to 99.5,261
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2015,Age,35 Months,95.6,91.2 to 98.2,535
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015,Age,35 Months,93.5,89.4 to 96.4,274
≥1 Dose Varicella,,States/Local Areas,Louisiana,2015-2016,Age,35 Months,93.4,90.0 to 96.0,540
PCV,≥4 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,82.9,76.3 to 88.6,257
Hep B,≥2 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,91.8,87.1 to 95.0,401
Hep B,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,91.1,87.6 to 93.8,812
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2019,Age,0-2 Days,74.3,67.2 to 80.4,411
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2018,Age,0-2 Days,74.6,68.0 to 80.3,401
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2018-2019,Age,0-2 Days,74.5,69.7 to 78.7,812
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2017,Age,0-2 Days,73.3,66.1 to 79.4,399
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2017-2018,Age,0-2 Days,74.0,69.1 to 78.3,800
PCV,≥4 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,82.9,76.2 to 88.7,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,94.5,89.9 to 97.5,257
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,91.2,86.1 to 95.0,399
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,91.4,88.2 to 94.1,800
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,92.6,87.7 to 96.1,411
PCV,≥4 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,78.5,71.9 to 84.5,238
PCV,≥4 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,78.8,73.8 to 83.5,499
PCV,≥4 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,79.3,72.0 to 85.7,261
PCV,≥4 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,79.5,74.7 to 84.0,535
PCV,≥4 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,79.7,72.9 to 85.8,274
PCV,≥4 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,78.4,73.0 to 83.3,540
≥1 Dose MMR,,States/Local Areas,Louisiana,2019,Age,24 Months,90.5,85.1 to 94.6,411
≥1 Dose MMR,,States/Local Areas,Louisiana,2012,Age,35 Months,95.1,90.9 to 97.7,249
≥1 Dose MMR,,States/Local Areas,Louisiana,2011,Age,35 Months,96.4,87.1 to 99.6,257
≥1 Dose MMR,,States/Local Areas,Louisiana,2013,Age,35 Months,91.9,86.1 to 96.0,238
≥1 Dose MMR,,States/Local Areas,Louisiana,2013-2014,Age,35 Months,95.9,91.3 to 98.5,499
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016,Age,35 Months,93.5,87.9 to 97.1,266
≥1 Dose Varicella,,States/Local Areas,Louisiana,2016-2017,Age,35 Months,94.5,91.1 to 96.9,665
Hep B,≥2 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,93.6,86.6 to 97.0,266
Hep B,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,94.3,90.5 to 96.6,665
Hep B,≥2 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,96.5,94.0 to 97.9,274
Hep B,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,95.0,91.6 to 97.1,540
Hep B,≥2 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,95.5,92.1 to 97.5,261
Hep B,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,96.0,94.0 to 97.3,535
Hib,≥1 Dose,States/Local Areas,Louisiana,2014,Age,3 Months,79.8,72.0 to 85.9,261
Hib,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,3 Months,81.9,76.8 to 86.0,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,92.6,87.4 to 96.2,399
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,93.1,89.9 to 95.5,800
PCV,≥3 Doses,States/Local Areas,Louisiana,2012,Age,19 Months,91.3,80.9 to 96.3,249
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,93.4,89.3 to 96.3,401
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,94.7,91.7 to 96.9,812
PCV,≥4 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,86.1,79.1 to 91.7,249
PCV,≥4 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,84.4,77.7 to 90.0,257
PCV,≥4 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,73.6,66.9 to 80.0,401
PCV,≥4 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,74.3,69.4 to 79.0,812
PCV,≥4 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,75.0,67.8 to 81.7,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,93.7,88.1 to 97.2,266
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,93.1,89.5 to 95.8,665
PCV,≥3 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,90.5,84.5 to 94.3,261
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,91.6,88.0 to 94.2,535
PCV,≥3 Doses,States/Local Areas,Louisiana,2013,Age,19 Months,88.7,83.3 to 92.6,238
PCV,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,89.6,87.2 to 91.6,499
PCV,≥3 Doses,States/Local Areas,Louisiana,2011,Age,19 Months,89.4,84.4 to 92.9,257
PCV,≥3 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,85.4,78.8 to 90.2,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,92.0,87.1 to 95.5,238
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,94.4,91.7 to 96.4,499
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,96.8,94.4 to 98.4,261
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,96.1,94.3 to 97.5,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,95.4,92.5 to 97.4,274
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,94.5,91.5 to 96.7,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,97.3,93.4 to 99.2,249
PCV,≥3 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,84.9,78.7 to 89.6,401
PCV,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,85.2,80.8 to 88.7,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,85.8,79.2 to 90.5,399
PCV,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,85.4,80.8 to 89.0,800
Hep B,≥2 Doses,States/Local Areas,Louisiana,2012,Age,13 Months,97.3,91.2 to 99.2,249
Hep B,≥2 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,92.5,89.1 to 94.8,238
Hep B,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,94.0,91.6 to 95.8,499
Hep B,≥2 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,94.8,87.5 to 97.9,257
Hep B,≥2 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,90.4,84.7 to 94.2,411
PCV,≥4 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,77.0,68.8 to 84.4,266
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,78.2,72.9 to 83.0,665
PCV,≥4 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,79.3,72.6 to 85.3,399
PCV,≥4 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,76.5,71.6 to 81.1,800
≥1 Dose MMR,,States/Local Areas,Louisiana,2015,Age,35 Months,95.0,91.2 to 97.5,274
≥1 Dose MMR,,States/Local Areas,Louisiana,2015-2016,Age,35 Months,93.6,90.0 to 96.2,540
≥1 Dose MMR,,States/Local Areas,Louisiana,2014,Age,35 Months,99.0,95.4 to 99.9,261
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2015,Age,35 Months,97.1,93.5 to 98.9,535
≥1 Dose MMR,,States/Local Areas,Louisiana,2016,Age,35 Months,92.4,86.4 to 96.4,266
≥1 Dose MMR,,States/Local Areas,Louisiana,2016-2017,Age,35 Months,94.6,91.1 to 97.0,665
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.6,88.1 to 97.1,162
PCV,≥3 Doses,States/Local Areas,Louisiana,2016,Age,13 Months,83.3,74.6 to 89.5,266
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,13 Months,84.5,79.3 to 88.7,665
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,91.7,87.2 to 95.0,401
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,92.2,89.0 to 94.7,812
PCV,≥3 Doses,States/Local Areas,Louisiana,2015,Age,13 Months,88.5,83.1 to 92.3,274
PCV,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,13 Months,85.9,80.9 to 89.8,540
PCV,≥3 Doses,States/Local Areas,Louisiana,2014,Age,13 Months,85.2,78.5 to 90.1,261
PCV,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,13 Months,86.9,82.7 to 90.1,535
Hep B,≥2 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,93.5,88.7 to 96.3,399
Hep B,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,92.7,89.5 to 94.9,800
PCV,≥3 Doses,States/Local Areas,Louisiana,2013,Age,13 Months,81.6,75.5 to 86.5,238
PCV,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,13 Months,83.4,81.2 to 85.4,499
Hep B,≥2 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,90.3,82.7 to 94.8,266
Hep B,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,91.9,87.6 to 94.8,665
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2016,Age,0-2 Days,77.6,69.4 to 84.1,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2016-2017,Age,0-2 Days,75.5,70.2 to 80.1,665
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,71.9,65.0 to 78.8,412
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.0,52.8 to 83.2,92
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2017,Age,0-1 Days,70.4,63.1 to 76.8,399
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2017-2018,Age,0-1 Days,71.2,66.2 to 75.6,800
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2016,Age,0-1 Days,73.6,65.3 to 80.6,266
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2016-2017,Age,0-1 Days,72.1,66.6 to 77.0,665
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,90.2,85.0 to 95.5,162
Hib,≥1 Dose,States/Local Areas,Louisiana,2011,Age,3 Months,82.4,79.5 to 84.9,257
Hib,≥1 Dose,States/Local Areas,Louisiana,2012,Age,3 Months,83.2,76.8 to 88.1,249
Hib,≥1 Dose,States/Local Areas,Louisiana,2013,Age,3 Months,80.3,72.5 to 86.3,238
Hib,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,3 Months,80.1,74.9 to 84.4,499
≥1 Dose MMR,,States/Local Areas,Louisiana,2017,Age,35 Months,96.8,93.2 to 98.8,399
≥1 Dose MMR,,States/Local Areas,Louisiana,2017-2018,Age,35 Months,95.9,93.1 to 97.8,800
≥1 Dose MMR,,States/Local Areas,Louisiana,2018,Age,35 Months,94.8,89.6 to 97.9,401
≥1 Dose MMR,,States/Local Areas,Louisiana,2018-2019,Age,35 Months,94.1,90.4 to 96.7,812
PCV,≥4 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,80.6,73.8 to 86.5,238
PCV,≥4 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,80.8,75.7 to 85.4,499
≥1 Dose MMR,,States/Local Areas,Louisiana,2019,Age,35 Months,93.5,87.6 to 97.2,411
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,82.1 to 98.0,92
≥1 Dose MMR,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,91.9,88.0 to 95.8,447
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.3,85.6 to 93.0,596
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,84.9 to 93.4,412
PCV,≥3 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,88.0,79.5 to 93.2,266
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,87.5,82.5 to 91.3,665
PCV,≥3 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,92.7,90.2 to 94.6,274
PCV,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,90.3,85.7 to 93.6,540
Hep B,≥2 Doses,States/Local Areas,Louisiana,2019,Age,13 Months,94.4,89.3 to 97.1,411
Hep A,≥1 Dose,States/Local Areas,Louisiana,2020,Age,35 Months,85.6,79.3 to 90.8,433
Hep B,≥2 Doses,States/Local Areas,Louisiana,2018,Age,13 Months,97.2,93.5 to 98.8,401
Hep B,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,13 Months,95.8,92.9 to 97.5,812
Hep B,≥2 Doses,States/Local Areas,Louisiana,2017,Age,13 Months,95.1,90.7 to 97.4,399
Hep B,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,13 Months,96.1,93.5 to 97.7,800
Hib,≥1 Dose,States/Local Areas,Louisiana,2017,Age,3 Months,84.7,78.2 to 89.6,399
Hib,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,3 Months,83.4,79.0 to 87.0,800
Hib,≥1 Dose,States/Local Areas,Louisiana,2016,Age,3 Months,80.5,71.7 to 87.0,266
Hib,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,3 Months,82.6,77.2 to 86.9,665
Hib,≥1 Dose,States/Local Areas,Louisiana,2015,Age,3 Months,83.9,77.0 to 89.0,274
Hib,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,3 Months,82.2,76.8 to 86.5,540
Hib,Primary Series,States/Local Areas,Louisiana,2011,Age,7 Months,64.5,56.0 to 72.2,257
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,78.8,71.0 to 86.6,256
Hib,Primary Series,States/Local Areas,Louisiana,2012,Age,7 Months,64.9,59.6 to 69.9,249
Hep A,≥2 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,39.1,31.6 to 47.7,238
Hep A,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,35.7,30.5 to 41.6,499
DTaP,≥4 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,60.3,53.1 to 67.1,401
DTaP,≥4 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,95.7,93.0 to 97.4,812
DTaP,≥4 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,69.0,61.5 to 75.6,399
DTaP,≥4 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,64.7,59.4 to 69.6,800
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,63.6,54.6 to 71.8,266
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,66.2,60.4 to 71.6,665
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,96.8,94.0 to 99.6,162
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,85.8 to 100.0,92
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020,Age,24 Months,91.3,86.5 to 94.9,433
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.5,91.8 to 97.1,448
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,90.3,82.1 to 98.4,152
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,88.7 to 95.6,596
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,89.2 to 96.2,412
PCV,≥2 Doses,States/Local Areas,Louisiana,2019,Age,5 Months,71.4,63.8 to 78.0,411
PCV,≥2 Doses,States/Local Areas,Louisiana,2018,Age,5 Months,69.9,62.6 to 76.4,401
PCV,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,5 Months,70.7,65.4 to 75.4,812
DTaP,≥4 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,80.9,74.7 to 86.5,238
DTaP,≥4 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,79.2,74.2 to 83.7,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,44.4,35.9 to 53.9,266
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,44.5,38.7 to 50.6,665
Hep A,≥2 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,44.6,37.4 to 52.5,399
Hep A,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,40.5,35.4 to 45.9,800
Hep A,≥2 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,36.0,29.5 to 43.5,401
Hep A,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,39.3,34.3 to 44.7,812
DTaP,≥4 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,81.2,74.2 to 87.2,249
DTaP,≥4 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,79.7,72.8 to 85.8,257
DTaP,≥4 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,65.7,58.3 to 72.5,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,61.0,55.9 to 65.8,238
Hep B,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,61.1,59.5 to 62.7,499
Hep B,≥3 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,66.1,61.2 to 70.7,257
Hep B,≥3 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,69.9,62.6 to 76.2,249
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,95.8,92.4 to 99.2,346
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,93.1,87.2 to 99.0,256
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,91.5,88.0 to 94.9,410
Polio,≥2 Doses,States/Local Areas,Louisiana,2014,Age,5 Months,67.9,59.6 to 75.2,261
Polio,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,5 Months,70.7,63.9 to 76.7,535
Polio,≥2 Doses,States/Local Areas,Louisiana,2013,Age,5 Months,69.6,66.5 to 72.5,238
Polio,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,5 Months,68.8,64.4 to 72.8,499
Polio,≥2 Doses,States/Local Areas,Louisiana,2011,Age,5 Months,70.6,63.3 to 76.9,257
Polio,≥2 Doses,States/Local Areas,Louisiana,2012,Age,5 Months,74.1,67.2 to 80.0,249
Hep A,≥1 Dose,States/Local Areas,Louisiana,2015,Age,35 Months,89.7,84.4 to 93.8,274
Hep A,≥1 Dose,States/Local Areas,Louisiana,2015-2016,Age,35 Months,90.5,86.5 to 93.6,540
Polio,≥3 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,98.3,93.6 to 99.8,249
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.4,76.5 to 86.3,448
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,80.0,71.4 to 88.6,162
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.0,72.9 to 91.2,92
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.5,74.8 to 84.3,596
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,81.5,76.2 to 86.8,412
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,74.9,64.4 to 85.5,152
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Overall,Overall,80.2,76.7 to 83.8,1012
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,81.3,76.4 to 86.2,410
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,79.3,72.7 to 85.9,346
Hib,Full Series,States/Local Areas,Louisiana,2012,Age,35 Months,88.1,81.7 to 93.1,249
Hib,Full Series,States/Local Areas,Louisiana,2011,Age,35 Months,93.1,78.9 to 99.0,257
Hib,Full Series,States/Local Areas,Louisiana,2013,Age,35 Months,76.6,69.6 to 83.1,238
Hib,Full Series,States/Local Areas,Louisiana,2013-2014,Age,35 Months,83.3,77.5 to 88.4,499
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,77.5,69.9 to 84.2,261
DTaP,≥4 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,77.5,72.4 to 82.3,535
DTaP,≥4 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,77.6,70.3 to 84.2,274
DTaP,≥4 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,77.3,71.7 to 82.5,540
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,77.0,68.4 to 84.8,266
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,77.2,71.8 to 82.3,665
Hep A,≥2 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,74.8,65.9 to 82.9,238
Hep A,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,70.9,63.8 to 77.7,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2012,Age,35 Months,68.8,57.8 to 79.3,249
Hep A,≥2 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,60.8,51.5 to 70.2,257
Hep A,≥2 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,42.5,35.3 to 50.5,411
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,66.9,58.0 to 74.8,266
Hep B,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,64.6,58.8 to 70.0,665
Polio,≥2 Doses,States/Local Areas,Louisiana,2015,Age,5 Months,73.6,65.9 to 80.0,274
Polio,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,5 Months,74.6,69.0 to 79.5,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,66.0,58.3 to 72.9,274
Hep B,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,66.4,60.6 to 71.8,540
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,61.3,53.5 to 68.5,261
Hep B,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,63.6,58.2 to 68.8,535
Polio,≥2 Doses,States/Local Areas,Louisiana,2017,Age,5 Months,71.5,64.0 to 78.0,399
Polio,≥2 Doses,States/Local Areas,Louisiana,2017-2018,Age,5 Months,71.8,66.6 to 76.6,800
Polio,≥2 Doses,States/Local Areas,Louisiana,2016,Age,5 Months,75.7,67.0 to 82.7,266
Polio,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,5 Months,73.7,68.1 to 78.6,665
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016,Age,35 Months,91.0,85.0 to 95.3,266
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2017,Age,35 Months,91.6,87.7 to 94.6,665
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,66.9,56.3 to 77.2,261
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,72.8,65.7 to 79.5,535
Hep B,≥3 Doses,States/Local Areas,Louisiana,2019,Age,7 Months,65.0,57.5 to 71.8,411
Polio,≥2 Doses,States/Local Areas,Louisiana,2013,Age,7 Months,84.6,79.8 to 88.4,238
Polio,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,7 Months,84.8,81.6 to 87.5,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,79.4,70.3 to 87.2,274
Hep A,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,75.8,69.1 to 82.1,540
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,73.1,63.4 to 82.1,266
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,73.1,66.8 to 79.0,665
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018,Age,7 Months,59.8,52.5 to 66.7,401
Hep B,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,7 Months,62.4,57.2 to 67.3,812
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017,Age,7 Months,62.1,54.5 to 69.2,399
Hep B,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,7 Months,61.0,55.7 to 66.0,800
Polio,≥2 Doses,States/Local Areas,Louisiana,2011,Age,7 Months,86.9,84.8 to 88.7,257
Polio,≥2 Doses,States/Local Areas,Louisiana,2012,Age,7 Months,92.1,85.8 to 95.7,249
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,91.6,86.8 to 96.3,162
Polio,≥2 Doses,States/Local Areas,Louisiana,2019,Age,5 Months,72.5,65.0 to 78.9,411
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014,Age,35 Months,85.0,78.3 to 90.6,261
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2015,Age,35 Months,87.3,83.1 to 90.9,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2013,Age,35 Months,87.7,81.5 to 92.6,238
Hep A,≥1 Dose,States/Local Areas,Louisiana,2013-2014,Age,35 Months,86.4,81.9 to 90.2,499
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,32.4,25.4 to 40.6,261
Hep A,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,37.5,32.0 to 43.6,535
Hep A,≥2 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,42.8,34.7 to 51.9,274
Hep A,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,43.6,37.5 to 50.1,540
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Overall,Overall,93.1,90.7 to 95.4,1012
≥1 Dose Varicella,,States/Local Areas,Louisiana,2011,Age,13 Months,51.2,42.4 to 60.0,257
Hep A,≥1 Dose,States/Local Areas,Louisiana,2018,Age,35 Months,87.8,81.3 to 92.9,401
Hep A,≥1 Dose,States/Local Areas,Louisiana,2018-2019,Age,35 Months,89.1,84.7 to 92.7,812
Hep A,≥1 Dose,States/Local Areas,Louisiana,2017,Age,35 Months,92.2,87.0 to 95.9,399
Hep A,≥1 Dose,States/Local Areas,Louisiana,2017-2018,Age,35 Months,90.0,86.0 to 93.2,800
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013,Age,13 Months,56.0,47.6 to 64.1,238
≥1 Dose Varicella,,States/Local Areas,Louisiana,2013-2014,Age,13 Months,57.6,52.7 to 62.3,499
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.5,82.9 to 94.0,162
Polio,≥2 Doses,States/Local Areas,Louisiana,2018,Age,5 Months,72.2,64.9 to 78.5,401
Polio,≥2 Doses,States/Local Areas,Louisiana,2018-2019,Age,5 Months,72.3,67.2 to 77.0,812
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,83.1,78.5 to 87.7,447
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,88.0,84.5 to 91.5,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2019,Age,35 Months,90.7,83.9 to 95.5,411
≥1 Dose Varicella,,States/Local Areas,Louisiana,2012,Age,13 Months,56.0,53.2 to 58.7,249
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014,Age,13 Months,59.2,50.8 to 67.0,261
≥1 Dose Varicella,,States/Local Areas,Louisiana,2014-2015,Age,13 Months,57.6,51.7 to 63.3,535
Hib,Full Series,States/Local Areas,Louisiana,2020,Age,24 Months,73.1,66.3 to 79.5,433
DTaP,≥4 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,89.0,80.2 to 95.1,257
DTaP,≥4 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,74.6,67.6 to 81.1,411
DTaP,≥4 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,77.5,70.6 to 83.7,399
DTaP,≥4 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,75.0,70.0 to 79.7,800
DTaP,≥4 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,72.5,65.6 to 79.0,401
DTaP,≥4 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,73.6,68.7 to 78.2,812
Hep B,≥3 Doses,States/Local Areas,Louisiana,2011,Age,13 Months,90.5,84.2 to 94.5,257
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,87.5,83.2 to 91.9,346
Polio,≥2 Doses,States/Local Areas,Louisiana,2016,Age,7 Months,86.8,78.9 to 92.1,266
Polio,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,7 Months,86.5,81.6 to 90.2,665
Polio,≥2 Doses,States/Local Areas,Louisiana,2015,Age,7 Months,91.5,86.5 to 94.8,274
Polio,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,7 Months,89.2,84.7 to 92.5,540
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Overall,Overall,85.3,82.4 to 88.1,1012
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,85.0,80.6 to 89.4,410
Polio,≥2 Doses,States/Local Areas,Louisiana,2014,Age,7 Months,85.0,78.4 to 89.9,261
Polio,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,7 Months,88.3,84.3 to 91.4,535
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.6,81.5 to 89.7,448
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,92.3,87.0 to 97.6,152
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.1,78.0 to 86.2,596
Hep A,≥1 Dose,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,82.0,76.8 to 87.2,412
Polio,≥3 Doses,States/Local Areas,Louisiana,2013,Age,35 Months,92.5,86.2 to 96.6,238
Polio,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,35 Months,92.8,88.6 to 95.8,499
Polio,≥3 Doses,States/Local Areas,Louisiana,2014,Age,35 Months,92.1,86.5 to 96.0,261
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,35 Months,94.4,91.2 to 96.7,535
Hib,Full Series,States/Local Areas,Louisiana,2019,Age,24 Months,73.1,66.0 to 79.8,411
DTaP,≥2 Doses,States/Local Areas,Louisiana,2011,Age,5 Months,72.0,64.1 to 78.7,257
DTaP,≥2 Doses,States/Local Areas,Louisiana,2012,Age,5 Months,75.2,68.3 to 80.9,249
DTaP,≥2 Doses,States/Local Areas,Louisiana,2013,Age,5 Months,72.8,69.9 to 75.4,238
DTaP,≥2 Doses,States/Local Areas,Louisiana,2013-2014,Age,5 Months,71.2,66.9 to 75.1,499
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.3,87.7 to 96.9,162
DTaP,≥2 Doses,States/Local Areas,Louisiana,2015,Age,5 Months,75.1,67.6 to 81.4,274
DTaP,≥2 Doses,States/Local Areas,Louisiana,2015-2016,Age,5 Months,75.5,69.9 to 80.3,540
DTaP,≥2 Doses,States/Local Areas,Louisiana,2016,Age,5 Months,75.9,67.2 to 82.8,266
DTaP,≥2 Doses,States/Local Areas,Louisiana,2016-2017,Age,5 Months,74.0,68.4 to 78.9,665
DTaP,≥2 Doses,States/Local Areas,Louisiana,2014,Age,5 Months,69.6,61.3 to 76.8,261
DTaP,≥2 Doses,States/Local Areas,Louisiana,2014-2015,Age,5 Months,72.4,65.8 to 78.0,535
Polio,≥3 Doses,States/Local Areas,Louisiana,2016,Age,35 Months,91.5,84.8 to 96.1,266
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,35 Months,92.4,88.0 to 95.6,665
Polio,≥3 Doses,States/Local Areas,Louisiana,2017,Age,35 Months,93.2,87.4 to 96.9,399
Polio,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,35 Months,93.5,90.1 to 96.0,800
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,94.2,91.0 to 97.4,447
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,91.9,88.6 to 95.1,535
Polio,≥3 Doses,States/Local Areas,Louisiana,2018,Age,35 Months,93.9,89.4 to 96.9,401
Polio,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,35 Months,95.0,92.1 to 97.1,812
Polio,≥3 Doses,States/Local Areas,Louisiana,2015,Age,35 Months,96.0,92.8 to 98.1,274
Polio,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,35 Months,93.9,90.2 to 96.6,540
Hib,Full Series,States/Local Areas,Louisiana,2017,Age,35 Months,81.7,74.2 to 88.1,399
Hib,Full Series,States/Local Areas,Louisiana,2017-2018,Age,35 Months,79.5,74.2 to 84.3,800
Polio,≥3 Doses,States/Local Areas,Louisiana,2019,Age,35 Months,97.0,92.9 to 99.0,411
Hib,Full Series,States/Local Areas,Louisiana,2016,Age,35 Months,81.9,72.8 to 89.3,266
Hib,Full Series,States/Local Areas,Louisiana,2016-2017,Age,35 Months,81.8,76.0 to 86.9,665
Hib,Full Series,States/Local Areas,Louisiana,2019,Age,35 Months,79.0,71.8 to 85.4,411
Hib,Full Series,States/Local Areas,Louisiana,2018,Age,35 Months,77.0,69.3 to 84.0,401
Hib,Full Series,States/Local Areas,Louisiana,2018-2019,Age,35 Months,78.1,72.8 to 83.1,812
Hib,Full Series,States/Local Areas,Louisiana,2015,Age,35 Months,86.9,81.1 to 91.7,274
Hib,Full Series,States/Local Areas,Louisiana,2015-2016,Age,35 Months,84.5,79.1 to 89.2,540
Hib,Full Series,States/Local Areas,Louisiana,2014,Age,35 Months,89.5,81.1 to 95.2,261
Hib,Full Series,States/Local Areas,Louisiana,2014-2015,Age,35 Months,88.3,83.2 to 92.4,535
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.7,73.4 to 88.0,162
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,79.5,74.8 to 84.2,535
Hib,Full Series,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,84.6,79.8 to 89.3,447
Hib,Full Series,States/Local Areas,Louisiana,2016,Age,24 Months,76.8,68.1 to 84.5,266
Hib,Full Series,States/Local Areas,Louisiana,2016-2017,Age,24 Months,76.5,70.9 to 81.6,665
Hib,≥3 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,89.4,83.7 to 93.8,261
Hib,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,91.8,88.4 to 94.5,535
Hib,≥3 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,90.7,85.0 to 94.9,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,92.8,88.0 to 96.2,249
Hib,≥3 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,88.0,82.5 to 92.5,238
Hib,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,88.7,84.6 to 92.1,499
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.7 to 96.4,448
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,94.7,91.0 to 98.4,162
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,85.8 to 100.0,92
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.2,87.6 to 94.7,596
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,87.6 to 95.1,412
Hib,Full Series,States/Local Areas,Louisiana,2017,Age,24 Months,76.1,69.0 to 82.6,399
Hib,Full Series,States/Local Areas,Louisiana,2017-2018,Age,24 Months,73.7,68.7 to 78.6,800
Hib,Full Series,States/Local Areas,Louisiana,2018,Age,24 Months,71.2,64.3 to 77.9,401
Hib,Full Series,States/Local Areas,Louisiana,2018-2019,Age,24 Months,72.2,67.2 to 76.9,812
DTaP,≥3 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,91.8,86.3 to 95.7,257
DTaP,≥3 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,95.6,92.0 to 97.9,249
Polio,≥3 Doses,States/Local Areas,Louisiana,2011,Age,35 Months,92.5,86.8 to 96.4,257
Hib,≥3 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,88.0,81.8 to 92.3,411
Polio,≥3 Doses,States/Local Areas,Louisiana,2019,Age,24 Months,94.4,89.8 to 97.4,411
Polio,≥3 Doses,States/Local Areas,Louisiana,2018,Age,24 Months,90.4,85.4 to 94.2,401
Polio,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,24 Months,92.3,89.1 to 94.9,812
Polio,≥3 Doses,States/Local Areas,Louisiana,2017,Age,24 Months,89.9,84.2 to 94.2,399
Polio,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,24 Months,90.1,86.2 to 93.3,800
Hib,Full Series,States/Local Areas,Louisiana,2015,Age,24 Months,80.2,73.6 to 86.1,274
Hib,Full Series,States/Local Areas,Louisiana,2015-2016,Age,24 Months,78.5,73.1 to 83.5,540
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,90.2,84.8 to 94.3,238
DTaP,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,91.1,87.1 to 94.2,499
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,90.4,85.0 to 94.0,401
DTaP,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,88.6,84.7 to 91.6,812
DTaP,≥3 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,91.1,85.3 to 94.8,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,88.6,82.2 to 92.9,399
DTaP,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,89.5,85.2 to 92.6,800
Polio,≥3 Doses,States/Local Areas,Louisiana,2014,Age,24 Months,90.5,85.1 to 94.6,261
Polio,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,24 Months,93.1,90.0 to 95.6,535
Polio,≥3 Doses,States/Local Areas,Louisiana,2015,Age,24 Months,95.3,91.9 to 97.6,274
Polio,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,24 Months,93.3,89.6 to 96.1,540
Hib,≥3 Doses,States/Local Areas,Louisiana,2018,Age,19 Months,86.0,79.9 to 90.4,401
Hib,≥3 Doses,States/Local Areas,Louisiana,2018-2019,Age,19 Months,73.8,68.8 to 78.2,812
Polio,≥3 Doses,States/Local Areas,Louisiana,2016,Age,24 Months,91.5,84.8 to 96.1,266
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,24 Months,90.8,86.5 to 94.1,665
Hib,≥3 Doses,States/Local Areas,Louisiana,2017,Age,19 Months,88.1,81.8 to 92.5,399
Hib,≥3 Doses,States/Local Areas,Louisiana,2017-2018,Age,19 Months,87.1,82.7 to 90.5,800
Hib,≥3 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,85.4,76.6 to 91.2,266
Hib,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,86.7,81.5 to 90.6,665
Hib,≥2 Doses,States/Local Areas,Louisiana,2020,Age,13 Months,92.0,87.1 to 95.2,433
Hib,≥3 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,93.3,92.3 to 94.2,274
Hib,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,89.3,84.4 to 92.8,540
Polio,≥3 Doses,States/Local Areas,Louisiana,2013,Age,24 Months,89.1,83.4 to 93.5,238
Polio,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,24 Months,89.9,85.8 to 93.2,499
Hib,≥3 Doses,States/Local Areas,Louisiana,2013-2014,Age,19 Months,87.3,84.5 to 89.7,499
Hib,≥3 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,88.2,81.9 to 92.6,261
Hib,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,90.8,87.1 to 93.5,535
Polio,≥3 Doses,States/Local Areas,Louisiana,2012,Age,24 Months,95.2,91.5 to 97.6,249
Polio,≥3 Doses,States/Local Areas,Louisiana,2011,Age,24 Months,91.7,86.1 to 95.6,257
Polio,≥3 Doses,States/Local Areas,Louisiana,2019,Age,19 Months,91.0,85.3 to 94.7,411
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015,Age,19 Months,94.0,91.5 to 95.8,274
DTaP,≥3 Doses,States/Local Areas,Louisiana,2015-2016,Age,19 Months,92.1,87.7 to 95.0,540
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014,Age,19 Months,91.9,85.9 to 95.5,261
DTaP,≥3 Doses,States/Local Areas,Louisiana,2014-2015,Age,19 Months,92.9,89.4 to 95.4,535
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016,Age,19 Months,90.3,82.1 to 94.9,266
DTaP,≥3 Doses,States/Local Areas,Louisiana,2016-2017,Age,19 Months,89.4,84.6 to 92.9,665
DTaP,≥3 Doses,States/Local Areas,Montana,2011,Age,24 Months,93.5,88.7 to 96.7,250
Hib,Primary Series,States/Local Areas,Montana,2011,Age,7 Months,78.6,73.0 to 83.4,250
Hib,Full Series,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,78.1,71.0 to 85.3,225
Hib,Primary Series,States/Local Areas,Montana,2012,Age,7 Months,76.4,71.6 to 80.7,219
Hib,Full Series,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,87.0,77.0 to 97.1,54
Hib,Full Series,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,71.4 to 89.4,96
Hib,Full Series,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.1,73.4 to 80.8,754
Hib,Full Series,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,76.7,70.4 to 83.0,251
Hib,Full Series,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.5,68.2 to 92.8,51
Polio,≥3 Doses,States/Local Areas,Montana,2011,Age,35 Months,95.2,90.3 to 98.1,250
DTaP,≥3 Doses,States/Local Areas,Montana,2012,Age,24 Months,93.9,89.3 to 96.9,219
DTaP,≥3 Doses,States/Local Areas,Montana,2016,Age,19 Months,87.4,80.6 to 92.1,257
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,88.2,83.9 to 91.4,522
DTaP,≥3 Doses,States/Local Areas,Montana,2015,Age,19 Months,90.3,83.1 to 94.6,256
DTaP,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,88.9,84.2 to 92.2,513
DTaP,≥3 Doses,States/Local Areas,Montana,2014,Age,19 Months,92.8,87.7 to 95.9,225
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,91.5,87.4 to 94.4,481
Hib,Full Series,States/Local Areas,Montana,2014-2017,Overall,Overall,78.0,74.7 to 81.2,910
Hib,Full Series,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,78.3,74.3 to 82.3,608
Hib,Full Series,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,76.7,70.6 to 82.7,242
Hib,Full Series,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,78.8,74.2 to 83.4,443
Polio,≥2 Doses,States/Local Areas,Montana,2020,Age,13 Months,87.8,81.6 to 92.1,220
Hib,≥3 Doses,States/Local Areas,Montana,2015,Age,19 Months,83.9,73.3 to 90.9,256
Hib,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,81.7,76.8 to 85.8,513
Polio,≥3 Doses,States/Local Areas,Montana,2013,Age,24 Months,85.5,79.3 to 90.7,249
Polio,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,88.7,84.7 to 92.1,474
Hib,≥3 Doses,States/Local Areas,Montana,2013,Age,19 Months,78.2,73.1 to 82.6,249
Hib,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,80.3,75.1 to 84.7,474
Hib,≥3 Doses,States/Local Areas,Montana,2014,Age,19 Months,82.4,75.5 to 87.6,225
Hib,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,83.1,78.4 to 87.0,481
Polio,≥3 Doses,States/Local Areas,Montana,2012,Age,24 Months,91.7,86.3 to 95.6,219
Polio,≥3 Doses,States/Local Areas,Montana,2011,Age,24 Months,93.5,88.8 to 96.7,250
Polio,≥3 Doses,States/Local Areas,Montana,2019,Age,19 Months,92.7,85.3 to 96.5,187
DTaP,≥3 Doses,States/Local Areas,Montana,2017,Age,19 Months,89.0,83.4 to 92.9,265
DTaP,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,91.3,87.7 to 93.8,498
DTaP,≥3 Doses,States/Local Areas,Montana,2018,Age,19 Months,93.5,88.4 to 96.5,233
DTaP,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,91.2,86.9 to 94.1,420
DTaP,≥3 Doses,States/Local Areas,Montana,2019,Age,19 Months,92.7,85.3 to 96.5,187
Polio,≥3 Doses,States/Local Areas,Montana,2014,Age,24 Months,91.8,86.9 to 95.4,225
Polio,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,91.2,87.3 to 94.2,481
Polio,≥3 Doses,States/Local Areas,Montana,2015,Age,24 Months,90.4,84.0 to 95.1,256
Polio,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,89.5,85.3 to 92.9,513
Hib,Full Series,States/Local Areas,Montana,2015,Age,24 Months,77.7,70.6 to 84.2,256
Hib,Full Series,States/Local Areas,Montana,2015-2016,Age,24 Months,75.7,70.7 to 80.4,513
DTaP,≥3 Doses,States/Local Areas,Montana,2013,Age,24 Months,87.5,81.7 to 92.2,249
DTaP,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,90.3,86.6 to 93.4,474
Hib,≥3 Doses,States/Local Areas,Montana,2018,Age,19 Months,85.4,78.9 to 90.1,233
Hib,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,47.7,41.7 to 53.7,420
Hib,≥3 Doses,States/Local Areas,Montana,2016,Age,19 Months,79.5,72.2 to 85.3,257
Hib,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,79.2,74.3 to 83.4,522
Polio,≥3 Doses,States/Local Areas,Montana,2016,Age,24 Months,88.5,82.6 to 93.1,257
Polio,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,90.1,86.4 to 93.1,522
Hib,≥3 Doses,States/Local Areas,Montana,2017,Age,19 Months,79.0,72.1 to 84.5,265
Hib,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,82.2,77.6 to 86.0,498
Polio,≥3 Doses,States/Local Areas,Montana,2018,Age,35 Months,97.7,95.0 to 99.1,233
Polio,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,96.7,93.7 to 98.5,420
Polio,≥3 Doses,States/Local Areas,Montana,2017,Age,24 Months,91.8,87.3 to 95.2,265
Polio,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,93.2,90.3 to 95.5,498
Hib,≥3 Doses,States/Local Areas,Montana,2019,Age,19 Months,85.9,77.6 to 91.5,187
Polio,≥3 Doses,States/Local Areas,Montana,2019,Age,24 Months,93.1,86.6 to 97.2,187
Polio,≥3 Doses,States/Local Areas,Montana,2018,Age,24 Months,94.6,90.7 to 97.2,233
Polio,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,93.9,90.3 to 96.5,420
Hib,Full Series,States/Local Areas,Montana,2017,Age,24 Months,77.1,70.5 to 83.2,265
Hib,Full Series,States/Local Areas,Montana,2017-2018,Age,24 Months,79.9,75.3 to 84.2,498
Hib,Full Series,States/Local Areas,Montana,2018,Age,24 Months,82.7,76.1 to 88.4,233
Hib,Full Series,States/Local Areas,Montana,2018-2019,Age,24 Months,80.1,74.9 to 84.7,420
Hib,Full Series,States/Local Areas,Montana,2016,Age,24 Months,73.8,66.7 to 80.4,257
Hib,Full Series,States/Local Areas,Montana,2016-2017,Age,24 Months,75.4,70.6 to 80.0,522
Hib,≥3 Doses,States/Local Areas,Montana,2014,Age,24 Months,87.2,81.2 to 92.0,225
Hib,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,86.6,82.2 to 90.4,481
Hib,≥3 Doses,States/Local Areas,Montana,2011,Age,24 Months,91.0,86.0 to 94.8,250
Hib,≥3 Doses,States/Local Areas,Montana,2012,Age,24 Months,88.8,82.8 to 93.4,219
Hib,≥3 Doses,States/Local Areas,Montana,2013,Age,24 Months,80.1,73.3 to 86.0,249
Hib,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,83.6,79.1 to 87.7,474
Hib,Full Series,States/Local Areas,Montana,2017,Age,35 Months,83.0,76.0 to 88.8,265
Hib,Full Series,States/Local Areas,Montana,2017-2018,Age,35 Months,85.8,81.2 to 89.7,498
Polio,≥3 Doses,States/Local Areas,Montana,2019,Age,35 Months,93.8,87.6 to 97.6,187
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,94.3,91.9 to 96.8,453
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,90.9,87.4 to 94.4,375
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,88.8,78.7 to 98.9,59
Hib,Full Series,States/Local Areas,Montana,2016,Age,35 Months,78.6,71.4 to 85.1,257
Hib,Full Series,States/Local Areas,Montana,2016-2017,Age,35 Months,80.8,75.8 to 85.3,522
Hib,Full Series,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,82.7,78.5 to 86.9,453
Hib,Full Series,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,71.2,56.4 to 86.1,59
Hib,Full Series,States/Local Areas,Montana,2019,Age,35 Months,82.2,74.4 to 88.8,187
Hib,Full Series,States/Local Areas,Montana,2018,Age,35 Months,88.4,82.3 to 93.1,233
Hib,Full Series,States/Local Areas,Montana,2018-2019,Age,35 Months,85.6,80.6 to 89.8,420
Hib,Full Series,States/Local Areas,Montana,2015,Age,35 Months,79.3,72.1 to 85.7,256
Hib,Full Series,States/Local Areas,Montana,2015-2016,Age,35 Months,78.9,73.9 to 83.5,513
Hib,Full Series,States/Local Areas,Montana,2014,Age,35 Months,83.3,76.8 to 88.8,225
Hib,Full Series,States/Local Areas,Montana,2014-2015,Age,35 Months,81.4,76.6 to 85.8,481
Hib,Full Series,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,76.7,71.7 to 81.6,375
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,88.4,77.3 to 99.5,54
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,88.4 to 98.9,96
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.6,89.1 to 94.1,754
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,85.0 to 94.6,251
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,87.5 to 100.0,51
Hib,Full Series,States/Local Areas,Montana,2012,Age,35 Months,85.6,78.6 to 91.2,219
Hib,Full Series,States/Local Areas,Montana,2011,Age,35 Months,87.1,81.1 to 91.9,250
Hib,Full Series,States/Local Areas,Montana,2013,Age,35 Months,76.6,69.2 to 83.4,249
Hib,Full Series,States/Local Areas,Montana,2013-2014,Age,35 Months,80.1,75.1 to 84.7,474
Hib,Full Series,States/Local Areas,Montana,2019,Age,24 Months,77.6,69.6 to 84.7,187
DTaP,≥2 Doses,States/Local Areas,Montana,2011,Age,5 Months,79.4,77.6 to 81.1,250
DTaP,≥2 Doses,States/Local Areas,Montana,2012,Age,5 Months,79.7,76.4 to 82.6,219
DTaP,≥2 Doses,States/Local Areas,Montana,2013,Age,5 Months,70.4,66.1 to 74.4,249
DTaP,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,5 Months,71.1,67.9 to 74.2,474
Polio,≥3 Doses,States/Local Areas,Montana,2012,Age,35 Months,93.9,88.5 to 97.3,219
Hib,Primary Series,States/Local Areas,Montana,2020,Age,24 Months,91.4,86.9 to 94.9,220
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,40.0,23.3 to 56.7,59
Hep A,≥1 Dose,States/Local Areas,Montana,2020,Age,35 Months,87.5,80.4 to 93.0,220
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,83.8,77.4 to 90.2,225
Polio,≥3 Doses,States/Local Areas,Montana,2013,Age,35 Months,89.6,82.6 to 94.6,249
Polio,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,90.5,86.2 to 93.9,474
Polio,≥3 Doses,States/Local Areas,Montana,2014,Age,35 Months,91.8,86.9 to 95.4,225
Polio,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,92.0,88.1 to 94.9,481
DTaP,≥2 Doses,States/Local Areas,Montana,2015,Age,5 Months,74.9,67.0 to 81.4,256
DTaP,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,5 Months,76.3,70.9 to 81.0,513
DTaP,≥2 Doses,States/Local Areas,Montana,2016,Age,5 Months,77.8,70.2 to 83.9,257
DTaP,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,5 Months,78.4,73.3 to 82.7,522
DTaP,≥2 Doses,States/Local Areas,Montana,2014,Age,5 Months,71.9,63.8 to 78.7,225
DTaP,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,5 Months,73.4,70.3 to 76.2,481
Polio,≥3 Doses,States/Local Areas,Montana,2016,Age,35 Months,93.1,86.0 to 97.4,257
Polio,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,94.2,90.3 to 96.9,522
Polio,≥3 Doses,States/Local Areas,Montana,2017,Age,35 Months,95.6,91.2 to 98.2,265
Polio,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,96.7,94.4 to 98.2,498
Polio,≥3 Doses,States/Local Areas,Montana,2015,Age,35 Months,92.3,86.0 to 96.4,256
Polio,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,93.3,88.3 to 96.6,513
Hep A,≥1 Dose,States/Local Areas,Montana,2016,Age,35 Months,80.5,72.0 to 87.7,257
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,35 Months,83.0,77.9 to 87.6,522
Hep A,≥1 Dose,States/Local Areas,Montana,2014,Age,35 Months,78.0,70.8 to 84.4,225
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,35 Months,81.0,76.1 to 85.5,481
Hep A,≥1 Dose,States/Local Areas,Montana,2013,Age,35 Months,72.9,64.4 to 80.7,249
Hep A,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,35 Months,75.4,69.9 to 80.5,474
DTaP,≥4 Doses,States/Local Areas,Montana,2013,Age,24 Months,66.4,58.8 to 73.8,249
DTaP,≥4 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,74.5,69.4 to 79.4,474
Hep A,≥2 Doses,States/Local Areas,Montana,2016,Age,24 Months,34.7,27.9 to 42.5,257
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,36.6,31.7 to 42.1,522
Hep A,≥2 Doses,States/Local Areas,Montana,2017,Age,24 Months,38.8,31.7 to 46.8,265
Hep A,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,36.7,31.6 to 42.3,498
Hep A,≥2 Doses,States/Local Areas,Montana,2018,Age,24 Months,34.6,27.7 to 42.7,233
Hep A,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,35.0,29.4 to 41.4,420
DTaP,≥4 Doses,States/Local Areas,Montana,2012,Age,24 Months,77.5,69.8 to 84.4,219
DTaP,≥4 Doses,States/Local Areas,Montana,2011,Age,24 Months,77.9,70.7 to 84.3,250
DTaP,≥4 Doses,States/Local Areas,Montana,2019,Age,19 Months,68.3,59.0 to 76.4,187
Hep B,≥3 Doses,States/Local Areas,Montana,2013,Age,7 Months,77.1,72.6 to 81.0,249
Hep B,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,75.4,69.4 to 80.6,474
Hep B,≥3 Doses,States/Local Areas,Montana,2011,Age,7 Months,76.8,72.9 to 80.3,250
Hep B,≥3 Doses,States/Local Areas,Montana,2012,Age,7 Months,81.2,78.0 to 84.1,219
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,94.0,91.8 to 96.3,443
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,94.8,91.0 to 98.5,225
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,89.0,84.3 to 93.7,242
Polio,≥2 Doses,States/Local Areas,Montana,2014,Age,5 Months,71.3,63.3 to 78.2,225
Polio,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,5 Months,73.0,70.1 to 75.7,481
Polio,≥2 Doses,States/Local Areas,Montana,2013,Age,5 Months,68.9,63.8 to 73.6,249
Polio,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,5 Months,70.1,66.8 to 73.3,474
Polio,≥2 Doses,States/Local Areas,Montana,2011,Age,5 Months,79.8,78.0 to 81.5,250
Polio,≥2 Doses,States/Local Areas,Montana,2012,Age,5 Months,77.8,74.6 to 80.7,219
Hep A,≥1 Dose,States/Local Areas,Montana,2015,Age,35 Months,84.4,77.6 to 90.0,256
Hep A,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,35 Months,82.5,77.1 to 87.3,513
Hib,≥3 Doses,States/Local Areas,Montana,2019,Age,35 Months,89.2,81.6 to 94.6,187
Hep A,≥2 Doses,States/Local Areas,Montana,2014,Age,24 Months,34.9,27.3 to 43.9,225
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,32.1,26.9 to 37.9,481
Hep A,≥2 Doses,States/Local Areas,Montana,2015,Age,24 Months,29.2,22.7 to 37.0,256
Hep A,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,31.9,27.1 to 37.3,513
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,92.4,90.3 to 94.5,910
Hep A,≥2 Doses,States/Local Areas,Montana,2013,Age,24 Months,26.1,20.2 to 33.2,249
Hep A,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,30.6,25.6 to 36.4,474
DTaP,≥4 Doses,States/Local Areas,Montana,2018,Age,19 Months,66.4,58.3 to 73.6,233
DTaP,≥4 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,94.8,91.1 to 97.0,420
DTaP,≥4 Doses,States/Local Areas,Montana,2017,Age,19 Months,62.6,55.1 to 69.6,265
DTaP,≥4 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,64.5,59.0 to 69.6,498
DTaP,≥4 Doses,States/Local Areas,Montana,2016,Age,19 Months,64.1,56.4 to 71.2,257
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,63.4,58.0 to 68.4,522
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,93.1,85.7 to 100.0,54
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,88.7 to 99.4,96
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,87.5 to 100.0,51
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,92.8,90.4 to 95.2,608
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.3,89.9 to 94.7,754
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,86.8 to 95.6,251
PCV,≥2 Doses,States/Local Areas,Montana,2019,Age,5 Months,86.1,78.3 to 91.4,187
PCV,≥2 Doses,States/Local Areas,Montana,2018,Age,5 Months,82.4,75.0 to 87.9,233
PCV,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,5 Months,84.2,79.1 to 88.3,420
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,78.7,63.5 to 94.0,54
≥1 Dose Varicella,,States/Local Areas,Montana,2017,Age,35 Months,86.9,81.6 to 91.4,265
≥1 Dose Varicella,,States/Local Areas,Montana,2017-2018,Age,35 Months,91.1,87.7 to 94.0,498
≥1 Dose Varicella,,States/Local Areas,Montana,2018,Age,35 Months,95.2,90.3 to 98.1,233
≥1 Dose Varicella,,States/Local Areas,Montana,2018-2019,Age,35 Months,94.0,90.2 to 96.6,420
Hep B,≥3 Doses,States/Local Areas,Montana,2012,Age,19 Months,91.0,86.4 to 94.2,219
Hep B,≥3 Doses,States/Local Areas,Montana,2011,Age,19 Months,90.0,87.4 to 92.1,250
Hep B,≥3 Doses,States/Local Areas,Montana,2019,Age,13 Months,90.7,83.6 to 94.9,187
Hep B,≥3 Doses,States/Local Areas,Montana,2018,Age,13 Months,92.2,87.7 to 95.2,233
Hep B,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,91.5,87.6 to 94.2,420
DTaP,≥4 Doses,States/Local Areas,Montana,2018,Age,35 Months,88.7,82.0 to 93.8,233
DTaP,≥4 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,85.8,80.5 to 90.3,420
≥1 Dose Varicella,,States/Local Areas,Montana,2017,Age,24 Months,83.3,77.5 to 88.4,265
≥1 Dose Varicella,,States/Local Areas,Montana,2017-2018,Age,24 Months,87.1,83.1 to 90.6,498
≥1 Dose Varicella,,States/Local Areas,Montana,2016,Age,24 Months,80.9,74.2 to 86.8,257
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2017,Age,24 Months,82.1,77.7 to 86.1,522
≥1 Dose Varicella,,States/Local Areas,Montana,2015,Age,24 Months,82.9,76.0 to 88.7,256
≥1 Dose Varicella,,States/Local Areas,Montana,2015-2016,Age,24 Months,81.9,77.2 to 86.2,513
≥1 Dose MMR,,States/Local Areas,Montana,2012,Age,24 Months,88.0,82.0 to 92.8,219
≥1 Dose MMR,,States/Local Areas,Montana,2011,Age,24 Months,90.5,85.1 to 94.5,250
≥1 Dose MMR,,States/Local Areas,Montana,2019,Age,19 Months,89.9,82.4 to 94.5,187
≥1 Dose MMR,,States/Local Areas,Montana,2018,Age,19 Months,85.7,78.2 to 91.0,233
≥1 Dose MMR,,States/Local Areas,Montana,2018-2019,Age,19 Months,94.6,90.9 to 96.9,420
PCV,≥4 Doses,States/Local Areas,Montana,2011,Age,19 Months,79.5,74.6 to 83.7,250
PCV,≥4 Doses,States/Local Areas,Montana,2012,Age,19 Months,73.6,67.2 to 79.1,219
PCV,≥4 Doses,States/Local Areas,Montana,2013,Age,19 Months,66.3,61.6 to 70.7,249
PCV,≥4 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,69.7,65.0 to 74.0,474
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2018,Age,0-1 Days,72.3,64.5 to 78.8,233
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2018-2019,Age,0-1 Days,70.0,64.1 to 75.3,420
Hep B,≥2 Doses,States/Local Areas,Montana,2018,Age,5 Months,92.9,88.7 to 95.6,233
Hep B,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,5 Months,92.0,88.1 to 94.6,420
Hep B,≥2 Doses,States/Local Areas,Montana,2017,Age,5 Months,88.1,82.4 to 92.1,265
Hep B,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,5 Months,90.5,87.1 to 93.1,498
Hep B,≥2 Doses,States/Local Areas,Montana,2011,Age,7 Months,90.0,87.3 to 92.3,250
Hep B,≥2 Doses,States/Local Areas,Montana,2019,Age,5 Months,91.0,83.8 to 95.2,187
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2017,Age,0-1 Days,67.7,60.4 to 74.3,265
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2017-2018,Age,0-1 Days,70.0,64.7 to 74.7,498
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2016,Age,0-1 Days,67.4,60.0 to 74.0,257
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2016-2017,Age,0-1 Days,67.6,62.5 to 72.3,522
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,88.5 to 93.6,754
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,58.1,51.5 to 64.8,608
Hep B,≥1 Dose,States/Local Areas,Montana,2017,Age,3 Months,92.1,87.2 to 95.2,265
Hep B,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,3 Months,93.2,90.3 to 95.3,498
Hep B,≥1 Dose,States/Local Areas,Montana,2016,Age,3 Months,95.0,90.6 to 97.4,257
Hep B,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,3 Months,93.5,90.5 to 95.7,522
Hep B,≥1 Dose,States/Local Areas,Montana,2015,Age,3 Months,95.9,92.3 to 97.8,256
Hep B,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,3 Months,95.4,92.9 to 97.1,513
Polio,≥2 Doses,States/Local Areas,Montana,2014,Age,13 Months,93.0,87.8 to 96.1,225
Polio,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,91.8,87.6 to 94.7,481
Polio,≥2 Doses,States/Local Areas,Montana,2013,Age,13 Months,86.6,84.7 to 88.3,249
Polio,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,89.8,87.6 to 91.7,474
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,63.4,52.5 to 74.2,242
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,65.1,59.8 to 70.3,910
Polio,≥2 Doses,States/Local Areas,Montana,2019,Age,7 Months,91.7,84.1 to 95.8,187
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",65.0,59.3 to 70.6,754
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,75.7,67.0 to 84.4,251
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.1,48.1 to 84.1,96
DTaP,≥4 Doses,States/Local Areas,Montana,2016,Age,35 Months,78.4,70.4 to 85.5,257
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,81.4,75.9 to 86.3,522
DTaP,≥4 Doses,States/Local Areas,Montana,2017,Age,35 Months,84.4,76.8 to 90.6,265
DTaP,≥4 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,86.3,81.4 to 90.4,498
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,64.8,45.3 to 84.2,54
Polio,≥2 Doses,States/Local Areas,Montana,2018,Age,7 Months,91.7,85.6 to 95.4,233
Polio,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,91.7,87.3 to 94.7,420
Polio,≥2 Doses,States/Local Areas,Montana,2017,Age,7 Months,87.6,81.9 to 91.7,265
Polio,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,89.6,85.7 to 92.6,498
Polio,≥2 Doses,States/Local Areas,Montana,2016,Age,7 Months,87.6,81.2 to 92.1,257
Polio,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,87.6,83.5 to 90.8,522
Hep B,≥1 Dose,States/Local Areas,Montana,2014,Age,3 Months,93.1,88.5 to 96.0,225
Hep B,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,3 Months,94.5,91.6 to 96.4,481
Hep B,≥1 Dose,States/Local Areas,Montana,2011,Age,3 Months,91.0,87.3 to 93.7,250
Hep B,≥1 Dose,States/Local Areas,Montana,2012,Age,3 Months,94.9,93.1 to 96.3,219
Hep B,≥1 Dose,States/Local Areas,Montana,2013,Age,3 Months,93.5,90.5 to 95.6,249
Hep B,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,3 Months,93.3,91.4 to 94.8,474
≥1 Dose MMR,,States/Local Areas,Montana,2015,Age,13 Months,51.9,44.2 to 59.6,256
≥1 Dose MMR,,States/Local Areas,Montana,2015-2016,Age,13 Months,54.0,48.6 to 59.3,513
≥1 Dose MMR,,States/Local Areas,Montana,2014,Age,13 Months,49.0,41.0 to 57.2,225
≥1 Dose MMR,,States/Local Areas,Montana,2014-2015,Age,13 Months,50.5,44.9 to 56.1,481
≥1 Dose Varicella,,States/Local Areas,Montana,2018,Age,13 Months,51.6,43.7 to 59.5,233
≥1 Dose Varicella,,States/Local Areas,Montana,2018-2019,Age,13 Months,52.6,46.5 to 58.6,420
≥1 Dose MMR,,States/Local Areas,Montana,2016,Age,13 Months,56.1,48.6 to 63.3,257
≥1 Dose MMR,,States/Local Areas,Montana,2016-2017,Age,13 Months,50.5,45.3 to 55.7,522
PCV,≥4 Doses,States/Local Areas,Montana,2020,Age,35 Months,74.6,66.8 to 81.8,220
≥1 Dose Varicella,,States/Local Areas,Montana,2012,Age,19 Months,82.4,79.0 to 85.4,219
≥1 Dose Varicella,,States/Local Areas,Montana,2013,Age,19 Months,78.6,73.9 to 82.5,249
≥1 Dose Varicella,,States/Local Areas,Montana,2013-2014,Age,19 Months,80.2,77.6 to 82.6,474
≥1 Dose Varicella,,States/Local Areas,Montana,2011,Age,19 Months,86.8,84.7 to 88.7,250
≥1 Dose Varicella,,States/Local Areas,Montana,2019,Age,13 Months,53.6,44.3 to 62.6,187
Hep A,≥2 Doses,States/Local Areas,Montana,2017,Age,35 Months,73.2,63.6 to 82.0,265
Hep A,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,71.0,63.9 to 77.7,498
Hep A,≥2 Doses,States/Local Areas,Montana,2018,Age,35 Months,68.5,58.6 to 78.0,233
Hep A,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,72.7,64.6 to 80.3,420
Hep B,≥3 Doses,States/Local Areas,Montana,2014,Age,13 Months,86.5,80.5 to 90.9,225
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,87.5,83.1 to 90.9,481
Hep B,≥3 Doses,States/Local Areas,Montana,2013,Age,13 Months,82.4,78.5 to 85.8,249
Hep B,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,84.5,81.9 to 86.8,474
DTaP,≥4 Doses,States/Local Areas,Montana,2013,Age,35 Months,76.0,67.4 to 83.8,249
DTaP,≥4 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,81.2,75.7 to 86.1,474
Hep B,≥3 Doses,States/Local Areas,Montana,2012,Age,13 Months,88.9,85.2 to 91.8,219
Hep A,≥2 Doses,States/Local Areas,Montana,2019,Age,35 Months,77.4,63.7 to 88.7,187
DTaP,≥4 Doses,States/Local Areas,Montana,2014,Age,35 Months,85.8,79.4 to 91.0,225
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,83.8,79.0 to 88.0,481
DTaP,≥4 Doses,States/Local Areas,Montana,2015,Age,35 Months,81.6,74.3 to 87.9,256
DTaP,≥4 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,80.1,74.7 to 85.0,513
DTaP,≥4 Doses,States/Local Areas,Montana,2012,Age,35 Months,91.3,84.7 to 95.8,219
DTaP,≥4 Doses,States/Local Areas,Montana,2011,Age,35 Months,83.2,75.7 to 89.4,250
DTaP,≥4 Doses,States/Local Areas,Montana,2019,Age,24 Months,77.2,68.3 to 85.2,187
DTaP,≥4 Doses,States/Local Areas,Montana,2017,Age,24 Months,74.6,67.5 to 81.2,265
DTaP,≥4 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,77.3,72.4 to 81.8,498
DTaP,≥4 Doses,States/Local Areas,Montana,2018,Age,24 Months,80.0,73.3 to 86.0,233
DTaP,≥4 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,78.6,73.1 to 83.6,420
Hep B,≥3 Doses,States/Local Areas,Montana,2011,Age,13 Months,87.7,83.6 to 90.9,250
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,77.6,73.0 to 82.2,443
Polio,≥2 Doses,States/Local Areas,Montana,2015,Age,7 Months,86.3,79.2 to 91.3,256
Polio,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,87.0,82.2 to 90.6,513
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Overall,Overall,77.3,73.9 to 80.6,910
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,73.1,66.7 to 79.5,242
Polio,≥2 Doses,States/Local Areas,Montana,2013,Age,7 Months,81.6,76.4 to 85.8,249
Polio,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,83.7,81.4 to 85.8,474
Polio,≥2 Doses,States/Local Areas,Montana,2014,Age,7 Months,85.8,78.8 to 90.7,225
Polio,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,86.0,81.2 to 89.8,481
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.9,70.5 to 93.4,51
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,73.4,69.1 to 77.8,608
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.9,73.2 to 80.5,754
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,83.7,78.2 to 89.1,251
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.7,75.3 to 92.0,96
DTaP,≥4 Doses,States/Local Areas,Montana,2014,Age,24 Months,82.1,75.8 to 87.5,225
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,79.2,74.5 to 83.5,481
DTaP,≥4 Doses,States/Local Areas,Montana,2015,Age,24 Months,75.9,68.7 to 82.4,256
DTaP,≥4 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,74.3,69.1 to 79.1,513
DTaP,≥4 Doses,States/Local Areas,Montana,2016,Age,24 Months,72.6,65.1 to 79.6,257
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,73.5,68.4 to 78.4,522
Hep A,≥2 Doses,States/Local Areas,Montana,2013,Age,35 Months,47.7,39.1 to 57.0,249
Hep A,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,57.0,50.3 to 63.9,474
Hep A,≥2 Doses,States/Local Areas,Montana,2012,Age,35 Months,69.3,58.4 to 79.6,219
Hep A,≥2 Doses,States/Local Areas,Montana,2011,Age,35 Months,67.3,56.1 to 78.0,250
Hep A,≥2 Doses,States/Local Areas,Montana,2019,Age,24 Months,35.9,27.0 to 46.6,187
Hep B,≥3 Doses,States/Local Areas,Montana,2016,Age,7 Months,78.9,72.0 to 84.5,257
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,80.3,75.7 to 84.2,522
Polio,≥2 Doses,States/Local Areas,Montana,2015,Age,5 Months,74.7,66.8 to 81.2,256
Polio,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,5 Months,75.7,70.3 to 80.4,513
Hep B,≥3 Doses,States/Local Areas,Montana,2015,Age,7 Months,79.2,71.7 to 85.2,256
Hep B,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,79.1,74.0 to 83.4,513
Hep B,≥3 Doses,States/Local Areas,Montana,2014,Age,7 Months,73.8,66.0 to 80.4,225
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,76.6,71.3 to 81.1,481
Polio,≥2 Doses,States/Local Areas,Montana,2017,Age,5 Months,78.1,71.2 to 83.8,265
Polio,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,5 Months,80.0,75.0 to 84.1,498
Polio,≥2 Doses,States/Local Areas,Montana,2016,Age,5 Months,76.8,69.3 to 83.0,257
Polio,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,5 Months,77.5,72.4 to 81.9,522
≥1 Dose Varicella,,States/Local Areas,Montana,2011,Age,13 Months,47.6,36.9 to 58.5,250
Hep B,≥3 Doses,States/Local Areas,Montana,2017,Age,13 Months,87.0,81.0 to 91.3,265
Hep B,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,89.6,86.0 to 92.4,498
Hep B,≥3 Doses,States/Local Areas,Montana,2015,Age,13 Months,88.5,81.4 to 93.1,256
Hep B,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,88.5,84.1 to 91.8,513
Hep B,≥3 Doses,States/Local Areas,Montana,2016,Age,13 Months,88.6,82.4 to 92.8,257
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,87.8,83.6 to 91.0,522
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,71.8,65.2 to 78.3,453
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,65.2,57.0 to 73.4,375
≥1 Dose MMR,,States/Local Areas,Montana,2011,Age,13 Months,48.3,37.1 to 59.6,250
≥1 Dose MMR,,States/Local Areas,Montana,2012,Age,13 Months,48.7,40.3 to 57.3,219
≥1 Dose MMR,,States/Local Areas,Montana,2013,Age,13 Months,39.0,29.5 to 49.5,249
≥1 Dose MMR,,States/Local Areas,Montana,2013-2014,Age,13 Months,44.1,37.8 to 50.6,474
≥1 Dose Varicella,,States/Local Areas,Montana,2015,Age,13 Months,48.9,41.1 to 56.7,256
≥1 Dose Varicella,,States/Local Areas,Montana,2015-2016,Age,13 Months,45.8,40.4 to 51.2,513
≥1 Dose Varicella,,States/Local Areas,Montana,2017,Age,13 Months,40.4,33.4 to 47.8,265
≥1 Dose Varicella,,States/Local Areas,Montana,2017-2018,Age,13 Months,46.0,40.6 to 51.4,498
≥1 Dose Varicella,,States/Local Areas,Montana,2016,Age,13 Months,42.6,35.5 to 50.1,257
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2017,Age,13 Months,41.5,36.5 to 46.7,522
Hep A,≥1 Dose,States/Local Areas,Montana,2018,Age,35 Months,88.3,82.3 to 93.0,233
Hep A,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,35 Months,88.5,84.2 to 92.1,420
Hep A,≥1 Dose,States/Local Areas,Montana,2017,Age,35 Months,85.1,79.5 to 89.8,265
Hep A,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,35 Months,86.9,82.8 to 90.4,498
≥1 Dose Varicella,,States/Local Areas,Montana,2013,Age,13 Months,34.9,29.9 to 40.2,249
≥1 Dose Varicella,,States/Local Areas,Montana,2013-2014,Age,13 Months,38.8,34.4 to 43.4,474
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,62.4,47.3 to 77.5,59
Polio,≥2 Doses,States/Local Areas,Montana,2018,Age,5 Months,81.8,74.3 to 87.5,233
Polio,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,5 Months,84.0,78.8 to 88.1,420
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,85.2,81.5 to 89.0,453
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,75.3,70.1 to 80.5,375
Hep A,≥1 Dose,States/Local Areas,Montana,2019,Age,35 Months,88.3,81.5 to 93.4,187
≥1 Dose Varicella,,States/Local Areas,Montana,2012,Age,13 Months,41.5,33.6 to 49.8,219
≥1 Dose Varicella,,States/Local Areas,Montana,2014,Age,13 Months,42.6,34.8 to 50.7,225
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2015,Age,13 Months,45.7,40.2 to 51.4,481
Hep A,≥2 Doses,States/Local Areas,Montana,2014,Age,35 Months,65.7,56.0 to 75.1,225
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,66.4,59.3 to 73.3,481
Hep B,≥3 Doses,States/Local Areas,Montana,2019,Age,7 Months,84.4,76.5 to 90.0,187
Hep A,≥2 Doses,States/Local Areas,Montana,2015,Age,35 Months,67.4,57.1 to 77.4,256
Hep A,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,64.4,57.7 to 71.1,513
Hep A,≥2 Doses,States/Local Areas,Montana,2016,Age,35 Months,61.0,52.5 to 69.5,257
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,67.4,60.7 to 73.9,522
Hep B,≥3 Doses,States/Local Areas,Montana,2018,Age,7 Months,83.3,76.3 to 88.6,233
Hep B,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,83.9,78.9 to 87.9,420
Hep B,≥3 Doses,States/Local Areas,Montana,2017,Age,7 Months,81.6,75.2 to 86.7,265
Hep B,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,82.5,77.9 to 86.2,498
Polio,≥2 Doses,States/Local Areas,Montana,2011,Age,7 Months,88.3,83.6 to 91.8,250
Polio,≥2 Doses,States/Local Areas,Montana,2012,Age,7 Months,85.9,79.9 to 90.3,219
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,72.1,57.4 to 86.8,54
Polio,≥2 Doses,States/Local Areas,Montana,2019,Age,5 Months,86.1,78.3 to 91.4,187
DTaP,≥3 Doses,States/Local Areas,Montana,2017,Age,13 Months,86.2,79.9 to 90.7,265
DTaP,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,88.4,84.4 to 91.5,498
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,77.0,71.2 to 82.7,242
DTaP,≥3 Doses,States/Local Areas,Montana,2016,Age,13 Months,84.0,76.7 to 89.4,257
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,85.1,80.5 to 88.8,522
Hib,≥2 Doses,States/Local Areas,Montana,2019,Age,13 Months,92.7,85.3 to 96.5,187
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.1,86.1 to 100.0,51
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,91.1,88.4 to 93.7,608
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,91.3,89.1 to 93.5,910
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,89.1,84.5 to 93.7,242
Hib,≥2 Doses,States/Local Areas,Montana,2017,Age,13 Months,89.2,83.6 to 93.1,265
Hib,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,92.9,89.7 to 95.1,498
Hib,≥2 Doses,States/Local Areas,Montana,2018,Age,13 Months,96.6,93.3 to 98.3,233
Hib,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,94.6,90.9 to 96.9,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,73.2,68.2 to 78.1,443
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,69.7,62.2 to 77.1,225
Hib,≥3 Doses,States/Local Areas,Montana,2012,Age,13 Months,61.9,59.2 to 64.5,219
Hib,≥3 Doses,States/Local Areas,Montana,2011,Age,13 Months,61.2,54.9 to 67.2,250
Hib,≥3 Doses,States/Local Areas,Montana,2014,Age,13 Months,57.5,49.2 to 65.4,225
Hib,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,58.0,52.3 to 63.5,481
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,92.9,90.4 to 95.4,443
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,91.6,87.0 to 96.2,225
Polio,≥3 Doses,States/Local Areas,Montana,2011,Age,19 Months,92.9,89.4 to 95.2,250
Hib,≥3 Doses,States/Local Areas,Montana,2013,Age,13 Months,60.3,55.6 to 64.9,249
Hib,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,58.9,55.4 to 62.4,474
Hib,≥2 Doses,States/Local Areas,Montana,2019,Age,7 Months,90.8,83.3 to 95.2,187
DTaP,≥3 Doses,States/Local Areas,Montana,2016,Age,7 Months,69.3,61.6 to 76.1,257
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,70.1,64.8 to 74.9,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2015,Age,0-3 Days,80.8,74.8 to 85.6,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2015-2016,Age,0-3 Days,76.9,72.3 to 80.9,513
DTaP,≥3 Doses,States/Local Areas,Montana,2014,Age,7 Months,60.8,52.6 to 68.5,225
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,63.8,58.2 to 69.1,481
DTaP,≥3 Doses,States/Local Areas,Montana,2015,Age,7 Months,66.8,58.9 to 73.9,256
DTaP,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,68.1,62.5 to 73.1,513
Polio,≥1 Dose,States/Local Areas,Montana,2018,Age,3 Months,88.4,81.6 to 92.9,233
Polio,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,3 Months,89.7,85.0 to 93.1,420
Polio,≥1 Dose,States/Local Areas,Montana,2017,Age,3 Months,87.0,81.3 to 91.1,265
Polio,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,3 Months,87.7,83.5 to 90.9,498
Hib,≥3 Doses,States/Local Areas,Montana,2016,Age,7 Months,21.2,15.8 to 27.8,257
Hib,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,19.9,16.1 to 24.4,522
Hib,≥3 Doses,States/Local Areas,Montana,2015,Age,7 Months,27.1,20.7 to 34.5,256
Hib,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,24.2,19.8 to 29.1,513
Hib,≥3 Doses,States/Local Areas,Montana,2014,Age,7 Months,28.3,21.3 to 36.4,225
Hib,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,27.7,22.8 to 33.1,481
PCV,≥3 Doses,States/Local Areas,Montana,2018,Age,35 Months,95.4,91.7 to 97.7,233
PCV,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,94.6,91.3 to 97.0,420
PCV,≥3 Doses,States/Local Areas,Montana,2017,Age,35 Months,95.1,89.5 to 98.2,265
PCV,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,95.0,92.0 to 97.1,498
Hib,≥2 Doses,States/Local Areas,Montana,2013,Age,13 Months,84.8,81.4 to 87.6,249
Hib,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,88.5,86.0 to 90.6,474
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,78.3,66.7 to 89.9,54
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,78.1 to 93.4,96
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.4,67.6 to 75.3,754
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,64.3,48.6 to 80.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,76.9,70.7 to 83.1,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Overall,Overall,73.8,70.4 to 77.2,910
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,73.2,69.1 to 77.3,608
DTaP,≥3 Doses,States/Local Areas,Montana,2014,Age,13 Months,89.4,83.2 to 93.5,225
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,88.1,83.7 to 91.5,481
DTaP,≥3 Doses,States/Local Areas,Montana,2013,Age,13 Months,82.6,81.0 to 84.0,249
DTaP,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,86.0,83.3 to 88.4,474
DTaP,≥3 Doses,States/Local Areas,Montana,2017,Age,7 Months,70.9,63.5 to 77.3,265
DTaP,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,71.4,66.0 to 76.3,498
DTaP,≥3 Doses,States/Local Areas,Montana,2019,Age,7 Months,78.7,69.8 to 85.5,187
DTaP,≥3 Doses,States/Local Areas,Montana,2018,Age,7 Months,72.0,63.8 to 78.9,233
DTaP,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,75.3,69.5 to 80.4,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,75.7,70.8 to 80.6,375
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,71.8,66.6 to 76.9,453
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,75.6,64.5 to 86.8,59
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2019,Age,0-3 Days,72.3,63.5 to 79.7,187
Polio,≥1 Dose,States/Local Areas,Montana,2019,Age,3 Months,91.1,83.4 to 95.5,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2018,Age,0-3 Days,75.7,68.3 to 81.9,233
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2018-2019,Age,0-3 Days,74.0,68.4 to 78.9,420
PCV,≥3 Doses,States/Local Areas,Montana,2019,Age,35 Months,93.1,86.6 to 97.2,187
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,88.3,78.8 to 97.9,59
DTaP,≥3 Doses,States/Local Areas,Montana,2012,Age,13 Months,88.3,85.2 to 90.9,219
DTaP,≥3 Doses,States/Local Areas,Montana,2015,Age,13 Months,86.9,79.7 to 91.8,256
DTaP,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,85.5,80.4 to 89.4,513
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,88.6 to 93.6,754
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,86.8 to 95.6,251
Hib,≥3 Doses,States/Local Areas,Montana,2019,Age,7 Months,18.3,12.3 to 26.4,187
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,93.1,90.4 to 95.8,453
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,91.9,88.7 to 95.1,375
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,91.7,83.9 to 99.6,54
PCV,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,88.1 to 98.9,96
Hib,≥3 Doses,States/Local Areas,Montana,2018,Age,7 Months,17.0,12.0 to 23.6,233
Hib,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,17.7,13.6 to 22.7,420
Hib,≥3 Doses,States/Local Areas,Montana,2017,Age,7 Months,18.6,13.5 to 25.1,265
Hib,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,17.8,14.1 to 22.3,498
Hib,≥2 Doses,States/Local Areas,Montana,2018,Age,7 Months,91.4,85.3 to 95.1,233
Hib,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,91.1,86.6 to 94.2,420
PCV,≥3 Doses,States/Local Areas,Montana,2014,Age,35 Months,90.9,85.6 to 94.8,225
PCV,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,91.3,87.3 to 94.4,481
PCV,≥3 Doses,States/Local Areas,Montana,2016,Age,35 Months,89.6,84.0 to 93.8,257
PCV,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,91.8,88.0 to 94.8,522
PCV,≥3 Doses,States/Local Areas,Montana,2015,Age,35 Months,92.0,86.0 to 96.1,256
PCV,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,90.8,86.8 to 94.0,513
Hib,≥2 Doses,States/Local Areas,Montana,2017,Age,7 Months,87.5,81.7 to 91.7,265
Hib,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,89.4,85.5 to 92.4,498
Hib,≥2 Doses,States/Local Areas,Montana,2016,Age,7 Months,87.5,81.1 to 91.9,257
Hib,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,87.5,83.3 to 90.7,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016,Age,0-3 Days,72.9,65.9 to 78.9,257
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2017,Age,0-3 Days,73.0,68.2 to 77.4,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2017,Age,0-3 Days,75.7,66.7 to 82.9,164
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2017-2018,Age,0-3 Days,74.5,69.5 to 78.9,498
Polio,≥1 Dose,States/Local Areas,Montana,2016,Age,3 Months,84.9,77.9 to 90.0,257
Polio,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,3 Months,85.9,81.6 to 89.4,522
Polio,≥1 Dose,States/Local Areas,Montana,2015,Age,3 Months,83.4,75.9 to 89.0,256
Polio,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,3 Months,84.2,79.1 to 88.2,513
Polio,≥1 Dose,States/Local Areas,Montana,2014,Age,3 Months,83.4,76.3 to 88.8,225
Polio,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,3 Months,83.4,78.4 to 87.5,481
Hib,≥3 Doses,States/Local Areas,Montana,2013,Age,7 Months,26.0,20.4 to 32.5,249
Hib,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,27.1,21.5 to 33.6,474
Hib,≥3 Doses,States/Local Areas,Montana,2011,Age,7 Months,26.9,22.8 to 31.4,250
Hib,≥3 Doses,States/Local Areas,Montana,2012,Age,7 Months,24.3,20.0 to 29.2,219
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,93.2,90.8 to 95.6,443
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,93.7,89.4 to 97.9,225
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,87.5,82.6 to 92.3,242
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2013,Age,0-3 Days,72.5,65.3 to 78.7,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2013-2014,Age,0-3 Days,68.8,63.6 to 73.7,474
Polio,≥1 Dose,States/Local Areas,Montana,2013,Age,3 Months,81.5,76.4 to 85.7,249
Polio,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,3 Months,82.5,80.4 to 84.5,474
Polio,≥1 Dose,States/Local Areas,Montana,2011,Age,3 Months,86.4,82.6 to 89.4,250
Polio,≥1 Dose,States/Local Areas,Montana,2012,Age,3 Months,86.9,84.3 to 89.1,219
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,91.3,89.1 to 93.5,910
PCV,≥1 Dose,States/Local Areas,Montana,2019,Age,3 Months,91.1,83.4 to 95.5,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014,Age,0-3 Days,65.3,57.4 to 72.4,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2014-2015,Age,0-3 Days,73.1,68.0 to 77.6,481
Hib,≥2 Doses,States/Local Areas,Montana,2014,Age,13 Months,92.1,86.7 to 95.4,225
Hib,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,90.9,86.7 to 93.8,481
Hib,≥2 Doses,States/Local Areas,Montana,2016,Age,13 Months,90.5,84.5 to 94.3,257
Hib,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,89.9,85.9 to 92.8,522
Hib,≥2 Doses,States/Local Areas,Montana,2015,Age,13 Months,89.7,82.6 to 94.1,256
Hib,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,90.1,85.8 to 93.2,513
Hib,≥2 Doses,States/Local Areas,Montana,2011,Age,13 Months,93.9,91.8 to 95.6,250
Hib,≥2 Doses,States/Local Areas,Montana,2012,Age,13 Months,92.0,86.9 to 95.2,219
DTaP,≥3 Doses,States/Local Areas,Montana,2011,Age,7 Months,69.0,64.1 to 73.5,250
DTaP,≥3 Doses,States/Local Areas,Montana,2012,Age,7 Months,71.3,66.9 to 75.4,219
DTaP,≥3 Doses,States/Local Areas,Montana,2013,Age,7 Months,65.0,60.7 to 69.0,249
DTaP,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,62.9,55.7 to 69.5,474
Hib,≥2 Doses,States/Local Areas,Montana,2015,Age,7 Months,86.1,79.0 to 91.1,256
Hib,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,86.8,82.0 to 90.5,513
PCV,≥3 Doses,States/Local Areas,Montana,2013,Age,35 Months,82.8,76.1 to 88.5,249
PCV,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,86.9,82.6 to 90.5,474
PCV,≥3 Doses,States/Local Areas,Montana,2011,Age,35 Months,94.7,89.6 to 97.7,250
PCV,≥3 Doses,States/Local Areas,Montana,2019,Age,24 Months,93.1,86.6 to 97.2,187
PCV,≥3 Doses,States/Local Areas,Montana,2012,Age,35 Months,92.5,86.6 to 96.4,219
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,94.2,87.1 to 100.0,54
DTaP,≥3 Doses,States/Local Areas,Montana,2011,Age,13 Months,89.2,84.3 to 92.7,250
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,85.8 to 97.9,96
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.5,79.9 to 100.0,51
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,91.9,89.3 to 94.5,608
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,69.0 to 88.4,96
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.0,76.4 to 83.5,754
PCV,≥1 Dose,States/Local Areas,Montana,2015,Age,3 Months,84.0,76.6 to 89.4,256
PCV,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,3 Months,84.3,79.3 to 88.3,513
PCV,≥1 Dose,States/Local Areas,Montana,2014,Age,3 Months,82.5,75.3 to 87.9,225
PCV,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,3 Months,83.3,78.3 to 87.3,481
PCV,≥3 Doses,States/Local Areas,Montana,2018,Age,24 Months,93.0,88.7 to 96.2,233
PCV,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,93.0,89.4 to 95.8,420
PCV,≥3 Doses,States/Local Areas,Montana,2017,Age,24 Months,90.2,85.3 to 94.0,265
PCV,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,91.6,88.5 to 94.2,498
Hib,≥2 Doses,States/Local Areas,Montana,2012,Age,7 Months,86.3,78.6 to 91.5,219
PCV,≥3 Doses,States/Local Areas,Montana,2016,Age,24 Months,89.6,84.0 to 93.8,257
PCV,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,89.9,86.2 to 92.9,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2011,Age,0-3 Days,71.6,63.9 to 78.2,250
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,91.9,88.6 to 95.1,375
PCV,≥1 Dose,States/Local Areas,Montana,2018,Age,3 Months,89.4,82.7 to 93.7,233
PCV,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,3 Months,90.3,85.6 to 93.6,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2012,Age,0-3 Days,71.1,61.8 to 78.8,219
Hib,≥3 Doses,States/Local Areas,Montana,2011,Age,19 Months,89.2,84.6 to 92.6,250
Hib,≥3 Doses,States/Local Areas,Montana,2012,Age,19 Months,87.1,80.3 to 91.8,219
Hib,≥3 Doses,States/Local Areas,Montana,2019,Age,13 Months,49.1,40.0 to 58.3,187
Polio,≥3 Doses,States/Local Areas,Montana,2013,Age,19 Months,82.4,78.6 to 85.6,249
Polio,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,86.4,84.8 to 87.8,474
Polio,≥3 Doses,States/Local Areas,Montana,2015,Age,19 Months,90.3,83.1 to 94.6,256
Polio,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,88.6,84.0 to 92.0,513
Polio,≥3 Doses,States/Local Areas,Montana,2012,Age,19 Months,90.5,86.4 to 93.5,219
Polio,≥3 Doses,States/Local Areas,Montana,2014,Age,19 Months,90.3,84.8 to 93.9,225
Polio,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,90.3,86.0 to 93.4,481
Hib,≥3 Doses,States/Local Areas,Montana,2015,Age,13 Months,58.4,50.5 to 66.0,256
Hib,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,55.1,49.5 to 60.6,513
Hib,≥3 Doses,States/Local Areas,Montana,2017,Age,13 Months,44.4,37.2 to 51.9,265
Hib,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,45.3,40.0 to 50.7,498
Hib,≥3 Doses,States/Local Areas,Montana,2016,Age,13 Months,51.8,44.1 to 59.4,257
Hib,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,48.1,42.8 to 53.4,522
DTaP,≥3 Doses,States/Local Areas,Montana,2012,Age,19 Months,92.6,83.4 to 96.9,219
DTaP,≥3 Doses,States/Local Areas,Montana,2013,Age,19 Months,84.8,83.0 to 86.5,249
DTaP,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,88.9,86.8 to 90.7,474
DTaP,≥3 Doses,States/Local Areas,Montana,2011,Age,19 Months,92.9,89.1 to 95.5,250
DTaP,≥3 Doses,States/Local Areas,Montana,2019,Age,13 Months,91.7,84.3 to 95.8,187
DTaP,≥3 Doses,States/Local Areas,Montana,2018,Age,13 Months,90.6,84.9 to 94.3,233
DTaP,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,91.2,86.9 to 94.1,420
Polio,≥3 Doses,States/Local Areas,Montana,2018,Age,19 Months,92.2,86.9 to 95.4,233
Polio,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,68.2,62.1 to 73.7,420
Hib,≥3 Doses,States/Local Areas,Montana,2018,Age,13 Months,46.2,38.5 to 54.1,233
Hib,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,47.7,41.7 to 53.7,420
Polio,≥3 Doses,States/Local Areas,Montana,2017,Age,19 Months,88.5,82.9 to 92.4,265
Polio,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,90.3,86.7 to 93.0,498
Polio,≥3 Doses,States/Local Areas,Montana,2016,Age,19 Months,86.9,80.1 to 91.7,257
Polio,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,87.7,83.5 to 91.0,522
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.5,69.7 to 93.2,51
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,79.6,76.4 to 82.9,910
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,77.0,72.7 to 81.2,608
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,73.5,67.0 to 80.0,242
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,82.4,78.1 to 86.6,443
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,84.3,78.1 to 90.5,225
Hib,≥2 Doses,States/Local Areas,Montana,2014,Age,7 Months,85.3,78.3 to 90.3,225
Hib,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,85.7,80.9 to 89.5,481
Hib,≥2 Doses,States/Local Areas,Montana,2013,Age,7 Months,81.8,76.1 to 86.4,249
Hib,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,83.6,80.9 to 86.0,474
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,84.5,79.0 to 89.9,251
PCV,≥1 Dose,States/Local Areas,Montana,2017,Age,3 Months,85.4,79.5 to 89.8,265
PCV,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,3 Months,87.4,83.2 to 90.7,498
PCV,≥1 Dose,States/Local Areas,Montana,2016,Age,3 Months,84.7,77.7 to 89.8,257
PCV,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,3 Months,85.0,80.6 to 88.6,522
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,92.8,90.1 to 95.5,453
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,88.6,78.6 to 98.6,59
Hep B,≥3 Doses,States/Local Areas,Montana,2020,Age,24 Months,88.3,82.5 to 92.8,220
PCV,≥3 Doses,States/Local Areas,Montana,2015,Age,24 Months,89.9,83.6 to 94.5,256
PCV,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,89.8,85.7 to 93.1,513
PCV,≥3 Doses,States/Local Areas,Montana,2014,Age,24 Months,90.9,85.6 to 94.8,225
PCV,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,90.3,86.3 to 93.5,481
PCV,≥3 Doses,States/Local Areas,Montana,2013,Age,24 Months,81.6,74.9 to 87.5,249
PCV,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,86.3,82.0 to 90.0,474
Hib,≥2 Doses,States/Local Areas,Montana,2017,Age,5 Months,76.2,69.0 to 82.2,265
Hib,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,5 Months,78.9,73.9 to 83.2,498
PCV,≥3 Doses,States/Local Areas,Montana,2012,Age,24 Months,88.5,82.3 to 93.3,219
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,85.9 to 94.6,251
Hib,≥2 Doses,States/Local Areas,Montana,2011,Age,7 Months,88.1,83.9 to 91.4,250
Hib,≥2 Doses,States/Local Areas,Montana,2019,Age,5 Months,84.4,76.6 to 89.9,187
Hib,≥2 Doses,States/Local Areas,Montana,2018,Age,5 Months,81.6,74.1 to 87.3,233
Hib,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,5 Months,83.0,77.8 to 87.2,420
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,85.8,82.1 to 89.6,453
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,78.7,73.7 to 83.7,375
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,64.4,49.2 to 79.6,59
PCV,≥4 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,82.4,70.0 to 94.8,54
PCV,≥1 Dose,States/Local Areas,Montana,2013,Age,3 Months,79.6,75.9 to 83.0,249
PCV,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,3 Months,81.1,79.4 to 82.7,474
PCV,≥1 Dose,States/Local Areas,Montana,2012,Age,3 Months,83.3,74.2 to 89.6,219
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Overall,Overall,88.3,85.8 to 90.8,910
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,85.0,79.8 to 90.2,242
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,88.0,84.9 to 91.1,608
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,89.2,86.1 to 92.4,443
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,91.6,87.1 to 96.1,225
PCV,≥1 Dose,States/Local Areas,Montana,2011,Age,3 Months,86.8,83.5 to 89.6,250
PCV,≥4 Doses,States/Local Areas,Montana,2017,Age,35 Months,85.0,77.9 to 90.9,265
PCV,≥4 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,86.9,82.5 to 90.7,498
Hib,Full Series,States/Local Areas,Montana,2020,Age,24 Months,74.6,67.2 to 81.4,220
PCV,≥4 Doses,States/Local Areas,Montana,2019,Age,35 Months,84.6,76.8 to 90.8,187
PCV,≥4 Doses,States/Local Areas,Montana,2018,Age,35 Months,88.9,83.1 to 93.4,233
PCV,≥4 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,86.8,82.1 to 90.8,420
Hib,≥2 Doses,States/Local Areas,Montana,2016,Age,5 Months,77.2,69.6 to 83.3,257
Hib,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,5 Months,76.7,71.6 to 81.2,522
Hib,≥2 Doses,States/Local Areas,Montana,2015,Age,5 Months,75.1,67.4 to 81.5,256
Hib,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,5 Months,76.1,70.8 to 80.8,513
PCV,≥3 Doses,States/Local Areas,Montana,2011,Age,24 Months,93.2,88.4 to 96.5,250
PCV,≥3 Doses,States/Local Areas,Montana,2019,Age,19 Months,92.0,84.6 to 96.0,187
PCV,≥3 Doses,States/Local Areas,Montana,2018,Age,19 Months,91.6,86.2 to 95.0,233
PCV,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,90.4,86.2 to 93.4,420
Hib,≥2 Doses,States/Local Areas,Montana,2011,Age,5 Months,79.7,78.0 to 81.4,250
Hib,≥2 Doses,States/Local Areas,Montana,2012,Age,5 Months,79.7,75.3 to 83.6,219
PCV,≥3 Doses,States/Local Areas,Montana,2017,Age,19 Months,88.1,82.4 to 92.1,265
PCV,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,89.8,86.1 to 92.6,498
Hib,≥2 Doses,States/Local Areas,Montana,2014,Age,5 Months,70.8,62.7 to 77.7,225
Hib,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,5 Months,72.9,69.5 to 76.2,481
Hib,≥2 Doses,States/Local Areas,Montana,2013,Age,5 Months,68.1,64.1 to 71.9,249
Hib,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,5 Months,69.4,66.6 to 72.1,474
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,87.7,84.2 to 91.1,443
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.3,80.5 to 98.2,51
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,85.1,81.7 to 88.6,608
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Overall,Overall,85.3,82.4 to 88.1,910
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,80.4,74.6 to 86.3,242
≥1 Dose MMR,,States/Local Areas,Montana,2017,Age,35 Months,93.8,89.4 to 96.8,265
≥1 Dose MMR,,States/Local Areas,Montana,2017-2018,Age,35 Months,95.0,92.2 to 97.1,498
≥1 Dose MMR,,States/Local Areas,Montana,2018,Age,35 Months,96.0,91.6 to 98.4,233
≥1 Dose MMR,,States/Local Areas,Montana,2018-2019,Age,35 Months,94.1,90.4 to 96.7,420
PCV,≥4 Doses,States/Local Areas,Montana,2013,Age,35 Months,73.5,65.7 to 80.9,249
PCV,≥4 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,77.4,72.2 to 82.3,474
≥1 Dose MMR,,States/Local Areas,Montana,2019,Age,35 Months,91.0,84.3 to 95.6,187
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,82.3 to 95.4,96
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,78.9,65.6 to 92.2,59
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.3,82.2 to 88.4,754
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,84.7,79.2 to 90.3,251
PCV,≥3 Doses,States/Local Areas,Montana,2016,Age,19 Months,86.5,79.7 to 91.3,257
PCV,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,87.3,83.0 to 90.6,522
PCV,≥3 Doses,States/Local Areas,Montana,2015,Age,19 Months,88.9,82.6 to 93.2,256
PCV,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,87.7,83.1 to 91.2,513
Hep B,≥2 Doses,States/Local Areas,Montana,2019,Age,13 Months,94.3,88.8 to 97.2,187
Hep B,≥2 Doses,States/Local Areas,Montana,2018,Age,13 Months,95.0,91.2 to 97.2,233
Hep B,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,94.7,91.6 to 96.6,420
Hep B,≥2 Doses,States/Local Areas,Montana,2017,Age,13 Months,89.8,84.3 to 93.5,265
Hep B,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,92.4,89.2 to 94.7,498
Hib,≥1 Dose,States/Local Areas,Montana,2017,Age,3 Months,85.2,79.0 to 89.8,265
Hib,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,3 Months,86.4,82.0 to 89.9,498
Hib,≥1 Dose,States/Local Areas,Montana,2016,Age,3 Months,84.3,77.3 to 89.4,257
Hib,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,3 Months,84.7,80.2 to 88.3,522
Hib,≥1 Dose,States/Local Areas,Montana,2015,Age,3 Months,83.6,76.3 to 89.0,256
Hib,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,3 Months,83.9,78.9 to 88.0,513
Hib,≥1 Dose,States/Local Areas,Montana,2019,Age,3 Months,89.2,81.7 to 93.9,187
Hib,≥1 Dose,States/Local Areas,Montana,2018,Age,3 Months,87.7,80.8 to 92.4,233
Hib,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,3 Months,88.5,83.7 to 92.0,420
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.8,85.0 to 90.7,754
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,88.4,83.6 to 93.3,251
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.0,79.8 to 98.1,51
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,88.5,83.0 to 93.9,225
Hep B,≥3 Doses,States/Local Areas,Montana,2019,Age,35 Months,92.5,86.0 to 96.6,187
Hep B,≥3 Doses,States/Local Areas,Montana,2018,Age,35 Months,94.1,90.4 to 96.7,233
Hep B,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,93.3,89.8 to 95.9,420
PCV,≥4 Doses,States/Local Areas,Montana,2014,Age,35 Months,81.3,74.7 to 87.1,225
PCV,≥4 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,81.7,77.0 to 86.0,481
PCV,≥4 Doses,States/Local Areas,Montana,2015,Age,35 Months,82.0,75.2 to 87.9,256
PCV,≥4 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,80.4,75.3 to 85.1,513
PCV,≥4 Doses,States/Local Areas,Montana,2016,Age,35 Months,78.9,71.4 to 85.4,257
PCV,≥4 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,81.9,76.8 to 86.6,522
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,88.3,84.5 to 92.1,375
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,91.9,89.2 to 94.6,453
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,90.6,82.2 to 99.0,54
≥1 Dose MMR,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,82.9 to 97.0,96
Hib,≥1 Dose,States/Local Areas,Montana,2011,Age,3 Months,86.9,83.6 to 89.7,250
Hib,≥1 Dose,States/Local Areas,Montana,2012,Age,3 Months,86.2,80.7 to 90.3,219
Hib,≥1 Dose,States/Local Areas,Montana,2013,Age,3 Months,80.6,77.4 to 83.5,249
Hib,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,3 Months,81.6,79.8 to 83.3,474
Hep B,≥2 Doses,States/Local Areas,Montana,2016,Age,13 Months,93.3,88.3 to 96.3,257
Hep B,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,91.5,88.0 to 94.1,522
Hep B,≥2 Doses,States/Local Areas,Montana,2015,Age,13 Months,90.7,83.6 to 94.9,256
Hep B,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,92.0,87.9 to 94.8,513
Hep B,≥2 Doses,States/Local Areas,Montana,2014,Age,13 Months,93.5,89.1 to 96.2,225
Hep B,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,92.1,88.0 to 94.8,481
Hib,≥1 Dose,States/Local Areas,Montana,2014,Age,3 Months,82.6,75.4 to 88.0,225
Hib,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,3 Months,83.1,78.1 to 87.1,481
Hep B,≥3 Doses,States/Local Areas,Montana,2017,Age,35 Months,92.1,87.5 to 95.5,265
Hep B,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,93.0,90.2 to 95.3,498
PCV,≥3 Doses,States/Local Areas,Montana,2012,Age,19 Months,88.5,80.9 to 93.3,219
PCV,≥4 Doses,States/Local Areas,Montana,2012,Age,35 Months,83.1,75.5 to 89.5,219
PCV,≥4 Doses,States/Local Areas,Montana,2011,Age,35 Months,83.2,76.8 to 88.7,250
PCV,≥4 Doses,States/Local Areas,Montana,2018,Age,24 Months,84.7,78.4 to 89.9,233
PCV,≥4 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,83.5,78.6 to 87.9,420
PCV,≥4 Doses,States/Local Areas,Montana,2019,Age,24 Months,82.5,74.7 to 89.0,187
Hep B,≥3 Doses,States/Local Areas,Montana,2016,Age,35 Months,96.1,90.1 to 99.0,257
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,94.5,90.7 to 97.1,522
PCV,≥3 Doses,States/Local Areas,Montana,2014,Age,19 Months,90.2,84.5 to 94.0,225
PCV,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,89.6,85.3 to 92.7,481
PCV,≥3 Doses,States/Local Areas,Montana,2013,Age,19 Months,80.7,78.0 to 83.2,249
PCV,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,85.6,83.3 to 87.6,474
PCV,≥3 Doses,States/Local Areas,Montana,2011,Age,19 Months,92.3,88.3 to 95.1,250
PCV,≥3 Doses,States/Local Areas,Montana,2019,Age,13 Months,90.7,83.3 to 95.0,187
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,72.6,58.6 to 86.6,59
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,90.0,86.8 to 93.2,453
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,84.7,80.4 to 89.0,375
≥1 Dose Varicella,,States/Local Areas,Montana,2019,Age,35 Months,92.6,86.1 to 96.7,187
≥1 Dose MMR,,States/Local Areas,Montana,2016,Age,35 Months,94.2,85.4 to 98.5,257
≥1 Dose MMR,,States/Local Areas,Montana,2016-2017,Age,35 Months,94.2,89.8 to 97.2,522
PCV,≥4 Doses,States/Local Areas,Montana,2015,Age,24 Months,80.7,73.8 to 86.7,256
PCV,≥4 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,78.5,73.4 to 83.2,513
PCV,≥4 Doses,States/Local Areas,Montana,2016,Age,24 Months,76.3,69.1 to 82.9,257
PCV,≥4 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,77.2,72.3 to 81.8,522
PCV,≥4 Doses,States/Local Areas,Montana,2017,Age,24 Months,78.3,71.6 to 84.4,265
PCV,≥4 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,81.5,76.9 to 85.7,498
≥1 Dose MMR,,States/Local Areas,Montana,2015,Age,35 Months,91.3,84.9 to 95.7,256
≥1 Dose MMR,,States/Local Areas,Montana,2015-2016,Age,35 Months,93.3,87.5 to 97.0,513
≥1 Dose MMR,,States/Local Areas,Montana,2014,Age,35 Months,89.8,84.6 to 93.9,225
≥1 Dose MMR,,States/Local Areas,Montana,2014-2015,Age,35 Months,90.4,86.3 to 93.7,481
PCV,≥3 Doses,States/Local Areas,Montana,2016,Age,13 Months,83.5,76.3 to 88.9,257
PCV,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,84.3,79.7 to 88.1,522
Hep B,≥3 Doses,States/Local Areas,Montana,2013,Age,35 Months,89.9,83.2 to 94.8,249
Hep B,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,89.8,85.4 to 93.3,474
Hep B,≥3 Doses,States/Local Areas,Montana,2014,Age,35 Months,89.6,84.5 to 93.6,225
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,91.2,87.1 to 94.5,481
Hep B,≥3 Doses,States/Local Areas,Montana,2015,Age,35 Months,92.8,85.9 to 97.1,256
Hep B,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,94.9,90.1 to 97.9,513
Hep B,≥3 Doses,States/Local Areas,Montana,2012,Age,35 Months,93.0,87.7 to 96.6,219
PCV,≥3 Doses,States/Local Areas,Montana,2018,Age,13 Months,90.2,84.7 to 93.8,233
PCV,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,90.4,86.2 to 93.4,420
PCV,≥3 Doses,States/Local Areas,Montana,2017,Age,13 Months,85.1,78.8 to 89.8,265
PCV,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,87.6,83.6 to 90.8,498
Hep B,≥2 Doses,States/Local Areas,Montana,2012,Age,13 Months,92.9,90.0 to 95.0,219
Hep B,≥2 Doses,States/Local Areas,Montana,2013,Age,13 Months,89.6,86.1 to 92.3,249
Hep B,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,91.5,90.0 to 92.9,474
Hep B,≥2 Doses,States/Local Areas,Montana,2011,Age,13 Months,92.0,90.0 to 93.7,250
Hep B,≥2 Doses,States/Local Areas,Montana,2019,Age,7 Months,92.4,85.1 to 96.3,187
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2015,Age,0-2 Days,80.8,74.8 to 85.6,256
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2015-2016,Age,0-2 Days,76.8,72.2 to 80.8,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2014,Age,0-2 Days,63.5,55.6 to 70.8,225
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2014-2015,Age,0-2 Days,72.2,67.1 to 76.8,481
≥1 Dose Varicella,,States/Local Areas,Montana,2013,Age,35 Months,88.1,81.5 to 93.2,249
≥1 Dose Varicella,,States/Local Areas,Montana,2013-2014,Age,35 Months,90.1,85.7 to 93.6,474
≥1 Dose MMR,,States/Local Areas,Montana,2018,Age,24 Months,92.1,87.0 to 95.7,233
≥1 Dose MMR,,States/Local Areas,Montana,2018-2019,Age,24 Months,91.4,87.4 to 94.6,420
PCV,≥4 Doses,States/Local Areas,Montana,2019,Age,19 Months,81.8,73.4 to 88.0,187
≥1 Dose Varicella,,States/Local Areas,Montana,2014,Age,35 Months,92.3,85.1 to 96.8,225
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2015,Age,35 Months,89.9,85.2 to 93.6,481
≥1 Dose Varicella,,States/Local Areas,Montana,2015,Age,35 Months,87.3,80.5 to 92.6,256
≥1 Dose Varicella,,States/Local Areas,Montana,2015-2016,Age,35 Months,89.6,84.2 to 93.7,513
PCV,≥4 Doses,States/Local Areas,Montana,2011,Age,24 Months,81.4,75.0 to 87.1,250
Hep B,≥3 Doses,States/Local Areas,Montana,2018,Age,24 Months,94.1,90.4 to 96.7,233
Hep B,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,93.3,89.8 to 95.9,420
PCV,≥3 Doses,States/Local Areas,Montana,2015,Age,13 Months,84.6,77.0 to 90.0,256
PCV,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,84.1,78.9 to 88.2,513
PCV,≥3 Doses,States/Local Areas,Montana,2014,Age,13 Months,86.5,79.9 to 91.1,225
PCV,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,13 Months,85.5,80.7 to 89.3,481
Hep B,≥2 Doses,States/Local Areas,Montana,2017,Age,7 Months,89.4,84.0 to 93.2,265
Hep B,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,92.1,89.0 to 94.5,498
PCV,≥3 Doses,States/Local Areas,Montana,2013,Age,13 Months,77.3,74.6 to 79.9,249
PCV,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,13 Months,82.0,78.8 to 84.7,474
Hep B,≥2 Doses,States/Local Areas,Montana,2016,Age,7 Months,89.1,82.9 to 93.2,257
Hep B,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,89.3,85.3 to 92.2,522
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2016,Age,0-2 Days,72.7,65.7 to 78.8,257
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2016-2017,Age,0-2 Days,71.7,66.8 to 76.2,522
Hep B,≥2 Doses,States/Local Areas,Montana,2018,Age,7 Months,94.9,91.0 to 97.1,233
Hep B,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,93.6,89.9 to 96.1,420
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2019,Age,0-2 Days,71.8,63.0 to 79.2,187
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2018,Age,0-2 Days,74.3,66.6 to 80.8,233
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2018-2019,Age,0-2 Days,73.1,67.4 to 78.1,420
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2017,Age,0-2 Days,70.7,63.5 to 77.0,265
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2017-2018,Age,0-2 Days,72.5,67.4 to 77.1,498
PCV,≥4 Doses,States/Local Areas,Montana,2012,Age,24 Months,78.8,70.9 to 85.7,219
Hep B,≥3 Doses,States/Local Areas,Montana,2011,Age,35 Months,91.4,85.9 to 95.3,250
Hep B,≥3 Doses,States/Local Areas,Montana,2017,Age,24 Months,91.0,86.2 to 94.7,265
Hep B,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,92.5,89.5 to 94.9,498
Hep B,≥3 Doses,States/Local Areas,Montana,2019,Age,24 Months,92.5,86.0 to 96.6,187
PCV,≥4 Doses,States/Local Areas,Montana,2013,Age,24 Months,70.0,62.6 to 77.1,249
PCV,≥4 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,74.6,69.5 to 79.4,474
PCV,≥4 Doses,States/Local Areas,Montana,2014,Age,24 Months,79.0,72.4 to 85.0,225
PCV,≥4 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,79.9,75.1 to 84.2,481
≥1 Dose MMR,,States/Local Areas,Montana,2019,Age,24 Months,90.5,83.6 to 95.3,187
≥1 Dose MMR,,States/Local Areas,Montana,2012,Age,35 Months,93.3,87.9 to 96.8,219
≥1 Dose MMR,,States/Local Areas,Montana,2011,Age,35 Months,92.0,86.7 to 95.8,250
≥1 Dose MMR,,States/Local Areas,Montana,2013,Age,35 Months,91.5,85.0 to 95.9,249
≥1 Dose MMR,,States/Local Areas,Montana,2013-2014,Age,35 Months,91.0,86.8 to 94.3,474
≥1 Dose Varicella,,States/Local Areas,Montana,2016,Age,35 Months,90.9,83.0 to 96.1,257
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2017,Age,35 Months,89.5,84.7 to 93.3,522
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2011,Age,0-2 Days,69.9,64.7 to 74.6,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2019,Age,0-1 Days,67.7,58.6 to 75.7,187
Hep B,≥2 Doses,States/Local Areas,Montana,2013,Age,7 Months,84.5,77.2 to 89.8,249
Hep B,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,86.0,82.7 to 88.7,474
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2012,Age,0-2 Days,70.4,68.7 to 72.1,219
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2013,Age,0-2 Days,72.0,58.9 to 82.2,249
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2013-2014,Age,0-2 Days,67.7,58.3 to 75.8,474
PCV,≥3 Doses,States/Local Areas,Montana,2011,Age,13 Months,88.8,83.6 to 92.5,250
PCV,≥3 Doses,States/Local Areas,Montana,2019,Age,7 Months,78.3,69.5 to 85.2,187
PCV,≥3 Doses,States/Local Areas,Montana,2018,Age,7 Months,70.4,62.3 to 77.5,233
PCV,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,7 Months,74.4,68.5 to 79.5,420
Hep B,≥2 Doses,States/Local Areas,Montana,2012,Age,7 Months,89.4,81.3 to 94.2,219
Hep B,≥2 Doses,States/Local Areas,Montana,2015,Age,7 Months,89.8,82.7 to 94.2,256
Hep B,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,89.4,85.1 to 92.6,513
Hep B,≥2 Doses,States/Local Areas,Montana,2014,Age,7 Months,87.4,81.3 to 91.7,225
Hep B,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,88.6,84.2 to 91.9,481
Hep B,≥3 Doses,States/Local Areas,Montana,2014,Age,24 Months,89.6,84.5 to 93.6,225
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,90.3,86.4 to 93.5,481
Hep B,≥3 Doses,States/Local Areas,Montana,2015,Age,24 Months,90.9,84.6 to 95.4,256
Hep B,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,90.8,86.8 to 93.9,513
Hep B,≥3 Doses,States/Local Areas,Montana,2016,Age,24 Months,90.6,85.2 to 94.6,257
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,90.8,87.3 to 93.6,522
PCV,≥3 Doses,States/Local Areas,Montana,2012,Age,13 Months,84.6,77.1 to 90.0,219
≥1 Dose MMR,,States/Local Areas,Montana,2016,Age,24 Months,85.4,79.3 to 90.4,257
≥1 Dose MMR,,States/Local Areas,Montana,2016-2017,Age,24 Months,87.2,83.1 to 90.6,522
≥1 Dose MMR,,States/Local Areas,Montana,2017,Age,24 Months,89.0,83.6 to 93.3,265
≥1 Dose MMR,,States/Local Areas,Montana,2017-2018,Age,24 Months,90.8,87.1 to 93.7,498
PCV,≥4 Doses,States/Local Areas,Montana,2018,Age,19 Months,77.2,69.4 to 83.6,233
PCV,≥4 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,79.6,73.5 to 84.7,367
PCV,≥4 Doses,States/Local Areas,Montana,2017,Age,19 Months,73.4,66.1 to 79.5,265
PCV,≥4 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,75.3,70.1 to 79.9,498
≥1 Dose Varicella,,States/Local Areas,Montana,2012,Age,35 Months,89.8,83.8 to 94.4,219
≥1 Dose Varicella,,States/Local Areas,Montana,2011,Age,35 Months,92.0,87.3 to 95.5,250
≥1 Dose Varicella,,States/Local Areas,Montana,2019,Age,24 Months,88.2,80.9 to 93.7,187
≥1 Dose MMR,,States/Local Areas,Montana,2013,Age,24 Months,84.4,78.1 to 89.8,249
≥1 Dose MMR,,States/Local Areas,Montana,2013-2014,Age,24 Months,86.4,82.3 to 89.9,474
≥1 Dose MMR,,States/Local Areas,Montana,2014,Age,24 Months,88.2,82.8 to 92.5,225
≥1 Dose MMR,,States/Local Areas,Montana,2014-2015,Age,24 Months,86.9,82.6 to 90.5,481
≥1 Dose MMR,,States/Local Areas,Montana,2015,Age,24 Months,85.4,78.8 to 90.8,256
≥1 Dose MMR,,States/Local Areas,Montana,2015-2016,Age,24 Months,85.4,80.8 to 89.3,513
≥1 Dose Varicella,,States/Local Areas,Montana,2018,Age,24 Months,91.1,85.5 to 95.2,233
≥1 Dose Varicella,,States/Local Areas,Montana,2018-2019,Age,24 Months,89.8,85.3 to 93.4,420
Hep B,≥3 Doses,States/Local Areas,Montana,2011,Age,24 Months,90.5,85.2 to 94.5,250
Hep B,≥3 Doses,States/Local Areas,Montana,2019,Age,19 Months,91.5,84.2 to 95.6,187
Hep B,≥3 Doses,States/Local Areas,Montana,2013,Age,24 Months,86.3,80.3 to 91.3,249
Hep B,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,24 Months,88.0,84.0 to 91.4,474
Hep B,≥3 Doses,States/Local Areas,Montana,2012,Age,24 Months,91.3,85.9 to 95.3,219
PCV,≥3 Doses,States/Local Areas,Montana,2016,Age,7 Months,68.2,60.5 to 75.0,257
PCV,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,7 Months,68.6,63.3 to 73.4,522
PCV,≥4 Doses,States/Local Areas,Montana,2016,Age,19 Months,74.2,66.6 to 80.6,257
PCV,≥4 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,73.8,68.6 to 78.4,522
PCV,≥4 Doses,States/Local Areas,Montana,2015,Age,19 Months,76.0,65.6 to 84.1,256
PCV,≥4 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,75.2,69.8 to 79.8,513
PCV,≥4 Doses,States/Local Areas,Montana,2014,Age,19 Months,73.0,65.4 to 79.4,225
PCV,≥4 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,74.5,69.3 to 79.2,481
PCV,≥3 Doses,States/Local Areas,Montana,2015,Age,7 Months,65.9,57.9 to 73.1,256
PCV,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,7 Months,67.0,61.5 to 72.1,513
PCV,≥3 Doses,States/Local Areas,Montana,2017,Age,7 Months,69.0,61.6 to 75.5,265
PCV,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,7 Months,69.7,64.3 to 74.6,498
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,71.4,56.4 to 86.3,59
≥1 Dose MMR,,States/Local Areas,Montana,2011,Age,19 Months,88.5,86.4 to 90.4,250
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,79.7,74.8 to 84.6,453
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,75.8,70.5 to 81.0,375
DTaP,≥4 Doses,States/Local Areas,Montana,2019,Age,35 Months,82.9,74.1 to 90.0,187
Polio,≥2 Doses,States/Local Areas,Montana,2017,Age,13 Months,89.4,83.9 to 93.2,265
Polio,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,13 Months,93.1,90.0 to 95.3,498
Polio,≥2 Doses,States/Local Areas,Montana,2016,Age,13 Months,90.7,84.7 to 94.5,257
Polio,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,13 Months,90.1,86.2 to 93.0,522
Polio,≥2 Doses,States/Local Areas,Montana,2015,Age,13 Months,90.7,83.6 to 94.9,256
Polio,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,13 Months,90.7,86.4 to 93.8,513
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,83.1,70.6 to 95.6,54
≥1 Dose Varicella,,States/Local Areas,Montana,2018,Age,19 Months,85.0,77.5 to 90.3,233
≥1 Dose Varicella,,States/Local Areas,Montana,2018-2019,Age,19 Months,52.6,46.5 to 58.6,420
≥1 Dose Varicella,,States/Local Areas,Montana,2017,Age,19 Months,80.1,73.6 to 85.3,265
≥1 Dose Varicella,,States/Local Areas,Montana,2017-2018,Age,19 Months,82.5,77.8 to 86.4,498
≥1 Dose MMR,,States/Local Areas,Montana,2012,Age,19 Months,85.7,80.3 to 89.8,219
≥1 Dose MMR,,States/Local Areas,Montana,2014,Age,19 Months,85.0,79.0 to 89.6,225
≥1 Dose MMR,,States/Local Areas,Montana,2014-2015,Age,19 Months,83.3,78.6 to 87.1,481
≥1 Dose MMR,,States/Local Areas,Montana,2013,Age,19 Months,81.8,73.5 to 87.9,249
≥1 Dose MMR,,States/Local Areas,Montana,2013-2014,Age,19 Months,83.4,80.7 to 85.8,474
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.8,69.2 to 92.5,51
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,76.0,69.3 to 82.7,251
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,75.9,72.3 to 79.4,910
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,75.3,70.9 to 79.7,608
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.4,67.0 to 87.9,96
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.1,71.1 to 79.1,754
≥1 Dose Varicella,,States/Local Areas,Montana,2012,Age,24 Months,83.5,76.9 to 89.2,219
≥1 Dose Varicella,,States/Local Areas,Montana,2011,Age,24 Months,90.5,85.6 to 94.3,250
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,70.0,63.2 to 76.8,242
≥1 Dose MMR,,States/Local Areas,Montana,2017,Age,19 Months,82.8,76.2 to 87.8,265
≥1 Dose MMR,,States/Local Areas,Montana,2017-2018,Age,19 Months,84.2,79.5 to 88.1,498
≥1 Dose MMR,,States/Local Areas,Montana,2016,Age,19 Months,81.2,74.1 to 86.7,257
≥1 Dose MMR,,States/Local Areas,Montana,2016-2017,Age,19 Months,82.0,77.3 to 85.9,522
≥1 Dose MMR,,States/Local Areas,Montana,2015,Age,19 Months,81.5,71.6 to 88.6,256
≥1 Dose MMR,,States/Local Areas,Montana,2015-2016,Age,19 Months,81.4,76.3 to 85.6,513
Hep B,≥3 Doses,States/Local Areas,Montana,2015,Age,19 Months,90.9,83.3 to 95.3,256
Hep B,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,90.5,86.2 to 93.5,513
Hep B,≥3 Doses,States/Local Areas,Montana,2014,Age,19 Months,88.4,82.8 to 92.4,225
Hep B,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,89.7,85.4 to 92.8,481
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,69.0,59.3 to 78.7,225
Hep B,≥3 Doses,States/Local Areas,Montana,2013,Age,19 Months,84.4,78.5 to 88.9,249
Hep B,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,86.4,83.3 to 89.1,474
Hep B,≥2 Doses,States/Local Areas,Montana,2013,Age,5 Months,81.9,77.2 to 85.8,249
Hep B,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,5 Months,81.2,77.3 to 84.6,474
Hep B,≥2 Doses,States/Local Areas,Montana,2011,Age,5 Months,87.7,84.6 to 90.3,250
Hep B,≥2 Doses,States/Local Areas,Montana,2012,Age,5 Months,87.3,81.1 to 91.7,219
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2011,Age,0-1 Days,67.2,62.0 to 72.1,250
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,65.1,58.2 to 72.0,443
Hep B,≥1 Dose,States/Local Areas,Montana,2019,Age,3 Months,96.7,93.2 to 98.4,187
Hep B,≥1 Dose,States/Local Areas,Montana,2018,Age,3 Months,94.4,90.4 to 96.8,233
Hep B,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,3 Months,95.5,93.1 to 97.1,420
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2015,Age,0-1 Days,76.3,69.7 to 81.9,256
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2015-2016,Age,0-1 Days,71.9,67.0 to 76.4,513
Hep B,≥2 Doses,States/Local Areas,Montana,2015,Age,5 Months,87.8,80.7 to 92.6,256
Hep B,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,5 Months,86.5,81.9 to 90.1,513
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2014,Age,0-1 Days,60.3,52.3 to 67.8,225
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2014-2015,Age,0-1 Days,68.3,63.1 to 73.2,481
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2013,Age,0-1 Days,68.4,53.2 to 80.5,249
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2013-2014,Age,0-1 Days,64.3,53.9 to 73.5,474
≥1 Dose Varicella,,States/Local Areas,Montana,2013,Age,24 Months,82.4,75.9 to 88.0,249
≥1 Dose Varicella,,States/Local Areas,Montana,2013-2014,Age,24 Months,84.7,80.6 to 88.4,474
≥1 Dose Varicella,,States/Local Areas,Montana,2014,Age,24 Months,86.9,81.4 to 91.5,225
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2015,Age,24 Months,85.0,80.6 to 88.9,481
≥1 Dose Varicella,,States/Local Areas,Montana,2019,Age,19 Months,85.9,77.8 to 91.4,187
Polio,≥2 Doses,States/Local Areas,Montana,2019,Age,13 Months,92.7,85.3 to 96.5,187
Polio,≥2 Doses,States/Local Areas,Montana,2018,Age,13 Months,96.9,93.6 to 98.5,233
Polio,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,13 Months,94.8,91.1 to 97.0,420
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2012,Age,0-1 Days,67.6,65.9 to 69.3,219
Hep B,≥2 Doses,States/Local Areas,Montana,2014,Age,5 Months,80.5,73.2 to 86.2,225
Hep B,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,5 Months,84.2,79.0 to 88.3,481
Hep B,≥2 Doses,States/Local Areas,Montana,2016,Age,5 Months,85.1,78.4 to 90.0,257
Hep B,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,5 Months,86.6,82.3 to 90.0,522
Hep B,≥3 Doses,States/Local Areas,Montana,2018,Age,19 Months,93.8,89.7 to 96.3,233
Hep B,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,91.5,87.6 to 94.2,420
Hep B,≥3 Doses,States/Local Areas,Montana,2017,Age,19 Months,89.0,83.3 to 92.9,265
Hep B,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,91.4,88.0 to 93.9,498
PCV,≥3 Doses,States/Local Areas,Montana,2012,Age,7 Months,70.5,62.5 to 77.4,219
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,80.4,75.8 to 85.1,443
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,76.4,68.7 to 84.1,225
PCV,≥3 Doses,States/Local Areas,Montana,2014,Age,7 Months,62.5,54.3 to 70.0,225
PCV,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,7 Months,64.2,58.5 to 69.5,481
Hep B,≥3 Doses,States/Local Areas,Montana,2016,Age,19 Months,90.0,84.1 to 93.8,257
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,89.5,85.6 to 92.4,522
PCV,≥3 Doses,States/Local Areas,Montana,2011,Age,7 Months,67.3,61.7 to 72.4,250
PCV,≥3 Doses,States/Local Areas,Montana,2013,Age,7 Months,60.4,54.7 to 65.8,249
PCV,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,7 Months,61.4,54.8 to 67.7,474
≥1 Dose MMR,,States/Local Areas,Montana,2017,Age,13 Months,44.9,37.7 to 52.3,265
≥1 Dose MMR,,States/Local Areas,Montana,2017-2018,Age,13 Months,54.9,49.4 to 60.3,498
≥1 Dose MMR,,States/Local Areas,Montana,2019,Age,13 Months,71.2,62.3 to 78.8,187
≥1 Dose MMR,,States/Local Areas,Montana,2018,Age,13 Months,65.1,56.8 to 72.6,233
≥1 Dose MMR,,States/Local Areas,Montana,2018-2019,Age,13 Months,68.2,62.1 to 73.7,420
Polio,≥2 Doses,States/Local Areas,Montana,2011,Age,13 Months,93.7,91.6 to 95.2,250
Polio,≥2 Doses,States/Local Areas,Montana,2012,Age,13 Months,92.7,88.7 to 95.3,219
≥1 Dose Varicella,,States/Local Areas,Montana,2016,Age,19 Months,76.6,69.0 to 82.8,257
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2017,Age,19 Months,78.3,73.4 to 82.6,522
≥1 Dose Varicella,,States/Local Areas,Montana,2015,Age,19 Months,80.2,69.6 to 87.8,256
≥1 Dose Varicella,,States/Local Areas,Montana,2015-2016,Age,19 Months,78.4,73.3 to 82.8,513
≥1 Dose Varicella,,States/Local Areas,Montana,2014,Age,19 Months,81.8,75.4 to 86.8,225
≥1 Dose Varicella,,States/Local Areas,Montana,2014-2015,Age,19 Months,81.0,76.2 to 85.1,481
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.2,61.7 to 94.8,51
Hep A,≥1 Dose,States/Local Areas,Missouri,2013,Age,19 Months,68.7,65.5 to 71.8,208
Hep A,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,19 Months,70.3,68.8 to 71.6,449
DTaP,≥1 Dose,States/Local Areas,Missouri,2017,Age,3 Months,85.1,79.4 to 89.4,384
DTaP,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,3 Months,87.0,83.1 to 90.1,800
DTaP,≥3 Doses,States/Local Areas,Missouri,2014,Age,24 Months,95.5,92.0 to 97.7,241
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,92.6,89.1 to 95.3,476
DTaP,≥3 Doses,States/Local Areas,Missouri,2015,Age,24 Months,89.5,83.2 to 94.1,235
DTaP,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,89.2,84.9 to 92.7,473
DTaP,≥1 Dose,States/Local Areas,Missouri,2018,Age,3 Months,88.9,83.1 to 92.8,416
DTaP,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,3 Months,89.1,85.3 to 91.9,818
DTaP,≥3 Doses,States/Local Areas,Missouri,2016,Age,24 Months,88.8,83.0 to 93.3,238
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,89.4,85.7 to 92.5,622
DTaP,≥1 Dose,States/Local Areas,Missouri,2019,Age,3 Months,89.2,84.0 to 92.9,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2011,Age,19 Months,68.5,65.1 to 71.7,228
Hep A,≥1 Dose,States/Local Areas,Missouri,2012,Age,19 Months,77.2,72.5 to 81.3,274
Hib,≥3 Doses,States/Local Areas,Missouri,2015,Age,24 Months,84.5,77.6 to 90.2,235
Hib,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,84.5,79.7 to 88.7,473
Hib,≥3 Doses,States/Local Areas,Missouri,2016,Age,24 Months,84.4,77.7 to 89.9,238
Hib,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,85.2,81.0 to 88.9,622
DTaP,≥3 Doses,States/Local Areas,Missouri,2019,Age,24 Months,87.0,81.4 to 91.5,402
Hib,≥3 Doses,States/Local Areas,Missouri,2017,Age,24 Months,85.9,80.5 to 90.5,384
Hib,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,88.8,85.4 to 91.8,800
Hib,≥2 Doses,States/Local Areas,Missouri,2021,Age,5 Months,81.5,74.4 to 87.0,267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.1,77.6 to 84.5,960
Hib,≥1 Dose,States/Local Areas,Missouri,2021,Age,3 Months,87.9,82.0 to 92.0,267
Hep A,≥1 Dose,States/Local Areas,Missouri,2014,Age,19 Months,71.8,64.3 to 78.2,241
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,19 Months,70.3,64.9 to 75.3,476
Hep A,≥1 Dose,States/Local Areas,Missouri,2015,Age,19 Months,68.9,64.9 to 72.6,235
Hep A,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,19 Months,70.5,64.6 to 75.8,473
Hib,≥3 Doses,States/Local Areas,Missouri,2021,Age,7 Months,50.9,43.0 to 58.7,267
PCV,≥3 Doses,States/Local Areas,Missouri,2021,Age,35 Months,92.3,87.5 to 95.7,267
Hib,≥3 Doses,States/Local Areas,Missouri,2021,Age,19 Months,87.5,81.2 to 92.0,267
Hib,Primary Series,States/Local Areas,Missouri,2021,Age,19 Months,92.9,88.2 to 95.8,267
Hib,Primary Series,States/Local Areas,Missouri,2020-2021,Age,24 Months,93.0,90.2 to 95.3,657
Hep B,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,91.1,87.9 to 93.5,657
DTaP,≥4 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,89.9,84.6 to 94.1,657
Hib,Full Series,States/Local Areas,Missouri,2021,Age,19 Months,72.4,64.6 to 79.1,267
PCV,≥4 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,81.8,77.1 to 86.1,657
Hep B,≥3 Doses,States/Local Areas,Missouri,2021,Age,19 Months,90.7,85.4 to 94.2,267
DTaP,≥1 Dose,States/Local Areas,Missouri,2012,Age,3 Months,91.0,86.5 to 94.1,274
DTaP,≥1 Dose,States/Local Areas,Missouri,2011,Age,3 Months,88.9,85.3 to 91.7,228
DTaP,≥1 Dose,States/Local Areas,Missouri,2013,Age,3 Months,82.3,78.6 to 85.4,208
DTaP,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,3 Months,84.0,78.5 to 88.4,449
DTaP,≥1 Dose,States/Local Areas,Missouri,2014,Age,3 Months,85.8,79.5 to 90.4,241
DTaP,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,3 Months,83.9,79.0 to 87.7,476
DTaP,≥1 Dose,States/Local Areas,Missouri,2015,Age,3 Months,81.9,74.3 to 87.7,235
DTaP,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,3 Months,84.4,79.5 to 88.3,473
DTaP,≥1 Dose,States/Local Areas,Missouri,2016,Age,3 Months,86.8,80.8 to 91.2,238
DTaP,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,3 Months,86.0,82.0 to 89.2,622
DTaP,≥3 Doses,States/Local Areas,Missouri,2017,Age,24 Months,90.0,85.1 to 93.8,384
DTaP,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,91.9,88.7 to 94.5,800
DTaP,≥3 Doses,States/Local Areas,Missouri,2018,Age,24 Months,93.9,89.3 to 97.0,416
DTaP,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,90.5,87.0 to 93.3,818
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,95.9,93.1 to 98.6,251
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,91.9,88.3 to 95.5,381
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,84.4,79.1 to 89.6,280
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,89.8,87.2 to 92.4,912
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,83.9,77.9 to 89.9,194
DTaP,≥2 Doses,States/Local Areas,Missouri,2018,Age,5 Months,82.1,75.6 to 87.2,416
DTaP,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,5 Months,79.9,75.3 to 83.8,818
DTaP,≥2 Doses,States/Local Areas,Missouri,2017,Age,5 Months,73.1,66.5 to 78.8,384
DTaP,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,5 Months,77.6,73.1 to 81.6,800
Combined 7 Series,,States/Local Areas,Missouri,2021,Age,35 Months,73.3,63.8 to 82.0,267
Hep A,≥2 Doses,States/Local Areas,Missouri,2021,Age,35 Months,89.5,70.3 to 98.5,267
Hib,Primary Series,States/Local Areas,Missouri,2021,Age,7 Months,82.6,75.8 to 87.8,267
Hib,≥3 Doses,States/Local Areas,Missouri,2012,Age,35 Months,91.5,85.5 to 95.7,274
Hib,≥3 Doses,States/Local Areas,Missouri,2011,Age,35 Months,90.3,83.6 to 95.1,228
Hep A,≥1 Dose,States/Local Areas,Missouri,2012,Age,35 Months,88.3,81.9 to 93.2,274
≥1 Dose MMR,,States/Local Areas,Missouri,2020-2021,Age,24 Months,91.7,88.6 to 94.3,657
PCV,≥2 Doses,States/Local Areas,Missouri,2021,Age,5 Months,80.8,73.6 to 86.4,267
DTaP,≥3 Doses,States/Local Areas,Missouri,2021,Age,7 Months,74.5,66.7 to 81.0,267
DTaP,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,92.1,88.9 to 94.5,657
Hep B,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,94.5,92.0 to 96.3,657
Polio,≥2 Doses,States/Local Areas,Missouri,2021,Age,7 Months,91.1,85.8 to 94.5,267
Hib,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,89.4,85.5 to 92.6,657
Polio,≥3 Doses,States/Local Areas,Missouri,2021,Age,35 Months,92.1,87.3 to 95.6,267
Hep B,≥2 Doses,States/Local Areas,Missouri,2021,Age,7 Months,92.7,88.1 to 95.6,267
≥1 Dose MMR,,States/Local Areas,Missouri,2021,Age,35 Months,92.8,87.8 to 96.3,267
Hib,≥2 Doses,States/Local Areas,Missouri,2021,Age,7 Months,92.3,87.6 to 95.3,267
Hep B,≥2 Doses,States/Local Areas,Missouri,2021,Age,5 Months,90.9,85.6 to 94.3,267
DTaP,≥4 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,79.7,74.9 to 84.1,657
Hep A,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,35 Months,89.3,85.0 to 92.8,657
PCV,≥3 Doses,States/Local Areas,Missouri,2021,Age,13 Months,89.4,83.7 to 93.3,267
≥1 Dose Varicella,,States/Local Areas,Missouri,2020-2021,Age,35 Months,94.0,90.5 to 96.6,657
PCV,≥3 Doses,States/Local Areas,Missouri,2021,Age,24 Months,92.3,87.5 to 95.7,267
≥1 Dose Varicella,,States/Local Areas,Missouri,2021,Age,24 Months,91.6,86.9 to 95.2,267
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2021,Age,0-1 Days,80.5,73.7 to 85.9,267
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2021,Age,0-2 Days,83.7,77.3 to 88.6,267
PCV,≥4 Doses,States/Local Areas,Missouri,2021,Age,24 Months,81.3,74.3 to 87.4,267
Hep A,≥1 Dose,States/Local Areas,Missouri,2021,Age,24 Months,87.9,82.1 to 92.5,267
DTaP,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,3 Months,90.2,86.7 to 92.8,657
Hib,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,93.7,91.0 to 95.6,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,93.2,90.2 to 95.6,657
PCV,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,5 Months,79.8,75.0 to 83.8,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2021,Age,13 Months,90.1,84.4 to 93.8,267
PCV,≥3 Doses,States/Local Areas,Missouri,2021,Age,7 Months,71.9,64.1 to 78.6,267
Hep A,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,23.5,19.5 to 27.9,657
Hep A,≥2 Doses,States/Local Areas,Missouri,2021,Age,24 Months,47.8,39.2 to 57.2,267
Hep B,≥3 Doses,States/Local Areas,Missouri,2021,Age,7 Months,69.1,61.8 to 75.6,267
Hep B,≥3 Doses,States/Local Areas,Missouri,2021,Age,24 Months,90.7,85.8 to 94.4,267
PCV,≥4 Doses,States/Local Areas,Missouri,2021,Age,19 Months,76.4,68.6 to 82.8,267
Hep A,≥1 Dose,States/Local Areas,Missouri,2021,Age,19 Months,85.4,79.4 to 89.9,267
Hep A,≥2 Doses,States/Local Areas,Missouri,2021,Age,19 Months,23.7,17.9 to 30.8,267
DTaP,≥3 Doses,States/Local Areas,Missouri,2021,Age,19 Months,92.0,86.7 to 95.3,267
PCV,≥4 Doses,States/Local Areas,Missouri,2021,Age,35 Months,82.0,74.9 to 88.0,267
DTaP,≥4 Doses,States/Local Areas,Missouri,2021,Age,24 Months,80.0,72.5 to 86.6,267
DTaP,≥1 Dose,States/Local Areas,Missouri,2021,Age,3 Months,90.2,84.5 to 94.0,267
Polio,≥3 Doses,States/Local Areas,Missouri,2021,Age,24 Months,92.1,87.3 to 95.6,267
Polio,≥1 Dose,States/Local Areas,Missouri,2021,Age,3 Months,90.0,84.3 to 93.8,267
Hib,Primary Series,States/Local Areas,Missouri,2021,Age,24 Months,92.9,88.6 to 95.9,267
≥1 Dose MMR,,States/Local Areas,Missouri,2021,Age,24 Months,92.0,87.1 to 95.5,267
Hib,≥3 Doses,States/Local Areas,Missouri,2021,Age,24 Months,88.9,83.3 to 93.3,267
Hib,Primary Series,States/Local Areas,Missouri,2020-2021,Age,13 Months,89.6,86.4 to 92.1,657
Hib,Full Series,States/Local Areas,Missouri,2021,Age,24 Months,80.1,72.8 to 86.4,267
DTaP,≥4 Doses,States/Local Areas,Missouri,2021,Age,19 Months,69.8,61.7 to 76.8,267
≥1 Dose Varicella,,States/Local Areas,Missouri,2021,Age,19 Months,91.1,85.9 to 94.5,267
Hep B,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,94.5,91.0 to 97.0,657
PCV,≥3 Doses,States/Local Areas,Missouri,2021,Age,19 Months,92.3,87.1 to 95.5,267
Hep A,≥2 Doses,States/Local Areas,Missouri,2015,Age,19 Months,20.7,17.6 to 24.1,235
Hep A,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,20.6,16.5 to 25.5,473
Hep A,≥2 Doses,States/Local Areas,Missouri,2016,Age,19 Months,20.5,14.8 to 27.7,238
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,21.3,17.4 to 25.8,622
Hib,≥3 Doses,States/Local Areas,Missouri,2013,Age,35 Months,93.7,87.4 to 97.5,208
Hib,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,93.6,90.1 to 96.2,449
Hib,≥3 Doses,States/Local Areas,Missouri,2014,Age,35 Months,93.8,89.8 to 96.7,241
Hib,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,89.5,85.5 to 92.8,476
Hib,≥3 Doses,States/Local Areas,Missouri,2015,Age,35 Months,85.1,78.1 to 90.8,235
Hib,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,86.0,81.2 to 90.0,473
Hep A,≥2 Doses,States/Local Areas,Missouri,2017,Age,19 Months,22.0,17.1 to 27.8,384
Hep A,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,24.1,20.2 to 28.4,800
Hep A,≥1 Dose,States/Local Areas,Missouri,2015,Age,24 Months,77.5,70.1 to 84.2,235
Hep A,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,24 Months,77.5,72.2 to 82.5,473
Hep A,≥1 Dose,States/Local Areas,Missouri,2016,Age,24 Months,77.5,69.9 to 84.3,238
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,24 Months,79.8,75.1 to 84.2,622
PCV,≥2 Doses,States/Local Areas,Missouri,2014,Age,5 Months,69.9,62.2 to 76.7,241
PCV,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,5 Months,68.3,64.4 to 72.0,476
PCV,≥2 Doses,States/Local Areas,Missouri,2015,Age,5 Months,66.7,58.2 to 74.1,235
PCV,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,5 Months,69.3,63.5 to 74.5,473
PCV,≥2 Doses,States/Local Areas,Missouri,2016,Age,5 Months,71.9,63.8 to 78.8,238
PCV,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,5 Months,71.6,66.5 to 76.3,622
DTaP,≥3 Doses,States/Local Areas,Missouri,2018,Age,35 Months,96.7,91.7 to 99.1,416
DTaP,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,93.3,88.9 to 96.4,818
DTaP,≥3 Doses,States/Local Areas,Missouri,2019,Age,35 Months,89.1,83.3 to 93.5,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2018,Age,24 Months,89.9,85.0 to 93.8,416
Hep A,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,24 Months,86.4,82.6 to 89.8,818
Hep A,≥1 Dose,States/Local Areas,Missouri,2019,Age,24 Months,82.8,76.8 to 88.0,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2011,Age,35 Months,85.5,77.1 to 91.9,228
PCV,≥2 Doses,States/Local Areas,Missouri,2017,Age,5 Months,71.3,64.7 to 77.1,384
PCV,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,5 Months,76.3,71.8 to 80.3,800
Hep A,≥1 Dose,States/Local Areas,Missouri,2021,Age,35 Months,91.0,84.8 to 95.4,267
Hep A,≥1 Dose,States/Local Areas,Missouri,2017,Age,24 Months,82.2,76.6 to 87.2,384
Hep A,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,24 Months,86.0,82.4 to 89.3,800
Hib,≥3 Doses,States/Local Areas,Missouri,2018,Age,35 Months,95.9,89.8 to 98.9,416
Hib,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,89.6,85.5 to 93.0,818
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,83.7,74.3 to 93.0,54
Hep A,≥2 Doses,States/Local Areas,Missouri,2012,Age,24 Months,37.5,28.6 to 48.0,274
DTaP,≥4 Doses,States/Local Areas,Missouri,2013,Age,19 Months,60.1,55.4 to 64.7,208
DTaP,≥4 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,63.0,60.4 to 65.6,449
DTaP,≥4 Doses,States/Local Areas,Missouri,2014,Age,19 Months,65.9,58.0 to 73.0,241
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,65.2,59.5 to 70.6,476
DTaP,≥4 Doses,States/Local Areas,Missouri,2015,Age,19 Months,64.6,60.6 to 68.4,235
DTaP,≥4 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,64.7,58.6 to 70.4,473
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,88.2,83.8 to 92.7,331
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,94.6,91.9 to 97.4,509
Hib,≥3 Doses,States/Local Areas,Missouri,2016,Age,35 Months,86.7,80.2 to 91.9,238
Hib,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,87.2,83.0 to 90.8,622
Hib,≥3 Doses,States/Local Areas,Missouri,2017,Age,35 Months,87.5,82.1 to 92.0,384
Hib,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,91.0,87.4 to 94.0,800
Hep A,≥2 Doses,States/Local Areas,Missouri,2018,Age,19 Months,26.1,20.5 to 32.6,416
Hep A,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,25.0,20.6 to 30.0,664
Hep A,≥2 Doses,States/Local Areas,Missouri,2019,Age,19 Months,23.6,18.5 to 29.7,402
Hep A,≥2 Doses,States/Local Areas,Missouri,2011,Age,24 Months,24.6,17.9 to 33.3,228
PCV,≥2 Doses,States/Local Areas,Missouri,2013,Age,5 Months,73.1,69.1 to 76.8,208
PCV,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,5 Months,71.5,68.0 to 74.8,449
PCV,≥2 Doses,States/Local Areas,Missouri,2012,Age,5 Months,73.4,65.2 to 80.2,274
PCV,≥2 Doses,States/Local Areas,Missouri,2011,Age,5 Months,71.5,68.3 to 74.5,228
DTaP,≥3 Doses,States/Local Areas,Missouri,2015,Age,35 Months,97.8,88.6 to 99.9,235
DTaP,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,92.3,87.9 to 95.6,473
DTaP,≥3 Doses,States/Local Areas,Missouri,2016,Age,35 Months,91.1,85.5 to 95.2,238
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,92.0,88.3 to 94.9,622
DTaP,≥4 Doses,States/Local Areas,Missouri,2012,Age,19 Months,64.9,59.4 to 70.1,274
DTaP,≥4 Doses,States/Local Areas,Missouri,2011,Age,19 Months,62.8,58.7 to 66.6,228
DTaP,≥3 Doses,States/Local Areas,Missouri,2017,Age,35 Months,93.0,87.9 to 96.5,384
DTaP,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,94.6,91.2 to 97.0,800
DTaP,≥3 Doses,States/Local Areas,Missouri,2013,Age,35 Months,92.8,86.4 to 96.9,208
DTaP,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,94.0,90.6 to 96.5,449
DTaP,≥3 Doses,States/Local Areas,Missouri,2012,Age,35 Months,95.1,90.1 to 98.0,274
DTaP,≥3 Doses,States/Local Areas,Missouri,2011,Age,35 Months,94.8,88.9 to 98.1,228
DTaP,≥3 Doses,States/Local Areas,Missouri,2014,Age,35 Months,95.5,92.0 to 97.7,241
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,95.9,90.9 to 98.6,476
Hep A,≥2 Doses,States/Local Areas,Missouri,2011,Age,19 Months,14.0,10.7 to 18.1,228
DTaP,≥2 Doses,States/Local Areas,Missouri,2019,Age,5 Months,77.6,70.9 to 83.1,402
Hep A,≥2 Doses,States/Local Areas,Missouri,2013,Age,19 Months,15.1,11.1 to 20.3,208
Hep A,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,18.7,16.1 to 21.5,449
Hep A,≥2 Doses,States/Local Areas,Missouri,2014,Age,19 Months,22.2,16.4 to 29.3,241
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,21.4,17.3 to 26.3,476
Hep A,≥2 Doses,States/Local Areas,Missouri,2012,Age,19 Months,15.0,8.7 to 24.6,274
Hib,≥3 Doses,States/Local Areas,Missouri,2018,Age,24 Months,91.7,87.0 to 95.2,416
Hib,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,87.4,83.7 to 90.6,818
Hib,≥3 Doses,States/Local Areas,Missouri,2019,Age,24 Months,83.0,77.2 to 88.1,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2019,Age,19 Months,78.6,72.1 to 84.0,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2011,Age,24 Months,74.1,65.7 to 81.8,228
Hep A,≥1 Dose,States/Local Areas,Missouri,2013,Age,24 Months,74.9,66.7 to 82.5,208
Hep A,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,24 Months,76.9,71.7 to 81.9,449
Hep A,≥1 Dose,States/Local Areas,Missouri,2014,Age,24 Months,79.0,72.3 to 85.0,241
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,24 Months,78.2,73.3 to 82.8,476
Hep A,≥1 Dose,States/Local Areas,Missouri,2012,Age,24 Months,80.9,74.6 to 86.5,274
Hep A,≥1 Dose,States/Local Areas,Missouri,2017,Age,19 Months,76.0,69.6 to 81.5,384
Hep A,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,19 Months,80.5,76.3 to 84.2,800
Hep A,≥1 Dose,States/Local Areas,Missouri,2018,Age,19 Months,85.0,79.3 to 89.3,416
Hep A,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,19 Months,81.2,76.1 to 85.4,664
Hep A,≥1 Dose,States/Local Areas,Missouri,2016,Age,19 Months,72.2,63.8 to 79.2,238
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,19 Months,74.1,68.8 to 78.7,622
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,90.8,88.6 to 92.7,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,90.6,88.1 to 92.7,589
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,79.5,72.5 to 85.1,327
Hib,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,91.4,89.3 to 93.1,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,93.2,90.8 to 95.0,315
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,94.0,88.9 to 96.8,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,92.1,88.5 to 94.6,607
Polio,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,89.9,84.1 to 93.7,314
Polio,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,92.0,88.6 to 94.5,664
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,73.4,67.1 to 78.8,350
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,76.4,71.9 to 80.5,677
Polio,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,94.3,90.0 to 96.8,350
Polio,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,70.5,65.4 to 75.2,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,90.1,84.6 to 93.7,327
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,91.4,89.3 to 93.1,261
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,94.3,90.4 to 96.6,315
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,90.4,88.6 to 92.0,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,90.7,88.1 to 92.7,589
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,93.8,89.5 to 96.4,350
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,91.9,88.6 to 94.3,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,91.1,85.2 to 94.8,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,90.3,86.5 to 93.2,607
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,77.1 to 95.4,132
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,89.5,84.0 to 93.3,314
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,91.6,88.3 to 94.0,664
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,72.2,64.1 to 79.1,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,71.8,66.5 to 76.6,607
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,71.3,64.3 to 77.5,314
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,72.3,67.7 to 76.5,664
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,89.8,83.5 to 93.9,296
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,89.3,84.9 to 92.5,596
Polio,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,88.8,85.4 to 91.5,300
Polio,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,91.6,87.7 to 94.4,593
Polio,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,88.6,86.7 to 90.3,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,89.2,86.6 to 91.3,589
Hib,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,96.9,93.7 to 98.5,350
Hib,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,95.6,93.2 to 97.2,677
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,91.4,89.0 to 93.9,1071
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,88.9,84.3 to 93.6,288
Hib,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,94.3,90.1 to 96.7,327
Hib,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,91.8,85.9 to 95.4,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,89.4,84.3 to 93.0,315
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,88.3,81.4 to 92.8,300
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,89.8,85.6 to 92.9,593
Hib,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,92.6,90.3 to 94.4,261
Hib,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,94.9,92.0 to 96.8,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,74.5,68.2 to 80.8,288
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,87.8,83.5 to 91.2,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,86.5,83.6 to 89.0,589
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,85.1,78.1 to 90.2,296
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,86.7,82.0 to 90.3,596
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,74.0,70.5 to 77.5,1071
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Overall,Overall,74.0,70.5 to 77.5,1071
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.6,47.6 to 71.5,132
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.0,67.8 to 78.1,468
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,89.3,82.3 to 96.4,137
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,94.6,92.2 to 97.0,646
Polio,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,90.7,88.7 to 92.3,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,82.6,79.4 to 85.5,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,78.3,76.4 to 80.2,589
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,73.8,66.4 to 80.0,296
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,74.0,68.8 to 78.6,596
Hib,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,85.2,82.7 to 87.4,315
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,74.2,66.5 to 80.7,300
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,73.1,67.6 to 78.0,593
Hib,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,81.7,77.1 to 85.5,261
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.3,93.9 to 98.7,468
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,89.0 to 93.9,1071
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,59.1,50.9 to 66.7,327
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,73.6,64.2 to 83.1,137
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,73.7,69.2 to 78.1,646
Polio,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,91.2,85.3 to 94.8,315
Hib,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,5 Months,83.5,77.2 to 88.3,350
Hib,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,5 Months,83.3,78.8 to 86.9,677
Hib,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,5 Months,83.0,76.3 to 88.2,327
Hib,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,88.6,86.2 to 90.6,261
PCV,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,3 Months,84.5,76.9 to 89.9,293
PCV,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,3 Months,84.8,80.0 to 88.6,607
PCV,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,3 Months,85.1,78.8 to 89.7,314
PCV,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,3 Months,87.5,83.6 to 90.5,664
PCV,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,3 Months,90.0,85.1 to 93.5,350
PCV,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,3 Months,90.3,86.8 to 92.9,677
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,86.6,82.1 to 91.1,353
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2011,Age,0-3 Days,76.9,69.2 to 83.1,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2012,Age,0-3 Days,73.3,66.4 to 79.3,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,94.3,91.9 to 96.7,702
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.9,84.5 to 93.3,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2013,Age,0-3 Days,74.8,68.0 to 80.6,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2013-2014,Age,0-3 Days,70.8,65.8 to 75.3,589
Hib,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,89.3,86.3 to 91.7,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,90.4,85.7 to 93.6,589
Hib,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,91.5,85.6 to 95.1,296
Hib,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,90.2,86.0 to 93.2,596
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,82.8,79.5 to 86.1,1071
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,75.5,69.2 to 81.9,288
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,78.4,69.1 to 87.8,137
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,91.3,88.4 to 94.1,646
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,90.4,87.8 to 93.0,1071
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,88.5,84.0 to 93.1,288
PCV,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,3 Months,90.5,85.0 to 94.1,327
Polio,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,3 Months,88.1,81.4 to 92.6,261
Polio,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,3 Months,90.6,88.6 to 92.2,315
Polio,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,3 Months,84.5,81.5 to 87.1,293
Polio,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,3 Months,88.2,83.6 to 91.7,589
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,70.2,67.2 to 73.1,261
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,70.6,64.8 to 75.8,315
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,69.7,60.9 to 77.3,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,67.8,61.4 to 73.6,589
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2015,Age,0-3 Days,68.8,61.1 to 75.6,300
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2015-2016,Age,0-3 Days,75.3,70.3 to 79.7,593
PCV,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,3 Months,88.9,85.0 to 91.9,315
PCV,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,94.6,90.3 to 97.3,315
Hib,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,92.0,87.8 to 94.8,315
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,92.8,87.8 to 96.3,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,92.6,89.3 to 95.2,607
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,92.3,87.8 to 95.7,314
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,93.5,90.8 to 95.7,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,94.8,91.5 to 97.1,350
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,92.4,89.4 to 94.8,677
PCV,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,3 Months,89.6,83.8 to 93.5,296
PCV,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,3 Months,87.9,83.5 to 91.2,596
PCV,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,3 Months,86.2,79.1 to 91.2,300
PCV,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,3 Months,85.3,80.3 to 89.2,593
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.3,73.9 to 92.6,132
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,90.5 to 96.3,468
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,82.8,79.5 to 86.1,1071
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,91.0,88.4 to 93.5,1071
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,87.4,82.3 to 92.6,288
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,90.5,84.1 to 96.9,137
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,94.5,92.1 to 96.9,646
PCV,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,3 Months,85.9,82.4 to 88.8,261
PCV,≥4 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,88.3,82.5 to 92.9,350
PCV,≥4 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,86.7,82.5 to 90.4,677
PCV,≥4 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,84.5,78.5 to 89.6,327
PCV,≥4 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,85.3,79.2 to 90.3,314
PCV,≥4 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,86.8,82.7 to 90.4,664
Hib,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,5 Months,77.7,69.4 to 84.2,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,5 Months,77.1,72.6 to 81.0,589
Hib,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,5 Months,76.5,68.7 to 82.8,296
Hib,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,5 Months,74.9,69.5 to 79.6,596
Hib,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,5 Months,77.5,72.8 to 81.5,261
Hib,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,5 Months,81.0,75.6 to 85.4,315
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,94.2,90.4 to 96.5,350
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,90.5,87.1 to 93.1,677
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,90.0,84.4 to 93.8,327
PCV,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,91.9,86.0 to 96.0,261
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,65.8,57.9 to 72.9,296
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,69.8,64.4 to 74.8,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,84.1,75.8 to 92.4,137
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,94.5,92.1 to 96.9,646
Hib,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,63.2,61.1 to 65.2,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,64.0,57.4 to 70.2,315
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,60.3,50.9 to 69.0,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,58.4,53.3 to 63.3,589
Polio,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,3 Months,92.2,86.6 to 95.5,296
Polio,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,3 Months,90.2,86.0 to 93.3,596
Polio,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,3 Months,88.3,81.3 to 93.0,300
Polio,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,3 Months,86.5,81.5 to 90.3,593
Polio,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,3 Months,84.9,77.3 to 90.3,293
Polio,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,3 Months,84.5,79.7 to 88.4,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016,Age,0-3 Days,80.8,74.1 to 86.0,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2017,Age,0-3 Days,79.7,75.1 to 83.6,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2017,Age,0-3 Days,76.6,64.0 to 85.8,178
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2017-2018,Age,0-3 Days,81.2,77.0 to 84.8,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,91.8,85.3 to 96.1,300
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,92.3,88.4 to 95.3,593
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,93.0,87.9 to 96.5,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,92.7,89.4 to 95.3,607
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,94.6,88.9 to 97.9,296
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,93.0,88.7 to 96.1,596
Hib,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,93.6,89.6 to 96.2,350
Hib,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,92.4,89.4 to 94.6,677
Hib,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,92.5,89.5 to 94.7,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,93.2,89.2 to 95.8,589
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,92.3,87.8 to 95.7,314
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,94.0,91.2 to 96.1,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,95.9,92.3 to 98.1,350
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,94.1,91.1 to 96.3,677
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,56.3,48.7 to 63.7,296
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,56.5,51.0 to 61.8,596
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,56.6,48.6 to 64.3,300
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,56.7,51.0 to 62.2,593
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,56.7,48.6 to 64.5,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,57.7,52.2 to 63.0,607
Polio,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,3 Months,84.0,77.6 to 88.9,314
Polio,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,3 Months,87.0,83.1 to 90.2,664
Polio,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,3 Months,90.2,85.3 to 93.6,350
Polio,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,3 Months,90.0,86.5 to 92.8,677
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2018,Age,0-3 Days,84.2,78.8 to 88.4,350
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2018-2019,Age,0-3 Days,80.4,75.9 to 84.3,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,73.8,66.1 to 80.3,300
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,75.6,70.4 to 80.1,593
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,77.1,69.8 to 83.0,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,78.2,73.3 to 82.3,607
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,79.4,72.8 to 84.8,314
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,77.7,73.0 to 81.7,664
Hib,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,91.2,86.3 to 94.4,327
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020,Age,24 Months,88.4,81.5 to 93.7,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014,Age,0-3 Days,66.4,59.0 to 73.2,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2015,Age,0-3 Days,67.6,62.3 to 72.5,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.0,92.3 to 97.7,468
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,90.4,87.8 to 93.0,1071
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,90.1,83.8 to 96.4,222
PCV,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,94.9,90.6 to 97.6,315
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,90.1,84.9 to 94.1,327
PCV,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,92.6,86.9 to 96.4,261
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,92.3,87.9 to 95.6,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,92.9,89.5 to 95.4,589
Hib,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,88.9,82.2 to 93.3,300
Hib,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,90.5,86.4 to 93.5,593
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,92.6,87.5 to 96.1,327
Hib,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,93.9,88.4 to 96.9,296
Hib,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,93.2,89.6 to 95.6,596
Polio,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,3 Months,89.9,84.1 to 93.7,327
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2019,Age,0-3 Days,76.7,69.2 to 82.9,327
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,73.4,69.0 to 77.8,702
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,74.9,69.2 to 80.5,353
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.7,70.8 to 82.7,249
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,75.8,69.1 to 81.5,350
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,75.2,70.3 to 79.6,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,74.6,67.0 to 81.0,327
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,78.3,71.4 to 85.3,222
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,86.1,83.0 to 88.8,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,58.8,51.5 to 65.7,314
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,57.2,52.2 to 62.1,664
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,55.5,48.7 to 62.1,350
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,57.3,52.0 to 62.4,677
Hib,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,90.0,84.4 to 93.7,314
Hib,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,93.4,90.2 to 95.5,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.5,84.0 to 93.1,249
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,92.8,87.9 to 97.7,222
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,82.5 to 97.1,132
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,95.3,93.1 to 97.4,702
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,88.4,84.2 to 92.7,353
Hib,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,91.8,86.1 to 95.3,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,90.6,86.9 to 93.4,607
Hib,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,89.3,83.8 to 93.1,314
Hib,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,91.4,88.1 to 93.9,664
Hib,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,92.5,86.8 to 95.8,300
Hib,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,93.6,90.3 to 95.9,593
Hib,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,94.6,89.8 to 97.2,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,92.4,89.1 to 94.8,607
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,91.5,88.7 to 94.3,702
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,90.9,88.3 to 93.4,1071
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,87.6,82.5 to 92.6,288
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,89.5,83.3 to 95.8,137
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,74.9,69.2 to 80.7,353
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,84.2,77.3 to 91.0,222
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.9,69.8 to 82.1,249
PCV,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,3 Months,83.7,80.6 to 86.4,293
PCV,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,3 Months,86.6,81.3 to 90.5,589
Hib,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,5 Months,73.3,65.1 to 80.2,300
Hib,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,5 Months,76.0,70.4 to 80.8,593
Hib,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,5 Months,78.2,70.3 to 84.5,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,5 Months,80.5,75.4 to 84.7,607
Hib,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,5 Months,83.1,76.6 to 88.1,314
Hib,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,5 Months,83.3,78.9 to 86.9,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,92.3,87.9 to 95.6,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,92.1,88.9 to 94.7,589
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,92.0,86.9 to 95.6,296
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,90.4,86.6 to 93.6,596
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,89.2,83.1 to 93.8,300
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,91.2,87.4 to 94.2,593
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,89.9,84.4 to 94.0,350
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,89.3,84.9 to 92.9,677
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.3,92.7 to 98.0,468
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,88.4 to 93.5,1071
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,94.4,92.0 to 96.8,646
Hib,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,3 Months,90.4,85.5 to 93.8,350
Hib,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,3 Months,90.6,87.1 to 93.2,677
Hib,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,3 Months,90.8,85.3 to 94.3,327
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017,Age,35 Months,93.2,88.5 to 96.5,314
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,92.4,89.3 to 94.9,664
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018,Age,35 Months,91.4,87.0 to 94.7,350
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,90.5,87.1 to 93.3,677
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014,Age,35 Months,97.3,93.3 to 99.2,296
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,94.1,90.4 to 96.8,596
Hib,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,3 Months,88.8,85.4 to 91.5,261
Hib,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,3 Months,91.1,89.0 to 92.9,315
Hib,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,3 Months,84.2,81.1 to 86.9,293
Hib,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,3 Months,87.4,81.3 to 91.7,589
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,90.5,86.1 to 94.8,222
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,77.5 to 94.9,132
Hib,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,3 Months,87.0,79.7 to 91.9,300
Hib,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,3 Months,85.8,80.8 to 89.7,593
Hib,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,3 Months,84.9,77.3 to 90.3,293
Hib,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,3 Months,85.2,80.4 to 89.0,607
Hib,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,3 Months,85.5,79.3 to 90.2,314
Hib,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,3 Months,87.9,84.0 to 90.9,664
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,91.0,85.5 to 94.5,314
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,93.5,90.4 to 95.6,664
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,96.2,92.9 to 98.0,350
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,94.4,91.5 to 96.3,677
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,92.6,87.6 to 95.7,327
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,89.2,87.6 to 90.5,300
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,91.0,87.0 to 93.9,593
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,92.6,87.0 to 95.9,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,92.1,88.5 to 94.6,607
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018,Age,35 Months,92.1,87.8 to 95.4,350
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,90.3,86.8 to 93.2,677
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017,Age,35 Months,93.0,88.2 to 96.3,314
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,92.6,89.5 to 95.1,664
PCV,≥4 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,90.0,85.0 to 94.0,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,85.6,81.2 to 89.5,589
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019,Age,35 Months,88.5,82.7 to 93.0,327
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,95.1,93.0 to 97.2,702
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.8,93.4 to 98.1,468
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,90.9,88.3 to 93.4,1071
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,80.0,72.9 to 86.2,296
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,81.4,76.5 to 85.9,596
PCV,≥4 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,82.9,75.8 to 88.8,300
PCV,≥4 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,86.1,81.5 to 90.1,593
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,88.8,82.5 to 93.6,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,87.2,82.9 to 90.8,607
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,87.7,83.2 to 92.2,353
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,91.4,87.2 to 95.6,222
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,84.8 to 98.4,132
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.2,83.2 to 93.1,249
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,91.5,86.3 to 94.8,314
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,92.8,89.7 to 95.0,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,90.0,85.0 to 93.9,327
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2016,Age,0-2 Days,79.3,72.6 to 84.8,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2016-2017,Age,0-2 Days,77.2,72.4 to 81.3,607
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,92.1,86.2 to 95.6,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,90.9,87.1 to 93.6,607
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,89.5,83.9 to 93.3,314
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,92.0,88.8 to 94.4,664
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,94.7,91.0 to 96.9,350
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,93.0,90.0 to 95.1,677
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,83.5,76.5 to 88.7,296
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,85.6,81.0 to 89.3,596
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,87.8,81.1 to 92.3,300
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,88.8,84.6 to 92.0,593
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,94.4,90.9 to 96.8,350
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,92.1,89.1 to 94.5,677
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,89.7,83.6 to 93.7,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,89.2,85.3 to 92.1,607
PCV,≥4 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,80.8,74.1 to 86.2,327
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018,Age,24 Months,91.7,87.5 to 95.0,350
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,89.6,86.1 to 92.5,677
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013,Age,35 Months,94.0,89.7 to 96.9,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,95.3,92.3 to 97.4,589
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014,Age,35 Months,98.3,95.1 to 99.6,296
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,93.8,90.1 to 96.5,596
PCV,≥4 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,84.8,77.8 to 90.5,261
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015,Age,35 Months,91.1,85.2 to 95.3,300
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,91.9,87.9 to 95.0,593
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2014,Age,0-2 Days,62.2,54.7 to 69.1,296
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2014-2015,Age,0-2 Days,64.3,58.9 to 69.3,596
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2015,Age,0-2 Days,66.3,58.6 to 73.3,300
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2015-2016,Age,0-2 Days,73.4,68.4 to 78.0,593
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,89.8,84.8 to 93.7,327
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,91.3,83.2 to 96.5,261
PCV,≥4 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,88.6,82.8 to 93.2,315
PCV,≥4 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,88.2,83.2 to 92.3,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,84.1,79.7 to 88.0,589
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,79.7,72.6 to 85.9,296
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,81.1,76.2 to 85.5,596
PCV,≥4 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,82.5,75.5 to 88.5,300
PCV,≥4 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,84.0,79.4 to 88.0,593
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019,Age,24 Months,87.4,81.6 to 92.0,327
≥1 Dose MMR,,States/Local Areas,District of Columbia,2011,Age,35 Months,93.4,87.2 to 97.2,261
≥1 Dose MMR,,States/Local Areas,District of Columbia,2012,Age,35 Months,94.5,90.1 to 97.3,315
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013,Age,35 Months,92.1,87.6 to 95.4,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,94.0,90.9 to 96.3,589
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016,Age,35 Months,92.3,86.5 to 96.3,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,92.9,89.3 to 95.6,607
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2017,Age,0-2 Days,74.6,67.6 to 80.6,314
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2017-2018,Age,0-2 Days,78.1,73.7 to 82.0,664
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2018,Age,0-2 Days,81.8,76.3 to 86.3,350
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2018-2019,Age,0-2 Days,78.6,73.9 to 82.6,677
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2019,Age,0-2 Days,75.3,67.6 to 81.7,327
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,91.4,86.3 to 94.7,327
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,91.3,85.0 to 95.1,261
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,95.5,91.1 to 97.7,315
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,94.1,92.6 to 95.3,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,95.0,92.7 to 96.6,589
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,88.6,83.1 to 92.4,314
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,90.8,87.5 to 93.2,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,93.1,89.0 to 95.7,350
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,90.5,87.1 to 93.1,677
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,89.3,84.0 to 93.5,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,92.2,88.5 to 95.0,589
Hib,Full Series,States/Local Areas,District of Columbia,2020,Age,24 Months,80.1,72.8 to 86.4,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,98.4,93.0 to 99.8,296
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,94.8,90.5 to 97.5,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,92.9,86.4 to 97.0,300
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,92.0,87.8 to 95.2,593
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,95.0,88.9 to 98.3,315
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,85.2,79.0 to 90.4,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,84.7,80.4 to 88.5,607
PCV,≥4 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,84.1,78.1 to 89.2,314
PCV,≥4 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,83.5,79.6 to 87.1,664
PCV,≥4 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,82.9,77.5 to 87.7,350
PCV,≥4 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,83.2,79.2 to 86.8,677
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015,Age,35 Months,92.1,86.2 to 96.1,300
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,91.7,87.6 to 94.9,593
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016,Age,35 Months,91.1,85.3 to 95.3,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,92.1,88.5 to 95.0,607
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019,Age,35 Months,89.4,84.0 to 93.7,327
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,94.2,91.8 to 96.5,702
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,88.3,84.0 to 92.6,353
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.3,84.7 to 94.0,249
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,94.7,91.3 to 97.1,350
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,92.4,89.4 to 94.8,677
PCV,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,93.9,88.8 to 96.7,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,89.6,84.4 to 93.7,314
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,92.1,89.0 to 94.6,664
PCV,≥4 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,83.5,77.5 to 88.7,327
PCV,≥4 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,85.1,78.1 to 90.8,261
PCV,≥4 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,90.2,84.3 to 94.6,315
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,88.0,82.2 to 92.0,327
PCV,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,91.0,89.1 to 92.6,261
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,92.3,89.7 to 94.3,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,90.9,88.4 to 92.9,589
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,89.5,83.3 to 93.5,296
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,89.3,85.0 to 92.5,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,91.9,86.1 to 96.0,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,90.8,87.1 to 93.9,607
Hib,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,3 Months,90.7,84.9 to 94.5,296
Hib,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,3 Months,88.8,84.4 to 92.1,596
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,96.0,91.9 to 98.0,296
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,94.0,90.7 to 96.2,596
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,92.1,86.3 to 95.5,300
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,94.0,90.6 to 96.2,593
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,95.5,90.8 to 97.9,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,93.4,90.1 to 95.6,607
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.7,85.0 to 94.5,468
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,84.8,79.7 to 89.8,1071
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,88.4,82.1 to 92.6,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,86.7,82.4 to 90.0,607
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,87.1,80.6 to 91.7,300
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,87.8,83.5 to 91.1,593
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,84.7,78.4 to 89.4,314
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,88.1,84.3 to 91.1,664
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,85.9,77.2 to 94.6,222
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,88.2,84.0 to 92.4,702
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,82.0,72.7 to 91.4,353
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.5,69.8 to 91.1,249
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,94.0,88.2 to 97.6,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,90.7,86.7 to 93.8,607
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,86.8,80.6 to 91.8,314
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,88.3,84.3 to 91.7,664
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,88.6,81.2 to 94.1,327
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,92.1,89.5 to 94.7,702
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,73.8,68.0 to 79.7,353
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.0,68.6 to 81.3,249
≥1 Dose MMR,,States/Local Areas,District of Columbia,2011,Age,19 Months,88.1,85.7 to 90.1,261
PCV,≥4 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,81.6,76.7 to 85.6,261
PCV,≥4 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,84.8,82.4 to 87.0,315
PCV,≥4 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,85.3,82.1 to 88.0,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,81.2,77.9 to 84.1,589
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018,Age,19 Months,90.0,84.9 to 93.5,350
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,95.6,93.2 to 97.2,677
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,76.9,69.2 to 83.1,296
PCV,≥4 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,79.0,73.8 to 83.4,596
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019,Age,19 Months,85.1,78.5 to 89.9,327
≥1 Dose MMR,,States/Local Areas,District of Columbia,2011,Age,24 Months,90.7,84.7 to 95.1,261
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,70.4,62.5 to 77.2,300
PCV,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,71.2,65.8 to 76.1,593
≥1 Dose MMR,,States/Local Areas,District of Columbia,2012,Age,24 Months,94.5,90.1 to 97.3,315
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015,Age,24 Months,88.8,82.7 to 93.5,300
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,89.3,85.2 to 92.7,593
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016,Age,24 Months,89.7,83.9 to 94.1,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,91.0,87.3 to 93.9,607
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017,Age,24 Months,92.2,87.7 to 95.5,314
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,91.5,88.5 to 94.0,664
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,5 Months,87.5,81.9 to 91.6,327
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,87.6,82.0 to 91.6,261
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,5 Months,92.2,87.7 to 95.2,350
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,5 Months,89.9,86.4 to 92.5,677
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2018,Age,0-1 Days,72.7,66.6 to 78.1,350
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2018-2019,Age,0-1 Days,71.3,66.4 to 75.8,677
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2016,Age,0-1 Days,68.0,60.4 to 74.7,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2016-2017,Age,0-1 Days,65.5,60.3 to 70.4,607
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2017,Age,0-1 Days,62.7,55.4 to 69.4,314
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2017-2018,Age,0-1 Days,67.6,62.8 to 72.0,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,89.6,84.1 to 93.3,327
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,88.4,82.1 to 93.3,261
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,88.6,83.3 to 92.8,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,90.6,87.2 to 93.4,589
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,91.6,86.6 to 95.2,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,93.0,88.5 to 96.2,296
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,90.7,87.1 to 93.6,596
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,71.9,64.2 to 78.4,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,74.6,69.6 to 79.1,607
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,77.8,71.1 to 83.3,314
PCV,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,74.7,70.1 to 78.9,664
PCV,≥4 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,81.2,78.8 to 83.3,300
PCV,≥4 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,81.8,76.9 to 85.9,593
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,82.3,75.3 to 87.6,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,81.5,76.8 to 85.4,607
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013,Age,24 Months,91.2,86.6 to 94.7,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,92.5,89.4 to 94.9,589
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014,Age,24 Months,94.0,89.4 to 97.1,296
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,91.7,88.0 to 94.6,596
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015,Age,24 Months,89.8,83.8 to 94.3,300
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,89.0,84.9 to 92.3,593
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018,Age,24 Months,90.7,86.5 to 94.1,350
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,89.6,86.2 to 92.4,677
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019,Age,24 Months,88.3,82.9 to 92.7,327
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2011,Age,35 Months,94.9,89.2 to 98.1,261
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2012,Age,35 Months,94.9,90.6 to 97.7,315
PCV,≥4 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,80.5,73.8 to 85.8,314
PCV,≥4 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,80.2,75.7 to 83.9,664
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,88.9,85.2 to 91.8,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,86.3,84.6 to 87.8,589
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,88.6,82.7 to 93.1,300
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,89.6,85.6 to 92.8,593
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,90.3,84.7 to 94.5,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,89.8,86.1 to 92.9,607
PCV,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,90.8,87.8 to 93.1,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,89.2,84.0 to 93.4,314
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,91.7,88.6 to 94.3,664
PCV,≥4 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,79.8,73.6 to 84.8,350
PCV,≥4 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,77.7,71.5 to 82.8,544
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016,Age,24 Months,88.3,82.4 to 92.9,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,90.2,86.5 to 93.3,607
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017,Age,24 Months,92.2,87.6 to 95.6,314
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,92.0,89.0 to 94.5,664
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,92.5,87.2 to 95.7,296
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,91.1,87.2 to 93.9,596
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,93.6,89.6 to 96.1,315
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,89.7,83.3 to 93.9,300
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,91.0,87.0 to 93.9,593
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,71.5,64.7 to 77.4,350
PCV,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,72.7,67.7 to 77.1,677
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,73.8,66.3 to 80.2,327
PCV,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,85.2,81.7 to 88.2,261
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2012,Age,0-2 Days,68.1,63.0 to 72.8,315
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2013,Age,0-2 Days,71.1,67.9 to 74.1,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2013-2014,Age,0-2 Days,66.7,61.9 to 71.3,589
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,90.1,87.9 to 91.9,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,91.2,88.5 to 93.4,589
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2019,Age,0-1 Days,70.0,62.1 to 76.9,327
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2011,Age,0-2 Days,71.6,68.2 to 74.8,261
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,35 Months,92.7,86.9 to 96.5,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,91.0,86.1 to 94.3,327
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,84.8,79.7 to 89.8,1071
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,91.1,81.7 to 100.0,288
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014,Age,19 Months,89.9,84.0 to 93.8,296
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,89.4,85.2 to 92.5,596
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015,Age,19 Months,88.9,82.2 to 93.3,300
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,89.7,85.5 to 92.7,593
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016,Age,19 Months,90.3,84.5 to 94.1,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,89.7,85.8 to 92.6,607
Polio,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,92.5,90.2 to 94.3,261
Polio,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,95.9,91.3 to 98.2,315
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018,Age,13 Months,74.3,67.4 to 80.1,350
≥1 Dose MMR,,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,70.5,65.4 to 75.2,677
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019,Age,13 Months,66.9,59.0 to 73.8,327
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017,Age,13 Months,68.9,61.5 to 75.4,314
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,71.5,66.5 to 76.0,664
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,3 Months,94.2,89.6 to 96.8,261
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,3 Months,96.1,92.9 to 97.9,315
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,3 Months,94.2,91.5 to 96.1,293
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,3 Months,95.4,93.5 to 96.8,589
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,3 Months,96.8,93.7 to 98.4,296
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,3 Months,94.2,91.0 to 96.3,596
Polio,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,89.7,84.1 to 93.5,314
Polio,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,91.5,88.0 to 94.0,664
Polio,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,93.3,88.8 to 96.1,350
Polio,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,92.1,89.0 to 94.4,677
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,92.8,90.1 to 95.5,646
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013,Age,19 Months,90.0,88.8 to 91.0,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,89.9,88.5 to 91.2,589
≥1 Dose MMR,,States/Local Areas,District of Columbia,2012,Age,19 Months,90.6,89.3 to 91.7,315
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014,Age,19 Months,89.9,83.7 to 93.9,296
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,89.6,85.3 to 92.7,596
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017,Age,19 Months,88.9,83.0 to 93.0,314
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,89.0,85.3 to 91.8,664
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018,Age,19 Months,89.0,84.1 to 92.6,350
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,68.3,63.2 to 73.0,677
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,85.2,79.0 to 91.5,222
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,78.1,66.8 to 87.6,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,13 Months,93.1,87.5 to 96.3,300
Polio,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,94.1,90.7 to 96.3,593
Polio,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,13 Months,94.9,90.1 to 97.5,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,93.0,89.7 to 95.3,607
Polio,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,13 Months,90.8,85.3 to 94.4,314
Polio,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,93.4,90.1 to 95.6,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,91.7,87.1 to 94.7,350
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,89.6,86.2 to 92.2,677
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,87.5,82.0 to 91.5,327
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,88.4,83.6 to 91.9,261
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,91.5,87.7 to 94.2,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,88.6,86.0 to 90.7,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,89.7,85.9 to 92.5,589
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,3 Months,96.0,92.0 to 98.0,350
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,3 Months,95.2,92.3 to 97.0,677
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019,Age,19 Months,86.4,80.1 to 90.9,327
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,3 Months,94.4,89.6 to 97.1,327
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2011,Age,0-1 Days,55.9,53.0 to 58.8,261
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2012,Age,0-1 Days,52.2,46.0 to 58.4,315
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,78.6,68.3 to 89.0,137
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,5 Months,82.9,79.1 to 86.2,261
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,5 Months,88.9,83.1 to 92.9,315
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,5 Months,86.2,82.9 to 89.0,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,5 Months,85.9,82.4 to 88.8,589
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,87.8,83.3 to 92.2,646
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,5 Months,85.6,79.0 to 90.3,296
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,5 Months,87.2,83.8 to 89.9,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,90.8,85.5 to 94.3,296
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,89.1,85.1 to 92.1,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,87.4,85.0 to 89.5,300
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,88.9,84.7 to 92.0,593
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015,Age,19 Months,89.3,79.1 to 94.8,300
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,88.6,84.3 to 91.8,593
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016,Age,19 Months,88.0,81.7 to 92.3,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,88.3,84.1 to 91.4,607
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,73.5,66.9 to 80.0,288
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017,Age,19 Months,88.6,82.5 to 92.7,314
≥1 Dose MMR,,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,89.2,85.5 to 92.1,664
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2011,Age,24 Months,90.7,85.0 to 94.9,261
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2012,Age,24 Months,94.9,90.6 to 97.7,315
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,79.9 to 96.3,132
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.3 to 94.8,468
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,82.5,79.2 to 85.9,1071
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,82.5,79.2 to 85.9,1071
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,90.1,84.0 to 94.0,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,89.0,84.9 to 92.0,607
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013,Age,24 Months,92.6,88.2 to 95.8,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,92.9,89.9 to 95.3,589
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014,Age,24 Months,93.0,88.5 to 96.2,296
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,90.9,87.2 to 93.9,596
Polio,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,13 Months,96.0,92.0 to 98.1,350
Polio,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,94.9,92.3 to 96.7,677
Polio,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,13 Months,93.9,89.8 to 96.4,327
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2013,Age,0-1 Days,54.4,50.5 to 58.3,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2013-2014,Age,0-1 Days,50.7,46.9 to 54.5,589
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2014,Age,0-1 Days,46.7,39.3 to 54.2,296
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2014-2015,Age,0-1 Days,48.7,43.3 to 54.1,596
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2015,Age,0-1 Days,50.6,42.9 to 58.3,300
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2015-2016,Age,0-1 Days,60.1,54.6 to 65.3,593
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,5 Months,88.8,82.4 to 93.0,300
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,5 Months,89.0,84.7 to 92.2,593
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,67.1,54.9 to 77.3,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,64.7,58.7 to 70.1,589
PCV,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,63.7,58.3 to 68.7,261
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,62.1,54.2 to 69.3,296
PCV,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,66.3,60.7 to 71.4,596
PCV,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,69.9,65.6 to 73.8,315
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,79.0,70.0 to 88.0,137
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,92.4,89.9 to 95.0,646
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,87.7,81.8 to 91.9,314
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,90.7,87.2 to 93.3,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,93.8,89.7 to 96.3,350
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,89.6,86.2 to 92.2,677
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,5 Months,89.1,82.8 to 93.3,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,5 Months,88.9,84.8 to 91.9,607
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,5 Months,88.5,82.9 to 92.4,314
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,5 Months,90.3,86.9 to 92.9,664
Hib,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,92.3,86.6 to 96.2,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,94.0,89.3 to 97.1,315
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,90.8,86.1 to 94.5,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,92.2,89.0 to 94.8,589
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,94.0,89.2 to 97.1,296
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,91.1,87.3 to 94.2,596
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,35 Months,94.6,90.1 to 97.5,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,95.6,92.6 to 97.7,589
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,35 Months,96.5,92.4 to 98.7,296
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,92.4,88.2 to 95.6,596
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,93.3,88.4 to 98.1,222
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,77.3 to 95.1,132
Polio,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,5 Months,82.1,75.2 to 87.4,327
Polio,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,87.2,83.2 to 90.3,261
Polio,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,91.3,86.7 to 94.4,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,7 Months,67.4,60.2 to 73.8,314
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,70.6,65.9 to 75.0,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,7 Months,74.1,67.8 to 79.5,350
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,73.3,68.5 to 77.6,677
Polio,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,87.4,83.4 to 90.5,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,90.1,86.2 to 92.9,589
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,7 Months,72.5,65.1 to 78.8,327
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,85.7,76.0 to 93.0,296
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,79.9,73.4 to 85.7,596
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,75.7,66.6 to 83.8,300
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,83.1,77.1 to 88.4,593
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,89.5,81.8 to 94.9,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,87.2,81.4 to 91.9,607
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014,Age,13 Months,64.3,56.6 to 71.3,296
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,65.9,60.5 to 71.0,596
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2012,Age,13 Months,68.6,63.8 to 73.0,315
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015,Age,13 Months,67.5,59.6 to 74.6,300
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,67.8,62.2 to 72.9,593
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,35 Months,91.7,86.6 to 95.4,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,92.7,90.1 to 95.3,702
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,86.4,81.5 to 91.2,353
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.9,80.7 to 91.2,249
Polio,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,5 Months,83.5,77.2 to 88.3,350
Polio,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,5 Months,82.8,78.3 to 86.5,677
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013,Age,13 Months,63.4,54.6 to 71.5,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,63.8,60.6 to 67.0,589
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,35 Months,88.7,81.7 to 93.9,300
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,92.1,88.0 to 95.3,593
Polio,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,5 Months,78.8,74.0 to 82.9,315
Polio,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,5 Months,73.6,64.1 to 81.3,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,5 Months,74.4,68.7 to 79.3,589
Polio,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,5 Months,75.2,67.4 to 81.7,296
Polio,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,5 Months,74.7,69.3 to 79.3,596
Polio,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,5 Months,74.1,65.9 to 80.9,300
Polio,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,5 Months,77.5,72.0 to 82.2,593
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,90.7,86.2 to 95.1,288
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,93.3,87.9 to 98.7,137
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,96.9,95.1 to 98.7,646
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,7 Months,52.1,46.6 to 57.6,261
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,7 Months,63.4,54.5 to 71.4,315
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,7 Months,64.7,60.9 to 68.4,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,64.6,59.7 to 69.3,589
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,71.4,63.4 to 78.2,327
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,79.9,72.4 to 86.5,261
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,84.0,77.6 to 89.4,315
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,84.5,78.8 to 89.4,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,81.3,76.6 to 85.5,589
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,53.0,45.0 to 61.5,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,51.7,46.2 to 57.5,607
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,50.2,43.0 to 58.0,314
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,48.3,43.3 to 53.6,664
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,78.1,70.8 to 84.7,296
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,80.0,75.0 to 84.7,596
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,46.4,39.6 to 53.6,350
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,47.1,41.9 to 52.7,677
PCV,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,5 Months,82.4,76.1 to 87.3,350
PCV,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,5 Months,81.4,76.8 to 85.3,677
PCV,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,5 Months,80.4,73.3 to 86.0,327
Polio,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,5 Months,77.4,73.2 to 81.1,261
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,94.7,90.2 to 99.2,222
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,86.5 to 99.5,132
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.4,95.2 to 99.6,468
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,91.6 to 95.9,1071
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,78.1,71.2 to 83.7,314
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,75.7,71.0 to 79.8,664
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,73.1,66.6 to 78.8,350
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,94.9,92.3 to 96.7,677
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,46.7,39.5 to 54.5,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,46.6,41.3 to 52.2,589
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,46.7,39.2 to 54.8,296
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,48.9,43.4 to 54.7,596
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,51.1,43.2 to 59.5,300
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,52.2,46.4 to 58.1,593
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,93.8,91.6 to 95.9,1071
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,91.7,86.9 to 95.3,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,35 Months,95.4,89.8 to 98.4,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,94.1,90.8 to 96.6,607
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,35 Months,93.0,88.3 to 96.3,314
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,93.9,90.9 to 96.2,664
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2011,Age,13 Months,65.5,61.9 to 68.9,261
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,35 Months,94.6,90.4 to 97.4,350
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,93.4,90.1 to 95.8,677
Polio,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,5 Months,80.4,72.6 to 86.4,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,5 Months,80.9,75.8 to 85.0,607
Polio,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,5 Months,81.4,74.7 to 86.6,314
Polio,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,5 Months,82.4,78.0 to 86.1,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,64.5,57.0 to 71.4,296
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,66.0,60.7 to 71.0,596
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,67.5,59.7 to 74.4,300
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,71.8,66.5 to 76.5,593
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,75.4,68.0 to 81.5,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,71.7,66.6 to 76.2,607
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,47.9,40.2 to 56.4,327
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,81.2,70.5 to 89.9,261
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,82.5,71.5 to 91.1,315
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,82.2,74.4 to 88.8,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,83.1,77.3 to 88.2,589
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,82.0,74.7 to 88.2,300
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,84.7,80.1 to 88.6,593
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,86.9,81.0 to 91.6,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,85.3,81.2 to 89.0,607
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,83.6,77.4 to 88.9,314
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,84.1,80.1 to 87.7,664
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,87.9,85.1 to 90.2,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,87.1,82.7 to 90.5,589
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,86.2,80.0 to 90.7,296
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,86.7,82.4 to 90.0,596
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,85.8,76.1 to 93.0,314
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,83.5,77.0 to 89.0,664
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,81.4,72.9 to 88.5,350
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,80.6,74.4 to 86.1,677
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,13 Months,89.8,87.1 to 91.9,315
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,79.3,70.3 to 87.1,327
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,86.8,81.0 to 91.5,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,85.4,80.8 to 89.4,589
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,84.7,77.3 to 90.8,296
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,85.1,79.6 to 89.8,596
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,85.7,79.4 to 90.9,315
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,85.4,77.4 to 91.8,300
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,90.4,85.6 to 94.0,593
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016,Age,13 Months,69.2,61.3 to 76.2,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,69.1,63.7 to 74.0,607
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018,Age,13 Months,70.1,63.3 to 76.1,350
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,68.3,63.2 to 73.0,677
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019,Age,13 Months,66.5,58.8 to 73.4,327
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2011,Age,19 Months,88.4,84.5 to 91.4,261
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2012,Age,19 Months,91.2,89.9 to 92.4,315
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013,Age,19 Months,89.9,86.7 to 92.4,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,89.9,87.8 to 91.7,589
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014,Age,13 Months,67.1,59.5 to 73.9,296
≥1 Dose MMR,,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,67.6,62.2 to 72.6,596
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015,Age,13 Months,68.2,60.3 to 75.1,300
≥1 Dose MMR,,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,68.8,63.2 to 73.8,593
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016,Age,13 Months,68.0,60.1 to 75.1,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,69.0,63.6 to 73.9,607
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017,Age,13 Months,70.1,62.7 to 76.5,314
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,70.1,65.1 to 74.6,664
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.6,89.5 to 95.7,468
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,86.1 to 91.8,1071
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,88.9,86.1 to 91.8,1071
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,84.9,79.2 to 90.6,288
Polio,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,7 Months,92.9,87.3 to 96.1,296
Polio,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,91.2,87.1 to 94.1,596
Polio,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,7 Months,89.6,82.9 to 93.9,300
Polio,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,91.2,87.1 to 94.1,593
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,88.7,81.8 to 95.5,137
Polio,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,7 Months,92.5,86.7 to 95.9,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,91.2,87.5 to 93.9,607
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,13 Months,82.6,78.4 to 86.1,261
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,84.7,79.5 to 89.1,350
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,81.9,77.5 to 86.0,677
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,79.2,71.9 to 85.6,327
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,87.4,80.0 to 93.1,261
Polio,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,94.0,88.8 to 97.3,261
≥1 Dose MMR,,States/Local Areas,District of Columbia,2011,Age,13 Months,66.1,62.1 to 69.9,261
≥1 Dose MMR,,States/Local Areas,District of Columbia,2012,Age,13 Months,67.9,62.9 to 72.5,315
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013,Age,13 Months,64.6,58.1 to 70.6,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,65.8,62.7 to 68.7,589
Polio,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,13 Months,93.5,89.6 to 96.0,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,94.4,91.1 to 96.5,589
Polio,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,13 Months,95.2,90.2 to 97.8,296
Polio,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,94.2,90.7 to 96.4,596
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,3 Months,91.7,85.7 to 95.3,300
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,3 Months,93.2,89.5 to 95.6,593
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,3 Months,94.4,89.1 to 97.2,293
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,3 Months,93.4,89.9 to 95.8,607
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,3 Months,92.3,86.7 to 95.7,314
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,3 Months,94.1,90.9 to 96.2,664
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,80.3 to 100.0,132
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,95.0,90.9 to 97.6,315
Hib,Full Series,States/Local Areas,District of Columbia,2016,Age,24 Months,82.7,76.3 to 88.2,293
Hib,Full Series,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,81.1,76.5 to 85.2,607
Hib,Full Series,States/Local Areas,District of Columbia,2017,Age,24 Months,79.1,72.6 to 85.0,314
Hib,Full Series,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,79.4,75.1 to 83.3,664
Hib,Full Series,States/Local Areas,District of Columbia,2018,Age,24 Months,79.6,74.0 to 84.7,350
Hib,Full Series,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,78.5,74.1 to 82.7,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,92.3,86.6 to 96.2,261
Polio,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,94.9,91.2 to 97.4,350
Polio,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,93.2,90.3 to 95.5,677
Polio,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,91.5,86.8 to 95.0,327
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,89.4,83.8 to 93.2,327
Polio,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,90.1,84.8 to 94.2,314
Polio,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,92.4,89.3 to 95.0,664
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,90.7,85.4 to 94.6,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,92.3,88.9 to 95.1,589
Hib,Full Series,States/Local Areas,District of Columbia,2015,Age,24 Months,74.8,67.2 to 81.8,300
Hib,Full Series,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,79.1,74.2 to 83.6,593
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,94.0,89.5 to 97.0,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,92.2,88.9 to 94.8,607
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,89.1,83.7 to 92.8,314
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,91.1,87.8 to 93.5,664
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,93.2,88.9 to 95.9,350
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,76.4,71.9 to 80.5,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,91.5,86.3 to 94.8,327
Polio,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,24 Months,89.4,84.1 to 93.5,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,90.5,86.8 to 93.5,589
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,90.4,84.2 to 94.3,296
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,88.9,84.5 to 92.2,596
Polio,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,91.6,85.9 to 95.7,261
Polio,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,92.1,87.2 to 95.6,315
Polio,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,91.5,86.3 to 94.8,327
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,91.8,86.3 to 95.7,296
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,90.2,86.2 to 93.5,596
Polio,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,88.8,82.5 to 93.6,300
Polio,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,91.6,88.0 to 94.5,593
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,92.3,87.3 to 95.4,314
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,93.3,90.2 to 95.4,664
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,94.3,90.0 to 96.8,350
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,91.9,88.6 to 94.3,677
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,87.5,85.8 to 89.0,300
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,90.0,85.8 to 93.0,593
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,92.0,86.5 to 95.4,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,90.7,87.0 to 93.3,607
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,95.1,90.2 to 97.6,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,93.8,90.6 to 95.9,607
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,90.9,84.5 to 94.8,296
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,90.6,86.3 to 93.6,596
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,90.2,89.1 to 91.2,300
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,92.9,89.1 to 95.4,593
Polio,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,89.8,84.6 to 93.9,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,91.9,88.1 to 94.9,589
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,95.0,88.0 to 98.6,296
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,93.5,88.8 to 96.7,596
Polio,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,97.9,90.0 to 99.8,315
Polio,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,92.1,85.4 to 96.5,300
Polio,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,94.0,90.1 to 96.8,593
Polio,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,92.1,87.4 to 95.6,327
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,96.5,94.6 to 98.4,702
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,87.7,83.4 to 92.1,353
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,96.0,90.5 to 98.8,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,93.1,89.7 to 95.7,607
Polio,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,90.1,84.8 to 94.2,314
Polio,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,92.9,89.7 to 95.4,664
Hib,Full Series,States/Local Areas,District of Columbia,2019,Age,24 Months,77.4,70.5 to 83.7,327
Hib,Full Series,States/Local Areas,District of Columbia,2011,Age,35 Months,84.7,77.8 to 90.4,261
Hib,Full Series,States/Local Areas,District of Columbia,2012,Age,35 Months,82.8,75.8 to 88.7,315
Hib,Full Series,States/Local Areas,District of Columbia,2013,Age,35 Months,87.4,81.9 to 92.0,293
Hib,Full Series,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,83.9,79.3 to 88.0,589
Hib,Full Series,States/Local Areas,District of Columbia,2014,Age,35 Months,80.9,72.9 to 87.7,296
Hib,Full Series,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,77.5,72.2 to 82.4,596
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,5 Months,79.2,76.0 to 82.1,261
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,5 Months,81.2,78.3 to 83.9,315
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,5 Months,75.8,66.2 to 83.3,293
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,5 Months,75.4,69.6 to 80.4,589
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,5 Months,75.1,67.2 to 81.6,296
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,5 Months,75.6,71.5 to 79.2,596
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,5 Months,76.1,67.9 to 82.7,300
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,5 Months,78.2,72.8 to 82.9,593
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,5 Months,80.0,72.3 to 86.1,293
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,5 Months,81.6,76.6 to 85.7,607
Polio,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,95.7,91.8 to 98.1,350
Polio,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,93.9,91.0 to 96.2,677
Hib,Full Series,States/Local Areas,District of Columbia,2017,Age,35 Months,79.3,72.7 to 85.1,314
Hib,Full Series,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,81.5,77.1 to 85.6,664
≥1 Dose Varicella,,States/Local Areas,Delaware,2020-2021,Age,35 Months,90.6,85.5 to 94.5,293
Rotavirus,,States/Local Areas,Delaware,2019-2020,Age,8 Months,76.9,70.7 to 82.1,388
PCV,≥3 Doses,States/Local Areas,Delaware,2021,Age,13 Months,84.9,74.6 to 91.4,110
Hib,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,88.7,83.2 to 92.6,293
Hep A,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,58.0,51.6 to 64.4,388
Polio,≥2 Doses,States/Local Areas,Delaware,2020,Age,13 Months,90.0,83.2 to 94.2,183
Hep A,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,24 Months,91.8,88.0 to 94.8,388
Hep A,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,35 Months,96.1,92.8 to 98.2,388
Hep A,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,91.6,84.8 to 96.1,388
Influenza,,States/Local Areas,Delaware,2019-2020,Age,24 Months,68.8,62.8 to 74.5,388
Hib,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,90.5,86.3 to 93.7,388
Hib,Primary Series,States/Local Areas,Delaware,2019-2020,Age,24 Months,92.0,88.1 to 94.9,388
Hib,Full Series,States/Local Areas,Delaware,2019-2020,Age,24 Months,80.4,74.9 to 85.4,388
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2019-2020,Age,0-1 Days,73.6,67.7 to 78.7,388
Hib,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,63.3,57.1 to 69.1,388
Combined 7 Series,,States/Local Areas,Delaware,2019-2020,Age,35 Months,77.9,71.6 to 83.6,388
Hep B,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,91.0,87.1 to 93.8,388
≥1 Dose Varicella,,States/Local Areas,Delaware,2019-2020,Age,19 Months,92.5,88.7 to 95.1,388
PCV,≥4 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,81.3,75.7 to 85.9,388
Hep A,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,19 Months,89.8,85.4 to 93.0,388
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2019-2020,Age,0-2 Days,79.9,74.4 to 84.5,388
Hep B,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,91.2,87.6 to 94.2,388
≥1 Dose Varicella,,States/Local Areas,Delaware,2019-2020,Age,24 Months,92.6,88.8 to 95.5,388
PCV,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,70.9,64.7 to 76.3,388
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2019-2020,Age,0-3 Days,81.5,76.0 to 85.9,388
PCV,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,93.1,89.4 to 95.9,388
PCV,≥4 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,85.5,80.5 to 89.9,388
Hep A,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,35.7,30.0 to 41.7,388
≥1 Dose MMR,,States/Local Areas,Delaware,2019-2020,Age,19 Months,92.3,88.5 to 94.9,388
Hib,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,88.2,83.5 to 91.7,388
Hib,Primary Series,States/Local Areas,Delaware,2019-2020,Age,19 Months,91.2,87.0 to 94.1,388
Hib,Full Series,States/Local Areas,Delaware,2019-2020,Age,19 Months,73.0,66.8 to 78.4,388
≥1 Dose MMR,,States/Local Areas,Delaware,2019-2020,Age,35 Months,95.1,91.9 to 97.4,388
Hib,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,92.7,88.6 to 95.7,388
Hib,Primary Series,States/Local Areas,Delaware,2019-2020,Age,35 Months,93.6,89.9 to 96.4,388
Hib,Full Series,States/Local Areas,Delaware,2019-2020,Age,35 Months,84.0,78.1 to 89.0,388
Hep B,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,93.6,90.0 to 96.3,388
≥1 Dose Varicella,,States/Local Areas,Delaware,2019-2020,Age,35 Months,93.0,89.2 to 95.9,388
PCV,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,95.7,92.2 to 97.9,388
PCV,≥4 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,88.7,83.1 to 93.1,388
DTaP,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,93.5,90.0 to 96.1,388
DTaP,≥4 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,85.4,80.3 to 89.8,388
Polio,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,24 Months,93.0,89.3 to 95.7,388
≥1 Dose MMR,,States/Local Areas,Delaware,2019-2020,Age,24 Months,94.3,91.0 to 96.7,388
Hep B,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,3 Months,95.0,91.7 to 97.1,388
Hib,Primary Series,States/Local Areas,Delaware,2020,Age,19 Months,88.1,81.0 to 92.8,183
Polio,≥3 Doses,States/Local Areas,Delaware,2020,Age,19 Months,89.6,82.9 to 93.9,183
≥1 Dose MMR,,States/Local Areas,Delaware,2020,Age,19 Months,89.9,83.4 to 94.1,183
DTaP,≥4 Doses,States/Local Areas,Delaware,2020,Age,19 Months,75.7,67.1 to 82.6,183
DTaP,≥3 Doses,States/Local Areas,Delaware,2020,Age,19 Months,91.1,84.7 to 95.0,183
PCV,≥2 Doses,States/Local Areas,Delaware,2020,Age,5 Months,78.5,69.7 to 85.2,183
DTaP,≥3 Doses,States/Local Areas,Delaware,2020,Age,7 Months,75.9,67.3 to 82.9,183
PCV,≥3 Doses,States/Local Areas,Delaware,2020,Age,13 Months,87.5,79.5 to 92.6,183
≥1 Dose Varicella,,States/Local Areas,Delaware,2020,Age,13 Months,56.0,47.0 to 64.7,183
Hep B,≥3 Doses,States/Local Areas,Delaware,2020,Age,13 Months,83.5,75.7 to 89.1,183
Hep B,≥2 Doses,States/Local Areas,Delaware,2020,Age,13 Months,91.1,84.7 to 95.0,183
Hib,Primary Series,States/Local Areas,Delaware,2020,Age,13 Months,80.3,71.7 to 86.7,183
Hib,≥3 Doses,States/Local Areas,Delaware,2020,Age,13 Months,74.0,65.4 to 81.1,183
PCV,≥4 Doses,States/Local Areas,Delaware,2020,Age,35 Months,87.5,78.9 to 93.8,183
PCV,≥4 Doses,States/Local Areas,Delaware,2020,Age,19 Months,81.5,73.3 to 87.6,183
≥1 Dose MMR,,States/Local Areas,Delaware,2020,Age,35 Months,93.4,88.0 to 97.0,183
Polio,≥3 Doses,States/Local Areas,Delaware,2020,Age,35 Months,93.4,86.6 to 97.5,183
DTaP,≥4 Doses,States/Local Areas,Delaware,2020,Age,35 Months,95.2,83.1 to 99.5,183
≥1 Dose Varicella,,States/Local Areas,Delaware,2020,Age,19 Months,89.3,82.7 to 93.6,183
PCV,≥3 Doses,States/Local Areas,Delaware,2020,Age,19 Months,90.3,83.4 to 94.5,183
Hep B,≥3 Doses,States/Local Areas,Delaware,2020,Age,19 Months,88.0,81.4 to 92.5,183
Hib,Full Series,States/Local Areas,Delaware,2020,Age,19 Months,72.6,63.7 to 80.1,183
PCV,≥3 Doses,States/Local Areas,Delaware,2020,Age,35 Months,93.6,86.5 to 97.7,183
≥1 Dose Varicella,,States/Local Areas,Delaware,2020,Age,35 Months,90.6,84.5 to 95.0,183
Hep B,≥3 Doses,States/Local Areas,Delaware,2020,Age,35 Months,92.0,85.5 to 96.3,183
Hib,Full Series,States/Local Areas,Delaware,2020,Age,35 Months,81.7,73.1 to 88.9,183
Hib,Primary Series,States/Local Areas,Delaware,2020,Age,35 Months,90.4,83.5 to 95.2,183
Hib,≥3 Doses,States/Local Areas,Delaware,2020,Age,35 Months,89.2,82.0 to 94.5,183
Hib,Primary Series,States/Local Areas,Delaware,2020,Age,24 Months,88.5,82.1 to 93.5,183
Hib,≥3 Doses,States/Local Areas,Delaware,2020,Age,24 Months,86.4,79.5 to 91.8,183
≥1 Dose MMR,,States/Local Areas,Delaware,2020,Age,24 Months,92.6,87.0 to 96.3,183
DTaP,≥4 Doses,States/Local Areas,Delaware,2020,Age,24 Months,85.8,78.8 to 91.5,183
Polio,≥3 Doses,States/Local Areas,Delaware,2020,Age,24 Months,90.0,83.9 to 94.5,183
DTaP,≥3 Doses,States/Local Areas,Delaware,2020,Age,24 Months,91.1,85.4 to 95.2,183
Hep B,≥2 Doses,States/Local Areas,Delaware,2020,Age,7 Months,90.9,84.6 to 94.8,183
Hib,Primary Series,States/Local Areas,Delaware,2020,Age,7 Months,70.2,61.2 to 77.8,183
Hib,≥3 Doses,States/Local Areas,Delaware,2020,Age,7 Months,63.7,54.7 to 71.8,183
Hib,≥2 Doses,States/Local Areas,Delaware,2020,Age,7 Months,85.4,77.4 to 90.9,183
Polio,≥2 Doses,States/Local Areas,Delaware,2020,Age,7 Months,86.5,78.7 to 91.7,183
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2020,Age,0-2 Days,80.6,72.8 to 86.7,183
DTaP,≥1 Dose,States/Local Areas,Delaware,2020,Age,3 Months,80.5,72.1 to 86.9,183
Hep A,≥2 Doses,States/Local Areas,Delaware,2020,Age,19 Months,37.8,29.7 to 46.6,183
Hep A,≥1 Dose,States/Local Areas,Delaware,2020,Age,19 Months,87.2,79.9 to 92.1,183
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2020,Age,0-1 Days,75.1,66.5 to 82.1,183
Combined 7 Series,,States/Local Areas,Delaware,2020,Age,35 Months,75.5,66.7 to 83.4,183
DTaP,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,5 Months,82.9,77.4 to 87.3,388
Polio,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,5 Months,82.9,77.4 to 87.3,388
Hib,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,5 Months,80.4,74.8 to 85.0,388
Polio,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,93.7,90.0 to 96.1,388
≥1 Dose MMR,,States/Local Areas,Delaware,2019-2020,Age,13 Months,63.5,57.3 to 69.3,388
Hib,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,77.8,72.3 to 82.5,388
Hib,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,92.9,89.0 to 95.5,388
Hib,Primary Series,States/Local Areas,Delaware,2019-2020,Age,13 Months,86.5,81.4 to 90.3,388
Hep B,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,94.0,90.5 to 96.3,388
Hep B,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,5 Months,90.7,86.5 to 93.7,388
PCV,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,5 Months,82.3,76.8 to 86.8,388
DTaP,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,74.7,68.7 to 79.9,388
Polio,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,89.2,84.3 to 92.7,388
Hep B,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,88.3,83.8 to 91.7,388
Hib,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,88.4,83.4 to 92.0,388
≥1 Dose Varicella,,States/Local Areas,Delaware,2019-2020,Age,13 Months,58.1,51.9 to 64.1,388
PCV,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,90.4,85.7 to 93.7,388
DTaP,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,93.0,89.1 to 95.5,388
Combined 7 Series,,States/Local Areas,Delaware,2019-2020,Age,24 Months,73.9,68.1 to 79.5,388
DTaP,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,95.2,91.8 to 97.5,388
DTaP,≥4 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,92.2,86.7 to 96.0,388
DTaP,≥3 Doses,States/Local Areas,Delaware,2020,Age,13 Months,87.0,79.4 to 92.1,183
PCV,≥3 Doses,States/Local Areas,Delaware,2020,Age,7 Months,71.9,63.0 to 79.4,183
Hep B,≥3 Doses,States/Local Areas,Delaware,2020,Age,24 Months,88.3,82.2 to 93.0,183
Hep B,≥1 Dose,States/Local Areas,Delaware,2020,Age,3 Months,92.4,86.4 to 95.9,183
Hep B,≥3 Doses,States/Local Areas,Delaware,2020,Age,7 Months,46.1,37.4 to 55.0,183
Hib,≥1 Dose,States/Local Areas,Delaware,2020,Age,3 Months,76.8,68.1 to 83.7,183
Polio,≥1 Dose,States/Local Areas,Delaware,2020,Age,3 Months,80.5,72.1 to 86.8,183
Hep B,≥2 Doses,States/Local Areas,Delaware,2020,Age,5 Months,86.3,78.7 to 91.4,183
Hib,≥2 Doses,States/Local Areas,Delaware,2020,Age,5 Months,73.5,64.5 to 80.8,183
Polio,≥2 Doses,States/Local Areas,Delaware,2020,Age,5 Months,77.1,68.4 to 84.0,183
DTaP,≥2 Doses,States/Local Areas,Delaware,2020,Age,5 Months,77.2,68.5 to 84.1,183
PCV,≥1 Dose,States/Local Areas,Delaware,2020,Age,3 Months,81.9,73.4 to 88.1,183
Hep A,≥2 Doses,States/Local Areas,Delaware,2020,Age,24 Months,58.4,49.6 to 67.5,183
Combined 7 Series,,States/Local Areas,Delaware,2020,Age,24 Months,72.4,64.1 to 80.2,183
Hep A,≥1 Dose,States/Local Areas,Delaware,2020,Age,24 Months,90.4,84.4 to 94.8,183
PCV,≥4 Doses,States/Local Areas,Delaware,2020,Age,24 Months,85.1,77.7 to 91.0,183
DTaP,≥3 Doses,States/Local Areas,Delaware,2020,Age,35 Months,93.3,86.6 to 97.4,183
PCV,≥3 Doses,States/Local Areas,Delaware,2020,Age,24 Months,91.3,85.2 to 95.6,183
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2020,Age,0-3 Days,82.0,74.2 to 87.8,183
Rotavirus,,States/Local Areas,Delaware,2020,Age,8 Months,74.3,65.1 to 81.7,183
Influenza,,States/Local Areas,Delaware,2020,Age,24 Months,62.3,53.7 to 71.0,183
Hib,≥3 Doses,States/Local Areas,Delaware,2020,Age,19 Months,86.0,78.5 to 91.1,183
DTaP,≥4 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,75.8,69.8 to 80.9,388
Polio,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,92.2,88.2 to 95.0,388
DTaP,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,13 Months,90.6,86.0 to 93.7,388
Hib,Primary Series,States/Local Areas,Delaware,2019-2020,Age,7 Months,72.5,66.4 to 77.9,388
DTaP,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,3 Months,86.9,81.8 to 90.8,388
Polio,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,3 Months,86.9,81.8 to 90.8,388
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2021,Age,0-2 Days,77.3,66.0 to 85.6,110
≥1 Dose Varicella,,States/Local Areas,Delaware,2021,Age,24 Months,88.9,81.0 to 94.6,110
Hep A,≥2 Doses,States/Local Areas,Delaware,2021,Age,19 Months,28.3,19.3 to 39.3,110
PCV,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,91.7,86.8 to 95.4,293
Hep B,≥3 Doses,States/Local Areas,Delaware,2021,Age,7 Months,47.8,36.5 to 59.4,110
Hep A,≥1 Dose,States/Local Areas,Delaware,2021,Age,19 Months,84.3,74.1 to 91.0,110
Hib,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,74.4,67.1 to 80.5,293
PCV,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,5 Months,77.0,70.0 to 82.8,293
DTaP,≥3 Doses,States/Local Areas,Delaware,2021,Age,19 Months,88.3,78.8 to 93.9,110
Hep A,≥2 Doses,States/Local Areas,Delaware,2021,Age,24 Months,44.2,33.6 to 56.5,110
Hep A,≥1 Dose,States/Local Areas,Delaware,2021,Age,24 Months,88.3,80.3 to 94.1,110
PCV,≥4 Doses,States/Local Areas,Delaware,2021,Age,24 Months,77.6,67.4 to 86.4,110
PCV,≥3 Doses,States/Local Areas,Delaware,2021,Age,24 Months,90.6,82.8 to 95.8,110
DTaP,≥3 Doses,States/Local Areas,Delaware,2021,Age,13 Months,87.0,77.4 to 92.9,110
DTaP,≥4 Doses,States/Local Areas,Delaware,2021,Age,24 Months,76.6,66.3 to 85.6,110
PCV,≥4 Doses,States/Local Areas,Delaware,2021,Age,35 Months,80.2,69.7 to 89.0,110
Combined 7 Series,,States/Local Areas,Delaware,2021,Age,24 Months,64.1,52.9 to 75.1,110
PCV,≥3 Doses,States/Local Areas,Delaware,2021,Age,7 Months,61.8,49.9 to 72.4,110
Hep B,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,89.8,84.5 to 93.8,293
Hib,Primary Series,States/Local Areas,Delaware,2021,Age,19 Months,86.9,76.2 to 93.2,110
Hib,≥3 Doses,States/Local Areas,Delaware,2021,Age,19 Months,82.3,70.8 to 89.9,110
Hib,≥2 Doses,States/Local Areas,Delaware,2021,Age,5 Months,76.3,64.9 to 84.8,110
Hib,Primary Series,States/Local Areas,Delaware,2020-2021,Age,24 Months,87.9,82.3 to 92.4,293
Hib,≥3 Doses,States/Local Areas,Delaware,2021,Age,7 Months,54.7,43.0 to 66.0,110
PCV,≥3 Doses,States/Local Areas,Delaware,2021,Age,35 Months,90.6,82.8 to 95.8,110
≥1 Dose MMR,,States/Local Areas,Delaware,2021,Age,35 Months,90.6,82.3 to 96.1,110
Hep A,≥1 Dose,States/Local Areas,Delaware,2011,Age,19 Months,81.7,78.2 to 84.7,264
DTaP,≥1 Dose,States/Local Areas,Delaware,2019,Age,3 Months,94.1,88.4 to 97.1,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2016,Age,24 Months,95.2,90.8 to 97.9,233
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,95.5,92.8 to 97.5,541
DTaP,≥1 Dose,States/Local Areas,Delaware,2018,Age,3 Months,92.3,88.0 to 95.2,248
DTaP,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,3 Months,93.2,90.0 to 95.4,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2015,Age,24 Months,95.0,89.9 to 98.0,227
DTaP,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,95.1,91.9 to 97.3,460
DTaP,≥3 Doses,States/Local Areas,Delaware,2014,Age,24 Months,93.1,87.6 to 96.8,234
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,24 Months,94.1,90.5 to 96.6,461
DTaP,≥1 Dose,States/Local Areas,Delaware,2017,Age,3 Months,90.8,86.2 to 94.0,308
DTaP,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,3 Months,91.5,88.5 to 93.8,556
DTaP,≥1 Dose,States/Local Areas,Delaware,2016,Age,3 Months,89.8,83.3 to 94.0,233
DTaP,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,3 Months,90.3,86.5 to 93.1,541
DTaP,≥1 Dose,States/Local Areas,Delaware,2015,Age,3 Months,89.0,82.1 to 93.4,227
DTaP,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,3 Months,89.4,84.9 to 92.7,460
DTaP,≥1 Dose,States/Local Areas,Delaware,2014,Age,3 Months,88.5,81.0 to 93.3,234
DTaP,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,3 Months,88.8,84.0 to 92.2,461
DTaP,≥1 Dose,States/Local Areas,Delaware,2013,Age,3 Months,91.4,89.3 to 93.1,222
DTaP,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,3 Months,90.0,87.9 to 91.7,456
DTaP,≥1 Dose,States/Local Areas,Delaware,2012,Age,3 Months,90.8,85.5 to 94.3,251
DTaP,≥1 Dose,States/Local Areas,Delaware,2011,Age,3 Months,92.2,86.1 to 95.8,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.8,77.3 to 86.2,438
Hep A,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,24 Months,89.4,84.5 to 93.2,293
≥1 Dose Varicella,,States/Local Areas,Delaware,2021,Age,19 Months,85.9,76.7 to 91.8,110
DTaP,≥4 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,88.2,81.0 to 93.6,293
Hep B,≥3 Doses,States/Local Areas,Delaware,2021,Age,19 Months,86.1,76.7 to 92.1,110
Hib,Full Series,States/Local Areas,Delaware,2020-2021,Age,24 Months,75.9,69.0 to 82.3,293
Hib,Full Series,States/Local Areas,Delaware,2021,Age,19 Months,66.7,54.9 to 76.7,110
Hib,≥2 Doses,States/Local Areas,Delaware,2021,Age,7 Months,80.0,68.7 to 88.0,110
PCV,≥4 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,81.2,74.9 to 86.7,293
Polio,≥2 Doses,States/Local Areas,Delaware,2021,Age,7 Months,81.7,70.5 to 89.2,110
Hib,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,85.8,80.0 to 90.6,293
Hep B,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,83.4,77.4 to 88.1,293
Hep B,≥2 Doses,States/Local Areas,Delaware,2021,Age,7 Months,90.1,81.6 to 94.9,110
DTaP,≥3 Doses,States/Local Areas,Delaware,2021,Age,7 Months,63.4,51.5 to 73.9,110
DTaP,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,89.7,84.3 to 93.3,293
Polio,≥3 Doses,States/Local Areas,Delaware,2021,Age,19 Months,88.3,78.8 to 93.9,110
PCV,≥2 Doses,States/Local Areas,Delaware,2021,Age,5 Months,75.7,64.2 to 84.4,110
Combined 7 Series,,States/Local Areas,Delaware,2021,Age,35 Months,71.9,59.3 to 83.4,110
PCV,≥4 Doses,States/Local Areas,Delaware,2021,Age,19 Months,76.2,65.2 to 84.6,110
Hep A,≥1 Dose,States/Local Areas,Delaware,2012,Age,19 Months,85.8,82.7 to 88.4,251
Hep A,≥2 Doses,States/Local Areas,Delaware,2021,Age,35 Months,77.1,59.9 to 90.7,110
PCV,≥3 Doses,States/Local Areas,Delaware,2021,Age,19 Months,89.0,80.1 to 94.3,110
Hib,Primary Series,States/Local Areas,Delaware,2021,Age,7 Months,60.4,48.3 to 71.3,110
Hep B,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,91.6,86.9 to 94.8,293
Hep B,≥3 Doses,States/Local Areas,Delaware,2021,Age,24 Months,87.3,78.8 to 93.6,110
DTaP,≥4 Doses,States/Local Areas,Delaware,2021,Age,19 Months,71.6,60.4 to 80.6,110
Hib,≥1 Dose,States/Local Areas,Delaware,2021,Age,3 Months,84.4,74.1 to 91.1,110
Hib,Primary Series,States/Local Areas,Delaware,2021,Age,24 Months,87.3,77.8 to 94.1,110
Hib,≥3 Doses,States/Local Areas,Delaware,2021,Age,24 Months,85.2,75.5 to 92.6,110
Hib,Full Series,States/Local Areas,Delaware,2021,Age,24 Months,73.0,62.1 to 82.9,110
≥1 Dose MMR,,States/Local Areas,Delaware,2021,Age,24 Months,89.4,81.4 to 94.9,110
Hep A,≥1 Dose,States/Local Areas,Delaware,2021,Age,35 Months,91.5,83.0 to 96.8,110
Polio,≥1 Dose,States/Local Areas,Delaware,2021,Age,3 Months,84.0,73.7 to 90.8,110
Polio,≥3 Doses,States/Local Areas,Delaware,2021,Age,24 Months,90.9,82.7 to 96.3,110
DTaP,≥1 Dose,States/Local Areas,Delaware,2021,Age,3 Months,84.0,73.7 to 90.8,110
Polio,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,35 Months,95.3,91.8 to 97.6,388
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,93.4,89.5 to 97.2,202
Polio,≥2 Doses,States/Local Areas,Delaware,2021,Age,13 Months,88.6,79.0 to 94.1,110
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.8,84.7 to 94.8,159
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.4,89.1 to 97.6,120
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,91.0 to 96.0,438
PCV,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,3 Months,86.4,81.1 to 90.3,388
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2021,Age,0-1 Days,74.4,63.2 to 83.1,110
Hib,≥1 Dose,States/Local Areas,Delaware,2019-2020,Age,3 Months,84.7,79.4 to 88.9,388
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,78.0,73.0 to 82.9,409
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.0,87.6 to 96.5,159
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,90.0,86.7 to 93.3,452
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.4,93.4 to 99.5,120
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,96.8,94.4 to 99.2,202
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.0,70.1 to 85.9,159
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.7,82.8 to 90.7,438
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,82.7,68.3 to 97.1,32
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,94.5,92.2 to 96.9,409
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.2 to 98.8,452
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,82.4,68.1 to 96.7,32
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.5,82.4 to 90.6,438
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,93.0,89.5 to 96.6,202
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,88.9,76.8 to 100.0,32
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.2,81.6 to 92.8,159
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,87.5,75.1 to 99.9,32
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,92.6,89.9 to 95.3,409
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,82.4,68.1 to 96.7,32
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.0,87.5 to 96.4,159
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.4,94.4 to 98.4,438
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,83.4 to 97.0,120
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,93.5,90.0 to 97.0,202
Influenza,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,78.9,74.6 to 83.2,452
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,91.7,80.7 to 100.0,32
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.4,86.9 to 96.0,159
Influenza,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.0,48.5 to 69.6,120
Influenza,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.1,48.1 to 66.0,159
Influenza,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.0,72.4 to 81.5,438
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,91.7,80.7 to 100.0,32
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.9,75.1 to 88.7,159
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.9,95.2 to 98.6,438
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,85.0,79.4 to 90.5,202
Rotavirus,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.5,72.4 to 88.6,120
Rotavirus,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,75.2,68.0 to 82.5,202
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.6,63.3 to 79.9,159
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,67.1 to 85.6,120
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,74.3,66.7 to 81.8,202
Rotavirus,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,74.4,69.5 to 79.3,409
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.1,71.2 to 80.9,438
Rotavirus,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,80.3,62.0 to 98.6,32
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.0,69.1 to 85.0,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.2,66.3 to 84.0,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,83.3,76.6 to 90.1,202
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,96.4,93.7 to 99.1,202
Influenza,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,68.9,51.6 to 86.2,32
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.8,75.5 to 92.1,120
Influenza,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,57.9,52.2 to 63.6,409
Rotavirus,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,84.5,80.3 to 88.7,452
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,95.0,92.8 to 97.2,409
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,97.6,96.0 to 99.1,452
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,89.2,85.8 to 92.6,409
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,83.7 to 97.1,120
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.6,86.8 to 96.4,159
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,94.8,91.8 to 97.7,202
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,64.7,44.1 to 85.4,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,84.6,80.8 to 88.4,409
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,88.5 to 94.4,438
Rotavirus,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",66.6,57.8 to 75.5,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.8,81.3 to 92.3,159
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,70.1,64.7 to 75.5,409
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,80.8,76.5 to 85.2,452
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.6,86.8 to 96.4,159
Rotavirus,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.1,81.0 to 89.2,438
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,88.0 to 94.3,438
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.6,89.6 to 95.5,438
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,82.0,77.6 to 86.5,452
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.5,80.5 to 90.5,438
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,78.8,63.8 to 93.8,32
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.4,95.9 to 99.0,438
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,91.7,80.7 to 100.0,32
Influenza,,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,82.0,77.0 to 87.0,270
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,78.5,72.9 to 84.1,303
Rotavirus,,States/Local Areas,Delaware,2016-2019,Overall,Overall,78.1,74.8 to 81.5,919
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,92.8,89.6 to 96.0,270
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,70.9,64.6 to 77.2,303
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,85.8,81.3 to 90.4,346
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,92.9,89.9 to 95.9,270
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,94.3,91.4 to 97.2,303
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,83.2,80.1 to 86.2,919
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,89.7,85.7 to 93.7,303
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,87.9,83.8 to 92.0,346
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,91.0,87.3 to 94.7,270
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,88.7,84.5 to 92.8,303
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,90.8,87.5 to 94.1,346
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,97.8,96.2 to 99.4,270
Influenza,,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,55.4,48.6 to 62.1,303
Influenza,,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,69.0,63.2 to 74.8,346
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,92.5,90.7 to 94.4,919
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,95.9,94.5 to 97.3,919
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,94.7,91.9 to 97.5,303
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,92.3,89.2 to 95.5,346
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,97.4,95.6 to 99.3,270
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,75.1,67.2 to 83.1,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,77.9,72.5 to 83.2,346
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,85.7,80.7 to 90.6,270
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,88.4,84.6 to 92.2,346
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,92.3,89.0 to 95.6,270
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,88.8 to 96.1,296
Rotavirus,,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,80.0,74.9 to 85.0,346
Rotavirus,,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,69.6,63.2 to 75.9,303
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.1,88.5 to 93.7,623
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,95.2,92.1 to 98.3,296
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.8,93.0 to 96.7,623
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,82.6,77.1 to 88.2,296
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,81.3 to 88.1,623
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.9,71.8 to 79.9,623
Influenza,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,69.3,63.0 to 75.6,296
Influenza,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.3,60.6 to 69.9,623
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,72.6 to 87.1,296
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,86.5,81.8 to 91.3,296
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,95.6,92.7 to 98.5,296
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.3,93.6 to 97.0,623
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,72.2,65.7 to 78.7,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,77.9,72.1 to 83.7,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,81.2 to 87.9,623
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,95.9,93.8 to 97.9,346
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,96.5,94.2 to 98.7,270
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Overall,Overall,74.7,71.2 to 78.2,919
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Overall,Overall,81.5,78.3 to 84.7,919
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,92.8,90.0 to 95.6,346
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,94.1,91.1 to 97.1,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,84.8,80.2 to 89.4,303
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,66.7,60.2 to 73.1,303
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,78.4,73.1 to 83.6,346
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,95.9,93.8 to 97.9,346
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,97.9,96.3 to 99.5,270
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Overall,Overall,91.6,89.4 to 93.7,919
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,81.2,77.0 to 85.5,919
Combined 7 Series,,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,82.5,77.6 to 87.5,270
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,91.4,87.9 to 94.8,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2016-2019,Overall,Overall,82.4,79.4 to 85.3,919
Influenza,,States/Local Areas,Delaware,2016-2019,Overall,Overall,66.6,62.8 to 70.3,919
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,93.0,89.8 to 96.2,303
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,95.4,93.1 to 97.7,346
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,84.0,77.7 to 90.4,346
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,87.5,81.5 to 93.5,270
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,87.3,82.9 to 91.7,303
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Poverty,133% to <400% FPL,91.8,88.5 to 95.0,346
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,85.4,82.6 to 88.1,919
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,94.9,93.3 to 96.5,919
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Overall,Overall,92.5,90.4 to 94.5,919
Rotavirus,,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,89.7,85.7 to 93.8,270
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Overall,Overall,90.3,88.0 to 92.5,919
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Overall,Overall,95.4,93.9 to 96.9,919
Influenza,,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,61.4,52.6 to 70.2,202
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.0,84.2 to 91.8,438
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,86.4,73.9 to 99.0,32
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,95.7,92.5 to 98.9,202
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,84.9,70.9 to 98.8,32
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,90.4,87.2 to 93.6,409
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.6 to 98.2,452
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.5,74.1 to 90.9,120
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,82.2,75.9 to 88.5,202
≥1 Dose Varicella,,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.7 to 98.1,452
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Other,100.0,,32
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,76.1,70.0 to 82.2,409
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,87.9,82.6 to 93.1,452
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,93.5,91.0 to 96.0,452
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.4,82.7 to 92.2,249
Hib,Full Series,States/Local Areas,District of Columbia,2015,Age,35 Months,75.1,67.5 to 82.1,300
Hib,Full Series,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,81.9,76.9 to 86.3,593
Hib,Full Series,States/Local Areas,District of Columbia,2016,Age,35 Months,87.4,80.9 to 92.5,293
Hib,Full Series,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,83.6,79.1 to 87.6,607
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,90.7,87.9 to 93.4,702
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,70.1,64.1 to 76.0,353
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.9,65.5 to 78.4,249
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,94.7,90.2 to 99.2,222
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,86.5 to 99.5,132
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,94.0 to 99.0,468
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,89.2 to 94.2,1071
Hib,Full Series,States/Local Areas,District of Columbia,2018,Age,35 Months,84.2,77.8 to 89.5,350
Hib,Full Series,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,83.4,78.5 to 87.6,677
Hib,Full Series,States/Local Areas,District of Columbia,2019,Age,35 Months,82.5,75.0 to 88.8,327
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,80.0,76.5 to 83.4,1071
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,68.6,61.9 to 75.3,288
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,80.3,71.9 to 88.6,137
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,83.1,76.8 to 89.4,222
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.8,73.7 to 91.9,132
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.6,87.0 to 94.1,468
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,80.0,76.5 to 83.4,1071
Hib,Primary Series,States/Local Areas,District of Columbia,2011,Age,7 Months,70.8,66.3 to 74.9,261
Hib,Full Series,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,90.4,87.4 to 93.4,646
Hib,Primary Series,States/Local Areas,District of Columbia,2012,Age,7 Months,71.6,67.0 to 75.8,315
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,90.7 to 97.3,296
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.8,89.6 to 94.1,623
Rotavirus,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,75.4,69.3 to 81.6,296
Rotavirus,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.5,75.5 to 83.4,623
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,89.8,85.6 to 94.0,296
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.5,87.8 to 93.1,623
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.1,76.8 to 87.5,623
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,78.7,72.6 to 84.8,296
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.9,79.2 to 86.6,623
≥1 Dose MMR,,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.7,89.2 to 94.2,623
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.5,79.8 to 87.1,623
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,96.1,93.4 to 98.9,296
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,94.2 to 97.4,623
Hep B,≥3 Doses,States/Local Areas,Delaware,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,90.7 to 97.4,296
DTaP,≥3 Doses,States/Local Areas,Texas,2012,Age,24 Months,93.0,90.6 to 95.0,1359
DTaP,≥3 Doses,States/Local Areas,Texas,2013,Age,19 Months,90.5,88.3 to 92.3,1375
DTaP,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,90.3,89.0 to 91.5,2788
Hib,≥3 Doses,States/Local Areas,Texas,2017,Age,19 Months,88.3,85.3 to 90.8,1271
Hib,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,89.5,87.4 to 91.3,2336
Polio,≥3 Doses,States/Local Areas,Texas,2016,Age,24 Months,90.6,88.4 to 92.6,1603
Polio,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,89.2,87.3 to 90.8,2874
Hib,≥3 Doses,States/Local Areas,Texas,2016,Age,19 Months,89.7,87.3 to 91.7,1603
Hib,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,89.0,87.2 to 90.6,2874
Hib,≥3 Doses,States/Local Areas,Texas,2015,Age,19 Months,91.2,88.4 to 93.4,1640
Hib,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,90.4,88.9 to 91.8,3243
Hib,≥3 Doses,States/Local Areas,Texas,2018,Age,19 Months,90.7,87.5 to 93.2,1065
Hib,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,82.1,79.1 to 84.7,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2017,Age,19 Months,88.8,85.8 to 91.3,1271
DTaP,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,90.8,88.8 to 92.5,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2016,Age,19 Months,91.1,88.8 to 92.9,1603
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,90.0,88.1 to 91.5,2874
Polio,≥3 Doses,States/Local Areas,Texas,2015,Age,24 Months,92.4,90.4 to 94.0,1640
Polio,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,91.5,90.1 to 92.8,3243
Polio,≥3 Doses,States/Local Areas,Texas,2014,Age,24 Months,90.8,88.5 to 92.8,1413
Polio,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,91.6,90.1 to 92.9,3053
Polio,≥3 Doses,States/Local Areas,Texas,2018,Age,19 Months,92.4,89.5 to 94.6,1065
Polio,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,71.0,67.6 to 74.3,1984
Polio,≥3 Doses,States/Local Areas,Texas,2019,Age,19 Months,90.7,87.0 to 93.3,919
Polio,≥3 Doses,States/Local Areas,Texas,2011,Age,24 Months,91.4,88.2 to 94.0,1195
Polio,≥3 Doses,States/Local Areas,Texas,2012,Age,24 Months,91.6,89.0 to 93.7,1359
Hib,≥3 Doses,States/Local Areas,Texas,2014,Age,19 Months,87.5,84.8 to 89.8,1413
Hib,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,89.4,87.7 to 90.8,3053
Hib,≥3 Doses,States/Local Areas,Texas,2013,Age,19 Months,89.1,87.1 to 90.8,1375
Hib,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,88.3,86.6 to 89.8,2788
Polio,≥3 Doses,States/Local Areas,Texas,2013,Age,24 Months,90.2,87.7 to 92.4,1375
Polio,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,90.5,88.8 to 92.0,2788
DTaP,≥3 Doses,States/Local Areas,Texas,2014,Age,19 Months,90.2,87.8 to 92.2,1413
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,91.4,89.8 to 92.7,3053
DTaP,≥3 Doses,States/Local Areas,Texas,2015,Age,19 Months,92.5,90.1 to 94.4,1640
DTaP,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,91.8,90.3 to 93.1,3243
DTaP,≥3 Doses,States/Local Areas,Texas,2018,Age,19 Months,92.9,89.9 to 95.0,1065
DTaP,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,89.6,87.1 to 91.6,1984
Hib,Full Series,States/Local Areas,Texas,2015,Age,24 Months,79.7,76.9 to 82.3,1640
Hib,Full Series,States/Local Areas,Texas,2015-2016,Age,24 Months,78.6,76.6 to 80.6,3243
Hib,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,79.1,73.5 to 83.7,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2019,Age,19 Months,91.8,88.5 to 94.3,919
DTaP,≥3 Doses,States/Local Areas,Texas,2011,Age,24 Months,94.4,91.8 to 96.5,1195
Polio,≥3 Doses,States/Local Areas,Texas,2012,Age,35 Months,92.9,90.3 to 95.1,1359
Polio,≥3 Doses,States/Local Areas,Texas,2011,Age,35 Months,91.8,88.6 to 94.3,1195
Hib,≥3 Doses,States/Local Areas,Texas,2019,Age,19 Months,90.9,87.4 to 93.5,919
Polio,≥3 Doses,States/Local Areas,Texas,2019,Age,24 Months,91.3,87.9 to 94.1,919
Polio,≥3 Doses,States/Local Areas,Texas,2018,Age,24 Months,93.5,91.0 to 95.5,1065
Polio,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,92.4,90.3 to 94.2,1984
Polio,≥3 Doses,States/Local Areas,Texas,2017,Age,24 Months,87.7,84.7 to 90.3,1271
Polio,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,90.6,88.6 to 92.3,2336
Hib,Full Series,States/Local Areas,Texas,2017,Age,24 Months,75.8,72.2 to 79.3,1271
Hib,Full Series,States/Local Areas,Texas,2017-2018,Age,24 Months,76.0,73.3 to 78.7,2336
Hib,Full Series,States/Local Areas,Texas,2016,Age,24 Months,77.5,74.5 to 80.4,1603
Hib,Full Series,States/Local Areas,Texas,2016-2017,Age,24 Months,76.7,74.3 to 79.0,2874
DTaP,≥2 Doses,States/Local Areas,Texas,2014,Age,5 Months,77.4,74.3 to 80.2,1413
DTaP,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,5 Months,79.3,77.1 to 81.3,3053
Polio,≥3 Doses,States/Local Areas,Texas,2015,Age,35 Months,95.2,93.3 to 96.8,1640
Polio,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,94.1,92.6 to 95.4,3243
Hib,≥3 Doses,States/Local Areas,Texas,2013,Age,24 Months,90.1,87.6 to 92.3,1375
Hib,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,90.2,88.4 to 91.7,2788
Hib,≥3 Doses,States/Local Areas,Texas,2012,Age,24 Months,91.8,89.2 to 94.0,1359
Hib,≥3 Doses,States/Local Areas,Texas,2011,Age,24 Months,93.2,90.3 to 95.5,1195
Polio,≥3 Doses,States/Local Areas,Texas,2017,Age,35 Months,89.1,86.0 to 91.8,1271
Polio,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,92.5,89.9 to 94.7,2336
Polio,≥3 Doses,States/Local Areas,Texas,2016,Age,35 Months,92.8,90.4 to 94.8,1603
Polio,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,91.1,89.1 to 92.9,2874
DTaP,≥2 Doses,States/Local Areas,Texas,2015,Age,5 Months,81.1,78.3 to 83.6,1640
DTaP,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,5 Months,79.5,77.5 to 81.4,3243
Polio,≥3 Doses,States/Local Areas,Texas,2018,Age,35 Months,95.3,92.2 to 97.5,1065
Polio,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,94.5,92.2 to 96.3,1984
Hib,Full Series,States/Local Areas,Texas,2014,Age,35 Months,83.4,80.2 to 86.3,1413
Hib,Full Series,States/Local Areas,Texas,2014-2015,Age,35 Months,84.4,82.2 to 86.5,3053
DTaP,≥2 Doses,States/Local Areas,Texas,2013,Age,5 Months,77.7,74.8 to 80.4,1375
DTaP,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,5 Months,77.6,76.0 to 79.1,2788
DTaP,≥2 Doses,States/Local Areas,Texas,2012,Age,5 Months,75.4,72.4 to 78.1,1359
DTaP,≥2 Doses,States/Local Areas,Texas,2011,Age,5 Months,77.2,69.6 to 83.4,1195
Polio,≥3 Doses,States/Local Areas,Texas,2014,Age,35 Months,92.7,90.3 to 94.8,1413
Polio,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,94.0,92.5 to 95.4,3053
Polio,≥3 Doses,States/Local Areas,Texas,2013,Age,35 Months,92.6,90.1 to 94.7,1375
Polio,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,92.7,91.0 to 94.1,2788
Hib,Full Series,States/Local Areas,Texas,2019,Age,24 Months,79.1,74.4 to 83.4,919
Hib,Full Series,States/Local Areas,Texas,2018,Age,24 Months,76.2,72.0 to 80.3,1065
Hib,Full Series,States/Local Areas,Texas,2018-2019,Age,24 Months,77.6,74.5 to 80.6,1984
Hib,Full Series,States/Local Areas,Texas,2011,Age,35 Months,83.7,78.9 to 87.8,1195
Hib,Full Series,States/Local Areas,Texas,2012,Age,35 Months,82.2,78.4 to 85.7,1359
Hib,Full Series,States/Local Areas,Texas,2013,Age,35 Months,81.7,78.1 to 85.0,1375
Hib,Full Series,States/Local Areas,Texas,2013-2014,Age,35 Months,82.6,80.2 to 84.8,2788
Hib,Full Series,States/Local Areas,Texas,2015,Age,35 Months,85.8,82.5 to 88.8,1640
Hib,Full Series,States/Local Areas,Texas,2015-2016,Age,35 Months,83.6,81.3 to 85.7,3243
Hib,Full Series,States/Local Areas,Texas,2017,Age,35 Months,78.6,74.9 to 82.1,1271
Hib,Full Series,States/Local Areas,Texas,2017-2018,Age,35 Months,79.2,76.3 to 81.9,2336
Hib,Full Series,States/Local Areas,Texas,2018,Age,35 Months,79.6,75.3 to 83.7,1065
Hib,Full Series,States/Local Areas,Texas,2018-2019,Age,35 Months,81.4,78.2 to 84.4,1984
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,92.9,91.2 to 94.5,2524
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,91.7,86.6 to 96.8,315
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,78.1,70.7 to 85.6,297
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,88.6,86.5 to 90.7,2412
Hib,Full Series,States/Local Areas,Texas,2016,Age,35 Months,81.4,78.1 to 84.4,1603
Hib,Full Series,States/Local Areas,Texas,2016-2017,Age,35 Months,80.1,77.6 to 82.5,2874
Hib,Full Series,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,82.8,80.4 to 85.1,2524
Hib,Full Series,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.5,64.6 to 78.4,363
Hib,Full Series,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,74.8,72.1 to 77.6,2412
Hib,Full Series,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.8,74.9 to 80.7,1801
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,91.3,89.7 to 92.9,2957
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,84.9 to 92.6,546
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.7,87.2 to 92.2,1682
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,88.5 to 92.1,3481
Hib,Full Series,States/Local Areas,Texas,2019,Age,35 Months,83.2,78.3 to 87.5,919
Polio,≥3 Doses,States/Local Areas,Texas,2019,Age,35 Months,93.6,90.2 to 96.1,919
Hib,Full Series,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,79.1,72.1 to 86.1,315
Polio,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.5,79.4 to 91.6,363
Hib,Primary Series,States/Local Areas,Texas,2011,Age,7 Months,67.3,61.6 to 72.5,1195
Hib,Full Series,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,86.3,83.6 to 89.1,1491
Hep A,≥2 Doses,States/Local Areas,Texas,2012,Age,24 Months,47.7,43.5 to 52.1,1359
Hib,Full Series,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,60.3,51.3 to 69.4,297
Hib,Full Series,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,78.3,75.9 to 80.8,2957
Hib,Full Series,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.4,72.3 to 82.4,546
Hib,Full Series,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.4,75.3 to 81.6,1682
Hib,Full Series,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,77.4,75.1 to 79.8,3481
Hib,Full Series,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,76.7,69.3 to 84.1,266
Hib,Full Series,States/Local Areas,Texas,2014-2017,Overall,Overall,77.5,75.8 to 79.3,5548
Hib,Full Series,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,72.7,69.9 to 75.6,2381
Hib,Full Series,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,78.2,75.0 to 81.4,1676
Hep A,≥1 Dose,States/Local Areas,Texas,2015,Age,35 Months,93.0,90.9 to 94.8,1640
Hep A,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,35 Months,92.6,91.1 to 94.0,3243
Hep A,≥1 Dose,States/Local Areas,Texas,2017,Age,35 Months,93.2,89.1 to 96.2,1271
Hep A,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,35 Months,93.0,90.7 to 95.0,2336
Polio,≥2 Doses,States/Local Areas,Texas,2016,Age,5 Months,77.4,74.4 to 80.2,1603
Polio,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,5 Months,76.7,74.4 to 78.9,2874
Polio,≥2 Doses,States/Local Areas,Texas,2017,Age,5 Months,76.0,72.3 to 79.3,1271
Polio,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,5 Months,79.8,77.2 to 82.2,2336
Hep B,≥3 Doses,States/Local Areas,Texas,2014,Age,7 Months,62.0,58.5 to 65.4,1413
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,64.9,62.5 to 67.2,3053
Hep B,≥3 Doses,States/Local Areas,Texas,2015,Age,7 Months,67.7,64.5 to 70.7,1640
Hep B,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,66.6,64.3 to 68.9,3243
Polio,≥2 Doses,States/Local Areas,Texas,2012,Age,5 Months,73.9,70.9 to 76.8,1359
Polio,≥2 Doses,States/Local Areas,Texas,2011,Age,5 Months,76.3,68.5 to 82.7,1195
Hep A,≥1 Dose,States/Local Areas,Texas,2012,Age,35 Months,93.2,90.3 to 95.5,1359
Polio,≥2 Doses,States/Local Areas,Texas,2013,Age,5 Months,76.4,73.4 to 79.3,1375
Polio,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,5 Months,76.7,75.1 to 78.1,2788
Polio,≥2 Doses,States/Local Areas,Texas,2014,Age,5 Months,76.9,73.8 to 79.7,1413
Polio,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,5 Months,78.6,76.4 to 80.6,3053
DTaP,≥4 Doses,States/Local Areas,Texas,2018,Age,19 Months,72.3,68.0 to 76.3,1065
DTaP,≥4 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,94.1,92.2 to 95.6,1984
Hep A,≥2 Doses,States/Local Areas,Texas,2013,Age,24 Months,47.3,43.6 to 51.2,1375
Hep A,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,46.7,44.1 to 49.4,2788
DTaP,≥4 Doses,States/Local Areas,Texas,2016,Age,19 Months,72.3,69.1 to 75.3,1603
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,72.2,69.8 to 74.5,2874
DTaP,≥4 Doses,States/Local Areas,Texas,2017,Age,19 Months,72.2,68.5 to 75.6,1271
DTaP,≥4 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,72.2,69.4 to 74.9,2336
PCV,≥2 Doses,States/Local Areas,Texas,2019,Age,5 Months,83.0,78.4 to 86.7,919
PCV,≥2 Doses,States/Local Areas,Texas,2017,Age,5 Months,74.9,71.2 to 78.2,1271
PCV,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,5 Months,77.9,75.2 to 80.5,2336
PCV,≥2 Doses,States/Local Areas,Texas,2018,Age,5 Months,81.0,76.8 to 84.6,1065
PCV,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,5 Months,82.0,79.0 to 84.7,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.7,79.6 to 91.8,363
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,92.6,91.1 to 94.1,2957
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,86.0 to 93.6,546
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.3,89.0 to 93.7,1682
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,89.2 to 92.8,3481
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,87.7,82.1 to 93.3,266
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.0,90.1 to 93.9,1801
Hib,≥3 Doses,States/Local Areas,Texas,2019,Age,35 Months,94.4,91.4 to 96.5,919
Hib,≥3 Doses,States/Local Areas,Texas,2018,Age,35 Months,92.1,89.1 to 94.6,1065
Hib,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,93.2,91.2 to 95.0,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,91.2,89.9 to 92.5,5548
Hep A,≥2 Doses,States/Local Areas,Texas,2014,Age,24 Months,46.2,42.6 to 50.0,1413
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,47.9,45.4 to 50.4,3053
Hep A,≥1 Dose,States/Local Areas,Texas,2013,Age,35 Months,91.1,88.3 to 93.4,1375
Hep A,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,35 Months,92.5,90.7 to 94.1,2788
Hep A,≥1 Dose,States/Local Areas,Texas,2014,Age,35 Months,93.7,91.3 to 95.7,1413
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,35 Months,93.4,91.8 to 94.8,3053
DTaP,≥4 Doses,States/Local Areas,Texas,2014,Age,24 Months,79.7,76.6 to 82.6,1413
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,79.5,77.4 to 81.5,3053
DTaP,≥4 Doses,States/Local Areas,Texas,2016,Age,24 Months,78.9,75.9 to 81.7,1603
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,78.7,76.4 to 80.9,2874
DTaP,≥4 Doses,States/Local Areas,Texas,2015,Age,24 Months,79.3,76.5 to 82.0,1640
DTaP,≥4 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,79.1,77.0 to 81.0,3243
Hep A,≥1 Dose,States/Local Areas,Texas,2016,Age,35 Months,92.2,89.9 to 94.2,1603
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,35 Months,92.6,90.5 to 94.4,2874
Hep B,≥3 Doses,States/Local Areas,Texas,2019,Age,24 Months,89.1,85.3 to 92.2,919
Hep B,≥3 Doses,States/Local Areas,Texas,2017,Age,24 Months,85.9,82.8 to 88.8,1271
Hep B,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,88.3,86.2 to 90.2,2336
Hep B,≥3 Doses,States/Local Areas,Texas,2011,Age,35 Months,87.4,83.7 to 90.6,1195
PCV,≥4 Doses,States/Local Areas,Texas,2012,Age,24 Months,81.3,77.9 to 84.5,1359
PCV,≥4 Doses,States/Local Areas,Texas,2014,Age,24 Months,83.2,80.4 to 85.8,1413
PCV,≥4 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,82.4,80.4 to 84.2,3053
PCV,≥4 Doses,States/Local Areas,Texas,2013,Age,24 Months,78.4,75.1 to 81.5,1375
PCV,≥4 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,80.8,78.6 to 82.8,2788
≥1 Dose MMR,,States/Local Areas,Texas,2019,Age,24 Months,89.1,85.4 to 92.3,919
≥1 Dose MMR,,States/Local Areas,Texas,2018,Age,24 Months,92.0,89.3 to 94.2,1065
≥1 Dose MMR,,States/Local Areas,Texas,2018-2019,Age,24 Months,90.5,88.3 to 92.5,1984
≥1 Dose MMR,,States/Local Areas,Texas,2011,Age,35 Months,91.6,87.9 to 94.5,1195
≥1 Dose MMR,,States/Local Areas,Texas,2012,Age,35 Months,93.5,91.0 to 95.5,1359
≥1 Dose Varicella,,States/Local Areas,Texas,2016,Age,35 Months,92.7,90.4 to 94.6,1603
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2017,Age,35 Months,92.5,90.5 to 94.3,2874
≥1 Dose MMR,,States/Local Areas,Texas,2013,Age,35 Months,91.1,88.6 to 93.2,1375
≥1 Dose MMR,,States/Local Areas,Texas,2013-2014,Age,35 Months,91.9,90.2 to 93.4,2788
Hep B,≥3 Doses,States/Local Areas,Texas,2018,Age,24 Months,90.7,87.7 to 93.2,1065
Hep B,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,89.9,87.5 to 91.9,1984
Hep B,≥2 Doses,States/Local Areas,Texas,2015,Age,7 Months,92.1,90.2 to 93.6,1640
Hep B,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,91.7,90.3 to 92.9,3243
PCV,≥3 Doses,States/Local Areas,Texas,2014,Age,13 Months,85.3,82.5 to 87.8,1413
PCV,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,86.1,84.3 to 87.8,3053
PCV,≥3 Doses,States/Local Areas,Texas,2015,Age,13 Months,86.9,84.4 to 89.1,1640
PCV,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,85.7,83.9 to 87.4,3243
Hep B,≥2 Doses,States/Local Areas,Texas,2018,Age,7 Months,94.0,91.4 to 95.9,1065
Hep B,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,92.9,90.9 to 94.5,1984
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2019,Age,0-2 Days,81.6,77.0 to 85.6,919
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2018,Age,0-2 Days,82.6,78.8 to 85.9,1065
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2018-2019,Age,0-2 Days,82.1,79.2 to 84.7,1984
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2017,Age,0-2 Days,76.1,72.2 to 79.5,1271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2017-2018,Age,0-2 Days,79.3,76.6 to 81.8,2336
≥1 Dose Varicella,,States/Local Areas,Texas,2015-2016,Age,35 Months,92.3,90.7 to 93.8,3243
≥1 Dose Varicella,,States/Local Areas,Texas,2017,Age,35 Months,92.6,88.6 to 95.6,1271
≥1 Dose Varicella,,States/Local Areas,Texas,2017-2018,Age,35 Months,92.8,90.5 to 94.6,2336
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2016,Age,0-2 Days,76.7,73.6 to 79.6,1603
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2016-2017,Age,0-2 Days,76.4,74.0 to 78.7,2874
Hep B,≥2 Doses,States/Local Areas,Texas,2016,Age,7 Months,91.3,89.0 to 93.1,1603
Hep B,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,90.0,88.3 to 91.6,2874
PCV,≥3 Doses,States/Local Areas,Texas,2013,Age,13 Months,85.6,83.3 to 87.6,1375
PCV,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,85.5,84.2 to 86.7,2788
Hep B,≥2 Doses,States/Local Areas,Texas,2017,Age,7 Months,88.8,85.9 to 91.1,1271
Hep B,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,91.4,89.5 to 93.0,2336
PCV,≥4 Doses,States/Local Areas,Texas,2019,Age,19 Months,81.3,76.6 to 85.3,919
≥1 Dose Varicella,,States/Local Areas,Texas,2013,Age,35 Months,91.2,88.5 to 93.4,1375
≥1 Dose Varicella,,States/Local Areas,Texas,2013-2014,Age,35 Months,92.5,90.8 to 94.0,2788
≥1 Dose Varicella,,States/Local Areas,Texas,2012,Age,35 Months,93.4,90.7 to 95.5,1359
≥1 Dose Varicella,,States/Local Areas,Texas,2015,Age,35 Months,92.1,89.5 to 94.2,1640
≥1 Dose Varicella,,States/Local Areas,Texas,2014,Age,35 Months,93.8,91.5 to 95.6,1413
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2015,Age,35 Months,92.9,91.3 to 94.4,3053
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2014,Age,0-2 Days,75.6,72.4 to 78.5,1413
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2014-2015,Age,0-2 Days,77.2,75.1 to 79.2,3053
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2015,Age,0-2 Days,78.9,76.0 to 81.4,1640
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2015-2016,Age,0-2 Days,77.8,75.7 to 79.8,3243
PCV,≥4 Doses,States/Local Areas,Texas,2018,Age,19 Months,79.7,75.7 to 83.1,1065
PCV,≥4 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,81.3,78.1 to 84.0,1672
PCV,≥4 Doses,States/Local Areas,Texas,2017,Age,19 Months,75.7,72.1 to 79.0,1271
PCV,≥4 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,77.7,75.0 to 80.1,2336
≥1 Dose MMR,,States/Local Areas,Texas,2017,Age,24 Months,88.7,85.8 to 91.3,1271
≥1 Dose MMR,,States/Local Areas,Texas,2017-2018,Age,24 Months,90.3,88.4 to 92.1,2336
≥1 Dose MMR,,States/Local Areas,Texas,2016,Age,24 Months,89.6,87.4 to 91.6,1603
≥1 Dose MMR,,States/Local Areas,Texas,2016-2017,Age,24 Months,89.2,87.4 to 90.8,2874
Hep B,≥2 Doses,States/Local Areas,Texas,2011,Age,7 Months,90.2,87.6 to 92.2,1195
PCV,≥3 Doses,States/Local Areas,Texas,2012,Age,13 Months,87.3,85.1 to 89.1,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2016,Age,24 Months,88.6,86.2 to 90.7,1603
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,87.3,85.3 to 89.1,2874
Hep B,≥3 Doses,States/Local Areas,Texas,2015,Age,24 Months,90.4,88.3 to 92.3,1640
Hep B,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,89.5,88.0 to 91.0,3243
Hep B,≥3 Doses,States/Local Areas,Texas,2014,Age,24 Months,88.6,86.2 to 90.8,1413
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,89.5,87.9 to 91.0,3053
PCV,≥3 Doses,States/Local Areas,Texas,2019,Age,7 Months,72.4,67.0 to 77.2,919
PCV,≥3 Doses,States/Local Areas,Texas,2011,Age,13 Months,85.2,78.2 to 90.3,1195
PCV,≥3 Doses,States/Local Areas,Texas,2018,Age,7 Months,73.6,69.2 to 77.6,1065
PCV,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,73.0,69.6 to 76.2,1984
Hep B,≥2 Doses,States/Local Areas,Texas,2014,Age,7 Months,91.3,89.1 to 93.1,1413
Hep B,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,91.7,90.3 to 92.9,3053
Hep B,≥2 Doses,States/Local Areas,Texas,2012,Age,7 Months,92.8,91.2 to 94.1,1359
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2019,Age,0-1 Days,79.2,74.3 to 83.3,919
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2011,Age,0-2 Days,78.4,74.2 to 82.0,1195
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2018,Age,0-1 Days,78.9,74.9 to 82.4,1065
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2018-2019,Age,0-1 Days,79.0,75.9 to 81.8,1984
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2013,Age,0-2 Days,75.9,72.6 to 79.0,1375
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2013-2014,Age,0-2 Days,75.8,73.7 to 77.7,2788
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2012,Age,0-2 Days,76.7,73.4 to 79.8,1359
Hep B,≥2 Doses,States/Local Areas,Texas,2013,Age,7 Months,90.5,88.7 to 92.2,1375
Hep B,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,90.9,89.5 to 92.1,2788
Hep B,≥3 Doses,States/Local Areas,Texas,2019,Age,19 Months,87.7,83.6 to 90.9,919
Hep B,≥3 Doses,States/Local Areas,Texas,2011,Age,24 Months,87.2,83.5 to 90.4,1195
Hep B,≥3 Doses,States/Local Areas,Texas,2013,Age,24 Months,87.9,85.2 to 90.4,1375
Hep B,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,88.3,86.5 to 89.9,2788
PCV,≥3 Doses,States/Local Areas,Texas,2016,Age,7 Months,68.7,65.4 to 71.8,1603
PCV,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,69.3,66.9 to 71.7,2874
Hep B,≥3 Doses,States/Local Areas,Texas,2012,Age,24 Months,89.7,86.9 to 92.0,1359
PCV,≥3 Doses,States/Local Areas,Texas,2017,Age,7 Months,69.9,66.2 to 73.5,1271
PCV,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,71.8,68.9 to 74.5,2336
PCV,≥3 Doses,States/Local Areas,Texas,2015,Age,7 Months,68.4,65.2 to 71.5,1640
PCV,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,68.6,66.3 to 70.8,3243
PCV,≥4 Doses,States/Local Areas,Texas,2014,Age,19 Months,76.5,73.3 to 79.4,1413
PCV,≥4 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,77.2,75.1 to 79.3,3053
PCV,≥4 Doses,States/Local Areas,Texas,2015,Age,19 Months,78.0,76.1 to 79.7,1640
PCV,≥4 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,77.2,75.0 to 79.2,3243
PCV,≥4 Doses,States/Local Areas,Texas,2016,Age,19 Months,76.4,73.2 to 79.2,1603
PCV,≥4 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,76.0,73.7 to 78.2,2874
≥1 Dose Varicella,,States/Local Areas,Texas,2018,Age,24 Months,92.0,89.2 to 94.3,1065
≥1 Dose Varicella,,States/Local Areas,Texas,2018-2019,Age,24 Months,90.7,88.4 to 92.6,1984
≥1 Dose MMR,,States/Local Areas,Texas,2015,Age,24 Months,90.2,88.0 to 92.1,1640
≥1 Dose MMR,,States/Local Areas,Texas,2015-2016,Age,24 Months,89.9,88.3 to 91.3,3243
≥1 Dose MMR,,States/Local Areas,Texas,2014,Age,24 Months,89.9,87.5 to 91.9,1413
≥1 Dose MMR,,States/Local Areas,Texas,2014-2015,Age,24 Months,90.0,88.4 to 91.5,3053
≥1 Dose MMR,,States/Local Areas,Texas,2013,Age,24 Months,88.8,86.2 to 91.1,1375
≥1 Dose MMR,,States/Local Areas,Texas,2013-2014,Age,24 Months,89.3,87.6 to 90.9,2788
≥1 Dose Varicella,,States/Local Areas,Texas,2019,Age,24 Months,89.3,85.7 to 92.4,919
≥1 Dose Varicella,,States/Local Areas,Texas,2017,Age,24 Months,87.1,84.0 to 89.7,1271
≥1 Dose Varicella,,States/Local Areas,Texas,2017-2018,Age,24 Months,89.5,87.5 to 91.3,2336
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2015,Age,0-1 Days,73.2,70.1 to 76.0,1640
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2015-2016,Age,0-1 Days,72.9,70.7 to 75.0,3243
Hep B,≥2 Doses,States/Local Areas,Texas,2018,Age,5 Months,90.1,87.0 to 92.5,1065
Hep B,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,5 Months,89.9,87.6 to 91.8,1984
Hep B,≥2 Doses,States/Local Areas,Texas,2019,Age,5 Months,89.7,86.0 to 92.5,919
Hep B,≥2 Doses,States/Local Areas,Texas,2017,Age,5 Months,85.2,82.1 to 87.9,1271
Hep B,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,5 Months,87.6,85.5 to 89.5,2336
≥1 Dose Varicella,,States/Local Areas,Texas,2014,Age,24 Months,90.8,88.5 to 92.8,1413
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2015,Age,24 Months,89.9,88.2 to 91.4,3053
PCV,≥4 Doses,States/Local Areas,Texas,2020,Age,35 Months,79.2,73.2 to 84.7,795
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2016,Age,0-1 Days,72.7,69.5 to 75.7,1603
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2016-2017,Age,0-1 Days,73.0,70.5 to 75.3,2874
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2017,Age,0-1 Days,73.3,69.4 to 76.8,1271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2017-2018,Age,0-1 Days,76.1,73.3 to 78.6,2336
≥1 Dose MMR,,States/Local Areas,Texas,2017,Age,19 Months,86.1,83.0 to 88.7,1271
≥1 Dose MMR,,States/Local Areas,Texas,2017-2018,Age,19 Months,87.5,85.3 to 89.4,2336
≥1 Dose MMR,,States/Local Areas,Texas,2019,Age,19 Months,87.0,82.9 to 90.3,919
≥1 Dose MMR,,States/Local Areas,Texas,2018,Age,19 Months,88.9,85.7 to 91.5,1065
≥1 Dose MMR,,States/Local Areas,Texas,2018-2019,Age,19 Months,93.8,91.9 to 95.3,1984
PCV,≥4 Doses,States/Local Areas,Texas,2013,Age,19 Months,75.6,72.6 to 78.4,1375
PCV,≥4 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,76.1,74.4 to 77.6,2788
PCV,≥4 Doses,States/Local Areas,Texas,2012,Age,19 Months,77.2,72.9 to 81.1,1359
PCV,≥4 Doses,States/Local Areas,Texas,2011,Age,19 Months,72.0,67.0 to 76.5,1195
≥1 Dose MMR,,States/Local Areas,Texas,2011,Age,24 Months,89.6,86.1 to 92.6,1195
≥1 Dose Varicella,,States/Local Areas,Texas,2015,Age,24 Months,88.9,86.5 to 91.0,1640
≥1 Dose Varicella,,States/Local Areas,Texas,2015-2016,Age,24 Months,89.2,87.5 to 90.7,3243
≥1 Dose Varicella,,States/Local Areas,Texas,2016,Age,24 Months,89.4,87.1 to 91.5,1603
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2017,Age,24 Months,88.3,86.4 to 90.0,2874
≥1 Dose Varicella,,States/Local Areas,Texas,2019,Age,19 Months,87.3,83.3 to 90.5,919
Polio,≥2 Doses,States/Local Areas,Texas,2019,Age,13 Months,93.2,89.9 to 95.4,919
Polio,≥2 Doses,States/Local Areas,Texas,2018,Age,13 Months,95.0,92.6 to 96.7,1065
Polio,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,94.1,92.2 to 95.6,1984
Polio,≥2 Doses,States/Local Areas,Texas,2017,Age,13 Months,89.5,86.6 to 91.9,1271
Polio,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,92.3,90.4 to 93.8,2336
≥1 Dose Varicella,,States/Local Areas,Texas,2013,Age,24 Months,88.0,85.3 to 90.4,1375
≥1 Dose Varicella,,States/Local Areas,Texas,2013-2014,Age,24 Months,89.4,87.7 to 91.0,2788
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2013,Age,0-1 Days,72.5,68.9 to 75.8,1375
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2013-2014,Age,0-1 Days,71.9,69.5 to 74.2,2788
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2014,Age,0-1 Days,71.4,68.1 to 74.5,1413
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2014-2015,Age,0-1 Days,72.3,70.0 to 74.4,3053
Hep B,≥2 Doses,States/Local Areas,Texas,2015,Age,5 Months,88.1,86.0 to 90.0,1640
Hep B,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,5 Months,87.8,86.2 to 89.3,3243
Hep B,≥3 Doses,States/Local Areas,Texas,2018,Age,19 Months,89.6,86.3 to 92.2,1065
Hep B,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,87.5,84.9 to 89.7,1984
Hep B,≥3 Doses,States/Local Areas,Texas,2017,Age,19 Months,85.2,81.9 to 88.0,1271
Hep B,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,87.4,85.1 to 89.4,2336
Hep B,≥2 Doses,States/Local Areas,Texas,2016,Age,5 Months,87.5,85.0 to 89.7,1603
Hep B,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,5 Months,86.4,84.4 to 88.1,2874
Hep B,≥2 Doses,States/Local Areas,Texas,2014,Age,5 Months,85.3,82.6 to 87.6,1413
Hep B,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,5 Months,86.7,84.8 to 88.4,3053
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2012,Age,0-1 Days,73.4,69.7 to 76.9,1359
PCV,≥3 Doses,States/Local Areas,Texas,2013,Age,7 Months,64.9,60.3 to 69.2,1375
PCV,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,65.0,62.1 to 67.9,2788
PCV,≥3 Doses,States/Local Areas,Texas,2011,Age,7 Months,62.6,55.4 to 69.3,1195
Hep B,≥3 Doses,States/Local Areas,Texas,2016,Age,19 Months,88.1,85.6 to 90.2,1603
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,86.7,84.7 to 88.4,2874
PCV,≥3 Doses,States/Local Areas,Texas,2014,Age,7 Months,65.1,61.6 to 68.5,1413
PCV,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,66.8,64.4 to 69.1,3053
PCV,≥3 Doses,States/Local Areas,Texas,2012,Age,7 Months,63.8,60.2 to 67.2,1359
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,78.3,75.1 to 81.5,1676
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,88.0,85.5 to 90.5,1491
≥1 Dose MMR,,States/Local Areas,Texas,2019,Age,13 Months,69.4,63.9 to 74.5,919
≥1 Dose Varicella,,States/Local Areas,Texas,2016,Age,19 Months,87.6,85.1 to 89.7,1603
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2017,Age,19 Months,86.2,84.3 to 88.0,2874
Polio,≥2 Doses,States/Local Areas,Texas,2015,Age,13 Months,93.6,91.7 to 95.1,1640
Polio,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,92.9,91.5 to 94.1,3243
Polio,≥2 Doses,States/Local Areas,Texas,2016,Age,13 Months,92.2,90.1 to 93.9,1603
Polio,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,90.9,89.1 to 92.4,2874
Hep B,≥1 Dose,States/Local Areas,Texas,2017,Age,3 Months,94.6,92.3 to 96.2,1271
Hep B,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,3 Months,95.3,93.7 to 96.5,2336
≥1 Dose Varicella,,States/Local Areas,Texas,2018,Age,19 Months,88.7,85.4 to 91.4,1065
≥1 Dose Varicella,,States/Local Areas,Texas,2018-2019,Age,19 Months,67.9,64.4 to 71.2,1984
≥1 Dose Varicella,,States/Local Areas,Texas,2017,Age,19 Months,84.9,81.7 to 87.6,1271
≥1 Dose Varicella,,States/Local Areas,Texas,2017-2018,Age,19 Months,86.8,84.6 to 88.8,2336
≥1 Dose MMR,,States/Local Areas,Texas,2013,Age,19 Months,86.2,83.1 to 88.7,1375
≥1 Dose MMR,,States/Local Areas,Texas,2013-2014,Age,19 Months,86.2,84.7 to 87.5,2788
≥1 Dose MMR,,States/Local Areas,Texas,2012,Age,19 Months,88.8,84.9 to 91.7,1359
DTaP,≥4 Doses,States/Local Areas,Texas,2018,Age,35 Months,84.7,80.3 to 88.6,1065
DTaP,≥4 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,85.2,81.9 to 88.1,1984
DTaP,≥4 Doses,States/Local Areas,Texas,2019,Age,35 Months,85.6,80.7 to 89.8,919
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,83.4,81.1 to 85.8,2524
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,76.1,73.4 to 78.8,2412
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.0,60.9 to 75.2,363
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,80.9,73.7 to 88.1,315
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,62.0,53.2 to 70.8,297
≥1 Dose MMR,,States/Local Areas,Texas,2011,Age,19 Months,86.8,82.6 to 90.2,1195
Hep B,≥3 Doses,States/Local Areas,Texas,2019,Age,13 Months,86.6,82.4 to 89.9,919
Hep B,≥3 Doses,States/Local Areas,Texas,2011,Age,19 Months,86.1,82.1 to 89.3,1195
Hep B,≥3 Doses,States/Local Areas,Texas,2018,Age,13 Months,88.4,85.0 to 91.2,1065
Hep B,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,87.5,84.9 to 89.7,1984
Hep B,≥3 Doses,States/Local Areas,Texas,2012,Age,19 Months,88.9,86.5 to 91.0,1359
Hep B,≥1 Dose,States/Local Areas,Texas,2019,Age,3 Months,96.2,93.7 to 97.7,919
Polio,≥2 Doses,States/Local Areas,Texas,2014,Age,13 Months,92.3,90.2 to 94.0,1413
Polio,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,93.0,91.6 to 94.1,3053
Hep B,≥1 Dose,States/Local Areas,Texas,2018,Age,3 Months,96.0,93.4 to 97.6,1065
Hep B,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,3 Months,96.1,94.4 to 97.3,1984
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2011,Age,0-1 Days,73.3,69.4 to 76.8,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,78.9,74.1 to 83.6,1676
Hep B,≥2 Doses,States/Local Areas,Texas,2012,Age,5 Months,87.3,85.6 to 88.9,1359
Hep B,≥2 Doses,States/Local Areas,Texas,2011,Age,5 Months,86.5,83.9 to 88.7,1195
Hep B,≥2 Doses,States/Local Areas,Texas,2013,Age,5 Months,85.2,82.4 to 87.6,1375
Hep B,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,5 Months,85.2,83.2 to 87.1,2788
Hep B,≥3 Doses,States/Local Areas,Texas,2013,Age,19 Months,86.8,84.4 to 88.8,1375
Hep B,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,87.0,85.5 to 88.3,2788
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,83.5,79.4 to 87.6,1491
Hep B,≥3 Doses,States/Local Areas,Texas,2014,Age,19 Months,87.2,84.6 to 89.4,1413
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,88.4,86.8 to 89.9,3053
Hep B,≥3 Doses,States/Local Areas,Texas,2015,Age,19 Months,89.7,87.7 to 91.3,1640
Hep B,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,88.9,87.3 to 90.3,3243
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,78.6,76.2 to 80.9,3481
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.3,76.5 to 82.1,1801
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,75.0,67.4 to 82.7,266
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,78.6,76.9 to 80.4,5548
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.1,76.4 to 85.9,546
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.8,76.7 to 82.9,1682
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,79.7,77.4 to 82.1,2957
≥1 Dose MMR,,States/Local Areas,Texas,2015,Age,19 Months,88.1,86.5 to 89.6,1640
≥1 Dose MMR,,States/Local Areas,Texas,2015-2016,Age,19 Months,87.9,86.2 to 89.4,3243
≥1 Dose MMR,,States/Local Areas,Texas,2016,Age,19 Months,87.7,85.3 to 89.8,1603
≥1 Dose MMR,,States/Local Areas,Texas,2016-2017,Age,19 Months,86.9,85.0 to 88.6,2874
≥1 Dose Varicella,,States/Local Areas,Texas,2011,Age,24 Months,90.8,87.5 to 93.6,1195
≥1 Dose Varicella,,States/Local Areas,Texas,2012,Age,24 Months,90.9,88.3 to 93.2,1359
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,74.1,71.3 to 76.9,2381
≥1 Dose MMR,,States/Local Areas,Texas,2014,Age,19 Months,86.2,83.5 to 88.5,1413
≥1 Dose MMR,,States/Local Areas,Texas,2014-2015,Age,19 Months,87.2,85.4 to 88.7,3053
DTaP,≥4 Doses,States/Local Areas,Texas,2017,Age,35 Months,82.6,78.9 to 86.0,1271
DTaP,≥4 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,83.8,80.9 to 86.5,2336
DTaP,≥4 Doses,States/Local Areas,Texas,2016,Age,35 Months,86.4,83.3 to 89.2,1603
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,84.8,82.3 to 87.0,2874
Hep B,≥3 Doses,States/Local Areas,Texas,2016,Age,13 Months,85.4,82.7 to 87.7,1603
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,84.1,82.0 to 86.0,2874
Hep B,≥3 Doses,States/Local Areas,Texas,2015,Age,13 Months,86.8,84.3 to 88.9,1640
Hep B,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,86.1,84.3 to 87.7,3243
DTaP,≥4 Doses,States/Local Areas,Texas,2015,Age,35 Months,88.8,85.3 to 91.8,1640
DTaP,≥4 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,87.5,85.1 to 89.6,3243
Hep B,≥3 Doses,States/Local Areas,Texas,2017,Age,13 Months,82.8,79.4 to 85.7,1271
Hep B,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,85.6,83.2 to 87.7,2336
PCV,≥4 Doses,States/Local Areas,Texas,2019,Age,35 Months,87.1,82.6 to 91.0,919
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,85.9,83.8 to 88.1,2524
≥1 Dose Varicella,,States/Local Areas,Texas,2011,Age,35 Months,92.9,89.3 to 95.6,1195
PCV,≥1 Dose,States/Local Areas,Texas,2012,Age,3 Months,84.6,82.8 to 86.3,1359
≥1 Dose MMR,,States/Local Areas,Texas,2012,Age,24 Months,91.5,89.0 to 93.7,1359
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,79.4,69.3 to 89.6,315
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.5,59.2 to 79.7,363
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,90.7,88.4 to 93.0,1491
Polio,≥2 Doses,States/Local Areas,Texas,2018,Age,7 Months,92.4,89.3 to 94.6,1065
Polio,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,92.2,90.0 to 94.0,1984
Hep B,≥1 Dose,States/Local Areas,Texas,2013,Age,3 Months,94.4,93.1 to 95.5,1375
Hep B,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,3 Months,94.6,93.6 to 95.5,2788
Hep B,≥1 Dose,States/Local Areas,Texas,2012,Age,3 Months,95.3,93.7 to 96.4,1359
Hep B,≥1 Dose,States/Local Areas,Texas,2011,Age,3 Months,94.5,92.1 to 96.2,1195
Polio,≥2 Doses,States/Local Areas,Texas,2016,Age,7 Months,87.8,85.3 to 90.0,1603
Polio,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,87.0,85.0 to 88.8,2874
Polio,≥2 Doses,States/Local Areas,Texas,2017,Age,7 Months,86.2,83.0 to 88.8,1271
Polio,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,89.2,87.1 to 91.0,2336
Polio,≥2 Doses,States/Local Areas,Texas,2019,Age,7 Months,92.1,88.5 to 94.6,919
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,80.1,77.4 to 82.7,5548
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,79.0,74.8 to 83.2,2381
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,70.5,60.1 to 80.9,266
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,79.7,76.1 to 83.3,2524
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,83.1,79.1 to 87.1,2412
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,55.7,44.2 to 67.3,297
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.4,73.6 to 83.2,1801
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,74.7 to 83.7,1682
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,82.6,79.5 to 85.8,3481
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,82.5,78.8 to 86.2,2957
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,74.1 to 86.5,546
≥1 Dose Varicella,,States/Local Areas,Texas,2016,Age,13 Months,66.3,63.0 to 69.5,1603
≥1 Dose Varicella,,States/Local Areas,Texas,2016-2017,Age,13 Months,64.3,61.8 to 66.8,2874
≥1 Dose Varicella,,States/Local Areas,Texas,2017,Age,13 Months,62.3,58.4 to 66.1,1271
≥1 Dose Varicella,,States/Local Areas,Texas,2017-2018,Age,13 Months,65.4,62.5 to 68.2,2336
≥1 Dose Varicella,,States/Local Areas,Texas,2015,Age,13 Months,62.2,58.8 to 65.4,1640
≥1 Dose Varicella,,States/Local Areas,Texas,2015-2016,Age,13 Months,64.2,61.9 to 66.5,3243
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.5,82.1 to 90.9,546
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.2,84.6 to 89.8,1682
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,88.7,86.9 to 90.6,3481
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,81.7,74.7 to 88.8,266
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.6,84.2 to 88.9,1801
Polio,≥2 Doses,States/Local Areas,Texas,2014,Age,7 Months,87.8,85.2 to 90.1,1413
Polio,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,88.8,87.1 to 90.3,3053
Polio,≥2 Doses,States/Local Areas,Texas,2013,Age,7 Months,86.8,84.0 to 89.2,1375
Polio,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,87.3,85.8 to 88.7,2788
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Overall,Overall,87.3,85.9 to 88.8,5548
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,86.0,83.6 to 88.4,2381
Polio,≥2 Doses,States/Local Areas,Texas,2015,Age,7 Months,89.7,87.5 to 91.6,1640
Polio,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,88.8,87.1 to 90.3,3243
Hep B,≥3 Doses,States/Local Areas,Texas,2011,Age,13 Months,82.1,78.2 to 85.5,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2018,Age,35 Months,81.1,75.6 to 86.1,1065
Hep A,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,82.9,78.8 to 86.7,1984
Hep A,≥2 Doses,States/Local Areas,Texas,2017,Age,35 Months,78.6,73.8 to 83.1,1271
Hep A,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,80.2,76.3 to 83.7,2336
Hep B,≥3 Doses,States/Local Areas,Texas,2013,Age,13 Months,84.0,80.7 to 86.8,1375
Hep B,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,83.8,81.8 to 85.7,2788
Hep B,≥3 Doses,States/Local Areas,Texas,2014,Age,13 Months,83.7,80.9 to 86.2,1413
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,85.2,83.4 to 86.9,3053
Hep A,≥2 Doses,States/Local Areas,Texas,2019,Age,35 Months,84.9,78.5 to 90.1,919
Hep B,≥3 Doses,States/Local Areas,Texas,2012,Age,13 Months,86.7,83.9 to 89.0,1359
DTaP,≥4 Doses,States/Local Areas,Texas,2013,Age,35 Months,84.2,80.6 to 87.5,1375
DTaP,≥4 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,85.1,82.7 to 87.4,2788
DTaP,≥4 Doses,States/Local Areas,Texas,2012,Age,35 Months,84.8,81.3 to 88.0,1359
DTaP,≥4 Doses,States/Local Areas,Texas,2014,Age,35 Months,85.9,82.6 to 88.8,1413
DTaP,≥4 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,87.2,84.8 to 89.4,3053
≥1 Dose Varicella,,States/Local Areas,Texas,2018,Age,13 Months,68.5,64.2 to 72.6,1065
≥1 Dose Varicella,,States/Local Areas,Texas,2018-2019,Age,13 Months,67.9,64.4 to 71.2,1984
≥1 Dose MMR,,States/Local Areas,Texas,2013,Age,13 Months,61.6,58.3 to 64.8,1375
≥1 Dose MMR,,States/Local Areas,Texas,2013-2014,Age,13 Months,61.9,59.3 to 64.3,2788
≥1 Dose Varicella,,States/Local Areas,Texas,2019,Age,13 Months,67.3,61.8 to 72.4,919
≥1 Dose Varicella,,States/Local Areas,Texas,2011,Age,19 Months,87.2,81.9 to 91.1,1195
≥1 Dose Varicella,,States/Local Areas,Texas,2012,Age,19 Months,88.0,84.2 to 90.9,1359
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,86.7,84.1 to 89.4,1676
≥1 Dose MMR,,States/Local Areas,Texas,2014,Age,13 Months,62.1,58.6 to 65.5,1413
≥1 Dose MMR,,States/Local Areas,Texas,2014-2015,Age,13 Months,63.3,60.9 to 65.7,3053
≥1 Dose MMR,,States/Local Areas,Texas,2015,Age,13 Months,64.6,61.2 to 67.7,1640
≥1 Dose MMR,,States/Local Areas,Texas,2015-2016,Age,13 Months,65.8,63.5 to 68.1,3243
Polio,≥2 Doses,States/Local Areas,Texas,2013,Age,13 Months,91.8,89.7 to 93.5,1375
Polio,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,92.1,90.8 to 93.2,2788
Hep B,≥1 Dose,States/Local Areas,Texas,2014,Age,3 Months,94.8,93.0 to 96.2,1413
Hep B,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,3 Months,95.0,93.8 to 95.9,3053
Hep B,≥1 Dose,States/Local Areas,Texas,2015,Age,3 Months,95.1,93.6 to 96.3,1640
Hep B,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,3 Months,95.2,94.1 to 96.1,3243
Hep B,≥1 Dose,States/Local Areas,Texas,2016,Age,3 Months,95.2,93.5 to 96.5,1603
Hep B,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,3 Months,94.9,93.6 to 96.0,2874
≥1 Dose MMR,,States/Local Areas,Texas,2018,Age,13 Months,72.6,68.4 to 76.5,1065
≥1 Dose MMR,,States/Local Areas,Texas,2018-2019,Age,13 Months,71.0,67.6 to 74.3,1984
≥1 Dose MMR,,States/Local Areas,Texas,2016,Age,13 Months,67.1,63.8 to 70.2,1603
≥1 Dose MMR,,States/Local Areas,Texas,2016-2017,Age,13 Months,65.9,63.3 to 68.3,2874
≥1 Dose MMR,,States/Local Areas,Texas,2017,Age,13 Months,64.6,60.7 to 68.3,1271
≥1 Dose MMR,,States/Local Areas,Texas,2017-2018,Age,13 Months,68.6,65.7 to 71.3,2336
≥1 Dose Varicella,,States/Local Areas,Texas,2014,Age,19 Months,86.7,84.0 to 88.9,1413
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2015,Age,19 Months,87.1,85.3 to 88.7,3053
≥1 Dose Varicella,,States/Local Areas,Texas,2015,Age,19 Months,87.5,86.1 to 88.8,1640
≥1 Dose Varicella,,States/Local Areas,Texas,2015-2016,Age,19 Months,87.5,85.8 to 89.1,3243
≥1 Dose Varicella,,States/Local Areas,Texas,2013,Age,19 Months,86.5,84.3 to 88.4,1375
≥1 Dose Varicella,,States/Local Areas,Texas,2013-2014,Age,19 Months,86.6,85.6 to 87.5,2788
Polio,≥2 Doses,States/Local Areas,Texas,2012,Age,13 Months,93.5,91.7 to 95.0,1359
Polio,≥2 Doses,States/Local Areas,Texas,2011,Age,13 Months,93.3,90.0 to 95.6,1195
DTaP,≥4 Doses,States/Local Areas,Texas,2019,Age,24 Months,79.1,74.3 to 83.5,919
DTaP,≥4 Doses,States/Local Areas,Texas,2011,Age,35 Months,84.1,79.1 to 88.5,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2015,Age,24 Months,49.5,46.2 to 53.0,1640
Hep A,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,49.2,46.8 to 51.8,3243
Hep A,≥2 Doses,States/Local Areas,Texas,2017,Age,24 Months,49.5,45.5 to 53.7,1271
Hep A,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,47.9,44.8 to 51.1,2336
Hep A,≥2 Doses,States/Local Areas,Texas,2016,Age,24 Months,48.9,45.4 to 52.5,1603
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,49.2,46.6 to 52.0,2874
DTaP,≥4 Doses,States/Local Areas,Texas,2013,Age,24 Months,77.7,74.3 to 80.9,1375
DTaP,≥4 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,78.6,76.4 to 80.8,2788
DTaP,≥4 Doses,States/Local Areas,Texas,2019,Age,19 Months,73.1,67.8 to 77.8,919
Hep B,≥3 Doses,States/Local Areas,Texas,2013,Age,7 Months,64.9,59.9 to 69.6,1375
Hep B,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,63.5,60.1 to 66.7,2788
DTaP,≥4 Doses,States/Local Areas,Texas,2011,Age,24 Months,76.7,72.0 to 81.1,1195
DTaP,≥4 Doses,States/Local Areas,Texas,2012,Age,24 Months,80.3,76.8 to 83.7,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2012,Age,7 Months,63.9,58.7 to 68.8,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2011,Age,7 Months,60.1,56.2 to 63.9,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,91.6,89.3 to 93.8,1676
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,94.6,92.8 to 96.5,1491
DTaP,≥4 Doses,States/Local Areas,Texas,2018,Age,24 Months,78.7,74.7 to 82.6,1065
DTaP,≥4 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,78.9,75.8 to 81.9,1984
DTaP,≥4 Doses,States/Local Areas,Texas,2017,Age,24 Months,78.5,75.0 to 81.8,1271
DTaP,≥4 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,78.6,76.0 to 81.2,2336
≥1 Dose MMR,,States/Local Areas,Texas,2012,Age,13 Months,64.0,59.4 to 68.5,1359
≥1 Dose MMR,,States/Local Areas,Texas,2011,Age,13 Months,62.4,57.1 to 67.5,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,89.3,87.2 to 91.4,2381
≥1 Dose Varicella,,States/Local Areas,Texas,2011,Age,13 Months,60.6,54.3 to 66.5,1195
≥1 Dose Varicella,,States/Local Areas,Texas,2013,Age,13 Months,61.2,58.0 to 64.3,1375
≥1 Dose Varicella,,States/Local Areas,Texas,2013-2014,Age,13 Months,61.2,59.1 to 63.3,2788
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.2,74.9 to 87.5,363
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,89.9,84.8 to 95.0,315
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,75.3,67.5 to 83.0,297
Polio,≥2 Doses,States/Local Areas,Texas,2018,Age,5 Months,83.7,79.8 to 87.0,1065
Polio,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,5 Months,83.8,80.9 to 86.4,1984
Hep A,≥1 Dose,States/Local Areas,Texas,2019,Age,35 Months,94.8,89.9 to 97.8,919
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,89.4,87.5 to 91.3,2524
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,86.6,84.3 to 88.9,2412
Hep A,≥1 Dose,States/Local Areas,Texas,2018,Age,35 Months,92.9,90.1 to 95.1,1065
Hep A,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,35 Months,93.6,91.1 to 95.6,1984
≥1 Dose Varicella,,States/Local Areas,Texas,2012,Age,13 Months,63.2,58.3 to 67.9,1359
≥1 Dose Varicella,,States/Local Areas,Texas,2014,Age,13 Months,61.2,57.7 to 64.7,1413
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2015,Age,13 Months,61.7,59.3 to 64.1,3053
Hep B,≥3 Doses,States/Local Areas,Texas,2019,Age,7 Months,64.3,58.6 to 69.6,919
Hep B,≥3 Doses,States/Local Areas,Texas,2016,Age,7 Months,65.5,62.2 to 68.7,1603
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,64.2,61.6 to 66.6,2874
Hep A,≥2 Doses,States/Local Areas,Texas,2014,Age,35 Months,77.2,73.0 to 81.1,1413
Hep A,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,80.0,77.0 to 82.9,3053
Hep A,≥2 Doses,States/Local Areas,Texas,2016,Age,35 Months,81.2,77.2 to 84.9,1603
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,80.2,77.1 to 83.1,2874
Hep A,≥2 Doses,States/Local Areas,Texas,2015,Age,35 Months,83.3,78.8 to 87.2,1640
Hep A,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,82.2,79.2 to 85.0,3243
Hep B,≥3 Doses,States/Local Areas,Texas,2018,Age,7 Months,70.0,65.6 to 74.0,1065
Hep B,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,67.1,63.6 to 70.5,1984
Hep B,≥3 Doses,States/Local Areas,Texas,2017,Age,7 Months,62.7,58.8 to 66.5,1271
Hep B,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,66.3,63.4 to 69.1,2336
Polio,≥2 Doses,States/Local Areas,Texas,2019,Age,5 Months,84.0,79.4 to 87.6,919
Hep A,≥1 Dose,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,88.9,87.0 to 90.8,2957
Polio,≥2 Doses,States/Local Areas,Texas,2012,Age,7 Months,88.1,86.4 to 89.5,1359
Polio,≥2 Doses,States/Local Areas,Texas,2011,Age,7 Months,90.5,85.4 to 94.0,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2018,Age,24 Months,46.2,41.5 to 51.2,1065
Hep A,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,51.7,47.9 to 55.5,1984
Hep A,≥2 Doses,States/Local Areas,Texas,2019,Age,24 Months,57.1,51.5 to 62.9,919
Polio,≥2 Doses,States/Local Areas,Texas,2015,Age,5 Months,80.3,77.5 to 82.8,1640
Polio,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,5 Months,78.9,76.8 to 80.8,3243
Hep A,≥2 Doses,States/Local Areas,Texas,2011,Age,35 Months,79.6,73.9 to 84.7,1195
Hep A,≥2 Doses,States/Local Areas,Texas,2012,Age,35 Months,76.2,71.3 to 80.8,1359
Hep A,≥2 Doses,States/Local Areas,Texas,2013,Age,35 Months,77.3,72.7 to 81.5,1375
Hep A,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,77.3,74.2 to 80.2,2788
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,90.1,84.9 to 93.7,363
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,89.4 to 95.4,594
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2021,Age,0-1 Days,69.7,60.2 to 77.7,216
Hib,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,95.2,91.6 to 97.3,579
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020,Age,13 Months,55.3,47.8 to 62.5,363
PCV,≥3 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,88.9,82.8 to 93.1,363
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,71.4,63.8 to 78.0,363
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,93.8,88.5 to 96.7,363
DTaP,≥4 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,71.5,64.1 to 77.9,363
Polio,≥3 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,93.8,88.5 to 96.8,363
≥1 Dose MMR,,States/Local Areas,Tennessee,2020,Age,19 Months,90.1,84.5 to 93.8,363
Hib,≥3 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,89.6,83.8 to 93.5,363
Rotavirus,,States/Local Areas,Tennessee,2020,Age,8 Months,70.0,62.2 to 76.7,363
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2020,Age,0-3 Days,71.0,63.4 to 77.5,363
Influenza,,States/Local Areas,Tennessee,2020,Age,24 Months,56.5,49.1 to 64.2,363
PCV,≥3 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,94.9,90.6 to 97.6,363
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,98.1,93.9 to 99.6,363
Hep A,≥1 Dose,States/Local Areas,Tennessee,2020,Age,24 Months,88.9,83.2 to 93.3,363
PCV,≥4 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,81.8,75.1 to 87.5,363
Hep A,≥2 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,51.2,43.7 to 59.1,363
PCV,≥1 Dose,States/Local Areas,Tennessee,2020,Age,3 Months,86.6,80.0 to 91.2,363
Combined 7 Series,,States/Local Areas,Tennessee,2020,Age,24 Months,65.3,58.0 to 72.5,363
Hep B,≥1 Dose,States/Local Areas,Tennessee,2020,Age,3 Months,96.9,93.2 to 98.7,363
DTaP,≥2 Doses,States/Local Areas,Tennessee,2020,Age,5 Months,77.1,69.5 to 83.2,363
Polio,≥2 Doses,States/Local Areas,Tennessee,2020,Age,5 Months,77.5,69.9 to 83.6,363
Hib,≥2 Doses,States/Local Areas,Tennessee,2020,Age,5 Months,75.0,67.4 to 81.3,363
Hep B,≥2 Doses,States/Local Areas,Tennessee,2020,Age,5 Months,88.7,82.4 to 92.9,363
Rotavirus,,States/Local Areas,Tennessee,2019-2020,Age,8 Months,70.9,65.9 to 75.5,759
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020-2021,Age,35 Months,96.0,92.7 to 98.1,579
Hib,≥1 Dose,States/Local Areas,Tennessee,2020,Age,3 Months,85.0,78.4 to 89.8,363
Polio,≥1 Dose,States/Local Areas,Tennessee,2020,Age,3 Months,87.6,81.3 to 92.0,363
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,72.8,65.4 to 79.1,363
PCV,≥3 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,69.3,61.5 to 76.1,363
Hep A,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,35 Months,93.5,89.6 to 96.3,579
PCV,≥3 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,93.2,86.4 to 96.7,216
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2020,Age,0-2 Days,71.0,63.4 to 77.5,363
Hib,≥2 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,89.3,83.3 to 93.3,363
DTaP,≥1 Dose,States/Local Areas,Tennessee,2020,Age,3 Months,87.9,81.5 to 92.2,363
Polio,≥2 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,90.1,84.2 to 94.0,363
Hib,≥3 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,42.8,35.7 to 50.2,363
Hib,Primary Series,States/Local Areas,Tennessee,2020,Age,7 Months,69.7,62.1 to 76.4,363
Hep B,≥2 Doses,States/Local Areas,Tennessee,2020,Age,7 Months,94.5,89.8 to 97.1,363
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,93.8,89.0 to 96.9,363
PCV,≥2 Doses,States/Local Areas,Tennessee,2020,Age,5 Months,75.0,67.3 to 81.4,363
DTaP,≥4 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,83.8,77.6 to 89.1,363
Polio,≥3 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,93.8,89.1 to 97.0,363
Hib,≥3 Doses,States/Local Areas,Tennessee,2020,Age,24 Months,92.9,88.2 to 96.2,363
≥1 Dose MMR,,States/Local Areas,Tennessee,2020,Age,24 Months,91.8,87.0 to 95.3,363
≥1 Dose MMR,,States/Local Areas,Tennessee,2020,Age,35 Months,94.6,90.1 to 97.5,363
Hib,Primary Series,States/Local Areas,Tennessee,2020,Age,24 Months,93.4,88.7 to 96.6,363
Hib,Primary Series,States/Local Areas,Tennessee,2020,Age,35 Months,95.7,91.2 to 98.4,363
Hib,≥3 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,95.5,90.9 to 98.2,363
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,95.7,91.7 to 98.1,363
Hib,Full Series,States/Local Areas,Tennessee,2020,Age,35 Months,78.2,71.4 to 84.4,363
Hib,Primary Series,States/Local Areas,Tennessee,2020,Age,19 Months,91.8,86.3 to 95.3,363
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020,Age,35 Months,95.8,91.7 to 98.2,363
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,93.3,88.5 to 96.2,363
Hib,Full Series,States/Local Areas,Tennessee,2020,Age,19 Months,68.3,60.6 to 75.0,363
PCV,≥3 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,94.6,89.8 to 97.2,363
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020,Age,19 Months,90.6,85.3 to 94.1,363
Polio,≥3 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,98.1,94.0 to 99.6,363
DTaP,≥4 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,88.0,82.0 to 92.7,363
PCV,≥4 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,77.4,70.0 to 83.4,363
PCV,≥3 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,95.3,91.0 to 98.0,363
PCV,≥4 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,84.8,78.2 to 90.3,363
Hib,≥3 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,62.4,55.0 to 69.3,363
Hib,Primary Series,States/Local Areas,Tennessee,2020,Age,13 Months,81.8,75.0 to 87.0,363
Hep B,≥2 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,95.3,90.5 to 97.7,363
Hep A,≥2 Doses,States/Local Areas,Tennessee,2020,Age,35 Months,86.8,77.8 to 93.4,363
Combined 7 Series,,States/Local Areas,Tennessee,2020,Age,35 Months,69.1,61.6 to 76.3,363
Hep A,≥1 Dose,States/Local Areas,Tennessee,2020,Age,19 Months,86.4,79.9 to 91.1,363
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2020,Age,0-1 Days,67.3,59.6 to 74.1,363
Hep A,≥2 Doses,States/Local Areas,Tennessee,2020,Age,19 Months,28.3,22.2 to 35.3,363
Hib,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,89.0,85.2 to 92.0,759
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,88.8,85.2 to 91.7,759
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,71.8,66.7 to 76.3,759
Hib,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,3 Months,86.2,82.0 to 89.5,759
Polio,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,3 Months,87.4,83.2 to 90.6,759
Polio,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,90.0,86.3 to 92.8,759
PCV,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,5 Months,77.0,72.1 to 81.3,759
Hep B,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,5 Months,88.2,84.2 to 91.3,759
Hep B,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,94.7,91.7 to 96.7,759
Hib,Primary Series,States/Local Areas,Tennessee,2019-2020,Age,13 Months,80.7,76.2 to 84.5,759
Hib,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,93.5,90.3 to 95.8,759
Hib,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,62.0,57.0 to 66.8,759
≥1 Dose MMR,,States/Local Areas,Tennessee,2019-2020,Age,13 Months,66.0,60.9 to 70.8,759
Polio,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,93.6,90.3 to 95.8,759
Polio,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,5 Months,78.8,73.9 to 82.9,759
Hib,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,5 Months,77.4,72.5 to 81.6,759
DTaP,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,5 Months,79.0,74.1 to 83.1,759
PCV,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,3 Months,87.2,83.1 to 90.5,759
Hep B,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,3 Months,97.0,94.9 to 98.3,759
≥1 Dose MMR,,States/Local Areas,Tennessee,2019-2020,Age,24 Months,90.8,87.4 to 93.5,759
DTaP,≥4 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,81.0,76.6 to 85.1,759
Polio,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,91.9,88.5 to 94.6,759
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,92.6,89.4 to 95.2,759
PCV,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,94.7,91.5 to 96.9,759
PCV,≥4 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,85.5,81.3 to 89.3,759
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019-2020,Age,35 Months,94.9,91.7 to 97.2,759
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,94.7,91.9 to 96.8,759
Hib,Full Series,States/Local Areas,Tennessee,2019-2020,Age,35 Months,77.4,72.7 to 81.8,759
Hib,Primary Series,States/Local Areas,Tennessee,2019-2020,Age,35 Months,94.7,91.3 to 97.1,759
Hib,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,94.6,91.2 to 97.0,759
≥1 Dose MMR,,States/Local Areas,Tennessee,2019-2020,Age,35 Months,93.7,90.3 to 96.2,759
Hib,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,89.0,85.3 to 91.9,759
Hib,Primary Series,States/Local Areas,Tennessee,2019-2020,Age,19 Months,91.0,87.5 to 93.6,759
≥1 Dose MMR,,States/Local Areas,Tennessee,2019-2020,Age,19 Months,87.6,83.7 to 90.7,759
Hep A,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,30.7,26.2 to 35.4,759
PCV,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,93.8,90.8 to 96.1,759
PCV,≥4 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,83.0,78.7 to 86.9,759
Hib,Full Series,States/Local Areas,Tennessee,2019-2020,Age,24 Months,74.9,70.2 to 79.3,759
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,92.9,89.8 to 95.3,759
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019-2020,Age,24 Months,91.4,88.2 to 94.1,759
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2019-2020,Age,0-3 Days,72.9,68.0 to 77.3,759
PCV,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,70.2,65.1 to 74.8,759
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2019-2020,Age,0-2 Days,72.4,67.5 to 76.8,759
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2019-2020,Age,0-1 Days,68.9,63.9 to 73.6,759
PCV,≥4 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,79.2,74.6 to 83.3,759
Hep A,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,19 Months,85.5,81.2 to 89.0,759
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019-2020,Age,19 Months,88.4,84.7 to 91.4,759
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,92.2,88.8 to 94.5,759
Hib,Full Series,States/Local Areas,Tennessee,2019-2020,Age,19 Months,69.8,64.7 to 74.4,759
Combined 7 Series,,States/Local Areas,Tennessee,2019-2020,Age,35 Months,69.2,64.1 to 74.3,759
Hib,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,44.7,39.7 to 49.8,759
Hib,Primary Series,States/Local Areas,Tennessee,2019-2020,Age,24 Months,92.6,89.4 to 95.1,759
Influenza,,States/Local Areas,Tennessee,2019-2020,Age,24 Months,60.1,55.0 to 65.2,759
Hib,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,91.6,88.3 to 94.3,759
Hep A,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,35 Months,92.6,88.9 to 95.4,759
Hep A,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,82.9,76.9 to 88.0,759
Hep A,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,24 Months,89.1,85.2 to 92.3,759
Hep A,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,24 Months,48.2,43.1 to 53.6,759
Polio,≥2 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,94.9,90.2 to 97.5,363
DTaP,≥1 Dose,States/Local Areas,Tennessee,2019-2020,Age,3 Months,88.7,84.7 to 91.8,759
Hib,Primary Series,States/Local Areas,Tennessee,2019-2020,Age,7 Months,70.6,65.6 to 75.2,759
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,88.8,85.0 to 91.8,759
Polio,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,91.5,87.8 to 94.1,759
DTaP,≥4 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,72.6,67.7 to 77.0,759
Polio,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,95.8,92.1 to 98.1,759
DTaP,≥4 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,86.2,81.9 to 89.9,759
Combined 7 Series,,States/Local Areas,Tennessee,2019-2020,Age,24 Months,64.4,59.4 to 69.4,759
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,19 Months,92.3,88.7 to 94.7,759
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,35 Months,96.5,93.0 to 98.6,759
≥1 Dose Varicella,,States/Local Areas,Tennessee,2019-2020,Age,13 Months,57.7,52.5 to 62.6,759
PCV,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,13 Months,88.2,84.2 to 91.3,759
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,92.3,88.4 to 96.2,469
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,59.6,52.8 to 66.3,469
Influenza,,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,75.9,69.1 to 82.6,312
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,80.6,76.9 to 84.3,1176
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,96.0,93.5 to 98.5,312
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,75.8,69.5 to 82.0,380
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,89.4,84.9 to 93.9,380
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,89.0,84.2 to 93.9,312
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,78.1,72.2 to 84.0,484
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,68.6,61.8 to 75.5,380
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,88.8,83.4 to 94.2,312
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,92.9,89.6 to 96.1,484
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,88.7,83.8 to 93.5,380
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,93.2,89.3 to 97.1,484
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,92.6,89.5 to 95.7,484
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,89.7,85.2 to 94.2,380
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,93.5,91.5 to 95.5,1176
Influenza,,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,60.2,53.1 to 67.2,484
Influenza,,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,49.6,42.6 to 56.6,380
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,94.8,91.5 to 98.2,312
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,90.4,86.0 to 94.8,380
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,93.7,91.5 to 95.8,1176
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,95.3,92.6 to 98.0,484
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,78.2,71.7 to 84.6,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,69.2,61.9 to 76.6,312
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,90.2,83.1 to 97.4,484
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,96.1,93.5 to 98.7,312
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,76.0,69.6 to 82.4,484
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,68.0,61.4 to 74.5,380
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,94.6,91.3 to 98.0,312
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,91.1,87.8 to 94.4,594
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,93.1,87.4 to 98.8,196
Hib,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,92.6,88.6 to 95.6,579
PCV,≥4 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,82.8,77.6 to 87.5,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,47.5,38.3 to 56.9,216
Hib,≥2 Doses,States/Local Areas,Tennessee,2021,Age,5 Months,76.0,66.6 to 83.5,216
Hib,Primary Series,States/Local Areas,Tennessee,2020-2021,Age,24 Months,94.4,91.0 to 96.9,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,89.9,81.8 to 94.6,216
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.0,90.5 to 97.5,386
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,92.0,85.7 to 98.3,196
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,93.8,91.1 to 96.5,594
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.9,79.5 to 90.4,386
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,77.0,66.5 to 87.5,196
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,78.9,73.6 to 84.3,594
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.8,61.5 to 76.2,386
Influenza,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,56.9,50.9 to 62.9,594
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,70.4,59.9 to 81.0,196
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,72.7,67.3 to 78.2,594
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.9,88.9 to 96.9,386
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,89.9,86.3 to 93.4,594
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,81.8,72.8 to 90.7,196
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,90.6,87.2 to 93.9,594
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,64.3,53.5 to 75.1,196
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,75.6,70.4 to 80.7,594
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.8,68.8 to 82.9,386
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,88.2,76.8 to 99.6,196
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,93.3,87.7 to 98.8,196
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.1,76.5 to 87.7,386
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,92.8,87.2 to 98.4,196
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.7,91.2 to 98.2,386
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,94.2,91.5 to 96.9,594
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,76.0,65.6 to 86.4,196
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.3,73.6 to 87.1,386
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,78.8,73.7 to 83.9,594
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,88.8 to 97.5,386
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,92.6 to 98.2,386
Hep B,≥2 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,95.7,91.3 to 98.0,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,86.8 to 99.1,95
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.3,77.4 to 91.2,386
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,84.9,76.6 to 93.3,594
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,85.7,81.2 to 90.2,612
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.3,88.7 to 100.0,97
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,88.2 to 99.0,97
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,90.0,81.4 to 98.6,187
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.4,92.1 to 96.7,797
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.7,79.5 to 87.8,797
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.4,92.0 to 96.8,797
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,83.0,71.6 to 94.5,41
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,91.0,86.9 to 95.1,469
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,88.1,78.9 to 97.4,54
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,84.0,72.7 to 95.2,41
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,96.4,94.4 to 98.3,612
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,90.4,86.0 to 94.9,469
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,69.2,50.7 to 87.8,41
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,70.8,64.5 to 77.1,469
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,83.6,72.5 to 94.6,54
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.6,81.1 to 96.2,97
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,84.5,73.7 to 95.4,54
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,86.9,76.4 to 97.4,54
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.3,90.9 to 95.7,797
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,73.2,66.6 to 79.7,469
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,74.3,59.6 to 89.1,54
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,79.2,66.2 to 92.1,41
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,95.1,92.5 to 97.6,612
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,93.4,90.2 to 96.7,469
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.5,91.0 to 100.0,97
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,91.8 to 96.5,797
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,86.9,76.4 to 97.4,54
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,84.2,72.7 to 95.6,41
Influenza,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",51.1,36.5 to 65.8,95
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,88.6,79.6 to 97.6,187
PCV,≥2 Doses,States/Local Areas,Tennessee,2021,Age,5 Months,79.7,70.4 to 86.6,216
Polio,≥2 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,93.2,86.5 to 96.7,216
Hep B,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,95.9,93.0 to 97.6,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,94.4,90.7 to 96.7,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,72.6,63.0 to 80.5,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,90.7,86.5 to 93.7,579
Hib,≥2 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,92.0,84.3 to 96.1,216
≥1 Dose MMR,,States/Local Areas,Tennessee,2021,Age,35 Months,95.7,90.0 to 98.6,216
PCV,≥3 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,95.5,89.9 to 98.5,216
Hib,Primary Series,States/Local Areas,Tennessee,2021,Age,19 Months,94.5,87.8 to 97.6,216
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,91.8,88.0 to 95.6,469
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,91.7 to 96.5,797
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.2,83.4 to 99.0,97
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,75.2,61.1 to 89.3,41
Influenza,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",63.9,58.8 to 69.0,797
Influenza,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",46.9,34.5 to 59.4,97
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,86.6,76.0 to 97.1,41
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.4,81.5 to 89.4,797
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.9,55.2 to 80.6,97
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,72.6,62.0 to 83.2,187
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,73.8,63.8 to 83.8,187
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,54.2,43.4 to 65.0,187
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,84.0,72.7 to 95.2,41
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.2,70.6 to 79.7,797
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",45.8,33.8 to 57.8,97
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,70.6,53.9 to 87.3,41
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,67.7,61.4 to 74.1,469
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,68.5,53.1 to 84.0,54
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.8,78.6 to 87.0,797
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,86.8,72.0 to 100.0,54
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,46.8,22.3 to 71.2,41
Influenza,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,52.7,35.4 to 70.0,54
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,76.6,67.7 to 85.4,187
Influenza,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,67.0,61.1 to 72.8,612
Influenza,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,55.0,48.2 to 61.8,469
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,70.6 to 92.0,95
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.1,60.5 to 87.7,95
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,82.9,78.1 to 87.7,612
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,61.6,41.4 to 81.8,41
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,86.9,76.4 to 97.4,54
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,81.3,68.3 to 94.3,41
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,94.1,91.6 to 96.5,612
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,96.8,95.0 to 98.6,612
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,83.6,73.6 to 93.7,187
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,80.7 to 95.6,95
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,79.3,74.3 to 84.3,469
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,78.9,64.8 to 93.0,54
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,92.7 to 96.8,797
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.8,80.3 to 97.3,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,68.6,49.7 to 87.6,41
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,78.0,68.8 to 87.3,380
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,66.0,60.3 to 71.7,612
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.0,72.5 to 89.5,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.3,57.3 to 83.4,95
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",58.4,45.7 to 71.0,97
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,75.5,70.2 to 80.9,612
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,86.1 to 99.5,95
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.9,74.7 to 83.0,797
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.9,52.5 to 79.4,95
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,91.4 to 96.0,797
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.3,84.6 to 98.1,97
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,67.7,51.8 to 83.6,54
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,88.3,81.0 to 95.6,187
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,91.5,85.1 to 97.8,196
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,93.5,90.8 to 96.2,594
Influenza,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,53.6,43.2 to 63.9,196
Influenza,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.9,58.2 to 73.5,386
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,64.6,58.8 to 70.4,594
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.2,90.6 to 97.9,386
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,86.6,77.7 to 95.4,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.8,62.6 to 77.0,386
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,93.2,87.6 to 98.7,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Principal City,71.9,67.0 to 76.8,594
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.6,88.7 to 96.5,386
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Urbanicity,Living In a Non-MSA,83.5,76.7 to 90.3,196
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,96.6,94.2 to 99.1,312
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,61.5,54.4 to 68.6,380
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Overall,Overall,76.7,72.9 to 80.4,1176
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,64.7,57.8 to 71.6,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,66.8,60.4 to 73.1,484
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,94.8,91.7 to 98.0,312
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,94.3,91.0 to 97.6,484
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Overall,Overall,74.4,70.5 to 78.3,1176
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,81.8,75.7 to 87.9,312
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Overall,Overall,91.9,89.7 to 94.2,1176
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,96.7,94.3 to 99.2,312
Combined 7 Series,,States/Local Areas,Tennessee,2016-2019,Overall,Overall,67.0,62.8 to 71.2,1176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,81.5,76.4 to 86.5,380
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,84.9,79.8 to 89.9,1176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Overall,Overall,73.1,69.5 to 76.7,1176
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Overall,Overall,91.4,88.9 to 93.8,1176
Hep B,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,92.0,88.6 to 95.5,380
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,90.6,86.5 to 94.8,380
Influenza,,States/Local Areas,Tennessee,2016-2019,Overall,Overall,59.3,55.0 to 63.6,1176
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,89.0,83.1 to 95.0,312
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,94.3,91.3 to 97.3,484
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,89.0,84.3 to 93.6,380
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Overall,Overall,91.9,89.5 to 94.3,1176
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,<133% FPL,75.3,68.6 to 81.9,380
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,93.4,91.3 to 95.5,1176
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,91.0,87.4 to 94.6,484
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,78.9,75.0 to 82.7,1176
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Overall,Overall,92.4,90.0 to 94.9,1176
Rotavirus,,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,83.9,77.8 to 90.0,312
Influenza,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,59.8,49.4 to 70.1,187
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,88.8,79.9 to 97.6,54
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,75.0,60.6 to 89.3,54
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,96.1,94.2 to 98.0,612
≥1 Dose MMR,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,89.0,84.5 to 93.6,469
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,73.7,67.3 to 80.2,469
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,86.6,76.0 to 97.1,41
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.2,65.2 to 89.1,95
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Other,86.9,76.4 to 97.4,54
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.7,54.9 to 80.4,97
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,69.9,59.2 to 80.6,187
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,89.1,84.7 to 93.4,612
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,82.6,73.6 to 91.6,469
≥1 Dose Varicella,,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.9,78.8 to 95.1,95
Influenza,,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Uninsured,36.3,15.1 to 57.6,41
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,83.0 to 91.1,546
PCV,≥3 Doses,States/Local Areas,Texas,2012,Age,35 Months,93.1,90.6 to 95.1,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,90.1,88.4 to 91.9,2957
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.4,86.1 to 90.7,1682
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,87.5 to 91.1,3481
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,83.0,76.6 to 89.3,266
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.5,86.4 to 90.7,1801
DTaP,≥3 Doses,States/Local Areas,Texas,2016,Age,7 Months,71.4,68.1 to 74.4,1603
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,71.8,69.3 to 74.1,2874
Hib,≥2 Doses,States/Local Areas,Texas,2015,Age,7 Months,89.7,87.5 to 91.6,1640
Hib,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,88.7,87.0 to 90.2,3243
PCV,≥3 Doses,States/Local Areas,Texas,2019,Age,24 Months,91.8,88.7 to 94.4,919
PCV,≥3 Doses,States/Local Areas,Texas,2011,Age,35 Months,91.8,88.7 to 94.4,1195
PCV,≥3 Doses,States/Local Areas,Texas,2013,Age,35 Months,92.5,89.9 to 94.7,1375
PCV,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,92.6,90.9 to 94.1,2788
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.0,76.8 to 89.3,363
Hib,≥2 Doses,States/Local Areas,Texas,2016,Age,7 Months,87.6,85.1 to 89.8,1603
Hib,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,87.2,85.2 to 88.9,2874
Hib,≥2 Doses,States/Local Areas,Texas,2017,Age,7 Months,86.8,83.7 to 89.4,1271
Hib,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,89.0,86.9 to 90.8,2336
PCV,≥3 Doses,States/Local Areas,Texas,2014,Age,35 Months,92.8,90.4 to 94.7,1413
PCV,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,93.4,91.9 to 94.7,3053
PCV,≥3 Doses,States/Local Areas,Texas,2015,Age,35 Months,94.1,92.1 to 95.6,1640
PCV,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,93.5,91.9 to 94.9,3243
PCV,≥3 Doses,States/Local Areas,Texas,2016,Age,35 Months,93.0,90.3 to 95.2,1603
PCV,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,91.7,89.6 to 93.5,2874
Hib,≥3 Doses,States/Local Areas,Texas,2011,Age,7 Months,64.9,59.3 to 70.1,1195
Hib,≥3 Doses,States/Local Areas,Texas,2012,Age,7 Months,61.1,58.2 to 63.8,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,87.0,84.4 to 89.7,1676
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,92.5,90.4 to 94.5,1491
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,87.5,85.4 to 89.7,2381
Hib,≥3 Doses,States/Local Areas,Texas,2013,Age,7 Months,59.3,54.4 to 63.9,1375
Hib,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,60.3,56.7 to 63.8,2788
Polio,≥1 Dose,States/Local Areas,Texas,2014,Age,3 Months,84.8,82.1 to 87.2,1413
Polio,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,3 Months,86.4,84.6 to 88.0,3053
Polio,≥1 Dose,States/Local Areas,Texas,2015,Age,3 Months,87.9,85.5 to 89.9,1640
Polio,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,3 Months,87.6,85.9 to 89.2,3243
Polio,≥1 Dose,States/Local Areas,Texas,2016,Age,3 Months,87.4,84.9 to 89.6,1603
Polio,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,3 Months,86.2,84.2 to 88.0,2874
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2017,Age,0-3 Days,76.5,71.7 to 80.8,889
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2017-2018,Age,0-3 Days,80.1,77.5 to 82.5,2336
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016,Age,0-3 Days,78.2,75.1 to 81.0,1603
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2017,Age,0-3 Days,77.8,75.4 to 80.0,2874
PCV,≥3 Doses,States/Local Areas,Texas,2018,Age,24 Months,93.2,90.6 to 95.3,1065
PCV,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,92.5,90.6 to 94.2,1984
PCV,≥1 Dose,States/Local Areas,Texas,2018,Age,3 Months,86.2,82.3 to 89.3,1065
PCV,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,3 Months,87.2,84.5 to 89.5,1984
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,88.6,87.2 to 89.9,5548
PCV,≥1 Dose,States/Local Areas,Texas,2019,Age,3 Months,88.2,84.2 to 91.3,919
Polio,≥1 Dose,States/Local Areas,Texas,2012,Age,3 Months,84.6,83.0 to 86.1,1359
Polio,≥1 Dose,States/Local Areas,Texas,2011,Age,3 Months,86.6,80.9 to 90.7,1195
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2013,Age,0-3 Days,76.2,72.8 to 79.4,1375
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2013-2014,Age,0-3 Days,76.6,74.4 to 78.8,2788
Polio,≥1 Dose,States/Local Areas,Texas,2013,Age,3 Months,86.7,83.2 to 89.6,1375
Polio,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,3 Months,85.8,83.6 to 87.7,2788
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014,Age,0-3 Days,77.0,74.0 to 79.9,1413
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2015,Age,0-3 Days,78.8,76.8 to 80.7,3053
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,73.3 to 83.4,546
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.6,79.7 to 85.5,1682
PCV,≥1 Dose,States/Local Areas,Texas,2014,Age,3 Months,83.7,80.9 to 86.2,1413
PCV,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,3 Months,84.7,82.9 to 86.4,3053
PCV,≥1 Dose,States/Local Areas,Texas,2015,Age,3 Months,85.7,83.2 to 88.0,1640
PCV,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,3 Months,85.9,84.0 to 87.5,3243
PCV,≥3 Doses,States/Local Areas,Texas,2017,Age,24 Months,89.4,86.6 to 91.8,1271
PCV,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,91.3,89.4 to 92.9,2336
PCV,≥3 Doses,States/Local Areas,Texas,2016,Age,24 Months,89.7,87.3 to 91.8,1603
PCV,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,89.5,87.7 to 91.2,2874
Hib,≥2 Doses,States/Local Areas,Texas,2012,Age,7 Months,87.2,85.7 to 88.6,1359
PCV,≥3 Doses,States/Local Areas,Texas,2015,Age,24 Months,92.6,90.7 to 94.2,1640
PCV,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,91.2,89.6 to 92.5,3243
Hib,≥2 Doses,States/Local Areas,Texas,2019,Age,5 Months,82.9,78.3 to 86.7,919
Hib,≥2 Doses,States/Local Areas,Texas,2011,Age,7 Months,90.9,85.5 to 94.5,1195
Hib,≥2 Doses,States/Local Areas,Texas,2018,Age,5 Months,82.1,77.9 to 85.5,1065
Hib,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,5 Months,82.5,79.5 to 85.1,1984
Hep A,≥1 Dose,States/Local Areas,Texas,2020,Age,35 Months,92.5,88.0 to 95.8,795
DTaP,≥3 Doses,States/Local Areas,Texas,2013,Age,7 Months,68.3,63.9 to 72.4,1375
DTaP,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,68.6,66.0 to 71.0,2788
DTaP,≥3 Doses,States/Local Areas,Texas,2012,Age,7 Months,65.5,62.5 to 68.4,1359
DTaP,≥3 Doses,States/Local Areas,Texas,2011,Age,7 Months,68.2,62.4 to 73.6,1195
Hib,≥2 Doses,States/Local Areas,Texas,2017,Age,5 Months,75.7,72.1 to 79.0,1271
Hib,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,5 Months,78.9,76.2 to 81.4,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2012,Age,13 Months,87.4,85.8 to 88.9,1359
DTaP,≥3 Doses,States/Local Areas,Texas,2015,Age,7 Months,72.8,69.7 to 75.7,1640
DTaP,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,72.1,69.9 to 74.2,3243
DTaP,≥3 Doses,States/Local Areas,Texas,2014,Age,7 Months,68.8,65.3 to 72.1,1413
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,70.8,68.5 to 73.0,3053
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2015,Age,0-3 Days,80.6,77.9 to 83.0,1640
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2015-2016,Age,0-3 Days,79.4,77.4 to 81.3,3243
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,93.8,92.3 to 95.3,2524
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,88.3,86.2 to 90.4,2412
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.2,80.2 to 92.1,363
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,78.9,71.4 to 86.3,297
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,91.5,89.9 to 93.1,2957
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,84.0 to 91.9,546
Hib,≥2 Doses,States/Local Areas,Texas,2015,Age,13 Months,93.8,91.9 to 95.3,1640
Hib,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,93.0,91.6 to 94.2,3243
Hib,≥2 Doses,States/Local Areas,Texas,2016,Age,13 Months,92.2,90.1 to 93.9,1603
Hib,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,91.4,89.7 to 92.9,2874
Hib,≥2 Doses,States/Local Areas,Texas,2014,Age,13 Months,91.6,89.3 to 93.4,1413
Hib,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,92.7,91.3 to 93.9,3053
Polio,≥1 Dose,States/Local Areas,Texas,2018,Age,3 Months,88.3,84.7 to 91.1,1065
Polio,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,3 Months,88.2,85.6 to 90.4,1984
Polio,≥1 Dose,States/Local Areas,Texas,2017,Age,3 Months,85.0,81.9 to 87.7,1271
Polio,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,3 Months,86.6,84.3 to 88.6,2336
Hib,≥3 Doses,States/Local Areas,Texas,2015,Age,7 Months,63.9,60.7 to 67.0,1640
Hib,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,7 Months,62.5,60.1 to 64.8,3243
Hib,≥3 Doses,States/Local Areas,Texas,2016,Age,7 Months,61.0,57.6 to 64.3,1603
Hib,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,7 Months,62.7,60.2 to 65.2,2874
PCV,≥3 Doses,States/Local Areas,Texas,2018,Age,35 Months,94.8,91.8 to 97.1,1065
PCV,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,94.2,92.0 to 96.0,1984
Hib,≥3 Doses,States/Local Areas,Texas,2014,Age,7 Months,61.4,57.8 to 64.8,1413
Hib,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,62.6,60.3 to 65.0,3053
Hib,≥2 Doses,States/Local Areas,Texas,2013,Age,13 Months,91.9,90.0 to 93.5,1375
Hib,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,91.7,90.4 to 92.9,2788
PCV,≥3 Doses,States/Local Areas,Texas,2017,Age,35 Months,89.9,87.0 to 92.4,1271
PCV,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,92.6,90.2 to 94.5,2336
Hib,≥2 Doses,States/Local Areas,Texas,2018,Age,7 Months,91.3,88.1 to 93.7,1065
Hib,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,91.7,89.5 to 93.4,1984
Hib,≥2 Doses,States/Local Areas,Texas,2019,Age,7 Months,92.1,88.8 to 94.5,919
Hib,≥2 Doses,States/Local Areas,Texas,2012,Age,13 Months,93.3,92.2 to 94.2,1359
Hib,≥2 Doses,States/Local Areas,Texas,2011,Age,13 Months,93.4,90.3 to 95.6,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2016,Age,13 Months,86.8,84.2 to 89.0,1603
DTaP,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,86.6,84.6 to 88.4,2874
DTaP,≥3 Doses,States/Local Areas,Texas,2017,Age,13 Months,86.5,83.3 to 89.1,1271
DTaP,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,88.3,86.1 to 90.2,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2015,Age,13 Months,89.3,87.0 to 91.3,1640
DTaP,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,88.1,86.4 to 89.6,3243
Hib,≥3 Doses,States/Local Areas,Texas,2012,Age,13 Months,83.3,80.9 to 85.4,1359
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,79.0,76.3 to 81.6,2381
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,76.0,72.8 to 79.3,1676
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,78.0,74.7 to 81.3,1491
Hib,≥3 Doses,States/Local Areas,Texas,2013,Age,13 Months,80.7,78.2 to 82.9,1375
Hib,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,80.5,78.3 to 82.5,2788
Polio,≥3 Doses,States/Local Areas,Texas,2011,Age,19 Months,90.1,86.1 to 93.0,1195
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,90.7,88.3 to 93.0,1676
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,94.5,92.7 to 96.2,1491
Hib,≥3 Doses,States/Local Areas,Texas,2014,Age,13 Months,80.3,77.2 to 83.0,1413
Hib,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,81.1,79.1 to 82.9,3053
Hib,≥3 Doses,States/Local Areas,Texas,2011,Age,13 Months,86.0,80.0 to 90.4,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2011,Age,13 Months,88.5,84.0 to 91.9,1195
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,73.0,64.9 to 81.2,297
Hib,Primary Series,States/Local Areas,Texas,2020,Age,24 Months,89.8,85.3 to 93.3,795
DTaP,≥3 Doses,States/Local Areas,Texas,2019,Age,7 Months,74.4,69.1 to 79.1,919
DTaP,≥3 Doses,States/Local Areas,Texas,2017,Age,7 Months,72.2,68.5 to 75.7,1271
DTaP,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,75.1,72.3 to 77.7,2336
DTaP,≥3 Doses,States/Local Areas,Texas,2018,Age,7 Months,78.0,73.8 to 81.6,1065
DTaP,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,76.2,72.9 to 79.2,1984
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2019,Age,0-3 Days,81.9,77.2 to 85.8,919
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.6,67.2 to 79.9,363
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,79.8,77.2 to 82.4,2412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,84.7,79.8 to 89.7,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,75.3,72.6 to 78.0,2524
Polio,≥1 Dose,States/Local Areas,Texas,2019,Age,3 Months,88.2,84.0 to 91.4,919
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2018,Age,0-3 Days,82.9,79.1 to 86.1,1065
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2018-2019,Age,0-3 Days,82.4,79.4 to 85.0,1984
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,93.7,89.6 to 97.8,315
PCV,≥3 Doses,States/Local Areas,Texas,2019,Age,35 Months,93.5,90.3 to 96.0,919
Hib,≥3 Doses,States/Local Areas,Texas,2018,Age,7 Months,70.3,65.9 to 74.4,1065
Hib,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,7 Months,68.3,64.7 to 71.6,1984
Hib,≥3 Doses,States/Local Areas,Texas,2017,Age,7 Months,64.5,60.6 to 68.2,1271
Hib,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,7 Months,67.4,64.5 to 70.2,2336
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,90.6,88.8 to 92.4,2524
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,92.7,88.7 to 96.7,315
PCV,≥1 Dose,States/Local Areas,Texas,2016,Age,3 Months,86.0,83.4 to 88.3,1603
PCV,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,3 Months,85.4,83.4 to 87.1,2874
PCV,≥1 Dose,States/Local Areas,Texas,2017,Age,3 Months,84.7,81.6 to 87.3,1271
PCV,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,3 Months,85.4,83.0 to 87.5,2336
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,80.5,78.3 to 82.7,3481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2012,Age,0-3 Days,77.9,74.1 to 81.2,1359
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,87.5,84.9 to 90.1,1491
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,77.4,74.8 to 80.1,2381
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,81.9,78.9 to 84.9,1676
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.4,79.8 to 85.1,1801
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,79.8,72.6 to 87.1,297
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,77.6,70.5 to 84.6,266
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,81.1,79.5 to 82.8,5548
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,87.4,85.2 to 89.6,2412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2011,Age,0-3 Days,79.2,75.0 to 82.8,1195
Hib,≥2 Doses,States/Local Areas,Texas,2013,Age,7 Months,85.9,83.3 to 88.2,1375
Hib,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,7 Months,86.3,84.8 to 87.7,2788
Hib,≥2 Doses,States/Local Areas,Texas,2014,Age,7 Months,86.7,83.9 to 89.1,1413
Hib,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,7 Months,88.2,86.5 to 89.8,3053
PCV,≥3 Doses,States/Local Areas,Texas,2019,Age,19 Months,91.3,88.0 to 93.8,919
PCV,≥3 Doses,States/Local Areas,Texas,2011,Age,24 Months,91.6,88.4 to 94.2,1195
PCV,≥3 Doses,States/Local Areas,Texas,2018,Age,19 Months,92.4,89.5 to 94.6,1065
PCV,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,19 Months,89.8,87.4 to 91.8,1984
Hep B,≥2 Doses,States/Local Areas,Texas,2019,Age,13 Months,94.2,91.3 to 96.1,919
Hib,Full Series,States/Local Areas,Texas,2020,Age,24 Months,78.3,72.4 to 83.7,795
Hib,≥2 Doses,States/Local Areas,Texas,2012,Age,5 Months,74.4,71.9 to 76.7,1359
Hib,≥2 Doses,States/Local Areas,Texas,2011,Age,5 Months,76.5,69.1 to 82.6,1195
Hib,≥2 Doses,States/Local Areas,Texas,2013,Age,5 Months,74.2,70.1 to 77.9,1375
Hib,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,5 Months,75.1,72.8 to 77.3,2788
Hib,≥2 Doses,States/Local Areas,Texas,2014,Age,5 Months,76.1,72.9 to 79.0,1413
Hib,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,5 Months,77.8,75.5 to 79.9,3053
PCV,≥3 Doses,States/Local Areas,Texas,2017,Age,19 Months,89.0,86.1 to 91.3,1271
PCV,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,90.7,88.7 to 92.4,2336
PCV,≥1 Dose,States/Local Areas,Texas,2011,Age,3 Months,83.7,78.8 to 87.6,1195
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,89.3,86.9 to 91.7,1676
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,93.0,91.0 to 95.0,1491
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,82.9,76.1 to 89.8,266
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.0,86.9 to 91.2,1801
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Overall,Overall,88.8,87.4 to 90.2,5548
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,86.4,84.1 to 88.7,2381
PCV,≥4 Doses,States/Local Areas,Texas,2017,Age,35 Months,80.7,76.9 to 84.2,1271
PCV,≥4 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,84.0,81.2 to 86.6,2336
PCV,≥4 Doses,States/Local Areas,Texas,2016,Age,35 Months,82.5,79.4 to 85.4,1603
PCV,≥4 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,81.6,79.2 to 83.9,2874
PCV,≥4 Doses,States/Local Areas,Texas,2018,Age,35 Months,86.8,82.8 to 90.3,1065
PCV,≥4 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,87.0,84.0 to 89.7,1984
Hib,≥2 Doses,States/Local Areas,Texas,2015,Age,5 Months,79.4,76.6 to 82.0,1640
Hib,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,5 Months,77.3,75.2 to 79.3,3243
Hib,≥2 Doses,States/Local Areas,Texas,2016,Age,5 Months,75.1,72.0 to 78.0,1603
Hib,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,5 Months,75.4,73.0 to 77.6,2874
PCV,≥1 Dose,States/Local Areas,Texas,2013,Age,3 Months,85.4,80.5 to 89.2,1375
PCV,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,3 Months,84.5,81.7 to 87.0,2788
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,83.3,76.9 to 89.7,315
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,67.0,58.6 to 75.5,297
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,78.3,75.7 to 81.0,2412
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.3,67.5 to 81.1,363
PCV,≥4 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,82.3,80.1 to 84.5,2957
PCV,≥3 Doses,States/Local Areas,Texas,2014,Age,24 Months,91.4,89.2 to 93.3,1413
PCV,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,24 Months,92.0,90.6 to 93.2,3053
PCV,≥3 Doses,States/Local Areas,Texas,2012,Age,24 Months,92.5,90.0 to 94.6,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2020,Age,24 Months,89.6,85.3 to 93.0,795
PCV,≥3 Doses,States/Local Areas,Texas,2013,Age,24 Months,91.1,88.6 to 93.3,1375
PCV,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,24 Months,91.2,89.6 to 92.7,2788
Hib,≥1 Dose,States/Local Areas,Texas,2019,Age,3 Months,88.0,83.9 to 91.1,919
Hib,≥1 Dose,States/Local Areas,Texas,2018,Age,3 Months,87.8,84.1 to 90.7,1065
Hib,≥1 Dose,States/Local Areas,Texas,2018-2019,Age,3 Months,87.9,85.2 to 90.1,1984
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.9,86.4 to 91.4,1682
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,87.5 to 91.2,3481
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,91.1,88.7 to 93.5,1491
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,88.9,86.4 to 91.3,1676
≥1 Dose Varicella,,States/Local Areas,Texas,2019,Age,35 Months,93.1,89.0 to 96.0,919
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,90.7,88.8 to 92.6,2524
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,87.9,85.6 to 90.1,2412
≥1 Dose Varicella,,States/Local Areas,Texas,2018,Age,35 Months,93.3,90.5 to 95.4,1065
≥1 Dose Varicella,,States/Local Areas,Texas,2018-2019,Age,35 Months,93.1,90.8 to 94.9,1984
PCV,≥4 Doses,States/Local Areas,Texas,2015,Age,24 Months,81.6,78.8 to 84.2,1640
PCV,≥4 Doses,States/Local Areas,Texas,2015-2016,Age,24 Months,80.8,78.8 to 82.7,3243
≥1 Dose MMR,,States/Local Areas,Texas,2016,Age,35 Months,92.0,89.9 to 93.9,1603
≥1 Dose MMR,,States/Local Areas,Texas,2016-2017,Age,35 Months,91.4,89.6 to 93.1,2874
≥1 Dose MMR,,States/Local Areas,Texas,2014,Age,35 Months,92.6,90.2 to 94.6,1413
≥1 Dose MMR,,States/Local Areas,Texas,2014-2015,Age,35 Months,92.8,91.1 to 94.2,3053
≥1 Dose MMR,,States/Local Areas,Texas,2015,Age,35 Months,93.0,90.7 to 94.8,1640
≥1 Dose MMR,,States/Local Areas,Texas,2015-2016,Age,35 Months,92.5,90.9 to 93.8,3243
PCV,≥4 Doses,States/Local Areas,Texas,2017,Age,24 Months,78.5,75.0 to 81.7,1271
PCV,≥4 Doses,States/Local Areas,Texas,2017-2018,Age,24 Months,80.5,78.0 to 82.9,2336
PCV,≥4 Doses,States/Local Areas,Texas,2016,Age,24 Months,80.0,77.1 to 82.8,1603
PCV,≥4 Doses,States/Local Areas,Texas,2016-2017,Age,24 Months,79.3,77.0 to 81.4,2874
PCV,≥3 Doses,States/Local Areas,Texas,2018,Age,13 Months,90.6,87.4 to 93.0,1065
PCV,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,89.8,87.4 to 91.8,1984
PCV,≥3 Doses,States/Local Areas,Texas,2017,Age,13 Months,86.1,83.0 to 88.7,1271
PCV,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,88.3,86.2 to 90.2,2336
Hep B,≥2 Doses,States/Local Areas,Texas,2019,Age,7 Months,91.8,88.4 to 94.3,919
Hep B,≥2 Doses,States/Local Areas,Texas,2011,Age,13 Months,93.1,89.9 to 95.4,1195
Hep B,≥2 Doses,States/Local Areas,Texas,2012,Age,13 Months,94.4,93.2 to 95.5,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2012,Age,35 Months,91.2,88.4 to 93.6,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2014,Age,35 Months,90.3,87.7 to 92.6,1413
Hep B,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,91.2,89.5 to 92.7,3053
Hep B,≥3 Doses,States/Local Areas,Texas,2013,Age,35 Months,89.7,87.0 to 92.1,1375
Hep B,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,90.0,88.1 to 91.7,2788
PCV,≥3 Doses,States/Local Areas,Texas,2016,Age,13 Months,84.5,81.7 to 86.9,1603
PCV,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,85.3,83.2 to 87.1,2874
PCV,≥4 Doses,States/Local Areas,Texas,2018,Age,24 Months,82.6,78.8 to 86.0,1065
PCV,≥4 Doses,States/Local Areas,Texas,2018-2019,Age,24 Months,82.8,80.0 to 85.5,1984
PCV,≥4 Doses,States/Local Areas,Texas,2019,Age,24 Months,83.1,78.7 to 87.1,919
PCV,≥4 Doses,States/Local Areas,Texas,2011,Age,35 Months,85.5,80.7 to 89.6,1195
PCV,≥4 Doses,States/Local Areas,Texas,2012,Age,35 Months,84.0,80.6 to 87.1,1359
PCV,≥3 Doses,States/Local Areas,Texas,2012,Age,19 Months,91.7,89.7 to 93.3,1359
Hep B,≥3 Doses,States/Local Areas,Texas,2017,Age,35 Months,89.8,86.0 to 92.9,1271
Hep B,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,35 Months,90.2,87.9 to 92.3,2336
PCV,≥3 Doses,States/Local Areas,Texas,2019,Age,13 Months,89.1,85.2 to 92.0,919
PCV,≥3 Doses,States/Local Areas,Texas,2011,Age,19 Months,90.0,84.3 to 93.7,1195
PCV,≥3 Doses,States/Local Areas,Texas,2013,Age,19 Months,89.8,87.7 to 91.6,1375
PCV,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,89.7,88.5 to 90.7,2788
Hep B,≥3 Doses,States/Local Areas,Texas,2015,Age,35 Months,92.2,90.0 to 94.1,1640
Hep B,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,91.0,89.3 to 92.5,3243
Hep B,≥3 Doses,States/Local Areas,Texas,2016,Age,35 Months,89.8,87.2 to 92.0,1603
Hep B,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,35 Months,89.7,87.6 to 91.7,2874
PCV,≥4 Doses,States/Local Areas,Texas,2013,Age,35 Months,82.0,78.5 to 85.2,1375
PCV,≥4 Doses,States/Local Areas,Texas,2013-2014,Age,35 Months,83.7,81.5 to 85.8,2788
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.3,77.0 to 89.6,363
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,79.3,72.0 to 86.5,297
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,90.0,88.3 to 91.7,2957
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,84.8 to 92.5,546
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,86.8,84.5 to 89.1,2412
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,91.9,90.2 to 93.6,2524
PCV,≥4 Doses,States/Local Areas,Texas,2015,Age,35 Months,86.1,83.3 to 88.7,1640
PCV,≥4 Doses,States/Local Areas,Texas,2015-2016,Age,35 Months,84.3,82.2 to 86.3,3243
PCV,≥4 Doses,States/Local Areas,Texas,2014,Age,35 Months,85.5,82.7 to 88.1,1413
PCV,≥4 Doses,States/Local Areas,Texas,2014-2015,Age,35 Months,85.8,83.8 to 87.6,3053
Hep B,≥2 Doses,States/Local Areas,Texas,2018,Age,13 Months,95.2,92.8 to 96.9,1065
Hep B,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,94.7,92.9 to 96.1,1984
Hep B,≥2 Doses,States/Local Areas,Texas,2016,Age,13 Months,93.5,91.5 to 95.1,1603
Hep B,≥2 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,92.9,91.4 to 94.2,2874
PCV,≥3 Doses,States/Local Areas,Texas,2015,Age,19 Months,91.8,90.0 to 93.3,1640
PCV,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,90.4,88.8 to 91.7,3243
PCV,≥3 Doses,States/Local Areas,Texas,2016,Age,19 Months,88.9,86.4 to 91.0,1603
PCV,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,88.9,87.1 to 90.6,2874
Hib,≥1 Dose,States/Local Areas,Texas,2015,Age,3 Months,87.5,85.1 to 89.5,1640
Hib,≥1 Dose,States/Local Areas,Texas,2015-2016,Age,3 Months,86.4,84.6 to 88.0,3243
Hib,≥1 Dose,States/Local Areas,Texas,2016,Age,3 Months,85.3,82.6 to 87.7,1603
Hib,≥1 Dose,States/Local Areas,Texas,2016-2017,Age,3 Months,85.2,83.2 to 87.0,2874
Hib,≥1 Dose,States/Local Areas,Texas,2017,Age,3 Months,85.1,82.0 to 87.7,1271
Hib,≥1 Dose,States/Local Areas,Texas,2017-2018,Age,3 Months,86.4,84.1 to 88.4,2336
Hep B,≥2 Doses,States/Local Areas,Texas,2017,Age,13 Months,92.3,89.8 to 94.2,1271
Hep B,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,93.8,92.1 to 95.1,2336
≥1 Dose MMR,,States/Local Areas,Texas,2018,Age,35 Months,92.9,90.2 to 95.0,1065
≥1 Dose MMR,,States/Local Areas,Texas,2018-2019,Age,35 Months,92.8,90.6 to 94.7,1984
≥1 Dose MMR,,States/Local Areas,Texas,2017,Age,35 Months,90.7,87.6 to 93.3,1271
≥1 Dose MMR,,States/Local Areas,Texas,2017-2018,Age,35 Months,91.7,89.8 to 93.5,2336
≥1 Dose MMR,,States/Local Areas,Texas,2019,Age,35 Months,93.0,88.7 to 96.1,919
≥1 Dose MMR,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,92.4,88.7 to 96.0,315
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,84.7 to 92.6,546
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.6,84.9 to 90.2,1682
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,87.0 to 90.8,3481
Hep B,≥3 Doses,States/Local Areas,Texas,2019,Age,35 Months,92.6,88.9 to 95.5,919
PCV,≥3 Doses,States/Local Areas,Texas,2014,Age,19 Months,89.6,87.1 to 91.6,1413
PCV,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,90.7,89.1 to 92.0,3053
Hep B,≥3 Doses,States/Local Areas,Texas,2018,Age,35 Months,90.9,87.9 to 93.4,1065
Hep B,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,35 Months,91.6,89.3 to 93.7,1984
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Overall,Overall,88.3,86.8 to 89.7,5548
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,86.5,84.2 to 88.9,2381
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,82.4,75.5 to 89.2,266
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.4,86.1 to 90.7,1801
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.0,75.5 to 88.5,363
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,89.9,84.4 to 95.4,315
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,72.2,63.8 to 80.5,297
≥1 Dose Varicella,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,90.0,88.2 to 91.8,2957
Hib,≥1 Dose,States/Local Areas,Texas,2013,Age,3 Months,84.8,80.4 to 88.3,1375
Hib,≥1 Dose,States/Local Areas,Texas,2013-2014,Age,3 Months,84.4,82.1 to 86.4,2788
Hib,≥1 Dose,States/Local Areas,Texas,2012,Age,3 Months,85.4,83.6 to 87.1,1359
Hib,≥1 Dose,States/Local Areas,Texas,2011,Age,3 Months,86.8,81.8 to 90.6,1195
Hib,≥1 Dose,States/Local Areas,Texas,2014,Age,3 Months,84.0,81.2 to 86.5,1413
Hib,≥1 Dose,States/Local Areas,Texas,2014-2015,Age,3 Months,85.7,83.9 to 87.4,3053
Hep B,≥2 Doses,States/Local Areas,Texas,2014,Age,13 Months,93.7,91.8 to 95.2,1413
Hep B,≥2 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,93.9,92.7 to 94.9,3053
Hep B,≥2 Doses,States/Local Areas,Texas,2015,Age,13 Months,94.1,92.5 to 95.4,1640
Hep B,≥2 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,93.8,92.6 to 94.9,3243
Hep B,≥2 Doses,States/Local Areas,Texas,2013,Age,13 Months,93.8,92.5 to 94.8,1375
Hep B,≥2 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,93.7,92.8 to 94.5,2788
PCV,≥4 Doses,States/Local Areas,Texas,2011,Age,24 Months,78.7,74.2 to 82.9,1195
Hib,≥3 Doses,States/Local Areas,Texas,2019,Age,7 Months,66.2,60.6 to 71.4,919
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.8,88.5 to 93.1,1682
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,90.5,88.7 to 92.3,3481
Polio,≥3 Doses,States/Local Areas,Texas,2012,Age,19 Months,90.3,88.2 to 92.0,1359
Polio,≥3 Doses,States/Local Areas,Texas,2013,Age,19 Months,89.2,86.7 to 91.3,1375
Polio,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,19 Months,88.9,87.6 to 90.0,2788
DTaP,≥3 Doses,States/Local Areas,Texas,2019,Age,13 Months,89.0,85.1 to 92.0,919
DTaP,≥3 Doses,States/Local Areas,Texas,2011,Age,19 Months,92.8,88.9 to 95.4,1195
DTaP,≥3 Doses,States/Local Areas,Texas,2012,Age,19 Months,92.0,89.7 to 93.8,1359
DTaP,≥3 Doses,States/Local Areas,Texas,2018,Age,13 Months,90.2,86.9 to 92.7,1065
DTaP,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,89.6,87.1 to 91.6,1984
DTaP,≥3 Doses,States/Local Areas,Texas,2013,Age,13 Months,87.5,85.3 to 89.4,1375
DTaP,≥3 Doses,States/Local Areas,Texas,2013-2014,Age,13 Months,87.1,85.8 to 88.2,2788
DTaP,≥3 Doses,States/Local Areas,Texas,2014,Age,13 Months,86.6,83.9 to 89.0,1413
DTaP,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,13 Months,88.0,86.2 to 89.5,3053
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,83.1,80.8 to 85.4,2957
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.2,72.2 to 82.1,546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.4,67.1 to 73.8,1682
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,78.9,76.7 to 81.1,3481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.3,74.4 to 80.1,1801
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,74.3,66.2 to 82.4,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2014-2017,Overall,Overall,77.9,76.1 to 79.6,5548
Hib,≥2 Doses,States/Local Areas,Texas,2019,Age,13 Months,93.7,90.7 to 95.7,919
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Overall,Overall,90.3,89.0 to 91.6,5548
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,88.1,85.9 to 90.2,2381
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,86.2,80.3 to 92.0,266
PCV,≥3 Doses,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.8,88.8 to 92.9,1801
Hib,≥2 Doses,States/Local Areas,Texas,2018,Age,13 Months,93.9,91.2 to 95.9,1065
Hib,≥2 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,93.8,91.9 to 95.3,1984
Hib,≥2 Doses,States/Local Areas,Texas,2017,Age,13 Months,90.6,87.8 to 92.8,1271
Hib,≥2 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,92.3,90.4 to 93.8,2336
Hib,≥3 Doses,States/Local Areas,Texas,2015,Age,13 Months,81.9,79.2 to 84.3,1640
Hib,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,13 Months,80.5,78.5 to 82.4,3243
Hib,≥3 Doses,States/Local Areas,Texas,2016,Age,13 Months,79.2,76.1 to 82.0,1603
Hib,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,13 Months,79.6,77.3 to 81.7,2874
Hib,≥3 Doses,States/Local Areas,Texas,2017,Age,13 Months,80.1,76.6 to 83.1,1271
Hib,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,13 Months,81.4,78.8 to 83.7,2336
Polio,≥3 Doses,States/Local Areas,Texas,2014,Age,19 Months,88.6,86.0 to 90.7,1413
Polio,≥3 Doses,States/Local Areas,Texas,2014-2015,Age,19 Months,89.9,88.3 to 91.4,3053
Hib,≥3 Doses,States/Local Areas,Texas,2019,Age,13 Months,81.5,76.7 to 85.4,919
Hib,≥3 Doses,States/Local Areas,Texas,2012,Age,19 Months,90.9,89.6 to 92.0,1359
Hib,≥3 Doses,States/Local Areas,Texas,2011,Age,19 Months,91.9,87.1 to 95.0,1195
Polio,≥3 Doses,States/Local Areas,Texas,2015,Age,19 Months,91.3,88.8 to 93.3,1640
Polio,≥3 Doses,States/Local Areas,Texas,2015-2016,Age,19 Months,90.6,89.1 to 92.0,3243
Hib,≥3 Doses,States/Local Areas,Texas,2018,Age,13 Months,82.7,78.8 to 86.0,1065
Hib,≥3 Doses,States/Local Areas,Texas,2018-2019,Age,13 Months,82.1,79.1 to 84.7,1984
Polio,≥3 Doses,States/Local Areas,Texas,2016,Age,19 Months,89.9,87.6 to 91.8,1603
Polio,≥3 Doses,States/Local Areas,Texas,2016-2017,Age,19 Months,88.6,86.7 to 90.2,2874
Polio,≥3 Doses,States/Local Areas,Texas,2017,Age,19 Months,87.2,84.1 to 89.8,1271
Polio,≥3 Doses,States/Local Areas,Texas,2017-2018,Age,19 Months,89.8,87.8 to 91.6,2336
≥1 Dose MMR,,States/Local Areas,Tennessee,2021,Age,24 Months,90.9,83.7 to 95.8,216
Hep A,≥2 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,73.1,61.7 to 83.4,216
Hib,Full Series,States/Local Areas,Tennessee,2021,Age,24 Months,74.0,65.1 to 82.2,216
≥1 Dose Varicella,,States/Local Areas,Tennessee,2021,Age,19 Months,88.2,80.3 to 93.3,216
DTaP,≥4 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,74.5,65.5 to 81.8,216
PCV,≥3 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,95.5,88.8 to 98.3,216
Hep A,≥1 Dose,States/Local Areas,Tennessee,2021,Age,35 Months,96.0,89.2 to 99.1,216
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2021,Age,0-2 Days,73.5,64.1 to 81.1,216
PCV,≥3 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,95.5,89.9 to 98.5,216
PCV,≥4 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,84.1,75.7 to 90.8,216
Hep A,≥1 Dose,States/Local Areas,Tennessee,2021,Age,24 Months,89.3,82.0 to 94.6,216
≥1 Dose Varicella,,States/Local Areas,Tennessee,2021,Age,24 Months,91.2,83.9 to 96.0,216
DTaP,≥3 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,95.0,88.5 to 97.9,216
PCV,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,5 Months,77.4,71.6 to 82.3,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,67.4,61.6 to 72.8,579
PCV,≥3 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,71.9,62.4 to 79.8,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2021,Age,7 Months,74.5,65.0 to 82.2,216
Hep A,≥2 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,47.2,37.9 to 57.6,216
DTaP,≥3 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,94.3,87.9 to 97.4,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,93.5,87.9 to 97.1,216
Hep A,≥2 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,33.2,24.6 to 43.1,216
PCV,≥4 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,89.0,79.7 to 95.2,216
DTaP,≥1 Dose,States/Local Areas,Tennessee,2021,Age,3 Months,95.8,91.2 to 98.0,216
DTaP,≥4 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,82.7,74.5 to 89.5,216
Hep A,≥1 Dose,States/Local Areas,Tennessee,2021,Age,19 Months,86.0,78.0 to 91.4,216
Polio,≥2 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,95.2,88.6 to 98.0,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,94.8,91.4 to 97.2,579
Polio,≥3 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,94.0,88.6 to 97.5,216
Polio,≥1 Dose,States/Local Areas,Tennessee,2021,Age,3 Months,95.4,90.8 to 97.8,216
Hib,≥3 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,92.8,85.4 to 97.2,216
Hib,Primary Series,States/Local Areas,Tennessee,2021,Age,24 Months,95.5,89.8 to 98.5,216
Combined 7 Series,,States/Local Areas,Connecticut,2016,Age,35 Months,82.7,73.3 to 90.3,182
Combined 7 Series,,States/Local Areas,Connecticut,2016-2017,Age,35 Months,82.3,75.7 to 88.0,366
Combined 7 Series,,States/Local Areas,Connecticut,2017,Age,35 Months,81.2,72.0 to 88.8,184
Combined 7 Series,,States/Local Areas,Connecticut,2017-2018,Age,35 Months,84.5,79.2 to 89.1,492
Combined 7 Series,,States/Local Areas,Connecticut,2011,Age,35 Months,80.8,73.7 to 86.9,243
Hib,Primary Series,States/Local Areas,Connecticut,2017,Age,35 Months,93.1,85.8 to 97.4,184
Hib,Primary Series,States/Local Areas,Connecticut,2017-2018,Age,35 Months,94.7,90.8 to 97.3,492
Hib,Primary Series,States/Local Areas,Connecticut,2011,Age,24 Months,97.6,94.6 to 99.1,243
Hib,Primary Series,States/Local Areas,Connecticut,2012,Age,24 Months,94.1,88.5 to 97.5,245
Hib,Primary Series,States/Local Areas,Connecticut,2013,Age,24 Months,99.3,97.8 to 99.8,255
Hib,Primary Series,States/Local Areas,Connecticut,2013-2014,Age,24 Months,97.6,95.8 to 98.8,518
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,100.0,,31
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.5,95.9 to 99.1,603
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,95.2,91.6 to 98.7,256
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,92.8,84.1 to 100.0,31
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,96.9,90.8 to 100.0,31
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,85.7 to 92.2,603
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,93.8 to 97.9,603
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,85.0,70.4 to 99.7,31
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,87.3 to 94.0,603
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,85.9,80.3 to 91.5,256
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,94.3,82.8 to 100.0,31
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,94.8,91.9 to 97.7,595
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.2,90.0 to 96.4,506
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,89.6,84.7 to 94.5,595
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,85.3,78.5 to 92.1,186
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,81.0,68.8 to 93.3,98
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,94.8,92.2 to 97.4,595
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,85.2,79.4 to 91.0,200
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.0,85.4 to 96.5,134
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,96.6,94.6 to 98.5,595
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,94.1,90.6 to 97.5,186
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,89.2,78.9 to 99.4,98
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,93.6,89.9 to 97.3,200
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,83.3,71.8 to 94.8,98
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,90.7 to 96.7,506
Influenza,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,76.5,69.0 to 84.1,200
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,96.3,94.7 to 98.0,890
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Overall,Overall,92.5,90.1 to 95.0,890
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,89.1,85.2 to 93.0,428
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Overall,Overall,94.4,92.3 to 96.5,890
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,84.4,78.6 to 90.1,286
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,95.9,94.2 to 97.6,890
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,90.3,87.5 to 93.1,890
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,88.8,83.0 to 94.6,286
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,92.7,88.7 to 96.7,176
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,90.9,85.6 to 96.3,428
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,85.1,78.1 to 92.0,286
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,95.2,91.6 to 98.9,286
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,92.5,88.2 to 96.7,176
Influenza,,States/Local Areas,Connecticut,2016-2019,Overall,Overall,80.1,76.4 to 83.9,890
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Overall,Overall,82.1,78.3 to 85.8,890
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,94.3,90.5 to 98.0,176
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,84.8,79.9 to 89.8,428
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,87.0,83.1 to 90.9,890
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Overall,Overall,93.6,91.3 to 95.9,890
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,98.4,96.8 to 100.0,428
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,96.0,92.5 to 99.6,286
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,77.4,70.3 to 84.4,286
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,79.8,73.3 to 86.3,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,81.2,73.2 to 89.2,176
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,94.1,90.5 to 97.7,428
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,95.7,92.0 to 99.4,286
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Overall,Overall,88.9,86.0 to 91.8,890
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Overall,Overall,81.3,77.8 to 84.8,890
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,97.8,96.1 to 99.6,428
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,96.0,92.5 to 99.6,286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,91.3,81.6 to 100.0,31
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,97.9,93.9 to 100.0,31
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,80.3 to 89.1,603
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,76.5,69.3 to 83.7,256
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,80.7,74.5 to 86.9,256
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,100.0,,31
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.9,95.2 to 98.6,603
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,95.1,91.5 to 98.6,256
Influenza,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,72.7,50.6 to 94.7,31
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,85.9,80.3 to 91.6,256
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.2,92.6 to 97.8,603
Rotavirus,,States/Local Areas,Connecticut,2019-2020,Age,8 Months,83.1,78.3 to 87.0,559
Polio,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,3 Months,91.1,87.2 to 93.9,559
DTaP,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,3 Months,91.8,88.0 to 94.5,559
Hib,Primary Series,States/Local Areas,Connecticut,2019-2020,Age,7 Months,77.8,72.7 to 82.2,559
PCV,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,79.9,75.0 to 84.0,559
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,93.4,89.8 to 95.7,559
Polio,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,93.7,90.3 to 96.0,559
DTaP,≥4 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,72.5,67.1 to 77.2,559
≥1 Dose MMR,,States/Local Areas,Connecticut,2019-2020,Age,35 Months,95.2,92.2 to 97.3,559
Polio,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,96.1,93.5 to 97.9,559
DTaP,≥4 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,94.8,90.9 to 97.5,559
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,96.2,93.5 to 98.0,559
Combined 7 Series,,States/Local Areas,Connecticut,2019-2020,Age,24 Months,78.0,73.0 to 82.7,559
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,94.9,91.5 to 97.0,559
PCV,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,93.9,90.6 to 96.2,559
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019-2020,Age,13 Months,63.6,58.2 to 68.8,559
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,92.0,88.5 to 94.5,559
Hib,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,94.5,91.1 to 96.7,559
Polio,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,94.1,90.8 to 96.3,559
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,79.5,74.4 to 83.7,559
PCV,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,5 Months,89.4,85.3 to 92.4,559
≥1 Dose MMR,,States/Local Areas,Connecticut,2020,Age,13 Months,71.7,63.0 to 79.1,248
Combined 7 Series,,States/Local Areas,Connecticut,2020,Age,35 Months,85.6,76.1 to 92.7,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2020,Age,0-1 Days,80.4,72.6 to 86.4,248
Hep A,≥2 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,32.8,26.0 to 40.5,248
Rotavirus,,States/Local Areas,Connecticut,2020,Age,8 Months,83.5,75.5 to 89.2,248
DTaP,≥1 Dose,States/Local Areas,Connecticut,2020,Age,3 Months,90.4,83.4 to 94.6,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2020,Age,0-2 Days,83.0,75.7 to 88.5,248
Hib,≥2 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,93.4,87.2 to 96.8,248
Hib,≥3 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,64.9,56.3 to 72.6,248
Hib,Primary Series,States/Local Areas,Connecticut,2020,Age,7 Months,76.8,68.6 to 83.4,248
Hep B,≥2 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,92.5,86.1 to 96.1,248
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,96.6,91.8 to 98.9,248
Polio,≥3 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,96.6,92.0 to 98.9,248
DTaP,≥4 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,83.6,75.9 to 89.9,248
≥1 Dose MMR,,States/Local Areas,Connecticut,2020,Age,24 Months,94.3,88.9 to 97.6,248
Hib,≥3 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,93.7,88.1 to 97.2,248
Hib,Primary Series,States/Local Areas,Connecticut,2020,Age,24 Months,94.0,88.5 to 97.5,248
Hib,≥3 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,93.7,88.1 to 97.2,248
Hib,Primary Series,States/Local Areas,Connecticut,2020,Age,35 Months,94.0,88.5 to 97.5,248
Hib,Full Series,States/Local Areas,Connecticut,2020,Age,35 Months,90.2,82.0 to 95.7,248
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,94.7,88.9 to 98.0,248
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020,Age,35 Months,96.8,91.2 to 99.2,248
PCV,≥3 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,94.2,88.9 to 97.5,248
Hib,Full Series,States/Local Areas,Connecticut,2020,Age,19 Months,75.6,67.1 to 82.5,248
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,92.8,86.4 to 96.3,248
PCV,≥3 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,94.2,88.1 to 97.3,248
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020,Age,19 Months,93.3,86.4 to 96.8,248
DTaP,≥4 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,95.2,88.4 to 98.6,248
Polio,≥3 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,96.6,92.0 to 98.9,248
≥1 Dose MMR,,States/Local Areas,Connecticut,2020,Age,35 Months,96.1,90.7 to 98.8,248
PCV,≥4 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,84.9,77.3 to 90.3,248
PCV,≥4 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,92.8,85.5 to 97.2,248
Hep A,≥1 Dose,States/Local Areas,Connecticut,2020,Age,19 Months,89.6,82.1 to 94.2,248
Hib,≥3 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,79.7,71.6 to 86.0,248
Hib,Primary Series,States/Local Areas,Connecticut,2020,Age,13 Months,89.9,83.0 to 94.2,248
Hep B,≥2 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,93.5,87.2 to 96.8,248
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,91.7,85.5 to 95.5,248
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020,Age,13 Months,64.4,55.8 to 72.2,248
PCV,≥3 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,93.4,87.3 to 96.7,248
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,77.9,69.7 to 84.4,248
Polio,≥2 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,93.3,87.0 to 96.6,248
PCV,≥2 Doses,States/Local Areas,Connecticut,2020,Age,5 Months,90.1,83.6 to 94.2,248
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,93.7,87.4 to 96.9,248
DTaP,≥4 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,69.7,61.1 to 77.1,248
≥1 Dose MMR,,States/Local Areas,Connecticut,2020,Age,19 Months,92.8,85.8 to 96.5,248
Polio,≥3 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,93.8,87.5 to 97.0,248
Influenza,,States/Local Areas,Connecticut,2020,Age,24 Months,83.3,75.9 to 89.4,248
Hib,Primary Series,States/Local Areas,Connecticut,2020,Age,19 Months,93.8,87.5 to 97.0,248
Hib,≥3 Doses,States/Local Areas,Connecticut,2020,Age,19 Months,93.1,86.9 to 96.5,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2020,Age,0-3 Days,84.1,76.9 to 89.4,248
PCV,≥3 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,94.2,88.9 to 97.5,248
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020,Age,35 Months,96.6,91.8 to 98.9,248
PCV,≥4 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,86.7,79.6 to 92.3,248
Hep A,≥1 Dose,States/Local Areas,Connecticut,2020,Age,24 Months,92.1,86.0 to 96.3,248
Combined 7 Series,,States/Local Areas,Connecticut,2020,Age,24 Months,74.7,66.3 to 82.5,248
Hep A,≥2 Doses,States/Local Areas,Connecticut,2020,Age,24 Months,58.5,49.9 to 67.4,248
PCV,≥1 Dose,States/Local Areas,Connecticut,2020,Age,3 Months,90.0,83.0 to 94.3,248
DTaP,≥2 Doses,States/Local Areas,Connecticut,2020,Age,5 Months,89.5,82.8 to 93.8,248
Polio,≥2 Doses,States/Local Areas,Connecticut,2020,Age,5 Months,89.3,82.7 to 93.6,248
Hib,≥2 Doses,States/Local Areas,Connecticut,2020,Age,5 Months,88.8,82.0 to 93.2,248
Hep B,≥2 Doses,States/Local Areas,Connecticut,2020,Age,5 Months,90.6,83.8 to 94.7,248
Polio,≥1 Dose,States/Local Areas,Connecticut,2020,Age,3 Months,90.0,83.1 to 94.3,248
Hib,≥1 Dose,States/Local Areas,Connecticut,2020,Age,3 Months,89.5,82.5 to 93.9,248
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,61.6,53.1 to 69.4,248
Hep B,≥1 Dose,States/Local Areas,Connecticut,2020,Age,3 Months,95.4,89.7 to 98.0,248
PCV,≥3 Doses,States/Local Areas,Connecticut,2020,Age,7 Months,80.7,72.8 to 86.8,248
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,92.4,86.1 to 96.0,248
Hep B,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,5 Months,92.9,89.2 to 95.4,559
Hep B,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,94.8,91.4 to 96.9,559
Hib,Primary Series,States/Local Areas,Connecticut,2019-2020,Age,13 Months,91.3,87.4 to 94.0,559
Hib,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,94.7,91.3 to 96.8,559
Hib,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,81.5,76.7 to 85.5,559
≥1 Dose MMR,,States/Local Areas,Connecticut,2019-2020,Age,13 Months,72.0,66.6 to 76.9,559
Polio,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,13 Months,94.7,91.3 to 96.8,559
Hib,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,5 Months,88.8,84.8 to 91.9,559
Polio,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,5 Months,88.8,84.7 to 91.9,559
DTaP,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,5 Months,89.4,85.4 to 92.5,559
PCV,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,3 Months,91.6,87.8 to 94.3,559
Hib,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,94.8,91.7 to 97.0,559
Hep B,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,3 Months,96.8,94.0 to 98.3,559
≥1 Dose MMR,,States/Local Areas,Connecticut,2019-2020,Age,24 Months,93.7,90.4 to 96.1,559
Polio,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,95.7,93.0 to 97.5,559
DTaP,≥4 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,86.6,82.1 to 90.5,559
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,96.2,93.5 to 98.0,559
PCV,≥4 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,93.3,89.4 to 96.2,559
PCV,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,95.3,92.4 to 97.4,559
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019-2020,Age,35 Months,97.6,95.0 to 99.0,559
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,95.1,92.0 to 97.3,559
Hib,Full Series,States/Local Areas,Connecticut,2019-2020,Age,35 Months,91.3,86.9 to 94.7,559
Hib,Primary Series,States/Local Areas,Connecticut,2019-2020,Age,35 Months,95.2,92.1 to 97.3,559
Hib,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,94.8,91.7 to 97.0,559
Hib,Full Series,States/Local Areas,Connecticut,2019-2020,Age,19 Months,80.3,75.1 to 84.5,559
Hib,Primary Series,States/Local Areas,Connecticut,2019-2020,Age,19 Months,95.1,91.7 to 97.1,559
Hib,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,94.5,91.1 to 96.7,559
≥1 Dose MMR,,States/Local Areas,Connecticut,2019-2020,Age,19 Months,92.8,89.0 to 95.4,559
Hep A,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,32.3,27.6 to 37.3,559
PCV,≥4 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,89.4,85.3 to 92.8,559
PCV,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,95.3,92.4 to 97.4,559
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019-2020,Age,24 Months,95.3,92.3 to 97.4,559
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,94.2,91.1 to 96.6,559
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2019-2020,Age,0-3 Days,85.1,80.6 to 88.7,559
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2019-2020,Age,0-2 Days,84.0,79.5 to 87.7,559
Hep A,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,19 Months,91.2,87.0 to 94.1,559
PCV,≥4 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,86.6,82.1 to 90.0,559
≥1 Dose Varicella,,States/Local Areas,Connecticut,2019-2020,Age,19 Months,93.9,90.2 to 96.2,559
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,93.8,90.4 to 96.1,559
Combined 7 Series,,States/Local Areas,Connecticut,2019-2020,Age,35 Months,85.9,80.9 to 90.1,559
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2019-2020,Age,0-1 Days,80.8,76.0 to 84.8,559
Hib,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,66.0,60.5 to 71.1,559
Hib,Full Series,States/Local Areas,Connecticut,2019-2020,Age,24 Months,87.5,83.1 to 91.2,559
Hib,Primary Series,States/Local Areas,Connecticut,2019-2020,Age,24 Months,95.2,92.1 to 97.3,559
Influenza,,States/Local Areas,Connecticut,2019-2020,Age,24 Months,84.0,79.5 to 88.0,559
Hep A,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,35 Months,88.1,82.1 to 92.8,559
Hep A,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,35 Months,95.9,92.2 to 98.2,559
Hep A,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,24 Months,93.2,89.7 to 95.8,559
Hep A,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,24 Months,57.3,51.7 to 63.1,559
Polio,≥2 Doses,States/Local Areas,Connecticut,2020,Age,13 Months,93.5,87.2 to 96.8,248
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,91.5,86.3 to 96.7,200
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,75.7,52.9 to 98.4,31
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,93.8,85.4 to 100.0,31
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.0,90.2 to 95.8,603
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,91.6,86.7 to 96.4,256
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.0,83.6 to 90.5,603
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,84.6,79.1 to 90.0,256
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,81.7,74.1 to 89.3,256
Influenza,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.0,78.8 to 87.2,603
Influenza,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,75.5,68.1 to 82.8,256
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,76.5,58.0 to 95.0,31
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.8,77.5 to 86.2,603
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,100.0,,31
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.3,89.1 to 95.5,603
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,86.8,81.2 to 92.4,256
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,100.0,,31
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.9,95.2 to 98.5,603
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,93.7,89.8 to 97.7,256
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.8,92.5 to 97.2,603
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a Non-MSA,92.6,82.4 to 100.0,31
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,81.9,75.6 to 88.2,176
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,91.1,86.1 to 96.1,256
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,95.1,92.2 to 98.0,428
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,87.4,81.1 to 93.7,286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,83.2,77.3 to 89.1,428
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,81.1,75.3 to 87.0,286
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,83.1,74.8 to 91.4,176
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,97.6,95.7 to 99.5,428
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,92.5,87.6 to 97.4,286
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,94.7,91.1 to 98.3,176
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,96.7,95.2 to 98.3,890
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,94.6,92.5 to 96.8,890
Influenza,,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,74.0,66.5 to 81.5,286
Influenza,,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,70.4,61.8 to 78.9,176
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,96.7,94.5 to 98.9,428
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,90.1,84.4 to 95.7,286
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,92.7,88.6 to 96.9,176
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,93.8,90.8 to 96.9,428
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,83.3,77.1 to 89.6,286
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,91.2,86.6 to 95.7,176
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Overall,Overall,88.3,85.5 to 91.1,890
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,94.1,90.4 to 97.8,176
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,93.7,90.5 to 96.8,428
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Poverty,133% to <400% FPL,84.0,77.4 to 90.6,286
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,86.6,81.2 to 92.0,176
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,95.1,92.3 to 97.9,428
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Overall,Overall,85.9,83.0 to 88.8,890
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,85.6,79.9 to 91.4,176
Influenza,,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,90.2,86.3 to 94.1,428
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,93.8,86.2 to 100.0,98
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",98.3,96.8 to 99.7,506
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,73.8,61.6 to 86.1,98
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.4,94.2 to 98.7,506
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,81.3,76.4 to 86.2,595
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.1,93.8 to 98.4,506
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.0,92.3 to 97.7,506
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.3,83.4 to 91.3,506
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,76.0 to 100.0,50
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,84.2,80.0 to 88.3,595
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,82.8,77.1 to 88.6,186
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.6,60.4 to 92.8,50
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.4,69.6 to 95.2,50
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,83.1,75.7 to 90.5,186
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,83.7,73.9 to 93.4,98
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,91.4,86.7 to 96.1,200
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,83.2 to 100.0,50
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,90.1 to 99.3,134
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,95.2,92.2 to 98.2,186
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,98.0,96.4 to 99.5,595
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,96.1,93.4 to 98.9,186
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,88.1,84.8 to 91.5,595
Influenza,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,72.6,64.4 to 80.8,186
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.6,87.1 to 98.1,134
Influenza,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,80.6,69.5 to 91.7,98
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,94.7,91.5 to 97.9,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,81.5,74.0 to 88.9,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,78.9 to 93.1,134
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.9,72.0 to 99.9,50
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,83.1,72.6 to 93.6,98
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.8,78.3 to 87.3,506
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,83.5,77.6 to 89.3,186
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,74.7,67.0 to 82.4,200
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.4,79.6 to 93.2,134
Combined 7 Series,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.9,72.0 to 99.9,50
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,82.0,76.0 to 88.0,200
Rotavirus,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,85.1 to 96.5,134
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,83.6,77.0 to 90.2,200
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.6,96.0 to 99.3,506
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,76.0 to 100.0,50
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,93.8,86.2 to 100.0,98
Influenza,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.5,80.1 to 88.9,506
Influenza,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",61.0,42.6 to 79.5,50
Influenza,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.9,75.8 to 91.9,134
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,83.2 to 100.0,50
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,93.8,86.2 to 100.0,98
Influenza,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,84.7,80.6 to 88.8,595
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,91.7,87.1 to 96.2,200
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.7,91.4 to 100.0,134
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.7,96.1 to 99.3,506
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,83.2 to 100.0,50
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,81.9,70.6 to 93.2,98
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,94.9,91.6 to 98.2,186
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,92.6,84.7 to 100.0,98
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,76.0 to 100.0,50
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,84.2,73.2 to 95.2,98
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,91.4,86.7 to 96.0,200
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.3,88.0 to 94.6,506
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,77.2,65.3 to 89.1,98
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,97.5,95.9 to 99.2,595
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,95.6,92.7 to 98.4,186
≥1 Dose Varicella,,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Other,88.4,78.0 to 98.7,98
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.6,86.0 to 93.2,506
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.8,72.8 to 100.0,50
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,95.1,91.9 to 98.2,200
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.9,92.9 to 100.0,134
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,90.9,87.6 to 94.1,595
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,83.2 to 100.0,50
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,87.3,82.3 to 92.4,186
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,83.2 to 100.0,50
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.4,66.5 to 86.4,115
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.9,72.8 to 83.0,421
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,73.4,66.4 to 80.5,261
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.6,72.7 to 82.5,478
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Overall,Overall,75.8,71.8 to 79.8,762
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,70.9,58.8 to 82.9,92
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.4,49.0 to 81.9,44
Combined 7 Series,,States/Local Areas,Connecticut,2018,Age,35 Months,87.5,82.5 to 91.7,308
Combined 7 Series,,States/Local Areas,Connecticut,2018-2019,Age,35 Months,87.3,83.8 to 90.5,619
Combined 7 Series,,States/Local Areas,Connecticut,2019,Age,35 Months,87.0,81.8 to 91.4,311
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,79.0,74.1 to 83.9,474
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,76.0,69.0 to 83.1,186
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,73.6,66.3 to 81.0,178
Hib,Full Series,States/Local Areas,Connecticut,2019,Age,19 Months,84.8,78.8 to 89.3,311
Hib,Full Series,States/Local Areas,Connecticut,2016,Age,19 Months,79.0,68.9 to 86.5,182
Hib,Full Series,States/Local Areas,Connecticut,2016-2017,Age,19 Months,78.8,72.1 to 84.3,366
Hib,Primary Series,States/Local Areas,Connecticut,2019,Age,7 Months,78.7,72.3 to 84.0,311
Hib,Primary Series,States/Local Areas,Connecticut,2011,Age,13 Months,96.7,95.4 to 97.6,243
Hib,Primary Series,States/Local Areas,Connecticut,2012,Age,13 Months,88.9,78.8 to 94.5,245
Hib,Primary Series,States/Local Areas,Connecticut,2013,Age,13 Months,94.8,92.6 to 96.4,255
Hib,Primary Series,States/Local Areas,Connecticut,2013-2014,Age,13 Months,93.3,91.0 to 95.1,518
Hib,Primary Series,States/Local Areas,Connecticut,2014,Age,13 Months,91.8,86.3 to 95.2,263
Hib,Primary Series,States/Local Areas,Connecticut,2014-2015,Age,13 Months,92.0,88.2 to 94.6,479
Hib,Full Series,States/Local Areas,Connecticut,2014,Age,19 Months,76.4,68.8 to 82.6,263
Hib,Full Series,States/Local Areas,Connecticut,2014-2015,Age,19 Months,76.8,71.2 to 81.5,479
Hib,Full Series,States/Local Areas,Connecticut,2015,Age,19 Months,77.1,74.4 to 79.6,216
Hib,Full Series,States/Local Areas,Connecticut,2015-2016,Age,19 Months,78.1,71.7 to 83.3,398
Hib,Full Series,States/Local Areas,Connecticut,2017,Age,19 Months,78.7,69.0 to 85.9,184
Hib,Full Series,States/Local Areas,Connecticut,2017-2018,Age,19 Months,81.3,75.8 to 85.8,492
Hib,Full Series,States/Local Areas,Connecticut,2018,Age,19 Months,84.0,78.2 to 88.5,308
Hib,Full Series,States/Local Areas,Connecticut,2018-2019,Age,19 Months,96.6,94.1 to 98.1,619
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,75.8,67.7 to 83.8,182
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,72.2,64.3 to 80.0,246
Combined 7 Series,,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,80.2,74.5 to 85.9,338
Hib,Full Series,States/Local Areas,Connecticut,2011,Age,19 Months,84.2,79.6 to 87.9,243
Hib,Full Series,States/Local Areas,Connecticut,2012,Age,19 Months,75.1,65.3 to 82.9,245
Hib,Full Series,States/Local Areas,Connecticut,2013,Age,19 Months,80.7,78.3 to 82.9,255
Hib,Full Series,States/Local Areas,Connecticut,2013-2014,Age,19 Months,78.6,75.0 to 81.7,518
Hib,Full Series,States/Local Areas,Connecticut,2011,Age,24 Months,91.9,87.6 to 95.2,243
Hib,Full Series,States/Local Areas,Connecticut,2012,Age,24 Months,83.9,76.5 to 90.0,245
Hib,Full Series,States/Local Areas,Connecticut,2013,Age,24 Months,86.6,80.2 to 91.8,255
Hib,Full Series,States/Local Areas,Connecticut,2013-2014,Age,24 Months,86.4,82.0 to 90.2,518
Hib,Full Series,States/Local Areas,Connecticut,2014,Age,24 Months,86.1,79.8 to 91.2,263
Hib,Full Series,States/Local Areas,Connecticut,2014-2015,Age,24 Months,85.1,80.3 to 89.3,479
Hib,Primary Series,States/Local Areas,Connecticut,2015,Age,35 Months,98.3,94.5 to 99.7,216
Hib,Primary Series,States/Local Areas,Connecticut,2015-2016,Age,35 Months,97.1,93.7 to 98.9,398
Hib,Primary Series,States/Local Areas,Connecticut,2016,Age,35 Months,96.4,90.1 to 99.1,182
Hib,Primary Series,States/Local Areas,Connecticut,2016-2017,Age,35 Months,94.8,90.3 to 97.6,366
Hib,Primary Series,States/Local Areas,Connecticut,2016,Age,24 Months,96.4,90.1 to 99.1,182
Hib,Primary Series,States/Local Areas,Connecticut,2016-2017,Age,24 Months,93.8,89.1 to 97.0,366
Combined 7 Series,,States/Local Areas,Connecticut,2012,Age,35 Months,78.8,71.3 to 85.5,245
Combined 7 Series,,States/Local Areas,Connecticut,2013,Age,35 Months,80.7,73.4 to 87.0,255
Combined 7 Series,,States/Local Areas,Connecticut,2013-2014,Age,35 Months,79.7,74.6 to 84.4,518
Combined 7 Series,,States/Local Areas,Connecticut,2014,Age,35 Months,78.7,71.5 to 85.1,263
Combined 7 Series,,States/Local Areas,Connecticut,2014-2015,Age,35 Months,80.8,75.2 to 85.8,479
Combined 7 Series,,States/Local Areas,Connecticut,2015,Age,35 Months,84.9,75.1 to 92.4,216
Combined 7 Series,,States/Local Areas,Connecticut,2015-2016,Age,35 Months,83.2,76.5 to 88.9,398
Combined 7 Series,,States/Local Areas,Connecticut,2017,Age,24 Months,77.4,68.3 to 85.3,184
Combined 7 Series,,States/Local Areas,Connecticut,2017-2018,Age,24 Months,81.2,75.9 to 86.0,492
Combined 7 Series,,States/Local Areas,Connecticut,2018,Age,24 Months,85.1,79.9 to 89.5,308
Combined 7 Series,,States/Local Areas,Connecticut,2018-2019,Age,24 Months,83.3,79.6 to 86.7,619
Combined 7 Series,,States/Local Areas,Connecticut,2014,Age,24 Months,74.9,67.5 to 81.8,263
Combined 7 Series,,States/Local Areas,Connecticut,2014-2015,Age,24 Months,75.1,69.5 to 80.3,479
Combined 7 Series,,States/Local Areas,Connecticut,2015,Age,24 Months,75.1,66.9 to 82.6,216
Combined 7 Series,,States/Local Areas,Connecticut,2015-2016,Age,24 Months,75.4,69.3 to 81.1,398
Hib,Primary Series,States/Local Areas,Connecticut,2018,Age,35 Months,96.3,92.6 to 98.5,308
Hib,Primary Series,States/Local Areas,Connecticut,2018-2019,Age,35 Months,96.3,93.9 to 98.0,619
Combined 7 Series,,States/Local Areas,Connecticut,2016,Age,24 Months,76.3,67.2 to 84.3,182
Combined 7 Series,,States/Local Areas,Connecticut,2016-2017,Age,24 Months,76.8,70.5 to 82.6,366
Hib,Primary Series,States/Local Areas,Connecticut,2019,Age,35 Months,96.3,92.9 to 98.4,311
Combined 7 Series,,States/Local Areas,Connecticut,2011,Age,24 Months,75.0,67.8 to 81.6,243
Combined 7 Series,,States/Local Areas,Connecticut,2013,Age,24 Months,77.0,69.8 to 83.6,255
Combined 7 Series,,States/Local Areas,Connecticut,2013-2014,Age,24 Months,76.0,70.9 to 80.8,518
Combined 7 Series,,States/Local Areas,Connecticut,2012,Age,24 Months,76.1,68.5 to 83.1,245
Hib,Primary Series,States/Local Areas,Connecticut,2011,Age,35 Months,97.6,94.6 to 99.1,243
Hib,Primary Series,States/Local Areas,Connecticut,2013,Age,35 Months,99.3,97.8 to 99.8,255
Hib,Primary Series,States/Local Areas,Connecticut,2013-2014,Age,35 Months,97.6,95.8 to 98.8,518
Hib,Primary Series,States/Local Areas,Connecticut,2012,Age,35 Months,94.1,88.5 to 97.5,245
Hib,Primary Series,States/Local Areas,Connecticut,2014,Age,35 Months,95.9,92.2 to 98.1,263
Hib,Primary Series,States/Local Areas,Connecticut,2014-2015,Age,35 Months,96.9,94.7 to 98.4,479
Hib,Primary Series,States/Local Areas,Connecticut,2014,Age,24 Months,95.9,92.2 to 98.1,263
Hib,Primary Series,States/Local Areas,Connecticut,2014-2015,Age,24 Months,96.1,93.5 to 97.9,479
Hib,Primary Series,States/Local Areas,Connecticut,2015,Age,24 Months,96.3,92.2 to 98.5,216
Hib,Primary Series,States/Local Areas,Connecticut,2015-2016,Age,24 Months,96.3,93.0 to 98.4,398
Hib,Primary Series,States/Local Areas,Connecticut,2019,Age,24 Months,96.3,92.9 to 98.4,311
Hib,Primary Series,States/Local Areas,Connecticut,2017,Age,24 Months,91.1,83.2 to 96.3,184
Hib,Primary Series,States/Local Areas,Connecticut,2017-2018,Age,24 Months,93.7,89.4 to 96.6,492
Hib,Primary Series,States/Local Areas,Connecticut,2018,Age,24 Months,96.2,92.5 to 98.4,308
Hib,Primary Series,States/Local Areas,Connecticut,2018-2019,Age,24 Months,96.3,93.9 to 97.9,619
Hib,Primary Series,States/Local Areas,Connecticut,2019,Age,19 Months,96.3,92.4 to 98.2,311
Hib,Primary Series,States/Local Areas,Connecticut,2018,Age,19 Months,95.7,91.4 to 97.9,308
Hib,Primary Series,States/Local Areas,Connecticut,2018-2019,Age,19 Months,93.1,90.2 to 95.2,619
Hib,Primary Series,States/Local Areas,Connecticut,2015,Age,19 Months,95.9,92.3 to 97.9,216
Hib,Primary Series,States/Local Areas,Connecticut,2015-2016,Age,19 Months,96.1,92.4 to 98.1,398
Hib,Primary Series,States/Local Areas,Connecticut,2019,Age,13 Months,92.6,88.2 to 95.4,311
Hib,Primary Series,States/Local Areas,Connecticut,2011,Age,19 Months,97.4,96.5 to 98.1,243
Hib,Primary Series,States/Local Areas,Connecticut,2016,Age,19 Months,96.4,88.5 to 98.9,182
Hib,Primary Series,States/Local Areas,Connecticut,2016-2017,Age,19 Months,93.8,88.5 to 96.7,366
Hib,Primary Series,States/Local Areas,Connecticut,2017,Age,19 Months,91.1,82.0 to 95.9,184
Hib,Primary Series,States/Local Areas,Connecticut,2017-2018,Age,19 Months,93.4,88.7 to 96.3,492
Hib,Primary Series,States/Local Areas,Connecticut,2018,Age,13 Months,93.6,89.3 to 96.3,308
Hib,Primary Series,States/Local Areas,Connecticut,2018-2019,Age,13 Months,93.1,90.2 to 95.2,619
Hib,Primary Series,States/Local Areas,Connecticut,2013,Age,7 Months,76.5,70.6 to 81.6,255
Hib,Primary Series,States/Local Areas,Connecticut,2013-2014,Age,7 Months,75.8,70.7 to 80.3,518
Hib,Primary Series,States/Local Areas,Connecticut,2014,Age,7 Months,75.2,67.4 to 81.6,263
Hib,Primary Series,States/Local Areas,Connecticut,2014-2015,Age,7 Months,76.8,71.5 to 81.3,479
Hib,Primary Series,States/Local Areas,Connecticut,2015,Age,7 Months,78.4,70.8 to 84.5,216
Hib,Primary Series,States/Local Areas,Connecticut,2015-2016,Age,7 Months,81.0,75.3 to 85.6,398
Hib,Primary Series,States/Local Areas,Connecticut,2012,Age,19 Months,92.3,81.4 to 97.0,245
Hib,Primary Series,States/Local Areas,Connecticut,2013,Age,19 Months,97.8,95.6 to 98.9,255
Hib,Primary Series,States/Local Areas,Connecticut,2013-2014,Age,19 Months,96.6,95.6 to 97.3,518
Hib,Primary Series,States/Local Areas,Connecticut,2014,Age,19 Months,95.3,91.0 to 97.6,263
Hib,Primary Series,States/Local Areas,Connecticut,2014-2015,Age,19 Months,95.6,92.8 to 97.3,479
Hib,Primary Series,States/Local Areas,Connecticut,2017,Age,13 Months,87.0,77.3 to 92.9,184
Hib,Primary Series,States/Local Areas,Connecticut,2017-2018,Age,13 Months,90.3,85.2 to 93.8,492
Hib,Primary Series,States/Local Areas,Connecticut,2015,Age,13 Months,92.1,86.3 to 95.6,216
Hib,Primary Series,States/Local Areas,Connecticut,2015-2016,Age,13 Months,92.5,87.8 to 95.4,398
Hib,Primary Series,States/Local Areas,Connecticut,2016,Age,13 Months,92.8,84.1 to 96.9,182
Hib,Primary Series,States/Local Areas,Connecticut,2016-2017,Age,13 Months,90.0,83.9 to 93.9,366
Hib,Primary Series,States/Local Areas,Connecticut,2016,Age,7 Months,83.6,74.5 to 89.9,182
Hib,Primary Series,States/Local Areas,Connecticut,2016-2017,Age,7 Months,80.2,73.8 to 85.4,366
Hib,Primary Series,States/Local Areas,Connecticut,2017,Age,7 Months,76.8,67.1 to 84.3,184
Hib,Primary Series,States/Local Areas,Connecticut,2017-2018,Age,7 Months,79.9,74.3 to 84.5,492
Hib,Primary Series,States/Local Areas,Connecticut,2018,Age,7 Months,83.0,77.2 to 87.5,308
Hib,Primary Series,States/Local Areas,Connecticut,2018-2019,Age,7 Months,80.9,76.6 to 84.5,619
≥1 Dose MMR,,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,91.4,86.8 to 96.1,256
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Principal City,93.8,89.7 to 97.8,256
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.1,84.6 to 93.5,603
Hep B,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.9,91.7 to 100.0,134
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,95.9,92.2 to 98.1,412
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.3,84.3 to 94.2,506
Combined 7 Series,,States/Local Areas,Connecticut,2019,Age,24 Months,81.5,75.9 to 86.5,311
Hib,≥1 Dose,States/Local Areas,Connecticut,2019-2020,Age,3 Months,91.2,87.3 to 94.0,559
Hib,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,96.0,92.8 to 97.8,412
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2021,Age,0-2 Days,82.6,72.9 to 89.4,164
≥1 Dose Varicella,,States/Local Areas,Connecticut,2021,Age,24 Months,95.5,89.1 to 98.7,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,96.1,93.3 to 98.0,412
Hep B,≥3 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,67.6,57.6 to 76.3,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,98.4,95.6 to 99.6,164
Hep A,≥1 Dose,States/Local Areas,Connecticut,2021,Age,24 Months,95.9,89.9 to 98.8,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,75.5,69.1 to 80.9,412
DTaP,≥3 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,98.6,96.2 to 99.5,164
PCV,≥4 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,90.8,82.9 to 96.1,164
Hep A,≥2 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,59.8,47.5 to 72.5,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,79.7,69.6 to 87.1,164
Combined 7 Series,,States/Local Areas,Connecticut,2021,Age,24 Months,78.4,69.1 to 86.5,164
DTaP,≥3 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,97.0,91.7 to 98.9,164
Hep A,≥2 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,33.2,24.4 to 43.4,164
PCV,≥4 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,96.0,89.3 to 99.0,164
Polio,≥2 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,98.9,96.6 to 99.7,164
Hep A,≥1 Dose,States/Local Areas,Connecticut,2021,Age,19 Months,92.5,84.9 to 96.4,164
DTaP,≥1 Dose,States/Local Areas,Connecticut,2021,Age,3 Months,95.8,87.8 to 98.7,164
≥1 Dose MMR,,States/Local Areas,Connecticut,2021,Age,24 Months,94.5,87.8 to 98.2,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,96.9,92.8 to 99.0,164
Hib,Primary Series,States/Local Areas,Connecticut,2021,Age,24 Months,96.2,91.8 to 98.6,164
Polio,≥3 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,94.1,87.4 to 97.9,164
Polio,≥1 Dose,States/Local Areas,Connecticut,2021,Age,3 Months,94.0,85.8 to 97.6,164
Hib,≥1 Dose,States/Local Areas,Connecticut,2021,Age,3 Months,92.9,84.3 to 96.9,164
DTaP,≥4 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,96.1,90.5 to 98.8,412
Hib,Full Series,States/Local Areas,Connecticut,2021,Age,24 Months,87.6,79.9 to 93.4,164
DTaP,≥4 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,81.4,71.9 to 88.2,164
Hep B,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,95.6,91.9 to 97.6,412
Hib,Primary Series,States/Local Areas,Connecticut,2021,Age,7 Months,75.2,65.0 to 83.3,164
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020-2021,Age,35 Months,97.7,92.3 to 99.6,412
Hep A,≥1 Dose,States/Local Areas,Connecticut,2021,Age,35 Months,98.5,96.4 to 99.5,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,97.1,93.7 to 98.7,164
PCV,≥4 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,87.2,78.6 to 92.6,164
Hep A,≥2 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,24.9,18.1 to 33.2,216
Hep A,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,28.0,22.6 to 34.1,398
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,31.1,22.8 to 40.9,182
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,36.3,30.0 to 43.1,366
Hib,≥3 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,98.6,96.2 to 99.6,255
Hib,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,97.2,95.2 to 98.5,518
Hib,≥3 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,95.5,91.8 to 97.9,263
Hib,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,95.5,92.4 to 97.6,479
Hib,≥3 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,95.8,89.6 to 98.8,216
Hib,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,95.4,91.5 to 97.9,398
Hep A,≥2 Doses,States/Local Areas,Connecticut,2017,Age,19 Months,41.7,32.8 to 51.2,184
Hep A,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,19 Months,40.0,34.4 to 45.9,492
Hep A,≥1 Dose,States/Local Areas,Connecticut,2015,Age,24 Months,90.7,85.1 to 94.9,216
Hep A,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,24 Months,88.9,84.0 to 92.9,398
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016,Age,24 Months,87.2,78.9 to 93.4,182
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,24 Months,87.6,82.0 to 92.2,366
PCV,≥2 Doses,States/Local Areas,Connecticut,2014,Age,5 Months,82.8,75.4 to 88.3,263
PCV,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,5 Months,84.1,79.8 to 87.7,479
PCV,≥2 Doses,States/Local Areas,Connecticut,2015,Age,5 Months,85.5,78.2 to 90.7,216
PCV,≥2 Doses,States/Local Areas,Connecticut,2015-2016,Age,5 Months,86.1,80.8 to 90.1,398
PCV,≥2 Doses,States/Local Areas,Connecticut,2016,Age,5 Months,86.8,78.2 to 92.3,182
PCV,≥2 Doses,States/Local Areas,Connecticut,2016-2017,Age,5 Months,84.0,78.1 to 88.6,366
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,96.8,93.0 to 98.8,308
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,96.5,94.1 to 98.1,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019,Age,35 Months,96.1,92.7 to 98.2,311
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,93.7,86.9 to 100.0,92
Hep A,≥1 Dose,States/Local Areas,Connecticut,2017,Age,24 Months,88.0,79.7 to 94.1,184
Hep A,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,24 Months,91.5,86.8 to 95.0,492
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,72.8,65.0 to 79.3,263
DTaP,≥4 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,69.6,63.7 to 74.9,479
DTaP,≥4 Doses,States/Local Areas,Connecticut,2015,Age,19 Months,66.4,64.4 to 68.3,216
DTaP,≥4 Doses,States/Local Areas,Connecticut,2015-2016,Age,19 Months,68.8,62.2 to 74.7,398
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.0 to 99.4,474
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,94.4,90.7 to 98.1,186
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016,Age,19 Months,71.2,61.2 to 79.5,182
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2017,Age,19 Months,72.2,65.3 to 78.2,366
Hep A,≥2 Doses,States/Local Areas,Connecticut,2018,Age,19 Months,38.3,31.7 to 45.3,308
Hep A,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,19 Months,31.9,27.1 to 37.2,520
Hep A,≥2 Doses,States/Local Areas,Connecticut,2019,Age,19 Months,31.8,25.7 to 38.5,311
Hep A,≥2 Doses,States/Local Areas,Connecticut,2011,Age,24 Months,44.9,37.1 to 53.5,243
Hib,≥3 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,95.7,89.4 to 98.7,182
Hib,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,94.3,89.8 to 97.2,366
Hib,≥3 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,92.9,85.6 to 97.3,184
Hib,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,94.3,90.3 to 97.0,492
Hep A,≥2 Doses,States/Local Areas,Connecticut,2012,Age,24 Months,46.2,38.2 to 55.0,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.7,80.4 to 100.0,44
Hib,≥3 Doses,States/Local Areas,Connecticut,2018,Age,35 Months,95.7,91.9 to 98.0,308
Hib,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,35 Months,95.8,93.3 to 97.5,619
Hep A,≥1 Dose,States/Local Areas,Connecticut,2012,Age,35 Months,91.6,85.5 to 95.8,245
PCV,≥2 Doses,States/Local Areas,Connecticut,2017,Age,5 Months,81.2,72.1 to 87.9,184
PCV,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,5 Months,84.2,78.9 to 88.3,492
PCV,≥2 Doses,States/Local Areas,Connecticut,2011,Age,5 Months,90.9,88.7 to 92.8,243
PCV,≥2 Doses,States/Local Areas,Connecticut,2012,Age,5 Months,80.2,70.4 to 87.3,245
PCV,≥2 Doses,States/Local Areas,Connecticut,2013,Age,5 Months,75.5,70.9 to 79.6,255
PCV,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,5 Months,79.1,75.3 to 82.4,518
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016,Age,35 Months,96.4,90.1 to 99.2,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,35 Months,94.8,90.3 to 97.6,366
DTaP,≥4 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,65.7,54.6 to 75.3,245
DTaP,≥4 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,73.7,70.6 to 76.6,255
DTaP,≥4 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,73.3,70.0 to 76.3,518
DTaP,≥4 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,78.6,74.8 to 82.0,243
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017,Age,35 Months,93.1,85.8 to 97.4,184
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,35 Months,94.9,91.0 to 97.5,492
Hep A,≥1 Dose,States/Local Areas,Connecticut,2019,Age,19 Months,92.6,88.0 to 95.5,311
Hep A,≥1 Dose,States/Local Areas,Connecticut,2011,Age,24 Months,93.4,89.4 to 96.2,243
Hep A,≥1 Dose,States/Local Areas,Connecticut,2013,Age,24 Months,92.5,86.9 to 96.3,255
Hep A,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,24 Months,91.0,87.3 to 93.9,518
Hep A,≥1 Dose,States/Local Areas,Connecticut,2012,Age,24 Months,90.5,84.6 to 94.9,245
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014,Age,24 Months,89.4,84.2 to 93.5,263
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,24 Months,90.1,86.4 to 93.1,479
DTaP,≥3 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,97.9,95.1 to 99.3,243
DTaP,≥3 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,95.1,89.7 to 98.2,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013,Age,35 Months,99.2,97.0 to 99.9,255
DTaP,≥3 Doses,States/Local Areas,Connecticut,2013-2014,Age,35 Months,97.9,95.9 to 99.0,518
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014,Age,35 Months,96.5,92.9 to 98.6,263
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,35 Months,96.8,94.1 to 98.5,479
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015,Age,35 Months,97.7,92.2 to 99.6,216
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,35 Months,96.5,92.7 to 98.6,398
Hep A,≥2 Doses,States/Local Areas,Connecticut,2011,Age,19 Months,23.8,16.0 to 33.9,243
Hep A,≥2 Doses,States/Local Areas,Connecticut,2013,Age,19 Months,31.1,21.0 to 43.3,255
Hep A,≥2 Doses,States/Local Areas,Connecticut,2013-2014,Age,19 Months,32.6,27.1 to 38.6,518
Hep A,≥2 Doses,States/Local Areas,Connecticut,2012,Age,19 Months,23.9,18.5 to 30.2,245
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014,Age,19 Months,34.2,27.2 to 42.0,263
Hep A,≥2 Doses,States/Local Areas,Connecticut,2014-2015,Age,19 Months,29.6,24.6 to 35.0,479
Hib,≥3 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,95.6,91.8 to 97.9,308
Hib,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,95.7,93.2 to 97.5,619
Hib,≥3 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,95.8,92.3 to 98.1,311
Hep A,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,24 Months,94.0,90.0 to 96.8,412
Hep A,≥1 Dose,States/Local Areas,Connecticut,2013,Age,19 Months,90.6,88.0 to 92.6,255
Hep A,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,19 Months,88.6,85.4 to 91.2,518
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016,Age,19 Months,86.5,77.3 to 92.3,182
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,19 Months,86.4,80.3 to 90.9,366
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020-2021,Age,13 Months,65.1,58.3 to 71.3,412
DTaP,≥2 Doses,States/Local Areas,Connecticut,2018,Age,5 Months,89.5,84.2 to 93.1,308
DTaP,≥2 Doses,States/Local Areas,Connecticut,2018-2019,Age,5 Months,89.4,85.8 to 92.2,619
DTaP,≥2 Doses,States/Local Areas,Connecticut,2019,Age,5 Months,89.4,83.9 to 93.2,311
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014,Age,19 Months,86.6,80.6 to 91.0,263
Hep A,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,19 Months,86.5,82.1 to 89.9,479
Hep A,≥1 Dose,States/Local Areas,Connecticut,2015,Age,19 Months,86.3,84.4 to 88.0,216
Hep A,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,19 Months,86.4,81.0 to 90.5,398
DTaP,≥1 Dose,States/Local Areas,Connecticut,2017,Age,3 Months,90.2,82.0 to 94.9,184
DTaP,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,3 Months,92.3,87.9 to 95.2,492
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014,Age,24 Months,96.3,92.6 to 98.4,263
DTaP,≥3 Doses,States/Local Areas,Connecticut,2014-2015,Age,24 Months,95.6,92.6 to 97.7,479
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,94.8,89.5 to 97.9,216
DTaP,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,95.6,91.9 to 97.9,398
DTaP,≥1 Dose,States/Local Areas,Connecticut,2018,Age,3 Months,94.4,89.8 to 97.0,308
DTaP,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,3 Months,93.8,90.9 to 95.8,619
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,96.4,90.1 to 99.2,182
DTaP,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,93.8,89.1 to 97.0,366
DTaP,≥1 Dose,States/Local Areas,Connecticut,2019,Age,3 Months,93.2,88.9 to 95.9,311
Hep A,≥1 Dose,States/Local Areas,Connecticut,2011,Age,19 Months,90.1,87.8 to 92.0,243
Hep A,≥1 Dose,States/Local Areas,Connecticut,2012,Age,19 Months,87.6,82.7 to 91.3,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.3,77.1 to 87.4,506
DTaP,≥1 Dose,States/Local Areas,Connecticut,2011,Age,3 Months,95.9,92.8 to 97.7,243
DTaP,≥1 Dose,States/Local Areas,Connecticut,2012,Age,3 Months,90.4,83.3 to 94.7,245
DTaP,≥1 Dose,States/Local Areas,Connecticut,2013,Age,3 Months,94.0,91.2 to 96.0,255
DTaP,≥1 Dose,States/Local Areas,Connecticut,2013-2014,Age,3 Months,92.7,90.5 to 94.4,518
DTaP,≥1 Dose,States/Local Areas,Connecticut,2014,Age,3 Months,91.3,84.9 to 95.1,263
DTaP,≥1 Dose,States/Local Areas,Connecticut,2014-2015,Age,3 Months,91.0,86.7 to 94.0,479
DTaP,≥1 Dose,States/Local Areas,Connecticut,2015,Age,3 Months,90.7,84.2 to 94.7,216
DTaP,≥1 Dose,States/Local Areas,Connecticut,2015-2016,Age,3 Months,91.3,86.5 to 94.5,398
DTaP,≥1 Dose,States/Local Areas,Connecticut,2016,Age,3 Months,91.8,83.6 to 96.1,182
DTaP,≥1 Dose,States/Local Areas,Connecticut,2016-2017,Age,3 Months,91.0,85.7 to 94.5,366
Hib,≥3 Doses,States/Local Areas,Connecticut,2015,Age,24 Months,93.6,87.7 to 97.2,216
Hib,≥3 Doses,States/Local Areas,Connecticut,2015-2016,Age,24 Months,94.6,90.6 to 97.3,398
Hib,≥3 Doses,States/Local Areas,Connecticut,2016,Age,24 Months,95.7,89.4 to 98.7,182
Hib,≥3 Doses,States/Local Areas,Connecticut,2016-2017,Age,24 Months,93.3,88.5 to 96.6,366
DTaP,≥3 Doses,States/Local Areas,Connecticut,2019,Age,24 Months,96.1,92.7 to 98.2,311
Hib,≥3 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,90.9,83.0 to 96.0,184
Hib,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,93.2,88.9 to 96.2,492
Hib,Full Series,States/Local Areas,Connecticut,2021,Age,19 Months,83.0,74.0 to 89.3,164
Hep B,≥3 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,96.2,90.2 to 98.6,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,98.4,95.6 to 99.6,164
≥1 Dose Varicella,,States/Local Areas,Connecticut,2021,Age,19 Months,93.0,84.7 to 97.0,164
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Overall,Overall,94.7,92.7 to 96.7,762
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,94.0,90.3 to 97.8,178
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,90.1,85.1 to 95.2,246
Polio,≥3 Doses,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,98.6,97.0 to 100.0,338
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017,Age,24 Months,91.1,83.2 to 96.3,184
DTaP,≥3 Doses,States/Local Areas,Connecticut,2017-2018,Age,24 Months,93.9,89.6 to 96.9,492
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018,Age,24 Months,96.7,92.9 to 98.8,308
DTaP,≥3 Doses,States/Local Areas,Connecticut,2018-2019,Age,24 Months,96.4,94.0 to 98.0,619
DTaP,≥2 Doses,States/Local Areas,Connecticut,2017,Age,5 Months,81.2,71.5 to 88.1,184
DTaP,≥2 Doses,States/Local Areas,Connecticut,2017-2018,Age,5 Months,85.3,79.9 to 89.5,492
Hep A,≥1 Dose,States/Local Areas,Connecticut,2017,Age,19 Months,86.4,77.2 to 92.3,184
Hep A,≥1 Dose,States/Local Areas,Connecticut,2017-2018,Age,19 Months,89.3,84.2 to 92.8,492
Hep A,≥1 Dose,States/Local Areas,Connecticut,2018,Age,19 Months,92.1,87.0 to 95.3,308
Hep A,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,19 Months,92.2,88.6 to 94.7,520
Combined 7 Series,,States/Local Areas,Connecticut,2021,Age,35 Months,96.7,82.6 to 99.9,164
Polio,≥2 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,97.0,92.1 to 98.9,164
PCV,≥4 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,88.7,83.6 to 92.7,412
Hep B,≥3 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,96.2,91.1 to 98.8,164
Hep A,≥2 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,96.6,85.2 to 99.8,164
Hep A,≥1 Dose,States/Local Areas,Connecticut,2018,Age,24 Months,94.9,90.8 to 97.6,308
Hep A,≥1 Dose,States/Local Areas,Connecticut,2018-2019,Age,24 Months,94.6,91.8 to 96.6,619
Hep A,≥1 Dose,States/Local Areas,Connecticut,2019,Age,24 Months,94.1,90.1 to 96.9,311
Hep A,≥1 Dose,States/Local Areas,Connecticut,2011,Age,35 Months,95.5,91.5 to 98.0,243
Polio,≥3 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,94.0,86.1 to 97.5,164
PCV,≥2 Doses,States/Local Areas,Connecticut,2021,Age,5 Months,82.7,72.5 to 89.7,164
Hib,≥2 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,95.6,90.6 to 98.0,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2011,Age,35 Months,97.6,94.6 to 99.1,243
Hib,≥3 Doses,States/Local Areas,Connecticut,2012,Age,35 Months,93.7,88.1 to 97.3,245
DTaP,≥3 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,82.6,72.7 to 89.5,164
Hep B,≥2 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,96.9,91.3 to 98.9,164
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,93.3,89.3 to 95.8,412
Hib,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,95.1,91.7 to 97.4,412
Hib,Primary Series,States/Local Areas,Connecticut,2020-2021,Age,24 Months,95.1,91.8 to 97.4,412
≥1 Dose MMR,,States/Local Areas,Connecticut,2021,Age,35 Months,94.5,87.8 to 98.2,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2021,Age,7 Months,53.8,43.2 to 64.0,164
DTaP,≥4 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,89.7,80.9 to 95.6,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2021,Age,19 Months,95.2,90.0 to 97.8,164
Hib,Primary Series,States/Local Areas,Connecticut,2021,Age,19 Months,96.2,91.1 to 98.4,164
Hib,Full Series,States/Local Areas,Connecticut,2020-2021,Age,24 Months,85.7,80.3 to 90.2,412
Rotavirus,,States/Local Areas,Washington,2014,Age,8 Months,70.2,62.7 to 76.8,304
Rotavirus,,States/Local Areas,Washington,2014-2015,Age,8 Months,72.4,66.9 to 77.2,582
Rotavirus,,States/Local Areas,Washington,2016,Age,8 Months,73.4,65.0 to 80.4,280
Rotavirus,,States/Local Areas,Washington,2016-2017,Age,8 Months,72.5,67.4 to 77.1,747
Rotavirus,,States/Local Areas,Washington,2015,Age,8 Months,74.5,66.5 to 81.2,278
Rotavirus,,States/Local Areas,Washington,2015-2016,Age,8 Months,74.0,68.3 to 79.0,558
Rotavirus,,States/Local Areas,Washington,2011,Age,8 Months,74.8,66.8 to 81.5,241
Rotavirus,,States/Local Areas,Washington,2013,Age,8 Months,73.1,66.5 to 78.8,313
Rotavirus,,States/Local Areas,Washington,2013-2014,Age,8 Months,71.7,66.7 to 76.1,617
Rotavirus,,States/Local Areas,Washington,2012,Age,8 Months,71.8,63.5 to 78.9,252
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,91.2,86.0 to 96.4,298
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.2,70.8 to 79.6,885
PCV,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,5 Months,79.9,75.3 to 83.8,707
Hib,Full Series,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.0,61.7 to 94.2,44
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,89.5,83.8 to 95.3,298
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,84.0,76.0 to 92.0,298
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,80.8,75.8 to 85.8,578
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,87.3 to 95.5,317
Hib,Primary Series,States/Local Areas,Washington,2018,Age,13 Months,93.9,90.5 to 96.1,492
Hib,Primary Series,States/Local Areas,Washington,2018-2019,Age,13 Months,93.7,91.3 to 95.4,947
Hib,Primary Series,States/Local Areas,Washington,2019-2020,Age,7 Months,78.0,74.1 to 81.6,900
Hep B,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,93.4,90.7 to 95.3,900
Hib,Full Series,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,78.3,71.2 to 85.3,298
Hib,Primary Series,States/Local Areas,Washington,2017,Age,19 Months,90.5,86.2 to 93.6,467
Hib,Primary Series,States/Local Areas,Washington,2017-2018,Age,19 Months,92.7,90.1 to 94.7,959
Hib,Primary Series,States/Local Areas,Washington,2017,Age,13 Months,88.8,84.2 to 92.2,467
Hib,Primary Series,States/Local Areas,Washington,2017-2018,Age,13 Months,91.3,88.6 to 93.5,959
Hib,Primary Series,States/Local Areas,Washington,2012,Age,19 Months,93.3,89.7 to 95.6,252
Hib,Primary Series,States/Local Areas,Washington,2014,Age,19 Months,90.0,84.3 to 93.8,304
Hib,Primary Series,States/Local Areas,Washington,2014-2015,Age,19 Months,89.5,85.4 to 92.6,582
Hib,Primary Series,States/Local Areas,Washington,2019,Age,13 Months,93.4,89.7 to 95.9,455
Hib,Primary Series,States/Local Areas,Washington,2013,Age,19 Months,92.5,88.5 to 95.2,313
Hib,Primary Series,States/Local Areas,Washington,2013-2014,Age,19 Months,91.2,88.0 to 93.7,617
Hib,Primary Series,States/Local Areas,Washington,2011,Age,19 Months,94.3,88.7 to 97.2,241
Hib,Primary Series,States/Local Areas,Washington,2014,Age,7 Months,70.2,62.8 to 76.7,304
Hib,Primary Series,States/Local Areas,Washington,2014-2015,Age,7 Months,70.4,65.0 to 75.3,582
Hib,Primary Series,States/Local Areas,Washington,2016,Age,7 Months,73.6,65.5 to 80.3,280
Hib,Primary Series,States/Local Areas,Washington,2016-2017,Age,7 Months,72.8,67.9 to 77.3,747
Hib,Primary Series,States/Local Areas,Washington,2017,Age,7 Months,72.1,66.0 to 77.4,467
Hib,Primary Series,States/Local Areas,Washington,2017-2018,Age,7 Months,75.4,71.4 to 79.0,959
Hib,Primary Series,States/Local Areas,Washington,2012,Age,24 Months,93.9,89.5 to 96.9,252
Hib,Primary Series,States/Local Areas,Washington,2011,Age,24 Months,95.0,90.7 to 97.7,241
Hib,Primary Series,States/Local Areas,Washington,2016,Age,19 Months,86.0,78.1 to 91.4,280
Hib,Primary Series,States/Local Areas,Washington,2016-2017,Age,19 Months,88.2,83.9 to 91.5,747
Hib,Primary Series,States/Local Areas,Washington,2015,Age,19 Months,89.0,86.6 to 91.0,278
Hib,Primary Series,States/Local Areas,Washington,2015-2016,Age,19 Months,87.5,82.6 to 91.2,558
Hib,Primary Series,States/Local Areas,Washington,2016,Age,13 Months,83.1,75.2 to 88.8,280
Hib,Primary Series,States/Local Areas,Washington,2016-2017,Age,13 Months,85.9,81.4 to 89.4,747
Hib,Primary Series,States/Local Areas,Washington,2019,Age,7 Months,81.5,76.2 to 85.9,455
Combined 7 Series,,States/Local Areas,Washington,2017,Age,35 Months,75.1,69.3 to 80.5,467
Combined 7 Series,,States/Local Areas,Washington,2017-2018,Age,35 Months,76.6,72.5 to 80.4,959
Combined 7 Series,,States/Local Areas,Washington,2016,Age,35 Months,73.3,64.8 to 81.1,280
Combined 7 Series,,States/Local Areas,Washington,2016-2017,Age,35 Months,74.0,69.0 to 78.8,747
Combined 7 Series,,States/Local Areas,Washington,2013,Age,24 Months,70.3,63.4 to 77.0,313
Combined 7 Series,,States/Local Areas,Washington,2013-2014,Age,24 Months,71.0,66.1 to 75.7,617
Combined 7 Series,,States/Local Areas,Washington,2014,Age,35 Months,74.6,67.6 to 81.2,304
Combined 7 Series,,States/Local Areas,Washington,2014-2015,Age,35 Months,70.8,65.1 to 76.2,582
Combined 7 Series,,States/Local Areas,Washington,2012,Age,35 Months,78.3,70.3 to 85.4,252
Hib,Primary Series,States/Local Areas,Washington,2019,Age,19 Months,96.0,92.8 to 97.8,455
Combined 7 Series,,States/Local Areas,Washington,2015,Age,24 Months,61.3,52.9 to 69.8,278
Combined 7 Series,,States/Local Areas,Washington,2015-2016,Age,24 Months,63.2,57.3 to 69.1,558
Hib,Primary Series,States/Local Areas,Washington,2018,Age,35 Months,96.1,93.6 to 97.8,492
Hib,Primary Series,States/Local Areas,Washington,2018-2019,Age,35 Months,96.6,94.9 to 97.8,947
Hib,Primary Series,States/Local Areas,Washington,2019,Age,35 Months,97.1,94.6 to 98.6,455
Combined 7 Series,,States/Local Areas,Washington,2016,Age,24 Months,65.1,57.0 to 73.2,280
Combined 7 Series,,States/Local Areas,Washington,2016-2017,Age,24 Months,68.9,63.9 to 73.8,747
Combined 7 Series,,States/Local Areas,Washington,2019,Age,24 Months,69.4,63.6 to 75.0,455
Combined 7 Series,,States/Local Areas,Washington,2017,Age,24 Months,72.7,67.0 to 78.1,467
Combined 7 Series,,States/Local Areas,Washington,2017-2018,Age,24 Months,73.2,69.2 to 77.1,959
Combined 7 Series,,States/Local Areas,Washington,2018,Age,24 Months,73.7,67.9 to 79.1,492
Combined 7 Series,,States/Local Areas,Washington,2018-2019,Age,24 Months,71.5,67.5 to 75.5,947
Combined 7 Series,,States/Local Areas,Washington,2014,Age,24 Months,71.7,64.7 to 78.3,304
Combined 7 Series,,States/Local Areas,Washington,2014-2015,Age,24 Months,66.4,60.9 to 71.9,582
Hib,Primary Series,States/Local Areas,Washington,2014,Age,35 Months,92.3,87.3 to 95.9,304
Hib,Primary Series,States/Local Areas,Washington,2014-2015,Age,35 Months,91.1,87.2 to 94.2,582
Hib,Primary Series,States/Local Areas,Washington,2013,Age,13 Months,89.8,85.9 to 92.8,313
Hib,Primary Series,States/Local Areas,Washington,2013-2014,Age,13 Months,88.9,84.8 to 92.0,617
Hib,Primary Series,States/Local Areas,Washington,2012,Age,13 Months,88.3,85.0 to 91.0,252
Hib,Primary Series,States/Local Areas,Washington,2011,Age,13 Months,91.1,87.9 to 93.6,241
Hib,Primary Series,States/Local Areas,Washington,2018,Age,7 Months,78.8,73.4 to 83.4,492
Hib,Primary Series,States/Local Areas,Washington,2018-2019,Age,7 Months,80.2,76.4 to 83.4,947
Hib,Primary Series,States/Local Areas,Washington,2015,Age,7 Months,70.6,62.3 to 77.6,278
Hib,Primary Series,States/Local Areas,Washington,2015-2016,Age,7 Months,72.1,66.4 to 77.1,558
Hib,Primary Series,States/Local Areas,Washington,2015,Age,13 Months,84.1,76.7 to 89.4,278
Hib,Primary Series,States/Local Areas,Washington,2015-2016,Age,13 Months,83.6,78.4 to 87.7,558
Hib,Primary Series,States/Local Areas,Washington,2014,Age,13 Months,87.9,81.7 to 92.2,304
Hib,Primary Series,States/Local Areas,Washington,2014-2015,Age,13 Months,86.0,81.4 to 89.6,582
Hib,Primary Series,States/Local Areas,Washington,2018,Age,19 Months,94.9,91.6 to 97.0,492
Hib,Primary Series,States/Local Areas,Washington,2018-2019,Age,19 Months,93.7,91.3 to 95.4,947
Hib,Primary Series,States/Local Areas,Washington,2012,Age,7 Months,72.1,64.7 to 78.4,252
Hib,Primary Series,States/Local Areas,Washington,2013,Age,7 Months,69.2,62.9 to 74.9,313
Hib,Primary Series,States/Local Areas,Washington,2013-2014,Age,7 Months,69.7,64.5 to 74.5,617
Combined 7 Series,,States/Local Areas,Washington,2011,Age,24 Months,69.1,60.8 to 77.1,241
Hib,Primary Series,States/Local Areas,Washington,2015,Age,24 Months,89.3,83.3 to 93.9,278
Hib,Primary Series,States/Local Areas,Washington,2015-2016,Age,24 Months,87.7,83.1 to 91.5,558
Hib,Primary Series,States/Local Areas,Washington,2014,Age,24 Months,90.6,85.4 to 94.5,304
Hib,Primary Series,States/Local Areas,Washington,2014-2015,Age,24 Months,90.0,86.1 to 93.1,582
Hib,Primary Series,States/Local Areas,Washington,2016,Age,24 Months,86.0,78.8 to 91.8,280
Hib,Primary Series,States/Local Areas,Washington,2016-2017,Age,24 Months,89.0,84.9 to 92.4,747
Hib,Primary Series,States/Local Areas,Washington,2018,Age,24 Months,96.1,93.6 to 97.8,492
Hib,Primary Series,States/Local Areas,Washington,2018-2019,Age,24 Months,96.5,94.9 to 97.8,947
Hib,Primary Series,States/Local Areas,Washington,2017,Age,24 Months,92.0,88.2 to 94.9,467
Hib,Primary Series,States/Local Areas,Washington,2017-2018,Age,24 Months,94.0,91.8 to 95.8,959
Hib,Primary Series,States/Local Areas,Washington,2013,Age,24 Months,93.3,88.9 to 96.4,313
Hib,Primary Series,States/Local Areas,Washington,2013-2014,Age,24 Months,91.9,88.6 to 94.6,617
Hib,Primary Series,States/Local Areas,Washington,2019,Age,24 Months,97.0,94.5 to 98.6,455
Hib,Primary Series,States/Local Areas,Washington,2011,Age,35 Months,95.2,90.8 to 97.9,241
Hib,Primary Series,States/Local Areas,Washington,2013,Age,35 Months,93.3,88.9 to 96.4,313
Hib,Primary Series,States/Local Areas,Washington,2013-2014,Age,35 Months,92.8,89.6 to 95.3,617
Combined 7 Series,,States/Local Areas,Washington,2012,Age,24 Months,69.8,61.8 to 77.4,252
Hib,Primary Series,States/Local Areas,Washington,2012,Age,35 Months,93.9,89.5 to 96.9,252
Hib,Primary Series,States/Local Areas,Washington,2016,Age,35 Months,87.1,79.7 to 92.8,280
Hib,Primary Series,States/Local Areas,Washington,2016-2017,Age,35 Months,90.0,85.9 to 93.3,747
Combined 7 Series,,States/Local Areas,Washington,2013,Age,35 Months,77.1,69.4 to 84.0,313
Combined 7 Series,,States/Local Areas,Washington,2013-2014,Age,35 Months,75.6,70.5 to 80.4,617
Hib,Primary Series,States/Local Areas,Washington,2017,Age,35 Months,92.9,89.2 to 95.6,467
Hib,Primary Series,States/Local Areas,Washington,2017-2018,Age,35 Months,94.6,92.4 to 96.3,959
Combined 7 Series,,States/Local Areas,Washington,2011,Age,35 Months,72.5,63.7 to 80.7,241
Hib,Primary Series,States/Local Areas,Washington,2015,Age,35 Months,90.1,83.8 to 94.6,278
Hib,Primary Series,States/Local Areas,Washington,2015-2016,Age,35 Months,88.6,83.9 to 92.4,558
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,70.1,62.0 to 78.3,210
Hib,Full Series,States/Local Areas,Washington,2012,Age,19 Months,73.7,66.0 to 80.2,252
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,76.4,70.6 to 82.2,448
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,67.2,60.8 to 73.6,412
Hib,Full Series,States/Local Areas,Washington,2011,Age,19 Months,74.3,67.0 to 80.5,241
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,61.4,54.8 to 68.0,352
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,76.0,71.5 to 80.6,679
Combined 7 Series,,States/Local Areas,Washington,2019,Age,35 Months,78.4,72.2 to 84.0,455
Combined 7 Series,,States/Local Areas,Washington,2018,Age,35 Months,78.3,72.3 to 83.7,492
Combined 7 Series,,States/Local Areas,Washington,2018-2019,Age,35 Months,78.3,74.1 to 82.3,947
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,82.0,69.8 to 94.2,52
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,63.3,55.4 to 71.2,237
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Overall,Overall,69.2,65.3 to 73.1,1097
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,68.0,56.8 to 79.3,113
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,68.3,63.0 to 73.6,593
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.8,64.3 to 77.3,391
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.7,61.4 to 72.0,651
Combined 7 Series,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.8,69.0 to 84.7,211
Hib,Full Series,States/Local Areas,Washington,2014,Age,19 Months,79.5,72.8 to 84.8,304
Hib,Full Series,States/Local Areas,Washington,2014-2015,Age,19 Months,76.5,71.4 to 80.9,582
Hib,Full Series,States/Local Areas,Washington,2015,Age,19 Months,73.5,70.2 to 76.6,278
Hib,Full Series,States/Local Areas,Washington,2015-2016,Age,19 Months,73.2,67.6 to 78.2,558
Hib,Full Series,States/Local Areas,Washington,2016,Age,19 Months,72.9,64.8 to 79.8,280
Hib,Full Series,States/Local Areas,Washington,2016-2017,Age,19 Months,74.3,69.4 to 78.7,747
Hib,Full Series,States/Local Areas,Washington,2018,Age,19 Months,82.3,77.1 to 86.5,492
Hib,Full Series,States/Local Areas,Washington,2018-2019,Age,19 Months,94.7,92.6 to 96.3,947
Hib,Full Series,States/Local Areas,Washington,2017,Age,19 Months,75.8,69.9 to 80.8,467
Hib,Full Series,States/Local Areas,Washington,2017-2018,Age,19 Months,79.0,75.1 to 82.4,959
Hib,Full Series,States/Local Areas,Washington,2011,Age,24 Months,80.3,73.1 to 86.6,241
Hib,Full Series,States/Local Areas,Washington,2012,Age,24 Months,83.1,76.1 to 89.0,252
Hib,Full Series,States/Local Areas,Washington,2013,Age,24 Months,82.5,76.6 to 87.7,313
Hib,Full Series,States/Local Areas,Washington,2013-2014,Age,24 Months,83.0,78.8 to 86.7,617
Hib,Full Series,States/Local Areas,Washington,2019,Age,19 Months,79.6,74.2 to 84.1,455
Hib,≥3 Doses,States/Local Areas,Washington,2011,Age,35 Months,95.5,90.8 to 98.2,241
DTaP,≥2 Doses,States/Local Areas,Washington,2019,Age,5 Months,89.3,84.7 to 92.6,455
Hib,≥1 Dose,States/Local Areas,Washington,2021,Age,3 Months,90.5,84.7 to 94.2,262
Hib,Full Series,States/Local Areas,Washington,2013,Age,19 Months,76.3,70.2 to 81.4,313
Hib,Full Series,States/Local Areas,Washington,2013-2014,Age,19 Months,77.9,74.2 to 81.1,617
Combined 7 Series,,States/Local Areas,Washington,2015,Age,35 Months,67.0,58.3 to 75.5,278
Combined 7 Series,,States/Local Areas,Washington,2015-2016,Age,35 Months,70.4,64.2 to 76.3,558
PCV,≥2 Doses,States/Local Areas,Washington,2012,Age,5 Months,82.0,77.1 to 86.1,252
PCV,≥2 Doses,States/Local Areas,Washington,2011,Age,5 Months,75.3,69.2 to 80.5,241
DTaP,≥3 Doses,States/Local Areas,Washington,2015,Age,35 Months,92.9,88.1 to 96.2,278
DTaP,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,92.2,88.6 to 95.0,558
DTaP,≥3 Doses,States/Local Areas,Washington,2016,Age,35 Months,91.6,85.6 to 95.8,280
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,92.9,89.5 to 95.5,747
Hep A,≥2 Doses,States/Local Areas,Washington,2014,Age,19 Months,21.8,16.6 to 28.1,304
Hep A,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,20.8,16.9 to 25.2,582
DTaP,≥4 Doses,States/Local Areas,Washington,2012,Age,19 Months,68.6,61.5 to 74.8,252
DTaP,≥4 Doses,States/Local Areas,Washington,2011,Age,19 Months,68.9,63.0 to 74.3,241
Hep A,≥2 Doses,States/Local Areas,Washington,2011,Age,19 Months,17.8,13.9 to 22.4,241
DTaP,≥3 Doses,States/Local Areas,Washington,2014,Age,35 Months,93.9,89.4 to 96.9,304
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,93.4,90.3 to 95.8,582
DTaP,≥3 Doses,States/Local Areas,Washington,2013,Age,35 Months,94.9,90.7 to 97.6,313
DTaP,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,94.4,91.5 to 96.6,617
DTaP,≥3 Doses,States/Local Areas,Washington,2012,Age,35 Months,96.1,92.2 to 98.4,252
DTaP,≥3 Doses,States/Local Areas,Washington,2011,Age,35 Months,95.7,90.4 to 98.6,241
Hep A,≥2 Doses,States/Local Areas,Washington,2013,Age,19 Months,19.0,14.8 to 24.0,313
Hep A,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,20.4,17.3 to 23.9,617
Hep A,≥2 Doses,States/Local Areas,Washington,2012,Age,19 Months,18.0,15.2 to 21.2,252
Hib,≥3 Doses,States/Local Areas,Washington,2019,Age,24 Months,96.9,94.4 to 98.4,455
Hib,≥3 Doses,States/Local Areas,Washington,2017,Age,24 Months,90.2,86.3 to 93.5,467
Hib,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,92.7,90.3 to 94.7,959
Hib,≥3 Doses,States/Local Areas,Washington,2018,Age,24 Months,95.2,92.4 to 97.2,492
Hib,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,95.9,94.1 to 97.3,947
Hib,≥3 Doses,States/Local Areas,Washington,2012,Age,35 Months,92.8,87.8 to 96.3,252
Hib,≥3 Doses,States/Local Areas,Washington,2015,Age,35 Months,90.0,83.8 to 94.6,278
Hib,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,87.7,83.0 to 91.6,558
Hep A,≥2 Doses,States/Local Areas,Washington,2015,Age,19 Months,19.7,17.0 to 22.7,278
Hep A,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,19.9,15.9 to 24.6,558
Hep A,≥2 Doses,States/Local Areas,Washington,2016,Age,19 Months,20.1,14.6 to 27.1,280
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,23.3,19.5 to 27.7,747
Hib,≥3 Doses,States/Local Areas,Washington,2013,Age,35 Months,92.9,88.4 to 96.1,313
Hib,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,92.3,89.0 to 94.9,617
Hib,≥3 Doses,States/Local Areas,Washington,2014,Age,35 Months,91.7,86.6 to 95.5,304
Hib,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,90.8,86.9 to 93.9,582
PCV,≥2 Doses,States/Local Areas,Washington,2015,Age,5 Months,74.6,66.1 to 81.5,278
PCV,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,5 Months,76.0,70.3 to 81.0,558
DTaP,≥3 Doses,States/Local Areas,Washington,2017,Age,35 Months,94.1,90.5 to 96.6,467
DTaP,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,95.5,93.5 to 97.1,959
PCV,≥2 Doses,States/Local Areas,Washington,2013,Age,5 Months,76.2,69.1 to 82.0,313
PCV,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,5 Months,77.0,72.3 to 81.1,617
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,91.7,82.2 to 100.0,52
DTaP,≥3 Doses,States/Local Areas,Washington,2019,Age,35 Months,97.6,95.3 to 98.9,455
DTaP,≥3 Doses,States/Local Areas,Washington,2018,Age,35 Months,96.9,94.6 to 98.4,492
DTaP,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,97.1,95.6 to 98.2,947
Hep A,≥1 Dose,States/Local Areas,Washington,2015,Age,24 Months,85.4,79.5 to 90.4,278
Hep A,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,24 Months,84.7,80.2 to 88.7,558
Hep A,≥1 Dose,States/Local Areas,Washington,2014,Age,24 Months,88.7,83.8 to 92.7,304
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,24 Months,87.2,83.4 to 90.5,582
Hep A,≥1 Dose,States/Local Areas,Washington,2016,Age,24 Months,84.0,76.9 to 89.9,280
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,24 Months,85.6,81.5 to 89.2,747
PCV,≥2 Doses,States/Local Areas,Washington,2014,Age,5 Months,77.8,71.1 to 83.4,304
PCV,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,5 Months,76.2,71.7 to 80.2,582
Hep A,≥2 Doses,States/Local Areas,Washington,2011,Age,24 Months,31.5,23.8 to 40.9,241
Hep A,≥2 Doses,States/Local Areas,Washington,2018,Age,19 Months,31.3,26.0 to 37.1,492
Hep A,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,19 Months,28.0,23.9 to 32.6,797
Hib,≥3 Doses,States/Local Areas,Washington,2016,Age,35 Months,85.3,78.0 to 91.2,280
Hib,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,88.7,84.6 to 92.1,747
Hib,≥3 Doses,States/Local Areas,Washington,2017,Age,35 Months,91.8,88.0 to 94.8,467
Hib,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,93.9,91.6 to 95.7,959
DTaP,≥4 Doses,States/Local Areas,Washington,2013,Age,19 Months,69.7,65.6 to 73.6,313
DTaP,≥4 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,72.1,68.9 to 75.1,617
DTaP,≥4 Doses,States/Local Areas,Washington,2014,Age,19 Months,74.4,67.2 to 80.4,304
DTaP,≥4 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,67.5,61.7 to 72.7,582
DTaP,≥4 Doses,States/Local Areas,Washington,2015,Age,19 Months,60.6,58.2 to 62.9,278
DTaP,≥4 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,65.4,59.3 to 71.1,558
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,91.2,87.7 to 94.6,352
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,94.4,91.9 to 96.9,679
Hep A,≥2 Doses,States/Local Areas,Washington,2017,Age,19 Months,26.6,21.6 to 32.2,467
Hep A,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,28.9,25.2 to 32.9,959
Hep A,≥1 Dose,States/Local Areas,Washington,2018,Age,19 Months,87.1,81.9 to 91.0,492
Hep A,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,19 Months,88.6,84.8 to 91.5,797
≥1 Dose MMR,,States/Local Areas,Washington,2020,Age,13 Months,72.8,66.7 to 78.2,445
Hep A,≥1 Dose,States/Local Areas,Washington,2019,Age,19 Months,87.5,83.0 to 90.9,455
Hep A,≥1 Dose,States/Local Areas,Washington,2012,Age,24 Months,82.7,76.3 to 88.1,252
Hep A,≥1 Dose,States/Local Areas,Washington,2011,Age,24 Months,82.0,74.2 to 88.5,241
Hep A,≥1 Dose,States/Local Areas,Washington,2013,Age,24 Months,83.6,77.9 to 88.5,313
Hep A,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,24 Months,86.3,82.5 to 89.5,617
Hep A,≥1 Dose,States/Local Areas,Washington,2016,Age,19 Months,80.3,72.4 to 86.3,280
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,19 Months,82.1,77.5 to 85.9,747
Hep A,≥1 Dose,States/Local Areas,Washington,2017,Age,19 Months,83.9,78.8 to 87.9,467
Hep A,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,19 Months,85.5,82.0 to 88.4,959
Hep A,≥1 Dose,States/Local Areas,Washington,2017,Age,24 Months,87.3,82.9 to 91.1,467
Hep A,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,24 Months,89.1,86.2 to 91.6,959
PCV,≥2 Doses,States/Local Areas,Washington,2016,Age,5 Months,77.5,69.3 to 84.0,280
PCV,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,5 Months,78.0,73.1 to 82.2,747
Hep A,≥2 Doses,States/Local Areas,Washington,2019,Age,19 Months,27.3,22.3 to 33.0,455
Hep A,≥1 Dose,States/Local Areas,Washington,2019,Age,24 Months,88.7,84.6 to 92.2,455
Hep A,≥1 Dose,States/Local Areas,Washington,2011,Age,35 Months,86.0,78.0 to 92.2,241
Hep A,≥1 Dose,States/Local Areas,Washington,2018,Age,24 Months,90.9,87.0 to 94.0,492
Hep A,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,24 Months,89.9,87.1 to 92.3,947
DTaP,≥1 Dose,States/Local Areas,Washington,2017,Age,3 Months,84.7,79.2 to 88.9,467
DTaP,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,3 Months,89.1,85.7 to 91.7,959
Hep A,≥1 Dose,States/Local Areas,Washington,2011,Age,19 Months,73.1,68.8 to 76.9,241
DTaP,≥3 Doses,States/Local Areas,Washington,2013,Age,24 Months,92.9,88.5 to 96.0,313
DTaP,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,24 Months,92.1,88.9 to 94.6,617
DTaP,≥1 Dose,States/Local Areas,Washington,2018,Age,3 Months,93.6,89.2 to 96.2,492
DTaP,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,3 Months,94.4,91.8 to 96.2,947
DTaP,≥1 Dose,States/Local Areas,Washington,2019,Age,3 Months,95.3,92.0 to 97.2,455
DTaP,≥3 Doses,States/Local Areas,Washington,2015,Age,24 Months,92.1,87.6 to 95.5,278
DTaP,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,91.8,88.2 to 94.7,558
DTaP,≥3 Doses,States/Local Areas,Washington,2014,Age,24 Months,91.3,86.4 to 94.9,304
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,91.7,88.5 to 94.3,582
Hep A,≥1 Dose,States/Local Areas,Washington,2015,Age,19 Months,80.6,78.5 to 82.6,278
Hep A,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,19 Months,80.4,75.2 to 84.8,558
Hep A,≥1 Dose,States/Local Areas,Washington,2014,Age,19 Months,83.0,76.4 to 88.1,304
Hep A,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,19 Months,81.8,77.0 to 85.8,582
Hep A,≥1 Dose,States/Local Areas,Washington,2013,Age,19 Months,78.6,71.9 to 84.1,313
Hep A,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,19 Months,80.8,77.5 to 83.7,617
DTaP,≥2 Doses,States/Local Areas,Washington,2017,Age,5 Months,80.1,74.5 to 84.8,467
DTaP,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,5 Months,82.9,79.2 to 86.0,959
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.8,84.3 to 93.4,391
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,89.2,80.9 to 97.4,113
DTaP,≥2 Doses,States/Local Areas,Washington,2016,Age,5 Months,79.0,70.9 to 85.4,280
DTaP,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,5 Months,79.6,74.7 to 83.7,747
DTaP,≥3 Doses,States/Local Areas,Washington,2017,Age,24 Months,93.1,89.4 to 95.8,467
DTaP,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,94.8,92.7 to 96.5,959
DTaP,≥3 Doses,States/Local Areas,Washington,2018,Age,24 Months,96.6,94.3 to 98.2,492
DTaP,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,97.0,95.5 to 98.1,947
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,92.7,88.7 to 96.8,448
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,87.4,82.3 to 92.4,412
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,87.8,82.5 to 93.0,237
Polio,≥3 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,89.4,86.6 to 92.1,1097
DTaP,≥3 Doses,States/Local Areas,Washington,2016,Age,24 Months,91.6,85.6 to 95.8,280
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,92.3,89.0 to 95.0,747
DTaP,≥3 Doses,States/Local Areas,Washington,2019,Age,24 Months,97.6,95.3 to 98.9,455
Hib,≥3 Doses,States/Local Areas,Washington,2015,Age,24 Months,89.3,83.3 to 93.9,278
Hib,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,86.8,82.2 to 90.7,558
Hib,≥3 Doses,States/Local Areas,Washington,2016,Age,24 Months,84.3,77.1 to 90.3,280
Hib,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,87.3,83.2 to 90.8,747
Polio,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,3 Months,89.6,86.5 to 92.1,900
DTaP,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,3 Months,90.7,87.7 to 93.1,900
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2019-2020,Age,0-3 Days,82.6,79.0 to 85.7,900
DTaP,≥3 Doses,States/Local Areas,Washington,2021,Age,24 Months,92.9,87.7 to 96.4,262
Hib,≥2 Doses,States/Local Areas,Washington,2021,Age,7 Months,90.5,84.6 to 94.3,262
DTaP,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,94.2,91.7 to 95.9,900
DTaP,≥4 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,73.3,69.2 to 77.1,900
PCV,≥4 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,83.5,79.9 to 86.7,900
Hep B,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,70.6,66.3 to 74.5,900
Hib,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,68.0,63.8 to 72.0,900
Hib,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,91.8,88.6 to 94.4,707
PCV,≥4 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,82.0,77.6 to 86.1,707
Hep A,≥1 Dose,States/Local Areas,Washington,2012,Age,19 Months,75.2,68.4 to 80.9,252
Hib,Full Series,States/Local Areas,Washington,2021,Age,19 Months,73.3,65.1 to 80.1,262
Hep A,≥2 Doses,States/Local Areas,Washington,2021,Age,35 Months,74.5,62.3 to 85.2,262
DTaP,≥4 Doses,States/Local Areas,Washington,2021,Age,19 Months,69.8,61.6 to 76.9,262
Combined 7 Series,,States/Local Areas,Washington,2021,Age,35 Months,89.3,72.6 to 97.9,262
Polio,≥3 Doses,States/Local Areas,Washington,2021,Age,35 Months,92.8,87.6 to 96.4,262
≥1 Dose MMR,,States/Local Areas,Washington,2020-2021,Age,24 Months,91.1,87.7 to 93.9,707
Hep B,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,94.5,91.4 to 96.5,707
Hib,Primary Series,States/Local Areas,Washington,2021,Age,7 Months,72.7,64.5 to 79.5,262
Hep B,≥2 Doses,States/Local Areas,Washington,2021,Age,5 Months,92.5,87.0 to 95.8,262
DTaP,≥3 Doses,States/Local Areas,Washington,2021,Age,7 Months,71.1,62.9 to 78.2,262
PCV,≥2 Doses,States/Local Areas,Washington,2021,Age,5 Months,79.5,72.0 to 85.4,262
Polio,≥2 Doses,States/Local Areas,Washington,2021,Age,7 Months,93.3,87.9 to 96.4,262
DTaP,≥1 Dose,States/Local Areas,Washington,2012,Age,3 Months,88.4,82.7 to 92.3,252
DTaP,≥1 Dose,States/Local Areas,Washington,2011,Age,3 Months,89.1,83.3 to 93.1,241
DTaP,≥1 Dose,States/Local Areas,Washington,2013,Age,3 Months,88.0,85.4 to 90.2,313
DTaP,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,3 Months,87.9,86.0 to 89.6,617
DTaP,≥1 Dose,States/Local Areas,Washington,2014,Age,3 Months,87.8,81.9 to 91.9,304
DTaP,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,3 Months,88.3,84.1 to 91.6,582
DTaP,≥1 Dose,States/Local Areas,Washington,2015,Age,3 Months,88.9,82.1 to 93.4,278
DTaP,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,3 Months,88.1,83.4 to 91.7,558
DTaP,≥1 Dose,States/Local Areas,Washington,2016,Age,3 Months,87.3,79.9 to 92.3,280
DTaP,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,3 Months,86.0,81.6 to 89.5,747
Hib,Primary Series,States/Local Areas,Washington,2021,Age,19 Months,94.2,89.1 to 97.0,262
Hib,Primary Series,States/Local Areas,Washington,2020-2021,Age,24 Months,93.5,90.7 to 95.7,707
DTaP,≥2 Doses,States/Local Areas,Washington,2018,Age,5 Months,85.7,80.7 to 89.6,492
DTaP,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,5 Months,87.5,84.2 to 90.2,947
Hib,≥3 Doses,States/Local Areas,Washington,2014,Age,24 Months,90.0,84.8 to 94.1,304
Hib,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,24 Months,89.7,85.8 to 92.9,582
Hep B,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,90.1,86.4 to 92.8,707
Hep B,≥3 Doses,States/Local Areas,Washington,2021,Age,19 Months,91.7,85.9 to 95.3,262
Hep A,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,35 Months,94.6,91.4 to 96.9,707
DTaP,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,3 Months,88.2,84.4 to 91.2,707
DTaP,≥3 Doses,States/Local Areas,Washington,2020,Age,13 Months,90.8,86.3 to 93.9,445
Hib,≥3 Doses,States/Local Areas,Washington,2020,Age,7 Months,63.7,57.5 to 69.5,445
Polio,≥2 Doses,States/Local Areas,Washington,2020,Age,7 Months,89.0,84.0 to 92.6,445
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.0,61.2 to 76.7,317
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,67.4,51.4 to 83.5,52
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,82.7 to 93.4,317
Hib,≥3 Doses,States/Local Areas,Washington,2021,Age,19 Months,90.9,84.9 to 94.7,262
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,87.6,79.8 to 95.4,132
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,88.2,80.1 to 96.3,132
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,76.5 to 85.0,858
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.8,77.8 to 87.8,554
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,80.7,71.3 to 90.1,132
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,66.1,55.5 to 76.8,132
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.4,66.6 to 78.2,554
Rotavirus,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,79.7,75.3 to 84.0,858
Influenza,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,72.1,67.6 to 76.6,858
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,88.8,85.2 to 92.4,858
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.0,81.6 to 90.5,554
Rotavirus,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,71.5,60.1 to 82.9,132
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,90.1 to 95.4,858
Hib,Full Series,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.5,78.7 to 88.4,554
Hib,Full Series,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,77.7,67.6 to 87.7,132
Hib,Full Series,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,80.4,76.0 to 84.7,858
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,81.4,69.4 to 93.4,132
Rotavirus,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.9,70.4 to 81.4,554
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,85.6,77.3 to 93.8,132
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,86.4,78.5 to 94.3,132
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,77.2,67.5 to 87.0,132
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,95.8,93.9 to 97.8,858
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.8,87.9 to 95.8,554
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.9,87.0 to 94.8,554
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.8,75.2 to 86.3,554
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,83.1,79.2 to 87.0,858
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,89.0,85.4 to 92.5,858
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.7,81.2 to 100.0,44
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,93.6,89.4 to 97.8,298
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.1 to 100.0,44
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,90.9 to 96.6,885
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.7,77.5 to 85.9,885
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,85.7,73.8 to 97.5,52
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,87.7,83.7 to 91.7,512
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,90.4,86.9 to 94.0,512
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,90.7 to 97.6,317
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,94.5,91.8 to 97.3,963
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,83.4,71.0 to 95.8,52
Hib,Full Series,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,80.3,66.8 to 93.7,52
Hib,Full Series,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,75.0,69.8 to 80.2,512
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,78.3,64.1 to 92.5,52
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,75.9,70.6 to 81.3,512
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,91.2,88.0 to 94.4,963
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,87.1,83.3 to 91.0,512
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.7,76.2 to 97.2,44
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,86.5,74.7 to 98.4,52
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,81.3 to 89.3,885
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,86.6,74.8 to 98.4,52
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,88.0 to 95.0,885
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,91.5,87.0 to 96.0,298
Influenza,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,70.9 to 84.2,317
Hep A,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,49.6,45.1 to 54.3,900
Influenza,,States/Local Areas,Washington,2019-2020,Age,24 Months,72.7,68.6 to 76.6,900
Hib,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,94.4,92.2 to 96.2,900
Hib,Primary Series,States/Local Areas,Washington,2019-2020,Age,24 Months,94.8,92.6 to 96.5,900
Hib,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,91.2,88.2 to 93.5,900
Combined 7 Series,,States/Local Areas,Washington,2019-2020,Age,35 Months,78.3,74.1 to 82.2,900
Hep B,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,92.5,89.8 to 94.5,900
Hib,Full Series,States/Local Areas,Washington,2019-2020,Age,19 Months,79.6,75.7 to 83.1,900
PCV,≥4 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,81.1,77.3 to 84.4,900
PCV,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,92.8,90.2 to 94.8,900
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2020,Age,0-1 Days,77.7,72.0 to 82.5,445
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2020,Age,0-2 Days,80.2,74.7 to 84.8,445
Hep A,≥2 Doses,States/Local Areas,Washington,2020,Age,19 Months,28.9,23.9 to 34.4,445
Hep A,≥1 Dose,States/Local Areas,Washington,2020,Age,19 Months,89.4,84.6 to 92.8,445
Hep A,≥2 Doses,States/Local Areas,Washington,2020,Age,35 Months,81.7,75.6 to 87.1,445
Combined 7 Series,,States/Local Areas,Washington,2020,Age,35 Months,78.8,73.0 to 84.1,445
Hep A,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,24 Months,90.0,87.1 to 92.4,900
Hep A,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,81.6,77.2 to 85.6,900
Hep A,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,35 Months,92.5,89.8 to 94.8,900
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,61.9,56.1 to 67.7,512
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,93.0,90.2 to 95.9,512
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,72.8,65.9 to 79.6,296
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,81.5,78.4 to 84.6,1544
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,79.9,74.9 to 85.0,578
Hib,Full Series,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,73.9,67.1 to 80.7,296
Hib,Full Series,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,81.1,76.0 to 86.1,578
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,91.3,87.3 to 95.2,578
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,88.3,83.3 to 93.4,296
Hib,Full Series,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,87.7,83.4 to 92.0,670
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,91.4,87.8 to 95.1,578
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,89.3,85.9 to 92.7,670
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,87.0,81.9 to 92.1,296
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,85.9,80.6 to 91.2,296
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,89.8,85.7 to 93.9,578
Influenza,,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,66.7,61.3 to 72.2,578
Influenza,,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,59.7,52.1 to 67.2,296
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,91.4,87.5 to 95.3,670
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,88.6,86.0 to 91.2,1544
Influenza,,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,82.4,77.7 to 87.1,670
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,94.0,92.1 to 95.9,1544
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,93.2,89.7 to 96.7,578
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,90.6,86.3 to 95.0,296
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,95.3,93.1 to 97.5,670
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,76.4,69.9 to 83.0,578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,81.2,76.7 to 85.8,670
Rotavirus,,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,67.6,60.3 to 74.8,296
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,90.6,86.6 to 94.5,670
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,90.7,87.4 to 94.1,858
Rotavirus,,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,75.4,70.0 to 80.8,578
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,89.4 to 96.0,858
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.1,87.0 to 95.1,554
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.3,84.1 to 92.5,554
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,91.5,84.6 to 98.4,132
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.3 to 95.7,858
Influenza,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.1,64.2 to 76.0,554
Influenza,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,57.5,46.0 to 69.0,132
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,68.3,63.5 to 73.0,858
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,86.7 to 94.7,554
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,90.9,84.0 to 97.9,132
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.4,84.1 to 92.7,554
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,76.1,71.8 to 80.4,858
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,84.0,75.4 to 92.7,132
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.0,76.0 to 86.0,554
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,94.8,91.3 to 98.3,670
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Urbanicity,Living In a Non-MSA,75.1,64.2 to 85.9,132
Hib,Full Series,States/Local Areas,Washington,2016-2019,Overall,Overall,81.3,78.2 to 84.4,1544
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,87.6,83.3 to 91.8,578
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,61.8,54.3 to 69.3,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,74.5,69.2 to 79.7,578
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,92.4,88.7 to 96.2,670
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,78.8,73.9 to 83.6,670
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,67.3,61.7 to 72.9,578
Rotavirus,,States/Local Areas,Washington,2016-2019,Overall,Overall,77.5,74.3 to 80.8,1544
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,77.4,73.4 to 81.5,1544
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Overall,Overall,89.3,86.7 to 91.8,1544
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,97.6,95.9 to 99.3,670
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Overall,Overall,91.5,89.3 to 93.7,1544
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Overall,Overall,87.5,84.8 to 90.1,1544
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,85.4,79.9 to 90.9,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Overall,Overall,77.8,74.7 to 80.9,1544
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,67.8,59.1 to 76.5,296
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Overall,Overall,69.6,66.1 to 73.1,1544
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,78.0,71.5 to 84.5,296
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,91.1,87.1 to 95.2,578
Influenza,,States/Local Areas,Washington,2016-2019,Overall,Overall,70.0,66.6 to 73.5,1544
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,87.8,82.5 to 93.0,296
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,82.5,76.5 to 88.5,296
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,88.1,83.5 to 92.7,670
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,95.6,92.3 to 99.0,670
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,91.5,87.9 to 95.2,670
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Poverty,133% to <400% FPL,87.5,83.4 to 91.7,578
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Poverty,<133% FPL,73.9,66.8 to 81.0,296
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,91.7,89.3 to 94.1,1544
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,81.7,78.7 to 84.8,1544
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Overall,Overall,91.7,89.3 to 94.0,1544
Rotavirus,,States/Local Areas,Washington,2016-2019,Poverty,>400% FPL,88.2,84.1 to 92.3,670
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,75.0,60.1 to 90.0,52
Influenza,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,66.8,59.2 to 74.3,298
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.1 to 100.0,44
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,73.9,68.6 to 79.2,512
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,94.4,92.3 to 96.4,963
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,90.1,79.6 to 100.0,52
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,89.8,86.3 to 93.3,512
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,87.2,75.4 to 98.9,52
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,82.2,75.6 to 88.9,298
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,73.9 to 87.4,317
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,82.2,77.4 to 87.0,963
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,75.2,68.8 to 81.6,512
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.2,71.4 to 97.1,44
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.9,83.2 to 94.5,317
DTaP,≥4 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,88.4,85.4 to 91.3,963
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.1,84.5 to 91.7,885
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2019-2020,Age,0-1 Days,78.6,74.7 to 82.0,900
PCV,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,72.7,68.5 to 76.5,900
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2019-2020,Age,0-2 Days,81.9,78.3 to 85.0,900
Hep B,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,93.7,91.4 to 95.6,900
Hib,Full Series,States/Local Areas,Washington,2019-2020,Age,24 Months,83.8,80.3 to 87.0,900
PCV,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,93.5,91.2 to 95.5,900
≥1 Dose Varicella,,States/Local Areas,Washington,2019-2020,Age,24 Months,90.9,88.1 to 93.3,900
Hep A,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,19 Months,88.2,85.1 to 90.8,900
Polio,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,92.6,89.8 to 94.6,900
Hib,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,92.4,89.6 to 94.4,900
≥1 Dose MMR,,States/Local Areas,Washington,2019-2020,Age,19 Months,89.9,86.8 to 92.4,900
≥1 Dose MMR,,States/Local Areas,Washington,2019-2020,Age,35 Months,92.6,89.7 to 94.9,900
Hib,Primary Series,States/Local Areas,Washington,2019-2020,Age,19 Months,94.1,91.6 to 95.8,900
Hib,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,95.1,92.8 to 96.8,900
Hib,Primary Series,States/Local Areas,Washington,2019-2020,Age,35 Months,95.3,93.1 to 97.0,900
Hib,Full Series,States/Local Areas,Washington,2019-2020,Age,35 Months,87.4,84.0 to 90.4,900
Hep B,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,94.2,92.0 to 96.0,900
≥1 Dose Varicella,,States/Local Areas,Washington,2019-2020,Age,35 Months,93.1,90.3 to 95.3,900
PCV,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,94.6,92.4 to 96.4,900
PCV,≥4 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,87.9,84.4 to 90.9,900
DTaP,≥4 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,81.7,78.0 to 85.2,900
DTaP,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,95.3,93.3 to 96.9,900
Polio,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,24 Months,93.8,91.4 to 95.7,900
Hep A,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,19 Months,27.9,24.3 to 31.8,900
≥1 Dose MMR,,States/Local Areas,Washington,2019-2020,Age,24 Months,90.8,87.9 to 93.2,900
Hib,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,3 Months,90.0,87.0 to 92.4,900
Hep B,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,3 Months,95.0,92.6 to 96.6,900
PCV,≥1 Dose,States/Local Areas,Washington,2019-2020,Age,3 Months,88.1,84.9 to 90.8,900
Polio,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,5 Months,84.4,80.8 to 87.4,900
DTaP,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,5 Months,85.6,82.1 to 88.5,900
DTaP,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,92.3,89.5 to 94.4,900
Polio,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,94.4,91.8 to 96.2,900
Hib,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,94.3,91.7 to 96.1,900
≥1 Dose MMR,,States/Local Areas,Washington,2019-2020,Age,13 Months,72.8,68.7 to 76.7,900
Hib,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,85.0,81.6 to 87.9,900
Hib,Primary Series,States/Local Areas,Washington,2019-2020,Age,13 Months,90.8,87.8 to 93.1,900
Hib,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,5 Months,85.2,81.7 to 88.1,900
Hep B,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,5 Months,91.1,88.1 to 93.4,900
PCV,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,5 Months,83.2,79.6 to 86.3,900
Polio,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,91.1,88.2 to 93.4,900
DTaP,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,7 Months,76.9,72.9 to 80.5,900
Hep B,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,89.7,86.5 to 92.2,900
Hep B,≥2 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,94.9,92.5 to 96.6,900
PCV,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,13 Months,89.8,86.8 to 92.2,900
≥1 Dose Varicella,,States/Local Areas,Washington,2019-2020,Age,13 Months,67.1,62.9 to 71.2,900
Combined 7 Series,,States/Local Areas,Washington,2019-2020,Age,24 Months,71.4,67.3 to 75.4,900
DTaP,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,96.2,94.1 to 97.7,900
DTaP,≥4 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,89.4,86.0 to 92.3,900
Polio,≥3 Doses,States/Local Areas,Washington,2019-2020,Age,35 Months,94.7,92.2 to 96.5,900
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.1 to 100.0,44
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,89.6,85.8 to 93.5,512
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,88.1 to 94.8,885
Influenza,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.0,58.9 to 89.2,44
Influenza,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.2,63.4 to 73.0,885
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.5,69.3 to 95.6,44
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,79.0,72.1 to 85.8,298
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.6,78.4 to 86.8,885
Rotavirus,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,75.0,67.9 to 82.1,298
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.2,49.4 to 85.0,44
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,70.9,63.5 to 78.2,298
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.3,64.6 to 74.1,885
Rotavirus,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,75.6,60.9 to 90.4,52
Rotavirus,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,68.0,62.4 to 73.6,512
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,82.0,75.5 to 88.6,298
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,68.1,51.0 to 85.3,52
Hib,Full Series,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.4,79.5 to 87.4,885
Influenza,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,61.5,43.9 to 79.0,52
Influenza,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,61.4,55.6 to 67.1,512
Influenza,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,79.7,75.8 to 83.6,963
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,74.7 to 87.9,317
Rotavirus,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,86.8,83.3 to 90.3,963
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,96.8,95.1 to 98.5,963
Polio,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,87.2,75.4 to 99.0,52
Rotavirus,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,74.5 to 88.0,317
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,92.2,89.3 to 95.1,963
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,93.0,89.2 to 96.8,298
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.9,78.9 to 98.9,44
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,86.4 to 95.4,317
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Insurance Coverage,Other,79.6,66.1 to 93.0,52
≥1 Dose MMR,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,87.9 to 94.4,885
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,76.1,71.1 to 81.2,512
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,79.8,75.9 to 83.7,963
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",61.3,42.3 to 80.2,44
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.0,76.0 to 88.0,317
Combined 7 Series,,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,77.9,73.8 to 81.9,963
Rotavirus,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.7,62.1 to 93.3,44
Rotavirus,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.3,72.7 to 81.8,885
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,79.2 to 99.0,44
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,91.3 to 97.9,317
≥1 Dose Varicella,,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.4,84.6 to 92.1,885
Hep B,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,89.9,84.4 to 95.3,298
Hib,≥2 Doses,States/Local Areas,Washington,2020,Age,5 Months,81.2,75.7 to 85.8,445
Polio,≥2 Doses,States/Local Areas,Washington,2020,Age,5 Months,80.7,75.0 to 85.3,445
DTaP,≥2 Doses,States/Local Areas,Washington,2020,Age,5 Months,81.8,76.2 to 86.3,445
PCV,≥1 Dose,States/Local Areas,Washington,2020,Age,3 Months,83.9,78.5 to 88.2,445
Hep B,≥1 Dose,States/Local Areas,Washington,2020,Age,3 Months,94.1,89.9 to 96.6,445
Hep A,≥1 Dose,States/Local Areas,Washington,2020,Age,24 Months,91.2,87.0 to 94.5,445
Hep A,≥2 Doses,States/Local Areas,Washington,2020,Age,24 Months,51.3,45.0 to 57.9,445
PCV,≥3 Doses,States/Local Areas,Washington,2020,Age,24 Months,91.4,87.3 to 94.6,445
PCV,≥4 Doses,States/Local Areas,Washington,2020,Age,24 Months,84.0,78.8 to 88.5,445
≥1 Dose Varicella,,States/Local Areas,Washington,2020,Age,24 Months,91.2,86.8 to 94.5,445
Influenza,,States/Local Areas,Washington,2020,Age,24 Months,70.2,64.2 to 75.9,445
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2020,Age,0-3 Days,81.6,76.1 to 86.0,445
Rotavirus,,States/Local Areas,Washington,2020,Age,8 Months,75.4,69.5 to 80.4,445
≥1 Dose MMR,,States/Local Areas,Washington,2020,Age,19 Months,89.2,84.1 to 92.8,445
Hib,≥3 Doses,States/Local Areas,Washington,2020,Age,19 Months,90.4,85.9 to 93.6,445
Combined 7 Series,,States/Local Areas,Washington,2020,Age,24 Months,74.0,68.2 to 79.5,445
Polio,≥3 Doses,States/Local Areas,Washington,2020,Age,19 Months,90.7,86.2 to 93.9,445
DTaP,≥4 Doses,States/Local Areas,Washington,2020,Age,19 Months,74.2,68.3 to 79.4,445
DTaP,≥3 Doses,States/Local Areas,Washington,2020,Age,19 Months,92.2,87.9 to 95.1,445
Hep B,≥2 Doses,States/Local Areas,Washington,2020,Age,5 Months,89.8,84.9 to 93.3,445
PCV,≥3 Doses,States/Local Areas,Washington,2020,Age,13 Months,88.0,83.0 to 91.7,445
DTaP,≥3 Doses,States/Local Areas,Washington,2020,Age,7 Months,72.8,66.6 to 78.2,445
≥1 Dose Varicella,,States/Local Areas,Washington,2020,Age,13 Months,65.2,58.9 to 71.0,445
PCV,≥2 Doses,States/Local Areas,Washington,2020,Age,5 Months,80.3,74.7 to 84.9,445
Hep B,≥3 Doses,States/Local Areas,Washington,2020,Age,13 Months,89.2,84.1 to 92.8,445
Hep B,≥2 Doses,States/Local Areas,Washington,2020,Age,13 Months,94.0,89.8 to 96.5,445
Hib,≥3 Doses,States/Local Areas,Washington,2020,Age,13 Months,82.9,77.5 to 87.1,445
Hib,Primary Series,States/Local Areas,Washington,2020,Age,13 Months,88.1,83.0 to 91.8,445
Hib,≥2 Doses,States/Local Areas,Washington,2020,Age,13 Months,91.1,86.2 to 94.3,445
PCV,≥3 Doses,States/Local Areas,Washington,2020,Age,35 Months,92.6,88.8 to 95.5,445
PCV,≥4 Doses,States/Local Areas,Washington,2020,Age,19 Months,82.0,76.4 to 86.4,445
Polio,≥3 Doses,States/Local Areas,Washington,2020,Age,35 Months,93.8,89.6 to 96.7,445
PCV,≥3 Doses,States/Local Areas,Washington,2020,Age,19 Months,91.4,87.0 to 94.5,445
DTaP,≥3 Doses,States/Local Areas,Washington,2020,Age,35 Months,95.0,91.2 to 97.5,445
DTaP,≥4 Doses,States/Local Areas,Washington,2020,Age,35 Months,87.8,83.0 to 91.8,445
≥1 Dose Varicella,,States/Local Areas,Washington,2020,Age,19 Months,89.7,84.8 to 93.2,445
Hep B,≥3 Doses,States/Local Areas,Washington,2020,Age,19 Months,92.3,88.0 to 95.2,445
Hib,Primary Series,States/Local Areas,Washington,2020,Age,19 Months,92.2,88.0 to 95.0,445
Hib,Full Series,States/Local Areas,Washington,2020,Age,19 Months,79.9,74.1 to 84.7,445
≥1 Dose Varicella,,States/Local Areas,Washington,2020,Age,35 Months,93.0,88.7 to 96.1,445
Hib,Full Series,States/Local Areas,Washington,2020,Age,35 Months,86.7,81.7 to 90.9,445
Hep B,≥3 Doses,States/Local Areas,Washington,2020,Age,35 Months,94.0,90.6 to 96.5,445
Hib,Primary Series,States/Local Areas,Washington,2020,Age,35 Months,93.8,90.0 to 96.6,445
Hib,≥3 Doses,States/Local Areas,Washington,2020,Age,35 Months,93.5,89.6 to 96.4,445
Hib,≥3 Doses,States/Local Areas,Washington,2020,Age,24 Months,92.1,88.2 to 95.1,445
≥1 Dose MMR,,States/Local Areas,Washington,2020,Age,35 Months,91.2,86.6 to 94.7,445
Polio,≥3 Doses,States/Local Areas,Washington,2020,Age,24 Months,91.9,88.0 to 94.9,445
≥1 Dose MMR,,States/Local Areas,Washington,2020,Age,24 Months,89.9,85.3 to 93.6,445
DTaP,≥4 Doses,States/Local Areas,Washington,2020,Age,24 Months,81.8,76.5 to 86.5,445
DTaP,≥3 Doses,States/Local Areas,Washington,2020,Age,24 Months,93.4,89.7 to 96.1,445
Hib,Primary Series,States/Local Areas,Washington,2020,Age,7 Months,74.5,68.4 to 79.7,445
Hib,≥2 Doses,States/Local Areas,Washington,2020,Age,7 Months,88.0,82.7 to 91.8,445
Polio,≥1 Dose,States/Local Areas,Washington,2020,Age,3 Months,85.1,79.7 to 89.3,445
Hep B,≥3 Doses,States/Local Areas,Washington,2020,Age,7 Months,68.9,62.6 to 74.6,445
PCV,≥3 Doses,States/Local Areas,Washington,2020,Age,7 Months,70.1,64.0 to 75.7,445
Hep B,≥2 Doses,States/Local Areas,Washington,2020,Age,7 Months,92.3,87.8 to 95.3,445
Hib,≥1 Dose,States/Local Areas,Washington,2020,Age,3 Months,84.9,79.6 to 89.0,445
DTaP,≥1 Dose,States/Local Areas,Washington,2020,Age,3 Months,85.8,80.4 to 89.9,445
Rotavirus,,States/Local Areas,Washington,2019-2020,Age,8 Months,77.6,73.6 to 81.1,900
PCV,≥4 Doses,States/Local Areas,Washington,2021,Age,19 Months,78.4,70.5 to 84.6,262
PCV,≥3 Doses,States/Local Areas,Washington,2021,Age,35 Months,93.2,88.0 to 96.7,262
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Principal City,79.1,73.7 to 84.4,858
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.4,66.5 to 80.4,554
Hep A,≥1 Dose,States/Local Areas,Washington,2021,Age,19 Months,87.1,80.7 to 91.6,262
PCV,≥3 Doses,States/Local Areas,Washington,2021,Age,13 Months,91.0,85.1 to 94.7,262
Hep A,≥2 Doses,States/Local Areas,Washington,2021,Age,24 Months,45.1,37.2 to 53.9,262
PCV,≥4 Doses,States/Local Areas,Washington,2021,Age,35 Months,93.1,80.2 to 98.8,262
Hep B,≥3 Doses,States/Local Areas,Washington,2021,Age,7 Months,68.1,59.9 to 75.3,262
DTaP,≥3 Doses,States/Local Areas,Washington,2021,Age,13 Months,92.3,86.5 to 95.7,262
PCV,≥3 Doses,States/Local Areas,Washington,2021,Age,7 Months,69.7,61.5 to 76.8,262
Hep A,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,28.2,24.0 to 32.8,707
Hep A,≥1 Dose,States/Local Areas,Washington,2021,Age,24 Months,90.7,85.2 to 94.7,262
Hib,Full Series,States/Local Areas,Washington,2021,Age,24 Months,81.5,74.2 to 87.7,262
DTaP,≥3 Doses,States/Local Areas,Washington,2021,Age,19 Months,92.9,87.1 to 96.2,262
≥1 Dose Varicella,,States/Local Areas,Washington,2021,Age,19 Months,89.6,83.2 to 93.7,262
Hep B,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,93.3,90.3 to 95.6,707
Hib,Primary Series,States/Local Areas,Washington,2020-2021,Age,13 Months,89.2,85.4 to 92.0,707
Hep A,≥1 Dose,States/Local Areas,Washington,2021,Age,35 Months,99.4,96.3 to 100.0,262
PCV,≥3 Doses,States/Local Areas,Washington,2021,Age,19 Months,92.8,87.0 to 96.1,262
Hib,≥3 Doses,States/Local Areas,Washington,2021,Age,7 Months,64.1,55.8 to 71.7,262
Polio,≥3 Doses,States/Local Areas,Washington,2021,Age,24 Months,92.8,87.6 to 96.4,262
DTaP,≥4 Doses,States/Local Areas,Washington,2021,Age,24 Months,78.2,70.4 to 85.1,262
DTaP,≥1 Dose,States/Local Areas,Washington,2021,Age,3 Months,90.6,84.6 to 94.4,262
≥1 Dose MMR,,States/Local Areas,Washington,2021,Age,24 Months,92.0,86.6 to 95.8,262
Hib,≥3 Doses,States/Local Areas,Washington,2021,Age,24 Months,91.3,85.8 to 95.3,262
Polio,≥1 Dose,States/Local Areas,Washington,2021,Age,3 Months,90.6,84.6 to 94.4,262
DTaP,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,95.0,91.6 to 97.4,707
Hib,Primary Series,States/Local Areas,Washington,2021,Age,24 Months,94.2,89.6 to 97.2,262
Hep B,≥2 Doses,States/Local Areas,Washington,2021,Age,7 Months,94.0,88.6 to 96.9,262
Hep B,≥3 Doses,States/Local Areas,Washington,2021,Age,24 Months,92.5,87.3 to 96.2,262
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2021,Age,0-2 Days,86.3,80.2 to 90.7,262
Combined 7 Series,,States/Local Areas,Washington,2020-2021,Age,35 Months,79.6,74.4 to 84.3,707
Hib,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,92.7,89.3 to 95.1,707
≥1 Dose Varicella,,States/Local Areas,Washington,2021,Age,24 Months,92.3,86.6 to 96.2,262
PCV,≥3 Doses,States/Local Areas,Washington,2021,Age,24 Months,93.2,88.0 to 96.7,262
≥1 Dose Varicella,,States/Local Areas,Washington,2020-2021,Age,35 Months,94.0,90.4 to 96.5,707
Polio,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,91.8,88.4 to 94.3,707
PCV,≥4 Doses,States/Local Areas,Washington,2021,Age,24 Months,80.0,72.7 to 86.5,262
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2021,Age,0-1 Days,86.3,80.2 to 90.7,262
≥1 Dose MMR,,States/Local Areas,Washington,2020-2021,Age,13 Months,71.9,67.0 to 76.3,707
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,90.6,88.9 to 92.0,2273
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,90.7,89.7 to 91.6,4660
Hib,≥3 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,89.7,87.4 to 91.7,2533
Hib,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,78.7,76.5 to 80.8,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,90.8,89.0 to 92.3,2387
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,91.7,90.5 to 92.7,5094
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,92.5,90.7 to 94.0,2707
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,91.8,90.6 to 92.8,5562
Hib,≥3 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,90.3,88.1 to 92.2,2707
Hib,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,89.6,88.4 to 90.7,5562
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,88.8,86.5 to 90.7,2732
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,90.6,89.1 to 91.9,5265
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,91.0,89.3 to 92.5,2855
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,89.9,88.5 to 91.2,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,87.7,85.5 to 89.6,2732
Hib,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,88.7,87.1 to 90.1,5265
Polio,≥3 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,90.8,89.0 to 92.3,2855
Polio,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,89.6,88.2 to 90.9,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,88.8,86.9 to 90.5,2855
Hib,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,88.3,86.8 to 89.6,5587
Polio,≥3 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,92.7,91.3 to 94.0,2707
Polio,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,91.8,90.7 to 92.8,5562
Polio,≥3 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,90.8,89.0 to 92.3,2387
Polio,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,91.8,90.6 to 92.8,5094
Polio,≥3 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,91.9,89.8 to 93.6,2533
Polio,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,68.5,66.0 to 71.0,4799
Polio,≥3 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,90.6,88.0 to 92.7,2266
Polio,≥3 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,91.6,89.3 to 93.5,2229
Polio,≥3 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,92.3,90.5 to 93.9,2367
Hib,≥3 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,87.5,85.5 to 89.4,2387
Hib,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,88.9,87.7 to 90.1,5094
Hib,≥3 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,88.3,86.5 to 89.8,2273
Hib,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,87.9,86.6 to 89.1,4660
Polio,≥3 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,90.5,88.5 to 92.2,2273
Polio,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,90.6,89.3 to 91.8,4660
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,92.4,90.4 to 94.1,2533
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,89.4,87.7 to 91.0,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,91.7,89.9 to 93.3,2273
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,91.9,90.7 to 93.0,4660
Hib,Full Series,HHS Regions/National,Region 6,2015,Age,24 Months,79.6,77.5 to 81.7,2707
Hib,Full Series,HHS Regions/National,Region 6,2015-2016,Age,24 Months,78.6,77.0 to 80.2,5562
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,91.5,89.1 to 93.5,2266
DTaP,≥3 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,94.0,92.1 to 95.5,2229
Polio,≥3 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,95.3,93.9 to 96.5,2707
Polio,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,93.9,92.8 to 94.9,5562
Hib,≥3 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,90.0,87.5 to 92.0,2266
Polio,≥3 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,91.7,89.3 to 93.8,2266
Polio,≥3 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,93.0,91.1 to 94.6,2533
Polio,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,92.4,90.9 to 93.7,4799
Polio,≥3 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,88.3,86.1 to 90.4,2732
Polio,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,90.6,89.2 to 92.0,5265
DTaP,≥2 Doses,HHS Regions/National,Region 6,2014,Age,5 Months,75.9,73.4 to 78.2,2387
DTaP,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,5 Months,77.5,75.2 to 79.7,5094
Hib,Full Series,HHS Regions/National,Region 6,2017,Age,24 Months,76.0,73.3 to 78.7,2732
Hib,Full Series,HHS Regions/National,Region 6,2017-2018,Age,24 Months,76.1,74.0 to 78.1,5265
Hib,Full Series,HHS Regions/National,Region 6,2016,Age,24 Months,77.6,75.2 to 79.9,2855
Hib,Full Series,HHS Regions/National,Region 6,2016-2017,Age,24 Months,76.8,75.0 to 78.6,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,89.6,87.7 to 91.3,2273
Hib,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,89.7,88.4 to 90.9,4660
Hib,≥3 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,92.0,90.0 to 93.6,2367
Hib,≥3 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,92.7,90.6 to 94.4,2229
Polio,≥3 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,90.4,88.0 to 92.5,2732
Polio,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,92.9,91.1 to 94.4,5265
Polio,≥3 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,92.4,90.6 to 94.0,2855
Polio,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,91.5,90.0 to 92.8,5587
DTaP,≥2 Doses,HHS Regions/National,Region 6,2015,Age,5 Months,79.2,77.0 to 81.2,2707
DTaP,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,5 Months,78.0,76.4 to 79.6,5562
Hib,Full Series,HHS Regions/National,Region 6,2018,Age,24 Months,76.2,73.0 to 79.2,2533
Hib,Full Series,HHS Regions/National,Region 6,2018-2019,Age,24 Months,77.5,75.2 to 79.8,4799
Hib,Full Series,HHS Regions/National,Region 6,2011,Age,35 Months,83.3,79.8 to 86.5,2229
Hib,Full Series,HHS Regions/National,Region 6,2012,Age,35 Months,82.7,79.9 to 85.4,2367
Hib,Full Series,HHS Regions/National,Region 6,2013,Age,35 Months,81.3,78.6 to 83.9,2273
Hib,Full Series,HHS Regions/National,Region 6,2013-2014,Age,35 Months,82.6,80.7 to 84.3,4660
DTaP,≥2 Doses,HHS Regions/National,Region 6,2013,Age,5 Months,76.3,73.6 to 78.8,2273
DTaP,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,5 Months,76.1,74.2 to 77.8,4660
DTaP,≥2 Doses,HHS Regions/National,Region 6,2012,Age,5 Months,75.4,72.8 to 77.8,2367
DTaP,≥2 Doses,HHS Regions/National,Region 6,2011,Age,5 Months,75.7,70.0 to 80.6,2229
Polio,≥3 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,92.8,90.9 to 94.4,2387
Polio,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,94.2,93.0 to 95.2,5094
Polio,≥3 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,92.9,91.0 to 94.5,2273
Polio,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,92.9,91.6 to 94.0,4660
Hib,Full Series,HHS Regions/National,Region 6,2019,Age,24 Months,78.9,75.5 to 82.2,2266
Polio,≥3 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,93.9,92.0 to 95.5,2367
Polio,≥3 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,95.1,92.9 to 96.8,2533
Polio,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,94.6,92.9 to 96.0,4799
Hib,Full Series,HHS Regions/National,Region 6,2014,Age,35 Months,83.6,81.1 to 86.0,2387
Hib,Full Series,HHS Regions/National,Region 6,2014-2015,Age,35 Months,84.5,82.8 to 86.2,5094
Hib,Full Series,HHS Regions/National,Region 6,2015,Age,35 Months,85.6,83.1 to 87.8,2707
Hib,Full Series,HHS Regions/National,Region 6,2015-2016,Age,35 Months,83.6,81.9 to 85.3,5562
Hib,Full Series,HHS Regions/National,Region 6,2017,Age,35 Months,79.4,76.6 to 82.1,2732
Hib,Full Series,HHS Regions/National,Region 6,2017-2018,Age,35 Months,79.8,77.7 to 81.9,5265
Hib,Full Series,HHS Regions/National,Region 6,2016,Age,35 Months,81.8,79.3 to 84.1,2855
Hib,Full Series,HHS Regions/National,Region 6,2016-2017,Age,35 Months,80.6,78.8 to 82.5,5587
Hib,Full Series,HHS Regions/National,Region 6,2018,Age,35 Months,80.2,76.9 to 83.2,2533
Hib,Full Series,HHS Regions/National,Region 6,2018-2019,Age,35 Months,81.7,79.3 to 84.0,4799
Hib,Full Series,HHS Regions/National,Region 6,2019,Age,35 Months,83.3,79.7 to 86.6,2266
PCV,≥4 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,78.8,75.6 to 81.8,2229
Hib,Primary Series,HHS Regions/National,Region 6,2012,Age,7 Months,65.3,62.6 to 67.9,2367
Hib,Primary Series,HHS Regions/National,Region 6,2011,Age,7 Months,66.2,61.9 to 70.3,2229
Polio,≥3 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,94.1,91.6 to 96.0,2266
Hep A,≥2 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,48.8,46.2 to 51.6,2707
Hep A,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,48.0,46.0 to 49.9,5562
Hep A,≥2 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,44.4,41.5 to 47.3,2387
Hep A,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,46.6,44.6 to 48.6,5094
Hep A,≥2 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,44.5,41.3 to 47.8,2367
Hep A,≥1 Dose,HHS Regions/National,Region 6,2013,Age,35 Months,90.7,88.5 to 92.5,2273
Hep A,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,35 Months,91.6,90.1 to 92.8,4660
Hep A,≥1 Dose,HHS Regions/National,Region 6,2014,Age,35 Months,92.4,90.4 to 94.0,2387
Hep A,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,35 Months,92.5,91.2 to 93.6,5094
DTaP,≥4 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,79.5,77.0 to 81.8,2387
DTaP,≥4 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,79.1,77.5 to 80.7,5094
DTaP,≥4 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,78.7,76.4 to 81.0,2855
DTaP,≥4 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,78.3,76.5 to 80.0,5587
DTaP,≥4 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,78.7,76.5 to 80.9,2707
DTaP,≥4 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,78.7,77.1 to 80.3,5562
Hep A,≥1 Dose,HHS Regions/National,Region 6,2016,Age,35 Months,91.8,90.0 to 93.3,2855
Hep A,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,35 Months,91.8,90.3 to 93.2,5587
Hep A,≥1 Dose,HHS Regions/National,Region 6,2017,Age,35 Months,91.9,89.4 to 94.0,2732
Hep A,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,35 Months,92.1,90.5 to 93.5,5265
Polio,≥2 Doses,HHS Regions/National,Region 6,2016,Age,5 Months,76.5,74.1 to 78.7,2855
Polio,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,5 Months,75.9,74.1 to 77.7,5587
Polio,≥2 Doses,HHS Regions/National,Region 6,2017,Age,5 Months,75.4,72.6 to 78.0,2732
Polio,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,5 Months,78.4,76.4 to 80.3,5265
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,63.2,60.4 to 65.8,2387
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,65.5,63.6 to 67.3,5094
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,67.7,65.2 to 70.1,2707
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,67.1,65.3 to 68.9,5562
Hep A,≥2 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,48.2,45.1 to 51.4,2732
Hep A,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,46.6,44.2 to 49.0,5265
Hep A,≥2 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,47.1,44.3 to 49.9,2855
Hep A,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,47.6,45.5 to 49.7,5587
DTaP,≥4 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,77.8,75.2 to 80.3,2273
DTaP,≥4 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,78.6,76.8 to 80.3,4660
DTaP,≥4 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,71.1,67.3 to 74.7,2266
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,66.2,62.6 to 69.6,2273
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,64.7,62.0 to 67.2,4660
DTaP,≥4 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,77.2,73.8 to 80.4,2229
DTaP,≥4 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,79.5,76.8 to 82.1,2367
Hep B,≥3 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,65.6,61.6 to 69.5,2367
Hep B,≥3 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,61.3,58.3 to 64.2,2229
Hep A,≥1 Dose,HHS Regions/National,Region 6,2015,Age,35 Months,92.5,90.8 to 94.0,2707
Hep A,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,35 Months,92.1,90.9 to 93.2,5562
Polio,≥2 Doses,HHS Regions/National,Region 6,2012,Age,5 Months,74.3,71.7 to 76.7,2367
Polio,≥2 Doses,HHS Regions/National,Region 6,2011,Age,5 Months,74.9,69.1 to 80.0,2229
Hep A,≥1 Dose,HHS Regions/National,Region 6,2012,Age,35 Months,91.9,89.7 to 93.8,2367
Polio,≥2 Doses,HHS Regions/National,Region 6,2013,Age,5 Months,74.9,72.0 to 77.6,2273
Polio,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,5 Months,75.0,73.1 to 76.8,4660
Polio,≥2 Doses,HHS Regions/National,Region 6,2014,Age,5 Months,75.1,72.6 to 77.4,2387
Polio,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,5 Months,76.7,74.3 to 79.0,5094
DTaP,≥4 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,70.6,67.4 to 73.7,2533
DTaP,≥4 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,94.2,92.8 to 95.3,4799
Hep A,≥2 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,45.9,42.9 to 48.9,2273
Hep A,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,45.1,43.0 to 47.2,4660
DTaP,≥4 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,70.9,68.4 to 73.3,2855
DTaP,≥4 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,70.8,69.0 to 72.6,5587
DTaP,≥4 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,70.7,67.9 to 73.4,2732
DTaP,≥4 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,70.7,68.6 to 72.7,5265
PCV,≥2 Doses,HHS Regions/National,Region 6,2019,Age,5 Months,80.6,77.3 to 83.6,2266
PCV,≥2 Doses,HHS Regions/National,Region 6,2017,Age,5 Months,74.3,71.5 to 76.9,2732
PCV,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,5 Months,76.5,74.5 to 78.5,5265
PCV,≥2 Doses,HHS Regions/National,Region 6,2018,Age,5 Months,78.8,75.7 to 81.6,2533
PCV,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,5 Months,79.7,77.5 to 81.8,4799
Hib,≥3 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,94.3,92.1 to 96.1,2266
≥1 Dose Varicella,,HHS Regions/National,Region 6,2011,Age,13 Months,57.5,52.4 to 62.4,2229
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013,Age,13 Months,58.9,55.6 to 62.0,2273
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013-2014,Age,13 Months,59.5,57.6 to 61.4,4660
Polio,≥2 Doses,HHS Regions/National,Region 6,2018,Age,5 Months,81.5,78.6 to 84.1,2533
Polio,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,5 Months,81.7,79.5 to 83.6,4799
Hep A,≥1 Dose,HHS Regions/National,Region 6,2019,Age,35 Months,94.0,90.8 to 96.3,2266
Hep A,≥1 Dose,HHS Regions/National,Region 6,2018,Age,35 Months,92.2,90.2 to 94.0,2533
Hep A,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,35 Months,92.9,91.2 to 94.4,4799
≥1 Dose Varicella,,HHS Regions/National,Region 6,2012,Age,13 Months,61.0,57.0 to 64.9,2367
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014,Age,13 Months,60.2,57.4 to 62.9,2387
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014-2015,Age,13 Months,60.5,58.6 to 62.4,5094
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,66.1,61.9 to 70.0,2266
Hep A,≥2 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,75.7,72.4 to 78.9,2387
Hep A,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,78.8,76.4 to 81.1,5094
Hep A,≥2 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,79.0,75.9 to 82.0,2855
Hep A,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,78.1,75.8 to 80.3,5587
Hep A,≥2 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,82.1,78.7 to 85.3,2707
Hep A,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,80.5,78.2 to 82.8,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,70.1,66.9 to 73.2,2533
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,68.1,65.5 to 70.6,4799
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,64.5,61.6 to 67.4,2732
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,67.3,65.1 to 69.4,5265
Polio,≥2 Doses,HHS Regions/National,Region 6,2019,Age,5 Months,81.8,78.5 to 84.7,2266
Polio,≥2 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,88.7,87.0 to 90.1,2367
Polio,≥2 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,89.2,85.4 to 92.1,2229
Hep A,≥2 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,45.0,41.4 to 48.7,2533
Hep A,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,49.0,46.2 to 51.9,4799
Hep A,≥2 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,53.1,48.9 to 57.5,2266
Polio,≥2 Doses,HHS Regions/National,Region 6,2015,Age,5 Months,78.4,76.2 to 80.5,2707
Polio,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,5 Months,77.4,75.8 to 79.0,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,66.5,63.9 to 69.0,2855
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,65.5,63.6 to 67.5,5587
Hep A,≥2 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,74.6,70.3 to 78.8,2229
Hep A,≥2 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,74.5,70.7 to 78.2,2367
Hep A,≥2 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,76.4,72.9 to 79.7,2273
Hep A,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,76.1,73.7 to 78.4,4660
Polio,≥2 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,91.4,89.2 to 93.2,2533
Polio,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,91.2,89.6 to 92.6,4799
Hep B,≥1 Dose,HHS Regions/National,Region 6,2013,Age,3 Months,94.5,93.4 to 95.4,2273
Hep B,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,3 Months,94.7,93.9 to 95.4,4660
Hep B,≥1 Dose,HHS Regions/National,Region 6,2012,Age,3 Months,95.5,94.2 to 96.5,2367
Hep B,≥1 Dose,HHS Regions/National,Region 6,2011,Age,3 Months,94.8,93.1 to 96.0,2229
Polio,≥2 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,87.7,85.8 to 89.5,2855
Polio,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,87.0,85.4 to 88.3,5587
Polio,≥2 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,86.2,83.8 to 88.2,2732
Polio,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,88.8,87.2 to 90.2,5265
Polio,≥2 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,91.0,88.5 to 93.0,2266
Polio,≥2 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,91.9,90.3 to 93.3,2273
Polio,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,92.3,91.4 to 93.1,4660
Hep B,≥1 Dose,HHS Regions/National,Region 6,2014,Age,3 Months,94.9,93.5 to 96.0,2387
Hep B,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,3 Months,95.2,94.4 to 95.9,5094
Hep B,≥1 Dose,HHS Regions/National,Region 6,2015,Age,3 Months,95.6,94.5 to 96.4,2707
Hep B,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,3 Months,95.4,94.6 to 96.1,5562
Hep B,≥1 Dose,HHS Regions/National,Region 6,2016,Age,3 Months,95.3,94.0 to 96.3,2855
Hep B,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,3 Months,95.1,94.1 to 95.9,5587
≥1 Dose MMR,,HHS Regions/National,Region 6,2018,Age,13 Months,70.3,67.1 to 73.3,2533
≥1 Dose MMR,,HHS Regions/National,Region 6,2018-2019,Age,13 Months,68.5,66.0 to 71.0,4799
≥1 Dose MMR,,HHS Regions/National,Region 6,2016,Age,13 Months,64.7,62.1 to 67.2,2855
≥1 Dose MMR,,HHS Regions/National,Region 6,2016-2017,Age,13 Months,64.1,62.2 to 66.0,5587
≥1 Dose MMR,,HHS Regions/National,Region 6,2017,Age,13 Months,63.5,60.6 to 66.4,2732
≥1 Dose MMR,,HHS Regions/National,Region 6,2017-2018,Age,13 Months,66.9,64.7 to 69.0,5265
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014,Age,19 Months,85.6,83.5 to 87.4,2387
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014-2015,Age,19 Months,86.1,84.7 to 87.5,5094
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015,Age,19 Months,86.7,85.5 to 87.8,2707
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015-2016,Age,19 Months,86.9,85.6 to 88.2,5562
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013,Age,19 Months,86.1,84.1 to 87.8,2273
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013-2014,Age,19 Months,85.8,84.6 to 87.0,4660
Polio,≥2 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,94.1,92.5 to 95.3,2367
Polio,≥2 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,93.7,91.5 to 95.3,2229
DTaP,≥4 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,78.4,74.8 to 81.7,2266
DTaP,≥4 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,84.4,80.8 to 87.6,2229
DTaP,≥4 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,85.2,81.5 to 88.5,2266
≥1 Dose MMR,,HHS Regions/National,Region 6,2011,Age,19 Months,85.3,81.8 to 88.2,2229
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,87.5,84.5 to 90.0,2266
Hep B,≥3 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,87.6,84.8 to 89.9,2229
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,88.6,86.1 to 90.7,2533
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,88.1,86.2 to 89.7,4799
Hep B,≥3 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,90.3,88.4 to 92.0,2367
≥1 Dose Varicella,,HHS Regions/National,Region 6,2011,Age,35 Months,93.1,90.8 to 95.0,2229
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,89.8,86.8 to 92.4,2206
Hib,Full Series,HHS Regions/National,Region 6,2020,Age,24 Months,77.1,72.9 to 81.1,2206
Polio,≥2 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,87.3,85.2 to 89.1,2387
Polio,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,88.3,87.0 to 89.5,5094
Polio,≥2 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,86.5,84.4 to 88.4,2273
Polio,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,86.9,85.6 to 88.1,4660
Polio,≥2 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,89.4,87.7 to 90.9,2707
Polio,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,88.6,87.3 to 89.8,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,83.8,80.9 to 86.3,2229
Hep A,≥2 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,78.4,74.3 to 82.2,2533
Hep A,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,80.0,77.0 to 82.9,4799
Hep A,≥2 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,76.9,73.5 to 80.1,2732
Hep A,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,77.7,75.0 to 80.3,5265
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,85.6,83.1 to 87.8,2273
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,85.6,83.8 to 87.3,4660
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,85.7,83.5 to 87.5,2387
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,86.5,85.1 to 87.7,5094
Hep A,≥2 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,81.8,77.1 to 86.1,2266
Hep B,≥3 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,87.7,85.5 to 89.6,2367
DTaP,≥4 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,84.8,82.0 to 87.3,2273
DTaP,≥4 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,85.7,83.8 to 87.4,4660
DTaP,≥4 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,85.0,82.3 to 87.5,2367
DTaP,≥4 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,86.5,84.0 to 88.8,2387
DTaP,≥4 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,87.1,85.3 to 88.9,5094
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018,Age,13 Months,66.4,63.1 to 69.5,2533
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018-2019,Age,13 Months,65.5,62.9 to 68.0,4799
≥1 Dose MMR,,HHS Regions/National,Region 6,2013,Age,13 Months,57.9,53.9 to 61.8,2273
≥1 Dose MMR,,HHS Regions/National,Region 6,2013-2014,Age,13 Months,59.4,57.1 to 61.7,4660
DTaP,≥4 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,77.3,74.3 to 80.2,2533
DTaP,≥4 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,77.9,75.5 to 80.1,4799
DTaP,≥4 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,77.8,75.1 to 80.3,2732
DTaP,≥4 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,77.6,75.6 to 79.5,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2012,Age,13 Months,60.8,56.4 to 64.9,2367
≥1 Dose MMR,,HHS Regions/National,Region 6,2011,Age,13 Months,57.5,52.0 to 62.8,2229
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016,Age,13 Months,63.7,61.1 to 66.3,2855
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016-2017,Age,13 Months,62.8,60.8 to 64.7,5587
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017,Age,13 Months,61.9,58.9 to 64.7,2732
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017-2018,Age,13 Months,64.1,61.9 to 66.2,5265
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015,Age,13 Months,60.8,58.1 to 63.3,2707
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015-2016,Age,13 Months,62.2,60.4 to 64.0,5562
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019,Age,13 Months,64.6,60.6 to 68.5,2266
≥1 Dose Varicella,,HHS Regions/National,Region 6,2011,Age,19 Months,85.8,81.9 to 89.0,2229
≥1 Dose Varicella,,HHS Regions/National,Region 6,2012,Age,19 Months,87.7,85.0 to 90.0,2367
≥1 Dose MMR,,HHS Regions/National,Region 6,2014,Age,13 Months,60.9,58.2 to 63.7,2387
≥1 Dose MMR,,HHS Regions/National,Region 6,2014-2015,Age,13 Months,61.5,59.6 to 63.4,5094
≥1 Dose MMR,,HHS Regions/National,Region 6,2015,Age,13 Months,62.0,59.4 to 64.6,2707
≥1 Dose MMR,,HHS Regions/National,Region 6,2015-2016,Age,13 Months,63.3,61.5 to 65.1,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,90.1,87.4 to 92.4,2266
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,87.2,84.9 to 89.4,2732
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,89.2,87.6 to 90.6,5265
Hep B,≥3 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,89.2,86.6 to 91.5,2229
PCV,≥4 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,80.7,78.1 to 83.2,2367
PCV,≥4 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,81.7,79.4 to 83.8,2387
PCV,≥4 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,81.0,79.5 to 82.5,5094
PCV,≥4 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,78.7,76.1 to 81.1,2273
PCV,≥4 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,80.1,78.5 to 81.8,4660
≥1 Dose MMR,,HHS Regions/National,Region 6,2019,Age,24 Months,89.3,86.6 to 91.7,2266
≥1 Dose MMR,,HHS Regions/National,Region 6,2018,Age,24 Months,91.6,89.6 to 93.3,2533
≥1 Dose MMR,,HHS Regions/National,Region 6,2018-2019,Age,24 Months,90.4,88.8 to 91.9,4799
≥1 Dose MMR,,HHS Regions/National,Region 6,2011,Age,35 Months,92.3,89.8 to 94.4,2229
≥1 Dose MMR,,HHS Regions/National,Region 6,2012,Age,35 Months,93.6,91.7 to 95.1,2367
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016,Age,35 Months,92.7,90.9 to 94.1,2855
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016-2017,Age,35 Months,92.5,91.0 to 93.8,5587
≥1 Dose MMR,,HHS Regions/National,Region 6,2013,Age,35 Months,91.1,89.2 to 92.8,2273
≥1 Dose MMR,,HHS Regions/National,Region 6,2013-2014,Age,35 Months,92.4,91.1 to 93.6,4660
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,91.1,89.0 to 93.0,2533
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,90.6,88.9 to 92.1,4799
Hep B,≥2 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,92.3,91.0 to 93.5,2707
Hep B,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,91.7,90.6 to 92.7,5562
PCV,≥3 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,85.2,83.0 to 87.1,2387
PCV,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,85.9,84.5 to 87.2,5094
PCV,≥3 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,86.6,84.7 to 88.4,2707
PCV,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,85.8,84.4 to 87.1,5562
Hep B,≥2 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,93.6,91.7 to 95.1,2533
Hep B,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,92.8,91.3 to 94.0,4799
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2019,Age,0-2 Days,79.9,76.5 to 82.9,2266
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2018,Age,0-2 Days,80.5,77.6 to 83.0,2533
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2018-2019,Age,0-2 Days,80.2,78.0 to 82.2,4799
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2017,Age,0-2 Days,76.0,73.1 to 78.6,2732
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2017-2018,Age,0-2 Days,78.2,76.2 to 80.1,5265
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017,Age,35 Months,92.3,89.8 to 94.4,2732
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017-2018,Age,35 Months,92.7,91.1 to 94.0,5265
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2016,Age,0-2 Days,76.1,73.7 to 78.4,2855
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2016-2017,Age,0-2 Days,76.1,74.2 to 77.8,5587
Hep B,≥2 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,91.1,89.3 to 92.6,2855
Hep B,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,90.2,88.9 to 91.4,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2013,Age,13 Months,85.4,83.6 to 87.1,2273
PCV,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,13 Months,85.3,84.2 to 86.3,4660
Hep B,≥2 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,89.3,87.2 to 91.1,2732
Hep B,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,91.4,90.1 to 92.7,5265
PCV,≥4 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,79.0,75.6 to 82.1,2266
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013,Age,35 Months,90.9,88.8 to 92.6,2273
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013-2014,Age,35 Months,92.5,91.1 to 93.7,4660
≥1 Dose Varicella,,HHS Regions/National,Region 6,2012,Age,35 Months,93.7,91.7 to 95.3,2367
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015,Age,35 Months,92.2,90.4 to 93.9,2707
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015-2016,Age,35 Months,92.4,91.2 to 93.6,5562
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014,Age,35 Months,94.0,92.3 to 95.5,2387
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014-2015,Age,35 Months,93.2,92.0 to 94.4,5094
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2014,Age,0-2 Days,74.2,71.7 to 76.5,2387
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2014-2015,Age,0-2 Days,76.1,74.5 to 77.7,5094
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2015,Age,0-2 Days,78.1,75.8 to 80.2,2707
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2015-2016,Age,0-2 Days,77.1,75.5 to 78.7,5562
PCV,≥4 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,77.8,74.8 to 80.5,2533
PCV,≥4 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,78.7,76.4 to 81.0,3947
PCV,≥4 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,76.0,73.2 to 78.5,2732
PCV,≥4 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,76.9,74.9 to 78.7,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2017,Age,24 Months,89.3,87.1 to 91.2,2732
≥1 Dose MMR,,HHS Regions/National,Region 6,2017-2018,Age,24 Months,90.4,88.9 to 91.7,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2016,Age,24 Months,89.8,88.1 to 91.4,2855
≥1 Dose MMR,,HHS Regions/National,Region 6,2016-2017,Age,24 Months,89.5,88.2 to 90.8,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2012,Age,13 Months,87.1,85.3 to 88.7,2367
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,89.4,87.6 to 91.1,2855
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,88.3,86.9 to 89.7,5587
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,91.2,89.6 to 92.6,2707
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,90.3,89.1 to 91.4,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,90.1,88.3 to 91.8,2387
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,90.6,89.5 to 91.7,5094
PCV,≥3 Doses,HHS Regions/National,Region 6,2019,Age,7 Months,70.6,66.6 to 74.2,2266
PCV,≥3 Doses,HHS Regions/National,Region 6,2011,Age,13 Months,85.2,80.5 to 88.9,2229
PCV,≥3 Doses,HHS Regions/National,Region 6,2018,Age,7 Months,70.5,67.3 to 73.6,2533
PCV,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,7 Months,70.6,68.0 to 73.0,4799
Hep B,≥2 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,91.2,89.5 to 92.6,2387
Hep B,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,91.8,90.7 to 92.7,5094
Hep B,≥2 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,93.0,91.7 to 94.1,2367
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2019,Age,0-1 Days,77.5,74.0 to 80.7,2266
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2011,Age,0-2 Days,77.7,74.4 to 80.6,2229
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2018,Age,0-1 Days,77.3,74.3 to 80.0,2533
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2018-2019,Age,0-1 Days,77.4,75.1 to 79.5,4799
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2013,Age,0-2 Days,75.5,72.9 to 77.9,2273
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2013-2014,Age,0-2 Days,74.8,73.2 to 76.4,4660
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2012,Age,0-2 Days,76.1,73.5 to 78.5,2367
Hep B,≥2 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,90.8,89.4 to 92.1,2273
Hep B,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,91.0,90.0 to 92.0,4660
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,88.9,86.0 to 91.3,2266
Hep B,≥3 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,88.9,86.3 to 91.2,2229
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013,Age,24 Months,89.2,87.1 to 91.0,2273
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,24 Months,89.7,88.3 to 90.9,4660
PCV,≥3 Doses,HHS Regions/National,Region 6,2016,Age,7 Months,66.8,64.2 to 69.3,2855
PCV,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,7 Months,67.3,65.4 to 69.2,5587
Hep B,≥3 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,91.2,89.2 to 92.9,2367
PCV,≥3 Doses,HHS Regions/National,Region 6,2017,Age,7 Months,67.8,65.0 to 70.6,2732
PCV,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,7 Months,69.2,67.0 to 71.3,5265
PCV,≥3 Doses,HHS Regions/National,Region 6,2015,Age,7 Months,65.4,62.9 to 67.9,2707
PCV,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,7 Months,66.1,64.3 to 67.9,5562
PCV,≥4 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,74.9,72.4 to 77.3,2387
PCV,≥4 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,75.4,73.6 to 77.0,5094
PCV,≥4 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,75.8,73.7 to 77.8,2707
PCV,≥4 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,75.8,74.1 to 77.4,5562
PCV,≥4 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,75.9,73.4 to 78.2,2855
PCV,≥4 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,75.9,74.1 to 77.6,5587
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018,Age,24 Months,91.4,89.3 to 93.2,2533
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018-2019,Age,24 Months,90.3,88.7 to 91.8,4799
≥1 Dose MMR,,HHS Regions/National,Region 6,2015,Age,24 Months,90.4,88.7 to 91.9,2707
≥1 Dose MMR,,HHS Regions/National,Region 6,2015-2016,Age,24 Months,90.1,88.9 to 91.2,5562
≥1 Dose MMR,,HHS Regions/National,Region 6,2014,Age,24 Months,90.2,88.4 to 91.9,2387
≥1 Dose MMR,,HHS Regions/National,Region 6,2014-2015,Age,24 Months,90.3,89.1 to 91.4,5094
≥1 Dose MMR,,HHS Regions/National,Region 6,2013,Age,24 Months,88.6,86.7 to 90.4,2273
≥1 Dose MMR,,HHS Regions/National,Region 6,2013-2014,Age,24 Months,89.4,88.1 to 90.7,4660
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019,Age,24 Months,89.3,86.6 to 91.6,2266
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017,Age,24 Months,87.8,85.5 to 89.8,2732
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017-2018,Age,24 Months,89.5,88.0 to 90.9,5265
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2015,Age,0-1 Days,72.9,70.5 to 75.1,2707
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2015-2016,Age,0-1 Days,72.7,70.9 to 74.3,5562
Hep B,≥2 Doses,HHS Regions/National,Region 6,2018,Age,5 Months,89.9,87.7 to 91.8,2533
Hep B,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,5 Months,89.7,88.0 to 91.2,4799
Hep B,≥2 Doses,HHS Regions/National,Region 6,2019,Age,5 Months,89.6,86.9 to 91.7,2266
Hep B,≥2 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,90.6,88.8 to 92.1,2229
Hep B,≥2 Doses,HHS Regions/National,Region 6,2017,Age,5 Months,85.6,83.2 to 87.6,2732
Hep B,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,5 Months,87.7,86.1 to 89.1,5265
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014,Age,24 Months,90.4,88.7 to 92.0,2387
≥1 Dose Varicella,,HHS Regions/National,Region 6,2014-2015,Age,24 Months,89.9,88.6 to 91.0,5094
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,86.7,83.1 to 89.7,2206
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2016,Age,0-1 Days,72.4,69.9 to 74.8,2855
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2016-2017,Age,0-1 Days,72.9,71.0 to 74.7,5587
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2017,Age,0-1 Days,73.3,70.4 to 76.0,2732
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2017-2018,Age,0-1 Days,75.3,73.2 to 77.2,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2017,Age,19 Months,86.5,84.2 to 88.5,2732
≥1 Dose MMR,,HHS Regions/National,Region 6,2017-2018,Age,19 Months,87.6,86.0 to 89.1,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2019,Age,19 Months,86.5,83.5 to 89.0,2266
≥1 Dose MMR,,HHS Regions/National,Region 6,2018,Age,19 Months,88.8,86.4 to 90.8,2533
≥1 Dose MMR,,HHS Regions/National,Region 6,2018-2019,Age,19 Months,93.8,92.4 to 94.9,4799
PCV,≥4 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,75.8,73.5 to 78.1,2273
PCV,≥4 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,75.4,73.8 to 76.9,4660
PCV,≥4 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,76.7,73.3 to 79.8,2367
PCV,≥4 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,72.0,68.5 to 75.4,2229
≥1 Dose MMR,,HHS Regions/National,Region 6,2011,Age,24 Months,89.5,87.1 to 91.7,2229
≥1 Dose MMR,,HHS Regions/National,Region 6,2012,Age,24 Months,91.3,89.4 to 93.0,2367
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015,Age,24 Months,89.2,87.4 to 90.9,2707
≥1 Dose Varicella,,HHS Regions/National,Region 6,2015-2016,Age,24 Months,89.4,88.1 to 90.6,5562
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016,Age,24 Months,89.6,87.8 to 91.2,2855
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016-2017,Age,24 Months,88.7,87.3 to 90.0,5587
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019,Age,19 Months,86.6,83.7 to 89.1,2266
Polio,≥2 Doses,HHS Regions/National,Region 6,2019,Age,13 Months,93.4,91.1 to 95.2,2266
Polio,≥2 Doses,HHS Regions/National,Region 6,2018,Age,13 Months,94.9,93.2 to 96.2,2533
Polio,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,13 Months,94.2,92.8 to 95.3,4799
Polio,≥2 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,90.0,87.8 to 91.8,2732
Polio,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,92.5,91.1 to 93.6,5265
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013,Age,24 Months,87.8,85.7 to 89.7,2273
≥1 Dose Varicella,,HHS Regions/National,Region 6,2013-2014,Age,24 Months,89.1,87.7 to 90.4,4660
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2013,Age,0-1 Days,71.4,68.7 to 74.0,2273
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2013-2014,Age,0-1 Days,70.6,68.6 to 72.5,4660
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2014,Age,0-1 Days,69.7,67.1 to 72.2,2387
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2014-2015,Age,0-1 Days,71.3,69.5 to 73.0,5094
Hep B,≥2 Doses,HHS Regions/National,Region 6,2015,Age,5 Months,88.1,86.4 to 89.6,2707
Hep B,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,5 Months,87.7,86.4 to 88.9,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,90.2,87.8 to 92.2,2533
Hep B,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,88.1,86.2 to 89.7,4799
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,86.4,84.0 to 88.5,2732
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,88.3,86.6 to 89.8,5265
Hep B,≥2 Doses,HHS Regions/National,Region 6,2016,Age,5 Months,87.3,85.3 to 89.1,2855
Hep B,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,5 Months,86.5,84.9 to 87.8,5587
Hep B,≥2 Doses,HHS Regions/National,Region 6,2014,Age,5 Months,85.6,83.6 to 87.5,2387
Hep B,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,5 Months,86.9,85.4 to 88.2,5094
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2012,Age,0-1 Days,71.7,68.7 to 74.5,2367
PCV,≥3 Doses,HHS Regions/National,Region 6,2013,Age,7 Months,62.8,58.7 to 66.6,2273
PCV,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,7 Months,63.1,60.6 to 65.5,4660
PCV,≥3 Doses,HHS Regions/National,Region 6,2011,Age,7 Months,61.5,56.1 to 66.5,2229
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,88.9,86.9 to 90.5,2855
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,87.6,86.1 to 89.0,5587
PCV,≥3 Doses,HHS Regions/National,Region 6,2014,Age,7 Months,63.4,60.7 to 66.1,2387
PCV,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,7 Months,64.4,62.6 to 66.2,5094
PCV,≥3 Doses,HHS Regions/National,Region 6,2012,Age,7 Months,63.4,60.4 to 66.3,2367
≥1 Dose MMR,,HHS Regions/National,Region 6,2019,Age,13 Months,66.7,62.7 to 70.5,2266
Hep B,≥1 Dose,HHS Regions/National,Region 6,2019,Age,3 Months,96.2,94.5 to 97.4,2266
Polio,≥2 Doses,HHS Regions/National,Region 6,2014,Age,13 Months,92.7,91.1 to 94.0,2387
Polio,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,13 Months,93.3,92.2 to 94.2,5094
Hep B,≥1 Dose,HHS Regions/National,Region 6,2018,Age,3 Months,95.8,94.0 to 97.1,2533
Hep B,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,3 Months,96.0,94.8 to 96.9,4799
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2011,Age,0-1 Days,72.7,69.6 to 75.6,2229
Hep B,≥2 Doses,HHS Regions/National,Region 6,2012,Age,5 Months,87.3,85.8 to 88.8,2367
Hep B,≥2 Doses,HHS Regions/National,Region 6,2011,Age,5 Months,86.2,84.3 to 88.0,2229
Hep B,≥2 Doses,HHS Regions/National,Region 6,2013,Age,5 Months,85.9,83.9 to 87.8,2273
Hep B,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,5 Months,85.8,84.2 to 87.3,4660
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,88.1,86.0 to 90.0,2273
Hep B,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,88.5,86.9 to 89.9,4660
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,88.9,87.0 to 90.5,2387
Hep B,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,89.5,88.3 to 90.6,5094
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,90.1,88.7 to 91.4,2707
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,89.5,88.3 to 90.6,5562
≥1 Dose MMR,,HHS Regions/National,Region 6,2015,Age,19 Months,87.4,86.1 to 88.6,2707
≥1 Dose MMR,,HHS Regions/National,Region 6,2015-2016,Age,19 Months,87.3,86.0 to 88.6,5562
≥1 Dose MMR,,HHS Regions/National,Region 6,2016,Age,19 Months,87.3,85.3 to 89.0,2855
≥1 Dose MMR,,HHS Regions/National,Region 6,2016-2017,Age,19 Months,86.9,85.4 to 88.2,5587
≥1 Dose Varicella,,HHS Regions/National,Region 6,2011,Age,24 Months,90.6,88.3 to 92.6,2229
≥1 Dose Varicella,,HHS Regions/National,Region 6,2012,Age,24 Months,90.8,88.8 to 92.5,2367
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016,Age,19 Months,87.2,85.2 to 88.9,2855
≥1 Dose Varicella,,HHS Regions/National,Region 6,2016-2017,Age,19 Months,86.3,84.8 to 87.7,5587
Polio,≥2 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,93.8,92.4 to 95.0,2707
Polio,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,93.1,92.1 to 94.1,5562
Polio,≥2 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,92.4,90.8 to 93.8,2855
Polio,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,91.2,89.9 to 92.4,5587
Hep B,≥1 Dose,HHS Regions/National,Region 6,2017,Age,3 Months,94.9,93.3 to 96.1,2732
Hep B,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,3 Months,95.3,94.2 to 96.3,5265
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018,Age,19 Months,88.4,86.0 to 90.5,2533
≥1 Dose Varicella,,HHS Regions/National,Region 6,2018-2019,Age,19 Months,65.5,62.9 to 68.0,4799
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017,Age,19 Months,85.5,83.1 to 87.6,2732
≥1 Dose Varicella,,HHS Regions/National,Region 6,2017-2018,Age,19 Months,86.9,85.3 to 88.4,5265
≥1 Dose MMR,,HHS Regions/National,Region 6,2013,Age,19 Months,85.9,83.6 to 88.0,2273
≥1 Dose MMR,,HHS Regions/National,Region 6,2013-2014,Age,19 Months,85.9,84.6 to 87.0,4660
≥1 Dose MMR,,HHS Regions/National,Region 6,2014,Age,19 Months,85.8,83.7 to 87.7,2387
≥1 Dose MMR,,HHS Regions/National,Region 6,2014-2015,Age,19 Months,86.6,85.2 to 87.9,5094
≥1 Dose MMR,,HHS Regions/National,Region 6,2012,Age,19 Months,88.2,85.2 to 90.6,2367
DTaP,≥4 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,84.3,81.2 to 87.2,2533
DTaP,≥4 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,84.8,82.4 to 87.0,4799
DTaP,≥4 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,83.5,80.7 to 86.1,2732
DTaP,≥4 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,84.0,81.9 to 86.0,5265
DTaP,≥4 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,86.5,84.1 to 88.7,2855
DTaP,≥4 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,85.1,83.3 to 86.9,5587
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016,Age,13 Months,86.2,84.1 to 88.0,2855
Hep B,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,13 Months,85.0,83.4 to 86.5,5587
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015,Age,13 Months,87.3,85.4 to 88.9,2707
Hep B,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,13 Months,86.7,85.4 to 88.0,5562
DTaP,≥4 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,87.9,85.2 to 90.2,2707
DTaP,≥4 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,87.1,85.3 to 88.8,5562
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017,Age,13 Months,83.8,81.3 to 86.0,2732
Hep B,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,13 Months,86.2,84.4 to 87.7,5265
Polio,≥3 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,92.4,90.2 to 94.3,2229
DTaP,≥3 Doses,HHS Regions/National,Region 6,2012,Age,24 Months,93.5,91.7 to 95.0,2367
PCV,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,88.9,86.6 to 90.9,4472
Influenza,,HHS Regions/National,Region 6,2011,Age,24 Months,43.7,40.1 to 47.5,2229
Influenza,,HHS Regions/National,Region 6,2012,Age,24 Months,48.0,44.9 to 51.2,2367
Influenza,,HHS Regions/National,Region 6,2013,Age,24 Months,45.3,42.4 to 48.3,2273
Influenza,,HHS Regions/National,Region 6,2013-2014,Age,24 Months,44.0,42.0 to 46.1,4660
Influenza,,HHS Regions/National,Region 6,2015,Age,24 Months,52.8,50.2 to 55.4,2707
Influenza,,HHS Regions/National,Region 6,2015-2016,Age,24 Months,51.7,49.8 to 53.6,5562
Influenza,,HHS Regions/National,Region 6,2014,Age,24 Months,42.8,40.1 to 45.6,2387
Influenza,,HHS Regions/National,Region 6,2014-2015,Age,24 Months,47.8,45.9 to 49.7,5094
Hep B,≥1 Dose,HHS Regions/National,Region 6,2021,Age,3 Months,97.3,96.0 to 98.2,1286
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,92.6,90.4 to 94.5,3492
PCV,≥4 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,78.2,74.9 to 81.2,3492
DTaP,≥4 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,79.5,76.1 to 82.7,3492
Polio,≥3 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,97.8,92.5 to 99.6,1286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2020-2021,Age,0-3 Days,81.6,78.4 to 84.4,3492
Influenza,,HHS Regions/National,Region 6,2020-2021,Age,24 Months,48.6,44.6 to 52.9,3492
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,92.3,90.0 to 94.2,3492
≥1 Dose Varicella,,HHS Regions/National,Region 6,2021,Age,35 Months,95.5,92.5 to 97.5,1286
Hep B,≥2 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,94.2,90.6 to 96.5,1286
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,68.1,63.9 to 72.0,3492
DTaP,≥4 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,96.1,87.7 to 99.3,1286
Hep B,≥3 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,93.1,89.6 to 95.8,1286
Hib,Primary Series,HHS Regions/National,Region 6,2021,Age,13 Months,86.3,80.7 to 90.5,1286
PCV,≥4 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,82.8,79.6 to 85.8,3492
PCV,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,90.8,88.4 to 92.6,3492
PCV,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,92.0,89.8 to 93.9,3492
Hep B,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,91.2,88.8 to 93.1,3492
≥1 Dose MMR,,HHS Regions/National,Region 6,2020-2021,Age,35 Months,93.9,91.5 to 95.8,3492
Polio,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,87.4,84.3 to 89.9,3492
DTaP,≥3 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,93.5,90.1 to 96.1,1286
Hib,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,3 Months,81.6,77.8 to 84.8,3492
Combined 7 Series,,HHS Regions/National,Region 6,2020-2021,Age,35 Months,73.4,68.4 to 78.1,3492
Polio,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,5 Months,76.7,72.6 to 80.4,3492
Hib,Full Series,HHS Regions/National,Region 6,2021,Age,35 Months,91.8,78.1 to 98.4,1286
Polio,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,92.7,90.2 to 94.7,3492
Hib,Primary Series,HHS Regions/National,Region 6,2020-2021,Age,13 Months,85.3,82.0 to 88.0,3492
Hib,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,88.7,85.8 to 91.0,3492
DTaP,≥4 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,71.6,67.9 to 75.0,3492
Hib,≥3 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,75.1,68.4 to 80.7,1286
Polio,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,91.2,88.8 to 93.0,3492
PCV,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,91.2,89.0 to 93.2,3492
Hep B,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,5 Months,86.8,83.6 to 89.5,3492
Hep A,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,47.8,43.7 to 52.0,3492
Combined 7 Series,,HHS Regions/National,Region 6,2020-2021,Age,24 Months,66.6,62.7 to 70.5,3492
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020-2021,Age,24 Months,91.1,89.1 to 92.9,3492
Hep B,≥2 Doses,States/Local Areas,Colorado,2021,Age,13 Months,90.5,82.4 to 95.1,171
Rotavirus,,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,90.0,85.8 to 94.1,367
Polio,≥2 Doses,States/Local Areas,Colorado,2021,Age,5 Months,75.7,65.5 to 83.6,171
Polio,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,89.7,84.6 to 93.2,482
≥1 Dose MMR,,States/Local Areas,Colorado,2021,Age,19 Months,82.4,72.7 to 89.1,171
Hib,Full Series,States/Local Areas,Colorado,2020-2021,Age,19 Months,71.7,65.8 to 77.1,482
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Colorado,2020-2021,Age,0-2 Days,80.5,75.0 to 85.0,482
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Colorado,2020-2021,Age,0-1 Days,79.1,73.5 to 83.7,482
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2020-2021,Age,0-3 Days,80.5,75.0 to 85.0,482
Hib,Primary Series,States/Local Areas,Colorado,2020-2021,Age,35 Months,88.9,84.0 to 92.9,482
≥1 Dose Varicella,,States/Local Areas,Colorado,2021,Age,13 Months,54.9,44.6 to 64.7,171
Hib,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,89.4,83.5 to 93.8,482
Hep A,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,19 Months,80.8,75.1 to 85.5,482
Hib,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,85.2,79.8 to 89.3,482
Combined 7 Series,,States/Local Areas,Colorado,2021,Age,24 Months,66.2,56.7 to 75.4,171
≥1 Dose Varicella,,States/Local Areas,Colorado,2021,Age,35 Months,84.0,75.1 to 91.1,171
Rotavirus,,States/Local Areas,Colorado,2017,Age,8 Months,84.0,76.5 to 89.4,231
Rotavirus,,States/Local Areas,Colorado,2017-2018,Age,8 Months,84.5,79.7 to 88.2,527
Rotavirus,,States/Local Areas,Colorado,2016,Age,8 Months,74.5,65.9 to 81.5,247
Rotavirus,,States/Local Areas,Colorado,2016-2017,Age,8 Months,79.2,73.6 to 83.8,478
Rotavirus,,States/Local Areas,Colorado,2015,Age,8 Months,75.4,67.8 to 81.7,272
Rotavirus,,States/Local Areas,Colorado,2015-2016,Age,8 Months,74.9,69.4 to 79.8,519
Rotavirus,,States/Local Areas,Colorado,2019,Age,8 Months,84.1,77.9 to 88.8,265
Rotavirus,,States/Local Areas,Colorado,2018,Age,8 Months,85.0,78.6 to 89.7,296
Rotavirus,,States/Local Areas,Colorado,2018-2019,Age,8 Months,84.5,80.1 to 88.1,561
Rotavirus,,States/Local Areas,Colorado,2011,Age,8 Months,72.6,65.0 to 79.0,277
Rotavirus,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.9,60.3 to 85.5,96
Rotavirus,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,75.2,67.7 to 82.7,203
Rotavirus,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,70.5,63.6 to 77.5,268
Rotavirus,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,84.6,80.2 to 88.9,564
Rotavirus,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,70.0,53.4 to 86.5,39
Rotavirus,,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,74.8,68.7 to 81.0,345
Rotavirus,,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,67.7,59.1 to 76.3,182
Rotavirus,,States/Local Areas,Colorado,2014-2017,Overall,Overall,77.2,73.3 to 81.0,894
Rotavirus,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.4,70.7 to 84.1,303
Rotavirus,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,78.5,68.8 to 88.2,87
Rotavirus,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,76.8,71.6 to 82.1,504
Rotavirus,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.9,76.3 to 85.6,570
Rotavirus,,States/Local Areas,Colorado,2013,Age,8 Months,69.0,60.6 to 76.3,250
Rotavirus,,States/Local Areas,Colorado,2013-2014,Age,8 Months,73.0,67.2 to 78.0,482
Rotavirus,,States/Local Areas,Colorado,2014,Age,8 Months,76.9,68.9 to 83.4,232
Rotavirus,,States/Local Areas,Colorado,2014-2015,Age,8 Months,76.2,70.8 to 80.8,504
Rotavirus,,States/Local Areas,Colorado,2012,Age,8 Months,70.8,63.5 to 77.2,297
Polio,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,84.7 to 100.0,96
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,Hispanic,79.1,72.0 to 86.2,200
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,77.3,70.8 to 83.8,244
DTaP,≥4 Doses,States/Local Areas,Colorado,2016-2019,Poverty,<133% FPL,64.6,55.2 to 74.0,156
PCV,≥4 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,90.7,87.1 to 94.2,624
Hep A,≥2 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,56.5 to 90.5,96
DTaP,≥2 Doses,States/Local Areas,Colorado,2021,Age,5 Months,74.3,63.9 to 82.5,171
Hep B,≥3 Doses,States/Local Areas,Colorado,2021,Age,13 Months,80.6,70.6 to 87.9,171
Hep B,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,87.3,82.2 to 91.2,482
PCV,≥1 Dose,States/Local Areas,Colorado,2021,Age,3 Months,78.3,68.1 to 85.8,171
DTaP,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,86.3,81.0 to 90.3,482
PCV,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,67.8,61.6 to 73.4,482
Polio,≥3 Doses,States/Local Areas,Colorado,2021,Age,19 Months,84.2,74.9 to 90.5,171
Hib,Full Series,States/Local Areas,Colorado,2020-2021,Age,35 Months,78.7,72.5 to 84.4,482
Influenza,,States/Local Areas,Colorado,2013,Age,24 Months,58.2,50.0 to 66.6,250
Influenza,,States/Local Areas,Colorado,2013-2014,Age,24 Months,61.2,55.3 to 67.1,482
Influenza,,States/Local Areas,Colorado,2016,Age,24 Months,67.6,59.3 to 75.6,247
Influenza,,States/Local Areas,Colorado,2016-2017,Age,24 Months,69.3,63.4 to 75.1,478
Influenza,,States/Local Areas,Colorado,2015,Age,24 Months,61.8,53.9 to 69.8,272
Influenza,,States/Local Areas,Colorado,2015-2016,Age,24 Months,64.7,59.0 to 70.4,519
Influenza,,States/Local Areas,Colorado,2014,Age,24 Months,64.3,56.0 to 72.5,232
Influenza,,States/Local Areas,Colorado,2014-2015,Age,24 Months,63.1,57.3 to 68.8,504
Influenza,,States/Local Areas,Colorado,2012,Age,24 Months,60.3,53.0 to 67.6,297
Influenza,,States/Local Areas,Colorado,2011,Age,24 Months,63.4,56.0 to 70.9,277
Influenza,,States/Local Areas,Colorado,2020-2021,Age,24 Months,67.8,61.9 to 73.6,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,64.9,58.7 to 70.7,482
Hep B,≥3 Doses,States/Local Areas,Colorado,2021,Age,35 Months,86.1,77.7 to 92.6,171
Hib,Primary Series,States/Local Areas,Colorado,2021,Age,13 Months,80.5,70.9 to 87.5,171
PCV,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,88.0,82.9 to 91.8,482
PCV,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,91.1,86.1 to 94.8,482
Combined 7 Series,,States/Local Areas,Colorado,2020-2021,Age,24 Months,66.1,60.2 to 71.9,482
Hib,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,3 Months,81.2,75.3 to 85.9,482
DTaP,≥4 Doses,States/Local Areas,Colorado,2021,Age,35 Months,76.7,66.4 to 85.7,171
Polio,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,86.0,80.7 to 90.1,482
PCV,≥4 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,80.7,75.3 to 85.6,482
Hib,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,85.5,80.0 to 89.7,482
Hep B,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,3 Months,93.6,89.8 to 96.0,482
Polio,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,5 Months,77.5,71.6 to 82.5,482
Combined 7 Series,,States/Local Areas,Colorado,2020-2021,Age,35 Months,72.1,65.6 to 78.3,482
Hib,Primary Series,States/Local Areas,Colorado,2020-2021,Age,7 Months,73.1,67.1 to 78.3,482
Polio,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,89.5,84.7 to 93.3,482
Polio,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,87.4,82.3 to 91.2,482
PCV,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,89.2,84.4 to 93.0,482
Hib,≥3 Doses,States/Local Areas,Colorado,2021,Age,13 Months,71.6,61.4 to 80.0,171
≥1 Dose Varicella,,States/Local Areas,Colorado,2020-2021,Age,19 Months,84.1,78.8 to 88.3,482
Hep B,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,89.8,85.4 to 93.0,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2021,Age,35 Months,84.5,75.7 to 91.5,171
Hib,Full Series,States/Local Areas,Colorado,2021,Age,35 Months,71.1,61.7 to 80.0,171
DTaP,≥4 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,68.3,62.2 to 73.9,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,71.1,65.0 to 76.6,482
Hib,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,5 Months,75.0,68.9 to 80.2,482
Polio,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,3 Months,83.9,78.2 to 88.3,482
≥1 Dose Varicella,,States/Local Areas,Colorado,2020-2021,Age,24 Months,85.3,80.3 to 89.7,482
Hep A,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,45.2,39.2 to 51.7,482
Hib,Primary Series,States/Local Areas,Colorado,2021,Age,35 Months,84.3,75.4 to 91.3,171
Hep B,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,88.2,83.4 to 92.1,482
Hib,≥2 Doses,States/Local Areas,Colorado,2021,Age,13 Months,84.8,75.1 to 91.2,171
Hep B,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,5 Months,85.5,80.1 to 89.5,482
PCV,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,85.9,80.7 to 89.9,482
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,71.4 to 95.4,96
Influenza,,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,85.1,80.1 to 90.0,367
Influenza,,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,62.7,55.9 to 69.5,345
Influenza,,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,52.2,42.8 to 61.6,182
Influenza,,States/Local Areas,Colorado,2014-2017,Overall,Overall,66.2,61.8 to 70.5,894
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,73.5,66.7 to 80.4,244
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,88.0,83.8 to 92.2,624
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Any Medicaid,89.9,85.7 to 94.2,244
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Insurance Coverage,Private Insurance Only,96.7,94.2 to 99.2,624
≥1 Dose MMR,,States/Local Areas,Colorado,2020-2021,Age,19 Months,84.7,79.3 to 88.9,482
Rotavirus,,States/Local Areas,Colorado,2021,Age,8 Months,70.5,60.0 to 79.2,171
Hep A,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,35 Months,78.8,71.1 to 85.6,482
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2021,Age,0-3 Days,81.0,71.5 to 87.9,171
PCV,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,3 Months,82.8,77.1 to 87.4,482
Hib,≥3 Doses,States/Local Areas,Colorado,2021,Age,35 Months,83.9,75.1 to 91.0,171
DTaP,≥3 Doses,States/Local Areas,Colorado,2021,Age,24 Months,84.2,75.4 to 91.2,171
Hib,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,13 Months,74.5,68.5 to 79.6,482
DTaP,≥2 Doses,States/Local Areas,Colorado,2020-2021,Age,5 Months,77.7,71.7 to 82.8,482
Polio,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,88.9,84.1 to 92.7,482
Hib,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,7 Months,55.9,49.8 to 61.9,482
≥1 Dose MMR,,States/Local Areas,Colorado,2021,Age,13 Months,64.8,54.3 to 74.1,171
Hep A,≥1 Dose,States/Local Areas,Colorado,2020-2021,Age,24 Months,82.8,77.3 to 87.5,482
≥1 Dose Varicella,,States/Local Areas,Colorado,2020-2021,Age,13 Months,56.2,49.9 to 62.3,482
Rotavirus,,States/Local Areas,Colorado,2020-2021,Age,8 Months,71.9,65.8 to 77.3,482
DTaP,≥3 Doses,States/Local Areas,Colorado,2020-2021,Age,24 Months,89.4,84.5 to 93.3,482
PCV,≥4 Doses,States/Local Areas,Colorado,2020-2021,Age,19 Months,78.8,73.1 to 83.5,482
≥1 Dose MMR,,States/Local Areas,Colorado,2020-2021,Age,35 Months,89.5,83.7 to 93.9,482
Hib,≥2 Doses,States/Local Areas,Colorado,2021,Age,5 Months,70.1,59.8 to 78.7,171
Hib,Full Series,States/Local Areas,Colorado,2019,Age,19 Months,77.9,70.7 to 83.8,265
Combined 7 Series,,States/Local Areas,Colorado,2019,Age,24 Months,73.7,66.6 to 80.5,265
Combined 7 Series,,States/Local Areas,Colorado,2015,Age,35 Months,77.6,69.1 to 85.0,272
Combined 7 Series,,States/Local Areas,Colorado,2015-2016,Age,35 Months,76.4,70.6 to 81.8,519
Combined 7 Series,,States/Local Areas,Colorado,2014,Age,35 Months,79.6,72.3 to 86.0,232
Combined 7 Series,,States/Local Areas,Colorado,2014-2015,Age,35 Months,78.3,72.9 to 83.3,504
Combined 7 Series,,States/Local Areas,Colorado,2013,Age,35 Months,79.7,72.2 to 86.3,250
Combined 7 Series,,States/Local Areas,Colorado,2013-2014,Age,35 Months,79.5,74.3 to 84.2,482
Combined 7 Series,,States/Local Areas,Colorado,2012,Age,35 Months,75.2,67.8 to 81.9,297
Combined 7 Series,,States/Local Areas,Colorado,2017,Age,35 Months,77.4,68.4 to 85.3,231
Combined 7 Series,,States/Local Areas,Colorado,2017-2018,Age,35 Months,74.4,68.3 to 80.1,527
Combined 7 Series,,States/Local Areas,Colorado,2016,Age,35 Months,75.8,67.5 to 83.4,247
Combined 7 Series,,States/Local Areas,Colorado,2016-2017,Age,35 Months,76.5,70.4 to 82.1,478
Hib,Primary Series,States/Local Areas,Colorado,2018,Age,13 Months,89.9,83.0 to 94.3,296
Hib,Primary Series,States/Local Areas,Colorado,2018-2019,Age,13 Months,89.6,85.6 to 92.7,561
Combined 7 Series,,States/Local Areas,Colorado,2012,Age,24 Months,72.0,65.0 to 78.6,297
Combined 7 Series,,States/Local Areas,Colorado,2013,Age,24 Months,73.1,65.6 to 80.2,250
Combined 7 Series,,States/Local Areas,Colorado,2013-2014,Age,24 Months,74.9,69.7 to 79.8,482
Combined 7 Series,,States/Local Areas,Colorado,2011,Age,24 Months,66.2,58.7 to 73.6,277
Hib,Primary Series,States/Local Areas,Colorado,2019,Age,24 Months,94.8,91.2 to 97.2,265
Hib,Primary Series,States/Local Areas,Colorado,2016,Age,35 Months,95.2,90.8 to 97.9,247
Hib,Primary Series,States/Local Areas,Colorado,2016-2017,Age,35 Months,95.1,91.9 to 97.3,478
Hib,Primary Series,States/Local Areas,Colorado,2015,Age,35 Months,90.6,85.9 to 94.2,272
Hib,Primary Series,States/Local Areas,Colorado,2015-2016,Age,35 Months,92.9,89.9 to 95.3,519
Hib,Primary Series,States/Local Areas,Colorado,2017,Age,13 Months,93.7,87.5 to 96.9,231
Hib,Primary Series,States/Local Areas,Colorado,2017-2018,Age,13 Months,91.8,87.5 to 94.7,527
Hib,Primary Series,States/Local Areas,Colorado,2014,Age,35 Months,95.5,90.5 to 98.3,232
Hib,Primary Series,States/Local Areas,Colorado,2014-2015,Age,35 Months,93.3,89.9 to 96.0,504
Hib,Primary Series,States/Local Areas,Colorado,2012,Age,35 Months,92.5,87.6 to 96.0,297
Hib,Primary Series,States/Local Areas,Colorado,2013,Age,35 Months,93.8,89.2 to 96.8,250
Hib,Primary Series,States/Local Areas,Colorado,2013-2014,Age,35 Months,94.7,91.5 to 97.0,482
Hib,Primary Series,States/Local Areas,Colorado,2011,Age,35 Months,90.9,85.7 to 94.7,277
Hib,Primary Series,States/Local Areas,Colorado,2019,Age,35 Months,95.4,92.0 to 97.7,265
Combined 7 Series,,States/Local Areas,Colorado,2016,Age,24 Months,71.3,63.0 to 79.2,247
Combined 7 Series,,States/Local Areas,Colorado,2016-2017,Age,24 Months,70.8,64.8 to 76.6,478
Hib,Primary Series,States/Local Areas,Colorado,2018,Age,35 Months,96.1,91.6 to 98.5,296
Hib,Primary Series,States/Local Areas,Colorado,2018-2019,Age,35 Months,95.8,93.2 to 97.6,561
Combined 7 Series,,States/Local Areas,Colorado,2015,Age,24 Months,70.6,63.1 to 77.7,272
Combined 7 Series,,States/Local Areas,Colorado,2015-2016,Age,24 Months,71.0,65.4 to 76.3,519
Combined 7 Series,,States/Local Areas,Colorado,2014,Age,24 Months,76.8,69.6 to 83.4,232
Combined 7 Series,,States/Local Areas,Colorado,2014-2015,Age,24 Months,73.7,68.5 to 78.7,504
Combined 7 Series,,States/Local Areas,Colorado,2018,Age,24 Months,67.8,59.8 to 75.5,296
Combined 7 Series,,States/Local Areas,Colorado,2018-2019,Age,24 Months,70.7,65.3 to 76.0,561
Combined 7 Series,,States/Local Areas,Colorado,2017,Age,24 Months,70.1,61.3 to 78.4,231
Combined 7 Series,,States/Local Areas,Colorado,2017-2018,Age,24 Months,68.9,62.9 to 74.7,527
Hep A,≥1 Dose,States/Local Areas,Colorado,2012,Age,19 Months,73.8,71.0 to 76.4,297
Hep A,≥1 Dose,States/Local Areas,Colorado,2011,Age,19 Months,70.3,62.2 to 77.4,277
DTaP,≥1 Dose,States/Local Areas,Colorado,2019,Age,3 Months,92.0,86.4 to 95.5,265
DTaP,≥3 Doses,States/Local Areas,Colorado,2016,Age,24 Months,95.3,91.1 to 97.9,247
DTaP,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,95.3,92.1 to 97.5,478
DTaP,≥1 Dose,States/Local Areas,Colorado,2018,Age,3 Months,92.6,86.9 to 96.0,296
DTaP,≥1 Dose,States/Local Areas,Colorado,2018-2019,Age,3 Months,92.3,88.6 to 94.9,561
DTaP,≥3 Doses,States/Local Areas,Colorado,2015,Age,24 Months,92.6,88.4 to 95.8,272
DTaP,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,94.0,91.1 to 96.1,519
DTaP,≥3 Doses,States/Local Areas,Colorado,2014,Age,24 Months,96.4,92.7 to 98.5,232
DTaP,≥3 Doses,States/Local Areas,Colorado,2014-2015,Age,24 Months,94.6,92.0 to 96.5,504
DTaP,≥1 Dose,States/Local Areas,Colorado,2017,Age,3 Months,91.4,84.1 to 95.6,231
DTaP,≥1 Dose,States/Local Areas,Colorado,2017-2018,Age,3 Months,92.0,87.7 to 94.9,527
Hep A,≥1 Dose,States/Local Areas,Colorado,2013,Age,19 Months,76.6,72.3 to 80.5,250
Hep A,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,19 Months,79.7,77.6 to 81.7,482
Hep A,≥1 Dose,States/Local Areas,Colorado,2016,Age,19 Months,84.1,76.6 to 89.5,247
Hep A,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,19 Months,84.7,79.8 to 88.5,478
Hep A,≥1 Dose,States/Local Areas,Colorado,2015,Age,19 Months,79.5,78.3 to 80.7,272
Hep A,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,19 Months,81.8,76.8 to 85.9,519
Hep A,≥1 Dose,States/Local Areas,Colorado,2014,Age,19 Months,82.8,75.5 to 88.3,232
Hep A,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,19 Months,81.2,76.2 to 85.3,504
DTaP,≥2 Doses,States/Local Areas,Colorado,2019,Age,5 Months,88.5,82.6 to 92.6,265
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,91.4,85.5 to 97.4,87
DTaP,≥2 Doses,States/Local Areas,Colorado,2018,Age,5 Months,90.6,84.9 to 94.3,296
DTaP,≥2 Doses,States/Local Areas,Colorado,2018-2019,Age,5 Months,89.6,85.7 to 92.4,561
DTaP,≥2 Doses,States/Local Areas,Colorado,2017,Age,5 Months,89.4,82.8 to 93.7,231
DTaP,≥2 Doses,States/Local Areas,Colorado,2017-2018,Age,5 Months,90.0,85.9 to 93.0,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2018,Age,24 Months,96.3,91.9 to 98.7,296
DTaP,≥3 Doses,States/Local Areas,Colorado,2018-2019,Age,24 Months,96.0,93.4 to 97.7,561
DTaP,≥3 Doses,States/Local Areas,Colorado,2017,Age,24 Months,95.3,89.8 to 98.3,231
DTaP,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,95.8,92.5 to 97.9,527
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,96.8,94.5 to 99.2,367
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,91.3,87.0 to 95.6,345
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,91.4,87.2 to 95.6,182
Polio,≥3 Doses,States/Local Areas,Colorado,2014-2017,Overall,Overall,92.9,90.7 to 95.2,894
Hib,≥3 Doses,States/Local Areas,Colorado,2017,Age,24 Months,94.4,88.9 to 97.7,231
Hib,≥3 Doses,States/Local Areas,Colorado,2017-2018,Age,24 Months,94.1,90.5 to 96.6,527
DTaP,≥3 Doses,States/Local Areas,Colorado,2019,Age,24 Months,95.6,92.3 to 97.8,265
Hib,≥3 Doses,States/Local Areas,Colorado,2016,Age,24 Months,91.6,86.2 to 95.5,247
Hib,≥3 Doses,States/Local Areas,Colorado,2016-2017,Age,24 Months,93.0,89.4 to 95.7,478
Hib,≥3 Doses,States/Local Areas,Colorado,2015,Age,24 Months,90.5,85.9 to 94.2,272
Hib,≥3 Doses,States/Local Areas,Colorado,2015-2016,Age,24 Months,91.1,87.7 to 93.9,519
DTaP,≥1 Dose,States/Local Areas,Colorado,2016,Age,3 Months,92.4,85.6 to 96.2,247
DTaP,≥1 Dose,States/Local Areas,Colorado,2016-2017,Age,3 Months,91.9,87.3 to 95.0,478
DTaP,≥1 Dose,States/Local Areas,Colorado,2015,Age,3 Months,88.8,83.5 to 92.5,272
DTaP,≥1 Dose,States/Local Areas,Colorado,2015-2016,Age,3 Months,90.6,86.7 to 93.5,519
DTaP,≥1 Dose,States/Local Areas,Colorado,2014,Age,3 Months,91.2,85.1 to 94.9,232
DTaP,≥1 Dose,States/Local Areas,Colorado,2014-2015,Age,3 Months,90.0,86.3 to 92.8,504
DTaP,≥1 Dose,States/Local Areas,Colorado,2013,Age,3 Months,87.0,84.2 to 89.4,250
DTaP,≥1 Dose,States/Local Areas,Colorado,2013-2014,Age,3 Months,89.1,87.7 to 90.4,482
DTaP,≥1 Dose,States/Local Areas,Colorado,2012,Age,3 Months,89.3,85.9 to 92.0,297
DTaP,≥1 Dose,States/Local Areas,Colorado,2011,Age,3 Months,87.9,83.0 to 91.6,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.5,69.3 to 79.6,610
Hib,≥1 Dose,States/Local Areas,Colorado,2021,Age,3 Months,74.8,64.6 to 82.8,171
≥1 Dose MMR,,States/Local Areas,Colorado,2021,Age,35 Months,83.4,74.5 to 90.5,171
Combined 7 Series,,States/Local Areas,Colorado,2011,Age,35 Months,71.7,63.7 to 79.2,277
PCV,≥3 Doses,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,85.0 to 100.0,96
Hib,Primary Series,States/Local Areas,Colorado,2019-2020,Age,7 Months,79.2,74.7 to 83.1,576
Hep B,≥2 Doses,States/Local Areas,Colorado,2019-2020,Age,7 Months,93.6,90.8 to 95.7,576
Hib,Full Series,States/Local Areas,Colorado,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,70.1 to 93.7,96
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,Hispanic,78.8,72.0 to 85.6,203
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Any Medicaid,66.9,59.8 to 74.0,268
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Private Insurance Only,75.9,70.5 to 81.4,564
Combined 7 Series,,States/Local Areas,Colorado,2019,Age,35 Months,80.2,72.8 to 86.6,265
Combined 7 Series,,States/Local Areas,Colorado,2018,Age,35 Months,71.6,63.4 to 79.4,296
Combined 7 Series,,States/Local Areas,Colorado,2018-2019,Age,35 Months,75.8,70.2 to 81.1,561
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Insurance Coverage,Other,79.5,65.7 to 93.4,39
Hib,Full Series,States/Local Areas,Colorado,2013,Age,19 Months,77.7,71.5 to 82.9,250
Hib,Full Series,States/Local Areas,Colorado,2013-2014,Age,19 Months,78.0,74.0 to 81.6,482
Hib,Full Series,States/Local Areas,Colorado,2012,Age,19 Months,73.4,65.3 to 80.3,297
Hib,Full Series,States/Local Areas,Colorado,2011,Age,19 Months,77.7,73.1 to 81.6,277
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Poverty,>400% FPL,81.0,75.0 to 86.9,367
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Poverty,133% to <400% FPL,70.1,63.4 to 76.8,345
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Overall,Overall,71.9,67.7 to 76.1,894
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a Non-MSA,62.8,49.4 to 76.2,87
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Poverty,<133% FPL,65.0,56.4 to 73.6,182
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.9,64.6 to 79.3,303
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Urbanicity,Living In a MSA Principal City,73.3,67.8 to 78.7,504
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.0,63.3 to 74.7,570
Combined 7 Series,,States/Local Areas,Colorado,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.8,55.5 to 82.1,96
Hib,Full Series,States/Local Areas,Colorado,2016,Age,19 Months,77.2,68.8 to 83.8,247
Hib,Full Series,States/Local Areas,Colorado,2016-2017,Age,19 Months,78.5,72.6 to 83.4,478
Hib,Full Series,States/Local Areas,Colorado,2014,Age,24 Months,80.9,74.0 to 87.0,232
Hib,Full Series,States/Local Areas,Colorado,2014-2015,Age,24 Months,82.7,78.2 to 86.7,504
Hib,Full Series,States/Local Areas,Colorado,2013,Age,24 Months,84.8,78.7 to 89.9,250
Hib,Full Series,States/Local Areas,Colorado,2013-2014,Age,24 Months,82.7,78.1 to 86.8,482
Hib,Full Series,States/Local Areas,Colorado,2012,Age,24 Months,81.0,74.5 to 86.7,297
Hib,Full Series,States/Local Areas,Colorado,2011,Age,24 Months,82.8,76.4 to 88.3,277
Hib,Primary Series,States/Local Areas,Colorado,2013,Age,24 Months,93.1,88.6 to 96.2,250
Hib,Primary Series,States/Local Areas,Colorado,2013-2014,Age,24 Months,93.5,90.2 to 96.0,482
Hib,Primary Series,States/Local Areas,Colorado,2012,Age,24 Months,92.5,87.6 to 96.0,297
Hib,Primary Series,States/Local Areas,Colorado,2011,Age,24 Months,90.9,85.7 to 94.7,277
Hib,Primary Series,States/Local Areas,Colorado,2017,Age,7 Months,83.4,75.9 to 88.9,231
Hib,Primary Series,States/Local Areas,Colorado,2017-2018,Age,7 Months,81.7,76.4 to 86.0,527
Hib,Primary Series,States/Local Areas,Colorado,2016,Age,7 Months,73.0,64.2 to 80.3,247
Hib,Primary Series,States/Local Areas,Colorado,2016-2017,Age,7 Months,78.1,72.4 to 82.9,478
Hib,Primary Series,States/Local Areas,Colorado,2018,Age,7 Months,79.9,72.0 to 86.1,296
Hib,Primary Series,States/Local Areas,Colorado,2018-2019,Age,7 Months,80.6,75.4 to 84.9,561
Hib,Primary Series,States/Local Areas,Colorado,2014,Age,13 Months,90.9,84.7 to 94.7,232
Hib,Primary Series,States/Local Areas,Colorado,2014-2015,Age,13 Months,89.8,85.8 to 92.7,504
Hib,Primary Series,States/Local Areas,Colorado,2013,Age,13 Months,91.2,85.7 to 94.8,250
Hib,Primary Series,States/Local Areas,Colorado,2013-2014,Age,13 Months,91.1,87.4 to 93.7,482
Hib,Primary Series,States/Local Areas,Colorado,2012,Age,13 Months,88.9,83.9 to 92.4,297
Hib,Primary Series,States/Local Areas,Colorado,2011,Age,13 Months,89.1,85.1 to 92.1,277
Hib,Primary Series,States/Local Areas,Colorado,2019,Age,7 Months,81.2,74.5 to 86.5,265
Hib,Primary Series,States/Local Areas,Colorado,2015,Age,13 Months,88.6,83.2 to 92.5,272
Hib,Primary Series,States/Local Areas,Colorado,2015-2016,Age,13 Months,88.8,84.6 to 92.0,519
Hib,Primary Series,States/Local Areas,Colorado,2015,Age,7 Months,77.2,70.1 to 83.1,272
Hib,Primary Series,States/Local Areas,Colorado,2015-2016,Age,7 Months,75.1,69.5 to 80.0,519
Hib,Primary Series,States/Local Areas,Colorado,2014,Age,7 Months,80.7,73.1 to 86.6,232
Hib,Primary Series,States/Local Areas,Colorado,2014-2015,Age,7 Months,79.0,73.9 to 83.3,504
Hib,Primary Series,States/Local Areas,Colorado,2013,Age,7 Months,71.1,65.2 to 76.3,250
Hib,Primary Series,States/Local Areas,Colorado,2013-2014,Age,7 Months,75.9,72.8 to 78.7,482
Hib,Full Series,States/Local Areas,Colorado,2018,Age,19 Months,77.5,69.3 to 84.0,296
Hib,Full Series,States/Local Areas,Colorado,2018-2019,Age,19 Months,95.0,92.1 to 96.9,561
Hib,Full Series,States/Local Areas,Colorado,2017,Age,19 Months,79.9,71.1 to 86.5,231
Hib,Full Series,States/Local Areas,Colorado,2017-2018,Age,19 Months,78.7,72.9 to 83.6,527
Hib,Full Series,States/Local Areas,Colorado,2015,Age,19 Months,77.8,76.3 to 79.2,272
Hib,Full Series,States/Local Areas,Colorado,2015-2016,Age,19 Months,77.5,72.1 to 82.1,519
Hib,Full Series,States/Local Areas,Colorado,2014,Age,19 Months,78.4,70.9 to 84.3,232
Hib,Full Series,States/Local Areas,Colorado,2014-2015,Age,19 Months,78.1,73.0 to 82.5,504
Hib,Primary Series,States/Local Areas,Colorado,2017,Age,35 Months,94.7,89.3 to 97.9,231
Hib,Primary Series,States/Local Areas,Colorado,2017-2018,Age,35 Months,95.4,92.1 to 97.6,527
Hib,Primary Series,States/Local Areas,Colorado,2014,Age,19 Months,93.5,87.4 to 96.7,232
Hib,Primary Series,States/Local Areas,Colorado,2014-2015,Age,19 Months,91.7,87.9 to 94.4,504
Hib,Primary Series,States/Local Areas,Colorado,2013,Age,19 Months,92.7,87.2 to 96.0,250
Hib,Primary Series,States/Local Areas,Colorado,2013-2014,Age,19 Months,93.1,89.8 to 95.4,482
Hib,Primary Series,States/Local Areas,Colorado,2012,Age,19 Months,92.4,85.8 to 96.1,297
Hib,Primary Series,States/Local Areas,Colorado,2016,Age,24 Months,94.1,89.8 to 97.0,247
Hib,Primary Series,States/Local Areas,Colorado,2016-2017,Age,24 Months,94.4,91.1 to 96.7,478
Hib,Primary Series,States/Local Areas,Colorado,2015,Age,24 Months,90.6,85.9 to 94.2,272
Hib,Primary Series,States/Local Areas,Colorado,2015-2016,Age,24 Months,92.4,89.3 to 94.8,519
Hib,Primary Series,States/Local Areas,Colorado,2014,Age,24 Months,94.0,88.7 to 97.3,232
Hib,Primary Series,States/Local Areas,Colorado,2014-2015,Age,24 Months,92.3,88.8 to 95.0,504
Hib,Primary Series,States/Local Areas,Colorado,2018,Age,24 Months,96.1,91.6 to 98.5,296
Hib,Primary Series,States/Local Areas,Colorado,2018-2019,Age,24 Months,95.4,92.8 to 97.3,561
Hib,Primary Series,States/Local Areas,Colorado,2017,Age,24 Months,94.7,89.3 to 97.9,231
Hib,Primary Series,States/Local Areas,Colorado,2017-2018,Age,24 Months,95.4,92.1 to 97.6,527
Hib,Primary Series,States/Local Areas,Colorado,2016,Age,13 Months,89.0,81.9 to 93.5,247
Hib,Primary Series,States/Local Areas,Colorado,2016-2017,Age,13 Months,91.3,86.9 to 94.3,478
DTaP,≥3 Doses,States/Local Areas,Colorado,2020,Age,13 Months,90.1,85.2 to 93.5,311
Hib,Primary Series,States/Local Areas,Colorado,2011,Age,19 Months,89.4,85.8 to 92.2,277
Hib,Primary Series,States/Local Areas,Colorado,2019,Age,13 Months,89.3,84.1 to 93.0,265
Hib,Primary Series,States/Local Areas,Colorado,2017,Age,19 Months,94.7,88.4 to 97.6,231
Hib,Primary Series,States/Local Areas,Colorado,2017-2018,Age,19 Months,95.1,91.5 to 97.2,527
Hib,Primary Series,States/Local Areas,Colorado,2016,Age,19 Months,93.8,89.0 to 96.6,247
Hib,Primary Series,States/Local Areas,Colorado,2016-2017,Age,19 Months,94.2,90.7 to 96.5,478
Hib,Primary Series,States/Local Areas,Colorado,2018,Age,19 Months,95.6,90.6 to 98.0,296
Hib,Primary Series,States/Local Areas,Colorado,2018-2019,Age,19 Months,89.6,85.6 to 92.7,561
Hib,Primary Series,States/Local Areas,Colorado,2019,Age,19 Months,94.4,90.5 to 96.8,265
Hib,Primary Series,States/Local Areas,Colorado,2015,Age,19 Months,90.0,87.0 to 92.4,272
Hib,Primary Series,States/Local Areas,Colorado,2015-2016,Age,19 Months,91.9,88.6 to 94.3,519
Hib,Primary Series,HHS Regions/National,Region 7,2019-2020,Age,7 Months,75.7,73.1 to 78.1,2549
Hep B,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,93.5,92.0 to 94.8,2549
Rotavirus,,HHS Regions/National,Region 7,2011,Age,8 Months,71.9,67.4 to 75.9,912
Rotavirus,,HHS Regions/National,Region 7,2012,Age,8 Months,75.3,71.2 to 79.1,977
Rotavirus,,HHS Regions/National,Region 7,2013,Age,8 Months,72.4,68.0 to 76.4,929
Rotavirus,,HHS Regions/National,Region 7,2013-2014,Age,8 Months,73.3,70.4 to 76.0,1906
Rotavirus,,HHS Regions/National,Region 7,2015,Age,8 Months,75.0,70.6 to 78.8,891
Rotavirus,,HHS Regions/National,Region 7,2015-2016,Age,8 Months,75.0,72.1 to 77.8,1851
Rotavirus,,HHS Regions/National,Region 7,2016,Age,8 Months,75.1,70.9 to 78.9,960
Rotavirus,,HHS Regions/National,Region 7,2016-2017,Age,8 Months,74.4,71.7 to 77.0,2192
Rotavirus,,HHS Regions/National,Region 7,2014,Age,8 Months,74.2,70.3 to 77.8,977
Rotavirus,,HHS Regions/National,Region 7,2014-2015,Age,8 Months,74.6,71.7 to 77.3,1868
Rotavirus,,HHS Regions/National,Region 7,2018,Age,8 Months,80.4,77.0 to 83.5,1345
Rotavirus,,HHS Regions/National,Region 7,2018-2019,Age,8 Months,77.4,74.9 to 79.8,2614
Rotavirus,,HHS Regions/National,Region 7,2017,Age,8 Months,73.7,70.1 to 77.0,1232
Rotavirus,,HHS Regions/National,Region 7,2017-2018,Age,8 Months,77.0,74.6 to 79.3,2577
Rotavirus,,HHS Regions/National,Region 7,2019,Age,8 Months,74.3,70.5 to 77.9,1269
Hib,Full Series,HHS Regions/National,Region 7,2011,Age,19 Months,70.9,67.7 to 73.9,912
Hib,Full Series,HHS Regions/National,Region 7,2012,Age,19 Months,75.8,72.1 to 79.1,977
Hib,Full Series,HHS Regions/National,Region 7,2013,Age,19 Months,75.9,71.2 to 80.0,929
Hib,Full Series,HHS Regions/National,Region 7,2013-2014,Age,19 Months,75.5,72.1 to 78.6,1906
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,91.2,88.7 to 93.3,1280
Combined 7 Series,,HHS Regions/National,Region 7,2015,Age,35 Months,79.1,73.9 to 83.8,891
Combined 7 Series,,HHS Regions/National,Region 7,2015-2016,Age,35 Months,74.8,71.5 to 78.0,1851
Hib,Full Series,HHS Regions/National,Region 7,2019,Age,19 Months,73.0,69.2 to 76.4,1269
Hib,Full Series,HHS Regions/National,Region 7,2018,Age,19 Months,76.7,73.3 to 79.9,1345
Hib,Full Series,HHS Regions/National,Region 7,2018-2019,Age,19 Months,95.3,94.0 to 96.4,2614
Hib,Full Series,HHS Regions/National,Region 7,2017,Age,19 Months,74.8,71.2 to 78.0,1232
Hib,Full Series,HHS Regions/National,Region 7,2017-2018,Age,19 Months,75.7,73.3 to 78.1,2577
Combined 7 Series,,HHS Regions/National,Region 7,2018,Age,35 Months,78.9,75.2 to 82.4,1345
Combined 7 Series,,HHS Regions/National,Region 7,2018-2019,Age,35 Months,76.8,74.1 to 79.4,2614
Combined 7 Series,,HHS Regions/National,Region 7,2019,Age,35 Months,74.6,70.6 to 78.4,1269
Hib,Primary Series,HHS Regions/National,Region 7,2017,Age,13 Months,89.0,86.2 to 91.3,1232
Hib,Primary Series,HHS Regions/National,Region 7,2017-2018,Age,13 Months,88.3,86.3 to 90.0,2577
Hib,Primary Series,HHS Regions/National,Region 7,2018,Age,13 Months,87.5,84.6 to 90.0,1345
Hib,Primary Series,HHS Regions/National,Region 7,2018-2019,Age,13 Months,86.4,84.2 to 88.3,2614
Hib,Primary Series,HHS Regions/National,Region 7,2011,Age,19 Months,91.4,88.3 to 93.7,912
Hib,Primary Series,HHS Regions/National,Region 7,2013,Age,19 Months,92.6,90.2 to 94.5,929
Hib,Primary Series,HHS Regions/National,Region 7,2013-2014,Age,19 Months,92.4,90.5 to 93.9,1906
Hib,Primary Series,HHS Regions/National,Region 7,2014,Age,19 Months,92.2,89.8 to 94.1,977
Hib,Primary Series,HHS Regions/National,Region 7,2014-2015,Age,19 Months,92.2,90.3 to 93.7,1868
Hib,Primary Series,HHS Regions/National,Region 7,2015,Age,19 Months,92.1,89.9 to 93.9,891
Hib,Primary Series,HHS Regions/National,Region 7,2015-2016,Age,19 Months,91.7,89.7 to 93.3,1851
Hib,Primary Series,HHS Regions/National,Region 7,2017,Age,19 Months,91.9,89.4 to 93.8,1232
Hib,Primary Series,HHS Regions/National,Region 7,2017-2018,Age,19 Months,92.6,90.9 to 94.0,2577
Hib,Primary Series,HHS Regions/National,Region 7,2019,Age,19 Months,91.6,88.8 to 93.8,1269
Hib,Primary Series,HHS Regions/National,Region 7,2012,Age,19 Months,93.5,91.0 to 95.3,977
Hib,Primary Series,HHS Regions/National,Region 7,2016,Age,19 Months,91.2,88.4 to 93.4,960
Hib,Primary Series,HHS Regions/National,Region 7,2016-2017,Age,19 Months,91.5,89.7 to 93.1,2192
Hib,Primary Series,HHS Regions/National,Region 7,2011,Age,24 Months,93.0,90.1 to 95.3,912
Hib,Primary Series,HHS Regions/National,Region 7,2012,Age,24 Months,94.5,92.2 to 96.3,977
Hib,Full Series,HHS Regions/National,Region 7,2013,Age,24 Months,80.6,76.5 to 84.4,929
Hib,Full Series,HHS Regions/National,Region 7,2013-2014,Age,24 Months,80.6,77.9 to 83.1,1906
Hib,Full Series,HHS Regions/National,Region 7,2014,Age,24 Months,80.5,76.9 to 83.9,977
Hib,Full Series,HHS Regions/National,Region 7,2014-2015,Age,24 Months,80.2,77.6 to 82.8,1868
Hib,Full Series,HHS Regions/National,Region 7,2016,Age,19 Months,71.4,67.0 to 75.6,960
Hib,Full Series,HHS Regions/National,Region 7,2016-2017,Age,19 Months,73.1,70.2 to 75.7,2192
Hib,Full Series,HHS Regions/National,Region 7,2015,Age,19 Months,75.6,72.6 to 78.4,891
Hib,Full Series,HHS Regions/National,Region 7,2015-2016,Age,19 Months,73.6,70.5 to 76.4,1851
Hib,Full Series,HHS Regions/National,Region 7,2014,Age,19 Months,75.1,71.1 to 78.7,977
Hib,Full Series,HHS Regions/National,Region 7,2014-2015,Age,19 Months,75.4,72.5 to 78.0,1868
Hib,Full Series,HHS Regions/National,Region 7,2012,Age,24 Months,83.5,79.9 to 86.8,977
Hib,Full Series,HHS Regions/National,Region 7,2011,Age,24 Months,77.4,73.0 to 81.5,912
Combined 7 Series,,HHS Regions/National,Region 7,2019,Age,24 Months,69.4,65.6 to 73.2,1269
Hep A,≥1 Dose,HHS Regions/National,Region 7,2012,Age,19 Months,80.0,76.8 to 82.9,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,91.1,88.3 to 93.5,1269
Hib,Primary Series,HHS Regions/National,Region 7,2020-2021,Age,24 Months,92.8,91.1 to 94.3,2168
Hib,Primary Series,HHS Regions/National,Region 7,2021,Age,19 Months,91.8,88.8 to 94.0,888
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,89.7,87.8 to 91.3,2168
Hib,Full Series,HHS Regions/National,Region 7,2021,Age,19 Months,70.6,66.0 to 74.8,888
Hib,≥2 Doses,HHS Regions/National,Region 7,2021,Age,5 Months,76.7,72.4 to 80.6,888
DTaP,≥1 Dose,HHS Regions/National,Region 7,2016,Age,3 Months,88.4,85.4 to 90.8,960
DTaP,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,3 Months,88.4,86.4 to 90.2,2192
DTaP,≥1 Dose,HHS Regions/National,Region 7,2015,Age,3 Months,86.9,83.1 to 89.9,891
DTaP,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,3 Months,87.6,85.2 to 89.7,1851
DTaP,≥1 Dose,HHS Regions/National,Region 7,2014,Age,3 Months,87.4,84.3 to 90.0,977
DTaP,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,3 Months,87.2,84.8 to 89.2,1868
DTaP,≥1 Dose,HHS Regions/National,Region 7,2013,Age,3 Months,86.3,82.1 to 89.6,929
DTaP,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,3 Months,86.9,83.6 to 89.6,1906
DTaP,≥1 Dose,HHS Regions/National,Region 7,2011,Age,3 Months,89.5,87.3 to 91.4,912
DTaP,≥1 Dose,HHS Regions/National,Region 7,2012,Age,3 Months,90.1,87.2 to 92.4,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,92.4,89.2 to 94.9,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,93.3,90.5 to 95.6,977
Hib,Primary Series,HHS Regions/National,Region 7,2017,Age,35 Months,93.8,91.6 to 95.6,1232
Hib,Primary Series,HHS Regions/National,Region 7,2017-2018,Age,35 Months,94.3,92.6 to 95.6,2577
Combined 7 Series,,HHS Regions/National,Region 7,2016,Age,24 Months,66.5,62.0 to 71.0,960
Combined 7 Series,,HHS Regions/National,Region 7,2016-2017,Age,24 Months,69.4,66.5 to 72.3,2192
Hib,Primary Series,HHS Regions/National,Region 7,2019,Age,35 Months,93.0,90.4 to 95.1,1269
Hib,≥3 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,88.2,84.9 to 91.1,960
Hib,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,88.8,86.7 to 90.7,2192
Hib,≥3 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,88.5,85.0 to 91.5,891
Hib,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,88.4,86.0 to 90.5,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,92.9,90.5 to 94.8,1232
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,93.7,92.2 to 95.1,2577
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,94.6,92.4 to 96.3,1345
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,92.9,91.2 to 94.4,2614
DTaP,≥2 Doses,HHS Regions/National,Region 7,2016,Age,5 Months,79.7,75.8 to 83.2,960
DTaP,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,5 Months,79.0,76.4 to 81.4,2192
DTaP,≥2 Doses,HHS Regions/National,Region 7,2018,Age,5 Months,85.0,81.8 to 87.8,1345
DTaP,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,5 Months,84.0,81.7 to 86.1,2614
DTaP,≥2 Doses,HHS Regions/National,Region 7,2017,Age,5 Months,78.3,74.8 to 81.4,1232
DTaP,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,5 Months,81.6,79.3 to 83.8,2577
Hep A,≥1 Dose,HHS Regions/National,Region 7,2013,Age,19 Months,78.0,71.0 to 83.8,929
Hep A,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,19 Months,77.7,73.4 to 81.5,1906
Hep A,≥1 Dose,HHS Regions/National,Region 7,2015,Age,19 Months,77.5,71.2 to 82.8,891
Hep A,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,19 Months,78.3,75.4 to 81.0,1851
Hep A,≥1 Dose,HHS Regions/National,Region 7,2014,Age,19 Months,77.4,73.6 to 80.7,977
Hep A,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,19 Months,77.4,74.7 to 80.0,1868
Hep A,≥1 Dose,HHS Regions/National,Region 7,2011,Age,19 Months,74.7,69.9 to 79.0,912
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,92.0,89.3 to 94.3,960
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,92.4,90.7 to 94.0,2192
DTaP,≥1 Dose,HHS Regions/National,Region 7,2019,Age,3 Months,91.3,88.6 to 93.4,1269
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,94.4,92.4 to 96.1,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,93.5,91.8 to 95.0,1868
DTaP,≥1 Dose,HHS Regions/National,Region 7,2017,Age,3 Months,88.4,85.6 to 90.7,1232
DTaP,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,3 Months,89.6,87.7 to 91.2,2577
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,92.5,89.6 to 94.9,891
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,92.3,90.3 to 94.0,1851
DTaP,≥1 Dose,HHS Regions/National,Region 7,2018,Age,3 Months,90.7,88.0 to 92.9,1345
DTaP,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,3 Months,91.0,89.1 to 92.5,2614
Hep A,≥1 Dose,HHS Regions/National,Region 7,2013,Age,24 Months,82.1,78.2 to 85.8,929
Hep A,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,24 Months,82.2,79.6 to 84.6,1906
Hep A,≥1 Dose,HHS Regions/National,Region 7,2011,Age,24 Months,78.5,74.3 to 82.5,912
Hep A,≥1 Dose,HHS Regions/National,Region 7,2019,Age,19 Months,84.1,80.8 to 86.9,1269
Hep A,≥1 Dose,HHS Regions/National,Region 7,2012,Age,24 Months,84.0,80.8 to 86.9,977
Hep A,≥1 Dose,HHS Regions/National,Region 7,2016,Age,19 Months,79.2,75.0 to 82.8,960
Hep A,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,19 Months,80.8,78.2 to 83.2,2192
Hep A,≥1 Dose,HHS Regions/National,Region 7,2017,Age,19 Months,82.5,79.3 to 85.3,1232
Hep A,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,19 Months,84.2,82.0 to 86.1,2577
Hep A,≥1 Dose,HHS Regions/National,Region 7,2018,Age,19 Months,85.9,82.9 to 88.4,1345
Hep A,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,19 Months,85.0,82.4 to 87.3,2113
DTaP,≥3 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,95.3,92.6 to 97.2,912
DTaP,≥3 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,95.8,93.3 to 97.5,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,95.4,92.6 to 97.4,929
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,95.6,94.0 to 96.9,1906
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,95.8,93.8 to 97.3,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,96.1,93.8 to 97.7,1868
Hep A,≥2 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,21.3,16.7 to 26.9,912
DTaP,≥2 Doses,HHS Regions/National,Region 7,2019,Age,5 Months,83.0,79.5 to 85.9,1269
Hep A,≥2 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,23.5,17.4 to 31.0,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,26.2,18.9 to 35.0,929
Hep A,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,27.1,22.2 to 32.6,1906
Hib,≥3 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,92.1,89.7 to 94.2,1345
Hib,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,90.7,88.8 to 92.3,2614
Hib,≥3 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,89.3,86.6 to 91.7,1232
Hib,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,90.7,88.9 to 92.4,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,89.2,86.3 to 91.7,1269
Hib,≥3 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,94.2,91.7 to 96.1,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,91.8,89.6 to 93.7,1868
Hib,≥3 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,94.5,91.8 to 96.5,929
Hib,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,94.3,92.5 to 95.8,1906
Hep A,≥2 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,29.9,26.3 to 33.9,960
Hep A,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,28.6,26.2 to 31.1,2192
Hep A,≥2 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,29.5,23.9 to 35.7,891
Hep A,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,29.7,27.0 to 32.5,1851
Hib,≥3 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,89.1,85.6 to 92.1,891
Hib,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,89.7,87.3 to 91.8,1851
PCV,≥2 Doses,HHS Regions/National,Region 7,2014,Age,5 Months,74.0,70.0 to 77.7,977
PCV,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,5 Months,74.5,69.9 to 78.7,1868
Hep A,≥1 Dose,HHS Regions/National,Region 7,2016,Age,24 Months,83.2,79.4 to 86.7,960
Hep A,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,24 Months,84.9,82.6 to 87.1,2192
Hep A,≥1 Dose,HHS Regions/National,Region 7,2015,Age,24 Months,81.8,78.0 to 85.3,891
Hep A,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,24 Months,82.5,79.8 to 85.0,1851
Hep A,≥1 Dose,HHS Regions/National,Region 7,2014,Age,24 Months,82.2,78.8 to 85.4,977
Hep A,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,24 Months,82.0,79.5 to 84.4,1868
PCV,≥2 Doses,HHS Regions/National,Region 7,2016,Age,5 Months,77.6,73.5 to 81.3,960
PCV,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,5 Months,77.5,74.8 to 80.0,2192
PCV,≥2 Doses,HHS Regions/National,Region 7,2015,Age,5 Months,75.0,70.7 to 78.9,891
PCV,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,5 Months,76.3,73.3 to 79.1,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,96.0,93.7 to 97.6,1345
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,94.4,92.6 to 95.9,2614
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,92.6,89.9 to 94.9,1269
Hep A,≥1 Dose,HHS Regions/National,Region 7,2018,Age,24 Months,89.4,86.8 to 91.8,1345
Hep A,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,24 Months,88.5,86.5 to 90.3,2614
Hep A,≥1 Dose,HHS Regions/National,Region 7,2011,Age,35 Months,88.1,84.0 to 91.6,912
Hep A,≥1 Dose,HHS Regions/National,Region 7,2019,Age,24 Months,87.5,84.5 to 90.2,1269
Hep A,≥1 Dose,HHS Regions/National,Region 7,2017,Age,24 Months,86.6,83.8 to 89.2,1232
Hep A,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,24 Months,88.0,86.1 to 89.8,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,94.6,92.0 to 96.6,1345
Hib,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,92.3,90.4 to 94.0,2614
Hep A,≥2 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,27.2,24.2 to 30.4,1232
Hep A,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,29.4,27.1 to 31.9,2577
DTaP,≥4 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,70.4,66.0 to 74.3,891
DTaP,≥4 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,69.7,66.5 to 72.7,1851
DTaP,≥4 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,69.7,65.5 to 73.6,977
DTaP,≥4 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,70.0,67.0 to 72.9,1868
DTaP,≥4 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,69.7,63.0 to 75.7,929
DTaP,≥4 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,69.7,65.7 to 73.4,1906
Hib,≥3 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,90.5,87.7 to 92.9,1232
Hib,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,92.5,90.6 to 94.1,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,90.2,87.1 to 92.8,960
Hib,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,90.4,88.3 to 92.2,2192
Hep A,≥2 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,31.7,28.3 to 35.4,1345
Hep A,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,33.0,30.1 to 36.0,2113
Hep A,≥2 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,37.5,33.1 to 42.3,912
Hep A,≥2 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,33.3,29.9 to 36.9,1269
Hib,≥3 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,92.2,89.9 to 94.1,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,90.4,88.3 to 92.2,1868
Hep A,≥2 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,27.9,24.4 to 31.7,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,28.7,26.1 to 31.5,1868
DTaP,≥4 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,66.5,62.3 to 70.4,912
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,94.9,92.4 to 96.7,1232
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,95.4,93.8 to 96.7,2577
Combined 7 Series,,HHS Regions/National,Region 7,2017,Age,24 Months,72.4,68.8 to 75.8,1232
Combined 7 Series,,HHS Regions/National,Region 7,2017-2018,Age,24 Months,72.6,70.1 to 75.1,2577
Combined 7 Series,,HHS Regions/National,Region 7,2018,Age,24 Months,72.9,69.3 to 76.4,1345
Combined 7 Series,,HHS Regions/National,Region 7,2018-2019,Age,24 Months,71.2,68.5 to 73.8,2614
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,93.4,90.7 to 95.5,960
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,94.1,92.3 to 95.6,2192
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,97.2,92.2 to 99.4,891
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,94.3,92.2 to 96.0,1851
PCV,≥2 Doses,HHS Regions/National,Region 7,2011,Age,5 Months,75.0,71.6 to 78.2,912
PCV,≥2 Doses,HHS Regions/National,Region 7,2012,Age,5 Months,76.4,72.4 to 80.1,977
PCV,≥2 Doses,HHS Regions/National,Region 7,2013,Age,5 Months,77.4,73.7 to 80.7,929
PCV,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,5 Months,75.7,72.3 to 78.8,1906
DTaP,≥4 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,70.4,65.2 to 75.1,977
Combined 7 Series,,HHS Regions/National,Region 7,2014,Age,24 Months,69.9,65.9 to 73.8,977
Combined 7 Series,,HHS Regions/National,Region 7,2014-2015,Age,24 Months,71.1,68.2 to 73.9,1868
Combined 7 Series,,HHS Regions/National,Region 7,2015,Age,24 Months,72.3,68.1 to 76.4,891
Combined 7 Series,,HHS Regions/National,Region 7,2015-2016,Age,24 Months,69.5,66.3 to 72.5,1851
Hib,Primary Series,HHS Regions/National,Region 7,2018,Age,35 Months,94.9,92.3 to 96.8,1345
Hib,Primary Series,HHS Regions/National,Region 7,2018-2019,Age,35 Months,93.9,92.1 to 95.4,2614
Combined 7 Series,,HHS Regions/National,Region 7,2011,Age,35 Months,75.1,69.8 to 80.1,912
Combined 7 Series,,HHS Regions/National,Region 7,2012,Age,35 Months,78.3,73.8 to 82.4,977
Combined 7 Series,,HHS Regions/National,Region 7,2014,Age,35 Months,76.1,72.0 to 80.1,977
Combined 7 Series,,HHS Regions/National,Region 7,2014-2015,Age,35 Months,77.5,74.3 to 80.5,1868
Hib,Primary Series,HHS Regions/National,Region 7,2016,Age,35 Months,92.0,89.4 to 94.2,960
Hib,Primary Series,HHS Regions/National,Region 7,2016-2017,Age,35 Months,92.9,91.2 to 94.3,2192
Hib,Primary Series,HHS Regions/National,Region 7,2015,Age,35 Months,95.2,91.6 to 97.7,891
Hib,Primary Series,HHS Regions/National,Region 7,2015-2016,Age,35 Months,93.1,91.2 to 94.6,1851
Combined 7 Series,,HHS Regions/National,Region 7,2013,Age,35 Months,73.8,69.0 to 78.4,929
Combined 7 Series,,HHS Regions/National,Region 7,2013-2014,Age,35 Months,75.0,71.8 to 78.0,1906
Combined 7 Series,,HHS Regions/National,Region 7,2016,Age,35 Months,71.0,66.4 to 75.5,960
Combined 7 Series,,HHS Regions/National,Region 7,2016-2017,Age,35 Months,74.7,71.7 to 77.6,2192
Combined 7 Series,,HHS Regions/National,Region 7,2017,Age,35 Months,78.7,75.0 to 82.2,1232
Combined 7 Series,,HHS Regions/National,Region 7,2017-2018,Age,35 Months,78.9,76.2 to 81.4,2577
Combined 7 Series,,HHS Regions/National,Region 7,2011,Age,24 Months,66.5,61.8 to 71.1,912
Combined 7 Series,,HHS Regions/National,Region 7,2012,Age,24 Months,71.3,66.9 to 75.5,977
Hib,Primary Series,HHS Regions/National,Region 7,2019,Age,7 Months,74.9,71.1 to 78.3,1269
Hib,Primary Series,HHS Regions/National,Region 7,2013,Age,7 Months,69.6,63.4 to 75.2,929
Hib,Primary Series,HHS Regions/National,Region 7,2013-2014,Age,7 Months,71.3,66.6 to 75.6,1906
Hib,Primary Series,HHS Regions/National,Region 7,2013,Age,35 Months,95.4,92.9 to 97.3,929
Hib,Primary Series,HHS Regions/National,Region 7,2013-2014,Age,35 Months,94.8,93.1 to 96.1,1906
Hib,Primary Series,HHS Regions/National,Region 7,2011,Age,35 Months,94.0,91.2 to 96.2,912
Hib,Primary Series,HHS Regions/National,Region 7,2019,Age,24 Months,92.0,89.4 to 94.2,1269
Hib,Primary Series,HHS Regions/National,Region 7,2012,Age,35 Months,95.4,93.2 to 97.0,977
Hib,Primary Series,HHS Regions/National,Region 7,2014,Age,35 Months,94.2,91.9 to 96.0,977
Hib,Primary Series,HHS Regions/National,Region 7,2014-2015,Age,35 Months,94.5,92.7 to 96.0,1868
Hib,Primary Series,HHS Regions/National,Region 7,2013,Age,24 Months,93.7,91.0 to 95.9,929
Hib,Primary Series,HHS Regions/National,Region 7,2013-2014,Age,24 Months,93.5,91.8 to 95.0,1906
Combined 7 Series,,HHS Regions/National,Region 7,2013,Age,24 Months,67.2,62.6 to 71.8,929
Combined 7 Series,,HHS Regions/National,Region 7,2013-2014,Age,24 Months,68.6,65.5 to 71.6,1906
Hib,Primary Series,HHS Regions/National,Region 7,2015,Age,24 Months,93.5,90.9 to 95.6,891
Hib,Primary Series,HHS Regions/National,Region 7,2015-2016,Age,24 Months,92.7,90.9 to 94.3,1851
Hib,Primary Series,HHS Regions/National,Region 7,2014,Age,24 Months,93.4,91.2 to 95.2,977
Hib,Primary Series,HHS Regions/National,Region 7,2014-2015,Age,24 Months,93.4,91.8 to 94.9,1868
Hib,Primary Series,HHS Regions/National,Region 7,2018,Age,24 Months,93.7,91.4 to 95.6,1345
Hib,Primary Series,HHS Regions/National,Region 7,2018-2019,Age,24 Months,92.9,91.1 to 94.4,2614
Hib,Primary Series,HHS Regions/National,Region 7,2016,Age,24 Months,91.9,89.3 to 94.1,960
Hib,Primary Series,HHS Regions/National,Region 7,2016-2017,Age,24 Months,92.5,90.8 to 94.0,2192
Hib,Primary Series,HHS Regions/National,Region 7,2017,Age,24 Months,93.2,90.9 to 95.1,1232
Hib,Primary Series,HHS Regions/National,Region 7,2017-2018,Age,24 Months,93.4,91.9 to 94.8,2577
Hib,Primary Series,HHS Regions/National,Region 7,2018,Age,7 Months,77.5,73.9 to 80.7,1345
Hib,Primary Series,HHS Regions/National,Region 7,2018-2019,Age,7 Months,76.2,73.6 to 78.6,2614
Hib,Primary Series,HHS Regions/National,Region 7,2011,Age,13 Months,88.4,85.0 to 91.2,912
Hib,Primary Series,HHS Regions/National,Region 7,2012,Age,13 Months,90.1,87.8 to 92.0,977
Hib,Primary Series,HHS Regions/National,Region 7,2013,Age,13 Months,86.8,82.7 to 90.0,929
Hib,Primary Series,HHS Regions/National,Region 7,2013-2014,Age,13 Months,88.2,85.4 to 90.4,1906
Hib,Primary Series,HHS Regions/National,Region 7,2015,Age,13 Months,88.7,85.4 to 91.4,891
Hib,Primary Series,HHS Regions/National,Region 7,2015-2016,Age,13 Months,88.1,85.7 to 90.1,1851
Hib,Primary Series,HHS Regions/National,Region 7,2014,Age,13 Months,89.5,86.7 to 91.8,977
Hib,Primary Series,HHS Regions/National,Region 7,2014-2015,Age,13 Months,89.1,87.0 to 90.9,1868
Hib,Primary Series,HHS Regions/National,Region 7,2017,Age,7 Months,74.8,71.3 to 78.1,1232
Hib,Primary Series,HHS Regions/National,Region 7,2017-2018,Age,7 Months,76.2,73.7 to 78.5,2577
Hib,Primary Series,HHS Regions/National,Region 7,2016,Age,7 Months,74.0,69.6 to 77.9,960
Hib,Primary Series,HHS Regions/National,Region 7,2016-2017,Age,7 Months,74.4,71.6 to 77.0,2192
Hib,Primary Series,HHS Regions/National,Region 7,2016,Age,13 Months,87.4,83.8 to 90.3,960
Hib,Primary Series,HHS Regions/National,Region 7,2016-2017,Age,13 Months,88.2,86.0 to 90.1,2192
Hib,Primary Series,HHS Regions/National,Region 7,2019,Age,13 Months,85.2,82.0 to 88.0,1269
Hib,Primary Series,HHS Regions/National,Region 7,2018,Age,19 Months,93.3,90.9 to 95.2,1345
Hib,Primary Series,HHS Regions/National,Region 7,2018-2019,Age,19 Months,86.4,84.2 to 88.3,2614
Hib,Primary Series,HHS Regions/National,Region 7,2015,Age,7 Months,74.1,69.9 to 77.9,891
Hib,Primary Series,HHS Regions/National,Region 7,2015-2016,Age,7 Months,74.0,71.0 to 76.8,1851
Hib,Primary Series,HHS Regions/National,Region 7,2014,Age,7 Months,73.0,68.8 to 76.7,977
Hib,Primary Series,HHS Regions/National,Region 7,2014-2015,Age,7 Months,73.5,70.6 to 76.2,1868
DTaP,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,3 Months,90.3,88.5 to 91.9,2549
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,72.6,70.0 to 75.0,2549
Polio,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,91.4,89.5 to 92.9,2549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2019-2020,Age,0-3 Days,83.2,81.0 to 85.2,2549
DTaP,≥4 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,72.7,70.1 to 75.3,2549
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,91.8,90.0 to 93.3,2549
Polio,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,94.0,92.2 to 95.5,2549
DTaP,≥4 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,88.1,85.6 to 90.3,2549
Combined 7 Series,,HHS Regions/National,Region 7,2019-2020,Age,24 Months,68.4,65.6 to 71.1,2549
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,93.9,92.1 to 95.4,2549
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019-2020,Age,13 Months,58.7,55.9 to 61.4,2549
PCV,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,89.0,86.9 to 90.7,2549
Hep B,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,94.6,93.1 to 95.7,2549
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,90.1,88.3 to 91.7,2549
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,74.4,71.7 to 77.0,2549
Polio,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,90.3,88.4 to 91.9,2549
PCV,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,5 Months,80.9,78.4 to 83.2,2549
Hep B,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,5 Months,92.0,90.4 to 93.4,2549
Hib,Primary Series,HHS Regions/National,Region 7,2019-2020,Age,13 Months,86.0,83.8 to 87.9,2549
Hib,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,5 Months,78.1,75.6 to 80.5,2549
Hib,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,64.9,62.2 to 67.6,2549
Hib,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,93.2,91.6 to 94.5,2549
≥1 Dose MMR,,HHS Regions/National,Region 7,2019-2020,Age,13 Months,65.2,62.4 to 67.9,2549
Polio,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,93.5,91.9 to 94.8,2549
Polio,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,5 Months,82.1,79.7 to 84.3,2549
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,13 Months,90.0,88.0 to 91.6,2549
DTaP,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,5 Months,82.4,80.0 to 84.6,2549
PCV,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,3 Months,89.0,87.1 to 90.6,2549
Hep B,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,3 Months,96.0,94.8 to 96.9,2549
≥1 Dose MMR,,HHS Regions/National,Region 7,2019-2020,Age,24 Months,89.9,88.0 to 91.7,2549
DTaP,≥4 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,81.0,78.5 to 83.3,2549
Polio,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,92.0,90.2 to 93.5,2549
PCV,≥4 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,84.8,82.4 to 87.0,2549
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,92.3,90.6 to 93.9,2549
PCV,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,93.2,91.5 to 94.7,2549
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019-2020,Age,35 Months,93.7,91.8 to 95.2,2549
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,94.1,92.4 to 95.6,2549
Hib,Full Series,HHS Regions/National,Region 7,2019-2020,Age,35 Months,80.6,78.1 to 83.0,2549
Hib,Primary Series,HHS Regions/National,Region 7,2019-2020,Age,35 Months,93.4,91.8 to 94.9,2549
Hib,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,91.7,89.8 to 93.4,2549
≥1 Dose MMR,,HHS Regions/National,Region 7,2019-2020,Age,35 Months,93.8,92.0 to 95.3,2549
Hib,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,87.3,85.1 to 89.2,2549
Hib,Primary Series,HHS Regions/National,Region 7,2019-2020,Age,19 Months,92.1,90.4 to 93.6,2549
≥1 Dose MMR,,HHS Regions/National,Region 7,2019-2020,Age,19 Months,88.3,86.3 to 90.1,2549
Hep A,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,31.7,29.2 to 34.2,2549
PCV,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,92.2,90.4 to 93.7,2549
PCV,≥4 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,82.9,80.5 to 85.1,2549
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019-2020,Age,24 Months,89.8,87.9 to 91.6,2549
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,92.8,91.1 to 94.2,2549
Hib,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,45.4,42.6 to 48.1,2549
PCV,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,72.3,69.6 to 74.9,2549
Hib,Full Series,HHS Regions/National,Region 7,2019-2020,Age,24 Months,77.7,75.2 to 80.1,2549
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2019-2020,Age,0-1 Days,79.2,76.7 to 81.4,2549
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2019-2020,Age,0-2 Days,82.2,79.9 to 84.3,2549
Hep A,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,19 Months,84.9,82.7 to 87.0,2549
PCV,≥4 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,80.5,78.1 to 82.8,2549
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,92.0,90.2 to 93.5,2549
PCV,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,19 Months,91.5,89.6 to 93.1,2549
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019-2020,Age,19 Months,87.8,85.7 to 89.6,2549
Combined 7 Series,,HHS Regions/National,Region 7,2019-2020,Age,35 Months,73.2,70.4 to 76.0,2549
Hib,Full Series,HHS Regions/National,Region 7,2019-2020,Age,19 Months,72.9,70.2 to 75.4,2549
Hib,Primary Series,HHS Regions/National,Region 7,2019-2020,Age,24 Months,92.7,91.0 to 94.2,2549
Hib,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,7 Months,89.7,87.7 to 91.4,2549
Influenza,,HHS Regions/National,Region 7,2019-2020,Age,24 Months,59.2,56.4 to 62.0,2549
Hib,≥3 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,89.5,87.5 to 91.3,2549
Hep A,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,24 Months,50.4,47.5 to 53.3,2549
Hep A,≥2 Doses,HHS Regions/National,Region 7,2019-2020,Age,35 Months,79.6,76.3 to 82.7,2549
Hep A,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,35 Months,90.1,87.9 to 92.0,2549
Hep A,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,24 Months,87.7,85.6 to 89.7,2549
Combined 7 Series,,HHS Regions/National,Region 7,2020,Age,35 Months,72.4,68.4 to 76.3,1280
Hep A,≥2 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,80.1,75.5 to 84.3,1280
≥1 Dose MMR,,HHS Regions/National,Region 7,2020,Age,13 Months,66.2,62.3 to 70.0,1280
Hep A,≥2 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,30.3,27.0 to 33.8,1280
Hep A,≥1 Dose,HHS Regions/National,Region 7,2020,Age,19 Months,86.0,82.8 to 88.7,1280
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2020,Age,0-2 Days,84.3,81.3 to 86.9,1280
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2020,Age,0-1 Days,82.0,78.8 to 84.7,1280
Polio,≥2 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,90.5,87.9 to 92.6,1280
Hib,≥2 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,90.1,87.5 to 92.2,1280
Hib,≥3 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,46.3,42.5 to 50.2,1280
Hib,Primary Series,HHS Regions/National,Region 7,2020,Age,7 Months,76.7,73.2 to 79.9,1280
Hep B,≥2 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,93.9,92.0 to 95.4,1280
PCV,≥2 Doses,HHS Regions/National,Region 7,2020,Age,5 Months,81.3,77.8 to 84.4,1280
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,93.5,91.3 to 95.3,1280
DTaP,≥4 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,80.3,76.8 to 83.6,1280
Polio,≥3 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,93.2,91.0 to 95.0,1280
Hib,≥3 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,89.8,87.0 to 92.3,1280
≥1 Dose MMR,,HHS Regions/National,Region 7,2020,Age,24 Months,90.9,88.4 to 93.1,1280
Hib,≥3 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,93.4,90.9 to 95.5,1280
≥1 Dose MMR,,HHS Regions/National,Region 7,2020,Age,35 Months,94.3,91.7 to 96.3,1280
Hib,Full Series,HHS Regions/National,Region 7,2020,Age,35 Months,81.1,77.5 to 84.5,1280
Hib,Primary Series,HHS Regions/National,Region 7,2020,Age,35 Months,93.8,91.6 to 95.6,1280
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020,Age,35 Months,94.3,91.8 to 96.3,1280
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,94.8,92.7 to 96.4,1280
Hib,Primary Series,HHS Regions/National,Region 7,2020,Age,19 Months,92.7,90.3 to 94.5,1280
Hib,Full Series,HHS Regions/National,Region 7,2020,Age,19 Months,72.9,69.2 to 76.3,1280
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,93.1,90.9 to 94.8,1280
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020,Age,19 Months,88.7,85.8 to 91.0,1280
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,95.1,92.9 to 96.8,1280
PCV,≥4 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,80.4,76.9 to 83.5,1280
PCV,≥3 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,92.5,90.1 to 94.4,1280
Polio,≥3 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,95.0,92.7 to 96.8,1280
DTaP,≥4 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,89.3,85.9 to 92.1,1280
Hib,≥2 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,93.5,91.4 to 95.1,1280
PCV,≥3 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,94.4,92.2 to 96.2,1280
Hib,Primary Series,HHS Regions/National,Region 7,2020,Age,13 Months,86.8,84.0 to 89.2,1280
Hib,≥3 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,67.3,63.5 to 70.9,1280
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,91.5,89.2 to 93.3,1280
Hep B,≥2 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,95.1,93.3 to 96.4,1280
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020,Age,13 Months,60.6,56.6 to 64.4,1280
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,76.7,73.0 to 80.1,1280
PCV,≥3 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,90.5,87.9 to 92.6,1280
DTaP,≥4 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,73.5,69.7 to 76.9,1280
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,92.6,90.2 to 94.5,1280
≥1 Dose MMR,,HHS Regions/National,Region 7,2020,Age,19 Months,89.4,86.7 to 91.7,1280
Polio,≥3 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,92.2,89.8 to 94.1,1280
Hib,≥3 Doses,HHS Regions/National,Region 7,2020,Age,19 Months,87.9,84.8 to 90.4,1280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2020,Age,0-3 Days,84.7,81.7 to 87.2,1280
Influenza,,HHS Regions/National,Region 7,2020,Age,24 Months,59.0,55.1 to 63.0,1280
Combined 7 Series,,HHS Regions/National,Region 7,2020,Age,24 Months,67.8,63.9 to 71.6,1280
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020,Age,24 Months,90.7,88.1 to 92.9,1280
Rotavirus,,HHS Regions/National,Region 7,2020,Age,8 Months,79.1,75.7 to 82.2,1280
PCV,≥3 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,93.3,91.1 to 95.1,1280
Hep A,≥1 Dose,HHS Regions/National,Region 7,2020,Age,24 Months,88.1,85.1 to 90.8,1280
PCV,≥4 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,83.0,79.7 to 86.1,1280
Hep A,≥2 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,48.7,44.8 to 52.8,1280
Hep B,≥1 Dose,HHS Regions/National,Region 7,2020,Age,3 Months,96.2,94.7 to 97.3,1280
DTaP,≥2 Doses,HHS Regions/National,Region 7,2020,Age,5 Months,82.1,78.6 to 85.2,1280
PCV,≥1 Dose,HHS Regions/National,Region 7,2020,Age,3 Months,88.9,86.3 to 91.1,1280
Polio,≥2 Doses,HHS Regions/National,Region 7,2020,Age,5 Months,81.7,78.1 to 84.7,1280
Hep B,≥2 Doses,HHS Regions/National,Region 7,2020,Age,5 Months,92.6,90.6 to 94.3,1280
Hib,≥2 Doses,HHS Regions/National,Region 7,2020,Age,5 Months,77.7,74.0 to 80.9,1280
Polio,≥1 Dose,HHS Regions/National,Region 7,2020,Age,3 Months,89.2,86.6 to 91.4,1280
DTaP,≥1 Dose,HHS Regions/National,Region 7,2020,Age,3 Months,89.5,86.9 to 91.6,1280
Hib,≥1 Dose,HHS Regions/National,Region 7,2020,Age,3 Months,85.2,82.3 to 87.6,1280
Rotavirus,,HHS Regions/National,Region 7,2019-2020,Age,8 Months,76.4,73.8 to 78.8,2549
Hib,≥1 Dose,HHS Regions/National,Region 7,2021,Age,3 Months,83.7,80.0 to 86.9,888
Combined 7 Series,,HHS Regions/National,Region 7,2021,Age,35 Months,74.4,68.6 to 79.9,888
Hib,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,89.9,87.8 to 91.8,2168
Polio,≥2 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,91.3,88.4 to 93.6,888
Hib,Primary Series,HHS Regions/National,Region 7,2021,Age,7 Months,75.8,71.6 to 79.6,888
Hep B,≥3 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,90.6,87.6 to 93.0,888
PCV,≥4 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,83.6,81.1 to 86.0,2168
DTaP,≥4 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,88.5,85.6 to 91.1,2168
DTaP,≥3 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,74.0,69.5 to 78.0,888
Polio,≥3 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,91.9,89.1 to 94.2,888
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,92.1,90.2 to 93.6,2168
Hep B,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,94.5,93.0 to 95.7,2168
Hep B,≥2 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,92.5,89.8 to 94.6,888
≥1 Dose MMR,,HHS Regions/National,Region 7,2021,Age,35 Months,94.7,90.4 to 97.4,888
Hib,≥2 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,90.3,87.2 to 92.8,888
Hib,≥3 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,44.6,40.0 to 49.2,888
PCV,≥3 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,75.1,71.3 to 78.5,1280
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020,Age,7 Months,73.8,70.3 to 77.0,1280
DTaP,≥4 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,80.6,77.9 to 83.2,2168
PCV,≥3 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,91.8,88.9 to 94.2,888
Hib,≥3 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,88.0,84.5 to 90.8,888
Hep B,≥2 Doses,HHS Regions/National,Region 7,2021,Age,5 Months,89.9,86.9 to 92.3,888
PCV,≥2 Doses,HHS Regions/National,Region 7,2021,Age,5 Months,79.9,75.6 to 83.6,888
Polio,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,3 Months,89.7,87.9 to 91.3,2549
Hib,≥1 Dose,HHS Regions/National,Region 7,2019-2020,Age,3 Months,86.2,84.2 to 88.0,2549
Hep A,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,35 Months,91.5,89.0 to 93.7,2168
Hib,Primary Series,States/Local Areas,Mississippi,2011,Age,7 Months,63.5,57.6 to 69.1,198
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,90.4,86.4 to 94.3,222
Hib,Primary Series,States/Local Areas,Mississippi,2012,Age,7 Months,72.1,66.4 to 77.3,230
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,62.1,46.0 to 78.1,87
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.4,61.4 to 87.3,77
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,75.2 to 83.3,597
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,79.5,72.0 to 87.1,195
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.9,70.8 to 82.9,334
Polio,≥3 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,95.5,89.7 to 98.6,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,95.7,90.9 to 98.4,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,92.0,85.4 to 95.8,307
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,91.9,87.9 to 94.7,628
DTaP,≥3 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,91.7,84.8 to 96.2,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,89.2,78.4 to 94.9,272
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,90.6,86.5 to 93.5,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,91.2,85.2 to 94.9,239
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,90.2,86.3 to 93.1,511
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Overall,Overall,76.7,73.3 to 80.1,1007
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,75.4,70.5 to 80.2,478
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,73.3,68.1 to 78.6,393
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,75.1,69.2 to 80.9,392
Hib,≥3 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,83.1,74.1 to 89.5,272
Hib,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,84.0,79.5 to 87.7,579
Polio,≥3 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,91.8,85.6 to 96.1,217
Polio,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,92.0,88.0 to 95.0,456
Hib,≥3 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,83.4,79.1 to 87.0,217
Hib,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,84.6,81.9 to 87.0,456
Hib,≥3 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,85.8,79.2 to 90.5,239
Hib,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,84.5,80.1 to 88.0,511
Polio,≥3 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,95.6,90.8 to 98.3,230
Polio,≥3 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,90.2,83.2 to 95.2,198
Polio,≥3 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,91.7,85.6 to 95.4,324
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,91.9,86.4 to 95.3,321
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,92.5,89.0 to 94.9,597
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,93.1,88.0 to 96.2,276
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,89.6,85.5 to 92.6,600
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,92.0,85.9 to 95.6,324
Polio,≥3 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,92.2,86.9 to 96.0,239
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,90.9,87.3 to 93.8,511
Polio,≥3 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,89.5,84.3 to 93.5,272
Polio,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,92.2,89.2 to 94.6,579
Hib,Full Series,States/Local Areas,Mississippi,2015,Age,24 Months,74.5,67.8 to 80.7,272
Hib,Full Series,States/Local Areas,Mississippi,2015-2016,Age,24 Months,75.4,70.6 to 79.9,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,91.4,85.2 to 95.8,217
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,91.9,87.9 to 95.0,456
Hib,≥3 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,89.0,83.0 to 93.1,276
Hib,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,58.8,53.3 to 64.1,600
Hib,≥3 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,84.9,77.8 to 90.0,307
Hib,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,85.2,80.8 to 88.8,628
Polio,≥3 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,94.7,91.0 to 97.2,307
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,94.3,91.7 to 96.4,628
Hib,≥3 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,85.5,79.5 to 90.0,321
Hib,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,87.3,83.2 to 90.5,597
Polio,≥3 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,92.2,87.4 to 95.7,276
Polio,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,93.7,90.3 to 96.1,600
Polio,≥3 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,94.0,89.7 to 96.9,321
Polio,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,93.2,90.1 to 95.6,597
Hib,≥3 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,85.7,79.0 to 90.5,324
Polio,≥3 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,92.9,87.9 to 96.3,324
Polio,≥3 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,92.2,87.4 to 95.7,276
Polio,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,92.6,89.2 to 95.2,600
Hib,Full Series,States/Local Areas,Mississippi,2017,Age,24 Months,82.6,76.5 to 87.8,321
Hib,Full Series,States/Local Areas,Mississippi,2017-2018,Age,24 Months,80.0,75.4 to 84.3,597
Hib,Full Series,States/Local Areas,Mississippi,2018,Age,24 Months,77.3,70.2 to 83.8,276
Hib,Full Series,States/Local Areas,Mississippi,2018-2019,Age,24 Months,78.7,73.9 to 83.1,600
Hib,Full Series,States/Local Areas,Mississippi,2016,Age,24 Months,76.3,69.2 to 82.8,307
Hib,Full Series,States/Local Areas,Mississippi,2016-2017,Age,24 Months,79.4,74.8 to 83.7,628
Hib,≥3 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,87.9,81.9 to 92.6,239
Hib,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,87.7,83.8 to 91.0,511
Hib,≥3 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,90.6,83.5 to 95.5,198
Hib,≥3 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,92.4,86.5 to 96.4,230
Hib,≥3 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,85.5,78.6 to 91.1,217
Hib,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,86.7,82.3 to 90.6,456
Hib,Full Series,States/Local Areas,Mississippi,2017,Age,35 Months,83.5,77.4 to 88.7,321
Hib,Full Series,States/Local Areas,Mississippi,2017-2018,Age,35 Months,83.3,78.6 to 87.4,597
Polio,≥3 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,94.4,89.8 to 97.4,324
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,93.1,90.5 to 95.8,441
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,93.2,90.6 to 95.9,519
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,89.1,79.8 to 98.5,32
Hib,Full Series,States/Local Areas,Mississippi,2016,Age,35 Months,81.0,73.4 to 87.4,307
Hib,Full Series,States/Local Areas,Mississippi,2016-2017,Age,35 Months,82.2,77.4 to 86.5,628
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,81.6,77.0 to 86.2,441
Polio,≥3 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,96.6,91.6 to 99.0,230
Hib,Full Series,States/Local Areas,Mississippi,2019,Age,35 Months,83.7,77.5 to 89.0,324
Hib,Full Series,States/Local Areas,Mississippi,2018,Age,35 Months,83.1,75.9 to 89.2,276
Hib,Full Series,States/Local Areas,Mississippi,2018-2019,Age,35 Months,83.5,78.8 to 87.7,600
Hib,Full Series,States/Local Areas,Mississippi,2015,Age,35 Months,76.3,69.6 to 82.4,272
Hib,Full Series,States/Local Areas,Mississippi,2015-2016,Age,35 Months,78.6,73.6 to 83.1,579
Hib,Full Series,States/Local Areas,Mississippi,2014,Age,35 Months,81.5,74.4 to 87.6,239
Hib,Full Series,States/Local Areas,Mississippi,2014-2015,Age,35 Months,78.8,74.0 to 83.2,511
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,75.2,70.5 to 79.9,519
Hib,Full Series,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.6,70.5 to 82.6,246
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,85.0,75.4 to 94.6,87
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,84.9 to 100.0,77
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,93.0 to 96.9,597
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.7 to 98.1,195
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.4 to 96.7,334
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.0,88.2 to 95.7,246
Hib,Full Series,States/Local Areas,Mississippi,2012,Age,35 Months,86.9,78.8 to 93.1,230
Hib,Full Series,States/Local Areas,Mississippi,2011,Age,35 Months,82.1,73.4 to 89.3,198
Hib,Full Series,States/Local Areas,Mississippi,2013,Age,35 Months,74.6,66.0 to 82.4,217
Hib,Full Series,States/Local Areas,Mississippi,2013-2014,Age,35 Months,78.0,72.4 to 83.1,456
Hib,Full Series,States/Local Areas,Mississippi,2019,Age,24 Months,79.9,73.3 to 85.8,324
DTaP,≥2 Doses,States/Local Areas,Mississippi,2011,Age,5 Months,76.1,71.4 to 80.3,198
DTaP,≥2 Doses,States/Local Areas,Mississippi,2012,Age,5 Months,76.0,69.8 to 81.3,230
DTaP,≥2 Doses,States/Local Areas,Mississippi,2013,Age,5 Months,80.7,74.5 to 85.7,217
DTaP,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,5 Months,80.7,77.7 to 83.4,456
Polio,≥3 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,91.8,85.6 to 96.1,217
Polio,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,92.0,88.0 to 95.0,456
Polio,≥3 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,92.2,86.9 to 96.0,239
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,90.9,87.3 to 93.8,511
DTaP,≥2 Doses,States/Local Areas,Mississippi,2015,Age,5 Months,76.2,69.4 to 82.0,272
DTaP,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,5 Months,76.8,71.6 to 81.2,579
DTaP,≥2 Doses,States/Local Areas,Mississippi,2016,Age,5 Months,77.3,69.6 to 83.5,307
DTaP,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,5 Months,75.7,70.3 to 80.4,628
DTaP,≥2 Doses,States/Local Areas,Mississippi,2014,Age,5 Months,80.8,73.4 to 86.5,239
DTaP,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,5 Months,78.5,75.7 to 81.1,511
Polio,≥3 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,94.9,91.3 to 97.4,307
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,94.9,92.2 to 96.9,628
Polio,≥3 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,94.8,90.2 to 97.6,321
Polio,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,93.7,90.6 to 96.1,597
Polio,≥3 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,89.5,84.3 to 93.5,272
Polio,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,92.3,89.3 to 94.7,579
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,75.3,68.8 to 81.8,222
Hep A,≥1 Dose,States/Local Areas,Mississippi,2020,Age,35 Months,76.6,67.5 to 84.7,308
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020,Age,24 Months,87.5,80.2 to 93.1,308
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014,Age,35 Months,70.2,62.5 to 77.6,239
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,35 Months,72.7,67.4 to 77.8,511
Hep A,≥1 Dose,States/Local Areas,Mississippi,2013,Age,35 Months,71.7,63.2 to 79.7,217
Hep A,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,35 Months,71.0,65.4 to 76.4,456
Hib,≥3 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,94.9,90.7 to 97.7,324
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,35.6,28.3 to 44.2,239
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,31.5,26.6 to 37.0,511
Hep A,≥2 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,27.2,21.3 to 34.5,272
Hep A,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,28.8,24.3 to 34.0,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,94.3,92.6 to 96.0,1007
Hep A,≥2 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,33.5,25.2 to 43.8,217
Hep A,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,34.5,28.7 to 41.2,456
DTaP,≥4 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,70.7,63.2 to 77.3,276
DTaP,≥4 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,93.8,90.4 to 96.0,600
DTaP,≥4 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,71.7,64.0 to 78.3,321
DTaP,≥4 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,71.2,65.9 to 76.0,597
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,70.3,62.8 to 76.9,307
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,71.0,65.8 to 75.8,628
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.3,90.0 to 96.5,246
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,91.0,83.6 to 98.4,87
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,81.4 to 98.7,77
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,91.7 to 98.4,334
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,93.9,91.4 to 96.4,478
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.0,94.3 to 97.7,597
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.7 to 98.1,195
PCV,≥2 Doses,States/Local Areas,Mississippi,2019,Age,5 Months,78.0,70.5 to 84.0,324
PCV,≥2 Doses,States/Local Areas,Mississippi,2018,Age,5 Months,76.1,68.6 to 82.3,276
PCV,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,5 Months,77.1,71.9 to 81.5,600
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013,Age,13 Months,65.1,57.2 to 72.3,217
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013-2014,Age,13 Months,62.8,58.7 to 66.7,456
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.1,62.4 to 75.9,246
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,62.3,42.0 to 82.5,32
Polio,≥2 Doses,States/Local Areas,Mississippi,2018,Age,5 Months,76.7,69.2 to 82.8,276
Polio,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,5 Months,77.8,72.6 to 82.2,600
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,72.9,68.1 to 77.7,441
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,71.6,66.7 to 76.5,519
Hep A,≥1 Dose,States/Local Areas,Mississippi,2019,Age,35 Months,70.8,61.8 to 79.3,324
≥1 Dose Varicella,,States/Local Areas,Mississippi,2012,Age,13 Months,58.5,50.2 to 66.4,230
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014,Age,13 Months,60.5,52.1 to 68.3,239
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2015,Age,13 Months,60.3,54.8 to 65.5,511
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,58.8,48.5 to 69.4,239
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,55.1,48.7 to 61.7,511
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,82.1,75.3 to 87.3,324
Hep A,≥2 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,52.4,44.2 to 61.1,272
Hep A,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,52.3,46.3 to 58.6,579
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,51.8,43.3 to 60.8,307
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,55.7,49.5 to 62.0,628
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,77.2,69.6 to 83.3,276
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,79.6,74.7 to 83.8,600
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,72.1,64.7 to 78.5,321
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,74.6,69.4 to 79.2,597
Polio,≥2 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,88.2,85.6 to 90.4,198
Polio,≥2 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,94.6,91.6 to 96.6,230
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,76.1,65.1 to 87.1,87
Polio,≥2 Doses,States/Local Areas,Mississippi,2019,Age,5 Months,78.9,71.4 to 84.8,324
DTaP,≥4 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,76.3,67.7 to 84.1,217
DTaP,≥4 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,78.2,72.7 to 83.3,456
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,30.4,24.2 to 37.7,307
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,32.1,27.4 to 37.4,628
Hep A,≥2 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,33.8,27.2 to 41.6,321
Hep A,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,37.3,32.1 to 43.0,597
Hep A,≥2 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,41.1,33.6 to 49.7,276
Hep A,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,35.8,30.6 to 41.6,600
DTaP,≥4 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,78.7,70.6 to 85.9,230
DTaP,≥4 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,81.0,72.5 to 88.2,198
DTaP,≥4 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,72.0,64.1 to 78.7,324
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,80.6,73.0 to 86.5,217
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,80.9,76.8 to 84.3,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,62.8,55.8 to 69.2,198
Hep B,≥3 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,78.8,71.3 to 84.7,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,94.0,91.1 to 96.9,392
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,96.4,93.9 to 98.9,222
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,93.8,91.2 to 96.4,393
Polio,≥2 Doses,States/Local Areas,Mississippi,2014,Age,5 Months,81.6,74.4 to 87.2,239
Polio,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,5 Months,78.9,76.0 to 81.6,511
Polio,≥2 Doses,States/Local Areas,Mississippi,2013,Age,5 Months,80.9,74.9 to 85.7,217
Polio,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,5 Months,81.3,78.7 to 83.6,456
Polio,≥2 Doses,States/Local Areas,Mississippi,2011,Age,5 Months,76.1,71.4 to 80.3,198
Polio,≥2 Doses,States/Local Areas,Mississippi,2012,Age,5 Months,75.4,69.0 to 80.9,230
Hep A,≥1 Dose,States/Local Areas,Mississippi,2015,Age,35 Months,74.7,67.5 to 81.4,272
Hep A,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,35 Months,76.5,71.5 to 81.3,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,84.8,83.0 to 86.5,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,60.0,50.7 to 68.6,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,64.7,53.1 to 74.8,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,70.4,66.7 to 73.9,217
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,71.0,69.6 to 72.2,456
Hib,≥2 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,93.0,87.8 to 96.1,239
Hib,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,92.8,89.5 to 95.0,511
Hib,≥2 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,94.0,87.5 to 97.2,307
Hib,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,93.7,90.0 to 96.1,628
Hib,≥2 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,92.5,87.8 to 95.5,272
Hib,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,93.2,89.7 to 95.6,579
Hib,≥2 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,88.2,82.7 to 92.1,272
Hib,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,88.8,84.5 to 92.0,579
PCV,≥3 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,91.2,85.0 to 95.6,217
PCV,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,92.0,88.0 to 95.0,456
PCV,≥3 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,96.2,90.4 to 99.0,198
PCV,≥3 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,91.8,86.3 to 95.7,324
PCV,≥3 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,95.5,90.6 to 98.2,230
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,81.8,69.7 to 94.0,87
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,82.4 to 98.4,77
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.3,85.8 to 94.7,334
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,93.9,91.5 to 96.3,478
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.4,92.1 to 96.6,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,86.3,79.9 to 90.9,321
Hib,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,88.1,84.0 to 91.3,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,89.4,82.6 to 93.7,307
Hib,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,87.9,83.4 to 91.2,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016,Age,0-3 Days,76.1,69.3 to 81.7,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2017,Age,0-3 Days,75.9,71.2 to 80.0,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2017,Age,0-3 Days,74.4,63.2 to 83.1,189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2017-2018,Age,0-3 Days,78.7,74.0 to 82.8,597
Polio,≥1 Dose,States/Local Areas,Mississippi,2016,Age,3 Months,89.8,84.4 to 93.5,307
Polio,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,3 Months,87.8,83.7 to 90.9,628
Polio,≥1 Dose,States/Local Areas,Mississippi,2015,Age,3 Months,88.3,82.7 to 92.2,272
Polio,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,3 Months,89.0,85.4 to 91.9,579
Polio,≥1 Dose,States/Local Areas,Mississippi,2014,Age,3 Months,89.1,82.3 to 93.4,239
Polio,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,3 Months,88.7,84.5 to 91.8,511
Hib,≥3 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,41.7,37.0 to 46.6,217
Hib,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,40.9,36.7 to 45.3,456
Hib,≥3 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,55.5,45.2 to 65.4,198
Hib,≥3 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,45.5,35.9 to 55.5,230
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,92.4,88.9 to 95.8,392
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,95.3,92.3 to 98.3,222
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,91.3,88.1 to 94.6,393
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2013,Age,0-3 Days,73.1,64.2 to 80.5,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2013-2014,Age,0-3 Days,77.2,71.7 to 82.0,456
Polio,≥1 Dose,States/Local Areas,Mississippi,2013,Age,3 Months,87.6,79.7 to 92.7,217
Polio,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,3 Months,88.3,83.4 to 92.0,456
Polio,≥1 Dose,States/Local Areas,Mississippi,2011,Age,3 Months,86.7,84.0 to 89.1,198
Polio,≥1 Dose,States/Local Areas,Mississippi,2012,Age,3 Months,88.4,80.1 to 93.6,230
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,92.4,90.3 to 94.4,1007
PCV,≥1 Dose,States/Local Areas,Mississippi,2019,Age,3 Months,90.4,84.4 to 94.2,324
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014,Age,0-3 Days,81.4,74.4 to 86.8,239
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2015,Age,0-3 Days,77.5,72.7 to 81.7,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,92.8 to 97.1,597
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,93.5,89.5 to 97.5,195
Hib,≥3 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,37.4,30.2 to 45.1,324
DTaP,≥3 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,91.0,87.2 to 93.8,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,83.5,77.0 to 88.5,272
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,86.1,81.7 to 89.6,579
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,78.9,73.8 to 83.9,393
Hib,≥2 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,95.1,91.2 to 97.3,198
Hib,≥2 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,96.3,94.7 to 97.5,230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,55.4,33.5 to 77.2,32
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,66.2,58.4 to 73.3,321
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,68.0,62.6 to 73.0,597
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,71.6,63.9 to 78.3,324
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,69.9,62.2 to 76.6,276
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,70.8,65.4 to 75.6,600
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,79.0,74.6 to 83.4,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.7,70.6 to 82.8,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,70.6,65.1 to 76.2,441
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2019,Age,0-3 Days,81.8,75.1 to 87.0,324
Polio,≥1 Dose,States/Local Areas,Mississippi,2019,Age,3 Months,91.5,85.8 to 95.1,324
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2018,Age,0-3 Days,81.9,75.1 to 87.1,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2018-2019,Age,0-3 Days,81.8,77.2 to 85.7,600
PCV,≥3 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,91.8,86.3 to 95.7,324
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,94.4,92.1 to 96.7,441
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,94.5,92.1 to 96.9,519
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.0,91.1 to 97.0,246
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,89.1,79.8 to 98.5,32
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,89.3,81.3 to 97.2,87
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,84.8 to 100.0,77
Hib,≥3 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,44.3,36.6 to 52.2,276
Hib,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,40.8,35.5 to 46.3,600
Hib,≥3 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,36.8,30.1 to 44.0,321
Hib,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,40.5,35.4 to 45.9,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,89.9,84.1 to 93.8,276
Hib,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,90.3,86.4 to 93.2,600
PCV,≥3 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,92.8,87.6 to 96.4,239
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,91.8,88.4 to 94.5,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,96.5,93.5 to 98.4,307
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,95.2,92.5 to 97.2,628
PCV,≥3 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,90.7,85.8 to 94.4,272
PCV,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,93.8,91.0 to 96.0,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,87.3,80.0 to 92.1,321
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,87.7,83.2 to 91.2,597
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,88.6,81.9 to 93.1,307
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,87.9,83.3 to 91.5,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,71.8,65.9 to 77.7,392
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,73.9,66.6 to 81.1,222
Hib,≥3 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,67.9,62.7 to 72.7,230
Hib,≥3 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,80.5,77.3 to 83.3,198
Hib,≥3 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,58.7,50.6 to 66.3,239
Hib,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,60.3,54.9 to 65.5,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,94.0,91.1 to 96.8,392
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,96.6,94.2 to 99.0,222
Polio,≥3 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,88.6,86.3 to 90.6,198
Hib,≥3 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,59.3,54.4 to 63.9,217
Hib,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,59.0,54.8 to 63.0,456
Hib,≥3 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,62.0,54.8 to 68.7,272
Hib,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,56.4,51.2 to 61.5,579
Hib,≥3 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,52.4,44.7 to 59.9,321
Hib,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,56.8,51.4 to 62.1,597
Hib,≥3 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,50.8,43.3 to 58.2,307
Hib,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,51.6,46.2 to 56.9,628
DTaP,≥3 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,95.4,93.0 to 97.0,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,91.2,87.6 to 93.8,217
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,91.2,88.7 to 93.2,456
DTaP,≥3 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,90.1,88.0 to 91.8,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,90.9,84.7 to 94.7,324
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,88.3,82.2 to 92.5,276
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,89.6,85.5 to 92.6,600
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,65.0,50.5 to 79.4,87
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.4,77.1 to 93.7,77
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.6,70.0 to 79.2,597
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.9,64.6 to 77.2,334
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,75.8,68.0 to 83.5,195
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Overall,Overall,75.6,72.2 to 79.1,1007
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,79.1,74.3 to 83.8,478
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,89.2,83.0 to 93.3,239
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,86.4,82.1 to 89.7,511
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,88.7,83.5 to 92.4,217
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,88.9,86.3 to 91.1,456
Hib,≥2 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,95.5,90.4 to 97.9,324
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.9,91.5 to 98.3,334
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,94.7,92.5 to 96.8,478
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,94.2,92.5 to 95.9,1007
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,93.6,91.0 to 96.3,393
Hib,≥2 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,93.4,88.3 to 96.4,321
Hib,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,94.2,91.1 to 96.3,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,95.0,90.7 to 97.4,276
Hib,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,95.2,92.3 to 97.1,600
Hib,≥2 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,90.7,84.8 to 94.5,324
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,63.6,55.7 to 70.9,307
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,64.9,59.3 to 70.1,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2015,Age,0-3 Days,73.6,66.7 to 79.5,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2015-2016,Age,0-3 Days,74.8,70.1 to 79.0,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,71.5,63.5 to 78.3,239
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,66.6,61.2 to 71.6,511
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,61.7,54.2 to 68.7,272
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,62.6,57.2 to 67.8,579
Polio,≥1 Dose,States/Local Areas,Mississippi,2018,Age,3 Months,88.9,83.0 to 92.9,276
Polio,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,3 Months,90.2,86.3 to 93.0,600
Polio,≥1 Dose,States/Local Areas,Mississippi,2017,Age,3 Months,85.7,79.2 to 90.4,321
Polio,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,3 Months,87.3,83.0 to 90.5,597
Hib,≥3 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,30.7,24.8 to 37.3,307
Hib,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,33.7,29.1 to 38.6,628
Hib,≥3 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,41.5,34.5 to 48.8,272
Hib,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,36.1,31.3 to 41.1,579
Hib,≥3 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,40.2,32.5 to 48.4,239
Hib,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,40.8,35.6 to 46.3,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,93.8,89.5 to 96.8,276
PCV,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,92.8,89.4 to 95.4,600
PCV,≥3 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,93.7,88.9 to 96.9,321
PCV,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,93.8,90.7 to 96.1,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,91.9,88.4 to 94.4,217
Hib,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,92.5,89.6 to 94.6,456
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.4,65.9 to 89.0,77
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.5,79.7 to 87.3,597
PCV,≥1 Dose,States/Local Areas,Mississippi,2015,Age,3 Months,87.1,81.5 to 91.2,272
PCV,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,3 Months,88.2,84.5 to 91.1,579
PCV,≥1 Dose,States/Local Areas,Mississippi,2014,Age,3 Months,88.9,82.2 to 93.3,239
PCV,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,3 Months,88.0,83.9 to 91.2,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,93.4,89.1 to 96.5,276
PCV,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,92.7,89.3 to 95.3,600
PCV,≥3 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,93.0,88.4 to 96.3,321
PCV,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,93.2,90.2 to 95.6,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,94.6,92.4 to 96.2,230
PCV,≥3 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,96.1,93.2 to 98.1,307
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,94.7,92.0 to 96.7,628
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2011,Age,0-3 Days,80.9,72.0 to 87.4,198
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,93.8,91.3 to 96.3,519
PCV,≥1 Dose,States/Local Areas,Mississippi,2018,Age,3 Months,88.8,82.8 to 92.9,276
PCV,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,3 Months,89.6,85.6 to 92.6,600
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2012,Age,0-3 Days,84.4,77.1 to 89.6,230
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.9,71.8 to 84.0,334
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,74.3,55.0 to 93.6,32
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,79.6,76.3 to 82.9,1007
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,80.0,75.3 to 84.6,478
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,76.0,70.9 to 81.2,393
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,79.3,73.6 to 85.0,392
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,90.9,86.9 to 94.8,222
Hib,≥2 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,88.8,82.5 to 93.1,239
Hib,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,88.5,84.5 to 91.6,511
Hib,≥2 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,86.7,81.0 to 90.9,217
Hib,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,87.8,84.7 to 90.3,456
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,81.4,74.2 to 88.6,195
PCV,≥1 Dose,States/Local Areas,Mississippi,2017,Age,3 Months,86.2,79.6 to 90.8,321
PCV,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,3 Months,87.5,83.2 to 90.8,597
PCV,≥1 Dose,States/Local Areas,Mississippi,2016,Age,3 Months,89.4,83.9 to 93.1,307
PCV,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,3 Months,87.8,83.7 to 90.9,628
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,91.4,88.1 to 94.8,441
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.9,88.3 to 95.5,246
PCV,≥3 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,90.7,85.8 to 94.4,272
PCV,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,93.6,90.8 to 95.8,579
PCV,≥3 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,92.8,87.6 to 96.4,239
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,91.8,88.4 to 94.5,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,91.2,85.0 to 95.6,217
PCV,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,92.0,88.0 to 95.0,456
Hib,≥2 Doses,States/Local Areas,Mississippi,2017,Age,5 Months,74.0,66.1 to 80.7,321
Hib,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,5 Months,76.1,70.9 to 80.7,597
PCV,≥3 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,95.5,90.6 to 98.2,230
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,86.1,82.3 to 90.0,441
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,76.9,72.3 to 81.6,519
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,68.1,48.6 to 87.7,32
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,64.8,48.9 to 80.6,87
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.5,71.5 to 83.5,246
PCV,≥1 Dose,States/Local Areas,Mississippi,2013,Age,3 Months,86.6,80.0 to 91.3,217
PCV,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,3 Months,87.7,83.7 to 90.9,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,88.6 to 97.2,195
Hib,≥2 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,88.2,85.6 to 90.4,198
Hib,≥2 Doses,States/Local Areas,Mississippi,2019,Age,5 Months,77.9,70.5 to 83.8,324
Hib,≥2 Doses,States/Local Areas,Mississippi,2018,Age,5 Months,78.2,70.9 to 84.0,276
Hib,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,5 Months,78.0,73.0 to 82.3,600
Hib,≥2 Doses,States/Local Areas,Mississippi,2016,Age,5 Months,75.8,68.1 to 82.2,307
Hib,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,5 Months,74.9,69.5 to 79.7,628
Hib,≥2 Doses,States/Local Areas,Mississippi,2015,Age,5 Months,75.9,69.1 to 81.6,272
Hib,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,5 Months,75.9,70.7 to 80.4,579
PCV,≥3 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,90.9,84.0 to 95.7,198
PCV,≥3 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,91.3,85.2 to 95.0,324
PCV,≥3 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,93.4,88.6 to 96.3,276
PCV,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,88.0,83.8 to 91.3,600
Hib,≥2 Doses,States/Local Areas,Mississippi,2011,Age,5 Months,76.1,71.4 to 80.3,198
Hib,≥2 Doses,States/Local Areas,Mississippi,2012,Age,5 Months,76.1,69.6 to 81.5,230
Hib,≥2 Doses,States/Local Areas,Mississippi,2014,Age,5 Months,80.8,73.5 to 86.5,239
Hib,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,5 Months,78.4,75.4 to 81.1,511
Hib,≥2 Doses,States/Local Areas,Mississippi,2013,Age,5 Months,78.4,74.6 to 81.8,217
Hib,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,5 Months,79.6,77.9 to 81.2,456
PCV,≥4 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,83.2,76.0 to 89.3,321
PCV,≥4 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,82.9,77.9 to 87.3,597
PCV,≥4 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,86.9,80.5 to 92.0,324
PCV,≥4 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,82.4,75.2 to 88.6,276
PCV,≥4 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,84.6,79.9 to 88.7,600
PCV,≥1 Dose,States/Local Areas,Mississippi,2012,Age,3 Months,88.5,82.2 to 92.8,230
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Overall,Overall,90.2,87.9 to 92.5,1007
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,88.2,84.4 to 92.0,393
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,89.4,86.1 to 92.8,478
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,91.0,87.4 to 94.6,392
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,94.5,91.3 to 97.7,222
PCV,≥1 Dose,States/Local Areas,Mississippi,2011,Age,3 Months,87.4,84.9 to 89.6,198
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.2,86.1 to 94.4,334
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,88.7,85.2 to 92.3,478
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Overall,Overall,90.1,87.8 to 92.4,1007
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,89.1,85.5 to 92.7,393
≥1 Dose MMR,,States/Local Areas,Mississippi,2017,Age,35 Months,92.9,87.9 to 96.4,321
≥1 Dose MMR,,States/Local Areas,Mississippi,2017-2018,Age,35 Months,92.4,89.0 to 95.1,597
≥1 Dose MMR,,States/Local Areas,Mississippi,2018,Age,35 Months,91.4,86.3 to 95.1,276
≥1 Dose MMR,,States/Local Areas,Mississippi,2018-2019,Age,35 Months,93.5,90.3 to 95.9,600
PCV,≥4 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,78.5,70.6 to 85.5,217
PCV,≥4 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,81.1,75.9 to 85.8,456
≥1 Dose MMR,,States/Local Areas,Mississippi,2019,Age,35 Months,95.2,91.0 to 97.8,324
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,80.3 to 97.2,77
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.8 to 94.1,597
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,93.4,89.3 to 97.6,195
PCV,≥3 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,92.2,85.5 to 96.0,307
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,92.6,88.7 to 95.2,628
PCV,≥3 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,88.0,76.8 to 94.2,272
PCV,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,90.1,86.0 to 93.1,579
Hep B,≥2 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,96.1,92.2 to 98.1,324
Hep B,≥2 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,94.4,89.8 to 97.0,276
Hep B,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,95.2,92.5 to 97.0,600
Hep B,≥2 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,93.0,87.8 to 96.1,321
Hep B,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,93.7,90.5 to 95.8,597
Hib,≥1 Dose,States/Local Areas,Mississippi,2017,Age,3 Months,86.1,79.6 to 90.8,321
Hib,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,3 Months,87.9,83.7 to 91.1,597
Hib,≥1 Dose,States/Local Areas,Mississippi,2016,Age,3 Months,89.3,83.9 to 93.1,307
Hib,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,3 Months,87.7,83.7 to 90.9,628
Hib,≥1 Dose,States/Local Areas,Mississippi,2015,Age,3 Months,87.6,82.0 to 91.6,272
Hib,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,3 Months,88.5,84.8 to 91.4,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,93.5,88.3 to 96.9,324
PCV,≥3 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,92.9,87.8 to 96.0,321
PCV,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,93.2,89.9 to 95.4,597
PCV,≥4 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,83.8,77.0 to 89.5,239
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,79.7,74.9 to 84.1,511
PCV,≥4 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,75.8,69.0 to 82.2,272
PCV,≥4 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,80.5,75.5 to 84.9,579
PCV,≥4 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,85.8,78.7 to 91.5,307
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,84.4,79.3 to 88.9,628
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,89.7,86.4 to 93.0,519
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,91.5,88.5 to 94.5,441
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.9,84.5 to 93.3,246
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,83.9,71.9 to 96.0,32
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,82.7,71.2 to 94.2,87
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.3,80.0 to 96.6,77
Hep B,≥2 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,96.7,93.4 to 98.3,307
Hep B,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,94.8,92.0 to 96.7,628
Hep B,≥2 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,93.1,88.2 to 96.1,272
Hep B,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,94.9,92.1 to 96.7,579
Hep B,≥2 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,93.9,88.4 to 96.9,239
Hep B,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,93.5,90.1 to 95.8,511
Hib,≥1 Dose,States/Local Areas,Mississippi,2014,Age,3 Months,89.2,82.5 to 93.5,239
Hib,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,3 Months,88.4,84.3 to 91.5,511
Hib,≥1 Dose,States/Local Areas,Mississippi,2011,Age,3 Months,86.7,84.0 to 89.1,198
Hib,≥1 Dose,States/Local Areas,Mississippi,2012,Age,3 Months,89.4,82.9 to 93.6,230
Hib,≥1 Dose,States/Local Areas,Mississippi,2013,Age,3 Months,87.1,80.0 to 91.9,217
Hib,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,3 Months,88.2,84.2 to 91.2,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,94.3,89.8 to 97.2,321
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,93.1,89.7 to 95.6,597
PCV,≥3 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,95.1,93.1 to 96.5,230
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,91.4,86.1 to 95.3,276
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,92.6,89.0 to 95.3,600
Hib,Full Series,States/Local Areas,Mississippi,2020,Age,24 Months,73.1,65.0 to 80.6,308
PCV,≥4 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,85.7,77.3 to 92.1,230
PCV,≥4 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,85.1,75.8 to 92.2,198
PCV,≥4 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,79.6,72.7 to 85.7,276
PCV,≥4 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,82.4,77.7 to 86.5,600
PCV,≥4 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,85.0,78.6 to 90.4,324
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,96.4,93.4 to 98.3,307
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,95.4,92.8 to 97.2,628
PCV,≥3 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,90.8,85.1 to 94.5,239
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,89.4,85.5 to 92.4,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,90.9,87.2 to 93.7,217
PCV,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,90.9,88.4 to 92.9,456
PCV,≥3 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,90.1,88.0 to 91.8,198
PCV,≥3 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,88.5,82.0 to 92.8,324
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.6,85.3 to 93.8,246
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,83.9,71.9 to 96.0,32
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,90.7,87.4 to 93.9,441
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,90.0,86.8 to 93.2,519
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019,Age,35 Months,95.3,91.3 to 97.8,324
≥1 Dose MMR,,States/Local Areas,Mississippi,2016,Age,35 Months,92.9,87.8 to 96.4,307
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2017,Age,35 Months,93.1,89.6 to 95.8,628
PCV,≥4 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,77.8,73.0 to 82.3,579
PCV,≥4 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,80.8,74.0 to 86.8,307
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,80.8,76.0 to 85.2,628
PCV,≥4 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,80.8,73.8 to 86.9,321
PCV,≥4 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,80.3,75.4 to 84.7,597
≥1 Dose MMR,,States/Local Areas,Mississippi,2015,Age,35 Months,89.1,83.7 to 93.3,272
≥1 Dose MMR,,States/Local Areas,Mississippi,2015-2016,Age,35 Months,91.1,87.5 to 94.0,579
≥1 Dose MMR,,States/Local Areas,Mississippi,2014,Age,35 Months,91.9,86.3 to 95.9,239
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2015,Age,35 Months,90.5,86.8 to 93.5,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,90.0,83.4 to 94.1,307
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,89.2,85.1 to 92.3,628
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,93.4,87.9 to 96.9,217
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,92.2,88.2 to 95.3,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,91.0,84.9 to 95.4,239
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,90.1,86.2 to 93.2,511
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,89.1,83.8 to 93.3,272
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,92.8,89.7 to 95.2,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,97.6,92.5 to 99.5,230
PCV,≥3 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,87.6,81.5 to 91.9,276
PCV,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,88.0,83.8 to 91.3,600
PCV,≥3 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,88.5,82.6 to 92.5,321
PCV,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,88.0,84.0 to 91.1,597
Hep B,≥2 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,95.1,91.9 to 97.1,230
Hep B,≥2 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,94.2,92.8 to 95.3,217
Hep B,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,94.0,92.3 to 95.4,456
Hep B,≥2 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,95.3,91.9 to 97.3,198
Hep B,≥2 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,93.1,87.7 to 96.2,324
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2015,Age,0-2 Days,72.8,65.9 to 78.7,272
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2015-2016,Age,0-2 Days,73.5,68.7 to 77.8,579
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2014,Age,0-2 Days,81.3,74.2 to 86.7,239
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2014-2015,Age,0-2 Days,77.0,72.2 to 81.2,511
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013,Age,35 Months,88.0,81.0 to 93.4,217
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013-2014,Age,35 Months,89.5,85.1 to 93.0,456
≥1 Dose MMR,,States/Local Areas,Mississippi,2018,Age,24 Months,91.4,86.3 to 95.1,276
≥1 Dose MMR,,States/Local Areas,Mississippi,2018-2019,Age,24 Months,92.5,89.1 to 95.1,600
PCV,≥4 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,76.8,69.0 to 83.0,324
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014,Age,35 Months,90.8,85.4 to 94.9,239
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2015,Age,35 Months,90.6,87.1 to 93.5,511
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015,Age,35 Months,90.3,85.4 to 94.2,272
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015-2016,Age,35 Months,91.8,88.4 to 94.6,579
PCV,≥4 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,81.2,72.7 to 88.4,198
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,91.4,86.1 to 95.3,276
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,91.7,88.1 to 94.6,600
PCV,≥3 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,82.7,76.1 to 87.8,272
PCV,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,86.3,82.0 to 89.8,579
PCV,≥3 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,88.6,82.5 to 92.8,239
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,85.7,81.4 to 89.1,511
Hep B,≥2 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,91.0,85.4 to 94.6,321
Hep B,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,91.1,87.4 to 93.8,597
PCV,≥3 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,88.2,84.3 to 91.2,217
PCV,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,88.4,85.9 to 90.5,456
Hep B,≥2 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,95.3,91.5 to 97.4,307
Hep B,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,93.2,90.0 to 95.4,628
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2016,Age,0-2 Days,74.3,67.3 to 80.1,307
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2016-2017,Age,0-2 Days,74.3,69.5 to 78.6,628
Hep B,≥2 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,91.3,85.7 to 94.8,276
Hep B,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,92.2,88.6 to 94.7,600
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2019,Age,0-2 Days,81.7,75.0 to 86.9,324
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2018,Age,0-2 Days,80.9,74.1 to 86.3,276
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2018-2019,Age,0-2 Days,81.3,76.7 to 85.2,600
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2017,Age,0-2 Days,74.4,67.3 to 80.3,321
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2017-2018,Age,0-2 Days,77.6,72.8 to 81.8,597
PCV,≥4 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,78.6,70.6 to 85.7,230
Hep B,≥3 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,92.6,87.6 to 96.2,198
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,92.6,88.0 to 95.9,321
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,92.0,88.6 to 94.7,597
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,92.0,86.6 to 95.8,324
PCV,≥4 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,76.9,69.2 to 84.0,217
PCV,≥4 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,79.0,73.8 to 83.7,456
PCV,≥4 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,81.1,74.3 to 87.0,239
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,78.0,73.2 to 82.4,511
PCV,≥4 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,74.9,68.0 to 81.2,272
≥1 Dose MMR,,States/Local Areas,Mississippi,2019,Age,24 Months,93.4,88.5 to 96.7,324
≥1 Dose MMR,,States/Local Areas,Mississippi,2012,Age,35 Months,94.8,89.1 to 98.1,230
≥1 Dose MMR,,States/Local Areas,Mississippi,2011,Age,35 Months,95.9,90.5 to 98.7,198
≥1 Dose MMR,,States/Local Areas,Mississippi,2013,Age,35 Months,91.1,85.0 to 95.3,217
≥1 Dose MMR,,States/Local Areas,Mississippi,2013-2014,Age,35 Months,91.4,87.4 to 94.5,456
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016,Age,35 Months,93.1,88.2 to 96.5,307
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2017,Age,35 Months,93.8,90.3 to 96.3,628
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2011,Age,0-2 Days,79.1,74.9 to 82.7,198
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2019,Age,0-1 Days,77.1,69.7 to 83.0,324
Hep B,≥2 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,93.5,91.3 to 95.1,217
Hep B,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,92.5,90.7 to 94.0,456
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2012,Age,0-2 Days,82.8,79.5 to 85.7,230
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2013,Age,0-2 Days,72.3,70.4 to 74.1,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2013-2014,Age,0-2 Days,76.8,74.4 to 79.0,456
PCV,≥3 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,85.8,83.5 to 87.8,198
PCV,≥3 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,69.0,61.1 to 75.9,324
PCV,≥3 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,66.8,59.0 to 73.7,276
PCV,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,67.9,62.4 to 72.9,600
Hep B,≥2 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,94.6,92.0 to 96.5,230
Hep B,≥2 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,90.2,84.9 to 93.8,272
Hep B,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,92.7,89.6 to 94.9,579
Hep B,≥2 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,91.6,85.3 to 95.3,239
Hep B,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,90.9,87.1 to 93.7,511
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,90.0,83.8 to 94.5,239
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,89.1,85.2 to 92.3,511
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,88.2,83.0 to 92.4,272
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,92.3,89.3 to 94.7,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,96.4,93.4 to 98.3,307
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,94.5,91.9 to 96.6,628
PCV,≥3 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,89.9,84.7 to 93.5,230
≥1 Dose MMR,,States/Local Areas,Mississippi,2016,Age,24 Months,90.8,85.9 to 94.6,307
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2017,Age,24 Months,90.7,87.4 to 93.5,628
≥1 Dose MMR,,States/Local Areas,Mississippi,2017,Age,24 Months,90.7,85.8 to 94.4,321
≥1 Dose MMR,,States/Local Areas,Mississippi,2017-2018,Age,24 Months,91.2,87.8 to 93.9,597
PCV,≥4 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,76.9,69.4 to 83.0,276
PCV,≥4 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,76.3,70.1 to 81.5,492
PCV,≥4 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,74.7,67.0 to 81.1,321
PCV,≥4 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,75.8,70.6 to 80.3,597
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.3,69.0 to 81.7,246
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,64.7,44.9 to 84.5,32
≥1 Dose MMR,,States/Local Areas,Mississippi,2011,Age,19 Months,87.0,83.7 to 89.7,198
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,82.7,78.2 to 87.3,441
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,75.9,71.2 to 80.7,519
DTaP,≥4 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,88.6,82.2 to 93.4,324
Polio,≥2 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,94.0,88.8 to 96.9,321
Polio,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,93.1,89.7 to 95.5,597
Polio,≥2 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,94.6,87.9 to 97.7,307
Polio,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,94.3,90.5 to 96.7,628
Polio,≥2 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,94.3,90.2 to 96.7,272
Polio,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,94.5,91.0 to 96.7,579
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,67.1,51.6 to 82.6,87
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018,Age,19 Months,87.8,81.5 to 92.1,276
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018-2019,Age,19 Months,66.4,61.0 to 71.5,600
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017,Age,19 Months,83.9,76.5 to 89.2,321
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017-2018,Age,19 Months,85.8,81.1 to 89.5,597
≥1 Dose MMR,,States/Local Areas,Mississippi,2012,Age,19 Months,90.0,85.6 to 93.1,230
≥1 Dose MMR,,States/Local Areas,Mississippi,2014,Age,19 Months,88.7,82.8 to 92.8,239
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2015,Age,19 Months,86.0,81.8 to 89.3,511
≥1 Dose MMR,,States/Local Areas,Mississippi,2013,Age,19 Months,87.0,80.9 to 91.4,217
≥1 Dose MMR,,States/Local Areas,Mississippi,2013-2014,Age,19 Months,87.9,83.9 to 91.0,456
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.8,70.7 to 82.9,334
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,81.5,74.1 to 88.9,195
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,77.8,74.4 to 81.3,1007
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,77.1,72.2 to 82.0,478
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.1,59.7 to 84.5,77
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.3,78.4 to 86.2,597
≥1 Dose Varicella,,States/Local Areas,Mississippi,2012,Age,24 Months,90.6,84.5 to 95.0,230
≥1 Dose Varicella,,States/Local Areas,Mississippi,2011,Age,24 Months,86.3,78.4 to 92.4,198
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,73.4,68.1 to 78.8,393
≥1 Dose MMR,,States/Local Areas,Mississippi,2017,Age,19 Months,85.8,79.6 to 90.3,321
≥1 Dose MMR,,States/Local Areas,Mississippi,2017-2018,Age,19 Months,88.0,84.0 to 91.1,597
≥1 Dose MMR,,States/Local Areas,Mississippi,2016,Age,19 Months,84.2,77.0 to 89.4,307
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2017,Age,19 Months,85.0,80.4 to 88.6,628
≥1 Dose MMR,,States/Local Areas,Mississippi,2015,Age,19 Months,83.1,73.6 to 89.7,272
≥1 Dose MMR,,States/Local Areas,Mississippi,2015-2016,Age,19 Months,83.7,79.0 to 87.5,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,87.8,78.9 to 93.3,272
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,90.9,87.0 to 93.7,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,90.0,83.2 to 94.2,239
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,88.9,84.8 to 92.0,511
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,63.5,53.1 to 73.8,222
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,91.2,86.7 to 94.3,217
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,90.6,89.0 to 92.0,456
Hep B,≥2 Doses,States/Local Areas,Mississippi,2013,Age,5 Months,87.1,84.3 to 89.4,217
Hep B,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,5 Months,88.4,85.4 to 90.8,456
Hep B,≥2 Doses,States/Local Areas,Mississippi,2011,Age,5 Months,88.5,84.0 to 91.9,198
Hep B,≥2 Doses,States/Local Areas,Mississippi,2012,Age,5 Months,90.4,87.4 to 92.8,230
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2011,Age,0-1 Days,76.1,74.2 to 77.8,198
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,57.5,49.5 to 65.6,392
Hep B,≥1 Dose,States/Local Areas,Mississippi,2019,Age,3 Months,97.9,95.9 to 98.9,324
Hep B,≥1 Dose,States/Local Areas,Mississippi,2018,Age,3 Months,96.7,93.7 to 98.3,276
Hep B,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,3 Months,97.3,95.7 to 98.3,600
≥1 Dose Varicella,,States/Local Areas,Mississippi,2012,Age,35 Months,95.1,89.3 to 98.3,230
≥1 Dose Varicella,,States/Local Areas,Mississippi,2011,Age,35 Months,91.4,84.1 to 96.3,198
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019,Age,24 Months,93.7,89.0 to 96.9,324
≥1 Dose MMR,,States/Local Areas,Mississippi,2013,Age,24 Months,90.3,84.4 to 94.6,217
≥1 Dose MMR,,States/Local Areas,Mississippi,2013-2014,Age,24 Months,90.3,86.4 to 93.4,456
≥1 Dose MMR,,States/Local Areas,Mississippi,2014,Age,24 Months,90.2,84.8 to 94.3,239
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2015,Age,24 Months,89.3,85.6 to 92.4,511
≥1 Dose MMR,,States/Local Areas,Mississippi,2015,Age,24 Months,88.2,82.9 to 92.5,272
≥1 Dose MMR,,States/Local Areas,Mississippi,2015-2016,Age,24 Months,89.5,86.0 to 92.5,579
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018,Age,24 Months,87.5,81.3 to 92.4,276
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018-2019,Age,24 Months,90.7,86.9 to 93.7,600
Hep B,≥3 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,92.6,87.6 to 96.2,198
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,91.7,85.7 to 95.3,324
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013,Age,24 Months,93.4,87.9 to 96.9,217
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,24 Months,91.6,87.7 to 94.7,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,93.9,88.1 to 97.4,230
PCV,≥3 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,62.5,54.5 to 69.8,307
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,63.1,57.6 to 68.4,628
PCV,≥4 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,78.2,70.9 to 84.1,307
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,76.5,71.3 to 81.0,628
PCV,≥4 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,69.9,60.5 to 77.9,272
PCV,≥4 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,74.0,68.9 to 78.6,579
PCV,≥4 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,76.3,68.7 to 82.5,239
PCV,≥4 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,73.1,67.9 to 77.7,511
PCV,≥3 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,62.3,54.9 to 69.2,272
PCV,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,62.4,56.9 to 67.6,579
PCV,≥3 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,63.8,55.9 to 71.1,321
PCV,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,65.3,59.8 to 70.4,597
Hep B,≥3 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,93.7,91.9 to 95.1,230
Hep B,≥3 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,91.8,86.8 to 95.1,198
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,91.4,85.5 to 95.1,324
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,90.4,84.6 to 94.2,276
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,90.9,87.0 to 93.7,600
DTaP,≥4 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,83.7,76.9 to 89.4,276
DTaP,≥4 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,86.1,81.6 to 90.0,600
Hib,≥1 Dose,States/Local Areas,Mississippi,2019,Age,3 Months,89.7,84.1 to 93.5,324
Hib,≥1 Dose,States/Local Areas,Mississippi,2018,Age,3 Months,89.7,84.0 to 93.5,276
Hib,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,3 Months,89.7,85.9 to 92.6,600
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,90.0 to 95.0,597
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,86.1 to 96.7,195
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.8,86.9 to 94.7,334
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,94.6,91.5 to 97.7,222
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,83.3,72.1 to 94.4,87
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017,Age,35 Months,94.0,89.0 to 97.2,321
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017-2018,Age,35 Months,90.9,87.1 to 94.0,597
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018,Age,35 Months,87.5,81.3 to 92.4,276
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018-2019,Age,35 Months,91.5,87.9 to 94.4,600
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2018,Age,0-1 Days,79.4,72.4 to 84.9,276
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2018-2019,Age,0-1 Days,78.2,73.3 to 82.4,600
Hep B,≥2 Doses,States/Local Areas,Mississippi,2018,Age,5 Months,89.6,83.6 to 93.5,276
Hep B,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,5 Months,90.8,87.0 to 93.6,600
Hep B,≥2 Doses,States/Local Areas,Mississippi,2017,Age,5 Months,83.4,76.3 to 88.6,321
Hep B,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,5 Months,86.5,82.0 to 89.9,597
Hep B,≥2 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,92.8,90.9 to 94.3,198
Hep B,≥2 Doses,States/Local Areas,Mississippi,2019,Age,5 Months,92.0,86.5 to 95.4,324
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2015,Age,0-1 Days,68.3,61.1 to 74.6,272
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2015-2016,Age,0-1 Days,68.5,63.5 to 73.1,579
Hep B,≥2 Doses,States/Local Areas,Mississippi,2015,Age,5 Months,83.3,76.7 to 88.3,272
Hep B,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,5 Months,86.6,82.5 to 89.9,579
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2014,Age,0-1 Days,79.5,72.4 to 85.1,239
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2014-2015,Age,0-1 Days,73.9,68.9 to 78.3,511
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2013,Age,0-1 Days,67.1,63.6 to 70.3,217
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2013-2014,Age,0-1 Days,73.2,71.9 to 74.6,456
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013,Age,24 Months,87.6,80.5 to 93.0,217
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013-2014,Age,24 Months,88.9,84.5 to 92.4,456
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014,Age,24 Months,90.1,84.7 to 94.2,239
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2015,Age,24 Months,89.8,86.3 to 92.8,511
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019,Age,19 Months,86.7,80.0 to 91.4,324
Polio,≥2 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,95.4,90.4 to 97.8,324
Polio,≥2 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,92.2,86.9 to 95.5,276
Polio,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,93.8,90.4 to 96.0,600
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2012,Age,0-1 Days,79.5,74.4 to 83.9,230
Hep B,≥2 Doses,States/Local Areas,Mississippi,2014,Age,5 Months,89.7,83.1 to 93.9,239
Hep B,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,5 Months,86.5,82.9 to 89.5,511
Hep B,≥2 Doses,States/Local Areas,Mississippi,2016,Age,5 Months,90.0,84.5 to 93.7,307
Hep B,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,5 Months,86.7,82.4 to 90.1,628
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,90.9,85.0 to 94.6,276
Hep B,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,90.9,87.0 to 93.7,600
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,91.6,86.0 to 95.1,321
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,91.2,87.5 to 94.0,597
PCV,≥3 Doses,States/Local Areas,Mississippi,2012,Age,7 Months,61.4,50.1 to 71.7,230
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,79.1,73.4 to 84.9,392
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,88.6,84.0 to 93.1,222
PCV,≥3 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,70.3,62.2 to 77.2,239
PCV,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,66.3,60.9 to 71.3,511
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,94.0,87.5 to 97.2,307
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,92.8,88.9 to 95.4,628
PCV,≥3 Doses,States/Local Areas,Mississippi,2011,Age,7 Months,60.2,51.1 to 68.6,198
PCV,≥3 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,69.6,66.9 to 72.1,217
PCV,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,69.9,68.3 to 71.5,456
≥1 Dose MMR,,States/Local Areas,Mississippi,2017,Age,13 Months,54.7,47.0 to 62.2,321
≥1 Dose MMR,,States/Local Areas,Mississippi,2017-2018,Age,13 Months,63.0,57.6 to 68.1,597
≥1 Dose MMR,,States/Local Areas,Mississippi,2019,Age,13 Months,62.9,54.8 to 70.2,324
≥1 Dose MMR,,States/Local Areas,Mississippi,2018,Age,13 Months,71.4,64.2 to 77.7,276
≥1 Dose MMR,,States/Local Areas,Mississippi,2018-2019,Age,13 Months,67.2,61.8 to 72.1,600
Polio,≥2 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,95.1,91.2 to 97.3,198
Polio,≥2 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,96.0,94.7 to 97.0,230
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016,Age,19 Months,84.3,77.0 to 89.6,307
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2017,Age,19 Months,84.1,79.2 to 88.0,628
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015,Age,19 Months,85.9,78.1 to 91.2,272
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015-2016,Age,19 Months,85.1,80.6 to 88.7,579
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014,Age,19 Months,89.4,83.5 to 93.4,239
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2015,Age,19 Months,87.7,83.7 to 90.8,511
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,60.5,51.8 to 69.2,334
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017,Age,24 Months,90.2,85.3 to 94.0,321
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017-2018,Age,24 Months,88.9,85.1 to 92.1,597
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016,Age,24 Months,89.9,84.7 to 93.9,307
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2017,Age,24 Months,90.0,86.6 to 92.9,628
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015,Age,24 Months,89.5,84.5 to 93.4,272
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015-2016,Age,24 Months,89.7,86.2 to 92.6,579
≥1 Dose MMR,,States/Local Areas,Mississippi,2012,Age,24 Months,90.4,84.3 to 94.9,230
≥1 Dose MMR,,States/Local Areas,Mississippi,2011,Age,24 Months,89.3,82.3 to 94.4,198
≥1 Dose MMR,,States/Local Areas,Mississippi,2019,Age,19 Months,87.1,80.4 to 91.7,324
≥1 Dose MMR,,States/Local Areas,Mississippi,2018,Age,19 Months,90.3,84.8 to 94.0,276
≥1 Dose MMR,,States/Local Areas,Mississippi,2018-2019,Age,19 Months,95.2,92.3 to 97.1,600
PCV,≥4 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,74.9,73.4 to 76.3,198
PCV,≥4 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,75.4,68.8 to 81.0,230
PCV,≥4 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,73.4,63.2 to 81.7,217
PCV,≥4 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,74.9,68.6 to 80.2,456
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2017,Age,0-1 Days,73.2,66.1 to 79.3,321
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2017-2018,Age,0-1 Days,76.3,71.4 to 80.5,597
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2016,Age,0-1 Days,68.7,61.5 to 75.1,307
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2016-2017,Age,0-1 Days,70.9,66.0 to 75.4,628
≥1 Dose Varicella,,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,89.3,85.2 to 93.3,392
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,55.5,47.3 to 63.8,478
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,55.0,47.0 to 63.1,393
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,57.1,52.0 to 62.3,1007
Polio,≥2 Doses,States/Local Areas,Mississippi,2019,Age,7 Months,91.2,85.3 to 94.9,324
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",59.6,53.0 to 66.2,597
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,56.0,45.6 to 66.3,195
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",61.3,45.2 to 77.5,77
Hep B,≥1 Dose,States/Local Areas,Mississippi,2017,Age,3 Months,94.7,90.1 to 97.2,321
Hep B,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,3 Months,95.7,93.2 to 97.3,597
Hep B,≥1 Dose,States/Local Areas,Mississippi,2016,Age,3 Months,97.8,94.8 to 99.1,307
Hep B,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,3 Months,96.2,93.8 to 97.8,628
Hep B,≥1 Dose,States/Local Areas,Mississippi,2015,Age,3 Months,93.7,89.5 to 96.3,272
Hep B,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,3 Months,95.7,93.4 to 97.3,579
Polio,≥2 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,93.0,87.8 to 96.1,239
Polio,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,93.7,90.6 to 95.8,511
Polio,≥2 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,91.9,88.2 to 94.5,217
Polio,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,92.4,89.5 to 94.6,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017,Age,13 Months,89.2,83.3 to 93.2,321
Hep B,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,13 Months,89.8,85.9 to 92.7,597
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015,Age,13 Months,85.8,79.9 to 90.2,272
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,13 Months,89.1,85.1 to 92.1,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016,Age,13 Months,92.4,86.1 to 96.0,307
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,13 Months,90.8,86.9 to 93.7,628
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,62.8,55.8 to 69.9,441
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,57.2,50.0 to 64.5,519
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",54.7,45.8 to 63.7,246
≥1 Dose MMR,,States/Local Areas,Mississippi,2015,Age,13 Months,55.5,48.2 to 62.5,272
≥1 Dose MMR,,States/Local Areas,Mississippi,2015-2016,Age,13 Months,57.5,52.1 to 62.6,579
≥1 Dose MMR,,States/Local Areas,Mississippi,2014,Age,13 Months,62.0,53.6 to 69.6,239
≥1 Dose MMR,,States/Local Areas,Mississippi,2014-2015,Age,13 Months,58.7,53.3 to 64.0,511
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018,Age,13 Months,68.1,60.6 to 74.7,276
≥1 Dose Varicella,,States/Local Areas,Mississippi,2018-2019,Age,13 Months,66.4,61.0 to 71.5,600
≥1 Dose MMR,,States/Local Areas,Mississippi,2016,Age,13 Months,59.5,51.8 to 66.7,307
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2017,Age,13 Months,57.1,51.7 to 62.4,628
≥1 Dose Varicella,,States/Local Areas,Mississippi,2012,Age,19 Months,90.5,85.2 to 94.1,230
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013,Age,19 Months,85.8,80.1 to 90.1,217
≥1 Dose Varicella,,States/Local Areas,Mississippi,2013-2014,Age,19 Months,87.6,83.8 to 90.7,456
≥1 Dose Varicella,,States/Local Areas,Mississippi,2011,Age,19 Months,86.1,81.6 to 89.6,198
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019,Age,13 Months,64.7,56.7 to 72.0,324
Hep A,≥2 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,59.6,51.1 to 68.4,321
Hep A,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,58.6,52.4 to 65.0,597
Hep A,≥2 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,57.4,48.8 to 66.2,276
Hep A,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,55.1,49.0 to 61.5,600
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014,Age,13 Months,88.8,82.0 to 93.2,239
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,13 Months,87.3,83.1 to 90.6,511
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013,Age,13 Months,90.8,87.1 to 93.5,217
Hep B,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,13 Months,89.8,88.2 to 91.2,456
DTaP,≥4 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,79.4,70.6 to 87.0,217
DTaP,≥4 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,81.6,76.0 to 86.6,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2012,Age,13 Months,90.5,88.1 to 92.5,230
Hep A,≥2 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,52.8,44.3 to 61.9,324
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,84.4,77.2 to 90.3,239
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,81.8,76.8 to 86.2,511
DTaP,≥4 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,79.3,72.1 to 85.6,272
DTaP,≥4 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,82.0,76.8 to 86.6,579
DTaP,≥4 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,92.0,85.2 to 96.4,230
Polio,≥2 Doses,States/Local Areas,Mississippi,2018,Age,7 Months,87.2,80.7 to 91.7,276
Polio,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,7 Months,89.2,85.1 to 92.3,600
Polio,≥2 Doses,States/Local Areas,Mississippi,2017,Age,7 Months,86.5,80.1 to 91.1,321
Polio,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,7 Months,86.8,82.5 to 90.2,597
Polio,≥2 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,90.0,83.1 to 94.3,307
Polio,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,88.3,83.9 to 91.6,628
Hep B,≥1 Dose,States/Local Areas,Mississippi,2014,Age,3 Months,95.3,89.7 to 98.0,239
Hep B,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,3 Months,94.5,91.4 to 96.5,511
Hep B,≥1 Dose,States/Local Areas,Mississippi,2011,Age,3 Months,95.7,89.8 to 98.2,198
Hep B,≥1 Dose,States/Local Areas,Mississippi,2012,Age,3 Months,96.1,92.9 to 97.8,230
Hep B,≥1 Dose,States/Local Areas,Mississippi,2013,Age,3 Months,96.6,94.7 to 97.8,217
Hep B,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,3 Months,96.0,95.0 to 96.7,456
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,9.6,-3.4 to 22.6,32
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,84.9,77.1 to 91.0,307
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,87.0,81.7 to 91.4,628
DTaP,≥4 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,89.3,81.6 to 94.7,321
DTaP,≥4 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,86.6,81.4 to 90.9,597
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,66.0,26.7 to 100.0,87
DTaP,≥4 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,86.4,76.4 to 93.6,198
DTaP,≥4 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,82.6,76.0 to 88.4,324
DTaP,≥4 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,81.1,74.0 to 87.3,321
DTaP,≥4 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,80.2,75.2 to 84.6,597
DTaP,≥4 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,79.2,72.2 to 85.4,276
DTaP,≥4 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,80.9,76.1 to 85.2,600
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015,Age,13 Months,60.1,52.8 to 66.9,272
≥1 Dose Varicella,,States/Local Areas,Mississippi,2015-2016,Age,13 Months,60.7,55.5 to 65.7,579
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017,Age,13 Months,57.9,50.1 to 65.3,321
≥1 Dose Varicella,,States/Local Areas,Mississippi,2017-2018,Age,13 Months,63.0,57.5 to 68.1,597
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016,Age,13 Months,61.3,53.8 to 68.4,307
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2017,Age,13 Months,59.6,54.3 to 64.7,628
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,80.2,73.4 to 86.2,239
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,76.7,71.8 to 81.2,511
DTaP,≥4 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,73.1,66.1 to 79.7,272
DTaP,≥4 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,75.1,70.0 to 79.9,579
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,77.1,69.9 to 83.6,307
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,79.1,74.2 to 83.7,628
Hep A,≥2 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,54.3,44.2 to 65.1,217
Hep A,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,55.8,48.9 to 62.9,456
Hep A,≥2 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,46.8,37.4 to 57.2,230
Hep A,≥2 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,44.7,34.5 to 56.4,198
Hep A,≥2 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,30.7,24.1 to 38.7,324
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016,Age,7 Months,77.3,70.0 to 83.2,307
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,7 Months,74.7,69.6 to 79.2,628
Polio,≥2 Doses,States/Local Areas,Mississippi,2015,Age,5 Months,76.2,69.4 to 82.0,272
Polio,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,5 Months,76.8,71.6 to 81.2,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,69.9,62.7 to 76.3,272
Hep B,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,73.6,68.6 to 78.1,579
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,81.1,73.6 to 86.8,239
Hep B,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,75.5,70.4 to 80.0,511
Polio,≥2 Doses,States/Local Areas,Mississippi,2017,Age,5 Months,72.8,64.8 to 79.5,321
Polio,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,5 Months,74.7,69.4 to 79.4,597
Polio,≥2 Doses,States/Local Areas,Mississippi,2016,Age,5 Months,77.3,69.6 to 83.5,307
Polio,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,5 Months,75.1,69.6 to 79.8,628
≥1 Dose Varicella,,States/Local Areas,Mississippi,2011,Age,13 Months,55.3,48.2 to 62.2,198
≥1 Dose MMR,,States/Local Areas,Mississippi,2011,Age,13 Months,49.9,45.8 to 53.9,198
≥1 Dose MMR,,States/Local Areas,Mississippi,2012,Age,13 Months,54.4,48.7 to 60.0,230
≥1 Dose MMR,,States/Local Areas,Mississippi,2013,Age,13 Months,62.3,56.9 to 67.4,217
≥1 Dose MMR,,States/Local Areas,Mississippi,2013-2014,Age,13 Months,62.1,57.5 to 66.6,456
Hep B,≥3 Doses,States/Local Areas,Mississippi,2011,Age,13 Months,87.0,83.9 to 89.5,198
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,70.7,64.7 to 76.7,392
Polio,≥2 Doses,States/Local Areas,Mississippi,2015,Age,7 Months,89.0,83.6 to 92.8,272
Polio,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,7 Months,89.5,85.3 to 92.6,579
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Overall,Overall,71.7,68.1 to 75.2,1007
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,71.1,65.6 to 76.6,393
Polio,≥2 Doses,States/Local Areas,Mississippi,2013,Age,7 Months,88.3,78.8 to 93.8,217
Polio,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,7 Months,89.0,84.0 to 92.5,456
Polio,≥2 Doses,States/Local Areas,Mississippi,2014,Age,7 Months,89.7,83.4 to 93.8,239
Polio,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,7 Months,89.3,85.4 to 92.3,511
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.0,67.0 to 79.0,334
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,68.1,62.8 to 73.5,478
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.4,69.1 to 77.8,597
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,77.7,69.8 to 85.6,195
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.4,57.2 to 81.5,77
Hep A,≥1 Dose,States/Local Areas,Mississippi,2018,Age,35 Months,77.0,70.1 to 83.4,276
Hep A,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,35 Months,74.0,68.3 to 79.5,600
Hep A,≥1 Dose,States/Local Areas,Mississippi,2017,Age,35 Months,81.0,74.5 to 86.7,321
Hep A,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,35 Months,79.5,74.6 to 83.9,597
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016,Age,35 Months,78.1,70.9 to 84.6,307
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,35 Months,79.6,74.7 to 84.0,628
Hib,Primary Series,States/Local Areas,Minnesota,2019,Age,13 Months,88.7,81.6 to 93.2,283
Hib,Primary Series,States/Local Areas,Minnesota,2013,Age,19 Months,93.9,90.7 to 96.0,293
Hib,Primary Series,States/Local Areas,Minnesota,2013-2014,Age,19 Months,94.4,92.6 to 95.9,562
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,97.2,93.3 to 99.1,217
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,96.2,93.6 to 97.9,507
DTaP,≥1 Dose,States/Local Areas,Minnesota,2019,Age,3 Months,90.9,83.9 to 95.0,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2011,Age,19 Months,67.4,64.8 to 69.9,208
DTaP,≥1 Dose,States/Local Areas,Minnesota,2017,Age,3 Months,94.1,89.7 to 96.8,290
DTaP,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,3 Months,92.6,89.2 to 95.0,618
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014,Age,24 Months,98.4,95.1 to 99.6,269
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,24 Months,96.7,94.4 to 98.2,496
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,94.9,91.1 to 97.5,227
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,96.1,93.5 to 97.9,444
DTaP,≥1 Dose,States/Local Areas,Minnesota,2018,Age,3 Months,91.0,85.4 to 94.6,328
DTaP,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,3 Months,91.0,86.8 to 93.9,611
Hib,Primary Series,States/Local Areas,Minnesota,2012,Age,19 Months,95.7,89.1 to 98.4,225
Hep A,≥1 Dose,States/Local Areas,Minnesota,2012,Age,19 Months,81.4,75.9 to 85.8,225
Hep A,≥1 Dose,States/Local Areas,Minnesota,2013,Age,19 Months,83.0,80.1 to 85.6,293
Hep A,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,19 Months,85.6,83.1 to 87.7,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014,Age,19 Months,88.1,82.3 to 92.2,269
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,19 Months,82.8,77.2 to 87.2,496
Hep A,≥1 Dose,States/Local Areas,Minnesota,2015,Age,19 Months,77.4,75.8 to 79.0,227
Hep A,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,19 Months,83.3,77.1 to 88.1,444
Hib,≥3 Doses,States/Local Areas,Minnesota,2015,Age,24 Months,88.2,81.5 to 93.3,227
Hib,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,24 Months,91.4,87.2 to 94.7,444
Hib,≥3 Doses,States/Local Areas,Minnesota,2016,Age,24 Months,94.7,88.9 to 98.0,217
Hib,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,24 Months,92.7,88.9 to 95.6,507
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,95.1,89.8 to 98.1,283
Hib,≥3 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,90.6,85.0 to 94.7,290
Hib,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,90.6,86.8 to 93.6,618
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017,Age,24 Months,95.1,91.1 to 97.7,290
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,24 Months,94.4,91.5 to 96.6,618
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,93.7,89.1 to 96.8,328
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,94.4,91.1 to 96.8,611
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,97.4,95.3 to 99.6,403
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,89.6,84.7 to 94.5,293
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,94.1,89.9 to 98.3,137
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Overall,Overall,93.9,91.8 to 96.1,833
Polio,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,95.5,92.1 to 98.9,175
DTaP,≥2 Doses,States/Local Areas,Minnesota,2018,Age,5 Months,82.5,75.8 to 87.6,328
DTaP,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,5 Months,83.1,78.3 to 87.1,611
DTaP,≥2 Doses,States/Local Areas,Minnesota,2017,Age,5 Months,84.0,76.9 to 89.2,290
DTaP,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,5 Months,83.2,78.6 to 87.1,618
Hib,Full Series,States/Local Areas,Minnesota,2021,Age,19 Months,66.9,56.3 to 76.0,176
DTaP,≥4 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,91.4,82.6 to 96.7,415
PCV,≥4 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,81.0,74.8 to 86.5,415
Hib,≥2 Doses,States/Local Areas,Minnesota,2021,Age,5 Months,74.8,64.3 to 83.0,176
Hep B,≥3 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,95.3,89.6 to 97.9,176
Hib,≥1 Dose,States/Local Areas,Minnesota,2021,Age,3 Months,84.1,74.5 to 90.5,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.0,69.6 to 80.4,753
Hib,Primary Series,States/Local Areas,Minnesota,2016,Age,13 Months,92.4,85.8 to 96.0,217
Hib,Primary Series,States/Local Areas,Minnesota,2016-2017,Age,13 Months,92.1,88.3 to 94.7,507
Hib,Primary Series,States/Local Areas,Minnesota,2017,Age,13 Months,91.8,86.9 to 95.0,290
Hib,Primary Series,States/Local Areas,Minnesota,2017-2018,Age,13 Months,89.8,86.0 to 92.6,618
Hib,Primary Series,States/Local Areas,Minnesota,2011,Age,19 Months,92.5,88.3 to 95.3,208
Hib,Primary Series,States/Local Areas,Minnesota,2018,Age,13 Months,87.8,81.6 to 92.0,328
Hib,Primary Series,States/Local Areas,Minnesota,2018-2019,Age,13 Months,88.2,83.8 to 91.5,611
Hib,Primary Series,States/Local Areas,Minnesota,2014,Age,19 Months,95.0,89.9 to 97.6,269
Hib,Primary Series,States/Local Areas,Minnesota,2014-2015,Age,19 Months,94.0,90.8 to 96.2,496
Hib,Primary Series,States/Local Areas,Minnesota,2017,Age,19 Months,94.4,89.7 to 97.0,290
Hib,Primary Series,States/Local Areas,Minnesota,2017-2018,Age,19 Months,93.9,90.7 to 96.0,618
Hib,Primary Series,States/Local Areas,Minnesota,2018,Age,19 Months,93.4,88.4 to 96.3,328
Hib,Primary Series,States/Local Areas,Minnesota,2018-2019,Age,19 Months,88.2,83.8 to 91.5,611
Hib,Primary Series,States/Local Areas,Minnesota,2019,Age,19 Months,93.6,86.9 to 97.0,283
Hib,Primary Series,States/Local Areas,Minnesota,2016,Age,7 Months,78.2,68.2 to 85.8,217
Hib,Primary Series,States/Local Areas,Minnesota,2016-2017,Age,7 Months,79.0,73.1 to 83.9,507
Hib,Primary Series,States/Local Areas,Minnesota,2017,Age,7 Months,79.8,72.7 to 85.4,290
Hib,Primary Series,States/Local Areas,Minnesota,2017-2018,Age,7 Months,80.9,76.1 to 84.8,618
Hib,Primary Series,States/Local Areas,Minnesota,2012,Age,24 Months,95.7,91.7 to 98.2,225
Hib,Primary Series,States/Local Areas,Minnesota,2011,Age,24 Months,93.5,87.9 to 97.1,208
Hib,Primary Series,States/Local Areas,Minnesota,2013,Age,24 Months,93.9,89.5 to 96.8,293
Hib,Primary Series,States/Local Areas,Minnesota,2013-2014,Age,24 Months,95.1,92.3 to 97.1,562
Hib,Primary Series,States/Local Areas,Minnesota,2015,Age,19 Months,93.0,91.4 to 94.3,227
Hib,Primary Series,States/Local Areas,Minnesota,2015-2016,Age,19 Months,95.1,92.1 to 97.0,444
Hib,Primary Series,States/Local Areas,Minnesota,2016,Age,19 Months,97.2,92.5 to 99.0,217
Hib,Primary Series,States/Local Areas,Minnesota,2016-2017,Age,19 Months,95.8,92.9 to 97.5,507
Hib,Primary Series,States/Local Areas,Minnesota,2019,Age,7 Months,82.9,75.3 to 88.5,283
Hib,Primary Series,States/Local Areas,Minnesota,2014,Age,7 Months,72.0,64.2 to 78.7,269
Hib,Primary Series,States/Local Areas,Minnesota,2014-2015,Age,7 Months,68.5,62.3 to 74.1,496
Hib,Primary Series,States/Local Areas,Minnesota,2015,Age,7 Months,65.0,55.2 to 73.7,227
Hib,Primary Series,States/Local Areas,Minnesota,2015-2016,Age,7 Months,71.6,64.7 to 77.6,444
Hib,Primary Series,States/Local Areas,Minnesota,2018,Age,7 Months,81.9,75.3 to 87.1,328
Hib,Primary Series,States/Local Areas,Minnesota,2018-2019,Age,7 Months,82.4,77.6 to 86.4,611
Hib,Primary Series,States/Local Areas,Minnesota,2013,Age,7 Months,77.1,67.3 to 84.6,293
Hib,Primary Series,States/Local Areas,Minnesota,2013-2014,Age,7 Months,74.6,68.7 to 79.6,562
DTaP,≥1 Dose,States/Local Areas,Minnesota,2012,Age,3 Months,90.8,88.4 to 92.8,225
DTaP,≥1 Dose,States/Local Areas,Minnesota,2011,Age,3 Months,90.9,81.7 to 95.7,208
DTaP,≥1 Dose,States/Local Areas,Minnesota,2013,Age,3 Months,91.1,87.1 to 93.9,293
DTaP,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,3 Months,91.3,88.5 to 93.5,562
DTaP,≥1 Dose,States/Local Areas,Minnesota,2014,Age,3 Months,91.6,86.0 to 95.1,269
DTaP,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,3 Months,87.4,82.4 to 91.2,496
DTaP,≥1 Dose,States/Local Areas,Minnesota,2015,Age,3 Months,83.3,74.5 to 89.5,227
DTaP,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,3 Months,88.8,83.6 to 92.5,444
DTaP,≥1 Dose,States/Local Areas,Minnesota,2016,Age,3 Months,94.4,87.6 to 97.6,217
DTaP,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,3 Months,94.3,90.6 to 96.6,507
Combined 7 Series,,States/Local Areas,Minnesota,2021,Age,35 Months,65.4,55.3 to 75.3,176
Hib,Primary Series,States/Local Areas,Minnesota,2021,Age,7 Months,64.9,54.3 to 74.2,176
Polio,≥2 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,83.8,73.2 to 90.7,176
PCV,≥2 Doses,States/Local Areas,Minnesota,2021,Age,5 Months,71.4,60.6 to 80.2,176
DTaP,≥3 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,61.0,50.2 to 70.9,176
Hib,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,90.3,85.8 to 93.9,415
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,91.4,86.8 to 94.5,415
Hep B,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,93.7,89.9 to 96.1,415
Hep B,≥2 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,95.2,89.1 to 98.0,176
Hib,≥2 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,86.1,76.0 to 92.3,176
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,89.8,85.1 to 93.2,415
≥1 Dose MMR,,States/Local Areas,Minnesota,2021,Age,35 Months,93.6,85.6 to 98.0,176
PCV,≥3 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,94.2,88.9 to 97.5,176
Hib,Primary Series,States/Local Areas,Minnesota,2020-2021,Age,24 Months,92.5,88.7 to 95.4,415
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016,Age,19 Months,89.2,80.8 to 94.2,217
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,19 Months,89.8,85.1 to 93.2,507
Hep A,≥1 Dose,States/Local Areas,Minnesota,2017,Age,19 Months,90.5,84.8 to 94.2,290
Hep A,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,19 Months,89.0,84.9 to 92.0,618
Hep A,≥1 Dose,States/Local Areas,Minnesota,2018,Age,19 Months,87.5,81.1 to 91.9,328
Hep A,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,19 Months,88.4,83.0 to 92.2,495
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,97.3,94.0 to 99.0,293
DTaP,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,97.7,95.7 to 99.0,562
DTaP,≥3 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,96.2,92.1 to 98.5,225
DTaP,≥3 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,94.0,88.4 to 97.5,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,98.4,95.1 to 99.6,269
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,96.7,94.4 to 98.2,496
Hep A,≥2 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,21.4,17.9 to 25.5,208
DTaP,≥2 Doses,States/Local Areas,Minnesota,2019,Age,5 Months,83.8,76.1 to 89.3,283
Hep A,≥2 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,30.3,28.1 to 32.6,293
Hep A,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,26.8,24.1 to 29.6,562
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,23.3,17.6 to 30.0,269
Hep A,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,20.3,15.9 to 25.5,496
Hep A,≥2 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,22.3,18.0 to 27.2,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2018,Age,24 Months,90.2,84.9 to 94.3,328
Hib,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,24 Months,90.8,87.1 to 93.9,611
Hib,≥3 Doses,States/Local Areas,Minnesota,2019,Age,24 Months,91.6,85.8 to 95.7,283
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,95.1,91.1 to 97.7,290
DTaP,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,95.6,92.8 to 97.5,618
DTaP,≥4 Doses,States/Local Areas,Minnesota,2011,Age,19 Months,79.4,73.4 to 84.3,208
DTaP,≥4 Doses,States/Local Areas,Minnesota,2012,Age,19 Months,82.5,75.7 to 87.8,225
PCV,≥2 Doses,States/Local Areas,Minnesota,2013,Age,5 Months,82.3,79.5 to 84.7,293
PCV,≥2 Doses,States/Local Areas,Minnesota,2013-2014,Age,5 Months,82.0,79.4 to 84.3,562
PCV,≥2 Doses,States/Local Areas,Minnesota,2012,Age,5 Months,82.7,78.3 to 86.3,225
PCV,≥2 Doses,States/Local Areas,Minnesota,2011,Age,5 Months,79.0,68.4 to 86.7,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,94.9,91.1 to 97.5,227
DTaP,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,96.2,93.6 to 98.0,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,98.0,93.8 to 99.6,217
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,96.4,93.8 to 98.1,507
Hep A,≥2 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,17.3,13.7 to 21.8,227
Hep A,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,26.2,20.4 to 32.9,444
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016,Age,19 Months,35.2,26.1 to 45.5,217
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,19 Months,32.9,27.1 to 39.2,507
Hib,≥3 Doses,States/Local Areas,Minnesota,2013,Age,35 Months,94.7,90.5 to 97.5,293
Hib,≥3 Doses,States/Local Areas,Minnesota,2013-2014,Age,35 Months,94.5,91.4 to 96.8,562
Hib,≥3 Doses,States/Local Areas,Minnesota,2014,Age,35 Months,94.0,88.9 to 97.2,269
Hib,≥3 Doses,States/Local Areas,Minnesota,2014-2015,Age,35 Months,92.6,88.4 to 95.8,496
Hib,≥3 Doses,States/Local Areas,Minnesota,2015,Age,35 Months,91.2,84.0 to 96.0,227
Hib,≥3 Doses,States/Local Areas,Minnesota,2015-2016,Age,35 Months,93.3,88.7 to 96.5,444
Hep A,≥2 Doses,States/Local Areas,Minnesota,2017,Age,19 Months,30.6,24.0 to 38.0,290
Hep A,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,19 Months,29.6,25.0 to 34.6,618
Hib,≥3 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,88.7,80.1 to 93.9,176
Hib,Primary Series,States/Local Areas,Minnesota,2021,Age,19 Months,93.8,87.7 to 97.0,176
Hib,≥3 Doses,States/Local Areas,Minnesota,2012,Age,35 Months,94.1,88.9 to 97.3,225
Hib,≥3 Doses,States/Local Areas,Minnesota,2011,Age,35 Months,93.5,87.9 to 97.1,208
Hep A,≥1 Dose,States/Local Areas,Minnesota,2015,Age,24 Months,82.5,74.0 to 89.5,227
Hep A,≥1 Dose,States/Local Areas,Minnesota,2015-2016,Age,24 Months,86.3,80.8 to 90.9,444
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016,Age,24 Months,90.1,82.6 to 95.4,217
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2017,Age,24 Months,90.6,86.2 to 94.1,507
PCV,≥2 Doses,States/Local Areas,Minnesota,2014,Age,5 Months,81.7,74.4 to 87.2,269
PCV,≥2 Doses,States/Local Areas,Minnesota,2014-2015,Age,5 Months,77.8,74.5 to 80.9,496
PCV,≥2 Doses,States/Local Areas,Minnesota,2015,Age,5 Months,74.0,64.2 to 81.9,227
PCV,≥2 Doses,States/Local Areas,Minnesota,2015-2016,Age,5 Months,79.8,73.6 to 84.9,444
PCV,≥2 Doses,States/Local Areas,Minnesota,2016,Age,5 Months,85.6,77.4 to 91.2,217
PCV,≥2 Doses,States/Local Areas,Minnesota,2016-2017,Age,5 Months,84.9,79.8 to 89.0,507
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,95.6,91.1 to 98.3,328
DTaP,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,95.7,92.4 to 97.8,611
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019,Age,35 Months,95.7,90.4 to 98.5,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2018,Age,24 Months,89.4,83.7 to 93.7,328
Hep A,≥1 Dose,States/Local Areas,Minnesota,2018-2019,Age,24 Months,90.2,86.3 to 93.3,611
Hep A,≥1 Dose,States/Local Areas,Minnesota,2019,Age,24 Months,91.0,85.2 to 95.1,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2011,Age,35 Months,76.7,67.3 to 85.0,208
PCV,≥2 Doses,States/Local Areas,Minnesota,2017,Age,5 Months,84.2,77.2 to 89.4,290
PCV,≥2 Doses,States/Local Areas,Minnesota,2017-2018,Age,5 Months,82.8,78.0 to 86.7,618
Hib,≥3 Doses,States/Local Areas,Minnesota,2018,Age,35 Months,93.7,88.6 to 97.0,328
Hib,≥3 Doses,States/Local Areas,Minnesota,2018-2019,Age,35 Months,93.7,90.0 to 96.3,611
Hep A,≥2 Doses,States/Local Areas,Minnesota,2012,Age,24 Months,40.3,31.3 to 50.9,225
DTaP,≥4 Doses,States/Local Areas,Minnesota,2013,Age,19 Months,77.3,72.0 to 81.8,293
DTaP,≥4 Doses,States/Local Areas,Minnesota,2013-2014,Age,19 Months,75.9,72.4 to 79.0,562
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014,Age,19 Months,74.5,66.9 to 80.8,269
DTaP,≥4 Doses,States/Local Areas,Minnesota,2014-2015,Age,19 Months,67.5,61.2 to 73.3,496
DTaP,≥4 Doses,States/Local Areas,Minnesota,2015,Age,19 Months,60.6,55.6 to 65.4,227
DTaP,≥4 Doses,States/Local Areas,Minnesota,2015-2016,Age,19 Months,71.7,65.0 to 77.5,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,92.9,88.7 to 97.1,221
DTaP,≥3 Doses,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,97.9,96.7 to 99.2,582
Hib,≥3 Doses,States/Local Areas,Minnesota,2016,Age,35 Months,94.7,88.9 to 98.0,217
Hib,≥3 Doses,States/Local Areas,Minnesota,2016-2017,Age,35 Months,93.1,89.2 to 95.9,507
Hib,≥3 Doses,States/Local Areas,Minnesota,2017,Age,35 Months,91.3,85.8 to 95.4,290
Hib,≥3 Doses,States/Local Areas,Minnesota,2017-2018,Age,35 Months,92.8,89.2 to 95.5,618
Hep A,≥2 Doses,States/Local Areas,Minnesota,2018,Age,19 Months,28.5,22.5 to 35.4,328
Hep A,≥2 Doses,States/Local Areas,Minnesota,2018-2019,Age,19 Months,28.8,23.2 to 35.1,495
Hep A,≥2 Doses,States/Local Areas,Minnesota,2019,Age,19 Months,31.5,24.8 to 39.0,283
Hep A,≥2 Doses,States/Local Areas,Minnesota,2011,Age,24 Months,31.0,22.9 to 41.1,208
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,98.2,96.4 to 99.9,200
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,91.3,86.9 to 95.6,444
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,85.5,80.5 to 90.5,444
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.9,87.7 to 96.1,361
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.8,72.2 to 89.4,361
PCV,≥3 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,76.5,68.6 to 82.9,239
Rotavirus,,States/Local Areas,Minnesota,2019-2020,Age,8 Months,80.8,75.5 to 85.1,522
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,79.6,74.0 to 85.2,444
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,83.2,74.4 to 92.0,200
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.7,75.8 to 87.6,361
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.0,89.2 to 96.9,361
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,76.8,66.3 to 87.3,200
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,81.6 to 96.7,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,97.5,95.4 to 99.6,444
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,86.7 to 95.6,361
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,94.5,89.4 to 99.5,200
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,83.0,77.5 to 88.6,444
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,81.8,72.4 to 91.2,200
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.7,74.5 to 86.9,361
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,96.5,94.2 to 98.9,444
Hib,Full Series,States/Local Areas,Minnesota,2019-2020,Age,19 Months,72.3,66.7 to 77.3,522
Hib,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,3 Months,88.8,83.9 to 92.3,522
Polio,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,3 Months,89.6,85.0 to 93.0,522
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,89.2,79.8 to 98.6,73
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,77.9,73.0 to 82.9,721
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,85.6 to 99.2,123
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.6,85.2 to 100.0,56
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.0,92.6 to 97.4,753
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.9,84.9 to 94.9,361
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,81.2,71.3 to 91.1,200
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.4,81.3 to 91.5,361
Influenza,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,68.8 to 81.5,444
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,69.6,58.0 to 81.1,200
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.0,68.4 to 81.6,361
Influenza,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.7,69.0 to 82.4,361
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.0,73.7 to 86.2,361
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,86.9 to 94.2,444
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,90.7,86.2 to 95.1,444
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,85.9,77.2 to 94.6,200
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,86.4 to 95.2,361
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,80.5,67.0 to 94.0,200
Influenza,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,68.8,57.8 to 79.9,200
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,96.0,93.3 to 98.7,444
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.4,85.9 to 94.9,361
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,97.1,94.5 to 99.7,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,76.3,70.6 to 82.1,444
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,68.9,62.4 to 75.3,444
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,70.3,58.0 to 82.5,200
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,90.8,86.6 to 95.1,387
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,97.8,96.0 to 99.7,491
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,93.2,87.8 to 98.7,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.3,73.6 to 87.0,361
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Overall,Overall,71.1,66.8 to 75.5,1005
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Overall,Overall,81.0,77.3 to 84.8,1005
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,89.8,85.1 to 94.5,387
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,97.5,95.6 to 99.4,491
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,73.7,62.0 to 85.3,127
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,65.6,54.3 to 76.8,127
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,92.5,88.5 to 96.5,387
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,65.0,57.3 to 72.6,387
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,99.0,98.2 to 99.9,491
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Overall,Overall,91.1,88.1 to 94.1,1005
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,79.1,73.7 to 84.6,491
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Overall,Overall,84.4,80.9 to 87.8,1005
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,84.7,78.8 to 90.5,1005
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,93.2,87.9 to 98.5,127
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Overall,Overall,76.6,72.4 to 80.8,1005
Influenza,,States/Local Areas,Minnesota,2016-2019,Overall,Overall,74.2,69.9 to 78.4,1005
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,93.2,87.8 to 98.6,127
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,91.9,87.9 to 95.9,387
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,78.8,70.6 to 87.1,387
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,93.5,88.7 to 98.2,491
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,85.1,76.2 to 94.0,127
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,85.1,81.6 to 88.6,1005
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,85.2,79.4 to 91.0,387
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Overall,Overall,92.4,89.8 to 95.0,1005
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,71.3,60.3 to 82.3,127
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,94.9,93.0 to 96.8,1005
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,94.0,91.5 to 96.5,491
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Overall,Overall,89.8,86.7 to 92.8,1005
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,94.3,92.2 to 96.4,1005
Influenza,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,71.3,57.4 to 85.2,73
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,82.1,78.3 to 85.9,1005
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,87.0,81.0 to 93.0,251
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.1 to 98.0,721
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.0,72.2 to 91.8,123
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.4,42.7 to 76.0,56
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,80.6,68.9 to 92.3,73
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,86.5 to 99.8,123
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,93.5,90.4 to 96.7,721
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,79.7,68.5 to 90.9,251
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,88.0,82.8 to 93.2,721
Hib,≥1 Dose,States/Local Areas,Minnesota,2020,Age,3 Months,88.1,80.6 to 92.9,239
Polio,≥1 Dose,States/Local Areas,Minnesota,2020,Age,3 Months,89.2,82.3 to 93.6,239
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,82.1,74.4 to 87.8,239
Combined 7 Series,,States/Local Areas,Minnesota,2019-2020,Age,35 Months,74.2,68.7 to 79.4,522
Hib,Primary Series,States/Local Areas,Minnesota,2019-2020,Age,24 Months,92.8,88.9 to 95.6,522
Hib,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,90.1,86.0 to 93.4,522
Influenza,,States/Local Areas,Minnesota,2019-2020,Age,24 Months,69.4,63.7 to 74.9,522
Hep A,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,81.7,74.0 to 88.3,522
Hep A,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,35 Months,94.7,91.1 to 97.2,522
Hep A,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,24 Months,92.0,88.5 to 94.8,522
Polio,≥2 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,90.6,83.8 to 94.7,239
Hep A,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,50.3,44.6 to 56.3,522
Hep A,≥2 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,84.2,73.6 to 92.2,239
≥1 Dose MMR,,States/Local Areas,Minnesota,2020,Age,13 Months,72.8,64.3 to 80.0,239
Combined 7 Series,,States/Local Areas,Minnesota,2020,Age,35 Months,75.3,67.7 to 82.4,239
Hep A,≥2 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,30.9,24.1 to 38.7,239
Hep A,≥1 Dose,States/Local Areas,Minnesota,2020,Age,19 Months,86.5,78.9 to 91.7,239
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2020,Age,0-2 Days,76.9,68.8 to 83.5,239
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2020,Age,0-1 Days,72.5,64.2 to 79.5,239
Polio,≥2 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,89.5,82.7 to 93.8,239
DTaP,≥1 Dose,States/Local Areas,Minnesota,2020,Age,3 Months,89.9,83.1 to 94.1,239
Hib,≥2 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,86.5,79.2 to 91.5,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,40.7,33.1 to 48.8,239
Hib,Primary Series,States/Local Areas,Minnesota,2020,Age,7 Months,74.4,66.3 to 81.1,239
Hep B,≥2 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,89.9,82.9 to 94.2,239
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,93.6,88.5 to 96.9,239
PCV,≥2 Doses,States/Local Areas,Minnesota,2020,Age,5 Months,81.1,73.2 to 87.1,239
Polio,≥3 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,93.0,87.7 to 96.6,239
DTaP,≥4 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,83.6,76.6 to 89.5,239
≥1 Dose MMR,,States/Local Areas,Minnesota,2020,Age,24 Months,92.1,86.7 to 95.8,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,88.3,81.8 to 93.2,239
≥1 Dose MMR,,States/Local Areas,Minnesota,2020,Age,35 Months,94.6,89.8 to 97.6,239
Hib,Primary Series,States/Local Areas,Minnesota,2020,Age,35 Months,91.2,85.2 to 95.5,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,89.4,83.1 to 94.2,239
Hib,Full Series,States/Local Areas,Minnesota,2020,Age,35 Months,77.8,70.2 to 84.6,239
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,92.2,85.5 to 96.6,239
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020,Age,35 Months,92.7,87.3 to 96.4,239
Hib,Primary Series,States/Local Areas,Minnesota,2020,Age,19 Months,87.9,80.7 to 92.7,239
Hib,Full Series,States/Local Areas,Minnesota,2020,Age,19 Months,70.5,62.0 to 77.7,239
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,62.0,53.5 to 70.6,251
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,91.0,86.1 to 95.8,251
Influenza,,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,85.8,80.7 to 90.8,491
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,72.8,61.8 to 83.7,127
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,95.6,93.2 to 98.0,491
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,79.7,73.3 to 86.0,387
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,72.3,61.6 to 82.9,127
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,86.2,81.7 to 90.7,491
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,93.2,87.8 to 98.6,127
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,88.0,80.4 to 95.6,127
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,78.0,71.2 to 84.7,387
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,90.5,86.6 to 94.5,491
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,91.3,84.5 to 98.1,127
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,87.6,81.9 to 93.2,387
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,94.0,90.1 to 97.8,491
Influenza,,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,61.6,49.6 to 73.6,127
Influenza,,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,67.3,60.0 to 74.6,387
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,93.8,91.5 to 96.0,1005
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Overall,Overall,95.4,93.5 to 97.3,1005
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,93.2,87.8 to 98.6,127
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,88.7,83.3 to 94.1,387
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,97.7,96.3 to 99.1,491
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,86.4,69.0 to 100.0,127
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,74.0,67.1 to 81.0,387
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,80.2,74.5 to 85.8,491
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,81.9,75.9 to 87.9,387
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,93.1,90.0 to 96.2,491
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,91.2,86.4 to 96.0,444
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Poverty,133% to <400% FPL,77.2,70.5 to 83.8,387
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Poverty,<133% FPL,77.2,67.6 to 86.8,127
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Principal City,96.7,94.4 to 99.0,444
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,97.1,94.7 to 99.5,200
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,86.9 to 95.6,361
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Urbanicity,Living In a Non-MSA,90.5,83.6 to 97.3,200
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,88.1,84.5 to 91.8,721
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.5,83.8 to 99.3,56
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,91.9,84.1 to 99.7,73
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,86.6 to 100.0,123
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.1,95.5 to 98.8,753
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.1,82.0 to 90.1,753
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,90.1,85.2 to 95.1,251
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,96.7,95.0 to 98.5,721
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.2,81.2 to 89.1,753
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,74.8,67.1 to 82.5,251
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.9,54.1 to 85.7,56
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,86.8,76.3 to 97.2,73
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,90.3,85.3 to 95.2,251
DTaP,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,72.8,64.7 to 80.9,251
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.2,82.0 to 98.4,56
Hep B,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,96.0,93.8 to 98.3,721
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.7,94.9 to 98.4,753
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,92.7,86.3 to 99.0,73
Influenza,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,82.0,77.4 to 86.7,721
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.2,82.0 to 98.4,56
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.4,93.2 to 97.6,753
Influenza,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",52.3,34.7 to 70.0,56
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.4,86.7 to 100.0,123
Influenza,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.1,62.8 to 85.5,123
Influenza,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.3,73.6 to 83.1,753
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",64.2,48.4 to 80.1,56
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,77.8,65.2 to 90.3,73
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.3,87.2 to 93.5,753
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.5,69.9 to 91.1,123
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,81.1,69.4 to 92.9,73
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.2,55.1 to 79.2,123
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",48.6,32.0 to 65.3,56
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.3,71.5 to 81.1,753
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,67.4,53.4 to 81.3,73
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.4,42.7 to 76.0,56
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,76.2,68.9 to 83.5,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.7,70.6 to 88.9,123
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,77.3,63.7 to 91.0,73
Polio,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,92.8,85.4 to 100.0,73
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.1,71.7 to 92.4,123
Influenza,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,63.4,55.0 to 71.8,251
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,89.9,86.7 to 93.2,721
DTaP,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,98.1,97.0 to 99.2,721
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,86.9,80.4 to 93.5,251
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.5,94.8 to 100.0,123
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.6,46.8 to 80.4,56
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,93.4,87.2 to 99.7,73
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,77.3,69.6 to 84.9,251
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.0,88.8 to 95.2,753
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.8,67.2 to 94.4,56
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.0,64.2 to 89.8,56
Combined 7 Series,,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,76.5,71.8 to 81.3,721
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.8,57.2 to 88.3,56
≥1 Dose Varicella,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,90.4 to 96.7,753
Rotavirus,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.0,83.3 to 90.8,753
≥1 Dose MMR,,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.8,93.7 to 97.9,753
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.6,80.8 to 92.5,753
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,90.4,85.9 to 93.5,522
Hib,≥3 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,30.3,22.3 to 39.6,176
Hep A,≥1 Dose,States/Local Areas,Minnesota,2012,Age,35 Months,91.7,84.0 to 96.6,225
Hib,Primary Series,States/Local Areas,Minnesota,2019-2020,Age,7 Months,78.8,73.5 to 83.4,522
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,91.8,87.9 to 94.6,522
Polio,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,91.8,87.6 to 94.6,522
DTaP,≥4 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,75.8,70.2 to 80.6,522
DTaP,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,3 Months,90.2,85.6 to 93.5,522
Hep A,≥1 Dose,States/Local Areas,Minnesota,2019,Age,19 Months,89.3,83.0 to 93.4,283
Hep A,≥1 Dose,States/Local Areas,Minnesota,2011,Age,24 Months,73.4,64.1 to 82.0,208
Hep A,≥1 Dose,States/Local Areas,Minnesota,2013,Age,24 Months,88.6,83.1 to 93.0,293
Hep A,≥1 Dose,States/Local Areas,Minnesota,2013-2014,Age,24 Months,89.3,85.7 to 92.4,562
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014,Age,24 Months,90.1,85.0 to 94.1,269
Hep A,≥1 Dose,States/Local Areas,Minnesota,2014-2015,Age,24 Months,86.3,81.5 to 90.4,496
Hep A,≥1 Dose,States/Local Areas,Minnesota,2012,Age,24 Months,83.6,76.4 to 89.6,225
Hep A,≥1 Dose,States/Local Areas,Minnesota,2017,Age,24 Months,91.0,85.9 to 94.9,290
Hep A,≥1 Dose,States/Local Areas,Minnesota,2017-2018,Age,24 Months,90.2,86.5 to 93.3,618
Polio,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,94.3,90.6 to 96.9,522
DTaP,≥4 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,90.6,85.1 to 94.6,522
Combined 7 Series,,States/Local Areas,Minnesota,2019-2020,Age,24 Months,71.4,65.9 to 76.6,522
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,92.9,88.9 to 95.5,522
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,95.2,91.8 to 97.5,522
PCV,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,90.9,86.8 to 93.8,522
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019-2020,Age,13 Months,66.0,60.2 to 71.4,522
Hib,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,89.5,84.9 to 92.8,522
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,89.0,84.4 to 92.3,522
Polio,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,90.3,85.9 to 93.4,522
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,77.9,72.5 to 82.5,522
PCV,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,5 Months,82.1,76.8 to 86.4,522
Hep B,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,5 Months,87.1,82.2 to 90.8,522
Hib,Primary Series,States/Local Areas,Minnesota,2019-2020,Age,13 Months,85.6,80.7 to 89.4,522
Hep B,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,92.9,88.9 to 95.6,522
Hib,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,92.5,88.3 to 95.3,522
Hib,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,49.8,44.1 to 55.4,522
≥1 Dose MMR,,States/Local Areas,Minnesota,2019-2020,Age,13 Months,68.1,62.2 to 73.4,522
Polio,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,13 Months,93.0,89.0 to 95.6,522
Hib,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,5 Months,81.5,76.1 to 85.8,522
Polio,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,5 Months,82.4,77.1 to 86.6,522
DTaP,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,5 Months,82.6,77.3 to 86.8,522
PCV,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,3 Months,89.0,84.2 to 92.5,522
≥1 Dose MMR,,States/Local Areas,Minnesota,2019-2020,Age,24 Months,92.6,89.0 to 95.4,522
Hep B,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,3 Months,93.4,89.5 to 96.0,522
Polio,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,93.6,90.0 to 96.2,522
DTaP,≥4 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,83.3,78.4 to 87.6,522
PCV,≥4 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,87.3,82.8 to 91.1,522
DTaP,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,94.5,91.2 to 96.9,522
PCV,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,92.9,89.3 to 95.7,522
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019-2020,Age,35 Months,94.2,90.8 to 96.6,522
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,92.6,88.6 to 95.6,522
Hib,Primary Series,States/Local Areas,Minnesota,2019-2020,Age,35 Months,93.2,89.3 to 96.0,522
Hib,Full Series,States/Local Areas,Minnesota,2019-2020,Age,35 Months,80.7,75.6 to 85.3,522
≥1 Dose MMR,,States/Local Areas,Minnesota,2019-2020,Age,35 Months,93.9,90.4 to 96.4,522
Hib,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,35 Months,91.8,87.8 to 94.9,522
Hib,Primary Series,States/Local Areas,Minnesota,2019-2020,Age,19 Months,91.0,86.6 to 94.1,522
Hib,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,85.8,80.9 to 89.7,522
≥1 Dose MMR,,States/Local Areas,Minnesota,2019-2020,Age,19 Months,91.3,87.2 to 94.2,522
Hep A,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,31.2,26.3 to 36.6,522
PCV,≥4 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,85.1,80.4 to 89.1,522
PCV,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,92.9,89.3 to 95.7,522
PCV,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,76.2,70.7 to 81.0,522
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2019-2020,Age,0-3 Days,78.5,73.1 to 83.1,522
Hib,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,40.3,35.0 to 45.9,522
Hib,Full Series,States/Local Areas,Minnesota,2019-2020,Age,24 Months,77.9,72.7 to 82.6,522
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,24 Months,91.9,88.0 to 95.0,522
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019-2020,Age,24 Months,92.8,89.4 to 95.5,522
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2019-2020,Age,0-1 Days,72.9,67.2 to 77.9,522
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2019-2020,Age,0-2 Days,77.5,72.0 to 82.2,522
Hep A,≥1 Dose,States/Local Areas,Minnesota,2019-2020,Age,19 Months,88.3,83.7 to 91.7,522
PCV,≥4 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,79.9,74.6 to 84.4,522
PCV,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,19 Months,92.2,88.1 to 94.9,522
≥1 Dose Varicella,,States/Local Areas,Minnesota,2019-2020,Age,19 Months,90.3,86.0 to 93.4,522
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,87.9,80.4 to 92.8,239
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020,Age,19 Months,87.9,80.5 to 92.7,239
PCV,≥3 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,89.8,83.0 to 94.1,239
DTaP,≥4 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,93.2,85.2 to 97.7,239
Polio,≥3 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,94.4,88.9 to 97.7,239
PCV,≥4 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,76.3,67.9 to 83.0,239
PCV,≥4 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,84.8,77.7 to 90.6,239
PCV,≥3 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,90.9,84.9 to 95.3,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,48.3,40.3 to 56.4,239
Hib,Primary Series,States/Local Areas,Minnesota,2020,Age,13 Months,81.8,74.1 to 87.6,239
Hep B,≥2 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,90.2,83.2 to 94.5,239
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,86.7,79.2 to 91.7,239
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020,Age,13 Months,68.8,60.4 to 76.2,239
PCV,≥3 Doses,States/Local Areas,Minnesota,2020,Age,13 Months,87.7,80.8 to 92.3,239
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020,Age,7 Months,77.5,69.6 to 83.8,239
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,90.8,84.2 to 94.8,239
DTaP,≥4 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,75.7,67.3 to 82.5,239
≥1 Dose MMR,,States/Local Areas,Minnesota,2020,Age,19 Months,90.6,83.9 to 94.7,239
Polio,≥3 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,90.0,83.3 to 94.2,239
Hib,≥3 Doses,States/Local Areas,Minnesota,2020,Age,19 Months,83.6,75.8 to 89.3,239
Combined 7 Series,,States/Local Areas,Minnesota,2020,Age,24 Months,72.8,65.2 to 80.0,239
Influenza,,States/Local Areas,Minnesota,2020,Age,24 Months,65.6,57.6 to 73.5,239
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2020,Age,0-3 Days,77.5,69.3 to 84.0,239
Rotavirus,,States/Local Areas,Minnesota,2020,Age,8 Months,77.8,70.0 to 84.1,239
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020,Age,24 Months,91.8,86.5 to 95.6,239
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020,Age,35 Months,94.4,89.2 to 97.6,239
PCV,≥3 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,90.9,84.9 to 95.3,239
PCV,≥4 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,81.7,74.3 to 88.0,239
Hep A,≥2 Doses,States/Local Areas,Minnesota,2020,Age,24 Months,53.4,45.4 to 61.8,239
Hep A,≥1 Dose,States/Local Areas,Minnesota,2020,Age,24 Months,92.3,87.2 to 95.9,239
PCV,≥1 Dose,States/Local Areas,Minnesota,2020,Age,3 Months,89.3,82.3 to 93.7,239
Hep B,≥1 Dose,States/Local Areas,Minnesota,2020,Age,3 Months,90.5,83.6 to 94.7,239
DTaP,≥2 Doses,States/Local Areas,Minnesota,2020,Age,5 Months,81.1,73.2 to 87.1,239
Polio,≥2 Doses,States/Local Areas,Minnesota,2020,Age,5 Months,81.1,73.2 to 87.1,239
Hib,≥2 Doses,States/Local Areas,Minnesota,2020,Age,5 Months,79.7,71.5 to 86.0,239
Hep B,≥2 Doses,States/Local Areas,Minnesota,2020,Age,5 Months,87.8,80.3 to 92.7,239
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020-2021,Age,35 Months,92.7,88.4 to 95.9,415
DTaP,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,3 Months,87.1,81.1 to 91.4,415
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2021,Age,0-1 Days,84.6,75.0 to 91.0,176
Hep A,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,35 Months,94.0,88.7 to 97.4,415
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2021,Age,0-2 Days,85.2,75.5 to 91.5,176
Hib,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,91.6,87.2 to 94.6,415
PCV,≥3 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,83.1,73.1 to 89.9,176
PCV,≥3 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,94.2,88.9 to 97.5,176
Hib,≥3 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,88.7,86.5 to 90.5,198
Hib,≥3 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,89.0,85.0 to 92.0,230
Hib,≥3 Doses,States/Local Areas,Mississippi,2019,Age,13 Months,56.1,48.3 to 63.7,324
Polio,≥3 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,91.5,88.5 to 93.8,217
Polio,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,90.9,89.1 to 92.3,456
Polio,≥3 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,86.8,76.8 to 92.9,272
Polio,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,89.2,85.0 to 92.3,579
Polio,≥3 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,95.2,93.0 to 96.8,230
Polio,≥3 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,90.2,84.0 to 94.1,239
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,88.5,84.4 to 91.6,511
Polio,≥3 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,91.7,86.4 to 95.1,276
Polio,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,67.2,61.8 to 72.1,600
Hib,≥3 Doses,States/Local Areas,Mississippi,2018,Age,13 Months,61.4,53.6 to 68.6,276
Hib,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,13 Months,58.8,53.3 to 64.1,600
Polio,≥3 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,91.4,85.9 to 94.8,321
Polio,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,91.5,88.0 to 94.1,597
Polio,≥3 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,91.6,85.0 to 95.5,307
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,91.5,87.5 to 94.3,628
≥1 Dose Varicella,,States/Local Areas,Minnesota,2021,Age,19 Months,90.6,81.8 to 95.4,176
DTaP,≥4 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,72.7,62.1 to 81.3,176
≥1 Dose MMR,,States/Local Areas,Minnesota,2020-2021,Age,24 Months,92.0,87.6 to 95.3,415
Hep A,≥2 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,88.6,59.2 to 99.5,176
Polio,≥1 Dose,States/Local Areas,Minnesota,2021,Age,3 Months,81.9,71.7 to 88.9,176
≥1 Dose MMR,,States/Local Areas,Minnesota,2021,Age,24 Months,93.0,85.0 to 97.6,176
Hib,≥3 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,91.9,84.8 to 96.5,176
Hib,Full Series,States/Local Areas,Minnesota,2021,Age,24 Months,73.1,63.0 to 82.3,176
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,94.1,90.0 to 96.9,415
PCV,≥3 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,91.8,84.4 to 95.8,176
Hep A,≥1 Dose,States/Local Areas,Minnesota,2021,Age,35 Months,89.6,81.1 to 95.3,176
PCV,≥4 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,80.2,70.6 to 88.3,176
Hep A,≥1 Dose,States/Local Areas,Minnesota,2021,Age,24 Months,87.8,79.8 to 93.7,176
≥1 Dose Varicella,,States/Local Areas,Minnesota,2021,Age,24 Months,92.4,84.5 to 97.2,176
DTaP,≥3 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,92.0,84.4 to 96.0,176
PCV,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,5 Months,76.2,69.4 to 81.9,415
Hib,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,47.1,40.7 to 53.7,415
Hep B,≥3 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,76.1,65.7 to 84.1,176
Hep A,≥2 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,42.6,32.2 to 54.9,176
PCV,≥3 Doses,States/Local Areas,Minnesota,2021,Age,7 Months,59.1,48.4 to 69.0,176
PCV,≥4 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,77.1,66.8 to 84.9,176
Hep B,≥3 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,95.3,90.4 to 98.1,176
DTaP,≥3 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,88.5,79.6 to 93.8,176
Hep A,≥1 Dose,States/Local Areas,Minnesota,2021,Age,19 Months,85.9,77.1 to 91.7,176
Polio,≥2 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,92.9,85.2 to 96.7,176
DTaP,≥1 Dose,States/Local Areas,Minnesota,2021,Age,3 Months,84.4,74.7 to 90.8,176
DTaP,≥4 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,80.5,70.8 to 88.6,176
Hep A,≥2 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,23.5,16.5 to 32.4,176
PCV,≥4 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,80.8,71.1 to 88.8,176
Polio,≥3 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,92.5,85.2 to 97.0,176
Hib,Primary Series,States/Local Areas,Minnesota,2021,Age,24 Months,93.8,88.4 to 97.2,176
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,89.1,80.8 to 97.4,111
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.0,47.1 to 78.9,45
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,68.9,52.5 to 85.3,111
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,88.6,80.2 to 96.9,111
Hib,Primary Series,States/Local Areas,Wisconsin,2017,Age,19 Months,93.7,87.1 to 97.0,238
Hib,Primary Series,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,91.2,86.8 to 94.2,479
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,91.0,87.3 to 93.7,511
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,75.4,70.0 to 80.1,511
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,72.3,60.9 to 83.7,111
Hib,Primary Series,States/Local Areas,Wisconsin,2015,Age,19 Months,93.2,91.5 to 94.6,262
Hib,Primary Series,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,93.4,90.6 to 95.4,537
Hib,Primary Series,States/Local Areas,Wisconsin,2018,Age,19 Months,88.6,81.8 to 93.1,241
Hib,Primary Series,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,85.0,80.1 to 88.9,465
Hib,Primary Series,States/Local Areas,Wisconsin,2016,Age,19 Months,93.5,89.3 to 96.1,275
Hib,Primary Series,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,93.6,90.0 to 96.0,513
Hib,Primary Series,States/Local Areas,Wisconsin,2012,Age,24 Months,91.2,86.2 to 95.0,226
Hib,Primary Series,States/Local Areas,Wisconsin,2011,Age,24 Months,92.1,86.0 to 96.3,225
Hib,Primary Series,States/Local Areas,Wisconsin,2014,Age,7 Months,68.7,59.8 to 76.4,224
Hib,Primary Series,States/Local Areas,Wisconsin,2014-2015,Age,7 Months,72.3,66.6 to 77.4,486
Hib,Primary Series,States/Local Areas,Wisconsin,2016,Age,7 Months,77.5,70.4 to 83.3,275
Hib,Primary Series,States/Local Areas,Wisconsin,2016-2017,Age,7 Months,79.0,73.9 to 83.4,513
Hib,Primary Series,States/Local Areas,Wisconsin,2017,Age,7 Months,80.6,72.9 to 86.5,238
Hib,Primary Series,States/Local Areas,Wisconsin,2017-2018,Age,7 Months,81.0,76.0 to 85.2,479
Hib,Primary Series,States/Local Areas,Wisconsin,2018,Age,13 Months,85.5,78.5 to 90.5,241
Hib,Primary Series,States/Local Areas,Wisconsin,2018-2019,Age,13 Months,85.0,80.1 to 88.9,465
Hib,Primary Series,States/Local Areas,Wisconsin,2019,Age,13 Months,84.6,76.9 to 90.1,224
Hib,Primary Series,States/Local Areas,Wisconsin,2016,Age,13 Months,89.6,84.0 to 93.4,275
Hib,Primary Series,States/Local Areas,Wisconsin,2016-2017,Age,13 Months,89.9,85.7 to 93.0,513
Hib,Primary Series,States/Local Areas,Wisconsin,2019,Age,7 Months,70.6,61.8 to 78.1,224
Hib,Primary Series,States/Local Areas,Wisconsin,2017,Age,13 Months,90.2,83.5 to 94.4,238
Hib,Primary Series,States/Local Areas,Wisconsin,2017-2018,Age,13 Months,87.9,83.3 to 91.3,479
Combined 7 Series,,States/Local Areas,Wisconsin,2017,Age,35 Months,75.2,65.1 to 84.3,238
Combined 7 Series,,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,76.5,70.1 to 82.4,479
Combined 7 Series,,States/Local Areas,Wisconsin,2016,Age,35 Months,76.9,70.2 to 83.1,275
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,75.8,70.0 to 81.2,513
Hib,Primary Series,States/Local Areas,Wisconsin,2017,Age,35 Months,93.9,88.1 to 97.5,238
Hib,Primary Series,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,94.5,89.6 to 97.5,479
Combined 7 Series,,States/Local Areas,Wisconsin,2013,Age,35 Months,75.2,67.7 to 82.1,235
Combined 7 Series,,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,76.3,70.4 to 81.7,459
Combined 7 Series,,States/Local Areas,Wisconsin,2013,Age,24 Months,72.0,64.8 to 78.9,235
Combined 7 Series,,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,71.8,66.2 to 77.1,459
Combined 7 Series,,States/Local Areas,Wisconsin,2014,Age,35 Months,77.0,68.4 to 84.7,224
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,76.6,70.8 to 81.9,486
Combined 7 Series,,States/Local Areas,Wisconsin,2012,Age,35 Months,70.7,62.6 to 78.3,226
Hib,Primary Series,States/Local Areas,Wisconsin,2019,Age,19 Months,89.7,83.0 to 93.9,224
Combined 7 Series,,States/Local Areas,Wisconsin,2015,Age,24 Months,68.1,61.1 to 74.9,262
Combined 7 Series,,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,71.8,66.9 to 76.4,537
Hib,Primary Series,States/Local Areas,Wisconsin,2018,Age,35 Months,94.0,86.7 to 98.1,241
Hib,Primary Series,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,92.5,88.3 to 95.6,465
Hib,Primary Series,States/Local Areas,Wisconsin,2019,Age,35 Months,91.6,85.7 to 95.8,224
Combined 7 Series,,States/Local Areas,Wisconsin,2014,Age,24 Months,71.6,63.4 to 79.3,224
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,69.9,64.5 to 75.2,486
Hib,Primary Series,States/Local Areas,Wisconsin,2012,Age,19 Months,91.2,86.2 to 94.6,226
Hib,Primary Series,States/Local Areas,Wisconsin,2014,Age,19 Months,88.4,81.2 to 93.1,224
Hib,Primary Series,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,90.8,86.9 to 93.7,486
Hib,Primary Series,States/Local Areas,Wisconsin,2012,Age,7 Months,70.8,63.4 to 77.2,226
Combined 7 Series,,States/Local Areas,Wisconsin,2016,Age,24 Months,75.3,68.6 to 81.6,275
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,71.8,66.4 to 76.9,513
Combined 7 Series,,States/Local Areas,Wisconsin,2019,Age,24 Months,70.4,62.3 to 78.1,224
Combined 7 Series,,States/Local Areas,Wisconsin,2017,Age,24 Months,67.7,59.6 to 75.6,238
Combined 7 Series,,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,71.8,66.4 to 77.1,479
Combined 7 Series,,States/Local Areas,Wisconsin,2018,Age,24 Months,75.7,68.5 to 82.3,241
Combined 7 Series,,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,73.1,67.7 to 78.3,465
Hib,Primary Series,States/Local Areas,Wisconsin,2014,Age,35 Months,90.6,84.3 to 95.1,224
Hib,Primary Series,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,92.0,88.5 to 94.8,486
Hib,Primary Series,States/Local Areas,Wisconsin,2013,Age,13 Months,84.6,76.7 to 90.2,235
Hib,Primary Series,States/Local Areas,Wisconsin,2013-2014,Age,13 Months,84.6,80.5 to 88.0,459
Hib,Primary Series,States/Local Areas,Wisconsin,2012,Age,13 Months,84.9,80.2 to 88.6,226
Hib,Primary Series,States/Local Areas,Wisconsin,2011,Age,13 Months,88.0,83.5 to 91.4,225
Hib,Primary Series,States/Local Areas,Wisconsin,2018,Age,7 Months,81.4,74.3 to 86.9,241
Hib,Primary Series,States/Local Areas,Wisconsin,2018-2019,Age,7 Months,76.0,70.4 to 80.9,465
Hib,Primary Series,States/Local Areas,Wisconsin,2015,Age,7 Months,76.0,69.2 to 81.6,262
Hib,Primary Series,States/Local Areas,Wisconsin,2015-2016,Age,7 Months,76.7,71.9 to 80.9,537
Hib,Primary Series,States/Local Areas,Wisconsin,2015,Age,13 Months,86.8,81.0 to 91.0,262
Hib,Primary Series,States/Local Areas,Wisconsin,2015-2016,Age,13 Months,88.2,84.4 to 91.2,537
Hib,Primary Series,States/Local Areas,Wisconsin,2014,Age,13 Months,84.7,76.9 to 90.2,224
Hib,Primary Series,States/Local Areas,Wisconsin,2014-2015,Age,13 Months,85.7,80.8 to 89.5,486
Hib,Primary Series,States/Local Areas,Wisconsin,2013,Age,7 Months,71.7,66.6 to 76.4,235
Hib,Primary Series,States/Local Areas,Wisconsin,2013-2014,Age,7 Months,70.2,68.1 to 72.3,459
Hib,Primary Series,States/Local Areas,Wisconsin,2013,Age,19 Months,90.0,82.7 to 94.5,235
Hib,Primary Series,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,89.2,87.0 to 91.1,459
Hib,Primary Series,States/Local Areas,Wisconsin,2011,Age,19 Months,91.3,85.2 to 95.1,225
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,76.4,67.1 to 85.7,125
Hib,Full Series,States/Local Areas,Wisconsin,2017,Age,19 Months,75.8,67.8 to 82.3,238
Hib,Full Series,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,75.2,69.8 to 79.9,479
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,69.2,63.0 to 75.4,332
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,78.0,73.7 to 82.3,548
Combined 7 Series,,States/Local Areas,Wisconsin,2019,Age,35 Months,73.6,65.0 to 81.4,224
Combined 7 Series,,States/Local Areas,Wisconsin,2018,Age,35 Months,77.4,70.1 to 84.0,241
Combined 7 Series,,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,75.6,70.0 to 80.8,465
Hib,Full Series,States/Local Areas,Wisconsin,2016,Age,19 Months,78.3,71.6 to 83.7,275
Hib,Full Series,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,77.1,72.0 to 81.5,513
Hib,Full Series,States/Local Areas,Wisconsin,2018,Age,19 Months,74.5,66.8 to 81.0,241
Hib,Full Series,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,95.9,93.2 to 97.5,465
Hib,Full Series,States/Local Areas,Wisconsin,2014,Age,19 Months,72.6,64.0 to 79.8,224
Hib,Full Series,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,74.8,69.3 to 79.6,486
Hib,Full Series,States/Local Areas,Wisconsin,2015,Age,19 Months,77.0,70.2 to 82.7,262
Hib,Full Series,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,77.7,73.1 to 81.7,537
Hib,Full Series,States/Local Areas,Wisconsin,2019,Age,19 Months,74.6,66.3 to 81.4,224
Hib,Full Series,States/Local Areas,Wisconsin,2013,Age,24 Months,79.8,73.1 to 85.8,235
Hib,Full Series,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,80.0,74.8 to 84.7,459
Hib,Full Series,States/Local Areas,Wisconsin,2013,Age,19 Months,76.1,68.8 to 82.1,235
Hib,Full Series,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,74.4,71.5 to 77.1,459
Hib,Full Series,States/Local Areas,Wisconsin,2011,Age,24 Months,79.7,71.6 to 86.7,225
Hib,Full Series,States/Local Areas,Wisconsin,2012,Age,24 Months,76.5,68.7 to 83.5,226
Combined 7 Series,,States/Local Areas,Wisconsin,2011,Age,24 Months,71.8,63.6 to 79.4,225
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,33.4,13.7 to 53.0,34
Combined 7 Series,,States/Local Areas,Wisconsin,2015,Age,35 Months,76.5,69.0 to 83.4,262
Combined 7 Series,,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,76.4,71.5 to 81.0,537
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,72.4,68.7 to 76.1,923
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,65.8,57.5 to 74.2,212
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.7,42.0 to 75.3,45
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,66.9,59.7 to 74.1,236
Hib,Full Series,States/Local Areas,Wisconsin,2012,Age,19 Months,72.0,65.4 to 77.8,226
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,83.6,78.5 to 88.6,303
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,68.7,62.8 to 74.6,384
Hib,Full Series,States/Local Areas,Wisconsin,2011,Age,19 Months,74.7,71.8 to 77.5,225
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,75.4,70.0 to 80.7,404
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.9,65.7 to 78.1,307
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.9,69.6 to 78.2,661
Combined 7 Series,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.2,57.0 to 79.3,92
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,5 Months,81.7,73.9 to 87.5,238
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,5 Months,80.2,75.0 to 84.5,479
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.7,89.9 to 97.5,307
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,85.0,78.6 to 91.4,212
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,5 Months,83.7,77.6 to 88.3,275
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,5 Months,82.7,77.9 to 86.6,513
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,94.8,89.5 to 97.9,238
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,92.8,89.1 to 95.6,479
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,90.6,84.9 to 94.8,241
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,90.0,85.9 to 93.3,465
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,96.4,93.9 to 99.0,303
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,91.3,87.5 to 95.0,384
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,86.9,81.5 to 92.3,236
Polio,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,91.4,88.9 to 93.8,923
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,94.2,90.5 to 96.8,275
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,94.5,91.4 to 96.8,513
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,89.3,83.0 to 94.0,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,92.2,87.8 to 95.5,262
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,91.7,88.5 to 94.3,537
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,24 Months,91.2,86.3 to 94.9,275
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,91.3,87.4 to 94.3,513
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,5 Months,78.6,71.1 to 84.6,241
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,5 Months,79.9,74.6 to 84.4,465
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,19 Months,78.7,73.7 to 82.9,262
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,81.5,77.1 to 85.1,537
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,19 Months,72.7,64.1 to 79.9,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,75.7,70.2 to 80.4,486
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,3 Months,90.7,83.9 to 94.9,238
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,3 Months,90.1,85.8 to 93.2,479
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,19 Months,80.6,67.9 to 89.1,225
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,24 Months,93.1,88.1 to 96.6,235
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,90.6,86.2 to 94.1,459
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,3 Months,89.4,83.1 to 93.6,241
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,3 Months,88.6,84.0 to 92.0,465
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,3 Months,87.7,80.3 to 92.6,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,24 Months,95.3,92.2 to 97.4,262
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,94.7,92.4 to 96.5,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,88.0,80.7 to 93.5,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,91.6,87.6 to 94.7,486
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,3 Months,84.7,79.9 to 88.4,235
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,3 Months,86.2,84.0 to 88.1,459
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,3 Months,87.7,80.6 to 92.4,224
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,3 Months,87.7,83.4 to 91.0,486
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,3 Months,87.8,81.9 to 91.9,262
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,3 Months,87.3,83.3 to 90.4,537
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,3 Months,86.8,80.9 to 91.1,275
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,3 Months,88.8,84.5 to 92.0,513
Hib,Full Series,States/Local Areas,Wisconsin,2021,Age,19 Months,73.1,64.0 to 80.7,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,24 Months,84.3,76.7 to 90.4,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,88.2,83.9 to 91.8,486
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,19 Months,75.2,72.1 to 78.1,235
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,74.0,71.2 to 76.6,459
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,89.4,83.0 to 94.2,485
PCV,≥4 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,83.9,79.0 to 88.2,485
Hib,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,5 Months,76.1,66.7 to 83.5,198
Combined 7 Series,,States/Local Areas,Wisconsin,2021,Age,35 Months,72.4,62.8 to 81.2,198
Hib,Primary Series,States/Local Areas,Wisconsin,2021,Age,7 Months,73.5,64.2 to 81.1,198
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,3 Months,87.8,81.6 to 92.1,226
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,3 Months,92.0,88.2 to 94.7,225
Hib,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,3 Months,84.9,76.5 to 90.6,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,88.5,80.5 to 93.5,198
PCV,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,5 Months,78.8,69.6 to 85.8,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,86.1,81.5 to 90.1,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,90.0,85.5 to 93.3,485
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,90.1,82.7 to 94.6,198
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,19 Months,79.2,74.0 to 83.6,226
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,91.9,88.0 to 94.7,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,70.1,60.1 to 78.6,198
Polio,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,85.7,77.2 to 91.4,198
Hib,Primary Series,States/Local Areas,Wisconsin,2021,Age,19 Months,86.8,78.5 to 92.3,198
Hib,Primary Series,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,90.8,86.6 to 94.1,485
Hib,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,81.5,72.8 to 87.9,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,21.0,14.6 to 29.2,198
Hib,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,82.6,73.6 to 88.9,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,87.0,82.1 to 90.8,485
≥1 Dose MMR,,States/Local Areas,Wisconsin,2021,Age,35 Months,89.7,82.8 to 94.7,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,88.3,81.8 to 93.3,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,93.3,89.3 to 96.3,262
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,23.7,19.3 to 28.7,262
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,25.8,21.6 to 30.4,537
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,19 Months,27.9,21.8 to 34.9,275
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,29.6,24.8 to 34.8,513
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,91.3,86.2 to 95.0,235
Hib,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,88.6,84.0 to 92.4,459
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,85.9,78.3 to 91.9,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,89.6,85.3 to 93.1,486
PCV,≥2 Doses,States/Local Areas,Wisconsin,2015,Age,5 Months,80.7,74.5 to 85.7,262
PCV,≥2 Doses,States/Local Areas,Wisconsin,2015-2016,Age,5 Months,81.4,77.1 to 85.0,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,94.8,89.5 to 97.9,238
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,93.0,89.3 to 95.8,479
PCV,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,5 Months,75.5,68.4 to 81.5,235
PCV,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,5 Months,72.1,68.1 to 75.7,459
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,35 Months,91.9,85.8 to 96.1,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,35 Months,91.1,85.2 to 95.3,241
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,35 Months,91.6,87.5 to 94.8,465
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2015,Age,24 Months,82.6,76.8 to 87.7,262
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,86.0,82.2 to 89.4,537
Hib,Primary Series,States/Local Areas,Wisconsin,2016,Age,24 Months,94.7,91.1 to 97.2,275
Hib,Primary Series,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,94.4,91.1 to 96.8,513
Hib,Primary Series,States/Local Areas,Wisconsin,2018,Age,24 Months,90.8,85.0 to 95.0,241
Hib,Primary Series,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,90.6,86.6 to 93.8,465
Hib,Primary Series,States/Local Areas,Wisconsin,2017,Age,24 Months,93.9,88.1 to 97.5,238
Hib,Primary Series,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,92.4,88.5 to 95.4,479
Hib,Primary Series,States/Local Areas,Wisconsin,2015,Age,24 Months,93.6,89.7 to 96.4,262
Hib,Primary Series,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,94.2,91.6 to 96.2,537
Hib,Primary Series,States/Local Areas,Wisconsin,2014,Age,24 Months,90.2,84.0 to 94.8,224
Hib,Primary Series,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,91.9,88.4 to 94.6,486
Hib,Primary Series,States/Local Areas,Wisconsin,2019,Age,24 Months,90.4,84.4 to 94.8,224
Hib,Primary Series,States/Local Areas,Wisconsin,2011,Age,35 Months,97.6,92.8 to 99.5,225
Hib,Primary Series,States/Local Areas,Wisconsin,2013,Age,35 Months,91.5,86.5 to 95.3,235
Hib,Primary Series,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,91.1,87.1 to 94.2,459
Hib,Primary Series,States/Local Areas,Wisconsin,2012,Age,35 Months,91.2,86.2 to 95.0,226
Combined 7 Series,,States/Local Areas,Wisconsin,2012,Age,24 Months,68.4,60.5 to 76.1,226
Hib,Primary Series,States/Local Areas,Wisconsin,2016,Age,35 Months,94.7,91.1 to 97.2,275
Hib,Primary Series,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,94.4,91.1 to 96.8,513
Hib,Primary Series,States/Local Areas,Wisconsin,2015,Age,35 Months,93.6,89.7 to 96.4,262
Hib,Primary Series,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,94.2,91.6 to 96.2,537
Hib,Primary Series,States/Local Areas,Wisconsin,2013,Age,24 Months,91.5,86.5 to 95.3,235
Hib,Primary Series,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,90.9,86.9 to 94.1,459
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,47.7,42.1 to 53.6,511
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,88.4,82.7 to 92.5,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,20.5,15.6 to 26.6,287
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,72.1,66.7 to 77.0,511
Polio,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,89.1,84.9 to 92.2,511
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,87.2,82.6 to 90.7,511
Hib,Primary Series,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,73.1,67.5 to 78.1,511
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,88.6,82.5 to 94.8,178
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,83.8,78.6 to 89.1,376
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.2,85.2 to 93.2,329
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,72.1,62.3 to 81.9,178
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,60.0,49.9 to 70.1,178
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.2,68.3 to 80.2,329
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,75.5,69.5 to 81.5,376
Influenza,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,68.9,62.5 to 75.3,376
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,86.6,81.6 to 91.6,376
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.3,83.4 to 93.2,329
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,65.5,56.3 to 74.8,178
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,85.5 to 94.6,376
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,80.0 to 89.4,329
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,74.4,65.1 to 83.8,178
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,75.2 to 86.4,376
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,65.8,53.5 to 78.1,178
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,66.3,59.4 to 73.3,301
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,87.8,82.8 to 92.9,301
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,71.3,63.2 to 79.3,193
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,83.7,80.2 to 87.1,883
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,86.1,81.0 to 91.2,373
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,70.8,62.8 to 78.8,193
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,80.9,75.5 to 86.4,373
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,91.9,88.0 to 95.8,373
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,85.8,79.6 to 92.0,193
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,90.6,86.3 to 94.8,317
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,90.1,85.5 to 94.7,373
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,89.8,85.1 to 94.4,317
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,83.4,76.8 to 90.0,193
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,82.8,76.2 to 89.4,193
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,86.1,80.9 to 91.4,373
Influenza,,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,65.0,58.5 to 71.5,373
Influenza,,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,50.1,41.5 to 58.6,193
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,94.6,90.7 to 98.4,317
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,91.8,89.3 to 94.2,883
Influenza,,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,84.0,78.4 to 89.6,317
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,92.7,90.3 to 95.1,883
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,94.8,91.6 to 97.9,373
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,85.7,79.5 to 92.0,193
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,95.6,92.4 to 98.9,317
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,72.9,65.2 to 80.6,373
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,81.1,75.7 to 86.5,317
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,65.0,56.6 to 73.3,193
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,91.7,87.4 to 96.1,317
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,79.9,74.5 to 85.3,373
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,86.7 to 95.3,376
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,85.0,77.8 to 92.2,178
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,90.8,85.4 to 96.1,178
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,86.7 to 95.3,376
Influenza,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.6,66.5 to 78.8,329
Influenza,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,49.6,39.9 to 59.2,178
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,73.9,67.9 to 80.0,376
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.6,91.7 to 97.6,329
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,84.9,77.9 to 92.0,178
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.0,87.0 to 95.0,329
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,83.6,79.1 to 88.1,376
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,78.2,69.2 to 87.1,178
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.4,79.4 to 89.4,329
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,94.8,91.5 to 98.1,317
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,80.9,73.1 to 88.7,178
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,81.1,77.5 to 84.6,883
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,62.2,53.8 to 70.6,193
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,82.7,77.7 to 87.8,373
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,95.2,92.4 to 98.0,317
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,81.1,75.3 to 86.9,317
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,70.6,64.2 to 76.9,373
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,77.4,73.6 to 81.1,883
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,75.0,69.8 to 80.2,883
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,87.6,84.5 to 90.8,883
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,96.1,93.2 to 99.0,317
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,89.9,87.0 to 92.8,883
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,84.4,80.9 to 87.9,883
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,90.2,85.2 to 95.1,193
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,90.4,86.2 to 94.7,373
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Overall,Overall,83.4,80.3 to 86.5,883
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,71.6,57.8 to 85.5,193
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,71.4,67.4 to 75.5,883
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,86.9,81.4 to 92.4,193
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,93.5,90.0 to 97.1,373
Influenza,,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,66.6,62.4 to 70.8,883
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,85.9,79.7 to 92.1,193
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,80.3,73.1 to 87.5,193
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,82.4,74.5 to 90.3,317
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,96.1,93.2 to 99.0,317
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,90.5,85.4 to 95.6,317
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,82.5,76.9 to 88.2,373
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,<133% FPL,70.9,62.7 to 79.1,193
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,92.2,89.7 to 94.7,883
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,81.1,77.4 to 84.8,883
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Overall,Overall,91.2,88.5 to 93.8,883
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Poverty,>400% FPL,85.2,79.7 to 90.7,317
Influenza,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,70.8,59.8 to 81.9,111
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,75.2,68.5 to 81.8,301
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.1,68.3 to 95.9,45
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.2 to 97.8,543
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,84.9,79.2 to 90.5,301
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,76.4,65.0 to 87.8,111
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,65.4 to 87.2,116
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,81.4,75.8 to 87.0,543
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,71.9,61.1 to 82.7,301
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,77.8 to 96.4,116
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.7,52.0 to 83.5,45
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,88.4,84.8 to 92.1,543
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,87.9 to 94.1,611
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,87.4,83.2 to 91.0,511
Influenza,,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,67.1,61.5 to 72.5,511
Hib,Primary Series,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,91.7,88.0 to 94.6,511
Combined 7 Series,,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,73.8,68.1 to 79.3,511
Hib,Full Series,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,75.2,69.8 to 79.8,511
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,84.0,79.1 to 87.9,511
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,92.3,88.7 to 94.8,511
PCV,≥4 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,79.5,74.4 to 83.8,511
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,82.7,77.9 to 86.6,511
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2019-2020,Age,0-1 Days,80.0,75.0 to 84.2,511
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2019-2020,Age,0-2 Days,83.3,78.4 to 87.2,511
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,68.1,62.3 to 73.3,511
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,23.8,19.5 to 28.7,511
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2019-2020,Age,0-3 Days,84.8,80.1 to 88.6,511
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,87.9,83.7 to 91.4,511
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,92.9,89.6 to 95.4,511
Hib,Full Series,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,80.2,75.3 to 84.7,511
PCV,≥4 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,82.4,77.7 to 86.6,511
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,90.6,86.7 to 93.7,511
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,28.8,24.1 to 33.9,511
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,88.2,83.9 to 91.5,511
Hib,Primary Series,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,90.1,86.0 to 93.1,511
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,84.7,80.1 to 88.4,511
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,90.0,85.7 to 93.4,511
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,93.8,90.0 to 96.5,511
Hib,Primary Series,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,92.6,89.0 to 95.4,511
Hib,Full Series,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,82.6,77.5 to 87.1,511
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,94.3,90.9 to 96.8,511
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,92.3,87.9 to 95.5,511
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,91.5,87.6 to 94.5,511
PCV,≥4 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,85.8,81.0 to 89.9,511
Polio,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,90.2,86.3 to 93.3,511
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,80.1,75.2 to 84.6,511
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,91.2,87.5 to 94.1,511
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,90.8,87.0 to 93.9,511
PCV,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,3 Months,85.6,80.9 to 89.4,511
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,3 Months,93.9,90.5 to 96.1,511
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,5 Months,79.1,73.8 to 83.5,511
Hib,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,5 Months,77.3,71.9 to 81.8,511
Polio,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,5 Months,78.0,72.7 to 82.6,511
Polio,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,92.3,88.6 to 94.9,511
≥1 Dose MMR,,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,67.3,61.6 to 72.5,511
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,41.8,36.4 to 47.4,511
Hib,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,92.0,88.2 to 94.6,511
Hib,Primary Series,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,84.2,79.3 to 88.1,511
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,93.9,90.6 to 96.0,511
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,5 Months,89.6,85.8 to 92.6,511
PCV,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,5 Months,78.3,72.9 to 82.8,511
Polio,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,85.4,80.5 to 89.3,511
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,68.5,62.8 to 73.7,511
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,89.4,85.2 to 92.5,511
Hib,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,7 Months,85.8,81.0 to 89.5,511
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,54.9,49.2 to 60.4,511
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,13 Months,86.4,81.7 to 90.0,511
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,90.1,86.0 to 93.1,511
Combined 7 Series,,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,68.6,63.2 to 73.9,511
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,93.7,90.1 to 96.4,511
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,85.8,80.8 to 90.1,511
Polio,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,92.8,89.0 to 95.7,511
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,88.1,83.1 to 93.1,301
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.8,66.9 to 94.7,45
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.9,88.9 to 94.9,611
Influenza,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.8,63.8 to 73.8,611
Influenza,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",44.2,27.5 to 61.0,45
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,80.9,70.5 to 91.2,111
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.7,56.5 to 86.8,45
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.9,83.2 to 90.6,611
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,77.2,66.3 to 88.1,111
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,68.5,56.8 to 80.2,111
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",58.7,42.4 to 75.0,45
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.0,69.4 to 78.7,611
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,67.7,61.0 to 74.5,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,87.8,80.9 to 94.8,111
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.3,82.7 to 89.9,611
Influenza,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,55.6,48.5 to 62.7,301
Influenza,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,78.5,73.7 to 83.3,543
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,67.7 to 89.7,116
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,88.8,85.5 to 92.2,543
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,97.1,95.3 to 98.8,543
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.3,63.6 to 85.0,116
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,93.6,90.8 to 96.4,543
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,87.8,79.0 to 96.6,111
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,76.9 to 95.6,116
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.0,65.0 to 93.1,45
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,89.6 to 95.4,611
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,86.8,82.0 to 91.5,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,83.6,79.8 to 87.4,543
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,74.0 to 92.9,116
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.2,76.9 to 97.5,45
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,78.2,73.6 to 82.8,543
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.9,78.0 to 85.7,611
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.3,77.3 to 85.4,611
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",53.3,36.7 to 70.0,45
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,92.6 to 99.6,116
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.8,64.7 to 92.8,45
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.0,85.5 to 92.5,611
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,92.4,85.2 to 99.6,111
Hib,Primary Series,States/Local Areas,Wisconsin,2020,Age,7 Months,75.9,68.8 to 81.9,287
Polio,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,86.9,80.7 to 91.3,287
Hib,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,87.6,81.5 to 91.9,287
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2020,Age,0-1 Days,78.6,72.0 to 84.0,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2020,Age,0-2 Days,82.8,76.6 to 87.6,287
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,31.5,25.2 to 38.6,287
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,19 Months,82.0,75.5 to 87.1,287
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020,Age,13 Months,68.0,60.5 to 74.7,287
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,80.5,72.7 to 87.3,287
Combined 7 Series,,States/Local Areas,Wisconsin,2020,Age,35 Months,74.5,66.6 to 81.7,287
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,24 Months,84.8,80.3 to 88.7,511
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,88.7,84.3 to 92.4,511
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2019-2020,Age,35 Months,80.5,74.5 to 85.9,511
Polio,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,92.5,87.5 to 95.6,287
Polio,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,3 Months,85.4,80.7 to 89.2,511
Hib,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,3 Months,84.4,79.5 to 88.3,511
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,5 Months,87.0,81.0 to 91.3,287
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,3 Months,83.4,76.7 to 88.5,287
Hib,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,5 Months,75.7,68.3 to 81.8,287
Polio,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,5 Months,76.4,69.1 to 82.4,287
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,5 Months,76.7,69.4 to 82.7,287
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2019-2020,Age,3 Months,85.6,80.9 to 89.4,511
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,19 Months,83.5,76.1 to 88.9,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2012,Age,24 Months,80.8,74.3 to 86.6,226
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,24 Months,83.0,76.8 to 88.3,225
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2013,Age,24 Months,77.9,70.5 to 84.6,235
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,77.3,71.8 to 82.3,459
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,80.8,67.3 to 94.3,34
Hib,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,92.9,89.9 to 95.3,537
Hib,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,97.3,92.2 to 99.4,225
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,5 Months,81.3,73.2 to 87.3,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,19 Months,82.9,76.0 to 88.1,241
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,82.7,76.7 to 87.4,369
PCV,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,3 Months,84.2,77.6 to 89.2,287
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,3 Months,91.7,86.5 to 95.1,287
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,24 Months,83.6,77.5 to 88.8,287
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,50.2,42.9 to 58.1,287
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,91.5,86.4 to 95.2,287
PCV,≥4 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,83.5,77.5 to 88.6,287
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020,Age,24 Months,88.1,82.7 to 92.4,287
Influenza,,States/Local Areas,Wisconsin,2020,Age,24 Months,66.7,59.5 to 73.8,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2020,Age,0-3 Days,85.8,79.9 to 90.1,287
Rotavirus,,States/Local Areas,Wisconsin,2020,Age,8 Months,75.5,68.2 to 81.6,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,86.0,79.9 to 90.5,287
Combined 7 Series,,States/Local Areas,Wisconsin,2020,Age,24 Months,66.8,59.6 to 73.8,287
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020,Age,19 Months,90.0,84.6 to 93.6,287
Polio,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,89.6,84.0 to 93.4,287
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,71.1,63.7 to 77.5,287
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,91.7,86.6 to 95.0,287
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,70.5,63.2 to 76.9,287
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020,Age,13 Months,56.0,48.5 to 63.2,287
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,87.7,81.7 to 92.0,287
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,87.3,81.3 to 91.7,287
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,92.3,87.3 to 95.4,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,13 Months,40.8,33.8 to 48.2,287
Hib,Primary Series,States/Local Areas,Wisconsin,2020,Age,13 Months,83.9,77.3 to 88.8,287
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,92.0,86.9 to 95.7,287
PCV,≥4 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,79.6,72.8 to 85.0,287
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,85.7,79.0 to 91.2,287
Polio,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,94.4,89.6 to 97.4,287
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,95.7,91.4 to 98.3,287
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,89.7,84.0 to 93.6,287
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020,Age,19 Months,84.8,78.5 to 89.5,287
Hib,Full Series,States/Local Areas,Wisconsin,2020,Age,19 Months,76.0,69.0 to 81.9,287
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,19 Months,91.4,86.4 to 94.7,287
Hib,Primary Series,States/Local Areas,Wisconsin,2020,Age,19 Months,90.6,85.2 to 94.2,287
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020,Age,35 Months,92.3,86.8 to 96.1,287
Hib,Full Series,States/Local Areas,Wisconsin,2020,Age,35 Months,84.0,77.5 to 89.5,287
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,94.6,89.5 to 97.7,287
Hib,Primary Series,States/Local Areas,Wisconsin,2020,Age,35 Months,93.6,89.4 to 96.6,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,35 Months,90.5,84.8 to 94.8,287
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020,Age,35 Months,94.3,89.9 to 97.2,287
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020,Age,24 Months,92.1,87.6 to 95.5,287
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,87.9,82.4 to 92.3,287
Polio,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,91.6,86.9 to 95.1,287
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,79.5,72.9 to 85.4,287
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,24 Months,93.1,89.1 to 96.1,287
PCV,≥2 Doses,States/Local Areas,Wisconsin,2020,Age,5 Months,76.8,69.6 to 82.8,287
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014,Age,24 Months,76.5,68.5 to 83.8,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,79.6,74.5 to 84.3,486
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,24 Months,89.4,84.2 to 93.4,275
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,87.9,83.8 to 91.4,513
PCV,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,5 Months,68.5,59.5 to 76.4,224
PCV,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,5 Months,74.6,70.5 to 78.3,486
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,24 Months,52.6,44.1 to 61.5,225
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2018,Age,19 Months,25.0,18.9 to 32.2,241
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2018-2019,Age,19 Months,24.1,18.8 to 30.3,369
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,92.3,87.7 to 95.7,275
Hib,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,92.0,88.2 to 95.0,513
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,35 Months,91.3,85.0 to 95.6,238
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,35 Months,90.6,86.3 to 94.1,479
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,75.1,67.8 to 81.3,235
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,72.6,69.7 to 75.3,459
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,70.0,61.4 to 77.4,224
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,72.0,66.4 to 76.9,486
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2015,Age,19 Months,73.9,68.9 to 78.4,262
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2015-2016,Age,19 Months,73.6,68.8 to 78.0,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,88.5,84.0 to 93.0,332
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,98.0,96.8 to 99.2,548
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2017,Age,19 Months,31.2,24.1 to 39.4,238
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,28.1,23.3 to 33.5,479
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,24 Months,86.4,79.9 to 91.7,238
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,86.1,81.8 to 89.9,479
PCV,≥2 Doses,States/Local Areas,Wisconsin,2016,Age,5 Months,82.1,75.9 to 87.0,275
PCV,≥2 Doses,States/Local Areas,Wisconsin,2016-2017,Age,5 Months,79.8,74.8 to 84.0,513
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2019,Age,19 Months,26.5,20.1 to 34.2,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2019,Age,24 Months,85.9,79.2 to 91.4,224
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2011,Age,35 Months,89.4,82.2 to 94.6,225
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2018,Age,24 Months,85.7,79.6 to 90.8,241
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,85.9,81.4 to 89.7,465
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016,Age,19 Months,84.3,78.2 to 88.9,275
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2017,Age,19 Months,83.0,78.1 to 86.9,513
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2017,Age,19 Months,81.6,73.8 to 87.5,238
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2017-2018,Age,19 Months,82.3,77.2 to 86.4,479
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,31.8,28.5 to 35.2,225
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014,Age,35 Months,88.1,80.8 to 93.6,224
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2014-2015,Age,35 Months,91.8,87.8 to 94.9,486
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013,Age,35 Months,93.1,88.1 to 96.6,235
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2013-2014,Age,35 Months,90.6,86.2 to 94.1,459
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2012,Age,35 Months,93.7,89.4 to 96.7,226
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2011,Age,35 Months,96.0,91.1 to 98.6,225
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2013,Age,19 Months,27.8,22.0 to 34.5,235
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2013-2014,Age,19 Months,28.6,24.4 to 33.2,459
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,33.2,27.3 to 39.8,226
Hib,≥3 Doses,States/Local Areas,Wisconsin,2019,Age,24 Months,87.0,80.5 to 92.1,224
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017,Age,24 Months,91.3,85.0 to 95.6,238
Hib,≥3 Doses,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,89.7,85.4 to 93.2,479
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018,Age,24 Months,87.7,81.4 to 92.6,241
Hib,≥3 Doses,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,87.3,82.9 to 91.0,465
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014,Age,19 Months,29.4,22.8 to 37.1,224
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2014-2015,Age,19 Months,26.5,22.1 to 31.5,486
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2012,Age,19 Months,71.3,59.1 to 81.1,226
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2011,Age,19 Months,76.1,75.2 to 77.0,225
PCV,≥2 Doses,States/Local Areas,Wisconsin,2012,Age,5 Months,76.5,70.9 to 81.3,226
PCV,≥2 Doses,States/Local Areas,Wisconsin,2011,Age,5 Months,79.5,73.5 to 84.5,225
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015,Age,35 Months,95.6,92.5 to 97.6,262
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2015-2016,Age,35 Months,95.4,93.3 to 97.0,537
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016,Age,35 Months,95.2,92.1 to 97.4,275
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2017,Age,35 Months,95.1,92.1 to 97.3,513
PCV,≥4 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,82.1,73.5 to 88.4,198
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,89.1,80.8 to 97.4,111
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,91.6 to 96.5,611
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.1,68.3 to 95.9,45
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.9,80.9 to 88.9,611
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,84.1,78.4 to 89.7,301
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,87.8,82.7 to 92.8,301
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,92.6 to 99.6,116
Polio,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.6 to 97.9,543
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,73.5,66.8 to 80.2,301
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,73.3,66.5 to 80.0,301
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.4 to 97.6,543
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,90.5,86.2 to 94.9,301
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.8,79.5 to 88.0,611
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.4,64.3 to 92.5,45
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,90.8 to 96.1,611
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,86.7,77.8 to 95.6,111
Influenza,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.4,53.9 to 76.9,116
Rotavirus,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.8,81.0 to 90.7,329
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,71.5,61.7 to 81.2,178
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,82.9,74.8 to 91.0,178
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a Non-MSA,72.8,62.8 to 82.8,178
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,91.6,87.3 to 95.8,376
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,92.1 to 97.9,329
≥1 Dose MMR,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,89.9 to 96.8,329
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,75.1 to 86.5,376
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.8,80.9 to 90.7,329
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,93.2,89.6 to 96.7,376
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.4,78.9 to 99.9,45
Combined 7 Series,,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.2,58.8 to 81.6,116
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,92.6 to 99.6,116
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,92.7 to 98.2,329
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,89.0,84.3 to 93.6,376
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.7,90.4 to 96.9,329
PCV,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,89.4,82.2 to 94.6,198
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Principal City,76.3,67.8 to 84.8,376
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,91.9,85.8 to 96.1,198
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,19 Months,84.2,75.9 to 90.0,198
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,31.6,23.5 to 41.0,198
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,79.9,71.7 to 87.1,198
Polio,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,91.5,83.9 to 95.7,198
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,3 Months,87.3,79.3 to 92.5,198
PCV,≥4 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,97.8,90.4 to 99.8,198
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,88.3,80.2 to 93.4,198
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.6,71.0 to 86.2,329
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,78.5,69.4 to 85.4,198
PCV,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,5 Months,77.8,72.2 to 82.6,485
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,48.5,39.2 to 58.6,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,39.2,33.6 to 45.1,485
PCV,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,7 Months,70.5,60.5 to 78.9,198
Hib,Full Series,States/Local Areas,Wisconsin,2021,Age,24 Months,75.2,66.7 to 82.9,198
PCV,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,89.0,81.0 to 93.9,198
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,35 Months,96.4,89.4 to 99.2,198
PCV,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,89.4,82.2 to 94.6,198
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2021,Age,24 Months,90.2,83.2 to 95.1,198
Hib,Primary Series,States/Local Areas,Wisconsin,2021,Age,24 Months,88.4,81.2 to 93.8,198
PCV,≥4 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,84.2,76.3 to 90.6,198
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,88.1,80.0 to 93.2,198
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,74.5,65.2 to 82.0,198
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2021,Age,19 Months,88.1,80.1 to 93.2,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,95.2,91.3 to 97.7,485
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,90.9,86.9 to 94.1,485
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,96.9,89.0 to 99.6,198
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,24 Months,87.0,79.5 to 92.8,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,84.4,76.9 to 90.6,198
Polio,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,90.6,83.7 to 95.4,198
≥1 Dose MMR,,States/Local Areas,Wisconsin,2021,Age,24 Months,89.7,82.8 to 94.7,198
PCV,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,88.3,80.3 to 93.3,198
Hib,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,90.4,85.9 to 93.6,485
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,70.4,63.1 to 76.8,287
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020,Age,7 Months,77.3,70.3 to 83.0,287
Polio,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,3 Months,83.4,76.7 to 88.5,287
Hib,≥1 Dose,States/Local Areas,Wisconsin,2020,Age,3 Months,83.1,76.2 to 88.3,287
Rotavirus,,States/Local Areas,Wisconsin,2019-2020,Age,8 Months,75.8,70.4 to 80.5,511
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,92.6,88.1 to 95.9,485
DTaP,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,3 Months,85.4,80.4 to 89.2,485
Polio,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,3 Months,87.3,79.3 to 92.5,198
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2021,Age,0-2 Days,80.4,70.8 to 87.4,198
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,91.3,86.6 to 94.9,485
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2021,Age,0-1 Days,77.7,68.0 to 85.0,198
Combined 7 Series,,States/Local Areas,Wisconsin,2011,Age,35 Months,77.7,69.5 to 84.9,225
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,60.6,46.7 to 74.4,59
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,74.4,70.4 to 78.5,630
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Overall,Overall,76.4,73.2 to 79.6,949
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,72.5,66.1 to 78.8,247
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,75.3,70.8 to 79.7,514
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.9,61.1 to 84.8,74
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,77.3,69.0 to 85.6,117
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.5,72.8 to 80.1,754
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,79.7,74.3 to 85.1,291
Hib,Primary Series,States/Local Areas,Wyoming,2011,Age,7 Months,63.8,57.4 to 69.7,214
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,85.8,79.5 to 92.1,188
Combined 7 Series,,States/Local Areas,Michigan,2014,Age,35 Months,72.7,64.8 to 80.0,250
Combined 7 Series,,States/Local Areas,Michigan,2014-2015,Age,35 Months,71.6,65.9 to 77.1,486
Combined 7 Series,,States/Local Areas,Michigan,2013,Age,35 Months,69.6,60.8 to 77.9,240
Combined 7 Series,,States/Local Areas,Michigan,2013-2014,Age,35 Months,71.2,65.1 to 77.0,490
Combined 7 Series,,States/Local Areas,Michigan,2012,Age,35 Months,63.2,54.0 to 72.5,212
Hep A,≥1 Dose,States/Local Areas,Michigan,2011,Age,19 Months,72.3,65.8 to 77.9,255
DTaP,≥1 Dose,States/Local Areas,Michigan,2019,Age,3 Months,92.6,88.2 to 95.4,375
DTaP,≥3 Doses,States/Local Areas,Michigan,2016,Age,24 Months,95.8,92.5 to 97.9,291
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,93.7,90.9 to 95.9,693
DTaP,≥1 Dose,States/Local Areas,Michigan,2018,Age,3 Months,89.9,84.6 to 93.4,415
DTaP,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,3 Months,91.2,88.0 to 93.6,790
DTaP,≥3 Doses,States/Local Areas,Michigan,2015,Age,24 Months,93.0,87.6 to 96.6,236
DTaP,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,94.4,91.4 to 96.6,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2014,Age,24 Months,95.1,90.7 to 97.8,250
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,94.0,90.7 to 96.5,486
DTaP,≥1 Dose,States/Local Areas,Michigan,2017,Age,3 Months,85.9,80.3 to 90.0,402
DTaP,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,3 Months,87.8,84.2 to 90.7,817
Combined 7 Series,,States/Local Areas,Michigan,2016,Age,35 Months,74.4,67.2 to 81.2,291
Combined 7 Series,,States/Local Areas,Michigan,2016-2017,Age,35 Months,73.3,68.2 to 78.1,693
Combined 7 Series,,States/Local Areas,Michigan,2017,Age,35 Months,72.3,65.4 to 78.8,402
Combined 7 Series,,States/Local Areas,Michigan,2017-2018,Age,35 Months,75.4,70.5 to 80.1,817
Combined 7 Series,,States/Local Areas,Michigan,2017,Age,24 Months,70.3,63.4 to 76.8,402
Combined 7 Series,,States/Local Areas,Michigan,2017-2018,Age,24 Months,71.4,66.7 to 76.0,817
Combined 7 Series,,States/Local Areas,Michigan,2018,Age,24 Months,72.7,66.2 to 79.0,415
Combined 7 Series,,States/Local Areas,Michigan,2018-2019,Age,24 Months,72.5,67.7 to 77.1,790
Combined 7 Series,,States/Local Areas,Michigan,2016,Age,24 Months,70.0,63.0 to 76.7,291
Combined 7 Series,,States/Local Areas,Michigan,2016-2017,Age,24 Months,70.1,65.2 to 75.0,693
Hib,Primary Series,States/Local Areas,Michigan,2019,Age,35 Months,97.6,94.0 to 99.3,375
Combined 7 Series,,States/Local Areas,Michigan,2014,Age,24 Months,67.5,59.9 to 74.9,250
Combined 7 Series,,States/Local Areas,Michigan,2014-2015,Age,24 Months,67.8,62.3 to 73.2,486
Hib,Primary Series,States/Local Areas,Michigan,2017,Age,24 Months,91.8,87.2 to 95.2,402
Hib,Primary Series,States/Local Areas,Michigan,2017-2018,Age,24 Months,94.1,91.4 to 96.2,817
Combined 7 Series,,States/Local Areas,Michigan,2019,Age,24 Months,72.3,65.2 to 78.9,375
Combined 7 Series,,States/Local Areas,Michigan,2011,Age,35 Months,75.5,66.3 to 83.7,255
Hep A,≥1 Dose,States/Local Areas,Michigan,2015,Age,19 Months,78.5,71.7 to 84.0,236
Hep A,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,19 Months,81.1,76.1 to 85.3,527
Hep A,≥1 Dose,States/Local Areas,Michigan,2014,Age,19 Months,79.7,72.6 to 85.3,250
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,19 Months,79.1,73.7 to 83.6,486
Hep A,≥1 Dose,States/Local Areas,Michigan,2013,Age,19 Months,76.5,73.0 to 79.7,240
Hep A,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,19 Months,78.1,75.7 to 80.3,490
DTaP,≥2 Doses,States/Local Areas,Michigan,2017,Age,5 Months,75.5,68.5 to 81.3,402
DTaP,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,5 Months,77.9,73.4 to 81.9,817
DTaP,≥2 Doses,States/Local Areas,Michigan,2018,Age,5 Months,80.4,74.3 to 85.3,415
DTaP,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,5 Months,83.2,79.2 to 86.6,790
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,92.5,87.8 to 97.2,158
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,93.4,91.4 to 95.4,997
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,90.8,86.7 to 94.9,267
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,93.5,90.8 to 96.2,414
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,97.3,94.3 to 100.0,316
Hib,≥3 Doses,States/Local Areas,Michigan,2017,Age,24 Months,89.6,84.4 to 93.6,402
Hib,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,92.7,89.6 to 95.1,817
DTaP,≥3 Doses,States/Local Areas,Michigan,2019,Age,24 Months,96.4,93.1 to 98.4,375
Hib,≥3 Doses,States/Local Areas,Michigan,2016,Age,24 Months,93.2,89.2 to 96.2,291
Hib,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,91.4,88.2 to 94.0,693
Hib,≥3 Doses,States/Local Areas,Michigan,2015,Age,24 Months,86.7,79.4 to 92.4,236
Hib,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,90.0,85.9 to 93.4,527
DTaP,≥1 Dose,States/Local Areas,Michigan,2016,Age,3 Months,87.4,81.8 to 91.5,291
DTaP,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,3 Months,86.6,82.9 to 89.7,693
DTaP,≥1 Dose,States/Local Areas,Michigan,2015,Age,3 Months,84.8,77.6 to 89.9,236
DTaP,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,3 Months,86.1,81.6 to 89.6,527
DTaP,≥1 Dose,States/Local Areas,Michigan,2014,Age,3 Months,82.8,76.2 to 87.9,250
DTaP,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,3 Months,83.8,79.0 to 87.7,486
DTaP,≥1 Dose,States/Local Areas,Michigan,2013,Age,3 Months,81.8,75.4 to 86.9,240
DTaP,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,3 Months,82.3,78.8 to 85.4,490
DTaP,≥1 Dose,States/Local Areas,Michigan,2011,Age,3 Months,85.8,83.5 to 87.9,255
DTaP,≥1 Dose,States/Local Areas,Michigan,2012,Age,3 Months,76.1,70.9 to 80.6,212
DTaP,≥4 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,87.3,81.9 to 91.6,771
Hib,Full Series,States/Local Areas,Michigan,2021,Age,19 Months,70.7,62.0 to 78.1,323
Hib,Primary Series,States/Local Areas,Michigan,2021,Age,19 Months,89.4,82.5 to 93.8,323
Hib,≥3 Doses,States/Local Areas,Michigan,2021,Age,19 Months,86.8,78.8 to 92.1,323
Hib,≥2 Doses,States/Local Areas,Michigan,2021,Age,5 Months,79.3,71.1 to 85.7,323
Hib,Primary Series,States/Local Areas,Michigan,2020-2021,Age,24 Months,90.9,87.2 to 93.9,771
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.4,77.8 to 84.9,944
Hib,≥1 Dose,States/Local Areas,Michigan,2021,Age,3 Months,82.8,74.8 to 88.6,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2018,Age,24 Months,97.9,95.4 to 99.2,415
DTaP,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,97.3,95.4 to 98.6,790
DTaP,≥3 Doses,States/Local Areas,Michigan,2017,Age,24 Months,91.6,86.7 to 95.2,402
DTaP,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,94.8,92.1 to 96.8,817
Hep B,≥3 Doses,States/Local Areas,Michigan,2021,Age,19 Months,92.2,86.6 to 95.5,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2012,Age,19 Months,69.4,65.6 to 73.0,212
PCV,≥4 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,82.3,77.6 to 86.5,771
Combined 7 Series,,States/Local Areas,Michigan,2015,Age,24 Months,68.2,60.2 to 75.9,236
Combined 7 Series,,States/Local Areas,Michigan,2015-2016,Age,24 Months,69.1,63.8 to 74.4,527
Hib,Primary Series,States/Local Areas,Michigan,2018,Age,35 Months,97.6,94.0 to 99.3,415
Hib,Primary Series,States/Local Areas,Michigan,2018-2019,Age,35 Months,97.6,95.2 to 99.0,790
Hib,Primary Series,States/Local Areas,Michigan,2016,Age,24 Months,94.9,91.3 to 97.3,291
Hib,Primary Series,States/Local Areas,Michigan,2016-2017,Age,24 Months,93.4,90.6 to 95.6,693
Hib,Primary Series,States/Local Areas,Michigan,2016,Age,35 Months,94.9,91.3 to 97.3,291
Hib,Primary Series,States/Local Areas,Michigan,2016-2017,Age,35 Months,93.6,90.8 to 95.7,693
Combined 7 Series,,States/Local Areas,Michigan,2011,Age,24 Months,70.1,62.6 to 77.4,255
Hib,Primary Series,States/Local Areas,Michigan,2011,Age,35 Months,90.7,85.2 to 94.7,255
Hib,Primary Series,States/Local Areas,Michigan,2018,Age,24 Months,96.6,93.4 to 98.5,415
Hib,Primary Series,States/Local Areas,Michigan,2018-2019,Age,24 Months,96.0,93.7 to 97.6,790
Hib,Primary Series,States/Local Areas,Michigan,2015,Age,24 Months,91.0,85.0 to 95.3,236
Hib,Primary Series,States/Local Areas,Michigan,2015-2016,Age,24 Months,93.0,89.6 to 95.6,527
Hib,Primary Series,States/Local Areas,Michigan,2014,Age,24 Months,94.4,90.0 to 97.3,250
Hib,Primary Series,States/Local Areas,Michigan,2014-2015,Age,24 Months,92.7,89.1 to 95.5,486
Hib,Primary Series,States/Local Areas,Michigan,2017,Age,35 Months,92.2,87.6 to 95.5,402
Hib,Primary Series,States/Local Areas,Michigan,2017-2018,Age,35 Months,94.8,92.1 to 96.8,817
Hib,Primary Series,States/Local Areas,Michigan,2015,Age,35 Months,92.6,87.0 to 96.3,236
Hib,Primary Series,States/Local Areas,Michigan,2015-2016,Age,35 Months,93.7,90.6 to 96.1,527
Hib,Primary Series,States/Local Areas,Michigan,2019,Age,24 Months,95.4,91.8 to 97.7,375
Hib,Primary Series,States/Local Areas,Michigan,2012,Age,35 Months,87.6,80.2 to 93.2,212
Hib,Primary Series,States/Local Areas,Michigan,2014,Age,35 Months,95.9,91.2 to 98.5,250
Hib,Primary Series,States/Local Areas,Michigan,2014-2015,Age,35 Months,94.4,90.8 to 96.9,486
Combined 7 Series,,States/Local Areas,Michigan,2013,Age,24 Months,62.0,53.8 to 70.2,240
Combined 7 Series,,States/Local Areas,Michigan,2013-2014,Age,24 Months,64.7,59.0 to 70.4,490
Combined 7 Series,,States/Local Areas,Michigan,2012,Age,24 Months,59.8,50.4 to 69.3,212
Hib,Primary Series,States/Local Areas,Michigan,2013,Age,35 Months,90.8,84.6 to 95.2,240
Hib,Primary Series,States/Local Areas,Michigan,2013-2014,Age,35 Months,93.2,88.8 to 96.3,490
Hib,Primary Series,States/Local Areas,Michigan,2019,Age,19 Months,93.5,89.0 to 96.2,375
Hib,Primary Series,States/Local Areas,Michigan,2016,Age,19 Months,92.6,87.7 to 95.7,291
Hib,Primary Series,States/Local Areas,Michigan,2016-2017,Age,19 Months,92.1,88.5 to 94.7,693
Hib,Primary Series,States/Local Areas,Michigan,2015,Age,19 Months,88.1,81.1 to 92.7,236
Hib,Primary Series,States/Local Areas,Michigan,2015-2016,Age,19 Months,90.4,86.2 to 93.4,527
Hib,Primary Series,States/Local Areas,Michigan,2013,Age,24 Months,90.4,84.3 to 94.9,240
Hib,Primary Series,States/Local Areas,Michigan,2013-2014,Age,24 Months,92.5,88.2 to 95.6,490
Hib,Primary Series,States/Local Areas,Michigan,2011,Age,24 Months,90.2,84.9 to 94.3,255
Hib,Primary Series,States/Local Areas,Michigan,2012,Age,24 Months,87.6,80.2 to 93.2,212
Hib,Primary Series,States/Local Areas,Michigan,2018,Age,19 Months,95.5,91.6 to 97.6,415
Hib,Primary Series,States/Local Areas,Michigan,2018-2019,Age,19 Months,89.4,86.0 to 92.0,790
Hib,Primary Series,States/Local Areas,Michigan,2017,Age,19 Months,91.7,86.7 to 94.9,402
Hib,Primary Series,States/Local Areas,Michigan,2017-2018,Age,19 Months,93.6,90.6 to 95.6,817
Hib,Primary Series,States/Local Areas,Michigan,2014,Age,19 Months,91.5,86.2 to 94.9,250
Hib,Primary Series,States/Local Areas,Michigan,2014-2015,Age,19 Months,89.8,85.5 to 92.9,486
Hib,Primary Series,States/Local Areas,Michigan,2013,Age,19 Months,86.0,78.9 to 91.0,240
Hib,Primary Series,States/Local Areas,Michigan,2013-2014,Age,19 Months,88.8,86.0 to 91.0,490
Hib,Primary Series,States/Local Areas,Michigan,2018,Age,13 Months,89.6,84.5 to 93.1,415
Hib,Primary Series,States/Local Areas,Michigan,2018-2019,Age,13 Months,89.4,86.0 to 92.0,790
Hib,Primary Series,States/Local Areas,Michigan,2011,Age,19 Months,88.5,84.3 to 91.7,255
Hib,Primary Series,States/Local Areas,Michigan,2012,Age,19 Months,86.5,80.1 to 91.1,212
Hib,Primary Series,States/Local Areas,Michigan,2019,Age,13 Months,89.2,84.2 to 92.8,375
Hib,Primary Series,States/Local Areas,Michigan,2017,Age,13 Months,84.1,77.8 to 88.9,402
Hib,Primary Series,States/Local Areas,Michigan,2017-2018,Age,13 Months,86.8,82.9 to 90.0,817
Hib,Primary Series,States/Local Areas,Michigan,2016,Age,13 Months,89.8,84.4 to 93.5,291
Hib,Primary Series,States/Local Areas,Michigan,2016-2017,Age,13 Months,87.0,82.8 to 90.3,693
Hib,Primary Series,States/Local Areas,Michigan,2013,Age,7 Months,63.4,59.8 to 66.9,240
Hib,Primary Series,States/Local Areas,Michigan,2013-2014,Age,7 Months,64.3,60.8 to 67.7,490
Hib,Primary Series,States/Local Areas,Michigan,2017,Age,7 Months,69.5,62.5 to 75.7,402
Hib,Primary Series,States/Local Areas,Michigan,2017-2018,Age,7 Months,71.4,66.6 to 75.7,817
Hib,Primary Series,States/Local Areas,Michigan,2016,Age,7 Months,75.0,68.2 to 80.8,291
Hib,Primary Series,States/Local Areas,Michigan,2016-2017,Age,7 Months,72.3,67.4 to 76.7,693
Hib,Primary Series,States/Local Areas,Michigan,2015,Age,7 Months,71.0,62.7 to 78.2,236
Hib,Primary Series,States/Local Areas,Michigan,2015-2016,Age,7 Months,73.0,67.7 to 77.7,527
Hib,Primary Series,States/Local Areas,Michigan,2014,Age,7 Months,65.2,57.5 to 72.2,250
Hib,Primary Series,States/Local Areas,Michigan,2014-2015,Age,7 Months,68.1,62.4 to 73.3,486
Hib,Primary Series,States/Local Areas,Michigan,2011,Age,13 Months,86.0,81.5 to 89.5,255
Hib,Primary Series,States/Local Areas,Michigan,2012,Age,13 Months,81.9,70.1 to 89.7,212
Hib,Primary Series,States/Local Areas,Michigan,2013,Age,13 Months,81.2,74.9 to 86.2,240
Hib,Primary Series,States/Local Areas,Michigan,2013-2014,Age,13 Months,83.4,80.4 to 86.1,490
Hib,Primary Series,States/Local Areas,Michigan,2018,Age,7 Months,73.2,66.6 to 79.0,415
Hib,Primary Series,States/Local Areas,Michigan,2018-2019,Age,7 Months,74.4,69.8 to 78.6,790
Hib,Primary Series,States/Local Areas,Michigan,2019,Age,7 Months,75.7,68.8 to 81.4,375
Hib,Primary Series,States/Local Areas,Michigan,2015,Age,13 Months,84.4,76.8 to 89.9,236
Hib,Primary Series,States/Local Areas,Michigan,2015-2016,Age,13 Months,87.1,82.6 to 90.6,527
Hib,Primary Series,States/Local Areas,Michigan,2014,Age,13 Months,85.7,79.4 to 90.3,250
Hib,Primary Series,States/Local Areas,Michigan,2014-2015,Age,13 Months,85.1,80.4 to 88.8,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,89.1,85.3 to 92.0,771
Hib,≥2 Doses,States/Local Areas,Michigan,2021,Age,7 Months,88.3,81.4 to 92.9,323
Hib,≥3 Doses,States/Local Areas,Michigan,2021,Age,7 Months,50.4,42.4 to 58.3,323
PCV,≥3 Doses,States/Local Areas,Michigan,2021,Age,35 Months,96.9,91.3 to 99.3,323
Polio,≥2 Doses,States/Local Areas,Michigan,2021,Age,7 Months,89.9,83.3 to 94.1,323
Hep B,≥2 Doses,States/Local Areas,Michigan,2021,Age,7 Months,93.6,87.9 to 96.7,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,90.9,87.1 to 93.7,771
Hib,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,88.9,84.6 to 92.4,771
≥1 Dose MMR,,States/Local Areas,Michigan,2021,Age,35 Months,93.5,87.3 to 97.3,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2021,Age,7 Months,73.7,65.6 to 80.5,323
Hep B,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,95.1,92.3 to 97.0,771
PCV,≥2 Doses,States/Local Areas,Michigan,2021,Age,5 Months,84.7,77.7 to 89.7,323
Combined 7 Series,,States/Local Areas,Michigan,2021,Age,35 Months,71.9,61.6 to 81.4,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2016,Age,19 Months,83.8,77.3 to 88.7,291
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,19 Months,84.9,80.5 to 88.5,693
Hep A,≥1 Dose,States/Local Areas,Michigan,2018,Age,19 Months,89.3,83.9 to 93.1,415
Hep A,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,19 Months,89.2,85.1 to 92.3,624
Hep A,≥1 Dose,States/Local Areas,Michigan,2017,Age,19 Months,86.0,80.0 to 90.4,402
Hep A,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,19 Months,87.6,83.8 to 90.7,817
Hib,≥3 Doses,States/Local Areas,Michigan,2019,Age,24 Months,93.8,89.6 to 96.7,375
Hib,≥3 Doses,States/Local Areas,Michigan,2018,Age,24 Months,95.8,92.4 to 97.9,415
Hib,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,94.8,92.3 to 96.8,790
Hep A,≥2 Doses,States/Local Areas,Michigan,2012,Age,19 Months,19.5,15.4 to 24.5,212
Hep A,≥2 Doses,States/Local Areas,Michigan,2014,Age,19 Months,26.9,20.7 to 34.3,250
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,28.5,23.8 to 33.6,486
Hep A,≥2 Doses,States/Local Areas,Michigan,2013,Age,19 Months,27.1,25.7 to 28.5,240
Hep A,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,27.0,24.5 to 29.7,490
DTaP,≥2 Doses,States/Local Areas,Michigan,2019,Age,5 Months,86.1,80.4 to 90.4,375
Hep A,≥2 Doses,States/Local Areas,Michigan,2011,Age,19 Months,18.7,12.6 to 26.9,255
DTaP,≥3 Doses,States/Local Areas,Michigan,2014,Age,35 Months,98.9,94.7 to 99.9,250
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,97.5,94.1 to 99.2,486
DTaP,≥3 Doses,States/Local Areas,Michigan,2011,Age,35 Months,92.3,86.9 to 96.0,255
DTaP,≥3 Doses,States/Local Areas,Michigan,2012,Age,35 Months,91.4,83.8 to 96.4,212
DTaP,≥3 Doses,States/Local Areas,Michigan,2013,Age,35 Months,93.6,87.4 to 97.4,240
DTaP,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,95.7,91.2 to 98.3,490
DTaP,≥3 Doses,States/Local Areas,Michigan,2017,Age,35 Months,96.0,92.6 to 98.2,402
DTaP,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,97.4,95.4 to 98.7,817
DTaP,≥4 Doses,States/Local Areas,Michigan,2011,Age,19 Months,66.8,60.4 to 72.6,255
DTaP,≥4 Doses,States/Local Areas,Michigan,2012,Age,19 Months,59.1,47.9 to 69.4,212
DTaP,≥3 Doses,States/Local Areas,Michigan,2016,Age,35 Months,95.8,92.5 to 97.9,291
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,96.0,93.7 to 97.6,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2015,Age,35 Months,96.2,91.3 to 98.7,236
DTaP,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,96.1,93.4 to 97.9,527
PCV,≥2 Doses,States/Local Areas,Michigan,2011,Age,5 Months,73.9,68.4 to 78.8,255
PCV,≥2 Doses,States/Local Areas,Michigan,2012,Age,5 Months,63.7,53.9 to 72.4,212
PCV,≥2 Doses,States/Local Areas,Michigan,2013,Age,5 Months,66.6,62.1 to 70.8,240
PCV,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,5 Months,68.3,63.6 to 72.7,490
Hep A,≥2 Doses,States/Local Areas,Michigan,2011,Age,24 Months,40.0,31.9 to 49.3,255
Hep A,≥2 Doses,States/Local Areas,Michigan,2019,Age,19 Months,32.8,26.2 to 40.1,375
Hep A,≥2 Doses,States/Local Areas,Michigan,2018,Age,19 Months,32.7,26.9 to 39.2,415
Hep A,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,35.3,29.5 to 41.6,624
Hib,≥3 Doses,States/Local Areas,Michigan,2017,Age,35 Months,91.5,86.7 to 95.1,402
Hib,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,94.2,91.2 to 96.4,817
Hib,≥3 Doses,States/Local Areas,Michigan,2016,Age,35 Months,93.2,89.2 to 96.2,291
Hib,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,92.4,89.4 to 94.9,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,96.1,94.0 to 98.1,609
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,92.9,89.6 to 96.1,359
DTaP,≥4 Doses,States/Local Areas,Michigan,2015,Age,19 Months,70.3,63.0 to 76.7,236
DTaP,≥4 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,71.0,65.7 to 75.9,527
DTaP,≥4 Doses,States/Local Areas,Michigan,2014,Age,19 Months,72.9,65.2 to 79.4,250
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,71.6,66.0 to 76.6,486
DTaP,≥4 Doses,States/Local Areas,Michigan,2013,Age,19 Months,65.4,57.7 to 72.3,240
DTaP,≥4 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,69.1,65.1 to 72.9,490
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.9,80.1 to 95.7,92
Hep A,≥2 Doses,States/Local Areas,Michigan,2012,Age,24 Months,39.1,30.3 to 49.4,212
Hib,≥3 Doses,States/Local Areas,Michigan,2018,Age,35 Months,97.0,93.1 to 99.0,415
Hib,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,96.4,93.8 to 98.2,790
Hep A,≥1 Dose,States/Local Areas,Michigan,2011,Age,35 Months,82.8,75.9 to 88.7,255
Hep A,≥1 Dose,States/Local Areas,Michigan,2019,Age,24 Months,93.1,88.9 to 96.1,375
Hep A,≥1 Dose,States/Local Areas,Michigan,2018,Age,24 Months,94.2,90.1 to 97.0,415
Hep A,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,24 Months,93.5,90.7 to 95.8,790
Hep A,≥1 Dose,States/Local Areas,Michigan,2017,Age,24 Months,90.5,85.3 to 94.4,402
Hep A,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,24 Months,92.2,88.9 to 94.9,817
DTaP,≥3 Doses,States/Local Areas,Michigan,2019,Age,35 Months,98.5,96.2 to 99.5,375
DTaP,≥3 Doses,States/Local Areas,Michigan,2018,Age,35 Months,97.9,95.4 to 99.2,415
DTaP,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,98.6,96.9 to 99.5,790
PCV,≥2 Doses,States/Local Areas,Michigan,2016,Age,5 Months,78.1,71.6 to 83.4,291
PCV,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,5 Months,76.0,71.2 to 80.2,693
PCV,≥2 Doses,States/Local Areas,Michigan,2015,Age,5 Months,72.3,63.9 to 79.5,236
PCV,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,5 Months,75.2,69.9 to 79.8,527
PCV,≥2 Doses,States/Local Areas,Michigan,2014,Age,5 Months,70.1,62.6 to 76.6,250
PCV,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,5 Months,71.2,68.7 to 73.6,486
Hep A,≥1 Dose,States/Local Areas,Michigan,2016,Age,24 Months,89.5,84.5 to 93.5,291
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,24 Months,90.0,86.6 to 92.9,693
Hep A,≥1 Dose,States/Local Areas,Michigan,2015,Age,24 Months,87.9,81.1 to 93.1,236
Hep A,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,24 Months,88.8,84.6 to 92.2,527
Hib,≥3 Doses,States/Local Areas,Michigan,2011,Age,35 Months,90.6,85.1 to 94.7,255
Hib,≥3 Doses,States/Local Areas,Michigan,2012,Age,35 Months,85.1,76.6 to 91.8,212
Hep A,≥1 Dose,States/Local Areas,Michigan,2012,Age,24 Months,77.4,68.3 to 85.4,212
Hep A,≥1 Dose,States/Local Areas,Michigan,2014,Age,24 Months,83.1,76.5 to 88.7,250
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,24 Months,85.4,80.9 to 89.4,486
Hep A,≥1 Dose,States/Local Areas,Michigan,2013,Age,24 Months,83.7,77.1 to 89.2,240
Hep A,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,24 Months,83.4,78.5 to 87.7,490
Hep A,≥1 Dose,States/Local Areas,Michigan,2011,Age,24 Months,78.4,71.7 to 84.5,255
Hep A,≥1 Dose,States/Local Areas,Michigan,2019,Age,19 Months,90.0,85.1 to 93.5,375
Hep A,≥2 Doses,States/Local Areas,Michigan,2017,Age,19 Months,27.6,22.0 to 33.9,402
Hep A,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,30.1,26.1 to 34.5,817
Hib,≥3 Doses,States/Local Areas,Michigan,2015,Age,35 Months,89.0,81.8 to 94.3,236
Hib,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,91.1,87.1 to 94.3,527
Hib,≥3 Doses,States/Local Areas,Michigan,2014,Age,35 Months,95.2,90.3 to 98.1,250
Hib,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,92.4,88.0 to 95.7,486
Hib,≥3 Doses,States/Local Areas,Michigan,2013,Age,35 Months,90.5,84.3 to 95.0,240
Hib,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,92.8,88.3 to 96.0,490
Hep A,≥2 Doses,States/Local Areas,Michigan,2016,Age,19 Months,33.8,27.5 to 40.7,291
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,30.7,26.4 to 35.4,693
Hep A,≥2 Doses,States/Local Areas,Michigan,2015,Age,19 Months,30.1,26.5 to 33.9,236
Hep A,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,31.9,27.3 to 37.0,527
Hep A,≥2 Doses,States/Local Areas,Michigan,2021,Age,35 Months,84.1,73.6 to 92.1,323
Hib,Primary Series,States/Local Areas,Michigan,2021,Age,7 Months,70.7,62.3 to 77.9,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2012,Age,35 Months,86.0,76.2 to 93.2,212
PCV,≥2 Doses,States/Local Areas,Michigan,2017,Age,5 Months,74.0,67.0 to 79.9,402
PCV,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,5 Months,76.5,71.9 to 80.5,817
Hep A,≥1 Dose,States/Local Areas,Michigan,2021,Age,35 Months,94.5,88.4 to 98.0,323
PCV,≥3 Doses,States/Local Areas,Michigan,2021,Age,19 Months,91.7,85.6 to 95.4,323
Hep B,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,92.1,89.0 to 94.7,771
≥1 Dose MMR,,States/Local Areas,Michigan,2020-2021,Age,24 Months,93.4,89.9 to 95.9,771
≥1 Dose Varicella,,States/Local Areas,Michigan,2021,Age,19 Months,89.5,82.7 to 93.8,323
Hib,Full Series,States/Local Areas,Michigan,2021,Age,24 Months,73.6,65.3 to 81.2,323
Hib,Primary Series,States/Local Areas,Michigan,2021,Age,24 Months,89.6,83.3 to 94.3,323
Hib,≥3 Doses,States/Local Areas,Michigan,2021,Age,24 Months,87.0,79.8 to 92.6,323
≥1 Dose MMR,,States/Local Areas,Michigan,2021,Age,24 Months,93.5,87.3 to 97.3,323
Polio,≥1 Dose,States/Local Areas,Michigan,2021,Age,3 Months,87.0,79.8 to 91.9,323
Polio,≥3 Doses,States/Local Areas,Michigan,2021,Age,24 Months,92.1,86.6 to 96.0,323
DTaP,≥4 Doses,States/Local Areas,Michigan,2021,Age,24 Months,79.0,70.4 to 86.4,323
DTaP,≥4 Doses,States/Local Areas,Michigan,2021,Age,19 Months,69.0,60.4 to 76.5,323
DTaP,≥1 Dose,States/Local Areas,Michigan,2021,Age,3 Months,87.0,79.8 to 91.9,323
PCV,≥4 Doses,States/Local Areas,Michigan,2021,Age,35 Months,87.2,79.9 to 92.8,323
Hep A,≥2 Doses,States/Local Areas,Michigan,2021,Age,19 Months,37.1,29.9 to 44.9,323
Polio,≥2 Doses,States/Local Areas,Michigan,2021,Age,13 Months,92.4,86.1 to 95.9,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2021,Age,19 Months,86.8,79.4 to 91.8,323
Hep B,≥3 Doses,States/Local Areas,Michigan,2021,Age,24 Months,93.6,88.8 to 96.9,323
PCV,≥4 Doses,States/Local Areas,Michigan,2021,Age,19 Months,78.6,70.7 to 84.8,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2021,Age,13 Months,88.8,81.9 to 93.2,323
Hep A,≥2 Doses,States/Local Areas,Michigan,2021,Age,24 Months,58.1,49.3 to 67.1,323
Hep B,≥3 Doses,States/Local Areas,Michigan,2021,Age,7 Months,67.9,60.2 to 74.8,323
Hib,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,71.2,66.0 to 76.0,771
Hep A,≥1 Dose,States/Local Areas,Michigan,2021,Age,24 Months,90.2,83.6 to 95.0,323
PCV,≥4 Doses,States/Local Areas,Michigan,2021,Age,24 Months,84.1,76.8 to 90.1,323
≥1 Dose Varicella,,States/Local Areas,Michigan,2021,Age,24 Months,92.9,87.4 to 96.6,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2021,Age,19 Months,91.7,85.6 to 95.4,323
PCV,≥3 Doses,States/Local Areas,Michigan,2021,Age,7 Months,74.0,66.0 to 80.7,323
PCV,≥3 Doses,States/Local Areas,Michigan,2021,Age,24 Months,92.5,87.0 to 96.2,323
PCV,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,5 Months,81.0,76.5 to 84.9,771
PCV,≥3 Doses,States/Local Areas,Michigan,2021,Age,13 Months,89.3,82.9 to 93.5,323
Hib,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,92.8,89.2 to 95.3,771
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2021,Age,0-2 Days,77.0,69.1 to 83.4,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,35 Months,94.2,90.8 to 96.6,771
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2021,Age,0-1 Days,73.3,65.3 to 80.0,323
DTaP,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,3 Months,86.7,82.4 to 90.1,771
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,81.4,71.7 to 91.1,120
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.7 to 98.0,147
Hep B,≥2 Doses,States/Local Areas,Michigan,2019-2020,Age,7 Months,94.1,91.5 to 95.9,823
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,Hispanic,91.0,79.8 to 100.0,120
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Poverty,>400% FPL,97.6,95.9 to 99.2,431
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,79.2,74.2 to 84.1,482
Hib,≥2 Doses,States/Local Areas,Michigan,2021,Age,13 Months,92.4,86.1 to 95.9,323
Polio,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,92.4,89.1 to 95.1,771
DTaP,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,5 Months,81.7,77.0 to 85.6,771
Hep B,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,92.0,88.9 to 94.6,771
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2021,Age,0-3 Days,77.8,69.9 to 84.2,323
Hib,≥3 Doses,States/Local Areas,Michigan,2021,Age,35 Months,90.1,82.4 to 95.4,323
Hep A,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,80.8,74.4 to 86.5,771
Polio,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,3 Months,86.4,82.2 to 89.8,771
≥1 Dose MMR,,States/Local Areas,Michigan,2021,Age,13 Months,66.3,57.9 to 73.8,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,24 Months,91.0,87.3 to 94.0,771
PCV,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,3 Months,85.6,81.4 to 88.9,771
PCV,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,88.4,84.4 to 91.5,771
Hep B,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,3 Months,95.0,92.0 to 96.9,771
Hib,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,52.7,47.4 to 58.0,771
≥1 Dose MMR,,States/Local Areas,Michigan,2020-2021,Age,19 Months,88.2,83.8 to 91.6,771
DTaP,≥3 Doses,States/Local Areas,Michigan,2021,Age,24 Months,92.5,87.0 to 96.3,323
Hib,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,88.7,84.5 to 91.8,771
Hib,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,90.6,86.5 to 93.9,771
Rotavirus,,States/Local Areas,Michigan,2020-2021,Age,8 Months,78.7,73.8 to 82.9,771
DTaP,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,92.7,89.3 to 95.3,771
Polio,≥3 Doses,States/Local Areas,Michigan,2021,Age,35 Months,96.1,90.0 to 99.0,323
≥1 Dose Varicella,,States/Local Areas,Michigan,2021,Age,35 Months,92.9,87.4 to 96.6,323
DTaP,≥4 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,78.6,73.3 to 83.5,771
DTaP,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,94.6,91.4 to 96.9,771
Hep B,≥2 Doses,States/Local Areas,Michigan,2021,Age,13 Months,95.6,90.5 to 98.0,323
PCV,≥4 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,78.5,73.4 to 82.8,771
Hep B,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,65.5,60.3 to 70.3,771
Influenza,,States/Local Areas,Michigan,2020-2021,Age,24 Months,64.4,58.8 to 69.9,771
DTaP,≥4 Doses,States/Local Areas,Michigan,2021,Age,35 Months,90.6,79.4 to 97.0,323
Hep B,≥3 Doses,States/Local Areas,Michigan,2021,Age,35 Months,93.6,88.8 to 96.9,323
PCV,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,90.9,87.1 to 93.7,771
Hib,Primary Series,States/Local Areas,Michigan,2021,Age,13 Months,82.3,74.3 to 88.3,323
PCV,≥4 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,85.4,80.8 to 89.3,771
PCV,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,94.5,91.4 to 96.8,771
≥1 Dose MMR,,States/Local Areas,Michigan,2020-2021,Age,35 Months,94.8,91.6 to 97.1,771
Hep B,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,93.4,90.2 to 95.6,771
Combined 7 Series,,States/Local Areas,Michigan,2020-2021,Age,35 Months,74.8,69.0 to 80.3,771
Polio,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,89.4,85.3 to 92.4,771
Polio,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,5 Months,81.4,76.7 to 85.3,771
Hib,Full Series,States/Local Areas,Michigan,2021,Age,35 Months,76.2,67.0 to 84.3,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2021,Age,35 Months,96.3,90.4 to 99.1,323
Combined 7 Series,,States/Local Areas,Michigan,2020-2021,Age,24 Months,67.7,62.3 to 73.0,771
Hib,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,3 Months,84.0,79.4 to 87.8,771
Polio,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,35 Months,93.7,90.4 to 96.2,771
≥1 Dose Varicella,,States/Local Areas,Michigan,2020-2021,Age,24 Months,92.9,89.6 to 95.4,771
Hib,Primary Series,States/Local Areas,Michigan,2020-2021,Age,7 Months,72.4,67.1 to 77.2,771
Hib,Primary Series,States/Local Areas,Michigan,2020-2021,Age,13 Months,83.8,79.0 to 87.7,771
PCV,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,92.8,89.5 to 95.4,771
Polio,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,90.9,87.1 to 93.7,771
DTaP,≥4 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,69.6,64.1 to 74.6,771
Hib,≥3 Doses,States/Local Areas,Michigan,2021,Age,13 Months,70.1,61.7 to 77.3,323
Hep B,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,5 Months,90.2,86.2 to 93.1,771
Hib,Primary Series,States/Local Areas,Michigan,2021,Age,35 Months,92.1,85.7 to 96.4,323
Rotavirus,,States/Local Areas,Michigan,2021,Age,8 Months,78.3,70.7 to 84.3,323
DTaP,≥2 Doses,States/Local Areas,Michigan,2021,Age,5 Months,83.5,76.1 to 89.0,323
Hep B,≥3 Doses,States/Local Areas,Michigan,2021,Age,13 Months,89.8,83.5 to 93.8,323
Hep A,≥1 Dose,States/Local Areas,Michigan,2020-2021,Age,19 Months,88.8,84.6 to 91.9,771
Polio,≥2 Doses,States/Local Areas,Michigan,2021,Age,5 Months,83.5,76.1 to 89.0,323
PCV,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,71.5,66.3 to 76.2,771
Hep A,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,35.2,30.5 to 40.2,771
≥1 Dose MMR,,States/Local Areas,Michigan,2021,Age,19 Months,86.3,78.7 to 91.5,323
Hep B,≥2 Doses,States/Local Areas,Michigan,2021,Age,5 Months,91.0,84.9 to 94.8,323
Polio,≥3 Doses,States/Local Areas,Michigan,2021,Age,19 Months,91.9,85.7 to 95.5,323
DTaP,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,88.3,84.1 to 91.5,771
Hep B,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,91.4,88.0 to 93.9,771
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2020-2021,Age,0-2 Days,76.8,71.8 to 81.2,771
Hib,Full Series,States/Local Areas,Michigan,2020-2021,Age,35 Months,79.6,74.2 to 84.5,771
≥1 Dose Varicella,,States/Local Areas,Michigan,2021,Age,13 Months,62.2,53.8 to 69.9,323
Polio,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,13 Months,92.7,89.1 to 95.2,771
Hib,Full Series,States/Local Areas,Michigan,2020-2021,Age,19 Months,72.6,67.1 to 77.5,771
≥1 Dose MMR,,States/Local Areas,Michigan,2020-2021,Age,13 Months,68.6,63.2 to 73.6,771
Hib,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,5 Months,79.2,74.2 to 83.4,771
Hib,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,19 Months,86.8,82.2 to 90.4,771
Hep A,≥2 Doses,States/Local Areas,Michigan,2020-2021,Age,24 Months,55.9,50.4 to 61.6,771
≥1 Dose Varicella,,States/Local Areas,Michigan,2020-2021,Age,19 Months,90.1,86.2 to 93.0,771
Hib,Primary Series,States/Local Areas,Michigan,2020-2021,Age,19 Months,89.5,85.4 to 92.5,771
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2020-2021,Age,0-1 Days,72.8,67.6 to 77.4,771
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2020-2021,Age,0-3 Days,78.3,73.3 to 82.6,771
Hib,Primary Series,States/Local Areas,Michigan,2020-2021,Age,35 Months,92.5,89.0 to 95.3,771
Combined 7 Series,,States/Local Areas,Michigan,2021,Age,24 Months,66.5,58.3 to 74.6,323
Rotavirus,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.0,74.1 to 83.9,481
Rotavirus,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,75.2,67.3 to 83.1,158
Rotavirus,,States/Local Areas,Michigan,2014-2017,Overall,Overall,74.5,70.9 to 78.2,997
Rotavirus,,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,61.0,53.8 to 68.3,267
Rotavirus,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,63.5,57.3 to 69.7,359
Rotavirus,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",51.3,39.2 to 63.4,92
Rotavirus,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,77.1,66.4 to 87.8,90
Rotavirus,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,67.1 to 85.2,122
Rotavirus,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,86.5,83.1 to 89.8,609
Rotavirus,,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,87.8,82.8 to 92.7,316
Rotavirus,,States/Local Areas,Michigan,2011,Age,8 Months,65.4,57.3 to 72.8,255
Rotavirus,,States/Local Areas,Michigan,2016,Age,8 Months,75.2,68.4 to 81.0,291
Rotavirus,,States/Local Areas,Michigan,2016-2017,Age,8 Months,74.0,69.2 to 78.4,693
Rotavirus,,States/Local Areas,Michigan,2013,Age,8 Months,63.4,54.8 to 71.2,240
Rotavirus,,States/Local Areas,Michigan,2013-2014,Age,8 Months,67.2,61.4 to 72.6,490
Rotavirus,,States/Local Areas,Michigan,2012,Age,8 Months,60.8,51.6 to 69.3,212
Rotavirus,,States/Local Areas,Michigan,2014,Age,8 Months,71.0,63.3 to 77.7,250
Rotavirus,,States/Local Areas,Michigan,2014-2015,Age,8 Months,73.1,67.6 to 78.0,486
Rotavirus,,States/Local Areas,Michigan,2018,Age,8 Months,74.7,67.9 to 80.5,415
Rotavirus,,States/Local Areas,Michigan,2018-2019,Age,8 Months,76.4,71.8 to 80.5,790
Rotavirus,,States/Local Areas,Michigan,2019,Age,8 Months,78.3,71.8 to 83.6,375
Rotavirus,,States/Local Areas,Michigan,2017,Age,8 Months,72.8,65.9 to 78.8,402
Rotavirus,,States/Local Areas,Michigan,2017-2018,Age,8 Months,73.8,69.0 to 78.0,817
Rotavirus,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.2,76.4 to 83.9,693
Rotavirus,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,69.5,63.2 to 75.8,358
Rotavirus,,States/Local Areas,Michigan,2015,Age,8 Months,75.2,67.1 to 81.7,236
Rotavirus,,States/Local Areas,Michigan,2015-2016,Age,8 Months,75.2,70.0 to 79.7,527
Rotavirus,,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,79.0,74.2 to 83.8,414
Hib,Full Series,States/Local Areas,Michigan,2018,Age,19 Months,79.4,73.3 to 84.5,415
Hib,Full Series,States/Local Areas,Michigan,2018-2019,Age,19 Months,96.2,94.2 to 97.5,790
Hib,Full Series,States/Local Areas,Michigan,2019,Age,19 Months,79.0,72.6 to 84.3,375
Hib,Full Series,States/Local Areas,Michigan,2014,Age,19 Months,74.3,66.6 to 80.8,250
Hib,Full Series,States/Local Areas,Michigan,2014-2015,Age,19 Months,73.8,68.2 to 78.6,486
Hib,Full Series,States/Local Areas,Michigan,2015,Age,19 Months,73.2,67.3 to 78.4,236
Hib,Full Series,States/Local Areas,Michigan,2015-2016,Age,19 Months,76.4,71.3 to 80.8,527
Hib,Full Series,States/Local Areas,Michigan,2016,Age,19 Months,79.5,73.2 to 84.7,291
Hib,Full Series,States/Local Areas,Michigan,2016-2017,Age,19 Months,75.5,70.7 to 79.8,693
Hib,Full Series,States/Local Areas,Michigan,2017,Age,19 Months,71.5,64.3 to 77.7,402
Hib,Full Series,States/Local Areas,Michigan,2017-2018,Age,19 Months,75.4,70.7 to 79.6,817
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,67.2,54.5 to 79.9,90
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",47.2,35.2 to 59.2,92
Combined 7 Series,,States/Local Areas,Michigan,2015,Age,35 Months,70.5,62.3 to 78.3,236
Combined 7 Series,,States/Local Areas,Michigan,2015-2016,Age,35 Months,72.7,67.3 to 77.9,527
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,79.1,75.1 to 83.2,609
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,63.7,57.3 to 70.1,359
Combined 7 Series,,States/Local Areas,Michigan,2019,Age,35 Months,77.6,70.3 to 84.2,375
Combined 7 Series,,States/Local Areas,Michigan,2018,Age,35 Months,79.8,72.4 to 86.3,415
Combined 7 Series,,States/Local Areas,Michigan,2018-2019,Age,35 Months,78.8,73.6 to 83.6,790
Hib,Full Series,States/Local Areas,Michigan,2012,Age,24 Months,71.9,62.9 to 80.3,212
Hib,Full Series,States/Local Areas,Michigan,2011,Age,24 Months,80.3,73.9 to 86.0,255
Hib,Full Series,States/Local Areas,Michigan,2013,Age,24 Months,75.0,66.9 to 82.4,240
Hib,Full Series,States/Local Areas,Michigan,2013-2014,Age,24 Months,75.8,70.2 to 81.0,490
Hib,Full Series,States/Local Areas,Michigan,2014,Age,24 Months,76.6,69.4 to 83.2,250
Hib,Full Series,States/Local Areas,Michigan,2014-2015,Age,24 Months,77.6,72.5 to 82.4,486
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Overall,Overall,70.7,66.9 to 74.5,997
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,74.6,66.4 to 82.8,158
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.5,66.4 to 84.5,122
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.7,72.7 to 80.7,693
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.6,69.4 to 79.9,481
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,65.2,58.6 to 71.7,358
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,73.1,67.8 to 78.3,414
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,82.9,77.4 to 88.3,316
Hib,Full Series,States/Local Areas,Michigan,2011,Age,19 Months,74.0,69.7 to 77.8,255
Hib,Full Series,States/Local Areas,Michigan,2012,Age,19 Months,67.6,55.7 to 77.7,212
Hib,Full Series,States/Local Areas,Michigan,2013,Age,19 Months,69.9,61.5 to 77.0,240
Hib,Full Series,States/Local Areas,Michigan,2013-2014,Age,19 Months,72.1,68.8 to 75.1,490
Combined 7 Series,,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,60.1,52.6 to 67.6,267
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,74.4,68.1 to 80.7,471
Hep B,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,93.6,90.9 to 95.5,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.5,94.0 to 99.0,382
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,79.3,74.9 to 83.6,716
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,74.7,69.1 to 80.2,484
Hep B,≥1 Dose,States/Local Areas,Maryland,2021,Age,3 Months,95.7,91.0 to 98.0,367
Rotavirus,,States/Local Areas,Maryland,2019,Age,8 Months,77.7,72.5 to 82.2,614
Rotavirus,,States/Local Areas,Maryland,2017,Age,8 Months,80.8,76.1 to 84.8,766
Rotavirus,,States/Local Areas,Maryland,2017-2018,Age,8 Months,81.8,78.8 to 84.5,1603
Rotavirus,,States/Local Areas,Maryland,2018,Age,8 Months,82.8,78.9 to 86.2,837
Rotavirus,,States/Local Areas,Maryland,2018-2019,Age,8 Months,80.3,77.0 to 83.2,1451
Rotavirus,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,67.4,60.6 to 74.3,399
Rotavirus,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.2,67.1 to 81.3,305
Rotavirus,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,73.2,64.2 to 82.3,279
Rotavirus,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.1,74.5 to 89.7,236
Rotavirus,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.5,72.2 to 80.8,1053
Rotavirus,,States/Local Areas,Maryland,2014-2017,Overall,Overall,79.3,75.9 to 82.7,1626
Rotavirus,,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,66.5,58.5 to 74.4,287
Rotavirus,,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,78.7,72.4 to 85.0,419
Rotavirus,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.2,80.7 to 89.7,806
Rotavirus,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,84.8,79.4 to 90.1,548
Rotavirus,,States/Local Areas,Maryland,2014,Age,8 Months,79.7,72.4 to 85.5,366
Rotavirus,,States/Local Areas,Maryland,2014-2015,Age,8 Months,79.6,74.7 to 83.8,738
Rotavirus,,States/Local Areas,Maryland,2012,Age,8 Months,74.2,65.5 to 81.3,328
Rotavirus,,States/Local Areas,Maryland,2013,Age,8 Months,77.7,70.7 to 83.4,361
Rotavirus,,States/Local Areas,Maryland,2013-2014,Age,8 Months,78.7,73.8 to 82.9,727
Rotavirus,,States/Local Areas,Maryland,2016,Age,8 Months,76.4,69.8 to 82.0,464
Rotavirus,,States/Local Areas,Maryland,2016-2017,Age,8 Months,78.6,74.5 to 82.2,1230
Rotavirus,,States/Local Areas,Maryland,2011,Age,8 Months,81.1,73.0 to 87.2,300
Rotavirus,,States/Local Areas,Maryland,2015,Age,8 Months,79.6,72.3 to 85.3,372
Rotavirus,,States/Local Areas,Maryland,2015-2016,Age,8 Months,78.0,73.2 to 82.2,836
Rotavirus,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,88.2,85.2 to 91.2,1180
Rotavirus,,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,88.9,85.3 to 92.5,920
Hib,Full Series,States/Local Areas,Maryland,2015,Age,19 Months,79.6,76.0 to 82.8,372
Hib,Full Series,States/Local Areas,Maryland,2015-2016,Age,19 Months,78.9,74.2 to 82.9,836
Hib,Full Series,States/Local Areas,Maryland,2016,Age,19 Months,78.1,71.6 to 83.5,464
Hib,Full Series,States/Local Areas,Maryland,2016-2017,Age,19 Months,79.1,75.2 to 82.6,1230
Hib,Full Series,States/Local Areas,Maryland,2013,Age,24 Months,81.7,75.0 to 87.4,361
Hib,Full Series,States/Local Areas,Maryland,2013-2014,Age,24 Months,79.3,74.3 to 83.9,727
Hib,Full Series,States/Local Areas,Maryland,2014,Age,24 Months,76.8,69.3 to 83.6,366
Hib,Full Series,States/Local Areas,Maryland,2014-2015,Age,24 Months,80.1,75.1 to 84.6,738
Hib,Full Series,States/Local Areas,Maryland,2012,Age,24 Months,80.8,73.2 to 87.3,328
Hib,Full Series,States/Local Areas,Maryland,2011,Age,24 Months,87.0,80.2 to 92.3,300
Hib,Full Series,States/Local Areas,Maryland,2018,Age,19 Months,79.6,75.4 to 83.2,837
Hib,Full Series,States/Local Areas,Maryland,2018-2019,Age,19 Months,97.1,95.7 to 98.0,1451
Hib,Full Series,States/Local Areas,Maryland,2019,Age,19 Months,74.5,69.1 to 79.2,614
Hib,Full Series,States/Local Areas,Maryland,2017,Age,19 Months,80.2,75.6 to 84.0,766
Hib,Full Series,States/Local Areas,Maryland,2017-2018,Age,19 Months,79.9,76.8 to 82.6,1603
Influenza,,States/Local Areas,Maryland,2013,Age,24 Months,61.2,53.3 to 69.2,361
Influenza,,States/Local Areas,Maryland,2013-2014,Age,24 Months,57.8,52.2 to 63.5,727
Influenza,,States/Local Areas,Maryland,2012,Age,24 Months,56.1,47.8 to 64.7,328
Influenza,,States/Local Areas,Maryland,2011,Age,24 Months,63.0,54.1 to 71.8,300
Influenza,,States/Local Areas,Maryland,2014,Age,24 Months,54.5,46.7 to 62.7,366
Influenza,,States/Local Areas,Maryland,2014-2015,Age,24 Months,58.4,52.7 to 64.2,738
Influenza,,States/Local Areas,Maryland,2015,Age,24 Months,62.3,54.3 to 70.5,372
Influenza,,States/Local Areas,Maryland,2015-2016,Age,24 Months,58.1,52.8 to 63.6,836
Influenza,,States/Local Areas,Maryland,2016,Age,24 Months,54.1,47.2 to 61.2,464
Influenza,,States/Local Areas,Maryland,2016-2017,Age,24 Months,59.2,54.8 to 63.6,1230
Influenza,,States/Local Areas,Maryland,2019,Age,24 Months,69.3,63.9 to 74.6,614
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,89.5,86.8 to 92.2,1716
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,88.6,85.4 to 91.8,716
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.5,95.5 to 99.5,382
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.9,66.6 to 81.3,471
Influenza,,States/Local Areas,Maryland,2017,Age,24 Months,64.4,59.1 to 69.7,766
Influenza,,States/Local Areas,Maryland,2017-2018,Age,24 Months,65.1,61.5 to 68.7,1603
Influenza,,States/Local Areas,Maryland,2018,Age,24 Months,65.9,61.1 to 70.6,837
Influenza,,States/Local Areas,Maryland,2018-2019,Age,24 Months,67.6,64.0 to 71.2,1451
Influenza,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,58.7,53.7 to 63.6,1053
Influenza,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.8,65.3 to 76.3,806
Influenza,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,60.1,52.9 to 67.3,548
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.2,75.9 to 88.5,382
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.5,72.0 to 89.0,382
Influenza,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",44.2,36.3 to 52.1,305
Influenza,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,53.6,43.7 to 63.4,279
Influenza,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.4,56.9 to 75.9,236
Influenza,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,70.0,65.6 to 74.4,1180
Influenza,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,45.0,37.9 to 52.1,399
Hib,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,91.6,88.3 to 94.1,861
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,78.1,70.7 to 85.5,471
PCV,≥1 Dose,States/Local Areas,Maryland,2021,Age,3 Months,90.2,84.6 to 93.9,367
≥1 Dose Varicella,,States/Local Areas,Maryland,2020-2021,Age,13 Months,71.3,66.7 to 75.4,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2021,Age,24 Months,96.1,91.7 to 98.5,367
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,96.8,95.3 to 98.3,1716
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,92.6,89.7 to 95.5,716
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,88.6,86.0 to 91.1,1716
Influenza,,States/Local Areas,Maryland,2014-2017,Overall,Overall,59.0,55.0 to 63.1,1626
Influenza,,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,47.0,38.6 to 55.3,287
Influenza,,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,53.8,46.2 to 61.3,419
Influenza,,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,71.7,66.6 to 76.8,920
Hep B,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,94.2,91.6 to 96.3,861
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.2,81.1 to 93.4,382
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,91.0,88.8 to 93.3,1716
Hib,≥2 Doses,States/Local Areas,Maryland,2021,Age,13 Months,95.4,90.7 to 97.8,367
DTaP,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,5 Months,86.3,82.4 to 89.5,861
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2021,Age,0-3 Days,79.5,72.2 to 85.2,367
Polio,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,96.0,93.7 to 97.7,861
Hib,≥3 Doses,States/Local Areas,Maryland,2021,Age,35 Months,95.9,91.4 to 98.4,367
≥1 Dose MMR,,States/Local Areas,Maryland,2021,Age,13 Months,76.2,69.2 to 82.1,367
Hep A,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,86.5,80.9 to 91.1,861
PCV,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,3 Months,89.7,86.3 to 92.3,861
Polio,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,3 Months,88.5,84.8 to 91.4,861
PCV,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,93.0,90.1 to 95.1,861
Hib,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,69.1,64.4 to 73.4,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,80.5,76.2 to 84.2,861
Hib,Primary Series,States/Local Areas,Maryland,2021,Age,35 Months,96.0,91.6 to 98.5,367
≥1 Dose MMR,,States/Local Areas,Maryland,2020-2021,Age,19 Months,92.9,90.0 to 95.0,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,99.6,98.1 to 100.0,861
Rotavirus,,States/Local Areas,Maryland,2020-2021,Age,8 Months,82.0,77.9 to 85.5,861
DTaP,≥4 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,87.3,83.7 to 90.5,861
Hep A,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,19 Months,87.9,84.5 to 90.6,861
Hib,Primary Series,States/Local Areas,Maryland,2020-2021,Age,19 Months,94.2,91.3 to 96.2,861
Hep B,≥2 Doses,States/Local Areas,Maryland,2021,Age,13 Months,96.1,91.8 to 98.2,367
Hep A,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,35 Months,94.4,91.5 to 96.6,861
Hib,Full Series,States/Local Areas,Maryland,2020-2021,Age,19 Months,77.5,73.1 to 81.4,861
PCV,≥4 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,85.5,81.7 to 88.6,861
Hib,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,97.0,93.4 to 98.9,861
Hep B,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,62.3,57.4 to 66.9,861
DTaP,≥4 Doses,States/Local Areas,Maryland,2021,Age,35 Months,93.1,81.1 to 98.6,367
PCV,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,95.8,93.5 to 97.3,861
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2020-2021,Age,0-1 Days,75.8,71.2 to 79.8,861
Influenza,,States/Local Areas,Maryland,2020-2021,Age,24 Months,66.5,61.9 to 71.1,861
PCV,≥4 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,89.9,85.9 to 93.2,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,96.1,93.7 to 97.8,861
Polio,≥3 Doses,States/Local Areas,Maryland,2021,Age,35 Months,96.1,91.6 to 98.5,367
≥1 Dose Varicella,,States/Local Areas,Maryland,2021,Age,35 Months,96.9,93.3 to 98.8,367
≥1 Dose MMR,,States/Local Areas,Maryland,2020-2021,Age,35 Months,96.1,93.8 to 97.8,861
Hep B,≥3 Doses,States/Local Areas,Maryland,2021,Age,35 Months,93.9,89.1 to 97.1,367
Hib,Primary Series,States/Local Areas,Maryland,2021,Age,13 Months,87.9,81.8 to 92.2,367
Hep B,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,93.2,90.2 to 95.4,861
Hib,Primary Series,States/Local Areas,Maryland,2020-2021,Age,13 Months,88.0,84.4 to 90.9,861
Combined 7 Series,,States/Local Areas,Maryland,2020-2021,Age,24 Months,75.7,71.4 to 79.9,861
Hib,Full Series,States/Local Areas,Maryland,2021,Age,35 Months,82.2,75.7 to 87.8,367
Polio,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,92.8,89.5 to 95.1,861
Polio,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,94.9,92.0 to 96.7,861
PCV,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,96.7,94.8 to 98.0,861
≥1 Dose MMR,,States/Local Areas,Maryland,2020-2021,Age,24 Months,95.4,93.0 to 97.1,861
Combined 7 Series,,States/Local Areas,Maryland,2020-2021,Age,35 Months,80.4,75.3 to 85.1,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2021,Age,35 Months,96.1,91.7 to 98.5,367
Hib,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,93.7,90.8 to 95.7,861
Hib,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,3 Months,85.5,81.6 to 88.6,861
Hib,Primary Series,States/Local Areas,Maryland,2020-2021,Age,7 Months,77.3,72.9 to 81.1,861
Hib,≥3 Doses,States/Local Areas,Maryland,2021,Age,13 Months,80.8,74.0 to 86.1,367
Polio,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,5 Months,86.4,82.4 to 89.5,861
Rotavirus,,States/Local Areas,Maryland,2021,Age,8 Months,81.4,74.7 to 86.6,367
Polio,≥2 Doses,States/Local Areas,Maryland,2021,Age,5 Months,86.2,79.6 to 90.9,367
≥1 Dose Varicella,,States/Local Areas,Maryland,2020-2021,Age,24 Months,95.8,93.6 to 97.3,861
DTaP,≥2 Doses,States/Local Areas,Maryland,2021,Age,5 Months,86.3,79.7 to 91.0,367
Hep B,≥3 Doses,States/Local Areas,Maryland,2021,Age,13 Months,91.1,85.2 to 94.8,367
Polio,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,98.6,95.7 to 99.7,861
Hep B,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,5 Months,90.4,86.7 to 93.1,861
≥1 Dose Varicella,,States/Local Areas,Maryland,2021,Age,13 Months,72.6,65.6 to 78.8,367
Polio,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,95.6,92.9 to 97.3,861
Hib,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,5 Months,83.7,79.8 to 87.1,861
DTaP,≥4 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,79.7,75.3 to 83.4,861
Influenza,,States/Local Areas,Maryland,2021,Age,24 Months,67.1,59.7 to 74.4,367
Hep B,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,93.5,90.5 to 95.6,861
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2020-2021,Age,0-2 Days,79.4,75.0 to 83.2,861
Hep B,≥2 Doses,States/Local Areas,Maryland,2021,Age,5 Months,89.1,82.5 to 93.4,367
≥1 Dose MMR,,States/Local Areas,Maryland,2021,Age,19 Months,93.0,88.1 to 95.9,367
Hep A,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,28.4,24.2 to 32.9,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,92.5,89.3 to 94.8,861
≥1 Dose MMR,,States/Local Areas,Maryland,2020-2021,Age,13 Months,76.0,71.6 to 80.0,861
Hep B,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,3 Months,95.6,93.0 to 97.3,861
≥1 Dose Varicella,,States/Local Areas,Maryland,2020-2021,Age,19 Months,93.3,90.6 to 95.3,861
PCV,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,7 Months,77.7,73.3 to 81.6,861
DTaP,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,3 Months,88.8,85.1 to 91.7,861
Hep A,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,44.8,40.0 to 49.9,861
Hib,Full Series,States/Local Areas,Maryland,2020-2021,Age,35 Months,85.1,81.0 to 88.7,861
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2020-2021,Age,0-3 Days,80.0,75.6 to 83.8,861
Hib,Primary Series,States/Local Areas,Maryland,2020-2021,Age,35 Months,97.2,93.8 to 99.0,861
Hep B,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,61.8,57.8 to 65.7,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,97.6,96.0 to 99.2,1341
Hib,Primary Series,States/Local Areas,Maryland,2016,Age,19 Months,92.7,87.9 to 95.7,464
Hib,Primary Series,States/Local Areas,Maryland,2016-2017,Age,19 Months,94.0,91.3 to 95.8,1230
Hib,Primary Series,States/Local Areas,Maryland,2015,Age,19 Months,95.8,89.8 to 98.3,372
Hib,Primary Series,States/Local Areas,Maryland,2015-2016,Age,19 Months,94.3,91.0 to 96.4,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2017,Age,35 Months,95.9,93.3 to 97.8,766
DTaP,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,96.3,94.6 to 97.6,1603
DTaP,≥3 Doses,States/Local Areas,Maryland,2016,Age,35 Months,94.3,90.2 to 97.1,464
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,95.1,92.8 to 96.9,1230
DTaP,≥3 Doses,States/Local Areas,Maryland,2015,Age,35 Months,96.8,91.8 to 99.1,372
DTaP,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,95.5,92.6 to 97.6,836
PCV,≥2 Doses,States/Local Areas,Maryland,2011,Age,5 Months,82.4,74.6 to 88.2,300
PCV,≥2 Doses,States/Local Areas,Maryland,2012,Age,5 Months,79.6,73.5 to 84.6,328
PCV,≥2 Doses,States/Local Areas,Maryland,2013,Age,5 Months,82.4,74.7 to 88.2,361
PCV,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,5 Months,82.0,77.1 to 86.0,727
Hib,Primary Series,States/Local Areas,Maryland,2013,Age,24 Months,95.8,92.2 to 98.0,361
Hib,Primary Series,States/Local Areas,Maryland,2013-2014,Age,24 Months,93.5,90.3 to 96.0,727
Hib,Primary Series,States/Local Areas,Maryland,2011,Age,24 Months,97.7,95.2 to 99.1,300
Hib,Primary Series,States/Local Areas,Maryland,2012,Age,24 Months,93.0,87.5 to 96.7,328
Hib,Primary Series,States/Local Areas,Maryland,2017,Age,19 Months,95.2,92.3 to 97.0,766
Hib,Primary Series,States/Local Areas,Maryland,2017-2018,Age,19 Months,95.3,93.6 to 96.6,1603
Hib,Primary Series,States/Local Areas,Maryland,2018,Age,19 Months,95.5,93.1 to 97.1,837
Hib,Primary Series,States/Local Areas,Maryland,2018-2019,Age,19 Months,89.4,86.8 to 91.5,1451
DTaP,≥4 Doses,States/Local Areas,Maryland,2011,Age,19 Months,73.9,68.6 to 78.5,300
DTaP,≥4 Doses,States/Local Areas,Maryland,2012,Age,19 Months,71.6,63.7 to 78.4,328
Hib,≥3 Doses,States/Local Areas,Maryland,2011,Age,35 Months,97.7,95.2 to 99.1,300
Hib,≥3 Doses,States/Local Areas,Maryland,2012,Age,35 Months,92.6,87.0 to 96.5,328
Hep A,≥1 Dose,States/Local Areas,Maryland,2012,Age,24 Months,86.7,79.9 to 92.1,328
Hep A,≥1 Dose,States/Local Areas,Maryland,2014,Age,24 Months,84.8,78.4 to 90.1,366
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,24 Months,84.7,80.2 to 88.6,738
Hep A,≥1 Dose,States/Local Areas,Maryland,2013,Age,24 Months,87.6,82.2 to 92.0,361
Hep A,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,24 Months,86.2,82.1 to 89.8,727
Hep A,≥1 Dose,States/Local Areas,Maryland,2011,Age,24 Months,86.1,79.5 to 91.4,300
Hep A,≥1 Dose,States/Local Areas,Maryland,2019,Age,19 Months,83.7,78.9 to 87.6,614
DTaP,≥3 Doses,States/Local Areas,Maryland,2019,Age,35 Months,96.2,93.2 to 98.1,614
DTaP,≥3 Doses,States/Local Areas,Maryland,2018,Age,35 Months,96.7,94.5 to 98.2,837
DTaP,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,96.5,94.7 to 97.8,1451
PCV,≥2 Doses,States/Local Areas,Maryland,2016,Age,5 Months,79.7,73.1 to 85.0,464
PCV,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,5 Months,82.2,78.3 to 85.5,1230
PCV,≥2 Doses,States/Local Areas,Maryland,2015,Age,5 Months,85.3,78.6 to 90.2,372
PCV,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,5 Months,82.5,78.0 to 86.3,836
PCV,≥2 Doses,States/Local Areas,Maryland,2014,Age,5 Months,81.5,74.0 to 87.2,366
PCV,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,5 Months,83.4,79.2 to 86.9,738
Hep A,≥1 Dose,States/Local Areas,Maryland,2016,Age,24 Months,85.4,79.6 to 90.2,464
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,24 Months,89.0,85.8 to 91.7,1230
Hep A,≥1 Dose,States/Local Areas,Maryland,2015,Age,24 Months,84.5,78.0 to 90.0,372
Hep A,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,24 Months,85.0,80.7 to 88.7,836
Hep A,≥1 Dose,States/Local Areas,Maryland,2018,Age,19 Months,84.7,80.7 to 88.0,837
Hep A,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,19 Months,85.0,81.7 to 87.9,1277
Hep A,≥1 Dose,States/Local Areas,Maryland,2017,Age,19 Months,87.8,84.1 to 90.7,766
Hep A,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,19 Months,86.2,83.6 to 88.5,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2019,Age,24 Months,93.5,90.3 to 96.0,614
Hib,≥3 Doses,States/Local Areas,Maryland,2018,Age,24 Months,94.8,92.4 to 96.6,837
Hib,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,94.2,92.3 to 95.8,1451
Hep A,≥2 Doses,States/Local Areas,Maryland,2012,Age,19 Months,16.3,12.7 to 20.7,328
Hep A,≥2 Doses,States/Local Areas,Maryland,2014,Age,19 Months,25.8,19.3 to 33.4,366
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,25.2,20.5 to 30.4,738
Hep A,≥2 Doses,States/Local Areas,Maryland,2013,Age,19 Months,17.4,12.7 to 23.4,361
Hep A,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,21.6,16.9 to 27.1,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2011,Age,19 Months,16.6,13.7 to 19.9,300
DTaP,≥3 Doses,States/Local Areas,Maryland,2014,Age,35 Months,95.0,90.3 to 97.9,366
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,95.9,92.7 to 97.9,738
DTaP,≥3 Doses,States/Local Areas,Maryland,2011,Age,35 Months,98.4,96.2 to 99.5,300
DTaP,≥3 Doses,States/Local Areas,Maryland,2012,Age,35 Months,92.6,87.0 to 96.5,328
DTaP,≥3 Doses,States/Local Areas,Maryland,2013,Age,35 Months,98.7,96.8 to 99.6,361
DTaP,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,97.0,94.4 to 98.6,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2011,Age,24 Months,35.3,26.8 to 45.4,300
Hep A,≥2 Doses,States/Local Areas,Maryland,2019,Age,19 Months,30.1,25.1 to 35.6,614
Hep A,≥2 Doses,States/Local Areas,Maryland,2018,Age,19 Months,28.8,24.7 to 33.3,837
Hep A,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,31.9,27.8 to 36.3,1277
Hib,≥3 Doses,States/Local Areas,Maryland,2017,Age,35 Months,95.5,92.9 to 97.4,766
Hib,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,96.1,94.4 to 97.4,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2016,Age,35 Months,93.9,89.8 to 96.8,464
Hib,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,94.8,92.4 to 96.6,1230
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.7 to 99.2,1180
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,89.8,85.2 to 94.5,399
DTaP,≥4 Doses,States/Local Areas,Maryland,2015,Age,19 Months,76.3,72.8 to 79.5,372
DTaP,≥4 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,76.1,71.2 to 80.4,836
DTaP,≥4 Doses,States/Local Areas,Maryland,2014,Age,19 Months,71.6,63.5 to 78.4,366
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,73.9,68.5 to 78.7,738
DTaP,≥4 Doses,States/Local Areas,Maryland,2013,Age,19 Months,73.7,65.3 to 80.7,361
DTaP,≥4 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,72.6,65.9 to 78.4,727
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.6,90.9 to 98.4,305
Hep A,≥2 Doses,States/Local Areas,Maryland,2012,Age,24 Months,28.9,22.0 to 37.6,328
Hib,≥3 Doses,States/Local Areas,Maryland,2018,Age,35 Months,96.9,94.4 to 98.5,837
Hib,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,95.5,93.5 to 97.1,1451
Hib,Primary Series,States/Local Areas,Maryland,2019,Age,19 Months,92.7,89.1 to 95.1,614
Hep A,≥1 Dose,States/Local Areas,Maryland,2016,Age,19 Months,80.1,73.6 to 85.3,464
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,19 Months,83.9,80.2 to 87.0,1230
PCV,≥2 Doses,States/Local Areas,Maryland,2017,Age,5 Months,84.7,80.3 to 88.2,766
PCV,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,5 Months,85.2,82.4 to 87.6,1603
Hep A,≥1 Dose,States/Local Areas,Maryland,2011,Age,35 Months,86.6,80.0 to 91.8,300
Hep A,≥1 Dose,States/Local Areas,Maryland,2019,Age,24 Months,88.8,84.5 to 92.3,614
Hep A,≥1 Dose,States/Local Areas,Maryland,2018,Age,24 Months,88.0,84.3 to 91.1,837
Hep A,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,24 Months,88.3,85.6 to 90.7,1451
Hep A,≥1 Dose,States/Local Areas,Maryland,2017,Age,24 Months,92.6,89.7 to 94.9,766
Hep A,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,24 Months,90.3,88.0 to 92.3,1603
Hep A,≥2 Doses,States/Local Areas,Maryland,2017,Age,19 Months,21.9,18.0 to 26.2,766
Hep A,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,25.3,22.4 to 28.5,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2015,Age,35 Months,96.4,91.6 to 98.9,372
Hib,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,95.2,92.3 to 97.3,836
Hib,≥3 Doses,States/Local Areas,Maryland,2014,Age,35 Months,90.0,84.3 to 94.3,366
Hib,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,93.3,89.7 to 96.0,738
Hib,≥3 Doses,States/Local Areas,Maryland,2013,Age,35 Months,97.7,94.2 to 99.3,361
Hib,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,93.9,90.3 to 96.5,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2016,Age,19 Months,20.7,15.8 to 26.6,464
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,21.3,18.1 to 24.9,1230
Hep A,≥2 Doses,States/Local Areas,Maryland,2015,Age,19 Months,24.5,17.6 to 33.1,372
Hep A,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,22.6,18.6 to 27.3,836
DTaP,≥2 Doses,States/Local Areas,Maryland,2017,Age,5 Months,85.1,80.7 to 88.6,766
DTaP,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,5 Months,85.8,83.0 to 88.2,1603
DTaP,≥2 Doses,States/Local Areas,Maryland,2018,Age,5 Months,86.4,82.7 to 89.5,837
DTaP,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,5 Months,85.8,82.8 to 88.3,1451
DTaP,≥2 Doses,States/Local Areas,Maryland,2019,Age,5 Months,85.1,80.4 to 88.9,614
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,93.6,91.3 to 95.9,1626
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,87.6,81.7 to 93.5,287
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,94.9,91.4 to 98.4,419
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,96.9,94.7 to 99.2,920
DTaP,≥3 Doses,States/Local Areas,Maryland,2018,Age,24 Months,96.0,93.8 to 97.6,837
DTaP,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,95.9,94.1 to 97.3,1451
DTaP,≥3 Doses,States/Local Areas,Maryland,2017,Age,24 Months,95.5,92.8 to 97.4,766
DTaP,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,95.7,94.1 to 97.1,1603
Hep A,≥1 Dose,States/Local Areas,Maryland,2012,Age,19 Months,79.2,74.1 to 83.4,328
Hep A,≥1 Dose,States/Local Areas,Maryland,2011,Age,19 Months,80.9,73.0 to 86.8,300
DTaP,≥1 Dose,States/Local Areas,Maryland,2019,Age,3 Months,94.3,91.0 to 96.5,614
DTaP,≥3 Doses,States/Local Areas,Maryland,2016,Age,24 Months,94.3,90.2 to 97.1,464
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,94.9,92.6 to 96.7,1230
DTaP,≥1 Dose,States/Local Areas,Maryland,2018,Age,3 Months,93.6,90.9 to 95.6,837
DTaP,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,3 Months,94.0,92.0 to 95.5,1451
DTaP,≥3 Doses,States/Local Areas,Maryland,2015,Age,24 Months,96.1,91.3 to 98.7,372
DTaP,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,95.2,92.3 to 97.3,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2014,Age,24 Months,93.2,88.2 to 96.6,366
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,94.6,91.4 to 96.9,738
DTaP,≥1 Dose,States/Local Areas,Maryland,2017,Age,3 Months,90.2,86.2 to 93.1,766
DTaP,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,3 Months,91.9,89.6 to 93.7,1603
DTaP,≥1 Dose,States/Local Areas,Maryland,2016,Age,3 Months,89.4,83.8 to 93.2,464
DTaP,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,3 Months,89.8,86.5 to 92.3,1230
DTaP,≥1 Dose,States/Local Areas,Maryland,2015,Age,3 Months,92.3,87.4 to 95.4,372
DTaP,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,3 Months,90.8,87.3 to 93.4,836
DTaP,≥1 Dose,States/Local Areas,Maryland,2014,Age,3 Months,89.3,83.0 to 93.5,366
DTaP,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,3 Months,90.8,87.0 to 93.6,738
DTaP,≥1 Dose,States/Local Areas,Maryland,2013,Age,3 Months,93.8,87.8 to 97.0,361
DTaP,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,3 Months,91.6,88.4 to 93.9,727
DTaP,≥1 Dose,States/Local Areas,Maryland,2011,Age,3 Months,94.2,90.8 to 96.4,300
DTaP,≥1 Dose,States/Local Areas,Maryland,2012,Age,3 Months,90.1,86.9 to 92.6,328
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.8,77.8 to 85.8,1186
Hep A,≥1 Dose,States/Local Areas,Maryland,2020-2021,Age,24 Months,92.5,89.9 to 94.7,861
Hib,≥3 Doses,States/Local Areas,Maryland,2017,Age,24 Months,94.6,91.9 to 96.6,766
Hib,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,94.6,92.9 to 96.1,1603
DTaP,≥3 Doses,States/Local Areas,Maryland,2019,Age,24 Months,95.7,92.7 to 97.7,614
Hib,≥3 Doses,States/Local Areas,Maryland,2016,Age,24 Months,93.9,89.8 to 96.8,464
Hib,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,94.2,91.9 to 96.1,1230
Hib,≥3 Doses,States/Local Areas,Maryland,2015,Age,24 Months,95.7,90.9 to 98.4,372
Hib,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,94.9,92.0 to 97.0,836
Hep A,≥1 Dose,States/Local Areas,Maryland,2013,Age,19 Months,83.5,74.4 to 89.7,361
Hep A,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,19 Months,82.4,78.9 to 85.4,727
Hep A,≥1 Dose,States/Local Areas,Maryland,2015,Age,19 Months,82.0,78.1 to 85.4,372
Hep A,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,19 Months,81.1,76.4 to 85.0,836
Hep A,≥1 Dose,States/Local Areas,Maryland,2014,Age,19 Months,81.3,74.2 to 86.8,366
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,19 Months,81.7,76.8 to 85.7,738
Hib,≥1 Dose,States/Local Areas,Maryland,2021,Age,3 Months,86.3,80.0 to 90.8,367
≥1 Dose Varicella,,States/Local Areas,Maryland,2021,Age,19 Months,94.4,90.2 to 96.9,367
Hib,Full Series,States/Local Areas,Maryland,2020-2021,Age,24 Months,82.9,79.0 to 86.5,861
Hib,Full Series,States/Local Areas,Maryland,2021,Age,19 Months,75.4,68.1 to 81.5,367
Hib,Primary Series,States/Local Areas,Maryland,2013,Age,7 Months,74.4,68.3 to 79.7,361
Hib,Primary Series,States/Local Areas,Maryland,2013-2014,Age,7 Months,74.7,70.2 to 78.6,727
Hep A,≥1 Dose,States/Local Areas,Maryland,2012,Age,35 Months,92.7,86.5 to 96.7,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2021,Age,19 Months,92.9,87.2 to 96.1,367
DTaP,≥4 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,91.9,88.1 to 94.9,861
Hib,Primary Series,States/Local Areas,Maryland,2021,Age,19 Months,94.7,89.5 to 97.4,367
Hib,≥2 Doses,States/Local Areas,Maryland,2021,Age,5 Months,84.2,77.6 to 89.1,367
Combined 7 Series,,States/Local Areas,Maryland,2011,Age,35 Months,80.1,72.0 to 87.2,300
Hib,Primary Series,States/Local Areas,Maryland,2017,Age,7 Months,77.8,73.0 to 82.0,766
Hib,Primary Series,States/Local Areas,Maryland,2017-2018,Age,7 Months,78.8,75.7 to 81.7,1603
Hib,Primary Series,States/Local Areas,Maryland,2016,Age,7 Months,75.4,68.7 to 81.0,464
Hib,Primary Series,States/Local Areas,Maryland,2016-2017,Age,7 Months,76.6,72.6 to 80.2,1230
Combined 7 Series,,States/Local Areas,Maryland,2014,Age,35 Months,73.9,65.9 to 81.3,366
Combined 7 Series,,States/Local Areas,Maryland,2014-2015,Age,35 Months,76.9,71.4 to 82.0,738
Combined 7 Series,,States/Local Areas,Maryland,2013,Age,35 Months,78.1,71.1 to 84.4,361
Combined 7 Series,,States/Local Areas,Maryland,2013-2014,Age,35 Months,76.1,70.8 to 81.1,727
Combined 7 Series,,States/Local Areas,Maryland,2012,Age,35 Months,75.1,66.6 to 83.0,328
Combined 7 Series,,States/Local Areas,Maryland,2019,Age,24 Months,72.9,67.6 to 77.9,614
Hib,Primary Series,States/Local Areas,Maryland,2015,Age,7 Months,79.6,71.8 to 85.7,372
Hib,Primary Series,States/Local Areas,Maryland,2015-2016,Age,7 Months,77.5,72.5 to 81.8,836
Hib,Primary Series,States/Local Areas,Maryland,2014,Age,7 Months,74.9,66.8 to 81.6,366
Hib,Primary Series,States/Local Areas,Maryland,2014-2015,Age,7 Months,77.2,71.8 to 81.9,738
Hib,Primary Series,States/Local Areas,Maryland,2015,Age,13 Months,94.1,88.5 to 97.1,372
Hib,Primary Series,States/Local Areas,Maryland,2015-2016,Age,13 Months,92.2,88.8 to 94.7,836
Hib,Primary Series,States/Local Areas,Maryland,2014,Age,13 Months,85.2,78.1 to 90.3,366
Hib,Primary Series,States/Local Areas,Maryland,2014-2015,Age,13 Months,89.6,85.3 to 92.8,738
Hib,Primary Series,States/Local Areas,Maryland,2014,Age,19 Months,90.3,84.1 to 94.2,366
Hib,Primary Series,States/Local Areas,Maryland,2014-2015,Age,19 Months,93.0,89.2 to 95.6,738
Hib,Primary Series,States/Local Areas,Maryland,2013,Age,19 Months,94.7,92.1 to 96.5,361
Hib,Primary Series,States/Local Areas,Maryland,2013-2014,Age,19 Months,92.5,89.1 to 94.9,727
Hib,Primary Series,States/Local Areas,Maryland,2018,Age,13 Months,90.7,87.3 to 93.2,837
Hib,Primary Series,States/Local Areas,Maryland,2018-2019,Age,13 Months,89.4,86.8 to 91.5,1451
Hib,Primary Series,States/Local Areas,Maryland,2011,Age,19 Months,97.6,96.6 to 98.3,300
Hib,Primary Series,States/Local Areas,Maryland,2012,Age,19 Months,91.8,87.2 to 94.9,328
≥1 Dose MMR,,States/Local Areas,Maryland,2020,Age,13 Months,75.8,70.0 to 80.8,494
Hib,Primary Series,States/Local Areas,Maryland,2011,Age,13 Months,97.2,96.0 to 98.1,300
Hib,Primary Series,States/Local Areas,Maryland,2012,Age,13 Months,89.1,84.2 to 92.6,328
Hib,Primary Series,States/Local Areas,Maryland,2013,Age,13 Months,89.5,85.9 to 92.3,361
Hib,Primary Series,States/Local Areas,Maryland,2013-2014,Age,13 Months,87.3,81.6 to 91.5,727
Hib,Primary Series,States/Local Areas,Maryland,2019,Age,13 Months,88.2,83.9 to 91.4,614
Hib,Primary Series,States/Local Areas,Maryland,2017,Age,13 Months,91.0,87.3 to 93.6,766
Hib,Primary Series,States/Local Areas,Maryland,2017-2018,Age,13 Months,90.8,88.5 to 92.7,1603
Hib,Primary Series,States/Local Areas,Maryland,2016,Age,13 Months,90.3,85.3 to 93.8,464
Hib,Primary Series,States/Local Areas,Maryland,2016-2017,Age,13 Months,90.6,87.7 to 92.9,1230
Hib,Primary Series,States/Local Areas,Maryland,2019,Age,7 Months,74.9,69.6 to 79.6,614
Hib,Primary Series,States/Local Areas,Maryland,2018,Age,7 Months,79.9,75.6 to 83.5,837
Hib,Primary Series,States/Local Areas,Maryland,2018-2019,Age,7 Months,77.4,74.0 to 80.4,1451
Combined 7 Series,,States/Local Areas,Maryland,2017,Age,24 Months,75.4,70.5 to 80.0,766
Combined 7 Series,,States/Local Areas,Maryland,2017-2018,Age,24 Months,75.4,72.2 to 78.6,1603
Combined 7 Series,,States/Local Areas,Maryland,2018,Age,24 Months,75.4,71.0 to 79.6,837
Combined 7 Series,,States/Local Areas,Maryland,2018-2019,Age,24 Months,74.1,70.7 to 77.5,1451
Combined 7 Series,,States/Local Areas,Maryland,2015,Age,24 Months,73.9,66.6 to 80.7,372
Combined 7 Series,,States/Local Areas,Maryland,2015-2016,Age,24 Months,73.7,68.8 to 78.3,836
Hib,Primary Series,States/Local Areas,Maryland,2018,Age,35 Months,96.9,94.5 to 98.5,837
Hib,Primary Series,States/Local Areas,Maryland,2018-2019,Age,35 Months,96.0,94.1 to 97.4,1451
Combined 7 Series,,States/Local Areas,Maryland,2016,Age,24 Months,73.5,66.9 to 79.7,464
Combined 7 Series,,States/Local Areas,Maryland,2016-2017,Age,24 Months,74.4,70.4 to 78.4,1230
Hib,Primary Series,States/Local Areas,Maryland,2019,Age,35 Months,95.1,92.2 to 97.2,614
Combined 7 Series,,States/Local Areas,Maryland,2014,Age,24 Months,70.0,62.4 to 77.3,366
Combined 7 Series,,States/Local Areas,Maryland,2014-2015,Age,24 Months,71.9,66.6 to 77.0,738
Combined 7 Series,,States/Local Areas,Maryland,2016,Age,35 Months,78.1,71.5 to 84.0,464
Combined 7 Series,,States/Local Areas,Maryland,2016-2017,Age,35 Months,79.2,75.2 to 82.9,1230
Combined 7 Series,,States/Local Areas,Maryland,2017,Age,35 Months,80.4,75.7 to 84.7,766
Combined 7 Series,,States/Local Areas,Maryland,2017-2018,Age,35 Months,80.9,77.7 to 83.9,1603
Hib,Primary Series,States/Local Areas,Maryland,2017,Age,24 Months,95.4,92.8 to 97.3,766
Hib,Primary Series,States/Local Areas,Maryland,2017-2018,Age,24 Months,95.5,93.9 to 96.8,1603
Hib,Primary Series,States/Local Areas,Maryland,2016,Age,24 Months,94.2,90.2 to 97.0,464
Hib,Primary Series,States/Local Areas,Maryland,2016-2017,Age,24 Months,94.8,92.5 to 96.6,1230
Hib,Primary Series,States/Local Areas,Maryland,2016,Age,35 Months,94.2,90.2 to 97.0,464
Hib,Primary Series,States/Local Areas,Maryland,2016-2017,Age,35 Months,95.0,92.7 to 96.7,1230
Combined 7 Series,,States/Local Areas,Maryland,2011,Age,24 Months,75.6,67.3 to 83.1,300
Hib,Primary Series,States/Local Areas,Maryland,2018,Age,24 Months,95.6,93.3 to 97.2,837
Hib,Primary Series,States/Local Areas,Maryland,2018-2019,Age,24 Months,95.4,93.6 to 96.9,1451
Hib,Primary Series,States/Local Areas,Maryland,2015,Age,24 Months,96.1,91.2 to 98.7,372
Hib,Primary Series,States/Local Areas,Maryland,2015-2016,Age,24 Months,95.2,92.3 to 97.3,836
Hib,Primary Series,States/Local Areas,Maryland,2014,Age,24 Months,91.3,85.8 to 95.4,366
Hib,Primary Series,States/Local Areas,Maryland,2014-2015,Age,24 Months,93.7,90.3 to 96.3,738
Hib,Primary Series,States/Local Areas,Maryland,2017,Age,35 Months,95.7,93.1 to 97.5,766
Hib,Primary Series,States/Local Areas,Maryland,2017-2018,Age,35 Months,96.2,94.5 to 97.5,1603
Hib,Primary Series,States/Local Areas,Maryland,2015,Age,35 Months,96.6,91.7 to 99.0,372
Hib,Primary Series,States/Local Areas,Maryland,2015-2016,Age,35 Months,95.5,92.6 to 97.5,836
Hib,Primary Series,States/Local Areas,Maryland,2019,Age,24 Months,95.1,92.2 to 97.2,614
Hib,Primary Series,States/Local Areas,Maryland,2012,Age,35 Months,93.3,87.8 to 97.0,328
Hib,Primary Series,States/Local Areas,Maryland,2014,Age,35 Months,91.3,85.8 to 95.4,366
Hib,Primary Series,States/Local Areas,Maryland,2014-2015,Age,35 Months,94.0,90.5 to 96.6,738
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,62.3,54.1 to 70.5,287
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Overall,Overall,72.8,69.1 to 76.5,1626
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.9,58.7 to 79.0,236
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.9,75.0 to 84.8,806
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.2,67.7 to 76.7,1053
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,74.2,67.6 to 80.7,548
Hib,Full Series,States/Local Areas,Maryland,2014,Age,19 Months,71.9,63.7 to 78.9,366
Hib,Full Series,States/Local Areas,Maryland,2014-2015,Age,19 Months,75.8,70.4 to 80.5,738
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,69.2,62.1 to 76.3,419
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,83.0,78.7 to 87.2,920
Hib,Full Series,States/Local Areas,Maryland,2011,Age,19 Months,78.9,72.8 to 84.0,300
Hib,Full Series,States/Local Areas,Maryland,2012,Age,19 Months,75.1,69.8 to 79.8,328
Hib,Full Series,States/Local Areas,Maryland,2013,Age,19 Months,76.3,70.8 to 81.1,361
Hib,Full Series,States/Local Areas,Maryland,2013-2014,Age,19 Months,74.1,68.3 to 79.2,727
Combined 7 Series,,States/Local Areas,Maryland,2015,Age,35 Months,79.8,72.2 to 86.4,372
Combined 7 Series,,States/Local Areas,Maryland,2015-2016,Age,35 Months,78.8,73.9 to 83.3,836
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.9,61.4 to 76.3,305
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,81.0,77.3 to 84.8,1180
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,62.4,55.3 to 69.5,399
Combined 7 Series,,States/Local Areas,Maryland,2019,Age,35 Months,77.6,71.9 to 82.8,614
Combined 7 Series,,States/Local Areas,Maryland,2018,Age,35 Months,81.6,77.1 to 85.6,837
Combined 7 Series,,States/Local Areas,Maryland,2018-2019,Age,35 Months,79.6,76.0 to 83.0,1451
Combined 7 Series,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,66.7,57.2 to 76.2,279
Hib,Primary Series,States/Local Areas,Maryland,2013,Age,35 Months,97.8,94.4 to 99.3,361
Hib,Primary Series,States/Local Areas,Maryland,2013-2014,Age,35 Months,94.5,91.1 to 97.0,727
Combined 7 Series,,States/Local Areas,Maryland,2013,Age,24 Months,72.5,65.3 to 79.3,361
Combined 7 Series,,States/Local Areas,Maryland,2013-2014,Age,24 Months,71.2,66.0 to 76.3,727
Combined 7 Series,,States/Local Areas,Maryland,2012,Age,24 Months,66.7,58.4 to 74.8,328
Hib,Primary Series,States/Local Areas,Maryland,2011,Age,35 Months,97.7,95.2 to 99.1,300
DTaP,≥3 Doses,States/Local Areas,Missouri,2017,Age,13 Months,87.2,81.6 to 91.3,384
DTaP,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,88.8,85.0 to 91.7,800
Influenza,,States/Local Areas,Missouri,2013,Age,24 Months,49.1,40.8 to 58.1,208
Influenza,,States/Local Areas,Missouri,2013-2014,Age,24 Months,49.3,43.6 to 55.4,449
Influenza,,States/Local Areas,Missouri,2011,Age,24 Months,60.4,51.8 to 69.1,228
Influenza,,States/Local Areas,Missouri,2012,Age,24 Months,51.3,43.1 to 60.0,274
Influenza,,States/Local Areas,Missouri,2015,Age,24 Months,49.6,41.7 to 58.1,235
Influenza,,States/Local Areas,Missouri,2015-2016,Age,24 Months,51.6,45.8 to 57.7,473
Influenza,,States/Local Areas,Missouri,2014,Age,24 Months,49.5,42.0 to 57.5,241
Influenza,,States/Local Areas,Missouri,2014-2015,Age,24 Months,49.6,44.0 to 55.4,476
PCV,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,90.2,86.8 to 92.9,657
Hep B,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,93.1,90.2 to 95.3,657
Hib,≥2 Doses,States/Local Areas,Missouri,2021,Age,13 Months,93.8,89.6 to 96.4,267
Hib,Primary Series,States/Local Areas,Missouri,2021,Age,35 Months,92.9,88.6 to 95.9,267
Rotavirus,,States/Local Areas,Missouri,2021,Age,8 Months,81.4,74.4 to 86.9,267
Hep A,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,44.1,38.8 to 49.9,657
≥1 Dose Varicella,,States/Local Areas,Missouri,2020-2021,Age,24 Months,91.3,88.1 to 93.9,657
Hib,Primary Series,States/Local Areas,Missouri,2020-2021,Age,7 Months,81.1,76.7 to 84.8,657
Polio,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,94.1,90.3 to 96.7,657
DTaP,≥4 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,70.9,65.7 to 75.5,657
Polio,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,91.8,88.5 to 94.2,657
Hib,≥3 Doses,States/Local Areas,Missouri,2021,Age,13 Months,71.1,63.4 to 77.8,267
PCV,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,92.9,89.9 to 95.3,657
≥1 Dose Varicella,,States/Local Areas,Missouri,2020-2021,Age,19 Months,89.7,86.2 to 92.4,657
Hep B,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,93.2,90.6 to 95.2,657
Hib,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,3 Months,87.8,84.2 to 90.7,657
Combined 7 Series,,States/Local Areas,Missouri,2020-2021,Age,24 Months,68.6,63.3 to 73.8,657
PCV,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,92.9,89.9 to 95.3,657
Combined 7 Series,,States/Local Areas,Missouri,2020-2021,Age,35 Months,75.6,69.4 to 81.4,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2021,Age,35 Months,92.0,87.1 to 95.5,267
Hib,Full Series,States/Local Areas,Missouri,2021,Age,35 Months,80.5,73.2 to 86.8,267
≥1 Dose MMR,,States/Local Areas,Missouri,2020-2021,Age,35 Months,94.6,91.1 to 97.1,657
Hib,Primary Series,States/Local Areas,Missouri,2021,Age,13 Months,90.6,85.7 to 93.9,267
PCV,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,92.3,89.1 to 94.7,657
DTaP,≥4 Doses,States/Local Areas,Missouri,2021,Age,35 Months,84.7,76.7 to 91.0,267
Hep B,≥3 Doses,States/Local Areas,Missouri,2021,Age,35 Months,91.5,86.5 to 95.2,267
Influenza,,States/Local Areas,Missouri,2020-2021,Age,24 Months,54.0,48.7 to 59.5,657
Hep B,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,68.9,64.1 to 73.3,657
PCV,≥4 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,85.7,80.0 to 90.4,657
Polio,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,90.5,87.1 to 93.1,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,75.6,70.4 to 80.1,657
Hep B,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,5 Months,92.2,89.2 to 94.4,657
Hib,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,5 Months,79.2,74.4 to 83.2,657
Polio,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,5 Months,80.6,75.9 to 84.6,657
PCV,≥4 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,78.4,73.3 to 82.7,657
Rotavirus,,States/Local Areas,Missouri,2020-2021,Age,8 Months,79.7,75.2 to 83.6,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,92.9,89.8 to 95.2,657
Hep B,≥2 Doses,States/Local Areas,Missouri,2021,Age,13 Months,94.1,90.0 to 96.6,267
≥1 Dose Varicella,,States/Local Areas,Missouri,2021,Age,35 Months,92.5,87.6 to 96.0,267
Polio,≥3 Doses,States/Local Areas,Missouri,2016,Age,19 Months,87.2,80.8 to 91.6,238
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,87.7,83.8 to 90.8,622
Polio,≥3 Doses,States/Local Areas,Missouri,2017,Age,19 Months,88.3,83.0 to 92.1,384
Polio,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,90.9,87.5 to 93.5,800
Hib,≥3 Doses,States/Local Areas,Missouri,2018,Age,13 Months,69.7,62.9 to 75.7,416
Hib,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,66.4,61.5 to 70.8,818
Polio,≥3 Doses,States/Local Areas,Missouri,2018,Age,19 Months,93.5,88.4 to 96.5,416
Polio,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,61.7,56.7 to 66.5,818
Hib,≥3 Doses,States/Local Areas,Missouri,2016,Age,13 Months,61.2,52.8 to 68.9,238
Hib,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,65.3,59.8 to 70.3,622
Hib,≥3 Doses,States/Local Areas,Missouri,2017,Age,13 Months,69.5,62.9 to 75.5,384
Hib,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,69.6,64.9 to 73.9,800
Hib,≥3 Doses,States/Local Areas,Missouri,2015,Age,13 Months,72.8,64.8 to 79.6,235
Hib,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,67.0,61.2 to 72.3,473
Hib,≥3 Doses,States/Local Areas,Missouri,2019,Age,13 Months,63.0,56.0 to 69.5,402
Hib,≥3 Doses,States/Local Areas,Missouri,2012,Age,19 Months,86.1,83.7 to 88.2,274
Hib,≥3 Doses,States/Local Areas,Missouri,2011,Age,19 Months,87.6,80.1 to 92.5,228
Polio,≥3 Doses,States/Local Areas,Missouri,2014,Age,19 Months,91.9,87.4 to 94.9,241
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,89.1,85.0 to 92.1,476
Polio,≥3 Doses,States/Local Areas,Missouri,2012,Age,19 Months,92.2,87.9 to 95.1,274
Polio,≥3 Doses,States/Local Areas,Missouri,2015,Age,19 Months,86.2,84.9 to 87.4,235
Polio,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,86.7,82.0 to 90.3,473
Polio,≥3 Doses,States/Local Areas,Missouri,2013,Age,19 Months,87.5,80.0 to 92.5,208
Polio,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,89.7,86.6 to 92.2,449
DTaP,≥3 Doses,States/Local Areas,Missouri,2018,Age,13 Months,90.4,84.7 to 94.2,416
DTaP,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,87.5,83.5 to 90.7,818
DTaP,≥3 Doses,States/Local Areas,Missouri,2019,Age,13 Months,84.5,78.4 to 89.2,402
DTaP,≥3 Doses,States/Local Areas,Missouri,2011,Age,19 Months,89.1,83.9 to 92.8,228
DTaP,≥3 Doses,States/Local Areas,Missouri,2013,Age,19 Months,90.1,86.1 to 93.0,208
DTaP,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,91.9,90.3 to 93.3,449
DTaP,≥3 Doses,States/Local Areas,Missouri,2012,Age,19 Months,93.2,87.9 to 96.3,274
DTaP,≥3 Doses,States/Local Areas,Missouri,2016,Age,13 Months,84.6,77.5 to 89.7,238
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,85.8,81.5 to 89.3,622
DTaP,≥3 Doses,States/Local Areas,Missouri,2015,Age,13 Months,86.3,79.2 to 91.3,235
DTaP,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,85.4,80.6 to 89.3,473
DTaP,≥3 Doses,States/Local Areas,Missouri,2012,Age,13 Months,88.6,82.4 to 92.8,274
Hib,≥3 Doses,States/Local Areas,Missouri,2019,Age,7 Months,43.7,37.3 to 50.4,402
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,87.1,82.3 to 91.8,382
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.2,87.2 to 93.2,662
Hib,≥3 Doses,States/Local Areas,Missouri,2013,Age,13 Months,73.4,69.8 to 76.8,208
Hib,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,75.7,69.9 to 80.7,449
Polio,≥3 Doses,States/Local Areas,Missouri,2011,Age,19 Months,87.4,83.2 to 90.6,228
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,96.5,94.0 to 99.0,251
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,90.3,86.2 to 94.5,381
Hib,≥3 Doses,States/Local Areas,Missouri,2014,Age,13 Months,77.9,70.6 to 83.8,241
Hib,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,75.4,70.0 to 80.0,476
Hib,≥3 Doses,States/Local Areas,Missouri,2011,Age,13 Months,80.9,74.7 to 85.8,228
Hib,≥3 Doses,States/Local Areas,Missouri,2012,Age,13 Months,73.8,71.8 to 75.6,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,84.6,79.1 to 90.0,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,75.8,70.4 to 81.2,381
Hib,≥2 Doses,States/Local Areas,Missouri,2015,Age,13 Months,88.5,81.8 to 93.0,235
Hib,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,88.6,84.2 to 91.9,473
Hib,≥2 Doses,States/Local Areas,Missouri,2016,Age,13 Months,88.7,82.8 to 92.8,238
Hib,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,90.6,86.9 to 93.3,622
Hib,≥2 Doses,States/Local Areas,Missouri,2014,Age,13 Months,93.3,88.8 to 96.1,241
Hib,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,90.9,87.1 to 93.7,476
Hib,≥2 Doses,States/Local Areas,Missouri,2012,Age,13 Months,95.1,94.0 to 96.0,274
Hib,≥2 Doses,States/Local Areas,Missouri,2011,Age,13 Months,91.5,83.6 to 95.8,228
DTaP,≥3 Doses,States/Local Areas,Missouri,2011,Age,13 Months,87.3,84.1 to 89.9,228
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,81.2,76.1 to 86.2,280
DTaP,≥3 Doses,States/Local Areas,Missouri,2013,Age,13 Months,86.8,83.0 to 89.8,208
DTaP,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,89.0,86.3 to 91.2,449
DTaP,≥3 Doses,States/Local Areas,Missouri,2014,Age,13 Months,91.1,86.0 to 94.5,241
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,88.7,84.5 to 91.9,476
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,71.1,62.9 to 79.2,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Overall,Overall,79.7,76.6 to 82.9,912
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,80.8,76.0 to 85.5,382
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.9,78.2 to 87.7,336
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.1,74.2 to 82.0,662
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.6,70.4 to 88.9,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,84.8,76.0 to 93.6,82
Hib,≥2 Doses,States/Local Areas,Missouri,2013,Age,13 Months,95.0,91.3 to 97.2,208
Hib,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,94.1,91.3 to 96.1,449
PCV,≥3 Doses,States/Local Areas,Missouri,2017,Age,35 Months,87.9,82.8 to 92.0,384
PCV,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,91.7,88.3 to 94.5,800
PCV,≥3 Doses,States/Local Areas,Missouri,2018,Age,35 Months,96.5,91.1 to 99.0,416
PCV,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,92.8,88.5 to 96.0,818
Hib,≥3 Doses,States/Local Areas,Missouri,2014,Age,7 Months,49.4,41.6 to 57.3,241
Hib,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,50.1,44.4 to 55.7,476
Hib,≥3 Doses,States/Local Areas,Missouri,2015,Age,7 Months,50.7,42.6 to 58.8,235
Hib,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,46.1,40.4 to 51.9,473
Hib,≥3 Doses,States/Local Areas,Missouri,2016,Age,7 Months,41.4,33.8 to 49.5,238
Hib,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,46.0,40.8 to 51.3,622
Polio,≥1 Dose,States/Local Areas,Missouri,2017,Age,3 Months,84.5,78.8 to 88.8,384
Polio,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,3 Months,86.5,82.6 to 89.6,800
Polio,≥1 Dose,States/Local Areas,Missouri,2018,Age,3 Months,88.5,82.7 to 92.5,416
Polio,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,3 Months,88.2,84.4 to 91.2,818
DTaP,≥3 Doses,States/Local Areas,Missouri,2015,Age,7 Months,63.0,54.6 to 70.6,235
DTaP,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,66.0,60.1 to 71.5,473
DTaP,≥3 Doses,States/Local Areas,Missouri,2014,Age,7 Months,65.8,57.8 to 72.9,241
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,64.4,58.7 to 69.7,476
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2015,Age,0-3 Days,84.5,78.6 to 89.1,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2015-2016,Age,0-3 Days,82.2,77.6 to 85.9,473
DTaP,≥3 Doses,States/Local Areas,Missouri,2016,Age,7 Months,69.2,60.7 to 76.5,238
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,66.6,61.3 to 71.6,622
Hib,≥2 Doses,States/Local Areas,Missouri,2019,Age,7 Months,84.3,78.1 to 88.9,402
PCV,≥3 Doses,States/Local Areas,Missouri,2019,Age,35 Months,88.6,82.9 to 93.1,402
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2018,Age,0-3 Days,85.0,78.7 to 89.7,416
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2018-2019,Age,0-3 Days,82.6,78.4 to 86.1,818
Polio,≥1 Dose,States/Local Areas,Missouri,2019,Age,3 Months,88.0,82.5 to 91.9,402
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2019,Age,0-3 Days,80.2,74.2 to 85.1,402
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,81.2,76.9 to 85.5,509
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.4,75.5 to 93.2,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,79.8,74.9 to 84.6,331
DTaP,≥3 Doses,States/Local Areas,Missouri,2018,Age,7 Months,74.3,67.4 to 80.2,416
DTaP,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,69.3,64.3 to 73.8,818
DTaP,≥3 Doses,States/Local Areas,Missouri,2019,Age,7 Months,64.1,57.0 to 70.7,402
DTaP,≥3 Doses,States/Local Areas,Missouri,2017,Age,7 Months,64.0,57.2 to 70.3,384
DTaP,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,69.2,64.4 to 73.6,800
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,70.8,55.7 to 86.0,54
Hib,≥2 Doses,States/Local Areas,Missouri,2018,Age,13 Months,94.8,90.4 to 97.3,416
Hib,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,92.7,89.5 to 95.0,818
Hib,≥2 Doses,States/Local Areas,Missouri,2017,Age,13 Months,92.5,87.6 to 95.5,384
Hib,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,93.7,90.6 to 95.8,800
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,83.5,78.1 to 88.8,280
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,89.0,86.3 to 91.7,912
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,85.6,79.9 to 91.2,194
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,89.4 to 96.7,336
Hib,≥2 Doses,States/Local Areas,Missouri,2019,Age,13 Months,90.5,85.3 to 94.0,402
DTaP,≥2 Doses,States/Local Areas,Missouri,2014,Age,5 Months,73.4,65.6 to 79.9,241
DTaP,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,5 Months,71.9,66.3 to 77.0,476
Polio,≥3 Doses,States/Local Areas,Missouri,2015,Age,35 Months,96.4,87.2 to 99.5,235
Polio,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,91.8,87.3 to 95.2,473
Hib,Primary Series,States/Local Areas,Missouri,2020,Age,24 Months,93.1,89.1 to 96.1,390
Hep A,≥1 Dose,States/Local Areas,Missouri,2016,Age,35 Months,81.0,73.1 to 87.8,238
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,35 Months,84.0,79.2 to 88.3,622
≥1 Dose Varicella,,States/Local Areas,Missouri,2016,Age,13 Months,58.6,50.3 to 66.4,238
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2017,Age,13 Months,56.6,51.2 to 61.8,622
≥1 Dose Varicella,,States/Local Areas,Missouri,2017,Age,13 Months,54.6,47.8 to 61.1,384
≥1 Dose Varicella,,States/Local Areas,Missouri,2017-2018,Age,13 Months,55.4,50.5 to 60.1,800
≥1 Dose Varicella,,States/Local Areas,Missouri,2015,Age,13 Months,51.0,42.7 to 59.1,235
≥1 Dose Varicella,,States/Local Areas,Missouri,2015-2016,Age,13 Months,54.7,48.8 to 60.5,473
DTaP,≥4 Doses,States/Local Areas,Missouri,2018,Age,24 Months,80.9,74.7 to 86.4,416
DTaP,≥4 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,79.3,74.9 to 83.4,818
DTaP,≥4 Doses,States/Local Areas,Missouri,2017,Age,24 Months,78.1,72.1 to 83.7,384
DTaP,≥4 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,79.6,75.3 to 83.6,800
DTaP,≥4 Doses,States/Local Areas,Missouri,2019,Age,24 Months,77.5,71.0 to 83.4,402
DTaP,≥4 Doses,States/Local Areas,Missouri,2011,Age,35 Months,86.3,76.9 to 93.3,228
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,75.7 to 92.8,97
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,82.7,77.7 to 87.7,382
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.6,73.4 to 81.8,662
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,63.3,54.2 to 72.4,194
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.8,75.4 to 86.3,336
Polio,≥2 Doses,States/Local Areas,Missouri,2014,Age,7 Months,87.4,81.4 to 91.7,241
Polio,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,86.1,81.6 to 89.6,476
Polio,≥2 Doses,States/Local Areas,Missouri,2013,Age,7 Months,88.3,83.8 to 91.7,208
Polio,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,87.9,82.7 to 91.6,449
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,74.1,67.8 to 80.3,280
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Overall,Overall,78.3,74.8 to 81.8,912
Polio,≥2 Doses,States/Local Areas,Missouri,2015,Age,7 Months,84.8,77.6 to 89.9,235
Polio,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,85.8,81.1 to 89.4,473
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,78.4,73.0 to 83.9,381
Hep B,≥3 Doses,States/Local Areas,Missouri,2011,Age,13 Months,83.6,71.8 to 91.0,228
≥1 Dose MMR,,States/Local Areas,Missouri,2013,Age,13 Months,41.7,36.3 to 47.2,208
≥1 Dose MMR,,States/Local Areas,Missouri,2013-2014,Age,13 Months,55.0,44.5 to 65.1,449
≥1 Dose MMR,,States/Local Areas,Missouri,2012,Age,13 Months,50.9,41.9 to 59.9,274
≥1 Dose MMR,,States/Local Areas,Missouri,2011,Age,13 Months,50.2,46.0 to 54.3,228
Polio,≥2 Doses,States/Local Areas,Missouri,2019,Age,5 Months,77.3,70.7 to 82.9,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,80.2,69.4 to 91.0,82
Polio,≥2 Doses,States/Local Areas,Missouri,2012,Age,7 Months,92.5,90.0 to 94.4,274
Polio,≥2 Doses,States/Local Areas,Missouri,2011,Age,7 Months,85.8,78.7 to 90.9,228
Hep B,≥3 Doses,States/Local Areas,Missouri,2017,Age,7 Months,52.4,45.6 to 59.0,384
Hep B,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,58.0,53.2 to 62.7,800
Hep B,≥3 Doses,States/Local Areas,Missouri,2018,Age,7 Months,63.6,56.7 to 70.0,416
Hep B,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,62.6,57.8 to 67.2,818
Hep A,≥2 Doses,States/Local Areas,Missouri,2016,Age,35 Months,69.6,58.7 to 79.9,238
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,70.3,63.2 to 77.1,622
Hep A,≥2 Doses,States/Local Areas,Missouri,2015,Age,35 Months,59.0,49.9 to 68.4,235
Hep A,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,65.1,57.4 to 72.6,473
Hep B,≥3 Doses,States/Local Areas,Missouri,2019,Age,7 Months,61.6,54.8 to 68.0,402
Hep A,≥2 Doses,States/Local Areas,Missouri,2014,Age,35 Months,66.3,57.4 to 75.0,241
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,62.9,56.4 to 69.3,476
≥1 Dose Varicella,,States/Local Areas,Missouri,2014,Age,13 Months,62.0,54.3 to 69.1,241
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2015,Age,13 Months,56.5,50.8 to 62.0,476
≥1 Dose Varicella,,States/Local Areas,Missouri,2012,Age,13 Months,48.8,38.8 to 59.0,274
Hep A,≥1 Dose,States/Local Areas,Missouri,2019,Age,35 Months,84.0,78.0 to 89.2,402
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,77.1,71.5 to 82.7,331
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,82.3,77.8 to 86.8,509
Polio,≥2 Doses,States/Local Areas,Missouri,2018,Age,5 Months,81.8,75.2 to 86.9,416
Polio,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,5 Months,79.6,75.0 to 83.5,818
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,57.3,40.5 to 74.1,54
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.3,63.2 to 87.4,71
≥1 Dose Varicella,,States/Local Areas,Missouri,2013,Age,13 Months,40.7,35.9 to 45.8,208
≥1 Dose Varicella,,States/Local Areas,Missouri,2013-2014,Age,13 Months,51.4,43.2 to 59.6,449
≥1 Dose Varicella,,States/Local Areas,Missouri,2011,Age,13 Months,50.4,47.7 to 53.1,228
Polio,≥2 Doses,States/Local Areas,Missouri,2016,Age,5 Months,76.5,68.9 to 82.8,238
Polio,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,5 Months,74.6,69.6 to 79.0,622
Polio,≥2 Doses,States/Local Areas,Missouri,2017,Age,5 Months,72.5,66.0 to 78.3,384
Polio,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,5 Months,77.2,72.7 to 81.2,800
Hep B,≥3 Doses,States/Local Areas,Missouri,2014,Age,7 Months,60.1,52.4 to 67.4,241
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,58.3,52.7 to 63.7,476
Hep B,≥3 Doses,States/Local Areas,Missouri,2015,Age,7 Months,56.4,48.3 to 64.2,235
Hep B,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,57.3,51.5 to 62.9,473
Polio,≥2 Doses,States/Local Areas,Missouri,2015,Age,5 Months,70.5,62.3 to 77.6,235
Polio,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,5 Months,73.5,67.9 to 78.4,473
Hep B,≥3 Doses,States/Local Areas,Missouri,2016,Age,7 Months,58.2,49.8 to 66.1,238
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,55.3,49.9 to 60.6,622
Hep A,≥2 Doses,States/Local Areas,Missouri,2019,Age,24 Months,39.6,33.1 to 47.0,402
Hep A,≥2 Doses,States/Local Areas,Missouri,2011,Age,35 Months,58.5,47.5 to 70.0,228
Hep A,≥2 Doses,States/Local Areas,Missouri,2012,Age,35 Months,67.3,54.4 to 79.7,274
Hep A,≥2 Doses,States/Local Areas,Missouri,2013,Age,35 Months,67.4,56.7 to 77.7,208
Hep A,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,66.6,59.7 to 73.3,449
DTaP,≥4 Doses,States/Local Areas,Missouri,2016,Age,24 Months,72.1,63.8 to 79.9,238
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,75.1,69.9 to 80.0,622
DTaP,≥4 Doses,States/Local Areas,Missouri,2015,Age,24 Months,73.1,65.2 to 80.5,235
DTaP,≥4 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,72.7,66.9 to 78.3,473
DTaP,≥4 Doses,States/Local Areas,Missouri,2014,Age,24 Months,78.8,71.9 to 84.9,241
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,76.0,70.8 to 80.9,476
Hep A,≥1 Dose,States/Local Areas,Missouri,2013,Age,35 Months,81.5,73.2 to 88.4,208
Hep A,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,35 Months,85.6,80.0 to 90.3,449
Hep A,≥1 Dose,States/Local Areas,Missouri,2014,Age,35 Months,89.1,81.7 to 94.4,241
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,35 Months,90.1,84.6 to 94.2,476
Hep A,≥1 Dose,States/Local Areas,Missouri,2015,Age,35 Months,91.8,83.5 to 96.9,235
Hep A,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,35 Months,85.4,79.4 to 90.4,473
Polio,≥2 Doses,States/Local Areas,Missouri,2012,Age,5 Months,73.8,65.4 to 80.9,274
Polio,≥2 Doses,States/Local Areas,Missouri,2011,Age,5 Months,77.7,69.6 to 84.1,228
Polio,≥2 Doses,States/Local Areas,Missouri,2013,Age,5 Months,71.2,65.9 to 76.0,208
Polio,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,5 Months,72.0,69.3 to 74.5,449
Polio,≥2 Doses,States/Local Areas,Missouri,2014,Age,5 Months,72.7,65.0 to 79.3,241
Polio,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,5 Months,71.6,66.4 to 76.3,476
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,85.0,79.8 to 90.2,280
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,96.9,94.4 to 99.3,251
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,93.5,90.4 to 96.7,381
Hep B,≥3 Doses,States/Local Areas,Missouri,2012,Age,7 Months,60.3,53.8 to 66.6,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2011,Age,7 Months,51.5,46.8 to 56.3,228
Hep B,≥3 Doses,States/Local Areas,Missouri,2013,Age,7 Months,58.0,52.6 to 63.3,208
Hep B,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,59.1,55.8 to 62.3,449
DTaP,≥4 Doses,States/Local Areas,Missouri,2019,Age,19 Months,68.0,61.0 to 74.2,402
DTaP,≥4 Doses,States/Local Areas,Missouri,2011,Age,24 Months,75.7,67.1 to 83.4,228
DTaP,≥4 Doses,States/Local Areas,Missouri,2012,Age,24 Months,77.9,70.2 to 84.8,274
Hep A,≥2 Doses,States/Local Areas,Missouri,2018,Age,24 Months,43.6,36.7 to 51.2,416
Hep A,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,41.6,36.8 to 46.9,818
Hep A,≥2 Doses,States/Local Areas,Missouri,2017,Age,24 Months,35.2,29.2 to 42.1,384
Hep A,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,39.3,34.7 to 44.4,800
Hep A,≥2 Doses,States/Local Areas,Missouri,2016,Age,24 Months,34.9,27.3 to 43.8,238
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,35.1,30.1 to 40.6,622
DTaP,≥4 Doses,States/Local Areas,Missouri,2013,Age,24 Months,73.8,65.3 to 81.6,208
DTaP,≥4 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,76.3,70.8 to 81.4,449
Polio,≥3 Doses,States/Local Areas,Missouri,2017,Age,35 Months,91.5,86.4 to 95.2,384
Polio,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,93.6,90.3 to 96.1,800
Polio,≥3 Doses,States/Local Areas,Missouri,2016,Age,35 Months,90.7,85.1 to 94.9,238
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,91.1,87.4 to 94.1,622
DTaP,≥2 Doses,States/Local Areas,Missouri,2016,Age,5 Months,76.3,68.6 to 82.5,238
DTaP,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,5 Months,74.7,69.7 to 79.1,622
DTaP,≥2 Doses,States/Local Areas,Missouri,2015,Age,5 Months,70.5,62.3 to 77.6,235
DTaP,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,5 Months,73.4,67.7 to 78.3,473
PCV,≥2 Doses,States/Local Areas,Missouri,2018,Age,5 Months,81.3,74.7 to 86.4,416
PCV,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,5 Months,78.0,73.4 to 82.1,818
PCV,≥2 Doses,States/Local Areas,Missouri,2019,Age,5 Months,74.7,67.8 to 80.6,402
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,90.7,86.6 to 94.8,382
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,89.9 to 95.2,662
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,85.7,80.0 to 91.3,194
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.9,90.4 to 97.3,336
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,82.6 to 98.3,97
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,90.8,84.1 to 97.6,82
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.5,73.3 to 93.7,71
DTaP,≥4 Doses,States/Local Areas,Missouri,2016,Age,19 Months,64.8,56.2 to 72.6,238
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,67.3,61.9 to 72.3,622
DTaP,≥4 Doses,States/Local Areas,Missouri,2017,Age,19 Months,70.0,63.2 to 75.9,384
DTaP,≥4 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,70.2,65.5 to 74.5,800
DTaP,≥4 Doses,States/Local Areas,Missouri,2018,Age,19 Months,70.5,63.7 to 76.5,416
DTaP,≥4 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,93.6,90.6 to 95.7,818
Hep A,≥2 Doses,States/Local Areas,Missouri,2013,Age,24 Months,31.5,23.8 to 40.9,208
Hep A,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,36.3,30.7 to 42.6,449
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,90.9,88.5 to 93.4,912
Hep A,≥2 Doses,States/Local Areas,Missouri,2015,Age,24 Months,35.5,28.2 to 44.0,235
Hep A,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,35.3,29.8 to 41.3,473
Hep A,≥2 Doses,States/Local Areas,Missouri,2014,Age,24 Months,41.0,33.4 to 49.7,241
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,38.3,32.9 to 44.3,476
Hib,≥3 Doses,States/Local Areas,Missouri,2019,Age,35 Months,84.1,78.2 to 89.1,402
DTaP,≥4 Doses,States/Local Areas,Missouri,2012,Age,35 Months,87.2,79.4 to 93.1,274
DTaP,≥4 Doses,States/Local Areas,Missouri,2015,Age,35 Months,84.8,74.3 to 92.7,235
DTaP,≥4 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,82.9,76.1 to 88.6,473
DTaP,≥4 Doses,States/Local Areas,Missouri,2014,Age,35 Months,85.7,78.6 to 91.3,241
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,84.7,78.9 to 89.7,476
Hep A,≥2 Doses,States/Local Areas,Missouri,2019,Age,35 Months,75.2,66.5 to 83.1,402
Hep B,≥3 Doses,States/Local Areas,Missouri,2012,Age,13 Months,89.1,84.5 to 92.4,274
DTaP,≥4 Doses,States/Local Areas,Missouri,2013,Age,35 Months,83.7,75.5 to 90.4,208
DTaP,≥4 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,84.6,79.3 to 89.2,449
Hep B,≥3 Doses,States/Local Areas,Missouri,2013,Age,13 Months,87.3,83.2 to 90.4,208
Hep B,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,87.7,84.9 to 90.0,449
Hep B,≥3 Doses,States/Local Areas,Missouri,2014,Age,13 Months,88.1,82.8 to 92.0,241
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,86.5,82.2 to 89.9,476
Hep A,≥2 Doses,States/Local Areas,Missouri,2018,Age,35 Months,85.3,75.5 to 92.7,416
Hep A,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,79.9,73.5 to 85.7,818
Hep A,≥2 Doses,States/Local Areas,Missouri,2017,Age,35 Months,70.4,62.5 to 77.9,384
Hep A,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,77.3,71.0 to 83.0,800
≥1 Dose Varicella,,States/Local Areas,Missouri,2019,Age,13 Months,52.1,45.2 to 58.8,402
≥1 Dose Varicella,,States/Local Areas,Missouri,2011,Age,19 Months,83.1,81.1 to 84.9,228
≥1 Dose Varicella,,States/Local Areas,Missouri,2013,Age,19 Months,82.4,77.8 to 86.2,208
≥1 Dose Varicella,,States/Local Areas,Missouri,2013-2014,Age,19 Months,84.2,80.9 to 87.0,449
≥1 Dose Varicella,,States/Local Areas,Missouri,2012,Age,19 Months,87.6,83.1 to 91.0,274
≥1 Dose MMR,,States/Local Areas,Missouri,2016,Age,13 Months,61.2,52.9 to 69.0,238
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2017,Age,13 Months,60.1,54.8 to 65.3,622
≥1 Dose Varicella,,States/Local Areas,Missouri,2018,Age,13 Months,56.2,49.2 to 63.0,416
≥1 Dose Varicella,,States/Local Areas,Missouri,2018-2019,Age,13 Months,54.1,49.2 to 59.0,818
≥1 Dose MMR,,States/Local Areas,Missouri,2014,Age,13 Months,68.2,60.9 to 74.7,241
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2015,Age,13 Months,61.8,56.2 to 67.1,476
≥1 Dose MMR,,States/Local Areas,Missouri,2015,Age,13 Months,55.4,47.1 to 63.4,235
≥1 Dose MMR,,States/Local Areas,Missouri,2015-2016,Age,13 Months,58.3,52.4 to 64.0,473
Hep B,≥1 Dose,States/Local Areas,Missouri,2013,Age,3 Months,93.3,91.3 to 94.9,208
Hep B,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,3 Months,92.9,91.1 to 94.4,449
Hep B,≥1 Dose,States/Local Areas,Missouri,2012,Age,3 Months,98.3,97.5 to 98.9,274
Hep B,≥1 Dose,States/Local Areas,Missouri,2011,Age,3 Months,94.5,86.7 to 97.8,228
Hep B,≥1 Dose,States/Local Areas,Missouri,2014,Age,3 Months,92.5,87.4 to 95.7,241
Hep B,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,3 Months,94.6,91.9 to 96.4,476
Polio,≥2 Doses,States/Local Areas,Missouri,2016,Age,7 Months,86.8,80.7 to 91.2,238
Polio,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,87.4,83.5 to 90.5,622
Polio,≥2 Doses,States/Local Areas,Missouri,2017,Age,7 Months,88.0,82.6 to 91.9,384
Polio,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,87.9,84.0 to 90.9,800
Polio,≥2 Doses,States/Local Areas,Missouri,2018,Age,7 Months,87.7,81.6 to 92.1,416
Polio,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,86.8,82.7 to 90.0,818
Hep A,≥1 Dose,States/Local Areas,Missouri,2017,Age,35 Months,87.2,81.5 to 91.7,384
Hep A,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,35 Months,90.2,86.4 to 93.3,800
Hep A,≥1 Dose,States/Local Areas,Missouri,2018,Age,35 Months,94.1,88.3 to 97.7,416
Hep A,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,35 Months,89.1,84.7 to 92.7,818
Hep A,≥1 Dose,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,85.9,80.1 to 91.8,251
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.4,47.6 to 93.2,71
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,59.5,49.6 to 69.4,331
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,73.2,67.0 to 79.4,509
Hep B,≥3 Doses,States/Local Areas,Missouri,2016,Age,13 Months,84.7,77.8 to 89.8,238
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,86.9,82.7 to 90.2,622
Hep B,≥3 Doses,States/Local Areas,Missouri,2015,Age,13 Months,84.9,77.6 to 90.1,235
Hep B,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,84.8,79.9 to 88.7,473
Hep B,≥3 Doses,States/Local Areas,Missouri,2017,Age,13 Months,89.1,84.0 to 92.7,384
Hep B,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,90.8,87.4 to 93.3,800
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,70.9,56.4 to 85.4,82
≥1 Dose Varicella,,States/Local Areas,Missouri,2014,Age,19 Months,86.0,79.8 to 90.5,241
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2015,Age,19 Months,83.1,78.3 to 87.0,476
≥1 Dose Varicella,,States/Local Areas,Missouri,2015,Age,19 Months,80.1,77.1 to 82.8,235
≥1 Dose Varicella,,States/Local Areas,Missouri,2015-2016,Age,19 Months,81.2,76.0 to 85.5,473
≥1 Dose Varicella,,States/Local Areas,Missouri,2016,Age,19 Months,82.3,74.8 to 88.0,238
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2017,Age,19 Months,84.3,79.7 to 88.0,622
Polio,≥2 Doses,States/Local Areas,Missouri,2012,Age,13 Months,95.4,93.6 to 96.8,274
Polio,≥2 Doses,States/Local Areas,Missouri,2011,Age,13 Months,90.7,81.7 to 95.5,228
≥1 Dose MMR,,States/Local Areas,Missouri,2018,Age,13 Months,62.9,55.8 to 69.5,416
≥1 Dose MMR,,States/Local Areas,Missouri,2018-2019,Age,13 Months,61.7,56.7 to 66.5,818
≥1 Dose MMR,,States/Local Areas,Missouri,2019,Age,13 Months,60.5,53.5 to 67.1,402
≥1 Dose MMR,,States/Local Areas,Missouri,2017,Age,13 Months,59.0,52.2 to 65.5,384
≥1 Dose MMR,,States/Local Areas,Missouri,2017-2018,Age,13 Months,61.0,56.1 to 65.6,800
PCV,≥3 Doses,States/Local Areas,Missouri,2013,Age,7 Months,56.4,50.8 to 61.8,208
PCV,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,59.2,56.9 to 61.5,449
PCV,≥3 Doses,States/Local Areas,Missouri,2011,Age,7 Months,67.3,60.2 to 73.6,228
Hep B,≥3 Doses,States/Local Areas,Missouri,2016,Age,19 Months,87.3,81.0 to 91.8,238
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,89.1,85.2 to 92.0,622
PCV,≥3 Doses,States/Local Areas,Missouri,2014,Age,7 Months,62.1,54.1 to 69.4,241
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,61.5,55.8 to 66.9,476
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,89.3,84.2 to 94.5,251
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,77.5,71.8 to 83.1,381
PCV,≥3 Doses,States/Local Areas,Missouri,2012,Age,7 Months,69.3,63.1 to 74.9,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2017,Age,19 Months,90.9,86.1 to 94.2,384
Hep B,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,92.3,89.2 to 94.6,800
Hep B,≥3 Doses,States/Local Areas,Missouri,2018,Age,19 Months,93.7,89.0 to 96.4,416
Hep B,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,89.6,85.9 to 92.3,818
Hep B,≥2 Doses,States/Local Areas,Missouri,2016,Age,5 Months,84.7,77.9 to 89.6,238
Hep B,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,5 Months,85.1,80.8 to 88.6,622
Hep B,≥2 Doses,States/Local Areas,Missouri,2014,Age,5 Months,86.5,80.7 to 90.8,241
Hep B,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,5 Months,86.4,83.4 to 88.8,476
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2012,Age,0-1 Days,65.9,61.1 to 70.4,274
Polio,≥2 Doses,States/Local Areas,Missouri,2018,Age,13 Months,96.2,92.4 to 98.2,416
Polio,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,93.6,90.6 to 95.7,818
Polio,≥2 Doses,States/Local Areas,Missouri,2019,Age,13 Months,90.9,85.9 to 94.3,402
≥1 Dose Varicella,,States/Local Areas,Missouri,2019,Age,19 Months,83.9,77.7 to 88.7,402
≥1 Dose Varicella,,States/Local Areas,Missouri,2014,Age,24 Months,89.9,84.6 to 94.0,241
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2015,Age,24 Months,88.4,84.4 to 91.9,476
≥1 Dose Varicella,,States/Local Areas,Missouri,2013,Age,24 Months,86.3,79.4 to 91.8,208
≥1 Dose Varicella,,States/Local Areas,Missouri,2013-2014,Age,24 Months,88.1,83.8 to 91.7,449
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2013,Age,0-1 Days,68.1,62.0 to 73.5,208
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2013-2014,Age,0-1 Days,67.6,61.9 to 72.8,449
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2014,Age,0-1 Days,67.1,59.4 to 74.0,241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2014-2015,Age,0-1 Days,69.4,64.1 to 74.3,476
Hep B,≥2 Doses,States/Local Areas,Missouri,2015,Age,5 Months,86.2,80.2 to 90.6,235
Hep B,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,5 Months,85.4,81.1 to 88.9,473
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2015,Age,0-1 Days,71.8,64.2 to 78.3,235
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2015-2016,Age,0-1 Days,70.2,64.6 to 75.2,473
Polio,≥2 Doses,States/Local Areas,Missouri,2013,Age,13 Months,94.2,88.6 to 97.2,208
Polio,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,93.8,90.6 to 95.9,449
Polio,≥2 Doses,States/Local Areas,Missouri,2014,Age,13 Months,93.3,88.8 to 96.1,241
Polio,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,91.5,87.8 to 94.1,476
Hep B,≥1 Dose,States/Local Areas,Missouri,2015,Age,3 Months,96.7,94.1 to 98.1,235
Hep B,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,3 Months,96.4,94.5 to 97.6,473
Hep B,≥1 Dose,States/Local Areas,Missouri,2016,Age,3 Months,96.1,93.0 to 97.8,238
Hep B,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,3 Months,95.4,93.1 to 97.0,622
Hep B,≥1 Dose,States/Local Areas,Missouri,2017,Age,3 Months,94.8,90.8 to 97.1,384
Hep B,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,3 Months,96.2,93.8 to 97.7,800
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",57.4,43.0 to 71.8,97
DTaP,≥4 Doses,States/Local Areas,Missouri,2017,Age,35 Months,83.1,76.7 to 88.5,384
DTaP,≥4 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,85.6,81.2 to 89.5,800
DTaP,≥4 Doses,States/Local Areas,Missouri,2016,Age,35 Months,81.2,72.2 to 88.7,238
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,82.4,76.8 to 87.3,622
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,29.8,11.2 to 48.4,54
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,71.2,62.8 to 79.7,382
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.2,57.4 to 69.0,662
Polio,≥2 Doses,States/Local Areas,Missouri,2019,Age,7 Months,85.8,79.9 to 90.2,402
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,64.4,58.8 to 70.0,912
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,56.8,46.6 to 67.0,280
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,46.6,35.2 to 58.0,194
PCV,≥4 Doses,States/Local Areas,Missouri,2013,Age,19 Months,72.0,62.5 to 79.9,208
PCV,≥4 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,74.9,66.5 to 81.7,449
PCV,≥4 Doses,States/Local Areas,Missouri,2012,Age,19 Months,77.6,75.8 to 79.3,274
PCV,≥4 Doses,States/Local Areas,Missouri,2011,Age,19 Months,72.0,69.1 to 74.8,228
≥1 Dose MMR,,States/Local Areas,Missouri,2018,Age,19 Months,88.7,83.0 to 92.7,416
≥1 Dose MMR,,States/Local Areas,Missouri,2018-2019,Age,19 Months,92.7,89.5 to 95.0,818
≥1 Dose MMR,,States/Local Areas,Missouri,2019,Age,19 Months,83.3,77.0 to 88.1,402
≥1 Dose MMR,,States/Local Areas,Missouri,2011,Age,24 Months,88.0,80.9 to 93.4,228
≥1 Dose MMR,,States/Local Areas,Missouri,2012,Age,24 Months,91.7,86.5 to 95.5,274
≥1 Dose Varicella,,States/Local Areas,Missouri,2015,Age,24 Months,86.9,80.5 to 92.0,235
≥1 Dose Varicella,,States/Local Areas,Missouri,2015-2016,Age,24 Months,86.5,82.1 to 90.3,473
≥1 Dose Varicella,,States/Local Areas,Missouri,2016,Age,24 Months,86.2,79.8 to 91.3,238
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2017,Age,24 Months,87.7,83.7 to 91.0,622
≥1 Dose Varicella,,States/Local Areas,Missouri,2017,Age,24 Months,89.2,84.4 to 93.0,384
≥1 Dose Varicella,,States/Local Areas,Missouri,2017-2018,Age,24 Months,90.4,87.1 to 93.1,800
Hep B,≥2 Doses,States/Local Areas,Missouri,2019,Age,5 Months,90.5,85.5 to 93.9,402
Hep B,≥2 Doses,States/Local Areas,Missouri,2011,Age,7 Months,90.8,83.0 to 95.2,228
Hep B,≥2 Doses,States/Local Areas,Missouri,2017,Age,5 Months,85.5,79.6 to 89.9,384
Hep B,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,5 Months,87.8,84.0 to 90.7,800
PCV,≥4 Doses,States/Local Areas,Missouri,2020,Age,35 Months,86.6,80.4 to 91.6,390
Hep B,≥2 Doses,States/Local Areas,Missouri,2018,Age,5 Months,90.0,84.6 to 93.6,416
Hep B,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,5 Months,90.2,86.8 to 92.9,818
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2018,Age,0-1 Days,80.4,73.9 to 85.5,416
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2018-2019,Age,0-1 Days,77.1,72.7 to 81.1,818
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2016,Age,0-1 Days,68.6,60.4 to 75.7,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2016-2017,Age,0-1 Days,71.2,66.1 to 75.8,622
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2017,Age,0-1 Days,74.0,67.6 to 79.5,384
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2017-2018,Age,0-1 Days,77.2,72.8 to 81.1,800
Hep B,≥1 Dose,States/Local Areas,Missouri,2018,Age,3 Months,97.6,94.1 to 99.0,416
Hep B,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,3 Months,96.6,94.4 to 98.0,818
Hep B,≥1 Dose,States/Local Areas,Missouri,2019,Age,3 Months,95.7,91.9 to 97.7,402
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,61.6,53.8 to 69.3,381
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2011,Age,0-1 Days,72.7,66.1 to 78.5,228
Hep B,≥2 Doses,States/Local Areas,Missouri,2012,Age,5 Months,92.8,84.4 to 96.8,274
Hep B,≥2 Doses,States/Local Areas,Missouri,2011,Age,5 Months,85.2,78.1 to 90.3,228
Hep B,≥2 Doses,States/Local Areas,Missouri,2013,Age,5 Months,82.3,75.3 to 87.6,208
Hep B,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,5 Months,84.4,79.1 to 88.6,449
Hep B,≥3 Doses,States/Local Areas,Missouri,2013,Age,19 Months,89.6,87.5 to 91.4,208
Hep B,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,90.0,88.6 to 91.2,449
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,81.2,73.5 to 89.0,251
Hep B,≥3 Doses,States/Local Areas,Missouri,2014,Age,19 Months,90.3,85.7 to 93.6,241
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,89.9,86.2 to 92.7,476
Hep B,≥3 Doses,States/Local Areas,Missouri,2015,Age,19 Months,89.5,84.8 to 92.9,235
Hep B,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,88.4,84.2 to 91.6,473
≥1 Dose MMR,,States/Local Areas,Missouri,2015,Age,19 Months,79.6,75.4 to 83.2,235
≥1 Dose MMR,,States/Local Areas,Missouri,2015-2016,Age,19 Months,81.1,75.7 to 85.5,473
≥1 Dose MMR,,States/Local Areas,Missouri,2016,Age,19 Months,82.6,74.8 to 88.3,238
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2017,Age,19 Months,84.2,79.5 to 87.9,622
≥1 Dose MMR,,States/Local Areas,Missouri,2017,Age,19 Months,85.8,80.1 to 90.1,384
≥1 Dose MMR,,States/Local Areas,Missouri,2017-2018,Age,19 Months,87.3,83.4 to 90.3,800
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,65.3,58.5 to 72.0,280
≥1 Dose Varicella,,States/Local Areas,Missouri,2011,Age,24 Months,84.1,76.7 to 90.2,228
≥1 Dose Varicella,,States/Local Areas,Missouri,2012,Age,24 Months,91.9,87.1 to 95.4,274
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.5,74.3 to 82.6,662
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,58.3 to 80.6,97
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,63.8,55.0 to 72.7,194
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,75.3,71.6 to 79.0,912
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,75.9,70.0 to 81.7,382
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.6,75.2 to 86.1,336
≥1 Dose MMR,,States/Local Areas,Missouri,2013,Age,19 Months,81.6,77.7 to 85.0,208
≥1 Dose MMR,,States/Local Areas,Missouri,2013-2014,Age,19 Months,85.6,81.5 to 88.9,449
≥1 Dose MMR,,States/Local Areas,Missouri,2014,Age,19 Months,89.4,84.3 to 93.0,241
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2015,Age,19 Months,84.5,79.8 to 88.3,476
≥1 Dose MMR,,States/Local Areas,Missouri,2012,Age,19 Months,86.2,81.2 to 90.1,274
≥1 Dose Varicella,,States/Local Areas,Missouri,2017,Age,19 Months,86.3,80.7 to 90.6,384
≥1 Dose Varicella,,States/Local Areas,Missouri,2017-2018,Age,19 Months,87.9,84.2 to 90.9,800
≥1 Dose Varicella,,States/Local Areas,Missouri,2018,Age,19 Months,89.5,84.3 to 93.1,416
≥1 Dose Varicella,,States/Local Areas,Missouri,2018-2019,Age,19 Months,54.1,49.2 to 59.0,818
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,72.4,60.3 to 84.5,82
Polio,≥2 Doses,States/Local Areas,Missouri,2015,Age,13 Months,89.6,83.2 to 93.8,235
Polio,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,90.0,85.9 to 93.1,473
Polio,≥2 Doses,States/Local Areas,Missouri,2016,Age,13 Months,90.4,85.0 to 94.0,238
Polio,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,91.3,87.9 to 93.9,622
Polio,≥2 Doses,States/Local Areas,Missouri,2017,Age,13 Months,92.3,87.4 to 95.4,384
Polio,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,94.3,91.4 to 96.2,800
DTaP,≥4 Doses,States/Local Areas,Missouri,2019,Age,35 Months,83.2,76.1 to 89.2,402
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,69.7,63.5 to 75.9,331
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,82.2,77.6 to 86.8,509
≥1 Dose MMR,,States/Local Areas,Missouri,2011,Age,19 Months,84.2,81.3 to 86.8,228
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,64.1,48.7 to 79.5,54
DTaP,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.7,53.4 to 80.1,71
DTaP,≥4 Doses,States/Local Areas,Missouri,2018,Age,35 Months,87.6,81.2 to 92.5,416
DTaP,≥4 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,85.7,81.0 to 89.7,818
Hep B,≥3 Doses,States/Local Areas,Missouri,2018,Age,13 Months,92.4,87.5 to 95.5,416
Hep B,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,89.6,85.9 to 92.3,818
Hep B,≥3 Doses,States/Local Areas,Missouri,2019,Age,13 Months,86.6,80.8 to 90.9,402
Hep B,≥3 Doses,States/Local Areas,Missouri,2011,Age,19 Months,88.4,77.2 to 94.5,228
Hep B,≥3 Doses,States/Local Areas,Missouri,2012,Age,19 Months,92.7,88.1 to 95.6,274
Hep A,≥1 Dose,States/Local Areas,Missouri,2020,Age,35 Months,88.0,81.8 to 92.8,390
PCV,≥3 Doses,States/Local Areas,Missouri,2017,Age,7 Months,60.0,53.2 to 66.4,384
PCV,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,66.7,61.9 to 71.2,800
PCV,≥3 Doses,States/Local Areas,Missouri,2015,Age,7 Months,61.0,52.5 to 68.8,235
PCV,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,62.7,56.7 to 68.3,473
PCV,≥4 Doses,States/Local Areas,Missouri,2014,Age,19 Months,77.7,70.9 to 83.3,241
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,74.2,68.8 to 78.9,476
PCV,≥4 Doses,States/Local Areas,Missouri,2015,Age,19 Months,70.6,65.8 to 75.0,235
PCV,≥4 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,69.7,63.7 to 75.1,473
PCV,≥4 Doses,States/Local Areas,Missouri,2016,Age,19 Months,68.8,60.4 to 76.1,238
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,73.0,67.8 to 77.6,622
PCV,≥3 Doses,States/Local Areas,Missouri,2016,Age,7 Months,64.5,55.9 to 72.2,238
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,62.3,56.8 to 67.4,622
Hep B,≥3 Doses,States/Local Areas,Missouri,2012,Age,24 Months,94.4,89.2 to 97.6,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2013,Age,24 Months,89.6,83.7 to 94.1,208
Hep B,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,91.0,87.5 to 93.8,449
Hep B,≥3 Doses,States/Local Areas,Missouri,2019,Age,19 Months,87.7,81.9 to 91.8,402
Hep B,≥3 Doses,States/Local Areas,Missouri,2011,Age,24 Months,91.7,86.5 to 95.5,228
≥1 Dose Varicella,,States/Local Areas,Missouri,2018,Age,24 Months,91.5,86.7 to 95.1,416
≥1 Dose Varicella,,States/Local Areas,Missouri,2018-2019,Age,24 Months,88.6,84.9 to 91.7,818
≥1 Dose MMR,,States/Local Areas,Missouri,2015,Age,24 Months,86.5,79.8 to 91.8,235
≥1 Dose MMR,,States/Local Areas,Missouri,2015-2016,Age,24 Months,86.7,82.1 to 90.6,473
≥1 Dose MMR,,States/Local Areas,Missouri,2014,Age,24 Months,93.4,89.6 to 96.2,241
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2015,Age,24 Months,89.9,86.1 to 93.0,476
≥1 Dose MMR,,States/Local Areas,Missouri,2013,Age,24 Months,86.1,78.8 to 91.9,208
≥1 Dose MMR,,States/Local Areas,Missouri,2013-2014,Age,24 Months,89.8,85.6 to 93.1,449
≥1 Dose Varicella,,States/Local Areas,Missouri,2019,Age,24 Months,85.2,79.5 to 90.0,402
≥1 Dose Varicella,,States/Local Areas,Missouri,2011,Age,35 Months,90.2,82.9 to 95.3,228
≥1 Dose Varicella,,States/Local Areas,Missouri,2012,Age,35 Months,94.9,90.2 to 97.7,274
PCV,≥4 Doses,States/Local Areas,Missouri,2017,Age,19 Months,77.3,71.0 to 82.6,384
PCV,≥4 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,78.7,74.2 to 82.6,800
PCV,≥4 Doses,States/Local Areas,Missouri,2018,Age,19 Months,80.0,73.3 to 85.4,416
PCV,≥4 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,77.8,72.4 to 82.5,664
≥1 Dose MMR,,States/Local Areas,Missouri,2017,Age,24 Months,87.9,82.8 to 92.1,384
≥1 Dose MMR,,States/Local Areas,Missouri,2017-2018,Age,24 Months,89.9,86.4 to 92.8,800
≥1 Dose MMR,,States/Local Areas,Missouri,2016,Age,24 Months,87.0,80.5 to 92.2,238
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2017,Age,24 Months,87.5,83.4 to 91.0,622
PCV,≥3 Doses,States/Local Areas,Missouri,2012,Age,13 Months,88.6,85.5 to 91.1,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2016,Age,24 Months,87.8,81.9 to 92.4,238
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,89.4,85.8 to 92.4,622
Hep B,≥3 Doses,States/Local Areas,Missouri,2015,Age,24 Months,90.8,85.5 to 94.8,235
Hep B,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,89.3,85.5 to 92.5,473
Hep B,≥3 Doses,States/Local Areas,Missouri,2014,Age,24 Months,92.3,88.3 to 95.3,241
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,91.6,88.4 to 94.2,476
Hep B,≥2 Doses,States/Local Areas,Missouri,2014,Age,7 Months,89.4,83.9 to 93.2,241
Hep B,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,90.2,86.5 to 93.0,476
Hep B,≥2 Doses,States/Local Areas,Missouri,2015,Age,7 Months,91.1,85.4 to 94.7,235
Hep B,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,91.1,87.7 to 93.7,473
Hep B,≥2 Doses,States/Local Areas,Missouri,2012,Age,7 Months,94.3,87.9 to 97.4,274
PCV,≥3 Doses,States/Local Areas,Missouri,2018,Age,7 Months,73.4,66.4 to 79.3,416
PCV,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,67.3,62.3 to 71.9,818
PCV,≥3 Doses,States/Local Areas,Missouri,2019,Age,7 Months,61.2,54.0 to 67.9,402
PCV,≥3 Doses,States/Local Areas,Missouri,2011,Age,13 Months,83.8,79.1 to 87.6,228
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2013,Age,0-2 Days,73.0,65.5 to 79.4,208
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2013-2014,Age,0-2 Days,73.6,67.3 to 79.1,449
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2012,Age,0-2 Days,72.1,67.4 to 76.3,274
Hep B,≥2 Doses,States/Local Areas,Missouri,2013,Age,7 Months,90.2,81.8 to 94.9,208
Hep B,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,89.8,84.1 to 93.6,449
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2019,Age,0-1 Days,73.9,67.3 to 79.5,402
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2011,Age,0-2 Days,80.5,70.2 to 87.8,228
≥1 Dose Varicella,,States/Local Areas,Missouri,2016,Age,35 Months,88.9,82.7 to 93.6,238
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2017,Age,35 Months,89.7,85.9 to 92.9,622
≥1 Dose MMR,,States/Local Areas,Missouri,2013,Age,35 Months,91.2,83.8 to 96.1,208
≥1 Dose MMR,,States/Local Areas,Missouri,2013-2014,Age,35 Months,92.6,88.7 to 95.5,449
≥1 Dose MMR,,States/Local Areas,Missouri,2011,Age,35 Months,94.2,87.5 to 97.9,228
≥1 Dose MMR,,States/Local Areas,Missouri,2012,Age,35 Months,93.4,88.5 to 96.7,274
≥1 Dose MMR,,States/Local Areas,Missouri,2019,Age,24 Months,84.9,79.2 to 89.8,402
PCV,≥4 Doses,States/Local Areas,Missouri,2014,Age,24 Months,80.4,74.1 to 86.1,241
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,78.8,73.9 to 83.4,476
PCV,≥4 Doses,States/Local Areas,Missouri,2013,Age,24 Months,74.6,66.7 to 81.9,208
PCV,≥4 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,77.6,72.5 to 82.3,449
Hep B,≥3 Doses,States/Local Areas,Missouri,2019,Age,24 Months,88.1,82.7 to 92.4,402
Hep B,≥3 Doses,States/Local Areas,Missouri,2017,Age,24 Months,91.1,86.6 to 94.5,384
Hep B,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,92.5,89.5 to 94.8,800
Hep B,≥3 Doses,States/Local Areas,Missouri,2011,Age,35 Months,91.7,86.5 to 95.5,228
PCV,≥4 Doses,States/Local Areas,Missouri,2012,Age,24 Months,84.7,78.1 to 90.2,274
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2017,Age,0-2 Days,78.8,72.7 to 83.9,384
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2017-2018,Age,0-2 Days,81.3,77.1 to 84.9,800
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2018,Age,0-2 Days,83.8,77.5 to 88.6,416
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2018-2019,Age,0-2 Days,80.4,76.1 to 84.1,818
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2019,Age,0-2 Days,77.0,70.6 to 82.3,402
Hep B,≥2 Doses,States/Local Areas,Missouri,2018,Age,7 Months,94.8,90.3 to 97.2,416
Hep B,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,93.3,90.3 to 95.4,818
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2016,Age,0-2 Days,77.3,69.8 to 83.4,238
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2016-2017,Age,0-2 Days,78.0,73.3 to 82.1,622
Hep B,≥2 Doses,States/Local Areas,Missouri,2016,Age,7 Months,91.2,86.3 to 94.4,238
Hep B,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,90.9,87.6 to 93.4,622
PCV,≥3 Doses,States/Local Areas,Missouri,2013,Age,13 Months,85.2,78.6 to 90.0,208
PCV,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,86.1,80.8 to 90.1,449
Hep B,≥2 Doses,States/Local Areas,Missouri,2017,Age,7 Months,90.6,85.5 to 94.1,384
Hep B,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,92.7,89.5 to 95.0,800
PCV,≥3 Doses,States/Local Areas,Missouri,2014,Age,13 Months,87.0,81.3 to 91.2,241
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,85.5,80.9 to 89.1,476
PCV,≥3 Doses,States/Local Areas,Missouri,2015,Age,13 Months,83.9,76.3 to 89.4,235
PCV,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,83.5,78.3 to 87.6,473
Hep B,≥3 Doses,States/Local Areas,Missouri,2018,Age,24 Months,93.8,89.6 to 96.8,416
Hep B,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,91.0,87.7 to 93.7,818
PCV,≥4 Doses,States/Local Areas,Missouri,2011,Age,24 Months,75.6,67.1 to 83.3,228
≥1 Dose Varicella,,States/Local Areas,Missouri,2015,Age,35 Months,89.3,82.8 to 94.1,235
≥1 Dose Varicella,,States/Local Areas,Missouri,2015-2016,Age,35 Months,89.1,84.7 to 92.7,473
≥1 Dose Varicella,,States/Local Areas,Missouri,2014,Age,35 Months,91.5,86.1 to 95.3,241
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2015,Age,35 Months,90.3,86.3 to 93.6,476
PCV,≥4 Doses,States/Local Areas,Missouri,2019,Age,19 Months,74.6,67.8 to 80.4,402
≥1 Dose MMR,,States/Local Areas,Missouri,2018,Age,24 Months,91.8,86.7 to 95.4,416
≥1 Dose MMR,,States/Local Areas,Missouri,2018-2019,Age,24 Months,88.6,84.8 to 91.8,818
≥1 Dose Varicella,,States/Local Areas,Missouri,2013,Age,35 Months,93.2,86.9 to 97.1,208
≥1 Dose Varicella,,States/Local Areas,Missouri,2013-2014,Age,35 Months,92.2,88.2 to 95.3,449
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2014,Age,0-2 Days,74.2,66.7 to 80.4,241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2014-2015,Age,0-2 Days,78.0,73.1 to 82.2,476
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2015,Age,0-2 Days,81.8,75.3 to 86.9,235
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2015-2016,Age,0-2 Days,79.6,74.7 to 83.7,473
Hep B,≥2 Doses,States/Local Areas,Missouri,2019,Age,7 Months,91.8,87.0 to 94.9,402
Hep B,≥2 Doses,States/Local Areas,Missouri,2011,Age,13 Months,94.8,91.1 to 97.0,228
Hep B,≥2 Doses,States/Local Areas,Missouri,2013,Age,13 Months,95.4,88.4 to 98.3,208
Hep B,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,13 Months,94.1,90.5 to 96.4,449
Hep B,≥2 Doses,States/Local Areas,Missouri,2012,Age,13 Months,96.3,89.6 to 98.7,274
PCV,≥3 Doses,States/Local Areas,Missouri,2017,Age,13 Months,84.5,78.7 to 89.0,384
PCV,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,86.8,82.8 to 89.9,800
PCV,≥3 Doses,States/Local Areas,Missouri,2018,Age,13 Months,89.0,83.1 to 93.0,416
PCV,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,86.1,81.9 to 89.4,818
Hep B,≥3 Doses,States/Local Areas,Missouri,2012,Age,35 Months,95.3,90.0 to 98.3,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2015,Age,35 Months,91.3,85.9 to 95.2,235
Hep B,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,90.9,87.1 to 94.0,473
Hep B,≥3 Doses,States/Local Areas,Missouri,2014,Age,35 Months,92.7,88.8 to 95.6,241
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,92.0,88.9 to 94.6,476
Hep B,≥3 Doses,States/Local Areas,Missouri,2013,Age,35 Months,89.6,83.7 to 94.1,208
Hep B,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,91.2,87.8 to 94.0,449
PCV,≥3 Doses,States/Local Areas,Missouri,2016,Age,13 Months,83.0,75.7 to 88.4,238
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,83.8,79.2 to 87.5,622
≥1 Dose MMR,,States/Local Areas,Missouri,2014,Age,35 Months,94.3,90.6 to 96.9,241
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2015,Age,35 Months,91.2,87.4 to 94.2,476
≥1 Dose MMR,,States/Local Areas,Missouri,2015,Age,35 Months,88.1,81.4 to 93.2,235
≥1 Dose MMR,,States/Local Areas,Missouri,2015-2016,Age,35 Months,88.6,84.1 to 92.2,473
PCV,≥4 Doses,States/Local Areas,Missouri,2017,Age,24 Months,78.9,72.9 to 84.3,384
PCV,≥4 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,81.3,77.0 to 85.1,800
PCV,≥4 Doses,States/Local Areas,Missouri,2016,Age,24 Months,74.2,66.4 to 81.4,238
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,76.6,71.6 to 81.2,622
PCV,≥4 Doses,States/Local Areas,Missouri,2015,Age,24 Months,77.3,69.6 to 84.2,235
PCV,≥4 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,75.7,70.2 to 80.9,473
≥1 Dose MMR,,States/Local Areas,Missouri,2016,Age,35 Months,89.2,82.8 to 93.9,238
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2017,Age,35 Months,89.5,85.5 to 92.8,622
≥1 Dose Varicella,,States/Local Areas,Missouri,2019,Age,35 Months,90.6,84.6 to 95.0,402
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,87.9,83.7 to 92.1,331
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,89.9,86.2 to 93.6,509
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,71.4,57.6 to 85.2,54
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.0,72.4 to 93.5,71
PCV,≥3 Doses,States/Local Areas,Missouri,2019,Age,13 Months,83.1,76.8 to 88.0,402
PCV,≥3 Doses,States/Local Areas,Missouri,2011,Age,19 Months,86.4,79.8 to 91.1,228
PCV,≥3 Doses,States/Local Areas,Missouri,2013,Age,19 Months,88.7,81.7 to 93.3,208
PCV,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,89.9,86.3 to 92.6,449
PCV,≥3 Doses,States/Local Areas,Missouri,2014,Age,19 Months,91.0,86.3 to 94.2,241
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,88.1,83.8 to 91.4,476
Hep B,≥3 Doses,States/Local Areas,Missouri,2016,Age,35 Months,90.3,84.5 to 94.5,238
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,92.2,88.5 to 95.0,622
PCV,≥4 Doses,States/Local Areas,Missouri,2019,Age,24 Months,76.7,70.3 to 82.5,402
PCV,≥4 Doses,States/Local Areas,Missouri,2018,Age,24 Months,83.6,77.4 to 88.9,416
PCV,≥4 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,80.2,75.8 to 84.3,818
PCV,≥4 Doses,States/Local Areas,Missouri,2011,Age,35 Months,81.9,72.7 to 89.5,228
PCV,≥4 Doses,States/Local Areas,Missouri,2012,Age,35 Months,88.3,81.9 to 93.3,274
PCV,≥3 Doses,States/Local Areas,Missouri,2012,Age,19 Months,93.3,89.2 to 95.8,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2017,Age,35 Months,94.0,89.5 to 97.1,384
Hep B,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,94.3,91.1 to 96.7,800
Hib,≥1 Dose,States/Local Areas,Missouri,2013,Age,3 Months,83.5,80.8 to 86.0,208
Hib,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,3 Months,84.3,79.1 to 88.4,449
Hib,≥1 Dose,States/Local Areas,Missouri,2012,Age,3 Months,88.5,81.5 to 93.1,274
Hib,≥1 Dose,States/Local Areas,Missouri,2011,Age,3 Months,87.3,82.3 to 91.0,228
Hib,≥1 Dose,States/Local Areas,Missouri,2014,Age,3 Months,85.1,78.8 to 89.7,241
Hib,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,3 Months,83.8,79.1 to 87.6,476
Hep B,≥2 Doses,States/Local Areas,Missouri,2014,Age,13 Months,92.8,88.6 to 95.6,241
Hep B,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,13 Months,92.6,89.3 to 95.0,476
Hep B,≥2 Doses,States/Local Areas,Missouri,2015,Age,13 Months,92.4,86.7 to 95.8,235
Hep B,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,13 Months,92.7,89.3 to 95.1,473
Hep B,≥2 Doses,States/Local Areas,Missouri,2016,Age,13 Months,93.0,88.3 to 95.9,238
Hep B,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,13 Months,93.4,90.4 to 95.5,622
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,78.0 to 97.2,97
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,85.0,75.4 to 94.7,82
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,75.8,63.4 to 88.1,54
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.1,71.5 to 92.8,71
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,90.0,86.2 to 93.9,509
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,87.8,83.6 to 92.0,331
PCV,≥4 Doses,States/Local Areas,Missouri,2016,Age,35 Months,74.7,66.8 to 81.9,238
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,77.8,72.9 to 82.5,622
PCV,≥4 Doses,States/Local Areas,Missouri,2015,Age,35 Months,80.4,72.7 to 87.1,235
PCV,≥4 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,77.5,72.0 to 82.6,473
PCV,≥4 Doses,States/Local Areas,Missouri,2014,Age,35 Months,84.7,78.3 to 90.1,241
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,82.5,77.6 to 86.9,476
PCV,≥3 Doses,States/Local Areas,Missouri,2017,Age,19 Months,87.7,82.3 to 91.6,384
Hep B,≥3 Doses,States/Local Areas,Missouri,2018,Age,35 Months,93.8,89.6 to 96.8,416
Hep B,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,92.3,88.9 to 94.9,818
Hep B,≥3 Doses,States/Local Areas,Missouri,2019,Age,35 Months,90.6,85.1 to 94.7,402
≥1 Dose Varicella,,States/Local Areas,Missouri,2017,Age,35 Months,90.5,85.7 to 94.2,384
≥1 Dose Varicella,,States/Local Areas,Missouri,2017-2018,Age,35 Months,92.4,89.0 to 95.1,800
≥1 Dose Varicella,,States/Local Areas,Missouri,2018,Age,35 Months,94.7,89.5 to 97.9,416
≥1 Dose Varicella,,States/Local Areas,Missouri,2018-2019,Age,35 Months,92.6,88.5 to 95.7,818
Hep A,≥2 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,63.7,55.6 to 71.7,336
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,84.2,74.3 to 94.0,82
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,94.0,90.6 to 97.3,251
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.9,85.4 to 94.3,336
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,86.4 to 94.2,382
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.1,87.3 to 93.0,662
Hib,≥1 Dose,States/Local Areas,Missouri,2018,Age,3 Months,86.5,80.6 to 90.8,416
Hib,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,3 Months,86.2,82.2 to 89.4,818
Hib,≥1 Dose,States/Local Areas,Missouri,2019,Age,3 Months,85.9,80.2 to 90.1,402
Hib,≥1 Dose,States/Local Areas,Missouri,2015,Age,3 Months,82.5,75.0 to 88.0,235
Hib,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,3 Months,84.1,79.3 to 88.0,473
Hib,≥1 Dose,States/Local Areas,Missouri,2016,Age,3 Months,85.8,79.6 to 90.3,238
Hib,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,3 Months,85.3,81.3 to 88.6,622
Hib,≥1 Dose,States/Local Areas,Missouri,2017,Age,3 Months,84.9,79.2 to 89.2,384
Hib,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,3 Months,85.7,81.8 to 88.9,800
Hep B,≥2 Doses,States/Local Areas,Missouri,2017,Age,13 Months,93.7,89.2 to 96.4,384
Hep B,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,13 Months,95.2,92.6 to 96.9,800
Hep B,≥2 Doses,States/Local Areas,Missouri,2018,Age,13 Months,96.7,93.4 to 98.3,416
Hep B,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,13 Months,95.1,92.4 to 96.8,818
Hep B,≥2 Doses,States/Local Areas,Missouri,2019,Age,13 Months,93.5,88.8 to 96.3,402
PCV,≥3 Doses,States/Local Areas,Missouri,2015,Age,19 Months,85.1,82.8 to 87.2,235
PCV,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,86.1,81.2 to 89.8,473
PCV,≥3 Doses,States/Local Areas,Missouri,2016,Age,19 Months,87.0,80.7 to 91.5,238
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,87.4,83.4 to 90.5,622
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,90.5,86.8 to 94.3,382
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.0,86.0 to 91.9,662
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,81.0 to 97.1,97
≥1 Dose MMR,,States/Local Areas,Missouri,2019,Age,35 Months,90.9,85.0 to 95.2,402
PCV,≥4 Doses,States/Local Areas,Missouri,2013,Age,35 Months,78.2,70.1 to 85.4,208
PCV,≥4 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,81.5,76.4 to 86.0,449
≥1 Dose MMR,,States/Local Areas,Missouri,2018,Age,35 Months,94.6,89.1 to 97.9,416
≥1 Dose MMR,,States/Local Areas,Missouri,2018-2019,Age,35 Months,92.7,88.7 to 95.7,818
≥1 Dose MMR,,States/Local Areas,Missouri,2017,Age,35 Months,89.9,84.7 to 93.9,384
≥1 Dose MMR,,States/Local Areas,Missouri,2017-2018,Age,35 Months,92.1,88.6 to 94.9,800
PCV,≥1 Dose,States/Local Areas,Missouri,2011,Age,3 Months,82.7,77.3 to 87.0,228
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,94.2,90.3 to 98.0,251
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,88.6,84.5 to 92.8,381
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,79.9,72.8 to 87.0,194
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,84.2,79.1 to 89.4,280
≥1 Dose MMR,,States/Local Areas,Missouri,2014-2017,Overall,Overall,88.1,85.4 to 90.9,912
PCV,≥1 Dose,States/Local Areas,Missouri,2012,Age,3 Months,90.8,86.1 to 94.1,274
PCV,≥4 Doses,States/Local Areas,Missouri,2018,Age,35 Months,86.9,80.6 to 91.9,416
PCV,≥4 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,82.6,78.2 to 86.7,818
PCV,≥4 Doses,States/Local Areas,Missouri,2019,Age,35 Months,78.1,71.6 to 84.0,402
Hib,Full Series,States/Local Areas,Missouri,2020,Age,24 Months,78.8,72.6 to 84.4,390
PCV,≥4 Doses,States/Local Areas,Missouri,2017,Age,35 Months,81.2,75.1 to 86.5,384
PCV,≥4 Doses,States/Local Areas,Missouri,2017-2018,Age,35 Months,84.3,80.0 to 88.1,800
Hib,≥2 Doses,States/Local Areas,Missouri,2013,Age,5 Months,72.6,68.0 to 76.8,208
Hib,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,5 Months,72.3,69.4 to 75.1,449
Hib,≥2 Doses,States/Local Areas,Missouri,2014,Age,5 Months,72.0,64.3 to 78.7,241
Hib,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,5 Months,71.3,67.0 to 75.3,476
PCV,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,90.6,87.1 to 93.2,800
Hib,≥2 Doses,States/Local Areas,Missouri,2012,Age,5 Months,70.8,64.7 to 76.1,274
Hib,≥2 Doses,States/Local Areas,Missouri,2011,Age,5 Months,76.8,72.3 to 80.8,228
PCV,≥3 Doses,States/Local Areas,Missouri,2018,Age,19 Months,93.4,88.4 to 96.4,416
PCV,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,86.1,81.9 to 89.4,818
PCV,≥3 Doses,States/Local Areas,Missouri,2019,Age,19 Months,86.3,80.3 to 90.7,402
PCV,≥3 Doses,States/Local Areas,Missouri,2011,Age,24 Months,91.6,85.2 to 95.9,228
PCV,≥3 Doses,States/Local Areas,Missouri,2012,Age,24 Months,94.8,90.5 to 97.6,274
Hep B,≥3 Doses,States/Local Areas,Missouri,2020,Age,24 Months,95.4,92.0 to 97.6,390
Hib,≥2 Doses,States/Local Areas,Missouri,2017,Age,5 Months,73.1,66.5 to 78.8,384
Hib,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,5 Months,76.3,71.8 to 80.3,800
PCV,≥3 Doses,States/Local Areas,Missouri,2013,Age,24 Months,88.7,82.5 to 93.5,208
PCV,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,90.8,87.1 to 93.8,449
PCV,≥3 Doses,States/Local Areas,Missouri,2014,Age,24 Months,92.9,88.7 to 95.9,241
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,90.3,86.4 to 93.4,476
PCV,≥3 Doses,States/Local Areas,Missouri,2015,Age,24 Months,87.4,80.7 to 92.7,235
PCV,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,87.7,83.3 to 91.4,473
Hib,≥2 Doses,States/Local Areas,Missouri,2015,Age,5 Months,70.6,62.5 to 77.6,235
Hib,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,5 Months,73.1,67.5 to 78.0,473
Hib,≥2 Doses,States/Local Areas,Missouri,2016,Age,5 Months,75.5,67.8 to 81.9,238
Hib,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,5 Months,74.3,69.4 to 78.8,622
Hib,≥2 Doses,States/Local Areas,Missouri,2013,Age,7 Months,87.7,83.3 to 91.0,208
Hib,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,87.4,82.2 to 91.3,449
Hib,≥2 Doses,States/Local Areas,Missouri,2014,Age,7 Months,87.2,81.1 to 91.5,241
Hib,≥2 Doses,States/Local Areas,Missouri,2014-2015,Age,7 Months,85.0,80.4 to 88.7,476
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,92.1,87.6 to 96.5,251
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,77.9,72.3 to 83.5,381
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,68.4,61.8 to 75.0,280
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,68.5,59.6 to 77.4,194
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,77.3,73.7 to 80.9,912
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,83.7,74.3 to 93.0,54
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.7,76.4 to 86.9,336
PCV,≥1 Dose,States/Local Areas,Missouri,2013,Age,3 Months,83.5,80.3 to 86.3,208
PCV,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,3 Months,83.3,76.6 to 88.3,449
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.7,58.7 to 84.7,71
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,77.5,66.1 to 88.9,82
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,59.6,43.0 to 76.2,54
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,74.2,68.3 to 80.1,331
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,82.7,78.2 to 87.3,509
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,83.3,78.1 to 88.6,280
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Overall,Overall,87.7,85.0 to 90.4,912
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,76.8,69.1 to 84.4,194
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.0,85.7 to 94.2,336
≥1 Dose Varicella,,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,88.5,84.4 to 92.6,381
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.2,79.5 to 96.8,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2012,Age,0-3 Days,72.9,63.9 to 80.3,274
PCV,≥1 Dose,States/Local Areas,Missouri,2018,Age,3 Months,87.7,81.9 to 91.8,416
PCV,≥1 Dose,States/Local Areas,Missouri,2018-2019,Age,3 Months,87.3,83.4 to 90.4,818
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,87.5,83.4 to 91.7,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2011,Age,0-3 Days,81.7,75.0 to 86.9,228
PCV,≥3 Doses,States/Local Areas,Missouri,2016,Age,24 Months,87.8,82.0 to 92.4,238
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,87.9,84.1 to 91.1,622
Hib,≥2 Doses,States/Local Areas,Missouri,2012,Age,7 Months,91.3,89.7 to 92.6,274
PCV,≥3 Doses,States/Local Areas,Missouri,2017,Age,24 Months,87.9,82.8 to 92.0,384
PCV,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,90.7,87.4 to 93.4,800
PCV,≥3 Doses,States/Local Areas,Missouri,2018,Age,24 Months,93.4,88.9 to 96.6,416
PCV,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,90.1,86.6 to 93.0,818
Hib,≥2 Doses,States/Local Areas,Missouri,2018,Age,5 Months,79.5,72.9 to 84.8,416
Hib,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,5 Months,76.6,71.9 to 80.7,818
Hib,≥2 Doses,States/Local Areas,Missouri,2019,Age,5 Months,73.6,66.7 to 79.5,402
Hib,≥2 Doses,States/Local Areas,Missouri,2011,Age,7 Months,86.1,79.0 to 91.1,228
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,93.1,90.2 to 95.9,509
PCV,≥1 Dose,States/Local Areas,Missouri,2016,Age,3 Months,84.2,77.7 to 89.0,238
PCV,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,3 Months,84.0,79.8 to 87.4,622
PCV,≥1 Dose,States/Local Areas,Missouri,2017,Age,3 Months,83.7,78.1 to 88.2,384
PCV,≥1 Dose,States/Local Areas,Missouri,2017-2018,Age,3 Months,85.7,81.9 to 88.9,800
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,77.6,71.9 to 83.3,382
PCV,≥1 Dose,States/Local Areas,Missouri,2014,Age,3 Months,83.0,76.6 to 87.9,241
PCV,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,3 Months,80.9,75.8 to 85.1,476
PCV,≥1 Dose,States/Local Areas,Missouri,2015,Age,3 Months,78.8,70.7 to 85.1,235
PCV,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,3 Months,81.4,76.3 to 85.7,473
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.1,74.9 to 83.2,662
PCV,≥4 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,63.5 to 84.8,97
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,87.9 to 94.9,382
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.3,87.6 to 93.0,662
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,83.2,77.3 to 89.2,194
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.5,87.6 to 95.4,336
PCV,≥3 Doses,States/Local Areas,Missouri,2012,Age,35 Months,95.3,91.0 to 98.0,274
PCV,≥3 Doses,States/Local Areas,Missouri,2019,Age,24 Months,86.7,81.1 to 91.3,402
PCV,≥3 Doses,States/Local Areas,Missouri,2011,Age,35 Months,91.6,85.2 to 95.9,228
PCV,≥3 Doses,States/Local Areas,Missouri,2013,Age,35 Months,92.2,85.9 to 96.3,208
PCV,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,93.4,89.9 to 96.1,449
Hib,≥2 Doses,States/Local Areas,Missouri,2015,Age,7 Months,82.8,75.4 to 88.4,235
Hib,≥2 Doses,States/Local Areas,Missouri,2015-2016,Age,7 Months,84.4,79.5 to 88.2,473
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014,Age,0-3 Days,75.7,68.4 to 81.7,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2014-2015,Age,0-3 Days,80.1,75.5 to 84.0,476
PCV,≥1 Dose,States/Local Areas,Missouri,2019,Age,3 Months,86.9,81.3 to 91.1,402
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Overall,Overall,89.9,87.5 to 92.3,912
Polio,≥1 Dose,States/Local Areas,Missouri,2012,Age,3 Months,91.0,86.5 to 94.1,274
Polio,≥1 Dose,States/Local Areas,Missouri,2011,Age,3 Months,87.8,84.5 to 90.5,228
Polio,≥1 Dose,States/Local Areas,Missouri,2013,Age,3 Months,80.8,77.4 to 83.9,208
Polio,≥1 Dose,States/Local Areas,Missouri,2013-2014,Age,3 Months,83.0,76.9 to 87.7,449
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2013,Age,0-3 Days,74.5,66.1 to 81.4,208
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2013-2014,Age,0-3 Days,75.1,69.7 to 79.8,449
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,85.9,81.2 to 90.6,280
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,95.1,92.3 to 97.9,251
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,91.0,87.4 to 94.5,381
Hib,≥3 Doses,States/Local Areas,Missouri,2012,Age,7 Months,53.3,51.7 to 54.9,274
Hib,≥3 Doses,States/Local Areas,Missouri,2011,Age,7 Months,63.2,54.7 to 71.0,228
Hib,≥3 Doses,States/Local Areas,Missouri,2013,Age,7 Months,45.8,37.3 to 54.5,208
Hib,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,47.6,43.5 to 51.8,449
Polio,≥1 Dose,States/Local Areas,Missouri,2014,Age,3 Months,85.1,78.8 to 89.8,241
Polio,≥1 Dose,States/Local Areas,Missouri,2014-2015,Age,3 Months,83.5,78.7 to 87.4,476
Polio,≥1 Dose,States/Local Areas,Missouri,2015,Age,3 Months,81.9,74.3 to 87.7,235
Polio,≥1 Dose,States/Local Areas,Missouri,2015-2016,Age,3 Months,84.3,79.5 to 88.2,473
Polio,≥1 Dose,States/Local Areas,Missouri,2016,Age,3 Months,86.8,80.8 to 91.1,238
Polio,≥1 Dose,States/Local Areas,Missouri,2016-2017,Age,3 Months,85.7,81.7 to 88.9,622
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2017,Age,0-3 Days,80.3,71.5 to 86.9,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2017-2018,Age,0-3 Days,82.2,78.0 to 85.8,800
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016,Age,0-3 Days,79.7,72.5 to 85.4,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2017,Age,0-3 Days,79.6,75.0 to 83.5,622
Hib,≥2 Doses,States/Local Areas,Missouri,2016,Age,7 Months,85.9,79.6 to 90.5,238
Hib,≥2 Doses,States/Local Areas,Missouri,2016-2017,Age,7 Months,87.1,83.2 to 90.3,622
Hib,≥2 Doses,States/Local Areas,Missouri,2017,Age,7 Months,88.4,83.0 to 92.2,384
Hib,≥2 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,87.7,83.7 to 90.7,800
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,83.2 to 97.9,97
Hep B,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,88.5,80.5 to 96.4,82
DTaP,≥3 Doses,States/Local Areas,Missouri,2013,Age,7 Months,60.4,55.0 to 65.5,208
DTaP,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,7 Months,63.1,60.7 to 65.4,449
DTaP,≥3 Doses,States/Local Areas,Missouri,2012,Age,7 Months,69.3,62.9 to 75.0,274
DTaP,≥3 Doses,States/Local Areas,Missouri,2011,Age,7 Months,70.3,61.3 to 78.0,228
PCV,≥3 Doses,States/Local Areas,Missouri,2015,Age,35 Months,96.2,86.0 to 99.6,235
PCV,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,35 Months,91.0,86.3 to 94.6,473
PCV,≥3 Doses,States/Local Areas,Missouri,2016,Age,35 Months,90.2,84.5 to 94.5,238
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,35 Months,89.3,85.5 to 92.4,622
PCV,≥3 Doses,States/Local Areas,Missouri,2014,Age,35 Months,94.7,90.8 to 97.3,241
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,94.7,89.4 to 97.8,476
Hib,≥2 Doses,States/Local Areas,Missouri,2018,Age,7 Months,86.9,80.7 to 91.4,416
Hib,≥2 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,85.6,81.4 to 89.0,818
Hib,≥3 Doses,States/Local Areas,Missouri,2017,Age,7 Months,50.8,44.1 to 57.5,384
Hib,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,7 Months,50.6,45.7 to 55.4,800
Hib,≥3 Doses,States/Local Areas,Missouri,2018,Age,7 Months,50.3,43.4 to 57.2,416
Hib,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,7 Months,47.0,42.3 to 51.8,818
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.6,82.8 to 98.4,97
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,90.8,84.1 to 97.6,82
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,82.4,72.7 to 92.1,54
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.2,68.8 to 91.6,71
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,86.7,81.9 to 91.4,331
PCV,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,92.1,88.8 to 95.4,509
Polio,≥3 Doses,States/Local Areas,Georgia,2018,Age,19 Months,89.4,82.2 to 93.8,282
Polio,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,60.9,54.5 to 67.0,555
Hib,≥3 Doses,States/Local Areas,Georgia,2018,Age,13 Months,68.9,60.3 to 76.3,282
Hib,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,67.6,61.2 to 73.3,555
Polio,≥3 Doses,States/Local Areas,Georgia,2016,Age,19 Months,93.2,88.5 to 96.1,334
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,92.2,88.4 to 94.8,626
Polio,≥3 Doses,States/Local Areas,Georgia,2017,Age,19 Months,91.2,84.7 to 95.1,292
Polio,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,90.3,85.4 to 93.7,574
Hib,≥2 Doses,States/Local Areas,Georgia,2019,Age,7 Months,89.6,82.0 to 94.2,273
Hib,≥3 Doses,States/Local Areas,Georgia,2013,Age,19 Months,93.3,85.8 to 97.0,276
Hib,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,90.9,85.6 to 94.4,560
Hib,≥3 Doses,States/Local Areas,Georgia,2019,Age,13 Months,66.3,56.7 to 74.7,273
Hib,≥3 Doses,States/Local Areas,Georgia,2011,Age,19 Months,92.0,86.9 to 95.2,219
Hib,≥3 Doses,States/Local Areas,Georgia,2012,Age,19 Months,90.2,88.2 to 92.0,270
Hib,≥3 Doses,States/Local Areas,Georgia,2016,Age,13 Months,74.0,66.9 to 80.0,334
Hib,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,74.4,69.2 to 78.9,626
Hib,≥3 Doses,States/Local Areas,Georgia,2017,Age,13 Months,74.8,67.0 to 81.2,292
Hib,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,71.9,66.1 to 77.0,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2019,Age,13 Months,91.4,84.5 to 95.4,273
DTaP,≥3 Doses,States/Local Areas,Georgia,2011,Age,19 Months,90.6,84.0 to 94.7,219
DTaP,≥3 Doses,States/Local Areas,Georgia,2012,Age,19 Months,92.4,90.4 to 94.1,270
DTaP,≥3 Doses,States/Local Areas,Georgia,2013,Age,19 Months,96.0,92.5 to 97.9,276
DTaP,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,93.8,89.0 to 96.6,560
DTaP,≥3 Doses,States/Local Areas,Georgia,2016,Age,13 Months,92.0,86.6 to 95.3,334
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,89.8,85.4 to 93.0,626
DTaP,≥3 Doses,States/Local Areas,Georgia,2017,Age,13 Months,87.7,80.1 to 92.6,292
DTaP,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,87.6,82.2 to 91.5,574
Polio,≥3 Doses,States/Local Areas,Georgia,2012,Age,19 Months,92.0,89.9 to 93.7,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,71.5,65.3 to 77.6,376
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,77.1,71.2 to 83.0,342
Polio,≥3 Doses,States/Local Areas,Georgia,2013,Age,19 Months,95.0,90.4 to 97.5,276
Polio,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,92.7,86.9 to 96.0,560
Polio,≥3 Doses,States/Local Areas,Georgia,2014,Age,19 Months,90.3,84.9 to 93.9,284
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,90.6,87.0 to 93.3,590
Polio,≥3 Doses,States/Local Areas,Georgia,2015,Age,19 Months,90.9,88.8 to 92.6,306
Polio,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,92.1,88.7 to 94.5,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2018,Age,13 Months,87.5,79.6 to 92.6,282
DTaP,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,89.5,84.5 to 92.9,555
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,91.5,87.6 to 95.3,376
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,96.8,94.4 to 99.2,342
Polio,≥3 Doses,States/Local Areas,Georgia,2011,Age,19 Months,89.6,81.3 to 94.5,219
Hib,≥3 Doses,States/Local Areas,Georgia,2013,Age,13 Months,75.8,67.7 to 82.4,276
Hib,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,72.9,67.8 to 77.5,560
Hib,≥3 Doses,States/Local Areas,Georgia,2014,Age,13 Months,70.0,62.6 to 76.5,284
Hib,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,68.8,63.5 to 73.6,590
Hib,≥3 Doses,States/Local Areas,Georgia,2012,Age,13 Months,82.3,78.3 to 85.6,270
Hib,≥3 Doses,States/Local Areas,Georgia,2015,Age,13 Months,67.5,60.0 to 74.2,306
Hib,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,70.7,65.6 to 75.3,640
Hib,≥3 Doses,States/Local Areas,Georgia,2011,Age,13 Months,87.8,83.3 to 91.2,219
Hib,≥2 Doses,States/Local Areas,Georgia,2016,Age,7 Months,89.2,82.6 to 93.5,334
Hib,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,87.4,82.5 to 91.1,626
Hib,≥2 Doses,States/Local Areas,Georgia,2017,Age,7 Months,85.7,77.8 to 91.1,292
Hib,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,86.2,80.6 to 90.3,574
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.6,89.2 to 96.0,535
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,92.5,88.9 to 96.0,418
Hib,≥3 Doses,States/Local Areas,Georgia,2019,Age,7 Months,48.2,39.1 to 57.3,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,79.6,74.6 to 84.7,372
DTaP,≥3 Doses,States/Local Areas,Georgia,2012,Age,13 Months,89.3,87.3 to 91.0,270
DTaP,≥3 Doses,States/Local Areas,Georgia,2015,Age,13 Months,89.5,83.6 to 93.5,306
DTaP,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,90.8,87.0 to 93.5,640
Hib,≥2 Doses,States/Local Areas,Georgia,2018,Age,13 Months,92.4,85.9 to 96.0,282
Hib,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,92.6,88.3 to 95.4,555
Hib,≥2 Doses,States/Local Areas,Georgia,2017,Age,13 Months,92.4,85.7 to 96.1,292
Hib,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,92.4,88.2 to 95.2,574
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,94.3,90.2 to 98.4,108
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.2,89.2 to 95.2,564
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,92.5,90.4 to 94.6,1090
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,91.1,87.6 to 94.7,372
Hib,≥2 Doses,States/Local Areas,Georgia,2019,Age,13 Months,92.9,86.0 to 96.5,273
Hib,≥2 Doses,States/Local Areas,Georgia,2018,Age,7 Months,86.7,79.0 to 91.9,282
Hib,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,88.2,83.1 to 91.9,555
PCV,≥3 Doses,States/Local Areas,Georgia,2014,Age,35 Months,91.6,86.6 to 95.3,284
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,93.6,90.5 to 95.9,590
PCV,≥3 Doses,States/Local Areas,Georgia,2015,Age,35 Months,96.0,92.6 to 98.1,306
PCV,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,94.2,91.1 to 96.4,640
PCV,≥3 Doses,States/Local Areas,Georgia,2016,Age,35 Months,92.9,87.9 to 96.3,334
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,92.2,88.6 to 95.0,626
DTaP,≥3 Doses,States/Local Areas,Georgia,2014,Age,7 Months,69.4,61.9 to 75.9,284
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,68.3,63.2 to 73.0,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,92.9,89.8 to 95.9,376
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,94.0,90.7 to 97.3,342
Hib,≥3 Doses,States/Local Areas,Georgia,2011,Age,7 Months,62.6,51.3 to 72.7,219
Hib,≥3 Doses,States/Local Areas,Georgia,2012,Age,7 Months,57.5,52.2 to 62.5,270
Hib,≥3 Doses,States/Local Areas,Georgia,2013,Age,7 Months,46.8,45.1 to 48.5,276
Hib,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,47.6,45.7 to 49.5,560
Polio,≥1 Dose,States/Local Areas,Georgia,2014,Age,3 Months,85.1,78.8 to 89.7,284
Polio,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,3 Months,86.2,82.1 to 89.5,590
Polio,≥1 Dose,States/Local Areas,Georgia,2015,Age,3 Months,87.4,81.6 to 91.5,306
Polio,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,3 Months,89.0,85.3 to 91.9,640
Polio,≥1 Dose,States/Local Areas,Georgia,2016,Age,3 Months,90.6,85.4 to 94.1,334
Polio,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,3 Months,89.4,85.3 to 92.5,626
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016,Age,0-3 Days,78.6,72.1 to 83.9,334
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2016-2017,Age,0-3 Days,77.6,72.6 to 81.8,626
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2017,Age,0-3 Days,74.1,62.6 to 83.0,166
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2017-2018,Age,0-3 Days,78.5,73.3 to 83.0,574
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2015,Age,0-3 Days,76.3,69.4 to 82.0,306
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2015-2016,Age,0-3 Days,77.4,72.8 to 81.4,640
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014,Age,0-3 Days,73.6,66.5 to 79.7,284
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2015,Age,0-3 Days,75.0,70.1 to 79.3,590
DTaP,≥3 Doses,States/Local Areas,Georgia,2011,Age,7 Months,68.2,59.4 to 75.8,219
DTaP,≥3 Doses,States/Local Areas,Georgia,2012,Age,7 Months,66.8,62.1 to 71.2,270
DTaP,≥3 Doses,States/Local Areas,Georgia,2013,Age,7 Months,71.0,65.3 to 76.2,276
DTaP,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,70.2,64.2 to 75.6,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2013,Age,0-3 Days,79.0,71.8 to 84.7,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2013-2014,Age,0-3 Days,76.3,71.3 to 80.6,560
Polio,≥1 Dose,States/Local Areas,Georgia,2013,Age,3 Months,92.1,90.9 to 93.2,276
Polio,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,3 Months,88.6,82.8 to 92.6,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,93.0,91.2 to 94.9,1090
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,92.7,89.5 to 95.8,372
PCV,≥1 Dose,States/Local Areas,Georgia,2019,Age,3 Months,88.1,80.5 to 93.0,273
Polio,≥1 Dose,States/Local Areas,Georgia,2011,Age,3 Months,83.4,71.2 to 91.1,219
Polio,≥1 Dose,States/Local Areas,Georgia,2012,Age,3 Months,86.1,80.0 to 90.5,270
Hib,≥2 Doses,States/Local Areas,Georgia,2015,Age,13 Months,92.7,87.4 to 95.9,306
Hib,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,94.4,91.3 to 96.5,640
Hib,≥2 Doses,States/Local Areas,Georgia,2016,Age,13 Months,96.2,91.8 to 98.3,334
Hib,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,94.3,90.6 to 96.6,626
Hib,≥3 Doses,States/Local Areas,Georgia,2017,Age,7 Months,54.7,46.4 to 62.7,292
Hib,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,52.6,46.5 to 58.7,574
Hib,≥3 Doses,States/Local Areas,Georgia,2018,Age,7 Months,50.5,41.9 to 59.2,282
Hib,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,49.4,43.1 to 55.7,555
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,93.3,87.0 to 99.6,50
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.3,88.0 to 96.6,192
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,92.5,88.4 to 96.6,215
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,87.5 to 98.2,148
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,93.2,90.3 to 96.1,576
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,92.1,88.8 to 95.5,396
Hib,≥2 Doses,States/Local Areas,Georgia,2011,Age,13 Months,95.3,91.0 to 97.6,219
Hib,≥2 Doses,States/Local Areas,Georgia,2012,Age,13 Months,93.1,89.5 to 95.5,270
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2018,Age,0-3 Days,80.5,72.9 to 86.4,282
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2018-2019,Age,0-3 Days,80.5,75.1 to 85.0,555
DTaP,≥3 Doses,States/Local Areas,Georgia,2015,Age,7 Months,67.2,59.7 to 74.0,306
DTaP,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,69.2,63.9 to 74.0,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2016,Age,7 Months,71.2,63.6 to 77.7,334
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,70.6,65.0 to 75.6,626
DTaP,≥3 Doses,States/Local Areas,Georgia,2017,Age,7 Months,70.0,61.5 to 77.3,292
DTaP,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,68.5,62.2 to 74.2,574
Hib,≥2 Doses,States/Local Areas,Georgia,2013,Age,13 Months,97.6,93.5 to 99.2,276
Hib,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,95.2,89.3 to 97.9,560
PCV,≥3 Doses,States/Local Areas,Georgia,2017,Age,35 Months,91.8,85.8 to 95.9,292
PCV,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,92.5,88.1 to 95.6,574
PCV,≥3 Doses,States/Local Areas,Georgia,2018,Age,35 Months,93.0,87.3 to 96.8,282
PCV,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,93.5,89.5 to 96.3,555
Hib,≥3 Doses,States/Local Areas,Georgia,2014,Age,7 Months,48.4,40.9 to 56.0,284
Hib,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,46.9,41.7 to 52.2,590
Hib,≥3 Doses,States/Local Areas,Georgia,2015,Age,7 Months,45.4,38.1 to 52.9,306
Hib,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,45.9,40.7 to 51.2,640
Hib,≥3 Doses,States/Local Areas,Georgia,2016,Age,7 Months,46.5,39.1 to 54.0,334
Hib,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,50.6,45.0 to 56.2,626
Polio,≥1 Dose,States/Local Areas,Georgia,2017,Age,3 Months,88.3,81.2 to 92.9,292
Polio,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,3 Months,88.4,83.7 to 91.9,574
Polio,≥1 Dose,States/Local Areas,Georgia,2018,Age,3 Months,88.5,81.2 to 93.2,282
Polio,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,3 Months,88.3,83.3 to 91.9,555
PCV,≥3 Doses,States/Local Areas,Georgia,2019,Age,35 Months,94.0,87.8 to 97.7,273
Hib,≥2 Doses,States/Local Areas,Georgia,2014,Age,13 Months,92.7,87.6 to 95.9,284
Hib,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,92.7,89.3 to 95.1,590
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,90.5,82.1 to 98.9,68
Polio,≥1 Dose,States/Local Areas,Georgia,2019,Age,3 Months,88.1,80.5 to 93.0,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2019,Age,0-3 Days,80.5,72.1 to 86.8,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,74.1,69.3 to 79.0,576
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,71.2,57.1 to 85.3,68
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,79.9,75.0 to 84.9,396
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.6,72.8 to 86.4,192
DTaP,≥3 Doses,States/Local Areas,Georgia,2018,Age,7 Months,67.0,58.0 to 74.9,282
DTaP,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,69.8,63.5 to 75.4,555
DTaP,≥3 Doses,States/Local Areas,Georgia,2019,Age,7 Months,72.5,63.5 to 80.1,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,66.6,50.1 to 83.1,50
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,81.2,74.0 to 88.4,215
DTaP,≥3 Doses,States/Local Areas,Georgia,2011,Age,13 Months,89.0,82.4 to 93.3,219
DTaP,≥3 Doses,States/Local Areas,Georgia,2013,Age,13 Months,95.4,91.6 to 97.6,276
DTaP,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,91.8,84.8 to 95.8,560
DTaP,≥3 Doses,States/Local Areas,Georgia,2014,Age,13 Months,88.3,82.4 to 92.4,284
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,88.9,84.9 to 91.9,590
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.2,71.5 to 80.8,564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,75.4,69.7 to 81.1,418
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,81.9,73.7 to 90.2,108
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Overall,Overall,76.5,73.1 to 79.8,1090
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,70.1 to 87.3,148
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.1,66.1 to 76.1,535
PCV,≥3 Doses,States/Local Areas,Georgia,2019-2020,Age,19 Months,91.4,87.2 to 94.3,611
Hep B,≥1 Dose,States/Local Areas,Georgia,2021,Age,3 Months,96.1,92.0 to 98.1,255
Influenza,,States/Local Areas,Georgia,2013,Age,24 Months,47.7,40.1 to 55.9,276
Influenza,,States/Local Areas,Georgia,2013-2014,Age,24 Months,50.1,44.8 to 55.6,560
Influenza,,States/Local Areas,Georgia,2016,Age,24 Months,48.4,41.1 to 56.3,334
Influenza,,States/Local Areas,Georgia,2016-2017,Age,24 Months,48.0,42.6 to 53.8,626
Influenza,,States/Local Areas,Georgia,2011,Age,24 Months,44.1,35.2 to 54.1,219
Influenza,,States/Local Areas,Georgia,2012,Age,24 Months,46.7,38.8 to 55.3,270
Influenza,,States/Local Areas,Georgia,2014,Age,24 Months,52.5,45.0 to 60.4,284
Influenza,,States/Local Areas,Georgia,2014-2015,Age,24 Months,50.2,44.9 to 55.8,590
Influenza,,States/Local Areas,Georgia,2015,Age,24 Months,48.0,40.8 to 55.8,306
Influenza,,States/Local Areas,Georgia,2015-2016,Age,24 Months,48.2,43.0 to 53.7,640
Influenza,,States/Local Areas,Georgia,2017,Age,24 Months,47.7,39.7 to 56.3,292
Influenza,,States/Local Areas,Georgia,2017-2018,Age,24 Months,44.0,38.2 to 50.2,574
Influenza,,States/Local Areas,Georgia,2018,Age,24 Months,40.2,32.5 to 49.0,282
Influenza,,States/Local Areas,Georgia,2018-2019,Age,24 Months,43.6,37.7 to 50.1,555
Influenza,,States/Local Areas,Georgia,2019,Age,24 Months,47.1,38.3 to 56.8,273
Influenza,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,60.6,54.9 to 66.3,576
Influenza,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,42.7,27.0 to 58.3,68
Influenza,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,42.4,36.3 to 48.6,396
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,91.4,87.8 to 95.1,629
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.1,64.5 to 89.8,212
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,85.7,80.5 to 90.9,344
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,78.5,66.5 to 90.4,171
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.3,66.8 to 87.7,147
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,95.2,92.7 to 97.8,629
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.1 to 95.4,344
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,82.9,78.1 to 87.6,629
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,71.6,65.0 to 78.3,344
Influenza,,States/Local Areas,Georgia,2014-2017,Overall,Overall,49.2,45.1 to 53.3,1090
Influenza,,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,43.5,37.1 to 50.0,372
Influenza,,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,42.6,35.7 to 49.5,376
Influenza,,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,70.4,63.6 to 77.2,342
PCV,≥1 Dose,States/Local Areas,Georgia,2021,Age,3 Months,85.1,76.8 to 90.8,255
Influenza,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,31.7,19.6 to 43.8,108
Influenza,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,52.8,47.3 to 58.3,564
Influenza,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",51.8,46.1 to 57.5,535
Influenza,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,49.0,42.2 to 55.7,418
Influenza,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,33.8,17.4 to 50.2,50
Influenza,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,47.2,38.2 to 56.3,215
Influenza,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",54.5,44.0 to 65.0,148
Influenza,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",44.7,36.0 to 53.3,192
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,76.0 to 95.5,147
DTaP,≥3 Doses,States/Local Areas,Georgia,2021,Age,24 Months,93.4,88.0 to 97.0,255
≥1 Dose Varicella,,States/Local Areas,Georgia,2020-2021,Age,13 Months,51.8,45.5 to 58.0,593
Hib,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,85.5,80.5 to 89.4,593
≥1 Dose MMR,,States/Local Areas,Georgia,2020-2021,Age,19 Months,82.6,77.1 to 87.0,593
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2021,Age,0-3 Days,77.1,68.7 to 83.8,255
Hib,≥2 Doses,States/Local Areas,Georgia,2021,Age,13 Months,92.7,85.8 to 96.4,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,69.2,63.3 to 74.6,593
PCV,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,84.2,78.9 to 88.4,593
≥1 Dose MMR,,States/Local Areas,Georgia,2021,Age,13 Months,65.5,56.1 to 73.7,255
Hib,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,47.4,41.4 to 53.5,593
PCV,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,3 Months,83.3,77.7 to 87.8,593
Polio,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,3 Months,85.3,79.9 to 89.4,593
Hep A,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,76.0,67.7 to 83.5,593
Hep A,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,24 Months,84.0,78.8 to 88.5,593
Hib,≥3 Doses,States/Local Areas,Georgia,2021,Age,35 Months,91.5,85.0 to 95.9,255
Hep B,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,91.1,87.3 to 94.1,593
DTaP,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,5 Months,78.6,72.9 to 83.4,593
Hep A,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,44.8,38.8 to 51.2,593
Hib,Primary Series,States/Local Areas,Georgia,2021,Age,35 Months,92.7,87.2 to 96.4,255
Polio,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,91.5,87.8 to 94.5,593
Hib,Primary Series,States/Local Areas,Georgia,2020-2021,Age,7 Months,66.5,60.5 to 72.1,593
≥1 Dose Varicella,,States/Local Areas,Georgia,2020-2021,Age,24 Months,85.0,80.1 to 89.3,593
Rotavirus,,States/Local Areas,Georgia,2021,Age,8 Months,72.1,63.1 to 79.6,255
Polio,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,92.9,89.1 to 95.7,593
Hep B,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,5 Months,89.0,84.7 to 92.3,593
≥1 Dose MMR,,States/Local Areas,Georgia,2020-2021,Age,24 Months,84.3,79.2 to 88.7,593
Combined 7 Series,,States/Local Areas,Georgia,2020-2021,Age,35 Months,66.1,60.0 to 72.1,593
Polio,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,5 Months,78.6,72.8 to 83.4,593
Polio,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,90.5,86.4 to 93.5,593
PCV,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,91.8,88.0 to 94.7,593
Combined 7 Series,,States/Local Areas,Georgia,2020-2021,Age,24 Months,64.3,58.3 to 70.3,593
Hib,≥3 Doses,States/Local Areas,Georgia,2021,Age,13 Months,64.1,54.7 to 72.6,255
DTaP,≥4 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,69.2,63.2 to 74.6,593
Hib,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,85.6,80.7 to 89.4,593
Hib,Full Series,States/Local Areas,Georgia,2021,Age,35 Months,68.9,59.5 to 77.8,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2021,Age,35 Months,93.4,88.0 to 97.0,255
Hib,Primary Series,States/Local Areas,Georgia,2020-2021,Age,13 Months,81.2,75.6 to 85.7,593
Hep B,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,92.0,88.0 to 94.7,593
Hib,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,3 Months,84.4,79.0 to 88.7,593
Polio,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,85.7,80.7 to 89.6,593
≥1 Dose MMR,,States/Local Areas,Georgia,2020-2021,Age,35 Months,88.8,82.9 to 93.4,593
PCV,≥4 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,78.6,73.0 to 83.8,593
Hep B,≥3 Doses,States/Local Areas,Georgia,2021,Age,35 Months,89.8,83.7 to 94.3,255
Influenza,,States/Local Areas,Georgia,2020-2021,Age,24 Months,40.4,34.6 to 46.7,593
DTaP,≥4 Doses,States/Local Areas,Georgia,2021,Age,35 Months,74.7,65.5 to 83.0,255
Hib,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,91.8,87.3 to 95.2,593
Hep B,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,63.9,58.0 to 69.4,593
PCV,≥4 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,76.2,70.4 to 81.2,593
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2020-2021,Age,0-1 Days,75.0,69.5 to 79.8,593
Hib,Primary Series,States/Local Areas,Georgia,2021,Age,13 Months,79.7,70.6 to 86.4,255
PCV,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,90.9,86.7 to 93.8,593
Combined 7 Series,,States/Local Areas,Georgia,2021,Age,24 Months,59.3,50.3 to 68.4,255
Hep B,≥2 Doses,States/Local Areas,Georgia,2021,Age,13 Months,93.9,88.0 to 97.0,255
Hep A,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,19 Months,81.1,75.5 to 85.6,593
DTaP,≥4 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,76.4,70.8 to 81.5,593
≥1 Dose Varicella,,States/Local Areas,Georgia,2021,Age,35 Months,91.0,78.4 to 97.7,255
Rotavirus,,States/Local Areas,Georgia,2020-2021,Age,8 Months,70.9,64.8 to 76.3,593
DTaP,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,92.6,89.1 to 95.4,593
Hib,Full Series,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,Hispanic,74.4,64.7 to 84.1,171
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,87.1 to 98.9,147
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Private Insurance Only,87.3,83.0 to 91.6,629
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2019,Poverty,<133% FPL,67.8,60.3 to 75.4,281
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2019,Insurance Coverage,Any Medicaid,75.7,69.5 to 81.9,344
DTaP,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,85.5,80.4 to 89.5,593
Hep B,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,90.1,86.0 to 93.1,593
≥1 Dose MMR,,States/Local Areas,Georgia,2020-2021,Age,13 Months,60.4,54.0 to 66.4,593
Hib,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,5 Months,77.0,71.2 to 81.9,593
Polio,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,13 Months,92.6,88.6 to 95.3,593
Hib,Full Series,States/Local Areas,Georgia,2020-2021,Age,19 Months,65.5,59.3 to 71.2,593
Polio,≥3 Doses,States/Local Areas,Georgia,2021,Age,35 Months,92.9,87.4 to 96.6,255
DTaP,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,24 Months,92.4,88.9 to 95.1,593
PCV,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,7 Months,66.3,60.3 to 71.9,593
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2020-2021,Age,0-3 Days,79.4,74.1 to 83.8,593
Hib,Primary Series,States/Local Areas,Georgia,2020-2021,Age,35 Months,92.6,88.8 to 95.5,593
Hib,Primary Series,States/Local Areas,Georgia,2020-2021,Age,19 Months,90.3,86.1 to 93.4,593
≥1 Dose Varicella,,States/Local Areas,Georgia,2020-2021,Age,19 Months,83.5,78.2 to 87.7,593
PCV,≥3 Doses,States/Local Areas,Georgia,2020-2021,Age,35 Months,91.9,88.1 to 94.8,593
Hep B,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,3 Months,96.2,94.0 to 97.6,593
DTaP,≥1 Dose,States/Local Areas,Georgia,2020-2021,Age,3 Months,85.7,80.4 to 89.8,593
Hib,Full Series,States/Local Areas,Georgia,2020-2021,Age,35 Months,72.3,65.9 to 78.4,593
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2020-2021,Age,0-2 Days,77.4,72.0 to 82.0,593
≥1 Dose MMR,,States/Local Areas,Georgia,2021,Age,19 Months,81.7,72.9 to 88.0,255
Hep A,≥2 Doses,States/Local Areas,Georgia,2020-2021,Age,19 Months,26.8,21.7 to 32.5,593
Hep B,≥2 Doses,States/Local Areas,Georgia,2021,Age,5 Months,88.3,81.0 to 93.1,255
Influenza,,States/Local Areas,Georgia,2021,Age,24 Months,41.6,33.3 to 51.1,255
≥1 Dose Varicella,,States/Local Areas,Georgia,2021,Age,13 Months,52.1,42.9 to 61.1,255
Hep B,≥3 Doses,States/Local Areas,Georgia,2021,Age,13 Months,84.2,76.6 to 89.7,255
DTaP,≥2 Doses,States/Local Areas,Georgia,2021,Age,5 Months,79.5,70.6 to 86.3,255
Polio,≥2 Doses,States/Local Areas,Georgia,2021,Age,5 Months,78.2,69.1 to 85.3,255
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,88.0 to 99.3,147
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.6,61.9 to 93.3,147
Hep B,≥1 Dose,States/Local Areas,Alaska,2021,Age,3 Months,94.2,88.6 to 97.1,190
Hep B,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,3 Months,92.2,88.6 to 94.7,492
Hib,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,80.4,75.2 to 84.8,492
Influenza,,States/Local Areas,Alaska,2021,Age,24 Months,51.4,42.1 to 61.4,190
≥1 Dose MMR,,States/Local Areas,Alaska,2021,Age,35 Months,83.4,75.1 to 90.2,190
Influenza,,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,69.0,62.7 to 75.4,283
Influenza,,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,49.2,43.4 to 54.9,404
Influenza,,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,41.5,33.9 to 49.1,218
Influenza,,States/Local Areas,Alaska,2014-2017,Overall,Overall,52.1,48.2 to 55.9,905
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,71.4,65.7 to 77.0,401
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,86.2,82.2 to 90.2,450
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,82.6,77.7 to 87.6,401
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,91.3,88.0 to 94.5,450
DTaP,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,5 Months,71.5,65.7 to 76.8,492
Hib,≥2 Doses,States/Local Areas,Alaska,2021,Age,13 Months,85.2,76.8 to 90.9,190
Hep A,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,24 Months,79.4,73.9 to 84.4,492
Influenza,,States/Local Areas,Alaska,2019,Age,24 Months,65.2,57.8 to 72.6,287
Influenza,,States/Local Areas,Alaska,2018,Age,24 Months,61.1,54.2 to 68.1,275
Influenza,,States/Local Areas,Alaska,2018-2019,Age,24 Months,63.1,58.0 to 68.2,562
Influenza,,States/Local Areas,Alaska,2017,Age,24 Months,54.1,46.7 to 61.8,258
Influenza,,States/Local Areas,Alaska,2017-2018,Age,24 Months,57.5,52.4 to 62.7,533
Influenza,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,43.4,37.5 to 49.3,357
Influenza,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,62.8,57.6 to 67.9,458
Influenza,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,47.5,32.4 to 62.6,61
Influenza,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,40.7,33.5 to 48.0,255
Influenza,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,43.9,35.6 to 52.3,187
Influenza,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,61.3,55.9 to 66.7,463
Influenza,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",54.2,48.9 to 59.4,481
Influenza,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",45.5,38.9 to 52.1,306
Influenza,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,65.8,54.9 to 76.7,97
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,67.3,61.5 to 73.0,401
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.8,76.4 to 87.2,341
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,72.7,60.2 to 85.2,106
Polio,≥3 Doses,States/Local Areas,Alaska,2021,Age,19 Months,85.9,77.1 to 91.7,190
Hep B,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,88.4,83.6 to 92.2,492
Polio,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,89.2,84.0 to 93.4,492
≥1 Dose Varicella,,States/Local Areas,Alaska,2020-2021,Age,24 Months,81.6,76.4 to 86.2,492
PCV,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,81.3,75.9 to 85.7,492
DTaP,≥4 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,80.5,74.3 to 86.0,492
≥1 Dose MMR,,States/Local Areas,Alaska,2020-2021,Age,19 Months,82.3,77.0 to 86.7,492
≥1 Dose MMR,,States/Local Areas,Alaska,2021,Age,13 Months,57.4,47.6 to 66.6,190
Hib,≥3 Doses,States/Local Areas,Alaska,2021,Age,35 Months,84.7,76.8 to 91.1,190
PCV,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,3 Months,81.6,76.4 to 85.9,492
≥1 Dose Varicella,,States/Local Areas,Alaska,2020-2021,Age,13 Months,41.2,35.3 to 47.3,492
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2021,Age,0-3 Days,74.0,64.6 to 81.6,190
Hib,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,58.1,52.0 to 63.9,492
Hib,Full Series,States/Local Areas,Alaska,2020-2021,Age,24 Months,73.9,68.5 to 79.1,492
Polio,≥2 Doses,States/Local Areas,Alaska,2021,Age,13 Months,86.5,77.9 to 92.0,190
Hib,Primary Series,States/Local Areas,Alaska,2021,Age,35 Months,87.9,80.5 to 93.4,190
Hib,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,4.7,2.7 to 8.0,492
Rotavirus,,States/Local Areas,Alaska,2021,Age,8 Months,73.2,63.6 to 81.0,190
Polio,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,81.1,75.7 to 85.5,492
PCV,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,84.5,79.4 to 88.6,492
Influenza,,States/Local Areas,Alaska,2020-2021,Age,24 Months,57.6,51.7 to 63.7,492
Hib,Primary Series,States/Local Areas,Alaska,2021,Age,13 Months,83.2,74.8 to 89.2,190
≥1 Dose MMR,,States/Local Areas,Alaska,2020-2021,Age,35 Months,86.7,81.1 to 91.3,492
Rotavirus,,States/Local Areas,Alaska,2020-2021,Age,8 Months,71.2,65.4 to 76.4,492
DTaP,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,88.1,83.2 to 92.2,492
PCV,≥4 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,76.6,71.0 to 81.8,492
Combined 7 Series,,States/Local Areas,Alaska,2020-2021,Age,35 Months,64.1,57.8 to 70.4,492
Hib,Primary Series,States/Local Areas,Alaska,2020-2021,Age,19 Months,87.5,82.8 to 91.1,492
Polio,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,5 Months,71.1,65.3 to 76.4,492
PCV,≥4 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,73.2,67.4 to 78.3,492
Hep B,≥3 Doses,States/Local Areas,Alaska,2021,Age,35 Months,87.6,80.1 to 93.3,190
DTaP,≥4 Doses,States/Local Areas,Alaska,2021,Age,35 Months,78.9,66.9 to 88.8,190
Hep B,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,87.9,83.4 to 91.3,492
PCV,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,86.2,81.2 to 90.4,492
Hib,Full Series,States/Local Areas,Alaska,2021,Age,35 Months,76.2,67.7 to 83.8,190
≥1 Dose Varicella,,States/Local Areas,Alaska,2020-2021,Age,19 Months,77.6,72.1 to 82.3,492
DTaP,≥3 Doses,States/Local Areas,Alaska,2021,Age,35 Months,87.1,78.8 to 93.2,190
Hib,≥3 Doses,States/Local Areas,Alaska,2021,Age,13 Months,62.3,52.6 to 71.1,190
Hib,Primary Series,States/Local Areas,Alaska,2020-2021,Age,7 Months,72.1,66.4 to 77.1,492
Hep A,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,32.0,26.3 to 38.5,492
PCV,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,87.1,82.1 to 91.3,492
Combined 7 Series,,States/Local Areas,Alaska,2020-2021,Age,24 Months,59.8,53.8 to 65.9,492
DTaP,≥4 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,61.9,55.7 to 67.7,492
DTaP,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,65.2,59.1 to 70.7,492
Hep B,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,5 Months,85.1,80.4 to 88.8,492
Hib,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,5 Months,71.2,65.4 to 76.3,492
Polio,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,24 Months,87.0,82.1 to 91.1,492
Polio,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,3 Months,81.7,76.5 to 85.9,492
Hep A,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,75.9,64.9 to 85.6,492
Influenza,,States/Local Areas,Alaska,2012,Age,24 Months,56.3,48.9 to 63.9,273
Influenza,,States/Local Areas,Alaska,2011,Age,24 Months,42.5,35.2 to 50.6,288
Influenza,,States/Local Areas,Alaska,2015,Age,24 Months,53.3,46.0 to 60.9,257
Influenza,,States/Local Areas,Alaska,2015-2016,Age,24 Months,54.1,48.9 to 59.6,485
Influenza,,States/Local Areas,Alaska,2014,Age,24 Months,52.3,45.4 to 59.6,275
Influenza,,States/Local Areas,Alaska,2014-2015,Age,24 Months,52.8,47.8 to 58.0,532
Influenza,,States/Local Areas,Alaska,2016,Age,24 Months,54.9,47.5 to 62.8,228
Influenza,,States/Local Areas,Alaska,2016-2017,Age,24 Months,54.5,49.2 to 60.0,486
Influenza,,States/Local Areas,Alaska,2013,Age,24 Months,48.1,41.4 to 55.4,303
Influenza,,States/Local Areas,Alaska,2013-2014,Age,24 Months,50.3,45.4 to 55.4,578
Hib,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,3 Months,80.9,75.7 to 85.3,492
≥1 Dose Varicella,,States/Local Areas,Alaska,2019-2020,Age,19 Months,75.8,70.9 to 80.2,589
Hep B,≥2 Doses,States/Local Areas,Alaska,2019-2020,Age,7 Months,88.8,84.9 to 91.8,589
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,70.4 to 82.0,341
Hib,Primary Series,States/Local Areas,Alaska,2019-2020,Age,7 Months,72.7,67.7 to 77.2,589
Rotavirus,,States/Local Areas,Alaska,2012,Age,8 Months,64.8,57.2 to 71.6,273
Hib,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,35 Months,83.6,78.7 to 88.0,492
Hep B,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,76.8,71.2 to 81.6,492
Hep A,≥1 Dose,States/Local Areas,Alaska,2020-2021,Age,19 Months,75.6,69.8 to 80.6,492
Rotavirus,,States/Local Areas,Alaska,2017,Age,8 Months,62.5,54.9 to 69.6,258
Rotavirus,,States/Local Areas,Alaska,2017-2018,Age,8 Months,63.6,58.4 to 68.5,533
≥1 Dose Varicella,,States/Local Areas,Alaska,2021,Age,35 Months,84.4,75.7 to 91.3,190
Hep B,≥2 Doses,States/Local Areas,Alaska,2021,Age,13 Months,90.5,83.0 to 94.9,190
DTaP,≥2 Doses,States/Local Areas,Alaska,2021,Age,5 Months,71.9,62.2 to 79.9,190
PCV,≥1 Dose,States/Local Areas,Alaska,2021,Age,3 Months,84.6,76.1 to 90.5,190
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Other,82.0,69.7 to 94.2,59
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Any Medicaid,79.3,74.3 to 84.3,401
Hep A,≥1 Dose,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,88.7,84.9 to 92.6,450
Polio,≥2 Doses,States/Local Areas,Alaska,2021,Age,5 Months,71.9,62.2 to 79.9,190
Hep B,≥3 Doses,States/Local Areas,Alaska,2021,Age,13 Months,84.3,75.2 to 90.4,190
≥1 Dose MMR,,States/Local Areas,Alaska,2021,Age,19 Months,83.4,74.3 to 89.7,190
Hib,≥2 Doses,States/Local Areas,Alaska,2021,Age,5 Months,72.3,62.8 to 80.1,190
≥1 Dose Varicella,,States/Local Areas,Alaska,2021,Age,13 Months,38.6,29.5 to 48.5,190
DTaP,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,86.4,81.3 to 90.3,492
Combined 7 Series,,States/Local Areas,Alaska,2021,Age,24 Months,60.9,51.4 to 70.6,190
Hib,Full Series,States/Local Areas,Alaska,2020-2021,Age,19 Months,72.7,67.0 to 77.8,492
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alaska,2020-2021,Age,0-2 Days,72.9,67.2 to 77.9,492
Hep A,≥2 Doses,States/Local Areas,Alaska,2021,Age,19 Months,20.3,13.6 to 29.3,190
Hib,Full Series,States/Local Areas,Alaska,2020-2021,Age,35 Months,74.3,68.9 to 79.5,492
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alaska,2020-2021,Age,0-1 Days,71.1,65.3 to 76.2,492
Hep B,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,87.1,82.3 to 90.8,492
Polio,≥2 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,86.4,81.4 to 90.2,492
DTaP,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,13 Months,83.9,78.6 to 88.0,492
PCV,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,7 Months,64.8,58.8 to 70.4,492
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alaska,2020-2021,Age,0-3 Days,73.4,67.7 to 78.4,492
Hib,Primary Series,States/Local Areas,Alaska,2020-2021,Age,35 Months,89.2,84.6 to 92.9,492
Hib,≥3 Doses,States/Local Areas,Alaska,2020-2021,Age,19 Months,81.7,76.4 to 86.0,492
Rotavirus,,States/Local Areas,Alaska,2019,Age,8 Months,66.5,58.7 to 73.5,287
Rotavirus,,States/Local Areas,Alaska,2018,Age,8 Months,64.7,57.5 to 71.3,275
Rotavirus,,States/Local Areas,Alaska,2018-2019,Age,8 Months,65.6,60.3 to 70.5,562
Rotavirus,,States/Local Areas,Alaska,2011,Age,8 Months,57.3,49.5 to 64.7,288
Rotavirus,,States/Local Areas,Alaska,2016,Age,8 Months,70.0,61.8 to 77.0,228
Rotavirus,,States/Local Areas,Alaska,2016-2017,Age,8 Months,66.5,61.0 to 71.7,486
Rotavirus,,States/Local Areas,Alaska,2015,Age,8 Months,69.9,62.9 to 76.1,257
Rotavirus,,States/Local Areas,Alaska,2015-2016,Age,8 Months,69.9,64.6 to 74.8,485
Rotavirus,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.6,57.1 to 70.1,306
Rotavirus,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,Hispanic,74.8,65.0 to 84.5,97
Rotavirus,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Any Medicaid,60.8,54.8 to 66.7,357
Rotavirus,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Private Insurance Only,77.3,72.9 to 81.7,458
Rotavirus,,States/Local Areas,Alaska,2014-2017,Insurance Coverage,Other,53.3,38.1 to 68.5,61
Rotavirus,,States/Local Areas,Alaska,2014,Age,8 Months,68.6,61.9 to 74.7,275
Rotavirus,,States/Local Areas,Alaska,2014-2015,Age,8 Months,69.3,64.5 to 73.7,532
Rotavirus,,States/Local Areas,Alaska,2013,Age,8 Months,70.0,63.3 to 76.0,303
Rotavirus,,States/Local Areas,Alaska,2013-2014,Age,8 Months,69.3,64.6 to 73.6,578
Rotavirus,,States/Local Areas,Alaska,2014-2017,Poverty,133% to <400% FPL,67.5,62.0 to 73.0,404
Rotavirus,,States/Local Areas,Alaska,2014-2017,Poverty,<133% FPL,57.4,49.7 to 65.0,218
Rotavirus,,States/Local Areas,Alaska,2014-2017,Overall,Overall,67.8,64.1 to 71.5,905
Rotavirus,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a Non-MSA,63.0,56.1 to 69.9,255
Rotavirus,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,62.6,54.4 to 70.9,187
Rotavirus,,States/Local Areas,Alaska,2014-2017,Urbanicity,Living In a MSA Principal City,72.4,67.3 to 77.6,463
Rotavirus,,States/Local Areas,Alaska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.2,65.4 to 75.0,481
Rotavirus,,States/Local Areas,Alaska,2014-2017,Poverty,>400% FPL,80.3,74.5 to 86.0,283
PCV,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,80.7 to 90.8,341
Hib,Full Series,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,Hispanic,82.5,73.5 to 91.6,106
Polio,≥3 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.8,83.0 to 92.7,341
DTaP,≥4 Doses,States/Local Areas,Alaska,2016-2019,Poverty,<133% FPL,68.1,60.4 to 75.8,212
PCV,≥4 Doses,States/Local Areas,Alaska,2016-2019,Insurance Coverage,Private Insurance Only,85.5,81.6 to 89.3,450
Hep A,≥2 Doses,States/Local Areas,Alaska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.1,62.4 to 77.8,341
Hib,Primary Series,States/Local Areas,Alaska,2015,Age,19 Months,90.8,88.7 to 92.5,257
Hib,Primary Series,States/Local Areas,Alaska,2015-2016,Age,19 Months,89.1,85.1 to 92.1,485
Hib,Primary Series,States/Local Areas,Alaska,2014,Age,19 Months,92.6,88.9 to 95.1,275
Hib,Primary Series,States/Local Areas,Alaska,2014-2015,Age,19 Months,91.7,88.8 to 93.9,532
Hib,Primary Series,States/Local Areas,Alaska,2013,Age,19 Months,87.9,85.0 to 90.3,303
Hib,Primary Series,States/Local Areas,Alaska,2013-2014,Age,19 Months,90.3,86.8 to 92.9,578
Hib,Primary Series,States/Local Areas,Alaska,2012,Age,19 Months,93.0,89.8 to 95.3,273
Hib,Primary Series,States/Local Areas,Alaska,2018,Age,19 Months,93.5,89.2 to 96.2,275
Hib,Primary Series,States/Local Areas,Alaska,2018-2019,Age,19 Months,86.4,82.3 to 89.7,562
Hib,Primary Series,States/Local Areas,Alaska,2019,Age,19 Months,88.5,82.2 to 92.8,287
Hib,Primary Series,States/Local Areas,Alaska,2017,Age,19 Months,86.8,81.2 to 90.9,258
Hib,Primary Series,States/Local Areas,Alaska,2017-2018,Age,19 Months,90.1,86.7 to 92.7,533
Hib,Primary Series,States/Local Areas,Alaska,2016,Age,19 Months,87.4,80.6 to 92.1,228
Hib,Primary Series,States/Local Areas,Alaska,2016-2017,Age,19 Months,87.1,82.9 to 90.4,486
Hib,Primary Series,States/Local Areas,Alaska,2013,Age,24 Months,87.9,82.5 to 92.3,303
Hib,Primary Series,States/Local Areas,Alaska,2013-2014,Age,24 Months,90.3,87.1 to 92.9,578
Hib,Primary Series,States/Local Areas,Alaska,2012,Age,24 Months,94.1,90.1 to 96.8,273
Hib,Primary Series,States/Local Areas,Alaska,2011,Age,24 Months,93.9,89.4 to 96.9,288
Hib,Primary Series,States/Local Areas,Alaska,2018,Age,7 Months,73.6,66.7 to 79.5,275
Hib,Primary Series,States/Local Areas,Alaska,2018-2019,Age,7 Months,74.1,69.2 to 78.4,562
Hib,Primary Series,States/Local Areas,Alaska,2017,Age,7 Months,76.0,68.9 to 81.9,258
Hib,Primary Series,States/Local Areas,Alaska,2017-2018,Age,7 Months,74.8,70.0 to 79.1,533
Hib,Primary Series,States/Local Areas,Alaska,2016,Age,7 Months,75.2,67.2 to 81.7,228
Hib,Primary Series,States/Local Areas,Alaska,2016-2017,Age,7 Months,75.6,70.3 to 80.2,486
Hib,Primary Series,States/Local Areas,Alaska,2016,Age,13 Months,85.6,78.6 to 90.6,228
Hib,Primary Series,States/Local Areas,Alaska,2016-2017,Age,13 Months,85.7,81.3 to 89.2,486
Hib,Primary Series,States/Local Areas,Alaska,2017,Age,13 Months,85.8,80.1 to 90.0,258
Hib,Primary Series,States/Local Areas,Alaska,2017-2018,Age,13 Months,87.0,83.3 to 90.0,533
Hib,Primary Series,States/Local Areas,Alaska,2015,Age,13 Months,87.1,81.5 to 91.1,257
Hib,Primary Series,States/Local Areas,Alaska,2015-2016,Age,13 Months,86.3,82.0 to 89.7,485
Hib,Primary Series,States/Local Areas,Alaska,2011,Age,19 Months,93.2,88.1 to 96.2,288
Hib,Primary Series,States/Local Areas,Alaska,2019,Age,13 Months,84.4,77.7 to 89.4,287
Hib,Primary Series,States/Local Areas,Alaska,2017,Age,35 Months,87.2,82.0 to 91.5,258
Hib,Primary Series,States/Local Areas,Alaska,2017-2018,Age,35 Months,90.5,87.2 to 93.2,533
Hib,Primary Series,States/Local Areas,Alaska,2018,Age,13 Months,88.3,82.9 to 92.2,275
Hib,Primary Series,States/Local Areas,Alaska,2018-2019,Age,13 Months,86.4,82.3 to 89.7,562
Combined 7 Series,,States/Local Areas,Alaska,2015,Age,35 Months,68.9,61.4 to 76.1,257
Combined 7 Series,,States/Local Areas,Alaska,2015-2016,Age,35 Months,68.0,62.7 to 73.2,485
Combined 7 Series,,States/Local Areas,Alaska,2014,Age,35 Months,76.1,69.3 to 82.3,275
Combined 7 Series,,States/Local Areas,Alaska,2014-2015,Age,35 Months,72.5,67.5 to 77.3,532
Combined 7 Series,,States/Local Areas,Alaska,2013,Age,35 Months,65.9,58.5 to 73.2,303
Combined 7 Series,,States/Local Areas,Alaska,2013-2014,Age,35 Months,71.2,66.1 to 76.1,578
Combined 7 Series,,States/Local Areas,Alaska,2012,Age,35 Months,76.0,68.7 to 82.7,273
Combined 7 Series,,States/Local Areas,Alaska,2017,Age,35 Months,69.0,61.2 to 76.5,258
Combined 7 Series,,States/Local Areas,Alaska,2017-2018,Age,35 Months,66.2,60.9 to 71.4,533
Combined 7 Series,,States/Local Areas,Alaska,2016,Age,35 Months,67.6,59.9 to 75.0,228
Combined 7 Series,,States/Local Areas,Alaska,2016-2017,Age,35 Months,68.0,62.6 to 73.4,486
Hib,Primary Series,States/Local Areas,Alaska,2015,Age,7 Months,77.6,71.0 to 83.1,257
Hib,Primary Series,States/Local Areas,Alaska,2015-2016,Age,7 Months,76.4,71.3 to 80.8,485
Hib,Primary Series,States/Local Areas,Alaska,2014,Age,7 Months,77.7,71.4 to 83.0,275
Hib,Primary Series,States/Local Areas,Alaska,2014-2015,Age,7 Months,77.7,73.2 to 81.6,532
Hib,Primary Series,States/Local Areas,Alaska,2013,Age,7 Months,78.2,73.3 to 82.4,303
Hib,Primary Series,States/Local Areas,Alaska,2013-2014,Age,7 Months,78.0,74.7 to 80.9,578
Hib,Primary Series,States/Local Areas,Alaska,2014,Age,13 Months,88.8,84.4 to 92.1,275
Hib,Primary Series,States/Local Areas,Alaska,2014-2015,Age,13 Months,87.9,84.5 to 90.7,532
Hib,Primary Series,States/Local Areas,Alaska,2013,Age,13 Months,85.4,80.0 to 89.5,303
Hib,Primary Series,States/Local Areas,Alaska,2013-2014,Age,13 Months,87.1,84.4 to 89.4,578
Hib,Primary Series,States/Local Areas,Alaska,2012,Age,13 Months,90.2,84.8 to 93.8,273
Hib,Primary Series,States/Local Areas,Alaska,2011,Age,13 Months,88.1,83.3 to 91.6,288
Hib,Primary Series,States/Local Areas,Alaska,2019,Age,7 Months,74.6,67.3 to 80.7,287
Combined 7 Series,,States/Local Areas,Alaska,2011,Age,35 Months,66.7,58.9 to 74.2,288
Combined 7 Series,,States/Local Areas,Alaska,2012,Age,24 Months,68.3,61.3 to 75.1,273
Combined 7 Series,,States/Local Areas,Alaska,2013,Age,24 Months,60.5,53.4 to 67.7,303
Combined 7 Series,,States/Local Areas,Alaska,2013-2014,Age,24 Months,65.0,60.1 to 69.8,578
Combined 7 Series,,States/Local Areas,Alaska,2011,Age,24 Months,63.2,55.7 to 70.8,288
Hib,Primary Series,States/Local Areas,Alaska,2016,Age,35 Months,89.7,84.1 to 94.0,228
Hib,Primary Series,States/Local Areas,Alaska,2016-2017,Age,35 Months,88.6,84.8 to 91.8,486
Hib,Primary Series,States/Local Areas,Alaska,2015,Age,35 Months,92.3,87.7 to 95.6,257
Hib,Primary Series,States/Local Areas,Alaska,2015-2016,Age,35 Months,90.9,87.4 to 93.8,485
Combined 7 Series,,States/Local Areas,Alaska,2019,Age,24 Months,63.2,55.6 to 70.7,287
Combined 7 Series,,States/Local Areas,Alaska,2018,Age,24 Months,60.0,53.0 to 67.1,275
Combined 7 Series,,States/Local Areas,Alaska,2018-2019,Age,24 Months,61.5,56.4 to 66.7,562
Combined 7 Series,,States/Local Areas,Alaska,2017,Age,24 Months,63.7,56.3 to 71.1,258
Combined 7 Series,,States/Local Areas,Alaska,2017-2018,Age,24 Months,61.8,56.7 to 67.0,533
Hib,Primary Series,States/Local Areas,Alaska,2019,Age,35 Months,89.0,83.1 to 93.5,287
Combined 7 Series,,States/Local Areas,Alaska,2016,Age,24 Months,66.0,58.5 to 73.5,228
Combined 7 Series,,States/Local Areas,Alaska,2016-2017,Age,24 Months,65.0,59.6 to 70.2,486
Hib,Primary Series,States/Local Areas,Alaska,2018,Age,35 Months,93.8,89.7 to 96.6,275
Hib,Primary Series,States/Local Areas,Alaska,2018-2019,Age,35 Months,91.5,88.0 to 94.2,562
Combined 7 Series,,States/Local Areas,Alaska,2015,Age,24 Months,64.4,57.2 to 71.5,257
Combined 7 Series,,States/Local Areas,Alaska,2015-2016,Age,24 Months,65.2,60.0 to 70.3,485
Combined 7 Series,,States/Local Areas,Alaska,2014,Age,24 Months,69.4,62.9 to 75.7,275
Combined 7 Series,,States/Local Areas,Alaska,2014-2015,Age,24 Months,66.8,62.0 to 71.6,532
Combined 7 Series,,States/Local Areas,Puerto Rico,2018,Age,24 Months,47.7,40.1 to 56.0,296
Combined 7 Series,,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,41.3,36.0 to 47.1,615
Combined 7 Series,,States/Local Areas,Puerto Rico,2019,Age,24 Months,34.7,27.8 to 42.7,319
Hib,Primary Series,States/Local Areas,Puerto Rico,2018,Age,24 Months,80.3,74.1 to 85.8,296
Hib,Primary Series,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,76.6,71.8 to 81.1,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2019,Age,24 Months,72.8,65.4 to 79.7,319
Hib,Primary Series,States/Local Areas,Puerto Rico,2018,Age,7 Months,46.7,39.1 to 54.5,296
Hib,Primary Series,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,42.8,37.5 to 48.3,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,40.1,34.8 to 45.7,656
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,76.5,71.8 to 80.7,656
Hib,Primary Series,States/Local Areas,Puerto Rico,2019,Age,7 Months,38.8,31.5 to 46.7,319
Hib,Primary Series,States/Local Areas,Puerto Rico,2019,Age,19 Months,68.8,61.1 to 75.5,319
Hib,Primary Series,States/Local Areas,Puerto Rico,2018,Age,19 Months,78.7,71.9 to 84.2,296
Hib,Primary Series,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,69.0,63.7 to 73.8,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2018,Age,13 Months,74.9,67.7 to 80.9,296
Hib,Primary Series,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,69.0,63.7 to 73.8,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2019,Age,13 Months,62.9,55.1 to 70.0,319
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,80.9,75.7 to 85.2,587
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,76.4,71.0 to 81.1,587
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2021,Age,13 Months,48.0,38.4 to 57.6,250
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,3 Months,76.4,67.5 to 83.5,250
Hib,Primary Series,States/Local Areas,Puerto Rico,2018,Age,35 Months,84.3,75.8 to 91.0,296
Hib,Primary Series,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,79.9,73.7 to 85.4,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2019,Age,35 Months,74.7,67.2 to 81.6,319
Hib,Full Series,States/Local Areas,Puerto Rico,2018,Age,19 Months,52.5,44.8 to 60.2,296
Hib,Full Series,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,83.5,79.3 to 87.1,615
Hib,Full Series,States/Local Areas,Puerto Rico,2019,Age,19 Months,38.3,31.1 to 46.1,319
Rotavirus,,States/Local Areas,Puerto Rico,2018,Age,8 Months,63.9,56.2 to 70.9,296
Rotavirus,,States/Local Areas,Puerto Rico,2018-2019,Age,8 Months,58.5,53.1 to 63.8,615
Rotavirus,,States/Local Areas,Puerto Rico,2019,Age,8 Months,53.0,45.2 to 60.6,319
Rotavirus,,States/Local Areas,Puerto Rico,2011,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Puerto Rico,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Puerto Rico,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Puerto Rico,2013-2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Puerto Rico,2014,Age,8 Months,NA,,
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,85.5,77.6 to 91.0,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,74.6,65.4 to 82.1,250
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,79.5,70.6 to 86.3,250
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,5 Months,58.6,48.9 to 67.6,250
Influenza,,States/Local Areas,Puerto Rico,2019,Age,24 Months,14.9,10.2 to 21.7,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2021,Age,35 Months,75.6,66.9 to 83.5,250
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,3 Months,92.8,85.3 to 96.6,250
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,3 Months,91.6,87.6 to 94.4,587
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,71.4,65.6 to 76.6,587
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,3 Months,68.1,62.3 to 73.4,587
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,74.9,69.2 to 79.8,587
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2020-2021,Age,0-2 Days,70.2,64.2 to 75.6,587
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,5 Months,50.1,44.0 to 56.2,587
Hib,Full Series,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,63.6,57.7 to 69.5,587
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,82.1,73.5 to 88.4,250
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,79.9,74.7 to 84.2,587
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,45.3,39.3 to 51.5,587
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,74.8,69.0 to 79.8,587
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,81.7,76.7 to 86.1,587
Hib,Primary Series,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,82.2,77.3 to 86.6,587
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,47.4,41.3 to 53.6,587
Hib,Full Series,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,67.7,61.4 to 73.9,587
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2020-2021,Age,0-1 Days,65.7,59.6 to 71.4,587
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,39.3,33.5 to 45.5,587
Combined 7 Series,,States/Local Areas,Puerto Rico,2021,Age,24 Months,58.4,48.6 to 68.6,250
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,80.9,75.7 to 85.3,587
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,19.3,13.0 to 27.8,250
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,5 Months,58.0,48.3 to 67.1,250
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,5 Months,57.9,48.2 to 67.0,250
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2021,Age,19 Months,75.2,65.9 to 82.7,250
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,3 Months,69.5,60.3 to 77.5,250
Influenza,,States/Local Areas,Puerto Rico,2021,Age,24 Months,14.4,9.0 to 22.5,250
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,65.0,59.0 to 70.9,587
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2021,Age,13 Months,46.9,37.5 to 56.6,250
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,3 Months,63.9,58.0 to 69.5,587
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,81.4,73.5 to 88.2,250
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,77.6,72.2 to 82.7,587
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,5 Months,53.8,47.6 to 59.8,587
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,74.6,69.0 to 79.6,587
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,76.2,68.5 to 83.1,587
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,73.7,68.2 to 78.5,587
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,42.5,36.5 to 48.7,587
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,75.0,69.6 to 80.1,587
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,83.1,74.5 to 89.2,250
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,78.9,73.7 to 83.6,587
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,79.8,74.8 to 84.5,587
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,70.7,65.1 to 75.9,587
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,73.6,62.5 to 83.6,587
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,3 Months,68.0,62.2 to 73.3,587
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,5 Months,52.8,46.7 to 58.9,587
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,5 Months,69.5,63.7 to 74.7,587
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,55.1,48.9 to 61.1,587
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,45.2,39.1 to 51.3,587
Rotavirus,,States/Local Areas,Puerto Rico,2021,Age,8 Months,66.0,56.6 to 74.3,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2021,Age,0-3 Days,73.6,64.2 to 81.2,250
Hib,Primary Series,States/Local Areas,Puerto Rico,2021,Age,35 Months,82.3,74.4 to 88.9,250
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,50.0,43.6 to 56.8,587
Hib,Primary Series,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,46.1,40.0 to 52.3,587
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,80.6,75.7 to 85.0,587
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,80.4,75.2 to 85.0,587
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,81.2,73.0 to 88.2,250
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,74.0,65.0 to 81.4,250
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,76.3,70.8 to 81.1,587
Hib,Full Series,States/Local Areas,Puerto Rico,2021,Age,35 Months,66.1,56.4 to 75.6,250
Combined 7 Series,,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,53.5,47.4 to 59.8,587
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,82.5,77.3 to 87.2,587
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,78.3,73.0 to 82.8,587
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,79.6,73.7 to 84.8,587
Hib,Primary Series,States/Local Areas,Puerto Rico,2021,Age,13 Months,78.0,69.1 to 84.8,250
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,79.4,74.2 to 83.8,587
Influenza,,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,16.8,12.8 to 21.8,587
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,71.1,65.0 to 77.1,587
Hib,Primary Series,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,80.6,75.4 to 84.9,587
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,7 Months,71.9,66.1 to 77.0,587
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,5 Months,52.0,45.8 to 58.1,587
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,69.5,58.3 to 80.0,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,76.8,68.2 to 84.4,250
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,57.4,51.2 to 63.3,587
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2020-2021,Age,0-3 Days,72.3,66.4 to 77.5,587
Rotavirus,,States/Local Areas,Puerto Rico,2020-2021,Age,8 Months,61.5,55.5 to 67.2,587
Hib,Full Series,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,56.1,50.0 to 62.1,587
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,81.9,77.0 to 86.4,587
Influenza,,States/Local Areas,Puerto Rico,2018,Age,24 Months,15.7,11.1 to 22.0,296
Influenza,,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,15.4,11.9 to 19.8,615
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,65.1,59.7 to 70.1,656
Combined 7 Series,,States/Local Areas,Puerto Rico,2018,Age,35 Months,53.4,45.4 to 61.9,296
Combined 7 Series,,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,49.2,43.2 to 55.5,615
Combined 7 Series,,States/Local Areas,Puerto Rico,2019,Age,35 Months,45.0,36.4 to 54.6,319
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,19 Months,57.9,50.1 to 65.3,319
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,19 Months,73.3,65.9 to 79.5,296
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,61.2,54.3 to 67.6,505
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,5 Months,59.2,51.5 to 66.5,319
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,79.5,73.2 to 85.0,296
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,75.8,71.0 to 80.3,615
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,72.0,64.7 to 79.0,319
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,83.5,75.0 to 90.3,296
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,79.2,72.9 to 84.8,615
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,10.5,6.9 to 15.5,296
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,9.9,6.8 to 14.3,505
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,11.0,7.1 to 16.7,319
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,86.7,79.0 to 92.6,296
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,82.5,76.6 to 87.6,615
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,77.2,69.8 to 83.9,319
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,24 Months,75.6,68.6 to 82.0,296
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,71.7,66.5 to 76.7,615
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,24 Months,67.8,60.1 to 75.2,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020,Age,13 Months,49.1,41.6 to 56.6,337
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,74.4,67.3 to 81.1,319
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2021,Age,35 Months,80.2,71.8 to 87.4,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,76.7,67.5 to 83.9,250
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,81.6,75.5 to 86.9,296
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,78.1,73.4 to 82.4,615
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,5 Months,60.3,52.4 to 67.7,296
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,5 Months,59.8,54.3 to 65.0,615
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,3 Months,75.5,68.5 to 81.4,319
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,3 Months,79.3,72.5 to 84.8,296
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,3 Months,77.4,72.7 to 81.6,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,81.4,76.5 to 85.7,587
Hib,Primary Series,States/Local Areas,Puerto Rico,2021,Age,19 Months,82.3,73.7 to 88.4,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,71.6,65.9 to 76.8,587
Hib,Full Series,States/Local Areas,Puerto Rico,2021,Age,19 Months,57.6,47.9 to 66.8,250
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,67.7,61.9 to 73.4,587
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,66.1,51.1 to 80.6,250
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,5 Months,75.0,65.9 to 82.3,250
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,79.0,73.6 to 83.6,587
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,80.9,75.0 to 86.1,587
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2020-2021,Age,3 Months,70.5,64.8 to 75.7,587
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,79.5,71.2 to 86.7,250
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,76.2,70.8 to 81.3,587
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,83.5,78.7 to 87.4,587
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,55.8,46.1 to 65.1,250
Combined 7 Series,,States/Local Areas,Puerto Rico,2021,Age,35 Months,58.7,48.9 to 68.9,250
Hib,Primary Series,States/Local Areas,Puerto Rico,2021,Age,7 Months,51.2,41.6 to 60.8,250
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,75.7,66.5 to 83.0,250
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,24 Months,80.8,75.9 to 85.2,587
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,5 Months,54.8,45.2 to 64.1,250
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,47.9,38.4 to 57.5,250
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,76.5,67.4 to 83.7,250
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,81.4,72.9 to 87.7,250
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,78.6,73.6 to 83.1,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,80.3,75.5 to 84.6,656
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,67.0,60.6 to 73.3,656
Combined 7 Series,,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,42.2,37.0 to 47.9,656
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,65.9,60.6 to 70.8,656
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,36.9,31.8 to 42.3,656
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,81.1,76.7 to 84.9,656
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,68.3,63.0 to 73.1,656
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,68.4,63.1 to 73.2,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,39.2,34.0 to 44.7,656
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,5 Months,49.1,43.7 to 54.5,656
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,5 Months,51.7,46.3 to 57.1,656
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,5 Months,68.6,63.4 to 73.3,656
Hib,Primary Series,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,66.3,61.0 to 71.2,656
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,36.9,31.8 to 42.3,656
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,63.2,57.8 to 68.3,656
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,78.9,74.4 to 82.8,656
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,79.8,75.4 to 83.6,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,13 Months,71.9,66.8 to 76.4,656
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,5 Months,52.0,46.6 to 57.3,656
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,5 Months,54.6,49.2 to 59.9,656
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,3 Months,64.1,58.8 to 69.0,656
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,3 Months,91.0,87.7 to 93.5,656
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,3 Months,65.7,60.4 to 70.6,656
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,16.4,12.9 to 20.7,656
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,76.1,71.4 to 80.7,656
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,56.0,50.7 to 61.5,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,78.3,73.7 to 82.6,656
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,62.2,56.5 to 67.9,656
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,76.8,71.8 to 81.4,656
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,78.1,72.6 to 83.1,656
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,75.8,70.6 to 80.7,656
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,77.2,72.4 to 81.7,656
Hib,Primary Series,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,77.8,73.0 to 82.2,656
Hib,Full Series,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,61.2,55.3 to 67.1,656
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,73.5,68.0 to 78.6,656
Hib,Primary Series,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,73.6,68.5 to 78.0,656
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,72.8,67.8 to 77.3,656
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,66.4,61.0 to 71.3,656
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,64.4,59.0 to 69.4,656
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,74.4,69.3 to 78.8,656
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,74.7,69.9 to 79.3,656
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,71.8,66.8 to 76.7,656
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,35.0,29.9 to 40.4,656
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2019-2020,Age,0-2 Days,66.9,61.5 to 71.8,656
Hib,Full Series,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,54.5,49.1 to 60.0,656
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,73.3,68.3 to 78.1,656
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2019-2020,Age,0-1 Days,62.2,56.7 to 67.3,656
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,46.8,41.5 to 52.3,656
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,72.6,67.5 to 77.1,656
Hib,Full Series,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,46.5,41.1 to 51.9,656
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,72.2,67.1 to 76.9,656
Combined 7 Series,,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,49.5,43.6 to 55.7,656
Hib,Primary Series,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,76.3,71.5 to 80.8,656
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,66.9,61.6 to 71.8,656
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,75.7,70.9 to 80.2,656
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,43.5,38.1 to 49.2,656
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,67.9,62.7 to 73.0,656
Influenza,,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,16.8,13.1 to 21.3,656
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,78.8,73.5 to 83.6,656
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,35 Months,61.2,52.7 to 69.9,656
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,73.3,68.3 to 78.1,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,75.6,68.8 to 81.2,337
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,72.8,61.4 to 83.1,337
Combined 7 Series,,States/Local Areas,Puerto Rico,2020,Age,35 Months,54.1,46.4 to 62.2,337
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,21.8,16.3 to 28.4,337
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,19 Months,74.9,68.0 to 80.7,337
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2020,Age,0-2 Days,69.6,62.1 to 76.1,337
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2020,Age,0-1 Days,66.1,58.6 to 72.9,337
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,68.0,60.5 to 74.6,337
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,66.2,58.7 to 73.0,337
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,39.2,31.9 to 46.9,337
Hib,Primary Series,States/Local Areas,Puerto Rico,2020,Age,7 Months,40.9,33.6 to 48.6,337
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,65.1,58.0 to 72.0,337
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,82.5,76.8 to 87.6,337
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,80.1,74.0 to 85.5,337
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020,Age,24 Months,76.6,70.1 to 82.7,337
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,80.0,74.1 to 85.4,337
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020,Age,35 Months,80.5,73.9 to 86.3,337
Hib,Primary Series,States/Local Areas,Puerto Rico,2020,Age,35 Months,81.4,75.5 to 86.6,337
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,81.1,75.2 to 86.3,337
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,74.2,67.4 to 80.5,337
Hib,Full Series,States/Local Areas,Puerto Rico,2020,Age,35 Months,67.1,59.6 to 74.4,337
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020,Age,35 Months,83.8,77.0 to 89.5,337
Hib,Full Series,States/Local Areas,Puerto Rico,2020,Age,19 Months,54.6,47.1 to 61.9,337
Hib,Primary Series,States/Local Areas,Puerto Rico,2020,Age,19 Months,78.9,72.3 to 84.2,337
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020,Age,19 Months,74.9,68.0 to 80.7,337
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,73.0,65.9 to 79.1,337
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,84.5,78.7 to 89.5,337
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,76.2,68.1 to 83.4,337
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,80.6,74.5 to 86.0,337
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,77.4,70.8 to 82.9,337
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,79.3,72.8 to 84.6,337
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,55.5,47.9 to 62.8,337
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,81.8,75.5 to 87.2,337
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,67.4,60.1 to 73.9,337
Hib,Primary Series,States/Local Areas,Puerto Rico,2020,Age,13 Months,70.0,62.8 to 76.3,337
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,81.4,75.3 to 86.4,337
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,68.6,61.3 to 75.1,337
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020,Age,13 Months,46.9,39.5 to 54.5,337
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,5 Months,45.3,37.9 to 53.0,337
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,5 Months,63.9,56.3 to 70.8,337
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,70.1,63.0 to 76.4,337
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,42.4,35.0 to 50.1,337
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,80.6,74.2 to 85.7,337
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,54.4,46.9 to 61.7,337
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,78.5,71.8 to 84.0,337
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020,Age,19 Months,74.1,67.1 to 80.1,337
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,19 Months,78.2,71.7 to 83.6,337
Combined 7 Series,,States/Local Areas,Puerto Rico,2020,Age,24 Months,49.0,41.6 to 56.8,337
Influenza,,States/Local Areas,Puerto Rico,2020,Age,24 Months,18.9,13.8 to 25.7,337
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020,Age,24 Months,77.9,71.5 to 83.7,337
Rotavirus,,States/Local Areas,Puerto Rico,2020,Age,8 Months,57.0,49.5 to 64.2,337
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2020,Age,0-3 Days,71.0,63.5 to 77.5,337
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,79.5,73.5 to 84.9,337
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,65.7,58.7 to 72.7,337
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,51.2,43.8 to 59.1,337
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,24 Months,78.9,72.5 to 84.6,337
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,3 Months,58.2,50.6 to 65.4,337
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,3 Months,90.4,85.5 to 93.7,337
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,5 Months,45.9,38.5 to 53.5,337
DTaP,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,5 Months,48.9,41.4 to 56.5,337
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,5 Months,47.6,40.2 to 55.2,337
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,3 Months,63.1,55.6 to 70.0,337
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,3 Months,61.0,53.5 to 68.1,337
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,76.4,69.8 to 81.9,337
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,3 Months,59.6,52.1 to 66.8,337
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,41.2,33.9 to 48.9,337
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,7 Months,37.4,30.3 to 45.1,337
Rotavirus,,States/Local Areas,Puerto Rico,2019-2020,Age,8 Months,55.1,49.7 to 60.4,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,81.2,73.0 to 88.2,250
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,3 Months,68.0,62.8 to 72.7,656
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,36.2,31.1 to 41.7,656
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,7 Months,43.8,38.4 to 49.3,656
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,24 Months,56.5,51.2 to 62.0,656
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,46.3,40.9 to 51.7,656
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019-2020,Age,19 Months,76.3,71.4 to 80.6,656
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2019-2020,Age,0-3 Days,70.1,64.9 to 74.8,656
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2019-2020,Age,3 Months,69.4,64.3 to 74.1,656
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,48.0,41.9 to 54.2,587
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2021,Age,0-1 Days,65.3,55.6 to 74.0,250
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,80.2,71.4 to 86.7,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,76.8,68.2 to 84.4,250
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2021,Age,24 Months,79.7,71.4 to 86.8,250
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,81.4,72.8 to 87.8,250
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,3 Months,74.9,65.8 to 82.2,250
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,83.8,78.6 to 88.4,587
Hib,Primary Series,States/Local Areas,Puerto Rico,2021,Age,24 Months,82.3,74.4 to 88.9,250
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,81.2,72.4 to 87.8,250
Hib,Full Series,States/Local Areas,Puerto Rico,2021,Age,24 Months,65.7,56.1 to 75.2,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,75.8,70.4 to 81.0,587
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,70.6,60.8 to 79.9,250
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,45.7,36.4 to 55.4,250
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2021,Age,19 Months,77.8,68.6 to 84.9,250
Hib,Primary Series,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,74.0,68.4 to 78.9,587
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,35 Months,76.5,67.6 to 84.4,250
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,84.1,77.9 to 89.3,587
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,81.4,73.4 to 88.2,250
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,70.3,60.5 to 79.5,250
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,13 Months,81.2,76.1 to 85.4,587
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,77.2,68.4 to 84.0,250
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,24 Months,76.2,67.3 to 84.2,250
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,13 Months,77.3,68.4 to 84.2,250
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2020-2021,Age,19 Months,20.5,16.1 to 25.8,587
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,49.0,38.2 to 61.0,250
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,49.4,39.9 to 59.0,250
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,7 Months,41.2,32.1 to 50.9,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2021,Age,0-2 Days,70.8,61.2 to 78.9,250
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2021,Age,19 Months,59.2,49.5 to 68.2,250
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,19 Months,74.7,65.2 to 82.3,250
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,35 Months,81.4,73.4 to 88.2,250
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,64.7,54.9 to 74.4,250
DTaP,≥1 Dose,States/Local Areas,Puerto Rico,2021,Age,3 Months,77.9,68.9 to 84.8,250
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,79.5,71.2 to 86.7,250
Combined 7 Series,,States/Local Areas,Puerto Rico,2020-2021,Age,35 Months,57.5,51.0 to 64.1,587
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2021,Age,24 Months,75.6,66.9 to 83.5,250
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2021,Age,24 Months,81.4,73.5 to 88.2,250
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,90.9,89.8 to 92.0,10389
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,89.7 to 91.4,24711
Hib,≥2 Doses,HHS Regions/National,United States,2015,Age,7 Months,88.7,87.5 to 89.7,15463
Hib,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,88.8,88.0 to 89.6,31419
PCV,≥3 Doses,HHS Regions/National,United States,2019,Age,24 Months,93.3,92.5 to 94.0,17265
PCV,≥3 Doses,HHS Regions/National,United States,2011,Age,35 Months,92.6,91.6 to 93.7,14513
PCV,≥3 Doses,HHS Regions/National,United States,2013,Age,35 Months,94.0,93.3 to 94.8,14872
PCV,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,93.1,92.4 to 93.7,30205
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.9,90.0 to 91.8,21757
Hib,≥2 Doses,HHS Regions/National,United States,2019,Age,7 Months,91.0,90.1 to 91.8,17265
Hib,≥2 Doses,HHS Regions/National,United States,2012,Age,13 Months,94.1,93.4 to 94.7,15039
Hib,≥2 Doses,HHS Regions/National,United States,2011,Age,13 Months,93.3,92.4 to 94.2,14513
Hib,≥2 Doses,HHS Regions/National,United States,2016,Age,7 Months,89.0,87.7 to 90.2,15956
Hib,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,88.7,87.9 to 89.5,33760
Hib,≥2 Doses,HHS Regions/National,United States,2017,Age,7 Months,88.5,87.4 to 89.5,17804
Hib,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,89.4,88.7 to 90.0,36630
Hib,≥2 Doses,HHS Regions/National,United States,2018,Age,7 Months,90.3,89.4 to 91.1,18826
Hib,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,90.6,90.0 to 91.2,36091
PCV,≥3 Doses,HHS Regions/National,United States,2014,Age,35 Months,92.1,91.0 to 93.1,15333
PCV,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,92.8,92.1 to 93.5,30796
PCV,≥3 Doses,HHS Regions/National,United States,2015,Age,35 Months,93.7,92.6 to 94.6,15463
PCV,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,93.3,92.6 to 93.9,31419
PCV,≥3 Doses,HHS Regions/National,United States,2016,Age,35 Months,93.0,92.0 to 93.9,15956
PCV,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,92.7,92.1 to 93.4,33760
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,89.3,88.3 to 90.3,17073
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,93.8,93.0 to 94.5,18707
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,90.0,89.0 to 91.0,21077
Hib,≥3 Doses,HHS Regions/National,United States,2012,Age,7 Months,57.5,55.7 to 59.3,15039
Hib,≥3 Doses,HHS Regions/National,United States,2011,Age,7 Months,63.0,61.2 to 64.9,14513
Hib,≥3 Doses,HHS Regions/National,United States,2013,Age,7 Months,54.5,52.4 to 56.6,14872
Hib,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,54.1,52.5 to 55.6,30205
Polio,≥1 Dose,HHS Regions/National,United States,2014,Age,3 Months,85.3,84.1 to 86.4,15333
Polio,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,3 Months,85.8,84.9 to 86.7,30796
Polio,≥1 Dose,HHS Regions/National,United States,2015,Age,3 Months,86.3,85.1 to 87.5,15463
Polio,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,3 Months,86.9,86.0 to 87.7,31419
Polio,≥1 Dose,HHS Regions/National,United States,2016,Age,3 Months,87.4,86.2 to 88.6,15956
Polio,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,3 Months,86.8,85.9 to 87.6,33760
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2017,Age,0-3 Days,77.1,75.0 to 79.0,10014
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2017-2018,Age,0-3 Days,78.1,77.2 to 79.0,36630
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016,Age,0-3 Days,75.6,74.0 to 77.1,15956
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2017,Age,0-3 Days,76.4,75.4 to 77.4,33760
PCV,≥3 Doses,HHS Regions/National,United States,2018,Age,24 Months,93.6,92.9 to 94.2,18826
PCV,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,93.4,92.9 to 93.9,36091
PCV,≥3 Doses,HHS Regions/National,United States,2012,Age,35 Months,93.5,92.5 to 94.4,15039
PCV,≥1 Dose,HHS Regions/National,United States,2019,Age,3 Months,89.2,88.2 to 90.1,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,90.8,90.2 to 91.3,56857
Polio,≥1 Dose,HHS Regions/National,United States,2012,Age,3 Months,86.3,85.2 to 87.4,15039
Polio,≥1 Dose,HHS Regions/National,United States,2011,Age,3 Months,86.9,85.7 to 88.1,14513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2013,Age,0-3 Days,72.6,71.2 to 74.0,14872
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2013-2014,Age,0-3 Days,71.8,70.7 to 72.8,30205
Polio,≥1 Dose,HHS Regions/National,United States,2013,Age,3 Months,85.8,84.8 to 86.8,14872
Polio,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,3 Months,85.6,84.7 to 86.4,30205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014,Age,0-3 Days,70.9,69.3 to 72.5,15333
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2015,Age,0-3 Days,72.1,70.9 to 73.3,30796
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.2,90.6 to 91.8,33203
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,89.0 to 92.0,7674
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.3,88.7 to 91.9,4191
DTaP,≥3 Doses,HHS Regions/National,United States,2013,Age,7 Months,68.2,66.8 to 69.5,14872
DTaP,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,68.0,66.9 to 69.1,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2012,Age,7 Months,68.3,66.7 to 69.8,15039
DTaP,≥3 Doses,HHS Regions/National,United States,2011,Age,7 Months,70.3,68.7 to 72.0,14513
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.6,82.8 to 84.4,33203
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.7,78.7 to 82.7,7674
PCV,≥1 Dose,HHS Regions/National,United States,2014,Age,3 Months,83.2,81.9 to 84.5,15333
PCV,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,3 Months,84.1,83.2 to 84.9,30796
PCV,≥1 Dose,HHS Regions/National,United States,2015,Age,3 Months,84.9,83.7 to 86.1,15463
PCV,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,3 Months,85.6,84.7 to 86.4,31419
PCV,≥3 Doses,HHS Regions/National,United States,2017,Age,24 Months,91.3,90.3 to 92.1,17804
PCV,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,92.4,91.8 to 93.0,36630
PCV,≥3 Doses,HHS Regions/National,United States,2016,Age,24 Months,92.0,91.1 to 92.9,15956
PCV,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,91.7,91.0 to 92.3,33760
Hib,≥2 Doses,HHS Regions/National,United States,2012,Age,7 Months,89.6,88.6 to 90.5,15039
Hib,≥2 Doses,HHS Regions/National,United States,2019,Age,5 Months,80.2,79.0 to 81.4,17265
Hib,≥2 Doses,HHS Regions/National,United States,2011,Age,7 Months,88.9,87.8 to 89.9,14513
Hib,≥2 Doses,HHS Regions/National,United States,2018,Age,5 Months,79.6,78.4 to 80.8,18826
Hib,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,5 Months,79.9,79.1 to 80.8,36091
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,90.0,87.9 to 92.2,2246
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,92.4,91.7 to 93.1,31919
PCV,≥1 Dose,HHS Regions/National,United States,2016,Age,3 Months,86.3,85.0 to 87.5,15956
PCV,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,3 Months,85.6,84.7 to 86.4,33760
PCV,≥1 Dose,HHS Regions/National,United States,2017,Age,3 Months,84.9,83.7 to 86.0,17804
PCV,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,3 Months,86.3,85.5 to 87.0,36630
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,81.3,80.2 to 82.4,24711
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2012,Age,0-3 Days,72.8,71.3 to 74.2,15039
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,90.0,89.0 to 91.1,18707
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,81.3,80.2 to 82.5,21077
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,75.5,74.1 to 76.8,17073
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.4,81.3 to 83.5,21757
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,80.2,77.1 to 83.3,1692
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,78.6,76.8 to 80.3,10389
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,81.5,80.7 to 82.2,56857
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,89.8,88.9 to 90.7,21000
PCV,≥1 Dose,HHS Regions/National,United States,2018,Age,3 Months,87.6,86.7 to 88.6,18826
PCV,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,3 Months,88.4,87.7 to 89.1,36091
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2011,Age,0-3 Days,73.2,71.7 to 74.7,14513
Hib,≥2 Doses,HHS Regions/National,United States,2013,Age,7 Months,88.9,87.9 to 89.8,14872
Hib,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,88.6,87.8 to 89.3,30205
Hib,≥2 Doses,HHS Regions/National,United States,2014,Age,7 Months,88.2,87.0 to 89.3,15333
Hib,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,88.4,87.6 to 89.2,30796
PCV,≥3 Doses,HHS Regions/National,United States,2019,Age,19 Months,92.2,91.4 to 93.0,17265
PCV,≥3 Doses,HHS Regions/National,United States,2011,Age,24 Months,91.6,90.4 to 92.6,14513
PCV,≥3 Doses,HHS Regions/National,United States,2018,Age,19 Months,92.9,92.2 to 93.6,18826
PCV,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,89.6,88.9 to 90.2,36091
Hep B,≥2 Doses,HHS Regions/National,United States,2019,Age,13 Months,95.3,94.7 to 95.9,17265
Hib,≥2 Doses,HHS Regions/National,United States,2012,Age,5 Months,76.3,75.2 to 77.4,15039
Hib,≥2 Doses,HHS Regions/National,United States,2011,Age,5 Months,77.6,76.1 to 79.1,14513
Hib,≥2 Doses,HHS Regions/National,United States,2013,Age,5 Months,74.8,73.2 to 76.4,14872
Hib,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,5 Months,75.6,74.5 to 76.6,30205
Hib,≥2 Doses,HHS Regions/National,United States,2014,Age,5 Months,76.3,74.9 to 77.7,15333
Hib,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,5 Months,76.5,75.4 to 77.6,30796
PCV,≥3 Doses,HHS Regions/National,United States,2017,Age,19 Months,90.4,89.4 to 91.3,17804
PCV,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,91.7,91.0 to 92.2,36630
PCV,≥1 Dose,HHS Regions/National,United States,2011,Age,3 Months,84.6,83.3 to 85.9,14513
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,94.5,93.8 to 95.2,18707
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,90.1,89.2 to 91.0,21077
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.5,89.7 to 91.4,21757
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,88.9,87.7 to 90.0,10389
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,87.9,87.0 to 88.9,17073
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Overall,Overall,90.4,89.9 to 91.0,56857
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,90.4,89.0 to 91.7,11789
PCV,≥1 Dose,HHS Regions/National,United States,2012,Age,3 Months,84.1,83.0 to 85.1,15039
PCV,≥4 Doses,HHS Regions/National,United States,2017,Age,35 Months,83.2,81.9 to 84.5,17804
PCV,≥4 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,84.9,84.1 to 85.8,36630
PCV,≥4 Doses,HHS Regions/National,United States,2019,Age,35 Months,86.6,85.3 to 87.7,17265
Hib,≥2 Doses,HHS Regions/National,United States,2015,Age,5 Months,76.7,75.2 to 78.2,15463
Hib,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,5 Months,77.1,76.0 to 78.2,31419
Hib,≥2 Doses,HHS Regions/National,United States,2016,Age,5 Months,77.6,76.0 to 79.1,15956
Hib,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,5 Months,77.4,76.3 to 78.4,33760
PCV,≥1 Dose,HHS Regions/National,United States,2013,Age,3 Months,84.7,83.4 to 85.9,14872
PCV,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,3 Months,83.9,82.9 to 84.9,30205
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.5,74.4 to 78.6,4191
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,80.4,78.5 to 82.2,11789
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,78.5,75.4 to 81.7,2246
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,62.2,58.2 to 66.2,1692
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,77.3,76.1 to 78.5,21000
PCV,≥3 Doses,HHS Regions/National,United States,2015,Age,24 Months,91.8,90.8 to 92.7,15463
PCV,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,91.9,91.2 to 92.6,31419
PCV,≥3 Doses,HHS Regions/National,United States,2014,Age,24 Months,91.2,90.1 to 92.2,15333
PCV,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,91.5,90.8 to 92.2,30796
PCV,≥3 Doses,HHS Regions/National,United States,2012,Age,24 Months,92.6,91.6 to 93.5,15039
Hib,≥2 Doses,HHS Regions/National,United States,2017,Age,5 Months,77.2,75.8 to 78.6,17804
Hib,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,5 Months,78.4,77.5 to 79.3,36630
PCV,≥3 Doses,HHS Regions/National,United States,2013,Age,24 Months,92.5,91.7 to 93.3,14872
PCV,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,91.9,91.2 to 92.5,30205
Hib,≥1 Dose,HHS Regions/National,United States,2019,Age,3 Months,88.8,87.8 to 89.7,17265
PCV,≥4 Doses,HHS Regions/National,United States,2016,Age,35 Months,84.5,83.0 to 85.9,15956
PCV,≥4 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,83.9,82.9 to 84.8,33760
PCV,≥4 Doses,HHS Regions/National,United States,2018,Age,35 Months,86.8,85.7 to 87.9,18826
PCV,≥4 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,86.7,85.9 to 87.5,36091
PCV,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,87.2,86.3 to 88.0,31919
Hib,≥1 Dose,HHS Regions/National,United States,2018,Age,3 Months,88.1,87.1 to 89.0,18826
Hib,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,3 Months,88.4,87.7 to 89.1,36091
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,89.4 to 92.2,7674
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,90.5,89.3 to 91.7,11789
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,92.9,92.2 to 93.6,31919
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,89.0,88.1 to 89.8,21000
PCV,≥4 Doses,HHS Regions/National,United States,2015,Age,35 Months,84.4,83.1 to 85.7,15463
PCV,≥4 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,84.4,83.4 to 85.4,31419
PCV,≥4 Doses,HHS Regions/National,United States,2014,Age,35 Months,84.1,82.7 to 85.4,15333
PCV,≥4 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,84.2,83.2 to 85.1,30796
Hep B,≥2 Doses,HHS Regions/National,United States,2018,Age,13 Months,95.4,94.7 to 96.0,18826
Hep B,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,95.4,94.9 to 95.8,36091
Hep B,≥2 Doses,HHS Regions/National,United States,2016,Age,13 Months,94.3,93.5 to 95.0,15956
Hep B,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,94.1,93.5 to 94.6,33760
PCV,≥3 Doses,HHS Regions/National,United States,2015,Age,19 Months,90.8,89.9 to 91.6,15463
PCV,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,90.9,90.1 to 91.6,31419
PCV,≥3 Doses,HHS Regions/National,United States,2016,Age,19 Months,90.9,89.9 to 91.9,15956
PCV,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,90.7,89.9 to 91.3,33760
Hib,≥1 Dose,HHS Regions/National,United States,2015,Age,3 Months,86.4,85.1 to 87.5,15463
Hib,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,3 Months,86.6,85.7 to 87.4,31419
Hib,≥1 Dose,HHS Regions/National,United States,2016,Age,3 Months,86.8,85.6 to 88.0,15956
Hib,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,3 Months,86.5,85.6 to 87.3,33760
Hib,≥1 Dose,HHS Regions/National,United States,2017,Age,3 Months,86.1,84.9 to 87.2,17804
Hib,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,3 Months,87.1,86.3 to 87.8,36630
Hep B,≥2 Doses,HHS Regions/National,United States,2017,Age,13 Months,93.8,93.0 to 94.6,17804
Hep B,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,94.6,94.1 to 95.1,36630
≥1 Dose MMR,,HHS Regions/National,United States,2018,Age,35 Months,94.7,93.9 to 95.4,18826
≥1 Dose MMR,,HHS Regions/National,United States,2018-2019,Age,35 Months,94.5,93.9 to 95.0,36091
≥1 Dose MMR,,HHS Regions/National,United States,2017,Age,35 Months,92.4,91.3 to 93.4,17804
≥1 Dose MMR,,HHS Regions/National,United States,2017-2018,Age,35 Months,93.5,92.8 to 94.1,36630
≥1 Dose MMR,,HHS Regions/National,United States,2019,Age,35 Months,94.3,93.4 to 95.1,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,89.5 to 91.0,24711
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.8,89.1 to 90.5,33203
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,89.1,87.0 to 91.2,2246
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,88.8 to 91.8,7674
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,94.0,93.3 to 94.8,18707
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,90.8,90.0 to 91.5,24711
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.7,90.0 to 91.3,33203
Hep B,≥3 Doses,HHS Regions/National,United States,2019,Age,35 Months,94.4,93.6 to 95.2,17265
PCV,≥3 Doses,HHS Regions/National,United States,2014,Age,19 Months,89.7,88.5 to 90.8,15333
PCV,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,90.2,89.4 to 91.0,30796
Hep B,≥3 Doses,HHS Regions/National,United States,2018,Age,35 Months,93.9,93.0 to 94.6,18826
Hep B,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,94.1,93.6 to 94.7,36091
PCV,≥4 Doses,HHS Regions/National,United States,2013,Age,35 Months,85.1,83.8 to 86.3,14872
PCV,≥4 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,84.6,83.6 to 85.5,30205
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.2,87.6 to 90.7,4191
≥1 Dose MMR,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,77.2,73.9 to 80.5,1692
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,89.1,88.2 to 90.1,21077
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.8,88.9 to 90.7,21757
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,88.1,86.9 to 89.3,10389
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,87.5,86.5 to 88.4,17073
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Overall,Overall,89.8,89.3 to 90.4,56857
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.0,87.4 to 90.6,4191
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,87.6,85.3 to 89.8,2246
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,71.9,68.2 to 75.5,1692
≥1 Dose Varicella,,HHS Regions/National,United States,2019,Age,35 Months,94.6,93.5 to 95.5,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,88.7,87.8 to 89.6,21000
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,92.3,91.6 to 93.0,31919
≥1 Dose Varicella,,HHS Regions/National,United States,2018,Age,35 Months,93.9,93.0 to 94.7,18826
≥1 Dose Varicella,,HHS Regions/National,United States,2018-2019,Age,35 Months,94.2,93.5 to 94.8,36091
PCV,≥4 Doses,HHS Regions/National,United States,2015,Age,24 Months,81.0,79.7 to 82.3,15463
PCV,≥4 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,81.2,80.2 to 82.2,31419
≥1 Dose MMR,,HHS Regions/National,United States,2016,Age,35 Months,93.3,92.3 to 94.1,15956
≥1 Dose MMR,,HHS Regions/National,United States,2016-2017,Age,35 Months,92.8,92.1 to 93.5,33760
≥1 Dose MMR,,HHS Regions/National,United States,2014,Age,35 Months,93.0,91.9 to 94.1,15333
≥1 Dose MMR,,HHS Regions/National,United States,2014-2015,Age,35 Months,93.2,92.5 to 93.9,30796
≥1 Dose MMR,,HHS Regions/National,United States,2015,Age,35 Months,93.4,92.6 to 94.2,15463
≥1 Dose MMR,,HHS Regions/National,United States,2015-2016,Age,35 Months,93.3,92.7 to 93.9,31419
PCV,≥4 Doses,HHS Regions/National,United States,2017,Age,24 Months,80.9,79.6 to 82.2,17804
PCV,≥4 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,82.2,81.4 to 83.1,36630
PCV,≥4 Doses,HHS Regions/National,United States,2016,Age,24 Months,81.4,79.9 to 82.9,15956
PCV,≥4 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,81.2,80.2 to 82.1,33760
PCV,≥3 Doses,HHS Regions/National,United States,2018,Age,13 Months,89.7,88.8 to 90.6,18826
PCV,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,89.6,88.9 to 90.2,36091
PCV,≥3 Doses,HHS Regions/National,United States,2017,Age,13 Months,87.1,86.0 to 88.2,17804
PCV,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,88.4,87.7 to 89.1,36630
Hep B,≥2 Doses,HHS Regions/National,United States,2019,Age,7 Months,93.3,92.5 to 94.0,17265
Hep B,≥2 Doses,HHS Regions/National,United States,2011,Age,13 Months,93.3,92.5 to 94.1,14513
Hep B,≥2 Doses,HHS Regions/National,United States,2012,Age,13 Months,94.1,93.4 to 94.7,15039
Hep B,≥3 Doses,HHS Regions/National,United States,2012,Age,35 Months,93.1,92.2 to 93.9,15039
Hep B,≥3 Doses,HHS Regions/National,United States,2014,Age,35 Months,91.8,90.7 to 92.9,15333
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,92.2,91.4 to 92.9,30796
Hep B,≥3 Doses,HHS Regions/National,United States,2013,Age,35 Months,93.0,92.2 to 93.8,14872
Hep B,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,92.4,91.7 to 93.1,30205
PCV,≥3 Doses,HHS Regions/National,United States,2016,Age,13 Months,87.6,86.2 to 88.8,15956
PCV,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,87.4,86.5 to 88.2,33760
PCV,≥4 Doses,HHS Regions/National,United States,2018,Age,24 Months,83.6,82.5 to 84.6,18826
PCV,≥4 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,83.4,82.7 to 84.2,36091
PCV,≥4 Doses,HHS Regions/National,United States,2019,Age,24 Months,83.3,82.1 to 84.4,17265
PCV,≥4 Doses,HHS Regions/National,United States,2011,Age,35 Months,84.6,83.1 to 86.1,14513
PCV,≥4 Doses,HHS Regions/National,United States,2012,Age,35 Months,85.4,84.1 to 86.7,15039
PCV,≥3 Doses,HHS Regions/National,United States,2012,Age,19 Months,91.5,90.6 to 92.3,15039
Hep B,≥3 Doses,HHS Regions/National,United States,2017,Age,35 Months,92.7,91.7 to 93.6,17804
Hep B,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,93.3,92.6 to 93.9,36630
PCV,≥3 Doses,HHS Regions/National,United States,2019,Age,13 Months,89.5,88.5 to 90.3,17265
PCV,≥3 Doses,HHS Regions/National,United States,2011,Age,19 Months,90.4,89.2 to 91.4,14513
PCV,≥3 Doses,HHS Regions/National,United States,2013,Age,19 Months,91.5,90.7 to 92.3,14872
PCV,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,90.6,89.9 to 91.3,30205
Hep B,≥3 Doses,HHS Regions/National,United States,2015,Age,35 Months,92.5,91.5 to 93.5,15463
Hep B,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,92.5,91.8 to 93.2,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2016,Age,35 Months,92.5,91.5 to 93.5,15956
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,92.6,91.9 to 93.3,33760
DTaP,≥3 Doses,HHS Regions/National,United States,2016,Age,13 Months,89.2,87.9 to 90.4,15956
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,89.1,88.3 to 89.8,33760
DTaP,≥3 Doses,HHS Regions/National,United States,2017,Age,13 Months,88.9,87.9 to 89.9,17804
DTaP,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,89.9,89.3 to 90.6,36630
DTaP,≥3 Doses,HHS Regions/National,United States,2015,Age,13 Months,89.7,88.6 to 90.7,15463
DTaP,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,89.5,88.6 to 90.2,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2012,Age,13 Months,90.0,89.1 to 90.8,15039
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,74.5,73.0 to 75.9,18707
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,72.5,71.2 to 73.8,21077
Hib,≥3 Doses,HHS Regions/National,United States,2013,Age,13 Months,78.4,76.4 to 80.2,14872
Hib,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,76.8,75.3 to 78.3,30205
Polio,≥3 Doses,HHS Regions/National,United States,2011,Age,19 Months,90.4,89.2 to 91.5,14513
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,95.6,94.8 to 96.4,18707
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,91.4,90.5 to 92.2,21077
Hib,≥3 Doses,HHS Regions/National,United States,2014,Age,13 Months,75.3,73.9 to 76.6,15333
Hib,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,75.7,74.7 to 76.6,30796
Hib,≥3 Doses,HHS Regions/National,United States,2011,Age,13 Months,83.5,82.1 to 84.8,14513
Hib,≥3 Doses,HHS Regions/National,United States,2012,Age,13 Months,80.9,79.3 to 82.4,15039
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,75.2,73.7 to 76.6,17073
Hib,≥3 Doses,HHS Regions/National,United States,2019,Age,7 Months,56.0,54.5 to 57.4,17265
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,90.5 to 92.1,24711
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,91.9 to 93.1,33203
Hib,≥2 Doses,HHS Regions/National,United States,2019,Age,13 Months,94.6,94.0 to 95.2,17265
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.1,91.3 to 92.8,21757
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,90.8,89.3 to 92.2,10389
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,88.9,88.0 to 89.9,17073
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,91.6,91.0 to 92.1,56857
Hib,≥2 Doses,HHS Regions/National,United States,2018,Age,13 Months,94.8,94.1 to 95.4,18826
Hib,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,94.7,94.2 to 95.1,36091
Hib,≥2 Doses,HHS Regions/National,United States,2017,Age,13 Months,93.0,92.2 to 93.8,17804
Hib,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,93.9,93.3 to 94.4,36630
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2019,Age,0-3 Days,81.5,80.4 to 82.6,17265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,74.1,71.0 to 77.3,2246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,73.1,72.0 to 74.2,31919
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.5,74.2 to 78.7,4191
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,75.5,74.2 to 76.8,21000
Polio,≥1 Dose,HHS Regions/National,United States,2019,Age,3 Months,89.9,89.0 to 90.7,17265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2018,Age,0-3 Days,79.1,77.8 to 80.3,18826
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2018-2019,Age,0-3 Days,80.3,79.4 to 81.1,36091
PCV,≥3 Doses,HHS Regions/National,United States,2019,Age,35 Months,94.1,93.3 to 94.9,17265
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,90.0,87.9 to 92.1,2246
Hib,≥3 Doses,HHS Regions/National,United States,2018,Age,7 Months,56.8,55.4 to 58.2,18826
Hib,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,56.4,55.4 to 57.4,36091
Hib,≥3 Doses,HHS Regions/National,United States,2017,Age,7 Months,55.5,54.0 to 57.0,17804
Hib,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,56.2,55.1 to 57.2,36630
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.1,88.7 to 91.6,4191
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,78.2,74.9 to 81.5,1692
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,88.6 to 91.9,7674
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,91.2,90.0 to 92.5,11789
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,89.9,89.0 to 90.7,21000
PCV,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,94.3,93.6 to 95.0,31919
DTaP,≥3 Doses,HHS Regions/National,United States,2011,Age,13 Months,89.2,88.0 to 90.3,14513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,67.5,63.8 to 71.2,1692
DTaP,≥3 Doses,HHS Regions/National,United States,2019,Age,7 Months,72.6,71.2 to 73.9,17265
DTaP,≥3 Doses,HHS Regions/National,United States,2017,Age,7 Months,69.9,68.4 to 71.4,17804
DTaP,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,72.0,71.0 to 72.9,36630
DTaP,≥3 Doses,HHS Regions/National,United States,2018,Age,7 Months,74.0,72.7 to 75.3,18826
DTaP,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,73.3,72.4 to 74.2,36091
Hib,≥2 Doses,HHS Regions/National,United States,2015,Age,13 Months,93.4,92.5 to 94.1,15463
Hib,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,93.3,92.7 to 93.9,31419
Hib,≥2 Doses,HHS Regions/National,United States,2016,Age,13 Months,93.3,92.4 to 94.2,15956
Hib,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,93.2,92.5 to 93.7,33760
Hib,≥2 Doses,HHS Regions/National,United States,2014,Age,13 Months,92.7,91.9 to 93.5,15333
Hib,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,93.1,92.4 to 93.6,30796
Polio,≥1 Dose,HHS Regions/National,United States,2018,Age,3 Months,89.2,88.3 to 90.1,18826
Polio,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,3 Months,89.6,88.9 to 90.2,36091
Polio,≥1 Dose,HHS Regions/National,United States,2017,Age,3 Months,86.1,84.9 to 87.2,17804
Polio,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,3 Months,87.7,86.9 to 88.4,36630
Hib,≥3 Doses,HHS Regions/National,United States,2015,Age,7 Months,52.4,50.6 to 54.1,15463
Hib,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,53.5,52.2 to 54.7,31419
Hib,≥3 Doses,HHS Regions/National,United States,2016,Age,7 Months,54.6,52.9 to 56.3,15956
Hib,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,55.0,53.9 to 56.2,33760
PCV,≥3 Doses,HHS Regions/National,United States,2018,Age,35 Months,94.7,94.0 to 95.4,18826
PCV,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,94.4,93.9 to 95.0,36091
Hib,≥3 Doses,HHS Regions/National,United States,2014,Age,7 Months,53.7,52.1 to 55.3,15333
Hib,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,53.0,51.8 to 54.2,30796
Hib,≥2 Doses,HHS Regions/National,United States,2013,Age,13 Months,94.1,93.5 to 94.7,14872
Hib,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,93.4,92.9 to 93.9,30205
PCV,≥3 Doses,HHS Regions/National,United States,2017,Age,35 Months,92.5,91.5 to 93.4,17804
PCV,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,93.6,93.0 to 94.2,36630
DTaP,≥3 Doses,HHS Regions/National,United States,2015,Age,7 Months,68.1,66.4 to 69.8,15463
DTaP,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,69.7,68.6 to 70.9,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2014,Age,7 Months,67.8,66.2 to 69.3,15333
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,67.9,66.8 to 69.1,30796
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2015,Age,0-3 Days,73.3,71.6 to 75.0,15463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2015-2016,Age,0-3 Days,74.4,73.3 to 75.6,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2016,Age,7 Months,71.4,69.7 to 73.0,15956
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,70.7,69.5 to 71.7,33760
DTaP,≥3 Doses,HHS Regions/National,United States,2013,Age,13 Months,90.4,89.4 to 91.3,14872
DTaP,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,89.4,88.4 to 90.3,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2014,Age,13 Months,88.4,87.2 to 89.4,15333
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,89.0,88.2 to 89.8,30796
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,75.4,73.7 to 77.1,10389
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Overall,Overall,74.1,73.2 to 74.9,56857
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.6,73.3 to 75.8,21757
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,73.2,71.9 to 74.5,24711
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.8,70.8 to 72.8,33203
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.6,72.3 to 76.9,7674
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,76.6,74.6 to 78.6,11789
Hib,≥3 Doses,HHS Regions/National,United States,2015,Age,13 Months,76.1,74.7 to 77.4,15463
Hib,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,75.2,74.2 to 76.2,31419
Hib,≥3 Doses,HHS Regions/National,United States,2016,Age,13 Months,74.3,72.8 to 75.8,15956
Hib,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,74.6,73.6 to 75.6,33760
Hib,≥3 Doses,HHS Regions/National,United States,2017,Age,13 Months,75.0,73.7 to 76.2,17804
Hib,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,75.2,74.4 to 76.1,36630
Polio,≥3 Doses,HHS Regions/National,United States,2014,Age,19 Months,89.2,88.0 to 90.2,15333
Polio,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,90.1,89.3 to 90.8,30796
Polio,≥3 Doses,HHS Regions/National,United States,2012,Age,19 Months,91.5,90.5 to 92.4,15039
Polio,≥3 Doses,HHS Regions/National,United States,2015,Age,19 Months,91.1,89.9 to 92.1,15463
Polio,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,91.2,90.5 to 91.8,31419
Polio,≥3 Doses,HHS Regions/National,United States,2013,Age,19 Months,90.8,90.0 to 91.5,14872
Polio,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,90.0,88.9 to 90.9,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2019,Age,13 Months,90.9,90.0 to 91.7,17265
DTaP,≥3 Doses,HHS Regions/National,United States,2011,Age,19 Months,92.5,91.3 to 93.5,14513
DTaP,≥3 Doses,HHS Regions/National,United States,2013,Age,19 Months,93.2,92.5 to 93.8,14872
DTaP,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,92.3,91.7 to 92.9,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2012,Age,19 Months,93.2,92.4 to 94.0,15039
DTaP,≥3 Doses,HHS Regions/National,United States,2018,Age,13 Months,91.0,90.1 to 91.8,18826
DTaP,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,90.9,90.3 to 91.5,36091
Hib,≥3 Doses,HHS Regions/National,United States,2019,Age,13 Months,75.4,74.2 to 76.6,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2020,Age,24 Months,91.0,90.0 to 91.9,17387
Hib,≥3 Doses,HHS Regions/National,United States,2012,Age,19 Months,90.7,89.7 to 91.6,15039
Hib,≥3 Doses,HHS Regions/National,United States,2011,Age,19 Months,90.8,89.7 to 91.9,14513
Hib,≥3 Doses,HHS Regions/National,United States,2018,Age,13 Months,75.5,74.3 to 76.7,18826
Hib,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,75.4,74.6 to 76.3,36091
Polio,≥3 Doses,HHS Regions/National,United States,2016,Age,19 Months,91.3,90.3 to 92.2,15956
Polio,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,90.8,90.1 to 91.5,33760
Polio,≥3 Doses,HHS Regions/National,United States,2017,Age,19 Months,90.3,89.3 to 91.2,17804
Polio,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,91.5,90.9 to 92.1,36630
Rotavirus,,HHS Regions/National,Region 10,2014,Age,8 Months,70.8,66.2 to 74.9,1050
Rotavirus,,HHS Regions/National,Region 10,2014-2015,Age,8 Months,72.5,69.3 to 75.6,2042
Rotavirus,,HHS Regions/National,Region 10,2016,Age,8 Months,74.4,69.2 to 79.1,875
Rotavirus,,HHS Regions/National,Region 10,2016-2017,Age,8 Months,73.5,70.3 to 76.5,2294
Rotavirus,,HHS Regions/National,Region 10,2015,Age,8 Months,74.3,69.5 to 78.6,992
Rotavirus,,HHS Regions/National,Region 10,2015-2016,Age,8 Months,74.4,70.9 to 77.6,1867
Polio,≥3 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,90.8,87.1 to 93.5,754
Hep B,≥3 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,89.1,85.3 to 91.9,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,91.2,89.0 to 93.0,2007
Combined 7 Series,,HHS Regions/National,Region 10,2021,Age,24 Months,68.3,63.0 to 73.5,754
Hep A,≥2 Doses,HHS Regions/National,Region 10,2021,Age,19 Months,29.0,24.4 to 34.0,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,89.7,87.4 to 91.6,2007
Polio,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,91.9,89.8 to 93.7,2007
PCV,≥1 Dose,HHS Regions/National,Region 10,2021,Age,3 Months,87.8,84.0 to 90.8,754
Polio,≥2 Doses,HHS Regions/National,Region 10,2021,Age,5 Months,80.2,75.5 to 84.2,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2021,Age,13 Months,62.5,57.1 to 67.6,754
Rotavirus,,HHS Regions/National,Region 10,2011,Age,8 Months,69.2,64.4 to 73.6,1041
Rotavirus,,HHS Regions/National,Region 10,2013,Age,8 Months,72.2,67.9 to 76.1,1048
Rotavirus,,HHS Regions/National,Region 10,2013-2014,Age,8 Months,71.5,68.4 to 74.4,2098
Rotavirus,,HHS Regions/National,Region 10,2012,Age,8 Months,71.8,66.8 to 76.2,977
Rotavirus,,HHS Regions/National,Region 10,2019,Age,8 Months,79.0,75.3 to 82.2,1312
Rotavirus,,HHS Regions/National,Region 10,2017,Age,8 Months,72.6,68.7 to 76.2,1419
Rotavirus,,HHS Regions/National,Region 10,2017-2018,Age,8 Months,75.9,73.2 to 78.3,2919
Rotavirus,,HHS Regions/National,Region 10,2018,Age,8 Months,79.2,75.7 to 82.3,1500
Rotavirus,,HHS Regions/National,Region 10,2018-2019,Age,8 Months,79.1,76.6 to 81.4,2812
Hep A,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,24 Months,89.2,86.9 to 91.2,2007
PCV,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,3 Months,85.5,83.0 to 87.8,2007
Hib,≥3 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,91.8,85.9 to 95.9,754
Hib,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,54.5,51.2 to 57.9,2007
Polio,≥2 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,92.1,88.6 to 94.5,754
Hib,Full Series,HHS Regions/National,Region 10,2020-2021,Age,24 Months,79.9,76.9 to 82.7,2007
Hep B,≥1 Dose,HHS Regions/National,Region 10,2021,Age,3 Months,93.6,90.3 to 95.9,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020-2021,Age,13 Months,62.3,58.9 to 65.5,2007
DTaP,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,5 Months,80.2,77.2 to 82.8,2007
Influenza,,HHS Regions/National,Region 10,2017,Age,24 Months,64.2,60.2 to 68.3,1419
Influenza,,HHS Regions/National,Region 10,2017-2018,Age,24 Months,67.4,64.7 to 70.1,2919
Influenza,,HHS Regions/National,Region 10,2018,Age,24 Months,70.6,67.0 to 74.2,1500
Influenza,,HHS Regions/National,Region 10,2018-2019,Age,24 Months,71.0,68.4 to 73.6,2812
Influenza,,HHS Regions/National,Region 10,2016,Age,24 Months,63.1,57.9 to 68.4,875
Influenza,,HHS Regions/National,Region 10,2016-2017,Age,24 Months,63.7,60.4 to 67.0,2294
Influenza,,HHS Regions/National,Region 10,2019,Age,24 Months,71.4,67.6 to 75.1,1312
Hep B,≥2 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,93.1,89.8 to 95.4,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2021,Age,35 Months,93.8,88.8 to 97.0,754
Rotavirus,,HHS Regions/National,Region 10,2020-2021,Age,8 Months,75.0,71.8 to 77.9,2007
Hib,Primary Series,HHS Regions/National,Region 10,2020-2021,Age,35 Months,92.7,90.4 to 94.7,2007
Hib,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,91.4,88.6 to 93.7,2007
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,90.5,88.2 to 92.3,2007
Hib,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,87.8,85.3 to 89.9,2007
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,72.2,68.9 to 75.2,2007
Hep A,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,19 Months,86.1,83.5 to 88.3,2007
≥1 Dose MMR,,HHS Regions/National,Region 10,2021,Age,19 Months,87.4,83.4 to 90.5,754
Hib,≥2 Doses,HHS Regions/National,Region 10,2021,Age,5 Months,79.1,74.4 to 83.2,754
Hib,Full Series,HHS Regions/National,Region 10,2020-2021,Age,19 Months,74.9,71.7 to 77.9,2007
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 10,2020-2021,Age,0-2 Days,82.6,79.9 to 84.9,2007
Hib,Full Series,HHS Regions/National,Region 10,2020-2021,Age,35 Months,84.0,80.9 to 86.9,2007
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 10,2020-2021,Age,0-1 Days,81.5,78.8 to 83.9,2007
PCV,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,70.1,66.8 to 73.2,2007
DTaP,≥2 Doses,HHS Regions/National,Region 10,2021,Age,5 Months,80.4,75.7 to 84.4,754
Hib,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,76.3,73.3 to 79.0,2007
Influenza,,HHS Regions/National,Region 10,2021,Age,24 Months,59.9,54.5 to 65.4,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020-2021,Age,24 Months,89.8,87.5 to 91.8,2007
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2021,Age,0-3 Days,84.2,80.1 to 87.5,754
Rotavirus,,HHS Regions/National,Region 10,2021,Age,8 Months,75.7,70.6 to 80.1,754
Hep B,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,3 Months,93.3,91.3 to 94.9,2007
Hib,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,87.8,85.3 to 89.9,2007
≥1 Dose MMR,,HHS Regions/National,Region 10,2021,Age,13 Months,70.1,64.9 to 74.8,754
≥1 Dose MMR,,HHS Regions/National,Region 10,2020-2021,Age,19 Months,87.7,85.2 to 89.9,2007
Hib,≥2 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,91.5,88.0 to 94.1,754
Hep A,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,48.7,45.1 to 52.3,2007
Hep B,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,5 Months,89.0,86.7 to 91.0,2007
DTaP,≥4 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,70.4,67.1 to 73.5,2007
Hib,Primary Series,HHS Regions/National,Region 10,2020-2021,Age,7 Months,73.8,70.6 to 76.8,2007
Hep B,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,91.3,89.2 to 93.1,2007
Hib,Primary Series,HHS Regions/National,Region 10,2021,Age,35 Months,92.1,88.9 to 94.6,754
Influenza,,HHS Regions/National,Region 10,2013,Age,24 Months,56.6,52.1 to 61.3,1048
Influenza,,HHS Regions/National,Region 10,2013-2014,Age,24 Months,55.1,51.8 to 58.4,2098
DTaP,≥4 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,88.8,81.5 to 94.2,754
Influenza,,HHS Regions/National,Region 10,2015,Age,24 Months,61.0,56.1 to 66.0,992
Influenza,,HHS Regions/National,Region 10,2015-2016,Age,24 Months,62.1,58.5 to 65.7,1867
Influenza,,HHS Regions/National,Region 10,2014,Age,24 Months,53.5,48.9 to 58.3,1050
Influenza,,HHS Regions/National,Region 10,2014-2015,Age,24 Months,57.3,53.9 to 60.7,2042
PCV,≥4 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,84.1,80.8 to 87.1,2007
Combined 7 Series,,HHS Regions/National,Region 10,2020-2021,Age,35 Months,75.4,71.8 to 78.8,2007
Hib,Primary Series,HHS Regions/National,Region 10,2020-2021,Age,19 Months,91.6,89.5 to 93.3,2007
Polio,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,89.1,86.8 to 91.1,2007
Hib,Primary Series,HHS Regions/National,Region 10,2021,Age,13 Months,87.5,83.6 to 90.6,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,90.0,87.7 to 91.9,2007
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 10,2020-2021,Age,0-3 Days,83.3,80.7 to 85.6,2007
Influenza,,HHS Regions/National,Region 10,2020-2021,Age,24 Months,63.5,60.1 to 66.8,2007
≥1 Dose MMR,,HHS Regions/National,Region 10,2020-2021,Age,35 Months,91.6,89.2 to 93.6,2007
Hep B,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,91.5,89.3 to 93.2,2007
Hep B,≥3 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,91.5,87.8 to 94.4,754
≥1 Dose Varicella,,HHS Regions/National,Region 10,2020-2021,Age,19 Months,87.3,84.9 to 89.5,2007
Hib,Full Series,HHS Regions/National,Region 10,2021,Age,35 Months,87.4,79.5 to 93.3,754
PCV,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,91.2,89.0 to 93.1,2007
Hib,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,3 Months,86.0,83.5 to 88.2,2007
Polio,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,92.6,89.9 to 94.8,2007
PCV,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,90.5,88.3 to 92.4,2007
Combined 7 Series,,HHS Regions/National,Region 10,2020-2021,Age,24 Months,69.2,65.9 to 72.4,2007
Hib,≥3 Doses,HHS Regions/National,Region 10,2021,Age,13 Months,76.9,72.2 to 81.0,754
DTaP,≥3 Doses,HHS Regions/National,Region 10,2021,Age,35 Months,92.7,88.9 to 95.6,754
Polio,≥1 Dose,HHS Regions/National,Region 10,2020-2021,Age,3 Months,86.4,83.8 to 88.6,2007
Hep A,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,35 Months,78.9,74.5 to 83.1,2007
Polio,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,91.0,88.8 to 92.9,2007
Hib,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,5 Months,78.8,75.8 to 81.5,2007
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,7 Months,72.0,68.7 to 75.0,2007
PCV,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,13 Months,87.1,84.6 to 89.2,2007
≥1 Dose Varicella,,HHS Regions/National,Region 10,2019-2020,Age,19 Months,87.7,85.6 to 89.5,2565
Influenza,,HHS Regions/National,Region 10,2011,Age,24 Months,50.2,45.1 to 55.5,1041
Influenza,,HHS Regions/National,Region 10,2012,Age,24 Months,56.9,51.9 to 62.1,977
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020-2021,Age,24 Months,92.0,89.9 to 93.8,2007
PCV,≥4 Doses,HHS Regions/National,Region 10,2020-2021,Age,19 Months,78.1,74.9 to 80.9,2007
Polio,≥2 Doses,HHS Regions/National,Region 10,2020-2021,Age,5 Months,79.5,76.5 to 82.2,2007
≥1 Dose MMR,,HHS Regions/National,Region 10,2021,Age,35 Months,94.6,88.9 to 97.9,754
Hib,Primary Series,HHS Regions/National,Region 10,2019-2020,Age,7 Months,77.0,74.3 to 79.4,2565
Combined 7 Series,,HHS Regions/National,Region 10,2016,Age,24 Months,67.0,61.8 to 72.2,875
Combined 7 Series,,HHS Regions/National,Region 10,2016-2017,Age,24 Months,69.1,65.9 to 72.4,2294
Combined 7 Series,,HHS Regions/National,Region 10,2019,Age,24 Months,70.5,66.6 to 74.3,1312
Hep B,≥2 Doses,HHS Regions/National,Region 10,2019-2020,Age,7 Months,92.3,90.5 to 93.7,2565
Combined 7 Series,,HHS Regions/National,Region 10,2011,Age,35 Months,71.4,66.0 to 76.7,1041
Combined 7 Series,,HHS Regions/National,Region 10,2017,Age,35 Months,74.6,70.6 to 78.4,1419
Combined 7 Series,,HHS Regions/National,Region 10,2017-2018,Age,35 Months,75.5,72.7 to 78.1,2919
Combined 7 Series,,HHS Regions/National,Region 10,2016,Age,35 Months,71.9,66.6 to 77.0,875
Combined 7 Series,,HHS Regions/National,Region 10,2016-2017,Age,35 Months,73.3,70.0 to 76.5,2294
Combined 7 Series,,HHS Regions/National,Region 10,2015,Age,24 Months,62.7,57.6 to 67.9,992
Combined 7 Series,,HHS Regions/National,Region 10,2015-2016,Age,24 Months,64.9,61.2 to 68.6,1867
Hib,Primary Series,HHS Regions/National,Region 10,2018,Age,35 Months,95.6,94.0 to 96.9,1500
Hib,Primary Series,HHS Regions/National,Region 10,2018-2019,Age,35 Months,95.6,94.3 to 96.6,2812
Hib,Primary Series,HHS Regions/National,Region 10,2019,Age,35 Months,95.4,93.5 to 96.9,1312
Combined 7 Series,,HHS Regions/National,Region 10,2013,Age,24 Months,68.6,64.2 to 72.9,1048
Combined 7 Series,,HHS Regions/National,Region 10,2013-2014,Age,24 Months,68.2,65.1 to 71.3,2098
Combined 7 Series,,HHS Regions/National,Region 10,2017,Age,24 Months,71.3,67.4 to 75.0,1419
Combined 7 Series,,HHS Regions/National,Region 10,2017-2018,Age,24 Months,71.8,69.2 to 74.4,2919
Combined 7 Series,,HHS Regions/National,Region 10,2018,Age,24 Months,72.4,68.7 to 76.0,1500
Combined 7 Series,,HHS Regions/National,Region 10,2018-2019,Age,24 Months,71.5,68.8 to 74.1,2812
Combined 7 Series,,HHS Regions/National,Region 10,2014,Age,24 Months,67.9,63.5 to 72.1,1050
Combined 7 Series,,HHS Regions/National,Region 10,2014-2015,Age,24 Months,65.3,61.9 to 68.6,2042
Hib,Primary Series,HHS Regions/National,Region 10,2014,Age,35 Months,92.2,89.4 to 94.6,1050
Hib,Primary Series,HHS Regions/National,Region 10,2014-2015,Age,35 Months,91.7,89.5 to 93.6,2042
Hib,Primary Series,HHS Regions/National,Region 10,2017,Age,13 Months,87.2,84.1 to 89.7,1419
Hib,Primary Series,HHS Regions/National,Region 10,2017-2018,Age,13 Months,89.5,87.6 to 91.1,2919
Hib,Primary Series,HHS Regions/National,Region 10,2012,Age,19 Months,92.2,89.4 to 94.3,977
Hib,Primary Series,HHS Regions/National,Region 10,2014,Age,19 Months,90.3,87.1 to 92.8,1050
Hib,Primary Series,HHS Regions/National,Region 10,2014-2015,Age,19 Months,90.1,87.8 to 92.1,2042
Hib,Primary Series,HHS Regions/National,Region 10,2019,Age,13 Months,90.8,88.1 to 93.0,1312
Hib,Primary Series,HHS Regions/National,Region 10,2013,Age,19 Months,92.5,90.4 to 94.2,1048
Hib,Primary Series,HHS Regions/National,Region 10,2013-2014,Age,19 Months,91.4,89.5 to 93.0,2098
Hib,Primary Series,HHS Regions/National,Region 10,2011,Age,19 Months,91.7,86.5 to 95.0,1041
Hib,Primary Series,HHS Regions/National,Region 10,2018,Age,13 Months,91.8,89.5 to 93.7,1500
Hib,Primary Series,HHS Regions/National,Region 10,2018-2019,Age,13 Months,91.3,89.6 to 92.8,2812
Hib,Primary Series,HHS Regions/National,Region 10,2016,Age,24 Months,88.5,84.1 to 92.1,875
Hib,Primary Series,HHS Regions/National,Region 10,2016-2017,Age,24 Months,89.7,87.2 to 91.9,2294
Hib,Primary Series,HHS Regions/National,Region 10,2018,Age,24 Months,95.5,93.9 to 96.9,1500
Hib,Primary Series,HHS Regions/National,Region 10,2018-2019,Age,24 Months,95.1,93.8 to 96.1,2812
Hib,Primary Series,HHS Regions/National,Region 10,2017,Age,24 Months,90.9,88.3 to 93.1,1419
Hib,Primary Series,HHS Regions/National,Region 10,2017-2018,Age,24 Months,93.2,91.7 to 94.5,2919
Hib,Primary Series,HHS Regions/National,Region 10,2015,Age,24 Months,90.2,86.8 to 93.1,992
Hib,Primary Series,HHS Regions/National,Region 10,2015-2016,Age,24 Months,89.3,86.6 to 91.7,1867
Hib,Primary Series,HHS Regions/National,Region 10,2014,Age,24 Months,90.9,88.0 to 93.4,1050
Hib,Primary Series,HHS Regions/National,Region 10,2014-2015,Age,24 Months,90.6,88.4 to 92.5,2042
Hib,Primary Series,HHS Regions/National,Region 10,2019,Age,24 Months,94.6,92.7 to 96.2,1312
Hib,Primary Series,HHS Regions/National,Region 10,2011,Age,35 Months,93.4,90.4 to 95.6,1041
Hib,Primary Series,HHS Regions/National,Region 10,2013,Age,35 Months,93.4,90.9 to 95.4,1048
Hib,Primary Series,HHS Regions/National,Region 10,2013-2014,Age,35 Months,92.8,91.0 to 94.4,2098
Hib,Primary Series,HHS Regions/National,Region 10,2012,Age,35 Months,93.7,91.1 to 95.8,977
Hib,Primary Series,HHS Regions/National,Region 10,2013,Age,24 Months,92.9,90.5 to 95.0,1048
Hib,Primary Series,HHS Regions/National,Region 10,2013-2014,Age,24 Months,91.9,90.0 to 93.6,2098
Combined 7 Series,,HHS Regions/National,Region 10,2012,Age,24 Months,66.3,61.3 to 71.2,977
Combined 7 Series,,HHS Regions/National,Region 10,2011,Age,24 Months,64.5,59.5 to 69.5,1041
Combined 7 Series,,HHS Regions/National,Region 10,2013,Age,35 Months,74.5,69.9 to 78.9,1048
Combined 7 Series,,HHS Regions/National,Region 10,2013-2014,Age,35 Months,73.6,70.4 to 76.7,2098
Hib,Primary Series,HHS Regions/National,Region 10,2016,Age,35 Months,89.2,84.8 to 92.8,875
Hib,Primary Series,HHS Regions/National,Region 10,2016-2017,Age,35 Months,90.4,87.9 to 92.5,2294
Combined 7 Series,,HHS Regions/National,Region 10,2014,Age,35 Months,72.8,68.3 to 77.1,1050
Combined 7 Series,,HHS Regions/National,Region 10,2014-2015,Age,35 Months,70.9,67.4 to 74.3,2042
Combined 7 Series,,HHS Regions/National,Region 10,2012,Age,35 Months,74.6,69.4 to 79.5,977
Hib,Primary Series,HHS Regions/National,Region 10,2015,Age,35 Months,91.4,87.7 to 94.3,992
Hib,Primary Series,HHS Regions/National,Region 10,2015-2016,Age,35 Months,90.4,87.6 to 92.8,1867
Hib,Primary Series,HHS Regions/National,Region 10,2019,Age,19 Months,93.9,91.8 to 95.6,1312
Hib,Full Series,HHS Regions/National,Region 10,2014,Age,19 Months,76.6,72.6 to 80.2,1050
Hib,Full Series,HHS Regions/National,Region 10,2014-2015,Age,19 Months,74.8,71.7 to 77.6,2042
Hib,Full Series,HHS Regions/National,Region 10,2015,Age,19 Months,73.0,70.9 to 75.0,992
Hib,Full Series,HHS Regions/National,Region 10,2015-2016,Age,19 Months,73.7,70.2 to 76.9,1867
Hib,Primary Series,HHS Regions/National,Region 10,2017,Age,35 Months,91.5,89.0 to 93.7,1419
Hib,Primary Series,HHS Regions/National,Region 10,2017-2018,Age,35 Months,93.6,92.1 to 94.9,2919
Hib,Full Series,HHS Regions/National,Region 10,2013,Age,19 Months,75.7,72.1 to 78.9,1048
Hib,Full Series,HHS Regions/National,Region 10,2013-2014,Age,19 Months,76.1,73.4 to 78.7,2098
Hib,Full Series,HHS Regions/National,Region 10,2017,Age,19 Months,73.9,70.0 to 77.4,1419
Hib,Full Series,HHS Regions/National,Region 10,2017-2018,Age,19 Months,76.8,74.3 to 79.2,2919
Hib,Full Series,HHS Regions/National,Region 10,2013,Age,24 Months,81.9,78.2 to 85.3,1048
Hib,Full Series,HHS Regions/National,Region 10,2013-2014,Age,24 Months,81.4,78.8 to 83.8,2098
Hib,Full Series,HHS Regions/National,Region 10,2016,Age,19 Months,74.4,69.3 to 78.9,875
Hib,Full Series,HHS Regions/National,Region 10,2016-2017,Age,19 Months,74.1,71.0 to 77.1,2294
Hib,Full Series,HHS Regions/National,Region 10,2018,Age,19 Months,79.8,76.5 to 82.8,1500
Hib,Full Series,HHS Regions/National,Region 10,2018-2019,Age,19 Months,94.7,93.4 to 95.7,2812
Hib,Full Series,HHS Regions/National,Region 10,2011,Age,24 Months,77.0,72.6 to 81.1,1041
Hib,Full Series,HHS Regions/National,Region 10,2012,Age,24 Months,79.7,75.4 to 83.7,977
DTaP,≥3 Doses,HHS Regions/National,Region 10,2020,Age,13 Months,89.2,86.2 to 91.7,1253
Hib,Primary Series,HHS Regions/National,Region 10,2018,Age,19 Months,94.4,92.3 to 95.9,1500
Hib,Primary Series,HHS Regions/National,Region 10,2018-2019,Age,19 Months,91.3,89.6 to 92.8,2812
Hib,Primary Series,HHS Regions/National,Region 10,2013,Age,7 Months,70.6,67.2 to 73.7,1048
Hib,Primary Series,HHS Regions/National,Region 10,2013-2014,Age,7 Months,70.0,66.9 to 72.9,2098
Hib,Primary Series,HHS Regions/National,Region 10,2012,Age,7 Months,73.1,68.5 to 77.2,977
Hib,Primary Series,HHS Regions/National,Region 10,2015,Age,13 Months,85.5,81.3 to 88.8,992
Hib,Primary Series,HHS Regions/National,Region 10,2015-2016,Age,13 Months,85.1,82.0 to 87.7,1867
Hib,Primary Series,HHS Regions/National,Region 10,2014,Age,13 Months,87.0,83.5 to 89.9,1050
Hib,Primary Series,HHS Regions/National,Region 10,2014-2015,Age,13 Months,86.3,83.6 to 88.5,2042
Hib,Primary Series,HHS Regions/National,Region 10,2013,Age,13 Months,88.8,86.1 to 91.0,1048
Hib,Primary Series,HHS Regions/National,Region 10,2013-2014,Age,13 Months,87.9,85.3 to 90.1,2098
Hib,Primary Series,HHS Regions/National,Region 10,2012,Age,13 Months,88.3,86.4 to 89.9,977
Hib,Primary Series,HHS Regions/National,Region 10,2011,Age,13 Months,88.6,84.3 to 91.8,1041
Hib,Primary Series,HHS Regions/National,Region 10,2018,Age,7 Months,78.5,75.0 to 81.6,1500
Hib,Primary Series,HHS Regions/National,Region 10,2018-2019,Age,7 Months,79.2,76.7 to 81.4,2812
Hib,Primary Series,HHS Regions/National,Region 10,2015,Age,7 Months,72.6,67.7 to 77.0,992
Hib,Primary Series,HHS Regions/National,Region 10,2015-2016,Age,7 Months,73.1,69.6 to 76.4,1867
Hib,Primary Series,HHS Regions/National,Region 10,2014,Age,7 Months,69.4,64.9 to 73.5,1050
Hib,Primary Series,HHS Regions/National,Region 10,2014-2015,Age,7 Months,71.0,67.7 to 74.1,2042
Hib,Primary Series,HHS Regions/National,Region 10,2016,Age,7 Months,73.7,68.5 to 78.3,875
Hib,Primary Series,HHS Regions/National,Region 10,2016-2017,Age,7 Months,73.2,70.0 to 76.2,2294
Hib,Primary Series,HHS Regions/National,Region 10,2017,Age,7 Months,72.8,68.8 to 76.4,1419
Hib,Primary Series,HHS Regions/National,Region 10,2017-2018,Age,7 Months,75.6,73.0 to 78.0,2919
Hib,Primary Series,HHS Regions/National,Region 10,2012,Age,24 Months,93.4,90.8 to 95.5,977
Hib,Primary Series,HHS Regions/National,Region 10,2011,Age,24 Months,92.8,90.0 to 95.0,1041
Hib,Primary Series,HHS Regions/National,Region 10,2016,Age,19 Months,87.5,82.7 to 91.0,875
Hib,Primary Series,HHS Regions/National,Region 10,2016-2017,Age,19 Months,88.4,85.7 to 90.7,2294
Hib,Primary Series,HHS Regions/National,Region 10,2015,Age,19 Months,90.0,88.1 to 91.5,992
Hib,Primary Series,HHS Regions/National,Region 10,2015-2016,Age,19 Months,88.7,85.8 to 91.1,1867
Hib,Primary Series,HHS Regions/National,Region 10,2016,Age,13 Months,84.7,79.9 to 88.5,875
Hib,Primary Series,HHS Regions/National,Region 10,2016-2017,Age,13 Months,85.9,83.2 to 88.3,2294
Hib,Primary Series,HHS Regions/National,Region 10,2019,Age,7 Months,79.8,76.3 to 83.0,1312
Hib,Primary Series,HHS Regions/National,Region 10,2017,Age,19 Months,89.4,86.5 to 91.7,1419
Hib,Primary Series,HHS Regions/National,Region 10,2017-2018,Age,19 Months,91.9,90.1 to 93.3,2919
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2019-2020,Age,0-1 Days,76.1,72.6 to 79.2,1097
Hep A,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,19 Months,81.7,78.3 to 84.6,1097
PCV,≥4 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,77.9,74.3 to 81.1,1097
≥1 Dose Varicella,,States/Local Areas,Illinois,2019-2020,Age,19 Months,87.2,84.2 to 89.8,1097
Hep B,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,91.6,89.0 to 93.6,1097
Hib,Full Series,States/Local Areas,Illinois,2019-2020,Age,19 Months,72.2,68.5 to 75.7,1097
Combined 7 Series,,States/Local Areas,Illinois,2019-2020,Age,35 Months,74.7,70.8 to 78.5,1097
Hib,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,55.3,51.4 to 59.2,1097
Hib,Primary Series,States/Local Areas,Illinois,2019-2020,Age,24 Months,92.8,90.4 to 94.7,1097
Hib,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,91.4,88.8 to 93.6,1097
Influenza,,States/Local Areas,Illinois,2019-2020,Age,24 Months,62.7,58.8 to 66.6,1097
Hep A,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,78.4,74.0 to 82.5,1097
Hep A,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,35 Months,92.0,89.1 to 94.3,1097
Hep A,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,24 Months,85.7,82.7 to 88.5,1097
Hep A,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,45.5,41.5 to 49.6,1097
Polio,≥2 Doses,States/Local Areas,Illinois,2020,Age,13 Months,94.8,92.0 to 96.6,549
Polio,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,3 Months,88.0,85.0 to 90.4,1097
DTaP,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,3 Months,88.8,85.9 to 91.2,1097
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,93.2,90.1 to 96.3,435
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.9,83.0 to 94.7,170
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,89.8 to 97.7,273
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,87.1,74.8 to 99.5,34
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.6,82.5 to 88.7,990
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,91.0,88.1 to 93.9,640
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,96.9,95.6 to 98.1,1184
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,61.4,41.0 to 81.8,34
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,82.3 to 88.3,990
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,67.2,47.6 to 86.8,34
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,93.5,85.6 to 100.0,34
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,86.3,82.0 to 90.6,435
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.4,76.7 to 90.2,170
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,81.2,66.3 to 96.2,34
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,90.9,88.1 to 93.7,640
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,72.9,68.5 to 77.3,640
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,91.7,83.1 to 100.0,34
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.2,79.6 to 92.8,170
Influenza,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,75.7,72.3 to 79.2,1184
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.4,94.6 to 98.2,990
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,91.1,87.7 to 94.5,435
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.4,96.1 to 98.7,990
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.8,80.5 to 93.2,170
Influenza,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.3,57.3 to 73.3,273
Influenza,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",44.1,35.2 to 53.0,170
Influenza,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",67.9,63.7 to 72.0,990
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,83.3,78.9 to 87.6,435
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.2,63.0 to 79.5,170
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,82.6,69.2 to 95.9,34
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.8,84.9 to 90.8,990
Rotavirus,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.3,70.5 to 84.2,273
Rotavirus,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,75.1,69.8 to 80.5,435
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,80.8,64.6 to 96.9,34
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.3,65.0 to 79.7,273
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.2,73.6 to 80.7,990
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.8,49.0 to 66.7,170
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,65.9,59.9 to 71.9,435
Rotavirus,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,68.8,64.3 to 73.3,640
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.0,61.7 to 78.2,170
Rotavirus,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,74.7,57.1 to 92.4,34
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,49.3,27.7 to 70.8,34
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.9,68.9 to 82.9,273
Influenza,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,37.4,17.5 to 57.2,34
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,80.7,76.2 to 85.3,435
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,92.7,89.6 to 95.9,435
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.4,78.5 to 90.3,273
Influenza,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,45.0,40.1 to 49.9,640
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,91.6,88.7 to 94.4,640
Rotavirus,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,86.6,83.9 to 89.2,1184
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,93.5,85.6 to 100.0,34
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,97.6,96.5 to 98.8,1184
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,88.6,85.5 to 91.8,640
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,88.0 to 96.8,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,80.4,65.1 to 95.7,34
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,90.3,86.6 to 93.9,435
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.7,82.0 to 93.3,170
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,78.3,74.4 to 82.2,640
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.4,82.3 to 88.5,990
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,78.9,75.8 to 82.0,1184
Rotavirus,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.2,56.6 to 73.7,170
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.2,64.3 to 80.1,170
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.4,90.1 to 94.7,990
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.4,84.0 to 94.7,170
Rotavirus,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.9,80.7 to 87.2,990
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.7,90.4 to 95.0,990
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,72.2 to 81.6,990
Hep A,≥2 Doses,States/Local Areas,Illinois,2020,Age,35 Months,77.3,70.8 to 83.2,549
Combined 7 Series,,States/Local Areas,Illinois,2020,Age,35 Months,75.1,69.6 to 80.3,549
Hep A,≥1 Dose,States/Local Areas,Illinois,2020,Age,19 Months,82.8,78.1 to 86.7,549
Hep A,≥2 Doses,States/Local Areas,Illinois,2020,Age,19 Months,31.4,26.6 to 36.8,549
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2020,Age,0-2 Days,81.2,76.7 to 85.1,549
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2020,Age,0-1 Days,78.4,73.8 to 82.4,549
Hib,≥2 Doses,States/Local Areas,Illinois,2020,Age,7 Months,90.2,86.3 to 93.0,549
Polio,≥2 Doses,States/Local Areas,Illinois,2020,Age,7 Months,91.0,87.2 to 93.8,549
DTaP,≥1 Dose,States/Local Areas,Illinois,2020,Age,3 Months,87.7,83.5 to 91.0,549
Hib,≥3 Doses,States/Local Areas,Illinois,2020,Age,7 Months,55.2,49.7 to 60.5,549
Hib,Primary Series,States/Local Areas,Illinois,2020,Age,7 Months,74.0,69.0 to 78.5,549
Hep B,≥2 Doses,States/Local Areas,Illinois,2020,Age,7 Months,91.6,88.1 to 94.1,549
DTaP,≥3 Doses,States/Local Areas,Illinois,2020,Age,24 Months,93.7,90.5 to 96.0,549
PCV,≥2 Doses,States/Local Areas,Illinois,2020,Age,5 Months,78.0,73.0 to 82.3,549
Polio,≥3 Doses,States/Local Areas,Illinois,2020,Age,24 Months,92.9,89.6 to 95.5,549
DTaP,≥4 Doses,States/Local Areas,Illinois,2020,Age,24 Months,83.0,78.5 to 87.1,549
≥1 Dose MMR,,States/Local Areas,Illinois,2020,Age,24 Months,92.3,88.7 to 95.1,549
Hib,≥3 Doses,States/Local Areas,Illinois,2020,Age,24 Months,92.1,88.4 to 94.9,549
Hib,Primary Series,States/Local Areas,Illinois,2020,Age,24 Months,93.1,89.9 to 95.6,549
≥1 Dose MMR,,States/Local Areas,Illinois,2020,Age,35 Months,96.0,93.1 to 97.9,549
Hib,≥3 Doses,States/Local Areas,Illinois,2020,Age,35 Months,93.8,90.5 to 96.2,549
Hib,Primary Series,States/Local Areas,Illinois,2020,Age,35 Months,95.2,92.4 to 97.2,549
Hib,Full Series,States/Local Areas,Illinois,2020,Age,35 Months,81.0,76.1 to 85.3,549
Hep B,≥3 Doses,States/Local Areas,Illinois,2020,Age,35 Months,94.0,90.5 to 96.5,549
≥1 Dose Varicella,,States/Local Areas,Illinois,2020,Age,35 Months,96.0,93.2 to 97.9,549
Hib,Primary Series,States/Local Areas,Illinois,2020,Age,19 Months,91.1,87.4 to 93.9,549
Hib,Full Series,States/Local Areas,Illinois,2020,Age,19 Months,72.7,67.5 to 77.4,549
Hep B,≥3 Doses,States/Local Areas,Illinois,2020,Age,19 Months,90.7,86.9 to 93.4,549
PCV,≥3 Doses,States/Local Areas,Illinois,2020,Age,19 Months,90.7,86.8 to 93.4,549
≥1 Dose Varicella,,States/Local Areas,Illinois,2020,Age,19 Months,88.8,84.4 to 92.0,549
DTaP,≥4 Doses,States/Local Areas,Illinois,2020,Age,35 Months,91.9,86.8 to 95.6,549
Polio,≥3 Doses,States/Local Areas,Illinois,2020,Age,35 Months,94.6,91.5 to 96.8,549
PCV,≥4 Doses,States/Local Areas,Illinois,2020,Age,19 Months,78.5,73.5 to 82.7,549
PCV,≥4 Doses,States/Local Areas,Illinois,2020,Age,35 Months,84.8,80.1 to 88.8,549
PCV,≥3 Doses,States/Local Areas,Illinois,2020,Age,35 Months,93.7,90.5 to 96.1,549
Hib,Primary Series,States/Local Areas,Illinois,2020,Age,13 Months,83.4,78.7 to 87.2,549
Hib,≥3 Doses,States/Local Areas,Illinois,2020,Age,13 Months,68.3,63.0 to 73.2,549
Hep B,≥2 Doses,States/Local Areas,Illinois,2020,Age,13 Months,95.3,92.7 to 97.0,549
Hep B,≥3 Doses,States/Local Areas,Illinois,2020,Age,13 Months,87.0,82.8 to 90.3,549
≥1 Dose Varicella,,States/Local Areas,Illinois,2020,Age,13 Months,61.6,56.2 to 66.7,549
PCV,≥3 Doses,States/Local Areas,Illinois,2020,Age,13 Months,87.1,82.7 to 90.5,549
DTaP,≥3 Doses,States/Local Areas,Illinois,2020,Age,7 Months,74.4,69.2 to 78.9,549
DTaP,≥3 Doses,States/Local Areas,Illinois,2020,Age,19 Months,92.0,88.4 to 94.6,549
DTaP,≥4 Doses,States/Local Areas,Illinois,2020,Age,19 Months,72.9,67.6 to 77.6,549
≥1 Dose MMR,,States/Local Areas,Illinois,2020,Age,19 Months,88.8,84.5 to 92.0,549
Polio,≥3 Doses,States/Local Areas,Illinois,2020,Age,19 Months,91.3,87.5 to 94.1,549
Hib,≥3 Doses,States/Local Areas,Illinois,2020,Age,19 Months,88.3,84.0 to 91.6,549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2020,Age,0-3 Days,82.7,78.2 to 86.4,549
Rotavirus,,States/Local Areas,Illinois,2020,Age,8 Months,77.5,72.5 to 81.8,549
Influenza,,States/Local Areas,Illinois,2020,Age,24 Months,60.1,54.7 to 65.7,549
DTaP,≥3 Doses,States/Local Areas,Illinois,2020,Age,35 Months,95.9,93.3 to 97.7,549
PCV,≥3 Doses,States/Local Areas,Illinois,2020,Age,24 Months,91.7,88.3 to 94.5,549
PCV,≥4 Doses,States/Local Areas,Illinois,2020,Age,24 Months,81.7,77.1 to 85.8,549
Hep A,≥2 Doses,States/Local Areas,Illinois,2020,Age,24 Months,46.5,41.2 to 52.2,549
Hep A,≥1 Dose,States/Local Areas,Illinois,2020,Age,24 Months,86.8,82.5 to 90.5,549
Combined 7 Series,,States/Local Areas,Illinois,2020,Age,24 Months,69.7,64.5 to 74.7,549
Hep B,≥1 Dose,States/Local Areas,Illinois,2020,Age,3 Months,96.4,94.0 to 97.8,549
PCV,≥1 Dose,States/Local Areas,Illinois,2020,Age,3 Months,86.2,82.0 to 89.6,549
DTaP,≥2 Doses,States/Local Areas,Illinois,2020,Age,5 Months,80.0,75.0 to 84.2,549
Polio,≥2 Doses,States/Local Areas,Illinois,2020,Age,5 Months,79.0,74.0 to 83.3,549
Hib,≥2 Doses,States/Local Areas,Illinois,2020,Age,5 Months,76.9,71.8 to 81.3,549
Hep B,≥2 Doses,States/Local Areas,Illinois,2020,Age,5 Months,89.6,85.8 to 92.5,549
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,58.6,45.0 to 72.2,128
Hib,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,3 Months,86.3,83.3 to 88.9,1097
Rotavirus,,States/Local Areas,Illinois,2019-2020,Age,8 Months,78.1,74.6 to 81.3,1097
PCV,≥3 Doses,States/Local Areas,Illinois,2020,Age,7 Months,71.1,65.9 to 75.9,549
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.1,93.4 to 96.9,990
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,80.5,74.4 to 86.5,846
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,88.2 to 93.7,846
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,83.5,80.0 to 87.1,846
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,90.6 to 95.0,894
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,88.3,85.8 to 90.7,1184
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.5,80.5 to 92.4,170
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,79.5,76.3 to 82.7,1184
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.2,87.9 to 96.5,273
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,95.0,92.9 to 97.1,846
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,93.8,88.5 to 99.1,128
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,93.0 to 97.0,894
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,78.5,69.4 to 87.6,128
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.6,79.2 to 86.0,894
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,89.7,82.6 to 96.8,128
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,90.7 to 95.3,846
Hib,Primary Series,States/Local Areas,Illinois,2019-2020,Age,7 Months,73.2,69.5 to 76.6,1097
DTaP,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,89.9,87.0 to 92.2,1097
Polio,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,91.5,88.8 to 93.5,1097
DTaP,≥4 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,71.8,68.1 to 75.3,1097
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,93.0,89.9 to 96.0,435
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,62.9,42.8 to 83.0,34
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.6,52.5 to 70.8,151
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.1,89.9 to 94.4,894
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,80.6,76.8 to 84.4,846
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.8,81.6 to 87.9,894
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,80.7,71.9 to 89.5,128
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,67.0,56.6 to 77.5,128
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.1,68.2 to 76.0,894
Influenza,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,64.0,59.4 to 68.6,846
Influenza,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,62.3,58.0 to 66.5,894
Rotavirus,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.6,75.0 to 82.2,894
Rotavirus,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,78.5,74.6 to 82.4,846
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,73.4,63.3 to 83.4,128
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,88.3,85.3 to 91.3,846
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.2,83.2 to 89.3,894
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,79.1,75.2 to 83.0,846
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.1,77.7 to 84.5,894
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,80.4,71.8 to 89.0,128
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,89.6 to 94.3,894
Rotavirus,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,74.6,64.8 to 84.5,128
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.3,69.6 to 79.1,894
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,58.6,37.7 to 79.5,34
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,62.2,57.4 to 67.0,640
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",98.0,96.7 to 99.3,990
Rotavirus,,States/Local Areas,Illinois,2016-2019,Overall,Overall,78.2,75.7 to 80.8,1868
Influenza,,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,81.5,77.4 to 85.5,802
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,77.1,72.4 to 81.8,485
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,92.2,89.8 to 94.7,802
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,79.5,75.2 to 83.7,581
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,71.9,66.8 to 77.0,485
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,89.3,86.4 to 92.2,802
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,90.6,87.2 to 94.0,485
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,81.5,79.0 to 83.9,1868
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,88.9,85.3 to 92.5,485
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,80.6,76.4 to 84.8,581
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,91.2,88.7 to 93.7,802
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,88.8,85.2 to 92.4,485
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,90.2,87.1 to 93.4,581
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,96.0,94.2 to 97.9,802
Influenza,,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,46.0,40.4 to 51.6,485
Influenza,,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,54.5,49.1 to 59.9,581
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,93.0,91.4 to 94.5,1868
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,94.9,93.4 to 96.3,1868
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,91.1,87.7 to 94.4,485
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,89.8,86.5 to 93.0,581
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,95.4,93.5 to 97.4,802
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,68.7,60.1 to 77.2,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,79.9,75.8 to 84.0,581
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,79.0,74.9 to 83.1,802
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,81.5,77.3 to 85.7,581
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,92.9,90.5 to 95.4,802
Rotavirus,,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,76.5,71.7 to 81.3,581
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,89.1 to 94.5,846
Rotavirus,,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,69.9,64.9 to 74.9,485
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,92.6,86.2 to 98.9,128
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,93.7,91.4 to 96.0,846
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.2,90.8 to 95.5,894
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,93.8,87.8 to 99.7,128
Influenza,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,35.5,25.3 to 45.8,128
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,94.2,92.0 to 96.5,846
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.2,92.1 to 96.3,894
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,94.3,89.2 to 99.4,128
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,70.3,65.9 to 74.8,846
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Principal City,78.7,75.0 to 82.3,846
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,94.7,92.3 to 97.1,581
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,97.4,96.1 to 98.7,802
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.7,75.2 to 82.2,894
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,81.1,72.4 to 89.8,128
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Urbanicity,Living In a Non-MSA,88.5,81.0 to 95.9,128
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Overall,Overall,71.0,68.2 to 73.8,1868
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Overall,Overall,80.3,77.8 to 82.7,1868
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,91.9,88.9 to 94.9,581
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,95.9,94.4 to 97.5,802
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,77.8,73.3 to 82.3,485
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,59.7,54.0 to 65.4,485
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,95.3,93.0 to 97.7,581
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,69.0,64.1 to 73.8,581
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,98.2,97.1 to 99.3,802
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Overall,Overall,91.7,90.0 to 93.4,1868
Combined 7 Series,,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,84.0,80.7 to 87.4,802
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,75.9,72.2 to 79.7,1868
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,91.0,87.8 to 94.1,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Overall,Overall,78.9,76.4 to 81.3,1868
Influenza,,States/Local Areas,Illinois,2016-2019,Overall,Overall,60.8,57.8 to 63.9,1868
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,89.3,85.7 to 92.8,485
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,93.6,90.8 to 96.3,581
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,71.0,64.8 to 77.1,581
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,89.0,84.9 to 93.1,802
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,83.9,79.7 to 88.0,485
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,83.9,81.7 to 86.2,1868
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Poverty,133% to <400% FPL,81.8,77.6 to 86.0,581
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Overall,Overall,91.4,89.7 to 93.1,1868
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,93.3,91.7 to 94.9,1868
Rotavirus,,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,87.8,84.6 to 91.0,802
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Overall,Overall,86.1,83.9 to 88.2,1868
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Overall,Overall,94.2,92.7 to 95.7,1868
Influenza,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,54.3,48.1 to 60.6,435
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,91.5,88.2 to 94.9,435
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,89.5,86.5 to 92.5,640
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Uninsured,93.5,85.6 to 100.0,34
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.7 to 95.5,1184
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,75.6 to 88.2,273
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,79.3,74.3 to 84.3,435
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.4,62.2 to 78.7,170
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.6,88.1 to 97.2,273
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,94.7,93.0 to 96.3,1184
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,69.5,62.8 to 76.2,640
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,83.1,79.2 to 86.9,1184
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,95.0,93.4 to 96.6,1184
Polio,≥1 Dose,States/Local Areas,Illinois,2020,Age,3 Months,86.9,82.7 to 90.2,549
Hib,≥1 Dose,States/Local Areas,Illinois,2020,Age,3 Months,84.5,80.1 to 88.0,549
Hep B,≥3 Doses,States/Local Areas,Illinois,2020,Age,7 Months,58.7,53.3 to 63.9,549
Combined 7 Series,,States/Local Areas,Illinois,2014,Age,35 Months,77.3,71.8 to 82.3,493
Combined 7 Series,,States/Local Areas,Illinois,2014-2015,Age,35 Months,77.3,73.1 to 81.2,960
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,72.2,66.5 to 77.9,408
Combined 7 Series,,States/Local Areas,Illinois,2018,Age,35 Months,76.9,71.1 to 82.2,542
Combined 7 Series,,States/Local Areas,Illinois,2018-2019,Age,35 Months,75.5,71.4 to 79.3,1090
Combined 7 Series,,States/Local Areas,Illinois,2019,Age,35 Months,74.0,68.3 to 79.5,548
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,70.0,65.5 to 74.4,624
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,77.4,74.1 to 80.7,1043
Combined 7 Series,,States/Local Areas,Illinois,2015,Age,35 Months,77.6,71.1 to 83.6,467
Combined 7 Series,,States/Local Areas,Illinois,2015-2016,Age,35 Months,77.2,73.0 to 81.2,951
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,72.8,68.5 to 77.2,751
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.9,70.3 to 77.6,850
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.9,74.6 to 81.1,930
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.7,66.4 to 81.0,231
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Overall,Overall,73.7,71.0 to 76.3,1720
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,76.3,67.3 to 85.2,119
Polio,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,94.3,92.0 to 96.2,1097
DTaP,≥4 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,91.2,87.1 to 94.4,1097
Combined 7 Series,,States/Local Areas,Illinois,2019-2020,Age,24 Months,69.0,65.2 to 72.7,1097
DTaP,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,92.5,89.9 to 94.4,1097
DTaP,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,95.0,92.8 to 96.8,1097
PCV,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,87.9,84.8 to 90.4,1097
≥1 Dose Varicella,,States/Local Areas,Illinois,2019-2020,Age,13 Months,59.0,55.1 to 62.7,1097
Hep B,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,87.9,85.1 to 90.3,1097
Hib,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,89.2,86.2 to 91.6,1097
Polio,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,89.7,86.7 to 92.1,1097
DTaP,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,72.4,68.7 to 75.9,1097
PCV,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,5 Months,78.0,74.4 to 81.2,1097
Hep B,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,5 Months,89.8,87.1 to 92.0,1097
Hib,Primary Series,States/Local Areas,Illinois,2019-2020,Age,13 Months,85.7,82.6 to 88.3,1097
Hep B,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,95.3,93.4 to 96.7,1097
Hib,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,93.6,91.3 to 95.4,1097
Hib,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,71.1,67.4 to 74.6,1097
≥1 Dose MMR,,States/Local Areas,Illinois,2019-2020,Age,13 Months,67.2,63.4 to 70.9,1097
Polio,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,13 Months,94.1,91.9 to 95.8,1097
Hib,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,5 Months,77.2,73.6 to 80.4,1097
Polio,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,5 Months,79.3,75.7 to 82.4,1097
DTaP,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,5 Months,80.0,76.5 to 83.1,1097
PCV,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,3 Months,87.1,84.0 to 89.6,1097
Hep B,≥1 Dose,States/Local Areas,Illinois,2019-2020,Age,3 Months,96.4,94.7 to 97.5,1097
≥1 Dose MMR,,States/Local Areas,Illinois,2019-2020,Age,24 Months,89.6,86.9 to 92.0,1097
Polio,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,92.8,90.4 to 94.8,1097
DTaP,≥4 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,81.8,78.4 to 84.9,1097
DTaP,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,93.6,91.3 to 95.5,1097
PCV,≥4 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,85.0,81.4 to 88.2,1097
PCV,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,93.5,91.0 to 95.5,1097
≥1 Dose Varicella,,States/Local Areas,Illinois,2019-2020,Age,35 Months,94.3,91.8 to 96.3,1097
Hep B,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,93.5,91.0 to 95.5,1097
Hib,Primary Series,States/Local Areas,Illinois,2019-2020,Age,35 Months,94.1,91.8 to 95.9,1097
Hib,Full Series,States/Local Areas,Illinois,2019-2020,Age,35 Months,81.6,78.0 to 84.9,1097
≥1 Dose MMR,,States/Local Areas,Illinois,2019-2020,Age,35 Months,94.5,91.9 to 96.4,1097
Hib,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,35 Months,92.7,90.1 to 94.7,1097
Hib,Primary Series,States/Local Areas,Illinois,2019-2020,Age,19 Months,91.5,89.0 to 93.6,1097
Hib,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,88.1,85.2 to 90.6,1097
≥1 Dose MMR,,States/Local Areas,Illinois,2019-2020,Age,19 Months,87.6,84.6 to 90.1,1097
Hep A,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,29.1,25.7 to 32.7,1097
PCV,≥4 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,81.1,77.7 to 84.2,1097
PCV,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,91.6,89.1 to 93.8,1097
Hib,Full Series,States/Local Areas,Illinois,2019-2020,Age,24 Months,77.9,74.4 to 81.2,1097
PCV,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,69.4,65.6 to 72.9,1097
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2019-2020,Age,0-3 Days,81.7,78.5 to 84.5,1097
≥1 Dose Varicella,,States/Local Areas,Illinois,2019-2020,Age,24 Months,89.8,87.1 to 92.2,1097
Hep B,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,24 Months,92.1,89.7 to 94.1,1097
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2019-2020,Age,0-2 Days,80.3,77.0 to 83.2,1097
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,67.7,62.6 to 72.9,515
Hib,Full Series,States/Local Areas,Illinois,2013,Age,19 Months,77.3,72.1 to 81.7,537
Hib,Full Series,States/Local Areas,Illinois,2013-2014,Age,19 Months,77.2,73.8 to 80.4,1030
Hib,Full Series,States/Local Areas,Illinois,2012,Age,19 Months,72.9,69.9 to 75.7,543
Hib,Full Series,States/Local Areas,Illinois,2011,Age,19 Months,73.7,70.6 to 76.5,583
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,83.2,79.7 to 86.7,686
Combined 7 Series,,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,70.2,65.5 to 74.9,519
Hib,Full Series,States/Local Areas,Illinois,2014,Age,24 Months,82.9,78.4 to 86.9,493
Hib,Full Series,States/Local Areas,Illinois,2014-2015,Age,24 Months,81.5,78.1 to 84.7,960
Hib,Full Series,States/Local Areas,Illinois,2013,Age,24 Months,82.3,78.0 to 86.2,537
Hib,Full Series,States/Local Areas,Illinois,2013-2014,Age,24 Months,82.6,79.6 to 85.5,1030
Hib,Full Series,States/Local Areas,Illinois,2011,Age,24 Months,83.0,78.7 to 86.9,583
Hib,Full Series,States/Local Areas,Illinois,2012,Age,24 Months,77.7,72.6 to 82.5,543
Hib,Full Series,States/Local Areas,Illinois,2017,Age,19 Months,77.1,71.9 to 81.5,502
Hib,Full Series,States/Local Areas,Illinois,2017-2018,Age,19 Months,73.9,70.2 to 77.3,1044
≥1 Dose MMR,,States/Local Areas,Illinois,2020,Age,13 Months,69.0,63.7 to 73.8,549
Hib,Full Series,States/Local Areas,Illinois,2018,Age,19 Months,70.6,65.2 to 75.5,542
Hib,Full Series,States/Local Areas,Illinois,2018-2019,Age,19 Months,95.6,93.7 to 97.0,1090
Hib,Full Series,States/Local Areas,Illinois,2019,Age,19 Months,71.8,66.3 to 76.6,548
Hib,Full Series,States/Local Areas,Illinois,2014,Age,19 Months,77.2,72.1 to 81.7,493
Hib,Full Series,States/Local Areas,Illinois,2014-2015,Age,19 Months,75.3,71.5 to 78.7,960
Hib,Full Series,States/Local Areas,Illinois,2015,Age,19 Months,73.4,68.4 to 77.8,467
Hib,Full Series,States/Local Areas,Illinois,2015-2016,Age,19 Months,74.2,70.2 to 77.9,951
Hib,Full Series,States/Local Areas,Illinois,2016,Age,19 Months,75.0,69.3 to 80.0,484
Hib,Full Series,States/Local Areas,Illinois,2016-2017,Age,19 Months,76.0,72.2 to 79.4,986
Combined 7 Series,,States/Local Areas,Illinois,2014,Age,24 Months,73.2,68.2 to 78.0,493
Combined 7 Series,,States/Local Areas,Illinois,2014-2015,Age,24 Months,72.6,68.8 to 76.3,960
Hib,Primary Series,States/Local Areas,Illinois,2015,Age,35 Months,94.8,91.9 to 96.9,467
Hib,Primary Series,States/Local Areas,Illinois,2015-2016,Age,35 Months,96.0,94.1 to 97.4,951
Hep B,≥2 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,92.0,89.5 to 94.0,1097
Rotavirus,,States/Local Areas,Illinois,2019,Age,8 Months,78.5,73.2 to 83.0,548
Combined 7 Series,,States/Local Areas,Illinois,2019,Age,24 Months,68.1,62.6 to 73.5,548
Hib,Primary Series,States/Local Areas,Illinois,2019,Age,35 Months,93.0,89.2 to 95.8,548
Combined 7 Series,,States/Local Areas,Illinois,2016,Age,24 Months,73.2,67.7 to 78.4,484
Combined 7 Series,,States/Local Areas,Illinois,2016-2017,Age,24 Months,72.3,68.4 to 76.1,986
Hib,Primary Series,States/Local Areas,Illinois,2018,Age,35 Months,94.3,91.2 to 96.5,542
Hib,Primary Series,States/Local Areas,Illinois,2018-2019,Age,35 Months,93.5,91.2 to 95.4,1090
Combined 7 Series,,States/Local Areas,Illinois,2015,Age,24 Months,72.1,66.4 to 77.6,467
Combined 7 Series,,States/Local Areas,Illinois,2015-2016,Age,24 Months,72.6,68.6 to 76.4,951
Combined 7 Series,,States/Local Areas,Illinois,2012,Age,35 Months,71.6,65.8 to 77.2,543
Combined 7 Series,,States/Local Areas,Illinois,2013,Age,35 Months,75.9,70.4 to 81.1,537
Combined 7 Series,,States/Local Areas,Illinois,2013-2014,Age,35 Months,76.5,72.6 to 80.1,1030
Rotavirus,,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,89.1,86.1 to 92.2,686
Rotavirus,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.6,70.5 to 84.6,231
Rotavirus,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,75.8,70.8 to 80.8,408
Rotavirus,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,68.5,64.1 to 72.9,624
Rotavirus,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.6,49.6 to 67.7,151
Rotavirus,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,76.9,72.9 to 81.0,751
Rotavirus,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.9,79.9 to 86.0,930
Rotavirus,,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,68.6,63.8 to 73.4,515
Rotavirus,,States/Local Areas,Illinois,2014-2017,Overall,Overall,77.2,74.7 to 79.7,1720
Rotavirus,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.8,74.3 to 81.3,850
Rotavirus,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,74.5,64.9 to 84.1,119
Rotavirus,,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,74.0,69.2 to 78.8,519
Rotavirus,,States/Local Areas,Illinois,2013,Age,8 Months,76.4,71.2 to 80.9,537
Rotavirus,,States/Local Areas,Illinois,2013-2014,Age,8 Months,75.8,72.1 to 79.1,1030
Rotavirus,,States/Local Areas,Illinois,2012,Age,8 Months,69.8,64.3 to 74.7,543
Rotavirus,,States/Local Areas,Illinois,2014,Age,8 Months,75.2,69.8 to 79.9,493
Rotavirus,,States/Local Areas,Illinois,2014-2015,Age,8 Months,73.8,70.0 to 77.4,960
Rotavirus,,States/Local Areas,Illinois,2015,Age,8 Months,72.5,66.7 to 77.6,467
Rotavirus,,States/Local Areas,Illinois,2015-2016,Age,8 Months,74.2,70.1 to 77.9,951
Rotavirus,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,67.8,49.0 to 86.5,34
Rotavirus,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,85.0,82.1 to 87.8,1043
Rotavirus,,States/Local Areas,Illinois,2018,Age,8 Months,76.7,71.5 to 81.2,542
Rotavirus,,States/Local Areas,Illinois,2018-2019,Age,8 Months,77.6,74.0 to 80.8,1090
Rotavirus,,States/Local Areas,Illinois,2011,Age,8 Months,73.4,67.9 to 78.2,583
Rotavirus,,States/Local Areas,Illinois,2017,Age,8 Months,75.3,70.0 to 80.0,502
Rotavirus,,States/Local Areas,Illinois,2017-2018,Age,8 Months,76.0,72.3 to 79.3,1044
Rotavirus,,States/Local Areas,Illinois,2016,Age,8 Months,75.8,70.0 to 80.9,484
Rotavirus,,States/Local Areas,Illinois,2016-2017,Age,8 Months,75.6,71.7 to 79.1,986
Hep B,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,7 Months,57.9,54.0 to 61.7,1097
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Poverty,>400% FPL,97.0,95.4 to 98.6,802
Hib,Primary Series,States/Local Areas,Illinois,2013,Age,7 Months,71.5,70.1 to 72.9,537
Hib,Primary Series,States/Local Areas,Illinois,2013-2014,Age,7 Months,74.2,72.9 to 75.4,1030
Hib,Primary Series,States/Local Areas,Illinois,2014,Age,7 Months,76.9,72.0 to 81.2,493
Hib,Primary Series,States/Local Areas,Illinois,2014-2015,Age,7 Months,73.9,70.2 to 77.4,960
Hib,Primary Series,States/Local Areas,Illinois,2015,Age,7 Months,71.0,65.2 to 76.2,467
Hib,Primary Series,States/Local Areas,Illinois,2015-2016,Age,7 Months,73.1,69.1 to 76.8,951
Hib,Primary Series,States/Local Areas,Illinois,2016,Age,7 Months,75.2,69.5 to 80.1,484
Hib,Primary Series,States/Local Areas,Illinois,2016-2017,Age,7 Months,76.2,72.3 to 79.6,986
Hib,Primary Series,States/Local Areas,Illinois,2017,Age,7 Months,77.2,72.1 to 81.6,502
Hib,Primary Series,States/Local Areas,Illinois,2017-2018,Age,7 Months,75.5,71.9 to 78.7,1044
Combined 7 Series,,States/Local Areas,Illinois,2017,Age,35 Months,76.0,70.3 to 81.3,502
Combined 7 Series,,States/Local Areas,Illinois,2017-2018,Age,35 Months,76.2,72.2 to 80.0,1044
Combined 7 Series,,States/Local Areas,Illinois,2016,Age,35 Months,77.2,71.7 to 82.3,484
Combined 7 Series,,States/Local Areas,Illinois,2016-2017,Age,35 Months,76.6,72.6 to 80.4,986
Combined 7 Series,,States/Local Areas,Illinois,2011,Age,35 Months,71.6,65.6 to 77.3,583
Combined 7 Series,,States/Local Areas,Illinois,2018,Age,24 Months,68.5,63.2 to 73.7,542
Combined 7 Series,,States/Local Areas,Illinois,2018-2019,Age,24 Months,68.3,64.5 to 72.1,1090
Combined 7 Series,,States/Local Areas,Illinois,2017,Age,24 Months,71.4,66.0 to 76.7,502
Combined 7 Series,,States/Local Areas,Illinois,2017-2018,Age,24 Months,70.0,66.2 to 73.7,1044
Combined 7 Series,,States/Local Areas,Illinois,2013,Age,24 Months,68.8,63.5 to 74.1,537
Combined 7 Series,,States/Local Areas,Illinois,2013-2014,Age,24 Months,71.0,67.3 to 74.6,1030
Hib,Primary Series,States/Local Areas,Illinois,2016,Age,35 Months,97.2,94.6 to 98.8,484
Hib,Primary Series,States/Local Areas,Illinois,2016-2017,Age,35 Months,95.6,93.6 to 97.1,986
Hib,Primary Series,States/Local Areas,Illinois,2017,Age,35 Months,93.8,90.6 to 96.2,502
Hib,Primary Series,States/Local Areas,Illinois,2017-2018,Age,35 Months,94.0,91.9 to 95.7,1044
Combined 7 Series,,States/Local Areas,Illinois,2011,Age,24 Months,64.5,58.8 to 70.1,583
Combined 7 Series,,States/Local Areas,Illinois,2012,Age,24 Months,63.4,57.9 to 69.0,543
Hib,Primary Series,States/Local Areas,Illinois,2013,Age,35 Months,96.4,92.9 to 98.5,537
Hib,Primary Series,States/Local Areas,Illinois,2013-2014,Age,35 Months,95.0,92.9 to 96.6,1030
Hib,Primary Series,States/Local Areas,Illinois,2011,Age,35 Months,96.7,94.3 to 98.2,583
Hib,Primary Series,States/Local Areas,Illinois,2014,Age,35 Months,94.2,91.0 to 96.5,493
Hib,Primary Series,States/Local Areas,Illinois,2014-2015,Age,35 Months,94.5,92.4 to 96.2,960
Hib,Primary Series,States/Local Areas,Illinois,2012,Age,35 Months,92.3,88.3 to 95.4,543
Hib,Primary Series,States/Local Areas,Illinois,2014,Age,24 Months,93.9,90.7 to 96.2,493
Hib,Primary Series,States/Local Areas,Illinois,2014-2015,Age,24 Months,94.2,92.2 to 95.9,960
Hib,Primary Series,States/Local Areas,Illinois,2015,Age,24 Months,94.6,91.7 to 96.8,467
Hib,Primary Series,States/Local Areas,Illinois,2015-2016,Age,24 Months,95.6,93.7 to 97.1,951
Hib,Primary Series,States/Local Areas,Illinois,2018,Age,24 Months,94.1,91.0 to 96.4,542
Hib,Primary Series,States/Local Areas,Illinois,2018-2019,Age,24 Months,93.3,91.0 to 95.2,1090
Hib,Primary Series,States/Local Areas,Illinois,2017,Age,24 Months,92.9,89.5 to 95.5,502
Hib,Primary Series,States/Local Areas,Illinois,2017-2018,Age,24 Months,93.5,91.3 to 95.3,1044
Hib,Primary Series,States/Local Areas,Illinois,2016,Age,24 Months,96.5,93.8 to 98.3,484
Hib,Primary Series,States/Local Areas,Illinois,2016-2017,Age,24 Months,94.8,92.7 to 96.4,986
Hib,Primary Series,States/Local Areas,Illinois,2019,Age,24 Months,92.5,88.8 to 95.3,548
Hib,Primary Series,States/Local Areas,Illinois,2016,Age,13 Months,90.9,86.7 to 93.8,484
Hib,Primary Series,States/Local Areas,Illinois,2016-2017,Age,13 Months,90.0,87.1 to 92.2,986
Hib,Primary Series,States/Local Areas,Illinois,2017,Age,13 Months,89.0,84.7 to 92.2,502
Hib,Primary Series,States/Local Areas,Illinois,2017-2018,Age,13 Months,89.2,86.4 to 91.5,1044
Hib,Primary Series,States/Local Areas,Illinois,2011,Age,19 Months,94.7,92.2 to 96.4,583
Hib,Primary Series,States/Local Areas,Illinois,2018,Age,13 Months,89.4,85.5 to 92.3,542
Hib,Primary Series,States/Local Areas,Illinois,2018-2019,Age,13 Months,88.7,85.8 to 91.0,1090
Hib,Primary Series,States/Local Areas,Illinois,2019,Age,13 Months,87.9,83.4 to 91.4,548
Hib,Primary Series,States/Local Areas,Illinois,2013,Age,19 Months,94.3,92.9 to 95.4,537
Hib,Primary Series,States/Local Areas,Illinois,2013-2014,Age,19 Months,93.8,92.7 to 94.8,1030
Hib,Primary Series,States/Local Areas,Illinois,2012,Age,19 Months,89.1,86.1 to 91.6,543
Hib,Primary Series,States/Local Areas,Illinois,2014,Age,19 Months,93.4,90.0 to 95.7,493
Hib,Primary Series,States/Local Areas,Illinois,2014-2015,Age,19 Months,93.8,91.5 to 95.4,960
Hib,Primary Series,States/Local Areas,Illinois,2017,Age,19 Months,92.2,88.4 to 94.8,502
Hib,Primary Series,States/Local Areas,Illinois,2017-2018,Age,19 Months,92.6,90.2 to 94.5,1044
Hib,Primary Series,States/Local Areas,Illinois,2018,Age,19 Months,93.1,89.6 to 95.4,542
Hib,Primary Series,States/Local Areas,Illinois,2018-2019,Age,19 Months,88.7,85.8 to 91.0,1090
Hib,Primary Series,States/Local Areas,Illinois,2016,Age,19 Months,95.1,91.5 to 97.2,484
Hib,Primary Series,States/Local Areas,Illinois,2016-2017,Age,19 Months,93.7,91.2 to 95.4,986
Hib,Primary Series,States/Local Areas,Illinois,2019,Age,19 Months,92.0,88.0 to 94.7,548
Hib,Primary Series,States/Local Areas,Illinois,2014,Age,13 Months,90.9,87.2 to 93.7,493
Hib,Primary Series,States/Local Areas,Illinois,2014-2015,Age,13 Months,88.6,85.6 to 91.1,960
Hib,Primary Series,States/Local Areas,Illinois,2015,Age,13 Months,86.3,81.3 to 90.1,467
Hib,Primary Series,States/Local Areas,Illinois,2015-2016,Age,13 Months,88.6,85.4 to 91.2,951
Hib,Primary Series,States/Local Areas,Illinois,2015,Age,19 Months,94.1,88.4 to 97.1,467
Hib,Primary Series,States/Local Areas,Illinois,2015-2016,Age,19 Months,94.6,92.4 to 96.2,951
Hib,Primary Series,States/Local Areas,Illinois,2012,Age,24 Months,90.9,87.2 to 93.9,543
Hib,Primary Series,States/Local Areas,Illinois,2011,Age,24 Months,95.3,92.9 to 97.0,583
Hib,Primary Series,States/Local Areas,Illinois,2013,Age,24 Months,94.6,91.9 to 96.7,537
Hib,Primary Series,States/Local Areas,Illinois,2013-2014,Age,24 Months,94.2,92.2 to 95.9,1030
Hib,Primary Series,States/Local Areas,Illinois,2013,Age,13 Months,89.7,88.0 to 91.3,537
Hib,Primary Series,States/Local Areas,Illinois,2013-2014,Age,13 Months,90.3,89.3 to 91.3,1030
Hib,Primary Series,States/Local Areas,Illinois,2012,Age,13 Months,83.2,81.1 to 85.2,543
Hib,Primary Series,States/Local Areas,Illinois,2011,Age,13 Months,91.2,89.4 to 92.8,583
Hib,Primary Series,States/Local Areas,Illinois,2019,Age,7 Months,72.6,67.1 to 77.4,548
Hib,Primary Series,States/Local Areas,Illinois,2018,Age,7 Months,73.7,68.5 to 78.2,542
Hib,Primary Series,States/Local Areas,Illinois,2018-2019,Age,7 Months,73.1,69.4 to 76.5,1090
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2019,Poverty,<133% FPL,72.3,67.2 to 77.5,485
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,76.3,72.1 to 80.4,640
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,76.4,71.1 to 81.6,435
Hib,Full Series,States/Local Areas,Illinois,2020-2021,Age,24 Months,76.7,72.5 to 80.7,918
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,89.5 to 97.4,273
Hib,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,5 Months,75.2,70.8 to 79.0,918
Polio,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,93.2,90.4 to 95.3,918
≥1 Dose MMR,,States/Local Areas,Illinois,2020-2021,Age,13 Months,66.0,61.5 to 70.1,918
DTaP,≥2 Doses,States/Local Areas,Illinois,2021,Age,5 Months,76.4,69.3 to 82.3,369
Polio,≥2 Doses,States/Local Areas,Illinois,2021,Age,5 Months,74.3,67.1 to 80.4,369
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.8,89.8 to 97.7,273
≥1 Dose Varicella,,States/Local Areas,Illinois,2020-2021,Age,19 Months,86.8,83.0 to 89.9,918
Hib,Primary Series,States/Local Areas,Illinois,2020-2021,Age,19 Months,91.1,87.9 to 93.5,918
DTaP,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,3 Months,87.3,83.8 to 90.1,918
Influenza,,States/Local Areas,Illinois,2019,Age,24 Months,65.0,59.4 to 70.5,548
PCV,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,69.2,64.8 to 73.3,918
Hib,Primary Series,States/Local Areas,Illinois,2020-2021,Age,35 Months,93.9,91.1 to 96.1,918
Hep B,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,3 Months,94.9,92.6 to 96.5,918
PCV,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,93.1,90.1 to 95.4,918
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2020-2021,Age,0-2 Days,77.9,73.8 to 81.5,918
Hib,Full Series,States/Local Areas,Illinois,2020-2021,Age,35 Months,79.5,75.2 to 83.5,918
DTaP,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,88.4,84.7 to 91.3,918
Hep B,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,89.4,86.0 to 92.0,918
Hep B,≥2 Doses,States/Local Areas,Illinois,2021,Age,5 Months,83.0,76.4 to 88.0,369
Hep A,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,29.9,26.0 to 34.1,918
≥1 Dose MMR,,States/Local Areas,Illinois,2021,Age,19 Months,86.0,79.6 to 90.6,369
Polio,≥3 Doses,States/Local Areas,Illinois,2021,Age,19 Months,90.4,84.5 to 94.2,369
Hib,Full Series,States/Local Areas,Illinois,2020-2021,Age,19 Months,70.0,65.6 to 74.0,918
≥1 Dose Varicella,,States/Local Areas,Illinois,2021,Age,13 Months,55.9,48.9 to 62.7,369
Hep B,≥3 Doses,States/Local Areas,Illinois,2021,Age,13 Months,84.5,78.0 to 89.3,369
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2020-2021,Age,0-3 Days,79.2,75.2 to 82.8,918
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.4,59.1 to 81.7,170
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,Hispanic,78.0,70.4 to 85.6,435
Influenza,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,71.1,67.4 to 74.8,1043
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.1,73.6 to 86.6,273
Influenza,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,46.3,41.6 to 51.1,624
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,83.2,79.4 to 86.9,640
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,89.6,87.3 to 91.9,1184
Influenza,,States/Local Areas,Illinois,2018,Age,24 Months,63.5,58.1 to 69.0,542
Influenza,,States/Local Areas,Illinois,2018-2019,Age,24 Months,64.3,60.4 to 68.2,1090
Influenza,,States/Local Areas,Illinois,2017,Age,24 Months,58.5,52.8 to 64.4,502
Influenza,,States/Local Areas,Illinois,2017-2018,Age,24 Months,61.0,57.0 to 65.0,1044
PCV,≥1 Dose,States/Local Areas,Illinois,2021,Age,3 Months,85.3,79.2 to 89.9,369
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,90.4,88.2 to 92.7,1184
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,85.5 to 94.9,273
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,74.6,70.4 to 78.9,640
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,64.5 to 82.5,273
Influenza,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,32.4,12.1 to 52.7,34
Influenza,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,62.5,57.9 to 67.2,751
Influenza,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",65.1,61.1 to 69.1,930
Influenza,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,58.8,54.7 to 62.9,850
Influenza,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,43.6,32.7 to 54.4,119
Influenza,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.4,58.3 to 74.5,231
Influenza,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,53.4,47.3 to 59.4,408
Influenza,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",40.8,31.8 to 49.7,151
DTaP,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,5 Months,78.2,73.9 to 82.0,918
Hib,≥2 Doses,States/Local Areas,Illinois,2021,Age,13 Months,91.5,86.1 to 95.0,369
Hep B,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,90.4,87.3 to 93.1,918
Influenza,,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,78.5,74.3 to 82.7,686
Influenza,,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,52.6,47.2 to 57.9,519
Influenza,,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,46.5,41.3 to 51.7,515
Influenza,,States/Local Areas,Illinois,2014-2017,Overall,Overall,59.1,56.1 to 62.1,1720
Hib,Full Series,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,85.9,83.2 to 88.6,1184
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Any Medicaid,89.7,86.7 to 92.8,640
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2019,Insurance Coverage,Private Insurance Only,96.6,95.2 to 98.0,1184
Influenza,,States/Local Areas,Illinois,2021,Age,24 Months,57.3,50.1 to 64.7,369
≥1 Dose Varicella,,States/Local Areas,Illinois,2020-2021,Age,13 Months,58.8,54.3 to 63.1,918
PCV,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,19 Months,91.3,90.6 to 91.9,34652
Influenza,,HHS Regions/National,United States,2013,Age,24 Months,53.7,52.1 to 55.3,14872
Influenza,,HHS Regions/National,United States,2013-2014,Age,24 Months,53.0,51.9 to 54.1,30205
Influenza,,HHS Regions/National,United States,2015,Age,24 Months,55.3,53.6 to 57.0,15463
Influenza,,HHS Regions/National,United States,2015-2016,Age,24 Months,56.0,54.8 to 57.2,31419
Influenza,,HHS Regions/National,United States,2014,Age,24 Months,52.3,50.6 to 53.9,15333
Influenza,,HHS Regions/National,United States,2014-2015,Age,24 Months,53.8,52.6 to 55.0,30796
Influenza,,HHS Regions/National,United States,2011,Age,24 Months,52.6,50.9 to 54.3,14513
Influenza,,HHS Regions/National,United States,2012,Age,24 Months,54.1,52.5 to 55.7,15038
DTaP,≥4 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,79.3,78.2 to 80.4,28668
DTaP,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,93.8,93.1 to 94.5,28668
Hep B,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,90.2,89.4 to 91.0,28668
Combined 7 Series,,States/Local Areas,District of Columbia,2017,Age,24 Months,72.0,65.2 to 78.6,314
Combined 7 Series,,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,71.2,66.6 to 75.7,664
Combined 7 Series,,States/Local Areas,District of Columbia,2018,Age,24 Months,70.3,64.0 to 76.4,350
Combined 7 Series,,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,69.7,64.7 to 74.5,677
Combined 7 Series,,States/Local Areas,District of Columbia,2014,Age,24 Months,66.9,59.3 to 74.3,296
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,66.5,61.0 to 71.9,596
Combined 7 Series,,States/Local Areas,District of Columbia,2015,Age,24 Months,66.3,58.4 to 74.0,300
Combined 7 Series,,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,68.8,63.4 to 74.1,593
Hib,Primary Series,States/Local Areas,District of Columbia,2018,Age,35 Months,96.1,92.3 to 98.3,350
Hib,Primary Series,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,94.1,91.1 to 96.3,677
Combined 7 Series,,States/Local Areas,District of Columbia,2016,Age,24 Months,70.8,63.5 to 77.9,293
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,71.5,66.4 to 76.3,607
Hib,Primary Series,States/Local Areas,District of Columbia,2019,Age,35 Months,92.0,87.2 to 95.5,327
Hib,Primary Series,States/Local Areas,District of Columbia,2015,Age,35 Months,94.6,89.5 to 97.7,300
Hib,Primary Series,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,95.1,91.7 to 97.5,593
Hib,Primary Series,States/Local Areas,District of Columbia,2016,Age,35 Months,95.4,90.7 to 98.1,293
Hib,Primary Series,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,93.3,90.1 to 95.7,607
Hib,Primary Series,States/Local Areas,District of Columbia,2011,Age,24 Months,92.3,86.6 to 96.2,261
Hib,Primary Series,States/Local Areas,District of Columbia,2012,Age,24 Months,94.3,89.6 to 97.3,315
Hib,Primary Series,States/Local Areas,District of Columbia,2013,Age,24 Months,91.2,86.5 to 94.8,293
Hib,Primary Series,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,93.3,90.2 to 95.6,589
Hib,Primary Series,States/Local Areas,District of Columbia,2017,Age,19 Months,90.5,85.2 to 94.0,314
Hib,Primary Series,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,92.5,89.4 to 94.8,664
Hib,Primary Series,States/Local Areas,District of Columbia,2011,Age,35 Months,94.6,89.5 to 97.7,261
Hib,Primary Series,States/Local Areas,District of Columbia,2013,Age,35 Months,91.6,86.9 to 95.1,293
Hib,Primary Series,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,93.5,90.4 to 95.8,589
Hib,Primary Series,States/Local Areas,District of Columbia,2012,Age,35 Months,94.9,90.2 to 97.8,315
Hib,Primary Series,States/Local Areas,District of Columbia,2014,Age,35 Months,95.8,91.7 to 98.2,296
Hib,Primary Series,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,95.6,92.1 to 97.9,596
Combined 7 Series,,States/Local Areas,District of Columbia,2011,Age,24 Months,71.1,63.0 to 78.8,261
Combined 7 Series,,States/Local Areas,District of Columbia,2013,Age,24 Months,74.0,67.5 to 80.2,293
Combined 7 Series,,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,70.4,65.4 to 75.3,589
Combined 7 Series,,States/Local Areas,District of Columbia,2012,Age,24 Months,73.5,66.3 to 80.2,315
Hib,Primary Series,States/Local Areas,District of Columbia,2019,Age,24 Months,91.0,86.2 to 94.7,327
Hib,Primary Series,States/Local Areas,District of Columbia,2014,Age,24 Months,95.8,91.7 to 98.2,296
Hib,Primary Series,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,93.1,89.7 to 95.7,596
Hib,Primary Series,States/Local Areas,District of Columbia,2015,Age,24 Months,90.9,85.1 to 95.0,300
Hib,Primary Series,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,93.0,89.7 to 95.6,593
Hib,Primary Series,States/Local Areas,District of Columbia,2015,Age,19 Months,90.6,89.8 to 91.4,300
Hib,Primary Series,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,92.1,88.3 to 94.8,593
Hib,Primary Series,States/Local Areas,District of Columbia,2019,Age,13 Months,88.1,82.2 to 92.2,327
Hib,Primary Series,States/Local Areas,District of Columbia,2011,Age,19 Months,91.4,89.3 to 93.1,261
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020,Age,13 Months,73.6,65.0 to 80.7,293
Hib,Primary Series,States/Local Areas,District of Columbia,2016,Age,19 Months,93.4,87.9 to 96.5,293
Hib,Primary Series,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,92.0,88.5 to 94.6,607
Hib,Primary Series,States/Local Areas,District of Columbia,2017,Age,24 Months,90.7,85.9 to 94.4,314
Hib,Primary Series,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,92.9,90.0 to 95.3,664
Hib,Primary Series,States/Local Areas,District of Columbia,2018,Age,24 Months,95.3,91.7 to 97.7,350
Hib,Primary Series,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,93.2,90.3 to 95.4,677
Hib,Primary Series,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,88.5,84.7 to 91.4,677
Hib,Primary Series,States/Local Areas,District of Columbia,2019,Age,19 Months,91.0,85.8 to 94.4,327
Hib,Primary Series,States/Local Areas,District of Columbia,2018,Age,19 Months,94.7,90.5 to 97.1,350
Hib,Primary Series,States/Local Areas,District of Columbia,2012,Age,19 Months,93.6,91.4 to 95.3,315
Hib,Primary Series,States/Local Areas,District of Columbia,2013,Age,19 Months,91.2,89.4 to 92.8,293
Hib,Primary Series,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,91.8,88.9 to 94.0,589
Hib,Primary Series,States/Local Areas,District of Columbia,2014,Age,19 Months,92.3,86.5 to 95.8,296
Hib,Primary Series,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,91.5,87.5 to 94.3,596
Hib,Primary Series,States/Local Areas,District of Columbia,2018,Age,13 Months,88.9,83.7 to 92.6,350
Hib,Primary Series,States/Local Areas,District of Columbia,2018-2019,Age,13 Months,88.5,84.7 to 91.4,677
Hib,Primary Series,States/Local Areas,District of Columbia,2013,Age,7 Months,68.7,60.2 to 76.1,293
Hib,Primary Series,States/Local Areas,District of Columbia,2013-2014,Age,7 Months,69.3,64.6 to 73.6,589
Hib,Primary Series,States/Local Areas,District of Columbia,2014,Age,7 Months,69.9,62.2 to 76.6,296
Hib,Primary Series,States/Local Areas,District of Columbia,2014-2015,Age,7 Months,69.2,63.7 to 74.2,596
Hib,Primary Series,States/Local Areas,District of Columbia,2015,Age,7 Months,68.5,60.4 to 75.6,300
Hib,Primary Series,States/Local Areas,District of Columbia,2015-2016,Age,7 Months,72.4,66.9 to 77.3,593
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,60.7,49.9 to 71.6,137
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,81.9,77.9 to 85.9,646
Hib,Full Series,States/Local Areas,District of Columbia,2011,Age,19 Months,78.1,70.4 to 84.2,261
Hib,Full Series,States/Local Areas,District of Columbia,2012,Age,19 Months,77.0,72.1 to 81.2,315
Hib,Full Series,States/Local Areas,District of Columbia,2013,Age,19 Months,82.3,79.2 to 85.0,293
Hib,Full Series,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,77.5,75.3 to 79.6,589
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.3,55.3 to 69.3,249
Combined 7 Series,,States/Local Areas,District of Columbia,2018,Age,35 Months,78.3,71.2 to 84.7,350
Combined 7 Series,,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,76.2,70.8 to 81.2,677
Combined 7 Series,,States/Local Areas,District of Columbia,2019,Age,35 Months,73.6,65.5 to 81.0,327
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,80.2,76.1 to 84.2,702
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,59.4,53.0 to 65.8,353
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,59.9,53.0 to 66.9,288
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,69.4,65.5 to 73.4,1071
Hib,Full Series,States/Local Areas,District of Columbia,2016,Age,19 Months,79.8,72.7 to 85.4,293
Hib,Full Series,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,77.3,72.3 to 81.5,607
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,69.6,61.6 to 77.6,222
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.8,54.3 to 77.3,132
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.9,78.5 to 87.4,468
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,69.4,65.5 to 73.4,1071
Hib,Full Series,States/Local Areas,District of Columbia,2017,Age,19 Months,74.4,67.2 to 80.4,314
Hib,Full Series,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,74.5,69.8 to 78.8,664
Hib,Full Series,States/Local Areas,District of Columbia,2018,Age,19 Months,74.7,68.3 to 80.2,350
Hib,Full Series,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,94.4,91.5 to 96.3,677
Hib,Full Series,States/Local Areas,District of Columbia,2014,Age,19 Months,72.5,64.8 to 79.1,296
Hib,Full Series,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,72.2,66.8 to 77.1,596
Hib,Full Series,States/Local Areas,District of Columbia,2015,Age,19 Months,71.9,68.5 to 75.1,300
Hib,Full Series,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,76.2,71.0 to 80.7,593
Hib,Primary Series,States/Local Areas,District of Columbia,2017,Age,13 Months,86.6,80.7 to 90.9,314
Hib,Primary Series,States/Local Areas,District of Columbia,2017-2018,Age,13 Months,87.7,84.0 to 90.7,664
Hib,Primary Series,States/Local Areas,District of Columbia,2015,Age,13 Months,84.6,77.4 to 89.9,300
Hib,Primary Series,States/Local Areas,District of Columbia,2015-2016,Age,13 Months,86.8,82.3 to 90.3,593
Hib,Primary Series,States/Local Areas,District of Columbia,2016,Age,13 Months,88.6,82.4 to 92.8,293
Hib,Primary Series,States/Local Areas,District of Columbia,2016-2017,Age,13 Months,87.7,83.6 to 90.8,607
Hib,Primary Series,States/Local Areas,District of Columbia,2019,Age,7 Months,71.7,64.0 to 78.3,327
Hib,Primary Series,States/Local Areas,District of Columbia,2011,Age,13 Months,87.8,84.4 to 90.6,261
Hib,Primary Series,States/Local Areas,District of Columbia,2012,Age,13 Months,91.0,88.8 to 92.8,315
Hib,Primary Series,States/Local Areas,District of Columbia,2013,Age,13 Months,88.0,85.7 to 90.1,293
Hib,Primary Series,States/Local Areas,District of Columbia,2013-2014,Age,13 Months,87.0,84.5 to 89.1,589
Hib,Primary Series,States/Local Areas,District of Columbia,2014,Age,13 Months,85.9,79.2 to 90.6,296
Hib,Primary Series,States/Local Areas,District of Columbia,2014-2015,Age,13 Months,85.2,80.5 to 89.0,596
Hib,Primary Series,States/Local Areas,District of Columbia,2016,Age,7 Months,75.6,68.0 to 81.9,293
Hib,Primary Series,States/Local Areas,District of Columbia,2016-2017,Age,7 Months,76.2,71.1 to 80.6,607
Hib,Primary Series,States/Local Areas,District of Columbia,2017,Age,7 Months,76.8,70.1 to 82.5,314
Hib,Primary Series,States/Local Areas,District of Columbia,2017-2018,Age,7 Months,75.8,71.1 to 79.9,664
Hib,Primary Series,States/Local Areas,District of Columbia,2018,Age,7 Months,74.6,67.9 to 80.3,350
Hib,Primary Series,States/Local Areas,District of Columbia,2018-2019,Age,7 Months,73.1,68.1 to 77.6,677
Hib,Full Series,States/Local Areas,District of Columbia,2011,Age,24 Months,83.3,76.3 to 89.1,261
Hib,Full Series,States/Local Areas,District of Columbia,2012,Age,24 Months,80.7,73.7 to 86.8,315
Hib,Full Series,States/Local Areas,District of Columbia,2013,Age,24 Months,85.8,80.2 to 90.5,293
Hib,Full Series,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,81.7,77.1 to 85.8,589
Hib,Full Series,States/Local Areas,District of Columbia,2014,Age,24 Months,77.4,70.2 to 84.0,296
Hib,Full Series,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,76.0,70.8 to 80.9,596
Hib,Full Series,States/Local Areas,District of Columbia,2019,Age,19 Months,73.7,66.2 to 80.1,327
Combined 7 Series,,States/Local Areas,District of Columbia,2016,Age,35 Months,76.0,68.4 to 82.9,293
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,74.5,69.4 to 79.3,607
Combined 7 Series,,States/Local Areas,District of Columbia,2017,Age,35 Months,72.8,65.9 to 79.4,314
Combined 7 Series,,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,75.4,70.5 to 80.0,664
Combined 7 Series,,States/Local Areas,District of Columbia,2011,Age,35 Months,74.9,66.8 to 82.4,261
Hib,Primary Series,States/Local Areas,District of Columbia,2017,Age,35 Months,91.0,86.1 to 94.7,314
Hib,Primary Series,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,93.5,90.5 to 95.8,664
Hib,Primary Series,States/Local Areas,District of Columbia,2016,Age,24 Months,95.0,90.6 to 97.7,293
Hib,Primary Series,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,93.0,89.9 to 95.4,607
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,94.4,92.3 to 96.5,792
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,87.3,83.0 to 91.7,792
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,84.0,76.0 to 92.0,347
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,93.0,90.7 to 95.4,792
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,82.0,74.2 to 89.7,228
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,77.4 to 94.2,134
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,92.9,90.4 to 95.4,792
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,87.6,83.3 to 91.8,347
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,94.8,91.7 to 97.9,228
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.5,87.5 to 93.5,525
Influenza,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,81.1,74.1 to 88.1,228
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,93.2,91.2 to 95.1,1155
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,90.1,87.7 to 92.5,1155
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,86.6,83.4 to 89.8,725
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,90.3,87.8 to 92.7,1155
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,93.0,91.1 to 95.0,1155
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,83.7,80.7 to 86.7,1155
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,87.8,81.4 to 94.2,156
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,88.6,83.6 to 93.5,274
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,88.7,84.4 to 92.9,725
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,93.2,82.3 to 100.0,156
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,88.6,82.1 to 95.1,156
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,92.7,89.1 to 96.3,274
Influenza,,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,69.1,65.3 to 73.0,1155
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Overall,Overall,80.8,77.7 to 83.8,1155
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,90.8,86.9 to 94.7,274
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,80.2,76.3 to 84.0,725
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,84.6,80.1 to 89.1,1155
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,90.3,87.9 to 92.7,1155
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,95.9,93.9 to 97.8,725
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,91.0,85.4 to 96.6,156
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,58.5,48.3 to 68.7,156
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,64.2,57.1 to 71.3,274
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,80.0,73.9 to 86.1,274
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,94.6,92.4 to 96.7,725
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,82.0,73.6 to 90.3,156
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,80.3,77.2 to 83.5,1155
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,70.5,66.7 to 74.2,1155
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,95.7,93.7 to 97.7,725
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,89.5,83.5 to 95.5,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,77.7 to 83.8,1155
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,70.5,66.7 to 74.2,1155
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,93.2,91.2 to 95.1,1155
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,83.7,80.7 to 86.7,1155
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,90.3,87.8 to 92.7,1155
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,88.5 to 93.3,1155
Combined 7 Series,,States/Local Areas,District of Columbia,2012,Age,35 Months,76.7,69.5 to 83.2,315
Combined 7 Series,,States/Local Areas,District of Columbia,2013,Age,35 Months,78.8,72.2 to 84.8,293
Combined 7 Series,,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,75.3,70.2 to 80.2,589
Combined 7 Series,,States/Local Areas,District of Columbia,2014,Age,35 Months,71.5,63.7 to 78.9,296
Combined 7 Series,,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,69.4,63.9 to 74.9,596
Combined 7 Series,,States/Local Areas,District of Columbia,2015,Age,35 Months,68.0,60.0 to 75.7,300
Combined 7 Series,,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,72.5,66.9 to 77.8,593
Influenza,,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,69.1,65.3 to 73.0,1155
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,83.0,79.9 to 86.1,1155
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,91.1 to 95.0,1155
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,75.8,69.9 to 81.7,274
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,67.9,58.3 to 77.5,156
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,90.3,87.9 to 92.7,1155
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,89.7,86.8 to 92.6,725
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,75.7,67.0 to 84.5,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,83.4,80.1 to 86.7,725
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,75.6,67.1 to 84.1,156
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,78.9,69.8 to 88.1,274
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,93.2,90.7 to 95.8,725
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,87.7,81.2 to 94.3,156
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,93.6,90.3 to 96.9,274
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,94.1,92.3 to 96.0,1155
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,90.9,88.5 to 93.3,1155
Influenza,,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,56.8,46.6 to 67.1,156
Influenza,,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,57.1,49.8 to 64.4,274
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,93.9,91.6 to 96.1,725
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,86.2,79.4 to 93.0,156
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,87.7,82.7 to 92.6,274
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,88.9,85.8 to 92.0,725
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,81.5,74.2 to 88.9,156
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,87.6,82.7 to 92.5,274
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,83.0,79.9 to 86.1,1155
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,91.9,88.2 to 95.6,274
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,85.5,82.1 to 89.0,725
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Poverty,133% to <400% FPL,78.6,70.7 to 86.5,156
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,74.5,68.1 to 80.8,274
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,92.2,89.8 to 94.7,725
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Overall,Overall,79.4,76.2 to 82.5,1155
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,80.0,74.1 to 85.9,274
Influenza,,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,83.3,79.2 to 87.3,725
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.1,95.1 to 99.2,525
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.5,93.2 to 97.7,525
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,83.0,79.7 to 86.2,792
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,91.9 to 97.2,525
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,92.3 to 97.2,525
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.3,82.7 to 89.9,525
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.2,82.6 to 91.9,268
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,77.5,73.5 to 81.4,792
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,63.7,57.3 to 70.0,347
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.2,79.4 to 89.1,268
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.8,68.9 to 80.7,268
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.2,89.2 to 95.1,525
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,78.3,72.8 to 83.7,347
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,91.3,87.1 to 95.6,228
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.9,82.2 to 91.6,268
≥1 Dose MMR,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.0,85.0 to 96.9,134
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,87.5,83.1 to 91.8,347
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.6 to 98.1,792
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,92.0,88.7 to 95.3,347
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,84.4,80.8 to 87.9,792
Influenza,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,54.6,48.0 to 61.1,347
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.4,72.0 to 90.8,134
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,96.1,93.6 to 98.6,228
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,74.6,66.3 to 83.0,228
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.9,57.3 to 80.6,134
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.0,70.0 to 81.9,268
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.6,76.4 to 84.9,525
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,74.6,69.2 to 80.0,347
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,64.2,55.5 to 72.8,228
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.3,54.5 to 78.2,134
Combined 7 Series,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.2,60.6 to 73.8,268
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,82.7,76.2 to 89.3,228
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,63.6 to 83.4,134
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,84.9,78.6 to 91.2,228
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.9,94.8 to 99.0,525
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.3,73.7 to 84.9,268
Influenza,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.5,84.1 to 90.9,525
Influenza,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",51.3,44.2 to 58.4,268
Influenza,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.8,64.5 to 85.0,134
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.0,86.1 to 93.9,268
Influenza,,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,82.3,78.5 to 86.1,792
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,91.5,87.4 to 95.6,228
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,81.7 to 95.8,134
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.1,93.8 to 98.3,525
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.8,87.0 to 94.7,268
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,87.1,82.7 to 91.5,347
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.0,82.3 to 91.7,268
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,94.5,91.5 to 97.5,228
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.1,82.4 to 89.9,525
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.4 to 97.9,792
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,90.2,86.6 to 93.8,347
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.3,86.0 to 92.6,525
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.8,73.1 to 84.6,268
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,96.4,93.9 to 98.8,228
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,86.9 to 98.1,134
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,88.1,85.1 to 91.1,792
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.7,88.2 to 95.3,268
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,78.1,72.5 to 83.7,347
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.9,84.7 to 93.1,268
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,91.3,86.0 to 96.6,228
Polio,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,91.8,88.3 to 94.5,620
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,88.0,82.6 to 92.4,620
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,92.0,88.5 to 94.7,620
Combined 7 Series,,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,68.8,63.0 to 74.4,620
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,91.6,88.0 to 94.2,620
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,88.4,84.2 to 91.6,620
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,69.1,63.5 to 74.3,620
Hib,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,89.7,85.7 to 92.7,620
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,88.0,84.1 to 91.1,620
Polio,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,90.1,86.3 to 93.0,620
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,73.7,68.0 to 78.8,620
PCV,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,5 Months,78.3,72.7 to 83.1,620
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,5 Months,87.7,83.6 to 90.9,620
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,92.2,88.6 to 94.7,620
Hib,Primary Series,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,87.9,83.7 to 91.2,620
Hib,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,93.1,89.7 to 95.4,620
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,78.5,73.2 to 83.0,620
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,70.0,64.4 to 75.2,620
Polio,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,92.9,89.6 to 95.2,620
Hib,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,5 Months,81.0,75.7 to 85.4,620
Polio,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,5 Months,80.8,75.5 to 85.2,620
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,5 Months,81.1,75.8 to 85.5,620
PCV,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,3 Months,87.7,83.2 to 91.2,620
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,3 Months,94.3,91.0 to 96.4,620
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,87.8,83.4 to 91.5,620
Polio,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,91.4,88.0 to 94.2,620
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,80.8,75.7 to 85.5,620
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,91.6,88.2 to 94.4,620
PCV,≥4 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,86.4,82.1 to 90.1,620
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,92.1,88.3 to 95.0,620
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,89.1,84.8 to 92.6,620
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,89.8,86.1 to 92.8,620
Hib,Full Series,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,82.8,77.6 to 87.5,620
Hib,Primary Series,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,91.6,88.1 to 94.4,620
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,91.5,87.9 to 94.4,620
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,88.7,84.3 to 92.3,620
Hib,Full Series,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,75.9,70.6 to 80.6,620
Hib,Primary Series,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,90.9,87.1 to 93.6,620
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,89.2,85.2 to 92.2,620
≥1 Dose MMR,,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,86.2,81.4 to 89.9,620
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,28.0,23.3 to 33.2,620
PCV,≥4 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,84.9,80.6 to 88.7,620
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,90.5,86.8 to 93.6,620
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2019-2020,Age,0-3 Days,77.5,72.2 to 82.0,620
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,71.8,66.0 to 76.9,620
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,88.2,83.9 to 91.7,620
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,89.7,86.0 to 92.7,620
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2019-2020,Age,0-2 Days,74.1,68.5 to 79.0,620
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,87.9,83.6 to 91.2,620
PCV,≥4 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,83.0,78.3 to 86.8,620
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,86.9,82.2 to 90.5,620
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,89.5,85.7 to 92.5,620
Combined 7 Series,,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,73.0,67.1 to 78.6,620
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,60.9,54.8 to 66.6,620
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2019-2020,Age,0-1 Days,69.4,63.7 to 74.6,620
Hib,Full Series,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,78.5,73.5 to 83.1,620
Hib,Primary Series,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,90.9,87.3 to 93.7,620
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,89.9,86.1 to 93.0,620
Influenza,,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,71.2,65.5 to 76.8,620
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,78.7,71.6 to 85.0,620
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,35 Months,92.1,88.5 to 95.0,620
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,89.3,85.4 to 92.6,620
Polio,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,91.8,86.0 to 95.4,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,24 Months,49.8,43.8 to 56.1,620
Combined 7 Series,,States/Local Areas,District of Columbia,2020,Age,35 Months,72.9,64.1 to 81.0,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2020,Age,0-1 Days,68.3,59.7 to 75.9,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,19 Months,89.1,82.0 to 93.6,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,25.1,18.9 to 32.4,293
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,3 Months,88.1,81.2 to 92.7,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2020,Age,0-2 Days,72.3,63.8 to 79.5,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,89.3,82.7 to 93.6,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,88.2,81.0 to 92.9,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,63.2,54.1 to 71.5,293
Hib,Primary Series,States/Local Areas,District of Columbia,2020,Age,7 Months,72.2,63.3 to 79.6,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,89.5,82.8 to 93.8,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,91.9,86.5 to 95.7,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,91.4,86.0 to 95.3,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,82.6,75.2 to 88.8,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020,Age,24 Months,88.7,81.7 to 93.9,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,89.4,83.4 to 94.0,293
Hib,Primary Series,States/Local Areas,District of Columbia,2020,Age,24 Months,91.1,85.7 to 95.1,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,91.2,85.5 to 95.3,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020,Age,35 Months,88.7,81.7 to 93.9,293
Hib,Primary Series,States/Local Areas,District of Columbia,2020,Age,35 Months,91.1,85.7 to 95.1,293
Hib,Full Series,States/Local Areas,District of Columbia,2020,Age,35 Months,83.7,76.1 to 89.9,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,89.4,83.7 to 93.8,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020,Age,35 Months,88.4,81.5 to 93.7,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,91.7,85.7 to 95.9,293
Hib,Full Series,States/Local Areas,District of Columbia,2020,Age,19 Months,78.6,70.7 to 84.8,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,89.4,83.2 to 93.5,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,91.2,84.9 to 95.0,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020,Age,19 Months,87.4,79.5 to 92.6,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,85.9,77.4 to 92.5,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,91.4,86.0 to 95.3,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,85.2,78.1 to 90.3,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,88.4,82.1 to 93.2,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,77.6,69.2 to 84.3,293
Hib,Primary Series,States/Local Areas,District of Columbia,2020,Age,13 Months,88.2,81.7 to 92.6,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,91.9,86.0 to 95.5,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,88.6,82.4 to 92.8,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020,Age,13 Months,72.1,63.5 to 79.4,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,89.3,82.5 to 93.7,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,72.2,63.1 to 79.7,293
PCV,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,5 Months,76.2,66.9 to 83.5,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,91.9,85.9 to 95.4,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,78.8,70.6 to 85.2,293
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020,Age,19 Months,87.5,79.6 to 92.6,293
Polio,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,91.4,85.5 to 95.0,293
Hib,Primary Series,States/Local Areas,District of Columbia,2020,Age,19 Months,91.1,85.2 to 94.8,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,19 Months,89.1,82.5 to 93.4,293
Influenza,,States/Local Areas,District of Columbia,2020,Age,24 Months,68.0,59.0 to 76.6,293
Rotavirus,,States/Local Areas,District of Columbia,2020,Age,8 Months,75.0,66.2 to 82.2,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2020,Age,0-3 Days,77.9,70.1 to 84.2,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,91.2,85.5 to 95.3,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,35 Months,91.9,86.5 to 95.7,293
PCV,≥4 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,86.7,80.4 to 91.8,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,24 Months,89.2,82.8 to 94.0,293
Combined 7 Series,,States/Local Areas,District of Columbia,2020,Age,24 Months,68.7,60.3 to 76.8,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,52.2,43.2 to 61.8,293
PCV,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,3 Months,84.7,76.8 to 90.3,293
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,5 Months,79.6,70.8 to 86.3,293
Polio,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,5 Months,79.1,70.4 to 85.8,293
Hib,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,5 Months,78.5,69.7 to 85.3,293
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2020,Age,5 Months,87.7,80.9 to 92.4,293
Polio,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,3 Months,87.4,80.5 to 92.1,293
Hib,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,3 Months,86.7,79.6 to 91.6,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,68.8,60.3 to 76.3,293
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2020,Age,3 Months,93.9,88.2 to 96.9,293
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,24 Months,89.4,83.7 to 93.8,293
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,7 Months,69.3,60.2 to 77.1,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020,Age,13 Months,89.9,83.3 to 94.0,293
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,87.6,82.1 to 92.0,463
Rotavirus,,States/Local Areas,District of Columbia,2019-2020,Age,8 Months,75.8,70.2 to 80.6,620
Polio,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,3 Months,88.8,84.6 to 91.9,620
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,3 Months,89.2,85.0 to 92.3,620
Hib,Primary Series,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,71.8,66.0 to 76.9,620
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,13 Months,89.9,85.9 to 92.9,620
Polio,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,91.4,87.7 to 94.0,620
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,74.8,69.2 to 79.7,620
Hib,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,90.3,85.0 to 93.9,463
PCV,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,87.4,77.4 to 93.3,170
Combined 7 Series,,States/Local Areas,District of Columbia,2019,Age,24 Months,69.1,61.3 to 76.6,327
Hib,≥1 Dose,States/Local Areas,District of Columbia,2019-2020,Age,3 Months,88.9,84.8 to 92.1,620
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,77.3 to 95.4,134
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.9,85.2 to 94.7,525
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,92.3 to 96.0,1155
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,80.3,77.2 to 83.5,1155
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,87.7 to 92.5,1155
Rotavirus,,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,79.4,76.2 to 82.5,1155
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Urbanicity,Living In a MSA Principal City,84.6,80.1 to 89.1,1155
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2021,Age,0-1 Days,67.3,54.8 to 77.8,170
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,73.2,68.5 to 77.4,315
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,75.0,67.7 to 81.0,261
PCV,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,5 Months,73.9,69.0 to 78.2,261
PCV,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,5 Months,80.8,78.2 to 83.2,315
PCV,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,5 Months,74.3,64.8 to 82.0,293
PCV,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,5 Months,74.1,69.6 to 78.2,589
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,95.3,89.2 to 98.5,300
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,95.5,91.6 to 97.9,593
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,95.6,90.9 to 98.3,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,94.2,91.1 to 96.4,607
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,92.5,87.9 to 95.8,314
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,94.1,91.2 to 96.3,664
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,25.2,19.7 to 31.5,300
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,28.7,23.8 to 34.2,593
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,31.7,24.6 to 39.8,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,30.1,25.3 to 35.4,607
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,91.6,86.9 to 95.2,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,93.3,90.1 to 95.8,589
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,97.3,92.0 to 99.4,296
Hib,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,93.8,89.4 to 96.7,596
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,35 Months,91.2,84.6 to 95.8,300
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,35 Months,92.9,89.0 to 95.8,593
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,19 Months,28.3,22.5 to 35.1,314
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,25.7,21.8 to 30.1,664
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,24 Months,84.0,77.2 to 89.7,300
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,86.7,82.5 to 90.4,593
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,24 Months,89.0,83.5 to 93.3,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,89.7,86.0 to 92.7,607
PCV,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,5 Months,74.0,66.2 to 80.5,296
PCV,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,5 Months,74.0,68.8 to 78.5,596
PCV,≥2 Doses,States/Local Areas,District of Columbia,2015,Age,5 Months,74.0,65.9 to 80.7,300
PCV,≥2 Doses,States/Local Areas,District of Columbia,2015-2016,Age,5 Months,77.3,71.9 to 82.0,593
PCV,≥2 Doses,States/Local Areas,District of Columbia,2016,Age,5 Months,80.1,72.3 to 86.1,293
PCV,≥2 Doses,States/Local Areas,District of Columbia,2016-2017,Age,5 Months,81.4,76.5 to 85.5,607
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,95.7,91.8 to 98.1,350
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,93.9,91.0 to 96.2,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,35 Months,92.1,87.4 to 95.6,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,24 Months,90.4,85.5 to 94.2,314
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,91.7,88.6 to 94.2,664
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,78.5,75.1 to 81.6,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,75.3,72.0 to 78.2,589
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,71.8,64.1 to 78.4,296
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,72.3,66.8 to 77.2,596
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2015,Age,19 Months,72.9,70.1 to 75.5,300
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,76.2,70.9 to 80.8,593
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.8 to 99.0,702
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,91.1,87.3 to 95.0,353
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016,Age,19 Months,78.9,71.7 to 84.7,293
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,78.5,73.7 to 82.7,607
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,19 Months,23.0,18.1 to 28.8,350
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,21.6,17.1 to 27.0,544
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,19 Months,30.5,23.9 to 37.8,327
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,24 Months,43.3,35.1 to 52.5,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,35 Months,94.5,89.7 to 97.5,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,35 Months,92.4,89.1 to 95.0,607
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,35 Months,90.0,85.0 to 93.9,314
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,35 Months,92.5,89.4 to 95.0,664
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,24 Months,49.5,41.9 to 57.5,315
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.7,87.7 to 95.7,249
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,35 Months,95.2,91.0 to 97.8,350
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,35 Months,93.5,90.4 to 95.9,677
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,35 Months,95.5,90.2 to 98.4,315
PCV,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,5 Months,83.0,76.5 to 87.9,314
PCV,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,5 Months,82.7,78.3 to 86.3,664
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,94.6,89.5 to 97.7,261
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,98.8,93.7 to 99.9,315
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013,Age,35 Months,92.8,87.6 to 96.4,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2013-2014,Age,35 Months,95.4,91.4 to 97.9,589
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,35 Months,97.9,92.5 to 99.7,296
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,35 Months,98.6,93.6 to 99.9,596
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2011,Age,19 Months,21.8,17.2 to 27.2,261
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2013,Age,19 Months,21.9,18.4 to 25.9,293
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,20.5,18.5 to 22.6,589
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2012,Age,19 Months,27.8,27.1 to 28.5,315
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014,Age,19 Months,19.0,14.3 to 24.7,296
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,22.1,18.1 to 26.6,596
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,93.9,90.2 to 96.6,350
Hib,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,92.3,89.3 to 94.7,677
Hib,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,90.7,85.8 to 94.4,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,19 Months,85.1,78.8 to 89.7,314
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,19 Months,86.4,82.4 to 89.6,664
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,19 Months,87.8,82.2 to 91.7,350
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,19 Months,86.8,81.7 to 90.6,544
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,19 Months,86.8,80.9 to 91.1,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,24 Months,89.1,82.9 to 93.8,261
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,24 Months,90.1,85.4 to 93.8,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,91.7,88.4 to 94.3,589
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,24 Months,90.6,85.4 to 94.5,315
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,24 Months,93.4,88.6 to 96.7,296
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,88.6,84.4 to 92.1,596
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,19 Months,87.3,81.1 to 91.6,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,19 Months,86.2,82.1 to 89.6,607
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2017,Age,5 Months,83.4,76.9 to 88.3,314
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2017-2018,Age,5 Months,83.8,79.4 to 87.4,664
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,24 Months,93.0,89.0 to 95.9,350
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,91.4,88.3 to 94.0,677
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,24 Months,89.8,84.9 to 93.7,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,35 Months,96.4,91.8 to 98.8,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2011,Age,35 Months,94.6,89.5 to 97.7,261
Hib,≥3 Doses,States/Local Areas,District of Columbia,2012,Age,35 Months,94.7,89.9 to 97.7,315
≥1 Dose MMR,,States/Local Areas,District of Columbia,2021,Age,35 Months,88.0,79.1 to 94.3,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,89.2,80.3 to 95.3,170
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,19 Months,86.7,76.4 to 92.9,170
Hib,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,67.5,55.4 to 77.6,170
Hib,Primary Series,States/Local Areas,District of Columbia,2021,Age,19 Months,88.1,78.0 to 93.9,170
Hib,Full Series,States/Local Areas,District of Columbia,2021,Age,19 Months,71.0,59.0 to 80.7,170
Hib,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,87.8,77.8 to 93.7,170
Hib,Full Series,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,79.6,73.6 to 85.1,463
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,86.9,77.1 to 92.9,170
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,83.6,76.0 to 89.9,463
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,3 Months,85.5,82.5 to 88.0,293
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,3 Months,88.7,84.4 to 92.0,589
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,3 Months,92.2,86.6 to 95.5,296
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,3 Months,90.8,86.7 to 93.7,596
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,3 Months,89.4,82.7 to 93.7,300
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,3 Months,87.6,82.7 to 91.2,593
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2016,Age,3 Months,86.0,78.5 to 91.2,293
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2016-2017,Age,3 Months,85.9,81.1 to 89.5,607
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2017,Age,3 Months,85.6,79.4 to 90.2,314
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2017-2018,Age,3 Months,88.2,84.4 to 91.2,664
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014,Age,24 Months,94.6,89.5 to 97.7,296
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,92.7,89.0 to 95.5,596
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,91.3,85.5 to 95.4,300
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,93.4,90.1 to 95.9,593
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2018,Age,3 Months,90.9,86.1 to 94.2,350
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2018-2019,Age,3 Months,90.5,86.9 to 93.1,677
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,95.1,90.8 to 97.8,293
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,93.9,90.9 to 96.2,607
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2019,Age,3 Months,90.0,84.2 to 93.8,327
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,19 Months,81.9,78.1 to 85.1,261
Hib,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,3 Months,88.7,79.3 to 94.2,170
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2021,Age,19 Months,84.6,73.6 to 91.6,170
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,19 Months,83.2,82.3 to 84.1,315
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,87.9,82.6 to 92.3,463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.1,79.1 to 87.1,525
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2011,Age,3 Months,89.9,85.7 to 92.9,261
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2012,Age,3 Months,91.9,90.4 to 93.1,315
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2013,Age,19 Months,86.1,81.5 to 89.7,293
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2013-2014,Age,19 Months,86.5,84.3 to 88.5,589
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014,Age,19 Months,86.9,80.3 to 91.6,296
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2014-2015,Age,19 Months,84.3,79.6 to 88.2,596
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2015,Age,19 Months,81.8,72.2 to 88.6,300
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2015-2016,Age,19 Months,84.8,80.2 to 88.5,593
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,91.7,89.2 to 94.2,1071
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,88.0,83.1 to 93.0,288
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,88.6,81.6 to 95.6,137
Polio,≥3 Doses,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,96.3,94.4 to 98.3,646
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,92.5,87.9 to 95.8,314
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,93.7,90.8 to 95.9,664
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018,Age,24 Months,94.9,91.2 to 97.4,350
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,93.2,90.3 to 95.5,677
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2018,Age,5 Months,84.2,77.9 to 89.0,350
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2018-2019,Age,5 Months,83.3,78.7 to 87.0,677
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2019,Age,5 Months,82.3,75.4 to 87.6,327
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015,Age,24 Months,88.6,82.3 to 93.4,300
Hib,≥3 Doses,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,91.3,87.7 to 94.2,593
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016,Age,24 Months,93.7,89.2 to 96.8,293
Hib,≥3 Doses,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,91.8,88.6 to 94.5,607
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2019,Age,24 Months,91.5,86.8 to 95.0,327
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017,Age,24 Months,89.8,84.8 to 93.7,314
Hib,≥3 Doses,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,91.8,88.7 to 94.3,664
Hib,Primary Series,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,90.0,85.1 to 93.9,463
Hib,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,5 Months,78.0,66.9 to 86.1,170
Hib,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,87.9,77.9 to 93.8,170
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,64.0,50.4 to 77.4,170
Polio,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,88.0,77.9 to 93.8,170
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,90.0,84.6 to 93.7,463
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,74.3,62.7 to 83.2,170
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,90.1,80.6 to 95.2,170
PCV,≥4 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,85.2,79.5 to 90.0,463
Hib,Primary Series,States/Local Areas,District of Columbia,2021,Age,7 Months,71.1,59.0 to 80.8,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,88.4,78.2 to 94.2,170
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,35 Months,86.9,77.7 to 93.6,170
PCV,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,5 Months,73.6,61.2 to 83.1,170
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,87.5,82.0 to 91.4,463
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,89.1,84.0 to 93.2,463
Polio,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,87.8,77.8 to 93.7,170
Hib,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,88.8,79.9 to 95.0,170
Hib,Primary Series,States/Local Areas,District of Columbia,2021,Age,24 Months,88.9,80.0 to 95.1,170
Hib,Full Series,States/Local Areas,District of Columbia,2021,Age,24 Months,79.2,69.2 to 87.7,170
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,67.7,55.1 to 78.1,170
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,87.8,79.0 to 94.2,170
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,91.3,86.1 to 94.6,463
PCV,≥4 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,79.0,67.3 to 87.3,170
Combined 7 Series,,States/Local Areas,District of Columbia,2021,Age,35 Months,74.4,63.1 to 84.4,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,64.7,52.1 to 75.5,170
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,33.7,23.5 to 45.6,170
PCV,≥4 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,83.9,73.9 to 91.6,170
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,77.8,66.7 to 87.2,170
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,3 Months,89.9,80.3 to 95.1,170
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,87.4,77.4 to 93.3,170
Polio,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,88.8,79.9 to 95.0,170
Polio,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,3 Months,89.9,80.3 to 95.1,170
≥1 Dose MMR,,States/Local Areas,District of Columbia,2021,Age,24 Months,88.0,79.1 to 94.3,170
Polio,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,88.8,78.7 to 94.4,170
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,24 Months,86.7,77.5 to 93.4,170
Combined 7 Series,,States/Local Areas,District of Columbia,2021,Age,24 Months,73.7,62.4 to 83.8,170
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,54.7,42.9 to 67.4,170
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,19 Months,88.1,78.0 to 93.9,170
PCV,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,5 Months,74.9,67.4 to 81.1,463
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,80.8,74.6 to 85.9,463
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2021,Age,0-2 Days,77.4,66.0 to 85.7,170
PCV,≥4 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,83.5,73.5 to 91.3,170
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,7 Months,66.8,54.6 to 77.0,170
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,88.6,83.6 to 92.7,463
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,90.9,85.6 to 94.8,463
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2021,Age,24 Months,86.7,77.5 to 93.4,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,89.2,80.3 to 95.3,170
Hib,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,5 Months,78.5,72.6 to 83.4,431
Hib,Full Series,States/Local Areas,South Carolina,2020-2021,Age,19 Months,64.9,58.6 to 70.8,431
Polio,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,93.1,88.6 to 95.9,431
DTaP,≥2 Doses,States/Local Areas,South Carolina,2021,Age,5 Months,79.9,70.8 to 86.7,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,72.4,66.0 to 77.9,431
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,85.3,80.0 to 90.7,247
Rotavirus,,States/Local Areas,South Carolina,2017,Age,8 Months,75.8,68.6 to 81.8,288
Rotavirus,,States/Local Areas,South Carolina,2017-2018,Age,8 Months,75.1,70.0 to 79.6,532
Rotavirus,,States/Local Areas,South Carolina,2019,Age,8 Months,81.0,73.4 to 86.7,245
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,70.0,53.6 to 86.3,47
Rotavirus,,States/Local Areas,South Carolina,2018,Age,8 Months,74.4,66.6 to 80.9,244
Rotavirus,,States/Local Areas,South Carolina,2018-2019,Age,8 Months,77.7,72.5 to 82.2,489
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,75.7,66.4 to 85.0,140
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.6,66.6 to 84.5,131
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,71.5,65.9 to 77.1,440
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,80.6,75.5 to 85.7,423
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.1,59.4 to 82.9,91
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,76.7,71.0 to 82.5,395
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.9,73.6 to 82.2,635
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.6,70.5 to 80.7,508
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,78.8,67.3 to 90.2,94
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,68.1,61.5 to 74.8,327
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Overall,Overall,76.4,72.7 to 80.0,997
Rotavirus,,States/Local Areas,South Carolina,2015,Age,8 Months,70.7,62.9 to 77.4,273
Rotavirus,,States/Local Areas,South Carolina,2015-2016,Age,8 Months,74.6,69.2 to 79.2,564
Rotavirus,,States/Local Areas,South Carolina,2016,Age,8 Months,78.6,71.0 to 84.6,291
Rotavirus,,States/Local Areas,South Carolina,2016-2017,Age,8 Months,77.2,72.1 to 81.6,579
Rotavirus,,States/Local Areas,South Carolina,2014,Age,8 Months,72.6,65.0 to 79.1,251
Rotavirus,,States/Local Areas,South Carolina,2014-2015,Age,8 Months,71.6,66.2 to 76.5,524
Rotavirus,,States/Local Areas,South Carolina,2012,Age,8 Months,64.4,55.5 to 72.4,255
Rotavirus,,States/Local Areas,South Carolina,2013,Age,8 Months,71.2,63.4 to 77.9,261
Rotavirus,,States/Local Areas,South Carolina,2013-2014,Age,8 Months,71.9,66.4 to 76.8,512
Rotavirus,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,84.0,79.9 to 88.1,501
Rotavirus,,States/Local Areas,South Carolina,2011,Age,8 Months,75.4,67.6 to 81.9,252
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,80.1 to 97.5,90
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,78.8,73.5 to 84.0,415
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,133% to <400% FPL,79.9,74.8 to 85.0,435
Hib,Full Series,States/Local Areas,South Carolina,2020-2021,Age,24 Months,70.0,63.9 to 75.9,431
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,87.9,74.3 to 100.0,138
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,87.6,80.3 to 95.0,138
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.4,75.4 to 83.4,610
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,89.9,84.8 to 93.4,431
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,88.0,82.8 to 91.9,431
Hib,Primary Series,States/Local Areas,South Carolina,2021,Age,13 Months,77.7,68.9 to 84.5,188
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2020-2021,Age,0-2 Days,78.6,73.0 to 83.4,431
Hib,Full Series,States/Local Areas,South Carolina,2020-2021,Age,35 Months,75.6,68.2 to 82.4,431
Polio,≥3 Doses,States/Local Areas,South Carolina,2021,Age,19 Months,89.9,82.2 to 94.5,188
≥1 Dose MMR,,States/Local Areas,South Carolina,2021,Age,19 Months,84.5,76.1 to 90.3,188
Hep A,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,34.2,28.5 to 40.3,431
Hep B,≥2 Doses,States/Local Areas,South Carolina,2021,Age,5 Months,87.3,78.8 to 92.7,188
≥1 Dose MMR,,States/Local Areas,South Carolina,2020-2021,Age,13 Months,59.4,53.1 to 65.4,431
≥1 Dose Varicella,,States/Local Areas,South Carolina,2021,Age,13 Months,52.5,43.3 to 61.5,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,90.7,82.9 to 95.2,188
Polio,≥2 Doses,States/Local Areas,South Carolina,2021,Age,5 Months,79.9,70.8 to 86.7,188
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,91.3,86.6 to 94.9,431
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2020-2021,Age,0-3 Days,80.2,74.7 to 84.8,431
Polio,≥3 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,89.9,83.0 to 94.9,188
≥1 Dose Varicella,,States/Local Areas,South Carolina,2021,Age,35 Months,88.3,80.9 to 93.8,188
DTaP,≥4 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,77.7,71.8 to 83.1,431
Hep A,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,19 Months,78.9,72.8 to 83.9,431
Combined 7 Series,,States/Local Areas,South Carolina,2021,Age,24 Months,63.7,54.5 to 72.8,188
Rotavirus,,States/Local Areas,South Carolina,2020-2021,Age,8 Months,78.1,71.9 to 83.3,431
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,90.7,86.1 to 94.4,431
Hib,Primary Series,States/Local Areas,South Carolina,2020-2021,Age,35 Months,91.3,86.6 to 94.9,431
Hib,Primary Series,States/Local Areas,South Carolina,2020-2021,Age,19 Months,88.9,83.7 to 92.6,431
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020-2021,Age,19 Months,84.7,79.1 to 89.0,431
Hep B,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,3 Months,94.8,90.4 to 97.2,431
PCV,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,89.9,84.9 to 93.8,431
DTaP,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,3 Months,89.1,83.9 to 92.8,431
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2020-2021,Age,0-1 Days,76.0,70.1 to 81.1,431
PCV,≥4 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,85.8,77.7 to 92.1,431
Hib,Full Series,States/Local Areas,South Carolina,2021,Age,35 Months,71.3,62.0 to 80.0,188
Hib,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,3 Months,86.4,81.0 to 90.4,431
Hep B,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,92.0,87.2 to 95.1,431
Hib,Primary Series,States/Local Areas,South Carolina,2020-2021,Age,13 Months,79.8,74.1 to 84.6,431
Rotavirus,,States/Local Areas,South Carolina,2021,Age,8 Months,77.8,68.4 to 85.0,188
PCV,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,89.9,84.9 to 93.8,431
Polio,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,89.0,83.8 to 92.7,431
Hib,≥3 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,57.4,48.1 to 66.2,188
DTaP,≥4 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,69.5,63.2 to 75.0,431
Hep B,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,5 Months,90.3,85.5 to 93.7,431
Hib,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,84.0,78.2 to 88.5,431
Combined 7 Series,,States/Local Areas,South Carolina,2020-2021,Age,24 Months,64.4,58.2 to 70.6,431
Influenza,,States/Local Areas,South Carolina,2020-2021,Age,24 Months,37.8,32.2 to 43.9,431
DTaP,≥4 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,85.4,76.3 to 92.3,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,91.5,84.6 to 96.1,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,62.6,56.2 to 68.6,431
PCV,≥4 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,76.6,70.4 to 81.9,431
Hib,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,88.3,82.9 to 92.6,431
PCV,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,19 Months,88.8,83.3 to 92.7,431
Polio,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,91.0,86.1 to 94.2,431
DTaP,≥3 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,90.9,84.2 to 95.6,188
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,91.4,86.9 to 94.9,431
≥1 Dose MMR,,States/Local Areas,South Carolina,2020-2021,Age,35 Months,91.9,86.6 to 95.7,431
Hep B,≥2 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,91.8,83.9 to 96.0,188
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020-2021,Age,13 Months,51.7,45.4 to 58.0,431
DTaP,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,72.5,66.1 to 78.0,431
Hib,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,46.5,40.4 to 52.7,431
Hep A,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,83.2,71.8 to 91.9,431
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2021,Age,0-3 Days,77.0,68.2 to 83.9,188
Hib,≥2 Doses,States/Local Areas,South Carolina,2021,Age,13 Months,91.1,83.3 to 95.4,188
Hib,Primary Series,States/Local Areas,South Carolina,2020-2021,Age,7 Months,69.7,63.3 to 75.5,431
DTaP,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,5 Months,81.4,75.6 to 86.1,431
Hib,Primary Series,States/Local Areas,South Carolina,2021,Age,35 Months,89.5,82.5 to 94.5,188
Hep A,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,48.4,42.1 to 55.0,431
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020-2021,Age,24 Months,88.3,83.4 to 92.3,431
Polio,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,35 Months,90.8,86.0 to 94.4,431
≥1 Dose MMR,,States/Local Areas,South Carolina,2020-2021,Age,24 Months,88.7,83.8 to 92.7,431
Combined 7 Series,,States/Local Areas,South Carolina,2020-2021,Age,35 Months,72.8,65.1 to 79.9,431
Polio,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,5 Months,81.0,75.1 to 85.7,431
PCV,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,13 Months,87.3,81.9 to 91.3,431
Influenza,,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,44.5,38.1 to 50.9,423
Influenza,,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,37.6,30.9 to 44.3,327
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,91.6,88.7 to 94.6,507
Influenza,,States/Local Areas,South Carolina,2021,Age,24 Months,35.1,27.4 to 44.2,188
DTaP,≥3 Doses,States/Local Areas,South Carolina,2021,Age,24 Months,90.9,84.2 to 95.6,188
Hib,≥2 Doses,States/Local Areas,South Carolina,2020-2021,Age,7 Months,90.5,85.6 to 93.8,431
≥1 Dose MMR,,States/Local Areas,South Carolina,2020-2021,Age,19 Months,84.7,79.1 to 89.0,431
Polio,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,3 Months,88.7,83.4 to 92.4,431
PCV,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,3 Months,88.9,83.7 to 92.6,431
≥1 Dose MMR,,States/Local Areas,South Carolina,2021,Age,13 Months,61.0,51.9 to 69.4,188
Hep A,≥1 Dose,States/Local Areas,South Carolina,2020-2021,Age,24 Months,84.4,79.0 to 89.0,431
Hib,≥3 Doses,States/Local Areas,South Carolina,2021,Age,35 Months,85.0,77.0 to 91.3,188
Polio,≥3 Doses,States/Local Areas,South Carolina,2020-2021,Age,24 Months,90.2,85.5 to 93.9,431
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,92.5,89.8 to 95.2,507
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.7,79.3 to 92.1,610
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.2,74.6 to 93.8,124
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Any Medicaid,87.3,83.0 to 91.6,415
Influenza,,States/Local Areas,South Carolina,2019,Age,24 Months,50.3,42.4 to 58.7,245
Influenza,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,44.6,38.9 to 50.2,508
Influenza,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,37.3,23.7 to 50.9,94
Influenza,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,47.3,40.7 to 54.0,395
Influenza,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",47.2,42.0 to 52.3,635
Influenza,,States/Local Areas,South Carolina,2017,Age,24 Months,42.1,35.0 to 50.1,288
Influenza,,States/Local Areas,South Carolina,2017-2018,Age,24 Months,41.7,36.4 to 47.5,532
Influenza,,States/Local Areas,South Carolina,2018,Age,24 Months,41.3,33.9 to 49.5,244
Influenza,,States/Local Areas,South Carolina,2018-2019,Age,24 Months,45.8,40.3 to 51.8,489
Influenza,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",40.6,30.9 to 50.3,131
Influenza,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,41.7,35.8 to 47.7,440
Influenza,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",41.3,28.1 to 54.5,91
Influenza,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,48.4,38.0 to 58.8,140
Influenza,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,51.3,45.4 to 57.2,501
Influenza,,States/Local Areas,South Carolina,2014-2017,Overall,Overall,45.0,40.9 to 49.1,997
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,84.4,75.6 to 93.2,138
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,83.2,78.7 to 87.7,507
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.4 to 98.6,507
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.0,73.0 to 96.9,90
Influenza,,States/Local Areas,South Carolina,2016,Age,24 Months,42.9,35.5 to 51.2,291
Influenza,,States/Local Areas,South Carolina,2016-2017,Age,24 Months,42.5,37.3 to 48.2,579
Influenza,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,27.5,11.4 to 43.5,47
Influenza,,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,61.5,53.5 to 69.4,247
PCV,≥1 Dose,States/Local Areas,South Carolina,2021,Age,3 Months,87.0,78.0 to 92.7,188
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,62.4 to 86.0,90
PCV,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,19 Months,91.7,86.8 to 94.8,488
Hep B,≥2 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,94.1,90.0 to 96.5,488
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2019,Poverty,>400% FPL,98.1,96.4 to 99.9,262
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019-2020,Age,7 Months,55.4,49.3 to 61.4,488
Hib,Full Series,States/Local Areas,South Carolina,2016-2019,Race and Ethnicity,Hispanic,69.6,59.0 to 80.2,138
Hib,Primary Series,States/Local Areas,South Carolina,2019,Age,19 Months,94.3,89.6 to 97.0,245
Hib,Primary Series,States/Local Areas,South Carolina,2011,Age,19 Months,93.1,87.7 to 96.2,252
Hib,Primary Series,States/Local Areas,South Carolina,2013,Age,19 Months,90.7,88.2 to 92.8,261
Hib,Primary Series,States/Local Areas,South Carolina,2013-2014,Age,19 Months,91.6,90.2 to 92.8,512
Hib,Primary Series,States/Local Areas,South Carolina,2014,Age,19 Months,92.4,87.0 to 95.7,251
Hib,Primary Series,States/Local Areas,South Carolina,2014-2015,Age,19 Months,94.0,91.1 to 96.1,524
Hib,Primary Series,States/Local Areas,South Carolina,2016,Age,13 Months,82.7,75.6 to 88.1,291
Hib,Primary Series,States/Local Areas,South Carolina,2016-2017,Age,13 Months,83.5,78.8 to 87.3,579
Hib,Primary Series,States/Local Areas,South Carolina,2011,Age,24 Months,93.1,88.4 to 96.4,252
Hib,Primary Series,States/Local Areas,South Carolina,2012,Age,24 Months,90.3,83.4 to 95.1,255
Hib,Primary Series,States/Local Areas,South Carolina,2017,Age,13 Months,84.2,77.4 to 89.2,288
Hib,Primary Series,States/Local Areas,South Carolina,2017-2018,Age,13 Months,84.9,80.2 to 88.6,532
Hib,Primary Series,States/Local Areas,South Carolina,2018,Age,13 Months,85.6,78.2 to 90.7,244
Hib,Primary Series,States/Local Areas,South Carolina,2018-2019,Age,13 Months,84.9,80.1 to 88.7,489
Hib,Primary Series,States/Local Areas,South Carolina,2012,Age,19 Months,90.3,83.8 to 94.3,255
Combined 7 Series,,States/Local Areas,South Carolina,2017,Age,24 Months,65.1,57.7 to 72.4,288
Combined 7 Series,,States/Local Areas,South Carolina,2017-2018,Age,24 Months,65.0,59.6 to 70.3,532
Combined 7 Series,,States/Local Areas,South Carolina,2018,Age,24 Months,64.8,56.8 to 72.8,244
Combined 7 Series,,States/Local Areas,South Carolina,2018-2019,Age,24 Months,67.5,62.0 to 73.0,489
Hib,Primary Series,States/Local Areas,South Carolina,2017,Age,7 Months,72.1,64.8 to 78.4,288
Hib,Primary Series,States/Local Areas,South Carolina,2017-2018,Age,7 Months,72.5,67.0 to 77.5,532
Hib,Primary Series,States/Local Areas,South Carolina,2016,Age,7 Months,72.2,64.3 to 78.9,291
Hib,Primary Series,States/Local Areas,South Carolina,2016-2017,Age,7 Months,72.2,66.9 to 76.9,579
Hib,Primary Series,States/Local Areas,South Carolina,2019,Age,7 Months,72.3,64.2 to 79.2,245
Hib,Primary Series,States/Local Areas,South Carolina,2012,Age,7 Months,73.0,68.6 to 77.1,255
Hib,Primary Series,States/Local Areas,South Carolina,2018,Age,7 Months,73.0,64.8 to 79.8,244
Hib,Primary Series,States/Local Areas,South Carolina,2018-2019,Age,7 Months,72.6,67.0 to 77.6,489
Hib,Primary Series,States/Local Areas,South Carolina,2015,Age,13 Months,86.4,79.0 to 91.5,273
Hib,Primary Series,States/Local Areas,South Carolina,2015-2016,Age,13 Months,84.6,79.7 to 88.5,564
Hib,Primary Series,States/Local Areas,South Carolina,2014,Age,13 Months,79.2,71.5 to 85.2,251
Hib,Primary Series,States/Local Areas,South Carolina,2014-2015,Age,13 Months,82.8,77.7 to 86.9,524
Hib,Primary Series,States/Local Areas,South Carolina,2015,Age,19 Months,95.6,95.1 to 96.2,273
Hib,Primary Series,States/Local Areas,South Carolina,2015-2016,Age,19 Months,93.9,91.0 to 95.9,564
Hib,Primary Series,States/Local Areas,South Carolina,2017,Age,19 Months,89.8,83.9 to 93.7,288
Hib,Primary Series,States/Local Areas,South Carolina,2017-2018,Age,19 Months,92.2,88.5 to 94.7,532
Hib,Primary Series,States/Local Areas,South Carolina,2018,Age,19 Months,94.5,89.3 to 97.3,244
Hib,Primary Series,States/Local Areas,South Carolina,2018-2019,Age,19 Months,84.9,80.1 to 88.7,489
Hib,Primary Series,States/Local Areas,South Carolina,2019,Age,13 Months,84.3,77.3 to 89.4,245
Hib,Primary Series,States/Local Areas,South Carolina,2015,Age,7 Months,69.2,60.6 to 76.7,273
Hib,Primary Series,States/Local Areas,South Carolina,2015-2016,Age,7 Months,70.7,64.9 to 75.9,564
Hib,Primary Series,States/Local Areas,South Carolina,2014,Age,7 Months,64.3,55.9 to 72.0,251
Hib,Primary Series,States/Local Areas,South Carolina,2014-2015,Age,7 Months,66.8,60.8 to 72.3,524
Hib,Primary Series,States/Local Areas,South Carolina,2016,Age,19 Months,92.1,86.8 to 95.4,291
Hib,Primary Series,States/Local Areas,South Carolina,2016-2017,Age,19 Months,91.0,87.2 to 93.7,579
Hib,Primary Series,States/Local Areas,South Carolina,2011,Age,13 Months,87.3,82.1 to 91.1,252
Hib,Primary Series,States/Local Areas,South Carolina,2012,Age,13 Months,84.8,78.6 to 89.5,255
Hib,Primary Series,States/Local Areas,South Carolina,2013,Age,13 Months,83.9,76.1 to 89.5,261
Hib,Primary Series,States/Local Areas,South Carolina,2013-2014,Age,13 Months,81.5,79.4 to 83.5,512
Hib,Primary Series,States/Local Areas,South Carolina,2015,Age,35 Months,97.1,94.5 to 98.7,273
Hib,Primary Series,States/Local Areas,South Carolina,2015-2016,Age,35 Months,96.2,93.5 to 98.0,564
Combined 7 Series,,States/Local Areas,South Carolina,2011,Age,24 Months,68.8,60.8 to 76.4,252
Hib,Primary Series,States/Local Areas,South Carolina,2013,Age,35 Months,92.8,87.2 to 96.5,261
Hib,Primary Series,States/Local Areas,South Carolina,2013-2014,Age,35 Months,94.0,90.9 to 96.4,512
Hib,Primary Series,States/Local Areas,South Carolina,2011,Age,35 Months,93.1,88.4 to 96.4,252
Hib,Primary Series,States/Local Areas,South Carolina,2019,Age,24 Months,95.7,92.4 to 97.9,245
Hib,Primary Series,States/Local Areas,South Carolina,2012,Age,35 Months,90.3,83.4 to 95.1,255
Hib,Primary Series,States/Local Areas,South Carolina,2014,Age,35 Months,95.3,92.0 to 97.5,251
Hib,Primary Series,States/Local Areas,South Carolina,2014-2015,Age,35 Months,96.2,94.3 to 97.7,524
Hib,Primary Series,States/Local Areas,South Carolina,2013,Age,24 Months,92.6,87.1 to 96.3,261
Hib,Primary Series,States/Local Areas,South Carolina,2013-2014,Age,24 Months,94.0,90.8 to 96.3,512
Combined 7 Series,,States/Local Areas,South Carolina,2013,Age,24 Months,61.5,53.8 to 69.2,261
Combined 7 Series,,States/Local Areas,South Carolina,2013-2014,Age,24 Months,61.4,55.8 to 67.0,512
Hib,Primary Series,States/Local Areas,South Carolina,2015,Age,24 Months,96.4,93.7 to 98.2,273
Hib,Primary Series,States/Local Areas,South Carolina,2015-2016,Age,24 Months,95.2,92.7 to 97.1,564
Hib,Primary Series,States/Local Areas,South Carolina,2014,Age,24 Months,95.3,92.0 to 97.5,251
Hib,Primary Series,States/Local Areas,South Carolina,2014-2015,Age,24 Months,95.9,93.9 to 97.4,524
Hib,Primary Series,States/Local Areas,South Carolina,2018,Age,24 Months,96.0,91.9 to 98.4,244
Hib,Primary Series,States/Local Areas,South Carolina,2018-2019,Age,24 Months,95.8,93.3 to 97.6,489
Hib,Primary Series,States/Local Areas,South Carolina,2016,Age,24 Months,93.9,89.3 to 97.0,291
Hib,Primary Series,States/Local Areas,South Carolina,2016-2017,Age,24 Months,92.0,88.6 to 94.7,579
Hib,Primary Series,States/Local Areas,South Carolina,2017,Age,24 Months,90.3,84.9 to 94.4,288
Hib,Primary Series,States/Local Areas,South Carolina,2017-2018,Age,24 Months,93.2,89.9 to 95.7,532
Combined 7 Series,,States/Local Areas,South Carolina,2012,Age,35 Months,77.2,66.5 to 86.4,255
Combined 7 Series,,States/Local Areas,South Carolina,2014,Age,35 Months,69.2,60.6 to 77.5,251
Combined 7 Series,,States/Local Areas,South Carolina,2014-2015,Age,35 Months,69.3,63.3 to 75.1,524
Hib,Primary Series,States/Local Areas,South Carolina,2017,Age,35 Months,91.0,85.5 to 95.0,288
Hib,Primary Series,States/Local Areas,South Carolina,2017-2018,Age,35 Months,94.2,91.0 to 96.5,532
Combined 7 Series,,States/Local Areas,South Carolina,2016,Age,24 Months,65.7,58.2 to 73.1,291
Combined 7 Series,,States/Local Areas,South Carolina,2016-2017,Age,24 Months,65.4,60.1 to 70.6,579
Hib,Primary Series,States/Local Areas,South Carolina,2019,Age,35 Months,96.2,93.0 to 98.2,245
Hib,Primary Series,States/Local Areas,South Carolina,2013,Age,7 Months,73.9,70.8 to 76.8,261
Hib,Primary Series,States/Local Areas,South Carolina,2013-2014,Age,7 Months,69.1,65.7 to 72.3,512
Combined 7 Series,,States/Local Areas,South Carolina,2019,Age,24 Months,70.1,62.4 to 77.4,245
Combined 7 Series,,States/Local Areas,South Carolina,2014,Age,24 Months,61.5,53.2 to 69.8,251
Combined 7 Series,,States/Local Areas,South Carolina,2014-2015,Age,24 Months,62.5,56.8 to 68.3,524
Combined 7 Series,,States/Local Areas,South Carolina,2015,Age,24 Months,63.6,55.8 to 71.4,273
Combined 7 Series,,States/Local Areas,South Carolina,2015-2016,Age,24 Months,64.7,59.2 to 70.1,564
Hib,Primary Series,States/Local Areas,South Carolina,2018,Age,35 Months,97.4,93.6 to 99.2,244
Hib,Primary Series,States/Local Areas,South Carolina,2018-2019,Age,35 Months,96.8,94.6 to 98.3,489
Combined 7 Series,,States/Local Areas,South Carolina,2013,Age,35 Months,70.0,61.9 to 77.8,261
Combined 7 Series,,States/Local Areas,South Carolina,2013-2014,Age,35 Months,69.7,63.7 to 75.4,512
Combined 7 Series,,States/Local Areas,South Carolina,2016,Age,35 Months,79.2,70.6 to 86.7,291
Combined 7 Series,,States/Local Areas,South Carolina,2016-2017,Age,35 Months,73.7,67.8 to 79.3,579
Combined 7 Series,,States/Local Areas,South Carolina,2017,Age,35 Months,67.5,60.0 to 74.8,288
Combined 7 Series,,States/Local Areas,South Carolina,2017-2018,Age,35 Months,70.8,64.7 to 76.6,532
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,43.1,26.1 to 60.1,47
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,65.8,60.4 to 71.2,508
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,66.6,60.2 to 72.9,395
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",65.5,60.7 to 70.4,635
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.1,53.0 to 77.2,91
Hep A,≥1 Dose,States/Local Areas,South Carolina,2013,Age,24 Months,84.1,77.7 to 89.5,261
Hep A,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,24 Months,84.6,80.3 to 88.4,512
Hep A,≥1 Dose,States/Local Areas,South Carolina,2011,Age,24 Months,81.3,74.1 to 87.6,252
Hep A,≥1 Dose,States/Local Areas,South Carolina,2019,Age,19 Months,89.2,83.7 to 93.0,245
Hep A,≥1 Dose,States/Local Areas,South Carolina,2012,Age,24 Months,78.4,70.2 to 85.5,255
Combined 7 Series,,States/Local Areas,South Carolina,2018,Age,35 Months,73.6,64.4 to 82.1,244
Combined 7 Series,,States/Local Areas,South Carolina,2018-2019,Age,35 Months,74.2,68.3 to 79.8,489
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,64.4,58.6 to 70.3,440
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,70.0,64.6 to 75.5,501
Combined 7 Series,,States/Local Areas,South Carolina,2019,Age,35 Months,74.7,67.0 to 81.9,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,94.4,89.7 to 97.4,291
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,94.2,91.2 to 96.4,579
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,97.7,95.1 to 99.1,273
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,96.3,93.7 to 98.0,564
PCV,≥2 Doses,States/Local Areas,South Carolina,2011,Age,5 Months,77.3,72.6 to 81.4,252
PCV,≥2 Doses,States/Local Areas,South Carolina,2012,Age,5 Months,70.3,64.8 to 75.3,255
PCV,≥2 Doses,States/Local Areas,South Carolina,2013,Age,5 Months,71.6,65.9 to 76.7,261
PCV,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,5 Months,73.9,70.2 to 77.2,512
DTaP,≥4 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,69.4,60.0 to 77.4,255
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,24.5,17.8 to 32.7,251
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,24.9,20.3 to 30.2,524
DTaP,≥4 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,67.8,60.1 to 74.6,252
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,93.9,89.7 to 96.8,288
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,95.9,92.6 to 98.1,532
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,67.5,57.4 to 77.5,140
Combined 7 Series,,States/Local Areas,South Carolina,2015,Age,35 Months,69.5,61.2 to 77.4,273
Combined 7 Series,,States/Local Areas,South Carolina,2015-2016,Age,35 Months,74.5,68.5 to 80.2,564
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Overall,Overall,65.8,61.8 to 69.8,997
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,62.5,48.8 to 76.3,94
Hib,≥3 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,89.8,80.0 to 96.1,252
Hib,≥3 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,90.6,82.1 to 96.1,255
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016,Age,19 Months,85.0,78.5 to 89.8,291
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,19 Months,84.3,80.0 to 87.9,579
Hep A,≥1 Dose,States/Local Areas,South Carolina,2017,Age,19 Months,83.6,77.3 to 88.4,288
Hep A,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,19 Months,85.8,81.5 to 89.3,532
Combined 7 Series,,States/Local Areas,South Carolina,2011,Age,35 Months,72.9,63.8 to 81.3,252
≥1 Dose MMR,,States/Local Areas,South Carolina,2020,Age,13 Months,57.7,49.0 to 65.9,243
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,60.4,53.7 to 67.1,327
Hib,Full Series,States/Local Areas,South Carolina,2016,Age,19 Months,72.3,64.7 to 78.8,291
Hib,Full Series,States/Local Areas,South Carolina,2016-2017,Age,19 Months,71.9,66.6 to 76.7,579
Hib,Full Series,States/Local Areas,South Carolina,2015,Age,19 Months,65.1,60.8 to 69.2,273
Hib,Full Series,States/Local Areas,South Carolina,2015-2016,Age,19 Months,68.7,63.0 to 73.8,564
Hib,Full Series,States/Local Areas,South Carolina,2014,Age,19 Months,63.1,55.0 to 70.6,251
Hib,Full Series,States/Local Areas,South Carolina,2014-2015,Age,19 Months,64.1,58.4 to 69.5,524
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.6,55.8 to 75.3,131
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,66.4,58.0 to 74.9,247
Combined 7 Series,,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,71.3,65.5 to 77.1,423
Hib,Full Series,States/Local Areas,South Carolina,2011,Age,19 Months,72.6,67.1 to 77.5,252
Hib,Full Series,States/Local Areas,South Carolina,2012,Age,19 Months,72.9,67.8 to 77.4,255
Hib,Full Series,States/Local Areas,South Carolina,2013,Age,19 Months,70.8,57.2 to 81.5,261
Hib,Full Series,States/Local Areas,South Carolina,2013-2014,Age,19 Months,67.0,62.4 to 71.2,512
Hib,Full Series,States/Local Areas,South Carolina,2019,Age,19 Months,72.0,64.0 to 78.8,245
Hib,Full Series,States/Local Areas,South Carolina,2018,Age,19 Months,69.2,60.9 to 76.4,244
Hib,Full Series,States/Local Areas,South Carolina,2018-2019,Age,19 Months,96.4,93.9 to 97.9,489
Hib,Full Series,States/Local Areas,South Carolina,2017,Age,19 Months,71.5,63.8 to 78.1,288
Hib,Full Series,States/Local Areas,South Carolina,2017-2018,Age,19 Months,70.4,64.9 to 75.3,532
Hib,Full Series,States/Local Areas,South Carolina,2012,Age,24 Months,77.7,70.0 to 84.6,255
Hib,Full Series,States/Local Areas,South Carolina,2011,Age,24 Months,78.0,70.4 to 84.8,252
Hib,Full Series,States/Local Areas,South Carolina,2013,Age,24 Months,74.3,66.9 to 81.1,261
Hib,Full Series,States/Local Areas,South Carolina,2013-2014,Age,24 Months,72.8,67.4 to 77.9,512
Hib,Full Series,States/Local Areas,South Carolina,2014,Age,24 Months,71.5,63.7 to 78.8,251
Hib,Full Series,States/Local Areas,South Carolina,2014-2015,Age,24 Months,71.7,66.2 to 76.9,524
Hib,Primary Series,States/Local Areas,South Carolina,2016,Age,35 Months,95.1,89.4 to 98.3,291
Hib,Primary Series,States/Local Areas,South Carolina,2016-2017,Age,35 Months,93.0,89.3 to 95.8,579
Combined 7 Series,,States/Local Areas,South Carolina,2012,Age,24 Months,67.3,58.7 to 75.6,255
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.8,50.3 to 100.0,44
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,74.7,66.7 to 82.6,223
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,85.2,80.5 to 89.9,557
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,91.4,86.8 to 94.5,507
Influenza,,States/Local Areas,NY-Rest of state,2016,Age,24 Months,62.3,53.1 to 71.6,203
Influenza,,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,65.5,59.2 to 71.7,448
Influenza,,States/Local Areas,NY-Rest of state,2017,Age,24 Months,68.9,60.4 to 77.0,245
Influenza,,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,69.5,63.9 to 75.0,527
Influenza,,States/Local Areas,NY-Rest of state,2018,Age,24 Months,70.2,62.6 to 77.4,282
Influenza,,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,69.7,63.7 to 75.4,507
Influenza,,States/Local Areas,NY-Rest of state,2019,Age,24 Months,69.0,59.8 to 77.9,225
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,51.6,37.3 to 66.0,83
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,88.8,83.5 to 92.6,466
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,75.2 to 93.4,125
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,65.6,56.0 to 75.3,140
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.9,51.5 to 74.3,129
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.5,41.6 to 77.5,43
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,60.2,52.8 to 67.6,252
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.5,64.4 to 74.7,564
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,66.9,58.4 to 75.4,225
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.3,64.3 to 74.3,576
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,53.2,38.9 to 67.6,75
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.5,73.1 to 97.9,125
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,75.0,66.6 to 82.7,466
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,91.4,86.6 to 94.6,466
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,75.0,69.0 to 80.2,466
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,94.5,86.6 to 98.5,184
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,3 Months,84.5,75.4 to 90.6,184
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,87.1,80.6 to 93.7,223
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,95.6,92.9 to 98.3,557
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,85.4,81.0 to 89.9,557
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,67.0,62.9 to 71.2,876
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,62.4,55.1 to 69.7,246
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,59.1,51.2 to 67.1,275
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,79.2,73.2 to 85.1,355
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,88.9,84.8 to 93.0,557
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,86.1,81.0 to 90.0,466
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,3 Months,92.9,88.3 to 95.8,466
Hib,Full Series,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,83.0,76.9 to 88.2,466
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,60.5,54.2 to 66.6,466
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,96.4,91.8 to 98.8,466
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,92.4,87.6 to 95.4,466
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2020-2021,Age,0-3 Days,79.2,73.4 to 84.0,466
Rotavirus,,States/Local Areas,NY-Rest of state,2020-2021,Age,8 Months,75.9,69.9 to 81.0,466
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2021,Age,35 Months,91.8,83.9 to 96.7,184
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,92.9,85.1 to 97.5,184
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,75.8,70.0 to 80.8,466
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,93.2,84.3 to 97.2,184
Hib,Full Series,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,71.9,65.8 to 77.2,466
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,91.6,84.1 to 96.5,466
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,76.6,70.6 to 81.8,466
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,93.7,89.4 to 96.6,466
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,88.8,78.6 to 95.5,184
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,48.4,42.1 to 54.7,466
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,87.5,82.3 to 91.8,466
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2020-2021,Age,0-1 Days,76.6,70.5 to 81.7,466
Influenza,,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,59.6,53.3 to 66.0,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,91.5,86.4 to 94.9,466
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,97.6,90.6 to 99.7,184
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,89.2,84.1 to 92.8,466
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,95.4,89.3 to 98.6,466
Hib,Primary Series,States/Local Areas,NY-Rest of state,2021,Age,13 Months,85.5,76.2 to 91.6,184
Combined 7 Series,,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,70.8,64.8 to 76.5,466
Hib,Full Series,States/Local Areas,NY-Rest of state,2021,Age,35 Months,83.2,73.2 to 91.0,184
Rotavirus,,States/Local Areas,NY-Rest of state,2021,Age,8 Months,76.4,66.7 to 84.0,184
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,94.5,86.6 to 98.5,184
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,90.6,85.4 to 94.1,466
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,91.8,87.0 to 94.9,466
Combined 7 Series,,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,80.4,73.5 to 86.5,466
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,3 Months,87.3,82.4 to 91.0,466
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,85.3,79.8 to 89.5,466
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,5 Months,82.6,77.0 to 87.0,466
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,96.5,92.0 to 98.8,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,92.2,87.5 to 95.6,466
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,5 Months,86.7,81.3 to 90.7,466
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,77.3,67.5 to 84.9,184
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,91.5,87.0 to 95.0,466
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2021,Age,0-3 Days,79.8,70.4 to 86.8,184
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,92.1,87.7 to 95.4,466
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,31.5,25.9 to 38.1,466
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,73.5,67.6 to 78.7,466
Hib,Primary Series,States/Local Areas,NY-Rest of state,2021,Age,35 Months,94.8,86.8 to 98.7,184
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,92.4,88.0 to 95.6,466
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,5 Months,83.2,77.7 to 87.6,466
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,93.4,84.4 to 97.3,184
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,94.4,86.5 to 98.4,184
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,92.9,88.6 to 96.0,466
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,3 Months,89.4,84.7 to 92.8,466
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,3 Months,85.7,80.4 to 89.7,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,89.0,83.8 to 92.7,466
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,61.6,55.4 to 67.5,466
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,89.2,84.3 to 92.7,466
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2021,Age,13 Months,58.7,48.7 to 68.0,184
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,50.6,44.3 to 56.8,466
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,91.6,87.4 to 94.5,507
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,74.2,61.6 to 86.8,156
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.2,95.6 to 100.0,125
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,94.0,88.8 to 99.2,156
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,77.9,69.4 to 86.5,156
Influenza,,States/Local Areas,NY-Rest of state,2014,Age,24 Months,65.6,58.3 to 72.8,287
Influenza,,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,66.8,61.6 to 71.9,541
Influenza,,States/Local Areas,NY-Rest of state,2015,Age,24 Months,68.1,60.6 to 75.3,254
Influenza,,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,65.2,59.2 to 71.1,457
Influenza,,States/Local Areas,NY-Rest of state,2012,Age,24 Months,65.8,58.3 to 73.1,249
Influenza,,States/Local Areas,NY-Rest of state,2011,Age,24 Months,60.1,51.5 to 68.8,217
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,97.6,95.5 to 99.8,398
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,48.7,42.5 to 55.0,507
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,3 Months,93.7,85.1 to 97.5,184
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,71.7,63.7 to 79.6,223
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,84.4 to 98.0,125
Influenza,,States/Local Areas,NY-Rest of state,2013,Age,24 Months,61.9,54.3 to 69.6,266
Influenza,,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,63.7,58.3 to 69.1,553
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,74.0,53.1 to 90.9,184
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016,Age,24 Months,67.5,58.3 to 76.4,203
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,69.6,63.3 to 75.6,448
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019,Age,35 Months,91.1,84.4 to 95.7,225
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014,Age,24 Months,73.3,66.2 to 80.0,287
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,71.0,65.9 to 76.1,541
Combined 7 Series,,States/Local Areas,NY-Rest of state,2015,Age,24 Months,68.8,61.2 to 76.1,254
Combined 7 Series,,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,68.2,62.2 to 74.0,457
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018,Age,35 Months,94.9,90.4 to 97.7,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,93.0,89.1 to 95.9,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,79.2,69.7 to 86.4,184
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,91.4,81.6 to 96.2,184
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,35 Months,89.3,78.8 to 96.0,184
Hib,Primary Series,States/Local Areas,NY-Rest of state,2021,Age,7 Months,77.7,68.7 to 84.8,184
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,92.2,87.4 to 95.3,466
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,93.9,86.3 to 98.1,184
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,71.9,62.0 to 80.1,184
Hib,Full Series,States/Local Areas,NY-Rest of state,2021,Age,24 Months,78.5,69.5 to 86.4,184
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,3 Months,89.2,80.9 to 94.1,184
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,94.4,86.5 to 98.4,184
Hib,Primary Series,States/Local Areas,NY-Rest of state,2021,Age,24 Months,94.8,86.8 to 98.7,184
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016,Age,35 Months,72.2,62.6 to 81.1,203
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,75.3,68.8 to 81.3,448
Combined 7 Series,,States/Local Areas,NY-Rest of state,2017,Age,35 Months,78.6,70.0 to 86.1,245
Combined 7 Series,,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,78.4,72.6 to 83.7,527
Combined 7 Series,,States/Local Areas,NY-Rest of state,2019,Age,24 Months,65.6,56.1 to 74.9,225
Combined 7 Series,,States/Local Areas,NY-Rest of state,2017,Age,24 Months,71.7,63.1 to 79.7,245
Combined 7 Series,,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,71.4,65.7 to 76.8,527
Combined 7 Series,,States/Local Areas,NY-Rest of state,2018,Age,24 Months,70.9,63.5 to 78.1,282
Combined 7 Series,,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,68.5,62.4 to 74.4,507
Combined 7 Series,,States/Local Areas,NY-Rest of state,2011,Age,35 Months,71.4,62.9 to 79.4,217
Combined 7 Series,,States/Local Areas,NY-Rest of state,2013,Age,35 Months,83.4,73.9 to 91.0,266
Combined 7 Series,,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,81.1,75.4 to 86.1,553
Combined 7 Series,,States/Local Areas,NY-Rest of state,2012,Age,35 Months,79.2,70.8 to 86.5,249
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014,Age,35 Months,79.6,72.4 to 86.0,287
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,76.5,71.2 to 81.4,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017,Age,24 Months,97.4,93.5 to 99.2,245
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,95.6,93.0 to 97.5,527
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018,Age,24 Months,93.9,89.6 to 96.8,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,92.5,88.6 to 95.4,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015,Age,13 Months,89.4,83.9 to 93.2,254
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,88.3,83.5 to 91.8,457
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014,Age,13 Months,94.9,90.8 to 97.2,287
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,92.1,88.9 to 94.5,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2012,Age,35 Months,95.1,90.8 to 97.8,249
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014,Age,35 Months,98.9,97.1 to 99.7,287
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,97.0,94.5 to 98.6,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2011,Age,35 Months,94.9,89.7 to 98.0,217
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019,Age,24 Months,91.1,84.4 to 95.7,225
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013,Age,35 Months,95.2,90.0 to 98.2,266
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,97.1,94.2 to 98.8,553
Combined 7 Series,,States/Local Areas,NY-Rest of state,2013,Age,24 Months,71.4,64.3 to 78.1,266
Combined 7 Series,,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,72.4,67.3 to 77.2,553
Combined 7 Series,,States/Local Areas,NY-Rest of state,2012,Age,24 Months,67.5,60.1 to 74.8,249
Combined 7 Series,,States/Local Areas,NY-Rest of state,2011,Age,24 Months,64.0,55.7 to 72.3,217
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015,Age,35 Months,94.3,90.2 to 97.0,254
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,94.1,90.1 to 96.8,457
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017,Age,35 Months,97.4,93.5 to 99.2,245
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,96.1,93.4 to 98.0,527
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016,Age,35 Months,93.6,86.4 to 97.8,203
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,95.5,91.4 to 98.0,448
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016,Age,24 Months,92.3,85.0 to 96.8,203
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,94.8,90.7 to 97.4,448
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019,Age,7 Months,69.5,60.0 to 77.6,225
Hib,Primary Series,States/Local Areas,NY-Rest of state,2011,Age,13 Months,87.1,75.8 to 93.6,217
Hib,Primary Series,States/Local Areas,NY-Rest of state,2012,Age,13 Months,93.4,89.8 to 95.8,249
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013,Age,13 Months,89.1,87.3 to 90.6,266
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,92.0,89.8 to 93.7,553
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015,Age,24 Months,94.2,90.2 to 97.0,254
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,93.3,89.3 to 96.2,457
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014,Age,24 Months,96.9,93.4 to 98.8,287
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,95.6,93.1 to 97.4,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013,Age,24 Months,94.2,89.3 to 97.3,266
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,95.5,92.7 to 97.5,553
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018,Age,7 Months,69.6,61.9 to 76.3,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,69.6,63.5 to 75.0,507
Hib,Full Series,States/Local Areas,NY-Rest of state,2012,Age,24 Months,83.1,76.9 to 88.5,249
Hib,Full Series,States/Local Areas,NY-Rest of state,2011,Age,24 Months,77.3,69.9 to 84.0,217
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013,Age,7 Months,62.8,58.6 to 66.8,266
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,69.6,63.9 to 74.7,553
Hib,Primary Series,States/Local Areas,NY-Rest of state,2011,Age,24 Months,94.0,88.9 to 97.2,217
Hib,Primary Series,States/Local Areas,NY-Rest of state,2012,Age,24 Months,95.1,90.8 to 97.8,249
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017,Age,7 Months,74.5,65.7 to 81.7,245
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,72.1,66.3 to 77.2,527
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016,Age,7 Months,68.5,58.7 to 76.9,203
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,71.4,64.9 to 77.2,448
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015,Age,7 Months,66.5,58.4 to 73.8,254
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,67.5,61.2 to 73.3,457
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014,Age,7 Months,76.4,69.4 to 82.2,287
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,71.5,66.2 to 76.2,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018,Age,19 Months,93.3,88.4 to 96.2,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,88.5,83.8 to 91.9,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019,Age,19 Months,91.1,83.5 to 95.4,225
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017,Age,19 Months,96.8,92.1 to 98.7,245
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,95.1,92.0 to 97.0,527
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016,Age,19 Months,91.3,83.1 to 95.7,203
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,94.0,89.4 to 96.6,448
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015,Age,19 Months,93.5,90.0 to 95.8,254
Hib,Primary Series,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,92.4,87.9 to 95.2,457
Hib,Primary Series,States/Local Areas,NY-Rest of state,2012,Age,19 Months,94.1,90.7 to 96.3,249
Hib,Primary Series,States/Local Areas,NY-Rest of state,2011,Age,19 Months,93.7,88.5 to 96.6,217
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013,Age,19 Months,93.8,92.2 to 95.1,266
Hib,Primary Series,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,95.2,92.8 to 96.8,553
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014,Age,19 Months,96.5,92.5 to 98.4,287
Hib,Primary Series,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,95.0,92.2 to 96.8,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017,Age,13 Months,91.1,84.4 to 95.1,245
Hib,Primary Series,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,90.0,85.8 to 93.1,527
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019,Age,13 Months,88.1,80.4 to 93.0,225
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018,Age,13 Months,88.9,82.7 to 93.1,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,88.5,83.8 to 91.9,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016,Age,13 Months,87.2,78.9 to 92.6,203
Hib,Primary Series,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,89.1,84.0 to 92.7,448
Hib,Full Series,States/Local Areas,NY-Rest of state,2013,Age,24 Months,83.8,77.4 to 89.2,266
Hib,Full Series,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,84.4,80.0 to 88.2,553
Hib,Full Series,States/Local Areas,NY-Rest of state,2014,Age,24 Months,85.0,78.8 to 90.1,287
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,83.1,78.6 to 87.1,541
Hib,Full Series,States/Local Areas,NY-Rest of state,2017,Age,19 Months,81.7,74.3 to 87.4,245
Hib,Full Series,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,77.6,72.5 to 82.0,527
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",55.1,35.6 to 74.7,43
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,62.6,55.0 to 70.1,246
Hib,Full Series,States/Local Areas,NY-Rest of state,2019,Age,19 Months,74.8,65.1 to 82.6,225
Hib,Full Series,States/Local Areas,NY-Rest of state,2018,Age,19 Months,73.4,66.1 to 79.6,282
Hib,Full Series,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,94.2,90.3 to 96.6,507
Hib,Full Series,States/Local Areas,NY-Rest of state,2014,Age,19 Months,77.0,69.8 to 82.9,287
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,75.6,70.5 to 80.0,541
Hib,Full Series,States/Local Areas,NY-Rest of state,2016,Age,19 Months,73.9,64.6 to 81.5,203
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,77.7,71.9 to 82.7,448
Hib,Full Series,States/Local Areas,NY-Rest of state,2015,Age,19 Months,74.1,67.7 to 79.6,254
Hib,Full Series,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,74.0,68.1 to 79.1,457
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,81.7,70.6 to 92.7,83
Influenza,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,75.3,70.4 to 80.3,524
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,66.6,56.4 to 76.8,140
Combined 7 Series,,States/Local Areas,NY-Rest of state,2015,Age,35 Months,73.5,65.8 to 80.6,254
Combined 7 Series,,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,72.9,66.7 to 78.7,457
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,71.9,64.9 to 78.9,275
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,78.1,71.8 to 84.3,355
Hib,Full Series,States/Local Areas,NY-Rest of state,2011,Age,19 Months,70.2,56.3 to 81.1,217
Hib,Full Series,States/Local Areas,NY-Rest of state,2012,Age,19 Months,78.2,73.7 to 82.1,249
Hib,Full Series,States/Local Areas,NY-Rest of state,2013,Age,19 Months,74.2,68.2 to 79.5,266
Hib,Full Series,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,75.6,73.0 to 78.1,553
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,70.7,66.6 to 74.7,876
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,79.9,69.6 to 90.2,75
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,65.8 to 84.8,129
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.9,68.0 to 77.8,564
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,68.1,59.4 to 76.9,225
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.2,65.1 to 75.2,576
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,73.4,68.1 to 78.6,524
Combined 7 Series,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,66.9,59.8 to 74.0,252
Combined 7 Series,,States/Local Areas,NY-Rest of state,2019,Age,35 Months,73.0,63.1 to 82.2,225
Combined 7 Series,,States/Local Areas,NY-Rest of state,2018,Age,35 Months,78.2,70.2 to 85.3,282
Combined 7 Series,,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,75.5,69.2 to 81.4,507
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,76.4,64.2 to 88.7,83
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,81.9,77.3 to 86.5,524
Rotavirus,,States/Local Areas,NY-Rest of state,2016,Age,8 Months,77.6,68.2 to 84.8,203
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2017,Age,8 Months,76.7,70.4 to 81.9,448
Rotavirus,,States/Local Areas,NY-Rest of state,2014,Age,8 Months,78.7,72.0 to 84.2,287
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2015,Age,8 Months,77.2,72.3 to 81.5,541
Rotavirus,,States/Local Areas,NY-Rest of state,2015,Age,8 Months,75.7,68.3 to 81.8,254
Rotavirus,,States/Local Areas,NY-Rest of state,2015-2016,Age,8 Months,76.7,70.8 to 81.6,457
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.9,73.2 to 82.5,564
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,80.1,72.5 to 87.6,225
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.7,62.6 to 84.8,129
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,70.5,63.3 to 77.7,252
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.1,41.8 to 80.4,43
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,77.4,68.8 to 86.1,140
Rotavirus,,States/Local Areas,NY-Rest of state,2019,Age,8 Months,80.5,71.4 to 87.3,225
Rotavirus,,States/Local Areas,NY-Rest of state,2017,Age,8 Months,75.7,66.9 to 82.7,245
Rotavirus,,States/Local Areas,NY-Rest of state,2017-2018,Age,8 Months,76.3,70.7 to 81.1,527
Rotavirus,,States/Local Areas,NY-Rest of state,2018,Age,8 Months,77.0,69.6 to 83.1,282
Rotavirus,,States/Local Areas,NY-Rest of state,2018-2019,Age,8 Months,78.8,73.1 to 83.5,507
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,77.9,71.3 to 84.4,355
Rotavirus,,States/Local Areas,NY-Rest of state,2013,Age,8 Months,72.2,64.6 to 78.7,266
Rotavirus,,States/Local Areas,NY-Rest of state,2013-2014,Age,8 Months,75.4,70.3 to 79.9,553
Rotavirus,,States/Local Areas,NY-Rest of state,2012,Age,8 Months,74.6,67.2 to 80.8,249
Rotavirus,,States/Local Areas,NY-Rest of state,2011,Age,8 Months,68.2,59.3 to 76.0,217
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,75.1,68.0 to 82.2,275
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,76.0,72.1 to 79.9,876
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,75.0,68.2 to 81.7,246
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.3,69.5 to 79.2,576
Rotavirus,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,76.9,63.8 to 90.1,75
Influenza,,States/Local Areas,NY-Rest of state,2021,Age,24 Months,62.6,52.7 to 72.5,184
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2021,Age,19 Months,89.6,81.0 to 94.5,184
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,5 Months,89.4,80.4 to 94.5,184
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,18.3,13.9 to 23.7,466
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,90.0,84.7 to 93.6,466
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,89.8,81.4 to 94.7,184
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2021,Age,13 Months,50.6,40.9 to 60.3,184
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,5 Months,84.0,74.8 to 90.3,184
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,5 Months,84.9,75.6 to 91.1,184
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,92.4,84.4 to 96.5,203
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,94.5,90.2 to 97.0,448
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,94.0,90.2 to 96.3,254
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,93.2,88.9 to 95.9,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,96.3,92.8 to 98.2,287
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,95.1,92.5 to 96.9,541
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,94.3,90.1 to 97.1,466
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,93.9,89.7 to 96.8,466
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,91.7,86.9 to 94.8,466
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2020-2021,Age,0-2 Days,77.8,71.8 to 82.8,466
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,69.5,63.3 to 75.1,466
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,5 Months,81.4,75.8 to 85.9,466
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,93.5,88.7 to 96.3,466
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,3 Months,90.2,85.5 to 93.5,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,7 Months,67.6,61.3 to 73.3,466
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,82.3,76.7 to 87.3,466
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,5 Months,81.4,74.5 to 86.8,254
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,5 Months,79.7,73.9 to 84.5,457
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,93.7,86.5 to 97.8,203
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,95.4,91.2 to 98.0,448
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,96.6,92.9 to 98.7,245
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,96.3,93.3 to 98.3,527
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,5 Months,83.8,77.3 to 88.7,287
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,5 Months,82.6,78.1 to 86.3,541
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,81.8,73.8 to 89.8,140
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.7,76.7 to 92.6,129
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.7,78.6 to 86.8,564
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,80.9,73.5 to 88.3,225
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.4,78.3 to 86.4,576
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,95.5,90.8 to 98.2,282
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,92.2,87.6 to 95.6,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,93.5,89.4 to 96.5,254
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,93.8,89.8 to 96.7,457
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,93.1,88.0 to 96.6,217
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,94.6,90.2 to 97.4,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,93.1,88.1 to 96.5,266
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,94.2,91.1 to 96.5,553
Hib,Full Series,States/Local Areas,NY-Rest of state,2016,Age,24 Months,81.1,72.9 to 88.1,203
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,83.0,77.7 to 87.6,448
Hib,Full Series,States/Local Areas,NY-Rest of state,2017,Age,24 Months,84.9,78.0 to 90.5,245
Hib,Full Series,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,82.5,77.7 to 86.7,527
Hib,Full Series,States/Local Areas,NY-Rest of state,2018,Age,24 Months,79.9,73.2 to 85.9,282
Hib,Full Series,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,78.6,73.0 to 83.7,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,96.6,92.9 to 98.7,245
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,95.2,92.4 to 97.2,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,90.8,83.2 to 95.1,225
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,88.9,80.9 to 94.6,225
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,93.6,89.2 to 96.6,282
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,91.3,86.8 to 94.7,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,96.7,93.1 to 98.7,249
Hib,Full Series,States/Local Areas,NY-Rest of state,2017,Age,35 Months,90.6,83.7 to 95.5,245
Hib,Full Series,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,88.6,83.7 to 92.6,527
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,5 Months,74.2,67.9 to 79.6,217
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,5 Months,79.2,74.9 to 82.9,249
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,5 Months,77.8,73.4 to 81.6,266
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,5 Months,80.8,76.1 to 84.8,553
Hib,Full Series,States/Local Areas,NY-Rest of state,2019,Age,24 Months,76.8,67.7 to 84.9,225
Hib,Full Series,States/Local Areas,NY-Rest of state,2012,Age,35 Months,87.0,80.5 to 92.1,249
Hib,Full Series,States/Local Areas,NY-Rest of state,2011,Age,35 Months,81.8,74.1 to 88.3,217
Hib,Full Series,States/Local Areas,NY-Rest of state,2013,Age,35 Months,93.5,83.8 to 98.3,266
Hib,Full Series,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,91.2,86.1 to 95.0,553
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,96.1,91.1 to 98.7,266
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,97.0,94.3 to 98.7,553
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,98.1,95.3 to 99.4,287
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,95.9,93.5 to 97.6,541
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,94.6,90.4 to 97.3,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,95.2,91.2 to 97.8,287
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,93.3,90.2 to 95.7,541
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,77.7,71.5 to 83.9,252
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.1,58.4 to 91.8,43
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,86.3,82.4 to 90.3,524
Hib,Full Series,States/Local Areas,NY-Rest of state,2015,Age,35 Months,86.2,79.9 to 91.3,254
Hib,Full Series,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,84.8,79.5 to 89.3,457
Hib,Full Series,States/Local Areas,NY-Rest of state,2014,Age,35 Months,90.3,84.7 to 94.5,287
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,88.2,84.0 to 91.7,541
Hib,Full Series,States/Local Areas,NY-Rest of state,2016,Age,35 Months,83.6,75.2 to 90.5,203
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,86.9,81.4 to 91.4,448
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,95.8,93.6 to 98.0,524
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,94.0,90.4 to 97.6,252
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,94.2,87.2 to 100.0,83
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,89.2,81.1 to 94.8,225
Hib,Primary Series,States/Local Areas,NY-Rest of state,2011,Age,7 Months,62.2,55.0 to 68.9,217
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,89.3,84.9 to 93.6,355
Hib,Primary Series,States/Local Areas,NY-Rest of state,2012,Age,7 Months,71.4,65.6 to 76.6,249
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",98.8,96.8 to 100.0,43
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,95.5,90.8 to 100.0,140
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.7,92.7 to 100.0,129
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,90.6 to 96.2,564
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,96.1,92.6 to 99.6,225
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,87.3,78.0 to 96.6,83
Hib,Full Series,States/Local Areas,NY-Rest of state,2019,Age,35 Months,82.9,73.6 to 90.4,225
Hib,Full Series,States/Local Areas,NY-Rest of state,2018,Age,35 Months,86.6,79.1 to 92.4,282
Hib,Full Series,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,84.3,78.5 to 89.2,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,94.6,89.5 to 97.7,217
Hib,Full Series,States/Local Areas,NY-Rest of state,2015,Age,24 Months,81.2,74.6 to 87.0,254
Hib,Full Series,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,81.2,76.0 to 85.9,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,95.3,90.7 to 98.0,266
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,96.8,94.3 to 98.4,553
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,96.8,92.1 to 98.7,245
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,94.9,91.9 to 96.8,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,88.8,80.5 to 93.8,203
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,91.9,87.3 to 95.0,448
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,92.3,85.3 to 96.7,203
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,94.5,90.5 to 97.2,448
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,95.2,90.2 to 97.8,245
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,92.2,88.8 to 94.7,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,89.2,83.6 to 93.0,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,77.9,72.4 to 82.5,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,95.7,90.0 to 98.6,217
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,90.7,82.2 to 95.4,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,92.9,88.0 to 95.9,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,89.8,85.0 to 93.2,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,97.1,94.2 to 98.8,287
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,95.3,92.9 to 97.1,541
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,93.5,89.4 to 96.4,254
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,93.0,89.1 to 95.9,457
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,95.1,90.6 to 97.9,266
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,96.1,93.5 to 97.8,553
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,92.7,91.1 to 94.0,266
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,92.9,89.0 to 95.4,553
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,93.0,88.3 to 95.9,287
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,91.9,88.4 to 94.4,541
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,94.6,90.4 to 97.3,249
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,92.0,86.3 to 95.9,217
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,88.8,79.8 to 94.1,225
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,90.7,88.2 to 92.8,254
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,89.7,85.0 to 93.1,457
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,82.3,78.9 to 85.7,876
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,85.7,76.6 to 94.7,75
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,76.0,69.4 to 82.6,246
Hib,Full Series,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,81.8,76.0 to 87.7,275
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,90.8,84.1 to 95.5,225
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,31.5,24.9 to 39.2,287
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,34.4,29.3 to 40.2,541
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,37.3,29.7 to 46.2,254
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,37.1,31.2 to 43.8,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,96.1,94.5 to 97.8,876
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,35 Months,88.1,81.8 to 93.0,287
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,87.1,82.3 to 91.1,541
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,35 Months,89.4,80.0 to 95.6,266
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,88.0,82.7 to 92.3,553
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,81.7,75.1 to 87.4,249
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,78.6,71.3 to 85.2,217
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,73.3,63.5 to 81.2,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,53.8,48.9 to 58.7,266
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,52.7,50.5 to 54.8,553
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,40.9,34.6 to 47.5,217
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,48.3,42.1 to 54.6,249
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,93.8,89.7 to 97.9,275
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,98.2,96.7 to 99.8,355
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,96.1,93.5 to 98.7,246
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,5 Months,80.7,73.9 to 86.1,287
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,5 Months,80.8,76.6 to 84.4,541
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,5 Months,74.4,70.3 to 78.0,266
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,5 Months,77.5,72.4 to 82.0,553
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,35 Months,82.2,75.2 to 88.2,249
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,5 Months,69.7,62.9 to 75.7,217
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,5 Months,74.8,69.0 to 79.9,249
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,35 Months,85.9,78.4 to 91.9,254
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,85.8,80.1 to 90.5,457
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,87.4,81.6 to 92.0,266
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,87.6,83.6 to 90.9,553
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,37.1,28.4 to 47.4,203
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,38.9,32.7 to 45.8,448
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,40.8,32.4 to 50.3,245
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,42.2,36.4 to 48.6,527
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,43.4,35.7 to 51.9,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,34.2,28.7 to 40.5,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015,Age,13 Months,48.3,40.3 to 56.4,254
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,50.6,44.4 to 56.9,457
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017,Age,13 Months,53.6,44.5 to 62.5,245
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,52.3,46.3 to 58.3,527
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016,Age,13 Months,52.9,43.4 to 62.2,203
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,53.2,46.6 to 59.7,448
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,88.2,81.9 to 93.2,245
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,85.3,80.9 to 89.2,527
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,82.2,75.8 to 87.8,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,81.4,75.9 to 86.2,507
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,88.2,80.5 to 93.9,217
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,79.6,70.6 to 87.3,225
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2011,Age,13 Months,43.9,35.4 to 52.9,217
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2012,Age,13 Months,43.7,35.2 to 52.5,249
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013,Age,13 Months,44.1,38.1 to 50.2,266
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,50.5,44.4 to 56.5,553
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.0,58.2 to 87.7,129
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2011,Age,13 Months,45.8,32.4 to 59.9,217
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,35 Months,88.7,82.4 to 93.6,245
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,88.0,83.7 to 91.7,527
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,35 Months,85.5,76.7 to 92.3,203
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,87.1,81.8 to 91.5,448
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,71.1,61.5 to 80.0,266
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,70.4,63.8 to 76.7,553
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,69.2,59.5 to 78.5,249
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,62.1,51.8 to 72.5,217
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,24.6,17.7 to 33.8,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,41.7,32.7 to 51.2,203
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,45.3,38.9 to 51.9,448
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,5 Months,80.9,74.0 to 86.4,254
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,5 Months,77.5,71.6 to 82.5,457
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,84.0,77.3 to 89.7,254
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,80.8,75.2 to 85.7,457
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,77.5,68.7 to 85.3,203
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,82.7,77.2 to 87.6,448
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,87.7,82.0 to 92.3,287
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,85.9,81.6 to 89.7,541
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,32.8,26.2 to 40.7,266
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,32.1,27.3 to 37.4,553
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,67.9,60.1 to 74.8,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,94.2,90.1 to 96.7,507
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,83.5,76.4 to 88.7,245
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,75.7,70.5 to 80.3,527
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,68.7,59.2 to 76.9,203
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,75.9,69.9 to 81.0,448
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,98.3,95.7 to 100.0,140
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.0,91.9 to 100.0,129
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",98.8,96.8 to 100.0,43
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.1,92.5 to 97.6,564
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,97.5,94.9 to 100.0,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.3,93.1 to 97.5,576
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,97.1,92.2 to 100.0,75
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,5 Months,84.0,75.6 to 89.8,225
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,5 Months,76.5,69.1 to 82.6,282
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,5 Months,80.2,74.9 to 84.7,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017,Age,19 Months,96.0,91.6 to 98.2,245
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,92.7,89.0 to 95.3,527
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016,Age,19 Months,83.1,74.1 to 89.5,203
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,89.4,84.3 to 93.0,448
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015,Age,19 Months,90.2,87.8 to 92.1,254
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,86.6,81.5 to 90.4,457
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,83.5,76.2 to 90.9,225
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.5,81.7 to 89.3,576
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,85.1,81.9 to 88.3,876
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,86.7,77.7 to 95.7,75
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.7,84.2 to 97.1,129
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.5,80.3 to 88.7,564
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,83.4,75.9 to 91.0,140
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,77.8,70.4 to 85.2,524
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,67.5,57.8 to 77.1,252
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.1,35.8 to 80.4,43
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,86.5,73.9 to 99.1,83
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,83.1,77.6 to 88.6,355
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,69.7,60.3 to 79.2,246
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,73.8,68.2 to 79.4,876
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,89.9,81.6 to 94.7,225
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.0,63.4 to 78.6,576
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,80.3,67.9 to 92.7,75
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.0,66.2 to 79.8,564
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,68.2 to 87.5,225
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,80.9,69.3 to 92.5,140
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,3 Months,92.0,84.4 to 96.0,203
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,3 Months,94.8,90.8 to 97.1,448
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,3 Months,93.6,89.0 to 96.3,254
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,3 Months,92.8,88.6 to 95.5,457
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,97.9,94.9 to 99.2,287
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,96.2,93.7 to 97.7,541
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,93.9,92.3 to 95.1,266
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,95.9,94.4 to 97.0,553
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,94.2,88.6 to 97.2,217
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,96.2,93.8 to 97.7,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013,Age,19 Months,86.1,82.4 to 89.1,266
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,87.0,85.2 to 88.5,553
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015,Age,19 Months,90.5,86.3 to 93.5,254
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,86.6,81.5 to 90.4,457
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014,Age,19 Months,87.9,81.7 to 92.1,287
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,89.2,85.4 to 92.1,541
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018,Age,13 Months,67.6,59.5 to 74.8,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,66.7,60.3 to 72.4,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017,Age,13 Months,59.3,50.1 to 67.9,245
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,63.4,57.3 to 69.2,527
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,83.1,74.9 to 89.0,217
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,80.7,74.3 to 87.1,275
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,93.1,88.6 to 95.9,254
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,88.6,83.5 to 92.3,457
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,81.5,78.1 to 84.9,876
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,80.5,74.7 to 86.4,246
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,89.0,85.8 to 91.5,266
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,91.3,88.9 to 93.2,553
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,93.7,89.2 to 96.4,287
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,93.4,90.4 to 95.5,541
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.5,75.1 to 84.0,564
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,86.0,80.0 to 92.0,225
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.8,74.3 to 83.3,576
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,87.4,78.7 to 96.1,75
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,80.7 to 95.3,129
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,81.5,72.2 to 89.1,245
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,80.0,73.7 to 85.7,527
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,78.4,69.5 to 86.1,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,78.2,70.3 to 85.1,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,89.1,83.6 to 92.9,287
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,89.4,85.8 to 92.2,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,87.7,84.3 to 90.4,266
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,88.4,85.9 to 90.5,553
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,94.8,89.2 to 98.0,266
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,94.7,91.3 to 97.1,553
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,85.2,83.4 to 86.9,249
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,77.5,64.9 to 88.0,225
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,94.8,90.7 to 97.5,287
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,90.3,85.9 to 93.8,541
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,91.4,84.2 to 96.2,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018,Age,13 Months,51.0,43.1 to 58.9,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,52.9,46.6 to 59.1,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016,Age,13 Months,51.9,42.4 to 61.3,203
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,55.5,48.9 to 62.0,448
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2012,Age,19 Months,85.8,81.7 to 89.1,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2011,Age,19 Months,83.5,74.9 to 89.6,217
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019,Age,13 Months,54.8,45.0 to 64.2,225
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015,Age,13 Months,59.4,51.5 to 66.9,254
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,55.6,49.4 to 61.7,457
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014,Age,13 Months,56.8,49.3 to 64.1,287
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,58.1,52.6 to 63.4,541
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013,Age,13 Months,48.4,43.2 to 53.7,266
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,48.7,45.4 to 51.9,553
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,5 Months,80.8,73.8 to 86.3,282
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,5 Months,82.6,77.4 to 86.9,507
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.3,54.9 to 89.7,43
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,86.3,77.1 to 95.5,83
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,82.1,77.5 to 86.6,524
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,81.1,75.0 to 87.1,252
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,35 Months,88.8,80.3 to 94.7,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2012,Age,13 Months,51.3,43.6 to 59.0,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014,Age,13 Months,48.9,41.5 to 56.4,287
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,48.6,43.1 to 54.1,541
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,69.3,60.4 to 77.8,287
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,71.7,64.7 to 78.4,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,52.4,42.9 to 61.8,225
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,74.0,63.3 to 83.5,254
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,71.8,64.0 to 79.2,457
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,69.7,58.9 to 80.0,203
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,75.6,68.2 to 82.4,448
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,52.3,44.3 to 60.1,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,52.3,46.1 to 58.5,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,49.2,40.3 to 58.2,245
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,50.7,44.7 to 56.7,527
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,84.6,80.1 to 88.3,217
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,89.7,83.1 to 93.9,249
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,85.1,77.9 to 92.4,140
Hib,Full Series,States/Local Areas,NY-Rest of state,2020,Age,24 Months,75.4,68.1 to 82.1,282
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,5 Months,84.5,76.1 to 90.4,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,48.9,41.0 to 56.8,254
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,45.2,39.1 to 51.5,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,51.5,44.1 to 58.7,287
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,50.2,44.7 to 55.6,541
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,5 Months,88.8,82.7 to 92.9,245
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,5 Months,84.8,80.3 to 88.4,527
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,5 Months,74.2,64.5 to 81.9,203
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,5 Months,81.3,75.4 to 86.0,448
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,35 Months,87.2,80.9 to 92.2,282
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,87.8,82.8 to 91.9,507
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,91.2,86.1 to 94.6,254
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,90.0,85.6 to 93.2,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,92.7,87.5 to 96.2,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,91.7,87.5 to 95.0,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,90.0,84.9 to 93.4,254
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,88.7,84.0 to 92.1,457
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,92.2,87.5 to 95.3,287
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,91.1,87.9 to 93.5,541
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,94.2,89.3 to 96.9,245
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,92.1,88.3 to 94.8,527
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,90.7,88.3 to 92.7,266
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,91.5,90.0 to 92.8,553
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,88.8,81.1 to 93.7,203
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,91.4,87.0 to 94.4,448
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2016,Age,0-2 Days,74.6,65.3 to 82.1,203
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2016-2017,Age,0-2 Days,78.4,72.4 to 83.3,448
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013,Age,35 Months,99.2,94.4 to 100.0,266
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,95.9,91.2 to 98.5,553
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018,Age,24 Months,94.6,90.4 to 97.4,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,93.3,89.4 to 96.2,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,76.2,66.7 to 83.7,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014,Age,35 Months,95.1,89.9 to 98.1,287
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,93.4,90.1 to 95.9,541
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015,Age,35 Months,91.7,87.2 to 95.2,254
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,91.9,87.6 to 95.2,457
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,83.5,76.7 to 89.2,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2015,Age,0-2 Days,72.8,65.1 to 79.4,254
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2015-2016,Age,0-2 Days,73.7,67.8 to 78.9,457
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2014,Age,0-2 Days,70.4,63.3 to 76.6,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2014-2015,Age,0-2 Days,71.6,66.4 to 76.2,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,94.8,90.7 to 97.4,287
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,94.1,91.2 to 96.2,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,93.3,88.9 to 96.4,254
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,91.5,87.3 to 94.8,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,89.9,82.5 to 95.0,203
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,92.0,87.8 to 95.2,448
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,93.2,89.3 to 95.7,249
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016,Age,24 Months,89.3,82.1 to 94.5,203
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,92.6,88.5 to 95.7,448
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017,Age,24 Months,96.0,92.1 to 98.3,245
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,95.3,92.6 to 97.3,527
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,78.4,71.4 to 84.2,282
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,78.2,71.3 to 83.8,428
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,85.1,77.3 to 90.6,245
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,81.8,76.8 to 86.0,527
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,89.6,80.4 to 94.8,217
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,68.5,58.8 to 76.8,225
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,67.4,59.4 to 74.4,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,67.9,61.7 to 73.5,507
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,90.1,87.5 to 92.1,249
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,91.6,86.3 to 95.0,287
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,91.4,88.0 to 94.0,541
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,90.0,86.9 to 92.4,266
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,90.8,87.4 to 93.4,553
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2012,Age,0-2 Days,71.9,62.4 to 79.9,249
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2013,Age,0-2 Days,66.6,57.9 to 74.3,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2013-2014,Age,0-2 Days,68.5,60.9 to 75.2,553
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2011,Age,0-2 Days,58.4,49.4 to 66.8,217
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2019,Age,0-1 Days,73.3,63.9 to 81.0,225
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2018,Age,0-1 Days,69.4,61.4 to 76.5,282
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2018-2019,Age,0-1 Days,71.4,65.3 to 76.8,507
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,35 Months,90.4,81.8 to 96.0,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,90.6,84.2 to 95.1,217
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,90.8,83.0 to 95.2,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,93.2,88.4 to 96.6,266
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,94.0,91.0 to 96.3,553
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,91.8,86.4 to 95.6,249
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,61.5,51.7 to 70.5,203
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,67.0,60.4 to 73.0,448
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,78.9,70.0 to 85.8,203
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,82.0,76.2 to 86.6,448
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,80.3,77.8 to 82.6,254
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,79.6,74.1 to 84.2,457
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,82.4,76.0 to 87.4,287
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,81.4,76.8 to 85.2,541
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,63.0,54.9 to 70.4,254
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,62.3,55.9 to 68.2,457
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,72.8,64.0 to 80.1,245
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,70.1,64.3 to 75.3,527
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013,Age,24 Months,91.9,86.6 to 95.6,266
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,90.9,86.8 to 94.2,553
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014,Age,24 Months,89.5,83.6 to 93.9,287
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,90.5,86.9 to 93.4,541
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015,Age,24 Months,91.5,87.1 to 94.9,254
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,90.5,86.3 to 93.8,457
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018,Age,24 Months,89.8,84.0 to 94.2,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,92.0,88.0 to 95.1,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2012,Age,35 Months,93.5,88.1 to 97.0,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2011,Age,35 Months,88.7,81.9 to 93.8,217
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019,Age,24 Months,94.2,87.9 to 97.9,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017,Age,24 Months,93.4,87.5 to 97.2,245
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,91.7,87.7 to 94.7,527
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2015,Age,0-1 Days,71.4,63.6 to 78.1,254
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2015-2016,Age,0-1 Days,71.8,65.8 to 77.0,457
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,5 Months,88.4,82.8 to 92.4,254
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,5 Months,85.4,80.2 to 89.4,457
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2014,Age,0-1 Days,67.3,60.0 to 73.8,287
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2014-2015,Age,0-1 Days,69.3,64.1 to 74.1,541
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2013,Age,0-1 Days,62.5,54.8 to 69.6,266
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2013-2014,Age,0-1 Days,64.9,57.8 to 71.3,553
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013,Age,24 Months,92.1,86.8 to 95.9,266
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,91.3,87.4 to 94.4,553
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014,Age,24 Months,90.2,84.9 to 94.3,287
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,91.0,87.6 to 93.8,541
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,96.7,92.1 to 98.7,245
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,95.8,93.0 to 97.6,527
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019,Age,19 Months,91.2,83.4 to 95.6,225
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,93.5,85.5 to 97.3,225
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,94.9,90.4 to 97.3,282
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,94.2,90.1 to 96.7,507
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2012,Age,0-1 Days,66.5,55.5 to 75.9,249
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,5 Months,88.8,83.5 to 92.6,287
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,5 Months,88.6,82.8 to 92.7,541
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,5 Months,82.4,73.4 to 88.8,203
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,5 Months,87.0,81.8 to 90.9,448
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,92.2,86.5 to 95.6,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,88.5,83.7 to 92.1,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,93.2,88.0 to 96.2,245
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,92.7,89.1 to 95.1,527
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,62.9,54.7 to 70.3,249
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,84.0,78.3 to 89.7,275
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,93.0,89.4 to 96.5,355
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,62.6,55.1 to 69.6,287
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,62.8,57.4 to 68.0,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,88.9,80.6 to 93.9,203
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,91.0,86.3 to 94.2,448
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,59.1,52.6 to 65.3,217
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,61.9,58.2 to 65.5,266
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,62.3,59.2 to 65.3,553
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016,Age,24 Months,88.7,81.5 to 94.0,203
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,91.0,86.4 to 94.5,448
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015,Age,24 Months,91.7,87.2 to 95.2,254
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,90.2,86.0 to 93.6,457
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2012,Age,24 Months,90.1,84.5 to 94.3,249
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2011,Age,24 Months,92.0,87.3 to 95.5,217
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019,Age,19 Months,89.0,80.6 to 94.1,225
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018,Age,19 Months,89.4,82.9 to 93.6,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,95.9,92.8 to 97.6,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,77.0,65.1 to 85.8,217
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,83.4,75.9 to 88.9,249
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,81.7,74.0 to 87.5,266
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,82.1,78.4 to 85.2,553
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,5 Months,88.0,81.2 to 92.5,282
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,5 Months,89.5,84.8 to 92.9,507
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,5 Months,91.9,86.4 to 95.3,245
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,5 Months,89.9,85.8 to 93.0,527
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,85.1,77.2 to 90.6,217
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,5 Months,91.0,83.5 to 95.3,225
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2017,Age,0-1 Days,79.4,71.5 to 85.6,245
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2017-2018,Age,0-1 Days,74.5,68.9 to 79.4,527
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2016,Age,0-1 Days,72.1,62.8 to 79.9,203
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2016-2017,Age,0-1 Days,75.7,69.6 to 80.9,448
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,3 Months,97.8,94.9 to 99.1,245
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,3 Months,94.5,91.0 to 96.7,527
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,91.7,83.7 to 95.9,203
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,94.1,89.7 to 96.7,448
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,94.4,90.0 to 96.9,254
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,93.0,88.8 to 95.7,457
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016,Age,19 Months,82.7,73.8 to 89.0,203
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,87.2,81.8 to 91.3,448
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019,Age,13 Months,65.7,55.9 to 74.3,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018,Age,19 Months,82.9,75.5 to 88.4,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,52.9,46.6 to 59.1,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017,Age,19 Months,92.0,84.9 to 95.9,245
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,87.5,82.7 to 91.1,527
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2012,Age,19 Months,84.4,80.4 to 87.8,249
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014,Age,19 Months,86.8,79.9 to 91.6,287
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,88.5,84.4 to 91.6,541
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013,Age,19 Months,87.5,81.3 to 91.8,266
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,87.1,85.4 to 88.7,553
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2011,Age,19 Months,88.2,79.6 to 93.4,217
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.5,66.6 to 98.3,43
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,91.2,83.9 to 98.5,83
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,88.5,84.7 to 92.3,524
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,81.4,75.4 to 87.3,252
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,87.6,78.5 to 94.1,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018,Age,35 Months,93.5,88.6 to 96.8,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,94.0,90.3 to 96.7,507
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,94.5,88.7 to 97.9,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,91.2,85.8 to 95.1,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,86.7,78.3 to 92.2,217
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,89.2,81.6 to 93.9,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,87.8,81.2 to 92.4,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,88.5,83.7 to 92.1,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,90.7,86.4 to 93.7,249
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,92.5,85.7 to 96.2,254
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,90.7,86.1 to 93.9,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,94.0,89.5 to 96.6,287
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,93.2,90.1 to 95.4,541
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,79.6,70.3 to 88.9,355
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,92.9,91.8 to 93.9,266
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,93.4,91.0 to 95.2,553
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,5 Months,84.9,80.7 to 88.3,266
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,5 Months,86.8,81.0 to 91.1,553
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,5 Months,78.1,70.8 to 84.0,217
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,5 Months,85.3,80.5 to 89.1,249
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2011,Age,0-1 Days,55.3,47.8 to 62.5,217
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,73.5,63.3 to 83.6,275
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,75.8,66.5 to 84.2,282
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,3 Months,97.2,92.0 to 99.0,225
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,3 Months,91.2,84.6 to 95.2,282
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,3 Months,94.2,90.4 to 96.6,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2012,Age,24 Months,89.9,84.8 to 93.8,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2011,Age,24 Months,87.3,80.6 to 92.6,217
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,78.7,72.2 to 85.2,246
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,88.3,81.5 to 92.8,282
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,89.1,84.1 to 92.6,507
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,95.7,91.0 to 98.0,245
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,92.0,88.1 to 94.7,527
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,84.3,75.0 to 90.6,203
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,89.8,84.6 to 93.5,448
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,3 Months,94.1,90.0 to 96.6,287
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,3 Months,93.8,91.0 to 95.8,541
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,3 Months,88.8,77.0 to 95.0,217
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,3 Months,93.7,90.5 to 95.9,249
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,3 Months,94.9,91.9 to 96.9,266
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,3 Months,94.5,90.1 to 97.0,553
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,91.3,86.0 to 94.7,245
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,89.6,85.5 to 92.6,527
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,84.1,77.4 to 89.7,254
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,85.2,78.9 to 90.3,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,89.8,84.4 to 93.4,254
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,88.0,83.3 to 91.6,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,86.3,78.1 to 91.8,203
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,88.7,84.0 to 92.2,448
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,85.0,74.7 to 92.7,203
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,89.4,83.2 to 94.1,448
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,94.4,87.7 to 98.1,245
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,94.4,90.4 to 97.1,527
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,80.9,72.1 to 87.4,218
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,5 Months,67.9,61.9 to 73.4,560
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2021,Age,0-1 Days,61.3,51.9 to 69.9,218
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,94.7,91.3 to 96.8,560
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2021,Age,0-2 Days,65.1,55.7 to 73.5,218
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2021,Age,24 Months,85.3,77.2 to 91.7,218
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,50.0,41.0 to 59.1,218
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,89.0,81.3 to 94.5,218
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,73.2,64.3 to 81.3,218
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,93.3,89.1 to 96.3,560
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,24 Months,73.2,64.3 to 81.4,218
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,92.3,87.7 to 95.6,560
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,89.0,80.6 to 94.0,218
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,29.9,21.7 to 40.3,218
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,77.0,71.7 to 81.5,560
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,54.9,45.6 to 63.9,218
Combined 7 Series,,States/Local Areas,NY-City of New York,2021,Age,24 Months,63.9,54.4 to 73.3,218
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,94.7,88.2 to 97.7,218
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,19 Months,66.1,56.6 to 74.5,218
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,17.4,11.5 to 25.5,218
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,3 Months,81.5,72.2 to 88.1,218
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,79.2,67.5 to 88.9,218
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,78.0,69.0 to 85.9,218
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,89.0,81.5 to 94.4,218
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,3 Months,81.5,72.3 to 88.2,218
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2021,Age,24 Months,87.0,79.2 to 93.0,218
Hib,Primary Series,States/Local Areas,NY-City of New York,2021,Age,24 Months,90.3,83.4 to 95.2,218
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,3 Months,80.9,71.7 to 87.7,218
Hib,Full Series,States/Local Areas,NY-City of New York,2021,Age,24 Months,77.3,68.3 to 85.3,218
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,86.4,78.0 to 92.0,218
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,69.5,60.0 to 77.5,218
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,92.6,88.5 to 95.3,560
Hib,Primary Series,States/Local Areas,NY-City of New York,2021,Age,7 Months,63.6,54.2 to 72.2,218
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,35 Months,84.2,73.8 to 92.2,218
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,87.3,79.0 to 92.7,218
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,90.7,84.0 to 95.4,218
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,68.5,59.2 to 76.6,218
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,57.8,44.3 to 71.8,218
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,96.1,91.5 to 98.2,245
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,93.9,90.8 to 96.0,527
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,88.9,81.0 to 93.8,203
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,92.4,87.9 to 95.3,448
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,76.8,69.6 to 82.7,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,77.9,72.4 to 82.5,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,91.8,86.7 to 95.0,282
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,66.7,60.3 to 72.4,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,92.8,85.7 to 96.5,217
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,93.0,89.1 to 95.6,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,78.9,70.4 to 85.5,225
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,94.9,91.1 to 97.2,287
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,93.4,90.4 to 95.4,541
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,93.8,91.3 to 95.6,266
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,94.4,92.4 to 95.8,553
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,78.6,70.5 to 85.0,245
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,77.7,72.4 to 82.2,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,74.9,65.8 to 82.2,203
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,76.7,70.7 to 81.8,448
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,91.8,85.8 to 95.4,254
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,90.3,85.9 to 93.5,457
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,91.5,88.6 to 93.7,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,80.3,73.1 to 85.9,254
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,77.5,71.9 to 82.4,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,95.4,90.7 to 97.7,249
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,94.7,91.9 to 96.6,266
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,95.5,93.2 to 97.1,553
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,93.5,88.4 to 96.4,217
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,90.0,81.6 to 94.8,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,89.6,83.5 to 93.6,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,89.8,85.0 to 93.2,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,83.9,76.8 to 91.0,140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,73.7 to 91.0,129
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.2,65.2 to 75.2,564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,75.8,68.2 to 83.3,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.6,67.8 to 77.4,576
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,74.3,70.5 to 78.1,876
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,81.5,71.1 to 91.8,75
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,94.6,90.3 to 97.0,287
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,93.6,90.7 to 95.7,541
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,92.1,89.2 to 94.3,266
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,93.3,90.5 to 95.4,553
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,96.6,91.3 to 98.7,225
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,93.8,91.8 to 95.8,876
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,93.5,90.0 to 96.9,246
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.3,89.6 to 95.0,576
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,97.1,92.2 to 100.0,75
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,96.8,92.1 to 98.7,245
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,96.0,93.1 to 97.7,527
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,95.1,90.6 to 97.5,282
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,95.9,92.8 to 97.6,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,94.7,91.0 to 97.0,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,82.1,76.7 to 86.4,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,82.9,72.0 to 90.1,217
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,78.3,71.7 to 83.8,287
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,79.3,74.6 to 83.4,541
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,90.7,86.2 to 95.3,275
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,97.0,94.9 to 99.0,355
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,89.7,86.1 to 92.5,217
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,80.1,77.1 to 82.8,266
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,79.2,76.1 to 82.1,553
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,73.4,68.5 to 79.6,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,71.1,64.5 to 77.7,355
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,93.3,87.6 to 96.4,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,90.6 to 96.1,564
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,96.1,92.8 to 99.4,225
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,59.5,49.9 to 68.4,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,92.7,87.9 to 95.7,254
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,91.8,87.5 to 94.7,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,95.8,91.1 to 98.1,245
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,92.7,89.1 to 95.2,527
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,91.0,83.1 to 95.4,203
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,93.3,89.0 to 96.1,448
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,89.8,81.4 to 94.6,217
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,75.0,66.4 to 82.0,245
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,75.1,69.6 to 80.0,527
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,70.7,61.0 to 78.9,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,75.3,67.7 to 81.5,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,73.0,66.9 to 78.3,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,79.1,73.4 to 84.9,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.4,41.9 to 78.9,43
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,72.5,67.3 to 77.8,524
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,73.7,61.4 to 86.0,83
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2019,Age,0-3 Days,78.2,69.4 to 85.1,225
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,3 Months,87.9,79.8 to 93.0,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2018,Age,0-3 Days,78.3,70.7 to 84.3,282
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2018-2019,Age,0-3 Days,78.2,72.5 to 83.1,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,92.5,85.7 to 96.8,225
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,98.4,96.1 to 100.0,83
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,96.7,92.7 to 98.5,287
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,95.3,92.6 to 97.1,541
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,90.5,82.3 to 95.2,203
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,93.6,89.0 to 96.3,448
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,94.0,89.5 to 96.6,254
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,92.2,87.8 to 95.1,457
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,3 Months,90.8,85.0 to 94.6,282
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,3 Months,89.4,84.7 to 92.7,507
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,3 Months,92.1,85.8 to 95.8,245
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,3 Months,91.5,87.5 to 94.3,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,54.6,45.0 to 63.9,203
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,56.4,49.8 to 62.8,448
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,52.7,44.6 to 60.7,254
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,53.7,47.3 to 59.9,457
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,57.8,50.4 to 64.8,287
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,55.3,49.7 to 60.7,541
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,93.5,87.9 to 97.1,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,93.2,88.8 to 96.3,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,97.5,93.4 to 99.3,245
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,95.7,92.3 to 97.9,527
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,95.6,92.7 to 97.4,266
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,96.2,93.7 to 97.7,553
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,66.7,56.9 to 75.2,203
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,70.7,64.3 to 76.4,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2015,Age,0-3 Days,76.2,69.0 to 82.1,254
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2015-2016,Age,0-3 Days,75.8,70.0 to 80.7,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,73.7,66.5 to 79.8,287
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,70.1,64.7 to 75.0,541
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,66.5,58.4 to 73.8,254
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,66.6,60.3 to 72.4,457
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,93.9,88.2 to 96.9,217
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,96.6,93.6 to 98.3,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016,Age,0-3 Days,75.4,66.0 to 82.8,203
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2017,Age,0-3 Days,79.9,74.0 to 84.7,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2017,Age,0-3 Days,77.9,64.4 to 87.3,126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2017-2018,Age,0-3 Days,81.4,76.4 to 85.6,527
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,3 Months,86.7,78.8 to 91.9,203
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,3 Months,89.3,84.5 to 92.8,448
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,3 Months,88.1,82.7 to 92.0,254
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,3 Months,87.4,82.8 to 90.9,457
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,3 Months,89.9,84.5 to 93.6,287
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,3 Months,89.0,85.4 to 91.8,541
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,49.7,45.4 to 54.0,266
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,53.7,50.1 to 57.3,553
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,54.8,46.7 to 62.7,217
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,55.4,50.7 to 60.0,249
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,92.2,87.9 to 96.6,275
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,94.9,92.1 to 97.6,355
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,94.4,91.2 to 97.5,246
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,95.7,91.1 to 98.0,245
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,91.9,87.9 to 94.6,527
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,7 Months,85.0,75.6 to 91.2,203
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,7 Months,90.2,84.9 to 93.8,448
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,95.8,93.8 to 97.9,524
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,91.6,87.5 to 95.8,252
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,96.2,92.5 to 100.0,140
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.0,85.0 to 97.0,129
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.1,91.5 to 100.0,43
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,54.6,46.7 to 62.3,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,57.0,50.8 to 63.1,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,7 Months,58.4,49.2 to 67.0,245
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,7 Months,56.5,50.5 to 62.3,527
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,89.5,81.7 to 94.9,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,78.1,72.1 to 84.1,246
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020,Age,24 Months,90.9,85.3 to 94.9,282
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,92.3,85.6 to 96.1,225
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,92.8,85.6 to 97.2,203
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,95.1,91.0 to 97.7,448
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,92.5,88.1 to 95.8,254
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,92.8,88.7 to 95.8,457
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,96.9,94.1 to 98.6,287
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,94.9,92.3 to 96.8,541
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,88.0,81.2 to 92.5,282
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,90.1,85.7 to 93.3,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,95.8,92.2 to 98.1,249
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,96.9,93.9 to 99.9,140
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.3,91.0 to 99.6,129
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.7,89.8 to 95.5,564
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,95.1,90.4 to 98.0,266
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,96.1,93.3 to 97.9,553
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,92.4,86.4 to 96.4,217
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,92.3,85.6 to 96.7,225
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,7 Months,91.5,86.8 to 94.7,254
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,7 Months,88.2,83.1 to 92.0,457
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,91.1,85.7 to 95.0,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,91.7,87.6 to 94.9,507
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,3 Months,81.5,71.3 to 88.7,217
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,3 Months,90.4,86.2 to 93.5,249
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,93.9,91.9 to 95.9,876
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,3 Months,91.2,84.0 to 95.3,225
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,3 Months,84.1,81.9 to 86.1,266
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,3 Months,87.0,82.0 to 90.8,553
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2013,Age,0-3 Days,67.4,60.0 to 73.9,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2013-2014,Age,0-3 Days,70.4,65.5 to 74.9,553
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,65.4,57.5 to 72.6,217
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,67.5,63.2 to 71.5,249
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,66.0,61.8 to 69.9,266
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,69.9,64.7 to 74.6,553
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014,Age,0-3 Days,73.4,66.4 to 79.5,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2014-2015,Age,0-3 Days,74.8,69.9 to 79.1,541
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,3 Months,86.2,80.6 to 90.4,254
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,3 Months,85.3,80.5 to 89.1,457
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,3 Months,85.2,79.2 to 89.6,287
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,3 Months,85.7,81.8 to 88.9,541
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,80.4 to 93.9,129
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.5,82.9 to 90.1,564
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,96.8,92.8 to 98.9,245
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,93.9,90.8 to 96.3,527
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,7 Months,93.3,84.8 to 97.2,249
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,91.4,84.2 to 96.1,203
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,94.0,90.0 to 96.8,448
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,7 Months,85.6,81.6 to 88.9,217
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,5 Months,83.0,74.8 to 88.9,225
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,5 Months,80.0,73.1 to 85.5,282
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,5 Months,81.5,76.3 to 85.7,507
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,3 Months,86.3,78.2 to 91.8,245
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,3 Months,85.7,80.6 to 89.7,527
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,3 Months,84.4,76.2 to 90.1,203
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,3 Months,85.3,79.8 to 89.5,448
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,94.5,92.2 to 96.9,524
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,98.4,96.1 to 100.0,83
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.4,82.7 to 100.0,43
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,95.7,92.2 to 99.2,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.8,90.2 to 95.4,576
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,96.3,91.3 to 100.0,75
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,92.7,88.8 to 96.6,252
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,85.0,81.9 to 88.2,876
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,91.4,84.0 to 98.8,75
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.1,77.9 to 86.3,576
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,80.7,74.7 to 86.7,246
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,83.7,78.0 to 89.4,275
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,90.8,86.4 to 95.1,355
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,5 Months,72.5,67.8 to 76.6,217
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,5 Months,74.3,68.9 to 79.0,249
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,96.5,91.9 to 98.6,245
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,93.4,90.0 to 95.7,527
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,5 Months,83.1,76.6 to 88.1,287
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,5 Months,80.7,75.3 to 85.2,541
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,5 Months,74.3,71.0 to 77.3,266
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,5 Months,78.7,74.8 to 82.2,553
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,92.2,86.3 to 96.2,217
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,90.8,82.7 to 95.3,225
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,90.2,84.3 to 94.1,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,87.3,82.2 to 91.1,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,92.1,89.9 to 94.3,876
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,90.8,86.7 to 94.9,246
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.9,88.0 to 93.8,576
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,95.7,90.4 to 100.0,75
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,90.0,85.5 to 94.6,275
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,95.4,92.9 to 97.9,355
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,3 Months,81.3,74.6 to 86.6,217
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,82.3,73.0 to 89.8,225
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,85.5,79.0 to 90.9,282
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,83.8,78.4 to 88.6,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,90.1,82.0 to 95.6,245
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,88.0,82.9 to 92.2,527
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,5 Months,78.0,68.2 to 85.4,203
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,5 Months,82.8,76.9 to 87.5,448
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,5 Months,78.3,71.1 to 84.1,254
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,5 Months,78.1,72.3 to 83.1,457
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,85.1 to 95.4,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2012,Age,0-3 Days,72.2,65.1 to 78.4,249
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,7 Months,94.8,90.3 to 97.3,287
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,7 Months,93.2,90.2 to 95.3,541
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,7 Months,91.0,87.3 to 93.7,266
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,7 Months,92.9,90.6 to 94.7,553
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,94.7,90.2 to 97.6,266
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,95.3,92.7 to 97.2,553
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,5 Months,87.9,81.0 to 92.5,245
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,5 Months,84.0,79.3 to 87.8,527
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,94.7,90.6 to 97.4,249
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,95.8,92.8 to 97.9,287
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,93.8,91.2 to 95.9,541
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,91.8,87.3 to 95.1,254
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,91.7,87.6 to 94.8,457
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,94.3,90.3 to 96.7,287
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,92.9,90.0 to 95.0,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,90.9,84.0 to 95.7,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,92.7,87.5 to 96.2,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,91.8,87.6 to 95.0,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,91.7,86.1 to 95.7,287
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,90.4,86.5 to 93.5,541
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,89.1,83.6 to 93.5,254
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,88.4,83.6 to 92.3,457
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,87.9,80.1 to 93.6,203
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,89.0,83.6 to 93.3,448
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,91.0,86.8 to 95.1,252
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.8 to 96.0,524
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,90.0,84.3 to 95.7,140
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.0,89.1 to 99.0,129
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.9,83.4 to 100.0,43
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,90.1,82.1 to 94.8,203
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,93.2,88.7 to 96.0,448
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,91.5,89.2 to 93.3,254
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,90.8,86.4 to 93.9,457
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,95.4,88.5 to 98.2,225
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,93.0,87.4 to 96.3,282
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,94.2,90.3 to 96.6,507
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,95.9,91.1 to 98.2,245
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,94.5,91.1 to 96.6,527
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,3 Months,90.3,83.0 to 94.7,245
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,3 Months,89.3,84.8 to 92.6,527
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,3 Months,88.4,80.4 to 93.4,203
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,3 Months,89.3,84.3 to 92.9,448
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,3 Months,87.0,81.4 to 91.0,254
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,3 Months,87.7,83.1 to 91.1,457
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017,Age,35 Months,97.1,92.7 to 99.2,245
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,96.5,93.8 to 98.3,527
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018,Age,35 Months,96.2,92.3 to 98.5,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,94.2,90.2 to 96.9,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,95.3,87.5 to 98.8,266
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,92.9,88.4 to 96.2,553
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019,Age,35 Months,92.1,85.0 to 96.7,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,89.9 to 99.4,129
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,94.7,89.2 to 100.0,83
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.2,85.8 to 92.5,564
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,86.9 to 96.5,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.9,83.4 to 100.0,43
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,90.9,83.7 to 98.1,83
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,94.3,91.7 to 96.9,524
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,89.9,85.5 to 94.3,252
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019,Age,35 Months,94.3,87.9 to 97.9,225
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016,Age,35 Months,92.1,84.2 to 97.0,203
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,94.6,90.1 to 97.4,448
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,84.9,78.7 to 90.0,254
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,84.7,79.9 to 89.0,457
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,84.7,77.0 to 90.9,203
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,85.2,80.0 to 89.7,448
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,85.7,78.5 to 91.5,245
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,84.9,80.1 to 89.0,527
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015,Age,35 Months,92.5,88.1 to 95.8,254
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,92.5,88.1 to 95.7,457
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014,Age,35 Months,94.8,90.0 to 97.8,287
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,93.6,90.1 to 96.2,541
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,87.4,79.1 to 92.7,203
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,90.4,85.4 to 93.8,448
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,95.0,89.9 to 98.0,266
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,95.8,92.6 to 97.9,553
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,96.6,92.8 to 98.7,287
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,95.4,92.6 to 97.3,541
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,94.3,90.0 to 97.2,254
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,92.3,88.0 to 95.5,457
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,92.8,87.2 to 96.6,249
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,13 Months,86.2,79.4 to 91.0,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,13 Months,87.3,82.2 to 91.1,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,13 Months,93.6,87.1 to 96.9,245
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,13 Months,89.9,85.6 to 93.0,527
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,13 Months,94.4,88.0 to 97.5,249
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,13 Months,94.2,93.0 to 95.2,266
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,13 Months,95.5,94.2 to 96.5,553
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,13 Months,89.9,81.4 to 94.8,217
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,7 Months,93.7,87.0 to 97.1,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,95.1,90.7 to 97.8,245
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,93.9,90.7 to 96.2,527
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,94.7,89.1 to 97.5,249
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,90.2,83.7 to 95.0,249
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,87.6,80.9 to 92.8,217
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,84.0,77.6 to 89.4,282
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,81.6,76.2 to 86.5,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,78.9,69.9 to 86.6,225
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,90.5,83.0 to 95.6,203
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,92.8,88.4 to 95.9,448
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,93.2,87.4 to 96.4,266
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,93.8,91.7 to 95.3,553
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,90.5,81.4 to 95.3,217
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,13 Months,88.4,79.9 to 93.6,225
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,13 Months,92.4,84.5 to 96.4,203
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,13 Months,94.1,89.8 to 96.7,448
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,13 Months,93.9,89.2 to 96.6,254
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,13 Months,93.1,88.9 to 95.8,457
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,13 Months,96.8,93.6 to 98.5,287
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,13 Months,95.4,92.7 to 97.1,541
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,3 Months,90.5,85.2 to 94.0,287
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,3 Months,88.7,85.1 to 91.5,541
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,3 Months,82.2,75.7 to 87.3,217
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,3 Months,91.2,87.2 to 94.1,249
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,3 Months,84.8,82.3 to 87.0,266
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,3 Months,87.6,84.2 to 90.5,553
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,81.2,75.6 to 86.9,252
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,92.0,84.3 to 99.7,83
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,81.3,72.8 to 89.9,140
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.4,64.2 to 96.7,43
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,3 Months,83.1,81.4 to 84.7,266
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,3 Months,84.1,79.8 to 87.7,553
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,3 Months,85.1,78.1 to 90.1,282
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,3 Months,88.1,83.4 to 91.6,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2011,Age,0-3 Days,61.7,53.0 to 69.8,217
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,88.7,85.1 to 92.4,524
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,3 Months,87.3,79.8 to 92.3,225
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,3 Months,88.3,82.1 to 92.5,282
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,3 Months,87.8,83.2 to 91.3,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,89.4 to 94.9,564
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,89.7 to 97.8,225
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,95.1,92.4 to 97.8,355
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,91.5,89.2 to 93.9,876
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,90.2,86.1 to 94.4,246
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.7,87.8 to 93.7,576
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,95.8,90.3 to 100.0,75
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,86.7,80.8 to 91.4,249
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,92.3,85.9 to 96.5,217
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,94.2,89.8 to 97.2,245
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,93.4,90.2 to 95.9,527
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,90.8,83.9 to 95.6,225
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2013,Age,24 Months,87.8,82.1 to 92.3,266
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,86.7,82.8 to 90.1,553
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,85.5,79.9 to 90.2,287
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,85.1,81.1 to 88.7,541
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019,Age,24 Months,91.9,84.8 to 96.5,225
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2012,Age,35 Months,94.2,89.0 to 97.4,249
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2011,Age,35 Months,93.3,88.4 to 96.6,217
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013,Age,35 Months,93.9,88.2 to 97.4,266
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,94.2,90.2 to 97.0,553
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016,Age,35 Months,91.6,84.0 to 96.5,203
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,94.1,89.4 to 97.1,448
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,89.1,84.1 to 94.0,275
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,3 Months,86.8,85.2 to 88.3,249
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2014-2017,Race and Ethnicity,Hispanic,95.2,90.7 to 99.6,140
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,7 Months,90.1,83.5 to 94.2,282
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,7 Months,91.9,87.5 to 94.8,507
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2019,Age,0-2 Days,76.6,67.5 to 83.8,225
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2018,Age,0-2 Days,73.9,66.1 to 80.4,282
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2018-2019,Age,0-2 Days,75.2,69.3 to 80.3,507
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2017,Age,0-2 Days,82.3,74.7 to 88.0,245
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2017-2018,Age,0-2 Days,78.1,72.8 to 82.7,527
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017,Age,35 Months,97.0,91.7 to 99.3,245
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,95.2,92.0 to 97.4,527
Combined 7 Series,,States/Local Areas,Pennsylvania,2017,Age,24 Months,79.1,73.0 to 84.5,560
Combined 7 Series,,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,76.7,72.6 to 80.7,1210
Combined 7 Series,,States/Local Areas,Pennsylvania,2018,Age,24 Months,74.4,68.5 to 79.9,650
Combined 7 Series,,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,73.9,69.8 to 77.8,1291
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,69.9,67.2 to 72.4,626
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,69.7,62.8 to 75.8,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,95.0,90.4 to 97.8,560
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,95.0,92.2 to 97.1,1210
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.8,92.4 to 98.0,580
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,95.4,92.7 to 97.3,1140
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,93.4,87.8 to 97.1,517
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,94.6,91.3 to 96.9,1097
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,5 Months,81.7,73.3 to 87.9,626
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,5 Months,74.9,67.6 to 81.0,611
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,5 Months,80.8,76.6 to 84.4,561
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,5 Months,78.9,75.5 to 81.8,1117
Combined 7 Series,,States/Local Areas,Pennsylvania,2016,Age,35 Months,85.0,78.9 to 90.0,580
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,83.6,79.4 to 87.4,1140
Combined 7 Series,,States/Local Areas,Pennsylvania,2017,Age,35 Months,82.3,76.3 to 87.6,560
Combined 7 Series,,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,79.7,75.6 to 83.6,1210
Hib,Primary Series,States/Local Areas,Pennsylvania,2018,Age,24 Months,93.1,88.9 to 96.1,650
Hib,Primary Series,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,94.1,91.6 to 96.1,1291
Combined 7 Series,,States/Local Areas,Pennsylvania,2016,Age,24 Months,78.8,72.7 to 84.3,580
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,79.0,74.7 to 82.9,1140
Hib,Primary Series,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.2,92.0 to 97.4,641
Combined 7 Series,,States/Local Areas,Pennsylvania,2012,Age,35 Months,78.6,71.9 to 84.6,611
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,19 Months,83.6,77.2 to 88.5,580
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,83.6,79.3 to 87.2,1140
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,35 Months,86.6,81.2 to 91.0,626
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,24 Months,92.5,88.7 to 95.4,641
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,24 Months,88.1,83.0 to 92.2,650
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,90.3,87.2 to 92.9,1291
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,35 Months,95.8,92.7 to 97.9,641
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,91.5,83.5 to 99.5,115
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,95.2,91.4 to 97.6,650
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,95.5,93.2 to 97.2,1291
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,5 Months,83.9,78.3 to 88.4,580
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,5 Months,82.5,78.3 to 86.0,1140
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,5 Months,73.1,65.4 to 79.7,517
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,5 Months,78.5,73.7 to 82.6,1097
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,5 Months,76.9,70.2 to 82.5,556
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,5 Months,75.0,69.1 to 80.2,1073
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,24 Months,86.3,80.7 to 91.0,580
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,87.0,83.2 to 90.4,1140
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,24 Months,84.8,78.3 to 90.3,517
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,85.5,81.2 to 89.2,1097
Combined 7 Series,,States/Local Areas,Pennsylvania,2019,Age,24 Months,73.5,67.7 to 79.0,641
Combined 7 Series,,States/Local Areas,Pennsylvania,2011,Age,35 Months,80.8,75.1 to 85.8,626
Combined 7 Series,,States/Local Areas,Pennsylvania,2014,Age,35 Months,73.3,66.3 to 79.9,556
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,74.8,69.3 to 79.9,1073
Combined 7 Series,,States/Local Areas,Pennsylvania,2013,Age,35 Months,77.1,70.0 to 83.6,561
Combined 7 Series,,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,75.1,70.1 to 79.8,1117
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,94.2,90.7 to 96.7,611
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,95.3,92.1 to 97.5,626
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,24 Months,82.8,76.4 to 88.3,611
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,24 Months,83.9,77.4 to 89.4,561
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,84.0,79.6 to 87.9,1117
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,24 Months,83.1,77.8 to 87.8,626
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,19 Months,89.3,84.9 to 92.5,641
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,19 Months,87.1,81.6 to 91.1,650
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,89.4,85.9 to 92.1,1060
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,19 Months,83.6,77.4 to 88.4,560
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,85.3,81.3 to 88.6,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,93.3,88.5 to 96.6,560
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,92.9,89.9 to 95.3,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,95.2,92.0 to 97.4,641
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,92.6,88.3 to 95.7,650
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,93.9,91.3 to 95.9,1291
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,19 Months,27.1,22.8 to 31.7,611
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,25.7,20.4 to 31.9,556
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,27.8,23.4 to 32.6,1073
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,26.1,21.6 to 31.0,561
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,25.9,21.9 to 30.3,1117
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,5 Months,85.0,80.0 to 88.9,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,19 Months,20.2,16.3 to 24.9,626
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,92.0,86.7 to 95.7,556
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,93.0,89.3 to 95.8,1073
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2011,Age,35 Months,96.0,93.0 to 98.0,626
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2012,Age,35 Months,96.2,93.3 to 98.1,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,96.5,92.7 to 98.6,561
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,94.3,91.1 to 96.6,1117
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2011,Age,24 Months,42.4,36.7 to 48.6,626
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2019,Age,19 Months,37.4,31.4 to 43.8,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,19 Months,32.0,26.6 to 37.9,650
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,34.6,29.9 to 39.6,1060
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,35 Months,94.7,90.1 to 97.6,560
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,93.9,90.9 to 96.2,1210
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.6,92.2 to 97.8,580
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,95.1,92.4 to 97.1,1140
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,19 Months,35.7,29.5 to 42.3,560
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,33.8,29.7 to 38.2,1210
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,98.1,97.2 to 99.1,1077
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,92.0,88.7 to 95.2,741
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,66.4,59.2 to 72.9,517
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,72.7,67.5 to 77.3,1097
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014,Age,19 Months,72.1,65.0 to 78.3,556
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,69.3,63.9 to 74.2,1073
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2013,Age,19 Months,70.8,63.2 to 77.5,561
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,71.5,65.4 to 76.9,1117
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2012,Age,24 Months,49.8,43.0 to 57.2,611
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,71.2,46.4 to 96.0,42
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,35 Months,93.1,88.9 to 96.2,650
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,94.2,91.6 to 96.2,1291
Combined 7 Series,,States/Local Areas,Pennsylvania,2014,Age,24 Months,71.8,64.9 to 78.3,556
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,70.7,65.4 to 75.8,1073
Combined 7 Series,,States/Local Areas,Pennsylvania,2015,Age,24 Months,69.8,61.9 to 77.4,517
Combined 7 Series,,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,74.2,69.2 to 79.0,1097
Hib,Primary Series,States/Local Areas,Pennsylvania,2018,Age,35 Months,93.6,89.5 to 96.6,650
Hib,Primary Series,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,94.5,91.9 to 96.4,1291
Hib,Primary Series,States/Local Areas,Pennsylvania,2017,Age,24 Months,93.3,88.4 to 96.6,560
Hib,Primary Series,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,93.2,90.1 to 95.5,1210
Hib,Primary Series,States/Local Areas,Pennsylvania,2013,Age,24 Months,96.0,92.4 to 98.2,561
Hib,Primary Series,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,92.7,89.5 to 95.3,1117
Hib,Primary Series,States/Local Areas,Pennsylvania,2016,Age,24 Months,95.5,92.2 to 97.7,580
Hib,Primary Series,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,94.4,91.6 to 96.5,1140
Hib,Primary Series,States/Local Areas,Pennsylvania,2015,Age,24 Months,92.7,86.8 to 96.6,517
Hib,Primary Series,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,94.1,90.8 to 96.5,1097
Hib,Primary Series,States/Local Areas,Pennsylvania,2014,Age,24 Months,89.5,83.9 to 93.8,556
Hib,Primary Series,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,91.2,87.3 to 94.2,1073
Hib,Primary Series,States/Local Areas,Pennsylvania,2012,Age,35 Months,94.4,90.9 to 96.9,611
Hib,Primary Series,States/Local Areas,Pennsylvania,2014,Age,35 Months,90.8,85.4 to 94.8,556
Hib,Primary Series,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,92.1,88.4 to 95.0,1073
Hib,Primary Series,States/Local Areas,Pennsylvania,2011,Age,35 Months,95.4,92.2 to 97.6,626
Hib,Primary Series,States/Local Areas,Pennsylvania,2019,Age,24 Months,95.2,92.0 to 97.4,641
Hib,Primary Series,States/Local Areas,Pennsylvania,2013,Age,35 Months,96.1,92.5 to 98.3,561
Hib,Primary Series,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,93.5,90.3 to 95.9,1117
Combined 7 Series,,States/Local Areas,Pennsylvania,2011,Age,24 Months,74.9,69.1 to 80.3,626
Combined 7 Series,,States/Local Areas,Pennsylvania,2012,Age,24 Months,71.5,64.9 to 77.8,611
Hib,Primary Series,States/Local Areas,Pennsylvania,2013,Age,7 Months,74.4,69.6 to 78.8,561
Hib,Primary Series,States/Local Areas,Pennsylvania,2013-2014,Age,7 Months,70.8,66.7 to 74.5,1117
Combined 7 Series,,States/Local Areas,Pennsylvania,2013,Age,24 Months,70.3,63.3 to 77.1,561
Combined 7 Series,,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,71.1,66.2 to 75.8,1117
Hib,Primary Series,States/Local Areas,Pennsylvania,2017,Age,35 Months,94.6,90.1 to 97.5,560
Hib,Primary Series,States/Local Areas,Pennsylvania,2017-2018,Age,35 Months,94.2,91.2 to 96.4,1210
Hib,Primary Series,States/Local Areas,Pennsylvania,2016,Age,35 Months,95.5,92.2 to 97.7,580
Hib,Primary Series,States/Local Areas,Pennsylvania,2016-2017,Age,35 Months,95.1,92.4 to 97.1,1140
Hib,Primary Series,States/Local Areas,Pennsylvania,2015,Age,35 Months,93.0,87.3 to 96.7,517
Hib,Primary Series,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,94.2,90.9 to 96.5,1097
Hib,Primary Series,States/Local Areas,Pennsylvania,2011,Age,13 Months,92.4,89.6 to 94.5,626
Hib,Primary Series,States/Local Areas,Pennsylvania,2012,Age,13 Months,85.8,81.1 to 89.5,611
Hib,Primary Series,States/Local Areas,Pennsylvania,2013,Age,13 Months,90.5,87.3 to 92.9,561
Hib,Primary Series,States/Local Areas,Pennsylvania,2013-2014,Age,13 Months,87.7,82.3 to 91.6,1117
Hib,Primary Series,States/Local Areas,Pennsylvania,2011,Age,24 Months,95.2,92.0 to 97.4,626
Hib,Primary Series,States/Local Areas,Pennsylvania,2012,Age,24 Months,94.4,90.9 to 96.9,611
Hib,Primary Series,States/Local Areas,Pennsylvania,2015,Age,19 Months,92.7,89.4 to 95.0,517
Hib,Primary Series,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,94.1,90.5 to 96.3,1097
Hib,Primary Series,States/Local Areas,Pennsylvania,2017,Age,7 Months,76.8,70.3 to 82.3,560
Hib,Primary Series,States/Local Areas,Pennsylvania,2017-2018,Age,7 Months,74.2,69.8 to 78.2,1210
Hib,Primary Series,States/Local Areas,Pennsylvania,2016,Age,7 Months,81.1,75.1 to 85.8,580
Hib,Primary Series,States/Local Areas,Pennsylvania,2016-2017,Age,7 Months,78.9,74.6 to 82.7,1140
Hib,Primary Series,States/Local Areas,Pennsylvania,2015,Age,7 Months,68.7,60.8 to 75.7,517
Hib,Primary Series,States/Local Areas,Pennsylvania,2015-2016,Age,7 Months,74.9,69.9 to 79.2,1097
Hib,Primary Series,States/Local Areas,Pennsylvania,2014,Age,7 Months,67.0,59.9 to 73.5,556
Hib,Primary Series,States/Local Areas,Pennsylvania,2014-2015,Age,7 Months,67.9,62.6 to 72.8,1073
Hib,Primary Series,States/Local Areas,Pennsylvania,2019,Age,7 Months,72.3,66.5 to 77.5,641
Hib,Primary Series,States/Local Areas,Pennsylvania,2018,Age,7 Months,71.6,65.4 to 77.0,650
Hib,Primary Series,States/Local Areas,Pennsylvania,2018-2019,Age,7 Months,72.0,67.8 to 75.8,1291
Hib,Primary Series,States/Local Areas,Pennsylvania,2016,Age,19 Months,95.4,91.7 to 97.5,580
Hib,Primary Series,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,94.1,91.1 to 96.1,1140
Hib,Primary Series,States/Local Areas,Pennsylvania,2017,Age,19 Months,92.7,87.4 to 95.9,560
Hib,Primary Series,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,92.7,89.4 to 95.0,1210
Hib,Primary Series,States/Local Areas,Pennsylvania,2015,Age,13 Months,89.5,82.3 to 94.0,517
Hib,Primary Series,States/Local Areas,Pennsylvania,2015-2016,Age,13 Months,91.3,87.3 to 94.2,1097
Hib,Primary Series,States/Local Areas,Pennsylvania,2014,Age,13 Months,84.9,78.5 to 89.7,556
Hib,Primary Series,States/Local Areas,Pennsylvania,2014-2015,Age,13 Months,87.2,82.7 to 90.7,1073
Hib,Primary Series,States/Local Areas,Pennsylvania,2018,Age,19 Months,92.6,88.1 to 95.5,650
Hib,Primary Series,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,89.3,86.2 to 91.8,1291
Hib,Primary Series,States/Local Areas,Pennsylvania,2019,Age,19 Months,94.9,91.5 to 97.0,641
Hib,Primary Series,States/Local Areas,Pennsylvania,2014,Age,19 Months,87.8,81.6 to 92.2,556
Hib,Primary Series,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,90.2,86.0 to 93.3,1073
Hib,Primary Series,States/Local Areas,Pennsylvania,2011,Age,19 Months,95.1,93.0 to 96.6,626
Hib,Primary Series,States/Local Areas,Pennsylvania,2013,Age,19 Months,95.0,93.6 to 96.1,561
Hib,Primary Series,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,91.4,84.8 to 95.3,1117
Hib,Primary Series,States/Local Areas,Pennsylvania,2019,Age,13 Months,89.8,85.5 to 92.9,641
Hib,Primary Series,States/Local Areas,Pennsylvania,2018,Age,13 Months,88.9,83.9 to 92.4,650
Hib,Primary Series,States/Local Areas,Pennsylvania,2018-2019,Age,13 Months,89.3,86.2 to 91.8,1291
Hib,Primary Series,States/Local Areas,Pennsylvania,2012,Age,19 Months,92.0,88.4 to 94.6,611
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020,Age,13 Months,65.4,59.1 to 71.1,655
Hib,Primary Series,States/Local Areas,Pennsylvania,2017,Age,13 Months,88.0,82.1 to 92.2,560
Hib,Primary Series,States/Local Areas,Pennsylvania,2017-2018,Age,13 Months,88.4,84.7 to 91.3,1210
Hib,Primary Series,States/Local Areas,Pennsylvania,2016,Age,13 Months,93.2,88.5 to 96.0,580
Hib,Primary Series,States/Local Areas,Pennsylvania,2016-2017,Age,13 Months,90.6,87.0 to 93.3,1140
Rotavirus,,States/Local Areas,Pennsylvania,2019-2020,Age,8 Months,78.2,74.1 to 81.8,1296
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,90.0,86.4 to 93.0,1121
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2021,Age,0-1 Days,81.2,75.1 to 86.1,466
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,85.6,81.8 to 89.4,1038
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.9 to 96.7,1122
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.9,83.5 to 90.3,1122
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,72.4,57.5 to 87.3,51
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,96.4,94.9 to 97.9,1038
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,93.8 to 97.8,1122
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,95.2,87.1 to 100.0,51
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,82.2,77.4 to 87.0,1038
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,88.0,82.9 to 91.8,655
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,67.7,61.4 to 73.5,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,91.6,87.4 to 94.8,655
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,3 Months,95.4,91.0 to 97.7,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,59.7,53.4 to 65.7,655
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,3 Months,82.5,76.8 to 87.0,655
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,3 Months,86.0,80.6 to 90.1,655
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,89.0,85.5 to 92.6,1244
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,47.1,20.1 to 74.2,32
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,79.5,73.2 to 85.8,804
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,91.1 to 98.6,323
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.7,75.9 to 89.5,345
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.4,78.8 to 92.0,323
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,86.1,80.1 to 92.2,354
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,90.6,83.2 to 98.0,131
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,85.5,62.9 to 100.0,32
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.8 to 97.8,1244
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,93.8,91.0 to 96.7,804
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,94.4,90.0 to 98.9,131
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.5,94.4 to 98.6,323
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,72.7,64.9 to 80.5,354
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,85.8,83.2 to 88.3,2211
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,81.3,71.8 to 90.9,131
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,95.2,93.7 to 96.7,2211
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,91.5,88.6 to 94.4,943
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,95.1,93.7 to 96.6,2211
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,78.8,73.2 to 84.3,584
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,94.6,93.0 to 96.2,2211
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,87.1,82.5 to 91.7,584
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,87.2,83.0 to 91.5,684
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,90.7,86.8 to 94.5,943
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,95.8,93.5 to 98.0,684
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,83.6,77.8 to 89.5,684
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,73.7,70.7 to 76.8,2211
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,92.3,88.9 to 95.7,584
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,90.2,88.0 to 92.3,2211
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,85.7,83.4 to 88.1,2211
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,92.5,88.7 to 96.2,584
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,83.8,80.3 to 87.2,2211
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,85.6,81.4 to 89.8,584
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,77.1,74.1 to 80.0,2211
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,94.3,92.6 to 96.0,2211
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,98.0,96.5 to 99.4,943
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,80.1,75.4 to 84.8,684
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,84.8,81.0 to 88.5,943
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,82.0,79.3 to 84.7,2211
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,96.4,94.3 to 98.6,684
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,94.9,92.4 to 97.4,943
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,95.4,93.2 to 97.7,684
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,65.2,59.0 to 71.5,584
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,84.5,81.9 to 87.0,2211
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,97.5,95.9 to 99.2,943
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,95.3,92.5 to 98.0,684
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,79.2,66.3 to 92.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.3,84.1 to 90.6,1122
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,91.9,81.9 to 100.0,51
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,76.5,72.3 to 80.8,1038
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,83.9,80.5 to 87.4,1038
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,95.2,87.1 to 100.0,51
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,95.3,93.5 to 97.1,1038
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,92.9 to 97.4,1122
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,64.3,46.6 to 81.9,51
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.5,92.1 to 96.8,1122
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,90.8,86.2 to 94.0,466
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,90.5,87.2 to 93.0,1121
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,90.7,87.6 to 93.3,1121
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,83.0,76.8 to 88.3,466
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2021,Age,24 Months,88.5,83.0 to 92.9,466
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,61.2,53.7 to 68.3,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,91.6,87.4 to 94.9,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,91.7,88.6 to 94.2,1121
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2021,Age,0-2 Days,83.7,77.7 to 88.3,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,91.5,86.9 to 94.5,466
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,3 Months,91.5,87.6 to 94.2,466
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,79.3,72.5 to 85.3,466
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,84.1,77.9 to 89.3,466
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,19 Months,81.0,74.0 to 86.5,466
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,92.7,88.2 to 95.6,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,90.2,85.6 to 93.5,466
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,26.9,20.9 to 33.8,466
Combined 7 Series,,States/Local Areas,Pennsylvania,2021,Age,24 Months,67.9,60.8 to 74.9,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,71.0,63.7 to 77.4,466
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,71.0,66.2 to 75.4,1121
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,5 Months,78.4,74.0 to 82.3,1121
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,24 Months,86.5,80.5 to 91.4,466
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,88.4,85.0 to 91.4,1121
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,90.5,85.8 to 93.8,466
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,90.8,86.2 to 94.0,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,72.7,65.5 to 78.9,466
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,89.0,83.8 to 92.7,466
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,91.5,86.9 to 94.5,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,90.3,87.1 to 92.8,1121
Combined 7 Series,,States/Local Areas,Pennsylvania,2021,Age,35 Months,71.7,63.2 to 79.7,466
Hib,Primary Series,States/Local Areas,Pennsylvania,2021,Age,7 Months,73.8,67.1 to 79.5,466
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,93.5,90.7 to 95.5,1121
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,85.5,76.7 to 92.3,466
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,80.6,74.0 to 85.8,466
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,35 Months,91.9,83.1 to 97.2,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,91.6,87.0 to 94.6,466
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,89.2,84.4 to 93.1,466
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,71.1,63.6 to 77.6,466
Hib,Full Series,States/Local Areas,Pennsylvania,2021,Age,24 Months,75.8,69.1 to 82.0,466
Hib,Primary Series,States/Local Areas,Pennsylvania,2021,Age,24 Months,90.5,86.2 to 94.0,466
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,90.1,85.8 to 93.6,466
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2021,Age,24 Months,88.6,83.2 to 92.9,466
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,3 Months,91.1,87.1 to 93.9,466
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,91.5,87.3 to 94.7,466
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,35 Months,92.1,86.0 to 96.2,517
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,93.7,90.4 to 96.3,1097
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,35 Months,90.0,84.6 to 94.2,556
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,35 Months,91.2,87.3 to 94.3,1073
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013,Age,35 Months,95.9,92.3 to 98.1,561
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2013-2014,Age,35 Months,93.0,89.8 to 95.5,1117
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,19 Months,36.7,30.4 to 43.6,580
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,36.2,31.7 to 40.9,1140
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2015,Age,19 Months,29.8,23.5 to 37.0,517
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,33.2,28.6 to 38.3,1097
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,24 Months,84.1,78.0 to 89.3,556
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,84.3,79.9 to 88.3,1073
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019,Age,24 Months,95.5,92.4 to 97.7,641
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,95.2,91.9 to 97.5,580
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,94.3,91.5 to 96.4,1140
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,91.9,85.8 to 96.0,517
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,93.5,90.1 to 96.0,1097
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2017,Age,5 Months,82.7,76.2 to 87.7,560
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,5 Months,81.9,77.7 to 85.4,1210
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2018,Age,5 Months,81.1,75.4 to 85.7,650
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,5 Months,83.0,79.4 to 86.2,1291
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2016,Age,5 Months,86.1,80.6 to 90.2,580
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,5 Months,84.4,80.3 to 87.8,1140
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.9,91.2 to 96.7,945
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,84.2,71.4 to 97.1,48
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,92.8,90.7 to 94.9,1975
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,88.8,84.2 to 93.5,636
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,92.6,88.8 to 96.3,551
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,97.0,95.3 to 98.8,788
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018,Age,24 Months,94.7,91.0 to 97.2,650
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,95.1,92.8 to 96.9,1291
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017,Age,24 Months,93.6,88.8 to 96.8,560
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,94.1,91.2 to 96.3,1210
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,19 Months,78.8,74.8 to 82.3,561
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,78.9,74.0 to 83.2,1117
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,19 Months,77.7,74.4 to 80.7,611
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,19 Months,77.6,73.0 to 81.6,626
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2019,Age,3 Months,92.5,88.3 to 95.2,641
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016,Age,24 Months,95.8,92.4 to 98.0,580
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,94.7,91.9 to 96.8,1140
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2018,Age,3 Months,89.7,84.9 to 93.1,650
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2018-2019,Age,3 Months,91.1,88.1 to 93.4,1291
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015,Age,24 Months,93.4,87.8 to 97.1,517
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,94.6,91.3 to 96.9,1097
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014,Age,24 Months,90.7,85.2 to 94.8,556
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,92.1,88.3 to 95.0,1073
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,3 Months,90.2,84.4 to 93.9,560
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,3 Months,89.9,86.4 to 92.6,1210
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2016,Age,3 Months,93.9,90.4 to 96.2,580
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2016-2017,Age,3 Months,92.1,88.8 to 94.4,1140
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,3 Months,84.2,76.7 to 89.7,517
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,3 Months,89.1,84.9 to 92.2,1097
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,3 Months,87.8,82.1 to 91.9,556
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,3 Months,86.0,81.5 to 89.6,1073
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2013,Age,3 Months,87.9,81.2 to 92.5,561
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2013-2014,Age,3 Months,87.9,83.8 to 91.0,1117
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2011,Age,3 Months,91.2,87.0 to 94.1,626
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2012,Age,3 Months,90.4,86.3 to 93.4,611
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2015,Age,19 Months,78.7,69.8 to 85.5,517
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,81.1,76.3 to 85.1,1097
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014,Age,19 Months,79.1,72.3 to 84.6,556
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,78.9,74.0 to 83.1,1073
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,85.9,82.1 to 89.3,1121
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,84.3,79.0 to 88.9,1121
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2021,Age,19 Months,87.2,81.1 to 91.5,466
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,3 Months,88.5,83.9 to 91.9,466
Hib,Full Series,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,74.1,69.6 to 78.5,1121
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2017,Age,24 Months,87.7,82.2 to 92.1,560
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,88.0,84.3 to 91.1,1210
Hib,Full Series,States/Local Areas,Pennsylvania,2021,Age,19 Months,72.2,64.9 to 78.5,466
Hib,Primary Series,States/Local Areas,Pennsylvania,2021,Age,19 Months,90.0,85.3 to 93.3,466
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,89.1,84.2 to 92.6,466
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,19 Months,89.6,84.9 to 92.9,466
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,5 Months,79.5,73.2 to 84.6,466
Hib,Primary Series,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,89.8,86.7 to 92.5,1121
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,7 Months,60.6,52.9 to 67.7,466
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2021,Age,35 Months,93.2,86.4 to 97.3,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,95.1,89.4 to 98.2,466
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,81.8,77.7 to 85.5,1121
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,87.5,83.8 to 90.4,1121
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,5 Months,80.0,73.4 to 85.2,466
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,3 Months,85.8,82.3 to 88.8,1296
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,71.2,67.0 to 75.1,1296
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,91.9,89.0 to 94.1,1296
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,91.2,88.2 to 93.4,1296
Hib,Primary Series,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,71.2,66.9 to 75.2,1296
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,3 Months,89.1,85.8 to 91.7,1296
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,3 Months,89.4,86.2 to 92.0,1296
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,90.5,87.5 to 92.9,1296
Combined 7 Series,,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,69.8,65.5 to 74.0,1296
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,93.4,90.7 to 95.6,1296
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,86.3,82.2 to 89.8,1296
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,93.2,90.5 to 95.3,1296
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,64.3,59.9 to 68.5,1296
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,92.3,89.4 to 94.5,1296
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,89.0,85.9 to 91.7,1296
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,80.1,75.1 to 84.7,1296
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,92.3,89.1 to 94.8,1296
Influenza,,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,69.1,64.7 to 73.4,1296
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,90.9,87.8 to 93.5,1296
Hib,Primary Series,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,92.2,89.4 to 94.4,1296
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,67.9,61.4 to 73.8,655
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,82.2,76.6 to 87.2,655
Hib,Primary Series,States/Local Areas,Pennsylvania,2020,Age,13 Months,83.1,77.4 to 87.6,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,92.0 to 96.2,1038
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,88.5 to 98.4,323
Hib,Full Series,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,77.2,73.2 to 80.9,1296
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2019-2020,Age,0-1 Days,81.7,78.1 to 84.9,1296
Combined 7 Series,,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,75.4,70.7 to 79.7,1296
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,58.7,54.1 to 63.1,1296
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,89.8,86.7 to 92.2,1296
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,92.5,89.8 to 94.6,1296
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,81.3,77.5 to 84.5,1296
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,86.8,83.4 to 89.6,1296
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2019-2020,Age,0-2 Days,84.1,80.6 to 87.1,1296
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,91.4,88.6 to 93.8,1296
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,93.3,90.7 to 95.3,1296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2019-2020,Age,0-3 Days,85.0,81.5 to 88.0,1296
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,71.8,67.5 to 75.7,1296
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,92.5,89.8 to 94.7,1296
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,84.2,80.6 to 87.4,1296
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,89.6,86.5 to 92.0,1296
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,34.5,30.4 to 38.9,1296
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,89.6,86.2 to 92.2,1296
Hib,Primary Series,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,91.7,88.8 to 94.0,1296
Hib,Full Series,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,73.1,69.0 to 77.0,1296
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,92.5,89.7 to 94.8,1296
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,91.6,88.5 to 94.1,1296
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,93.8,91.2 to 95.9,1296
Hib,Full Series,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,82.3,78.0 to 86.2,1296
Hib,Primary Series,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,92.3,89.5 to 94.6,1296
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,92.9,90.2 to 95.1,1296
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,92.4,89.6 to 94.8,1296
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,35 Months,86.5,82.8 to 89.7,1296
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,93.0,90.2 to 95.2,1296
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,79.6,75.6 to 83.2,1296
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,92.7,90.0 to 94.9,1296
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,92.0,89.2 to 94.3,1296
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,3 Months,96.5,93.8 to 98.0,1296
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2019-2020,Age,3 Months,89.4,86.2 to 91.9,1296
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,5 Months,81.0,77.1 to 84.4,1296
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,5 Months,80.9,76.9 to 84.3,1296
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,5 Months,77.7,73.6 to 81.4,1296
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,93.4,90.5 to 95.4,1296
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,67.3,63.0 to 71.3,1296
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,74.3,70.0 to 78.3,1296
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,92.7,89.7 to 94.8,1296
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,94.7,91.9 to 96.6,1296
Hib,Primary Series,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,86.6,83.1 to 89.4,1296
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,5 Months,90.9,87.6 to 93.4,1296
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,5 Months,80.6,76.7 to 84.0,1296
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,72.7,68.4 to 76.6,1296
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,89.8,86.4 to 92.4,1296
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,13 Months,89.7,86.4 to 92.3,1296
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,88.9,85.4 to 91.6,1296
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,77.3,71.3 to 82.3,655
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,91.2,86.7 to 94.7,655
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,83.6,77.3 to 88.9,655
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020,Age,19 Months,88.1,83.0 to 91.7,655
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,88.6,83.6 to 92.2,655
Hib,Full Series,States/Local Areas,Pennsylvania,2020,Age,19 Months,68.6,62.1 to 74.3,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,91.1,86.5 to 94.2,655
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020,Age,35 Months,89.6,84.9 to 93.4,655
Hib,Primary Series,States/Local Areas,Pennsylvania,2020,Age,19 Months,88.4,83.3 to 92.1,655
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,90.2,85.6 to 93.8,655
Hib,Full Series,States/Local Areas,Pennsylvania,2020,Age,35 Months,77.5,70.8 to 83.7,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,91.8,87.5 to 95.0,655
Hib,Primary Series,States/Local Areas,Pennsylvania,2020,Age,35 Months,89.3,84.5 to 93.2,655
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,87.7,82.4 to 92.0,655
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020,Age,35 Months,89.0,84.1 to 92.9,655
Hib,Primary Series,States/Local Areas,Pennsylvania,2020,Age,24 Months,89.0,84.3 to 92.9,655
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,86.5,81.1 to 91.0,655
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020,Age,24 Months,88.4,83.6 to 92.4,655
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,76.4,70.5 to 81.8,655
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,90.7,86.2 to 94.2,655
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,90.8,85.7 to 94.2,655
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,90.3,85.6 to 93.9,655
Hib,Primary Series,States/Local Areas,Pennsylvania,2020,Age,7 Months,69.9,63.5 to 75.6,655
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,54.2,47.9 to 60.4,655
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,84.7,78.7 to 89.2,655
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,85.7,79.9 to 90.0,655
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2020,Age,0-2 Days,82.0,76.6 to 86.4,655
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,3 Months,86.6,81.3 to 90.5,655
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,19 Months,84.2,78.7 to 88.6,655
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,31.5,26.2 to 37.4,655
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2020,Age,0-1 Days,80.4,74.9 to 84.9,655
Combined 7 Series,,States/Local Areas,Pennsylvania,2020,Age,35 Months,72.7,65.6 to 79.3,655
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,76.7,69.4 to 83.4,655
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,24 Months,53.2,48.7 to 57.9,1296
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,90.8,86.0 to 94.1,655
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,5 Months,73.3,66.9 to 78.9,655
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,5 Months,89.0,83.7 to 92.7,655
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,5 Months,76.8,70.5 to 82.1,655
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,5 Months,76.6,70.3 to 81.8,655
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,3 Months,86.6,81.4 to 90.5,655
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,50.8,44.5 to 57.4,655
Combined 7 Series,,States/Local Areas,Pennsylvania,2020,Age,24 Months,66.0,59.8 to 72.2,655
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2020,Age,24 Months,85.5,80.3 to 89.9,655
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,80.6,75.0 to 85.6,655
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,35 Months,90.8,86.1 to 94.4,655
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,24 Months,89.7,85.1 to 93.3,655
Rotavirus,,States/Local Areas,Pennsylvania,2020,Age,8 Months,77.0,70.8 to 82.3,655
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2020,Age,0-3 Days,82.9,77.5 to 87.2,655
Influenza,,States/Local Areas,Pennsylvania,2020,Age,24 Months,62.7,56.3 to 69.0,655
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,84.1,78.2 to 88.7,655
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020,Age,19 Months,86.4,81.1 to 90.4,655
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,89.3,84.2 to 92.9,655
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,89.2,84.1 to 92.8,655
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2020,Age,19 Months,67.1,60.8 to 72.9,655
PCV,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,5 Months,76.9,70.7 to 82.1,655
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,7 Months,69.5,63.1 to 75.2,655
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,87.2,81.9 to 91.1,655
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020,Age,13 Months,60.0,53.7 to 66.1,655
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,87.1,81.7 to 91.0,655
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2020,Age,13 Months,94.1,89.8 to 96.6,655
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.4,91.9 to 96.8,1122
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,83.5,79.2 to 87.7,684
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,69.8,63.7 to 75.9,584
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,94.4,92.5 to 96.4,1038
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,93.8,91.6 to 96.1,943
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,87.6,83.6 to 91.6,684
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,87.2,83.8 to 90.5,943
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,84.5,79.8 to 89.2,684
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,74.6,67.0 to 82.1,584
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,96.9,95.4 to 98.5,943
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,93.3,90.0 to 96.6,584
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,96.0,94.6 to 97.4,2211
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,94.3,92.7 to 96.0,2211
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,71.3,65.8 to 76.8,684
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,60.5,54.1 to 66.9,584
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,97.4,95.8 to 98.9,943
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,92.5,89.1 to 96.0,684
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,92.3,88.9 to 95.8,584
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,93.8,90.5 to 97.1,584
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,92.0,89.1 to 94.9,943
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,92.7,89.4 to 95.9,684
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,92.5,89.2 to 95.9,584
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,92.4,90.1 to 94.8,943
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,86.4,82.4 to 90.4,684
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,73.4,67.4 to 79.5,584
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,<133% FPL,81.3,76.4 to 86.2,584
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,95.5,93.7 to 97.4,943
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Overall,Overall,87.8,85.6 to 90.0,2211
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,88.3,85.0 to 91.6,943
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,94.9,92.6 to 97.3,804
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,72.2,67.2 to 77.2,804
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,95.6,93.1 to 98.1,354
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,81.0 to 88.2,1122
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,79.7,65.5 to 93.9,51
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,95.5,93.8 to 97.2,1038
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,90.4,87.4 to 93.3,1038
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.7,80.1 to 87.4,1122
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,87.9 to 93.8,1122
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,81.2,66.3 to 96.0,51
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,75.9 to 83.8,1038
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.9,71.7 to 80.0,1122
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,71.4,66.8 to 76.0,1038
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,69.9,54.9 to 84.9,51
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.0,73.9 to 82.0,1122
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,86.8,83.9 to 89.7,1038
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,85.8 to 92.1,1122
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,80.8,66.9 to 94.7,51
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,92.5,83.2 to 100.0,51
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,95.1,93.3 to 96.9,1038
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,93.3 to 97.4,1122
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,94.9,86.8 to 100.0,51
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,76.2,60.7 to 91.7,51
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,91.7,81.7 to 100.0,51
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,80.1 to 89.4,1122
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a MSA Principal City,84.8,81.2 to 88.3,1038
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Urbanicity,Living In a Non-MSA,81.8,65.3 to 98.3,51
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,72.3,60.7 to 83.8,131
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.8,64.4 to 81.3,323
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,92.4 to 96.9,1189
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.1,92.9 to 97.3,1189
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.9,86.8 to 97.1,345
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.9,96.2 to 99.6,323
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.8,92.5 to 97.2,1189
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,83.8,80.4 to 87.2,1244
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.7,60.2 to 77.2,345
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.8,82.5 to 89.2,1189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.8,80.4 to 93.2,323
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.7,79.3 to 90.1,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,85.3,81.6 to 89.0,804
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,86.0,82.6 to 89.5,1244
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.5,87.6 to 97.5,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,88.0,82.0 to 94.0,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,82.2,66.4 to 97.9,32
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,96.7,95.2 to 98.3,1244
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,90.3 to 98.2,323
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,94.8,91.7 to 97.8,354
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,98.1,96.9 to 99.2,1244
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,80.2,56.1 to 100.0,32
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,73.1 to 88.1,323
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,37.0,10.5 to 63.6,32
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,90.2,87.6 to 92.7,1244
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,83.8,80.3 to 87.2,1244
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.7,78.8 to 92.5,323
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,63.6,58.2 to 69.0,804
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,74.4,64.1 to 84.7,131
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.2,81.8 to 88.7,1189
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,71.9,54.9 to 88.8,131
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,75.5,46.6 to 100.0,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,82.2,74.0 to 90.4,354
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,95.4,92.6 to 98.2,354
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,75.0,70.1 to 79.9,804
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.5,68.7 to 84.4,345
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,76.2,66.0 to 86.4,131
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,51.2,24.0 to 78.4,32
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,79.7,73.2 to 86.2,354
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.7,74.7 to 82.6,1189
Combined 7 Series,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.1,63.2 to 79.1,345
Rotavirus,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,80.3,73.9 to 86.7,354
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,74.4,48.0 to 100.0,32
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,73.6,49.1 to 98.0,32
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,88.2,83.7 to 92.7,354
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,50.4,23.5 to 77.3,32
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.1,74.3 to 88.0,345
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.6,86.6 to 92.5,1189
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.4,71.2 to 79.5,1189
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.8,54.5 to 71.2,345
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,93.6 to 97.7,1189
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,94.3,91.9 to 96.7,804
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,89.1,81.2 to 97.0,131
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.0,88.5 to 97.5,345
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.2,90.8 to 99.6,323
Influenza,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,71.0 to 85.7,323
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,93.6,90.3 to 96.9,354
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,96.0,94.2 to 97.8,1244
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.1,88.6 to 97.6,345
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.5,93.4 to 97.5,1189
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,89.4,81.6 to 97.2,131
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,75.2,50.9 to 99.5,32
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,94.5,91.8 to 97.2,804
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,79.1,68.1 to 90.2,131
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,57.1,30.3 to 83.9,32
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,82.6,78.2 to 86.9,804
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,83.2 to 95.1,345
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,87.7,79.8 to 95.7,131
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.4 to 93.4,1189
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,85.0,75.5 to 94.6,131
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,82.8,73.5 to 92.1,131
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,54.8,28.0 to 81.6,32
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,79.5,74.8 to 84.1,804
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.7 to 99.2,1244
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,93.8,91.1 to 96.4,804
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,62.7,35.0 to 90.4,32
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,93.3,90.5 to 96.2,804
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.4,82.9 to 89.9,1189
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Uninsured,59.1,31.9 to 86.2,32
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Other,92.5,87.2 to 97.8,131
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,96.0,93.4 to 98.5,354
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.7,89.2 to 98.1,345
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.2,94.2 to 98.1,1189
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,90.8,87.9 to 93.6,1244
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.4,87.3 to 97.4,345
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,95.1,91.1 to 97.4,214
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,94.9,92.1 to 96.7,432
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,94.7,92.2 to 96.4,218
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,96.0,93.5 to 97.6,444
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,97.4,94.2 to 98.9,226
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,95.1,92.0 to 97.0,430
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,88.4,81.5 to 93.0,235
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,94.0,87.1 to 97.3,224
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,65.4,59.4 to 71.0,459
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,93.3,88.9 to 96.4,283
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,95.4,92.1 to 97.6,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,93.7,89.3 to 96.4,214
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,94.0,91.1 to 96.0,432
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,94.0,91.4 to 95.9,236
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,93.9,92.0 to 95.4,450
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,94.7,90.2 to 97.6,236
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,95.2,92.6 to 97.1,450
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,93.3,86.6 to 96.8,224
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,86.7,82.0 to 90.3,459
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,91.9,85.9 to 95.4,204
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,92.6,88.5 to 95.3,428
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,97.3,94.4 to 98.9,226
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,95.7,93.1 to 97.5,430
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,97.0,93.8 to 98.6,226
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,94.4,91.2 to 96.5,430
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,92.8,87.1 to 96.1,204
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,93.7,89.8 to 96.2,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,94.7,87.8 to 97.8,224
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,89.7,85.0 to 93.0,459
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,90.1,83.5 to 94.2,235
Hib,Full Series,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,90.0,83.9 to 94.5,204
Hib,Full Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,88.6,83.2 to 92.9,428
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,82.4,75.7 to 89.2,170
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,83.7,79.5 to 87.9,411
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,84.2,81.0 to 87.3,791
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,59.7,54.8 to 64.3,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,86.4,80.6 to 92.2,210
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,61.9,57.9 to 65.7,283
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,84.2,81.0 to 87.3,791
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.0,75.9 to 88.0,231
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.5,74.6 to 92.3,116
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,82.4,76.1 to 88.7,196
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,85.7,79.8 to 90.7,214
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,85.8,81.6 to 89.6,432
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,92.0,86.8 to 95.7,226
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,89.0,85.0 to 92.3,430
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,85.6,79.3 to 90.8,218
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,88.7,84.7 to 92.0,444
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,5 Months,77.7,69.6 to 84.2,218
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,5 Months,80.7,75.4 to 85.1,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,56.3,47.4 to 64.8,226
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,54.6,48.3 to 60.8,430
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,49.4,40.8 to 58.7,235
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,78.3,69.3 to 86.1,283
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,81.6,73.5 to 88.5,280
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,84.9,74.8 to 92.5,236
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,88.5,81.9 to 93.5,450
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,95.8,91.3 to 98.4,226
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,97.2,94.1 to 98.9,430
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,5 Months,73.9,65.9 to 80.5,214
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,5 Months,75.8,71.7 to 79.5,432
Hib,Full Series,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,87.1,77.9 to 93.9,224
Hib,Full Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,82.3,76.5 to 87.5,459
Hib,Full Series,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,78.1,69.7 to 85.5,235
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,89.6,79.6 to 99.6,53
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,95.2,93.5 to 96.8,791
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.3,89.1 to 97.5,231
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.6,91.4 to 99.8,116
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,96.4,94.1 to 98.7,196
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.3,92.7 to 98.0,248
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,98.0,93.5 to 99.7,224
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,94.5,90.1 to 97.4,459
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,91.0,83.1 to 96.1,235
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,96.2,91.8 to 100.0,53
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,93.8,91.5 to 96.2,440
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,98.6,97.2 to 100.0,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,91.8,87.4 to 95.2,226
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,91.0,87.4 to 93.9,430
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,88.2,82.2 to 92.9,214
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,89.8,84.0 to 94.2,432
Hib,Full Series,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,89.6,81.3 to 95.3,218
Hib,Full Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,90.5,86.0 to 94.0,444
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,86.7,82.0 to 91.4,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.2,81.3 to 91.2,248
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,83.0,78.9 to 87.1,440
Hib,Full Series,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,90.4,84.0 to 95.0,236
Hib,Full Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,89.6,85.2 to 93.1,450
Hib,Full Series,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,90.5,85.6 to 94.3,283
Hib,Full Series,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,88.9,82.5 to 93.7,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,75.0,67.1 to 82.3,235
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,5 Months,73.6,65.3 to 80.6,236
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,5 Months,73.8,67.3 to 79.4,450
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,5 Months,72.7,70.1 to 75.1,280
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,5 Months,77.3,70.4 to 83.0,283
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,94.9,91.3 to 97.4,214
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,94.6,92.0 to 96.6,432
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,96.1,92.8 to 98.1,280
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,97.7,94.1 to 99.3,214
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,95.9,93.2 to 97.8,432
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,96.6,92.4 to 98.8,236
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,97.1,94.5 to 98.6,450
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,96.3,92.2 to 98.6,204
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,97.1,94.2 to 98.8,428
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,97.3,94.4 to 98.9,226
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,96.7,94.2 to 98.3,430
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,5 Months,77.7,69.6 to 84.2,218
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,5 Months,80.7,75.4 to 85.1,444
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,94.7,90.3 to 97.5,218
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,96.0,93.5 to 97.7,444
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,95.0,90.5 to 97.8,236
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,95.0,92.3 to 97.0,450
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,95.2,91.6 to 97.6,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,95.9,92.2 to 98.1,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,96.2,91.8 to 98.7,236
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,96.2,93.7 to 98.0,450
Hib,Full Series,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,83.3,76.9 to 88.7,218
Hib,Full Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,85.8,81.7 to 89.4,444
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,95.7,92.0 to 98.0,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,96.4,93.4 to 98.3,280
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,94.6,88.6 to 98.0,224
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,91.7,87.6 to 94.9,459
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,88.8,82.5 to 93.7,235
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,88.3,81.2 to 92.9,235
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,94.2,89.7 to 97.2,204
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,94.3,90.8 to 96.8,428
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,94.7,90.3 to 97.5,218
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,96.0,93.5 to 97.7,444
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,95.7,92.4 to 97.9,214
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,95.2,92.6 to 97.1,432
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,94.3,91.2 to 96.3,218
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,95.6,93.1 to 97.3,444
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,95.9,91.7 to 98.3,283
Hib,Full Series,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,83.0,75.7 to 89.1,224
Hib,Full Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,79.0,73.7 to 83.9,459
Hib,Full Series,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,82.9,75.9 to 88.7,204
Hib,Full Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,83.0,78.1 to 87.4,428
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,88.6,83.1 to 92.9,226
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,85.9,81.6 to 89.7,430
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,98.5,94.9 to 99.7,204
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,97.9,94.2 to 99.4,428
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,5 Months,83.8,76.6 to 89.1,226
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,5 Months,83.1,78.0 to 87.2,430
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,5 Months,82.4,74.9 to 88.0,204
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,5 Months,79.1,73.5 to 83.8,428
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,55.2,47.0 to 63.2,214
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,57.6,51.8 to 63.2,432
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,60.0,51.8 to 67.7,218
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,58.2,52.2 to 64.0,444
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,5 Months,77.0,68.7 to 83.6,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,86.0,79.2 to 92.8,196
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,90.5,89.2 to 91.6,280
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,90.3,86.6 to 93.1,283
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,53.0,44.1 to 61.6,204
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,56.8,50.7 to 62.7,428
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,60.7,52.4 to 68.4,224
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,62.0,56.2 to 67.6,459
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,86.7,75.6 to 94.4,226
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,84.8,78.0 to 90.4,430
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,74.9,65.1 to 83.7,218
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,80.0,72.7 to 86.5,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,63.3,54.9 to 71.0,235
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,91.9,84.3 to 96.6,214
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,83.7,76.3 to 89.9,432
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,60.9,52.7 to 68.5,214
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,56.6,50.7 to 62.2,432
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,59.9,53.9 to 65.6,280
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,97.4,91.5 to 99.5,224
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,94.3,89.8 to 97.2,459
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,91.4,84.9 to 95.9,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,87.8,84.0 to 91.5,440
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,95.2,92.1 to 98.2,280
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.4,90.4 to 96.4,248
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,93.6,87.8 to 99.3,53
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,5 Months,75.7,67.1 to 82.7,224
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,5 Months,76.3,70.5 to 81.3,459
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,59.3,49.1 to 68.8,236
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,60.1,52.8 to 66.9,450
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,56.8,51.5 to 62.0,283
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,5 Months,74.2,65.6 to 81.3,224
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,5 Months,75.5,69.7 to 80.5,459
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,5 Months,76.8,68.6 to 83.4,235
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,5 Months,81.4,73.9 to 87.2,204
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,5 Months,77.9,72.3 to 82.7,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,95.8,94.3 to 97.3,791
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,89.8 to 98.1,231
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,92.0 to 100.0,116
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,96.4,94.1 to 98.7,196
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.5,94.4 to 98.6,248
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,82.5,75.3 to 88.0,226
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,79.9,74.7 to 84.3,430
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,77.3,69.3 to 83.7,204
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,75.4,69.7 to 80.4,428
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,73.4,64.8 to 80.6,224
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,95.3,91.5 to 97.4,459
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,41.9,34.3 to 50.5,236
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,46.0,40.3 to 52.0,450
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,95.0,88.4 to 98.4,218
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,95.7,91.5 to 98.2,444
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,5 Months,72.6,70.2 to 74.8,280
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,5 Months,75.8,69.3 to 81.3,283
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,95.8,92.2 to 98.1,280
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,5 Months,73.9,68.4 to 78.9,236
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,5 Months,73.9,69.2 to 78.1,450
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,5 Months,73.9,65.9 to 80.5,214
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,5 Months,75.8,71.7 to 79.5,432
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,95.7,93.7 to 97.7,411
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,97.8,96.0 to 99.6,210
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,94.0,89.8 to 98.2,170
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,60.1,55.5 to 64.6,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,45.7,40.8 to 50.7,283
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,57.3,50.2 to 64.2,236
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,56.3,50.5 to 61.9,450
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,67.4,58.8 to 74.9,235
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,86.0,80.5 to 90.7,283
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,81.5,75.3 to 86.9,280
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,62.5,54.1 to 71.0,224
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,56.0,49.9 to 62.3,459
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,55.6,46.8 to 64.9,204
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,59.0,52.8 to 65.2,428
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,56.6,47.9 to 65.7,226
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,56.1,49.8 to 62.7,430
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,85.7,79.4 to 90.8,236
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,85.8,81.6 to 89.5,450
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,61.6,53.4 to 69.2,214
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,58.1,52.3 to 63.7,432
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,54.5,46.1 to 62.6,218
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,60.0,54.0 to 65.8,444
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,63.6,55.0 to 71.4,235
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,94.8,91.2 to 97.0,283
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,91.9,88.7 to 94.3,280
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,85.8,79.1 to 92.6,170
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,58.5,50.5 to 66.0,236
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,60.0,54.3 to 65.5,450
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,66.3,57.6 to 74.0,224
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,65.0,58.9 to 70.6,459
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,90.8,84.7 to 95.2,280
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,93.4,88.2 to 96.9,214
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,93.0,85.5 to 97.4,432
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,76.6,66.4 to 85.5,235
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,86.4,84.8 to 87.9,280
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,92.9,86.7 to 96.9,236
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,94.1,89.7 to 97.1,450
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,89.6,87.4 to 91.5,236
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,89.3,87.9 to 90.6,450
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,89.0,83.0 to 93.0,214
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,89.7,85.9 to 92.5,432
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,78.8,69.6 to 86.8,224
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,77.5,70.7 to 83.7,459
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,84.6,75.6 to 91.7,204
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,81.5,75.0 to 87.2,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,65.3,56.6 to 73.2,226
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,64.3,58.0 to 70.1,430
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,63.2,54.0 to 71.6,204
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,64.7,58.5 to 70.5,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,52.2,43.9 to 60.4,218
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,58.7,52.6 to 64.5,444
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,82.2 to 97.0,116
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,90.4,87.9 to 93.0,791
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,84.9 to 94.9,231
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,88.5,81.8 to 92.9,214
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,90.1,85.9 to 93.1,432
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,93.3,90.9 to 95.0,236
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,90.9,88.9 to 92.5,450
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,91.3,88.4 to 94.3,411
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,90.4,87.9 to 93.0,791
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,91.7,85.8 to 95.3,218
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,93.0,89.5 to 95.4,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,89.5,83.3 to 93.6,283
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,57.3,50.8 to 63.7,280
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,55.7,50.2 to 61.1,283
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,95.7,89.4 to 98.8,236
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,96.6,92.1 to 98.8,450
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,97.1,92.6 to 99.2,214
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,96.3,91.7 to 98.7,432
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,95.8,94.3 to 97.3,791
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,39.6,32.0 to 48.4,218
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,48.1,42.1 to 54.5,444
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,50.2,42.1 to 59.0,214
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,44.9,39.2 to 51.0,432
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,89.1,82.6 to 94.0,235
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,85.4,77.7 to 91.5,224
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,81.3,75.9 to 86.2,459
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,85.5,79.1 to 90.7,204
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,85.5,80.6 to 89.7,428
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,77.2,69.1 to 84.5,235
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,92.3,87.4 to 95.9,283
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,65.7,56.9 to 73.4,226
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,63.6,57.3 to 69.4,430
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,68.2,59.5 to 75.8,224
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,65.4,59.4 to 71.0,459
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,91.6,86.7 to 94.8,214
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,89.5,85.7 to 92.4,432
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,87.4,82.7 to 91.0,218
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,89.2,84.9 to 92.5,444
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,89.4,86.7 to 91.6,236
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,90.5,88.4 to 92.2,450
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,95.4,94.7 to 96.0,280
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,95.6,91.6 to 97.8,283
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,96.8,95.7 to 97.6,236
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,96.4,95.5 to 97.1,450
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,3 Months,94.8,90.7 to 97.2,214
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,3 Months,95.5,92.6 to 97.4,432
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,3 Months,96.3,90.9 to 98.5,218
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,3 Months,97.1,94.5 to 98.5,444
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,3 Months,98.1,95.8 to 99.1,226
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,3 Months,98.0,96.5 to 98.9,430
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,84.0 to 100.0,116
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,54.1,46.7 to 62.0,280
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,61.5,52.4 to 69.9,204
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,64.8,58.6 to 70.6,428
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,72.3,60.8 to 83.8,196
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,85.6,80.0 to 91.3,791
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,85.8,77.9 to 91.2,235
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,85.6,80.0 to 91.3,791
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,85.9,78.4 to 93.4,411
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,3 Months,94.7,93.4 to 95.8,236
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,3 Months,94.8,93.4 to 95.9,450
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,3 Months,91.7,89.0 to 93.9,280
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,3 Months,96.0,94.3 to 97.2,283
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,94.3,89.8 to 96.8,226
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,94.0,91.0 to 96.1,430
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,93.8,89.0 to 96.6,204
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,92.4,88.2 to 95.2,428
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,90.9,83.3 to 95.2,224
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,88.4,83.2 to 92.1,459
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,85.9,76.4 to 95.4,440
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,87.6,81.8 to 93.3,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,93.1,87.7 to 96.2,226
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,91.8,87.9 to 94.5,430
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,90.3,85.2 to 93.8,218
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,91.7,88.2 to 94.2,444
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,90.9,81.7 to 96.6,218
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,92.8,88.6 to 95.8,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,90.5,84.1 to 94.5,204
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,91.2,87.1 to 94.1,428
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,91.7,86.0 to 95.7,204
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,90.1,85.3 to 93.8,428
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,95.7,92.1 to 97.9,226
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,93.8,90.7 to 96.2,430
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,86.8,81.2 to 92.4,196
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.1,80.6 to 91.6,231
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.3,79.4 to 95.3,116
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,87.3,84.5 to 90.1,791
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,87.3,84.5 to 90.1,791
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,90.2,88.5 to 91.7,218
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,89.9,85.9 to 92.9,444
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,89.7,83.0 to 93.9,226
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,90.1,85.7 to 93.2,430
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,90.4,84.0 to 94.4,204
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,90.5,86.2 to 93.6,428
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,87.0,83.2 to 90.8,411
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,96.0,92.3 to 98.2,283
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,93.8,89.5 to 96.7,280
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,3 Months,98.5,95.6 to 99.5,224
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,3 Months,95.8,92.1 to 97.8,459
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,96.0,92.6 to 97.9,214
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,96.0,93.5 to 97.6,432
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,3 Months,93.2,86.0 to 96.8,235
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,80.5,71.4 to 89.6,170
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2011,Age,0-1 Days,67.0,60.2 to 73.2,283
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,5 Months,84.3,81.1 to 87.1,280
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,5 Months,90.0,85.6 to 93.2,283
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,5 Months,92.9,89.0 to 95.4,236
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,5 Months,92.0,88.6 to 94.4,450
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,92.8,90.6 to 94.5,236
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,93.2,92.2 to 94.1,450
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,82.3,73.8 to 90.9,210
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,93.6,89.3 to 96.3,214
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,94.4,91.8 to 96.2,432
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,95.2,93.1 to 96.6,218
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,95.0,92.5 to 96.7,444
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,88.3,80.4 to 94.1,224
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,84.5,78.9 to 89.4,459
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,86.9,84.4 to 89.1,236
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,88.7,86.0 to 90.9,450
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,90.4,85.1 to 94.0,214
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,90.3,86.7 to 93.0,432
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,88.9,85.9 to 91.3,280
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,89.5,82.9 to 93.8,204
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,89.8,85.3 to 93.0,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,90.0,83.1 to 94.3,224
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,65.0,58.9 to 70.6,459
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,62.6,54.0 to 70.5,235
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,91.1,84.3 to 95.1,226
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,90.3,85.9 to 93.5,430
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,96.0,91.4 to 98.1,218
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,96.7,94.2 to 98.1,444
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,97.4,94.2 to 98.9,226
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,96.7,94.2 to 98.2,430
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,3 Months,97.9,95.3 to 99.1,204
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,3 Months,98.2,96.5 to 99.1,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,62.0,53.0 to 70.3,236
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,59.5,55.6 to 63.3,450
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,56.0,53.0 to 59.0,283
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,94.9,90.6 to 97.3,226
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,94.4,91.2 to 96.5,430
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,56.8,48.6 to 64.7,214
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,60.0,54.1 to 65.5,432
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,91.9,87.9 to 96.0,210
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,82.8,76.0 to 89.6,170
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,57.6,52.2 to 62.8,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,93.9,88.3 to 96.9,204
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,94.0,90.3 to 96.3,428
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,94.1,88.1 to 97.1,224
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,88.8,84.1 to 92.2,459
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,5 Months,92.7,87.3 to 96.0,226
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,5 Months,92.1,88.2 to 94.8,430
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,5 Months,91.1,85.9 to 94.5,214
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,5 Months,91.3,86.7 to 94.3,432
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2012,Age,0-1 Days,64.1,59.4 to 68.6,280
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,98.7,94.9 to 99.7,224
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,95.3,91.5 to 97.4,459
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,91.9,84.8 to 95.9,235
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,88.4,81.5 to 92.9,235
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,96.0,91.5 to 98.2,204
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,97.3,94.8 to 98.7,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,94.9,91.1 to 97.4,214
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,93.1,88.0 to 96.5,236
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,94.0,91.0 to 96.3,450
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2013,Age,0-1 Days,68.8,67.0 to 70.6,236
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2013-2014,Age,0-1 Days,70.3,68.3 to 72.3,450
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2014,Age,0-1 Days,71.9,64.4 to 78.3,214
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2014-2015,Age,0-1 Days,71.4,66.0 to 76.2,432
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,5 Months,91.4,85.4 to 95.1,218
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,5 Months,92.1,88.3 to 94.7,444
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2015,Age,0-1 Days,70.9,63.0 to 77.7,218
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2015-2016,Age,0-1 Days,71.9,66.3 to 76.9,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,89.2,87.2 to 90.9,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,91.9,86.0 to 95.5,224
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,88.8,84.1 to 92.2,459
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,85.7,77.8 to 91.1,235
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,93.4,88.4 to 96.4,283
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,80.5,72.3 to 87.5,235
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,87.3,83.7 to 90.8,440
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,88.5,84.0 to 93.0,280
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.2,83.8 to 92.6,248
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,94.8,87.5 to 100.0,53
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,94.0,91.2 to 95.9,283
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,78.5,74.9 to 81.8,236
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,79.3,76.6 to 81.8,450
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,75.3,68.0 to 81.4,280
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,82.3,76.3 to 87.1,283
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,90.6,83.9 to 94.7,224
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,94.5,90.8 to 96.8,459
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,88.3,81.5 to 92.9,235
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,95.3,91.3 to 97.8,283
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,91.9,87.0 to 95.5,280
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,92.9,88.4 to 96.2,218
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,93.3,90.1 to 95.8,444
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,93.7,88.8 to 97.0,226
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,92.8,89.3 to 95.4,430
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,5 Months,87.3,79.7 to 92.4,235
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,93.6,89.8 to 96.0,283
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,5 Months,91.5,85.2 to 95.2,204
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,5 Months,93.0,89.4 to 95.5,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,93.9,91.1 to 96.1,432
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,5 Months,94.6,90.3 to 97.1,224
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,5 Months,91.0,86.7 to 94.0,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2016,Age,0-1 Days,72.9,64.6 to 79.9,226
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2016-2017,Age,0-1 Days,71.7,65.8 to 77.0,430
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2017,Age,0-1 Days,70.5,61.8 to 77.9,204
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2017-2018,Age,0-1 Days,74.0,68.4 to 78.9,428
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,94.0,93.3 to 94.7,280
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,93.3,88.6 to 96.2,218
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,95.3,92.3 to 97.1,444
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,93.7,90.5 to 95.9,236
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,94.1,92.1 to 95.6,450
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,93.6,88.2 to 96.6,226
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,90.8,86.9 to 93.7,430
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,88.1,81.7 to 92.5,204
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,89.5,85.2 to 92.6,428
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,94.5,90.4 to 96.9,214
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,93.9,90.8 to 96.1,432
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,41.2,33.9 to 49.3,466
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,90.9,84.3 to 94.8,224
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,86.7,82.0 to 90.3,459
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,97.3,94.0 to 98.8,226
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,94.9,91.8 to 96.9,430
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,92.6,86.8 to 96.0,204
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,93.3,89.2 to 95.9,428
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,82.5,75.0 to 88.1,235
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,94.4,89.3 to 97.1,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,94.2,90.0 to 96.7,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,92.3,86.8 to 95.6,236
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,91.2,89.7 to 92.6,450
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,90.2,84.4 to 94.0,214
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,91.2,87.5 to 93.8,432
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,78.3,74.6 to 82.0,791
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,78.3,74.6 to 82.0,791
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.0,66.8 to 81.2,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.7,66.2 to 87.2,116
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,84.5,78.2 to 90.8,196
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,52.9,44.3 to 61.2,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,91.7 to 95.8,791
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.3,87.9 to 96.7,231
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,94.0,87.3 to 97.2,224
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,89.7,85.0 to 93.0,459
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,85.4,77.7 to 90.7,235
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,95.0,92.0 to 96.9,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,94.1,91.1 to 96.1,236
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,94.6,93.4 to 95.6,450
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,94.1,90.4 to 96.4,280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,79.0,73.9 to 84.0,411
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,89.8,87.8 to 91.6,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,88.3,81.9 to 92.7,218
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,90.9,87.0 to 93.8,444
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,95.6,92.1 to 97.9,280
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,89.9,83.5 to 94.6,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,95.0,90.9 to 97.6,283
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,94.7,89.8 to 97.7,236
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,95.8,91.9 to 98.2,450
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,91.1,85.1 to 94.8,218
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,92.4,88.8 to 94.8,444
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,93.4,87.4 to 97.1,224
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,91.6,87.5 to 94.8,459
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,66.3,57.5 to 74.0,204
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,65.3,59.2 to 70.9,428
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,64.2,55.6 to 72.1,224
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,58.6,52.5 to 64.4,459
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.9,91.8 to 98.1,248
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,81.9 to 97.3,116
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,95.5,92.6 to 98.4,196
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,93.1,90.6 to 95.6,440
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,97.9,96.2 to 99.7,280
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,88.3,76.7 to 100.0,53
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,90.6,85.1 to 94.7,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,90.3,83.8 to 94.9,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2018,Age,0-3 Days,86.2,80.1 to 90.7,224
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2018-2019,Age,0-3 Days,83.4,78.5 to 87.4,459
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,3 Months,87.1,79.2 to 92.2,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2019,Age,0-3 Days,80.6,72.6 to 86.8,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,64.4,47.7 to 81.2,53
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,82.2,76.4 to 88.0,280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.7,71.3 to 84.2,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,79.2,74.6 to 83.9,440
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,67.5,58.8 to 75.2,224
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,62.4,56.3 to 68.2,459
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,57.3,48.6 to 65.5,235
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,69.5,60.8 to 76.9,204
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,68.5,62.4 to 74.0,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,91.3,87.5 to 94.1,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,96.7,93.4 to 98.3,226
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,94.1,90.9 to 96.2,430
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,91.6,85.7 to 95.1,204
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,92.7,88.8 to 95.4,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,92.2,86.9 to 95.4,218
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,94.4,91.5 to 96.4,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,94.5,91.6 to 97.5,196
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,85.5,77.7 to 90.9,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,81.7,75.3 to 88.2,210
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,73.3,64.7 to 81.8,170
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,88.3,80.4 to 93.3,236
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,87.7,85.0 to 89.9,450
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,92.5,85.7 to 96.3,283
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,97.3,95.2 to 99.3,210
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,94.0,89.8 to 98.2,170
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,87.0,80.5 to 91.5,214
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,87.7,83.3 to 91.0,432
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,91.2,87.7 to 93.7,283
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,86.8,83.7 to 89.3,280
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,97.4,93.6 to 99.0,224
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,94.5,90.8 to 96.8,459
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,94.7,89.9 to 97.3,204
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,96.0,93.2 to 97.7,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,92.3,89.3 to 95.4,411
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,93.7,91.7 to 95.8,791
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,92.1,86.1 to 95.7,318
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,91.6,84.7 to 95.5,235
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,93.2,91.3 to 94.6,236
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,90.0,88.4 to 91.4,450
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,86.8,79.9 to 91.6,214
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,88.9,84.6 to 92.1,432
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2012,Age,0-3 Days,73.2,66.0 to 79.3,280
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,83.5,80.2 to 86.8,791
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2011,Age,0-3 Days,78.3,71.0 to 84.1,283
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,3 Months,90.5,83.2 to 94.8,224
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,3 Months,88.3,83.2 to 92.0,459
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,87.1,77.2 to 96.9,53
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,97.0,94.9 to 99.1,280
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,3 Months,90.1,84.4 to 93.8,226
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,3 Months,90.6,87.0 to 93.3,430
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,3 Months,91.1,85.8 to 94.6,204
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,3 Months,90.8,86.6 to 93.8,428
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,5 Months,72.7,64.1 to 79.9,224
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,5 Months,73.6,67.8 to 78.7,459
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,5 Months,74.5,66.3 to 81.2,235
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,92.7,90.3 to 94.6,283
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,96.8,93.8 to 98.7,226
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,95.4,92.8 to 97.3,430
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,89.9,88.2 to 91.4,280
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,94.2,89.7 to 97.2,204
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,93.6,90.0 to 96.3,428
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014,Age,0-3 Days,79.3,72.6 to 84.8,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2014-2015,Age,0-3 Days,79.6,74.7 to 83.7,432
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,61.2,53.8 to 68.2,236
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,60.3,56.0 to 64.5,450
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,60.0,54.8 to 65.1,280
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,59.9,56.4 to 63.3,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2013,Age,0-3 Days,77.4,70.1 to 83.4,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2013-2014,Age,0-3 Days,78.4,73.5 to 82.6,450
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,3 Months,86.4,81.4 to 90.2,236
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,3 Months,86.0,82.1 to 89.1,450
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,3 Months,86.1,78.2 to 91.4,235
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,94.2,92.4 to 96.0,791
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,3 Months,89.0,86.2 to 91.3,280
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,3 Months,87.4,83.2 to 90.6,283
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,94.2,92.4 to 96.0,791
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,94.5,92.4 to 96.6,440
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.5,93.0 to 98.0,248
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.2,79.7 to 90.8,231
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,75.5 to 93.1,116
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,3 Months,82.3,75.3 to 87.6,214
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,3 Months,84.7,80.1 to 88.4,432
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,3 Months,87.2,80.5 to 91.8,218
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,3 Months,88.6,84.4 to 91.8,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,87.6 to 96.3,231
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.9,87.1 to 100.0,116
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,86.8,79.0 to 92.1,224
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,86.2,80.9 to 90.2,459
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,96.0,90.0 to 98.9,214
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,95.1,91.2 to 97.7,432
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,93.6,88.8 to 96.8,218
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,95.2,92.5 to 97.2,444
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,96.8,93.8 to 98.7,226
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,95.9,93.1 to 97.8,430
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,93.7,89.1 to 96.4,226
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,93.2,90.1 to 95.4,430
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,92.8,87.7 to 95.8,204
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,89.9,85.4 to 93.1,428
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,93.8,91.3 to 96.4,411
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,96.7,94.4 to 98.9,210
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,92.9,88.3 to 97.5,170
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,57.1,52.2 to 61.9,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,7 Months,58.6,55.2 to 62.0,283
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,61.2,56.1 to 66.1,236
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,58.6,55.7 to 61.5,450
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,3 Months,85.5,78.7 to 90.4,214
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,3 Months,87.2,82.7 to 90.7,432
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,3 Months,89.0,82.3 to 93.3,218
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,3 Months,90.4,86.4 to 93.4,444
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,3 Months,91.9,86.5 to 95.3,226
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,3 Months,92.4,88.9 to 94.8,430
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2017,Age,0-3 Days,77.5,65.8 to 86.1,128
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2017-2018,Age,0-3 Days,83.2,78.2 to 87.2,428
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016,Age,0-3 Days,81.4,73.5 to 87.3,226
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2017,Age,0-3 Days,80.8,75.4 to 85.3,430
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,95.8,92.7 to 97.6,280
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,96.3,93.5 to 97.9,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,67.6,59.4 to 74.8,218
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,71.3,65.6 to 76.3,444
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,59.4,51.1 to 67.2,214
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,63.5,57.7 to 68.9,432
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2015,Age,0-3 Days,79.8,72.3 to 85.7,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2015-2016,Age,0-3 Days,80.6,75.3 to 84.9,444
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,75.1,67.0 to 81.7,226
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,72.3,66.4 to 77.4,430
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,96.6,94.9 to 97.7,236
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,95.4,94.7 to 96.1,450
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,95.2,90.4 to 98.0,204
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,96.4,93.4 to 98.3,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,97.5,93.2 to 99.4,224
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,94.4,90.4 to 97.1,459
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,56.0,47.7 to 63.9,214
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,60.9,55.1 to 66.4,432
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,65.9,57.6 to 73.3,218
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,67.6,61.8 to 73.0,444
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,69.4,60.8 to 76.9,226
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,67.8,61.8 to 73.4,430
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,3 Months,92.8,87.8 to 95.8,204
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,3 Months,92.0,87.9 to 94.8,428
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,3 Months,91.2,83.8 to 95.4,224
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,3 Months,89.1,84.1 to 92.7,459
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,95.3,90.8 to 97.6,218
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,96.2,93.7 to 97.8,444
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,97.2,94.0 to 98.7,226
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,95.9,93.3 to 97.6,430
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,94.2,90.0 to 96.7,214
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,94.7,91.9 to 96.6,432
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,94.8,88.7 to 98.2,318
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2018,Age,0-1 Days,77.6,70.1 to 83.7,224
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2018-2019,Age,0-1 Days,75.7,70.1 to 80.5,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2019,Age,0-1 Days,73.8,65.1 to 80.9,235
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2011,Age,0-2 Days,77.6,74.8 to 80.1,283
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2013,Age,0-2 Days,77.2,75.7 to 78.7,236
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2013-2014,Age,0-2 Days,76.9,76.1 to 77.6,450
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2012,Age,0-2 Days,72.1,67.3 to 76.4,280
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,95.4,94.2 to 96.3,236
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,94.1,92.6 to 95.4,450
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,92.9,87.9 to 95.9,214
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,94.3,91.3 to 96.3,432
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,7 Months,89.0,86.6 to 91.0,280
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,66.6,57.9 to 74.4,224
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,62.7,56.6 to 68.4,459
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,58.8,50.1 to 67.0,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,91.8,89.2 to 93.8,283
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,79.4,71.7 to 85.4,204
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,79.0,73.5 to 83.6,428
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,78.5,70.1 to 85.1,224
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,75.9,69.1 to 81.7,361
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,93.4,88.4 to 96.8,204
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,93.3,89.7 to 96.0,428
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,93.8,89.0 to 97.0,226
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,93.7,90.4 to 96.2,430
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,87.3,85.5 to 88.8,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,94.9,91.1 to 97.4,226
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,94.5,91.5 to 96.7,430
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,95.8,92.8 to 97.8,218
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,95.4,93.1 to 97.1,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,94.6,90.7 to 97.2,214
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,95.1,92.8 to 96.9,432
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2016,Age,0-2 Days,80.1,72.3 to 86.2,226
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2016-2017,Age,0-2 Days,79.7,74.3 to 84.2,430
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,94.4,90.0 to 96.9,226
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,93.2,89.6 to 95.6,430
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,89.2,87.4 to 90.7,236
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,88.7,86.5 to 90.5,450
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,92.0,85.7 to 95.7,204
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,93.8,90.3 to 96.2,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,88.1,82.1 to 92.3,214
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,88.0,83.8 to 91.2,432
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,87.8,81.5 to 92.2,218
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,91.1,87.4 to 93.7,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,94.1,88.8 to 97.4,224
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,92.2,88.2 to 95.2,459
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,95.7,91.5 to 97.9,218
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,95.1,92.3 to 96.9,444
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,96.2,93.1 to 98.1,226
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,96.6,94.3 to 98.1,430
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,95.6,91.0 to 98.3,236
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,96.1,92.7 to 98.2,450
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,96.4,92.3 to 98.6,283
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,95.7,90.9 to 98.4,280
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,90.8,85.0 to 95.0,235
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,86.3,80.2 to 91.3,214
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,85.2,80.8 to 89.0,432
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,83.5,77.0 to 89.0,236
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,84.8,80.4 to 88.6,450
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,90.2,83.8 to 94.8,235
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,94.1,89.1 to 97.3,204
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,94.1,90.7 to 96.6,428
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,96.3,93.1 to 98.3,283
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,82.7,76.7 to 88.0,280
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2017,Age,0-2 Days,79.3,71.2 to 85.6,204
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2017-2018,Age,0-2 Days,81.7,76.7 to 85.9,428
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2018,Age,0-2 Days,84.3,77.6 to 89.2,224
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2018-2019,Age,0-2 Days,82.2,77.1 to 86.3,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2019,Age,0-2 Days,80.1,72.1 to 86.3,235
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,95.7,91.4 to 97.9,224
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,91.9,87.6 to 94.8,459
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,91.6,86.2 to 95.5,204
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,92.1,88.2 to 95.1,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,90.5,84.7 to 94.8,235
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,96.6,93.0 to 98.7,283
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,98.0,94.5 to 99.5,280
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,92.6,86.5 to 96.6,224
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,91.6,87.5 to 94.7,459
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,93.7,89.3 to 96.8,218
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,93.7,90.7 to 96.1,444
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,93.1,88.7 to 96.3,214
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,93.5,90.5 to 95.8,432
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,92.6,87.4 to 96.2,236
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,92.8,89.5 to 95.4,450
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,68.0,59.3 to 75.6,204
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,67.3,61.2 to 72.9,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,63.1,54.8 to 70.7,218
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,67.8,62.1 to 73.1,444
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,80.1,73.0 to 85.7,214
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,79.1,74.0 to 83.4,432
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,78.1,69.5 to 84.8,218
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,80.1,74.9 to 84.5,444
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,82.2,74.7 to 87.9,226
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,80.8,75.6 to 85.1,430
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,72.7,64.6 to 79.6,226
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,70.3,64.4 to 75.6,430
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,91.6,87.2 to 94.9,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,94.1,89.4 to 97.2,236
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,94.3,91.4 to 96.4,450
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,88.2,80.9 to 93.0,235
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,94.9,91.8 to 97.2,283
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2014,Age,0-2 Days,76.6,69.3 to 82.6,214
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2014-2015,Age,0-2 Days,77.2,72.1 to 81.6,432
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2015,Age,0-2 Days,77.8,70.2 to 83.9,218
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2015-2016,Age,0-2 Days,79.0,73.7 to 83.4,444
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,87.2,82.0 to 91.5,283
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,96.1,91.6 to 98.6,218
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,96.4,93.5 to 98.2,444
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,99.0,96.3 to 99.8,214
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,97.2,94.4 to 98.8,432
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,73.6,65.3 to 80.6,235
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,93.2,87.4 to 97.0,224
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,92.0,88.1 to 95.0,459
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,97.1,93.2 to 99.1,236
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,97.8,95.2 to 99.1,450
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.8,74.4 to 93.3,231
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,91.9,86.1 to 97.7,210
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,94.6,86.2 to 100.0,53
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.9,82.6 to 99.1,248
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,94.0,87.8 to 97.6,224
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,93.1,89.0 to 96.1,459
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,3 Months,86.9,84.3 to 89.1,236
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,3 Months,85.6,83.3 to 87.7,450
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,3 Months,87.2,83.4 to 90.2,280
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,3 Months,88.3,84.6 to 91.1,283
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,3 Months,84.4,77.5 to 89.5,214
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,3 Months,86.5,81.9 to 90.0,432
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,95.4,91.8 to 97.5,214
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,96.5,94.3 to 97.8,432
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,97.6,94.6 to 98.9,218
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,97.6,95.7 to 98.7,444
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,97.5,96.4 to 98.3,236
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,96.5,95.3 to 97.4,450
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,85.8,78.4 to 90.9,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,94.1,91.2 to 96.1,283
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,92.1,89.3 to 94.2,236
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,92.9,90.3 to 94.8,450
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,96.2,93.3 to 98.1,218
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,95.6,93.3 to 97.3,444
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,94.9,91.1 to 97.4,226
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,95.0,91.9 to 97.2,430
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,80.1,72.5 to 86.8,235
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,87.3,80.2 to 92.7,224
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,83.7,78.6 to 88.1,459
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,90.5,85.4 to 94.4,283
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,89.4,83.2 to 94.0,280
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,94.4,91.3 to 96.4,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,95.0,89.7 to 98.1,204
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,95.0,91.6 to 97.4,428
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,88.0,80.3 to 93.0,235
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,96.4,94.1 to 97.8,283
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,93.6,92.2 to 94.7,280
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,89.5,83.2 to 93.6,204
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,90.5,86.3 to 93.5,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,91.6,85.0 to 95.4,224
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,88.7,84.0 to 92.1,459
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,91.9,87.5 to 95.3,280
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,95.9,92.1 to 98.2,214
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,95.8,93.6 to 97.5,432
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,95.4,90.8 to 98.1,236
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,95.6,92.7 to 97.6,450
Hib,Full Series,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,75.4,68.5 to 81.9,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,94.4,90.4 to 96.8,226
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,91.9,88.4 to 94.4,430
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,99.3,95.7 to 100.0,214
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,96.3,92.6 to 98.5,432
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,95.6,90.8 to 98.3,218
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,95.8,93.0 to 97.7,444
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,81.5,74.5 to 87.5,204
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,84.3,79.5 to 88.5,428
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,89.4,84.0 to 93.6,226
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,85.6,81.2 to 89.4,430
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,84.3,77.7 to 89.9,218
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,86.8,82.5 to 90.4,444
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,95.9,92.7 to 98.0,226
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,96.6,94.4 to 98.1,430
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,92.2,86.1 to 96.3,235
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,92.1,89.3 to 94.8,440
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,97.7,95.9 to 99.4,280
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.9,92.3 to 97.6,248
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,94.6,88.5 to 100.0,53
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,93.2,91.2 to 95.3,791
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.4,88.0 to 96.9,231
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,96.9,92.7 to 100.0,53
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,81.8 to 96.9,116
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,92.5,86.4 to 96.6,235
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,88.2,81.9 to 93.1,236
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,94.7,89.0 to 98.0,224
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,93.6,89.6 to 96.4,459
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,97.0,93.7 to 98.9,204
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,96.1,93.0 to 98.1,428
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,3 Months,88.6,82.0 to 93.0,218
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,3 Months,90.0,86.0 to 93.0,444
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,3 Months,91.5,86.0 to 95.0,226
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,3 Months,92.0,88.6 to 94.5,430
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,3 Months,92.6,87.6 to 95.7,204
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,3 Months,91.1,87.0 to 94.0,428
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,96.2,91.7 to 98.3,204
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,97.4,94.9 to 98.7,428
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,98.7,94.9 to 99.7,224
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,94.9,91.0 to 97.1,459
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,97.7,94.4 to 99.1,226
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,96.9,94.5 to 98.3,430
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,92.2,86.5 to 95.6,218
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,94.5,91.3 to 96.6,444
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,96.8,93.3 to 98.5,226
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,94.4,91.2 to 96.5,430
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.5,91.7 to 97.3,248
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.8,91.9 to 99.8,116
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,92.7,88.5 to 96.9,196
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,97.1,95.1 to 99.1,280
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,91.9,89.0 to 94.7,440
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,89.3,80.8 to 95.2,218
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,91.1,86.3 to 94.7,444
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,89.6,83.7 to 94.0,214
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,89.1,84.0 to 93.2,432
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,94.9,89.7 to 98.0,224
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,93.2,89.1 to 96.2,459
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,91.6,84.5 to 96.3,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,93.7,89.3 to 96.4,214
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,93.0,89.6 to 95.3,432
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,96.7,93.2 to 98.6,204
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,95.7,92.5 to 97.8,428
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,93.1,89.0 to 97.2,196
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,89.4,83.6 to 95.2,170
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,88.8,84.6 to 92.2,450
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,97.2,95.3 to 99.2,210
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,91.8 to 95.6,791
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,87.6 to 96.6,231
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,3 Months,89.7,82.4 to 94.1,224
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,3 Months,87.1,82.1 to 90.9,459
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,3 Months,84.6,76.9 to 90.0,235
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,93.1,90.4 to 95.8,411
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,93.2,91.2 to 95.3,791
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,3 Months,84.9,82.6 to 86.9,236
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,3 Months,83.6,81.2 to 85.7,450
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.8,78.1 to 89.6,248
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,80.9,74.2 to 87.7,196
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,80.4,65.8 to 95.1,53
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,82.0,77.7 to 86.2,440
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,93.6,88.8 to 96.8,218
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,95.2,92.5 to 97.2,444
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,94.1,90.1 to 96.9,214
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,93.9,90.9 to 96.1,432
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,95.2,91.7 to 97.6,280
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,5 Months,81.3,73.7 to 87.1,204
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,5 Months,77.1,71.4 to 81.9,428
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,92.9,87.9 to 96.3,236
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,93.5,90.4 to 95.9,450
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,5 Months,77.2,69.0 to 83.7,218
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,5 Months,79.4,74.0 to 83.9,444
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,5 Months,81.7,74.2 to 87.4,226
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,5 Months,81.5,76.4 to 85.7,430
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,87.8,80.7 to 93.2,224
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,85.6,80.2 to 90.1,459
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,93.5,89.2 to 96.5,226
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,89.6,85.7 to 92.9,430
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,83.6,75.3 to 90.4,235
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,85.5,78.6 to 91.0,204
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,86.7,81.9 to 90.7,428
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,3 Months,86.7,82.6 to 89.9,283
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,96.5,94.4 to 98.7,210
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,88.0,82.0 to 94.0,170
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,94.7,92.5 to 97.0,411
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,93.7,91.8 to 95.6,791
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,5 Months,74.7,67.8 to 80.5,236
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,5 Months,73.2,67.5 to 78.2,450
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,5 Months,71.6,63.6 to 78.5,214
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,5 Months,74.4,69.6 to 78.6,432
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,91.9,86.0 to 95.4,204
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,92.6,88.6 to 95.3,428
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,5 Months,71.7,69.7 to 73.6,280
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,5 Months,77.9,71.0 to 83.5,283
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,91.1,83.8 to 95.3,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,93.4,86.6 to 96.9,224
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,88.7,84.0 to 92.1,459
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,89.4,82.3 to 93.9,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,94.1,90.1 to 96.9,283
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,92.1,88.3 to 95.9,280
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,3 Months,84.9,81.2 to 88.1,280
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,92.1,87.5 to 96.6,210
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,83.2,76.3 to 90.0,170
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,80.5,75.7 to 85.3,411
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,83.5,80.2 to 86.8,791
PCV,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,92.1,90.6 to 93.4,4830
Hep B,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,92.9,91.4 to 94.1,4830
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,57.0,54.5 to 59.4,4830
Hib,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,91.6,89.5 to 93.4,3970
Hib,Full Series,HHS Regions/National,Region 3,2020-2021,Age,19 Months,72.2,69.7 to 74.7,3970
≥1 Dose Varicella,,HHS Regions/National,Region 3,2021,Age,35 Months,93.4,89.5 to 96.2,1580
Polio,≥3 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,93.1,90.4 to 95.3,1580
DTaP,≥4 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,80.5,78.1 to 82.7,3970
Hep A,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,19 Months,83.6,81.3 to 85.6,3970
Rotavirus,,HHS Regions/National,Region 3,2020-2021,Age,8 Months,77.7,75.3 to 79.9,3970
Influenza,,HHS Regions/National,Region 3,2012,Age,24 Months,55.3,51.1 to 59.7,2101
Influenza,,HHS Regions/National,Region 3,2011,Age,24 Months,61.6,57.3 to 66.0,1959
Hib,Primary Series,HHS Regions/National,Region 3,2020-2021,Age,19 Months,90.0,88.2 to 91.6,3970
Influenza,,HHS Regions/National,Region 3,2014,Age,24 Months,56.6,52.3 to 60.9,2071
Influenza,,HHS Regions/National,Region 3,2014-2015,Age,24 Months,57.9,54.9 to 61.0,4142
Influenza,,HHS Regions/National,Region 3,2015,Age,24 Months,59.2,54.9 to 63.5,2071
Influenza,,HHS Regions/National,Region 3,2015-2016,Age,24 Months,63.0,60.1 to 65.8,4326
Influenza,,HHS Regions/National,Region 3,2013,Age,24 Months,59.2,55.0 to 63.4,2037
Influenza,,HHS Regions/National,Region 3,2013-2014,Age,24 Months,57.9,54.9 to 60.9,4108
PCV,≥4 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,84.3,82.0 to 86.5,3970
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,56.9,54.2 to 59.6,3970
≥1 Dose MMR,,HHS Regions/National,Region 3,2020-2021,Age,35 Months,91.3,89.4 to 93.0,3970
PCV,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,90.8,89.1 to 92.3,3970
Hep B,≥3 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,91.0,88.4 to 93.3,1580
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2020-2021,Age,0-1 Days,76.2,73.9 to 78.4,3970
Influenza,,HHS Regions/National,Region 3,2020-2021,Age,24 Months,62.5,59.8 to 65.2,3970
DTaP,≥4 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,85.1,80.8 to 88.8,1580
PCV,≥4 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,79.5,77.2 to 81.7,3970
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2020-2021,Age,0-3 Days,80.0,77.7 to 82.1,3970
Hep A,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,35 Months,91.4,89.2 to 93.2,3970
Hep B,≥2 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,93.1,90.6 to 95.0,1580
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,93.9,91.8 to 95.7,3970
Hep B,≥1 Dose,HHS Regions/National,Region 3,2021,Age,3 Months,94.4,92.1 to 96.0,1580
Rotavirus,,HHS Regions/National,Region 3,2011,Age,8 Months,76.1,72.1 to 79.7,1959
Rotavirus,,HHS Regions/National,Region 3,2015,Age,8 Months,75.1,71.0 to 78.8,2071
Rotavirus,,HHS Regions/National,Region 3,2015-2016,Age,8 Months,78.2,75.6 to 80.6,4326
Rotavirus,,HHS Regions/National,Region 3,2016,Age,8 Months,81.4,78.1 to 84.2,2255
Rotavirus,,HHS Regions/National,Region 3,2016-2017,Age,8 Months,79.7,77.3 to 81.9,4881
Rotavirus,,HHS Regions/National,Region 3,2014,Age,8 Months,76.1,72.2 to 79.5,2071
Rotavirus,,HHS Regions/National,Region 3,2014-2015,Age,8 Months,75.6,72.8 to 78.2,4142
Rotavirus,,HHS Regions/National,Region 3,2012,Age,8 Months,71.8,67.7 to 75.6,2101
Rotavirus,,HHS Regions/National,Region 3,2013,Age,8 Months,74.0,70.0 to 77.6,2037
Rotavirus,,HHS Regions/National,Region 3,2013-2014,Age,8 Months,75.0,72.3 to 77.6,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020-2021,Age,13 Months,62.9,60.2 to 65.5,3970
Rotavirus,,HHS Regions/National,Region 3,2018,Age,8 Months,77.9,74.7 to 80.8,2888
Rotavirus,,HHS Regions/National,Region 3,2018-2019,Age,8 Months,78.3,76.1 to 80.3,5328
Rotavirus,,HHS Regions/National,Region 3,2017,Age,8 Months,78.0,74.5 to 81.2,2626
Rotavirus,,HHS Regions/National,Region 3,2017-2018,Age,8 Months,78.0,75.6 to 80.2,5514
Rotavirus,,HHS Regions/National,Region 3,2019,Age,8 Months,78.7,75.6 to 81.5,2440
Hib,Full Series,HHS Regions/National,Region 3,2011,Age,19 Months,77.3,74.8 to 79.6,1959
Hib,Full Series,HHS Regions/National,Region 3,2012,Age,19 Months,73.3,68.1 to 77.9,2101
Hib,Full Series,HHS Regions/National,Region 3,2013,Age,19 Months,75.2,72.6 to 77.6,2037
Hib,Full Series,HHS Regions/National,Region 3,2013-2014,Age,19 Months,74.4,72.0 to 76.7,4108
Combined 7 Series,,HHS Regions/National,Region 3,2015,Age,35 Months,77.1,72.7 to 81.3,2071
Combined 7 Series,,HHS Regions/National,Region 3,2015-2016,Age,35 Months,78.6,75.9 to 81.3,4326
Combined 7 Series,,HHS Regions/National,Region 3,2018,Age,35 Months,78.8,75.3 to 82.1,2888
Combined 7 Series,,HHS Regions/National,Region 3,2018-2019,Age,35 Months,78.6,76.3 to 80.9,5328
Combined 7 Series,,HHS Regions/National,Region 3,2019,Age,35 Months,78.5,75.2 to 81.6,2440
Hib,Full Series,HHS Regions/National,Region 3,2013,Age,24 Months,80.3,76.8 to 83.5,2037
Hib,Full Series,HHS Regions/National,Region 3,2013-2014,Age,24 Months,80.5,78.0 to 82.8,4108
Hib,Full Series,HHS Regions/National,Region 3,2014,Age,24 Months,80.6,77.1 to 83.9,2071
Hib,Full Series,HHS Regions/National,Region 3,2014-2015,Age,24 Months,80.5,77.9 to 83.0,4142
Hib,Full Series,HHS Regions/National,Region 3,2016,Age,19 Months,79.3,75.9 to 82.4,2255
Hib,Full Series,HHS Regions/National,Region 3,2016-2017,Age,19 Months,78.6,76.2 to 80.8,4881
Hib,Full Series,HHS Regions/National,Region 3,2015,Age,19 Months,74.0,69.2 to 78.3,2071
Hib,Full Series,HHS Regions/National,Region 3,2015-2016,Age,19 Months,76.7,74.0 to 79.1,4326
Hib,Full Series,HHS Regions/National,Region 3,2014,Age,19 Months,73.7,69.7 to 77.3,2071
Hib,Full Series,HHS Regions/National,Region 3,2014-2015,Age,19 Months,73.8,71.0 to 76.5,4142
Hib,Full Series,HHS Regions/National,Region 3,2012,Age,24 Months,79.9,76.2 to 83.3,2101
Hib,Full Series,HHS Regions/National,Region 3,2011,Age,24 Months,83.8,80.4 to 86.9,1959
Hib,Full Series,HHS Regions/National,Region 3,2019,Age,19 Months,76.5,73.4 to 79.3,2440
Hib,Full Series,HHS Regions/National,Region 3,2018,Age,19 Months,77.1,74.0 to 79.9,2888
Hib,Full Series,HHS Regions/National,Region 3,2018-2019,Age,19 Months,95.7,94.5 to 96.7,5328
Hib,Full Series,HHS Regions/National,Region 3,2017,Age,19 Months,77.8,74.3 to 80.9,2626
Hib,Full Series,HHS Regions/National,Region 3,2017-2018,Age,19 Months,77.4,75.1 to 79.6,5514
Combined 7 Series,,HHS Regions/National,Region 3,2011,Age,35 Months,78.6,74.4 to 82.5,1959
Hib,Primary Series,HHS Regions/National,Region 3,2017,Age,35 Months,94.0,91.7 to 95.8,2626
Hib,Primary Series,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.4,92.8 to 95.7,5514
Hib,Primary Series,HHS Regions/National,Region 3,2016,Age,35 Months,95.3,93.5 to 96.8,2255
Hib,Primary Series,HHS Regions/National,Region 3,2016-2017,Age,35 Months,94.7,93.3 to 95.9,4881
Hib,Primary Series,HHS Regions/National,Region 3,2015,Age,35 Months,94.8,92.1 to 96.8,2071
Hib,Primary Series,HHS Regions/National,Region 3,2015-2016,Age,35 Months,95.0,93.4 to 96.3,4326
Combined 7 Series,,HHS Regions/National,Region 3,2011,Age,24 Months,71.8,67.6 to 75.8,1959
Combined 7 Series,,HHS Regions/National,Region 3,2012,Age,24 Months,67.4,63.3 to 71.5,2101
Hib,Primary Series,HHS Regions/National,Region 3,2019,Age,13 Months,89.4,87.1 to 91.3,2440
Hib,Primary Series,HHS Regions/National,Region 3,2013,Age,35 Months,95.7,93.5 to 97.3,2037
Hib,Primary Series,HHS Regions/National,Region 3,2013-2014,Age,35 Months,94.4,92.6 to 95.8,4108
Hib,Primary Series,HHS Regions/National,Region 3,2011,Age,35 Months,95.6,93.4 to 97.2,1959
Hib,Primary Series,HHS Regions/National,Region 3,2019,Age,24 Months,95.5,94.0 to 96.8,2440
Hib,Primary Series,HHS Regions/National,Region 3,2012,Age,35 Months,93.8,91.1 to 95.9,2101
Hib,Primary Series,HHS Regions/National,Region 3,2014,Age,35 Months,93.0,90.3 to 95.2,2071
Hib,Primary Series,HHS Regions/National,Region 3,2014-2015,Age,35 Months,93.8,91.9 to 95.3,4142
Hib,Primary Series,HHS Regions/National,Region 3,2013,Age,24 Months,94.6,92.6 to 96.2,2037
Hib,Primary Series,HHS Regions/National,Region 3,2013-2014,Age,24 Months,93.4,91.7 to 94.8,4108
Hib,Primary Series,HHS Regions/National,Region 3,2018,Age,24 Months,93.5,91.4 to 95.3,2888
Hib,Primary Series,HHS Regions/National,Region 3,2018-2019,Age,24 Months,94.6,93.3 to 95.7,5328
Hib,Primary Series,HHS Regions/National,Region 3,2016,Age,24 Months,95.3,93.4 to 96.7,2255
Hib,Primary Series,HHS Regions/National,Region 3,2016-2017,Age,24 Months,94.3,92.9 to 95.6,4881
Combined 7 Series,,HHS Regions/National,Region 3,2013,Age,24 Months,68.5,64.5 to 72.5,2037
Combined 7 Series,,HHS Regions/National,Region 3,2013-2014,Age,24 Months,70.3,67.5 to 73.1,4108
Hib,Primary Series,HHS Regions/National,Region 3,2017,Age,24 Months,93.4,91.0 to 95.3,2626
Hib,Primary Series,HHS Regions/National,Region 3,2017-2018,Age,24 Months,93.5,91.9 to 94.8,5514
Hib,Primary Series,HHS Regions/National,Region 3,2019,Age,7 Months,74.1,70.9 to 77.1,2440
Hib,Primary Series,HHS Regions/National,Region 3,2018,Age,7 Months,73.3,69.9 to 76.4,2888
Hib,Primary Series,HHS Regions/National,Region 3,2018-2019,Age,7 Months,73.7,71.4 to 75.9,5328
Hib,Primary Series,HHS Regions/National,Region 3,2015,Age,24 Months,93.7,91.1 to 95.8,2071
Hib,Primary Series,HHS Regions/National,Region 3,2015-2016,Age,24 Months,94.5,92.9 to 95.8,4326
Hib,Primary Series,HHS Regions/National,Region 3,2014,Age,24 Months,92.1,89.4 to 94.4,2071
Hib,Primary Series,HHS Regions/National,Region 3,2014-2015,Age,24 Months,93.0,91.1 to 94.6,4142
Hib,Primary Series,HHS Regions/National,Region 3,2015,Age,13 Months,90.9,87.7 to 93.3,2071
Hib,Primary Series,HHS Regions/National,Region 3,2015-2016,Age,13 Months,91.1,89.1 to 92.7,4326
Hib,Primary Series,HHS Regions/National,Region 3,2014,Age,13 Months,87.3,84.1 to 89.9,2071
Hib,Primary Series,HHS Regions/National,Region 3,2014-2015,Age,13 Months,89.1,86.9 to 90.9,4142
Hib,Primary Series,HHS Regions/National,Region 3,2011,Age,13 Months,93.4,91.9 to 94.7,1959
Hib,Primary Series,HHS Regions/National,Region 3,2012,Age,13 Months,86.6,84.4 to 88.5,2101
Hib,Primary Series,HHS Regions/National,Region 3,2013,Age,13 Months,87.6,85.1 to 89.8,2037
Hib,Primary Series,HHS Regions/National,Region 3,2013-2014,Age,13 Months,87.5,84.8 to 89.7,4108
Hib,Primary Series,HHS Regions/National,Region 3,2017,Age,7 Months,75.3,71.6 to 78.7,2626
Hib,Primary Series,HHS Regions/National,Region 3,2017-2018,Age,7 Months,74.3,71.8 to 76.6,5514
Hib,Primary Series,HHS Regions/National,Region 3,2016,Age,7 Months,78.0,74.6 to 81.1,2255
Hib,Primary Series,HHS Regions/National,Region 3,2016-2017,Age,7 Months,76.7,74.2 to 79.0,4881
Hib,Primary Series,HHS Regions/National,Region 3,2016,Age,13 Months,91.2,88.7 to 93.3,2255
Hib,Primary Series,HHS Regions/National,Region 3,2016-2017,Age,13 Months,89.2,87.2 to 90.9,4881
Hib,Primary Series,HHS Regions/National,Region 3,2015,Age,7 Months,73.2,69.1 to 77.0,2071
Hib,Primary Series,HHS Regions/National,Region 3,2015-2016,Age,7 Months,75.6,72.9 to 78.1,4326
Hib,Primary Series,HHS Regions/National,Region 3,2014,Age,7 Months,72.0,68.0 to 75.6,2071
Hib,Primary Series,HHS Regions/National,Region 3,2014-2015,Age,7 Months,72.6,69.7 to 75.3,4142
Hib,Primary Series,HHS Regions/National,Region 3,2017,Age,13 Months,87.1,84.0 to 89.8,2626
Hib,Primary Series,HHS Regions/National,Region 3,2017-2018,Age,13 Months,87.4,85.3 to 89.2,5514
Hib,Primary Series,HHS Regions/National,Region 3,2018,Age,13 Months,87.6,84.9 to 89.9,2888
Hib,Primary Series,HHS Regions/National,Region 3,2018-2019,Age,13 Months,88.5,86.8 to 90.1,5328
Hib,Primary Series,HHS Regions/National,Region 3,2011,Age,19 Months,95.2,93.9 to 96.3,1959
Hib,Primary Series,HHS Regions/National,Region 3,2013,Age,19 Months,93.3,92.0 to 94.4,2037
Hib,Primary Series,HHS Regions/National,Region 3,2013-2014,Age,19 Months,92.2,89.6 to 94.2,4108
Hib,Primary Series,HHS Regions/National,Region 3,2014,Age,19 Months,91.1,88.1 to 93.4,2071
Hib,Primary Series,HHS Regions/National,Region 3,2014-2015,Age,19 Months,92.4,90.4 to 93.9,4142
Hib,Primary Series,HHS Regions/National,Region 3,2015,Age,19 Months,93.6,91.9 to 95.0,2071
Hib,Primary Series,HHS Regions/National,Region 3,2015-2016,Age,19 Months,94.2,92.5 to 95.5,4326
Hib,Primary Series,HHS Regions/National,Region 3,2017,Age,19 Months,92.7,90.2 to 94.6,2626
Hib,Primary Series,HHS Regions/National,Region 3,2017-2018,Age,19 Months,92.9,91.3 to 94.3,5514
Hib,Primary Series,HHS Regions/National,Region 3,2012,Age,19 Months,90.8,88.8 to 92.4,2101
≥1 Dose MMR,,HHS Regions/National,Region 3,2020,Age,13 Months,67.0,63.6 to 70.1,2390
Hib,Primary Series,HHS Regions/National,Region 3,2018,Age,19 Months,93.1,90.9 to 94.8,2888
Hib,Primary Series,HHS Regions/National,Region 3,2018-2019,Age,19 Months,88.5,86.8 to 90.1,5328
Hib,Primary Series,HHS Regions/National,Region 3,2019,Age,19 Months,94.6,92.9 to 95.9,2440
Hib,Primary Series,HHS Regions/National,Region 3,2016,Age,19 Months,94.7,92.7 to 96.2,2255
Hib,Primary Series,HHS Regions/National,Region 3,2016-2017,Age,19 Months,93.7,92.2 to 95.0,4881
Hib,Primary Series,HHS Regions/National,Region 3,2011,Age,24 Months,95.4,93.2 to 97.0,1959
Hib,Primary Series,HHS Regions/National,Region 3,2012,Age,24 Months,93.0,90.5 to 95.0,2101
Combined 7 Series,,HHS Regions/National,Region 3,2019,Age,24 Months,73.9,70.7 to 77.0,2440
Hib,Primary Series,HHS Regions/National,Region 3,2013,Age,7 Months,70.9,67.6 to 74.0,2037
Hib,Primary Series,HHS Regions/National,Region 3,2013-2014,Age,7 Months,71.4,68.8 to 73.9,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,94.7,92.8 to 96.2,2255
Hib,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,93.7,92.2 to 95.0,4881
Hib,≥3 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,93.2,90.4 to 95.4,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,93.9,92.3 to 95.3,4326
Hep A,≥1 Dose,HHS Regions/National,Region 3,2013,Age,19 Months,80.2,77.6 to 82.5,2037
Hep A,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,19 Months,80.3,78.0 to 82.3,4108
Hep A,≥1 Dose,HHS Regions/National,Region 3,2011,Age,19 Months,77.4,72.6 to 81.5,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,95.6,93.9 to 97.0,2255
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,94.6,93.2 to 95.9,4881
DTaP,≥1 Dose,HHS Regions/National,Region 3,2019,Age,3 Months,93.0,90.8 to 94.7,2440
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,93.0,90.3 to 95.1,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,94.0,92.2 to 95.5,4142
DTaP,≥1 Dose,HHS Regions/National,Region 3,2017,Age,3 Months,90.0,87.3 to 92.2,2626
DTaP,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,3 Months,89.9,88.1 to 91.5,5514
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,95.0,92.6 to 96.9,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,95.3,93.9 to 96.5,4326
DTaP,≥1 Dose,HHS Regions/National,Region 3,2018,Age,3 Months,89.9,87.3 to 91.9,2888
DTaP,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,3 Months,91.4,89.8 to 92.8,5328
Hib,Full Series,HHS Regions/National,Region 3,2021,Age,19 Months,72.7,68.8 to 76.3,1580
Hib,Full Series,HHS Regions/National,Region 3,2020-2021,Age,24 Months,76.7,74.3 to 79.1,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,94.3,92.1 to 96.1,2888
Hib,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,94.6,93.2 to 95.8,5328
Hep A,≥2 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,30.1,26.7 to 33.6,2626
Hep A,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,30.0,27.7 to 32.3,5514
DTaP,≥4 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,70.9,66.7 to 74.9,2071
DTaP,≥4 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,74.5,71.8 to 77.0,4326
DTaP,≥4 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,71.0,66.9 to 74.8,2071
DTaP,≥4 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,71.0,68.0 to 73.7,4142
DTaP,≥4 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,71.0,66.3 to 75.3,2037
DTaP,≥4 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,71.0,67.9 to 73.9,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,93.7,91.4 to 95.5,2626
Hib,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.0,92.4 to 95.4,5514
Hib,≥3 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,94.9,93.0 to 96.4,2255
Hib,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,94.3,92.9 to 95.6,4881
Hep A,≥2 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,29.9,26.9 to 33.0,2888
Hep A,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,32.3,29.6 to 35.0,4447
Hep A,≥2 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,39.3,35.2 to 43.8,1959
Hep A,≥2 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,33.0,29.7 to 36.4,2440
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,96.7,94.5 to 98.2,2440
Hep A,≥1 Dose,HHS Regions/National,Region 3,2018,Age,24 Months,87.0,84.3 to 89.6,2888
Hep A,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,24 Months,89.1,87.3 to 90.7,5328
Hep A,≥1 Dose,HHS Regions/National,Region 3,2011,Age,35 Months,87.3,83.8 to 90.3,1959
Hep A,≥1 Dose,HHS Regions/National,Region 3,2019,Age,24 Months,91.2,89.0 to 93.1,2440
Hep A,≥1 Dose,HHS Regions/National,Region 3,2017,Age,24 Months,87.5,84.5 to 90.2,2626
Hep A,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,24 Months,87.3,85.2 to 89.2,5514
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,93.6,91.3 to 95.5,2626
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,94.1,92.6 to 95.4,5514
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,94.6,92.6 to 96.1,2888
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,94.7,93.4 to 95.9,5328
DTaP,≥2 Doses,HHS Regions/National,Region 3,2016,Age,5 Months,84.7,81.7 to 87.3,2255
DTaP,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,5 Months,84.1,82.0 to 86.1,4881
DTaP,≥2 Doses,HHS Regions/National,Region 3,2018,Age,5 Months,82.6,79.5 to 85.2,2888
DTaP,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,5 Months,83.5,81.5 to 85.4,5328
DTaP,≥2 Doses,HHS Regions/National,Region 3,2017,Age,5 Months,83.6,80.4 to 86.4,2626
DTaP,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,5 Months,83.1,80.9 to 85.1,5514
Hep A,≥1 Dose,HHS Regions/National,Region 3,2015,Age,19 Months,80.9,76.7 to 84.5,2071
Hep A,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,19 Months,82.5,80.1 to 84.7,4326
Hep A,≥1 Dose,HHS Regions/National,Region 3,2014,Age,19 Months,80.3,76.6 to 83.6,2071
Hep A,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,19 Months,80.6,78.0 to 83.0,4142
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,94.9,93.0 to 96.4,2440
Hep A,≥1 Dose,HHS Regions/National,Region 3,2012,Age,19 Months,76.2,73.1 to 79.0,2101
DTaP,≥4 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,86.6,83.8 to 89.1,3970
≥1 Dose Varicella,,HHS Regions/National,Region 3,2021,Age,19 Months,87.7,84.5 to 90.2,1580
DTaP,≥1 Dose,HHS Regions/National,Region 3,2016,Age,3 Months,91.7,89.4 to 93.6,2255
DTaP,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,3 Months,90.9,89.1 to 92.3,4881
DTaP,≥1 Dose,HHS Regions/National,Region 3,2015,Age,3 Months,87.8,84.2 to 90.7,2071
DTaP,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,3 Months,89.8,87.6 to 91.5,4326
DTaP,≥1 Dose,HHS Regions/National,Region 3,2014,Age,3 Months,88.5,85.4 to 91.0,2071
DTaP,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,3 Months,88.1,85.8 to 90.1,4142
DTaP,≥1 Dose,HHS Regions/National,Region 3,2013,Age,3 Months,87.8,84.4 to 90.5,2037
DTaP,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,3 Months,88.1,85.9 to 90.1,4108
DTaP,≥1 Dose,HHS Regions/National,Region 3,2011,Age,3 Months,91.5,88.6 to 93.7,1959
DTaP,≥1 Dose,HHS Regions/National,Region 3,2012,Age,3 Months,88.6,85.9 to 90.9,2101
Hep B,≥3 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,89.9,87.1 to 92.2,1580
Hep A,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,24 Months,87.5,85.5 to 89.3,3970
Combined 7 Series,,HHS Regions/National,Region 3,2016,Age,24 Months,75.6,72.2 to 79.0,2255
Combined 7 Series,,HHS Regions/National,Region 3,2016-2017,Age,24 Months,75.2,72.8 to 77.6,4881
Hib,Primary Series,HHS Regions/National,Region 3,2019,Age,35 Months,95.7,94.1 to 96.9,2440
Hib,≥3 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,95.8,93.5 to 97.5,1959
Hib,≥3 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,92.5,89.6 to 94.8,2101
Hep A,≥1 Dose,HHS Regions/National,Region 3,2013,Age,24 Months,83.7,80.2 to 86.9,2037
Hep A,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,24 Months,84.7,82.3 to 86.9,4108
Hep A,≥1 Dose,HHS Regions/National,Region 3,2011,Age,24 Months,82.7,79.1 to 86.0,1959
Hep A,≥1 Dose,HHS Regions/National,Region 3,2019,Age,19 Months,86.7,84.1 to 88.9,2440
Hep A,≥1 Dose,HHS Regions/National,Region 3,2012,Age,24 Months,82.1,78.4 to 85.5,2101
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,95.7,93.9 to 97.1,2255
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,95.1,93.7 to 96.3,4881
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,95.3,92.9 to 97.1,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,95.5,94.1 to 96.7,4326
PCV,≥2 Doses,HHS Regions/National,Region 3,2011,Age,5 Months,80.1,75.5 to 84.0,1959
PCV,≥2 Doses,HHS Regions/National,Region 3,2012,Age,5 Months,74.2,69.9 to 78.0,2101
PCV,≥2 Doses,HHS Regions/National,Region 3,2013,Age,5 Months,78.7,75.3 to 81.8,2037
PCV,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,5 Months,78.2,76.2 to 80.1,4108
DTaP,≥4 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,68.4,64.2 to 72.2,2101
DTaP,≥4 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,69.9,66.7 to 72.9,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,94.4,92.2 to 96.2,2626
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,95.0,93.5 to 96.3,5514
DTaP,≥2 Doses,HHS Regions/National,Region 3,2019,Age,5 Months,84.5,81.7 to 87.0,2440
Hep A,≥2 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,21.5,17.9 to 25.5,2101
Hep A,≥2 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,24.3,21.0 to 27.9,2071
Hep A,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,25.2,22.7 to 27.9,4142
Hep A,≥2 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,24.2,21.1 to 27.5,2037
Hep A,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,24.2,22.1 to 26.4,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,92.6,90.4 to 94.5,2888
Hib,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,93.6,92.2 to 94.8,5328
Hib,≥3 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,92.6,90.2 to 94.6,2626
Hib,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,92.6,91.0 to 94.1,5514
Hib,≥3 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,94.6,92.9 to 96.0,2440
Hib,≥3 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,92.4,89.6 to 94.7,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,93.3,91.3 to 94.9,4142
Hib,≥3 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,95.2,92.9 to 96.9,2037
Hib,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,93.8,92.1 to 95.3,4108
Hep A,≥2 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,28.4,25.0 to 32.0,2255
Hep A,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,29.2,26.8 to 31.7,4881
Hep A,≥2 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,26.1,22.1 to 30.6,2071
Hep A,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,27.2,24.7 to 29.9,4326
Hib,≥3 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,94.3,91.5 to 96.4,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,94.5,92.9 to 95.9,4326
Hep A,≥1 Dose,HHS Regions/National,Region 3,2016,Age,19 Months,84.2,81.0 to 86.9,2255
Hep A,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,19 Months,83.7,81.4 to 85.7,4881
Hep A,≥1 Dose,HHS Regions/National,Region 3,2017,Age,19 Months,83.2,79.8 to 86.1,2626
Hep A,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,19 Months,83.3,81.0 to 85.3,5514
Hep A,≥1 Dose,HHS Regions/National,Region 3,2018,Age,19 Months,83.4,80.4 to 86.0,2888
Hep A,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,19 Months,85.3,83.1 to 87.2,4447
DTaP,≥3 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,96.1,93.9 to 97.6,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,93.8,91.3 to 95.7,2101
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,96.3,94.1 to 97.9,2037
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,95.4,93.7 to 96.7,4108
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,94.3,91.8 to 96.3,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,94.9,93.2 to 96.3,4142
Hep A,≥2 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,20.9,18.1 to 24.0,1959
PCV,≥2 Doses,HHS Regions/National,Region 3,2014,Age,5 Months,77.7,73.9 to 81.1,2071
PCV,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,5 Months,78.0,75.4 to 80.5,4142
Hep A,≥1 Dose,HHS Regions/National,Region 3,2016,Age,24 Months,87.5,84.6 to 90.1,2255
Hep A,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,24 Months,87.5,85.4 to 89.4,4881
Hep A,≥1 Dose,HHS Regions/National,Region 3,2015,Age,24 Months,86.0,82.7 to 88.9,2071
Hep A,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,24 Months,86.7,84.6 to 88.7,4326
Hep A,≥1 Dose,HHS Regions/National,Region 3,2014,Age,24 Months,85.7,82.3 to 88.7,2071
Hep A,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,24 Months,85.8,83.5 to 88.0,4142
PCV,≥2 Doses,HHS Regions/National,Region 3,2016,Age,5 Months,82.7,79.5 to 85.4,2255
PCV,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,5 Months,82.0,79.7 to 84.0,4881
PCV,≥2 Doses,HHS Regions/National,Region 3,2015,Age,5 Months,78.4,74.4 to 81.9,2071
PCV,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,5 Months,80.5,78.0 to 82.8,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,95.7,93.7 to 97.2,2888
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,96.2,94.7 to 97.5,5328
Combined 7 Series,,HHS Regions/National,Region 3,2017,Age,24 Months,74.8,71.3 to 78.2,2626
Combined 7 Series,,HHS Regions/National,Region 3,2017-2018,Age,24 Months,74.1,71.7 to 76.4,5514
Combined 7 Series,,HHS Regions/National,Region 3,2018,Age,24 Months,73.3,70.1 to 76.5,2888
Combined 7 Series,,HHS Regions/National,Region 3,2018-2019,Age,24 Months,73.6,71.4 to 75.8,5328
Combined 7 Series,,HHS Regions/National,Region 3,2012,Age,35 Months,73.0,68.8 to 77.0,2101
Combined 7 Series,,HHS Regions/National,Region 3,2014,Age,35 Months,76.3,72.1 to 80.2,2071
Combined 7 Series,,HHS Regions/National,Region 3,2014-2015,Age,35 Months,76.6,73.6 to 79.6,4142
Combined 7 Series,,HHS Regions/National,Region 3,2014,Age,24 Months,72.0,68.1 to 75.9,2071
Combined 7 Series,,HHS Regions/National,Region 3,2014-2015,Age,24 Months,71.6,68.7 to 74.4,4142
Combined 7 Series,,HHS Regions/National,Region 3,2015,Age,24 Months,71.1,66.9 to 75.2,2071
Combined 7 Series,,HHS Regions/National,Region 3,2015-2016,Age,24 Months,73.4,70.6 to 76.0,4326
Hib,Primary Series,HHS Regions/National,Region 3,2018,Age,35 Months,94.8,92.6 to 96.5,2888
Hib,Primary Series,HHS Regions/National,Region 3,2018-2019,Age,35 Months,95.2,93.9 to 96.3,5328
Combined 7 Series,,HHS Regions/National,Region 3,2013,Age,35 Months,75.5,71.5 to 79.4,2037
Combined 7 Series,,HHS Regions/National,Region 3,2013-2014,Age,35 Months,75.9,73.0 to 78.7,4108
Combined 7 Series,,HHS Regions/National,Region 3,2016,Age,35 Months,80.4,76.9 to 83.6,2255
Combined 7 Series,,HHS Regions/National,Region 3,2016-2017,Age,35 Months,79.7,77.3 to 82.0,4881
Combined 7 Series,,HHS Regions/National,Region 3,2017,Age,35 Months,79.0,75.6 to 82.3,2626
Combined 7 Series,,HHS Regions/National,Region 3,2017-2018,Age,35 Months,78.8,76.4 to 81.2,5514
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,88.1,84.5 to 91.0,1121
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,69.4,64.6 to 73.8,1121
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,94.6,91.3 to 97.9,354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.7,83.8 to 89.6,1189
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,87.2,78.4 to 96.1,354
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,84.2,80.1 to 88.3,804
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,133% to <400% FPL,85.9,81.6 to 90.3,684
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,83.9 to 95.7,323
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,63.0,58.6 to 67.2,1296
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Poverty,>400% FPL,97.1,95.4 to 98.8,943
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,86.5,80.8 to 92.3,354
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,3 Months,94.2,90.6 to 96.5,466
Hib,Full Series,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,79.2,73.6 to 84.3,1121
Hib,Primary Series,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,90.6,87.4 to 93.3,1121
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,7 Months,92.6,89.5 to 94.9,1296
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,86.1,81.6 to 90.6,788
Rotavirus,,States/Local Areas,Pennsylvania,2019,Age,8 Months,79.4,73.9 to 84.0,641
Rotavirus,,States/Local Areas,Pennsylvania,2017,Age,8 Months,77.3,70.7 to 82.8,560
Rotavirus,,States/Local Areas,Pennsylvania,2017-2018,Age,8 Months,78.2,73.9 to 82.0,1210
Rotavirus,,States/Local Areas,Pennsylvania,2018,Age,8 Months,79.2,73.4 to 84.0,650
Rotavirus,,States/Local Areas,Pennsylvania,2018-2019,Age,8 Months,79.3,75.4 to 82.7,1291
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,66.1,51.9 to 80.2,115
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,87.3,83.9 to 90.6,1077
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,68.0,62.2 to 73.8,741
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.5,53.4 to 71.6,320
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,69.6,60.5 to 78.8,323
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,35.5,14.0 to 56.9,42
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.0,76.7 to 85.2,1044
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,74.5,69.4 to 79.6,982
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.8,66.8 to 84.7,288
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,81.4,76.1 to 86.7,551
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,76.4,73.1 to 79.8,1975
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,61.5,54.9 to 68.2,636
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.9,73.4 to 82.4,945
Rotavirus,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,73.3,57.7 to 89.0,48
Rotavirus,,States/Local Areas,Pennsylvania,2016,Age,8 Months,84.4,78.4 to 89.0,580
Rotavirus,,States/Local Areas,Pennsylvania,2016-2017,Age,8 Months,80.9,76.5 to 84.6,1140
Rotavirus,,States/Local Areas,Pennsylvania,2014,Age,8 Months,70.9,63.7 to 77.3,556
Rotavirus,,States/Local Areas,Pennsylvania,2014-2015,Age,8 Months,71.4,66.1 to 76.2,1073
Rotavirus,,States/Local Areas,Pennsylvania,2012,Age,8 Months,74.6,68.0 to 80.3,611
Rotavirus,,States/Local Areas,Pennsylvania,2013,Age,8 Months,75.8,68.5 to 81.8,561
Rotavirus,,States/Local Areas,Pennsylvania,2013-2014,Age,8 Months,73.4,68.3 to 77.9,1117
Rotavirus,,States/Local Areas,Pennsylvania,2015,Age,8 Months,71.9,64.0 to 78.6,517
Rotavirus,,States/Local Areas,Pennsylvania,2015-2016,Age,8 Months,78.1,73.2 to 82.4,1097
Hib,Full Series,States/Local Areas,Pennsylvania,2014,Age,19 Months,72.8,65.8 to 78.9,556
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2015,Age,19 Months,69.8,64.5 to 74.7,1073
Hib,Full Series,States/Local Areas,Pennsylvania,2017,Age,19 Months,79.3,73.0 to 84.5,560
Hib,Full Series,States/Local Areas,Pennsylvania,2017-2018,Age,19 Months,79.7,75.6 to 83.3,1210
Hib,Full Series,States/Local Areas,Pennsylvania,2019,Age,19 Months,77.6,72.0 to 82.3,641
Hib,Full Series,States/Local Areas,Pennsylvania,2018,Age,19 Months,80.1,74.5 to 84.8,650
Hib,Full Series,States/Local Areas,Pennsylvania,2018-2019,Age,19 Months,95.6,93.2 to 97.1,1291
Hib,Full Series,States/Local Areas,Pennsylvania,2016,Age,19 Months,79.7,73.2 to 84.9,580
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2017,Age,19 Months,79.5,75.1 to 83.3,1140
Hib,Full Series,States/Local Areas,Pennsylvania,2015,Age,19 Months,66.8,60.0 to 73.0,517
Hib,Full Series,States/Local Areas,Pennsylvania,2015-2016,Age,19 Months,73.2,68.0 to 77.9,1097
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,64.9,58.2 to 71.5,636
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.0,54.3 to 73.7,320
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,67.6 to 84.8,288
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.6,71.2 to 80.1,1044
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,73.4,68.2 to 78.5,982
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.8,71.2 to 80.4,945
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,77.9,72.3 to 83.5,551
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,80.4,75.4 to 85.3,788
Hib,Full Series,States/Local Areas,Pennsylvania,2011,Age,19 Months,78.1,75.1 to 80.9,626
Hib,Full Series,States/Local Areas,Pennsylvania,2012,Age,19 Months,73.5,63.0 to 81.9,611
Hib,Full Series,States/Local Areas,Pennsylvania,2013,Age,19 Months,77.5,73.8 to 80.8,561
Hib,Full Series,States/Local Areas,Pennsylvania,2013-2014,Age,19 Months,75.2,71.6 to 78.5,1117
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,74.5,71.1 to 77.9,1975
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,67.4,51.5 to 83.3,48
Hib,Full Series,States/Local Areas,Pennsylvania,2013,Age,24 Months,84.0,78.2 to 89.0,561
Hib,Full Series,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,81.8,77.5 to 85.7,1117
Hib,Full Series,States/Local Areas,Pennsylvania,2014,Age,24 Months,79.5,73.1 to 85.2,556
Hib,Full Series,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,77.7,72.8 to 82.4,1073
Hib,Full Series,States/Local Areas,Pennsylvania,2012,Age,24 Months,81.5,75.5 to 86.8,611
Hib,Full Series,States/Local Areas,Pennsylvania,2011,Age,24 Months,86.1,81.5 to 90.1,626
Combined 7 Series,,States/Local Areas,Pennsylvania,2015,Age,35 Months,78.0,69.1 to 85.8,517
Combined 7 Series,,States/Local Areas,Pennsylvania,2015-2016,Age,35 Months,81.1,75.9 to 85.8,1097
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,76.4,67.9 to 84.8,323
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,81.0,77.1 to 85.0,1077
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,69.7,63.9 to 75.6,741
Combined 7 Series,,States/Local Areas,Pennsylvania,2019,Age,35 Months,77.9,71.9 to 83.4,641
Combined 7 Series,,States/Local Areas,Pennsylvania,2018,Age,35 Months,77.0,71.2 to 82.5,650
Combined 7 Series,,States/Local Areas,Pennsylvania,2018-2019,Age,35 Months,77.4,73.3 to 81.2,1291
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,69.6,55.8 to 83.5,115
Combined 7 Series,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,44.8,20.5 to 69.1,42
Rotavirus,,States/Local Areas,Pennsylvania,2011,Age,8 Months,77.1,71.4 to 82.0,626
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2019-2020,Age,19 Months,91.6,88.7 to 93.8,1296
Influenza,,States/Local Areas,Pennsylvania,2017,Age,24 Months,72.6,66.3 to 78.5,560
Influenza,,States/Local Areas,Pennsylvania,2017-2018,Age,24 Months,73.1,68.8 to 77.2,1210
Influenza,,States/Local Areas,Pennsylvania,2018,Age,24 Months,73.4,67.5 to 79.0,650
Influenza,,States/Local Areas,Pennsylvania,2018-2019,Age,24 Months,74.3,70.2 to 78.3,1291
Influenza,,States/Local Areas,Pennsylvania,2016,Age,24 Months,69.7,63.3 to 76.0,580
Influenza,,States/Local Areas,Pennsylvania,2016-2017,Age,24 Months,71.1,66.6 to 75.5,1140
Influenza,,States/Local Areas,Pennsylvania,2019,Age,24 Months,75.2,69.3 to 80.7,641
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.1,66.7 to 85.6,345
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.9,81.9 to 90.0,1189
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Any Medicaid,87.3,83.3 to 91.4,804
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,94.5,92.8 to 96.3,1244
Influenza,,States/Local Areas,Pennsylvania,2012,Age,24 Months,57.9,50.9 to 65.0,611
Influenza,,States/Local Areas,Pennsylvania,2011,Age,24 Months,68.6,62.6 to 74.4,626
Influenza,,States/Local Areas,Pennsylvania,2014,Age,24 Months,58.5,51.4 to 65.9,556
Influenza,,States/Local Areas,Pennsylvania,2014-2015,Age,24 Months,55.8,50.5 to 61.2,1073
Influenza,,States/Local Areas,Pennsylvania,2015,Age,24 Months,52.8,45.3 to 60.8,517
Influenza,,States/Local Areas,Pennsylvania,2015-2016,Age,24 Months,61.3,56.2 to 66.4,1097
Influenza,,States/Local Areas,Pennsylvania,2013,Age,24 Months,63.3,56.2 to 70.4,561
Influenza,,States/Local Areas,Pennsylvania,2013-2014,Age,24 Months,60.9,55.8 to 66.1,1117
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Private Insurance Only,75.3,71.0 to 79.6,1077
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2021,Age,3 Months,88.9,83.8 to 92.5,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,24 Months,91.6,87.3 to 94.8,466
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,62.1,57.1 to 66.8,1121
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,86.9,83.2 to 89.9,1121
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Other,58.2,44.1 to 72.4,115
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Uninsured,26.6,7.9 to 45.3,42
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,Hispanic,60.2,50.5 to 70.0,323
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.1,63.2 to 80.9,288
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Insurance Coverage,Any Medicaid,51.5,45.5 to 57.6,741
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",56.8,47.7 to 65.8,320
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.1,58.2 to 68.0,1044
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Principal City,63.7,58.2 to 69.2,982
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a MSA Non-Principal City,66.2,61.4 to 71.1,945
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Urbanicity,Living In a Non-MSA,30.3,15.3 to 45.3,48
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Poverty,>400% FPL,80.5,75.9 to 85.2,788
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,93.5,91.5 to 95.5,1244
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.0,69.2 to 90.7,323
Polio,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,3 Months,88.6,85.3 to 91.2,1121
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,57.4,52.5 to 62.3,1121
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,89.0,85.6 to 91.7,1121
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2021,Age,13 Months,62.4,54.6 to 69.6,466
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,90.4,87.3 to 93.0,1121
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,97.5,96.3 to 98.8,1244
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,80.4 to 92.2,323
Hib,Full Series,States/Local Areas,Pennsylvania,2016-2019,Insurance Coverage,Private Insurance Only,90.4,87.8 to 93.1,1244
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Overall,Overall,63.1,59.4 to 66.7,1975
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2016-2019,Race and Ethnicity,Hispanic,90.0,85.0 to 95.0,354
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Poverty,<133% FPL,48.5,41.9 to 55.1,636
Influenza,,States/Local Areas,Pennsylvania,2014-2017,Poverty,133% to <400% FPL,60.0,53.5 to 66.5,551
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,91.3,86.7 to 94.4,466
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,5 Months,79.6,75.4 to 83.3,1121
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2021,Age,0-3 Days,84.1,78.2 to 88.7,466
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,94.1,88.2 to 97.6,466
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,91.2,88.2 to 93.7,1121
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,78.8,72.4 to 84.6,1121
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,86.8,83.0 to 89.9,1121
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Pennsylvania,2020-2021,Age,0-3 Days,83.5,79.6 to 86.8,1121
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,91.0,88.0 to 93.6,1121
Rotavirus,,States/Local Areas,Pennsylvania,2020-2021,Age,8 Months,79.0,74.8 to 82.6,1121
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2021,Age,35 Months,93.6,86.3 to 97.7,466
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,94.7,89.1 to 98.0,466
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,92.9,88.6 to 95.7,466
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,90.2,86.0 to 93.7,1121
Hib,Full Series,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,70.4,65.6 to 74.8,1121
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,83.3,79.1 to 87.1,1121
Influenza,,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,61.7,56.6 to 66.8,1121
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Pennsylvania,2020-2021,Age,0-1 Days,80.8,76.8 to 84.3,1121
Hib,Primary Series,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,84.3,80.5 to 87.4,1121
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,90.8,87.6 to 93.3,1121
PCV,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,3 Months,87.7,84.3 to 90.5,1121
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,71.1,66.4 to 75.4,1121
Hib,Primary Series,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,89.2,85.9 to 91.8,1121
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,77.9,73.5 to 82.1,1121
Hep A,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,82.6,78.3 to 86.3,1121
PCV,≥4 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,78.9,74.6 to 82.7,1121
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,60.5,55.6 to 65.2,1121
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,89.9,86.5 to 92.8,1121
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,82.0,74.4 to 88.5,466
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,89.7,84.9 to 93.5,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,90.1,86.9 to 92.6,1121
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,88.7,85.2 to 91.8,1121
DTaP,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,5 Months,82.4,76.4 to 87.2,466
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,87.9,82.5 to 91.8,466
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2021,Age,13 Months,64.1,56.4 to 71.1,466
Hib,Primary Series,States/Local Areas,Pennsylvania,2021,Age,35 Months,94.0,88.1 to 97.6,466
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,5 Months,79.3,75.1 to 83.0,1121
Hib,Primary Series,States/Local Areas,Pennsylvania,2020-2021,Age,7 Months,71.8,67.3 to 76.0,1121
Hib,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,5 Months,76.4,72.0 to 80.4,1121
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,91.8,88.7 to 94.1,1121
Influenza,,States/Local Areas,Pennsylvania,2021,Age,24 Months,60.0,52.4 to 67.8,466
DTaP,≥4 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,69.1,64.3 to 73.6,1121
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2021,Age,19 Months,87.3,81.4 to 91.5,466
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,29.2,25.1 to 33.7,1121
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,5 Months,89.4,84.7 to 92.8,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,89.1,85.8 to 91.7,1121
Hep B,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,90.0,86.8 to 92.6,1121
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Pennsylvania,2020-2021,Age,0-2 Days,82.9,79.0 to 86.2,1121
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020-2021,Age,13 Months,63.9,58.9 to 68.6,1121
DTaP,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,3 Months,89.0,85.8 to 91.6,1121
≥1 Dose Varicella,,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,87.6,83.8 to 90.6,1121
Hep B,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,3 Months,94.8,92.2 to 96.5,1121
Hep A,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,46.6,41.5 to 51.9,1121
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,89.7,86.1 to 92.7,1121
Hib,Primary Series,States/Local Areas,Pennsylvania,2021,Age,13 Months,85.4,80.2 to 89.4,466
Hib,Full Series,States/Local Areas,Pennsylvania,2021,Age,35 Months,80.6,71.9 to 88.0,466
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,92.0,88.8 to 94.5,1121
Combined 7 Series,,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,67.1,62.4 to 71.9,1121
DTaP,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,35 Months,94.7,89.2 to 97.9,466
PCV,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,90.7,87.7 to 93.3,1121
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,90.4,87.2 to 92.9,1121
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,19 Months,86.9,83.2 to 89.8,1121
Hib,≥1 Dose,States/Local Areas,Pennsylvania,2020-2021,Age,3 Months,85.5,82.0 to 88.5,1121
≥1 Dose MMR,,States/Local Areas,Pennsylvania,2020-2021,Age,24 Months,88.6,85.0 to 91.6,1121
Combined 7 Series,,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,73.4,67.5 to 79.1,1121
Polio,≥3 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,35 Months,92.1,89.1 to 94.6,1121
Rotavirus,,States/Local Areas,Pennsylvania,2021,Age,8 Months,80.9,75.0 to 85.6,466
Hep B,≥2 Doses,States/Local Areas,Pennsylvania,2020-2021,Age,5 Months,89.2,85.8 to 91.8,1121
Hib,≥3 Doses,States/Local Areas,Pennsylvania,2021,Age,13 Months,74.0,66.8 to 80.1,466
Polio,≥2 Doses,States/Local Areas,Pennsylvania,2021,Age,5 Months,82.0,76.0 to 86.8,466
Combined 7 Series,,States/Local Areas,Missouri,2018,Age,35 Months,77.3,70.5 to 83.5,416
Combined 7 Series,,States/Local Areas,Missouri,2018-2019,Age,35 Months,73.6,68.6 to 78.4,818
Combined 7 Series,,States/Local Areas,Missouri,2019,Age,35 Months,69.6,62.3 to 76.7,402
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,61.9,55.5 to 68.2,331
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,72.6,67.6 to 77.7,509
Hib,Full Series,States/Local Areas,Missouri,2016,Age,19 Months,64.2,55.6 to 72.0,238
Hib,Full Series,States/Local Areas,Missouri,2016-2017,Age,19 Months,68.1,62.7 to 73.1,622
Combined 7 Series,,States/Local Areas,Missouri,2015,Age,35 Months,77.3,67.7 to 85.8,235
Combined 7 Series,,States/Local Areas,Missouri,2015-2016,Age,35 Months,69.2,62.9 to 75.4,473
Hep A,≥2 Doses,States/Local Areas,Missouri,2020,Age,35 Months,78.9,70.7 to 86.0,390
≥1 Dose MMR,,States/Local Areas,Missouri,2020,Age,13 Months,68.2,61.3 to 74.3,390
Combined 7 Series,,States/Local Areas,Missouri,2020,Age,35 Months,77.0,70.1 to 83.4,390
Hep A,≥2 Doses,States/Local Areas,Missouri,2020,Age,19 Months,23.2,18.4 to 28.8,390
Hib,Full Series,States/Local Areas,Missouri,2019-2020,Age,19 Months,71.3,66.6 to 75.6,792
Combined 7 Series,,States/Local Areas,Missouri,2019-2020,Age,35 Months,72.9,67.8 to 77.8,792
Hib,Primary Series,States/Local Areas,Missouri,2019-2020,Age,24 Months,90.6,87.2 to 93.3,792
Hib,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,86.3,82.3 to 89.8,792
Hep B,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,64.7,60.0 to 69.1,792
Hep A,≥1 Dose,States/Local Areas,Missouri,2020,Age,19 Months,84.0,77.8 to 88.7,390
Polio,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,3 Months,89.0,85.5 to 91.7,792
DTaP,≥4 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,69.6,64.8 to 74.1,792
DTaP,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,89.6,86.0 to 92.4,792
Hib,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,86.7,82.8 to 89.9,792
Hep A,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,40.4,35.7 to 45.5,792
Influenza,,States/Local Areas,Missouri,2019-2020,Age,24 Months,57.2,52.3 to 62.2,792
Hep A,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,77.4,71.5 to 82.8,792
Hep A,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,35 Months,85.8,81.6 to 89.5,792
Hep A,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,24 Months,84.1,80.0 to 87.8,792
Hib,Full Series,States/Local Areas,Missouri,2020,Age,19 Months,74.4,67.9 to 80.1,390
Hep B,≥3 Doses,States/Local Areas,Missouri,2020,Age,19 Months,94.0,90.1 to 96.4,390
≥1 Dose Varicella,,States/Local Areas,Missouri,2020,Age,19 Months,88.2,83.0 to 92.0,390
DTaP,≥3 Doses,States/Local Areas,Missouri,2020,Age,35 Months,94.3,90.1 to 97.1,390
DTaP,≥4 Doses,States/Local Areas,Missouri,2020,Age,35 Months,91.2,85.5 to 95.3,390
PCV,≥4 Doses,States/Local Areas,Missouri,2020,Age,19 Months,80.3,73.8 to 85.5,390
Polio,≥3 Doses,States/Local Areas,Missouri,2020,Age,35 Months,94.7,90.2 to 97.6,390
PCV,≥3 Doses,States/Local Areas,Missouri,2020,Age,19 Months,92.3,87.7 to 95.3,390
Hib,≥2 Doses,States/Local Areas,Missouri,2020,Age,13 Months,93.6,89.6 to 96.1,390
PCV,≥3 Doses,States/Local Areas,Missouri,2020,Age,35 Months,93.5,89.4 to 96.4,390
Hib,≥3 Doses,States/Local Areas,Missouri,2020,Age,13 Months,73.2,66.6 to 79.0,390
Hib,Primary Series,States/Local Areas,Missouri,2020,Age,13 Months,88.7,83.9 to 92.1,390
Hep B,≥2 Doses,States/Local Areas,Missouri,2020,Age,13 Months,94.9,91.5 to 97.0,390
Hep B,≥3 Doses,States/Local Areas,Missouri,2020,Age,13 Months,92.5,88.5 to 95.2,390
≥1 Dose Varicella,,States/Local Areas,Missouri,2020,Age,13 Months,62.6,55.8 to 69.0,390
PCV,≥3 Doses,States/Local Areas,Missouri,2020,Age,13 Months,91.1,86.5 to 94.2,390
DTaP,≥3 Doses,States/Local Areas,Missouri,2020,Age,7 Months,76.6,69.9 to 82.2,390
DTaP,≥3 Doses,States/Local Areas,Missouri,2020,Age,19 Months,92.3,87.7 to 95.3,390
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2020,Age,0-1 Days,81.7,76.0 to 86.3,390
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2020,Age,0-2 Days,84.4,79.0 to 88.7,390
Polio,≥2 Doses,States/Local Areas,Missouri,2020,Age,7 Months,89.9,84.9 to 93.4,390
Hib,≥2 Doses,States/Local Areas,Missouri,2020,Age,7 Months,89.8,84.8 to 93.3,390
Hib,≥3 Doses,States/Local Areas,Missouri,2020,Age,7 Months,55.4,48.5 to 62.0,390
Hib,Primary Series,States/Local Areas,Missouri,2020,Age,7 Months,79.5,73.7 to 84.4,390
Hep B,≥2 Doses,States/Local Areas,Missouri,2020,Age,7 Months,93.8,90.3 to 96.1,390
PCV,≥2 Doses,States/Local Areas,Missouri,2020,Age,5 Months,78.8,72.0 to 84.3,390
DTaP,≥4 Doses,States/Local Areas,Missouri,2020,Age,24 Months,79.6,73.1 to 85.3,390
DTaP,≥3 Doses,States/Local Areas,Missouri,2020,Age,24 Months,93.6,89.6 to 96.5,390
Polio,≥3 Doses,States/Local Areas,Missouri,2020,Age,24 Months,93.6,89.6 to 96.5,390
≥1 Dose MMR,,States/Local Areas,Missouri,2020,Age,24 Months,91.5,87.1 to 94.8,390
Hib,≥3 Doses,States/Local Areas,Missouri,2020,Age,24 Months,89.6,84.0 to 93.9,390
≥1 Dose MMR,,States/Local Areas,Missouri,2020,Age,35 Months,94.7,90.4 to 97.4,390
Hib,Primary Series,States/Local Areas,Missouri,2020,Age,35 Months,94.1,89.8 to 97.0,390
Hib,≥3 Doses,States/Local Areas,Missouri,2020,Age,35 Months,95.0,90.4 to 97.8,390
Hib,Full Series,States/Local Areas,Missouri,2020,Age,35 Months,86.4,80.4 to 91.2,390
Hep B,≥3 Doses,States/Local Areas,Missouri,2020,Age,35 Months,96.2,92.6 to 98.3,390
≥1 Dose Varicella,,States/Local Areas,Missouri,2020,Age,35 Months,93.9,89.3 to 96.9,390
Hib,Primary Series,States/Local Areas,Missouri,2020,Age,19 Months,92.2,87.6 to 95.2,390
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2019-2020,Age,0-3 Days,82.0,78.0 to 85.5,792
DTaP,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,3 Months,89.6,86.2 to 92.3,792
Polio,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,91.9,88.1 to 94.9,792
DTaP,≥4 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,87.3,82.6 to 91.3,792
Combined 7 Series,,States/Local Areas,Missouri,2019-2020,Age,24 Months,66.7,61.9 to 71.4,792
DTaP,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,91.7,88.2 to 94.5,792
PCV,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,86.7,82.7 to 89.8,792
≥1 Dose Varicella,,States/Local Areas,Missouri,2019-2020,Age,13 Months,56.5,51.6 to 61.3,792
Hep B,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,93.9,91.0 to 95.9,792
Hep B,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,89.4,85.9 to 92.1,792
Polio,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,87.6,83.8 to 90.6,792
DTaP,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,69.8,64.8 to 74.3,792
PCV,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,5 Months,76.4,71.6 to 80.6,792
Hep B,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,5 Months,91.7,88.6 to 93.9,792
Hib,Primary Series,States/Local Areas,Missouri,2019-2020,Age,13 Months,84.7,80.7 to 88.0,792
Hib,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,5 Months,74.9,70.1 to 79.1,792
Hib,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,91.7,88.5 to 94.1,792
≥1 Dose MMR,,States/Local Areas,Missouri,2019-2020,Age,13 Months,63.7,58.7 to 68.4,792
Hib,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,68.0,63.2 to 72.5,792
Polio,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,92.1,89.0 to 94.4,792
DTaP,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,13 Months,87.7,83.9 to 90.8,792
Polio,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,5 Months,78.0,73.3 to 82.0,792
DTaP,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,5 Months,78.1,73.4 to 82.2,792
PCV,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,3 Months,88.1,84.5 to 90.9,792
Hep B,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,3 Months,95.7,93.4 to 97.2,792
≥1 Dose MMR,,States/Local Areas,Missouri,2019-2020,Age,24 Months,88.0,84.3 to 91.1,792
Polio,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,90.0,86.5 to 92.9,792
DTaP,≥4 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,78.6,74.1 to 82.8,792
DTaP,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,90.3,86.9 to 93.2,792
PCV,≥4 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,81.7,77.2 to 85.9,792
PCV,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,91.0,87.5 to 93.8,792
≥1 Dose Varicella,,States/Local Areas,Missouri,2019-2020,Age,35 Months,92.3,88.6 to 95.1,792
Hep B,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,93.3,89.9 to 95.9,792
Hib,Primary Series,States/Local Areas,Missouri,2019-2020,Age,35 Months,91.5,88.0 to 94.3,792
Hib,Full Series,States/Local Areas,Missouri,2019-2020,Age,35 Months,81.0,76.3 to 85.2,792
≥1 Dose MMR,,States/Local Areas,Missouri,2019-2020,Age,35 Months,92.9,89.3 to 95.6,792
Hib,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,35 Months,89.8,85.8 to 93.1,792
Hib,Primary Series,States/Local Areas,Missouri,2019-2020,Age,19 Months,89.9,86.3 to 92.6,792
Hib,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,84.7,80.4 to 88.2,792
≥1 Dose MMR,,States/Local Areas,Missouri,2019-2020,Age,19 Months,86.5,82.6 to 89.6,792
Polio,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,89.2,85.5 to 92.1,792
Hep A,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,23.2,19.6 to 27.2,792
Hib,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,3 Months,86.8,83.1 to 89.7,792
PCV,≥4 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,79.1,74.6 to 83.2,792
PCV,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,90.1,86.7 to 93.0,792
≥1 Dose Varicella,,States/Local Areas,Missouri,2019-2020,Age,24 Months,87.7,84.0 to 90.9,792
PCV,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,67.6,62.6 to 72.2,792
Hib,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,49.3,44.5 to 54.1,792
Hib,Full Series,States/Local Areas,Missouri,2019-2020,Age,24 Months,76.0,71.5 to 80.2,792
Hep B,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,24 Months,91.5,88.3 to 94.1,792
Hep A,≥1 Dose,States/Local Areas,Missouri,2019-2020,Age,19 Months,81.2,76.8 to 85.0,792
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2019-2020,Age,0-1 Days,77.2,72.8 to 81.1,792
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2019-2020,Age,0-2 Days,80.1,75.9 to 83.8,792
PCV,≥4 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,77.0,72.3 to 81.1,792
PCV,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,89.1,85.3 to 91.9,792
≥1 Dose Varicella,,States/Local Areas,Missouri,2019-2020,Age,19 Months,85.8,81.8 to 89.0,792
Hep B,≥3 Doses,States/Local Areas,Missouri,2019-2020,Age,19 Months,90.6,87.2 to 93.2,792
DTaP,≥4 Doses,States/Local Areas,Missouri,2020,Age,19 Months,72.0,65.2 to 77.9,390
≥1 Dose MMR,,States/Local Areas,Missouri,2020,Age,19 Months,90.2,85.4 to 93.6,390
Polio,≥3 Doses,States/Local Areas,Missouri,2020,Age,19 Months,92.3,87.7 to 95.3,390
Hib,≥3 Doses,States/Local Areas,Missouri,2020,Age,19 Months,87.4,81.3 to 91.7,390
Combined 7 Series,,States/Local Areas,Missouri,2020,Age,24 Months,70.3,63.7 to 76.7,390
Influenza,,States/Local Areas,Missouri,2020,Age,24 Months,60.2,53.3 to 67.2,390
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2020,Age,0-3 Days,84.6,79.1 to 88.8,390
Rotavirus,,States/Local Areas,Missouri,2020,Age,8 Months,78.0,71.9 to 83.1,390
≥1 Dose Varicella,,States/Local Areas,Missouri,2020,Age,24 Months,90.7,86.1 to 94.3,390
PCV,≥3 Doses,States/Local Areas,Missouri,2020,Age,24 Months,93.5,89.4 to 96.4,390
PCV,≥4 Doses,States/Local Areas,Missouri,2020,Age,24 Months,82.3,76.1 to 87.7,390
Hep A,≥1 Dose,States/Local Areas,Missouri,2020,Age,24 Months,85.6,79.8 to 90.5,390
Hep A,≥2 Doses,States/Local Areas,Missouri,2020,Age,24 Months,41.1,34.7 to 48.2,390
PCV,≥1 Dose,States/Local Areas,Missouri,2020,Age,3 Months,89.4,84.7 to 92.8,390
Hep B,≥1 Dose,States/Local Areas,Missouri,2020,Age,3 Months,95.9,92.9 to 97.7,390
DTaP,≥2 Doses,States/Local Areas,Missouri,2020,Age,5 Months,79.3,72.5 to 84.8,390
Polio,≥2 Doses,States/Local Areas,Missouri,2020,Age,5 Months,79.2,72.4 to 84.7,390
Hib,≥2 Doses,States/Local Areas,Missouri,2020,Age,5 Months,76.8,70.1 to 82.5,390
DTaP,≥1 Dose,States/Local Areas,Missouri,2020,Age,3 Months,90.2,85.4 to 93.5,390
Hep B,≥2 Doses,States/Local Areas,Missouri,2020,Age,5 Months,93.6,90.2 to 95.9,390
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,85.1,81.4 to 88.9,793
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.4,76.7 to 94.1,91
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,79.4,69.0 to 89.9,107
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,87.0 to 99.6,128
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,75.9,62.4 to 89.5,62
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.8,89.2 to 94.4,960
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.2,75.4 to 82.9,960
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,74.9,61.9 to 88.0,62
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,82.3,77.5 to 87.1,413
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.2 to 98.2,793
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,61.0,45.1 to 76.9,62
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,73.2 to 80.7,960
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,66.9,60.9 to 72.8,413
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.5,69.7 to 91.3,91
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,76.4,65.6 to 87.3,107
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,64.6,49.0 to 80.3,62
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,84.2,79.6 to 88.8,413
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,80.5,68.6 to 92.5,62
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,69.9,63.9 to 75.8,413
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.4,76.7 to 94.1,91
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.9 to 97.9,793
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.7,88.0 to 93.3,960
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,82.2,72.4 to 92.1,107
Influenza,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,74.1,69.6 to 78.5,793
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.4,76.7 to 94.1,91
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,88.4 to 93.7,960
Influenza,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",40.3,28.6 to 52.1,91
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,87.0 to 99.6,128
Influenza,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.4,51.0 to 73.8,128
Influenza,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",61.2,56.8 to 65.5,960
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,65.5,50.5 to 80.5,62
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.7,59.2 to 82.3,91
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,74.3,62.5 to 86.0,107
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.9,77.4 to 84.5,960
Rotavirus,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.1,61.6 to 82.6,128
Rotavirus,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,71.1,59.4 to 82.8,107
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,76.9,63.5 to 90.2,62
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.0,50.7 to 73.4,128
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",60.1,48.0 to 72.2,91
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.3,66.3 to 74.3,960
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,64.3,51.6 to 77.0,107
Rotavirus,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,60.1,44.3 to 75.9,62
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.6,56.9 to 80.4,91
Rotavirus,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,67.0,61.1 to 72.9,413
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,60.4,31.5 to 89.3,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,74.0 to 92.4,128
Influenza,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,25.2,12.6 to 37.9,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,88.9,81.7 to 96.0,107
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,77.0,66.1 to 87.9,107
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,66.1 to 86.5,128
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,53.2,37.0 to 69.5,62
Influenza,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,44.2,38.0 to 50.5,413
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,82.1,70.3 to 93.9,62
Rotavirus,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,81.8,77.9 to 85.8,793
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.3 to 98.3,793
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,84.8,80.4 to 89.3,413
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.5,80.4 to 98.5,128
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,71.6,57.7 to 85.5,62
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.0,79.3 to 96.8,91
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,82.3,72.5 to 92.1,107
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,78.9,73.9 to 83.9,413
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.0,80.7 to 87.4,960
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.0,65.6 to 86.3,91
Rotavirus,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.5,56.2 to 78.8,91
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,76.9,72.7 to 81.0,793
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.7,79.0 to 96.4,91
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.9,86.0 to 91.7,960
Rotavirus,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.0,72.1 to 79.8,960
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.4,86.5 to 92.2,960
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.6,68.9 to 80.3,960
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,59.1,52.9 to 65.3,413
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,83.9,79.1 to 88.6,413
Influenza,,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,80.4,75.0 to 85.7,401
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,66.6,60.0 to 73.1,335
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,91.8,87.8 to 95.7,401
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,77.9,73.0 to 82.8,550
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,63.6,57.0 to 70.1,335
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,88.9,84.6 to 93.2,401
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,80.5,75.0 to 86.0,335
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,81.9,76.5 to 87.3,335
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,79.4,74.5 to 84.3,550
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,90.2,85.8 to 94.6,401
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,82.4,77.2 to 87.7,335
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,91.4,88.2 to 94.6,550
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,92.4,88.5 to 96.4,401
Influenza,,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,42.8,36.1 to 49.6,335
Influenza,,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,59.1,53.3 to 65.0,550
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,89.9,87.5 to 92.3,1286
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,90.0,87.5 to 92.4,1286
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,81.9,76.5 to 87.3,335
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,91.7,88.5 to 95.0,550
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,92.6,88.1 to 97.1,401
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,67.6,57.6 to 77.6,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,78.2,73.3 to 83.1,550
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,85.4,80.7 to 90.0,401
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,81.4,76.8 to 86.0,550
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,91.9,88.0 to 95.8,401
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.3 to 95.6,547
Rotavirus,,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,73.8,68.6 to 79.0,550
Rotavirus,,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,66.2,59.8 to 72.7,335
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,89.7,85.8 to 93.5,547
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,81.7,75.2 to 88.2,252
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,89.1 to 95.8,487
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,81.9,75.4 to 88.4,252
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.6,85.5 to 93.7,487
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,66.7,58.4 to 75.1,252
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.9,75.8 to 86.0,487
Influenza,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,63.8,58.0 to 69.6,547
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,53.5,45.1 to 61.9,252
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.3,63.5 to 75.0,487
Influenza,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,62.7,56.5 to 68.8,487
Rotavirus,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.0,71.7 to 82.2,487
Rotavirus,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,76.5,71.3 to 81.7,547
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,88.3,84.3 to 92.3,547
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,69.8,61.8 to 77.8,252
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.7,78.8 to 88.5,487
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,52.7,41.7 to 63.7,252
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,80.8,70.6 to 91.1,107
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.8,76.4 to 93.3,91
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,84.6,80.9 to 88.3,793
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,95.2 to 100.0,128
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,75.0 to 84.7,547
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,61.9,53.6 to 70.2,252
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.4,71.1 to 81.8,487
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,86.1 to 94.4,487
Rotavirus,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,62.4,54.3 to 70.6,252
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,83.1,75.8 to 90.5,547
Influenza,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,35.3,27.4 to 43.3,252
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,90.3,86.5 to 94.0,547
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.2,89.9 to 96.4,487
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,79.9,73.1 to 86.6,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,81.0,76.5 to 85.5,547
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,72.2,66.9 to 77.5,547
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,78.0,70.9 to 85.0,252
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,92.7,89.6 to 95.7,550
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,97.2,94.8 to 99.6,401
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,77.0,69.7 to 84.3,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.2,78.5 to 88.0,487
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Overall,Overall,67.5,64.0 to 71.1,1286
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Overall,Overall,75.2,71.8 to 78.5,1286
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,92.1,88.9 to 95.4,550
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,96.4,93.9 to 98.9,401
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,82.2,77.0 to 87.4,335
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,55.9,49.2 to 62.6,335
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,93.2,90.2 to 96.2,550
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,68.8,63.4 to 74.2,550
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,97.2,94.8 to 99.6,401
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Overall,Overall,88.4,85.9 to 90.9,1286
Combined 7 Series,,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,84.2,79.5 to 89.0,401
Rotavirus,,States/Local Areas,Missouri,2016-2019,Overall,Overall,74.0,70.6 to 77.4,1286
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,74.3,69.1 to 79.6,1286
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,83.3,78.2 to 88.5,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2016-2019,Overall,Overall,81.2,78.2 to 84.2,1286
Influenza,,States/Local Areas,Missouri,2016-2019,Overall,Overall,57.9,54.1 to 61.7,1286
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,81.1,75.6 to 86.5,335
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,92.0,88.9 to 95.1,550
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,72.5,65.4 to 79.5,550
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,86.1,80.0 to 92.1,401
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,74.9,68.8 to 81.0,335
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,78.4,75.1 to 81.7,1286
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Poverty,133% to <400% FPL,85.5,81.3 to 89.7,550
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Overall,Overall,88.4,85.8 to 91.0,1286
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Poverty,<133% FPL,66.2,59.7 to 72.8,335
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,89.1,86.6 to 91.6,1286
Rotavirus,,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,86.7,81.8 to 91.7,401
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Overall,Overall,83.1,80.0 to 86.1,1286
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,89.3,86.8 to 91.7,1286
Influenza,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,57.4,44.2 to 70.6,107
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Overall,Overall,77.0,73.6 to 80.4,1286
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,82.1,70.3 to 93.9,62
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,83.8,79.1 to 88.5,413
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Uninsured,82.1,70.3 to 93.9,62
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,93.5,90.6 to 96.4,793
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.3,63.1 to 83.5,128
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.2,58.4 to 82.0,91
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,75.4,64.0 to 86.7,107
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,85.7 to 98.2,128
≥1 Dose Varicella,,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,92.8,90.0 to 95.6,793
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,64.4,54.6 to 74.2,413
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,84.3,78.9 to 89.7,793
Polio,≥1 Dose,States/Local Areas,Missouri,2020,Age,3 Months,90.0,85.3 to 93.4,390
Hib,≥1 Dose,States/Local Areas,Missouri,2020,Age,3 Months,87.8,82.9 to 91.4,390
PCV,≥3 Doses,States/Local Areas,Missouri,2020,Age,7 Months,75.2,68.5 to 80.9,390
Rotavirus,,States/Local Areas,Missouri,2019-2020,Age,8 Months,70.9,66.1 to 75.3,792
Hep B,≥3 Doses,States/Local Areas,Missouri,2020,Age,7 Months,68.6,62.3 to 74.3,390
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,86.7 to 94.3,547
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.1 to 96.5,487
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,77.4,70.1 to 84.7,252
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,81.4,76.6 to 86.3,547
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,62.8,54.5 to 71.2,252
DTaP,≥4 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.0,73.8 to 84.3,487
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,87.3 to 94.4,547
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,88.3 to 93.7,960
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.5,65.4 to 79.6,487
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a Non-MSA,82.7,76.3 to 89.2,252
≥1 Dose MMR,,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,88.3 to 95.2,547
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Principal City,81.5,76.8 to 86.3,547
Hep B,≥3 Doses,States/Local Areas,Missouri,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,89.7 to 96.5,487
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,51.8,42.6 to 61.1,194
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Overall,Overall,65.9,61.9 to 69.8,912
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,58.6,51.6 to 65.6,280
Hib,Full Series,States/Local Areas,Missouri,2014,Age,19 Months,71.2,63.5 to 77.8,241
Hib,Full Series,States/Local Areas,Missouri,2014-2015,Age,19 Months,71.9,66.5 to 76.8,476
Hib,Full Series,States/Local Areas,Missouri,2013,Age,19 Months,69.2,60.4 to 76.8,208
Hib,Full Series,States/Local Areas,Missouri,2013-2014,Age,19 Months,70.2,65.2 to 74.7,449
Hib,Full Series,States/Local Areas,Missouri,2012,Age,19 Months,72.1,69.2 to 74.9,274
Hib,Full Series,States/Local Areas,Missouri,2011,Age,19 Months,69.8,66.7 to 72.7,228
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,81.0,75.1 to 86.9,251
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,64.7,58.4 to 71.0,381
Hib,Full Series,States/Local Areas,Missouri,2015,Age,19 Months,72.7,71.8 to 73.6,235
Hib,Full Series,States/Local Areas,Missouri,2015-2016,Age,19 Months,68.5,62.5 to 73.9,473
Hib,Full Series,States/Local Areas,Missouri,2019,Age,19 Months,68.5,61.6 to 74.7,402
Hib,Full Series,States/Local Areas,Missouri,2018,Age,19 Months,73.0,66.4 to 78.8,416
Hib,Full Series,States/Local Areas,Missouri,2018-2019,Age,19 Months,95.1,92.4 to 96.8,818
Hib,Full Series,States/Local Areas,Missouri,2017,Age,19 Months,72.1,65.5 to 77.9,384
Hib,Full Series,States/Local Areas,Missouri,2017-2018,Age,19 Months,72.6,68.0 to 76.7,800
Hib,Full Series,States/Local Areas,Missouri,2014,Age,24 Months,76.6,69.5 to 83.0,241
Hib,Full Series,States/Local Areas,Missouri,2014-2015,Age,24 Months,76.1,70.9 to 80.9,476
Hib,Full Series,States/Local Areas,Missouri,2013,Age,24 Months,74.8,66.3 to 82.6,208
Hib,Full Series,States/Local Areas,Missouri,2013-2014,Age,24 Months,75.7,70.2 to 80.8,449
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,65.3,52.4 to 78.2,82
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,66.2,60.0 to 72.4,382
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.0,67.1 to 78.8,336
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.6,64.1 to 73.2,662
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.0,48.3 to 71.8,97
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,46.5,29.3 to 63.7,54
Combined 7 Series,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",57.6,44.0 to 71.3,71
Combined 7 Series,,States/Local Areas,Missouri,2017,Age,35 Months,74.8,68.3 to 80.8,384
Combined 7 Series,,States/Local Areas,Missouri,2017-2018,Age,35 Months,76.1,71.4 to 80.5,800
Combined 7 Series,,States/Local Areas,Missouri,2016,Age,35 Months,61.8,53.3 to 70.5,238
Combined 7 Series,,States/Local Areas,Missouri,2016-2017,Age,35 Months,68.1,62.6 to 73.5,622
Combined 7 Series,,States/Local Areas,Missouri,2012,Age,35 Months,74.8,65.9 to 83.0,274
Combined 7 Series,,States/Local Areas,Missouri,2013,Age,35 Months,66.8,57.2 to 76.2,208
Combined 7 Series,,States/Local Areas,Missouri,2013-2014,Age,35 Months,71.2,65.0 to 77.1,449
Combined 7 Series,,States/Local Areas,Missouri,2014,Age,35 Months,75.7,67.8 to 82.9,241
Combined 7 Series,,States/Local Areas,Missouri,2014-2015,Age,35 Months,76.2,70.2 to 81.8,476
Combined 7 Series,,States/Local Areas,Missouri,2018,Age,24 Months,70.6,63.9 to 77.0,416
Combined 7 Series,,States/Local Areas,Missouri,2018-2019,Age,24 Months,67.3,62.5 to 72.0,818
Combined 7 Series,,States/Local Areas,Missouri,2017,Age,24 Months,70.0,63.7 to 76.2,384
Combined 7 Series,,States/Local Areas,Missouri,2017-2018,Age,24 Months,70.3,65.7 to 74.8,800
Combined 7 Series,,States/Local Areas,Missouri,2014,Age,24 Months,67.3,59.9 to 74.6,241
Combined 7 Series,,States/Local Areas,Missouri,2014-2015,Age,24 Months,67.9,62.5 to 73.2,476
Hib,Primary Series,States/Local Areas,Missouri,2019,Age,35 Months,88.7,83.3 to 93.0,402
Combined 7 Series,,States/Local Areas,Missouri,2016,Age,24 Months,58.3,50.0 to 66.9,238
Combined 7 Series,,States/Local Areas,Missouri,2016-2017,Age,24 Months,64.1,58.7 to 69.5,622
Hib,Primary Series,States/Local Areas,Missouri,2014,Age,24 Months,93.8,89.7 to 96.6,241
Hib,Primary Series,States/Local Areas,Missouri,2014-2015,Age,24 Months,92.8,89.5 to 95.3,476
Hib,Primary Series,States/Local Areas,Missouri,2015,Age,24 Months,91.7,86.3 to 95.5,235
Hib,Primary Series,States/Local Areas,Missouri,2015-2016,Age,24 Months,89.7,86.0 to 92.8,473
Hib,Full Series,States/Local Areas,Missouri,2011,Age,24 Months,75.1,66.8 to 82.7,228
Hib,Full Series,States/Local Areas,Missouri,2012,Age,24 Months,83.8,76.7 to 89.6,274
Hib,Primary Series,States/Local Areas,Missouri,2012,Age,19 Months,92.4,87.1 to 95.6,274
Combined 7 Series,,States/Local Areas,Missouri,2011,Age,35 Months,70.7,60.8 to 79.9,228
Combined 7 Series,,States/Local Areas,Missouri,2019,Age,24 Months,63.8,57.0 to 70.7,402
Combined 7 Series,,States/Local Areas,Missouri,2012,Age,24 Months,68.8,60.4 to 76.9,274
Combined 7 Series,,States/Local Areas,Missouri,2013,Age,24 Months,57.8,48.9 to 67.0,208
Combined 7 Series,,States/Local Areas,Missouri,2013-2014,Age,24 Months,62.5,56.7 to 68.4,449
Rotavirus,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,59.1,42.5 to 75.6,54
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,79.4,69.0 to 89.9,107
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,85.1 to 98.6,128
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,79.2,62.5 to 95.9,107
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,70.2,64.3 to 76.1,413
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,Hispanic,74.0,62.2 to 85.7,107
Hib,Primary Series,States/Local Areas,Missouri,2014,Age,13 Months,88.8,83.1 to 92.7,241
Hib,Primary Series,States/Local Areas,Missouri,2014-2015,Age,13 Months,87.5,83.3 to 90.7,476
Hib,Primary Series,States/Local Areas,Missouri,2015,Age,13 Months,86.2,79.5 to 90.9,235
Hib,Primary Series,States/Local Areas,Missouri,2015-2016,Age,13 Months,83.6,78.6 to 87.7,473
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Poverty,>400% FPL,96.7,94.2 to 99.2,401
Hep B,≥2 Doses,States/Local Areas,Missouri,2019-2020,Age,7 Months,92.4,89.4 to 94.6,792
Hib,Primary Series,States/Local Areas,Missouri,2019-2020,Age,7 Months,72.6,68.0 to 76.9,792
Hib,Primary Series,States/Local Areas,Missouri,2018,Age,35 Months,96.3,90.5 to 99.0,416
Hib,Primary Series,States/Local Areas,Missouri,2018-2019,Age,35 Months,92.5,88.4 to 95.5,818
Combined 7 Series,,States/Local Areas,Missouri,2015,Age,24 Months,68.4,60.5 to 76.1,235
Combined 7 Series,,States/Local Areas,Missouri,2015-2016,Age,24 Months,63.5,57.6 to 69.4,473
Hib,Primary Series,States/Local Areas,Missouri,2016,Age,24 Months,87.8,82.2 to 92.3,238
Hib,Primary Series,States/Local Areas,Missouri,2016-2017,Age,24 Months,89.6,86.1 to 92.5,622
Hib,Primary Series,States/Local Areas,Missouri,2018,Age,24 Months,93.0,88.3 to 96.3,416
Hib,Primary Series,States/Local Areas,Missouri,2018-2019,Age,24 Months,90.6,87.1 to 93.4,818
Combined 7 Series,,States/Local Areas,Missouri,2011,Age,24 Months,60.1,51.4 to 69.0,228
Hib,Primary Series,States/Local Areas,Missouri,2017,Age,24 Months,91.5,87.0 to 94.9,384
Hib,Primary Series,States/Local Areas,Missouri,2017-2018,Age,24 Months,92.3,89.2 to 94.8,800
Hib,Primary Series,States/Local Areas,Missouri,2019,Age,24 Months,88.1,82.7 to 92.5,402
Hib,Primary Series,States/Local Areas,Missouri,2013,Age,35 Months,94.2,87.9 to 97.8,208
Hib,Primary Series,States/Local Areas,Missouri,2013-2014,Age,35 Months,93.8,90.4 to 96.3,449
Hib,Primary Series,States/Local Areas,Missouri,2011,Age,35 Months,93.2,87.5 to 97.0,228
Hib,Primary Series,States/Local Areas,Missouri,2014,Age,35 Months,93.8,89.7 to 96.6,241
Hib,Primary Series,States/Local Areas,Missouri,2014-2015,Age,35 Months,92.8,89.5 to 95.3,476
Hib,Primary Series,States/Local Areas,Missouri,2012,Age,35 Months,94.4,89.7 to 97.4,274
Hib,Primary Series,States/Local Areas,Missouri,2015,Age,35 Months,91.7,86.3 to 95.5,235
Hib,Primary Series,States/Local Areas,Missouri,2015-2016,Age,35 Months,89.9,86.2 to 93.0,473
Hib,Primary Series,States/Local Areas,Missouri,2017,Age,35 Months,92.4,87.8 to 95.7,384
Hib,Primary Series,States/Local Areas,Missouri,2017-2018,Age,35 Months,93.8,90.4 to 96.3,800
Hib,Primary Series,States/Local Areas,Missouri,2019,Age,13 Months,81.0,74.5 to 86.2,402
Hib,Primary Series,States/Local Areas,Missouri,2016,Age,35 Months,88.1,82.5 to 92.5,238
Hib,Primary Series,States/Local Areas,Missouri,2016-2017,Age,35 Months,90.1,86.5 to 93.0,622
Hib,Primary Series,States/Local Areas,Missouri,2013,Age,19 Months,90.0,86.5 to 92.7,208
Hib,Primary Series,States/Local Areas,Missouri,2013-2014,Age,19 Months,90.9,88.0 to 93.2,449
Hib,Primary Series,States/Local Areas,Missouri,2016,Age,13 Months,81.0,73.4 to 86.9,238
Hib,Primary Series,States/Local Areas,Missouri,2016-2017,Age,13 Months,84.1,79.5 to 87.9,622
Hib,Primary Series,States/Local Areas,Missouri,2017,Age,13 Months,87.4,81.9 to 91.3,384
Hib,Primary Series,States/Local Areas,Missouri,2017-2018,Age,13 Months,86.7,82.8 to 89.8,800
Hib,Primary Series,States/Local Areas,Missouri,2014,Age,19 Months,91.8,87.0 to 95.0,241
Hib,Primary Series,States/Local Areas,Missouri,2014-2015,Age,19 Months,90.8,87.0 to 93.5,476
Hib,Primary Series,States/Local Areas,Missouri,2011,Age,19 Months,90.4,86.8 to 93.1,228
Hib,Primary Series,States/Local Areas,Missouri,2018,Age,13 Months,86.0,80.0 to 90.4,416
Hib,Primary Series,States/Local Areas,Missouri,2018-2019,Age,13 Months,83.5,79.3 to 87.1,818
Hib,Primary Series,States/Local Areas,Missouri,2017,Age,19 Months,89.8,84.6 to 93.4,384
Hib,Primary Series,States/Local Areas,Missouri,2017-2018,Age,19 Months,91.4,88.0 to 93.9,800
Hib,Primary Series,States/Local Areas,Missouri,2018,Age,19 Months,93.0,87.8 to 96.1,416
Hib,Primary Series,States/Local Areas,Missouri,2018-2019,Age,19 Months,83.5,79.3 to 87.1,818
Hib,Primary Series,States/Local Areas,Missouri,2014,Age,7 Months,66.8,58.8 to 74.0,241
Hib,Primary Series,States/Local Areas,Missouri,2014-2015,Age,7 Months,66.9,61.3 to 72.1,476
Hib,Primary Series,States/Local Areas,Missouri,2015,Age,7 Months,66.9,58.9 to 74.1,235
Hib,Primary Series,States/Local Areas,Missouri,2015-2016,Age,7 Months,67.6,61.7 to 72.9,473
Hib,Primary Series,States/Local Areas,Missouri,2019,Age,19 Months,87.6,81.8 to 91.7,402
DTaP,≥3 Doses,States/Local Areas,Missouri,2020,Age,13 Months,91.8,87.2 to 94.8,390
Hib,Primary Series,States/Local Areas,Missouri,2015,Age,19 Months,89.7,88.4 to 90.9,235
Hib,Primary Series,States/Local Areas,Missouri,2015-2016,Age,19 Months,88.5,84.4 to 91.6,473
Hib,Primary Series,States/Local Areas,Missouri,2016,Age,19 Months,87.3,81.3 to 91.6,238
Hib,Primary Series,States/Local Areas,Missouri,2016-2017,Age,19 Months,88.5,84.7 to 91.5,622
Hib,Primary Series,States/Local Areas,Missouri,2016,Age,7 Months,68.2,59.7 to 75.7,238
Hib,Primary Series,States/Local Areas,Missouri,2016-2017,Age,7 Months,68.9,63.5 to 73.8,622
Hib,Primary Series,States/Local Areas,Missouri,2017,Age,7 Months,69.5,62.9 to 75.5,384
Hib,Primary Series,States/Local Areas,Missouri,2017-2018,Age,7 Months,71.5,66.7 to 75.8,800
Hib,Primary Series,States/Local Areas,Missouri,2012,Age,24 Months,92.9,88.0 to 96.3,274
Hib,Primary Series,States/Local Areas,Missouri,2011,Age,24 Months,93.2,87.5 to 97.0,228
Hib,Primary Series,States/Local Areas,Missouri,2013,Age,24 Months,91.4,85.4 to 95.6,208
Hib,Primary Series,States/Local Areas,Missouri,2013-2014,Age,24 Months,92.6,89.1 to 95.3,449
Hib,Primary Series,States/Local Areas,Missouri,2019,Age,7 Months,66.1,58.9 to 72.5,402
Hib,Primary Series,States/Local Areas,Missouri,2018,Age,7 Months,73.4,66.4 to 79.3,416
Hib,Primary Series,States/Local Areas,Missouri,2018-2019,Age,7 Months,69.7,64.8 to 74.2,818
Hib,Primary Series,States/Local Areas,Missouri,2013,Age,7 Months,61.0,55.1 to 66.6,208
Hib,Primary Series,States/Local Areas,Missouri,2013-2014,Age,7 Months,64.0,60.6 to 67.2,449
Hib,Primary Series,States/Local Areas,Missouri,2013,Age,13 Months,81.6,78.5 to 84.3,208
Hib,Primary Series,States/Local Areas,Missouri,2013-2014,Age,13 Months,85.2,80.3 to 89.1,449
Hib,Primary Series,States/Local Areas,Missouri,2012,Age,13 Months,87.6,84.6 to 90.0,274
Hib,Primary Series,States/Local Areas,Missouri,2011,Age,13 Months,87.6,81.8 to 91.8,228
Rotavirus,,States/Local Areas,Missouri,2018,Age,8 Months,80.4,73.9 to 85.7,416
Rotavirus,,States/Local Areas,Missouri,2018-2019,Age,8 Months,72.8,68.0 to 77.2,818
Rotavirus,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.8,61.0 to 82.6,97
Rotavirus,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,73.5,61.9 to 85.0,82
Rotavirus,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.1,59.3 to 82.9,71
Rotavirus,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,66.0,59.7 to 72.2,331
Rotavirus,,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,85.6,80.2 to 91.0,251
Rotavirus,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,79.6,75.1 to 84.1,509
Rotavirus,,States/Local Areas,Missouri,2017,Age,8 Months,71.9,65.2 to 77.7,384
Rotavirus,,States/Local Areas,Missouri,2017-2018,Age,8 Months,76.2,71.6 to 80.2,800
Rotavirus,,States/Local Areas,Missouri,2019,Age,8 Months,65.1,58.0 to 71.7,402
Rotavirus,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,72.8,67.0 to 78.7,382
Rotavirus,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.1,67.6 to 76.6,662
Rotavirus,,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,63.8,57.0 to 70.6,280
Rotavirus,,States/Local Areas,Missouri,2014-2017,Overall,Overall,72.1,68.3 to 75.8,912
Rotavirus,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,63.0,54.3 to 71.7,194
Rotavirus,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.7,70.0 to 81.5,336
Rotavirus,,States/Local Areas,Missouri,2011,Age,8 Months,69.6,61.0 to 77.0,228
Rotavirus,,States/Local Areas,Missouri,2014,Age,8 Months,74.5,67.0 to 80.8,241
Rotavirus,,States/Local Areas,Missouri,2014-2015,Age,8 Months,71.6,66.2 to 76.5,476
Rotavirus,,States/Local Areas,Missouri,2012,Age,8 Months,77.3,69.2 to 83.8,274
Rotavirus,,States/Local Areas,Missouri,2013,Age,8 Months,65.7,56.8 to 73.6,208
Rotavirus,,States/Local Areas,Missouri,2013-2014,Age,8 Months,70.1,64.3 to 75.4,449
Rotavirus,,States/Local Areas,Missouri,2015,Age,8 Months,68.7,60.5 to 75.9,235
Rotavirus,,States/Local Areas,Missouri,2015-2016,Age,8 Months,68.6,62.8 to 73.9,473
Rotavirus,,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,72.5,66.7 to 78.4,381
Rotavirus,,States/Local Areas,Missouri,2016,Age,8 Months,68.5,60.2 to 75.7,238
Rotavirus,,States/Local Areas,Missouri,2016-2017,Age,8 Months,70.1,64.8 to 74.9,622
Hib,Full Series,States/Local Areas,Missouri,2020-2021,Age,19 Months,73.4,68.4 to 77.9,657
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Missouri,2020-2021,Age,0-2 Days,84.1,80.0 to 87.4,657
≥1 Dose MMR,,States/Local Areas,Missouri,2021,Age,19 Months,90.8,85.5 to 94.3,267
≥1 Dose Varicella,,States/Local Areas,Missouri,2021,Age,13 Months,55.5,47.6 to 63.1,267
Polio,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,93.4,90.5 to 95.5,657
DTaP,≥2 Doses,States/Local Areas,Missouri,2021,Age,5 Months,82.3,75.2 to 87.7,267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2020-2021,Age,0-3 Days,85.0,81.1 to 88.2,657
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.9,59.9 to 93.8,91
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Missouri,2020-2021,Age,0-1 Days,81.1,76.8 to 84.8,657
Hib,Full Series,States/Local Areas,Missouri,2020-2021,Age,35 Months,84.7,79.4 to 89.3,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,90.9,87.5 to 93.5,657
PCV,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,73.6,68.4 to 78.2,657
Polio,≥3 Doses,States/Local Areas,Missouri,2021,Age,19 Months,91.3,86.0 to 94.8,267
≥1 Dose MMR,,States/Local Areas,Missouri,2020-2021,Age,13 Months,67.6,62.4 to 72.3,657
Hep B,≥3 Doses,States/Local Areas,Missouri,2021,Age,13 Months,89.7,84.4 to 93.4,267
Polio,≥2 Doses,States/Local Areas,Missouri,2021,Age,5 Months,82.0,74.9 to 87.5,267
Influenza,,States/Local Areas,Missouri,2018,Age,24 Months,63.9,56.9 to 70.9,416
Influenza,,States/Local Areas,Missouri,2018-2019,Age,24 Months,59.2,54.2 to 64.2,818
Influenza,,States/Local Areas,Missouri,2017,Age,24 Months,53.1,46.5 to 60.0,384
Influenza,,States/Local Areas,Missouri,2017-2018,Age,24 Months,58.4,53.6 to 63.3,800
Hib,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,87.5,83.3 to 90.7,657
Combined 7 Series,,States/Local Areas,Missouri,2021,Age,24 Months,67.4,59.0 to 75.6,267
Influenza,,States/Local Areas,Missouri,2019,Age,24 Months,54.4,47.7 to 61.4,402
Influenza,,States/Local Areas,Missouri,2016,Age,24 Months,53.6,45.4 to 62.3,238
Influenza,,States/Local Areas,Missouri,2016-2017,Age,24 Months,53.4,48.0 to 59.0,622
Hib,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,94.0,89.4 to 97.1,657
Hep A,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,19 Months,84.7,80.5 to 88.1,657
Hib,Primary Series,States/Local Areas,Missouri,2020-2021,Age,35 Months,94.0,90.7 to 96.4,657
Hib,Primary Series,States/Local Areas,Missouri,2020-2021,Age,19 Months,92.5,89.5 to 94.8,657
PCV,≥1 Dose,States/Local Areas,Missouri,2021,Age,3 Months,89.5,83.8 to 93.4,267
Hep B,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,19 Months,92.3,89.2 to 94.6,657
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,77.5,72.1 to 82.9,413
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,88.6,85.2 to 92.0,793
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.1,62.9 to 83.3,128
Influenza,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,57.6,51.2 to 64.0,382
Influenza,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",54.8,49.8 to 59.7,662
Influenza,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,29.7,21.9 to 37.4,194
Influenza,,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,54.3,47.6 to 61.0,336
Influenza,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",50.6,38.6 to 62.7,97
Influenza,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,51.3,38.0 to 64.6,82
Influenza,,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",32.7,20.9 to 44.5,71
Influenza,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,12.4,2.9 to 21.9,54
Influenza,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,42.1,35.7 to 48.5,331
Hep A,≥2 Doses,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.2,49.3 to 75.1,128
Influenza,,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,65.1,59.6 to 70.6,509
PCV,≥4 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,87.7,84.3 to 91.1,793
Hep A,≥1 Dose,States/Local Areas,Missouri,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.6,77.9 to 93.4,128
Polio,≥2 Doses,States/Local Areas,Missouri,2021,Age,13 Months,93.1,88.1 to 96.1,267
Hep A,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,35 Months,80.1,73.2 to 86.2,657
Polio,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,3 Months,90.0,86.5 to 92.7,657
≥1 Dose MMR,,States/Local Areas,Missouri,2020-2021,Age,19 Months,90.5,87.1 to 93.1,657
Influenza,,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,75.3,68.4 to 82.2,251
Influenza,,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,48.6,42.2 to 55.1,381
Influenza,,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,40.3,33.4 to 47.2,280
Influenza,,States/Local Areas,Missouri,2014-2017,Overall,Overall,51.1,47.0 to 55.2,912
Hib,Full Series,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,84.4,80.8 to 88.1,793
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Any Medicaid,83.0,78.3 to 87.8,413
PCV,≥3 Doses,States/Local Areas,Missouri,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.4 to 97.6,793
Influenza,,States/Local Areas,Missouri,2021,Age,24 Months,47.5,40.0 to 55.6,267
Hib,Full Series,States/Local Areas,Missouri,2020-2021,Age,24 Months,79.3,74.6 to 83.6,657
Hep B,≥1 Dose,States/Local Areas,Missouri,2021,Age,3 Months,94.5,90.2 to 97.0,267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Missouri,2021,Age,0-3 Days,85.4,79.4 to 89.9,267
Hib,≥3 Doses,States/Local Areas,Missouri,2021,Age,35 Months,88.9,83.3 to 93.3,267
PCV,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,3 Months,89.4,85.9 to 92.2,657
≥1 Dose Varicella,,States/Local Areas,Missouri,2020-2021,Age,13 Months,59.0,53.8 to 64.0,657
Hep B,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,3 Months,95.2,92.8 to 96.9,657
Hib,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,91.0,87.8 to 93.5,657
DTaP,≥2 Doses,States/Local Areas,Missouri,2020-2021,Age,5 Months,80.8,76.1 to 84.8,657
Hib,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,13 Months,72.2,67.2 to 76.6,657
Hep A,≥1 Dose,States/Local Areas,Missouri,2020-2021,Age,24 Months,86.6,82.6 to 90.1,657
≥1 Dose MMR,,States/Local Areas,Missouri,2021,Age,13 Months,67.0,59.1 to 74.1,267
Hib,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,7 Months,53.1,47.8 to 58.4,657
DTaP,≥3 Doses,States/Local Areas,Missouri,2021,Age,24 Months,92.0,87.1 to 95.5,267
Polio,≥3 Doses,States/Local Areas,Missouri,2020-2021,Age,24 Months,92.9,89.9 to 95.3,657
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,89.9,83.9 to 93.9,214
Hib,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,96.0,90.8 to 98.3,225
Hib,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,95.5,91.2 to 97.8,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,95.5,92.3 to 97.5,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,95.5,91.2 to 97.7,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,90.9,84.5 to 94.8,223
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,91.1,87.2 to 93.9,454
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,91.4,86.3 to 94.7,231
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,91.7,88.1 to 94.3,475
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,92.0,86.1 to 95.6,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,93.7,90.4 to 95.9,513
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,96.2,92.5 to 98.1,269
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,93.1,89.6 to 95.5,483
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,89.9,83.9 to 93.9,214
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,98.1,96.6 to 98.9,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,96.4,94.2 to 97.7,222
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,97.1,95.7 to 98.1,441
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,96.3,90.5 to 98.6,225
Polio,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,95.4,93.7 to 96.6,222
Polio,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,96.3,95.1 to 97.2,441
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,97.2,93.4 to 98.8,219
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,96.1,93.5 to 97.7,442
Polio,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,95.3,86.7 to 98.5,225
Polio,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,95.1,93.7 to 96.2,223
Polio,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,94.6,91.5 to 96.6,454
Polio,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,96.4,92.8 to 98.2,269
Polio,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,71.1,65.8 to 75.8,483
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,95.4,91.7 to 97.5,269
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,92.7,89.2 to 95.1,483
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,94.0,89.2 to 96.8,231
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,95.4,92.4 to 97.3,475
Polio,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,96.7,91.7 to 98.7,244
Polio,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,96.6,93.9 to 98.1,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,74.1,68.2 to 80.0,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,72.0,66.3 to 77.7,329
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,90.4,83.2 to 94.7,223
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,91.3,87.0 to 94.2,454
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,95.6,91.5 to 97.8,225
Hib,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,97.8,94.5 to 99.1,269
Hib,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,96.8,94.5 to 98.2,483
Hib,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,96.5,90.9 to 98.7,244
Hib,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,97.1,94.3 to 98.6,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,88.2,81.6 to 94.8,173
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,95.0,93.1 to 96.9,817
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,96.0,93.5 to 98.5,344
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.3,94.1 to 98.5,328
Hib,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,95.8,91.7 to 97.9,214
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,94.5,91.0 to 96.7,222
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,93.0,91.2 to 94.6,441
Polio,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,96.0,94.4 to 97.2,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,97.6,95.9 to 99.3,315
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,96.3,94.1 to 98.5,329
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,91.5,85.8 to 95.1,219
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,91.2,87.2 to 94.0,442
Hib,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,94.5,89.3 to 97.3,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,94.9,91.8 to 96.8,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,71.9,63.6 to 80.1,173
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,76.2,68.4 to 82.5,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,90.5,84.0 to 97.1,145
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.1,94.3 to 97.9,659
Hib,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,97.1,92.8 to 98.9,189
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,94.6,91.3 to 96.6,222
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,94.8,92.6 to 96.4,441
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,95.1,90.4 to 97.6,219
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,92.8,88.7 to 95.4,442
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,72.4,66.5 to 78.2,344
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Overall,Overall,72.8,69.1 to 76.4,817
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,71.6,62.6 to 80.7,145
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.7,68.2 to 79.2,328
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.5,68.4 to 76.6,659
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.5,63.3 to 85.8,82
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,79.3,67.3 to 91.3,60
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,92.2,87.0 to 95.4,231
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,94.3,91.1 to 96.4,475
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,96.4,91.5 to 98.5,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,96.3,93.6 to 97.9,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,95.0,89.5 to 98.1,225
Hib,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,93.7,88.4 to 96.7,214
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,78.9,71.7 to 84.7,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,80.8,76.2 to 84.7,513
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,82.7,76.5 to 87.6,269
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,79.5,74.6 to 83.7,483
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,90.5 to 100.0,82
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,91.4,83.3 to 99.4,60
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,92.6,88.7 to 96.5,286
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.9 to 98.9,484
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,92.5,86.9 to 96.4,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2018,Age,0-3 Days,85.4,79.4 to 89.9,269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2018-2019,Age,0-3 Days,86.3,82.1 to 89.6,483
Polio,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,3 Months,91.5,86.1 to 94.9,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2019,Age,0-3 Days,87.1,80.6 to 91.7,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,74.5,69.9 to 79.1,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,70.2,63.8 to 76.7,286
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,84.2,78.0 to 88.9,269
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,80.6,75.7 to 84.7,483
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,76.9,69.2 to 83.2,214
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,83.6,77.0 to 88.7,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,83.9,79.5 to 87.5,513
Hib,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,96.3,90.5 to 98.6,225
Hib,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,95.8,91.7 to 97.9,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,79.6,72.1 to 85.6,223
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,78.4,73.2 to 82.9,454
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,74.1,66.5 to 80.5,219
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,76.9,71.7 to 81.4,442
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2015,Age,0-3 Days,71.3,63.2 to 78.2,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2015-2016,Age,0-3 Days,71.3,65.7 to 76.2,454
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,77.2,69.6 to 83.3,231
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,80.5,75.6 to 84.6,475
Hib,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,95.6,91.9 to 97.6,222
Hib,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,96.9,94.4 to 98.3,441
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,97.0,92.8 to 99.1,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,98.4,95.6 to 99.6,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,99.3,96.5 to 99.9,269
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,96.6,92.9 to 98.7,483
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,72.0,64.3 to 78.5,219
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,75.8,70.6 to 80.3,442
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,79.5,72.4 to 85.2,223
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,77.5,72.4 to 81.9,454
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,75.4,67.8 to 81.7,231
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,77.2,72.1 to 81.6,475
Polio,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,3 Months,96.9,92.0 to 98.8,244
Polio,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,3 Months,96.7,94.1 to 98.2,513
Polio,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,3 Months,96.5,93.1 to 98.3,269
Polio,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,3 Months,94.0,91.0 to 96.1,483
Hib,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,95.6,90.0 to 98.1,223
Hib,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,95.1,91.8 to 97.1,454
Hib,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,94.6,90.1 to 97.1,231
Hib,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,95.6,92.5 to 97.4,475
Hib,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,98.2,94.9 to 99.4,219
Hib,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,96.9,93.9 to 98.4,442
PCV,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,3 Months,86.3,80.9 to 90.4,222
PCV,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,3 Months,86.8,83.5 to 89.5,441
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,81.5,69.5 to 93.6,60
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,81.5,75.8 to 87.1,286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2011,Age,0-3 Days,73.5,65.2 to 80.5,244
PCV,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,3 Months,95.3,91.8 to 97.4,269
PCV,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,3 Months,93.6,90.7 to 95.6,483
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,96.4,94.1 to 98.6,484
PCV,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,3 Months,91.3,86.0 to 94.7,231
PCV,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,3 Months,93.7,90.5 to 95.9,475
PCV,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,3 Months,96.1,91.2 to 98.3,244
PCV,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,3 Months,95.7,93.0 to 97.4,513
Hib,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,5 Months,88.7,83.3 to 92.5,269
Hib,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,5 Months,86.5,82.3 to 89.9,483
Hib,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,5 Months,84.3,77.4 to 89.4,214
Hib,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,94.2,88.9 to 97.1,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,91.3,86.4 to 94.9,231
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,94.2,91.2 to 96.4,475
Hib,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,95.3,90.5 to 97.8,225
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,97.0,92.8 to 99.1,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,96.9,94.5 to 98.4,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,96.8,93.7 to 98.6,269
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,94.6,91.6 to 96.9,483
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020,Age,24 Months,90.5,83.5 to 95.4,189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014,Age,0-3 Days,72.8,65.3 to 79.2,219
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2014-2015,Age,0-3 Days,72.1,66.7 to 76.9,442
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,72.8,68.8 to 76.4,222
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,73.4,69.2 to 77.3,441
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,79.0,75.6 to 82.1,225
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,78.5,69.4 to 85.4,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2013,Age,0-3 Days,65.9,57.6 to 73.3,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2013-2014,Age,0-3 Days,69.3,63.8 to 74.3,441
Polio,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,3 Months,89.0,84.4 to 92.4,222
Polio,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,3 Months,90.4,87.7 to 92.5,441
PCV,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,3 Months,91.8,86.7 to 95.0,214
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,94.2,92.1 to 96.4,817
Polio,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,3 Months,92.6,87.5 to 95.7,225
Polio,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,3 Months,91.3,87.3 to 94.2,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.1,87.4 to 92.9,659
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,69.8 to 91.0,82
PCV,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,3 Months,87.3,81.2 to 91.6,219
PCV,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,3 Months,89.3,85.1 to 92.4,442
PCV,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,3 Months,91.3,84.6 to 95.3,223
PCV,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,3 Months,91.3,87.3 to 94.1,454
Hib,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,92.3,85.9 to 95.9,223
Hib,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,92.0,88.1 to 94.6,454
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,92.5,86.9 to 96.4,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,95.2,90.8 to 97.9,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,93.0,87.8 to 96.5,222
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,95.4,92.6 to 97.4,441
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,90.1,83.4 to 96.9,145
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,92.4,88.5 to 96.4,286
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,92.6,89.9 to 95.3,484
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,94.8 to 98.2,659
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,96.4,94.0 to 98.8,344
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.1,90.9 to 97.3,328
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,86.4 to 99.7,82
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,84.8,73.0 to 96.6,60
Hib,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,96.3,92.4 to 98.2,269
Hib,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,95.0,92.0 to 96.9,483
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,98.0,95.3 to 99.3,219
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,97.5,95.4 to 98.8,442
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,96.9,93.3 to 98.9,223
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,94.6,91.7 to 96.7,454
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,92.2,87.4 to 95.6,231
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,94.7,91.7 to 96.8,475
Hib,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,91.6,86.6 to 94.9,231
Hib,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,93.9,90.7 to 96.1,475
Hib,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,96.1,90.7 to 98.5,244
Hib,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,96.2,93.3 to 97.9,513
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,87.4,80.6 to 94.1,173
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,96.7,94.0 to 99.4,315
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,95.8,93.3 to 98.3,329
Hib,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,74.5,71.2 to 77.5,225
Hib,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,76.1,66.3 to 83.7,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,68.9,64.3 to 73.1,222
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,70.4,65.8 to 74.6,441
Polio,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,3 Months,91.8,86.4 to 95.2,219
Polio,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,3 Months,92.4,88.5 to 95.0,442
Polio,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,3 Months,92.9,86.7 to 96.4,223
Polio,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,3 Months,92.3,88.5 to 94.9,454
Polio,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,3 Months,91.6,86.2 to 95.0,231
Polio,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,3 Months,94.3,91.1 to 96.4,475
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2017,Age,0-3 Days,83.3,72.5 to 90.4,141
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2017-2018,Age,0-3 Days,84.0,79.7 to 87.6,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016,Age,0-3 Days,71.3,63.3 to 78.0,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2017,Age,0-3 Days,77.1,72.0 to 81.5,475
Hib,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,3 Months,90.5,87.3 to 93.0,222
Hib,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,3 Months,90.5,87.6 to 92.8,441
Hib,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,3 Months,92.1,86.8 to 95.4,225
Hib,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,3 Months,91.4,85.0 to 95.2,244
Hib,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,3 Months,90.5,85.0 to 94.1,219
Hib,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,3 Months,90.1,85.9 to 93.1,442
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,96.9,92.4 to 98.7,219
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,96.3,93.3 to 98.0,442
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,95.8,90.5 to 98.2,223
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,94.7,91.6 to 96.8,454
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,93.6,88.9 to 96.4,231
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,96.1,93.6 to 97.6,475
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,88.6,82.1 to 93.0,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,95.2,89.1 to 97.9,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,91.4,89.7 to 92.8,222
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,94.2,92.1 to 95.8,441
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,97.1,93.2 to 98.8,219
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,96.8,94.3 to 98.2,442
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,94.1,89.5 to 97.2,231
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,96.4,93.9 to 98.1,475
PCV,≥4 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,82.5,75.5 to 88.5,214
PCV,≥4 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,92.0,87.4 to 95.5,269
PCV,≥4 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,87.4,83.2 to 91.0,483
PCV,≥4 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,89.5,83.8 to 93.8,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,89.0,82.3 to 94.0,225
PCV,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,93.4,88.7 to 96.2,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,98.4,96.1 to 99.5,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,96.7,94.7 to 98.1,513
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,94.8,90.5 to 97.2,214
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,94.7,91.0 to 96.9,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,94.9,93.0 to 96.3,222
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,95.9,93.4 to 97.4,441
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,93.6,83.8 to 97.7,225
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,95.5,90.6 to 97.9,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,95.3,92.4 to 97.1,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,95.0,91.0 to 97.3,269
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,91.9,88.1 to 94.5,483
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,92.9,87.6 to 96.4,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,93.5,87.7 to 97.2,223
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,93.8,90.2 to 96.5,454
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,95.4,91.2 to 98.0,219
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,94.4,91.0 to 96.8,442
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,96.7,93.3 to 98.6,222
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,96.0,93.5 to 97.8,441
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,89.9,84.5 to 93.6,231
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,92.8,89.4 to 95.1,475
Hib,Full Series,States/Local Areas,New Hampshire,2020,Age,24 Months,87.1,79.9 to 92.7,189
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014,Age,35 Months,95.6,91.5 to 98.1,219
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,95.6,92.8 to 97.5,442
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015,Age,35 Months,95.7,91.3 to 98.3,223
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,94.2,90.8 to 96.7,454
PCV,≥4 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,92.8,88.0 to 96.2,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,92.4,89.2 to 95.0,513
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,85.3,79.3 to 90.3,231
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,89.2,85.4 to 92.3,475
PCV,≥4 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,88.5,82.5 to 93.2,223
PCV,≥4 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,87.0,82.8 to 90.5,454
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016,Age,35 Months,92.5,86.8 to 96.4,231
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,95.6,92.6 to 97.6,475
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019,Age,35 Months,95.5,91.6 to 97.9,214
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,91.8,88.1 to 95.4,286
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,92.4,89.6 to 95.3,484
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017,Age,35 Months,95.3,88.9 to 98.6,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,96.5,93.3 to 98.5,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2017,Age,0-2 Days,80.2,73.4 to 85.6,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2017-2018,Age,0-2 Days,81.7,77.3 to 85.5,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2018,Age,0-2 Days,83.3,77.1 to 88.1,269
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2018-2019,Age,0-2 Days,84.0,79.5 to 87.6,483
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2019,Age,0-2 Days,84.7,77.8 to 89.7,214
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,96.8,93.5 to 98.4,269
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,95.8,93.3 to 97.4,483
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016,Age,35 Months,88.0,81.0 to 93.3,231
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,91.7,87.3 to 95.1,475
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013,Age,35 Months,93.1,86.4 to 97.2,222
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,94.0,90.4 to 96.7,441
≥1 Dose MMR,,States/Local Areas,New Hampshire,2011,Age,35 Months,95.7,92.0 to 98.0,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2012,Age,35 Months,96.1,91.9 to 98.5,225
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019,Age,24 Months,92.9,88.1 to 96.2,214
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,90.3,85.1 to 94.3,219
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,89.4,85.5 to 92.6,442
PCV,≥4 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,85.2,78.3 to 90.8,222
PCV,≥4 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,87.7,83.4 to 91.3,441
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,93.7,88.9 to 96.9,214
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,98.4,96.1 to 99.5,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,96.7,94.7 to 98.1,513
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,96.1,92.7 to 98.2,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,88.2,81.4 to 93.3,225
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,90.8,84.6 to 97.0,145
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,89.7 to 94.5,659
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.2,94.0 to 100.0,82
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019,Age,35 Months,96.2,92.5 to 98.4,214
PCV,≥4 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,86.9,79.9 to 92.3,222
PCV,≥4 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,88.9,84.6 to 92.5,441
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018,Age,35 Months,94.9,90.7 to 97.7,269
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,95.7,92.9 to 97.7,483
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017,Age,35 Months,98.4,96.0 to 99.5,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,96.6,94.3 to 98.2,513
Hib,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,3 Months,89.7,82.7 to 94.0,223
Hib,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,3 Months,90.4,86.3 to 93.4,454
Hib,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,3 Months,91.2,86.0 to 94.6,231
Hib,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,3 Months,93.2,89.9 to 95.5,475
Hib,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,3 Months,95.1,89.8 to 97.7,244
Hib,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,3 Months,95.3,92.4 to 97.1,513
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,98.4,95.7 to 99.4,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,97.8,96.0 to 98.8,513
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,97.2,94.0 to 98.7,269
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,96.9,94.7 to 98.2,483
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,96.6,93.0 to 98.4,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,96.5,94.5 to 97.7,223
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,93.9,90.8 to 96.0,454
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,91.3,86.0 to 94.7,231
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,94.2,91.0 to 96.3,475
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,92.6,84.3 to 96.7,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,91.5,86.5 to 94.8,269
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,91.5,88.0 to 94.1,483
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,91.5,85.7 to 95.0,214
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,94.0,89.5 to 96.7,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,97.8,90.0 to 99.8,269
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,89.1,83.4 to 93.5,483
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018,Age,35 Months,97.9,95.5 to 99.1,269
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,96.7,94.5 to 98.2,483
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,82.3,70.4 to 94.2,60
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,88.2,81.9 to 94.4,173
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,90.9,88.5 to 93.4,817
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,91.7,88.0 to 95.4,344
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.3,86.6 to 94.0,328
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,91.6,88.3 to 94.9,315
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,90.6,86.6 to 94.5,329
Hib,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,3 Months,95.5,91.8 to 97.5,269
Hib,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,3 Months,93.0,89.9 to 95.2,483
Hib,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,3 Months,90.5,85.0 to 94.2,214
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.0,95.5 to 100.0,82
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,86.6,76.0 to 97.3,60
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,96.2,94.4 to 98.0,484
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,92.5,89.0 to 96.1,286
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,86.9,80.9 to 91.8,231
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,90.9,87.1 to 94.0,475
PCV,≥4 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,89.5,83.4 to 94.0,223
PCV,≥4 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,88.2,84.0 to 91.7,454
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,91.1,85.9 to 94.9,219
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,90.2,86.4 to 93.4,442
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,95.0,91.5 to 97.4,269
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,95.0,92.3 to 97.1,483
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,95.1,90.6 to 97.9,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,96.5,93.0 to 98.5,223
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,93.9,91.0 to 96.2,454
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,98.0,95.3 to 99.3,219
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,97.3,95.2 to 98.6,442
PCV,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,93.9,88.1 to 97.5,225
Hib,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,5 Months,88.6,82.0 to 93.0,244
Hib,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,5 Months,88.7,84.6 to 91.7,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,92.5,87.3 to 96.1,222
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,95.2,92.3 to 97.2,441
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,93.0,89.9 to 96.1,315
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.7,89.5 to 95.9,328
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,85.5 to 97.4,145
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.6,92.7 to 96.5,659
Hib,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,5 Months,85.5,78.2 to 90.6,223
Hib,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,5 Months,83.3,78.4 to 87.3,454
Hib,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,5 Months,81.0,74.0 to 86.5,231
Hib,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,5 Months,84.9,80.4 to 88.6,475
PCV,≥4 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,95.1,89.8 to 98.1,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,93.8,90.7 to 96.2,513
PCV,≥4 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,93.1,88.9 to 96.2,269
PCV,≥4 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,89.3,85.2 to 92.7,483
PCV,≥4 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,85.2,78.0 to 91.0,214
PCV,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,3 Months,87.9,77.8 to 93.8,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,96.6,94.6 to 98.6,315
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,93.3,90.3 to 96.4,329
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,96.0,93.8 to 98.1,344
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,89.6,83.7 to 95.5,173
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,93.7,91.7 to 95.7,817
PCV,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,3 Months,87.6,82.9 to 91.2,225
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,96.8,93.3 to 98.5,269
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,91.9,88.1 to 94.5,483
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,89.8,83.2 to 93.9,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,95.2,90.8 to 97.9,244
Hib,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,5 Months,83.0,77.7 to 87.2,222
Hib,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,5 Months,82.9,78.8 to 86.4,441
Hib,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,5 Months,82.9,76.0 to 88.1,219
Hib,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,5 Months,84.2,81.7 to 86.4,442
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,97.0,91.9 to 98.9,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,96.9,94.3 to 98.4,513
Hib,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,5 Months,86.1,80.8 to 90.2,225
Hib,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,5 Months,86.6,79.2 to 91.6,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,93.3,90.2 to 96.5,315
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,88.7,84.7 to 92.7,329
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,75.7,67.4 to 84.0,173
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,89.7,85.7 to 93.7,344
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,87.4,84.6 to 90.3,817
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.6,84.6 to 92.6,328
Hib,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,92.2,87.4 to 95.3,222
Hib,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,93.9,90.7 to 96.0,441
Hib,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,95.7,91.9 to 97.7,219
Hib,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,94.0,90.5 to 96.2,442
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2012,Age,0-3 Days,73.5,65.6 to 80.2,225
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,80.7,72.4 to 89.1,145
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,88.4,84.3 to 92.6,329
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,75.6,67.3 to 83.9,173
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,88.9,84.6 to 93.1,344
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,85.9,82.8 to 88.9,817
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,51.4,44.2 to 58.9,269
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,45.3,40.0 to 51.0,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,50.8,43.2 to 58.9,244
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,51.1,45.8 to 56.6,513
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,43.0,35.6 to 51.3,231
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,47.0,41.6 to 52.8,475
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,84.0,77.5 to 89.4,222
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,87.3,83.3 to 90.8,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,35 Months,87.7,81.6 to 92.6,223
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,87.1,82.2 to 91.1,454
Polio,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,5 Months,86.8,80.8 to 91.1,225
Polio,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,5 Months,87.2,80.7 to 91.8,244
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,35 Months,92.7,86.5 to 96.7,225
Polio,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,5 Months,78.8,73.3 to 83.3,222
Polio,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,5 Months,81.2,77.2 to 84.6,441
Polio,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,5 Months,83.7,76.9 to 88.8,219
Polio,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,5 Months,85.5,83.3 to 87.5,442
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,89.9,83.6 to 96.2,173
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,98.2,96.8 to 99.6,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,97.2,95.0 to 99.3,329
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,80.2,73.6 to 85.5,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,63.8,58.9 to 68.4,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,72.3,67.4 to 76.7,222
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,75.8,70.3 to 80.5,441
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,71.8,63.6 to 78.7,214
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,90.2,85.1 to 94.1,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,91.0,86.0 to 94.7,225
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,35 Months,83.7,76.4 to 89.7,222
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,87.2,82.9 to 90.9,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,35 Months,91.2,86.4 to 94.8,219
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,89.6,85.7 to 92.8,442
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,95.9,94.1 to 97.8,817
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,45.9,38.2 to 54.3,223
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,44.5,39.1 to 50.4,454
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,40.2,32.7 to 48.6,219
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,43.0,37.6 to 48.9,442
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,94.0,89.1 to 97.2,214
PCV,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,5 Months,88.0,82.6 to 91.9,269
PCV,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,5 Months,86.7,82.5 to 90.0,483
PCV,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,5 Months,85.3,78.6 to 90.2,214
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,89.9,83.0 to 96.8,145
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.1,95.5 to 98.7,659
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,97.9,96.1 to 99.7,344
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.1,95.1 to 99.1,328
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.0,90.9 to 100.0,82
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,93.1,85.4 to 100.0,60
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,77.8,70.3 to 83.8,231
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,81.9,77.2 to 85.9,475
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,85.9,79.8 to 90.4,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,85.0,80.9 to 88.4,513
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,84.2,78.2 to 88.7,269
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,97.1,94.8 to 98.4,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,36.1,28.9 to 44.5,222
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,38.1,32.8 to 43.9,441
Polio,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,5 Months,81.6,74.5 to 87.0,231
Polio,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,5 Months,85.9,81.4 to 89.5,475
Polio,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,5 Months,90.1,83.8 to 94.1,244
Polio,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,5 Months,89.4,85.5 to 92.4,513
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,79.4,72.1 to 85.1,219
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,77.8,72.6 to 82.3,442
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,76.2,68.3 to 82.7,223
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,76.4,71.0 to 81.1,454
Polio,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,5 Months,84.3,77.4 to 89.4,214
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,84.2,73.2 to 95.2,60
Polio,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,93.4,87.0 to 96.7,225
Polio,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,93.2,89.8 to 95.6,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,85.5,78.9 to 90.3,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,83.7,79.3 to 87.3,513
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,81.9,75.5 to 86.8,269
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,81.3,76.7 to 85.1,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,78.5,69.2 to 86.5,231
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,83.9,78.2 to 88.8,475
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,83.2,73.4 to 91.0,223
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,80.4,73.6 to 86.4,454
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,80.7,73.8 to 86.1,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,77.2,69.3 to 84.3,219
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,79.6,73.4 to 85.1,442
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014,Age,13 Months,61.2,53.4 to 68.4,219
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,58.7,53.0 to 64.2,442
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2012,Age,13 Months,52.1,46.5 to 57.6,225
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,35 Months,93.2,88.2 to 96.6,214
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,84.9,80.0 to 89.7,286
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,91.7,89.1 to 94.3,484
Polio,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,5 Months,88.8,83.4 to 92.6,269
Polio,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,5 Months,86.6,82.3 to 89.9,483
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013,Age,13 Months,59.3,53.0 to 65.2,222
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,60.2,55.0 to 65.2,441
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014,Age,13 Months,59.9,52.2 to 67.2,219
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,59.1,53.4 to 64.4,442
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015,Age,13 Months,58.2,50.1 to 66.0,223
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,60.5,54.8 to 66.0,454
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019,Age,13 Months,62.0,53.7 to 69.6,214
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2011,Age,19 Months,89.3,86.3 to 91.7,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2012,Age,19 Months,89.0,82.6 to 93.3,225
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016,Age,13 Months,62.9,54.9 to 70.3,231
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,64.3,58.8 to 69.5,475
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018,Age,13 Months,68.6,61.7 to 74.7,269
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,65.3,59.9 to 70.4,483
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,35 Months,96.9,90.2 to 99.4,189
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,97.6,92.5 to 99.5,225
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,92.2,86.1 to 96.4,223
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,90.7,86.0 to 94.3,454
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,93.6,88.4 to 97.0,219
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,93.0,89.1 to 95.8,442
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,81.8,71.6 to 90.0,214
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,89.8,80.4 to 95.0,225
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,92.6,84.9 to 97.3,222
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,93.3,88.7 to 96.5,441
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,92.7,90.4 to 94.5,222
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,93.1,90.9 to 94.7,441
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,93.4,88.5 to 96.4,219
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,91.6,87.3 to 94.5,442
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,82.3,75.0 to 88.4,269
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,82.2,76.0 to 87.6,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,89.2,82.4 to 94.2,244
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,86.3,81.4 to 90.4,513
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,90.8,85.6 to 94.7,219
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,89.9,86.1 to 93.1,442
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,83.1,76.3 to 88.8,231
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,86.6,82.4 to 90.3,475
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,89.0,83.1 to 93.5,223
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,86.1,81.7 to 90.0,454
Polio,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,5 Months,87.3,80.5 to 92.0,223
Polio,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,5 Months,84.5,79.8 to 88.3,454
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,76.6,68.9 to 82.9,231
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,81.2,76.3 to 85.3,475
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,38.8,31.5 to 47.2,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,62.9,53.0 to 72.7,244
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,73.9,64.7 to 82.3,225
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,67.4,58.3 to 76.2,222
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,72.5,66.4 to 78.3,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,35 Months,86.1,78.7 to 92.0,231
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,90.9,86.9 to 94.2,475
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2011,Age,13 Months,59.1,55.6 to 62.5,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013,Age,13 Months,58.9,52.4 to 65.1,222
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,59.4,52.9 to 65.6,441
≥1 Dose MMR,,States/Local Areas,New Hampshire,2012,Age,13 Months,52.5,45.7 to 59.2,225
≥1 Dose MMR,,States/Local Areas,New Hampshire,2011,Age,13 Months,54.2,50.6 to 57.7,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,76.6,69.0 to 83.5,214
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,92.9,87.8 to 96.4,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,89.5,84.5 to 93.4,269
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,83.2,78.6 to 87.3,483
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,90.0,84.7 to 94.1,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,89.7,86.2 to 92.7,513
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016,Age,13 Months,60.1,51.9 to 67.7,231
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,63.4,57.8 to 68.7,475
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017,Age,13 Months,66.6,58.9 to 73.5,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,67.6,62.5 to 72.3,513
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015,Age,13 Months,56.3,48.0 to 64.3,223
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,58.1,52.3 to 63.7,454
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,90.3 to 98.9,82
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,89.5,82.9 to 96.0,145
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.7,84.9 to 90.6,659
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,85.6,81.2 to 90.0,344
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.2,84.3 to 92.1,328
Polio,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,96.8,93.5 to 98.5,219
Polio,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,94.4,90.9 to 96.6,442
Polio,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,91.6,88.2 to 94.1,222
Polio,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,94.2,92.2 to 95.7,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,79.8,72.6 to 87.1,173
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,87.5,84.8 to 90.1,817
Polio,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,92.1,85.5 to 95.8,223
Polio,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,91.9,88.0 to 94.6,454
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,87.9,83.7 to 92.1,329
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,87.6,84.5 to 90.2,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017,Age,13 Months,65.6,57.9 to 72.6,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,67.9,62.7 to 72.6,513
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018,Age,13 Months,70.2,63.3 to 76.3,269
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,71.1,65.8 to 75.8,483
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019,Age,13 Months,72.0,63.9 to 78.8,214
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014,Age,19 Months,93.2,88.6 to 96.0,219
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,91.6,88.3 to 94.1,442
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015,Age,19 Months,90.1,82.4 to 94.7,223
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,87.9,83.7 to 91.2,454
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013,Age,19 Months,87.0,83.9 to 89.7,222
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,90.1,87.1 to 92.4,441
Polio,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,96.3,90.5 to 98.6,225
Polio,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,95.9,92.5 to 97.8,244
Polio,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,95.4,93.8 to 96.6,222
Polio,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,97.1,95.5 to 98.1,441
Polio,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,98.8,95.9 to 99.6,219
Polio,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,96.8,93.8 to 98.4,442
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,3 Months,96.1,89.8 to 98.5,223
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,3 Months,96.5,93.3 to 98.2,454
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,3 Months,97.0,93.5 to 98.7,231
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,3 Months,98.4,96.7 to 99.2,475
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.5,63.6 to 89.5,82
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,35 Months,95.6,92.1 to 97.9,244
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,95.7,92.9 to 97.6,513
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,35 Months,96.1,91.6 to 98.5,269
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,94.8,91.4 to 97.2,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,82.9,72.9 to 92.8,145
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.6,76.9 to 86.3,659
Polio,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,93.7,88.4 to 96.7,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,80.5,76.2 to 84.8,817
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,69.1,56.9 to 81.4,173
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,76.3,69.3 to 83.3,344
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.9,76.6 to 89.2,328
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,94.5,89.0 to 97.8,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,96.0,90.3 to 98.8,513
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,88.9,81.8 to 94.2,231
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,91.7,87.4 to 95.0,475
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,91.0,85.4 to 94.7,231
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,94.1,90.8 to 96.3,475
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,89.7,82.2 to 94.3,223
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,90.4,85.9 to 93.5,454
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,97.0,92.0 to 99.0,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,94.3,91.2 to 96.4,513
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,76.7,61.0 to 92.4,60
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,3 Months,94.7,93.3 to 95.8,222
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,3 Months,94.9,93.1 to 96.2,441
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,3 Months,94.3,83.6 to 98.1,225
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,3 Months,91.4,87.5 to 94.1,244
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,3 Months,95.0,89.3 to 97.8,219
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,3 Months,95.5,91.8 to 97.6,442
Polio,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,91.7,86.6 to 94.9,231
Polio,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,94.3,91.2 to 96.3,475
Polio,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,96.8,91.9 to 98.8,244
Polio,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,96.4,93.7 to 98.0,513
Polio,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,96.0,92.1 to 98.0,269
Polio,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,94.9,91.8 to 96.8,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,78.0,70.1 to 85.9,286
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,85.5,80.7 to 90.2,484
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.7,86.9 to 92.5,659
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,81.0 to 97.8,82
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,90.7,86.8 to 94.5,344
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,87.7,84.8 to 90.5,817
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,81.8,73.6 to 90.0,145
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.7,83.5 to 91.8,328
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015,Age,19 Months,93.1,89.0 to 95.8,223
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,91.3,87.7 to 93.9,454
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016,Age,19 Months,89.3,83.4 to 93.2,231
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,93.8,90.7 to 95.9,475
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017,Age,19 Months,98.1,95.3 to 99.2,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,96.0,93.4 to 97.6,513
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,79.9,72.3 to 87.5,173
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2011,Age,24 Months,91.8,86.9 to 95.4,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2012,Age,24 Months,88.0,81.8 to 92.8,225
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,3 Months,97.9,94.6 to 99.2,269
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,3 Months,98.0,96.1 to 99.0,483
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,3 Months,98.1,95.1 to 99.3,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,79.1,72.9 to 85.3,329
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2011,Age,0-1 Days,37.9,31.7 to 44.6,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,5 Months,87.5,73.9 to 94.5,225
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,5 Months,88.6,82.8 to 92.7,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,5 Months,89.3,87.0 to 91.2,222
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,5 Months,90.7,87.8 to 93.0,441
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,94.6,93.5 to 95.6,222
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,94.7,93.3 to 95.8,441
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,87.2,81.4 to 92.9,315
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,94.7,89.9 to 97.3,219
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,93.5,89.7 to 95.9,442
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,92.3,89.6 to 94.3,223
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,92.5,88.6 to 95.2,454
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,81.5,73.5 to 88.2,214
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,82.9,77.7 to 88.2,286
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,92.8,90.0 to 95.6,484
≥1 Dose MMR,,States/Local Areas,New Hampshire,2011,Age,19 Months,92.0,89.2 to 94.1,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013,Age,19 Months,88.4,81.5 to 92.9,222
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,91.2,86.2 to 94.5,441
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014,Age,19 Months,94.2,89.5 to 96.8,219
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,93.6,90.6 to 95.8,442
≥1 Dose MMR,,States/Local Areas,New Hampshire,2012,Age,19 Months,93.0,88.4 to 95.8,225
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017,Age,19 Months,93.6,87.1 to 97.0,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,94.4,91.0 to 96.6,513
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018,Age,19 Months,95.2,91.5 to 97.3,269
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,65.3,59.9 to 70.4,483
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,76.8,63.9 to 89.8,60
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,76.7,66.2 to 85.9,189
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016,Age,19 Months,85.6,78.7 to 90.6,231
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,89.7,85.3 to 92.9,475
Polio,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,94.8,89.1 to 97.7,223
Polio,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,94.9,91.5 to 97.0,454
Polio,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,13 Months,94.9,90.4 to 97.3,231
Polio,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,96.2,93.3 to 97.9,475
Polio,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,13 Months,97.5,92.2 to 99.2,244
Polio,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,97.9,95.2 to 99.1,513
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,3 Months,99.7,98.8 to 99.9,244
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,3 Months,98.8,97.2 to 99.5,513
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2016,Age,0-1 Days,43.9,36.3 to 51.9,231
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2016-2017,Age,0-1 Days,50.7,45.3 to 56.2,475
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2017,Age,0-1 Days,57.2,49.5 to 64.5,244
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2017-2018,Age,0-1 Days,66.3,61.2 to 71.1,513
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,5 Months,93.3,88.5 to 96.2,214
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,90.2,85.4 to 93.5,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,5 Months,96.7,91.8 to 98.7,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,5 Months,96.0,93.4 to 97.6,513
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,5 Months,95.3,91.7 to 97.4,269
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,5 Months,94.3,91.6 to 96.2,483
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2018,Age,0-1 Days,75.6,68.8 to 81.4,269
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2018-2019,Age,0-1 Days,78.8,74.0 to 82.9,483
PCV,≥4 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,82.3,75.0 to 87.8,222
PCV,≥4 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,84.0,78.1 to 88.5,441
PCV,≥4 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,85.6,80.7 to 89.4,225
PCV,≥4 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,88.2,84.0 to 91.4,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018,Age,19 Months,93.9,89.1 to 96.7,269
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,96.8,94.5 to 98.2,483
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019,Age,19 Months,90.7,84.8 to 94.5,214
≥1 Dose MMR,,States/Local Areas,New Hampshire,2011,Age,24 Months,94.8,91.1 to 97.3,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2012,Age,24 Months,93.0,88.4 to 96.2,225
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015,Age,24 Months,90.6,85.7 to 94.5,223
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,87.9,83.8 to 91.3,454
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016,Age,24 Months,85.1,78.5 to 90.5,231
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,89.6,85.5 to 93.0,475
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017,Age,24 Months,93.9,88.2 to 97.5,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,95.2,92.0 to 97.3,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,65.7,58.9 to 71.8,222
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,67.9,61.7 to 73.5,441
PCV,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,7 Months,74.2,66.8 to 80.5,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,92.8,87.7 to 95.9,231
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,95.7,93.0 to 97.3,475
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,70.2,62.5 to 76.9,219
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,74.4,69.1 to 79.1,442
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,92.1,88.6 to 95.6,315
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,88.0,83.6 to 92.4,329
PCV,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,69.9,63.4 to 75.7,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,98.4,95.7 to 99.4,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,96.5,94.4 to 97.9,513
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,94.6,90.7 to 97.0,269
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,91.5,88.0 to 94.1,483
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,5 Months,87.5,81.2 to 91.9,231
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,5 Months,92.2,88.6 to 94.8,475
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,5 Months,92.1,86.4 to 95.6,219
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,5 Months,92.2,89.4 to 94.3,442
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2012,Age,0-1 Days,41.5,35.1 to 48.2,225
Polio,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,13 Months,98.3,94.8 to 99.4,269
Polio,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,97.1,94.8 to 98.4,483
Polio,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,13 Months,95.8,91.7 to 97.9,214
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019,Age,19 Months,90.1,84.2 to 93.9,214
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014,Age,24 Months,94.3,90.2 to 97.1,219
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,92.5,89.4 to 95.0,442
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013,Age,24 Months,87.3,81.3 to 92.0,222
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,90.8,87.2 to 93.6,441
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2013,Age,0-1 Days,40.0,35.7 to 44.6,222
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2013-2014,Age,0-1 Days,40.0,36.4 to 43.7,441
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2014,Age,0-1 Days,39.9,32.3 to 48.1,219
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2014-2015,Age,0-1 Days,37.1,31.8 to 42.7,442
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,5 Months,92.2,85.7 to 95.9,223
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,5 Months,89.9,85.7 to 93.0,454
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2015,Age,0-1 Days,34.3,27.2 to 42.2,223
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2015-2016,Age,0-1 Days,39.0,33.7 to 44.6,454
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019,Age,24 Months,92.2,87.4 to 95.7,214
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2011,Age,35 Months,94.6,89.6 to 97.7,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2012,Age,35 Months,94.2,88.1 to 97.7,225
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018,Age,24 Months,96.5,93.4 to 98.4,269
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,94.4,91.7 to 96.5,483
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015,Age,24 Months,93.9,89.8 to 96.8,223
≥1 Dose MMR,,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,92.2,88.9 to 94.9,454
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014,Age,24 Months,95.3,91.3 to 97.9,219
≥1 Dose MMR,,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,94.6,91.9 to 96.6,442
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013,Age,24 Months,88.7,82.7 to 93.4,222
≥1 Dose MMR,,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,92.0,88.4 to 94.8,441
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,83.2,76.6 to 88.3,244
PCV,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,80.7,76.0 to 84.6,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,78.6,71.0 to 84.6,223
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,76.5,71.2 to 81.0,454
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,85.7,79.5 to 90.3,219
PCV,≥4 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,86.0,81.6 to 89.5,442
PCV,≥4 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,86.3,81.7 to 89.9,223
PCV,≥4 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,84.8,80.2 to 88.5,454
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,83.2,76.3 to 88.3,231
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,87.7,83.6 to 90.9,475
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,74.2,66.6 to 80.6,231
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,78.8,73.9 to 83.1,475
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,92.9,87.6 to 96.4,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,95.3,91.8 to 97.6,222
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,95.2,92.7 to 97.1,441
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,93.7,88.3 to 96.7,214
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,95.2,91.6 to 97.5,244
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2019,Age,0-1 Days,82.0,74.9 to 87.4,214
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2011,Age,0-2 Days,63.1,55.5 to 70.1,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2013,Age,0-2 Days,60.7,56.5 to 64.8,222
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2013-2014,Age,0-2 Days,63.0,59.4 to 66.4,441
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2012,Age,0-2 Days,64.9,59.2 to 70.2,225
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,7 Months,94.5,93.0 to 95.7,222
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,94.8,93.3 to 96.0,441
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,7 Months,95.1,90.4 to 97.5,219
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,94.4,91.1 to 96.6,442
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,7 Months,93.8,88.1 to 96.9,223
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,7 Months,90.6,79.0 to 96.1,225
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,7 Months,78.1,71.2 to 83.7,269
PCV,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,77.3,72.3 to 81.7,483
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,7 Months,76.5,68.9 to 82.8,214
PCV,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,13 Months,92.4,84.9 to 96.3,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,92.0,86.7 to 95.3,244
PCV,≥4 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,91.3,87.8 to 93.8,513
PCV,≥4 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,90.6,85.5 to 94.0,269
PCV,≥4 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,85.3,79.8 to 89.5,410
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017,Age,24 Months,98.4,96.0 to 99.5,244
≥1 Dose MMR,,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,96.6,94.3 to 98.2,513
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016,Age,24 Months,90.5,85.1 to 94.5,231
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,94.5,91.7 to 96.6,475
PCV,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,13 Months,90.5,83.0 to 94.8,225
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,93.2,88.5 to 96.4,231
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,95.8,93.4 to 97.6,475
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,93.5,87.7 to 97.2,223
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,93.2,89.6 to 95.9,454
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,95.2,90.9 to 97.8,219
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,94.2,90.8 to 96.7,442
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2014,Age,0-2 Days,65.3,57.4 to 72.4,219
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2014-2015,Age,0-2 Days,66.1,60.5 to 71.3,442
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2015,Age,0-2 Days,66.9,58.7 to 74.1,223
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2015-2016,Age,0-2 Days,67.4,61.8 to 72.5,454
PCV,≥4 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,89.5,83.8 to 93.8,244
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015,Age,35 Months,91.9,86.8 to 95.6,223
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,90.2,85.8 to 93.7,454
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014,Age,35 Months,94.6,90.5 to 97.4,219
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,93.2,90.1 to 95.6,442
PCV,≥4 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,80.0,72.4 to 86.0,214
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018,Age,24 Months,94.9,90.7 to 97.7,269
≥1 Dose MMR,,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,93.9,90.8 to 96.2,483
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013,Age,35 Months,93.5,87.6 to 97.2,222
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,94.0,90.3 to 96.6,441
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2016,Age,0-2 Days,67.9,60.0 to 74.9,231
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2016-2017,Age,0-2 Days,74.2,69.0 to 78.8,475
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,7 Months,91.6,86.2 to 95.0,231
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,95.1,92.3 to 96.9,475
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,13 Months,90.9,89.1 to 92.5,222
PCV,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,91.4,88.0 to 94.0,441
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,7 Months,98.4,95.7 to 99.4,244
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,97.6,95.7 to 98.6,513
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,13 Months,91.9,86.7 to 95.2,219
PCV,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,91.3,87.2 to 94.2,442
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,13 Months,90.7,83.5 to 94.9,223
PCV,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,90.3,86.1 to 93.3,454
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,95.0,91.5 to 97.4,269
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,94.4,91.5 to 96.5,483
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,92.7,89.1 to 95.2,454
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.1,79.3 to 89.0,328
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,83.7,75.8 to 91.6,145
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.1,83.9 to 90.3,659
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.8,78.6 to 96.9,82
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,81.6,69.8 to 93.4,60
Hib,Primary Series,States/Local Areas,New Hampshire,2012,Age,7 Months,75.2,73.1 to 77.2,225
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,89.4,85.1 to 93.7,315
Hib,Primary Series,States/Local Areas,New Hampshire,2011,Age,7 Months,76.2,66.5 to 83.8,244
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,90.4,83.7 to 97.1,145
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.9,95.3 to 98.5,659
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.0,93.4 to 100.0,82
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,93.1,85.4 to 100.0,60
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,79.7,74.0 to 85.4,286
Polio,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,94.0,89.1 to 97.2,214
Hib,Full Series,States/Local Areas,New Hampshire,2018,Age,35 Months,94.4,90.4 to 97.1,269
Hib,Full Series,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,88.1,83.8 to 91.7,483
Hib,Full Series,States/Local Areas,New Hampshire,2019,Age,35 Months,81.4,73.7 to 88.0,214
Hib,Full Series,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,91.4,88.3 to 94.5,484
Hib,Full Series,States/Local Areas,New Hampshire,2014,Age,35 Months,92.7,87.9 to 96.1,219
Hib,Full Series,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,91.4,88.0 to 94.2,442
Hib,Full Series,States/Local Areas,New Hampshire,2015,Age,35 Months,89.9,84.6 to 93.9,223
Hib,Full Series,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,90.2,84.8 to 94.3,454
Hib,Full Series,States/Local Areas,New Hampshire,2016,Age,35 Months,89.6,80.7 to 95.6,231
Hib,Full Series,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,91.9,86.1 to 95.9,475
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,5 Months,82.0,76.8 to 86.3,222
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,5 Months,83.7,80.3 to 86.5,441
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,5 Months,89.0,83.8 to 92.7,225
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,5 Months,88.4,80.5 to 93.4,244
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,93.7,90.1 to 97.4,286
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,98.2,97.0 to 99.4,484
Polio,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,99.0,95.1 to 99.9,269
Polio,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,96.7,93.2 to 98.7,483
Hib,Full Series,States/Local Areas,New Hampshire,2017,Age,35 Months,93.3,87.5 to 97.1,244
Hib,Full Series,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,93.7,90.4 to 96.2,513
Hib,Full Series,States/Local Areas,New Hampshire,2019,Age,24 Months,77.4,70.0 to 84.2,214
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,99.1,96.4 to 99.9,219
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,98.0,95.7 to 99.2,442
Polio,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,96.6,93.0 to 98.7,222
Polio,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,97.8,95.7 to 99.0,441
Hib,Full Series,States/Local Areas,New Hampshire,2013,Age,35 Months,94.3,87.4 to 98.0,222
Hib,Full Series,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,93.2,89.3 to 96.1,441
Hib,Full Series,States/Local Areas,New Hampshire,2011,Age,35 Months,92.8,85.3 to 97.3,244
Hib,Full Series,States/Local Areas,New Hampshire,2012,Age,35 Months,94.8,88.5 to 98.2,225
Polio,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,95.3,90.5 to 98.1,225
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,5 Months,85.4,78.9 to 90.1,219
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,5 Months,86.3,84.5 to 88.0,442
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,97.1,93.5 to 98.7,269
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,93.1,89.6 to 95.5,483
Polio,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,96.9,92.7 to 99.0,223
Polio,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,95.9,93.0 to 97.8,454
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,5 Months,81.6,74.6 to 87.1,231
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,5 Months,86.1,81.6 to 89.6,475
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,5 Months,87.3,80.0 to 92.2,223
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,5 Months,84.5,79.7 to 88.4,454
Polio,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,96.7,92.5 to 98.9,244
Polio,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,97.7,94.9 to 99.2,513
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,94.9,90.6 to 97.6,231
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,95.8,93.1 to 97.7,475
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,96.1,92.0 to 98.4,222
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,97.1,94.8 to 98.6,441
Hib,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,96.0,91.6 to 98.5,225
Hib,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,95.5,91.2 to 98.1,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,98.2,95.5 to 99.4,219
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,96.9,94.7 to 98.4,442
Hib,Full Series,States/Local Areas,New Hampshire,2016,Age,24 Months,83.0,76.1 to 88.9,231
Hib,Full Series,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,86.0,81.7 to 89.8,475
Hib,Full Series,States/Local Areas,New Hampshire,2018,Age,24 Months,91.5,87.2 to 94.9,269
Hib,Full Series,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,84.6,80.2 to 88.5,483
Hib,Full Series,States/Local Areas,New Hampshire,2017,Age,24 Months,88.9,83.3 to 93.2,244
Hib,Full Series,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,90.1,86.7 to 93.0,513
Polio,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,97.6,94.7 to 99.1,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,98.1,95.5 to 99.4,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,98.5,96.4 to 99.5,225
Polio,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,96.9,93.8 to 98.7,269
Polio,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,95.4,92.7 to 97.4,483
Polio,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,94.0,89.1 to 97.2,214
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,91.4,85.6 to 95.1,214
Polio,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,96.7,92.5 to 98.9,244
Polio,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,96.8,94.4 to 98.4,513
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,91.4,85.6 to 95.1,214
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,96.4,92.7 to 98.5,222
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,97.6,95.5 to 98.8,441
Hib,Full Series,States/Local Areas,New Hampshire,2015,Age,24 Months,89.1,83.9 to 93.3,223
Hib,Full Series,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,86.1,81.9 to 89.8,454
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,97.0,91.9 to 98.9,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,97.0,94.4 to 98.5,513
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,95.5,93.1 to 97.1,223
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,94.7,91.7 to 96.6,454
Polio,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,95.8,91.8 to 98.2,223
Polio,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,94.9,92.1 to 97.0,454
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,98.8,96.4 to 99.7,219
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,97.4,95.2 to 98.7,442
Polio,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,3 Months,92.1,87.9 to 94.9,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,96.2,92.6 to 98.1,269
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,92.7,89.2 to 95.1,483
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,95.5,90.0 to 98.0,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,95.8,92.9 to 97.6,513
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,94.0,89.7 to 97.0,231
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,95.4,92.6 to 97.4,475
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,93.8,88.9 to 96.6,231
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,94.6,91.4 to 96.7,475
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,94.0,89.2 to 96.8,231
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,95.6,92.5 to 97.4,475
Polio,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,91.3,85.5 to 95.0,214
Polio,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,96.1,92.7 to 98.2,244
Polio,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,95.3,90.5 to 98.1,225
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,96.9,92.8 to 98.7,219
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,96.2,93.6 to 97.8,442
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,96.1,93.5 to 97.6,222
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,96.5,94.8 to 97.6,441
Polio,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,24 Months,95.4,91.8 to 97.7,222
Polio,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,97.1,95.0 to 98.4,441
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,98.0,94.1 to 99.3,219
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,96.6,93.5 to 98.3,442
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,95.3,92.5 to 97.1,223
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,94.7,91.2 to 96.8,454
DTaP,≥4 Doses,States/Local Areas,Nevada,2012,Age,19 Months,63.4,54.8 to 71.3,272
DTaP,≥4 Doses,States/Local Areas,Nevada,2011,Age,19 Months,64.6,62.2 to 66.9,293
Hep A,≥1 Dose,States/Local Areas,Nevada,2017,Age,24 Months,87.7,82.2 to 92.1,344
Hep A,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,24 Months,90.2,86.8 to 93.0,722
Hib,≥3 Doses,States/Local Areas,Nevada,2011,Age,35 Months,93.6,89.0 to 96.7,293
Hib,≥3 Doses,States/Local Areas,Nevada,2012,Age,35 Months,89.9,84.2 to 94.2,272
Hib,≥3 Doses,States/Local Areas,Nevada,2017,Age,24 Months,86.5,80.9 to 91.1,344
Hib,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,90.0,86.5 to 92.8,722
DTaP,≥3 Doses,States/Local Areas,Nevada,2019,Age,24 Months,91.3,86.3 to 95.0,340
Hib,≥3 Doses,States/Local Areas,Nevada,2016,Age,24 Months,83.1,77.2 to 88.2,327
Hib,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,84.8,80.8 to 88.4,671
Hib,≥3 Doses,States/Local Areas,Nevada,2015,Age,24 Months,88.1,83.1 to 92.2,253
Hib,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,85.6,81.8 to 89.0,580
Hep A,≥1 Dose,States/Local Areas,Nevada,2016,Age,19 Months,81.8,75.5 to 86.7,327
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,19 Months,81.5,77.1 to 85.2,671
Hep A,≥1 Dose,States/Local Areas,Nevada,2012,Age,24 Months,82.8,76.1 to 88.5,272
Hep A,≥1 Dose,States/Local Areas,Nevada,2014,Age,24 Months,85.0,77.9 to 90.9,186
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,24 Months,86.2,81.8 to 90.0,439
Hep A,≥1 Dose,States/Local Areas,Nevada,2013,Age,24 Months,85.4,79.3 to 90.4,234
Hep A,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,24 Months,85.3,80.7 to 89.3,420
Hep A,≥1 Dose,States/Local Areas,Nevada,2011,Age,24 Months,85.1,79.3 to 89.9,293
Hep A,≥1 Dose,States/Local Areas,Nevada,2019,Age,19 Months,83.8,77.9 to 88.3,340
DTaP,≥3 Doses,States/Local Areas,Nevada,2016,Age,35 Months,92.4,87.2 to 96.0,327
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,92.0,88.3 to 94.8,671
DTaP,≥3 Doses,States/Local Areas,Nevada,2015,Age,35 Months,91.8,87.3 to 95.1,253
DTaP,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,91.9,88.5 to 94.6,580
PCV,≥2 Doses,States/Local Areas,Nevada,2011,Age,5 Months,64.4,55.7 to 72.3,293
PCV,≥2 Doses,States/Local Areas,Nevada,2012,Age,5 Months,63.9,56.8 to 70.5,272
PCV,≥2 Doses,States/Local Areas,Nevada,2013,Age,5 Months,75.9,70.7 to 80.5,234
PCV,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,5 Months,73.5,69.7 to 77.0,420
DTaP,≥3 Doses,States/Local Areas,Nevada,2017,Age,35 Months,91.6,86.5 to 95.3,344
DTaP,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,94.7,91.9 to 96.8,722
Hib,Primary Series,States/Local Areas,Nevada,2021,Age,19 Months,85.1,77.5 to 90.5,237
DTaP,≥1 Dose,States/Local Areas,Nevada,2018,Age,3 Months,92.0,87.7 to 94.9,378
DTaP,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,3 Months,90.6,87.3 to 93.1,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2015,Age,24 Months,90.2,85.4 to 93.9,253
DTaP,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,88.8,85.4 to 91.8,580
DTaP,≥3 Doses,States/Local Areas,Nevada,2014,Age,24 Months,90.9,85.2 to 95.0,186
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,90.5,86.9 to 93.4,439
DTaP,≥1 Dose,States/Local Areas,Nevada,2017,Age,3 Months,83.7,77.4 to 88.6,344
DTaP,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,3 Months,87.9,84.1 to 90.8,722
Hep A,≥1 Dose,States/Local Areas,Nevada,2011,Age,19 Months,78.7,75.2 to 81.7,293
DTaP,≥1 Dose,States/Local Areas,Nevada,2019,Age,3 Months,89.2,83.7 to 93.0,340
DTaP,≥3 Doses,States/Local Areas,Nevada,2016,Age,24 Months,87.6,82.3 to 91.9,327
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,89.0,85.4 to 92.1,671
Hep A,≥1 Dose,States/Local Areas,Nevada,2012,Age,19 Months,76.3,68.6 to 82.5,272
Hep B,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,84.6,79.3 to 88.8,560
Hib,Full Series,States/Local Areas,Nevada,2021,Age,19 Months,66.2,57.2 to 74.2,237
DTaP,≥4 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,78.9,72.0 to 85.0,560
Hib,Primary Series,States/Local Areas,Nevada,2020-2021,Age,24 Months,86.8,82.0 to 90.8,560
Hep A,≥1 Dose,States/Local Areas,Nevada,2015,Age,19 Months,81.9,75.0 to 87.2,253
Hep A,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,19 Months,81.8,77.5 to 85.5,580
Hep A,≥1 Dose,States/Local Areas,Nevada,2014,Age,19 Months,73.3,63.8 to 81.1,186
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,19 Months,77.6,72.0 to 82.4,439
Hep B,≥2 Doses,States/Local Areas,Nevada,2021,Age,5 Months,79.4,70.9 to 85.9,237
Combined 7 Series,,States/Local Areas,Nevada,2021,Age,35 Months,64.0,54.4 to 73.6,237
Hib,Primary Series,States/Local Areas,Nevada,2021,Age,7 Months,63.2,53.9 to 71.5,237
DTaP,≥4 Doses,States/Local Areas,Nevada,2021,Age,19 Months,62.6,53.5 to 70.8,237
DTaP,≥1 Dose,States/Local Areas,Nevada,2016,Age,3 Months,84.0,77.7 to 88.7,327
DTaP,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,3 Months,83.9,79.5 to 87.4,671
DTaP,≥1 Dose,States/Local Areas,Nevada,2015,Age,3 Months,82.9,76.0 to 88.1,253
DTaP,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,3 Months,83.4,79.0 to 87.1,580
DTaP,≥1 Dose,States/Local Areas,Nevada,2014,Age,3 Months,80.9,72.8 to 87.1,186
DTaP,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,3 Months,81.9,76.8 to 86.1,439
DTaP,≥1 Dose,States/Local Areas,Nevada,2013,Age,3 Months,84.9,80.0 to 88.7,234
DTaP,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,3 Months,82.9,77.7 to 87.1,420
DTaP,≥1 Dose,States/Local Areas,Nevada,2011,Age,3 Months,83.4,79.9 to 86.5,293
DTaP,≥1 Dose,States/Local Areas,Nevada,2012,Age,3 Months,77.1,73.2 to 80.5,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.0,71.3 to 80.7,529
Hib,≥1 Dose,States/Local Areas,Nevada,2021,Age,3 Months,82.8,75.1 to 88.6,237
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,80.1,74.7 to 85.5,940
Hep A,≥2 Doses,States/Local Areas,Nevada,2021,Age,35 Months,60.5,47.8 to 73.4,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2021,Age,19 Months,85.9,78.2 to 91.2,237
PCV,≥4 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,74.4,68.6 to 79.8,560
Hep A,≥1 Dose,States/Local Areas,Nevada,2013,Age,19 Months,82.5,70.6 to 90.2,234
Hep A,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,19 Months,77.9,71.4 to 83.2,420
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,89.0,86.5 to 91.5,973
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,87.4,83.3 to 91.5,341
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,88.8,84.9 to 92.7,389
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,92.8,88.3 to 97.4,243
DTaP,≥3 Doses,States/Local Areas,Nevada,2018,Age,24 Months,96.5,93.5 to 98.4,378
DTaP,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,93.9,91.0 to 96.1,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2017,Age,24 Months,90.4,85.4 to 94.3,344
DTaP,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,93.5,90.6 to 95.7,722
DTaP,≥2 Doses,States/Local Areas,Nevada,2018,Age,5 Months,84.5,79.0 to 88.7,378
DTaP,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,5 Months,82.1,78.1 to 85.6,718
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,84.8,75.3 to 94.4,109
DTaP,≥2 Doses,States/Local Areas,Nevada,2017,Age,5 Months,72.7,65.3 to 79.1,344
DTaP,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,5 Months,78.6,74.0 to 82.6,722
Hep A,≥2 Doses,States/Local Areas,Nevada,2011,Age,24 Months,42.5,35.2 to 50.6,293
Hep A,≥2 Doses,States/Local Areas,Nevada,2019,Age,19 Months,36.1,29.7 to 43.1,340
Hep A,≥2 Doses,States/Local Areas,Nevada,2018,Age,19 Months,29.6,24.0 to 35.9,378
Hep A,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,33.8,28.6 to 39.6,594
Hib,≥3 Doses,States/Local Areas,Nevada,2017,Age,35 Months,87.7,82.0 to 92.2,344
Hib,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,90.7,87.2 to 93.5,722
Hib,≥3 Doses,States/Local Areas,Nevada,2016,Age,35 Months,89.5,83.7 to 93.9,327
Hib,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,88.7,84.5 to 92.1,671
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,91.2,87.9 to 94.5,520
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,87.8,84.0 to 91.6,374
DTaP,≥4 Doses,States/Local Areas,Nevada,2015,Age,19 Months,65.5,60.7 to 70.0,253
DTaP,≥4 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,66.2,61.1 to 70.9,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2014,Age,19 Months,61.2,51.9 to 69.8,186
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,63.4,57.4 to 68.9,439
DTaP,≥4 Doses,States/Local Areas,Nevada,2013,Age,19 Months,76.4,67.6 to 83.4,234
DTaP,≥4 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,68.8,59.0 to 77.1,420
Hep A,≥2 Doses,States/Local Areas,Nevada,2012,Age,24 Months,37.1,29.7 to 45.7,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,90.4,81.3 to 99.5,52
Hib,≥3 Doses,States/Local Areas,Nevada,2018,Age,35 Months,93.7,89.3 to 96.7,378
Hib,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,91.9,88.5 to 94.5,718
PCV,≥2 Doses,States/Local Areas,Nevada,2017,Age,5 Months,70.7,63.3 to 77.2,344
PCV,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,5 Months,75.4,70.6 to 79.6,722
Hep A,≥1 Dose,States/Local Areas,Nevada,2011,Age,35 Months,95.7,89.8 to 98.7,293
Hep A,≥1 Dose,States/Local Areas,Nevada,2019,Age,24 Months,88.8,84.0 to 92.7,340
Hep A,≥1 Dose,States/Local Areas,Nevada,2018,Age,24 Months,92.7,88.3 to 95.8,378
Hep A,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,24 Months,90.8,87.6 to 93.4,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2019,Age,35 Months,93.1,88.1 to 96.5,340
DTaP,≥3 Doses,States/Local Areas,Nevada,2018,Age,35 Months,97.9,95.4 to 99.2,378
DTaP,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,95.5,92.7 to 97.4,718
PCV,≥2 Doses,States/Local Areas,Nevada,2016,Age,5 Months,71.4,64.4 to 77.5,327
PCV,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,5 Months,71.1,66.0 to 75.6,671
PCV,≥2 Doses,States/Local Areas,Nevada,2015,Age,5 Months,70.0,62.4 to 76.6,253
PCV,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,5 Months,70.7,65.6 to 75.3,580
PCV,≥2 Doses,States/Local Areas,Nevada,2014,Age,5 Months,71.2,62.4 to 78.6,186
PCV,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,5 Months,70.6,66.8 to 74.1,439
Hep A,≥1 Dose,States/Local Areas,Nevada,2016,Age,24 Months,84.1,78.4 to 89.0,327
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,24 Months,85.9,82.0 to 89.4,671
Hep A,≥1 Dose,States/Local Areas,Nevada,2015,Age,24 Months,87.3,81.8 to 91.8,253
Hep A,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,24 Months,85.7,81.8 to 89.2,580
Hep A,≥2 Doses,States/Local Areas,Nevada,2017,Age,19 Months,32.4,26.0 to 39.7,344
Hep A,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,31.0,26.6 to 35.8,722
Hib,≥3 Doses,States/Local Areas,Nevada,2015,Age,35 Months,89.9,84.9 to 93.7,253
Hib,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,89.6,85.9 to 92.7,580
Hib,≥3 Doses,States/Local Areas,Nevada,2014,Age,35 Months,90.4,84.3 to 94.8,186
Hib,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,90.1,86.3 to 93.2,439
Hib,≥3 Doses,States/Local Areas,Nevada,2013,Age,35 Months,96.2,92.3 to 98.5,234
Hib,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,94.2,90.5 to 96.9,420
Hep A,≥2 Doses,States/Local Areas,Nevada,2016,Age,19 Months,24.9,19.8 to 30.8,327
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,28.7,24.5 to 33.3,671
Hep A,≥2 Doses,States/Local Areas,Nevada,2015,Age,19 Months,30.0,24.4 to 36.3,253
Hep A,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,27.5,23.1 to 32.3,580
Hib,≥3 Doses,States/Local Areas,Nevada,2019,Age,24 Months,88.8,83.7 to 92.9,340
Hib,≥3 Doses,States/Local Areas,Nevada,2018,Age,24 Months,93.4,89.1 to 96.5,378
Hib,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,91.1,87.9 to 93.8,718
Hep A,≥2 Doses,States/Local Areas,Nevada,2012,Age,19 Months,16.9,14.2 to 20.0,272
Hep A,≥2 Doses,States/Local Areas,Nevada,2014,Age,19 Months,20.9,14.8 to 28.7,186
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,25.5,20.7 to 31.0,439
Hep A,≥2 Doses,States/Local Areas,Nevada,2013,Age,19 Months,27.1,20.0 to 35.5,234
Hep A,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,24.0,19.5 to 29.2,420
DTaP,≥2 Doses,States/Local Areas,Nevada,2019,Age,5 Months,79.8,73.4 to 84.9,340
Hep A,≥2 Doses,States/Local Areas,Nevada,2011,Age,19 Months,14.0,11.9 to 16.5,293
DTaP,≥3 Doses,States/Local Areas,Nevada,2014,Age,35 Months,94.9,87.8 to 98.5,186
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,93.2,88.7 to 96.4,439
DTaP,≥3 Doses,States/Local Areas,Nevada,2011,Age,35 Months,97.1,93.4 to 99.1,293
DTaP,≥3 Doses,States/Local Areas,Nevada,2012,Age,35 Months,90.6,84.6 to 95.0,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2013,Age,35 Months,96.9,93.1 to 98.9,234
DTaP,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,95.8,92.1 to 98.1,420
Hep A,≥1 Dose,States/Local Areas,Nevada,2018,Age,19 Months,88.7,83.5 to 92.4,378
Hep A,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,19 Months,88.8,84.9 to 91.8,594
Hep A,≥1 Dose,States/Local Areas,Nevada,2017,Age,19 Months,81.2,74.7 to 86.3,344
Hep A,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,19 Months,84.9,80.9 to 88.2,722
Hib,≥2 Doses,States/Local Areas,Nevada,2020,Age,5 Months,74.9,66.6 to 81.7,323
Polio,≥2 Doses,States/Local Areas,Nevada,2020,Age,5 Months,74.8,66.5 to 81.6,323
DTaP,≥2 Doses,States/Local Areas,Nevada,2020,Age,5 Months,75.1,66.8 to 81.9,323
Hep B,≥1 Dose,States/Local Areas,Nevada,2020,Age,3 Months,95.7,91.3 to 97.9,323
PCV,≥1 Dose,States/Local Areas,Nevada,2020,Age,3 Months,83.7,75.9 to 89.3,323
Hep A,≥2 Doses,States/Local Areas,Nevada,2020,Age,24 Months,49.3,41.7 to 57.6,323
Hep A,≥1 Dose,States/Local Areas,Nevada,2020,Age,24 Months,83.3,75.6 to 89.7,323
PCV,≥4 Doses,States/Local Areas,Nevada,2020,Age,24 Months,75.2,67.5 to 82.2,323
PCV,≥3 Doses,States/Local Areas,Nevada,2020,Age,24 Months,89.7,82.8 to 94.7,323
≥1 Dose Varicella,,States/Local Areas,Nevada,2020,Age,24 Months,83.8,76.3 to 90.0,323
Rotavirus,,States/Local Areas,Nevada,2020,Age,8 Months,72.8,65.1 to 79.3,323
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2020,Age,0-3 Days,78.7,71.2 to 84.7,323
Influenza,,States/Local Areas,Nevada,2020,Age,24 Months,50.3,42.9 to 58.2,323
Combined 7 Series,,States/Local Areas,Nevada,2020,Age,24 Months,65.1,57.3 to 72.7,323
Hib,≥3 Doses,States/Local Areas,Nevada,2020,Age,19 Months,81.2,73.4 to 87.1,323
≥1 Dose MMR,,States/Local Areas,Nevada,2020,Age,19 Months,81.1,73.1 to 87.1,323
Polio,≥3 Doses,States/Local Areas,Nevada,2020,Age,19 Months,87.4,79.8 to 92.4,323
DTaP,≥4 Doses,States/Local Areas,Nevada,2020,Age,19 Months,62.5,54.5 to 69.9,323
DTaP,≥3 Doses,States/Local Areas,Nevada,2020,Age,19 Months,87.7,80.1 to 92.7,323
DTaP,≥3 Doses,States/Local Areas,Nevada,2020,Age,7 Months,67.9,59.6 to 75.2,323
PCV,≥3 Doses,States/Local Areas,Nevada,2020,Age,13 Months,85.6,78.1 to 90.9,323
Hep B,≥2 Doses,States/Local Areas,Nevada,2020,Age,5 Months,86.1,78.5 to 91.3,323
≥1 Dose Varicella,,States/Local Areas,Nevada,2020,Age,13 Months,64.1,56.1 to 71.4,323
PCV,≥2 Doses,States/Local Areas,Nevada,2020,Age,5 Months,74.2,66.0 to 81.0,323
Hep B,≥3 Doses,States/Local Areas,Nevada,2020,Age,13 Months,85.4,77.8 to 90.6,323
Hep B,≥2 Doses,States/Local Areas,Nevada,2020,Age,13 Months,90.0,82.5 to 94.5,323
Hib,Primary Series,States/Local Areas,Nevada,2020,Age,13 Months,82.0,74.1 to 87.8,323
Hib,≥3 Doses,States/Local Areas,Nevada,2020,Age,13 Months,64.8,57.0 to 71.9,323
PCV,≥3 Doses,States/Local Areas,Nevada,2020,Age,35 Months,89.8,82.9 to 94.8,323
Hib,≥2 Doses,States/Local Areas,Nevada,2020,Age,13 Months,87.9,80.2 to 92.8,323
PCV,≥3 Doses,States/Local Areas,Nevada,2020,Age,19 Months,87.4,79.7 to 92.4,323
Polio,≥3 Doses,States/Local Areas,Nevada,2020,Age,35 Months,90.0,83.0 to 95.0,323
PCV,≥4 Doses,States/Local Areas,Nevada,2020,Age,19 Months,69.2,61.1 to 76.3,323
DTaP,≥4 Doses,States/Local Areas,Nevada,2020,Age,35 Months,80.1,72.0 to 87.2,323
DTaP,≥3 Doses,States/Local Areas,Nevada,2020,Age,35 Months,89.8,82.8 to 94.8,323
Hep B,≥3 Doses,States/Local Areas,Nevada,2020,Age,19 Months,86.6,79.1 to 91.8,323
≥1 Dose Varicella,,States/Local Areas,Nevada,2020,Age,19 Months,78.9,70.7 to 85.2,323
Hib,Full Series,States/Local Areas,Nevada,2020,Age,19 Months,62.5,54.4 to 69.9,323
Hib,Primary Series,States/Local Areas,Nevada,2020,Age,19 Months,86.8,79.2 to 92.0,323
≥1 Dose Varicella,,States/Local Areas,Nevada,2020,Age,35 Months,89.0,80.6 to 94.9,323
Hep B,≥3 Doses,States/Local Areas,Nevada,2020,Age,35 Months,90.3,83.3 to 95.2,323
Hib,Full Series,States/Local Areas,Nevada,2020,Age,35 Months,76.8,68.6 to 84.2,323
Hib,≥3 Doses,States/Local Areas,Nevada,2020,Age,35 Months,85.7,78.4 to 91.5,323
Hib,Primary Series,States/Local Areas,Nevada,2020,Age,35 Months,88.5,81.4 to 93.8,323
≥1 Dose MMR,,States/Local Areas,Nevada,2020,Age,35 Months,87.2,79.9 to 92.9,323
Hib,≥3 Doses,States/Local Areas,Nevada,2020,Age,24 Months,84.5,77.1 to 90.5,323
≥1 Dose MMR,,States/Local Areas,Nevada,2020,Age,24 Months,84.7,77.3 to 90.8,323
Polio,≥3 Doses,States/Local Areas,Nevada,2020,Age,24 Months,89.2,82.2 to 94.3,323
DTaP,≥3 Doses,States/Local Areas,Nevada,2020,Age,24 Months,89.1,82.1 to 94.3,323
DTaP,≥4 Doses,States/Local Areas,Nevada,2020,Age,24 Months,74.1,66.3 to 81.3,323
Hib,Primary Series,States/Local Areas,Nevada,2020,Age,7 Months,64.7,56.4 to 72.1,323
Hib,≥3 Doses,States/Local Areas,Nevada,2020,Age,7 Months,42.0,34.7 to 49.7,323
Hib,≥2 Doses,States/Local Areas,Nevada,2020,Age,7 Months,84.9,77.1 to 90.3,323
Polio,≥2 Doses,States/Local Areas,Nevada,2020,Age,7 Months,84.8,77.0 to 90.2,323
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2020,Age,0-2 Days,78.4,70.9 to 84.4,323
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2020,Age,0-1 Days,73.4,65.7 to 79.9,323
Hep A,≥1 Dose,States/Local Areas,Nevada,2020,Age,19 Months,77.5,69.1 to 84.0,323
Hep A,≥2 Doses,States/Local Areas,Nevada,2020,Age,19 Months,31.7,25.5 to 38.6,323
Combined 7 Series,,States/Local Areas,Nevada,2020,Age,35 Months,73.3,64.0 to 81.8,323
≥1 Dose MMR,,States/Local Areas,Nevada,2020,Age,13 Months,64.3,56.4 to 71.6,323
Hep A,≥2 Doses,States/Local Areas,Nevada,2020,Age,35 Months,72.4,63.2 to 81.0,323
Hep A,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,24 Months,86.1,81.5 to 90.0,663
Hep A,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,71.8,65.6 to 77.6,663
Hep A,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,35 Months,91.3,86.4 to 94.9,663
Influenza,,States/Local Areas,Nevada,2019-2020,Age,24 Months,52.6,47.4 to 58.0,663
Hep A,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,50.3,45.0 to 55.9,663
Hib,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,85.4,80.7 to 89.1,663
Hib,Primary Series,States/Local Areas,Nevada,2019-2020,Age,24 Months,89.5,85.4 to 92.9,663
Hib,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,86.9,82.5 to 90.6,663
Combined 7 Series,,States/Local Areas,Nevada,2019-2020,Age,35 Months,74.1,68.0 to 79.8,663
Hep B,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,88.2,83.8 to 91.6,663
Hib,Full Series,States/Local Areas,Nevada,2019-2020,Age,19 Months,67.0,61.7 to 72.0,663
PCV,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,89.1,84.6 to 92.3,663
PCV,≥4 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,73.8,68.6 to 78.4,663
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2019-2020,Age,0-2 Days,80.4,75.8 to 84.4,663
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2019-2020,Age,0-1 Days,76.2,71.4 to 80.5,663
Hep B,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,89.6,85.4 to 93.0,663
Hib,Full Series,States/Local Areas,Nevada,2019-2020,Age,24 Months,74.3,69.1 to 79.1,663
Hib,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,44.8,39.6 to 50.0,663
PCV,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,66.9,61.6 to 71.9,663
≥1 Dose Varicella,,States/Local Areas,Nevada,2019-2020,Age,24 Months,86.7,82.3 to 90.5,663
PCV,≥4 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,78.3,73.4 to 82.8,663
PCV,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,90.2,86.1 to 93.5,663
Polio,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,89.1,84.7 to 92.4,663
Hep A,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,33.8,29.2 to 38.7,663
≥1 Dose MMR,,States/Local Areas,Nevada,2019-2020,Age,19 Months,83.1,78.3 to 87.0,663
Hib,Primary Series,States/Local Areas,Nevada,2019-2020,Age,19 Months,88.8,84.3 to 92.1,663
Hib,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,83.9,79.2 to 87.7,663
≥1 Dose MMR,,States/Local Areas,Nevada,2019-2020,Age,35 Months,90.0,85.7 to 93.5,663
Hib,Full Series,States/Local Areas,Nevada,2019-2020,Age,35 Months,78.2,72.9 to 83.1,663
Hib,Primary Series,States/Local Areas,Nevada,2019-2020,Age,35 Months,89.8,85.7 to 93.2,663
Hib,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,88.0,83.7 to 91.7,663
Hep B,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,91.8,87.8 to 94.9,663
≥1 Dose Varicella,,States/Local Areas,Nevada,2019-2020,Age,35 Months,90.7,86.1 to 94.3,663
PCV,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,90.7,86.6 to 93.9,663
PCV,≥4 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,82.1,76.8 to 86.8,663
DTaP,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,90.3,86.2 to 93.7,663
DTaP,≥4 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,76.6,71.6 to 81.3,663
Polio,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,24 Months,90.3,86.2 to 93.6,663
Hib,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,3 Months,86.3,81.8 to 89.9,663
≥1 Dose MMR,,States/Local Areas,Nevada,2019-2020,Age,24 Months,87.2,82.8 to 90.9,663
Hep B,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,3 Months,96.4,93.8 to 97.9,663
PCV,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,3 Months,86.0,81.4 to 89.6,663
DTaP,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,5 Months,77.9,72.8 to 82.3,663
Polio,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,5 Months,77.1,72.0 to 81.5,663
DTaP,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,87.1,82.6 to 90.6,663
Polio,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,89.7,85.3 to 92.9,663
Hib,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,89.9,85.5 to 93.1,663
≥1 Dose MMR,,States/Local Areas,Nevada,2019-2020,Age,13 Months,64.3,59.0 to 69.3,663
Hib,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,5 Months,76.4,71.2 to 80.9,663
Hib,Primary Series,States/Local Areas,Nevada,2019-2020,Age,13 Months,83.8,79.0 to 87.7,663
Hib,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,66.7,61.5 to 71.5,663
Hep B,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,5 Months,87.0,82.5 to 90.4,663
PCV,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,5 Months,75.8,70.6 to 80.3,663
DTaP,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,70.9,65.6 to 75.6,663
Polio,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,85.4,80.7 to 89.1,663
Hep B,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,86.9,82.5 to 90.4,663
Hep B,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,92.3,88.2 to 95.1,663
≥1 Dose Varicella,,States/Local Areas,Nevada,2019-2020,Age,13 Months,63.7,58.4 to 68.8,663
PCV,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,13 Months,86.2,81.5 to 89.8,663
DTaP,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,91.4,87.3 to 94.6,663
Combined 7 Series,,States/Local Areas,Nevada,2019-2020,Age,24 Months,68.4,63.2 to 73.5,663
DTaP,≥4 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,81.3,76.2 to 86.0,663
Polio,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,35 Months,91.5,87.4 to 94.7,663
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,82.7 to 95.1,208
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,89.4,82.7 to 96.1,119
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,87.9 to 93.1,940
Rotavirus,,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,71.2,65.8 to 76.7,543
Rotavirus,,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,68.4,62.6 to 74.2,408
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,89.5 to 94.2,940
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,90.7,86.4 to 95.1,316
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,76.8,71.8 to 81.8,543
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,82.8,77.3 to 88.3,316
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,77.5,72.8 to 82.1,543
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,74.3,66.5 to 82.1,408
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,92.1,87.4 to 96.7,316
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,92.4,89.2 to 95.6,408
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,90.3,86.9 to 93.7,543
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,92.3,90.3 to 94.3,1267
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,91.6,89.6 to 93.6,1267
Influenza,,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,49.5,43.7 to 55.3,543
Influenza,,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,45.4,39.2 to 51.7,408
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,93.0,88.8 to 97.1,316
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,89.6,86.0 to 93.2,543
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,91.9,88.5 to 95.3,408
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,86.0,80.1 to 91.8,316
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,77.4,72.5 to 82.2,543
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,91.9,88.5 to 95.3,408
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,90.9,87.3 to 94.5,408
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,86.1,80.4 to 91.8,316
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,77.8,73.0 to 82.6,543
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,71.9,66.2 to 77.6,408
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,89.8,84.6 to 95.0,316
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,73.6,68.1 to 79.1,408
Influenza,,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,62.7,55.0 to 70.3,316
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,92.7,89.8 to 95.5,511
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,64.7,59.3 to 70.1,511
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.6,89.6 to 95.5,529
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,85.1 to 96.3,208
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,89.3,81.3 to 97.2,119
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,89.1,86.4 to 91.9,940
Rotavirus,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.4,56.4 to 74.5,208
Rotavirus,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,71.3 to 78.9,940
Influenza,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,48.0,38.7 to 57.2,208
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,61.8,52.5 to 71.0,208
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,63.7,51.1 to 76.3,119
Influenza,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,51.1,46.8 to 55.4,940
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.9,64.4 to 81.4,208
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,77.4,67.1 to 87.7,119
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.3,83.3 to 95.2,208
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,93.8,89.2 to 98.4,119
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,80.0,76.5 to 83.4,940
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,89.3 to 94.1,940
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,88.5 to 93.4,940
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,51.1,30.7 to 71.5,43
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.7,60.0 to 77.3,200
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,87.0 to 95.8,200
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,87.7 to 94.2,529
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.8,73.2 to 86.5,529
Hib,≥2 Doses,States/Local Areas,Nevada,2021,Age,7 Months,83.8,76.1 to 89.3,237
Hib,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,83.9,78.9 to 88.3,560
Hib,≥3 Doses,States/Local Areas,Nevada,2021,Age,19 Months,81.8,74.1 to 87.7,237
Polio,≥2 Doses,States/Local Areas,Nevada,2021,Age,7 Months,83.0,75.1 to 88.7,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2021,Age,24 Months,87.7,80.8 to 93.0,237
Polio,≥3 Doses,States/Local Areas,Nevada,2021,Age,35 Months,88.0,81.3 to 93.1,237
Hep B,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,90.2,85.5 to 93.6,560
DTaP,≥3 Doses,States/Local Areas,Nevada,2021,Age,7 Months,63.4,54.2 to 71.7,237
≥1 Dose MMR,,States/Local Areas,Nevada,2020-2021,Age,24 Months,87.9,83.2 to 91.8,560
PCV,≥2 Doses,States/Local Areas,Nevada,2021,Age,5 Months,72.8,64.2 to 79.9,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,89.4,85.0 to 92.6,663
DTaP,≥4 Doses,States/Local Areas,Nevada,2019-2020,Age,19 Months,67.3,61.9 to 72.2,663
Hep B,≥3 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,70.0,64.7 to 74.8,663
DTaP,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,3 Months,87.0,82.4 to 90.5,663
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2019-2020,Age,0-3 Days,81.0,76.3 to 84.9,663
Polio,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,3 Months,86.3,81.7 to 89.9,663
Hep A,≥1 Dose,States/Local Areas,Nevada,2019-2020,Age,19 Months,80.8,75.8 to 85.0,663
Hib,≥1 Dose,States/Local Areas,Nevada,2020,Age,3 Months,84.2,76.4 to 89.8,323
Hep B,≥2 Doses,States/Local Areas,Nevada,2020,Age,7 Months,87.6,79.9 to 92.6,323
Polio,≥1 Dose,States/Local Areas,Nevada,2020,Age,3 Months,83.8,76.1 to 89.4,323
DTaP,≥1 Dose,States/Local Areas,Nevada,2020,Age,3 Months,84.5,76.7 to 90.0,323
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,88.6,82.3 to 95.0,659
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,77.4,70.6 to 84.2,511
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.6,88.1 to 97.1,200
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,89.8,86.4 to 93.3,659
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.7,49.6 to 77.8,71
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,78.2,73.0 to 83.3,467
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,76.8 to 89.9,200
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,80.9,63.7 to 98.1,43
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,94.0,87.0 to 100.0,54
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,90.6,87.4 to 93.9,659
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,92.0,89.0 to 95.0,511
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,86.7,70.2 to 100.0,43
Influenza,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,49.0,42.9 to 55.0,467
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,78.2,75.0 to 81.4,1267
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,54.9,35.2 to 74.7,43
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,91.7,89.7 to 93.8,1267
Rotavirus,,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,87.7,82.8 to 92.6,316
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,90.1,87.8 to 92.4,1267
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,74.8,69.3 to 80.4,408
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Overall,Overall,91.3,89.2 to 93.4,1267
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,89.5,85.9 to 93.0,543
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,78.5,75.3 to 81.6,1267
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,89.2,85.3 to 93.1,408
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,84.3,75.7 to 93.0,316
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Overall,Overall,89.4,87.1 to 91.8,1267
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,86.3,80.0 to 92.5,543
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,89.6,86.0 to 93.2,543
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,88.8,84.7 to 92.8,408
Influenza,,States/Local Areas,Nevada,2016-2019,Overall,Overall,50.6,46.9 to 54.4,1267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Overall,Overall,79.3,76.4 to 82.2,1267
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,91.3,87.9 to 94.8,408
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Overall,Overall,81.0,76.4 to 85.5,1267
Rotavirus,,States/Local Areas,Nevada,2016-2019,Overall,Overall,73.5,70.2 to 76.9,1267
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Overall,Overall,91.2,89.1 to 93.3,1267
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,93.4,89.3 to 97.6,316
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,66.6,61.2 to 72.0,543
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,91.6,88.4 to 94.8,543
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,81.4,75.1 to 87.8,316
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,63.2,57.0 to 69.3,408
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,95.7,92.6 to 98.9,316
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Poverty,<133% FPL,79.4,74.5 to 84.3,408
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,89.7,86.3 to 93.1,543
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Overall,Overall,77.3,74.1 to 80.5,1267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.6,72.2 to 87.0,208
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,89.2,81.1 to 97.3,119
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,93.8,89.7 to 97.8,316
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,133% to <400% FPL,91.4,88.3 to 94.5,543
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Overall,Overall,68.4,64.8 to 71.9,1267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,80.0,71.1 to 88.9,119
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,70.5,66.5 to 74.4,940
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,79.2,75.8 to 82.5,940
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,92.8,87.7 to 97.9,119
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.9,88.1 to 97.6,208
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,91.3,88.8 to 93.7,940
Influenza,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,52.9,40.3 to 65.5,119
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,88.6 to 98.0,208
Rotavirus,,States/Local Areas,Nevada,2019-2020,Age,8 Months,72.0,67.0 to 76.6,663
PCV,≥3 Doses,States/Local Areas,Nevada,2020,Age,7 Months,66.0,57.8 to 73.3,323
Hep B,≥3 Doses,States/Local Areas,Nevada,2020,Age,7 Months,67.6,59.3 to 74.9,323
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.0,67.8 to 84.3,208
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,79.3,75.7 to 82.8,940
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,93.1,88.1 to 98.1,119
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,88.7 to 98.0,208
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,72.4,60.3 to 84.6,119
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,91.9,89.5 to 94.3,940
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.1,72.7 to 93.5,208
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,88.3,80.0 to 96.6,119
Rotavirus,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,77.9,68.4 to 87.3,119
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.0,85.6 to 96.4,208
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.2,67.9 to 84.4,208
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,77.6,67.2 to 88.1,119
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a MSA Principal City,77.5,73.8 to 81.1,940
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Urbanicity,Living In a Non-MSA,81.6,69.5 to 93.6,119
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,89.1 to 96.8,200
Rotavirus,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.0,74.3 to 83.7,529
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,87.9 to 94.4,529
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.9,68.9 to 92.9,71
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,74.0,69.2 to 78.8,659
Rotavirus,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",54.0,39.6 to 68.4,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,80.1,76.0 to 84.2,659
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.1,85.5 to 92.7,529
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.0,63.5 to 88.4,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,78.4,73.9 to 82.8,511
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,92.5,89.2 to 95.7,467
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.9,75.1 to 96.7,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,87.4,77.2 to 97.5,43
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,76.5,63.1 to 90.0,54
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,87.5 to 96.5,200
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,92.8,89.9 to 95.6,511
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,92.6,89.7 to 95.5,659
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,92.2,84.5 to 99.9,54
Rotavirus,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,79.3,74.8 to 83.9,659
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,74.2 to 88.7,200
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,66.3,49.4 to 83.3,54
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,93.9,91.1 to 96.8,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,81.7,77.1 to 86.3,467
Influenza,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,45.0,39.3 to 50.6,511
Influenza,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,45.6,28.4 to 62.8,54
Influenza,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,42.0,22.8 to 61.2,43
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.5,75.9 to 89.0,200
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,77.5,59.6 to 95.4,54
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,65.6,40.6 to 90.6,43
Rotavirus,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,68.8,63.6 to 74.0,511
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.7,43.3 to 72.0,71
Rotavirus,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,51.9,32.5 to 71.3,43
Rotavirus,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,83.3,72.2 to 94.4,54
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,67.6,61.9 to 73.3,467
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.7,67.5 to 77.9,529
Combined 7 Series,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",54.8,40.2 to 69.4,71
Rotavirus,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,73.8,68.4 to 79.1,467
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,96.0,91.4 to 100.0,54
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.4,76.9 to 85.8,529
Rotavirus,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.9,63.4 to 80.3,200
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,92.2,84.5 to 99.9,54
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,78.1,73.1 to 83.1,467
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,75.8,62.0 to 89.6,54
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",64.2,50.5 to 78.0,71
Influenza,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",51.6,45.8 to 57.5,529
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,88.9 to 96.7,200
Influenza,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",35.8,22.0 to 49.5,71
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.0,89.0 to 95.1,529
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.1,65.8 to 90.3,71
Influenza,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,58.2,52.9 to 63.5,659
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,80.9,63.7 to 98.1,43
Influenza,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.3,53.3 to 71.3,200
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,93.0,89.9 to 96.0,467
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.0 to 93.8,529
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,93.9,91.1 to 96.6,467
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,92.7,89.9 to 95.4,659
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.0,58.6 to 85.4,71
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,76.7,71.9 to 81.4,511
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,94.0,87.0 to 100.0,54
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,80.9,63.7 to 98.1,43
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,91.3,88.3 to 94.4,511
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,66.3,49.4 to 83.3,54
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,61.0,40.8 to 81.2,43
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,91.5,88.1 to 95.0,467
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,88.5,74.2 to 100.0,43
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.9,68.8 to 93.0,71
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,79.6,62.3 to 96.8,43
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.3,75.7 to 84.9,529
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,75.1,70.3 to 80.0,511
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,71.6,56.3 to 86.9,54
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,63.3,43.7 to 82.9,43
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,92.8,90.1 to 95.5,659
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,91.4,88.3 to 94.6,511
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,96.2,92.4 to 100.0,54
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.9,75.1 to 84.7,529
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.2,89.2 to 95.2,529
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Other,83.4,66.5 to 100.0,43
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Uninsured,95.5,90.2 to 100.0,54
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,95.6,93.3 to 97.9,467
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.1,63.4 to 88.9,71
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,82.6,78.3 to 86.9,659
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.8,65.7 to 90.0,71
DTaP,≥1 Dose,States/Local Areas,Illinois,2017,Age,3 Months,89.3,85.3 to 92.3,502
DTaP,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,3 Months,88.3,85.4 to 90.6,1044
DTaP,≥3 Doses,States/Local Areas,Illinois,2014,Age,24 Months,96.2,93.8 to 97.9,493
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,95.9,94.1 to 97.3,960
DTaP,≥3 Doses,States/Local Areas,Illinois,2015,Age,24 Months,95.6,92.7 to 97.6,467
DTaP,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,96.1,94.1 to 97.5,951
DTaP,≥1 Dose,States/Local Areas,Illinois,2018,Age,3 Months,87.2,82.9 to 90.6,542
DTaP,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,3 Months,88.5,85.6 to 90.9,1090
Hep A,≥1 Dose,States/Local Areas,Illinois,2016,Age,19 Months,83.8,79.0 to 87.7,484
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,19 Months,82.3,78.9 to 85.3,986
DTaP,≥4 Doses,States/Local Areas,Illinois,2021,Age,19 Months,68.6,61.5 to 75.0,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2021,Age,35 Months,91.2,85.3 to 95.5,369
PCV,≥3 Doses,States/Local Areas,Illinois,2021,Age,19 Months,88.8,82.6 to 93.0,369
Hep A,≥2 Doses,States/Local Areas,Illinois,2021,Age,35 Months,76.7,63.2 to 88.0,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2014,Age,19 Months,80.4,75.6 to 84.4,493
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,19 Months,77.6,73.9 to 80.9,960
Hep A,≥1 Dose,States/Local Areas,Illinois,2015,Age,19 Months,74.7,67.8 to 80.6,467
Hep A,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,19 Months,79.3,75.6 to 82.6,951
Hep A,≥1 Dose,States/Local Areas,Illinois,2013,Age,19 Months,75.4,70.9 to 79.3,537
Hep A,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,19 Months,77.9,74.1 to 81.2,1030
DTaP,≥3 Doses,States/Local Areas,Illinois,2016,Age,24 Months,96.4,93.4 to 98.3,484
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,96.1,94.2 to 97.5,986
DTaP,≥1 Dose,States/Local Areas,Illinois,2019,Age,3 Months,89.9,85.6 to 93.0,548
Hep A,≥1 Dose,States/Local Areas,Illinois,2011,Age,19 Months,77.8,73.3 to 81.7,583
DTaP,≥2 Doses,States/Local Areas,Illinois,2017,Age,5 Months,84.0,79.5 to 87.7,502
DTaP,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,5 Months,82.5,79.4 to 85.3,1044
Hep B,≥3 Doses,States/Local Areas,Illinois,2021,Age,24 Months,89.2,83.6 to 93.5,369
PCV,≥4 Doses,States/Local Areas,Illinois,2021,Age,35 Months,79.3,72.6 to 85.3,369
Hep B,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,92.6,89.1 to 95.3,918
Polio,≥3 Doses,States/Local Areas,Illinois,2021,Age,24 Months,93.3,88.6 to 96.6,369
Polio,≥1 Dose,States/Local Areas,Illinois,2021,Age,3 Months,85.8,79.7 to 90.3,369
Hib,≥3 Doses,States/Local Areas,Illinois,2021,Age,24 Months,91.5,86.6 to 95.2,369
Hib,Primary Series,States/Local Areas,Illinois,2021,Age,24 Months,91.7,86.9 to 95.3,369
≥1 Dose MMR,,States/Local Areas,Illinois,2021,Age,24 Months,93.2,87.7 to 96.8,369
Hib,Full Series,States/Local Areas,Illinois,2021,Age,24 Months,75.2,68.4 to 81.6,369
≥1 Dose Varicella,,States/Local Areas,Illinois,2021,Age,19 Months,84.9,78.4 to 89.7,369
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.9,77.6 to 84.2,990
Hib,≥1 Dose,States/Local Areas,Illinois,2021,Age,3 Months,83.2,77.1 to 87.9,369
Hib,Full Series,States/Local Areas,Illinois,2021,Age,19 Months,67.2,60.2 to 73.5,369
DTaP,≥1 Dose,States/Local Areas,Illinois,2012,Age,3 Months,86.4,82.6 to 89.4,543
DTaP,≥1 Dose,States/Local Areas,Illinois,2011,Age,3 Months,90.0,86.6 to 92.5,583
Combined 7 Series,,States/Local Areas,Illinois,2021,Age,35 Months,66.9,59.4 to 74.3,369
PCV,≥2 Doses,States/Local Areas,Illinois,2021,Age,5 Months,75.1,68.0 to 81.1,369
DTaP,≥3 Doses,States/Local Areas,Illinois,2021,Age,7 Months,70.1,62.9 to 76.4,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2012,Age,19 Months,75.1,72.8 to 77.3,543
Hep B,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,93.5,90.7 to 95.5,918
Polio,≥2 Doses,States/Local Areas,Illinois,2021,Age,7 Months,85.3,78.7 to 90.1,369
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,98.7,97.7 to 99.6,686
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,92.7,90.1 to 95.4,519
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,93.8,91.5 to 96.2,515
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,95.0,93.8 to 96.3,1720
DTaP,≥2 Doses,States/Local Areas,Illinois,2019,Age,5 Months,79.7,74.4 to 84.1,548
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,97.1,94.5 to 99.7,119
DTaP,≥2 Doses,States/Local Areas,Illinois,2018,Age,5 Months,81.0,76.3 to 85.0,542
DTaP,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,5 Months,80.4,76.9 to 83.4,1090
DTaP,≥3 Doses,States/Local Areas,Illinois,2017,Age,24 Months,95.6,93.0 to 97.5,502
DTaP,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,94.5,92.4 to 96.2,1044
DTaP,≥3 Doses,States/Local Areas,Illinois,2018,Age,24 Months,93.4,89.8 to 96.0,542
DTaP,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,93.5,91.1 to 95.5,1090
Hib,≥3 Doses,States/Local Areas,Illinois,2015,Age,24 Months,93.1,89.7 to 95.8,467
Hib,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,93.8,91.5 to 95.7,951
Hib,≥3 Doses,States/Local Areas,Illinois,2016,Age,24 Months,94.5,91.2 to 96.8,484
Hib,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,93.1,90.8 to 95.1,986
DTaP,≥3 Doses,States/Local Areas,Illinois,2019,Age,24 Months,93.6,90.0 to 96.3,548
Hib,≥3 Doses,States/Local Areas,Illinois,2017,Age,24 Months,91.8,88.2 to 94.6,502
Hib,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,91.3,88.8 to 93.5,1044
DTaP,≥4 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,89.5,83.4 to 94.2,918
Hep B,≥3 Doses,States/Local Areas,Illinois,2021,Age,19 Months,88.0,82.0 to 92.3,369
DTaP,≥1 Dose,States/Local Areas,Illinois,2013,Age,3 Months,88.4,84.4 to 91.4,537
DTaP,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,3 Months,90.8,88.7 to 92.6,1030
DTaP,≥1 Dose,States/Local Areas,Illinois,2014,Age,3 Months,93.3,90.3 to 95.4,493
DTaP,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,3 Months,90.8,88.2 to 92.9,960
DTaP,≥1 Dose,States/Local Areas,Illinois,2015,Age,3 Months,88.2,83.7 to 91.6,467
DTaP,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,3 Months,88.8,85.7 to 91.4,951
DTaP,≥1 Dose,States/Local Areas,Illinois,2016,Age,3 Months,89.4,84.5 to 92.9,484
DTaP,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,3 Months,89.4,86.2 to 91.9,986
Hib,Primary Series,States/Local Areas,Illinois,2021,Age,7 Months,66.7,59.6 to 73.1,369
≥1 Dose Varicella,,States/Local Areas,Illinois,2020-2021,Age,35 Months,95.3,92.2 to 97.4,918
Hep A,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,35 Months,92.9,89.5 to 95.5,918
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2021,Age,0-1 Days,70.7,63.7 to 76.9,369
PCV,≥3 Doses,States/Local Areas,Illinois,2021,Age,13 Months,85.8,79.4 to 90.5,369
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2021,Age,0-2 Days,74.5,67.6 to 80.4,369
Hib,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,92.5,89.5 to 94.7,918
PCV,≥3 Doses,States/Local Areas,Illinois,2021,Age,24 Months,91.9,86.7 to 95.6,369
PCV,≥4 Doses,States/Local Areas,Illinois,2021,Age,24 Months,79.0,72.3 to 85.0,369
≥1 Dose Varicella,,States/Local Areas,Illinois,2021,Age,24 Months,91.1,85.5 to 95.2,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2021,Age,24 Months,86.0,79.9 to 91.0,369
DTaP,≥3 Doses,States/Local Areas,Illinois,2021,Age,19 Months,90.9,85.0 to 94.6,369
Hib,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,66.7,62.3 to 70.9,918
PCV,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,5 Months,76.6,72.3 to 80.4,918
Hep B,≥3 Doses,States/Local Areas,Illinois,2021,Age,7 Months,56.4,49.5 to 63.0,369
PCV,≥3 Doses,States/Local Areas,Illinois,2021,Age,7 Months,67.3,60.1 to 73.7,369
Hep A,≥2 Doses,States/Local Areas,Illinois,2021,Age,24 Months,40.1,33.6 to 47.4,369
DTaP,≥3 Doses,States/Local Areas,Illinois,2021,Age,13 Months,88.2,81.8 to 92.5,369
PCV,≥4 Doses,States/Local Areas,Illinois,2021,Age,19 Months,75.3,68.1 to 81.3,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2021,Age,19 Months,79.0,72.3 to 84.4,369
Polio,≥2 Doses,States/Local Areas,Illinois,2021,Age,13 Months,91.7,86.2 to 95.1,369
Hep A,≥2 Doses,States/Local Areas,Illinois,2021,Age,19 Months,28.3,22.5 to 34.9,369
DTaP,≥1 Dose,States/Local Areas,Illinois,2021,Age,3 Months,86.8,80.8 to 91.2,369
DTaP,≥4 Doses,States/Local Areas,Illinois,2021,Age,24 Months,76.9,70.1 to 83.1,369
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,81.7,77.1 to 86.2,517
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,75.5,67.8 to 83.2,202
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,86.8,78.8 to 94.8,93
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,77.0,68.9 to 85.2,170
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,81.3 to 99.6,69
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.9,88.3 to 97.6,193
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,81.7,77.1 to 86.2,517
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,65.8,59.2 to 71.8,244
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,86.7,80.2 to 93.2,222
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,64.6,56.5 to 71.9,213
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,41.8,33.4 to 51.4,188
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,39.9,32.8 to 48.0,310
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,68.4,58.0 to 77.3,159
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,96.0,92.1 to 98.0,333
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,68.8,58.8 to 77.3,162
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,68.6,61.5 to 74.9,321
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,73.2,61.4 to 82.5,157
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,71.1,63.8 to 77.5,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,97.6,95.0 to 100.0,170
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.7,96.1 to 100.0,69
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",99.0,97.4 to 100.0,193
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,97.2,95.6 to 98.7,517
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,5 Months,81.8,72.4 to 88.4,174
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,5 Months,78.1,68.4 to 85.5,159
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,5 Months,79.9,73.4 to 85.2,333
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,81.0,73.1 to 87.8,188
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,82.0,75.4 to 87.7,310
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,41.4,31.1 to 53.5,157
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,41.4,34.0 to 49.6,319
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,41.9,32.5 to 52.9,162
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,41.9,34.8 to 49.8,321
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,82.8,72.2 to 91.1,122
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,82.6,75.4 to 88.7,266
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,41.8,31.8 to 53.6,159
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,43.7,36.4 to 51.8,333
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,80.5,71.8 to 87.8,213
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,79.5,71.7 to 86.4,244
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,69.2,58.3 to 78.3,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,55.3,49.4 to 61.1,188
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,61.1,53.5 to 68.1,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,40.1,33.1 to 47.6,244
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,45.8,30.2 to 62.3,213
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,98.0,95.4 to 100.0,93
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,98.6,96.7 to 100.0,222
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,95.9,93.0 to 98.7,202
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,5 Months,75.9,64.1 to 84.7,122
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,5 Months,76.0,66.9 to 83.2,266
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,5 Months,72.9,68.6 to 76.9,188
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,5 Months,74.4,69.6 to 78.7,310
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,5 Months,75.8,69.9 to 80.9,244
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,5 Months,68.9,65.9 to 71.8,213
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,94.2,86.1 to 98.3,144
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,97.0,92.9 to 99.1,301
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,82.7,72.6 to 90.7,144
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,82.8,75.3 to 89.0,301
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,83.0,71.7 to 91.7,157
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,81.3,74.4 to 87.3,319
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,5 Months,79.3,67.6 to 87.6,122
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,5 Months,79.9,73.2 to 85.2,266
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,91.4,83.7 to 95.6,162
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,93.8,89.5 to 96.4,321
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,98.8,96.8 to 99.6,157
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,95.7,92.2 to 98.0,319
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,92.3,85.5 to 96.7,162
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,94.5,90.6 to 97.1,321
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,5 Months,80.4,69.7 to 88.0,144
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,5 Months,79.3,71.4 to 85.5,301
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,5 Months,78.2,65.6 to 87.2,157
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,5 Months,77.5,69.0 to 84.2,319
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,5 Months,77.7,70.5 to 83.5,244
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,5 Months,71.5,67.5 to 75.1,213
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,5 Months,76.3,70.9 to 81.0,188
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,5 Months,77.8,74.6 to 80.7,310
Hib,Full Series,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,78.6,69.0 to 86.9,174
Hib,Full Series,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,81.8,74.1 to 88.3,213
Hib,Full Series,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,87.1,77.0 to 94.3,244
Hib,Full Series,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,84.8,77.6 to 90.6,188
Hib,Full Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,84.4,78.0 to 89.8,310
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,94.3,88.8 to 97.7,188
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,95.7,91.2 to 98.3,310
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,94.3,86.3 to 98.4,122
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,95.8,91.1 to 98.5,266
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,86.7,79.6 to 92.4,213
Hib,Full Series,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,76.8,67.3 to 85.2,162
Hib,Full Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,81.3,73.6 to 87.9,321
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.8,89.4 to 98.2,85
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,97.3,90.9 to 99.5,144
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,98.1,95.0 to 99.5,301
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,95.6,92.2 to 98.9,170
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,93.9 to 100.0,69
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.3,93.6 to 100.0,193
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,95.8,93.8 to 97.7,517
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,85.7,79.6 to 91.8,289
Hib,Full Series,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,82.1,69.6 to 91.6,174
Hib,Full Series,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,85.5,73.7 to 93.9,159
Hib,Full Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,83.9,75.3 to 90.8,333
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.0,63.3 to 84.8,85
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,78.8,71.9 to 85.6,212
Hib,Full Series,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,83.4,73.3 to 91.3,144
Hib,Full Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,85.7,77.9 to 91.9,301
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,83.7,73.2 to 91.7,122
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,83.5,76.4 to 89.5,266
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,87.7,75.3 to 95.6,157
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,82.7,75.3 to 88.9,319
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,97.6,95.3 to 99.9,289
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,93.9,90.7 to 97.2,212
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,97.8,92.2 to 99.7,174
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,93.0,84.4 to 97.8,122
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,94.4,88.3 to 98.0,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,90.3,82.8 to 95.5,188
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,91.8,86.2 to 95.7,310
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,38.1,27.3 to 51.4,122
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,38.8,31.1 to 47.6,266
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,39.6,29.1 to 52.3,144
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,40.4,32.9 to 48.9,301
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,97.2,95.6 to 98.7,517
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,96.5,92.2 to 98.8,159
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,96.8,92.9 to 98.9,333
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,94.7,87.4 to 98.4,174
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,80.5,69.5 to 89.5,188
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,73.6,64.4 to 82.0,310
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,75.8,65.4 to 85.0,213
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,74.4,62.5 to 84.9,244
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,45.8,35.6 to 57.4,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,44.1,33.4 to 55.3,157
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,46.5,39.0 to 54.2,319
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,5 Months,76.2,65.4 to 84.4,144
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,5 Months,77.2,69.2 to 83.5,301
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,49.9,38.7 to 61.1,144
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,47.0,39.1 to 54.9,301
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,66.8,55.6 to 76.5,122
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,58.5,50.2 to 66.3,266
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,5 Months,75.6,65.8 to 83.3,162
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,5 Months,77.0,70.3 to 82.6,321
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,5 Months,78.1,65.5 to 87.0,157
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,5 Months,76.9,68.5 to 83.6,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,55.5,48.3 to 62.4,244
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,92.9,86.8 to 96.8,159
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,94.7,89.7 to 97.7,333
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,93.3,86.9 to 97.3,162
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,93.2,89.0 to 96.2,321
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,98.3,95.4 to 99.5,157
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,95.9,92.5 to 98.1,319
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,68.6,54.6 to 81.8,122
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,74.9,64.5 to 84.2,266
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,62.2,52.0 to 71.5,174
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,86.5,83.7 to 88.8,188
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,88.5,86.4 to 90.4,310
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,83.6,67.0 to 94.8,144
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,82.0,71.7 to 90.3,301
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,80.0,67.5 to 90.0,157
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,78.1,69.6 to 85.5,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,60.4,50.3 to 69.8,159
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,61.3,54.2 to 68.0,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,49.2,39.7 to 58.8,162
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,54.7,47.6 to 61.6,321
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,91.1,84.6 to 95.1,244
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,80.8,75.0 to 85.5,213
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,91.5,85.9 to 97.0,170
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,5 Months,83.2,73.9 to 89.7,174
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,59.7,54.0 to 65.1,188
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,64.3,58.1 to 69.9,310
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.6,83.7 to 97.5,85
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,5 Months,78.5,68.9 to 85.8,159
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,5 Months,80.8,74.3 to 86.0,333
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,91.1,86.1 to 96.1,289
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,90.9,86.2 to 95.5,212
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,96.6,89.9 to 99.3,174
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,58.7,51.5 to 65.6,213
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,52.2,40.8 to 63.4,144
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,58.4,50.2 to 66.2,301
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,68.9,57.5 to 78.3,122
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,60.6,52.4 to 68.3,266
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,88.5,80.1 to 94.4,244
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,82.8,72.7 to 90.8,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,84.3,78.6 to 88.7,244
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,89.1,81.0 to 97.2,93
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,91.0,76.7 to 96.9,157
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,89.9,82.8 to 94.3,319
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,90.3,80.9 to 95.3,144
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,90.7,83.2 to 95.0,301
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,91.4,88.1 to 94.7,517
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,92.3,87.8 to 96.8,202
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,90.6,81.4 to 95.5,122
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,90.5,84.5 to 94.3,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.7,88.9 to 98.6,193
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,88.1 to 94.7,517
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,75.3 to 98.8,69
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,57.6,47.7 to 67.0,162
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,62.7,55.6 to 69.2,321
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,64.5,52.6 to 74.9,157
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,61.2,53.2 to 68.7,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,68.0,57.8 to 76.7,159
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,60.4,53.0 to 67.3,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,66.8,54.7 to 77.0,157
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,67.3,59.0 to 74.6,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,82.8,78.7 to 86.3,213
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,87.6,83.3 to 91.0,188
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,89.2,84.8 to 92.4,310
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,87.1,83.7 to 90.0,244
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,52.4,42.0 to 62.6,174
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,66.3,54.8 to 76.2,144
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,66.5,58.3 to 73.9,301
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,73.3,61.8 to 82.4,122
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,69.9,61.9 to 76.8,266
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,75.4,64.1 to 85.3,162
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,79.9,70.5 to 87.9,321
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,88.2,71.0 to 97.5,159
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,83.7,71.0 to 93.0,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,88.7,78.4 to 94.5,122
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,89.3,83.1 to 93.4,266
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,88.4,84.2 to 91.6,188
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,88.6,83.8 to 92.0,310
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,88.5,80.6 to 94.2,188
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,86.7,80.1 to 91.9,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,77.1,72.8 to 80.9,213
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,75.2,62.4 to 86.3,174
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,85.2,74.6 to 93.1,122
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,87.1,78.1 to 93.6,266
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,83.7,73.4 to 91.7,144
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,89.9,83.0 to 94.8,301
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,83.5,74.7 to 90.6,213
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,79.6,70.5 to 87.3,162
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,78.7,72.2 to 84.6,321
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,77.9,68.3 to 86.3,159
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,80.0,73.1 to 86.1,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,54.2,51.1 to 57.2,244
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,53.1,43.0 to 62.9,213
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,54.7,48.7 to 60.5,188
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,64.0,52.2 to 74.3,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,82.2,73.0 to 88.8,162
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,87.0,81.3 to 91.1,321
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,89.8,81.3 to 94.7,144
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,89.6,84.2 to 93.3,301
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,89.4,81.4 to 94.2,157
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,85.9,80.1 to 90.3,319
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.2,52.4 to 80.0,85
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,93.4,86.7 to 97.4,157
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,90.6,84.7 to 94.8,319
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,86.2,77.0 to 93.0,162
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,87.0,80.9 to 91.9,321
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,83.8,73.5 to 94.1,170
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,87.8,79.2 to 94.1,159
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,87.9,81.4 to 92.9,333
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,83.2,76.0 to 90.4,289
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,76.6,66.7 to 86.4,212
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,92.8,84.2 to 96.9,159
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,93.4,88.3 to 96.4,333
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,88.7,80.4 to 93.8,162
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,90.7,85.3 to 94.3,321
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,3 Months,95.6,85.0 to 98.8,122
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,3 Months,96.1,90.8 to 98.4,266
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,3 Months,96.3,91.7 to 98.4,244
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,3 Months,91.0,85.6 to 94.5,213
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,3 Months,92.6,89.8 to 94.7,188
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,3 Months,94.1,90.4 to 96.4,310
DTaP,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,91.4,88.1 to 93.9,918
Hep B,≥2 Doses,States/Local Areas,Illinois,2021,Age,7 Months,88.5,82.8 to 92.5,369
Hib,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,91.7,88.7 to 94.1,918
Hep B,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,85.8,82.1 to 88.8,918
PCV,≥4 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,80.4,76.3 to 84.1,918
≥1 Dose MMR,,States/Local Areas,Illinois,2021,Age,35 Months,94.1,88.2 to 97.6,369
Hib,≥3 Doses,States/Local Areas,Illinois,2021,Age,7 Months,50.1,43.2 to 57.0,369
Hib,≥2 Doses,States/Local Areas,Illinois,2021,Age,7 Months,85.5,79.2 to 90.1,369
PCV,≥3 Doses,States/Local Areas,Illinois,2021,Age,35 Months,92.3,87.0 to 96.0,369
Hib,Primary Series,States/Local Areas,Illinois,2020-2021,Age,24 Months,92.4,89.6 to 94.6,918
Hib,≥2 Doses,States/Local Areas,Illinois,2021,Age,5 Months,73.4,66.3 to 79.4,369
Hib,Primary Series,States/Local Areas,Illinois,2021,Age,19 Months,91.0,85.7 to 94.4,369
DTaP,≥3 Doses,States/Local Areas,Illinois,2013,Age,35 Months,95.6,92.9 to 97.4,537
DTaP,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,96.2,94.5 to 97.5,1030
DTaP,≥3 Doses,States/Local Areas,Illinois,2012,Age,35 Months,92.4,88.3 to 95.4,543
DTaP,≥3 Doses,States/Local Areas,Illinois,2011,Age,35 Months,96.9,94.6 to 98.4,583
DTaP,≥3 Doses,States/Local Areas,Illinois,2014,Age,35 Months,96.8,94.4 to 98.3,493
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,96.6,94.8 to 97.9,960
Hep A,≥2 Doses,States/Local Areas,Illinois,2011,Age,19 Months,18.2,16.1 to 20.4,583
Hep A,≥2 Doses,States/Local Areas,Illinois,2013,Age,19 Months,27.2,23.6 to 31.1,537
Hep A,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,24.6,21.4 to 28.1,1030
Hep A,≥2 Doses,States/Local Areas,Illinois,2014,Age,19 Months,21.9,17.8 to 26.7,493
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,21.1,18.1 to 24.4,960
Hep A,≥2 Doses,States/Local Areas,Illinois,2012,Age,19 Months,20.7,18.6 to 23.0,543
Hib,≥3 Doses,States/Local Areas,Illinois,2018,Age,24 Months,90.9,87.0 to 94.0,542
Hib,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,90.8,88.1 to 93.1,1090
Hib,≥3 Doses,States/Local Areas,Illinois,2019,Age,24 Months,90.7,86.7 to 93.9,548
DTaP,≥3 Doses,States/Local Areas,Illinois,2017,Age,35 Months,95.7,93.1 to 97.6,502
DTaP,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,94.6,92.4 to 96.3,1044
DTaP,≥4 Doses,States/Local Areas,Illinois,2011,Age,19 Months,70.5,67.3 to 73.5,583
DTaP,≥4 Doses,States/Local Areas,Illinois,2012,Age,19 Months,72.1,69.3 to 74.8,543
PCV,≥2 Doses,States/Local Areas,Illinois,2013,Age,5 Months,75.3,73.4 to 77.1,537
PCV,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,5 Months,76.5,74.5 to 78.4,1030
PCV,≥2 Doses,States/Local Areas,Illinois,2012,Age,5 Months,73.1,68.6 to 77.3,543
PCV,≥2 Doses,States/Local Areas,Illinois,2011,Age,5 Months,81.6,76.4 to 85.9,583
DTaP,≥3 Doses,States/Local Areas,Illinois,2015,Age,35 Months,96.3,93.3 to 98.2,467
DTaP,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,96.6,94.6 to 98.0,951
DTaP,≥3 Doses,States/Local Areas,Illinois,2016,Age,35 Months,96.8,93.8 to 98.6,484
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,96.3,94.4 to 97.6,986
Hep A,≥2 Doses,States/Local Areas,Illinois,2015,Age,19 Months,20.2,17.7 to 22.9,467
Hep A,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,23.0,19.7 to 26.6,951
Hep A,≥2 Doses,States/Local Areas,Illinois,2016,Age,19 Months,25.8,20.8 to 31.4,484
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,23.7,20.4 to 27.4,986
Hib,≥3 Doses,States/Local Areas,Illinois,2013,Age,35 Months,96.1,93.0 to 98.1,537
Hib,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,94.3,92.1 to 96.1,1030
Hib,≥3 Doses,States/Local Areas,Illinois,2014,Age,35 Months,92.8,89.3 to 95.4,493
Hib,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,93.1,90.7 to 95.0,960
Hib,≥3 Doses,States/Local Areas,Illinois,2015,Age,35 Months,93.4,89.9 to 96.0,467
Hib,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,94.6,92.4 to 96.4,951
Hep A,≥2 Doses,States/Local Areas,Illinois,2017,Age,19 Months,21.6,17.4 to 26.5,502
Hep A,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,22.9,19.9 to 26.2,1044
Hep A,≥1 Dose,States/Local Areas,Illinois,2017,Age,19 Months,80.7,75.5 to 84.9,502
Hep A,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,19 Months,81.3,77.9 to 84.3,1044
Hep A,≥1 Dose,States/Local Areas,Illinois,2018,Age,19 Months,82.0,77.2 to 86.0,542
Hep A,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,19 Months,80.2,75.9 to 83.9,879
Hib,≥3 Doses,States/Local Areas,Illinois,2012,Age,35 Months,92.5,88.5 to 95.5,543
Hib,≥3 Doses,States/Local Areas,Illinois,2011,Age,35 Months,96.7,94.3 to 98.3,583
Hep A,≥1 Dose,States/Local Areas,Illinois,2016,Age,24 Months,89.6,85.6 to 92.8,484
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,24 Months,86.3,83.2 to 89.0,986
PCV,≥2 Doses,States/Local Areas,Illinois,2014,Age,5 Months,77.7,72.7 to 82.1,493
PCV,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,5 Months,77.1,75.1 to 79.1,960
PCV,≥2 Doses,States/Local Areas,Illinois,2015,Age,5 Months,76.5,70.9 to 81.3,467
PCV,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,5 Months,79.4,75.6 to 82.7,951
PCV,≥2 Doses,States/Local Areas,Illinois,2016,Age,5 Months,82.3,76.9 to 86.7,484
PCV,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,5 Months,81.5,77.9 to 84.6,986
DTaP,≥3 Doses,States/Local Areas,Illinois,2018,Age,35 Months,93.4,89.8 to 96.0,542
DTaP,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,93.7,91.2 to 95.7,1090
DTaP,≥3 Doses,States/Local Areas,Illinois,2019,Age,35 Months,94.1,90.3 to 96.8,548
Hep A,≥1 Dose,States/Local Areas,Illinois,2017,Age,24 Months,83.0,78.2 to 87.2,502
Hep A,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,24 Months,84.5,81.3 to 87.4,1044
Hib,≥3 Doses,States/Local Areas,Illinois,2018,Age,35 Months,92.8,89.0 to 95.7,542
Hib,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,92.2,89.4 to 94.4,1090
Hep A,≥2 Doses,States/Local Areas,Illinois,2012,Age,24 Months,36.2,31.1 to 41.9,543
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.7,88.2 to 97.2,151
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,86.5,74.5 to 98.6,34
DTaP,≥4 Doses,States/Local Areas,Illinois,2013,Age,19 Months,72.8,68.5 to 76.7,537
DTaP,≥4 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,73.7,70.4 to 76.8,1030
DTaP,≥4 Doses,States/Local Areas,Illinois,2014,Age,19 Months,74.7,69.5 to 79.2,493
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,72.1,68.2 to 75.7,960
DTaP,≥4 Doses,States/Local Areas,Illinois,2015,Age,19 Months,69.6,65.1 to 73.7,467
DTaP,≥4 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,69.9,65.7 to 73.7,951
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,95.3,93.4 to 97.2,624
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,97.5,96.2 to 98.7,1043
Hib,≥3 Doses,States/Local Areas,Illinois,2016,Age,35 Months,96.1,93.1 to 98.1,484
Hib,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,94.4,92.2 to 96.1,986
Hib,≥3 Doses,States/Local Areas,Illinois,2017,Age,35 Months,92.7,89.2 to 95.3,502
Hib,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,92.7,90.2 to 94.8,1044
Hep A,≥2 Doses,States/Local Areas,Illinois,2018,Age,19 Months,24.2,20.1 to 28.9,542
Hep A,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,24.4,20.6 to 28.6,879
Hep A,≥2 Doses,States/Local Areas,Illinois,2019,Age,19 Months,26.4,21.9 to 31.6,548
Hep A,≥2 Doses,States/Local Areas,Illinois,2011,Age,24 Months,38.3,32.6 to 44.7,583
Hep A,≥1 Dose,States/Local Areas,Illinois,2018,Age,24 Months,86.1,81.9 to 89.8,542
Hep A,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,24 Months,85.4,82.4 to 88.2,1090
Hep A,≥1 Dose,States/Local Areas,Illinois,2019,Age,24 Months,84.7,80.2 to 88.6,548
Hep A,≥1 Dose,States/Local Areas,Illinois,2011,Age,35 Months,87.8,83.9 to 91.2,583
PCV,≥2 Doses,States/Local Areas,Illinois,2017,Age,5 Months,80.6,75.8 to 84.7,502
PCV,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,5 Months,79.9,76.6 to 82.9,1044
Hep A,≥1 Dose,States/Local Areas,Illinois,2012,Age,35 Months,85.3,80.7 to 89.4,543
Hep A,≥1 Dose,States/Local Areas,Illinois,2019,Age,19 Months,80.7,75.7 to 84.9,548
Hep A,≥1 Dose,States/Local Areas,Illinois,2011,Age,24 Months,82.5,78.4 to 86.2,583
Hep A,≥1 Dose,States/Local Areas,Illinois,2013,Age,24 Months,80.3,75.7 to 84.5,537
Hep A,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,24 Months,83.6,80.6 to 86.4,1030
Hep A,≥1 Dose,States/Local Areas,Illinois,2014,Age,24 Months,86.9,82.9 to 90.3,493
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,24 Months,84.6,81.4 to 87.5,960
Hep A,≥1 Dose,States/Local Areas,Illinois,2012,Age,24 Months,81.7,77.1 to 86.0,543
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,97.9,94.0 to 99.3,157
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,94.8,90.8 to 97.1,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,95.7,94.1 to 96.8,144
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,96.8,93.0 to 98.5,301
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,94.5,84.8 to 98.2,122
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,95.1,89.8 to 97.7,266
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,96.8,91.8 to 98.8,157
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,92.2,87.4 to 95.3,319
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,95.7,94.1 to 96.8,144
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,96.2,92.3 to 98.2,301
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,91.8,86.5 to 95.6,188
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,92.3,87.9 to 95.5,310
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,92.8,83.3 to 97.1,122
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,94.2,88.8 to 97.1,266
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,86.7,79.6 to 92.4,213
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,93.1,88.1 to 96.6,244
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,95.4,87.8 to 98.4,174
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,92.8,85.1 to 97.4,122
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,95.0,90.4 to 97.8,266
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,97.3,90.9 to 99.5,144
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,98.1,95.0 to 99.5,301
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,98.8,96.8 to 99.6,157
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,95.6,92.1 to 97.8,319
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,87.2,78.4 to 92.7,162
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,91.1,86.1 to 94.4,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,95.2,90.1 to 97.7,159
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,88.4,83.2 to 92.1,333
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,95.5,87.8 to 98.4,174
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,96.3,91.5 to 98.4,159
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,94.7,90.7 to 97.0,333
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,93.5,88.4 to 96.9,244
Hib,Full Series,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,81.3,71.3 to 89.5,144
Hib,Full Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,83.0,75.7 to 89.1,301
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,94.2,89.0 to 97.5,188
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,95.6,91.9 to 97.9,310
Hep A,≥1 Dose,States/Local Areas,Illinois,2015,Age,24 Months,82.2,77.1 to 86.8,467
Hep A,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,24 Months,85.9,82.6 to 88.8,951
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,88.2,81.1 to 93.5,213
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,92.0,85.2 to 96.5,162
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,93.9,90.0 to 96.6,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,90.6,82.5 to 95.2,174
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,95.4,89.1 to 98.6,174
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,95.8,91.6 to 98.3,159
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,95.6,92.2 to 97.9,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,90.3,83.7 to 95.0,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,93.5,85.5 to 97.9,122
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,95.3,90.6 to 98.0,266
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,93.5,88.4 to 96.9,244
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,87.5,80.4 to 92.9,213
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,92.6,87.2 to 96.3,188
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,93.1,88.6 to 96.3,310
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,95.5,89.9 to 98.5,244
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,84.7,73.7 to 92.8,157
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,79.7,72.9 to 85.7,319
Hib,Full Series,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,74.4,65.0 to 82.9,162
Hib,Full Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,76.7,70.2 to 82.6,321
Hib,Full Series,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,79.2,70.0 to 87.0,159
Hib,Full Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,78.8,72.2 to 84.7,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,61.9,51.0 to 71.7,174
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,74.8,64.4 to 82.9,159
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,68.5,61.0 to 75.2,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,67.9,57.8 to 76.6,162
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,71.2,64.2 to 77.4,321
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,95.1,91.3 to 97.3,244
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,87.2,84.1 to 89.8,213
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,94.2,89.0 to 97.0,157
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,91.8,87.6 to 94.6,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,90.7,83.1 to 95.1,144
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,92.4,86.8 to 95.8,301
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,90.8,81.9 to 95.5,122
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,90.7,84.3 to 94.7,266
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,76.8,67.4 to 86.1,202
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,79.0,72.8 to 85.3,517
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,94.1,86.7 to 97.5,174
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.5,81.0 to 95.9,193
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,3 Months,94.7,88.7 to 97.6,162
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,3 Months,95.6,91.9 to 97.7,321
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,3 Months,98.6,96.1 to 99.5,157
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,3 Months,96.7,93.8 to 98.3,319
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,3 Months,96.7,89.7 to 99.0,144
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,3 Months,97.6,94.4 to 99.0,301
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,92.6,83.4 to 96.9,122
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,94.4,89.3 to 97.1,266
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,92.3,89.3 to 94.5,188
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,92.4,90.7 to 93.9,310
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,94.1,85.2 to 98.5,144
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,95.0,90.5 to 97.8,301
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,88.6,81.7 to 93.8,213
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,91.0,85.7 to 95.0,244
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,95.4,91.2 to 98.0,157
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,94.3,91.0 to 96.6,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,93.0,87.6 to 96.7,162
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,92.7,88.4 to 95.8,321
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2018,Age,0-1 Days,79.9,71.1 to 86.5,159
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2018-2019,Age,0-1 Days,74.1,67.2 to 80.0,333
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,5 Months,92.7,85.7 to 96.5,159
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,5 Months,90.3,85.1 to 93.9,333
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,5 Months,85.3,77.1 to 90.9,162
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,5 Months,88.9,83.8 to 92.6,321
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,89.8,85.7 to 92.8,244
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,5 Months,87.8,78.9 to 93.2,174
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2017,Age,0-1 Days,68.3,58.6 to 76.6,162
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2017-2018,Age,0-1 Days,73.9,67.5 to 79.5,321
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2016,Age,0-1 Days,76.2,65.8 to 84.2,157
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2016-2017,Age,0-1 Days,72.4,65.4 to 78.5,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,91.4,85.2 to 95.7,188
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,93.0,88.8 to 96.0,310
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,94.4,88.2 to 98.0,122
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,94.8,90.0 to 97.8,266
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,95.0,87.2 to 98.1,174
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,97.0,92.5 to 98.8,159
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,96.0,92.1 to 98.0,333
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,5 Months,90.7,82.8 to 95.2,144
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,5 Months,88.3,81.2 to 93.0,301
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2015,Age,0-1 Days,66.5,54.7 to 76.5,144
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2015-2016,Age,0-1 Days,71.4,63.5 to 78.1,301
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2014,Age,0-1 Days,74.1,62.4 to 83.2,122
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2014-2015,Age,0-1 Days,70.4,62.1 to 77.5,266
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2013,Age,0-1 Days,69.9,63.4 to 75.7,188
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2013-2014,Age,0-1 Days,72.0,67.6 to 76.0,310
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,5 Months,86.0,73.3 to 93.2,157
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,5 Months,85.7,78.7 to 90.6,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,93.6,87.2 to 96.9,159
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,91.0,86.1 to 94.3,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,85.7,76.9 to 91.5,162
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,89.6,84.3 to 93.2,321
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,64.2,57.6 to 70.3,213
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,90.1,83.2 to 97.0,93
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,91.2,85.7 to 96.8,222
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,69.2,56.7 to 79.3,122
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,67.8,59.6 to 75.1,266
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,92.9,86.0 to 96.5,157
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,89.5,84.2 to 93.1,319
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,62.8,56.0 to 69.2,244
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,68.5,65.8 to 71.1,188
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,68.8,64.5 to 72.8,310
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,85.3,78.1 to 91.2,213
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,89.3,83.6 to 93.7,244
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,73.9,66.1 to 81.7,202
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,90.9,84.3 to 94.9,162
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,90.9,86.0 to 94.3,321
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,93.8,88.5 to 96.7,157
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,92.4,88.5 to 95.1,319
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,92.4,89.1 to 94.8,144
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,93.1,87.8 to 96.2,301
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,83.0,78.5 to 87.5,517
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,83.0,78.5 to 87.5,517
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,84.2 to 100.0,69
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,93.5 to 99.5,193
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,94.0,91.3 to 95.9,144
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,93.5,88.7 to 96.3,301
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,90.8,80.2 to 96.0,122
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,92.4,86.3 to 95.9,266
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,88.3,80.8 to 95.8,222
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,5 Months,87.4,75.5 to 94.0,122
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,5 Months,89.0,85.2 to 92.0,266
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,89.6,85.6 to 92.6,188
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,90.2,86.7 to 92.9,310
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,5 Months,87.7,83.7 to 90.7,188
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,5 Months,87.5,85.0 to 89.7,310
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,5 Months,86.3,80.6 to 90.5,244
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,5 Months,74.8,68.9 to 79.9,213
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2011,Age,0-1 Days,73.5,62.8 to 81.9,244
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,74.6,55.2 to 94.0,93
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2012,Age,0-1 Days,72.8,66.0 to 78.7,213
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,3 Months,97.7,94.1 to 99.2,174
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,85.7,75.4 to 92.2,174
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,3 Months,96.6,90.5 to 98.8,159
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,3 Months,97.2,94.0 to 98.7,333
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,91.6,83.9 to 95.8,162
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,94.2,90.0 to 96.7,321
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,99.2,97.3 to 99.8,157
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,95.6,91.7 to 97.7,319
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,96.2,89.3 to 98.7,144
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,97.7,94.4 to 99.1,301
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,78.5,70.2 to 86.7,170
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,92.1,83.8 to 96.4,159
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,60.4,53.0 to 67.3,333
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,89.1,81.9 to 93.7,162
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,90.6,85.6 to 94.0,321
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,82.5,79.7 to 85.0,213
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,87.4,74.4 to 94.3,122
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,89.9,82.1 to 94.5,266
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,88.2,83.6 to 91.6,188
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,87.8,80.5 to 92.6,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,87.0,82.6 to 90.4,244
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,89.9,81.6 to 94.7,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,92.0,85.3 to 95.8,159
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,91.0,86.1 to 94.3,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,83.6,78.5 to 87.7,213
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,91.2,85.1 to 95.5,188
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,91.8,86.3 to 95.7,310
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,93.3,82.9 to 98.4,122
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,95.8,89.4 to 98.9,266
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,96.5,87.8 to 99.5,144
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,96.2,92.3 to 98.4,301
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,92.1,84.9 to 96.7,159
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,91.5,86.3 to 95.4,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,87.7,81.9 to 92.3,244
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,93.2,85.2 to 97.0,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,90.1,84.1 to 94.6,188
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,92.0,87.5 to 95.4,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,94.2,87.3 to 98.0,122
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,95.6,91.4 to 98.1,266
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,83.6,76.3 to 89.7,213
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,66.9,54.6 to 77.2,157
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,67.6,59.3 to 74.9,319
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,83.2,71.3 to 90.8,157
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,79.3,71.2 to 85.6,319
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,79.0,73.5 to 83.7,144
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,81.1,73.4 to 87.0,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,66.5,55.0 to 76.3,144
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,66.7,58.4 to 74.0,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,68.4,58.3 to 77.0,162
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,69.8,62.7 to 76.0,321
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,97.0,90.6 to 99.5,144
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,94.9,91.0 to 97.5,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,88.8,86.2 to 91.0,188
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,88.8,86.4 to 90.8,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,92.9,86.9 to 96.8,157
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,90.4,85.6 to 94.1,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,87.7,79.7 to 93.6,162
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,90.6,85.8 to 94.3,321
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,80.5,75.9 to 84.5,213
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,95.1,90.9 to 97.8,157
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,94.2,91.0 to 96.6,319
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,93.3,88.0 to 96.8,162
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,92.2,87.8 to 95.5,321
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,77.9,67.2 to 85.8,159
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,74.9,65.9 to 82.1,266
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,75.0,65.2 to 82.7,162
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,76.4,69.4 to 82.2,321
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,87.5,81.9 to 91.5,244
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,71.5,61.3 to 79.9,174
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,71.3,61.0 to 79.8,159
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,71.4,64.3 to 77.6,333
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,80.3,76.1 to 83.9,213
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,92.2,84.2 to 96.3,144
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,95.3,91.2 to 97.5,301
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,92.2,83.0 to 96.6,122
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,92.2,86.7 to 95.5,266
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,91.3,89.0 to 93.2,188
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,91.8,87.5 to 94.7,310
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2012,Age,0-2 Days,77.6,73.5 to 81.2,213
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2013,Age,0-2 Days,78.9,70.4 to 85.5,188
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2013-2014,Age,0-2 Days,80.5,77.1 to 83.5,310
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2011,Age,0-2 Days,78.5,70.6 to 84.8,244
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2019,Age,0-1 Days,68.0,57.2 to 77.2,174
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2019,Age,0-2 Days,78.3,67.9 to 86.0,174
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2018,Age,0-2 Days,82.8,74.3 to 88.9,159
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2018-2019,Age,0-2 Days,80.6,74.2 to 85.7,333
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2017,Age,0-2 Days,73.8,64.5 to 81.4,162
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2017-2018,Age,0-2 Days,78.2,72.0 to 83.3,321
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,76.6,68.3 to 84.1,213
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,93.5,85.8 to 97.8,244
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,93.2,86.3 to 97.3,174
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,81.3,74.2 to 87.4,188
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,80.5,74.2 to 86.2,310
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,79.8,69.3 to 88.5,122
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,82.1,75.2 to 88.0,266
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,84.3,75.0 to 91.5,144
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,88.0,82.5 to 92.4,301
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,86.2,77.4 to 92.8,174
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,90.7,83.9 to 95.5,213
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,93.9,88.5 to 97.3,244
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,95.0,88.8 to 98.4,188
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,94.6,88.8 to 97.9,310
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,97.6,94.2 to 99.2,157
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,95.9,93.0 to 97.9,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,96.4,90.1 to 99.1,188
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,96.5,92.2 to 98.7,310
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,91.0,83.4 to 96.0,159
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,88.6,83.1 to 93.0,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,74.6,63.3 to 83.3,174
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,95.3,88.9 to 98.5,122
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,95.5,90.6 to 98.2,266
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,94.1,85.2 to 98.5,144
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,96.5,92.1 to 98.8,301
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,92.4,85.3 to 96.9,173
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,76.7,69.1 to 83.6,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2015,Age,0-2 Days,77.1,65.6 to 85.6,144
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2015-2016,Age,0-2 Days,77.8,70.3 to 83.8,301
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2014,Age,0-2 Days,82.1,70.8 to 89.6,122
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2014-2015,Age,0-2 Days,79.6,71.9 to 85.6,266
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,86.1,76.3 to 92.2,174
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,76.1,64.6 to 84.8,122
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,77.6,69.9 to 83.7,266
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,91.0,82.4 to 95.6,159
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,95.0,90.7 to 97.4,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,69.4,60.8 to 76.9,244
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,70.0,60.0 to 78.4,213
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,75.4,72.4 to 78.1,188
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,75.8,71.8 to 79.3,310
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,92.0,86.5 to 97.4,222
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,79.0,72.8 to 85.3,517
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.1,62.3 to 83.9,85
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,88.9,87.0 to 90.6,244
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,90.4,85.3 to 95.6,289
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,77.6,70.5 to 84.7,212
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,87.6,77.4 to 94.7,174
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,94.9,89.8 to 97.5,157
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,91.3,86.8 to 94.4,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,93.6,88.0 to 97.2,159
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,93.4,89.2 to 96.4,333
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,91.0,82.5 to 95.6,144
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,92.9,88.2 to 95.9,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,88.7,78.9 to 94.3,122
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,89.8,83.8 to 93.8,266
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,94.2,87.5 to 97.5,159
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,93.7,89.2 to 96.4,333
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,89.3,81.7 to 94.0,162
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,91.7,87.0 to 94.8,321
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,98.4,96.0 to 99.4,157
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,94.1,90.2 to 96.5,319
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2016,Age,0-2 Days,78.4,68.1 to 86.1,157
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2016-2017,Age,0-2 Days,76.2,69.4 to 81.9,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,88.7,80.6 to 94.4,162
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,91.5,86.6 to 95.1,321
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,85.2,82.4 to 87.6,213
Hib,Full Series,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,70.1,60.7 to 79.0,173
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,94.4,88.6 to 97.8,159
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,93.8,89.6 to 96.7,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,79.1,70.7 to 86.5,213
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,79.5,71.5 to 86.4,244
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,82.7,73.7 to 90.0,159
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,82.2,75.4 to 88.0,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,81.8,71.4 to 90.3,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,92.9,86.9 to 96.8,157
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,90.9,86.0 to 94.6,319
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,92.2,82.4 to 96.7,122
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,94.3,89.2 to 97.1,266
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,92.1,89.6 to 94.1,188
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,92.1,90.1 to 93.8,310
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,91.2,89.4 to 92.8,244
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,92.6,85.5 to 96.4,174
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,90.2,84.1 to 94.7,188
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,94.6,89.2 to 97.8,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,97.3,90.9 to 99.5,122
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,97.7,93.2 to 99.5,266
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,97.2,90.6 to 99.5,144
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,95.0,91.1 to 97.6,301
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,83.6,76.3 to 89.7,213
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,95.3,90.5 to 97.7,159
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,94.0,90.1 to 96.4,333
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,87.4,78.8 to 92.8,162
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,91.2,86.4 to 94.5,321
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,88.7,84.2 to 92.0,213
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,92.2,89.6 to 94.2,188
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,93.8,89.4 to 96.4,310
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,92.9,90.9 to 94.5,244
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,93.1,85.9 to 96.8,174
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,91.6,85.9 to 95.6,157
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,85.4,80.5 to 89.7,319
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,78.5,69.7 to 86.2,162
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,80.6,74.3 to 86.1,321
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,96.5,87.8 to 99.5,144
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,97.8,94.7 to 99.3,301
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,93.3,82.9 to 98.4,122
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,95.8,89.4 to 98.9,266
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,97.2,93.8 to 99.0,157
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,95.2,92.2 to 97.3,319
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.1,83.0 to 97.2,85
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,94.3,89.2 to 97.5,162
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,93.4,89.2 to 96.4,321
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,92.1,84.9 to 96.7,159
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,94.0,88.8 to 97.3,333
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,89.0,81.6 to 94.3,213
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,92.0,86.2 to 96.0,244
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,90.6,82.4 to 96.0,174
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.2,59.9 to 94.5,69
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,95.7,92.2 to 99.3,170
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.3,95.6 to 100.0,69
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,93.8,89.3 to 98.2,289
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,93.6,90.0 to 97.2,212
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,95.1,88.0 to 98.6,174
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,80.3,69.8 to 89.0,122
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,82.4,75.5 to 88.3,266
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,84.3,75.0 to 91.5,144
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,88.8,83.4 to 93.1,301
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,93.1,87.6 to 96.7,157
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,87.4,82.4 to 91.5,319
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,92.3,87.9 to 96.6,212
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.7,81.6 to 97.7,85
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,94.8,91.0 to 98.6,170
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",100.0,,69
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,3 Months,84.8,75.9 to 90.8,244
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,3 Months,79.6,75.6 to 83.1,213
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,3 Months,80.7,77.4 to 83.7,188
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,3 Months,83.0,74.2 to 89.2,310
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,95.3,85.1 to 98.6,122
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,94.8,89.2 to 97.6,266
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,3 Months,85.3,74.0 to 92.2,122
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,3 Months,86.3,79.0 to 91.3,266
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,94.3,85.8 to 97.8,144
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,96.6,92.4 to 98.5,301
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,98.9,96.9 to 99.6,157
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,95.3,91.5 to 97.5,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,93.2,86.3 to 97.3,174
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,88.4,79.8 to 93.7,162
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,91.9,87.1 to 95.1,321
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.7,95.6 to 99.9,193
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,94.7,92.0 to 97.4,517
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,94.1,89.9 to 98.4,222
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,93.3,88.0 to 96.8,162
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,92.8,88.5 to 96.0,321
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,92.4,84.9 to 97.0,159
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,92.8,87.6 to 96.4,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,83.9,76.8 to 89.9,188
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,82.0,75.5 to 87.5,310
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,93.6,86.0 to 97.8,174
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,96.7,93.1 to 100.0,289
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.5,90.1 to 98.9,193
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,94.1,91.4 to 96.8,517
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,97.2,93.0 to 98.9,157
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,93.0,88.6 to 95.8,319
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,96.5,89.6 to 98.9,144
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,96.8,93.7 to 98.4,301
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,94.1,86.7 to 97.5,174
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,95.5,89.4 to 98.2,159
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,94.8,90.6 to 97.2,333
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,91.4,83.8 to 95.7,162
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,93.4,88.9 to 96.2,321
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,3 Months,81.8,72.4 to 88.5,162
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,3 Months,86.0,80.3 to 90.3,321
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,3 Months,86.1,73.0 to 93.4,157
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,3 Months,84.0,75.6 to 90.0,319
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,3 Months,87.3,78.1 to 93.0,144
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,3 Months,86.7,79.2 to 91.8,301
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,80.9,72.0 to 88.5,162
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,83.0,76.7 to 88.4,321
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,3 Months,88.5,79.4 to 93.9,174
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,3 Months,90.5,83.5 to 94.7,159
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,3 Months,89.5,84.2 to 93.2,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,89.2,75.6 to 97.1,174
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,85.2,76.0 to 92.2,159
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,86.5,78.3 to 92.8,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,94.7,92.0 to 97.4,517
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,91.3,86.1 to 96.6,202
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,96.7,93.7 to 99.7,93
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,98.8,97.2 to 100.0,222
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,3 Months,81.7,70.6 to 89.2,244
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,3 Months,77.2,73.8 to 80.2,213
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,5 Months,76.4,64.6 to 85.2,122
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,5 Months,78.0,68.6 to 85.3,266
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,5 Months,74.4,69.2 to 78.9,188
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,5 Months,75.4,69.4 to 80.6,310
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,92.4,86.9 to 96.2,244
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,94.8,87.5 to 98.0,174
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,95.6,90.9 to 98.0,159
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,94.0,90.1 to 96.4,333
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,80.8,74.8 to 86.8,212
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.8,65.5 to 86.2,85
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,81.7,75.0 to 88.5,170
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,3 Months,81.8,77.0 to 85.8,188
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,3 Months,83.9,75.6 to 89.8,310
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,86.8,80.7 to 92.8,289
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,93.0,87.6 to 96.6,188
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,92.5,87.9 to 95.9,310
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,5 Months,76.3,66.5 to 83.9,162
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,5 Months,77.4,70.7 to 82.9,321
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,86.1,78.9 to 91.8,213
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,92.2,83.9 to 97.1,122
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,95.2,90.8 to 97.9,266
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,98.3,95.4 to 99.5,144
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,98.4,96.3 to 99.5,301
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,5 Months,77.0,64.6 to 86.1,157
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,5 Months,76.7,68.3 to 83.4,319
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,5 Months,79.7,69.0 to 87.4,144
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,5 Months,78.4,70.5 to 84.6,301
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,91.1,81.8 to 95.9,122
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,91.1,85.1 to 94.9,266
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,86.0,83.0 to 88.5,188
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,88.5,86.9 to 90.0,310
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,96.6,93.4 to 99.8,93
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,94.1,91.4 to 96.8,517
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,93.0,88.5 to 97.5,202
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,83.1,78.9 to 87.2,517
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,78.9,72.2 to 85.5,202
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,87.3,79.8 to 94.8,93
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,87.3,80.3 to 94.3,222
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,3 Months,81.6,72.3 to 88.4,162
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,3 Months,85.7,79.9 to 90.0,321
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,3 Months,86.2,73.0 to 93.5,157
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,3 Months,84.0,75.5 to 89.9,319
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.5,87.6 to 97.4,85
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,94.4,91.1 to 97.7,289
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,95.6,91.5 to 98.1,159
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,95.2,91.8 to 97.5,333
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,88.7,80.9 to 94.3,162
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,92.1,87.7 to 95.4,321
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,79.9,73.9 to 84.8,213
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,98.3,95.5 to 99.5,157
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,93.6,89.7 to 96.4,319
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,91.1,84.6 to 95.1,244
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,5 Months,78.3,68.2 to 86.0,174
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,5 Months,78.5,68.9 to 85.8,159
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,5 Months,78.4,71.7 to 84.0,333
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,3 Months,88.7,80.2 to 93.8,144
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,3 Months,87.4,80.0 to 92.3,301
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,3 Months,86.1,75.0 to 92.8,122
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,3 Months,87.4,80.8 to 91.9,266
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,67.9 to 94.6,69
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,89.4 to 98.2,193
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,83.1,78.9 to 87.2,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2012,Age,0-3 Days,79.4,72.0 to 85.3,213
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,94.0,90.8 to 97.3,212
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,3 Months,89.9,82.7 to 94.3,159
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,3 Months,90.3,85.2 to 93.8,333
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2011,Age,0-3 Days,79.3,71.5 to 85.5,244
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,5 Months,77.2,70.4 to 82.8,244
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,5 Months,70.3,65.7 to 74.6,213
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2015,Age,0-3 Days,80.5,69.6 to 88.2,144
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2015-2016,Age,0-3 Days,80.8,73.9 to 86.3,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014,Age,0-3 Days,83.2,71.9 to 90.5,122
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2015,Age,0-3 Days,81.9,74.4 to 87.5,266
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,66.3,59.4 to 72.5,244
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,64.9,57.6 to 71.5,213
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,72.4,68.3 to 76.1,188
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,77.7,74.5 to 80.6,310
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,3 Months,83.2,75.4 to 88.9,244
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,3 Months,79.6,76.0 to 82.8,213
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,94.4,92.2 to 96.6,517
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,94.4,91.0 to 97.8,202
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,3 Months,90.8,82.3 to 95.5,174
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,3 Months,81.6,77.2 to 85.3,188
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,3 Months,83.1,75.3 to 88.9,310
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2013,Age,0-3 Days,82.2,74.8 to 87.8,188
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2013-2014,Age,0-3 Days,82.7,76.1 to 87.7,310
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.1,92.3 to 99.9,193
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,91.1,81.6 to 96.0,144
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,90.7,83.2 to 95.1,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016,Age,0-3 Days,81.2,71.6 to 88.0,157
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2017,Age,0-3 Days,79.4,73.0 to 84.6,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2017,Age,0-3 Days,81.7,70.0 to 89.6,93
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2017-2018,Age,0-3 Days,80.2,74.2 to 85.1,321
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,3 Months,87.1,73.6 to 94.2,157
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,3 Months,84.2,75.7 to 90.1,319
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,3 Months,83.3,73.6 to 89.9,144
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,3 Months,85.2,77.6 to 90.5,301
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,3 Months,84.7,73.5 to 91.7,122
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,3 Months,84.0,76.7 to 89.3,266
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,67.8,65.1 to 70.4,188
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,69.3,67.6 to 71.0,310
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,7 Months,65.8,59.2 to 71.8,244
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,7 Months,63.7,56.1 to 70.7,213
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,95.7,92.1 to 99.2,93
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,93.6,89.2 to 98.0,222
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,83.1,72.1 to 90.3,122
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,76.0,68.1 to 82.5,266
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,99.2,97.1 to 99.8,157
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,94.1,90.2 to 96.8,319
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,98.3,95.4 to 99.5,144
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,99.0,97.0 to 99.7,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,92.5,84.1 to 97.4,122
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,95.4,90.9 to 98.1,266
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,92.3,83.8 to 96.5,159
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,91.9,86.5 to 95.2,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,94.4,92.2 to 96.6,517
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,96.8,93.9 to 99.6,170
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,87.3,80.1 to 92.8,213
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,93.0,87.6 to 96.6,188
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,92.7,88.1 to 96.1,310
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,94.3,88.5 to 97.7,244
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,94.8,88.7 to 98.2,174
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,88.7,80.4 to 93.8,162
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,90.5,85.0 to 94.1,321
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,90.4,76.5 to 96.4,157
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,89.6,82.5 to 94.0,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,72.3,62.1 to 80.6,174
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,73.5,63.2 to 81.7,159
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,72.9,65.8 to 78.9,333
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.4,62.6 to 84.2,85
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,80.4,73.9 to 86.9,212
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,91.0,84.2 to 95.6,173
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,80.4,74.1 to 86.8,289
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2019,Age,0-3 Days,82.4,72.9 to 89.1,174
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,3 Months,91.1,82.4 to 95.7,174
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,92.8,83.5 to 97.0,122
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,94.9,89.7 to 97.5,266
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,96.7,91.1 to 99.2,174
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,3 Months,89.2,81.7 to 93.8,159
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,3 Months,90.1,84.8 to 93.7,333
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,3 Months,81.1,71.8 to 87.9,162
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,3 Months,85.1,79.2 to 89.5,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,63.2,51.2 to 73.8,157
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,63.1,54.9 to 70.6,319
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,66.8,55.3 to 76.6,144
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,65.0,56.8 to 72.4,301
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,70.9,58.5 to 80.9,122
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,68.9,60.5 to 76.2,266
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,96.3,92.1 to 98.6,159
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,96.3,92.7 to 98.5,333
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,88.7,80.9 to 94.3,162
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,92.5,88.1 to 95.7,321
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,92.5,89.7 to 94.5,188
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,92.6,90.8 to 94.1,310
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,72.4,62.4 to 80.6,162
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,72.9,65.9 to 79.0,321
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,66.9,54.5 to 77.3,157
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,69.5,61.1 to 76.9,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,68.8,57.2 to 78.4,144
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,67.9,59.5 to 75.2,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2018,Age,0-3 Days,83.0,74.5 to 89.1,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2018-2019,Age,0-3 Days,82.7,76.7 to 87.5,333
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,95.1,91.3 to 97.3,244
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,87.6,84.5 to 90.1,213
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,85.0,77.2 to 91.3,213
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,5 Months,74.0,64.1 to 81.9,162
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,5 Months,76.0,69.2 to 81.7,321
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,89.3,82.8 to 94.1,244
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,86.5,77.6 to 93.1,174
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,91.2,85.1 to 95.5,159
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,88.9,83.7 to 93.1,333
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,32.2,24.8 to 41.2,244
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,23.4,16.0 to 32.8,174
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,20.7,13.7 to 30.0,159
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,18.7,13.5 to 25.5,266
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,89.2,82.2 to 94.4,162
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,92.5,88.4 to 95.6,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,98.8,96.8 to 99.6,157
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,94.3,90.6 to 96.9,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,98.7,97.2 to 100.0,289
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,95.7,92.9 to 98.4,212
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,67.1,52.6 to 78.9,144
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,70.2,62.0 to 77.2,301
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,69.7,56.8 to 80.1,122
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,68.4,59.9 to 75.8,266
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,71.4,67.6 to 74.9,188
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,70.6,67.6 to 73.4,310
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.4,90.3 to 98.6,85
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,40.0,31.6 to 49.7,213
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,95.9,91.4 to 98.5,159
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,95.0,90.6 to 97.8,333
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,88.3,81.2 to 93.7,162
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,89.7,85.1 to 93.3,321
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,97.8,92.2 to 99.7,174
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,96.3,92.1 to 98.6,159
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,96.7,92.9 to 98.8,333
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,5 Months,77.7,65.1 to 86.6,157
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,5 Months,75.9,67.5 to 82.7,319
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,5 Months,79.2,68.5 to 87.0,144
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,5 Months,78.4,70.5 to 84.7,301
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,5 Months,70.0,57.4 to 80.1,122
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,5 Months,74.5,69.5 to 79.0,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,95.9,91.8 to 98.3,157
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,92.1,88.0 to 95.2,319
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,92.0,83.7 to 97.0,144
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,94.1,89.6 to 97.1,301
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,19.3,13.2 to 27.3,162
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,20.0,15.1 to 25.9,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,97.0,91.2 to 99.4,144
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,97.9,95.0 to 99.4,301
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,94.8,86.8 to 98.7,122
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,96.0,91.3 to 98.6,266
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,92.6,87.2 to 96.3,188
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,93.9,89.4 to 96.9,310
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,23.5,15.1 to 34.8,157
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,21.5,15.9 to 28.4,319
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,17.3,11.6 to 25.1,144
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,20.4,14.8 to 27.5,301
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,98.8,96.8 to 99.6,157
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,95.7,92.2 to 98.0,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,97.6,91.5 to 99.6,144
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,98.2,95.3 to 99.5,301
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,5 Months,74.8,65.7 to 82.1,244
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,5 Months,67.3,60.0 to 73.8,213
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,5 Months,72.9,69.7 to 75.8,188
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,5 Months,71.4,67.8 to 74.8,310
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,69.2,63.2 to 74.5,213
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,65.2,58.3 to 71.5,244
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,92.3,85.5 to 96.7,162
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,94.3,90.4 to 97.0,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,67.1,57.0 to 75.8,162
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,70.1,63.0 to 76.4,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016,Age,7 Months,66.1,53.8 to 76.5,157
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,7 Months,66.6,58.2 to 74.0,319
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,92.7,87.3 to 96.4,188
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,93.7,89.3 to 96.7,310
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,93.5,88.4 to 96.9,244
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,87.5,80.4 to 92.9,213
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,86.8,83.3 to 89.6,213
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,92.2,89.4 to 94.3,188
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,93.0,90.9 to 94.6,310
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,91.1,81.8 to 95.9,144
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,93.0,88.1 to 95.9,301
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,91.4,82.2 to 96.0,122
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,91.2,85.3 to 94.9,266
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,71.1,60.7 to 79.7,174
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,89.2,82.0 to 93.7,244
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,81.0,75.1 to 85.8,213
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,89.1,87.0 to 90.8,188
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,90.2,89.1 to 91.2,310
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,73.3,63.0 to 81.6,159
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,72.3,65.1 to 78.4,333
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,95.2,90.1 to 97.7,159
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,91.3,86.5 to 94.6,333
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,91.1,82.9 to 95.6,174
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,95.7,94.1 to 96.8,144
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,96.8,93.0 to 98.5,301
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,87.7,78.8 to 93.1,162
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,91.3,86.4 to 94.6,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,97.9,94.0 to 99.3,157
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,93.0,88.3 to 95.9,319
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,93.8,84.3 to 97.7,122
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,94.7,89.4 to 97.4,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,81.5,73.7 to 88.1,213
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,87.5,78.2 to 94.1,122
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,90.1,84.1 to 94.5,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,84.6,77.3 to 90.6,188
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,86.1,80.3 to 90.9,310
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,85.5,79.1 to 90.8,244
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,83.5,73.5 to 90.3,174
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013,Age,7 Months,71.0,67.6 to 74.1,188
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,7 Months,74.5,72.5 to 76.3,310
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015,Age,7 Months,67.6,56.1 to 77.3,144
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,7 Months,66.9,58.6 to 74.2,301
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014,Age,7 Months,78.0,66.5 to 86.3,122
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,7 Months,72.8,64.8 to 79.6,266
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,95.7,90.3 to 98.6,244
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,88.8,81.6 to 94.1,213
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,92.0,84.6 to 96.7,174
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,95.2,90.7 to 97.9,159
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,93.6,89.6 to 96.5,333
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,20.7,19.3 to 22.2,213
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,17.4,10.7 to 27.1,122
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,17.4,12.5 to 23.8,266
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,22.5,20.1 to 25.1,188
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,20.0,14.4 to 27.0,310
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,16.7,13.3 to 20.9,244
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,97.0,90.6 to 99.5,122
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,97.5,93.4 to 99.3,266
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,95.7,90.3 to 98.6,244
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,88.2,81.1 to 93.5,213
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,94.2,89.0 to 97.5,188
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,95.8,92.1 to 98.1,310
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,96.4,92.1 to 98.7,107
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,78.3,71.2 to 84.6,280
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,85.6,73.0 to 93.0,107
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,85.4,78.8 to 90.2,280
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,89.3,82.3 to 93.8,159
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,86.6,80.0 to 91.2,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,86.4,78.6 to 91.7,162
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,87.8,82.8 to 91.5,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,92.6,82.6 to 97.0,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,91.9,82.2 to 96.6,107
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,85.6,73.0 to 93.0,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,90.9,85.6 to 94.9,280
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,90.0,83.9 to 94.0,280
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,87.6,76.6 to 93.9,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,95.5,84.4 to 99.4,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,54.2,42.0 to 65.9,107
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,5 Months,76.2,63.4 to 85.5,107
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,90.9,85.6 to 94.9,280
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,94.1,89.4 to 96.8,280
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,5 Months,78.4,65.1 to 87.6,107
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,73.6,60.6 to 83.5,107
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,75.4,64.2 to 85.2,244
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,84.5,75.6 to 90.6,162
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,89.4,84.2 to 93.0,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,88.1,79.0 to 93.5,174
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,94.5,89.4 to 97.2,159
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,91.3,86.5 to 94.6,333
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,91.3,85.8 to 94.9,244
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,94.8,89.9 to 97.4,157
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,89.9,84.9 to 93.3,319
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,98.8,96.8 to 99.6,157
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,94.5,90.8 to 97.0,319
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,89.7,82.6 to 94.7,162
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,92.3,88.2 to 95.4,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,95.2,90.7 to 97.9,159
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,93.6,89.5 to 96.4,333
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,97.0,91.2 to 99.4,144
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,97.9,95.0 to 99.4,301
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,94.5,86.6 to 98.5,122
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,95.8,91.2 to 98.4,266
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,88.8,81.6 to 94.1,213
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,94.8,86.8 to 98.7,122
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,96.0,91.3 to 98.5,266
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,91.9,84.5 to 96.6,174
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2011,Age,35 Months,95.7,90.3 to 98.6,244
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,92.7,87.3 to 96.4,188
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,93.9,89.4 to 96.9,310
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,65.6,55.8 to 75.2,162
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,67.2,60.1 to 74.0,321
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,68.8,58.8 to 78.4,159
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,69.0,61.6 to 76.2,333
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,69.5,58.8 to 79.5,174
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,72.0,63.9 to 79.6,188
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,71.7,64.6 to 78.4,310
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,61.3,52.5 to 70.2,213
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,63.1,54.6 to 71.7,244
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,97.0,91.2 to 99.4,144
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,97.9,95.0 to 99.4,301
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,89.7,82.6 to 94.7,162
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,92.7,88.7 to 95.8,321
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,98.8,96.8 to 99.6,157
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,94.5,90.8 to 97.0,319
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,71.4,60.0 to 81.9,122
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,74.6,66.9 to 81.6,266
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,78.3,68.1 to 87.1,144
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,76.9,69.4 to 83.7,301
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,95.9,91.4 to 98.5,159
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,95.0,90.5 to 97.7,333
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,75.6,64.8 to 85.2,157
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,70.8,63.0 to 78.2,319
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,94.6,87.3 to 98.4,174
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016,Age,35 Months,76.8,65.4 to 86.5,157
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2017,Age,35 Months,73.8,65.5 to 81.5,319
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2017,Age,35 Months,70.9,60.2 to 80.8,162
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2017-2018,Age,35 Months,74.2,65.6 to 82.1,321
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2013,Age,35 Months,82.0,73.8 to 88.8,188
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2013-2014,Age,35 Months,78.2,71.0 to 84.6,310
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2012,Age,35 Months,65.3,56.2 to 74.2,213
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014,Age,35 Months,74.9,63.3 to 85.2,122
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2015,Age,35 Months,77.1,69.3 to 84.1,266
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,70.8,57.9 to 81.1,122
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,71.2,62.7 to 78.4,266
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,76.6,64.2 to 85.6,157
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,72.8,65.4 to 79.1,319
Hib,Full Series,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,71.6,56.8 to 82.9,144
Hib,Full Series,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,74.1,65.9 to 80.9,301
Hib,Full Series,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,68.7,58.8 to 77.1,162
Hib,Full Series,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,71.9,65.0 to 77.9,321
Hib,Full Series,States/Local Areas,IL-City of Chicago,2019,Age,19 Months,71.4,60.7 to 80.2,174
Hib,Full Series,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,75.3,65.3 to 83.1,159
Hib,Full Series,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,94.8,90.6 to 97.2,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,63.9,53.7 to 73.0,173
Hib,Full Series,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,78.0,70.1 to 85.0,213
Hib,Full Series,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,77.2,69.0 to 84.6,244
Hib,Full Series,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,83.6,76.4 to 89.6,188
Hib,Full Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,82.3,75.9 to 87.8,310
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,80.9,70.4 to 89.4,122
Hib,Full Series,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,81.0,73.9 to 87.3,266
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,79.6,70.0 to 89.1,93
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,76.2,68.1 to 84.3,222
Hib,Full Series,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,66.4,60.1 to 72.2,244
Hib,Full Series,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,68.5,64.5 to 72.2,213
Hib,Full Series,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,76.7,71.3 to 81.3,188
Hib,Full Series,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,73.8,70.4 to 76.8,310
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,72.3,66.8 to 77.7,517
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,61.7 to 89.0,69
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.8,77.0 to 90.7,193
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,72.3,66.8 to 77.7,517
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,66.0,57.0 to 75.0,202
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,68.2,57.9 to 78.4,170
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2015,Age,35 Months,79.3,69.0 to 88.1,144
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2015-2016,Age,35 Months,78.0,70.2 to 85.0,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.7,92.9 to 100.0,77
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,73.7,65.0 to 82.3,189
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,93.8 to 100.0,77
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.1,54.6 to 77.7,85
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,74.9,67.8 to 82.0,289
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,70.6,62.3 to 79.0,212
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2019,Age,35 Months,73.1,62.4 to 82.8,174
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2018,Age,35 Months,77.7,64.3 to 88.7,159
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2018-2019,Age,35 Months,75.5,66.7 to 83.4,333
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,80.5,69.7 to 91.2,93
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,75.7,70.6 to 80.8,517
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,61.9,53.7 to 70.1,202
Hib,Full Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,73.4,66.2 to 80.1,280
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,91.3,86.6 to 96.0,333
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,72.9,65.1 to 80.7,206
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,76.6,70.1 to 83.0,242
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,58.7,46.1 to 70.3,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,90.5,81.2 to 95.4,144
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,91.5,86.5 to 94.8,301
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,66.2,58.2 to 73.4,280
Hib,Full Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,69.2,61.5 to 75.9,280
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,89.5,77.6 to 95.4,107
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,28.4,21.7 to 36.1,280
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,5 Months,87.6,76.6 to 93.9,107
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,89.9,84.1 to 93.7,280
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,88.2,81.9 to 92.5,280
Hib,Full Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,77.8,69.6 to 85.1,280
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2020-2021,Age,0-2 Days,80.7,73.7 to 86.2,280
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,92.6,82.6 to 97.0,107
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,93.3,88.3 to 96.2,280
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,5 Months,73.3,65.4 to 79.9,280
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,3 Months,86.4,79.8 to 91.1,280
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,64.7,56.5 to 72.1,280
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,89.5,83.3 to 93.5,280
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,89.2,82.6 to 93.4,280
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,3 Months,92.6,87.1 to 95.9,280
Influenza,,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,55.5,46.0 to 65.5,162
Influenza,,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,62.2,55.2 to 69.3,321
Influenza,,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,68.9,59.0 to 78.5,159
Influenza,,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,67.6,60.1 to 74.8,333
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,5 Months,82.0,69.4 to 90.2,107
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,5 Months,82.0,69.4 to 90.2,107
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,19 Months,91.4,83.7 to 95.6,162
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,19 Months,93.5,89.3 to 96.2,321
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,97.9,94.0 to 99.3,157
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,94.8,90.8 to 97.1,319
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,91.9,85.8 to 95.6,159
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,88.4,83.2 to 92.1,333
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,19 Months,95.8,91.0 to 98.1,159
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,19 Months,68.5,61.0 to 75.2,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,87.3,76.6 to 93.5,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,98.1,95.7 to 100.0,289
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,92.5,88.7 to 96.3,212
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.4,88.4 to 98.4,85
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,93.7,89.2 to 98.2,170
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.3,92.0 to 100.0,69
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,7 Months,69.7,59.2 to 78.4,159
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,7 Months,67.0,59.8 to 73.6,333
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,7 Months,62.9,52.9 to 71.9,162
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,7 Months,66.2,59.1 to 72.7,321
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,98.8,96.4 to 99.6,157
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,95.3,91.5 to 97.5,319
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,97.0,89.5 to 99.2,144
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,97.9,94.5 to 99.2,301
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,79.9 to 98.1,69
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,85.7,79.7 to 91.6,170
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,89.2,82.0 to 93.7,244
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,91.4,83.3 to 95.8,174
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",99.0,97.4 to 100.0,193
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,95.2,93.0 to 97.5,517
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,7 Months,64.3,53.8 to 73.6,174
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,80.9,76.5 to 85.3,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,80.9,76.5 to 85.3,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,70.4 to 92.2,69
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.5,78.5 to 86.4,193
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,92.8,83.5 to 97.0,122
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,92.1,86.2 to 95.6,266
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,90.9,88.7 to 92.7,188
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,91.8,90.1 to 93.3,310
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,82.2,75.8 to 88.5,202
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,83.8,76.1 to 89.5,213
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,13 Months,91.4,82.0 to 96.1,144
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,13 Months,93.8,88.8 to 96.6,301
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,95.2,93.0 to 97.5,517
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,93.9,90.4 to 97.4,202
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,96.1,91.3 to 98.3,157
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,93.2,88.8 to 95.9,319
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,95.2,90.4 to 97.7,159
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,94.7,90.7 to 97.0,333
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,90.0,82.0 to 94.7,162
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,92.6,88.1 to 95.5,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,13 Months,80.8,75.2 to 85.4,213
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,13 Months,89.2,82.0 to 93.7,244
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,13 Months,87.5,77.8 to 93.4,122
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,13 Months,89.0,82.8 to 93.1,266
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,95.1,90.0 to 100.0,93
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,97.3,93.8 to 100.0,222
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,92.0,87.7 to 94.9,244
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,13 Months,87.0,85.0 to 88.9,188
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,13 Months,87.3,85.1 to 89.2,310
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,77.0,66.7 to 87.3,93
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,81.6,74.0 to 89.2,222
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,86.7,83.3 to 89.5,213
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,88.2,83.4 to 91.7,213
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,93.7,91.3 to 95.5,188
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,94.1,91.4 to 96.1,310
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,91.3,85.8 to 94.9,244
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,94.1,86.7 to 97.5,174
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,81.6,72.7 to 88.2,162
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,86.7,81.3 to 90.7,321
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,13 Months,92.6,86.8 to 96.0,157
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,13 Months,87.4,82.1 to 91.2,319
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,95.1,93.2 to 96.4,144
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,96.5,92.7 to 98.3,301
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,92.8,83.8 to 97.0,122
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,93.9,88.7 to 96.8,266
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,90.9,88.6 to 92.8,188
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,91.9,90.1 to 93.4,310
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,92.9,84.5 to 96.9,174
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,13 Months,91.6,83.9 to 95.8,162
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,13 Months,94.2,90.0 to 96.7,321
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,13 Months,97.0,92.5 to 98.8,159
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,13 Months,95.0,90.7 to 97.4,333
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,92.0,89.1 to 94.2,188
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,92.4,89.9 to 94.4,310
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,91.3,85.8 to 94.9,244
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,86.8,83.3 to 89.6,213
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,90.9,83.3 to 95.3,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,13 Months,84.6,75.7 to 90.7,174
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,85.1,75.7 to 91.2,173
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,92.7,87.3 to 96.4,280
Influenza,,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,65.4,54.8 to 75.7,174
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.0,57.1 to 82.8,103
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,86.8,81.7 to 91.8,242
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.8 to 98.0,333
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",45.6,33.4 to 57.7,85
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,58.4,48.4 to 68.3,170
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.1,71.5 to 92.8,69
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.3,76.2 to 90.4,193
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,63.3,57.6 to 69.0,517
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,78.4 to 96.9,77
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,3 Months,85.2,72.8 to 92.5,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.4 to 99.5,333
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,91.0,87.0 to 95.0,242
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,86.3,80.7 to 91.9,333
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,63.3,57.6 to 69.0,517
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,74.1,67.2 to 81.0,242
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,53.6,44.7 to 62.5,202
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,58.2,45.8 to 70.6,93
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,81.6,73.9 to 89.3,222
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.8,91.1 to 100.0,77
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,91.5,86.5 to 95.2,280
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,93.6,83.5 to 97.7,107
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,54.7,46.1 to 63.2,212
Influenza,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,75.9,68.9 to 82.9,289
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,86.0,75.9 to 96.1,189
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,58.2,50.2 to 65.7,280
Influenza,,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,62.9,51.0 to 74.9,107
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,55.8 to 92.5,77
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,5 Months,78.0,70.5 to 84.0,280
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,96.2,86.3 to 99.6,107
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,91.9,86.9 to 95.5,280
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,74.2,64.0 to 83.4,280
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,89.1,83.8 to 93.3,280
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,68.7,55.6 to 79.3,107
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,3 Months,84.9,77.8 to 90.0,280
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,54.7,46.8 to 62.4,280
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,85.3,78.5 to 90.1,280
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,68.8,60.8 to 75.9,280
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,3 Months,86.4,79.8 to 91.1,280
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,87.3,80.5 to 92.0,280
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,92.6,84.2 to 97.4,107
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,83.9,76.6 to 89.2,280
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,66.7,55.4 to 77.6,107
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,94.6,89.6 to 97.7,280
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2020-2021,Age,0-1 Days,75.6,68.5 to 81.5,280
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,83.5,76.5 to 88.7,280
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,90.9,85.5 to 94.8,280
Rotavirus,,States/Local Areas,IL-City of Chicago,2020-2021,Age,8 Months,75.9,68.2 to 82.2,280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2020-2021,Age,0-3 Days,81.6,74.6 to 86.9,280
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,81.8,75.3 to 87.5,280
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,97.0,92.7 to 99.1,107
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,96.2,86.3 to 99.6,107
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,92.4,82.4 to 97.0,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,88.6,82.3 to 92.8,280
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,91.9,86.5 to 95.7,280
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,60.3,52.5 to 67.7,280
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,85.3,76.0 to 92.4,107
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,92.6,84.1 to 97.5,107
Influenza,,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,64.4,56.7 to 72.2,280
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,77.2,69.7 to 83.3,280
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,90.8,85.2 to 95.0,280
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,80.7,72.7 to 87.5,280
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,95.8,90.8 to 98.6,280
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,87.9,81.4 to 92.4,280
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,5 Months,78.0,70.5 to 84.0,280
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,91.6,86.9 to 95.1,280
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,85.0,77.7 to 90.2,280
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,96.2,86.3 to 99.6,107
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,78.8,71.4 to 84.8,280
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,3 Months,81.2,73.9 to 86.8,280
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,63.9,56.3 to 71.5,280
Hib,Full Series,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,76.9,66.4 to 86.0,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,89.2,83.1 to 93.3,280
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,81.1,69.7 to 88.9,107
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,94.0,88.9 to 97.2,280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2021,Age,0-3 Days,80.1,68.4 to 88.2,107
Rotavirus,,States/Local Areas,IL-City of Chicago,2021,Age,8 Months,77.9,64.8 to 87.0,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,88.6,82.8 to 93.1,280
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,68.9,59.9 to 77.4,280
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,94.0,90.0 to 96.8,280
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,73.4,65.8 to 79.8,280
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,70.8,58.9 to 80.4,107
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,19 Months,91.1,85.3 to 94.7,280
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,5 Months,86.8,80.2 to 91.4,280
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,96.2,86.3 to 99.6,107
Influenza,,States/Local Areas,IL-City of Chicago,2012,Age,24 Months,57.7,49.2 to 66.5,213
Influenza,,States/Local Areas,IL-City of Chicago,2011,Age,24 Months,54.2,45.6 to 63.3,244
Influenza,,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,53.7,41.8 to 66.5,122
Influenza,,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,56.5,48.4 to 65.0,266
Influenza,,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,59.3,48.4 to 70.4,144
Influenza,,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,63.7,55.7 to 71.6,301
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,3 Months,89.1,77.9 to 95.0,107
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,24 Months,44.1,36.5 to 52.6,280
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020-2021,Age,7 Months,63.4,55.3 to 70.8,280
Influenza,,States/Local Areas,IL-City of Chicago,2013,Age,24 Months,58.8,50.1 to 67.7,188
Influenza,,States/Local Areas,IL-City of Chicago,2013-2014,Age,24 Months,56.3,48.7 to 64.1,310
Influenza,,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,68.0,56.7 to 78.9,157
Influenza,,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,62.0,54.2 to 69.9,319
Hib,≥3 Doses,States/Local Areas,Illinois,2021,Age,19 Months,87.9,82.1 to 92.1,369
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,90.6,85.1 to 94.2,347
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,97.3,95.1 to 99.5,263
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,57.9,50.7 to 64.7,347
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,90.6,85.3 to 94.2,347
Rotavirus,,States/Local Areas,IL-City of Chicago,2011,Age,8 Months,71.4,62.9 to 78.6,244
Rotavirus,,States/Local Areas,IL-City of Chicago,2014,Age,8 Months,67.9,54.4 to 79.0,122
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2015,Age,8 Months,69.7,61.0 to 77.2,266
Rotavirus,,States/Local Areas,IL-City of Chicago,2012,Age,8 Months,66.2,57.3 to 74.1,213
Rotavirus,,States/Local Areas,IL-City of Chicago,2013,Age,8 Months,78.7,70.6 to 85.1,188
Rotavirus,,States/Local Areas,IL-City of Chicago,2013-2014,Age,8 Months,73.3,65.2 to 80.1,310
Rotavirus,,States/Local Areas,IL-City of Chicago,2016,Age,8 Months,72.4,59.8 to 82.2,157
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2017,Age,8 Months,72.0,64.4 to 78.6,319
Rotavirus,,States/Local Areas,IL-City of Chicago,2017,Age,8 Months,71.7,61.8 to 79.8,162
Rotavirus,,States/Local Areas,IL-City of Chicago,2015,Age,8 Months,71.5,59.9 to 80.8,144
Rotavirus,,States/Local Areas,IL-City of Chicago,2015-2016,Age,8 Months,71.9,63.6 to 79.0,301
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Private Insurance Only,89.7,84.7 to 94.8,289
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.9,46.7 to 71.0,85
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Insurance Coverage,Any Medicaid,64.5,56.6 to 72.4,212
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,Hispanic,73.2,64.9 to 81.5,170
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,84.5 to 98.0,69
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.2,86.2 to 96.1,193
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Urbanicity,Living In a MSA Principal City,75.7,70.6 to 80.8,517
Rotavirus,,States/Local Areas,IL-City of Chicago,2018,Age,8 Months,79.9,70.6 to 86.9,159
Rotavirus,,States/Local Areas,IL-City of Chicago,2018-2019,Age,8 Months,79.5,72.7 to 84.9,333
Rotavirus,,States/Local Areas,IL-City of Chicago,2019,Age,8 Months,79.0,68.3 to 86.7,174
Rotavirus,,States/Local Areas,IL-City of Chicago,2017-2018,Age,8 Months,75.7,69.0 to 81.4,321
Rotavirus,,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,93.7,89.6 to 97.8,222
Influenza,,HHS Regions/National,United States,2019,Age,24 Months,63.8,62.3 to 65.2,17265
Influenza,,HHS Regions/National,United States,2016,Age,24 Months,56.7,55.0 to 58.4,15956
Influenza,,HHS Regions/National,United States,2016-2017,Age,24 Months,57.5,56.3 to 58.6,33760
Influenza,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",43.4,40.9 to 45.9,4191
Influenza,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,46.8,45.4 to 48.2,21000
Influenza,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.3,57.9 to 62.8,7674
Influenza,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,53.5,51.3 to 55.7,11789
Influenza,,HHS Regions/National,United States,2018,Age,24 Months,63.1,61.7 to 64.4,18826
Influenza,,HHS Regions/National,United States,2018-2019,Age,24 Months,63.4,62.4 to 64.4,36091
Influenza,,HHS Regions/National,United States,2017,Age,24 Months,58.2,56.7 to 59.7,17804
Influenza,,HHS Regions/National,United States,2017-2018,Age,24 Months,60.6,59.6 to 61.6,36630
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.9,71.8 to 78.0,4715
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,89.5,88.7 to 90.3,37121
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,85.1,84.1 to 86.1,22343
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.4,77.1 to 79.6,37179
Influenza,,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,73.6,72.2 to 75.1,18707
Influenza,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,48.5,44.8 to 52.2,2246
Influenza,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,34.7,30.5 to 38.9,1692
Influenza,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,57.5,56.1 to 58.9,21757
Influenza,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,44.0,42.1 to 45.8,10389
Influenza,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,57.2,55.9 to 58.6,24711
Influenza,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",59.1,58.1 to 60.2,33203
Influenza,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,66.8,65.6 to 68.0,31919
Influenza,,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,53.4,52.0 to 54.9,21077
Influenza,,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,45.3,43.8 to 46.9,17073
Influenza,,HHS Regions/National,United States,2014-2017,Overall,Overall,55.8,54.9 to 56.7,56857
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,87.9,86.7 to 89.1,12650
Hib,Full Series,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,85.7,84.8 to 86.5,37121
Hib,Full Series,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,78.5 to 82.1,8905
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,95.3,94.7 to 95.8,37121
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,90.5 to 93.2,8905
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.7,74.0 to 79.4,8905
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,88.5,87.8 to 89.3,37121
DTaP,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,70.2,69.0 to 71.4,28668
PCV,≥1 Dose,HHS Regions/National,United States,2021,Age,3 Months,85.9,84.4 to 87.2,11281
Hep B,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,91.1,90.3 to 91.8,28668
Hib,Primary Series,HHS Regions/National,United States,2021,Age,35 Months,92.7,91.4 to 93.9,11281
DTaP,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,5 Months,78.5,77.4 to 79.6,28668
Hib,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,53.8,52.5 to 55.0,28668
PCV,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,3 Months,85.2,84.3 to 86.1,28668
PCV,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,87.3,86.4 to 88.1,28668
≥1 Dose MMR,,HHS Regions/National,United States,2021,Age,13 Months,65.4,63.5 to 67.2,11281
Hib,≥3 Doses,HHS Regions/National,United States,2021,Age,35 Months,91.7,90.2 to 93.0,11281
DTaP,≥3 Doses,HHS Regions/National,United States,2021,Age,24 Months,92.5,91.4 to 93.5,11281
Polio,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,91.9,91.2 to 92.6,28668
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2021,Age,0-3 Days,78.9,77.2 to 80.4,11281
Rotavirus,,HHS Regions/National,United States,2021,Age,8 Months,75.4,73.6 to 77.0,11281
Hib,≥2 Doses,HHS Regions/National,United States,2021,Age,13 Months,92.1,90.9 to 93.1,11281
PCV,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,91.6,90.9 to 92.3,28668
Hib,≥3 Doses,HHS Regions/National,United States,2021,Age,13 Months,72.4,70.6 to 74.1,11281
≥1 Dose Varicella,,HHS Regions/National,United States,2020-2021,Age,24 Months,89.9,89.1 to 90.6,28668
Combined 7 Series,,HHS Regions/National,United States,2020-2021,Age,35 Months,72.8,71.4 to 74.1,28668
Hib,Primary Series,HHS Regions/National,United States,2020-2021,Age,13 Months,85.0,84.1 to 85.9,28668
≥1 Dose MMR,,HHS Regions/National,United States,2020-2021,Age,24 Months,90.3,89.6 to 91.0,28668
Hib,Primary Series,HHS Regions/National,United States,2020-2021,Age,7 Months,69.8,68.6 to 71.0,28668
Polio,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,93.3,92.5 to 94.0,28668
DTaP,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,91.6,90.9 to 92.3,28668
Hib,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,88.3,87.5 to 89.1,28668
Polio,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,5 Months,78.0,76.9 to 79.1,28668
Hep A,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,46.0,44.8 to 47.2,28668
Hep A,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,19 Months,82.3,81.3 to 83.3,28668
≥1 Dose Varicella,,HHS Regions/National,United States,2021,Age,35 Months,94.4,92.2 to 96.2,11281
Polio,≥3 Doses,HHS Regions/National,United States,2021,Age,35 Months,93.2,91.6 to 94.6,11281
Hep A,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,35 Months,90.8,89.8 to 91.8,28668
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2020-2021,Age,0-3 Days,79.5,78.5 to 80.5,28668
Rotavirus,,HHS Regions/National,United States,2020-2021,Age,8 Months,75.1,74.0 to 76.2,28668
DTaP,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,92.5,91.8 to 93.2,28668
PCV,≥4 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,77.1,76.0 to 78.2,28668
Hep B,≥2 Doses,HHS Regions/National,United States,2021,Age,13 Months,93.0,91.8 to 94.0,11281
Hib,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,91.7,90.9 to 92.5,28668
Hep B,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,63.1,61.9 to 64.3,28668
DTaP,≥4 Doses,HHS Regions/National,United States,2021,Age,35 Months,87.0,83.7 to 89.8,11281
Hib,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,5 Months,75.7,74.5 to 76.8,28668
Hib,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,87.4,86.5 to 88.3,28668
Hib,Full Series,HHS Regions/National,United States,2020-2021,Age,19 Months,71.4,70.2 to 72.5,28668
PCV,≥4 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,83.7,82.6 to 84.8,28668
≥1 Dose MMR,,HHS Regions/National,United States,2020-2021,Age,35 Months,92.9,92.1 to 93.7,28668
Hep B,≥3 Doses,HHS Regions/National,United States,2021,Age,35 Months,92.4,91.1 to 93.6,11281
PCV,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,90.6,89.8 to 91.3,28668
Influenza,,HHS Regions/National,United States,2020-2021,Age,24 Months,55.6,54.4 to 56.8,28668
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2020-2021,Age,0-1 Days,76.2,75.1 to 77.2,28668
Hib,Primary Series,HHS Regions/National,United States,2021,Age,13 Months,84.7,83.2 to 86.1,11281
Combined 7 Series,,HHS Regions/National,United States,2020-2021,Age,24 Months,66.9,65.7 to 68.2,28668
Hib,Full Series,HHS Regions/National,United States,2021,Age,35 Months,80.3,77.9 to 82.5,11281
DTaP,≥3 Doses,HHS Regions/National,United States,2021,Age,35 Months,94.1,92.4 to 95.6,11281
Polio,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,90.8,90.0 to 91.5,28668
Polio,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,88.3,87.4 to 89.1,28668
PCV,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,5 Months,77.0,75.8 to 78.0,28668
Hep B,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,5 Months,87.4,86.5 to 88.3,28668
Hep B,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,90.7,89.9 to 91.5,28668
Hib,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,3 Months,83.6,82.6 to 84.5,28668
Polio,≥3 Doses,States/Local Areas,Idaho,2017,Age,19 Months,90.6,86.0 to 93.7,499
Polio,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,92.7,90.0 to 94.7,942
Polio,≥3 Doses,States/Local Areas,Idaho,2016,Age,19 Months,93.0,88.3 to 96.0,190
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,91.8,88.7 to 94.1,689
Hib,≥3 Doses,States/Local Areas,Idaho,2018,Age,13 Months,53.8,47.6 to 59.9,443
Hib,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,53.8,48.8 to 58.7,749
Polio,≥3 Doses,States/Local Areas,Idaho,2018,Age,19 Months,94.9,91.5 to 96.9,443
Polio,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,73.6,69.0 to 77.8,749
Hib,≥3 Doses,States/Local Areas,Idaho,2013,Age,19 Months,84.9,81.4 to 87.8,224
Hib,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,86.1,81.4 to 89.7,425
Hib,≥3 Doses,States/Local Areas,Idaho,2011,Age,19 Months,90.2,86.4 to 93.0,246
Hib,≥3 Doses,States/Local Areas,Idaho,2012,Age,19 Months,88.4,85.6 to 90.7,223
Hib,≥3 Doses,States/Local Areas,Idaho,2019,Age,13 Months,53.8,46.1 to 61.3,306
Hib,≥3 Doses,States/Local Areas,Idaho,2015,Age,13 Months,64.6,56.0 to 72.3,214
Hib,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,66.2,60.1 to 71.9,404
Polio,≥3 Doses,States/Local Areas,Idaho,2015,Age,19 Months,88.5,86.4 to 90.3,214
Polio,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,90.7,86.6 to 93.7,404
Polio,≥3 Doses,States/Local Areas,Idaho,2014,Age,19 Months,93.6,88.6 to 96.5,201
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,91.0,86.9 to 93.9,415
Polio,≥3 Doses,States/Local Areas,Idaho,2013,Age,19 Months,90.2,87.4 to 92.4,224
Polio,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,91.9,89.4 to 93.9,425
DTaP,≥3 Doses,States/Local Areas,Idaho,2012,Age,19 Months,88.1,82.4 to 92.2,223
DTaP,≥3 Doses,States/Local Areas,Idaho,2013,Age,19 Months,91.4,88.7 to 93.5,224
DTaP,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,92.5,90.7 to 94.0,425
DTaP,≥3 Doses,States/Local Areas,Idaho,2011,Age,19 Months,93.2,89.8 to 95.5,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2019,Age,13 Months,88.5,82.2 to 92.7,306
Hib,≥3 Doses,States/Local Areas,Idaho,2017,Age,13 Months,61.5,55.6 to 67.0,499
Hib,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,57.7,53.4 to 61.9,942
Hib,≥3 Doses,States/Local Areas,Idaho,2016,Age,13 Months,67.9,58.9 to 75.8,190
Hib,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,64.7,59.4 to 69.7,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2019-2020,Age,19 Months,86.3,81.8 to 89.8,592
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.8,68.2 to 95.4,91
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,61.5 to 90.6,91
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,78.7,70.8 to 86.6,215
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2020-2021,Age,0-3 Days,83.9,78.5 to 88.1,457
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,80.1,75.2 to 85.1,521
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,75.9,69.5 to 82.3,386
PCV,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,5 Months,77.7,71.2 to 83.0,457
Hep A,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,19 Months,84.9,78.9 to 89.4,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,80.9,74.5 to 86.1,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,89.5,83.6 to 93.4,457
Hib,Primary Series,States/Local Areas,Idaho,2020-2021,Age,35 Months,93.1,86.2 to 97.3,457
Hib,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,89.5,80.1 to 95.7,457
Hib,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,3 Months,85.4,79.9 to 89.7,457
Hep B,≥2 Doses,States/Local Areas,Idaho,2021,Age,13 Months,91.5,83.3 to 95.8,171
Polio,≥3 Doses,States/Local Areas,Idaho,2021,Age,19 Months,86.0,75.5 to 92.5,171
Polio,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,88.0,82.5 to 92.4,457
Rotavirus,,States/Local Areas,Idaho,2021,Age,8 Months,72.9,61.9 to 81.7,171
Hib,≥2 Doses,States/Local Areas,Idaho,2021,Age,13 Months,85.4,74.8 to 92.0,171
Hep B,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,89.6,84.2 to 93.8,457
PCV,≥1 Dose,States/Local Areas,Idaho,2021,Age,3 Months,86.0,76.5 to 92.0,171
Hep B,≥3 Doses,States/Local Areas,Idaho,2021,Age,13 Months,85.1,74.5 to 91.8,171
Polio,≥2 Doses,States/Local Areas,Idaho,2021,Age,5 Months,79.1,68.2 to 87.0,171
≥1 Dose MMR,,States/Local Areas,Idaho,2021,Age,19 Months,81.1,70.1 to 88.7,171
Hib,≥2 Doses,States/Local Areas,Idaho,2021,Age,5 Months,77.9,67.0 to 85.9,171
≥1 Dose Varicella,,States/Local Areas,Idaho,2021,Age,13 Months,55.5,44.5 to 66.0,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,89.4,83.6 to 93.3,457
Combined 7 Series,,States/Local Areas,Idaho,2021,Age,24 Months,68.9,58.6 to 78.6,171
Hep A,≥2 Doses,States/Local Areas,Idaho,2021,Age,19 Months,36.4,26.8 to 47.1,171
Hib,Full Series,States/Local Areas,Idaho,2020-2021,Age,19 Months,76.3,69.9 to 81.7,457
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2020-2021,Age,0-2 Days,83.8,78.4 to 88.0,457
≥1 Dose Varicella,,States/Local Areas,Idaho,2021,Age,35 Months,87.2,77.9 to 93.9,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,88.3,82.5 to 92.4,457
Polio,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,90.3,84.5 to 94.1,457
PCV,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,72.9,66.3 to 78.7,457
Hib,Full Series,States/Local Areas,Idaho,2020-2021,Age,35 Months,81.7,74.7 to 87.8,457
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2020-2021,Age,0-1 Days,82.9,77.5 to 87.2,457
Hib,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,83.3,77.0 to 88.1,457
≥1 Dose MMR,,States/Local Areas,Idaho,2020-2021,Age,35 Months,91.7,85.5 to 96.0,457
PCV,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,94.2,86.6 to 98.2,457
Combined 7 Series,,States/Local Areas,Idaho,2020-2021,Age,24 Months,69.4,63.0 to 75.6,457
Hib,Full Series,States/Local Areas,Idaho,2021,Age,35 Months,75.1,64.7 to 84.4,171
≥1 Dose Varicella,,States/Local Areas,Idaho,2020-2021,Age,19 Months,83.3,77.4 to 88.0,457
PCV,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,88.8,83.4 to 93.1,457
Polio,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,93.2,85.7 to 97.5,457
DTaP,≥3 Doses,States/Local Areas,Idaho,2021,Age,35 Months,91.0,81.0 to 96.9,171
Hib,≥3 Doses,States/Local Areas,Idaho,2021,Age,13 Months,58.9,48.0 to 69.0,171
Hep A,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,51.9,45.1 to 59.0,457
Hib,Primary Series,States/Local Areas,Idaho,2020-2021,Age,7 Months,75.4,68.6 to 81.1,457
Hib,Primary Series,States/Local Areas,Idaho,2021,Age,35 Months,88.1,79.4 to 94.3,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,73.4,66.7 to 79.1,457
DTaP,≥4 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,73.8,67.3 to 79.4,457
Hep B,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,5 Months,89.4,84.1 to 93.1,457
Hib,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,5 Months,77.1,70.6 to 82.5,457
Polio,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,3 Months,85.9,80.2 to 90.1,457
Hep A,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,76.8,66.9 to 85.5,457
DTaP,≥4 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,82.6,74.5 to 89.3,457
PCV,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,87.1,81.3 to 91.3,457
≥1 Dose Varicella,,States/Local Areas,Idaho,2020-2021,Age,24 Months,86.0,80.6 to 90.5,457
DTaP,≥2 Doses,States/Local Areas,Idaho,2021,Age,5 Months,79.6,68.6 to 87.4,171
Hib,Primary Series,States/Local Areas,Idaho,2021,Age,13 Months,82.5,72.2 to 89.6,171
DTaP,≥4 Doses,States/Local Areas,Idaho,2021,Age,35 Months,78.2,67.4 to 87.4,171
PCV,≥4 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,83.1,77.3 to 88.2,457
Hib,Primary Series,States/Local Areas,Idaho,2020-2021,Age,19 Months,90.4,85.1 to 93.9,457
Combined 7 Series,,States/Local Areas,Idaho,2020-2021,Age,35 Months,74.6,67.4 to 81.2,457
Polio,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,5 Months,78.6,72.2 to 83.9,457
Polio,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,86.0,79.9 to 90.5,457
PCV,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,88.5,82.6 to 92.6,457
Influenza,,States/Local Areas,Idaho,2020-2021,Age,24 Months,56.4,49.8 to 63.2,457
Hep B,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,90.0,84.6 to 93.7,457
PCV,≥4 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,80.1,73.7 to 85.3,457
Hib,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,85.8,79.7 to 90.2,457
Hep B,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,3 Months,94.5,90.5 to 96.9,457
Rotavirus,,States/Local Areas,Idaho,2020-2021,Age,8 Months,75.7,69.2 to 81.3,457
DTaP,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,89.7,84.4 to 93.8,457
Hib,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,59.1,52.3 to 65.5,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2021,Age,35 Months,90.9,80.9 to 96.9,171
Polio,≥2 Doses,States/Local Areas,Idaho,2021,Age,13 Months,86.7,76.0 to 93.0,171
Hib,Full Series,States/Local Areas,Idaho,2020-2021,Age,24 Months,78.5,72.4 to 84.0,457
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.9,54.2 to 83.7,91
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.7,50.4 to 87.1,91
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,71.7 to 97.3,91
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,88.9,85.7 to 92.1,741
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,79.6,74.6 to 84.6,521
Hep A,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,24 Months,89.3,84.4 to 93.2,457
≥1 Dose MMR,,States/Local Areas,Idaho,2020-2021,Age,19 Months,84.2,77.9 to 88.9,457
≥1 Dose MMR,,States/Local Areas,Idaho,2021,Age,35 Months,89.8,81.4 to 95.4,171
Hep B,≥1 Dose,States/Local Areas,Idaho,2021,Age,3 Months,94.9,87.8 to 97.9,171
Hib,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,7 Months,35.3,29.2 to 42.0,457
DTaP,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,5 Months,79.4,73.0 to 84.6,457
≥1 Dose MMR,,States/Local Areas,Idaho,2021,Age,13 Months,67.5,56.4 to 76.9,171
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2021,Age,0-3 Days,84.2,74.9 to 90.5,171
PCV,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,3 Months,86.3,80.8 to 90.4,457
Hib,≥3 Doses,States/Local Areas,Idaho,2021,Age,35 Months,80.2,69.9 to 88.8,171
Influenza,,States/Local Areas,Idaho,2021,Age,24 Months,55.8,45.3 to 66.8,171
≥1 Dose Varicella,,States/Local Areas,Idaho,2020-2021,Age,13 Months,54.8,48.0 to 61.4,457
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.4 to 97.5,741
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,91.0,87.3 to 94.7,521
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,84.7,81.0 to 88.5,741
Influenza,,States/Local Areas,Idaho,2014-2017,Overall,Overall,54.3,49.8 to 58.8,726
Influenza,,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,48.6,40.7 to 56.5,230
Influenza,,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,52.9,46.7 to 59.0,382
Influenza,,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,74.7,65.4 to 84.0,114
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,93.0,90.6 to 95.5,741
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.7 to 94.6,521
Influenza,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,49.0,42.2 to 55.9,303
Influenza,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,61.8,55.9 to 67.7,377
Influenza,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,56.6,45.5 to 67.8,104
Influenza,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",57.3,37.1 to 77.4,39
Influenza,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,42.6,34.7 to 50.5,246
Influenza,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,61.5,53.9 to 69.2,236
Influenza,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",53.1,48.2 to 58.1,581
Influenza,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,57.9,50.5 to 65.3,244
Influenza,,States/Local Areas,Idaho,2016,Age,24 Months,55.7,46.8 to 65.0,190
Influenza,,States/Local Areas,Idaho,2016-2017,Age,24 Months,59.2,53.8 to 64.6,689
Influenza,,States/Local Areas,Idaho,2014,Age,24 Months,48.3,39.9 to 57.4,201
Influenza,,States/Local Areas,Idaho,2014-2015,Age,24 Months,50.5,44.5 to 56.8,415
Influenza,,States/Local Areas,Idaho,2015,Age,24 Months,52.5,44.4 to 61.1,214
Influenza,,States/Local Areas,Idaho,2015-2016,Age,24 Months,54.1,48.0 to 60.5,404
Influenza,,States/Local Areas,Idaho,2012,Age,24 Months,50.8,42.6 to 59.7,223
Influenza,,States/Local Areas,Idaho,2011,Age,24 Months,48.2,40.7 to 56.2,246
Influenza,,States/Local Areas,Idaho,2017,Age,24 Months,62.5,56.8 to 68.1,499
Influenza,,States/Local Areas,Idaho,2017-2018,Age,24 Months,60.8,56.6 to 65.1,942
Influenza,,States/Local Areas,Idaho,2018,Age,24 Months,58.8,52.6 to 65.1,443
Influenza,,States/Local Areas,Idaho,2018-2019,Age,24 Months,63.6,58.7 to 68.5,749
Influenza,,States/Local Areas,Idaho,2019,Age,24 Months,68.3,60.8 to 75.5,306
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,85.4,71.4 to 99.4,215
Influenza,,States/Local Areas,Idaho,2013,Age,24 Months,53.1,45.2 to 61.5,224
Influenza,,States/Local Areas,Idaho,2013-2014,Age,24 Months,50.7,44.8 to 56.9,425
DTaP,≥4 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,77.1,71.0 to 82.8,457
Rotavirus,,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,90.3,84.2 to 96.4,114
Combined 7 Series,,HHS Regions/National,Region 6,2019,Age,35 Months,75.0,70.9 to 78.9,2266
Combined 7 Series,,HHS Regions/National,Region 6,2018,Age,35 Months,71.7,68.0 to 75.2,2533
Combined 7 Series,,HHS Regions/National,Region 6,2018-2019,Age,35 Months,73.3,70.6 to 76.0,4799
Hib,Full Series,HHS Regions/National,Region 6,2018,Age,19 Months,71.9,68.5 to 75.0,2533
Hib,Full Series,HHS Regions/National,Region 6,2018-2019,Age,19 Months,94.8,93.6 to 95.9,4799
Hib,Full Series,HHS Regions/National,Region 6,2017,Age,19 Months,71.7,68.9 to 74.5,2732
Hib,Full Series,HHS Regions/National,Region 6,2017-2018,Age,19 Months,71.8,69.6 to 73.9,5265
Hib,Full Series,HHS Regions/National,Region 6,2014,Age,19 Months,70.5,67.8 to 73.0,2387
Hib,Full Series,HHS Regions/National,Region 6,2014-2015,Age,19 Months,72.1,70.3 to 73.8,5094
Hib,Full Series,HHS Regions/National,Region 6,2015,Age,19 Months,73.8,72.0 to 75.5,2707
Hib,Full Series,HHS Regions/National,Region 6,2015-2016,Age,19 Months,73.1,71.3 to 74.7,5562
Hib,Full Series,HHS Regions/National,Region 6,2016,Age,19 Months,72.4,69.8 to 74.8,2855
Hib,Full Series,HHS Regions/National,Region 6,2016-2017,Age,19 Months,72.1,70.1 to 73.9,5587
Hib,Full Series,HHS Regions/National,Region 6,2011,Age,24 Months,78.4,75.2 to 81.5,2229
Hib,Full Series,HHS Regions/National,Region 6,2012,Age,24 Months,78.4,75.6 to 81.0,2367
Hep A,≥2 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,91.5,80.6 to 97.5,1286
Hib,Full Series,HHS Regions/National,Region 6,2013,Age,19 Months,72.6,70.0 to 75.1,2273
Hib,Full Series,HHS Regions/National,Region 6,2013-2014,Age,19 Months,71.6,69.9 to 73.2,4660
Hib,Full Series,HHS Regions/National,Region 6,2012,Age,19 Months,73.4,71.2 to 75.5,2367
Hib,Full Series,HHS Regions/National,Region 6,2011,Age,19 Months,69.2,65.6 to 72.6,2229
PCV,≥3 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,94.0,91.5 to 95.8,1286
Hep A,≥1 Dose,HHS Regions/National,Region 6,2021,Age,35 Months,95.0,91.6 to 97.4,1286
DTaP,≥4 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,75.0,69.3 to 80.0,1286
≥1 Dose Varicella,,HHS Regions/National,Region 6,2021,Age,19 Months,91.7,89.0 to 93.7,1286
≥1 Dose Varicella,,HHS Regions/National,Region 6,2021,Age,24 Months,93.7,91.6 to 95.5,1286
Hib,Full Series,HHS Regions/National,Region 6,2019,Age,19 Months,75.0,71.4 to 78.4,2266
PCV,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,5 Months,74.8,70.6 to 78.5,3492
PCV,≥3 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,90.6,86.9 to 93.3,1286
PCV,≥4 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,84.3,79.6 to 88.4,1286
PCV,≥3 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,94.1,91.8 to 96.0,1286
Hib,Primary Series,HHS Regions/National,Region 6,2021,Age,24 Months,91.6,87.2 to 95.0,1286
Combined 7 Series,,HHS Regions/National,Region 6,2015,Age,35 Months,74.4,71.2 to 77.5,2707
Combined 7 Series,,HHS Regions/National,Region 6,2015-2016,Age,35 Months,73.7,71.6 to 75.7,5562
≥1 Dose MMR,,HHS Regions/National,Region 6,2020-2021,Age,24 Months,91.7,89.7 to 93.4,3492
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,93.0,90.3 to 95.2,3492
Hib,Full Series,HHS Regions/National,Region 6,2021,Age,24 Months,78.5,72.5 to 84.0,1286
Hib,≥3 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,90.9,86.5 to 94.3,1286
Polio,≥1 Dose,HHS Regions/National,Region 6,2021,Age,3 Months,86.5,80.8 to 90.8,1286
Polio,≥3 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,92.8,89.5 to 95.4,1286
DTaP,≥4 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,82.4,77.2 to 87.1,1286
≥1 Dose MMR,,HHS Regions/National,Region 6,2021,Age,24 Months,94.6,92.5 to 96.2,1286
DTaP,≥1 Dose,HHS Regions/National,Region 6,2021,Age,3 Months,86.8,81.0 to 91.0,1286
PCV,≥4 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,87.8,82.4 to 92.1,1286
Hep A,≥2 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,31.2,25.2 to 38.0,1286
Hep A,≥1 Dose,HHS Regions/National,Region 6,2021,Age,19 Months,88.6,85.0 to 91.4,1286
Polio,≥2 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,92.5,88.2 to 95.3,1286
Hep B,≥3 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,92.5,89.1 to 95.1,1286
PCV,≥4 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,81.2,76.0 to 85.4,1286
DTaP,≥3 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,91.2,87.1 to 94.1,1286
PCV,≥3 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,70.0,63.4 to 75.8,1286
Hep A,≥2 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,45.3,38.7 to 52.3,1286
Hep B,≥3 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,70.1,63.4 to 76.1,1286
DTaP,≥3 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,93.0,89.4 to 95.4,1286
Hep A,≥1 Dose,HHS Regions/National,Region 6,2021,Age,24 Months,92.2,89.1 to 94.7,1286
Hib,Primary Series,HHS Regions/National,Region 6,2021,Age,19 Months,91.3,86.5 to 94.4,1286
Hib,≥3 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,89.0,83.9 to 92.6,1286
Hib,≥3 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,55.1,48.2 to 61.7,1286
≥1 Dose MMR,,HHS Regions/National,Region 6,2021,Age,35 Months,95.6,92.8 to 97.5,1286
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,88.2,85.4 to 90.5,3492
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2021,Age,0-1 Days,79.3,73.6 to 84.0,1286
Hep A,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,35 Months,93.5,91.4 to 95.3,3492
Hib,Primary Series,HHS Regions/National,Region 6,2020-2021,Age,24 Months,91.0,88.4 to 93.2,3492
Hib,≥2 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,86.0,79.7 to 90.6,1286
PCV,≥3 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,94.4,92.0 to 96.3,1286
Polio,≥2 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,89.1,84.0 to 92.7,1286
PCV,≥3 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,66.3,61.4 to 70.9,2206
Rotavirus,,HHS Regions/National,Region 6,2019-2020,Age,8 Months,74.3,71.3 to 77.1,4472
Hep B,≥2 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,92.9,89.4 to 95.4,1286
Hib,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,90.2,87.6 to 92.5,3492
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,91.7,89.4 to 93.6,3492
DTaP,≥3 Doses,HHS Regions/National,Region 6,2021,Age,7 Months,71.4,64.7 to 77.3,1286
DTaP,≥4 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,69.2,66.1 to 72.1,4472
Polio,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,90.1,88.0 to 91.8,4472
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,87.5,85.2 to 89.5,4472
Hib,Primary Series,HHS Regions/National,Region 6,2019-2020,Age,7 Months,70.6,67.5 to 73.5,4472
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,65.6,62.4 to 68.7,4472
Polio,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,3 Months,85.0,82.4 to 87.2,4472
DTaP,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,3 Months,85.4,82.9 to 87.6,4472
Hib,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,3 Months,83.6,81.0 to 85.9,4472
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,66.0,61.2 to 70.6,2206
Hib,≥1 Dose,HHS Regions/National,Region 6,2020,Age,3 Months,80.6,76.3 to 84.4,2206
Polio,≥1 Dose,HHS Regions/National,Region 6,2020,Age,3 Months,83.0,78.8 to 86.5,2206
Hib,≥2 Doses,HHS Regions/National,Region 6,2020,Age,5 Months,74.4,69.8 to 78.6,2206
Hep B,≥2 Doses,HHS Regions/National,Region 6,2020,Age,5 Months,85.7,81.7 to 88.9,2206
DTaP,≥1 Dose,HHS Regions/National,Region 6,2020,Age,3 Months,83.4,79.2 to 86.8,2206
Polio,≥2 Doses,HHS Regions/National,Region 6,2020,Age,5 Months,76.4,71.7 to 80.4,2206
DTaP,≥2 Doses,HHS Regions/National,Region 6,2020,Age,5 Months,77.0,72.4 to 81.0,2206
Hep B,≥1 Dose,HHS Regions/National,Region 6,2020,Age,3 Months,94.8,92.5 to 96.4,2206
PCV,≥1 Dose,HHS Regions/National,Region 6,2020,Age,3 Months,81.3,76.9 to 85.1,2206
Hep A,≥2 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,50.0,45.1 to 55.2,2206
Hep A,≥1 Dose,HHS Regions/National,Region 6,2020,Age,24 Months,88.3,85.2 to 91.0,2206
PCV,≥3 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,88.3,84.6 to 91.5,2206
PCV,≥4 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,77.9,73.6 to 81.9,2206
Rotavirus,,HHS Regions/National,Region 6,2020,Age,8 Months,74.1,69.4 to 78.3,2206
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020,Age,24 Months,88.5,85.2 to 91.4,2206
Influenza,,HHS Regions/National,Region 6,2020,Age,24 Months,51.2,46.4 to 56.3,2206
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2020,Age,0-3 Days,82.0,78.6 to 84.9,2206
Hib,≥3 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,88.4,85.0 to 91.1,2206
Combined 7 Series,,HHS Regions/National,Region 6,2020,Age,24 Months,64.7,60.0 to 69.5,2206
≥1 Dose MMR,,HHS Regions/National,Region 6,2020,Age,19 Months,86.8,83.4 to 89.6,2206
Polio,≥3 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,89.9,86.6 to 92.5,2206
DTaP,≥4 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,68.2,63.3 to 72.6,2206
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,90.4,87.1 to 93.0,2206
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,70.1,65.2 to 74.5,2206
PCV,≥3 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,84.0,79.9 to 87.4,2206
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020,Age,13 Months,68.1,63.4 to 72.4,2206
Hep B,≥2 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,92.0,88.9 to 94.2,2206
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,87.3,84.0 to 90.0,2206
Hib,≥3 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,77.6,73.6 to 81.2,2206
Hib,Primary Series,HHS Regions/National,Region 6,2020,Age,13 Months,84.2,80.4 to 87.5,2206
PCV,≥3 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,89.5,85.7 to 92.6,2206
Polio,≥3 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,91.1,88.0 to 93.8,2206
PCV,≥4 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,75.2,70.8 to 79.2,2206
DTaP,≥4 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,84.5,79.3 to 89.0,2206
PCV,≥3 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,87.5,83.5 to 90.6,2206
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,91.6,88.5 to 94.2,2206
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020,Age,19 Months,86.6,83.1 to 89.5,2206
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,88.7,85.5 to 91.3,2206
Hib,Full Series,HHS Regions/National,Region 6,2020,Age,19 Months,71.7,67.2 to 75.8,2206
Hib,Primary Series,HHS Regions/National,Region 6,2020,Age,19 Months,89.7,86.4 to 92.3,2206
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020,Age,35 Months,92.3,88.5 to 95.2,2206
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,92.0,88.6 to 94.6,2206
Hib,Full Series,HHS Regions/National,Region 6,2020,Age,35 Months,80.1,75.8 to 84.1,2206
Hib,≥3 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,90.2,87.0 to 92.9,2206
Hib,Primary Series,HHS Regions/National,Region 6,2020,Age,35 Months,90.9,87.7 to 93.6,2206
Hib,≥3 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,89.6,86.4 to 92.3,2206
≥1 Dose MMR,,HHS Regions/National,Region 6,2020,Age,35 Months,91.7,87.9 to 94.7,2206
Polio,≥3 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,90.8,87.6 to 93.4,2206
≥1 Dose MMR,,HHS Regions/National,Region 6,2020,Age,24 Months,88.7,85.4 to 91.5,2206
DTaP,≥4 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,76.5,71.9 to 80.8,2206
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020,Age,24 Months,91.2,88.1 to 93.8,2206
PCV,≥2 Doses,HHS Regions/National,Region 6,2020,Age,5 Months,73.9,69.0 to 78.2,2206
Hep B,≥2 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,89.4,85.9 to 92.1,2206
Hib,Primary Series,HHS Regions/National,Region 6,2020,Age,7 Months,69.6,64.8 to 74.0,2206
Hib,≥3 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,59.5,54.7 to 64.2,2206
Hib,≥2 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,85.2,81.1 to 88.5,2206
Polio,≥2 Doses,HHS Regions/National,Region 6,2020,Age,7 Months,85.7,81.6 to 89.0,2206
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2020,Age,0-1 Days,78.9,75.1 to 82.2,2206
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2020,Age,0-2 Days,80.6,77.0 to 83.8,2206
Hep A,≥1 Dose,HHS Regions/National,Region 6,2020,Age,19 Months,83.7,80.1 to 86.7,2206
Hep A,≥2 Doses,HHS Regions/National,Region 6,2020,Age,19 Months,30.7,26.3 to 35.4,2206
Hep A,≥2 Doses,HHS Regions/National,Region 6,2020,Age,35 Months,76.7,71.3 to 81.7,2206
≥1 Dose MMR,,HHS Regions/National,Region 6,2020,Age,13 Months,69.5,64.9 to 73.7,2206
Combined 7 Series,,HHS Regions/National,Region 6,2020,Age,35 Months,71.5,65.9 to 76.9,2206
Hep A,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,51.7,48.4 to 55.1,4472
Polio,≥2 Doses,HHS Regions/National,Region 6,2020,Age,13 Months,90.5,87.1 to 93.0,2206
Hep A,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,24 Months,88.5,86.5 to 90.4,4472
Hep A,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,79.2,75.6 to 82.6,4472
Hep A,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,35 Months,93.0,90.9 to 94.8,4472
Hib,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,90.3,88.3 to 92.1,4472
Influenza,,HHS Regions/National,Region 6,2019-2020,Age,24 Months,52.8,49.5 to 56.1,4472
Hib,Primary Series,HHS Regions/National,Region 6,2019-2020,Age,24 Months,91.0,89.0 to 92.8,4472
Hib,Full Series,HHS Regions/National,Region 6,2019-2020,Age,19 Months,73.2,70.3 to 76.0,4472
Combined 7 Series,,HHS Regions/National,Region 6,2019-2020,Age,35 Months,72.8,69.4 to 76.2,4472
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019-2020,Age,19 Months,86.5,84.3 to 88.5,4472
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,88.7,86.5 to 90.5,4472
PCV,≥4 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,76.8,74.0 to 79.5,4472
Hep A,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,19 Months,84.1,81.7 to 86.2,4472
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2019-2020,Age,0-2 Days,80.0,77.5 to 82.3,4472
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2019-2020,Age,0-1 Days,78.1,75.6 to 80.5,4472
PCV,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,67.7,64.5 to 70.7,4472
Hib,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,59.3,56.1 to 62.4,4472
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2019-2020,Age,0-3 Days,80.9,78.5 to 83.1,4472
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019-2020,Age,24 Months,89.1,87.0 to 91.0,4472
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,89.8,87.7 to 91.6,4472
Hib,Full Series,HHS Regions/National,Region 6,2019-2020,Age,24 Months,77.9,75.2 to 80.6,4472
PCV,≥4 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,79.5,76.8 to 82.2,4472
PCV,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,89.7,87.5 to 91.7,4472
Hep A,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,31.3,28.3 to 34.3,4472
≥1 Dose MMR,,HHS Regions/National,Region 6,2019-2020,Age,19 Months,86.4,84.2 to 88.4,4472
Hib,Primary Series,HHS Regions/National,Region 6,2019-2020,Age,19 Months,90.3,88.2 to 92.1,4472
Hib,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,89.0,86.9 to 90.8,4472
≥1 Dose MMR,,HHS Regions/National,Region 6,2019-2020,Age,35 Months,92.7,90.4 to 94.7,4472
Hib,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,91.9,89.8 to 93.7,4472
Hib,Primary Series,HHS Regions/National,Region 6,2019-2020,Age,35 Months,92.4,90.3 to 94.1,4472
Hib,Full Series,HHS Regions/National,Region 6,2019-2020,Age,35 Months,81.5,78.7 to 84.1,4472
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,93.0,90.8 to 94.8,4472
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019-2020,Age,35 Months,93.1,90.8 to 95.0,4472
PCV,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,91.2,88.9 to 93.1,4472
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,91.7,89.7 to 93.5,4472
PCV,≥4 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,82.0,79.2 to 84.6,4472
Polio,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,91.1,89.1 to 92.9,4472
DTaP,≥4 Doses,HHS Regions/National,Region 6,2019-2020,Age,24 Months,77.4,74.5 to 80.2,4472
≥1 Dose MMR,,HHS Regions/National,Region 6,2019-2020,Age,24 Months,89.1,87.0 to 91.0,4472
Hep B,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,3 Months,95.4,93.9 to 96.5,4472
PCV,≥1 Dose,HHS Regions/National,Region 6,2019-2020,Age,3 Months,83.9,81.2 to 86.3,4472
DTaP,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,5 Months,79.3,76.5 to 81.9,4472
Hib,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,5 Months,77.4,74.5 to 80.1,4472
Polio,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,5 Months,78.9,76.1 to 81.5,4472
Polio,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,91.7,89.7 to 93.4,4472
≥1 Dose MMR,,HHS Regions/National,Region 6,2019-2020,Age,13 Months,67.7,64.6 to 70.6,4472
Hib,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,91.7,89.7 to 93.4,4472
Hib,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,77.6,74.9 to 80.1,4472
Hep B,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,93.1,91.3 to 94.6,4472
Hib,Primary Series,HHS Regions/National,Region 6,2019-2020,Age,13 Months,85.7,83.3 to 87.8,4472
Hep B,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,5 Months,87.6,85.3 to 89.6,4472
PCV,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,5 Months,76.9,73.9 to 79.6,4472
Polio,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,88.0,85.6 to 90.1,4472
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,70.6,67.5 to 73.5,4472
Hep B,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,87.3,85.1 to 89.2,4472
Hib,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,87.7,85.3 to 89.7,4472
PCV,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,13 Months,85.6,83.1 to 87.9,4472
≥1 Dose Varicella,,HHS Regions/National,Region 6,2019-2020,Age,13 Months,66.0,62.9 to 69.0,4472
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,94.0,92.0 to 95.6,4472
Combined 7 Series,,HHS Regions/National,Region 6,2019-2020,Age,24 Months,66.9,63.8 to 70.0,4472
DTaP,≥4 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,84.5,81.4 to 87.4,4472
Polio,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,35 Months,93.0,90.9 to 94.7,4472
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019-2020,Age,19 Months,90.7,88.7 to 92.5,4472
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2021,Age,0-2 Days,80.8,75.1 to 85.5,1286
DTaP,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,3 Months,85.1,81.7 to 87.9,3492
Hib,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,90.6,87.7 to 92.9,3492
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020-2021,Age,35 Months,94.1,91.6 to 96.1,3492
≥1 Dose Varicella,,HHS Regions/National,Region 7,2011,Age,35 Months,93.1,89.3 to 95.9,912
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017,Age,35 Months,93.0,90.6 to 94.9,1232
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017-2018,Age,35 Months,93.8,92.2 to 95.2,2577
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2017,Age,0-2 Days,81.0,77.8 to 83.9,1232
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2017-2018,Age,0-2 Days,81.7,79.4 to 83.8,2577
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2018,Age,0-2 Days,82.4,79.0 to 85.3,1345
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2018-2019,Age,0-2 Days,81.6,79.2 to 83.7,2614
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2019,Age,0-2 Days,80.7,77.4 to 83.7,1269
Hep B,≥2 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,94.5,92.4 to 96.1,1345
Hep B,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,94.0,92.5 to 95.2,2614
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014,Age,35 Months,92.8,89.9 to 95.0,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014-2015,Age,35 Months,92.2,90.1 to 94.1,1868
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015,Age,35 Months,91.5,88.2 to 94.2,891
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015-2016,Age,35 Months,91.4,89.1 to 93.3,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2012,Age,35 Months,94.6,92.4 to 96.3,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013,Age,35 Months,93.3,90.3 to 95.6,929
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013-2014,Age,35 Months,93.0,91.0 to 94.7,1906
PCV,≥4 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,81.1,77.6 to 84.2,1269
Hep B,≥2 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,93.1,90.7 to 95.0,1232
Hep B,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,93.8,92.3 to 95.1,2577
PCV,≥3 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,88.0,84.3 to 90.9,929
PCV,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,87.6,84.9 to 89.9,1906
Hep B,≥2 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,92.2,89.8 to 94.1,960
Hep B,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,92.7,91.0 to 94.0,2192
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2016,Age,0-2 Days,79.2,75.4 to 82.6,960
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2016-2017,Age,0-2 Days,80.1,77.7 to 82.3,2192
≥1 Dose MMR,,HHS Regions/National,Region 7,2019,Age,35 Months,93.4,90.7 to 95.6,1269
≥1 Dose MMR,,HHS Regions/National,Region 7,2017,Age,35 Months,92.8,90.4 to 94.8,1232
≥1 Dose MMR,,HHS Regions/National,Region 7,2017-2018,Age,35 Months,93.9,92.3 to 95.4,2577
≥1 Dose MMR,,HHS Regions/National,Region 7,2018,Age,35 Months,95.1,92.7 to 97.0,1345
≥1 Dose MMR,,HHS Regions/National,Region 7,2018-2019,Age,35 Months,94.2,92.4 to 95.7,2614
Hep B,≥2 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,95.0,92.9 to 96.5,1232
Hep B,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,95.6,94.4 to 96.6,2577
Hib,≥1 Dose,HHS Regions/National,Region 7,2017,Age,3 Months,87.7,84.9 to 90.1,1232
Hib,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,3 Months,87.8,85.8 to 89.5,2577
Hib,≥1 Dose,HHS Regions/National,Region 7,2016,Age,3 Months,87.5,84.4 to 90.1,960
Hib,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,3 Months,87.6,85.6 to 89.4,2192
Hib,≥1 Dose,HHS Regions/National,Region 7,2015,Age,3 Months,86.6,83.0 to 89.5,891
Hib,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,3 Months,87.0,84.7 to 89.1,1851
PCV,≥3 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,89.9,86.8 to 92.3,960
PCV,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,90.3,88.4 to 92.0,2192
PCV,≥3 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,89.9,86.5 to 92.6,891
PCV,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,89.9,87.6 to 91.8,1851
Hep B,≥2 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,94.1,91.9 to 95.8,960
Hep B,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,94.6,93.1 to 95.7,2192
Hep B,≥2 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,96.3,94.7 to 97.4,1345
Hep B,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,95.3,94.0 to 96.4,2614
PCV,≥4 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,85.5,82.2 to 88.5,977
PCV,≥4 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,85.7,83.2 to 88.0,1868
PCV,≥4 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,85.9,82.1 to 89.4,891
PCV,≥4 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,83.8,81.0 to 86.3,1851
PCV,≥4 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,80.5,76.2 to 84.5,912
Hep B,≥2 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,96.0,93.6 to 97.5,929
Hep B,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,94.6,92.9 to 96.0,1906
Hep B,≥2 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,94.2,91.5 to 96.1,891
Hep B,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,94.2,92.5 to 95.5,1851
Hep B,≥2 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,93.2,91.0 to 94.9,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,93.7,92.1 to 95.0,1868
Hib,≥1 Dose,HHS Regions/National,Region 7,2014,Age,3 Months,86.3,83.1 to 88.9,977
Hib,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,3 Months,86.4,84.1 to 88.5,1868
Hib,≥1 Dose,HHS Regions/National,Region 7,2011,Age,3 Months,88.3,85.4 to 90.6,912
Hib,≥1 Dose,HHS Regions/National,Region 7,2012,Age,3 Months,88.4,85.0 to 91.2,977
Hib,≥1 Dose,HHS Regions/National,Region 7,2013,Age,3 Months,86.0,83.3 to 88.3,929
Hib,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,3 Months,86.1,83.4 to 88.4,1906
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,94.8,92.8 to 96.4,1345
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,94.1,92.5 to 95.5,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,90.9,88.4 to 92.9,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,90.4,88.3 to 92.2,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,93.5,90.9 to 95.6,1269
PCV,≥4 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,83.9,80.0 to 87.4,929
PCV,≥4 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,84.7,82.1 to 87.0,1906
Hib,≥1 Dose,HHS Regions/National,Region 7,2018,Age,3 Months,87.9,84.9 to 90.3,1345
Hib,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,3 Months,87.6,85.5 to 89.4,2614
Hib,≥1 Dose,HHS Regions/National,Region 7,2019,Age,3 Months,87.3,84.3 to 89.8,1269
PCV,≥3 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,91.9,89.0 to 94.3,929
PCV,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,91.9,90.1 to 93.5,1906
Hib,≥2 Doses,HHS Regions/National,Region 7,2017,Age,5 Months,77.9,74.5 to 81.1,1232
Hib,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,5 Months,79.9,77.6 to 82.1,2577
PCV,≥3 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,94.8,92.6 to 96.5,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,91.9,89.5 to 93.9,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,91.5,89.6 to 93.2,1868
PCV,≥4 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,84.7,81.3 to 87.8,1269
Hib,≥2 Doses,HHS Regions/National,Region 7,2016,Age,5 Months,78.9,74.9 to 82.4,960
Hib,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,5 Months,78.4,75.8 to 80.8,2192
Hib,≥2 Doses,HHS Regions/National,Region 7,2015,Age,5 Months,77.1,73.0 to 80.8,891
Hib,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,5 Months,78.0,75.1 to 80.6,1851
PCV,≥1 Dose,HHS Regions/National,Region 7,2013,Age,3 Months,86.1,83.3 to 88.5,929
PCV,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,3 Months,85.6,82.2 to 88.5,1906
PCV,≥4 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,88.8,85.6 to 91.6,1345
PCV,≥4 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,86.8,84.5 to 88.9,2614
PCV,≥4 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,81.7,77.7 to 85.4,960
PCV,≥4 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,83.5,80.9 to 85.9,2192
PCV,≥1 Dose,HHS Regions/National,Region 7,2011,Age,3 Months,85.5,82.0 to 88.4,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020,Age,24 Months,94.0,92.1 to 95.7,1280
PCV,≥3 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,90.8,88.2 to 92.9,1232
PCV,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,91.8,90.0 to 93.3,2577
Hib,≥2 Doses,HHS Regions/National,Region 7,2014,Age,5 Months,74.9,70.9 to 78.6,977
Hib,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,5 Months,76.0,71.9 to 79.7,1868
Hib,≥2 Doses,HHS Regions/National,Region 7,2013,Age,5 Months,77.4,73.5 to 80.8,929
Hib,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,5 Months,76.1,73.0 to 79.0,1906
Hib,≥2 Doses,HHS Regions/National,Region 7,2011,Age,5 Months,77.9,74.9 to 80.6,912
Hib,≥2 Doses,HHS Regions/National,Region 7,2012,Age,5 Months,75.7,71.9 to 79.2,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,94.3,92.0 to 96.0,1269
Hib,Full Series,HHS Regions/National,Region 7,2020,Age,24 Months,76.6,73.0 to 80.0,1280
PCV,≥3 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,92.8,90.3 to 94.7,1345
PCV,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,88.8,86.7 to 90.6,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,92.0,88.9 to 94.5,912
PCV,≥3 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,90.7,87.8 to 93.0,1269
Hib,≥2 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,88.7,85.6 to 91.1,977
Hib,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,88.2,85.9 to 90.2,1868
Hib,≥2 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,89.8,87.0 to 92.0,929
Hib,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,89.2,86.4 to 91.5,1906
PCV,≥4 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,85.3,82.0 to 88.3,1232
PCV,≥4 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,87.1,84.8 to 89.2,2577
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2012,Age,0-3 Days,75.1,70.7 to 79.0,977
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2011,Age,0-3 Days,80.1,76.4 to 83.3,912
Hib,≥2 Doses,HHS Regions/National,Region 7,2018,Age,5 Months,82.0,78.6 to 84.9,1345
Hib,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,5 Months,80.4,77.9 to 82.6,2614
Hib,≥2 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,88.2,84.4 to 91.2,912
Hib,≥2 Doses,HHS Regions/National,Region 7,2019,Age,5 Months,78.7,75.1 to 82.0,1269
PCV,≥3 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,91.1,88.0 to 93.8,891
PCV,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,91.3,89.1 to 93.1,1851
Hib,≥2 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,91.4,89.6 to 92.9,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,91.3,88.5 to 93.6,960
PCV,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,91.2,89.4 to 92.9,2192
PCV,≥3 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,91.1,88.6 to 93.3,1232
PCV,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,92.2,90.5 to 93.7,2577
PCV,≥1 Dose,HHS Regions/National,Region 7,2017,Age,3 Months,87.6,84.8 to 90.0,1232
PCV,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,3 Months,88.6,86.6 to 90.2,2577
PCV,≥1 Dose,HHS Regions/National,Region 7,2016,Age,3 Months,86.8,83.7 to 89.5,960
PCV,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,3 Months,87.2,85.1 to 89.1,2192
PCV,≥1 Dose,HHS Regions/National,Region 7,2015,Age,3 Months,84.6,80.6 to 87.8,891
PCV,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,3 Months,85.7,83.2 to 87.9,1851
PCV,≥1 Dose,HHS Regions/National,Region 7,2014,Age,3 Months,85.1,81.9 to 87.9,977
PCV,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,3 Months,84.9,82.4 to 87.1,1868
PCV,≥1 Dose,HHS Regions/National,Region 7,2012,Age,3 Months,88.4,85.3 to 90.9,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,93.3,90.9 to 95.2,1345
PCV,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,92.2,90.4 to 93.7,2614
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2016,Age,0-3 Days,80.7,77.0 to 83.9,960
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2016-2017,Age,0-3 Days,81.1,78.8 to 83.3,2192
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2017,Age,0-3 Days,83.0,78.5 to 86.7,677
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2017-2018,Age,0-3 Days,82.5,80.3 to 84.6,2577
Polio,≥1 Dose,HHS Regions/National,Region 7,2016,Age,3 Months,88.1,85.1 to 90.6,960
Polio,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,3 Months,88.1,86.1 to 89.9,2192
Polio,≥1 Dose,HHS Regions/National,Region 7,2015,Age,3 Months,86.6,82.8 to 89.6,891
Polio,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,3 Months,87.3,84.9 to 89.4,1851
Polio,≥1 Dose,HHS Regions/National,Region 7,2014,Age,3 Months,86.6,83.5 to 89.2,977
Polio,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,3 Months,86.6,84.2 to 88.7,1868
Hib,≥3 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,46.4,41.4 to 51.6,929
Hib,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,48.0,44.7 to 51.3,1906
Hib,≥3 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,60.5,55.2 to 65.5,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,52.9,48.3 to 57.6,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,92.4,89.7 to 94.7,960
PCV,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,92.0,90.2 to 93.6,2192
PCV,≥3 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,95.1,90.0 to 98.1,891
PCV,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,93.0,90.8 to 94.8,1851
PCV,≥3 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,94.1,91.8 to 96.0,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,94.4,92.0 to 96.3,1868
DTaP,≥4 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,88.4,85.2 to 91.3,1345
DTaP,≥4 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,87.8,85.4 to 89.9,2614
≥1 Dose MMR,,HHS Regions/National,Region 7,2012,Age,19 Months,88.1,85.2 to 90.5,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2014,Age,19 Months,90.3,87.8 to 92.4,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2014-2015,Age,19 Months,87.7,85.4 to 89.7,1868
≥1 Dose MMR,,HHS Regions/National,Region 7,2013,Age,19 Months,87.3,83.6 to 90.2,929
≥1 Dose MMR,,HHS Regions/National,Region 7,2013-2014,Age,19 Months,88.8,86.3 to 90.9,1906
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017,Age,19 Months,89.3,86.6 to 91.5,1232
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017-2018,Age,19 Months,89.8,87.9 to 91.3,2577
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018,Age,19 Months,90.3,87.6 to 92.4,1345
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018-2019,Age,19 Months,58.3,55.5 to 61.0,2614
Hep B,≥1 Dose,HHS Regions/National,Region 7,2017,Age,3 Months,96.5,94.7 to 97.7,1232
Hep B,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,3 Months,96.9,95.8 to 97.8,2577
Polio,≥2 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,92.8,90.2 to 94.7,960
Polio,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,93.3,91.6 to 94.6,2192
Polio,≥2 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,92.9,90.0 to 95.0,891
Polio,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,92.8,90.9 to 94.4,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016,Age,19 Months,85.2,81.6 to 88.3,960
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016-2017,Age,19 Months,87.2,85.0 to 89.2,2192
≥1 Dose MMR,,HHS Regions/National,Region 7,2019,Age,13 Months,64.6,60.7 to 68.4,1269
PCV,≥3 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,69.7,66.8 to 72.5,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,65.9,61.7 to 69.9,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,67.1,64.1 to 70.0,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,90.5,87.6 to 92.8,960
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,91.6,89.8 to 93.1,2192
PCV,≥3 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,68.3,64.7 to 71.8,912
PCV,≥3 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,64.7,57.9 to 71.0,929
PCV,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,65.3,61.4 to 69.1,1906
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2012,Age,0-1 Days,68.7,64.3 to 72.7,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2014,Age,5 Months,88.1,85.2 to 90.5,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,5 Months,88.5,86.5 to 90.2,1868
Hep B,≥2 Doses,HHS Regions/National,Region 7,2016,Age,5 Months,88.7,85.5 to 91.2,960
Hep B,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,5 Months,89.1,87.1 to 90.9,2192
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,92.7,90.4 to 94.5,1232
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,93.4,91.9 to 94.7,2577
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,94.2,92.1 to 95.8,1345
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,90.4,88.5 to 91.9,2614
DTaP,≥4 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,79.2,75.8 to 82.4,1232
DTaP,≥4 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,81.0,78.6 to 83.2,2577
DTaP,≥4 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,82.7,79.4 to 85.7,1345
DTaP,≥4 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,82.2,79.8 to 84.4,2614
Hep B,≥3 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,92.9,90.7 to 94.6,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,91.8,89.4 to 93.7,1345
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,90.4,88.5 to 91.9,2614
Hep B,≥3 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,90.3,85.5 to 93.6,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,88.9,86.0 to 91.3,1269
≥1 Dose MMR,,HHS Regions/National,Region 7,2011,Age,19 Months,85.9,83.4 to 88.1,912
DTaP,≥4 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,87.0,83.4 to 90.1,1269
Hep B,≥2 Doses,HHS Regions/National,Region 7,2015,Age,5 Months,88.8,85.7 to 91.4,891
Hep B,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,5 Months,88.8,86.6 to 90.6,1851
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2014,Age,0-1 Days,69.0,65.0 to 72.8,977
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2014-2015,Age,0-1 Days,70.4,67.4 to 73.1,1868
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2013,Age,0-1 Days,69.6,65.6 to 73.4,929
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2013-2014,Age,0-1 Days,69.3,66.1 to 72.4,1906
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013,Age,24 Months,89.5,86.3 to 92.3,929
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013-2014,Age,24 Months,89.8,87.8 to 91.7,1906
Polio,≥2 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,93.8,91.5 to 95.5,1232
Polio,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,94.8,93.4 to 96.0,2577
Polio,≥2 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,95.9,94.1 to 97.2,1345
Polio,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,94.6,93.2 to 95.8,2614
Polio,≥2 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,93.3,90.8 to 95.2,1269
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019,Age,19 Months,87.2,84.1 to 89.8,1269
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016,Age,24 Months,88.4,85.3 to 91.2,960
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016-2017,Age,24 Months,89.9,87.9 to 91.7,2192
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015,Age,24 Months,88.6,85.3 to 91.5,891
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015-2016,Age,24 Months,88.5,86.3 to 90.6,1851
≥1 Dose MMR,,HHS Regions/National,Region 7,2012,Age,24 Months,92.2,89.6 to 94.3,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2011,Age,24 Months,89.3,85.8 to 92.3,912
PCV,≥4 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,76.0,72.5 to 79.2,912
PCV,≥4 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,79.9,77.2 to 82.4,977
PCV,≥4 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,77.5,72.0 to 82.1,929
PCV,≥4 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,78.3,73.8 to 82.2,1906
≥1 Dose MMR,,HHS Regions/National,Region 7,2018,Age,19 Months,90.6,87.9 to 92.8,1345
≥1 Dose MMR,,HHS Regions/National,Region 7,2018-2019,Age,19 Months,94.1,92.5 to 95.3,2614
≥1 Dose MMR,,HHS Regions/National,Region 7,2019,Age,19 Months,87.5,84.3 to 90.1,1269
≥1 Dose MMR,,HHS Regions/National,Region 7,2017,Age,19 Months,89.4,86.6 to 91.6,1232
≥1 Dose MMR,,HHS Regions/National,Region 7,2017-2018,Age,19 Months,90.0,88.1 to 91.6,2577
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2017,Age,0-1 Days,77.1,73.7 to 80.2,1232
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2017-2018,Age,0-1 Days,78.4,76.0 to 80.6,2577
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2016,Age,0-1 Days,73.5,69.3 to 77.3,960
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2016-2017,Age,0-1 Days,75.3,72.6 to 77.7,2192
PCV,≥4 Doses,HHS Regions/National,Region 7,2020,Age,35 Months,85.6,82.2 to 88.6,1280
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014,Age,24 Months,90.2,87.5 to 92.5,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014-2015,Age,24 Months,89.4,87.3 to 91.3,1868
Hep B,≥2 Doses,HHS Regions/National,Region 7,2017,Age,5 Months,89.6,86.7 to 91.9,1232
Hep B,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,5 Months,90.8,88.9 to 92.3,2577
Hep B,≥2 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,92.2,88.8 to 94.6,912
Hep B,≥2 Doses,HHS Regions/National,Region 7,2019,Age,5 Months,91.8,89.3 to 93.8,1269
Hep B,≥2 Doses,HHS Regions/National,Region 7,2018,Age,5 Months,92.0,89.4 to 93.9,1345
Hep B,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,5 Months,91.9,90.2 to 93.3,2614
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2015,Age,0-1 Days,71.7,67.3 to 75.7,891
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2015-2016,Age,0-1 Days,72.6,69.6 to 75.4,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017,Age,24 Months,91.4,89.0 to 93.4,1232
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017-2018,Age,24 Months,91.8,90.1 to 93.3,2577
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019,Age,24 Months,89.2,86.2 to 91.7,1269
≥1 Dose MMR,,HHS Regions/National,Region 7,2013,Age,24 Months,91.0,87.6 to 93.8,929
≥1 Dose MMR,,HHS Regions/National,Region 7,2013-2014,Age,24 Months,91.9,89.9 to 93.6,1906
≥1 Dose MMR,,HHS Regions/National,Region 7,2014,Age,24 Months,92.8,90.7 to 94.6,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2014-2015,Age,24 Months,91.1,89.2 to 92.8,1868
≥1 Dose MMR,,HHS Regions/National,Region 7,2015,Age,24 Months,89.4,86.1 to 92.2,891
≥1 Dose MMR,,HHS Regions/National,Region 7,2015-2016,Age,24 Months,89.5,87.2 to 91.5,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018,Age,24 Months,92.2,89.8 to 94.3,1345
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018-2019,Age,24 Months,90.7,88.9 to 92.4,2614
PCV,≥4 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,75.8,71.5 to 79.6,960
PCV,≥4 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,77.7,75.0 to 80.2,2192
PCV,≥4 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,78.4,73.0 to 83.0,891
PCV,≥4 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,77.1,74.1 to 79.9,1851
PCV,≥4 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,79.2,75.6 to 82.4,977
PCV,≥4 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,78.8,76.1 to 81.3,1868
PCV,≥3 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,68.3,63.8 to 72.5,891
PCV,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,69.5,66.4 to 72.5,1851
PCV,≥3 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,66.7,63.0 to 70.3,1232
PCV,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,70.9,68.3 to 73.4,2577
Hep B,≥3 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,94.2,91.8 to 96.1,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,70.8,66.3 to 74.9,960
PCV,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,68.8,65.9 to 71.6,2192
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,93.0,90.4 to 95.2,929
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,92.8,91.2 to 94.3,1906
Hep B,≥3 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,92.0,89.2 to 94.2,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,91.1,88.3 to 93.3,1269
Hep B,≥2 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,92.4,88.7 to 94.9,929
Hep B,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,91.7,88.7 to 94.0,1906
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2012,Age,0-2 Days,74.1,70.3 to 77.5,977
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2013,Age,0-2 Days,74.6,70.7 to 78.2,929
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2013-2014,Age,0-2 Days,74.4,71.3 to 77.3,1906
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2018,Age,0-1 Days,79.7,76.3 to 82.8,1345
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2018-2019,Age,0-1 Days,78.5,76.0 to 80.7,2614
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2011,Age,0-2 Days,78.8,73.5 to 83.3,912
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2019,Age,0-1 Days,77.1,73.6 to 80.4,1269
Hep B,≥2 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,93.3,90.2 to 95.5,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,91.0,88.4 to 93.2,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,91.6,89.7 to 93.1,1868
PCV,≥3 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,75.1,71.4 to 78.4,1345
PCV,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,72.7,70.0 to 75.3,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,87.1,83.3 to 90.2,912
PCV,≥3 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,70.3,66.3 to 74.1,1269
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,92.6,90.5 to 94.4,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,92.7,91.0 to 94.1,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,92.7,90.1 to 94.9,891
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,91.8,90.0 to 93.5,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,91.0,88.2 to 93.3,960
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,92.2,90.5 to 93.7,2192
PCV,≥3 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,90.9,88.6 to 92.8,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2016,Age,24 Months,89.6,86.4 to 92.3,960
≥1 Dose MMR,,HHS Regions/National,Region 7,2016-2017,Age,24 Months,90.5,88.5 to 92.2,2192
≥1 Dose MMR,,HHS Regions/National,Region 7,2017,Age,24 Months,91.3,88.9 to 93.4,1232
≥1 Dose MMR,,HHS Regions/National,Region 7,2017-2018,Age,24 Months,92.3,90.6 to 93.8,2577
PCV,≥4 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,79.7,76.3 to 82.7,1232
PCV,≥4 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,81.0,78.7 to 83.2,2577
PCV,≥4 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,82.4,79.0 to 85.4,1345
PCV,≥4 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,82.3,79.5 to 84.8,2113
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2015,Age,0-2 Days,78.6,74.5 to 82.2,891
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2015-2016,Age,0-2 Days,78.9,76.2 to 81.4,1851
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2014,Age,0-2 Days,74.2,70.3 to 77.7,977
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2014-2015,Age,0-2 Days,76.4,73.6 to 78.9,1868
PCV,≥3 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,87.9,84.2 to 90.8,891
PCV,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,87.5,85.0 to 89.7,1851
PCV,≥3 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,87.2,84.2 to 89.7,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,87.5,85.2 to 89.5,1868
Hep B,≥2 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,92.1,89.2 to 94.3,891
Hep B,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,92.1,90.3 to 93.6,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,94.5,92.5 to 96.2,1345
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,93.1,91.5 to 94.5,2614
≥1 Dose MMR,,HHS Regions/National,Region 7,2013,Age,35 Months,93.6,90.4 to 96.0,929
≥1 Dose MMR,,HHS Regions/National,Region 7,2013-2014,Age,35 Months,94.6,92.7 to 96.1,1906
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016,Age,35 Months,91.2,88.1 to 93.8,960
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016-2017,Age,35 Months,92.1,90.2 to 93.8,2192
≥1 Dose MMR,,HHS Regions/National,Region 7,2012,Age,35 Months,94.6,92.3 to 96.4,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2011,Age,35 Months,94.7,91.1 to 97.2,912
≥1 Dose MMR,,HHS Regions/National,Region 7,2018,Age,24 Months,93.2,90.8 to 95.2,1345
≥1 Dose MMR,,HHS Regions/National,Region 7,2018-2019,Age,24 Months,91.3,89.4 to 92.9,2614
≥1 Dose MMR,,HHS Regions/National,Region 7,2019,Age,24 Months,89.2,86.3 to 91.8,1269
PCV,≥4 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,81.6,77.8 to 85.2,929
PCV,≥4 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,82.1,79.6 to 84.5,1906
PCV,≥4 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,82.6,79.3 to 85.7,977
PCV,≥4 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,82.7,80.2 to 85.1,1868
PCV,≥4 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,85.5,82.1 to 88.5,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,93.1,90.4 to 95.3,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,93.5,91.3 to 95.3,1232
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,94.0,92.6 to 95.3,2577
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,91.6,89.0 to 93.9,1269
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,92.7,89.9 to 95.0,960
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,93.9,92.1 to 95.4,2192
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,93.5,90.8 to 95.6,891
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,93.3,91.3 to 94.9,1851
PCV,≥3 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,91.6,87.9 to 94.3,929
PCV,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,91.3,89.2 to 93.0,1906
PCV,≥3 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,89.8,85.0 to 93.2,912
PCV,≥3 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,87.8,84.6 to 90.4,1269
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,95.2,92.9 to 96.9,1232
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,95.1,93.5 to 96.4,2577
PCV,≥3 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,93.9,91.9 to 95.4,977
PCV,≥4 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,89.4,86.2 to 92.1,977
PCV,≥4 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,85.6,80.9 to 89.6,912
PCV,≥4 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,83.3,79.9 to 86.3,1269
PCV,≥4 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,85.8,82.7 to 88.7,1345
PCV,≥4 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,84.6,82.3 to 86.7,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,87.2,83.7 to 90.0,960
PCV,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,87.3,85.1 to 89.3,2192
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,93.6,90.9 to 95.7,929
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,93.7,92.0 to 95.1,1906
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,93.8,91.6 to 95.5,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,93.7,92.0 to 95.1,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,95.1,92.8 to 96.9,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,95.8,93.0 to 97.5,977
Hep B,≥2 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,94.9,92.7 to 96.4,912
Hep B,≥2 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,93.5,91.1 to 95.3,1269
PCV,≥3 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,87.5,84.5 to 90.0,1232
PCV,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,88.6,86.6 to 90.4,2577
PCV,≥3 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,89.7,86.8 to 92.0,1345
PCV,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,88.8,86.7 to 90.6,2614
PCV,≥4 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,80.0,76.0 to 83.7,960
PCV,≥4 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,81.1,78.6 to 83.5,2192
PCV,≥4 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,82.2,79.0 to 85.3,1232
PCV,≥4 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,84.0,81.8 to 86.1,2577
≥1 Dose MMR,,HHS Regions/National,Region 7,2015,Age,35 Months,91.4,88.1 to 94.1,891
≥1 Dose MMR,,HHS Regions/National,Region 7,2015-2016,Age,35 Months,92.0,89.8 to 94.0,1851
≥1 Dose MMR,,HHS Regions/National,Region 7,2014,Age,35 Months,95.5,93.3 to 97.1,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2014-2015,Age,35 Months,93.6,91.6 to 95.2,1868
≥1 Dose MMR,,HHS Regions/National,Region 7,2016,Age,35 Months,92.5,89.3 to 95.0,960
≥1 Dose MMR,,HHS Regions/National,Region 7,2016-2017,Age,35 Months,92.7,90.7 to 94.3,2192
PCV,≥4 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,82.9,79.0 to 86.4,891
PCV,≥4 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,81.5,78.7 to 84.1,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018,Age,35 Months,94.8,92.3 to 96.7,1345
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018-2019,Age,35 Months,93.8,92.0 to 95.4,2614
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019,Age,35 Months,93.0,90.2 to 95.3,1269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2014,Age,0-3 Days,75.3,71.6 to 78.8,977
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2014-2015,Age,0-3 Days,77.8,75.1 to 80.2,1868
Polio,≥1 Dose,HHS Regions/National,Region 7,2013,Age,3 Months,85.5,81.1 to 89.1,929
Polio,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,3 Months,86.1,82.6 to 89.0,1906
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2013,Age,0-3 Days,76.5,72.5 to 80.2,929
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2013-2014,Age,0-3 Days,75.9,73.2 to 78.5,1906
Polio,≥1 Dose,HHS Regions/National,Region 7,2011,Age,3 Months,88.9,86.6 to 90.8,912
Polio,≥1 Dose,HHS Regions/National,Region 7,2012,Age,3 Months,89.5,86.8 to 91.7,977
PCV,≥1 Dose,HHS Regions/National,Region 7,2019,Age,3 Months,89.2,86.2 to 91.5,1269
PCV,≥1 Dose,HHS Regions/National,Region 7,2018,Age,3 Months,89.5,86.7 to 91.7,1345
PCV,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,3 Months,89.3,87.3 to 91.0,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,95.0,92.8 to 96.7,977
PCV,≥3 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,94.7,91.8 to 96.8,929
PCV,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,94.4,92.6 to 95.9,1906
PCV,≥3 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,92.5,89.5 to 95.0,912
PCV,≥3 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,91.0,88.2 to 93.4,1269
Hib,≥2 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,87.8,84.2 to 90.6,891
Hib,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,88.0,85.6 to 90.0,1851
Hib,≥2 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,90.0,87.0 to 92.3,1345
Hib,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,89.7,87.7 to 91.5,2614
Hib,≥2 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,89.4,86.6 to 91.7,1232
Hib,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,89.7,87.7 to 91.4,2577
Hib,≥2 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,88.2,85.0 to 90.7,960
Hib,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,88.8,86.7 to 90.6,2192
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,72.8,68.5 to 76.8,960
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,70.8,67.9 to 73.5,2192
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2015,Age,0-3 Days,80.2,76.2 to 83.6,891
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2015-2016,Age,0-3 Days,80.4,77.8 to 82.8,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,68.9,64.7 to 72.8,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,69.5,66.5 to 72.4,1868
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,70.2,65.7 to 74.3,891
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,71.5,68.4 to 74.4,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,71.8,67.4 to 75.8,912
DTaP,≥3 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,70.8,67.5 to 73.8,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,68.1,61.7 to 73.9,929
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,68.5,64.8 to 72.0,1906
Hib,≥2 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,92.9,88.7 to 95.6,912
Hib,≥2 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,95.1,93.6 to 96.3,977
Hib,≥2 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,89.5,86.5 to 91.9,1269
Polio,≥3 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,92.8,89.9 to 95.1,1269
Hib,Full Series,HHS Regions/National,Region 6,2013-2014,Age,24 Months,77.9,76.2 to 79.7,4660
Hep A,≥1 Dose,HHS Regions/National,Region 7,2016,Age,35 Months,87.0,83.1 to 90.4,960
Hep A,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,35 Months,88.7,86.4 to 90.9,2192
DTaP,≥4 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,79.0,75.0 to 82.8,891
DTaP,≥4 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,78.0,75.0 to 80.9,1851
DTaP,≥4 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,77.0,72.7 to 81.0,960
DTaP,≥4 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,78.1,75.3 to 80.7,2192
DTaP,≥4 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,80.4,76.8 to 83.8,977
DTaP,≥4 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,79.7,77.0 to 82.3,1868
Hep A,≥1 Dose,HHS Regions/National,Region 7,2014,Age,35 Months,90.5,86.5 to 93.7,977
Hep A,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,35 Months,90.4,87.5 to 92.9,1868
Hep A,≥1 Dose,HHS Regions/National,Region 7,2013,Age,35 Months,87.3,83.4 to 90.6,929
Hep A,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,35 Months,88.9,86.2 to 91.3,1906
Hep A,≥2 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,45.6,40.8 to 50.7,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,74.7,69.5 to 79.7,929
Hep A,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,72.9,69.3 to 76.4,1906
Hep A,≥2 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,74.4,68.7 to 79.8,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,66.1,60.1 to 72.0,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,67.0,62.6 to 71.1,960
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,65.6,62.7 to 68.4,2192
Polio,≥2 Doses,HHS Regions/National,Region 7,2015,Age,5 Months,77.3,73.1 to 81.0,891
Polio,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,5 Months,78.4,75.6 to 81.0,1851
Hep A,≥2 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,52.2,48.2 to 56.3,1269
Hep A,≥2 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,50.5,46.5 to 54.7,1345
Hep A,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,51.3,48.5 to 54.2,2614
Polio,≥2 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,88.5,84.6 to 91.5,912
Polio,≥2 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,91.8,90.0 to 93.3,977
Polio,≥2 Doses,HHS Regions/National,Region 7,2019,Age,5 Months,82.8,79.3 to 85.8,1269
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,64.2,60.4 to 67.8,1232
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,68.2,65.6 to 70.7,2577
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,72.3,68.7 to 75.7,1345
Hep B,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,72.1,69.5 to 74.5,2614
Hep A,≥2 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,70.5,65.5 to 75.4,891
Hep A,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,72.8,68.8 to 76.7,1851
Hep A,≥2 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,74.5,68.7 to 79.9,960
Hep A,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,75.5,71.7 to 79.1,2192
Hep A,≥2 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,71.3,66.2 to 76.3,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,71.0,67.4 to 74.5,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,71.8,68.1 to 75.3,1269
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014,Age,13 Months,61.2,57.1 to 65.2,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014-2015,Age,13 Months,58.4,55.4 to 61.5,1868
≥1 Dose Varicella,,HHS Regions/National,Region 7,2012,Age,13 Months,52.4,45.7 to 59.1,977
Hep A,≥1 Dose,HHS Regions/National,Region 7,2018,Age,35 Months,92.7,89.9 to 94.9,1345
Hep A,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,35 Months,91.2,89.1 to 93.0,2614
Hep A,≥1 Dose,HHS Regions/National,Region 7,2019,Age,35 Months,89.7,86.6 to 92.4,1269
Polio,≥2 Doses,HHS Regions/National,Region 7,2018,Age,5 Months,84.6,81.4 to 87.4,1345
Polio,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,5 Months,83.7,81.4 to 85.8,2614
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013,Age,13 Months,51.7,43.0 to 60.2,929
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013-2014,Age,13 Months,56.5,50.8 to 62.0,1906
≥1 Dose Varicella,,HHS Regions/National,Region 7,2011,Age,13 Months,53.0,49.0 to 57.0,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,90.0,87.1 to 92.5,1269
PCV,≥2 Doses,HHS Regions/National,Region 7,2018,Age,5 Months,83.6,80.3 to 86.4,1345
PCV,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,5 Months,82.2,79.8 to 84.4,2614
PCV,≥2 Doses,HHS Regions/National,Region 7,2017,Age,5 Months,77.4,73.9 to 80.5,1232
PCV,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,5 Months,80.5,78.1 to 82.6,2577
PCV,≥2 Doses,HHS Regions/National,Region 7,2019,Age,5 Months,80.7,77.1 to 83.9,1269
DTaP,≥4 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,69.5,65.8 to 72.9,1232
DTaP,≥4 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,71.8,69.2 to 74.2,2577
DTaP,≥4 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,69.0,64.5 to 73.2,960
DTaP,≥4 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,69.2,66.4 to 72.0,2192
Hep A,≥2 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,44.1,39.8 to 48.7,929
Hep A,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,45.1,42.0 to 48.3,1906
DTaP,≥4 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,74.1,70.5 to 77.4,1345
DTaP,≥4 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,94.6,93.2 to 95.8,2614
Polio,≥2 Doses,HHS Regions/National,Region 7,2014,Age,5 Months,75.1,71.0 to 78.7,977
Polio,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,5 Months,76.2,72.0 to 79.9,1868
Polio,≥2 Doses,HHS Regions/National,Region 7,2013,Age,5 Months,77.3,72.2 to 81.8,929
Polio,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,5 Months,76.2,72.6 to 79.4,1906
Hep A,≥1 Dose,HHS Regions/National,Region 7,2012,Age,35 Months,89.9,86.8 to 92.6,977
Polio,≥2 Doses,HHS Regions/National,Region 7,2011,Age,5 Months,78.8,74.9 to 82.3,912
Polio,≥2 Doses,HHS Regions/National,Region 7,2012,Age,5 Months,77.8,73.5 to 81.5,977
Hep A,≥1 Dose,HHS Regions/National,Region 7,2015,Age,35 Months,90.4,85.9 to 94.0,891
Hep A,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,35 Months,88.3,85.4 to 90.9,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2011,Age,7 Months,58.3,53.1 to 63.4,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2012,Age,7 Months,64.7,60.2 to 68.8,977
DTaP,≥4 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,81.2,77.3 to 84.9,977
DTaP,≥4 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,80.2,75.9 to 84.2,912
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,67.1,59.4 to 74.0,929
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,67.8,61.7 to 73.3,1906
DTaP,≥4 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,72.3,68.5 to 75.8,1269
DTaP,≥4 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,80.5,76.4 to 84.4,929
DTaP,≥4 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,80.5,77.7 to 83.1,1906
Hep A,≥2 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,46.5,42.1 to 51.2,960
Hep A,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,45.8,42.8 to 48.8,2192
Hep A,≥2 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,45.0,41.3 to 48.9,1232
Hep A,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,47.7,45.0 to 50.5,2577
≥1 Dose MMR,,HHS Regions/National,Region 7,2013,Age,13 Months,52.8,44.8 to 60.6,929
≥1 Dose MMR,,HHS Regions/National,Region 7,2013-2014,Age,13 Months,59.7,54.4 to 64.9,1906
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018,Age,13 Months,59.1,55.1 to 62.9,1345
≥1 Dose Varicella,,HHS Regions/National,Region 7,2018-2019,Age,13 Months,58.3,55.5 to 61.0,2614
DTaP,≥4 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,87.1,83.3 to 90.4,977
DTaP,≥4 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,87.4,84.3 to 90.1,1868
DTaP,≥4 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,89.8,86.0 to 93.0,977
DTaP,≥4 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,87.7,83.8 to 91.1,929
DTaP,≥4 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,87.4,84.7 to 89.8,1906
Hep B,≥3 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,88.8,86.0 to 91.1,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,78.8,74.2 to 83.2,1269
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,89.4,86.7 to 91.6,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,88.8,86.6 to 90.6,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,89.5,86.5 to 91.9,929
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,89.5,87.0 to 91.5,1906
Hep A,≥2 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,76.6,72.0 to 80.9,1232
Hep A,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,79.2,75.8 to 82.4,2577
Hep A,≥2 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,82.0,76.8 to 86.6,1345
Hep A,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,80.4,76.9 to 83.6,2614
Hep B,≥3 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,85.7,80.3 to 89.8,912
Polio,≥2 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,88.7,85.2 to 91.4,891
Polio,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,88.5,86.2 to 90.4,1851
Polio,≥2 Doses,HHS Regions/National,Region 7,2013,Age,7 Months,90.2,87.4 to 92.4,929
Polio,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,7 Months,89.4,86.6 to 91.8,1906
Polio,≥2 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,88.7,85.7 to 91.2,977
Polio,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,88.7,86.5 to 90.6,1868
Hep A,≥2 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,46.0,41.7 to 50.5,977
Hep A,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,46.4,43.3 to 49.7,1868
Hep A,≥2 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,46.9,42.4 to 51.5,891
Hep A,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,46.7,43.5 to 50.0,1851
≥1 Dose MMR,,HHS Regions/National,Region 7,2015,Age,13 Months,60.9,56.3 to 65.3,891
≥1 Dose MMR,,HHS Regions/National,Region 7,2015-2016,Age,13 Months,62.4,59.2 to 65.4,1851
≥1 Dose MMR,,HHS Regions/National,Region 7,2014,Age,13 Months,66.7,62.7 to 70.5,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2014-2015,Age,13 Months,63.8,60.8 to 66.7,1868
≥1 Dose Varicella,,HHS Regions/National,Region 7,2012,Age,19 Months,87.9,85.5 to 89.9,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2011,Age,19 Months,84.3,82.1 to 86.2,912
≥1 Dose Varicella,,HHS Regions/National,Region 7,2019,Age,13 Months,57.5,53.6 to 61.4,1269
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015,Age,13 Months,55.6,51.1 to 60.1,891
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015-2016,Age,13 Months,57.8,54.6 to 60.9,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017,Age,13 Months,58.5,54.7 to 62.2,1232
≥1 Dose Varicella,,HHS Regions/National,Region 7,2017-2018,Age,13 Months,58.8,56.1 to 61.5,2577
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016,Age,13 Months,59.9,55.5 to 64.2,960
≥1 Dose Varicella,,HHS Regions/National,Region 7,2016-2017,Age,13 Months,59.2,56.3 to 62.1,2192
≥1 Dose MMR,,HHS Regions/National,Region 7,2011,Age,13 Months,53.3,49.4 to 57.1,912
≥1 Dose MMR,,HHS Regions/National,Region 7,2012,Age,13 Months,54.8,48.8 to 60.7,977
≥1 Dose MMR,,HHS Regions/National,Region 7,2018,Age,13 Months,65.1,61.2 to 68.9,1345
≥1 Dose MMR,,HHS Regions/National,Region 7,2018-2019,Age,13 Months,64.9,62.1 to 67.6,2614
Hep B,≥1 Dose,HHS Regions/National,Region 7,2016,Age,3 Months,96.3,94.8 to 97.4,960
Hep B,≥1 Dose,HHS Regions/National,Region 7,2016-2017,Age,3 Months,96.4,95.3 to 97.2,2192
Hep B,≥1 Dose,HHS Regions/National,Region 7,2015,Age,3 Months,96.2,94.4 to 97.4,891
Hep B,≥1 Dose,HHS Regions/National,Region 7,2015-2016,Age,3 Months,96.2,95.1 to 97.1,1851
Hep B,≥1 Dose,HHS Regions/National,Region 7,2014,Age,3 Months,94.3,92.0 to 95.9,977
Hep B,≥1 Dose,HHS Regions/National,Region 7,2014-2015,Age,3 Months,95.2,93.9 to 96.3,1868
Polio,≥2 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,94.9,92.5 to 96.5,929
Polio,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,94.4,92.9 to 95.6,1906
Polio,≥2 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,90.3,87.4 to 92.6,1269
Polio,≥2 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,89.5,86.7 to 91.7,1232
Polio,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,90.0,88.1 to 91.7,2577
Polio,≥2 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,88.3,85.2 to 90.8,960
Polio,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,88.9,86.8 to 90.6,2192
Hep B,≥1 Dose,HHS Regions/National,Region 7,2011,Age,3 Months,95.5,92.4 to 97.3,912
Hep B,≥1 Dose,HHS Regions/National,Region 7,2012,Age,3 Months,96.2,94.1 to 97.5,977
Hep B,≥1 Dose,HHS Regions/National,Region 7,2013,Age,3 Months,94.7,93.3 to 95.8,929
Hep B,≥1 Dose,HHS Regions/National,Region 7,2013-2014,Age,3 Months,94.5,93.1 to 95.7,1906
Polio,≥2 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,90.6,87.7 to 92.9,1345
Polio,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,90.5,88.5 to 92.2,2614
DTaP,≥4 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,88.1,83.4 to 92.0,912
DTaP,≥4 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,81.6,78.1 to 84.8,1269
Polio,≥2 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,92.8,88.2 to 95.7,912
Polio,≥2 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,95.2,93.8 to 96.2,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013,Age,19 Months,86.8,82.9 to 90.0,929
≥1 Dose Varicella,,HHS Regions/National,Region 7,2013-2014,Age,19 Months,87.4,84.8 to 89.6,1906
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015,Age,19 Months,84.2,80.7 to 87.1,891
≥1 Dose Varicella,,HHS Regions/National,Region 7,2015-2016,Age,19 Months,84.7,82.1 to 87.0,1851
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014,Age,19 Months,87.9,84.9 to 90.4,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2014-2015,Age,19 Months,86.0,83.6 to 88.1,1868
≥1 Dose MMR,,HHS Regions/National,Region 7,2017,Age,13 Months,63.7,59.9 to 67.3,1232
≥1 Dose MMR,,HHS Regions/National,Region 7,2017-2018,Age,13 Months,64.4,61.7 to 67.0,2577
≥1 Dose MMR,,HHS Regions/National,Region 7,2016,Age,13 Months,63.9,59.5 to 68.1,960
≥1 Dose MMR,,HHS Regions/National,Region 7,2016-2017,Age,13 Months,63.8,60.9 to 66.6,2192
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,89.9,87.3 to 92.0,1232
Hep B,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,90.9,89.2 to 92.3,2577
DTaP,≥4 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,88.3,83.1 to 92.5,891
DTaP,≥4 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,86.1,82.7 to 89.2,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,88.1,84.7 to 90.9,891
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,87.8,85.4 to 89.8,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,87.4,84.1 to 90.1,960
Hep B,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,88.6,86.6 to 90.4,2192
DTaP,≥4 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,84.5,80.0 to 88.5,960
DTaP,≥4 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,85.3,82.4 to 87.9,2192
DTaP,≥4 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,86.0,82.5 to 89.1,1232
DTaP,≥4 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,87.3,84.9 to 89.4,2577
≥1 Dose Varicella,,HHS Regions/National,Region 7,2012,Age,24 Months,91.5,89.0 to 93.7,977
≥1 Dose Varicella,,HHS Regions/National,Region 7,2011,Age,24 Months,86.7,83.0 to 89.9,912
≥1 Dose MMR,,HHS Regions/National,Region 7,2016,Age,19 Months,85.8,82.1 to 88.9,960
≥1 Dose MMR,,HHS Regions/National,Region 7,2016-2017,Age,19 Months,87.6,85.3 to 89.5,2192
≥1 Dose MMR,,HHS Regions/National,Region 7,2015,Age,19 Months,85.1,80.6 to 88.7,891
≥1 Dose MMR,,HHS Regions/National,Region 7,2015-2016,Age,19 Months,85.5,82.8 to 87.7,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,91.4,88.5 to 93.7,891
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,91.0,89.0 to 92.7,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,91.4,89.1 to 93.4,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,91.4,89.6 to 93.0,1868
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,92.3,89.7 to 94.3,929
Hep B,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,91.9,90.0 to 93.4,1906
Hep B,≥2 Doses,HHS Regions/National,Region 7,2013,Age,5 Months,86.3,82.1 to 89.7,929
Hep B,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,5 Months,87.2,83.7 to 90.1,1906
Hep B,≥2 Doses,HHS Regions/National,Region 7,2011,Age,5 Months,88.1,84.4 to 91.0,912
Hep B,≥2 Doses,HHS Regions/National,Region 7,2012,Age,5 Months,90.0,85.9 to 92.9,977
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2011,Age,0-1 Days,72.2,67.5 to 76.4,912
Hep A,≥1 Dose,HHS Regions/National,Region 7,2020,Age,35 Months,90.7,87.5 to 93.3,1280
Hep B,≥1 Dose,HHS Regions/National,Region 7,2018,Age,3 Months,97.4,95.8 to 98.4,1345
Hep B,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,3 Months,96.7,95.5 to 97.6,2614
Polio,≥2 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,94.0,91.8 to 95.6,977
Polio,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,93.5,91.7 to 94.9,1868
Hep B,≥1 Dose,HHS Regions/National,Region 7,2019,Age,3 Months,95.9,93.9 to 97.3,1269
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,68.0,63.7 to 72.0,891
Hep B,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,67.5,64.4 to 70.4,1851
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,68.5,64.4 to 72.3,977
Hep B,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,68.2,65.3 to 71.0,1868
Polio,≥2 Doses,HHS Regions/National,Region 7,2017,Age,5 Months,78.0,74.5 to 81.1,1232
Polio,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,5 Months,81.3,78.9 to 83.4,2577
Polio,≥2 Doses,HHS Regions/National,Region 7,2016,Age,5 Months,79.6,75.6 to 83.0,960
Polio,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,5 Months,78.8,76.2 to 81.2,2192
Hep A,≥1 Dose,HHS Regions/National,Region 7,2017,Age,35 Months,90.6,87.8 to 92.9,1232
Hep A,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,35 Months,91.6,89.7 to 93.3,2577
Hib,Full Series,HHS Regions/National,Region 7,2019,Age,35 Months,80.2,76.7 to 83.5,1269
Hib,Full Series,HHS Regions/National,Region 7,2018,Age,35 Months,84.5,81.3 to 87.4,1345
Hib,Full Series,HHS Regions/National,Region 7,2018-2019,Age,35 Months,82.5,80.1 to 84.7,2614
Polio,≥3 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,95.5,93.3 to 97.2,1345
Polio,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,94.2,92.4 to 95.7,2614
Hib,Primary Series,HHS Regions/National,Region 7,2011,Age,7 Months,73.2,69.8 to 76.4,912
Hib,Primary Series,HHS Regions/National,Region 7,2012,Age,7 Months,72.5,69.9 to 75.0,977
Hib,Full Series,HHS Regions/National,Region 7,2016,Age,35 Months,80.9,76.5 to 84.9,960
Hib,Full Series,HHS Regions/National,Region 7,2016-2017,Age,35 Months,82.2,79.4 to 84.8,2192
Hib,Full Series,HHS Regions/National,Region 7,2014,Age,35 Months,85.9,82.1 to 89.2,977
Hib,Full Series,HHS Regions/National,Region 7,2014-2015,Age,35 Months,84.8,82.1 to 87.3,1868
Polio,≥3 Doses,HHS Regions/National,Region 7,2011,Age,35 Months,94.6,91.9 to 96.7,912
Polio,≥3 Doses,HHS Regions/National,Region 7,2012,Age,35 Months,95.2,92.8 to 97.1,977
Hib,Full Series,HHS Regions/National,Region 7,2019,Age,24 Months,78.8,75.3 to 82.1,1269
Polio,≥3 Doses,HHS Regions/National,Region 7,2013,Age,35 Months,96.4,92.6 to 98.6,929
Polio,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,35 Months,96.0,93.8 to 97.6,1906
Polio,≥3 Doses,HHS Regions/National,Region 7,2014,Age,35 Months,95.3,93.0 to 96.9,977
Polio,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,35 Months,95.4,93.0 to 97.1,1868
Hib,Full Series,HHS Regions/National,Region 7,2017,Age,35 Months,83.5,80.2 to 86.6,1232
Hib,Full Series,HHS Regions/National,Region 7,2017-2018,Age,35 Months,84.1,81.8 to 86.2,2577
Hib,Full Series,HHS Regions/National,Region 7,2015,Age,35 Months,83.5,79.5 to 87.1,891
Hib,Full Series,HHS Regions/National,Region 7,2015-2016,Age,35 Months,82.2,79.3 to 85.0,1851
Hib,Full Series,HHS Regions/National,Region 7,2013,Age,35 Months,83.4,79.1 to 87.2,929
Hib,Full Series,HHS Regions/National,Region 7,2013-2014,Age,35 Months,84.7,81.9 to 87.3,1906
Hib,Full Series,HHS Regions/National,Region 7,2012,Age,35 Months,88.1,84.6 to 91.1,977
Hib,Full Series,HHS Regions/National,Region 7,2011,Age,35 Months,83.6,78.9 to 87.7,912
Hib,Full Series,HHS Regions/National,Region 7,2018,Age,24 Months,80.9,77.7 to 84.0,1345
Hib,Full Series,HHS Regions/National,Region 7,2018-2019,Age,24 Months,79.9,77.5 to 82.1,2614
DTaP,≥2 Doses,HHS Regions/National,Region 7,2011,Age,5 Months,79.6,76.2 to 82.6,912
DTaP,≥2 Doses,HHS Regions/National,Region 7,2012,Age,5 Months,78.2,73.9 to 82.0,977
DTaP,≥2 Doses,HHS Regions/National,Region 7,2013,Age,5 Months,78.2,74.0 to 82.0,929
DTaP,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,5 Months,77.0,74.0 to 79.8,1906
DTaP,≥2 Doses,HHS Regions/National,Region 7,2015,Age,5 Months,77.6,73.5 to 81.3,891
DTaP,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,5 Months,78.7,75.8 to 81.3,1851
Polio,≥3 Doses,HHS Regions/National,Region 7,2016,Age,35 Months,92.8,90.2 to 95.0,960
Polio,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,35 Months,93.5,91.7 to 95.0,2192
Polio,≥3 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,94.1,91.7 to 96.1,1232
Polio,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,94.8,93.2 to 96.2,2577
Polio,≥3 Doses,HHS Regions/National,Region 7,2015,Age,35 Months,95.9,91.2 to 98.5,891
Polio,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,35 Months,93.7,91.6 to 95.4,1851
DTaP,≥2 Doses,HHS Regions/National,Region 7,2014,Age,5 Months,75.8,71.8 to 79.4,977
DTaP,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,5 Months,76.7,72.3 to 80.6,1868
Hib,Full Series,HHS Regions/National,Region 7,2016,Age,24 Months,76.7,72.4 to 80.8,960
Hib,Full Series,HHS Regions/National,Region 7,2016-2017,Age,24 Months,78.3,75.6 to 80.9,2192
Hib,Full Series,HHS Regions/National,Region 7,2017,Age,24 Months,79.9,76.6 to 83.1,1232
Hib,Full Series,HHS Regions/National,Region 7,2017-2018,Age,24 Months,80.4,78.1 to 82.6,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,91.6,88.4 to 94.2,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,91.8,88.9 to 94.1,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,91.8,88.9 to 94.2,929
Hib,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,92.0,90.2 to 93.6,1906
Polio,≥3 Doses,HHS Regions/National,Region 7,2017,Age,24 Months,92.2,89.8 to 94.2,1232
Polio,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,24 Months,93.2,91.6 to 94.6,2577
Polio,≥3 Doses,HHS Regions/National,Region 7,2018,Age,24 Months,94.1,91.9 to 95.9,1345
Polio,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,24 Months,92.4,90.7 to 94.0,2614
Polio,≥3 Doses,HHS Regions/National,Region 7,2019,Age,24 Months,90.7,87.8 to 93.1,1269
Hib,≥3 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,86.6,83.4 to 89.3,1269
Hib,Full Series,HHS Regions/National,Region 7,2015,Age,24 Months,79.9,75.9 to 83.6,891
Hib,Full Series,HHS Regions/National,Region 7,2015-2016,Age,24 Months,78.4,75.4 to 81.2,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,93.5,90.7 to 95.7,929
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,94.0,92.3 to 95.4,1906
DTaP,≥3 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,95.3,92.9 to 97.0,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,94.0,91.2 to 96.2,912
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,90.9,88.0 to 93.2,1269
Polio,≥2 Doses,HHS Regions/National,Region 7,2020,Age,13 Months,93.9,91.8 to 95.5,1280
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,94.1,91.8 to 95.8,1345
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,90.1,88.1 to 91.8,2614
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,92.6,90.3 to 94.5,2266
Hib,≥3 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,91.0,88.4 to 93.1,1345
Hib,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,64.7,62.0 to 67.3,2614
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,90.6,87.7 to 93.0,960
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,91.5,89.6 to 93.1,2192
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,92.4,89.9 to 94.3,1232
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,93.3,91.6 to 94.6,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,87.3,84.1 to 90.0,891
Hib,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,86.2,83.7 to 88.5,1851
Hib,≥3 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,85.1,81.4 to 88.2,960
Hib,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,85.6,83.3 to 87.7,2192
Polio,≥3 Doses,HHS Regions/National,Region 7,2016,Age,24 Months,91.4,88.6 to 93.7,960
Polio,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,24 Months,91.8,90.0 to 93.4,2192
Hib,≥3 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,86.2,83.1 to 88.8,1232
Hib,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,88.6,86.6 to 90.3,2577
Polio,≥3 Doses,HHS Regions/National,Region 7,2013,Age,24 Months,92.1,89.2 to 94.5,929
Polio,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,24 Months,92.7,90.9 to 94.2,1906
Hib,≥3 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,89.7,86.6 to 92.2,929
Hib,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,89.6,87.6 to 91.4,1906
Hib,≥3 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,89.6,86.7 to 91.8,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,88.4,86.2 to 90.4,1868
Polio,≥3 Doses,HHS Regions/National,Region 7,2012,Age,24 Months,94.3,91.9 to 96.2,977
Polio,≥3 Doses,HHS Regions/National,Region 7,2011,Age,24 Months,93.2,90.3 to 95.5,912
Polio,≥3 Doses,HHS Regions/National,Region 7,2019,Age,19 Months,90.5,87.5 to 92.9,1269
Polio,≥3 Doses,HHS Regions/National,Region 7,2018,Age,19 Months,93.7,91.4 to 95.5,1345
Polio,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,19 Months,64.9,62.1 to 67.6,2614
Polio,≥3 Doses,HHS Regions/National,Region 7,2014,Age,24 Months,93.3,91.2 to 95.1,977
Polio,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,24 Months,92.6,90.8 to 94.1,1868
Polio,≥3 Doses,HHS Regions/National,Region 7,2015,Age,24 Months,91.8,88.9 to 94.3,891
Polio,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,24 Months,91.6,89.6 to 93.4,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,90.8,87.4 to 93.4,891
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,90.7,88.5 to 92.6,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,93.2,90.9 to 94.9,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,92.0,90.1 to 93.6,1868
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,93.3,90.0 to 95.5,929
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,93.2,91.6 to 94.5,1906
Hib,≥3 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,93.2,91.2 to 94.8,2367
Hib,≥3 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,93.1,91.0 to 94.8,2229
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,91.1,88.8 to 93.1,2732
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,93.5,91.8 to 95.0,5265
DTaP,≥4 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,64.4,61.8 to 66.9,2229
Hep A,≥2 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,23.2,21.0 to 25.6,2387
Hep A,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,25.1,23.4 to 26.7,5094
Hib,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,76.3,72.5 to 79.8,3492
DTaP,≥4 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,71.0,68.4 to 73.5,2367
PCV,≥2 Doses,HHS Regions/National,Region 6,2013,Age,5 Months,73.9,71.0 to 76.5,2273
PCV,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,5 Months,73.8,71.5 to 75.9,4660
PCV,≥2 Doses,HHS Regions/National,Region 6,2012,Age,5 Months,73.7,71.6 to 75.8,2367
PCV,≥2 Doses,HHS Regions/National,Region 6,2011,Age,5 Months,72.1,65.8 to 77.6,2229
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,95.9,94.5 to 97.0,2707
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,94.6,93.6 to 95.6,5562
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,93.4,91.7 to 94.8,2855
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,92.2,90.8 to 93.5,5587
Hep A,≥2 Doses,HHS Regions/National,Region 6,2011,Age,19 Months,19.8,16.7 to 23.3,2229
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,93.9,92.0 to 95.4,2387
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,94.9,93.8 to 95.9,5094
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,93.8,92.0 to 95.4,2273
DTaP,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,93.8,92.6 to 94.9,4660
DTaP,≥3 Doses,HHS Regions/National,Region 6,2012,Age,35 Months,94.6,92.8 to 96.1,2367
DTaP,≥3 Doses,HHS Regions/National,Region 6,2011,Age,35 Months,94.9,93.0 to 96.4,2229
Hep A,≥1 Dose,HHS Regions/National,Region 6,2018,Age,19 Months,84.9,82.3 to 87.1,2533
Hep A,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,19 Months,85.1,83.0 to 87.0,3947
Hep A,≥1 Dose,HHS Regions/National,Region 6,2017,Age,19 Months,83.3,80.8 to 85.4,2732
Hep A,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,19 Months,84.1,82.3 to 85.6,5265
Hep A,≥1 Dose,HHS Regions/National,Region 6,2016,Age,19 Months,84.0,81.9 to 85.9,2855
Hep A,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,19 Months,83.6,82.0 to 85.1,5587
Hep A,≥1 Dose,HHS Regions/National,Region 6,2017,Age,24 Months,86.6,84.3 to 88.7,2732
Hep A,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,24 Months,88.0,86.4 to 89.4,5265
Hep A,≥1 Dose,HHS Regions/National,Region 6,2019,Age,24 Months,88.4,85.6 to 90.8,2266
Hep A,≥1 Dose,HHS Regions/National,Region 6,2011,Age,35 Months,90.3,87.1 to 92.9,2229
Hep A,≥1 Dose,HHS Regions/National,Region 6,2018,Age,24 Months,89.4,87.3 to 91.3,2533
Hep A,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,24 Months,88.9,87.2 to 90.5,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2019,Age,35 Months,95.7,93.6 to 97.3,2266
Hep A,≥1 Dose,HHS Regions/National,Region 6,2012,Age,24 Months,86.9,84.6 to 88.9,2367
Hep A,≥1 Dose,HHS Regions/National,Region 6,2019,Age,19 Months,84.5,81.4 to 87.2,2266
Hep A,≥1 Dose,HHS Regions/National,Region 6,2011,Age,24 Months,84.2,81.4 to 86.7,2229
Hep A,≥1 Dose,HHS Regions/National,Region 6,2013,Age,24 Months,86.0,83.9 to 88.0,2273
Hep A,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,24 Months,86.6,85.2 to 88.0,4660
Hib,≥3 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,89.9,88.0 to 91.6,2387
Hib,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,90.9,89.7 to 92.0,5094
Hep A,≥2 Doses,HHS Regions/National,Region 6,2019,Age,19 Months,32.5,28.6 to 36.6,2266
Hep A,≥2 Doses,HHS Regions/National,Region 6,2011,Age,24 Months,44.3,40.5 to 48.2,2229
Hep A,≥2 Doses,HHS Regions/National,Region 6,2018,Age,19 Months,26.4,23.4 to 29.6,2533
Hep A,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,19 Months,30.4,27.7 to 33.3,3947
Hib,≥3 Doses,HHS Regions/National,Region 6,2016,Age,35 Months,92.2,90.3 to 93.9,2855
Hib,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,35 Months,91.0,89.6 to 92.4,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2017,Age,35 Months,89.7,87.5 to 91.7,2732
Hib,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,35 Months,91.0,89.4 to 92.4,5265
DTaP,≥4 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,69.1,65.9 to 72.3,2273
DTaP,≥4 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,67.9,65.5 to 70.2,4660
DTaP,≥4 Doses,HHS Regions/National,Region 6,2014,Age,19 Months,66.6,63.9 to 69.3,2387
DTaP,≥4 Doses,HHS Regions/National,Region 6,2014-2015,Age,19 Months,67.7,65.8 to 69.5,5094
DTaP,≥4 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,68.7,66.7 to 70.7,2707
DTaP,≥4 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,69.8,68.0 to 71.5,5562
Hep A,≥2 Doses,HHS Regions/National,Region 6,2017,Age,19 Months,30.2,27.4 to 33.2,2732
Hep A,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,19 Months,28.3,26.2 to 30.5,5265
Hib,≥3 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,92.2,90.0 to 94.1,2533
Hib,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,93.2,91.7 to 94.5,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018,Age,35 Months,95.8,93.7 to 97.4,2533
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,35 Months,95.8,94.3 to 97.0,4799
PCV,≥2 Doses,HHS Regions/National,Region 6,2015,Age,5 Months,76.0,73.7 to 78.1,2707
PCV,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,5 Months,75.1,73.4 to 76.7,5562
PCV,≥2 Doses,HHS Regions/National,Region 6,2016,Age,5 Months,74.2,71.7 to 76.5,2855
PCV,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,5 Months,74.2,72.4 to 76.0,5587
Hep A,≥1 Dose,HHS Regions/National,Region 6,2014,Age,24 Months,87.2,85.3 to 89.1,2387
Hep A,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,24 Months,88.0,86.7 to 89.2,5094
Hep A,≥1 Dose,HHS Regions/National,Region 6,2015,Age,24 Months,88.7,86.9 to 90.3,2707
Hep A,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,24 Months,88.0,86.7 to 89.2,5562
Hep A,≥1 Dose,HHS Regions/National,Region 6,2016,Age,24 Months,87.3,85.4 to 89.0,2855
Hep A,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,24 Months,86.9,85.4 to 88.3,5587
PCV,≥2 Doses,HHS Regions/National,Region 6,2014,Age,5 Months,73.7,71.2 to 76.1,2387
PCV,≥2 Doses,HHS Regions/National,Region 6,2014-2015,Age,5 Months,74.9,72.3 to 77.2,5094
Hib,≥3 Doses,HHS Regions/National,Region 6,2015,Age,35 Months,94.6,93.0 to 96.0,2707
Hib,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,35 Months,93.5,92.2 to 94.6,5562
Hep A,≥2 Doses,HHS Regions/National,Region 6,2015,Age,19 Months,26.9,24.6 to 29.3,2707
Hep A,≥2 Doses,HHS Regions/National,Region 6,2015-2016,Age,19 Months,27.4,25.8 to 29.2,5562
Hep A,≥2 Doses,HHS Regions/National,Region 6,2016,Age,19 Months,28.0,25.7 to 30.5,2855
Hep A,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,19 Months,29.1,27.3 to 31.0,5587
Hib,≥3 Doses,HHS Regions/National,Region 6,2013,Age,35 Months,92.0,90.0 to 93.7,2273
Hib,≥3 Doses,HHS Regions/National,Region 6,2013-2014,Age,35 Months,92.0,90.6 to 93.3,4660
Hib,≥3 Doses,HHS Regions/National,Region 6,2014,Age,35 Months,92.1,90.1 to 93.8,2387
Hib,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,35 Months,93.4,92.1 to 94.5,5094
Hib,≥3 Doses,HHS Regions/National,Region 6,2019,Age,24 Months,91.3,88.9 to 93.4,2266
Hib,≥3 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,88.5,86.3 to 90.5,2732
Hib,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,89.6,88.0 to 91.0,5265
Hib,≥3 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,90.6,88.4 to 92.6,2533
Hib,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,91.0,89.4 to 92.4,4799
Hep A,≥2 Doses,HHS Regions/National,Region 6,2013,Age,19 Months,24.6,21.7 to 27.7,2273
Hep A,≥2 Doses,HHS Regions/National,Region 6,2013-2014,Age,19 Months,23.9,22.0 to 25.9,4660
Hep A,≥2 Doses,HHS Regions/National,Region 6,2012,Age,19 Months,23.3,20.1 to 26.7,2367
DTaP,≥2 Doses,HHS Regions/National,Region 6,2019,Age,5 Months,82.0,78.7 to 84.9,2266
PCV,≥2 Doses,HHS Regions/National,Region 6,2021,Age,5 Months,75.7,69.1 to 81.2,1286
Hib,Primary Series,HHS Regions/National,Region 6,2021,Age,7 Months,67.2,60.3 to 73.5,1286
Hep B,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,93.1,90.8 to 94.8,3492
Hib,≥1 Dose,HHS Regions/National,Region 6,2021,Age,3 Months,82.5,76.0 to 87.6,1286
DTaP,≥1 Dose,HHS Regions/National,Region 6,2012,Age,3 Months,85.7,83.8 to 87.4,2367
DTaP,≥1 Dose,HHS Regions/National,Region 6,2011,Age,3 Months,85.9,81.8 to 89.2,2229
DTaP,≥1 Dose,HHS Regions/National,Region 6,2013,Age,3 Months,86.6,83.5 to 89.1,2273
DTaP,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,3 Months,85.5,83.5 to 87.3,4660
DTaP,≥1 Dose,HHS Regions/National,Region 6,2014,Age,3 Months,84.5,82.3 to 86.5,2387
DTaP,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,3 Months,86.1,84.7 to 87.4,5094
DTaP,≥1 Dose,HHS Regions/National,Region 6,2015,Age,3 Months,87.7,85.9 to 89.4,2707
DTaP,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,3 Months,87.4,86.0 to 88.6,5562
DTaP,≥1 Dose,HHS Regions/National,Region 6,2016,Age,3 Months,87.0,85.0 to 88.8,2855
DTaP,≥1 Dose,HHS Regions/National,Region 6,2016-2017,Age,3 Months,86.3,84.9 to 87.7,5587
Combined 7 Series,,HHS Regions/National,Region 6,2021,Age,35 Months,87.0,69.8 to 96.9,1286
Hib,≥2 Doses,HHS Regions/National,Region 6,2021,Age,5 Months,72.6,65.5 to 78.7,1286
DTaP,≥4 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,87.2,83.1 to 90.8,3492
PCV,≥4 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,81.1,77.9 to 84.1,3492
Hep B,≥3 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,92.0,88.4 to 94.5,1286
Hib,Full Series,HHS Regions/National,Region 6,2021,Age,19 Months,73.1,66.7 to 78.6,1286
DTaP,≥1 Dose,HHS Regions/National,Region 6,2018,Age,3 Months,87.9,85.3 to 90.1,2533
DTaP,≥1 Dose,HHS Regions/National,Region 6,2018-2019,Age,3 Months,87.9,86.1 to 89.6,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,93.8,92.5 to 95.1,2707
DTaP,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,92.9,91.8 to 93.9,5562
DTaP,≥1 Dose,HHS Regions/National,Region 6,2017,Age,3 Months,85.7,83.4 to 87.7,2732
DTaP,≥1 Dose,HHS Regions/National,Region 6,2017-2018,Age,3 Months,86.8,85.1 to 88.3,5265
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014,Age,24 Months,92.1,90.4 to 93.6,2387
DTaP,≥3 Doses,HHS Regions/National,Region 6,2014-2015,Age,24 Months,93.0,91.9 to 94.0,5094
DTaP,≥1 Dose,HHS Regions/National,Region 6,2019,Age,3 Months,88.0,85.1 to 90.4,2266
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,92.0,90.3 to 93.4,2855
DTaP,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,90.7,89.3 to 91.9,5587
Hep A,≥1 Dose,HHS Regions/National,Region 6,2011,Age,19 Months,77.9,72.5 to 82.4,2229
Hep A,≥1 Dose,HHS Regions/National,Region 6,2014,Age,19 Months,81.5,79.2 to 83.5,2387
Hep A,≥1 Dose,HHS Regions/National,Region 6,2014-2015,Age,19 Months,83.0,81.5 to 84.4,5094
Hep A,≥1 Dose,HHS Regions/National,Region 6,2015,Age,19 Months,84.4,83.0 to 85.8,2707
Hep A,≥1 Dose,HHS Regions/National,Region 6,2015-2016,Age,19 Months,84.2,82.8 to 85.5,5562
DTaP,≥2 Doses,HHS Regions/National,Region 6,2017,Age,5 Months,76.0,73.3 to 78.6,2732
DTaP,≥2 Doses,HHS Regions/National,Region 6,2017-2018,Age,5 Months,78.9,77.0 to 80.8,5265
DTaP,≥2 Doses,HHS Regions/National,Region 6,2018,Age,5 Months,81.9,79.0 to 84.4,2533
DTaP,≥2 Doses,HHS Regions/National,Region 6,2018-2019,Age,5 Months,81.9,79.8 to 83.9,4799
DTaP,≥2 Doses,HHS Regions/National,Region 6,2016,Age,5 Months,76.9,74.5 to 79.1,2855
DTaP,≥2 Doses,HHS Regions/National,Region 6,2016-2017,Age,5 Months,76.5,74.7 to 78.2,5587
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018,Age,24 Months,93.5,91.7 to 95.1,2533
DTaP,≥3 Doses,HHS Regions/National,Region 6,2018-2019,Age,24 Months,93.1,91.6 to 94.3,4799
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017,Age,24 Months,89.4,87.2 to 91.3,2732
DTaP,≥3 Doses,HHS Regions/National,Region 6,2017-2018,Age,24 Months,91.5,90.0 to 92.7,5265
Hep A,≥1 Dose,HHS Regions/National,Region 6,2012,Age,19 Months,83.1,80.2 to 85.7,2367
Hep A,≥1 Dose,HHS Regions/National,Region 6,2013,Age,19 Months,81.6,79.5 to 83.5,2273
Hep A,≥1 Dose,HHS Regions/National,Region 6,2013-2014,Age,19 Months,81.5,79.9 to 83.1,4660
Hib,≥3 Doses,HHS Regions/National,Region 6,2015,Age,24 Months,91.9,90.4 to 93.2,2707
Hib,≥3 Doses,HHS Regions/National,Region 6,2015-2016,Age,24 Months,91.2,90.0 to 92.3,5562
Hib,≥3 Doses,HHS Regions/National,Region 6,2016,Age,24 Months,90.5,88.7 to 92.1,2855
Hib,≥3 Doses,HHS Regions/National,Region 6,2016-2017,Age,24 Months,89.5,88.1 to 90.8,5587
DTaP,≥3 Doses,States/Local Areas,Illinois,2014,Age,19 Months,95.0,91.7 to 97.0,493
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,94.6,92.3 to 96.2,960
DTaP,≥3 Doses,States/Local Areas,Illinois,2015,Age,19 Months,94.2,91.3 to 96.2,467
DTaP,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,94.6,92.2 to 96.3,951
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.6,92.7 to 96.4,850
Polio,≥3 Doses,States/Local Areas,Illinois,2011,Age,35 Months,96.1,93.4 to 97.9,583
DTaP,≥3 Doses,States/Local Areas,Illinois,2017,Age,19 Months,94.6,91.3 to 96.6,502
DTaP,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,93.0,90.5 to 94.9,1044
DTaP,≥3 Doses,States/Local Areas,Illinois,2016,Age,19 Months,95.0,91.2 to 97.2,484
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,94.8,92.5 to 96.4,986
Polio,≥3 Doses,States/Local Areas,Illinois,2019,Age,19 Months,91.6,87.5 to 94.5,548
Polio,≥3 Doses,States/Local Areas,Illinois,2011,Age,24 Months,93.9,91.4 to 96.0,583
Polio,≥3 Doses,States/Local Areas,Illinois,2012,Age,24 Months,88.9,84.7 to 92.3,543
Hib,≥3 Doses,States/Local Areas,Illinois,2014,Age,19 Months,90.7,86.8 to 93.5,493
Hib,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,91.0,88.3 to 93.1,960
Polio,≥3 Doses,States/Local Areas,Illinois,2013,Age,24 Months,93.6,90.8 to 95.9,537
Polio,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,93.9,91.9 to 95.5,1030
Hib,≥3 Doses,States/Local Areas,Illinois,2015,Age,19 Months,91.3,86.0 to 94.8,467
Hib,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,91.8,89.1 to 93.9,951
Hib,≥3 Doses,States/Local Areas,Illinois,2016,Age,19 Months,92.2,88.3 to 94.9,484
Hib,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,91.6,88.9 to 93.6,986
Hib,≥3 Doses,States/Local Areas,Illinois,2018,Age,19 Months,89.0,84.6 to 92.3,542
Hib,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,74.2,70.5 to 77.5,1090
Hib,≥3 Doses,States/Local Areas,Illinois,2017,Age,19 Months,90.8,86.9 to 93.7,502
Hib,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,89.9,87.1 to 92.2,1044
Polio,≥3 Doses,States/Local Areas,Illinois,2016,Age,24 Months,95.1,91.7 to 97.5,484
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,95.0,92.8 to 96.7,986
Polio,≥3 Doses,States/Local Areas,Illinois,2015,Age,24 Months,94.5,91.4 to 96.8,467
Polio,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,94.9,92.6 to 96.6,951
Polio,≥3 Doses,States/Local Areas,Illinois,2014,Age,24 Months,94.3,91.5 to 96.4,493
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,94.4,92.4 to 96.0,960
DTaP,≥3 Doses,States/Local Areas,Illinois,2018,Age,19 Months,91.4,87.2 to 94.3,542
DTaP,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,90.6,87.8 to 92.8,1090
DTaP,≥3 Doses,States/Local Areas,Illinois,2019,Age,19 Months,92.9,88.9 to 95.5,548
Polio,≥3 Doses,States/Local Areas,Illinois,2017,Age,24 Months,94.9,91.9 to 97.0,502
Polio,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,94.0,91.8 to 95.8,1044
DTaP,≥3 Doses,States/Local Areas,Illinois,2012,Age,24 Months,89.8,85.8 to 93.1,543
DTaP,≥3 Doses,States/Local Areas,Illinois,2011,Age,24 Months,95.6,93.3 to 97.3,583
DTaP,≥3 Doses,States/Local Areas,Illinois,2013,Age,24 Months,95.1,92.4 to 97.1,537
DTaP,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,95.7,93.9 to 97.1,1030
Hib,Full Series,States/Local Areas,Illinois,2015,Age,24 Months,80.2,75.0 to 85.0,467
Hib,Full Series,States/Local Areas,Illinois,2015-2016,Age,24 Months,82.6,79.0 to 85.8,951
Polio,≥3 Doses,States/Local Areas,Illinois,2018,Age,24 Months,93.1,89.6 to 95.7,542
Polio,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,92.9,90.5 to 95.0,1090
Polio,≥3 Doses,States/Local Areas,Illinois,2019,Age,24 Months,92.7,88.9 to 95.6,548
Hib,≥3 Doses,States/Local Areas,Illinois,2019,Age,19 Months,87.8,83.3 to 91.1,548
Hib,≥3 Doses,States/Local Areas,Illinois,2013,Age,24 Months,93.9,91.0 to 96.1,537
Hib,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,93.1,90.9 to 94.9,1030
Hib,≥3 Doses,States/Local Areas,Illinois,2012,Age,24 Months,90.2,86.3 to 93.4,543
Hib,≥3 Doses,States/Local Areas,Illinois,2011,Age,24 Months,95.0,92.6 to 96.8,583
Hib,≥3 Doses,States/Local Areas,Illinois,2014,Age,24 Months,92.1,88.7 to 94.8,493
Hib,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,92.6,90.3 to 94.6,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2020,Age,24 Months,91.7,88.3 to 94.4,549
Hib,Full Series,States/Local Areas,Illinois,2016,Age,24 Months,85.0,80.2 to 89.1,484
Hib,Full Series,States/Local Areas,Illinois,2016-2017,Age,24 Months,83.0,79.7 to 86.1,986
Hib,Full Series,States/Local Areas,Illinois,2017,Age,24 Months,81.0,76.1 to 85.4,502
Hib,Full Series,States/Local Areas,Illinois,2017-2018,Age,24 Months,78.9,75.5 to 82.1,1044
Hib,Full Series,States/Local Areas,Illinois,2015,Age,35 Months,82.9,77.1 to 87.9,467
Hib,Full Series,States/Local Areas,Illinois,2015-2016,Age,35 Months,85.1,81.4 to 88.4,951
Hib,Full Series,States/Local Areas,Illinois,2018,Age,24 Months,76.8,71.8 to 81.4,542
Hib,Full Series,States/Local Areas,Illinois,2018-2019,Age,24 Months,77.0,73.4 to 80.3,1090
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,95.2,93.4 to 97.1,751
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.4,95.0 to 97.8,930
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.5,91.2 to 97.9,231
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,95.0,92.6 to 97.4,408
Hib,Full Series,States/Local Areas,Illinois,2018,Age,35 Months,83.4,78.3 to 87.9,542
Hib,Full Series,States/Local Areas,Illinois,2018-2019,Age,35 Months,82.8,79.1 to 86.2,1090
Hib,Full Series,States/Local Areas,Illinois,2019,Age,35 Months,82.2,76.7 to 87.0,548
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,86.6,83.8 to 89.3,1043
Hib,Full Series,States/Local Areas,Illinois,2016,Age,35 Months,87.5,82.7 to 91.5,484
Hib,Full Series,States/Local Areas,Illinois,2016-2017,Age,35 Months,85.8,82.4 to 88.9,986
Hib,Full Series,States/Local Areas,Illinois,2014,Age,35 Months,84.6,80.1 to 88.5,493
Hib,Full Series,States/Local Areas,Illinois,2014-2015,Age,35 Months,83.7,80.2 to 87.0,960
Polio,≥3 Doses,States/Local Areas,Illinois,2019,Age,35 Months,94.1,90.3 to 96.8,548
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,93.7,91.5 to 95.9,624
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,86.5,74.5 to 98.6,34
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,96.5,95.1 to 97.9,1043
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,79.8,76.0 to 83.6,624
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.4,67.2 to 83.6,151
Hib,Full Series,States/Local Areas,Illinois,2017,Age,35 Months,84.1,79.0 to 88.5,502
Hib,Full Series,States/Local Areas,Illinois,2017-2018,Age,35 Months,83.7,80.1 to 86.9,1044
Polio,≥3 Doses,States/Local Areas,Illinois,2018,Age,35 Months,93.3,89.8 to 95.9,542
Polio,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,93.6,91.2 to 95.6,1090
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.7,85.6 to 95.8,151
DTaP,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,5 Months,82.6,79.2 to 85.5,960
Hib,≥3 Doses,States/Local Areas,Illinois,2019,Age,35 Months,91.4,87.3 to 94.6,548
Polio,≥3 Doses,States/Local Areas,Illinois,2015,Age,35 Months,95.9,92.6 to 98.0,467
Polio,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,95.8,93.6 to 97.5,951
DTaP,≥2 Doses,States/Local Areas,Illinois,2016,Age,5 Months,83.0,77.6 to 87.3,484
DTaP,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,5 Months,83.5,79.9 to 86.5,986
DTaP,≥2 Doses,States/Local Areas,Illinois,2015,Age,5 Months,80.8,75.6 to 85.2,467
DTaP,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,5 Months,81.9,78.3 to 85.0,951
Polio,≥3 Doses,States/Local Areas,Illinois,2017,Age,35 Months,95.0,92.0 to 97.1,502
Polio,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,94.1,91.9 to 95.9,1044
Polio,≥3 Doses,States/Local Areas,Illinois,2016,Age,35 Months,95.5,92.1 to 97.8,484
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,95.2,93.0 to 96.9,986
DTaP,≥2 Doses,States/Local Areas,Illinois,2014,Age,5 Months,84.4,79.9 to 88.0,493
DTaP,≥2 Doses,States/Local Areas,Illinois,2013,Age,5 Months,81.8,79.7 to 83.8,537
DTaP,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,5 Months,83.1,80.8 to 85.2,1030
DTaP,≥2 Doses,States/Local Areas,Illinois,2012,Age,5 Months,77.5,73.7 to 80.9,543
DTaP,≥2 Doses,States/Local Areas,Illinois,2011,Age,5 Months,84.8,80.6 to 88.3,583
Hib,Full Series,States/Local Areas,Illinois,2013,Age,35 Months,87.3,83.1 to 90.9,537
Hib,Full Series,States/Local Areas,Illinois,2013-2014,Age,35 Months,85.8,82.8 to 88.6,1030
Hib,Full Series,States/Local Areas,Illinois,2011,Age,35 Months,88.1,83.6 to 91.8,583
Hib,Full Series,States/Local Areas,Illinois,2012,Age,35 Months,84.5,78.8 to 89.3,543
Hib,Full Series,States/Local Areas,Illinois,2019,Age,24 Months,77.2,72.0 to 82.0,548
Polio,≥3 Doses,States/Local Areas,Illinois,2014,Age,35 Months,95.4,92.7 to 97.4,493
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,95.6,93.6 to 97.1,960
Polio,≥3 Doses,States/Local Areas,Illinois,2013,Age,35 Months,95.1,92.4 to 97.1,537
Polio,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,95.2,93.3 to 96.7,1030
Polio,≥3 Doses,States/Local Areas,Illinois,2012,Age,35 Months,91.8,87.6 to 95.0,543
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,66.8,47.2 to 86.4,34
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,78.9,74.7 to 83.1,519
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,78.9,74.5 to 83.3,515
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Overall,Overall,83.2,80.9 to 85.4,1720
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,82.3,74.1 to 90.4,119
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,82.2,78.5 to 85.9,751
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.9 to 89.4,930
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.9,76.7 to 89.1,231
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,80.9,76.3 to 85.6,408
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.1,81.2 to 87.1,850
Hib,Primary Series,States/Local Areas,Illinois,2012,Age,7 Months,65.9,63.1 to 68.5,543
Hib,Full Series,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,91.8,89.1 to 94.5,686
Hib,Primary Series,States/Local Areas,Illinois,2011,Age,7 Months,78.0,71.7 to 83.2,583
Hep A,≥2 Doses,States/Local Areas,Illinois,2011,Age,35 Months,73.2,66.4 to 79.6,583
Hep A,≥2 Doses,States/Local Areas,Illinois,2012,Age,35 Months,72.8,65.8 to 79.5,543
Hep A,≥2 Doses,States/Local Areas,Illinois,2013,Age,35 Months,70.3,63.8 to 76.5,537
Hep A,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,72.6,68.1 to 76.9,1030
DTaP,≥4 Doses,States/Local Areas,Illinois,2016,Age,24 Months,83.0,78.0 to 87.5,484
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,83.2,79.9 to 86.2,986
DTaP,≥4 Doses,States/Local Areas,Illinois,2015,Age,24 Months,81.3,76.0 to 86.0,467
DTaP,≥4 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,82.1,78.5 to 85.5,951
Hep A,≥1 Dose,States/Local Areas,Illinois,2015,Age,35 Months,90.3,85.2 to 94.2,467
Hep A,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,35 Months,90.8,87.8 to 93.3,951
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,96.3,95.2 to 97.3,1720
Hep A,≥2 Doses,States/Local Areas,Illinois,2015,Age,24 Months,40.0,34.2 to 46.4,467
Hep A,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,43.2,38.9 to 47.6,951
Hep A,≥2 Doses,States/Local Areas,Illinois,2014,Age,24 Months,40.5,35.1 to 46.5,493
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,40.2,36.2 to 44.5,960
Hep A,≥1 Dose,States/Local Areas,Illinois,2013,Age,35 Months,87.9,83.2 to 91.8,537
Hep A,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,35 Months,89.0,86.1 to 91.6,1030
Hep A,≥1 Dose,States/Local Areas,Illinois,2014,Age,35 Months,90.3,86.5 to 93.3,493
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,35 Months,90.2,87.2 to 92.8,960
≥1 Dose Varicella,,States/Local Areas,Illinois,2011,Age,13 Months,60.4,57.5 to 63.3,583
Polio,≥2 Doses,States/Local Areas,Illinois,2016,Age,5 Months,81.3,75.8 to 85.7,484
Polio,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,5 Months,82.2,78.6 to 85.3,986
Polio,≥2 Doses,States/Local Areas,Illinois,2017,Age,5 Months,83.2,78.7 to 86.9,502
Polio,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,5 Months,82.0,78.8 to 84.8,1044
Hep B,≥3 Doses,States/Local Areas,Illinois,2014,Age,7 Months,58.7,53.3 to 63.8,493
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,52.1,48.1 to 56.1,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2015,Age,7 Months,45.6,39.8 to 51.4,467
Hep B,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,48.9,44.7 to 53.1,951
Polio,≥2 Doses,States/Local Areas,Illinois,2015,Age,5 Months,78.2,72.9 to 82.7,467
Polio,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,5 Months,79.7,76.0 to 83.0,951
Hep B,≥3 Doses,States/Local Areas,Illinois,2016,Age,7 Months,52.2,46.3 to 58.1,484
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,53.5,49.3 to 57.6,986
Hep A,≥2 Doses,States/Local Areas,Illinois,2019,Age,24 Months,44.1,38.5 to 50.1,548
PCV,≥2 Doses,States/Local Areas,Illinois,2018,Age,5 Months,79.2,74.3 to 83.4,542
PCV,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,5 Months,78.5,74.9 to 81.7,1090
PCV,≥2 Doses,States/Local Areas,Illinois,2019,Age,5 Months,77.7,72.3 to 82.3,548
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,96.9,95.4 to 98.3,751
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.6,96.4 to 98.8,930
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.8,94.1 to 97.5,850
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,96.3,93.2 to 99.4,119
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,92.4 to 98.7,231
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,95.9,93.6 to 98.2,408
DTaP,≥4 Doses,States/Local Areas,Illinois,2016,Age,19 Months,70.2,64.3 to 75.4,484
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,72.5,68.6 to 76.0,986
DTaP,≥4 Doses,States/Local Areas,Illinois,2017,Age,19 Months,74.9,69.6 to 79.5,502
DTaP,≥4 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,71.6,67.8 to 75.1,1044
DTaP,≥4 Doses,States/Local Areas,Illinois,2018,Age,19 Months,68.3,62.7 to 73.3,542
DTaP,≥4 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,94.4,92.1 to 96.0,1090
Hep A,≥2 Doses,States/Local Areas,Illinois,2013,Age,24 Months,41.4,36.2 to 47.2,537
Hep A,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,41.0,37.2 to 45.1,1030
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,90.1,87.1 to 93.1,751
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.7,81.8 to 87.7,930
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.1,82.1 to 88.0,850
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,79.0,70.2 to 87.8,119
Polio,≥2 Doses,States/Local Areas,Illinois,2014,Age,7 Months,93.4,90.3 to 95.5,493
Polio,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,91.6,89.0 to 93.6,960
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,87.4,83.8 to 91.0,515
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Overall,Overall,86.6,84.5 to 88.6,1720
Polio,≥2 Doses,States/Local Areas,Illinois,2015,Age,7 Months,89.8,85.4 to 93.1,467
Polio,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,91.0,87.9 to 93.3,951
Polio,≥2 Doses,States/Local Areas,Illinois,2016,Age,7 Months,92.1,87.4 to 95.1,484
Polio,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,92.2,89.5 to 94.3,986
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,80.7,76.4 to 85.0,519
Hep B,≥3 Doses,States/Local Areas,Illinois,2011,Age,13 Months,85.6,83.1 to 87.8,583
DTaP,≥4 Doses,States/Local Areas,Illinois,2018,Age,35 Months,88.6,83.4 to 92.8,542
DTaP,≥4 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,89.0,85.4 to 92.0,1090
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,61.6,29.0 to 94.1,34
≥1 Dose MMR,,States/Local Areas,Illinois,2013,Age,13 Months,49.0,43.4 to 54.5,537
≥1 Dose MMR,,States/Local Areas,Illinois,2013-2014,Age,13 Months,59.0,51.4 to 66.3,1030
≥1 Dose MMR,,States/Local Areas,Illinois,2012,Age,13 Months,51.0,47.0 to 54.9,543
≥1 Dose MMR,,States/Local Areas,Illinois,2011,Age,13 Months,57.4,54.4 to 60.4,583
DTaP,≥4 Doses,States/Local Areas,Illinois,2018,Age,24 Months,78.4,73.4 to 83.1,542
DTaP,≥4 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,79.3,75.8 to 82.6,1090
DTaP,≥4 Doses,States/Local Areas,Illinois,2017,Age,24 Months,83.4,78.8 to 87.4,502
DTaP,≥4 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,80.9,77.5 to 84.1,1044
Hep A,≥1 Dose,States/Local Areas,Illinois,2017,Age,35 Months,87.4,82.7 to 91.4,502
Hep A,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,35 Months,88.5,85.4 to 91.2,1044
Hep A,≥1 Dose,States/Local Areas,Illinois,2018,Age,35 Months,89.7,85.4 to 93.1,542
Hep A,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,35 Months,89.9,86.8 to 92.5,1090
Polio,≥2 Doses,States/Local Areas,Illinois,2012,Age,5 Months,74.4,70.3 to 78.0,543
Polio,≥2 Doses,States/Local Areas,Illinois,2011,Age,5 Months,82.0,77.4 to 85.8,583
Polio,≥2 Doses,States/Local Areas,Illinois,2013,Age,5 Months,78.2,76.5 to 79.8,537
Polio,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,5 Months,79.5,76.9 to 81.9,1030
Polio,≥2 Doses,States/Local Areas,Illinois,2014,Age,5 Months,80.8,76.2 to 84.8,493
Polio,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,5 Months,79.5,75.7 to 82.9,960
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,95.3,93.2 to 97.3,515
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,99.4,98.8 to 100.0,686
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,94.0,91.5 to 96.6,519
Hep B,≥3 Doses,States/Local Areas,Illinois,2012,Age,7 Months,46.4,41.6 to 51.4,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2011,Age,7 Months,48.2,40.3 to 56.3,583
Hep B,≥3 Doses,States/Local Areas,Illinois,2013,Age,7 Months,55.4,51.3 to 59.4,537
Hep B,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,57.0,52.4 to 61.6,1030
DTaP,≥4 Doses,States/Local Areas,Illinois,2019,Age,19 Months,70.7,65.2 to 75.7,548
DTaP,≥4 Doses,States/Local Areas,Illinois,2011,Age,24 Months,85.6,81.6 to 89.2,583
DTaP,≥4 Doses,States/Local Areas,Illinois,2012,Age,24 Months,81.7,76.9 to 86.0,543
Hep A,≥2 Doses,States/Local Areas,Illinois,2018,Age,24 Months,42.5,37.2 to 48.2,542
Hep A,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,43.2,39.3 to 47.3,1090
DTaP,≥4 Doses,States/Local Areas,Illinois,2014,Age,24 Months,83.1,78.6 to 87.0,493
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,82.2,78.8 to 85.4,960
Hep A,≥2 Doses,States/Local Areas,Illinois,2017,Age,24 Months,39.7,34.2 to 45.8,502
Hep A,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,41.1,37.2 to 45.2,1044
Hep A,≥2 Doses,States/Local Areas,Illinois,2016,Age,24 Months,46.5,40.5 to 52.8,484
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,43.1,39.0 to 47.5,986
DTaP,≥4 Doses,States/Local Areas,Illinois,2013,Age,24 Months,82.1,77.7 to 86.1,537
DTaP,≥4 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,82.6,79.5 to 85.5,1030
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.6,85.2 to 96.0,151
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,78.3,62.1 to 94.6,34
≥1 Dose MMR,,States/Local Areas,Illinois,2016,Age,35 Months,94.7,91.5 to 97.0,484
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2017,Age,35 Months,94.1,91.8 to 95.9,986
≥1 Dose MMR,,States/Local Areas,Illinois,2014,Age,35 Months,92.8,89.1 to 95.6,493
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2015,Age,35 Months,93.2,90.6 to 95.2,960
≥1 Dose MMR,,States/Local Areas,Illinois,2015,Age,35 Months,93.6,89.6 to 96.4,467
≥1 Dose MMR,,States/Local Areas,Illinois,2015-2016,Age,35 Months,94.1,91.7 to 96.1,951
PCV,≥4 Doses,States/Local Areas,Illinois,2017,Age,24 Months,83.4,78.9 to 87.5,502
PCV,≥4 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,83.2,80.0 to 86.2,1044
PCV,≥4 Doses,States/Local Areas,Illinois,2016,Age,24 Months,87.3,83.0 to 91.0,484
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,85.4,82.3 to 88.2,986
Hep B,≥2 Doses,States/Local Areas,Illinois,2019,Age,7 Months,92.4,88.5 to 95.1,548
Hep B,≥2 Doses,States/Local Areas,Illinois,2011,Age,13 Months,94.3,92.8 to 95.5,583
Hep B,≥2 Doses,States/Local Areas,Illinois,2013,Age,13 Months,94.5,92.6 to 96.0,537
Hep B,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,95.2,93.9 to 96.3,1030
Hep B,≥2 Doses,States/Local Areas,Illinois,2012,Age,13 Months,92.3,89.1 to 94.6,543
PCV,≥3 Doses,States/Local Areas,Illinois,2017,Age,13 Months,90.6,86.8 to 93.3,502
PCV,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,90.5,87.8 to 92.7,1044
PCV,≥3 Doses,States/Local Areas,Illinois,2018,Age,13 Months,90.5,86.3 to 93.5,542
PCV,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,89.5,86.6 to 91.9,1090
Hep B,≥3 Doses,States/Local Areas,Illinois,2012,Age,35 Months,90.9,86.9 to 94.1,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2015,Age,35 Months,94.5,90.4 to 97.3,467
Hep B,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,93.3,90.6 to 95.4,951
Hep B,≥3 Doses,States/Local Areas,Illinois,2014,Age,35 Months,95.8,93.3 to 97.6,493
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,95.0,92.8 to 96.7,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2013,Age,35 Months,93.4,90.7 to 95.6,537
Hep B,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,94.8,93.0 to 96.3,1030
PCV,≥3 Doses,States/Local Areas,Illinois,2019,Age,13 Months,88.6,84.0 to 92.0,548
PCV,≥3 Doses,States/Local Areas,Illinois,2011,Age,19 Months,92.6,91.2 to 93.7,583
PCV,≥3 Doses,States/Local Areas,Illinois,2013,Age,19 Months,91.4,89.1 to 93.2,537
PCV,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,91.9,90.2 to 93.3,1030
PCV,≥3 Doses,States/Local Areas,Illinois,2014,Age,19 Months,92.4,88.8 to 95.0,493
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,92.4,89.8 to 94.4,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2016,Age,35 Months,92.5,88.9 to 95.3,484
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,92.4,89.9 to 94.4,986
PCV,≥4 Doses,States/Local Areas,Illinois,2019,Age,24 Months,80.5,75.5 to 85.1,548
PCV,≥4 Doses,States/Local Areas,Illinois,2018,Age,24 Months,83.0,78.3 to 87.3,542
PCV,≥4 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,81.8,78.3 to 85.0,1090
PCV,≥4 Doses,States/Local Areas,Illinois,2011,Age,35 Months,81.5,76.3 to 86.1,583
PCV,≥4 Doses,States/Local Areas,Illinois,2012,Age,35 Months,82.9,78.1 to 87.1,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2018,Age,35 Months,95.1,92.3 to 97.2,542
Hep B,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,94.2,91.9 to 96.0,1090
Hib,Full Series,States/Local Areas,Illinois,2020,Age,24 Months,78.3,73.5 to 82.8,549
PCV,≥3 Doses,States/Local Areas,Illinois,2012,Age,19 Months,88.8,85.3 to 91.6,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2017,Age,35 Months,92.2,88.6 to 95.1,502
Hep B,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,93.6,91.4 to 95.5,1044
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.0,90.4 to 97.6,231
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,92.1,88.9 to 95.4,408
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.3,84.4 to 96.2,151
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,70.2,50.6 to 89.8,34
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,92.7,90.4 to 94.9,624
PCV,≥4 Doses,States/Local Areas,Illinois,2016,Age,35 Months,88.8,84.5 to 92.4,484
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,87.2,84.1 to 89.9,986
PCV,≥4 Doses,States/Local Areas,Illinois,2015,Age,35 Months,84.7,78.6 to 89.9,467
PCV,≥4 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,86.7,83.0 to 89.9,951
PCV,≥4 Doses,States/Local Areas,Illinois,2014,Age,35 Months,84.9,80.5 to 88.8,493
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,84.5,80.9 to 87.8,960
≥1 Dose Varicella,,States/Local Areas,Illinois,2019,Age,35 Months,92.8,88.4 to 95.9,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,92.3,90.0 to 94.7,624
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,94.0,92.0 to 95.9,1043
Hep B,≥2 Doses,States/Local Areas,Illinois,2016,Age,13 Months,96.6,93.5 to 98.3,484
Hep B,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,96.1,94.1 to 97.4,986
Hep B,≥2 Doses,States/Local Areas,Illinois,2015,Age,13 Months,94.8,91.6 to 96.8,467
Hep B,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,95.7,93.6 to 97.1,951
Hib,≥1 Dose,States/Local Areas,Illinois,2014,Age,3 Months,90.2,86.5 to 93.0,493
Hib,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,3 Months,89.1,86.2 to 91.4,960
Hep B,≥2 Doses,States/Local Areas,Illinois,2014,Age,13 Months,96.0,93.3 to 97.6,493
Hep B,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,95.4,93.4 to 96.8,960
Hib,≥1 Dose,States/Local Areas,Illinois,2013,Age,3 Months,85.4,81.6 to 88.4,537
Hib,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,3 Months,87.8,84.1 to 90.7,1030
Hib,≥1 Dose,States/Local Areas,Illinois,2012,Age,3 Months,84.9,81.1 to 88.0,543
Hib,≥1 Dose,States/Local Areas,Illinois,2011,Age,3 Months,89.2,85.3 to 92.1,583
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2014,Age,0-2 Days,72.9,67.8 to 77.5,493
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2014-2015,Age,0-2 Days,71.3,67.5 to 74.8,960
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2015,Age,0-2 Days,69.7,64.0 to 74.8,467
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2015-2016,Age,0-2 Days,71.7,67.8 to 75.4,951
PCV,≥4 Doses,States/Local Areas,Illinois,2011,Age,24 Months,79.4,74.3 to 84.0,583
Hep A,≥1 Dose,States/Local Areas,Illinois,2020,Age,35 Months,93.4,89.9 to 96.1,549
≥1 Dose Varicella,,States/Local Areas,Illinois,2015,Age,35 Months,93.7,89.6 to 96.5,467
≥1 Dose Varicella,,States/Local Areas,Illinois,2015-2016,Age,35 Months,95.3,93.0 to 97.0,951
≥1 Dose Varicella,,States/Local Areas,Illinois,2014,Age,35 Months,93.3,90.3 to 95.7,493
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2015,Age,35 Months,93.6,91.2 to 95.5,960
PCV,≥4 Doses,States/Local Areas,Illinois,2019,Age,19 Months,77.4,72.1 to 82.0,548
≥1 Dose MMR,,States/Local Areas,Illinois,2018,Age,24 Months,91.2,87.3 to 94.2,542
≥1 Dose MMR,,States/Local Areas,Illinois,2018-2019,Age,24 Months,89.3,86.5 to 91.8,1090
≥1 Dose Varicella,,States/Local Areas,Illinois,2013,Age,35 Months,94.3,91.1 to 96.7,537
≥1 Dose Varicella,,States/Local Areas,Illinois,2013-2014,Age,35 Months,93.7,91.5 to 95.4,1030
≥1 Dose Varicella,,States/Local Areas,Illinois,2016,Age,35 Months,96.7,94.1 to 98.4,484
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2017,Age,35 Months,94.9,92.8 to 96.6,986
≥1 Dose MMR,,States/Local Areas,Illinois,2013,Age,35 Months,94.6,91.4 to 96.9,537
≥1 Dose MMR,,States/Local Areas,Illinois,2013-2014,Age,35 Months,93.4,91.1 to 95.4,1030
≥1 Dose MMR,,States/Local Areas,Illinois,2011,Age,35 Months,96.3,93.5 to 98.1,583
≥1 Dose MMR,,States/Local Areas,Illinois,2012,Age,35 Months,91.8,88.1 to 94.7,543
≥1 Dose MMR,,States/Local Areas,Illinois,2019,Age,24 Months,87.3,83.0 to 90.9,548
PCV,≥4 Doses,States/Local Areas,Illinois,2015,Age,24 Months,79.7,74.4 to 84.5,467
PCV,≥4 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,83.5,80.1 to 86.7,951
PCV,≥4 Doses,States/Local Areas,Illinois,2014,Age,24 Months,83.4,79.0 to 87.3,493
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,81.6,78.2 to 84.8,960
PCV,≥4 Doses,States/Local Areas,Illinois,2013,Age,24 Months,82.2,77.6 to 86.4,537
PCV,≥4 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,82.8,79.6 to 85.7,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2019,Age,24 Months,92.5,88.9 to 95.2,548
Hep B,≥3 Doses,States/Local Areas,Illinois,2011,Age,35 Months,93.2,89.2 to 96.2,583
PCV,≥4 Doses,States/Local Areas,Illinois,2012,Age,24 Months,80.7,75.9 to 85.1,543
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2017,Age,0-2 Days,75.8,70.5 to 80.5,502
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2017-2018,Age,0-2 Days,76.8,73.2 to 80.0,1044
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2018,Age,0-2 Days,77.8,72.8 to 82.1,542
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2018-2019,Age,0-2 Days,78.6,75.2 to 81.7,1090
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2019,Age,0-2 Days,79.5,74.6 to 83.6,548
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2019,Age,0-1 Days,73.9,68.7 to 78.5,548
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2011,Age,0-2 Days,64.9,58.0 to 71.3,583
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2013,Age,0-2 Days,67.8,61.4 to 73.6,537
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2013-2014,Age,0-2 Days,70.3,65.9 to 74.4,1030
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2012,Age,0-2 Days,68.6,63.1 to 73.6,543
Hep B,≥2 Doses,States/Local Areas,Illinois,2013,Age,7 Months,92.9,91.6 to 94.0,537
Hep B,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,93.5,92.2 to 94.5,1030
Hep B,≥2 Doses,States/Local Areas,Illinois,2014,Age,7 Months,94.0,91.2 to 96.0,493
Hep B,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,92.6,90.3 to 94.4,960
Hep B,≥2 Doses,States/Local Areas,Illinois,2015,Age,7 Months,91.3,87.4 to 94.0,467
Hep B,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,92.9,90.5 to 94.7,951
Hep B,≥2 Doses,States/Local Areas,Illinois,2012,Age,7 Months,88.0,84.0 to 91.2,543
PCV,≥3 Doses,States/Local Areas,Illinois,2018,Age,7 Months,70.9,65.5 to 75.7,542
PCV,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,69.3,65.5 to 72.9,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2019,Age,7 Months,67.8,62.2 to 72.9,548
PCV,≥3 Doses,States/Local Areas,Illinois,2011,Age,13 Months,89.8,87.2 to 91.9,583
PCV,≥4 Doses,States/Local Areas,Illinois,2017,Age,19 Months,81.0,76.1 to 85.1,502
PCV,≥4 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,79.7,76.2 to 82.9,1044
PCV,≥4 Doses,States/Local Areas,Illinois,2018,Age,19 Months,78.4,73.2 to 82.9,542
PCV,≥4 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,76.0,71.4 to 80.1,879
≥1 Dose MMR,,States/Local Areas,Illinois,2017,Age,24 Months,92.3,88.7 to 95.1,502
≥1 Dose MMR,,States/Local Areas,Illinois,2017-2018,Age,24 Months,91.8,89.2 to 93.9,1044
≥1 Dose MMR,,States/Local Areas,Illinois,2016,Age,24 Months,93.3,90.1 to 95.8,484
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2017,Age,24 Months,92.8,90.5 to 94.8,986
PCV,≥3 Doses,States/Local Areas,Illinois,2012,Age,13 Months,84.9,81.9 to 87.4,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2017,Age,24 Months,92.0,88.4 to 94.9,502
Hep B,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,92.7,90.3 to 94.7,1044
Hep B,≥3 Doses,States/Local Areas,Illinois,2016,Age,24 Months,92.2,88.6 to 95.1,484
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,92.1,89.6 to 94.2,986
PCV,≥3 Doses,States/Local Areas,Illinois,2013,Age,13 Months,89.0,87.6 to 90.2,537
PCV,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,89.7,88.0 to 91.1,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2015,Age,24 Months,91.5,87.5 to 94.6,467
Hep B,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,91.8,89.2 to 94.0,951
PCV,≥3 Doses,States/Local Areas,Illinois,2017,Age,7 Months,71.8,66.2 to 76.7,502
PCV,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,71.3,67.5 to 74.8,1044
PCV,≥3 Doses,States/Local Areas,Illinois,2015,Age,7 Months,66.6,60.7 to 72.0,467
PCV,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,69.9,65.8 to 73.7,951
PCV,≥4 Doses,States/Local Areas,Illinois,2015,Age,19 Months,74.9,70.2 to 79.0,467
PCV,≥4 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,78.5,74.7 to 82.0,951
PCV,≥4 Doses,States/Local Areas,Illinois,2016,Age,19 Months,82.2,76.9 to 86.5,484
PCV,≥4 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,81.6,78.0 to 84.7,986
PCV,≥3 Doses,States/Local Areas,Illinois,2016,Age,7 Months,73.2,67.4 to 78.3,484
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,72.5,68.5 to 76.1,986
Hep B,≥3 Doses,States/Local Areas,Illinois,2012,Age,24 Months,88.6,84.7 to 91.9,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2014,Age,24 Months,94.1,91.4 to 96.1,493
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,92.8,90.5 to 94.8,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2013,Age,24 Months,93.4,90.6 to 95.6,537
Hep B,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,93.8,91.9 to 95.3,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2019,Age,19 Months,92.5,88.6 to 95.1,548
Hep B,≥3 Doses,States/Local Areas,Illinois,2011,Age,24 Months,89.8,86.1 to 92.9,583
≥1 Dose Varicella,,States/Local Areas,Illinois,2018,Age,24 Months,91.7,88.1 to 94.6,542
≥1 Dose Varicella,,States/Local Areas,Illinois,2018-2019,Age,24 Months,89.9,87.2 to 92.2,1090
≥1 Dose MMR,,States/Local Areas,Illinois,2015,Age,24 Months,91.7,87.9 to 94.7,467
≥1 Dose MMR,,States/Local Areas,Illinois,2015-2016,Age,24 Months,92.5,90.1 to 94.5,951
≥1 Dose MMR,,States/Local Areas,Illinois,2014,Age,24 Months,92.2,88.5 to 95.1,493
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2015,Age,24 Months,92.0,89.4 to 94.2,960
≥1 Dose MMR,,States/Local Areas,Illinois,2013,Age,24 Months,89.5,85.8 to 92.6,537
≥1 Dose MMR,,States/Local Areas,Illinois,2013-2014,Age,24 Months,90.8,88.2 to 93.0,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2012,Age,19 Months,87.0,83.4 to 89.9,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2018,Age,13 Months,89.9,85.9 to 92.9,542
Hep B,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,89.4,86.6 to 91.7,1090
Hep B,≥3 Doses,States/Local Areas,Illinois,2019,Age,13 Months,88.9,84.6 to 92.0,548
Hep B,≥3 Doses,States/Local Areas,Illinois,2011,Age,19 Months,87.6,85.2 to 89.7,583
≥1 Dose MMR,,States/Local Areas,Illinois,2013,Age,19 Months,86.0,83.7 to 88.0,537
≥1 Dose MMR,,States/Local Areas,Illinois,2013-2014,Age,19 Months,88.2,84.3 to 91.2,1030
≥1 Dose MMR,,States/Local Areas,Illinois,2014,Age,19 Months,90.4,86.1 to 93.5,493
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2015,Age,19 Months,88.2,85.0 to 90.8,960
≥1 Dose MMR,,States/Local Areas,Illinois,2012,Age,19 Months,84.1,81.0 to 86.8,543
≥1 Dose Varicella,,States/Local Areas,Illinois,2017,Age,19 Months,88.7,84.4 to 92.0,502
≥1 Dose Varicella,,States/Local Areas,Illinois,2017-2018,Age,19 Months,88.8,85.9 to 91.2,1044
≥1 Dose Varicella,,States/Local Areas,Illinois,2018,Age,19 Months,88.9,84.6 to 92.1,542
≥1 Dose Varicella,,States/Local Areas,Illinois,2018-2019,Age,19 Months,60.7,56.8 to 64.5,1090
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,81.8,77.0 to 86.5,408
Polio,≥2 Doses,States/Local Areas,Illinois,2015,Age,13 Months,94.4,90.8 to 96.6,467
Polio,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,95.8,93.6 to 97.2,951
Polio,≥2 Doses,States/Local Areas,Illinois,2016,Age,13 Months,97.2,94.1 to 98.7,484
Polio,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,96.3,94.4 to 97.6,986
Polio,≥2 Doses,States/Local Areas,Illinois,2017,Age,13 Months,95.4,92.5 to 97.2,502
Polio,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,95.3,93.4 to 96.7,1044
Hep B,≥1 Dose,States/Local Areas,Illinois,2018,Age,3 Months,96.2,93.1 to 97.9,542
Hep B,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,3 Months,96.3,94.4 to 97.6,1090
≥1 Dose Varicella,,States/Local Areas,Illinois,2019,Age,19 Months,85.8,81.2 to 89.4,548
Hep B,≥1 Dose,States/Local Areas,Illinois,2019,Age,3 Months,96.5,93.7 to 98.0,548
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2012,Age,0-1 Days,63.9,58.2 to 69.3,543
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,70.4,64.2 to 76.6,519
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2011,Age,0-1 Days,59.8,52.8 to 66.4,583
Hep B,≥2 Doses,States/Local Areas,Illinois,2012,Age,5 Months,84.4,79.4 to 88.4,543
Hep B,≥2 Doses,States/Local Areas,Illinois,2011,Age,5 Months,87.1,84.7 to 89.1,583
Hep B,≥2 Doses,States/Local Areas,Illinois,2013,Age,5 Months,89.8,88.0 to 91.3,537
Hep B,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,5 Months,90.1,88.3 to 91.6,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2013,Age,19 Months,93.0,90.0 to 95.2,537
Hep B,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,93.2,91.3 to 94.7,1030
Hep B,≥2 Doses,States/Local Areas,Illinois,2014,Age,5 Months,90.4,86.5 to 93.3,493
Hep B,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,5 Months,88.2,86.5 to 89.8,960
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,87.0,82.8 to 91.2,686
Hep B,≥3 Doses,States/Local Areas,Illinois,2014,Age,19 Months,93.4,90.2 to 95.6,493
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,92.0,89.4 to 94.0,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2015,Age,19 Months,90.6,87.0 to 93.2,467
Hep B,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,91.2,88.5 to 93.4,951
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.8,85.2 to 90.4,930
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,78.3 to 90.6,231
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,83.5,81.2 to 85.8,1720
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,83.7,75.9 to 91.4,119
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,83.2,79.5 to 86.9,751
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.7,80.6 to 86.9,850
≥1 Dose MMR,,States/Local Areas,Illinois,2015,Age,19 Months,86.0,82.3 to 89.0,467
≥1 Dose MMR,,States/Local Areas,Illinois,2015-2016,Age,19 Months,88.1,85.0 to 90.7,951
≥1 Dose MMR,,States/Local Areas,Illinois,2016,Age,19 Months,90.3,86.1 to 93.3,484
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2017,Age,19 Months,90.3,87.5 to 92.6,986
≥1 Dose MMR,,States/Local Areas,Illinois,2017,Age,19 Months,90.4,86.3 to 93.4,502
≥1 Dose MMR,,States/Local Areas,Illinois,2017-2018,Age,19 Months,89.4,86.5 to 91.8,1044
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,76.7,72.1 to 81.3,515
≥1 Dose Varicella,,States/Local Areas,Illinois,2011,Age,24 Months,89.0,85.5 to 91.9,583
≥1 Dose Varicella,,States/Local Areas,Illinois,2012,Age,24 Months,87.3,83.0 to 91.0,543
PCV,≥3 Doses,States/Local Areas,Illinois,2013,Age,7 Months,67.3,63.5 to 70.8,537
PCV,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,68.2,65.8 to 70.5,1030
PCV,≥3 Doses,States/Local Areas,Illinois,2011,Age,7 Months,71.2,64.5 to 77.0,583
Hep B,≥3 Doses,States/Local Areas,Illinois,2016,Age,19 Months,91.9,87.9 to 94.6,484
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,91.5,88.8 to 93.6,986
PCV,≥3 Doses,States/Local Areas,Illinois,2014,Age,7 Months,69.1,63.6 to 74.0,493
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,67.8,63.9 to 71.5,960
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,93.0,90.6 to 95.5,686
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,81.0,76.9 to 85.1,519
PCV,≥3 Doses,States/Local Areas,Illinois,2012,Age,7 Months,64.7,61.7 to 67.6,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2017,Age,19 Months,91.1,87.1 to 93.9,502
Hep B,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,91.7,89.0 to 93.7,1044
Hep B,≥3 Doses,States/Local Areas,Illinois,2018,Age,19 Months,92.2,88.4 to 94.9,542
Hep B,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,89.4,86.6 to 91.7,1090
Hep B,≥2 Doses,States/Local Areas,Illinois,2016,Age,5 Months,89.9,85.4 to 93.2,484
Hep B,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,5 Months,90.2,87.4 to 92.4,986
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2016,Age,0-2 Days,73.8,68.2 to 78.7,484
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Illinois,2016-2017,Age,0-2 Days,74.8,71.0 to 78.3,986
Hep B,≥2 Doses,States/Local Areas,Illinois,2016,Age,7 Months,94.5,91.2 to 96.6,484
Hep B,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,94.1,92.0 to 95.7,986
Hep B,≥2 Doses,States/Local Areas,Illinois,2017,Age,7 Months,93.7,90.6 to 95.8,502
Hep B,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,93.7,91.6 to 95.3,1044
Hep B,≥2 Doses,States/Local Areas,Illinois,2018,Age,7 Months,93.8,90.5 to 96.0,542
Hep B,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,93.1,90.7 to 95.0,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2014,Age,13 Months,90.3,86.5 to 93.2,493
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,89.0,86.1 to 91.4,960
PCV,≥3 Doses,States/Local Areas,Illinois,2015,Age,13 Months,87.7,82.9 to 91.3,467
PCV,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,89.5,86.4 to 92.0,951
Hep B,≥3 Doses,States/Local Areas,Illinois,2018,Age,24 Months,93.4,90.2 to 95.8,542
Hep B,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,93.0,90.7 to 94.9,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2016,Age,13 Months,91.3,87.0 to 94.3,484
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,90.9,88.2 to 93.1,986
PCV,≥3 Doses,States/Local Areas,Illinois,2017,Age,19 Months,93.4,90.1 to 95.7,502
PCV,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,92.6,90.1 to 94.5,1044
Hep B,≥3 Doses,States/Local Areas,Illinois,2019,Age,35 Months,92.6,89.1 to 95.4,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,89.1 to 96.7,231
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,93.7,90.7 to 96.7,408
≥1 Dose Varicella,,States/Local Areas,Illinois,2018,Age,35 Months,94.7,91.3 to 97.0,542
≥1 Dose Varicella,,States/Local Areas,Illinois,2018-2019,Age,35 Months,93.7,91.1 to 95.8,1090
≥1 Dose Varicella,,States/Local Areas,Illinois,2017,Age,35 Months,93.2,89.6 to 95.8,502
≥1 Dose Varicella,,States/Local Areas,Illinois,2017-2018,Age,35 Months,93.8,91.5 to 95.7,1044
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2013,Age,0-1 Days,62.5,57.9 to 66.8,537
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2013-2014,Age,0-1 Days,64.4,61.1 to 67.6,1030
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2014,Age,0-1 Days,66.4,61.1 to 71.3,493
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2014-2015,Age,0-1 Days,64.5,60.6 to 68.3,960
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2015,Age,0-1 Days,62.7,56.8 to 68.2,467
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2015-2016,Age,0-1 Days,66.5,62.5 to 70.4,951
Hep B,≥2 Doses,States/Local Areas,Illinois,2015,Age,5 Months,86.1,81.3 to 89.8,467
Hep B,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,5 Months,88.0,84.9 to 90.6,951
Polio,≥2 Doses,States/Local Areas,Illinois,2018,Age,13 Months,95.2,92.3 to 97.1,542
Polio,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,94.4,92.1 to 96.0,1090
Polio,≥2 Doses,States/Local Areas,Illinois,2019,Age,13 Months,93.5,89.7 to 96.0,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2014,Age,24 Months,92.0,88.9 to 94.5,493
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2015,Age,24 Months,92.1,89.7 to 94.1,960
≥1 Dose Varicella,,States/Local Areas,Illinois,2013,Age,24 Months,89.9,86.3 to 92.9,537
≥1 Dose Varicella,,States/Local Areas,Illinois,2013-2014,Age,24 Months,91.0,88.7 to 93.0,1030
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2016,Age,0-1 Days,70.3,64.6 to 75.4,484
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2016-2017,Age,0-1 Days,70.2,66.3 to 73.9,986
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2017,Age,0-1 Days,70.2,64.6 to 75.2,502
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2017-2018,Age,0-1 Days,73.1,69.3 to 76.5,1044
Hep B,≥2 Doses,States/Local Areas,Illinois,2019,Age,5 Months,90.0,85.8 to 93.1,548
Hep B,≥2 Doses,States/Local Areas,Illinois,2011,Age,7 Months,91.8,89.6 to 93.6,583
Hep B,≥2 Doses,States/Local Areas,Illinois,2017,Age,5 Months,90.5,86.9 to 93.2,502
Hep B,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,5 Months,90.4,87.9 to 92.5,1044
Hep B,≥2 Doses,States/Local Areas,Illinois,2018,Age,5 Months,90.3,86.4 to 93.2,542
Hep B,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,5 Months,90.2,87.4 to 92.4,1090
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2018,Age,0-1 Days,76.0,71.0 to 80.4,542
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2018-2019,Age,0-1 Days,75.0,71.4 to 78.2,1090
DTaP,≥4 Doses,States/Local Areas,Illinois,2019,Age,35 Months,89.2,84.0 to 93.3,548
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,78.8,74.9 to 82.7,624
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,88.1,85.5 to 90.7,1043
≥1 Dose MMR,,States/Local Areas,Illinois,2011,Age,19 Months,89.5,86.6 to 91.8,583
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.4,61.8 to 79.1,151
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,66.9,47.3 to 86.6,34
PCV,≥4 Doses,States/Local Areas,Illinois,2013,Age,19 Months,77.7,73.9 to 81.1,537
PCV,≥4 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,79.2,75.6 to 82.4,1030
PCV,≥4 Doses,States/Local Areas,Illinois,2012,Age,19 Months,75.2,71.0 to 78.9,543
PCV,≥4 Doses,States/Local Areas,Illinois,2011,Age,19 Months,73.9,69.1 to 78.2,583
≥1 Dose MMR,,States/Local Areas,Illinois,2018,Age,19 Months,88.4,83.9 to 91.7,542
≥1 Dose MMR,,States/Local Areas,Illinois,2018-2019,Age,19 Months,94.2,92.0 to 95.9,1090
PCV,≥4 Doses,States/Local Areas,Illinois,2014,Age,19 Months,80.7,76.0 to 84.7,493
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,77.8,74.1 to 81.1,960
≥1 Dose MMR,,States/Local Areas,Illinois,2019,Age,19 Months,86.4,81.9 to 90.0,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2017,Age,24 Months,91.1,87.2 to 94.2,502
≥1 Dose Varicella,,States/Local Areas,Illinois,2017-2018,Age,24 Months,91.4,88.8 to 93.6,1044
≥1 Dose Varicella,,States/Local Areas,Illinois,2016,Age,24 Months,94.6,91.9 to 96.7,484
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2017,Age,24 Months,92.9,90.6 to 94.8,986
≥1 Dose MMR,,States/Local Areas,Illinois,2011,Age,24 Months,92.2,89.3 to 94.5,583
≥1 Dose MMR,,States/Local Areas,Illinois,2012,Age,24 Months,88.8,84.8 to 92.1,543
≥1 Dose Varicella,,States/Local Areas,Illinois,2015,Age,24 Months,91.9,88.1 to 94.9,467
≥1 Dose Varicella,,States/Local Areas,Illinois,2015-2016,Age,24 Months,93.3,91.0 to 95.2,951
Polio,≥2 Doses,States/Local Areas,Illinois,2013,Age,13 Months,95.3,94.0 to 96.4,537
Polio,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,95.7,93.7 to 97.1,1030
Polio,≥2 Doses,States/Local Areas,Illinois,2014,Age,13 Months,96.1,93.5 to 97.7,493
Polio,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,95.2,93.2 to 96.7,960
Hep B,≥1 Dose,States/Local Areas,Illinois,2015,Age,3 Months,95.2,92.0 to 97.1,467
Hep B,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,3 Months,95.6,93.5 to 97.1,951
Hep B,≥1 Dose,States/Local Areas,Illinois,2016,Age,3 Months,96.1,92.7 to 98.0,484
Hep B,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,3 Months,96.3,94.3 to 97.6,986
Hep B,≥1 Dose,States/Local Areas,Illinois,2017,Age,3 Months,96.5,93.9 to 98.0,502
Hep B,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,3 Months,96.3,94.5 to 97.6,1044
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.7,71.2 to 88.3,231
≥1 Dose Varicella,,States/Local Areas,Illinois,2014,Age,19 Months,89.0,85.2 to 92.0,493
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2015,Age,19 Months,87.8,84.8 to 90.3,960
≥1 Dose Varicella,,States/Local Areas,Illinois,2015,Age,19 Months,86.7,82.8 to 89.8,467
≥1 Dose Varicella,,States/Local Areas,Illinois,2015-2016,Age,19 Months,89.1,86.1 to 91.5,951
≥1 Dose Varicella,,States/Local Areas,Illinois,2016,Age,19 Months,91.5,87.6 to 94.3,484
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2017,Age,19 Months,90.2,87.4 to 92.4,986
Polio,≥2 Doses,States/Local Areas,Illinois,2012,Age,13 Months,90.3,85.3 to 93.7,543
Polio,≥2 Doses,States/Local Areas,Illinois,2011,Age,13 Months,95.8,94.2 to 97.0,583
≥1 Dose MMR,,States/Local Areas,Illinois,2017,Age,13 Months,66.8,61.1 to 72.1,502
≥1 Dose MMR,,States/Local Areas,Illinois,2017-2018,Age,13 Months,70.0,66.1 to 73.6,1044
≥1 Dose MMR,,States/Local Areas,Illinois,2018,Age,13 Months,73.2,67.8 to 78.0,542
≥1 Dose MMR,,States/Local Areas,Illinois,2018-2019,Age,13 Months,69.4,65.6 to 73.0,1090
≥1 Dose MMR,,States/Local Areas,Illinois,2019,Age,13 Months,65.5,59.9 to 70.7,548
Hep B,≥1 Dose,States/Local Areas,Illinois,2013,Age,3 Months,95.9,93.0 to 97.6,537
Hep B,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,3 Months,95.8,94.3 to 96.9,1030
Hep B,≥1 Dose,States/Local Areas,Illinois,2012,Age,3 Months,93.0,90.5 to 94.9,543
Hep B,≥1 Dose,States/Local Areas,Illinois,2011,Age,3 Months,94.8,92.7 to 96.4,583
Hep B,≥1 Dose,States/Local Areas,Illinois,2014,Age,3 Months,95.7,93.0 to 97.4,493
Hep B,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,3 Months,95.4,93.5 to 96.8,960
Polio,≥2 Doses,States/Local Areas,Illinois,2017,Age,7 Months,92.4,88.9 to 94.9,502
Polio,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,90.8,88.1 to 92.9,1044
Polio,≥2 Doses,States/Local Areas,Illinois,2018,Age,7 Months,89.1,84.7 to 92.3,542
Polio,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,88.9,85.8 to 91.3,1090
≥1 Dose Varicella,,States/Local Areas,Illinois,2019,Age,24 Months,88.0,83.7 to 91.5,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2011,Age,35 Months,92.5,89.1 to 95.2,583
≥1 Dose Varicella,,States/Local Areas,Illinois,2012,Age,35 Months,92.0,88.1 to 95.0,543
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,79.1,74.2 to 84.1,751
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.8,72.5 to 81.2,930
Polio,≥2 Doses,States/Local Areas,Illinois,2019,Age,7 Months,88.7,83.8 to 92.2,548
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,77.3,74.0 to 80.5,1720
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,74.8,69.0 to 80.6,515
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.6,73.1 to 82.0,850
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,65.8,53.5 to 78.0,119
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,91.0,88.2 to 93.7,686
Hep B,≥3 Doses,States/Local Areas,Illinois,2016,Age,13 Months,89.2,84.9 to 92.3,484
Hep B,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,88.7,85.8 to 91.0,986
Hep B,≥3 Doses,States/Local Areas,Illinois,2015,Age,13 Months,84.3,79.3 to 88.3,467
Hep B,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,86.7,83.5 to 89.4,951
Hep B,≥3 Doses,States/Local Areas,Illinois,2017,Age,13 Months,88.2,84.0 to 91.4,502
Hep B,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,89.1,86.3 to 91.3,1044
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,83.2,77.3 to 89.1,408
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,74.4,69.2 to 79.5,624
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,81.6,77.6 to 85.6,1043
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.3,56.2 to 76.4,151
DTaP,≥4 Doses,States/Local Areas,Illinois,2017,Age,35 Months,87.8,83.2 to 91.7,502
DTaP,≥4 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,87.9,84.6 to 90.9,1044
DTaP,≥4 Doses,States/Local Areas,Illinois,2016,Age,35 Months,90.5,86.2 to 93.9,484
DTaP,≥4 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,89.1,86.0 to 91.8,986
DTaP,≥4 Doses,States/Local Areas,Illinois,2012,Age,35 Months,86.3,80.8 to 90.8,543
DTaP,≥4 Doses,States/Local Areas,Illinois,2015,Age,35 Months,88.0,81.7 to 92.9,467
DTaP,≥4 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,89.4,85.7 to 92.5,951
DTaP,≥4 Doses,States/Local Areas,Illinois,2014,Age,35 Months,88.5,83.8 to 92.4,493
DTaP,≥4 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,88.3,84.6 to 91.6,960
Hep A,≥2 Doses,States/Local Areas,Illinois,2019,Age,35 Months,79.5,73.3 to 85.0,548
Hep B,≥3 Doses,States/Local Areas,Illinois,2012,Age,13 Months,83.4,79.5 to 86.7,543
DTaP,≥4 Doses,States/Local Areas,Illinois,2013,Age,35 Months,89.3,85.2 to 92.6,537
DTaP,≥4 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,88.8,85.7 to 91.4,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2013,Age,13 Months,90.7,87.6 to 93.0,537
Hep B,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,90.7,88.8 to 92.4,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2014,Age,13 Months,90.8,87.4 to 93.4,493
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,87.6,84.6 to 90.0,960
Hep A,≥2 Doses,States/Local Areas,Illinois,2018,Age,35 Months,75.3,67.9 to 82.0,542
Hep A,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,77.3,72.4 to 81.9,1090
Hep A,≥2 Doses,States/Local Areas,Illinois,2017,Age,35 Months,73.2,66.7 to 79.3,502
Hep A,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,73.6,69.0 to 78.1,1044
≥1 Dose MMR,,States/Local Areas,Illinois,2014,Age,13 Months,69.2,64.0 to 74.0,493
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2015,Age,13 Months,66.4,62.4 to 70.1,960
≥1 Dose MMR,,States/Local Areas,Illinois,2015,Age,13 Months,63.5,57.5 to 69.1,467
≥1 Dose MMR,,States/Local Areas,Illinois,2015-2016,Age,13 Months,65.6,61.4 to 69.5,951
≥1 Dose Varicella,,States/Local Areas,Illinois,2019,Age,13 Months,56.3,50.7 to 61.7,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2011,Age,19 Months,87.6,85.1 to 89.6,583
≥1 Dose Varicella,,States/Local Areas,Illinois,2013,Age,19 Months,86.7,83.9 to 89.1,537
≥1 Dose Varicella,,States/Local Areas,Illinois,2013-2014,Age,19 Months,87.9,84.9 to 90.3,1030
≥1 Dose Varicella,,States/Local Areas,Illinois,2012,Age,19 Months,84.4,81.9 to 86.7,543
≥1 Dose MMR,,States/Local Areas,Illinois,2016,Age,13 Months,67.6,61.6 to 73.0,484
≥1 Dose MMR,,States/Local Areas,Illinois,2016-2017,Age,13 Months,67.2,63.1 to 71.1,986
≥1 Dose Varicella,,States/Local Areas,Illinois,2018,Age,13 Months,65.0,59.6 to 70.1,542
≥1 Dose Varicella,,States/Local Areas,Illinois,2018-2019,Age,13 Months,60.7,56.8 to 64.5,1090
≥1 Dose Varicella,,States/Local Areas,Illinois,2016,Age,13 Months,61.5,55.5 to 67.1,484
≥1 Dose Varicella,,States/Local Areas,Illinois,2016-2017,Age,13 Months,58.1,53.9 to 62.2,986
≥1 Dose Varicella,,States/Local Areas,Illinois,2017,Age,13 Months,54.5,48.7 to 60.2,502
≥1 Dose Varicella,,States/Local Areas,Illinois,2017-2018,Age,13 Months,59.7,55.7 to 63.6,1044
DTaP,≥4 Doses,States/Local Areas,Illinois,2019,Age,24 Months,80.3,75.3 to 84.9,548
DTaP,≥4 Doses,States/Local Areas,Illinois,2011,Age,35 Months,92.3,88.3 to 95.3,583
≥1 Dose Varicella,,States/Local Areas,Illinois,2014,Age,13 Months,60.5,55.1 to 65.6,493
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2015,Age,13 Months,57.4,53.4 to 61.3,960
≥1 Dose Varicella,,States/Local Areas,Illinois,2015,Age,13 Months,54.4,48.4 to 60.2,467
≥1 Dose Varicella,,States/Local Areas,Illinois,2015-2016,Age,13 Months,57.9,53.7 to 62.0,951
≥1 Dose Varicella,,States/Local Areas,Illinois,2012,Age,13 Months,54.2,50.4 to 57.9,543
Hep A,≥1 Dose,States/Local Areas,Illinois,2019,Age,35 Months,90.2,85.6 to 93.8,548
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,86.6,83.3 to 89.9,624
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,87.2,84.5 to 90.0,1043
Polio,≥2 Doses,States/Local Areas,Illinois,2018,Age,5 Months,80.8,76.1 to 84.8,542
Polio,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,5 Months,80.0,76.5 to 83.1,1090
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.3,80.4 to 94.1,151
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,72.2,54.9 to 89.6,34
≥1 Dose Varicella,,States/Local Areas,Illinois,2013,Age,13 Months,51.5,46.6 to 56.3,537
≥1 Dose Varicella,,States/Local Areas,Illinois,2013-2014,Age,13 Months,56.0,50.7 to 61.1,1030
Polio,≥2 Doses,States/Local Areas,Illinois,2019,Age,5 Months,79.2,73.9 to 83.7,548
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,80.7 to 91.7,231
Hep A,≥1 Dose,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,90.2,86.6 to 93.9,408
Polio,≥2 Doses,States/Local Areas,Illinois,2012,Age,7 Months,84.3,79.7 to 88.0,543
Polio,≥2 Doses,States/Local Areas,Illinois,2011,Age,7 Months,92.6,88.8 to 95.1,583
Hep B,≥3 Doses,States/Local Areas,Illinois,2017,Age,7 Months,54.8,49.0 to 60.4,502
Hep B,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,53.7,49.7 to 57.6,1044
Hep B,≥3 Doses,States/Local Areas,Illinois,2018,Age,7 Months,52.6,47.2 to 58.0,542
Hep B,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,54.9,51.0 to 58.7,1090
Hep A,≥2 Doses,States/Local Areas,Illinois,2016,Age,35 Months,79.2,73.0 to 84.8,484
Hep A,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,76.1,71.6 to 80.3,986
Hep A,≥2 Doses,States/Local Areas,Illinois,2015,Age,35 Months,74.9,68.0 to 81.3,467
Hep A,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,77.0,72.4 to 81.4,951
Polio,≥2 Doses,States/Local Areas,Illinois,2013,Age,7 Months,91.4,88.9 to 93.4,537
Polio,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,92.4,90.4 to 94.0,1030
Hep B,≥3 Doses,States/Local Areas,Illinois,2019,Age,7 Months,57.1,51.6 to 62.5,548
Hep A,≥2 Doses,States/Local Areas,Illinois,2014,Age,35 Months,74.4,68.2 to 80.3,493
Hep A,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,74.8,70.1 to 79.1,960
Hep A,≥1 Dose,States/Local Areas,Illinois,2016,Age,35 Months,91.4,87.5 to 94.4,484
Hep A,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,35 Months,89.5,86.5 to 92.0,986
PCV,≥3 Doses,States/Local Areas,Illinois,2019-2020,Age,19 Months,90.7,88.0 to 92.9,1097
Hep B,≥3 Doses,States/Local Areas,Illinois,2021,Age,35 Months,90.3,84.7 to 94.5,369
Hep B,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,57.6,53.2 to 61.8,918
Hib,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,93.0,90.0 to 95.3,918
PCV,≥4 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,76.9,72.6 to 80.7,918
Hep B,≥2 Doses,States/Local Areas,Illinois,2021,Age,13 Months,91.6,86.3 to 95.0,369
DTaP,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,93.8,91.2 to 95.9,918
Rotavirus,,States/Local Areas,Illinois,2020-2021,Age,8 Months,74.9,70.6 to 78.8,918
DTaP,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,95.3,92.7 to 97.2,918
Combined 7 Series,,States/Local Areas,Illinois,2021,Age,24 Months,63.0,56.0 to 70.0,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,19 Months,80.9,76.9 to 84.4,918
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Illinois,2020-2021,Age,0-1 Days,74.6,70.4 to 78.4,918
PCV,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,91.9,88.7 to 94.4,918
Polio,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,94.4,91.6 to 96.5,918
Hib,≥3 Doses,States/Local Areas,Illinois,2021,Age,13 Months,65.1,58.1 to 71.6,369
DTaP,≥4 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,70.8,66.3 to 74.8,918
Polio,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,90.9,87.5 to 93.4,918
Hib,Full Series,States/Local Areas,Illinois,2021,Age,35 Months,77.9,70.7 to 84.3,369
Hib,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,88.1,84.6 to 91.0,918
Combined 7 Series,,States/Local Areas,Illinois,2020-2021,Age,24 Months,66.4,62.0 to 70.7,918
Hib,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,3 Months,83.8,80.2 to 86.9,918
Hib,Primary Series,States/Local Areas,Illinois,2020-2021,Age,13 Months,82.9,79.1 to 86.2,918
DTaP,≥3 Doses,States/Local Areas,Illinois,2021,Age,35 Months,94.5,89.6 to 97.5,369
Polio,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,88.1,84.4 to 91.1,918
≥1 Dose MMR,,States/Local Areas,Illinois,2020-2021,Age,24 Months,92.7,89.6 to 95.1,918
PCV,≥4 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,82.6,78.3 to 86.5,918
Hib,Primary Series,States/Local Areas,Illinois,2021,Age,13 Months,82.5,76.4 to 87.3,369
Polio,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,5 Months,76.7,72.3 to 80.5,918
Hep B,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,90.1,86.9 to 92.6,918
≥1 Dose MMR,,States/Local Areas,Illinois,2020-2021,Age,35 Months,95.5,92.4 to 97.6,918
PCV,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,19 Months,89.7,86.2 to 92.4,918
Influenza,,States/Local Areas,Illinois,2020-2021,Age,24 Months,58.7,54.2 to 63.2,918
DTaP,≥4 Doses,States/Local Areas,Illinois,2021,Age,35 Months,81.6,73.1 to 88.8,369
Hep B,≥1 Dose,States/Local Areas,Illinois,2021,Age,3 Months,93.4,89.2 to 96.1,369
Influenza,,States/Local Areas,Illinois,2015,Age,24 Months,54.6,48.7 to 60.7,467
Influenza,,States/Local Areas,Illinois,2015-2016,Age,24 Months,57.1,52.9 to 61.5,951
Influenza,,States/Local Areas,Illinois,2014,Age,24 Months,56.9,51.4 to 62.5,493
Influenza,,States/Local Areas,Illinois,2014-2015,Age,24 Months,55.8,51.7 to 59.9,960
Influenza,,States/Local Areas,Illinois,2011,Age,24 Months,53.4,47.7 to 59.3,583
Influenza,,States/Local Areas,Illinois,2012,Age,24 Months,43.9,38.7 to 49.5,543
Influenza,,States/Local Areas,Illinois,2016,Age,24 Months,59.7,53.7 to 65.8,484
Influenza,,States/Local Areas,Illinois,2016-2017,Age,24 Months,59.1,54.9 to 63.4,986
Influenza,,States/Local Areas,Illinois,2013,Age,24 Months,54.4,49.0 to 59.9,537
Influenza,,States/Local Areas,Illinois,2013-2014,Age,24 Months,55.7,51.8 to 59.6,1030
Hep A,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,43.4,39.0 to 48.0,918
Hib,Primary Series,States/Local Areas,Illinois,2021,Age,35 Months,92.6,87.7 to 96.1,369
Hib,Primary Series,States/Local Areas,Illinois,2020-2021,Age,7 Months,70.4,66.0 to 74.4,918
Rotavirus,,States/Local Areas,Illinois,2021,Age,8 Months,72.3,65.2 to 78.5,369
≥1 Dose Varicella,,States/Local Areas,Illinois,2020-2021,Age,24 Months,91.4,88.2 to 94.0,918
Combined 7 Series,,States/Local Areas,Illinois,2020-2021,Age,35 Months,71.7,66.8 to 76.4,918
Hep B,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,5 Months,86.3,82.6 to 89.3,918
≥1 Dose Varicella,,States/Local Areas,Illinois,2021,Age,35 Months,94.0,88.0 to 97.6,369
DTaP,≥4 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,80.0,75.9 to 83.8,918
Hib,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,87.8,84.2 to 90.7,918
DTaP,≥3 Doses,States/Local Areas,Illinois,2021,Age,24 Months,93.9,89.1 to 97.0,369
≥1 Dose MMR,,States/Local Areas,Illinois,2020-2021,Age,19 Months,87.4,83.6 to 90.4,918
DTaP,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,72.3,67.9 to 76.3,918
Polio,≥3 Doses,States/Local Areas,Illinois,2021,Age,35 Months,94.0,89.0 to 97.2,369
PCV,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,13 Months,86.5,82.6 to 89.6,918
Hib,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,7 Months,52.7,48.2 to 57.1,918
PCV,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,3 Months,85.8,82.2 to 88.7,918
≥1 Dose MMR,,States/Local Areas,Illinois,2021,Age,13 Months,62.9,55.8 to 69.5,369
Hep A,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,24 Months,86.3,82.7 to 89.4,918
Hep A,≥2 Doses,States/Local Areas,Illinois,2020-2021,Age,35 Months,76.3,70.1 to 82.0,918
Polio,≥3 Doses,States/Local Areas,Illinois,2020-2021,Age,24 Months,93.2,90.4 to 95.3,918
Hib,≥3 Doses,States/Local Areas,Illinois,2021,Age,35 Months,92.4,87.3 to 95.9,369
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2021,Age,0-3 Days,75.8,68.9 to 81.5,369
Polio,≥1 Dose,States/Local Areas,Illinois,2020-2021,Age,3 Months,86.3,82.8 to 89.2,918
Hib,Full Series,HHS Regions/National,United States,2020-2021,Age,35 Months,80.7,79.6 to 81.8,28668
Hib,Primary Series,HHS Regions/National,United States,2020-2021,Age,35 Months,92.7,91.9 to 93.4,28668
Hep B,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,3 Months,94.6,94.1 to 95.2,28668
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2021,Age,0-1 Days,75.6,73.9 to 77.2,11281
PCV,≥3 Doses,HHS Regions/National,United States,2021,Age,13 Months,87.5,86.1 to 88.7,11281
Hib,≥2 Doses,HHS Regions/National,United States,2021,Age,5 Months,75.2,73.3 to 76.9,11281
Influenza,,HHS Regions/National,United States,2021,Age,24 Months,53.4,51.4 to 55.4,11281
≥1 Dose MMR,,HHS Regions/National,United States,2020-2021,Age,13 Months,65.8,64.6 to 67.0,28668
Polio,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,92.5,91.7 to 93.1,28668
DTaP,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,3 Months,86.5,85.6 to 87.4,28668
≥1 Dose Varicella,,HHS Regions/National,United States,2020-2021,Age,19 Months,87.3,86.5 to 88.1,28668
DTaP,≥4 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,69.9,68.7 to 71.1,28668
Hep A,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,19 Months,27.8,26.8 to 28.9,28668
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2020-2021,Age,0-2 Days,78.7,77.6 to 79.7,28668
PCV,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,7 Months,67.5,66.3 to 68.7,28668
Hib,Primary Series,HHS Regions/National,United States,2020-2021,Age,19 Months,90.8,90.0 to 91.5,28668
≥1 Dose MMR,,HHS Regions/National,United States,2021,Age,19 Months,87.9,86.6 to 89.0,11281
Polio,≥2 Doses,HHS Regions/National,United States,2021,Age,5 Months,77.9,76.1 to 79.6,11281
≥1 Dose Varicella,,HHS Regions/National,United States,2021,Age,13 Months,60.1,58.2 to 62.0,11281
Hep B,≥3 Doses,HHS Regions/National,United States,2021,Age,13 Months,87.7,86.3 to 88.9,11281
Hib,≥3 Doses,HHS Regions/National,United States,2021,Age,19 Months,88.4,87.1 to 89.6,11281
Hep B,≥2 Doses,HHS Regions/National,United States,2021,Age,5 Months,87.3,85.7 to 88.6,11281
DTaP,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,88.7,87.8 to 89.5,28668
DTaP,≥2 Doses,HHS Regions/National,United States,2021,Age,5 Months,78.5,76.7 to 80.1,11281
Rotavirus,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,82.1,81.1 to 83.1,31919
Rotavirus,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,67.9,64.2 to 71.5,2246
Rotavirus,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,56.6,52.5 to 60.6,1692
Rotavirus,,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,84.4,83.0 to 85.8,18707
Rotavirus,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,71.7,69.6 to 73.7,11789
Rotavirus,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.9,63.4 to 68.3,4191
Rotavirus,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,66.9,65.5 to 68.3,21000
Rotavirus,,HHS Regions/National,United States,2018,Age,8 Months,77.4,76.1 to 78.6,18826
Rotavirus,,HHS Regions/National,United States,2018-2019,Age,8 Months,77.1,76.2 to 78.0,36091
Rotavirus,,HHS Regions/National,United States,2019,Age,8 Months,76.8,75.5 to 78.0,17265
Rotavirus,,HHS Regions/National,United States,2017,Age,8 Months,74.0,72.6 to 75.4,17804
Rotavirus,,HHS Regions/National,United States,2017-2018,Age,8 Months,75.7,74.8 to 76.6,36630
Rotavirus,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.7,70.5 to 75.0,7674
Rotavirus,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,73.8,72.5 to 75.1,24711
Rotavirus,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.3,76.4 to 78.2,33203
Rotavirus,,HHS Regions/National,United States,2011,Age,8 Months,70.8,69.2 to 72.3,14513
Rotavirus,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.8,73.5 to 76.1,21757
Rotavirus,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,69.8,67.9 to 71.7,10389
Rotavirus,,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,65.4,63.9 to 66.9,17073
Rotavirus,,HHS Regions/National,United States,2014-2017,Overall,Overall,73.7,72.9 to 74.6,56857
Rotavirus,,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,74.5,73.2 to 75.9,21077
Rotavirus,,HHS Regions/National,United States,2013,Age,8 Months,72.5,71.1 to 73.9,14872
Rotavirus,,HHS Regions/National,United States,2013-2014,Age,8 Months,72.4,71.3 to 73.4,30205
Rotavirus,,HHS Regions/National,United States,2012,Age,8 Months,71.3,69.7 to 72.7,15039
Rotavirus,,HHS Regions/National,United States,2014,Age,8 Months,72.3,70.8 to 73.8,15333
Rotavirus,,HHS Regions/National,United States,2014-2015,Age,8 Months,72.2,71.0 to 73.3,30796
Rotavirus,,HHS Regions/National,United States,2016,Age,8 Months,75.1,73.5 to 76.6,15956
Rotavirus,,HHS Regions/National,United States,2016-2017,Age,8 Months,74.6,73.5 to 75.6,33760
Rotavirus,,HHS Regions/National,United States,2015,Age,8 Months,72.1,70.4 to 73.7,15463
Rotavirus,,HHS Regions/National,United States,2015-2016,Age,8 Months,73.6,72.4 to 74.7,31419
Hep B,≥1 Dose,HHS Regions/National,United States,2021,Age,3 Months,94.6,93.7 to 95.4,11281
Hib,≥3 Doses,States/Local Areas,Maine,2015,Age,13 Months,79.4,73.4 to 84.3,278
Hib,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,77.5,72.9 to 81.6,521
Hib,≥3 Doses,States/Local Areas,Maine,2016,Age,13 Months,75.7,68.4 to 81.8,243
Hib,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,74.8,69.8 to 79.2,502
Hib,≥3 Doses,States/Local Areas,Maine,2017,Age,13 Months,73.8,66.8 to 79.8,259
Hib,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,75.6,70.8 to 79.8,510
Polio,≥3 Doses,States/Local Areas,Maine,2014,Age,19 Months,88.9,84.0 to 92.5,275
Polio,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,91.2,88.1 to 93.5,553
Polio,≥3 Doses,States/Local Areas,Maine,2015,Age,19 Months,93.5,90.5 to 95.6,278
Polio,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,92.7,89.7 to 94.9,521
Polio,≥3 Doses,States/Local Areas,Maine,2013,Age,19 Months,93.3,92.1 to 94.4,244
Polio,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,91.2,89.4 to 92.7,519
Polio,≥3 Doses,States/Local Areas,Maine,2018,Age,19 Months,96.2,92.2 to 98.2,251
Polio,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,68.3,63.0 to 73.1,495
Hib,≥3 Doses,States/Local Areas,Maine,2018,Age,13 Months,77.3,70.6 to 82.8,251
Hib,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,77.4,72.8 to 81.4,495
Polio,≥3 Doses,States/Local Areas,Maine,2016,Age,19 Months,91.9,87.1 to 95.0,243
Polio,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,91.8,88.6 to 94.2,502
Polio,≥3 Doses,States/Local Areas,Maine,2017,Age,19 Months,91.7,87.0 to 94.8,259
Polio,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,94.0,91.1 to 95.9,510
Hib,≥3 Doses,States/Local Areas,Maine,2019,Age,13 Months,77.4,70.8 to 82.9,244
Hib,≥3 Doses,States/Local Areas,Maine,2012,Age,19 Months,94.6,89.2 to 97.3,233
Hib,≥3 Doses,States/Local Areas,Maine,2011,Age,19 Months,94.0,87.5 to 97.2,203
DTaP,≥3 Doses,States/Local Areas,Maine,2018,Age,13 Months,95.0,90.8 to 97.4,251
DTaP,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,93.8,90.7 to 95.9,495
DTaP,≥3 Doses,States/Local Areas,Maine,2019,Age,13 Months,92.5,87.4 to 95.7,244
DTaP,≥3 Doses,States/Local Areas,Maine,2011,Age,19 Months,96.1,91.5 to 98.3,203
DTaP,≥3 Doses,States/Local Areas,Maine,2013,Age,19 Months,94.8,91.4 to 97.0,244
DTaP,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,93.6,91.6 to 95.2,519
DTaP,≥3 Doses,States/Local Areas,Maine,2012,Age,19 Months,98.4,97.9 to 98.8,233
≥1 Dose MMR,,States/Local Areas,Maine,2020-2021,Age,19 Months,93.1,89.1 to 95.7,366
DTaP,≥3 Doses,States/Local Areas,Maine,2011,Age,13 Months,94.6,91.1 to 96.7,203
Hib,≥2 Doses,States/Local Areas,Maine,2020,Age,13 Months,97.6,94.8 to 98.9,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,70.3,64.2 to 76.5,275
Polio,≥3 Doses,States/Local Areas,Maine,2012,Age,19 Months,93.6,90.3 to 95.8,233
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,75.0,68.0 to 82.0,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,64.3,58.7 to 69.8,430
Hib,≥2 Doses,States/Local Areas,Maine,2018,Age,13 Months,96.9,92.8 to 98.7,251
Hib,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,13 Months,96.0,93.1 to 97.7,495
Hib,≥2 Doses,States/Local Areas,Maine,2017,Age,13 Months,93.8,90.0 to 96.2,259
Hib,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,95.4,92.9 to 97.0,510
Hib,≥2 Doses,States/Local Areas,Maine,2019,Age,13 Months,95.1,90.1 to 97.7,244
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,86.8,82.3 to 91.3,275
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,91.0,88.8 to 93.3,950
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,91.1,87.8 to 94.4,371
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.6,90.7 to 96.6,395
DTaP,≥3 Doses,States/Local Areas,Maine,2015,Age,13 Months,92.2,87.5 to 95.2,278
DTaP,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,91.7,88.5 to 94.1,521
DTaP,≥3 Doses,States/Local Areas,Maine,2012,Age,13 Months,95.8,93.6 to 97.2,233
DTaP,≥3 Doses,States/Local Areas,Maine,2016,Age,13 Months,91.3,86.2 to 94.6,243
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,91.3,88.0 to 93.8,502
DTaP,≥3 Doses,States/Local Areas,Maine,2017,Age,13 Months,91.3,86.4 to 94.5,259
DTaP,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,13 Months,93.2,90.2 to 95.3,510
Hib,≥2 Doses,States/Local Areas,Maine,2014,Age,13 Months,93.0,88.9 to 95.7,275
Hib,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,93.9,91.3 to 95.8,553
Hib,≥3 Doses,States/Local Areas,Maine,2017,Age,7 Months,58.7,51.2 to 65.7,259
Hib,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,58.7,53.5 to 63.7,510
Hib,≥3 Doses,States/Local Areas,Maine,2018,Age,7 Months,58.7,51.4 to 65.6,251
Hib,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,59.7,54.5 to 64.7,495
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,85.5 to 98.2,66
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,93.1,86.2 to 100.0,40
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,75.8,59.3 to 92.3,38
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,88.4,84.4 to 92.3,365
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,95.8,94.0 to 97.6,530
Hib,≥2 Doses,States/Local Areas,Maine,2015,Age,13 Months,94.8,91.0 to 97.0,278
Hib,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,13 Months,93.7,90.9 to 95.7,521
Hib,≥2 Doses,States/Local Areas,Maine,2016,Age,13 Months,92.6,88.0 to 95.6,243
Hib,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,13 Months,93.2,90.4 to 95.3,502
Hib,≥3 Doses,States/Local Areas,Maine,2013,Age,13 Months,84.7,80.9 to 87.9,244
Hib,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,79.9,76.2 to 83.2,519
Polio,≥3 Doses,States/Local Areas,Maine,2011,Age,19 Months,93.2,86.8 to 96.6,203
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,97.8,96.1 to 99.6,245
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,91.0,87.3 to 94.6,430
Hib,≥3 Doses,States/Local Areas,Maine,2014,Age,13 Months,75.0,68.3 to 80.7,275
Hib,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,77.2,72.8 to 81.1,553
Hib,≥3 Doses,States/Local Areas,Maine,2011,Age,13 Months,92.2,87.9 to 95.0,203
Hib,≥3 Doses,States/Local Areas,Maine,2012,Age,13 Months,86.2,80.2 to 90.6,233
DTaP,≥3 Doses,States/Local Areas,Maine,2013,Age,13 Months,92.3,90.7 to 93.6,244
DTaP,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,91.3,89.6 to 92.7,519
DTaP,≥3 Doses,States/Local Areas,Maine,2014,Age,13 Months,90.2,85.4 to 93.6,275
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,13 Months,91.2,88.0 to 93.6,553
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,75.7,57.8 to 93.5,40
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.6,65.8 to 73.3,821
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.1,51.5 to 78.6,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Overall,Overall,68.7,65.1 to 72.2,950
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,68.0,62.2 to 73.9,371
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,65.3,56.9 to 73.7,184
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.0,65.7 to 76.3,395
Hib,≥3 Doses,States/Local Areas,Maine,2019,Age,7 Months,60.8,53.4 to 67.7,244
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,86.0,79.3 to 92.8,184
PCV,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.0,89.7 to 94.3,821
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2015,Age,0-3 Days,69.0,62.2 to 75.1,278
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2015-2016,Age,0-3 Days,69.8,64.5 to 74.5,521
≥1 Dose Varicella,,States/Local Areas,Maine,2020,Age,24 Months,94.5,90.7 to 97.1,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014,Age,0-3 Days,63.0,55.9 to 69.5,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2015,Age,0-3 Days,66.0,61.1 to 70.6,553
DTaP,≥3 Doses,States/Local Areas,Maine,2013,Age,7 Months,74.6,67.2 to 80.8,244
DTaP,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,75.0,71.7 to 78.0,519
DTaP,≥3 Doses,States/Local Areas,Maine,2012,Age,7 Months,76.7,73.8 to 79.3,233
DTaP,≥3 Doses,States/Local Areas,Maine,2011,Age,7 Months,72.5,67.2 to 77.2,203
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2013,Age,0-3 Days,70.1,62.1 to 77.1,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2013-2014,Age,0-3 Days,66.6,61.3 to 71.5,519
Polio,≥1 Dose,States/Local Areas,Maine,2013,Age,3 Months,90.2,87.3 to 92.5,244
Polio,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,3 Months,89.3,87.5 to 90.9,519
PCV,≥1 Dose,States/Local Areas,Maine,2019,Age,3 Months,93.3,88.7 to 96.1,244
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,89.6,87.4 to 91.8,950
Polio,≥1 Dose,States/Local Areas,Maine,2012,Age,3 Months,91.3,87.5 to 94.0,233
Polio,≥1 Dose,States/Local Areas,Maine,2011,Age,3 Months,90.1,82.3 to 94.7,203
PCV,≥3 Doses,States/Local Areas,Maine,2012,Age,35 Months,98.0,95.6 to 99.2,233
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,81.7 to 95.9,66
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.9,80.7 to 87.0,821
PCV,≥4 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,70.6 to 90.7,66
PCV,≥1 Dose,States/Local Areas,Maine,2014,Age,3 Months,84.2,78.2 to 88.8,275
PCV,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,3 Months,85.3,81.3 to 88.5,553
PCV,≥1 Dose,States/Local Areas,Maine,2015,Age,3 Months,86.4,80.8 to 90.6,278
PCV,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,3 Months,88.1,84.4 to 91.0,521
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,92.1,84.8 to 99.5,40
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,87.7,81.6 to 93.8,184
DTaP,≥3 Doses,States/Local Areas,Maine,2014,Age,7 Months,75.4,68.9 to 80.9,275
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,75.6,71.2 to 79.5,553
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,87.5,83.3 to 91.7,275
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,94.4,91.6 to 97.2,245
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,88.9,85.4 to 92.3,430
Hib,≥3 Doses,States/Local Areas,Maine,2012,Age,7 Months,65.3,58.8 to 71.4,233
Hib,≥3 Doses,States/Local Areas,Maine,2011,Age,7 Months,71.7,67.5 to 75.7,203
Hib,≥3 Doses,States/Local Areas,Maine,2013,Age,7 Months,62.8,53.5 to 71.2,244
Hib,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,7 Months,62.2,58.8 to 65.6,519
Polio,≥1 Dose,States/Local Areas,Maine,2014,Age,3 Months,88.4,83.1 to 92.1,275
Polio,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,3 Months,89.5,86.0 to 92.1,553
Polio,≥1 Dose,States/Local Areas,Maine,2015,Age,3 Months,90.6,85.7 to 93.9,278
Polio,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,3 Months,90.2,86.8 to 92.8,521
Polio,≥1 Dose,States/Local Areas,Maine,2016,Age,3 Months,89.9,84.7 to 93.5,243
Polio,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,3 Months,89.5,86.2 to 92.1,502
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2017,Age,0-3 Days,72.0,61.5 to 80.5,153
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2017-2018,Age,0-3 Days,73.2,68.3 to 77.7,510
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016,Age,0-3 Days,70.5,62.4 to 77.5,243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2017,Age,0-3 Days,72.3,67.0 to 77.1,502
Hib,≥2 Doses,States/Local Areas,Maine,2018,Age,7 Months,94.2,89.6 to 96.8,251
Hib,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,93.4,90.2 to 95.6,495
PCV,≥3 Doses,States/Local Areas,Maine,2014,Age,35 Months,91.5,87.0 to 94.9,275
PCV,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,91.3,88.1 to 93.9,553
PCV,≥3 Doses,States/Local Areas,Maine,2015,Age,35 Months,91.1,86.5 to 94.7,278
PCV,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,91.7,88.6 to 94.3,521
PCV,≥3 Doses,States/Local Areas,Maine,2016,Age,35 Months,92.5,87.9 to 95.9,243
PCV,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,93.0,89.9 to 95.5,502
Hib,≥2 Doses,States/Local Areas,Maine,2016,Age,7 Months,90.1,84.5 to 93.8,243
Hib,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,90.7,87.2 to 93.3,502
Hib,≥2 Doses,States/Local Areas,Maine,2017,Age,7 Months,91.3,86.5 to 94.5,259
Hib,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,92.8,89.7 to 95.0,510
PCV,≥3 Doses,States/Local Areas,Maine,2019,Age,24 Months,93.6,89.4 to 96.5,244
PCV,≥3 Doses,States/Local Areas,Maine,2011,Age,35 Months,95.6,90.9 to 98.3,203
PCV,≥3 Doses,States/Local Areas,Maine,2013,Age,35 Months,96.9,94.2 to 98.5,244
PCV,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,94.3,91.8 to 96.3,519
Hib,≥2 Doses,States/Local Areas,Maine,2015,Age,7 Months,92.4,88.0 to 95.3,278
Hib,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,91.3,87.9 to 93.8,521
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.8,87.5 to 92.2,821
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,90.6,87.5 to 93.7,371
Hep B,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.7,86.6 to 92.9,395
Hib,≥2 Doses,States/Local Areas,Maine,2019,Age,7 Months,92.5,87.3 to 95.7,244
Hib,≥2 Doses,States/Local Areas,Maine,2012,Age,13 Months,97.7,96.9 to 98.2,233
Hib,≥2 Doses,States/Local Areas,Maine,2011,Age,13 Months,96.1,93.3 to 97.7,203
DTaP,≥3 Doses,States/Local Areas,Maine,2015,Age,7 Months,75.8,69.6 to 81.1,278
DTaP,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,73.6,68.8 to 77.9,521
DTaP,≥3 Doses,States/Local Areas,Maine,2016,Age,7 Months,71.4,63.9 to 77.9,243
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,72.3,67.2 to 76.8,502
Hib,≥2 Doses,States/Local Areas,Maine,2013,Age,13 Months,95.2,94.1 to 96.1,244
Hib,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,13 Months,94.1,93.1 to 95.0,519
PCV,≥3 Doses,States/Local Areas,Maine,2017,Age,35 Months,93.0,88.6 to 96.2,259
PCV,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,94.7,91.9 to 96.7,510
PCV,≥3 Doses,States/Local Areas,Maine,2018,Age,35 Months,95.8,92.2 to 98.0,251
PCV,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,95.7,92.9 to 97.6,495
Hib,≥3 Doses,States/Local Areas,Maine,2014,Age,7 Months,61.6,54.5 to 68.3,275
Hib,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,7 Months,62.7,57.7 to 67.3,553
Hib,≥3 Doses,States/Local Areas,Maine,2015,Age,7 Months,63.7,56.8 to 70.1,278
Hib,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,7 Months,59.7,54.5 to 64.7,521
Hib,≥3 Doses,States/Local Areas,Maine,2016,Age,7 Months,55.7,47.8 to 63.4,243
Hib,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,7 Months,57.2,51.7 to 62.4,502
Polio,≥1 Dose,States/Local Areas,Maine,2017,Age,3 Months,89.2,84.7 to 92.5,259
Polio,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,3 Months,89.9,86.7 to 92.5,510
Polio,≥1 Dose,States/Local Areas,Maine,2018,Age,3 Months,90.7,85.5 to 94.1,251
Polio,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,3 Months,92.1,88.9 to 94.5,495
PCV,≥3 Doses,States/Local Areas,Maine,2019,Age,35 Months,95.5,90.7 to 98.2,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2018,Age,0-3 Days,72.3,65.0 to 78.6,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2018-2019,Age,0-3 Days,78.0,73.2 to 82.1,495
Polio,≥1 Dose,States/Local Areas,Maine,2019,Age,3 Months,93.7,89.1 to 96.4,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2019,Age,0-3 Days,83.9,77.5 to 88.7,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,70.1,65.4 to 74.7,530
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,70.0,64.5 to 75.5,365
DTaP,≥3 Doses,States/Local Areas,Maine,2018,Age,7 Months,73.5,66.6 to 79.5,251
DTaP,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,7 Months,75.3,70.5 to 79.5,495
DTaP,≥3 Doses,States/Local Areas,Maine,2019,Age,7 Months,77.1,70.4 to 82.6,244
DTaP,≥3 Doses,States/Local Areas,Maine,2017,Age,7 Months,73.1,66.1 to 79.2,259
DTaP,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,7 Months,73.3,68.5 to 77.7,510
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,43.8,24.6 to 63.1,38
Influenza,,States/Local Areas,Maine,2013,Age,24 Months,67.6,59.8 to 75.2,244
Influenza,,States/Local Areas,Maine,2013-2014,Age,24 Months,62.3,57.1 to 67.6,519
Influenza,,States/Local Areas,Maine,2011,Age,24 Months,65.1,56.8 to 73.2,203
Influenza,,States/Local Areas,Maine,2012,Age,24 Months,65.9,57.4 to 74.1,233
Influenza,,States/Local Areas,Maine,2015,Age,24 Months,66.0,59.2 to 72.7,278
Influenza,,States/Local Areas,Maine,2015-2016,Age,24 Months,64.8,59.6 to 69.9,521
Influenza,,States/Local Areas,Maine,2014,Age,24 Months,56.9,50.0 to 64.0,275
Influenza,,States/Local Areas,Maine,2014-2015,Age,24 Months,61.5,56.6 to 66.4,553
Influenza,,States/Local Areas,Maine,2016,Age,24 Months,63.6,55.8 to 71.3,243
Influenza,,States/Local Areas,Maine,2016-2017,Age,24 Months,66.3,60.9 to 71.5,502
PCV,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,95.5,92.7 to 97.2,467
Influenza,,States/Local Areas,Maine,2019,Age,24 Months,72.7,65.4 to 79.6,244
Influenza,,States/Local Areas,Maine,2018,Age,24 Months,76.5,69.9 to 82.6,251
Influenza,,States/Local Areas,Maine,2018-2019,Age,24 Months,74.6,69.7 to 79.3,495
Influenza,,States/Local Areas,Maine,2017,Age,24 Months,69.1,61.9 to 75.9,259
Influenza,,States/Local Areas,Maine,2017-2018,Age,24 Months,72.8,68.0 to 77.5,510
Influenza,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,56.9,50.9 to 63.0,365
Influenza,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,70.8,66.2 to 75.5,530
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,89.1 to 99.4,63
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,85.8,81.4 to 90.2,349
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,92.2,89.2 to 95.1,522
Influenza,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.6,55.2 to 80.0,66
Influenza,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,72.5,55.7 to 89.4,40
Hib,Full Series,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.9,75.8 to 96.0,63
Influenza,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,69.9,61.6 to 78.3,184
Influenza,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.1,59.1 to 67.1,821
Influenza,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,59.9,53.7 to 66.1,371
Influenza,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,63.0,57.3 to 68.7,395
Influenza,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,40.9,21.8 to 60.1,38
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.4,69.8 to 93.1,63
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,75.2,57.6 to 92.8,42
Influenza,,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,81.1,75.3 to 86.8,245
Influenza,,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,64.3,58.8 to 69.8,430
Influenza,,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,51.4,44.3 to 58.5,275
Influenza,,States/Local Areas,Maine,2014-2017,Overall,Overall,63.3,59.6 to 67.1,950
Hib,Full Series,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,89.7,86.0 to 93.4,522
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,90.4,87.0 to 93.9,349
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.4 to 98.7,522
Hib,≥3 Doses,States/Local Areas,Maine,2021,Age,35 Months,95.7,91.6 to 98.2,143
DTaP,≥3 Doses,States/Local Areas,Maine,2021,Age,24 Months,95.7,91.6 to 98.2,143
PCV,≥1 Dose,States/Local Areas,Maine,2021,Age,3 Months,91.2,84.3 to 95.2,143
≥1 Dose MMR,,States/Local Areas,Maine,2021,Age,13 Months,66.0,55.8 to 74.9,143
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2021,Age,0-3 Days,80.8,71.5 to 87.6,143
Hib,Primary Series,States/Local Areas,Maine,2021,Age,35 Months,96.5,92.6 to 98.6,143
DTaP,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,5 Months,85.2,79.7 to 89.4,366
Hib,≥2 Doses,States/Local Areas,Maine,2021,Age,13 Months,97.0,92.8 to 98.8,143
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,91.0,87.8 to 94.3,522
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,86.2 to 98.1,63
Hib,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,93.8,89.9 to 96.2,366
Hep B,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,93.7,90.3 to 96.2,366
PCV,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,91.6,86.8 to 94.8,366
Hib,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,61.8,55.3 to 67.9,366
PCV,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,3 Months,90.9,86.4 to 94.1,366
DTaP,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,74.7,68.6 to 80.0,366
Polio,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,95.5,92.5 to 97.5,366
Hep A,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,56.3,49.5 to 63.4,366
Hib,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,94.5,91.2 to 96.6,366
Hib,Primary Series,States/Local Areas,Maine,2020-2021,Age,7 Months,75.8,69.6 to 81.1,366
DTaP,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,95.5,92.3 to 97.4,366
Polio,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,96.9,94.1 to 98.6,366
Hib,≥3 Doses,States/Local Areas,Maine,2021,Age,13 Months,80.2,71.3 to 86.9,143
≥1 Dose Varicella,,States/Local Areas,Maine,2020-2021,Age,24 Months,91.1,86.9 to 94.4,366
Rotavirus,,States/Local Areas,Maine,2021,Age,8 Months,72.6,62.6 to 80.8,143
PCV,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,5 Months,84.8,79.3 to 89.0,366
Hep B,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,5 Months,90.4,86.1 to 93.4,366
Hib,Primary Series,States/Local Areas,Maine,2020-2021,Age,13 Months,92.1,87.6 to 95.0,366
Hib,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,3 Months,90.2,85.6 to 93.4,366
Combined 7 Series,,States/Local Areas,Maine,2020-2021,Age,35 Months,78.4,72.1 to 84.0,366
≥1 Dose MMR,,States/Local Areas,Maine,2020-2021,Age,24 Months,94.2,90.7 to 96.7,366
Polio,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,94.8,91.3 to 97.0,366
Polio,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,93.7,89.7 to 96.2,366
Polio,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,5 Months,84.5,79.0 to 88.8,366
PCV,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,96.1,93.2 to 98.0,366
DTaP,≥3 Doses,States/Local Areas,Maine,2021,Age,35 Months,95.7,91.6 to 98.2,143
Hep B,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,91.4,87.4 to 94.3,366
Combined 7 Series,,States/Local Areas,Maine,2020-2021,Age,24 Months,74.4,68.4 to 80.0,366
Hib,Full Series,States/Local Areas,Maine,2021,Age,35 Months,81.2,71.9 to 89.0,143
≥1 Dose MMR,,States/Local Areas,Maine,2020-2021,Age,35 Months,95.1,91.6 to 97.4,366
Hib,Primary Series,States/Local Areas,Maine,2021,Age,13 Months,90.5,82.3 to 95.2,143
PCV,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,95.4,91.9 to 97.4,366
Hep B,≥3 Doses,States/Local Areas,Maine,2021,Age,35 Months,92.4,86.7 to 96.3,143
PCV,≥4 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,88.8,83.8 to 92.8,366
Influenza,,States/Local Areas,Maine,2020-2021,Age,24 Months,73.0,66.8 to 78.8,366
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2020-2021,Age,0-1 Days,76.6,70.7 to 81.5,366
Hep B,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,62.5,56.2 to 68.4,366
DTaP,≥4 Doses,States/Local Areas,Maine,2021,Age,35 Months,82.3,72.9 to 89.9,143
Hep B,≥2 Doses,States/Local Areas,Maine,2021,Age,13 Months,94.9,89.1 to 97.7,143
Hib,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,96.8,94.4 to 98.4,366
PCV,≥4 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,86.2,81.0 to 90.2,366
≥1 Dose Varicella,,States/Local Areas,Maine,2021,Age,35 Months,91.3,82.9 to 96.6,143
Rotavirus,,States/Local Areas,Maine,2020-2021,Age,8 Months,75.8,69.6 to 81.0,366
DTaP,≥4 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,86.1,81.0 to 90.5,366
DTaP,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,97.3,95.0 to 98.8,366
Hib,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,5 Months,84.4,78.8 to 88.6,366
Hib,Full Series,States/Local Areas,Maine,2020-2021,Age,19 Months,81.8,76.0 to 86.5,366
Hep A,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,35 Months,88.6,82.8 to 93.1,366
Hep A,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,19 Months,84.9,78.7 to 89.5,366
Polio,≥3 Doses,States/Local Areas,Maine,2021,Age,35 Months,94.4,89.2 to 97.6,143
Hep B,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,92.6,88.7 to 95.2,366
DTaP,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,96.2,93.7 to 97.9,366
Hib,Primary Series,States/Local Areas,Maine,2020-2021,Age,19 Months,95.4,92.3 to 97.3,366
Hep A,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,31.0,25.6 to 37.0,366
PCV,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,7 Months,74.8,68.7 to 80.0,366
Hib,Primary Series,States/Local Areas,Maine,2020-2021,Age,35 Months,97.3,95.1 to 98.7,366
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2020-2021,Age,0-3 Days,82.8,77.3 to 87.2,366
Hib,Full Series,States/Local Areas,Maine,2020-2021,Age,35 Months,84.6,79.1 to 89.2,366
DTaP,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,3 Months,89.5,84.4 to 93.1,366
≥1 Dose Varicella,,States/Local Areas,Maine,2020-2021,Age,19 Months,90.3,85.7 to 93.5,366
Hep B,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,3 Months,94.2,90.4 to 96.6,366
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2020-2021,Age,0-2 Days,81.2,75.6 to 85.8,366
Polio,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,96.5,93.6 to 98.1,366
≥1 Dose MMR,,States/Local Areas,Maine,2020-2021,Age,13 Months,69.8,63.5 to 75.4,366
DTaP,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,92.8,88.3 to 95.6,366
DTaP,≥4 Doses,States/Local Areas,Maine,2020-2021,Age,19 Months,81.3,75.5 to 85.9,366
Influenza,,States/Local Areas,Maine,2021,Age,24 Months,72.7,63.1 to 81.6,143
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2021,Age,0-1 Days,77.8,68.5 to 84.9,143
Hib,≥2 Doses,States/Local Areas,Maine,2021,Age,5 Months,82.5,73.7 to 88.8,143
PCV,≥3 Doses,States/Local Areas,Maine,2021,Age,13 Months,88.7,80.4 to 93.8,143
Hep B,≥2 Doses,States/Local Areas,Maine,2021,Age,5 Months,88.3,81.0 to 93.0,143
≥1 Dose Varicella,,States/Local Areas,Maine,2021,Age,13 Months,50.0,40.2 to 59.8,143
DTaP,≥2 Doses,States/Local Areas,Maine,2021,Age,5 Months,83.2,74.3 to 89.4,143
≥1 Dose MMR,,States/Local Areas,Maine,2021,Age,19 Months,91.3,83.7 to 95.5,143
Polio,≥2 Doses,States/Local Areas,Maine,2021,Age,5 Months,82.5,73.7 to 88.8,143
Rotavirus,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.6,69.6 to 89.6,66
Rotavirus,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,74.8,58.5 to 91.0,40
Rotavirus,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,73.0,67.6 to 78.4,365
Rotavirus,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,71.0,62.7 to 79.3,184
Rotavirus,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.2,73.8 to 80.7,821
Rotavirus,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,63.8,46.0 to 81.6,38
Rotavirus,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,81.9,78.1 to 85.7,530
Hep B,≥3 Doses,States/Local Areas,Maine,2021,Age,13 Months,90.0,83.1 to 94.3,143
Rotavirus,,States/Local Areas,Maine,2017,Age,8 Months,74.7,67.6 to 80.7,259
Rotavirus,,States/Local Areas,Maine,2017-2018,Age,8 Months,79.2,74.7 to 83.1,510
Rotavirus,,States/Local Areas,Maine,2019,Age,8 Months,73.8,66.5 to 80.1,244
Rotavirus,,States/Local Areas,Maine,2018,Age,8 Months,83.6,77.7 to 88.2,251
Rotavirus,,States/Local Areas,Maine,2018-2019,Age,8 Months,78.8,74.1 to 82.8,495
Rotavirus,,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,78.4,73.7 to 83.2,430
Rotavirus,,States/Local Areas,Maine,2011,Age,8 Months,69.0,60.7 to 76.3,203
Rotavirus,,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,68.5,62.2 to 74.8,275
Rotavirus,,States/Local Areas,Maine,2014-2017,Overall,Overall,76.6,73.3 to 79.9,950
Rotavirus,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,78.7,73.9 to 83.4,371
Rotavirus,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.6,72.7 to 82.5,395
Rotavirus,,States/Local Areas,Maine,2014,Age,8 Months,73.7,67.3 to 79.3,275
Rotavirus,,States/Local Areas,Maine,2014-2015,Age,8 Months,76.3,71.9 to 80.1,553
Rotavirus,,States/Local Areas,Maine,2012,Age,8 Months,76.1,68.5 to 82.3,233
Rotavirus,,States/Local Areas,Maine,2013,Age,8 Months,77.1,69.7 to 83.1,244
Rotavirus,,States/Local Areas,Maine,2013-2014,Age,8 Months,75.4,70.6 to 79.7,519
Rotavirus,,States/Local Areas,Maine,2015,Age,8 Months,78.8,72.8 to 83.8,278
Rotavirus,,States/Local Areas,Maine,2015-2016,Age,8 Months,79.4,74.9 to 83.3,521
Rotavirus,,States/Local Areas,Maine,2016,Age,8 Months,80.0,72.8 to 85.6,243
Rotavirus,,States/Local Areas,Maine,2016-2017,Age,8 Months,77.4,72.5 to 81.7,502
Rotavirus,,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,85.8,80.8 to 90.8,245
Polio,≥3 Doses,HHS Regions/National,United States,2011,Age,35 Months,93.8,92.7 to 94.8,14513
DTaP,≥3 Doses,HHS Regions/National,United States,2012,Age,24 Months,94.2,93.4 to 94.8,15039
DTaP,≥3 Doses,HHS Regions/National,United States,2014,Age,19 Months,91.5,90.4 to 92.4,15333
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,92.2,91.5 to 92.8,30796
DTaP,≥3 Doses,HHS Regions/National,United States,2015,Age,19 Months,92.9,92.0 to 93.6,15463
DTaP,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,92.8,92.2 to 93.3,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2016,Age,19 Months,92.6,91.8 to 93.4,15956
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,92.3,91.6 to 92.8,33760
Hib,≥3 Doses,HHS Regions/National,United States,2017,Age,19 Months,88.8,87.7 to 89.7,17804
Hib,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,89.7,89.0 to 90.3,36630
Polio,≥3 Doses,HHS Regions/National,United States,2016,Age,24 Months,92.5,91.6 to 93.4,15956
Polio,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,92.0,91.4 to 92.6,33760
Hib,≥3 Doses,HHS Regions/National,United States,2016,Age,19 Months,89.1,88.0 to 90.2,15956
Hib,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,89.0,88.2 to 89.7,33760
Hib,≥3 Doses,HHS Regions/National,United States,2015,Age,19 Months,89.2,88.3 to 90.0,15463
Hib,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,89.2,88.4 to 89.9,31419
Hib,≥3 Doses,HHS Regions/National,United States,2018,Age,19 Months,90.6,89.7 to 91.4,18826
Hib,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,75.4,74.6 to 76.3,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2017,Age,19 Months,91.9,91.0 to 92.7,17804
DTaP,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,92.8,92.2 to 93.3,36630
Polio,≥3 Doses,HHS Regions/National,United States,2015,Age,24 Months,92.6,91.7 to 93.4,15463
Polio,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,92.5,91.9 to 93.1,31419
Polio,≥3 Doses,HHS Regions/National,United States,2014,Age,24 Months,91.0,89.9 to 92.1,15333
Polio,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,91.8,91.1 to 92.5,30796
Polio,≥3 Doses,HHS Regions/National,United States,2018,Age,19 Months,92.8,92.0 to 93.5,18826
Polio,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,67.9,66.9 to 68.9,36091
Polio,≥3 Doses,HHS Regions/National,United States,2019,Age,19 Months,92.0,91.2 to 92.8,17265
Polio,≥3 Doses,HHS Regions/National,United States,2011,Age,24 Months,92.0,90.9 to 93.0,14513
Polio,≥3 Doses,HHS Regions/National,United States,2012,Age,24 Months,93.0,92.3 to 93.7,15039
Hib,≥3 Doses,HHS Regions/National,United States,2014,Age,19 Months,88.5,87.4 to 89.6,15333
Hib,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,88.9,88.1 to 89.6,30796
Hib,≥3 Doses,HHS Regions/National,United States,2013,Age,19 Months,90.7,89.9 to 91.5,14872
Hib,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,89.6,88.9 to 90.2,30205
Polio,≥3 Doses,HHS Regions/National,United States,2013,Age,24 Months,92.3,91.5 to 93.1,14872
Polio,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,91.7,91.0 to 92.3,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2018,Age,19 Months,93.7,93.0 to 94.4,18826
DTaP,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,90.9,90.3 to 91.5,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2013,Age,24 Months,94.2,93.5 to 94.9,14872
DTaP,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,93.6,93.0 to 94.2,30205
Hib,Full Series,HHS Regions/National,United States,2015,Age,24 Months,79.6,78.3 to 81.0,15463
Hib,Full Series,HHS Regions/National,United States,2015-2016,Age,24 Months,79.8,78.8 to 80.8,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2019,Age,19 Months,93.2,92.4 to 93.9,17265
DTaP,≥3 Doses,HHS Regions/National,United States,2011,Age,24 Months,93.6,92.6 to 94.5,14513
Hib,≥3 Doses,HHS Regions/National,United States,2019,Age,19 Months,90.5,89.7 to 91.3,17265
Polio,≥3 Doses,HHS Regions/National,United States,2019,Age,24 Months,93.0,92.2 to 93.8,17265
Polio,≥3 Doses,HHS Regions/National,United States,2018,Age,24 Months,93.8,93.1 to 94.4,18826
Polio,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,93.4,92.9 to 93.9,36091
Polio,≥3 Doses,HHS Regions/National,United States,2017,Age,24 Months,91.5,90.6 to 92.4,17804
Polio,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,92.6,92.0 to 93.2,36630
Hib,Full Series,HHS Regions/National,United States,2018,Age,24 Months,80.2,79.0 to 81.3,18826
Hib,Full Series,HHS Regions/National,United States,2018-2019,Age,24 Months,80.0,79.2 to 80.9,36091
Hib,Full Series,HHS Regions/National,United States,2017,Age,24 Months,79.1,77.8 to 80.5,17804
Hib,Full Series,HHS Regions/National,United States,2017-2018,Age,24 Months,79.6,78.7 to 80.5,36630
Hib,Full Series,HHS Regions/National,United States,2016,Age,24 Months,80.0,78.6 to 81.5,15956
Hib,Full Series,HHS Regions/National,United States,2016-2017,Age,24 Months,79.6,78.6 to 80.6,33760
DTaP,≥2 Doses,HHS Regions/National,United States,2014,Age,5 Months,77.8,76.4 to 79.2,15333
DTaP,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,5 Months,78.1,77.1 to 79.2,30796
Polio,≥3 Doses,HHS Regions/National,United States,2015,Age,35 Months,94.3,93.5 to 95.1,15463
Polio,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,94.3,93.6 to 94.9,31419
Hib,≥3 Doses,HHS Regions/National,United States,2013,Age,24 Months,92.4,91.6 to 93.1,14872
Hib,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,91.4,90.8 to 92.1,30205
Hib,≥3 Doses,HHS Regions/National,United States,2012,Age,24 Months,92.3,91.5 to 93.0,15039
Hib,≥3 Doses,HHS Regions/National,United States,2011,Age,24 Months,92.1,91.1 to 93.1,14513
Polio,≥3 Doses,HHS Regions/National,United States,2017,Age,35 Months,92.9,92.0 to 93.8,17804
Polio,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,93.9,93.3 to 94.5,36630
Polio,≥3 Doses,HHS Regions/National,United States,2016,Age,35 Months,94.2,93.2 to 95.2,15956
Polio,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,93.6,92.9 to 94.2,33760
DTaP,≥2 Doses,HHS Regions/National,United States,2015,Age,5 Months,78.5,77.0 to 79.9,15463
DTaP,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,5 Months,78.8,77.8 to 79.9,31419
Hib,Full Series,HHS Regions/National,United States,2011,Age,35 Months,84.8,83.2 to 86.3,14513
Hib,Full Series,HHS Regions/National,United States,2012,Age,35 Months,84.7,83.2 to 86.0,15039
Hib,Full Series,HHS Regions/National,United States,2013,Age,35 Months,85.0,83.7 to 86.1,14872
Hib,Full Series,HHS Regions/National,United States,2013-2014,Age,35 Months,84.5,83.3 to 85.6,30205
DTaP,≥2 Doses,HHS Regions/National,United States,2013,Age,5 Months,77.2,75.7 to 78.6,14872
DTaP,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,5 Months,77.5,76.4 to 78.5,30205
DTaP,≥2 Doses,HHS Regions/National,United States,2012,Age,5 Months,78.0,76.8 to 79.0,15039
DTaP,≥2 Doses,HHS Regions/National,United States,2011,Age,5 Months,78.9,77.3 to 80.4,14513
Polio,≥3 Doses,HHS Regions/National,United States,2014,Age,35 Months,93.2,92.1 to 94.2,15333
Polio,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,93.8,93.1 to 94.4,30796
Polio,≥3 Doses,HHS Regions/National,United States,2013,Age,35 Months,94.4,93.6 to 95.2,14872
Polio,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,93.8,93.1 to 94.4,30205
Hib,Full Series,HHS Regions/National,United States,2019,Age,24 Months,79.9,78.7 to 81.1,17265
Polio,≥3 Doses,HHS Regions/National,United States,2012,Age,35 Months,94.3,93.6 to 95.0,15039
Hib,≥3 Doses,HHS Regions/National,United States,2014,Age,24 Months,90.5,89.4 to 91.5,15333
Hib,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,90.8,90.1 to 91.5,30796
Hib,Full Series,HHS Regions/National,United States,2014,Age,35 Months,84.0,82.1 to 85.7,15333
Hib,Full Series,HHS Regions/National,United States,2014-2015,Age,35 Months,83.8,82.6 to 85.0,30796
Hib,Full Series,HHS Regions/National,United States,2015,Age,35 Months,83.6,82.2 to 84.9,15463
Hib,Full Series,HHS Regions/National,United States,2015-2016,Age,35 Months,83.6,82.6 to 84.6,31419
Hib,Full Series,HHS Regions/National,United States,2017,Age,35 Months,83.0,81.5 to 84.4,17804
Hib,Full Series,HHS Regions/National,United States,2017-2018,Age,35 Months,83.5,82.5 to 84.4,36630
Hib,Full Series,HHS Regions/National,United States,2016,Age,35 Months,83.6,82.1 to 85.0,15956
Hib,Full Series,HHS Regions/National,United States,2016-2017,Age,35 Months,83.3,82.2 to 84.3,33760
Polio,≥3 Doses,HHS Regions/National,United States,2018,Age,35 Months,94.9,94.1 to 95.6,18826
Polio,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,94.6,94.1 to 95.2,36091
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,90.2,88.1 to 92.4,2246
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,79.9,76.8 to 83.1,1692
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,90.1,89.2 to 91.0,21000
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,94.5,93.9 to 95.1,31919
Hib,Full Series,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.3,73.2 to 77.4,4191
Hib,Full Series,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,75.7,74.5 to 77.0,21000
Hib,Full Series,HHS Regions/National,United States,2018,Age,35 Months,84.0,82.8 to 85.2,18826
Hib,Full Series,HHS Regions/National,United States,2018-2019,Age,35 Months,84.2,83.4 to 85.1,36091
Hib,Full Series,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,85.0,84.0 to 85.9,31919
Polio,≥3 Doses,HHS Regions/National,United States,2019,Age,35 Months,94.4,93.6 to 95.1,17265
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,91.8,91.1 to 92.6,24711
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,91.9 to 93.0,33203
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,90.3 to 93.2,7674
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,91.5,90.3 to 92.7,11789
Hib,Full Series,HHS Regions/National,United States,2019,Age,35 Months,84.5,83.2 to 85.7,17265
Hib,Full Series,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,77.6,74.5 to 80.8,2246
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.5,88.9 to 92.1,4191
Hib,Primary Series,HHS Regions/National,United States,2012,Age,7 Months,68.7,67.1 to 70.3,15039
Hib,Full Series,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,87.9,86.8 to 89.0,18707
Hib,Primary Series,HHS Regions/National,United States,2011,Age,7 Months,70.3,68.7 to 71.8,14513
Hib,Full Series,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.5,79.4 to 81.7,21757
Hib,Full Series,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,79.4,78.3 to 80.6,24711
Hib,Full Series,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.3,80.4 to 82.1,33203
Hib,Full Series,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,77.8 to 81.8,7674
Hib,Full Series,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,78.6,76.7 to 80.5,11789
Hib,Full Series,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,79.7,78.6 to 80.9,21077
Hib,Full Series,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,73.6,72.2 to 75.0,17073
Hib,Full Series,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,77.0,75.2 to 78.7,10389
Hib,Full Series,HHS Regions/National,United States,2014-2017,Overall,Overall,79.6,78.9 to 80.4,56857
Hib,Full Series,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,59.8,55.8 to 63.9,1692
≥1 Dose MMR,,HHS Regions/National,United States,2012,Age,13 Months,53.8,51.8 to 55.7,15039
≥1 Dose MMR,,HHS Regions/National,United States,2011,Age,13 Months,54.0,51.8 to 56.2,14513
Hep A,≥2 Doses,HHS Regions/National,United States,2012,Age,24 Months,39.9,38.3 to 41.6,15039
≥1 Dose Varicella,,HHS Regions/National,United States,2011,Age,13 Months,56.2,54.0 to 58.3,14513
Hep A,≥1 Dose,HHS Regions/National,United States,2017,Age,35 Months,90.2,89.1 to 91.3,17804
Hep A,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,35 Months,91.1,90.4 to 91.9,36630
Polio,≥2 Doses,HHS Regions/National,United States,2016,Age,5 Months,78.0,76.4 to 79.5,15956
Polio,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,5 Months,77.7,76.7 to 78.8,33760
Polio,≥2 Doses,HHS Regions/National,United States,2017,Age,5 Months,77.5,76.1 to 78.8,17804
Polio,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,5 Months,79.0,78.1 to 79.9,36630
Hep B,≥3 Doses,HHS Regions/National,United States,2014,Age,7 Months,58.9,57.3 to 60.4,15333
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,59.0,57.8 to 60.2,30796
Hep B,≥3 Doses,HHS Regions/National,United States,2015,Age,7 Months,59.1,57.4 to 60.9,15463
Hep B,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,59.5,58.3 to 60.8,31419
≥1 Dose Varicella,,HHS Regions/National,United States,2013,Age,13 Months,56.3,54.6 to 58.1,14872
≥1 Dose Varicella,,HHS Regions/National,United States,2013-2014,Age,13 Months,57.1,55.9 to 58.2,30205
Polio,≥2 Doses,HHS Regions/National,United States,2018,Age,5 Months,80.6,79.4 to 81.8,18826
Polio,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,5 Months,81.1,80.2 to 81.9,36091
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.1,81.2 to 85.0,4191
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,82.6,79.9 to 85.2,2246
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,67.8,64.0 to 71.5,1692
Hep A,≥1 Dose,HHS Regions/National,United States,2019,Age,35 Months,92.6,91.6 to 93.6,17265
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,83.7,82.7 to 84.7,21000
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,87.1,86.2 to 87.9,31919
Hep A,≥1 Dose,HHS Regions/National,United States,2018,Age,35 Months,92.1,91.1 to 93.1,18826
Hep A,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,35 Months,92.4,91.6 to 93.1,36091
≥1 Dose Varicella,,HHS Regions/National,United States,2012,Age,13 Months,56.7,55.2 to 58.2,15039
≥1 Dose Varicella,,HHS Regions/National,United States,2014,Age,13 Months,57.8,56.2 to 59.4,15333
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2015,Age,13 Months,57.6,56.4 to 58.7,30796
Hep B,≥3 Doses,HHS Regions/National,United States,2019,Age,7 Months,62.5,61.0 to 63.9,17265
Hep A,≥2 Doses,HHS Regions/National,United States,2014,Age,35 Months,73.6,71.8 to 75.4,15333
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,74.9,73.5 to 76.3,30796
Hep A,≥2 Doses,HHS Regions/National,United States,2016,Age,35 Months,76.2,74.3 to 78.0,15956
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,76.8,75.6 to 78.0,33760
Hep A,≥2 Doses,HHS Regions/National,United States,2015,Age,35 Months,76.4,74.3 to 78.5,15463
Hep A,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,76.3,74.9 to 77.7,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2018,Age,7 Months,63.6,62.2 to 64.9,18826
Hep B,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,63.0,62.0 to 64.0,36091
Hep B,≥3 Doses,HHS Regions/National,United States,2017,Age,7 Months,59.5,58.0 to 61.0,17804
Hep B,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,61.5,60.5 to 62.5,36630
Polio,≥2 Doses,HHS Regions/National,United States,2019,Age,5 Months,81.5,80.3 to 82.6,17265
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,86.5,85.2 to 87.9,11789
Polio,≥2 Doses,HHS Regions/National,United States,2012,Age,7 Months,89.6,88.7 to 90.5,15039
Polio,≥2 Doses,HHS Regions/National,United States,2011,Age,7 Months,88.9,87.8 to 89.9,14513
Hep A,≥2 Doses,HHS Regions/National,United States,2018,Age,24 Months,47.2,45.8 to 48.7,18826
Hep A,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,47.6,46.5 to 48.6,36091
Hep A,≥2 Doses,HHS Regions/National,United States,2019,Age,24 Months,47.9,46.4 to 49.5,17265
Polio,≥2 Doses,HHS Regions/National,United States,2015,Age,5 Months,76.8,75.2 to 78.3,15463
Polio,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,5 Months,77.4,76.3 to 78.4,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2016,Age,7 Months,60.0,58.2 to 61.7,15956
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,59.7,58.6 to 60.9,33760
Hep A,≥2 Doses,HHS Regions/National,United States,2011,Age,35 Months,71.1,69.1 to 73.0,14513
Hep A,≥2 Doses,HHS Regions/National,United States,2012,Age,35 Months,72.8,70.8 to 74.8,15039
Hep A,≥2 Doses,HHS Regions/National,United States,2013,Age,35 Months,74.5,72.7 to 76.2,14872
Hep A,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,74.0,72.8 to 75.3,30205
DTaP,≥4 Doses,HHS Regions/National,United States,2014,Age,24 Months,80.1,78.7 to 81.5,15333
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,80.4,79.4 to 81.3,30796
DTaP,≥4 Doses,HHS Regions/National,United States,2016,Age,24 Months,80.4,78.9 to 81.8,15956
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,80.6,79.7 to 81.6,33760
DTaP,≥4 Doses,HHS Regions/National,United States,2015,Age,24 Months,80.7,79.4 to 82.0,15463
DTaP,≥4 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,80.5,79.5 to 81.5,31419
Hep A,≥1 Dose,HHS Regions/National,United States,2016,Age,35 Months,89.9,88.7 to 91.1,15956
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,35 Months,90.1,89.3 to 90.8,33760
Hib,≥1 Dose,HHS Regions/National,United States,2013,Age,3 Months,85.5,84.4 to 86.5,14872
Hib,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,3 Months,85.3,84.5 to 86.0,30205
Hib,≥1 Dose,HHS Regions/National,United States,2012,Age,3 Months,86.1,85.1 to 87.1,15039
Hib,≥1 Dose,HHS Regions/National,United States,2011,Age,3 Months,87.1,85.8 to 88.2,14513
Hib,≥1 Dose,HHS Regions/National,United States,2014,Age,3 Months,85.0,83.8 to 86.2,15333
Hib,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,3 Months,85.7,84.8 to 86.5,30796
Hep B,≥2 Doses,HHS Regions/National,United States,2014,Age,13 Months,92.9,91.9 to 93.7,15333
Hep B,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,93.2,92.5 to 93.8,30796
Hep B,≥2 Doses,HHS Regions/National,United States,2015,Age,13 Months,93.5,92.6 to 94.4,15463
Hep B,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,93.9,93.3 to 94.5,31419
Hep B,≥2 Doses,HHS Regions/National,United States,2013,Age,13 Months,94.4,93.8 to 95.0,14872
Hep B,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,93.6,93.0 to 94.3,30205
Hib,Full Series,HHS Regions/National,United States,2020,Age,24 Months,77.6,76.3 to 78.8,17387
Hep B,≥2 Doses,HHS Regions/National,United States,2018,Age,7 Months,92.9,92.1 to 93.6,18826
Hep B,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,93.1,92.5 to 93.6,36091
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2019,Age,0-2 Days,80.5,79.3 to 81.6,17265
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2018,Age,0-2 Days,77.6,76.3 to 78.9,18826
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2018-2019,Age,0-2 Days,79.0,78.2 to 79.9,36091
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2017,Age,0-2 Days,75.6,74.2 to 76.8,17804
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2017-2018,Age,0-2 Days,76.6,75.7 to 77.5,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2017,Age,35 Months,92.9,91.9 to 93.8,17804
≥1 Dose Varicella,,HHS Regions/National,United States,2017-2018,Age,35 Months,93.4,92.7 to 94.0,36630
Hep B,≥3 Doses,HHS Regions/National,United States,2019,Age,24 Months,92.6,91.8 to 93.3,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2017,Age,24 Months,91.1,90.2 to 92.0,17804
Hep B,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,91.8,91.2 to 92.4,36630
Hep B,≥3 Doses,HHS Regions/National,United States,2011,Age,35 Months,91.2,90.1 to 92.3,14513
PCV,≥4 Doses,HHS Regions/National,United States,2012,Age,24 Months,82.4,81.1 to 83.6,15039
PCV,≥4 Doses,HHS Regions/National,United States,2014,Age,24 Months,81.3,80.0 to 82.6,15333
PCV,≥4 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,81.2,80.2 to 82.1,30796
PCV,≥4 Doses,HHS Regions/National,United States,2013,Age,24 Months,81.7,80.4 to 82.9,14872
PCV,≥4 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,81.5,80.6 to 82.4,30205
≥1 Dose MMR,,HHS Regions/National,United States,2019,Age,24 Months,91.7,90.9 to 92.5,17265
≥1 Dose MMR,,HHS Regions/National,United States,2011,Age,35 Months,93.2,91.9 to 94.3,14513
≥1 Dose MMR,,HHS Regions/National,United States,2012,Age,35 Months,94.1,93.3 to 94.8,15039
≥1 Dose Varicella,,HHS Regions/National,United States,2016,Age,35 Months,93.5,92.6 to 94.3,15956
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2017,Age,35 Months,93.2,92.5 to 93.8,33760
≥1 Dose MMR,,HHS Regions/National,United States,2013,Age,35 Months,93.1,92.2 to 93.9,14872
≥1 Dose MMR,,HHS Regions/National,United States,2013-2014,Age,35 Months,93.1,92.4 to 93.8,30205
Hep B,≥3 Doses,HHS Regions/National,United States,2018,Age,24 Months,92.5,91.7 to 93.3,18826
Hep B,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,92.6,92.0 to 93.1,36091
Hep B,≥2 Doses,HHS Regions/National,United States,2015,Age,7 Months,90.3,89.2 to 91.4,15463
Hep B,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,90.9,90.1 to 91.6,31419
PCV,≥3 Doses,HHS Regions/National,United States,2014,Age,13 Months,86.1,84.8 to 87.3,15333
PCV,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,86.7,85.8 to 87.5,30796
PCV,≥3 Doses,HHS Regions/National,United States,2015,Age,13 Months,87.3,86.1 to 88.4,15463
PCV,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,87.4,86.5 to 88.3,31419
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2016,Age,0-2 Days,74.1,72.5 to 75.6,15956
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2016-2017,Age,0-2 Days,74.8,73.8 to 75.8,33760
Hep B,≥2 Doses,HHS Regions/National,United States,2016,Age,7 Months,91.5,90.4 to 92.5,15956
Hep B,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,91.2,90.5 to 91.9,33760
PCV,≥3 Doses,HHS Regions/National,United States,2013,Age,13 Months,88.2,87.2 to 89.2,14872
PCV,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,87.2,86.1 to 88.2,30205
Hep B,≥2 Doses,HHS Regions/National,United States,2017,Age,7 Months,90.9,89.9 to 91.8,17804
Hep B,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,91.9,91.2 to 92.5,36630
≥1 Dose MMR,,HHS Regions/National,United States,2018,Age,24 Months,92.3,91.5 to 93.0,18826
≥1 Dose MMR,,HHS Regions/National,United States,2018-2019,Age,24 Months,92.0,91.4 to 92.6,36091
PCV,≥4 Doses,HHS Regions/National,United States,2019,Age,19 Months,80.1,78.9 to 81.3,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2013,Age,35 Months,92.9,91.9 to 93.7,14872
≥1 Dose Varicella,,HHS Regions/National,United States,2013-2014,Age,35 Months,93.0,92.1 to 93.9,30205
PCV,≥4 Doses,HHS Regions/National,United States,2011,Age,24 Months,80.8,79.4 to 82.2,14513
≥1 Dose Varicella,,HHS Regions/National,United States,2012,Age,35 Months,94.0,93.2 to 94.7,15039
≥1 Dose Varicella,,HHS Regions/National,United States,2015,Age,35 Months,93.0,92.2 to 93.8,15463
≥1 Dose Varicella,,HHS Regions/National,United States,2015-2016,Age,35 Months,93.3,92.7 to 93.9,31419
≥1 Dose Varicella,,HHS Regions/National,United States,2014,Age,35 Months,93.1,91.6 to 94.4,15333
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2015,Age,35 Months,93.1,92.2 to 94.0,30796
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2014,Age,0-2 Days,69.4,67.8 to 71.0,15333
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2014-2015,Age,0-2 Days,70.6,69.4 to 71.7,30796
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2015,Age,0-2 Days,71.7,70.0 to 73.4,15463
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2015-2016,Age,0-2 Days,72.9,71.8 to 74.1,31419
PCV,≥4 Doses,HHS Regions/National,United States,2018,Age,19 Months,79.7,78.5 to 80.8,18826
PCV,≥4 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,79.9,78.9 to 80.8,29598
PCV,≥4 Doses,HHS Regions/National,United States,2017,Age,19 Months,77.4,76.0 to 78.8,17804
PCV,≥4 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,78.6,77.7 to 79.4,36630
≥1 Dose MMR,,HHS Regions/National,United States,2017,Age,24 Months,90.4,89.3 to 91.3,17804
≥1 Dose MMR,,HHS Regions/National,United States,2017-2018,Age,24 Months,91.3,90.7 to 91.9,36630
≥1 Dose MMR,,HHS Regions/National,United States,2016,Age,24 Months,90.8,89.8 to 91.7,15956
≥1 Dose MMR,,HHS Regions/National,United States,2016-2017,Age,24 Months,90.6,89.9 to 91.3,33760
PCV,≥3 Doses,HHS Regions/National,United States,2012,Age,13 Months,88.0,87.0 to 88.9,15039
Hep B,≥3 Doses,HHS Regions/National,United States,2016,Age,24 Months,91.4,90.4 to 92.3,15956
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,91.2,90.6 to 91.9,33760
Hep B,≥3 Doses,HHS Regions/National,United States,2015,Age,24 Months,90.6,89.5 to 91.6,15463
Hep B,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,91.0,90.2 to 91.7,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2014,Age,24 Months,90.2,89.1 to 91.2,15333
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,90.4,89.6 to 91.1,30796
PCV,≥3 Doses,HHS Regions/National,United States,2019,Age,7 Months,70.0,68.6 to 71.3,17265
PCV,≥3 Doses,HHS Regions/National,United States,2011,Age,13 Months,86.9,85.6 to 88.0,14513
PCV,≥3 Doses,HHS Regions/National,United States,2018,Age,7 Months,70.3,69.0 to 71.6,18826
PCV,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,70.1,69.2 to 71.1,36091
Hep B,≥2 Doses,HHS Regions/National,United States,2014,Age,7 Months,89.8,88.7 to 90.9,15333
Hep B,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,90.1,89.3 to 90.8,30796
Hep B,≥2 Doses,HHS Regions/National,United States,2012,Age,7 Months,91.2,90.4 to 92.0,15039
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2019,Age,0-1 Days,77.0,75.7 to 78.2,17265
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2011,Age,0-2 Days,71.5,69.4 to 73.5,14513
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2018,Age,0-1 Days,73.6,72.3 to 74.9,18826
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2018-2019,Age,0-1 Days,75.3,74.4 to 76.2,36091
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2013,Age,0-2 Days,70.9,69.1 to 72.7,14872
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2013-2014,Age,0-2 Days,70.2,68.3 to 71.9,30205
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,United States,2012,Age,0-2 Days,71.2,68.9 to 73.4,15039
Hep B,≥2 Doses,HHS Regions/National,United States,2013,Age,7 Months,91.1,90.3 to 91.9,14872
Hep B,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,90.5,89.6 to 91.3,30205
Hep B,≥3 Doses,HHS Regions/National,United States,2019,Age,19 Months,91.6,90.8 to 92.3,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2011,Age,24 Months,89.8,88.7 to 90.8,14513
Hep B,≥3 Doses,HHS Regions/National,United States,2013,Age,24 Months,91.6,90.7 to 92.4,14872
Hep B,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,90.9,90.2 to 91.6,30205
PCV,≥3 Doses,HHS Regions/National,United States,2016,Age,7 Months,67.9,66.2 to 69.5,15956
PCV,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,67.3,66.1 to 68.4,33760
Hep B,≥3 Doses,HHS Regions/National,United States,2012,Age,24 Months,91.4,90.6 to 92.2,15039
Hep A,≥1 Dose,HHS Regions/National,United States,2020,Age,35 Months,91.2,90.0 to 92.3,17387
PCV,≥3 Doses,HHS Regions/National,United States,2017,Age,7 Months,66.7,65.2 to 68.2,17804
PCV,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,68.5,67.5 to 69.5,36630
PCV,≥3 Doses,HHS Regions/National,United States,2015,Age,7 Months,63.7,61.9 to 65.4,15463
PCV,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,65.7,64.5 to 67.0,31419
PCV,≥4 Doses,HHS Regions/National,United States,2014,Age,19 Months,77.0,75.5 to 78.4,15333
PCV,≥4 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,76.6,75.6 to 77.6,30796
PCV,≥4 Doses,HHS Regions/National,United States,2015,Age,19 Months,76.3,74.9 to 77.7,15463
PCV,≥4 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,76.8,75.7 to 77.8,31419
PCV,≥4 Doses,HHS Regions/National,United States,2016,Age,19 Months,77.2,75.7 to 78.7,15956
PCV,≥4 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,77.3,76.3 to 78.3,33760
≥1 Dose Varicella,,HHS Regions/National,United States,2018,Age,24 Months,91.2,90.3 to 92.0,18826
≥1 Dose Varicella,,HHS Regions/National,United States,2018-2019,Age,24 Months,91.2,90.5 to 91.8,36091
≥1 Dose MMR,,HHS Regions/National,United States,2015,Age,24 Months,90.8,89.9 to 91.6,15463
≥1 Dose MMR,,HHS Regions/National,United States,2015-2016,Age,24 Months,90.8,90.1 to 91.4,31419
≥1 Dose MMR,,HHS Regions/National,United States,2014,Age,24 Months,89.8,88.7 to 90.8,15333
≥1 Dose MMR,,HHS Regions/National,United States,2014-2015,Age,24 Months,90.3,89.6 to 90.9,30796
≥1 Dose MMR,,HHS Regions/National,United States,2013,Age,24 Months,90.3,89.2 to 91.2,14872
≥1 Dose MMR,,HHS Regions/National,United States,2013-2014,Age,24 Months,90.0,89.3 to 90.7,30205
≥1 Dose Varicella,,HHS Regions/National,United States,2019,Age,24 Months,91.1,90.2 to 92.0,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2017,Age,24 Months,89.9,88.9 to 90.9,17804
≥1 Dose Varicella,,HHS Regions/National,United States,2017-2018,Age,24 Months,90.5,89.9 to 91.2,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2011,Age,35 Months,92.7,91.5 to 93.8,14513
Hep B,≥2 Doses,HHS Regions/National,United States,2018,Age,5 Months,89.8,88.8 to 90.7,18826
Hep B,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,5 Months,90.1,89.5 to 90.7,36091
Hep B,≥2 Doses,HHS Regions/National,United States,2019,Age,5 Months,90.4,89.5 to 91.2,17265
Hep B,≥2 Doses,HHS Regions/National,United States,2011,Age,7 Months,89.6,88.6 to 90.5,14513
Hep B,≥2 Doses,HHS Regions/National,United States,2017,Age,5 Months,87.4,86.3 to 88.4,17804
Hep B,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,5 Months,88.6,87.9 to 89.3,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2014,Age,24 Months,89.1,88.0 to 90.1,15333
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2015,Age,24 Months,89.7,88.9 to 90.3,30796
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2016,Age,0-1 Days,68.1,66.5 to 69.7,15956
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2016-2017,Age,0-1 Days,69.1,68.1 to 70.2,33760
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2017,Age,0-1 Days,70.2,68.8 to 71.5,17804
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2017-2018,Age,0-1 Days,71.9,70.9 to 72.8,36630
≥1 Dose MMR,,HHS Regions/National,United States,2019,Age,19 Months,89.2,88.2 to 90.1,17265
≥1 Dose MMR,,HHS Regions/National,United States,2018,Age,19 Months,90.0,89.1 to 90.8,18826
≥1 Dose MMR,,HHS Regions/National,United States,2018-2019,Age,19 Months,94.7,94.2 to 95.1,36091
PCV,≥4 Doses,HHS Regions/National,United States,2013,Age,19 Months,77.6,76.3 to 78.9,14872
PCV,≥4 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,77.3,76.2 to 78.4,30205
PCV,≥4 Doses,HHS Regions/National,United States,2012,Age,19 Months,77.5,76.1 to 78.9,15039
PCV,≥4 Doses,HHS Regions/National,United States,2011,Age,19 Months,75.9,74.5 to 77.2,14513
≥1 Dose MMR,,HHS Regions/National,United States,2011,Age,24 Months,90.1,89.0 to 91.2,14513
≥1 Dose MMR,,HHS Regions/National,United States,2012,Age,24 Months,90.6,89.7 to 91.4,15039
≥1 Dose Varicella,,HHS Regions/National,United States,2015,Age,24 Months,90.2,89.3 to 91.1,15463
≥1 Dose Varicella,,HHS Regions/National,United States,2015-2016,Age,24 Months,90.3,89.6 to 90.9,31419
≥1 Dose Varicella,,HHS Regions/National,United States,2016,Age,24 Months,90.3,89.3 to 91.3,15956
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2017,Age,24 Months,90.1,89.4 to 90.8,33760
≥1 Dose Varicella,,HHS Regions/National,United States,2019,Age,19 Months,88.5,87.5 to 89.4,17265
Polio,≥2 Doses,HHS Regions/National,United States,2019,Age,13 Months,94.5,93.9 to 95.1,17265
Polio,≥2 Doses,HHS Regions/National,United States,2018,Age,13 Months,95.1,94.4 to 95.7,18826
Polio,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,94.8,94.4 to 95.2,36091
Polio,≥2 Doses,HHS Regions/National,United States,2017,Age,13 Months,93.1,92.2 to 93.8,17804
Polio,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,94.1,93.6 to 94.6,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2013,Age,24 Months,89.6,88.5 to 90.6,14872
≥1 Dose Varicella,,HHS Regions/National,United States,2013-2014,Age,24 Months,89.3,88.6 to 90.1,30205
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2013,Age,0-1 Days,64.2,62.1 to 66.3,14872
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2013-2014,Age,0-1 Days,64.0,62.0 to 66.0,30205
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2014,Age,0-1 Days,63.8,62.1 to 65.4,15333
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2014-2015,Age,0-1 Days,64.3,63.1 to 65.4,30796
Hep B,≥2 Doses,HHS Regions/National,United States,2015,Age,5 Months,86.2,84.8 to 87.4,15463
Hep B,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,5 Months,86.9,85.9 to 87.8,31419
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2015,Age,0-1 Days,64.8,63.0 to 66.5,15463
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2015-2016,Age,0-1 Days,66.4,65.2 to 67.6,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2018,Age,19 Months,91.8,91.0 to 92.6,18826
Hep B,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,89.0,88.3 to 89.6,36091
Hep B,≥3 Doses,HHS Regions/National,United States,2017,Age,19 Months,90.2,89.3 to 91.1,17804
Hep B,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,91.0,90.4 to 91.6,36630
Hep B,≥2 Doses,HHS Regions/National,United States,2016,Age,5 Months,87.6,86.2 to 88.9,15956
Hep B,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,5 Months,87.5,86.6 to 88.3,33760
Hep B,≥2 Doses,HHS Regions/National,United States,2014,Age,5 Months,85.3,84.0 to 86.5,15333
Hep B,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,5 Months,85.7,84.7 to 86.7,30796
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2012,Age,0-1 Days,64.6,62.1 to 66.9,15039
PCV,≥3 Doses,HHS Regions/National,United States,2013,Age,7 Months,64.7,63.3 to 66.1,14872
PCV,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,64.1,62.9 to 65.3,30205
PCV,≥3 Doses,HHS Regions/National,United States,2011,Age,7 Months,64.9,63.2 to 66.4,14513
Hep B,≥3 Doses,HHS Regions/National,United States,2016,Age,19 Months,90.6,89.5 to 91.5,15956
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,90.4,89.7 to 91.1,33760
PCV,≥3 Doses,HHS Regions/National,United States,2014,Age,7 Months,63.5,61.9 to 65.1,15333
PCV,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,63.6,62.4 to 64.8,30796
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,88.6,87.5 to 89.8,18707
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,80.4,79.2 to 81.6,21077
PCV,≥3 Doses,HHS Regions/National,United States,2012,Age,7 Months,64.5,62.8 to 66.1,15039
≥1 Dose MMR,,HHS Regions/National,United States,2019,Age,13 Months,67.3,65.9 to 68.6,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2016,Age,19 Months,86.6,85.4 to 87.8,15956
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2017,Age,19 Months,86.7,85.9 to 87.5,33760
Polio,≥2 Doses,HHS Regions/National,United States,2015,Age,13 Months,93.4,92.4 to 94.2,15463
Polio,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,93.3,92.6 to 93.9,31419
Polio,≥2 Doses,HHS Regions/National,United States,2016,Age,13 Months,93.2,92.2 to 94.1,15956
Polio,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,93.1,92.5 to 93.7,33760
Hep B,≥1 Dose,HHS Regions/National,United States,2017,Age,3 Months,95.1,94.4 to 95.8,17804
Hep B,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,3 Months,95.5,95.1 to 95.9,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2018,Age,19 Months,88.8,87.9 to 89.7,18826
≥1 Dose Varicella,,HHS Regions/National,United States,2018-2019,Age,19 Months,61.9,60.9 to 62.9,36091
≥1 Dose Varicella,,HHS Regions/National,United States,2017,Age,19 Months,86.8,85.7 to 87.9,17804
≥1 Dose Varicella,,HHS Regions/National,United States,2017-2018,Age,19 Months,87.8,87.1 to 88.5,36630
≥1 Dose MMR,,HHS Regions/National,United States,2013,Age,19 Months,87.1,86.2 to 88.0,14872
≥1 Dose MMR,,HHS Regions/National,United States,2013-2014,Age,19 Months,87.2,86.5 to 87.8,30205
≥1 Dose MMR,,HHS Regions/National,United States,2014,Age,19 Months,87.2,86.1 to 88.2,15333
≥1 Dose MMR,,HHS Regions/National,United States,2014-2015,Age,19 Months,87.3,86.5 to 88.0,30796
≥1 Dose MMR,,HHS Regions/National,United States,2012,Age,19 Months,86.8,85.8 to 87.7,15039
DTaP,≥4 Doses,HHS Regions/National,United States,2018,Age,35 Months,89.3,88.1 to 90.3,18826
DTaP,≥4 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,88.7,87.8 to 89.5,36091
DTaP,≥4 Doses,HHS Regions/National,United States,2019,Age,35 Months,88.1,86.8 to 89.3,17265
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,76.6,75.3 to 77.8,21000
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,85.7,84.8 to 86.6,31919
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.2,73.1 to 77.3,4191
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,77.6,74.3 to 80.8,2246
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,61.8,57.8 to 65.8,1692
≥1 Dose MMR,,HHS Regions/National,United States,2011,Age,19 Months,86.8,85.6 to 88.0,14513
Hep B,≥3 Doses,HHS Regions/National,United States,2019,Age,13 Months,89.2,88.3 to 90.1,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2011,Age,19 Months,88.3,87.3 to 89.3,14513
Hep B,≥3 Doses,HHS Regions/National,United States,2018,Age,13 Months,88.7,87.7 to 89.6,18826
Hep B,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,13 Months,89.0,88.3 to 89.6,36091
Hep A,≥2 Doses,HHS Regions/National,United States,2020,Age,35 Months,78.1,76.4 to 79.8,17387
Hep B,≥3 Doses,HHS Regions/National,United States,2012,Age,19 Months,90.4,89.4 to 91.3,15039
Hep B,≥1 Dose,HHS Regions/National,United States,2019,Age,3 Months,96.4,95.8 to 96.9,17265
Polio,≥2 Doses,HHS Regions/National,United States,2014,Age,13 Months,92.8,91.9 to 93.6,15333
Polio,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,93.1,92.4 to 93.7,30796
Hep B,≥1 Dose,HHS Regions/National,United States,2018,Age,3 Months,95.9,95.3 to 96.5,18826
Hep B,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,3 Months,96.1,95.7 to 96.5,36091
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,75.0,73.1 to 76.8,21077
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,United States,2011,Age,0-1 Days,64.4,62.2 to 66.6,14513
Hep B,≥2 Doses,HHS Regions/National,United States,2012,Age,5 Months,86.4,85.3 to 87.4,15039
Hep B,≥2 Doses,HHS Regions/National,United States,2011,Age,5 Months,84.9,83.8 to 86.0,14513
Hep B,≥2 Doses,HHS Regions/National,United States,2013,Age,5 Months,86.3,85.2 to 87.4,14872
Hep B,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,5 Months,85.8,84.8 to 86.8,30205
Hep B,≥3 Doses,HHS Regions/National,United States,2013,Age,19 Months,90.8,90.0 to 91.5,14872
Hep B,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,89.8,88.8 to 90.8,30205
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,82.3,80.5 to 84.1,18707
Hep B,≥3 Doses,HHS Regions/National,United States,2014,Age,19 Months,88.9,87.7 to 90.0,15333
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,89.3,88.4 to 90.0,30796
Hep B,≥3 Doses,HHS Regions/National,United States,2015,Age,19 Months,89.6,88.8 to 90.4,15463
Hep B,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,90.1,89.3 to 90.8,31419
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,79.6,77.8 to 81.5,11789
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.2,81.4 to 83.1,33203
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,78.4 to 82.5,7674
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,76.7,75.1 to 78.3,10389
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,80.4,79.7 to 81.1,56857
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.4,80.2 to 82.5,21757
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,80.4,79.3 to 81.6,24711
≥1 Dose MMR,,HHS Regions/National,United States,2015,Age,19 Months,87.4,86.3 to 88.3,15463
≥1 Dose MMR,,HHS Regions/National,United States,2015-2016,Age,19 Months,87.3,86.5 to 88.1,31419
≥1 Dose MMR,,HHS Regions/National,United States,2016,Age,19 Months,87.3,86.1 to 88.4,15956
≥1 Dose MMR,,HHS Regions/National,United States,2016-2017,Age,19 Months,87.4,86.6 to 88.2,33760
≥1 Dose MMR,,HHS Regions/National,United States,2017,Age,19 Months,87.5,86.4 to 88.6,17804
≥1 Dose MMR,,HHS Regions/National,United States,2017-2018,Age,19 Months,88.7,88.0 to 89.4,36630
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,74.6,73.3 to 76.0,17073
≥1 Dose Varicella,,HHS Regions/National,United States,2011,Age,24 Months,89.2,88.1 to 90.3,14513
≥1 Dose Varicella,,HHS Regions/National,United States,2012,Age,24 Months,90.2,89.3 to 91.0,15039
DTaP,≥4 Doses,HHS Regions/National,United States,2017,Age,35 Months,87.5,86.2 to 88.8,17804
DTaP,≥4 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,88.4,87.5 to 89.2,36630
DTaP,≥4 Doses,HHS Regions/National,United States,2016,Age,35 Months,87.8,86.4 to 89.2,15956
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,87.7,86.7 to 88.6,33760
Hep B,≥3 Doses,HHS Regions/National,United States,2016,Age,13 Months,87.6,86.4 to 88.7,15956
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,13 Months,87.5,86.7 to 88.2,33760
Hep B,≥3 Doses,HHS Regions/National,United States,2015,Age,13 Months,86.4,85.1 to 87.6,15463
Hep B,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,13 Months,87.0,86.1 to 87.8,31419
DTaP,≥4 Doses,HHS Regions/National,United States,2015,Age,35 Months,88.1,86.8 to 89.4,15463
DTaP,≥4 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,88.0,87.0 to 88.9,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2017,Age,13 Months,87.3,86.3 to 88.3,17804
Hep B,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,13 Months,88.0,87.3 to 88.7,36630
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,88.6,87.5 to 89.7,18707
Polio,≥2 Doses,HHS Regions/National,United States,2018,Age,7 Months,90.8,89.9 to 91.6,18826
Polio,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,7 Months,90.8,90.2 to 91.4,36091
Hep B,≥1 Dose,HHS Regions/National,United States,2013,Age,3 Months,94.5,94.0 to 95.0,14872
Hep B,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,3 Months,93.9,93.3 to 94.6,30205
Hep B,≥1 Dose,HHS Regions/National,United States,2012,Age,3 Months,93.8,92.8 to 94.7,15039
Hep B,≥1 Dose,HHS Regions/National,United States,2011,Age,3 Months,93.6,92.8 to 94.4,14513
Polio,≥2 Doses,HHS Regions/National,United States,2016,Age,7 Months,88.9,87.6 to 90.1,15956
Polio,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,7 Months,88.6,87.8 to 89.4,33760
Polio,≥2 Doses,HHS Regions/National,United States,2017,Age,7 Months,88.4,87.3 to 89.4,17804
Polio,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,7 Months,89.6,88.9 to 90.3,36630
Polio,≥2 Doses,HHS Regions/National,United States,2019,Age,7 Months,90.8,89.9 to 91.6,17265
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,76.1,75.1 to 77.2,56857
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,72.9,71.0 to 74.8,17073
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.8,75.2 to 78.5,21757
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,90.0,88.8 to 91.2,11789
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,49.7,44.1 to 55.3,1692
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,75.4,70.8 to 80.1,2246
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,74.4,72.7 to 76.2,21000
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,79.7,78.3 to 81.1,31919
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.4,69.0 to 75.7,4191
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,71.9,69.6 to 74.2,10389
Polio,≥2 Doses,HHS Regions/National,United States,2013,Age,13 Months,94.0,93.4 to 94.6,14872
Polio,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,93.4,92.9 to 93.9,30205
Hep B,≥1 Dose,HHS Regions/National,United States,2014,Age,3 Months,93.4,92.5 to 94.3,15333
Hep B,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,3 Months,93.6,92.9 to 94.2,30796
Hep B,≥1 Dose,HHS Regions/National,United States,2015,Age,3 Months,93.7,92.7 to 94.6,15463
Hep B,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,3 Months,94.3,93.6 to 94.9,31419
Hep B,≥1 Dose,HHS Regions/National,United States,2016,Age,3 Months,94.8,93.8 to 95.6,15956
Hep B,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,3 Months,95.0,94.4 to 95.5,33760
≥1 Dose MMR,,HHS Regions/National,United States,2018,Age,13 Months,68.5,67.1 to 69.9,18826
≥1 Dose MMR,,HHS Regions/National,United States,2018-2019,Age,13 Months,67.9,66.9 to 68.9,36091
≥1 Dose MMR,,HHS Regions/National,United States,2016,Age,13 Months,61.8,60.2 to 63.4,15956
≥1 Dose MMR,,HHS Regions/National,United States,2016-2017,Age,13 Months,62.0,60.9 to 63.1,33760
≥1 Dose MMR,,HHS Regions/National,United States,2017,Age,13 Months,62.1,60.6 to 63.6,17804
≥1 Dose MMR,,HHS Regions/National,United States,2017-2018,Age,13 Months,65.3,64.3 to 66.3,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2014,Age,19 Months,86.8,85.7 to 87.9,15333
≥1 Dose Varicella,,HHS Regions/National,United States,2014-2015,Age,19 Months,86.8,86.0 to 87.6,30796
≥1 Dose Varicella,,HHS Regions/National,United States,2015,Age,19 Months,86.8,85.8 to 87.8,15463
≥1 Dose Varicella,,HHS Regions/National,United States,2015-2016,Age,19 Months,86.7,85.9 to 87.5,31419
≥1 Dose Varicella,,HHS Regions/National,United States,2013,Age,19 Months,86.8,85.8 to 87.7,14872
≥1 Dose Varicella,,HHS Regions/National,United States,2013-2014,Age,19 Months,86.8,86.1 to 87.5,30205
Polio,≥2 Doses,HHS Regions/National,United States,2012,Age,13 Months,94.2,93.5 to 94.8,15039
Polio,≥2 Doses,HHS Regions/National,United States,2011,Age,13 Months,93.5,92.4 to 94.4,14513
DTaP,≥4 Doses,HHS Regions/National,United States,2019,Age,24 Months,81.2,80.0 to 82.4,17265
DTaP,≥4 Doses,HHS Regions/National,United States,2011,Age,35 Months,87.6,86.1 to 89.1,14513
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.0,73.0 to 79.0,7674
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,78.6,76.2 to 81.1,11789
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,76.6,74.9 to 78.2,24711
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.7,74.4 to 77.0,33203
DTaP,≥4 Doses,HHS Regions/National,United States,2018,Age,24 Months,82.3,81.2 to 83.4,18826
DTaP,≥4 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,81.8,81.0 to 82.6,36091
DTaP,≥4 Doses,HHS Regions/National,United States,2017,Age,24 Months,80.9,79.7 to 82.1,17804
DTaP,≥4 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,81.6,80.8 to 82.4,36630
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,84.0 to 87.7,7674
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.7,83.7 to 85.7,21757
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,80.9,79.3 to 82.6,10389
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,85.7,84.8 to 86.7,24711
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.8,83.0 to 84.7,33203
Polio,≥2 Doses,HHS Regions/National,United States,2014,Age,7 Months,88.2,87.0 to 89.2,15333
Polio,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,7 Months,88.6,87.8 to 89.4,30796
Polio,≥2 Doses,HHS Regions/National,United States,2013,Age,7 Months,88.6,87.7 to 89.5,14872
Polio,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,88.4,87.6 to 89.1,30205
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,82.8,81.7 to 83.9,17073
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Overall,Overall,84.7,84.1 to 85.4,56857
Polio,≥2 Doses,HHS Regions/National,United States,2015,Age,7 Months,89.1,88.0 to 90.1,15463
Polio,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,7 Months,89.0,88.2 to 89.8,31419
Hep B,≥3 Doses,HHS Regions/National,United States,2011,Age,13 Months,84.0,82.8 to 85.1,14513
Hep A,≥2 Doses,HHS Regions/National,United States,2018,Age,35 Months,78.9,77.2 to 80.6,18826
Hep A,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,79.8,78.6 to 81.0,36091
Hep A,≥2 Doses,HHS Regions/National,United States,2017,Age,35 Months,77.4,75.8 to 79.1,17804
Hep A,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,78.1,76.9 to 79.3,36630
Hep B,≥3 Doses,HHS Regions/National,United States,2013,Age,13 Months,87.8,86.9 to 88.7,14872
Hep B,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,13 Months,86.7,85.7 to 87.7,30205
Hep B,≥3 Doses,HHS Regions/National,United States,2014,Age,13 Months,85.7,84.4 to 86.9,15333
Hep B,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,13 Months,86.1,85.2 to 86.9,30796
Hep A,≥2 Doses,HHS Regions/National,United States,2019,Age,35 Months,80.7,79.0 to 82.4,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2012,Age,13 Months,87.4,86.2 to 88.4,15039
DTaP,≥4 Doses,HHS Regions/National,United States,2013,Age,35 Months,88.2,87.0 to 89.3,14872
DTaP,≥4 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,87.9,86.8 to 88.9,30205
DTaP,≥4 Doses,HHS Regions/National,United States,2012,Age,35 Months,88.6,87.3 to 89.8,15039
DTaP,≥4 Doses,HHS Regions/National,United States,2014,Age,35 Months,87.5,85.8 to 89.1,15333
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,87.8,86.7 to 88.9,30796
≥1 Dose Varicella,,HHS Regions/National,United States,2018,Age,13 Months,62.0,60.6 to 63.4,18826
≥1 Dose Varicella,,HHS Regions/National,United States,2018-2019,Age,13 Months,61.9,60.9 to 62.9,36091
≥1 Dose MMR,,HHS Regions/National,United States,2013,Age,13 Months,54.0,52.3 to 55.7,14872
≥1 Dose MMR,,HHS Regions/National,United States,2013-2014,Age,13 Months,57.3,56.2 to 58.5,30205
≥1 Dose Varicella,,HHS Regions/National,United States,2019,Age,13 Months,61.7,60.3 to 63.1,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2011,Age,19 Months,86.5,85.1 to 87.7,14513
≥1 Dose Varicella,,HHS Regions/National,United States,2012,Age,19 Months,86.3,85.1 to 87.4,15039
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,83.8,82.7 to 85.0,21077
≥1 Dose MMR,,HHS Regions/National,United States,2014,Age,13 Months,60.7,59.1 to 62.2,15333
≥1 Dose MMR,,HHS Regions/National,United States,2014-2015,Age,13 Months,60.4,59.2 to 61.5,30796
≥1 Dose MMR,,HHS Regions/National,United States,2015,Age,13 Months,60.0,58.3 to 61.7,15463
≥1 Dose MMR,,HHS Regions/National,United States,2015-2016,Age,13 Months,60.9,59.7 to 62.1,31419
Hep A,≥2 Doses,HHS Regions/National,United States,2017,Age,24 Months,45.6,44.1 to 47.2,17804
Hep A,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,46.4,45.4 to 47.5,36630
Hep A,≥2 Doses,HHS Regions/National,United States,2016,Age,24 Months,44.8,43.0 to 46.6,15956
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,45.2,44.0 to 46.4,33760
DTaP,≥4 Doses,HHS Regions/National,United States,2013,Age,24 Months,81.2,79.9 to 82.5,14872
DTaP,≥4 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,80.6,79.7 to 81.6,30205
DTaP,≥4 Doses,HHS Regions/National,United States,2019,Age,19 Months,72.4,71.1 to 73.7,17265
Hep B,≥3 Doses,HHS Regions/National,United States,2013,Age,7 Months,61.2,59.1 to 63.1,14872
Hep B,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,7 Months,60.0,58.4 to 61.7,30205
DTaP,≥4 Doses,HHS Regions/National,United States,2011,Age,24 Months,80.7,79.3 to 82.0,14513
DTaP,≥4 Doses,HHS Regions/National,United States,2012,Age,24 Months,81.4,80.1 to 82.7,15039
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,90.8,89.9 to 91.7,17073
Polio,≥2 Doses,HHS Regions/National,United States,2012,Age,5 Months,76.4,75.3 to 77.5,15039
Polio,≥2 Doses,HHS Regions/National,United States,2011,Age,5 Months,77.5,75.9 to 79.1,14513
Hep A,≥1 Dose,HHS Regions/National,United States,2012,Age,35 Months,88.4,87.1 to 89.7,15039
Polio,≥2 Doses,HHS Regions/National,United States,2013,Age,5 Months,75.3,73.8 to 76.8,14872
Polio,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,5 Months,75.9,74.9 to 77.0,30205
Polio,≥2 Doses,HHS Regions/National,United States,2014,Age,5 Months,76.5,75.1 to 77.9,15333
Polio,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,5 Months,76.6,75.4 to 77.8,30796
DTaP,≥4 Doses,HHS Regions/National,United States,2018,Age,19 Months,72.2,70.9 to 73.5,18826
DTaP,≥4 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,94.8,94.4 to 95.2,36091
Hep A,≥2 Doses,HHS Regions/National,United States,2013,Age,24 Months,42.4,40.8 to 44.0,14872
Hep A,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,24 Months,42.9,41.8 to 44.1,30205
DTaP,≥4 Doses,HHS Regions/National,United States,2016,Age,19 Months,70.0,68.3 to 71.6,15956
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,70.8,69.6 to 71.8,33760
DTaP,≥4 Doses,HHS Regions/National,United States,2017,Age,19 Months,71.6,70.1 to 72.9,17804
DTaP,≥4 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,71.9,70.9 to 72.8,36630
PCV,≥2 Doses,HHS Regions/National,United States,2019,Age,5 Months,80.5,79.2 to 81.6,17265
PCV,≥2 Doses,HHS Regions/National,United States,2017,Age,5 Months,76.1,74.7 to 77.4,17804
PCV,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,5 Months,77.6,76.6 to 78.5,36630
PCV,≥2 Doses,HHS Regions/National,United States,2018,Age,5 Months,79.1,77.9 to 80.3,18826
PCV,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,5 Months,79.8,78.9 to 80.6,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,92.7 to 94.2,21757
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,92.2,91.1 to 93.3,10389
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,93.5,92.9 to 94.1,24711
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.0,93.5 to 94.5,33203
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,91.8 to 94.4,7674
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,93.2,92.1 to 94.2,11789
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.5,90.0 to 92.9,4191
≥1 Dose Varicella,,HHS Regions/National,United States,2020,Age,24 Months,89.7,88.6 to 90.7,17387
Hib,≥3 Doses,HHS Regions/National,United States,2019,Age,35 Months,93.9,93.1 to 94.6,17265
≥1 Dose Varicella,,HHS Regions/National,United States,2016,Age,13 Months,59.8,58.2 to 61.4,15956
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2017,Age,13 Months,59.9,58.8 to 61.0,33760
≥1 Dose Varicella,,HHS Regions/National,United States,2017,Age,13 Months,60.0,58.5 to 61.5,17804
≥1 Dose Varicella,,HHS Regions/National,United States,2017-2018,Age,13 Months,61.0,60.0 to 62.0,36630
≥1 Dose Varicella,,HHS Regions/National,United States,2015,Age,13 Months,57.3,55.6 to 59.0,15463
≥1 Dose Varicella,,HHS Regions/National,United States,2015-2016,Age,13 Months,58.6,57.4 to 59.7,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,96.9,96.4 to 97.4,18707
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,93.3,92.6 to 94.1,21077
Hep B,≥3 Doses,HHS Regions/National,United States,2012,Age,7 Months,59.2,57.2 to 61.1,15039
Hep B,≥3 Doses,HHS Regions/National,United States,2011,Age,7 Months,52.9,51.1 to 54.8,14513
Hep A,≥1 Dose,HHS Regions/National,United States,2015,Age,35 Months,90.2,89.1 to 91.2,15463
Hep A,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,35 Months,90.0,89.2 to 90.8,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,93.3,92.9 to 93.8,56857
Hep A,≥2 Doses,HHS Regions/National,United States,2015,Age,24 Months,43.3,41.5 to 45.1,15463
Hep A,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,44.0,42.8 to 45.3,31419
Hep A,≥2 Doses,HHS Regions/National,United States,2014,Age,24 Months,43.5,41.8 to 45.2,15333
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,43.4,42.1 to 44.6,30796
Hep A,≥1 Dose,HHS Regions/National,United States,2013,Age,35 Months,88.5,87.4 to 89.6,14872
Hep A,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,35 Months,88.5,87.6 to 89.3,30205
Hep A,≥1 Dose,HHS Regions/National,United States,2014,Age,35 Months,88.5,87.2 to 89.7,15333
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,35 Months,89.3,88.4 to 90.1,30796
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,92.7,88.1 to 96.0,230
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,92.8,89.9 to 95.2,459
DTaP,≥1 Dose,States/Local Areas,Hawaii,2019,Age,3 Months,89.1,84.0 to 92.7,246
Hep A,≥1 Dose,States/Local Areas,Hawaii,2011,Age,19 Months,69.9,63.6 to 75.5,244
DTaP,≥1 Dose,States/Local Areas,Hawaii,2017,Age,3 Months,90.1,85.2 to 93.6,229
DTaP,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,3 Months,91.0,87.7 to 93.5,497
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014,Age,24 Months,90.8,86.0 to 94.6,248
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,24 Months,91.5,88.1 to 94.3,488
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,92.3,87.1 to 95.9,240
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,92.6,89.3 to 95.2,470
DTaP,≥1 Dose,States/Local Areas,Hawaii,2018,Age,3 Months,91.9,86.9 to 95.1,268
DTaP,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,3 Months,90.5,87.1 to 93.0,514
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016,Age,19 Months,80.7,73.4 to 86.4,230
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,19 Months,82.8,78.1 to 86.7,459
DTaP,≥2 Doses,States/Local Areas,Hawaii,2017,Age,5 Months,75.1,67.6 to 81.3,229
DTaP,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,5 Months,81.1,76.3 to 85.1,497
Hep A,≥1 Dose,States/Local Areas,Hawaii,2013,Age,19 Months,79.5,74.6 to 83.7,261
Hep A,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,19 Months,78.5,73.7 to 82.7,509
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014,Age,19 Months,77.6,70.6 to 83.3,248
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,19 Months,80.7,76.1 to 84.6,488
Hep A,≥1 Dose,States/Local Areas,Hawaii,2015,Age,19 Months,83.9,81.9 to 85.7,240
Hep A,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,19 Months,82.3,77.6 to 86.2,470
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,94.6,91.8 to 97.4,293
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,88.9,85.0 to 92.9,376
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,86.6,80.8 to 92.4,174
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Overall,Overall,90.0,87.5 to 92.5,843
DTaP,≥2 Doses,States/Local Areas,Hawaii,2019,Age,5 Months,85.6,80.2 to 89.8,246
Polio,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,90.4,85.7 to 95.1,177
DTaP,≥2 Doses,States/Local Areas,Hawaii,2018,Age,5 Months,87.1,80.9 to 91.5,268
DTaP,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,5 Months,86.4,82.4 to 89.5,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,92.9,89.0 to 95.9,229
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,92.6,89.6 to 94.9,497
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,92.1,87.5 to 95.6,268
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,92.4,89.4 to 94.7,514
Hib,≥3 Doses,States/Local Areas,Hawaii,2015,Age,24 Months,88.5,82.4 to 93.2,240
Hib,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,24 Months,88.9,85.0 to 92.3,470
Hib,≥3 Doses,States/Local Areas,Hawaii,2016,Age,24 Months,89.8,84.3 to 94.1,230
Hib,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,24 Months,90.1,86.6 to 93.1,459
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,92.6,88.7 to 95.6,246
Hib,≥3 Doses,States/Local Areas,Hawaii,2017,Age,24 Months,90.7,86.2 to 94.3,229
Hib,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,24 Months,90.2,86.8 to 93.1,497
Hib,Primary Series,States/Local Areas,Hawaii,2020-2021,Age,24 Months,89.9,85.5 to 93.5,353
Hep A,≥1 Dose,States/Local Areas,Hawaii,2012,Age,19 Months,78.6,65.9 to 87.4,270
Hib,Primary Series,States/Local Areas,Hawaii,2021,Age,19 Months,92.7,85.9 to 96.3,152
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,87.2,82.4 to 90.8,353
Hep B,≥3 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,94.0,89.0 to 96.8,152
Hib,≥1 Dose,States/Local Areas,Hawaii,2021,Age,3 Months,85.0,77.5 to 90.2,152
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",71.4,63.0 to 79.7,176
DTaP,≥1 Dose,States/Local Areas,Hawaii,2012,Age,3 Months,87.0,82.2 to 90.6,270
DTaP,≥1 Dose,States/Local Areas,Hawaii,2011,Age,3 Months,87.1,83.5 to 90.1,244
DTaP,≥1 Dose,States/Local Areas,Hawaii,2013,Age,3 Months,82.2,76.4 to 86.7,261
DTaP,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,3 Months,84.5,80.5 to 87.8,509
DTaP,≥1 Dose,States/Local Areas,Hawaii,2014,Age,3 Months,86.9,81.0 to 91.1,248
DTaP,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,3 Months,85.9,81.6 to 89.4,488
DTaP,≥1 Dose,States/Local Areas,Hawaii,2015,Age,3 Months,85.0,78.1 to 90.0,240
DTaP,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,3 Months,85.5,81.0 to 89.0,470
DTaP,≥1 Dose,States/Local Areas,Hawaii,2016,Age,3 Months,86.0,79.5 to 90.6,230
DTaP,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,3 Months,87.9,84.0 to 91.0,459
DTaP,≥4 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,81.2,72.9 to 87.4,152
Combined 7 Series,,States/Local Areas,Hawaii,2021,Age,35 Months,78.2,65.0 to 89.1,152
DTaP,≥4 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,81.4,76.1 to 86.1,353
PCV,≥4 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,77.6,71.7 to 82.9,353
Hib,Full Series,States/Local Areas,Hawaii,2021,Age,19 Months,75.3,66.3 to 82.6,152
DTaP,≥4 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,85.2,79.7 to 89.8,353
Hep B,≥2 Doses,States/Local Areas,Hawaii,2021,Age,5 Months,91.8,85.8 to 95.4,152
Hib,Primary Series,States/Local Areas,Hawaii,2021,Age,7 Months,78.7,69.4 to 85.8,152
PCV,≥2 Doses,States/Local Areas,Hawaii,2021,Age,5 Months,84.5,76.5 to 90.1,152
≥1 Dose MMR,,States/Local Areas,Hawaii,2020-2021,Age,24 Months,87.6,83.1 to 91.4,353
Polio,≥2 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,91.3,84.0 to 95.4,152
DTaP,≥3 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,79.7,70.4 to 86.6,152
Polio,≥3 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,95.5,87.5 to 99.0,152
Hep B,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,91.7,87.9 to 94.3,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,88.6,84.0 to 92.3,353
Hib,≥2 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,89.4,82.0 to 94.0,152
Hep A,≥2 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,85.8,71.9 to 95.0,152
Hep B,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,89.4,85.8 to 92.2,447
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,93.6,90.6 to 96.7,328
Hib,Primary Series,States/Local Areas,Hawaii,2018,Age,7 Months,75.0,67.2 to 81.4,268
Hib,Primary Series,States/Local Areas,Hawaii,2018-2019,Age,7 Months,78.7,73.9 to 82.7,514
Hib,Primary Series,States/Local Areas,Hawaii,2013,Age,13 Months,87.7,85.2 to 89.8,261
Hib,Primary Series,States/Local Areas,Hawaii,2013-2014,Age,13 Months,87.0,83.6 to 89.7,509
Hib,Primary Series,States/Local Areas,Hawaii,2012,Age,13 Months,88.5,79.4 to 93.9,270
Hib,Primary Series,States/Local Areas,Hawaii,2011,Age,13 Months,91.1,87.5 to 93.7,244
Hib,Primary Series,States/Local Areas,Hawaii,2014,Age,7 Months,70.8,63.0 to 77.6,248
Hib,Primary Series,States/Local Areas,Hawaii,2014-2015,Age,7 Months,70.6,65.2 to 75.5,488
Hib,Primary Series,States/Local Areas,Hawaii,2015,Age,7 Months,70.4,62.7 to 77.1,240
Hib,Primary Series,States/Local Areas,Hawaii,2015-2016,Age,7 Months,71.0,65.6 to 75.9,470
Hib,Primary Series,States/Local Areas,Hawaii,2013,Age,7 Months,71.8,64.4 to 78.2,261
Hib,Primary Series,States/Local Areas,Hawaii,2013-2014,Age,7 Months,71.3,68.3 to 74.2,509
Hib,Primary Series,States/Local Areas,Hawaii,2019,Age,7 Months,82.4,76.6 to 87.0,246
Hib,Primary Series,States/Local Areas,Hawaii,2014,Age,13 Months,86.2,79.4 to 91.0,248
Hib,Primary Series,States/Local Areas,Hawaii,2014-2015,Age,13 Months,84.6,79.8 to 88.4,488
Hib,Primary Series,States/Local Areas,Hawaii,2015,Age,13 Months,82.9,75.7 to 88.4,240
Hib,Primary Series,States/Local Areas,Hawaii,2015-2016,Age,13 Months,85.2,80.6 to 88.9,470
Hib,Primary Series,States/Local Areas,Hawaii,2016,Age,13 Months,87.4,81.3 to 91.7,230
Hib,Primary Series,States/Local Areas,Hawaii,2016-2017,Age,13 Months,86.4,82.0 to 89.9,459
Hib,Primary Series,States/Local Areas,Hawaii,2018,Age,19 Months,90.6,84.9 to 94.3,268
Hib,Primary Series,States/Local Areas,Hawaii,2018-2019,Age,19 Months,90.7,87.4 to 93.2,514
Hib,Primary Series,States/Local Areas,Hawaii,2017,Age,19 Months,92.3,88.0 to 95.2,229
Hib,Primary Series,States/Local Areas,Hawaii,2017-2018,Age,19 Months,91.5,88.1 to 94.0,497
Hib,Primary Series,States/Local Areas,Hawaii,2016,Age,19 Months,90.5,85.0 to 94.2,230
Hib,Primary Series,States/Local Areas,Hawaii,2016-2017,Age,19 Months,91.4,88.0 to 93.9,459
Hib,Primary Series,States/Local Areas,Hawaii,2011,Age,19 Months,91.8,88.7 to 94.2,244
Hib,Primary Series,States/Local Areas,Hawaii,2014,Age,19 Months,91.1,85.8 to 94.5,248
Hib,Primary Series,States/Local Areas,Hawaii,2014-2015,Age,19 Months,90.1,86.1 to 93.0,488
Hib,Primary Series,States/Local Areas,Hawaii,2013,Age,19 Months,92.4,87.5 to 95.4,261
Hib,Primary Series,States/Local Areas,Hawaii,2013-2014,Age,19 Months,91.7,88.9 to 93.8,509
Hib,Primary Series,States/Local Areas,Hawaii,2012,Age,19 Months,91.1,82.2 to 95.8,270
Hib,Primary Series,States/Local Areas,Hawaii,2018,Age,13 Months,89.6,83.8 to 93.4,268
Hib,Primary Series,States/Local Areas,Hawaii,2018-2019,Age,13 Months,90.7,87.4 to 93.2,514
Hib,Primary Series,States/Local Areas,Hawaii,2019,Age,13 Months,91.8,87.9 to 94.5,246
Hib,Primary Series,States/Local Areas,Hawaii,2017,Age,13 Months,85.3,78.4 to 90.3,229
Hib,Primary Series,States/Local Areas,Hawaii,2017-2018,Age,13 Months,87.4,83.1 to 90.8,497
Combined 7 Series,,States/Local Areas,Hawaii,2016,Age,35 Months,80.4,72.3 to 87.3,230
Combined 7 Series,,States/Local Areas,Hawaii,2016-2017,Age,35 Months,75.4,69.7 to 80.7,459
Combined 7 Series,,States/Local Areas,Hawaii,2017,Age,35 Months,70.7,62.7 to 78.3,229
Combined 7 Series,,States/Local Areas,Hawaii,2017-2018,Age,35 Months,76.2,70.9 to 81.2,497
≥1 Dose MMR,,States/Local Areas,Hawaii,2021,Age,35 Months,90.2,83.7 to 94.8,152
Hib,Primary Series,States/Local Areas,Hawaii,2016,Age,35 Months,91.6,86.6 to 95.4,230
Hib,Primary Series,States/Local Areas,Hawaii,2016-2017,Age,35 Months,93.3,89.6 to 96.0,459
Hib,Primary Series,States/Local Areas,Hawaii,2017,Age,35 Months,94.8,89.7 to 97.9,229
Hib,Primary Series,States/Local Areas,Hawaii,2017-2018,Age,35 Months,93.6,90.3 to 96.1,497
Combined 7 Series,,States/Local Areas,Hawaii,2012,Age,24 Months,72.4,65.6 to 78.8,270
Combined 7 Series,,States/Local Areas,Hawaii,2011,Age,24 Months,66.5,58.4 to 74.5,244
Hib,Primary Series,States/Local Areas,Hawaii,2014,Age,35 Months,91.9,86.6 to 95.6,248
Hib,Primary Series,States/Local Areas,Hawaii,2014-2015,Age,35 Months,92.2,88.0 to 95.4,488
Hib,Primary Series,States/Local Areas,Hawaii,2012,Age,35 Months,93.2,88.8 to 96.3,270
Hib,Primary Series,States/Local Areas,Hawaii,2015,Age,35 Months,92.4,85.9 to 96.7,240
Hib,Primary Series,States/Local Areas,Hawaii,2015-2016,Age,35 Months,92.6,88.2 to 95.8,470
Combined 7 Series,,States/Local Areas,Hawaii,2013,Age,24 Months,69.9,62.4 to 77.2,261
Combined 7 Series,,States/Local Areas,Hawaii,2013-2014,Age,24 Months,69.1,63.9 to 74.2,509
Hib,Primary Series,States/Local Areas,Hawaii,2016,Age,24 Months,91.1,86.2 to 94.8,230
Hib,Primary Series,States/Local Areas,Hawaii,2016-2017,Age,24 Months,91.7,88.5 to 94.2,459
Hib,Primary Series,States/Local Areas,Hawaii,2013,Age,35 Months,94.4,90.3 to 97.1,261
Hib,Primary Series,States/Local Areas,Hawaii,2013-2014,Age,35 Months,93.0,89.8 to 95.5,509
Hib,Primary Series,States/Local Areas,Hawaii,2011,Age,35 Months,93.3,88.5 to 96.6,244
Hib,Primary Series,States/Local Areas,Hawaii,2019,Age,24 Months,93.6,90.2 to 96.1,246
Hib,Primary Series,States/Local Areas,Hawaii,2018,Age,24 Months,90.6,85.4 to 94.6,268
Hib,Primary Series,States/Local Areas,Hawaii,2018-2019,Age,24 Months,92.1,89.1 to 94.6,514
Hib,Primary Series,States/Local Areas,Hawaii,2017,Age,24 Months,92.3,88.3 to 95.3,229
Hib,Primary Series,States/Local Areas,Hawaii,2017-2018,Age,24 Months,91.5,88.3 to 94.1,497
Hib,Primary Series,States/Local Areas,Hawaii,2012,Age,24 Months,92.6,88.2 to 95.8,270
Hib,Primary Series,States/Local Areas,Hawaii,2011,Age,24 Months,93.0,88.3 to 96.3,244
Hib,Primary Series,States/Local Areas,Hawaii,2013,Age,24 Months,92.4,87.8 to 95.7,261
Hib,Primary Series,States/Local Areas,Hawaii,2013-2014,Age,24 Months,91.8,88.6 to 94.4,509
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,85.2,77.7 to 90.5,201
Hib,Primary Series,States/Local Areas,Hawaii,2019,Age,19 Months,92.9,89.2 to 95.4,246
Hib,Primary Series,States/Local Areas,Hawaii,2015,Age,19 Months,89.1,83.5 to 93.0,240
Hib,Primary Series,States/Local Areas,Hawaii,2015-2016,Age,19 Months,89.8,85.8 to 92.8,470
Hib,Primary Series,States/Local Areas,Hawaii,2014,Age,24 Months,91.2,86.4 to 94.9,248
Hib,Primary Series,States/Local Areas,Hawaii,2014-2015,Age,24 Months,90.2,86.5 to 93.2,488
Hib,Primary Series,States/Local Areas,Hawaii,2015,Age,24 Months,89.1,83.2 to 93.7,240
Hib,Primary Series,States/Local Areas,Hawaii,2015-2016,Age,24 Months,90.1,86.4 to 93.2,470
Combined 7 Series,,States/Local Areas,Hawaii,2014,Age,35 Months,74.3,66.7 to 81.4,248
Combined 7 Series,,States/Local Areas,Hawaii,2014-2015,Age,35 Months,74.7,69.4 to 79.7,488
Combined 7 Series,,States/Local Areas,Hawaii,2013,Age,35 Months,80.5,73.1 to 87.0,261
Combined 7 Series,,States/Local Areas,Hawaii,2013-2014,Age,35 Months,77.2,71.9 to 82.2,509
Combined 7 Series,,States/Local Areas,Hawaii,2012,Age,35 Months,79.4,72.4 to 85.6,270
Combined 7 Series,,States/Local Areas,Hawaii,2015,Age,24 Months,71.8,64.6 to 78.6,240
Combined 7 Series,,States/Local Areas,Hawaii,2015-2016,Age,24 Months,72.8,67.7 to 77.6,470
Hib,Primary Series,States/Local Areas,Hawaii,2018,Age,35 Months,92.5,88.0 to 95.8,268
Hib,Primary Series,States/Local Areas,Hawaii,2018-2019,Age,35 Months,93.1,90.3 to 95.3,514
Combined 7 Series,,States/Local Areas,Hawaii,2016,Age,24 Months,73.9,66.6 to 80.7,230
Combined 7 Series,,States/Local Areas,Hawaii,2016-2017,Age,24 Months,70.7,65.3 to 75.8,459
Hib,Primary Series,States/Local Areas,Hawaii,2019,Age,35 Months,93.6,90.2 to 96.1,246
Combined 7 Series,,States/Local Areas,Hawaii,2014,Age,24 Months,68.4,61.0 to 75.5,248
Combined 7 Series,,States/Local Areas,Hawaii,2014-2015,Age,24 Months,70.0,64.9 to 75.1,488
Combined 7 Series,,States/Local Areas,Hawaii,2019,Age,24 Months,70.5,63.4 to 77.3,246
Combined 7 Series,,States/Local Areas,Hawaii,2011,Age,35 Months,67.2,59.0 to 75.1,244
Hib,Full Series,States/Local Areas,Hawaii,2014,Age,19 Months,76.1,68.7 to 82.1,248
Hib,Full Series,States/Local Areas,Hawaii,2014-2015,Age,19 Months,74.0,68.8 to 78.6,488
Combined 7 Series,,States/Local Areas,Hawaii,2017,Age,24 Months,67.2,59.4 to 74.8,229
Combined 7 Series,,States/Local Areas,Hawaii,2017-2018,Age,24 Months,73.1,67.9 to 78.2,497
Combined 7 Series,,States/Local Areas,Hawaii,2018,Age,24 Months,79.2,72.3 to 85.4,268
Combined 7 Series,,States/Local Areas,Hawaii,2018-2019,Age,24 Months,74.9,69.9 to 79.6,514
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,59.4,50.8 to 68.0,174
Hib,Full Series,States/Local Areas,Hawaii,2013,Age,24 Months,76.7,69.5 to 83.3,261
Hib,Full Series,States/Local Areas,Hawaii,2013-2014,Age,24 Months,78.0,73.1 to 82.6,509
Hib,Full Series,States/Local Areas,Hawaii,2014,Age,24 Months,79.4,72.6 to 85.5,248
Hib,Full Series,States/Local Areas,Hawaii,2014-2015,Age,24 Months,78.0,73.1 to 82.5,488
Hib,Full Series,States/Local Areas,Hawaii,2012,Age,24 Months,85.1,79.7 to 89.8,270
Hib,Full Series,States/Local Areas,Hawaii,2011,Age,24 Months,78.6,71.2 to 85.3,244
Hib,Full Series,States/Local Areas,Hawaii,2018,Age,19 Months,78.4,71.1 to 84.2,268
Hib,Full Series,States/Local Areas,Hawaii,2018-2019,Age,19 Months,92.9,90.1 to 95.0,514
Hib,Full Series,States/Local Areas,Hawaii,2019,Age,19 Months,73.0,66.0 to 79.0,246
Hib,Full Series,States/Local Areas,Hawaii,2015,Age,19 Months,71.9,68.2 to 75.4,240
Hib,Full Series,States/Local Areas,Hawaii,2015-2016,Age,19 Months,72.8,67.4 to 77.5,470
Hib,Full Series,States/Local Areas,Hawaii,2016,Age,19 Months,73.6,66.0 to 80.0,230
Hib,Full Series,States/Local Areas,Hawaii,2016-2017,Age,19 Months,73.4,68.1 to 78.0,459
Hib,Full Series,States/Local Areas,Hawaii,2017,Age,19 Months,73.1,65.5 to 79.6,229
Hib,Full Series,States/Local Areas,Hawaii,2017-2018,Age,19 Months,75.7,70.6 to 80.3,497
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,75.1,67.3 to 82.9,145
Combined 7 Series,,States/Local Areas,Hawaii,2015,Age,35 Months,75.0,67.7 to 81.8,240
Combined 7 Series,,States/Local Areas,Hawaii,2015-2016,Age,35 Months,77.5,72.1 to 82.5,470
Combined 7 Series,,States/Local Areas,Hawaii,2018,Age,35 Months,81.9,75.2 to 87.7,268
Combined 7 Series,,States/Local Areas,Hawaii,2018-2019,Age,35 Months,78.1,73.1 to 82.7,514
Combined 7 Series,,States/Local Areas,Hawaii,2019,Age,35 Months,74.1,66.9 to 80.9,246
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,66.8,60.4 to 73.3,293
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,72.5,67.9 to 77.2,522
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,70.3,63.8 to 76.7,273
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.6,63.0 to 74.2,393
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.8,61.6 to 78.0,185
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.8,62.7 to 72.9,507
Hib,Full Series,States/Local Areas,Hawaii,2013,Age,19 Months,68.6,66.4 to 70.6,261
Hib,Full Series,States/Local Areas,Hawaii,2013-2014,Age,19 Months,72.3,67.3 to 76.8,509
Hib,Full Series,States/Local Areas,Hawaii,2012,Age,19 Months,75.2,65.1 to 83.1,270
Hib,Full Series,States/Local Areas,Hawaii,2011,Age,19 Months,70.9,65.0 to 76.2,244
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,77.9,72.2 to 83.6,293
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,69.8,64.2 to 75.4,376
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Overall,Overall,69.5,65.7 to 73.3,843
Combined 7 Series,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,70.3,61.9 to 78.8,177
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,87.4 to 93.5,541
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,75.9,68.0 to 83.8,167
Influenza,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,55.7,49.0 to 62.4,293
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,86.2 to 92.7,541
Hep B,≥3 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,90.0,83.4 to 94.2,152
≥1 Dose Varicella,,States/Local Areas,Hawaii,2021,Age,13 Months,72.7,63.5 to 80.3,152
DTaP,≥2 Doses,States/Local Areas,Hawaii,2021,Age,5 Months,85.3,77.2 to 90.8,152
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,75.3,69.2 to 81.3,323
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,62.4,53.6 to 71.2,181
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,83.4,79.4 to 87.5,535
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,76.3,70.5 to 82.0,293
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,67.8,61.3 to 74.4,273
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.7,69.6 to 83.8,185
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.9,62.9 to 73.0,507
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,69.6,61.1 to 78.1,145
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,65.8,59.5 to 72.2,293
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,74.2,69.6 to 78.8,522
Rotavirus,,States/Local Areas,Hawaii,2019,Age,8 Months,80.2,73.8 to 85.3,246
Rotavirus,,States/Local Areas,Hawaii,2011,Age,8 Months,69.4,61.8 to 76.2,244
Rotavirus,,States/Local Areas,Hawaii,2016,Age,8 Months,70.5,62.7 to 77.3,230
Rotavirus,,States/Local Areas,Hawaii,2016-2017,Age,8 Months,71.2,65.7 to 76.1,459
Rotavirus,,States/Local Areas,Hawaii,2017,Age,8 Months,71.9,64.1 to 78.6,229
Rotavirus,,States/Local Areas,Hawaii,2017-2018,Age,8 Months,75.9,70.7 to 80.4,497
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,70.1,64.5 to 75.8,376
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,60.8,52.3 to 69.2,174
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Overall,Overall,69.5,65.8 to 73.3,843
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.5,64.0 to 75.0,393
Rotavirus,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,71.8,63.4 to 80.2,177
Rotavirus,,States/Local Areas,Hawaii,2013,Age,8 Months,73.2,65.7 to 79.6,261
Rotavirus,,States/Local Areas,Hawaii,2013-2014,Age,8 Months,70.5,65.2 to 75.3,509
Rotavirus,,States/Local Areas,Hawaii,2014,Age,8 Months,67.8,60.1 to 74.6,248
Rotavirus,,States/Local Areas,Hawaii,2014-2015,Age,8 Months,68.5,63.2 to 73.4,488
Rotavirus,,States/Local Areas,Hawaii,2012,Age,8 Months,71.9,65.1 to 77.9,270
Rotavirus,,States/Local Areas,Hawaii,2015,Age,8 Months,69.3,61.6 to 76.1,240
Rotavirus,,States/Local Areas,Hawaii,2015-2016,Age,8 Months,69.9,64.5 to 74.8,470
Rotavirus,,States/Local Areas,Hawaii,2018,Age,8 Months,79.8,72.9 to 85.3,268
Rotavirus,,States/Local Areas,Hawaii,2018-2019,Age,8 Months,80.0,75.4 to 83.9,514
Hib,Primary Series,States/Local Areas,Hawaii,2019-2020,Age,7 Months,78.5,73.5 to 82.8,447
Hib,Primary Series,States/Local Areas,Hawaii,2016,Age,7 Months,71.6,63.5 to 78.4,230
Hib,Primary Series,States/Local Areas,Hawaii,2016-2017,Age,7 Months,71.1,65.6 to 76.1,459
Hib,Primary Series,States/Local Areas,Hawaii,2017,Age,7 Months,70.6,62.9 to 77.3,229
Hib,Primary Series,States/Local Areas,Hawaii,2017-2018,Age,7 Months,72.8,67.5 to 77.5,497
Influenza,,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,60.1,54.9 to 65.3,522
Influenza,,States/Local Areas,Hawaii,2017,Age,24 Months,56.9,49.1 to 65.1,229
Influenza,,States/Local Areas,Hawaii,2017-2018,Age,24 Months,62.1,56.5 to 67.8,497
Influenza,,States/Local Areas,Hawaii,2018,Age,24 Months,67.4,59.7 to 75.0,268
Influenza,,States/Local Areas,Hawaii,2018-2019,Age,24 Months,66.6,61.3 to 71.8,514
Influenza,,States/Local Areas,Hawaii,2019,Age,24 Months,65.8,58.8 to 72.7,246
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.9,73.3 to 82.6,541
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,71.4,60.2 to 82.5,167
Influenza,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Principal City,63.0,56.4 to 69.7,273
Influenza,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"White, Non-Hispanic",65.3,57.2 to 73.4,185
Influenza,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a MSA Non-Principal City,60.8,55.0 to 66.5,393
Influenza,,States/Local Areas,Hawaii,2014-2017,Urbanicity,Living In a Non-MSA,44.1,34.8 to 53.3,177
Influenza,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.0,53.7 to 64.3,507
Influenza,,States/Local Areas,Hawaii,2014-2017,Race and Ethnicity,Hispanic,51.0,41.5 to 60.5,145
Polio,≥2 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,94.5,89.6 to 97.2,152
Influenza,,States/Local Areas,Hawaii,2014-2017,Poverty,>400% FPL,62.8,55.8 to 69.7,293
Influenza,,States/Local Areas,Hawaii,2014-2017,Poverty,133% to <400% FPL,59.6,53.6 to 65.6,376
Influenza,,States/Local Areas,Hawaii,2014-2017,Poverty,<133% FPL,49.2,40.7 to 57.8,174
Influenza,,States/Local Areas,Hawaii,2014-2017,Overall,Overall,57.8,53.7 to 61.9,843
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,72.5,66.3 to 78.7,323
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,84.4,80.6 to 88.2,535
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,90.4,86.6 to 94.1,323
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,89.4,86.0 to 92.8,535
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.0,64.8 to 77.2,541
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,80.5 to 88.7,541
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,83.7,78.5 to 88.9,323
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,85.7,81.8 to 89.6,535
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020-2021,Age,13 Months,68.1,61.6 to 74.0,353
Influenza,,States/Local Areas,Hawaii,2021,Age,24 Months,62.2,52.8 to 71.7,152
Hib,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,87.5,82.5 to 91.2,353
Hep A,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,24 Months,86.1,81.5 to 90.1,353
Hep B,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,3 Months,94.2,91.2 to 96.2,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,74.5,68.3 to 79.8,353
Hib,≥2 Doses,States/Local Areas,Hawaii,2021,Age,5 Months,82.2,74.1 to 88.1,152
Hib,≥3 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,92.0,86.0 to 96.2,152
PCV,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,3 Months,86.3,81.5 to 90.1,353
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2021,Age,0-3 Days,86.9,79.2 to 92.1,152
≥1 Dose MMR,,States/Local Areas,Hawaii,2021,Age,13 Months,76.7,68.0 to 83.7,152
Hep B,≥1 Dose,States/Local Areas,Hawaii,2021,Age,3 Months,95.7,90.8 to 98.0,152
Hib,Full Series,States/Local Areas,Hawaii,2020-2021,Age,24 Months,77.5,71.9 to 82.7,353
Rotavirus,,States/Local Areas,Hawaii,2021,Age,8 Months,72.9,62.9 to 81.0,152
DTaP,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,5 Months,82.4,76.8 to 86.9,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,61.9,55.3 to 68.1,353
Hep A,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,73.1,64.5 to 81.1,353
PCV,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,86.7,81.7 to 90.5,353
≥1 Dose MMR,,States/Local Areas,Hawaii,2020-2021,Age,19 Months,85.2,80.0 to 89.2,353
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,89.6,85.5 to 92.9,353
Hib,≥2 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,95.1,90.2 to 97.6,152
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020-2021,Age,24 Months,87.4,82.9 to 91.1,353
Polio,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,88.9,84.4 to 92.6,353
Polio,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,3 Months,85.3,80.2 to 89.3,353
Hib,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,5 Months,80.4,74.8 to 85.0,353
Hib,Primary Series,States/Local Areas,Hawaii,2021,Age,35 Months,92.7,86.7 to 96.6,152
Hep B,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,5 Months,89.3,85.1 to 92.5,353
PCV,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,88.8,84.2 to 92.5,353
Hib,Primary Series,States/Local Areas,Hawaii,2020-2021,Age,7 Months,76.1,70.0 to 81.3,353
Hep A,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,41.6,35.4 to 48.4,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,81.1,72.7 to 87.3,152
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,74.6,68.2 to 80.1,353
Polio,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,91.9,87.2 to 95.5,353
DTaP,≥3 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,93.0,87.2 to 96.8,152
DTaP,≥4 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,76.9,70.9 to 82.0,353
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020-2021,Age,19 Months,85.7,80.7 to 89.6,353
Hib,Full Series,States/Local Areas,Hawaii,2021,Age,35 Months,80.3,71.7 to 87.6,152
Combined 7 Series,,States/Local Areas,Hawaii,2020-2021,Age,24 Months,69.1,62.9 to 75.1,353
PCV,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,90.7,85.9 to 94.3,353
Hib,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,3 Months,84.1,78.9 to 88.2,353
Hep B,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,90.0,85.9 to 93.1,353
≥1 Dose MMR,,States/Local Areas,Hawaii,2020-2021,Age,35 Months,89.9,85.4 to 93.5,353
PCV,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,88.0,83.2 to 91.6,353
Polio,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,88.4,83.5 to 92.0,353
Polio,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,5 Months,81.1,75.4 to 85.7,353
Hib,Primary Series,States/Local Areas,Hawaii,2020-2021,Age,19 Months,89.2,84.4 to 92.6,353
PCV,≥4 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,83.2,77.0 to 88.5,353
Combined 7 Series,,States/Local Areas,Hawaii,2020-2021,Age,35 Months,74.7,68.0 to 80.9,353
DTaP,≥4 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,93.4,85.5 to 97.8,152
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,24 Months,89.7,85.3 to 93.2,353
Rotavirus,,States/Local Areas,Hawaii,2020-2021,Age,8 Months,73.1,66.6 to 78.8,353
PCV,≥4 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,76.4,70.3 to 81.6,353
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,67.0,60.8 to 72.7,353
Hep B,≥2 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,94.5,89.6 to 97.2,152
≥1 Dose Varicella,,States/Local Areas,Hawaii,2021,Age,35 Months,89.2,82.7 to 94.0,152
Hib,Primary Series,States/Local Areas,Hawaii,2021,Age,13 Months,84.7,76.7 to 90.3,152
Hep B,≥3 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,94.0,89.5 to 97.0,152
Influenza,,States/Local Areas,Hawaii,2020-2021,Age,24 Months,62.7,56.3 to 69.2,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,87.0,81.6 to 91.0,353
Hep A,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,19 Months,84.3,79.1 to 88.4,353
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,89.4,85.1 to 92.6,353
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2020-2021,Age,0-3 Days,83.9,78.8 to 88.0,353
Hib,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,91.0,86.3 to 94.5,353
Hib,Primary Series,States/Local Areas,Hawaii,2020-2021,Age,35 Months,91.0,86.4 to 94.5,353
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2020-2021,Age,0-1 Days,82.5,77.3 to 86.7,353
Hib,Full Series,States/Local Areas,Hawaii,2020-2021,Age,35 Months,81.1,75.4 to 86.2,353
PCV,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,7 Months,72.5,66.0 to 78.1,353
Polio,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,91.3,87.1 to 94.2,353
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,87.0,82.0 to 90.8,353
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2020-2021,Age,0-2 Days,83.3,78.2 to 87.4,353
Hib,Full Series,States/Local Areas,Hawaii,2020-2021,Age,19 Months,73.5,67.2 to 78.9,353
Hep A,≥2 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,31.7,23.6 to 41.2,152
Combined 7 Series,,States/Local Areas,Hawaii,2021,Age,24 Months,68.0,58.8 to 77.0,152
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,88.4,83.6 to 92.0,353
PCV,≥1 Dose,States/Local Areas,Hawaii,2021,Age,3 Months,90.1,83.7 to 94.2,152
Polio,≥2 Doses,States/Local Areas,Hawaii,2021,Age,5 Months,84.4,76.3 to 90.1,152
≥1 Dose MMR,,States/Local Areas,Hawaii,2021,Age,19 Months,90.2,83.0 to 94.5,152
Polio,≥3 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,91.1,84.1 to 95.2,152
Polio,≥3 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,91.8,89.2 to 93.8,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,89.9,86.7 to 92.4,558
Polio,≥3 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,88.1,80.8 to 92.9,287
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,91.2,87.1 to 94.1,607
Polio,≥3 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,94.5,90.4 to 96.9,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,94.3,92.5 to 95.7,320
Polio,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,93.7,90.4 to 95.9,672
Hib,≥3 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,65.4,56.8 to 73.1,314
Hib,≥3 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,94.3,90.4 to 96.7,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,93.8,86.3 to 97.3,252
Hib,≥3 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,59.9,51.0 to 68.2,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,62.7,56.5 to 68.4,585
Polio,≥3 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,93.0,88.7 to 95.8,352
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,92.3,88.3 to 94.9,644
Polio,≥3 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,91.5,84.4 to 95.5,292
Polio,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,93.0,88.8 to 95.7,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,95.6,91.9 to 97.7,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,96.4,94.1 to 97.8,585
Hib,≥3 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,61.5,54.2 to 68.4,320
Hib,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,60.5,55.3 to 65.4,672
Hib,≥3 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,59.4,52.1 to 66.2,352
Hib,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,57.9,52.4 to 63.2,644
Hib,≥3 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,56.4,48.3 to 64.3,292
Hib,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,58.2,52.2 to 63.9,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,97.1,93.9 to 98.6,314
DTaP,≥3 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,94.5,86.8 to 97.8,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,92.1,90.1 to 93.7,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,91.3,89.1 to 93.0,558
DTaP,≥3 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,95.6,92.2 to 97.5,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,88.7,85.6 to 91.2,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,87.9,85.4 to 89.9,558
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,87.0,79.4 to 92.1,287
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,90.3,86.1 to 93.4,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,84.9,78.0 to 91.8,180
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Overall,Overall,76.4,72.9 to 79.9,1155
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.5,67.6 to 79.4,469
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,75.6,70.3 to 80.9,506
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.8,71.3 to 80.3,703
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.7,60.5 to 83.0,129
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,83.1,76.6 to 89.6,198
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,88.7,81.3 to 93.4,292
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,92.1,88.1 to 94.9,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,93.6,89.1 to 96.4,320
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,92.2,88.7 to 94.7,672
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,77.5,71.9 to 83.0,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,73.6,67.9 to 79.3,474
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.0,88.5 to 95.4,469
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,88.5 to 95.7,506
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.4,89.7 to 95.1,703
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,78.2 to 96.0,129
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,94.7,90.7 to 98.7,198
PCV,≥3 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,95.7,92.1 to 97.9,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,96.5,92.3 to 98.5,314
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,90.7,85.6 to 94.1,352
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,89.7,85.4 to 92.9,644
DTaP,≥3 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,94.4,90.5 to 96.7,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,97.2,93.6 to 98.8,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,97.3,95.1 to 98.5,585
Hib,≥2 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,96.4,91.8 to 98.4,292
Hib,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,96.8,94.2 to 98.2,563
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,96.9,93.8 to 100.0,180
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.4,88.8 to 96.1,469
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,93.7,90.3 to 97.2,302
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,93.7,91.6 to 95.9,1155
Hib,≥2 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,97.5,93.9 to 99.0,314
Hib,≥3 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,61.2,56.2 to 65.9,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,59.6,55.7 to 63.5,558
Polio,≥3 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,94.2,87.3 to 97.4,252
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,96.7,94.4 to 98.9,379
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,91.9,87.8 to 95.9,474
Hib,≥3 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,58.1,49.9 to 65.9,287
Hib,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,59.8,54.3 to 65.1,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,81.3,78.3 to 83.9,252
Hib,≥3 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,76.9,70.4 to 82.2,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,78.7,72.4 to 85.1,302
Hib,≥3 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,46.4,38.0 to 55.0,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,90.4 to 97.2,506
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.6,92.3 to 97.0,703
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,75.2,63.8 to 86.7,198
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020,Age,24 Months,91.0,86.3 to 94.5,459
≥1 Dose MMR,,States/Local Areas,North Carolina,2013,Age,13 Months,57.4,49.5 to 64.9,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2013-2014,Age,13 Months,59.7,56.9 to 62.4,558
≥1 Dose MMR,,States/Local Areas,North Carolina,2012,Age,13 Months,64.2,58.5 to 69.6,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2011,Age,13 Months,66.5,60.4 to 72.1,252
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014,Age,19 Months,85.5,78.2 to 90.6,287
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2015,Age,19 Months,88.2,83.9 to 91.5,607
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015,Age,19 Months,90.9,88.4 to 92.9,320
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015-2016,Age,19 Months,89.4,85.4 to 92.4,672
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013,Age,19 Months,89.1,87.3 to 90.6,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013-2014,Age,19 Months,87.3,83.1 to 90.5,558
Polio,≥2 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,95.9,93.1 to 97.6,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,93.9,86.6 to 97.3,252
Polio,≥2 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,91.8,89.3 to 93.8,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,90.7,87.4 to 93.3,558
Polio,≥2 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,89.7,82.4 to 94.2,287
Polio,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,92.4,88.5 to 95.1,607
Hep B,≥1 Dose,States/Local Areas,North Carolina,2015,Age,3 Months,95.3,91.2 to 97.6,320
Hep B,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,3 Months,95.8,92.6 to 97.6,672
Hep B,≥1 Dose,States/Local Areas,North Carolina,2016,Age,3 Months,96.2,92.3 to 98.2,352
Hep B,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,3 Months,97.4,95.2 to 98.6,644
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.5,51.2 to 85.8,129
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,55.5,33.6 to 77.4,34
DTaP,≥4 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,86.5,79.2 to 92.3,292
DTaP,≥4 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,94.6,86.3 to 98.6,563
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,89.9,83.5 to 94.6,352
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,88.3,83.2 to 92.4,644
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,92.6,87.9 to 95.6,352
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,91.8,88.2 to 94.4,644
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,87.5,81.4 to 91.8,320
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,90.0,86.1 to 92.9,672
DTaP,≥4 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,90.6,84.1 to 95.2,320
DTaP,≥4 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,90.2,85.7 to 93.8,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,91.0,85.1 to 94.7,292
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,90.7,86.3 to 93.8,563
Hep B,≥1 Dose,States/Local Areas,North Carolina,2013,Age,3 Months,95.4,92.2 to 97.3,271
Hep B,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,3 Months,94.2,92.5 to 95.5,558
Hep B,≥1 Dose,States/Local Areas,North Carolina,2012,Age,3 Months,96.4,94.8 to 97.5,271
Hep B,≥1 Dose,States/Local Areas,North Carolina,2011,Age,3 Months,93.4,89.1 to 96.0,252
Hep B,≥1 Dose,States/Local Areas,North Carolina,2014,Age,3 Months,93.0,87.7 to 96.1,287
Hep B,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,3 Months,94.2,91.1 to 96.2,607
Polio,≥2 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,88.7,82.9 to 92.7,352
Polio,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,89.6,85.3 to 92.8,644
Polio,≥2 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,90.5,83.5 to 94.8,292
Polio,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,93.5,89.7 to 96.0,563
Polio,≥2 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,96.5,93.4 to 98.2,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,95.9,93.1 to 97.6,585
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,69.2,61.7 to 76.8,419
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,85.5,80.0 to 91.1,673
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,83.7,76.7 to 90.7,198
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.6,82.9 to 90.3,703
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.3,60.7 to 83.8,129
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,83.5,76.1 to 90.8,180
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,83.5,80.3 to 86.7,1155
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.0,79.1 to 89.0,469
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,83.2,78.2 to 88.1,506
≥1 Dose MMR,,States/Local Areas,North Carolina,2015,Age,19 Months,91.2,88.4 to 93.4,320
≥1 Dose MMR,,States/Local Areas,North Carolina,2015-2016,Age,19 Months,90.0,86.0 to 92.9,672
≥1 Dose MMR,,States/Local Areas,North Carolina,2016,Age,19 Months,88.7,83.0 to 92.7,352
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2017,Age,19 Months,88.7,84.4 to 91.9,644
≥1 Dose MMR,,States/Local Areas,North Carolina,2017,Age,19 Months,88.6,81.7 to 93.2,292
≥1 Dose MMR,,States/Local Areas,North Carolina,2017-2018,Age,19 Months,89.7,85.2 to 93.0,563
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,77.2,71.0 to 83.4,302
≥1 Dose Varicella,,States/Local Areas,North Carolina,2011,Age,24 Months,92.4,86.5 to 96.4,252
≥1 Dose Varicella,,States/Local Areas,North Carolina,2012,Age,24 Months,90.5,84.9 to 94.6,271
Hep B,≥1 Dose,States/Local Areas,North Carolina,2018,Age,3 Months,96.1,90.2 to 98.5,271
Hep B,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,3 Months,97.2,94.4 to 98.7,585
Hep B,≥1 Dose,States/Local Areas,North Carolina,2019,Age,3 Months,98.4,96.2 to 99.3,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,79.2,72.2 to 86.2,474
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2011,Age,0-1 Days,74.4,71.6 to 77.0,252
Hep B,≥2 Doses,States/Local Areas,North Carolina,2012,Age,5 Months,93.7,91.6 to 95.3,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2011,Age,5 Months,87.3,78.2 to 93.0,252
Hep B,≥2 Doses,States/Local Areas,North Carolina,2013,Age,5 Months,90.4,87.6 to 92.5,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,5 Months,89.2,86.7 to 91.2,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,91.5,90.0 to 92.7,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,90.0,85.3 to 93.3,558
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,87.4,80.2 to 94.5,379
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,88.6,81.5 to 93.1,287
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,89.4,85.2 to 92.6,607
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,90.3,83.8 to 94.3,320
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,92.2,88.5 to 94.7,672
DTaP,≥4 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,97.9,95.5 to 99.2,314
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,79.6,74.4 to 84.7,419
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,89.6,86.2 to 92.9,673
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,67.1,45.9 to 88.3,34
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.6,72.9 to 90.3,125
≥1 Dose MMR,,States/Local Areas,North Carolina,2011,Age,19 Months,91.9,86.6 to 95.2,252
≥1 Dose MMR,,States/Local Areas,North Carolina,2013,Age,19 Months,90.1,88.2 to 91.8,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2013-2014,Age,19 Months,88.7,85.6 to 91.1,558
≥1 Dose MMR,,States/Local Areas,North Carolina,2014,Age,19 Months,87.2,80.1 to 92.0,287
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2015,Age,19 Months,89.2,85.0 to 92.3,607
≥1 Dose MMR,,States/Local Areas,North Carolina,2012,Age,19 Months,89.3,85.8 to 92.1,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017,Age,19 Months,88.4,81.5 to 93.0,292
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017-2018,Age,19 Months,89.5,84.9 to 92.8,563
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018,Age,19 Months,90.5,83.6 to 94.7,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018-2019,Age,19 Months,67.7,61.6 to 73.2,585
≥1 Dose MMR,,States/Local Areas,North Carolina,2019,Age,13 Months,78.7,70.8 to 84.9,314
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016,Age,19 Months,87.8,82.0 to 91.9,352
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2017,Age,19 Months,88.1,83.8 to 91.4,644
Polio,≥2 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,95.2,91.3 to 97.4,320
Polio,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,95.2,92.2 to 97.1,672
Polio,≥2 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,95.2,91.3 to 97.4,352
Polio,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,95.8,93.0 to 97.5,644
Hep B,≥1 Dose,States/Local Areas,North Carolina,2017,Age,3 Months,98.6,96.4 to 99.5,292
Hep B,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,3 Months,97.4,94.5 to 98.8,563
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,73.0,66.0 to 79.9,506
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.6,72.6 to 84.6,703
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,80.3,70.1 to 90.4,180
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.6,67.1 to 84.1,469
Polio,≥2 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,95.2,89.8 to 97.8,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,75.2,70.3 to 80.0,1155
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,64.0,55.2 to 72.7,302
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,89.8,85.7 to 93.9,379
Hep A,≥1 Dose,States/Local Areas,North Carolina,2020,Age,35 Months,90.8,85.8 to 94.5,459
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2016,Age,0-1 Days,71.4,64.2 to 77.7,352
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2016-2017,Age,0-1 Days,74.4,69.3 to 79.0,644
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2017,Age,0-1 Days,77.4,69.8 to 83.5,292
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2017-2018,Age,0-1 Days,75.7,70.1 to 80.5,563
Hep B,≥2 Doses,States/Local Areas,North Carolina,2019,Age,5 Months,94.2,89.2 to 96.9,314
Hep B,≥2 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,91.4,84.1 to 95.5,252
Hep B,≥2 Doses,States/Local Areas,North Carolina,2017,Age,5 Months,95.0,90.7 to 97.4,292
Hep B,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,5 Months,93.7,89.6 to 96.2,563
Hep B,≥2 Doses,States/Local Areas,North Carolina,2018,Age,5 Months,92.3,84.6 to 96.3,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,5 Months,93.2,89.0 to 95.9,585
PCV,≥3 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,62.6,57.9 to 67.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,65.5,61.0 to 69.7,558
PCV,≥3 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,68.6,66.0 to 71.1,252
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,94.1,90.1 to 96.6,352
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,93.3,89.9 to 95.6,644
PCV,≥3 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,68.3,60.0 to 75.6,287
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,68.5,63.0 to 73.5,607
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,95.0,91.9 to 98.2,379
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,82.4,77.3 to 87.4,474
PCV,≥3 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,76.9,71.7 to 81.4,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,92.5,86.7 to 95.9,292
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,92.8,88.7 to 95.5,563
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,93.2,86.3 to 96.7,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,91.4,86.9 to 94.5,585
Hep B,≥2 Doses,States/Local Areas,North Carolina,2016,Age,5 Months,90.0,84.6 to 93.7,352
Hep B,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,5 Months,92.5,89.2 to 94.9,644
Hep B,≥2 Doses,States/Local Areas,North Carolina,2014,Age,5 Months,88.0,81.2 to 92.6,287
Hep B,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,5 Months,89.4,87.2 to 91.3,607
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2012,Age,0-1 Days,78.3,66.3 to 86.9,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,97.8,94.7 to 99.1,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,97.6,95.6 to 98.8,585
Polio,≥2 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,97.5,93.9 to 99.0,314
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019,Age,19 Months,94.5,89.1 to 97.3,314
Polio,≥2 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,96.4,91.8 to 98.4,292
Polio,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,97.1,94.6 to 98.4,563
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014,Age,24 Months,87.2,80.5 to 92.5,287
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2015,Age,24 Months,90.4,86.5 to 93.5,607
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013,Age,24 Months,90.7,85.0 to 94.8,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013-2014,Age,24 Months,88.9,84.7 to 92.5,558
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2013,Age,0-1 Days,74.1,68.7 to 78.7,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2013-2014,Age,0-1 Days,72.7,70.9 to 74.4,558
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2014,Age,0-1 Days,71.3,63.4 to 78.1,287
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2014-2015,Age,0-1 Days,72.2,66.9 to 76.9,607
Hep B,≥2 Doses,States/Local Areas,North Carolina,2015,Age,5 Months,90.9,85.4 to 94.4,320
Hep B,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,5 Months,90.5,86.6 to 93.3,672
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2015,Age,0-1 Days,73.1,66.0 to 79.2,320
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2015-2016,Age,0-1 Days,72.3,67.2 to 76.8,672
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017,Age,24 Months,92.4,86.2 to 96.5,292
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017-2018,Age,24 Months,91.9,87.7 to 95.1,563
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019,Age,24 Months,98.0,95.6 to 99.2,314
≥1 Dose Varicella,,States/Local Areas,North Carolina,2011,Age,35 Months,94.9,88.6 to 98.3,252
≥1 Dose Varicella,,States/Local Areas,North Carolina,2012,Age,35 Months,94.6,89.7 to 97.7,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018,Age,24 Months,91.5,85.3 to 95.8,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018-2019,Age,24 Months,94.7,91.3 to 97.1,585
≥1 Dose MMR,,States/Local Areas,North Carolina,2015,Age,24 Months,93.7,89.7 to 96.6,320
≥1 Dose MMR,,States/Local Areas,North Carolina,2015-2016,Age,24 Months,92.9,89.6 to 95.5,672
≥1 Dose MMR,,States/Local Areas,North Carolina,2014,Age,24 Months,89.1,82.8 to 93.9,287
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2015,Age,24 Months,91.4,87.7 to 94.3,607
≥1 Dose MMR,,States/Local Areas,North Carolina,2013,Age,24 Months,91.5,86.3 to 95.3,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2013-2014,Age,24 Months,90.3,86.3 to 93.5,558
PCV,≥3 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,64.4,55.8 to 72.2,292
PCV,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,70.3,64.3 to 75.7,563
PCV,≥3 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,68.7,61.1 to 75.4,320
PCV,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,70.9,65.7 to 75.6,672
PCV,≥4 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,76.9,68.9 to 83.3,287
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,80.8,75.9 to 84.9,607
PCV,≥4 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,84.8,80.4 to 88.3,320
PCV,≥4 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,80.9,76.2 to 84.9,672
PCV,≥4 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,77.0,69.8 to 82.9,352
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,80.3,75.3 to 84.5,644
PCV,≥3 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,73.1,66.1 to 79.0,352
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,68.7,63.1 to 73.8,644
Hep B,≥3 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,92.5,87.1 to 96.3,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,92.8,87.4 to 96.5,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,91.0,86.9 to 94.1,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,92.5,86.2 to 96.1,314
Hep B,≥3 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,92.5,87.3 to 96.1,252
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2018,Age,0-1 Days,74.0,65.3 to 81.1,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2018-2019,Age,0-1 Days,79.9,74.4 to 84.4,585
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2019,Age,0-1 Days,85.8,78.9 to 90.8,314
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2011,Age,0-2 Days,79.2,74.9 to 82.9,252
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2013,Age,0-2 Days,77.6,73.5 to 81.2,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2013-2014,Age,0-2 Days,75.7,73.3 to 78.0,558
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2012,Age,0-2 Days,82.4,74.4 to 88.3,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,94.4,92.0 to 96.1,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,92.2,88.2 to 94.9,558
Hep B,≥2 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,90.1,83.4 to 94.3,287
Hep B,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,92.0,88.2 to 94.6,607
Hep B,≥2 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,95.4,92.9 to 97.1,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,76.4,68.1 to 83.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,74.9,69.1 to 79.8,585
PCV,≥3 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,73.4,65.0 to 80.3,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,89.8,85.5 to 92.9,252
PCV,≥4 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,83.6,76.2 to 89.1,292
PCV,≥4 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,84.9,80.0 to 88.8,563
PCV,≥4 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,86.2,79.0 to 91.3,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,88.2,83.0 to 92.0,442
≥1 Dose MMR,,States/Local Areas,North Carolina,2017,Age,24 Months,91.6,85.6 to 95.8,292
≥1 Dose MMR,,States/Local Areas,North Carolina,2017-2018,Age,24 Months,92.5,88.6 to 95.4,563
≥1 Dose MMR,,States/Local Areas,North Carolina,2016,Age,24 Months,92.1,87.3 to 95.5,352
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2017,Age,24 Months,91.8,88.1 to 94.7,644
PCV,≥3 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,93.2,88.3 to 96.1,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,95.0,91.4 to 97.5,352
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,94.0,90.8 to 96.3,644
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,91.0,85.9 to 94.9,320
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,93.1,89.7 to 95.7,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,89.2,82.8 to 93.9,287
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,90.1,86.1 to 93.3,607
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,83.3,78.5 to 88.1,506
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.6,80.9 to 88.3,703
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,57.7 to 81.3,129
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,84.6,77.9 to 91.3,198
Hep A,≥1 Dose,States/Local Areas,North Carolina,2017,Age,35 Months,89.3,81.8 to 94.7,292
Hep A,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,35 Months,94.6,86.5 to 98.6,563
≥1 Dose Varicella,,States/Local Areas,North Carolina,2011,Age,13 Months,60.9,56.0 to 65.5,252
Hep A,≥2 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,39.3,31.4 to 48.4,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,41.1,35.3 to 47.4,585
Hep A,≥2 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,44.9,36.9 to 53.7,292
Hep A,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,42.1,36.4 to 48.3,563
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,35.0,28.6 to 42.5,352
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,40.0,34.7 to 45.7,644
DTaP,≥4 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,80.7,73.2 to 87.1,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,80.9,75.7 to 85.6,558
Hep A,≥1 Dose,States/Local Areas,North Carolina,2015,Age,35 Months,87.7,81.0 to 93.0,320
Hep A,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,35 Months,88.8,84.1 to 92.5,672
Hep A,≥1 Dose,States/Local Areas,North Carolina,2018,Age,35 Months,97.4,87.4 to 99.8,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,35 Months,93.8,88.6 to 97.2,585
Polio,≥2 Doses,States/Local Areas,North Carolina,2016,Age,5 Months,77.7,70.5 to 83.6,352
Polio,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,5 Months,77.8,72.4 to 82.4,644
Polio,≥2 Doses,States/Local Areas,North Carolina,2017,Age,5 Months,77.9,69.5 to 84.4,292
Polio,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,5 Months,82.7,77.3 to 87.0,563
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,69.4,61.3 to 76.4,287
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,67.2,61.7 to 72.2,607
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,65.0,57.5 to 71.8,320
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,67.5,62.3 to 72.2,672
Polio,≥2 Doses,States/Local Areas,North Carolina,2019,Age,5 Months,85.2,78.1 to 90.4,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,87.9,82.2 to 93.5,198
Polio,≥2 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,94.4,92.0 to 96.1,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,91.9,86.7 to 95.1,252
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,66.0,57.7 to 73.5,292
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,68.8,62.9 to 74.2,563
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,71.7,63.0 to 79.0,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,69.3,63.2 to 74.7,585
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,73.0,65.0 to 80.5,352
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,73.8,67.4 to 79.9,644
Hep A,≥2 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,76.0,66.7 to 84.4,320
Hep A,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,74.6,68.4 to 80.4,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,66.8,58.0 to 74.5,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,72.0,62.4 to 81.0,287
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,73.8,67.1 to 80.2,607
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014,Age,13 Months,56.6,48.4 to 64.4,287
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2015,Age,13 Months,58.4,52.8 to 63.8,607
≥1 Dose Varicella,,States/Local Areas,North Carolina,2012,Age,13 Months,66.3,61.4 to 70.9,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2019,Age,35 Months,93.4,87.7 to 97.1,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,80.7,75.9 to 85.6,419
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,86.2,82.5 to 89.9,673
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,65.6,44.5 to 86.8,34
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.9,68.9 to 86.9,125
Polio,≥2 Doses,States/Local Areas,North Carolina,2018,Age,5 Months,87.6,80.4 to 92.4,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,5 Months,86.4,81.6 to 90.1,585
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013,Age,13 Months,60.3,54.9 to 65.5,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013-2014,Age,13 Months,58.5,54.4 to 62.4,558
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,69.1,48.3 to 89.8,34
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,81.1,73.5 to 87.6,287
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,82.5,77.7 to 86.8,607
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,83.5,77.4 to 88.7,352
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,83.7,79.0 to 87.9,644
DTaP,≥4 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,83.8,77.8 to 89.0,320
DTaP,≥4 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,83.7,79.2 to 87.6,672
Polio,≥2 Doses,States/Local Areas,North Carolina,2015,Age,5 Months,82.4,75.9 to 87.5,320
Polio,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,5 Months,80.1,75.2 to 84.2,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,70.0,63.1 to 76.1,352
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,68.0,62.6 to 72.9,644
Hep A,≥2 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,42.9,34.8 to 52.0,314
Hep A,≥2 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,69.1,58.1 to 79.5,252
Hep A,≥2 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,72.7,61.8 to 82.6,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,73.5,64.1 to 82.1,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,72.7,65.9 to 79.1,558
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016,Age,35 Months,90.2,84.0 to 94.7,352
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,35 Months,89.5,84.6 to 93.3,644
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,83.1,78.2 to 87.9,474
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,78.3,72.4 to 84.1,302
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,82.1,75.2 to 89.1,180
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Overall,Overall,82.8,79.7 to 85.9,1155
Polio,≥2 Doses,States/Local Areas,North Carolina,2012,Age,5 Months,82.8,78.5 to 86.4,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2011,Age,5 Months,85.8,79.4 to 90.5,252
Hep A,≥1 Dose,States/Local Areas,North Carolina,2012,Age,35 Months,90.1,83.7 to 94.8,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2013,Age,5 Months,74.4,67.5 to 80.2,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,5 Months,77.2,74.4 to 79.8,558
Polio,≥2 Doses,States/Local Areas,North Carolina,2014,Age,5 Months,80.1,72.2 to 86.1,287
Polio,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,5 Months,81.2,78.6 to 83.6,607
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,93.9,90.3 to 97.5,302
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,97.3,95.2 to 99.5,379
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,91.9,87.8 to 95.9,474
Hep B,≥3 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,67.6,64.2 to 70.9,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,57.7,54.7 to 60.7,252
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,60.4,54.6 to 66.0,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,64.9,57.9 to 71.4,558
DTaP,≥4 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,77.8,69.9 to 84.1,314
DTaP,≥4 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,85.5,78.7 to 91.1,252
DTaP,≥4 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,85.7,79.2 to 91.0,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2013,Age,35 Months,90.4,83.5 to 95.2,271
Hep A,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,35 Months,85.6,80.6 to 89.9,558
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014,Age,35 Months,82.2,74.8 to 88.6,287
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,35 Months,84.8,79.9 to 89.1,607
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,94.0,91.8 to 96.1,1155
Hep A,≥2 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,35.3,28.7 to 42.9,320
Hep A,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,35.1,30.4 to 40.4,672
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,33.0,25.7 to 41.8,287
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,34.2,29.2 to 39.8,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,98.0,95.6 to 99.3,314
PCV,≥2 Doses,States/Local Areas,North Carolina,2018,Age,5 Months,86.3,78.6 to 91.5,271
PCV,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,5 Months,87.2,82.5 to 90.8,585
PCV,≥2 Doses,States/Local Areas,North Carolina,2019,Age,5 Months,88.1,81.8 to 92.4,314
PCV,≥2 Doses,States/Local Areas,North Carolina,2017,Age,5 Months,79.7,71.8 to 85.9,292
PCV,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,5 Months,83.0,77.6 to 87.2,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,94.5,90.4 to 98.7,180
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.0 to 97.0,469
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,94.1,90.7 to 97.5,506
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.0,91.5 to 96.6,703
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.1,85.4 to 98.7,125
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,85.8 to 100.0,129
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,96.3,92.5 to 100.0,198
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,69.5,62.1 to 76.0,352
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,72.7,67.3 to 77.5,644
DTaP,≥4 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,75.9,67.9 to 82.4,292
DTaP,≥4 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,74.5,68.6 to 79.6,563
DTaP,≥4 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,73.0,64.1 to 80.4,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,97.6,95.6 to 98.8,585
Hep A,≥2 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,34.3,27.3 to 42.5,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,33.6,28.4 to 39.5,558
≥1 Dose MMR,,States/Local Areas,North Carolina,2014,Age,13 Months,61.9,53.7 to 69.5,287
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2015,Age,13 Months,63.4,57.8 to 68.6,607
≥1 Dose MMR,,States/Local Areas,North Carolina,2015,Age,13 Months,64.9,57.5 to 71.7,320
≥1 Dose MMR,,States/Local Areas,North Carolina,2015-2016,Age,13 Months,65.6,60.4 to 70.5,672
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019,Age,13 Months,69.6,61.1 to 76.9,314
≥1 Dose Varicella,,States/Local Areas,North Carolina,2011,Age,19 Months,90.5,86.1 to 93.7,252
≥1 Dose Varicella,,States/Local Areas,North Carolina,2012,Age,19 Months,88.4,85.3 to 91.0,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2016,Age,13 Months,66.3,59.1 to 72.9,352
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2017,Age,13 Months,62.9,57.3 to 68.2,644
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018,Age,13 Months,65.8,56.9 to 73.8,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018-2019,Age,13 Months,67.7,61.6 to 73.2,585
DTaP,≥4 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,89.6,83.4 to 94.3,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,85.2,77.7 to 91.2,287
DTaP,≥4 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,87.9,82.9 to 92.0,607
Hep A,≥2 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,79.5,70.0 to 87.6,314
Hep B,≥3 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,90.8,86.9 to 93.7,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,88.7,80.9 to 94.3,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,86.8,81.5 to 91.2,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,89.6,88.1 to 90.9,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,86.8,82.9 to 90.0,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,84.1,76.5 to 89.6,287
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,85.8,81.1 to 89.4,607
Hep A,≥2 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,78.1,65.2 to 88.8,271
Hep A,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,79.0,71.3 to 85.8,585
Hep A,≥2 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,74.8,64.5 to 84.0,292
Hep A,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,76.5,68.3 to 83.8,563
DTaP,≥4 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,91.7,86.4 to 95.6,314
DTaP,≥4 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,91.6,84.7 to 96.2,252
DTaP,≥4 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,83.0,75.3 to 89.4,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,87.3,82.6 to 91.2,585
DTaP,≥4 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,83.8,76.5 to 89.8,292
DTaP,≥4 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,83.3,78.1 to 87.9,563
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016,Age,13 Months,65.9,58.7 to 72.4,352
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2017,Age,13 Months,61.3,55.8 to 66.6,644
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017,Age,13 Months,56.8,48.5 to 64.8,292
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017-2018,Age,13 Months,61.3,55.2 to 67.1,563
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015,Age,13 Months,60.1,52.7 to 67.1,320
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015-2016,Age,13 Months,63.0,57.8 to 67.9,672
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.8,63.7 to 85.8,129
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,82.9,76.2 to 89.6,180
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.7,75.4 to 86.0,469
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,83.6,79.0 to 88.2,506
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.8,80.0 to 87.6,703
Polio,≥2 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,87.2,79.8 to 92.1,287
Polio,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,90.5,86.4 to 93.5,607
Polio,≥2 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,87.2,84.2 to 89.8,271
Polio,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,87.2,85.0 to 89.1,558
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,77.9,71.9 to 83.9,302
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Overall,Overall,82.4,79.3 to 85.6,1155
Polio,≥2 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,93.8,89.6 to 96.4,320
Polio,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,91.3,87.6 to 93.9,672
Hep A,≥1 Dose,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,82.4,77.6 to 87.3,474
Hep B,≥3 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,86.2,78.6 to 91.4,252
≥1 Dose MMR,,States/Local Areas,North Carolina,2017,Age,13 Months,59.5,51.1 to 67.4,292
≥1 Dose MMR,,States/Local Areas,North Carolina,2017-2018,Age,13 Months,63.4,57.2 to 69.1,563
≥1 Dose MMR,,States/Local Areas,North Carolina,2018,Age,13 Months,67.3,58.2 to 75.3,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2018-2019,Age,13 Months,73.0,67.0 to 78.2,585
PCV,≥4 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,77.3,73.5 to 80.6,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,77.1,74.8 to 79.2,558
PCV,≥4 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,81.3,74.8 to 86.4,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,84.4,81.7 to 86.7,252
≥1 Dose MMR,,States/Local Areas,North Carolina,2018,Age,19 Months,90.8,84.0 to 94.9,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2018-2019,Age,19 Months,97.3,95.1 to 98.5,585
≥1 Dose MMR,,States/Local Areas,North Carolina,2019,Age,19 Months,94.6,89.2 to 97.4,314
≥1 Dose MMR,,States/Local Areas,North Carolina,2011,Age,24 Months,93.7,87.8 to 97.4,252
≥1 Dose MMR,,States/Local Areas,North Carolina,2012,Age,24 Months,90.2,84.6 to 94.4,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015,Age,24 Months,93.5,89.4 to 96.4,320
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015-2016,Age,24 Months,92.0,88.5 to 94.7,672
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016,Age,24 Months,90.4,85.2 to 94.3,352
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2017,Age,24 Months,91.3,87.5 to 94.4,644
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2014,Age,0-2 Days,73.9,66.0 to 80.5,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2014-2015,Age,0-2 Days,74.2,69.0 to 78.9,607
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2015,Age,0-2 Days,74.6,67.5 to 80.6,320
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2015-2016,Age,0-2 Days,74.3,69.2 to 78.7,672
PCV,≥4 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,88.2,81.6 to 93.2,252
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015,Age,35 Months,95.5,91.2 to 98.1,320
≥1 Dose Varicella,,States/Local Areas,North Carolina,2015-2016,Age,35 Months,95.0,91.3 to 97.4,672
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014,Age,35 Months,87.4,80.6 to 92.6,287
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2015,Age,35 Months,91.4,87.5 to 94.5,607
PCV,≥4 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,90.1,84.3 to 93.9,314
≥1 Dose MMR,,States/Local Areas,North Carolina,2018,Age,24 Months,93.3,88.1 to 96.8,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2018-2019,Age,24 Months,95.6,92.7 to 97.6,585
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013,Age,35 Months,94.9,88.3 to 98.3,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2013-2014,Age,35 Months,90.5,86.2 to 94.0,558
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2016,Age,0-2 Days,73.9,66.8 to 79.9,352
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2016-2017,Age,0-2 Days,76.6,71.5 to 81.0,644
Hep B,≥2 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,93.2,88.5 to 96.1,352
Hep B,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,94.7,91.7 to 96.7,644
PCV,≥3 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,86.2,82.7 to 89.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,85.8,83.0 to 88.2,558
Hep B,≥2 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,96.2,91.9 to 98.3,292
Hep B,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,96.9,94.6 to 98.3,563
PCV,≥3 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,85.5,77.8 to 90.8,287
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,88.7,84.3 to 92.0,607
PCV,≥3 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,91.9,87.2 to 95.0,320
PCV,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,91.2,87.5 to 93.8,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,93.2,87.2 to 97.0,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,94.3,90.5 to 96.9,585
Hep B,≥2 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,93.8,89.5 to 96.4,320
Hep B,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,93.5,90.1 to 95.8,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,92.4,90.2 to 94.2,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,90.5,83.0 to 94.9,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,91.4,86.9 to 94.5,585
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,92.3,86.1 to 95.9,314
Hep B,≥3 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,91.0,84.7 to 94.8,252
DTaP,≥4 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,96.7,90.1 to 99.4,271
DTaP,≥4 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,97.7,94.0 to 99.4,585
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017,Age,35 Months,92.4,86.2 to 96.5,292
≥1 Dose Varicella,,States/Local Areas,North Carolina,2017-2018,Age,35 Months,96.7,90.3 to 99.3,563
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2017,Age,0-2 Days,79.2,71.7 to 85.1,292
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2017-2018,Age,0-2 Days,78.0,72.4 to 82.7,563
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2018,Age,0-2 Days,76.8,68.1 to 83.7,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2018-2019,Age,0-2 Days,82.6,77.3 to 87.0,585
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2019,Age,0-2 Days,88.5,82.0 to 92.8,314
Hep B,≥2 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,97.6,94.6 to 99.0,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,97.8,96.2 to 98.7,585
Hib,≥1 Dose,States/Local Areas,North Carolina,2013,Age,3 Months,85.9,81.4 to 89.4,271
Hib,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,3 Months,86.9,84.3 to 89.1,558
Hib,≥1 Dose,States/Local Areas,North Carolina,2012,Age,3 Months,90.6,88.1 to 92.7,271
Hib,≥1 Dose,States/Local Areas,North Carolina,2011,Age,3 Months,89.1,82.2 to 93.5,252
Hib,≥1 Dose,States/Local Areas,North Carolina,2014,Age,3 Months,87.9,80.7 to 92.6,287
Hib,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,3 Months,89.0,84.7 to 92.2,607
Hep B,≥2 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,90.9,84.1 to 94.9,287
Hep B,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,93.6,89.9 to 96.0,607
Hep B,≥2 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,96.3,92.7 to 98.2,320
Hep B,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,95.9,92.9 to 97.7,672
Hep B,≥2 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,95.5,91.5 to 97.7,352
Hep B,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,96.0,93.2 to 97.7,644
PCV,≥3 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,96.6,93.1 to 98.4,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2011,Age,19 Months,93.1,87.3 to 96.4,252
PCV,≥3 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,89.4,87.0 to 91.5,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,89.1,86.4 to 91.3,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,95.7,92.1 to 98.0,352
Hep B,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,94.6,91.4 to 96.9,644
PCV,≥4 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,94.8,91.1 to 97.3,314
PCV,≥4 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,88.0,81.6 to 93.0,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,91.4,87.6 to 94.3,585
PCV,≥4 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,88.8,82.1 to 93.8,252
PCV,≥4 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,89.5,83.5 to 94.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2012,Age,19 Months,94.3,90.4 to 96.6,271
Hib,Full Series,States/Local Areas,North Carolina,2020,Age,24 Months,82.2,76.7 to 87.0,459
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,93.5,88.2 to 97.0,292
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,93.4,89.6 to 96.2,563
Hep B,≥2 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,98.0,95.9 to 99.0,314
Hep B,≥2 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,93.7,89.1 to 96.5,252
Hep B,≥2 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,94.6,92.4 to 96.2,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,92.8,88.6 to 95.5,558
Hep B,≥2 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,96.7,95.7 to 97.4,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,89.2,82.2 to 93.7,292
PCV,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,91.3,87.0 to 94.2,563
PCV,≥3 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,93.3,87.6 to 96.5,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,95.0,91.8 to 96.9,585
Hep B,≥3 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,95.4,91.0 to 98.1,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,94.6,88.1 to 98.2,320
Hep B,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,95.2,91.4 to 97.7,672
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,89.5,83.1 to 94.2,287
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,91.7,87.5 to 95.0,607
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,92.8,87.4 to 96.5,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,91.1,87.1 to 94.3,558
PCV,≥3 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,90.4,85.1 to 94.0,352
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,89.8,85.6 to 92.9,644
≥1 Dose MMR,,States/Local Areas,North Carolina,2014,Age,35 Months,89.2,82.9 to 94.0,287
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2015,Age,35 Months,92.1,88.4 to 95.0,607
≥1 Dose MMR,,States/Local Areas,North Carolina,2015,Age,35 Months,95.1,91.0 to 97.8,320
≥1 Dose MMR,,States/Local Areas,North Carolina,2015-2016,Age,35 Months,94.3,90.9 to 96.8,672
PCV,≥4 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,85.4,78.6 to 91.0,292
PCV,≥4 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,86.7,82.1 to 90.6,563
PCV,≥4 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,84.0,78.2 to 89.0,352
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,84.7,80.3 to 88.6,644
PCV,≥4 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,87.8,82.7 to 92.0,320
PCV,≥4 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,85.9,81.9 to 89.5,672
≥1 Dose MMR,,States/Local Areas,North Carolina,2016,Age,35 Months,93.7,88.7 to 96.9,352
≥1 Dose MMR,,States/Local Areas,North Carolina,2016-2017,Age,35 Months,92.5,88.7 to 95.4,644
≥1 Dose Varicella,,States/Local Areas,North Carolina,2019,Age,35 Months,98.8,97.3 to 99.6,314
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,90.8,87.2 to 94.4,419
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,93.9,91.3 to 96.5,673
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,81.8,65.0 to 98.5,34
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.3,86.2 to 98.3,125
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016,Age,35 Months,95.1,89.4 to 98.3,352
≥1 Dose Varicella,,States/Local Areas,North Carolina,2016-2017,Age,35 Months,93.6,89.3 to 96.6,644
≥1 Dose MMR,,States/Local Areas,North Carolina,2013,Age,35 Months,95.8,90.2 to 98.7,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2013-2014,Age,35 Months,92.2,88.2 to 95.3,558
≥1 Dose MMR,,States/Local Areas,North Carolina,2011,Age,35 Months,95.1,88.9 to 98.4,252
≥1 Dose MMR,,States/Local Areas,North Carolina,2012,Age,35 Months,94.7,89.8 to 97.7,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2019,Age,24 Months,97.9,95.6 to 99.2,314
PCV,≥4 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,79.7,72.2 to 86.2,287
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,83.7,79.2 to 87.8,607
PCV,≥4 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,78.2,70.9 to 84.8,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,79.0,73.8 to 83.8,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,95.3,90.1 to 98.2,314
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,92.9,87.6 to 96.4,292
Hep B,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,93.0,89.2 to 95.8,563
Hep B,≥3 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,93.1,87.8 to 96.7,252
PCV,≥4 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,86.4,80.0 to 91.5,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018,Age,35 Months,97.9,90.3 to 99.8,271
≥1 Dose Varicella,,States/Local Areas,North Carolina,2018-2019,Age,35 Months,98.6,94.2 to 99.8,585
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,89.9,84.2 to 95.5,198
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,93.2,89.3 to 97.0,180
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.0,85.9 to 94.2,469
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,91.3,87.3 to 95.4,302
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Overall,Overall,91.6,89.3 to 93.9,1155
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,88.7 to 95.5,506
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.0,89.2 to 94.8,703
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,83.5 to 98.1,129
≥1 Dose MMR,,States/Local Areas,North Carolina,2019,Age,35 Months,98.8,97.3 to 99.6,314
PCV,≥4 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,82.1,74.3 to 88.6,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,80.9,75.7 to 85.7,558
≥1 Dose MMR,,States/Local Areas,North Carolina,2018,Age,35 Months,94.6,89.3 to 97.8,271
≥1 Dose MMR,,States/Local Areas,North Carolina,2018-2019,Age,35 Months,96.7,93.9 to 98.4,585
≥1 Dose MMR,,States/Local Areas,North Carolina,2017,Age,35 Months,91.6,85.6 to 95.8,292
≥1 Dose MMR,,States/Local Areas,North Carolina,2017-2018,Age,35 Months,93.2,89.3 to 96.0,563
Hib,≥1 Dose,States/Local Areas,North Carolina,2015,Age,3 Months,90.1,84.5 to 93.8,320
Hib,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,3 Months,89.6,85.6 to 92.5,672
Hib,≥1 Dose,States/Local Areas,North Carolina,2016,Age,3 Months,89.0,83.6 to 92.8,352
Hib,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,3 Months,89.9,85.9 to 92.9,644
Hib,≥1 Dose,States/Local Areas,North Carolina,2017,Age,3 Months,90.8,84.3 to 94.8,292
Hib,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,3 Months,89.9,85.3 to 93.2,563
Hep B,≥2 Doses,States/Local Areas,North Carolina,2017,Age,13 Months,96.5,92.2 to 98.5,292
Hep B,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,13 Months,97.1,94.8 to 98.5,563
Hep B,≥2 Doses,States/Local Areas,North Carolina,2018,Age,13 Months,97.8,94.7 to 99.1,271
Hep B,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,13 Months,98.1,96.5 to 99.0,585
Hep B,≥2 Doses,States/Local Areas,North Carolina,2019,Age,13 Months,98.4,96.4 to 99.3,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,94.6,92.9 to 95.9,320
PCV,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,93.6,90.3 to 95.8,672
PCV,≥3 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,92.6,87.9 to 95.6,352
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,91.8,88.0 to 94.5,644
Hep A,≥2 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.8,60.0 to 83.6,125
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,89.1,84.9 to 93.2,474
Hib,≥1 Dose,States/Local Areas,North Carolina,2018,Age,3 Months,89.0,81.5 to 93.7,271
Hib,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,3 Months,91.8,87.6 to 94.7,585
Hib,≥1 Dose,States/Local Areas,North Carolina,2019,Age,3 Months,94.6,90.1 to 97.2,314
≥1 Dose Varicella,,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,96.2,93.8 to 98.6,379
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,90.6 to 97.0,506
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.9,90.4 to 95.4,703
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.5,87.6 to 99.4,125
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,91.4,79.7 to 100.0,34
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.4,80.6 to 96.1,129
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,93.3,88.8 to 97.8,198
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,94.4,92.0 to 96.8,673
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,91.6,88.2 to 94.9,419
PCV,≥4 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,85.8,79.9 to 90.7,352
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,86.0,81.5 to 89.8,644
PCV,≥4 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,89.9,84.5 to 94.0,320
PCV,≥4 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,87.8,83.7 to 91.3,672
PCV,≥4 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,80.4,72.9 to 87.0,287
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,85.0,80.4 to 89.0,607
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,93.2,87.2 to 97.0,271
Hep B,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,94.4,90.6 to 97.1,585
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,95.6,90.3 to 98.5,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,88.8,81.5 to 93.5,287
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,91.7,87.7 to 94.5,607
PCV,≥3 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,95.2,91.7 to 97.5,320
PCV,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,94.8,91.9 to 97.0,672
PCV,≥3 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,91.8,85.5 to 96.1,287
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,93.5,90.0 to 96.1,607
PCV,≥3 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,94.9,91.4 to 97.3,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2017,Age,5 Months,80.5,72.5 to 86.6,292
Hib,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,5 Months,83.7,78.6 to 87.7,563
PCV,≥3 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,89.4,83.4 to 94.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,90.7,86.5 to 94.1,558
PCV,≥1 Dose,States/Local Areas,North Carolina,2013,Age,3 Months,82.6,78.5 to 86.1,271
PCV,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,3 Months,85.1,82.2 to 87.6,558
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.6,74.4 to 90.9,125
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,82.2,75.4 to 89.0,198
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,71.2,50.6 to 91.8,34
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,81.5,76.7 to 86.3,419
Hib,≥2 Doses,States/Local Areas,North Carolina,2015,Age,5 Months,82.1,75.6 to 87.2,320
Hib,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,5 Months,80.6,75.8 to 84.7,672
Hib,≥2 Doses,States/Local Areas,North Carolina,2016,Age,5 Months,79.1,72.1 to 84.8,352
Hib,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,5 Months,79.8,74.6 to 84.1,644
PCV,≥1 Dose,States/Local Areas,North Carolina,2011,Age,3 Months,87.0,79.3 to 92.2,252
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,95.8,93.2 to 98.3,379
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,90.9,87.1 to 94.7,474
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,91.7,87.5 to 95.9,180
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.6,87.9 to 95.2,469
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,92.7,89.1 to 96.3,302
≥1 Dose MMR,,States/Local Areas,North Carolina,2014-2017,Overall,Overall,92.7,90.6 to 94.8,1155
PCV,≥3 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,94.6,88.9 to 97.5,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,95.0,91.8 to 96.9,585
PCV,≥3 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,97.0,93.5 to 98.7,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,95.2,90.4 to 98.1,252
Hib,≥2 Doses,States/Local Areas,North Carolina,2013,Age,5 Months,76.2,69.7 to 81.7,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,5 Months,78.3,75.9 to 80.6,558
Hib,≥2 Doses,States/Local Areas,North Carolina,2014,Age,5 Months,80.4,72.6 to 86.4,287
Hib,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,5 Months,81.3,78.7 to 83.6,607
PCV,≥3 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,91.0,84.5 to 95.0,292
PCV,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,92.8,88.8 to 95.4,563
Hib,≥2 Doses,States/Local Areas,North Carolina,2012,Age,5 Months,82.8,78.5 to 86.4,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2011,Age,5 Months,86.7,82.1 to 90.3,252
PCV,≥4 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,86.3,79.3 to 91.8,292
PCV,≥4 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,87.2,82.6 to 91.1,563
PCV,≥4 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,88.2,81.7 to 93.2,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,92.4,88.7 to 95.2,585
PCV,≥4 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,96.6,93.6 to 98.5,314
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,93.3,90.2 to 96.4,379
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,83.9,79.0 to 88.8,474
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,79.7,74.0 to 85.5,302
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.2,77.1 to 87.3,469
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,80.2,61.5 to 98.9,34
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,84.0,77.3 to 90.7,180
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,84.6,81.6 to 87.6,1155
Hib,≥2 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,88.7,85.5 to 91.2,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,88.5,86.7 to 90.1,558
Hib,≥2 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,88.3,80.9 to 93.1,287
Hib,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,90.7,86.6 to 93.6,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2012,Age,0-3 Days,83.7,77.1 to 88.7,271
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,86.6,82.2 to 91.1,506
PCV,≥1 Dose,States/Local Areas,North Carolina,2012,Age,3 Months,91.1,88.8 to 93.0,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2011,Age,0-3 Days,79.8,72.0 to 85.8,252
PCV,≥1 Dose,States/Local Areas,North Carolina,2018,Age,3 Months,91.2,84.1 to 95.4,271
PCV,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,3 Months,93.3,89.4 to 95.8,585
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,92.6,89.2 to 96.0,419
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,89.2,85.9 to 92.6,673
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.3,87.3 to 99.4,125
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.8 to 96.1,673
PCV,≥1 Dose,States/Local Areas,North Carolina,2016,Age,3 Months,89.6,84.2 to 93.3,352
PCV,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,3 Months,89.8,85.8 to 92.8,644
PCV,≥1 Dose,States/Local Areas,North Carolina,2017,Age,3 Months,90.1,83.6 to 94.2,292
PCV,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,3 Months,90.6,86.2 to 93.8,563
Hib,≥2 Doses,States/Local Areas,North Carolina,2018,Age,5 Months,86.9,80.1 to 91.7,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,5 Months,86.6,82.0 to 90.1,585
Hib,≥2 Doses,States/Local Areas,North Carolina,2019,Age,5 Months,86.2,79.4 to 91.0,314
Hib,≥2 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,92.2,87.0 to 95.5,252
PCV,≥3 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,94.5,90.4 to 97.2,352
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,92.8,89.3 to 95.6,644
Hib,≥2 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,93.0,90.1 to 95.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,91.0,85.2 to 95.3,292
PCV,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,92.8,89.1 to 95.6,563
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014,Age,0-3 Days,74.0,66.1 to 80.6,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2015,Age,0-3 Days,74.5,69.3 to 79.2,607
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,64.6,59.8 to 69.1,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,67.5,64.2 to 70.6,558
DTaP,≥3 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,78.7,73.2 to 83.4,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,72.2,70.0 to 74.3,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2013,Age,0-3 Days,80.3,73.1 to 85.9,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2013-2014,Age,0-3 Days,77.1,71.9 to 81.6,558
Polio,≥1 Dose,States/Local Areas,North Carolina,2013,Age,3 Months,84.3,79.7 to 88.0,271
Polio,≥1 Dose,States/Local Areas,North Carolina,2013-2014,Age,3 Months,85.5,82.9 to 87.7,558
PCV,≥1 Dose,States/Local Areas,North Carolina,2019,Age,3 Months,95.4,91.0 to 97.7,314
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Overall,Overall,92.5,90.2 to 94.7,1155
Polio,≥1 Dose,States/Local Areas,North Carolina,2012,Age,3 Months,91.4,89.3 to 93.1,271
Polio,≥1 Dose,States/Local Areas,North Carolina,2011,Age,3 Months,88.3,79.5 to 93.6,252
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.1 to 90.2,703
PCV,≥4 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,71.9 to 91.8,129
PCV,≥1 Dose,States/Local Areas,North Carolina,2014,Age,3 Months,87.6,80.5 to 92.3,287
PCV,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,3 Months,88.5,84.3 to 91.7,607
PCV,≥1 Dose,States/Local Areas,North Carolina,2015,Age,3 Months,89.5,83.9 to 93.3,320
PCV,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,3 Months,89.5,85.6 to 92.5,672
PCV,≥3 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,94.6,89.6 to 97.7,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,96.2,93.4 to 98.0,585
Hib,≥2 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,93.1,88.8 to 95.8,320
Hib,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,91.2,87.5 to 93.9,672
PCV,≥3 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,97.8,94.9 to 99.2,314
PCV,≥3 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,95.2,90.4 to 98.1,252
PCV,≥3 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,89.4,83.4 to 94.0,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,90.7,86.5 to 94.1,558
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,94.5,90.0 to 99.0,180
Hib,≥2 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,89.3,83.5 to 93.3,352
Hib,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,90.6,86.5 to 93.6,644
Hib,≥2 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,91.9,85.4 to 95.6,292
Hib,≥2 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,92.9,89.0 to 95.5,563
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,93.7,90.4 to 97.0,302
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,94.6,91.4 to 97.7,379
Hep B,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,89.9,85.6 to 94.2,474
Hib,≥3 Doses,States/Local Areas,North Carolina,2012,Age,7 Months,56.1,52.1 to 60.0,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2011,Age,7 Months,56.8,54.1 to 59.4,252
Hib,≥3 Doses,States/Local Areas,North Carolina,2013,Age,7 Months,38.4,32.3 to 44.9,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,7 Months,38.2,34.4 to 42.3,558
Polio,≥1 Dose,States/Local Areas,North Carolina,2014,Age,3 Months,86.6,79.5 to 91.6,287
Polio,≥1 Dose,States/Local Areas,North Carolina,2014-2015,Age,3 Months,88.7,84.4 to 91.9,607
Polio,≥1 Dose,States/Local Areas,North Carolina,2015,Age,3 Months,90.7,85.1 to 94.3,320
Polio,≥1 Dose,States/Local Areas,North Carolina,2015-2016,Age,3 Months,89.4,85.4 to 92.4,672
Polio,≥1 Dose,States/Local Areas,North Carolina,2016,Age,3 Months,88.1,82.4 to 92.1,352
Polio,≥1 Dose,States/Local Areas,North Carolina,2016-2017,Age,3 Months,88.3,83.8 to 91.6,644
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2017,Age,0-3 Days,83.0,73.9 to 89.4,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2017-2018,Age,0-3 Days,80.7,75.2 to 85.2,563
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016,Age,0-3 Days,73.9,66.8 to 79.9,352
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2016-2017,Age,0-3 Days,78.3,73.4 to 82.6,644
Hib,≥2 Doses,States/Local Areas,North Carolina,2012,Age,13 Months,95.8,93.4 to 97.4,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,93.9,86.6 to 97.4,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,69.1,61.5 to 75.8,320
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,72.4,67.2 to 77.0,672
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,70.4,62.1 to 77.5,287
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,69.7,64.2 to 74.8,607
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2015,Age,0-3 Days,75.1,68.0 to 81.0,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2015-2016,Age,0-3 Days,74.5,69.5 to 78.9,672
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,75.7,68.8 to 81.5,352
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,70.7,65.1 to 75.8,644
Hib,≥2 Doses,States/Local Areas,North Carolina,2013,Age,13 Months,91.5,89.7 to 93.0,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,13 Months,91.2,89.3 to 92.8,558
PCV,≥3 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,92.8,87.1 to 96.6,292
PCV,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,93.7,90.1 to 96.3,563
PCV,≥3 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,94.6,89.6 to 97.7,271
PCV,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,96.3,93.5 to 98.1,585
Hib,≥3 Doses,States/Local Areas,North Carolina,2014,Age,7 Months,38.0,30.5 to 46.2,287
Hib,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,7 Months,37.0,31.9 to 42.4,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2015,Age,7 Months,36.0,29.4 to 43.1,320
Hib,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,7 Months,39.0,34.2 to 44.0,672
Hib,≥3 Doses,States/Local Areas,North Carolina,2016,Age,7 Months,42.0,35.3 to 49.1,352
Hib,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,7 Months,39.4,34.3 to 44.7,644
Polio,≥1 Dose,States/Local Areas,North Carolina,2017,Age,3 Months,88.4,81.0 to 93.2,292
Polio,≥1 Dose,States/Local Areas,North Carolina,2017-2018,Age,3 Months,89.8,84.9 to 93.2,563
Polio,≥1 Dose,States/Local Areas,North Carolina,2018,Age,3 Months,91.1,83.9 to 95.3,271
Polio,≥1 Dose,States/Local Areas,North Carolina,2018-2019,Age,3 Months,92.4,88.2 to 95.1,585
Hib,≥2 Doses,States/Local Areas,North Carolina,2015,Age,13 Months,94.5,90.5 to 96.9,320
Hib,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,13 Months,94.9,91.8 to 96.8,672
Hib,≥2 Doses,States/Local Areas,North Carolina,2016,Age,13 Months,95.3,91.3 to 97.5,352
Hib,≥2 Doses,States/Local Areas,North Carolina,2016-2017,Age,13 Months,95.8,93.0 to 97.5,644
Hib,≥2 Doses,States/Local Areas,North Carolina,2014,Age,13 Months,91.0,83.9 to 95.1,287
Hib,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,13 Months,92.7,88.9 to 95.3,607
Hib,≥2 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,94.0,88.3 to 97.0,271
Hib,≥2 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,95.2,92.0 to 97.2,585
PCV,≥3 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,91.8,85.5 to 96.1,287
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,94.7,90.8 to 97.3,607
PCV,≥3 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,97.6,92.8 to 99.5,320
PCV,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,97.2,94.2 to 98.9,672
PCV,≥3 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,96.9,93.3 to 98.8,352
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,94.9,91.5 to 97.2,644
Hib,≥3 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,36.8,29.6 to 44.7,292
Hib,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,41.0,35.3 to 46.9,563
Hib,≥3 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,45.3,36.8 to 54.1,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,45.9,39.9 to 52.0,585
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.1,85.5 to 98.7,125
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,80.2,61.5 to 98.9,34
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,85.1 to 99.5,129
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,94.0,89.8 to 98.3,198
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,93.4,90.1 to 96.7,419
PCV,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,95.3,93.1 to 97.6,673
PCV,≥3 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,98.0,95.2 to 99.3,314
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2018,Age,0-3 Days,78.7,70.0 to 85.5,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2018-2019,Age,0-3 Days,85.0,79.8 to 89.0,585
Polio,≥1 Dose,States/Local Areas,North Carolina,2019,Age,3 Months,93.6,88.2 to 96.6,314
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2019,Age,0-3 Days,91.3,85.9 to 94.7,314
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,76.0,71.5 to 80.6,673
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.5,64.9 to 84.2,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,76.5,71.0 to 82.0,419
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018,Age,7 Months,80.5,72.9 to 86.3,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,7 Months,77.1,71.5 to 81.8,585
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019,Age,7 Months,73.6,65.2 to 80.6,314
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017,Age,7 Months,65.8,57.1 to 73.5,292
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,7 Months,73.0,67.2 to 78.2,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2011,Age,13 Months,92.2,85.9 to 95.8,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,74.5,55.5 to 93.6,34
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,3 Months,87.5,81.3 to 91.9,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,81.3,72.7 to 89.9,557
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,68.2,57.9 to 78.4,223
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.0 to 97.9,557
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.8,93.4 to 100.0,125
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.2,52.9 to 89.4,44
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,80.1,71.5 to 88.7,156
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,83.1 to 97.7,125
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,94.4,87.3 to 100.0,89
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,94.6,91.8 to 97.3,557
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,91.7,86.4 to 97.1,223
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,92.4,83.7 to 100.0,89
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,80.5,76.5 to 84.6,882
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,71.9,62.6 to 81.1,156
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,85.2,74.3 to 96.0,89
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,93.6,91.0 to 96.2,882
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,79.4,72.9 to 86.0,398
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,92.2,89.3 to 95.1,882
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,69.0,60.7 to 77.3,221
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,92.8,90.1 to 95.4,882
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,82.1,75.2 to 89.0,263
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,81.7,77.8 to 85.6,882
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,75.1,67.5 to 82.7,221
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,88.1,77.9 to 98.3,398
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,80.9,76.9 to 84.8,882
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,93.1,88.2 to 98.1,263
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,74.1,64.3 to 83.8,263
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,86.0,79.5 to 92.4,221
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,68.4,64.0 to 72.8,882
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,76.0,71.8 to 80.1,882
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,87.3,81.1 to 93.5,221
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,76.0,69.5 to 82.6,882
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,78.0,71.5 to 84.5,398
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,74.8,70.3 to 79.2,882
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,90.6,87.6 to 93.6,882
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,98.2,96.3 to 100.0,398
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,67.4,59.2 to 75.6,263
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,94.6,90.4 to 98.8,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,78.9,71.8 to 86.1,221
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,56.0,47.5 to 64.5,221
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,94.5,91.0 to 97.9,398
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,93.1,88.4 to 97.7,263
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,67.1,62.6 to 71.7,882
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,78.2,74.2 to 82.3,882
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,97.6,95.4 to 99.8,398
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,93.2,88.6 to 97.9,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,77.6,65.9 to 89.3,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.5,69.3 to 79.8,580
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,92.3,85.0 to 99.5,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,79.3,70.7 to 87.9,201
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,66.1,56.0 to 76.2,201
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,95.4,89.5 to 100.0,101
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,86.9 to 99.0,201
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,89.8 to 96.4,580
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,49.8,36.0 to 63.5,101
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,83.4,74.9 to 91.8,201
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.9,88.6 to 95.2,580
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,5 Months,80.3,74.6 to 85.0,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,88.5,79.0 to 94.0,184
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2021,Age,0-1 Days,75.5,65.6 to 83.3,184
Rotavirus,,States/Local Areas,NY-Rest of state,2019-2020,Age,8 Months,77.5,71.6 to 82.4,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,97.5,90.1 to 99.7,466
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2021,Age,0-2 Days,77.1,67.4 to 84.6,184
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,93.3,88.6 to 96.2,466
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2021,Age,24 Months,90.5,82.8 to 95.7,184
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,92.9,85.1 to 97.5,184
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,3 Months,91.2,82.9 to 95.6,184
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,82.0,73.0 to 89.5,184
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,89.5,80.7 to 95.5,184
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,21.0,14.2 to 29.8,184
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,93.4,84.4 to 97.3,184
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,13 Months,87.9,78.4 to 93.6,184
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,19 Months,77.4,68.1 to 84.6,184
Combined 7 Series,,States/Local Areas,NY-Rest of state,2021,Age,24 Months,73.8,64.8 to 82.2,184
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,76.1,70.1 to 81.2,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,72.0,62.2 to 80.2,184
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,3 Months,92.1,83.6 to 96.4,184
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,32.6,23.7 to 43.6,184
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,97.3,93.4 to 99.2,466
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,92.2,83.6 to 97.2,184
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,93.6,84.6 to 97.5,184
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,92.8,88.1 to 96.1,466
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2021,Age,24 Months,81.4,72.7 to 88.6,184
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2021,Age,24 Months,84.2,75.5 to 91.1,184
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2021,Age,24 Months,91.8,83.9 to 96.7,184
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,50.8,41.1 to 60.5,184
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,63.1,55.0 to 70.5,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,92.2,86.3 to 95.6,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,45.8,38.3 to 53.6,282
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,3 Months,92.0,86.2 to 95.5,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,91.0,85.3 to 95.1,282
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,3 Months,85.5,78.9 to 90.2,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,77.0,67.3 to 86.7,201
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,93.6,87.2 to 100.0,101
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.3,76.5 to 86.0,580
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,83.4,73.5 to 93.4,101
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,87.4 to 99.4,201
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.2 to 97.4,580
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,73.2,60.6 to 85.8,201
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,85.9 to 98.4,201
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,95.6,89.7 to 100.0,101
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,90.3,83.5 to 97.1,201
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,77.4,64.4 to 90.4,101
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.8,67.5 to 86.0,580
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,67.7,59.1 to 76.3,221
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,77.2,69.7 to 84.8,263
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,91.0,86.2 to 95.8,398
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,76.8,70.2 to 83.3,398
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,83.9,77.4 to 90.4,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,71.8,68.5 to 79.6,263
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,67.7,57.4 to 78.0,221
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,96.3,93.4 to 99.1,398
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,92.6,88.2 to 97.0,263
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,82.5 to 96.0,201
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,91.1,85.5 to 96.8,221
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,91.5,88.7 to 94.4,882
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Overall,Overall,94.5,92.0 to 97.0,882
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,63.9,55.7 to 72.2,263
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,58.9,50.7 to 67.1,221
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,95.6,92.8 to 98.5,398
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,87.3,81.1 to 93.5,221
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,88.4,82.6 to 94.3,263
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,91.4,87.1 to 95.6,398
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,81.1,74.0 to 88.2,263
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,89.1,83.2 to 95.0,221
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,90.0,84.2 to 95.8,221
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,87.5,82.5 to 92.5,398
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,66.0,57.8 to 74.2,221
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Poverty,133% to <400% FPL,81.3,74.5 to 88.2,263
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,85.7,80.1 to 91.3,398
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Poverty,<133% FPL,70.0,62.1 to 78.0,221
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Poverty,>400% FPL,81.7,75.9 to 87.4,398
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,91.1,85.2 to 97.1,223
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,70.3,56.3 to 84.4,89
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,59.6,51.0 to 68.2,223
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.2,86.2 to 94.3,557
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.6,89.2 to 96.1,557
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.0,72.6 to 83.5,557
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",99.1,97.5 to 100.0,125
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.5,85.4 to 93.6,557
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.7,77.4 to 100.0,44
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.5,43.4 to 81.5,44
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",48.2,28.2 to 68.3,44
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,73.7,68.1 to 79.3,557
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.7,76.7 to 86.7,557
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,77.6,70.3 to 84.9,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,74.4,68.8 to 80.0,557
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,91.3,85.7 to 96.9,156
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.7,82.1 to 100.0,44
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,83.1,72.0 to 94.2,89
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,86.8,80.4 to 93.2,223
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,97.0,94.9 to 99.1,557
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.7,94.7 to 100.0,125
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,82.9,78.1 to 87.7,557
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,82.6 to 97.3,125
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,58.6,50.1 to 67.1,223
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,96.5,92.5 to 100.0,156
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,80.8,72.5 to 89.0,156
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,55.5,40.7 to 70.3,89
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,77.2 to 93.3,125
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,76.6,61.2 to 91.9,89
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,67.5,59.0 to 75.9,223
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.5,50.3 to 86.6,44
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,66.7,52.2 to 81.2,89
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,62.2,51.9 to 72.6,156
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.3,63.5 to 75.1,557
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",48.6,29.7 to 67.6,44
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,76.0,67.1 to 84.9,156
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.2,63.7 to 86.8,125
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.7,77.7 to 87.7,557
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,79.1,70.5 to 87.6,156
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.6,52.4 to 88.8,44
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.3,62.6 to 74.0,557
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.4,59.5 to 83.3,125
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.1,94.7 to 100.0,125
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",56.0,37.7 to 74.3,44
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.3,88.5 to 96.0,557
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.4,75.1 to 100.0,44
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,77.1,72.1 to 82.1,557
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,91.0,81.9 to 100.0,89
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,91.3,85.2 to 97.4,156
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.8,86.8 to 94.8,557
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.1,73.4 to 100.0,44
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,95.0,92.3 to 97.6,557
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,69.5,61.1 to 77.8,223
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,94.4,87.3 to 100.0,89
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,86.3,79.7 to 92.8,223
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,88.9,79.3 to 98.6,89
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,83.4,72.8 to 93.9,89
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,77.0,68.1 to 85.9,156
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.6,51.6 to 89.6,44
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,94.3,87.1 to 100.0,89
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.5,73.1 to 83.8,557
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,68.0,59.8 to 76.2,223
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,82.0,70.3 to 93.7,89
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.1 to 98.6,557
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,90.2,84.2 to 96.2,223
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.8,74.5 to 85.1,557
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,89.2 to 96.6,557
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Other,84.3,72.2 to 96.3,89
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.4,75.1 to 100.0,44
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,98.1,95.5 to 100.0,156
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,87.7,83.5 to 91.9,557
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.4,64.0 to 94.7,44
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,Hispanic,95.5,91.6 to 99.5,156
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,5 Months,83.9,76.5 to 89.3,282
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,5 Months,80.0,72.7 to 85.7,282
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,5 Months,81.1,73.9 to 86.6,282
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,3 Months,86.9,80.6 to 91.3,282
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,5 Months,81.5,74.3 to 87.0,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,30.9,24.1 to 39.0,282
Combined 7 Series,,States/Local Areas,NY-Rest of state,2020,Age,24 Months,67.4,59.7 to 75.0,282
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,24 Months,81.7,75.1 to 87.3,282
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,82.8,75.9 to 88.6,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,92.2,86.9 to 95.9,282
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2020,Age,0-3 Days,78.6,71.1 to 84.6,282
Rotavirus,,States/Local Areas,NY-Rest of state,2020,Age,8 Months,75.3,67.8 to 81.6,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,96.3,91.1 to 98.9,282
Influenza,,States/Local Areas,NY-Rest of state,2020,Age,24 Months,56.7,49.1 to 64.6,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020,Age,19 Months,91.9,85.8 to 95.5,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,90.3,84.0 to 94.3,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020,Age,19 Months,88.7,82.6 to 92.9,282
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,91.6,85.7 to 95.2,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,67.0,59.0 to 74.1,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,93.6,87.9 to 96.7,282
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,92.0,86.2 to 95.5,282
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,5 Months,80.7,73.6 to 86.2,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020,Age,13 Months,50.5,42.8 to 58.2,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,89.6,83.6 to 93.5,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,70.3,62.4 to 77.2,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,87.7,81.1 to 92.2,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020,Age,13 Months,85.0,78.2 to 90.0,282
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,91.1,84.8 to 94.9,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,74.8,67.3 to 81.0,282
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,19 Months,74.2,66.6 to 80.6,282
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,85.2,78.5 to 90.7,282
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,73.9,65.9 to 80.6,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020,Age,35 Months,96.0,90.4 to 98.8,282
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,96.7,92.0 to 99.0,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,90.6,83.2 to 95.6,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020,Age,19 Months,83.1,76.1 to 88.4,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,91.8,85.9 to 95.3,282
Hib,Full Series,States/Local Areas,NY-Rest of state,2020,Age,19 Months,69.2,61.4 to 76.1,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,90.7,84.5 to 94.6,282
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,92.8,87.5 to 96.4,282
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2020,Age,35 Months,97.4,90.0 to 99.7,282
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,96.7,91.7 to 99.1,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,35 Months,92.7,87.4 to 96.3,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020,Age,35 Months,93.8,88.8 to 97.0,282
Hib,Full Series,States/Local Areas,NY-Rest of state,2020,Age,35 Months,81.4,73.9 to 87.9,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020,Age,24 Months,92.5,87.2 to 96.3,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,90.9,85.3 to 95.1,282
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020,Age,24 Months,93.0,88.3 to 96.3,282
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,93.0,87.9 to 96.5,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,82.2,75.2 to 88.3,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,24 Months,93.6,88.5 to 96.9,282
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,89.0,82.6 to 93.3,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020,Age,7 Months,69.1,61.3 to 76.0,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,56.4,48.5 to 64.0,282
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,7 Months,89.9,83.7 to 94.0,282
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2020,Age,3 Months,88.3,82.0 to 92.6,282
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,90.8,85.9 to 94.1,507
Hib,Full Series,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,71.4,65.2 to 76.9,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,91.4,86.8 to 94.8,507
Hib,Full Series,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,81.2,75.2 to 86.6,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,92.1,87.6 to 95.4,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,95.8,90.3 to 98.7,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,93.5,88.9 to 96.7,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,92.9,88.9 to 95.9,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,83.1,77.3 to 88.1,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,91.7,87.1 to 95.2,507
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,80.7,74.9 to 85.8,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,90.5,85.6 to 94.3,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,92.6,88.5 to 95.7,507
Hep B,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,3 Months,94.9,91.6 to 96.9,507
PCV,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,3 Months,89.2,84.7 to 92.5,507
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,5 Months,82.9,77.4 to 87.2,507
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,5 Months,82.2,76.7 to 86.7,507
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,5 Months,81.0,75.5 to 85.5,507
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,93.9,89.6 to 96.4,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,64.2,57.9 to 70.0,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,76.1,70.3 to 81.1,507
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,95.3,92.1 to 97.2,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,85.8,80.6 to 89.8,507
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,93.5,89.5 to 96.0,507
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,5 Months,87.5,82.6 to 91.2,507
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,5 Months,81.8,76.3 to 86.2,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,70.0,63.8 to 75.6,507
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,90.6,85.6 to 94.0,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,88.8,84.1 to 92.2,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,52.6,46.4 to 58.8,507
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,90.8,86.3 to 94.0,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,89.2,84.3 to 92.7,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,91.7,86.7 to 95.0,507
Combined 7 Series,,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,65.7,59.4 to 71.9,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,92.8,88.0 to 96.2,507
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,87.9,82.0 to 92.6,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,92.1,87.0 to 95.7,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,93.7,89.4 to 96.7,507
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,13 Months,93.6,87.9 to 96.7,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,27.7,22.6 to 33.7,507
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,80.7,75.1 to 85.7,507
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,76.7,67.9 to 84.5,507
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,87.9,82.0 to 92.6,507
Influenza,,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,62.2,56.1 to 68.3,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,90.3,85.7 to 93.9,507
Hib,Full Series,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,75.5,69.6 to 81.1,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,91.3,86.7 to 94.7,507
Combined 7 Series,,States/Local Areas,NY-Rest of state,2019-2020,Age,35 Months,72.7,65.9 to 79.1,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,57.4,51.2 to 63.5,507
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2019-2020,Age,0-1 Days,76.0,70.2 to 81.0,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,87.3,82.5 to 91.0,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,91.0,86.6 to 94.1,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,74.7,68.5 to 80.0,507
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,73.7,67.6 to 79.0,507
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2019-2020,Age,0-2 Days,78.0,72.3 to 82.8,507
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,92.8,88.8 to 95.7,507
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,91.2,87.0 to 94.4,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2019-2020,Age,0-3 Days,78.8,73.2 to 83.5,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,65.4,59.0 to 71.2,507
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,92.5,88.4 to 95.5,507
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,24 Months,80.5,74.7 to 85.7,507
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,89.0,84.1 to 92.5,507
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-Rest of state,2020,Age,0-2 Days,78.4,70.9 to 84.4,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2020,Age,19 Months,15.5,10.6 to 22.1,282
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-Rest of state,2020,Age,0-1 Days,77.7,70.1 to 83.7,282
Combined 7 Series,,States/Local Areas,NY-Rest of state,2020,Age,35 Months,75.7,66.5 to 83.9,282
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,76.0,66.9 to 85.1,201
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,84.4,72.9 to 96.0,101
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.8,67.8 to 87.8,125
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.2,95.7 to 100.0,125
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.2,73.2 to 83.1,580
Hib,Full Series,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,82.6,72.3 to 93.0,101
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.0,89.9 to 96.2,580
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,72.3 to 89.2,201
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.8,74.9 to 84.8,580
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,86.3,76.5 to 96.1,101
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,77.0,67.1 to 86.9,201
Rotavirus,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.5,68.2 to 78.9,580
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.5,65.2 to 75.7,580
Influenza,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,72.4,63.4 to 81.5,201
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,71.6,59.4 to 83.9,101
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,83.9,74.1 to 93.8,101
Combined 7 Series,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,66.6,61.0 to 72.3,580
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.7,75.8 to 85.5,580
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,83.9 to 97.9,201
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.8 to 95.6,580
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,93.9,86.4 to 100.0,101
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,87.0 to 94.4,580
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,91.3,82.3 to 100.0,101
Hib,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,3 Months,86.6,81.8 to 90.3,507
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,69.9,63.7 to 75.5,507
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,89.8,84.5 to 93.4,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2019-2020,Age,7 Months,68.8,62.6 to 74.4,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,13 Months,90.7,85.7 to 94.1,507
Polio,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,3 Months,88.0,83.2 to 91.6,507
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2019-2020,Age,3 Months,89.1,84.3 to 92.5,507
Hib,Primary Series,States/Local Areas,NY-Rest of state,2021,Age,19 Months,92.9,84.2 to 97.0,184
Hib,Primary Series,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,93.6,89.3 to 96.6,466
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,92.5,83.9 to 96.7,184
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,5 Months,82.8,73.6 to 89.2,184
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,14.6,10.8 to 19.5,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019-2020,Age,19 Months,89.9,85.0 to 93.4,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,66.7,56.8 to 75.3,184
Polio,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,89.3,79.7 to 94.6,184
PCV,≥4 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,83.7,78.3 to 88.4,466
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,92.6,88.2 to 95.7,466
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,13 Months,88.8,83.8 to 92.4,466
Hep B,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,89.4,80.4 to 94.5,184
PCV,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,35 Months,92.2,83.6 to 97.2,184
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2021,Age,35 Months,90.5,82.8 to 95.7,184
Hib,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,87.8,78.3 to 93.5,184
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,92.0,83.3 to 96.4,184
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,19 Months,93.6,88.9 to 96.4,466
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,7 Months,79.6,69.9 to 86.7,184
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2021,Age,5 Months,79.9,70.4 to 86.9,184
Combined 7 Series,,States/Local Areas,NY-Rest of state,2021,Age,35 Months,85.1,73.9 to 93.3,184
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,3 Months,88.7,80.7 to 93.6,203
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,3 Months,90.7,85.9 to 94.0,448
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,3 Months,90.1,84.9 to 93.6,254
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,3 Months,89.4,84.9 to 92.6,457
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,3 Months,93.3,88.5 to 96.1,287
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,3 Months,91.7,88.4 to 94.1,541
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,3 Months,87.6,83.5 to 90.8,266
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,3 Months,90.4,84.0 to 94.5,553
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,3 Months,86.0,77.9 to 91.5,217
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,3 Months,93.3,88.4 to 96.2,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.0,68.3 to 79.6,557
≥1 Dose Varicella,,States/Local Areas,NY-Rest of state,2021,Age,19 Months,89.0,80.5 to 94.0,184
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.8,66.1 to 83.6,557
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,81.6,76.3 to 86.4,466
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2020-2021,Age,35 Months,91.5,85.3 to 95.8,466
Hib,Full Series,States/Local Areas,NY-Rest of state,2020-2021,Age,24 Months,77.0,71.3 to 82.3,466
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,3 Months,91.0,85.1 to 94.7,282
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,3 Months,90.2,85.6 to 93.5,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,94.7,90.8 to 97.3,254
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,94.1,90.3 to 96.8,457
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,24 Months,98.2,95.8 to 99.4,287
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,96.5,94.3 to 98.0,541
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,3 Months,92.8,86.3 to 96.3,245
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,3 Months,91.9,87.8 to 94.7,527
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,19 Months,64.7,59.3 to 69.8,217
DTaP,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,3 Months,89.5,81.4 to 94.3,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,93.4,86.4 to 97.5,203
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,95.3,91.4 to 97.8,448
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,19 Months,66.0,56.2 to 74.5,249
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,19 Months,77.3,76.0 to 78.5,254
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,75.8,70.0 to 80.7,457
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,19 Months,75.4,68.4 to 81.3,287
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,76.3,71.4 to 80.6,541
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,19 Months,71.2,64.7 to 77.0,266
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,73.3,66.5 to 79.2,553
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,94.6,90.4 to 97.4,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,92.7,88.6 to 95.8,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,97.4,93.5 to 99.2,245
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,96.0,93.3 to 97.8,527
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,5 Months,82.6,75.7 to 87.8,282
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,5 Months,84.0,78.9 to 88.1,507
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,5 Months,78.1,68.3 to 85.4,203
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,5 Months,83.8,78.0 to 88.3,448
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.6,91.0 to 96.2,576
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,97.1,92.2 to 100.0,75
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,5 Months,89.8,83.8 to 93.8,245
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,5 Months,86.2,81.8 to 89.7,527
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,24 Months,32.2,24.7 to 41.3,217
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,19 Months,13.8,8.6 to 21.5,225
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2018,Age,19 Months,22.4,16.5 to 29.6,282
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,19.0,13.8 to 25.5,428
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,96.9,92.4 to 99.1,245
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,94.8,91.8 to 97.0,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,90.5,83.0 to 95.6,203
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,93.6,89.3 to 96.6,448
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.1 to 99.2,524
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,94.3,90.7 to 97.9,252
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,71.4,67.0 to 75.5,254
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,70.1,64.0 to 75.5,457
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,75.8,68.5 to 81.8,287
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,73.6,68.4 to 78.2,541
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,72.2,63.2 to 79.7,266
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,74.0,70.1 to 77.5,553
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,24 Months,35.8,28.8 to 43.9,249
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,92.7,88.0 to 96.1,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,92.1,88.1 to 95.1,507
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,24 Months,96.0,91.6 to 98.4,245
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,93.8,90.7 to 96.1,527
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,90.7,83.3 to 95.8,225
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,24 Months,90.3,82.9 to 95.4,203
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,93.1,88.8 to 96.2,448
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,24 Months,91.5,86.3 to 95.3,254
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,90.9,86.6 to 94.3,457
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Overall,Overall,94.6,92.7 to 96.6,876
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,<133% FPL,95.9,93.2 to 98.5,246
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,133% to <400% FPL,92.3,87.8 to 96.8,275
Polio,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Poverty,>400% FPL,95.4,92.5 to 98.2,355
Hep B,≥3 Doses,States/Local Areas,NY-Rest of state,2021,Age,19 Months,92.6,84.1 to 96.7,184
Hib,Full Series,States/Local Areas,NY-Rest of state,2021,Age,19 Months,74.4,64.8 to 82.2,184
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,24 Months,87.0,80.6 to 92.1,245
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,24 Months,84.3,79.8 to 88.2,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,95.7,90.4 to 98.6,217
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,94.6,90.2 to 97.4,249
≥1 Dose MMR,,States/Local Areas,NY-Rest of state,2020,Age,13 Months,62.4,54.5 to 69.7,282
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,68.2,64.9 to 71.3,249
DTaP,≥4 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,65.1,52.4 to 76.0,217
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,19 Months,74.3,65.0 to 81.8,203
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,78.3,72.4 to 83.2,448
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2012,Age,24 Months,77.0,69.8 to 83.5,249
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2013,Age,24 Months,77.3,69.6 to 84.3,266
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2013-2014,Age,24 Months,79.3,74.4 to 83.9,553
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,24 Months,74.8,67.0 to 82.0,217
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,19 Months,74.5,65.2 to 82.0,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016,Age,35 Months,93.4,86.4 to 97.5,203
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,35 Months,95.3,91.4 to 97.8,448
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,94.7,90.8 to 97.3,254
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,94.1,90.3 to 96.8,457
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,5 Months,69.0,65.5 to 72.2,217
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,5 Months,72.3,64.1 to 79.2,249
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,5 Months,70.8,68.5 to 72.9,266
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,5 Months,74.8,69.8 to 79.2,553
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017,Age,35 Months,97.4,93.5 to 99.2,245
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,35 Months,96.7,93.9 to 98.5,527
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,5 Months,83.6,75.9 to 89.2,245
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,5 Months,80.1,74.9 to 84.4,527
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2011,Age,35 Months,85.8,77.9 to 92.0,217
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2019,Age,24 Months,81.3,72.7 to 88.6,225
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,24 Months,81.4,74.9 to 87.1,282
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,81.4,76.1 to 86.1,507
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,35 Months,90.7,83.3 to 95.8,225
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2017,Insurance Coverage,Other,98.9,96.8 to 100.0,83
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,35 Months,96.2,91.6 to 98.6,282
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,35 Months,93.5,89.2 to 96.5,507
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,5 Months,73.3,63.5 to 81.3,203
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,5 Months,78.3,72.1 to 83.5,448
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,5 Months,77.3,70.2 to 83.2,254
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,5 Months,75.3,69.3 to 80.4,457
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,5 Months,78.8,72.0 to 84.3,287
PCV,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,5 Months,78.1,72.1 to 83.1,541
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016,Age,24 Months,80.5,72.2 to 87.6,203
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2016-2017,Age,24 Months,83.7,78.5 to 88.3,448
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2015,Age,24 Months,80.3,73.6 to 86.2,254
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2015-2016,Age,24 Months,80.4,75.1 to 85.1,457
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014,Age,24 Months,81.3,74.9 to 86.9,287
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2014-2015,Age,24 Months,80.7,76.2 to 84.9,541
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2017,Age,19 Months,27.3,20.1 to 35.8,245
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,24.8,20.1 to 30.3,527
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015,Age,35 Months,94.2,90.0 to 97.0,254
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,35 Months,92.2,88.0 to 95.4,457
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,98.1,95.5 to 99.3,287
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,96.5,93.8 to 98.2,541
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,94.3,88.8 to 97.7,266
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,96.4,93.2 to 98.4,553
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016,Age,19 Months,20.3,13.3 to 29.7,203
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2016-2017,Age,19 Months,23.7,18.5 to 29.8,448
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2015,Age,19 Months,23.2,21.1 to 25.5,254
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2015-2016,Age,19 Months,21.8,16.8 to 27.6,457
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2019,Age,24 Months,90.8,84.1 to 95.5,225
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018,Age,24 Months,91.5,86.6 to 95.1,282
Hib,≥3 Doses,States/Local Areas,NY-Rest of state,2018-2019,Age,24 Months,91.3,87.3 to 94.4,507
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2012,Age,19 Months,20.4,16.3 to 25.3,249
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014,Age,19 Months,18.8,13.9 to 25.1,287
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,19 Months,21.0,16.9 to 25.9,541
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2013,Age,19 Months,17.4,13.3 to 22.6,266
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,19 Months,18.1,15.2 to 21.5,553
DTaP,≥2 Doses,States/Local Areas,NY-Rest of state,2019,Age,5 Months,85.4,77.1 to 91.1,225
Hep A,≥2 Doses,States/Local Areas,NY-Rest of state,2011,Age,19 Months,17.4,13.0 to 22.9,217
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014,Age,35 Months,99.2,97.7 to 99.8,287
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2014-2015,Age,35 Months,97.1,94.8 to 98.6,541
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2011,Age,35 Months,95.5,90.2 to 98.4,217
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2012,Age,35 Months,96.7,93.1 to 98.7,249
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013,Age,35 Months,96.2,91.1 to 98.8,266
DTaP,≥3 Doses,States/Local Areas,NY-Rest of state,2013-2014,Age,35 Months,97.8,95.0 to 99.2,553
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2018,Age,19 Months,75.7,68.6 to 81.7,282
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2018-2019,Age,19 Months,77.1,70.4 to 82.7,428
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2017,Age,19 Months,82.5,75.2 to 88.0,245
Hep A,≥1 Dose,States/Local Areas,NY-Rest of state,2017-2018,Age,19 Months,79.1,74.2 to 83.4,527
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.6,77.7 to 87.6,469
Hib,Primary Series,States/Local Areas,North Carolina,2012,Age,7 Months,81.1,75.6 to 85.7,271
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,89.4,84.9 to 94.0,379
Hib,Primary Series,States/Local Areas,North Carolina,2011,Age,7 Months,71.7,70.3 to 73.0,252
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,89.4 to 96.4,506
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,89.1 to 95.1,703
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,85.1 to 99.5,129
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,95.1,90.9 to 99.2,198
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.8,85.2 to 98.5,125
Hib,Full Series,States/Local Areas,North Carolina,2018,Age,35 Months,88.3,81.6 to 93.4,271
Hib,Full Series,States/Local Areas,North Carolina,2018-2019,Age,35 Months,91.2,87.4 to 94.3,585
Hib,Full Series,States/Local Areas,North Carolina,2019,Age,35 Months,94.2,90.3 to 96.9,314
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.6,75.3 to 91.8,125
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,80.1,75.2 to 85.1,419
Hib,Full Series,States/Local Areas,North Carolina,2015,Age,35 Months,85.9,79.9 to 90.8,320
Hib,Full Series,States/Local Areas,North Carolina,2015-2016,Age,35 Months,87.0,82.7 to 90.6,672
Hib,Full Series,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,87.0,83.4 to 90.6,673
Hib,Full Series,States/Local Areas,North Carolina,2014,Age,35 Months,82.4,75.1 to 88.6,287
Hib,Full Series,States/Local Areas,North Carolina,2014-2015,Age,35 Months,83.9,79.3 to 88.0,607
Polio,≥3 Doses,States/Local Areas,North Carolina,2019,Age,35 Months,98.5,95.9 to 99.6,314
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,77.4,57.8 to 97.0,34
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,91.4,87.7 to 95.2,419
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,95.7,93.5 to 97.9,673
Hib,Full Series,States/Local Areas,North Carolina,2016,Age,35 Months,88.2,82.4 to 92.8,352
Hib,Full Series,States/Local Areas,North Carolina,2016-2017,Age,35 Months,88.2,83.7 to 91.9,644
Polio,≥3 Doses,States/Local Areas,North Carolina,2018,Age,35 Months,96.3,92.9 to 98.4,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,35 Months,97.3,95.1 to 98.7,585
DTaP,≥2 Doses,States/Local Areas,North Carolina,2013,Age,5 Months,77.0,70.4 to 82.5,271
DTaP,≥2 Doses,States/Local Areas,North Carolina,2013-2014,Age,5 Months,79.5,77.1 to 81.8,558
DTaP,≥2 Doses,States/Local Areas,North Carolina,2012,Age,5 Months,82.9,78.7 to 86.4,271
DTaP,≥2 Doses,States/Local Areas,North Carolina,2011,Age,5 Months,87.1,81.8 to 91.0,252
Hib,Full Series,States/Local Areas,North Carolina,2017,Age,35 Months,87.7,80.9 to 93.0,292
Hib,Full Series,States/Local Areas,North Carolina,2017-2018,Age,35 Months,88.1,83.4 to 91.9,563
Hib,Full Series,States/Local Areas,North Carolina,2011,Age,35 Months,90.3,84.3 to 94.8,252
Hib,Full Series,States/Local Areas,North Carolina,2012,Age,35 Months,88.3,81.9 to 93.2,271
Hib,Full Series,States/Local Areas,North Carolina,2019,Age,24 Months,90.6,85.4 to 94.6,314
Polio,≥3 Doses,States/Local Areas,North Carolina,2014,Age,35 Months,88.4,81.8 to 93.5,287
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,35 Months,92.3,88.4 to 95.2,607
Polio,≥3 Doses,States/Local Areas,North Carolina,2013,Age,35 Months,91.8,86.1 to 95.8,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,35 Months,90.1,85.9 to 93.6,558
Hib,Full Series,States/Local Areas,North Carolina,2013,Age,35 Months,85.2,78.4 to 90.8,271
Hib,Full Series,States/Local Areas,North Carolina,2013-2014,Age,35 Months,83.8,78.9 to 88.1,558
Polio,≥3 Doses,States/Local Areas,North Carolina,2012,Age,35 Months,97.2,93.5 to 99.0,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,87.7,81.1 to 92.9,287
Hib,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,90.1,86.3 to 93.3,607
DTaP,≥2 Doses,States/Local Areas,North Carolina,2014,Age,5 Months,82.0,74.2 to 87.9,287
DTaP,≥2 Doses,States/Local Areas,North Carolina,2014-2015,Age,5 Months,82.3,80.3 to 84.2,607
Polio,≥3 Doses,States/Local Areas,North Carolina,2017,Age,35 Months,93.1,87.0 to 97.0,292
Polio,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,35 Months,94.7,91.3 to 97.1,563
Polio,≥3 Doses,States/Local Areas,North Carolina,2016,Age,35 Months,95.8,92.3 to 98.0,352
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,35 Months,94.4,90.9 to 96.9,644
DTaP,≥2 Doses,States/Local Areas,North Carolina,2015,Age,5 Months,82.6,76.1 to 87.6,320
DTaP,≥2 Doses,States/Local Areas,North Carolina,2015-2016,Age,5 Months,81.9,77.1 to 85.8,672
Hib,≥3 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,89.8,83.8 to 94.2,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,88.7,84.4 to 92.3,558
Hib,≥3 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,94.6,91.0 to 97.1,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,94.0,88.5 to 97.4,252
Polio,≥3 Doses,States/Local Areas,North Carolina,2015,Age,35 Months,96.5,92.1 to 98.9,320
Polio,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,35 Months,96.2,93.1 to 98.1,672
Hib,Full Series,States/Local Areas,North Carolina,2017,Age,24 Months,86.6,79.9 to 91.9,292
Hib,Full Series,States/Local Areas,North Carolina,2017-2018,Age,24 Months,85.8,81.0 to 89.9,563
Hib,Full Series,States/Local Areas,North Carolina,2016,Age,24 Months,85.5,79.9 to 90.2,352
Hib,Full Series,States/Local Areas,North Carolina,2016-2017,Age,24 Months,86.0,81.8 to 89.7,644
DTaP,≥3 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,95.6,92.2 to 97.9,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2011,Age,35 Months,94.9,89.4 to 98.1,252
Hib,Full Series,States/Local Areas,North Carolina,2018,Age,24 Months,85.0,78.0 to 90.8,271
Hib,Full Series,States/Local Areas,North Carolina,2018-2019,Age,24 Months,87.8,83.5 to 91.5,585
Polio,≥3 Doses,States/Local Areas,North Carolina,2018,Age,24 Months,96.3,92.9 to 98.4,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,24 Months,97.1,94.9 to 98.4,585
Polio,≥3 Doses,States/Local Areas,North Carolina,2019,Age,24 Months,97.9,95.2 to 99.2,314
Hib,≥3 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,92.1,85.8 to 95.7,314
Polio,≥3 Doses,States/Local Areas,North Carolina,2017,Age,24 Months,91.5,85.2 to 95.8,292
Polio,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,24 Months,93.9,90.3 to 96.5,563
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,92.1,86.4 to 96.1,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,91.5,87.4 to 94.8,558
Hib,Full Series,States/Local Areas,North Carolina,2015,Age,24 Months,81.6,75.7 to 86.8,320
Hib,Full Series,States/Local Areas,North Carolina,2015-2016,Age,24 Months,83.6,79.4 to 87.3,672
DTaP,≥3 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,94.5,89.1 to 97.8,252
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,96.3,92.6 to 98.1,271
DTaP,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,96.4,94.1 to 97.8,585
DTaP,≥3 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,97.8,94.5 to 99.1,314
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,90.4,83.2 to 94.7,287
DTaP,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,92.9,89.0 to 95.5,607
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,95.4,94.6 to 96.0,320
DTaP,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,94.6,91.4 to 96.6,672
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,93.7,89.4 to 96.4,352
DTaP,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,92.7,88.7 to 95.3,644
Polio,≥3 Doses,States/Local Areas,North Carolina,2019,Age,19 Months,96.0,90.9 to 98.3,314
Polio,≥3 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,94.5,89.0 to 97.3,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,73.0,67.0 to 78.2,585
Polio,≥3 Doses,States/Local Areas,North Carolina,2011,Age,24 Months,94.4,88.9 to 97.7,252
Polio,≥3 Doses,States/Local Areas,North Carolina,2012,Age,24 Months,95.5,92.0 to 97.7,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2014,Age,19 Months,84.2,76.7 to 89.6,287
Hib,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,19 Months,87.1,82.7 to 90.5,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2013,Age,19 Months,87.8,85.3 to 89.9,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,19 Months,86.0,84.2 to 87.6,558
Polio,≥3 Doses,States/Local Areas,North Carolina,2013,Age,24 Months,91.8,86.1 to 95.8,271
Polio,≥3 Doses,States/Local Areas,North Carolina,2013-2014,Age,24 Months,90.0,85.7 to 93.4,558
Hib,≥3 Doses,States/Local Areas,North Carolina,2015,Age,19 Months,90.0,85.4 to 93.3,320
Hib,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,19 Months,89.3,85.4 to 92.3,672
Polio,≥3 Doses,States/Local Areas,North Carolina,2015,Age,24 Months,95.2,91.3 to 97.7,320
Polio,≥3 Doses,States/Local Areas,North Carolina,2015-2016,Age,24 Months,95.1,92.2 to 97.2,672
Polio,≥3 Doses,States/Local Areas,North Carolina,2014,Age,24 Months,88.1,81.5 to 93.2,287
Polio,≥3 Doses,States/Local Areas,North Carolina,2014-2015,Age,24 Months,91.6,87.8 to 94.6,607
Hib,≥3 Doses,States/Local Areas,North Carolina,2018,Age,19 Months,89.8,82.4 to 94.2,271
Hib,≥3 Doses,States/Local Areas,North Carolina,2018-2019,Age,19 Months,62.7,56.5 to 68.4,585
Hib,≥3 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,89.6,82.7 to 93.9,292
Hib,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,89.7,85.0 to 93.0,563
Polio,≥3 Doses,States/Local Areas,North Carolina,2016,Age,24 Months,95.0,91.5 to 97.4,352
Polio,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,24 Months,93.3,89.7 to 96.0,644
Hib,≥3 Doses,States/Local Areas,North Carolina,2016,Age,19 Months,88.6,82.8 to 92.6,352
Hib,≥3 Doses,States/Local Areas,North Carolina,2016-2017,Age,19 Months,89.1,84.9 to 92.3,644
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017,Age,19 Months,91.6,84.5 to 95.6,292
DTaP,≥3 Doses,States/Local Areas,North Carolina,2017-2018,Age,19 Months,93.9,90.1 to 96.3,563
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.2,73.6 to 84.7,456
Influenza,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,52.1,42.4 to 61.7,152
Influenza,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",45.5,38.6 to 52.5,289
Influenza,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",18.1,5.3 to 30.8,36
Influenza,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,41.8,36.5 to 47.0,498
Polio,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,93.9,87.6 to 97.1,148
Influenza,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",48.3,43.0 to 53.7,519
Influenza,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,53.6,46.8 to 60.3,313
Influenza,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,50.5,44.2 to 56.8,355
Influenza,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,31.6,25.7 to 37.5,328
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,62.2 to 76.9,247
Influenza,,States/Local Areas,Oklahoma,2017,Age,24 Months,53.1,45.2 to 61.4,243
Influenza,,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,50.1,44.2 to 56.2,437
Influenza,,States/Local Areas,Oklahoma,2018,Age,24 Months,47.1,38.8 to 56.3,194
Influenza,,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,48.7,42.4 to 55.4,399
Influenza,,States/Local Areas,Oklahoma,2016,Age,24 Months,46.5,40.1 to 53.3,319
Influenza,,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,49.6,44.5 to 54.9,562
Influenza,,States/Local Areas,Oklahoma,2013,Age,24 Months,39.1,31.2 to 48.2,198
Influenza,,States/Local Areas,Oklahoma,2013-2014,Age,24 Months,41.6,35.9 to 47.9,425
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,3 Months,96.4,91.0 to 98.6,148
Influenza,,States/Local Areas,Oklahoma,2019,Age,24 Months,50.2,41.0 to 60.1,205
Influenza,,States/Local Areas,Oklahoma,2012,Age,24 Months,38.3,31.2 to 46.5,260
Influenza,,States/Local Areas,Oklahoma,2011,Age,24 Months,38.6,31.7 to 46.5,279
Influenza,,States/Local Areas,Oklahoma,2014,Age,24 Months,44.2,36.2 to 53.1,227
Influenza,,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,45.2,39.9 to 51.0,502
Influenza,,States/Local Areas,Oklahoma,2015,Age,24 Months,46.3,39.4 to 53.9,275
Influenza,,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,46.4,41.7 to 51.4,594
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,85.7,81.9 to 89.5,453
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,88.1,84.3 to 91.9,368
Influenza,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,56.8,51.1 to 62.5,439
Influenza,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,35.6,15.3 to 55.8,32
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,58.2,51.8 to 64.4,446
Hib,Full Series,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,75.6,70.0 to 80.8,446
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,91.2,87.4 to 95.0,368
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,81.9,77.0 to 86.8,368
Influenza,,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,46.3,42.5 to 50.1,996
Influenza,,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,38.4,32.5 to 44.3,370
Influenza,,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,46.0,40.0 to 52.0,404
Influenza,,States/Local Areas,Oklahoma,2021,Age,24 Months,40.1,31.1 to 50.5,148
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.4,58.7 to 76.2,247
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Private Insurance Only,82.0,76.7 to 87.3,368
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,72.5,66.7 to 77.6,446
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,85.1,79.8 to 89.3,446
Polio,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,92.6,89.0 to 95.4,446
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,85.9,80.9 to 89.8,446
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2021,Age,0-3 Days,79.1,69.6 to 86.2,148
Hib,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,93.7,85.1 to 98.1,148
Polio,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,3 Months,85.2,80.3 to 89.1,446
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,78.5,71.3 to 85.0,446
≥1 Dose MMR,,States/Local Areas,Oklahoma,2021,Age,13 Months,62.7,52.2 to 72.0,148
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,87.8,82.9 to 91.8,446
PCV,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,3 Months,84.4,79.6 to 88.3,446
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,5 Months,77.8,72.3 to 82.5,446
Hep B,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,3 Months,94.6,91.3 to 96.7,446
Hib,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,87.6,83.2 to 91.0,446
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,43.2,37.1 to 49.6,446
Influenza,,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,67.8,60.8 to 74.9,222
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,24 Months,93.2,87.4 to 96.9,148
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,92.8,89.2 to 95.6,446
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oklahoma,2020-2021,Age,0-3 Days,77.2,71.5 to 82.1,446
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2021,Age,35 Months,86.1,77.9 to 92.4,148
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,96.3,90.1 to 98.7,148
PCV,≥4 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,74.1,67.9 to 79.5,446
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,73.3,67.7 to 78.2,446
Influenza,,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,44.0,38.0 to 50.5,446
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,93.5,81.3 to 98.8,148
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,92.1,86.3 to 96.1,148
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,90.8,86.7 to 93.8,446
Hib,Primary Series,States/Local Areas,Oklahoma,2021,Age,13 Months,89.1,82.5 to 93.4,148
Polio,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,5 Months,78.1,72.6 to 82.7,446
Polio,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,88.3,83.7 to 91.7,446
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,78.2,72.5 to 83.4,446
Rotavirus,,States/Local Areas,Oklahoma,2020-2021,Age,8 Months,73.9,68.2 to 78.9,446
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,92.8,89.2 to 95.6,446
PCV,≥4 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,84.9,76.5 to 91.5,446
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,92.5,88.8 to 95.4,446
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,95.2,87.1 to 98.9,446
Hib,Primary Series,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,83.8,79.1 to 87.7,446
Hib,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,3 Months,83.9,79.0 to 87.9,446
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,35 Months,93.2,87.4 to 96.9,148
Combined 7 Series,,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,71.7,63.4 to 79.5,446
Combined 7 Series,,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,64.9,58.7 to 71.1,446
Hib,Full Series,States/Local Areas,Oklahoma,2021,Age,35 Months,81.4,72.9 to 88.6,148
Polio,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,92.6,89.0 to 95.4,446
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,90.7,86.3 to 93.8,446
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,85.4,79.9 to 89.6,446
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,92.5,88.7 to 95.3,446
Polio,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,91.2,87.2 to 94.1,446
Hib,Primary Series,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,70.5,64.8 to 75.7,446
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,48.7,42.4 to 55.4,446
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,87.2,82.2 to 91.3,446
Hib,Primary Series,States/Local Areas,Oklahoma,2021,Age,35 Months,94.6,87.2 to 98.4,148
Polio,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,5 Months,81.5,73.1 to 87.7,148
DTaP,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,5 Months,81.5,73.1 to 87.7,148
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,69.1,62.7 to 74.9,446
Hib,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,67.0,56.6 to 75.9,148
Hib,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,5 Months,75.0,69.4 to 79.9,446
Rotavirus,,States/Local Areas,Oklahoma,2021,Age,8 Months,75.9,66.7 to 83.1,148
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,5 Months,87.1,82.3 to 90.7,446
Hib,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,93.8,87.5 to 97.0,148
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,24 Months,91.1,87.1 to 94.2,446
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,13 Months,90.5,84.0 to 94.5,148
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2021,Age,13 Months,56.5,46.3 to 66.2,148
Rotavirus,,States/Local Areas,Oklahoma,2019,Age,8 Months,74.8,65.2 to 82.4,205
Rotavirus,,States/Local Areas,Oklahoma,2017,Age,8 Months,73.6,66.0 to 80.0,243
Rotavirus,,States/Local Areas,Oklahoma,2017-2018,Age,8 Months,72.6,66.9 to 77.7,437
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.0,68.1 to 77.9,519
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Principal City,68.7,62.5 to 74.9,313
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.9,58.1 to 71.6,289
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Other,63.3,43.7 to 83.0,32
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Private Insurance Only,78.9,74.1 to 83.8,439
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oklahoma,2020-2021,Age,0-1 Days,74.5,68.5 to 79.7,446
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.5,49.6 to 83.5,36
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Insurance Coverage,Any Medicaid,64.4,59.3 to 69.5,498
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Race and Ethnicity,Hispanic,64.9,56.0 to 73.9,152
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Poverty,133% to <400% FPL,74.6,69.3 to 79.9,404
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Overall,Overall,68.8,65.2 to 72.4,996
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Poverty,<133% FPL,58.2,52.1 to 64.2,370
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.8,72.6 to 82.9,355
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Urbanicity,Living In a Non-MSA,58.2,51.4 to 64.9,328
Hib,Primary Series,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,93.5,90.1 to 96.1,446
Combined 7 Series,,States/Local Areas,Oklahoma,2021,Age,24 Months,70.5,60.7 to 79.7,148
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2021,Age,5 Months,90.0,82.5 to 94.5,148
≥1 Dose MMR,,States/Local Areas,Oklahoma,2021,Age,19 Months,87.7,79.0 to 93.1,148
Polio,≥3 Doses,States/Local Areas,Oklahoma,2021,Age,19 Months,92.5,86.1 to 96.1,148
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,35.2,29.4 to 41.4,446
DTaP,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,88.2,83.9 to 91.5,446
PCV,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,7 Months,68.6,62.6 to 74.0,446
Hep B,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,89.6,85.2 to 92.7,446
Hib,Full Series,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,83.2,75.6 to 89.6,446
Hib,Full Series,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,68.3,62.1 to 73.9,446
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oklahoma,2020-2021,Age,0-2 Days,76.6,70.8 to 81.5,446
Polio,≥2 Doses,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,92.2,88.3 to 94.9,446
PCV,≥1 Dose,States/Local Areas,Oklahoma,2021,Age,3 Months,88.9,81.6 to 93.5,148
≥1 Dose MMR,,States/Local Areas,Oklahoma,2020-2021,Age,13 Months,63.2,56.7 to 69.2,446
≥1 Dose Varicella,,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,85.4,80.1 to 89.5,446
Hib,Primary Series,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,91.1,87.1 to 93.9,446
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2020-2021,Age,19 Months,83.9,78.5 to 88.1,446
Hib,≥3 Doses,States/Local Areas,Oklahoma,2020-2021,Age,35 Months,90.9,86.8 to 94.2,446
Rotavirus,,States/Local Areas,Oklahoma,2016,Age,8 Months,68.9,62.3 to 74.8,319
Rotavirus,,States/Local Areas,Oklahoma,2016-2017,Age,8 Months,71.2,66.3 to 75.6,562
Rotavirus,,States/Local Areas,Oklahoma,2014,Age,8 Months,68.3,59.9 to 75.6,227
Rotavirus,,States/Local Areas,Oklahoma,2014-2015,Age,8 Months,67.9,62.5 to 72.9,502
Rotavirus,,States/Local Areas,Oklahoma,2018,Age,8 Months,71.6,62.8 to 79.1,194
Rotavirus,,States/Local Areas,Oklahoma,2018-2019,Age,8 Months,73.2,66.9 to 78.7,399
Rotavirus,,States/Local Areas,Oklahoma,2011,Age,8 Months,58.8,51.1 to 66.1,279
Rotavirus,,States/Local Areas,Oklahoma,2012,Age,8 Months,64.4,56.6 to 71.5,260
Rotavirus,,States/Local Areas,Oklahoma,2013,Age,8 Months,63.5,54.1 to 71.9,198
Rotavirus,,States/Local Areas,Oklahoma,2013-2014,Age,8 Months,65.9,59.6 to 71.6,425
Rotavirus,,States/Local Areas,Oklahoma,2015,Age,8 Months,67.6,60.5 to 74.0,275
Rotavirus,,States/Local Areas,Oklahoma,2015-2016,Age,8 Months,68.2,63.5 to 72.7,594
Rotavirus,,States/Local Areas,Oklahoma,2014-2017,Poverty,>400% FPL,84.3,79.0 to 89.5,222
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,88.7,82.3 to 95.2,140
Hep A,≥2 Doses,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,77.3,67.0 to 87.6,140
DTaP,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,133% to <400% FPL,79.9,74.7 to 85.2,354
PCV,≥4 Doses,States/Local Areas,Oklahoma,2016-2019,Insurance Coverage,Any Medicaid,78.3,73.7 to 82.9,453
Hep A,≥1 Dose,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,75.6 to 87.4,247
Hib,Full Series,States/Local Areas,Oklahoma,2016-2019,Race and Ethnicity,Hispanic,79.0,70.6 to 87.4,140
Hep B,≥2 Doses,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,90.5,86.1 to 93.6,503
PCV,≥3 Doses,States/Local Areas,Oklahoma,2016-2019,Poverty,>400% FPL,94.1,90.3 to 97.9,205
Combined 7 Series,,States/Local Areas,Oklahoma,2016,Age,35 Months,70.7,63.9 to 77.2,319
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,72.1,66.8 to 77.1,562
Combined 7 Series,,States/Local Areas,Oklahoma,2017,Age,35 Months,73.7,65.5 to 81.2,243
Combined 7 Series,,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,70.9,64.8 to 76.7,437
Combined 7 Series,,States/Local Areas,Oklahoma,2016,Age,24 Months,63.8,57.4 to 70.2,319
Combined 7 Series,,States/Local Areas,Oklahoma,2016-2017,Age,24 Months,66.8,61.7 to 71.7,562
Hib,Primary Series,States/Local Areas,Oklahoma,2019,Age,35 Months,92.6,86.7 to 96.6,205
Hib,Primary Series,States/Local Areas,Oklahoma,2019-2020,Age,7 Months,70.5,64.8 to 75.7,503
Combined 7 Series,,States/Local Areas,Oklahoma,2019,Age,24 Months,68.1,59.0 to 76.8,205
Combined 7 Series,,States/Local Areas,Oklahoma,2014,Age,35 Months,73.6,64.8 to 81.8,227
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2015,Age,35 Months,72.5,66.9 to 77.9,502
Combined 7 Series,,States/Local Areas,Oklahoma,2013,Age,35 Months,73.1,64.8 to 80.9,198
Combined 7 Series,,States/Local Areas,Oklahoma,2013-2014,Age,35 Months,73.4,67.3 to 79.1,425
Combined 7 Series,,States/Local Areas,Oklahoma,2012,Age,35 Months,71.1,63.0 to 78.9,260
Hib,Primary Series,States/Local Areas,Oklahoma,2017,Age,35 Months,88.8,82.4 to 93.8,243
Hib,Primary Series,States/Local Areas,Oklahoma,2017-2018,Age,35 Months,91.3,87.4 to 94.3,437
Hib,Primary Series,States/Local Areas,Oklahoma,2016,Age,35 Months,89.4,84.9 to 93.1,319
Hib,Primary Series,States/Local Areas,Oklahoma,2016-2017,Age,35 Months,89.1,85.3 to 92.3,562
Hib,Primary Series,States/Local Areas,Oklahoma,2015,Age,35 Months,93.5,89.5 to 96.4,275
Hib,Primary Series,States/Local Areas,Oklahoma,2015-2016,Age,35 Months,91.5,88.6 to 93.9,594
Combined 7 Series,,States/Local Areas,Oklahoma,2017,Age,24 Months,69.9,62.0 to 77.4,243
Combined 7 Series,,States/Local Areas,Oklahoma,2017-2018,Age,24 Months,65.9,60.1 to 71.6,437
Combined 7 Series,,States/Local Areas,Oklahoma,2018,Age,24 Months,62.0,53.4 to 70.7,194
Combined 7 Series,,States/Local Areas,Oklahoma,2018-2019,Age,24 Months,65.0,58.8 to 71.2,399
Combined 7 Series,,States/Local Areas,Oklahoma,2014,Age,24 Months,65.4,57.1 to 73.6,227
Combined 7 Series,,States/Local Areas,Oklahoma,2014-2015,Age,24 Months,65.1,59.7 to 70.5,502
Combined 7 Series,,States/Local Areas,Oklahoma,2015,Age,24 Months,64.8,57.9 to 71.7,275
Combined 7 Series,,States/Local Areas,Oklahoma,2015-2016,Age,24 Months,64.3,59.5 to 69.1,594
Hib,Primary Series,States/Local Areas,Oklahoma,2018,Age,35 Months,93.8,89.4 to 96.8,194
Hib,Primary Series,States/Local Areas,Oklahoma,2018-2019,Age,35 Months,93.2,89.7 to 95.9,399
Combined 7 Series,,States/Local Areas,Oklahoma,2011,Age,35 Months,71.8,65.0 to 78.2,279
Hib,≥2 Doses,States/Local Areas,Montana,2021,Age,5 Months,70.0,59.3 to 78.9,127
Rotavirus,,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,74.1,66.6 to 81.6,225
Rotavirus,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,76.0,71.1 to 81.0,453
Rotavirus,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,65.8,51.4 to 80.3,59
Rotavirus,,States/Local Areas,Montana,2019,Age,8 Months,77.0,67.8 to 84.2,187
Rotavirus,,States/Local Areas,Montana,2017,Age,8 Months,71.4,64.2 to 77.7,265
Rotavirus,,States/Local Areas,Montana,2017-2018,Age,8 Months,73.3,68.2 to 77.8,498
Rotavirus,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.0,52.9 to 87.1,51
Rotavirus,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,67.8,63.2 to 72.5,608
Rotavirus,,States/Local Areas,Montana,2014-2017,Overall,Overall,69.8,66.0 to 73.5,910
Rotavirus,,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,59.4,52.0 to 66.8,242
Rotavirus,,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,76.1,71.5 to 80.8,443
Rotavirus,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,66.9,61.1 to 72.7,375
Rotavirus,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,67.5,51.9 to 83.0,54
Rotavirus,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.7,51.2 to 74.1,96
Rotavirus,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.8,67.7 to 75.8,754
Rotavirus,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,73.5,66.7 to 80.2,251
Rotavirus,,States/Local Areas,Montana,2016,Age,8 Months,67.8,60.2 to 74.5,257
Rotavirus,,States/Local Areas,Montana,2016-2017,Age,8 Months,69.6,64.4 to 74.3,522
Rotavirus,,States/Local Areas,Montana,2013,Age,8 Months,59.4,51.5 to 66.8,249
Rotavirus,,States/Local Areas,Montana,2013-2014,Age,8 Months,63.3,57.6 to 68.6,474
Rotavirus,,States/Local Areas,Montana,2012,Age,8 Months,67.8,58.7 to 75.8,219
Rotavirus,,States/Local Areas,Montana,2014,Age,8 Months,67.1,59.0 to 74.3,225
Rotavirus,,States/Local Areas,Montana,2014-2015,Age,8 Months,70.5,65.0 to 75.5,481
Rotavirus,,States/Local Areas,Montana,2018,Age,8 Months,75.1,67.6 to 81.4,233
Rotavirus,,States/Local Areas,Montana,2018-2019,Age,8 Months,76.1,70.3 to 81.0,420
Rotavirus,,States/Local Areas,Montana,2011,Age,8 Months,68.7,60.8 to 75.7,250
Rotavirus,,States/Local Areas,Montana,2015,Age,8 Months,73.9,66.2 to 80.3,256
Rotavirus,,States/Local Areas,Montana,2015-2016,Age,8 Months,70.9,65.5 to 75.7,513
Hib,Full Series,States/Local Areas,Montana,2018,Age,19 Months,75.3,67.5 to 81.8,233
Hib,Full Series,States/Local Areas,Montana,2018-2019,Age,19 Months,94.7,91.6 to 96.6,420
Hib,Full Series,States/Local Areas,Montana,2017,Age,19 Months,71.8,64.6 to 78.1,265
Hib,Full Series,States/Local Areas,Montana,2017-2018,Age,19 Months,73.6,68.3 to 78.2,498
Hib,Full Series,States/Local Areas,Montana,2015,Age,19 Months,74.4,65.7 to 81.5,256
Hib,Full Series,States/Local Areas,Montana,2015-2016,Age,19 Months,72.6,67.3 to 77.3,513
Hib,Full Series,States/Local Areas,Montana,2014,Age,19 Months,73.6,65.9 to 80.1,225
Hib,Full Series,States/Local Areas,Montana,2014-2015,Age,19 Months,74.0,68.7 to 78.7,481
Hib,Full Series,States/Local Areas,Montana,2016,Age,19 Months,70.7,63.2 to 77.3,257
Hib,Full Series,States/Local Areas,Montana,2016-2017,Age,19 Months,71.3,66.1 to 76.0,522
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,68.3,52.1 to 84.4,54
Combined 7 Series,,States/Local Areas,Montana,2015,Age,35 Months,66.6,58.9 to 74.1,256
Combined 7 Series,,States/Local Areas,Montana,2015-2016,Age,35 Months,65.3,59.8 to 70.8,513
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,69.0,63.7 to 74.4,453
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,61.7,55.7 to 67.7,375
Combined 7 Series,,States/Local Areas,Montana,2019,Age,35 Months,76.2,67.2 to 84.2,187
Combined 7 Series,,States/Local Areas,Montana,2018,Age,35 Months,74.1,66.5 to 81.1,233
Combined 7 Series,,States/Local Areas,Montana,2018-2019,Age,35 Months,75.1,69.4 to 80.6,420
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,56.3,40.6 to 72.0,59
Hib,Full Series,States/Local Areas,Montana,2012,Age,24 Months,81.2,74.0 to 87.5,219
Hib,Full Series,States/Local Areas,Montana,2011,Age,24 Months,84.3,78.5 to 89.2,250
Hib,Full Series,States/Local Areas,Montana,2013,Age,24 Months,73.2,66.1 to 79.9,249
Hib,Full Series,States/Local Areas,Montana,2013-2014,Age,24 Months,77.6,72.7 to 82.2,474
Hib,Full Series,States/Local Areas,Montana,2014,Age,24 Months,81.9,75.4 to 87.5,225
Hib,Full Series,States/Local Areas,Montana,2014-2015,Age,24 Months,79.9,75.1 to 84.3,481
Hib,Primary Series,States/Local Areas,Montana,2018,Age,7 Months,78.2,70.2 to 84.6,233
Hib,Primary Series,States/Local Areas,Montana,2018-2019,Age,7 Months,79.8,74.3 to 84.4,420
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,67.3,61.9 to 72.7,443
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,64.3,56.3 to 72.4,225
Hib,Full Series,States/Local Areas,Montana,2011,Age,19 Months,81.5,78.4 to 84.3,250
Hib,Full Series,States/Local Areas,Montana,2012,Age,19 Months,77.4,70.8 to 82.9,219
Hib,Full Series,States/Local Areas,Montana,2013,Age,19 Months,71.0,65.0 to 76.4,249
Hib,Full Series,States/Local Areas,Montana,2013-2014,Age,19 Months,72.3,66.7 to 77.3,474
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,57.8,50.4 to 65.2,242
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Overall,Overall,63.3,59.4 to 67.2,910
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,62.1,57.2 to 67.0,608
Hib,Primary Series,States/Local Areas,Montana,2015,Age,13 Months,86.6,79.6 to 91.5,256
Hib,Primary Series,States/Local Areas,Montana,2015-2016,Age,13 Months,86.2,81.7 to 89.7,513
Hib,Primary Series,States/Local Areas,Montana,2014,Age,13 Months,86.9,80.8 to 91.2,225
Hib,Primary Series,States/Local Areas,Montana,2014-2015,Age,13 Months,86.7,82.4 to 90.2,481
Hib,Primary Series,States/Local Areas,Montana,2018,Age,19 Months,93.1,88.0 to 96.2,233
Hib,Primary Series,States/Local Areas,Montana,2018-2019,Age,19 Months,89.9,85.6 to 93.0,420
Hib,Primary Series,States/Local Areas,Montana,2017,Age,19 Months,89.5,84.0 to 93.3,265
Hib,Primary Series,States/Local Areas,Montana,2017-2018,Age,19 Months,91.3,87.8 to 93.9,498
Hib,Primary Series,States/Local Areas,Montana,2014,Age,19 Months,90.1,84.6 to 93.8,225
Hib,Primary Series,States/Local Areas,Montana,2014-2015,Age,19 Months,89.9,85.6 to 93.0,481
Hib,Primary Series,States/Local Areas,Montana,2013,Age,19 Months,85.1,77.3 to 90.6,249
Hib,Primary Series,States/Local Areas,Montana,2013-2014,Age,19 Months,87.6,85.0 to 89.9,474
Hib,Primary Series,States/Local Areas,Montana,2018,Age,13 Months,90.3,84.6 to 94.0,233
Hib,Primary Series,States/Local Areas,Montana,2018-2019,Age,13 Months,89.9,85.6 to 93.0,420
Hib,Primary Series,States/Local Areas,Montana,2011,Age,19 Months,93.8,90.2 to 96.1,250
Hib,Primary Series,States/Local Areas,Montana,2012,Age,19 Months,91.5,85.3 to 95.2,219
DTaP,≥3 Doses,States/Local Areas,Montana,2020,Age,13 Months,83.6,76.6 to 88.8,220
Hib,Primary Series,States/Local Areas,Montana,2019,Age,13 Months,89.5,82.2 to 94.0,187
Hib,Primary Series,States/Local Areas,Montana,2017,Age,13 Months,87.7,82.0 to 91.8,265
Hib,Primary Series,States/Local Areas,Montana,2017-2018,Age,13 Months,89.0,85.2 to 91.9,498
Hib,Primary Series,States/Local Areas,Montana,2016,Age,13 Months,85.8,79.4 to 90.4,257
Hib,Primary Series,States/Local Areas,Montana,2016-2017,Age,13 Months,86.8,82.6 to 90.0,522
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.3,54.6 to 78.1,96
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",62.7,58.4 to 67.0,754
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.5,55.8 to 85.3,51
Combined 7 Series,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,64.2,57.0 to 71.5,251
Hib,Primary Series,States/Local Areas,Montana,2011,Age,13 Months,90.0,86.9 to 92.4,250
Hib,Primary Series,States/Local Areas,Montana,2012,Age,13 Months,88.4,80.8 to 93.3,219
Hib,Primary Series,States/Local Areas,Montana,2013,Age,13 Months,80.2,70.6 to 87.2,249
Hib,Primary Series,States/Local Areas,Montana,2013-2014,Age,13 Months,83.6,79.8 to 86.8,474
Hib,Primary Series,States/Local Areas,Montana,2015,Age,7 Months,77.8,70.2 to 83.8,256
Hib,Primary Series,States/Local Areas,Montana,2015-2016,Age,7 Months,77.7,72.6 to 82.1,513
Hib,Primary Series,States/Local Areas,Montana,2014,Age,7 Months,74.8,67.1 to 81.2,225
Hib,Primary Series,States/Local Areas,Montana,2014-2015,Age,7 Months,76.3,71.0 to 80.8,481
Hib,Primary Series,States/Local Areas,Montana,2017,Age,7 Months,80.7,74.4 to 85.8,265
Hib,Primary Series,States/Local Areas,Montana,2017-2018,Age,7 Months,79.5,74.5 to 83.7,498
Hib,Primary Series,States/Local Areas,Montana,2016,Age,7 Months,77.7,70.6 to 83.4,257
Hib,Primary Series,States/Local Areas,Montana,2016-2017,Age,7 Months,79.2,74.5 to 83.2,522
Hib,Primary Series,States/Local Areas,Montana,2019,Age,7 Months,81.4,73.4 to 87.5,187
Hib,Primary Series,States/Local Areas,Montana,2013,Age,7 Months,71.6,59.3 to 81.4,249
Hib,Primary Series,States/Local Areas,Montana,2013-2014,Age,7 Months,73.2,63.8 to 80.9,474
Combined 7 Series,,States/Local Areas,Montana,2011,Age,24 Months,65.3,57.6 to 72.9,250
Hib,Full Series,States/Local Areas,Montana,2019,Age,19 Months,76.1,67.5 to 83.0,187
Hib,Primary Series,States/Local Areas,Montana,2019,Age,24 Months,93.0,86.5 to 97.1,187
Hib,Primary Series,States/Local Areas,Montana,2015,Age,24 Months,90.0,83.5 to 94.7,256
Hib,Primary Series,States/Local Areas,Montana,2015-2016,Age,24 Months,90.8,86.8 to 94.0,513
Hib,Primary Series,States/Local Areas,Montana,2014,Age,24 Months,91.2,86.3 to 94.9,225
Hib,Primary Series,States/Local Areas,Montana,2014-2015,Age,24 Months,90.6,86.7 to 93.8,481
Hib,Primary Series,States/Local Areas,Montana,2012,Age,35 Months,94.5,89.0 to 97.7,219
Hib,Primary Series,States/Local Areas,Montana,2014,Age,35 Months,91.2,86.3 to 94.9,225
Hib,Primary Series,States/Local Areas,Montana,2014-2015,Age,35 Months,91.5,87.5 to 94.5,481
Hib,Primary Series,States/Local Areas,Montana,2011,Age,35 Months,94.8,90.2 to 97.7,250
Hib,Primary Series,States/Local Areas,Montana,2013,Age,35 Months,88.1,81.7 to 93.0,249
Hib,Primary Series,States/Local Areas,Montana,2013-2014,Age,35 Months,89.7,85.6 to 93.0,474
Combined 7 Series,,States/Local Areas,Montana,2013,Age,24 Months,57.8,50.2 to 65.7,249
Combined 7 Series,,States/Local Areas,Montana,2013-2014,Age,24 Months,63.0,57.5 to 68.4,474
Combined 7 Series,,States/Local Areas,Montana,2012,Age,24 Months,65.6,57.2 to 73.9,219
Hib,Primary Series,States/Local Areas,Montana,2016,Age,35 Months,91.6,86.5 to 95.3,257
Hib,Primary Series,States/Local Areas,Montana,2016-2017,Age,35 Months,91.7,88.3 to 94.4,522
Hib,Primary Series,States/Local Areas,Montana,2019,Age,19 Months,93.0,85.6 to 96.7,187
Hib,Primary Series,States/Local Areas,Montana,2017,Age,35 Months,91.7,87.1 to 95.1,265
Hib,Primary Series,States/Local Areas,Montana,2017-2018,Age,35 Months,93.7,90.7 to 96.0,498
Hib,Primary Series,States/Local Areas,Montana,2015,Age,35 Months,92.0,85.7 to 96.2,256
Hib,Primary Series,States/Local Areas,Montana,2015-2016,Age,35 Months,91.7,87.8 to 94.8,513
Hib,Primary Series,States/Local Areas,Montana,2016,Age,19 Months,90.8,85.2 to 94.4,257
Hib,Primary Series,States/Local Areas,Montana,2016-2017,Age,19 Months,90.1,86.4 to 92.9,522
Hib,Primary Series,States/Local Areas,Montana,2015,Age,19 Months,89.6,82.8 to 94.0,256
Hib,Primary Series,States/Local Areas,Montana,2015-2016,Age,19 Months,90.2,85.9 to 93.3,513
Hib,Primary Series,States/Local Areas,Montana,2013,Age,24 Months,86.2,80.2 to 91.2,249
Hib,Primary Series,States/Local Areas,Montana,2013-2014,Age,24 Months,88.8,84.8 to 92.1,474
Hib,Primary Series,States/Local Areas,Montana,2011,Age,24 Months,94.8,90.2 to 97.7,250
Hib,Primary Series,States/Local Areas,Montana,2012,Age,24 Months,91.5,85.9 to 95.4,219
Influenza,,States/Local Areas,Montana,2012,Age,24 Months,58.4,49.2 to 67.9,219
Influenza,,States/Local Areas,Montana,2011,Age,24 Months,59.8,51.8 to 67.9,250
Influenza,,States/Local Areas,Montana,2014,Age,24 Months,52.2,44.2 to 60.7,225
Influenza,,States/Local Areas,Montana,2014-2015,Age,24 Months,53.2,47.6 to 59.0,481
Influenza,,States/Local Areas,Montana,2015,Age,24 Months,54.1,46.4 to 62.2,256
Influenza,,States/Local Areas,Montana,2015-2016,Age,24 Months,55.8,50.5 to 61.3,513
Hib,Primary Series,States/Local Areas,Montana,2019-2020,Age,7 Months,78.1,72.9 to 82.6,407
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,91.2,86.7 to 95.7,248
Hep B,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,88.8,84.4 to 92.1,407
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,77.5,72.2 to 82.8,338
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.5,70.7 to 88.2,109
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,62.6,45.9 to 79.4,52
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.4 to 96.8,109
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,95.1,90.5 to 99.7,52
≥1 Dose Varicella,,States/Local Areas,Montana,2021,Age,35 Months,85.0,77.8 to 90.9,127
Hib,Full Series,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,70.9,56.7 to 85.1,52
PCV,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,82.5,77.2 to 86.9,347
≥1 Dose Varicella,,States/Local Areas,Montana,2020-2021,Age,24 Months,82.8,77.7 to 87.3,347
Hep A,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,34.2,28.4 to 40.9,347
DTaP,≥4 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,62.7,56.1 to 68.9,347
Hib,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,5 Months,72.8,66.4 to 78.4,347
Hep B,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,5 Months,81.8,76.2 to 86.3,347
DTaP,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,66.9,60.2 to 73.0,347
Polio,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,3 Months,82.3,76.7 to 86.8,347
Hib,Primary Series,States/Local Areas,Montana,2021,Age,35 Months,87.4,80.5 to 92.7,127
Hib,≥2 Doses,States/Local Areas,Montana,2021,Age,13 Months,86.9,79.4 to 92.0,127
Hep B,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,87.2,82.6 to 91.0,347
Polio,≥3 Doses,States/Local Areas,Montana,2021,Age,19 Months,86.7,79.0 to 91.8,127
DTaP,≥2 Doses,States/Local Areas,Montana,2021,Age,5 Months,72.7,62.0 to 81.3,127
Rotavirus,,States/Local Areas,Montana,2021,Age,8 Months,62.5,51.9 to 72.1,127
Polio,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,87.0,82.3 to 90.6,347
Polio,≥2 Doses,States/Local Areas,Montana,2021,Age,5 Months,69.1,58.2 to 78.2,127
Hep B,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,86.1,81.1 to 89.9,347
PCV,≥1 Dose,States/Local Areas,Montana,2021,Age,3 Months,85.0,76.9 to 90.6,127
PCV,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,65.4,58.7 to 71.6,347
DTaP,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,84.0,78.8 to 88.1,347
Hib,Full Series,States/Local Areas,Montana,2020-2021,Age,35 Months,75.3,69.1 to 81.2,347
≥1 Dose MMR,,States/Local Areas,Montana,2021,Age,19 Months,85.5,77.7 to 90.9,127
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2020-2021,Age,0-2 Days,70.4,63.9 to 76.1,347
Hib,Full Series,States/Local Areas,Montana,2020-2021,Age,19 Months,68.2,61.7 to 74.1,347
Hep A,≥2 Doses,States/Local Areas,Montana,2021,Age,19 Months,26.0,18.3 to 35.6,127
Hep B,≥3 Doses,States/Local Areas,Montana,2021,Age,13 Months,84.4,76.4 to 90.0,127
≥1 Dose Varicella,,States/Local Areas,Montana,2021,Age,13 Months,47.1,37.0 to 57.4,127
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2020-2021,Age,0-1 Days,68.5,62.0 to 74.3,347
Combined 7 Series,,States/Local Areas,Montana,2021,Age,24 Months,57.8,47.6 to 68.4,127
Hib,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,86.7,81.2 to 91.3,347
Hep A,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,19 Months,76.0,69.9 to 81.3,347
Hib,Primary Series,States/Local Areas,Montana,2020-2021,Age,35 Months,90.4,86.1 to 93.8,347
Hib,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,77.3,71.2 to 82.4,347
Hep B,≥2 Doses,States/Local Areas,Montana,2021,Age,13 Months,88.6,81.5 to 93.1,127
Influenza,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,51.2,45.1 to 57.2,375
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,87.5,83.9 to 91.1,493
≥1 Dose MMR,,States/Local Areas,Montana,2020-2021,Age,19 Months,83.4,78.3 to 87.6,347
PCV,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,3 Months,82.5,77.2 to 86.8,347
Hib,≥3 Doses,States/Local Areas,Montana,2021,Age,35 Months,85.6,73.7 to 94.0,127
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2021,Age,0-3 Days,68.7,58.2 to 77.5,127
Hib,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,43.4,37.0 to 50.0,347
DTaP,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,5 Months,75.0,68.6 to 80.4,347
Hib,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,83.5,78.5 to 87.6,347
Hep B,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,3 Months,87.9,83.1 to 91.5,347
≥1 Dose Varicella,,States/Local Areas,Montana,2020-2021,Age,13 Months,48.7,42.2 to 55.3,347
Polio,≥2 Doses,States/Local Areas,Montana,2021,Age,13 Months,86.2,78.5 to 91.4,127
Hep B,≥1 Dose,States/Local Areas,Montana,2021,Age,3 Months,88.0,80.0 to 93.0,127
Hib,Full Series,States/Local Areas,Montana,2020-2021,Age,24 Months,72.5,66.3 to 78.4,347
Influenza,,States/Local Areas,Montana,2021,Age,24 Months,52.0,41.9 to 62.9,127
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,94.1,91.7 to 96.5,493
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,92.9,89.9 to 96.0,338
Hib,Full Series,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,80.6,76.3 to 84.9,493
Influenza,,States/Local Areas,Montana,2014-2017,Overall,Overall,56.1,52.1 to 60.0,910
Influenza,,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,48.3,41.1 to 55.6,242
Influenza,,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,57.5,51.7 to 63.3,443
Influenza,,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,66.6,58.7 to 74.6,225
Polio,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,89.7,85.4 to 93.2,347
DTaP,≥3 Doses,States/Local Areas,Montana,2021,Age,24 Months,87.4,80.5 to 92.7,127
Hep A,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,62.7,53.8 to 71.5,347
Hib,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,17.1,12.9 to 22.4,347
DTaP,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,90.1,85.9 to 93.5,347
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2020-2021,Age,0-3 Days,71.7,65.2 to 77.3,347
PCV,≥4 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,68.1,61.4 to 74.1,347
Rotavirus,,States/Local Areas,Montana,2020-2021,Age,8 Months,65.5,58.8 to 71.6,347
DTaP,≥4 Doses,States/Local Areas,Montana,2021,Age,35 Months,77.8,65.7 to 87.9,127
Polio,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,85.0,80.0 to 88.9,347
PCV,≥4 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,74.3,67.7 to 80.5,347
Polio,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,5 Months,72.4,65.8 to 78.1,347
≥1 Dose MMR,,States/Local Areas,Montana,2020-2021,Age,35 Months,87.1,82.4 to 91.1,347
Hib,Full Series,States/Local Areas,Montana,2021,Age,35 Months,73.2,62.5 to 82.8,127
DTaP,≥3 Doses,States/Local Areas,Montana,2021,Age,35 Months,87.4,80.5 to 92.7,127
Combined 7 Series,,States/Local Areas,Montana,2020-2021,Age,35 Months,62.4,55.6 to 69.2,347
Hep B,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,78.3,72.5 to 83.2,347
PCV,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,87.0,82.3 to 90.7,347
Influenza,,States/Local Areas,Montana,2020-2021,Age,24 Months,54.8,48.3 to 61.6,347
Hep B,≥3 Doses,States/Local Areas,Montana,2021,Age,35 Months,85.8,78.7 to 91.5,127
Hib,Primary Series,States/Local Areas,Montana,2021,Age,13 Months,82.9,74.1 to 89.2,127
Hib,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,3 Months,82.6,77.3 to 86.8,347
PCV,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,89.6,84.9 to 93.3,347
Combined 7 Series,,States/Local Areas,Montana,2020-2021,Age,24 Months,57.8,51.2 to 64.5,347
Hep B,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,7 Months,85.9,81.1 to 89.7,347
≥1 Dose Varicella,,States/Local Areas,Montana,2020-2021,Age,19 Months,80.6,75.2 to 85.0,347
Polio,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,89.7,85.4 to 93.2,347
Hib,Primary Series,States/Local Areas,Montana,2020-2021,Age,7 Months,75.3,69.3 to 80.4,347
≥1 Dose MMR,,States/Local Areas,Montana,2021,Age,13 Months,54.5,43.9 to 64.8,127
Hep A,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,24 Months,78.2,72.4 to 83.4,347
PCV,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,88.0,83.5 to 91.7,347
Hib,≥3 Doses,States/Local Areas,Montana,2021,Age,13 Months,39.9,30.2 to 50.3,127
Polio,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,87.5,83.0 to 91.0,347
Influenza,,States/Local Areas,Montana,2016,Age,24 Months,57.7,50.3 to 65.2,257
Influenza,,States/Local Areas,Montana,2016-2017,Age,24 Months,59.2,54.0 to 64.5,522
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,88.0,84.7 to 91.3,493
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,79.6,74.6 to 84.6,338
Influenza,,States/Local Areas,Montana,2019,Age,24 Months,72.6,64.1 to 80.6,187
Influenza,,States/Local Areas,Montana,2013,Age,24 Months,47.3,40.0 to 55.3,249
Influenza,,States/Local Areas,Montana,2013-2014,Age,24 Months,49.8,44.3 to 55.7,474
Influenza,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,47.0,31.4 to 62.6,59
Influenza,,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,65.6,60.2 to 71.0,453
Influenza,,States/Local Areas,Montana,2017,Age,24 Months,60.7,53.4 to 68.1,265
Influenza,,States/Local Areas,Montana,2017-2018,Age,24 Months,62.9,57.6 to 68.3,498
Influenza,,States/Local Areas,Montana,2018,Age,24 Months,65.2,57.4 to 72.9,233
Influenza,,States/Local Areas,Montana,2018-2019,Age,24 Months,68.9,63.0 to 74.5,420
Influenza,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,Hispanic,42.2,26.4 to 57.9,54
Influenza,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.8,49.7 to 72.0,96
Influenza,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,62.4,47.2 to 77.5,51
Influenza,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,54.0,49.1 to 58.9,608
Influenza,,States/Local Areas,Montana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",56.4,52.1 to 60.8,754
Influenza,,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a MSA Principal City,59.1,51.6 to 66.6,251
Hib,Full Series,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.0,66.6 to 85.3,109
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.4,46.7 to 80.2,109
Combined 7 Series,,States/Local Areas,TX-City of Houston,2017,Age,35 Months,71.5,61.8 to 80.5,171
Combined 7 Series,,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,74.2,67.6 to 80.4,394
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016,Age,35 Months,77.8,68.6 to 85.8,168
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,74.7,68.0 to 80.9,339
Combined 7 Series,,States/Local Areas,TX-City of Houston,2011,Age,35 Months,71.0,60.9 to 80.4,213
Combined 7 Series,,States/Local Areas,TX-City of Houston,2012,Age,35 Months,77.3,69.2 to 84.5,244
Combined 7 Series,,States/Local Areas,TX-City of Houston,2013,Age,35 Months,73.6,65.3 to 81.3,205
Combined 7 Series,,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,75.5,69.2 to 81.4,359
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014,Age,35 Months,76.9,67.5 to 85.2,154
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,78.8,71.5 to 85.3,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017,Age,24 Months,91.0,84.4 to 95.6,171
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,91.5,87.2 to 94.8,394
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014,Age,7 Months,73.4,63.4 to 81.5,154
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,74.8,67.8 to 80.6,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015,Age,7 Months,76.1,65.9 to 84.0,141
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,72.5,65.8 to 78.3,309
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016,Age,24 Months,71.0,61.9 to 79.6,168
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,69.0,62.6 to 75.3,339
Combined 7 Series,,States/Local Areas,TX-City of Houston,2018,Age,24 Months,71.0,62.3 to 79.2,223
Combined 7 Series,,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,68.5,62.3 to 74.6,419
Combined 7 Series,,States/Local Areas,TX-City of Houston,2017,Age,24 Months,66.9,57.7 to 75.9,171
Combined 7 Series,,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,69.1,62.8 to 75.2,394
Combined 7 Series,,States/Local Areas,TX-City of Houston,2019,Age,24 Months,65.9,57.0 to 74.6,196
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014,Age,35 Months,90.5,84.1 to 95.1,154
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,93.7,90.1 to 96.4,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018,Age,35 Months,91.9,85.8 to 96.0,223
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,91.3,86.8 to 94.7,419
Combined 7 Series,,States/Local Areas,TX-City of Houston,2015,Age,24 Months,73.0,63.0 to 82.1,141
Combined 7 Series,,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,71.9,65.2 to 78.4,309
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014,Age,24 Months,74.0,64.6 to 82.6,154
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,73.5,66.7 to 79.9,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019,Age,35 Months,90.7,83.6 to 95.5,196
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017,Age,35 Months,91.0,84.4 to 95.6,171
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,91.5,87.2 to 94.8,394
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016,Age,24 Months,92.1,85.5 to 96.4,168
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,91.6,87.1 to 94.9,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018,Age,24 Months,91.9,85.8 to 96.0,223
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,91.3,86.8 to 94.7,419
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013,Age,24 Months,94.4,89.3 to 97.5,205
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,92.5,88.5 to 95.5,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014,Age,24 Months,90.5,84.1 to 95.1,154
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,93.7,90.1 to 96.4,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015,Age,24 Months,96.8,92.6 to 98.9,141
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,94.4,90.7 to 97.0,309
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017,Age,13 Months,84.0,75.7 to 89.9,171
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,86.5,81.4 to 90.4,394
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019,Age,13 Months,86.8,78.9 to 92.1,196
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018,Age,13 Months,89.1,82.2 to 93.5,223
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,88.0,83.0 to 91.6,419
Hib,Primary Series,States/Local Areas,TX-City of Houston,2012,Age,35 Months,93.8,89.0 to 97.0,244
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019,Age,24 Months,90.7,83.6 to 95.5,196
Hib,Primary Series,States/Local Areas,TX-City of Houston,2011,Age,35 Months,95.5,88.2 to 98.9,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013,Age,35 Months,95.1,90.1 to 98.0,205
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,92.9,89.0 to 95.8,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016,Age,35 Months,95.6,90.7 to 98.3,168
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,93.1,89.0 to 96.1,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015,Age,35 Months,96.8,92.6 to 98.9,141
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,96.5,93.1 to 98.5,309
Combined 7 Series,,States/Local Areas,TX-City of Houston,2011,Age,24 Months,66.0,56.2 to 75.5,213
Combined 7 Series,,States/Local Areas,TX-City of Houston,2012,Age,24 Months,74.0,65.9 to 81.5,244
Combined 7 Series,,States/Local Areas,TX-City of Houston,2013,Age,24 Months,66.4,58.4 to 74.3,205
Combined 7 Series,,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,70.1,63.9 to 76.2,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014,Age,19 Months,90.5,83.4 to 94.8,154
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,93.6,89.6 to 96.1,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013,Age,19 Months,93.9,89.8 to 96.4,205
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,92.1,87.5 to 95.1,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2011,Age,19 Months,94.2,88.3 to 97.2,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2012,Age,19 Months,90.8,87.4 to 93.4,244
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016,Age,13 Months,87.8,79.7 to 93.0,168
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,86.0,80.5 to 90.1,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014,Age,13 Months,90.0,82.8 to 94.4,154
Hib,Primary Series,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,92.4,88.3 to 95.2,295
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015,Age,13 Months,94.8,89.3 to 97.5,141
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,91.3,86.7 to 94.5,309
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018,Age,19 Months,91.9,85.0 to 95.7,223
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,88.0,83.0 to 91.6,419
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019,Age,19 Months,89.9,82.0 to 94.6,196
Hib,Primary Series,States/Local Areas,TX-City of Houston,2012,Age,24 Months,91.5,85.9 to 95.6,244
Hib,Primary Series,States/Local Areas,TX-City of Houston,2011,Age,24 Months,94.2,88.4 to 97.7,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017,Age,19 Months,89.9,82.4 to 94.4,171
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,90.9,86.2 to 94.1,394
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015,Age,19 Months,96.5,95.2 to 97.4,141
Hib,Primary Series,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,94.0,89.9 to 96.5,309
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016,Age,19 Months,91.5,84.1 to 95.6,168
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,90.7,85.9 to 94.0,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019,Age,7 Months,73.9,64.6 to 81.4,196
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018,Age,7 Months,77.8,69.8 to 84.2,223
Hib,Primary Series,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,75.9,70.0 to 81.0,419
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013,Age,13 Months,89.8,86.0 to 92.7,205
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,89.9,84.5 to 93.6,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2012,Age,13 Months,88.3,85.3 to 90.8,244
Hib,Primary Series,States/Local Areas,TX-City of Houston,2011,Age,13 Months,91.3,81.5 to 96.1,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016,Age,7 Months,68.7,59.5 to 76.7,168
Hib,Primary Series,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,69.5,63.0 to 75.3,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017,Age,7 Months,70.3,60.8 to 78.2,171
Hib,Primary Series,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,74.0,67.9 to 79.2,394
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013,Age,7 Months,68.0,62.5 to 72.9,205
Hib,Primary Series,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,70.8,64.2 to 76.6,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2012,Age,7 Months,62.2,58.9 to 65.3,244
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,97.1,94.1 to 98.6,126
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,87.8,82.1 to 92.3,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,92.2,86.8 to 96.0,339
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,67.1,53.5 to 78.3,126
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,74.1,52.7 to 91.3,126
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2021,Age,19 Months,86.1,74.7 to 92.9,126
Hib,Full Series,States/Local Areas,TX-City of Houston,2021,Age,24 Months,72.0,59.6 to 83.3,126
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,3 Months,86.6,74.3 to 93.5,126
Hib,Primary Series,States/Local Areas,TX-City of Houston,2021,Age,24 Months,94.8,87.4 to 98.5,126
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,92.1,82.6 to 97.4,126
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2021,Age,24 Months,88.8,79.6 to 95.1,126
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,91.7,82.7 to 97.1,126
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,71.8,59.2 to 83.2,126
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,21.4,13.7 to 31.8,126
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,3 Months,86.9,74.5 to 93.8,126
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,94.8,85.7 to 98.2,126
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,83.4,71.7 to 92.2,126
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,35 Months,95.0,89.1 to 98.2,126
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,19 Months,91.6,82.6 to 96.2,126
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,77.5,64.9 to 86.5,126
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,91.2,82.8 to 96.5,126
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,94.7,85.7 to 98.1,126
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,70.3,57.1 to 80.9,126
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,40.4,27.3 to 56.7,126
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,5 Months,80.8,73.4 to 86.4,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,73.4,60.3 to 83.4,126
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,81.6,70.3 to 90.6,126
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2021,Age,24 Months,89.7,80.7 to 95.7,126
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,24 Months,94.6,88.9 to 97.9,126
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,97.1,94.5 to 98.7,126
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2021,Age,0-1 Days,81.0,69.3 to 89.0,126
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,74.2,68.0 to 80.4,303
Hib,Full Series,States/Local Areas,TX-City of Houston,2011,Age,24 Months,81.7,72.8 to 89.0,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2012,Age,24 Months,80.5,73.0 to 87.1,244
Hib,Full Series,States/Local Areas,TX-City of Houston,2014,Age,24 Months,82.5,74.1 to 89.4,154
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,83.7,78.1 to 88.5,295
Hib,Full Series,States/Local Areas,TX-City of Houston,2013,Age,24 Months,78.4,70.9 to 85.0,205
Hib,Full Series,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,80.3,74.8 to 85.3,359
Hib,Full Series,States/Local Areas,TX-City of Houston,2015,Age,19 Months,77.2,69.3 to 83.6,141
Hib,Full Series,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,76.2,69.4 to 81.8,309
Hib,Full Series,States/Local Areas,TX-City of Houston,2014,Age,19 Months,71.3,61.1 to 79.7,154
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,74.3,67.3 to 80.3,295
Hib,Full Series,States/Local Areas,TX-City of Houston,2017,Age,19 Months,69.7,60.1 to 77.8,171
Hib,Full Series,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,74.7,68.6 to 80.0,394
Hib,Full Series,States/Local Areas,TX-City of Houston,2016,Age,19 Months,75.1,65.7 to 82.5,168
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,72.4,65.9 to 78.1,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2019,Age,19 Months,75.6,66.8 to 82.7,196
Hib,Full Series,States/Local Areas,TX-City of Houston,2018,Age,19 Months,80.0,72.1 to 86.2,223
Hib,Full Series,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,93.4,89.1 to 96.1,419
Combined 7 Series,,States/Local Areas,TX-City of Houston,2015,Age,35 Months,79.9,69.0 to 88.9,141
Combined 7 Series,,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,78.8,71.8 to 85.1,309
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,84.8,74.0 to 95.5,32
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,71.4,66.6 to 76.3,560
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.7,56.3 to 85.2,66
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.0,68.0 to 85.9,129
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,71.4,66.6 to 76.3,560
Combined 7 Series,,States/Local Areas,TX-City of Houston,2019,Age,35 Months,72.7,62.6 to 81.9,196
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,79.3,71.8 to 86.7,203
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,66.8,60.0 to 73.6,296
Combined 7 Series,,States/Local Areas,TX-City of Houston,2018,Age,35 Months,76.9,68.2 to 84.7,223
Combined 7 Series,,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,75.7,68.6 to 82.2,419
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",57.6,43.3 to 71.9,62
Rotavirus,,States/Local Areas,TX-City of Houston,2011,Age,8 Months,72.3,61.7 to 80.9,213
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,64.7,58.1 to 71.2,319
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.0,73.1 to 90.8,129
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,76.2,71.9 to 80.6,560
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,63.3 to 89.2,66
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,80.1,71.2 to 89.0,107
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,76.2,71.9 to 80.6,560
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,72.0,66.0 to 78.0,319
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,92.0,83.5 to 100.0,32
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,89.8,85.5 to 94.1,203
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.6,54.8 to 80.3,62
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,68.2,61.6 to 74.8,296
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,77.0,71.2 to 82.8,303
Rotavirus,,States/Local Areas,TX-City of Houston,2012,Age,8 Months,71.5,63.0 to 78.7,244
Rotavirus,,States/Local Areas,TX-City of Houston,2013,Age,8 Months,72.6,64.2 to 79.7,205
Rotavirus,,States/Local Areas,TX-City of Houston,2013-2014,Age,8 Months,75.2,68.8 to 80.7,359
Rotavirus,,States/Local Areas,TX-City of Houston,2015,Age,8 Months,75.1,64.8 to 83.2,141
Rotavirus,,States/Local Areas,TX-City of Houston,2015-2016,Age,8 Months,74.8,68.1 to 80.5,309
Rotavirus,,States/Local Areas,TX-City of Houston,2016,Age,8 Months,74.5,65.3 to 81.9,168
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2017,Age,8 Months,70.9,64.4 to 76.6,339
Rotavirus,,States/Local Areas,TX-City of Houston,2014,Age,8 Months,77.6,67.8 to 85.1,154
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2015,Age,8 Months,76.3,69.4 to 82.1,295
Hib,Full Series,States/Local Areas,TX-City of Houston,2013,Age,19 Months,72.4,66.2 to 77.8,205
Hib,Full Series,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,71.8,65.9 to 77.1,359
Hib,Full Series,States/Local Areas,TX-City of Houston,2012,Age,19 Months,77.3,70.7 to 82.8,244
Hib,Full Series,States/Local Areas,TX-City of Houston,2011,Age,19 Months,76.3,68.1 to 83.0,213
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,80.7,72.0 to 89.4,107
Combined 7 Series,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,85.3,76.8 to 93.8,134
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,90.2,86.2 to 94.1,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.2,68.8 to 87.6,166
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,78.3,71.5 to 85.1,335
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,87.6,81.4 to 92.0,339
Rotavirus,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,86.4,78.9 to 93.8,134
Rotavirus,,States/Local Areas,TX-City of Houston,2019,Age,8 Months,73.9,64.4 to 81.5,196
Rotavirus,,States/Local Areas,TX-City of Houston,2017,Age,8 Months,67.2,57.6 to 75.5,171
Rotavirus,,States/Local Areas,TX-City of Houston,2017-2018,Age,8 Months,75.3,69.2 to 80.5,394
Rotavirus,,States/Local Areas,TX-City of Houston,2018,Age,8 Months,83.8,76.2 to 89.3,223
Rotavirus,,States/Local Areas,TX-City of Houston,2018-2019,Age,8 Months,78.9,73.0 to 83.9,419
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,95.5,92.3 to 98.8,286
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,87.6,81.7 to 93.5,286
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,90.8,86.9 to 94.7,335
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,55.7,50.6 to 60.9,560
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,48.9,27.3 to 70.6,32
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,78.1,70.3 to 85.9,203
Influenza,,States/Local Areas,TX-City of Houston,2019,Age,24 Months,62.7,53.7 to 71.7,196
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.5,57.0 to 86.1,86
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,60.3 to 90.3,86
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,94.6,90.7 to 98.4,286
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,90.0,85.5 to 94.6,311
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.6,87.0 to 100.0,166
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,3 Months,94.5,85.5 to 98.0,126
Influenza,,States/Local Areas,TX-City of Houston,2013,Age,24 Months,50.3,42.0 to 59.2,205
Influenza,,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,48.5,42.0 to 55.3,359
Influenza,,States/Local Areas,TX-City of Houston,2015,Age,24 Months,56.9,47.0 to 67.2,141
Influenza,,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,59.0,52.0 to 66.1,309
Influenza,,States/Local Areas,TX-City of Houston,2014,Age,24 Months,46.8,37.4 to 57.2,154
Influenza,,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,51.8,44.9 to 59.2,295
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,88.6,83.1 to 92.5,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,70.5,62.5 to 77.4,339
Influenza,,States/Local Areas,TX-City of Houston,2011,Age,24 Months,45.2,35.9 to 55.7,213
Influenza,,States/Local Areas,TX-City of Houston,2012,Age,24 Months,63.0,55.0 to 70.9,244
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,73.4,67.0 to 79.0,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,97.7,95.8 to 99.5,202
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,78.8,73.3 to 84.2,335
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,76.5,68.2 to 84.7,169
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,79.1,73.5 to 84.8,311
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,74.7 to 98.8,86
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,91.0,87.2 to 94.8,335
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,91.7,81.0 to 96.7,126
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2021,Age,19 Months,85.7,74.5 to 92.4,126
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,5 Months,91.0,81.4 to 95.9,126
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,91.2,85.9 to 94.7,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,90.0,76.7 to 97.4,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,89.2,83.5 to 93.2,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,90.5,87.4 to 93.6,560
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,92.5,87.3 to 95.7,339
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2020-2021,Age,0-1 Days,76.7,69.7 to 82.5,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,93.6,88.9 to 96.7,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,92.1,86.7 to 95.9,339
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,87.1,81.4 to 91.3,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,93.3,88.7 to 96.5,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2020-2021,Age,0-3 Days,79.7,72.9 to 85.1,339
Rotavirus,,States/Local Areas,TX-City of Houston,2020-2021,Age,8 Months,75.4,67.7 to 81.8,339
Combined 7 Series,,States/Local Areas,TX-City of Houston,2021,Age,24 Months,60.6,48.2 to 73.2,126
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2021,Age,35 Months,89.7,80.7 to 95.7,126
Influenza,,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,56.8,49.1 to 64.8,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,72.0,64.3 to 78.7,339
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,82.3,64.9 to 94.3,126
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,97.0,86.4 to 99.8,126
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,93.3,89.1 to 95.9,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2021,Age,13 Months,91.6,82.3 to 96.2,126
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,78.9,71.6 to 84.8,339
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,83.7,76.6 to 89.6,339
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,93.9,85.2 to 97.6,126
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,5 Months,78.9,71.0 to 85.0,339
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,89.3,82.8 to 93.5,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,94.3,90.6 to 96.9,339
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,3 Months,83.9,77.0 to 89.0,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,89.1,83.3 to 93.6,339
Combined 7 Series,,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,65.7,57.9 to 73.4,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,89.5,83.8 to 93.3,339
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,91.6,86.3 to 95.0,339
Combined 7 Series,,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,83.3,68.7 to 93.6,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,95.1,87.6 to 98.7,126
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,86.2,79.7 to 90.9,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2021,Age,35 Months,75.1,61.8 to 86.6,126
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,97.9,92.5 to 99.7,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,90.9,85.0 to 94.7,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2021,Age,0-3 Days,83.5,72.2 to 90.8,126
Rotavirus,,States/Local Areas,TX-City of Houston,2021,Age,8 Months,77.6,64.3 to 86.9,126
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,68.9,60.8 to 76.0,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,88.8,77.8 to 94.8,126
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,93.8,90.2 to 96.5,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,90.3,84.3 to 94.2,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2021,Age,35 Months,98.2,91.0 to 99.9,126
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,48.0,39.7 to 57.0,339
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,88.5,82.8 to 92.9,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,95.2,85.8 to 98.5,126
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,89.8,84.5 to 93.8,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,5 Months,77.9,70.2 to 84.0,339
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,5 Months,89.0,83.1 to 93.0,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,68.8,60.7 to 75.9,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,85.6,79.2 to 90.3,339
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,3 Months,84.5,77.4 to 89.7,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,90.5,85.0 to 94.1,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,90.8,85.4 to 94.9,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,97.3,87.2 to 99.8,126
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,80.2,67.3 to 90.4,339
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,90.9,86.4 to 94.4,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2021,Age,13 Months,70.9,58.3 to 80.9,126
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,3 Months,93.2,88.1 to 96.2,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,90.8,84.9 to 94.6,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,66.7,58.5 to 74.0,339
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,3 Months,87.1,80.9 to 91.5,339
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,5 Months,78.7,70.9 to 84.9,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,24 Months,95.1,87.6 to 98.7,126
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,94.7,85.6 to 98.1,126
Influenza,,States/Local Areas,TX-City of Houston,2021,Age,24 Months,55.7,43.4 to 68.7,126
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,65.3,57.5 to 72.3,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,7 Months,72.1,64.1 to 78.9,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,76.3,68.9 to 83.1,339
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,46.9,40.2 to 53.6,319
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,58.9,46.7 to 71.1,107
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,83.5,75.3 to 91.7,134
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,90.7,86.1 to 95.3,286
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,73.7 to 96.9,86
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,49.2,42.3 to 56.1,303
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.0,51.2 to 80.8,66
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",41.7,27.2 to 56.1,62
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,46.9,40.0 to 53.8,296
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.4,72.4 to 88.5,129
Influenza,,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,55.7,50.6 to 60.9,560
Influenza,,States/Local Areas,TX-City of Houston,2016,Age,24 Months,61.2,51.4 to 71.1,168
Influenza,,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,56.4,49.7 to 63.4,339
Influenza,,States/Local Areas,TX-City of Houston,2018,Age,24 Months,60.5,51.8 to 69.3,223
Influenza,,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,61.6,55.3 to 67.9,419
Influenza,,States/Local Areas,TX-City of Houston,2017,Age,24 Months,51.5,42.3 to 61.3,171
Influenza,,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,55.9,49.6 to 62.4,394
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,28.3,22.2 to 35.3,339
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,93.0,87.9 to 96.1,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,72.0,64.0 to 78.8,339
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2020-2021,Age,0-2 Days,78.8,72.0 to 84.3,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,69.9,62.1 to 76.7,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,92.9,90.5 to 94.7,244
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,92.7,84.5 to 96.7,205
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,90.3,86.8 to 92.9,359
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2021,Age,13 Months,64.7,52.2 to 75.5,126
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,3 Months,90.7,81.0 to 95.7,126
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,91.2,81.5 to 96.0,126
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,5 Months,76.1,62.5 to 85.8,126
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,5 Months,76.1,62.5 to 85.8,126
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,85.5,77.0 to 91.3,196
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,94.0,87.9 to 97.1,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,94.0,92.3 to 95.3,244
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,91.6,85.8 to 95.1,223
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,88.6,83.7 to 92.2,419
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,85.7,76.9 to 91.5,168
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,82.7,76.9 to 87.4,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,79.7,71.0 to 86.3,171
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,81.8,76.3 to 86.3,394
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,89.1,81.7 to 93.7,141
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,87.4,82.0 to 91.4,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,87.0,83.9 to 89.6,244
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,88.0,80.0 to 93.0,154
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,92.0,87.6 to 95.0,295
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,82.3,73.5 to 88.6,196
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,90.8,87.4 to 93.4,244
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,93.5,86.7 to 97.0,213
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,96.0,94.3 to 97.2,141
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,93.4,89.1 to 96.1,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,84.1,76.4 to 89.6,223
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,83.2,77.6 to 87.6,419
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,90.7,83.0 to 95.2,168
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,89.5,84.5 to 93.1,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,88.3,80.7 to 93.2,171
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,90.8,86.2 to 93.9,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,78.8,69.6 to 86.7,213
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,83.2,75.8 to 89.4,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,62.8,57.4 to 67.9,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,58.0,52.8 to 63.1,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,95.2,91.1 to 99.2,107
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,98.7,97.1 to 100.0,134
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,90.4,86.4 to 94.4,319
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,5 Months,76.3,69.4 to 82.1,244
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,5 Months,76.9,69.1 to 83.1,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,35 Months,92.1,86.0 to 96.3,244
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,5 Months,79.1,74.5 to 83.1,205
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,5 Months,79.2,76.0 to 82.1,359
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,5 Months,79.3,70.5 to 86.0,154
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,5 Months,82.8,78.9 to 86.2,295
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,52.4,42.2 to 63.3,141
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,48.9,41.8 to 56.6,309
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,59.6,50.3 to 69.1,171
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,56.5,50.0 to 63.2,394
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,45.5,36.2 to 56.1,168
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,52.5,45.6 to 59.7,339
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,78.9,71.2 to 85.7,205
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,81.1,75.6 to 86.1,359
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,35 Months,95.7,89.5 to 98.7,141
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,94.8,90.4 to 97.5,309
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,35 Months,97.7,91.7 to 99.7,171
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,95.8,90.6 to 98.6,394
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,5 Months,80.3,71.4 to 87.0,168
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,5 Months,80.3,74.4 to 85.2,339
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,5 Months,80.3,71.9 to 86.7,171
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,5 Months,82.4,76.9 to 86.9,394
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,64.1,53.8 to 73.3,154
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,70.6,63.5 to 76.8,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,76.8,66.8 to 84.5,141
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,74.1,67.3 to 79.9,309
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,70.4,66.2 to 74.3,205
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,67.2,64.1 to 70.0,359
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,53.0,44.4 to 62.2,223
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,53.4,47.0 to 60.1,419
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,53.7,44.4 to 63.5,196
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,5 Months,86.2,77.4 to 91.9,141
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,5 Months,83.3,77.4 to 88.0,309
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,77.9,66.6 to 87.5,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,77.4,67.8 to 85.8,244
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,73.2,62.7 to 82.7,205
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,76.4,68.8 to 83.2,359
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,76.2,67.5 to 84.1,168
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,78.4,72.5 to 83.8,339
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,83.7,75.9 to 90.1,141
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,80.0,74.1 to 85.3,309
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,83.5,75.4 to 90.2,154
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,83.8,78.3 to 88.6,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,69.0,59.9 to 76.9,196
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,71.3,61.8 to 79.2,168
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,70.4,63.9 to 76.2,339
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,79.6,69.4 to 88.2,154
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,90.1,78.4 to 97.0,295
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,86.9,77.4 to 93.7,168
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,83.9,76.7 to 89.9,339
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,92.6,78.8 to 98.7,141
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,91.4,81.4 to 97.2,309
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,74.1,66.3 to 80.6,223
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,71.6,65.8 to 76.8,419
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,69.6,60.2 to 77.5,171
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,71.8,65.8 to 77.1,394
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,5 Months,78.9,70.0 to 85.8,196
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,89.1,84.6 to 93.7,303
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,92.1,89.1 to 94.3,244
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,91.6,87.7 to 94.3,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.7,80.7 to 98.8,62
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,89.0,75.7 to 100.0,32
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,5 Months,84.6,76.7 to 90.2,223
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,5 Months,81.9,76.1 to 86.5,419
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,35 Months,95.1,89.7 to 98.2,196
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,94.6,91.2 to 98.1,203
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,88.5,83.7 to 93.3,296
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,35 Months,92.7,86.5 to 96.7,223
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,94.1,90.1 to 96.9,419
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2012,Age,13 Months,63.7,56.6 to 70.2,244
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014,Age,13 Months,62.3,52.2 to 71.5,154
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,61.2,53.8 to 68.1,295
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2011,Age,13 Months,68.7,55.9 to 79.2,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013,Age,13 Months,62.8,55.1 to 69.8,205
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,62.6,55.8 to 68.8,359
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016,Age,13 Months,68.9,59.5 to 77.0,168
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,65.1,58.5 to 71.2,339
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017,Age,13 Months,61.2,51.7 to 69.8,171
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,66.1,59.8 to 72.0,394
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015,Age,13 Months,60.1,49.2 to 70.1,141
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,64.5,57.2 to 71.1,309
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,80.1 to 99.5,66
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.6,89.4 to 99.8,129
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,90.2,87.0 to 93.5,560
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,84.9,76.0 to 90.9,154
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,88.8,83.5 to 92.6,295
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,86.9,82.9 to 90.0,205
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,85.9,83.2 to 88.2,359
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,90.2,87.0 to 93.5,560
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,88.6,84.0 to 93.1,319
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,92.6,85.7 to 96.3,141
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,92.3,87.8 to 95.2,309
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,83.7,79.2 to 87.4,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,35 Months,92.9,86.2 to 97.1,168
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,97.1,91.6 to 99.4,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2012,Age,13 Months,66.8,60.9 to 72.2,244
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2011,Age,13 Months,71.0,59.1 to 80.6,213
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,79.0,70.5 to 86.4,223
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,78.2,72.3 to 83.6,419
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,80.4,72.4 to 87.3,171
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,80.3,74.5 to 85.4,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,77.3,68.8 to 84.8,196
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,84.9,75.5 to 92.1,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,77.3,68.0 to 85.4,223
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,83.4,75.9 to 89.7,419
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,81.9,71.9 to 90.1,171
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,80.0,73.0 to 86.2,394
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,87.2,82.9 to 90.5,205
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,86.9,82.5 to 90.3,359
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,86.7,78.9 to 91.9,154
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,88.3,83.1 to 92.1,295
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,88.1,77.4 to 95.2,196
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,88.8,85.7 to 91.4,244
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,85.9,77.8 to 92.1,205
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,85.5,80.1 to 90.2,359
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,85.2,77.3 to 91.5,154
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,87.1,81.6 to 91.6,295
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,89.2,82.8 to 94.0,244
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014,Age,13 Months,66.8,56.6 to 75.6,154
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,64.4,57.0 to 71.2,295
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015,Age,13 Months,62.1,51.1 to 72.0,141
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,65.4,58.1 to 72.1,309
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019,Age,13 Months,63.0,53.7 to 71.5,196
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2011,Age,19 Months,86.3,74.2 to 93.3,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2012,Age,19 Months,89.0,85.7 to 91.6,244
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,90.4,83.5 to 97.3,107
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018,Age,13 Months,71.3,63.0 to 78.4,223
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,67.3,61.1 to 72.9,419
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013,Age,13 Months,63.6,53.6 to 72.6,205
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,65.3,56.2 to 73.3,359
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,95.7,92.4 to 99.0,134
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,92.6,86.5 to 96.0,223
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,91.8,87.2 to 94.8,419
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,3 Months,94.7,91.5 to 96.8,205
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,3 Months,92.8,90.3 to 94.6,359
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,3 Months,96.7,92.0 to 98.7,244
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,3 Months,96.4,94.9 to 97.4,213
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,92.0,85.1 to 95.9,168
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,91.0,86.4 to 94.2,339
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,90.0,82.7 to 94.4,171
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,91.2,86.9 to 94.3,394
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,88.0,79.6 to 93.2,168
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,87.0,81.6 to 91.0,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,89.9,81.9 to 94.6,141
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,89.0,83.6 to 92.8,309
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,89.0,80.6 to 94.9,141
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,86.4,80.4 to 91.2,309
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,86.0,78.1 to 91.4,171
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,88.1,83.3 to 91.6,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,83.8,75.8 to 90.3,171
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,84.4,78.8 to 89.2,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,83.8,75.2 to 90.8,168
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,83.9,78.1 to 88.8,339
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,84.2,68.5 to 99.9,32
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.3,69.6 to 100.0,62
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,89.7,81.6 to 97.7,203
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,86.4,75.8 to 97.0,296
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,90.9,83.0 to 95.4,196
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,86.5,79.3 to 93.7,560
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,84.9,75.8 to 94.1,319
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.3,74.4 to 98.2,129
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,86.5,79.3 to 93.7,560
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,82.3,74.9 to 89.6,303
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,95.5,92.5 to 97.3,205
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,93.3,90.5 to 95.2,359
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,3 Months,90.9,84.2 to 95.0,154
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,3 Months,94.0,90.2 to 96.3,295
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,3 Months,96.9,92.4 to 98.8,141
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,3 Months,97.2,94.2 to 98.7,309
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,3 Months,97.6,91.9 to 99.3,168
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,3 Months,97.4,93.7 to 98.9,339
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014,Age,19 Months,88.3,80.5 to 93.2,154
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,88.5,82.8 to 92.5,295
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015,Age,19 Months,88.7,85.0 to 91.6,141
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,90.0,84.6 to 93.7,309
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013,Age,19 Months,88.2,85.0 to 90.7,205
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,88.2,86.9 to 89.4,359
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,95.4,92.6 to 97.1,244
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,93.7,87.2 to 97.0,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018,Age,13 Months,73.6,65.3 to 80.5,223
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,72.2,66.1 to 77.6,419
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016,Age,13 Months,68.8,59.4 to 76.9,168
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,67.9,61.4 to 73.9,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,91.0,85.0 to 94.7,223
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,86.6,81.5 to 90.4,419
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,87.8,79.9 to 92.9,171
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,89.4,84.6 to 92.8,394
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,5 Months,90.8,82.8 to 95.3,168
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,5 Months,89.7,84.3 to 93.3,339
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,5 Months,83.9,75.6 to 89.8,154
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,5 Months,89.3,82.8 to 93.5,295
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2012,Age,0-1 Days,76.9,73.0 to 80.5,244
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,68.5,63.2 to 73.3,205
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,69.3,65.5 to 72.8,359
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,59.0,52.2 to 65.4,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,90.3,82.4 to 94.8,168
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,89.1,83.9 to 92.7,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,70.1,60.0 to 78.5,154
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,70.1,63.0 to 76.4,295
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,61.3,59.2 to 63.3,244
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,87.0,79.6 to 94.3,107
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,94.1,90.2 to 97.9,134
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017,Age,19 Months,90.8,84.6 to 94.7,171
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,90.9,86.9 to 93.8,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019,Age,19 Months,84.2,75.7 to 90.1,196
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,83.3,75.0 to 90.1,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018,Age,19 Months,91.0,85.0 to 94.7,223
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,92.4,87.5 to 95.5,419
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,79.1,75.8 to 82.1,205
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,81.4,77.3 to 85.0,359
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,81.3,77.2 to 84.9,244
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,74.8,69.4 to 79.5,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2011,Age,24 Months,89.8,82.4 to 95.0,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015,Age,24 Months,93.5,86.6 to 97.6,141
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,92.5,87.7 to 95.9,309
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016,Age,24 Months,92.3,86.1 to 96.5,168
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,90.9,86.3 to 94.4,339
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,3 Months,91.7,84.4 to 95.7,196
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,91.2,84.1 to 95.3,154
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,94.1,90.2 to 96.5,295
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,3 Months,97.2,93.2 to 98.9,223
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,3 Months,94.5,90.7 to 96.8,419
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2011,Age,0-1 Days,78.9,73.1 to 83.6,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,84.3,71.6 to 97.1,107
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,5 Months,89.2,85.9 to 91.8,244
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,5 Months,86.7,81.7 to 90.5,213
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,5 Months,89.1,84.5 to 92.4,205
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,5 Months,86.4,83.7 to 88.7,359
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,89.6,84.2 to 93.3,205
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,88.7,86.1 to 90.8,359
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,91.5,85.0 to 97.9,134
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,87.8,80.0 to 92.8,154
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,91.1,86.7 to 94.2,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,94.4,91.5 to 96.3,141
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,92.3,87.9 to 95.2,309
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015,Age,19 Months,92.7,87.9 to 95.7,141
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,91.4,86.9 to 94.4,309
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016,Age,19 Months,90.0,83.1 to 94.3,168
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,90.4,86.1 to 93.5,339
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2011,Age,24 Months,88.6,81.2 to 94.1,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2012,Age,24 Months,90.6,85.0 to 94.8,244
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,73.6,67.6 to 79.6,319
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014,Age,19 Months,90.1,82.9 to 94.5,154
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,91.4,86.9 to 94.5,295
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,79.8,75.6 to 84.1,560
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,79.8,75.6 to 84.1,560
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.7,74.0 to 95.4,66
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.9,78.7 to 93.1,129
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,80.5,74.8 to 86.1,303
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019,Age,13 Months,70.7,61.3 to 78.6,196
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016,Age,19 Months,91.4,84.5 to 95.4,168
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,89.1,84.2 to 92.6,339
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,96.9,92.0 to 98.8,141
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,95.5,91.8 to 97.5,309
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,94.0,87.4 to 97.2,168
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,93.1,88.8 to 95.9,339
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,3 Months,97.2,90.2 to 99.2,171
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,3 Months,97.2,93.9 to 98.7,394
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018,Age,19 Months,91.1,85.1 to 94.8,223
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,67.3,61.1 to 72.9,419
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017,Age,19 Months,86.7,78.9 to 91.9,171
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,88.8,84.2 to 92.3,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013,Age,19 Months,87.2,84.0 to 89.9,205
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,88.7,87.3 to 90.0,359
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2012,Age,19 Months,90.3,88.1 to 92.2,244
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,84.8,76.4 to 91.5,223
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,86.3,79.5 to 91.8,419
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,82.2,74.5 to 88.0,223
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,83.1,77.0 to 87.9,334
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,73.8,64.6 to 81.4,171
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,77.9,72.1 to 82.9,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017,Age,24 Months,92.9,87.4 to 96.5,171
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,92.8,89.2 to 95.6,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016,Age,24 Months,91.3,85.1 to 95.7,168
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,92.1,88.1 to 95.1,339
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,90.8,85.4 to 94.4,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,89.1,83.0 to 93.2,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,90.3,83.2 to 95.2,168
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,90.2,85.4 to 94.0,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,95.5,91.3 to 98.1,141
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,93.0,89.0 to 96.0,309
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,88.3,81.2 to 93.6,154
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,92.0,88.1 to 95.1,295
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,67.6,58.0 to 75.9,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,86.2,78.0 to 91.6,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,74.4,65.8 to 81.4,223
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,71.1,64.8 to 76.6,419
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,89.2,82.1 to 93.7,154
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,92.6,88.6 to 95.3,295
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,94.2,91.1 to 96.2,244
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2019,Age,0-1 Days,76.0,67.2 to 83.1,196
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2011,Age,0-2 Days,81.4,75.9 to 85.9,213
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2018,Age,0-1 Days,76.8,67.9 to 83.8,223
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2018-2019,Age,0-1 Days,76.4,70.4 to 81.6,419
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2013,Age,0-2 Days,80.0,70.6 to 86.9,205
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2013-2014,Age,0-2 Days,80.4,76.3 to 83.9,359
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2012,Age,0-2 Days,81.8,78.6 to 84.7,244
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,90.8,85.7 to 94.1,205
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,90.0,86.6 to 92.6,359
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,85.1,76.7 to 90.8,196
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,88.9,81.5 to 94.3,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,90.1,84.2 to 94.5,205
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,89.2,84.7 to 92.8,359
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,69.3,59.9 to 77.3,168
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,66.8,60.2 to 72.8,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,89.9,84.1 to 94.3,244
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,64.2,54.6 to 72.8,171
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,69.2,62.8 to 74.9,394
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,70.1,59.6 to 78.8,141
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,69.7,62.7 to 75.8,309
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,83.6,75.2 to 89.5,154
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,80.6,74.2 to 85.8,295
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,77.8,66.7 to 86.0,141
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,78.7,72.1 to 84.1,309
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,79.7,70.8 to 86.4,168
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,76.8,70.6 to 82.1,339
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018,Age,24 Months,92.6,87.3 to 96.3,223
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,89.8,85.3 to 93.3,419
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015,Age,24 Months,95.3,90.4 to 98.2,141
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,93.3,89.4 to 96.1,309
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014,Age,24 Months,92.3,86.2 to 96.4,154
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,93.8,90.1 to 96.5,295
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013,Age,24 Months,90.1,84.2 to 94.5,205
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,91.3,87.2 to 94.5,359
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019,Age,24 Months,86.8,79.4 to 92.5,196
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017,Age,24 Months,89.3,82.2 to 94.4,171
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,91.0,86.7 to 94.4,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017,Age,13 Months,67.0,57.7 to 75.2,171
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,70.2,64.0 to 75.8,394
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019,Age,19 Months,83.7,75.4 to 89.6,196
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,91.5,83.4 to 95.9,196
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,94.7,88.6 to 97.6,223
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,93.1,88.5 to 96.0,419
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,92.3,85.3 to 96.1,171
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,93.5,89.2 to 96.1,394
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013,Age,24 Months,90.9,85.2 to 95.0,205
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,91.1,86.9 to 94.4,359
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2013,Age,0-1 Days,75.4,64.1 to 84.0,205
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2013-2014,Age,0-1 Days,74.5,70.3 to 78.3,359
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2014,Age,0-1 Days,73.7,64.2 to 81.4,154
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2014-2015,Age,0-1 Days,74.9,68.0 to 80.7,295
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,5 Months,94.5,89.4 to 97.2,141
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,5 Months,92.6,88.3 to 95.5,309
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2015,Age,0-1 Days,76.0,65.6 to 84.0,141
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2015-2016,Age,0-1 Days,75.6,68.6 to 81.6,309
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,5 Months,89.5,83.5 to 93.5,223
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,5 Months,87.3,82.4 to 91.0,419
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,5 Months,85.0,76.5 to 90.8,196
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,5 Months,88.5,80.2 to 93.6,171
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,5 Months,89.0,84.2 to 92.5,394
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014,Age,24 Months,91.5,84.7 to 96.0,154
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,92.4,87.7 to 95.7,295
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2016,Age,0-1 Days,75.3,65.2 to 83.2,168
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2016-2017,Age,0-1 Days,77.2,70.6 to 82.6,339
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2017,Age,0-1 Days,79.2,70.2 to 86.0,171
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2017-2018,Age,0-1 Days,78.0,71.9 to 83.1,394
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,86.0,78.3 to 92.0,196
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,90.0,82.8 to 95.0,171
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,90.8,86.4 to 94.2,394
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,89.0,81.6 to 94.4,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,84.3,77.4 to 89.9,244
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,87.9,81.0 to 93.2,154
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,85.7,80.1 to 90.3,295
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,82.4,75.6 to 88.2,205
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,85.3,80.6 to 89.3,359
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019,Age,24 Months,87.1,79.7 to 92.8,196
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018,Age,24 Months,92.6,87.3 to 96.3,223
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,89.9,85.5 to 93.4,419
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2011,Age,35 Months,90.0,82.5 to 95.2,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2012,Age,35 Months,93.0,87.7 to 96.6,244
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016,Age,35 Months,95.6,90.0 to 98.6,168
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,97.4,92.2 to 99.5,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013,Age,35 Months,92.7,86.6 to 96.7,205
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,93.8,90.2 to 96.3,359
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2016,Age,0-2 Days,78.6,69.0 to 85.9,168
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2016-2017,Age,0-2 Days,81.9,75.7 to 86.9,339
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,77.0,67.7 to 85.3,213
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,86.1,76.2 to 93.4,196
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,87.4,81.8 to 93.0,203
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,76.6,70.5 to 82.7,296
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.6,54.6 to 80.6,62
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,87.5,77.4 to 97.6,32
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2011,Age,19 Months,88.3,76.7 to 94.5,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,82.8,74.1 to 89.0,196
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,88.9,84.0 to 92.5,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,90.2,84.2 to 94.1,223
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,86.6,81.5 to 90.4,419
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,89.8,87.3 to 91.8,244
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2011,Age,35 Months,89.7,82.0 to 95.0,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,82.3 to 99.6,66
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2012,Age,24 Months,92.0,86.7 to 95.7,244
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,94.2,89.4 to 96.9,223
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,91.0,86.3 to 94.2,419
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2019,Age,0-2 Days,77.9,69.1 to 84.8,196
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2018,Age,0-2 Days,81.0,72.2 to 87.5,223
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2018-2019,Age,0-2 Days,79.5,73.5 to 84.4,419
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2017,Age,0-2 Days,85.4,76.8 to 91.2,171
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2017-2018,Age,0-2 Days,83.2,77.3 to 87.9,394
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015,Age,35 Months,94.6,88.0 to 98.2,141
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,94.9,90.7 to 97.6,309
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017,Age,35 Months,97.5,90.1 to 99.7,171
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,95.7,90.5 to 98.5,394
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,91.6,86.1 to 95.5,223
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,88.8,84.3 to 92.6,419
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,95.9,91.1 to 98.1,141
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,95.4,91.8 to 97.5,309
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,89.1,81.9 to 93.7,154
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,89.1,84.1 to 92.7,295
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,89.2,81.2 to 94.0,141
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,87.8,82.5 to 91.7,309
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,95.0,88.5 to 97.9,168
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,94.0,89.9 to 96.5,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,89.5,85.2 to 92.7,205
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,89.3,87.0 to 91.2,359
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,93.1,86.4 to 96.6,171
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,93.6,89.8 to 96.0,394
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,79.4,70.5 to 86.2,196
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013,Age,35 Months,97.0,92.5 to 99.2,205
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,95.8,92.8 to 97.8,359
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2012,Age,35 Months,93.7,87.8 to 97.4,244
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014,Age,35 Months,94.4,89.6 to 97.5,154
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,94.4,90.6 to 97.0,295
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2014,Age,0-2 Days,80.8,71.8 to 87.4,154
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2014-2015,Age,0-2 Days,81.2,74.6 to 86.4,295
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2015,Age,0-2 Days,81.5,71.2 to 88.7,141
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2015-2016,Age,0-2 Days,80.1,73.3 to 85.5,309
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019,Age,35 Months,89.1,81.7 to 94.5,196
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,95.4,91.9 to 98.9,203
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,88.6,83.7 to 93.6,296
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018,Age,35 Months,93.2,87.9 to 96.7,223
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,91.4,86.9 to 94.8,419
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,83.4,74.7 to 90.4,141
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,82.7,76.9 to 87.8,309
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016,Age,35 Months,95.8,90.3 to 98.6,168
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,94.6,90.9 to 97.1,339
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014,Age,35 Months,94.6,90.4 to 97.3,154
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,95.2,92.1 to 97.3,295
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015,Age,35 Months,95.8,90.8 to 98.5,141
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,95.8,92.2 to 98.0,309
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,79.1,70.9 to 86.3,171
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,82.5,77.3 to 87.2,394
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,82.1,73.9 to 88.9,168
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,80.6,74.9 to 85.7,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,88.8,81.9 to 93.3,223
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,86.6,81.3 to 90.5,419
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,84.7,77.1 to 90.2,171
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,86.7,81.9 to 90.4,394
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,87.7,79.1 to 93.0,196
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,91.2,86.2 to 94.5,213
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,95.0,92.3 to 96.8,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,90.1,84.3 to 94.4,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,88.3,81.2 to 93.6,154
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,93.0,89.0 to 95.9,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,90.1,84.2 to 94.5,205
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,89.2,84.7 to 92.8,359
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,86.4,78.3 to 91.8,168
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,85.6,80.3 to 89.6,339
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,86.1,79.2 to 91.6,223
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,83.1,77.8 to 87.7,419
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,80.0,71.7 to 87.1,196
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,87.7,76.2 to 95.3,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,87.2,80.7 to 92.3,244
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,92.8,88.1 to 95.7,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,94.4,86.1 to 98.5,171
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,92.9,88.4 to 96.1,394
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,84.2,75.4 to 90.3,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,89.8,86.3 to 92.5,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,93.8,89.2 to 96.5,205
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,91.9,89.6 to 93.7,359
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,97.1,93.4 to 99.0,141
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,96.3,92.9 to 98.4,309
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,95.0,89.1 to 98.3,168
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,94.7,89.3 to 97.9,339
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,3 Months,82.3,73.5 to 88.6,154
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,3 Months,86.1,80.4 to 90.4,295
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,90.8,83.6 to 95.0,154
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,94.2,90.3 to 96.6,295
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,97.4,93.0 to 99.1,141
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,96.9,94.0 to 98.5,309
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,94.5,91.2 to 96.6,205
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,92.6,90.2 to 94.4,359
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,3 Months,84.6,77.8 to 89.6,205
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,3 Months,83.4,80.1 to 86.2,359
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,3 Months,85.1,81.0 to 88.4,244
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,3 Months,87.2,82.1 to 91.0,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,87.8,80.9 to 93.1,205
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,88.2,83.4 to 92.1,359
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.9,78.5 to 97.3,62
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,89.5,85.0 to 93.9,303
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,79.7 to 100.0,66
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,88.0,83.2 to 92.9,296
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,96.2,92.8 to 99.6,203
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,87.9,79.7 to 93.9,141
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,85.7,79.9 to 90.5,309
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,88.5,81.5 to 93.7,154
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,88.4,83.1 to 92.7,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,90.5,82.1 to 95.9,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,90.1,83.0 to 94.5,154
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,92.6,88.5 to 95.3,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,91.6,86.1 to 95.5,223
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,91.4,86.3 to 95.1,419
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.8,93.1 to 100.0,129
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,87.4 to 93.8,560
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,97.3,94.5 to 100.0,134
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,92.4,86.6 to 98.2,107
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,96.4,91.3 to 98.6,168
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,95.2,91.4 to 97.4,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,94.9,91.1 to 97.1,141
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,93.1,89.0 to 95.8,309
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,91.3,83.9 to 95.4,168
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,89.2,84.3 to 92.7,339
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,3 Months,89.9,81.2 to 94.8,141
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,3 Months,89.4,84.0 to 93.2,309
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,3 Months,89.0,81.2 to 93.8,168
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,3 Months,87.7,82.5 to 91.6,339
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,3 Months,86.4,78.5 to 91.8,171
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,3 Months,87.1,81.8 to 91.0,394
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,93.9,87.1 to 97.2,171
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,94.9,91.2 to 97.1,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018,Age,35 Months,92.9,87.6 to 96.5,223
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,92.8,88.4 to 96.0,419
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017,Age,35 Months,94.0,88.6 to 97.3,171
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,93.6,90.1 to 96.3,394
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019,Age,35 Months,92.3,85.0 to 96.9,196
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,95.3,88.7 to 100.0,32
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,79.5 to 99.2,66
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.9,91.0 to 100.0,129
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,90.8,87.6 to 94.1,560
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,90.8,87.6 to 94.1,560
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,88.5,83.7 to 93.2,319
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.4,76.9 to 97.9,62
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,97.4,92.2 to 100.0,32
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,90.8,86.4 to 95.2,303
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,3 Months,84.8,76.5 to 90.6,196
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,3 Months,87.7,79.8 to 92.8,223
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,3 Months,86.3,80.9 to 90.4,419
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,96.1,91.5 to 98.2,223
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,93.4,89.1 to 96.1,419
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,79.5,71.2 to 86.6,171
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,83.1,77.8 to 87.7,394
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,83.1,74.8 to 89.9,168
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,81.2,75.5 to 86.3,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,88.4,81.1 to 93.8,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,86.8,79.8 to 92.3,223
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,85.1,79.6 to 89.7,419
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,3 Months,81.4,77.1 to 85.1,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,93.2,87.6 to 98.8,107
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,96.8,92.8 to 100.0,134
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,90.6,87.4 to 93.8,560
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,88.0,83.4 to 92.6,319
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,5 Months,76.6,73.0 to 79.9,244
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,5 Months,77.3,70.1 to 83.2,213
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,5 Months,73.3,69.4 to 76.9,205
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,5 Months,76.8,71.5 to 81.4,359
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,87.0,79.4 to 92.1,171
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,89.2,84.4 to 92.7,394
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,87.6,79.3 to 92.9,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,90.4,82.9 to 95.5,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,91.5,84.7 to 95.5,223
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,86.6,81.3 to 90.5,419
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,93.5,88.5 to 96.8,244
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,94.3,89.2 to 97.5,205
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,92.2,88.2 to 95.3,359
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,90.1,83.7 to 94.8,154
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,92.6,88.8 to 95.4,295
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,3 Months,86.3,81.0 to 90.3,205
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,3 Months,84.2,81.4 to 86.7,359
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,96.2,90.8 to 100.0,32
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,77.7,71.9 to 83.6,296
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.2,70.2 to 92.3,62
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,81.3,75.8 to 86.8,303
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,5 Months,80.1,71.2 to 86.7,154
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,5 Months,83.0,79.1 to 86.4,295
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,90.7,82.6 to 95.2,196
Hib,Full Series,States/Local Areas,TX-City of Houston,2020,Age,24 Months,80.5,72.5 to 87.4,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,82.5,74.0 to 89.4,196
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,91.9,87.5 to 96.3,203
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,96.1,93.2 to 98.9,134
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,77.2,71.6 to 82.8,319
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,89.3,81.9 to 96.6,107
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,82.8,78.8 to 86.7,560
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,89.1,82.3 to 94.2,171
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,90.3,85.9 to 93.8,394
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,93.0,86.6 to 97.0,168
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,91.1,86.6 to 94.5,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,89.7,83.6 to 93.6,244
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,94.9,90.4 to 97.7,141
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,93.9,90.2 to 96.5,309
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,5 Months,80.2,71.5 to 86.8,196
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,92.0,88.6 to 94.5,213
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,5 Months,84.6,76.6 to 90.2,223
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,5 Months,82.5,76.8 to 87.0,419
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,5 Months,78.7,70.2 to 85.4,171
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,5 Months,81.6,76.0 to 86.1,394
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,86.0,80.8 to 89.9,205
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,85.6,82.1 to 88.5,359
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,85.3,76.4 to 91.2,154
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,89.4,84.2 to 93.1,295
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,93.6,89.9 to 97.4,203
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,99.0,97.1 to 100.0,32
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,3 Months,89.4,81.7 to 94.1,168
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,3 Months,87.4,82.2 to 91.3,339
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,3 Months,85.3,77.2 to 90.9,171
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,3 Months,85.4,79.9 to 89.6,394
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,5 Months,85.9,77.1 to 91.7,141
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,5 Months,81.3,75.2 to 86.2,309
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,5 Months,76.6,67.4 to 83.8,168
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,5 Months,77.6,71.6 to 82.7,339
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,82.8,78.8 to 86.7,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2012,Age,0-3 Days,83.0,76.4 to 88.1,244
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,3 Months,82.3,73.5 to 88.6,154
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,3 Months,85.5,79.8 to 89.9,295
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,3 Months,88.7,80.1 to 93.9,141
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,3 Months,89.1,83.7 to 92.8,309
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.0,69.0 to 93.1,66
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.4,83.2 to 95.7,129
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,3 Months,85.5,82.7 to 87.8,244
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,63.1,54.2 to 71.2,205
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,66.4,60.8 to 71.6,359
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,3 Months,81.5,72.7 to 87.9,154
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,3 Months,85.9,80.2 to 90.2,295
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,3 Months,90.2,81.5 to 95.1,141
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,3 Months,90.8,85.5 to 94.3,309
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,3 Months,91.5,83.8 to 95.7,168
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,3 Months,89.1,84.0 to 92.7,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2017,Age,0-3 Days,84.4,70.8 to 92.4,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2017-2018,Age,0-3 Days,84.7,78.9 to 89.1,394
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016,Age,0-3 Days,79.6,69.9 to 86.8,168
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2017,Age,0-3 Days,83.8,77.6 to 88.5,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,90.1,83.7 to 94.8,154
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,93.3,89.4 to 96.1,295
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,96.0,91.4 to 98.5,141
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,96.1,93.1 to 98.1,309
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,96.2,92.2 to 98.5,168
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,92.6,88.6 to 95.7,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,91.9,85.0 to 95.8,168
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,90.1,85.3 to 93.4,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,88.2,80.6 to 93.1,171
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,89.8,85.1 to 93.2,394
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,66.0,59.1 to 72.2,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,60.3,57.2 to 63.4,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,90.7,84.7 to 96.8,107
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,95.9,92.4 to 99.4,134
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,88.9,84.5 to 93.3,319
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,88.1,83.4 to 92.8,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2011,Age,0-3 Days,82.3,72.9 to 88.9,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.5,80.8 to 98.2,62
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,88.4,80.8 to 94.0,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,90.4,82.9 to 95.5,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,95.8,90.8 to 98.5,205
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,93.1,89.2 to 96.0,359
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,93.4,86.5 to 96.9,141
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,92.7,88.2 to 95.5,309
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,91.5,85.4 to 95.8,223
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,90.0,85.3 to 93.7,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,7 Months,73.3,67.9 to 78.0,205
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,7 Months,71.6,67.4 to 75.4,359
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,7 Months,65.1,61.8 to 68.3,244
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,7 Months,66.5,60.5 to 72.1,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,35 Months,91.5,84.6 to 96.2,213
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014,Age,0-3 Days,81.8,73.4 to 88.0,154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2015,Age,0-3 Days,81.7,75.3 to 86.7,295
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,3 Months,85.5,77.2 to 91.1,223
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,3 Months,84.7,79.0 to 89.0,419
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,90.5,87.4 to 93.6,560
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,3 Months,83.8,75.2 to 89.8,196
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,3 Months,84.3,78.1 to 89.0,244
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,3 Months,86.6,80.8 to 90.8,213
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,3 Months,89.8,84.2 to 93.6,205
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,3 Months,85.5,82.8 to 87.8,359
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2013,Age,0-3 Days,80.0,71.8 to 86.2,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2013-2014,Age,0-3 Days,80.9,75.2 to 85.6,359
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020,Age,24 Months,91.3,84.7 to 95.8,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,69.4,59.8 to 77.6,196
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,71.4,62.2 to 79.2,171
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,74.7,68.8 to 79.9,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,78.2,70.2 to 84.5,223
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,73.9,67.7 to 79.3,419
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2019,Age,0-3 Days,77.9,69.1 to 84.8,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.5,63.1 to 88.0,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,81.7,76.0 to 87.3,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,95.2,89.4 to 100.0,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,77.6,69.8 to 85.4,203
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,3 Months,83.7,75.1 to 89.7,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2018,Age,0-3 Days,81.0,72.2 to 87.5,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2018-2019,Age,0-3 Days,79.5,73.5 to 84.4,419
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,100.0,,32
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,91.2,82.9 to 96.5,196
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,72.6,64.3 to 79.6,223
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,70.1,63.9 to 75.7,419
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,7 Months,66.3,56.8 to 74.7,171
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,7 Months,69.4,63.2 to 75.0,394
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,3 Months,87.2,79.3 to 92.4,223
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,3 Months,85.5,80.0 to 89.7,419
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,3 Months,86.7,78.8 to 91.9,171
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,3 Months,87.0,81.7 to 90.9,394
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,70.2,59.9 to 78.8,141
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,67.9,61.0 to 74.1,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,65.5,56.1 to 73.9,168
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,65.9,59.3 to 72.0,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,91.5,85.4 to 95.8,223
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,91.6,86.5 to 95.4,419
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,69.5,59.4 to 78.0,154
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,69.9,62.8 to 76.1,295
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,94.4,93.0 to 95.6,205
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,93.2,89.8 to 95.5,359
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,89.1,82.3 to 94.2,171
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,90.3,85.9 to 93.8,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,7 Months,76.8,66.6 to 84.6,141
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,7 Months,74.6,67.9 to 80.3,309
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,7 Months,70.0,60.0 to 78.4,154
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,7 Months,73.4,66.5 to 79.4,295
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,7 Months,72.3,63.1 to 79.9,168
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,7 Months,71.9,65.5 to 77.5,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2015,Age,0-3 Days,81.5,71.2 to 88.7,141
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2015-2016,Age,0-3 Days,80.6,73.8 to 86.0,309
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,96.1,93.5 to 98.8,203
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,89.3,84.9 to 93.6,296
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.7,94.2 to 100.0,62
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,90.9,86.8 to 95.1,303
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.4,78.4 to 98.5,66
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,97.8,92.6 to 99.4,141
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,95.7,92.1 to 97.7,309
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,93.5,87.1 to 96.9,168
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,92.1,87.5 to 95.0,339
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,92.0,84.9 to 95.9,154
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,94.9,91.0 to 97.2,295
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,95.0,90.4 to 97.8,244
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,91.8,87.7 to 95.8,303
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.9,77.8 to 97.9,66
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.5,83.1 to 95.9,129
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,7 Months,91.6,84.7 to 95.5,223
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,7 Months,91.2,86.4 to 94.4,419
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,90.8,82.8 to 95.3,196
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,94.6,88.6 to 97.5,244
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,94.2,88.3 to 97.2,213
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,13 Months,91.5,83.4 to 95.9,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,91.7,88.9 to 94.5,560
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,88.9,84.7 to 93.1,319
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,13 Months,93.2,86.2 to 96.8,223
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,13 Months,92.4,87.5 to 95.5,419
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,90.5,83.1 to 94.9,171
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,91.8,87.2 to 94.9,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,13 Months,91.7,88.4 to 94.1,244
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,91.0,81.4 to 95.9,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,91.4,89.4 to 93.0,205
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,89.3,86.2 to 91.8,359
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,87.3,79.3 to 92.5,154
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,91.4,86.9 to 94.5,295
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,86.5,81.7 to 91.3,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.4,62.0 to 88.8,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.4,65.1 to 85.6,129
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,81.2,77.0 to 85.4,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,81.2,77.0 to 85.4,560
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,7 Months,67.5,57.9 to 75.9,196
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.8,84.8 to 96.8,129
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,88.9 to 94.5,560
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,13 Months,88.1,80.0 to 93.2,168
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,13 Months,87.8,82.6 to 91.6,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,13 Months,87.5,80.2 to 92.4,171
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,13 Months,89.5,85.1 to 92.7,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,13 Months,95.3,89.9 to 97.9,141
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,13 Months,91.8,87.2 to 94.8,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,13 Months,85.0,79.3 to 89.3,205
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,13 Months,86.6,82.4 to 90.0,359
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,92.9,85.2 to 96.8,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,94.8,90.5 to 99.0,107
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,98.1,96.1 to 100.0,134
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,13 Months,88.2,80.7 to 93.0,154
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,13 Months,88.7,83.7 to 92.2,295
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,13 Months,90.0,78.3 to 95.7,213
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,76.8,65.8 to 87.8,107
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,77.5,68.0 to 87.1,134
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,83.6,78.6 to 88.6,319
Influenza,,States/Local Areas,Texas,2013,Age,24 Months,45.0,41.3 to 48.8,1375
Influenza,,States/Local Areas,Texas,2013-2014,Age,24 Months,44.9,42.3 to 47.5,2788
Influenza,,States/Local Areas,Texas,2015,Age,24 Months,55.5,52.2 to 58.8,1640
Influenza,,States/Local Areas,Texas,2015-2016,Age,24 Months,53.8,51.4 to 56.2,3243
Influenza,,States/Local Areas,Texas,2014,Age,24 Months,44.8,41.4 to 48.4,1413
Influenza,,States/Local Areas,Texas,2014-2015,Age,24 Months,50.2,47.8 to 52.6,3053
Influenza,,States/Local Areas,Texas,2011,Age,24 Months,45.2,40.3 to 50.4,1195
Influenza,,States/Local Areas,Texas,2012,Age,24 Months,50.1,46.0 to 54.3,1359
Polio,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,3 Months,84.8,80.0 to 88.6,1241
Hep A,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,24 Months,91.8,88.9 to 94.3,1241
≥1 Dose MMR,,States/Local Areas,Texas,2021,Age,13 Months,74.6,65.5 to 81.9,446
Hib,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,60.5,54.4 to 66.3,1241
PCV,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,3 Months,84.0,79.2 to 87.9,1241
DTaP,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,5 Months,77.4,71.6 to 82.4,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2021,Age,35 Months,94.3,89.5 to 97.4,446
PCV,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,91.4,88.3 to 94.0,1241
Hib,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,5 Months,73.0,66.9 to 78.3,1241
Hep A,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,47.8,42.2 to 53.7,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,71.5,65.6 to 76.8,1241
≥1 Dose Varicella,,States/Local Areas,Texas,2020-2021,Age,24 Months,92.3,89.6 to 94.5,1241
≥1 Dose MMR,,States/Local Areas,Texas,2020-2021,Age,19 Months,91.4,88.5 to 93.6,1241
PCV,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,88.3,84.5 to 91.3,1241
Polio,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,92.1,88.9 to 94.6,1241
Hep A,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,79.3,72.2 to 85.5,1241
Hib,≥2 Doses,States/Local Areas,Texas,2021,Age,13 Months,90.8,82.9 to 95.2,446
Hep B,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,91.3,88.2 to 93.9,1241
Hib,Primary Series,States/Local Areas,Texas,2020-2021,Age,7 Months,67.8,61.8 to 73.4,1241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2021,Age,0-3 Days,82.0,73.7 to 88.0,446
Hib,≥3 Doses,States/Local Areas,Texas,2021,Age,35 Months,92.0,85.5 to 96.3,446
PCV,≥4 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,80.5,75.8 to 84.5,1241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2020-2021,Age,0-3 Days,83.1,78.5 to 86.9,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,92.6,89.4 to 95.1,1241
Hep B,≥2 Doses,States/Local Areas,Texas,2021,Age,13 Months,94.3,88.9 to 97.2,446
Polio,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,5 Months,77.1,71.3 to 82.0,1241
PCV,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,91.3,88.0 to 93.7,1241
Hib,Primary Series,States/Local Areas,Texas,2021,Age,13 Months,86.2,78.1 to 91.6,446
PCV,≥4 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,83.3,78.9 to 87.3,1241
Polio,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,87.5,83.1 to 90.9,1241
Hep B,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,67.1,61.2 to 72.5,1241
DTaP,≥4 Doses,States/Local Areas,Texas,2021,Age,35 Months,97.3,89.5 to 99.7,446
Hep B,≥3 Doses,States/Local Areas,Texas,2021,Age,35 Months,93.3,88.4 to 96.6,446
≥1 Dose MMR,,States/Local Areas,Texas,2020-2021,Age,35 Months,94.6,91.5 to 96.8,1241
Hib,Primary Series,States/Local Areas,Texas,2020-2021,Age,13 Months,85.3,80.6 to 89.0,1241
PCV,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,92.1,89.0 to 94.6,1241
Hib,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,3 Months,80.7,75.4 to 85.1,1241
Hep B,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,91.3,87.8 to 93.8,1241
Combined 7 Series,,States/Local Areas,Texas,2020-2021,Age,24 Months,66.8,61.4 to 72.2,1241
Hib,Full Series,States/Local Areas,Texas,2021,Age,35 Months,95.6,83.4 to 99.6,446
Influenza,,States/Local Areas,Texas,2020-2021,Age,24 Months,50.8,45.1 to 56.7,1241
Combined 7 Series,,States/Local Areas,Texas,2020-2021,Age,35 Months,74.1,67.2 to 80.6,1241
Polio,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,92.8,89.5 to 95.4,1241
Hib,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,89.6,85.4 to 92.7,1241
DTaP,≥4 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,73.5,68.4 to 78.1,1241
Hib,≥3 Doses,States/Local Areas,Texas,2021,Age,13 Months,76.5,67.0 to 84.0,446
Polio,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,91.8,88.4 to 94.2,1241
Hep B,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,5 Months,86.3,81.7 to 89.9,1241
Rotavirus,,States/Local Areas,Texas,2021,Age,8 Months,78.9,70.2 to 85.6,446
Hib,Primary Series,States/Local Areas,Texas,2021,Age,35 Months,92.4,85.9 to 96.6,446
Hep B,≥1 Dose,States/Local Areas,Texas,2021,Age,3 Months,97.7,95.8 to 98.8,446
DTaP,≥4 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,80.0,75.2 to 84.3,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,24 Months,92.4,89.3 to 94.9,1241
Rotavirus,,States/Local Areas,Texas,2020-2021,Age,8 Months,76.4,71.1 to 80.9,1241
≥1 Dose Varicella,,States/Local Areas,Texas,2021,Age,35 Months,97.5,94.1 to 99.2,446
Hib,Primary Series,States/Local Areas,Texas,2019-2020,Age,7 Months,71.3,67.0 to 75.2,1714
Rotavirus,,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,82.1,79.0 to 85.2,1491
Hib,Full Series,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.9,60.7 to 75.2,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.7,71.0 to 78.4,1416
Polio,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,91.1,89.1 to 93.1,2285
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,91.9,90.0 to 93.7,2285
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.3,82.6 to 92.0,517
DTaP,≥4 Doses,States/Local Areas,Texas,2016-2019,Poverty,133% to <400% FPL,77.2,73.8 to 80.7,1546
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,82.0,78.2 to 85.8,2285
Hib,Primary Series,States/Local Areas,Texas,2020-2021,Age,35 Months,91.4,87.6 to 94.4,1241
Rotavirus,,States/Local Areas,Texas,2014-2017,Overall,Overall,72.9,71.0 to 74.7,5548
Rotavirus,,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,67.1,64.1 to 70.0,2381
Rotavirus,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,70.3,62.5 to 78.0,266
Rotavirus,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.9,68.8 to 75.0,1801
Rotavirus,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,71.9,63.9 to 79.8,315
Rotavirus,,States/Local Areas,Texas,2019,Age,8 Months,76.6,71.6 to 81.0,919
Rotavirus,,States/Local Areas,Texas,2017,Age,8 Months,69.5,65.6 to 73.1,1271
Rotavirus,,States/Local Areas,Texas,2017-2018,Age,8 Months,74.4,71.6 to 77.0,2336
Rotavirus,,States/Local Areas,Texas,2018,Age,8 Months,79.4,75.3 to 82.9,1065
Rotavirus,,States/Local Areas,Texas,2018-2019,Age,8 Months,78.0,74.8 to 80.9,1984
Rotavirus,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,80.9,78.5 to 83.3,2524
Rotavirus,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.1,58.0 to 72.2,363
Rotavirus,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,67.7,64.8 to 70.6,2412
Rotavirus,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,72.7,70.1 to 75.3,2957
Rotavirus,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.8,72.6 to 79.0,1682
Rotavirus,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,74.0,71.7 to 76.4,3481
Rotavirus,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.7,68.4 to 79.1,546
Rotavirus,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,59.1,50.2 to 67.9,297
Rotavirus,,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,74.7,71.3 to 78.0,1676
Rotavirus,,States/Local Areas,Texas,2013,Age,8 Months,71.5,67.8 to 74.9,1375
Rotavirus,,States/Local Areas,Texas,2013-2014,Age,8 Months,71.7,69.2 to 74.0,2788
Rotavirus,,States/Local Areas,Texas,2012,Age,8 Months,70.4,66.5 to 74.1,1359
Rotavirus,,States/Local Areas,Texas,2011,Age,8 Months,68.4,63.5 to 73.0,1195
Rotavirus,,States/Local Areas,Texas,2014,Age,8 Months,71.9,68.5 to 75.0,1413
Rotavirus,,States/Local Areas,Texas,2014-2015,Age,8 Months,73.0,70.7 to 75.1,3053
Rotavirus,,States/Local Areas,Texas,2016,Age,8 Months,73.3,70.1 to 76.3,1603
Rotavirus,,States/Local Areas,Texas,2016-2017,Age,8 Months,71.4,68.9 to 73.8,2874
Rotavirus,,States/Local Areas,Texas,2015,Age,8 Months,74.1,71.0 to 76.9,1640
Rotavirus,,States/Local Areas,Texas,2015-2016,Age,8 Months,73.7,71.5 to 75.8,3243
Influenza,,States/Local Areas,Texas,2019,Age,24 Months,55.4,49.8 to 61.2,919
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.6,66.6 to 84.7,331
Influenza,,States/Local Areas,Texas,2018,Age,24 Months,56.6,51.9 to 61.3,1065
Influenza,,States/Local Areas,Texas,2018-2019,Age,24 Months,56.0,52.3 to 59.7,1984
Influenza,,States/Local Areas,Texas,2017,Age,24 Months,50.7,46.7 to 54.8,1271
Influenza,,States/Local Areas,Texas,2017-2018,Age,24 Months,53.6,50.5 to 56.7,2336
Polio,≥2 Doses,States/Local Areas,Texas,2021,Age,5 Months,77.6,68.1 to 84.9,446
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,90.1,88.1 to 92.1,2267
Influenza,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Uninsured,28.5,21.2 to 35.9,297
Influenza,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,Hispanic,45.7,42.8 to 48.6,2957
Influenza,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",56.2,50.1 to 62.3,546
Influenza,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",42.6,35.4 to 49.9,363
Influenza,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Any Medicaid,42.7,39.7 to 45.8,2412
Influenza,,States/Local Areas,Texas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",60.2,56.7 to 63.8,1682
Influenza,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Principal City,52.1,49.5 to 54.8,3481
Influenza,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a Non-MSA,36.9,28.4 to 45.4,266
Influenza,,States/Local Areas,Texas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,50.9,47.5 to 54.3,1801
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,94.2,92.6 to 95.7,2267
PCV,≥3 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,86.5 to 94.1,517
Hib,Full Series,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,83.2,80.7 to 85.7,2267
Hib,Full Series,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,70.5 to 82.1,517
Influenza,,States/Local Areas,Texas,2014-2017,Overall,Overall,50.6,48.5 to 52.6,5548
Influenza,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Other,42.9,34.7 to 51.1,315
Influenza,,States/Local Areas,Texas,2014-2017,Insurance Coverage,Private Insurance Only,63.8,60.8 to 66.7,2524
PCV,≥4 Doses,States/Local Areas,Texas,2016-2019,Insurance Coverage,Private Insurance Only,86.7,84.3 to 89.0,2267
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Race and Ethnicity,Hispanic,88.9,86.6 to 91.1,2285
Influenza,,States/Local Areas,Texas,2014-2017,Poverty,<133% FPL,41.3,38.3 to 44.3,2381
Influenza,,States/Local Areas,Texas,2014-2017,Poverty,133% to <400% FPL,51.2,47.4 to 55.0,1676
Influenza,,States/Local Areas,Texas,2014-2017,Poverty,>400% FPL,68.3,64.5 to 72.1,1491
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.9,73.7 to 86.0,517
Hep A,≥1 Dose,States/Local Areas,Texas,2016-2019,Insurance Coverage,Any Medicaid,87.7,85.1 to 90.3,1780
Hib,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,85.1,80.0 to 89.1,1241
Polio,≥2 Doses,States/Local Areas,Texas,2021,Age,13 Months,92.7,86.3 to 96.3,446
Hep B,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,3 Months,96.3,94.4 to 97.5,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2021,Age,24 Months,94.3,89.5 to 97.4,446
Influenza,,States/Local Areas,Texas,2021,Age,24 Months,48.1,39.2 to 57.9,446
≥1 Dose Varicella,,States/Local Areas,Texas,2020-2021,Age,13 Months,70.4,65.0 to 75.4,1241
Hib,Full Series,States/Local Areas,Texas,2020-2021,Age,24 Months,78.3,73.3 to 83.0,1241
DTaP,≥2 Doses,States/Local Areas,Texas,2021,Age,5 Months,77.7,68.2 to 85.0,446
PCV,≥1 Dose,States/Local Areas,Texas,2021,Age,3 Months,86.4,78.4 to 91.8,446
Influenza,,States/Local Areas,Texas,2016,Age,24 Months,52.0,48.6 to 55.5,1603
Influenza,,States/Local Areas,Texas,2016-2017,Age,24 Months,51.3,48.7 to 54.0,2874
Hep A,≥2 Doses,States/Local Areas,Texas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.9,76.9 to 87.0,1416
≥1 Dose Varicella,,States/Local Areas,Texas,2021,Age,13 Months,70.5,61.2 to 78.4,446
Hep B,≥3 Doses,States/Local Areas,Texas,2021,Age,13 Months,89.5,82.1 to 94.1,446
Polio,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,91.4,87.7 to 94.1,1241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Texas,2020-2021,Age,0-2 Days,82.4,77.7 to 86.2,1241
Hib,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,35 Months,91.1,87.3 to 94.1,1241
Hep A,≥1 Dose,States/Local Areas,Texas,2020-2021,Age,19 Months,88.4,85.0 to 91.1,1241
PCV,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,7 Months,69.4,63.4 to 74.7,1241
Hep A,≥2 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,32.1,26.9 to 37.9,1241
Polio,≥3 Doses,States/Local Areas,Texas,2021,Age,19 Months,93.7,88.4 to 96.7,446
≥1 Dose MMR,,States/Local Areas,Texas,2021,Age,19 Months,95.0,91.7 to 97.1,446
Hep B,≥2 Doses,States/Local Areas,Texas,2021,Age,5 Months,87.7,79.5 to 92.9,446
≥1 Dose MMR,,States/Local Areas,Texas,2020-2021,Age,13 Months,73.3,68.0 to 78.0,1241
Hib,Full Series,States/Local Areas,Texas,2020-2021,Age,19 Months,74.1,68.7 to 78.8,1241
DTaP,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,13 Months,89.6,85.8 to 92.5,1241
Hib,Full Series,States/Local Areas,Texas,2020-2021,Age,35 Months,81.1,75.7 to 85.9,1241
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Texas,2020-2021,Age,0-1 Days,81.0,76.3 to 85.0,1241
Hep B,≥3 Doses,States/Local Areas,Texas,2020-2021,Age,19 Months,90.6,87.3 to 93.1,1241
≥1 Dose Varicella,,States/Local Areas,Texas,2020-2021,Age,19 Months,90.9,87.9 to 93.2,1241
Hib,Primary Series,States/Local Areas,Texas,2020-2021,Age,19 Months,90.6,86.6 to 93.5,1241
Combined 7 Series,,States/Local Areas,Texas,2021,Age,24 Months,68.5,59.7 to 77.0,446
PCV,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,19 Months,88.0,83.7 to 91.2,472
Hep B,≥1 Dose,States/Local Areas,West Virginia,2021,Age,3 Months,97.0,89.2 to 99.2,157
Influenza,,States/Local Areas,West Virginia,2012,Age,24 Months,41.5,33.9 to 50.0,254
Influenza,,States/Local Areas,West Virginia,2011,Age,24 Months,44.0,35.4 to 53.6,231
Influenza,,States/Local Areas,West Virginia,2014,Age,24 Months,38.7,32.1 to 46.1,268
Influenza,,States/Local Areas,West Virginia,2014-2015,Age,24 Months,43.6,38.8 to 48.7,549
Influenza,,States/Local Areas,West Virginia,2015,Age,24 Months,48.5,41.8 to 55.7,281
Influenza,,States/Local Areas,West Virginia,2015-2016,Age,24 Months,49.0,44.3 to 53.9,577
Influenza,,States/Local Areas,West Virginia,2013,Age,24 Months,38.8,31.5 to 47.0,243
Influenza,,States/Local Areas,West Virginia,2013-2014,Age,24 Months,38.8,33.7 to 44.3,511
Influenza,,States/Local Areas,West Virginia,2019,Age,24 Months,52.1,44.2 to 60.5,201
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,92.6,89.7 to 95.5,399
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Any Medicaid,86.0,82.3 to 89.8,444
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.9,75.5 to 84.3,794
Influenza,,States/Local Areas,West Virginia,2016,Age,24 Months,49.6,43.0 to 56.5,296
Influenza,,States/Local Areas,West Virginia,2016-2017,Age,24 Months,50.2,45.3 to 55.3,555
Influenza,,States/Local Areas,West Virginia,2018,Age,24 Months,54.6,47.4 to 62.1,252
Influenza,,States/Local Areas,West Virginia,2018-2019,Age,24 Months,53.4,48.0 to 59.0,453
Influenza,,States/Local Areas,West Virginia,2017,Age,24 Months,50.7,43.4 to 58.4,259
Influenza,,States/Local Areas,West Virginia,2017-2018,Age,24 Months,52.7,47.5 to 58.0,511
Influenza,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",43.7,31.8 to 55.7,87
Influenza,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,32.2,15.0 to 49.4,39
Influenza,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,38.2,33.4 to 43.0,500
Influenza,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,42.4,36.9 to 47.9,386
Influenza,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,52.4,46.2 to 58.7,335
Influenza,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",48.5,44.6 to 52.3,872
Influenza,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,46.1,39.5 to 52.6,302
Influenza,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,46.6,32.9 to 60.2,67
Influenza,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,62.0,56.8 to 67.2,432
Influenza,,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,65.4,57.6 to 73.3,195
Influenza,,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,36.9,31.6 to 42.3,410
Influenza,,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,51.7,46.3 to 57.2,418
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,81.9 to 97.3,65
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,93.9,91.1 to 96.7,399
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,64.0 to 88.7,65
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,78.0,63.1 to 92.9,34
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,85.7,81.5 to 89.8,399
Influenza,,States/Local Areas,West Virginia,2014-2017,Overall,Overall,46.9,43.3 to 50.4,1023
PCV,≥1 Dose,States/Local Areas,West Virginia,2021,Age,3 Months,81.8,71.9 to 88.8,157
DTaP,≥3 Doses,States/Local Areas,West Virginia,2021,Age,24 Months,89.6,81.4 to 95.2,157
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020-2021,Age,13 Months,44.0,38.0 to 50.2,428
Hib,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,84.7,79.1 to 89.0,428
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,87.6,82.6 to 91.6,428
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2021,Age,0-3 Days,78.9,69.1 to 86.2,157
≥1 Dose MMR,,States/Local Areas,West Virginia,2021,Age,13 Months,53.8,43.5 to 63.8,157
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Insurance Coverage,Private Insurance Only,89.0,85.5 to 92.5,399
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.8,72.9 to 96.7,65
DTaP,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,5 Months,75.1,69.0 to 80.4,428
≥1 Dose MMR,,States/Local Areas,West Virginia,2020-2021,Age,19 Months,83.6,77.9 to 88.1,428
Hib,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,55.3,49.1 to 61.4,428
PCV,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,81.8,75.8 to 86.5,428
Polio,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,3 Months,84.0,78.5 to 88.3,428
PCV,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,3 Months,83.5,78.0 to 87.8,428
Hep A,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,76.6,69.7 to 83.0,428
Hib,≥3 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,88.6,80.3 to 94.5,157
Polio,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,88.3,83.4 to 92.3,428
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,68.5,62.3 to 74.1,428
Rotavirus,,States/Local Areas,West Virginia,2021,Age,8 Months,70.5,59.8 to 79.3,157
Polio,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,90.8,85.4 to 94.8,428
Hep B,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,5 Months,85.7,80.4 to 89.8,428
Hib,Primary Series,States/Local Areas,West Virginia,2021,Age,35 Months,89.1,80.9 to 94.8,157
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020-2021,Age,24 Months,86.9,81.5 to 91.3,428
Hib,≥2 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,92.4,83.9 to 96.6,157
Hib,Primary Series,States/Local Areas,West Virginia,2020-2021,Age,7 Months,66.9,60.7 to 72.5,428
Hep A,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,47.1,41.0 to 53.6,428
Hib,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,86.3,81.0 to 90.3,428
Hib,Full Series,States/Local Areas,West Virginia,2021,Age,35 Months,79.7,68.2 to 89.2,157
Hib,≥3 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,72.0,61.6 to 80.4,157
≥1 Dose MMR,,States/Local Areas,West Virginia,2020-2021,Age,24 Months,87.6,82.4 to 91.9,428
Combined 7 Series,,States/Local Areas,West Virginia,2020-2021,Age,35 Months,68.8,62.0 to 75.4,428
Hib,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,3 Months,81.2,75.6 to 85.8,428
Polio,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,5 Months,75.3,69.2 to 80.6,428
DTaP,≥3 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,89.6,81.4 to 95.2,157
Polio,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,87.8,82.5 to 91.6,428
PCV,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,88.4,83.5 to 92.3,428
Polio,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,85.8,80.4 to 90.0,428
DTaP,≥4 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,62.1,55.5 to 68.2,428
Hib,Primary Series,States/Local Areas,West Virginia,2020-2021,Age,13 Months,80.1,74.1 to 85.0,428
≥1 Dose MMR,,States/Local Areas,West Virginia,2020-2021,Age,35 Months,91.3,85.0 to 95.7,428
PCV,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,87.4,82.3 to 91.3,428
Hep B,≥3 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,88.7,80.1 to 94.8,157
Hep B,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,89.5,84.6 to 92.9,428
Hib,Primary Series,States/Local Areas,West Virginia,2021,Age,13 Months,79.4,68.8 to 87.1,157
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2020-2021,Age,0-1 Days,75.5,69.6 to 80.6,428
PCV,≥4 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,78.1,72.1 to 83.6,428
Influenza,,States/Local Areas,West Virginia,2020-2021,Age,24 Months,46.5,40.6 to 52.9,428
Hib,Full Series,States/Local Areas,West Virginia,2020-2021,Age,19 Months,65.1,58.6 to 71.1,428
Hep A,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,35 Months,92.6,85.8 to 96.9,428
Polio,≥3 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,89.7,81.5 to 95.4,157
≥1 Dose Varicella,,States/Local Areas,West Virginia,2021,Age,35 Months,89.7,79.3 to 96.2,157
DTaP,≥4 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,74.2,68.2 to 79.9,428
Hep A,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,19 Months,81.2,75.5 to 85.8,428
Combined 7 Series,,States/Local Areas,West Virginia,2021,Age,24 Months,63.4,53.2 to 73.5,157
Hep B,≥2 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,92.9,84.2 to 96.9,157
Hib,Primary Series,States/Local Areas,West Virginia,2020-2021,Age,19 Months,87.8,82.6 to 91.7,428
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2020-2021,Age,0-3 Days,80.0,74.2 to 84.7,428
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,90.2,84.8 to 94.2,428
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,24 Months,88.9,84.1 to 92.8,428
Rotavirus,,States/Local Areas,West Virginia,2020-2021,Age,8 Months,72.3,65.8 to 78.0,428
PCV,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,65.8,59.6 to 71.5,428
Hib,Primary Series,States/Local Areas,West Virginia,2020-2021,Age,35 Months,88.4,83.4 to 92.4,428
Hib,Full Series,States/Local Areas,West Virginia,2020-2021,Age,35 Months,79.1,72.8 to 84.9,428
Rotavirus,,States/Local Areas,West Virginia,2013,Age,8 Months,70.6,62.8 to 77.3,243
Rotavirus,,States/Local Areas,West Virginia,2013-2014,Age,8 Months,67.5,62.2 to 72.4,511
Rotavirus,,States/Local Areas,West Virginia,2012,Age,8 Months,63.5,55.1 to 71.2,254
Rotavirus,,States/Local Areas,West Virginia,2015,Age,8 Months,73.0,66.2 to 78.8,281
Rotavirus,,States/Local Areas,West Virginia,2015-2016,Age,8 Months,72.3,67.4 to 76.8,577
Rotavirus,,States/Local Areas,West Virginia,2011,Age,8 Months,67.7,58.8 to 75.4,231
DTaP,≥2 Doses,States/Local Areas,West Virginia,2021,Age,5 Months,75.1,64.5 to 83.3,157
Polio,≥2 Doses,States/Local Areas,West Virginia,2021,Age,5 Months,75.5,65.0 to 83.7,157
DTaP,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,83.8,78.0 to 88.3,428
≥1 Dose MMR,,States/Local Areas,West Virginia,2020-2021,Age,13 Months,56.6,50.3 to 62.8,428
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,87.3,82.1 to 91.2,428
Hep B,≥2 Doses,States/Local Areas,West Virginia,2021,Age,5 Months,87.6,78.3 to 93.2,157
≥1 Dose MMR,,States/Local Areas,West Virginia,2021,Age,19 Months,81.3,71.3 to 88.4,157
Hep A,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,25.1,20.2 to 30.7,428
DTaP,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,3 Months,83.5,77.9 to 87.8,428
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2020-2021,Age,0-2 Days,78.9,73.1 to 83.7,428
Hib,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,5 Months,72.7,66.5 to 78.1,428
Polio,≥2 Doses,States/Local Areas,West Virginia,2020-2021,Age,13 Months,90.3,85.5 to 93.6,428
Influenza,,States/Local Areas,West Virginia,2021,Age,24 Months,46.0,36.6 to 56.6,157
Hep B,≥3 Doses,States/Local Areas,West Virginia,2021,Age,13 Months,86.5,77.2 to 92.4,157
PCV,≥4 Doses,States/Local Areas,West Virginia,2020-2021,Age,19 Months,70.4,63.9 to 76.2,428
Hep B,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,7 Months,62.6,56.4 to 68.5,428
Hib,≥3 Doses,States/Local Areas,West Virginia,2020-2021,Age,35 Months,87.2,82.2 to 91.4,428
DTaP,≥4 Doses,States/Local Areas,West Virginia,2021,Age,35 Months,83.7,70.1 to 93.5,157
Combined 7 Series,,States/Local Areas,West Virginia,2020-2021,Age,24 Months,63.2,57.0 to 69.4,428
≥1 Dose Varicella,,States/Local Areas,West Virginia,2021,Age,13 Months,44.8,35.0 to 55.0,157
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020-2021,Age,19 Months,79.3,73.4 to 84.2,428
Hep B,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,3 Months,95.8,92.0 to 97.8,428
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,69.4,56.4 to 82.4,67
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,81.5,77.2 to 85.7,432
Rotavirus,,States/Local Areas,West Virginia,2014,Age,8 Months,64.4,57.1 to 71.1,268
Rotavirus,,States/Local Areas,West Virginia,2014-2015,Age,8 Months,68.7,63.7 to 73.2,549
Rotavirus,,States/Local Areas,West Virginia,2016,Age,8 Months,71.6,64.4 to 77.9,296
Rotavirus,,States/Local Areas,West Virginia,2016-2017,Age,8 Months,73.2,68.2 to 77.6,555
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,66.0,61.2 to 70.9,500
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,63.9,47.4 to 80.3,39
Rotavirus,,States/Local Areas,West Virginia,2017,Age,8 Months,74.8,67.7 to 80.8,259
Rotavirus,,States/Local Areas,West Virginia,2017-2018,Age,8 Months,74.1,69.2 to 78.4,511
Rotavirus,,States/Local Areas,West Virginia,2019,Age,8 Months,64.0,55.7 to 71.5,201
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.7,51.1 to 74.2,87
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.3,69.7 to 76.9,872
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,74.4,68.4 to 80.3,302
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,74.5,69.7 to 79.4,418
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,69.3,64.0 to 74.6,386
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.2,66.1 to 78.2,335
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Overall,Overall,71.8,68.5 to 75.1,1023
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,65.3,59.9 to 70.7,410
Rotavirus,,States/Local Areas,West Virginia,2018,Age,8 Months,73.4,66.4 to 79.4,252
Rotavirus,,States/Local Areas,West Virginia,2018-2019,Age,8 Months,68.7,63.3 to 73.6,453
Rotavirus,,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,84.9,79.3 to 90.6,195
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.2,77.0 to 83.3,794
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,92.1,83.5 to 100.0,34
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,39.5,19.6 to 59.5,34
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,92.0,83.3 to 100.0,34
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,76.2 to 93.1,65
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2019,Poverty,133% to <400% FPL,78.3,73.3 to 83.3,387
Combined 7 Series,,States/Local Areas,West Virginia,2018,Age,35 Months,69.8,62.5 to 76.9,252
Combined 7 Series,,States/Local Areas,West Virginia,2018-2019,Age,35 Months,68.4,62.4 to 74.2,453
Combined 7 Series,,States/Local Areas,West Virginia,2019,Age,35 Months,68.0,58.2 to 77.4,201
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,75.6,70.8 to 80.3,432
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,60.5,55.5 to 65.6,500
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,64.8,51.1 to 78.5,67
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,56.7,39.1 to 74.4,39
Combined 7 Series,,States/Local Areas,West Virginia,2015,Age,35 Months,79.8,72.8 to 86.0,281
Combined 7 Series,,States/Local Areas,West Virginia,2015-2016,Age,35 Months,76.8,71.7 to 81.5,577
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,57.0,51.4 to 62.6,410
Hib,Full Series,States/Local Areas,West Virginia,2011,Age,19 Months,66.1,59.1 to 72.4,231
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,70.3,65.0 to 75.6,418
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,80.8,74.7 to 86.9,195
Hib,Full Series,States/Local Areas,West Virginia,2012,Age,19 Months,70.7,68.5 to 72.8,254
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,62.3,56.6 to 68.0,386
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Overall,Overall,65.6,62.1 to 69.1,1023
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.6,59.4 to 81.8,87
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.2,62.4 to 69.9,872
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.6,63.6 to 75.6,335
Combined 7 Series,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,65.3,58.8 to 71.8,302
Hib,Full Series,States/Local Areas,West Virginia,2015,Age,19 Months,71.7,69.6 to 73.6,281
Hib,Full Series,States/Local Areas,West Virginia,2015-2016,Age,19 Months,72.2,67.5 to 76.5,577
Hib,Full Series,States/Local Areas,West Virginia,2013,Age,19 Months,72.0,65.2 to 77.9,243
Hib,Full Series,States/Local Areas,West Virginia,2013-2014,Age,19 Months,66.5,60.2 to 72.2,511
Hib,Full Series,States/Local Areas,West Virginia,2014,Age,19 Months,60.8,53.6 to 67.6,268
Hib,Full Series,States/Local Areas,West Virginia,2014-2015,Age,19 Months,66.2,61.3 to 70.9,549
Hib,Full Series,States/Local Areas,West Virginia,2018,Age,19 Months,67.3,60.1 to 73.7,252
Hib,Full Series,States/Local Areas,West Virginia,2018-2019,Age,19 Months,96.0,93.6 to 97.5,453
Hib,Full Series,States/Local Areas,West Virginia,2016,Age,19 Months,72.9,66.2 to 78.6,296
Hib,Full Series,States/Local Areas,West Virginia,2016-2017,Age,19 Months,75.7,71.0 to 79.8,555
Hib,Full Series,States/Local Areas,West Virginia,2017,Age,19 Months,78.5,71.8 to 84.0,259
Hib,Full Series,States/Local Areas,West Virginia,2017-2018,Age,19 Months,72.9,68.2 to 77.3,511
Hib,Full Series,States/Local Areas,West Virginia,2012,Age,24 Months,75.6,68.0 to 82.5,254
Hib,Full Series,States/Local Areas,West Virginia,2011,Age,24 Months,80.9,73.3 to 87.5,231
Hib,Full Series,States/Local Areas,West Virginia,2013,Age,24 Months,77.4,70.1 to 83.9,243
Hib,Full Series,States/Local Areas,West Virginia,2013-2014,Age,24 Months,74.2,69.3 to 78.9,511
Hib,Full Series,States/Local Areas,West Virginia,2019,Age,19 Months,63.6,55.2 to 71.4,201
Hib,Primary Series,States/Local Areas,West Virginia,2019,Age,19 Months,90.1,83.9 to 94.1,201
Combined 7 Series,,States/Local Areas,West Virginia,2012,Age,35 Months,68.4,59.7 to 76.8,254
Combined 7 Series,,States/Local Areas,West Virginia,2014,Age,35 Months,71.9,64.3 to 79.0,268
Combined 7 Series,,States/Local Areas,West Virginia,2014-2015,Age,35 Months,75.8,70.7 to 80.7,549
Combined 7 Series,,States/Local Areas,West Virginia,2013,Age,35 Months,69.4,59.9 to 78.4,243
Combined 7 Series,,States/Local Areas,West Virginia,2013-2014,Age,35 Months,70.7,64.7 to 76.5,511
Combined 7 Series,,States/Local Areas,West Virginia,2016,Age,35 Months,73.5,66.3 to 80.3,296
Combined 7 Series,,States/Local Areas,West Virginia,2016-2017,Age,35 Months,76.9,71.8 to 81.7,555
Combined 7 Series,,States/Local Areas,West Virginia,2017,Age,35 Months,80.6,73.2 to 87.0,259
Combined 7 Series,,States/Local Areas,West Virginia,2017-2018,Age,35 Months,75.1,70.0 to 80.0,511
Hib,Primary Series,States/Local Areas,West Virginia,2014,Age,35 Months,95.3,91.7 to 97.7,268
Hib,Primary Series,States/Local Areas,West Virginia,2014-2015,Age,35 Months,95.2,92.1 to 97.4,549
Hib,Primary Series,States/Local Areas,West Virginia,2017,Age,35 Months,91.5,86.4 to 95.3,259
Hib,Primary Series,States/Local Areas,West Virginia,2017-2018,Age,35 Months,93.4,90.3 to 95.8,511
Combined 7 Series,,States/Local Areas,West Virginia,2018,Age,24 Months,63.3,56.4 to 70.3,252
Combined 7 Series,,States/Local Areas,West Virginia,2018-2019,Age,24 Months,60.4,55.0 to 65.9,453
Combined 7 Series,,States/Local Areas,West Virginia,2017,Age,24 Months,73.9,67.2 to 80.2,259
Combined 7 Series,,States/Local Areas,West Virginia,2017-2018,Age,24 Months,68.7,63.9 to 73.4,511
Hib,Primary Series,States/Local Areas,West Virginia,2019,Age,7 Months,60.2,51.7 to 68.1,201
Hib,Primary Series,States/Local Areas,West Virginia,2017,Age,19 Months,90.9,85.3 to 94.5,259
Hib,Primary Series,States/Local Areas,West Virginia,2017-2018,Age,19 Months,92.5,89.2 to 94.8,511
Hib,Primary Series,States/Local Areas,West Virginia,2015,Age,19 Months,91.1,87.7 to 93.6,281
Hib,Primary Series,States/Local Areas,West Virginia,2015-2016,Age,19 Months,92.5,89.3 to 94.7,577
Hib,Primary Series,States/Local Areas,West Virginia,2015,Age,35 Months,95.8,90.2 to 98.7,281
Hib,Primary Series,States/Local Areas,West Virginia,2015-2016,Age,35 Months,94.5,91.2 to 96.8,577
Hib,Primary Series,States/Local Areas,West Virginia,2016,Age,35 Months,94.3,90.4 to 97.0,296
Hib,Primary Series,States/Local Areas,West Virginia,2016-2017,Age,35 Months,92.9,89.8 to 95.4,555
Hib,Primary Series,States/Local Areas,West Virginia,2012,Age,35 Months,96.2,90.9 to 98.9,254
Combined 7 Series,,States/Local Areas,West Virginia,2011,Age,24 Months,66.0,57.2 to 74.7,231
Hib,Primary Series,States/Local Areas,West Virginia,2016,Age,19 Months,93.9,89.7 to 96.5,296
Hib,Primary Series,States/Local Areas,West Virginia,2016-2017,Age,19 Months,92.4,89.1 to 94.8,555
Combined 7 Series,,States/Local Areas,West Virginia,2012,Age,24 Months,61.9,53.8 to 70.0,254
Hib,Primary Series,States/Local Areas,West Virginia,2013,Age,24 Months,92.1,86.7 to 95.9,243
Hib,Primary Series,States/Local Areas,West Virginia,2013-2014,Age,24 Months,92.9,89.7 to 95.4,511
Combined 7 Series,,States/Local Areas,West Virginia,2014,Age,24 Months,58.3,51.2 to 65.6,268
Combined 7 Series,,States/Local Areas,West Virginia,2014-2015,Age,24 Months,64.5,59.6 to 69.4,549
Combined 7 Series,,States/Local Areas,West Virginia,2013,Age,24 Months,61.7,53.2 to 70.3,243
Combined 7 Series,,States/Local Areas,West Virginia,2013-2014,Age,24 Months,60.1,54.5 to 65.8,511
Hib,Primary Series,States/Local Areas,West Virginia,2013,Age,35 Months,96.0,90.4 to 98.8,243
Hib,Primary Series,States/Local Areas,West Virginia,2013-2014,Age,35 Months,95.6,92.6 to 97.6,511
Hib,Primary Series,States/Local Areas,West Virginia,2011,Age,35 Months,94.2,89.2 to 97.4,231
Hib,Primary Series,States/Local Areas,West Virginia,2019,Age,24 Months,91.3,85.8 to 95.3,201
Hib,Primary Series,States/Local Areas,West Virginia,2014,Age,24 Months,93.8,89.9 to 96.6,268
Hib,Primary Series,States/Local Areas,West Virginia,2014-2015,Age,24 Months,92.9,90.0 to 95.2,549
Hib,Primary Series,States/Local Areas,West Virginia,2015,Age,24 Months,92.0,87.4 to 95.4,281
Hib,Primary Series,States/Local Areas,West Virginia,2015-2016,Age,24 Months,92.9,90.0 to 95.2,577
Hib,Primary Series,States/Local Areas,West Virginia,2017,Age,24 Months,91.5,86.4 to 95.3,259
Hib,Primary Series,States/Local Areas,West Virginia,2017-2018,Age,24 Months,92.9,89.9 to 95.4,511
Hib,Primary Series,States/Local Areas,West Virginia,2018,Age,24 Months,94.4,90.7 to 97.0,252
Hib,Primary Series,States/Local Areas,West Virginia,2018-2019,Age,24 Months,92.9,89.7 to 95.4,453
Hib,Primary Series,States/Local Areas,West Virginia,2016,Age,24 Months,93.9,90.1 to 96.6,296
Hib,Primary Series,States/Local Areas,West Virginia,2016-2017,Age,24 Months,92.7,89.6 to 95.2,555
Hib,Full Series,States/Local Areas,West Virginia,2016-2019,Race and Ethnicity,Hispanic,86.6,75.2 to 97.9,34
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,62.8,57.3 to 67.9,472
Hep B,≥2 Doses,States/Local Areas,West Virginia,2019-2020,Age,7 Months,90.0,85.9 to 93.0,472
Combined 7 Series,,States/Local Areas,West Virginia,2019,Age,24 Months,57.8,49.4 to 66.5,201
Combined 7 Series,,States/Local Areas,West Virginia,2016,Age,24 Months,63.9,57.2 to 70.5,296
Combined 7 Series,,States/Local Areas,West Virginia,2016-2017,Age,24 Months,68.9,64.0 to 73.6,555
Hib,Primary Series,States/Local Areas,West Virginia,2019,Age,35 Months,91.3,85.8 to 95.3,201
Hib,Primary Series,States/Local Areas,West Virginia,2018,Age,35 Months,95.6,91.6 to 98.0,252
Hib,Primary Series,States/Local Areas,West Virginia,2018-2019,Age,35 Months,93.5,90.2 to 95.9,453
Combined 7 Series,,States/Local Areas,West Virginia,2015,Age,24 Months,70.7,64.0 to 77.2,281
Combined 7 Series,,States/Local Areas,West Virginia,2015-2016,Age,24 Months,67.4,62.6 to 72.1,577
Hib,Primary Series,States/Local Areas,West Virginia,2014,Age,7 Months,63.2,55.9 to 69.9,268
Hib,Primary Series,States/Local Areas,West Virginia,2014-2015,Age,7 Months,64.7,59.7 to 69.4,549
Combined 7 Series,,States/Local Areas,West Virginia,2011,Age,35 Months,75.5,64.9 to 84.8,231
Hib,Primary Series,States/Local Areas,West Virginia,2013,Age,7 Months,59.3,57.7 to 60.9,243
Hib,Primary Series,States/Local Areas,West Virginia,2013-2014,Age,7 Months,61.2,55.8 to 66.4,511
Hib,Primary Series,States/Local Areas,West Virginia,2012,Age,7 Months,68.2,64.1 to 72.1,254
Hib,Primary Series,States/Local Areas,West Virginia,2017,Age,7 Months,67.4,59.8 to 74.2,259
Hib,Primary Series,States/Local Areas,West Virginia,2017-2018,Age,7 Months,70.8,65.7 to 75.4,511
Hib,Primary Series,States/Local Areas,West Virginia,2016,Age,7 Months,73.2,66.8 to 78.8,296
Hib,Primary Series,States/Local Areas,West Virginia,2016-2017,Age,7 Months,70.4,65.4 to 74.8,555
Hib,Primary Series,States/Local Areas,West Virginia,2014,Age,13 Months,83.7,77.5 to 88.4,268
Hib,Primary Series,States/Local Areas,West Virginia,2014-2015,Age,13 Months,86.5,82.7 to 89.6,549
Hib,Primary Series,States/Local Areas,West Virginia,2015,Age,13 Months,89.4,84.4 to 93.0,281
Hib,Primary Series,States/Local Areas,West Virginia,2015-2016,Age,13 Months,90.5,87.3 to 93.0,577
Hib,Primary Series,States/Local Areas,West Virginia,2015,Age,7 Months,66.2,59.3 to 72.5,281
Hib,Primary Series,States/Local Areas,West Virginia,2015-2016,Age,7 Months,69.6,64.9 to 73.9,577
Hib,Primary Series,States/Local Areas,West Virginia,2019,Age,13 Months,77.6,69.4 to 84.0,201
Hib,Primary Series,States/Local Areas,West Virginia,2011,Age,19 Months,93.6,90.3 to 95.8,231
Hib,Primary Series,States/Local Areas,West Virginia,2013,Age,19 Months,89.2,86.7 to 91.3,243
Hib,Primary Series,States/Local Areas,West Virginia,2013-2014,Age,19 Months,91.3,89.1 to 93.1,511
Hib,Primary Series,States/Local Areas,West Virginia,2011,Age,24 Months,93.6,88.6 to 96.9,231
Hib,Primary Series,States/Local Areas,West Virginia,2012,Age,24 Months,91.6,85.6 to 95.8,254
Hib,Primary Series,States/Local Areas,West Virginia,2016,Age,13 Months,91.7,87.1 to 94.8,296
Hib,Primary Series,States/Local Areas,West Virginia,2016-2017,Age,13 Months,88.6,84.7 to 91.6,555
Hib,Primary Series,States/Local Areas,West Virginia,2018,Age,7 Months,74.3,67.4 to 80.1,252
Hib,Primary Series,States/Local Areas,West Virginia,2018-2019,Age,7 Months,67.3,61.8 to 72.3,453
Hib,Primary Series,States/Local Areas,West Virginia,2011,Age,13 Months,87.8,82.0 to 91.9,231
Hib,Primary Series,States/Local Areas,West Virginia,2012,Age,13 Months,86.0,80.3 to 90.3,254
Hib,Primary Series,States/Local Areas,West Virginia,2013,Age,13 Months,84.5,82.7 to 86.1,243
Hib,Primary Series,States/Local Areas,West Virginia,2013-2014,Age,13 Months,84.1,79.7 to 87.7,511
Hib,Primary Series,States/Local Areas,West Virginia,2014,Age,19 Months,93.4,89.1 to 96.1,268
Hib,Primary Series,States/Local Areas,West Virginia,2014-2015,Age,19 Months,92.3,89.1 to 94.6,549
Hib,Primary Series,States/Local Areas,West Virginia,2012,Age,19 Months,89.9,86.3 to 92.6,254
Hib,Primary Series,States/Local Areas,West Virginia,2018,Age,13 Months,84.3,78.3 to 88.9,252
Hib,Primary Series,States/Local Areas,West Virginia,2018-2019,Age,13 Months,81.0,76.0 to 85.1,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2020,Age,13 Months,59.5,51.9 to 66.6,271
Hib,Primary Series,States/Local Areas,West Virginia,2017,Age,13 Months,85.4,78.9 to 90.2,259
Hib,Primary Series,States/Local Areas,West Virginia,2017-2018,Age,13 Months,84.9,80.6 to 88.3,511
Hib,Primary Series,States/Local Areas,West Virginia,2018,Age,19 Months,94.1,90.0 to 96.6,252
Hib,Primary Series,States/Local Areas,West Virginia,2018-2019,Age,19 Months,81.0,76.0 to 85.1,453
Hib,≥3 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,81.0,76.7 to 84.6,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,88.0,81.6 to 92.4,808
Combined 7 Series,,HHS Regions/National,Region 9,2021,Age,24 Months,53.7,46.3 to 61.5,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2021,Age,35 Months,97.1,88.5 to 99.7,808
Hib,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,87.0,83.4 to 89.9,2037
Hep A,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,19 Months,79.4,74.5 to 83.5,2037
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,86.1,82.2 to 89.2,2037
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2020-2021,Age,0-1 Days,72.1,67.5 to 76.2,2037
Hib,Full Series,HHS Regions/National,Region 9,2020-2021,Age,35 Months,78.2,73.8 to 82.4,2037
Hib,Primary Series,HHS Regions/National,Region 9,2020-2021,Age,35 Months,91.6,88.6 to 94.1,2037
Rotavirus,,HHS Regions/National,Region 9,2020-2021,Age,8 Months,72.5,67.8 to 76.7,2037
Hib,Full Series,HHS Regions/National,Region 9,2020-2021,Age,19 Months,68.7,63.9 to 73.2,2037
Hep A,≥2 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,23.5,18.1 to 30.0,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2021,Age,13 Months,54.5,46.9 to 62.0,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,59.1,54.2 to 63.8,2037
Hib,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,90.6,87.4 to 93.3,2037
Polio,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,90.8,87.5 to 93.3,2037
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2020-2021,Age,0-2 Days,73.7,69.1 to 77.8,2037
PCV,≥1 Dose,HHS Regions/National,Region 9,2021,Age,3 Months,83.3,77.0 to 88.2,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,84.7,78.3 to 89.5,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,90.2,83.3 to 95.1,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020-2021,Age,19 Months,85.1,81.4 to 88.2,2037
Combined 7 Series,,HHS Regions/National,Region 9,2020-2021,Age,24 Months,60.7,55.8 to 65.7,2037
≥1 Dose MMR,,HHS Regions/National,Region 9,2020-2021,Age,35 Months,91.4,87.6 to 94.3,2037
PCV,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,88.6,85.0 to 91.5,2037
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,61.8,56.8 to 66.4,2037
DTaP,≥4 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,63.2,58.1 to 68.0,2037
Polio,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,91.5,88.2 to 94.2,2037
Hib,Primary Series,HHS Regions/National,Region 9,2020-2021,Age,7 Months,63.0,58.2 to 67.5,2037
Combined 7 Series,,HHS Regions/National,Region 9,2020-2021,Age,35 Months,66.8,61.7 to 71.8,2037
Hep B,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,86.8,82.7 to 90.0,2037
Hib,Full Series,HHS Regions/National,Region 9,2021,Age,35 Months,77.4,69.0 to 84.9,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,92.7,86.3 to 96.8,808
Hib,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,3 Months,80.7,76.8 to 84.1,2037
PCV,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,92.1,88.8 to 94.7,2037
Influenza,,HHS Regions/National,Region 9,2020-2021,Age,24 Months,57.8,53.1 to 62.7,2037
Hib,Primary Series,HHS Regions/National,Region 9,2021,Age,13 Months,83.6,77.4 to 88.3,808
Hib,Primary Series,HHS Regions/National,Region 9,2020-2021,Age,19 Months,88.2,84.7 to 91.0,2037
Polio,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,86.0,82.2 to 89.1,2037
DTaP,≥4 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,78.8,66.9 to 88.7,808
Hib,Primary Series,HHS Regions/National,Region 9,2021,Age,35 Months,94.9,88.7 to 98.3,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020-2021,Age,24 Months,87.0,83.6 to 90.0,2037
Hep A,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,49.1,44.3 to 54.0,2037
Polio,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,89.5,86.2 to 92.3,2037
Polio,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,3 Months,83.2,79.3 to 86.5,2037
Hep B,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,5 Months,82.6,78.2 to 86.2,2037
Hib,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,5 Months,71.0,66.3 to 75.3,2037
Hib,≥3 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,75.9,69.0 to 81.7,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,90.3,87.1 to 92.9,2037
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,88.0,84.4 to 91.0,2037
Hib,≥2 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,91.3,86.1 to 94.6,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,84.5,80.6 to 87.8,2037
≥1 Dose MMR,,HHS Regions/National,Region 9,2020-2021,Age,19 Months,85.3,81.5 to 88.4,2037
Hib,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,76.1,71.8 to 79.9,2037
Rotavirus,,HHS Regions/National,Region 9,2021,Age,8 Months,71.9,64.7 to 78.2,808
PCV,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,3 Months,83.4,79.6 to 86.5,2037
Hib,≥3 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,94.0,86.5 to 98.0,808
Hep A,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,73.5,67.5 to 79.2,2037
Hib,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,50.3,45.6 to 55.0,2037
≥1 Dose MMR,,HHS Regions/National,Region 9,2021,Age,13 Months,59.6,52.0 to 66.8,808
Hib,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,85.9,82.2 to 88.9,2037
Influenza,,HHS Regions/National,Region 9,2021,Age,24 Months,52.0,44.4 to 60.0,808
DTaP,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,5 Months,73.5,68.8 to 77.7,2037
Hep A,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,24 Months,83.9,79.3 to 87.9,2037
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2021,Age,0-3 Days,73.0,65.7 to 79.3,808
Hep B,≥1 Dose,HHS Regions/National,Region 9,2021,Age,3 Months,91.9,86.4 to 95.3,808
Polio,≥2 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,89.7,83.7 to 93.6,808
Influenza,,HHS Regions/National,Region 9,2017,Age,24 Months,58.3,52.1 to 64.6,1269
Influenza,,HHS Regions/National,Region 9,2017-2018,Age,24 Months,62.4,58.3 to 66.5,2758
Influenza,,HHS Regions/National,Region 9,2018,Age,24 Months,66.7,61.7 to 71.6,1489
Influenza,,HHS Regions/National,Region 9,2018-2019,Age,24 Months,67.5,64.0 to 71.0,2847
Hib,Full Series,HHS Regions/National,Region 9,2020-2021,Age,24 Months,73.4,68.8 to 77.8,2037
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020-2021,Age,13 Months,55.2,50.5 to 59.8,2037
Polio,≥2 Doses,HHS Regions/National,Region 9,2021,Age,5 Months,71.3,63.7 to 77.9,808
Polio,≥3 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,89.1,83.1 to 93.1,808
≥1 Dose MMR,,HHS Regions/National,Region 9,2021,Age,19 Months,86.1,80.1 to 90.5,808
DTaP,≥2 Doses,HHS Regions/National,Region 9,2021,Age,5 Months,71.3,63.7 to 77.9,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,87.0,83.3 to 90.0,2037
Influenza,,HHS Regions/National,Region 9,2019,Age,24 Months,68.3,63.5 to 73.1,1358
Influenza,,HHS Regions/National,Region 9,2016,Age,24 Months,61.4,53.9 to 69.1,1120
Influenza,,HHS Regions/National,Region 9,2016-2017,Age,24 Months,59.9,55.0 to 64.9,2389
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,90.4,87.4 to 93.0,2037
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,7 Months,61.0,56.2 to 65.6,2037
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2020-2021,Age,0-3 Days,74.1,69.5 to 78.2,2037
PCV,≥4 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,80.7,75.6 to 85.3,2037
Polio,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,5 Months,73.3,68.6 to 77.5,2037
PCV,≥4 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,71.3,66.3 to 75.7,2037
Influenza,,HHS Regions/National,Region 9,2012,Age,24 Months,57.1,50.4 to 64.1,1139
Influenza,,HHS Regions/National,Region 9,2011,Age,24 Months,58.5,51.6 to 65.5,1101
Influenza,,HHS Regions/National,Region 9,2014,Age,24 Months,52.6,45.5 to 60.1,1048
Influenza,,HHS Regions/National,Region 9,2014-2015,Age,24 Months,53.5,48.1 to 59.0,2082
Influenza,,HHS Regions/National,Region 9,2015,Age,24 Months,54.2,46.6 to 62.3,1034
Influenza,,HHS Regions/National,Region 9,2015-2016,Age,24 Months,57.9,52.4 to 63.4,2154
Influenza,,HHS Regions/National,Region 9,2013,Age,24 Months,56.5,49.7 to 63.5,1078
Influenza,,HHS Regions/National,Region 9,2013-2014,Age,24 Months,54.5,49.5 to 59.7,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019-2020,Age,19 Months,85.8,82.7 to 88.5,2587
Hep B,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,3 Months,92.5,89.5 to 94.8,2037
Polio,≥3 Doses,States/Local Areas,Maryland,2011,Age,35 Months,98.4,96.2 to 99.5,300
PCV,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,93.5,90.8 to 95.4,1108
Hib,≥3 Doses,States/Local Areas,Maryland,2011,Age,19 Months,97.6,96.6 to 98.3,300
Hib,≥3 Doses,States/Local Areas,Maryland,2012,Age,19 Months,91.2,87.7 to 93.8,328
Hib,≥3 Doses,States/Local Areas,Maryland,2019,Age,13 Months,79.0,74.1 to 83.3,614
Polio,≥3 Doses,States/Local Areas,Maryland,2018,Age,19 Months,95.7,93.3 to 97.2,837
Polio,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,73.2,69.6 to 76.5,1451
Hib,≥3 Doses,States/Local Areas,Maryland,2018,Age,13 Months,80.5,76.5 to 84.0,837
Hib,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,79.8,76.7 to 82.6,1451
Polio,≥3 Doses,States/Local Areas,Maryland,2017,Age,19 Months,94.6,91.5 to 96.7,766
Polio,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,95.2,93.3 to 96.5,1603
Polio,≥3 Doses,States/Local Areas,Maryland,2016,Age,19 Months,92.3,87.5 to 95.4,464
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,93.5,90.8 to 95.4,1230
Hib,≥3 Doses,States/Local Areas,Maryland,2017,Age,13 Months,77.7,72.7 to 81.9,766
Hib,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,79.1,76.0 to 81.9,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2016,Age,13 Months,79.6,73.4 to 84.7,464
Hib,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,78.7,74.8 to 82.1,1230
Polio,≥3 Doses,States/Local Areas,Maryland,2013,Age,19 Months,95.7,93.8 to 97.1,361
Polio,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,93.6,90.6 to 95.7,727
Polio,≥3 Doses,States/Local Areas,Maryland,2015,Age,19 Months,95.6,91.1 to 97.9,372
Polio,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,94.0,90.7 to 96.1,836
Polio,≥3 Doses,States/Local Areas,Maryland,2014,Age,19 Months,91.4,85.4 to 95.1,366
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,93.5,89.8 to 95.9,738
DTaP,≥3 Doses,States/Local Areas,Maryland,2012,Age,19 Months,91.2,87.7 to 93.8,328
DTaP,≥3 Doses,States/Local Areas,Maryland,2013,Age,19 Months,97.2,93.4 to 98.8,361
DTaP,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,95.2,92.2 to 97.0,727
DTaP,≥3 Doses,States/Local Areas,Maryland,2011,Age,19 Months,97.1,92.5 to 98.9,300
DTaP,≥3 Doses,States/Local Areas,Maryland,2019,Age,13 Months,92.8,88.9 to 95.4,614
DTaP,≥3 Doses,States/Local Areas,Maryland,2018,Age,13 Months,93.2,90.2 to 95.4,837
DTaP,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,93.0,90.7 to 94.8,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.2,90.4 to 96.0,1053
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,94.5,92.4 to 96.5,1626
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,89.5,84.3 to 94.7,287
Hib,≥2 Doses,States/Local Areas,Maryland,2020,Age,13 Months,94.9,91.3 to 97.1,494
Hib,≥2 Doses,States/Local Areas,Maryland,2019,Age,13 Months,96.4,93.8 to 97.9,614
Hib,≥2 Doses,States/Local Areas,Maryland,2017,Age,13 Months,95.5,92.5 to 97.4,766
Hib,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,96.1,94.5 to 97.3,1603
Hib,≥2 Doses,States/Local Areas,Maryland,2018,Age,13 Months,96.8,94.7 to 98.1,837
Hib,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,96.6,95.0 to 97.7,1451
DTaP,≥3 Doses,States/Local Areas,Maryland,2017,Age,13 Months,93.3,90.1 to 95.5,766
DTaP,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,93.2,91.2 to 94.9,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2012,Age,13 Months,81.1,76.3 to 85.1,328
Hib,≥3 Doses,States/Local Areas,Maryland,2011,Age,13 Months,89.0,88.0 to 90.0,300
Hib,≥3 Doses,States/Local Areas,Maryland,2014,Age,13 Months,76.7,69.1 to 83.0,366
Hib,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,77.9,72.5 to 82.4,738
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,95.4,92.0 to 98.7,419
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,97.4,95.2 to 99.6,920
Polio,≥3 Doses,States/Local Areas,Maryland,2011,Age,19 Months,98.2,96.7 to 99.0,300
Hib,≥3 Doses,States/Local Areas,Maryland,2013,Age,13 Months,83.8,77.6 to 88.5,361
Hib,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,80.3,72.5 to 86.2,727
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,75.1,68.7 to 81.5,419
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,79.9,75.5 to 84.2,920
Polio,≥3 Doses,States/Local Areas,Maryland,2012,Age,19 Months,90.9,87.1 to 93.6,328
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,93.5 to 99.5,806
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,96.8,94.2 to 99.3,548
Hib,≥3 Doses,States/Local Areas,Maryland,2019,Age,7 Months,63.2,57.6 to 68.5,614
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.6,71.4 to 79.8,1053
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,77.4,71.5 to 83.2,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Overall,Overall,76.5,73.1 to 79.8,1626
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.1,59.5 to 78.7,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.7,70.4 to 81.0,806
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,77.0,68.8 to 85.3,279
DTaP,≥3 Doses,States/Local Areas,Maryland,2014,Age,13 Months,86.8,79.9 to 91.6,366
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,90.5,86.3 to 93.6,738
DTaP,≥3 Doses,States/Local Areas,Maryland,2013,Age,13 Months,92.6,90.6 to 94.2,361
DTaP,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,89.7,84.8 to 93.2,727
DTaP,≥3 Doses,States/Local Areas,Maryland,2012,Age,13 Months,90.8,87.1 to 93.5,328
DTaP,≥3 Doses,States/Local Areas,Maryland,2015,Age,13 Months,94.3,88.6 to 97.2,372
DTaP,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,92.9,89.5 to 95.3,836
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,73.2,66.0 to 80.3,287
Hib,≥3 Doses,States/Local Areas,Maryland,2015,Age,13 Months,79.0,71.2 to 85.1,372
Hib,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,79.3,74.4 to 83.4,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2016,Age,13 Months,91.5,86.6 to 94.7,464
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,92.4,89.6 to 94.4,1230
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,81.6 to 96.0,236
DTaP,≥3 Doses,States/Local Areas,Maryland,2011,Age,13 Months,96.2,91.6 to 98.4,300
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.3 to 99.1,1180
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,90.2,85.5 to 94.8,399
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.3,91.7 to 98.9,305
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,89.8,83.6 to 96.0,279
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.0,90.1 to 97.9,236
Hib,≥3 Doses,States/Local Areas,Maryland,2018,Age,7 Months,67.6,63.0 to 71.9,837
Hib,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,65.4,61.8 to 68.9,1451
Hib,≥3 Doses,States/Local Areas,Maryland,2017,Age,7 Months,63.1,57.6 to 68.2,766
Hib,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,65.3,61.8 to 68.7,1603
DTaP,≥3 Doses,States/Local Areas,Maryland,2017,Age,7 Months,77.5,72.5 to 81.9,766
DTaP,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,79.1,75.9 to 81.9,1603
DTaP,≥3 Doses,States/Local Areas,Maryland,2019,Age,7 Months,76.9,71.5 to 81.5,614
DTaP,≥3 Doses,States/Local Areas,Maryland,2018,Age,7 Months,80.6,76.4 to 84.2,837
DTaP,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,78.8,75.4 to 81.8,1451
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,75.4,69.4 to 81.5,399
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.2,74.5 to 86.0,305
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,78.4,74.7 to 82.2,1180
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2019,Age,0-3 Days,80.6,75.8 to 84.6,614
Polio,≥1 Dose,States/Local Areas,Maryland,2019,Age,3 Months,93.0,89.4 to 95.4,614
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2018,Age,0-3 Days,80.8,76.6 to 84.5,837
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2018-2019,Age,0-3 Days,80.7,77.6 to 83.5,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2019,Age,35 Months,95.2,92.0 to 97.4,614
Hib,≥2 Doses,States/Local Areas,Maryland,2018,Age,7 Months,94.0,91.3 to 96.0,837
Hib,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,93.6,91.6 to 95.2,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2014,Age,35 Months,94.2,89.3 to 97.3,366
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,95.4,92.2 to 97.5,738
PCV,≥3 Doses,States/Local Areas,Maryland,2016,Age,35 Months,93.6,89.4 to 96.6,464
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,94.9,92.5 to 96.7,1230
PCV,≥3 Doses,States/Local Areas,Maryland,2015,Age,35 Months,96.4,91.7 to 98.8,372
PCV,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,95.0,92.1 to 97.1,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,92.3,87.9 to 96.7,548
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,87.9,81.5 to 94.4,279
PCV,≥3 Doses,States/Local Areas,Maryland,2012,Age,35 Months,91.3,85.4 to 95.5,328
Hib,≥2 Doses,States/Local Areas,Maryland,2011,Age,13 Months,98.1,97.0 to 98.8,300
Hib,≥2 Doses,States/Local Areas,Maryland,2012,Age,13 Months,93.3,87.1 to 96.6,328
Hib,≥2 Doses,States/Local Areas,Maryland,2016,Age,13 Months,95.0,90.9 to 97.3,464
Hib,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,95.3,92.9 to 96.9,1230
Hib,≥2 Doses,States/Local Areas,Maryland,2015,Age,13 Months,95.6,90.0 to 98.1,372
Hib,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,95.3,92.3 to 97.2,836
Hib,≥2 Doses,States/Local Areas,Maryland,2017,Age,7 Months,92.7,89.0 to 95.3,766
Hib,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,93.4,91.2 to 95.1,1603
Hib,≥2 Doses,States/Local Areas,Maryland,2016,Age,7 Months,92.2,87.5 to 95.2,464
Hib,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,92.4,89.6 to 94.5,1230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016,Age,0-3 Days,76.7,70.2 to 82.2,464
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2017,Age,0-3 Days,79.1,75.3 to 82.5,1230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2017,Age,0-3 Days,79.0,72.2 to 84.4,421
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2017-2018,Age,0-3 Days,81.2,78.2 to 83.9,1603
Polio,≥1 Dose,States/Local Areas,Maryland,2016,Age,3 Months,90.0,84.5 to 93.7,464
Polio,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,3 Months,90.1,86.9 to 92.6,1230
Polio,≥1 Dose,States/Local Areas,Maryland,2015,Age,3 Months,91.1,85.5 to 94.7,372
Polio,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,3 Months,90.6,86.9 to 93.3,836
Polio,≥1 Dose,States/Local Areas,Maryland,2014,Age,3 Months,89.1,82.8 to 93.3,366
Polio,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,3 Months,90.1,86.1 to 93.1,738
Hib,≥3 Doses,States/Local Areas,Maryland,2013,Age,7 Months,66.6,61.2 to 71.5,361
Hib,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,65.0,59.2 to 70.4,727
Hib,≥3 Doses,States/Local Areas,Maryland,2011,Age,7 Months,72.5,67.8 to 76.7,300
Hib,≥3 Doses,States/Local Areas,Maryland,2012,Age,7 Months,68.6,63.4 to 73.3,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,92.2,88.0 to 96.4,419
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,94.3,91.4 to 97.2,920
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,87.7,82.0 to 93.4,287
DTaP,≥3 Doses,States/Local Areas,Maryland,2014,Age,7 Months,73.9,65.8 to 80.7,366
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,76.3,70.8 to 81.1,738
≥1 Dose Varicella,,States/Local Areas,Maryland,2020,Age,24 Months,95.3,92.3 to 97.4,494
Hib,≥2 Doses,States/Local Areas,Maryland,2019,Age,7 Months,93.2,89.8 to 95.5,614
DTaP,≥3 Doses,States/Local Areas,Maryland,2016,Age,7 Months,71.3,64.3 to 77.3,464
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,74.4,70.1 to 78.3,1230
DTaP,≥3 Doses,States/Local Areas,Maryland,2015,Age,7 Months,78.7,70.9 to 84.9,372
DTaP,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,75.0,69.9 to 79.5,836
Polio,≥1 Dose,States/Local Areas,Maryland,2018,Age,3 Months,93.5,90.7 to 95.5,837
Polio,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,3 Months,93.2,91.1 to 94.9,1451
Polio,≥1 Dose,States/Local Areas,Maryland,2017,Age,3 Months,90.2,86.3 to 93.2,766
Polio,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,3 Months,91.9,89.5 to 93.7,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2016,Age,7 Months,61.9,54.8 to 68.5,464
Hib,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,62.5,58.0 to 66.7,1230
Hib,≥3 Doses,States/Local Areas,Maryland,2015,Age,7 Months,64.4,56.0 to 72.0,372
Hib,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,63.2,57.7 to 68.3,836
Hib,≥3 Doses,States/Local Areas,Maryland,2014,Age,7 Months,63.4,55.2 to 71.0,366
Hib,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,63.9,58.1 to 69.3,738
PCV,≥3 Doses,States/Local Areas,Maryland,2018,Age,35 Months,96.5,94.4 to 98.0,837
PCV,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,95.8,93.9 to 97.3,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2017,Age,35 Months,96.2,93.8 to 97.9,766
PCV,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,96.3,94.7 to 97.5,1603
Hib,≥2 Doses,States/Local Areas,Maryland,2013,Age,13 Months,95.4,93.3 to 96.8,361
Hib,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,93.9,91.5 to 95.6,727
Hib,≥2 Doses,States/Local Areas,Maryland,2014,Age,13 Months,92.4,86.8 to 95.7,366
Hib,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,94.0,90.4 to 96.3,738
Hib,≥2 Doses,States/Local Areas,Maryland,2016,Age,5 Months,80.9,74.5 to 86.0,464
Hib,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,5 Months,83.7,79.9 to 87.0,1230
Hib,≥2 Doses,States/Local Areas,Maryland,2015,Age,5 Months,85.1,78.3 to 90.1,372
Hib,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,5 Months,83.0,78.5 to 86.7,836
PCV,≥3 Doses,States/Local Areas,Maryland,2011,Age,24 Months,96.6,93.3 to 98.6,300
PCV,≥3 Doses,States/Local Areas,Maryland,2019,Age,19 Months,93.0,89.3 to 95.6,614
PCV,≥3 Doses,States/Local Areas,Maryland,2018,Age,19 Months,95.2,92.8 to 96.9,837
PCV,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,91.2,88.7 to 93.2,1451
Hib,≥2 Doses,States/Local Areas,Maryland,2011,Age,5 Months,85.4,78.4 to 90.4,300
Hib,≥2 Doses,States/Local Areas,Maryland,2012,Age,5 Months,83.6,78.6 to 87.6,328
PCV,≥4 Doses,States/Local Areas,Maryland,2017,Age,35 Months,90.0,86.2 to 93.1,766
PCV,≥4 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,90.2,87.6 to 92.5,1603
PCV,≥4 Doses,States/Local Areas,Maryland,2019,Age,35 Months,86.4,81.6 to 90.5,614
PCV,≥4 Doses,States/Local Areas,Maryland,2018,Age,35 Months,90.5,86.8 to 93.6,837
PCV,≥4 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,88.6,85.6 to 91.2,1451
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Overall,Overall,92.5,90.3 to 94.8,1626
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,88.9,83.8 to 94.0,287
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,91.5,87.2 to 95.9,419
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,95.8,93.2 to 98.4,920
PCV,≥1 Dose,States/Local Areas,Maryland,2011,Age,3 Months,92.1,85.9 to 95.7,300
PCV,≥1 Dose,States/Local Areas,Maryland,2012,Age,3 Months,87.7,84.5 to 90.4,328
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.9,77.9 to 85.9,1053
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,83.7,80.6 to 86.9,1626
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,69.4,61.6 to 77.1,287
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,85.5,80.1 to 91.0,419
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,92.7,89.9 to 95.5,920
Hib,≥2 Doses,States/Local Areas,Maryland,2014,Age,7 Months,89.4,83.0 to 93.6,366
Hib,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,90.8,86.6 to 93.8,738
Hib,≥2 Doses,States/Local Areas,Maryland,2013,Age,7 Months,93.2,89.8 to 95.5,361
Hib,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,91.3,87.5 to 94.0,727
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,87.8,82.9 to 92.8,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2011,Age,0-3 Days,76.6,68.2 to 83.2,300
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,87.9,82.9 to 92.9,399
PCV,≥1 Dose,States/Local Areas,Maryland,2018,Age,3 Months,92.2,89.1 to 94.5,837
PCV,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,3 Months,91.6,89.1 to 93.5,1451
PCV,≥1 Dose,States/Local Areas,Maryland,2017,Age,3 Months,89.7,85.8 to 92.7,766
PCV,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,3 Months,91.0,88.6 to 92.9,1603
PCV,≥1 Dose,States/Local Areas,Maryland,2016,Age,3 Months,88.9,83.4 to 92.7,464
PCV,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,3 Months,89.3,86.1 to 91.8,1230
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,95.4,93.4 to 97.3,1180
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.2,90.7 to 97.7,305
PCV,≥3 Doses,States/Local Areas,Maryland,2018,Age,24 Months,95.2,93.0 to 96.9,837
PCV,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,95.0,93.1 to 96.5,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2017,Age,24 Months,96.2,93.8 to 97.9,766
PCV,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,95.7,94.1 to 97.0,1603
Hib,≥2 Doses,States/Local Areas,Maryland,2012,Age,7 Months,91.3,86.2 to 94.6,328
PCV,≥3 Doses,States/Local Areas,Maryland,2016,Age,24 Months,93.4,89.2 to 96.3,464
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,94.7,92.4 to 96.5,1230
Hib,≥2 Doses,States/Local Areas,Maryland,2014,Age,5 Months,82.1,74.7 to 87.7,366
Hib,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,5 Months,83.6,79.2 to 87.2,738
Hib,≥2 Doses,States/Local Areas,Maryland,2013,Age,5 Months,81.0,75.5 to 85.5,361
Hib,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,5 Months,81.6,77.3 to 85.2,727
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.1,75.8 to 90.5,236
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.7,84.5 to 92.9,806
PCV,≥1 Dose,States/Local Areas,Maryland,2015,Age,3 Months,90.7,85.1 to 94.3,372
PCV,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,3 Months,89.8,86.0 to 92.6,836
PCV,≥1 Dose,States/Local Areas,Maryland,2014,Age,3 Months,88.3,81.9 to 92.7,366
PCV,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,3 Months,89.5,85.5 to 92.5,738
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2015,Age,0-3 Days,73.7,66.0 to 80.1,372
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2015-2016,Age,0-3 Days,75.2,70.3 to 79.5,836
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014,Age,0-3 Days,75.3,67.9 to 81.5,366
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2014-2015,Age,0-3 Days,74.5,69.3 to 79.1,738
DTaP,≥3 Doses,States/Local Areas,Maryland,2011,Age,7 Months,80.6,76.2 to 84.4,300
DTaP,≥3 Doses,States/Local Areas,Maryland,2012,Age,7 Months,77.6,74.0 to 80.9,328
DTaP,≥3 Doses,States/Local Areas,Maryland,2013,Age,7 Months,76.4,69.6 to 82.0,361
DTaP,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,75.1,70.3 to 79.5,727
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2013,Age,0-3 Days,79.6,72.6 to 85.1,361
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2013-2014,Age,0-3 Days,77.4,72.5 to 81.7,727
Polio,≥1 Dose,States/Local Areas,Maryland,2013,Age,3 Months,93.2,84.3 to 97.2,361
Polio,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,3 Months,91.2,87.5 to 93.8,727
Polio,≥1 Dose,States/Local Areas,Maryland,2011,Age,3 Months,94.2,90.8 to 96.4,300
Polio,≥1 Dose,States/Local Areas,Maryland,2012,Age,3 Months,89.8,86.5 to 92.4,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,91.8,89.4 to 94.2,1626
PCV,≥1 Dose,States/Local Areas,Maryland,2019,Age,3 Months,90.9,86.9 to 93.7,614
Hib,≥2 Doses,States/Local Areas,Maryland,2015,Age,7 Months,92.2,85.7 to 95.9,372
Hib,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,92.2,88.5 to 94.8,836
PCV,≥3 Doses,States/Local Areas,Maryland,2013,Age,35 Months,96.1,92.6 to 98.2,361
PCV,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,95.2,92.3 to 97.3,727
PCV,≥3 Doses,States/Local Areas,Maryland,2011,Age,35 Months,96.6,93.3 to 98.6,300
PCV,≥3 Doses,States/Local Areas,Maryland,2019,Age,24 Months,94.7,91.4 to 97.0,614
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.4,88.5 to 94.4,1053
Hib,≥2 Doses,States/Local Areas,Maryland,2011,Age,7 Months,94.6,91.9 to 96.5,300
Hib,≥2 Doses,States/Local Areas,Maryland,2019,Age,5 Months,81.3,76.4 to 85.4,614
Hib,≥2 Doses,States/Local Areas,Maryland,2018,Age,5 Months,86.3,82.6 to 89.3,837
Hib,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,5 Months,83.8,80.8 to 86.4,1451
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2012,Age,0-3 Days,76.7,68.0 to 83.5,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.0,89.1 to 96.8,806
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2015,Age,0-2 Days,72.4,64.7 to 78.9,372
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2015-2016,Age,0-2 Days,73.4,68.5 to 77.8,836
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2014,Age,0-2 Days,73.7,66.3 to 80.0,366
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2014-2015,Age,0-2 Days,73.1,67.8 to 77.7,738
≥1 Dose Varicella,,States/Local Areas,Maryland,2013,Age,35 Months,95.5,91.6 to 97.9,361
≥1 Dose Varicella,,States/Local Areas,Maryland,2013-2014,Age,35 Months,94.0,90.8 to 96.3,727
≥1 Dose MMR,,States/Local Areas,Maryland,2018,Age,24 Months,92.4,89.4 to 94.8,837
≥1 Dose MMR,,States/Local Areas,Maryland,2018-2019,Age,24 Months,92.8,90.6 to 94.7,1451
PCV,≥4 Doses,States/Local Areas,Maryland,2019,Age,19 Months,82.0,77.1 to 86.1,614
≥1 Dose Varicella,,States/Local Areas,Maryland,2014,Age,35 Months,92.0,86.9 to 95.7,366
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2015,Age,35 Months,93.0,89.3 to 95.7,738
≥1 Dose Varicella,,States/Local Areas,Maryland,2015,Age,35 Months,93.8,88.2 to 97.3,372
≥1 Dose Varicella,,States/Local Areas,Maryland,2015-2016,Age,35 Months,94.9,91.4 to 97.4,836
PCV,≥4 Doses,States/Local Areas,Maryland,2011,Age,24 Months,91.8,86.0 to 95.8,300
Hep B,≥3 Doses,States/Local Areas,Maryland,2018,Age,24 Months,94.8,92.7 to 96.5,837
Hep B,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,93.9,91.9 to 95.5,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2015,Age,13 Months,93.2,87.6 to 96.4,372
PCV,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,91.9,88.4 to 94.4,836
PCV,≥3 Doses,States/Local Areas,Maryland,2014,Age,13 Months,90.2,83.8 to 94.2,366
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,91.7,87.7 to 94.4,738
Hep B,≥2 Doses,States/Local Areas,Maryland,2017,Age,7 Months,93.9,91.0 to 96.0,766
Hep B,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,94.8,93.1 to 96.1,1603
PCV,≥3 Doses,States/Local Areas,Maryland,2013,Age,13 Months,93.6,88.5 to 96.6,361
PCV,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,91.9,87.5 to 94.8,727
Hep B,≥2 Doses,States/Local Areas,Maryland,2016,Age,7 Months,93.1,88.6 to 95.8,464
Hep B,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,93.5,91.0 to 95.3,1230
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2016,Age,0-2 Days,74.5,67.8 to 80.2,464
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2016-2017,Age,0-2 Days,77.3,73.4 to 80.9,1230
Hep B,≥2 Doses,States/Local Areas,Maryland,2018,Age,7 Months,95.6,93.5 to 97.1,837
Hep B,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,95.4,93.8 to 96.7,1451
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2019,Age,0-2 Days,79.8,75.0 to 83.9,614
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2018,Age,0-2 Days,79.5,75.1 to 83.2,837
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2018-2019,Age,0-2 Days,79.6,76.5 to 82.5,1451
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2017,Age,0-2 Days,80.2,75.7 to 84.1,766
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2017-2018,Age,0-2 Days,79.8,76.8 to 82.6,1603
PCV,≥4 Doses,States/Local Areas,Maryland,2012,Age,24 Months,81.8,74.4 to 88.2,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2011,Age,35 Months,95.0,90.9 to 97.7,300
Hep B,≥3 Doses,States/Local Areas,Maryland,2017,Age,24 Months,94.1,91.4 to 96.2,766
Hep B,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,94.5,92.8 to 95.9,1603
Hep B,≥3 Doses,States/Local Areas,Maryland,2019,Age,24 Months,92.9,89.4 to 95.6,614
PCV,≥4 Doses,States/Local Areas,Maryland,2013,Age,24 Months,85.6,79.7 to 90.5,361
PCV,≥4 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,84.0,79.6 to 87.9,727
PCV,≥4 Doses,States/Local Areas,Maryland,2014,Age,24 Months,82.3,75.5 to 88.1,366
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,82.8,78.1 to 87.0,738
PCV,≥4 Doses,States/Local Areas,Maryland,2015,Age,24 Months,83.3,76.6 to 89.0,372
PCV,≥4 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,83.3,78.9 to 87.1,836
≥1 Dose MMR,,States/Local Areas,Maryland,2019,Age,24 Months,93.5,89.8 to 96.2,614
≥1 Dose MMR,,States/Local Areas,Maryland,2012,Age,35 Months,92.2,86.4 to 96.2,328
≥1 Dose MMR,,States/Local Areas,Maryland,2011,Age,35 Months,98.5,95.8 to 99.6,300
≥1 Dose MMR,,States/Local Areas,Maryland,2013,Age,35 Months,96.6,93.7 to 98.5,361
≥1 Dose MMR,,States/Local Areas,Maryland,2013-2014,Age,35 Months,94.1,91.1 to 96.3,727
≥1 Dose Varicella,,States/Local Areas,Maryland,2016,Age,35 Months,95.8,91.2 to 98.4,464
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2017,Age,35 Months,96.1,93.5 to 97.9,1230
Hep B,≥2 Doses,States/Local Areas,Maryland,2016,Age,13 Months,95.9,92.9 to 97.7,464
Hep B,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,96.1,94.2 to 97.4,1230
Hep B,≥2 Doses,States/Local Areas,Maryland,2015,Age,13 Months,94.0,88.0 to 97.1,372
Hep B,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,95.0,91.9 to 96.9,836
Hep B,≥2 Doses,States/Local Areas,Maryland,2014,Age,13 Months,94.9,90.4 to 97.3,366
Hep B,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,94.5,91.1 to 96.6,738
Hib,≥1 Dose,States/Local Areas,Maryland,2014,Age,3 Months,87.7,81.2 to 92.1,366
Hib,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,3 Months,89.2,85.0 to 92.2,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2017,Age,35 Months,96.5,93.7 to 98.2,766
Hep B,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,95.9,94.1 to 97.3,1603
PCV,≥3 Doses,States/Local Areas,Maryland,2012,Age,19 Months,89.3,85.7 to 92.1,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2018,Age,35 Months,95.1,93.0 to 96.7,837
Hep B,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,94.6,92.6 to 96.2,1451
PCV,≥4 Doses,States/Local Areas,Maryland,2012,Age,35 Months,83.8,76.5 to 89.9,328
PCV,≥4 Doses,States/Local Areas,Maryland,2011,Age,35 Months,93.4,88.1 to 96.8,300
PCV,≥4 Doses,States/Local Areas,Maryland,2018,Age,24 Months,86.7,83.0 to 90.0,837
PCV,≥4 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,85.6,82.7 to 88.3,1451
PCV,≥4 Doses,States/Local Areas,Maryland,2019,Age,24 Months,84.6,80.0 to 88.7,614
Hep B,≥3 Doses,States/Local Areas,Maryland,2016,Age,35 Months,92.9,88.6 to 96.0,464
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,94.4,91.9 to 96.4,1230
PCV,≥3 Doses,States/Local Areas,Maryland,2014,Age,19 Months,93.1,87.6 to 96.3,366
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,93.7,90.2 to 96.0,738
PCV,≥3 Doses,States/Local Areas,Maryland,2013,Age,19 Months,94.9,88.5 to 97.9,361
PCV,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,94.0,90.6 to 96.3,727
PCV,≥3 Doses,States/Local Areas,Maryland,2011,Age,19 Months,96.6,94.5 to 97.9,300
PCV,≥3 Doses,States/Local Areas,Maryland,2019,Age,13 Months,90.5,86.2 to 93.5,614
PCV,≥3 Doses,States/Local Areas,Maryland,2016,Age,13 Months,90.6,85.6 to 94.0,464
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,91.3,88.4 to 93.5,1230
Hib,Full Series,States/Local Areas,Maryland,2020,Age,24 Months,83.8,79.1 to 88.0,494
Hep B,≥3 Doses,States/Local Areas,Maryland,2013,Age,35 Months,94.7,90.4 to 97.5,361
Hep B,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,92.9,89.7 to 95.4,727
Hep B,≥3 Doses,States/Local Areas,Maryland,2014,Age,35 Months,91.1,86.1 to 94.9,366
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,91.5,87.7 to 94.4,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2015,Age,35 Months,91.8,85.9 to 95.9,372
Hep B,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,92.5,89.0 to 95.2,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2012,Age,35 Months,89.4,82.8 to 94.3,328
PCV,≥3 Doses,States/Local Areas,Maryland,2018,Age,13 Months,91.9,88.8 to 94.2,837
PCV,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,91.2,88.7 to 93.2,1451
PCV,≥3 Doses,States/Local Areas,Maryland,2017,Age,13 Months,92.0,88.5 to 94.5,766
PCV,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,92.0,89.7 to 93.7,1603
Hep B,≥2 Doses,States/Local Areas,Maryland,2012,Age,13 Months,92.6,87.8 to 95.6,328
Hep B,≥2 Doses,States/Local Areas,Maryland,2013,Age,13 Months,96.4,94.1 to 97.8,361
Hep B,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,95.6,93.3 to 97.2,727
Hep B,≥2 Doses,States/Local Areas,Maryland,2011,Age,13 Months,96.5,94.9 to 97.6,300
Hep B,≥2 Doses,States/Local Areas,Maryland,2019,Age,7 Months,95.2,92.4 to 97.1,614
PCV,≥4 Doses,States/Local Areas,Maryland,2016,Age,24 Months,83.2,77.4 to 88.2,464
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,85.2,81.7 to 88.3,1230
PCV,≥4 Doses,States/Local Areas,Maryland,2017,Age,24 Months,87.3,83.3 to 90.7,766
PCV,≥4 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,87.0,84.3 to 89.4,1603
≥1 Dose MMR,,States/Local Areas,Maryland,2015,Age,35 Months,95.1,90.0 to 98.1,372
≥1 Dose MMR,,States/Local Areas,Maryland,2015-2016,Age,35 Months,95.2,91.7 to 97.5,836
≥1 Dose MMR,,States/Local Areas,Maryland,2014,Age,35 Months,91.4,86.1 to 95.3,366
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2015,Age,35 Months,93.4,89.8 to 96.0,738
≥1 Dose MMR,,States/Local Areas,Maryland,2016,Age,35 Months,95.0,90.0 to 97.9,464
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2017,Age,35 Months,95.7,92.9 to 97.6,1230
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.2,85.6 to 94.8,305
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.4,71.2 to 91.6,236
DTaP,≥4 Doses,States/Local Areas,Maryland,2018,Age,35 Months,92.6,88.7 to 95.5,837
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2017,Age,0-1 Days,73.1,68.2 to 77.5,766
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2017-2018,Age,0-1 Days,73.9,70.6 to 76.9,1603
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2016,Age,0-1 Days,67.5,60.7 to 73.7,464
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2016-2017,Age,0-1 Days,70.3,66.1 to 74.1,1230
≥1 Dose Varicella,,States/Local Areas,Maryland,2017,Age,35 Months,96.3,93.8 to 98.0,766
≥1 Dose Varicella,,States/Local Areas,Maryland,2017-2018,Age,35 Months,95.9,94.1 to 97.3,1603
≥1 Dose Varicella,,States/Local Areas,Maryland,2018,Age,35 Months,95.5,92.5 to 97.5,837
≥1 Dose Varicella,,States/Local Areas,Maryland,2018-2019,Age,35 Months,94.4,92.2 to 96.2,1451
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,90.2,84.4 to 95.9,279
Hib,≥1 Dose,States/Local Areas,Maryland,2011,Age,3 Months,94.1,91.1 to 96.1,300
Hib,≥1 Dose,States/Local Areas,Maryland,2012,Age,3 Months,90.0,86.6 to 92.5,328
Hib,≥1 Dose,States/Local Areas,Maryland,2013,Age,3 Months,90.8,84.3 to 94.7,361
Hib,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,3 Months,89.2,85.7 to 91.9,727
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,94.8,92.7 to 96.9,1180
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,90.0,85.5 to 94.5,399
≥1 Dose Varicella,,States/Local Areas,Maryland,2019,Age,35 Months,93.7,89.9 to 96.4,614
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,91.3,86.9 to 95.7,419
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,87.2 to 93.6,1053
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Overall,Overall,92.1,89.8 to 94.4,1626
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,88.7,83.6 to 93.8,287
≥1 Dose MMR,,States/Local Areas,Maryland,2017,Age,35 Months,96.4,93.9 to 98.1,766
≥1 Dose MMR,,States/Local Areas,Maryland,2017-2018,Age,35 Months,95.7,93.9 to 97.1,1603
≥1 Dose MMR,,States/Local Areas,Maryland,2018,Age,35 Months,95.0,92.2 to 97.0,837
≥1 Dose MMR,,States/Local Areas,Maryland,2018-2019,Age,35 Months,94.5,92.2 to 96.2,1451
PCV,≥4 Doses,States/Local Areas,Maryland,2013,Age,35 Months,89.3,83.7 to 93.6,361
PCV,≥4 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,86.7,82.4 to 90.4,727
≥1 Dose MMR,,States/Local Areas,Maryland,2019,Age,35 Months,94.0,90.3 to 96.6,614
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,87.1 to 97.0,236
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,94.9,92.6 to 97.2,1180
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.4,90.9 to 97.9,806
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.6 to 98.3,548
PCV,≥3 Doses,States/Local Areas,Maryland,2016,Age,19 Months,92.0,87.1 to 95.1,464
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,94.0,91.4 to 95.9,1230
PCV,≥3 Doses,States/Local Areas,Maryland,2015,Age,19 Months,94.3,86.7 to 97.7,372
PCV,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,93.1,89.8 to 95.4,836
Hep B,≥2 Doses,States/Local Areas,Maryland,2019,Age,13 Months,96.8,94.3 to 98.2,614
Hep B,≥2 Doses,States/Local Areas,Maryland,2018,Age,13 Months,97.4,95.8 to 98.4,837
Hep B,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,97.1,95.7 to 98.0,1451
Hep B,≥2 Doses,States/Local Areas,Maryland,2017,Age,13 Months,96.2,93.6 to 97.8,766
Hep B,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,96.8,95.3 to 97.8,1603
Hib,≥1 Dose,States/Local Areas,Maryland,2017,Age,3 Months,90.5,86.5 to 93.3,766
Hib,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,3 Months,91.7,89.4 to 93.5,1603
Hib,≥1 Dose,States/Local Areas,Maryland,2016,Age,3 Months,89.6,84.1 to 93.3,464
Hib,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,3 Months,90.0,86.8 to 92.5,1230
Hib,≥1 Dose,States/Local Areas,Maryland,2015,Age,3 Months,90.6,85.0 to 94.3,372
Hib,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,3 Months,90.1,86.4 to 92.9,836
Hib,≥1 Dose,States/Local Areas,Maryland,2019,Age,3 Months,91.7,88.2 to 94.2,614
Hib,≥1 Dose,States/Local Areas,Maryland,2018,Age,3 Months,92.9,90.1 to 95.0,837
Hib,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,3 Months,92.3,90.2 to 94.0,1451
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.3,90.9 to 97.8,806
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,96.1,93.3 to 98.9,548
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.7,87.5 to 93.8,1053
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,95.1,92.4 to 97.9,920
PCV,≥4 Doses,States/Local Areas,Maryland,2014,Age,35 Months,83.7,76.8 to 89.4,366
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,85.4,80.6 to 89.5,738
PCV,≥4 Doses,States/Local Areas,Maryland,2015,Age,35 Months,87.1,80.4 to 92.5,372
PCV,≥4 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,86.4,82.1 to 90.1,836
PCV,≥4 Doses,States/Local Areas,Maryland,2016,Age,35 Months,86.0,80.3 to 90.7,464
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,88.0,84.6 to 90.9,1230
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,90.0,85.5 to 94.5,399
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.8,87.6 to 96.0,305
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,91.4,85.9 to 96.9,279
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,83.7 to 96.3,236
Hep B,≥3 Doses,States/Local Areas,Maryland,2019,Age,35 Months,94.0,90.4 to 96.6,614
PCV,≥3 Doses,States/Local Areas,Maryland,2017,Age,19 Months,96.1,93.5 to 97.7,766
PCV,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,95.7,94.0 to 96.9,1603
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,89.5,86.1 to 93.0,920
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,91.3,88.7 to 93.9,1180
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,74.2,67.7 to 80.7,399
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,78.7,69.8 to 87.6,279
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.8,74.6 to 87.1,305
PCV,≥1 Dose,States/Local Areas,Maryland,2013,Age,3 Months,90.8,81.1 to 95.8,361
PCV,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,3 Months,89.6,85.8 to 92.4,727
PCV,≥3 Doses,States/Local Areas,Maryland,2015,Age,24 Months,94.9,90.3 to 97.8,372
PCV,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,94.2,91.2 to 96.4,836
PCV,≥3 Doses,States/Local Areas,Maryland,2014,Age,24 Months,94.2,89.3 to 97.3,366
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,94.5,91.4 to 96.8,738
PCV,≥3 Doses,States/Local Areas,Maryland,2013,Age,24 Months,95.3,91.8 to 97.6,361
PCV,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,94.7,91.9 to 96.8,727
Hib,≥2 Doses,States/Local Areas,Maryland,2017,Age,5 Months,86.6,82.4 to 89.9,766
Hib,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,5 Months,86.4,83.7 to 88.7,1603
PCV,≥3 Doses,States/Local Areas,Maryland,2012,Age,24 Months,90.6,84.7 to 94.9,328
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,78.8,71.7 to 85.9,548
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,68.0,58.8 to 77.1,287
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,77.3,72.9 to 81.6,1626
Polio,≥2 Doses,States/Local Areas,Maryland,2019,Age,7 Months,94.0,90.7 to 96.1,614
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.4,78.2 to 88.7,806
DTaP,≥4 Doses,States/Local Areas,Maryland,2016,Age,35 Months,91.8,85.2 to 96.2,464
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,90.9,87.2 to 93.9,1230
DTaP,≥4 Doses,States/Local Areas,Maryland,2017,Age,35 Months,90.1,86.0 to 93.4,766
DTaP,≥4 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,91.1,88.4 to 93.4,1603
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,78.6,68.2 to 89.0,279
Hep B,≥3 Doses,States/Local Areas,Maryland,2017,Age,13 Months,91.8,88.5 to 94.2,766
Hep B,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,92.3,90.3 to 93.9,1603
Hep B,≥3 Doses,States/Local Areas,Maryland,2015,Age,13 Months,89.0,82.4 to 93.3,372
Hep B,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,88.6,84.6 to 91.7,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2016,Age,13 Months,88.3,82.8 to 92.2,464
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,90.0,86.9 to 92.4,1230
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,83.0,78.4 to 87.7,1180
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,68.7,60.7 to 76.8,399
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.9,57.3 to 76.6,305
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.0,72.3 to 85.7,305
≥1 Dose MMR,,States/Local Areas,Maryland,2011,Age,19 Months,95.2,92.1 to 97.1,300
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,88.4,85.2 to 91.6,1180
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,74.6,68.0 to 81.2,399
DTaP,≥4 Doses,States/Local Areas,Maryland,2019,Age,35 Months,87.5,82.3 to 91.8,614
Polio,≥2 Doses,States/Local Areas,Maryland,2017,Age,13 Months,95.9,93.0 to 97.7,766
Polio,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,13 Months,96.2,94.5 to 97.4,1603
Polio,≥2 Doses,States/Local Areas,Maryland,2016,Age,13 Months,94.9,90.8 to 97.3,464
Polio,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,13 Months,95.4,93.1 to 97.0,1230
Polio,≥2 Doses,States/Local Areas,Maryland,2015,Age,13 Months,96.0,90.3 to 98.4,372
Polio,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,13 Months,95.5,92.4 to 97.3,836
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,77.6,68.9 to 86.3,279
≥1 Dose Varicella,,States/Local Areas,Maryland,2018,Age,19 Months,91.4,88.3 to 93.8,837
≥1 Dose Varicella,,States/Local Areas,Maryland,2018-2019,Age,19 Months,68.6,65.0 to 72.0,1451
≥1 Dose Varicella,,States/Local Areas,Maryland,2017,Age,19 Months,92.6,89.5 to 94.8,766
≥1 Dose Varicella,,States/Local Areas,Maryland,2017-2018,Age,19 Months,92.0,89.9 to 93.7,1603
≥1 Dose MMR,,States/Local Areas,Maryland,2012,Age,19 Months,88.7,83.1 to 92.6,328
≥1 Dose MMR,,States/Local Areas,Maryland,2014,Age,19 Months,90.2,84.5 to 93.9,366
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2015,Age,19 Months,90.9,87.0 to 93.7,738
≥1 Dose MMR,,States/Local Areas,Maryland,2013,Age,19 Months,94.0,92.0 to 95.5,361
≥1 Dose MMR,,States/Local Areas,Maryland,2013-2014,Age,19 Months,92.1,88.7 to 94.5,727
Polio,≥2 Doses,States/Local Areas,Maryland,2018,Age,7 Months,94.5,91.8 to 96.3,837
Polio,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,94.2,92.2 to 95.7,1451
Polio,≥2 Doses,States/Local Areas,Maryland,2017,Age,7 Months,93.1,89.4 to 95.6,766
Polio,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,93.8,91.6 to 95.4,1603
Hep B,≥1 Dose,States/Local Areas,Maryland,2014,Age,3 Months,97.1,94.2 to 98.5,366
Hep B,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,3 Months,96.1,93.3 to 97.8,738
Hep B,≥1 Dose,States/Local Areas,Maryland,2011,Age,3 Months,93.9,89.4 to 96.5,300
Hep B,≥1 Dose,States/Local Areas,Maryland,2012,Age,3 Months,96.3,91.4 to 98.4,328
Hep B,≥1 Dose,States/Local Areas,Maryland,2013,Age,3 Months,97.7,94.3 to 99.1,361
Hep B,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,3 Months,97.4,95.7 to 98.4,727
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.0,77.9 to 86.0,1053
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,82.8,76.7 to 88.8,548
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,82.1,78.7 to 85.4,1626
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.3,68.8 to 87.8,236
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.7,83.4 to 92.1,806
≥1 Dose Varicella,,States/Local Areas,Maryland,2012,Age,24 Months,89.8,83.8 to 94.3,328
≥1 Dose Varicella,,States/Local Areas,Maryland,2011,Age,24 Months,96.9,94.8 to 98.3,300
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,72.3,64.7 to 80.0,287
≥1 Dose MMR,,States/Local Areas,Maryland,2017,Age,19 Months,93.3,90.4 to 95.4,766
≥1 Dose MMR,,States/Local Areas,Maryland,2017-2018,Age,19 Months,92.3,90.2 to 94.0,1603
≥1 Dose MMR,,States/Local Areas,Maryland,2016,Age,19 Months,88.7,83.3 to 92.5,464
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2017,Age,19 Months,91.0,88.0 to 93.3,1230
≥1 Dose MMR,,States/Local Areas,Maryland,2015,Age,19 Months,91.6,86.3 to 95.0,372
≥1 Dose MMR,,States/Local Areas,Maryland,2015-2016,Age,19 Months,90.2,86.4 to 93.0,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2015,Age,19 Months,90.6,86.8 to 93.4,372
Hep B,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,90.1,86.1 to 93.0,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2014,Age,19 Months,89.4,83.7 to 93.3,366
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,90.0,86.0 to 93.0,738
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,87.3,82.6 to 91.9,920
Hep B,≥3 Doses,States/Local Areas,Maryland,2013,Age,19 Months,94.3,90.3 to 96.7,361
Hep B,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,91.8,87.7 to 94.7,727
Hep B,≥2 Doses,States/Local Areas,Maryland,2013,Age,5 Months,90.8,85.1 to 94.4,361
Hep B,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,5 Months,90.2,86.8 to 92.7,727
Hep B,≥2 Doses,States/Local Areas,Maryland,2011,Age,5 Months,86.4,81.3 to 90.3,300
Hep B,≥2 Doses,States/Local Areas,Maryland,2012,Age,5 Months,85.2,83.5 to 86.7,328
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2011,Age,0-1 Days,58.3,53.5 to 63.0,300
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,73.6,64.8 to 82.4,419
Hep B,≥1 Dose,States/Local Areas,Maryland,2019,Age,3 Months,98.2,96.7 to 99.1,614
Hep B,≥1 Dose,States/Local Areas,Maryland,2018,Age,3 Months,97.5,95.7 to 98.6,837
Hep B,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,3 Months,97.9,96.8 to 98.6,1451
Hep B,≥3 Doses,States/Local Areas,Maryland,2012,Age,19 Months,87.7,86.2 to 89.0,328
Hep B,≥3 Doses,States/Local Areas,Maryland,2011,Age,19 Months,92.8,87.0 to 96.2,300
Hep B,≥3 Doses,States/Local Areas,Maryland,2019,Age,13 Months,91.0,87.1 to 93.8,614
Hep B,≥3 Doses,States/Local Areas,Maryland,2018,Age,13 Months,92.9,90.1 to 94.9,837
Hep B,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,91.9,89.6 to 93.7,1451
DTaP,≥4 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,90.0,86.8 to 92.8,1451
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2018,Age,0-1 Days,74.8,70.3 to 78.8,837
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2018-2019,Age,0-1 Days,74.4,71.1 to 77.5,1451
Hep B,≥2 Doses,States/Local Areas,Maryland,2018,Age,5 Months,93.2,90.5 to 95.2,837
Hep B,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,5 Months,91.7,89.3 to 93.5,1451
Hep B,≥2 Doses,States/Local Areas,Maryland,2017,Age,5 Months,91.2,87.9 to 93.6,766
Hep B,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,5 Months,92.2,90.2 to 93.8,1603
Hep B,≥2 Doses,States/Local Areas,Maryland,2011,Age,7 Months,91.6,87.9 to 94.3,300
Hep B,≥2 Doses,States/Local Areas,Maryland,2019,Age,5 Months,90.1,86.0 to 93.1,614
≥1 Dose Varicella,,States/Local Areas,Maryland,2015,Age,24 Months,92.1,86.5 to 96.0,372
≥1 Dose Varicella,,States/Local Areas,Maryland,2015-2016,Age,24 Months,91.8,88.4 to 94.5,836
≥1 Dose MMR,,States/Local Areas,Maryland,2012,Age,24 Months,91.2,85.5 to 95.3,328
≥1 Dose MMR,,States/Local Areas,Maryland,2011,Age,24 Months,97.3,94.7 to 98.8,300
≥1 Dose Varicella,,States/Local Areas,Maryland,2016,Age,24 Months,91.4,87.0 to 94.8,464
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2017,Age,24 Months,92.9,90.4 to 94.9,1230
≥1 Dose Varicella,,States/Local Areas,Maryland,2017,Age,24 Months,94.4,91.8 to 96.5,766
≥1 Dose Varicella,,States/Local Areas,Maryland,2017-2018,Age,24 Months,93.7,91.8 to 95.3,1603
≥1 Dose MMR,,States/Local Areas,Maryland,2019,Age,19 Months,89.0,84.4 to 92.3,614
≥1 Dose MMR,,States/Local Areas,Maryland,2018,Age,19 Months,91.2,87.9 to 93.7,837
≥1 Dose MMR,,States/Local Areas,Maryland,2018-2019,Age,19 Months,96.6,95.0 to 97.7,1451
PCV,≥4 Doses,States/Local Areas,Maryland,2011,Age,19 Months,85.6,81.4 to 88.9,300
PCV,≥4 Doses,States/Local Areas,Maryland,2012,Age,19 Months,79.7,73.7 to 84.6,328
PCV,≥4 Doses,States/Local Areas,Maryland,2013,Age,19 Months,82.6,72.7 to 89.4,361
PCV,≥4 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,81.6,74.8 to 86.9,727
≥1 Dose Varicella,,States/Local Areas,Maryland,2013,Age,24 Months,91.4,86.6 to 95.0,361
≥1 Dose Varicella,,States/Local Areas,Maryland,2013-2014,Age,24 Months,91.4,88.1 to 94.2,727
≥1 Dose Varicella,,States/Local Areas,Maryland,2014,Age,24 Months,91.5,86.4 to 95.2,366
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2015,Age,24 Months,91.8,88.1 to 94.7,738
≥1 Dose Varicella,,States/Local Areas,Maryland,2019,Age,19 Months,88.3,83.8 to 91.7,614
Polio,≥2 Doses,States/Local Areas,Maryland,2019,Age,13 Months,96.6,94.0 to 98.1,614
Polio,≥2 Doses,States/Local Areas,Maryland,2018,Age,13 Months,96.5,94.4 to 97.9,837
Polio,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,13 Months,96.6,95.0 to 97.6,1451
Hep B,≥2 Doses,States/Local Areas,Maryland,2015,Age,5 Months,90.1,83.9 to 94.1,372
Hep B,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,5 Months,89.2,85.2 to 92.2,836
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2015,Age,0-1 Days,66.4,58.6 to 73.5,372
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2015-2016,Age,0-1 Days,67.0,61.9 to 71.7,836
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2014,Age,0-1 Days,66.8,59.0 to 73.7,366
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2014-2015,Age,0-1 Days,66.6,61.1 to 71.6,738
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2013,Age,0-1 Days,65.1,57.4 to 72.0,361
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2013-2014,Age,0-1 Days,65.9,62.5 to 69.2,727
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2012,Age,0-1 Days,66.1,61.5 to 70.3,328
Hep B,≥2 Doses,States/Local Areas,Maryland,2014,Age,5 Months,89.6,84.1 to 93.3,366
Hep B,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,5 Months,89.8,87.0 to 92.1,738
Hep B,≥2 Doses,States/Local Areas,Maryland,2016,Age,5 Months,88.2,82.7 to 92.2,464
Hep B,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,5 Months,89.7,86.7 to 92.1,1230
Hep B,≥3 Doses,States/Local Areas,Maryland,2018,Age,19 Months,94.8,92.6 to 96.4,837
Hep B,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,91.9,89.6 to 93.7,1451
Hep B,≥3 Doses,States/Local Areas,Maryland,2017,Age,19 Months,93.9,91.0 to 96.0,766
Hep B,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,94.4,92.6 to 95.7,1603
PCV,≥3 Doses,States/Local Areas,Maryland,2012,Age,7 Months,72.5,68.7 to 76.1,328
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,78.9,72.2 to 85.6,419
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,91.5,88.4 to 94.5,920
PCV,≥3 Doses,States/Local Areas,Maryland,2014,Age,7 Months,70.9,62.7 to 77.9,366
PCV,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,74.5,68.9 to 79.3,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2016,Age,19 Months,89.5,84.1 to 93.2,464
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,91.7,88.8 to 93.9,1230
PCV,≥3 Doses,States/Local Areas,Maryland,2011,Age,7 Months,77.8,71.4 to 83.1,300
PCV,≥3 Doses,States/Local Areas,Maryland,2013,Age,7 Months,74.4,66.4 to 81.0,361
PCV,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,72.6,66.5 to 78.0,727
≥1 Dose Varicella,,States/Local Areas,Maryland,2012,Age,35 Months,92.8,87.0 to 96.6,328
≥1 Dose Varicella,,States/Local Areas,Maryland,2011,Age,35 Months,98.4,96.4 to 99.4,300
≥1 Dose Varicella,,States/Local Areas,Maryland,2019,Age,24 Months,93.3,89.5 to 96.0,614
≥1 Dose MMR,,States/Local Areas,Maryland,2013,Age,24 Months,95.2,92.1 to 97.4,361
≥1 Dose MMR,,States/Local Areas,Maryland,2013-2014,Age,24 Months,92.9,89.9 to 95.2,727
≥1 Dose MMR,,States/Local Areas,Maryland,2014,Age,24 Months,90.6,85.4 to 94.5,366
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2015,Age,24 Months,92.0,88.4 to 94.8,738
≥1 Dose MMR,,States/Local Areas,Maryland,2015,Age,24 Months,93.2,88.0 to 96.8,372
≥1 Dose MMR,,States/Local Areas,Maryland,2015-2016,Age,24 Months,92.1,88.7 to 94.8,836
≥1 Dose Varicella,,States/Local Areas,Maryland,2018,Age,24 Months,92.9,90.2 to 95.2,837
≥1 Dose Varicella,,States/Local Areas,Maryland,2018-2019,Age,24 Months,93.0,90.8 to 94.9,1451
Hep B,≥3 Doses,States/Local Areas,Maryland,2011,Age,24 Months,95.0,90.9 to 97.6,300
Hep B,≥3 Doses,States/Local Areas,Maryland,2019,Age,19 Months,91.7,87.9 to 94.5,614
Hep B,≥3 Doses,States/Local Areas,Maryland,2013,Age,24 Months,94.3,89.9 to 97.2,361
Hep B,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,92.3,89.1 to 94.9,727
Hep B,≥3 Doses,States/Local Areas,Maryland,2014,Age,24 Months,90.4,85.3 to 94.3,366
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,90.9,87.2 to 93.9,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2012,Age,24 Months,88.4,81.9 to 93.4,328
PCV,≥3 Doses,States/Local Areas,Maryland,2016,Age,7 Months,71.3,64.4 to 77.3,464
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,73.8,69.6 to 77.6,1230
PCV,≥4 Doses,States/Local Areas,Maryland,2016,Age,19 Months,80.1,73.7 to 85.2,464
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,82.5,78.8 to 85.7,1230
PCV,≥4 Doses,States/Local Areas,Maryland,2015,Age,19 Months,82.3,78.1 to 85.9,372
PCV,≥4 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,81.2,76.6 to 85.1,836
PCV,≥4 Doses,States/Local Areas,Maryland,2014,Age,19 Months,80.7,73.2 to 86.4,366
PCV,≥4 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,81.5,76.5 to 85.6,738
PCV,≥3 Doses,States/Local Areas,Maryland,2015,Age,7 Months,78.0,70.3 to 84.2,372
PCV,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,74.7,69.6 to 79.2,836
PCV,≥3 Doses,States/Local Areas,Maryland,2017,Age,7 Months,76.4,71.3 to 80.8,766
PCV,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,77.3,74.0 to 80.2,1603
Hep A,≥1 Dose,States/Local Areas,Maryland,2020,Age,35 Months,93.1,89.1 to 96.1,494
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2011,Age,0-2 Days,71.4,68.3 to 74.3,300
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2019,Age,0-1 Days,74.1,68.9 to 78.7,614
Hep B,≥2 Doses,States/Local Areas,Maryland,2013,Age,7 Months,94.9,91.4 to 97.0,361
Hep B,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,94.0,91.4 to 95.8,727
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2012,Age,0-2 Days,73.6,64.3 to 81.2,328
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2013,Age,0-2 Days,76.8,69.5 to 82.8,361
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2013-2014,Age,0-2 Days,75.3,70.6 to 79.4,727
PCV,≥3 Doses,States/Local Areas,Maryland,2011,Age,13 Months,94.8,92.6 to 96.4,300
PCV,≥3 Doses,States/Local Areas,Maryland,2019,Age,7 Months,72.5,66.9 to 77.5,614
PCV,≥3 Doses,States/Local Areas,Maryland,2018,Age,7 Months,78.2,73.8 to 82.0,837
PCV,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,75.4,71.9 to 78.6,1451
Hep B,≥2 Doses,States/Local Areas,Maryland,2012,Age,7 Months,89.9,85.7 to 92.9,328
Hep B,≥2 Doses,States/Local Areas,Maryland,2015,Age,7 Months,92.1,85.7 to 95.7,372
Hep B,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,92.6,89.0 to 95.1,836
Hep B,≥2 Doses,States/Local Areas,Maryland,2014,Age,7 Months,93.1,88.3 to 96.0,366
Hep B,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,92.6,88.9 to 95.1,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2015,Age,24 Months,91.4,85.6 to 95.6,372
Hep B,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,92.1,88.7 to 94.9,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2016,Age,24 Months,92.7,88.4 to 95.8,464
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,93.3,90.9 to 95.3,1230
PCV,≥3 Doses,States/Local Areas,Maryland,2012,Age,13 Months,88.1,84.7 to 90.8,328
≥1 Dose MMR,,States/Local Areas,Maryland,2016,Age,24 Months,90.9,86.2 to 94.6,464
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2017,Age,24 Months,92.8,90.1 to 94.9,1230
≥1 Dose MMR,,States/Local Areas,Maryland,2017,Age,24 Months,94.7,92.1 to 96.6,766
≥1 Dose MMR,,States/Local Areas,Maryland,2017-2018,Age,24 Months,93.5,91.6 to 95.1,1603
PCV,≥4 Doses,States/Local Areas,Maryland,2018,Age,19 Months,84.5,80.5 to 87.8,837
PCV,≥4 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,82.4,78.8 to 85.6,1277
PCV,≥4 Doses,States/Local Areas,Maryland,2017,Age,19 Months,85.0,80.7 to 88.5,766
PCV,≥4 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,84.8,81.9 to 87.2,1603
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.9,75.8 to 84.0,1053
Hib,≥3 Doses,States/Local Areas,Maryland,2019,Age,35 Months,94.1,90.8 to 96.6,614
DTaP,≥4 Doses,States/Local Areas,Maryland,2011,Age,35 Months,90.9,84.0 to 95.6,300
DTaP,≥4 Doses,States/Local Areas,Maryland,2019,Age,24 Months,82.6,77.7 to 86.9,614
DTaP,≥4 Doses,States/Local Areas,Maryland,2017,Age,24 Months,84.0,79.7 to 87.9,766
DTaP,≥4 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,84.1,81.2 to 86.8,1603
DTaP,≥4 Doses,States/Local Areas,Maryland,2018,Age,24 Months,84.2,80.2 to 87.8,837
DTaP,≥4 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,83.4,80.2 to 86.2,1451
Hep B,≥1 Dose,States/Local Areas,Maryland,2017,Age,3 Months,97.0,94.7 to 98.4,766
Hep B,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,3 Months,97.3,95.9 to 98.2,1603
Hep B,≥1 Dose,States/Local Areas,Maryland,2016,Age,3 Months,96.6,93.4 to 98.2,464
Hep B,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,3 Months,96.8,95.0 to 98.0,1230
Hep B,≥1 Dose,States/Local Areas,Maryland,2015,Age,3 Months,95.2,89.6 to 97.8,372
Hep B,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,3 Months,95.9,93.0 to 97.6,836
Polio,≥2 Doses,States/Local Areas,Maryland,2014,Age,13 Months,94.7,89.9 to 97.3,366
Polio,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,95.4,92.1 to 97.3,738
Polio,≥2 Doses,States/Local Areas,Maryland,2013,Age,13 Months,97.1,94.2 to 98.6,361
Polio,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,95.9,94.0 to 97.3,727
≥1 Dose MMR,,States/Local Areas,Maryland,2011,Age,13 Months,70.2,64.7 to 75.2,300
≥1 Dose MMR,,States/Local Areas,Maryland,2012,Age,13 Months,65.9,59.5 to 71.8,328
≥1 Dose MMR,,States/Local Areas,Maryland,2013,Age,13 Months,67.7,61.0 to 73.8,361
≥1 Dose MMR,,States/Local Areas,Maryland,2013-2014,Age,13 Months,70.3,65.3 to 75.0,727
Hep B,≥3 Doses,States/Local Areas,Maryland,2011,Age,13 Months,88.0,81.3 to 92.5,300
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,84.4,78.8 to 90.0,419
Polio,≥2 Doses,States/Local Areas,Maryland,2016,Age,7 Months,92.3,87.6 to 95.3,464
Polio,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,92.7,89.9 to 94.8,1230
Polio,≥2 Doses,States/Local Areas,Maryland,2015,Age,7 Months,92.8,86.4 to 96.4,372
Polio,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,92.6,88.9 to 95.1,836
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Overall,Overall,86.5,83.6 to 89.3,1626
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,84.2,78.1 to 90.4,287
Polio,≥2 Doses,States/Local Areas,Maryland,2014,Age,7 Months,91.6,85.7 to 95.3,366
Polio,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,92.2,88.2 to 95.0,738
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.8,81.1 to 88.6,1053
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.4,83.0 to 91.7,806
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,85.1 to 93.7,548
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.8,81.2 to 94.3,236
≥1 Dose Varicella,,States/Local Areas,Maryland,2015,Age,13 Months,60.5,52.2 to 68.3,372
≥1 Dose Varicella,,States/Local Areas,Maryland,2015-2016,Age,13 Months,65.1,59.9 to 70.0,836
≥1 Dose Varicella,,States/Local Areas,Maryland,2017,Age,13 Months,66.6,61.3 to 71.6,766
≥1 Dose Varicella,,States/Local Areas,Maryland,2017-2018,Age,13 Months,68.0,64.5 to 71.3,1603
≥1 Dose Varicella,,States/Local Areas,Maryland,2016,Age,13 Months,69.7,63.0 to 75.7,464
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2017,Age,13 Months,68.2,64.0 to 72.1,1230
≥1 Dose MMR,,States/Local Areas,Maryland,2017,Age,13 Months,72.0,66.8 to 76.6,766
≥1 Dose MMR,,States/Local Areas,Maryland,2017-2018,Age,13 Months,72.8,69.4 to 75.9,1603
≥1 Dose MMR,,States/Local Areas,Maryland,2019,Age,13 Months,72.8,67.3 to 77.7,614
≥1 Dose MMR,,States/Local Areas,Maryland,2018,Age,13 Months,73.6,69.0 to 77.7,837
≥1 Dose MMR,,States/Local Areas,Maryland,2018-2019,Age,13 Months,73.2,69.6 to 76.5,1451
Polio,≥2 Doses,States/Local Areas,Maryland,2011,Age,13 Months,98.5,97.0 to 99.2,300
Polio,≥2 Doses,States/Local Areas,Maryland,2012,Age,13 Months,93.3,87.5 to 96.5,328
≥1 Dose Varicella,,States/Local Areas,Maryland,2016,Age,19 Months,90.0,85.0 to 93.5,464
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2017,Age,19 Months,91.3,88.5 to 93.5,1230
≥1 Dose Varicella,,States/Local Areas,Maryland,2015,Age,19 Months,90.4,87.1 to 92.9,372
≥1 Dose Varicella,,States/Local Areas,Maryland,2015-2016,Age,19 Months,90.2,86.4 to 93.1,836
≥1 Dose Varicella,,States/Local Areas,Maryland,2014,Age,19 Months,91.4,85.9 to 94.9,366
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2015,Age,19 Months,90.9,86.9 to 93.8,738
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.4,70.9 to 81.9,1053
Hep A,≥2 Doses,States/Local Areas,Maryland,2013,Age,24 Months,34.4,27.4 to 42.7,361
Hep A,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,39.1,33.6 to 45.0,727
DTaP,≥4 Doses,States/Local Areas,Maryland,2018,Age,19 Months,77.4,73.1 to 81.3,837
DTaP,≥4 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,96.6,95.0 to 97.6,1451
DTaP,≥4 Doses,States/Local Areas,Maryland,2017,Age,19 Months,77.4,72.5 to 81.6,766
DTaP,≥4 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,77.4,74.1 to 80.4,1603
DTaP,≥4 Doses,States/Local Areas,Maryland,2016,Age,19 Months,76.0,69.4 to 81.6,464
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,76.7,72.6 to 80.3,1230
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,89.5,83.3 to 95.8,279
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.6 to 98.8,236
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.4,90.6 to 96.3,1053
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.7,93.7 to 99.7,806
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,95.5,92.2 to 98.7,548
PCV,≥2 Doses,States/Local Areas,Maryland,2019,Age,5 Months,82.6,77.6 to 86.7,614
PCV,≥2 Doses,States/Local Areas,Maryland,2018,Age,5 Months,85.7,81.9 to 88.7,837
PCV,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,5 Months,84.1,81.1 to 86.8,1451
≥1 Dose Varicella,,States/Local Areas,Maryland,2013,Age,13 Months,62.6,54.4 to 70.2,361
≥1 Dose Varicella,,States/Local Areas,Maryland,2013-2014,Age,13 Months,65.3,60.3 to 70.0,727
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.7,80.1 to 91.2,305
Polio,≥2 Doses,States/Local Areas,Maryland,2018,Age,5 Months,86.3,82.5 to 89.3,837
Polio,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,5 Months,85.4,82.5 to 87.9,1451
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,88.2,85.1 to 91.2,1180
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,86.0,80.7 to 91.2,399
Hep A,≥1 Dose,States/Local Areas,Maryland,2019,Age,35 Months,91.3,87.0 to 94.6,614
≥1 Dose Varicella,,States/Local Areas,Maryland,2012,Age,13 Months,66.6,59.5 to 73.0,328
≥1 Dose Varicella,,States/Local Areas,Maryland,2014,Age,13 Months,68.0,59.8 to 75.2,366
≥1 Dose Varicella,,States/Local Areas,Maryland,2014-2015,Age,13 Months,64.3,58.5 to 69.7,738
≥1 Dose MMR,,States/Local Areas,Maryland,2015,Age,13 Months,69.5,61.5 to 76.5,372
≥1 Dose MMR,,States/Local Areas,Maryland,2015-2016,Age,13 Months,70.9,65.8 to 75.5,836
≥1 Dose MMR,,States/Local Areas,Maryland,2014,Age,13 Months,73.0,64.9 to 79.8,366
≥1 Dose MMR,,States/Local Areas,Maryland,2014-2015,Age,13 Months,71.2,65.6 to 76.3,738
≥1 Dose Varicella,,States/Local Areas,Maryland,2018,Age,13 Months,69.3,64.7 to 73.6,837
≥1 Dose Varicella,,States/Local Areas,Maryland,2018-2019,Age,13 Months,68.6,65.0 to 72.0,1451
≥1 Dose MMR,,States/Local Areas,Maryland,2016,Age,13 Months,72.2,65.6 to 78.0,464
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2017,Age,13 Months,72.1,68.0 to 75.9,1230
≥1 Dose Varicella,,States/Local Areas,Maryland,2012,Age,19 Months,87.1,80.2 to 91.8,328
≥1 Dose Varicella,,States/Local Areas,Maryland,2013,Age,19 Months,90.3,86.4 to 93.2,361
≥1 Dose Varicella,,States/Local Areas,Maryland,2013-2014,Age,19 Months,90.9,87.7 to 93.3,727
≥1 Dose Varicella,,States/Local Areas,Maryland,2011,Age,19 Months,94.7,92.8 to 96.1,300
≥1 Dose Varicella,,States/Local Areas,Maryland,2019,Age,13 Months,67.8,62.2 to 73.0,614
Hep A,≥2 Doses,States/Local Areas,Maryland,2017,Age,35 Months,80.4,74.3 to 85.9,766
Hep A,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,79.9,75.5 to 83.9,1603
Hep A,≥2 Doses,States/Local Areas,Maryland,2018,Age,35 Months,77.9,72.5 to 82.9,837
Hep A,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,79.9,75.5 to 83.9,1451
Hep B,≥3 Doses,States/Local Areas,Maryland,2014,Age,13 Months,86.1,79.6 to 90.8,366
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,13 Months,87.6,83.2 to 90.9,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2013,Age,13 Months,92.6,88.7 to 95.2,361
Hep B,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,13 Months,89.3,84.9 to 92.6,727
DTaP,≥4 Doses,States/Local Areas,Maryland,2013,Age,35 Months,89.8,84.2 to 94.1,361
DTaP,≥4 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,87.8,83.1 to 91.7,727
Hep B,≥3 Doses,States/Local Areas,Maryland,2012,Age,13 Months,84.4,82.2 to 86.3,328
Hep A,≥2 Doses,States/Local Areas,Maryland,2019,Age,35 Months,81.6,74.6 to 87.6,614
DTaP,≥4 Doses,States/Local Areas,Maryland,2014,Age,35 Months,85.1,77.6 to 91.2,366
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,86.0,80.9 to 90.3,738
DTaP,≥4 Doses,States/Local Areas,Maryland,2015,Age,35 Months,86.5,79.3 to 92.2,372
DTaP,≥4 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,89.1,84.3 to 93.0,836
DTaP,≥4 Doses,States/Local Areas,Maryland,2012,Age,35 Months,89.0,81.7 to 94.4,328
Hep A,≥1 Dose,States/Local Areas,Maryland,2014,Age,35 Months,91.3,86.0 to 95.2,366
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2015,Age,35 Months,90.8,86.7 to 94.0,738
Hep A,≥1 Dose,States/Local Areas,Maryland,2013,Age,35 Months,94.4,89.6 to 97.4,361
Hep A,≥1 Dose,States/Local Areas,Maryland,2013-2014,Age,35 Months,93.1,89.7 to 95.7,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2014,Age,24 Months,43.6,35.8 to 52.3,366
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,39.5,34.0 to 45.5,738
Hep A,≥2 Doses,States/Local Areas,Maryland,2015,Age,24 Months,35.2,28.0 to 43.5,372
Hep A,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,35.0,30.1 to 40.4,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Overall,Overall,94.2,92.1 to 96.4,1626
Hib,Primary Series,States/Local Areas,Maryland,2011,Age,7 Months,81.7,77.1 to 85.6,300
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,90.4,87.2 to 93.6,920
Hib,Primary Series,States/Local Areas,Maryland,2012,Age,7 Months,78.5,71.9 to 83.9,328
DTaP,≥4 Doses,States/Local Areas,Maryland,2013,Age,24 Months,83.2,76.8 to 88.6,361
DTaP,≥4 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,82.5,77.8 to 86.7,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2016,Age,24 Months,34.8,28.6 to 41.8,464
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,35.2,31.2 to 39.6,1230
Hep A,≥2 Doses,States/Local Areas,Maryland,2017,Age,24 Months,35.7,30.8 to 41.1,766
Hep A,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,38.8,35.3 to 42.4,1603
Hep A,≥2 Doses,States/Local Areas,Maryland,2018,Age,24 Months,41.8,37.2 to 46.8,837
Hep A,≥2 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,43.8,40.1 to 47.7,1451
DTaP,≥4 Doses,States/Local Areas,Maryland,2012,Age,24 Months,79.1,71.4 to 85.9,328
DTaP,≥4 Doses,States/Local Areas,Maryland,2011,Age,24 Months,87.2,79.9 to 92.7,300
DTaP,≥4 Doses,States/Local Areas,Maryland,2019,Age,19 Months,76.5,71.3 to 81.0,614
Hep B,≥3 Doses,States/Local Areas,Maryland,2013,Age,7 Months,62.1,55.4 to 68.4,361
Hep B,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,59.8,56.4 to 63.1,727
Hep B,≥3 Doses,States/Local Areas,Maryland,2011,Age,7 Months,45.4,38.9 to 52.0,300
Hep B,≥3 Doses,States/Local Areas,Maryland,2012,Age,7 Months,53.1,49.3 to 56.9,328
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,94.5,90.6 to 98.4,419
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,>400% FPL,97.4,95.1 to 99.6,920
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,89.5,84.2 to 94.8,287
Polio,≥2 Doses,States/Local Areas,Maryland,2014,Age,5 Months,82.4,74.9 to 88.0,366
Polio,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,5 Months,83.9,79.4 to 87.6,738
Polio,≥2 Doses,States/Local Areas,Maryland,2013,Age,5 Months,85.2,81.4 to 88.4,361
Polio,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,5 Months,83.8,80.3 to 86.8,727
Polio,≥2 Doses,States/Local Areas,Maryland,2011,Age,5 Months,84.6,77.7 to 89.7,300
Polio,≥2 Doses,States/Local Areas,Maryland,2012,Age,5 Months,82.7,77.5 to 86.9,328
Hep A,≥1 Dose,States/Local Areas,Maryland,2015,Age,35 Months,90.4,84.0 to 95.1,372
Hep A,≥1 Dose,States/Local Areas,Maryland,2015-2016,Age,35 Months,90.9,86.4 to 94.4,836
DTaP,≥4 Doses,States/Local Areas,Maryland,2014,Age,24 Months,81.8,74.7 to 88.0,366
DTaP,≥4 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,81.0,76.1 to 85.5,738
DTaP,≥4 Doses,States/Local Areas,Maryland,2015,Age,24 Months,80.3,73.2 to 86.5,372
DTaP,≥4 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,82.5,78.0 to 86.6,836
DTaP,≥4 Doses,States/Local Areas,Maryland,2016,Age,24 Months,84.9,79.1 to 89.8,464
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,84.4,80.9 to 87.6,1230
Hep A,≥2 Doses,States/Local Areas,Maryland,2013,Age,35 Months,78.6,69.6 to 86.5,361
Hep A,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,78.8,72.7 to 84.3,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2012,Age,35 Months,80.9,70.7 to 89.4,328
Hep A,≥2 Doses,States/Local Areas,Maryland,2011,Age,35 Months,70.9,61.0 to 80.2,300
Hep A,≥2 Doses,States/Local Areas,Maryland,2019,Age,24 Months,45.8,40.2 to 51.8,614
Hep B,≥3 Doses,States/Local Areas,Maryland,2016,Age,7 Months,53.2,46.2 to 60.1,464
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,7 Months,56.9,52.5 to 61.1,1230
Polio,≥2 Doses,States/Local Areas,Maryland,2015,Age,5 Months,85.4,78.6 to 90.4,372
Polio,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,5 Months,83.0,78.4 to 86.7,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2015,Age,7 Months,54.7,46.6 to 62.5,372
Hep B,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,7 Months,53.9,48.6 to 59.2,836
Hep B,≥3 Doses,States/Local Areas,Maryland,2014,Age,7 Months,57.5,49.4 to 65.2,366
Hep B,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,7 Months,56.1,50.3 to 61.7,738
Polio,≥2 Doses,States/Local Areas,Maryland,2017,Age,5 Months,85.2,80.9 to 88.8,766
Polio,≥2 Doses,States/Local Areas,Maryland,2017-2018,Age,5 Months,85.8,83.0 to 88.1,1603
Polio,≥2 Doses,States/Local Areas,Maryland,2016,Age,5 Months,80.5,73.9 to 85.8,464
Polio,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,5 Months,82.9,78.9 to 86.2,1230
≥1 Dose Varicella,,States/Local Areas,Maryland,2011,Age,13 Months,71.4,64.9 to 77.1,300
Hep A,≥1 Dose,States/Local Areas,Maryland,2018,Age,35 Months,93.1,89.5 to 95.9,837
Hep A,≥1 Dose,States/Local Areas,Maryland,2018-2019,Age,35 Months,92.2,89.5 to 94.5,1451
Hep A,≥1 Dose,States/Local Areas,Maryland,2017,Age,35 Months,95.5,92.7 to 97.5,766
Hep A,≥1 Dose,States/Local Areas,Maryland,2017-2018,Age,35 Months,94.3,92.1 to 96.1,1603
Hep A,≥1 Dose,States/Local Areas,Maryland,2016,Age,35 Months,91.2,84.6 to 95.7,464
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2017,Age,35 Months,93.3,89.8 to 95.9,1230
Hep A,≥2 Doses,States/Local Areas,Maryland,2014,Age,35 Months,79.1,70.6 to 86.4,366
Hep A,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,74.9,68.5 to 80.8,738
Hep B,≥3 Doses,States/Local Areas,Maryland,2019,Age,7 Months,56.3,50.6 to 61.7,614
Polio,≥2 Doses,States/Local Areas,Maryland,2013,Age,7 Months,95.5,91.8 to 97.6,361
Polio,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,7 Months,93.6,90.3 to 95.8,727
Hep A,≥2 Doses,States/Local Areas,Maryland,2015,Age,35 Months,69.5,60.3 to 78.3,372
Hep A,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,74.3,68.2 to 80.0,836
Hep A,≥2 Doses,States/Local Areas,Maryland,2016,Age,35 Months,77.4,69.6 to 84.4,464
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,78.9,74.0 to 83.5,1230
Hep B,≥3 Doses,States/Local Areas,Maryland,2018,Age,7 Months,58.6,53.9 to 63.1,837
Hep B,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,7 Months,57.4,53.7 to 61.0,1451
Hep B,≥3 Doses,States/Local Areas,Maryland,2017,Age,7 Months,60.6,55.5 to 65.4,766
Hep B,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,7 Months,59.6,56.1 to 63.0,1603
Polio,≥2 Doses,States/Local Areas,Maryland,2011,Age,7 Months,94.6,91.9 to 96.4,300
Polio,≥2 Doses,States/Local Areas,Maryland,2012,Age,7 Months,91.1,86.5 to 94.3,328
Hep A,≥1 Dose,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,85.7,78.7 to 92.7,279
Polio,≥2 Doses,States/Local Areas,Maryland,2019,Age,5 Months,84.6,79.8 to 88.4,614
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,75.8,67.1 to 84.5,279
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.8,68.4 to 87.1,236
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.8,83.7 to 91.9,806
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,83.7,77.8 to 89.6,548
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Overall,Overall,80.9,77.5 to 84.2,1626
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Poverty,<133% FPL,69.9,62.1 to 77.7,287
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Poverty,133% to <400% FPL,78.9,72.4 to 85.4,419
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.7,90.9 to 98.4,305
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,97.6,96.0 to 99.1,1180
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,87.8,82.7 to 92.9,399
Polio,≥3 Doses,States/Local Areas,Maryland,2018,Age,35 Months,96.5,94.3 to 98.0,837
Polio,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,35 Months,95.8,94.0 to 97.3,1451
Hib,Full Series,States/Local Areas,Maryland,2017,Age,35 Months,88.5,84.6 to 91.8,766
Hib,Full Series,States/Local Areas,Maryland,2017-2018,Age,35 Months,89.3,86.6 to 91.6,1603
Polio,≥3 Doses,States/Local Areas,Maryland,2019,Age,35 Months,95.2,92.0 to 97.4,614
Hib,Full Series,States/Local Areas,Maryland,2016,Age,35 Months,86.0,80.3 to 90.8,464
Hib,Full Series,States/Local Areas,Maryland,2016-2017,Age,35 Months,87.2,83.8 to 90.2,1230
Hib,Full Series,States/Local Areas,Maryland,2019,Age,35 Months,84.7,79.5 to 89.3,614
Hib,Full Series,States/Local Areas,Maryland,2018,Age,35 Months,90.4,86.6 to 93.5,837
Hib,Full Series,States/Local Areas,Maryland,2018-2019,Age,35 Months,87.5,84.4 to 90.4,1451
Hib,Full Series,States/Local Areas,Maryland,2015,Age,35 Months,88.8,82.3 to 93.7,372
Hib,Full Series,States/Local Areas,Maryland,2015-2016,Age,35 Months,87.3,83.1 to 90.9,836
Hib,Full Series,States/Local Areas,Maryland,2014,Age,35 Months,81.5,73.8 to 88.1,366
Hib,Full Series,States/Local Areas,Maryland,2014-2015,Age,35 Months,85.2,80.2 to 89.5,738
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Any Medicaid,72.2,65.5 to 78.9,399
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.1,69.2 to 83.1,305
Hib,Full Series,States/Local Areas,Maryland,2014-2017,Insurance Coverage,Private Insurance Only,88.4,85.4 to 91.5,1180
Polio,≥3 Doses,States/Local Areas,Maryland,2012,Age,35 Months,92.6,86.9 to 96.4,328
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.3,90.4 to 96.2,1053
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,Hispanic,86.6,79.2 to 94.0,279
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.4,93.5 to 99.3,236
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.5,92.3 to 98.7,806
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2017,Urbanicity,Living In a MSA Principal City,95.3,92.1 to 98.6,548
DTaP,≥2 Doses,States/Local Areas,Maryland,2015,Age,5 Months,86.2,79.4 to 91.0,372
DTaP,≥2 Doses,States/Local Areas,Maryland,2015-2016,Age,5 Months,83.5,79.0 to 87.2,836
DTaP,≥2 Doses,States/Local Areas,Maryland,2016,Age,5 Months,80.8,74.2 to 85.9,464
DTaP,≥2 Doses,States/Local Areas,Maryland,2016-2017,Age,5 Months,82.9,79.0 to 86.2,1230
Polio,≥3 Doses,States/Local Areas,Maryland,2016,Age,35 Months,94.2,90.1 to 97.0,464
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,35 Months,94.6,92.3 to 96.5,1230
Polio,≥3 Doses,States/Local Areas,Maryland,2017,Age,35 Months,95.2,92.3 to 97.2,766
Polio,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,35 Months,95.8,94.1 to 97.1,1603
DTaP,≥2 Doses,States/Local Areas,Maryland,2014,Age,5 Months,82.6,75.1 to 88.2,366
DTaP,≥2 Doses,States/Local Areas,Maryland,2014-2015,Age,5 Months,84.4,80.4 to 87.7,738
Polio,≥3 Doses,States/Local Areas,Maryland,2015,Age,35 Months,96.4,91.5 to 98.8,372
Polio,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,35 Months,95.3,92.4 to 97.3,836
Hib,Full Series,States/Local Areas,Maryland,2012,Age,35 Months,86.9,79.5 to 92.7,328
Hib,Full Series,States/Local Areas,Maryland,2011,Age,35 Months,91.7,85.8 to 95.8,300
Hib,Full Series,States/Local Areas,Maryland,2013,Age,35 Months,86.1,80.0 to 91.1,361
Hib,Full Series,States/Local Areas,Maryland,2013-2014,Age,35 Months,83.8,79.0 to 88.1,727
Polio,≥3 Doses,States/Local Areas,Maryland,2013,Age,35 Months,97.2,93.7 to 99.0,361
Polio,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,35 Months,94.4,91.1 to 96.9,727
Polio,≥3 Doses,States/Local Areas,Maryland,2014,Age,35 Months,91.6,86.1 to 95.5,366
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,35 Months,94.0,90.5 to 96.5,738
Hib,Full Series,States/Local Areas,Maryland,2019,Age,24 Months,79.3,74.3 to 83.8,614
DTaP,≥2 Doses,States/Local Areas,Maryland,2011,Age,5 Months,84.6,77.7 to 89.7,300
DTaP,≥2 Doses,States/Local Areas,Maryland,2012,Age,5 Months,83.7,78.8 to 87.6,328
DTaP,≥2 Doses,States/Local Areas,Maryland,2013,Age,5 Months,84.6,81.2 to 87.5,361
DTaP,≥2 Doses,States/Local Areas,Maryland,2013-2014,Age,5 Months,83.6,80.4 to 86.4,727
Hib,≥3 Doses,States/Local Areas,Maryland,2014,Age,24 Months,89.9,84.2 to 94.2,366
Hib,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,92.8,89.3 to 95.5,738
Hib,≥3 Doses,States/Local Areas,Maryland,2011,Age,24 Months,97.7,95.2 to 99.1,300
Hib,≥3 Doses,States/Local Areas,Maryland,2012,Age,24 Months,92.3,86.7 to 96.2,328
Hib,≥3 Doses,States/Local Areas,Maryland,2013,Age,24 Months,95.6,92.1 to 97.9,361
Hib,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,92.8,89.5 to 95.3,727
Hib,Full Series,States/Local Areas,Maryland,2017,Age,24 Months,84.7,80.7 to 88.3,766
Hib,Full Series,States/Local Areas,Maryland,2017-2018,Age,24 Months,84.8,82.1 to 87.3,1603
Hib,Full Series,States/Local Areas,Maryland,2018,Age,24 Months,84.9,81.2 to 88.3,837
Hib,Full Series,States/Local Areas,Maryland,2018-2019,Age,24 Months,82.1,79.0 to 85.0,1451
Hib,Full Series,States/Local Areas,Maryland,2016,Age,24 Months,83.4,77.5 to 88.4,464
Hib,Full Series,States/Local Areas,Maryland,2016-2017,Age,24 Months,84.0,80.5 to 87.2,1230
Polio,≥3 Doses,States/Local Areas,Maryland,2017,Age,24 Months,94.7,91.8 to 96.8,766
Polio,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,24 Months,95.2,93.5 to 96.6,1603
DTaP,≥3 Doses,States/Local Areas,Maryland,2016,Age,19 Months,92.8,88.0 to 95.8,464
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,94.0,91.3 to 95.9,1230
DTaP,≥3 Doses,States/Local Areas,Maryland,2011,Age,24 Months,98.3,96.0 to 99.4,300
DTaP,≥3 Doses,States/Local Areas,Maryland,2012,Age,24 Months,92.3,86.7 to 96.2,328
Hib,≥3 Doses,States/Local Areas,Maryland,2019,Age,19 Months,89.6,85.5 to 92.6,614
Polio,≥3 Doses,States/Local Areas,Maryland,2019,Age,24 Months,94.7,91.5 to 97.0,614
Polio,≥3 Doses,States/Local Areas,Maryland,2018,Age,24 Months,95.8,93.6 to 97.4,837
Polio,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,24 Months,95.3,93.4 to 96.8,1451
Hib,Full Series,States/Local Areas,Maryland,2015,Age,24 Months,83.4,76.8 to 89.0,372
Hib,Full Series,States/Local Areas,Maryland,2015-2016,Age,24 Months,83.4,79.1 to 87.2,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2013,Age,24 Months,97.5,95.6 to 98.7,361
DTaP,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,95.4,92.7 to 97.3,727
DTaP,≥3 Doses,States/Local Areas,Maryland,2018,Age,19 Months,95.9,93.5 to 97.4,837
DTaP,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,93.0,90.7 to 94.8,1451
DTaP,≥3 Doses,States/Local Areas,Maryland,2019,Age,19 Months,94.5,91.0 to 96.7,614
Polio,≥3 Doses,States/Local Areas,Maryland,2014,Age,24 Months,91.6,86.1 to 95.5,366
Polio,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,24 Months,93.9,90.4 to 96.4,738
Polio,≥3 Doses,States/Local Areas,Maryland,2015,Age,24 Months,96.2,91.4 to 98.7,372
Polio,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,24 Months,95.0,92.2 to 97.1,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2017,Age,19 Months,95.2,92.2 to 97.1,766
DTaP,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,95.5,93.7 to 96.8,1603
Hib,≥3 Doses,States/Local Areas,Maryland,2018,Age,19 Months,93.5,90.9 to 95.5,837
Hib,≥3 Doses,States/Local Areas,Maryland,2018-2019,Age,19 Months,79.8,76.7 to 82.6,1451
Hib,≥3 Doses,States/Local Areas,Maryland,2016,Age,19 Months,91.6,86.6 to 94.8,464
Hib,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,19 Months,92.7,90.0 to 94.7,1230
Polio,≥3 Doses,States/Local Areas,Maryland,2016,Age,24 Months,93.8,89.7 to 96.7,464
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2017,Age,24 Months,94.2,91.8 to 96.1,1230
Hib,≥3 Doses,States/Local Areas,Maryland,2017,Age,19 Months,93.8,90.9 to 95.9,766
Hib,≥3 Doses,States/Local Areas,Maryland,2017-2018,Age,19 Months,93.7,91.8 to 95.2,1603
DTaP,≥3 Doses,States/Local Areas,Maryland,2015,Age,19 Months,95.5,89.9 to 98.1,372
DTaP,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,94.2,90.9 to 96.3,836
DTaP,≥3 Doses,States/Local Areas,Maryland,2014,Age,19 Months,93.2,87.6 to 96.3,366
DTaP,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,94.3,90.8 to 96.5,738
Hib,≥3 Doses,States/Local Areas,Maryland,2015,Age,19 Months,94.1,87.0 to 97.4,372
Hib,≥3 Doses,States/Local Areas,Maryland,2015-2016,Age,19 Months,92.8,89.3 to 95.2,836
Polio,≥3 Doses,States/Local Areas,Maryland,2013,Age,24 Months,96.1,92.5 to 98.2,361
Polio,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,24 Months,93.8,90.7 to 96.2,727
Hib,≥3 Doses,States/Local Areas,Maryland,2013,Age,19 Months,94.3,91.4 to 96.2,361
Hib,≥3 Doses,States/Local Areas,Maryland,2013-2014,Age,19 Months,92.0,88.8 to 94.4,727
Hib,≥3 Doses,States/Local Areas,Maryland,2014,Age,19 Months,89.8,83.6 to 93.8,366
Hib,≥3 Doses,States/Local Areas,Maryland,2014-2015,Age,19 Months,91.9,88.0 to 94.6,738
Polio,≥3 Doses,States/Local Areas,Maryland,2012,Age,24 Months,92.2,86.6 to 96.1,328
Polio,≥3 Doses,States/Local Areas,Maryland,2011,Age,24 Months,98.3,96.0 to 99.4,300
Polio,≥3 Doses,States/Local Areas,Maryland,2019,Age,19 Months,93.1,89.4 to 95.5,614
Polio,≥3 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,94.9,93.5 to 96.1,1537
Polio,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,95.2,93.9 to 96.2,3101
Polio,≥3 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,94.8,91.2 to 97.0,1509
Polio,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,94.8,93.2 to 96.1,2930
Polio,≥3 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,94.1,91.3 to 96.0,1457
Polio,≥3 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,94.9,92.2 to 96.7,1584
Polio,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,95.7,94.1 to 96.8,3342
Polio,≥3 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,94.8,92.1 to 96.6,1421
Polio,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,94.9,92.9 to 96.3,3005
Hib,≥3 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,84.7,82.0 to 87.0,1758
Hib,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,84.6,82.8 to 86.2,3433
Hib,≥3 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,95.5,93.6 to 96.9,1422
Hib,≥3 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,93.7,90.5 to 95.8,1457
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,95.1,92.7 to 96.9,1536
Hib,≥3 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,84.5,81.9 to 86.8,1675
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,95.6,93.3 to 97.1,1758
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,95.2,93.8 to 96.3,3433
DTaP,≥3 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,96.3,94.7 to 97.5,1457
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,96.4,95.7 to 97.1,1537
DTaP,≥3 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,97.6,96.9 to 98.1,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,94.8,92.8 to 96.3,1675
Polio,≥3 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,95.4,93.7 to 96.7,1564
Polio,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,95.1,93.8 to 96.2,3073
Hib,≥3 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,85.1,82.2 to 87.6,1584
Hib,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,84.9,82.9 to 86.6,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,82.6,78.9 to 85.8,1421
Hib,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,83.9,81.5 to 86.0,3005
Hib,≥3 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,84.2,81.3 to 86.8,1509
Hib,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,83.4,81.1 to 85.5,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,94.7,92.6 to 96.2,1509
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,93.9,92.1 to 95.3,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,93.9,91.1 to 95.9,1584
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,94.8,93.0 to 96.1,3342
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,93.1,90.0 to 95.3,1421
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,93.5,91.4 to 95.2,3005
Hib,≥3 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,85.3,78.5 to 90.2,1457
Hib,≥3 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,89.2,82.0 to 93.8,1422
Hib,≥3 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,84.9,82.2 to 87.2,1564
Hib,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,84.6,82.6 to 86.3,3073
Polio,≥3 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,95.0,92.6 to 96.7,1422
Hib,≥3 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,86.6,80.2 to 91.1,1537
Hib,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,85.7,79.3 to 90.4,3101
Hib,≥2 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,96.1,93.6 to 97.7,1584
Hib,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,97.0,95.7 to 97.9,3342
Hib,≥2 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,97.8,96.7 to 98.6,1758
Hib,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,97.1,96.1 to 97.9,3433
Hib,≥2 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,96.3,94.5 to 97.6,1675
Hib,≥2 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,96.5,95.0 to 97.6,1422
Hib,≥2 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,95.7,92.9 to 97.4,1457
Hib,≥2 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,95.0,92.8 to 96.5,1675
DTaP,≥3 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,93.0,88.6 to 95.7,1457
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,94.9,92.7 to 96.4,1564
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,94.8,93.3 to 95.9,3073
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,95.2,94.1 to 96.1,1537
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,95.0,93.9 to 96.0,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,69.3,65.3 to 73.1,1675
PCV,≥1 Dose,HHS Regions/National,Region 1,2011,Age,3 Months,91.7,89.5 to 93.4,1422
PCV,≥4 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,90.5,87.2 to 93.3,1584
PCV,≥4 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,91.3,89.0 to 93.2,3342
Hib,≥2 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,95.2,93.2 to 96.6,1564
Hib,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,94.7,93.3 to 95.9,3073
Hib,≥2 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,93.1,90.7 to 94.9,1537
Hib,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,94.1,92.0 to 95.7,3101
PCV,≥1 Dose,HHS Regions/National,Region 1,2012,Age,3 Months,90.0,86.6 to 92.7,1457
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2011,Age,0-3 Days,75.9,71.7 to 79.6,1422
PCV,≥1 Dose,HHS Regions/National,Region 1,2018,Age,3 Months,91.9,88.7 to 94.2,1758
PCV,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,3 Months,92.8,90.9 to 94.4,3433
PCV,≥1 Dose,HHS Regions/National,Region 1,2017,Age,3 Months,90.3,86.4 to 93.2,1584
PCV,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,3 Months,91.1,88.6 to 93.0,3342
PCV,≥1 Dose,HHS Regions/National,Region 1,2016,Age,3 Months,92.7,89.7 to 94.8,1421
PCV,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,3 Months,91.5,88.8 to 93.6,3005
Hib,≥2 Doses,HHS Regions/National,Region 1,2018,Age,5 Months,86.9,83.5 to 89.7,1758
Hib,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,5 Months,87.4,85.1 to 89.4,3433
Hib,≥2 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,94.3,91.8 to 96.1,1422
Hib,≥2 Doses,HHS Regions/National,Region 1,2019,Age,5 Months,87.9,84.6 to 90.5,1675
Hib,≥2 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,93.2,88.7 to 95.9,1457
PCV,≥3 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,94.3,91.6 to 96.3,1421
PCV,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,94.6,92.6 to 96.1,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,94.9,92.3 to 96.8,1584
PCV,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,95.2,93.4 to 96.6,3342
PCV,≥1 Dose,HHS Regions/National,Region 1,2015,Age,3 Months,91.5,88.9 to 93.6,1509
PCV,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,3 Months,92.1,90.2 to 93.7,2930
PCV,≥1 Dose,HHS Regions/National,Region 1,2014,Age,3 Months,89.1,85.9 to 91.7,1564
PCV,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,3 Months,90.3,88.3 to 92.0,3073
DTaP,≥3 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,81.6,78.5 to 84.3,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,75.0,69.2 to 80.0,1457
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,77.5,74.0 to 80.7,1537
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,77.9,74.9 to 80.7,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020,Age,24 Months,94.9,92.4 to 96.8,1536
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017,Age,35 Months,96.2,93.7 to 98.0,1584
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017-2018,Age,35 Months,96.4,94.8 to 97.6,3342
PCV,≥4 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,90.2,87.3 to 92.6,1537
PCV,≥4 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,90.6,88.6 to 92.3,3101
PCV,≥4 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,93.4,90.3 to 95.7,1675
Hib,≥2 Doses,HHS Regions/National,Region 1,2016,Age,5 Months,86.2,82.3 to 89.4,1421
Hib,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,5 Months,85.0,81.9 to 87.6,3005
Hib,≥2 Doses,HHS Regions/National,Region 1,2015,Age,5 Months,88.5,85.5 to 90.9,1509
Hib,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,5 Months,87.4,85.0 to 89.4,2930
Hib,≥1 Dose,HHS Regions/National,Region 1,2018,Age,3 Months,92.6,89.7 to 94.8,1758
Hib,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,3 Months,93.2,91.3 to 94.6,3433
PCV,≥4 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,92.0,88.9 to 94.6,1758
PCV,≥4 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,92.9,90.7 to 94.7,3433
PCV,≥4 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,90.3,86.9 to 93.1,1421
PCV,≥4 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,90.5,88.1 to 92.7,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,94.7,92.0 to 96.5,1584
PCV,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,95.0,93.1 to 96.3,3342
Hib,≥2 Doses,HHS Regions/National,Region 1,2014,Age,5 Months,87.3,84.4 to 89.7,1564
Hib,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,5 Months,87.9,84.8 to 90.4,3073
Hib,≥2 Doses,HHS Regions/National,Region 1,2013,Age,5 Months,83.7,81.0 to 86.1,1537
Hib,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,5 Months,85.5,82.7 to 87.9,3101
Hib,≥2 Doses,HHS Regions/National,Region 1,2011,Age,5 Months,86.9,82.4 to 90.3,1422
Hib,≥2 Doses,HHS Regions/National,Region 1,2012,Age,5 Months,83.8,79.2 to 87.6,1457
Hep B,≥2 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,96.2,94.0 to 97.6,1675
PCV,≥3 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,95.2,92.4 to 97.1,1758
PCV,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,93.4,91.5 to 94.9,3433
PCV,≥3 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,95.7,93.3 to 97.4,1422
PCV,≥3 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,95.9,94.1 to 97.2,1675
PCV,≥3 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,95.5,92.8 to 97.3,1758
PCV,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,95.9,94.4 to 97.1,3433
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2016,Age,0-3 Days,78.8,74.5 to 82.5,1421
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2016-2017,Age,0-3 Days,81.0,78.2 to 83.5,3005
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2017,Age,0-3 Days,82.2,76.7 to 86.7,937
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2017-2018,Age,0-3 Days,82.2,79.7 to 84.4,3342
Polio,≥1 Dose,HHS Regions/National,Region 1,2016,Age,3 Months,93.3,90.4 to 95.4,1421
Polio,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,3 Months,92.4,89.7 to 94.5,3005
Polio,≥1 Dose,HHS Regions/National,Region 1,2015,Age,3 Months,92.5,89.9 to 94.5,1509
Polio,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,3 Months,92.9,91.0 to 94.4,2930
Polio,≥1 Dose,HHS Regions/National,Region 1,2014,Age,3 Months,91.0,87.8 to 93.4,1564
Polio,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,3 Months,91.7,89.8 to 93.3,3073
Hib,≥3 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,67.7,61.1 to 73.7,1537
Hib,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,67.7,61.7 to 73.2,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,74.2,67.9 to 79.5,1422
Hib,≥3 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,65.9,58.7 to 72.5,1457
PCV,≥3 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,94.5,91.8 to 96.5,1421
PCV,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,94.9,93.0 to 96.4,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,95.8,93.9 to 97.3,1509
PCV,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,95.1,93.5 to 96.4,2930
PCV,≥3 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,96.8,95.5 to 97.9,1564
PCV,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,96.4,95.2 to 97.3,3073
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2014,Age,0-3 Days,72.3,68.1 to 76.0,1564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2014-2015,Age,0-3 Days,72.5,69.5 to 75.3,3073
Polio,≥1 Dose,HHS Regions/National,Region 1,2013,Age,3 Months,92.2,90.2 to 93.8,1537
Polio,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,3 Months,91.6,90.4 to 92.6,3101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2013,Age,0-3 Days,74.2,70.3 to 77.8,1537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2013-2014,Age,0-3 Days,73.2,70.4 to 75.9,3101
Polio,≥1 Dose,HHS Regions/National,Region 1,2011,Age,3 Months,93.8,91.2 to 95.7,1422
Polio,≥1 Dose,HHS Regions/National,Region 1,2012,Age,3 Months,92.0,88.7 to 94.3,1457
PCV,≥1 Dose,HHS Regions/National,Region 1,2019,Age,3 Months,93.9,91.4 to 95.6,1675
PCV,≥3 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,95.0,92.5 to 96.9,1457
PCV,≥3 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,97.1,95.3 to 98.3,1537
PCV,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,96.9,95.9 to 97.8,3101
PCV,≥3 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,95.9,93.5 to 97.6,1422
PCV,≥3 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,96.4,94.7 to 97.7,1675
Hib,≥2 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,94.3,92.0 to 96.0,1509
Hib,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,93.8,92.1 to 95.2,2930
Hib,≥2 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,95.9,94.1 to 97.2,1758
Hib,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,95.4,94.1 to 96.5,3433
Hib,≥2 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,92.9,89.0 to 95.5,1584
Hib,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,94.4,92.3 to 95.9,3342
Hib,≥2 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,93.3,90.5 to 95.4,1421
Hib,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,93.1,90.5 to 95.1,3005
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,81.3,76.9 to 85.0,1421
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,80.2,76.9 to 83.1,3005
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2015,Age,0-3 Days,72.8,68.4 to 76.7,1509
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2015-2016,Age,0-3 Days,75.8,72.7 to 78.6,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,78.4,74.4 to 81.9,1564
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,80.0,77.3 to 82.4,3073
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,81.5,77.8 to 84.8,1509
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,81.4,78.6 to 83.9,2930
PCV,≥3 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,95.4,92.9 to 97.2,1584
PCV,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,95.9,94.2 to 97.2,3342
Hib,≥2 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,97.2,96.1 to 98.1,1537
Hib,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,97.5,96.5 to 98.3,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,67.7,63.6 to 71.5,1564
Hib,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,69.2,66.4 to 71.9,3073
PCV,≥3 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,96.5,94.1 to 98.1,1758
PCV,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.5,95.0 to 97.6,3433
Hib,≥3 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,67.3,62.4 to 71.9,1421
Hib,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,68.2,64.9 to 71.4,3005
Hib,≥3 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,70.8,66.9 to 74.5,1509
Hib,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,69.1,65.9 to 72.1,2930
Polio,≥1 Dose,HHS Regions/National,Region 1,2017,Age,3 Months,91.5,87.6 to 94.3,1584
Polio,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,3 Months,92.9,90.8 to 94.6,3342
Polio,≥1 Dose,HHS Regions/National,Region 1,2018,Age,3 Months,94.3,92.2 to 95.9,1758
Polio,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,3 Months,94.5,93.1 to 95.6,3433
Hib,≥3 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,69.1,64.8 to 73.2,1584
Hib,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,69.6,66.6 to 72.4,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,70.0,66.0 to 73.8,1758
Hib,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,69.7,66.8 to 72.4,3433
PCV,≥3 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,96.5,94.9 to 97.8,1675
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2018,Age,0-3 Days,81.2,77.6 to 84.4,1758
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2018-2019,Age,0-3 Days,83.8,81.5 to 85.9,3433
Polio,≥1 Dose,HHS Regions/National,Region 1,2019,Age,3 Months,94.6,92.7 to 96.1,1675
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2019,Age,0-3 Days,86.5,83.5 to 89.0,1675
Hib,≥2 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,97.8,96.6 to 98.6,1564
Hib,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,97.0,95.9 to 97.8,3073
Hib,≥2 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,95.8,93.3 to 97.4,1421
Hib,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,96.0,94.1 to 97.3,3005
Hib,≥2 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,96.2,94.2 to 97.5,1509
Hib,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,96.0,94.5 to 97.1,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,83.2,79.5 to 86.4,1758
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,82.3,79.8 to 84.7,3433
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,79.1,74.6 to 82.9,1584
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,81.1,78.3 to 83.7,3342
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,81.5,77.7 to 84.7,1675
DTaP,≥3 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,95.7,93.1 to 97.4,1422
Polio,≥3 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,96.0,94.1 to 97.5,1675
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2012,Age,0-3 Days,73.5,69.4 to 77.3,1457
Hib,≥2 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,95.0,92.3 to 96.8,1536
Hep A,≥1 Dose,HHS Regions/National,Region 1,2016,Age,35 Months,93.1,89.8 to 95.7,1421
Hep A,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,35 Months,94.4,92.0 to 96.2,3005
DTaP,≥4 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,86.9,83.5 to 90.0,1509
DTaP,≥4 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,86.6,84.0 to 88.9,2930
DTaP,≥4 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,86.2,82.4 to 89.5,1421
DTaP,≥4 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,86.5,83.9 to 88.9,3005
DTaP,≥4 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,88.5,85.5 to 91.1,1564
DTaP,≥4 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,87.7,85.5 to 89.8,3073
Hep A,≥1 Dose,HHS Regions/National,Region 1,2014,Age,35 Months,92.5,89.4 to 95.0,1564
Hep A,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,35 Months,93.0,91.0 to 94.7,3073
Hep A,≥1 Dose,HHS Regions/National,Region 1,2013,Age,35 Months,89.1,86.2 to 91.7,1537
Hep A,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,35 Months,90.9,88.7 to 92.7,3101
Hep A,≥2 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,43.3,39.0 to 48.0,1457
Hib,≥3 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,96.2,94.5 to 97.5,1675
PCV,≥2 Doses,HHS Regions/National,Region 1,2018,Age,5 Months,85.4,81.7 to 88.4,1758
PCV,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,5 Months,86.7,84.3 to 88.8,3433
PCV,≥2 Doses,HHS Regions/National,Region 1,2017,Age,5 Months,83.5,79.3 to 87.0,1584
PCV,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,5 Months,84.4,81.7 to 86.8,3342
PCV,≥2 Doses,HHS Regions/National,Region 1,2019,Age,5 Months,88.0,84.8 to 90.7,1675
DTaP,≥4 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,77.9,73.8 to 81.6,1584
DTaP,≥4 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,78.7,75.9 to 81.2,3342
DTaP,≥4 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,76.1,71.3 to 80.3,1421
DTaP,≥4 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,77.0,73.9 to 79.9,3005
Hep A,≥2 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,47.7,43.4 to 52.2,1537
Hep A,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,47.0,43.9 to 50.2,3101
DTaP,≥4 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,79.4,75.7 to 82.7,1758
DTaP,≥4 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,97.2,96.2 to 98.0,3433
Polio,≥2 Doses,HHS Regions/National,Region 1,2014,Age,5 Months,86.8,83.6 to 89.5,1564
Polio,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,5 Months,88.0,85.2 to 90.3,3073
Polio,≥2 Doses,HHS Regions/National,Region 1,2013,Age,5 Months,83.7,80.1 to 86.7,1537
Polio,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,5 Months,85.2,82.7 to 87.5,3101
Hep A,≥1 Dose,HHS Regions/National,Region 1,2012,Age,35 Months,90.6,87.5 to 93.2,1457
Polio,≥2 Doses,HHS Regions/National,Region 1,2011,Age,5 Months,87.0,82.5 to 90.5,1422
Polio,≥2 Doses,HHS Regions/National,Region 1,2012,Age,5 Months,83.8,79.0 to 87.6,1457
Hep A,≥1 Dose,HHS Regions/National,Region 1,2015,Age,35 Months,93.0,90.5 to 95.0,1509
Hep A,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,35 Months,93.3,91.1 to 95.1,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,47.5,41.7 to 53.4,1422
Hep B,≥3 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,58.4,50.8 to 65.6,1457
DTaP,≥4 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,87.0,83.5 to 90.1,1457
DTaP,≥4 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,90.4,87.2 to 93.0,1422
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,67.9,63.7 to 71.9,1537
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,65.0,60.2 to 69.4,3101
DTaP,≥4 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,77.4,73.4 to 81.0,1675
DTaP,≥4 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,87.4,84.0 to 90.3,1537
DTaP,≥4 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,87.9,85.7 to 89.9,3101
Hep A,≥2 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,52.3,46.9 to 57.9,1421
Hep A,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,52.1,48.6 to 55.7,3005
Hep A,≥2 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,51.8,47.2 to 56.7,1584
Hep A,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,52.2,48.9 to 55.5,3342
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,66.4,62.1 to 70.4,1509
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,66.9,63.4 to 70.2,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,61.9,57.4 to 66.2,1564
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,64.1,61.0 to 67.1,3073
Polio,≥2 Doses,HHS Regions/National,Region 1,2017,Age,5 Months,84.2,79.9 to 87.7,1584
Polio,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,5 Months,86.6,84.0 to 88.8,3342
Polio,≥2 Doses,HHS Regions/National,Region 1,2016,Age,5 Months,87.4,83.5 to 90.4,1421
Polio,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,5 Months,85.8,82.8 to 88.4,3005
Hep A,≥1 Dose,HHS Regions/National,Region 1,2017,Age,35 Months,95.7,92.2 to 97.9,1584
Hep A,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,35 Months,95.5,93.3 to 97.2,3342
Hep A,≥2 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,78.1,73.0 to 82.7,1537
Hep A,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,76.6,73.2 to 79.8,3101
Hep A,≥2 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,80.3,75.5 to 84.8,1457
Hep A,≥2 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,75.3,69.4 to 80.9,1422
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,67.4,61.7 to 72.6,1421
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,65.3,61.5 to 68.8,3005
Polio,≥2 Doses,HHS Regions/National,Region 1,2015,Age,5 Months,89.1,86.1 to 91.4,1509
Polio,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,5 Months,88.2,85.9 to 90.2,2930
Hep A,≥2 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,49.6,45.0 to 54.5,1675
Hep A,≥2 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,52.5,48.1 to 57.1,1758
Hep A,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,51.1,47.8 to 54.4,3433
Polio,≥2 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,93.7,90.6 to 95.8,1422
Polio,≥2 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,92.8,89.5 to 95.2,1457
Polio,≥2 Doses,HHS Regions/National,Region 1,2019,Age,5 Months,87.8,84.6 to 90.5,1675
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,63.1,58.3 to 67.6,1584
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,63.9,60.7 to 67.0,3342
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,64.8,60.5 to 68.9,1758
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,65.6,62.6 to 68.6,3433
Hep A,≥2 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,84.0,78.9 to 88.4,1509
Hep A,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,82.9,79.3 to 86.2,2930
Hep A,≥2 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,82.1,76.8 to 86.8,1421
Hep A,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,83.9,80.4 to 87.1,3005
Hep A,≥2 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,75.0,70.4 to 79.4,1564
Hep A,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,79.2,75.8 to 82.4,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,66.5,62.2 to 70.5,1675
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014,Age,13 Months,52.1,47.7 to 56.5,1564
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014-2015,Age,13 Months,54.4,51.2 to 57.5,3073
≥1 Dose Varicella,,HHS Regions/National,Region 1,2012,Age,13 Months,55.9,52.4 to 59.4,1457
Hep A,≥1 Dose,HHS Regions/National,Region 1,2018,Age,35 Months,95.2,93.0 to 96.9,1758
Hep A,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,35 Months,95.7,94.2 to 96.9,3433
Hep A,≥1 Dose,HHS Regions/National,Region 1,2019,Age,35 Months,96.4,94.0 to 98.0,1675
Polio,≥2 Doses,HHS Regions/National,Region 1,2018,Age,5 Months,89.0,86.1 to 91.3,1758
Polio,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,5 Months,88.4,86.3 to 90.2,3433
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013,Age,13 Months,53.3,50.4 to 56.1,1537
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013-2014,Age,13 Months,52.7,50.4 to 55.0,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2011,Age,13 Months,53.9,49.4 to 58.4,1422
Hib,Full Series,HHS Regions/National,Region 1,2019,Age,35 Months,91.8,88.4 to 94.5,1675
Hib,Full Series,HHS Regions/National,Region 1,2018,Age,35 Months,92.9,90.5 to 94.8,1758
Hib,Full Series,HHS Regions/National,Region 1,2018-2019,Age,35 Months,92.4,90.3 to 94.1,3433
Polio,≥3 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,97.1,95.2 to 98.4,1758
Polio,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.6,95.3 to 97.6,3433
Hib,Primary Series,HHS Regions/National,Region 1,2011,Age,7 Months,81.3,78.5 to 83.9,1422
Hib,Primary Series,HHS Regions/National,Region 1,2012,Age,7 Months,74.0,69.3 to 78.2,1457
Hib,Full Series,HHS Regions/National,Region 1,2016,Age,35 Months,89.1,85.5 to 92.2,1421
Hib,Full Series,HHS Regions/National,Region 1,2016-2017,Age,35 Months,89.6,87.0 to 92.0,3005
Hib,Full Series,HHS Regions/National,Region 1,2014,Age,35 Months,91.7,89.1 to 93.9,1564
Hib,Full Series,HHS Regions/National,Region 1,2014-2015,Age,35 Months,91.1,89.3 to 92.8,3073
Hib,≥3 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,96.5,94.8 to 97.7,1564
Hib,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,95.7,94.4 to 96.8,3073
Polio,≥3 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,96.4,94.3 to 97.9,1457
Hib,Full Series,HHS Regions/National,Region 1,2019,Age,24 Months,86.1,82.4 to 89.3,1675
Polio,≥3 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,97.0,95.3 to 98.2,1537
Polio,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,97.1,96.1 to 97.9,3101
Polio,≥3 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,97.3,95.9 to 98.3,1564
Polio,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,96.7,95.5 to 97.6,3073
Hib,Full Series,HHS Regions/National,Region 1,2017,Age,35 Months,90.7,86.4 to 94.1,1584
Hib,Full Series,HHS Regions/National,Region 1,2017-2018,Age,35 Months,91.6,89.4 to 93.5,3342
Hib,Full Series,HHS Regions/National,Region 1,2015,Age,35 Months,90.3,87.6 to 92.6,1509
Hib,Full Series,HHS Regions/National,Region 1,2015-2016,Age,35 Months,89.8,87.5 to 91.8,2930
Hib,Full Series,HHS Regions/National,Region 1,2013,Age,35 Months,89.7,85.4 to 93.2,1537
Hib,Full Series,HHS Regions/National,Region 1,2013-2014,Age,35 Months,90.7,88.3 to 92.8,3101
Hib,Full Series,HHS Regions/National,Region 1,2012,Age,35 Months,89.6,86.4 to 92.4,1457
Hib,Full Series,HHS Regions/National,Region 1,2011,Age,35 Months,89.5,85.7 to 92.7,1422
Hib,Full Series,HHS Regions/National,Region 1,2018,Age,24 Months,90.7,88.0 to 92.9,1758
Hib,Full Series,HHS Regions/National,Region 1,2018-2019,Age,24 Months,88.4,86.2 to 90.4,3433
DTaP,≥2 Doses,HHS Regions/National,Region 1,2011,Age,5 Months,88.2,83.7 to 91.6,1422
DTaP,≥2 Doses,HHS Regions/National,Region 1,2012,Age,5 Months,85.3,80.1 to 89.3,1457
DTaP,≥2 Doses,HHS Regions/National,Region 1,2013,Age,5 Months,86.2,82.6 to 89.1,1537
DTaP,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,5 Months,87.6,84.6 to 90.1,3101
Polio,≥3 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,96.0,93.9 to 97.5,1509
Polio,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,95.6,94.1 to 96.9,2930
DTaP,≥2 Doses,HHS Regions/National,Region 1,2015,Age,5 Months,89.7,86.8 to 92.0,1509
DTaP,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,5 Months,88.4,86.0 to 90.4,2930
Polio,≥3 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,95.5,93.0 to 97.3,1421
Polio,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,95.9,94.1 to 97.3,3005
Polio,≥3 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,96.5,94.2 to 98.1,1584
Polio,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,96.8,95.4 to 97.9,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,96.8,95.1 to 98.0,1422
Hib,≥3 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,94.8,92.4 to 96.6,1457
Hib,≥3 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,95.8,93.8 to 97.3,1537
Hib,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,96.1,94.9 to 97.1,3101
DTaP,≥2 Doses,HHS Regions/National,Region 1,2014,Age,5 Months,89.1,86.3 to 91.4,1564
DTaP,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,5 Months,89.4,86.3 to 91.9,3073
Hib,Full Series,HHS Regions/National,Region 1,2016,Age,24 Months,87.3,83.8 to 90.4,1421
Hib,Full Series,HHS Regions/National,Region 1,2016-2017,Age,24 Months,86.9,84.4 to 89.2,3005
Hib,Full Series,HHS Regions/National,Region 1,2017,Age,24 Months,86.5,83.0 to 89.7,1584
Hib,Full Series,HHS Regions/National,Region 1,2017-2018,Age,24 Months,88.6,86.4 to 90.6,3342
Polio,≥3 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,96.5,93.9 to 98.2,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,97.0,94.9 to 98.3,1457
Polio,≥3 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,95.5,93.0 to 97.3,1584
Polio,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,96.1,94.6 to 97.3,3342
Polio,≥3 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,96.7,94.8 to 98.0,1758
Polio,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,96.2,94.9 to 97.3,3433
Polio,≥3 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,95.7,93.8 to 97.2,1675
Hib,≥3 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,95.5,93.7 to 96.8,1675
DTaP,≥3 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,97.9,96.2 to 98.9,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,96.1,94.3 to 97.4,1675
Hib,≥3 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,95.3,93.5 to 96.7,1758
Hib,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,84.6,82.8 to 86.2,3433
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,96.8,94.8 to 98.0,1758
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,95.2,93.8 to 96.3,3433
Hib,Full Series,HHS Regions/National,Region 1,2015,Age,24 Months,88.7,85.9 to 91.1,1509
Hib,Full Series,HHS Regions/National,Region 1,2015-2016,Age,24 Months,88.0,85.8 to 90.0,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,97.2,95.5 to 98.4,1537
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,97.6,96.7 to 98.3,3101
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,95.3,92.6 to 97.1,1421
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,95.3,93.3 to 96.7,3005
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,95.3,92.6 to 97.1,1584
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,96.0,94.4 to 97.2,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,94.5,91.2 to 96.6,1509
Hib,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,94.2,92.5 to 95.6,2930
Hib,≥3 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,94.0,91.1 to 96.0,1421
Hib,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,94.4,92.4 to 95.9,3005
Polio,≥3 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,95.3,92.8 to 97.2,1421
Polio,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,95.4,93.6 to 96.9,3005
Hib,≥3 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,94.8,92.2 to 96.6,1584
Hib,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,95.1,93.5 to 96.3,3342
Polio,≥3 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,95.9,94.1 to 97.2,1537
Polio,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,96.1,95.0 to 97.0,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,94.7,93.7 to 95.6,1537
Hib,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,95.1,93.3 to 96.4,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,95.4,93.6 to 96.8,1564
Hib,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,95.0,93.6 to 96.0,3073
Polio,≥3 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,94.9,92.7 to 96.5,1457
Polio,≥3 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,95.8,93.2 to 97.5,1422
Polio,≥3 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,95.1,93.0 to 96.5,1675
Polio,≥3 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,96.4,94.4 to 97.7,1758
Polio,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,72.6,69.6 to 75.4,3433
Polio,≥3 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,96.4,95.0 to 97.5,1564
Polio,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,95.8,94.6 to 96.8,3073
Polio,≥3 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,95.2,93.1 to 96.8,1509
Polio,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,95.3,93.7 to 96.5,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,95.7,92.8 to 97.5,1509
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,95.5,93.9 to 96.7,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,97.5,96.4 to 98.3,1564
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,96.6,95.5 to 97.5,3073
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,97.0,95.9 to 97.8,3101
DTaP,≥3 Doses,HHS Regions/National,United States,2019,Age,24 Months,94.0,93.2 to 94.6,17265
Hep A,≥1 Dose,HHS Regions/National,United States,2013,Age,19 Months,78.5,77.2 to 79.9,14872
Hep A,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,19 Months,78.7,77.6 to 79.7,30205
Hib,≥3 Doses,HHS Regions/National,United States,2012,Age,35 Months,93.7,92.9 to 94.5,15039
Hib,≥3 Doses,HHS Regions/National,United States,2011,Age,35 Months,93.5,92.4 to 94.4,14513
≥1 Dose MMR,,HHS Regions/National,Region 1,2015,Age,13 Months,64.1,59.6 to 68.3,1509
≥1 Dose MMR,,HHS Regions/National,Region 1,2015-2016,Age,13 Months,64.2,60.7 to 67.4,2930
≥1 Dose MMR,,HHS Regions/National,Region 1,2014,Age,13 Months,62.4,58.0 to 66.6,1564
≥1 Dose MMR,,HHS Regions/National,Region 1,2014-2015,Age,13 Months,63.2,60.1 to 66.3,3073
≥1 Dose Varicella,,HHS Regions/National,Region 1,2012,Age,19 Months,89.5,87.4 to 91.3,1457
≥1 Dose Varicella,,HHS Regions/National,Region 1,2011,Age,19 Months,90.7,88.1 to 92.8,1422
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019,Age,13 Months,61.3,56.8 to 65.7,1675
≥1 Dose MMR,,HHS Regions/National,Region 1,2013,Age,13 Months,54.6,49.5 to 59.7,1537
≥1 Dose MMR,,HHS Regions/National,Region 1,2013-2014,Age,13 Months,58.5,54.6 to 62.3,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018,Age,13 Months,58.4,53.9 to 62.8,1758
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018-2019,Age,13 Months,59.9,56.7 to 63.0,3433
DTaP,≥4 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,94.2,91.8 to 96.0,1564
DTaP,≥4 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,93.5,91.7 to 95.0,3073
DTaP,≥4 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,91.9,88.5 to 94.7,1457
DTaP,≥4 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,89.8,86.4 to 92.6,1537
DTaP,≥4 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,92.1,90.1 to 93.9,3101
Hep B,≥3 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,89.1,83.9 to 92.8,1457
Hep A,≥2 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,89.7,86.0 to 92.8,1675
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,90.5,87.6 to 92.9,1564
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,90.9,88.9 to 92.6,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,92.9,91.0 to 94.4,1537
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,91.7,89.7 to 93.4,3101
Hep A,≥2 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,85.7,80.8 to 89.9,1584
Hep A,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,85.6,82.4 to 88.4,3342
Hep A,≥2 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,85.4,81.5 to 88.9,1758
Hep A,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,87.5,84.8 to 90.0,3433
Hep B,≥3 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,88.0,85.3 to 90.2,1422
Polio,≥2 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,93.9,91.5 to 95.6,1509
Polio,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,94.0,92.3 to 95.3,2930
Polio,≥2 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,92.8,90.0 to 94.9,1537
Polio,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,93.7,92.1 to 95.0,3101
Polio,≥2 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,94.6,92.1 to 96.3,1564
Polio,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,94.2,92.6 to 95.5,3073
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015,Age,13 Months,56.6,52.0 to 61.1,1509
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015-2016,Age,13 Months,58.3,54.8 to 61.7,2930
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017,Age,13 Months,61.6,56.9 to 66.1,1584
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017-2018,Age,13 Months,60.0,56.8 to 63.2,3342
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016,Age,13 Months,60.0,54.8 to 65.0,1421
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016-2017,Age,13 Months,60.8,57.2 to 64.2,3005
≥1 Dose MMR,,HHS Regions/National,Region 1,2011,Age,13 Months,57.2,53.6 to 60.7,1422
≥1 Dose MMR,,HHS Regions/National,Region 1,2012,Age,13 Months,52.7,49.3 to 56.0,1457
Hep A,≥2 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,46.2,41.8 to 50.8,1564
Hep A,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,46.3,43.1 to 49.6,3073
Hep A,≥2 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,46.4,41.9 to 51.2,1509
Hep A,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,49.4,45.8 to 53.0,2930
DTaP,≥4 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,86.9,83.3 to 90.0,1584
DTaP,≥4 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,89.1,87.0 to 91.1,3342
DTaP,≥4 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,91.3,88.8 to 93.5,1758
DTaP,≥4 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,89.1,87.0 to 91.0,3433
≥1 Dose MMR,,HHS Regions/National,Region 1,2018,Age,13 Months,74.4,70.4 to 78.0,1758
≥1 Dose MMR,,HHS Regions/National,Region 1,2018-2019,Age,13 Months,72.6,69.6 to 75.4,3433
Hep B,≥1 Dose,HHS Regions/National,Region 1,2016,Age,3 Months,95.8,93.2 to 97.5,1421
Hep B,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,3 Months,96.3,94.5 to 97.5,3005
Hep B,≥1 Dose,HHS Regions/National,Region 1,2015,Age,3 Months,94.7,92.3 to 96.3,1509
Hep B,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,3 Months,95.2,93.6 to 96.5,2930
Hep B,≥1 Dose,HHS Regions/National,Region 1,2014,Age,3 Months,95.1,92.7 to 96.8,1564
Hep B,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,3 Months,94.9,93.3 to 96.1,3073
Polio,≥2 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,96.7,95.8 to 97.4,1537
Polio,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,97.0,95.9 to 97.8,3101
Polio,≥2 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,94.4,92.1 to 96.1,1675
Polio,≥2 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,92.8,89.0 to 95.4,1584
Polio,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,94.6,92.5 to 96.1,3342
Polio,≥2 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,94.0,91.3 to 95.9,1421
Polio,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,93.4,90.8 to 95.4,3005
Hep B,≥1 Dose,HHS Regions/National,Region 1,2011,Age,3 Months,93.2,90.8 to 95.1,1422
Hep B,≥1 Dose,HHS Regions/National,Region 1,2012,Age,3 Months,94.1,89.8 to 96.6,1457
Hep B,≥1 Dose,HHS Regions/National,Region 1,2013,Age,3 Months,95.5,94.0 to 96.6,1537
Hep B,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,3 Months,95.3,94.2 to 96.2,3101
Polio,≥2 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,96.3,94.6 to 97.5,1758
Polio,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,95.4,94.0 to 96.5,3433
Hep A,≥1 Dose,HHS Regions/National,Region 1,2020,Age,35 Months,97.8,95.4 to 99.1,1536
DTaP,≥4 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,93.9,91.3 to 96.0,1422
DTaP,≥4 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,86.7,83.2 to 89.7,1675
Polio,≥2 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,97.1,96.4 to 97.6,1422
Polio,≥2 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,95.9,93.5 to 97.4,1457
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013,Age,19 Months,91.5,89.1 to 93.5,1537
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013-2014,Age,19 Months,90.6,89.2 to 91.8,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015,Age,19 Months,90.6,87.8 to 92.8,1509
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015-2016,Age,19 Months,90.0,87.7 to 91.8,2930
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014,Age,19 Months,89.7,86.5 to 92.2,1564
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014-2015,Age,19 Months,90.2,88.1 to 91.9,3073
≥1 Dose MMR,,HHS Regions/National,Region 1,2017,Age,13 Months,69.3,64.7 to 73.6,1584
≥1 Dose MMR,,HHS Regions/National,Region 1,2017-2018,Age,13 Months,71.8,68.8 to 74.7,3342
≥1 Dose MMR,,HHS Regions/National,Region 1,2016,Age,13 Months,64.3,59.1 to 69.1,1421
≥1 Dose MMR,,HHS Regions/National,Region 1,2016-2017,Age,13 Months,66.8,63.3 to 70.1,3005
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,93.0,90.3 to 95.0,1584
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,88.8,86.6 to 90.8,3342
DTaP,≥4 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,92.9,90.0 to 95.2,1509
DTaP,≥4 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,91.4,89.0 to 93.4,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,91.4,88.5 to 93.6,1509
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,92.0,90.0 to 93.6,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,92.6,89.7 to 94.7,1421
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,92.8,90.7 to 94.4,3005
DTaP,≥4 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,90.0,86.1 to 93.1,1421
DTaP,≥4 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,91.5,88.5 to 94.0,3005
DTaP,≥4 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,93.4,89.1 to 96.5,1584
DTaP,≥4 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,94.3,91.7 to 96.3,3342
≥1 Dose Varicella,,HHS Regions/National,Region 1,2012,Age,24 Months,92.0,89.2 to 94.4,1457
≥1 Dose Varicella,,HHS Regions/National,Region 1,2011,Age,24 Months,91.6,88.3 to 94.3,1422
≥1 Dose MMR,,HHS Regions/National,Region 1,2017,Age,19 Months,93.2,90.3 to 95.3,1584
≥1 Dose MMR,,HHS Regions/National,Region 1,2017-2018,Age,19 Months,93.9,92.1 to 95.4,3342
≥1 Dose MMR,,HHS Regions/National,Region 1,2016,Age,19 Months,92.6,89.7 to 94.7,1421
≥1 Dose MMR,,HHS Regions/National,Region 1,2016-2017,Age,19 Months,92.9,90.8 to 94.6,3005
≥1 Dose MMR,,HHS Regions/National,Region 1,2015,Age,19 Months,93.3,91.0 to 95.0,1509
≥1 Dose MMR,,HHS Regions/National,Region 1,2015-2016,Age,19 Months,92.9,91.2 to 94.4,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,92.8,89.2 to 95.3,1509
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,93.6,91.9 to 95.0,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,92.6,90.0 to 94.6,1564
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,92.7,91.0 to 94.2,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,94.2,92.3 to 95.7,1537
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,93.4,91.9 to 94.7,3101
Hep B,≥2 Doses,HHS Regions/National,Region 1,2013,Age,5 Months,90.6,89.3 to 91.8,1537
Hep B,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,5 Months,90.3,89.1 to 91.4,3101
Hep B,≥2 Doses,HHS Regions/National,Region 1,2011,Age,5 Months,88.4,85.3 to 90.9,1422
Hep B,≥2 Doses,HHS Regions/National,Region 1,2012,Age,5 Months,87.0,82.5 to 90.5,1457
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2011,Age,0-1 Days,55.8,51.5 to 59.9,1422
Hep B,≥1 Dose,HHS Regions/National,Region 1,2018,Age,3 Months,97.2,95.0 to 98.4,1758
Hep B,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,3 Months,97.7,96.6 to 98.5,3433
Polio,≥2 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,97.3,96.2 to 98.1,1564
Polio,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,96.5,95.4 to 97.4,3073
Hep B,≥1 Dose,HHS Regions/National,Region 1,2019,Age,3 Months,98.3,97.5 to 98.9,1675
DTaP,≥4 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,94.8,92.7 to 96.5,1758
DTaP,≥4 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,94.4,92.6 to 95.9,3433
≥1 Dose MMR,,HHS Regions/National,Region 1,2012,Age,19 Months,91.2,89.4 to 92.7,1457
≥1 Dose MMR,,HHS Regions/National,Region 1,2014,Age,19 Months,92.4,89.5 to 94.5,1564
≥1 Dose MMR,,HHS Regions/National,Region 1,2014-2015,Age,19 Months,92.8,91.1 to 94.3,3073
≥1 Dose MMR,,HHS Regions/National,Region 1,2013,Age,19 Months,92.4,90.4 to 94.0,1537
≥1 Dose MMR,,HHS Regions/National,Region 1,2013-2014,Age,19 Months,92.4,90.4 to 94.0,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017,Age,19 Months,91.9,89.0 to 94.2,1584
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017-2018,Age,19 Months,92.3,90.3 to 93.9,3342
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018,Age,19 Months,92.7,89.8 to 94.9,1758
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018-2019,Age,19 Months,59.9,56.7 to 63.0,3433
Hep B,≥1 Dose,HHS Regions/National,Region 1,2017,Age,3 Months,96.8,94.5 to 98.1,1584
Hep B,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,3 Months,97.0,95.5 to 98.0,3342
Polio,≥2 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,95.8,93.3 to 97.4,1421
Polio,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,95.9,94.1 to 97.2,3005
Polio,≥2 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,95.7,93.7 to 97.1,1509
Polio,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,95.7,94.2 to 96.9,2930
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016,Age,19 Months,89.3,85.4 to 92.2,1421
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016-2017,Age,19 Months,90.6,88.1 to 92.6,3005
≥1 Dose MMR,,HHS Regions/National,Region 1,2019,Age,13 Months,70.8,66.3 to 74.9,1675
PCV,≥3 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,69.5,63.9 to 74.5,1457
PCV,≥3 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,73.6,69.4 to 77.4,1564
PCV,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,75.9,73.0 to 78.5,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,94.5,91.9 to 96.2,1421
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,94.3,92.4 to 95.8,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,76.8,74.3 to 79.1,1422
PCV,≥3 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,72.9,68.6 to 76.9,1537
PCV,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,73.3,69.9 to 76.4,3101
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2012,Age,0-1 Days,55.2,51.0 to 59.4,1457
Hep B,≥2 Doses,HHS Regions/National,Region 1,2014,Age,5 Months,90.0,87.1 to 92.4,1564
Hep B,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,5 Months,90.8,88.8 to 92.4,3073
Hep B,≥2 Doses,HHS Regions/National,Region 1,2016,Age,5 Months,92.8,90.0 to 94.9,1421
Hep B,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,5 Months,92.6,90.3 to 94.3,3005
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,94.2,91.5 to 96.0,1584
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,93.4,91.6 to 94.9,3342
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,92.7,89.9 to 94.8,1758
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,87.2,84.9 to 89.3,3433
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2015,Age,0-1 Days,56.0,51.4 to 60.5,1509
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2015-2016,Age,0-1 Days,59.8,56.3 to 63.2,2930
Hep B,≥2 Doses,HHS Regions/National,Region 1,2015,Age,5 Months,91.5,88.7 to 93.6,1509
Hep B,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,5 Months,92.2,90.3 to 93.7,2930
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2014,Age,0-1 Days,55.0,50.7 to 59.3,1564
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2014-2015,Age,0-1 Days,55.5,52.3 to 58.6,3073
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2013,Age,0-1 Days,56.1,49.9 to 62.0,1537
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2013-2014,Age,0-1 Days,55.6,51.8 to 59.2,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013,Age,24 Months,93.1,90.8 to 95.0,1537
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013-2014,Age,24 Months,92.5,90.8 to 94.1,3101
Polio,≥2 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,96.1,93.6 to 97.7,1584
Polio,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,97.1,95.8 to 98.0,3342
Polio,≥2 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,98.1,97.0 to 98.8,1758
Polio,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,97.2,96.2 to 98.0,3433
Polio,≥2 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,96.3,94.5 to 97.6,1675
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019,Age,19 Months,93.8,91.4 to 95.5,1675
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016,Age,24 Months,91.9,88.9 to 94.3,1421
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016-2017,Age,24 Months,92.6,90.5 to 94.4,3005
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015,Age,24 Months,93.7,91.6 to 95.5,1509
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015-2016,Age,24 Months,92.8,91.0 to 94.3,2930
≥1 Dose MMR,,HHS Regions/National,Region 1,2012,Age,24 Months,92.9,90.1 to 95.1,1457
≥1 Dose MMR,,HHS Regions/National,Region 1,2011,Age,24 Months,95.5,93.6 to 96.9,1422
PCV,≥4 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,86.6,84.1 to 88.7,1422
PCV,≥4 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,82.4,75.6 to 87.6,1457
PCV,≥4 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,85.9,84.0 to 87.6,1537
PCV,≥4 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,86.0,83.9 to 87.9,3101
≥1 Dose MMR,,HHS Regions/National,Region 1,2018,Age,19 Months,94.7,92.3 to 96.3,1758
≥1 Dose MMR,,HHS Regions/National,Region 1,2018-2019,Age,19 Months,97.1,96.1 to 97.9,3433
≥1 Dose MMR,,HHS Regions/National,Region 1,2019,Age,19 Months,93.4,91.0 to 95.2,1675
≥1 Dose Varicella,,HHS Regions/National,Region 1,2011,Age,35 Months,95.5,91.9 to 97.9,1422
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017,Age,24 Months,93.3,90.5 to 95.5,1584
≥1 Dose Varicella,,HHS Regions/National,Region 1,2017-2018,Age,24 Months,94.0,92.1 to 95.5,3342
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019,Age,24 Months,94.5,92.3 to 96.2,1675
≥1 Dose MMR,,HHS Regions/National,Region 1,2013,Age,24 Months,94.2,92.0 to 96.0,1537
≥1 Dose MMR,,HHS Regions/National,Region 1,2013-2014,Age,24 Months,93.9,92.1 to 95.3,3101
≥1 Dose MMR,,HHS Regions/National,Region 1,2014,Age,24 Months,93.4,90.7 to 95.6,1564
≥1 Dose MMR,,HHS Regions/National,Region 1,2014-2015,Age,24 Months,94.2,92.5 to 95.5,3073
≥1 Dose MMR,,HHS Regions/National,Region 1,2015,Age,24 Months,94.9,92.9 to 96.5,1509
≥1 Dose MMR,,HHS Regions/National,Region 1,2015-2016,Age,24 Months,94.1,92.4 to 95.5,2930
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018,Age,24 Months,94.6,92.1 to 96.6,1758
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018-2019,Age,24 Months,94.6,93.0 to 95.9,3433
PCV,≥4 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,87.1,83.5 to 89.9,1421
PCV,≥4 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,87.0,84.5 to 89.2,3005
PCV,≥4 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,84.2,81.7 to 86.3,1509
PCV,≥4 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,85.6,83.1 to 87.8,2930
PCV,≥4 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,86.2,82.9 to 88.9,1564
PCV,≥4 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,85.2,82.8 to 87.3,3073
PCV,≥3 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,78.1,74.2 to 81.7,1509
PCV,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,77.8,74.8 to 80.5,2930
PCV,≥3 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,76.3,71.9 to 80.3,1584
PCV,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,76.5,73.5 to 79.4,3342
Hep B,≥3 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,93.2,90.8 to 95.2,1457
PCV,≥3 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,77.5,72.9 to 81.5,1421
PCV,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,76.9,73.6 to 79.9,3005
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,94.5,92.6 to 96.0,1537
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,93.8,92.3 to 95.1,3101
Hep B,≥3 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,92.3,89.1 to 94.8,1422
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,94.7,92.6 to 96.3,1675
Hep B,≥2 Doses,HHS Regions/National,Region 1,2013,Age,7 Months,94.0,92.0 to 95.5,1537
Hep B,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,7 Months,93.6,92.4 to 94.6,3101
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2012,Age,0-2 Days,70.6,65.9 to 74.8,1457
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2013,Age,0-2 Days,69.1,64.7 to 73.2,1537
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2013-2014,Age,0-2 Days,68.8,65.7 to 71.6,3101
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2018,Age,0-1 Days,73.2,69.0 to 77.0,1758
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2018-2019,Age,0-1 Days,77.3,74.6 to 79.7,3433
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2011,Age,0-2 Days,71.0,67.4 to 74.4,1422
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2019,Age,0-1 Days,81.4,78.0 to 84.4,1675
Hep B,≥2 Doses,HHS Regions/National,Region 1,2012,Age,7 Months,90.4,86.6 to 93.2,1457
Hep B,≥2 Doses,HHS Regions/National,Region 1,2014,Age,7 Months,93.2,90.6 to 95.2,1564
Hep B,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,7 Months,93.4,91.6 to 94.8,3073
PCV,≥3 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,76.8,72.4 to 80.6,1758
PCV,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,78.5,75.6 to 81.1,3433
PCV,≥3 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,93.2,91.5 to 94.6,1422
PCV,≥3 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,80.3,76.5 to 83.5,1675
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,93.1,90.6 to 95.1,1564
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,93.2,91.5 to 94.6,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,93.2,90.7 to 95.2,1509
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,94.0,92.3 to 95.4,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,94.8,92.4 to 96.7,1421
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,94.7,92.9 to 96.2,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,91.7,88.4 to 94.2,1457
≥1 Dose MMR,,HHS Regions/National,Region 1,2016,Age,24 Months,93.3,90.5 to 95.5,1421
≥1 Dose MMR,,HHS Regions/National,Region 1,2016-2017,Age,24 Months,93.9,91.9 to 95.5,3005
≥1 Dose MMR,,HHS Regions/National,Region 1,2017,Age,24 Months,94.5,91.8 to 96.5,1584
≥1 Dose MMR,,HHS Regions/National,Region 1,2017-2018,Age,24 Months,95.1,93.4 to 96.4,3342
PCV,≥4 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,87.0,83.4 to 89.9,1584
PCV,≥4 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,86.0,83.4 to 88.2,3342
PCV,≥4 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,85.0,81.2 to 88.2,1758
PCV,≥4 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,85.5,82.4 to 88.2,2825
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2015,Age,0-2 Days,71.1,66.7 to 75.1,1509
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2015-2016,Age,0-2 Days,73.8,70.7 to 76.6,2930
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2014,Age,0-2 Days,68.4,64.2 to 72.4,1564
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2014-2015,Age,0-2 Days,69.8,66.7 to 72.6,3073
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2017,Age,0-1 Days,67.5,63.3 to 71.5,1584
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2017-2018,Age,0-1 Days,70.3,67.4 to 73.1,3342
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2016,Age,0-1 Days,63.7,58.5 to 68.6,1421
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2016-2017,Age,0-1 Days,65.6,62.2 to 68.8,3005
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014,Age,24 Months,92.0,89.1 to 94.3,1564
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014-2015,Age,24 Months,92.8,91.1 to 94.4,3073
Hep B,≥2 Doses,HHS Regions/National,Region 1,2017,Age,5 Months,92.3,88.7 to 94.8,1584
Hep B,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,5 Months,93.0,91.0 to 94.7,3342
Hep B,≥2 Doses,HHS Regions/National,Region 1,2011,Age,7 Months,90.4,87.4 to 92.8,1422
Hep B,≥2 Doses,HHS Regions/National,Region 1,2019,Age,5 Months,94.1,91.8 to 95.9,1675
Hep B,≥2 Doses,HHS Regions/National,Region 1,2018,Age,5 Months,93.8,91.4 to 95.5,1758
Hep B,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,5 Months,94.0,92.4 to 95.3,3433
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014,Age,35 Months,95.8,93.3 to 97.6,1564
≥1 Dose Varicella,,HHS Regions/National,Region 1,2014-2015,Age,35 Months,95.7,94.0 to 97.0,3073
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015,Age,35 Months,95.6,93.6 to 97.1,1509
≥1 Dose Varicella,,HHS Regions/National,Region 1,2015-2016,Age,35 Months,95.4,93.5 to 96.9,2930
≥1 Dose Varicella,,HHS Regions/National,Region 1,2012,Age,35 Months,94.7,92.1 to 96.7,1457
PCV,≥4 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,89.0,85.5 to 92.0,1422
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013,Age,35 Months,97.0,94.8 to 98.5,1537
≥1 Dose Varicella,,HHS Regions/National,Region 1,2013-2014,Age,35 Months,96.5,94.9 to 97.8,3101
PCV,≥4 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,86.3,82.7 to 89.2,1675
≥1 Dose MMR,,HHS Regions/National,Region 1,2018,Age,24 Months,95.6,93.5 to 97.2,1758
≥1 Dose MMR,,HHS Regions/National,Region 1,2018-2019,Age,24 Months,95.0,93.5 to 96.2,3433
Hep B,≥2 Doses,HHS Regions/National,Region 1,2017,Age,7 Months,94.6,91.9 to 96.4,1584
Hep B,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,7 Months,94.9,93.2 to 96.2,3342
PCV,≥3 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,94.3,93.1 to 95.4,1537
PCV,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,93.2,91.2 to 94.7,3101
Hep B,≥2 Doses,HHS Regions/National,Region 1,2016,Age,7 Months,94.0,91.2 to 95.9,1421
Hep B,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,7 Months,94.3,92.3 to 95.8,3005
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2016,Age,0-2 Days,76.4,72.0 to 80.3,1421
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2016-2017,Age,0-2 Days,78.5,75.7 to 81.1,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,93.3,90.9 to 95.1,1509
PCV,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,92.7,90.8 to 94.2,2930
PCV,≥3 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,92.0,89.5 to 94.0,1564
PCV,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,92.6,91.0 to 94.0,3073
Hep B,≥2 Doses,HHS Regions/National,Region 1,2015,Age,7 Months,93.6,91.0 to 95.4,1509
Hep B,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,7 Months,93.8,92.0 to 95.2,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,93.8,91.2 to 95.9,1758
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,94.4,92.8 to 95.7,3433
≥1 Dose MMR,,HHS Regions/National,Region 1,2013,Age,35 Months,97.4,94.9 to 98.8,1537
≥1 Dose MMR,,HHS Regions/National,Region 1,2013-2014,Age,35 Months,96.8,95.0 to 98.1,3101
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016,Age,35 Months,94.8,91.8 to 97.0,1421
≥1 Dose Varicella,,HHS Regions/National,Region 1,2016-2017,Age,35 Months,95.5,93.5 to 97.1,3005
≥1 Dose MMR,,HHS Regions/National,Region 1,2012,Age,35 Months,95.1,92.7 to 97.0,1457
≥1 Dose MMR,,HHS Regions/National,Region 1,2011,Age,35 Months,96.0,94.1 to 97.4,1422
≥1 Dose MMR,,HHS Regions/National,Region 1,2019,Age,24 Months,94.3,92.1 to 96.1,1675
PCV,≥4 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,89.3,86.4 to 91.7,1537
PCV,≥4 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,88.8,86.8 to 90.6,3101
PCV,≥4 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,88.3,85.3 to 90.9,1564
PCV,≥4 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,89.0,86.8 to 90.9,3073
PCV,≥4 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,85.1,81.4 to 88.4,1457
Hep B,≥3 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,93.4,90.2 to 95.9,1422
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,94.5,92.1 to 96.4,1584
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,94.2,92.4 to 95.6,3342
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,94.9,92.8 to 96.5,1675
Hep B,≥3 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,92.2,89.2 to 94.4,1457
Hep A,≥2 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,88.7,83.7 to 92.8,1536
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,84.7,81.0 to 87.7,1758
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,87.2,84.9 to 89.3,3433
Hep B,≥3 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,91.5,89.7 to 93.1,1422
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,89.9,86.6 to 92.4,1675
≥1 Dose MMR,,HHS Regions/National,Region 1,2011,Age,19 Months,93.4,91.1 to 95.1,1422
DTaP,≥4 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,94.0,90.8 to 96.4,1675
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2017,Age,0-2 Days,80.7,77.1 to 83.9,1584
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2017-2018,Age,0-2 Days,80.3,77.7 to 82.6,3342
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2018,Age,0-2 Days,79.8,76.1 to 83.1,1758
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2018-2019,Age,0-2 Days,82.7,80.3 to 84.9,3433
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2019,Age,0-2 Days,85.6,82.6 to 88.2,1675
Hep B,≥2 Doses,HHS Regions/National,Region 1,2018,Age,7 Months,95.2,92.9 to 96.8,1758
Hep B,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,7 Months,95.1,93.5 to 96.3,3433
Hep B,≥2 Doses,HHS Regions/National,Region 1,2013,Age,13 Months,96.0,94.5 to 97.1,1537
Hep B,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,13 Months,95.2,94.0 to 96.2,3101
Hep B,≥2 Doses,HHS Regions/National,Region 1,2015,Age,13 Months,95.1,92.8 to 96.7,1509
Hep B,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,13 Months,95.1,93.5 to 96.4,2930
Hep B,≥2 Doses,HHS Regions/National,Region 1,2014,Age,13 Months,94.5,91.9 to 96.3,1564
Hep B,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,13 Months,94.8,93.1 to 96.0,3073
Hib,≥1 Dose,HHS Regions/National,Region 1,2014,Age,3 Months,90.9,87.7 to 93.3,1564
Hib,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,3 Months,91.3,89.3 to 93.0,3073
Hib,≥1 Dose,HHS Regions/National,Region 1,2011,Age,3 Months,94.4,92.4 to 95.9,1422
Hib,≥1 Dose,HHS Regions/National,Region 1,2012,Age,3 Months,91.2,87.2 to 94.0,1457
Hib,≥1 Dose,HHS Regions/National,Region 1,2013,Age,3 Months,91.8,90.7 to 92.7,1537
Hib,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,3 Months,91.3,90.1 to 92.4,3101
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,94.9,92.5 to 96.8,1421
Hep B,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,95.0,93.2 to 96.4,3005
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,93.8,91.3 to 95.7,1509
Hep B,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,94.3,92.6 to 95.7,2930
PCV,≥3 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,95.9,95.0 to 96.7,1537
PCV,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,95.8,94.5 to 96.7,3101
PCV,≥3 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,94.9,93.2 to 96.1,1422
PCV,≥3 Doses,HHS Regions/National,Region 1,2019,Age,13 Months,94.2,92.0 to 95.8,1675
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,95.1,92.6 to 96.9,1584
Hep B,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,95.5,93.9 to 96.8,3342
PCV,≥3 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,93.5,90.7 to 95.6,1457
PCV,≥4 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,88.2,84.8 to 91.2,1457
PCV,≥4 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,90.8,87.2 to 93.7,1422
PCV,≥4 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,89.0,85.7 to 91.9,1675
PCV,≥4 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,90.0,86.8 to 92.7,1758
PCV,≥4 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,89.6,87.3 to 91.6,3433
PCV,≥3 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,92.1,88.9 to 94.3,1421
PCV,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,92.6,90.5 to 94.3,3005
Hib,Full Series,HHS Regions/National,Region 1,2020,Age,24 Months,87.0,83.4 to 90.1,1536
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,95.3,93.4 to 96.8,1537
Hep B,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,95.2,93.5 to 96.6,3101
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,95.2,92.1 to 97.3,1564
Hep B,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,94.6,92.6 to 96.3,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,94.2,91.8 to 96.1,1457
Hep B,≥2 Doses,HHS Regions/National,Region 1,2012,Age,13 Months,93.8,91.0 to 95.7,1457
Hep B,≥2 Doses,HHS Regions/National,Region 1,2011,Age,13 Months,94.4,93.2 to 95.5,1422
Hep B,≥2 Doses,HHS Regions/National,Region 1,2019,Age,7 Months,94.9,92.5 to 96.6,1675
PCV,≥3 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,93.2,90.4 to 95.3,1584
PCV,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,92.9,90.8 to 94.6,3342
PCV,≥3 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,92.6,89.3 to 95.0,1758
PCV,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,93.4,91.5 to 94.9,3433
PCV,≥4 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,88.6,85.3 to 91.4,1421
PCV,≥4 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,88.8,86.4 to 90.9,3005
PCV,≥4 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,88.9,85.5 to 91.8,1584
PCV,≥4 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,89.4,87.1 to 91.5,3342
≥1 Dose MMR,,HHS Regions/National,Region 1,2015,Age,35 Months,96.2,94.3 to 97.6,1509
≥1 Dose MMR,,HHS Regions/National,Region 1,2015-2016,Age,35 Months,95.9,94.1 to 97.2,2930
≥1 Dose MMR,,HHS Regions/National,Region 1,2014,Age,35 Months,96.0,93.5 to 97.8,1564
≥1 Dose MMR,,HHS Regions/National,Region 1,2014-2015,Age,35 Months,96.1,94.6 to 97.4,3073
≥1 Dose MMR,,HHS Regions/National,Region 1,2016,Age,35 Months,95.3,92.4 to 97.3,1421
≥1 Dose MMR,,HHS Regions/National,Region 1,2016-2017,Age,35 Months,96.1,94.1 to 97.5,3005
PCV,≥4 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,89.5,86.5 to 92.2,1509
PCV,≥4 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,89.1,86.9 to 91.1,2930
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018,Age,35 Months,96.6,94.8 to 97.9,1758
≥1 Dose Varicella,,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.3,95.0 to 97.4,3433
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019,Age,35 Months,95.9,93.8 to 97.5,1675
≥1 Dose MMR,,HHS Regions/National,Region 1,2019,Age,35 Months,95.7,93.6 to 97.3,1675
≥1 Dose MMR,,HHS Regions/National,Region 1,2017,Age,35 Months,97.0,94.4 to 98.6,1584
≥1 Dose MMR,,HHS Regions/National,Region 1,2017-2018,Age,35 Months,96.8,95.3 to 97.9,3342
≥1 Dose MMR,,HHS Regions/National,Region 1,2018,Age,35 Months,96.9,95.2 to 98.1,1758
≥1 Dose MMR,,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.3,95.0 to 97.4,3433
Hep B,≥2 Doses,HHS Regions/National,Region 1,2017,Age,13 Months,95.8,93.4 to 97.4,1584
Hep B,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,13 Months,96.2,94.7 to 97.3,3342
Hib,≥1 Dose,HHS Regions/National,Region 1,2017,Age,3 Months,91.6,87.7 to 94.4,1584
Hib,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,3 Months,92.1,89.8 to 93.9,3342
Hib,≥1 Dose,HHS Regions/National,Region 1,2016,Age,3 Months,93.0,90.0 to 95.1,1421
Hib,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,3 Months,92.3,89.6 to 94.4,3005
Hib,≥1 Dose,HHS Regions/National,Region 1,2015,Age,3 Months,91.8,89.1 to 93.8,1509
Hib,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,3 Months,92.4,90.5 to 93.9,2930
PCV,≥3 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,93.9,91.1 to 95.9,1421
PCV,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,94.3,92.3 to 95.8,3005
PCV,≥3 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,95.2,92.1 to 97.1,1509
PCV,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,94.6,92.9 to 95.9,2930
Hep B,≥2 Doses,HHS Regions/National,Region 1,2016,Age,13 Months,95.2,92.7 to 96.9,1421
Hep B,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,13 Months,95.5,93.7 to 96.9,3005
Hep B,≥2 Doses,HHS Regions/National,Region 1,2018,Age,13 Months,96.6,94.7 to 97.9,1758
Hep B,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,13 Months,96.4,95.0 to 97.4,3433
PCV,≥4 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,90.8,88.2 to 93.1,1564
PCV,≥4 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,91.6,89.7 to 93.2,3073
PCV,≥4 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,92.3,89.5 to 94.6,1509
PCV,≥4 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,91.3,89.2 to 93.2,2930
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,96.1,94.0 to 97.6,1758
Hep B,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,95.9,94.5 to 97.0,3433
PCV,≥3 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,95.6,94.0 to 96.8,1564
PCV,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,95.4,94.1 to 96.4,3073
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,95.6,93.6 to 97.1,1675
Hib,≥1 Dose,HHS Regions/National,Region 1,2019,Age,3 Months,93.7,91.3 to 95.5,1675
PCV,≥3 Doses,HHS Regions/National,Region 1,2013,Age,24 Months,96.8,95.1 to 98.0,1537
PCV,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,24 Months,96.5,95.4 to 97.3,3101
Hib,≥2 Doses,HHS Regions/National,Region 1,2017,Age,5 Months,83.7,79.3 to 87.2,1584
Hib,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,5 Months,85.3,82.6 to 87.6,3342
PCV,≥3 Doses,HHS Regions/National,Region 1,2012,Age,24 Months,94.7,92.2 to 96.6,1457
PCV,≥3 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,96.1,94.6 to 97.3,1564
PCV,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,95.7,94.5 to 96.7,3073
PCV,≥3 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,95.3,93.3 to 96.8,1509
PCV,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,94.8,93.2 to 96.1,2930
PCV,≥1 Dose,HHS Regions/National,Region 1,2013,Age,3 Months,90.4,88.4 to 92.1,1537
PCV,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,3 Months,89.8,88.3 to 91.1,3101
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,93.0,92.1 to 93.8,10973
Influenza,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,47.8,45.8 to 49.8,10973
Influenza,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,62.6,61.4 to 63.9,24947
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,92.3 to 93.6,27529
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,91.7,90.8 to 92.7,10973
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,92.1 to 93.6,24947
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,69.7,68.5 to 71.0,27529
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.1,78.0 to 80.1,24947
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,76.7,75.6 to 77.8,27529
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,88.9,87.8 to 90.0,10973
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,89.9 to 91.6,24947
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,78.4,76.6 to 80.2,10973
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,96.4,95.9 to 96.9,22558
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,91.9,91.1 to 92.7,24430
Hib,Full Series,HHS Regions/National,United States,2016-2019,Overall,Overall,79.8,79.0 to 80.5,63449
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,62.1,60.5 to 63.6,16461
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,94.5,93.8 to 95.1,22558
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,77.0,75.9 to 78.1,24430
Rotavirus,,HHS Regions/National,United States,2016-2019,Overall,Overall,77.6,76.8 to 78.3,63449
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,69.5,68.2 to 70.8,24430
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,80.6,79.4 to 81.8,22558
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,97.1,96.6 to 97.6,22558
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Overall,Overall,90.6,90.1 to 91.1,63449
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,77.8,76.8 to 78.8,63449
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,72.6,70.7 to 74.5,16461
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Overall,Overall,70.0,69.2 to 70.8,63449
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,78.4,77.0 to 79.7,16461
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,89.7,88.7 to 90.6,16461
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Overall,Overall,86.8,86.2 to 87.4,63449
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Overall,Overall,77.9,77.2 to 78.6,63449
Influenza,,HHS Regions/National,United States,2016-2019,Overall,Overall,60.6,59.8 to 61.4,63449
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,88.9,88.0 to 89.9,16461
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,92.7,91.9 to 93.4,24430
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,84.2,82.7 to 85.8,22558
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,83.8,82.7 to 84.9,16461
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,86.3,85.3 to 87.2,24430
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,91.1,90.2 to 92.1,22558
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Overall,Overall,91.1,90.6 to 91.7,63449
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,92.4,92.0 to 92.9,63449
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,73.8,72.4 to 75.2,16461
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,80.9,80.2 to 81.7,63449
Rotavirus,,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,86.9,85.9 to 87.9,22558
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,92.7,92.3 to 93.2,63449
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.3,88.8 to 91.8,4715
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,77.5,76.2 to 78.7,22343
Influenza,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,58.2,56.3 to 60.2,12650
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,77.0,73.7 to 80.3,2369
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,89.7,87.5 to 92.0,2369
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,89.1,88.3 to 90.0,22343
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,93.9,93.3 to 94.5,37121
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,90.8,88.8 to 92.8,2369
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,84.5,81.4 to 87.6,1616
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,79.0 to 82.7,8905
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,79.3,77.6 to 81.1,12650
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.6,72.5 to 76.8,4715
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,88.7 to 91.6,8905
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,75.3,73.6 to 77.0,22343
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,82.2,81.0 to 83.4,37121
Influenza,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,37.5,33.2 to 41.8,1616
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,47.9,43.4 to 52.3,1616
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.8,80.0 to 83.6,8905
Influenza,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,72.6,71.6 to 73.6,37121
Rotavirus,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,84.6,83.7 to 85.4,37121
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,83.1,80.0 to 86.3,1616
Rotavirus,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.4,74.5 to 78.3,8905
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,89.7,87.6 to 91.8,2369
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,96.4,96.0 to 96.9,37121
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.9,87.3 to 90.5,4715
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.0,89.7 to 92.4,8905
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,90.2,89.1 to 91.4,12650
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,93.2,92.6 to 93.8,37121
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,78.1,77.0 to 79.3,22343
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,78.0,74.9 to 81.2,2369
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.3,91.7 to 92.9,37179
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Insurance Coverage,Uninsured,69.6,65.5 to 73.7,1616
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,78.2,77.3 to 79.1,37121
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.8,74.7 to 78.9,4715
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.8,76.9 to 80.7,8905
Rotavirus,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",66.7,64.4 to 69.1,4715
Rotavirus,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.7,78.9 to 80.6,37179
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Private Insurance Only,77.0,76.0 to 77.9,37121
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,90.9 to 92.1,37179
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.0,87.4 to 90.6,4715
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,91.6 to 94.2,8905
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.2,68.2 to 72.2,8905
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Other,66.6,63.1 to 70.2,2369
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,90.1 to 92.8,8905
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,64.5,63.2 to 65.9,22343
Influenza,,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,78.5,77.2 to 79.7,22558
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Insurance Coverage,Any Medicaid,91.7,90.9 to 92.5,22343
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,82.2,81.5 to 82.9,63449
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,74.8,73.4 to 76.2,16461
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,82.5,81.4 to 83.5,24430
Hib,Full Series,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,72.6,71.1 to 74.0,16461
Hib,Full Series,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,80.0,79.0 to 81.1,24430
Hib,Full Series,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,88.4,87.4 to 89.4,22558
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,89.6,88.7 to 90.5,16461
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,93.0,92.2 to 93.7,24430
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,91.1,90.3 to 91.9,24430
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,89.7,88.7 to 90.8,22558
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,87.8,86.8 to 88.8,16461
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,87.5,86.5 to 88.6,16461
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,90.4,89.6 to 91.3,24430
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,94.5,93.8 to 95.3,22558
Influenza,,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,48.8,47.2 to 50.3,16461
Influenza,,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,58.1,56.7 to 59.4,24430
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,91.8,91.4 to 92.3,63449
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Overall,Overall,93.7,93.3 to 94.1,63449
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,90.4,89.5 to 91.3,16461
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,94.2,93.6 to 94.8,24430
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,95.4,94.7 to 96.0,22558
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,77.8,76.2 to 79.5,24430
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,78.5,77.3 to 79.7,22558
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,91.2,90.3 to 92.1,22558
Rotavirus,,HHS Regions/National,United States,2016-2019,Poverty,<133% FPL,67.6,66.1 to 69.2,16461
≥1 Dose Varicella,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,90.0 to 91.6,27529
Rotavirus,,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,76.7,75.5 to 77.8,24430
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,91.7,90.7 to 92.7,10973
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,91.1,89.7 to 92.5,10973
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,92.1 to 93.5,24947
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,91.7 to 93.1,27529
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,79.1,77.4 to 80.8,10973
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.4,82.3 to 84.4,24947
PCV,≥4 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,81.9,80.8 to 83.0,27529
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,71.1,69.9 to 72.4,24947
Combined 7 Series,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,66.5,64.6 to 68.5,10973
Influenza,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,61.7,60.4 to 62.9,27529
Rotavirus,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,76.3,75.2 to 77.5,27529
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,89.4,88.2 to 90.5,10973
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,82.7,81.0 to 84.4,10973
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.8,85.9 to 87.8,24947
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,87.7,86.8 to 88.5,27529
Rotavirus,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,71.8,69.8 to 73.7,10973
Hib,Full Series,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,77.7,75.9 to 79.5,10973
Hib,Full Series,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.4,79.4 to 81.5,24947
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,91.4,90.6 to 92.1,27529
Hib,Full Series,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,79.6,78.5 to 80.8,27529
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,71.3,68.7 to 73.9,10973
Rotavirus,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.6,76.5 to 78.7,24947
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.7,93.0 to 94.4,24947
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,93.8,93.2 to 94.5,27529
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a Non-MSA,77.1,75.5 to 78.7,10973
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.1,81.0 to 83.2,24947
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,79.6 to 81.9,27529
≥1 Dose MMR,,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.4,90.6 to 92.2,24947
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.3,91.5 to 93.0,24947
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,91.1,90.0 to 92.2,12650
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.8,76.3 to 79.4,24947
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,79.3,77.8 to 80.8,27529
Hep B,≥3 Doses,HHS Regions/National,United States,2016-2019,Urbanicity,Living In a MSA Principal City,91.5,90.7 to 92.3,27529
Hib,Primary Series,HHS Regions/National,United States,2021,Age,19 Months,90.8,89.6 to 91.9,11281
Hib,≥3 Doses,HHS Regions/National,United States,2021,Age,7 Months,53.1,51.2 to 55.1,11281
Hib,≥2 Doses,HHS Regions/National,United States,2021,Age,7 Months,87.0,85.5 to 88.4,11281
Hib,Primary Series,HHS Regions/National,United States,2020-2021,Age,24 Months,91.6,90.8 to 92.3,28668
DTaP,≥4 Doses,HHS Regions/National,United States,2021,Age,24 Months,79.1,77.3 to 80.8,11281
Hib,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,90.1,89.3 to 90.9,28668
≥1 Dose MMR,,HHS Regions/National,United States,2021,Age,35 Months,93.1,91.8 to 94.3,11281
Hep B,≥2 Doses,HHS Regions/National,United States,2021,Age,7 Months,90.5,89.1 to 91.7,11281
PCV,≥2 Doses,HHS Regions/National,United States,2021,Age,5 Months,77.0,75.2 to 78.7,11281
Polio,≥3 Doses,HHS Regions/National,United States,2021,Age,19 Months,90.9,89.7 to 91.9,11281
PCV,≥4 Doses,HHS Regions/National,United States,2020-2021,Age,24 Months,80.7,79.6 to 81.8,28668
Hep B,≥3 Doses,HHS Regions/National,United States,2020-2021,Age,13 Months,87.6,86.8 to 88.5,28668
DTaP,≥3 Doses,HHS Regions/National,United States,2021,Age,7 Months,69.4,67.5 to 71.3,11281
Polio,≥2 Doses,HHS Regions/National,United States,2021,Age,7 Months,87.8,86.3 to 89.1,11281
Polio,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,3 Months,86.1,85.1 to 87.0,28668
Combined 7 Series,,HHS Regions/National,United States,2021,Age,35 Months,72.2,69.6 to 74.7,11281
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,91.0 to 93.7,8905
DTaP,≥1 Dose,HHS Regions/National,United States,2012,Age,3 Months,87.4,86.3 to 88.4,15039
DTaP,≥1 Dose,HHS Regions/National,United States,2011,Age,3 Months,88.1,86.9 to 89.2,14513
DTaP,≥1 Dose,HHS Regions/National,United States,2013,Age,3 Months,87.6,86.6 to 88.5,14872
DTaP,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,3 Months,87.2,86.4 to 88.0,30205
DTaP,≥1 Dose,HHS Regions/National,United States,2014,Age,3 Months,86.8,85.7 to 87.9,15333
DTaP,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,3 Months,87.3,86.5 to 88.1,30796
DTaP,≥1 Dose,HHS Regions/National,United States,2015,Age,3 Months,87.8,86.7 to 88.9,15463
DTaP,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,3 Months,88.2,87.4 to 88.9,31419
DTaP,≥1 Dose,HHS Regions/National,United States,2016,Age,3 Months,88.5,87.3 to 89.6,15956
DTaP,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,3 Months,87.8,87.0 to 88.6,33760
≥1 Dose Varicella,,HHS Regions/National,United States,2020-2021,Age,13 Months,60.6,59.4 to 61.8,28668
Hib,Full Series,HHS Regions/National,United States,2020-2021,Age,24 Months,76.8,75.7 to 77.9,28668
Hib,Full Series,HHS Regions/National,United States,2021,Age,19 Months,70.6,68.7 to 72.4,11281
Hep B,≥3 Doses,HHS Regions/National,United States,2021,Age,19 Months,90.5,89.3 to 91.6,11281
DTaP,≥1 Dose,HHS Regions/National,United States,2018,Age,3 Months,89.9,89.0 to 90.7,18826
DTaP,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,3 Months,90.4,89.8 to 91.0,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2015,Age,24 Months,93.9,93.1 to 94.6,15463
DTaP,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,93.8,93.2 to 94.3,31419
DTaP,≥1 Dose,HHS Regions/National,United States,2017,Age,3 Months,87.1,86.0 to 88.2,17804
DTaP,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,3 Months,88.5,87.8 to 89.2,36630
DTaP,≥3 Doses,HHS Regions/National,United States,2014,Age,24 Months,93.0,92.1 to 93.9,15333
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,24 Months,93.4,92.8 to 94.0,30796
DTaP,≥1 Dose,HHS Regions/National,United States,2019,Age,3 Months,90.9,90.1 to 91.7,17265
DTaP,≥3 Doses,HHS Regions/National,United States,2016,Age,24 Months,93.7,92.8 to 94.4,15956
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,93.2,92.6 to 93.7,33760
Hep A,≥1 Dose,HHS Regions/National,United States,2011,Age,19 Months,75.0,73.0 to 76.9,14513
≥1 Dose MMR,,HHS Regions/National,United States,2020-2021,Age,19 Months,87.7,86.8 to 88.4,28668
≥1 Dose Varicella,,HHS Regions/National,United States,2021,Age,19 Months,87.8,86.5 to 89.0,11281
PCV,≥3 Doses,HHS Regions/National,United States,2021,Age,35 Months,93.0,91.8 to 94.1,11281
Hep A,≥2 Doses,HHS Regions/National,United States,2020-2021,Age,35 Months,77.7,76.1 to 79.2,28668
Hep A,≥1 Dose,HHS Regions/National,United States,2020-2021,Age,24 Months,86.5,85.6 to 87.4,28668
Hep A,≥1 Dose,HHS Regions/National,United States,2012,Age,19 Months,76.8,75.3 to 78.2,15039
Hep A,≥1 Dose,HHS Regions/National,United States,2014,Age,19 Months,78.8,77.4 to 80.0,15333
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,19 Months,79.2,78.2 to 80.1,30796
Hep A,≥1 Dose,HHS Regions/National,United States,2015,Age,19 Months,79.6,77.7 to 81.3,15463
Hep A,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,19 Months,80.2,79.2 to 81.1,31419
DTaP,≥2 Doses,HHS Regions/National,United States,2017,Age,5 Months,78.4,77.1 to 79.8,17804
DTaP,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,5 Months,80.0,79.1 to 80.9,36630
DTaP,≥2 Doses,HHS Regions/National,United States,2018,Age,5 Months,81.6,80.4 to 82.7,18826
DTaP,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,5 Months,81.9,81.0 to 82.7,36091
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.2,91.4 to 93.0,21757
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,90.8,89.6 to 92.0,10389
DTaP,≥2 Doses,HHS Regions/National,United States,2016,Age,5 Months,79.2,77.6 to 80.7,15956
DTaP,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,5 Months,78.8,77.8 to 79.8,33760
DTaP,≥3 Doses,HHS Regions/National,United States,2018,Age,24 Months,94.6,93.9 to 95.2,18826
DTaP,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,94.3,93.8 to 94.7,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2017,Age,24 Months,92.6,91.8 to 93.5,17804
DTaP,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,93.6,93.1 to 94.1,36630
Hib,≥3 Doses,HHS Regions/National,United States,2015,Age,24 Months,91.1,90.1 to 92.0,15463
Hib,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,24 Months,91.0,90.3 to 91.7,31419
Hib,≥3 Doses,HHS Regions/National,United States,2016,Age,24 Months,91.0,89.9 to 92.0,15956
Hib,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,24 Months,90.7,90.0 to 91.4,33760
Hep A,≥2 Doses,HHS Regions/National,United States,2019,Age,19 Months,29.3,28.0 to 30.6,17265
Hep A,≥2 Doses,HHS Regions/National,United States,2011,Age,24 Months,39.9,38.1 to 41.6,14513
Hep A,≥2 Doses,HHS Regions/National,United States,2018,Age,19 Months,26.9,25.7 to 28.1,18826
Hep A,≥2 Doses,HHS Regions/National,United States,2018-2019,Age,19 Months,28.4,27.4 to 29.5,29598
Hib,≥3 Doses,HHS Regions/National,United States,2016,Age,35 Months,92.6,91.5 to 93.6,15956
Hib,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,92.2,91.5 to 92.9,33760
Hib,≥3 Doses,HHS Regions/National,United States,2017,Age,35 Months,91.8,90.8 to 92.7,17804
Hib,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,92.7,92.1 to 93.4,36630
DTaP,≥4 Doses,HHS Regions/National,United States,2013,Age,19 Months,70.6,69.2 to 71.9,14872
DTaP,≥4 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,69.8,68.9 to 70.8,30205
DTaP,≥4 Doses,HHS Regions/National,United States,2014,Age,19 Months,69.1,67.5 to 70.6,15333
DTaP,≥4 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,69.3,68.2 to 70.4,30796
DTaP,≥4 Doses,HHS Regions/National,United States,2015,Age,19 Months,69.6,68.0 to 71.1,15463
DTaP,≥4 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,69.8,68.6 to 70.9,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,91.6,90.8 to 92.3,21000
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,96.0,95.5 to 96.5,31919
Hep A,≥2 Doses,HHS Regions/National,United States,2017,Age,19 Months,27.0,25.7 to 28.3,17804
Hep A,≥2 Doses,HHS Regions/National,United States,2017-2018,Age,19 Months,26.9,26.0 to 27.8,36630
Hib,≥3 Doses,HHS Regions/National,United States,2018,Age,35 Months,93.7,92.8 to 94.5,18826
Hib,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,93.8,93.2 to 94.4,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,81.9,78.9 to 84.9,1692
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,95.8,95.2 to 96.4,18707
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,91.2,90.3 to 92.2,21077
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,89.6,88.7 to 90.6,17073
Polio,≥3 Doses,HHS Regions/National,United States,2014-2017,Overall,Overall,91.9,91.4 to 92.4,56857
Hep A,≥1 Dose,HHS Regions/National,United States,2017,Age,24 Months,85.9,84.8 to 87.0,17804
Hep A,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,24 Months,86.9,86.2 to 87.7,36630
Hep A,≥1 Dose,HHS Regions/National,United States,2019,Age,24 Months,88.3,87.3 to 89.2,17265
Hep A,≥1 Dose,HHS Regions/National,United States,2011,Age,35 Months,87.4,86.0 to 88.8,14513
Hep A,≥1 Dose,HHS Regions/National,United States,2018,Age,24 Months,87.9,86.9 to 88.9,18826
Hep A,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,24 Months,88.1,87.4 to 88.8,36091
DTaP,≥3 Doses,HHS Regions/National,United States,2019,Age,35 Months,95.6,94.8 to 96.3,17265
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,91.7,89.7 to 93.7,2246
DTaP,≥3 Doses,HHS Regions/National,United States,2018,Age,35 Months,95.7,95.0 to 96.4,18826
DTaP,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,35 Months,95.6,95.1 to 96.1,36091
PCV,≥2 Doses,HHS Regions/National,United States,2015,Age,5 Months,75.3,73.8 to 76.8,15463
PCV,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,5 Months,76.1,75.0 to 77.1,31419
PCV,≥2 Doses,HHS Regions/National,United States,2016,Age,5 Months,76.8,75.3 to 78.4,15956
PCV,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,5 Months,76.5,75.4 to 77.5,33760
Hep A,≥1 Dose,HHS Regions/National,United States,2014,Age,24 Months,83.4,82.1 to 84.6,15333
Hep A,≥1 Dose,HHS Regions/National,United States,2014-2015,Age,24 Months,84.0,83.1 to 84.8,30796
Hib,≥3 Doses,HHS Regions/National,United States,2015,Age,35 Months,93.2,92.2 to 94.1,15463
Hib,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,92.9,92.2 to 93.6,31419
Hep A,≥2 Doses,HHS Regions/National,United States,2015,Age,19 Months,24.1,23.0 to 25.3,15463
Hep A,≥2 Doses,HHS Regions/National,United States,2015-2016,Age,19 Months,25.1,24.1 to 26.1,31419
Hep A,≥2 Doses,HHS Regions/National,United States,2016,Age,19 Months,26.0,24.5 to 27.5,15956
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2017,Age,19 Months,26.5,25.5 to 27.5,33760
Hib,≥3 Doses,HHS Regions/National,United States,2013,Age,35 Months,94.1,93.3 to 94.8,14872
Hib,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,92.9,92.3 to 93.6,30205
Hib,≥3 Doses,HHS Regions/National,United States,2014,Age,35 Months,91.8,90.8 to 92.8,15333
Hib,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,92.5,91.8 to 93.1,30796
Hib,≥3 Doses,HHS Regions/National,United States,2019,Age,24 Months,92.6,91.8 to 93.3,17265
Hib,≥3 Doses,HHS Regions/National,United States,2017,Age,24 Months,90.5,89.5 to 91.4,17804
Hib,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,24 Months,91.2,90.6 to 91.8,36630
Hib,≥3 Doses,HHS Regions/National,United States,2018,Age,24 Months,92.0,91.2 to 92.8,18826
Hib,≥3 Doses,HHS Regions/National,United States,2018-2019,Age,24 Months,92.3,91.7 to 92.8,36091
Hep A,≥2 Doses,HHS Regions/National,United States,2013,Age,19 Months,24.1,22.4 to 25.9,14872
Hep A,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,19 Months,23.9,22.6 to 25.2,30205
Hep A,≥2 Doses,HHS Regions/National,United States,2014,Age,19 Months,23.6,22.3 to 25.1,15333
Hep A,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,19 Months,23.9,22.9 to 24.9,30796
Hep A,≥2 Doses,HHS Regions/National,United States,2012,Age,19 Months,21.2,19.9 to 22.5,15039
DTaP,≥2 Doses,HHS Regions/National,United States,2019,Age,5 Months,82.2,81.0 to 83.3,17265
Hep A,≥2 Doses,HHS Regions/National,United States,2011,Age,19 Months,20.2,19.0 to 21.4,14513
DTaP,≥3 Doses,HHS Regions/National,United States,2014,Age,35 Months,94.5,93.5 to 95.3,15333
DTaP,≥3 Doses,HHS Regions/National,United States,2014-2015,Age,35 Months,94.9,94.3 to 95.4,30796
DTaP,≥3 Doses,HHS Regions/National,United States,2013,Age,35 Months,95.6,94.9 to 96.2,14872
DTaP,≥3 Doses,HHS Regions/National,United States,2013-2014,Age,35 Months,95.0,94.5 to 95.6,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2012,Age,35 Months,95.3,94.6 to 95.9,15039
DTaP,≥3 Doses,HHS Regions/National,United States,2011,Age,35 Months,95.0,93.9 to 95.9,14513
Hep A,≥1 Dose,HHS Regions/National,United States,2018,Age,19 Months,83.8,82.7 to 84.8,18826
Hep A,≥1 Dose,HHS Regions/National,United States,2018-2019,Age,19 Months,84.2,83.3 to 85.1,29598
Hep A,≥1 Dose,HHS Regions/National,United States,2017,Age,19 Months,81.8,80.5 to 82.9,17804
Hep A,≥1 Dose,HHS Regions/National,United States,2017-2018,Age,19 Months,82.8,81.9 to 83.6,36630
Hep A,≥1 Dose,HHS Regions/National,United States,2015,Age,24 Months,84.6,83.4 to 85.7,15463
Hep A,≥1 Dose,HHS Regions/National,United States,2015-2016,Age,24 Months,84.9,84.1 to 85.8,31419
Hep A,≥1 Dose,HHS Regions/National,United States,2016,Age,24 Months,85.3,84.1 to 86.5,15956
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,24 Months,85.6,84.8 to 86.4,33760
PCV,≥2 Doses,HHS Regions/National,United States,2014,Age,5 Months,74.4,72.9 to 75.8,15333
PCV,≥2 Doses,HHS Regions/National,United States,2014-2015,Age,5 Months,74.8,73.5 to 76.1,30796
Hep A,≥1 Dose,HHS Regions/National,United States,2016,Age,19 Months,80.8,79.4 to 82.2,15956
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2017,Age,19 Months,81.3,80.3 to 82.2,33760
Hib,≥2 Doses,HHS Regions/National,United States,2020,Age,13 Months,92.1,91.2 to 92.9,17387
Hep A,≥1 Dose,HHS Regions/National,United States,2012,Age,24 Months,82.8,81.6 to 84.1,15039
Hep A,≥1 Dose,HHS Regions/National,United States,2019,Age,19 Months,84.5,83.4 to 85.5,17265
Hep A,≥1 Dose,HHS Regions/National,United States,2011,Age,24 Months,80.6,79.2 to 81.9,14513
Hep A,≥1 Dose,HHS Regions/National,United States,2013,Age,24 Months,83.1,81.9 to 84.3,14872
Hep A,≥1 Dose,HHS Regions/National,United States,2013-2014,Age,24 Months,83.2,82.4 to 84.1,30205
DTaP,≥3 Doses,HHS Regions/National,United States,2017,Age,35 Months,93.8,92.9 to 94.6,17804
DTaP,≥3 Doses,HHS Regions/National,United States,2017-2018,Age,35 Months,94.7,94.2 to 95.3,36630
DTaP,≥4 Doses,HHS Regions/National,United States,2011,Age,19 Months,69.2,67.6 to 70.7,14513
DTaP,≥4 Doses,HHS Regions/National,United States,2012,Age,19 Months,69.0,67.5 to 70.5,15039
PCV,≥2 Doses,HHS Regions/National,United States,2013,Age,5 Months,74.2,72.8 to 75.6,14872
PCV,≥2 Doses,HHS Regions/National,United States,2013-2014,Age,5 Months,74.3,73.1 to 75.4,30205
PCV,≥2 Doses,HHS Regions/National,United States,2012,Age,5 Months,74.3,73.0 to 75.6,15039
PCV,≥2 Doses,HHS Regions/National,United States,2011,Age,5 Months,74.6,73.0 to 76.2,14513
DTaP,≥3 Doses,HHS Regions/National,United States,2015,Age,35 Months,95.3,94.6 to 96.0,15463
DTaP,≥3 Doses,HHS Regions/National,United States,2015-2016,Age,35 Months,94.9,94.4 to 95.4,31419
DTaP,≥3 Doses,HHS Regions/National,United States,2016,Age,35 Months,94.6,93.7 to 95.4,15956
DTaP,≥3 Doses,HHS Regions/National,United States,2016-2017,Age,35 Months,94.2,93.6 to 94.8,33760
Hib,Primary Series,HHS Regions/National,Region 1,2020-2021,Age,19 Months,95.5,93.9 to 96.7,2578
PCV,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,78.3,75.1 to 81.2,2578
Hep A,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,32.7,29.5 to 36.2,2578
Hib,Primary Series,HHS Regions/National,Region 1,2020-2021,Age,35 Months,96.1,94.6 to 97.2,2578
Hib,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,5 Months,87.5,84.9 to 89.7,2578
DTaP,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,3 Months,93.8,91.9 to 95.3,2578
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2020-2021,Age,0-2 Days,83.3,80.1 to 86.1,2578
≥1 Dose MMR,,HHS Regions/National,Region 1,2020-2021,Age,13 Months,73.2,69.7 to 76.4,2578
Hib,Full Series,HHS Regions/National,Region 1,2020-2021,Age,35 Months,93.2,90.2 to 95.6,2578
Hep B,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,3 Months,96.9,95.8 to 97.7,2578
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020-2021,Age,19 Months,92.6,90.4 to 94.3,2578
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,94.9,93.2 to 96.2,2578
DTaP,≥4 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,78.5,75.1 to 81.6,2578
Polio,≥2 Doses,HHS Regions/National,Region 1,2021,Age,5 Months,89.3,85.7 to 92.0,1042
PCV,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,5 Months,87.2,84.5 to 89.5,2578
Hep B,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,5 Months,94.4,92.9 to 95.7,2578
Combined 7 Series,,HHS Regions/National,Region 1,2020-2021,Age,35 Months,88.6,85.0 to 91.7,2578
Polio,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,95.9,94.4 to 97.0,2578
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,96.2,94.6 to 97.3,2578
Polio,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,98.1,95.9 to 99.3,2578
Hib,≥2 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,97.4,95.4 to 98.5,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,95.8,94.1 to 97.1,2578
≥1 Dose MMR,,HHS Regions/National,Region 1,2020-2021,Age,24 Months,94.9,92.9 to 96.5,2578
Hib,Primary Series,HHS Regions/National,Region 1,2020-2021,Age,13 Months,92.9,91.1 to 94.4,2578
Hib,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,3 Months,92.0,89.8 to 93.8,2578
Hib,Primary Series,HHS Regions/National,Region 1,2020-2021,Age,7 Months,79.5,76.4 to 82.3,2578
DTaP,≥3 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,97.3,95.5 to 98.6,1042
Hib,Full Series,HHS Regions/National,Region 1,2021,Age,35 Months,95.6,88.8 to 98.9,1042
Hep B,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,95.3,93.8 to 96.4,2578
PCV,≥4 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,93.6,91.3 to 95.5,2578
DTaP,≥4 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,93.7,90.0 to 96.4,1042
Polio,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,95.4,93.9 to 96.5,2578
≥1 Dose MMR,,HHS Regions/National,Region 1,2020-2021,Age,35 Months,96.5,94.5 to 97.9,2578
Hib,Primary Series,HHS Regions/National,Region 1,2021,Age,13 Months,93.7,91.3 to 95.5,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,95.3,93.4 to 96.6,2578
Hep B,≥3 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,97.2,95.7 to 98.3,1042
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,72.2,68.9 to 75.2,2578
Hep A,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,51.9,48.2 to 55.7,2578
Hib,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,94.6,93.0 to 95.8,2578
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020-2021,Age,24 Months,95.0,93.2 to 96.5,2578
Hib,≥3 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,82.3,78.7 to 85.3,1042
DTaP,≥3 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,97.3,95.5 to 98.6,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,97.1,95.2 to 98.4,1042
PCV,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,3 Months,91.9,89.6 to 93.8,2578
Hib,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,67.9,64.6 to 71.0,2578
Polio,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,5 Months,89.4,87.0 to 91.3,2578
DTaP,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,5 Months,89.7,87.3 to 91.7,2578
Hib,Primary Series,HHS Regions/National,Region 1,2021,Age,35 Months,97.0,95.0 to 98.3,1042
Hep B,≥3 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,93.8,91.1 to 95.8,1042
Influenza,,HHS Regions/National,Region 1,2019,Age,24 Months,82.9,79.2 to 86.3,1675
Influenza,,HHS Regions/National,Region 1,2016,Age,24 Months,76.4,72.3 to 80.3,1421
Influenza,,HHS Regions/National,Region 1,2016-2017,Age,24 Months,78.1,75.4 to 80.8,3005
PCV,≥1 Dose,HHS Regions/National,Region 1,2021,Age,3 Months,92.2,88.3 to 94.9,1042
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,96.0,94.6 to 97.1,2578
≥1 Dose MMR,,HHS Regions/National,Region 1,2021,Age,13 Months,74.0,68.8 to 78.7,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,93.3,91.2 to 94.9,2578
Influenza,,HHS Regions/National,Region 1,2017,Age,24 Months,79.9,76.2 to 83.4,1584
Influenza,,HHS Regions/National,Region 1,2017-2018,Age,24 Months,79.5,76.8 to 82.0,3342
Influenza,,HHS Regions/National,Region 1,2018,Age,24 Months,79.0,75.1 to 82.6,1758
Influenza,,HHS Regions/National,Region 1,2018-2019,Age,24 Months,80.9,78.3 to 83.5,3433
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,80.8,77.7 to 83.5,2578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2021,Age,0-3 Days,83.8,78.5 to 88.0,1042
Rotavirus,,HHS Regions/National,Region 1,2021,Age,8 Months,87.4,84.2 to 90.1,1042
Polio,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,96.4,95.1 to 97.5,2578
≥1 Dose Varicella,,HHS Regions/National,Region 1,2021,Age,13 Months,62.4,56.5 to 68.0,1042
Polio,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,96.8,95.5 to 97.7,2578
Influenza,,HHS Regions/National,Region 1,2021,Age,24 Months,76.1,70.4 to 81.4,1042
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2021,Age,0-1 Days,81.4,76.1 to 85.8,1042
Hib,≥2 Doses,HHS Regions/National,Region 1,2021,Age,5 Months,87.3,83.2 to 90.4,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,94.0,91.0 to 96.0,1042
Hep B,≥2 Doses,HHS Regions/National,Region 1,2021,Age,5 Months,95.8,94.0 to 97.0,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,95.3,93.1 to 96.8,1042
DTaP,≥2 Doses,HHS Regions/National,Region 1,2021,Age,5 Months,89.7,86.1 to 92.4,1042
≥1 Dose MMR,,HHS Regions/National,Region 1,2021,Age,19 Months,93.7,90.1 to 96.0,1042
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2020-2021,Age,0-3 Days,83.8,80.7 to 86.6,2578
Rotavirus,,HHS Regions/National,Region 1,2020-2021,Age,8 Months,85.8,83.4 to 88.0,2578
PCV,≥4 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,86.9,83.9 to 89.5,2578
Hep B,≥2 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,97.8,96.6 to 98.6,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,96.2,94.7 to 97.4,2578
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2020-2021,Age,0-1 Days,80.3,77.0 to 83.2,2578
Influenza,,HHS Regions/National,Region 1,2020-2021,Age,24 Months,75.0,71.3 to 78.5,2578
Combined 7 Series,,HHS Regions/National,Region 1,2020-2021,Age,24 Months,79.6,76.3 to 82.7,2578
Hep A,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,35 Months,97.4,94.5 to 99.0,2578
Hib,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,7 Months,94.7,93.0 to 96.0,2578
Polio,≥3 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,97.4,95.7 to 98.6,1042
Hep A,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,19 Months,88.4,85.6 to 90.7,2578
Hib,Full Series,HHS Regions/National,Region 1,2020-2021,Age,19 Months,82.8,79.9 to 85.3,2578
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,96.7,95.2 to 97.8,2578
≥1 Dose Varicella,,HHS Regions/National,Region 1,2021,Age,35 Months,99.5,97.6 to 100.0,1042
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,98.6,96.1 to 99.7,2578
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,19 Months,95.7,94.3 to 96.8,2578
DTaP,≥4 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,87.8,85.1 to 90.2,2578
Influenza,,HHS Regions/National,Region 1,2014,Age,24 Months,68.6,64.5 to 72.5,1564
Influenza,,HHS Regions/National,Region 1,2014-2015,Age,24 Months,70.7,67.7 to 73.5,3073
Influenza,,HHS Regions/National,Region 1,2015,Age,24 Months,72.8,68.6 to 76.8,1509
Influenza,,HHS Regions/National,Region 1,2015-2016,Age,24 Months,74.6,71.7 to 77.4,2930
Influenza,,HHS Regions/National,Region 1,2013,Age,24 Months,75.3,71.5 to 79.0,1537
Influenza,,HHS Regions/National,Region 1,2013-2014,Age,24 Months,72.0,69.2 to 74.7,3101
Influenza,,HHS Regions/National,Region 1,2012,Age,24 Months,73.7,69.7 to 77.6,1457
Influenza,,HHS Regions/National,Region 1,2011,Age,24 Months,73.1,68.8 to 77.3,1422
Hib,Primary Series,States/Local Areas,Wyoming,2015,Age,7 Months,67.4,60.3 to 73.8,283
Hib,Primary Series,States/Local Areas,Wyoming,2015-2016,Age,7 Months,68.9,63.9 to 73.5,514
Hib,Primary Series,States/Local Areas,Wyoming,2017,Age,19 Months,91.7,87.4 to 94.6,287
Hib,Primary Series,States/Local Areas,Wyoming,2017-2018,Age,19 Months,91.8,88.7 to 94.1,567
Hib,Primary Series,States/Local Areas,Wyoming,2015,Age,19 Months,91.9,90.3 to 93.2,283
Hib,Primary Series,States/Local Areas,Wyoming,2015-2016,Age,19 Months,91.0,87.5 to 93.5,514
Hib,Primary Series,States/Local Areas,Wyoming,2018,Age,19 Months,91.9,86.8 to 95.1,280
Hib,Primary Series,States/Local Areas,Wyoming,2018-2019,Age,19 Months,89.3,85.5 to 92.2,540
Hib,Primary Series,States/Local Areas,Wyoming,2016,Age,19 Months,90.1,84.7 to 93.7,231
Hib,Primary Series,States/Local Areas,Wyoming,2016-2017,Age,19 Months,90.8,87.5 to 93.3,518
Hib,Primary Series,States/Local Areas,Wyoming,2018,Age,7 Months,77.1,70.3 to 82.8,280
Hib,Primary Series,States/Local Areas,Wyoming,2018-2019,Age,7 Months,75.7,70.6 to 80.1,540
Hib,Primary Series,States/Local Areas,Wyoming,2020,Age,24 Months,90.6,85.7 to 94.4,296
Hib,Primary Series,States/Local Areas,Wyoming,2011,Age,13 Months,86.6,83.5 to 89.1,214
Hib,Primary Series,States/Local Areas,Wyoming,2012,Age,13 Months,88.2,85.8 to 90.3,217
Hib,Primary Series,States/Local Areas,Wyoming,2013,Age,13 Months,91.0,84.0 to 95.1,215
Hib,Primary Series,States/Local Areas,Wyoming,2013-2014,Age,13 Months,86.8,81.5 to 90.7,480
Polio,≥1 Dose,States/Local Areas,Wyoming,2020,Age,3 Months,87.0,81.0 to 91.3,296
DTaP,≥1 Dose,States/Local Areas,Wyoming,2020,Age,3 Months,88.0,82.2 to 92.0,296
Hep B,≥2 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,90.3,84.8 to 94.0,296
Hib,≥1 Dose,States/Local Areas,Wyoming,2020,Age,3 Months,87.0,81.0 to 91.3,296
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,78.0,71.1 to 83.6,296
PCV,≥3 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,69.5,62.0 to 76.1,296
Hib,Primary Series,States/Local Areas,Wyoming,2017,Age,7 Months,71.2,64.1 to 77.4,287
Hib,Primary Series,States/Local Areas,Wyoming,2017-2018,Age,7 Months,74.0,69.1 to 78.3,567
Hib,Primary Series,States/Local Areas,Wyoming,2016,Age,7 Months,70.3,63.0 to 76.7,231
Hib,Primary Series,States/Local Areas,Wyoming,2016-2017,Age,7 Months,70.8,65.7 to 75.3,518
Hib,Primary Series,States/Local Areas,Wyoming,2011,Age,24 Months,88.4,82.1 to 93.2,214
Hib,Primary Series,States/Local Areas,Wyoming,2012,Age,24 Months,93.2,87.3 to 97.0,217
Hib,Primary Series,States/Local Areas,Wyoming,2013,Age,7 Months,75.8,71.4 to 79.7,215
Hib,Primary Series,States/Local Areas,Wyoming,2013-2014,Age,7 Months,69.8,64.9 to 74.3,480
Hib,Primary Series,States/Local Areas,Wyoming,2014,Age,7 Months,63.6,56.0 to 70.5,265
Hib,Primary Series,States/Local Areas,Wyoming,2014-2015,Age,7 Months,65.5,60.4 to 70.3,548
Hib,Primary Series,States/Local Areas,Wyoming,2012,Age,7 Months,70.6,64.3 to 76.3,217
Hib,Primary Series,States/Local Areas,Wyoming,2014,Age,13 Months,82.4,76.5 to 87.1,265
Hib,Primary Series,States/Local Areas,Wyoming,2014-2015,Age,13 Months,85.5,81.7 to 88.6,548
Hib,Primary Series,States/Local Areas,Wyoming,2015,Age,13 Months,88.5,83.2 to 92.3,283
Hib,Primary Series,States/Local Areas,Wyoming,2015-2016,Age,13 Months,86.7,82.9 to 89.8,514
Hib,Full Series,States/Local Areas,Wyoming,2019,Age,19 Months,78.1,70.7 to 84.1,260
Combined 7 Series,,States/Local Areas,Wyoming,2011,Age,35 Months,66.0,57.3 to 74.6,214
Combined 7 Series,,States/Local Areas,Wyoming,2016,Age,35 Months,75.0,68.1 to 81.4,231
Combined 7 Series,,States/Local Areas,Wyoming,2016-2017,Age,35 Months,74.3,69.4 to 78.9,518
Combined 7 Series,,States/Local Areas,Wyoming,2012,Age,35 Months,83.6,71.3 to 92.7,217
Combined 7 Series,,States/Local Areas,Wyoming,2014,Age,35 Months,69.3,62.2 to 76.1,265
Combined 7 Series,,States/Local Areas,Wyoming,2014-2015,Age,35 Months,70.7,65.1 to 76.1,548
Hib,Primary Series,States/Local Areas,Wyoming,2019,Age,19 Months,91.8,85.9 to 95.4,260
Combined 7 Series,,States/Local Areas,Wyoming,2014,Age,24 Months,64.9,57.8 to 72.0,265
Combined 7 Series,,States/Local Areas,Wyoming,2014-2015,Age,24 Months,64.0,59.0 to 69.0,548
Combined 7 Series,,States/Local Areas,Wyoming,2013,Age,24 Months,71.8,63.7 to 79.4,215
Combined 7 Series,,States/Local Areas,Wyoming,2013-2014,Age,24 Months,68.4,63.1 to 73.7,480
Combined 7 Series,,States/Local Areas,Wyoming,2019,Age,24 Months,72.7,65.1 to 79.9,260
Combined 7 Series,,States/Local Areas,Wyoming,2016,Age,24 Months,72.3,65.4 to 78.9,231
Combined 7 Series,,States/Local Areas,Wyoming,2016-2017,Age,24 Months,71.2,66.3 to 75.9,518
Hib,Primary Series,States/Local Areas,Wyoming,2019,Age,35 Months,92.8,87.3 to 96.5,260
Hib,Primary Series,States/Local Areas,Wyoming,2018,Age,35 Months,94.6,91.1 to 97.1,280
Hib,Primary Series,States/Local Areas,Wyoming,2018-2019,Age,35 Months,93.7,90.5 to 96.1,540
Combined 7 Series,,States/Local Areas,Wyoming,2015,Age,24 Months,63.1,56.1 to 70.1,283
Combined 7 Series,,States/Local Areas,Wyoming,2015-2016,Age,24 Months,67.8,62.9 to 72.7,514
Combined 7 Series,,States/Local Areas,Wyoming,2018,Age,24 Months,69.9,62.7 to 76.9,280
Combined 7 Series,,States/Local Areas,Wyoming,2018-2019,Age,24 Months,71.4,66.2 to 76.4,540
Combined 7 Series,,States/Local Areas,Wyoming,2017,Age,24 Months,69.6,62.8 to 76.1,287
Combined 7 Series,,States/Local Areas,Wyoming,2017-2018,Age,24 Months,69.8,64.8 to 74.6,567
Hib,Primary Series,States/Local Areas,Wyoming,2017,Age,35 Months,92.8,89.2 to 95.5,287
Hib,Primary Series,States/Local Areas,Wyoming,2017-2018,Age,35 Months,93.6,91.2 to 95.6,567
Combined 7 Series,,States/Local Areas,Wyoming,2013,Age,35 Months,79.2,71.3 to 86.1,215
Combined 7 Series,,States/Local Areas,Wyoming,2013-2014,Age,35 Months,74.3,69.0 to 79.3,480
Hib,Full Series,States/Local Areas,Wyoming,2012,Age,24 Months,81.0,72.8 to 87.9,217
Hib,Full Series,States/Local Areas,Wyoming,2011,Age,24 Months,73.1,64.6 to 81.0,214
Hib,Full Series,States/Local Areas,Wyoming,2013,Age,24 Months,78.8,71.0 to 85.6,215
Hib,Full Series,States/Local Areas,Wyoming,2013-2014,Age,24 Months,77.1,72.1 to 81.8,480
Hib,Full Series,States/Local Areas,Wyoming,2013,Age,19 Months,75.5,71.5 to 79.0,215
Hib,Full Series,States/Local Areas,Wyoming,2013-2014,Age,19 Months,71.7,68.2 to 74.9,480
Hib,Full Series,States/Local Areas,Wyoming,2015,Age,19 Months,71.6,69.9 to 73.3,283
Hib,Full Series,States/Local Areas,Wyoming,2015-2016,Age,19 Months,74.8,70.0 to 79.0,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,88.1,82.6 to 92.0,296
Hib,Primary Series,States/Local Areas,Wyoming,2011,Age,19 Months,88.0,85.6 to 90.1,214
Hib,Primary Series,States/Local Areas,Wyoming,2013,Age,19 Months,94.9,87.4 to 98.1,215
Hib,Primary Series,States/Local Areas,Wyoming,2013-2014,Age,19 Months,92.6,87.2 to 95.8,480
Hib,Primary Series,States/Local Areas,Wyoming,2019,Age,13 Months,88.2,82.1 to 92.5,260
Hib,Primary Series,States/Local Areas,Wyoming,2014,Age,19 Months,90.1,85.8 to 93.2,265
Hib,Primary Series,States/Local Areas,Wyoming,2014-2015,Age,19 Months,91.0,88.0 to 93.3,548
Hib,Primary Series,States/Local Areas,Wyoming,2012,Age,19 Months,89.5,86.0 to 92.1,217
Hib,Primary Series,States/Local Areas,Wyoming,2018,Age,13 Months,90.6,85.6 to 94.0,280
Hib,Primary Series,States/Local Areas,Wyoming,2018-2019,Age,13 Months,89.3,85.5 to 92.2,540
Hib,Primary Series,States/Local Areas,Wyoming,2016,Age,13 Months,85.0,79.0 to 89.5,231
Hib,Primary Series,States/Local Areas,Wyoming,2016-2017,Age,13 Months,86.4,82.5 to 89.6,518
Hib,Primary Series,States/Local Areas,Wyoming,2019,Age,7 Months,74.3,66.4 to 80.9,260
Hib,Primary Series,States/Local Areas,Wyoming,2017,Age,13 Months,88.1,82.6 to 92.0,287
Hib,Primary Series,States/Local Areas,Wyoming,2017-2018,Age,13 Months,89.2,85.7 to 92.0,567
Hib,Primary Series,States/Local Areas,Wyoming,2015,Age,35 Months,93.1,88.9 to 96.1,283
Hib,Primary Series,States/Local Areas,Wyoming,2015-2016,Age,35 Months,92.4,89.3 to 94.8,514
Hib,Primary Series,States/Local Areas,Wyoming,2016,Age,35 Months,91.7,87.1 to 95.1,231
Hib,Primary Series,States/Local Areas,Wyoming,2016-2017,Age,35 Months,92.2,89.3 to 94.6,518
Hib,Primary Series,States/Local Areas,Wyoming,2012,Age,35 Months,95.9,90.6 to 98.7,217
Combined 7 Series,,States/Local Areas,Wyoming,2011,Age,24 Months,64.6,56.0 to 73.1,214
Hib,Primary Series,States/Local Areas,Wyoming,2013,Age,24 Months,94.9,90.5 to 97.7,215
Hib,Primary Series,States/Local Areas,Wyoming,2013-2014,Age,24 Months,92.7,89.8 to 94.9,480
Combined 7 Series,,States/Local Areas,Wyoming,2012,Age,24 Months,68.1,58.8 to 77.1,217
Hib,Primary Series,States/Local Areas,Wyoming,2013,Age,35 Months,94.9,90.5 to 97.7,215
Hib,Primary Series,States/Local Areas,Wyoming,2013-2014,Age,35 Months,92.7,89.8 to 94.9,480
Hib,Primary Series,States/Local Areas,Wyoming,2011,Age,35 Months,89.6,83.1 to 94.3,214
Hib,Primary Series,States/Local Areas,Wyoming,2019,Age,24 Months,92.5,87.1 to 96.2,260
Hib,Primary Series,States/Local Areas,Wyoming,2014,Age,24 Months,90.3,86.2 to 93.6,265
Hib,Primary Series,States/Local Areas,Wyoming,2014-2015,Age,24 Months,91.5,88.7 to 93.8,548
Hib,Primary Series,States/Local Areas,Wyoming,2015,Age,24 Months,92.6,88.4 to 95.7,283
Hib,Primary Series,States/Local Areas,Wyoming,2015-2016,Age,24 Months,92.1,89.1 to 94.6,514
Hib,Primary Series,States/Local Areas,Wyoming,2017,Age,24 Months,92.8,89.2 to 95.5,287
Hib,Primary Series,States/Local Areas,Wyoming,2017-2018,Age,24 Months,93.6,91.2 to 95.6,567
Hib,Primary Series,States/Local Areas,Wyoming,2018,Age,24 Months,94.6,91.1 to 97.1,280
Hib,Primary Series,States/Local Areas,Wyoming,2018-2019,Age,24 Months,93.5,90.3 to 95.9,540
Hib,Primary Series,States/Local Areas,Wyoming,2016,Age,24 Months,91.7,87.1 to 95.1,231
Hib,Primary Series,States/Local Areas,Wyoming,2016-2017,Age,24 Months,92.2,89.3 to 94.6,518
Hib,Primary Series,States/Local Areas,Wyoming,2014,Age,35 Months,90.3,86.2 to 93.6,265
Hib,Primary Series,States/Local Areas,Wyoming,2014-2015,Age,35 Months,91.7,88.9 to 94.0,548
Rotavirus,,States/Local Areas,Wyoming,2019-2020,Age,8 Months,79.2,74.4 to 83.3,556
≥1 Dose MMR,,States/Local Areas,Wyoming,2020-2021,Age,13 Months,62.5,55.9 to 68.6,497
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2021,Age,0-1 Days,71.3,61.1 to 79.7,201
PCV,≥3 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,86.2,77.4 to 92.0,201
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020-2021,Age,35 Months,90.5,85.0 to 94.6,497
Hep A,≥1 Dose,States/Local Areas,Wyoming,2021,Age,24 Months,85.3,76.8 to 91.9,201
PCV,≥4 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,79.2,70.1 to 87.0,201
PCV,≥3 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,90.7,83.5 to 95.7,201
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2021,Age,0-2 Days,71.3,61.1 to 79.7,201
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,93.0,88.8 to 96.0,497
≥1 Dose Varicella,,States/Local Areas,Wyoming,2021,Age,24 Months,89.5,81.2 to 95.2,201
Hep B,≥2 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,92.1,84.0 to 96.3,201
Hib,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,92.2,87.8 to 95.1,497
Hib,Primary Series,States/Local Areas,Wyoming,2021,Age,24 Months,92.3,85.1 to 96.9,201
Polio,≥1 Dose,States/Local Areas,Wyoming,2021,Age,3 Months,92.8,84.8 to 96.8,201
Hib,≥3 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,88.2,80.0 to 94.1,201
≥1 Dose MMR,,States/Local Areas,Wyoming,2021,Age,24 Months,91.1,83.3 to 96.2,201
Polio,≥3 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,92.0,84.7 to 96.7,201
Hep A,≥1 Dose,States/Local Areas,Wyoming,2021,Age,35 Months,92.5,80.0 to 98.5,201
PCV,≥3 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,89.5,81.1 to 94.5,201
DTaP,≥1 Dose,States/Local Areas,Wyoming,2021,Age,3 Months,92.8,84.8 to 96.8,201
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,90.9,86.5 to 94.3,497
≥1 Dose Varicella,,States/Local Areas,Wyoming,2021,Age,19 Months,85.3,75.5 to 91.6,201
Hib,≥3 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,36.4,27.2 to 46.7,201
Hib,Full Series,States/Local Areas,Wyoming,2021,Age,24 Months,80.2,71.3 to 87.7,201
PCV,≥3 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,60.1,49.3 to 69.9,201
DTaP,≥3 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,88.2,79.6 to 93.5,201
Hep A,≥2 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,54.0,43.6 to 65.2,201
Hep A,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,31.2,25.5 to 37.6,497
Hep B,≥3 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,76.4,66.0 to 84.4,201
PCV,≥4 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,81.4,71.9 to 89.3,201
Hib,Primary Series,States/Local Areas,Wyoming,2020-2021,Age,13 Months,88.6,83.9 to 92.1,497
DTaP,≥4 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,76.8,67.0 to 85.5,201
Hep A,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,35 Months,86.4,80.8 to 91.0,497
DTaP,≥3 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,90.6,82.0 to 95.3,201
Hep A,≥1 Dose,States/Local Areas,Wyoming,2021,Age,19 Months,80.0,70.3 to 87.1,201
Influenza,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.2,43.6 to 74.8,66
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,93.3,88.8 to 97.8,141
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,89.8 to 94.4,744
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,97.8,95.2 to 100.0,40
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,83.2,72.7 to 93.8,68
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.0,73.2 to 80.7,744
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,98.6,96.5 to 100.0,40
DTaP,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,3 Months,90.4,86.0 to 93.5,497
Hep B,≥3 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,91.7,83.9 to 96.7,201
PCV,≥4 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,75.9,65.7 to 83.9,201
Hib,Primary Series,States/Local Areas,Wyoming,2019-2020,Age,7 Months,76.2,71.1 to 80.6,556
Hep B,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,92.8,89.3 to 95.2,556
Hib,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,89.7,85.0 to 93.5,497
Hib,Primary Series,States/Local Areas,Wyoming,2020-2021,Age,35 Months,92.5,88.3 to 95.6,497
≥1 Dose Varicella,,States/Local Areas,Wyoming,2021,Age,35 Months,89.5,81.2 to 95.2,201
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,81.0,73.7 to 88.4,141
Hib,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,85.6,80.2 to 89.8,497
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2020-2021,Age,0-2 Days,74.4,68.2 to 79.8,497
Hib,Full Series,States/Local Areas,Wyoming,2020-2021,Age,19 Months,74.8,68.6 to 80.1,497
Hep A,≥2 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,33.4,24.4 to 43.7,201
Hib,Full Series,States/Local Areas,Wyoming,2020-2021,Age,35 Months,81.5,75.9 to 86.5,497
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2020-2021,Age,0-1 Days,74.4,68.2 to 79.8,497
Hep A,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,19 Months,78.1,72.2 to 83.1,497
Combined 7 Series,,States/Local Areas,Wyoming,2021,Age,24 Months,63.6,53.4 to 73.7,201
Hep B,≥2 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,93.5,85.1 to 97.3,201
Hib,≥2 Doses,States/Local Areas,Wyoming,2021,Age,5 Months,78.6,68.7 to 86.0,201
Hep A,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,48.5,41.9 to 55.4,497
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020-2021,Age,24 Months,87.9,82.9 to 92.0,497
Hib,≥2 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,92.6,84.2 to 96.7,201
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,90.3,85.9 to 93.8,497
PCV,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,86.3,81.3 to 90.2,497
Polio,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,93.0,88.7 to 96.1,497
Hib,Primary Series,States/Local Areas,Wyoming,2020-2021,Age,7 Months,78.1,72.2 to 83.0,497
Polio,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,89.3,84.5 to 92.7,497
PCV,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,89.7,85.4 to 93.2,497
Hib,≥3 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,54.6,44.3 to 64.6,201
DTaP,≥4 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,68.2,61.8 to 74.1,497
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,68.1,61.5 to 74.0,497
Hep B,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,5 Months,86.5,81.0 to 90.5,497
Hib,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,5 Months,79.0,73.2 to 83.9,497
Polio,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,90.4,86.1 to 93.8,497
Polio,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,3 Months,89.9,85.5 to 93.2,497
Hib,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,3 Months,88.9,84.3 to 92.3,497
PCV,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,91.4,87.1 to 94.7,497
Combined 7 Series,,States/Local Areas,Wyoming,2020-2021,Age,24 Months,65.2,58.7 to 71.5,497
Hep B,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,91.2,86.8 to 94.3,497
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020-2021,Age,19 Months,84.5,78.8 to 88.8,497
Rotavirus,,States/Local Areas,Wyoming,2021,Age,8 Months,77.2,67.3 to 84.7,201
Combined 7 Series,,States/Local Areas,Wyoming,2020-2021,Age,35 Months,72.5,64.9 to 79.6,497
≥1 Dose MMR,,States/Local Areas,Wyoming,2020-2021,Age,35 Months,92.2,86.9 to 95.9,497
Polio,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,5 Months,80.1,74.3 to 84.9,497
Hib,Primary Series,States/Local Areas,Wyoming,2020-2021,Age,19 Months,90.8,86.2 to 94.0,497
PCV,≥4 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,80.5,74.8 to 85.6,497
Polio,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,90.3,85.8 to 93.5,497
DTaP,≥4 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,89.2,73.8 to 97.5,201
PCV,≥4 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,74.6,68.4 to 80.0,497
Influenza,,States/Local Areas,Wyoming,2020-2021,Age,24 Months,54.3,47.9 to 60.9,497
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,77.2,71.1 to 82.3,497
PCV,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,88.7,84.0 to 92.2,497
Hib,Primary Series,States/Local Areas,Wyoming,2021,Age,13 Months,88.4,79.9 to 93.6,201
Hep B,≥3 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,91.7,83.9 to 96.7,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2020-2021,Age,0-3 Days,74.5,68.2 to 79.8,497
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,90.9,86.7 to 94.2,497
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2021,Age,0-3 Days,71.4,61.2 to 79.8,201
Hib,Full Series,States/Local Areas,Wyoming,2021,Age,35 Months,83.0,72.5 to 91.2,201
DTaP,≥3 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,92.7,85.0 to 97.3,201
Rotavirus,,States/Local Areas,Wyoming,2020-2021,Age,8 Months,77.0,71.1 to 82.0,497
Hib,≥3 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,88.8,80.4 to 94.7,201
PCV,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,3 Months,88.3,83.5 to 91.8,497
≥1 Dose MMR,,States/Local Areas,Wyoming,2021,Age,13 Months,64.8,54.1 to 74.3,201
Influenza,,States/Local Areas,Wyoming,2021,Age,24 Months,54.2,44.2 to 64.8,201
≥1 Dose MMR,,States/Local Areas,Wyoming,2020-2021,Age,19 Months,86.3,80.8 to 90.4,497
Hep A,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,69.0,61.3 to 76.3,497
Hib,Primary Series,States/Local Areas,Wyoming,2021,Age,35 Months,92.9,85.4 to 97.4,201
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020-2021,Age,13 Months,60.6,54.0 to 66.9,497
Hep B,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,3 Months,94.7,91.4 to 96.8,497
Hib,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,89.6,85.0 to 92.9,497
Hep A,≥1 Dose,States/Local Areas,Wyoming,2020-2021,Age,24 Months,82.5,77.2 to 87.2,497
Hib,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,37.8,31.8 to 44.2,497
DTaP,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,5 Months,80.7,74.9 to 85.4,497
Hib,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,56.3,49.8 to 62.6,497
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.1,79.5 to 98.7,66
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,94.6,92.5 to 96.8,573
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,67.1 to 90.3,66
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,67.3,54.2 to 80.3,68
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,78.7,70.4 to 87.1,141
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,84.6,81.0 to 88.2,573
Influenza,,States/Local Areas,Wyoming,2014-2017,Overall,Overall,48.9,45.0 to 52.7,949
Hib,Full Series,States/Local Areas,Wyoming,2020-2021,Age,24 Months,79.3,73.7 to 84.3,497
Hep B,≥1 Dose,States/Local Areas,Wyoming,2021,Age,3 Months,97.0,93.4 to 98.7,201
Polio,≥2 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,92.9,84.4 to 97.0,201
Influenza,,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,67.8,59.9 to 75.7,188
Influenza,,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,38.4,31.1 to 45.7,247
Influenza,,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,47.9,42.7 to 53.2,514
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,88.2,85.2 to 91.2,573
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",61.4,39.2 to 83.6,66
Influenza,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,47.2,42.6 to 51.9,630
Influenza,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",49.0,44.7 to 53.2,754
Influenza,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,51.2,44.3 to 58.1,291
Influenza,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,35.4,21.3 to 49.5,59
Influenza,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,50.1,29.4 to 70.9,37
Influenza,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,54.4,49.7 to 59.1,595
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,78.7,74.6 to 82.8,573
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,77.5,71.2 to 83.8,276
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.9,62.9 to 74.9,744
Influenza,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",48.8,35.6 to 62.0,74
Influenza,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,47.6,37.1 to 58.2,117
Influenza,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,41.7,34.4 to 49.0,258
Influenza,,States/Local Areas,Wyoming,2016,Age,24 Months,52.1,44.6 to 60.1,231
Influenza,,States/Local Areas,Wyoming,2016-2017,Age,24 Months,54.2,48.9 to 59.6,518
Influenza,,States/Local Areas,Wyoming,2018,Age,24 Months,60.6,53.3 to 68.0,280
Influenza,,States/Local Areas,Wyoming,2018-2019,Age,24 Months,62.4,56.9 to 67.8,540
Influenza,,States/Local Areas,Wyoming,2017,Age,24 Months,56.6,49.4 to 64.0,287
Influenza,,States/Local Areas,Wyoming,2017-2018,Age,24 Months,58.5,53.3 to 63.8,567
PCV,≥1 Dose,States/Local Areas,Wyoming,2021,Age,3 Months,90.7,82.2 to 95.4,201
Influenza,,States/Local Areas,Wyoming,2019,Age,24 Months,63.9,55.9 to 71.8,260
DTaP,≥2 Doses,States/Local Areas,Wyoming,2021,Age,5 Months,80.5,70.6 to 87.6,201
Polio,≥3 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,90.6,82.0 to 95.3,201
Hep B,≥3 Doses,States/Local Areas,Wyoming,2021,Age,13 Months,88.9,80.2 to 94.1,201
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,89.1,84.3 to 92.6,497
Polio,≥2 Doses,States/Local Areas,Wyoming,2021,Age,5 Months,80.5,70.6 to 87.6,201
PCV,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,7 Months,64.7,58.1 to 70.9,497
Polio,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,91.9,87.5 to 94.9,497
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,88.2,83.4 to 91.7,497
≥1 Dose Varicella,,States/Local Areas,Wyoming,2021,Age,13 Months,61.0,50.2 to 70.8,201
≥1 Dose MMR,,States/Local Areas,Wyoming,2021,Age,19 Months,86.9,77.4 to 92.8,201
Rotavirus,,States/Local Areas,Wyoming,2011,Age,8 Months,66.1,57.3 to 73.9,214
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,91.3,85.8 to 96.7,141
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,63.1,51.2 to 75.0,141
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,94.1,90.2 to 98.1,141
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.5,62.4 to 88.6,66
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,81.6,77.3 to 85.9,488
Rotavirus,,States/Local Areas,Wyoming,2015,Age,8 Months,71.3,64.2 to 77.5,283
Rotavirus,,States/Local Areas,Wyoming,2015-2016,Age,8 Months,72.8,67.7 to 77.3,514
Rotavirus,,States/Local Areas,Wyoming,2016,Age,8 Months,74.2,67.0 to 80.3,231
Rotavirus,,States/Local Areas,Wyoming,2016-2017,Age,8 Months,73.9,69.0 to 78.3,518
Rotavirus,,States/Local Areas,Wyoming,2014,Age,8 Months,65.3,57.9 to 72.1,265
Rotavirus,,States/Local Areas,Wyoming,2014-2015,Age,8 Months,68.3,63.3 to 73.0,548
Rotavirus,,States/Local Areas,Wyoming,2013,Age,8 Months,77.9,70.3 to 84.0,215
Rotavirus,,States/Local Areas,Wyoming,2013-2014,Age,8 Months,71.7,66.5 to 76.5,480
Rotavirus,,States/Local Areas,Wyoming,2012,Age,8 Months,76.6,68.5 to 83.1,217
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,60.0,53.0 to 67.0,258
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,70.0,60.5 to 79.5,117
Rotavirus,,States/Local Areas,Wyoming,2018,Age,8 Months,78.1,71.0 to 83.9,280
Rotavirus,,States/Local Areas,Wyoming,2018-2019,Age,8 Months,80.1,75.4 to 84.1,540
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,59.8,45.8 to 73.7,59
Rotavirus,,States/Local Areas,Wyoming,2017,Age,8 Months,73.6,66.6 to 79.6,287
Rotavirus,,States/Local Areas,Wyoming,2017-2018,Age,8 Months,75.7,70.8 to 80.0,567
Rotavirus,,States/Local Areas,Wyoming,2019,Age,8 Months,81.9,75.2 to 87.1,260
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,67.1,49.9 to 84.3,37
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,79.2,75.5 to 82.9,595
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",56.6,43.6 to 69.6,74
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.9,69.2 to 76.7,754
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,75.8,70.0 to 81.6,291
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,68.9,64.6 to 73.1,630
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Overall,Overall,71.2,67.8 to 74.6,949
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,59.3,52.2 to 66.4,247
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,86.9,81.5 to 92.2,188
Rotavirus,,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,72.4,67.8 to 76.9,514
Combined 7 Series,,States/Local Areas,Wyoming,2017,Age,35 Months,73.3,66.4 to 79.9,287
Combined 7 Series,,States/Local Areas,Wyoming,2017-2018,Age,35 Months,74.0,68.8 to 79.0,567
Combined 7 Series,,States/Local Areas,Wyoming,2015,Age,35 Months,71.7,63.3 to 79.5,283
Combined 7 Series,,States/Local Areas,Wyoming,2015-2016,Age,35 Months,73.6,68.1 to 78.9,514
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,64.0,54.1 to 73.9,117
Hib,Full Series,States/Local Areas,Wyoming,2014,Age,19 Months,67.7,60.5 to 74.2,265
Hib,Full Series,States/Local Areas,Wyoming,2014-2015,Age,19 Months,69.7,64.7 to 74.2,548
Hib,Full Series,States/Local Areas,Wyoming,2018,Age,19 Months,77.9,71.0 to 83.6,280
Hib,Full Series,States/Local Areas,Wyoming,2018-2019,Age,19 Months,94.9,91.8 to 96.9,540
Hib,Full Series,States/Local Areas,Wyoming,2016,Age,19 Months,77.8,71.0 to 83.4,231
Hib,Full Series,States/Local Areas,Wyoming,2016-2017,Age,19 Months,76.2,71.4 to 80.4,518
Hib,Full Series,States/Local Areas,Wyoming,2017,Age,19 Months,74.4,67.4 to 80.4,287
Hib,Full Series,States/Local Areas,Wyoming,2017-2018,Age,19 Months,76.1,71.2 to 80.3,567
Combined 7 Series,,States/Local Areas,Wyoming,2018,Age,35 Months,75.0,66.9 to 82.3,280
Combined 7 Series,,States/Local Areas,Wyoming,2018-2019,Age,35 Months,75.8,70.3 to 80.9,540
Combined 7 Series,,States/Local Areas,Wyoming,2019,Age,35 Months,76.7,68.9 to 83.8,260
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,71.4,67.2 to 75.7,595
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,58.6,51.3 to 65.9,258
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,49.2,35.0 to 63.5,59
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,55.6,36.3 to 75.0,37
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,61.7,57.2 to 66.2,630
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Overall,Overall,65.1,61.5 to 68.7,949
Hib,Full Series,States/Local Areas,Wyoming,2011,Age,19 Months,65.9,55.7 to 74.8,214
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,64.2,59.3 to 69.1,514
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,78.3,71.1 to 85.5,188
Hib,Full Series,States/Local Areas,Wyoming,2012,Age,19 Months,71.9,65.1 to 77.8,217
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",58.8,45.9 to 71.8,74
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",65.8,61.7 to 69.9,754
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,69.8,63.5 to 76.0,291
Combined 7 Series,,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,58.2,50.9 to 65.5,247
Hep B,≥3 Doses,States/Local Areas,New York,2020,Age,7 Months,50.3,45.0 to 55.7,624
Hep B,≥1 Dose,States/Local Areas,New York,2020,Age,3 Months,93.1,89.6 to 95.5,624
Hep B,≥3 Doses,States/Local Areas,New York,2020,Age,24 Months,92.0,88.6 to 94.7,624
Hib,≥1 Dose,States/Local Areas,New York,2020,Age,3 Months,82.8,78.3 to 86.6,624
Polio,≥1 Dose,States/Local Areas,New York,2020,Age,3 Months,85.1,80.8 to 88.6,624
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,78.2,72.5 to 83.9,1314
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,70.4,64.5 to 76.4,701
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.3,91.7 to 97.0,466
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,94.5,92.7 to 96.3,1314
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.9,71.1 to 86.6,198
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,79.2,74.2 to 84.2,566
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,85.6 to 93.6,466
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,86.9,80.6 to 93.1,263
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.6,93.3 to 97.9,466
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,94.4,92.6 to 96.2,1314
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,89.6,86.3 to 92.9,701
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,86.8,80.7 to 93.0,263
Influenza,,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,68.3,63.0 to 73.7,566
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,80.2,77.6 to 82.8,2302
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,72.9,65.0 to 80.9,263
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,92.1,90.3 to 93.8,2302
Rotavirus,,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,80.7,76.4 to 84.9,975
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,91.3,89.4 to 93.1,2302
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,73.5,68.7 to 78.2,683
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Overall,Overall,91.4,89.6 to 93.1,2302
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,78.0,73.1 to 83.0,644
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,79.1,76.6 to 81.7,2302
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,76.9,72.6 to 81.3,683
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,79.5,72.1 to 86.8,975
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Overall,Overall,79.5,77.0 to 82.0,2302
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,70.6,63.7 to 77.6,644
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,89.6,85.9 to 93.3,644
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,88.0,84.6 to 91.5,683
Influenza,,States/Local Areas,New York,2016-2019,Overall,Overall,66.6,63.7 to 69.4,2302
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Overall,Overall,74.7,72.1 to 77.4,2302
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,88.4,85.0 to 91.7,683
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,73.1,69.1 to 77.1,2302
Combined 7 Series,,States/Local Areas,New York,2016-2019,Overall,Overall,67.0,64.1 to 69.9,2302
Rotavirus,,States/Local Areas,New York,2016-2019,Overall,Overall,73.8,71.0 to 76.6,2302
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Overall,Overall,89.9,88.0 to 91.8,2302
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,97.1,95.4 to 98.8,975
Combined 7 Series,,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,64.2,58.6 to 69.8,644
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,91.7,88.5 to 94.9,644
Combined 7 Series,,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,76.4,72.1 to 80.8,975
Combined 7 Series,,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,61.0,56.1 to 66.0,683
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,92.9,90.2 to 95.5,975
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Poverty,<133% FPL,77.5,73.3 to 81.7,683
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,88.7,84.9 to 92.5,644
Hib,Full Series,States/Local Areas,New York,2016-2019,Overall,Overall,78.5,75.9 to 81.0,2302
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,74.5,71.4 to 77.6,1621
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,92.3,85.0 to 99.5,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.5,69.3 to 79.8,580
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,96.2,94.3 to 98.0,975
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,89.5,85.8 to 93.1,644
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,77.6,65.9 to 89.3,101
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,95.4,89.5 to 100.0,101
Combined 7 Series,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,66.7,63.2 to 70.1,1621
Influenza,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,49.8,36.0 to 63.5,101
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,89.8 to 96.4,580
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,91.1,88.9 to 93.2,1621
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.9,88.6 to 95.2,580
PCV,≥3 Doses,States/Local Areas,New York,2021,Age,13 Months,85.1,79.0 to 89.6,402
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,88.7 to 94.3,1072
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.7,94.6 to 98.7,466
Rotavirus,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.8,68.6 to 77.0,1072
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.7,85.5 to 91.8,1072
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.6,83.6 to 95.5,198
Combined 7 Series,,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,73.5,69.7 to 77.3,1314
Rotavirus,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.9,56.4 to 75.3,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,74.4,70.7 to 78.2,1314
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.1,72.1 to 80.1,1072
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.0,66.9 to 83.1,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,77.6,73.4 to 81.8,701
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,89.6,86.2 to 93.0,566
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.3,84.7 to 95.8,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Insurance Coverage,Other,69.8,61.7 to 77.9,263
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.1,92.8 to 97.5,466
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,87.8,84.3 to 91.4,701
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,96.9,95.5 to 98.3,1314
Rotavirus,,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,82.1,78.8 to 85.4,1314
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,83.2 to 91.5,466
Influenza,,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,76.2,72.7 to 79.7,1314
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,93.0,90.1 to 95.8,566
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,82.0,77.6 to 86.3,566
Influenza,,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,59.0,54.1 to 63.9,701
Influenza,,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,52.2,43.3 to 61.1,263
Hib,Full Series,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,72.8 to 80.9,1072
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,65.2,54.1 to 76.3,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,75.3 to 85.3,466
Rotavirus,,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,68.6,63.8 to 73.4,701
Hib,Full Series,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.9,70.3 to 85.5,198
Rotavirus,,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,61.2,52.4 to 69.9,263
Combined 7 Series,,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,64.0,58.2 to 69.7,566
Combined 7 Series,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.8,61.4 to 70.3,1072
Combined 7 Series,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.0,56.0 to 73.9,198
Rotavirus,,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,75.9,71.0 to 80.9,566
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.0,74.0 to 81.9,1072
Rotavirus,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.4,73.7 to 85.2,466
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,78.1,73.2 to 83.1,566
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.2,67.1 to 83.2,198
Influenza,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",66.2,61.9 to 70.6,1072
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,93.1 to 98.0,466
Influenza,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",56.3,47.5 to 65.0,198
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.0,88.1 to 93.9,1072
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.5,83.7 to 95.3,198
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,88.3,84.9 to 91.8,701
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,85.3,78.7 to 91.9,263
Influenza,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.0,66.9 to 79.1,466
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,89.9,86.4 to 93.3,566
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.2,87.2 to 93.3,1072
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,93.7,91.8 to 95.7,1314
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.1,82.1 to 94.2,198
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,72.9,68.1 to 77.6,701
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,86.1,79.7 to 92.5,263
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,87.5,84.0 to 91.1,701
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,76.2,68.1 to 84.3,263
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,81.1,76.5 to 85.8,566
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,75.4,67.7 to 83.1,263
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.3,71.1 to 87.4,198
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,84.1,77.3 to 90.9,263
Hib,Full Series,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,72.4,67.7 to 77.0,701
Hib,Full Series,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,72.1,64.2 to 80.1,263
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,96.0,94.5 to 97.5,1314
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,89.5,86.0 to 92.9,701
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.9,73.8 to 82.0,1072
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.3,89.4 to 95.1,1072
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,81.8,74.5 to 89.1,263
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,95.1,92.9 to 97.4,566
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.4,84.7 to 96.1,198
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,88.1,85.3 to 90.9,1314
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.7,80.2 to 93.1,198
Polio,≥2 Doses,States/Local Areas,New York,2020,Age,5 Months,76.3,71.2 to 80.8,624
PCV,≥1 Dose,States/Local Areas,New York,2020,Age,3 Months,82.8,78.4 to 86.5,624
DTaP,≥2 Doses,States/Local Areas,New York,2020,Age,5 Months,76.2,71.0 to 80.7,624
Hep A,≥2 Doses,States/Local Areas,New York,2020,Age,24 Months,32.7,27.8 to 38.2,624
Combined 7 Series,,States/Local Areas,New York,2020,Age,24 Months,69.6,64.3 to 74.7,624
Hep A,≥1 Dose,States/Local Areas,New York,2020,Age,24 Months,81.4,77.0 to 85.5,624
PCV,≥4 Doses,States/Local Areas,New York,2020,Age,24 Months,81.7,77.0 to 86.0,624
PCV,≥3 Doses,States/Local Areas,New York,2020,Age,24 Months,92.4,89.0 to 95.2,624
DTaP,≥3 Doses,States/Local Areas,New York,2020,Age,35 Months,96.2,93.0 to 98.2,624
Rotavirus,,States/Local Areas,New York,2020,Age,8 Months,76.6,71.6 to 80.9,624
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2020,Age,0-3 Days,78.7,73.9 to 82.9,624
Influenza,,States/Local Areas,New York,2020,Age,24 Months,62.7,57.4 to 68.0,624
Hib,Primary Series,States/Local Areas,New York,2020,Age,19 Months,92.8,89.2 to 95.3,624
Hib,≥3 Doses,States/Local Areas,New York,2020,Age,19 Months,91.4,87.6 to 94.1,624
≥1 Dose MMR,,States/Local Areas,New York,2020,Age,19 Months,86.3,82.0 to 89.6,624
Polio,≥3 Doses,States/Local Areas,New York,2020,Age,19 Months,92.2,88.6 to 94.8,624
DTaP,≥4 Doses,States/Local Areas,New York,2020,Age,19 Months,69.3,63.9 to 74.2,624
DTaP,≥3 Doses,States/Local Areas,New York,2020,Age,19 Months,93.9,90.5 to 96.1,624
Polio,≥2 Doses,States/Local Areas,New York,2020,Age,7 Months,92.2,88.7 to 94.7,624
PCV,≥2 Doses,States/Local Areas,New York,2020,Age,5 Months,74.7,69.5 to 79.2,624
≥1 Dose Varicella,,States/Local Areas,New York,2020,Age,13 Months,55.7,50.3 to 61.0,624
PCV,≥3 Doses,States/Local Areas,New York,2020,Age,13 Months,88.9,84.8 to 91.9,624
DTaP,≥3 Doses,States/Local Areas,New York,2020,Age,7 Months,69.4,64.1 to 74.3,624
Hep B,≥3 Doses,States/Local Areas,New York,2020,Age,13 Months,88.1,84.0 to 91.3,624
Hib,Primary Series,States/Local Areas,New York,2020,Age,13 Months,86.6,82.4 to 90.0,624
Hep B,≥2 Doses,States/Local Areas,New York,2020,Age,13 Months,92.3,88.6 to 94.9,624
Hib,≥3 Doses,States/Local Areas,New York,2020,Age,13 Months,75.9,71.0 to 80.2,624
Hep A,≥1 Dose,States/Local Areas,New York,2020,Age,19 Months,74.1,69.0 to 78.6,624
PCV,≥4 Doses,States/Local Areas,New York,2020,Age,35 Months,85.2,80.4 to 89.4,624
PCV,≥4 Doses,States/Local Areas,New York,2020,Age,19 Months,73.8,68.5 to 78.4,624
≥1 Dose MMR,,States/Local Areas,New York,2020,Age,35 Months,95.7,92.3 to 97.9,624
Polio,≥3 Doses,States/Local Areas,New York,2020,Age,35 Months,96.5,93.4 to 98.4,624
DTaP,≥4 Doses,States/Local Areas,New York,2020,Age,35 Months,91.0,86.3 to 94.6,624
≥1 Dose Varicella,,States/Local Areas,New York,2020,Age,19 Months,85.1,80.7 to 88.7,624
PCV,≥3 Doses,States/Local Areas,New York,2020,Age,19 Months,91.3,87.4 to 94.1,624
Hib,Full Series,States/Local Areas,New York,2020,Age,19 Months,71.6,66.4 to 76.4,624
Hep B,≥3 Doses,States/Local Areas,New York,2020,Age,19 Months,91.6,88.0 to 94.2,624
PCV,≥3 Doses,States/Local Areas,New York,2020,Age,35 Months,94.9,90.7 to 97.6,624
≥1 Dose Varicella,,States/Local Areas,New York,2020,Age,35 Months,96.2,92.4 to 98.5,624
Hep B,≥3 Doses,States/Local Areas,New York,2020,Age,35 Months,96.0,92.5 to 98.2,624
Hib,≥3 Doses,States/Local Areas,New York,2020,Age,35 Months,93.5,90.2 to 96.0,624
Hib,Primary Series,States/Local Areas,New York,2020,Age,35 Months,94.5,91.4 to 96.8,624
Hib,Full Series,States/Local Areas,New York,2020,Age,35 Months,84.1,79.2 to 88.4,624
Hib,Primary Series,States/Local Areas,New York,2020,Age,24 Months,93.5,90.2 to 96.0,624
Hib,≥3 Doses,States/Local Areas,New York,2020,Age,24 Months,92.1,88.6 to 94.9,624
≥1 Dose MMR,,States/Local Areas,New York,2020,Age,24 Months,90.2,86.6 to 93.1,624
Polio,≥3 Doses,States/Local Areas,New York,2020,Age,24 Months,93.9,90.7 to 96.2,624
DTaP,≥4 Doses,States/Local Areas,New York,2020,Age,24 Months,82.7,78.0 to 86.9,624
DTaP,≥3 Doses,States/Local Areas,New York,2020,Age,24 Months,94.2,91.1 to 96.5,624
Hep B,≥2 Doses,States/Local Areas,New York,2020,Age,7 Months,90.5,86.6 to 93.3,624
Hib,Primary Series,States/Local Areas,New York,2020,Age,7 Months,69.7,64.3 to 74.5,624
Hib,≥3 Doses,States/Local Areas,New York,2020,Age,7 Months,56.8,51.4 to 62.1,624
Hib,≥2 Doses,States/Local Areas,New York,2020,Age,7 Months,89.7,85.8 to 92.7,624
DTaP,≥1 Dose,States/Local Areas,New York,2020,Age,3 Months,85.9,81.6 to 89.3,624
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2020,Age,0-2 Days,78.3,73.5 to 82.4,624
Hep A,≥2 Doses,States/Local Areas,New York,2020,Age,19 Months,17.5,13.8 to 21.9,624
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2020,Age,0-1 Days,76.5,71.7 to 80.8,624
Combined 7 Series,,States/Local Areas,New York,2020,Age,35 Months,77.5,71.7 to 82.8,624
≥1 Dose Varicella,,States/Local Areas,New York,2020-2021,Age,35 Months,96.2,92.2 to 98.5,1026
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2021,Age,0-1 Days,69.1,62.4 to 75.1,402
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,77.7,74.7 to 80.8,1621
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,95.6,89.7 to 100.0,101
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,88.7,86.3 to 91.1,1621
PCV,≥3 Doses,States/Local Areas,New York,2020,Age,7 Months,62.8,57.3 to 68.0,624
DTaP,≥3 Doses,States/Local Areas,New York,2020,Age,13 Months,91.0,87.3 to 93.7,624
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.3,76.5 to 86.0,580
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,79.3,76.1 to 82.5,1621
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.2 to 97.4,580
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,83.4,73.5 to 93.4,101
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,90.8 to 94.7,1621
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.8,67.5 to 86.0,580
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,90.4,88.1 to 92.6,1621
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.0,89.9 to 96.2,580
Hib,Full Series,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,82.6,72.3 to 93.0,101
Hib,Full Series,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.2,73.2 to 83.1,580
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,84.4,72.9 to 96.0,101
Hib,Full Series,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,78.2,75.1 to 81.2,1621
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,86.3,76.5 to 96.1,101
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.8,74.9 to 84.8,580
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,78.6,75.6 to 81.6,1621
Rotavirus,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,73.6,70.3 to 76.9,1621
Rotavirus,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.5,68.2 to 78.9,580
Influenza,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.5,65.2 to 75.7,580
Combined 7 Series,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,71.6,59.4 to 83.9,101
Combined 7 Series,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,66.6,61.0 to 72.3,580
Influenza,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,66.1,62.7 to 69.5,1621
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,83.9,74.1 to 93.8,101
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.7,75.8 to 85.5,580
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,91.3,82.3 to 100.0,101
Hep B,≥2 Doses,States/Local Areas,New York,2020,Age,5 Months,85.7,81.2 to 89.3,624
Hib,≥2 Doses,States/Local Areas,New York,2020,Age,5 Months,75.1,69.9 to 79.7,624
Polio,≥2 Doses,States/Local Areas,New York,2019-2020,Age,5 Months,78.0,74.4 to 81.2,1261
Hib,≥2 Doses,States/Local Areas,New York,2019-2020,Age,5 Months,76.7,73.1 to 80.0,1261
Polio,≥2 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,93.7,91.2 to 95.5,1261
≥1 Dose MMR,,States/Local Areas,New York,2019-2020,Age,13 Months,64.6,60.7 to 68.4,1261
Hib,≥3 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,76.3,72.7 to 79.6,1261
Hib,≥2 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,94.3,92.2 to 95.8,1261
Hib,Primary Series,States/Local Areas,New York,2019-2020,Age,13 Months,86.3,83.2 to 89.0,1261
Hep B,≥2 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,93.7,91.3 to 95.4,1261
Hep B,≥2 Doses,States/Local Areas,New York,2019-2020,Age,5 Months,88.0,85.0 to 90.5,1261
PCV,≥2 Doses,States/Local Areas,New York,2019-2020,Age,5 Months,76.7,73.1 to 79.9,1261
DTaP,≥3 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,68.1,64.1 to 71.8,1261
Hib,≥2 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,89.5,86.7 to 91.8,1261
Polio,≥2 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,90.0,87.0 to 92.3,1261
≥1 Dose Varicella,,States/Local Areas,New York,2019-2020,Age,13 Months,55.9,51.9 to 59.9,1261
Hep B,≥3 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,87.7,84.8 to 90.1,1261
PCV,≥3 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,88.1,85.1 to 90.6,1261
DTaP,≥3 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,92.6,89.8 to 94.7,1261
Combined 7 Series,,States/Local Areas,New York,2019-2020,Age,24 Months,68.0,64.0 to 71.9,1261
DTaP,≥3 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,94.0,91.2 to 96.1,1261
DTaP,≥4 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,88.5,84.9 to 91.6,1261
Polio,≥3 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,93.1,90.1 to 95.4,1261
≥1 Dose MMR,,States/Local Areas,New York,2019-2020,Age,35 Months,94.1,91.3 to 96.2,1261
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,87.0 to 94.4,580
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,93.9,86.4 to 100.0,101
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.8 to 95.6,580
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,90.4,88.2 to 92.7,1621
Rotavirus,,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,71.7,66.4 to 76.9,644
Rotavirus,,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,69.4,64.5 to 74.3,683
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,86.9 to 91.5,1621
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,87.9,84.5 to 91.3,975
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,78.0,73.1 to 82.8,644
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Poverty,>400% FPL,74.1,69.7 to 78.4,975
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,71.9,66.6 to 77.2,644
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,69.9,64.0 to 75.8,683
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,95.3,93.1 to 97.4,975
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,92.0,89.0 to 95.0,683
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,89.5,86.1 to 93.0,644
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,93.5,91.9 to 95.1,2302
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Overall,Overall,89.9,88.0 to 91.8,2302
Influenza,,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,59.8,54.2 to 65.4,644
Influenza,,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,60.1,55.2 to 64.9,683
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,94.6,92.5 to 96.8,975
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,86.9,82.8 to 91.0,644
≥1 Dose Varicella,,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,88.1,84.7 to 91.5,683
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,90.3,87.2 to 93.3,975
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,89.4,86.1 to 92.7,683
Polio,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,90.6,87.5 to 93.7,683
Hib,Full Series,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,87.4,84.0 to 90.8,975
Hib,Full Series,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,77.7,72.9 to 82.6,644
Hib,Full Series,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,71.3,66.6 to 75.9,683
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,83.8,80.0 to 87.6,975
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Poverty,<133% FPL,72.3,67.8 to 76.9,683
Influenza,,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,80.2,76.2 to 84.2,975
DTaP,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,91.8,88.7 to 94.9,701
Combined 7 Series,,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,62.1,57.1 to 67.0,701
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.2,85.0 to 91.4,1072
Polio,≥2 Doses,States/Local Areas,New York,2020,Age,13 Months,94.2,90.9 to 96.3,624
Hep A,≥2 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,32.0,28.4 to 35.9,1261
Hep A,≥1 Dose,States/Local Areas,New York,2019-2020,Age,24 Months,81.7,78.3 to 84.9,1261
Hep A,≥2 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,76.5,70.5 to 81.9,1261
Hep A,≥1 Dose,States/Local Areas,New York,2019-2020,Age,35 Months,88.6,84.8 to 91.8,1261
Influenza,,States/Local Areas,New York,2019-2020,Age,24 Months,65.0,61.1 to 68.9,1261
Hib,≥3 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,91.7,89.0 to 93.9,1261
Hib,Full Series,States/Local Areas,New York,2019-2020,Age,24 Months,77.8,74.1 to 81.3,1261
Hib,Primary Series,States/Local Areas,New York,2019-2020,Age,24 Months,92.5,89.9 to 94.7,1261
Combined 7 Series,,States/Local Areas,New York,2019-2020,Age,35 Months,75.1,70.7 to 79.2,1261
Hib,≥3 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,55.3,51.3 to 59.2,1261
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2019-2020,Age,0-1 Days,75.0,71.4 to 78.3,1261
≥1 Dose Varicella,,States/Local Areas,New York,2019-2020,Age,19 Months,87.9,84.9 to 90.3,1261
Hep B,≥3 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,90.9,88.3 to 93.0,1261
PCV,≥4 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,73.6,69.8 to 77.1,1261
Hep A,≥1 Dose,States/Local Areas,New York,2019-2020,Age,19 Months,75.1,71.4 to 78.5,1261
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2019-2020,Age,0-2 Days,77.6,74.1 to 80.7,1261
≥1 Dose Varicella,,States/Local Areas,New York,2019-2020,Age,24 Months,91.9,89.4 to 94.0,1261
Hep B,≥3 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,91.3,88.8 to 93.4,1261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2019-2020,Age,0-3 Days,79.0,75.6 to 82.1,1261
PCV,≥3 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,62.7,58.7 to 66.6,1261
PCV,≥3 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,92.5,90.0 to 94.5,1261
PCV,≥4 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,80.0,76.4 to 83.5,1261
≥1 Dose MMR,,States/Local Areas,New York,2019-2020,Age,19 Months,88.3,85.3 to 90.7,1261
Hep A,≥2 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,16.2,13.5 to 19.3,1261
Hib,≥3 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,90.6,87.7 to 92.9,1261
Hib,Primary Series,States/Local Areas,New York,2019-2020,Age,19 Months,91.8,89.0 to 94.0,1261
Hib,Full Series,States/Local Areas,New York,2019-2020,Age,19 Months,71.7,67.9 to 75.3,1261
Hib,≥3 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,92.5,89.8 to 94.7,1261
Hib,Full Series,States/Local Areas,New York,2019-2020,Age,35 Months,83.2,79.4 to 86.6,1261
Hep B,≥3 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,93.3,90.4 to 95.6,1261
Hib,Primary Series,States/Local Areas,New York,2019-2020,Age,35 Months,93.0,90.4 to 95.1,1261
≥1 Dose Varicella,,States/Local Areas,New York,2019-2020,Age,35 Months,95.8,92.8 to 97.8,1261
PCV,≥3 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,93.7,91.0 to 95.8,1261
PCV,≥4 Doses,States/Local Areas,New York,2019-2020,Age,35 Months,83.8,80.1 to 87.1,1261
DTaP,≥3 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,92.9,90.2 to 95.0,1261
DTaP,≥4 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,81.7,78.1 to 85.0,1261
Polio,≥3 Doses,States/Local Areas,New York,2019-2020,Age,24 Months,91.6,88.7 to 94.0,1261
≥1 Dose MMR,,States/Local Areas,New York,2019-2020,Age,24 Months,91.4,88.8 to 93.6,1261
Hep B,≥1 Dose,States/Local Areas,New York,2019-2020,Age,3 Months,94.9,92.9 to 96.4,1261
PCV,≥1 Dose,States/Local Areas,New York,2019-2020,Age,3 Months,85.6,82.6 to 88.1,1261
Hib,≥1 Dose,States/Local Areas,New York,2019-2020,Age,3 Months,85.3,82.2 to 87.9,1261
Rotavirus,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,77.4,64.4 to 90.4,101
≥1 Dose MMR,,States/Local Areas,New York,2016-2019,Urbanicity,Living In a Non-MSA,93.6,87.2 to 100.0,101
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Urbanicity,Living In a MSA Principal City,70.7,66.2 to 75.2,1621
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,91.8,88.7 to 94.8,566
Combined 7 Series,,States/Local Areas,New York,2016-2019,Insurance Coverage,Other,62.6,53.8 to 71.4,263
Combined 7 Series,,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.0,71.7 to 82.4,466
Hep B,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,91.6 to 96.7,466
Hib,Primary Series,States/Local Areas,New York,2021,Age,19 Months,91.7,86.4 to 95.1,402
DTaP,≥4 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,70.6,66.7 to 74.2,1261
Polio,≥3 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,90.7,87.6 to 93.0,1261
Hib,Primary Series,States/Local Areas,New York,2019-2020,Age,7 Months,67.4,63.5 to 71.1,1261
DTaP,≥3 Doses,States/Local Areas,New York,2019-2020,Age,13 Months,90.1,87.1 to 92.4,1261
Polio,≥1 Dose,States/Local Areas,New York,2019-2020,Age,3 Months,86.9,83.8 to 89.4,1261
DTaP,≥1 Dose,States/Local Areas,New York,2019-2020,Age,3 Months,88.1,85.1 to 90.5,1261
DTaP,≥2 Doses,States/Local Areas,New York,2019-2020,Age,5 Months,78.6,75.0 to 81.8,1261
DTaP,≥4 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,89.8,85.6 to 93.1,1026
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.3,64.0 to 72.7,1072
≥1 Dose Varicella,,States/Local Areas,New York,2021,Age,19 Months,86.8,81.1 to 91.0,402
DTaP,≥1 Dose,States/Local Areas,New York,2016,Age,3 Months,84.9,79.8 to 88.9,506
DTaP,≥1 Dose,States/Local Areas,New York,2016-2017,Age,3 Months,87.8,84.7 to 90.3,1154
DTaP,≥1 Dose,States/Local Areas,New York,2015,Age,3 Months,87.5,83.3 to 90.7,503
DTaP,≥1 Dose,States/Local Areas,New York,2015-2016,Age,3 Months,86.1,83.0 to 88.8,1009
DTaP,≥1 Dose,States/Local Areas,New York,2014,Age,3 Months,89.6,86.1 to 92.2,592
DTaP,≥1 Dose,States/Local Areas,New York,2014-2015,Age,3 Months,88.5,85.9 to 90.7,1095
DTaP,≥1 Dose,States/Local Areas,New York,2013,Age,3 Months,86.7,83.5 to 89.3,545
DTaP,≥1 Dose,States/Local Areas,New York,2013-2014,Age,3 Months,88.1,84.2 to 91.1,1137
DTaP,≥1 Dose,States/Local Areas,New York,2011,Age,3 Months,85.7,81.5 to 89.1,466
DTaP,≥1 Dose,States/Local Areas,New York,2012,Age,3 Months,90.6,87.4 to 93.0,492
Hep B,≥3 Doses,States/Local Areas,New York,2021,Age,19 Months,91.7,86.5 to 95.0,402
Hib,Full Series,States/Local Areas,New York,2020-2021,Age,24 Months,78.1,74.2 to 81.8,1026
DTaP,≥1 Dose,States/Local Areas,New York,2018,Age,3 Months,89.4,85.8 to 92.2,733
DTaP,≥1 Dose,States/Local Areas,New York,2018-2019,Age,3 Months,89.5,86.7 to 91.7,1370
DTaP,≥3 Doses,States/Local Areas,New York,2015,Age,24 Months,93.0,89.5 to 95.6,503
DTaP,≥3 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,92.4,89.7 to 94.6,1009
DTaP,≥3 Doses,States/Local Areas,New York,2014,Age,24 Months,95.2,92.9 to 96.9,592
DTaP,≥3 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,94.1,92.1 to 95.7,1095
DTaP,≥1 Dose,States/Local Areas,New York,2017,Age,3 Months,90.9,87.1 to 93.6,648
DTaP,≥1 Dose,States/Local Areas,New York,2017-2018,Age,3 Months,90.2,87.6 to 92.2,1381
Hep A,≥1 Dose,States/Local Areas,New York,2011,Age,19 Months,65.6,62.5 to 68.5,466
DTaP,≥1 Dose,States/Local Areas,New York,2019,Age,3 Months,89.6,85.1 to 92.8,637
DTaP,≥3 Doses,States/Local Areas,New York,2016,Age,24 Months,91.7,87.5 to 94.9,506
DTaP,≥3 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,93.7,91.3 to 95.7,1154
Hep A,≥1 Dose,States/Local Areas,New York,2012,Age,19 Months,65.3,60.0 to 70.2,492
Hep A,≥1 Dose,States/Local Areas,New York,2015,Age,19 Months,74.7,71.3 to 77.9,503
Hep A,≥1 Dose,States/Local Areas,New York,2015-2016,Age,19 Months,71.6,67.8 to 75.2,1009
Hep A,≥1 Dose,States/Local Areas,New York,2014,Age,19 Months,70.5,65.7 to 74.9,592
Hep A,≥1 Dose,States/Local Areas,New York,2014-2015,Age,19 Months,72.6,69.2 to 75.8,1095
Hep A,≥1 Dose,States/Local Areas,New York,2013,Age,19 Months,71.5,66.8 to 75.8,545
Hep A,≥1 Dose,States/Local Areas,New York,2013-2014,Age,19 Months,71.0,66.3 to 75.3,1137
DTaP,≥3 Doses,States/Local Areas,New York,2018,Age,24 Months,94.3,91.6 to 96.4,733
DTaP,≥3 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,93.1,90.7 to 95.1,1370
DTaP,≥3 Doses,States/Local Areas,New York,2017,Age,24 Months,95.8,93.3 to 97.6,648
DTaP,≥3 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,95.1,93.3 to 96.5,1381
DTaP,≥2 Doses,States/Local Areas,New York,2018,Age,5 Months,81.9,77.7 to 85.5,733
DTaP,≥2 Doses,States/Local Areas,New York,2018-2019,Age,5 Months,81.5,78.3 to 84.3,1370
DTaP,≥2 Doses,States/Local Areas,New York,2016,Age,5 Months,76.0,70.1 to 81.1,506
DTaP,≥2 Doses,States/Local Areas,New York,2016-2017,Age,5 Months,79.7,76.0 to 82.9,1154
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,97.1,92.2 to 100.0,75
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.6,91.0 to 96.2,576
DTaP,≥2 Doses,States/Local Areas,New York,2017,Age,5 Months,83.6,79.3 to 87.1,648
DTaP,≥2 Doses,States/Local Areas,New York,2017-2018,Age,5 Months,82.8,79.8 to 85.4,1381
Hib,≥2 Doses,States/Local Areas,New York,2021,Age,7 Months,87.6,81.5 to 91.8,402
PCV,≥3 Doses,States/Local Areas,New York,2021,Age,35 Months,90.8,85.3 to 94.9,402
≥1 Dose MMR,,States/Local Areas,New York,2021,Age,35 Months,94.1,88.1 to 97.7,402
Hib,Primary Series,States/Local Areas,New York,2020-2021,Age,24 Months,93.1,90.3 to 95.3,1026
Hib,≥3 Doses,States/Local Areas,New York,2021,Age,19 Months,90.1,84.6 to 93.8,402
Hib,≥2 Doses,States/Local Areas,New York,2021,Age,5 Months,77.9,71.4 to 83.2,402
Hib,≥3 Doses,States/Local Areas,New York,2021,Age,7 Months,61.0,54.2 to 67.4,402
Polio,≥2 Doses,States/Local Areas,New York,2021,Age,7 Months,88.1,82.1 to 92.3,402
PCV,≥4 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,80.6,76.7 to 84.1,1026
Hep B,≥2 Doses,States/Local Areas,New York,2021,Age,7 Months,89.5,83.9 to 93.3,402
Hib,≥3 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,92.0,89.1 to 94.4,1026
Hep B,≥3 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,88.5,85.2 to 91.1,1026
DTaP,≥3 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,92.7,89.7 to 94.9,1026
DTaP,≥3 Doses,States/Local Areas,New York,2021,Age,7 Months,71.8,65.1 to 77.6,402
PCV,≥2 Doses,States/Local Areas,New York,2021,Age,5 Months,74.6,68.0 to 80.2,402
Polio,≥3 Doses,States/Local Areas,New York,2021,Age,19 Months,90.5,85.0 to 94.2,402
Combined 7 Series,,States/Local Areas,New York,2021,Age,35 Months,77.4,69.5 to 84.5,402
Combined 7 Series,,States/Local Areas,New York,2015,Age,24 Months,66.9,61.4 to 72.3,503
Combined 7 Series,,States/Local Areas,New York,2015-2016,Age,24 Months,65.3,61.2 to 69.3,1009
Hib,Primary Series,States/Local Areas,New York,2018,Age,35 Months,92.9,89.8 to 95.3,733
Hib,Primary Series,States/Local Areas,New York,2018-2019,Age,35 Months,92.3,89.9 to 94.3,1370
Combined 7 Series,,States/Local Areas,New York,2019,Age,24 Months,67.5,61.7 to 73.3,637
Combined 7 Series,,States/Local Areas,New York,2017,Age,24 Months,70.2,65.0 to 75.3,648
Combined 7 Series,,States/Local Areas,New York,2017-2018,Age,24 Months,70.4,66.9 to 73.9,1381
Combined 7 Series,,States/Local Areas,New York,2018,Age,24 Months,70.7,65.9 to 75.4,733
Combined 7 Series,,States/Local Areas,New York,2018-2019,Age,24 Months,69.2,65.5 to 72.9,1370
Combined 7 Series,,States/Local Areas,New York,2016,Age,24 Months,63.8,57.8 to 69.7,506
Combined 7 Series,,States/Local Areas,New York,2016-2017,Age,24 Months,66.9,62.9 to 70.9,1154
Hib,Primary Series,States/Local Areas,New York,2019,Age,35 Months,91.9,88.0 to 94.9,637
Combined 7 Series,,States/Local Areas,New York,2014,Age,24 Months,68.3,63.5 to 73.1,592
Combined 7 Series,,States/Local Areas,New York,2014-2015,Age,24 Months,67.6,64.0 to 71.2,1095
Combined 7 Series,,States/Local Areas,New York,2014,Age,35 Months,74.2,69.3 to 78.8,592
Combined 7 Series,,States/Local Areas,New York,2014-2015,Age,35 Months,73.6,69.9 to 77.2,1095
Hib,Primary Series,States/Local Areas,New York,2016,Age,35 Months,91.6,87.2 to 95.0,506
Hib,Primary Series,States/Local Areas,New York,2016-2017,Age,35 Months,93.2,90.6 to 95.3,1154
Combined 7 Series,,States/Local Areas,New York,2011,Age,24 Months,66.2,60.5 to 71.7,466
Hep A,≥2 Doses,States/Local Areas,New York,2021,Age,35 Months,63.8,53.1 to 74.4,402
PCV,≥4 Doses,States/Local Areas,New York,2021,Age,19 Months,74.4,67.9 to 80.0,402
PCV,≥3 Doses,States/Local Areas,New York,2021,Age,19 Months,89.6,83.7 to 93.5,402
Hep A,≥1 Dose,States/Local Areas,New York,2021,Age,35 Months,87.6,80.4 to 93.1,402
Hib,Primary Series,States/Local Areas,New York,2021,Age,7 Months,71.4,64.9 to 77.1,402
Hep B,≥2 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,92.4,89.4 to 94.6,1026
Hep B,≥3 Doses,States/Local Areas,New York,2021,Age,24 Months,92.3,87.6 to 95.8,402
DTaP,≥4 Doses,States/Local Areas,New York,2021,Age,19 Months,70.8,64.1 to 76.8,402
Hib,Full Series,States/Local Areas,New York,2021,Age,24 Months,78.1,71.7 to 83.9,402
Hib,≥1 Dose,States/Local Areas,New York,2021,Age,3 Months,85.5,79.6 to 89.8,402
Combined 7 Series,,States/Local Areas,New York,2011,Age,35 Months,74.7,68.8 to 80.2,466
Combined 7 Series,,States/Local Areas,New York,2016,Age,35 Months,68.9,62.7 to 74.9,506
Combined 7 Series,,States/Local Areas,New York,2016-2017,Age,35 Months,72.2,68.1 to 76.1,1154
Combined 7 Series,,States/Local Areas,New York,2017,Age,35 Months,75.7,70.5 to 80.6,648
Combined 7 Series,,States/Local Areas,New York,2017-2018,Age,35 Months,76.6,73.0 to 80.1,1381
Combined 7 Series,,States/Local Areas,New York,2013,Age,35 Months,77.8,72.1 to 83.1,545
Combined 7 Series,,States/Local Areas,New York,2013-2014,Age,35 Months,75.9,72.2 to 79.4,1137
Combined 7 Series,,States/Local Areas,New York,2012,Age,35 Months,77.4,71.3 to 83.1,492
Hib,Primary Series,States/Local Areas,New York,2017,Age,35 Months,94.8,92.0 to 96.8,648
Hib,Primary Series,States/Local Areas,New York,2017-2018,Age,35 Months,93.8,91.8 to 95.4,1381
Hib,Primary Series,States/Local Areas,New York,2015,Age,35 Months,91.9,88.4 to 94.8,503
Hib,Primary Series,States/Local Areas,New York,2015-2016,Age,35 Months,92.0,89.2 to 94.3,1009
Combined 7 Series,,States/Local Areas,New York,2013,Age,24 Months,69.7,64.8 to 74.5,545
Combined 7 Series,,States/Local Areas,New York,2013-2014,Age,24 Months,69.1,65.6 to 72.5,1137
Combined 7 Series,,States/Local Areas,New York,2012,Age,24 Months,66.3,61.0 to 71.5,492
Hib,Primary Series,States/Local Areas,New York,2017,Age,24 Months,94.8,92.0 to 96.8,648
Hib,Primary Series,States/Local Areas,New York,2017-2018,Age,24 Months,93.5,91.5 to 95.2,1381
Hib,Primary Series,States/Local Areas,New York,2018,Age,24 Months,92.2,89.2 to 94.6,733
Hib,Primary Series,States/Local Areas,New York,2018-2019,Age,24 Months,92.0,89.6 to 94.0,1370
Hib,Primary Series,States/Local Areas,New York,2013,Age,7 Months,61.7,58.6 to 64.8,545
Hib,Primary Series,States/Local Areas,New York,2013-2014,Age,7 Months,66.7,63.4 to 69.9,1137
Hib,Primary Series,States/Local Areas,New York,2012,Age,35 Months,95.8,93.1 to 97.7,492
Hib,Primary Series,States/Local Areas,New York,2014,Age,35 Months,96.1,93.6 to 97.8,592
Hib,Primary Series,States/Local Areas,New York,2014-2015,Age,35 Months,94.2,92.0 to 96.0,1095
Hib,Primary Series,States/Local Areas,New York,2011,Age,35 Months,93.4,89.7 to 96.1,466
Hib,Primary Series,States/Local Areas,New York,2019,Age,24 Months,91.9,88.0 to 94.9,637
Hib,Primary Series,States/Local Areas,New York,2013,Age,35 Months,95.0,91.8 to 97.3,545
Hib,Primary Series,States/Local Areas,New York,2013-2014,Age,35 Months,95.5,93.6 to 97.0,1137
Hib,Primary Series,States/Local Areas,New York,2016,Age,24 Months,90.5,86.1 to 94.0,506
Hib,Primary Series,States/Local Areas,New York,2016-2017,Age,24 Months,92.6,90.0 to 94.7,1154
Hib,Primary Series,States/Local Areas,New York,2015,Age,24 Months,91.9,88.3 to 94.7,503
Hib,Primary Series,States/Local Areas,New York,2015-2016,Age,24 Months,91.3,88.5 to 93.6,1009
Hib,Primary Series,States/Local Areas,New York,2014,Age,24 Months,94.4,91.9 to 96.3,592
Hib,Primary Series,States/Local Areas,New York,2014-2015,Age,24 Months,93.1,91.0 to 94.9,1095
Hib,Primary Series,States/Local Areas,New York,2013,Age,24 Months,93.9,90.8 to 96.2,545
Hib,Primary Series,States/Local Areas,New York,2013-2014,Age,24 Months,94.1,92.2 to 95.7,1137
Hib,Primary Series,States/Local Areas,New York,2015,Age,13 Months,86.6,82.3 to 90.1,503
Hib,Primary Series,States/Local Areas,New York,2015-2016,Age,13 Months,85.1,81.8 to 88.0,1009
Hib,Primary Series,States/Local Areas,New York,2014,Age,13 Months,89.5,86.2 to 92.1,592
Hib,Primary Series,States/Local Areas,New York,2014-2015,Age,13 Months,88.1,85.4 to 90.3,1095
Hib,Primary Series,States/Local Areas,New York,2011,Age,13 Months,88.3,82.3 to 92.5,466
Hib,Primary Series,States/Local Areas,New York,2012,Age,13 Months,90.2,87.6 to 92.3,492
Hib,Primary Series,States/Local Areas,New York,2013,Age,13 Months,86.6,84.1 to 88.7,545
Hib,Primary Series,States/Local Areas,New York,2013-2014,Age,13 Months,88.0,84.9 to 90.6,1137
Hib,Primary Series,States/Local Areas,New York,2019,Age,7 Months,66.2,60.4 to 71.5,637
Hib,Primary Series,States/Local Areas,New York,2018,Age,7 Months,69.0,64.1 to 73.5,733
Hib,Primary Series,States/Local Areas,New York,2018-2019,Age,7 Months,67.6,63.8 to 71.1,1370
Hib,Primary Series,States/Local Areas,New York,2015,Age,7 Months,63.4,57.7 to 68.8,503
Hib,Primary Series,States/Local Areas,New York,2015-2016,Age,7 Months,64.3,60.1 to 68.2,1009
Hib,Primary Series,States/Local Areas,New York,2014,Age,7 Months,71.7,67.0 to 76.0,592
Hib,Primary Series,States/Local Areas,New York,2014-2015,Age,7 Months,67.6,63.9 to 71.1,1095
≥1 Dose MMR,,States/Local Areas,New York,2021,Age,24 Months,89.0,83.7 to 93.2,402
Hib,Primary Series,States/Local Areas,New York,2021,Age,24 Months,92.6,87.8 to 96.0,402
Polio,≥3 Doses,States/Local Areas,New York,2021,Age,24 Months,91.0,85.9 to 94.8,402
Polio,≥1 Dose,States/Local Areas,New York,2021,Age,3 Months,86.8,81.1 to 91.0,402
DTaP,≥4 Doses,States/Local Areas,New York,2021,Age,24 Months,80.3,74.0 to 86.0,402
PCV,≥4 Doses,States/Local Areas,New York,2021,Age,35 Months,85.7,78.0 to 91.8,402
DTaP,≥1 Dose,States/Local Areas,New York,2021,Age,3 Months,87.3,81.5 to 91.5,402
Hep A,≥1 Dose,States/Local Areas,New York,2021,Age,19 Months,72.3,65.8 to 78.0,402
Hep A,≥2 Doses,States/Local Areas,New York,2021,Age,19 Months,19.4,14.6 to 25.2,402
Hib,≥3 Doses,States/Local Areas,New York,2021,Age,24 Months,92.1,86.9 to 95.7,402
Polio,≥2 Doses,States/Local Areas,New York,2021,Age,13 Months,93.9,88.8 to 96.8,402
Hep B,≥3 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,96.2,92.9 to 98.2,1026
DTaP,≥3 Doses,States/Local Areas,New York,2021,Age,13 Months,87.2,81.2 to 91.5,402
Combined 7 Series,,States/Local Areas,New York,2021,Age,24 Months,69.4,62.8 to 75.8,402
PCV,≥3 Doses,States/Local Areas,New York,2021,Age,7 Months,64.3,57.5 to 70.6,402
Hep B,≥3 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,92.1,89.3 to 94.4,1026
Hib,≥3 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,76.5,72.5 to 80.1,1026
DTaP,≥3 Doses,States/Local Areas,New York,2021,Age,19 Months,91.5,86.0 to 95.0,402
PCV,≥4 Doses,States/Local Areas,New York,2021,Age,24 Months,79.2,73.1 to 84.7,402
PCV,≥3 Doses,States/Local Areas,New York,2021,Age,24 Months,90.8,85.3 to 94.9,402
≥1 Dose Varicella,,States/Local Areas,New York,2021,Age,24 Months,88.8,83.5 to 93.1,402
PCV,≥3 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,93.9,89.6 to 96.8,1026
Hep A,≥1 Dose,States/Local Areas,New York,2021,Age,24 Months,77.7,71.6 to 83.3,402
Hep B,≥3 Doses,States/Local Areas,New York,2021,Age,7 Months,50.5,43.7 to 57.2,402
Hep A,≥2 Doses,States/Local Areas,New York,2021,Age,24 Months,31.4,25.1 to 38.9,402
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2021,Age,0-2 Days,71.7,65.1 to 77.6,402
PCV,≥2 Doses,States/Local Areas,New York,2020-2021,Age,5 Months,74.6,70.5 to 78.3,1026
Hib,≥2 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,93.9,91.2 to 95.9,1026
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,91.4,87.5 to 94.2,279
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,89.8,86.8 to 92.2,584
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,88.2,83.5 to 91.7,305
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,88.9,85.1 to 91.8,554
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,89.2,84.8 to 93.6,312
Rotavirus,,States/Local Areas,New York,2019-2020,Age,8 Months,77.0,73.3 to 80.3,1261
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,90.4,85.4 to 93.8,243
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,89.5,87.6 to 91.2,249
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,88.0,83.5 to 91.3,552
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,75.0,68.8 to 80.3,412
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,88.8,86.4 to 90.8,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,90.1,85.1 to 93.5,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,90.9,87.3 to 93.6,279
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,88.3,83.3 to 91.9,584
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,85.6,80.3 to 89.7,305
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,87.2,83.2 to 90.3,554
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,66.3,62.6 to 70.0,1046
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,66.3,62.6 to 70.0,1046
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",48.7,42.1 to 55.2,391
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.8,62.0 to 77.6,226
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,73.8,67.6 to 79.9,312
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,86.6,81.0 to 90.7,412
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020,Age,24 Months,89.5,84.5 to 93.5,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,68.4,62.8 to 74.0,400
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,89.7,85.0 to 93.1,451
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,89.1,85.7 to 91.8,863
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,88.5,83.1 to 92.3,412
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,94.2,88.8 to 97.1,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,93.6,89.3 to 96.2,279
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,92.0,88.5 to 94.5,584
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,94.9,90.1 to 97.4,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,50.0,43.6 to 56.5,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,89.1,86.7 to 91.6,1046
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.3,81.6 to 91.0,391
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,76.3,68.9 to 82.4,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,73.4,68.0 to 78.1,552
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,70.5,62.7 to 77.3,303
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,71.8,66.8 to 76.3,706
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,73.2,66.8 to 78.7,403
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,73.4,69.1 to 77.3,854
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,89.9,85.1 to 93.3,451
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,69.4,65.0 to 73.4,863
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,73.6,67.7 to 78.8,451
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,74.3,70.1 to 78.1,863
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,86.4,79.8 to 91.1,303
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,88.2,84.1 to 91.3,706
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,90.1,84.8 to 93.7,403
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,90.0,86.6 to 92.6,854
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,67.5,59.8 to 74.3,303
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,67.3,62.3 to 72.0,706
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,90.7,87.9 to 92.8,279
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,91.7,89.4 to 93.6,584
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,92.0,87.6 to 95.2,403
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,92.0,88.9 to 94.4,854
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,91.8,87.2 to 95.2,451
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,91.8,88.8 to 94.3,863
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,53.7,46.9 to 60.4,305
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,51.1,45.9 to 56.3,554
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,48.5,40.7 to 56.4,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,48.5,43.2 to 53.9,552
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,48.5,41.1 to 55.9,303
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,50.9,45.9 to 55.8,706
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,3 Months,85.7,80.2 to 89.9,403
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,3 Months,85.4,81.7 to 88.5,854
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,3 Months,85.1,79.8 to 89.3,451
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,3 Months,86.6,83.0 to 89.5,863
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,89.4,82.7 to 93.7,249
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,88.4,83.9 to 91.8,552
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,87.4,80.6 to 92.1,303
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,89.3,85.2 to 92.3,706
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,92.8,88.8 to 95.5,305
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,91.1,87.4 to 93.8,554
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,88.8,83.6 to 92.5,451
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,87.7,84.1 to 90.6,863
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,93.1,88.6 to 96.3,305
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,91.6,87.4 to 94.8,554
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,89.8,81.8 to 95.2,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,88.8,84.5 to 92.4,552
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,88.5,82.8 to 93.0,303
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,90.2,86.6 to 93.1,706
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,95.3,93.7 to 96.6,243
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,91.0,82.1 to 95.7,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,59.7,51.5 to 67.3,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,63.6,58.1 to 68.8,552
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,65.0,58.3 to 71.1,305
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,62.3,57.1 to 67.3,554
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2015,Age,0-3 Days,67.7,59.8 to 74.6,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2015-2016,Age,0-3 Days,67.2,61.8 to 72.2,552
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,53.5,47.0 to 59.9,403
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,55.0,50.6 to 59.4,854
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,56.6,50.4 to 62.5,451
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,53.4,48.9 to 57.8,863
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.1,81.8 to 94.5,117
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,84.8 to 95.8,226
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,91.9,88.3 to 95.5,312
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,89.7,86.3 to 93.2,393
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,91.8,88.6 to 94.9,524
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,80.5,71.2 to 89.8,120
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,91.8,87.6 to 95.0,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2018,Age,0-3 Days,78.3,72.8 to 82.9,451
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2018-2019,Age,0-3 Days,78.8,74.9 to 82.2,863
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,3 Months,88.0,82.8 to 91.8,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2019,Age,0-3 Days,79.2,73.6 to 83.9,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,61.4,50.1 to 72.7,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,63.8,58.4 to 69.2,524
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.6,73.7 to 89.5,117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,70.0,64.4 to 75.6,393
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,73.0,67.0 to 78.2,451
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,68.9,64.6 to 73.0,863
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,64.7,58.2 to 70.7,412
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,67.1,60.5 to 73.2,403
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,70.0,65.6 to 74.1,854
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,90.3,86.2 to 93.3,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,84.3,77.3 to 89.5,303
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,86.5,82.2 to 89.9,706
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,88.9,83.5 to 92.7,403
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,89.3,85.9 to 92.0,854
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,88.7,82.1 to 93.1,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,86.5,81.9 to 90.1,552
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,63.4,57.1 to 69.7,398
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,65.8,58.2 to 73.4,248
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,76.6,72.9 to 79.9,279
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,74.7,70.8 to 78.2,584
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,90.2,83.4 to 94.4,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,93.4,89.9 to 96.9,398
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,85.5,80.0 to 91.0,248
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,72.8,66.3 to 78.5,305
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,74.6,69.8 to 78.8,554
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,85.5,78.2 to 90.6,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,79.3,72.3 to 85.0,243
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,88.9,84.3 to 92.3,243
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,92.6,88.2 to 95.4,451
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,91.8,88.7 to 94.2,863
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,91.2,86.3 to 94.5,403
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,91.9,88.8 to 94.2,854
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,88.5,84.8 to 92.3,400
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,89.1,86.7 to 91.6,1046
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,91.1,86.1 to 94.4,412
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,94.9,90.9 to 97.2,342
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,86.7,84.0 to 89.4,1046
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.1,78.0 to 88.2,391
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,80.7,71.6 to 89.7,120
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.7,86.1 to 95.3,226
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019,Age,35 Months,93.8,89.7 to 96.6,412
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,78.9,72.1 to 85.0,279
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,79.6,75.0 to 83.8,584
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018,Age,35 Months,95.5,91.8 to 97.9,451
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,94.7,92.1 to 96.7,863
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017,Age,35 Months,91.4,87.2 to 94.7,403
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,93.4,90.7 to 95.5,854
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,3 Months,82.2,75.0 to 87.6,249
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,3 Months,79.3,74.1 to 83.6,552
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,3 Months,76.5,68.8 to 82.8,303
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,3 Months,80.5,75.7 to 84.5,706
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,3 Months,84.8,79.2 to 89.0,403
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,3 Months,85.2,81.5 to 88.3,854
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,93.3,88.5 to 96.2,403
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,93.2,90.2 to 95.4,854
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,93.1,88.7 to 95.8,451
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,93.4,90.6 to 95.4,863
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,93.8,89.6 to 96.4,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,87.3,83.6 to 90.2,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,86.4,81.8 to 90.0,552
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,85.7,79.2 to 90.4,303
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,87.1,83.1 to 90.3,706
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.8,80.1 to 93.6,117
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,87.8 to 96.2,226
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,91.2,87.2 to 95.1,312
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,92.9,90.1 to 95.7,524
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,87.0,83.0 to 91.0,393
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,70.0,62.2 to 77.4,303
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,76.3,71.4 to 81.0,706
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,81.4,72.8 to 88.7,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,74.8,69.2 to 80.2,552
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,80.3,74.3 to 85.7,305
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,80.4,75.4 to 85.0,554
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,92.8,87.8 to 96.3,451
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,91.8,88.3 to 94.5,863
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,90.0,85.2 to 93.7,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,86.6,82.4 to 89.9,554
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,90.6,86.6 to 94.7,398
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,88.3,85.8 to 90.8,1046
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.3,79.3 to 89.3,391
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,3 Months,75.8,63.8 to 84.8,279
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,3 Months,77.2,70.1 to 83.0,584
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.5,58.5 to 78.5,117
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,80.4,74.9 to 85.9,312
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,62.3,51.0 to 73.6,120
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,71.8,66.3 to 77.3,393
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,87.4,80.8 to 92.6,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,88.1,83.9 to 91.7,552
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,90.1,85.6 to 93.7,305
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,88.8,84.9 to 92.1,554
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,93.2,87.8 to 96.7,243
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,5 Months,73.6,67.1 to 79.2,403
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,5 Months,76.5,72.2 to 80.2,854
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,91.2,86.7 to 94.7,279
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,90.6,87.5 to 93.2,584
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,83.0,77.5 to 87.8,403
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,83.6,79.7 to 87.1,854
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,84.6,78.7 to 89.5,451
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,83.9,79.8 to 87.5,863
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,83.3,77.6 to 88.3,412
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,3 Months,75.6,69.5 to 80.9,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,91.2,87.0 to 95.4,398
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,86.4,80.9 to 91.8,248
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,87.7,84.0 to 91.5,400
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,88.3,85.8 to 90.8,1046
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,5 Months,74.4,66.8 to 80.8,249
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,5 Months,71.6,66.2 to 76.4,552
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,5 Months,68.9,61.1 to 75.8,303
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,5 Months,71.1,66.1 to 75.7,706
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,3 Months,77.4,70.0 to 83.5,243
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,90.0,85.2 to 93.4,451
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,86.1,82.5 to 89.1,863
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,89.6,84.6 to 93.1,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,92.5,87.4 to 96.1,249
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,5 Months,69.8,64.8 to 74.4,279
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,5 Months,70.0,66.4 to 73.5,584
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,5 Months,70.3,63.7 to 76.1,305
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,5 Months,72.3,69.6 to 74.9,554
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,88.7,83.4 to 92.4,403
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,89.3,85.9 to 92.0,854
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,5 Months,72.8,68.9 to 76.4,243
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,5 Months,76.5,73.3 to 79.4,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,82.6,77.5 to 87.7,398
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,67.8,60.2 to 75.3,248
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,72.2,66.8 to 77.6,400
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,74.0,70.5 to 77.5,1046
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,85.2,82.7 to 87.4,279
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,85.6,82.9 to 88.0,584
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,86.0,80.6 to 90.1,305
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,85.7,81.5 to 89.1,554
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2012,Age,0-3 Days,53.0,45.0 to 60.8,243
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,74.0,70.5 to 77.5,1046
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,3 Months,85.7,80.5 to 89.8,451
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,3 Months,86.1,82.4 to 89.1,863
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,3 Months,86.4,80.9 to 90.5,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2011,Age,0-3 Days,60.3,52.4 to 67.7,249
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,3 Months,81.5,76.0 to 86.0,451
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,3 Months,83.0,79.3 to 86.2,863
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,88.5,84.6 to 92.3,393
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,80.5,76.0 to 85.0,524
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.6,86.0 to 97.2,117
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,5 Months,79.5,73.7 to 84.2,451
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,5 Months,76.4,72.2 to 80.1,863
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,5 Months,73.2,66.9 to 78.7,412
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,87.9,83.3 to 91.4,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,88.5,82.8 to 93.0,303
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,90.0,86.5 to 93.0,706
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,88.1,85.7 to 90.2,243
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,91.6,87.2 to 94.9,403
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,91.4,88.4 to 93.9,854
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,78.5,68.6 to 88.4,120
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,90.2,86.9 to 93.5,524
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,3 Months,76.0,68.6 to 82.1,303
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,3 Months,79.0,74.3 to 83.0,706
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,3 Months,82.2,76.6 to 86.8,403
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,3 Months,81.9,78.1 to 85.2,854
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.5,62.2 to 74.8,391
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,70.8 to 85.2,226
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,3 Months,78.5,72.4 to 83.5,305
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,3 Months,77.5,72.7 to 81.6,554
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,3 Months,76.5,68.8 to 82.7,249
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,3 Months,76.2,71.0 to 80.7,552
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014,Age,0-3 Days,62.4,55.7 to 68.7,305
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2014-2015,Age,0-3 Days,65.0,59.9 to 69.8,554
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,59.5,54.4 to 64.4,279
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,62.2,56.6 to 67.6,584
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,64.4,59.0 to 69.5,243
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,64.8,56.2 to 72.5,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2013,Age,0-3 Days,56.4,49.2 to 63.4,279
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2013-2014,Age,0-3 Days,59.4,54.5 to 64.2,584
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,3 Months,82.2,72.3 to 89.0,279
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,3 Months,83.5,77.2 to 88.4,584
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,3 Months,84.6,79.1 to 88.8,412
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,87.8,85.2 to 90.5,1046
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,3 Months,83.9,80.2 to 87.0,243
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,3 Months,82.2,73.4 to 88.6,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,90.9,86.5 to 94.3,451
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,91.3,88.4 to 93.8,863
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,85.4,78.5 to 90.4,249
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,82.7,77.8 to 86.8,552
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,91.8,87.6 to 95.0,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,93.7,88.3 to 97.2,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,93.2,88.2 to 96.6,279
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,93.0,89.8 to 95.5,584
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,87.8,85.2 to 90.5,1046
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.8,76.3 to 87.3,391
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,89.5 to 97.0,226
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,93.9,88.5 to 97.3,243
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,80.2,72.7 to 86.0,303
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,83.1,78.5 to 86.9,706
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,86.3,80.8 to 90.4,403
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,87.5,83.9 to 90.4,854
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,87.9,84.0 to 91.7,400
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,90.3,86.2 to 94.5,398
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,85.0,79.1 to 90.8,248
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,52.9,46.4 to 59.2,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,57.7,53.9 to 61.5,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,51.5,47.2 to 55.7,279
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,52.6,49.3 to 55.9,584
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,3 Months,84.9,79.4 to 89.1,305
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,3 Months,82.8,78.5 to 86.5,554
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,3 Months,80.8,73.8 to 86.3,249
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,3 Months,80.0,75.1 to 84.1,552
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,3 Months,79.2,72.0 to 84.9,303
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,3 Months,82.3,77.9 to 86.1,706
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2017,Age,0-3 Days,73.3,62.6 to 81.8,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2017-2018,Age,0-3 Days,74.2,70.1 to 77.9,854
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016,Age,0-3 Days,66.8,59.1 to 73.6,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2017,Age,0-3 Days,68.4,63.5 to 73.0,706
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,78.3,70.7 to 85.9,312
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,64.6,59.8 to 69.4,1046
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",46.7,38.5 to 54.9,391
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,86.8,81.3 to 90.9,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,64.6,59.8 to 69.4,1046
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,67.6,60.4 to 74.9,400
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,78.8,73.3 to 84.3,398
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,49.7,36.9 to 62.5,120
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2016,Age,0-1 Days,54.0,46.4 to 61.4,303
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2016-2017,Age,0-1 Days,55.9,50.9 to 60.8,706
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2017,Age,0-1 Days,57.9,51.4 to 64.2,403
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2017-2018,Age,0-1 Days,64.5,60.2 to 68.7,854
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,5 Months,88.8,83.8 to 92.4,412
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,88.7,83.9 to 92.1,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,5 Months,86.7,81.2 to 90.7,403
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,5 Months,86.9,83.4 to 89.8,854
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,5 Months,87.2,82.2 to 91.0,451
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,5 Months,88.0,84.6 to 90.7,863
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,86.7,81.0 to 91.3,412
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,75.6,70.3 to 81.0,393
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,81.8,77.2 to 86.3,524
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,63.2,51.9 to 74.5,120
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.4,66.3 to 84.6,117
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2011,Age,19 Months,90.9,87.7 to 93.4,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013,Age,19 Months,87.0,83.2 to 90.0,279
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,85.7,83.3 to 87.8,584
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014,Age,19 Months,84.4,78.7 to 88.8,305
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,86.7,82.7 to 89.8,554
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2012,Age,19 Months,89.7,76.4 to 95.9,243
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017,Age,19 Months,87.4,82.2 to 91.3,403
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,87.8,84.3 to 90.6,854
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018,Age,19 Months,88.1,83.1 to 91.8,451
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,61.3,56.8 to 65.6,863
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016,Age,19 Months,82.7,75.8 to 87.9,303
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,85.0,80.7 to 88.4,706
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,90.8,84.1 to 94.8,249
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,89.2,84.8 to 92.5,552
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,87.7,81.2 to 92.2,303
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,90.3,86.4 to 93.1,706
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,3 Months,93.6,89.2 to 96.3,403
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,3 Months,92.7,89.8 to 94.9,854
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,90.0,84.3 to 94.2,403
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,89.5,85.6 to 92.8,854
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,84.7,77.4 to 90.6,303
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,87.3,82.7 to 91.1,706
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,79.5,72.2 to 85.2,303
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,81.7,77.1 to 85.5,706
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,86.5,79.7 to 91.3,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,83.0,78.1 to 86.9,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,84.1,78.4 to 88.5,403
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,85.4,81.7 to 88.4,854
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,3 Months,90.6,85.4 to 94.0,279
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,3 Months,91.3,88.7 to 93.4,584
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,3 Months,92.7,88.4 to 95.5,243
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,3 Months,89.9,85.7 to 93.0,249
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,3 Months,92.1,87.6 to 95.1,305
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,3 Months,92.0,88.5 to 94.5,554
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,81.2,74.1 to 86.7,303
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,85.2,80.8 to 88.6,706
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,89.4,84.5 to 92.9,403
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,88.0,84.5 to 90.8,854
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,86.6,81.1 to 90.6,451
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,86.7,83.0 to 89.7,863
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,68.1,60.5 to 75.7,393
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,66.5,59.7 to 73.3,524
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,79.7,74.0 to 85.3,312
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.1,62.6 to 75.6,391
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.2,78.5 to 91.8,226
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,76.3,72.8 to 79.7,1046
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,76.3,72.8 to 79.7,1046
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015,Age,19 Months,88.9,83.7 to 92.6,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,85.4,80.9 to 88.9,552
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016,Age,19 Months,81.9,75.0 to 87.3,303
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,85.9,81.8 to 89.2,706
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017,Age,19 Months,90.2,85.7 to 93.4,403
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,91.1,88.1 to 93.4,854
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,76.5,71.3 to 81.7,400
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2011,Age,24 Months,93.9,90.0 to 96.6,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2012,Age,24 Months,92.9,88.0 to 96.2,243
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,3 Months,91.9,87.2 to 94.9,451
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,3 Months,93.8,91.0 to 95.8,863
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,3 Months,95.8,92.0 to 97.8,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,72.5,62.9 to 81.3,342
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,59.4,49.8 to 69.0,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2011,Age,0-1 Days,55.1,52.0 to 58.1,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,5 Months,82.9,75.8 to 88.3,243
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,5 Months,83.3,78.7 to 87.0,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,5 Months,84.3,79.0 to 88.4,279
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,5 Months,81.9,76.9 to 86.1,584
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,89.5,85.2 to 92.7,279
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,89.1,85.9 to 91.6,584
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,65.4,57.0 to 73.9,398
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,88.6,83.7 to 92.2,305
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,88.2,84.2 to 91.3,554
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,87.8,83.1 to 91.4,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,84.9,80.2 to 88.7,552
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,5 Months,75.9,70.0 to 80.9,451
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,5 Months,74.2,70.0 to 78.0,863
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,5 Months,72.4,66.1 to 78.0,412
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,89.7 to 93.8,1046
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.6,83.1 to 92.1,391
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.5,85.9 to 97.0,117
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.4,92.1 to 98.7,226
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,94.2,91.4 to 97.1,312
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,64.2,56.5 to 71.3,303
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,66.7,61.6 to 71.4,706
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,69.4,62.9 to 75.2,403
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,69.7,65.3 to 73.8,854
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,70.0,63.9 to 75.5,451
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,92.1,89.0 to 94.4,863
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,33.0,26.2 to 40.9,279
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,34.4,29.7 to 39.7,584
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,75.7,69.6 to 81.4,305
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,76.4,71.7 to 80.8,554
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,74.3,66.8 to 81.2,303
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,78.8,74.0 to 83.2,706
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,77.1,69.8 to 83.7,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,75.7,70.5 to 80.6,552
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,5 Months,71.6,63.8 to 78.2,249
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,5 Months,72.1,66.8 to 76.8,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,55.6,48.1 to 62.9,303
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,53.6,48.6 to 58.5,706
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,38.0,31.7 to 45.0,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,70.7,60.2 to 80.5,249
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,62.0,52.5 to 71.6,243
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,80.3,70.2 to 88.8,279
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,73.2,66.3 to 79.6,584
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,35 Months,78.8,70.8 to 85.9,303
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,83.3,78.4 to 87.7,706
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014,Age,13 Months,65.6,58.8 to 71.7,305
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,66.5,61.5 to 71.2,554
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015,Age,13 Months,67.5,59.8 to 74.4,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,65.3,59.9 to 70.3,552
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019,Age,13 Months,57.0,50.5 to 63.3,412
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2011,Age,19 Months,88.8,82.2 to 93.2,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2012,Age,19 Months,86.7,80.5 to 91.2,243
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016,Age,13 Months,63.0,55.4 to 70.1,303
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,67.0,62.0 to 71.7,706
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018,Age,13 Months,65.5,59.3 to 71.2,451
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,61.3,56.8 to 65.6,863
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,93.5,87.2 to 97.4,243
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,87.1,79.3 to 93.1,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,85.7,80.5 to 90.2,552
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,84.8,78.8 to 89.8,305
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,85.7,81.1 to 89.7,554
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,83.5,70.9 to 92.8,412
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,85.6,82.3 to 88.3,243
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,88.7,82.7 to 93.4,279
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,86.8,82.6 to 90.4,584
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,85.1,82.9 to 87.1,279
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,83.8,79.1 to 87.7,584
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,82.6,76.8 to 87.1,305
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,84.5,80.3 to 88.0,554
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,78.7,70.6 to 85.8,451
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,79.3,72.6 to 85.3,863
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,71.9,64.3 to 79.0,403
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,75.0,69.5 to 80.2,854
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,82.4,76.6 to 87.4,412
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,94.1,87.5 to 97.8,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,81.7,76.3 to 86.6,451
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,82.0,78.1 to 85.6,863
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,83.6,77.9 to 88.5,403
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,82.8,78.9 to 86.3,854
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016,Age,13 Months,57.3,49.7 to 64.6,303
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,61.5,56.4 to 66.3,706
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017,Age,13 Months,65.9,59.4 to 71.9,403
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,65.7,61.3 to 69.9,854
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015,Age,13 Months,60.5,52.6 to 67.9,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,58.9,53.4 to 64.2,552
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.9,76.6 to 89.2,226
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,75.2,71.8 to 78.6,1046
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",60.0,53.4 to 66.6,391
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,87.2,82.1 to 91.0,305
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,87.2,83.1 to 90.4,554
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,88.4,84.1 to 91.6,279
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,87.8,84.3 to 90.6,584
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,76.9,71.9 to 81.8,400
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,75.2,71.8 to 78.6,1046
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,87.2,80.4 to 91.9,249
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,84.2,79.4 to 88.0,552
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,68.5,60.9 to 76.1,248
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,80.6,74.8 to 85.3,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017,Age,13 Months,71.4,65.1 to 76.9,403
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,72.7,68.4 to 76.5,854
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018,Age,13 Months,74.0,68.0 to 79.2,451
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,69.4,65.0 to 73.4,863
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019,Age,13 Months,64.6,58.1 to 70.7,412
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,61.3,50.1 to 72.5,120
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,89.9,87.5 to 92.2,1046
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.2,79.1 to 89.3,391
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,89.9 to 97.3,226
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,93.4,90.1 to 96.7,312
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,72.4,65.4 to 79.5,248
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,75.0,69.8 to 80.1,400
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,77.0,73.6 to 80.3,1046
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013,Age,13 Months,59.3,54.3 to 64.1,279
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,62.4,59.9 to 64.9,584
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2012,Age,13 Months,64.3,52.6 to 74.5,243
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2011,Age,13 Months,60.8,55.0 to 66.2,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014,Age,19 Months,84.7,79.2 to 88.9,305
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,84.8,80.7 to 88.1,554
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015,Age,19 Months,84.9,77.8 to 90.0,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,83.8,79.2 to 87.5,552
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013,Age,19 Months,87.1,80.7 to 91.6,279
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,85.9,82.4 to 88.8,584
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,94.4,92.9 to 95.5,243
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,93.0,84.8 to 97.0,249
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,93.6,89.8 to 96.0,279
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,93.3,90.3 to 95.4,584
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,93.0,89.0 to 95.6,305
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,91.9,88.3 to 94.5,554
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,3 Months,91.9,85.8 to 95.5,249
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,3 Months,90.2,86.0 to 93.3,552
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,3 Months,88.6,82.0 to 93.0,303
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,3 Months,91.0,87.1 to 93.8,706
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.4,68.8 to 88.1,226
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,55.4,47.9 to 62.7,279
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,56.8,51.3 to 62.2,584
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,58.5,50.8 to 65.9,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,82.1,75.0 to 87.6,303
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,84.8,80.4 to 88.3,706
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,58.3,51.5 to 64.7,305
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,54.2,49.0 to 59.3,554
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,84.6,79.4 to 89.8,398
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,67.2,59.6 to 74.9,248
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,51.5,48.1 to 55.0,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,87.7,82.3 to 91.6,403
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,88.0,84.5 to 90.8,854
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,88.3,83.4 to 91.9,451
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,85.1,81.3 to 88.2,863
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,5 Months,80.5,73.5 to 86.1,303
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,5 Months,83.5,79.1 to 87.1,706
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,5 Months,79.6,73.6 to 84.6,305
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,5 Months,81.1,76.7 to 84.9,554
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2012,Age,0-1 Days,42.3,38.9 to 45.8,243
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,91.7,87.0 to 94.9,451
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,92.1,89.0 to 94.4,863
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,92.4,87.8 to 95.4,412
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019,Age,19 Months,88.7,84.1 to 92.1,412
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,93.0,88.4 to 95.8,403
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,92.4,89.3 to 94.6,854
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014,Age,24 Months,84.7,79.3 to 89.3,305
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,87.7,84.1 to 90.9,554
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013,Age,24 Months,92.7,88.5 to 95.8,279
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,88.8,85.5 to 91.7,584
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2013,Age,0-1 Days,48.0,40.7 to 55.4,279
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2013-2014,Age,0-1 Days,52.1,47.0 to 57.1,584
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2014,Age,0-1 Days,56.2,49.4 to 62.7,305
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2014-2015,Age,0-1 Days,58.9,53.7 to 63.8,554
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,5 Months,82.7,75.4 to 88.1,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,5 Months,81.6,76.7 to 85.6,552
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2015,Age,0-1 Days,61.6,53.6 to 68.9,249
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2015-2016,Age,0-1 Days,57.8,52.3 to 63.1,552
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017,Age,24 Months,90.8,86.6 to 94.2,403
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,91.1,88.2 to 93.5,854
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019,Age,24 Months,91.6,87.6 to 94.7,412
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2011,Age,35 Months,96.6,92.7 to 98.7,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2012,Age,35 Months,94.2,89.5 to 97.2,243
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018,Age,24 Months,91.5,87.3 to 94.7,451
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,91.6,88.8 to 93.9,863
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015,Age,24 Months,91.4,86.2 to 95.2,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,87.7,83.6 to 91.2,552
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014,Age,24 Months,87.9,82.9 to 92.1,305
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,89.6,86.1 to 92.6,554
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013,Age,24 Months,92.9,88.4 to 96.1,279
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,90.5,87.2 to 93.2,584
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,61.1,54.5 to 67.4,403
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,62.8,58.2 to 67.1,854
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,50.1,42.2 to 58.0,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,53.5,48.1 to 58.9,552
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,67.7,61.2 to 73.6,305
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,67.3,62.2 to 72.0,554
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,66.9,65.2 to 68.7,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,65.0,59.5 to 70.2,552
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,63.2,55.4 to 70.3,303
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,67.8,62.7 to 72.5,706
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,56.8,49.2 to 64.1,303
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,58.9,53.8 to 63.8,706
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,35 Months,84.6,78.4 to 89.9,342
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,92.9,88.8 to 95.9,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,93.4,89.5 to 96.2,279
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,91.5,88.6 to 93.9,584
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,88.3,83.1 to 92.0,412
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,89.6,83.5 to 94.2,249
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2018,Age,0-1 Days,71.4,65.6 to 76.6,451
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2018-2019,Age,0-1 Days,71.8,67.7 to 75.7,863
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2019,Age,0-1 Days,72.3,66.2 to 77.7,412
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2011,Age,0-2 Days,59.6,57.2 to 61.9,249
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2013,Age,0-2 Days,55.3,45.6 to 64.7,279
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2013-2014,Age,0-2 Days,58.2,53.0 to 63.3,584
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2012,Age,0-2 Days,50.4,45.9 to 55.0,243
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,89.0,83.2 to 92.9,279
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,87.6,82.6 to 91.3,584
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,86.3,80.9 to 90.3,305
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,87.0,82.9 to 90.2,554
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,90.0,87.9 to 91.7,243
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,64.5,58.3 to 70.2,451
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,61.0,56.6 to 65.3,863
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,57.5,50.9 to 63.8,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,87.2,83.0 to 90.5,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,72.7,66.3 to 78.3,403
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,73.2,68.9 to 77.1,854
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,73.7,67.9 to 78.8,451
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,72.2,67.3 to 76.6,712
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017,Age,24 Months,90.7,86.5 to 94.0,403
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,92.3,89.6 to 94.5,854
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016,Age,24 Months,84.2,77.8 to 89.5,303
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,87.3,83.5 to 90.6,706
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,87.0,86.0 to 87.9,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,85.4,79.1 to 90.6,303
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,87.6,83.7 to 90.9,706
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,87.8,81.5 to 92.8,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,86.7,82.3 to 90.4,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,89.5,85.0 to 93.1,305
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,88.7,84.9 to 91.9,554
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,69.8,56.5 to 80.5,279
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,68.7,59.9 to 76.4,584
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,68.3,62.0 to 73.9,243
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,71.2,67.0 to 75.0,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018,Age,19 Months,92.1,87.6 to 95.0,451
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,91.8,88.7 to 94.2,863
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019,Age,19 Months,90.6,86.2 to 93.8,412
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2011,Age,24 Months,94.8,91.2 to 97.3,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2012,Age,24 Months,95.0,90.5 to 97.8,243
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015,Age,24 Months,90.7,85.4 to 94.7,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,88.1,84.1 to 91.5,552
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016,Age,24 Months,85.4,79.2 to 90.5,303
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,88.0,84.2 to 91.2,706
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2014,Age,0-2 Days,61.2,54.4 to 67.5,305
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2014-2015,Age,0-2 Days,64.0,58.9 to 68.8,554
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2015,Age,0-2 Days,66.8,58.9 to 73.8,249
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2015-2016,Age,0-2 Days,66.0,60.6 to 71.0,552
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,78.7,71.4 to 85.2,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015,Age,35 Months,92.9,87.5 to 96.6,249
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,92.0,88.3 to 94.9,552
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014,Age,35 Months,90.4,85.3 to 94.3,305
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,91.9,88.3 to 94.7,554
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,70.9,64.6 to 76.6,412
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018,Age,24 Months,94.0,90.2 to 96.6,451
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,93.3,90.8 to 95.4,863
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013,Age,35 Months,95.1,91.1 to 97.7,279
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,92.9,89.7 to 95.4,584
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,3 Months,82.7,77.9 to 86.6,279
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,3 Months,82.5,78.3 to 86.1,584
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,3 Months,83.9,77.3 to 88.9,243
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,3 Months,83.2,75.2 to 89.0,249
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,3 Months,82.3,76.5 to 87.0,305
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,3 Months,82.2,77.8 to 86.0,554
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,90.9,86.3 to 94.0,305
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,91.1,87.5 to 93.7,554
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,91.3,85.0 to 95.0,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,89.9,85.7 to 93.0,552
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,88.6,82.1 to 92.9,303
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,90.9,87.0 to 93.7,706
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,85.2,79.6 to 89.4,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,90.5,87.9 to 92.6,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,88.8,81.2 to 93.5,279
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,87.4,82.6 to 91.0,584
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,85.9,80.6 to 90.0,305
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,90.0,83.9 to 94.5,303
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,90.1,86.3 to 93.3,706
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,79.1,73.4 to 84.4,412
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,80.6,75.3 to 85.5,451
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,79.9,76.0 to 83.5,863
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,87.4,81.1 to 92.4,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,80.7,73.5 to 86.9,243
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,91.6,87.9 to 94.2,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,90.1,85.3 to 93.8,403
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,91.2,87.9 to 93.9,854
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,91.0,86.2 to 94.2,412
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,13 Months,92.3,86.9 to 95.5,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,93.9,87.7 to 97.1,279
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,92.4,87.3 to 95.6,584
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,13 Months,94.3,93.0 to 95.4,243
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,13 Months,85.8,80.3 to 89.9,403
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,86.4,82.9 to 89.3,854
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,87.1,82.1 to 90.8,451
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,86.1,82.5 to 89.1,863
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,95.1,90.9 to 97.7,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,87.8,81.5 to 92.8,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,89.6,85.1 to 93.2,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,92.2,87.7 to 95.5,305
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,90.4,86.5 to 93.5,554
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,94.8,90.6 to 97.5,279
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,93.6,90.6 to 95.9,584
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,13 Months,77.4,69.9 to 83.5,303
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,81.4,76.8 to 85.3,706
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014,Age,35 Months,95.2,91.1 to 97.8,305
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,93.7,90.3 to 96.2,554
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015,Age,35 Months,91.4,86.2 to 95.2,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,92.8,89.2 to 95.5,552
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,79.5,73.8 to 84.8,403
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,80.0,76.2 to 83.7,854
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,66.6,59.0 to 73.9,303
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,72.8,67.9 to 77.5,706
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,73.8,66.1 to 80.9,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,69.9,64.6 to 75.2,552
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016,Age,35 Months,93.0,87.8 to 96.5,303
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,92.2,88.9 to 94.8,706
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019,Age,35 Months,96.1,92.1 to 98.4,412
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,85.7,81.5 to 89.9,393
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,91.2,88.0 to 94.3,524
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,77.8,68.2 to 87.4,120
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.6,73.4 to 89.7,117
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2016,Age,0-2 Days,65.2,57.5 to 72.2,303
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2016-2017,Age,0-2 Days,66.7,61.7 to 71.3,706
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,7 Months,84.4,77.5 to 89.5,303
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,86.8,82.6 to 90.1,706
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,13 Months,82.5,74.6 to 88.4,279
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,82.4,76.8 to 86.8,584
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,89.4,84.2 to 93.0,403
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,89.6,86.2 to 92.2,854
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,13 Months,82.2,76.4 to 86.8,305
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,82.1,77.6 to 85.9,554
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,13 Months,82.0,74.6 to 87.6,249
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,79.7,74.5 to 84.0,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,88.9,84.3 to 92.7,451
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,89.1,85.8 to 91.9,863
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,87.7,81.0 to 92.3,249
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,86.0,81.4 to 89.7,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,91.6,88.7 to 93.8,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,13 Months,86.7,81.7 to 90.5,451
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,85.1,81.3 to 88.2,863
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,13 Months,83.4,77.6 to 87.9,412
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,87.0,84.3 to 89.3,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,88.8,82.9 to 93.4,451
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,87.8,83.7 to 91.2,863
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017,Age,35 Months,93.2,88.4 to 96.5,403
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,93.7,90.5 to 96.0,854
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2017,Age,0-2 Days,68.2,61.9 to 73.9,403
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2017-2018,Age,0-2 Days,72.5,68.3 to 76.3,854
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2018,Age,0-2 Days,76.9,71.4 to 81.7,451
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2018-2019,Age,0-2 Days,76.5,72.5 to 80.1,863
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2019,Age,0-2 Days,76.1,70.2 to 81.1,412
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,89.8,85.1 to 93.2,451
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,90.4,87.2 to 92.9,863
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016,Age,35 Months,91.0,85.6 to 95.0,303
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,92.0,88.4 to 94.9,706
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013,Age,35 Months,95.7,91.4 to 98.2,279
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,95.5,92.6 to 97.5,584
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2011,Age,35 Months,98.0,94.9 to 99.4,249
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2012,Age,35 Months,96.3,91.8 to 98.7,243
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019,Age,24 Months,92.6,88.8 to 95.5,412
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,77.3,71.3 to 82.8,305
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,75.5,70.7 to 80.0,554
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,74.7,68.1 to 80.8,279
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,75.9,71.5 to 80.1,584
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,89.3,84.6 to 93.2,412
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,89.9,85.1 to 93.6,403
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,89.5,86.2 to 92.2,854
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,92.6,87.2 to 96.4,249
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,77.8,70.8 to 84.1,243
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018,Age,35 Months,94.2,90.0 to 97.0,451
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,94.9,92.2 to 97.0,863
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,90.8,87.0 to 94.6,312
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.5,48.5 to 72.6,117
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,84.5,78.7 to 90.3,248
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,85.5,81.4 to 89.6,400
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,86.7,84.0 to 89.4,1046
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,35 Months,89.9,84.3 to 94.1,279
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,88.7,84.7 to 92.0,584
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,35 Months,87.0,81.3 to 91.7,305
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,88.1,83.5 to 92.0,554
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,91.7,89.7 to 93.8,1046
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,37.6,30.1 to 46.3,249
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,36.2,31.1 to 41.9,552
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,35.9,29.7 to 43.0,305
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,36.6,31.7 to 42.1,554
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,92.5,88.2 to 95.6,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,41.6,35.5 to 48.3,451
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,39.8,35.3 to 44.6,863
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,38.1,31.9 to 45.0,403
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,39.9,35.5 to 44.6,854
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,34.9,28.1 to 42.8,303
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,36.5,31.7 to 41.7,706
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,80.1,73.9 to 85.7,279
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,77.9,73.6 to 82.0,584
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,35 Months,89.5,81.1 to 95.3,249
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,83.4,77.9 to 88.3,552
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,5 Months,73.4,64.5 to 80.8,243
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,5 Months,74.1,71.4 to 76.7,249
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,35 Months,85.9,77.9 to 92.1,243
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,5 Months,71.5,64.8 to 77.4,279
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,5 Months,72.3,67.6 to 76.6,584
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,5 Months,73.2,66.8 to 78.7,305
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,5 Months,72.4,69.0 to 75.4,554
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,91.0,87.8 to 94.1,400
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,95.2,92.1 to 98.3,398
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,89.3,84.5 to 94.1,248
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,52.0,46.9 to 57.1,243
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,44.4,36.9 to 52.3,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,7 Months,54.2,51.6 to 56.9,279
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,51.0,47.4 to 54.6,584
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,69.4,63.0 to 75.1,412
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,82.6,75.6 to 88.5,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,84.7,78.2 to 90.2,243
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,35 Months,88.1,82.8 to 92.4,403
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,87.8,83.9 to 91.1,854
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,35 Months,87.5,81.4 to 92.3,451
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,89.7,86.0 to 92.8,863
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,5 Months,72.6,65.1 to 79.0,303
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,5 Months,74.2,69.4 to 78.5,706
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,5 Months,75.9,69.6 to 81.3,403
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,5 Months,76.9,72.7 to 80.6,854
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,7 Months,47.8,41.1 to 54.6,305
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,49.2,44.0 to 54.4,554
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,7 Months,50.7,42.7 to 58.5,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,53.2,47.8 to 58.5,552
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,5 Months,75.0,68.8 to 80.4,412
Hib,Full Series,States/Local Areas,NY-City of New York,2020,Age,24 Months,81.4,75.1 to 86.9,342
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,83.3,78.2 to 88.4,312
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,7 Months,88.8,86.2 to 91.0,243
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,7 Months,87.4,81.5 to 91.7,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,7 Months,51.4,44.9 to 57.8,403
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,53.1,48.7 to 57.5,854
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,7 Months,54.9,48.8 to 60.9,451
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,52.0,47.6 to 56.5,863
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,62.2,53.3 to 71.1,303
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,66.9,60.9 to 72.7,706
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,71.9,62.2 to 81.0,249
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,66.4,59.9 to 72.9,552
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,7 Months,49.1,42.7 to 55.5,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,65.3,57.0 to 73.5,305
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,68.5,62.2 to 74.7,554
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014,Age,13 Months,58.3,51.6 to 64.6,305
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,59.4,54.3 to 64.3,554
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2012,Age,13 Months,57.8,50.9 to 64.3,243
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,35 Months,91.8,87.1 to 95.3,412
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,76.9,71.8 to 82.0,393
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,76.1,71.2 to 81.0,524
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,68.8,57.7 to 79.8,120
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.2,72.9 to 89.5,117
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,5 Months,77.9,72.1 to 82.8,451
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,5 Months,76.5,72.3 to 80.2,863
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013,Age,13 Months,56.1,52.0 to 60.1,279
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,57.2,52.8 to 61.4,584
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2011,Age,13 Months,57.4,53.5 to 61.2,249
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.5,84.6 to 96.4,117
Hib,Primary Series,States/Local Areas,NY-City of New York,2012,Age,7 Months,61.8,56.2 to 67.1,243
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,84.5,79.3 to 89.8,398
Hib,Primary Series,States/Local Areas,NY-City of New York,2011,Age,7 Months,62.0,56.4 to 67.3,249
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,77.0,73.6 to 80.3,1046
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.1,67.0 to 79.2,391
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.0,73.0 to 87.0,226
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,81.3,76.0 to 86.6,312
Hib,Full Series,States/Local Areas,NY-City of New York,2018,Age,35 Months,85.0,79.0 to 90.0,451
Hib,Full Series,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,83.8,79.7 to 87.6,863
Hib,Full Series,States/Local Areas,NY-City of New York,2019,Age,35 Months,82.6,76.8 to 87.8,412
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,95.0,91.0 to 97.6,451
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,93.7,90.8 to 96.0,863
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,5 Months,73.9,67.5 to 79.4,305
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,5 Months,74.8,72.2 to 77.3,554
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,92.2,87.7 to 95.5,412
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,82.6,73.7 to 91.5,120
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,89.7,86.1 to 93.3,393
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,92.6,89.7 to 95.5,524
Hib,Full Series,States/Local Areas,NY-City of New York,2016,Age,35 Months,77.6,70.3 to 84.1,303
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,80.7,76.1 to 84.9,706
Hib,Full Series,States/Local Areas,NY-City of New York,2014,Age,35 Months,83.7,77.7 to 88.8,305
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,81.2,76.3 to 85.5,554
Hib,Full Series,States/Local Areas,NY-City of New York,2015,Age,35 Months,78.1,70.3 to 85.0,249
Hib,Full Series,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,77.6,72.4 to 82.5,552
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,82.7,78.2 to 87.1,524
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.7,64.4 to 83.0,117
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,77.0,72.0 to 82.0,393
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,93.2,88.9 to 96.3,403
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,94.0,91.1 to 96.2,854
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,91.0,85.3 to 95.2,303
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,92.2,88.7 to 95.0,706
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,5 Months,75.7,68.1 to 82.0,249
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,5 Months,74.8,69.6 to 79.4,552
Hep A,≥1 Dose,States/Local Areas,New York,2020-2021,Age,24 Months,79.6,75.9 to 83.1,1026
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,93.8,88.6 to 97.2,249
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,90.7,84.8 to 95.1,249
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,91.4,87.2 to 94.6,552
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,94.4,90.2 to 97.2,243
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,93.4,88.6 to 96.7,305
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,92.5,88.4 to 95.5,554
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,95.8,91.8 to 98.2,279
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,94.7,91.7 to 96.9,584
Hib,Full Series,States/Local Areas,NY-City of New York,2013,Age,35 Months,81.6,75.3 to 87.2,279
Hib,Full Series,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,82.5,78.1 to 86.4,584
Hib,Full Series,States/Local Areas,NY-City of New York,2011,Age,35 Months,85.5,79.1 to 90.8,249
Hib,Full Series,States/Local Areas,NY-City of New York,2012,Age,35 Months,86.2,77.8 to 92.6,243
Hib,Full Series,States/Local Areas,NY-City of New York,2019,Age,24 Months,79.3,73.4 to 84.6,412
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,5 Months,74.8,68.6 to 80.0,279
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,5 Months,74.3,69.9 to 78.3,584
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,5 Months,76.4,68.2 to 83.0,243
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,5 Months,77.6,70.9 to 83.1,249
Hib,Full Series,States/Local Areas,NY-City of New York,2017,Age,35 Months,84.0,78.5 to 88.8,403
Hib,Full Series,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,84.2,80.3 to 87.7,854
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,97.3,94.2 to 99.0,243
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,93.2,89.4 to 96.0,451
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,91.9,89.1 to 94.3,863
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,90.6,86.2 to 94.1,412
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,89.4,84.2 to 93.1,412
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,92.1,87.7 to 95.4,403
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,92.6,89.8 to 94.9,854
Hib,Full Series,States/Local Areas,NY-City of New York,2018,Age,24 Months,79.2,73.7 to 84.2,451
Hib,Full Series,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,79.2,75.2 to 82.9,863
Hib,Full Series,States/Local Areas,NY-City of New York,2017,Age,24 Months,82.1,76.5 to 87.0,403
Hib,Full Series,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,80.7,76.8 to 84.3,854
Hib,Full Series,States/Local Areas,NY-City of New York,2016,Age,24 Months,75.7,68.6 to 82.3,303
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,78.8,74.2 to 83.0,706
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,92.5,88.2 to 95.7,279
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,91.2,88.1 to 93.7,584
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,95.0,91.2 to 97.6,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,91.5,85.7 to 95.6,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,89.5,85.0 to 93.2,305
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,89.6,85.9 to 92.6,554
Hep A,≥2 Doses,States/Local Areas,New York,2011,Age,24 Months,32.1,26.9 to 38.0,466
Hep A,≥2 Doses,States/Local Areas,New York,2019,Age,19 Months,14.5,11.0 to 18.9,637
Hep A,≥2 Doses,States/Local Areas,New York,2018,Age,19 Months,20.7,17.0 to 25.1,733
Hep A,≥2 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,17.9,14.6 to 21.6,1140
Hib,≥3 Doses,States/Local Areas,New York,2017,Age,35 Months,93.8,90.8 to 96.1,648
Hib,≥3 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,92.8,90.7 to 94.6,1381
Hib,≥3 Doses,States/Local Areas,New York,2016,Age,35 Months,90.0,85.4 to 93.6,506
Hib,≥3 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,91.9,89.2 to 94.2,1154
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,96.3,95.0 to 97.7,1048
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,93.1,90.7 to 95.4,645
DTaP,≥4 Doses,States/Local Areas,New York,2015,Age,19 Months,68.6,65.7 to 71.4,503
DTaP,≥4 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,67.5,63.5 to 71.3,1009
DTaP,≥4 Doses,States/Local Areas,New York,2014,Age,19 Months,69.2,64.4 to 73.6,592
DTaP,≥4 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,68.9,65.3 to 72.2,1095
DTaP,≥4 Doses,States/Local Areas,New York,2013,Age,19 Months,71.3,63.6 to 77.9,545
DTaP,≥4 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,70.2,64.8 to 75.1,1137
Hep A,≥2 Doses,States/Local Areas,New York,2012,Age,24 Months,34.7,29.5 to 40.6,492
Hib,≥3 Doses,States/Local Areas,New York,2018,Age,35 Months,91.8,88.6 to 94.3,733
Hib,≥3 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,91.8,89.3 to 93.9,1370
Hib,≥3 Doses,States/Local Areas,New York,2017,Age,24 Months,93.4,90.3 to 95.7,648
Hib,≥3 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,92.1,89.9 to 93.9,1381
DTaP,≥3 Doses,States/Local Areas,New York,2019,Age,24 Months,91.8,87.6 to 95.0,637
Hib,≥3 Doses,States/Local Areas,New York,2016,Age,24 Months,89.4,84.9 to 93.1,506
Hib,≥3 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,91.4,88.6 to 93.7,1154
Hib,≥3 Doses,States/Local Areas,New York,2015,Age,24 Months,90.5,86.7 to 93.7,503
Hib,≥3 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,90.0,87.1 to 92.5,1009
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,92.3,90.7 to 93.8,1922
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,92.9,90.7 to 95.0,646
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,88.7,85.1 to 92.4,523
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,94.8,92.7 to 97.0,753
Hib,Full Series,States/Local Areas,New York,2021,Age,19 Months,72.8,66.3 to 78.5,402
Hep A,≥1 Dose,States/Local Areas,New York,2017,Age,24 Months,84.7,80.5 to 88.3,648
Hep A,≥1 Dose,States/Local Areas,New York,2017-2018,Age,24 Months,82.7,79.8 to 85.4,1381
DTaP,≥3 Doses,States/Local Areas,New York,2018,Age,35 Months,96.0,93.1 to 98.0,733
DTaP,≥3 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,94.2,91.7 to 96.1,1370
PCV,≥2 Doses,States/Local Areas,New York,2016,Age,5 Months,69.5,63.4 to 75.0,506
PCV,≥2 Doses,States/Local Areas,New York,2016-2017,Age,5 Months,73.2,69.2 to 76.8,1154
PCV,≥2 Doses,States/Local Areas,New York,2015,Age,5 Months,72.2,66.8 to 76.9,503
PCV,≥2 Doses,States/Local Areas,New York,2015-2016,Age,5 Months,70.8,66.8 to 74.5,1009
PCV,≥2 Doses,States/Local Areas,New York,2014,Age,5 Months,72.9,68.2 to 77.1,592
PCV,≥2 Doses,States/Local Areas,New York,2014-2015,Age,5 Months,72.5,66.9 to 77.5,1095
Hep A,≥1 Dose,States/Local Areas,New York,2016,Age,24 Months,74.2,68.7 to 79.4,506
Hep A,≥1 Dose,States/Local Areas,New York,2016-2017,Age,24 Months,79.3,75.8 to 82.6,1154
Hep A,≥1 Dose,States/Local Areas,New York,2015,Age,24 Months,78.7,73.9 to 83.1,503
Hep A,≥1 Dose,States/Local Areas,New York,2015-2016,Age,24 Months,76.4,72.7 to 79.9,1009
PCV,≥2 Doses,States/Local Areas,New York,2017,Age,5 Months,77.0,72.1 to 81.3,648
PCV,≥2 Doses,States/Local Areas,New York,2017-2018,Age,5 Months,76.6,73.3 to 79.6,1381
Hep A,≥1 Dose,States/Local Areas,New York,2011,Age,35 Months,87.5,81.6 to 92.3,466
Hep A,≥1 Dose,States/Local Areas,New York,2019,Age,24 Months,82.7,77.7 to 87.2,637
Hep A,≥1 Dose,States/Local Areas,New York,2018,Age,24 Months,80.7,76.4 to 84.6,733
Hep A,≥1 Dose,States/Local Areas,New York,2018-2019,Age,24 Months,81.7,78.4 to 84.7,1370
DTaP,≥3 Doses,States/Local Areas,New York,2019,Age,35 Months,92.4,88.2 to 95.5,637
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,89.7,84.3 to 95.0,203
Hep A,≥1 Dose,States/Local Areas,New York,2014,Age,24 Months,79.1,74.8 to 83.1,592
Hep A,≥1 Dose,States/Local Areas,New York,2014-2015,Age,24 Months,78.9,75.7 to 81.9,1095
Hep A,≥2 Doses,States/Local Areas,New York,2017,Age,19 Months,22.2,17.9 to 27.2,648
Hep A,≥2 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,21.5,18.5 to 24.7,1381
Hib,≥3 Doses,States/Local Areas,New York,2015,Age,35 Months,92.0,88.4 to 94.9,503
Hib,≥3 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,91.0,88.1 to 93.5,1009
Hib,≥3 Doses,States/Local Areas,New York,2014,Age,35 Months,95.1,92.2 to 97.1,592
Hib,≥3 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,93.7,91.4 to 95.6,1095
Hib,≥3 Doses,States/Local Areas,New York,2013,Age,35 Months,94.5,91.0 to 96.9,545
Hib,≥3 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,94.7,92.6 to 96.4,1137
Hep A,≥2 Doses,States/Local Areas,New York,2016,Age,19 Months,16.4,12.2 to 21.6,506
Hep A,≥2 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,19.2,16.1 to 22.7,1154
Hep A,≥2 Doses,States/Local Areas,New York,2015,Age,19 Months,19.7,16.8 to 23.0,503
Hep A,≥2 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,18.0,15.0 to 21.5,1009
Hib,≥3 Doses,States/Local Areas,New York,2019,Age,24 Months,91.7,87.8 to 94.7,637
Hib,≥3 Doses,States/Local Areas,New York,2018,Age,24 Months,90.8,87.5 to 93.4,733
Hib,≥3 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,91.2,88.7 to 93.3,1370
Hep A,≥2 Doses,States/Local Areas,New York,2012,Age,19 Months,17.8,14.4 to 21.9,492
Hep A,≥2 Doses,States/Local Areas,New York,2014,Age,19 Months,17.6,14.2 to 21.6,592
Hep A,≥2 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,18.6,15.9 to 21.7,1095
Hep A,≥2 Doses,States/Local Areas,New York,2013,Age,19 Months,17.0,14.0 to 20.4,545
Hep A,≥2 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,17.3,15.1 to 19.7,1137
DTaP,≥2 Doses,States/Local Areas,New York,2019,Age,5 Months,81.1,76.1 to 85.2,637
Hep A,≥2 Doses,States/Local Areas,New York,2011,Age,19 Months,14.6,11.9 to 17.9,466
DTaP,≥3 Doses,States/Local Areas,New York,2014,Age,35 Months,97.4,95.1 to 98.8,592
DTaP,≥3 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,95.5,93.3 to 97.1,1095
DTaP,≥3 Doses,States/Local Areas,New York,2011,Age,35 Months,96.0,92.9 to 98.0,466
DTaP,≥3 Doses,States/Local Areas,New York,2012,Age,35 Months,97.3,95.1 to 98.7,492
DTaP,≥3 Doses,States/Local Areas,New York,2013,Age,35 Months,96.7,93.8 to 98.4,545
DTaP,≥3 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,97.2,95.4 to 98.5,1137
Hep A,≥1 Dose,States/Local Areas,New York,2018,Age,19 Months,74.5,69.9 to 78.6,733
Hep A,≥1 Dose,States/Local Areas,New York,2018-2019,Age,19 Months,75.6,71.5 to 79.3,1140
Hep A,≥1 Dose,States/Local Areas,New York,2017,Age,19 Months,78.6,74.0 to 82.7,648
Hep A,≥1 Dose,States/Local Areas,New York,2017-2018,Age,19 Months,76.6,73.4 to 79.5,1381
Hep A,≥1 Dose,States/Local Areas,New York,2016,Age,19 Months,68.6,62.7 to 74.0,506
Hep A,≥1 Dose,States/Local Areas,New York,2016-2017,Age,19 Months,73.5,69.7 to 76.9,1154
Hep A,≥1 Dose,States/Local Areas,New York,2012,Age,24 Months,75.8,70.6 to 80.7,492
Hep A,≥1 Dose,States/Local Areas,New York,2013,Age,24 Months,79.9,75.1 to 84.3,545
Hep A,≥1 Dose,States/Local Areas,New York,2013-2014,Age,24 Months,79.5,76.3 to 82.5,1137
Hep A,≥1 Dose,States/Local Areas,New York,2011,Age,24 Months,74.9,69.7 to 79.9,466
Hep A,≥1 Dose,States/Local Areas,New York,2019,Age,19 Months,76.6,71.3 to 81.2,637
DTaP,≥3 Doses,States/Local Areas,New York,2016,Age,35 Months,92.8,88.6 to 95.9,506
DTaP,≥3 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,94.4,91.9 to 96.3,1154
DTaP,≥3 Doses,States/Local Areas,New York,2015,Age,35 Months,93.0,89.5 to 95.6,503
DTaP,≥3 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,93.1,90.4 to 95.3,1009
PCV,≥2 Doses,States/Local Areas,New York,2011,Age,5 Months,68.8,63.9 to 73.2,466
PCV,≥2 Doses,States/Local Areas,New York,2012,Age,5 Months,69.0,64.1 to 73.4,492
PCV,≥2 Doses,States/Local Areas,New York,2013,Age,5 Months,69.1,63.4 to 74.3,545
PCV,≥2 Doses,States/Local Areas,New York,2013-2014,Age,5 Months,71.0,66.4 to 75.2,1137
DTaP,≥3 Doses,States/Local Areas,New York,2017,Age,35 Months,95.8,93.3 to 97.6,648
DTaP,≥3 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,95.9,94.1 to 97.3,1381
DTaP,≥4 Doses,States/Local Areas,New York,2012,Age,19 Months,64.5,59.9 to 68.9,492
DTaP,≥4 Doses,States/Local Areas,New York,2011,Age,19 Months,67.4,60.9 to 73.3,466
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,90.5,86.0 to 93.6,305
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,90.7,87.0 to 93.4,554
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,90.9,88.4 to 92.8,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,89.6,85.3 to 92.7,552
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,88.3,81.9 to 92.6,303
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,90.1,86.3 to 93.0,706
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,90.3,85.5 to 93.6,412
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,93.8,88.6 to 97.2,249
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,93.1,89.0 to 96.1,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,87.2,82.1 to 91.0,305
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,87.9,83.9 to 91.0,554
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,88.4,86.1 to 90.4,279
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,87.8,85.7 to 89.6,584
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,93.6,89.6 to 96.4,279
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,92.0,89.2 to 94.3,584
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,88.6,83.5 to 92.2,451
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,74.3,70.1 to 78.1,863
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,89.0,83.6 to 92.7,403
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,88.8,85.3 to 91.5,854
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,88.2,82.3 to 92.9,303
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,90.1,86.5 to 93.2,706
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,85.2,78.5 to 90.1,303
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,87.0,82.8 to 90.3,706
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,92.1,87.2 to 95.2,403
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,92.5,89.4 to 94.7,854
Hib,≥3 Doses,States/Local Areas,New York,2011,Age,35 Months,93.9,90.1 to 96.6,466
Hib,≥3 Doses,States/Local Areas,New York,2012,Age,35 Months,95.7,92.9 to 97.6,492
≥1 Dose MMR,,States/Local Areas,New York,2020,Age,13 Months,63.7,58.3 to 68.8,624
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,88.6,85.6 to 91.0,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,86.8,82.3 to 90.3,552
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,90.7,84.8 to 95.1,249
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,89.5,85.4 to 92.9,552
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,90.4,86.2 to 93.7,305
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,90.6,87.1 to 93.4,554
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,92.9,88.6 to 95.7,451
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,89.1,85.7 to 91.8,863
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,92.7,88.2 to 95.5,412
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,24 Months,95.6,91.9 to 97.9,279
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,93.9,91.3 to 95.9,584
Hib,Full Series,States/Local Areas,NY-City of New York,2015,Age,24 Months,74.5,66.9 to 81.5,249
Hib,Full Series,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,75.1,69.9 to 80.0,552
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,96.2,92.1 to 98.5,249
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,88.4,82.3 to 94.4,467
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,86.5 to 95.3,200
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,77.0,71.8 to 82.2,467
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,Hispanic,93.4,90.3 to 96.6,467
Hib,Primary Series,States/Local Areas,Nevada,2019-2020,Age,7 Months,68.5,63.2 to 73.3,663
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Poverty,>400% FPL,93.9,89.9 to 97.9,316
Hep B,≥2 Doses,States/Local Areas,Nevada,2019-2020,Age,7 Months,90.2,85.9 to 93.2,663
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,76.2,71.4 to 81.0,511
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,83.9 to 95.3,200
≥1 Dose Varicella,,States/Local Areas,Nevada,2021,Age,13 Months,52.3,43.3 to 61.2,237
Combined 7 Series,,States/Local Areas,Nevada,2021,Age,24 Months,60.5,51.6 to 69.6,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,87.7,82.6 to 91.5,560
PCV,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,61.3,55.2 to 67.1,560
Hep B,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,86.3,81.2 to 90.2,560
Hep B,≥2 Doses,States/Local Areas,Nevada,2021,Age,13 Months,90.4,83.4 to 94.7,237
Hib,Primary Series,States/Local Areas,Nevada,2020-2021,Age,35 Months,87.4,82.6 to 91.5,560
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,83.2,79.0 to 87.4,659
≥1 Dose Varicella,,States/Local Areas,Nevada,2021,Age,35 Months,91.7,85.5 to 96.0,237
Influenza,,States/Local Areas,Nevada,2019,Age,24 Months,55.0,48.0 to 62.2,340
Influenza,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,51.4,45.7 to 57.1,520
Influenza,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,40.1,34.0 to 46.3,374
Influenza,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,39.6,22.6 to 56.7,52
Influenza,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,40.2,33.6 to 46.9,326
Influenza,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",53.7,43.3 to 64.1,151
Influenza,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",30.2,17.6 to 42.7,66
Influenza,,States/Local Areas,Nevada,2016,Age,24 Months,45.0,38.3 to 52.4,327
Influenza,,States/Local Areas,Nevada,2016-2017,Age,24 Months,45.9,40.9 to 51.3,671
Influenza,,States/Local Areas,Nevada,2017,Age,24 Months,46.8,39.6 to 54.5,344
Influenza,,States/Local Areas,Nevada,2017-2018,Age,24 Months,50.7,45.7 to 55.9,722
Influenza,,States/Local Areas,Nevada,2018,Age,24 Months,54.6,48.0 to 61.6,378
Influenza,,States/Local Areas,Nevada,2018-2019,Age,24 Months,54.8,49.9 to 59.8,718
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,89.1,85.5 to 92.6,511
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",50.3,33.1 to 67.5,71
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,89.3,85.8 to 92.8,659
Polio,≥3 Doses,States/Local Areas,Nevada,2021,Age,19 Months,88.0,80.6 to 92.8,237
DTaP,≥2 Doses,States/Local Areas,Nevada,2021,Age,5 Months,76.8,68.6 to 83.4,237
PCV,≥1 Dose,States/Local Areas,Nevada,2021,Age,3 Months,82.0,74.3 to 87.8,237
Polio,≥2 Doses,States/Local Areas,Nevada,2021,Age,5 Months,78.1,70.1 to 84.5,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2021,Age,13 Months,83.9,76.0 to 89.5,237
≥1 Dose MMR,,States/Local Areas,Nevada,2021,Age,19 Months,86.1,78.4 to 91.3,237
Hib,≥2 Doses,States/Local Areas,Nevada,2021,Age,5 Months,77.9,69.7 to 84.4,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2020-2021,Age,0-2 Days,77.3,71.5 to 82.1,560
Hib,Full Series,States/Local Areas,Nevada,2020-2021,Age,19 Months,64.3,58.3 to 69.9,560
Hep A,≥2 Doses,States/Local Areas,Nevada,2021,Age,19 Months,28.8,21.4 to 37.5,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,84.8,79.4 to 88.9,560
Polio,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,88.2,83.2 to 91.9,560
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2020-2021,Age,0-1 Days,70.9,64.8 to 76.2,560
Hib,Full Series,States/Local Areas,Nevada,2020-2021,Age,35 Months,77.4,70.6 to 83.6,560
Hib,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,85.4,80.3 to 89.8,560
Hep A,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,19 Months,80.1,74.5 to 84.7,560
Hib,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,81.5,76.3 to 85.8,560
Influenza,,States/Local Areas,Nevada,2021,Age,24 Months,34.4,27.2 to 42.8,237
Hep B,≥1 Dose,States/Local Areas,Nevada,2021,Age,3 Months,93.5,87.0 to 96.9,237
Hib,Full Series,States/Local Areas,Nevada,2020-2021,Age,24 Months,72.0,66.1 to 77.6,560
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,65.2 to 85.5,200
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,90.4,87.0 to 93.9,659
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Any Medicaid,90.1,86.8 to 93.5,511
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Insurance Coverage,Private Insurance Only,81.4,77.0 to 85.9,659
Influenza,,States/Local Areas,Nevada,2014-2017,Overall,Overall,44.2,40.2 to 48.3,973
Influenza,,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,37.3,30.9 to 43.7,341
Influenza,,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,46.0,39.5 to 52.5,389
Influenza,,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,56.7,48.3 to 65.1,243
Influenza,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,43.5,33.9 to 53.1,172
Influenza,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,42.8,31.1 to 54.5,109
Influenza,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",49.5,43.3 to 55.7,430
Influenza,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,44.6,39.8 to 49.4,692
Hib,Full Series,States/Local Areas,Nevada,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.1,76.7 to 89.4,200
Hib,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,42.5,36.8 to 48.4,560
DTaP,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,5 Months,76.0,70.2 to 80.9,560
≥1 Dose MMR,,States/Local Areas,Nevada,2020-2021,Age,19 Months,83.5,78.2 to 87.7,560
Polio,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,88.7,84.0 to 92.6,560
Hep A,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,24 Months,86.7,81.8 to 90.9,560
Hib,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,64.4,58.6 to 69.8,560
Hib,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,84.3,79.0 to 88.5,560
Hep B,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,3 Months,94.6,91.0 to 96.8,560
≥1 Dose Varicella,,States/Local Areas,Nevada,2020-2021,Age,13 Months,58.3,52.2 to 64.1,560
Polio,≥2 Doses,States/Local Areas,Nevada,2021,Age,13 Months,88.8,81.4 to 93.4,237
Hib,Primary Series,States/Local Areas,Nevada,2021,Age,35 Months,86.7,79.3 to 92.5,237
≥1 Dose Varicella,,States/Local Areas,Nevada,2020-2021,Age,24 Months,87.5,82.7 to 91.6,560
DTaP,≥3 Doses,States/Local Areas,Nevada,2021,Age,35 Months,87.7,80.8 to 93.0,237
Hib,≥3 Doses,States/Local Areas,Nevada,2021,Age,13 Months,64.0,55.3 to 71.9,237
Hep A,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,47.8,41.8 to 54.1,560
DTaP,≥4 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,62.6,56.5 to 68.2,560
Hib,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,5 Months,76.4,70.6 to 81.3,560
Hep B,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,5 Months,82.8,77.2 to 87.2,560
Hib,≥2 Doses,States/Local Areas,Nevada,2021,Age,13 Months,88.1,80.8 to 92.9,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,88.4,83.6 to 92.3,560
Hep A,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,70.0,62.0 to 77.6,560
DTaP,≥4 Doses,States/Local Areas,Nevada,2021,Age,35 Months,73.9,64.0 to 82.9,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,65.7,59.5 to 71.4,560
Polio,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,3 Months,83.3,78.1 to 87.5,560
Rotavirus,,States/Local Areas,Nevada,2021,Age,8 Months,67.9,59.2 to 75.5,237
PCV,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,83.5,78.3 to 87.7,560
Hib,≥3 Doses,States/Local Areas,Nevada,2021,Age,35 Months,84.6,77.1 to 90.7,237
PCV,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,3 Months,82.8,77.6 to 87.0,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2021,Age,0-3 Days,76.8,67.8 to 83.8,237
≥1 Dose MMR,,States/Local Areas,Nevada,2021,Age,13 Months,56.8,47.7 to 65.5,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,66.2,60.0 to 71.9,560
PCV,≥4 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,68.3,62.3 to 73.7,560
DTaP,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,88.5,83.7 to 92.4,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2020-2021,Age,0-3 Days,77.8,72.0 to 82.6,560
Rotavirus,,States/Local Areas,Nevada,2020-2021,Age,8 Months,70.3,64.6 to 75.5,560
Polio,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,5 Months,76.4,70.7 to 81.4,560
Polio,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,83.9,78.5 to 88.1,560
PCV,≥4 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,79.8,72.5 to 86.3,560
Combined 7 Series,,States/Local Areas,Nevada,2020-2021,Age,35 Months,71.9,63.2 to 80.1,560
Hib,Primary Series,States/Local Areas,Nevada,2020-2021,Age,19 Months,86.0,80.9 to 89.9,560
Hep B,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,7 Months,86.4,81.1 to 90.5,560
Hep B,≥3 Doses,States/Local Areas,Nevada,2021,Age,35 Months,90.8,83.2 to 95.9,237
Hib,Primary Series,States/Local Areas,Nevada,2021,Age,13 Months,81.6,73.7 to 87.6,237
PCV,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,86.4,81.2 to 90.3,560
Influenza,,States/Local Areas,Nevada,2020-2021,Age,24 Months,42.5,37.1 to 48.3,560
≥1 Dose MMR,,States/Local Areas,Nevada,2020-2021,Age,35 Months,89.3,84.5 to 93.1,560
Hib,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,3 Months,83.5,78.3 to 87.7,560
PCV,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,88.7,83.9 to 92.6,560
Combined 7 Series,,States/Local Areas,Nevada,2020-2021,Age,24 Months,63.1,57.1 to 69.0,560
≥1 Dose Varicella,,States/Local Areas,Nevada,2020-2021,Age,19 Months,81.8,76.3 to 86.2,560
Hib,Full Series,States/Local Areas,Nevada,2021,Age,35 Months,74.0,65.1 to 82.3,237
Polio,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,89.4,84.6 to 93.2,560
PCV,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,88.6,83.9 to 92.5,560
Hib,Primary Series,States/Local Areas,Nevada,2020-2021,Age,7 Months,63.9,57.8 to 69.6,560
≥1 Dose MMR,,States/Local Areas,Nevada,2021,Age,35 Months,91.4,85.3 to 95.7,237
Rotavirus,,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,83.3,76.7 to 89.8,243
Rotavirus,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,63.9,58.1 to 69.7,374
Rotavirus,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.6,46.9 to 74.4,66
Rotavirus,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,70.1,64.1 to 76.2,326
Rotavirus,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,67.5 to 84.9,151
Rotavirus,,States/Local Areas,Nevada,2019,Age,8 Months,70.4,63.5 to 76.5,340
Rotavirus,,States/Local Areas,Nevada,2017,Age,8 Months,68.5,61.0 to 75.1,344
Rotavirus,,States/Local Areas,Nevada,2017-2018,Age,8 Months,72.0,67.0 to 76.4,722
Rotavirus,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.3,62.5 to 80.1,172
Rotavirus,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,68.2,56.2 to 80.2,109
Rotavirus,,States/Local Areas,Nevada,2014-2017,Overall,Overall,71.0,67.3 to 74.7,973
Rotavirus,,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,65.8,59.7 to 71.8,341
Rotavirus,,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,70.8,64.9 to 76.8,389
Rotavirus,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,79.2,74.5 to 83.8,520
Rotavirus,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,76.2,62.5 to 89.9,52
Rotavirus,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.1,67.5 to 78.7,430
Rotavirus,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,71.2,66.9 to 75.5,692
Rotavirus,,States/Local Areas,Nevada,2013,Age,8 Months,69.0,61.2 to 75.9,234
Rotavirus,,States/Local Areas,Nevada,2013-2014,Age,8 Months,67.9,62.0 to 73.3,420
Rotavirus,,States/Local Areas,Nevada,2012,Age,8 Months,62.4,54.4 to 69.8,272
Rotavirus,,States/Local Areas,Nevada,2014,Age,8 Months,66.8,57.7 to 74.8,186
Rotavirus,,States/Local Areas,Nevada,2014-2015,Age,8 Months,67.2,61.3 to 72.5,439
Rotavirus,,States/Local Areas,Nevada,2018,Age,8 Months,75.5,68.7 to 81.2,378
Rotavirus,,States/Local Areas,Nevada,2018-2019,Age,8 Months,73.0,68.3 to 77.2,718
Rotavirus,,States/Local Areas,Nevada,2016,Age,8 Months,74.4,67.6 to 80.2,327
Rotavirus,,States/Local Areas,Nevada,2016-2017,Age,8 Months,71.4,66.4 to 76.0,671
Rotavirus,,States/Local Areas,Nevada,2011,Age,8 Months,65.1,57.9 to 71.7,293
Rotavirus,,States/Local Areas,Nevada,2015,Age,8 Months,67.5,59.9 to 74.3,253
Rotavirus,,States/Local Areas,Nevada,2015-2016,Age,8 Months,71.0,65.9 to 75.5,580
Hib,Full Series,States/Local Areas,Nevada,2014,Age,19 Months,65.7,56.3 to 74.1,186
Hib,Full Series,States/Local Areas,Nevada,2014-2015,Age,19 Months,68.7,62.8 to 74.1,439
Hib,Full Series,States/Local Areas,Nevada,2019,Age,19 Months,71.4,64.5 to 77.5,340
Hib,Full Series,States/Local Areas,Nevada,2018,Age,19 Months,73.2,66.6 to 78.8,378
Hib,Full Series,States/Local Areas,Nevada,2018-2019,Age,19 Months,95.9,93.5 to 97.5,718
Hib,Full Series,States/Local Areas,Nevada,2015,Age,19 Months,71.7,65.3 to 77.3,253
Hib,Full Series,States/Local Areas,Nevada,2015-2016,Age,19 Months,71.6,66.6 to 76.1,580
Hib,Full Series,States/Local Areas,Nevada,2016,Age,19 Months,71.5,64.5 to 77.6,327
Hib,Full Series,States/Local Areas,Nevada,2016-2017,Age,19 Months,71.0,66.0 to 75.5,671
Hib,Full Series,States/Local Areas,Nevada,2017,Age,19 Months,70.5,63.3 to 76.8,344
Hib,Full Series,States/Local Areas,Nevada,2017-2018,Age,19 Months,71.8,67.0 to 76.2,722
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",53.1,39.1 to 67.2,66
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,70.5,54.0 to 87.1,52
Hib,Full Series,States/Local Areas,Nevada,2013,Age,24 Months,81.9,75.6 to 87.5,234
Hib,Full Series,States/Local Areas,Nevada,2013-2014,Age,24 Months,78.7,73.5 to 83.5,420
Hib,Full Series,States/Local Areas,Nevada,2014,Age,24 Months,75.6,67.3 to 83.1,186
Hib,Full Series,States/Local Areas,Nevada,2014-2015,Age,24 Months,75.2,69.8 to 80.2,439
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,69.4,64.1 to 74.7,520
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,62.5,56.4 to 68.5,374
Combined 7 Series,,States/Local Areas,Nevada,2019,Age,35 Months,74.1,67.1 to 80.6,340
Combined 7 Series,,States/Local Areas,Nevada,2018,Age,35 Months,78.0,69.9 to 85.2,378
Combined 7 Series,,States/Local Areas,Nevada,2018-2019,Age,35 Months,76.1,70.7 to 81.2,718
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Overall,Overall,65.3,61.4 to 69.2,973
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,56.4,44.0 to 68.8,109
Hib,Full Series,States/Local Areas,Nevada,2012,Age,24 Months,72.4,64.8 to 79.5,272
Hib,Full Series,States/Local Areas,Nevada,2011,Age,24 Months,75.5,68.8 to 81.7,293
Hib,Primary Series,States/Local Areas,Nevada,2018,Age,24 Months,94.3,90.4 to 97.0,378
Hib,Primary Series,States/Local Areas,Nevada,2018-2019,Age,24 Months,92.4,89.3 to 94.9,718
Hib,Primary Series,States/Local Areas,Nevada,2015,Age,24 Months,90.6,85.9 to 94.3,253
Hib,Primary Series,States/Local Areas,Nevada,2015-2016,Age,24 Months,88.9,85.4 to 91.9,580
Hib,Primary Series,States/Local Areas,Nevada,2014,Age,24 Months,90.9,85.3 to 95.1,186
Hib,Primary Series,States/Local Areas,Nevada,2014-2015,Age,24 Months,90.8,87.2 to 93.7,439
Hib,Primary Series,States/Local Areas,Nevada,2012,Age,35 Months,91.7,86.6 to 95.4,272
Hib,Primary Series,States/Local Areas,Nevada,2014,Age,35 Months,90.9,85.3 to 95.1,186
Hib,Primary Series,States/Local Areas,Nevada,2014-2015,Age,35 Months,91.1,87.5 to 94.0,439
Hib,Primary Series,States/Local Areas,Nevada,2011,Age,35 Months,94.5,90.1 to 97.4,293
Hib,Primary Series,States/Local Areas,Nevada,2019,Age,24 Months,90.5,85.5 to 94.3,340
Hib,Primary Series,States/Local Areas,Nevada,2013,Age,35 Months,97.0,93.4 to 98.9,234
Hib,Primary Series,States/Local Areas,Nevada,2013-2014,Age,35 Months,94.8,91.4 to 97.1,420
Combined 7 Series,,States/Local Areas,Nevada,2013,Age,24 Months,66.7,59.0 to 74.2,234
Combined 7 Series,,States/Local Areas,Nevada,2013-2014,Age,24 Months,68.8,63.0 to 74.4,420
Combined 7 Series,,States/Local Areas,Nevada,2012,Age,24 Months,64.3,56.5 to 72.0,272
Hib,Primary Series,States/Local Areas,Nevada,2016,Age,35 Months,92.1,86.6 to 96.0,327
Hib,Primary Series,States/Local Areas,Nevada,2016-2017,Age,35 Months,90.5,86.6 to 93.6,671
DTaP,≥3 Doses,States/Local Areas,Nevada,2020,Age,13 Months,86.1,78.5 to 91.3,323
Hib,Primary Series,States/Local Areas,Nevada,2019,Age,19 Months,90.4,84.9 to 94.0,340
Hib,Primary Series,States/Local Areas,Nevada,2017,Age,35 Months,89.1,83.9 to 93.2,344
Hib,Primary Series,States/Local Areas,Nevada,2017-2018,Age,35 Months,91.9,88.7 to 94.4,722
Hib,Primary Series,States/Local Areas,Nevada,2015,Age,35 Months,91.2,86.4 to 94.8,253
Hib,Primary Series,States/Local Areas,Nevada,2015-2016,Age,35 Months,91.4,87.8 to 94.3,580
Hib,Primary Series,States/Local Areas,Nevada,2016,Age,19 Months,86.6,80.7 to 90.9,327
Hib,Primary Series,States/Local Areas,Nevada,2016-2017,Age,19 Months,87.7,83.8 to 90.7,671
Hib,Primary Series,States/Local Areas,Nevada,2015,Age,19 Months,90.5,87.7 to 92.8,253
Hib,Primary Series,States/Local Areas,Nevada,2015-2016,Age,19 Months,88.6,84.9 to 91.5,580
Hib,Primary Series,States/Local Areas,Nevada,2013,Age,24 Months,92.9,88.1 to 96.3,234
Hib,Primary Series,States/Local Areas,Nevada,2013-2014,Age,24 Months,91.8,88.3 to 94.6,420
Hib,Primary Series,States/Local Areas,Nevada,2011,Age,24 Months,92.4,87.7 to 95.8,293
Hib,Primary Series,States/Local Areas,Nevada,2012,Age,24 Months,90.5,85.3 to 94.5,272
Hib,Primary Series,States/Local Areas,Nevada,2017,Age,19 Months,88.8,83.1 to 92.7,344
Hib,Primary Series,States/Local Areas,Nevada,2017-2018,Age,19 Months,91.4,88.1 to 93.9,722
Hib,Primary Series,States/Local Areas,Nevada,2014,Age,19 Months,86.1,78.7 to 91.3,186
Hib,Primary Series,States/Local Areas,Nevada,2014-2015,Age,19 Months,88.3,84.1 to 91.6,439
Hib,Primary Series,States/Local Areas,Nevada,2013,Age,19 Months,92.5,85.0 to 96.4,234
Hib,Primary Series,States/Local Areas,Nevada,2013-2014,Age,19 Months,89.3,83.7 to 93.1,420
Hib,Primary Series,States/Local Areas,Nevada,2018,Age,13 Months,88.7,83.6 to 92.3,378
Hib,Primary Series,States/Local Areas,Nevada,2018-2019,Age,13 Months,87.4,83.6 to 90.4,718
Hib,Primary Series,States/Local Areas,Nevada,2011,Age,19 Months,90.6,86.1 to 93.8,293
Hib,Primary Series,States/Local Areas,Nevada,2018,Age,19 Months,94.1,89.8 to 96.6,378
Hib,Primary Series,States/Local Areas,Nevada,2018-2019,Age,19 Months,87.4,83.6 to 90.4,718
Hib,Primary Series,States/Local Areas,Nevada,2012,Age,19 Months,89.0,84.4 to 92.3,272
Hib,Primary Series,States/Local Areas,Nevada,2019,Age,13 Months,86.0,80.1 to 90.5,340
Hib,Primary Series,States/Local Areas,Nevada,2017,Age,13 Months,85.1,79.1 to 89.7,344
Hib,Primary Series,States/Local Areas,Nevada,2017-2018,Age,13 Months,86.9,83.1 to 90.0,722
Hib,Primary Series,States/Local Areas,Nevada,2016,Age,13 Months,81.9,75.3 to 87.1,327
Hib,Primary Series,States/Local Areas,Nevada,2016-2017,Age,13 Months,83.5,79.2 to 87.1,671
Hib,Primary Series,States/Local Areas,Nevada,2017,Age,7 Months,68.1,60.6 to 74.8,344
Hib,Primary Series,States/Local Areas,Nevada,2017-2018,Age,7 Months,72.1,67.3 to 76.4,722
Hib,Primary Series,States/Local Areas,Nevada,2016,Age,7 Months,68.5,61.5 to 74.7,327
Hib,Primary Series,States/Local Areas,Nevada,2016-2017,Age,7 Months,68.3,63.2 to 73.0,671
Hib,Primary Series,States/Local Areas,Nevada,2015,Age,7 Months,65.0,57.4 to 71.9,253
Hib,Primary Series,States/Local Areas,Nevada,2015-2016,Age,7 Months,66.7,61.6 to 71.5,580
Hib,Primary Series,States/Local Areas,Nevada,2014,Age,7 Months,69.8,60.9 to 77.5,186
Hib,Primary Series,States/Local Areas,Nevada,2014-2015,Age,7 Months,67.4,61.6 to 72.7,439
Hib,Primary Series,States/Local Areas,Nevada,2011,Age,13 Months,85.2,80.8 to 88.8,293
Hib,Primary Series,States/Local Areas,Nevada,2012,Age,13 Months,83.3,75.9 to 88.8,272
Hib,Primary Series,States/Local Areas,Nevada,2013,Age,13 Months,88.4,83.2 to 92.2,234
Hib,Primary Series,States/Local Areas,Nevada,2013-2014,Age,13 Months,86.5,82.4 to 89.8,420
Hib,Primary Series,States/Local Areas,Nevada,2018,Age,7 Months,76.1,70.2 to 81.2,378
Hib,Primary Series,States/Local Areas,Nevada,2018-2019,Age,7 Months,73.7,69.2 to 77.7,718
Hib,Primary Series,States/Local Areas,Nevada,2019,Age,7 Months,71.2,64.4 to 77.1,340
Hib,Primary Series,States/Local Areas,Nevada,2015,Age,13 Months,85.2,79.1 to 89.7,253
Hib,Primary Series,States/Local Areas,Nevada,2015-2016,Age,13 Months,83.6,79.2 to 87.2,580
Hib,Primary Series,States/Local Areas,Nevada,2014,Age,13 Months,84.6,77.2 to 90.0,186
Hib,Primary Series,States/Local Areas,Nevada,2014-2015,Age,13 Months,84.9,80.3 to 88.6,439
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,59.7,53.2 to 66.2,341
Combined 7 Series,,States/Local Areas,Nevada,2015,Age,35 Months,67.8,60.4 to 75.0,253
Combined 7 Series,,States/Local Areas,Nevada,2015-2016,Age,35 Months,71.6,66.1 to 76.8,580
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,65.9,59.9 to 71.9,389
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,76.7,69.4 to 84.0,243
Hib,Full Series,States/Local Areas,Nevada,2011,Age,19 Months,67.7,63.9 to 71.3,293
Hib,Full Series,States/Local Areas,Nevada,2012,Age,19 Months,67.2,60.0 to 73.6,272
Hib,Full Series,States/Local Areas,Nevada,2013,Age,19 Months,78.9,74.1 to 83.0,234
Hib,Full Series,States/Local Areas,Nevada,2013-2014,Age,19 Months,72.3,66.9 to 77.1,420
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.9,64.9 to 82.9,151
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.1,64.5 to 75.6,430
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,62.8,53.7 to 71.9,172
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,66.9,62.3 to 71.5,692
Hep A,≥1 Dose,States/Local Areas,Nevada,2021,Age,35 Months,91.6,85.2 to 95.9,237
PCV,≥3 Doses,States/Local Areas,Nevada,2021,Age,19 Months,85.3,77.9 to 90.6,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,90.4,85.5 to 94.1,560
Hib,Primary Series,States/Local Areas,Nevada,2020-2021,Age,13 Months,81.8,76.3 to 86.2,560
Combined 7 Series,,States/Local Areas,Nevada,2016,Age,35 Months,74.8,67.1 to 81.9,327
Combined 7 Series,,States/Local Areas,Nevada,2016-2017,Age,35 Months,75.1,69.6 to 80.3,671
Combined 7 Series,,States/Local Areas,Nevada,2017,Age,35 Months,75.2,67.4 to 82.3,344
Combined 7 Series,,States/Local Areas,Nevada,2017-2018,Age,35 Months,76.6,71.0 to 81.7,722
Combined 7 Series,,States/Local Areas,Nevada,2011,Age,35 Months,70.6,61.6 to 79.1,293
Hib,Primary Series,States/Local Areas,Nevada,2013,Age,7 Months,66.6,60.1 to 72.6,234
Hib,Primary Series,States/Local Areas,Nevada,2013-2014,Age,7 Months,68.3,62.7 to 73.3,420
Hib,≥3 Doses,States/Local Areas,Nevada,2021,Age,7 Months,43.0,34.5 to 52.0,237
≥1 Dose Varicella,,States/Local Areas,Nevada,2021,Age,19 Months,84.7,76.9 to 90.3,237
Hib,Full Series,States/Local Areas,Nevada,2021,Age,24 Months,71.9,63.3 to 80.0,237
Hib,Primary Series,States/Local Areas,Nevada,2021,Age,24 Months,85.1,78.1 to 90.8,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2021,Age,19 Months,87.7,80.1 to 92.7,237
Polio,≥1 Dose,States/Local Areas,Nevada,2021,Age,3 Months,82.8,75.1 to 88.5,237
Hib,≥3 Doses,States/Local Areas,Nevada,2021,Age,24 Months,83.1,75.9 to 89.2,237
≥1 Dose MMR,,States/Local Areas,Nevada,2021,Age,24 Months,91.4,85.3 to 95.7,237
DTaP,≥4 Doses,States/Local Areas,Nevada,2021,Age,24 Months,69.3,60.4 to 77.7,237
Combined 7 Series,,States/Local Areas,Nevada,2014,Age,35 Months,73.7,65.4 to 81.4,186
Combined 7 Series,,States/Local Areas,Nevada,2014-2015,Age,35 Months,70.8,65.2 to 76.2,439
Combined 7 Series,,States/Local Areas,Nevada,2019,Age,24 Months,71.1,64.2 to 77.6,340
Combined 7 Series,,States/Local Areas,Nevada,2017,Age,24 Months,64.9,57.7 to 72.0,344
Combined 7 Series,,States/Local Areas,Nevada,2017-2018,Age,24 Months,67.9,63.0 to 72.6,722
Combined 7 Series,,States/Local Areas,Nevada,2018,Age,24 Months,70.9,64.5 to 77.1,378
Combined 7 Series,,States/Local Areas,Nevada,2018-2019,Age,24 Months,71.0,66.3 to 75.6,718
Combined 7 Series,,States/Local Areas,Nevada,2013,Age,35 Months,74.5,66.6 to 81.8,234
Combined 7 Series,,States/Local Areas,Nevada,2013-2014,Age,35 Months,74.2,68.5 to 79.7,420
Combined 7 Series,,States/Local Areas,Nevada,2012,Age,35 Months,75.5,67.1 to 83.1,272
Combined 7 Series,,States/Local Areas,Nevada,2015,Age,24 Months,59.1,51.9 to 66.6,253
Combined 7 Series,,States/Local Areas,Nevada,2015-2016,Age,24 Months,61.4,56.4 to 66.6,580
Hib,Primary Series,States/Local Areas,Nevada,2018,Age,35 Months,94.6,90.7 to 97.3,378
Hib,Primary Series,States/Local Areas,Nevada,2018-2019,Age,35 Months,92.8,89.7 to 95.2,718
Combined 7 Series,,States/Local Areas,Nevada,2011,Age,24 Months,56.2,49.0 to 63.7,293
Combined 7 Series,,States/Local Areas,Nevada,2016,Age,24 Months,63.8,56.7 to 70.8,327
Combined 7 Series,,States/Local Areas,Nevada,2016-2017,Age,24 Months,64.3,59.2 to 69.4,671
Hib,Primary Series,States/Local Areas,Nevada,2019,Age,35 Months,90.9,85.9 to 94.7,340
Combined 7 Series,,States/Local Areas,Nevada,2014,Age,24 Months,70.5,62.0 to 78.5,186
Combined 7 Series,,States/Local Areas,Nevada,2014-2015,Age,24 Months,64.9,59.2 to 70.5,439
Hib,Primary Series,States/Local Areas,Nevada,2017,Age,24 Months,89.1,83.9 to 93.2,344
Hib,Primary Series,States/Local Areas,Nevada,2017-2018,Age,24 Months,91.7,88.5 to 94.3,722
Hib,Primary Series,States/Local Areas,Nevada,2016,Age,24 Months,87.2,81.8 to 91.7,327
Hib,Primary Series,States/Local Areas,Nevada,2016-2017,Age,24 Months,88.2,84.5 to 91.3,671
Polio,≥3 Doses,States/Local Areas,Nevada,2021,Age,24 Months,88.0,81.3 to 93.1,237
DTaP,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,3 Months,84.2,79.0 to 88.3,560
PCV,≥4 Doses,States/Local Areas,Nevada,2021,Age,35 Months,73.4,64.9 to 81.4,237
PCV,≥3 Doses,States/Local Areas,Nevada,2021,Age,35 Months,87.5,80.5 to 92.8,237
Hep A,≥1 Dose,States/Local Areas,Nevada,2020-2021,Age,35 Months,90.8,84.8 to 95.2,560
Hep A,≥1 Dose,States/Local Areas,Nevada,2021,Age,19 Months,82.8,75.0 to 88.5,237
PCV,≥4 Doses,States/Local Areas,Nevada,2021,Age,19 Months,67.3,58.4 to 75.1,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2021,Age,24 Months,88.1,81.2 to 93.3,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,35 Months,89.2,84.3 to 93.0,560
DTaP,≥1 Dose,States/Local Areas,Nevada,2021,Age,3 Months,83.9,76.2 to 89.5,237
DTaP,≥3 Doses,States/Local Areas,Nevada,2021,Age,13 Months,83.4,75.5 to 89.1,237
Hep A,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,30.2,25.3 to 35.7,560
Hep A,≥1 Dose,States/Local Areas,Nevada,2021,Age,24 Months,90.6,84.3 to 95.1,237
Polio,≥3 Doses,States/Local Areas,Nevada,2020-2021,Age,19 Months,87.7,82.7 to 91.4,560
PCV,≥3 Doses,States/Local Areas,Nevada,2021,Age,24 Months,87.5,80.5 to 92.8,237
PCV,≥4 Doses,States/Local Areas,Nevada,2021,Age,24 Months,73.4,64.9 to 81.4,237
PCV,≥3 Doses,States/Local Areas,Nevada,2021,Age,7 Months,56.6,47.5 to 65.2,237
Hep A,≥2 Doses,States/Local Areas,Nevada,2021,Age,24 Months,46.2,37.0 to 56.3,237
PCV,≥3 Doses,States/Local Areas,Nevada,2021,Age,13 Months,81.4,73.6 to 87.2,237
Hep B,≥3 Doses,States/Local Areas,Nevada,2021,Age,7 Months,64.8,55.5 to 73.0,237
≥1 Dose Varicella,,States/Local Areas,Nevada,2021,Age,24 Months,91.7,85.5 to 96.0,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2021,Age,0-2 Days,76.1,67.1 to 83.2,237
Hep B,≥2 Doses,States/Local Areas,Nevada,2021,Age,7 Months,85.2,77.3 to 90.8,237
Hib,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,13 Months,88.0,83.0 to 91.6,560
≥1 Dose Varicella,,States/Local Areas,Nevada,2020-2021,Age,35 Months,91.1,85.0 to 95.5,560
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2021,Age,0-1 Days,68.3,59.0 to 76.3,237
≥1 Dose MMR,,States/Local Areas,Nevada,2020-2021,Age,13 Months,60.6,54.6 to 66.3,560
Combined 7 Series,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,61.5,54.9 to 68.2,326
Hib,Full Series,States/Local Areas,Rhode Island,2019,Age,19 Months,83.5,77.0 to 88.4,277
Combined 7 Series,,States/Local Areas,Rhode Island,2015,Age,35 Months,72.1,64.5 to 79.2,248
Combined 7 Series,,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,76.0,70.7 to 81.0,498
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.0,59.3 to 80.7,94
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.2,72.9 to 81.4,523
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,72.3,66.1 to 78.5,272
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.8,70.8 to 78.8,641
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,67.2,61.0 to 73.5,279
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.0,44.9 to 79.1,38
Hib,Full Series,States/Local Areas,Rhode Island,2013,Age,19 Months,78.7,75.2 to 81.8,252
Hib,Full Series,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,81.0,77.8 to 83.8,497
Hib,Full Series,States/Local Areas,Rhode Island,2012,Age,19 Months,80.3,73.6 to 85.7,233
Hib,Full Series,States/Local Areas,Rhode Island,2011,Age,19 Months,82.0,78.5 to 85.0,221
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,73.2,66.8 to 79.6,276
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,82.4,78.1 to 86.8,358
Hib,Primary Series,States/Local Areas,Rhode Island,2012,Age,24 Months,99.4,97.2 to 99.9,233
Hib,Primary Series,States/Local Areas,Rhode Island,2011,Age,24 Months,98.5,96.0 to 99.6,221
Hib,Primary Series,States/Local Areas,Rhode Island,2016,Age,19 Months,97.4,94.7 to 98.7,250
Hib,Primary Series,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,96.9,94.8 to 98.2,487
Hib,Primary Series,States/Local Areas,Rhode Island,2019,Age,13 Months,92.5,87.1 to 95.7,277
Hib,Primary Series,States/Local Areas,Rhode Island,2018,Age,13 Months,91.9,86.1 to 95.5,225
Hib,Primary Series,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,92.2,88.5 to 94.8,502
Hib,Primary Series,States/Local Areas,Rhode Island,2017,Age,13 Months,89.3,83.5 to 93.3,237
Hib,Primary Series,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,90.6,86.6 to 93.5,462
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,74.0,70.7 to 77.4,913
Hib,Primary Series,States/Local Areas,Rhode Island,2018,Age,19 Months,96.5,91.7 to 98.5,225
Hib,Primary Series,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,92.2,88.5 to 94.8,502
Hib,Primary Series,States/Local Areas,Rhode Island,2017,Age,19 Months,96.5,92.4 to 98.4,237
Hib,Primary Series,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,96.5,93.3 to 98.2,462
Hib,Primary Series,States/Local Areas,Rhode Island,2015,Age,19 Months,96.7,92.8 to 98.5,248
Hib,Primary Series,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,97.0,95.1 to 98.2,498
Hib,Primary Series,States/Local Areas,Rhode Island,2014,Age,19 Months,97.8,93.8 to 99.2,245
Hib,Primary Series,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,97.2,95.0 to 98.5,493
Hib,Primary Series,States/Local Areas,Rhode Island,2013,Age,19 Months,96.0,92.2 to 98.0,252
Hib,Primary Series,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,96.9,94.2 to 98.3,497
Hib,Primary Series,States/Local Areas,Rhode Island,2011,Age,19 Months,98.4,95.6 to 99.4,221
Combined 7 Series,,States/Local Areas,Rhode Island,2019,Age,24 Months,79.6,73.2 to 85.2,277
Hib,Primary Series,States/Local Areas,Rhode Island,2019,Age,35 Months,96.1,91.5 to 98.6,277
Combined 7 Series,,States/Local Areas,Rhode Island,2016,Age,24 Months,72.6,65.7 to 79.2,250
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,74.9,70.0 to 79.6,487
Hib,Primary Series,States/Local Areas,Rhode Island,2017,Age,35 Months,97.1,93.7 to 98.9,237
Hib,Primary Series,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,97.8,95.0 to 99.2,462
Hib,Primary Series,States/Local Areas,Rhode Island,2013,Age,13 Months,90.2,87.3 to 92.5,252
Hib,Primary Series,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,91.4,89.2 to 93.2,497
Hib,Primary Series,States/Local Areas,Rhode Island,2012,Age,13 Months,93.1,90.3 to 95.2,233
Hib,Primary Series,States/Local Areas,Rhode Island,2011,Age,13 Months,95.1,89.4 to 97.8,221
Hib,Primary Series,States/Local Areas,Rhode Island,2018,Age,7 Months,88.4,82.1 to 92.6,225
Hib,Primary Series,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,87.5,83.2 to 90.8,502
Hib,Primary Series,States/Local Areas,Rhode Island,2019,Age,19 Months,95.8,90.5 to 98.2,277
Hib,Primary Series,States/Local Areas,Rhode Island,2016,Age,7 Months,86.1,80.1 to 90.5,250
Hib,Primary Series,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,85.3,81.1 to 88.7,487
Hib,Primary Series,States/Local Areas,Rhode Island,2017,Age,7 Months,84.5,77.9 to 89.3,237
Hib,Primary Series,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,86.4,81.8 to 90.0,462
Hib,Primary Series,States/Local Areas,Rhode Island,2014,Age,13 Months,92.7,87.4 to 95.9,245
Hib,Primary Series,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,89.8,85.9 to 92.7,493
Hib,Primary Series,States/Local Areas,Rhode Island,2015,Age,13 Months,87.0,80.7 to 91.4,248
Hib,Primary Series,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,90.6,87.1 to 93.2,498
Hib,Primary Series,States/Local Areas,Rhode Island,2019,Age,7 Months,86.6,80.0 to 91.2,277
Hib,Primary Series,States/Local Areas,Rhode Island,2012,Age,19 Months,97.5,95.8 to 98.5,233
Combined 7 Series,,States/Local Areas,Rhode Island,2013,Age,35 Months,75.9,68.7 to 82.5,252
Combined 7 Series,,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,79.2,74.1 to 83.8,497
Combined 7 Series,,States/Local Areas,Rhode Island,2014,Age,35 Months,82.7,75.4 to 88.8,245
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,77.2,72.0 to 82.1,493
Combined 7 Series,,States/Local Areas,Rhode Island,2012,Age,35 Months,82.0,74.7 to 88.1,233
Hib,Primary Series,States/Local Areas,Rhode Island,2014,Age,7 Months,90.0,84.1 to 93.9,245
Hib,Primary Series,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,86.8,82.6 to 90.1,493
Hib,Primary Series,States/Local Areas,Rhode Island,2015,Age,7 Months,83.7,77.2 to 88.6,248
Hib,Primary Series,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,84.9,80.7 to 88.4,498
Combined 7 Series,,States/Local Areas,Rhode Island,2018,Age,24 Months,78.6,71.7 to 84.9,225
Combined 7 Series,,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,79.1,74.4 to 83.4,502
Combined 7 Series,,States/Local Areas,Rhode Island,2017,Age,24 Months,77.2,70.2 to 83.5,237
Combined 7 Series,,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,77.9,72.9 to 82.6,462
Hib,Primary Series,States/Local Areas,Rhode Island,2013,Age,7 Months,83.3,81.1 to 85.4,252
Hib,Primary Series,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,86.6,84.4 to 88.5,497
Hib,Primary Series,States/Local Areas,Rhode Island,2012,Age,7 Months,86.6,80.1 to 91.2,233
Hib,Primary Series,States/Local Areas,Rhode Island,2018,Age,35 Months,97.8,93.4 to 99.5,225
Hib,Primary Series,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,96.8,93.8 to 98.6,502
Combined 7 Series,,States/Local Areas,Rhode Island,2015,Age,24 Months,68.9,61.7 to 75.8,248
Combined 7 Series,,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,70.8,65.9 to 75.5,498
Combined 7 Series,,States/Local Areas,Rhode Island,2014,Age,24 Months,79.8,72.6 to 86.1,245
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,74.3,69.2 to 79.1,493
Rotavirus,,States/Local Areas,Rhode Island,2019,Age,8 Months,90.7,84.9 to 94.4,277
Rotavirus,,States/Local Areas,Rhode Island,2017,Age,8 Months,84.8,78.0 to 89.7,237
Rotavirus,,States/Local Areas,Rhode Island,2017-2018,Age,8 Months,88.2,83.9 to 91.4,462
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,90.5,87.5 to 93.6,525
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,83.9,79.3 to 88.5,361
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.2,79.4 to 98.9,38
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,87.6,83.0 to 92.3,258
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,87.1,84.4 to 89.7,913
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,82.8,77.5 to 88.0,279
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.7,86.7 to 92.8,641
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,87.7,83.1 to 92.4,276
Rotavirus,,States/Local Areas,Rhode Island,2018,Age,8 Months,91.6,86.7 to 94.8,225
Rotavirus,,States/Local Areas,Rhode Island,2018-2019,Age,8 Months,91.1,87.6 to 93.7,502
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,91.2,87.9 to 94.6,358
Hib,Full Series,States/Local Areas,Rhode Island,2011,Age,24 Months,88.8,82.7 to 93.4,221
Hib,Full Series,States/Local Areas,Rhode Island,2012,Age,24 Months,84.8,78.1 to 90.4,233
Hib,Full Series,States/Local Areas,Rhode Island,2018,Age,19 Months,82.6,75.5 to 88.0,225
Hib,Full Series,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,98.5,96.5 to 99.4,502
Combined 7 Series,,States/Local Areas,Rhode Island,2019,Age,35 Months,84.6,78.4 to 89.8,277
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,79.3,75.4 to 83.3,525
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,69.5,63.9 to 75.1,361
Combined 7 Series,,States/Local Areas,Rhode Island,2018,Age,35 Months,80.1,73.2 to 86.3,225
Combined 7 Series,,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,82.5,77.8 to 86.7,502
Combined 7 Series,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,72.1,65.7 to 78.5,258
Hib,Full Series,States/Local Areas,Rhode Island,2017,Age,19 Months,85.8,79.5 to 90.4,237
Hib,Full Series,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,84.2,79.6 to 88.0,462
Hib,Full Series,States/Local Areas,Rhode Island,2014,Age,19 Months,83.5,76.4 to 88.8,245
Hib,Full Series,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,79.6,74.7 to 83.8,493
Hib,Full Series,States/Local Areas,Rhode Island,2015,Age,19 Months,75.8,74.2 to 77.3,248
Hib,Full Series,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,80.1,75.5 to 84.0,498
Hib,Full Series,States/Local Areas,Rhode Island,2016,Age,19 Months,84.3,78.3 to 88.9,250
Hib,Full Series,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,85.1,80.9 to 88.4,487
Hib,Full Series,States/Local Areas,Rhode Island,2014,Age,24 Months,88.0,82.0 to 92.8,245
Hib,Full Series,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,84.2,79.9 to 88.1,493
Hib,Full Series,States/Local Areas,Rhode Island,2013,Age,24 Months,85.5,79.3 to 90.5,252
Hib,Full Series,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,86.7,82.5 to 90.3,497
Hib,Primary Series,States/Local Areas,Rhode Island,2016,Age,13 Months,94.1,90.5 to 96.4,250
Hib,Primary Series,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,91.7,88.5 to 94.2,487
Influenza,,States/Local Areas,Rhode Island,2013,Age,24 Months,76.7,69.9 to 82.8,252
Influenza,,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,73.3,68.2 to 78.2,497
Influenza,,States/Local Areas,Rhode Island,2015,Age,24 Months,75.1,68.2 to 81.5,248
Influenza,,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,75.8,71.1 to 80.3,498
Influenza,,States/Local Areas,Rhode Island,2014,Age,24 Months,69.8,62.1 to 77.2,245
Influenza,,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,72.5,67.3 to 77.4,493
Influenza,,States/Local Areas,Rhode Island,2011,Age,24 Months,77.8,70.5 to 84.4,221
Influenza,,States/Local Areas,Rhode Island,2012,Age,24 Months,78.8,71.9 to 84.9,233
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,97.4,94.8 to 98.7,578
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,85.6 to 98.5,86
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,95.1,92.0 to 97.2,542
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,58.2,52.5 to 64.0,542
Polio,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,96.3,93.4 to 98.2,542
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,87.4,82.9 to 90.8,542
Hib,Primary Series,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,85.2,80.4 to 89.0,542
Polio,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,5 Months,91.4,87.6 to 94.2,542
Hib,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,96.7,92.0 to 98.7,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2021,Age,0-3 Days,80.3,72.1 to 86.6,241
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,5 Months,91.4,87.6 to 94.2,542
Hib,Primary Series,States/Local Areas,Rhode Island,2021,Age,35 Months,93.4,87.9 to 97.0,241
Hib,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,23.9,17.6 to 31.6,241
Polio,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,96.3,93.4 to 98.2,542
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,90.0,82.4 to 95.2,542
PCV,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,3 Months,96.4,93.7 to 97.9,542
Combined 7 Series,,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,77.8,72.8 to 82.3,542
Hib,Full Series,States/Local Areas,Rhode Island,2021,Age,35 Months,86.3,79.4 to 91.8,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,94.4,88.8 to 97.7,241
Polio,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,96.1,93.4 to 97.8,542
Polio,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,96.3,93.0 to 98.1,542
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,5 Months,97.3,94.9 to 98.6,542
PCV,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,5 Months,90.0,86.1 to 93.0,542
Hib,Primary Series,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,89.8,85.6 to 92.9,542
Hib,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,3 Months,95.3,92.5 to 97.2,542
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,95.8,93.1 to 97.7,542
Combined 7 Series,,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,84.1,78.2 to 89.2,542
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,97.6,95.2 to 98.8,542
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,96.2,93.2 to 98.1,542
Rotavirus,,States/Local Areas,Rhode Island,2021,Age,8 Months,80.6,72.5 to 86.8,241
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,88.3,84.1 to 91.7,542
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2020-2021,Age,0-3 Days,81.6,76.6 to 85.8,542
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,96.5,93.5 to 98.4,542
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,96.8,93.8 to 98.4,542
Rotavirus,,States/Local Areas,Rhode Island,2020-2021,Age,8 Months,86.2,81.4 to 89.9,542
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2021,Age,35 Months,93.6,88.0 to 97.2,241
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,89.3,85.1 to 92.5,542
Polio,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,94.2,88.7 to 97.6,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,96.5,93.5 to 98.4,542
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,95.0,90.0 to 98.0,542
Hib,Full Series,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,81.7,76.9 to 85.8,542
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,92.1,88.5 to 94.6,542
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,89.1,82.0 to 94.3,241
PCV,≥4 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,87.8,83.5 to 91.1,542
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,95.9,91.1 to 98.5,542
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,97.2,92.3 to 99.0,241
PCV,≥4 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,93.5,89.7 to 96.3,542
Influenza,,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,80.3,75.4 to 84.8,542
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2020-2021,Age,0-1 Days,78.6,73.5 to 82.9,542
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,95.4,90.3 to 98.3,241
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,96.2,92.9 to 98.0,542
Hib,Primary Series,States/Local Areas,Rhode Island,2021,Age,13 Months,88.5,81.6 to 93.0,241
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,96.0,93.2 to 97.9,542
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,3 Months,97.7,92.5 to 99.3,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.6,73.2 to 82.0,504
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,97.9,95.7 to 100.0,237
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,84.8,77.1 to 92.5,237
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,97.7,95.2 to 98.9,578
Polio,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,3 Months,97.1,94.6 to 98.5,542
Rotavirus,,States/Local Areas,Rhode Island,2013,Age,8 Months,83.9,77.3 to 88.9,252
Rotavirus,,States/Local Areas,Rhode Island,2013-2014,Age,8 Months,85.1,80.4 to 88.8,497
Rotavirus,,States/Local Areas,Rhode Island,2012,Age,8 Months,93.0,88.1 to 96.0,233
Rotavirus,,States/Local Areas,Rhode Island,2011,Age,8 Months,90.1,85.0 to 93.6,221
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.0 to 90.3,523
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,81.1,75.8 to 86.4,272
Rotavirus,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.8,78.0 to 95.6,94
Rotavirus,,States/Local Areas,Rhode Island,2014,Age,8 Months,86.3,78.9 to 91.4,245
Rotavirus,,States/Local Areas,Rhode Island,2014-2015,Age,8 Months,86.8,82.2 to 90.3,493
Rotavirus,,States/Local Areas,Rhode Island,2016,Age,8 Months,87.2,81.4 to 91.3,250
Rotavirus,,States/Local Areas,Rhode Island,2016-2017,Age,8 Months,86.0,81.8 to 89.4,487
Rotavirus,,States/Local Areas,Rhode Island,2015,Age,8 Months,87.2,80.9 to 91.6,248
Rotavirus,,States/Local Areas,Rhode Island,2015-2016,Age,8 Months,87.2,83.2 to 90.4,498
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,87.1,81.8 to 92.4,288
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,87.4,82.8 to 92.1,349
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.9,95.1 to 100.0,86
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,94.2,91.3 to 97.1,349
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.0,85.8 to 94.2,504
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2021,Age,13 Months,73.3,65.3 to 80.0,241
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,94.5,88.7 to 97.5,241
Polio,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,98.1,95.6 to 99.2,542
Hib,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,5 Months,89.5,83.4 to 93.5,241
Hib,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,5 Months,89.8,85.8 to 92.8,542
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,73.9,68.4 to 78.8,542
Influenza,,States/Local Areas,Rhode Island,2021,Age,24 Months,75.7,67.8 to 82.8,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,95.3,92.0 to 97.3,542
PCV,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,91.3,84.7 to 95.2,241
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,77.6,72.5 to 82.0,542
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2020-2021,Age,0-2 Days,80.9,75.8 to 85.0,542
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,5 Months,96.3,91.5 to 98.4,241
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,3 Months,97.1,94.6 to 98.5,542
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,93.7,90.2 to 96.0,542
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,3 Months,98.4,96.0 to 99.4,542
Hib,Full Series,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,89.8,84.6 to 93.8,542
Hib,Primary Series,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,95.2,91.9 to 97.4,542
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,83.8,78.3 to 89.3,237
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,90.8,87.2 to 93.5,578
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,98.1,96.6 to 99.7,329
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,38.8,33.5 to 44.4,542
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,77.9,72.7 to 82.5,542
Hib,Primary Series,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,94.6,90.9 to 96.9,542
Influenza,,States/Local Areas,Rhode Island,2019,Age,24 Months,82.3,75.9 to 87.8,277
Influenza,,States/Local Areas,Rhode Island,2018,Age,24 Months,80.6,73.5 to 86.8,225
Influenza,,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,81.4,76.6 to 85.6,502
Influenza,,States/Local Areas,Rhode Island,2017,Age,24 Months,83.7,77.3 to 89.2,237
Influenza,,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,82.2,77.5 to 86.3,462
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,94.2,91.8 to 96.7,487
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.2,69.4 to 100.0,39
Polio,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,5 Months,91.5,85.5 to 95.2,241
≥1 Dose MMR,,States/Local Areas,Rhode Island,2021,Age,19 Months,92.0,85.8 to 95.6,241
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,5 Months,91.5,85.5 to 95.2,241
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.4 to 97.7,487
Influenza,,States/Local Areas,Rhode Island,2016,Age,24 Months,76.6,70.2 to 82.5,250
Influenza,,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,80.1,75.6 to 84.3,487
Influenza,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.1,73.7 to 82.4,523
Influenza,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,73.7,67.7 to 79.7,272
Influenza,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.3,73.5 to 81.2,641
Influenza,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,75.9,70.1 to 81.7,258
Influenza,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.3,66.7 to 85.9,94
Influenza,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,72.8,67.5 to 78.0,361
Influenza,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.9,42.7 to 77.2,38
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,97.2,95.5 to 99.0,487
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,89.4,86.1 to 92.7,487
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,94.6,90.9 to 98.2,237
Influenza,,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,76.2,72.9 to 79.4,913
Influenza,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,80.5,76.5 to 84.6,525
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,79.5,74.3 to 83.9,542
≥1 Dose MMR,,States/Local Areas,Rhode Island,2021,Age,13 Months,77.2,69.5 to 83.5,241
Hib,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,95.2,92.1 to 97.1,542
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,7 Months,9.2,6.4 to 13.1,542
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,94.3,90.8 to 96.6,542
PCV,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,3 Months,95.2,90.0 to 97.8,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,94.4,88.8 to 97.7,241
Hib,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,92.9,86.8 to 96.9,241
Influenza,,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,70.7,64.7 to 76.7,279
Influenza,,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,74.9,68.7 to 81.0,276
Influenza,,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,83.4,78.9 to 87.8,358
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",100.0,,86
DTaP,≥4 Doses,States/Local Areas,Delaware,2011,Age,19 Months,78.7,73.6 to 83.0,264
DTaP,≥4 Doses,States/Local Areas,Delaware,2012,Age,19 Months,76.1,69.6 to 81.6,251
Hib,≥3 Doses,States/Local Areas,Delaware,2012,Age,35 Months,96.6,93.7 to 98.4,251
Hib,≥3 Doses,States/Local Areas,Delaware,2011,Age,35 Months,99.6,97.7 to 100.0,264
Hep A,≥1 Dose,States/Local Areas,Delaware,2014,Age,24 Months,88.9,82.4 to 93.8,234
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,24 Months,88.5,84.1 to 92.1,461
Hep A,≥1 Dose,States/Local Areas,Delaware,2012,Age,24 Months,89.9,85.4 to 93.5,251
Hep A,≥1 Dose,States/Local Areas,Delaware,2013,Age,24 Months,90.6,85.1 to 94.6,222
Hep A,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,24 Months,89.6,85.5 to 93.0,456
Hep A,≥1 Dose,States/Local Areas,Delaware,2011,Age,24 Months,85.3,79.1 to 90.4,264
Hep A,≥1 Dose,States/Local Areas,Delaware,2019,Age,19 Months,92.1,86.5 to 95.5,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2017,Age,35 Months,97.2,93.9 to 99.0,308
DTaP,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,96.7,94.5 to 98.2,556
DTaP,≥3 Doses,States/Local Areas,Delaware,2016,Age,35 Months,95.2,90.8 to 97.9,233
DTaP,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,96.2,93.6 to 98.0,541
DTaP,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,95.1,91.9 to 97.3,460
PCV,≥2 Doses,States/Local Areas,Delaware,2013,Age,5 Months,84.7,81.1 to 87.6,222
PCV,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,5 Months,80.5,77.8 to 82.9,456
PCV,≥2 Doses,States/Local Areas,Delaware,2012,Age,5 Months,76.0,68.8 to 82.0,251
PCV,≥2 Doses,States/Local Areas,Delaware,2011,Age,5 Months,81.6,74.4 to 87.2,264
Hep A,≥1 Dose,States/Local Areas,Delaware,2018,Age,19 Months,86.3,81.0 to 90.3,248
Hep A,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,19 Months,89.8,85.6 to 92.9,375
Hep A,≥1 Dose,States/Local Areas,Delaware,2017,Age,19 Months,86.1,80.0 to 90.6,308
Hep A,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,19 Months,86.2,82.3 to 89.4,556
Hib,≥3 Doses,States/Local Areas,Delaware,2019,Age,24 Months,94.7,90.1 to 97.6,205
Hib,≥3 Doses,States/Local Areas,Delaware,2018,Age,24 Months,94.2,90.5 to 96.9,248
Hib,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,94.5,91.7 to 96.6,453
Hep A,≥2 Doses,States/Local Areas,Delaware,2014,Age,19 Months,25.3,19.1 to 32.8,234
Hep A,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,29.1,24.2 to 34.5,461
Hep A,≥2 Doses,States/Local Areas,Delaware,2012,Age,19 Months,35.5,30.7 to 40.6,251
Hep A,≥2 Doses,States/Local Areas,Delaware,2013,Age,19 Months,33.1,29.5 to 36.9,222
Hep A,≥2 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,29.2,27.1 to 31.4,456
Hep A,≥2 Doses,States/Local Areas,Delaware,2011,Age,19 Months,30.5,23.9 to 38.1,264
DTaP,≥3 Doses,States/Local Areas,Delaware,2015,Age,35 Months,95.0,89.9 to 98.0,227
DTaP,≥3 Doses,States/Local Areas,Delaware,2014,Age,35 Months,96.2,89.8 to 99.1,234
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,95.1,91.4 to 97.5,461
DTaP,≥3 Doses,States/Local Areas,Delaware,2013,Age,35 Months,96.7,92.9 to 98.8,222
DTaP,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,96.1,92.9 to 98.1,456
DTaP,≥3 Doses,States/Local Areas,Delaware,2012,Age,35 Months,98.2,95.6 to 99.4,251
DTaP,≥3 Doses,States/Local Areas,Delaware,2011,Age,35 Months,99.7,98.8 to 99.9,264
PCV,≥2 Doses,States/Local Areas,Delaware,2017,Age,5 Months,82.8,76.2 to 87.9,308
PCV,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,5 Months,82.8,78.4 to 86.5,556
Hep A,≥1 Dose,States/Local Areas,Delaware,2012,Age,35 Months,95.1,91.3 to 97.6,251
Hib,≥3 Doses,States/Local Areas,Delaware,2018,Age,35 Months,95.3,91.5 to 97.7,248
Hib,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,95.7,93.1 to 97.6,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.1,87.1 to 97.1,125
Hep A,≥2 Doses,States/Local Areas,Delaware,2012,Age,24 Months,52.5,44.9 to 60.6,251
Hib,≥3 Doses,States/Local Areas,Delaware,2017,Age,35 Months,96.2,93.0 to 98.2,308
Hib,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,35 Months,95.8,93.5 to 97.5,556
Hib,≥3 Doses,States/Local Areas,Delaware,2016,Age,35 Months,93.8,88.7 to 97.1,233
Hib,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,35 Months,95.0,92.1 to 97.1,541
Hep A,≥2 Doses,States/Local Areas,Delaware,2011,Age,24 Months,46.4,39.0 to 54.5,264
Hep A,≥2 Doses,States/Local Areas,Delaware,2019,Age,19 Months,34.5,26.9 to 43.0,205
Hep A,≥2 Doses,States/Local Areas,Delaware,2018,Age,19 Months,31.1,24.8 to 38.2,248
Hep A,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,19 Months,34.8,28.7 to 41.4,375
DTaP,≥4 Doses,States/Local Areas,Delaware,2016,Age,19 Months,71.3,63.0 to 78.3,233
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,74.2,69.0 to 78.8,541
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,96.2,93.7 to 98.7,384
DTaP,≥3 Doses,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,97.0,95.2 to 98.7,445
DTaP,≥4 Doses,States/Local Areas,Delaware,2015,Age,19 Months,71.1,63.6 to 77.7,227
DTaP,≥4 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,71.2,65.5 to 76.3,460
DTaP,≥4 Doses,States/Local Areas,Delaware,2014,Age,19 Months,74.8,66.8 to 81.5,234
DTaP,≥4 Doses,States/Local Areas,Delaware,2014-2015,Age,19 Months,73.0,67.4 to 77.9,461
DTaP,≥4 Doses,States/Local Areas,Delaware,2013,Age,19 Months,76.1,72.7 to 79.3,222
DTaP,≥4 Doses,States/Local Areas,Delaware,2013-2014,Age,19 Months,75.5,73.4 to 77.5,456
Hep A,≥1 Dose,States/Local Areas,Delaware,2017,Age,24 Months,88.7,83.3 to 93.1,308
Hep A,≥1 Dose,States/Local Areas,Delaware,2017-2018,Age,24 Months,88.9,85.4 to 91.9,556
DTaP,≥3 Doses,States/Local Areas,Delaware,2019,Age,35 Months,97.5,94.2 to 99.2,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2018,Age,35 Months,96.4,93.0 to 98.4,248
DTaP,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,35 Months,96.9,94.8 to 98.4,453
PCV,≥2 Doses,States/Local Areas,Delaware,2016,Age,5 Months,82.9,75.6 to 88.4,233
PCV,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,5 Months,82.9,78.1 to 86.8,541
PCV,≥2 Doses,States/Local Areas,Delaware,2015,Age,5 Months,81.1,73.4 to 87.0,227
PCV,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,5 Months,82.0,76.9 to 86.2,460
PCV,≥2 Doses,States/Local Areas,Delaware,2014,Age,5 Months,76.4,68.2 to 83.0,234
PCV,≥2 Doses,States/Local Areas,Delaware,2014-2015,Age,5 Months,78.8,75.8 to 81.4,461
Hep A,≥1 Dose,States/Local Areas,Delaware,2016,Age,24 Months,87.7,81.3 to 92.8,233
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,24 Months,88.3,84.1 to 91.7,541
Hep A,≥1 Dose,States/Local Areas,Delaware,2015,Age,24 Months,88.2,82.0 to 93.0,227
Hep A,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,24 Months,87.9,83.6 to 91.6,460
Hep A,≥2 Doses,States/Local Areas,Delaware,2017,Age,19 Months,34.9,28.7 to 41.6,308
Hep A,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,19 Months,33.0,28.5 to 37.9,556
Hib,≥3 Doses,States/Local Areas,Delaware,2015,Age,35 Months,96.0,89.4 to 99.0,227
Hib,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,35 Months,95.9,90.8 to 98.6,460
Hib,≥3 Doses,States/Local Areas,Delaware,2014,Age,35 Months,95.0,89.3 to 98.2,234
Hib,≥3 Doses,States/Local Areas,Delaware,2014-2015,Age,35 Months,95.3,91.3 to 97.9,461
Hib,≥3 Doses,States/Local Areas,Delaware,2013,Age,35 Months,94.8,90.7 to 97.5,222
Hib,≥3 Doses,States/Local Areas,Delaware,2013-2014,Age,35 Months,94.6,91.4 to 96.9,456
Hep A,≥2 Doses,States/Local Areas,Delaware,2016,Age,19 Months,32.5,25.8 to 40.0,233
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2017,Age,19 Months,33.7,29.0 to 38.7,541
Hep A,≥2 Doses,States/Local Areas,Delaware,2015,Age,19 Months,32.9,29.4 to 36.5,227
Hep A,≥2 Doses,States/Local Areas,Delaware,2015-2016,Age,19 Months,32.7,27.7 to 38.1,460
Hep A,≥1 Dose,States/Local Areas,Delaware,2011,Age,35 Months,90.3,84.2 to 94.8,264
Hep A,≥1 Dose,States/Local Areas,Delaware,2019,Age,24 Months,92.8,87.7 to 96.3,205
Hep A,≥1 Dose,States/Local Areas,Delaware,2018,Age,24 Months,89.1,84.5 to 92.9,248
Hep A,≥1 Dose,States/Local Areas,Delaware,2018-2019,Age,24 Months,90.9,87.6 to 93.6,453
Hib,≥3 Doses,States/Local Areas,Delaware,2017,Age,24 Months,96.2,93.0 to 98.2,308
Hib,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,95.3,92.9 to 97.0,556
DTaP,≥3 Doses,States/Local Areas,Delaware,2019,Age,24 Months,96.2,92.0 to 98.5,205
Hib,≥3 Doses,States/Local Areas,Delaware,2016,Age,24 Months,93.3,88.3 to 96.8,233
Hib,≥3 Doses,States/Local Areas,Delaware,2016-2017,Age,24 Months,94.9,91.9 to 97.0,541
Hib,≥3 Doses,States/Local Areas,Delaware,2015,Age,24 Months,92.5,86.8 to 96.3,227
Hib,≥3 Doses,States/Local Areas,Delaware,2015-2016,Age,24 Months,92.8,89.2 to 95.6,460
Hib,Full Series,States/Local Areas,Delaware,2019,Age,19 Months,73.7,64.8 to 81.0,205
Hib,Full Series,States/Local Areas,Delaware,2016,Age,19 Months,73.1,65.0 to 80.0,233
Hib,Full Series,States/Local Areas,Delaware,2016-2017,Age,19 Months,74.9,69.7 to 79.4,541
DTaP,≥2 Doses,States/Local Areas,Delaware,2017,Age,5 Months,83.1,76.4 to 88.1,308
DTaP,≥2 Doses,States/Local Areas,Delaware,2017-2018,Age,5 Months,83.5,79.1 to 87.1,556
DTaP,≥2 Doses,States/Local Areas,Delaware,2019,Age,5 Months,89.3,82.4 to 93.7,205
DTaP,≥2 Doses,States/Local Areas,Delaware,2018,Age,5 Months,84.0,77.8 to 88.7,248
DTaP,≥2 Doses,States/Local Areas,Delaware,2018-2019,Age,5 Months,86.6,82.2 to 90.0,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2018,Age,24 Months,95.2,91.9 to 97.5,248
DTaP,≥3 Doses,States/Local Areas,Delaware,2018-2019,Age,24 Months,95.7,93.2 to 97.5,453
DTaP,≥3 Doses,States/Local Areas,Delaware,2017,Age,24 Months,95.6,91.8 to 98.0,308
DTaP,≥3 Doses,States/Local Areas,Delaware,2017-2018,Age,24 Months,95.4,93.0 to 97.2,556
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,95.2,92.2 to 98.2,270
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,94.0,90.4 to 97.6,284
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,95.0,92.0 to 98.0,319
Polio,≥3 Doses,States/Local Areas,Delaware,2014-2017,Overall,Overall,94.8,92.9 to 96.6,873
Hep A,≥1 Dose,States/Local Areas,Delaware,2016,Age,19 Months,81.7,74.1 to 87.4,233
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2017,Age,19 Months,83.9,79.2 to 87.7,541
Hep A,≥1 Dose,States/Local Areas,Delaware,2015,Age,19 Months,83.1,69.6 to 91.3,227
Hep A,≥1 Dose,States/Local Areas,Delaware,2015-2016,Age,19 Months,82.4,77.2 to 86.6,460
Hep A,≥1 Dose,States/Local Areas,Delaware,2014,Age,19 Months,79.4,70.7 to 86.1,234
Hep A,≥1 Dose,States/Local Areas,Delaware,2014-2015,Age,19 Months,81.3,75.7 to 85.8,461
Hep A,≥1 Dose,States/Local Areas,Delaware,2013,Age,19 Months,89.3,86.2 to 91.7,222
Hep A,≥1 Dose,States/Local Areas,Delaware,2013-2014,Age,19 Months,84.3,78.2 to 89.0,456
Combined 7 Series,,States/Local Areas,Delaware,2011,Age,35 Months,78.9,71.7 to 85.4,264
Combined 7 Series,,States/Local Areas,Delaware,2018,Age,24 Months,77.0,70.8 to 82.7,248
Combined 7 Series,,States/Local Areas,Delaware,2018-2019,Age,24 Months,76.4,71.3 to 81.2,453
Combined 7 Series,,States/Local Areas,Delaware,2017,Age,24 Months,76.2,70.1 to 81.9,308
Combined 7 Series,,States/Local Areas,Delaware,2017-2018,Age,24 Months,76.6,72.3 to 80.7,556
Hib,Primary Series,States/Local Areas,Delaware,2019,Age,35 Months,96.9,93.7 to 98.8,205
Combined 7 Series,,States/Local Areas,Delaware,2016,Age,24 Months,70.6,62.8 to 78.0,233
Combined 7 Series,,States/Local Areas,Delaware,2016-2017,Age,24 Months,73.4,68.3 to 78.2,541
Hib,Primary Series,States/Local Areas,Delaware,2018,Age,35 Months,96.4,93.0 to 98.4,248
Hib,Primary Series,States/Local Areas,Delaware,2018-2019,Age,35 Months,96.7,94.5 to 98.1,453
Combined 7 Series,,States/Local Areas,Delaware,2015,Age,24 Months,70.1,62.3 to 77.5,227
Combined 7 Series,,States/Local Areas,Delaware,2015-2016,Age,24 Months,70.4,64.8 to 75.7,460
Combined 7 Series,,States/Local Areas,Delaware,2014,Age,24 Months,78.5,71.3 to 85.0,234
Combined 7 Series,,States/Local Areas,Delaware,2014-2015,Age,24 Months,74.2,68.9 to 79.3,461
Combined 7 Series,,States/Local Areas,Delaware,2019,Age,24 Months,75.9,67.6 to 83.4,205
Combined 7 Series,,States/Local Areas,Delaware,2017,Age,35 Months,86.9,81.7 to 91.3,308
Combined 7 Series,,States/Local Areas,Delaware,2017-2018,Age,35 Months,85.3,81.2 to 89.0,556
Combined 7 Series,,States/Local Areas,Delaware,2016,Age,35 Months,76.6,67.7 to 84.6,233
Combined 7 Series,,States/Local Areas,Delaware,2016-2017,Age,35 Months,82.0,76.7 to 86.7,541
Hib,Primary Series,States/Local Areas,Delaware,2014,Age,13 Months,91.9,85.6 to 95.6,234
Hib,Primary Series,States/Local Areas,Delaware,2014-2015,Age,13 Months,90.5,86.1 to 93.6,461
Hib,Primary Series,States/Local Areas,Delaware,2013,Age,13 Months,91.5,87.5 to 94.2,222
Hib,Primary Series,States/Local Areas,Delaware,2013-2014,Age,13 Months,91.7,88.1 to 94.3,456
Hib,Primary Series,States/Local Areas,Delaware,2012,Age,13 Months,95.2,92.8 to 96.8,251
Hib,Primary Series,States/Local Areas,Delaware,2011,Age,13 Months,93.1,90.2 to 95.2,264
Hib,Primary Series,States/Local Areas,Delaware,2019,Age,7 Months,74.7,66.2 to 81.7,205
Hib,Primary Series,States/Local Areas,Delaware,2015,Age,13 Months,89.0,82.1 to 93.5,227
Hib,Primary Series,States/Local Areas,Delaware,2015-2016,Age,13 Months,89.2,84.8 to 92.5,460
Hib,Primary Series,States/Local Areas,Delaware,2017,Age,19 Months,94.8,90.3 to 97.3,308
Hib,Primary Series,States/Local Areas,Delaware,2017-2018,Age,19 Months,95.0,92.3 to 96.8,556
Hib,Primary Series,States/Local Areas,Delaware,2018,Age,19 Months,95.2,91.5 to 97.3,248
Hib,Primary Series,States/Local Areas,Delaware,2018-2019,Age,19 Months,92.9,89.7 to 95.2,453
Hib,Primary Series,States/Local Areas,Delaware,2019,Age,19 Months,94.5,89.5 to 97.2,205
Hib,Primary Series,States/Local Areas,Delaware,2013,Age,24 Months,96.1,92.2 to 98.4,222
Hib,Primary Series,States/Local Areas,Delaware,2013-2014,Age,24 Months,94.6,91.5 to 96.9,456
Hib,Primary Series,States/Local Areas,Delaware,2012,Age,24 Months,97.8,95.2 to 99.2,251
Hib,Primary Series,States/Local Areas,Delaware,2011,Age,24 Months,97.4,94.0 to 99.1,264
Hib,Primary Series,States/Local Areas,Delaware,2017,Age,7 Months,74.7,67.7 to 80.7,308
Hib,Primary Series,States/Local Areas,Delaware,2017-2018,Age,7 Months,75.8,71.1 to 80.0,556
Hib,Primary Series,States/Local Areas,Delaware,2016,Age,7 Months,71.9,64.0 to 78.6,233
Hib,Primary Series,States/Local Areas,Delaware,2016-2017,Age,7 Months,73.3,68.1 to 78.0,541
Hib,Primary Series,States/Local Areas,Delaware,2018,Age,7 Months,77.0,70.5 to 82.3,248
Hib,Primary Series,States/Local Areas,Delaware,2018-2019,Age,7 Months,75.8,70.7 to 80.4,453
Hib,Primary Series,States/Local Areas,Delaware,2015,Age,19 Months,92.6,89.7 to 94.7,227
Hib,Primary Series,States/Local Areas,Delaware,2015-2016,Age,19 Months,92.2,88.1 to 94.9,460
Hib,Primary Series,States/Local Areas,Delaware,2015,Age,7 Months,72.1,63.8 to 79.1,227
Hib,Primary Series,States/Local Areas,Delaware,2015-2016,Age,7 Months,72.0,66.3 to 77.0,460
Hib,Primary Series,States/Local Areas,Delaware,2014,Age,7 Months,73.4,64.8 to 80.5,234
Hib,Primary Series,States/Local Areas,Delaware,2014-2015,Age,7 Months,72.7,66.9 to 77.9,461
Hib,Primary Series,States/Local Areas,Delaware,2013,Age,7 Months,77.9,76.7 to 79.0,222
Hib,Primary Series,States/Local Areas,Delaware,2013-2014,Age,7 Months,75.6,73.0 to 78.1,456
Combined 7 Series,,States/Local Areas,Delaware,2015,Age,35 Months,78.4,68.9 to 86.6,227
Combined 7 Series,,States/Local Areas,Delaware,2015-2016,Age,35 Months,77.8,70.8 to 84.1,460
Combined 7 Series,,States/Local Areas,Delaware,2014,Age,35 Months,83.0,75.3 to 89.5,234
Combined 7 Series,,States/Local Areas,Delaware,2014-2015,Age,35 Months,80.7,74.6 to 86.2,461
Combined 7 Series,,States/Local Areas,Delaware,2013,Age,35 Months,82.4,75.6 to 88.2,222
Combined 7 Series,,States/Local Areas,Delaware,2013-2014,Age,35 Months,82.7,77.8 to 87.0,456
Combined 7 Series,,States/Local Areas,Delaware,2012,Age,35 Months,81.9,75.0 to 87.8,251
Hib,Primary Series,States/Local Areas,Delaware,2019,Age,24 Months,95.6,91.5 to 98.1,205
Combined 7 Series,,States/Local Areas,Delaware,2012,Age,24 Months,76.3,69.6 to 82.5,251
Combined 7 Series,,States/Local Areas,Delaware,2013,Age,24 Months,75.3,67.9 to 82.1,222
Combined 7 Series,,States/Local Areas,Delaware,2013-2014,Age,24 Months,76.8,71.7 to 81.5,456
Combined 7 Series,,States/Local Areas,Delaware,2011,Age,24 Months,75.1,68.0 to 81.7,264
Hib,Primary Series,States/Local Areas,Delaware,2016,Age,35 Months,93.5,88.4 to 96.9,233
Hib,Primary Series,States/Local Areas,Delaware,2016-2017,Age,35 Months,95.1,92.2 to 97.2,541
Hib,Primary Series,States/Local Areas,Delaware,2015,Age,35 Months,95.9,89.2 to 99.0,227
Hib,Primary Series,States/Local Areas,Delaware,2015-2016,Age,35 Months,95.7,90.4 to 98.5,460
Hib,Primary Series,States/Local Areas,Delaware,2014,Age,35 Months,95.6,89.9 to 98.6,234
Hib,Primary Series,States/Local Areas,Delaware,2014-2015,Age,35 Months,95.5,91.5 to 98.0,461
Hib,Primary Series,States/Local Areas,Delaware,2012,Age,35 Months,97.8,95.2 to 99.2,251
Hib,Primary Series,States/Local Areas,Delaware,2013,Age,35 Months,96.1,92.2 to 98.4,222
Hib,Primary Series,States/Local Areas,Delaware,2013-2014,Age,35 Months,95.6,92.5 to 97.7,456
Hib,Primary Series,States/Local Areas,Delaware,2011,Age,35 Months,99.6,97.7 to 100.0,264
Hib,Primary Series,States/Local Areas,Delaware,2017,Age,35 Months,96.5,93.3 to 98.4,308
Hib,Primary Series,States/Local Areas,Delaware,2017-2018,Age,35 Months,96.4,94.3 to 97.9,556
Hib,Full Series,States/Local Areas,Delaware,2013,Age,19 Months,75.5,72.9 to 77.8,222
Hib,Full Series,States/Local Areas,Delaware,2013-2014,Age,19 Months,77.6,74.5 to 80.3,456
Hib,Full Series,States/Local Areas,Delaware,2012,Age,19 Months,80.4,72.6 to 86.5,251
Hib,Full Series,States/Local Areas,Delaware,2011,Age,19 Months,78.8,72.9 to 83.7,264
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,78.4,72.6 to 84.2,270
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,79.1,73.4 to 84.8,284
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,69.7,64.0 to 75.4,384
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,80.4,76.0 to 84.8,445
Combined 7 Series,,States/Local Areas,Delaware,2019,Age,35 Months,78.4,69.9 to 85.9,205
Combined 7 Series,,States/Local Areas,Delaware,2018,Age,35 Months,83.4,76.9 to 88.9,248
Combined 7 Series,,States/Local Areas,Delaware,2018-2019,Age,35 Months,81.0,75.7 to 85.7,453
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.0,56.2 to 75.9,125
Hib,Primary Series,States/Local Areas,Delaware,2018,Age,13 Months,93.2,88.9 to 96.0,248
Hib,Primary Series,States/Local Areas,Delaware,2018-2019,Age,13 Months,92.9,89.7 to 95.2,453
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Overall,Overall,74.1,70.4 to 77.7,873
Hib,Primary Series,States/Local Areas,Delaware,2016,Age,13 Months,89.5,83.2 to 93.6,233
Hib,Primary Series,States/Local Areas,Delaware,2016-2017,Age,13 Months,89.8,85.7 to 92.8,541
Hib,Primary Series,States/Local Areas,Delaware,2017,Age,13 Months,90.1,84.8 to 93.8,308
Hib,Primary Series,States/Local Areas,Delaware,2017-2018,Age,13 Months,91.7,88.4 to 94.1,556
Hib,Primary Series,States/Local Areas,Delaware,2016,Age,19 Months,91.8,85.7 to 95.4,233
Hib,Primary Series,States/Local Areas,Delaware,2016-2017,Age,19 Months,93.3,89.7 to 95.7,541
Hib,Primary Series,States/Local Areas,Delaware,2014,Age,19 Months,93.2,87.0 to 96.6,234
Hib,Primary Series,States/Local Areas,Delaware,2014-2015,Age,19 Months,92.9,88.8 to 95.6,461
Hib,Primary Series,States/Local Areas,Delaware,2013,Age,19 Months,96.1,91.7 to 98.2,222
Hib,Primary Series,States/Local Areas,Delaware,2013-2014,Age,19 Months,94.6,91.0 to 96.9,456
Hib,Primary Series,States/Local Areas,Delaware,2012,Age,19 Months,97.0,94.4 to 98.4,251
≥1 Dose MMR,,States/Local Areas,Delaware,2020,Age,13 Months,60.3,51.2 to 68.7,183
Hib,Primary Series,States/Local Areas,Delaware,2011,Age,19 Months,96.1,93.1 to 97.8,264
Hib,Primary Series,States/Local Areas,Delaware,2019,Age,13 Months,92.6,87.0 to 95.9,205
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,69.4,61.7 to 77.1,214
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.2,69.9 to 78.6,581
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,73.8,67.2 to 80.4,292
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.1,75.6 to 84.6,420
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.3,62.8 to 83.8,114
Hib,Full Series,States/Local Areas,Delaware,2014,Age,24 Months,88.5,82.3 to 93.2,234
Hib,Full Series,States/Local Areas,Delaware,2014-2015,Age,24 Months,87.2,82.9 to 90.8,461
Hib,Full Series,States/Local Areas,Delaware,2013,Age,24 Months,80.6,73.5 to 86.8,222
Hib,Full Series,States/Local Areas,Delaware,2013-2014,Age,24 Months,84.3,79.7 to 88.3,456
Hib,Full Series,States/Local Areas,Delaware,2012,Age,24 Months,85.9,80.3 to 90.5,251
Hib,Full Series,States/Local Areas,Delaware,2011,Age,24 Months,86.0,79.7 to 91.1,264
Combined 7 Series,,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,67.4,60.9 to 73.8,319
Hib,Full Series,States/Local Areas,Delaware,2015,Age,19 Months,78.0,70.8 to 83.8,227
Hib,Full Series,States/Local Areas,Delaware,2015-2016,Age,19 Months,75.6,70.1 to 80.3,460
Hib,Full Series,States/Local Areas,Delaware,2014,Age,19 Months,79.7,72.2 to 85.5,234
Hib,Full Series,States/Local Areas,Delaware,2014-2015,Age,19 Months,78.8,73.7 to 83.2,461
Hib,Full Series,States/Local Areas,Delaware,2018,Age,19 Months,76.5,70.1 to 81.9,248
Hib,Full Series,States/Local Areas,Delaware,2018-2019,Age,19 Months,96.7,94.5 to 98.0,453
Hib,Full Series,States/Local Areas,Delaware,2017,Age,19 Months,76.6,70.2 to 82.0,308
Hib,Full Series,States/Local Areas,Delaware,2017-2018,Age,19 Months,76.5,72.1 to 80.5,556
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,91.1 to 98.6,120
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,82.4,78.0 to 86.9,409
DTaP,≥4 Doses,States/Local Areas,Delaware,2016-2019,Poverty,<133% FPL,74.2,68.1 to 80.2,303
PCV,≥4 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,89.5,86.2 to 92.8,452
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,68.8 to 93.0,120
Polio,≥3 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.2,93.0 to 99.5,120
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,77.5,70.3 to 84.7,202
Influenza,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,52.8,46.7 to 58.8,384
Rotavirus,,States/Local Areas,Delaware,2012,Age,8 Months,79.5,72.4 to 85.1,251
Rotavirus,,States/Local Areas,Delaware,2014,Age,8 Months,78.6,70.8 to 84.8,234
Rotavirus,,States/Local Areas,Delaware,2014-2015,Age,8 Months,79.1,73.8 to 83.6,461
Rotavirus,,States/Local Areas,Delaware,2013,Age,8 Months,81.3,74.0 to 86.9,222
Rotavirus,,States/Local Areas,Delaware,2013-2014,Age,8 Months,80.0,74.7 to 84.3,456
≥1 Dose Varicella,,States/Local Areas,Delaware,2020-2021,Age,13 Months,53.7,46.3 to 61.0,293
Rotavirus,,States/Local Areas,Delaware,2011,Age,8 Months,83.6,77.5 to 88.3,264
Rotavirus,,States/Local Areas,Delaware,2016,Age,8 Months,73.6,65.4 to 80.4,233
Rotavirus,,States/Local Areas,Delaware,2016-2017,Age,8 Months,76.4,71.2 to 80.9,541
Rotavirus,,States/Local Areas,Delaware,2015,Age,8 Months,79.7,72.0 to 85.7,227
Rotavirus,,States/Local Areas,Delaware,2015-2016,Age,8 Months,76.6,71.2 to 81.3,460
Rotavirus,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,73.5 to 90.2,114
Rotavirus,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,71.2,63.7 to 78.6,214
Rotavirus,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.8,64.6 to 83.1,125
Rotavirus,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Any Medicaid,75.7,70.5 to 80.9,384
Rotavirus,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,87.8,84.3 to 91.3,445
Rotavirus,,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,78.6,72.9 to 84.3,284
Rotavirus,,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,74.0,68.0 to 80.0,319
Rotavirus,,States/Local Areas,Delaware,2014-2017,Overall,Overall,79.9,76.6 to 83.2,873
Rotavirus,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.9,76.9 to 84.9,581
Rotavirus,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,78.0,72.1 to 83.9,292
Rotavirus,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.7,81.8 to 89.7,420
Rotavirus,,States/Local Areas,Delaware,2019,Age,8 Months,80.8,72.8 to 86.8,205
Rotavirus,,States/Local Areas,Delaware,2018,Age,8 Months,78.1,71.7 to 83.5,248
Rotavirus,,States/Local Areas,Delaware,2018-2019,Age,8 Months,79.4,74.5 to 83.6,453
Rotavirus,,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,90.7,86.5 to 94.9,270
Rotavirus,,States/Local Areas,Delaware,2017,Age,8 Months,79.3,72.4 to 84.8,308
Rotavirus,,States/Local Areas,Delaware,2017-2018,Age,8 Months,78.7,74.1 to 82.7,556
Hib,Primary Series,States/Local Areas,Delaware,2016,Age,24 Months,93.5,88.4 to 96.9,233
Hib,Primary Series,States/Local Areas,Delaware,2016-2017,Age,24 Months,95.1,92.2 to 97.2,541
Hib,Primary Series,States/Local Areas,Delaware,2015,Age,24 Months,93.0,87.4 to 96.8,227
Hib,Primary Series,States/Local Areas,Delaware,2015-2016,Age,24 Months,93.2,89.6 to 95.9,460
Hib,Primary Series,States/Local Areas,Delaware,2014,Age,24 Months,93.2,87.7 to 96.8,234
Hib,Primary Series,States/Local Areas,Delaware,2014-2015,Age,24 Months,93.1,89.4 to 95.9,461
Hib,Primary Series,States/Local Areas,Delaware,2018,Age,24 Months,95.2,91.9 to 97.5,248
Hib,Primary Series,States/Local Areas,Delaware,2018-2019,Age,24 Months,95.4,92.9 to 97.2,453
Hib,Primary Series,States/Local Areas,Delaware,2017,Age,24 Months,96.5,93.3 to 98.4,308
Hib,Primary Series,States/Local Areas,Delaware,2017-2018,Age,24 Months,95.8,93.7 to 97.4,556
Hep B,≥2 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,93.6,90.1 to 95.9,388
Hep B,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,7 Months,46.9,40.8 to 53.1,388
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Poverty,>400% FPL,97.4,95.5 to 99.2,270
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.2,71.3 to 89.1,120
Hep B,≥1 Dose,States/Local Areas,Delaware,2021,Age,3 Months,95.3,88.4 to 98.2,110
Hep B,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,3 Months,93.9,89.8 to 96.4,293
≥1 Dose Varicella,,States/Local Areas,Delaware,2020-2021,Age,19 Months,87.6,82.2 to 91.5,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2020-2021,Age,0-3 Days,80.7,74.2 to 85.9,293
Hib,Full Series,States/Local Areas,Delaware,2020-2021,Age,35 Months,80.5,73.2 to 86.9,293
DTaP,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,90.5,85.6 to 94.2,293
Polio,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,89.2,83.8 to 93.0,293
Hib,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,5 Months,74.9,67.9 to 80.8,293
≥1 Dose MMR,,States/Local Areas,Delaware,2020-2021,Age,13 Months,57.3,49.8 to 64.5,293
Hep B,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,87.0,81.5 to 91.1,293
DTaP,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,87.0,81.2 to 91.1,293
Hep B,≥2 Doses,States/Local Areas,Delaware,2021,Age,5 Months,90.1,81.6 to 94.9,110
Hep A,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,32.9,26.6 to 39.9,293
≥1 Dose MMR,,States/Local Areas,Delaware,2021,Age,19 Months,87.2,78.0 to 92.9,110
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Delaware,2020-2021,Age,0-2 Days,78.9,72.2 to 84.4,293
Influenza,,States/Local Areas,Delaware,2021,Age,24 Months,55.2,43.9 to 67.2,110
DTaP,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,3 Months,82.3,76.0 to 87.2,293
PCV,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,66.7,59.3 to 73.4,293
Hib,≥3 Doses,States/Local Areas,Delaware,2021,Age,13 Months,74.8,62.9 to 83.8,110
≥1 Dose Varicella,,States/Local Areas,Delaware,2020-2021,Age,24 Months,89.4,84.6 to 93.3,293
Rotavirus,,States/Local Areas,Delaware,2021,Age,8 Months,68.1,56.3 to 78.0,110
Hib,Primary Series,States/Local Areas,Delaware,2020-2021,Age,35 Months,88.8,83.1 to 93.3,293
Polio,≥2 Doses,States/Local Areas,Delaware,2021,Age,5 Months,77.9,66.7 to 86.1,110
DTaP,≥2 Doses,States/Local Areas,Delaware,2021,Age,5 Months,77.9,66.7 to 86.1,110
Hep B,≥3 Doses,States/Local Areas,Delaware,2021,Age,13 Months,83.4,73.4 to 90.1,110
≥1 Dose Varicella,,States/Local Areas,Delaware,2021,Age,13 Months,51.4,40.0 to 62.8,110
Polio,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,91.7,86.7 to 95.4,293
Hib,Primary Series,States/Local Areas,Delaware,2020-2021,Age,7 Months,65.2,57.5 to 72.1,293
DTaP,≥4 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,73.6,66.7 to 79.5,293
Hib,≥2 Doses,States/Local Areas,Delaware,2021,Age,13 Months,88.6,79.0 to 94.1,110
DTaP,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,5 Months,77.6,70.7 to 83.2,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Delaware,2021,Age,0-3 Days,79.5,68.5 to 87.3,110
Hep A,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,84.9,75.2 to 92.3,293
Hib,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,59.1,51.5 to 66.3,293
PCV,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,13 Months,86.1,80.0 to 90.6,293
DTaP,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,69.5,62.1 to 76.0,293
Polio,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,3 Months,82.3,76.0 to 87.2,293
PCV,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,3 Months,82.9,76.5 to 87.8,293
≥1 Dose MMR,,States/Local Areas,Delaware,2020-2021,Age,19 Months,88.5,83.2 to 92.3,293
Rotavirus,,States/Local Areas,Delaware,2020-2021,Age,8 Months,71.1,63.7 to 77.5,293
Hib,Primary Series,States/Local Areas,Delaware,2020-2021,Age,19 Months,87.5,81.4 to 91.8,293
≥1 Dose Varicella,,States/Local Areas,Delaware,2021,Age,35 Months,90.3,81.8 to 95.8,110
Polio,≥3 Doses,States/Local Areas,Delaware,2021,Age,35 Months,90.9,82.7 to 96.3,110
Hep B,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,47.0,39.8 to 54.3,293
DTaP,≥4 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,81.1,74.8 to 86.6,293
Hep A,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,19 Months,85.7,79.8 to 90.1,293
Hep B,≥2 Doses,States/Local Areas,Delaware,2021,Age,13 Months,92.1,84.0 to 96.3,110
PCV,≥4 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,78.8,72.2 to 84.2,293
Hib,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,87.2,81.3 to 92.0,293
DTaP,≥4 Doses,States/Local Areas,Delaware,2021,Age,35 Months,84.3,73.3 to 92.5,110
DTaP,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,91.8,86.7 to 95.5,293
Hep A,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,35 Months,92.5,87.2 to 96.2,293
PCV,≥4 Doses,States/Local Areas,Delaware,2020-2021,Age,35 Months,83.9,77.1 to 89.6,293
≥1 Dose MMR,,States/Local Areas,Delaware,2020-2021,Age,35 Months,92.0,87.1 to 95.6,293
Hep B,≥3 Doses,States/Local Areas,Delaware,2021,Age,35 Months,88.5,80.0 to 94.5,110
PCV,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,89.6,84.4 to 93.3,293
Hib,Primary Series,States/Local Areas,Delaware,2021,Age,13 Months,82.4,71.3 to 89.9,110
Hep B,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,90.5,85.6 to 93.9,293
Combined 7 Series,,States/Local Areas,Delaware,2020-2021,Age,24 Months,68.1,60.9 to 75.1,293
Influenza,,States/Local Areas,Delaware,2020-2021,Age,24 Months,58.7,51.3 to 66.2,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Delaware,2020-2021,Age,0-1 Days,74.8,67.8 to 80.6,293
Hib,Full Series,States/Local Areas,Delaware,2021,Age,35 Months,78.8,67.7 to 88.1,110
DTaP,≥3 Doses,States/Local Areas,Delaware,2021,Age,35 Months,91.0,82.7 to 96.3,110
Polio,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,84.0,77.5 to 88.9,293
Polio,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,88.9,83.5 to 92.7,293
Hib,Primary Series,States/Local Areas,Delaware,2020-2021,Age,13 Months,81.4,74.5 to 86.8,293
Polio,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,5 Months,77.5,70.7 to 83.2,293
Hib,≥1 Dose,States/Local Areas,Delaware,2020-2021,Age,3 Months,80.7,74.3 to 85.8,293
Combined 7 Series,,States/Local Areas,Delaware,2020-2021,Age,35 Months,73.5,65.8 to 80.7,293
≥1 Dose MMR,,States/Local Areas,Delaware,2020-2021,Age,24 Months,91.0,86.3 to 94.6,293
Hib,Full Series,States/Local Areas,Delaware,2020-2021,Age,19 Months,69.6,62.1 to 76.1,293
Hib,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,19 Months,84.1,77.5 to 89.0,293
PCV,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,90.9,86.2 to 94.6,293
Hep B,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,5 Months,88.2,82.9 to 92.1,293
Hep A,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,51.2,44.0 to 58.8,293
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,92.7,89.9 to 95.6,452
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,88.7,85.1 to 92.2,409
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.8,57.8 to 79.7,159
Influenza,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Non-Principal City,61.3,56.4 to 66.2,581
Influenza,,States/Local Areas,Delaware,2014-2017,Urbanicity,Living In a MSA Principal City,66.5,59.6 to 73.3,292
Influenza,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.2,68.2 to 78.1,420
Influenza,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",48.1,37.9 to 58.2,125
Influenza,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.7,49.9 to 71.5,114
Influenza,,States/Local Areas,Delaware,2014-2017,Race and Ethnicity,Hispanic,58.0,49.6 to 66.3,214
Influenza,,States/Local Areas,Delaware,2018,Age,24 Months,65.3,58.4 to 72.1,248
Influenza,,States/Local Areas,Delaware,2018-2019,Age,24 Months,69.9,64.7 to 75.0,453
Influenza,,States/Local Areas,Delaware,2017,Age,24 Months,60.9,53.9 to 68.0,308
Influenza,,States/Local Areas,Delaware,2017-2018,Age,24 Months,63.1,58.1 to 68.0,556
Hep A,≥2 Doses,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,Hispanic,87.7,80.5 to 94.8,202
Influenza,,States/Local Areas,Delaware,2019,Age,24 Months,74.7,66.7 to 82.1,205
DTaP,≥3 Doses,States/Local Areas,Delaware,2021,Age,24 Months,89.9,81.5 to 95.5,110
PCV,≥1 Dose,States/Local Areas,Delaware,2021,Age,3 Months,83.8,73.3 to 90.7,110
Influenza,,States/Local Areas,Delaware,2014-2017,Poverty,>400% FPL,79.5,74.0 to 84.9,270
Influenza,,States/Local Areas,Delaware,2014-2017,Poverty,133% to <400% FPL,67.6,61.1 to 74.1,284
Influenza,,States/Local Areas,Delaware,2014-2017,Poverty,<133% FPL,49.2,42.5 to 55.9,319
Influenza,,States/Local Areas,Delaware,2014-2017,Overall,Overall,63.1,59.1 to 67.0,873
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,76.9,71.8 to 82.0,409
Hib,Full Series,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,88.3,84.6 to 91.9,452
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Any Medicaid,93.7,91.3 to 96.2,409
PCV,≥3 Doses,States/Local Areas,Delaware,2016-2019,Insurance Coverage,Private Insurance Only,97.3,95.7 to 98.9,452
Hib,≥2 Doses,States/Local Areas,Delaware,2020-2021,Age,7 Months,82.6,75.9 to 87.8,293
Influenza,,States/Local Areas,Delaware,2014-2017,Insurance Coverage,Private Insurance Only,76.7,72.2 to 81.2,445
Hib,Primary Series,States/Local Areas,Delaware,2021,Age,35 Months,87.3,77.8 to 94.1,110
Hep A,≥1 Dose,States/Local Areas,Delaware,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,79.9 to 95.3,120
Polio,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,90.5,85.6 to 94.3,293
Hib,≥3 Doses,States/Local Areas,Delaware,2021,Age,35 Months,85.2,75.5 to 92.6,110
Hep B,≥3 Doses,States/Local Areas,Delaware,2020-2021,Age,24 Months,87.8,82.7 to 91.9,293
≥1 Dose MMR,,States/Local Areas,Delaware,2021,Age,13 Months,54.5,42.9 to 65.6,110
PCV,≥3 Doses,States/Local Areas,Delaware,2019-2020,Age,19 Months,92.6,88.4 to 95.3,388
Polio,≥3 Doses,States/Local Areas,Virginia,2019,Age,35 Months,98.8,94.7 to 99.9,452
Polio,≥3 Doses,States/Local Areas,Virginia,2013,Age,24 Months,89.1,83.4 to 93.5,357
Polio,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,91.2,87.5 to 94.2,708
Hib,≥3 Doses,States/Local Areas,Virginia,2016,Age,19 Months,93.7,88.0 to 96.8,389
Hib,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,91.6,87.7 to 94.4,808
Hib,≥3 Doses,States/Local Areas,Virginia,2017,Age,19 Months,89.5,83.2 to 93.6,419
Hib,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,89.6,85.3 to 92.7,970
Polio,≥3 Doses,States/Local Areas,Virginia,2014,Age,24 Months,93.3,88.0 to 96.8,351
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,94.1,90.9 to 96.5,725
Polio,≥3 Doses,States/Local Areas,Virginia,2015,Age,24 Months,94.9,90.5 to 97.7,374
Polio,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,96.0,93.1 to 97.9,763
DTaP,≥3 Doses,States/Local Areas,Virginia,2018,Age,19 Months,93.2,87.9 to 96.3,551
DTaP,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,89.5,85.4 to 92.6,1003
Polio,≥3 Doses,States/Local Areas,Virginia,2019,Age,19 Months,91.7,85.7 to 95.3,452
Hib,≥3 Doses,States/Local Areas,Virginia,2018,Age,19 Months,89.7,83.9 to 93.5,551
Hib,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,81.5,76.8 to 85.4,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2016,Age,19 Months,96.8,91.4 to 98.8,389
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,94.1,90.5 to 96.4,808
DTaP,≥3 Doses,States/Local Areas,Virginia,2017,Age,19 Months,91.4,85.4 to 95.0,419
DTaP,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,92.3,88.2 to 95.0,970
DTaP,≥3 Doses,States/Local Areas,Virginia,2014,Age,19 Months,95.1,89.3 to 97.8,351
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,95.5,92.1 to 97.5,725
DTaP,≥3 Doses,States/Local Areas,Virginia,2015,Age,19 Months,96.0,93.9 to 97.3,374
DTaP,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,96.4,93.2 to 98.1,763
Hib,≥3 Doses,States/Local Areas,Virginia,2015,Age,19 Months,92.8,89.1 to 95.3,374
Hib,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,93.3,89.6 to 95.7,763
Polio,≥3 Doses,States/Local Areas,Virginia,2018,Age,19 Months,91.2,85.4 to 94.8,551
Polio,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,68.7,63.5 to 73.5,1003
Hib,≥3 Doses,States/Local Areas,Virginia,2019,Age,13 Months,84.3,77.5 to 89.4,452
Hib,≥3 Doses,States/Local Areas,Virginia,2014,Age,19 Months,93.0,86.2 to 96.6,351
Hib,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,92.9,88.9 to 95.6,725
Hib,≥3 Doses,States/Local Areas,Virginia,2013,Age,19 Months,89.1,85.5 to 91.9,357
Hib,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,91.1,87.0 to 94.0,708
Polio,≥3 Doses,States/Local Areas,Virginia,2012,Age,24 Months,90.1,83.3 to 94.9,342
Polio,≥3 Doses,States/Local Areas,Virginia,2011,Age,24 Months,92.9,85.9 to 97.2,277
DTaP,≥3 Doses,States/Local Areas,Virginia,2013,Age,19 Months,92.4,89.3 to 94.7,357
DTaP,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,93.7,91.1 to 95.6,708
Hib,Full Series,States/Local Areas,Virginia,2017,Age,24 Months,76.9,69.0 to 83.9,419
Hib,Full Series,States/Local Areas,Virginia,2017-2018,Age,24 Months,79.4,74.3 to 84.1,970
Polio,≥3 Doses,States/Local Areas,Virginia,2011,Age,35 Months,94.9,88.7 to 98.3,277
Rotavirus,,States/Local Areas,Vermont,2019-2020,Age,8 Months,82.8,78.6 to 86.2,641
PCV,≥3 Doses,States/Local Areas,Vermont,2020,Age,7 Months,81.5,74.8 to 86.7,307
DTaP,≥3 Doses,States/Local Areas,Vermont,2020,Age,13 Months,95.1,91.5 to 97.3,307
Hep B,≥3 Doses,States/Local Areas,Vermont,2020,Age,7 Months,83.0,76.8 to 87.9,307
Hep B,≥1 Dose,States/Local Areas,Vermont,2020,Age,3 Months,95.2,90.0 to 97.8,307
Hep B,≥3 Doses,States/Local Areas,Vermont,2020,Age,24 Months,95.2,90.6 to 98.0,307
Polio,≥1 Dose,States/Local Areas,Vermont,2020,Age,3 Months,92.4,86.8 to 95.7,307
Hib,≥1 Dose,States/Local Areas,Vermont,2020,Age,3 Months,92.0,86.3 to 95.4,307
Hib,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,96.8,93.4 to 98.5,500
PCV,≥3 Doses,States/Local Areas,Vermont,2021,Age,13 Months,89.1,81.4 to 93.8,193
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Vermont,2021,Age,0-1 Days,76.3,67.6 to 83.3,193
DTaP,≥3 Doses,States/Local Areas,Virginia,2012,Age,19 Months,90.2,85.5 to 93.5,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2011,Age,19 Months,94.4,91.4 to 96.4,277
Hep A,≥2 Doses,States/Local Areas,Vermont,2021,Age,19 Months,17.8,12.1 to 25.5,193
PCV,≥4 Doses,States/Local Areas,Vermont,2021,Age,35 Months,88.7,81.0 to 94.3,193
DTaP,≥4 Doses,States/Local Areas,Vermont,2021,Age,24 Months,87.5,79.4 to 93.5,193
Hep A,≥2 Doses,States/Local Areas,Vermont,2021,Age,24 Months,34.6,26.2 to 44.9,193
DTaP,≥3 Doses,States/Local Areas,Vermont,2021,Age,19 Months,95.4,88.5 to 98.2,193
Hib,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,92.3,88.2 to 95.1,500
Hep B,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,24 Months,94.7,91.1 to 97.2,500
PCV,≥3 Doses,States/Local Areas,Vermont,2021,Age,7 Months,75.9,66.9 to 83.2,193
Combined 7 Series,,States/Local Areas,Vermont,2021,Age,24 Months,74.8,65.7 to 83.0,193
DTaP,≥3 Doses,States/Local Areas,Vermont,2021,Age,13 Months,89.5,81.6 to 94.2,193
Polio,≥2 Doses,States/Local Areas,Vermont,2021,Age,13 Months,94.3,86.3 to 97.7,193
DTaP,≥4 Doses,States/Local Areas,Vermont,2021,Age,19 Months,74.6,65.4 to 82.1,193
Hep B,≥3 Doses,States/Local Areas,Vermont,2021,Age,24 Months,94.3,88.3 to 97.9,193
DTaP,≥1 Dose,States/Local Areas,Vermont,2021,Age,3 Months,91.1,83.9 to 95.2,193
Hep A,≥1 Dose,States/Local Areas,Vermont,2021,Age,19 Months,85.1,77.1 to 90.6,193
PCV,≥3 Doses,States/Local Areas,Vermont,2021,Age,19 Months,94.8,88.4 to 97.8,193
Hep B,≥2 Doses,States/Local Areas,Vermont,2020-2021,Age,13 Months,94.6,90.3 to 97.1,500
≥1 Dose Varicella,,States/Local Areas,Vermont,2020-2021,Age,35 Months,94.4,90.6 to 97.0,500
Hib,Primary Series,States/Local Areas,Vermont,2021,Age,7 Months,75.5,66.3 to 82.8,193
Hep A,≥1 Dose,States/Local Areas,Vermont,2021,Age,35 Months,94.5,87.8 to 98.2,193
PCV,≥4 Doses,States/Local Areas,Vermont,2021,Age,19 Months,82.9,74.9 to 88.8,193
Hep A,≥2 Doses,States/Local Areas,Vermont,2021,Age,35 Months,83.3,71.9 to 92.0,193
≥1 Dose MMR,,States/Local Areas,Vermont,2021,Age,24 Months,96.0,90.1 to 98.8,193
Polio,≥3 Doses,States/Local Areas,Vermont,2021,Age,24 Months,93.5,86.9 to 97.5,193
Polio,≥1 Dose,States/Local Areas,Vermont,2021,Age,3 Months,89.8,81.8 to 94.5,193
Hib,≥3 Doses,States/Local Areas,Vermont,2021,Age,24 Months,95.1,89.2 to 98.3,193
Hib,Primary Series,States/Local Areas,Vermont,2021,Age,24 Months,95.1,89.2 to 98.3,193
DTaP,≥4 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,90.7,85.0 to 94.9,500
Hib,Full Series,States/Local Areas,Vermont,2021,Age,24 Months,85.8,78.0 to 92.0,193
≥1 Dose Varicella,,States/Local Areas,Vermont,2021,Age,24 Months,93.0,87.0 to 96.9,193
PCV,≥4 Doses,States/Local Areas,Vermont,2021,Age,24 Months,86.4,79.1 to 92.1,193
Hep B,≥3 Doses,States/Local Areas,Vermont,2021,Age,7 Months,75.4,66.3 to 82.7,193
PCV,≥3 Doses,States/Local Areas,Vermont,2021,Age,24 Months,94.8,89.3 to 98.0,193
PCV,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,96.9,93.8 to 98.7,500
Hep A,≥1 Dose,States/Local Areas,Vermont,2021,Age,24 Months,90.4,83.8 to 95.1,193
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Vermont,2021,Age,0-2 Days,76.9,68.1 to 83.8,193
Hib,≥1 Dose,States/Local Areas,Vermont,2021,Age,3 Months,91.9,84.8 to 95.8,193
Hep B,≥3 Doses,States/Local Areas,Vermont,2020-2021,Age,35 Months,95.1,91.4 to 97.5,500
Hib,≥3 Doses,States/Local Areas,Virginia,2017,Age,7 Months,65.7,57.0 to 73.6,419
Hib,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,63.4,57.6 to 68.8,970
Hib,≥2 Doses,States/Local Areas,Virginia,2018,Age,7 Months,88.8,82.5 to 93.0,551
Hib,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,90.6,86.7 to 93.5,1003
Hib,≥2 Doses,States/Local Areas,Virginia,2011,Age,13 Months,94.2,90.8 to 96.4,277
Hib,≥2 Doses,States/Local Areas,Virginia,2012,Age,13 Months,92.3,88.1 to 95.1,342
PCV,≥1 Dose,States/Local Areas,Virginia,2019,Age,3 Months,91.4,85.6 to 95.0,452
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016,Age,0-3 Days,74.9,67.1 to 81.4,389
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2017,Age,0-3 Days,75.2,69.7 to 80.0,808
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2017,Age,0-3 Days,83.3,73.8 to 89.9,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2017-2018,Age,0-3 Days,77.4,72.4 to 81.8,970
Polio,≥1 Dose,States/Local Areas,Virginia,2016,Age,3 Months,90.7,84.0 to 94.8,389
Polio,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,3 Months,88.9,84.2 to 92.4,808
Polio,≥1 Dose,States/Local Areas,Virginia,2015,Age,3 Months,89.0,81.0 to 93.9,374
Polio,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,3 Months,89.8,85.0 to 93.2,763
Polio,≥1 Dose,States/Local Areas,Virginia,2014,Age,3 Months,88.1,80.6 to 92.9,351
Polio,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,3 Months,88.5,83.4 to 92.2,725
Hib,≥3 Doses,States/Local Areas,Virginia,2013,Age,7 Months,56.8,47.7 to 65.6,357
Hib,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,59.4,52.9 to 65.6,708
Hib,≥3 Doses,States/Local Areas,Virginia,2012,Age,7 Months,64.9,53.8 to 74.7,342
Hib,≥3 Doses,States/Local Areas,Virginia,2011,Age,7 Months,68.7,56.2 to 79.0,277
PCV,≥3 Doses,States/Local Areas,Virginia,2017,Age,35 Months,90.7,85.0 to 94.9,419
PCV,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,91.9,87.9 to 95.0,970
Hib,≥2 Doses,States/Local Areas,Virginia,2013,Age,13 Months,92.9,89.9 to 95.1,357
Hib,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,94.9,92.0 to 96.8,708
PCV,≥3 Doses,States/Local Areas,Virginia,2018,Age,35 Months,93.3,87.7 to 97.0,551
PCV,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,94.7,91.4 to 97.1,1003
Hib,≥3 Doses,States/Local Areas,Virginia,2014,Age,7 Months,62.0,52.8 to 70.4,351
Hib,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,61.6,55.2 to 67.6,725
Hib,≥3 Doses,States/Local Areas,Virginia,2015,Age,7 Months,61.2,52.3 to 69.4,374
Hib,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,63.2,57.1 to 68.9,763
Polio,≥1 Dose,States/Local Areas,Virginia,2017,Age,3 Months,87.1,79.5 to 92.1,419
Polio,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,3 Months,86.7,82.1 to 90.3,970
DTaP,≥3 Doses,States/Local Areas,Virginia,2014,Age,7 Months,78.8,70.6 to 85.2,351
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,75.6,69.6 to 80.7,725
DTaP,≥3 Doses,States/Local Areas,Virginia,2015,Age,7 Months,72.4,63.6 to 79.8,374
DTaP,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,75.9,70.1 to 80.8,763
DTaP,≥3 Doses,States/Local Areas,Virginia,2016,Age,7 Months,79.3,71.6 to 85.3,389
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,76.5,70.8 to 81.4,808
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2015,Age,0-3 Days,69.7,61.1 to 77.0,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2015-2016,Age,0-3 Days,72.3,66.6 to 77.4,763
Hib,≥2 Doses,States/Local Areas,Virginia,2020,Age,13 Months,92.0,87.5 to 95.0,494
DTaP,≥3 Doses,States/Local Areas,Virginia,2016,Age,13 Months,96.7,91.4 to 98.8,389
DTaP,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,93.0,89.2 to 95.5,808
DTaP,≥3 Doses,States/Local Areas,Virginia,2017,Age,13 Months,89.1,82.7 to 93.3,419
DTaP,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,87.9,83.3 to 91.3,970
DTaP,≥3 Doses,States/Local Areas,Virginia,2015,Age,13 Months,94.2,88.7 to 97.1,374
DTaP,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,95.4,92.1 to 97.4,763
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.2,93.8 to 98.7,829
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,93.6,89.9 to 97.4,604
Hib,≥2 Doses,States/Local Areas,Virginia,2016,Age,13 Months,97.8,93.5 to 99.3,389
Hib,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,95.6,92.6 to 97.5,808
Hib,≥2 Doses,States/Local Areas,Virginia,2015,Age,13 Months,95.2,89.6 to 97.9,374
Hib,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,96.5,93.4 to 98.2,763
Hib,≥2 Doses,States/Local Areas,Virginia,2014,Age,13 Months,97.0,91.2 to 99.0,351
Hib,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,96.1,92.6 to 98.0,725
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,97.2,95.6 to 98.8,1104
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,90.6,84.9 to 96.3,149
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,85.5 to 98.2,222
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,91.1,84.1 to 98.1,172
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.1,88.3 to 99.9,93
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2018,Age,0-3 Days,79.3,72.9 to 84.6,551
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2018-2019,Age,0-3 Days,81.4,77.0 to 85.2,1003
Polio,≥1 Dose,States/Local Areas,Virginia,2018,Age,3 Months,86.3,80.0 to 90.9,551
Polio,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,3 Months,89.4,85.4 to 92.4,1003
Polio,≥1 Dose,States/Local Areas,Virginia,2019,Age,3 Months,92.6,86.9 to 95.9,452
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,75.2,66.6 to 83.9,149
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.2,64.4 to 86.0,93
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,73.9,69.0 to 78.7,1104
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,57.2,32.8 to 81.6,40
Hib,≥2 Doses,States/Local Areas,Virginia,2019,Age,7 Months,92.5,86.9 to 95.8,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2020,Age,24 Months,90.2,85.5 to 93.8,494
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,88.2,73.0 to 100.0,40
PCV,≥3 Doses,States/Local Areas,Virginia,2016,Age,35 Months,95.9,91.3 to 98.5,389
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,93.5,90.1 to 96.1,808
PCV,≥3 Doses,States/Local Areas,Virginia,2019,Age,35 Months,96.2,91.7 to 98.6,452
DTaP,≥3 Doses,States/Local Areas,Virginia,2017,Age,7 Months,73.5,64.7 to 80.8,419
DTaP,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,73.3,67.5 to 78.4,970
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2019,Age,0-3 Days,83.6,76.9 to 88.6,452
DTaP,≥3 Doses,States/Local Areas,Virginia,2018,Age,7 Months,73.0,65.6 to 79.4,551
DTaP,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,76.8,71.7 to 81.2,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2018,Age,13 Months,86.7,80.2 to 91.3,551
DTaP,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,89.5,85.4 to 92.6,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2019,Age,13 Months,92.4,86.6 to 95.8,452
Polio,≥3 Doses,States/Local Areas,Virginia,2014,Age,19 Months,93.3,87.3 to 96.5,351
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,92.3,88.3 to 95.1,725
Polio,≥3 Doses,States/Local Areas,Virginia,2012,Age,19 Months,88.5,82.9 to 92.5,342
Polio,≥3 Doses,States/Local Areas,Virginia,2013,Age,19 Months,87.4,79.1 to 92.7,357
Polio,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,90.3,85.0 to 93.9,708
Hib,≥3 Doses,States/Local Areas,Virginia,2017,Age,13 Months,77.9,69.8 to 84.3,419
Hib,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,78.3,73.0 to 82.8,970
Hib,≥3 Doses,States/Local Areas,Virginia,2016,Age,13 Months,79.7,71.9 to 85.8,389
Hib,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,78.8,73.4 to 83.4,808
Polio,≥3 Doses,States/Local Areas,Virginia,2017,Age,19 Months,88.3,80.9 to 93.0,419
Polio,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,89.7,85.1 to 93.1,970
Polio,≥3 Doses,States/Local Areas,Virginia,2016,Age,19 Months,96.0,90.8 to 98.3,389
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,92.2,88.0 to 95.0,808
Polio,≥3 Doses,States/Local Areas,Virginia,2015,Age,19 Months,91.4,86.3 to 94.7,374
Polio,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,93.7,89.9 to 96.2,763
Hib,≥2 Doses,States/Local Areas,Virginia,2017,Age,13 Months,93.4,87.9 to 96.5,419
Hib,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,93.8,89.9 to 96.2,970
Hib,≥2 Doses,States/Local Areas,Virginia,2018,Age,13 Months,94.1,89.1 to 96.9,551
Hib,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,95.0,91.8 to 97.0,1003
Hib,≥2 Doses,States/Local Areas,Virginia,2019,Age,13 Months,95.9,90.7 to 98.2,452
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,96.4,90.9 to 100.0,39
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.6,91.6 to 97.6,673
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,94.3,92.1 to 96.5,1316
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,89.1,82.6 to 95.6,127
DTaP,≥3 Doses,States/Local Areas,Virginia,2012,Age,13 Months,87.0,79.8 to 91.9,342
Hib,≥3 Doses,States/Local Areas,Virginia,2011,Age,19 Months,93.2,90.2 to 95.3,277
Hib,≥3 Doses,States/Local Areas,Virginia,2012,Age,19 Months,85.6,79.2 to 90.3,342
Hib,≥3 Doses,States/Local Areas,Virginia,2018,Age,13 Months,78.7,71.8 to 84.2,551
Hib,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,81.5,76.8 to 85.4,1003
Hib,≥3 Doses,States/Local Areas,Virginia,2015,Age,13 Months,82.2,74.7 to 87.8,374
Hib,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,80.9,75.8 to 85.2,763
DTaP,≥3 Doses,States/Local Areas,Virginia,2011,Age,13 Months,94.3,91.4 to 96.3,277
DTaP,≥3 Doses,States/Local Areas,Virginia,2014,Age,13 Months,93.2,87.3 to 96.5,351
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,93.7,90.0 to 96.1,725
DTaP,≥3 Doses,States/Local Areas,Virginia,2013,Age,13 Months,89.0,83.4 to 92.9,357
DTaP,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,91.1,87.2 to 93.9,708
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,78.3,68.1 to 88.6,172
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,62.5 to 84.5,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.5,64.7 to 76.3,829
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.5,68.8 to 80.2,673
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,73.4,66.8 to 79.9,604
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,61.5,42.1 to 80.9,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Overall,Overall,73.1,68.8 to 77.3,1316
Hib,≥3 Doses,States/Local Areas,Virginia,2019,Age,7 Months,69.7,62.0 to 76.5,452
Hib,≥3 Doses,States/Local Areas,Virginia,2018,Age,7 Months,61.0,53.5 to 68.0,551
Hib,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,65.3,60.0 to 70.3,1003
Hib,≥3 Doses,States/Local Areas,Virginia,2016,Age,7 Months,65.2,56.8 to 72.8,389
Hib,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,65.5,59.5 to 71.0,808
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,64.8,56.7 to 73.0,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,76.4,70.7 to 82.1,844
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,78.5,69.9 to 87.0,127
Polio,≥3 Doses,States/Local Areas,Virginia,2011,Age,19 Months,91.4,88.4 to 93.7,277
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,93.5,89.4 to 97.5,345
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,98.0,96.6 to 99.5,844
Hib,≥3 Doses,States/Local Areas,Virginia,2013,Age,13 Months,74.7,67.5 to 80.8,357
Hib,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,77.4,71.5 to 82.4,708
Hib,≥3 Doses,States/Local Areas,Virginia,2014,Age,13 Months,80.1,71.8 to 86.5,351
Hib,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,81.2,75.8 to 85.6,725
Hib,≥3 Doses,States/Local Areas,Virginia,2012,Age,13 Months,80.1,71.6 to 86.6,342
Hib,≥3 Doses,States/Local Areas,Virginia,2011,Age,13 Months,88.5,80.9 to 93.3,277
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,90.9,84.9 to 96.9,127
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,92.9,89.0 to 96.8,345
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,92.0,88.4 to 95.7,844
PCV,≥3 Doses,States/Local Areas,Virginia,2015,Age,35 Months,94.7,89.9 to 97.8,374
PCV,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,95.3,92.2 to 97.5,763
PCV,≥3 Doses,States/Local Areas,Virginia,2014,Age,35 Months,93.0,87.1 to 96.8,351
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,93.9,90.3 to 96.5,725
Hib,≥2 Doses,States/Local Areas,Virginia,2017,Age,7 Months,89.3,81.9 to 93.8,419
Hib,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,89.0,84.3 to 92.5,970
Hib,≥2 Doses,States/Local Areas,Virginia,2016,Age,7 Months,94.5,89.1 to 97.3,389
Hib,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,91.9,87.7 to 94.8,808
PCV,≥3 Doses,States/Local Areas,Virginia,2018,Age,24 Months,91.3,86.1 to 95.1,551
PCV,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,93.6,90.4 to 96.0,1003
Hib,≥2 Doses,States/Local Areas,Virginia,2015,Age,7 Months,92.5,86.4 to 96.0,374
Hib,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,93.5,89.8 to 96.0,763
PCV,≥3 Doses,States/Local Areas,Virginia,2013,Age,35 Months,91.2,85.5 to 95.3,357
PCV,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,92.1,88.2 to 95.1,708
PCV,≥3 Doses,States/Local Areas,Virginia,2011,Age,35 Months,92.7,85.1 to 97.3,277
PCV,≥3 Doses,States/Local Areas,Virginia,2019,Age,24 Months,95.9,91.5 to 98.4,452
PCV,≥3 Doses,States/Local Areas,Virginia,2012,Age,35 Months,88.3,81.2 to 93.6,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2019,Age,7 Months,80.5,73.3 to 86.2,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",98.8,96.9 to 100.0,93
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,93.0 to 99.2,222
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,83.5,74.3 to 92.7,172
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,96.4,90.9 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.9,88.3 to 95.5,673
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,88.0 to 95.1,829
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,91.6,87.6 to 95.6,604
DTaP,≥3 Doses,States/Local Areas,Virginia,2011,Age,7 Months,74.6,67.2 to 80.9,277
DTaP,≥3 Doses,States/Local Areas,Virginia,2012,Age,7 Months,67.1,59.5 to 74.0,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2013,Age,7 Months,65.9,61.0 to 70.4,357
DTaP,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,72.3,66.6 to 77.3,708
PCV,≥1 Dose,States/Local Areas,Virginia,2018,Age,3 Months,86.2,80.0 to 90.8,551
PCV,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,3 Months,88.8,84.8 to 91.9,1003
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014,Age,0-3 Days,71.8,62.7 to 79.4,351
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2014-2015,Age,0-3 Days,70.7,64.6 to 76.2,725
Polio,≥1 Dose,States/Local Areas,Virginia,2011,Age,3 Months,87.6,77.2 to 93.6,277
Polio,≥1 Dose,States/Local Areas,Virginia,2012,Age,3 Months,84.6,78.2 to 89.4,342
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,92.1,89.6 to 94.6,1316
Polio,≥1 Dose,States/Local Areas,Virginia,2013,Age,3 Months,79.8,74.5 to 84.3,357
Polio,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,3 Months,83.9,78.0 to 88.5,708
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2013,Age,0-3 Days,70.6,62.0 to 77.9,357
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2013-2014,Age,0-3 Days,71.2,65.1 to 76.6,708
PCV,≥1 Dose,States/Local Areas,Virginia,2012,Age,3 Months,82.0,74.5 to 87.7,342
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,77.7 to 95.7,222
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.7,85.5 to 93.8,829
PCV,≥1 Dose,States/Local Areas,Virginia,2014,Age,3 Months,85.3,77.2 to 90.8,351
PCV,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,3 Months,85.6,80.1 to 89.8,725
PCV,≥3 Doses,States/Local Areas,Virginia,2015,Age,24 Months,94.7,89.8 to 97.7,374
PCV,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,95.3,92.2 to 97.5,763
Hib,≥2 Doses,States/Local Areas,Virginia,2012,Age,7 Months,88.0,85.2 to 90.3,342
PCV,≥3 Doses,States/Local Areas,Virginia,2017,Age,24 Months,90.2,84.5 to 94.5,419
PCV,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,90.8,86.8 to 94.0,970
Hib,≥2 Doses,States/Local Areas,Virginia,2011,Age,7 Months,89.4,82.8 to 93.7,277
Hib,≥2 Doses,States/Local Areas,Virginia,2017,Age,5 Months,80.7,72.7 to 86.8,419
Hib,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,5 Months,80.5,75.2 to 84.9,970
PCV,≥3 Doses,States/Local Areas,Virginia,2016,Age,24 Months,95.9,91.3 to 98.5,389
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,93.2,89.7 to 95.8,808
Hib,≥2 Doses,States/Local Areas,Virginia,2018,Age,5 Months,80.3,73.3 to 85.8,551
Hib,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,5 Months,81.4,76.6 to 85.4,1003
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,95.4,93.0 to 97.8,844
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,81.1,72.2 to 89.9,127
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,85.4,79.3 to 91.6,345
Hib,≥2 Doses,States/Local Areas,Virginia,2014,Age,7 Months,94.6,88.4 to 97.5,351
Hib,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,93.5,89.5 to 96.1,725
Hib,≥2 Doses,States/Local Areas,Virginia,2013,Age,7 Months,88.3,80.7 to 93.2,357
Hib,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,91.4,86.4 to 94.7,708
PCV,≥1 Dose,States/Local Areas,Virginia,2017,Age,3 Months,84.9,77.5 to 90.2,419
PCV,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,3 Months,85.6,81.0 to 89.2,970
PCV,≥1 Dose,States/Local Areas,Virginia,2016,Age,3 Months,89.4,82.5 to 93.7,389
PCV,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,3 Months,87.2,82.4 to 90.8,808
Hib,≥2 Doses,States/Local Areas,Virginia,2019,Age,5 Months,82.5,75.5 to 87.9,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,86.4,69.3 to 100.0,40
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,93.2,90.6 to 95.9,1104
PCV,≥1 Dose,States/Local Areas,Virginia,2015,Age,3 Months,85.9,77.6 to 91.4,374
PCV,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,3 Months,87.6,82.6 to 91.4,763
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,89.0,84.0 to 94.1,604
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2012,Age,0-3 Days,67.9,58.5 to 75.9,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2011,Age,0-3 Days,77.8,67.6 to 85.5,277
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,92.1,86.9 to 97.4,149
PCV,≥3 Doses,States/Local Areas,Virginia,2018,Age,19 Months,91.3,85.6 to 94.8,551
PCV,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,89.0,85.0 to 92.0,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,92.2 to 97.8,673
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,92.7,84.0 to 100.0,39
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Overall,Overall,93.8,91.5 to 96.1,1316
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,88.6,81.7 to 95.5,127
PCV,≥1 Dose,States/Local Areas,Virginia,2011,Age,3 Months,88.5,80.6 to 93.5,277
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,93.7,90.0 to 97.5,345
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,96.9,95.1 to 98.7,844
PCV,≥4 Doses,States/Local Areas,Virginia,2018,Age,35 Months,87.6,81.0 to 92.7,551
PCV,≥4 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,90.5,85.5 to 94.3,1003
PCV,≥4 Doses,States/Local Areas,Virginia,2016,Age,35 Months,95.6,91.4 to 98.1,389
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,88.7,84.6 to 92.1,808
Hep B,≥2 Doses,States/Local Areas,Virginia,2019,Age,13 Months,96.1,91.1 to 98.4,452
PCV,≥4 Doses,States/Local Areas,Virginia,2017,Age,35 Months,81.9,75.0 to 87.8,419
PCV,≥4 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,85.0,80.2 to 89.2,970
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.3,84.0 to 92.5,673
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,90.3,76.8 to 100.0,39
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,88.7,85.5 to 91.9,1316
PCV,≥3 Doses,States/Local Areas,Virginia,2011,Age,24 Months,92.5,84.9 to 97.1,277
PCV,≥3 Doses,States/Local Areas,Virginia,2017,Age,19 Months,89.4,83.0 to 93.6,419
PCV,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,90.4,86.0 to 93.4,970
Hib,≥2 Doses,States/Local Areas,Virginia,2013,Age,5 Months,73.6,64.3 to 81.2,357
Hib,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,5 Months,78.6,71.8 to 84.0,708
Hib,≥2 Doses,States/Local Areas,Virginia,2011,Age,5 Months,80.2,73.8 to 85.3,277
Hib,≥2 Doses,States/Local Areas,Virginia,2012,Age,5 Months,74.0,64.6 to 81.6,342
Hib,≥1 Dose,States/Local Areas,Virginia,2019,Age,3 Months,91.6,85.9 to 95.1,452
Hib,≥1 Dose,States/Local Areas,Virginia,2018,Age,3 Months,87.4,81.3 to 91.8,551
Hib,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,3 Months,89.5,85.5 to 92.5,1003
Hib,≥2 Doses,States/Local Areas,Virginia,2016,Age,5 Months,86.7,79.9 to 91.4,389
Hib,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,5 Months,83.8,78.7 to 87.8,808
Hib,≥2 Doses,States/Local Areas,Virginia,2015,Age,5 Months,81.0,72.9 to 87.1,374
Hib,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,5 Months,83.8,78.8 to 87.9,763
Hib,≥2 Doses,States/Local Areas,Virginia,2014,Age,5 Months,83.6,75.2 to 89.6,351
Hib,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,5 Months,82.3,79.6 to 84.7,725
PCV,≥1 Dose,States/Local Areas,Virginia,2013,Age,3 Months,80.3,73.5 to 85.7,357
PCV,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,3 Months,82.8,78.1 to 86.7,708
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,83.7,75.6 to 91.7,149
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,79.7,59.4 to 100.0,40
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,84.3,75.2 to 93.4,172
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.6,84.9 to 98.2,93
PCV,≥3 Doses,States/Local Areas,Virginia,2016,Age,13 Months,95.3,90.2 to 97.8,389
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,91.2,87.3 to 94.1,808
Hep B,≥2 Doses,States/Local Areas,Virginia,2019,Age,7 Months,94.6,89.5 to 97.3,452
PCV,≥3 Doses,States/Local Areas,Virginia,2018,Age,13 Months,86.3,80.1 to 90.9,551
PCV,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,89.0,85.0 to 92.0,1003
Hib,Full Series,States/Local Areas,Virginia,2020,Age,24 Months,76.6,70.5 to 82.2,494
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2018,Age,0-2 Days,75.9,69.2 to 81.6,551
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2018-2019,Age,0-2 Days,79.5,74.9 to 83.4,1003
Hep B,≥2 Doses,States/Local Areas,Virginia,2018,Age,7 Months,90.0,84.5 to 93.7,551
Hep B,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,92.3,88.8 to 94.7,1003
Hep B,≥3 Doses,States/Local Areas,Virginia,2013,Age,35 Months,90.4,84.6 to 94.7,357
Hep B,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,91.4,87.5 to 94.5,708
Hep B,≥3 Doses,States/Local Areas,Virginia,2014,Age,35 Months,92.5,86.7 to 96.3,351
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,92.7,89.1 to 95.5,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2012,Age,35 Months,86.5,79.8 to 91.8,342
PCV,≥3 Doses,States/Local Areas,Virginia,2017,Age,13 Months,87.1,80.3 to 91.8,419
PCV,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,86.7,82.0 to 90.3,970
Hep B,≥2 Doses,States/Local Areas,Virginia,2012,Age,13 Months,91.7,86.2 to 95.2,342
Hep B,≥2 Doses,States/Local Areas,Virginia,2011,Age,13 Months,95.0,92.3 to 96.8,277
PCV,≥4 Doses,States/Local Areas,Virginia,2016,Age,24 Months,94.7,90.3 to 97.6,389
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,88.2,84.1 to 91.7,808
PCV,≥4 Doses,States/Local Areas,Virginia,2017,Age,24 Months,81.8,74.8 to 87.7,419
PCV,≥4 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,82.6,77.9 to 86.8,970
≥1 Dose MMR,,States/Local Areas,Virginia,2014,Age,35 Months,96.3,91.7 to 98.8,351
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2015,Age,35 Months,95.8,93.0 to 97.7,725
≥1 Dose MMR,,States/Local Areas,Virginia,2015,Age,35 Months,95.3,91.6 to 97.7,374
≥1 Dose MMR,,States/Local Areas,Virginia,2015-2016,Age,35 Months,94.9,92.0 to 97.0,763
≥1 Dose Varicella,,States/Local Areas,Virginia,2018,Age,35 Months,94.7,88.5 to 98.1,551
≥1 Dose Varicella,,States/Local Areas,Virginia,2018-2019,Age,35 Months,95.9,92.0 to 98.3,1003
PCV,≥4 Doses,States/Local Areas,Virginia,2015,Age,24 Months,88.0,80.9 to 93.4,374
PCV,≥4 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,91.3,87.2 to 94.5,763
≥1 Dose MMR,,States/Local Areas,Virginia,2016,Age,35 Months,94.6,89.5 to 97.7,389
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2017,Age,35 Months,93.2,89.6 to 95.8,808
≥1 Dose Varicella,,States/Local Areas,Virginia,2019,Age,35 Months,96.4,91.6 to 98.9,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,95.2,93.1 to 97.2,1104
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,94.2,89.4 to 98.9,149
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,94.5,84.5 to 100.0,40
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.8,92.6 to 100.0,93
Hep B,≥3 Doses,States/Local Areas,Virginia,2016,Age,35 Months,96.8,93.8 to 98.6,389
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,94.5,91.7 to 96.6,808
Hep B,≥3 Doses,States/Local Areas,Virginia,2015,Age,35 Months,93.1,88.1 to 96.5,374
Hep B,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,95.0,92.2 to 97.0,763
PCV,≥3 Doses,States/Local Areas,Virginia,2013,Age,19 Months,89.1,81.7 to 93.8,357
PCV,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,91.0,86.8 to 94.0,708
PCV,≥3 Doses,States/Local Areas,Virginia,2011,Age,19 Months,92.5,89.0 to 94.9,277
PCV,≥4 Doses,States/Local Areas,Virginia,2018,Age,24 Months,83.3,77.0 to 88.6,551
PCV,≥4 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,85.5,81.3 to 89.2,1003
PCV,≥4 Doses,States/Local Areas,Virginia,2019,Age,24 Months,87.7,81.8 to 92.4,452
PCV,≥4 Doses,States/Local Areas,Virginia,2012,Age,35 Months,76.9,68.3 to 84.5,342
PCV,≥4 Doses,States/Local Areas,Virginia,2011,Age,35 Months,82.0,72.5 to 89.8,277
Hep B,≥3 Doses,States/Local Areas,Virginia,2017,Age,35 Months,92.2,87.2 to 95.7,419
Hep B,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,92.6,88.6 to 95.6,970
PCV,≥3 Doses,States/Local Areas,Virginia,2012,Age,19 Months,88.1,81.7 to 92.5,342
Hep B,≥2 Doses,States/Local Areas,Virginia,2014,Age,13 Months,93.1,86.9 to 96.5,351
Hep B,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,93.4,89.4 to 95.9,725
Hib,≥1 Dose,States/Local Areas,Virginia,2014,Age,3 Months,88.2,80.7 to 93.0,351
Hib,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,3 Months,87.7,82.4 to 91.5,725
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2019,Age,0-2 Days,83.1,76.4 to 88.2,452
Hep B,≥2 Doses,States/Local Areas,Virginia,2013,Age,13 Months,89.8,86.6 to 92.4,357
Hep B,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,91.5,89.1 to 93.4,708
Hep B,≥2 Doses,States/Local Areas,Virginia,2015,Age,13 Months,93.6,88.0 to 96.7,374
Hep B,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,95.8,92.8 to 97.5,763
Hib,≥1 Dose,States/Local Areas,Virginia,2011,Age,3 Months,90.0,80.5 to 95.1,277
Hib,≥1 Dose,States/Local Areas,Virginia,2012,Age,3 Months,84.4,76.9 to 89.8,342
Hib,≥1 Dose,States/Local Areas,Virginia,2013,Age,3 Months,82.0,73.7 to 88.1,357
Hib,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,3 Months,85.1,78.9 to 89.7,708
Hib,Full Series,States/Local Areas,Virginia,2016,Age,24 Months,85.7,79.4 to 90.9,389
Hib,Full Series,States/Local Areas,Virginia,2016-2017,Age,24 Months,81.3,76.3 to 85.8,808
Hib,Full Series,States/Local Areas,Virginia,2015,Age,24 Months,84.5,77.4 to 90.3,374
Hib,Full Series,States/Local Areas,Virginia,2015-2016,Age,24 Months,85.1,80.5 to 89.1,763
Hib,Full Series,States/Local Areas,Virginia,2014,Age,24 Months,86.3,79.5 to 91.8,351
Hib,Full Series,States/Local Areas,Virginia,2014-2015,Age,24 Months,85.4,80.6 to 89.5,725
Polio,≥3 Doses,States/Local Areas,Virginia,2016,Age,24 Months,97.0,92.7 to 99.1,389
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,93.0,89.2 to 95.9,808
Hib,≥3 Doses,States/Local Areas,Virginia,2019,Age,19 Months,95.2,90.3 to 97.7,452
Hib,≥3 Doses,States/Local Areas,Virginia,2011,Age,24 Months,93.2,86.3 to 97.4,277
Hib,≥3 Doses,States/Local Areas,Virginia,2012,Age,24 Months,87.5,79.9 to 93.2,342
Hib,≥3 Doses,States/Local Areas,Virginia,2013,Age,24 Months,91.2,86.2 to 95.0,357
Hib,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,93.8,90.5 to 96.2,708
Polio,≥3 Doses,States/Local Areas,Virginia,2018,Age,24 Months,91.5,86.2 to 95.3,551
Polio,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,92.0,88.4 to 94.9,1003
Polio,≥3 Doses,States/Local Areas,Virginia,2019,Age,24 Months,92.6,87.2 to 96.3,452
Polio,≥3 Doses,States/Local Areas,Virginia,2017,Age,24 Months,89.0,82.4 to 94.0,419
Polio,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,90.3,86.0 to 93.7,970
DTaP,≥3 Doses,States/Local Areas,Virginia,2012,Age,24 Months,90.4,83.6 to 95.2,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2011,Age,24 Months,94.4,87.6 to 98.2,277
DTaP,≥3 Doses,States/Local Areas,Virginia,2019,Age,19 Months,93.6,87.7 to 96.8,452
Hep A,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,24 Months,85.4,81.3 to 89.0,804
Hib,Full Series,States/Local Areas,Virginia,2016,Age,35 Months,86.6,80.3 to 91.7,389
Hib,Full Series,States/Local Areas,Virginia,2016-2017,Age,35 Months,84.1,79.3 to 88.4,808
Hib,Full Series,States/Local Areas,Virginia,2018,Age,24 Months,82.0,75.5 to 87.6,551
Hib,Full Series,States/Local Areas,Virginia,2018-2019,Age,24 Months,82.7,78.4 to 86.7,1003
Hib,Full Series,States/Local Areas,Virginia,2019,Age,24 Months,83.6,77.5 to 88.9,452
Hib,Full Series,States/Local Areas,Virginia,2012,Age,35 Months,80.7,72.4 to 87.8,342
Hib,Full Series,States/Local Areas,Virginia,2011,Age,35 Months,89.6,80.5 to 95.7,277
Polio,≥3 Doses,States/Local Areas,Virginia,2012,Age,35 Months,90.4,83.7 to 95.2,342
DTaP,≥2 Doses,States/Local Areas,Virginia,2011,Age,5 Months,81.3,74.3 to 86.7,277
DTaP,≥2 Doses,States/Local Areas,Virginia,2012,Age,5 Months,73.6,63.3 to 81.8,342
DTaP,≥2 Doses,States/Local Areas,Virginia,2013,Age,5 Months,74.9,67.3 to 81.2,357
DTaP,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,5 Months,79.4,73.4 to 84.4,708
Polio,≥3 Doses,States/Local Areas,Virginia,2014,Age,35 Months,95.3,90.2 to 98.2,351
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,96.1,93.1 to 98.0,725
Polio,≥3 Doses,States/Local Areas,Virginia,2013,Age,35 Months,91.7,86.1 to 95.6,357
Polio,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,93.4,89.8 to 96.0,708
Hib,Full Series,States/Local Areas,Virginia,2013,Age,35 Months,79.1,71.2 to 86.0,357
Hib,Full Series,States/Local Areas,Virginia,2013-2014,Age,35 Months,86.5,81.0 to 91.0,708
Polio,≥3 Doses,States/Local Areas,Virginia,2015,Age,35 Months,96.6,92.8 to 98.7,374
Polio,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,97.2,94.6 to 98.8,763
Polio,≥3 Doses,States/Local Areas,Virginia,2016,Age,35 Months,97.1,92.8 to 99.2,389
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,94.3,91.0 to 96.8,808
Polio,≥3 Doses,States/Local Areas,Virginia,2017,Age,35 Months,91.3,85.7 to 95.4,419
Polio,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,91.6,87.6 to 94.7,970
Hib,Full Series,States/Local Areas,Virginia,2014,Age,35 Months,92.4,86.0 to 96.5,351
Hib,Full Series,States/Local Areas,Virginia,2014-2015,Age,35 Months,89.2,84.3 to 93.1,725
Hib,Full Series,States/Local Areas,Virginia,2015,Age,35 Months,85.3,78.2 to 91.0,374
Hib,Full Series,States/Local Areas,Virginia,2015-2016,Age,35 Months,85.9,81.3 to 89.9,763
DTaP,≥2 Doses,States/Local Areas,Virginia,2014,Age,5 Months,84.1,75.6 to 90.0,351
DTaP,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,5 Months,83.2,80.8 to 85.3,725
DTaP,≥2 Doses,States/Local Areas,Virginia,2015,Age,5 Months,82.3,74.3 to 88.2,374
DTaP,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,5 Months,85.3,80.3 to 89.1,763
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,96.0,93.8 to 98.1,1104
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,92.4,86.9 to 97.8,149
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,87.5,71.5 to 100.0,40
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,86.7,82.8 to 90.6,1104
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,81.6,74.1 to 89.1,149
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.8,75.5 to 94.2,93
Polio,≥3 Doses,States/Local Areas,Virginia,2018,Age,35 Months,91.5,86.2 to 95.3,551
Polio,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,94.9,90.3 to 97.8,1003
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.9 to 100.0,93
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,76.2,54.7 to 97.7,40
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.3,92.2 to 100.0,222
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,89.4,81.7 to 97.1,172
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.2,91.2 to 97.3,829
Polio,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,87.9 to 96.3,604
Hib,Full Series,States/Local Areas,Virginia,2019,Age,35 Months,92.9,84.7 to 97.6,452
Hib,Full Series,States/Local Areas,Virginia,2017,Age,35 Months,81.6,73.9 to 88.1,419
Hib,Full Series,States/Local Areas,Virginia,2017-2018,Age,35 Months,84.1,79.0 to 88.6,970
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,93.1,83.9 to 100.0,39
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Overall,Overall,84.2,80.7 to 87.7,1316
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,78.2,69.5 to 87.0,127
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,82.5,76.1 to 88.9,345
Hib,Full Series,States/Local Areas,Virginia,2018,Age,35 Months,86.5,79.8 to 91.9,551
Hib,Full Series,States/Local Areas,Virginia,2018-2019,Age,35 Months,88.7,83.7 to 92.7,1003
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,81.1 to 95.4,222
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,76.9,66.3 to 87.5,172
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.8,80.2 to 89.4,829
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,81.5,75.6 to 87.4,604
Hib,Primary Series,States/Local Areas,Virginia,2011,Age,7 Months,73.0,63.3 to 80.9,277
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,89.1,85.0 to 93.2,844
Hib,Full Series,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.1,80.3 to 89.8,673
≥1 Dose MMR,,States/Local Areas,Virginia,2011,Age,13 Months,35.9,26.6 to 46.5,277
Hep A,≥2 Doses,States/Local Areas,Virginia,2017,Age,24 Months,37.2,29.6 to 46.1,419
Hep A,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,38.3,33.0 to 44.0,970
Hep A,≥2 Doses,States/Local Areas,Virginia,2015,Age,24 Months,32.1,24.7 to 41.0,374
Hep A,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,35.4,29.9 to 41.7,763
Hep A,≥2 Doses,States/Local Areas,Virginia,2016,Age,24 Months,38.9,31.1 to 47.9,389
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,38.0,32.4 to 44.3,808
DTaP,≥4 Doses,States/Local Areas,Virginia,2013,Age,24 Months,80.0,72.8 to 86.3,357
DTaP,≥4 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,83.0,78.1 to 87.4,708
DTaP,≥4 Doses,States/Local Areas,Virginia,2018,Age,19 Months,68.6,61.1 to 75.2,551
DTaP,≥4 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,93.6,90.0 to 96.0,1003
Hib,≥3 Doses,States/Local Areas,Virginia,2018,Age,35 Months,94.7,89.4 to 97.9,551
Hib,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,95.1,91.7 to 97.3,1003
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,95.8,93.9 to 97.7,1316
Hep A,≥2 Doses,States/Local Areas,Virginia,2014,Age,24 Months,36.2,28.0 to 45.9,351
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,34.2,28.5 to 40.7,725
≥1 Dose Varicella,,States/Local Areas,Virginia,2013,Age,13 Months,48.6,40.5 to 56.8,357
≥1 Dose Varicella,,States/Local Areas,Virginia,2013-2014,Age,13 Months,54.8,46.9 to 62.4,708
≥1 Dose Varicella,,States/Local Areas,Virginia,2011,Age,13 Months,47.4,33.4 to 61.9,277
Hib,≥3 Doses,States/Local Areas,Virginia,2019,Age,35 Months,95.6,91.2 to 98.2,452
Polio,≥2 Doses,States/Local Areas,Virginia,2014,Age,5 Months,83.5,75.1 to 89.5,351
Polio,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,5 Months,83.5,80.2 to 86.3,725
Polio,≥2 Doses,States/Local Areas,Virginia,2013,Age,5 Months,71.5,63.3 to 78.5,357
Polio,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,5 Months,77.5,70.7 to 83.0,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2012,Age,35 Months,80.2,71.8 to 87.3,342
Polio,≥2 Doses,States/Local Areas,Virginia,2011,Age,5 Months,78.6,70.4 to 85.1,277
Polio,≥2 Doses,States/Local Areas,Virginia,2012,Age,5 Months,72.5,61.9 to 81.1,342
DTaP,≥4 Doses,States/Local Areas,Virginia,2012,Age,24 Months,76.9,68.1 to 84.8,342
DTaP,≥4 Doses,States/Local Areas,Virginia,2011,Age,24 Months,77.5,67.7 to 86.0,277
Hep B,≥3 Doses,States/Local Areas,Virginia,2011,Age,7 Months,37.2,27.8 to 47.6,277
Hep B,≥3 Doses,States/Local Areas,Virginia,2012,Age,7 Months,42.4,35.2 to 49.9,342
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,95.6,92.4 to 98.9,345
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,98.0,96.5 to 99.5,844
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,92.2,86.5 to 97.9,127
Hep A,≥1 Dose,States/Local Areas,Virginia,2018,Age,35 Months,94.6,89.1 to 97.9,551
Hep A,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,35 Months,95.0,91.4 to 97.4,1003
≥1 Dose Varicella,,States/Local Areas,Virginia,2012,Age,13 Months,45.5,42.2 to 48.9,342
≥1 Dose Varicella,,States/Local Areas,Virginia,2014,Age,13 Months,61.1,51.7 to 69.7,351
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2015,Age,13 Months,64.6,58.3 to 70.4,725
Hep A,≥1 Dose,States/Local Areas,Virginia,2019,Age,35 Months,95.5,90.5 to 98.3,452
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,90.3,87.2 to 93.5,1104
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,87.5,81.1 to 93.9,149
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,87.2,72.0 to 100.0,40
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.2,86.3 to 98.0,93
Hep B,≥3 Doses,States/Local Areas,Virginia,2017,Age,7 Months,44.1,35.7 to 52.8,419
Hep B,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,42.9,37.4 to 48.7,970
Polio,≥2 Doses,States/Local Areas,Virginia,2018,Age,5 Months,81.1,74.1 to 86.5,551
Polio,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,5 Months,82.1,77.3 to 86.0,1003
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,85.7,76.7 to 94.6,172
Polio,≥2 Doses,States/Local Areas,Virginia,2011,Age,7 Months,92.3,87.4 to 95.4,277
Polio,≥2 Doses,States/Local Areas,Virginia,2012,Age,7 Months,88.0,84.6 to 90.7,342
Hep A,≥2 Doses,States/Local Areas,Virginia,2016,Age,35 Months,87.7,79.8 to 93.5,389
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,81.7,75.6 to 87.1,808
Hep A,≥2 Doses,States/Local Areas,Virginia,2015,Age,35 Months,75.8,66.2 to 84.3,374
Hep A,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,82.8,76.2 to 88.4,763
Hep A,≥2 Doses,States/Local Areas,Virginia,2014,Age,35 Months,67.5,57.5 to 77.1,351
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,71.6,64.6 to 78.4,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2016,Age,7 Months,43.3,35.0 to 51.9,389
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,43.7,37.7 to 49.8,808
PCV,≥2 Doses,States/Local Areas,Virginia,2017,Age,5 Months,80.1,72.4 to 86.0,419
PCV,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,5 Months,80.2,75.1 to 84.5,970
PCV,≥2 Doses,States/Local Areas,Virginia,2018,Age,5 Months,80.4,73.5 to 85.9,551
PCV,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,5 Months,82.0,77.2 to 85.9,1003
PCV,≥2 Doses,States/Local Areas,Virginia,2019,Age,5 Months,83.5,76.5 to 88.8,452
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.8,92.3 to 100.0,93
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.9,97.7 to 100.0,222
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,91.2,84.2 to 98.1,172
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,96.4,90.9 to 100.0,39
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.1,93.6 to 98.6,673
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.9,93.4 to 98.5,829
DTaP,≥3 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.1 to 98.6,604
DTaP,≥4 Doses,States/Local Areas,Virginia,2017,Age,19 Months,75.1,67.1 to 81.6,419
DTaP,≥4 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,71.8,66.3 to 76.8,970
DTaP,≥4 Doses,States/Local Areas,Virginia,2016,Age,19 Months,80.4,73.0 to 86.1,389
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,77.8,72.5 to 82.3,808
Hep A,≥2 Doses,States/Local Areas,Virginia,2013,Age,24 Months,38.7,30.6 to 48.2,357
Hep A,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,37.5,31.5 to 44.1,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2014,Age,35 Months,94.3,88.3 to 97.8,351
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,35 Months,93.8,89.8 to 96.6,725
Hep A,≥1 Dose,States/Local Areas,Virginia,2013,Age,35 Months,86.4,79.3 to 92.0,357
Hep A,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,35 Months,90.9,85.9 to 94.7,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2015,Age,35 Months,93.1,87.3 to 96.8,374
Hep A,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,35 Months,92.5,88.3 to 95.7,763
Hep B,≥3 Doses,States/Local Areas,Virginia,2014,Age,7 Months,46.4,37.3 to 55.7,351
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,44.5,38.2 to 50.9,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2015,Age,7 Months,42.5,34.1 to 51.3,374
Hep B,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,42.9,36.9 to 49.1,763
Polio,≥2 Doses,States/Local Areas,Virginia,2017,Age,5 Months,82.2,74.4 to 88.0,419
Polio,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,5 Months,81.6,76.4 to 85.9,970
Polio,≥2 Doses,States/Local Areas,Virginia,2016,Age,5 Months,88.0,81.5 to 92.5,389
Polio,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,5 Months,85.2,80.3 to 89.0,808
Hep A,≥2 Doses,States/Local Areas,Virginia,2018,Age,24 Months,39.3,32.6 to 46.9,551
Hep A,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,42.0,37.0 to 47.4,1003
Hep B,≥3 Doses,States/Local Areas,Virginia,2013,Age,7 Months,47.0,44.4 to 49.7,357
Hep B,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,46.7,43.1 to 50.3,708
Hep A,≥2 Doses,States/Local Areas,Virginia,2019,Age,24 Months,44.7,37.5 to 52.6,452
Polio,≥2 Doses,States/Local Areas,Virginia,2015,Age,5 Months,83.4,75.8 to 89.0,374
Polio,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,5 Months,85.7,80.9 to 89.5,763
Hep A,≥2 Doses,States/Local Areas,Virginia,2013,Age,35 Months,73.1,62.8 to 82.6,357
Hep A,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,70.7,63.4 to 77.7,708
Hep A,≥2 Doses,States/Local Areas,Virginia,2012,Age,35 Months,67.6,57.2 to 77.5,342
Hep A,≥2 Doses,States/Local Areas,Virginia,2011,Age,35 Months,69.3,56.9 to 81.0,277
DTaP,≥4 Doses,States/Local Areas,Virginia,2014,Age,24 Months,86.2,79.2 to 91.8,351
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,86.5,81.8 to 90.5,725
DTaP,≥4 Doses,States/Local Areas,Virginia,2016,Age,24 Months,89.5,83.6 to 94.0,389
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,84.4,79.8 to 88.5,808
DTaP,≥4 Doses,States/Local Areas,Virginia,2015,Age,24 Months,86.8,80.0 to 92.1,374
DTaP,≥4 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,88.0,83.7 to 91.7,763
DTaP,≥4 Doses,States/Local Areas,Virginia,2019,Age,19 Months,76.1,68.9 to 82.1,452
Hep A,≥1 Dose,States/Local Areas,Virginia,2016,Age,35 Months,91.1,85.6 to 95.1,389
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,35 Months,88.2,83.6 to 92.0,808
Hep A,≥1 Dose,States/Local Areas,Virginia,2017,Age,35 Months,84.9,77.4 to 91.0,419
Hep A,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,35 Months,89.9,85.0 to 93.8,970
Hep A,≥2 Doses,States/Local Areas,Virginia,2012,Age,24 Months,28.2,20.8 to 37.6,342
PCV,≥3 Doses,States/Local Areas,Virginia,2019,Age,19 Months,94.6,89.4 to 97.3,452
PCV,≥3 Doses,States/Local Areas,Virginia,2012,Age,24 Months,88.3,81.2 to 93.6,342
PCV,≥3 Doses,States/Local Areas,Virginia,2013,Age,24 Months,90.2,84.6 to 94.5,357
PCV,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,91.6,87.8 to 94.7,708
PCV,≥3 Doses,States/Local Areas,Virginia,2014,Age,24 Months,93.0,87.1 to 96.8,351
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,93.9,90.2 to 96.5,725
PCV,≥4 Doses,States/Local Areas,Virginia,2019,Age,35 Months,93.8,85.6 to 98.1,452
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,93.3,90.9 to 95.8,1104
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,87.9,79.3 to 96.5,172
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.7,89.3 to 96.1,829
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,92.6,88.6 to 96.5,604
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,96.7,95.1 to 98.3,844
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,94.4,91.0 to 97.9,345
Hib,≥1 Dose,States/Local Areas,Virginia,2017,Age,3 Months,85.9,78.1 to 91.3,419
Hib,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,3 Months,86.7,82.0 to 90.3,970
PCV,≥4 Doses,States/Local Areas,Virginia,2014,Age,35 Months,89.8,82.3 to 95.1,351
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,89.4,84.2 to 93.4,725
PCV,≥4 Doses,States/Local Areas,Virginia,2015,Age,35 Months,88.6,81.5 to 93.9,374
PCV,≥4 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,92.0,87.9 to 95.1,763
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.8,95.9 to 99.7,222
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,88.0,79.6 to 96.4,172
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",98.6,96.7 to 100.0,93
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,93.1,87.9 to 98.3,149
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,94.5,92.1 to 96.9,1104
Hep B,≥3 Doses,States/Local Areas,Virginia,2018,Age,35 Months,92.8,86.5 to 96.9,551
Hep B,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,95.4,91.1 to 98.0,1003
PCV,≥3 Doses,States/Local Areas,Virginia,2014,Age,19 Months,93.0,86.4 to 96.5,351
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,93.9,89.9 to 96.3,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2019,Age,35 Months,98.0,93.2 to 99.7,452
Hep B,≥2 Doses,States/Local Areas,Virginia,2017,Age,13 Months,94.0,87.5 to 97.2,419
Hep B,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,93.8,90.3 to 96.1,970
Hib,≥1 Dose,States/Local Areas,Virginia,2016,Age,3 Months,90.0,83.3 to 94.2,389
Hib,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,3 Months,88.0,83.1 to 91.6,808
Hib,≥1 Dose,States/Local Areas,Virginia,2015,Age,3 Months,87.2,79.1 to 92.5,374
Hib,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,3 Months,88.6,83.6 to 92.2,763
PCV,≥3 Doses,States/Local Areas,Virginia,2016,Age,19 Months,95.9,90.6 to 98.3,389
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,92.7,88.9 to 95.3,808
PCV,≥3 Doses,States/Local Areas,Virginia,2015,Age,19 Months,94.7,91.5 to 96.8,374
PCV,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,95.3,91.9 to 97.3,763
Hep B,≥2 Doses,States/Local Areas,Virginia,2016,Age,13 Months,97.9,95.6 to 99.0,389
Hep B,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,96.0,92.8 to 97.8,808
Hep B,≥2 Doses,States/Local Areas,Virginia,2018,Age,13 Months,93.7,89.1 to 96.4,551
Hep B,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,94.9,91.8 to 96.8,1003
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,96.2,90.7 to 100.0,39
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.2,91.2 to 97.2,673
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Overall,Overall,94.0,91.8 to 96.2,1316
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,89.1,82.2 to 96.1,127
≥1 Dose MMR,,States/Local Areas,Virginia,2018,Age,24 Months,89.6,84.1 to 93.9,551
≥1 Dose MMR,,States/Local Areas,Virginia,2018-2019,Age,24 Months,92.4,89.0 to 95.1,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2019,Age,24 Months,95.3,90.9 to 97.9,452
≥1 Dose MMR,,States/Local Areas,Virginia,2012,Age,35 Months,86.7,79.3 to 92.4,342
≥1 Dose MMR,,States/Local Areas,Virginia,2011,Age,35 Months,91.7,84.0 to 96.6,277
≥1 Dose Varicella,,States/Local Areas,Virginia,2016,Age,35 Months,94.8,90.0 to 97.7,389
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2017,Age,35 Months,92.5,89.1 to 95.2,808
≥1 Dose MMR,,States/Local Areas,Virginia,2013,Age,35 Months,86.7,80.2 to 91.9,357
≥1 Dose MMR,,States/Local Areas,Virginia,2013-2014,Age,35 Months,91.3,87.3 to 94.5,708
PCV,≥4 Doses,States/Local Areas,Virginia,2014,Age,24 Months,87.0,80.0 to 92.5,351
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,87.5,82.7 to 91.6,725
PCV,≥4 Doses,States/Local Areas,Virginia,2013,Age,24 Months,76.1,68.1 to 83.3,357
PCV,≥4 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,81.5,76.2 to 86.2,708
Hep B,≥3 Doses,States/Local Areas,Virginia,2017,Age,24 Months,89.6,83.4 to 94.2,419
Hep B,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,90.0,85.9 to 93.4,970
Hep B,≥3 Doses,States/Local Areas,Virginia,2019,Age,24 Months,92.6,87.3 to 96.2,452
PCV,≥4 Doses,States/Local Areas,Virginia,2012,Age,24 Months,74.8,66.2 to 82.7,342
Hep B,≥3 Doses,States/Local Areas,Virginia,2011,Age,35 Months,90.5,82.8 to 95.7,277
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2017,Age,0-2 Days,73.8,65.7 to 80.7,419
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2017-2018,Age,0-2 Days,74.9,69.8 to 79.4,970
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2016,Age,0-2 Days,73.5,65.7 to 80.0,389
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2016-2017,Age,0-2 Days,73.7,68.1 to 78.5,808
PCV,≥4 Doses,States/Local Areas,Virginia,2011,Age,24 Months,76.6,67.1 to 85.0,277
≥1 Dose MMR,,States/Local Areas,Virginia,2018,Age,35 Months,95.0,89.7 to 98.1,551
≥1 Dose MMR,,States/Local Areas,Virginia,2018-2019,Age,35 Months,96.0,92.8 to 98.1,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2017,Age,35 Months,91.8,86.3 to 95.7,419
≥1 Dose MMR,,States/Local Areas,Virginia,2017-2018,Age,35 Months,93.8,89.7 to 96.6,970
≥1 Dose MMR,,States/Local Areas,Virginia,2019,Age,35 Months,96.8,92.4 to 99.0,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.8,96.1 to 99.5,222
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,94.4,84.4 to 100.0,40
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,91.0 to 96.7,829
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,93.4,89.7 to 97.0,604
PCV,≥4 Doses,States/Local Areas,Virginia,2013,Age,35 Months,81.3,73.2 to 88.2,357
PCV,≥4 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,85.8,80.0 to 90.6,708
PCV,≥3 Doses,States/Local Areas,Virginia,2019,Age,13 Months,91.7,86.1 to 95.1,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2017,Age,35 Months,90.6,85.2 to 94.7,419
≥1 Dose Varicella,,States/Local Areas,Virginia,2017-2018,Age,35 Months,92.4,88.3 to 95.5,970
≥1 Dose Varicella,,States/Local Areas,Virginia,2015,Age,35 Months,97.1,92.3 to 99.3,374
≥1 Dose Varicella,,States/Local Areas,Virginia,2015-2016,Age,35 Months,96.1,92.8 to 98.2,763
Hep B,≥2 Doses,States/Local Areas,Virginia,2017,Age,7 Months,92.1,85.5 to 95.9,419
Hep B,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,91.1,86.8 to 94.1,970
PCV,≥3 Doses,States/Local Areas,Virginia,2013,Age,13 Months,85.0,76.4 to 90.9,357
PCV,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,88.7,82.7 to 92.8,708
Hep B,≥2 Doses,States/Local Areas,Virginia,2016,Age,7 Months,95.7,92.2 to 97.7,389
Hep B,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,94.0,90.5 to 96.2,808
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2018,Age,0-1 Days,71.9,65.0 to 78.0,551
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2018-2019,Age,0-1 Days,75.7,70.9 to 79.9,1003
Hep B,≥3 Doses,States/Local Areas,Virginia,2019,Age,19 Months,92.1,86.3 to 95.6,452
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2011,Age,0-2 Days,77.4,69.8 to 83.5,277
Hep B,≥2 Doses,States/Local Areas,Virginia,2013,Age,7 Months,85.7,79.2 to 90.4,357
Hep B,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,87.9,84.8 to 90.5,708
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2012,Age,0-2 Days,65.1,58.3 to 71.4,342
Hep B,≥2 Doses,States/Local Areas,Virginia,2014,Age,7 Months,90.3,83.5 to 94.4,351
Hep B,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,90.5,86.1 to 93.6,725
Hep B,≥2 Doses,States/Local Areas,Virginia,2012,Age,7 Months,85.3,75.7 to 91.5,342
PCV,≥3 Doses,States/Local Areas,Virginia,2018,Age,7 Months,70.9,63.5 to 77.3,551
PCV,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,74.0,68.9 to 78.5,1003
PCV,≥3 Doses,States/Local Areas,Virginia,2011,Age,13 Months,89.5,84.4 to 93.0,277
Hep B,≥3 Doses,States/Local Areas,Virginia,2014,Age,24 Months,92.4,86.7 to 96.3,351
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,24 Months,92.4,88.8 to 95.2,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2015,Age,24 Months,92.6,87.6 to 96.1,374
Hep B,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,24 Months,94.2,91.4 to 96.3,763
Hep B,≥3 Doses,States/Local Areas,Virginia,2016,Age,24 Months,95.9,92.7 to 97.9,389
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,24 Months,92.8,89.4 to 95.4,808
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2019,Age,0-1 Days,79.6,72.7 to 85.1,452
Hep A,≥1 Dose,States/Local Areas,Virginia,2020,Age,35 Months,90.7,84.9 to 94.9,494
Hep B,≥2 Doses,States/Local Areas,Virginia,2011,Age,7 Months,87.9,82.7 to 91.7,277
PCV,≥3 Doses,States/Local Areas,Virginia,2012,Age,13 Months,82.6,75.0 to 88.3,342
≥1 Dose MMR,,States/Local Areas,Virginia,2016,Age,24 Months,94.3,89.2 to 97.5,389
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2017,Age,24 Months,92.7,89.1 to 95.4,808
≥1 Dose MMR,,States/Local Areas,Virginia,2017,Age,24 Months,91.2,85.7 to 95.2,419
≥1 Dose MMR,,States/Local Areas,Virginia,2017-2018,Age,24 Months,90.4,86.5 to 93.6,970
PCV,≥4 Doses,States/Local Areas,Virginia,2018,Age,19 Months,77.7,70.6 to 83.5,551
PCV,≥4 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,80.7,75.1 to 85.2,829
PCV,≥4 Doses,States/Local Areas,Virginia,2017,Age,19 Months,77.8,69.8 to 84.1,419
PCV,≥4 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,77.7,72.4 to 82.3,970
PCV,≥4 Doses,States/Local Areas,Virginia,2016,Age,19 Months,90.7,84.3 to 94.6,389
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,84.3,79.4 to 88.3,808
PCV,≥4 Doses,States/Local Areas,Virginia,2015,Age,19 Months,84.3,77.9 to 89.0,374
PCV,≥4 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,87.5,82.6 to 91.1,763
PCV,≥3 Doses,States/Local Areas,Virginia,2017,Age,7 Months,67.8,58.9 to 75.6,419
PCV,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,69.4,63.6 to 74.6,970
PCV,≥4 Doses,States/Local Areas,Virginia,2014,Age,19 Months,82.7,74.6 to 88.7,351
PCV,≥4 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,83.5,78.0 to 87.8,725
PCV,≥3 Doses,States/Local Areas,Virginia,2015,Age,7 Months,65.4,56.4 to 73.5,374
PCV,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,71.2,65.2 to 76.4,763
PCV,≥3 Doses,States/Local Areas,Virginia,2016,Age,7 Months,76.9,69.1 to 83.1,389
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,72.4,66.6 to 77.6,808
Hep B,≥3 Doses,States/Local Areas,Virginia,2012,Age,24 Months,86.5,79.8 to 91.8,342
Hep B,≥2 Doses,States/Local Areas,Virginia,2018,Age,5 Months,88.0,82.3 to 92.1,551
Hep B,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,5 Months,89.4,85.6 to 92.3,1003
Hep B,≥2 Doses,States/Local Areas,Virginia,2019,Age,5 Months,90.8,85.0 to 94.5,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2013,Age,24 Months,88.3,82.2 to 93.1,357
Hep B,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,24 Months,90.2,86.1 to 93.4,708
Hep B,≥3 Doses,States/Local Areas,Virginia,2011,Age,24 Months,88.4,80.4 to 94.3,277
≥1 Dose Varicella,,States/Local Areas,Virginia,2018,Age,24 Months,87.8,82.0 to 92.4,551
≥1 Dose Varicella,,States/Local Areas,Virginia,2018-2019,Age,24 Months,89.8,86.1 to 92.9,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2014,Age,24 Months,95.2,90.4 to 98.1,351
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2015,Age,24 Months,95.3,92.4 to 97.3,725
≥1 Dose MMR,,States/Local Areas,Virginia,2013,Age,24 Months,86.3,79.8 to 91.5,357
≥1 Dose MMR,,States/Local Areas,Virginia,2013-2014,Age,24 Months,90.6,86.6 to 93.8,708
≥1 Dose Varicella,,States/Local Areas,Virginia,2017,Age,24 Months,90.2,84.7 to 94.3,419
≥1 Dose Varicella,,States/Local Areas,Virginia,2017-2018,Age,24 Months,89.0,84.9 to 92.3,970
≥1 Dose Varicella,,States/Local Areas,Virginia,2019,Age,24 Months,91.9,87.0 to 95.4,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2018,Age,24 Months,90.3,85.1 to 94.3,551
Hep B,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,91.5,87.9 to 94.3,1003
Hep B,≥2 Doses,States/Local Areas,Virginia,2015,Age,7 Months,90.7,84.4 to 94.6,374
Hep B,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,93.2,89.8 to 95.6,763
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2013,Age,0-2 Days,68.5,61.4 to 74.9,357
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2013-2014,Age,0-2 Days,69.7,66.4 to 72.7,708
PCV,≥3 Doses,States/Local Areas,Virginia,2014,Age,13 Months,92.4,85.9 to 96.1,351
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,92.5,88.4 to 95.2,725
PCV,≥3 Doses,States/Local Areas,Virginia,2015,Age,13 Months,92.5,86.4 to 96.0,374
PCV,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,93.9,90.3 to 96.2,763
≥1 Dose Varicella,,States/Local Areas,Virginia,2014,Age,35 Months,96.3,91.6 to 98.7,351
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2015,Age,35 Months,96.9,93.5 to 98.8,725
≥1 Dose MMR,,States/Local Areas,Virginia,2015,Age,24 Months,95.3,91.6 to 97.6,374
≥1 Dose MMR,,States/Local Areas,Virginia,2015-2016,Age,24 Months,94.8,91.8 to 96.9,763
≥1 Dose Varicella,,States/Local Areas,Virginia,2012,Age,35 Months,86.3,78.3 to 92.5,342
PCV,≥3 Doses,States/Local Areas,Virginia,2019,Age,7 Months,77.2,69.8 to 83.2,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2013,Age,35 Months,87.5,80.6 to 92.8,357
≥1 Dose Varicella,,States/Local Areas,Virginia,2013-2014,Age,35 Months,91.8,87.6 to 95.0,708
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2014,Age,0-2 Days,70.8,61.8 to 78.5,351
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2014-2015,Age,0-2 Days,69.0,62.7 to 74.6,725
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2015,Age,0-2 Days,67.1,58.3 to 74.9,374
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2015-2016,Age,0-2 Days,70.3,64.5 to 75.6,763
PCV,≥3 Doses,States/Local Areas,Virginia,2014,Age,7 Months,70.5,61.3 to 78.2,351
PCV,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,68.0,61.6 to 73.7,725
PCV,≥3 Doses,States/Local Areas,Virginia,2012,Age,7 Months,61.4,53.4 to 68.8,342
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,83.3,77.0 to 89.6,345
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,92.9,90.1 to 95.7,844
Hep B,≥3 Doses,States/Local Areas,Virginia,2016,Age,19 Months,95.8,92.3 to 97.7,389
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,19 Months,91.8,88.0 to 94.5,808
PCV,≥3 Doses,States/Local Areas,Virginia,2011,Age,7 Months,66.1,57.5 to 73.7,277
PCV,≥3 Doses,States/Local Areas,Virginia,2013,Age,7 Months,62.5,54.8 to 69.5,357
PCV,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,66.4,61.1 to 71.3,708
Hep B,≥2 Doses,States/Local Areas,Virginia,2014,Age,5 Months,85.6,77.9 to 90.9,351
Hep B,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,5 Months,85.6,82.3 to 88.4,725
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2012,Age,0-1 Days,56.8,51.5 to 62.0,342
Hep B,≥2 Doses,States/Local Areas,Virginia,2016,Age,5 Months,91.2,85.8 to 94.7,389
Hep B,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,5 Months,90.6,86.6 to 93.5,808
Hep B,≥3 Doses,States/Local Areas,Virginia,2017,Age,19 Months,87.7,80.7 to 92.5,419
Hep B,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,19 Months,88.8,84.3 to 92.2,970
Polio,≥2 Doses,States/Local Areas,Virginia,2017,Age,13 Months,93.4,88.0 to 96.5,419
Polio,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,92.9,88.9 to 95.6,970
≥1 Dose Varicella,,States/Local Areas,Virginia,2013,Age,24 Months,86.8,80.1 to 92.1,357
≥1 Dose Varicella,,States/Local Areas,Virginia,2013-2014,Age,24 Months,90.7,86.5 to 94.0,708
Polio,≥2 Doses,States/Local Areas,Virginia,2018,Age,13 Months,92.4,86.8 to 95.8,551
Polio,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,93.6,90.0 to 96.0,1003
≥1 Dose Varicella,,States/Local Areas,Virginia,2019,Age,19 Months,89.4,83.7 to 93.2,452
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2014,Age,0-1 Days,63.1,53.7 to 71.5,351
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2014-2015,Age,0-1 Days,60.6,54.2 to 66.7,725
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2013,Age,0-1 Days,64.1,56.7 to 70.8,357
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2013-2014,Age,0-1 Days,63.6,59.6 to 67.4,708
Hep B,≥2 Doses,States/Local Areas,Virginia,2015,Age,5 Months,85.6,78.3 to 90.7,374
Hep B,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,5 Months,88.4,84.1 to 91.7,763
Polio,≥2 Doses,States/Local Areas,Virginia,2019,Age,13 Months,94.8,89.3 to 97.6,452
≥1 Dose MMR,,States/Local Areas,Virginia,2017,Age,19 Months,88.6,82.0 to 93.0,419
≥1 Dose MMR,,States/Local Areas,Virginia,2017-2018,Age,19 Months,87.3,82.6 to 90.9,970
PCV,≥4 Doses,States/Local Areas,Virginia,2011,Age,19 Months,76.6,71.5 to 81.0,277
PCV,≥4 Doses,States/Local Areas,Virginia,2012,Age,19 Months,71.1,62.5 to 78.4,342
PCV,≥4 Doses,States/Local Areas,Virginia,2013,Age,19 Months,73.9,70.9 to 76.6,357
PCV,≥4 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,78.3,74.4 to 81.7,708
≥1 Dose Varicella,,States/Local Areas,Virginia,2015,Age,24 Months,94.3,89.9 to 97.2,374
≥1 Dose Varicella,,States/Local Areas,Virginia,2015-2016,Age,24 Months,94.3,91.2 to 96.5,763
≥1 Dose MMR,,States/Local Areas,Virginia,2018,Age,19 Months,86.0,79.4 to 90.7,551
≥1 Dose MMR,,States/Local Areas,Virginia,2018-2019,Age,19 Months,95.0,91.8 to 97.0,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2011,Age,24 Months,86.8,78.4 to 93.1,277
≥1 Dose Varicella,,States/Local Areas,Virginia,2016,Age,24 Months,94.3,89.6 to 97.3,389
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2017,Age,24 Months,92.1,88.6 to 94.8,808
≥1 Dose MMR,,States/Local Areas,Virginia,2019,Age,19 Months,91.1,85.5 to 94.6,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2014,Age,24 Months,94.6,89.6 to 97.7,351
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2015,Age,24 Months,94.5,91.3 to 96.8,725
Hep B,≥2 Doses,States/Local Areas,Virginia,2017,Age,5 Months,90.0,83.1 to 94.2,419
Hep B,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,5 Months,89.0,84.6 to 92.3,970
Hep B,≥3 Doses,States/Local Areas,Virginia,2018,Age,19 Months,89.9,84.2 to 93.7,551
Hep B,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,19 Months,86.9,82.8 to 90.2,1003
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2015,Age,0-1 Days,58.2,49.3 to 66.5,374
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2015-2016,Age,0-1 Days,62.0,56.0 to 67.7,763
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2017,Age,0-1 Days,67.5,59.0 to 74.9,419
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2017-2018,Age,0-1 Days,69.7,64.3 to 74.6,970
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2016,Age,0-1 Days,65.8,57.6 to 73.2,389
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2016-2017,Age,0-1 Days,66.6,60.8 to 72.0,808
≥1 Dose Varicella,,States/Local Areas,Virginia,2017,Age,19 Months,90.1,84.1 to 93.9,419
≥1 Dose Varicella,,States/Local Areas,Virginia,2017-2018,Age,19 Months,86.9,82.2 to 90.4,970
≥1 Dose MMR,,States/Local Areas,Virginia,2012,Age,19 Months,81.9,76.1 to 86.5,342
≥1 Dose MMR,,States/Local Areas,Virginia,2013,Age,19 Months,83.7,75.3 to 89.7,357
≥1 Dose MMR,,States/Local Areas,Virginia,2013-2014,Age,19 Months,87.6,79.7 to 92.7,708
Hep B,≥1 Dose,States/Local Areas,Virginia,2017,Age,3 Months,97.3,93.9 to 98.8,419
Hep B,≥1 Dose,States/Local Areas,Virginia,2017-2018,Age,3 Months,96.4,94.1 to 97.8,970
Polio,≥2 Doses,States/Local Areas,Virginia,2016,Age,13 Months,98.1,93.5 to 99.4,389
Polio,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,95.8,92.7 to 97.6,808
≥1 Dose Varicella,,States/Local Areas,Virginia,2018,Age,19 Months,83.7,76.9 to 88.7,551
≥1 Dose Varicella,,States/Local Areas,Virginia,2018-2019,Age,19 Months,59.8,54.5 to 64.8,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2019,Age,13 Months,74.6,67.6 to 80.5,452
≥1 Dose Varicella,,States/Local Areas,Virginia,2016,Age,19 Months,91.5,85.7 to 95.1,389
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2017,Age,19 Months,90.8,86.9 to 93.6,808
Polio,≥2 Doses,States/Local Areas,Virginia,2015,Age,13 Months,95.9,91.1 to 98.2,374
Polio,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,97.0,94.2 to 98.5,763
Hep B,≥3 Doses,States/Local Areas,Virginia,2019,Age,13 Months,89.5,83.5 to 93.5,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2018,Age,13 Months,84.4,78.0 to 89.2,551
Hep B,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,13 Months,86.9,82.8 to 90.2,1003
Polio,≥2 Doses,States/Local Areas,Virginia,2019,Age,7 Months,90.6,84.7 to 94.3,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2012,Age,19 Months,84.2,78.5 to 88.6,342
Hep B,≥3 Doses,States/Local Areas,Virginia,2011,Age,19 Months,87.7,79.7 to 92.8,277
≥1 Dose MMR,,States/Local Areas,Virginia,2011,Age,19 Months,82.5,75.3 to 87.9,277
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,70.6,48.0 to 93.1,40
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.6,71.4 to 91.7,93
DTaP,≥4 Doses,States/Local Areas,Virginia,2019,Age,35 Months,90.3,84.1 to 94.9,452
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,89.7,86.4 to 93.1,1104
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,83.6,76.4 to 90.8,149
DTaP,≥4 Doses,States/Local Areas,Virginia,2018,Age,35 Months,92.7,86.1 to 96.9,551
DTaP,≥4 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,91.5,86.9 to 94.9,1003
Hep B,≥3 Doses,States/Local Areas,Virginia,2014,Age,19 Months,90.4,83.1 to 94.7,351
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,19 Months,90.8,86.5 to 93.9,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2015,Age,19 Months,91.3,87.4 to 94.1,374
Hep B,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,19 Months,93.5,90.3 to 95.8,763
Hep B,≥3 Doses,States/Local Areas,Virginia,2013,Age,19 Months,88.0,84.4 to 90.9,357
Hep B,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,19 Months,89.2,87.4 to 90.8,708
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,87.0,80.2 to 93.8,844
Hep B,≥2 Doses,States/Local Areas,Virginia,2013,Age,5 Months,82.3,74.9 to 87.8,357
Hep B,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,5 Months,83.9,81.1 to 86.5,708
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2011,Age,0-1 Days,65.9,57.7 to 73.3,277
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,74.6,64.0 to 85.3,345
Hep B,≥2 Doses,States/Local Areas,Virginia,2011,Age,5 Months,82.4,76.0 to 87.4,277
Hep B,≥2 Doses,States/Local Areas,Virginia,2012,Age,5 Months,75.7,65.0 to 83.9,342
Polio,≥2 Doses,States/Local Areas,Virginia,2014,Age,13 Months,95.3,89.5 to 98.0,351
Polio,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,95.6,92.3 to 97.6,725
Hep B,≥1 Dose,States/Local Areas,Virginia,2018,Age,3 Months,95.6,91.7 to 97.7,551
Hep B,≥1 Dose,States/Local Areas,Virginia,2018-2019,Age,3 Months,96.2,93.5 to 97.8,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2016,Age,19 Months,92.3,86.2 to 95.8,389
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2017,Age,19 Months,90.5,86.3 to 93.5,808
≥1 Dose MMR,,States/Local Areas,Virginia,2015,Age,19 Months,93.4,87.4 to 96.7,374
≥1 Dose MMR,,States/Local Areas,Virginia,2015-2016,Age,19 Months,92.9,89.3 to 95.3,763
≥1 Dose Varicella,,States/Local Areas,Virginia,2012,Age,24 Months,84.2,76.6 to 90.5,342
≥1 Dose Varicella,,States/Local Areas,Virginia,2011,Age,24 Months,89.8,82.6 to 95.0,277
≥1 Dose MMR,,States/Local Areas,Virginia,2014,Age,19 Months,91.6,84.7 to 95.5,351
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2015,Age,19 Months,92.5,88.6 to 95.2,725
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,79.7,71.0 to 88.5,127
Hep B,≥1 Dose,States/Local Areas,Virginia,2019,Age,3 Months,96.8,91.8 to 98.8,452
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,80.5,70.5 to 90.4,172
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,81.5 to 96.0,222
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.0,85.2 to 92.8,829
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.8,83.4 to 92.2,673
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,84.3,78.9 to 89.7,604
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,90.3,79.0 to 100.0,39
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,86.5,83.2 to 89.7,1316
≥1 Dose MMR,,States/Local Areas,Virginia,2017,Age,13 Months,63.4,54.8 to 71.3,419
≥1 Dose MMR,,States/Local Areas,Virginia,2017-2018,Age,13 Months,63.2,57.4 to 68.6,970
≥1 Dose MMR,,States/Local Areas,Virginia,2016,Age,13 Months,62.8,53.9 to 70.9,389
≥1 Dose MMR,,States/Local Areas,Virginia,2016-2017,Age,13 Months,63.1,56.9 to 68.8,808
≥1 Dose Varicella,,States/Local Areas,Virginia,2014,Age,19 Months,91.2,84.1 to 95.2,351
≥1 Dose Varicella,,States/Local Areas,Virginia,2014-2015,Age,19 Months,91.9,87.7 to 94.7,725
≥1 Dose Varicella,,States/Local Areas,Virginia,2015,Age,19 Months,92.6,88.3 to 95.4,374
≥1 Dose Varicella,,States/Local Areas,Virginia,2015-2016,Age,19 Months,92.1,88.4 to 94.7,763
Polio,≥2 Doses,States/Local Areas,Virginia,2011,Age,13 Months,95.4,87.9 to 98.3,277
Polio,≥2 Doses,States/Local Areas,Virginia,2012,Age,13 Months,92.1,88.2 to 94.8,342
≥1 Dose Varicella,,States/Local Areas,Virginia,2013,Age,19 Months,85.8,80.4 to 89.9,357
≥1 Dose Varicella,,States/Local Areas,Virginia,2013-2014,Age,19 Months,88.4,83.5 to 92.0,708
Hep B,≥3 Doses,States/Local Areas,Virginia,2017,Age,13 Months,85.5,78.1 to 90.6,419
Hep B,≥3 Doses,States/Local Areas,Virginia,2017-2018,Age,13 Months,85.0,80.1 to 88.8,970
≥1 Dose MMR,,States/Local Areas,Virginia,2018,Age,13 Months,62.9,55.3 to 69.9,551
≥1 Dose MMR,,States/Local Areas,Virginia,2018-2019,Age,13 Months,68.7,63.5 to 73.5,1003
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,74.0,62.5 to 85.6,127
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Overall,Overall,80.0,74.4 to 85.6,1316
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,66.1,39.5 to 92.7,39
Hep B,≥1 Dose,States/Local Areas,Virginia,2016,Age,3 Months,94.9,90.3 to 97.4,389
Hep B,≥1 Dose,States/Local Areas,Virginia,2016-2017,Age,3 Months,96.1,93.4 to 97.7,808
Hep B,≥1 Dose,States/Local Areas,Virginia,2015,Age,3 Months,93.1,87.5 to 96.3,374
Hep B,≥1 Dose,States/Local Areas,Virginia,2015-2016,Age,3 Months,94.0,90.6 to 96.2,763
Hep B,≥1 Dose,States/Local Areas,Virginia,2014,Age,3 Months,91.4,84.6 to 95.4,351
Hep B,≥1 Dose,States/Local Areas,Virginia,2014-2015,Age,3 Months,92.3,88.1 to 95.1,725
Polio,≥2 Doses,States/Local Areas,Virginia,2013,Age,13 Months,91.7,89.2 to 93.7,357
Polio,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,93.5,91.3 to 95.2,708
Polio,≥2 Doses,States/Local Areas,Virginia,2017,Age,7 Months,89.3,82.0 to 93.9,419
Polio,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,7 Months,88.2,83.4 to 91.8,970
Polio,≥2 Doses,States/Local Areas,Virginia,2016,Age,7 Months,94.9,89.3 to 97.6,389
Polio,≥2 Doses,States/Local Areas,Virginia,2016-2017,Age,7 Months,92.1,87.9 to 95.0,808
Hep B,≥1 Dose,States/Local Areas,Virginia,2011,Age,3 Months,94.3,92.2 to 95.9,277
Hep B,≥1 Dose,States/Local Areas,Virginia,2012,Age,3 Months,89.6,84.0 to 93.4,342
Hep B,≥1 Dose,States/Local Areas,Virginia,2013,Age,3 Months,88.2,83.3 to 91.9,357
Hep B,≥1 Dose,States/Local Areas,Virginia,2013-2014,Age,3 Months,89.8,87.0 to 92.1,708
Polio,≥2 Doses,States/Local Areas,Virginia,2018,Age,7 Months,87.2,80.5 to 91.8,551
Polio,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,88.9,84.7 to 92.0,1003
≥1 Dose Varicella,,States/Local Areas,Virginia,2019,Age,13 Months,65.2,57.9 to 71.9,452
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,92.7,89.3 to 96.1,844
PCV,≥4 Doses,States/Local Areas,Virginia,2019,Age,19 Months,86.0,79.6 to 90.6,452
≥1 Dose MMR,,States/Local Areas,Virginia,2012,Age,24 Months,85.5,78.1 to 91.4,342
≥1 Dose Varicella,,States/Local Areas,Virginia,2011,Age,35 Months,92.6,85.9 to 96.9,277
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.6,72.1 to 87.1,673
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.4,77.1 to 89.7,829
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,82.4,74.0 to 90.7,604
Hep B,≥3 Doses,States/Local Areas,Virginia,2016,Age,13 Months,92.0,86.5 to 95.4,389
Hep B,≥3 Doses,States/Local Areas,Virginia,2016-2017,Age,13 Months,88.8,84.4 to 92.1,808
Hep B,≥3 Doses,States/Local Areas,Virginia,2015,Age,13 Months,88.4,82.0 to 92.8,374
Hep B,≥3 Doses,States/Local Areas,Virginia,2015-2016,Age,13 Months,90.2,86.2 to 93.2,763
DTaP,≥4 Doses,States/Local Areas,Virginia,2015,Age,35 Months,92.0,85.7 to 96.2,374
DTaP,≥4 Doses,States/Local Areas,Virginia,2015-2016,Age,35 Months,91.7,87.4 to 94.9,763
DTaP,≥4 Doses,States/Local Areas,Virginia,2016,Age,35 Months,90.8,84.7 to 95.2,389
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2017,Age,35 Months,87.5,82.9 to 91.3,808
DTaP,≥4 Doses,States/Local Areas,Virginia,2017,Age,35 Months,84.1,76.9 to 90.0,419
DTaP,≥4 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,88.3,83.3 to 92.4,970
Hep A,≥2 Doses,States/Local Areas,Virginia,2018,Age,35 Months,74.0,65.1 to 82.1,551
Hep A,≥2 Doses,States/Local Areas,Virginia,2018-2019,Age,35 Months,80.3,74.3 to 85.7,1003
Hep A,≥2 Doses,States/Local Areas,Virginia,2017,Age,35 Months,76.3,67.1 to 84.6,419
Hep A,≥2 Doses,States/Local Areas,Virginia,2017-2018,Age,35 Months,75.1,68.7 to 81.1,970
Hep B,≥3 Doses,States/Local Areas,Virginia,2014,Age,13 Months,86.4,78.8 to 91.6,351
Hep B,≥3 Doses,States/Local Areas,Virginia,2014-2015,Age,13 Months,87.4,82.6 to 91.1,725
Hep B,≥3 Doses,States/Local Areas,Virginia,2013,Age,13 Months,84.2,78.3 to 88.7,357
Hep B,≥3 Doses,States/Local Areas,Virginia,2013-2014,Age,13 Months,85.3,81.7 to 88.3,708
DTaP,≥4 Doses,States/Local Areas,Virginia,2013,Age,35 Months,88.4,80.0 to 94.5,357
DTaP,≥4 Doses,States/Local Areas,Virginia,2013-2014,Age,35 Months,91.6,86.4 to 95.4,708
Hep B,≥3 Doses,States/Local Areas,Virginia,2012,Age,13 Months,81.3,72.2 to 88.0,342
Hep A,≥2 Doses,States/Local Areas,Virginia,2019,Age,35 Months,88.9,79.7 to 95.2,452
DTaP,≥4 Doses,States/Local Areas,Virginia,2014,Age,35 Months,93.7,87.4 to 97.5,351
DTaP,≥4 Doses,States/Local Areas,Virginia,2014-2015,Age,35 Months,93.3,88.8 to 96.4,725
DTaP,≥4 Doses,States/Local Areas,Virginia,2012,Age,35 Months,82.7,74.1 to 89.8,342
≥1 Dose MMR,,States/Local Areas,Virginia,2014,Age,13 Months,63.5,54.0 to 72.0,351
≥1 Dose MMR,,States/Local Areas,Virginia,2014-2015,Age,13 Months,65.9,59.6 to 71.7,725
≥1 Dose MMR,,States/Local Areas,Virginia,2015,Age,13 Months,68.3,59.9 to 75.6,374
≥1 Dose MMR,,States/Local Areas,Virginia,2015-2016,Age,13 Months,65.5,59.4 to 71.2,763
≥1 Dose Varicella,,States/Local Areas,Virginia,2012,Age,19 Months,80.5,73.9 to 85.8,342
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,85.0,79.2 to 90.8,345
≥1 Dose Varicella,,States/Local Areas,Virginia,2011,Age,19 Months,87.3,82.2 to 91.1,277
≥1 Dose MMR,,States/Local Areas,Virginia,2013,Age,13 Months,38.4,33.0 to 44.2,357
≥1 Dose MMR,,States/Local Areas,Virginia,2013-2014,Age,13 Months,50.8,42.9 to 58.7,708
≥1 Dose Varicella,,States/Local Areas,Virginia,2018,Age,13 Months,54.4,47.0 to 61.7,551
≥1 Dose Varicella,,States/Local Areas,Virginia,2018-2019,Age,13 Months,59.8,54.5 to 64.8,1003
Polio,≥2 Doses,States/Local Areas,Virginia,2014,Age,7 Months,93.5,87.5 to 96.7,351
Polio,≥2 Doses,States/Local Areas,Virginia,2014-2015,Age,7 Months,93.5,89.6 to 96.0,725
Polio,≥2 Doses,States/Local Areas,Virginia,2013,Age,7 Months,88.2,81.7 to 92.6,357
Polio,≥2 Doses,States/Local Areas,Virginia,2013-2014,Age,7 Months,90.8,87.1 to 93.6,708
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Overall,Overall,88.5,85.5 to 91.5,1316
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,86.4,79.2 to 93.6,127
Hep B,≥3 Doses,States/Local Areas,Virginia,2019,Age,7 Months,42.0,34.7 to 49.6,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2011,Age,13 Months,83.3,75.5 to 89.0,277
Polio,≥2 Doses,States/Local Areas,Virginia,2015,Age,7 Months,93.5,87.8 to 96.6,374
Polio,≥2 Doses,States/Local Areas,Virginia,2015-2016,Age,7 Months,94.2,90.6 to 96.4,763
≥1 Dose Varicella,,States/Local Areas,Virginia,2017,Age,13 Months,66.8,58.3 to 74.3,419
≥1 Dose Varicella,,States/Local Areas,Virginia,2017-2018,Age,13 Months,60.6,54.8 to 66.1,970
≥1 Dose Varicella,,States/Local Areas,Virginia,2016,Age,13 Months,58.3,49.5 to 66.6,389
≥1 Dose Varicella,,States/Local Areas,Virginia,2016-2017,Age,13 Months,62.5,56.3 to 68.2,808
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,83.3 to 97.3,222
≥1 Dose Varicella,,States/Local Areas,Virginia,2015,Age,13 Months,68.2,59.8 to 75.5,374
≥1 Dose Varicella,,States/Local Areas,Virginia,2015-2016,Age,13 Months,63.2,57.1 to 69.0,763
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,87.9,76.6 to 99.1,39
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.5,81.8 to 91.1,673
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.3,83.1 to 91.5,829
Hep A,≥1 Dose,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,87.5 to 95.1,604
DTaP,≥4 Doses,States/Local Areas,Virginia,2018,Age,24 Months,81.5,74.8 to 87.4,551
DTaP,≥4 Doses,States/Local Areas,Virginia,2018-2019,Age,24 Months,83.4,78.8 to 87.4,1003
DTaP,≥4 Doses,States/Local Areas,Virginia,2017,Age,24 Months,79.5,72.1 to 86.0,419
DTaP,≥4 Doses,States/Local Areas,Virginia,2017-2018,Age,24 Months,80.5,75.5 to 85.1,970
DTaP,≥4 Doses,States/Local Areas,Virginia,2011,Age,35 Months,90.7,79.3 to 97.2,277
DTaP,≥4 Doses,States/Local Areas,Virginia,2019,Age,24 Months,85.4,79.1 to 90.5,452
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.4,65.2 to 89.6,222
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,69.4,52.5 to 86.3,172
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,96.9,90.7 to 100.0,40
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,82.0,76.5 to 87.6,1104
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,75.5,63.6 to 87.4,149
Hep A,≥2 Doses,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.4,69.5 to 100.0,93
Polio,≥2 Doses,States/Local Areas,Virginia,2019,Age,5 Months,83.1,76.1 to 88.4,452
Hep B,≥3 Doses,States/Local Areas,Virginia,2018,Age,7 Months,41.8,34.8 to 49.1,551
Hep B,≥3 Doses,States/Local Areas,Virginia,2018-2019,Age,7 Months,41.9,36.8 to 47.2,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2012,Age,13 Months,45.4,41.5 to 49.4,342
Hep B,≥2 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,92.4,89.0 to 94.7,1062
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2020-2021,Age,0-1 Days,79.0,76.3 to 81.6,2759
Rotavirus,,HHS Regions/National,Region 8,2020-2021,Age,8 Months,73.7,70.6 to 76.6,2759
Combined 7 Series,,HHS Regions/National,Region 8,2021,Age,24 Months,68.4,63.3 to 73.3,1062
Hib,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,87.2,84.7 to 89.3,2759
Hib,Primary Series,HHS Regions/National,Region 8,2020-2021,Age,19 Months,90.1,87.8 to 92.1,2759
Hib,Primary Series,HHS Regions/National,Region 8,2020-2021,Age,35 Months,91.2,88.9 to 93.1,2759
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,88.2,85.8 to 90.2,2759
PCV,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,69.6,66.4 to 72.7,2759
Influenza,,HHS Regions/National,Region 8,2016,Age,24 Months,60.3,55.9 to 64.6,1490
Influenza,,HHS Regions/National,Region 8,2016-2017,Age,24 Months,62.8,59.6 to 66.0,3133
Influenza,,HHS Regions/National,Region 8,2019,Age,24 Months,74.5,70.8 to 78.1,1623
≥1 Dose MMR,,HHS Regions/National,Region 8,2021,Age,19 Months,85.2,80.7 to 88.8,1062
≥1 Dose Varicella,,HHS Regions/National,Region 8,2021,Age,13 Months,58.6,53.2 to 63.8,1062
Polio,≥3 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,88.2,84.2 to 91.3,1062
Hib,Full Series,HHS Regions/National,Region 8,2020-2021,Age,35 Months,82.2,79.0 to 85.1,2759
Hep A,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,19 Months,82.6,79.8 to 85.0,2759
Hib,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,90.3,87.8 to 92.5,2759
Rotavirus,,HHS Regions/National,Region 8,2018,Age,8 Months,83.4,80.1 to 86.1,1790
Rotavirus,,HHS Regions/National,Region 8,2018-2019,Age,8 Months,83.2,81.0 to 85.3,3413
Rotavirus,,HHS Regions/National,Region 8,2019,Age,8 Months,83.1,79.9 to 85.9,1623
Rotavirus,,HHS Regions/National,Region 8,2017,Age,8 Months,80.4,76.4 to 83.8,1643
Rotavirus,,HHS Regions/National,Region 8,2017-2018,Age,8 Months,81.8,79.3 to 84.1,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2021,Age,13 Months,64.8,59.5 to 69.9,1062
Influenza,,HHS Regions/National,Region 8,2021,Age,24 Months,62.1,57.0 to 67.2,1062
Influenza,,HHS Regions/National,Region 8,2018,Age,24 Months,70.8,66.7 to 74.9,1790
Influenza,,HHS Regions/National,Region 8,2018-2019,Age,24 Months,72.7,69.9 to 75.4,3413
Influenza,,HHS Regions/National,Region 8,2017,Age,24 Months,65.4,60.8 to 70.0,1643
Influenza,,HHS Regions/National,Region 8,2017-2018,Age,24 Months,68.1,65.0 to 71.2,3433
Polio,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,91.4,89.2 to 93.2,2759
Polio,≥2 Doses,HHS Regions/National,Region 8,2021,Age,5 Months,77.4,72.5 to 81.6,1062
PCV,≥1 Dose,HHS Regions/National,Region 8,2021,Age,3 Months,83.2,78.4 to 87.1,1062
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,89.3,87.0 to 91.3,2759
Hib,Full Series,HHS Regions/National,Region 8,2020-2021,Age,19 Months,72.7,69.6 to 75.5,2759
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2020-2021,Age,0-2 Days,80.7,78.0 to 83.2,2759
DTaP,≥2 Doses,HHS Regions/National,Region 8,2021,Age,5 Months,77.2,72.2 to 81.5,1062
Hep B,≥3 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,86.3,81.9 to 89.8,1062
Hib,Full Series,HHS Regions/National,Region 8,2020-2021,Age,24 Months,77.5,74.6 to 80.3,2759
Polio,≥2 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,89.8,85.8 to 92.8,1062
Hib,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,56.0,52.8 to 59.1,2759
DTaP,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,5 Months,79.4,76.5 to 82.1,2759
Hib,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,74.3,71.4 to 76.9,2759
Hep B,≥1 Dose,HHS Regions/National,Region 8,2021,Age,3 Months,94.0,91.3 to 95.9,1062
PCV,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,86.9,84.4 to 89.0,2759
Hib,≥3 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,87.9,83.9 to 91.4,1062
DTaP,≥3 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,88.6,84.7 to 92.0,1062
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2021,Age,0-3 Days,81.3,76.9 to 85.1,1062
Rotavirus,,HHS Regions/National,Region 8,2021,Age,8 Months,72.8,67.6 to 77.5,1062
Hep A,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,24 Months,85.6,82.9 to 88.0,2759
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020-2021,Age,13 Months,58.8,55.5 to 62.1,2759
Hep B,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,3 Months,93.9,92.2 to 95.2,2759
PCV,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,3 Months,85.2,82.4 to 87.5,2759
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,72.5,69.4 to 75.4,2759
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,89.9,87.7 to 91.9,2759
Polio,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,90.7,88.5 to 92.6,2759
Hep A,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,79.0,75.0 to 82.7,2759
≥1 Dose MMR,,HHS Regions/National,Region 8,2020-2021,Age,19 Months,86.5,83.9 to 88.7,2759
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020-2021,Age,24 Months,87.1,84.7 to 89.3,2759
Hep A,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,46.6,43.3 to 50.1,2759
Hib,Primary Series,HHS Regions/National,Region 8,2021,Age,35 Months,88.7,84.7 to 92.0,1062
Hib,Primary Series,HHS Regions/National,Region 8,2020-2021,Age,7 Months,74.8,71.8 to 77.6,2759
Polio,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,89.7,87.5 to 91.7,2759
Hib,≥3 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,73.6,68.9 to 77.9,1062
PCV,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,90.3,88.1 to 92.3,2759
Hib,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,5 Months,77.5,74.5 to 80.2,2759
Hep B,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,5 Months,87.1,84.6 to 89.2,2759
Hib,Full Series,HHS Regions/National,Region 8,2021,Age,35 Months,79.0,73.9 to 83.6,1062
Polio,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,3 Months,86.4,83.8 to 88.7,2759
Hib,≥2 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,89.0,84.8 to 92.1,1062
≥1 Dose MMR,,HHS Regions/National,Region 8,2020-2021,Age,35 Months,90.8,88.1 to 93.2,2759
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,70.5,67.4 to 73.6,2759
PCV,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,89.1,86.8 to 91.1,2759
Influenza,,HHS Regions/National,Region 8,2020-2021,Age,24 Months,64.0,60.8 to 67.2,2759
DTaP,≥4 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,82.4,76.7 to 87.3,1062
Hib,Primary Series,HHS Regions/National,Region 8,2021,Age,13 Months,84.9,80.6 to 88.4,1062
PCV,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,91.4,89.1 to 93.4,2759
DTaP,≥3 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,89.4,85.4 to 92.7,1062
Combined 7 Series,,HHS Regions/National,Region 8,2020-2021,Age,35 Months,74.0,70.5 to 77.3,2759
Polio,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,91.4,89.2 to 93.3,2759
Combined 7 Series,,HHS Regions/National,Region 8,2020-2021,Age,24 Months,68.0,64.9 to 71.1,2759
Hib,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,3 Months,84.8,82.1 to 87.2,2759
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020-2021,Age,19 Months,85.6,83.1 to 87.8,2759
Hep B,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,90.9,88.8 to 92.5,2759
DTaP,≥4 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,69.8,66.7 to 72.8,2759
Influenza,,HHS Regions/National,Region 8,2011,Age,24 Months,57.9,53.7 to 62.2,1500
Influenza,,HHS Regions/National,Region 8,2012,Age,24 Months,56.3,52.1 to 60.6,1498
Influenza,,HHS Regions/National,Region 8,2013,Age,24 Months,54.8,50.4 to 59.3,1423
Influenza,,HHS Regions/National,Region 8,2013-2014,Age,24 Months,56.5,53.4 to 59.7,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,91.1,88.9 to 93.0,2759
PCV,≥4 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,78.4,75.6 to 81.1,2759
≥1 Dose Varicella,,HHS Regions/National,Region 8,2021,Age,35 Months,87.7,83.3 to 91.3,1062
Polio,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,88.1,85.6 to 90.2,2759
Polio,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,5 Months,78.9,76.0 to 81.6,2759
Influenza,,HHS Regions/National,Region 8,2015,Age,24 Months,60.1,55.8 to 64.4,1488
Influenza,,HHS Regions/National,Region 8,2015-2016,Age,24 Months,60.2,57.1 to 63.2,2978
Influenza,,HHS Regions/National,Region 8,2014,Age,24 Months,58.2,53.9 to 62.6,1484
Influenza,,HHS Regions/National,Region 8,2014-2015,Age,24 Months,59.1,56.1 to 62.2,2972
PCV,≥4 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,81.5,78.7 to 84.1,2759
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2020-2021,Age,0-3 Days,81.1,78.4 to 83.5,2759
Hep B,≥3 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,90.0,86.2 to 93.2,1062
Rotavirus,,HHS Regions/National,Region 8,2014,Age,8 Months,75.0,71.1 to 78.6,1484
Rotavirus,,HHS Regions/National,Region 8,2014-2015,Age,8 Months,75.2,72.5 to 77.8,2972
Rotavirus,,HHS Regions/National,Region 8,2016,Age,8 Months,75.2,71.1 to 78.9,1490
Rotavirus,,HHS Regions/National,Region 8,2016-2017,Age,8 Months,77.8,74.9 to 80.4,3133
Rotavirus,,HHS Regions/National,Region 8,2015,Age,8 Months,75.4,71.5 to 79.0,1488
Rotavirus,,HHS Regions/National,Region 8,2015-2016,Age,8 Months,75.3,72.6 to 77.9,2978
Rotavirus,,HHS Regions/National,Region 8,2013,Age,8 Months,71.2,67.0 to 75.2,1423
Rotavirus,,HHS Regions/National,Region 8,2013-2014,Age,8 Months,73.1,70.3 to 75.9,2907
Rotavirus,,HHS Regions/National,Region 8,2012,Age,8 Months,71.7,67.8 to 75.4,1498
Rotavirus,,HHS Regions/National,Region 8,2011,Age,8 Months,72.3,68.3 to 76.0,1500
Hib,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,7 Months,87.4,84.9 to 89.6,2759
Combined 7 Series,,HHS Regions/National,Region 8,2019,Age,24 Months,73.2,69.4 to 76.8,1623
Hib,Primary Series,HHS Regions/National,Region 8,2019,Age,35 Months,95.6,93.8 to 97.0,1623
Combined 7 Series,,HHS Regions/National,Region 8,2016,Age,24 Months,71.2,67.1 to 75.3,1490
Combined 7 Series,,HHS Regions/National,Region 8,2016-2017,Age,24 Months,71.5,68.5 to 74.5,3133
Hib,Primary Series,HHS Regions/National,Region 8,2017,Age,35 Months,94.2,91.6 to 96.2,1643
Hib,Primary Series,HHS Regions/National,Region 8,2017-2018,Age,35 Months,95.1,93.6 to 96.4,3433
Hib,Primary Series,HHS Regions/National,Region 8,2016,Age,24 Months,92.9,90.7 to 94.7,1490
Hib,Primary Series,HHS Regions/National,Region 8,2016-2017,Age,24 Months,93.5,91.9 to 94.9,3133
Hib,Primary Series,HHS Regions/National,Region 8,2018,Age,24 Months,95.8,93.9 to 97.3,1790
Hib,Primary Series,HHS Regions/National,Region 8,2018-2019,Age,24 Months,95.3,94.0 to 96.4,3413
Hib,Primary Series,HHS Regions/National,Region 8,2014,Age,35 Months,92.8,90.2 to 94.9,1484
Hib,Primary Series,HHS Regions/National,Region 8,2014-2015,Age,35 Months,92.2,90.3 to 93.8,2972
Hib,Primary Series,HHS Regions/National,Region 8,2012,Age,35 Months,93.6,91.0 to 95.6,1498
Hib,Primary Series,HHS Regions/National,Region 8,2019,Age,24 Months,94.8,92.9 to 96.3,1623
Hib,Primary Series,HHS Regions/National,Region 8,2011,Age,35 Months,92.4,89.7 to 94.6,1500
Hib,Primary Series,HHS Regions/National,Region 8,2013,Age,35 Months,93.2,90.3 to 95.5,1423
Hib,Primary Series,HHS Regions/National,Region 8,2013-2014,Age,35 Months,93.3,91.2 to 95.0,2907
Combined 7 Series,,HHS Regions/National,Region 8,2012,Age,24 Months,70.4,66.5 to 74.2,1498
Hib,Primary Series,HHS Regions/National,Region 8,2015,Age,35 Months,91.5,88.8 to 93.8,1488
Hib,Primary Series,HHS Regions/National,Region 8,2015-2016,Age,35 Months,92.4,90.7 to 93.9,2978
Combined 7 Series,,HHS Regions/National,Region 8,2013,Age,35 Months,74.1,69.8 to 78.1,1423
Combined 7 Series,,HHS Regions/National,Region 8,2013-2014,Age,35 Months,76.0,73.2 to 78.8,2907
Hib,Primary Series,HHS Regions/National,Region 8,2016,Age,35 Months,93.4,91.2 to 95.2,1490
Hib,Primary Series,HHS Regions/National,Region 8,2016-2017,Age,35 Months,93.8,92.2 to 95.2,3133
Hep B,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,93.1,91.6 to 94.3,3320
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,89.6,87.1 to 91.6,1697
Combined 7 Series,,HHS Regions/National,Region 8,2014,Age,35 Months,78.1,74.3 to 81.7,1484
Combined 7 Series,,HHS Regions/National,Region 8,2014-2015,Age,35 Months,77.3,74.4 to 80.1,2972
Combined 7 Series,,HHS Regions/National,Region 8,2012,Age,35 Months,76.4,72.2 to 80.3,1498
Combined 7 Series,,HHS Regions/National,Region 8,2017,Age,35 Months,78.0,73.6 to 82.1,1643
Combined 7 Series,,HHS Regions/National,Region 8,2017-2018,Age,35 Months,77.7,74.7 to 80.6,3433
Combined 7 Series,,HHS Regions/National,Region 8,2016,Age,35 Months,75.7,71.4 to 79.7,1490
Combined 7 Series,,HHS Regions/National,Region 8,2016-2017,Age,35 Months,76.8,73.7 to 79.7,3133
Hib,Primary Series,HHS Regions/National,Region 8,2019-2020,Age,7 Months,78.0,75.7 to 80.2,3320
Combined 7 Series,,HHS Regions/National,Region 8,2018,Age,24 Months,73.1,69.0 to 77.1,1790
Combined 7 Series,,HHS Regions/National,Region 8,2018-2019,Age,24 Months,73.1,70.4 to 75.9,3413
Combined 7 Series,,HHS Regions/National,Region 8,2017,Age,24 Months,71.7,67.3 to 75.9,1643
Combined 7 Series,,HHS Regions/National,Region 8,2017-2018,Age,24 Months,72.4,69.4 to 75.3,3433
Hib,Primary Series,HHS Regions/National,Region 8,2018,Age,35 Months,96.0,94.1 to 97.5,1790
Hib,Primary Series,HHS Regions/National,Region 8,2018-2019,Age,35 Months,95.8,94.5 to 96.9,3413
Combined 7 Series,,HHS Regions/National,Region 8,2015,Age,24 Months,69.5,65.4 to 73.5,1488
Combined 7 Series,,HHS Regions/National,Region 8,2015-2016,Age,24 Months,70.4,67.5 to 73.2,2978
Combined 7 Series,,HHS Regions/National,Region 8,2014,Age,24 Months,73.7,69.9 to 77.3,1484
Combined 7 Series,,HHS Regions/National,Region 8,2014-2015,Age,24 Months,71.6,68.8 to 74.3,2972
Hib,Primary Series,HHS Regions/National,Region 8,2019,Age,19 Months,94.2,92.2 to 95.7,1623
Hib,Primary Series,HHS Regions/National,Region 8,2012,Age,24 Months,92.6,90.1 to 94.7,1498
Hib,Primary Series,HHS Regions/National,Region 8,2011,Age,24 Months,92.3,89.7 to 94.5,1500
Hib,Primary Series,HHS Regions/National,Region 8,2018,Age,19 Months,95.3,93.2 to 96.8,1790
Hib,Primary Series,HHS Regions/National,Region 8,2018-2019,Age,19 Months,90.1,88.1 to 91.7,3413
Hib,Primary Series,HHS Regions/National,Region 8,2016,Age,19 Months,92.3,90.0 to 94.1,1490
Hib,Primary Series,HHS Regions/National,Region 8,2016-2017,Age,19 Months,93.0,91.3 to 94.4,3133
Hib,Primary Series,HHS Regions/National,Region 8,2012,Age,19 Months,91.9,89.3 to 94.0,1498
Combined 7 Series,,HHS Regions/National,Region 8,2011,Age,35 Months,72.0,67.6 to 76.3,1500
Hib,Primary Series,HHS Regions/National,Region 8,2018,Age,13 Months,90.8,87.8 to 93.1,1790
Hib,Primary Series,HHS Regions/National,Region 8,2018-2019,Age,13 Months,90.1,88.1 to 91.7,3413
Hib,Primary Series,HHS Regions/National,Region 8,2017,Age,13 Months,91.9,89.1 to 94.0,1643
Hib,Primary Series,HHS Regions/National,Region 8,2017-2018,Age,13 Months,91.4,89.4 to 93.0,3433
Hib,Primary Series,HHS Regions/National,Region 8,2019,Age,13 Months,89.4,86.7 to 91.6,1623
Hib,Primary Series,HHS Regions/National,Region 8,2012,Age,7 Months,72.2,67.1 to 76.8,1498
Hib,Primary Series,HHS Regions/National,Region 8,2014,Age,7 Months,75.5,71.7 to 79.0,1484
Hib,Primary Series,HHS Regions/National,Region 8,2014-2015,Age,7 Months,75.1,72.4 to 77.6,2972
Hib,Primary Series,HHS Regions/National,Region 8,2015,Age,7 Months,74.7,70.8 to 78.2,1488
Hib,Primary Series,HHS Regions/National,Region 8,2015-2016,Age,7 Months,74.3,71.4 to 76.9,2978
Hib,Primary Series,HHS Regions/National,Region 8,2013,Age,7 Months,71.6,67.9 to 74.9,1423
Hib,Primary Series,HHS Regions/National,Region 8,2013-2014,Age,7 Months,73.5,71.3 to 75.6,2907
Hib,Primary Series,HHS Regions/National,Region 8,2017,Age,19 Months,93.7,91.0 to 95.6,1643
Hib,Primary Series,HHS Regions/National,Region 8,2017-2018,Age,19 Months,94.5,92.9 to 95.8,3433
Hib,Primary Series,HHS Regions/National,Region 8,2015,Age,19 Months,90.2,88.0 to 92.1,1488
Hib,Primary Series,HHS Regions/National,Region 8,2015-2016,Age,19 Months,91.3,89.5 to 92.8,2978
Hib,Primary Series,HHS Regions/National,Region 8,2014,Age,19 Months,91.4,88.5 to 93.5,1484
Hib,Primary Series,HHS Regions/National,Region 8,2014-2015,Age,19 Months,90.8,88.8 to 92.5,2972
Hib,Primary Series,HHS Regions/National,Region 8,2013,Age,19 Months,90.2,86.7 to 92.8,1423
Hib,Primary Series,HHS Regions/National,Region 8,2013-2014,Age,19 Months,90.8,88.7 to 92.5,2907
Hib,Primary Series,HHS Regions/National,Region 8,2011,Age,19 Months,91.4,87.9 to 93.9,1500
Hib,Primary Series,HHS Regions/National,Region 8,2016,Age,13 Months,88.7,85.6 to 91.2,1490
Hib,Primary Series,HHS Regions/National,Region 8,2016-2017,Age,13 Months,90.3,88.3 to 92.0,3133
Hib,Primary Series,HHS Regions/National,Region 8,2013,Age,13 Months,87.8,83.7 to 90.9,1423
Hib,Primary Series,HHS Regions/National,Region 8,2013-2014,Age,13 Months,87.9,85.4 to 90.1,2907
Hib,Primary Series,HHS Regions/National,Region 8,2012,Age,13 Months,88.9,86.6 to 90.9,1498
Hib,Primary Series,HHS Regions/National,Region 8,2011,Age,13 Months,89.4,86.1 to 92.0,1500
Hib,Primary Series,HHS Regions/National,Region 8,2018,Age,7 Months,77.8,73.9 to 81.3,1790
Hib,Primary Series,HHS Regions/National,Region 8,2018-2019,Age,7 Months,78.6,76.0 to 81.0,3413
Hib,Primary Series,HHS Regions/National,Region 8,2013,Age,24 Months,91.3,88.7 to 93.6,1423
Hib,Primary Series,HHS Regions/National,Region 8,2013-2014,Age,24 Months,91.5,89.7 to 93.2,2907
Hib,Primary Series,HHS Regions/National,Region 8,2016,Age,7 Months,73.8,69.6 to 77.7,1490
Hib,Primary Series,HHS Regions/National,Region 8,2016-2017,Age,7 Months,77.8,75.1 to 80.4,3133
Hib,Primary Series,HHS Regions/National,Region 8,2017,Age,7 Months,82.0,78.3 to 85.1,1643
Hib,Primary Series,HHS Regions/National,Region 8,2017-2018,Age,7 Months,79.9,77.3 to 82.4,3433
Hib,Primary Series,HHS Regions/National,Region 8,2014,Age,13 Months,88.1,85.1 to 90.6,1484
Hib,Primary Series,HHS Regions/National,Region 8,2014-2015,Age,13 Months,88.4,86.3 to 90.2,2972
Hib,Primary Series,HHS Regions/National,Region 8,2015,Age,13 Months,88.6,85.7 to 91.0,1488
Hib,Primary Series,HHS Regions/National,Region 8,2015-2016,Age,13 Months,88.7,86.6 to 90.5,2978
Hib,Primary Series,HHS Regions/National,Region 8,2017,Age,24 Months,94.2,91.6 to 96.2,1643
Hib,Primary Series,HHS Regions/National,Region 8,2017-2018,Age,24 Months,95.0,93.4 to 96.3,3433
Hib,Primary Series,HHS Regions/National,Region 8,2014,Age,24 Months,91.8,89.1 to 94.0,1484
Hib,Primary Series,HHS Regions/National,Region 8,2014-2015,Age,24 Months,91.2,89.3 to 92.9,2972
Hib,Primary Series,HHS Regions/National,Region 8,2015,Age,24 Months,90.7,87.9 to 93.0,1488
Hib,Primary Series,HHS Regions/National,Region 8,2015-2016,Age,24 Months,91.8,90.0 to 93.3,2978
Combined 7 Series,,HHS Regions/National,Region 8,2013,Age,24 Months,67.9,63.7 to 72.0,1423
Combined 7 Series,,HHS Regions/National,Region 8,2013-2014,Age,24 Months,70.8,67.9 to 73.5,2907
Combined 7 Series,,HHS Regions/National,Region 8,2011,Age,24 Months,66.9,62.7 to 71.1,1500
Hib,Primary Series,HHS Regions/National,Region 8,2019,Age,7 Months,79.4,75.9 to 82.4,1623
Combined 7 Series,,States/Local Areas,Maine,2015,Age,35 Months,76.9,70.2 to 83.0,278
Combined 7 Series,,States/Local Areas,Maine,2015-2016,Age,35 Months,83.3,75.4 to 89.8,521
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,62.0,43.5 to 80.6,38
DTaP,≥4 Doses,States/Local Areas,Maine,2011,Age,19 Months,80.6,72.0 to 87.1,203
DTaP,≥4 Doses,States/Local Areas,Maine,2012,Age,19 Months,78.9,71.2 to 85.0,233
Hib,≥3 Doses,States/Local Areas,Maine,2012,Age,35 Months,98.1,95.9 to 99.2,233
Hib,≥3 Doses,States/Local Areas,Maine,2011,Age,35 Months,94.0,89.2 to 97.1,203
DTaP,≥3 Doses,States/Local Areas,Maine,2017,Age,35 Months,96.5,93.4 to 98.4,259
DTaP,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,96.8,94.6 to 98.3,510
PCV,≥2 Doses,States/Local Areas,Maine,2013,Age,5 Months,85.9,82.7 to 88.6,244
PCV,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,5 Months,79.4,75.2 to 83.0,519
PCV,≥2 Doses,States/Local Areas,Maine,2012,Age,5 Months,83.8,82.0 to 85.5,233
PCV,≥2 Doses,States/Local Areas,Maine,2011,Age,5 Months,78.7,74.5 to 82.4,203
DTaP,≥3 Doses,States/Local Areas,Maine,2015,Age,35 Months,94.6,90.8 to 97.2,278
DTaP,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,94.5,92.0 to 96.5,521
DTaP,≥3 Doses,States/Local Areas,Maine,2016,Age,35 Months,94.6,90.8 to 97.2,243
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,95.8,93.5 to 97.5,502
Hep A,≥1 Dose,States/Local Areas,Maine,2017,Age,19 Months,81.4,74.8 to 86.6,259
Hep A,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,19 Months,85.5,81.4 to 88.8,510
Hep A,≥1 Dose,States/Local Areas,Maine,2018,Age,19 Months,89.5,84.3 to 93.1,251
Hep A,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,19 Months,86.3,80.9 to 90.4,411
DTaP,≥3 Doses,States/Local Areas,Maine,2013,Age,35 Months,97.1,94.4 to 98.7,244
DTaP,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,95.3,93.1 to 97.0,519
DTaP,≥3 Doses,States/Local Areas,Maine,2012,Age,35 Months,98.7,97.1 to 99.5,233
DTaP,≥3 Doses,States/Local Areas,Maine,2011,Age,35 Months,97.8,94.3 to 99.4,203
DTaP,≥3 Doses,States/Local Areas,Maine,2014,Age,35 Months,93.5,89.7 to 96.2,275
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,94.0,91.5 to 96.0,553
Hep A,≥2 Doses,States/Local Areas,Maine,2011,Age,19 Months,28.2,18.3 to 40.8,203
Hep A,≥2 Doses,States/Local Areas,Maine,2013,Age,19 Months,19.9,17.3 to 22.8,244
Hep A,≥2 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,23.3,20.7 to 26.3,519
Hep A,≥2 Doses,States/Local Areas,Maine,2014,Age,19 Months,26.9,21.1 to 33.6,275
Hep A,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,27.3,23.1 to 32.0,553
Hep A,≥2 Doses,States/Local Areas,Maine,2012,Age,19 Months,20.6,19.3 to 22.1,233
Hib,≥3 Doses,States/Local Areas,Maine,2018,Age,24 Months,95.5,92.0 to 97.7,251
Hib,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,94.7,91.9 to 96.7,495
Hib,≥3 Doses,States/Local Areas,Maine,2019,Age,24 Months,93.9,89.3 to 97.0,244
Hep A,≥2 Doses,States/Local Areas,Maine,2015,Age,19 Months,27.8,24.2 to 31.6,278
Hep A,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,29.4,24.9 to 34.3,521
Hep A,≥2 Doses,States/Local Areas,Maine,2016,Age,19 Months,31.0,24.4 to 38.4,243
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,19 Months,29.6,25.0 to 34.7,502
Hib,≥3 Doses,States/Local Areas,Maine,2013,Age,35 Months,96.8,94.3 to 98.5,244
Hib,≥3 Doses,States/Local Areas,Maine,2013-2014,Age,35 Months,94.0,91.6 to 95.9,519
Hib,≥3 Doses,States/Local Areas,Maine,2014,Age,35 Months,91.1,86.8 to 94.4,275
Hib,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,35 Months,92.3,89.6 to 94.6,553
Hib,≥3 Doses,States/Local Areas,Maine,2015,Age,35 Months,93.6,89.8 to 96.4,278
Hib,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,35 Months,92.8,89.9 to 95.0,521
Hep A,≥2 Doses,States/Local Areas,Maine,2017,Age,19 Months,28.2,22.0 to 35.3,259
Hep A,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,19 Months,31.2,26.6 to 36.1,510
Hep A,≥1 Dose,States/Local Areas,Maine,2015,Age,24 Months,85.9,80.9 to 90.1,278
Hep A,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,24 Months,87.9,84.4 to 90.8,521
Hep A,≥1 Dose,States/Local Areas,Maine,2016,Age,24 Months,89.8,84.8 to 93.7,243
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,24 Months,87.6,83.9 to 90.8,502
PCV,≥2 Doses,States/Local Areas,Maine,2014,Age,5 Months,72.7,65.6 to 78.8,275
PCV,≥2 Doses,States/Local Areas,Maine,2014-2015,Age,5 Months,76.5,73.1 to 79.7,553
PCV,≥2 Doses,States/Local Areas,Maine,2015,Age,5 Months,80.4,74.3 to 85.4,278
PCV,≥2 Doses,States/Local Areas,Maine,2015-2016,Age,5 Months,80.8,76.4 to 84.5,521
PCV,≥2 Doses,States/Local Areas,Maine,2016,Age,5 Months,81.1,74.5 to 86.3,243
PCV,≥2 Doses,States/Local Areas,Maine,2016-2017,Age,5 Months,79.0,74.3 to 83.0,502
DTaP,≥3 Doses,States/Local Areas,Maine,2018,Age,35 Months,96.3,92.7 to 98.4,251
DTaP,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,95.8,93.2 to 97.7,495
DTaP,≥3 Doses,States/Local Areas,Maine,2019,Age,35 Months,95.4,91.0 to 98.1,244
Hep A,≥1 Dose,States/Local Areas,Maine,2017,Age,24 Months,85.3,79.5 to 90.1,259
Hep A,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,24 Months,88.1,84.5 to 91.2,510
Hep A,≥1 Dose,States/Local Areas,Maine,2018,Age,24 Months,90.7,86.1 to 94.3,251
Hep A,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,24 Months,89.9,86.5 to 92.8,495
Hep A,≥1 Dose,States/Local Areas,Maine,2019,Age,24 Months,89.1,83.7 to 93.3,244
Hep A,≥1 Dose,States/Local Areas,Maine,2011,Age,35 Months,80.1,72.9 to 86.3,203
PCV,≥2 Doses,States/Local Areas,Maine,2017,Age,5 Months,76.7,69.9 to 82.4,259
PCV,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,5 Months,81.3,76.8 to 85.1,510
Hib,≥3 Doses,States/Local Areas,Maine,2018,Age,35 Months,95.9,92.5 to 98.0,251
Hib,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,35 Months,94.9,92.2 to 97.0,495
Hep A,≥2 Doses,States/Local Areas,Maine,2012,Age,24 Months,41.6,33.7 to 50.6,233
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Uninsured,83.2,70.5 to 96.0,38
DTaP,≥4 Doses,States/Local Areas,Maine,2013,Age,19 Months,79.9,66.7 to 88.7,244
DTaP,≥4 Doses,States/Local Areas,Maine,2013-2014,Age,19 Months,78.8,70.3 to 85.4,519
DTaP,≥4 Doses,States/Local Areas,Maine,2014,Age,19 Months,77.8,71.3 to 83.1,275
DTaP,≥4 Doses,States/Local Areas,Maine,2014-2015,Age,19 Months,79.3,74.9 to 83.1,553
DTaP,≥4 Doses,States/Local Areas,Maine,2015,Age,19 Months,80.9,78.5 to 83.1,278
DTaP,≥4 Doses,States/Local Areas,Maine,2015-2016,Age,19 Months,77.5,72.7 to 81.6,521
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,92.8,89.8 to 95.8,365
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,97.3,95.9 to 98.8,530
Hib,≥3 Doses,States/Local Areas,Maine,2016,Age,35 Months,91.9,87.4 to 95.3,243
Hib,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,35 Months,93.0,90.1 to 95.4,502
Hib,≥3 Doses,States/Local Areas,Maine,2017,Age,35 Months,93.8,89.7 to 96.7,259
Hib,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,35 Months,94.9,92.3 to 96.8,510
Hep A,≥2 Doses,States/Local Areas,Maine,2018,Age,19 Months,34.0,27.5 to 41.3,251
Hep A,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,19 Months,31.1,25.6 to 37.2,411
Hep A,≥2 Doses,States/Local Areas,Maine,2019,Age,19 Months,35.7,28.8 to 43.2,244
Hep A,≥2 Doses,States/Local Areas,Maine,2011,Age,24 Months,49.0,40.5 to 58.1,203
Hep A,≥1 Dose,States/Local Areas,Maine,2019,Age,19 Months,87.0,80.8 to 91.5,244
Hep A,≥1 Dose,States/Local Areas,Maine,2011,Age,24 Months,78.5,71.4 to 84.8,203
Hep A,≥1 Dose,States/Local Areas,Maine,2013,Age,24 Months,79.6,72.5 to 85.9,244
Hep A,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,24 Months,78.5,73.8 to 82.8,519
Hep A,≥1 Dose,States/Local Areas,Maine,2014,Age,24 Months,77.3,71.1 to 83.0,275
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,24 Months,81.6,77.6 to 85.3,553
Hep A,≥1 Dose,States/Local Areas,Maine,2012,Age,24 Months,80.8,74.2 to 86.6,233
Hep A,≥1 Dose,States/Local Areas,Maine,2012,Age,35 Months,84.9,78.5 to 90.2,233
Hib,≥3 Doses,States/Local Areas,Maine,2015,Age,24 Months,93.6,89.8 to 96.4,278
Hib,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,92.8,89.9 to 95.0,521
Hib,≥3 Doses,States/Local Areas,Maine,2016,Age,24 Months,91.9,87.4 to 95.3,243
Hib,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,92.5,89.5 to 94.9,502
DTaP,≥3 Doses,States/Local Areas,Maine,2019,Age,24 Months,95.4,91.0 to 98.1,244
Hib,≥3 Doses,States/Local Areas,Maine,2017,Age,24 Months,93.0,88.9 to 96.0,259
Hib,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,94.2,91.6 to 96.2,510
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,97.2,95.1 to 99.3,245
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,92.1,88.8 to 95.4,430
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,90.3,86.7 to 94.0,275
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Overall,Overall,92.6,90.6 to 94.6,950
DTaP,≥2 Doses,States/Local Areas,Maine,2019,Age,5 Months,84.5,78.3 to 89.1,244
Polio,≥3 Doses,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,92.4,89.5 to 95.2,371
DTaP,≥2 Doses,States/Local Areas,Maine,2018,Age,5 Months,87.3,81.1 to 91.7,251
DTaP,≥2 Doses,States/Local Areas,Maine,2018-2019,Age,5 Months,85.9,81.8 to 89.3,495
DTaP,≥2 Doses,States/Local Areas,Maine,2017,Age,5 Months,81.5,74.9 to 86.6,259
DTaP,≥2 Doses,States/Local Areas,Maine,2017-2018,Age,5 Months,84.4,80.1 to 87.9,510
DTaP,≥3 Doses,States/Local Areas,Maine,2017,Age,24 Months,94.5,91.1 to 96.9,259
DTaP,≥3 Doses,States/Local Areas,Maine,2017-2018,Age,24 Months,95.4,93.1 to 97.1,510
DTaP,≥3 Doses,States/Local Areas,Maine,2018,Age,24 Months,96.3,92.7 to 98.4,251
DTaP,≥3 Doses,States/Local Areas,Maine,2018-2019,Age,24 Months,95.8,93.2 to 97.7,495
Hep A,≥1 Dose,States/Local Areas,Maine,2016,Age,19 Months,84.5,78.2 to 89.2,243
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,19 Months,83.0,78.6 to 86.6,502
Hep A,≥1 Dose,States/Local Areas,Maine,2013,Age,19 Months,76.4,72.1 to 80.3,244
Hep A,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,19 Months,74.6,71.6 to 77.5,519
DTaP,≥3 Doses,States/Local Areas,Maine,2016,Age,24 Months,94.6,90.8 to 97.2,243
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2017,Age,24 Months,94.5,92.1 to 96.4,502
DTaP,≥1 Dose,States/Local Areas,Maine,2019,Age,3 Months,93.9,89.3 to 96.6,244
Hep A,≥1 Dose,States/Local Areas,Maine,2011,Age,19 Months,71.8,62.7 to 79.3,203
DTaP,≥1 Dose,States/Local Areas,Maine,2017,Age,3 Months,90.3,85.9 to 93.5,259
DTaP,≥1 Dose,States/Local Areas,Maine,2017-2018,Age,3 Months,91.2,88.0 to 93.6,510
DTaP,≥3 Doses,States/Local Areas,Maine,2014,Age,24 Months,93.2,89.5 to 96.0,275
DTaP,≥3 Doses,States/Local Areas,Maine,2014-2015,Age,24 Months,93.9,91.4 to 95.9,553
DTaP,≥3 Doses,States/Local Areas,Maine,2015,Age,24 Months,94.6,90.8 to 97.2,278
DTaP,≥3 Doses,States/Local Areas,Maine,2015-2016,Age,24 Months,94.5,92.0 to 96.5,521
DTaP,≥1 Dose,States/Local Areas,Maine,2018,Age,3 Months,92.0,86.9 to 95.2,251
DTaP,≥1 Dose,States/Local Areas,Maine,2018-2019,Age,3 Months,92.9,89.7 to 95.2,495
Hib,Full Series,States/Local Areas,Maine,2020-2021,Age,24 Months,83.8,78.4 to 88.5,366
Hib,Full Series,States/Local Areas,Maine,2021,Age,19 Months,77.5,67.7 to 85.0,143
Combined 7 Series,,States/Local Areas,Maine,2018,Age,35 Months,84.5,78.2 to 89.8,251
Combined 7 Series,,States/Local Areas,Maine,2018-2019,Age,35 Months,81.2,76.1 to 85.8,495
Combined 7 Series,,States/Local Areas,Maine,2019,Age,35 Months,77.2,69.0 to 84.5,244
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Any Medicaid,70.2,64.7 to 75.8,365
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Insurance Coverage,Private Insurance Only,76.5,72.0 to 80.9,530
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,Hispanic,82.7,70.3 to 95.1,40
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Principal City,72.2,63.9 to 80.5,184
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.4,63.8 to 74.9,395
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.8,70.2 to 77.5,821
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.1,63.9 to 86.3,66
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Overall,Overall,72.8,69.3 to 76.3,950
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Urbanicity,Living In a Non-MSA,76.9,71.9 to 82.0,371
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Poverty,<133% FPL,65.8,59.2 to 72.3,275
Hib,Full Series,States/Local Areas,Maine,2013,Age,19 Months,83.0,81.4 to 84.5,244
Hib,Full Series,States/Local Areas,Maine,2013-2014,Age,19 Months,80.9,78.2 to 83.3,519
Hib,Full Series,States/Local Areas,Maine,2012,Age,19 Months,80.3,73.1 to 86.0,233
Hib,Full Series,States/Local Areas,Maine,2011,Age,19 Months,77.2,62.7 to 87.2,203
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Poverty,>400% FPL,80.8,74.9 to 86.7,245
Combined 7 Series,,States/Local Areas,Maine,2014-2017,Poverty,133% to <400% FPL,74.4,69.2 to 79.5,430
Hib,Full Series,States/Local Areas,Maine,2017,Age,19 Months,79.6,72.8 to 85.0,259
Hib,Full Series,States/Local Areas,Maine,2017-2018,Age,19 Months,81.2,76.8 to 85.0,510
Hib,Full Series,States/Local Areas,Maine,2019,Age,19 Months,80.8,74.3 to 86.0,244
Hib,Full Series,States/Local Areas,Maine,2015,Age,19 Months,82.5,77.4 to 86.6,278
Hib,Full Series,States/Local Areas,Maine,2015-2016,Age,19 Months,81.7,77.2 to 85.4,521
Hib,Full Series,States/Local Areas,Maine,2018,Age,19 Months,82.9,76.5 to 87.8,251
Hib,Full Series,States/Local Areas,Maine,2018-2019,Age,19 Months,93.7,90.3 to 96.0,495
Hib,Full Series,States/Local Areas,Maine,2016,Age,19 Months,80.8,74.0 to 86.2,243
Hib,Full Series,States/Local Areas,Maine,2016-2017,Age,19 Months,80.2,75.5 to 84.2,502
Hib,Full Series,States/Local Areas,Maine,2014,Age,19 Months,78.8,72.4 to 84.0,275
Hib,Full Series,States/Local Areas,Maine,2014-2015,Age,19 Months,80.6,76.3 to 84.3,553
Hib,Primary Series,States/Local Areas,Maine,2012,Age,19 Months,96.0,93.0 to 97.8,233
Hib,Full Series,States/Local Areas,Maine,2014,Age,24 Months,83.2,77.6 to 88.0,275
Hib,Full Series,States/Local Areas,Maine,2014-2015,Age,24 Months,84.1,80.1 to 87.6,553
Hib,Full Series,States/Local Areas,Maine,2013,Age,24 Months,86.1,79.8 to 91.2,244
Hib,Full Series,States/Local Areas,Maine,2013-2014,Age,24 Months,84.7,80.6 to 88.3,519
Hib,Full Series,States/Local Areas,Maine,2011,Age,24 Months,81.0,73.7 to 87.3,203
Hib,Full Series,States/Local Areas,Maine,2012,Age,24 Months,85.2,78.7 to 90.5,233
Hib,Primary Series,States/Local Areas,Maine,2016,Age,13 Months,90.2,84.9 to 93.8,243
Hib,Primary Series,States/Local Areas,Maine,2016-2017,Age,13 Months,89.2,85.6 to 91.9,502
Hib,Primary Series,States/Local Areas,Maine,2017,Age,13 Months,88.1,82.7 to 92.0,259
Hib,Primary Series,States/Local Areas,Maine,2017-2018,Age,13 Months,90.3,86.9 to 93.0,510
Hib,Primary Series,States/Local Areas,Maine,2019,Age,13 Months,91.2,85.9 to 94.6,244
Hib,Primary Series,States/Local Areas,Maine,2017,Age,19 Months,91.8,87.0 to 95.0,259
Hib,Primary Series,States/Local Areas,Maine,2017-2018,Age,19 Months,93.9,91.0 to 95.9,510
Hib,Primary Series,States/Local Areas,Maine,2013,Age,19 Months,94.8,93.1 to 96.0,244
Hib,Primary Series,States/Local Areas,Maine,2013-2014,Age,19 Months,92.5,90.6 to 94.0,519
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.9 to 99.8,63
Hib,Full Series,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,84.2,72.7 to 95.7,42
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,75.5,69.0 to 82.0,231
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,81.7,76.9 to 86.5,349
Hib,Primary Series,States/Local Areas,Maine,2016,Age,24 Months,93.8,90.0 to 96.5,243
Hib,Primary Series,States/Local Areas,Maine,2016-2017,Age,24 Months,93.9,91.4 to 95.9,502
Hib,Primary Series,States/Local Areas,Maine,2015,Age,35 Months,93.7,89.9 to 96.5,278
Hib,Primary Series,States/Local Areas,Maine,2015-2016,Age,35 Months,93.7,91.2 to 95.8,521
Hib,Primary Series,States/Local Areas,Maine,2017,Age,35 Months,94.7,91.1 to 97.1,259
Hib,Primary Series,States/Local Areas,Maine,2017-2018,Age,35 Months,95.5,93.2 to 97.2,510
Combined 7 Series,,States/Local Areas,Maine,2012,Age,24 Months,75.2,67.7 to 82.2,233
Combined 7 Series,,States/Local Areas,Maine,2013,Age,24 Months,73.8,66.4 to 80.8,244
Combined 7 Series,,States/Local Areas,Maine,2013-2014,Age,24 Months,71.7,66.7 to 76.5,519
Hib,Primary Series,States/Local Areas,Maine,2016,Age,35 Months,93.8,90.0 to 96.5,243
Hib,Primary Series,States/Local Areas,Maine,2016-2017,Age,35 Months,94.4,91.9 to 96.3,502
Hib,Primary Series,States/Local Areas,Maine,2011,Age,35 Months,94.0,89.2 to 97.1,203
Hib,Primary Series,States/Local Areas,Maine,2014,Age,35 Months,91.4,87.2 to 94.6,275
Hib,Primary Series,States/Local Areas,Maine,2014-2015,Age,35 Months,92.5,89.8 to 94.8,553
Hib,Primary Series,States/Local Areas,Maine,2012,Age,35 Months,97.8,95.5 to 99.1,233
Hib,Primary Series,States/Local Areas,Maine,2013,Age,35 Months,96.8,94.3 to 98.5,244
Hib,Primary Series,States/Local Areas,Maine,2013-2014,Age,35 Months,94.1,91.8 to 96.0,519
Combined 7 Series,,States/Local Areas,Maine,2011,Age,24 Months,72.2,64.5 to 79.4,203
Hib,Primary Series,States/Local Areas,Maine,2019,Age,24 Months,94.2,89.5 to 97.2,244
Hep B,≥1 Dose,States/Local Areas,Maine,2021,Age,3 Months,92.9,86.1 to 96.5,143
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,98.9,97.8 to 100.0,269
Hep B,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,58.0,52.5 to 63.3,467
Hep B,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,91.7,87.9 to 94.4,467
Combined 7 Series,,States/Local Areas,Maine,2019,Age,24 Months,73.3,66.0 to 80.2,244
Hib,Primary Series,States/Local Areas,Maine,2014,Age,7 Months,75.5,69.0 to 81.0,275
Hib,Primary Series,States/Local Areas,Maine,2014-2015,Age,7 Months,76.0,71.5 to 79.9,553
Hib,Primary Series,States/Local Areas,Maine,2015,Age,7 Months,76.5,70.2 to 81.9,278
Hib,Primary Series,States/Local Areas,Maine,2015-2016,Age,7 Months,73.9,69.0 to 78.2,521
Hib,Primary Series,States/Local Areas,Maine,2014,Age,13 Months,87.0,81.7 to 90.9,275
Hib,Primary Series,States/Local Areas,Maine,2014-2015,Age,13 Months,88.4,85.0 to 91.2,553
Hib,Primary Series,States/Local Areas,Maine,2015,Age,13 Months,89.8,84.9 to 93.3,278
Hib,Primary Series,States/Local Areas,Maine,2015-2016,Age,13 Months,90.0,86.6 to 92.6,521
Hib,Primary Series,States/Local Areas,Maine,2016,Age,7 Months,71.2,63.6 to 77.8,243
Hib,Primary Series,States/Local Areas,Maine,2016-2017,Age,7 Months,72.5,67.5 to 77.0,502
Hib,Primary Series,States/Local Areas,Maine,2017,Age,7 Months,73.9,67.0 to 79.8,259
Hib,Primary Series,States/Local Areas,Maine,2017-2018,Age,7 Months,74.5,69.7 to 78.7,510
Hib,Primary Series,States/Local Areas,Maine,2019,Age,19 Months,93.8,88.7 to 96.7,244
Hib,Primary Series,States/Local Areas,Maine,2018,Age,7 Months,75.0,68.2 to 80.8,251
Hib,Primary Series,States/Local Areas,Maine,2018-2019,Age,7 Months,75.9,71.2 to 80.0,495
Hib,Primary Series,States/Local Areas,Maine,2013,Age,13 Months,90.9,89.0 to 92.4,244
Hib,Primary Series,States/Local Areas,Maine,2013-2014,Age,13 Months,89.0,87.5 to 90.3,519
Hib,Primary Series,States/Local Areas,Maine,2012,Age,13 Months,91.9,88.3 to 94.4,233
Hib,Primary Series,States/Local Areas,Maine,2011,Age,13 Months,92.7,88.7 to 95.4,203
Hib,Primary Series,States/Local Areas,Maine,2011,Age,19 Months,94.0,87.5 to 97.2,203
Hib,Primary Series,States/Local Areas,Maine,2018,Age,13 Months,92.5,87.4 to 95.7,251
Hib,Primary Series,States/Local Areas,Maine,2018-2019,Age,13 Months,91.9,88.4 to 94.3,495
Hib,Primary Series,States/Local Areas,Maine,2014,Age,19 Months,90.1,85.5 to 93.4,275
Hib,Primary Series,States/Local Areas,Maine,2014-2015,Age,19 Months,91.9,89.0 to 94.2,553
Hib,Primary Series,States/Local Areas,Maine,2018,Age,19 Months,95.9,91.9 to 98.0,251
Hib,Primary Series,States/Local Areas,Maine,2018-2019,Age,19 Months,91.9,88.4 to 94.3,495
Hib,Primary Series,States/Local Areas,Maine,2019,Age,7 Months,76.8,70.1 to 82.4,244
Hib,Primary Series,States/Local Areas,Maine,2012,Age,24 Months,97.4,95.1 to 98.8,233
Hib,Primary Series,States/Local Areas,Maine,2011,Age,24 Months,94.0,89.2 to 97.1,203
Hib,Primary Series,States/Local Areas,Maine,2013,Age,24 Months,96.8,94.3 to 98.5,244
Hib,Primary Series,States/Local Areas,Maine,2013-2014,Age,24 Months,94.1,91.8 to 96.0,519
Hib,Primary Series,States/Local Areas,Maine,2015,Age,19 Months,93.7,90.0 to 96.1,278
Hib,Primary Series,States/Local Areas,Maine,2015-2016,Age,19 Months,93.2,90.3 to 95.3,521
Hib,Primary Series,States/Local Areas,Maine,2016,Age,19 Months,92.7,88.1 to 95.6,243
Hib,Primary Series,States/Local Areas,Maine,2016-2017,Age,19 Months,92.3,89.2 to 94.6,502
Combined 7 Series,,States/Local Areas,Maine,2017,Age,35 Months,74.9,68.1 to 81.2,259
Combined 7 Series,,States/Local Areas,Maine,2017-2018,Age,35 Months,79.6,75.0 to 83.8,510
Combined 7 Series,,States/Local Areas,Maine,2016,Age,35 Months,87.0,76.6 to 94.3,243
Combined 7 Series,,States/Local Areas,Maine,2016-2017,Age,35 Months,80.5,74.4 to 85.9,502
Hib,Primary Series,States/Local Areas,Maine,2014,Age,24 Months,91.4,87.2 to 94.6,275
Hib,Primary Series,States/Local Areas,Maine,2014-2015,Age,24 Months,92.5,89.8 to 94.8,553
Hib,Primary Series,States/Local Areas,Maine,2015,Age,24 Months,93.7,89.9 to 96.5,278
Hib,Primary Series,States/Local Areas,Maine,2015-2016,Age,24 Months,93.7,91.2 to 95.8,521
Hib,Primary Series,States/Local Areas,Maine,2018,Age,24 Months,95.9,92.3 to 98.1,251
Hib,Primary Series,States/Local Areas,Maine,2018-2019,Age,24 Months,95.1,92.3 to 97.1,495
Hib,Primary Series,States/Local Areas,Maine,2017,Age,24 Months,94.0,90.4 to 96.5,259
Hib,Primary Series,States/Local Areas,Maine,2017-2018,Age,24 Months,95.0,92.7 to 96.8,510
Combined 7 Series,,States/Local Areas,Maine,2012,Age,35 Months,79.1,71.2 to 86.0,233
Combined 7 Series,,States/Local Areas,Maine,2013,Age,35 Months,76.3,68.9 to 83.0,244
Combined 7 Series,,States/Local Areas,Maine,2013-2014,Age,35 Months,75.3,70.3 to 80.1,519
Combined 7 Series,,States/Local Areas,Maine,2014,Age,35 Months,74.7,67.8 to 81.1,275
Combined 7 Series,,States/Local Areas,Maine,2014-2015,Age,35 Months,75.8,71.0 to 80.3,553
Hib,Primary Series,States/Local Areas,Maine,2013,Age,7 Months,73.5,68.1 to 78.3,244
Hib,Primary Series,States/Local Areas,Maine,2013-2014,Age,7 Months,74.5,72.0 to 76.8,519
Combined 7 Series,,States/Local Areas,Maine,2014,Age,24 Months,69.4,62.8 to 75.8,275
Combined 7 Series,,States/Local Areas,Maine,2014-2015,Age,24 Months,71.7,67.0 to 76.2,553
Hib,Primary Series,States/Local Areas,Maine,2019,Age,35 Months,94.2,89.5 to 97.2,244
Combined 7 Series,,States/Local Areas,Maine,2016,Age,24 Months,74.9,67.6 to 81.6,243
Combined 7 Series,,States/Local Areas,Maine,2016-2017,Age,24 Months,74.1,69.2 to 78.8,502
Hib,Primary Series,States/Local Areas,Maine,2018,Age,35 Months,95.9,92.3 to 98.1,251
Hib,Primary Series,States/Local Areas,Maine,2018-2019,Age,35 Months,95.1,92.3 to 97.1,495
Combined 7 Series,,States/Local Areas,Maine,2015,Age,24 Months,73.9,67.2 to 80.2,278
Combined 7 Series,,States/Local Areas,Maine,2015-2016,Age,24 Months,74.4,69.5 to 79.1,521
Combined 7 Series,,States/Local Areas,Maine,2018,Age,24 Months,80.9,74.8 to 86.4,251
Combined 7 Series,,States/Local Areas,Maine,2018-2019,Age,24 Months,77.5,72.7 to 82.0,495
Combined 7 Series,,States/Local Areas,Maine,2017,Age,24 Months,73.4,66.6 to 79.8,259
Combined 7 Series,,States/Local Areas,Maine,2017-2018,Age,24 Months,77.2,72.6 to 81.4,510
Hib,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,97.3,95.1 to 98.5,366
DTaP,≥3 Doses,States/Local Areas,Maine,2020,Age,13 Months,95.2,90.0 to 97.8,223
PCV,≥3 Doses,States/Local Areas,Maine,2020,Age,7 Months,79.1,71.2 to 85.2,223
Rotavirus,,States/Local Areas,Maine,2019-2020,Age,8 Months,76.3,71.1 to 80.9,467
Hep B,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,94.7,91.2 to 97.1,366
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,87.8 to 94.6,403
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.0,80.4 to 89.5,403
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,86.5,82.0 to 91.1,349
Influenza,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,83.0,76.3 to 89.7,162
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.7,68.2 to 79.2,403
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,79.1,73.7 to 84.6,349
Influenza,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.5,65.1 to 76.0,403
Rotavirus,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.7,70.4 to 81.0,403
Rotavirus,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,79.6,72.1 to 87.1,162
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,93.3,88.7 to 97.8,162
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,86.1,81.7 to 90.5,349
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.7,84.8 to 92.5,403
Hib,Full Series,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,85.6,79.5 to 91.8,162
Hib,Full Series,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.3,77.4 to 87.2,403
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,82.7,75.8 to 89.6,349
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.2 to 96.3,403
Hib,Full Series,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,87.4,83.2 to 91.6,349
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,86.2,77.6 to 94.8,162
Rotavirus,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,80.7,76.0 to 85.5,349
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.9,70.4 to 83.4,403
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,92.9 to 98.9,162
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.1 to 96.6,403
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,94.0,91.1 to 96.8,349
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,90.0,84.8 to 95.2,162
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,87.5,83.3 to 91.6,349
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.7,77.8 to 87.6,403
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,86.0 to 95.6,162
Influenza,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,67.7,61.3 to 74.1,349
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,96.3,93.5 to 99.2,162
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.9,89.6 to 96.2,403
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,94.3,91.5 to 97.0,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,72.8 to 86.9,162
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,77.4,70.0 to 84.8,162
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,71.9,65.9 to 77.8,349
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,95.3,92.9 to 97.8,414
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,99.1,98.0 to 100.0,269
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,94.2,91.5 to 96.9,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.9,71.8 to 82.0,403
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Overall,Overall,76.2,72.7 to 79.7,914
Hib,Full Series,States/Local Areas,Maine,2016-2019,Overall,Overall,84.7,81.8 to 87.7,914
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,92.1,89.2 to 95.1,414
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,96.4,94.3 to 98.5,269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,72.9,66.3 to 79.5,231
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,64.4,57.0 to 71.8,231
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,95.7,93.2 to 98.1,414
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,79.0,74.0 to 83.9,414
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,99.4,98.5 to 100.0,269
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Overall,Overall,92.4,90.3 to 94.4,914
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,84.7,79.4 to 90.1,269
Rotavirus,,States/Local Areas,Maine,2016-2019,Overall,Overall,78.3,75.0 to 81.6,914
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,81.0,76.7 to 85.4,914
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,85.6,80.5 to 90.6,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Overall,Overall,75.7,72.2 to 79.1,914
Influenza,,States/Local Areas,Maine,2016-2019,Overall,Overall,71.7,68.1 to 75.3,914
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,84.7,79.1 to 90.2,231
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,94.4,91.6 to 97.2,414
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,80.2,73.7 to 86.7,414
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,91.2,86.1 to 96.4,269
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,81.0,74.9 to 87.1,231
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,85.6,82.7 to 88.4,914
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,89.7,86.3 to 93.2,414
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Overall,Overall,93.0,90.9 to 95.0,914
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,92.6,90.5 to 94.8,914
Rotavirus,,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,88.9,84.7 to 93.1,269
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Overall,Overall,88.7,86.2 to 91.2,914
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,94.1,92.2 to 95.9,914
Influenza,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,70.2,53.7 to 86.8,42
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,95.2,88.3 to 100.0,42
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,89.4,85.7 to 93.2,349
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,97.0,94.9 to 99.1,522
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,83.3,70.1 to 96.5,32
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,78.6 to 96.8,63
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,84.6,73.4 to 95.7,42
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,86.2 to 98.0,63
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.0 to 98.0,522
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,75.6,68.0 to 83.1,349
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,86.6,82.1 to 91.0,522
Hib,≥1 Dose,States/Local Areas,Maine,2020,Age,3 Months,89.1,82.0 to 93.6,223
Polio,≥1 Dose,States/Local Areas,Maine,2020,Age,3 Months,89.5,82.4 to 94.0,223
Hep B,≥3 Doses,States/Local Areas,Maine,2020,Age,7 Months,67.1,59.4 to 74.0,223
Hep B,≥3 Doses,States/Local Areas,Maine,2020,Age,24 Months,94.8,90.7 to 97.5,223
Hep B,≥1 Dose,States/Local Areas,Maine,2020,Age,3 Months,95.6,90.9 to 97.9,223
PCV,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,95.5,93.0 to 97.4,467
Hep B,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,92.5,89.0 to 95.2,467
≥1 Dose Varicella,,States/Local Areas,Maine,2019-2020,Age,24 Months,94.4,91.8 to 96.3,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2019-2020,Age,0-3 Days,84.3,80.0 to 87.9,467
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2019-2020,Age,0-2 Days,82.0,77.4 to 85.9,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,79.1,74.9 to 83.3,522
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.6 to 98.7,63
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,93.8,87.4 to 100.0,42
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.6,89.3 to 93.9,780
Hep A,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,19 Months,89.2,85.2 to 92.3,467
PCV,≥4 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,86.5,82.2 to 89.9,467
≥1 Dose Varicella,,States/Local Areas,Maine,2019-2020,Age,19 Months,93.7,90.7 to 95.7,467
Hep B,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,92.2,88.5 to 94.8,467
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2019-2020,Age,0-1 Days,74.3,69.1 to 78.9,467
Hib,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,61.1,55.6 to 66.3,467
Combined 7 Series,,States/Local Areas,Maine,2019-2020,Age,35 Months,79.7,74.5 to 84.5,467
Hib,Full Series,States/Local Areas,Maine,2019-2020,Age,24 Months,86.1,82.0 to 89.6,467
Hib,Primary Series,States/Local Areas,Maine,2019-2020,Age,24 Months,95.1,92.3 to 97.2,467
Influenza,,States/Local Areas,Maine,2019-2020,Age,24 Months,72.6,67.3 to 77.7,467
Hep A,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,88.6,82.8 to 93.1,467
Hep A,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,35 Months,94.3,90.0 to 97.1,467
Hep A,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,24 Months,90.2,86.5 to 93.3,467
Polio,≥2 Doses,States/Local Areas,Maine,2020,Age,13 Months,98.2,95.9 to 99.2,223
Hep A,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,62.0,56.4 to 67.7,467
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,61.1,40.8 to 81.3,32
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,71.7,66.2 to 77.3,349
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,92.7 to 96.7,780
Influenza,,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,87.9,83.2 to 92.7,269
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,74.1,67.3 to 80.8,231
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,95.5,93.1 to 97.9,269
Hib,Full Series,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,88.7,84.9 to 92.5,414
Hib,Full Series,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,72.8,66.0 to 79.6,231
Hib,Full Series,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,91.0,86.5 to 95.4,269
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,87.9,83.0 to 92.7,231
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,85.8,82.9 to 88.7,914
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,85.7,80.5 to 90.8,231
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,88.3,84.3 to 92.3,414
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,94.1,90.1 to 98.0,269
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,86.0,81.0 to 91.1,231
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,93.8,91.1 to 96.6,414
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,96.9,94.9 to 98.9,269
Influenza,,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,58.6,50.9 to 66.3,231
Influenza,,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,71.2,65.8 to 76.6,414
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,91.3,89.2 to 93.4,914
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Overall,Overall,94.8,93.0 to 96.5,914
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,89.5,85.0 to 94.0,231
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,94.2,91.3 to 97.1,414
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,99.1,98.1 to 100.0,269
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,74.4,65.2 to 83.5,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,74.9,69.7 to 80.1,414
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,80.3,74.2 to 86.3,269
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,89.6,86.0 to 93.2,414
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Poverty,>400% FPL,91.6,87.3 to 95.8,269
Rotavirus,,States/Local Areas,Maine,2016-2019,Poverty,133% to <400% FPL,81.2,76.7 to 85.8,414
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,87.1 to 96.5,162
Rotavirus,,States/Local Areas,Maine,2016-2019,Poverty,<133% FPL,64.6,57.2 to 71.9,231
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,92.2,87.7 to 96.7,162
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,93.5,90.5 to 96.6,349
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.5 to 95.6,403
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,92.4,89.4 to 95.3,349
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,91.1,87.5 to 94.7,522
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,98.2,94.7 to 100.0,42
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.9 to 99.8,63
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.5,83.4 to 89.6,780
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,78.6,63.8 to 93.3,32
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,91.8,88.6 to 95.1,349
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,96.7,94.6 to 98.8,522
Hib,Full Series,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.4,82.2 to 88.6,780
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,76.3,61.3 to 91.3,32
Hib,Full Series,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,79.8,74.8 to 84.7,349
Hib,Full Series,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,79.5,65.1 to 93.8,32
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,91.2,81.0 to 100.0,42
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,82.3,68.9 to 95.7,32
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,89.7,86.2 to 93.1,349
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,81.3,67.5 to 95.2,32
DTaP,≥4 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,80.6,75.8 to 85.5,349
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,73.6,54.8 to 92.4,32
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,93.3,90.7 to 95.9,522
PCV,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.6,91.4 to 95.7,780
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,90.7,80.1 to 100.0,42
Influenza,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,80.7,76.5 to 84.9,522
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.0,91.9 to 96.1,780
Influenza,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.8,61.2 to 86.4,63
Influenza,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.8,66.9 to 74.7,780
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,85.4,73.3 to 97.4,42
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,66.0,46.4 to 85.7,32
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.7,83.6 to 89.8,780
Rotavirus,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.7,63.7 to 87.7,63
Rotavirus,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,73.8,58.6 to 89.1,42
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.1,67.7 to 90.5,63
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,83.4,70.3 to 96.5,32
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.1,73.3 to 80.8,780
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,74.5,59.2 to 89.9,42
Rotavirus,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,72.2,66.7 to 77.7,349
Rotavirus,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,71.2,54.7 to 87.8,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.1,55.1 to 83.0,63
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,57.9,35.7 to 80.0,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,78.9,64.9 to 92.9,42
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,98.2,94.7 to 100.0,42
Influenza,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,51.7,30.5 to 73.0,32
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,77.4 to 94.6,63
Influenza,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,62.6,56.5 to 68.6,349
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,92.9,89.9 to 95.9,349
Rotavirus,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,85.1,81.2 to 88.9,522
Polio,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,84.5,71.9 to 97.2,32
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,97.2,95.2 to 99.3,522
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,90.3,86.9 to 93.7,349
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,82.0 to 98.9,63
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,Hispanic,89.7,78.3 to 100.0,42
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Insurance Coverage,Uninsured,52.5,30.9 to 74.0,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Insurance Coverage,Any Medicaid,74.3,69.0 to 79.7,349
Hep A,≥1 Dose,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,86.1 to 91.6,780
Combined 7 Series,,States/Local Areas,Maine,2016-2019,Insurance Coverage,Private Insurance Only,81.9,77.5 to 86.3,522
≥1 Dose Varicella,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,91.0 to 95.2,780
Rotavirus,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.0,76.6 to 83.5,780
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,91.7 to 95.9,780
Hep A,≥2 Doses,States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.0,75.5 to 84.6,780
PCV,≥3 Doses,States/Local Areas,Maine,2020,Age,35 Months,99.4,97.9 to 99.9,223
Hib,Full Series,States/Local Areas,Maine,2020,Age,19 Months,86.3,80.1 to 90.8,223
Hep B,≥3 Doses,States/Local Areas,Maine,2020,Age,19 Months,94.3,89.7 to 96.9,223
≥1 Dose Varicella,,States/Local Areas,Maine,2020,Age,19 Months,94.6,90.6 to 97.0,223
PCV,≥3 Doses,States/Local Areas,Maine,2020,Age,19 Months,97.5,93.7 to 99.1,223
DTaP,≥4 Doses,States/Local Areas,Maine,2020,Age,35 Months,95.5,89.4 to 98.7,223
Polio,≥3 Doses,States/Local Areas,Maine,2020,Age,35 Months,98.4,95.7 to 99.6,223
PCV,≥4 Doses,States/Local Areas,Maine,2020,Age,19 Months,90.2,83.8 to 94.2,223
≥1 Dose MMR,,States/Local Areas,Maine,2020,Age,35 Months,96.2,92.9 to 98.3,223
Hep A,≥1 Dose,States/Local Areas,Maine,2020,Age,19 Months,91.1,85.1 to 94.8,223
PCV,≥4 Doses,States/Local Areas,Maine,2020,Age,35 Months,92.1,86.3 to 96.1,223
Hib,≥3 Doses,States/Local Areas,Maine,2020,Age,13 Months,78.4,71.4 to 84.0,223
Hep B,≥2 Doses,States/Local Areas,Maine,2020,Age,13 Months,94.8,90.2 to 97.3,223
Hib,Primary Series,States/Local Areas,Maine,2020,Age,13 Months,93.7,89.1 to 96.4,223
Hep B,≥3 Doses,States/Local Areas,Maine,2020,Age,13 Months,93.0,88.4 to 95.8,223
≥1 Dose Varicella,,States/Local Areas,Maine,2020,Age,13 Months,58.7,50.7 to 66.2,223
PCV,≥3 Doses,States/Local Areas,Maine,2020,Age,13 Months,94.6,88.5 to 97.5,223
DTaP,≥3 Doses,States/Local Areas,Maine,2020,Age,7 Months,78.5,70.6 to 84.7,223
Polio,≥2 Doses,States/Local Areas,Maine,2020,Age,7 Months,95.4,90.1 to 97.9,223
PCV,≥2 Doses,States/Local Areas,Maine,2020,Age,5 Months,87.2,79.7 to 92.1,223
DTaP,≥3 Doses,States/Local Areas,Maine,2020,Age,19 Months,96.7,92.7 to 98.5,223
DTaP,≥4 Doses,States/Local Areas,Maine,2020,Age,19 Months,85.1,78.5 to 89.9,223
≥1 Dose MMR,,States/Local Areas,Maine,2020,Age,19 Months,94.9,91.3 to 97.1,223
Polio,≥3 Doses,States/Local Areas,Maine,2020,Age,19 Months,96.7,92.7 to 98.5,223
Influenza,,States/Local Areas,Maine,2020,Age,24 Months,73.3,65.6 to 80.5,223
Hib,Primary Series,States/Local Areas,Maine,2020,Age,19 Months,95.7,91.5 to 97.9,223
Hib,≥3 Doses,States/Local Areas,Maine,2020,Age,19 Months,95.2,90.9 to 97.5,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2020,Age,0-3 Days,84.9,78.5 to 89.6,223
Rotavirus,,States/Local Areas,Maine,2020,Age,8 Months,79.1,71.2 to 85.2,223
PCV,≥3 Doses,States/Local Areas,Maine,2020,Age,24 Months,97.5,94.3 to 99.2,223
DTaP,≥3 Doses,States/Local Areas,Maine,2020,Age,35 Months,98.4,95.7 to 99.6,223
PCV,≥4 Doses,States/Local Areas,Maine,2020,Age,24 Months,90.9,85.1 to 95.1,223
Hep A,≥1 Dose,States/Local Areas,Maine,2020,Age,24 Months,91.3,85.9 to 95.3,223
Combined 7 Series,,States/Local Areas,Maine,2020,Age,24 Months,80.3,73.6 to 86.3,223
Hep A,≥2 Doses,States/Local Areas,Maine,2020,Age,24 Months,66.4,58.3 to 74.3,223
PCV,≥1 Dose,States/Local Areas,Maine,2020,Age,3 Months,90.6,83.6 to 94.8,223
DTaP,≥2 Doses,States/Local Areas,Maine,2020,Age,5 Months,87.3,79.9 to 92.2,223
Polio,≥2 Doses,States/Local Areas,Maine,2020,Age,5 Months,86.5,79.2 to 91.6,223
Hib,≥2 Doses,States/Local Areas,Maine,2020,Age,5 Months,86.3,78.9 to 91.3,223
Hep B,≥2 Doses,States/Local Areas,Maine,2020,Age,5 Months,92.5,87.4 to 95.7,223
Combined 7 Series,,States/Local Areas,Maine,2020,Age,35 Months,82.9,76.1 to 88.7,223
≥1 Dose MMR,,States/Local Areas,Maine,2020,Age,13 Months,73.7,66.5 to 79.9,223
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maine,2020,Age,0-1 Days,75.3,67.7 to 81.6,223
Hep A,≥2 Doses,States/Local Areas,Maine,2020,Age,19 Months,34.5,27.4 to 42.4,223
DTaP,≥1 Dose,States/Local Areas,Maine,2020,Age,3 Months,90.1,83.1 to 94.4,223
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2020,Age,0-2 Days,82.7,75.9 to 87.9,223
Hib,≥2 Doses,States/Local Areas,Maine,2020,Age,7 Months,94.8,89.4 to 97.5,223
Hib,≥3 Doses,States/Local Areas,Maine,2020,Age,7 Months,61.3,53.2 to 68.8,223
Hib,Primary Series,States/Local Areas,Maine,2020,Age,7 Months,78.0,70.2 to 84.2,223
Hep B,≥2 Doses,States/Local Areas,Maine,2020,Age,7 Months,93.0,87.9 to 96.1,223
DTaP,≥3 Doses,States/Local Areas,Maine,2020,Age,24 Months,96.7,93.2 to 98.7,223
Polio,≥3 Doses,States/Local Areas,Maine,2020,Age,24 Months,96.7,93.2 to 98.7,223
DTaP,≥4 Doses,States/Local Areas,Maine,2020,Age,24 Months,92.4,87.7 to 95.7,223
≥1 Dose MMR,,States/Local Areas,Maine,2020,Age,24 Months,95.6,92.3 to 97.7,223
Hib,≥3 Doses,States/Local Areas,Maine,2020,Age,24 Months,95.6,91.8 to 97.9,223
Hib,≥3 Doses,States/Local Areas,Maine,2020,Age,35 Months,97.4,94.3 to 99.1,223
Hib,Primary Series,States/Local Areas,Maine,2020,Age,24 Months,96.1,92.4 to 98.3,223
Hib,Primary Series,States/Local Areas,Maine,2020,Age,35 Months,97.7,94.8 to 99.2,223
Hib,Full Series,States/Local Areas,Maine,2020,Age,35 Months,88.4,82.8 to 92.8,223
Hep B,≥3 Doses,States/Local Areas,Maine,2020,Age,35 Months,96.3,92.0 to 98.6,223
≥1 Dose Varicella,,States/Local Areas,Maine,2020,Age,35 Months,95.1,91.3 to 97.6,223
PCV,≥4 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,88.4,84.5 to 91.6,467
Hib,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,3 Months,91.6,87.6 to 94.4,467
Hib,≥3 Doses,States/Local Areas,Maine,2021,Age,19 Months,93.9,88.1 to 96.9,143
Polio,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,3 Months,91.7,87.7 to 94.5,467
DTaP,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,3 Months,92.1,88.1 to 94.8,467
Hib,Primary Series,States/Local Areas,Maine,2019-2020,Age,7 Months,77.1,72.1 to 81.5,467
DTaP,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,93.9,90.6 to 96.1,467
PCV,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,76.4,71.2 to 80.9,467
Polio,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,95.4,92.3 to 97.2,467
DTaP,≥4 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,82.4,77.7 to 86.2,467
Hib,Primary Series,States/Local Areas,Maine,2021,Age,19 Months,95.1,89.6 to 97.8,143
≥1 Dose MMR,,States/Local Areas,Maine,2019-2020,Age,35 Months,96.3,93.6 to 98.1,467
DTaP,≥4 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,94.4,88.3 to 97.9,467
Polio,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,97.1,94.5 to 98.7,467
Combined 7 Series,,States/Local Areas,Maine,2019-2020,Age,24 Months,76.8,71.8 to 81.5,467
DTaP,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,97.2,94.5 to 98.8,467
DTaP,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,95.4,92.4 to 97.3,467
PCV,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,92.6,88.8 to 95.2,467
≥1 Dose Varicella,,States/Local Areas,Maine,2019-2020,Age,13 Months,58.8,53.3 to 64.1,467
Hep B,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,89.9,86.0 to 92.8,467
Hib,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,93.7,90.3 to 96.0,467
DTaP,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,77.6,72.5 to 81.9,467
Polio,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,7 Months,94.0,90.7 to 96.2,467
PCV,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,5 Months,86.1,81.6 to 89.7,467
Hep B,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,5 Months,91.4,87.6 to 94.1,467
Hib,Primary Series,States/Local Areas,Maine,2019-2020,Age,13 Months,92.4,89.1 to 94.8,467
Hep B,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,93.7,90.2 to 96.0,467
Hib,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,96.5,93.9 to 98.0,467
Hib,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,78.1,73.5 to 82.2,467
≥1 Dose MMR,,States/Local Areas,Maine,2019-2020,Age,13 Months,71.7,66.5 to 76.3,467
Polio,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,13 Months,96.8,94.3 to 98.3,467
Hib,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,5 Months,85.2,80.6 to 88.8,467
Polio,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,5 Months,85.2,80.6 to 88.9,467
DTaP,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,5 Months,85.7,81.1 to 89.3,467
PCV,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,3 Months,92.0,88.1 to 94.7,467
≥1 Dose MMR,,States/Local Areas,Maine,2019-2020,Age,24 Months,94.7,92.0 to 96.7,467
Hep B,≥1 Dose,States/Local Areas,Maine,2019-2020,Age,3 Months,94.7,91.3 to 96.8,467
Hib,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,94.7,91.9 to 96.8,467
Polio,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,96.0,93.3 to 97.8,467
DTaP,≥4 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,87.8,83.7 to 91.2,467
DTaP,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,24 Months,96.0,93.4 to 97.8,467
PCV,≥4 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,90.0,86.0 to 93.3,467
PCV,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,97.5,94.9 to 98.9,467
≥1 Dose Varicella,,States/Local Areas,Maine,2019-2020,Age,35 Months,95.4,92.8 to 97.3,467
Hib,Primary Series,States/Local Areas,Maine,2019-2020,Age,35 Months,96.2,93.4 to 98.0,467
Hib,Full Series,States/Local Areas,Maine,2019-2020,Age,35 Months,87.7,83.5 to 91.2,467
Hep B,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,93.7,90.1 to 96.4,467
Hib,Full Series,States/Local Areas,Maine,2019-2020,Age,19 Months,83.4,79.0 to 87.0,467
Hib,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,35 Months,95.9,93.1 to 97.8,467
Hib,Primary Series,States/Local Areas,Maine,2019-2020,Age,19 Months,94.8,91.7 to 96.8,467
Hib,≥3 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,94.0,90.9 to 96.1,467
≥1 Dose MMR,,States/Local Areas,Maine,2019-2020,Age,19 Months,93.1,90.1 to 95.2,467
Hep A,≥2 Doses,States/Local Areas,Maine,2019-2020,Age,19 Months,35.1,30.0 to 40.5,467
Hep A,≥1 Dose,States/Local Areas,Maine,2012,Age,19 Months,76.8,73.6 to 79.8,233
Hep B,≥3 Doses,States/Local Areas,Maine,2021,Age,19 Months,91.0,84.1 to 95.0,143
Hep A,≥1 Dose,States/Local Areas,Maine,2014,Age,19 Months,72.8,66.0 to 78.7,275
Hep A,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,19 Months,77.6,73.2 to 81.5,553
Hep A,≥1 Dose,States/Local Areas,Maine,2015,Age,19 Months,82.5,79.3 to 85.2,278
Hep A,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,19 Months,83.5,79.4 to 86.9,521
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maine,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,73.3 to 80.5,780
DTaP,≥1 Dose,States/Local Areas,Maine,2012,Age,3 Months,92.7,90.4 to 94.5,233
DTaP,≥1 Dose,States/Local Areas,Maine,2011,Age,3 Months,91.0,83.9 to 95.1,203
DTaP,≥1 Dose,States/Local Areas,Maine,2013,Age,3 Months,92.5,89.9 to 94.4,244
DTaP,≥1 Dose,States/Local Areas,Maine,2013-2014,Age,3 Months,92.0,89.9 to 93.8,519
DTaP,≥1 Dose,States/Local Areas,Maine,2014,Age,3 Months,91.6,86.8 to 94.7,275
DTaP,≥1 Dose,States/Local Areas,Maine,2014-2015,Age,3 Months,91.1,87.9 to 93.6,553
DTaP,≥1 Dose,States/Local Areas,Maine,2015,Age,3 Months,90.7,85.8 to 94.0,278
DTaP,≥1 Dose,States/Local Areas,Maine,2015-2016,Age,3 Months,90.5,87.0 to 93.0,521
DTaP,≥1 Dose,States/Local Areas,Maine,2016,Age,3 Months,90.2,84.9 to 93.8,243
DTaP,≥1 Dose,States/Local Areas,Maine,2016-2017,Age,3 Months,90.3,87.0 to 92.8,502
Combined 7 Series,,States/Local Areas,Maine,2021,Age,35 Months,74.8,63.5 to 84.8,143
≥1 Dose Varicella,,States/Local Areas,Maine,2021,Age,19 Months,86.1,77.7 to 91.7,143
PCV,≥3 Doses,States/Local Areas,Maine,2021,Age,35 Months,94.6,89.5 to 97.8,143
≥1 Dose Varicella,,States/Local Areas,Maine,2020-2021,Age,13 Months,54.3,47.9 to 60.5,366
Polio,≥3 Doses,States/Local Areas,Maine,2021,Age,19 Months,93.1,86.5 to 96.5,143
PCV,≥2 Doses,States/Local Areas,Maine,2021,Age,5 Months,82.5,73.7 to 88.9,143
Polio,≥2 Doses,States/Local Areas,Maine,2021,Age,7 Months,92.0,85.2 to 95.9,143
DTaP,≥3 Doses,States/Local Areas,Maine,2021,Age,7 Months,71.1,61.6 to 79.1,143
Hep B,≥2 Doses,States/Local Areas,Maine,2021,Age,7 Months,89.9,82.9 to 94.2,143
Hep A,≥1 Dose,States/Local Areas,Maine,2020-2021,Age,24 Months,86.0,80.3 to 90.8,366
≥1 Dose MMR,,States/Local Areas,Maine,2021,Age,35 Months,93.7,87.1 to 97.6,143
Hib,≥2 Doses,States/Local Areas,Maine,2021,Age,7 Months,92.8,86.1 to 96.4,143
Hib,Primary Series,States/Local Areas,Maine,2020-2021,Age,24 Months,96.3,93.8 to 97.9,366
Hep B,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,91.4,87.5 to 94.2,366
Hib,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,95.7,93.1 to 97.5,366
PCV,≥4 Doses,States/Local Areas,Maine,2020-2021,Age,24 Months,87.1,82.3 to 91.2,366
Hib,≥3 Doses,States/Local Areas,Maine,2021,Age,7 Months,62.4,52.4 to 71.4,143
Combined 7 Series,,States/Local Areas,Maine,2011,Age,35 Months,74.9,67.2 to 82.0,203
Polio,≥3 Doses,States/Local Areas,Maine,2021,Age,24 Months,94.4,89.2 to 97.6,143
Polio,≥1 Dose,States/Local Areas,Maine,2021,Age,3 Months,88.9,80.5 to 94.0,143
≥1 Dose MMR,,States/Local Areas,Maine,2021,Age,24 Months,93.0,86.6 to 97.0,143
Hib,≥3 Doses,States/Local Areas,Maine,2021,Age,24 Months,95.7,91.6 to 98.2,143
Hib,Primary Series,States/Local Areas,Maine,2021,Age,24 Months,96.5,92.6 to 98.6,143
Hib,≥1 Dose,States/Local Areas,Maine,2021,Age,3 Months,91.2,84.3 to 95.2,143
DTaP,≥4 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,92.3,82.4 to 97.7,366
Hib,Full Series,States/Local Areas,Maine,2021,Age,24 Months,79.5,70.4 to 87.3,143
DTaP,≥4 Doses,States/Local Areas,Maine,2021,Age,19 Months,77.6,68.0 to 85.0,143
Hep B,≥3 Doses,States/Local Areas,Maine,2021,Age,24 Months,92.4,86.7 to 96.3,143
PCV,≥3 Doses,States/Local Areas,Maine,2021,Age,19 Months,93.3,86.8 to 96.8,143
Hep B,≥2 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,94.8,91.5 to 96.9,366
Hep A,≥1 Dose,States/Local Areas,Maine,2021,Age,35 Months,82.6,72.6 to 90.6,143
≥1 Dose Varicella,,States/Local Areas,Maine,2020-2021,Age,35 Months,92.9,88.7 to 95.9,366
Hib,Primary Series,States/Local Areas,Maine,2021,Age,7 Months,73.7,63.9 to 81.6,143
PCV,≥4 Doses,States/Local Areas,Maine,2021,Age,19 Months,82.5,73.7 to 88.8,143
Hep A,≥2 Doses,States/Local Areas,Maine,2021,Age,35 Months,69.2,55.9 to 81.5,143
DTaP,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a Non-MSA,95.9,93.8 to 98.1,349
≥1 Dose MMR,,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,84.2 to 95.9,162
PCV,≥4 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Principal City,85.3,79.1 to 91.6,162
Hep B,≥3 Doses,States/Local Areas,Maine,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,87.2 to 94.1,403
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maine,2021,Age,0-2 Days,79.8,70.5 to 86.7,143
Hep B,≥3 Doses,States/Local Areas,Maine,2021,Age,7 Months,58.1,48.2 to 67.3,143
≥1 Dose Varicella,,States/Local Areas,Maine,2021,Age,24 Months,87.8,80.4 to 93.4,143
PCV,≥3 Doses,States/Local Areas,Maine,2021,Age,24 Months,94.6,89.5 to 97.8,143
Hib,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,13 Months,79.3,73.6 to 84.0,366
PCV,≥4 Doses,States/Local Areas,Maine,2021,Age,24 Months,83.5,75.5 to 90.0,143
Hep A,≥1 Dose,States/Local Areas,Maine,2021,Age,24 Months,81.0,71.2 to 89.0,143
Hep A,≥2 Doses,States/Local Areas,Maine,2021,Age,24 Months,46.0,36.0 to 57.2,143
DTaP,≥3 Doses,States/Local Areas,Maine,2021,Age,19 Months,94.4,88.7 to 97.3,143
PCV,≥3 Doses,States/Local Areas,Maine,2021,Age,7 Months,70.7,61.1 to 78.7,143
Combined 7 Series,,States/Local Areas,Maine,2021,Age,24 Months,68.5,59.0 to 77.6,143
PCV,≥3 Doses,States/Local Areas,Maine,2020-2021,Age,35 Months,97.8,94.8 to 99.2,366
Polio,≥2 Doses,States/Local Areas,Maine,2021,Age,13 Months,94.9,89.1 to 97.7,143
DTaP,≥3 Doses,States/Local Areas,Maine,2021,Age,13 Months,90.4,82.5 to 95.0,143
Hep A,≥1 Dose,States/Local Areas,Maine,2021,Age,19 Months,78.9,68.3 to 86.7,143
DTaP,≥1 Dose,States/Local Areas,Maine,2021,Age,3 Months,88.9,80.5 to 94.0,143
Hep A,≥2 Doses,States/Local Areas,Maine,2021,Age,19 Months,27.6,19.9 to 36.9,143
PCV,≥4 Doses,States/Local Areas,Maine,2021,Age,35 Months,85.3,76.9 to 91.9,143
DTaP,≥4 Doses,States/Local Areas,Maine,2021,Age,24 Months,80.1,71.3 to 87.6,143
Influenza,,States/Local Areas,Ohio,2011,Age,24 Months,48.6,40.7 to 57.2,229
Influenza,,States/Local Areas,Ohio,2012,Age,24 Months,56.3,47.4 to 65.6,239
Influenza,,States/Local Areas,Ohio,2015,Age,24 Months,47.2,40.1 to 54.9,292
Influenza,,States/Local Areas,Ohio,2015-2016,Age,24 Months,51.7,46.3 to 57.3,575
Influenza,,States/Local Areas,Ohio,2014,Age,24 Months,54.7,46.3 to 63.6,232
Influenza,,States/Local Areas,Ohio,2014-2015,Age,24 Months,50.8,45.2 to 56.7,524
Influenza,,States/Local Areas,Ohio,2013,Age,24 Months,50.4,42.1 to 59.4,207
Influenza,,States/Local Areas,Ohio,2013-2014,Age,24 Months,52.5,46.4 to 58.9,439
Hep B,≥1 Dose,States/Local Areas,Ohio,2021,Age,3 Months,93.9,88.2 to 96.9,275
PCV,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,19 Months,92.0,88.9 to 94.3,868
DTaP,≥4 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,82.0,77.6 to 86.0,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2021,Age,35 Months,90.2,84.1 to 94.7,275
Polio,≥3 Doses,States/Local Areas,Ohio,2021,Age,35 Months,94.2,87.7 to 97.9,275
Rotavirus,,States/Local Areas,Ohio,2020-2021,Age,8 Months,74.9,70.1 to 79.3,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,92.0,88.9 to 94.5,759
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2020-2021,Age,0-3 Days,84.8,80.9 to 88.1,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,93.4,90.2 to 95.8,759
Hib,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,91.4,88.2 to 94.0,759
Combined 7 Series,,States/Local Areas,Ohio,2021,Age,24 Months,71.0,63.2 to 78.4,275
Hib,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,89.9,86.1 to 92.7,759
Hep A,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,48.3,43.2 to 53.8,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2020-2021,Age,24 Months,88.9,85.3 to 92.0,759
Hep B,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,5 Months,88.0,84.0 to 91.1,759
Hib,Full Series,States/Local Areas,Ohio,2021,Age,35 Months,78.5,71.0 to 85.2,275
Combined 7 Series,,States/Local Areas,Ohio,2020-2021,Age,24 Months,69.9,65.1 to 74.5,759
Hib,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,3 Months,81.5,77.1 to 85.2,759
Polio,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,92.7,89.4 to 95.2,759
Hib,Primary Series,States/Local Areas,Ohio,2020-2021,Age,13 Months,85.0,81.0 to 88.3,759
Combined 7 Series,,States/Local Areas,Ohio,2020-2021,Age,35 Months,74.3,69.1 to 79.2,759
Polio,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,5 Months,77.3,72.4 to 81.5,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2021,Age,35 Months,94.6,88.4 to 98.0,275
Polio,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,87.3,83.2 to 90.5,759
Hep B,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,90.4,86.8 to 93.1,759
≥1 Dose MMR,,States/Local Areas,Ohio,2020-2021,Age,35 Months,92.0,88.4 to 94.9,759
PCV,≥4 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,82.8,78.5 to 86.8,759
PCV,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,91.5,88.0 to 94.3,759
Hib,Primary Series,States/Local Areas,Ohio,2021,Age,13 Months,85.9,79.3 to 90.6,275
PCV,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,90.6,87.0 to 93.4,759
Hep B,≥3 Doses,States/Local Areas,Ohio,2021,Age,35 Months,96.2,91.4 to 98.7,275
DTaP,≥4 Doses,States/Local Areas,Ohio,2021,Age,35 Months,88.9,79.3 to 95.3,275
Influenza,,States/Local Areas,Ohio,2020-2021,Age,24 Months,56.4,51.3 to 61.6,759
Hep B,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,57.7,52.6 to 62.6,759
PCV,≥4 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,79.3,74.7 to 83.3,759
Hep B,≥2 Doses,States/Local Areas,Ohio,2021,Age,13 Months,94.1,89.7 to 96.7,275
Hib,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,61.4,56.3 to 66.2,759
Hep A,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,24 Months,86.2,82.0 to 89.8,759
≥1 Dose MMR,,States/Local Areas,Ohio,2021,Age,13 Months,66.7,58.6 to 74.0,275
Polio,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,3 Months,84.2,79.9 to 87.8,759
Hep A,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,35 Months,80.3,74.2 to 85.7,759
Hep B,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,3 Months,94.3,91.3 to 96.4,759
PCV,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,3 Months,84.2,79.9 to 87.7,759
Influenza,,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,69.8,61.5 to 78.1,283
Hib,≥2 Doses,States/Local Areas,Ohio,2021,Age,13 Months,91.2,85.4 to 94.9,275
Hib,≥3 Doses,States/Local Areas,Ohio,2021,Age,35 Months,91.0,85.7 to 95.0,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Ohio,2021,Age,0-3 Days,85.6,79.2 to 90.3,275
Hib,Primary Series,States/Local Areas,Ohio,2020-2021,Age,7 Months,69.2,64.3 to 73.8,759
Hib,Primary Series,States/Local Areas,Ohio,2021,Age,35 Months,92.1,87.2 to 95.6,275
PCV,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,88.1,84.1 to 91.1,759
DTaP,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,5 Months,78.3,73.5 to 82.4,759
Polio,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,91.5,88.4 to 94.1,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,70.0,65.0 to 74.6,759
Rotavirus,,States/Local Areas,Ohio,2021,Age,8 Months,75.3,67.1 to 82.0,275
Hib,≥3 Doses,States/Local Areas,Ohio,2021,Age,13 Months,79.9,72.4 to 85.7,275
DTaP,≥4 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,72.2,67.2 to 76.7,759
Polio,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,90.4,86.8 to 93.0,759
PCV,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,90.8,87.3 to 93.6,759
Influenza,,States/Local Areas,Ohio,2019,Age,24 Months,66.4,59.2 to 73.6,384
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.7,69.9 to 93.5,91
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,88.8,84.8 to 92.9,757
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,81.6,76.6 to 86.6,412
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.8,73.4 to 84.2,891
Influenza,,States/Local Areas,Ohio,2018,Age,24 Months,64.5,57.7 to 71.2,406
Influenza,,States/Local Areas,Ohio,2018-2019,Age,24 Months,65.6,60.6 to 70.5,790
Influenza,,States/Local Areas,Ohio,2017,Age,24 Months,50.8,43.2 to 59.0,283
Influenza,,States/Local Areas,Ohio,2017-2018,Age,24 Months,57.7,52.4 to 63.0,689
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.0,64.5 to 85.4,138
Influenza,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,40.1,29.3 to 51.0,159
Influenza,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,55.8,49.3 to 62.2,423
Influenza,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,54.7,48.0 to 61.3,391
Influenza,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",54.2,49.2 to 59.2,669
Influenza,,States/Local Areas,Ohio,2021,Age,24 Months,51.9,43.7 to 60.5,275
Hib,Full Series,States/Local Areas,Ohio,2020-2021,Age,24 Months,77.3,72.8 to 81.6,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2020-2021,Age,13 Months,60.4,55.4 to 65.3,759
Influenza,,States/Local Areas,Ohio,2016,Age,24 Months,56.4,48.4 to 64.6,283
Influenza,,States/Local Areas,Ohio,2016-2017,Age,24 Months,53.6,48.0 to 59.4,566
Influenza,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,63.0,57.2 to 68.9,554
Influenza,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,43.2,36.9 to 49.5,386
Influenza,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",38.4,27.3 to 49.5,104
Influenza,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",57.0,44.5 to 69.5,111
Influenza,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,59.9,43.5 to 76.3,89
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,87.3,83.1 to 91.6,757
Influenza,,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,56.4,49.6 to 63.1,353
Influenza,,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,40.6,33.8 to 47.4,337
Influenza,,States/Local Areas,Ohio,2014-2017,Overall,Overall,52.5,48.2 to 56.7,973
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,84.0,79.6 to 88.4,757
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Private Insurance Only,92.7,89.0 to 96.4,757
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,61.4 to 90.7,138
Hib,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,86.5,82.3 to 89.9,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2021,Age,24 Months,91.3,86.0 to 95.2,275
≥1 Dose MMR,,States/Local Areas,Ohio,2020-2021,Age,19 Months,88.1,84.3 to 91.0,759
Hep A,≥1 Dose,States/Local Areas,Ohio,2020-2021,Age,19 Months,81.9,77.2 to 85.8,759
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.8,78.6 to 96.9,138
PCV,≥4 Doses,States/Local Areas,Ohio,2016-2019,Insurance Coverage,Any Medicaid,74.9,69.3 to 80.5,412
DTaP,≥4 Doses,States/Local Areas,Ohio,2016-2019,Poverty,133% to <400% FPL,78.5,72.8 to 84.1,467
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,88.0,77.7 to 98.2,90
Hib,Full Series,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,76.9,64.3 to 89.5,90
Hep A,≥2 Doses,States/Local Areas,Ohio,2016-2019,Race and Ethnicity,Hispanic,80.1,62.4 to 97.8,90
Hep B,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,24 Months,91.4,88.5 to 93.8,759
Hib,Primary Series,States/Local Areas,Ohio,2020-2021,Age,35 Months,92.5,89.6 to 94.9,759
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Ohio,2020-2021,Age,0-1 Days,79.2,74.8 to 83.0,759
Hib,Primary Series,States/Local Areas,Ohio,2020-2021,Age,19 Months,91.7,88.4 to 94.1,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2020-2021,Age,19 Months,86.8,82.8 to 90.0,759
DTaP,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,87.8,83.9 to 90.9,759
Polio,≥3 Doses,States/Local Areas,Ohio,2021,Age,19 Months,88.5,82.1 to 92.8,275
Hep A,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,31.3,27.0 to 35.9,759
PCV,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,7 Months,68.1,63.1 to 72.8,759
≥1 Dose MMR,,States/Local Areas,Ohio,2021,Age,19 Months,88.6,82.0 to 93.0,275
Hep B,≥2 Doses,States/Local Areas,Ohio,2021,Age,5 Months,87.1,80.1 to 91.9,275
Hib,Full Series,States/Local Areas,Ohio,2020-2021,Age,35 Months,78.2,73.6 to 82.5,759
Hep B,≥3 Doses,States/Local Areas,Ohio,2020-2021,Age,19 Months,90.9,87.8 to 93.2,759
≥1 Dose MMR,,States/Local Areas,Ohio,2020-2021,Age,13 Months,67.7,62.8 to 72.3,759
Hib,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,5 Months,75.1,70.3 to 79.3,759
≥1 Dose Varicella,,States/Local Areas,Ohio,2021,Age,13 Months,61.4,53.3 to 68.9,275
Polio,≥2 Doses,States/Local Areas,Ohio,2021,Age,5 Months,76.1,67.9 to 82.7,275
Hep B,≥3 Doses,States/Local Areas,Ohio,2021,Age,13 Months,87.7,81.3 to 92.1,275
PCV,≥1 Dose,States/Local Areas,Ohio,2021,Age,3 Months,86.2,79.1 to 91.2,275
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Ohio,2020-2021,Age,0-2 Days,84.0,80.0 to 87.3,759
Polio,≥2 Doses,States/Local Areas,Ohio,2020-2021,Age,13 Months,91.7,88.4 to 94.2,759
Hib,Full Series,States/Local Areas,Ohio,2020-2021,Age,19 Months,72.5,67.7 to 76.9,759
DTaP,≥2 Doses,States/Local Areas,Ohio,2021,Age,5 Months,77.9,69.8 to 84.4,275
Hep B,≥2 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,91.5,88.4 to 93.8,868
PCV,≥3 Doses,States/Local Areas,Ohio,2016-2019,Poverty,>400% FPL,95.9,90.2 to 100.0,420
Hep B,≥3 Doses,States/Local Areas,Ohio,2019-2020,Age,7 Months,58.3,53.7 to 62.8,868
Rotavirus,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,63.4,49.2 to 77.5,89
Rotavirus,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,66.9,61.0 to 72.7,386
Rotavirus,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.9,47.5 to 70.4,104
Rotavirus,,States/Local Areas,Ohio,2017,Age,8 Months,75.0,66.7 to 81.8,283
Rotavirus,,States/Local Areas,Ohio,2017-2018,Age,8 Months,72.8,67.5 to 77.6,689
Rotavirus,,States/Local Areas,Ohio,2019,Age,8 Months,77.4,70.4 to 83.1,384
Rotavirus,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,76.3,70.7 to 82.0,554
Rotavirus,,States/Local Areas,Ohio,2018,Age,8 Months,70.6,63.6 to 76.8,406
Rotavirus,,States/Local Areas,Ohio,2018-2019,Age,8 Months,74.0,69.1 to 78.3,790
Rotavirus,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.4,61.9 to 84.8,111
Rotavirus,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,69.4,63.1 to 75.6,391
Rotavirus,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.0,69.3 to 78.8,669
Rotavirus,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,74.8,66.7 to 83.0,159
Rotavirus,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.8,63.5 to 76.1,423
Rotavirus,,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,61.9,55.3 to 68.5,337
Rotavirus,,States/Local Areas,Ohio,2014-2017,Overall,Overall,70.5,66.6 to 74.5,973
Rotavirus,,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,75.8,69.5 to 82.1,353
Rotavirus,,States/Local Areas,Ohio,2014,Age,8 Months,72.0,64.1 to 78.7,232
Rotavirus,,States/Local Areas,Ohio,2014-2015,Age,8 Months,69.0,63.7 to 73.9,524
Rotavirus,,States/Local Areas,Ohio,2011,Age,8 Months,67.5,59.3 to 74.8,229
Rotavirus,,States/Local Areas,Ohio,2012,Age,8 Months,77.2,69.5 to 83.4,239
Rotavirus,,States/Local Areas,Ohio,2013,Age,8 Months,71.6,63.0 to 78.8,207
Rotavirus,,States/Local Areas,Ohio,2013-2014,Age,8 Months,71.8,65.9 to 77.0,439
Rotavirus,,States/Local Areas,Ohio,2016,Age,8 Months,71.9,64.1 to 78.7,283
Rotavirus,,States/Local Areas,Ohio,2016-2017,Age,8 Months,73.5,67.9 to 78.4,566
Rotavirus,,States/Local Areas,Ohio,2015,Age,8 Months,66.1,58.8 to 72.7,292
Rotavirus,,States/Local Areas,Ohio,2015-2016,Age,8 Months,69.0,63.7 to 73.9,575
Hib,Primary Series,States/Local Areas,Ohio,2017,Age,19 Months,86.4,78.4 to 91.7,283
Hib,Primary Series,States/Local Areas,Ohio,2017-2018,Age,19 Months,88.6,84.2 to 91.9,689
DTaP,≥3 Doses,States/Local Areas,Ohio,2017,Age,35 Months,90.1,82.2 to 95.5,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2017-2018,Age,35 Months,92.6,88.3 to 95.7,689
PCV,≥2 Doses,States/Local Areas,Ohio,2013,Age,5 Months,67.0,60.7 to 72.7,207
PCV,≥2 Doses,States/Local Areas,Ohio,2013-2014,Age,5 Months,71.0,68.7 to 73.1,439
PCV,≥2 Doses,States/Local Areas,Ohio,2012,Age,5 Months,76.1,71.7 to 80.0,239
PCV,≥2 Doses,States/Local Areas,Ohio,2011,Age,5 Months,66.7,58.8 to 73.8,229
DTaP,≥3 Doses,States/Local Areas,Ohio,2015,Age,35 Months,89.8,85.0 to 93.6,292
DTaP,≥3 Doses,States/Local Areas,Ohio,2015-2016,Age,35 Months,91.7,88.4 to 94.4,575
DTaP,≥3 Doses,States/Local Areas,Ohio,2016,Age,35 Months,93.9,88.9 to 97.2,283
DTaP,≥3 Doses,States/Local Areas,Ohio,2016-2017,Age,35 Months,91.6,87.2 to 94.9,566
Hib,Primary Series,States/Local Areas,Ohio,2016,Age,19 Months,92.3,86.7 to 95.6,283
Hib,Primary Series,States/Local Areas,Ohio,2016-2017,Age,19 Months,89.3,84.7 to 92.7,566
Hib,Primary Series,States/Local Areas,Ohio,2019,Age,19 Months,92.4,87.8 to 95.4,384
Hib,Primary Series,States/Local Areas,Ohio,2018,Age,19 Months,90.8,86.3 to 94.0,406
Hib,Primary Series,States/Local Areas,Ohio,2018-2019,Age,19 Months,85.1,81.1 to 88.4,790
Hib,Primary Series,States/Local Areas,Ohio,2013,Age,19 Months,90.9,87.2 to 93.7,207
Hib,Primary Series,States/Local Areas,Ohio,2013-2014,Age,19 Months,90.7,89.3 to 91.9,439
Hib,Primary Series,States/Local Areas,Ohio,2011,Age,19 Months,90.7,86.8 to 93.6,229
Hib,Primary Series,States/Local Areas,Ohio,2014,Age,19 Months,90.4,85.0 to 93.9,232
Hib,Primary Series,States/Local Areas,Ohio,2014-2015,Age,19 Months,88.4,84.7 to 91.3,524
DTaP,≥4 Doses,States/Local Areas,Ohio,2011,Age,19 Months,63.8,56.5 to 70.4,229
DTaP,≥4 Doses,States/Local Areas,Ohio,2012,Age,19 Months,80.8,73.9 to 86.1,239
Hib,Primary Series,States/Local Areas,Ohio,2015,Age,19 Months,86.4,84.5 to 88.2,292
Hib,Primary Series,States/Local Areas,Ohio,2015-2016,Age,19 Months,89.3,85.6 to 92.2,575
Hib,Primary Series,States/Local Areas,Ohio,2012,Age,24 Months,95.6,92.0 to 97.9,239
Hib,Primary Series,States/Local Areas,Ohio,2011,Age,24 Months,91.2,85.1 to 95.5,229
Hib,Primary Series,States/Local Areas,Ohio,2017,Age,13 Months,84.5,76.6 to 90.1,283
Hib,Primary Series,States/Local Areas,Ohio,2017-2018,Age,13 Months,84.7,80.1 to 88.4,689
Hib,Primary Series,States/Local Areas,Ohio,2014,Age,7 Months,67.7,59.3 to 75.0,232
Hib,Primary Series,States/Local Areas,Ohio,2014-2015,Age,7 Months,64.7,59.3 to 69.8,524
Hib,Primary Series,States/Local Areas,Ohio,2015,Age,7 Months,61.8,54.6 to 68.5,292
Hib,Primary Series,States/Local Areas,Ohio,2015-2016,Age,7 Months,63.2,57.8 to 68.3,575
Hib,Primary Series,States/Local Areas,Ohio,2018,Age,13 Months,84.8,79.4 to 89.0,406
Hib,Primary Series,States/Local Areas,Ohio,2018-2019,Age,13 Months,85.1,81.1 to 88.4,790
Hib,Primary Series,States/Local Areas,Ohio,2019,Age,13 Months,85.4,79.0 to 90.1,384
Hib,Primary Series,States/Local Areas,Ohio,2013,Age,7 Months,58.6,54.9 to 62.2,207
Hib,Primary Series,States/Local Areas,Ohio,2013-2014,Age,7 Months,63.1,59.0 to 67.1,439
Hib,Primary Series,States/Local Areas,Ohio,2016,Age,24 Months,92.8,87.7 to 96.3,283
Hib,Primary Series,States/Local Areas,Ohio,2016-2017,Age,24 Months,89.6,85.3 to 93.1,566
Hib,Primary Series,States/Local Areas,Ohio,2016,Age,13 Months,86.7,80.0 to 91.3,283
Hib,Primary Series,States/Local Areas,Ohio,2016-2017,Age,13 Months,85.6,80.6 to 89.5,566
Hib,Primary Series,States/Local Areas,Ohio,2016,Age,7 Months,64.6,56.3 to 72.0,283
Hib,Primary Series,States/Local Areas,Ohio,2016-2017,Age,7 Months,67.5,61.8 to 72.8,566
Hib,Primary Series,States/Local Areas,Ohio,2017,Age,7 Months,70.4,62.2 to 77.5,283
Hib,Primary Series,States/Local Areas,Ohio,2017-2018,Age,7 Months,68.4,63.0 to 73.2,689
Hib,Primary Series,States/Local Areas,Ohio,2018,Age,7 Months,66.2,59.2 to 72.6,406
Hib,Primary Series,States/Local Areas,Ohio,2018-2019,Age,7 Months,64.3,59.3 to 69.0,790
Hib,≥3 Doses,States/Local Areas,Ohio,2012,Age,35 Months,95.6,92.0 to 97.9,239
Hib,≥3 Doses,States/Local Areas,Ohio,2011,Age,35 Months,91.1,85.0 to 95.4,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2019,Age,19 Months,84.8,78.5 to 89.4,384
Hep A,≥1 Dose,States/Local Areas,Ohio,2011,Age,24 Months,73.9,66.3 to 80.9,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2013,Age,24 Months,78.4,70.4 to 85.4,207
Hep A,≥1 Dose,States/Local Areas,Ohio,2013-2014,Age,24 Months,79.4,74.1 to 84.3,439
Hep A,≥1 Dose,States/Local Areas,Ohio,2012,Age,24 Months,84.2,77.7 to 89.6,239
Hib,Primary Series,States/Local Areas,Ohio,2012,Age,19 Months,95.6,88.8 to 98.4,239
Combined 7 Series,,States/Local Areas,Ohio,2011,Age,35 Months,64.0,55.3 to 72.7,229
Hep A,≥1 Dose,States/Local Areas,Ohio,2016,Age,19 Months,80.1,72.4 to 86.1,283
Hep A,≥1 Dose,States/Local Areas,Ohio,2016-2017,Age,19 Months,79.6,74.1 to 84.2,566
Hep A,≥1 Dose,States/Local Areas,Ohio,2017,Age,19 Months,79.1,70.8 to 85.6,283
Hep A,≥1 Dose,States/Local Areas,Ohio,2017-2018,Age,19 Months,79.8,74.6 to 84.1,689
Hep A,≥1 Dose,States/Local Areas,Ohio,2018,Age,19 Months,80.4,73.8 to 85.7,406
Hep A,≥1 Dose,States/Local Areas,Ohio,2018-2019,Age,19 Months,82.4,77.2 to 86.7,644
DTaP,≥3 Doses,States/Local Areas,Ohio,2013,Age,35 Months,94.3,89.8 to 97.3,207
DTaP,≥3 Doses,States/Local Areas,Ohio,2013-2014,Age,35 Months,93.2,90.2 to 95.6,439
DTaP,≥3 Doses,States/Local Areas,Ohio,2012,Age,35 Months,96.0,92.3 to 98.2,239
Hib,Full Series,States/Local Areas,Ohio,2018,Age,19 Months,68.5,61.6 to 74.7,406
Hib,Full Series,States/Local Areas,Ohio,2018-2019,Age,19 Months,95.2,92.7 to 96.8,790
Hib,Full Series,States/Local Areas,Ohio,2019,Age,19 Months,74.1,66.7 to 80.3,384
Hib,Full Series,States/Local Areas,Ohio,2017,Age,19 Months,76.5,68.4 to 83.1,283
Hib,Full Series,States/Local Areas,Ohio,2017-2018,Age,19 Months,72.5,67.3 to 77.2,689
Rotavirus,,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,79.1,71.4 to 86.8,283
Hib,Full Series,States/Local Areas,Ohio,2015,Age,19 Months,66.3,60.5 to 71.6,292
Hib,Full Series,States/Local Areas,Ohio,2015-2016,Age,19 Months,70.5,65.2 to 75.3,575
Hib,Full Series,States/Local Areas,Ohio,2016,Age,19 Months,74.7,66.7 to 81.3,283
Hib,Full Series,States/Local Areas,Ohio,2016-2017,Age,19 Months,75.6,70.1 to 80.4,566
Hib,Full Series,States/Local Areas,Ohio,2014,Age,19 Months,74.9,67.2 to 81.2,232
Hib,Full Series,States/Local Areas,Ohio,2014-2015,Age,19 Months,70.6,65.3 to 75.4,524
Hib,Full Series,States/Local Areas,Ohio,2011,Age,24 Months,71.4,63.4 to 79.0,229
Hib,Full Series,States/Local Areas,Ohio,2012,Age,24 Months,85.5,78.7 to 91.0,239
Hib,Full Series,States/Local Areas,Ohio,2013,Age,19 Months,68.0,59.3 to 75.7,207
Hib,Full Series,States/Local Areas,Ohio,2013-2014,Age,19 Months,71.5,65.3 to 76.9,439
Hib,Full Series,States/Local Areas,Ohio,2012,Age,19 Months,80.0,78.0 to 81.9,239
Hib,Full Series,States/Local Areas,Ohio,2011,Age,19 Months,62.6,57.8 to 67.2,229
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Poverty,>400% FPL,81.9,74.7 to 89.2,283
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Poverty,133% to <400% FPL,71.1,64.8 to 77.4,353
Hib,Primary Series,States/Local Areas,Ohio,2018,Age,35 Months,93.7,89.9 to 96.5,406
Hib,Primary Series,States/Local Areas,Ohio,2018-2019,Age,35 Months,93.8,91.1 to 95.9,790
Combined 7 Series,,States/Local Areas,Ohio,2015,Age,24 Months,58.6,51.4 to 66.0,292
Combined 7 Series,,States/Local Areas,Ohio,2015-2016,Age,24 Months,65.4,60.1 to 70.7,575
Combined 7 Series,,States/Local Areas,Ohio,2014,Age,24 Months,67.1,59.0 to 75.1,232
Combined 7 Series,,States/Local Areas,Ohio,2014-2015,Age,24 Months,62.9,57.4 to 68.4,524
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Poverty,<133% FPL,55.7,48.9 to 62.6,337
Hib,Full Series,States/Local Areas,Ohio,2014,Age,24 Months,79.1,72.2 to 85.3,232
Hib,Full Series,States/Local Areas,Ohio,2014-2015,Age,24 Months,75.1,70.2 to 79.8,524
Hib,Full Series,States/Local Areas,Ohio,2013,Age,24 Months,78.8,71.1 to 85.6,207
Hib,Full Series,States/Local Areas,Ohio,2013-2014,Age,24 Months,78.9,73.7 to 83.7,439
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.0,60.7 to 73.4,423
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a MSA Principal City,70.0,63.8 to 76.2,391
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.1,64.4 to 73.9,669
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.0,53.9 to 78.0,111
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,Hispanic,66.3,51.6 to 80.9,89
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Urbanicity,Living In a Non-MSA,59.0,48.7 to 69.4,159
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Overall,Overall,66.8,62.7 to 70.8,973
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.5,46.7 to 70.3,104
Combined 7 Series,,States/Local Areas,Ohio,2018,Age,35 Months,78.1,70.4 to 84.9,406
Combined 7 Series,,States/Local Areas,Ohio,2018-2019,Age,35 Months,76.1,70.5 to 81.3,790
Combined 7 Series,,States/Local Areas,Ohio,2019,Age,35 Months,73.1,65.5 to 80.3,384
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Any Medicaid,61.2,55.0 to 67.4,386
Combined 7 Series,,States/Local Areas,Ohio,2014-2017,Insurance Coverage,Private Insurance Only,73.5,68.0 to 79.0,554
Combined 7 Series,,States/Local Areas,Ohio,2015,Age,35 Months,66.9,58.4 to 75.2,292
Combined 7 Series,,States/Local Areas,Ohio,2015-2016,Age,35 Months,71.1,65.4 to 76.5,575
Hib,Primary Series,States/Local Areas,Ohio,2019,Age,35 Months,93.6,89.5 to 96.5,384
Combined 7 Series,,States/Local Areas,Ohio,2016,Age,24 Months,72.3,64.6 to 79.4,283
Combined 7 Series,,States/Local Areas,Ohio,2016-2017,Age,24 Months,71.2,65.7 to 76.5,566
Combined 7 Series,,States/Local Areas,Ohio,2017,Age,35 Months,76.2,67.9 to 83.7,283
Combined 7 Series,,States/Local Areas,Ohio,2017-2018,Age,35 Months,77.3,71.7 to 82.5,689
Combined 7 Series,,States/Local Areas,Ohio,2016,Age,35 Months,75.6,67.9 to 82.6,283
Combined 7 Series,,States/Local Areas,Ohio,2016-2017,Age,35 Months,75.8,70.2 to 81.0,566
Combined 7 Series,,States/Local Areas,Ohio,2019,Age,24 Months,68.2,60.7 to 75.4,384
Combined 7 Series,,States/Local Areas,Ohio,2018,Age,24 Months,65.7,58.6 to 72.6,406
Combined 7 Series,,States/Local Areas,Ohio,2018-2019,Age,24 Months,66.7,61.6 to 71.8,790
Combined 7 Series,,States/Local Areas,Ohio,2017,Age,24 Months,70.1,62.3 to 77.6,283
Combined 7 Series,,States/Local Areas,Ohio,2017-2018,Age,24 Months,67.9,62.6 to 73.1,689
Hib,Primary Series,States/Local Areas,Ohio,2013,Age,13 Months,87.4,82.5 to 91.2,207
Hib,Primary Series,States/Local Areas,Ohio,2013-2014,Age,13 Months,87.6,85.7 to 89.3,439
Hib,Primary Series,States/Local Areas,Ohio,2012,Age,13 Months,90.7,84.5 to 94.6,239
Hib,Primary Series,States/Local Areas,Ohio,2011,Age,13 Months,84.7,80.6 to 88.0,229
Hib,Primary Series,States/Local Areas,Ohio,2019,Age,7 Months,62.3,55.0 to 69.1,384
Hib,Primary Series,States/Local Areas,Ohio,2014,Age,24 Months,91.3,86.7 to 94.8,232
Hib,Primary Series,States/Local Areas,Ohio,2014-2015,Age,24 Months,89.5,86.3 to 92.3,524
Hib,Primary Series,States/Local Areas,Ohio,2015,Age,24 Months,87.7,82.9 to 91.7,292
Hib,Primary Series,States/Local Areas,Ohio,2015-2016,Age,24 Months,90.2,86.9 to 93.0,575
Hib,Primary Series,States/Local Areas,Ohio,2018,Age,24 Months,92.6,88.7 to 95.5,406
Hib,Primary Series,States/Local Areas,Ohio,2018-2019,Age,24 Months,93.2,90.5 to 95.3,790
Hib,Primary Series,States/Local Areas,Ohio,2014,Age,13 Months,87.8,81.6 to 92.1,232
Hib,Primary Series,States/Local Areas,Ohio,2014-2015,Age,13 Months,84.4,80.1 to 88.0,524
Hib,Primary Series,States/Local Areas,Ohio,2015,Age,13 Months,81.1,74.7 to 86.1,292
Hib,Primary Series,States/Local Areas,Ohio,2015-2016,Age,13 Months,83.9,79.5 to 87.5,575
Hib,Primary Series,States/Local Areas,Ohio,2013,Age,24 Months,92.1,87.2 to 95.6,207
Hib,Primary Series,States/Local Areas,Ohio,2013-2014,Age,24 Months,91.7,88.5 to 94.3,439
Hib,Primary Series,States/Local Areas,Ohio,2017,Age,24 Months,86.4,79.1 to 92.1,283
Hib,Primary Series,States/Local Areas,Ohio,2017-2018,Age,24 Months,89.5,85.4 to 92.9,689
Hib,Primary Series,States/Local Areas,Ohio,2013,Age,35 Months,94.2,89.6 to 97.2,207
Hib,Primary Series,States/Local Areas,Ohio,2013-2014,Age,35 Months,93.0,89.9 to 95.4,439
Hib,Primary Series,States/Local Areas,Ohio,2019,Age,24 Months,93.6,89.5 to 96.5,384
Hib,Primary Series,States/Local Areas,Ohio,2011,Age,35 Months,91.5,85.4 to 95.8,229
Hib,Primary Series,States/Local Areas,Ohio,2014,Age,35 Months,91.6,87.0 to 95.1,232
Hib,Primary Series,States/Local Areas,Ohio,2014-2015,Age,35 Months,90.3,87.1 to 93.0,524
Hib,Primary Series,States/Local Areas,Ohio,2012,Age,35 Months,96.2,92.7 to 98.4,239
Combined 7 Series,,States/Local Areas,Ohio,2013,Age,24 Months,65.4,56.9 to 73.7,207
Combined 7 Series,,States/Local Areas,Ohio,2013-2014,Age,24 Months,66.2,60.3 to 72.0,439
Combined 7 Series,,States/Local Areas,Ohio,2011,Age,24 Months,56.8,48.7 to 65.3,229
Combined 7 Series,,States/Local Areas,Ohio,2012,Age,24 Months,77.0,69.6 to 83.7,239
Hib,Primary Series,States/Local Areas,Ohio,2015,Age,35 Months,89.0,84.2 to 92.9,292
Hib,Primary Series,States/Local Areas,Ohio,2015-2016,Age,35 Months,91.0,87.7 to 93.7,575
Combined 7 Series,,States/Local Areas,Ohio,2013,Age,35 Months,70.4,61.6 to 78.7,207
Combined 7 Series,,States/Local Areas,Ohio,2013-2014,Age,35 Months,71.1,65.2 to 76.8,439
Combined 7 Series,,States/Local Areas,Ohio,2014,Age,35 Months,72.1,63.9 to 79.9,232
Combined 7 Series,,States/Local Areas,Ohio,2014-2015,Age,35 Months,69.5,63.5 to 75.3,524
Combined 7 Series,,States/Local Areas,Ohio,2012,Age,35 Months,80.6,72.9 to 87.2,239
Hib,Primary Series,States/Local Areas,Ohio,2016,Age,35 Months,93.1,88.1 to 96.6,283
Hib,Primary Series,States/Local Areas,Ohio,2016-2017,Age,35 Months,90.8,86.4 to 94.2,566
Hib,Primary Series,States/Local Areas,Ohio,2017,Age,35 Months,89.3,81.1 to 95.0,283
Hib,Primary Series,States/Local Areas,Ohio,2017-2018,Age,35 Months,91.5,87.1 to 94.8,689
Influenza,,States/Local Areas,New Jersey,2013,Age,24 Months,67.4,59.8 to 74.9,252
Influenza,,States/Local Areas,New Jersey,2013-2014,Age,24 Months,64.3,59.1 to 69.5,586
Influenza,,States/Local Areas,New Jersey,2014,Age,24 Months,61.1,54.0 to 68.2,334
Influenza,,States/Local Areas,New Jersey,2014-2015,Age,24 Months,64.8,59.8 to 69.7,649
Influenza,,States/Local Areas,New Jersey,2015,Age,24 Months,68.2,61.3 to 74.9,315
Influenza,,States/Local Areas,New Jersey,2015-2016,Age,24 Months,63.1,57.6 to 68.6,613
Influenza,,States/Local Areas,New Jersey,2012,Age,24 Months,62.5,55.3 to 69.7,288
Influenza,,States/Local Areas,New Jersey,2011,Age,24 Months,56.6,48.3 to 65.1,264
PCV,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,19 Months,90.6,86.3 to 93.7,547
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,95.5,91.6 to 97.9,436
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2020-2021,Age,0-3 Days,81.5,76.0 to 86.0,436
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,91.2,86.3 to 94.4,436
Rotavirus,,States/Local Areas,New Jersey,2020-2021,Age,8 Months,75.0,68.6 to 80.4,436
Polio,≥3 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,94.2,87.4 to 98.0,168
≥1 Dose Varicella,,States/Local Areas,New Jersey,2021,Age,35 Months,87.4,76.3 to 95.0,168
Hep A,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,19 Months,75.2,68.9 to 80.7,436
DTaP,≥4 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,83.0,76.8 to 88.4,436
DTaP,≥4 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,91.3,81.1 to 97.2,168
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,63.2,56.6 to 69.8,321
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.8,49.4 to 76.1,71
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,69.3,62.5 to 76.1,299
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.9,71.5 to 86.3,206
Rotavirus,,States/Local Areas,New Jersey,2018,Age,8 Months,81.2,74.1 to 86.7,269
Rotavirus,,States/Local Areas,New Jersey,2018-2019,Age,8 Months,75.1,69.3 to 80.0,548
Rotavirus,,States/Local Areas,New Jersey,2019,Age,8 Months,68.8,59.8 to 76.5,279
Rotavirus,,States/Local Areas,New Jersey,2017,Age,8 Months,68.3,60.0 to 75.6,263
Rotavirus,,States/Local Areas,New Jersey,2017-2018,Age,8 Months,74.7,69.3 to 79.5,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,64.3,57.7 to 70.5,436
Hib,Primary Series,States/Local Areas,New Jersey,2020-2021,Age,19 Months,91.0,85.9 to 94.4,436
Rotavirus,,States/Local Areas,New Jersey,2016,Age,8 Months,70.0,61.8 to 77.1,298
Rotavirus,,States/Local Areas,New Jersey,2016-2017,Age,8 Months,69.2,63.4 to 74.4,561
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.0,72.3 to 79.6,952
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Overall,Overall,73.4,69.9 to 76.9,1114
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,67.4,60.3 to 74.5,257
Hib,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,5 Months,73.9,67.4 to 79.4,436
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,80.8,77.1 to 84.5,756
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.8,71.9 to 81.8,538
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,63.1,53.8 to 72.5,162
Rotavirus,,States/Local Areas,New Jersey,2013,Age,8 Months,75.6,68.0 to 81.9,252
Rotavirus,,States/Local Areas,New Jersey,2013-2014,Age,8 Months,76.0,71.1 to 80.3,586
Rotavirus,,States/Local Areas,New Jersey,2012,Age,8 Months,65.5,58.0 to 72.3,288
Rotavirus,,States/Local Areas,New Jersey,2014,Age,8 Months,76.4,70.1 to 81.7,334
Rotavirus,,States/Local Areas,New Jersey,2014-2015,Age,8 Months,74.9,70.3 to 78.9,649
Rotavirus,,States/Local Areas,New Jersey,2015,Age,8 Months,73.4,66.5 to 79.2,315
Rotavirus,,States/Local Areas,New Jersey,2015-2016,Age,8 Months,71.7,66.4 to 76.4,613
Rotavirus,,States/Local Areas,New Jersey,2011,Age,8 Months,68.3,60.2 to 75.5,264
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,69.4,62.8 to 76.0,328
Rotavirus,,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,81.9,77.3 to 86.4,529
PCV,≥1 Dose,States/Local Areas,New Jersey,2021,Age,3 Months,83.2,73.7 to 89.8,168
Hib,≥3 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,89.5,81.3 to 95.2,168
DTaP,≥3 Doses,States/Local Areas,New Jersey,2021,Age,24 Months,94.4,87.4 to 98.2,168
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.9,73.1 to 96.7,167
Hib,Primary Series,States/Local Areas,New Jersey,2021,Age,35 Months,90.8,82.8 to 96.0,168
Hib,Primary Series,States/Local Areas,New Jersey,2020-2021,Age,7 Months,69.6,63.2 to 75.3,436
Hib,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,89.3,84.0 to 93.0,436
DTaP,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,5 Months,77.0,70.6 to 82.3,436
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2021,Age,0-3 Days,79.5,70.2 to 86.4,168
Hib,≥2 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,90.6,80.7 to 95.7,168
Polio,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,93.4,89.2 to 96.3,436
Polio,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,5 Months,77.0,70.7 to 82.2,436
Hep A,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,76.9,67.0 to 85.5,436
Polio,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,3 Months,84.6,79.3 to 88.7,436
PCV,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,3 Months,80.5,74.6 to 85.3,436
PCV,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,85.5,79.7 to 89.8,436
Hib,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,65.5,58.9 to 71.5,436
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,72.6,66.1 to 78.2,436
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,94.9,91.0 to 97.5,436
Hep A,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,35 Months,89.3,82.7 to 94.1,436
Hib,Full Series,States/Local Areas,New Jersey,2020-2021,Age,19 Months,66.6,59.9 to 72.8,436
Hib,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,92.5,87.7 to 96.0,436
PCV,≥4 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,74.4,67.8 to 80.1,436
Hep B,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,42.4,36.1 to 49.0,436
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2020-2021,Age,0-1 Days,75.2,69.1 to 80.5,436
Influenza,,States/Local Areas,New Jersey,2020-2021,Age,24 Months,64.5,58.0 to 70.9,436
PCV,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,89.8,84.7 to 93.4,436
Hep B,≥3 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,91.5,83.6 to 96.6,168
Hib,Primary Series,States/Local Areas,New Jersey,2021,Age,13 Months,83.4,73.2 to 90.2,168
≥1 Dose MMR,,States/Local Areas,New Jersey,2020-2021,Age,35 Months,92.1,86.2 to 96.1,436
Hep B,≥2 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,95.9,88.2 to 98.7,168
PCV,≥4 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,83.6,76.6 to 89.5,436
Hep B,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,91.7,87.1 to 94.7,436
Combined 7 Series,,States/Local Areas,New Jersey,2020-2021,Age,24 Months,63.7,57.0 to 70.3,436
Hib,Full Series,States/Local Areas,New Jersey,2021,Age,35 Months,85.0,73.9 to 93.1,168
DTaP,≥3 Doses,States/Local Areas,New Jersey,2021,Age,35 Months,94.4,87.4 to 98.2,168
Polio,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,89.5,84.1 to 93.2,436
Polio,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,89.9,84.9 to 93.4,436
Combined 7 Series,,States/Local Areas,New Jersey,2020-2021,Age,35 Months,66.7,59.8 to 73.4,436
≥1 Dose MMR,,States/Local Areas,New Jersey,2020-2021,Age,24 Months,89.3,83.6 to 93.7,436
Hib,Primary Series,States/Local Areas,New Jersey,2020-2021,Age,13 Months,84.9,79.1 to 89.3,436
Hib,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,3 Months,81.5,75.7 to 86.1,436
Hib,≥3 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,81.5,71.3 to 88.7,168
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020-2021,Age,24 Months,88.9,83.1 to 93.4,436
PCV,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,93.2,88.6 to 96.4,436
Hep B,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,5 Months,89.1,84.3 to 92.5,436
Rotavirus,,States/Local Areas,New Jersey,2021,Age,8 Months,74.4,64.0 to 82.7,168
Hep A,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,24 Months,34.2,28.1 to 41.3,436
Polio,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,35 Months,96.2,92.4 to 98.4,436
≥1 Dose MMR,,States/Local Areas,New Jersey,2021,Age,13 Months,53.8,43.5 to 63.9,168
Hib,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,7 Months,86.6,80.7 to 90.9,436
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.6 to 98.5,695
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,86.3,82.4 to 90.3,695
Influenza,,States/Local Areas,New Jersey,2014-2017,Overall,Overall,63.6,59.7 to 67.4,1114
Influenza,,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,50.3,42.7 to 57.9,257
Influenza,,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,61.4,54.5 to 68.4,328
Influenza,,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,76.9,71.7 to 82.0,529
Influenza,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,65.9,61.8 to 70.0,952
Influenza,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.5,62.9 to 74.0,538
Influenza,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,54.6,44.8 to 64.4,162
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,80.2 to 95.0,167
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,88.5,85.1 to 92.0,695
Influenza,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,57.5,50.3 to 64.6,299
Influenza,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.4,63.8 to 80.9,206
Influenza,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",48.9,34.3 to 63.5,71
Influenza,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,73.8,69.5 to 78.1,756
Influenza,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,50.4,43.6 to 57.3,321
Influenza,,States/Local Areas,New Jersey,2017,Age,24 Months,62.0,54.0 to 70.0,263
Influenza,,States/Local Areas,New Jersey,2017-2018,Age,24 Months,70.0,64.5 to 75.3,532
Influenza,,States/Local Areas,New Jersey,2018,Age,24 Months,78.2,71.1 to 84.5,269
Influenza,,States/Local Areas,New Jersey,2018-2019,Age,24 Months,73.9,68.5 to 79.1,548
Influenza,,States/Local Areas,New Jersey,2016,Age,24 Months,58.0,49.7 to 66.5,298
Influenza,,States/Local Areas,New Jersey,2016-2017,Age,24 Months,60.0,54.2 to 65.8,561
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,81.6,76.1 to 87.2,286
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.2,64.3 to 100.0,59
Influenza,,States/Local Areas,New Jersey,2019,Age,24 Months,69.5,61.2 to 77.5,279
Polio,≥2 Doses,States/Local Areas,New Jersey,2021,Age,5 Months,79.1,68.9 to 86.6,168
≥1 Dose MMR,,States/Local Areas,New Jersey,2021,Age,19 Months,78.9,68.0 to 86.8,168
Hib,Primary Series,States/Local Areas,New Jersey,2020-2021,Age,35 Months,95.4,89.2 to 98.6,436
≥1 Dose Varicella,,States/Local Areas,New Jersey,2021,Age,13 Months,42.5,33.0 to 52.6,168
DTaP,≥2 Doses,States/Local Areas,New Jersey,2021,Age,5 Months,78.2,67.9 to 85.9,168
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Private Insurance Only,82.3,78.3 to 86.3,695
Hep B,≥3 Doses,States/Local Areas,New Jersey,2021,Age,13 Months,86.3,76.8 to 92.3,168
Hib,≥2 Doses,States/Local Areas,New Jersey,2021,Age,5 Months,75.4,64.9 to 83.5,168
Polio,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,93.0,88.0 to 96.1,436
DTaP,≥4 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,68.1,61.4 to 74.1,436
Influenza,,States/Local Areas,New Jersey,2021,Age,24 Months,63.2,53.0 to 73.4,168
Hep B,≥2 Doses,States/Local Areas,New Jersey,2021,Age,5 Months,89.5,81.4 to 94.3,168
Hep A,≥2 Doses,States/Local Areas,New Jersey,2020-2021,Age,19 Months,17.4,13.1 to 22.6,436
DTaP,≥3 Doses,States/Local Areas,New Jersey,2020-2021,Age,13 Months,89.5,84.2 to 93.1,436
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2020-2021,Age,0-2 Days,79.5,73.9 to 84.2,436
≥1 Dose MMR,,States/Local Areas,New Jersey,2020-2021,Age,13 Months,58.0,51.3 to 64.4,436
DTaP,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,3 Months,85.9,80.6 to 89.9,436
Hep B,≥1 Dose,States/Local Areas,New Jersey,2020-2021,Age,3 Months,96.6,93.8 to 98.2,436
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020-2021,Age,19 Months,82.9,76.5 to 87.9,436
Hib,Full Series,States/Local Areas,New Jersey,2020-2021,Age,35 Months,86.3,79.5 to 91.8,436
≥1 Dose MMR,,States/Local Areas,New Jersey,2020-2021,Age,19 Months,82.5,76.1 to 87.5,436
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,73.7,61.4 to 86.0,276
Hib,Full Series,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,71.7,64.3 to 79.1,276
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,Hispanic,88.8,83.6 to 94.0,276
Hep B,≥1 Dose,States/Local Areas,New Jersey,2021,Age,3 Months,96.1,91.6 to 98.3,168
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.9,91.4 to 100.0,167
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2019,Insurance Coverage,Any Medicaid,72.9,66.1 to 79.7,286
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,80.6 to 95.7,167
Combined 7 Series,,States/Local Areas,New Jersey,2015,Age,24 Months,71.8,65.1 to 78.2,315
Combined 7 Series,,States/Local Areas,New Jersey,2015-2016,Age,24 Months,71.0,65.7 to 76.1,613
Hib,Primary Series,States/Local Areas,New Jersey,2018,Age,35 Months,96.1,91.7 to 98.5,269
Hib,Primary Series,States/Local Areas,New Jersey,2018-2019,Age,35 Months,96.7,92.7 to 98.8,548
Hep B,≥2 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,90.9,86.6 to 93.9,547
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2019,Poverty,>400% FPL,97.6,95.5 to 99.7,515
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019-2020,Age,7 Months,36.6,31.2 to 42.4,547
Combined 7 Series,,States/Local Areas,New Jersey,2016,Age,24 Months,70.2,61.9 to 78.0,298
Combined 7 Series,,States/Local Areas,New Jersey,2016-2017,Age,24 Months,68.3,62.6 to 73.9,561
Hib,Primary Series,States/Local Areas,New Jersey,2019,Age,35 Months,97.0,89.2 to 99.6,279
Combined 7 Series,,States/Local Areas,New Jersey,2014,Age,24 Months,64.4,57.6 to 71.1,334
Combined 7 Series,,States/Local Areas,New Jersey,2014-2015,Age,24 Months,68.0,63.2 to 72.8,649
Hep B,≥2 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,92.2,91.0 to 93.2,4262
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,7 Months,64.4,62.4 to 66.3,4262
PCV,≥3 Doses,HHS Regions/National,Region 5,2019-2020,Age,19 Months,91.4,90.1 to 92.5,4262
Hib,Full Series,HHS Regions/National,Region 5,2020-2021,Age,24 Months,77.4,75.3 to 79.4,3717
Rotavirus,,HHS Regions/National,Region 5,2015,Age,8 Months,70.6,67.5 to 73.4,1735
Rotavirus,,HHS Regions/National,Region 5,2015-2016,Age,8 Months,73.3,71.2 to 75.3,3570
Rotavirus,,HHS Regions/National,Region 5,2016,Age,8 Months,76.1,73.2 to 78.7,1835
Rotavirus,,HHS Regions/National,Region 5,2016-2017,Age,8 Months,75.9,73.9 to 77.8,3854
Rotavirus,,HHS Regions/National,Region 5,2014,Age,8 Months,74.0,71.1 to 76.8,1726
Rotavirus,,HHS Regions/National,Region 5,2014-2015,Age,8 Months,72.3,70.2 to 74.3,3461
Rotavirus,,HHS Regions/National,Region 5,2017,Age,8 Months,75.8,73.0 to 78.4,2019
Rotavirus,,HHS Regions/National,Region 5,2017-2018,Age,8 Months,75.4,73.5 to 77.2,4223
Rotavirus,,HHS Regions/National,Region 5,2019,Age,8 Months,78.1,75.3 to 80.6,2023
Rotavirus,,HHS Regions/National,Region 5,2018,Age,8 Months,75.0,72.3 to 77.5,2204
Rotavirus,,HHS Regions/National,Region 5,2018-2019,Age,8 Months,76.5,74.6 to 78.3,4227
Rotavirus,,HHS Regions/National,Region 5,2012,Age,8 Months,71.5,68.4 to 74.4,1752
Rotavirus,,HHS Regions/National,Region 5,2013,Age,8 Months,72.7,69.6 to 75.6,1730
Rotavirus,,HHS Regions/National,Region 5,2013-2014,Age,8 Months,73.4,71.2 to 75.4,3456
Rotavirus,,HHS Regions/National,Region 5,2011,Age,8 Months,69.6,66.5 to 72.6,1771
PCV,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,91.9,90.5 to 93.2,3717
DTaP,≥4 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,71.8,69.6 to 73.9,3717
Hib,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,87.9,86.2 to 89.4,3717
Hib,Primary Series,HHS Regions/National,Region 5,2020-2021,Age,7 Months,71.2,69.0 to 73.3,3717
Hib,Primary Series,HHS Regions/National,Region 5,2021,Age,35 Months,93.7,90.1 to 96.3,1478
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020-2021,Age,24 Months,91.0,89.5 to 92.3,3717
Polio,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,93.6,92.3 to 94.8,3717
Combined 7 Series,,HHS Regions/National,Region 5,2020-2021,Age,35 Months,73.6,71.3 to 75.9,3717
Hep B,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,5 Months,87.9,86.2 to 89.4,3717
Polio,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,5 Months,77.4,75.3 to 79.4,3717
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,91.6,90.2 to 92.8,3717
Hep A,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,49.9,47.6 to 52.3,3717
DTaP,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,5 Months,78.3,76.2 to 80.3,3717
Hib,Full Series,HHS Regions/National,Region 5,2021,Age,35 Months,77.6,74.1 to 80.9,1478
Polio,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,90.7,89.1 to 92.0,3717
Hib,Primary Series,HHS Regions/National,Region 5,2020-2021,Age,13 Months,84.3,82.5 to 85.9,3717
Hib,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,3 Months,83.7,81.8 to 85.3,3717
Combined 7 Series,,HHS Regions/National,Region 5,2020-2021,Age,24 Months,68.7,66.5 to 70.9,3717
Hib,≥3 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,64.5,61.0 to 67.8,1478
≥1 Dose MMR,,HHS Regions/National,Region 5,2020-2021,Age,24 Months,91.8,90.4 to 93.1,3717
Polio,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,87.9,86.1 to 89.4,3717
Hep B,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,91.0,89.6 to 92.3,3717
≥1 Dose MMR,,HHS Regions/National,Region 5,2020-2021,Age,35 Months,93.8,92.4 to 95.1,3717
PCV,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,90.7,89.2 to 92.0,3717
Influenza,,HHS Regions/National,Region 5,2020-2021,Age,24 Months,60.2,57.9 to 62.5,3717
Hib,Primary Series,HHS Regions/National,Region 5,2021,Age,13 Months,83.9,81.0 to 86.4,1478
PCV,≥4 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,84.7,82.6 to 86.6,3717
DTaP,≥3 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,97.8,91.1 to 99.8,1478
Hep B,≥3 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,93.5,91.3 to 95.4,1478
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2020-2021,Age,0-3 Days,81.4,79.4 to 83.1,3717
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,64.6,62.4 to 66.8,3717
Hep B,≥2 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,93.9,91.9 to 95.4,1478
DTaP,≥4 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,87.8,82.1 to 92.4,1478
Hib,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,91.7,90.2 to 93.1,3717
PCV,≥4 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,78.6,76.5 to 80.5,3717
Polio,≥3 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,93.7,91.3 to 95.6,1478
≥1 Dose Varicella,,HHS Regions/National,Region 5,2021,Age,35 Months,93.1,90.0 to 95.5,1478
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2020-2021,Age,0-1 Days,76.6,74.5 to 78.5,3717
Hep A,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,19 Months,84.4,82.5 to 86.0,3717
Combined 7 Series,,HHS Regions/National,Region 5,2021,Age,24 Months,67.5,64.0 to 71.0,1478
DTaP,≥4 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,80.7,78.7 to 82.7,3717
Hep B,≥1 Dose,HHS Regions/National,Region 5,2021,Age,3 Months,94.7,92.8 to 96.1,1478
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,93.1,91.8 to 94.3,3717
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,94.6,93.3 to 95.7,3717
Influenza,,HHS Regions/National,Region 5,2012,Age,24 Months,54.1,50.8 to 57.5,1751
Influenza,,HHS Regions/National,Region 5,2011,Age,24 Months,54.0,50.8 to 57.3,1771
Influenza,,HHS Regions/National,Region 5,2014,Age,24 Months,57.2,54.1 to 60.4,1726
Influenza,,HHS Regions/National,Region 5,2014-2015,Age,24 Months,56.8,54.6 to 59.1,3461
Influenza,,HHS Regions/National,Region 5,2015,Age,24 Months,56.5,53.3 to 59.7,1735
Influenza,,HHS Regions/National,Region 5,2015-2016,Age,24 Months,57.2,54.9 to 59.5,3570
Influenza,,HHS Regions/National,Region 5,2013,Age,24 Months,53.3,50.1 to 56.6,1730
Influenza,,HHS Regions/National,Region 5,2013-2014,Age,24 Months,55.3,53.0 to 57.6,3456
Rotavirus,,HHS Regions/National,Region 5,2020-2021,Age,8 Months,75.8,73.7 to 77.8,3717
Rotavirus,,HHS Regions/National,Region 5,2021,Age,8 Months,75.2,71.8 to 78.4,1478
Hib,≥2 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,91.9,89.6 to 93.7,1478
Hep A,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,80.1,77.1 to 82.9,3717
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2021,Age,0-3 Days,81.1,78.0 to 83.8,1478
Polio,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,24 Months,92.5,91.1 to 93.7,3717
≥1 Dose MMR,,HHS Regions/National,Region 5,2020-2021,Age,19 Months,88.3,86.6 to 89.8,3717
Hib,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,49.1,46.9 to 51.3,3717
PCV,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,87.5,85.8 to 89.1,3717
PCV,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,3 Months,85.2,83.4 to 86.8,3717
Polio,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,3 Months,85.3,83.4 to 86.9,3717
Hep A,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,24 Months,88.4,86.8 to 89.9,3717
≥1 Dose MMR,,HHS Regions/National,Region 5,2021,Age,13 Months,64.8,61.3 to 68.3,1478
Influenza,,HHS Regions/National,Region 5,2021,Age,24 Months,58.7,55.0 to 62.5,1478
DTaP,≥3 Doses,HHS Regions/National,Region 5,2021,Age,24 Months,92.9,90.8 to 94.8,1478
Hib,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,87.3,85.5 to 88.9,3717
Influenza,,HHS Regions/National,Region 5,2019,Age,24 Months,67.2,64.2 to 70.3,2023
Influenza,,HHS Regions/National,Region 5,2016,Age,24 Months,57.9,54.7 to 61.0,1835
Influenza,,HHS Regions/National,Region 5,2016-2017,Age,24 Months,59.2,57.0 to 61.4,3854
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020-2021,Age,13 Months,61.0,58.8 to 63.2,3717
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,70.3,68.0 to 72.4,3717
Hib,≥3 Doses,HHS Regions/National,Region 5,2021,Age,35 Months,92.6,88.5 to 95.6,1478
Hib,Full Series,HHS Regions/National,Region 5,2020-2021,Age,19 Months,72.2,70.0 to 74.2,3717
Polio,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,92.6,91.2 to 93.7,3717
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,13 Months,88.6,86.9 to 90.1,3717
Hib,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,5 Months,76.3,74.2 to 78.3,3717
Influenza,,HHS Regions/National,Region 5,2017,Age,24 Months,60.5,57.5 to 63.5,2019
Influenza,,HHS Regions/National,Region 5,2017-2018,Age,24 Months,63.1,61.0 to 65.2,4223
Influenza,,HHS Regions/National,Region 5,2018,Age,24 Months,65.8,63.0 to 68.6,2204
Influenza,,HHS Regions/National,Region 5,2018-2019,Age,24 Months,66.5,64.5 to 68.6,4227
≥1 Dose Varicella,,HHS Regions/National,Region 5,2021,Age,13 Months,59.3,55.7 to 62.8,1478
PCV,≥1 Dose,HHS Regions/National,Region 5,2021,Age,3 Months,85.9,83.1 to 88.3,1478
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020-2021,Age,19 Months,87.6,86.0 to 89.2,3717
Hep B,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,3 Months,94.7,93.5 to 95.6,3717
PCV,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,35 Months,92.8,91.4 to 94.0,3717
Hib,Primary Series,HHS Regions/National,Region 5,2020-2021,Age,19 Months,91.0,89.5 to 92.2,3717
≥1 Dose MMR,,HHS Regions/National,Region 5,2020-2021,Age,13 Months,67.2,64.9 to 69.3,3717
Polio,≥3 Doses,HHS Regions/National,Region 5,2021,Age,19 Months,90.3,87.8 to 92.3,1478
Hep A,≥2 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,31.5,29.5 to 33.6,3717
≥1 Dose MMR,,HHS Regions/National,Region 5,2021,Age,19 Months,87.7,84.9 to 90.0,1478
Hep B,≥2 Doses,HHS Regions/National,Region 5,2021,Age,5 Months,87.2,84.4 to 89.5,1478
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,19 Months,90.6,89.2 to 91.9,3717
DTaP,≥2 Doses,HHS Regions/National,Region 5,2021,Age,5 Months,78.3,74.9 to 81.3,1478
Polio,≥2 Doses,HHS Regions/National,Region 5,2021,Age,5 Months,76.9,73.5 to 80.0,1478
PCV,≥3 Doses,HHS Regions/National,Region 5,2020-2021,Age,7 Months,68.5,66.3 to 70.7,3717
Hib,Primary Series,HHS Regions/National,Region 5,2020-2021,Age,35 Months,93.1,91.8 to 94.3,3717
DTaP,≥1 Dose,HHS Regions/National,Region 5,2020-2021,Age,3 Months,86.0,84.2 to 87.6,3717
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2020-2021,Age,0-2 Days,80.2,78.3 to 82.0,3717
Hib,Full Series,HHS Regions/National,Region 5,2020-2021,Age,35 Months,79.7,77.6 to 81.7,3717
Hep B,≥3 Doses,HHS Regions/National,Region 5,2021,Age,13 Months,87.5,84.8 to 89.8,1478
Polio,≥3 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,93.6,88.3 to 97.0,245
Influenza,,States/Local Areas,South Carolina,2012,Age,24 Months,41.9,34.1 to 50.8,255
Influenza,,States/Local Areas,South Carolina,2011,Age,24 Months,36.5,28.8 to 45.5,252
Influenza,,States/Local Areas,South Carolina,2014,Age,24 Months,44.6,36.8 to 53.2,251
Influenza,,States/Local Areas,South Carolina,2014-2015,Age,24 Months,45.1,39.6 to 51.0,524
Influenza,,States/Local Areas,South Carolina,2015,Age,24 Months,45.6,38.2 to 53.8,273
Influenza,,States/Local Areas,South Carolina,2015-2016,Age,24 Months,44.3,39.0 to 50.0,564
Influenza,,States/Local Areas,South Carolina,2013,Age,24 Months,39.2,32.3 to 47.1,261
Influenza,,States/Local Areas,South Carolina,2013-2014,Age,24 Months,41.9,36.5 to 47.7,512
Hep B,≥1 Dose,States/Local Areas,South Carolina,2021,Age,3 Months,93.2,85.3 to 97.0,188
Polio,≥3 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,92.4,90.0 to 94.2,261
Polio,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,91.9,90.5 to 93.2,512
Polio,≥3 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,89.6,79.6 to 95.0,255
Polio,≥3 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,89.8,84.5 to 93.5,288
Polio,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,91.2,87.6 to 93.8,532
Polio,≥3 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,93.1,88.0 to 96.1,291
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,91.5,88.0 to 94.0,579
Hib,≥3 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,59.4,51.2 to 67.2,244
Hib,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,62.1,56.3 to 67.5,489
Polio,≥3 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,92.7,91.7 to 93.6,273
Polio,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,92.9,89.4 to 95.3,564
Hib,≥3 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,84.8,78.6 to 89.4,252
Hib,≥3 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,83.2,72.0 to 90.5,255
Hib,≥3 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,64.6,56.5 to 72.0,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,91.7,86.3 to 95.1,244
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,91.8,88.1 to 94.5,489
DTaP,≥3 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,90.7,80.1 to 95.9,255
DTaP,≥3 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,92.5,87.9 to 95.5,252
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,91.9,86.0 to 95.5,245
Polio,≥3 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,91.5,85.8 to 95.1,251
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,92.1,88.4 to 94.7,524
Hib,≥3 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,51.9,44.2 to 59.4,288
Hib,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,55.6,50.1 to 61.1,532
Hib,≥3 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,52.6,44.7 to 60.4,291
Hib,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,52.2,46.7 to 57.7,579
Hib,≥3 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,52.5,44.5 to 60.4,273
Hib,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,52.6,46.9 to 58.2,564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,76.0,70.1 to 81.9,327
DTaP,≥3 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,85.4,80.9 to 89.0,255
Hib,≥2 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,90.3,83.0 to 94.6,252
Hib,≥2 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,91.4,87.8 to 94.0,255
Hib,≥2 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,89.2,82.2 to 93.6,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,93.1,88.4 to 97.8,140
Hib,≥3 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,53.5,49.5 to 57.5,255
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,88.8 to 95.5,395
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.0,89.2 to 94.8,635
Hib,≥3 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,52.0,43.8 to 60.1,245
Hib,≥2 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,90.8,85.1 to 94.5,288
Hib,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,92.9,89.4 to 95.3,532
Hib,≥2 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,94.9,90.1 to 97.4,244
Hib,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,94.1,90.7 to 96.3,489
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,90.0 to 96.0,508
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,90.7,82.4 to 98.9,94
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,90.7,86.7 to 94.7,327
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,92.4,90.2 to 94.6,997
Hib,≥2 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,93.4,87.5 to 96.6,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Overall,Overall,73.5,69.8 to 77.2,997
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,75.4,64.3 to 86.5,94
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.3,68.0 to 78.5,508
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,73.3,67.3 to 79.3,395
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.8,67.0 to 76.5,635
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,70.9 to 89.7,91
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,75.1,65.6 to 84.5,140
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,90.2,83.8 to 94.2,251
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,90.2,86.2 to 93.2,524
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,88.3,85.5 to 90.7,261
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,89.2,87.7 to 90.6,512
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,90.3,84.3 to 94.1,273
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,89.9,85.8 to 93.0,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,84.7,77.8 to 89.7,288
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,88.2,84.0 to 91.4,532
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,89.6,83.1 to 93.7,291
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,87.1,82.6 to 90.6,579
Hib,≥3 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,69.5,66.0 to 72.8,252
Hib,≥3 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,49.0,40.8 to 57.2,251
Hib,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,50.7,45.0 to 56.5,524
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,95.9,93.4 to 98.5,247
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,92.4,89.0 to 95.8,423
Polio,≥3 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,92.5,87.9 to 95.5,252
Hib,≥3 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,51.4,45.0 to 57.7,261
Hib,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,50.2,46.0 to 54.3,512
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,71.5,63.5 to 79.5,247
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,71.8,65.9 to 77.8,423
Hib,≥2 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,93.9,89.0 to 96.8,251
Hib,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,92.9,88.5 to 95.6,524
Hib,≥2 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,93.5,88.3 to 96.4,291
Hib,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,92.2,88.6 to 94.7,579
Hib,≥2 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,91.8,83.8 to 96.0,273
Hib,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,92.6,88.3 to 95.4,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.4,88.2 to 98.6,131
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,81.1,68.5 to 93.6,47
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,84.8 to 97.5,91
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,92.9,88.1 to 97.8,140
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,91.8,88.5 to 95.1,440
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,94.2,91.5 to 96.9,501
Hib,≥3 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,37.4,30.4 to 45.1,288
Hib,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,40.8,35.6 to 46.4,532
Hib,≥3 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,44.2,36.6 to 52.2,244
Hib,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,48.2,42.5 to 53.9,489
PCV,≥3 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,95.3,91.1 to 97.9,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2018,Age,0-3 Days,80.9,74.1 to 86.3,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2018-2019,Age,0-3 Days,81.2,76.3 to 85.3,489
Polio,≥1 Dose,States/Local Areas,South Carolina,2019,Age,3 Months,91.2,85.7 to 94.7,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,69.6,63.8 to 75.3,501
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.7,64.6 to 82.7,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,76.6,71.5 to 81.7,440
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2019,Age,0-3 Days,81.5,73.9 to 87.2,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,69.6,61.2 to 76.8,244
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,72.1,66.4 to 77.2,489
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,66.9,59.3 to 73.8,288
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,68.3,62.6 to 73.5,532
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,74.6,66.3 to 81.4,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,87.5,82.4 to 91.3,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,72.4,56.8 to 88.0,47
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2018,Age,0-1 Days,72.9,65.2 to 79.5,244
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2018-2019,Age,0-1 Days,76.1,70.9 to 80.7,489
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2011,Age,0-2 Days,71.2,61.9 to 79.0,252
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2019,Age,0-1 Days,79.2,71.6 to 85.2,245
Hep B,≥2 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,91.8,89.5 to 93.6,255
Hep B,≥2 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,91.7,86.1 to 95.2,251
Hep B,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,90.4,86.3 to 93.4,524
PCV,≥3 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,66.7,58.2 to 74.1,244
PCV,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,69.6,63.8 to 74.9,489
PCV,≥3 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,87.3,82.1 to 91.1,252
PCV,≥3 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,72.5,64.2 to 79.5,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,93.6,89.3 to 96.7,251
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,94.3,91.4 to 96.5,524
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,95.0,90.6 to 97.7,273
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,95.1,92.2 to 97.1,564
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,95.4,91.1 to 98.0,291
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,93.2,90.2 to 95.6,579
PCV,≥3 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,82.1,76.4 to 86.7,255
Hep B,≥2 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,93.3,89.0 to 95.9,252
≥1 Dose MMR,,States/Local Areas,South Carolina,2016,Age,24 Months,85.4,78.9 to 90.7,291
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2017,Age,24 Months,87.8,83.8 to 91.2,579
≥1 Dose MMR,,States/Local Areas,South Carolina,2017,Age,24 Months,90.1,85.2 to 94.0,288
≥1 Dose MMR,,States/Local Areas,South Carolina,2017-2018,Age,24 Months,90.4,86.6 to 93.4,532
PCV,≥4 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,74.6,66.9 to 81.0,288
PCV,≥4 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,76.2,71.0 to 80.7,532
PCV,≥4 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,77.9,70.3 to 84.0,244
PCV,≥4 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,81.2,74.8 to 86.3,382
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2015,Age,0-2 Days,69.3,61.4 to 76.2,273
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2015-2016,Age,0-2 Days,73.8,68.6 to 78.4,564
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2014,Age,0-2 Days,69.8,61.9 to 76.7,251
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2014-2015,Age,0-2 Days,69.5,64.0 to 74.6,524
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,77.3,70.3 to 84.3,395
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.3,69.2 to 79.5,635
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.2,72.6 to 83.7,508
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,65.7,50.3 to 81.1,94
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,76.5,69.9 to 83.1,440
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,78.0,72.5 to 83.6,501
≥1 Dose MMR,,States/Local Areas,South Carolina,2012,Age,24 Months,86.1,78.9 to 91.8,255
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014,Age,35 Months,93.5,89.5 to 96.4,251
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2015,Age,35 Months,93.9,91.0 to 96.1,524
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015,Age,35 Months,95.0,90.6 to 97.7,273
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015-2016,Age,35 Months,93.2,89.1 to 96.1,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2012,Age,35 Months,95.6,85.1 to 99.4,255
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013,Age,35 Months,93.7,88.7 to 97.0,261
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013-2014,Age,35 Months,93.6,90.6 to 95.9,512
PCV,≥4 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,85.2,78.3 to 90.2,245
Hep B,≥2 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,87.2,81.0 to 91.6,288
Hep B,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,91.1,87.6 to 93.7,532
PCV,≥3 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,83.9,82.0 to 85.7,261
PCV,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,85.6,84.3 to 86.9,512
Hep B,≥2 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,94.9,90.1 to 97.4,291
Hep B,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,91.0,87.3 to 93.8,579
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2016,Age,0-2 Days,78.4,71.4 to 84.1,291
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2016-2017,Age,0-2 Days,75.4,70.3 to 79.8,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,95.4,91.1 to 98.0,291
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,94.7,91.5 to 96.9,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,96.3,92.1 to 98.6,273
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,95.9,93.1 to 97.8,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,89.8,87.6 to 91.7,261
PCV,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,91.4,90.1 to 92.5,512
PCV,≥3 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,91.2,87.7 to 93.8,252
PCV,≥3 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,92.8,87.9 to 95.8,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,94.2,89.4 to 97.3,288
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,94.8,91.8 to 96.9,532
PCV,≥3 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,89.1,75.5 to 95.6,255
Hib,Full Series,States/Local Areas,South Carolina,2020,Age,24 Months,70.6,62.3 to 78.5,243
PCV,≥4 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,82.3,73.8 to 89.3,255
PCV,≥4 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,80.7,73.5 to 86.9,252
PCV,≥4 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,86.2,79.7 to 91.4,245
PCV,≥4 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,82.4,75.7 to 88.2,244
PCV,≥4 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,84.3,79.8 to 88.3,489
PCV,≥3 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,88.3,81.8 to 92.7,291
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,86.1,81.6 to 89.6,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,91.0,85.5 to 95.0,261
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,94.7,91.5 to 97.0,512
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,97.6,95.3 to 98.9,251
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,97.0,94.9 to 98.4,524
Hep B,≥3 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,89.9,83.2 to 94.8,255
Hep B,≥2 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,94.1,90.6 to 96.4,255
Hep B,≥2 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,95.2,90.3 to 97.7,252
Hep B,≥2 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,93.2,87.2 to 96.5,245
PCV,≥3 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,83.9,77.0 to 89.0,288
PCV,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,87.5,83.1 to 90.8,532
PCV,≥3 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,91.1,84.9 to 94.9,244
PCV,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,92.0,88.3 to 94.6,489
PCV,≥4 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,81.8,74.9 to 87.7,291
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,80.6,75.8 to 85.0,579
PCV,≥4 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,79.5,72.6 to 85.6,288
PCV,≥4 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,81.0,76.3 to 85.3,532
≥1 Dose MMR,,States/Local Areas,South Carolina,2015,Age,35 Months,92.0,87.2 to 95.5,273
≥1 Dose MMR,,States/Local Areas,South Carolina,2015-2016,Age,35 Months,91.5,87.4 to 94.6,564
≥1 Dose MMR,,States/Local Areas,South Carolina,2014,Age,35 Months,94.2,90.7 to 96.8,251
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2015,Age,35 Months,93.2,90.4 to 95.5,524
≥1 Dose MMR,,States/Local Areas,South Carolina,2016,Age,35 Months,90.5,83.6 to 95.3,291
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2017,Age,35 Months,91.4,87.3 to 94.6,579
PCV,≥4 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,81.9,75.1 to 87.8,273
PCV,≥4 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,81.9,77.1 to 86.1,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018,Age,35 Months,94.1,88.6 to 97.5,244
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018-2019,Age,35 Months,93.3,89.7 to 96.0,489
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,90.9,87.5 to 94.3,440
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,91.1,88.0 to 94.2,501
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019,Age,35 Months,92.6,87.5 to 96.2,245
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.0,88.2 to 97.8,131
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,64.3,47.8 to 80.8,47
PCV,≥3 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,90.2,84.1 to 94.1,273
PCV,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,89.3,85.1 to 92.4,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,87.3,80.5 to 92.0,251
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,88.7,84.3 to 92.0,524
Hep B,≥2 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,89.1,82.5 to 93.4,273
Hep B,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,92.0,88.1 to 94.6,564
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,91.7,86.4 to 95.5,244
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,92.4,88.8 to 95.1,489
≥1 Dose MMR,,States/Local Areas,South Carolina,2013,Age,35 Months,90.7,85.2 to 94.7,261
≥1 Dose MMR,,States/Local Areas,South Carolina,2013-2014,Age,35 Months,92.5,89.3 to 95.1,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016,Age,35 Months,91.3,84.4 to 96.0,291
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2017,Age,35 Months,91.1,87.0 to 94.3,579
≥1 Dose MMR,,States/Local Areas,South Carolina,2012,Age,35 Months,91.0,82.1 to 96.6,255
≥1 Dose MMR,,States/Local Areas,South Carolina,2011,Age,35 Months,89.4,81.5 to 94.9,252
≥1 Dose MMR,,States/Local Areas,South Carolina,2018,Age,24 Months,90.5,84.4 to 95.0,244
≥1 Dose MMR,,States/Local Areas,South Carolina,2018-2019,Age,24 Months,92.0,88.4 to 94.8,489
≥1 Dose MMR,,States/Local Areas,South Carolina,2019,Age,24 Months,93.4,89.3 to 96.3,245
PCV,≥4 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,79.9,73.0 to 85.9,261
PCV,≥4 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,83.4,78.9 to 87.4,512
PCV,≥4 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,86.9,81.0 to 91.7,251
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,84.4,80.0 to 88.3,524
PCV,≥4 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,79.2,71.3 to 86.2,255
Hep B,≥3 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,95.0,90.8 to 97.7,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,91.3,86.6 to 94.9,288
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,91.5,88.1 to 94.2,532
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,93.0,87.8 to 96.6,245
PCV,≥4 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,79.5,72.3 to 85.8,252
Hep B,≥2 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,93.0,90.9 to 94.6,261
Hep B,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,94.2,92.7 to 95.3,512
Hep B,≥2 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,95.0,90.2 to 97.5,273
Hep B,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,95.6,92.6 to 97.4,564
Hep B,≥2 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,95.3,91.3 to 97.6,251
Hep B,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,95.2,92.3 to 97.0,524
Hib,≥1 Dose,States/Local Areas,South Carolina,2014,Age,3 Months,88.3,82.7 to 92.2,251
Hib,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,3 Months,86.7,81.9 to 90.4,524
Hib,≥1 Dose,States/Local Areas,South Carolina,2011,Age,3 Months,86.1,83.5 to 88.3,252
Hib,≥1 Dose,States/Local Areas,South Carolina,2012,Age,3 Months,85.9,78.4 to 91.0,255
Hib,≥1 Dose,States/Local Areas,South Carolina,2013,Age,3 Months,86.7,81.9 to 90.4,261
Hib,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,3 Months,87.5,81.8 to 91.6,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,91.2,85.3 to 97.1,140
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017,Age,35 Months,90.4,85.1 to 94.5,288
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017-2018,Age,35 Months,92.4,88.8 to 95.2,532
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2017,Age,0-2 Days,72.3,64.8 to 78.8,288
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2017-2018,Age,0-2 Days,76.2,71.2 to 80.6,532
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2018,Age,0-2 Days,80.1,73.3 to 85.6,244
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2018-2019,Age,0-2 Days,80.8,75.9 to 84.9,489
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2019,Age,0-2 Days,81.4,73.8 to 87.2,245
Hep B,≥2 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,94.9,91.4 to 97.1,244
Hep B,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,94.0,90.8 to 96.2,489
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.5,85.0 to 92.0,508
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,86.5,76.3 to 96.8,94
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,88.3,84.1 to 92.4,327
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Overall,Overall,89.8,87.4 to 92.2,997
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,91.8,88.7 to 94.9,423
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,89.1 to 95.2,395
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.6,86.5 to 92.6,635
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,70.8 to 91.1,91
≥1 Dose MMR,,States/Local Areas,South Carolina,2019,Age,35 Months,95.2,91.4 to 97.6,245
≥1 Dose MMR,,States/Local Areas,South Carolina,2017,Age,35 Months,92.3,87.2 to 95.9,288
≥1 Dose MMR,,States/Local Areas,South Carolina,2017-2018,Age,35 Months,93.2,89.6 to 95.8,532
≥1 Dose MMR,,States/Local Areas,South Carolina,2018,Age,35 Months,94.0,88.4 to 97.5,244
≥1 Dose MMR,,States/Local Areas,South Carolina,2018-2019,Age,35 Months,94.7,91.4 to 96.9,489
Hep B,≥2 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,92.8,87.8 to 95.8,288
Hep B,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,94.8,92.0 to 96.7,532
Hib,≥1 Dose,States/Local Areas,South Carolina,2017,Age,3 Months,84.2,77.6 to 89.1,288
Hib,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,3 Months,85.3,80.7 to 88.9,532
Hib,≥1 Dose,States/Local Areas,South Carolina,2016,Age,3 Months,92.2,86.6 to 95.6,291
Hib,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,3 Months,88.2,84.1 to 91.3,579
Hib,≥1 Dose,States/Local Areas,South Carolina,2015,Age,3 Months,85.2,77.1 to 90.7,273
Hib,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,3 Months,88.6,83.9 to 92.1,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,92.3,87.0 to 95.5,291
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,90.6,87.0 to 93.3,579
PCV,≥3 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,92.3,89.7 to 94.3,273
PCV,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,92.3,88.7 to 94.8,564
Hep B,≥2 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,96.2,91.6 to 98.3,291
Hep B,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,94.5,91.4 to 96.5,579
Hep B,≥2 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,96.8,93.5 to 98.5,244
Hep B,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,96.4,93.9 to 97.9,489
PCV,≥4 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,88.6,82.8 to 93.1,251
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,87.4,82.9 to 91.1,524
PCV,≥4 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,86.4,79.2 to 92.0,273
PCV,≥4 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,87.3,82.4 to 91.4,564
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,91.6,88.7 to 94.5,501
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,88.8,85.1 to 92.6,440
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,75.0 to 94.3,91
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,89.3,82.3 to 96.3,140
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.3,84.7 to 96.0,131
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,73.1,58.0 to 88.2,47
PCV,≥4 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,83.5,76.5 to 89.3,261
PCV,≥4 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,86.0,81.6 to 89.9,512
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,95.5,91.6 to 98.0,244
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,94.8,91.7 to 97.1,489
PCV,≥3 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,92.9,87.5 to 96.1,251
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,92.6,89.0 to 95.1,524
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,94.1,88.9 to 97.4,245
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,89.1,83.8 to 94.4,247
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,92.6,89.6 to 95.6,395
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.5,86.6 to 92.5,635
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.5,67.5 to 89.4,131
≥1 Dose Varicella,,States/Local Areas,South Carolina,2011,Age,35 Months,91.1,84.7 to 95.6,252
Hib,≥1 Dose,States/Local Areas,South Carolina,2018,Age,3 Months,86.3,79.4 to 91.2,244
Hib,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,3 Months,88.3,84.0 to 91.6,489
Hib,≥1 Dose,States/Local Areas,South Carolina,2019,Age,3 Months,90.2,84.6 to 94.0,245
PCV,≥3 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,90.3,84.3 to 94.7,261
PCV,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,92.4,88.9 to 95.1,512
PCV,≥3 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,89.1,81.8 to 94.4,255
PCV,≥3 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,94.5,90.6 to 97.2,251
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,93.6,90.4 to 95.9,524
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,87.8,84.1 to 91.5,501
PCV,≥4 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,88.4,82.1 to 93.3,245
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.2,74.5 to 89.8,131
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,86.6,80.0 to 93.3,140
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,82.9,78.2 to 87.5,440
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,57.8,40.8 to 74.8,47
PCV,≥1 Dose,States/Local Areas,South Carolina,2013,Age,3 Months,85.7,82.1 to 88.7,261
PCV,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,3 Months,87.0,82.8 to 90.2,512
Hib,≥2 Doses,States/Local Areas,South Carolina,2016,Age,5 Months,80.4,72.9 to 86.3,291
Hib,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,5 Months,78.1,73.0 to 82.4,579
Hib,≥2 Doses,States/Local Areas,South Carolina,2015,Age,5 Months,72.4,63.7 to 79.7,273
Hib,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,5 Months,76.4,70.7 to 81.3,564
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,87.6,83.3 to 91.9,327
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Overall,Overall,89.2,86.7 to 91.7,997
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.7,82.9 to 90.6,508
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,87.5,77.5 to 97.6,94
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,89.2,84.1 to 94.3,247
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,90.8,87.3 to 94.4,423
PCV,≥1 Dose,States/Local Areas,South Carolina,2011,Age,3 Months,85.9,83.0 to 88.3,252
PCV,≥4 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,89.6,81.3 to 95.3,244
PCV,≥4 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,88.6,83.9 to 92.5,489
PCV,≥4 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,87.8,80.8 to 93.2,291
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,84.7,79.8 to 89.0,579
PCV,≥4 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,81.4,74.6 to 87.3,288
PCV,≥4 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,85.5,80.0 to 90.2,532
PCV,≥3 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,89.0,83.3 to 92.9,288
PCV,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,91.8,88.3 to 94.3,532
Hib,≥2 Doses,States/Local Areas,South Carolina,2014,Age,5 Months,78.2,70.7 to 84.1,251
Hib,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,5 Months,75.3,71.4 to 78.8,524
Hib,≥2 Doses,States/Local Areas,South Carolina,2013,Age,5 Months,74.4,69.4 to 78.8,261
Hib,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,5 Months,76.3,72.8 to 79.4,512
Hib,≥2 Doses,States/Local Areas,South Carolina,2011,Age,5 Months,77.1,73.9 to 80.0,252
Hib,≥2 Doses,States/Local Areas,South Carolina,2012,Age,5 Months,74.2,68.6 to 79.0,255
Hep B,≥2 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,96.0,91.6 to 98.1,245
PCV,≥3 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,94.6,89.8 to 97.2,244
PCV,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,92.0,88.3 to 94.6,489
PCV,≥3 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,92.0,86.7 to 95.8,252
PCV,≥3 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,94.2,89.3 to 96.9,245
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,83.8,80.8 to 86.9,997
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,77.4,65.1 to 89.8,94
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.1,80.0 to 88.3,508
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,86.0,74.3 to 97.7,47
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,84.7,80.1 to 89.3,423
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,78.9,73.2 to 84.5,327
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,92.3,88.8 to 95.8,247
Hib,≥2 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,85.4,78.4 to 90.4,251
Hib,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,84.5,79.1 to 88.7,524
Hib,≥2 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,87.2,84.2 to 89.6,261
Hib,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,86.3,84.7 to 87.7,512
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2012,Age,0-3 Days,72.4,64.2 to 79.3,255
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,84.8,80.1 to 89.5,395
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2011,Age,0-3 Days,71.4,63.0 to 78.6,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,94.3,91.5 to 97.2,440
PCV,≥1 Dose,States/Local Areas,South Carolina,2017,Age,3 Months,84.5,78.0 to 89.4,288
PCV,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,3 Months,86.6,82.2 to 90.0,532
PCV,≥1 Dose,States/Local Areas,South Carolina,2016,Age,3 Months,90.4,84.6 to 94.2,291
PCV,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,3 Months,87.5,83.3 to 90.7,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.6 to 96.9,501
Hib,≥2 Doses,States/Local Areas,South Carolina,2018,Age,5 Months,76.8,68.6 to 83.3,244
Hib,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,5 Months,77.9,72.4 to 82.5,489
Hib,≥2 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,87.3,81.3 to 91.5,252
Hib,≥2 Doses,States/Local Areas,South Carolina,2019,Age,5 Months,78.9,71.2 to 85.0,245
PCV,≥3 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,92.6,87.4 to 96.2,273
PCV,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,92.4,89.1 to 95.1,564
Hib,≥2 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,84.6,80.7 to 87.9,255
PCV,≥3 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,92.3,87.5 to 95.7,291
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,91.1,87.6 to 93.9,579
PCV,≥3 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,89.8,84.5 to 93.9,288
PCV,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,92.3,89.0 to 94.9,532
PCV,≥1 Dose,States/Local Areas,South Carolina,2015,Age,3 Months,83.5,75.4 to 89.3,273
PCV,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,3 Months,86.9,82.1 to 90.6,564
PCV,≥1 Dose,States/Local Areas,South Carolina,2014,Age,3 Months,88.2,82.6 to 92.1,251
PCV,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,3 Months,85.8,81.0 to 89.6,524
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.6,80.9 to 88.3,635
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.8,70.6 to 90.9,91
Hib,≥2 Doses,States/Local Areas,South Carolina,2017,Age,5 Months,75.7,68.5 to 81.7,288
Hib,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,5 Months,76.2,70.8 to 80.9,532
PCV,≥1 Dose,States/Local Areas,South Carolina,2012,Age,3 Months,84.1,79.2 to 88.1,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014,Age,0-3 Days,70.3,62.3 to 77.2,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2014-2015,Age,0-3 Days,70.1,64.6 to 75.2,524
Polio,≥1 Dose,States/Local Areas,South Carolina,2013,Age,3 Months,86.9,82.5 to 90.3,261
Polio,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,3 Months,88.3,83.7 to 91.7,512
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2013,Age,0-3 Days,72.6,65.1 to 79.0,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2013-2014,Age,0-3 Days,71.4,66.0 to 76.3,512
Polio,≥1 Dose,States/Local Areas,South Carolina,2011,Age,3 Months,87.1,84.9 to 89.0,252
Polio,≥1 Dose,States/Local Areas,South Carolina,2012,Age,3 Months,84.7,79.3 to 89.0,255
PCV,≥1 Dose,States/Local Areas,South Carolina,2019,Age,3 Months,92.4,87.0 to 95.6,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,94.1,92.2 to 95.9,997
PCV,≥1 Dose,States/Local Areas,South Carolina,2018,Age,3 Months,88.6,82.1 to 93.0,244
PCV,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,3 Months,90.5,86.6 to 93.4,489
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.4,90.6 to 96.3,508
PCV,≥3 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,94.8,90.5 to 97.6,244
PCV,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,95.1,92.2 to 97.1,489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016,Age,0-3 Days,78.6,71.6 to 84.3,291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2016-2017,Age,0-3 Days,76.2,71.2 to 80.6,579
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2017,Age,0-3 Days,75.8,65.7 to 83.6,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2017-2018,Age,0-3 Days,77.3,72.4 to 81.6,532
Polio,≥1 Dose,States/Local Areas,South Carolina,2016,Age,3 Months,91.8,86.4 to 95.2,291
Polio,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,3 Months,88.7,84.6 to 91.8,579
Polio,≥1 Dose,States/Local Areas,South Carolina,2015,Age,3 Months,85.6,77.5 to 91.1,273
Polio,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,3 Months,88.7,84.0 to 92.1,564
Polio,≥1 Dose,States/Local Areas,South Carolina,2014,Age,3 Months,89.7,84.3 to 93.5,251
Polio,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,3 Months,87.7,83.0 to 91.2,524
Hib,≥3 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,34.9,32.4 to 37.4,261
Hib,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,32.2,31.3 to 33.2,512
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,93.5,90.0 to 96.9,327
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,94.6,91.2 to 98.0,247
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,94.5,92.0 to 97.0,423
Hib,≥3 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,36.3,31.5 to 41.4,255
Hib,≥3 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,55.1,50.6 to 59.4,252
PCV,≥3 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,92.3,87.5 to 95.7,291
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,95.1,90.4 to 98.0,579
PCV,≥3 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,94.1,89.7 to 97.0,273
PCV,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,93.4,90.3 to 95.8,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,95.9,92.7 to 98.0,251
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,95.0,92.4 to 97.0,524
DTaP,≥3 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,73.1,68.7 to 77.1,252
DTaP,≥3 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,60.1,55.0 to 64.9,255
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,71.3,68.9 to 73.5,261
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,70.5,66.8 to 73.9,512
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,93.1,85.2 to 100.0,94
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,95.0,92.7 to 97.4,395
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.1,91.9 to 96.3,635
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.4,87.9 to 98.9,91
PCV,≥3 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,91.0,83.0 to 96.2,255
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.7,90.0 to 99.4,131
PCV,≥3 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,91.7,86.0 to 95.7,261
PCV,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,93.8,90.7 to 96.2,512
PCV,≥3 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,94.1,88.2 to 97.7,252
PCV,≥3 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,95.3,91.1 to 97.9,245
Hib,≥2 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,83.6,75.0 to 89.6,273
Hib,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,86.7,81.6 to 90.5,564
Hib,≥2 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,90.7,84.7 to 94.5,244
Hib,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,89.9,85.6 to 93.0,489
Hib,≥2 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,82.8,76.0 to 88.0,288
Hib,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,86.7,82.4 to 90.1,532
Hib,≥2 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,89.8,83.8 to 93.8,291
Hib,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,86.3,82.0 to 89.7,579
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,69.4,61.1 to 76.5,291
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,68.2,62.6 to 73.2,579
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2015,Age,0-3 Days,70.0,62.1 to 76.9,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Carolina,2015-2016,Age,0-3 Days,74.2,69.0 to 78.8,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,69.7,61.6 to 76.8,251
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,68.5,62.8 to 73.7,524
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,67.4,59.3 to 74.5,273
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,68.4,62.7 to 73.5,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,96.3,91.1 to 98.9,288
PCV,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,95.8,91.9 to 98.2,532
Hib,≥2 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,92.4,89.9 to 94.3,261
Hib,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,93.2,91.6 to 94.5,512
Hib,≥3 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,29.6,22.8 to 37.3,251
Hib,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,32.1,27.2 to 37.5,524
PCV,≥3 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,95.2,90.8 to 97.9,244
PCV,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,95.3,92.4 to 97.3,489
Hib,≥3 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,39.4,32.1 to 47.2,291
Hib,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,38.4,33.3 to 43.8,579
Hib,≥3 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,34.6,27.7 to 42.3,273
Hib,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,37.0,31.8 to 42.4,564
Polio,≥1 Dose,States/Local Areas,South Carolina,2017,Age,3 Months,85.5,79.0 to 90.3,288
Polio,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,3 Months,86.6,82.1 to 90.1,532
Polio,≥1 Dose,States/Local Areas,South Carolina,2018,Age,3 Months,87.6,80.9 to 92.2,244
Polio,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,3 Months,89.4,85.3 to 92.5,489
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,53.2,35.7 to 70.6,47
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016,Age,35 Months,88.7,82.5 to 93.4,291
Hep A,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,35 Months,89.6,85.6 to 92.9,579
DTaP,≥4 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,79.3,72.4 to 85.4,273
DTaP,≥4 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,81.5,76.8 to 85.7,564
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,83.6,77.1 to 89.1,291
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,78.5,73.6 to 82.9,579
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,78.9,71.2 to 85.6,251
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,79.1,74.0 to 83.8,524
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014,Age,35 Months,86.9,80.7 to 91.9,251
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,35 Months,89.6,85.7 to 92.8,524
Hep A,≥1 Dose,States/Local Areas,South Carolina,2013,Age,35 Months,87.5,81.3 to 92.5,261
Hep A,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,35 Months,87.3,83.0 to 90.9,512
Hep A,≥2 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,39.1,31.3 to 48.1,255
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,46.5,38.2 to 55.5,251
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,44.7,39.2 to 50.6,524
Hep A,≥2 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,43.0,35.8 to 50.9,273
Hep A,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,41.4,36.1 to 47.1,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,94.7,93.0 to 96.5,997
Hib,≥3 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,93.8,88.3 to 97.3,244
Hib,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,92.2,88.2 to 95.2,489
Hib,≥3 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,90.5,84.3 to 94.9,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.4,91.8 to 97.1,508
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,93.7,88.3 to 99.1,94
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,93.0 to 97.8,395
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,92.8 to 97.0,635
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,85.7 to 97.9,91
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,94.7,90.4 to 99.0,140
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.5,91.1 to 99.8,131
PCV,≥2 Doses,States/Local Areas,South Carolina,2018,Age,5 Months,77.2,69.0 to 83.8,244
PCV,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,5 Months,78.5,73.0 to 83.1,489
PCV,≥2 Doses,States/Local Areas,South Carolina,2017,Age,5 Months,74.4,67.0 to 80.6,288
PCV,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,5 Months,75.8,70.3 to 80.6,532
PCV,≥2 Doses,States/Local Areas,South Carolina,2019,Age,5 Months,79.6,71.8 to 85.7,245
DTaP,≥4 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,64.4,56.7 to 71.5,288
DTaP,≥4 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,64.7,59.2 to 69.8,532
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,71.2,63.6 to 77.7,291
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,67.8,62.5 to 72.7,579
Hep A,≥2 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,37.9,30.8 to 46.0,261
Hep A,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,42.1,36.6 to 48.1,512
DTaP,≥4 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,64.9,56.8 to 72.2,244
DTaP,≥4 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,94.8,91.7 to 96.7,489
Polio,≥2 Doses,States/Local Areas,South Carolina,2014,Age,5 Months,79.0,71.6 to 84.9,251
Polio,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,5 Months,77.6,74.0 to 80.8,524
Polio,≥2 Doses,States/Local Areas,South Carolina,2013,Age,5 Months,75.6,70.4 to 80.1,261
Polio,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,5 Months,77.3,74.4 to 80.0,512
Hep A,≥1 Dose,States/Local Areas,South Carolina,2012,Age,35 Months,89.1,78.6 to 95.8,255
Polio,≥2 Doses,States/Local Areas,South Carolina,2011,Age,5 Months,78.1,74.4 to 81.4,252
Polio,≥2 Doses,States/Local Areas,South Carolina,2012,Age,5 Months,73.8,68.3 to 78.7,255
≥1 Dose MMR,,States/Local Areas,South Carolina,2013,Age,13 Months,40.8,38.6 to 43.0,261
≥1 Dose MMR,,States/Local Areas,South Carolina,2013-2014,Age,13 Months,45.8,41.6 to 50.1,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018,Age,13 Months,56.4,48.3 to 64.2,244
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018-2019,Age,13 Months,59.6,53.8 to 65.0,489
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,91.5,81.1 to 97.4,251
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,89.2,83.8 to 93.3,524
DTaP,≥4 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,86.4,76.4 to 93.7,255
DTaP,≥4 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,84.4,77.0 to 90.4,261
DTaP,≥4 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,87.4,80.8 to 92.5,512
Hep B,≥3 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,84.9,81.3 to 87.9,255
Hep A,≥2 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,84.0,76.0 to 90.5,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,88.6,82.0 to 92.9,251
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,88.6,84.4 to 91.8,524
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,83.6,80.9 to 86.0,261
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,86.1,83.7 to 88.2,512
Hep A,≥2 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,79.6,70.0 to 87.7,288
Hep A,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,84.6,77.1 to 90.7,532
Hep A,≥2 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,89.3,77.6 to 96.5,244
Hep A,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,85.1,79.1 to 90.2,489
Hep B,≥3 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,86.7,82.1 to 90.2,252
Polio,≥2 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,87.2,80.1 to 92.0,273
Polio,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,88.6,84.2 to 91.9,564
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,84.4,79.4 to 89.4,327
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Overall,Overall,86.8,84.1 to 89.5,997
Polio,≥2 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,87.8,85.2 to 90.0,261
Polio,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,86.5,85.5 to 87.4,512
Polio,≥2 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,85.2,78.0 to 90.4,251
Polio,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,86.2,81.4 to 89.9,524
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.6,81.8 to 89.4,508
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,76.2,63.1 to 89.3,94
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,87.0 to 94.1,395
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.0,83.7 to 90.3,635
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,76.6 to 95.4,91
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,96.7,94.5 to 98.9,247
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,95.5,93.1 to 97.9,423
Hep B,≥3 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,54.8,47.7 to 61.6,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,57.1,48.2 to 65.5,255
DTaP,≥4 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,77.4,69.3 to 84.6,255
DTaP,≥4 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,76.3,68.7 to 83.2,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,61.1,55.7 to 66.2,261
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,61.7,57.3 to 65.9,512
DTaP,≥4 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,76.8,69.3 to 82.9,245
DTaP,≥4 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,77.1,70.0 to 83.6,261
DTaP,≥4 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,77.9,72.7 to 82.7,512
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,39.7,32.3 to 48.0,291
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,40.5,35.2 to 46.2,579
Hep A,≥2 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,41.2,34.0 to 49.3,288
Hep A,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,44.4,38.8 to 50.3,532
≥1 Dose Varicella,,States/Local Areas,South Carolina,2020,Age,24 Months,88.7,81.7 to 93.9,243
≥1 Dose MMR,,States/Local Areas,South Carolina,2015,Age,13 Months,55.7,47.8 to 63.3,273
≥1 Dose MMR,,States/Local Areas,South Carolina,2015-2016,Age,13 Months,53.4,47.8 to 58.9,564
≥1 Dose MMR,,States/Local Areas,South Carolina,2014,Age,13 Months,50.7,42.5 to 59.0,251
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2015,Age,13 Months,53.2,47.4 to 58.9,524
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,89.3,85.8 to 92.8,423
≥1 Dose Varicella,,States/Local Areas,South Carolina,2012,Age,19 Months,82.3,71.6 to 89.6,255
≥1 Dose Varicella,,States/Local Areas,South Carolina,2011,Age,19 Months,86.4,80.6 to 90.7,252
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019,Age,13 Months,62.6,54.6 to 70.0,245
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015,Age,13 Months,53.5,45.5 to 61.3,273
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015-2016,Age,13 Months,53.3,47.7 to 58.8,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017,Age,13 Months,55.3,47.6 to 62.7,288
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017-2018,Age,13 Months,55.9,50.3 to 61.3,532
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016,Age,13 Months,53.0,45.2 to 60.7,291
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2017,Age,13 Months,54.2,48.7 to 59.6,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,60.1,52.1 to 67.6,273
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,61.9,56.3 to 67.2,564
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,62.3,54.1 to 69.8,251
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,61.2,55.5 to 66.6,524
Polio,≥2 Doses,States/Local Areas,South Carolina,2017,Age,5 Months,76.8,69.6 to 82.7,288
Polio,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,5 Months,77.0,71.5 to 81.7,532
Polio,≥2 Doses,States/Local Areas,South Carolina,2016,Age,5 Months,79.1,71.5 to 85.1,291
Polio,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,5 Months,77.9,72.9 to 82.3,579
Hep A,≥1 Dose,States/Local Areas,South Carolina,2017,Age,35 Months,90.1,84.5 to 94.3,288
Hep A,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,35 Months,92.8,88.7 to 95.8,532
Hep A,≥1 Dose,States/Local Areas,South Carolina,2015,Age,35 Months,92.2,87.4 to 95.7,273
Hep A,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,35 Months,90.6,86.6 to 93.8,564
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,79.7,74.5 to 84.9,423
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,69.4,63.0 to 75.8,327
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Overall,Overall,75.8,72.2 to 79.4,997
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,67.5,54.1 to 80.9,94
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,78.2,72.6 to 83.8,395
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.1,72.8 to 81.4,635
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.8,61.8 to 83.8,91
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,79.9,71.9 to 87.9,140
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.4,70.4 to 80.3,508
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.8,90.2 to 99.3,131
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,81.8,75.1 to 88.5,247
Hib,Primary Series,States/Local Areas,South Carolina,2011,Age,7 Months,79.9,75.7 to 83.6,252
Hep A,≥2 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,73.6,63.4 to 82.8,261
Hep A,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,73.2,66.8 to 79.3,512
Hep A,≥2 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,66.6,56.1 to 76.8,255
Hep A,≥2 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,69.7,59.0 to 79.8,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,63.7,55.8 to 70.9,291
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,61.3,55.8 to 66.5,579
Polio,≥2 Doses,States/Local Areas,South Carolina,2015,Age,5 Months,76.1,68.1 to 82.6,273
Polio,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,5 Months,77.6,72.2 to 82.2,564
Hep A,≥2 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,50.7,42.6 to 59.3,245
Hep A,≥2 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,47.6,39.6 to 56.3,244
Hep A,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,49.1,43.4 to 55.2,489
Polio,≥2 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,88.7,83.2 to 92.6,252
Polio,≥2 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,84.0,80.3 to 87.1,255
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,86.6,79.5 to 93.8,140
Polio,≥2 Doses,States/Local Areas,South Carolina,2019,Age,5 Months,80.5,72.8 to 86.4,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,58.8,51.1 to 66.1,288
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,62.2,56.5 to 67.5,532
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,65.6,57.6 to 72.7,244
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,60.2,54.4 to 65.7,489
Hep A,≥2 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,76.1,67.3 to 83.9,273
Hep A,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,78.4,72.1 to 84.2,564
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,80.9,71.4 to 88.8,291
Hep A,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,80.1,73.5 to 86.0,579
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,74.6,66.1 to 82.3,251
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,75.2,69.1 to 80.8,524
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,55.0,46.7 to 63.0,245
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014,Age,13 Months,48.9,40.8 to 57.1,251
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2015,Age,13 Months,51.2,45.4 to 56.9,524
≥1 Dose Varicella,,States/Local Areas,South Carolina,2012,Age,13 Months,48.2,44.4 to 51.9,255
Hep A,≥1 Dose,States/Local Areas,South Carolina,2018,Age,35 Months,95.4,87.6 to 98.9,244
Hep A,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,35 Months,94.3,90.5 to 96.9,489
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,87.4,83.3 to 91.5,440
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,88.0,84.5 to 91.4,501
Hep A,≥1 Dose,States/Local Areas,South Carolina,2019,Age,35 Months,93.7,89.2 to 96.8,245
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.8,80.4 to 93.3,131
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,65.1,48.9 to 81.2,47
Polio,≥2 Doses,States/Local Areas,South Carolina,2018,Age,5 Months,77.2,69.0 to 83.7,244
Polio,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,5 Months,78.9,73.4 to 83.5,489
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013,Age,13 Months,47.4,44.4 to 50.4,261
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013-2014,Age,13 Months,48.1,43.9 to 52.4,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2011,Age,13 Months,56.3,50.3 to 62.1,252
DTaP,≥4 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,82.4,73.1 to 90.0,252
DTaP,≥4 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,82.9,76.1 to 88.6,245
Polio,≥2 Doses,States/Local Areas,South Carolina,2011,Age,13 Months,91.7,85.8 to 95.3,252
Polio,≥2 Doses,States/Local Areas,South Carolina,2012,Age,13 Months,91.1,87.2 to 93.9,255
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013,Age,19 Months,89.7,87.1 to 91.8,261
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013-2014,Age,19 Months,88.5,86.4 to 90.3,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015,Age,19 Months,86.6,83.6 to 89.1,273
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015-2016,Age,19 Months,85.8,81.4 to 89.2,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014,Age,19 Months,87.3,81.2 to 91.7,251
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2015,Age,19 Months,87.0,82.8 to 90.2,524
≥1 Dose MMR,,States/Local Areas,South Carolina,2017,Age,13 Months,54.1,46.5 to 61.6,288
≥1 Dose MMR,,States/Local Areas,South Carolina,2017-2018,Age,13 Months,59.0,53.3 to 64.4,532
≥1 Dose MMR,,States/Local Areas,South Carolina,2016,Age,13 Months,51.0,43.2 to 58.8,291
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2017,Age,13 Months,52.6,47.1 to 58.0,579
≥1 Dose MMR,,States/Local Areas,South Carolina,2018,Age,13 Months,63.8,55.6 to 71.4,244
≥1 Dose MMR,,States/Local Areas,South Carolina,2018-2019,Age,13 Months,66.9,61.3 to 72.1,489
Hep B,≥1 Dose,States/Local Areas,South Carolina,2016,Age,3 Months,97.8,94.2 to 99.2,291
Hep B,≥1 Dose,States/Local Areas,South Carolina,2016-2017,Age,3 Months,96.1,93.4 to 97.7,579
Hep B,≥1 Dose,States/Local Areas,South Carolina,2015,Age,3 Months,93.1,87.1 to 96.4,273
Hep B,≥1 Dose,States/Local Areas,South Carolina,2015-2016,Age,3 Months,95.4,92.1 to 97.4,564
Hep B,≥1 Dose,States/Local Areas,South Carolina,2014,Age,3 Months,95.7,92.0 to 97.7,251
Hep B,≥1 Dose,States/Local Areas,South Carolina,2014-2015,Age,3 Months,94.4,91.1 to 96.5,524
Polio,≥2 Doses,States/Local Areas,South Carolina,2013,Age,13 Months,92.4,89.8 to 94.3,261
Polio,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,13 Months,93.0,91.3 to 94.4,512
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.7,64.0 to 89.5,91
DTaP,≥4 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,73.5,66.3 to 80.2,288
DTaP,≥4 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,77.0,72.0 to 81.6,532
DTaP,≥4 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,80.6,73.7 to 86.7,244
DTaP,≥4 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,81.8,77.0 to 86.1,489
≥1 Dose MMR,,States/Local Areas,South Carolina,2011,Age,13 Months,43.8,35.8 to 52.1,252
≥1 Dose MMR,,States/Local Areas,South Carolina,2012,Age,13 Months,42.7,36.7 to 49.0,255
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,93.2,89.7 to 96.6,327
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,90.0,78.8 to 100.0,140
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,75.1,67.7 to 82.4,327
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,76.9,72.6 to 81.2,997
Polio,≥2 Doses,States/Local Areas,South Carolina,2019,Age,7 Months,91.2,85.0 to 95.0,245
Polio,≥2 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,83.7,76.8 to 88.8,288
Polio,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,87.6,83.4 to 90.9,532
Polio,≥2 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,90.0,84.0 to 93.9,291
Polio,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,86.8,82.5 to 90.2,579
Hep B,≥1 Dose,States/Local Areas,South Carolina,2011,Age,3 Months,93.8,91.2 to 95.7,252
Hep B,≥1 Dose,States/Local Areas,South Carolina,2012,Age,3 Months,94.4,91.4 to 96.4,255
Hep B,≥1 Dose,States/Local Areas,South Carolina,2013,Age,3 Months,94.3,90.5 to 96.6,261
Hep B,≥1 Dose,States/Local Areas,South Carolina,2013-2014,Age,3 Months,95.0,91.6 to 97.1,512
Polio,≥2 Doses,States/Local Areas,South Carolina,2018,Age,7 Months,91.5,85.7 to 95.1,244
Polio,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,7 Months,91.4,87.4 to 94.2,489
Hep A,≥1 Dose,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,86.9,81.4 to 92.4,247
Hep A,≥1 Dose,States/Local Areas,South Carolina,2020,Age,35 Months,89.7,82.8 to 94.7,243
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,<133% FPL,76.0,70.2 to 81.8,327
≥1 Dose Varicella,,States/Local Areas,South Carolina,2012,Age,24 Months,86.9,79.7 to 92.5,255
≥1 Dose Varicella,,States/Local Areas,South Carolina,2011,Age,24 Months,89.7,84.1 to 94.0,252
≥1 Dose MMR,,States/Local Areas,South Carolina,2016,Age,19 Months,83.1,76.1 to 88.4,291
≥1 Dose MMR,,States/Local Areas,South Carolina,2016-2017,Age,19 Months,85.4,81.0 to 88.9,579
≥1 Dose MMR,,States/Local Areas,South Carolina,2015,Age,19 Months,87.0,85.1 to 88.7,273
≥1 Dose MMR,,States/Local Areas,South Carolina,2015-2016,Age,19 Months,85.1,80.5 to 88.7,564
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,82.1,73.7 to 90.5,140
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.4,73.9 to 82.9,635
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,66.0 to 87.9,91
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Overall,Overall,79.5,76.1 to 83.0,997
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a Non-MSA,68.2,55.0 to 81.5,94
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.6,75.0 to 84.2,508
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,81.9,76.5 to 87.2,395
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,93.0,91.5 to 94.3,273
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,93.4,89.9 to 95.7,564
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,93.3,88.5 to 96.2,251
Hep B,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,93.2,89.7 to 95.5,524
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,77.3,68.9 to 85.7,247
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,89.1,86.9 to 90.9,261
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,91.2,88.6 to 93.3,512
Hep B,≥2 Doses,States/Local Areas,South Carolina,2013,Age,5 Months,86.8,85.7 to 87.9,261
Hep B,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,5 Months,88.2,86.2 to 89.9,512
Hep B,≥2 Doses,States/Local Areas,South Carolina,2011,Age,5 Months,86.3,81.8 to 89.8,252
Hep B,≥2 Doses,States/Local Areas,South Carolina,2012,Age,5 Months,84.3,78.4 to 88.9,255
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,78.8,72.2 to 85.3,423
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2011,Age,0-1 Days,61.1,52.6 to 69.0,252
Hep B,≥1 Dose,States/Local Areas,South Carolina,2018,Age,3 Months,96.9,93.2 to 98.7,244
Hep B,≥1 Dose,States/Local Areas,South Carolina,2018-2019,Age,3 Months,96.6,93.8 to 98.1,489
Polio,≥2 Doses,States/Local Areas,South Carolina,2014,Age,13 Months,93.6,88.7 to 96.5,251
Polio,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,13 Months,94.5,91.4 to 96.5,524
Hep B,≥1 Dose,States/Local Areas,South Carolina,2019,Age,3 Months,96.2,91.4 to 98.4,245
Hep B,≥3 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,89.4,81.2 to 94.3,255
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,87.6,81.4 to 92.0,244
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,89.7,85.7 to 92.7,489
Hep B,≥3 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,93.4,88.4 to 96.4,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,91.7,85.7 to 95.3,245
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.2,73.4 to 89.0,131
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,56.2,39.3 to 73.2,47
≥1 Dose MMR,,States/Local Areas,South Carolina,2011,Age,19 Months,85.3,81.8 to 88.2,252
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,78.4,73.4 to 83.4,440
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,83.6,79.0 to 88.3,501
DTaP,≥4 Doses,States/Local Areas,South Carolina,2019,Age,35 Months,89.0,82.3 to 94.0,245
DTaP,≥4 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,87.6,81.1 to 92.6,244
DTaP,≥4 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,88.3,83.8 to 92.0,489
≥1 Dose MMR,,States/Local Areas,South Carolina,2012,Age,19 Months,82.0,73.9 to 88.0,255
≥1 Dose MMR,,States/Local Areas,South Carolina,2014,Age,19 Months,87.3,81.4 to 91.6,251
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2015,Age,19 Months,87.2,83.0 to 90.4,524
≥1 Dose MMR,,States/Local Areas,South Carolina,2013,Age,19 Months,89.6,86.7 to 91.9,261
≥1 Dose MMR,,States/Local Areas,South Carolina,2013-2014,Age,19 Months,88.5,86.5 to 90.2,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017,Age,19 Months,86.2,80.2 to 90.6,288
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017-2018,Age,19 Months,88.0,83.9 to 91.1,532
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018,Age,19 Months,89.7,83.5 to 93.8,244
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018-2019,Age,19 Months,59.6,53.8 to 65.0,489
Hep B,≥1 Dose,States/Local Areas,South Carolina,2017,Age,3 Months,94.4,89.7 to 97.0,288
Hep B,≥1 Dose,States/Local Areas,South Carolina,2017-2018,Age,3 Months,95.7,92.9 to 97.4,532
Polio,≥2 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,93.1,88.1 to 96.2,291
Polio,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,91.7,88.1 to 94.3,579
Polio,≥2 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,95.4,90.8 to 97.7,273
Polio,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,94.3,91.2 to 96.3,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016,Age,19 Months,84.9,78.2 to 89.8,291
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2017,Age,19 Months,85.6,81.3 to 89.0,579
≥1 Dose MMR,,States/Local Areas,South Carolina,2019,Age,13 Months,69.9,62.0 to 76.8,245
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,>400% FPL,83.2,76.2 to 90.3,247
DTaP,≥4 Doses,States/Local Areas,South Carolina,2014-2017,Poverty,133% to <400% FPL,81.5,76.4 to 86.7,423
PCV,≥3 Doses,States/Local Areas,South Carolina,2012,Age,7 Months,56.4,51.1 to 61.5,255
PCV,≥3 Doses,States/Local Areas,South Carolina,2014,Age,7 Months,65.8,57.5 to 73.1,251
PCV,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,7 Months,65.0,59.3 to 70.4,524
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,93.7,88.8 to 96.6,291
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,91.9,88.6 to 94.4,579
PCV,≥3 Doses,States/Local Areas,South Carolina,2011,Age,7 Months,70.5,64.8 to 75.7,252
PCV,≥3 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,63.8,58.7 to 68.6,261
PCV,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,64.8,60.1 to 69.2,512
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2012,Age,0-1 Days,61.3,53.9 to 68.2,255
Hep B,≥2 Doses,States/Local Areas,South Carolina,2014,Age,5 Months,89.5,83.8 to 93.4,251
Hep B,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,5 Months,87.8,84.5 to 90.5,524
Hep B,≥2 Doses,States/Local Areas,South Carolina,2016,Age,5 Months,93.1,88.1 to 96.1,291
Hep B,≥2 Doses,States/Local Areas,South Carolina,2016-2017,Age,5 Months,89.7,85.9 to 92.6,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,90.1,84.9 to 93.7,288
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,90.9,87.2 to 93.6,532
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,91.7,85.8 to 95.2,244
Hep B,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,89.7,85.7 to 92.7,489
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,86.7,80.5 to 91.1,288
Hep B,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,87.1,83.0 to 90.4,532
DTaP,≥4 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,89.3,82.7 to 94.1,273
DTaP,≥4 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,90.3,85.7 to 94.0,564
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015,Age,13 Months,88.7,82.6 to 92.8,273
Hep B,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,13 Months,90.3,86.6 to 93.1,564
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016,Age,13 Months,92.0,86.9 to 95.3,291
Hep B,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,13 Months,89.4,85.5 to 92.3,579
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,91.0,83.7 to 96.0,291
DTaP,≥4 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,89.7,84.7 to 93.5,579
DTaP,≥4 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,88.2,81.2 to 93.5,288
DTaP,≥4 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,87.9,83.1 to 91.9,532
Hep A,≥2 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,70.8,49.9 to 91.7,47
Hep B,≥2 Doses,States/Local Areas,South Carolina,2015,Age,5 Months,86.1,79.5 to 90.8,273
Hep B,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,5 Months,89.6,85.6 to 92.5,564
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2014,Age,0-1 Days,64.3,56.0 to 71.7,251
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2014-2015,Age,0-1 Days,63.8,58.1 to 69.2,524
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2013,Age,0-1 Days,66.3,64.8 to 67.7,261
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2013-2014,Age,0-1 Days,65.3,61.2 to 69.1,512
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013,Age,24 Months,91.7,86.4 to 95.5,261
≥1 Dose Varicella,,States/Local Areas,South Carolina,2013-2014,Age,24 Months,92.1,89.0 to 94.7,512
Polio,≥2 Doses,States/Local Areas,South Carolina,2017,Age,13 Months,90.2,84.5 to 94.0,288
Polio,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,13 Months,92.3,88.9 to 94.8,532
Polio,≥2 Doses,States/Local Areas,South Carolina,2018,Age,13 Months,94.5,89.7 to 97.1,244
Polio,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,13 Months,94.8,91.7 to 96.7,489
Polio,≥2 Doses,States/Local Areas,South Carolina,2019,Age,13 Months,95.0,90.5 to 97.5,245
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019,Age,19 Months,89.2,83.3 to 93.1,245
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016,Age,24 Months,87.1,81.0 to 92.0,291
≥1 Dose Varicella,,States/Local Areas,South Carolina,2016-2017,Age,24 Months,87.8,83.9 to 91.1,579
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015,Age,24 Months,90.5,85.6 to 94.3,273
≥1 Dose Varicella,,States/Local Areas,South Carolina,2015-2016,Age,24 Months,88.8,85.0 to 92.0,564
≥1 Dose MMR,,States/Local Areas,South Carolina,2011,Age,24 Months,87.4,81.1 to 92.4,252
PCV,≥4 Doses,States/Local Areas,South Carolina,2011,Age,19 Months,77.2,73.2 to 80.7,252
PCV,≥4 Doses,States/Local Areas,South Carolina,2012,Age,19 Months,75.1,68.2 to 80.9,255
PCV,≥4 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,77.2,71.6 to 82.0,261
PCV,≥4 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,79.8,77.2 to 82.2,512
≥1 Dose MMR,,States/Local Areas,South Carolina,2018,Age,19 Months,89.1,82.3 to 93.5,244
≥1 Dose MMR,,States/Local Areas,South Carolina,2018-2019,Age,19 Months,94.1,90.7 to 96.3,489
≥1 Dose MMR,,States/Local Areas,South Carolina,2019,Age,19 Months,91.3,86.2 to 94.7,245
≥1 Dose MMR,,States/Local Areas,South Carolina,2017,Age,19 Months,87.7,81.9 to 91.9,288
≥1 Dose MMR,,States/Local Areas,South Carolina,2017-2018,Age,19 Months,88.4,84.2 to 91.6,532
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2017,Age,0-1 Days,68.9,61.3 to 75.7,288
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2017-2018,Age,0-1 Days,70.9,65.6 to 75.7,532
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2016,Age,0-1 Days,73.7,66.4 to 79.9,291
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2016-2017,Age,0-1 Days,71.3,66.1 to 76.0,579
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014,Age,24 Months,92.6,88.4 to 95.6,251
≥1 Dose Varicella,,States/Local Areas,South Carolina,2014-2015,Age,24 Months,91.5,88.4 to 94.1,524
Hep B,≥2 Doses,States/Local Areas,South Carolina,2017,Age,5 Months,86.4,80.0 to 90.9,288
Hep B,≥2 Doses,States/Local Areas,South Carolina,2017-2018,Age,5 Months,89.1,85.2 to 92.1,532
Hep B,≥2 Doses,States/Local Areas,South Carolina,2019,Age,5 Months,90.2,83.3 to 94.5,245
Hep B,≥2 Doses,States/Local Areas,South Carolina,2018,Age,5 Months,91.8,86.6 to 95.1,244
Hep B,≥2 Doses,States/Local Areas,South Carolina,2018-2019,Age,5 Months,91.0,86.9 to 93.9,489
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2015,Age,0-1 Days,63.4,55.4 to 70.8,273
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Carolina,2015-2016,Age,0-1 Days,68.5,63.1 to 73.4,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017,Age,24 Months,88.5,83.3 to 92.6,288
≥1 Dose Varicella,,States/Local Areas,South Carolina,2017-2018,Age,24 Months,89.8,86.2 to 92.9,532
≥1 Dose Varicella,,States/Local Areas,South Carolina,2019,Age,24 Months,90.4,85.1 to 94.5,245
≥1 Dose MMR,,States/Local Areas,South Carolina,2013,Age,24 Months,90.3,84.9 to 94.4,261
≥1 Dose MMR,,States/Local Areas,South Carolina,2013-2014,Age,24 Months,90.7,87.3 to 93.4,512
≥1 Dose MMR,,States/Local Areas,South Carolina,2014,Age,24 Months,91.0,86.5 to 94.4,251
≥1 Dose MMR,,States/Local Areas,South Carolina,2014-2015,Age,24 Months,90.9,87.8 to 93.5,524
≥1 Dose MMR,,States/Local Areas,South Carolina,2015,Age,24 Months,90.8,86.1 to 94.5,273
≥1 Dose MMR,,States/Local Areas,South Carolina,2015-2016,Age,24 Months,88.2,84.2 to 91.5,564
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018,Age,24 Months,91.2,85.6 to 95.3,244
≥1 Dose Varicella,,States/Local Areas,South Carolina,2018-2019,Age,24 Months,90.8,87.1 to 93.8,489
PCV,≥4 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,76.4,68.7 to 82.7,291
PCV,≥4 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,75.5,70.2 to 80.1,579
PCV,≥4 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,76.0,67.8 to 82.6,273
PCV,≥4 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,76.2,70.8 to 80.8,564
PCV,≥4 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,82.4,75.5 to 87.7,251
PCV,≥4 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,79.2,74.0 to 83.6,524
PCV,≥3 Doses,States/Local Areas,South Carolina,2015,Age,7 Months,64.3,56.2 to 71.6,273
PCV,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,7 Months,65.0,59.3 to 70.3,564
PCV,≥3 Doses,States/Local Areas,South Carolina,2017,Age,7 Months,64.1,56.4 to 71.1,288
PCV,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,7 Months,65.4,59.6 to 70.7,532
Hep B,≥3 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,89.9,83.2 to 94.8,255
PCV,≥3 Doses,States/Local Areas,South Carolina,2016,Age,7 Months,65.6,57.5 to 72.9,291
PCV,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,7 Months,64.9,59.3 to 70.0,579
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,89.3,83.8 to 93.6,261
Hep B,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,91.5,88.1 to 94.2,512
Hep B,≥3 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,94.9,90.8 to 97.6,252
Hep B,≥3 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,93.0,87.2 to 96.3,245
Hep B,≥2 Doses,States/Local Areas,South Carolina,2013,Age,7 Months,90.4,86.9 to 93.0,261
Hep B,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,7 Months,91.1,88.2 to 93.3,512
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2012,Age,0-2 Days,71.0,67.2 to 74.5,255
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2013,Age,0-2 Days,70.2,68.2 to 72.0,261
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Carolina,2013-2014,Age,0-2 Days,70.0,64.0 to 75.4,512
Hib,Full Series,States/Local Areas,South Carolina,2018,Age,35 Months,79.4,71.5 to 86.3,244
Hib,Full Series,States/Local Areas,South Carolina,2018-2019,Age,35 Months,79.2,73.9 to 84.1,489
Hib,Full Series,States/Local Areas,South Carolina,2019,Age,35 Months,78.7,71.3 to 85.3,245
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,94.8,92.3 to 97.2,395
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.5,91.2 to 95.8,635
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,85.1 to 97.5,91
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,Hispanic,94.5,90.1 to 98.8,140
Polio,≥3 Doses,States/Local Areas,South Carolina,2018,Age,35 Months,96.0,91.5 to 98.5,244
Polio,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,35 Months,94.7,91.5 to 97.0,489
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.1,62.9 to 81.3,131
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,73.6,68.3 to 79.0,440
Hib,Full Series,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,80.9,76.2 to 85.6,501
Hib,Full Series,States/Local Areas,South Carolina,2016,Age,35 Months,83.8,75.6 to 90.5,291
Hib,Full Series,States/Local Areas,South Carolina,2016-2017,Age,35 Months,80.9,75.4 to 85.8,579
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Any Medicaid,93.5,90.6 to 96.4,440
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Uninsured,84.0,70.6 to 97.3,47
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2017,Insurance Coverage,Private Insurance Only,95.6,93.7 to 97.4,501
Hib,Full Series,States/Local Areas,South Carolina,2014,Age,35 Months,77.3,69.5 to 84.3,251
Hib,Full Series,States/Local Areas,South Carolina,2014-2015,Age,35 Months,77.2,71.6 to 82.4,524
Polio,≥3 Doses,States/Local Areas,South Carolina,2012,Age,35 Months,92.2,83.8 to 97.2,255
Hib,Full Series,States/Local Areas,South Carolina,2017,Age,35 Months,77.4,70.2 to 83.8,288
Hib,Full Series,States/Local Areas,South Carolina,2017-2018,Age,35 Months,78.4,73.2 to 83.2,532
Hib,Full Series,States/Local Areas,South Carolina,2015,Age,35 Months,77.3,69.3 to 84.5,273
Hib,Full Series,States/Local Areas,South Carolina,2015-2016,Age,35 Months,80.6,75.1 to 85.6,564
Hib,Full Series,States/Local Areas,South Carolina,2013,Age,35 Months,80.5,72.9 to 87.1,261
Hib,Full Series,States/Local Areas,South Carolina,2013-2014,Age,35 Months,78.9,73.4 to 83.9,512
Hib,Full Series,States/Local Areas,South Carolina,2012,Age,35 Months,84.4,75.1 to 91.7,255
Hib,Full Series,States/Local Areas,South Carolina,2011,Age,35 Months,83.6,74.0 to 91.2,252
Hib,Full Series,States/Local Areas,South Carolina,2018,Age,24 Months,75.0,67.2 to 82.1,244
Hib,Full Series,States/Local Areas,South Carolina,2018-2019,Age,24 Months,76.0,70.8 to 81.0,489
Hib,Full Series,States/Local Areas,South Carolina,2019,Age,24 Months,77.0,69.7 to 83.7,245
Polio,≥3 Doses,States/Local Areas,South Carolina,2013,Age,35 Months,93.6,88.6 to 96.9,261
Polio,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,35 Months,95.5,92.7 to 97.4,512
Polio,≥3 Doses,States/Local Areas,South Carolina,2014,Age,35 Months,97.5,95.3 to 98.9,251
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,35 Months,96.4,94.0 to 98.1,524
DTaP,≥2 Doses,States/Local Areas,South Carolina,2011,Age,5 Months,78.1,74.4 to 81.4,252
DTaP,≥2 Doses,States/Local Areas,South Carolina,2012,Age,5 Months,74.8,69.4 to 79.6,255
DTaP,≥2 Doses,States/Local Areas,South Carolina,2013,Age,5 Months,76.2,70.9 to 80.9,261
DTaP,≥2 Doses,States/Local Areas,South Carolina,2013-2014,Age,5 Months,79.0,75.9 to 81.8,512
Polio,≥3 Doses,States/Local Areas,South Carolina,2015,Age,35 Months,95.3,91.0 to 97.9,273
Polio,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,35 Months,94.6,91.7 to 96.8,564
DTaP,≥2 Doses,States/Local Areas,South Carolina,2015,Age,5 Months,76.2,68.2 to 82.7,273
DTaP,≥2 Doses,States/Local Areas,South Carolina,2015-2016,Age,5 Months,78.3,72.9 to 82.8,564
Polio,≥3 Doses,States/Local Areas,South Carolina,2016,Age,35 Months,93.8,89.3 to 96.9,291
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,35 Months,93.4,90.4 to 95.8,579
Polio,≥3 Doses,States/Local Areas,South Carolina,2017,Age,35 Months,92.9,88.5 to 96.1,288
Polio,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,35 Months,95.0,91.6 to 97.3,532
Hib,≥3 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,85.9,79.1 to 91.4,252
Hib,≥3 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,86.9,79.8 to 92.5,255
Hib,≥3 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,87.5,81.6 to 92.3,261
Hib,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,90.1,86.5 to 93.0,512
DTaP,≥2 Doses,States/Local Areas,South Carolina,2014,Age,5 Months,81.8,74.7 to 87.3,251
DTaP,≥2 Doses,States/Local Areas,South Carolina,2014-2015,Age,5 Months,79.0,75.2 to 82.3,524
Hib,Full Series,States/Local Areas,South Carolina,2016,Age,24 Months,78.0,71.0 to 84.3,291
Hib,Full Series,States/Local Areas,South Carolina,2016-2017,Age,24 Months,76.5,71.6 to 81.2,579
Hib,Full Series,States/Local Areas,South Carolina,2017,Age,24 Months,75.2,68.1 to 81.8,288
Hib,Full Series,States/Local Areas,South Carolina,2017-2018,Age,24 Months,75.1,70.0 to 79.9,532
Hib,Full Series,States/Local Areas,South Carolina,2015,Age,24 Months,72.0,64.2 to 79.4,273
Hib,Full Series,States/Local Areas,South Carolina,2015-2016,Age,24 Months,75.0,69.7 to 79.9,564
Polio,≥3 Doses,States/Local Areas,South Carolina,2011,Age,35 Months,95.4,89.2 to 98.6,252
DTaP,≥3 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,90.7,83.8 to 95.4,255
Polio,≥3 Doses,States/Local Areas,South Carolina,2017,Age,24 Months,91.6,87.1 to 95.0,288
Polio,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,24 Months,92.6,89.6 to 95.0,532
Polio,≥3 Doses,States/Local Areas,South Carolina,2018,Age,24 Months,93.7,89.3 to 96.7,244
Polio,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,24 Months,93.6,90.3 to 96.1,489
Polio,≥3 Doses,States/Local Areas,South Carolina,2019,Age,24 Months,93.6,88.3 to 97.0,245
Hib,≥3 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,86.7,79.9 to 91.4,245
DTaP,≥3 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,93.6,88.4 to 97.0,252
DTaP,≥3 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,92.8,86.8 to 96.2,245
Hib,≥3 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,87.9,81.6 to 92.2,244
Hib,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,62.1,56.3 to 67.5,489
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,94.2,89.4 to 96.9,244
DTaP,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,91.8,88.1 to 94.5,489
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,93.4,88.3 to 96.4,291
DTaP,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,92.9,89.7 to 95.2,579
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,92.4,87.7 to 95.4,288
DTaP,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,93.3,90.2 to 95.5,532
Hib,≥3 Doses,States/Local Areas,South Carolina,2016,Age,19 Months,88.1,82.0 to 92.3,291
Hib,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,19 Months,85.8,81.5 to 89.3,579
Polio,≥3 Doses,States/Local Areas,South Carolina,2016,Age,24 Months,93.8,89.3 to 96.9,291
Polio,≥3 Doses,States/Local Areas,South Carolina,2016-2017,Age,24 Months,92.7,89.6 to 95.1,579
Hib,≥3 Doses,States/Local Areas,South Carolina,2017,Age,19 Months,83.6,76.8 to 88.7,288
Hib,≥3 Doses,States/Local Areas,South Carolina,2017-2018,Age,19 Months,85.7,81.3 to 89.3,532
Hep B,≥3 Doses,States/Local Areas,South Carolina,2020,Age,24 Months,91.1,84.6 to 95.7,243
Hib,≥3 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,80.9,76.5 to 84.6,273
Hib,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,84.4,79.5 to 88.4,564
Polio,≥3 Doses,States/Local Areas,South Carolina,2013,Age,24 Months,92.9,87.9 to 96.4,261
Polio,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,24 Months,93.8,90.8 to 96.1,512
Hib,≥3 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,85.3,82.0 to 88.1,261
Hib,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,86.6,85.5 to 87.6,512
Hib,≥3 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,87.9,82.0 to 92.0,251
Hib,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,84.4,79.5 to 88.3,524
Polio,≥3 Doses,States/Local Areas,South Carolina,2012,Age,24 Months,89.6,82.9 to 94.6,255
Polio,≥3 Doses,States/Local Areas,South Carolina,2011,Age,24 Months,92.7,87.4 to 96.4,252
Polio,≥3 Doses,States/Local Areas,South Carolina,2019,Age,19 Months,92.8,86.8 to 96.2,245
Polio,≥3 Doses,States/Local Areas,South Carolina,2018,Age,19 Months,92.5,87.2 to 95.7,244
Polio,≥3 Doses,States/Local Areas,South Carolina,2018-2019,Age,19 Months,66.9,61.3 to 72.1,489
Polio,≥3 Doses,States/Local Areas,South Carolina,2014,Age,24 Months,94.9,91.1 to 97.4,251
Polio,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,24 Months,94.7,92.0 to 96.7,524
Polio,≥3 Doses,States/Local Areas,South Carolina,2015,Age,24 Months,94.6,90.4 to 97.4,273
Polio,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,24 Months,94.2,91.2 to 96.4,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015,Age,19 Months,93.3,92.2 to 94.3,273
DTaP,≥3 Doses,States/Local Areas,South Carolina,2015-2016,Age,19 Months,93.3,89.9 to 95.7,564
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014,Age,19 Months,93.7,88.6 to 96.6,251
DTaP,≥3 Doses,States/Local Areas,South Carolina,2014-2015,Age,19 Months,93.5,90.0 to 95.8,524
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013,Age,19 Months,93.5,92.0 to 94.7,261
DTaP,≥3 Doses,States/Local Areas,South Carolina,2013-2014,Age,19 Months,93.6,92.5 to 94.6,512
Combined 7 Series,,States/Local Areas,Virginia,2011,Age,35 Months,75.4,64.7 to 84.9,277
Hib,Primary Series,States/Local Areas,Virginia,2014,Age,7 Months,78.4,70.1 to 84.9,351
Hib,Primary Series,States/Local Areas,Virginia,2014-2015,Age,7 Months,77.5,71.7 to 82.4,725
Combined 7 Series,,States/Local Areas,Virginia,2019,Age,24 Months,78.2,71.5 to 84.2,452
Combined 7 Series,,States/Local Areas,Virginia,2016,Age,24 Months,76.1,68.6 to 82.9,389
Combined 7 Series,,States/Local Areas,Virginia,2016-2017,Age,24 Months,72.4,66.9 to 77.7,808
Hib,Primary Series,States/Local Areas,Virginia,2019,Age,35 Months,97.5,93.8 to 99.2,452
Hib,Primary Series,States/Local Areas,Virginia,2018,Age,35 Months,94.8,89.3 to 98.0,551
Hib,Primary Series,States/Local Areas,Virginia,2018-2019,Age,35 Months,95.9,92.9 to 97.9,1003
Combined 7 Series,,States/Local Areas,Virginia,2015,Age,24 Months,71.7,63.3 to 79.7,374
Combined 7 Series,,States/Local Areas,Virginia,2015-2016,Age,24 Months,73.9,68.3 to 79.2,763
Hib,Primary Series,States/Local Areas,Virginia,2017,Age,24 Months,92.1,86.8 to 95.8,419
Hib,Primary Series,States/Local Areas,Virginia,2017-2018,Age,24 Months,92.2,88.4 to 95.1,970
Hib,Primary Series,States/Local Areas,Virginia,2018,Age,24 Months,92.2,87.2 to 95.8,551
Hib,Primary Series,States/Local Areas,Virginia,2018-2019,Age,24 Months,94.9,91.9 to 97.0,1003
Hib,Primary Series,States/Local Areas,Virginia,2016,Age,24 Months,96.2,91.8 to 98.6,389
Hib,Primary Series,States/Local Areas,Virginia,2016-2017,Age,24 Months,94.2,90.9 to 96.6,808
Hib,Primary Series,States/Local Areas,Virginia,2014,Age,24 Months,95.6,90.6 to 98.3,351
Hib,Primary Series,States/Local Areas,Virginia,2014-2015,Age,24 Months,94.9,91.6 to 97.2,725
Hib,Primary Series,States/Local Areas,Virginia,2015,Age,24 Months,94.2,89.3 to 97.3,374
Hib,Primary Series,States/Local Areas,Virginia,2015-2016,Age,24 Months,95.1,91.9 to 97.3,763
Hib,Primary Series,States/Local Areas,Virginia,2014,Age,35 Months,95.6,90.6 to 98.3,351
Hib,Primary Series,States/Local Areas,Virginia,2014-2015,Age,35 Months,94.9,91.6 to 97.2,725
Hib,Primary Series,States/Local Areas,Virginia,2017,Age,35 Months,92.1,86.9 to 95.9,419
Hib,Primary Series,States/Local Areas,Virginia,2017-2018,Age,35 Months,93.2,89.4 to 96.1,970
Combined 7 Series,,States/Local Areas,Virginia,2018,Age,24 Months,71.9,64.8 to 78.7,551
Combined 7 Series,,States/Local Areas,Virginia,2018-2019,Age,24 Months,75.0,70.1 to 79.6,1003
Combined 7 Series,,States/Local Areas,Virginia,2017,Age,24 Months,68.8,60.7 to 76.7,419
Combined 7 Series,,States/Local Areas,Virginia,2017-2018,Age,24 Months,70.3,64.9 to 75.6,970
Combined 7 Series,,States/Local Areas,Virginia,2014,Age,24 Months,76.2,68.0 to 83.6,351
Combined 7 Series,,States/Local Areas,Virginia,2014-2015,Age,24 Months,74.1,68.2 to 79.6,725
Combined 7 Series,,States/Local Areas,Virginia,2013,Age,24 Months,63.6,55.2 to 72.0,357
Combined 7 Series,,States/Local Areas,Virginia,2013-2014,Age,24 Months,69.8,63.8 to 75.5,708
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.5,62.2 to 84.8,93
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,71.9 to 91.1,222
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.0,68.3 to 79.7,829
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.2,69.5 to 80.9,673
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,71.4,64.5 to 78.3,604
Hib,Primary Series,States/Local Areas,Virginia,2018,Age,13 Months,83.7,77.0 to 88.7,551
Hib,Primary Series,States/Local Areas,Virginia,2018-2019,Age,13 Months,87.7,83.6 to 90.9,1003
≥1 Dose MMR,,States/Local Areas,Virginia,2020,Age,13 Months,64.3,57.6 to 70.4,494
Hib,Primary Series,States/Local Areas,Virginia,2017,Age,13 Months,83.2,75.2 to 88.9,419
Hib,Primary Series,States/Local Areas,Virginia,2017-2018,Age,13 Months,83.4,78.3 to 87.6,970
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,61.1,50.5 to 71.7,127
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,78.3,58.1 to 98.6,39
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Overall,Overall,73.7,69.4 to 78.0,1316
Hib,Primary Series,States/Local Areas,Virginia,2018,Age,7 Months,70.2,62.6 to 76.8,551
Hib,Primary Series,States/Local Areas,Virginia,2018-2019,Age,7 Months,74.4,69.2 to 78.9,1003
Hib,Primary Series,States/Local Areas,Virginia,2011,Age,13 Months,93.8,90.7 to 95.9,277
Hib,Primary Series,States/Local Areas,Virginia,2012,Age,13 Months,84.7,81.3 to 87.5,342
Hib,Primary Series,States/Local Areas,Virginia,2013,Age,13 Months,82.6,76.9 to 87.1,357
Hib,Primary Series,States/Local Areas,Virginia,2013-2014,Age,13 Months,87.5,82.4 to 91.2,708
Hib,Primary Series,States/Local Areas,Virginia,2016,Age,19 Months,95.8,90.5 to 98.2,389
Hib,Primary Series,States/Local Areas,Virginia,2016-2017,Age,19 Months,93.6,90.0 to 96.0,808
Hib,Primary Series,States/Local Areas,Virginia,2011,Age,19 Months,94.2,90.8 to 96.4,277
Hib,Primary Series,States/Local Areas,Virginia,2013,Age,19 Months,90.7,87.7 to 93.0,357
Hib,Primary Series,States/Local Areas,Virginia,2013-2014,Age,19 Months,93.1,89.8 to 95.3,708
Hib,Primary Series,States/Local Areas,Virginia,2016,Age,13 Months,89.6,83.1 to 93.8,389
Hib,Primary Series,States/Local Areas,Virginia,2016-2017,Age,13 Months,86.5,81.5 to 90.2,808
Hib,Primary Series,States/Local Areas,Virginia,2014,Age,19 Months,95.4,89.7 to 98.1,351
Hib,Primary Series,States/Local Areas,Virginia,2014-2015,Age,19 Months,94.8,91.2 to 97.0,725
Hib,Primary Series,States/Local Areas,Virginia,2012,Age,19 Months,87.5,83.6 to 90.6,342
Combined 7 Series,,States/Local Areas,Virginia,2012,Age,35 Months,64.0,54.9 to 73.1,342
Combined 7 Series,,States/Local Areas,Virginia,2014,Age,35 Months,82.6,74.2 to 89.6,351
Combined 7 Series,,States/Local Areas,Virginia,2014-2015,Age,35 Months,79.4,73.2 to 85.1,725
Combined 7 Series,,States/Local Areas,Virginia,2016,Age,35 Months,77.8,70.3 to 84.5,389
Combined 7 Series,,States/Local Areas,Virginia,2016-2017,Age,35 Months,75.5,70.0 to 80.6,808
Combined 7 Series,,States/Local Areas,Virginia,2017,Age,35 Months,73.2,65.1 to 80.7,419
Combined 7 Series,,States/Local Areas,Virginia,2017-2018,Age,35 Months,76.1,70.5 to 81.3,970
Combined 7 Series,,States/Local Areas,Virginia,2013,Age,35 Months,72.1,63.1 to 80.5,357
Combined 7 Series,,States/Local Areas,Virginia,2013-2014,Age,35 Months,77.6,71.2 to 83.3,708
Hib,Primary Series,States/Local Areas,Virginia,2019,Age,19 Months,96.7,92.3 to 98.6,452
Hib,Primary Series,States/Local Areas,Virginia,2017,Age,7 Months,72.8,63.9 to 80.2,419
Hib,Primary Series,States/Local Areas,Virginia,2017-2018,Age,7 Months,71.5,65.7 to 76.7,970
Hib,Primary Series,States/Local Areas,Virginia,2016,Age,7 Months,77.5,69.5 to 83.8,389
Hib,Primary Series,States/Local Areas,Virginia,2016-2017,Age,7 Months,75.2,69.4 to 80.2,808
Hib,Primary Series,States/Local Areas,Virginia,2017,Age,19 Months,91.3,85.4 to 95.0,419
Hib,Primary Series,States/Local Areas,Virginia,2017-2018,Age,19 Months,91.4,87.3 to 94.3,970
Hib,Primary Series,States/Local Areas,Virginia,2012,Age,7 Months,72.0,67.3 to 76.3,342
Hib,Primary Series,States/Local Areas,Virginia,2013,Age,7 Months,65.4,59.9 to 70.5,357
Hib,Primary Series,States/Local Areas,Virginia,2013-2014,Age,7 Months,71.8,66.0 to 77.0,708
Hib,Primary Series,States/Local Areas,Virginia,2015,Age,7 Months,76.7,68.3 to 83.4,374
Hib,Primary Series,States/Local Areas,Virginia,2015-2016,Age,7 Months,77.1,71.5 to 81.8,763
Hib,Primary Series,States/Local Areas,Virginia,2014,Age,13 Months,92.4,86.5 to 95.9,351
Hib,Primary Series,States/Local Areas,Virginia,2014-2015,Age,13 Months,91.9,88.0 to 94.7,725
Hib,Primary Series,States/Local Areas,Virginia,2015,Age,13 Months,91.5,85.3 to 95.2,374
Hib,Primary Series,States/Local Areas,Virginia,2015-2016,Age,13 Months,90.5,86.4 to 93.5,763
Hib,Primary Series,States/Local Areas,Virginia,2015,Age,19 Months,94.2,91.0 to 96.3,374
Hib,Primary Series,States/Local Areas,Virginia,2015-2016,Age,19 Months,95.0,91.6 to 97.1,763
Hib,Primary Series,States/Local Areas,Virginia,2011,Age,24 Months,94.2,87.4 to 98.0,277
Hib,Primary Series,States/Local Areas,Virginia,2012,Age,24 Months,90.8,84.2 to 95.4,342
Hib,Primary Series,States/Local Areas,Virginia,2019,Age,13 Months,91.8,86.4 to 95.2,452
Hib,Primary Series,States/Local Areas,Virginia,2018,Age,19 Months,91.5,85.9 to 95.0,551
Hib,Primary Series,States/Local Areas,Virginia,2018-2019,Age,19 Months,87.7,83.6 to 90.9,1003
Rotavirus,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,55.3,30.1 to 80.6,40
Rotavirus,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,86.3,82.5 to 90.1,1104
Rotavirus,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.0,66.7 to 87.4,222
Rotavirus,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.1,78.1 to 88.0,829
Rotavirus,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,79.4,73.0 to 85.8,604
Rotavirus,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,73.6,64.9 to 82.3,149
Rotavirus,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.3,64.0 to 86.6,93
Rotavirus,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,82.7,73.7 to 91.7,172
Rotavirus,,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,81.2,74.6 to 87.8,345
Rotavirus,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,78.8,63.2 to 94.4,39
Rotavirus,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.1,77.1 to 87.1,673
Rotavirus,,States/Local Areas,Virginia,2014-2017,Overall,Overall,80.7,76.9 to 84.6,1316
Rotavirus,,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,67.8,57.8 to 77.8,127
Rotavirus,,States/Local Areas,Virginia,2018,Age,8 Months,73.3,66.0 to 79.6,551
Rotavirus,,States/Local Areas,Virginia,2018-2019,Age,8 Months,77.2,72.2 to 81.5,1003
Rotavirus,,States/Local Areas,Virginia,2017,Age,8 Months,77.1,68.8 to 83.7,419
Rotavirus,,States/Local Areas,Virginia,2017-2018,Age,8 Months,75.2,69.7 to 80.0,970
Rotavirus,,States/Local Areas,Virginia,2019,Age,8 Months,81.1,74.1 to 86.6,452
Rotavirus,,States/Local Areas,Virginia,2015,Age,8 Months,76.6,68.0 to 83.4,374
Rotavirus,,States/Local Areas,Virginia,2015-2016,Age,8 Months,80.4,75.0 to 84.9,763
Rotavirus,,States/Local Areas,Virginia,2016,Age,8 Months,84.2,77.0 to 89.4,389
Rotavirus,,States/Local Areas,Virginia,2016-2017,Age,8 Months,80.7,75.4 to 85.1,808
Rotavirus,,States/Local Areas,Virginia,2014,Age,8 Months,83.1,75.3 to 88.7,351
Rotavirus,,States/Local Areas,Virginia,2014-2015,Age,8 Months,79.8,74.2 to 84.5,725
Rotavirus,,States/Local Areas,Virginia,2012,Age,8 Months,66.9,57.4 to 75.2,342
Rotavirus,,States/Local Areas,Virginia,2013,Age,8 Months,69.3,60.6 to 76.8,357
Rotavirus,,States/Local Areas,Virginia,2013-2014,Age,8 Months,76.1,70.3 to 81.1,708
Rotavirus,,States/Local Areas,Virginia,2011,Age,8 Months,73.2,62.8 to 81.5,277
Hib,Full Series,States/Local Areas,Virginia,2013,Age,24 Months,74.5,66.7 to 81.6,357
Hib,Full Series,States/Local Areas,Virginia,2013-2014,Age,24 Months,80.3,75.2 to 85.1,708
Hib,Full Series,States/Local Areas,Virginia,2012,Age,24 Months,77.4,68.9 to 84.9,342
Hib,Full Series,States/Local Areas,Virginia,2011,Age,24 Months,78.6,69.5 to 86.4,277
Hib,Full Series,States/Local Areas,Virginia,2018,Age,19 Months,73.1,65.8 to 79.4,551
Hib,Full Series,States/Local Areas,Virginia,2018-2019,Age,19 Months,94.9,91.8 to 96.8,1003
Hib,Full Series,States/Local Areas,Virginia,2016,Age,19 Months,81.6,74.3 to 87.1,389
Hib,Full Series,States/Local Areas,Virginia,2016-2017,Age,19 Months,77.9,72.5 to 82.5,808
Hib,Full Series,States/Local Areas,Virginia,2017,Age,19 Months,74.2,65.8 to 81.1,419
Hib,Full Series,States/Local Areas,Virginia,2017-2018,Age,19 Months,73.7,68.1 to 78.6,970
Hib,Full Series,States/Local Areas,Virginia,2013,Age,19 Months,71.3,64.6 to 77.1,357
Hib,Full Series,States/Local Areas,Virginia,2013-2014,Age,19 Months,74.6,69.6 to 79.1,708
Hib,Full Series,States/Local Areas,Virginia,2015,Age,19 Months,80.0,77.0 to 82.7,374
Hib,Full Series,States/Local Areas,Virginia,2015-2016,Age,19 Months,80.8,75.7 to 85.1,763
Hib,Full Series,States/Local Areas,Virginia,2014,Age,19 Months,78.1,69.5 to 84.8,351
Hib,Full Series,States/Local Areas,Virginia,2014-2015,Age,19 Months,79.1,73.5 to 83.7,725
Combined 7 Series,,States/Local Areas,Virginia,2018,Age,35 Months,79.2,71.5 to 85.9,551
Combined 7 Series,,States/Local Areas,Virginia,2018-2019,Age,35 Months,80.8,75.8 to 85.4,1003
Combined 7 Series,,States/Local Areas,Virginia,2019,Age,35 Months,82.4,75.7 to 88.2,452
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,79.2,74.7 to 83.6,1104
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,69.4,59.9 to 78.8,149
Hib,Full Series,States/Local Areas,Virginia,2019,Age,19 Months,79.3,72.5 to 84.9,452
Combined 7 Series,,States/Local Areas,Virginia,2015,Age,35 Months,75.2,66.5 to 83.1,374
Combined 7 Series,,States/Local Areas,Virginia,2015-2016,Age,35 Months,76.6,70.8 to 81.9,763
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,64.1,51.9 to 76.4,172
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,52.7,28.0 to 77.5,40
Hib,Full Series,States/Local Areas,Virginia,2011,Age,19 Months,76.8,71.6 to 81.3,277
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,71.9,64.2 to 79.7,345
Combined 7 Series,,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,82.5,77.5 to 87.4,844
Hib,Full Series,States/Local Areas,Virginia,2012,Age,19 Months,71.2,59.5 to 80.7,342
Hib,Primary Series,States/Local Areas,Virginia,2019,Age,7 Months,78.6,71.3 to 84.4,452
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,75.9,67.1 to 84.7,244
Hep B,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,44.1,39.1 to 49.1,946
Polio,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,91.7,88.0 to 94.3,804
Hib,Full Series,States/Local Areas,Virginia,2020-2021,Age,35 Months,79.1,73.8 to 84.0,804
Hep B,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,3 Months,93.8,90.4 to 96.1,804
≥1 Dose Varicella,,States/Local Areas,Virginia,2020-2021,Age,19 Months,85.7,81.3 to 89.2,804
Hib,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,5 Months,76.8,71.5 to 81.4,804
PCV,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,69.1,63.6 to 74.1,804
Hib,Primary Series,States/Local Areas,Virginia,2020-2021,Age,35 Months,91.3,87.7 to 94.2,804
Hep B,≥2 Doses,States/Local Areas,Virginia,2019-2020,Age,7 Months,93.3,90.3 to 95.4,946
DTaP,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,92.2,88.6 to 94.9,804
Rotavirus,,States/Local Areas,Virginia,2020-2021,Age,8 Months,74.7,69.3 to 79.4,804
Combined 7 Series,,States/Local Areas,Virginia,2021,Age,24 Months,67.8,60.4 to 75.1,310
Hep A,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,19 Months,81.8,77.1 to 85.7,804
DTaP,≥4 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,79.8,75.1 to 84.2,804
≥1 Dose Varicella,,States/Local Areas,Virginia,2021,Age,35 Months,92.1,84.4 to 96.9,310
DTaP,≥2 Doses,States/Local Areas,Virginia,2021,Age,5 Months,81.2,72.4 to 87.6,310
Hib,Primary Series,States/Local Areas,Virginia,2020-2021,Age,19 Months,88.8,84.5 to 92.0,804
DTaP,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,92.8,89.2 to 95.5,804
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2020-2021,Age,0-3 Days,75.2,70.3 to 79.6,804
Polio,≥2 Doses,States/Local Areas,Virginia,2021,Age,5 Months,81.1,72.3 to 87.5,310
Hep B,≥2 Doses,States/Local Areas,Virginia,2021,Age,13 Months,91.6,84.9 to 95.5,310
Polio,≥3 Doses,States/Local Areas,Virginia,2021,Age,35 Months,90.8,84.6 to 95.2,310
Hib,Full Series,States/Local Areas,Virginia,2020-2021,Age,19 Months,72.3,67.3 to 76.9,804
DTaP,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,87.5,83.0 to 90.9,804
Hep A,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,26.0,21.7 to 30.9,804
≥1 Dose MMR,,States/Local Areas,Virginia,2021,Age,19 Months,83.7,76.4 to 89.0,310
Hep B,≥2 Doses,States/Local Areas,Virginia,2021,Age,5 Months,89.0,82.4 to 93.4,310
≥1 Dose MMR,,States/Local Areas,Virginia,2020-2021,Age,13 Months,65.3,60.0 to 70.2,804
Hep B,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,89.2,85.3 to 92.1,804
DTaP,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,3 Months,88.0,83.7 to 91.3,804
Influenza,,States/Local Areas,Virginia,2021,Age,24 Months,65.6,57.7 to 73.3,310
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Virginia,2020-2021,Age,0-2 Days,74.1,69.1 to 78.5,804
≥1 Dose Varicella,,States/Local Areas,Virginia,2021,Age,13 Months,64.4,56.4 to 71.7,310
Hep B,≥3 Doses,States/Local Areas,Virginia,2021,Age,13 Months,87.4,80.8 to 92.0,310
Hep B,≥1 Dose,States/Local Areas,Virginia,2021,Age,3 Months,93.2,86.7 to 96.6,310
Polio,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,90.7,84.4 to 97.0,244
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,82.2 to 96.0,120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.7,72.7 to 82.6,974
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,90.5,84.2 to 96.8,244
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,63.8,51.8 to 75.8,244
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.9,80.4 to 95.4,300
DTaP,≥4 Doses,States/Local Areas,Virginia,2016-2019,Poverty,133% to <400% FPL,85.8,80.6 to 91.0,397
Rotavirus,,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,87.8,83.3 to 92.2,844
Influenza,,States/Local Areas,Virginia,2012,Age,24 Months,51.9,43.0 to 61.3,342
Influenza,,States/Local Areas,Virginia,2011,Age,24 Months,54.0,43.9 to 64.7,277
Influenza,,States/Local Areas,Virginia,2014,Age,24 Months,58.6,49.5 to 67.9,351
Influenza,,States/Local Areas,Virginia,2014-2015,Age,24 Months,62.6,56.4 to 68.9,725
Influenza,,States/Local Areas,Virginia,2015,Age,24 Months,66.7,58.2 to 74.9,374
Influenza,,States/Local Areas,Virginia,2015-2016,Age,24 Months,70.6,64.9 to 76.1,763
Influenza,,States/Local Areas,Virginia,2013,Age,24 Months,54.8,46.3 to 63.8,357
Influenza,,States/Local Areas,Virginia,2013-2014,Age,24 Months,56.7,50.4 to 63.1,708
Influenza,,States/Local Areas,Virginia,2014-2017,Poverty,>400% FPL,81.3,76.1 to 86.5,844
Influenza,,States/Local Areas,Virginia,2014-2017,Poverty,<133% FPL,49.3,38.6 to 60.0,127
Influenza,,States/Local Areas,Virginia,2014-2017,Poverty,133% to <400% FPL,64.2,56.0 to 72.4,345
Influenza,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Other,61.6,37.3 to 85.9,40
Influenza,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Private Insurance Only,75.7,71.0 to 80.5,1104
PCV,≥4 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,91.7,89.2 to 94.1,1368
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,68.8 to 91.9,300
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,87.1 to 99.5,300
PCV,≥3 Doses,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.8 to 98.2,1368
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,75.5 to 93.1,300
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,Hispanic,84.8,77.3 to 92.2,244
Hib,Full Series,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,88.4,85.2 to 91.6,1368
Influenza,,States/Local Areas,Virginia,2014-2017,Overall,Overall,67.7,63.2 to 72.2,1316
PCV,≥1 Dose,States/Local Areas,Virginia,2021,Age,3 Months,89.3,82.6 to 93.6,310
DTaP,≥3 Doses,States/Local Areas,Virginia,2021,Age,24 Months,90.9,84.7 to 95.3,310
Hib,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,87.2,82.8 to 90.6,804
Hep B,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,90.6,87.1 to 93.5,804
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Virginia,2021,Age,0-3 Days,76.4,68.3 to 83.0,310
≥1 Dose MMR,,States/Local Areas,Virginia,2021,Age,13 Months,66.3,58.1 to 73.5,310
≥1 Dose Varicella,,States/Local Areas,Virginia,2020-2021,Age,13 Months,61.6,56.4 to 66.6,804
DTaP,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,5 Months,80.2,75.0 to 84.6,804
Hib,≥2 Doses,States/Local Areas,Virginia,2021,Age,13 Months,91.8,85.5 to 95.5,310
PCV,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,13 Months,86.7,82.3 to 90.2,804
Hib,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,60.6,55.1 to 65.8,804
DTaP,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,71.0,65.6 to 75.9,804
≥1 Dose MMR,,States/Local Areas,Virginia,2020-2021,Age,19 Months,84.6,80.0 to 88.3,804
Polio,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,3 Months,87.7,83.4 to 91.0,804
PCV,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,3 Months,87.4,83.1 to 90.8,804
Hep A,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,75.3,68.8 to 81.4,804
Polio,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,91.6,88.0 to 94.5,804
Hib,≥3 Doses,States/Local Areas,Virginia,2021,Age,35 Months,89.3,82.8 to 94.2,310
Hib,≥3 Doses,States/Local Areas,Virginia,2021,Age,13 Months,79.0,71.4 to 85.0,310
Rotavirus,,States/Local Areas,Virginia,2021,Age,8 Months,77.4,68.9 to 84.1,310
Polio,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,92.2,88.6 to 95.0,804
Hep B,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,5 Months,88.3,84.3 to 91.4,804
≥1 Dose Varicella,,States/Local Areas,Virginia,2020-2021,Age,24 Months,89.5,85.8 to 92.6,804
Hib,Primary Series,States/Local Areas,Virginia,2021,Age,35 Months,90.6,84.3 to 95.0,310
Hib,Primary Series,States/Local Areas,Virginia,2020-2021,Age,7 Months,66.7,61.3 to 71.8,804
Hep A,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,40.3,35.2 to 45.8,804
Combined 7 Series,,States/Local Areas,Virginia,2020-2021,Age,24 Months,67.8,62.8 to 72.7,804
Hib,Full Series,States/Local Areas,Virginia,2021,Age,35 Months,79.5,71.0 to 86.8,310
Hib,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,87.5,83.1 to 90.9,804
DTaP,≥3 Doses,States/Local Areas,Virginia,2021,Age,35 Months,90.9,84.7 to 95.3,310
DTaP,≥4 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,72.5,67.4 to 77.0,804
Polio,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,89.0,84.6 to 92.2,804
PCV,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,24 Months,90.6,86.9 to 93.5,804
Polio,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,5 Months,79.8,74.6 to 84.3,804
Combined 7 Series,,States/Local Areas,Virginia,2020-2021,Age,35 Months,73.2,67.5 to 78.6,804
≥1 Dose MMR,,States/Local Areas,Virginia,2020-2021,Age,24 Months,88.0,84.1 to 91.4,804
Hib,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,3 Months,84.8,80.3 to 88.4,804
Hib,Primary Series,States/Local Areas,Virginia,2020-2021,Age,13 Months,82.8,78.1 to 86.6,804
Hep B,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,90.7,87.0 to 93.4,804
Hib,Primary Series,States/Local Areas,Virginia,2021,Age,13 Months,83.0,75.6 to 88.5,310
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Virginia,2020-2021,Age,0-1 Days,71.3,66.3 to 75.8,804
PCV,≥4 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,82.4,77.7 to 86.7,804
≥1 Dose MMR,,States/Local Areas,Virginia,2020-2021,Age,35 Months,90.4,86.2 to 93.8,804
PCV,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,89.1,84.7 to 92.3,804
Polio,≥2 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,87.5,83.1 to 90.9,804
Hep B,≥3 Doses,States/Local Areas,Virginia,2021,Age,35 Months,91.6,85.4 to 95.9,310
PCV,≥4 Doses,States/Local Areas,Virginia,2020-2021,Age,19 Months,77.5,72.6 to 81.8,804
Hib,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,35 Months,90.5,86.8 to 93.6,804
Hep B,≥3 Doses,States/Local Areas,Virginia,2020-2021,Age,7 Months,47.5,42.3 to 52.9,804
DTaP,≥4 Doses,States/Local Areas,Virginia,2021,Age,35 Months,83.4,74.8 to 90.4,310
Influenza,,States/Local Areas,Virginia,2020-2021,Age,24 Months,63.7,58.5 to 68.9,804
Hep A,≥1 Dose,States/Local Areas,Virginia,2020-2021,Age,35 Months,90.3,85.9 to 93.8,804
Influenza,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.2,59.0 to 81.3,222
Influenza,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,Hispanic,58.8,46.3 to 71.4,172
Influenza,,States/Local Areas,Virginia,2014-2017,Insurance Coverage,Any Medicaid,53.8,43.8 to 63.8,149
Influenza,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.4,56.3 to 80.5,93
Influenza,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a Non-MSA,61.6,41.9 to 81.2,39
Influenza,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.1,62.0 to 74.1,673
Influenza,,States/Local Areas,Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.5,63.6 to 75.4,829
Influenza,,States/Local Areas,Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,68.4,61.2 to 75.5,604
Influenza,,States/Local Areas,Virginia,2018,Age,24 Months,70.4,63.3 to 77.1,551
Influenza,,States/Local Areas,Virginia,2018-2019,Age,24 Months,73.0,68.0 to 77.7,1003
Influenza,,States/Local Areas,Virginia,2017,Age,24 Months,60.5,52.0 to 69.1,419
Influenza,,States/Local Areas,Virginia,2017-2018,Age,24 Months,65.4,59.7 to 71.1,970
Influenza,,States/Local Areas,Virginia,2016,Age,24 Months,74.5,67.0 to 81.5,389
Influenza,,States/Local Areas,Virginia,2016-2017,Age,24 Months,67.6,61.8 to 73.3,808
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.1,70.0 to 94.1,120
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Private Insurance Only,90.5,87.6 to 93.4,1368
Hep A,≥1 Dose,States/Local Areas,Virginia,2016-2019,Insurance Coverage,Any Medicaid,85.1,78.7 to 91.5,213
Hep A,≥2 Doses,States/Local Areas,Virginia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.0,79.2 to 90.8,974
Influenza,,States/Local Areas,Virginia,2019,Age,24 Months,75.6,68.7 to 82.0,452
PCV,≥3 Doses,States/Local Areas,Virginia,2019-2020,Age,19 Months,92.5,89.2 to 94.9,946
Hib,≥2 Doses,States/Local Areas,Arizona,2019,Age,7 Months,87.3,79.9 to 92.2,235
Hib,≥3 Doses,States/Local Areas,Arizona,2016,Age,13 Months,76.3,69.2 to 82.1,257
Hib,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,74.4,69.4 to 79.0,535
Hib,≥3 Doses,States/Local Areas,Arizona,2017,Age,13 Months,72.6,65.1 to 79.0,278
Hib,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,77.7,72.9 to 81.9,562
Polio,≥3 Doses,States/Local Areas,Arizona,2018,Age,19 Months,98.2,94.7 to 99.4,284
Polio,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,75.4,70.0 to 80.1,519
Hib,≥3 Doses,States/Local Areas,Arizona,2018,Age,13 Months,82.9,76.7 to 87.8,284
Hib,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,79.3,74.2 to 83.6,519
Polio,≥3 Doses,States/Local Areas,Arizona,2016,Age,19 Months,93.4,89.1 to 96.1,257
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,91.6,88.1 to 94.1,535
Polio,≥3 Doses,States/Local Areas,Arizona,2017,Age,19 Months,89.7,83.8 to 93.6,278
Polio,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,93.9,90.7 to 96.1,562
Hib,≥3 Doses,States/Local Areas,Arizona,2019,Age,13 Months,75.6,67.7 to 82.1,235
Hib,≥3 Doses,States/Local Areas,Arizona,2011,Age,19 Months,88.9,79.2 to 94.4,266
Hib,≥3 Doses,States/Local Areas,Arizona,2012,Age,19 Months,83.4,79.3 to 86.8,277
Hib,≥3 Doses,States/Local Areas,Arizona,2013,Age,19 Months,85.5,83.8 to 87.0,264
Hib,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,88.3,85.0 to 90.9,523
DTaP,≥3 Doses,States/Local Areas,Arizona,2019,Age,13 Months,89.8,83.3 to 93.9,235
DTaP,≥3 Doses,States/Local Areas,Arizona,2011,Age,19 Months,90.5,80.7 to 95.6,266
DTaP,≥3 Doses,States/Local Areas,Arizona,2012,Age,19 Months,86.7,82.3 to 90.2,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2013,Age,19 Months,90.3,88.3 to 92.0,264
DTaP,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,91.6,88.9 to 93.7,523
DTaP,≥3 Doses,States/Local Areas,Arizona,2016,Age,13 Months,91.1,86.3 to 94.3,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,88.9,85.2 to 91.8,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2017,Age,13 Months,86.7,80.5 to 91.2,278
DTaP,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,91.3,87.7 to 93.9,562
Polio,≥3 Doses,States/Local Areas,Arizona,2012,Age,19 Months,84.6,77.4 to 89.8,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,75.7,70.8 to 80.6,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,78.9,72.9 to 84.9,225
Polio,≥3 Doses,States/Local Areas,Arizona,2013,Age,19 Months,87.0,83.2 to 90.1,264
Polio,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,89.3,85.7 to 92.1,523
Polio,≥3 Doses,States/Local Areas,Arizona,2014,Age,19 Months,91.6,86.2 to 95.0,259
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,89.8,86.0 to 92.6,507
Polio,≥3 Doses,States/Local Areas,Arizona,2015,Age,19 Months,87.9,84.4 to 90.7,248
Polio,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,90.6,87.1 to 93.3,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2018,Age,13 Months,95.9,91.6 to 98.1,284
DTaP,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,92.9,89.2 to 95.4,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.6,68.8 to 86.4,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.1,64.8 to 75.4,441
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,79.0,74.9 to 83.1,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.0,76.5 to 85.5,345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,82.3,69.5 to 95.1,48
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Overall,Overall,79.8,76.8 to 82.8,930
DTaP,≥3 Doses,States/Local Areas,Arizona,2013,Age,13 Months,88.4,86.1 to 90.3,264
DTaP,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,88.0,84.8 to 90.6,523
DTaP,≥3 Doses,States/Local Areas,Arizona,2014,Age,13 Months,87.6,81.0 to 92.1,259
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,87.1,82.9 to 90.5,507
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,86.3 to 93.5,441
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,88.3 to 94.2,537
Hib,≥3 Doses,States/Local Areas,Arizona,2019,Age,7 Months,57.7,49.1 to 65.9,235
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.3,85.5 to 93.2,345
Hib,≥3 Doses,States/Local Areas,Arizona,2011,Age,13 Months,77.2,68.4 to 84.2,266
Hib,≥2 Doses,States/Local Areas,Arizona,2015,Age,13 Months,91.3,86.1 to 94.7,248
Hib,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,93.3,90.2 to 95.5,505
Hib,≥2 Doses,States/Local Areas,Arizona,2016,Age,13 Months,95.3,91.2 to 97.6,257
Hib,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,93.7,90.5 to 95.8,535
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,83.3,78.5 to 88.0,326
DTaP,≥3 Doses,States/Local Areas,Arizona,2012,Age,13 Months,83.1,79.6 to 86.1,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2015,Age,13 Months,86.7,80.5 to 91.1,248
DTaP,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,88.9,85.1 to 91.8,505
Hib,≥2 Doses,States/Local Areas,Arizona,2018,Age,13 Months,98.7,96.0 to 99.6,284
Hib,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,95.1,91.8 to 97.2,519
Hib,≥2 Doses,States/Local Areas,Arizona,2019,Age,13 Months,91.5,85.1 to 95.3,235
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,93.3,84.2 to 100.0,48
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,90.7,88.5 to 93.0,930
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,90.6,87.1 to 94.2,326
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,89.0,85.3 to 92.7,379
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,94.5,90.0 to 99.1,225
Polio,≥3 Doses,States/Local Areas,Arizona,2011,Age,19 Months,87.4,80.3 to 92.2,266
Hib,≥3 Doses,States/Local Areas,Arizona,2013,Age,13 Months,72.4,69.9 to 74.7,264
Hib,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,75.2,71.6 to 78.5,523
Hib,≥3 Doses,States/Local Areas,Arizona,2014,Age,13 Months,78.1,70.8 to 83.9,259
Hib,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,75.3,70.1 to 79.9,507
Hib,≥3 Doses,States/Local Areas,Arizona,2012,Age,13 Months,70.5,67.2 to 73.6,277
Hib,≥3 Doses,States/Local Areas,Arizona,2015,Age,13 Months,72.5,64.7 to 79.2,248
Hib,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,74.4,69.2 to 78.9,505
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014,Age,0-3 Days,75.4,68.0 to 81.6,259
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2015,Age,0-3 Days,77.1,72.1 to 81.5,507
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2015,Age,0-3 Days,78.8,71.8 to 84.5,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2015-2016,Age,0-3 Days,80.4,75.8 to 84.3,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2011,Age,7 Months,67.5,61.0 to 73.5,266
DTaP,≥3 Doses,States/Local Areas,Arizona,2012,Age,7 Months,71.4,67.9 to 74.7,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2013,Age,7 Months,63.4,56.5 to 69.8,264
DTaP,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,66.7,60.8 to 72.0,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,88.2,85.8 to 90.6,930
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,89.2,85.4 to 92.9,326
PCV,≥1 Dose,States/Local Areas,Arizona,2019,Age,3 Months,86.7,79.6 to 91.7,235
Polio,≥1 Dose,States/Local Areas,Arizona,2011,Age,3 Months,81.9,75.2 to 87.1,266
Polio,≥1 Dose,States/Local Areas,Arizona,2012,Age,3 Months,85.5,83.4 to 87.3,277
Polio,≥1 Dose,States/Local Areas,Arizona,2013,Age,3 Months,80.2,74.9 to 84.7,264
Polio,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,3 Months,82.7,77.4 to 86.9,523
Polio,≥1 Dose,States/Local Areas,Arizona,2014,Age,3 Months,85.1,78.2 to 90.1,259
Polio,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,3 Months,84.9,80.4 to 88.5,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,89.3,85.5 to 93.0,329
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,82.5 to 95.6,125
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.7,83.0 to 90.4,441
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,85.8 to 92.1,537
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.1,81.8 to 90.4,345
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,95.3,89.9 to 100.0,48
Hib,≥2 Doses,States/Local Areas,Arizona,2017,Age,7 Months,86.9,80.5 to 91.4,278
Hib,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,90.3,86.4 to 93.2,562
Hib,≥2 Doses,States/Local Areas,Arizona,2018,Age,7 Months,93.7,88.6 to 96.7,284
Hib,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,90.5,86.3 to 93.6,519
PCV,≥3 Doses,States/Local Areas,Arizona,2014,Age,35 Months,94.2,89.7 to 97.2,259
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,91.2,87.6 to 94.1,507
PCV,≥3 Doses,States/Local Areas,Arizona,2015,Age,35 Months,88.8,83.0 to 93.3,248
PCV,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,91.7,87.9 to 94.7,505
PCV,≥3 Doses,States/Local Areas,Arizona,2016,Age,35 Months,97.0,89.2 to 99.6,257
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,94.1,90.2 to 96.8,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2014,Age,7 Months,69.9,61.9 to 76.9,259
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,66.0,60.2 to 71.3,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,86.0,81.9 to 90.0,379
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,90.2,85.1 to 95.2,225
Hib,≥3 Doses,States/Local Areas,Arizona,2011,Age,7 Months,58.0,44.1 to 70.7,266
Hib,≥3 Doses,States/Local Areas,Arizona,2012,Age,7 Months,53.5,47.7 to 59.2,277
Hib,≥3 Doses,States/Local Areas,Arizona,2013,Age,7 Months,45.3,37.3 to 53.6,264
Hib,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,49.4,42.9 to 56.0,523
Polio,≥1 Dose,States/Local Areas,Arizona,2015,Age,3 Months,84.6,78.3 to 89.4,248
Polio,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,3 Months,87.3,83.4 to 90.4,505
Polio,≥1 Dose,States/Local Areas,Arizona,2016,Age,3 Months,90.0,84.9 to 93.4,257
Polio,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,3 Months,89.2,85.5 to 92.0,535
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016,Age,0-3 Days,81.9,75.6 to 86.9,257
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2017,Age,0-3 Days,84.2,80.3 to 87.4,535
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2017,Age,0-3 Days,85.7,78.3 to 90.9,166
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2017-2018,Age,0-3 Days,87.5,83.9 to 90.4,562
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,91.2,88.2 to 94.3,493
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,91.6,88.3 to 94.9,356
Hib,≥2 Doses,States/Local Areas,Arizona,2017,Age,13 Months,92.0,86.5 to 95.3,278
Hib,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,95.3,92.4 to 97.2,562
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,85.9,71.6 to 100.0,34
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.9,77.5 to 100.0,35
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,91.7,88.2 to 95.1,329
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.6,84.4 to 96.8,125
Hib,≥3 Doses,States/Local Areas,Arizona,2017,Age,7 Months,53.8,46.1 to 61.2,278
Hib,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,60.6,55.1 to 65.8,562
Hib,≥3 Doses,States/Local Areas,Arizona,2018,Age,7 Months,67.5,59.7 to 74.5,284
Hib,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,62.7,56.7 to 68.2,519
PCV,≥3 Doses,States/Local Areas,Arizona,2019,Age,35 Months,91.1,85.4 to 95.3,235
Hib,≥2 Doses,States/Local Areas,Arizona,2014,Age,13 Months,92.5,87.2 to 95.7,259
Hib,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,91.9,88.4 to 94.4,507
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,80.7,66.3 to 95.2,47
Polio,≥1 Dose,States/Local Areas,Arizona,2019,Age,3 Months,87.7,80.6 to 92.5,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2019,Age,0-3 Days,77.5,69.2 to 84.1,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,80.1,67.0 to 93.1,47
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,72.5,67.7 to 77.2,493
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,86.0,82.0 to 90.1,356
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.4,57.7 to 91.0,35
DTaP,≥3 Doses,States/Local Areas,Arizona,2018,Age,7 Months,82.6,75.8 to 87.8,284
DTaP,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,78.1,72.7 to 82.8,519
DTaP,≥3 Doses,States/Local Areas,Arizona,2019,Age,7 Months,73.6,65.0 to 80.7,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,88.4,84.7 to 92.1,329
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,81.0,64.2 to 97.7,34
DTaP,≥3 Doses,States/Local Areas,Arizona,2011,Age,13 Months,86.0,80.1 to 90.3,266
Hib,≥2 Doses,States/Local Areas,Arizona,2011,Age,13 Months,90.4,83.6 to 94.6,266
Hib,≥2 Doses,States/Local Areas,Arizona,2012,Age,13 Months,90.2,88.6 to 91.7,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2018,Age,0-3 Days,88.5,82.8 to 92.5,284
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2018-2019,Age,0-3 Days,83.1,78.2 to 87.1,519
DTaP,≥3 Doses,States/Local Areas,Arizona,2015,Age,7 Months,61.9,53.6 to 69.6,248
DTaP,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,69.1,63.6 to 74.1,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2016,Age,7 Months,76.4,69.1 to 82.3,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,72.0,66.8 to 76.6,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2017,Age,7 Months,67.5,60.0 to 74.3,278
DTaP,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,75.0,70.0 to 79.5,562
Hib,≥2 Doses,States/Local Areas,Arizona,2013,Age,13 Months,92.2,90.1 to 93.8,264
Hib,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,92.3,90.2 to 94.0,523
PCV,≥3 Doses,States/Local Areas,Arizona,2017,Age,35 Months,93.1,87.9 to 96.6,278
PCV,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.1,92.9 to 98.2,562
PCV,≥3 Doses,States/Local Areas,Arizona,2018,Age,35 Months,99.4,97.5 to 99.9,284
PCV,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,97.6,93.1 to 99.5,519
Hib,≥3 Doses,States/Local Areas,Arizona,2014,Age,7 Months,53.6,45.4 to 61.6,259
Hib,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,52.0,46.2 to 57.8,507
Hib,≥3 Doses,States/Local Areas,Arizona,2015,Age,7 Months,50.5,42.4 to 58.5,248
Hib,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,56.5,50.8 to 62.0,505
Hib,≥3 Doses,States/Local Areas,Arizona,2016,Age,7 Months,62.6,54.7 to 69.9,257
Hib,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,58.2,52.7 to 63.6,535
Polio,≥1 Dose,States/Local Areas,Arizona,2017,Age,3 Months,88.4,82.5 to 92.5,278
Polio,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,3 Months,89.1,85.2 to 92.1,562
Polio,≥1 Dose,States/Local Areas,Arizona,2018,Age,3 Months,89.9,84.1 to 93.7,284
Polio,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,3 Months,88.8,84.5 to 92.0,519
Polio,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,93.5,90.4 to 95.6,505
Polio,≥2 Doses,States/Local Areas,Arizona,2016,Age,13 Months,95.6,91.5 to 97.7,257
Polio,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,93.9,90.8 to 96.1,535
Polio,≥2 Doses,States/Local Areas,Arizona,2017,Age,13 Months,92.3,86.8 to 95.6,278
Polio,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,95.6,92.7 to 97.4,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2016,Age,19 Months,89.8,84.5 to 93.4,257
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,89.3,85.7 to 92.1,535
PCV,≥3 Doses,States/Local Areas,Arizona,2011,Age,7 Months,65.6,57.8 to 72.6,266
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.8,74.9 to 92.7,125
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.3,73.4 to 83.3,441
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,79.9,75.5 to 84.3,537
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.8,67.8 to 79.8,345
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,81.6,69.2 to 94.0,48
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,77.8,74.4 to 81.3,930
≥1 Dose MMR,,States/Local Areas,Arizona,2015,Age,19 Months,82.1,80.3 to 83.7,248
≥1 Dose MMR,,States/Local Areas,Arizona,2015-2016,Age,19 Months,85.8,81.3 to 89.3,505
≥1 Dose MMR,,States/Local Areas,Arizona,2016,Age,19 Months,89.5,83.9 to 93.3,257
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2017,Age,19 Months,86.5,82.4 to 89.8,535
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,76.5,70.9 to 82.0,326
≥1 Dose MMR,,States/Local Areas,Arizona,2017,Age,19 Months,83.5,77.0 to 88.5,278
≥1 Dose MMR,,States/Local Areas,Arizona,2017-2018,Age,19 Months,89.3,85.4 to 92.3,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2011,Age,24 Months,84.7,78.1 to 90.3,266
≥1 Dose Varicella,,States/Local Areas,Arizona,2012,Age,24 Months,84.3,77.4 to 90.0,277
Hep B,≥1 Dose,States/Local Areas,Arizona,2018,Age,3 Months,99.0,97.8 to 99.6,284
Hep B,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,3 Months,95.9,92.9 to 97.7,519
≥1 Dose Varicella,,States/Local Areas,Arizona,2019,Age,19 Months,92.0,86.3 to 95.5,235
Hep B,≥1 Dose,States/Local Areas,Arizona,2019,Age,3 Months,92.8,86.8 to 96.2,235
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2011,Age,0-1 Days,74.1,67.7 to 79.7,266
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2012,Age,0-1 Days,75.9,71.4 to 79.9,277
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,70.9,63.6 to 78.1,379
Hep B,≥2 Doses,States/Local Areas,Arizona,2011,Age,5 Months,83.4,78.9 to 87.1,266
Hep B,≥2 Doses,States/Local Areas,Arizona,2012,Age,5 Months,83.3,81.1 to 85.2,277
Hep B,≥2 Doses,States/Local Areas,Arizona,2013,Age,5 Months,85.9,80.8 to 89.9,264
Hep B,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,5 Months,86.4,82.8 to 89.4,523
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,76.8,67.0 to 86.7,225
Hep B,≥2 Doses,States/Local Areas,Arizona,2014,Age,5 Months,86.9,81.2 to 91.1,259
Hep B,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,5 Months,85.1,81.5 to 88.1,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2014,Age,19 Months,88.6,83.0 to 92.5,259
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,85.3,80.9 to 88.9,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2015,Age,19 Months,82.0,76.5 to 86.5,248
Hep B,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,85.9,81.5 to 89.4,505
PCV,≥4 Doses,States/Local Areas,Arizona,2017,Age,19 Months,71.1,63.7 to 77.6,278
PCV,≥4 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,76.7,71.8 to 81.0,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2019,Age,24 Months,93.0,87.8 to 96.6,235
≥1 Dose Varicella,,States/Local Areas,Arizona,2011,Age,35 Months,89.6,83.0 to 94.5,266
≥1 Dose Varicella,,States/Local Areas,Arizona,2012,Age,35 Months,93.4,81.6 to 98.8,277
≥1 Dose MMR,,States/Local Areas,Arizona,2013,Age,24 Months,88.1,81.7 to 93.1,264
≥1 Dose MMR,,States/Local Areas,Arizona,2013-2014,Age,24 Months,87.8,83.6 to 91.3,523
≥1 Dose MMR,,States/Local Areas,Arizona,2014,Age,24 Months,87.6,82.0 to 92.2,259
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2015,Age,24 Months,87.4,83.3 to 90.9,507
≥1 Dose MMR,,States/Local Areas,Arizona,2015,Age,24 Months,87.2,81.0 to 92.2,248
≥1 Dose MMR,,States/Local Areas,Arizona,2015-2016,Age,24 Months,89.1,85.2 to 92.4,505
≥1 Dose Varicella,,States/Local Areas,Arizona,2018,Age,24 Months,97.3,93.9 to 99.0,284
≥1 Dose Varicella,,States/Local Areas,Arizona,2018-2019,Age,24 Months,95.3,92.3 to 97.4,519
Hep B,≥3 Doses,States/Local Areas,Arizona,2019,Age,19 Months,88.9,82.9 to 93.0,235
Hep B,≥3 Doses,States/Local Areas,Arizona,2011,Age,24 Months,84.2,77.5 to 89.8,266
Hep B,≥3 Doses,States/Local Areas,Arizona,2013,Age,24 Months,88.9,83.1 to 93.4,264
Hep B,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,89.6,85.8 to 92.7,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2012,Age,24 Months,85.1,78.8 to 90.4,277
Hep B,≥3 Doses,States/Local Areas,Arizona,2014,Age,24 Months,90.2,85.2 to 94.1,259
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,87.0,82.9 to 90.5,507
PCV,≥3 Doses,States/Local Areas,Arizona,2016,Age,7 Months,73.2,65.7 to 79.6,257
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,68.5,63.2 to 73.3,535
PCV,≥3 Doses,States/Local Areas,Arizona,2017,Age,7 Months,63.7,56.0 to 70.8,278
PCV,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,71.4,66.0 to 76.1,562
PCV,≥4 Doses,States/Local Areas,Arizona,2015,Age,19 Months,70.8,68.6 to 72.9,248
PCV,≥4 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,73.1,67.9 to 77.8,505
PCV,≥4 Doses,States/Local Areas,Arizona,2016,Age,19 Months,75.5,68.2 to 81.5,257
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,73.3,68.2 to 77.9,535
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2019,Age,0-1 Days,76.3,68.1 to 83.0,235
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2011,Age,0-2 Days,77.4,71.5 to 82.4,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2012,Age,0-2 Days,78.4,74.1 to 82.2,277
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2013,Age,0-2 Days,76.3,74.5 to 78.1,264
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2013-2014,Age,0-2 Days,75.3,70.2 to 79.8,523
Hep B,≥2 Doses,States/Local Areas,Arizona,2013,Age,7 Months,90.8,87.6 to 93.2,264
Hep B,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,89.9,86.3 to 92.7,523
Hep B,≥2 Doses,States/Local Areas,Arizona,2014,Age,7 Months,89.1,83.5 to 92.9,259
Hep B,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,87.7,83.8 to 90.8,507
Hep B,≥2 Doses,States/Local Areas,Arizona,2012,Age,7 Months,88.1,85.9 to 90.0,277
Hep B,≥2 Doses,States/Local Areas,Arizona,2015,Age,7 Months,86.3,80.3 to 90.7,248
Hep B,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,88.7,85.0 to 91.6,505
PCV,≥3 Doses,States/Local Areas,Arizona,2018,Age,7 Months,79.1,72.0 to 84.8,284
PCV,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,74.9,69.3 to 79.7,519
PCV,≥3 Doses,States/Local Areas,Arizona,2019,Age,7 Months,70.5,61.9 to 77.9,235
PCV,≥3 Doses,States/Local Areas,Arizona,2011,Age,13 Months,85.4,78.1 to 90.5,266
PCV,≥3 Doses,States/Local Areas,Arizona,2013,Age,13 Months,85.5,82.0 to 88.5,264
PCV,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,86.0,83.0 to 88.6,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2015,Age,24 Months,83.7,77.0 to 89.3,248
Hep B,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,86.8,82.7 to 90.4,505
Hep B,≥3 Doses,States/Local Areas,Arizona,2016,Age,24 Months,90.1,85.3 to 93.9,257
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,89.9,86.5 to 92.7,535
PCV,≥3 Doses,States/Local Areas,Arizona,2012,Age,13 Months,80.6,77.9 to 83.0,277
Hep B,≥3 Doses,States/Local Areas,Arizona,2017,Age,24 Months,89.8,84.8 to 93.6,278
Hep B,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,93.5,90.7 to 95.7,562
PCV,≥4 Doses,States/Local Areas,Arizona,2018,Age,19 Months,82.3,75.7 to 87.4,284
PCV,≥4 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,77.4,71.0 to 82.8,430
≥1 Dose MMR,,States/Local Areas,Arizona,2016,Age,24 Months,90.6,85.6 to 94.5,257
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2017,Age,24 Months,90.1,86.4 to 93.1,535
≥1 Dose MMR,,States/Local Areas,Arizona,2017,Age,24 Months,89.5,83.9 to 93.8,278
≥1 Dose MMR,,States/Local Areas,Arizona,2017-2018,Age,24 Months,93.7,90.5 to 96.1,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2017,Age,35 Months,93.5,88.5 to 96.8,278
≥1 Dose Varicella,,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.2,93.3 to 98.0,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2018,Age,35 Months,98.6,95.5 to 99.7,284
≥1 Dose Varicella,,States/Local Areas,Arizona,2018-2019,Age,35 Months,96.3,93.0 to 98.3,519
≥1 Dose MMR,,States/Local Areas,Arizona,2014,Age,35 Months,93.8,89.1 to 97.0,259
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2015,Age,35 Months,92.0,88.1 to 95.1,507
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2017,Age,0-2 Days,84.4,79.0 to 88.6,278
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2017-2018,Age,0-2 Days,86.3,82.6 to 89.4,562
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2018,Age,0-2 Days,88.3,82.6 to 92.3,284
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2018-2019,Age,0-2 Days,82.8,77.9 to 86.8,519
Hep B,≥3 Doses,States/Local Areas,Arizona,2012,Age,35 Months,89.3,81.8 to 94.6,277
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2019,Age,0-2 Days,77.1,68.9 to 83.7,235
Hep B,≥3 Doses,States/Local Areas,Arizona,2019,Age,24 Months,91.6,86.5 to 95.3,235
Hep B,≥3 Doses,States/Local Areas,Arizona,2011,Age,35 Months,86.7,79.0 to 92.6,266
PCV,≥4 Doses,States/Local Areas,Arizona,2012,Age,24 Months,77.0,69.7 to 83.6,277
PCV,≥4 Doses,States/Local Areas,Arizona,2013,Age,24 Months,81.0,73.7 to 87.4,264
PCV,≥4 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,80.6,75.6 to 85.1,523
PCV,≥4 Doses,States/Local Areas,Arizona,2014,Age,24 Months,80.1,73.0 to 86.2,259
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,76.7,71.6 to 81.5,507
PCV,≥4 Doses,States/Local Areas,Arizona,2015,Age,24 Months,73.4,65.9 to 80.4,248
PCV,≥4 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,75.0,70.0 to 79.8,505
≥1 Dose MMR,,States/Local Areas,Arizona,2019,Age,24 Months,92.3,87.0 to 96.0,235
≥1 Dose MMR,,States/Local Areas,Arizona,2011,Age,35 Months,89.7,83.1 to 94.5,266
≥1 Dose MMR,,States/Local Areas,Arizona,2012,Age,35 Months,89.1,79.6 to 95.5,277
≥1 Dose MMR,,States/Local Areas,Arizona,2013,Age,35 Months,91.9,85.7 to 96.1,264
≥1 Dose MMR,,States/Local Areas,Arizona,2013-2014,Age,35 Months,92.8,89.0 to 95.6,523
≥1 Dose Varicella,,States/Local Areas,Arizona,2016,Age,35 Months,95.1,89.9 to 98.2,257
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2017,Age,35 Months,94.5,91.1 to 96.9,535
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2014,Age,0-2 Days,74.3,66.9 to 80.6,259
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2014-2015,Age,0-2 Days,76.1,71.1 to 80.5,507
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2015,Age,0-2 Days,77.9,70.8 to 83.6,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2015-2016,Age,0-2 Days,79.2,74.6 to 83.2,505
PCV,≥4 Doses,States/Local Areas,Arizona,2019,Age,19 Months,76.5,68.3 to 83.1,235
≥1 Dose MMR,,States/Local Areas,Arizona,2018,Age,24 Months,97.8,94.8 to 99.3,284
≥1 Dose MMR,,States/Local Areas,Arizona,2018-2019,Age,24 Months,95.1,92.2 to 97.2,519
≥1 Dose Varicella,,States/Local Areas,Arizona,2013,Age,35 Months,91.0,84.9 to 95.4,264
≥1 Dose Varicella,,States/Local Areas,Arizona,2013-2014,Age,35 Months,92.5,88.8 to 95.3,523
≥1 Dose Varicella,,States/Local Areas,Arizona,2014,Age,35 Months,93.9,89.5 to 96.9,259
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2015,Age,35 Months,92.9,89.3 to 95.5,507
PCV,≥4 Doses,States/Local Areas,Arizona,2011,Age,24 Months,77.9,70.8 to 84.4,266
≥1 Dose Varicella,,States/Local Areas,Arizona,2015,Age,35 Months,91.8,86.1 to 95.8,248
≥1 Dose Varicella,,States/Local Areas,Arizona,2015-2016,Age,35 Months,93.5,89.7 to 96.2,505
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2016,Age,0-2 Days,80.6,74.1 to 85.8,257
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2016-2017,Age,0-2 Days,82.5,78.4 to 85.9,535
Hep B,≥2 Doses,States/Local Areas,Arizona,2016,Age,7 Months,91.1,86.2 to 94.3,257
Hep B,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,92.5,89.5 to 94.7,535
Hep B,≥2 Doses,States/Local Areas,Arizona,2017,Age,7 Months,94.0,89.8 to 96.6,278
Hep B,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,7 Months,94.7,91.5 to 96.8,562
Hep B,≥2 Doses,States/Local Areas,Arizona,2018,Age,7 Months,95.4,89.5 to 98.1,284
Hep B,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,7 Months,93.7,89.8 to 96.2,519
PCV,≥3 Doses,States/Local Areas,Arizona,2014,Age,13 Months,86.5,79.9 to 91.1,259
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,85.2,80.8 to 88.7,507
PCV,≥3 Doses,States/Local Areas,Arizona,2015,Age,13 Months,83.9,77.5 to 88.8,248
PCV,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,86.5,82.5 to 89.7,505
Hep B,≥3 Doses,States/Local Areas,Arizona,2018,Age,35 Months,97.1,94.4 to 98.8,284
Hep B,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,94.4,91.6 to 96.5,519
PCV,≥3 Doses,States/Local Areas,Arizona,2012,Age,19 Months,84.0,80.0 to 87.3,277
Hep B,≥3 Doses,States/Local Areas,Arizona,2017,Age,35 Months,92.9,86.8 to 96.8,278
Hep B,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,94.8,91.7 to 97.0,562
PCV,≥4 Doses,States/Local Areas,Arizona,2019,Age,24 Months,78.7,71.0 to 85.5,235
PCV,≥4 Doses,States/Local Areas,Arizona,2011,Age,35 Months,88.0,74.8 to 96.2,266
PCV,≥4 Doses,States/Local Areas,Arizona,2012,Age,35 Months,78.6,71.4 to 85.1,277
PCV,≥3 Doses,States/Local Areas,Arizona,2019,Age,13 Months,86.6,79.3 to 91.6,235
PCV,≥3 Doses,States/Local Areas,Arizona,2011,Age,19 Months,87.3,79.6 to 92.4,266
PCV,≥3 Doses,States/Local Areas,Arizona,2013,Age,19 Months,89.1,87.0 to 91.0,264
PCV,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,90.4,88.0 to 92.3,523
PCV,≥3 Doses,States/Local Areas,Arizona,2014,Age,19 Months,91.6,86.2 to 95.0,259
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,88.8,84.9 to 91.8,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2016,Age,35 Months,92.1,87.6 to 95.4,257
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,92.7,89.0 to 95.5,535
Hep B,≥2 Doses,States/Local Areas,Arizona,2019,Age,7 Months,92.0,85.7 to 95.7,235
Hep B,≥2 Doses,States/Local Areas,Arizona,2011,Age,13 Months,90.4,85.9 to 93.6,266
Hep B,≥2 Doses,States/Local Areas,Arizona,2012,Age,13 Months,90.4,88.0 to 92.4,277
Hep B,≥2 Doses,States/Local Areas,Arizona,2013,Age,13 Months,94.6,91.9 to 96.5,264
Hep B,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,13 Months,92.8,88.8 to 95.5,523
PCV,≥3 Doses,States/Local Areas,Arizona,2017,Age,13 Months,83.9,77.1 to 89.0,278
PCV,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,88.9,84.9 to 91.9,562
PCV,≥3 Doses,States/Local Areas,Arizona,2018,Age,13 Months,94.0,89.6 to 96.6,284
PCV,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,90.3,86.2 to 93.3,519
Hep B,≥3 Doses,States/Local Areas,Arizona,2013,Age,35 Months,91.1,85.4 to 95.2,264
Hep B,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,92.3,89.0 to 95.0,523
Hep B,≥3 Doses,States/Local Areas,Arizona,2014,Age,35 Months,93.7,90.0 to 96.4,259
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,90.1,86.5 to 93.0,507
Hep B,≥3 Doses,States/Local Areas,Arizona,2015,Age,35 Months,86.5,80.3 to 91.5,248
Hep B,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,89.2,85.5 to 92.4,505
PCV,≥4 Doses,States/Local Areas,Arizona,2016,Age,24 Months,76.6,69.8 to 82.9,257
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,76.2,71.3 to 80.8,535
PCV,≥4 Doses,States/Local Areas,Arizona,2017,Age,24 Months,75.7,68.8 to 82.1,278
PCV,≥4 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,82.0,77.6 to 86.0,562
PCV,≥4 Doses,States/Local Areas,Arizona,2018,Age,24 Months,88.2,83.0 to 92.4,284
PCV,≥4 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,83.7,79.0 to 87.8,519
≥1 Dose MMR,,States/Local Areas,Arizona,2015,Age,35 Months,90.2,83.6 to 94.9,248
≥1 Dose MMR,,States/Local Areas,Arizona,2015-2016,Age,35 Months,92.1,88.1 to 95.2,505
≥1 Dose MMR,,States/Local Areas,Arizona,2016,Age,35 Months,93.8,89.0 to 97.0,257
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2017,Age,35 Months,94.1,90.9 to 96.5,535
≥1 Dose MMR,,States/Local Areas,Arizona,2017,Age,35 Months,94.1,89.3 to 97.2,278
≥1 Dose MMR,,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.8,94.2 to 98.4,562
≥1 Dose Varicella,,States/Local Areas,Arizona,2019,Age,35 Months,93.3,87.9 to 96.8,235
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,91.6,88.7 to 94.6,493
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,89.4,85.8 to 93.0,356
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,82.7,68.9 to 96.6,47
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,79.7,61.4 to 98.0,34
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.5,80.8 to 100.0,35
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,89.0,85.2 to 92.9,329
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.9,91.7 to 100.0,125
Hib,≥1 Dose,States/Local Areas,Arizona,2011,Age,3 Months,84.1,79.5 to 87.8,266
Hib,≥1 Dose,States/Local Areas,Arizona,2012,Age,3 Months,82.6,79.9 to 85.0,277
Hib,≥1 Dose,States/Local Areas,Arizona,2013,Age,3 Months,80.3,73.9 to 85.4,264
Hib,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,3 Months,82.2,76.7 to 86.6,523
Hib,≥1 Dose,States/Local Areas,Arizona,2014,Age,3 Months,84.1,76.8 to 89.4,259
Hib,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,3 Months,84.3,79.6 to 88.0,507
Hep B,≥2 Doses,States/Local Areas,Arizona,2014,Age,13 Months,91.1,85.7 to 94.5,259
Hep B,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,13 Months,90.9,87.4 to 93.4,507
Hep B,≥2 Doses,States/Local Areas,Arizona,2015,Age,13 Months,90.7,85.7 to 94.0,248
Hep B,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,13 Months,92.9,89.9 to 95.1,505
Hib,≥1 Dose,States/Local Areas,Arizona,2015,Age,3 Months,84.4,78.0 to 89.2,248
Hib,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,3 Months,87.5,83.7 to 90.6,505
Hep B,≥2 Doses,States/Local Areas,Arizona,2016,Age,13 Months,95.2,91.2 to 97.4,257
Hep B,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,95.2,92.6 to 96.9,535
PCV,≥3 Doses,States/Local Areas,Arizona,2016,Age,13 Months,89.2,83.9 to 92.9,257
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,13 Months,86.6,82.4 to 89.9,535
Hep B,≥3 Doses,States/Local Areas,Arizona,2018,Age,24 Months,97.1,94.4 to 98.8,284
Hep B,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,94.4,91.6 to 96.5,519
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.1,84.3 to 92.0,441
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,88.0 to 94.0,537
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,81.3 to 90.5,345
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,94.9,90.7 to 99.1,225
PCV,≥4 Doses,States/Local Areas,Arizona,2014,Age,35 Months,87.0,80.0 to 92.5,259
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,81.4,76.1 to 86.1,507
PCV,≥4 Doses,States/Local Areas,Arizona,2015,Age,35 Months,75.9,68.2 to 82.9,248
PCV,≥4 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,78.2,73.0 to 83.0,505
PCV,≥4 Doses,States/Local Areas,Arizona,2016,Age,35 Months,80.3,73.3 to 86.4,257
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,80.4,75.5 to 84.9,535
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,89.8,86.3 to 93.3,356
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,89.0,85.1 to 92.8,329
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.2,91.1 to 99.2,125
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.9,69.8 to 100.0,35
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,78.3,59.9 to 96.7,34
PCV,≥3 Doses,States/Local Areas,Arizona,2017,Age,19 Months,88.5,82.2 to 92.8,278
PCV,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,92.5,89.0 to 94.9,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2019,Age,35 Months,91.6,86.5 to 95.3,235
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,88.6,84.8 to 92.4,379
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.7,83.4 to 92.0,345
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,90.0,79.8 to 100.0,48
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Overall,Overall,89.7,87.3 to 92.1,930
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,88.6,84.6 to 92.5,326
≥1 Dose MMR,,States/Local Areas,Arizona,2018,Age,35 Months,99.4,98.1 to 99.8,284
≥1 Dose MMR,,States/Local Areas,Arizona,2018-2019,Age,35 Months,96.1,92.8 to 98.2,519
PCV,≥4 Doses,States/Local Areas,Arizona,2013,Age,35 Months,83.7,76.3 to 89.9,264
PCV,≥4 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,85.3,80.3 to 89.7,523
≥1 Dose MMR,,States/Local Areas,Arizona,2019,Age,35 Months,92.3,87.0 to 96.0,235
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,74.2,57.6 to 90.9,47
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,90.9,87.8 to 94.0,493
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.7,84.9 to 92.4,441
≥1 Dose Varicella,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,90.9,87.9 to 93.8,537
Hib,≥1 Dose,States/Local Areas,Arizona,2016,Age,3 Months,90.7,85.7 to 94.1,257
Hib,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,3 Months,89.4,85.8 to 92.2,535
Hib,≥1 Dose,States/Local Areas,Arizona,2017,Age,3 Months,88.1,82.2 to 92.3,278
Hib,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,3 Months,88.8,84.9 to 91.7,562
Hep B,≥2 Doses,States/Local Areas,Arizona,2017,Age,13 Months,95.2,91.1 to 97.4,278
Hep B,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,13 Months,97.0,95.0 to 98.3,562
Hep B,≥2 Doses,States/Local Areas,Arizona,2018,Age,13 Months,98.9,97.8 to 99.5,284
Hep B,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,13 Months,96.6,94.0 to 98.1,519
Hep B,≥2 Doses,States/Local Areas,Arizona,2019,Age,13 Months,94.2,89.0 to 97.0,235
PCV,≥3 Doses,States/Local Areas,Arizona,2015,Age,19 Months,86.0,79.8 to 90.5,248
PCV,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,89.3,85.5 to 92.2,505
PCV,≥3 Doses,States/Local Areas,Arizona,2016,Age,19 Months,92.6,87.6 to 95.6,257
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,90.6,86.8 to 93.4,535
PCV,≥4 Doses,States/Local Areas,Arizona,2017,Age,35 Months,80.6,73.6 to 86.8,278
PCV,≥4 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,85.9,81.3 to 89.9,562
PCV,≥4 Doses,States/Local Areas,Arizona,2018,Age,35 Months,91.0,85.1 to 95.3,284
PCV,≥4 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,85.2,80.3 to 89.5,519
PCV,≥4 Doses,States/Local Areas,Arizona,2019,Age,35 Months,79.1,71.4 to 85.9,235
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,90.0,79.8 to 100.0,48
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Overall,Overall,89.1,86.6 to 91.6,930
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,88.1,84.1 to 92.2,326
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,88.1,84.3 to 91.9,379
≥1 Dose MMR,,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,93.4,88.9 to 97.9,225
PCV,≥1 Dose,States/Local Areas,Arizona,2011,Age,3 Months,82.4,77.2 to 86.5,266
PCV,≥1 Dose,States/Local Areas,Arizona,2012,Age,3 Months,82.8,81.8 to 83.8,277
Hib,≥1 Dose,States/Local Areas,Arizona,2018,Age,3 Months,89.4,83.6 to 93.3,284
Hib,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,3 Months,87.4,82.9 to 90.8,519
Hib,≥1 Dose,States/Local Areas,Arizona,2019,Age,3 Months,85.3,78.0 to 90.4,235
PCV,≥3 Doses,States/Local Areas,Arizona,2012,Age,24 Months,85.9,79.4 to 91.2,277
PCV,≥3 Doses,States/Local Areas,Arizona,2018,Age,19 Months,96.5,93.0 to 98.3,284
PCV,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,90.3,86.2 to 93.3,519
PCV,≥3 Doses,States/Local Areas,Arizona,2019,Age,19 Months,90.8,84.5 to 94.7,235
PCV,≥3 Doses,States/Local Areas,Arizona,2011,Age,24 Months,87.5,81.3 to 92.5,266
Hib,≥2 Doses,States/Local Areas,Arizona,2015,Age,5 Months,71.6,63.6 to 78.5,248
Hib,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,5 Months,77.0,71.8 to 81.4,505
Hib,≥2 Doses,States/Local Areas,Arizona,2016,Age,5 Months,82.4,75.9 to 87.5,257
Hib,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,5 Months,78.7,73.8 to 82.8,535
PCV,≥3 Doses,States/Local Areas,Arizona,2015,Age,24 Months,88.4,82.7 to 92.9,248
PCV,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,90.6,87.1 to 93.5,505
PCV,≥3 Doses,States/Local Areas,Arizona,2014,Age,24 Months,91.9,87.0 to 95.5,259
PCV,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,90.2,86.5 to 93.2,507
Hib,≥2 Doses,States/Local Areas,Arizona,2017,Age,5 Months,74.9,67.5 to 81.1,278
Hib,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,5 Months,80.8,76.1 to 84.7,562
PCV,≥3 Doses,States/Local Areas,Arizona,2013,Age,24 Months,91.2,85.3 to 95.4,264
PCV,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,24 Months,91.6,87.9 to 94.6,523
Hib,≥2 Doses,States/Local Areas,Arizona,2011,Age,5 Months,73.2,67.5 to 78.1,266
Hib,≥2 Doses,States/Local Areas,Arizona,2012,Age,5 Months,72.6,66.9 to 77.7,277
Hib,≥2 Doses,States/Local Areas,Arizona,2013,Age,5 Months,65.6,58.1 to 72.4,264
Hib,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,5 Months,71.9,64.0 to 78.7,523
Hib,≥2 Doses,States/Local Areas,Arizona,2014,Age,5 Months,78.3,70.6 to 84.4,259
Hib,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,5 Months,75.0,71.7 to 78.0,507
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,81.8,77.8 to 85.9,493
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,73.9,68.4 to 79.3,356
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,64.3,47.0 to 81.5,47
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,73.7,53.7 to 93.6,34
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,76.3,70.9 to 81.7,329
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.6,58.0 to 91.2,35
PCV,≥1 Dose,States/Local Areas,Arizona,2013,Age,3 Months,81.0,74.5 to 86.1,264
PCV,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,3 Months,81.6,76.0 to 86.1,523
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,71.9 to 90.7,125
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.2,71.2 to 81.2,441
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,77.6,73.1 to 82.0,537
PCV,≥1 Dose,States/Local Areas,Arizona,2014,Age,3 Months,82.2,75.0 to 87.7,259
PCV,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,3 Months,82.4,77.7 to 86.3,507
PCV,≥1 Dose,States/Local Areas,Arizona,2015,Age,3 Months,82.6,76.0 to 87.6,248
PCV,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,3 Months,85.4,81.4 to 88.7,505
Hib,≥2 Doses,States/Local Areas,Arizona,2018,Age,5 Months,86.7,80.6 to 91.1,284
Hib,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,5 Months,82.5,77.4 to 86.6,519
Hib,≥2 Doses,States/Local Areas,Arizona,2019,Age,5 Months,78.2,69.9 to 84.7,235
Hib,≥2 Doses,States/Local Areas,Arizona,2011,Age,7 Months,89.2,82.4 to 93.5,266
Hib,≥2 Doses,States/Local Areas,Arizona,2012,Age,7 Months,87.2,84.7 to 89.4,277
PCV,≥3 Doses,States/Local Areas,Arizona,2016,Age,24 Months,92.7,88.2 to 96.0,257
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,91.4,87.9 to 94.2,535
PCV,≥3 Doses,States/Local Areas,Arizona,2017,Age,24 Months,90.0,84.5 to 94.2,278
PCV,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,93.6,90.6 to 96.0,562
PCV,≥3 Doses,States/Local Areas,Arizona,2018,Age,24 Months,97.2,94.2 to 98.9,284
PCV,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,94.3,91.1 to 96.6,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2011,Age,0-3 Days,77.9,70.7 to 83.8,266
PCV,≥1 Dose,States/Local Areas,Arizona,2018,Age,3 Months,88.6,82.6 to 92.6,284
PCV,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,3 Months,87.7,83.2 to 91.0,519
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,90.9,87.6 to 94.3,356
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2012,Age,0-3 Days,79.5,73.1 to 84.6,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2013,Age,0-3 Days,77.2,68.9 to 83.7,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2013-2014,Age,0-3 Days,76.3,70.9 to 80.9,523
PCV,≥1 Dose,States/Local Areas,Arizona,2016,Age,3 Months,88.3,83.0 to 92.1,257
PCV,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,3 Months,87.0,83.0 to 90.2,535
PCV,≥1 Dose,States/Local Areas,Arizona,2017,Age,3 Months,85.7,79.1 to 90.5,278
PCV,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,3 Months,87.1,82.7 to 90.5,562
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.0,69.2 to 80.8,345
Hep B,≥3 Doses,States/Local Areas,Arizona,2020,Age,24 Months,82.5,75.8 to 88.2,271
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,82.8,67.0 to 98.6,34
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,79.7,66.0 to 93.4,48
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,76.7,73.3 to 80.1,930
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,74.0,68.5 to 79.5,326
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,77.7,72.7 to 82.7,379
PCV,≥4 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,82.3,74.3 to 90.4,225
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,78.9,63.3 to 94.5,47
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,86.6,83.1 to 90.1,493
Hep B,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.5,73.3 to 100.0,35
Hib,≥2 Doses,States/Local Areas,Arizona,2013,Age,7 Months,84.4,81.3 to 87.1,264
Hib,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,7 Months,87.5,83.4 to 90.8,523
Hib,≥2 Doses,States/Local Areas,Arizona,2014,Age,7 Months,90.6,85.1 to 94.3,259
Hib,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,7 Months,87.6,83.7 to 90.8,507
Hib,≥2 Doses,States/Local Areas,Arizona,2016,Age,7 Months,91.8,86.9 to 95.0,257
Hib,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,7 Months,89.4,85.5 to 92.3,535
Hib,≥2 Doses,States/Local Areas,Arizona,2015,Age,7 Months,84.6,78.3 to 89.3,248
Hib,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,7 Months,88.2,84.4 to 91.2,505
PCV,≥3 Doses,States/Local Areas,Arizona,2019,Age,24 Months,91.1,85.4 to 95.3,235
PCV,≥3 Doses,States/Local Areas,Arizona,2011,Age,35 Months,89.2,82.6 to 94.1,266
PCV,≥3 Doses,States/Local Areas,Arizona,2013,Age,35 Months,93.2,87.9 to 96.7,264
PCV,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,93.7,90.3 to 96.2,523
PCV,≥3 Doses,States/Local Areas,Arizona,2012,Age,35 Months,92.7,83.9 to 97.6,277
≥1 Dose Varicella,,States/Local Areas,Arizona,2019-2020,Age,19 Months,87.1,82.4 to 90.6,506
Influenza,,States/Local Areas,Arizona,2011,Age,24 Months,52.4,44.3 to 61.1,266
Influenza,,States/Local Areas,Arizona,2012,Age,24 Months,49.6,41.8 to 58.0,277
Influenza,,States/Local Areas,Arizona,2014,Age,24 Months,44.2,36.5 to 52.7,259
Influenza,,States/Local Areas,Arizona,2014-2015,Age,24 Months,44.1,38.6 to 50.1,507
Influenza,,States/Local Areas,Arizona,2015,Age,24 Months,44.0,36.4 to 52.5,248
Influenza,,States/Local Areas,Arizona,2015-2016,Age,24 Months,50.7,45.1 to 56.6,505
Influenza,,States/Local Areas,Arizona,2016,Age,24 Months,57.4,49.6 to 65.5,257
Influenza,,States/Local Areas,Arizona,2016-2017,Age,24 Months,57.7,52.2 to 63.3,535
Influenza,,States/Local Areas,Arizona,2013,Age,24 Months,46.3,38.3 to 55.1,264
Influenza,,States/Local Areas,Arizona,2013-2014,Age,24 Months,45.2,39.6 to 51.3,523
Polio,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,5 Months,73.9,67.3 to 79.6,437
Hib,Primary Series,States/Local Areas,Arizona,2020-2021,Age,19 Months,88.0,82.1 to 92.1,437
PCV,≥4 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,80.1,73.7 to 85.8,437
Combined 7 Series,,States/Local Areas,Arizona,2020-2021,Age,35 Months,71.0,62.3 to 79.1,437
Hib,Primary Series,States/Local Areas,Arizona,2021,Age,35 Months,86.8,77.2 to 93.8,166
Polio,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,89.2,84.1 to 93.3,437
Hep A,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,41.6,35.3 to 48.5,437
DTaP,≥3 Doses,States/Local Areas,Arizona,2021,Age,35 Months,89.9,81.2 to 95.7,166
≥1 Dose Varicella,,States/Local Areas,Arizona,2020-2021,Age,19 Months,85.0,79.5 to 89.3,437
Hib,Full Series,States/Local Areas,Arizona,2021,Age,35 Months,78.1,65.2 to 88.8,166
Hep B,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,85.8,79.8 to 90.3,437
Rotavirus,,States/Local Areas,Arizona,2020-2021,Age,8 Months,69.6,62.8 to 75.7,437
Combined 7 Series,,States/Local Areas,Arizona,2020-2021,Age,24 Months,62.9,56.3 to 69.5,437
PCV,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,88.8,83.8 to 92.8,437
≥1 Dose MMR,,States/Local Areas,Arizona,2020-2021,Age,35 Months,89.6,83.9 to 94.0,437
Hib,Primary Series,States/Local Areas,Arizona,2021,Age,13 Months,82.0,71.4 to 89.3,166
Hep B,≥3 Doses,States/Local Areas,Arizona,2021,Age,35 Months,86.3,77.3 to 93.0,166
Influenza,,States/Local Areas,Arizona,2020-2021,Age,24 Months,48.8,42.2 to 55.9,437
PCV,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,88.4,83.1 to 92.3,437
Polio,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,83.4,77.3 to 88.2,437
≥1 Dose Varicella,,States/Local Areas,Arizona,2020-2021,Age,24 Months,86.9,81.7 to 91.2,437
DTaP,≥4 Doses,States/Local Areas,Arizona,2021,Age,35 Months,78.9,67.5 to 88.4,166
PCV,≥4 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,73.6,67.0 to 79.2,437
Hep B,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,59.8,53.0 to 66.1,437
Combined 7 Series,,States/Local Areas,Arizona,2021,Age,24 Months,62.8,52.2 to 73.5,166
Hep B,≥2 Doses,States/Local Areas,Arizona,2021,Age,13 Months,86.2,75.4 to 92.7,166
≥1 Dose Varicella,,States/Local Areas,Arizona,2021,Age,35 Months,88.1,79.8 to 94.2,166
DTaP,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,89.5,84.4 to 93.5,437
Hib,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,86.5,80.5 to 90.8,437
Hep B,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,84.1,78.3 to 88.6,437
Hib,Primary Series,States/Local Areas,Arizona,2020-2021,Age,35 Months,89.3,83.6 to 93.7,437
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2020-2021,Age,0-3 Days,80.5,74.3 to 85.5,437
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2020-2021,Age,0-1 Days,78.6,72.4 to 83.8,437
Hib,Full Series,States/Local Areas,Arizona,2020-2021,Age,35 Months,79.0,70.9 to 86.2,437
PCV,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,64.2,57.3 to 70.7,437
DTaP,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,86.9,81.1 to 91.2,437
Polio,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,88.4,82.5 to 92.5,437
≥1 Dose Varicella,,States/Local Areas,Arizona,2021,Age,13 Months,58.5,47.3 to 68.9,166
≥1 Dose MMR,,States/Local Areas,Arizona,2021,Age,19 Months,85.6,76.2 to 91.7,166
PCV,≥1 Dose,States/Local Areas,Arizona,2021,Age,3 Months,83.7,72.9 to 90.8,166
Hep B,≥3 Doses,States/Local Areas,Arizona,2021,Age,13 Months,83.6,72.9 to 90.6,166
Polio,≥3 Doses,States/Local Areas,Arizona,2021,Age,19 Months,89.6,79.6 to 95.0,166
Hep A,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,19 Months,78.8,72.7 to 83.8,437
Hib,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,87.0,81.5 to 91.6,437
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2020-2021,Age,0-2 Days,80.1,73.9 to 85.1,437
Hib,Full Series,States/Local Areas,Arizona,2020-2021,Age,19 Months,68.1,61.3 to 74.2,437
Hep A,≥2 Doses,States/Local Areas,Arizona,2021,Age,19 Months,25.6,17.3 to 36.1,166
Hib,Full Series,States/Local Areas,Arizona,2020-2021,Age,24 Months,71.9,65.3 to 78.1,437
Influenza,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,44.7,38.5 to 50.9,329
Influenza,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.3,60.2 to 80.5,125
Influenza,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",40.9,22.0 to 59.8,35
Influenza,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",57.1,51.2 to 63.0,441
Influenza,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,55.5,50.3 to 60.7,537
Influenza,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,45.7,39.1 to 52.3,345
Influenza,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,51.0,34.0 to 68.1,48
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,93.8,91.3 to 96.2,547
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,91.7,87.9 to 95.5,335
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,83.6,79.7 to 87.5,547
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,73.8,68.0 to 79.7,335
Influenza,,States/Local Areas,Arizona,2014-2017,Overall,Overall,51.9,47.8 to 55.9,930
Influenza,,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,45.7,39.4 to 52.1,326
Influenza,,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,50.3,44.0 to 56.7,379
Influenza,,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,71.1,63.3 to 79.0,225
Polio,≥2 Doses,States/Local Areas,Arizona,2021,Age,13 Months,87.7,76.9 to 93.9,166
Influenza,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,37.7,21.8 to 53.6,34
≥1 Dose Varicella,,States/Local Areas,Arizona,2020-2021,Age,13 Months,62.0,55.1 to 68.5,437
Influenza,,States/Local Areas,Arizona,2021,Age,24 Months,46.9,36.3 to 58.8,166
Hib,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,83.0,76.8 to 87.8,437
Hep B,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,3 Months,95.1,91.2 to 97.4,437
Hib,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,76.4,70.0 to 81.8,437
DTaP,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,5 Months,74.0,67.4 to 79.7,437
Hep A,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,24 Months,84.7,79.3 to 89.4,437
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2021,Age,0-3 Days,79.5,68.4 to 87.4,166
PCV,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,3 Months,80.8,74.6 to 85.8,437
Hib,≥3 Doses,States/Local Areas,Arizona,2021,Age,35 Months,86.7,77.1 to 93.7,166
≥1 Dose MMR,,States/Local Areas,Arizona,2021,Age,13 Months,58.5,47.3 to 68.9,166
Hep B,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,84.4,78.9 to 89.1,437
Hib,≥2 Doses,States/Local Areas,Arizona,2021,Age,13 Months,87.7,76.9 to 93.9,166
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.5,80.5 to 94.6,133
Rotavirus,,States/Local Areas,Arizona,2021,Age,8 Months,68.0,56.6 to 77.5,166
Hib,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,57.1,50.4 to 63.6,437
Hep A,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,76.2,65.7 to 85.4,437
≥1 Dose MMR,,States/Local Areas,Arizona,2020-2021,Age,19 Months,83.8,78.2 to 88.2,437
PCV,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,84.5,78.5 to 89.0,437
Polio,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,3 Months,83.2,77.3 to 87.9,437
Polio,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,88.2,83.1 to 92.4,437
Hib,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,5 Months,72.0,65.3 to 77.8,437
Hep B,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,5 Months,83.1,77.1 to 87.9,437
DTaP,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,7 Months,68.6,61.7 to 74.8,437
DTaP,≥4 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,69.0,62.2 to 75.0,437
Hib,≥3 Doses,States/Local Areas,Arizona,2021,Age,13 Months,77.4,66.3 to 85.6,166
PCV,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,88.4,83.4 to 92.5,437
Hib,Primary Series,States/Local Areas,Arizona,2020-2021,Age,7 Months,65.5,58.6 to 71.8,437
Hib,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,3 Months,81.5,75.5 to 86.3,437
Hep B,≥1 Dose,States/Local Areas,Arizona,2021,Age,3 Months,93.7,85.6 to 97.4,166
Influenza,,States/Local Areas,Arizona,2017,Age,24 Months,58.0,50.7 to 65.6,278
Influenza,,States/Local Areas,Arizona,2017-2018,Age,24 Months,58.3,52.8 to 63.8,562
Influenza,,States/Local Areas,Arizona,2018,Age,24 Months,58.5,50.7 to 66.5,284
Influenza,,States/Local Areas,Arizona,2018-2019,Age,24 Months,60.5,54.8 to 66.3,519
Influenza,,States/Local Areas,Arizona,2019,Age,24 Months,62.4,54.2 to 70.6,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,93.4,91.2 to 95.7,547
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,85.8,81.1 to 90.6,335
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,80.8,65.9 to 95.7,48
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,76.0,68.4 to 83.5,335
Influenza,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,46.6,28.2 to 65.0,47
Influenza,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,60.0,54.4 to 65.7,493
Influenza,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,46.6,40.4 to 52.8,356
Hep B,≥1 Dose,States/Local Areas,Kentucky,2021,Age,3 Months,92.9,86.9 to 96.3,216
Influenza,,States/Local Areas,Kentucky,2016,Age,24 Months,51.6,42.0 to 62.0,181
Influenza,,States/Local Areas,Kentucky,2016-2017,Age,24 Months,52.1,45.8 to 58.7,419
Influenza,,States/Local Areas,Kentucky,2015,Age,24 Months,44.5,36.7 to 53.1,210
Influenza,,States/Local Areas,Kentucky,2015-2016,Age,24 Months,48.0,41.7 to 54.7,391
Influenza,,States/Local Areas,Kentucky,2014,Age,24 Months,40.8,33.5 to 49.0,246
Influenza,,States/Local Areas,Kentucky,2014-2015,Age,24 Months,42.6,37.2 to 48.6,456
Influenza,,States/Local Areas,Kentucky,2011,Age,24 Months,39.3,30.9 to 48.9,217
Influenza,,States/Local Areas,Kentucky,2012,Age,24 Months,45.0,37.1 to 53.8,236
Influenza,,States/Local Areas,Kentucky,2013,Age,24 Months,36.1,28.9 to 44.6,236
Influenza,,States/Local Areas,Kentucky,2013-2014,Age,24 Months,38.5,33.2 to 44.3,482
PCV,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,19 Months,91.6,87.6 to 94.4,595
Combined 7 Series,,States/Local Areas,Kentucky,2021,Age,24 Months,67.3,58.4 to 75.9,216
PCV,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,70.8,65.1 to 75.9,540
Hep B,≥3 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,90.3,83.8 to 94.4,216
Polio,≥2 Doses,States/Local Areas,Kentucky,2021,Age,5 Months,80.2,71.8 to 86.6,216
DTaP,≥4 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,89.0,80.1 to 95.1,216
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,58.4,52.5 to 64.0,540
PCV,≥4 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,74.9,69.2 to 79.8,540
Hib,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,91.7,87.2 to 95.0,540
Hib,Primary Series,States/Local Areas,Kentucky,2020-2021,Age,19 Months,89.6,85.1 to 92.8,540
Rotavirus,,States/Local Areas,Kentucky,2020-2021,Age,8 Months,69.2,63.6 to 74.4,540
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,93.7,89.6 to 96.6,540
Hib,Full Series,States/Local Areas,Kentucky,2020-2021,Age,19 Months,63.2,57.2 to 68.9,540
Polio,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,87.9,83.2 to 91.4,540
Hep B,≥3 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,92.6,87.4 to 96.3,216
Influenza,,States/Local Areas,Kentucky,2020-2021,Age,24 Months,45.9,40.3 to 51.9,540
Hep B,≥2 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,93.4,87.5 to 96.6,216
Polio,≥3 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,94.0,88.4 to 97.5,216
≥1 Dose Varicella,,States/Local Areas,Kentucky,2021,Age,35 Months,89.9,83.0 to 94.8,216
DTaP,≥4 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,79.3,73.9 to 84.2,540
Hep A,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,19 Months,83.6,78.4 to 87.8,540
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,92.2,88.2 to 95.2,540
Hib,Primary Series,States/Local Areas,Kentucky,2020-2021,Age,35 Months,92.8,88.6 to 95.8,540
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2020-2021,Age,0-3 Days,79.8,74.8 to 84.1,540
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020-2021,Age,19 Months,81.9,76.4 to 86.4,540
PCV,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,93.3,89.6 to 96.0,540
Hep B,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,3 Months,93.9,90.6 to 96.1,540
DTaP,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,3 Months,84.8,79.9 to 88.6,540
Hib,Full Series,States/Local Areas,Kentucky,2020-2021,Age,35 Months,74.1,68.4 to 79.5,540
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Kentucky,2020-2021,Age,0-2 Days,78.9,73.9 to 83.2,540
≥1 Dose MMR,,States/Local Areas,Kentucky,2020-2021,Age,13 Months,62.7,56.9 to 68.3,540
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,90.2,85.9 to 93.3,540
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,88.1,83.4 to 91.7,540
Hep B,≥2 Doses,States/Local Areas,Kentucky,2021,Age,5 Months,89.1,82.3 to 93.5,216
Hep A,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,31.2,26.2 to 36.6,540
≥1 Dose MMR,,States/Local Areas,Kentucky,2021,Age,19 Months,84.2,75.7 to 90.1,216
Hib,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,5 Months,74.4,68.6 to 79.4,540
Polio,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,92.2,88.2 to 95.0,540
≥1 Dose Varicella,,States/Local Areas,Kentucky,2021,Age,13 Months,57.5,48.4 to 66.1,216
DTaP,≥2 Doses,States/Local Areas,Kentucky,2021,Age,5 Months,81.0,72.7 to 87.3,216
Influenza,,States/Local Areas,Kentucky,2018,Age,24 Months,56.6,49.6 to 63.9,278
Influenza,,States/Local Areas,Kentucky,2018-2019,Age,24 Months,58.0,52.5 to 63.7,549
Influenza,,States/Local Areas,Kentucky,2017,Age,24 Months,52.6,44.9 to 60.7,238
Influenza,,States/Local Areas,Kentucky,2017-2018,Age,24 Months,54.6,49.3 to 60.0,516
Polio,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.3,78.7 to 97.9,91
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,87.7,82.9 to 92.4,335
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,89.5,85.7 to 93.4,467
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.0,55.6 to 92.4,51
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,71.9,55.4 to 88.4,75
Influenza,,States/Local Areas,Kentucky,2019,Age,24 Months,59.4,51.1 to 67.9,271
Influenza,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,37.5,30.8 to 44.1,307
Influenza,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,59.7,53.6 to 65.8,397
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,74.0 to 94.6,91
Influenza,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,50.2,42.5 to 57.8,267
Influenza,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",46.8,41.7 to 52.0,566
Influenza,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,35.8,28.5 to 43.2,248
Influenza,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,55.3,47.3 to 63.4,233
PCV,≥1 Dose,States/Local Areas,Kentucky,2021,Age,3 Months,87.3,80.6 to 91.9,216
Influenza,,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,63.5,54.2 to 72.8,185
Influenza,,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,51.6,44.4 to 58.7,300
Influenza,,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,34.8,27.8 to 41.8,263
Influenza,,States/Local Areas,Kentucky,2014-2017,Overall,Overall,47.1,42.6 to 51.7,748
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,85.0,80.5 to 89.6,467
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,90.7,86.3 to 95.1,335
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,96.9,95.0 to 98.9,467
DTaP,≥3 Doses,States/Local Areas,Kentucky,2021,Age,24 Months,94.3,88.7 to 97.7,216
Influenza,,States/Local Areas,Kentucky,2021,Age,24 Months,47.7,39.3 to 56.8,216
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020-2021,Age,13 Months,57.5,51.6 to 63.2,540
Influenza,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",57.6,43.9 to 71.3,71
Influenza,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,38.8,24.7 to 52.9,73
Influenza,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",42.2,22.2 to 62.1,38
Hep A,≥2 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.5,50.7 to 80.3,91
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Private Insurance Only,89.4,85.6 to 93.1,467
Hep A,≥1 Dose,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,72.9 to 93.9,91
Hib,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,87.4,82.7 to 91.0,540
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Kentucky,2021,Age,0-3 Days,76.1,67.9 to 82.8,216
Hib,≥2 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,92.4,86.0 to 96.0,216
≥1 Dose MMR,,States/Local Areas,Kentucky,2020-2021,Age,19 Months,83.9,78.5 to 88.1,540
DTaP,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,72.2,66.6 to 77.2,540
PCV,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,13 Months,87.5,82.7 to 91.1,540
≥1 Dose MMR,,States/Local Areas,Kentucky,2021,Age,13 Months,64.4,55.5 to 72.5,216
Hep A,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,24 Months,88.8,84.4 to 92.4,540
Hep A,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,77.6,70.8 to 83.7,540
Hib,≥3 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,92.1,85.1 to 96.6,216
Polio,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,91.9,87.9 to 94.9,540
DTaP,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,5 Months,78.0,72.5 to 82.7,540
Hib,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,49.1,43.3 to 55.0,540
PCV,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,3 Months,83.7,78.7 to 87.6,540
Polio,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,3 Months,84.8,80.0 to 88.6,540
Hep B,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,91.5,87.7 to 94.5,540
Hep A,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,51.9,46.1 to 58.1,540
Hib,Primary Series,States/Local Areas,Kentucky,2021,Age,35 Months,93.1,86.7 to 97.1,216
Rotavirus,,States/Local Areas,Kentucky,2021,Age,8 Months,77.0,69.0 to 83.4,216
≥1 Dose Varicella,,States/Local Areas,Kentucky,2020-2021,Age,24 Months,86.7,82.0 to 90.7,540
Hib,Primary Series,States/Local Areas,Kentucky,2020-2021,Age,7 Months,67.1,61.3 to 72.4,540
Hep B,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,5 Months,88.6,84.0 to 91.9,540
Polio,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,93.7,89.6 to 96.6,540
Hib,≥3 Doses,States/Local Areas,Kentucky,2021,Age,13 Months,66.5,57.6 to 74.4,216
DTaP,≥4 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,67.6,61.5 to 73.1,540
PCV,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,24 Months,92.2,88.5 to 95.1,540
Polio,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,90.9,86.7 to 93.9,540
≥1 Dose MMR,,States/Local Areas,Kentucky,2020-2021,Age,24 Months,88.5,84.0 to 92.1,540
Combined 7 Series,,States/Local Areas,Kentucky,2020-2021,Age,35 Months,66.6,60.7 to 72.4,540
Polio,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,5 Months,77.4,71.8 to 82.1,540
Hib,Full Series,States/Local Areas,Kentucky,2021,Age,35 Months,77.9,69.2 to 85.5,216
Combined 7 Series,,States/Local Areas,Kentucky,2020-2021,Age,24 Months,64.1,58.3 to 69.9,540
Hib,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,85.8,80.8 to 89.6,540
Hib,Primary Series,States/Local Areas,Kentucky,2020-2021,Age,13 Months,81.1,75.9 to 85.4,540
Hep B,≥2 Doses,States/Local Areas,Kentucky,2020-2021,Age,7 Months,90.5,86.2 to 93.5,540
Hib,≥1 Dose,States/Local Areas,Kentucky,2020-2021,Age,3 Months,80.9,75.5 to 85.2,540
DTaP,≥3 Doses,States/Local Areas,Kentucky,2021,Age,35 Months,94.3,88.7 to 97.7,216
≥1 Dose MMR,,States/Local Areas,Kentucky,2020-2021,Age,35 Months,90.9,86.4 to 94.3,540
PCV,≥4 Doses,States/Local Areas,Kentucky,2020-2021,Age,35 Months,82.8,77.4 to 87.5,540
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Kentucky,2020-2021,Age,0-1 Days,76.4,71.2 to 81.0,540
PCV,≥3 Doses,States/Local Areas,Kentucky,2020-2021,Age,19 Months,91.3,87.2 to 94.1,540
Hib,Primary Series,States/Local Areas,Kentucky,2021,Age,13 Months,82.4,74.5 to 88.3,216
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,81.3,76.3 to 86.4,397
Rotavirus,,States/Local Areas,Kentucky,2018,Age,8 Months,75.1,67.9 to 81.1,278
Rotavirus,,States/Local Areas,Kentucky,2018-2019,Age,8 Months,77.8,72.7 to 82.1,549
Rotavirus,,States/Local Areas,Kentucky,2017,Age,8 Months,69.1,61.4 to 75.8,238
Rotavirus,,States/Local Areas,Kentucky,2017-2018,Age,8 Months,72.0,66.9 to 76.7,516
Rotavirus,,States/Local Areas,Kentucky,2019,Age,8 Months,80.5,72.9 to 86.4,271
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Poverty,>400% FPL,84.5,77.4 to 91.7,185
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Principal City,74.5,67.3 to 81.7,267
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.7,70.0 to 79.4,566
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,62.1 to 86.3,71
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,72.0,57.2 to 86.7,73
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,68.0,61.4 to 74.7,307
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.0,46.7 to 87.4,38
Rotavirus,,States/Local Areas,Kentucky,2015,Age,8 Months,81.0,73.1 to 87.0,210
Rotavirus,,States/Local Areas,Kentucky,2015-2016,Age,8 Months,79.6,73.5 to 84.5,391
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Poverty,133% to <400% FPL,75.7,69.2 to 82.3,300
Rotavirus,,States/Local Areas,Kentucky,2013,Age,8 Months,64.1,56.0 to 71.5,236
Rotavirus,,States/Local Areas,Kentucky,2013-2014,Age,8 Months,65.5,59.8 to 70.8,482
Rotavirus,,States/Local Areas,Kentucky,2012,Age,8 Months,64.3,55.9 to 71.9,236
Rotavirus,,States/Local Areas,Kentucky,2014,Age,8 Months,67.0,58.9 to 74.1,246
Rotavirus,,States/Local Areas,Kentucky,2014-2015,Age,8 Months,74.0,68.5 to 78.8,456
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Poverty,<133% FPL,66.9,59.7 to 74.0,263
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Overall,Overall,73.9,69.8 to 78.1,748
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a Non-MSA,71.0,63.6 to 78.5,248
Rotavirus,,States/Local Areas,Kentucky,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.2,69.3 to 83.1,233
Rotavirus,,States/Local Areas,Kentucky,2016,Age,8 Months,78.1,68.4 to 85.4,181
Rotavirus,,States/Local Areas,Kentucky,2016-2017,Age,8 Months,73.6,67.6 to 78.9,419
Rotavirus,,States/Local Areas,Kentucky,2011,Age,8 Months,70.2,61.4 to 77.7,217
Hib,Full Series,States/Local Areas,Kentucky,2020-2021,Age,24 Months,72.3,66.6 to 77.8,540
Hib,Full Series,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,Hispanic,66.0,51.1 to 80.9,75
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,76.2 to 96.5,91
DTaP,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,<133% FPL,74.1,67.0 to 81.2,251
PCV,≥4 Doses,States/Local Areas,Kentucky,2016-2019,Insurance Coverage,Any Medicaid,79.1,73.4 to 84.7,335
Hep B,≥2 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,92.1,88.1 to 94.9,595
PCV,≥3 Doses,States/Local Areas,Kentucky,2016-2019,Poverty,>400% FPL,97.6,95.4 to 99.8,232
Hep B,≥3 Doses,States/Local Areas,Kentucky,2019-2020,Age,7 Months,60.9,55.2 to 66.4,595
Hib,Primary Series,States/Local Areas,Kentucky,2018,Age,24 Months,92.5,87.8 to 95.9,278
Hib,Primary Series,States/Local Areas,Kentucky,2018-2019,Age,24 Months,93.2,89.9 to 95.8,549
Hib,Primary Series,States/Local Areas,Kentucky,2017,Age,24 Months,93.2,88.0 to 96.7,238
Hib,Primary Series,States/Local Areas,Kentucky,2017-2018,Age,24 Months,92.9,89.5 to 95.5,516
Combined 7 Series,,States/Local Areas,Kentucky,2011,Age,24 Months,68.8,60.0 to 77.2,217
Hib,Primary Series,States/Local Areas,Kentucky,2016,Age,24 Months,96.8,91.5 to 99.2,181
Hib,Primary Series,States/Local Areas,Kentucky,2016-2017,Age,24 Months,95.0,91.6 to 97.4,419
Combined 7 Series,,States/Local Areas,Kentucky,2012,Age,24 Months,68.7,60.7 to 76.3,236
Combined 7 Series,,States/Local Areas,Kentucky,2013,Age,24 Months,69.9,62.3 to 77.3,236
Combined 7 Series,,States/Local Areas,Kentucky,2013-2014,Age,24 Months,69.9,64.3 to 75.3,482
Hib,Primary Series,States/Local Areas,Kentucky,2016,Age,35 Months,97.0,91.5 to 99.3,181
Hib,Primary Series,States/Local Areas,Kentucky,2016-2017,Age,35 Months,96.6,92.9 to 98.7,419
Hib,Primary Series,States/Local Areas,Kentucky,2014,Age,24 Months,92.7,87.5 to 96.2,246
Hib,Primary Series,States/Local Areas,Kentucky,2014-2015,Age,24 Months,94.7,91.4 to 97.0,456
Hib,Primary Series,States/Local Areas,Kentucky,2015,Age,24 Months,96.7,91.9 to 99.1,210
Hib,Primary Series,States/Local Areas,Kentucky,2015-2016,Age,24 Months,96.8,93.5 to 98.7,391
Hib,Primary Series,States/Local Areas,Kentucky,2019,Age,24 Months,94.0,88.8 to 97.3,271
Hib,Primary Series,States/Local Areas,Kentucky,2013,Age,35 Months,94.0,89.4 to 97.0,236
Hib,Primary Series,States/Local Areas,Kentucky,2013-2014,Age,35 Months,93.8,90.3 to 96.3,482
Hib,Primary Series,States/Local Areas,Kentucky,2015,Age,35 Months,98.5,94.7 to 99.8,210
Hib,Primary Series,States/Local Areas,Kentucky,2015-2016,Age,35 Months,97.7,94.6 to 99.2,391
Hib,Primary Series,States/Local Areas,Kentucky,2014,Age,35 Months,93.4,88.2 to 96.8,246
Hib,Primary Series,States/Local Areas,Kentucky,2014-2015,Age,35 Months,96.2,93.1 to 98.1,456
Hib,Primary Series,States/Local Areas,Kentucky,2012,Age,35 Months,94.3,89.3 to 97.5,236
Combined 7 Series,,States/Local Areas,Kentucky,2017,Age,35 Months,77.8,70.4 to 84.5,238
Combined 7 Series,,States/Local Areas,Kentucky,2017-2018,Age,35 Months,78.0,72.8 to 82.9,516
Combined 7 Series,,States/Local Areas,Kentucky,2016,Age,35 Months,79.4,70.4 to 87.1,181
Combined 7 Series,,States/Local Areas,Kentucky,2016-2017,Age,35 Months,78.8,73.0 to 84.0,419
Hib,Primary Series,States/Local Areas,Kentucky,2011,Age,35 Months,91.1,84.5 to 95.7,217
Hib,Primary Series,States/Local Areas,Kentucky,2017,Age,35 Months,96.5,89.5 to 99.3,238
Hib,Primary Series,States/Local Areas,Kentucky,2017-2018,Age,35 Months,95.7,90.9 to 98.4,516
Hib,Full Series,States/Local Areas,Kentucky,2015,Age,19 Months,73.7,61.6 to 83.0,210
Hib,Full Series,States/Local Areas,Kentucky,2015-2016,Age,19 Months,77.2,71.4 to 82.2,391
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,Hispanic,63.2,48.0 to 78.4,73
Combined 7 Series,,States/Local Areas,Kentucky,2015,Age,35 Months,74.1,65.7 to 81.8,210
Combined 7 Series,,States/Local Areas,Kentucky,2015-2016,Age,35 Months,76.8,70.7 to 82.4,391
Combined 7 Series,,States/Local Areas,Kentucky,2018,Age,35 Months,78.3,71.0 to 84.8,278
Combined 7 Series,,States/Local Areas,Kentucky,2018-2019,Age,35 Months,79.1,73.8 to 84.1,549
Combined 7 Series,,States/Local Areas,Kentucky,2019,Age,35 Months,79.9,71.8 to 87.0,271
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Any Medicaid,70.2,63.8 to 76.7,307
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Insurance Coverage,Private Insurance Only,75.0,69.3 to 80.8,397
Hib,Full Series,States/Local Areas,Kentucky,2014,Age,24 Months,76.7,68.8 to 83.8,246
Hib,Full Series,States/Local Areas,Kentucky,2014-2015,Age,24 Months,78.9,73.5 to 83.8,456
Hib,Full Series,States/Local Areas,Kentucky,2013,Age,24 Months,76.8,69.8 to 83.3,236
Hib,Full Series,States/Local Areas,Kentucky,2013-2014,Age,24 Months,76.8,71.5 to 81.7,482
Combined 7 Series,,States/Local Areas,Kentucky,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.9,51.9 to 89.9,38
Hib,Full Series,States/Local Areas,Kentucky,2017,Age,19 Months,78.6,71.5 to 84.3,238
Hib,Full Series,States/Local Areas,Kentucky,2017-2018,Age,19 Months,74.2,69.2 to 78.7,516
Hib,Full Series,States/Local Areas,Kentucky,2011,Age,24 Months,74.3,65.6 to 82.2,217
Hib,Full Series,States/Local Areas,Kentucky,2012,Age,24 Months,79.5,72.1 to 86.0,236
Hib,Full Series,States/Local Areas,Kentucky,2019,Age,19 Months,72.1,63.6 to 79.3,271
≥1 Dose MMR,,States/Local Areas,Kentucky,2020,Age,13 Months,61.1,53.4 to 68.2,324
Hib,Full Series,States/Local Areas,Kentucky,2018,Age,19 Months,69.8,62.5 to 76.2,278
Hib,Full Series,States/Local Areas,Kentucky,2018-2019,Age,19 Months,95.0,91.6 to 97.0,549
Hib,Full Series,States/Local Areas,Kentucky,2014,Age,19 Months,69.8,61.5 to 77.1,246
Hib,Full Series,States/Local Areas,Kentucky,2014-2015,Age,19 Months,71.7,66.0 to 76.9,456
Hib,Full Series,States/Local Areas,Kentucky,2016,Age,19 Months,80.8,72.2 to 87.2,181
Hib,Full Series,States/Local Areas,Kentucky,2016-2017,Age,19 Months,79.7,74.3 to 84.2,419
Hib,Primary Series,States/Local Areas,Kentucky,2019,Age,13 Months,85.7,78.2 to 90.9,271
Hib,Primary Series,States/Local Areas,Kentucky,2012,Age,19 Months,93.5,89.2 to 96.1,236
Hib,Primary Series,States/Local Areas,Kentucky,2016,Age,13 Months,91.9,84.2 to 96.1,181
Hib,Primary Series,States/Local Areas,Kentucky,2016-2017,Age,13 Months,91.8,87.4 to 94.8,419
Hib,Primary Series,States/Local Areas,Kentucky,2017,Age,13 Months,91.7,85.9 to 95.2,238
Hib,Primary Series,States/Local Areas,Kentucky,2017-2018,Age,13 Months,89.2,85.2 to 92.2,516
Hib,Primary Series,States/Local Areas,Kentucky,2011,Age,19 Months,89.8,83.7 to 93.7,217
Hib,Primary Series,States/Local Areas,Kentucky,2018,Age,13 Months,86.8,80.7 to 91.2,278
Hib,Primary Series,States/Local Areas,Kentucky,2018-2019,Age,13 Months,86.2,81.6 to 89.8,549
Hib,Primary Series,States/Local Areas,Kentucky,2013,Age,19 Months,91.5,85.1 to 95.3,236
Hib,Primary Series,States/Local Areas,Kentucky,2013-2014,Age,19 Months,89.9,85.8 to 92.9,482
Hib,Primary Series,States/Local Areas,Kentucky,2017,Age,19 Months,92.6,86.7 to 96.0,238
Hib,Primary Series,States/Local Areas,Kentucky,2017-2018,Age,19 Months,92.0,88.2 to 94.7,516
Hib,Primary Series,States/Local Areas,Kentucky,2018,Age,19 Months,91.4,85.8 to 95.0,278
Hib,Primary Series,States/Local Areas,Kentucky,2018-2019,Age,19 Months,86.2,81.6 to 89.8,549
Hib,Primary Series,States/Local Areas,Kentucky,2014,Age,19 Months,88.3,81.5 to 92.8,246
Hib,Primary Series,States/Local Areas,Kentucky,2014-2015,Age,19 Months,92.1,88.0 to 94.9,456
Hib,Primary Series,States/Local Areas,Kentucky,2016,Age,19 Months,96.2,89.8 to 98.6,181
Hib,Primary Series,States/Local Areas,Kentucky,2016-2017,Age,19 Months,94.4,90.6 to 96.7,419
Hib,Primary Series,States/Local Areas,Kentucky,2019,Age,19 Months,93.7,87.9 to 96.8,271
Hib,Primary Series,States/Local Areas,Kentucky,2015,Age,19 Months,95.9,92.1 to 97.9,210
Hib,Primary Series,States/Local Areas,Kentucky,2015-2016,Age,19 Months,96.1,92.3 to 98.0,391
Combined 7 Series,,States/Local Areas,Kentucky,2019,Age,24 Months,74.7,66.7 to 82.0,271
Hib,Primary Series,States/Local Areas,Kentucky,2014,Age,7 Months,68.6,60.1 to 76.0,246
Hib,Primary Series,States/Local Areas,Kentucky,2014-2015,Age,7 Months,71.8,66.1 to 76.9,456
Hib,Primary Series,States/Local Areas,Kentucky,2015,Age,7 Months,75.0,66.9 to 81.7,210
Hib,Primary Series,States/Local Areas,Kentucky,2015-2016,Age,7 Months,74.4,68.2 to 79.8,391
Hib,Primary Series,States/Local Areas,Kentucky,2012,Age,24 Months,94.0,89.0 to 97.2,236
Hib,Primary Series,States/Local Areas,Kentucky,2011,Age,24 Months,90.2,83.7 to 94.9,217
Hib,Primary Series,States/Local Areas,Kentucky,2013,Age,24 Months,92.8,88.1 to 96.1,236
Hib,Primary Series,States/Local Areas,Kentucky,2013-2014,Age,24 Months,92.8,89.3 to 95.4,482
Hib,Primary Series,States/Local Areas,Kentucky,2019,Age,7 Months,74.7,66.4 to 81.5,271
Hib,Primary Series,States/Local Areas,Kentucky,2014,Age,13 Months,84.8,77.9 to 89.8,246
Hib,Primary Series,States/Local Areas,Kentucky,2014-2015,Age,13 Months,88.2,83.8 to 91.6,456
Hib,Primary Series,States/Local Areas,Kentucky,2015,Age,13 Months,91.7,85.3 to 95.4,210
Hib,Primary Series,States/Local Areas,Kentucky,2015-2016,Age,13 Months,91.8,87.2 to 94.8,391
Combined 7 Series,,States/Local Areas,Kentucky,2014,Age,24 Months,69.7,61.7 to 77.4,246
Combined 7 Series,,States/Local Areas,Kentucky,2014-2015,Age,24 Months,69.1,63.4 to 74.7,456
Hib,Primary Series,States/Local Areas,Kentucky,2016,Age,7 Months,73.8,63.9 to 81.8,181
Hib,Primary Series,States/Local Areas,Kentucky,2016-2017,Age,7 Months,71.8,65.7 to 77.2,419
Hib,Primary Series,States/Local Areas,Kentucky,2017,Age,7 Months,69.8,62.0 to 76.5,238
Hib,Primary Series,States/Local Areas,Kentucky,2017-2018,Age,7 Months,71.5,66.3 to 76.2,516
Hib,Primary Series,States/Local Areas,Kentucky,2013,Age,7 Months,61.7,54.7 to 68.3,236
Hib,Primary Series,States/Local Areas,Kentucky,2013-2014,Age,7 Months,65.2,61.0 to 69.1,482
Hib,Primary Series,States/Local Areas,Kentucky,2013,Age,13 Months,84.9,76.8 to 90.6,236
Hib,Primary Series,States/Local Areas,Kentucky,2013-2014,Age,13 Months,84.9,80.6 to 88.3,482
Hib,Primary Series,States/Local Areas,Kentucky,2012,Age,13 Months,89.8,83.3 to 93.9,236
Hib,Primary Series,States/Local Areas,Kentucky,2011,Age,13 Months,86.8,83.4 to 89.5,217
Combined 7 Series,,States/Local Areas,Kentucky,2012,Age,35 Months,80.2,70.0 to 88.7,236
Combined 7 Series,,States/Local Areas,Kentucky,2013,Age,35 Months,73.4,65.0 to 81.3,236
Combined 7 Series,,States/Local Areas,Kentucky,2013-2014,Age,35 Months,74.0,68.3 to 79.5,482
Combined 7 Series,,States/Local Areas,Kentucky,2014,Age,35 Months,74.8,66.7 to 82.3,246
Combined 7 Series,,States/Local Areas,Kentucky,2014-2015,Age,35 Months,74.5,68.7 to 79.9,456
Combined 7 Series,,States/Local Areas,Kentucky,2011,Age,35 Months,77.1,67.7 to 85.3,217
Hib,Primary Series,States/Local Areas,Kentucky,2019,Age,35 Months,95.3,90.0 to 98.3,271
Combined 7 Series,,States/Local Areas,Kentucky,2016,Age,24 Months,77.8,68.9 to 85.6,181
Combined 7 Series,,States/Local Areas,Kentucky,2016-2017,Age,24 Months,74.6,68.9 to 80.0,419
Hib,Primary Series,States/Local Areas,Kentucky,2018,Age,35 Months,94.0,89.0 to 97.2,278
Hib,Primary Series,States/Local Areas,Kentucky,2018-2019,Age,35 Months,94.8,91.3 to 97.3,549
Combined 7 Series,,States/Local Areas,Kentucky,2015,Age,24 Months,68.4,60.2 to 76.3,210
Combined 7 Series,,States/Local Areas,Kentucky,2015-2016,Age,24 Months,73.1,67.1 to 78.8,391
Hib,Primary Series,States/Local Areas,Kentucky,2018,Age,7 Months,73.2,66.1 to 79.3,278
Hib,Primary Series,States/Local Areas,Kentucky,2018-2019,Age,7 Months,74.0,68.6 to 78.7,549
Combined 7 Series,,States/Local Areas,Kentucky,2018,Age,24 Months,71.8,64.7 to 78.7,278
Combined 7 Series,,States/Local Areas,Kentucky,2018-2019,Age,24 Months,73.2,67.9 to 78.3,549
Combined 7 Series,,States/Local Areas,Kentucky,2017,Age,24 Months,71.4,64.0 to 78.3,238
Combined 7 Series,,States/Local Areas,Kentucky,2017-2018,Age,24 Months,71.6,66.4 to 76.5,516
PCV,≥3 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,61.4,53.9 to 68.5,357
Polio,≥3 Doses,States/Local Areas,New York,2011,Age,35 Months,95.2,91.6 to 97.5,466
DTaP,≥3 Doses,States/Local Areas,New York,2016,Age,19 Months,90.4,85.7 to 93.6,506
DTaP,≥3 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,92.4,89.7 to 94.4,1154
DTaP,≥3 Doses,States/Local Areas,New York,2015,Age,19 Months,92.4,89.8 to 94.4,503
DTaP,≥3 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,91.4,88.5 to 93.6,1009
DTaP,≥3 Doses,States/Local Areas,New York,2014,Age,19 Months,93.4,90.7 to 95.3,592
DTaP,≥3 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,92.9,90.7 to 94.6,1095
Polio,≥3 Doses,States/Local Areas,New York,2013,Age,24 Months,94.3,91.5 to 96.5,545
Polio,≥3 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,94.0,92.2 to 95.5,1137
Hib,≥3 Doses,States/Local Areas,New York,2013,Age,19 Months,90.5,88.0 to 92.6,545
Hib,≥3 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,90.3,87.3 to 92.7,1137
Hib,≥3 Doses,States/Local Areas,New York,2014,Age,19 Months,90.1,86.8 to 92.7,592
Hib,≥3 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,89.9,87.3 to 92.0,1095
Polio,≥3 Doses,States/Local Areas,New York,2012,Age,24 Months,93.8,91.0 to 96.0,492
Polio,≥3 Doses,States/Local Areas,New York,2011,Age,24 Months,92.9,89.2 to 95.7,466
Polio,≥3 Doses,States/Local Areas,New York,2019,Age,19 Months,89.5,84.7 to 92.9,637
Hib,≥3 Doses,States/Local Areas,New York,2015,Age,19 Months,89.6,87.5 to 91.4,503
Hib,≥3 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,88.3,85.2 to 90.8,1009
DTaP,≥3 Doses,States/Local Areas,New York,2011,Age,24 Months,95.4,92.3 to 97.5,466
Rotavirus,,States/Local Areas,New Mexico,2019-2020,Age,8 Months,82.2,77.9 to 85.8,731
Hep A,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,35 Months,89.0,84.4 to 92.7,595
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2021,Age,0-2 Days,67.2,58.3 to 74.9,238
Hib,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,90.9,86.9 to 93.7,595
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020-2021,Age,35 Months,90.8,86.2 to 94.3,595
DTaP,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,3 Months,87.8,83.6 to 91.0,595
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2021,Age,0-1 Days,63.8,55.0 to 71.7,238
PCV,≥3 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,88.5,81.3 to 93.9,238
PCV,≥4 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,78.6,70.3 to 85.9,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2021,Age,24 Months,84.1,76.3 to 90.5,238
PCV,≥3 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,85.4,77.6 to 90.9,238
≥1 Dose Varicella,,States/Local Areas,New Mexico,2021,Age,24 Months,86.0,78.1 to 92.2,238
DTaP,≥3 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,86.2,77.8 to 91.8,238
PCV,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,5 Months,75.2,69.8 to 79.9,595
Hep B,≥3 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,65.6,56.5 to 73.7,238
Hep A,≥2 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,53.3,43.8 to 63.5,238
PCV,≥3 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,62.3,53.0 to 70.7,238
DTaP,≥3 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,83.4,75.0 to 89.3,238
Hep B,≥3 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,84.1,76.0 to 90.6,238
PCV,≥4 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,74.1,65.2 to 81.5,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2021,Age,19 Months,81.0,72.1 to 87.5,238
Polio,≥2 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,89.6,82.6 to 94.0,238
Hep A,≥2 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,26.9,20.2 to 34.9,238
DTaP,≥4 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,70.7,61.7 to 79.2,238
DTaP,≥1 Dose,States/Local Areas,New Mexico,2021,Age,3 Months,85.6,78.3 to 90.8,238
PCV,≥4 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,94.1,79.6 to 99.4,238
Polio,≥3 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,85.5,77.7 to 91.6,238
Hib,Primary Series,States/Local Areas,New Mexico,2021,Age,24 Months,86.4,78.7 to 92.4,238
PCV,≥3 Doses,States/Local Areas,New York,2012,Age,35 Months,94.9,91.8 to 97.1,492
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,92.3,89.3 to 95.3,452
PCV,≥3 Doses,States/Local Areas,New York,2016,Age,35 Months,90.7,86.4 to 94.1,506
PCV,≥3 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,92.7,90.1 to 94.8,1154
PCV,≥3 Doses,States/Local Areas,New York,2015,Age,35 Months,91.2,86.7 to 94.7,503
PCV,≥3 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,90.8,87.9 to 93.3,1009
PCV,≥3 Doses,States/Local Areas,New York,2014,Age,35 Months,95.0,92.4 to 96.9,592
PCV,≥3 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,93.2,90.8 to 95.2,1095
Hib,≥2 Doses,States/Local Areas,New York,2018,Age,7 Months,88.4,84.3 to 91.5,733
Hib,≥2 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,89.0,86.2 to 91.2,1370
DTaP,≥3 Doses,States/Local Areas,New York,2017,Age,13 Months,92.4,89.1 to 94.8,648
DTaP,≥3 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,91.1,88.7 to 93.0,1381
DTaP,≥3 Doses,States/Local Areas,New York,2016,Age,13 Months,87.7,82.8 to 91.3,506
DTaP,≥3 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,90.0,87.1 to 92.3,1154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Poverty,<133% FPL,72.8,68.6 to 76.9,646
≥1 Dose Varicella,,States/Local Areas,New York,2020,Age,24 Months,90.5,86.8 to 93.5,624
Hib,≥2 Doses,States/Local Areas,New York,2019,Age,7 Months,89.6,85.5 to 92.6,637
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016,Age,0-3 Days,71.1,65.2 to 76.3,506
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2016-2017,Age,0-3 Days,74.2,70.4 to 77.6,1154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2017,Age,0-3 Days,75.6,67.3 to 82.4,313
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2017-2018,Age,0-3 Days,77.9,74.7 to 80.8,1381
Polio,≥1 Dose,States/Local Areas,New York,2016,Age,3 Months,82.9,77.8 to 87.1,506
Polio,≥1 Dose,States/Local Areas,New York,2016-2017,Age,3 Months,85.9,82.7 to 88.5,1154
Polio,≥1 Dose,States/Local Areas,New York,2015,Age,3 Months,84.4,80.1 to 88.0,503
Polio,≥1 Dose,States/Local Areas,New York,2015-2016,Age,3 Months,83.7,80.4 to 86.5,1009
Polio,≥1 Dose,States/Local Areas,New York,2014,Age,3 Months,87.4,83.7 to 90.3,592
Polio,≥1 Dose,States/Local Areas,New York,2014-2015,Age,3 Months,85.9,83.2 to 88.3,1095
Hib,≥3 Doses,States/Local Areas,New York,2013,Age,7 Months,50.6,47.6 to 53.5,545
Hib,≥3 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,53.2,50.8 to 55.5,1137
Hib,≥3 Doses,States/Local Areas,New York,2011,Age,7 Months,56.3,51.5 to 60.9,466
Hib,≥3 Doses,States/Local Areas,New York,2012,Age,7 Months,54.1,50.2 to 58.0,492
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,88.9,85.3 to 92.5,523
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,92.8,90.4 to 95.2,753
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,90.8,88.2 to 93.4,646
Hib,≥2 Doses,States/Local Areas,New York,2017,Age,7 Months,91.1,87.7 to 93.6,648
Hib,≥2 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,89.7,87.2 to 91.8,1381
Hib,≥2 Doses,States/Local Areas,New York,2016,Age,7 Months,82.6,76.9 to 87.1,506
Hib,≥2 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,86.7,83.4 to 89.4,1154
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,91.4 to 97.1,355
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,96.3,91.3 to 100.0,75
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.8,90.2 to 95.4,576
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.7,86.0 to 91.5,955
PCV,≥3 Doses,States/Local Areas,New York,2013,Age,35 Months,94.2,90.9 to 96.6,545
PCV,≥3 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,94.5,92.5 to 96.2,1137
PCV,≥3 Doses,States/Local Areas,New York,2011,Age,35 Months,93.1,89.2 to 96.0,466
PCV,≥3 Doses,States/Local Areas,New York,2019,Age,24 Months,92.2,88.4 to 95.1,637
Hib,≥2 Doses,States/Local Areas,New York,2015,Age,7 Months,88.5,84.4 to 91.6,503
Hib,≥2 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,85.5,82.0 to 88.4,1009
PCV,≥3 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,91.5,89.1 to 93.6,1370
Polio,≥1 Dose,States/Local Areas,New York,2011,Age,3 Months,81.9,75.5 to 86.9,466
Polio,≥1 Dose,States/Local Areas,New York,2012,Age,3 Months,87.1,83.5 to 90.1,492
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,90.9,89.2 to 92.5,1922
PCV,≥1 Dose,States/Local Areas,New York,2019,Age,3 Months,88.0,83.8 to 91.2,637
Polio,≥1 Dose,States/Local Areas,New York,2013,Age,3 Months,83.1,78.7 to 86.8,545
Polio,≥1 Dose,States/Local Areas,New York,2013-2014,Age,3 Months,85.3,81.5 to 88.4,1137
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2013,Age,0-3 Days,61.9,56.8 to 66.7,545
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2013-2014,Age,0-3 Days,64.9,61.4 to 68.2,1137
DTaP,≥3 Doses,States/Local Areas,New York,2011,Age,7 Months,65.1,59.3 to 70.4,466
DTaP,≥3 Doses,States/Local Areas,New York,2012,Age,7 Months,65.9,62.2 to 69.5,492
DTaP,≥3 Doses,States/Local Areas,New York,2013,Age,7 Months,62.7,58.9 to 66.5,545
DTaP,≥3 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,66.0,62.1 to 69.7,1137
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014,Age,0-3 Days,67.9,63.1 to 72.4,592
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2015,Age,0-3 Days,69.9,66.4 to 73.2,1095
PCV,≥1 Dose,States/Local Areas,New York,2015,Age,3 Months,81.3,76.6 to 85.3,503
PCV,≥1 Dose,States/Local Areas,New York,2015-2016,Age,3 Months,80.8,77.3 to 83.8,1009
PCV,≥1 Dose,States/Local Areas,New York,2014,Age,3 Months,81.8,77.7 to 85.3,592
PCV,≥1 Dose,States/Local Areas,New York,2014-2015,Age,3 Months,81.6,78.5 to 84.3,1095
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,77.3 to 87.4,355
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.0,76.7 to 83.4,955
PCV,≥3 Doses,States/Local Areas,New York,2018,Age,24 Months,91.0,87.6 to 93.7,733
PCV,≥3 Doses,States/Local Areas,New York,2017,Age,24 Months,94.2,91.4 to 96.4,648
PCV,≥3 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,92.7,90.5 to 94.5,1381
Hib,≥2 Doses,States/Local Areas,New York,2012,Age,7 Months,90.7,86.7 to 93.6,492
PCV,≥3 Doses,States/Local Areas,New York,2016,Age,24 Months,89.9,85.6 to 93.4,506
PCV,≥3 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,92.0,89.4 to 94.2,1154
Hib,≥2 Doses,States/Local Areas,New York,2011,Age,7 Months,86.8,83.9 to 89.2,466
Hib,≥2 Doses,States/Local Areas,New York,2019,Age,5 Months,78.3,73.3 to 82.6,637
Hib,≥2 Doses,States/Local Areas,New York,2018,Age,5 Months,79.7,75.3 to 83.5,733
Hib,≥2 Doses,States/Local Areas,New York,2018-2019,Age,5 Months,79.0,75.8 to 82.0,1370
PCV,≥1 Dose,States/Local Areas,New York,2017,Age,3 Months,84.3,79.6 to 88.1,648
PCV,≥1 Dose,States/Local Areas,New York,2017-2018,Age,3 Months,83.8,80.8 to 86.5,1381
PCV,≥1 Dose,States/Local Areas,New York,2016,Age,3 Months,80.2,74.9 to 84.6,506
PCV,≥1 Dose,States/Local Areas,New York,2016-2017,Age,3 Months,82.2,78.7 to 85.2,1154
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,92.6,90.6 to 94.6,1048
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,87.1,81.0 to 93.2,203
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.5,86.9 to 96.2,160
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,87.2 to 91.6,1271
Hep B,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,90.4,87.6 to 93.2,645
PCV,≥1 Dose,States/Local Areas,New York,2018,Age,3 Months,83.4,79.1 to 86.9,733
PCV,≥1 Dose,States/Local Areas,New York,2018-2019,Age,3 Months,85.7,82.8 to 88.1,1370
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2011,Age,0-3 Days,61.0,55.2 to 66.6,466
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.1,77.9 to 86.3,576
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,91.4,84.0 to 98.8,75
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,79.6,77.2 to 81.9,1922
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,75.9,71.9 to 80.0,646
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,76.5,71.7 to 81.2,523
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,87.1,83.7 to 90.4,753
Hib,≥2 Doses,States/Local Areas,New York,2011,Age,5 Months,74.5,71.3 to 77.4,466
Hib,≥2 Doses,States/Local Areas,New York,2012,Age,5 Months,73.5,70.3 to 76.5,492
PCV,≥3 Doses,States/Local Areas,New York,2017,Age,19 Months,92.7,89.4 to 95.0,648
PCV,≥3 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,91.4,89.1 to 93.3,1381
Hib,≥2 Doses,States/Local Areas,New York,2014,Age,5 Months,76.7,72.2 to 80.7,592
Hib,≥2 Doses,States/Local Areas,New York,2014-2015,Age,5 Months,76.5,72.2 to 80.4,1095
Hib,≥2 Doses,States/Local Areas,New York,2013,Age,5 Months,72.0,68.6 to 75.2,545
Hib,≥2 Doses,States/Local Areas,New York,2013-2014,Age,5 Months,74.4,70.3 to 78.1,1137
PCV,≥3 Doses,States/Local Areas,New York,2011,Age,24 Months,92.3,88.6 to 95.2,466
PCV,≥3 Doses,States/Local Areas,New York,2019,Age,19 Months,90.2,85.8 to 93.4,637
PCV,≥3 Doses,States/Local Areas,New York,2018,Age,19 Months,90.1,86.5 to 92.9,733
PCV,≥3 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,86.7,83.7 to 89.3,1370
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,95.7,90.4 to 100.0,75
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.9,88.0 to 93.8,576
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Overall,Overall,90.2,88.6 to 91.9,1922
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,89.1,86.3 to 91.9,646
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,88.3,84.8 to 91.8,523
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,93.5,91.1 to 95.9,753
PCV,≥1 Dose,States/Local Areas,New York,2011,Age,3 Months,78.5,73.5 to 82.7,466
PCV,≥4 Doses,States/Local Areas,New York,2019,Age,35 Months,82.7,77.3 to 87.5,637
PCV,≥4 Doses,States/Local Areas,New York,2018,Age,35 Months,85.0,80.7 to 88.8,733
PCV,≥4 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,83.8,80.4 to 86.9,1370
PCV,≥4 Doses,States/Local Areas,New York,2017,Age,35 Months,86.9,82.1 to 90.9,648
PCV,≥4 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,86.0,82.8 to 88.9,1381
Hib,≥2 Doses,States/Local Areas,New York,2016,Age,5 Months,73.4,67.4 to 78.7,506
Hib,≥2 Doses,States/Local Areas,New York,2016-2017,Age,5 Months,77.0,73.2 to 80.4,1154
Hib,≥2 Doses,States/Local Areas,New York,2015,Age,5 Months,76.3,71.2 to 80.8,503
Hib,≥2 Doses,States/Local Areas,New York,2015-2016,Age,5 Months,74.9,71.0 to 78.4,1009
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,77.2,74.2 to 80.2,1271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2012,Age,0-3 Days,62.6,57.3 to 67.6,492
Hib,≥2 Doses,States/Local Areas,New York,2014,Age,7 Months,90.4,87.1 to 92.9,592
Hib,≥2 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,89.4,86.9 to 91.5,1095
Hib,≥2 Doses,States/Local Areas,New York,2013,Age,7 Months,88.1,84.6 to 90.9,545
Hib,≥2 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,89.2,86.3 to 91.6,1137
PCV,≥3 Doses,States/Local Areas,New York,2013,Age,24 Months,93.0,89.9 to 95.4,545
PCV,≥3 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,93.0,91.0 to 94.6,1137
Hib,≥2 Doses,States/Local Areas,New York,2017,Age,5 Months,80.8,76.3 to 84.7,648
Hib,≥2 Doses,States/Local Areas,New York,2017-2018,Age,5 Months,80.3,77.2 to 83.1,1381
PCV,≥3 Doses,States/Local Areas,New York,2012,Age,24 Months,93.9,90.7 to 96.3,492
PCV,≥3 Doses,States/Local Areas,New York,2014,Age,24 Months,93.0,90.3 to 95.1,592
PCV,≥3 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,91.3,89.0 to 93.3,1095
PCV,≥3 Doses,States/Local Areas,New York,2015,Age,24 Months,89.6,85.7 to 92.8,503
PCV,≥3 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,89.9,87.0 to 92.4,1009
Hep B,≥3 Doses,States/Local Areas,New York,2019,Age,35 Months,90.5,86.3 to 93.7,637
Hep B,≥3 Doses,States/Local Areas,New York,2018,Age,35 Months,92.7,89.2 to 95.4,733
Hep B,≥3 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,91.6,89.0 to 93.9,1370
PCV,≥4 Doses,States/Local Areas,New York,2014,Age,35 Months,85.9,81.8 to 89.4,592
PCV,≥4 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,85.4,82.3 to 88.3,1095
PCV,≥4 Doses,States/Local Areas,New York,2015,Age,35 Months,85.2,80.1 to 89.6,503
PCV,≥4 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,81.6,77.9 to 85.1,1009
PCV,≥4 Doses,States/Local Areas,New York,2016,Age,35 Months,79.0,73.5 to 83.9,506
PCV,≥4 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,82.8,79.2 to 86.1,1154
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,88.8,85.9 to 91.7,645
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,93.2,91.3 to 95.1,1048
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,90.8,87.5 to 94.1,452
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,90.0 to 96.6,355
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.4,82.9 to 93.8,160
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,76.1,72.2 to 80.1,645
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,74.5,66.5 to 82.6,203
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,80.6,75.9 to 85.3,452
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.0,63.4 to 80.6,160
PCV,≥1 Dose,States/Local Areas,New York,2013,Age,3 Months,79.5,73.7 to 84.3,545
PCV,≥1 Dose,States/Local Areas,New York,2013-2014,Age,3 Months,80.6,76.3 to 84.4,1137
PCV,≥4 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,85.0,82.2 to 87.9,1048
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.3,86.8 to 91.8,955
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,87.3 to 91.6,1271
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,93.0,90.6 to 95.4,753
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,77.8,73.1 to 82.6,452
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.8,69.9 to 81.7,355
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",62.5,58.4 to 66.6,955
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.6,67.8 to 77.4,576
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,68.2,64.9 to 71.5,1271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,81.5,71.1 to 91.8,75
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Overall,Overall,70.3,67.7 to 73.0,1922
DTaP,≥3 Doses,States/Local Areas,New York,2014,Age,13 Months,90.1,86.8 to 92.6,592
DTaP,≥3 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,90.4,88.0 to 92.4,1095
DTaP,≥3 Doses,States/Local Areas,New York,2013,Age,13 Months,91.5,89.3 to 93.3,545
DTaP,≥3 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,90.8,87.4 to 93.3,1137
Polio,≥3 Doses,States/Local Areas,New York,2014,Age,19 Months,91.6,88.7 to 93.8,592
Polio,≥3 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,91.1,88.8 to 93.0,1095
Polio,≥3 Doses,States/Local Areas,New York,2013,Age,19 Months,92.6,90.2 to 94.5,545
Polio,≥3 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,92.1,89.6 to 94.0,1137
Hib,≥3 Doses,States/Local Areas,New York,2017,Age,13 Months,76.0,70.9 to 80.4,648
Hib,≥3 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,75.6,72.3 to 78.7,1381
Hib,≥3 Doses,States/Local Areas,New York,2016,Age,13 Months,72.7,66.8 to 77.9,506
Hib,≥3 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,74.3,70.4 to 77.8,1154
Polio,≥3 Doses,States/Local Areas,New York,2015,Age,19 Months,90.7,87.6 to 93.0,503
Polio,≥3 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,89.1,86.1 to 91.6,1009
Polio,≥3 Doses,States/Local Areas,New York,2012,Age,19 Months,91.0,88.1 to 93.2,492
Hib,≥3 Doses,States/Local Areas,New York,2015,Age,13 Months,78.3,73.3 to 82.6,503
Hib,≥3 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,75.4,71.6 to 78.9,1009
Polio,≥3 Doses,States/Local Areas,New York,2017,Age,19 Months,93.1,89.9 to 95.4,648
Polio,≥3 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,92.0,89.8 to 93.8,1381
Polio,≥3 Doses,States/Local Areas,New York,2016,Age,19 Months,87.7,82.8 to 91.3,506
Polio,≥3 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,90.3,87.4 to 92.6,1154
Hib,≥3 Doses,States/Local Areas,New York,2018,Age,13 Months,75.2,70.7 to 79.3,733
Hib,≥3 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,76.1,72.7 to 79.2,1370
Polio,≥3 Doses,States/Local Areas,New York,2018,Age,19 Months,90.9,87.6 to 93.3,733
Polio,≥3 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,68.0,64.1 to 71.6,1370
PCV,≥3 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,88.4,80.4 to 93.4,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2021,Age,35 Months,85.7,77.6 to 91.9,238
Hep A,≥2 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,69.2,57.6 to 80.2,238
Hib,≥3 Doses,States/Local Areas,New York,2011,Age,19 Months,91.4,87.0 to 94.5,466
Hib,≥3 Doses,States/Local Areas,New York,2012,Age,19 Months,90.9,88.3 to 92.9,492
Hib,≥3 Doses,States/Local Areas,New York,2019,Age,13 Months,77.0,71.9 to 81.5,637
≥1 Dose MMR,,States/Local Areas,New Mexico,2021,Age,24 Months,87.2,79.5 to 93.0,238
Hib,≥3 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,84.8,77.1 to 91.1,238
Hib,Full Series,States/Local Areas,New Mexico,2021,Age,24 Months,74.2,65.6 to 82.1,238
Polio,≥1 Dose,States/Local Areas,New Mexico,2021,Age,3 Months,84.3,76.8 to 89.6,238
≥1 Dose Varicella,,States/Local Areas,New Mexico,2021,Age,19 Months,82.4,73.4 to 88.8,238
DTaP,≥4 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,62.1,53.2 to 70.3,238
≥1 Dose MMR,,States/Local Areas,New Mexico,2020-2021,Age,24 Months,89.6,85.2 to 93.2,595
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,89.1,84.5 to 92.8,595
DTaP,≥3 Doses,States/Local Areas,New York,2012,Age,19 Months,95.1,92.1 to 97.0,492
DTaP,≥3 Doses,States/Local Areas,New York,2013,Age,19 Months,94.1,91.6 to 95.9,545
DTaP,≥3 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,93.8,91.2 to 95.6,1137
DTaP,≥3 Doses,States/Local Areas,New York,2011,Age,19 Months,93.9,90.5 to 96.1,466
DTaP,≥3 Doses,States/Local Areas,New York,2019,Age,13 Months,89.3,84.6 to 92.6,637
DTaP,≥3 Doses,States/Local Areas,New York,2018,Age,13 Months,89.7,86.0 to 92.4,733
DTaP,≥3 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,89.5,86.6 to 91.7,1370
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.8,88.3 to 93.3,955
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,90.5,88.5 to 92.6,1271
Hib,≥3 Doses,States/Local Areas,New York,2019,Age,7 Months,54.9,49.1 to 60.7,637
Hib,≥2 Doses,States/Local Areas,New York,2020,Age,13 Months,94.0,90.8 to 96.2,624
Hib,≥2 Doses,States/Local Areas,New York,2019,Age,13 Months,94.0,90.8 to 96.1,637
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,97.1,92.2 to 100.0,75
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.3,89.6 to 95.0,576
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,91.5,89.9 to 93.1,1922
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,90.7,88.2 to 93.3,646
Hib,≥2 Doses,States/Local Areas,New York,2017,Age,13 Months,94.1,91.0 to 96.1,648
Hib,≥2 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,94.0,92.0 to 95.5,1381
Hib,≥2 Doses,States/Local Areas,New York,2018,Age,13 Months,93.9,91.0 to 95.9,733
Hib,≥2 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,93.9,91.9 to 95.5,1370
DTaP,≥3 Doses,States/Local Areas,New York,2012,Age,13 Months,91.8,88.4 to 94.3,492
DTaP,≥3 Doses,States/Local Areas,New York,2015,Age,13 Months,90.7,86.8 to 93.5,503
DTaP,≥3 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,89.2,86.1 to 91.6,1009
Hib,≥3 Doses,States/Local Areas,New York,2012,Age,13 Months,80.7,76.6 to 84.2,492
Hib,≥3 Doses,States/Local Areas,New York,2011,Age,13 Months,84.2,78.1 to 88.8,466
Hib,≥3 Doses,States/Local Areas,New York,2014,Age,13 Months,75.6,71.0 to 79.7,592
Hib,≥3 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,76.9,73.6 to 80.0,1095
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,88.3,84.8 to 91.9,523
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,95.4,93.4 to 97.3,753
Polio,≥3 Doses,States/Local Areas,New York,2011,Age,19 Months,89.9,86.4 to 92.6,466
Hib,≥3 Doses,States/Local Areas,New York,2013,Age,13 Months,78.3,75.9 to 80.6,545
Hib,≥3 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,77.0,74.5 to 79.2,1137
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,69.9,64.7 to 75.1,523
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Poverty,>400% FPL,67.6,63.0 to 72.2,753
DTaP,≥3 Doses,States/Local Areas,New York,2011,Age,13 Months,90.1,85.8 to 93.1,466
DTaP,≥3 Doses,States/Local Areas,New York,2017,Age,7 Months,71.1,65.8 to 75.9,648
DTaP,≥3 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,72.6,69.1 to 75.9,1381
DTaP,≥3 Doses,States/Local Areas,New York,2019,Age,7 Months,67.9,62.1 to 73.2,637
DTaP,≥3 Doses,States/Local Areas,New York,2018,Age,7 Months,74.1,69.4 to 78.4,733
DTaP,≥3 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,71.0,67.3 to 74.5,1370
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,74.2,70.2 to 78.3,645
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.5,67.6 to 83.5,160
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,68.6,64.8 to 72.4,1048
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2014-2017,Insurance Coverage,Other,66.7,58.2 to 75.2,203
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2019,Age,0-3 Days,78.7,73.5 to 83.1,637
Polio,≥1 Dose,States/Local Areas,New York,2019,Age,3 Months,88.0,83.4 to 91.4,637
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2018,Age,0-3 Days,78.3,73.7 to 82.3,733
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2018-2019,Age,0-3 Days,78.5,75.1 to 81.6,1370
PCV,≥3 Doses,States/Local Areas,New York,2019,Age,35 Months,92.2,88.4 to 95.2,637
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,88.3,82.6 to 94.0,203
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,94.0,92.2 to 95.8,1048
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,90.6,87.9 to 93.3,645
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,93.6,91.0 to 96.3,452
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.6,86.6 to 94.7,355
PCV,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.4,85.6 to 95.2,160
Hib,≥3 Doses,States/Local Areas,New York,2018,Age,7 Months,55.6,50.5 to 60.5,733
Hib,≥3 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,55.3,51.4 to 59.1,1370
Hib,≥3 Doses,States/Local Areas,New York,2017,Age,7 Months,56.0,50.4 to 61.5,648
Hib,≥3 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,55.8,52.0 to 59.5,1381
Hib,≥2 Doses,States/Local Areas,New York,2014,Age,13 Months,94.8,92.2 to 96.5,592
Hib,≥2 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,93.2,91.0 to 94.9,1095
Hib,≥2 Doses,States/Local Areas,New York,2016,Age,13 Months,89.0,84.0 to 92.5,506
Hib,≥2 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,91.4,88.6 to 93.6,1154
Hib,≥2 Doses,States/Local Areas,New York,2015,Age,13 Months,91.7,87.9 to 94.4,503
Hib,≥2 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,90.3,87.3 to 92.7,1009
Polio,≥1 Dose,States/Local Areas,New York,2018,Age,3 Months,88.1,84.3 to 91.0,733
Polio,≥1 Dose,States/Local Areas,New York,2018-2019,Age,3 Months,88.0,85.2 to 90.4,1370
Polio,≥1 Dose,States/Local Areas,New York,2017,Age,3 Months,89.0,85.1 to 92.0,648
Polio,≥1 Dose,States/Local Areas,New York,2017-2018,Age,3 Months,88.5,85.9 to 90.7,1381
Hib,≥3 Doses,States/Local Areas,New York,2016,Age,7 Months,51.5,45.5 to 57.5,506
Hib,≥3 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,53.7,49.5 to 57.8,1154
Hib,≥3 Doses,States/Local Areas,New York,2015,Age,7 Months,50.6,44.9 to 56.3,503
Hib,≥3 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,51.1,46.9 to 55.2,1009
Hib,≥3 Doses,States/Local Areas,New York,2014,Age,7 Months,55.8,50.7 to 60.7,592
Hib,≥3 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,53.2,49.4 to 57.0,1095
PCV,≥3 Doses,States/Local Areas,New York,2018,Age,35 Months,93.2,89.2 to 96.1,733
PCV,≥3 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,92.7,90.0 to 94.9,1370
PCV,≥3 Doses,States/Local Areas,New York,2017,Age,35 Months,94.8,92.0 to 96.8,648
PCV,≥3 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,94.0,91.7 to 95.9,1381
Hib,≥2 Doses,States/Local Areas,New York,2013,Age,13 Months,93.1,89.7 to 95.5,545
Hib,≥2 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,93.9,91.5 to 95.7,1137
DTaP,≥3 Doses,States/Local Areas,New York,2016,Age,7 Months,67.1,61.0 to 72.6,506
DTaP,≥3 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,69.0,65.0 to 72.8,1154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2015,Age,0-3 Days,71.9,66.7 to 76.6,503
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2015-2016,Age,0-3 Days,71.5,67.6 to 75.1,1009
DTaP,≥3 Doses,States/Local Areas,New York,2014,Age,7 Months,69.4,64.5 to 73.8,592
DTaP,≥3 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,66.2,62.5 to 69.8,1095
DTaP,≥3 Doses,States/Local Areas,New York,2015,Age,7 Months,63.1,57.4 to 68.4,503
DTaP,≥3 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,65.1,61.0 to 69.0,1009
Hib,≥2 Doses,States/Local Areas,New York,2011,Age,13 Months,92.5,87.0 to 95.7,466
Hib,≥2 Doses,States/Local Areas,New York,2012,Age,13 Months,96.0,94.4 to 97.1,492
DTaP,≥3 Doses,States/Local Areas,New York,2017,Age,19 Months,94.5,91.4 to 96.5,648
DTaP,≥3 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,93.7,91.7 to 95.3,1381
Polio,≥3 Doses,States/Local Areas,New York,2014,Age,24 Months,93.7,91.2 to 95.7,592
Polio,≥3 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,92.9,90.9 to 94.7,1095
Polio,≥3 Doses,States/Local Areas,New York,2015,Age,24 Months,92.1,88.6 to 94.9,503
Polio,≥3 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,91.3,88.5 to 93.6,1009
Hib,≥3 Doses,States/Local Areas,New York,2016,Age,19 Months,87.0,82.0 to 90.7,506
Hib,≥3 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,89.5,86.5 to 91.8,1154
Polio,≥3 Doses,States/Local Areas,New York,2016,Age,24 Months,90.2,85.9 to 93.7,506
Polio,≥3 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,92.3,89.7 to 94.5,1154
Hib,≥3 Doses,States/Local Areas,New York,2017,Age,19 Months,92.1,88.7 to 94.6,648
Hib,≥3 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,90.5,88.2 to 92.5,1381
Hib,≥3 Doses,States/Local Areas,New York,2018,Age,19 Months,88.9,85.3 to 91.7,733
Hib,≥3 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,76.1,72.7 to 79.2,1370
DTaP,≥3 Doses,States/Local Areas,New York,2018,Age,19 Months,92.9,89.9 to 95.1,733
DTaP,≥3 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,89.5,86.6 to 91.7,1370
DTaP,≥3 Doses,States/Local Areas,New York,2019,Age,19 Months,91.7,87.1 to 94.7,637
≥1 Dose Varicella,,States/Local Areas,New York,2020-2021,Age,13 Months,54.7,50.4 to 59.0,1026
Hib,Full Series,States/Local Areas,New York,2015,Age,24 Months,77.8,72.8 to 82.5,503
Hib,Full Series,States/Local Areas,New York,2015-2016,Age,24 Months,78.2,74.5 to 81.6,1009
DTaP,≥3 Doses,States/Local Areas,New York,2013,Age,24 Months,95.5,92.7 to 97.4,545
DTaP,≥3 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,95.3,93.6 to 96.7,1137
Polio,≥3 Doses,States/Local Areas,New York,2017,Age,24 Months,94.4,91.7 to 96.5,648
Polio,≥3 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,93.9,92.0 to 95.5,1381
Hib,≥3 Doses,States/Local Areas,New York,2019,Age,19 Months,90.1,85.9 to 93.2,637
Polio,≥3 Doses,States/Local Areas,New York,2019,Age,24 Months,89.7,85.2 to 93.3,637
Polio,≥3 Doses,States/Local Areas,New York,2018,Age,24 Months,93.3,90.4 to 95.5,733
Polio,≥3 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,91.6,89.0 to 93.8,1370
DTaP,≥3 Doses,States/Local Areas,New York,2012,Age,24 Months,97.0,94.8 to 98.4,492
Hib,Full Series,States/Local Areas,New York,2017,Age,24 Months,83.5,79.2 to 87.4,648
Hib,Full Series,States/Local Areas,New York,2017-2018,Age,24 Months,81.6,78.6 to 84.4,1381
Hib,Full Series,States/Local Areas,New York,2018,Age,24 Months,79.6,75.3 to 83.6,733
Hib,Full Series,States/Local Areas,New York,2018-2019,Age,24 Months,78.8,75.4 to 82.1,1370
Hib,Full Series,States/Local Areas,New York,2016,Age,24 Months,78.4,73.1 to 83.4,506
Hib,Full Series,States/Local Areas,New York,2016-2017,Age,24 Months,80.9,77.4 to 84.1,1154
DTaP,≥2 Doses,States/Local Areas,New York,2015,Age,5 Months,78.6,73.5 to 82.9,503
DTaP,≥2 Doses,States/Local Areas,New York,2015-2016,Age,5 Months,77.3,73.4 to 80.7,1009
Polio,≥3 Doses,States/Local Areas,New York,2015,Age,35 Months,92.2,88.6 to 94.9,503
Polio,≥3 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,92.6,89.8 to 94.9,1009
Hib,≥3 Doses,States/Local Areas,New York,2014,Age,24 Months,92.4,89.4 to 94.7,592
Hib,≥3 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,91.4,89.1 to 93.4,1095
Hib,≥3 Doses,States/Local Areas,New York,2011,Age,24 Months,92.3,88.6 to 95.2,466
Hib,≥3 Doses,States/Local Areas,New York,2012,Age,24 Months,94.8,92.1 to 96.9,492
Hib,≥3 Doses,States/Local Areas,New York,2013,Age,24 Months,93.0,89.8 to 95.5,545
Hib,≥3 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,92.7,90.6 to 94.5,1137
Polio,≥3 Doses,States/Local Areas,New York,2016,Age,35 Months,92.3,88.0 to 95.5,506
Polio,≥3 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,93.8,91.2 to 95.9,1154
Polio,≥3 Doses,States/Local Areas,New York,2017,Age,35 Months,95.0,92.2 to 97.0,648
Polio,≥3 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,95.1,93.1 to 96.7,1381
DTaP,≥2 Doses,States/Local Areas,New York,2014,Age,5 Months,78.9,74.4 to 82.7,592
DTaP,≥2 Doses,States/Local Areas,New York,2014-2015,Age,5 Months,78.7,74.7 to 82.2,1095
Polio,≥3 Doses,States/Local Areas,New York,2012,Age,35 Months,94.5,91.6 to 96.6,492
Polio,≥3 Doses,States/Local Areas,New York,2013,Age,35 Months,95.9,93.0 to 97.9,545
Polio,≥3 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,96.0,94.0 to 97.5,1137
Polio,≥3 Doses,States/Local Areas,New York,2014,Age,35 Months,95.8,93.1 to 97.7,592
Polio,≥3 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,94.1,91.8 to 95.9,1095
Hib,Full Series,States/Local Areas,New York,2012,Age,35 Months,86.5,81.3 to 90.9,492
Hib,Full Series,States/Local Areas,New York,2011,Age,35 Months,83.6,78.6 to 87.9,466
Hib,Full Series,States/Local Areas,New York,2013,Age,35 Months,86.5,81.4 to 90.8,545
Hib,Full Series,States/Local Areas,New York,2013-2014,Age,35 Months,86.5,83.3 to 89.3,1137
Hib,Full Series,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,84.7,81.8 to 87.7,1048
Polio,≥3 Doses,States/Local Areas,New York,2018,Age,35 Months,95.1,92.1 to 97.2,733
Polio,≥3 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,92.8,90.1 to 95.0,1370
Hib,Full Series,States/Local Areas,New York,2019,Age,24 Months,77.9,72.4 to 83.0,637
DTaP,≥2 Doses,States/Local Areas,New York,2011,Age,5 Months,75.9,71.0 to 80.1,466
DTaP,≥2 Doses,States/Local Areas,New York,2012,Age,5 Months,77.8,73.2 to 81.8,492
DTaP,≥2 Doses,States/Local Areas,New York,2013,Age,5 Months,76.3,72.8 to 79.4,545
DTaP,≥2 Doses,States/Local Areas,New York,2013-2014,Age,5 Months,77.6,73.9 to 80.9,1137
Hib,Full Series,States/Local Areas,New York,2017,Age,35 Months,87.3,83.0 to 90.9,648
Hib,Full Series,States/Local Areas,New York,2017-2018,Age,35 Months,86.4,83.3 to 89.1,1381
Polio,≥3 Doses,States/Local Areas,New York,2019,Age,35 Months,90.4,85.9 to 94.0,637
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,94.3,92.6 to 96.1,1048
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,91.7,89.1 to 94.3,645
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,87.7,81.7 to 93.6,203
Hib,Full Series,States/Local Areas,New York,2016,Age,35 Months,80.6,75.2 to 85.5,506
Hib,Full Series,States/Local Areas,New York,2016-2017,Age,35 Months,83.8,80.3 to 87.0,1154
Hib,Full Series,States/Local Areas,New York,2019,Age,35 Months,82.7,77.2 to 87.6,637
Hib,Full Series,States/Local Areas,New York,2018,Age,35 Months,85.8,81.0 to 89.9,733
Hib,Full Series,States/Local Areas,New York,2018-2019,Age,35 Months,84.1,80.5 to 87.3,1370
Hib,Full Series,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,72.1,64.2 to 80.1,203
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.8,65.6 to 83.9,355
Hib,Full Series,States/Local Areas,New York,2015,Age,35 Months,82.2,77.2 to 86.7,503
Hib,Full Series,States/Local Areas,New York,2015-2016,Age,35 Months,81.3,77.6 to 84.7,1009
Hib,Full Series,States/Local Areas,New York,2014,Age,35 Months,86.8,82.8 to 90.3,592
Hib,Full Series,States/Local Areas,New York,2014-2015,Age,35 Months,84.7,81.5 to 87.6,1095
Hib,Full Series,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,77.3,73.4 to 81.3,645
Hib,Full Series,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.1,65.8 to 82.4,160
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,94.1,91.4 to 96.9,452
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.1,92.4 to 97.8,355
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.1,87.5 to 92.6,955
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,91.1,89.1 to 93.1,1271
Polio,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.8,88.5 to 97.1,160
Hib,Primary Series,States/Local Areas,New York,2011,Age,7 Months,62.1,57.5 to 66.5,466
Hib,Full Series,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,87.1,83.7 to 90.5,753
Hib,Primary Series,States/Local Areas,New York,2012,Age,7 Months,66.6,61.6 to 71.3,492
Hib,Full Series,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,81.4,76.9 to 85.9,452
Hib,Full Series,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.3,77.0 to 87.6,355
Hib,Full Series,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,75.8 to 82.7,955
Hib,Full Series,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,74.7 to 80.8,1271
Hib,Full Series,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.4,78.3 to 86.4,576
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,67.4,63.0 to 71.8,1271
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,79.3,72.7 to 85.8,452
Hep A,≥1 Dose,States/Local Areas,New York,2018,Age,35 Months,87.4,83.1 to 91.0,733
Hep A,≥1 Dose,States/Local Areas,New York,2018-2019,Age,35 Months,88.7,85.5 to 91.5,1370
Hep A,≥1 Dose,States/Local Areas,New York,2017,Age,35 Months,88.5,84.5 to 91.9,648
Hep A,≥1 Dose,States/Local Areas,New York,2017-2018,Age,35 Months,87.9,85.0 to 90.5,1381
Hib,Full Series,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,85.7,76.6 to 94.7,75
Hib,Full Series,States/Local Areas,New York,2014-2017,Overall,Overall,79.7,77.3 to 82.0,1922
Hib,Full Series,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,75.4,71.3 to 79.6,646
Hib,Full Series,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,77.6,73.0 to 82.1,523
DTaP,≥4 Doses,States/Local Areas,New York,2013,Age,24 Months,83.7,79.5 to 87.4,545
DTaP,≥4 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,82.7,79.8 to 85.4,1137
Hep A,≥2 Doses,States/Local Areas,New York,2016,Age,24 Months,36.0,30.3 to 42.4,506
Hep A,≥2 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,37.8,33.8 to 42.1,1154
Hep A,≥2 Doses,States/Local Areas,New York,2017,Age,24 Months,39.7,34.3 to 45.5,648
Hep A,≥2 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,41.1,37.3 to 45.0,1381
Hep A,≥2 Doses,States/Local Areas,New York,2018,Age,24 Months,42.5,37.4 to 47.9,733
Hep A,≥2 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,36.8,33.1 to 40.7,1370
Hib,≥3 Doses,States/Local Areas,New York,2019,Age,35 Months,91.8,87.9 to 94.8,637
Hep A,≥2 Doses,States/Local Areas,New York,2014,Age,24 Months,33.7,29.1 to 38.8,592
Hep A,≥2 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,35.5,31.9 to 39.4,1095
Hep A,≥2 Doses,States/Local Areas,New York,2015,Age,24 Months,37.4,31.9 to 43.5,503
Hep A,≥2 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,36.7,32.7 to 41.0,1009
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,94.0,92.6 to 95.3,1922
Hep A,≥1 Dose,States/Local Areas,New York,2014,Age,35 Months,87.7,83.5 to 91.2,592
Hep A,≥1 Dose,States/Local Areas,New York,2014-2015,Age,35 Months,87.6,84.3 to 90.6,1095
Hep A,≥1 Dose,States/Local Areas,New York,2013,Age,35 Months,89.4,84.0 to 93.6,545
Hep A,≥1 Dose,States/Local Areas,New York,2013-2014,Age,35 Months,88.3,85.1 to 91.1,1137
DTaP,≥4 Doses,States/Local Areas,New York,2012,Age,24 Months,83.1,78.5 to 87.1,492
DTaP,≥4 Doses,States/Local Areas,New York,2011,Age,24 Months,80.6,75.6 to 85.1,466
DTaP,≥4 Doses,States/Local Areas,New York,2019,Age,19 Months,71.4,65.7 to 76.6,637
Hep B,≥3 Doses,States/Local Areas,New York,2013,Age,7 Months,54.0,51.3 to 56.8,545
Hep B,≥3 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,51.8,49.7 to 54.0,1137
Hep B,≥3 Doses,States/Local Areas,New York,2011,Age,7 Months,42.7,37.3 to 48.2,466
Hep B,≥3 Doses,States/Local Areas,New York,2012,Age,7 Months,50.2,46.0 to 54.4,492
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,91.7,88.6 to 94.9,523
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,96.9,95.2 to 98.5,753
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,93.3,91.2 to 95.4,646
Polio,≥2 Doses,States/Local Areas,New York,2014,Age,5 Months,76.9,72.4 to 80.9,592
Polio,≥2 Doses,States/Local Areas,New York,2014-2015,Age,5 Months,76.6,72.2 to 80.4,1095
Polio,≥2 Doses,States/Local Areas,New York,2013,Age,5 Months,72.9,69.3 to 76.3,545
Polio,≥2 Doses,States/Local Areas,New York,2013-2014,Age,5 Months,74.9,71.3 to 78.2,1137
Hep A,≥1 Dose,States/Local Areas,New York,2012,Age,35 Months,84.0,78.8 to 88.5,492
Polio,≥2 Doses,States/Local Areas,New York,2011,Age,5 Months,71.9,67.9 to 75.7,466
Polio,≥2 Doses,States/Local Areas,New York,2012,Age,5 Months,74.1,68.9 to 78.8,492
Hep A,≥1 Dose,States/Local Areas,New York,2015,Age,35 Months,87.7,82.2 to 92.1,503
Hep A,≥1 Dose,States/Local Areas,New York,2015-2016,Age,35 Months,84.6,80.7 to 88.1,1009
≥1 Dose Varicella,,States/Local Areas,New York,2011,Age,13 Months,51.6,43.7 to 59.4,466
≥1 Dose Varicella,,States/Local Areas,New York,2013,Age,13 Months,52.3,47.4 to 57.2,545
≥1 Dose Varicella,,States/Local Areas,New York,2013-2014,Age,13 Months,52.9,49.0 to 56.8,1137
Polio,≥2 Doses,States/Local Areas,New York,2018,Age,5 Months,79.4,75.0 to 83.2,733
Polio,≥2 Doses,States/Local Areas,New York,2018-2019,Age,5 Months,79.7,76.4 to 82.6,1370
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.5,70.7 to 86.3,160
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,76.5,68.7 to 84.3,203
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,79.4,76.0 to 82.7,1048
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,78.8,74.9 to 82.7,645
Hep A,≥1 Dose,States/Local Areas,New York,2019,Age,35 Months,90.2,85.3 to 94.0,637
≥1 Dose Varicella,,States/Local Areas,New York,2012,Age,13 Months,54.6,49.2 to 59.8,492
≥1 Dose Varicella,,States/Local Areas,New York,2014,Age,13 Months,53.6,48.6 to 58.5,592
≥1 Dose Varicella,,States/Local Areas,New York,2014-2015,Age,13 Months,54.0,50.2 to 57.7,1095
Hep A,≥2 Doses,States/Local Areas,New York,2014,Age,35 Months,67.1,61.0 to 73.0,592
Hep A,≥2 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,70.1,65.4 to 74.7,1095
Hep B,≥3 Doses,States/Local Areas,New York,2019,Age,7 Months,50.8,45.0 to 56.6,637
Hep A,≥2 Doses,States/Local Areas,New York,2015,Age,35 Months,73.1,65.8 to 79.9,503
Hep A,≥2 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,69.2,64.2 to 74.2,1009
Hep A,≥2 Doses,States/Local Areas,New York,2016,Age,35 Months,66.1,59.1 to 73.0,506
Hep A,≥2 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,71.3,66.6 to 75.8,1154
Hep B,≥3 Doses,States/Local Areas,New York,2018,Age,7 Months,53.6,48.5 to 58.5,733
Hep B,≥3 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,52.2,48.3 to 56.0,1370
Hep B,≥3 Doses,States/Local Areas,New York,2017,Age,7 Months,50.3,44.7 to 55.8,648
Hep B,≥3 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,51.9,48.1 to 55.6,1381
Polio,≥2 Doses,States/Local Areas,New York,2011,Age,7 Months,86.0,82.6 to 88.9,466
Polio,≥2 Doses,States/Local Areas,New York,2012,Age,7 Months,89.2,86.0 to 91.8,492
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,84.0,79.8 to 88.2,452
Hib,Full Series,States/Local Areas,New York,2020,Age,24 Months,78.2,73.3 to 82.7,624
Polio,≥2 Doses,States/Local Areas,New York,2019,Age,5 Months,80.0,74.9 to 84.2,637
Hep B,≥3 Doses,States/Local Areas,New York,2015,Age,7 Months,49.8,44.1 to 55.4,503
Hep B,≥3 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,49.2,45.1 to 53.3,1009
Hep B,≥3 Doses,States/Local Areas,New York,2014,Age,7 Months,49.6,44.6 to 54.6,592
Hep B,≥3 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,49.7,45.9 to 53.5,1095
Polio,≥2 Doses,States/Local Areas,New York,2017,Age,5 Months,82.5,78.2 to 86.1,648
Polio,≥2 Doses,States/Local Areas,New York,2017-2018,Age,5 Months,80.9,77.9 to 83.6,1381
Polio,≥2 Doses,States/Local Areas,New York,2016,Age,5 Months,73.4,67.4 to 78.6,506
Polio,≥2 Doses,States/Local Areas,New York,2016-2017,Age,5 Months,77.8,74.1 to 81.1,1154
Hep A,≥1 Dose,States/Local Areas,New York,2016,Age,35 Months,82.2,76.3 to 87.3,506
Hep A,≥1 Dose,States/Local Areas,New York,2016-2017,Age,35 Months,85.3,81.7 to 88.5,1154
Hep A,≥2 Doses,States/Local Areas,New York,2013,Age,35 Months,77.1,69.8 to 83.8,545
Hep A,≥2 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,72.1,67.2 to 76.8,1137
Hep A,≥2 Doses,States/Local Areas,New York,2012,Age,35 Months,65.7,58.8 to 72.5,492
Hep A,≥2 Doses,States/Local Areas,New York,2011,Age,35 Months,66.8,59.3 to 74.2,466
Hep A,≥2 Doses,States/Local Areas,New York,2019,Age,24 Months,30.8,25.8 to 36.5,637
Hep B,≥3 Doses,States/Local Areas,New York,2016,Age,7 Months,48.6,42.7 to 54.6,506
Hep B,≥3 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,49.4,45.3 to 53.5,1154
Polio,≥2 Doses,States/Local Areas,New York,2015,Age,5 Months,76.2,71.1 to 80.7,503
Polio,≥2 Doses,States/Local Areas,New York,2015-2016,Age,5 Months,74.8,70.9 to 78.3,1009
DTaP,≥4 Doses,States/Local Areas,New York,2015,Age,24 Months,80.6,75.7 to 85.0,503
DTaP,≥4 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,78.2,74.5 to 81.8,1009
DTaP,≥4 Doses,States/Local Areas,New York,2016,Age,24 Months,75.9,70.2 to 81.3,506
DTaP,≥4 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,80.8,77.2 to 84.1,1154
DTaP,≥4 Doses,States/Local Areas,New York,2014,Age,24 Months,81.7,77.6 to 85.4,592
DTaP,≥4 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,81.2,78.1 to 84.1,1095
Hep A,≥2 Doses,States/Local Areas,New York,2013,Age,24 Months,32.9,28.1 to 38.4,545
Hep A,≥2 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,33.3,29.9 to 37.0,1137
DTaP,≥4 Doses,States/Local Areas,New York,2018,Age,19 Months,68.9,64.0 to 73.4,733
DTaP,≥4 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,93.2,90.8 to 95.0,1370
DTaP,≥4 Doses,States/Local Areas,New York,2017,Age,19 Months,76.5,71.8 to 80.7,648
DTaP,≥4 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,72.8,69.4 to 75.9,1381
DTaP,≥4 Doses,States/Local Areas,New York,2016,Age,19 Months,66.5,60.4 to 72.1,506
DTaP,≥4 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,71.3,67.5 to 74.9,1154
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,95.8,93.8 to 97.9,452
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.6,93.0 to 98.3,355
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.5,89.5 to 97.6,160
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,97.1,92.2 to 100.0,75
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.3,93.1 to 97.5,576
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.4,90.1 to 94.7,955
DTaP,≥3 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,91.1 to 94.7,1271
PCV,≥2 Doses,States/Local Areas,New York,2019,Age,5 Months,78.4,73.4 to 82.7,637
PCV,≥2 Doses,States/Local Areas,New York,2018,Age,5 Months,76.2,71.6 to 80.3,733
PCV,≥2 Doses,States/Local Areas,New York,2018-2019,Age,5 Months,77.3,73.9 to 80.4,1370
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.0,78.6 to 91.5,160
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,83.5,77.1 to 90.0,203
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,92.9,90.9 to 94.9,1048
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,87.7,84.6 to 90.7,645
≥1 Dose Varicella,,States/Local Areas,New York,2019,Age,35 Months,95.3,91.4 to 97.8,637
≥1 Dose MMR,,States/Local Areas,New York,2016,Age,35 Months,92.6,88.1 to 95.9,506
≥1 Dose MMR,,States/Local Areas,New York,2016-2017,Age,35 Months,93.4,90.8 to 95.5,1154
PCV,≥4 Doses,States/Local Areas,New York,2015,Age,24 Months,79.3,74.4 to 83.8,503
PCV,≥4 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,77.3,73.7 to 80.8,1009
PCV,≥4 Doses,States/Local Areas,New York,2016,Age,24 Months,75.7,70.2 to 80.7,506
PCV,≥4 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,79.1,75.5 to 82.4,1154
PCV,≥4 Doses,States/Local Areas,New York,2017,Age,24 Months,82.7,78.2 to 86.8,648
PCV,≥4 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,82.5,79.5 to 85.3,1381
≥1 Dose MMR,,States/Local Areas,New York,2015,Age,35 Months,92.0,88.7 to 94.6,503
≥1 Dose MMR,,States/Local Areas,New York,2015-2016,Age,35 Months,92.7,89.9 to 94.9,1009
≥1 Dose MMR,,States/Local Areas,New York,2014,Age,35 Months,95.2,92.3 to 97.2,592
≥1 Dose MMR,,States/Local Areas,New York,2014-2015,Age,35 Months,93.6,91.3 to 95.5,1095
PCV,≥3 Doses,States/Local Areas,New York,2016,Age,13 Months,82.4,77.1 to 86.7,506
PCV,≥3 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,86.0,82.7 to 88.7,1154
Hep B,≥3 Doses,States/Local Areas,New York,2013,Age,35 Months,94.9,91.8 to 97.1,545
Hep B,≥3 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,94.7,92.7 to 96.3,1137
Hep B,≥3 Doses,States/Local Areas,New York,2014,Age,35 Months,94.3,91.5 to 96.4,592
Hep B,≥3 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,92.8,90.5 to 94.8,1095
Hep B,≥3 Doses,States/Local Areas,New York,2015,Age,35 Months,91.1,87.3 to 94.1,503
Hep B,≥3 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,90.9,87.9 to 93.4,1009
Hep B,≥3 Doses,States/Local Areas,New York,2012,Age,35 Months,93.9,90.5 to 96.4,492
PCV,≥3 Doses,States/Local Areas,New York,2018,Age,13 Months,86.6,82.6 to 89.9,733
PCV,≥3 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,86.7,83.7 to 89.3,1370
PCV,≥3 Doses,States/Local Areas,New York,2017,Age,13 Months,89.7,85.9 to 92.6,648
PCV,≥3 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,88.2,85.5 to 90.4,1381
Hep B,≥2 Doses,States/Local Areas,New York,2012,Age,13 Months,94.3,91.6 to 96.2,492
Hep B,≥2 Doses,States/Local Areas,New York,2013,Age,13 Months,94.0,91.4 to 95.9,545
Hep B,≥2 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,94.0,91.4 to 95.8,1137
Hep B,≥2 Doses,States/Local Areas,New York,2011,Age,13 Months,91.1,86.6 to 94.2,466
Hep B,≥2 Doses,States/Local Areas,New York,2019,Age,7 Months,92.4,88.7 to 95.0,637
Hep B,≥3 Doses,States/Local Areas,New York,2017,Age,35 Months,92.6,89.5 to 95.1,648
Hep B,≥3 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,92.6,90.3 to 94.4,1381
PCV,≥3 Doses,States/Local Areas,New York,2012,Age,19 Months,93.1,89.9 to 95.4,492
PCV,≥4 Doses,States/Local Areas,New York,2012,Age,35 Months,85.5,80.6 to 89.7,492
PCV,≥4 Doses,States/Local Areas,New York,2011,Age,35 Months,87.5,82.9 to 91.3,466
PCV,≥4 Doses,States/Local Areas,New York,2018,Age,24 Months,82.4,78.2 to 86.1,733
PCV,≥4 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,80.8,77.5 to 83.9,1370
PCV,≥4 Doses,States/Local Areas,New York,2019,Age,24 Months,79.1,73.7 to 83.9,637
Hep B,≥3 Doses,States/Local Areas,New York,2016,Age,35 Months,90.2,85.5 to 93.9,506
Hep B,≥3 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,91.5,88.6 to 93.8,1154
PCV,≥3 Doses,States/Local Areas,New York,2014,Age,19 Months,90.1,86.9 to 92.6,592
PCV,≥3 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,89.7,87.2 to 91.8,1095
PCV,≥3 Doses,States/Local Areas,New York,2013,Age,19 Months,91.0,86.1 to 94.3,545
PCV,≥3 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,90.6,87.0 to 93.2,1137
PCV,≥3 Doses,States/Local Areas,New York,2011,Age,19 Months,90.5,86.3 to 93.5,466
PCV,≥3 Doses,States/Local Areas,New York,2019,Age,13 Months,86.8,82.1 to 90.5,637
Hep B,≥2 Doses,States/Local Areas,New York,2016,Age,13 Months,90.5,85.8 to 93.7,506
Hep B,≥2 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,92.5,89.8 to 94.5,1154
Hep B,≥2 Doses,States/Local Areas,New York,2015,Age,13 Months,92.6,88.9 to 95.1,503
Hep B,≥2 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,91.5,88.7 to 93.7,1009
Hep B,≥2 Doses,States/Local Areas,New York,2014,Age,13 Months,93.9,91.2 to 95.7,592
Hep B,≥2 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,93.2,91.1 to 94.9,1095
Hib,≥1 Dose,States/Local Areas,New York,2014,Age,3 Months,86.4,82.6 to 89.5,592
Hib,≥1 Dose,States/Local Areas,New York,2014-2015,Age,3 Months,85.5,82.7 to 87.9,1095
Hib,≥1 Dose,States/Local Areas,New York,2011,Age,3 Months,82.7,77.8 to 86.7,466
Hib,≥1 Dose,States/Local Areas,New York,2012,Age,3 Months,87.6,83.3 to 90.9,492
Hib,≥1 Dose,States/Local Areas,New York,2013,Age,3 Months,83.7,81.2 to 86.0,545
Hib,≥1 Dose,States/Local Areas,New York,2013-2014,Age,3 Months,85.1,82.0 to 87.7,1137
PCV,≥3 Doses,States/Local Areas,New York,2016,Age,19 Months,87.9,83.1 to 91.4,506
PCV,≥3 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,90.2,87.4 to 92.4,1154
PCV,≥3 Doses,States/Local Areas,New York,2015,Age,19 Months,89.4,86.8 to 91.5,503
PCV,≥3 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,88.6,85.6 to 91.1,1009
Hep B,≥2 Doses,States/Local Areas,New York,2019,Age,13 Months,94.6,91.1 to 96.8,637
Hep B,≥2 Doses,States/Local Areas,New York,2018,Age,13 Months,93.0,89.7 to 95.3,733
Hep B,≥2 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,93.8,91.6 to 95.5,1370
Hep B,≥2 Doses,States/Local Areas,New York,2017,Age,13 Months,94.7,91.6 to 96.7,648
Hep B,≥2 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,93.9,91.7 to 95.5,1381
Hib,≥1 Dose,States/Local Areas,New York,2017,Age,3 Months,87.6,83.3 to 90.9,648
Hib,≥1 Dose,States/Local Areas,New York,2017-2018,Age,3 Months,87.3,84.5 to 89.7,1381
Hib,≥1 Dose,States/Local Areas,New York,2016,Age,3 Months,82.4,77.1 to 86.7,506
Hib,≥1 Dose,States/Local Areas,New York,2016-2017,Age,3 Months,84.9,81.6 to 87.8,1154
Hib,≥1 Dose,States/Local Areas,New York,2015,Age,3 Months,84.6,80.2 to 88.1,503
Hib,≥1 Dose,States/Local Areas,New York,2015-2016,Age,3 Months,83.5,80.1 to 86.4,1009
≥1 Dose MMR,,States/Local Areas,New York,2017,Age,35 Months,94.2,91.4 to 96.3,648
≥1 Dose MMR,,States/Local Areas,New York,2017-2018,Age,35 Months,94.9,93.1 to 96.4,1381
≥1 Dose MMR,,States/Local Areas,New York,2018,Age,35 Months,95.9,93.3 to 97.7,733
≥1 Dose MMR,,States/Local Areas,New York,2018-2019,Age,35 Months,94.4,92.1 to 96.2,1370
PCV,≥4 Doses,States/Local Areas,New York,2013,Age,35 Months,86.7,81.3 to 91.2,545
PCV,≥4 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,86.0,82.9 to 88.9,1137
≥1 Dose MMR,,States/Local Areas,New York,2019,Age,35 Months,92.9,88.8 to 95.8,637
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,89.4 to 96.2,355
≥1 Dose MMR,,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,86.8,81.0 to 92.7,203
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.0,84.2 to 89.8,955
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,87.7,85.4 to 90.1,1271
Hib,≥1 Dose,States/Local Areas,New York,2019,Age,3 Months,86.9,82.4 to 90.3,637
Hib,≥1 Dose,States/Local Areas,New York,2018,Age,3 Months,87.0,83.2 to 90.1,733
Hib,≥1 Dose,States/Local Areas,New York,2018-2019,Age,3 Months,87.0,84.1 to 89.4,1370
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,95.8,90.3 to 100.0,75
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.7,87.8 to 93.7,576
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Overall,Overall,89.1,87.4 to 90.9,1922
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,87.7,84.7 to 90.6,646
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,87.0,83.2 to 90.8,523
PCV,≥4 Doses,States/Local Areas,New York,2012,Age,24 Months,82.2,77.7 to 86.3,492
Hep B,≥3 Doses,States/Local Areas,New York,2011,Age,35 Months,92.4,88.4 to 95.5,466
Hep B,≥3 Doses,States/Local Areas,New York,2017,Age,24 Months,92.1,88.9 to 94.6,648
Hep B,≥3 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,91.5,89.3 to 93.4,1381
Hep B,≥3 Doses,States/Local Areas,New York,2019,Age,24 Months,90.1,86.0 to 93.4,637
PCV,≥4 Doses,States/Local Areas,New York,2013,Age,24 Months,81.1,76.9 to 85.1,545
PCV,≥4 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,81.3,78.4 to 84.0,1137
PCV,≥4 Doses,States/Local Areas,New York,2014,Age,24 Months,81.4,77.4 to 85.1,592
PCV,≥4 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,80.3,77.1 to 83.2,1095
≥1 Dose MMR,,States/Local Areas,New York,2019,Age,24 Months,92.3,88.4 to 95.3,637
≥1 Dose MMR,,States/Local Areas,New York,2012,Age,35 Months,95.2,92.0 to 97.4,492
≥1 Dose MMR,,States/Local Areas,New York,2011,Age,35 Months,95.7,92.6 to 97.7,466
≥1 Dose MMR,,States/Local Areas,New York,2013,Age,35 Months,94.8,91.4 to 97.2,545
≥1 Dose MMR,,States/Local Areas,New York,2013-2014,Age,35 Months,94.9,92.6 to 96.7,1137
≥1 Dose Varicella,,States/Local Areas,New York,2016,Age,35 Months,91.3,86.8 to 94.8,506
≥1 Dose Varicella,,States/Local Areas,New York,2016-2017,Age,35 Months,93.0,90.3 to 95.3,1154
Hep B,≥2 Doses,States/Local Areas,New York,2018,Age,7 Months,90.0,86.1 to 92.8,733
Hep B,≥2 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,91.2,88.6 to 93.2,1370
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2019,Age,0-2 Days,76.3,71.0 to 81.0,637
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2018,Age,0-2 Days,75.4,70.6 to 79.6,733
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2018-2019,Age,0-2 Days,75.8,72.3 to 79.1,1370
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2017,Age,0-2 Days,75.3,70.5 to 79.6,648
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2017-2018,Age,0-2 Days,75.4,72.0 to 78.4,1381
≥1 Dose Varicella,,States/Local Areas,New York,2017,Age,35 Months,94.9,91.6 to 97.2,648
≥1 Dose Varicella,,States/Local Areas,New York,2017-2018,Age,35 Months,94.4,92.3 to 96.2,1381
≥1 Dose Varicella,,States/Local Areas,New York,2018,Age,35 Months,93.9,90.8 to 96.2,733
≥1 Dose Varicella,,States/Local Areas,New York,2018-2019,Age,35 Months,94.6,92.3 to 96.4,1370
Hep B,≥2 Doses,States/Local Areas,New York,2015,Age,7 Months,89.5,85.4 to 92.5,503
Hep B,≥2 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,88.0,84.9 to 90.5,1009
Hep B,≥3 Doses,States/Local Areas,New York,2018,Age,24 Months,90.8,87.5 to 93.6,733
Hep B,≥3 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,90.5,87.9 to 92.7,1370
PCV,≥3 Doses,States/Local Areas,New York,2015,Age,13 Months,86.0,81.6 to 89.4,503
PCV,≥3 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,84.2,80.8 to 87.0,1009
PCV,≥3 Doses,States/Local Areas,New York,2014,Age,13 Months,87.2,83.6 to 90.1,592
PCV,≥3 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,86.6,83.8 to 88.9,1095
Hep B,≥2 Doses,States/Local Areas,New York,2017,Age,7 Months,91.8,88.5 to 94.2,648
Hep B,≥2 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,90.9,88.5 to 92.9,1381
PCV,≥3 Doses,States/Local Areas,New York,2013,Age,13 Months,86.6,82.0 to 90.2,545
PCV,≥3 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,86.9,83.0 to 90.0,1137
Hep B,≥2 Doses,States/Local Areas,New York,2016,Age,7 Months,86.6,81.7 to 90.4,506
Hep B,≥2 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,89.1,86.2 to 91.5,1154
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2016,Age,0-2 Days,69.9,64.0 to 75.3,506
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2016-2017,Age,0-2 Days,72.5,68.7 to 76.1,1154
Hep B,≥3 Doses,States/Local Areas,New York,2014,Age,24 Months,92.2,89.3 to 94.5,592
Hep B,≥3 Doses,States/Local Areas,New York,2014-2015,Age,24 Months,91.4,89.1 to 93.4,1095
Hep B,≥3 Doses,States/Local Areas,New York,2015,Age,24 Months,90.6,86.8 to 93.6,503
Hep B,≥3 Doses,States/Local Areas,New York,2015-2016,Age,24 Months,89.1,86.1 to 91.7,1009
Hep B,≥3 Doses,States/Local Areas,New York,2016,Age,24 Months,87.6,83.0 to 91.5,506
Hep B,≥3 Doses,States/Local Areas,New York,2016-2017,Age,24 Months,89.8,87.0 to 92.2,1154
PCV,≥3 Doses,States/Local Areas,New York,2012,Age,13 Months,90.1,87.2 to 92.4,492
≥1 Dose MMR,,States/Local Areas,New York,2016,Age,24 Months,86.8,82.2 to 90.8,506
≥1 Dose MMR,,States/Local Areas,New York,2016-2017,Age,24 Months,90.0,87.3 to 92.4,1154
≥1 Dose MMR,,States/Local Areas,New York,2017,Age,24 Months,93.4,90.7 to 95.6,648
≥1 Dose MMR,,States/Local Areas,New York,2017-2018,Age,24 Months,93.8,92.0 to 95.4,1381
PCV,≥4 Doses,States/Local Areas,New York,2018,Age,19 Months,76.1,71.6 to 80.1,733
PCV,≥4 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,75.3,71.2 to 79.0,1140
PCV,≥4 Doses,States/Local Areas,New York,2017,Age,19 Months,79.0,74.2 to 83.2,648
PCV,≥4 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,77.6,74.3 to 80.5,1381
PCV,≥3 Doses,States/Local Areas,New York,2011,Age,13 Months,88.4,83.5 to 92.0,466
PCV,≥3 Doses,States/Local Areas,New York,2019,Age,7 Months,63.2,57.4 to 68.6,637
PCV,≥3 Doses,States/Local Areas,New York,2018,Age,7 Months,66.0,61.0 to 70.6,733
PCV,≥3 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,64.6,60.8 to 68.2,1370
Hep B,≥2 Doses,States/Local Areas,New York,2012,Age,7 Months,90.0,88.4 to 91.4,492
Hep B,≥2 Doses,States/Local Areas,New York,2014,Age,7 Months,89.0,85.4 to 91.8,592
Hep B,≥2 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,89.2,86.6 to 91.4,1095
Hep B,≥2 Doses,States/Local Areas,New York,2013,Age,7 Months,89.5,86.4 to 91.9,545
Hep B,≥2 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,89.2,86.2 to 91.7,1137
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2012,Age,0-2 Days,61.1,51.4 to 70.1,492
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2013,Age,0-2 Days,60.9,53.5 to 68.0,545
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2013-2014,Age,0-2 Days,63.4,57.5 to 68.8,1137
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2011,Age,0-2 Days,59.0,54.4 to 63.4,466
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2019,Age,0-1 Days,72.8,67.3 to 77.8,637
Hep B,≥3 Doses,States/Local Areas,New York,2011,Age,24 Months,90.1,85.8 to 93.5,466
Hep B,≥3 Doses,States/Local Areas,New York,2019,Age,19 Months,89.6,85.2 to 92.7,637
Hep B,≥3 Doses,States/Local Areas,New York,2013,Age,24 Months,93.3,90.3 to 95.6,545
Hep B,≥3 Doses,States/Local Areas,New York,2013-2014,Age,24 Months,92.8,90.8 to 94.5,1137
Hep B,≥3 Doses,States/Local Areas,New York,2012,Age,24 Months,92.3,89.1 to 94.9,492
Hep A,≥1 Dose,States/Local Areas,New York,2020,Age,35 Months,88.6,82.4 to 93.3,624
PCV,≥3 Doses,States/Local Areas,New York,2016,Age,7 Months,59.2,53.0 to 65.1,506
PCV,≥3 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,63.0,58.8 to 66.9,1154
PCV,≥4 Doses,States/Local Areas,New York,2016,Age,19 Months,71.1,65.2 to 76.3,506
PCV,≥4 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,74.9,71.1 to 78.3,1154
PCV,≥4 Doses,States/Local Areas,New York,2015,Age,19 Months,73.6,67.6 to 78.8,503
PCV,≥4 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,72.3,68.4 to 75.9,1009
PCV,≥4 Doses,States/Local Areas,New York,2014,Age,19 Months,75.0,70.6 to 79.0,592
PCV,≥4 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,74.3,70.9 to 77.4,1095
PCV,≥3 Doses,States/Local Areas,New York,2015,Age,7 Months,56.5,50.9 to 62.0,503
PCV,≥3 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,57.9,53.7 to 61.9,1009
PCV,≥3 Doses,States/Local Areas,New York,2017,Age,7 Months,67.0,61.6 to 72.1,648
PCV,≥3 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,66.5,62.8 to 70.0,1381
≥1 Dose MMR,,States/Local Areas,New York,2013,Age,24 Months,92.4,89.1 to 95.0,545
≥1 Dose MMR,,States/Local Areas,New York,2013-2014,Age,24 Months,90.8,88.2 to 92.9,1137
≥1 Dose MMR,,States/Local Areas,New York,2014,Age,24 Months,88.8,85.1 to 92.0,592
≥1 Dose MMR,,States/Local Areas,New York,2014-2015,Age,24 Months,90.1,87.7 to 92.2,1095
≥1 Dose MMR,,States/Local Areas,New York,2015,Age,24 Months,91.4,88.1 to 94.1,503
≥1 Dose MMR,,States/Local Areas,New York,2015-2016,Age,24 Months,89.1,86.3 to 91.6,1009
≥1 Dose Varicella,,States/Local Areas,New York,2018,Age,24 Months,90.7,87.1 to 93.5,733
≥1 Dose Varicella,,States/Local Areas,New York,2018-2019,Age,24 Months,91.8,89.4 to 93.9,1370
≥1 Dose Varicella,,States/Local Areas,New York,2012,Age,35 Months,94.0,90.5 to 96.5,492
≥1 Dose Varicella,,States/Local Areas,New York,2011,Age,35 Months,92.8,88.8 to 95.8,466
≥1 Dose Varicella,,States/Local Areas,New York,2019,Age,24 Months,93.0,89.5 to 95.7,637
≥1 Dose Varicella,,States/Local Areas,New York,2017-2018,Age,24 Months,91.4,89.0 to 93.4,1381
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2015,Age,0-1 Days,66.5,61.0 to 71.6,503
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2015-2016,Age,0-1 Days,64.8,60.7 to 68.6,1009
Hep B,≥2 Doses,States/Local Areas,New York,2015,Age,5 Months,85.5,81.1 to 89.1,503
Hep B,≥2 Doses,States/Local Areas,New York,2015-2016,Age,5 Months,83.5,80.0 to 86.4,1009
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2014,Age,0-1 Days,61.7,56.8 to 66.4,592
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2014-2015,Age,0-1 Days,64.1,60.4 to 67.6,1095
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2013,Age,0-1 Days,55.2,47.7 to 62.5,545
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2013-2014,Age,0-1 Days,58.5,52.4 to 64.3,1137
≥1 Dose Varicella,,States/Local Areas,New York,2013,Age,24 Months,92.4,89.1 to 95.0,545
≥1 Dose Varicella,,States/Local Areas,New York,2013-2014,Age,24 Months,90.1,87.6 to 92.2,1137
≥1 Dose Varicella,,States/Local Areas,New York,2014,Age,24 Months,87.4,83.8 to 90.6,592
≥1 Dose Varicella,,States/Local Areas,New York,2014-2015,Age,24 Months,89.4,86.9 to 91.5,1095
Polio,≥2 Doses,States/Local Areas,New York,2017,Age,13 Months,94.9,92.0 to 96.8,648
Polio,≥2 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,94.1,92.2 to 95.6,1381
≥1 Dose Varicella,,States/Local Areas,New York,2019,Age,19 Months,90.0,85.8 to 93.1,637
Polio,≥2 Doses,States/Local Areas,New York,2019,Age,13 Months,93.0,88.8 to 95.7,637
Polio,≥2 Doses,States/Local Areas,New York,2018,Age,13 Months,93.4,90.3 to 95.5,733
Polio,≥2 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,93.2,90.8 to 95.0,1370
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2012,Age,0-1 Days,54.4,43.8 to 64.6,492
Hep B,≥2 Doses,States/Local Areas,New York,2014,Age,5 Months,84.2,80.3 to 87.5,592
Hep B,≥2 Doses,States/Local Areas,New York,2014-2015,Age,5 Months,84.9,79.9 to 88.8,1095
Hep B,≥2 Doses,States/Local Areas,New York,2016,Age,5 Months,81.5,76.0 to 85.9,506
Hep B,≥2 Doses,States/Local Areas,New York,2016-2017,Age,5 Months,85.3,82.0 to 88.1,1154
Hep B,≥3 Doses,States/Local Areas,New York,2018,Age,19 Months,90.3,86.8 to 93.0,733
Hep B,≥3 Doses,States/Local Areas,New York,2018-2019,Age,19 Months,86.9,83.9 to 89.3,1370
Hep B,≥3 Doses,States/Local Areas,New York,2017,Age,19 Months,90.5,86.9 to 93.1,648
Hep B,≥3 Doses,States/Local Areas,New York,2017-2018,Age,19 Months,90.4,88.0 to 92.3,1381
PCV,≥3 Doses,States/Local Areas,New York,2012,Age,7 Months,57.2,50.5 to 63.6,492
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,76.3,71.5 to 81.1,523
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,89.2,86.1 to 92.3,753
PCV,≥3 Doses,States/Local Areas,New York,2014,Age,7 Months,60.4,55.4 to 65.2,592
PCV,≥3 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,58.5,54.7 to 62.2,1095
Hep B,≥3 Doses,States/Local Areas,New York,2016,Age,19 Months,85.5,80.4 to 89.5,506
Hep B,≥3 Doses,States/Local Areas,New York,2016-2017,Age,19 Months,87.9,84.9 to 90.4,1154
PCV,≥3 Doses,States/Local Areas,New York,2011,Age,7 Months,58.8,53.8 to 63.6,466
PCV,≥3 Doses,States/Local Areas,New York,2013,Age,7 Months,58.7,54.0 to 63.2,545
PCV,≥3 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,59.5,56.1 to 62.9,1137
≥1 Dose Varicella,,States/Local Areas,New York,2013,Age,35 Months,97.3,92.4 to 99.4,545
≥1 Dose Varicella,,States/Local Areas,New York,2013-2014,Age,35 Months,94.3,91.7 to 96.2,1137
≥1 Dose MMR,,States/Local Areas,New York,2018,Age,24 Months,94.3,91.6 to 96.3,733
≥1 Dose MMR,,States/Local Areas,New York,2018-2019,Age,24 Months,93.3,91.0 to 95.2,1370
PCV,≥4 Doses,States/Local Areas,New York,2019,Age,19 Months,73.7,68.1 to 78.6,637
≥1 Dose Varicella,,States/Local Areas,New York,2014,Age,35 Months,92.7,89.4 to 95.4,592
≥1 Dose Varicella,,States/Local Areas,New York,2014-2015,Age,35 Months,92.6,90.3 to 94.6,1095
≥1 Dose Varicella,,States/Local Areas,New York,2015,Age,35 Months,92.3,88.8 to 95.0,503
≥1 Dose Varicella,,States/Local Areas,New York,2015-2016,Age,35 Months,92.0,89.2 to 94.3,1009
PCV,≥4 Doses,States/Local Areas,New York,2011,Age,24 Months,81.1,76.2 to 85.6,466
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2015,Age,0-2 Days,69.8,64.3 to 74.7,503
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2015-2016,Age,0-2 Days,69.9,65.9 to 73.5,1009
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2014,Age,0-2 Days,65.8,60.9 to 70.3,592
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2014-2015,Age,0-2 Days,67.8,64.2 to 71.2,1095
≥1 Dose Varicella,,States/Local Areas,New York,2017,Age,24 Months,92.1,88.7 to 94.8,648
≥1 Dose Varicella,,States/Local Areas,New York,2016,Age,24 Months,87.1,82.5 to 91.0,506
≥1 Dose Varicella,,States/Local Areas,New York,2016-2017,Age,24 Months,89.5,86.6 to 92.0,1154
≥1 Dose Varicella,,States/Local Areas,New York,2015,Age,24 Months,91.2,87.8 to 94.0,503
≥1 Dose Varicella,,States/Local Areas,New York,2015-2016,Age,24 Months,89.1,86.3 to 91.6,1009
≥1 Dose MMR,,States/Local Areas,New York,2012,Age,24 Months,92.5,89.2 to 95.2,492
≥1 Dose MMR,,States/Local Areas,New York,2011,Age,24 Months,93.5,90.6 to 95.8,466
≥1 Dose MMR,,States/Local Areas,New York,2019,Age,19 Months,89.8,85.3 to 93.1,637
≥1 Dose MMR,,States/Local Areas,New York,2018,Age,19 Months,90.7,86.9 to 93.5,733
≥1 Dose MMR,,States/Local Areas,New York,2018-2019,Age,19 Months,93.9,91.9 to 95.5,1370
PCV,≥4 Doses,States/Local Areas,New York,2011,Age,19 Months,74.1,67.4 to 79.8,466
PCV,≥4 Doses,States/Local Areas,New York,2012,Age,19 Months,75.8,68.8 to 81.7,492
PCV,≥4 Doses,States/Local Areas,New York,2013,Age,19 Months,75.7,67.3 to 82.5,545
PCV,≥4 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,75.4,69.6 to 80.4,1137
Hep B,≥1 Dose,States/Local Areas,New York,2017,Age,3 Months,95.7,93.3 to 97.3,648
Hep B,≥1 Dose,States/Local Areas,New York,2017-2018,Age,3 Months,93.7,91.5 to 95.3,1381
Polio,≥2 Doses,States/Local Areas,New York,2016,Age,13 Months,89.7,85.0 to 93.1,506
Polio,≥2 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,92.2,89.5 to 94.3,1154
Polio,≥2 Doses,States/Local Areas,New York,2015,Age,13 Months,92.6,88.8 to 95.1,503
Polio,≥2 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,91.1,88.2 to 93.4,1009
≥1 Dose Varicella,,States/Local Areas,New York,2016,Age,19 Months,82.7,77.3 to 87.0,506
≥1 Dose Varicella,,States/Local Areas,New York,2016-2017,Age,19 Months,86.1,82.8 to 88.9,1154
≥1 Dose Varicella,,States/Local Areas,New York,2018,Age,19 Months,85.4,81.1 to 88.9,733
≥1 Dose Varicella,,States/Local Areas,New York,2018-2019,Age,19 Months,57.0,53.0 to 60.8,1370
≥1 Dose Varicella,,States/Local Areas,New York,2017,Age,19 Months,89.7,85.7 to 92.7,648
≥1 Dose Varicella,,States/Local Areas,New York,2017-2018,Age,19 Months,87.6,84.7 to 90.0,1381
≥1 Dose MMR,,States/Local Areas,New York,2012,Age,19 Months,87.1,81.1 to 91.4,492
≥1 Dose MMR,,States/Local Areas,New York,2014,Age,19 Months,85.6,81.3 to 89.0,592
≥1 Dose MMR,,States/Local Areas,New York,2014-2015,Age,19 Months,87.6,84.8 to 89.9,1095
≥1 Dose MMR,,States/Local Areas,New York,2013,Age,19 Months,87.2,83.8 to 90.0,545
≥1 Dose MMR,,States/Local Areas,New York,2013-2014,Age,19 Months,86.4,84.9 to 87.8,1137
≥1 Dose MMR,,States/Local Areas,New York,2011,Age,19 Months,89.5,85.2 to 92.7,466
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.5,69.5 to 85.5,160
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,75.4,67.6 to 83.3,203
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,85.5,82.6 to 88.4,1048
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,78.3,74.3 to 82.3,645
DTaP,≥4 Doses,States/Local Areas,New York,2019,Age,35 Months,87.2,81.9 to 91.6,637
Hep B,≥3 Doses,States/Local Areas,New York,2015,Age,19 Months,90.2,85.9 to 93.3,503
Hep B,≥3 Doses,States/Local Areas,New York,2015-2016,Age,19 Months,87.8,84.6 to 90.4,1009
Hep B,≥3 Doses,States/Local Areas,New York,2014,Age,19 Months,91.3,88.2 to 93.7,592
Hep B,≥3 Doses,States/Local Areas,New York,2014-2015,Age,19 Months,90.7,88.3 to 92.7,1095
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,72.7,66.5 to 79.0,753
Hep B,≥3 Doses,States/Local Areas,New York,2013,Age,19 Months,91.2,89.1 to 93.0,545
Hep B,≥3 Doses,States/Local Areas,New York,2013-2014,Age,19 Months,91.3,89.0 to 93.1,1137
Hep B,≥2 Doses,States/Local Areas,New York,2013,Age,5 Months,84.6,81.4 to 87.3,545
Hep B,≥2 Doses,States/Local Areas,New York,2013-2014,Age,5 Months,84.4,80.3 to 87.7,1137
Hep B,≥2 Doses,States/Local Areas,New York,2011,Age,5 Months,80.7,76.2 to 84.5,466
Hep B,≥2 Doses,States/Local Areas,New York,2012,Age,5 Months,84.1,79.9 to 87.6,492
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2011,Age,0-1 Days,55.2,51.2 to 59.2,466
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,66.8,59.7 to 73.8,523
Hep A,≥2 Doses,States/Local Areas,New York,2020,Age,35 Months,74.6,67.9 to 80.8,624
Hep B,≥1 Dose,States/Local Areas,New York,2019,Age,3 Months,96.5,93.8 to 98.1,637
Hep B,≥1 Dose,States/Local Areas,New York,2018,Age,3 Months,91.5,87.7 to 94.2,733
Hep B,≥1 Dose,States/Local Areas,New York,2018-2019,Age,3 Months,94.0,91.8 to 95.7,1370
≥1 Dose Varicella,,States/Local Areas,New York,2012,Age,24 Months,91.4,88.0 to 94.1,492
≥1 Dose Varicella,,States/Local Areas,New York,2011,Age,24 Months,90.7,86.8 to 93.8,466
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,77.5,73.4 to 81.6,646
≥1 Dose MMR,,States/Local Areas,New York,2017,Age,19 Months,93.2,90.3 to 95.3,648
≥1 Dose MMR,,States/Local Areas,New York,2017-2018,Age,19 Months,92.0,89.7 to 93.8,1381
≥1 Dose MMR,,States/Local Areas,New York,2016,Age,19 Months,82.5,77.1 to 86.9,506
≥1 Dose MMR,,States/Local Areas,New York,2016-2017,Age,19 Months,87.7,84.5 to 90.3,1154
≥1 Dose MMR,,States/Local Areas,New York,2015,Age,19 Months,89.6,87.0 to 91.6,503
≥1 Dose MMR,,States/Local Areas,New York,2015-2016,Age,19 Months,86.0,82.7 to 88.7,1009
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.5,81.7 to 89.3,576
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,74.6 to 80.9,1271
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,86.7,77.7 to 95.7,75
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,80.8,78.4 to 83.1,1922
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.9,83.3 to 92.6,355
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.0,75.4 to 82.6,955
DTaP,≥4 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,81.1,76.6 to 85.7,452
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,72.4,67.4 to 77.4,1048
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,67.7,61.7 to 73.8,645
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.4,49.6 to 71.2,160
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2018,Age,0-1 Days,70.4,65.5 to 74.9,733
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2018-2019,Age,0-1 Days,71.6,67.9 to 75.0,1370
Hep B,≥2 Doses,States/Local Areas,New York,2018,Age,5 Months,87.6,83.6 to 90.7,733
Hep B,≥2 Doses,States/Local Areas,New York,2018-2019,Age,5 Months,88.8,86.0 to 91.1,1370
Hep B,≥2 Doses,States/Local Areas,New York,2017,Age,5 Months,89.3,85.7 to 92.1,648
Hep B,≥2 Doses,States/Local Areas,New York,2017-2018,Age,5 Months,88.5,85.8 to 90.7,1381
Hep B,≥2 Doses,States/Local Areas,New York,2011,Age,7 Months,86.9,82.3 to 90.4,466
Hep B,≥2 Doses,States/Local Areas,New York,2019,Age,5 Months,89.9,85.7 to 93.0,637
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2017,Age,0-1 Days,68.8,63.8 to 73.5,648
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2017-2018,Age,0-1 Days,69.6,66.1 to 72.9,1381
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2016,Age,0-1 Days,63.1,57.1 to 68.7,506
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2016-2017,Age,0-1 Days,65.9,61.9 to 69.6,1154
DTaP,≥4 Doses,States/Local Areas,New York,2018,Age,35 Months,92.3,88.1 to 95.5,733
DTaP,≥4 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,89.9,86.4 to 92.8,1370
Hep B,≥3 Doses,States/Local Areas,New York,2011,Age,19 Months,86.9,82.8 to 90.1,466
Hep B,≥3 Doses,States/Local Areas,New York,2019,Age,13 Months,86.4,81.9 to 90.0,637
Hep B,≥3 Doses,States/Local Areas,New York,2018,Age,13 Months,87.3,83.3 to 90.4,733
Hep B,≥3 Doses,States/Local Areas,New York,2018-2019,Age,13 Months,86.9,83.9 to 89.3,1370
Hep B,≥3 Doses,States/Local Areas,New York,2012,Age,19 Months,91.1,88.7 to 93.1,492
PCV,≥1 Dose,States/Local Areas,New York,2012,Age,3 Months,82.1,77.1 to 86.2,492
≥1 Dose Varicella,,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,92.5,89.7 to 95.4,452
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,66.4,55.7 to 77.1,203
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,81.1,77.2 to 85.0,753
Polio,≥2 Doses,States/Local Areas,New York,2018,Age,7 Months,87.4,83.3 to 90.7,733
Polio,≥2 Doses,States/Local Areas,New York,2018-2019,Age,7 Months,87.9,84.9 to 90.4,1370
Polio,≥2 Doses,States/Local Areas,New York,2017,Age,7 Months,92.6,89.5 to 94.9,648
Polio,≥2 Doses,States/Local Areas,New York,2017-2018,Age,7 Months,90.1,87.5 to 92.1,1381
Polio,≥2 Doses,States/Local Areas,New York,2016,Age,7 Months,82.8,77.2 to 87.2,506
Polio,≥2 Doses,States/Local Areas,New York,2016-2017,Age,7 Months,87.5,84.3 to 90.2,1154
Hep B,≥1 Dose,States/Local Areas,New York,2014,Age,3 Months,93.1,90.2 to 95.2,592
Hep B,≥1 Dose,States/Local Areas,New York,2014-2015,Age,3 Months,92.9,90.8 to 94.6,1095
Hep B,≥1 Dose,States/Local Areas,New York,2011,Age,3 Months,89.4,83.8 to 93.2,466
Hep B,≥1 Dose,States/Local Areas,New York,2012,Age,3 Months,93.2,90.5 to 95.2,492
Hep B,≥1 Dose,States/Local Areas,New York,2013,Age,3 Months,92.7,89.6 to 95.0,545
Hep B,≥1 Dose,States/Local Areas,New York,2013-2014,Age,3 Months,92.9,90.2 to 94.9,1137
Hep B,≥3 Doses,States/Local Areas,New York,2017,Age,13 Months,87.7,84.0 to 90.7,648
Hep B,≥3 Doses,States/Local Areas,New York,2017-2018,Age,13 Months,87.5,84.9 to 89.7,1381
Hep B,≥3 Doses,States/Local Areas,New York,2015,Age,13 Months,88.1,84.0 to 91.3,503
Hep B,≥3 Doses,States/Local Areas,New York,2015-2016,Age,13 Months,85.5,82.2 to 88.2,1009
Hep B,≥3 Doses,States/Local Areas,New York,2016,Age,13 Months,82.9,77.7 to 87.1,506
Hep B,≥3 Doses,States/Local Areas,New York,2016-2017,Age,13 Months,85.2,82.0 to 87.9,1154
DTaP,≥4 Doses,States/Local Areas,New York,2016,Age,35 Months,84.9,78.8 to 89.9,506
DTaP,≥4 Doses,States/Local Areas,New York,2016-2017,Age,35 Months,88.4,84.7 to 91.5,1154
DTaP,≥4 Doses,States/Local Areas,New York,2017,Age,35 Months,92.1,88.0 to 95.1,648
DTaP,≥4 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,92.1,89.3 to 94.4,1381
Hep B,≥1 Dose,States/Local Areas,New York,2016,Age,3 Months,90.3,85.7 to 93.5,506
Hep B,≥1 Dose,States/Local Areas,New York,2016-2017,Age,3 Months,92.9,90.3 to 94.9,1154
Hep B,≥1 Dose,States/Local Areas,New York,2015,Age,3 Months,92.8,89.2 to 95.2,503
Hep B,≥1 Dose,States/Local Areas,New York,2015-2016,Age,3 Months,91.5,88.7 to 93.7,1009
Polio,≥2 Doses,States/Local Areas,New York,2014,Age,13 Months,95.5,93.2 to 97.0,592
Polio,≥2 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,94.0,91.9 to 95.6,1095
Polio,≥2 Doses,States/Local Areas,New York,2013,Age,13 Months,93.7,91.9 to 95.2,545
Polio,≥2 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,94.6,92.8 to 96.0,1137
Polio,≥2 Doses,States/Local Areas,New York,2011,Age,13 Months,93.6,88.9 to 96.4,466
Polio,≥2 Doses,States/Local Areas,New York,2012,Age,13 Months,95.3,93.9 to 96.4,492
≥1 Dose Varicella,,States/Local Areas,New York,2013,Age,19 Months,86.6,83.0 to 89.5,545
≥1 Dose Varicella,,States/Local Areas,New York,2013-2014,Age,19 Months,86.4,84.5 to 88.1,1137
≥1 Dose Varicella,,States/Local Areas,New York,2015,Age,19 Months,87.7,83.6 to 90.9,503
≥1 Dose Varicella,,States/Local Areas,New York,2015-2016,Age,19 Months,85.2,81.9 to 87.9,1009
≥1 Dose Varicella,,States/Local Areas,New York,2014,Age,19 Months,86.3,82.3 to 89.4,592
≥1 Dose Varicella,,States/Local Areas,New York,2014-2015,Age,19 Months,87.0,84.3 to 89.3,1095
≥1 Dose MMR,,States/Local Areas,New York,2019,Age,13 Months,65.2,59.3 to 70.7,637
≥1 Dose MMR,,States/Local Areas,New York,2018,Age,13 Months,70.7,65.7 to 75.3,733
≥1 Dose MMR,,States/Local Areas,New York,2018-2019,Age,13 Months,68.0,64.1 to 71.6,1370
≥1 Dose MMR,,States/Local Areas,New York,2017,Age,13 Months,65.3,59.6 to 70.5,648
≥1 Dose MMR,,States/Local Areas,New York,2017-2018,Age,13 Months,68.0,64.2 to 71.5,1381
Hep B,≥3 Doses,States/Local Areas,New York,2011,Age,13 Months,81.8,76.9 to 85.9,466
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,75.2,70.2 to 80.2,523
Polio,≥2 Doses,States/Local Areas,New York,2015,Age,7 Months,90.1,86.2 to 93.0,503
Polio,≥2 Doses,States/Local Areas,New York,2015-2016,Age,7 Months,86.4,83.0 to 89.2,1009
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Overall,Overall,78.4,76.0 to 80.8,1922
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,78.5,74.7 to 82.3,646
Polio,≥2 Doses,States/Local Areas,New York,2013,Age,7 Months,88.7,86.1 to 90.8,545
Polio,≥2 Doses,States/Local Areas,New York,2013-2014,Age,7 Months,89.6,87.2 to 91.5,1137
Polio,≥2 Doses,States/Local Areas,New York,2014,Age,7 Months,90.4,87.2 to 92.9,592
Polio,≥2 Doses,States/Local Areas,New York,2014-2015,Age,7 Months,90.3,87.9 to 92.3,1095
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,87.4,78.7 to 96.1,75
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.8,74.3 to 83.3,576
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.5,68.7 to 76.3,955
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,77.4,74.4 to 80.4,1271
Hep A,≥1 Dose,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.3,80.5 to 90.1,355
≥1 Dose Varicella,,States/Local Areas,New York,2015,Age,13 Months,54.4,48.8 to 59.9,503
≥1 Dose Varicella,,States/Local Areas,New York,2015-2016,Age,13 Months,54.8,50.6 to 58.9,1009
≥1 Dose Varicella,,States/Local Areas,New York,2017,Age,13 Months,59.7,54.0 to 65.1,648
≥1 Dose Varicella,,States/Local Areas,New York,2017-2018,Age,13 Months,58.9,55.1 to 62.6,1381
≥1 Dose Varicella,,States/Local Areas,New York,2016,Age,13 Months,55.1,49.0 to 61.1,506
≥1 Dose Varicella,,States/Local Areas,New York,2016-2017,Age,13 Months,57.3,53.1 to 61.4,1154
DTaP,≥4 Doses,States/Local Areas,New York,2017,Age,24 Months,86.0,81.8 to 89.6,648
DTaP,≥4 Doses,States/Local Areas,New York,2017-2018,Age,24 Months,84.1,81.2 to 86.8,1381
DTaP,≥4 Doses,States/Local Areas,New York,2018,Age,24 Months,82.2,78.0 to 86.0,733
DTaP,≥4 Doses,States/Local Areas,New York,2018-2019,Age,24 Months,81.7,78.3 to 84.8,1370
DTaP,≥4 Doses,States/Local Areas,New York,2011,Age,35 Months,90.4,85.3 to 94.3,466
DTaP,≥4 Doses,States/Local Areas,New York,2019,Age,24 Months,80.9,75.6 to 85.8,637
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,80.3,67.9 to 92.7,75
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.0,63.4 to 78.6,576
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,68.6,62.7 to 74.5,646
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Overall,Overall,69.2,65.5 to 72.9,1922
Polio,≥2 Doses,States/Local Areas,New York,2019,Age,7 Months,88.4,83.8 to 91.9,637
Hep A,≥2 Doses,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.1,57.6 to 68.6,955
≥1 Dose MMR,,States/Local Areas,New York,2011,Age,13 Months,52.4,45.0 to 59.6,466
≥1 Dose MMR,,States/Local Areas,New York,2012,Age,13 Months,54.0,45.5 to 62.3,492
≥1 Dose MMR,,States/Local Areas,New York,2013,Age,13 Months,51.7,43.8 to 59.5,545
≥1 Dose MMR,,States/Local Areas,New York,2013-2014,Age,13 Months,56.4,51.0 to 61.7,1137
Hep A,≥2 Doses,States/Local Areas,New York,2017,Age,35 Months,76.7,70.9 to 82.2,648
Hep A,≥2 Doses,States/Local Areas,New York,2017-2018,Age,35 Months,77.7,73.5 to 81.6,1381
Hep A,≥2 Doses,States/Local Areas,New York,2018,Age,35 Months,78.6,72.4 to 84.1,733
Hep A,≥2 Doses,States/Local Areas,New York,2018-2019,Age,35 Months,78.8,73.4 to 83.8,1370
Hep B,≥3 Doses,States/Local Areas,New York,2014,Age,13 Months,85.8,82.0 to 88.9,592
Hep B,≥3 Doses,States/Local Areas,New York,2014-2015,Age,13 Months,87.0,84.3 to 89.3,1095
Hep B,≥3 Doses,States/Local Areas,New York,2013,Age,13 Months,86.4,84.4 to 88.2,545
Hep B,≥3 Doses,States/Local Areas,New York,2013-2014,Age,13 Months,86.1,83.5 to 88.4,1137
DTaP,≥4 Doses,States/Local Areas,New York,2013,Age,35 Months,91.7,87.6 to 94.8,545
DTaP,≥4 Doses,States/Local Areas,New York,2013-2014,Age,35 Months,90.6,88.0 to 92.9,1137
Hep B,≥3 Doses,States/Local Areas,New York,2012,Age,13 Months,85.4,83.6 to 87.1,492
Hep A,≥2 Doses,States/Local Areas,New York,2019,Age,35 Months,79.2,70.0 to 87.2,637
DTaP,≥4 Doses,States/Local Areas,New York,2014,Age,35 Months,89.7,86.1 to 92.8,592
DTaP,≥4 Doses,States/Local Areas,New York,2014-2015,Age,35 Months,88.0,84.9 to 90.7,1095
DTaP,≥4 Doses,States/Local Areas,New York,2015,Age,35 Months,85.6,80.5 to 90.0,503
DTaP,≥4 Doses,States/Local Areas,New York,2015-2016,Age,35 Months,85.5,81.5 to 89.1,1009
DTaP,≥4 Doses,States/Local Areas,New York,2012,Age,35 Months,92.1,87.5 to 95.5,492
≥1 Dose Varicella,,States/Local Areas,New York,2018,Age,13 Months,58.1,52.9 to 63.0,733
≥1 Dose Varicella,,States/Local Areas,New York,2018-2019,Age,13 Months,57.0,53.0 to 60.8,1370
≥1 Dose MMR,,States/Local Areas,New York,2016,Age,13 Months,57.5,51.3 to 63.4,506
≥1 Dose MMR,,States/Local Areas,New York,2016-2017,Age,13 Months,61.2,57.1 to 65.3,1154
≥1 Dose Varicella,,States/Local Areas,New York,2012,Age,19 Months,86.3,82.7 to 89.2,492
≥1 Dose Varicella,,States/Local Areas,New York,2011,Age,19 Months,86.2,80.6 to 90.3,466
≥1 Dose Varicella,,States/Local Areas,New York,2019,Age,13 Months,55.8,49.9 to 61.7,637
≥1 Dose MMR,,States/Local Areas,New York,2015,Age,13 Months,63.5,58.0 to 68.6,503
≥1 Dose MMR,,States/Local Areas,New York,2015-2016,Age,13 Months,60.4,56.3 to 64.4,1009
≥1 Dose MMR,,States/Local Areas,New York,2014,Age,13 Months,61.2,56.1 to 66.0,592
≥1 Dose MMR,,States/Local Areas,New York,2014-2015,Age,13 Months,62.3,58.6 to 65.9,1095
Hib,Primary Series,States/Local Areas,Michigan,2011,Age,7 Months,68.0,61.7 to 73.8,255
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,90.6,86.4 to 94.9,316
Hib,Primary Series,States/Local Areas,Michigan,2012,Age,7 Months,60.8,46.1 to 73.8,212
Polio,≥3 Doses,States/Local Areas,Michigan,2011,Age,35 Months,92.5,87.0 to 96.3,255
DTaP,≥3 Doses,States/Local Areas,Michigan,2011,Age,24 Months,90.9,85.6 to 94.9,255
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.0,83.3 to 90.6,481
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,79.8,68.9 to 90.7,90
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.5,80.8 to 94.2,122
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,83.0 to 89.4,693
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,74.8,68.6 to 81.1,358
DTaP,≥3 Doses,States/Local Areas,Michigan,2015,Age,19 Months,91.4,86.2 to 94.8,236
DTaP,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,91.9,88.1 to 94.5,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2014,Age,19 Months,91.1,85.6 to 94.6,250
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,91.2,87.4 to 94.0,486
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Overall,Overall,81.4,78.1 to 84.7,997
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,83.1,76.5 to 89.8,158
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,71.5,64.5 to 78.4,267
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,85.2,81.4 to 89.1,414
DTaP,≥3 Doses,States/Local Areas,Michigan,2016,Age,19 Months,92.3,87.3 to 95.4,291
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,90.3,86.4 to 93.2,693
Hib,≥3 Doses,States/Local Areas,Michigan,2015,Age,19 Months,82.9,75.2 to 88.5,236
Hib,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,85.7,81.0 to 89.4,527
Polio,≥3 Doses,States/Local Areas,Michigan,2013,Age,24 Months,90.2,83.9 to 94.8,240
Polio,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,92.8,88.5 to 96.0,490
Hib,≥3 Doses,States/Local Areas,Michigan,2013,Age,19 Months,85.3,78.7 to 90.1,240
Hib,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,86.5,83.9 to 88.8,490
Hib,≥3 Doses,States/Local Areas,Michigan,2014,Age,19 Months,87.8,81.5 to 92.1,250
Hib,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,85.3,80.4 to 89.2,486
Polio,≥3 Doses,States/Local Areas,Michigan,2012,Age,24 Months,86.6,78.6 to 92.7,212
Polio,≥3 Doses,States/Local Areas,Michigan,2011,Age,24 Months,90.2,84.8 to 94.2,255
Polio,≥3 Doses,States/Local Areas,Michigan,2019,Age,19 Months,93.9,89.5 to 96.6,375
Polio,≥3 Doses,States/Local Areas,Michigan,2014,Age,24 Months,95.2,90.8 to 97.9,250
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,93.9,90.5 to 96.3,486
Polio,≥3 Doses,States/Local Areas,Michigan,2015,Age,24 Months,92.6,87.1 to 96.3,236
Polio,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,93.7,90.6 to 96.0,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2017,Age,19 Months,88.3,82.5 to 92.4,402
DTaP,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,92.9,89.7 to 95.2,817
Hib,≥3 Doses,States/Local Areas,Michigan,2018,Age,19 Months,94.1,90.2 to 96.6,415
Hib,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,71.9,67.3 to 76.1,790
Hib,≥3 Doses,States/Local Areas,Michigan,2016,Age,19 Months,88.6,83.1 to 92.5,291
Hib,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,86.9,82.7 to 90.2,693
Polio,≥3 Doses,States/Local Areas,Michigan,2016,Age,24 Months,94.6,91.2 to 97.0,291
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,92.2,89.3 to 94.6,693
Hib,≥3 Doses,States/Local Areas,Michigan,2017,Age,19 Months,85.2,79.1 to 89.8,402
Hib,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,89.6,86.0 to 92.4,817
DTaP,≥3 Doses,States/Local Areas,Michigan,2018,Age,19 Months,97.5,94.6 to 98.9,415
DTaP,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,92.8,89.9 to 94.9,790
DTaP,≥3 Doses,States/Local Areas,Michigan,2019,Age,19 Months,93.9,89.4 to 96.5,375
Hib,Full Series,States/Local Areas,Michigan,2015,Age,24 Months,78.7,71.0 to 85.4,236
Hib,Full Series,States/Local Areas,Michigan,2015-2016,Age,24 Months,81.9,77.2 to 86.1,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2013,Age,24 Months,91.5,85.4 to 95.8,240
DTaP,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,93.4,89.1 to 96.4,490
DTaP,≥3 Doses,States/Local Areas,Michigan,2012,Age,24 Months,87.5,79.7 to 93.3,212
Hib,Full Series,States/Local Areas,Michigan,2016,Age,24 Months,85.0,79.5 to 89.8,291
Hib,Full Series,States/Local Areas,Michigan,2016-2017,Age,24 Months,81.9,77.5 to 85.9,693
Polio,≥3 Doses,States/Local Areas,Michigan,2017,Age,24 Months,89.8,84.6 to 93.7,402
Polio,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,93.2,90.2 to 95.5,817
Hib,≥3 Doses,States/Local Areas,Michigan,2019,Age,19 Months,89.1,83.5 to 92.9,375
Polio,≥3 Doses,States/Local Areas,Michigan,2019,Age,24 Months,96.3,93.0 to 98.4,375
Polio,≥3 Doses,States/Local Areas,Michigan,2018,Age,24 Months,96.6,93.3 to 98.5,415
Polio,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,96.5,94.4 to 98.0,790
Hib,Full Series,States/Local Areas,Michigan,2017,Age,24 Months,78.8,72.2 to 84.7,402
Hib,Full Series,States/Local Areas,Michigan,2017-2018,Age,24 Months,81.1,76.8 to 85.1,817
Hib,Full Series,States/Local Areas,Michigan,2018,Age,24 Months,83.3,77.7 to 88.2,415
Hib,Full Series,States/Local Areas,Michigan,2018-2019,Age,24 Months,83.3,79.3 to 86.8,790
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,95.1,92.9 to 97.4,609
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,92.7,89.4 to 95.9,359
Polio,≥3 Doses,States/Local Areas,Michigan,2018,Age,35 Months,96.7,93.4 to 98.7,415
Polio,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,97.8,95.5 to 99.1,790
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.9,80.1 to 95.7,92
Polio,≥3 Doses,States/Local Areas,Michigan,2019,Age,35 Months,98.4,96.1 to 99.5,375
Hib,≥3 Doses,States/Local Areas,Michigan,2014,Age,24 Months,92.1,86.6 to 96.0,250
Hib,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,89.4,85.0 to 93.0,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2020,Age,24 Months,90.6,86.1 to 94.1,448
Hib,≥3 Doses,States/Local Areas,Michigan,2011,Age,24 Months,89.3,83.8 to 93.5,255
Hib,≥3 Doses,States/Local Areas,Michigan,2012,Age,24 Months,82.6,74.1 to 89.6,212
Hib,≥3 Doses,States/Local Areas,Michigan,2013,Age,24 Months,90.2,84.0 to 94.7,240
Hib,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,91.2,86.7 to 94.6,490
Hib,Full Series,States/Local Areas,Michigan,2017,Age,35 Months,81.8,75.4 to 87.5,402
Hib,Full Series,States/Local Areas,Michigan,2017-2018,Age,35 Months,83.0,78.7 to 86.9,817
Hib,Full Series,States/Local Areas,Michigan,2016,Age,35 Months,86.1,80.4 to 90.8,291
Hib,Full Series,States/Local Areas,Michigan,2016-2017,Age,35 Months,84.0,79.6 to 87.9,693
Hib,Full Series,States/Local Areas,Michigan,2019,Age,35 Months,85.9,80.1 to 90.8,375
Hib,Full Series,States/Local Areas,Michigan,2018,Age,35 Months,83.5,77.9 to 88.4,415
Hib,Full Series,States/Local Areas,Michigan,2018-2019,Age,35 Months,84.8,80.8 to 88.3,790
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,88.9,85.9 to 92.0,609
Polio,≥3 Doses,States/Local Areas,Michigan,2012,Age,35 Months,89.3,81.5 to 94.8,212
Hib,Full Series,States/Local Areas,Michigan,2015,Age,35 Months,79.1,71.4 to 85.9,236
Hib,Full Series,States/Local Areas,Michigan,2015-2016,Age,35 Months,82.7,77.9 to 86.9,527
Hib,Full Series,States/Local Areas,Michigan,2014,Age,35 Months,82.0,74.5 to 88.4,250
Hib,Full Series,States/Local Areas,Michigan,2014-2015,Age,35 Months,80.8,75.4 to 85.6,486
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,74.9,69.2 to 80.6,359
Hib,Full Series,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.8,49.3 to 72.2,92
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,94.5,88.3 to 100.0,90
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.0,91.1 to 99.0,122
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.7,92.7 to 96.7,693
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,91.8,87.9 to 95.7,358
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.4,93.2 to 97.5,481
DTaP,≥2 Doses,States/Local Areas,Michigan,2015,Age,5 Months,76.3,68.0 to 82.9,236
DTaP,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,5 Months,77.5,72.2 to 81.9,527
DTaP,≥2 Doses,States/Local Areas,Michigan,2016,Age,5 Months,78.6,72.0 to 84.0,291
DTaP,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,5 Months,77.1,72.3 to 81.2,693
DTaP,≥2 Doses,States/Local Areas,Michigan,2014,Age,5 Months,74.2,67.0 to 80.3,250
DTaP,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,5 Months,75.2,72.7 to 77.6,486
Polio,≥3 Doses,States/Local Areas,Michigan,2016,Age,35 Months,94.7,91.3 to 97.1,291
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,94.1,91.4 to 96.2,693
Polio,≥3 Doses,States/Local Areas,Michigan,2017,Age,35 Months,93.5,88.9 to 96.7,402
Polio,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,95.3,92.5 to 97.3,817
Hib,Full Series,States/Local Areas,Michigan,2012,Age,35 Months,75.8,66.9 to 83.9,212
Hib,Full Series,States/Local Areas,Michigan,2011,Age,35 Months,89.1,79.6 to 95.5,255
Hib,Full Series,States/Local Areas,Michigan,2013,Age,35 Months,77.6,69.4 to 84.9,240
Hib,Full Series,States/Local Areas,Michigan,2013-2014,Age,35 Months,79.7,74.0 to 84.9,490
Hib,Full Series,States/Local Areas,Michigan,2019,Age,24 Months,83.2,77.5 to 88.2,375
Polio,≥3 Doses,States/Local Areas,Michigan,2015,Age,35 Months,93.9,88.6 to 97.2,236
Polio,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,94.4,91.4 to 96.6,527
Polio,≥3 Doses,States/Local Areas,Michigan,2013,Age,35 Months,92.2,85.9 to 96.4,240
Polio,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,95.1,90.6 to 97.8,490
Polio,≥3 Doses,States/Local Areas,Michigan,2014,Age,35 Months,98.9,94.8 to 99.9,250
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,96.4,92.7 to 98.6,486
DTaP,≥2 Doses,States/Local Areas,Michigan,2011,Age,5 Months,76.7,72.8 to 80.2,255
DTaP,≥2 Doses,States/Local Areas,Michigan,2012,Age,5 Months,68.9,60.0 to 76.7,212
DTaP,≥2 Doses,States/Local Areas,Michigan,2013,Age,5 Months,68.2,65.6 to 70.7,240
DTaP,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,5 Months,71.2,67.4 to 74.8,490
Hib,≥3 Doses,States/Local Areas,Michigan,2019,Age,35 Months,95.8,91.7 to 98.2,375
Hep A,≥2 Doses,States/Local Areas,Michigan,2014,Age,24 Months,45.4,37.8 to 53.7,250
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,47.4,41.7 to 53.4,486
Hep A,≥2 Doses,States/Local Areas,Michigan,2015,Age,24 Months,49.5,41.3 to 58.2,236
Hep A,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,51.7,46.2 to 57.5,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,94.0,92.1 to 96.0,997
Hep A,≥1 Dose,States/Local Areas,Michigan,2018,Age,35 Months,96.1,91.1 to 98.7,415
Hep A,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,35 Months,95.8,92.7 to 97.8,790
Hep A,≥1 Dose,States/Local Areas,Michigan,2017,Age,35 Months,94.1,89.6 to 97.0,402
Hep A,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,35 Months,95.0,92.0 to 97.2,817
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,78.0,70.4 to 85.6,358
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.1,55.1 to 79.1,122
Hep A,≥1 Dose,States/Local Areas,Michigan,2016,Age,35 Months,92.0,86.8 to 95.7,291
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,35 Months,93.1,89.9 to 95.6,693
DTaP,≥4 Doses,States/Local Areas,Michigan,2013,Age,24 Months,78.0,70.2 to 84.9,240
DTaP,≥4 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,77.7,72.2 to 82.7,490
Hep A,≥2 Doses,States/Local Areas,Michigan,2016,Age,24 Months,54.0,46.7 to 61.6,291
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,55.6,50.5 to 60.8,693
Hep A,≥2 Doses,States/Local Areas,Michigan,2017,Age,24 Months,57.1,50.1 to 64.4,402
Hep A,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,56.4,51.5 to 61.5,817
Hep A,≥2 Doses,States/Local Areas,Michigan,2018,Age,24 Months,55.3,48.4 to 62.4,415
Hep A,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,56.2,51.0 to 61.5,790
DTaP,≥4 Doses,States/Local Areas,Michigan,2012,Age,24 Months,70.3,60.4 to 79.6,212
DTaP,≥4 Doses,States/Local Areas,Michigan,2011,Age,24 Months,81.2,74.5 to 87.0,255
DTaP,≥4 Doses,States/Local Areas,Michigan,2019,Age,19 Months,74.7,67.8 to 80.6,375
Hep B,≥3 Doses,States/Local Areas,Michigan,2013,Age,7 Months,47.0,39.3 to 54.9,240
Hep B,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,50.2,44.0 to 56.4,490
Hep B,≥3 Doses,States/Local Areas,Michigan,2011,Age,7 Months,50.7,45.4 to 56.0,255
Hep B,≥3 Doses,States/Local Areas,Michigan,2012,Age,7 Months,56.4,45.6 to 66.6,212
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,94.4,92.0 to 96.9,414
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,97.7,94.8 to 100.0,316
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,91.1,87.0 to 95.2,267
Polio,≥2 Doses,States/Local Areas,Michigan,2014,Age,5 Months,74.0,66.8 to 80.1,250
Polio,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,5 Months,75.2,72.6 to 77.6,486
Polio,≥2 Doses,States/Local Areas,Michigan,2013,Age,5 Months,67.4,64.6 to 70.0,240
Polio,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,5 Months,70.7,67.0 to 74.1,490
Polio,≥2 Doses,States/Local Areas,Michigan,2011,Age,5 Months,76.0,71.2 to 80.2,255
Polio,≥2 Doses,States/Local Areas,Michigan,2012,Age,5 Months,68.2,57.1 to 77.5,212
Hep A,≥1 Dose,States/Local Areas,Michigan,2015,Age,35 Months,88.2,81.4 to 93.4,236
Hep A,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,35 Months,90.0,85.9 to 93.4,527
DTaP,≥4 Doses,States/Local Areas,Michigan,2014,Age,24 Months,77.5,70.2 to 84.0,250
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,79.7,74.6 to 84.3,486
DTaP,≥4 Doses,States/Local Areas,Michigan,2015,Age,24 Months,81.8,74.3 to 88.2,236
DTaP,≥4 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,82.2,77.4 to 86.5,527
DTaP,≥4 Doses,States/Local Areas,Michigan,2016,Age,24 Months,82.6,76.2 to 88.0,291
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,80.7,76.1 to 84.9,693
Hep A,≥2 Doses,States/Local Areas,Michigan,2013,Age,35 Months,75.1,65.7 to 83.5,240
Hep A,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,73.4,66.8 to 79.6,490
Hep A,≥2 Doses,States/Local Areas,Michigan,2012,Age,35 Months,64.5,53.2 to 75.6,212
Hep A,≥2 Doses,States/Local Areas,Michigan,2011,Age,35 Months,64.9,55.6 to 74.2,255
Hep A,≥2 Doses,States/Local Areas,Michigan,2019,Age,24 Months,56.9,49.4 to 64.8,375
Hep B,≥3 Doses,States/Local Areas,Michigan,2016,Age,7 Months,64.0,56.9 to 70.5,291
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,63.3,58.3 to 68.0,693
Polio,≥2 Doses,States/Local Areas,Michigan,2015,Age,5 Months,76.3,68.1 to 82.9,236
Polio,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,5 Months,76.9,71.7 to 81.4,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2015,Age,7 Months,59.6,51.3 to 67.5,236
Hep B,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,61.8,56.3 to 67.0,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2014,Age,7 Months,53.3,45.7 to 60.9,250
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,56.5,50.8 to 62.0,486
Polio,≥2 Doses,States/Local Areas,Michigan,2017,Age,5 Months,74.8,67.9 to 80.7,402
Polio,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,5 Months,77.1,72.6 to 81.1,817
Polio,≥2 Doses,States/Local Areas,Michigan,2016,Age,5 Months,77.5,70.9 to 83.0,291
Polio,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,5 Months,76.2,71.4 to 80.4,693
≥1 Dose Varicella,,States/Local Areas,Michigan,2011,Age,13 Months,51.7,43.0 to 60.4,255
Hep A,≥1 Dose,States/Local Areas,Michigan,2014,Age,35 Months,92.1,86.2 to 96.2,250
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,35 Months,91.7,86.3 to 95.5,486
Hep A,≥1 Dose,States/Local Areas,Michigan,2013,Age,35 Months,85.9,79.5 to 91.2,240
Hep A,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,35 Months,89.4,84.3 to 93.5,490
Hep A,≥2 Doses,States/Local Areas,Michigan,2013,Age,24 Months,50.5,42.2 to 59.4,240
Hep A,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,47.9,42.1 to 54.1,490
DTaP,≥4 Doses,States/Local Areas,Michigan,2018,Age,19 Months,76.7,70.5 to 82.0,415
DTaP,≥4 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,97.0,95.2 to 98.1,790
DTaP,≥4 Doses,States/Local Areas,Michigan,2017,Age,19 Months,68.8,61.6 to 75.2,402
DTaP,≥4 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,72.8,68.0 to 77.0,817
DTaP,≥4 Doses,States/Local Areas,Michigan,2016,Age,19 Months,71.8,64.7 to 77.9,291
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,70.3,65.2 to 74.9,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,94.5,88.3 to 100.0,90
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.0,96.2 to 99.9,122
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.8,93.8 to 97.8,481
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,92.5,87.8 to 97.2,158
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.0,93.1 to 97.0,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,89.0 to 96.5,358
PCV,≥2 Doses,States/Local Areas,Michigan,2019,Age,5 Months,83.2,76.9 to 88.0,375
PCV,≥2 Doses,States/Local Areas,Michigan,2018,Age,5 Months,79.1,72.8 to 84.2,415
PCV,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,5 Months,81.1,76.8 to 84.8,790
Hep B,≥3 Doses,States/Local Areas,Michigan,2012,Age,19 Months,84.6,80.4 to 87.9,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2011,Age,19 Months,85.7,82.0 to 88.7,255
Hep B,≥3 Doses,States/Local Areas,Michigan,2019,Age,13 Months,91.7,87.3 to 94.6,375
Hep B,≥3 Doses,States/Local Areas,Michigan,2018,Age,13 Months,91.6,86.8 to 94.7,415
Hep B,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,91.6,88.6 to 93.9,790
Polio,≥2 Doses,States/Local Areas,Michigan,2017,Age,13 Months,93.2,88.8 to 96.0,402
Polio,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,95.5,93.0 to 97.1,817
Polio,≥2 Doses,States/Local Areas,Michigan,2016,Age,13 Months,93.8,89.6 to 96.4,291
Polio,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,93.5,90.6 to 95.5,693
Polio,≥2 Doses,States/Local Areas,Michigan,2015,Age,13 Months,93.0,87.1 to 96.4,236
Polio,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,93.4,90.1 to 95.7,527
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,85.2,76.0 to 94.3,90
≥1 Dose Varicella,,States/Local Areas,Michigan,2018,Age,19 Months,91.6,86.8 to 94.8,415
≥1 Dose Varicella,,States/Local Areas,Michigan,2018-2019,Age,19 Months,62.8,57.7 to 67.5,790
≥1 Dose Varicella,,States/Local Areas,Michigan,2017,Age,19 Months,87.4,81.6 to 91.6,402
≥1 Dose Varicella,,States/Local Areas,Michigan,2017-2018,Age,19 Months,89.5,85.9 to 92.3,817
≥1 Dose MMR,,States/Local Areas,Michigan,2012,Age,19 Months,77.5,71.8 to 82.3,212
≥1 Dose MMR,,States/Local Areas,Michigan,2014,Age,19 Months,85.5,78.8 to 90.3,250
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2015,Age,19 Months,84.1,79.3 to 88.1,486
≥1 Dose MMR,,States/Local Areas,Michigan,2013,Age,19 Months,82.6,76.5 to 87.4,240
≥1 Dose MMR,,States/Local Areas,Michigan,2013-2014,Age,19 Months,84.1,81.8 to 86.1,490
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,81.9 to 90.0,481
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,76.8,70.7 to 82.9,358
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,81.6,78.3 to 84.9,997
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,82.2,75.1 to 89.3,158
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,79.7 to 94.4,122
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.3,80.7 to 87.9,693
≥1 Dose Varicella,,States/Local Areas,Michigan,2012,Age,24 Months,79.8,70.8 to 87.5,212
≥1 Dose Varicella,,States/Local Areas,Michigan,2011,Age,24 Months,86.9,81.5 to 91.4,255
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,71.0,64.1 to 78.0,267
≥1 Dose MMR,,States/Local Areas,Michigan,2017,Age,19 Months,87.3,81.3 to 91.6,402
≥1 Dose MMR,,States/Local Areas,Michigan,2017-2018,Age,19 Months,88.6,84.8 to 91.6,817
≥1 Dose MMR,,States/Local Areas,Michigan,2016,Age,19 Months,88.1,82.9 to 91.8,291
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2017,Age,19 Months,87.7,83.6 to 90.8,693
≥1 Dose MMR,,States/Local Areas,Michigan,2015,Age,19 Months,82.8,78.6 to 86.3,236
≥1 Dose MMR,,States/Local Areas,Michigan,2015-2016,Age,19 Months,85.4,81.1 to 88.9,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2015,Age,19 Months,90.6,87.3 to 93.2,236
Hep B,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,91.4,87.6 to 94.1,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2014,Age,19 Months,91.2,86.0 to 94.6,250
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,90.9,87.1 to 93.7,486
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,83.4,76.8 to 90.0,316
Hep B,≥3 Doses,States/Local Areas,Michigan,2013,Age,19 Months,89.1,80.0 to 94.4,240
Hep B,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,90.2,87.0 to 92.7,490
Hep B,≥2 Doses,States/Local Areas,Michigan,2013,Age,5 Months,86.3,80.8 to 90.4,240
Hep B,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,5 Months,86.7,85.3 to 87.9,490
Hep B,≥2 Doses,States/Local Areas,Michigan,2011,Age,5 Months,83.0,80.0 to 85.7,255
Hep B,≥2 Doses,States/Local Areas,Michigan,2012,Age,5 Months,85.2,79.7 to 89.5,212
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2011,Age,0-1 Days,66.7,57.7 to 74.5,255
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,83.6,77.8 to 89.3,414
Hep B,≥1 Dose,States/Local Areas,Michigan,2019,Age,3 Months,97.3,94.9 to 98.6,375
Hep B,≥1 Dose,States/Local Areas,Michigan,2018,Age,3 Months,96.9,93.5 to 98.5,415
Hep B,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,3 Months,97.1,95.2 to 98.3,790
Polio,≥2 Doses,States/Local Areas,Michigan,2018,Age,7 Months,92.3,87.7 to 95.3,415
Polio,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,92.3,89.3 to 94.5,790
Polio,≥2 Doses,States/Local Areas,Michigan,2017,Age,7 Months,87.3,81.6 to 91.5,402
Polio,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,89.8,86.3 to 92.5,817
Hep B,≥1 Dose,States/Local Areas,Michigan,2014,Age,3 Months,92.8,88.3 to 95.7,250
Hep B,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,3 Months,94.2,91.4 to 96.2,486
Hep B,≥1 Dose,States/Local Areas,Michigan,2011,Age,3 Months,94.0,91.7 to 95.7,255
Hep B,≥1 Dose,States/Local Areas,Michigan,2012,Age,3 Months,88.0,83.6 to 91.4,212
Hep B,≥1 Dose,States/Local Areas,Michigan,2013,Age,3 Months,93.9,91.3 to 95.7,240
Hep B,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,3 Months,93.3,91.1 to 95.1,490
≥1 Dose MMR,,States/Local Areas,Michigan,2017,Age,13 Months,57.0,49.9 to 63.8,402
≥1 Dose MMR,,States/Local Areas,Michigan,2017-2018,Age,13 Months,63.6,58.6 to 68.3,817
≥1 Dose MMR,,States/Local Areas,Michigan,2019,Age,13 Months,67.8,60.4 to 74.3,375
≥1 Dose MMR,,States/Local Areas,Michigan,2018,Age,13 Months,70.2,63.5 to 76.2,415
≥1 Dose MMR,,States/Local Areas,Michigan,2018-2019,Age,13 Months,69.0,64.1 to 73.5,790
Polio,≥2 Doses,States/Local Areas,Michigan,2011,Age,13 Months,89.0,85.1 to 92.0,255
Polio,≥2 Doses,States/Local Areas,Michigan,2012,Age,13 Months,88.6,82.5 to 92.8,212
≥1 Dose Varicella,,States/Local Areas,Michigan,2016,Age,19 Months,86.9,81.2 to 91.0,291
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2017,Age,19 Months,87.2,83.0 to 90.4,693
≥1 Dose Varicella,,States/Local Areas,Michigan,2015,Age,19 Months,84.3,81.1 to 87.0,236
≥1 Dose Varicella,,States/Local Areas,Michigan,2015-2016,Age,19 Months,85.6,81.0 to 89.2,527
≥1 Dose Varicella,,States/Local Areas,Michigan,2014,Age,19 Months,85.7,78.6 to 90.7,250
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2015,Age,19 Months,85.0,79.9 to 89.0,486
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.7,74.7 to 86.6,481
Hep B,≥3 Doses,States/Local Areas,Michigan,2017,Age,13 Months,87.3,81.6 to 91.4,402
Hep B,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,89.4,85.9 to 92.1,817
Hep B,≥3 Doses,States/Local Areas,Michigan,2015,Age,13 Months,83.5,75.9 to 89.0,236
Hep B,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,86.7,82.2 to 90.2,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2016,Age,13 Months,90.0,84.5 to 93.6,291
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,88.6,84.6 to 91.7,693
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,84.3,79.8 to 88.8,609
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,73.0,65.3 to 80.8,359
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.4,62.3 to 90.5,92
DTaP,≥4 Doses,States/Local Areas,Michigan,2016,Age,35 Months,89.5,82.2 to 94.8,291
DTaP,≥4 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,89.0,84.2 to 92.9,693
DTaP,≥4 Doses,States/Local Areas,Michigan,2017,Age,35 Months,88.1,81.5 to 93.2,402
DTaP,≥4 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,91.0,86.6 to 94.5,817
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,86.7,73.1 to 100.0,90
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,91.3,87.0 to 95.5,316
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,73.0,61.2 to 84.7,158
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,70.2,61.0 to 79.4,267
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,78.5,74.1 to 82.9,997
Polio,≥2 Doses,States/Local Areas,Michigan,2019,Age,7 Months,92.3,87.8 to 95.2,375
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.1,74.4 to 83.9,693
DTaP,≥4 Doses,States/Local Areas,Michigan,2011,Age,35 Months,89.4,81.1 to 95.2,255
DTaP,≥4 Doses,States/Local Areas,Michigan,2019,Age,24 Months,82.3,75.9 to 87.9,375
DTaP,≥4 Doses,States/Local Areas,Michigan,2017,Age,24 Months,78.9,72.4 to 84.8,402
DTaP,≥4 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,82.5,78.3 to 86.3,817
DTaP,≥4 Doses,States/Local Areas,Michigan,2018,Age,24 Months,86.1,80.8 to 90.5,415
DTaP,≥4 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,84.2,80.1 to 87.8,790
Hep B,≥3 Doses,States/Local Areas,Michigan,2011,Age,13 Months,81.1,75.7 to 85.5,255
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,88.1,84.5 to 91.7,414
Polio,≥2 Doses,States/Local Areas,Michigan,2016,Age,7 Months,91.0,86.0 to 94.4,291
Polio,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,89.2,85.2 to 92.2,693
Polio,≥2 Doses,States/Local Areas,Michigan,2015,Age,7 Months,87.4,80.2 to 92.2,236
Polio,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,89.2,85.0 to 92.3,527
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Overall,Overall,87.3,84.6 to 89.9,997
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,83.9,78.5 to 89.3,267
Polio,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,84.5,82.9 to 85.9,490
Polio,≥2 Doses,States/Local Areas,Michigan,2014,Age,7 Months,86.9,80.9 to 91.3,250
Polio,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,87.1,82.7 to 90.6,486
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.1,84.4 to 91.8,481
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,85.3,78.7 to 92.0,158
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.9,84.9 to 90.9,693
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,87.2,82.6 to 91.7,358
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,83.8 to 96.4,122
Hep B,≥1 Dose,States/Local Areas,Michigan,2017,Age,3 Months,94.8,91.0 to 97.1,402
Hep B,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,3 Months,95.8,93.5 to 97.4,817
Hep B,≥1 Dose,States/Local Areas,Michigan,2016,Age,3 Months,95.7,92.7 to 97.5,291
Hep B,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,3 Months,95.2,93.0 to 96.8,693
Hep B,≥1 Dose,States/Local Areas,Michigan,2015,Age,3 Months,95.7,91.5 to 97.8,236
Hep B,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,3 Months,95.7,93.3 to 97.2,527
Polio,≥2 Doses,States/Local Areas,Michigan,2014,Age,13 Months,92.1,86.8 to 95.4,250
Polio,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,92.6,88.9 to 95.1,486
Polio,≥2 Doses,States/Local Areas,Michigan,2013,Age,13 Months,90.0,82.7 to 94.5,240
Polio,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,91.0,88.5 to 93.1,490
≥1 Dose MMR,,States/Local Areas,Michigan,2011,Age,13 Months,46.1,36.4 to 56.0,255
≥1 Dose MMR,,States/Local Areas,Michigan,2012,Age,13 Months,52.8,41.2 to 64.2,212
≥1 Dose MMR,,States/Local Areas,Michigan,2013,Age,13 Months,49.7,42.8 to 56.7,240
≥1 Dose MMR,,States/Local Areas,Michigan,2013-2014,Age,13 Months,56.3,48.0 to 64.2,490
≥1 Dose Varicella,,States/Local Areas,Michigan,2015,Age,13 Months,62.5,54.1 to 70.2,236
≥1 Dose Varicella,,States/Local Areas,Michigan,2015-2016,Age,13 Months,60.0,54.4 to 65.4,527
≥1 Dose Varicella,,States/Local Areas,Michigan,2017,Age,13 Months,59.6,52.5 to 66.3,402
≥1 Dose Varicella,,States/Local Areas,Michigan,2017-2018,Age,13 Months,62.0,57.1 to 66.6,817
≥1 Dose Varicella,,States/Local Areas,Michigan,2016,Age,13 Months,57.6,50.3 to 64.6,291
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2017,Age,13 Months,58.6,53.4 to 63.6,693
≥1 Dose MMR,,States/Local Areas,Michigan,2015,Age,13 Months,63.1,54.8 to 70.6,236
≥1 Dose MMR,,States/Local Areas,Michigan,2015-2016,Age,13 Months,62.3,56.8 to 67.5,527
≥1 Dose MMR,,States/Local Areas,Michigan,2014,Age,13 Months,62.8,55.1 to 69.8,250
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2015,Age,13 Months,62.9,57.3 to 68.2,486
≥1 Dose Varicella,,States/Local Areas,Michigan,2018,Age,13 Months,64.4,57.6 to 70.7,415
≥1 Dose Varicella,,States/Local Areas,Michigan,2018-2019,Age,13 Months,62.8,57.7 to 67.5,790
≥1 Dose MMR,,States/Local Areas,Michigan,2016,Age,13 Months,61.6,54.4 to 68.3,291
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2017,Age,13 Months,59.3,54.1 to 64.3,693
≥1 Dose Varicella,,States/Local Areas,Michigan,2012,Age,19 Months,77.1,73.0 to 80.7,212
≥1 Dose Varicella,,States/Local Areas,Michigan,2013,Age,19 Months,81.2,77.9 to 84.0,240
≥1 Dose Varicella,,States/Local Areas,Michigan,2013-2014,Age,19 Months,83.4,81.6 to 85.1,490
≥1 Dose Varicella,,States/Local Areas,Michigan,2011,Age,19 Months,83.7,80.1 to 86.8,255
≥1 Dose Varicella,,States/Local Areas,Michigan,2019,Age,13 Months,61.0,53.5 to 68.1,375
Hep A,≥2 Doses,States/Local Areas,Michigan,2017,Age,35 Months,83.5,76.3 to 89.4,402
Hep A,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,85.9,80.4 to 90.4,817
Hep A,≥2 Doses,States/Local Areas,Michigan,2018,Age,35 Months,89.5,80.5 to 95.5,415
Hep A,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,89.1,83.4 to 93.5,790
Hep B,≥3 Doses,States/Local Areas,Michigan,2014,Age,13 Months,86.7,80.9 to 91.0,250
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,85.1,80.5 to 88.8,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2013,Age,13 Months,85.0,77.9 to 90.2,240
Hep B,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,85.9,83.3 to 88.1,490
DTaP,≥4 Doses,States/Local Areas,Michigan,2013,Age,35 Months,88.1,80.2 to 93.9,240
DTaP,≥4 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,87.1,81.7 to 91.6,490
Hep B,≥3 Doses,States/Local Areas,Michigan,2012,Age,13 Months,81.2,76.3 to 85.2,212
Hep A,≥2 Doses,States/Local Areas,Michigan,2019,Age,35 Months,87.9,80.6 to 93.4,375
DTaP,≥4 Doses,States/Local Areas,Michigan,2014,Age,35 Months,85.8,78.9 to 91.4,250
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,84.8,79.7 to 89.1,486
DTaP,≥4 Doses,States/Local Areas,Michigan,2015,Age,35 Months,83.6,76.0 to 89.9,236
DTaP,≥4 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,87.2,81.6 to 91.8,527
DTaP,≥4 Doses,States/Local Areas,Michigan,2012,Age,35 Months,78.6,68.6 to 87.1,212
≥1 Dose Varicella,,States/Local Areas,Michigan,2013,Age,13 Months,55.8,46.2 to 64.9,240
≥1 Dose Varicella,,States/Local Areas,Michigan,2013-2014,Age,13 Months,58.3,51.1 to 65.2,490
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.8,72.7 to 91.0,92
Polio,≥2 Doses,States/Local Areas,Michigan,2018,Age,5 Months,79.4,73.3 to 84.5,415
Polio,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,5 Months,82.7,78.6 to 86.2,790
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,89.8,86.7 to 92.9,609
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,86.0,81.6 to 90.3,359
Hep A,≥1 Dose,States/Local Areas,Michigan,2019,Age,35 Months,95.7,91.1 to 98.3,375
≥1 Dose Varicella,,States/Local Areas,Michigan,2012,Age,13 Months,54.0,44.7 to 63.1,212
≥1 Dose Varicella,,States/Local Areas,Michigan,2014,Age,13 Months,60.9,53.2 to 68.1,250
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2015,Age,13 Months,61.7,56.0 to 67.0,486
Hep A,≥2 Doses,States/Local Areas,Michigan,2014,Age,35 Months,71.4,62.5 to 79.8,250
Hep A,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,74.3,67.6 to 80.5,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2019,Age,7 Months,67.1,59.9 to 73.6,375
Polio,≥2 Doses,States/Local Areas,Michigan,2013,Age,7 Months,82.0,75.5 to 87.0,240
Hep A,≥2 Doses,States/Local Areas,Michigan,2015,Age,35 Months,77.0,67.1 to 85.7,236
Hep A,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,78.4,71.6 to 84.4,527
Hep A,≥2 Doses,States/Local Areas,Michigan,2016,Age,35 Months,78.5,69.7 to 86.2,291
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,81.1,75.5 to 86.0,693
Hep B,≥3 Doses,States/Local Areas,Michigan,2018,Age,7 Months,60.0,53.1 to 66.6,415
Hep B,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,63.5,58.5 to 68.2,790
Hep B,≥3 Doses,States/Local Areas,Michigan,2017,Age,7 Months,62.6,55.6 to 69.0,402
Hep B,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,61.3,56.4 to 66.0,817
Polio,≥2 Doses,States/Local Areas,Michigan,2011,Age,7 Months,85.7,80.6 to 89.6,255
Polio,≥2 Doses,States/Local Areas,Michigan,2012,Age,7 Months,79.9,68.7 to 87.8,212
Hep A,≥1 Dose,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,92.8,86.0 to 99.6,90
Polio,≥2 Doses,States/Local Areas,Michigan,2019,Age,5 Months,86.0,80.3 to 90.3,375
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,83.6 to 94.9,122
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.9,82.6 to 89.2,693
PCV,≥1 Dose,States/Local Areas,Michigan,2015,Age,3 Months,81.6,73.9 to 87.4,236
PCV,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,3 Months,83.6,78.9 to 87.5,527
PCV,≥1 Dose,States/Local Areas,Michigan,2014,Age,3 Months,81.7,75.0 to 86.9,250
PCV,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,3 Months,81.6,76.6 to 85.8,486
PCV,≥3 Doses,States/Local Areas,Michigan,2018,Age,24 Months,97.6,95.3 to 99.0,415
PCV,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,96.6,94.9 to 97.9,790
PCV,≥3 Doses,States/Local Areas,Michigan,2017,Age,24 Months,89.5,84.4 to 93.4,402
PCV,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,93.4,90.5 to 95.6,817
Hib,≥2 Doses,States/Local Areas,Michigan,2012,Age,7 Months,78.5,69.3 to 85.6,212
PCV,≥3 Doses,States/Local Areas,Michigan,2016,Age,24 Months,93.9,90.1 to 96.6,291
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,91.7,88.6 to 94.2,693
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2011,Age,0-3 Days,74.0,65.9 to 80.8,255
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,89.9,85.8 to 94.0,359
PCV,≥1 Dose,States/Local Areas,Michigan,2018,Age,3 Months,88.6,83.2 to 92.5,415
PCV,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,3 Months,89.1,85.5 to 91.9,790
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2012,Age,0-3 Days,82.0,74.0 to 88.0,212
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,76.2,70.2 to 82.3,358
PCV,≥1 Dose,States/Local Areas,Michigan,2017,Age,3 Months,85.4,79.9 to 89.6,402
PCV,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,3 Months,87.0,83.4 to 90.0,817
PCV,≥1 Dose,States/Local Areas,Michigan,2016,Age,3 Months,85.7,80.0 to 90.0,291
PCV,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,3 Months,85.6,81.7 to 88.7,693
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,93.6,91.0 to 96.2,609
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.3,76.0 to 94.6,92
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.4,83.7 to 91.1,481
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,82.3,79.1 to 85.5,997
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,84.3,78.0 to 90.6,158
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,71.4,64.6 to 78.1,267
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,85.9,82.3 to 89.6,414
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,93.2,89.2 to 97.2,316
Hib,≥2 Doses,States/Local Areas,Michigan,2014,Age,7 Months,87.7,81.7 to 91.9,250
Hib,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,85.8,81.1 to 89.6,486
Hib,≥2 Doses,States/Local Areas,Michigan,2013,Age,7 Months,83.8,77.5 to 88.6,240
Hib,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,85.7,83.7 to 87.5,490
PCV,≥1 Dose,States/Local Areas,Michigan,2012,Age,3 Months,73.7,68.1 to 78.5,212
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Overall,Overall,90.2,87.7 to 92.8,997
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,86.8,81.4 to 92.1,267
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,90.6,85.3 to 95.9,158
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,90.6,87.5 to 93.8,414
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,94.8,91.3 to 98.4,316
PCV,≥1 Dose,States/Local Areas,Michigan,2011,Age,3 Months,83.9,79.7 to 87.4,255
PCV,≥4 Doses,States/Local Areas,Michigan,2017,Age,35 Months,79.4,73.1 to 85.1,402
PCV,≥4 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,84.6,80.4 to 88.2,817
PCV,≥4 Doses,States/Local Areas,Michigan,2019,Age,35 Months,88.4,82.9 to 92.8,375
PCV,≥4 Doses,States/Local Areas,Michigan,2018,Age,35 Months,90.9,85.3 to 95.0,415
PCV,≥4 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,89.5,85.8 to 92.7,790
Hib,≥2 Doses,States/Local Areas,Michigan,2011,Age,5 Months,76.3,71.5 to 80.5,255
Hib,≥2 Doses,States/Local Areas,Michigan,2012,Age,5 Months,69.2,58.7 to 78.0,212
Hib,≥2 Doses,States/Local Areas,Michigan,2014,Age,5 Months,71.5,64.1 to 78.0,250
Hib,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,5 Months,71.7,68.2 to 75.0,486
Hib,≥2 Doses,States/Local Areas,Michigan,2013,Age,5 Months,67.7,65.2 to 70.2,240
Hib,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,5 Months,69.6,67.1 to 72.1,490
PCV,≥3 Doses,States/Local Areas,Michigan,2011,Age,24 Months,89.7,84.3 to 93.9,255
PCV,≥3 Doses,States/Local Areas,Michigan,2019,Age,19 Months,93.0,88.5 to 95.8,375
PCV,≥3 Doses,States/Local Areas,Michigan,2018,Age,19 Months,95.9,92.2 to 97.8,415
PCV,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,92.9,90.0 to 95.0,790
Hib,≥2 Doses,States/Local Areas,Michigan,2016,Age,5 Months,80.2,73.9 to 85.3,291
Hib,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,5 Months,77.2,72.5 to 81.4,693
Hib,≥2 Doses,States/Local Areas,Michigan,2015,Age,5 Months,71.9,63.4 to 79.1,236
Hib,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,5 Months,76.1,70.7 to 80.7,527
PCV,≥3 Doses,States/Local Areas,Michigan,2015,Age,24 Months,91.2,85.2 to 95.5,236
PCV,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,92.6,89.1 to 95.2,527
PCV,≥3 Doses,States/Local Areas,Michigan,2014,Age,24 Months,93.2,88.7 to 96.4,250
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,92.2,88.5 to 95.0,486
PCV,≥3 Doses,States/Local Areas,Michigan,2013,Age,24 Months,87.7,80.9 to 92.9,240
PCV,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,90.5,86.0 to 94.0,490
Hib,≥2 Doses,States/Local Areas,Michigan,2017,Age,5 Months,74.2,67.3 to 80.1,402
Hib,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,5 Months,77.3,72.9 to 81.3,817
PCV,≥3 Doses,States/Local Areas,Michigan,2012,Age,24 Months,84.4,76.3 to 90.9,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2019,Age,35 Months,99.2,97.5 to 99.8,375
PCV,≥3 Doses,States/Local Areas,Michigan,2017,Age,19 Months,88.6,83.0 to 92.5,402
PCV,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,92.2,89.0 to 94.5,817
PCV,≥4 Doses,States/Local Areas,Michigan,2014,Age,35 Months,83.2,76.8 to 88.6,250
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,81.7,76.8 to 86.1,486
PCV,≥4 Doses,States/Local Areas,Michigan,2015,Age,35 Months,80.1,72.4 to 86.8,236
PCV,≥4 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,81.6,76.7 to 86.0,527
PCV,≥4 Doses,States/Local Areas,Michigan,2016,Age,35 Months,83.0,76.8 to 88.4,291
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,81.2,76.7 to 85.3,693
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,87.8,83.3 to 92.2,359
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.2,70.0 to 90.5,92
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,96.4,91.9 to 100.0,90
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.2,91.9 to 98.5,122
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,89.6,86.5 to 92.7,609
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,76.3,70.8 to 81.8,359
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,81.3,70.4 to 92.1,90
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.7,54.5 to 76.9,92
PCV,≥1 Dose,States/Local Areas,Michigan,2013,Age,3 Months,79.1,74.3 to 83.3,240
PCV,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,3 Months,80.4,77.7 to 82.9,490
Hib,≥2 Doses,States/Local Areas,Michigan,2011,Age,7 Months,86.2,81.7 to 89.8,255
Hib,≥2 Doses,States/Local Areas,Michigan,2019,Age,5 Months,84.1,78.0 to 88.7,375
Hib,≥2 Doses,States/Local Areas,Michigan,2018,Age,5 Months,80.5,74.6 to 85.3,415
Hib,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,5 Months,82.3,78.1 to 85.8,790
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.4,88.8 to 93.9,693
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,84.1 to 93.7,358
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.5,88.4 to 94.6,481
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,96.1,92.9 to 99.3,316
Hib,Full Series,States/Local Areas,Michigan,2020,Age,24 Months,79.4,73.3 to 84.8,448
≥1 Dose MMR,,States/Local Areas,Michigan,2017,Age,35 Months,95.9,92.4 to 98.2,402
≥1 Dose MMR,,States/Local Areas,Michigan,2017-2018,Age,35 Months,95.7,93.0 to 97.7,817
≥1 Dose MMR,,States/Local Areas,Michigan,2018,Age,35 Months,95.3,90.5 to 98.1,415
≥1 Dose MMR,,States/Local Areas,Michigan,2018-2019,Age,35 Months,96.6,93.6 to 98.4,790
PCV,≥4 Doses,States/Local Areas,Michigan,2013,Age,35 Months,81.0,73.2 to 87.7,240
PCV,≥4 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,82.1,76.8 to 86.7,490
≥1 Dose MMR,,States/Local Areas,Michigan,2019,Age,35 Months,97.8,93.6 to 99.5,375
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.2,92.0 to 98.5,122
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,93.7,91.2 to 96.1,609
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.3,89.8 to 94.7,693
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,84.5 to 94.0,358
PCV,≥3 Doses,States/Local Areas,Michigan,2016,Age,19 Months,91.5,86.5 to 94.8,291
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,90.1,86.2 to 92.9,693
PCV,≥3 Doses,States/Local Areas,Michigan,2015,Age,19 Months,90.1,85.5 to 93.3,236
PCV,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,90.8,86.8 to 93.7,527
Hep B,≥2 Doses,States/Local Areas,Michigan,2019,Age,13 Months,96.0,93.4 to 97.6,375
Hep B,≥2 Doses,States/Local Areas,Michigan,2018,Age,13 Months,96.4,92.8 to 98.2,415
Hep B,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,96.2,94.2 to 97.5,790
Hep B,≥2 Doses,States/Local Areas,Michigan,2017,Age,13 Months,95.0,91.2 to 97.2,402
Hep B,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,95.7,93.3 to 97.3,817
Hib,≥1 Dose,States/Local Areas,Michigan,2017,Age,3 Months,85.5,80.0 to 89.8,402
Hib,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,3 Months,87.1,83.5 to 90.0,817
Hib,≥1 Dose,States/Local Areas,Michigan,2016,Age,3 Months,85.0,78.9 to 89.5,291
Hib,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,3 Months,85.2,81.3 to 88.5,693
Hib,≥1 Dose,States/Local Areas,Michigan,2015,Age,3 Months,82.4,75.0 to 88.0,236
Hib,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,3 Months,83.7,79.0 to 87.5,527
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.2,72.1 to 92.4,92
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,94.1,91.7 to 96.5,609
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,88.5,84.1 to 92.8,359
≥1 Dose Varicella,,States/Local Areas,Michigan,2019,Age,35 Months,99.0,96.4 to 99.8,375
≥1 Dose MMR,,States/Local Areas,Michigan,2016,Age,35 Months,92.4,87.8 to 95.7,291
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2017,Age,35 Months,94.2,91.1 to 96.5,693
PCV,≥4 Doses,States/Local Areas,Michigan,2016,Age,24 Months,81.9,75.6 to 87.3,291
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,80.6,76.0 to 84.7,693
PCV,≥4 Doses,States/Local Areas,Michigan,2017,Age,24 Months,79.2,72.9 to 84.9,402
PCV,≥4 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,83.8,79.7 to 87.5,817
≥1 Dose MMR,,States/Local Areas,Michigan,2015,Age,35 Months,95.0,85.9 to 99.0,236
≥1 Dose MMR,,States/Local Areas,Michigan,2015-2016,Age,35 Months,92.8,88.4 to 95.9,527
≥1 Dose MMR,,States/Local Areas,Michigan,2014,Age,35 Months,95.2,90.4 to 98.1,250
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2015,Age,35 Months,94.6,90.4 to 97.3,486
PCV,≥3 Doses,States/Local Areas,Michigan,2016,Age,13 Months,87.7,82.0 to 91.8,291
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,85.1,80.7 to 88.7,693
Hep B,≥3 Doses,States/Local Areas,Michigan,2013,Age,35 Months,91.9,86.6 to 95.6,240
Hep B,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,93.0,89.0 to 96.0,490
Hep B,≥3 Doses,States/Local Areas,Michigan,2014,Age,35 Months,94.3,89.8 to 97.2,250
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,92.7,89.0 to 95.5,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2015,Age,35 Months,90.6,84.8 to 94.9,236
Hep B,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,92.4,88.9 to 95.2,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2012,Age,35 Months,89.9,82.3 to 95.2,212
PCV,≥3 Doses,States/Local Areas,Michigan,2018,Age,13 Months,94.6,90.5 to 96.9,415
PCV,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,92.9,90.0 to 95.0,790
PCV,≥3 Doses,States/Local Areas,Michigan,2017,Age,13 Months,82.5,76.1 to 87.6,402
PCV,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,88.5,84.7 to 91.5,817
Hep B,≥2 Doses,States/Local Areas,Michigan,2012,Age,13 Months,90.1,86.1 to 93.0,212
Hep B,≥2 Doses,States/Local Areas,Michigan,2013,Age,13 Months,91.1,86.3 to 94.4,240
Hep B,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,92.4,90.9 to 93.6,490
Hep B,≥2 Doses,States/Local Areas,Michigan,2011,Age,13 Months,89.3,85.7 to 92.1,255
Hep B,≥2 Doses,States/Local Areas,Michigan,2019,Age,7 Months,94.8,91.2 to 97.0,375
Hib,≥1 Dose,States/Local Areas,Michigan,2019,Age,3 Months,89.9,84.7 to 93.4,375
Hib,≥1 Dose,States/Local Areas,Michigan,2018,Age,3 Months,88.7,83.4 to 92.4,415
Hib,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,3 Months,89.3,85.8 to 92.0,790
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,90.3,87.0 to 93.5,414
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.9,90.0 to 95.8,481
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,88.7,83.0 to 94.4,158
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Overall,Overall,90.7,88.2 to 93.3,997
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,87.5,82.2 to 92.7,267
Hep B,≥2 Doses,States/Local Areas,Michigan,2016,Age,13 Months,95.1,91.6 to 97.2,291
Hep B,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,95.1,92.7 to 96.7,693
Hep B,≥2 Doses,States/Local Areas,Michigan,2015,Age,13 Months,93.8,88.4 to 96.8,236
Hep B,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,94.4,91.5 to 96.4,527
Hep B,≥2 Doses,States/Local Areas,Michigan,2014,Age,13 Months,93.6,88.6 to 96.5,250
Hep B,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,93.7,90.3 to 95.9,486
Hib,≥1 Dose,States/Local Areas,Michigan,2014,Age,3 Months,82.5,75.8 to 87.6,250
Hib,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,3 Months,82.4,77.5 to 86.4,486
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,92.8,85.6 to 100.0,90
Hib,≥1 Dose,States/Local Areas,Michigan,2011,Age,3 Months,85.3,82.4 to 87.7,255
Hib,≥1 Dose,States/Local Areas,Michigan,2012,Age,3 Months,76.3,70.6 to 81.2,212
Hib,≥1 Dose,States/Local Areas,Michigan,2013,Age,3 Months,80.7,73.5 to 86.2,240
Hib,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,3 Months,81.6,77.5 to 85.0,490
Hep B,≥3 Doses,States/Local Areas,Michigan,2017,Age,35 Months,95.0,91.4 to 97.4,402
Hep B,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,95.9,93.5 to 97.5,817
PCV,≥3 Doses,States/Local Areas,Michigan,2012,Age,19 Months,82.4,71.1 to 89.9,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2018,Age,35 Months,96.2,93.0 to 98.3,415
Hep B,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,98.5,96.7 to 99.4,790
PCV,≥4 Doses,States/Local Areas,Michigan,2012,Age,35 Months,72.7,63.5 to 81.3,212
PCV,≥4 Doses,States/Local Areas,Michigan,2011,Age,35 Months,82.2,73.8 to 89.2,255
PCV,≥4 Doses,States/Local Areas,Michigan,2018,Age,24 Months,88.8,83.5 to 93.0,415
PCV,≥4 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,87.3,83.6 to 90.5,790
PCV,≥4 Doses,States/Local Areas,Michigan,2019,Age,24 Months,85.9,80.5 to 90.5,375
Hep B,≥3 Doses,States/Local Areas,Michigan,2016,Age,35 Months,94.2,89.7 to 97.1,291
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,94.5,91.4 to 96.7,693
PCV,≥3 Doses,States/Local Areas,Michigan,2014,Age,19 Months,90.0,84.6 to 93.7,250
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,90.1,86.0 to 93.1,486
PCV,≥3 Doses,States/Local Areas,Michigan,2013,Age,19 Months,84.8,81.3 to 87.7,240
PCV,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,87.4,85.2 to 89.4,490
PCV,≥3 Doses,States/Local Areas,Michigan,2011,Age,19 Months,88.1,83.8 to 91.3,255
PCV,≥3 Doses,States/Local Areas,Michigan,2019,Age,13 Months,91.1,86.5 to 94.3,375
≥1 Dose Varicella,,States/Local Areas,Michigan,2017,Age,35 Months,95.5,92.0 to 97.8,402
≥1 Dose Varicella,,States/Local Areas,Michigan,2017-2018,Age,35 Months,96.0,93.6 to 97.7,817
≥1 Dose Varicella,,States/Local Areas,Michigan,2018,Age,35 Months,96.4,92.8 to 98.5,415
≥1 Dose Varicella,,States/Local Areas,Michigan,2018-2019,Age,35 Months,97.3,94.4 to 99.0,790
PCV,≥4 Doses,States/Local Areas,Michigan,2012,Age,24 Months,72.7,63.5 to 81.3,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2011,Age,35 Months,89.7,84.6 to 93.7,255
Hep B,≥3 Doses,States/Local Areas,Michigan,2017,Age,24 Months,92.4,88.0 to 95.6,402
Hep B,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,24 Months,94.2,91.5 to 96.2,817
Hep B,≥3 Doses,States/Local Areas,Michigan,2019,Age,24 Months,94.8,91.5 to 97.1,375
PCV,≥4 Doses,States/Local Areas,Michigan,2013,Age,24 Months,76.6,68.8 to 83.6,240
PCV,≥4 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,78.8,73.5 to 83.6,490
PCV,≥4 Doses,States/Local Areas,Michigan,2014,Age,24 Months,81.0,74.5 to 86.8,250
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,80.4,75.5 to 84.9,486
PCV,≥4 Doses,States/Local Areas,Michigan,2015,Age,24 Months,79.7,72.0 to 86.4,236
PCV,≥4 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,80.8,75.9 to 85.2,527
≥1 Dose MMR,,States/Local Areas,Michigan,2019,Age,24 Months,94.1,90.4 to 96.8,375
≥1 Dose MMR,,States/Local Areas,Michigan,2012,Age,35 Months,92.6,84.9 to 97.2,212
≥1 Dose MMR,,States/Local Areas,Michigan,2011,Age,35 Months,94.4,87.6 to 98.1,255
≥1 Dose MMR,,States/Local Areas,Michigan,2013,Age,35 Months,87.1,80.8 to 92.1,240
≥1 Dose MMR,,States/Local Areas,Michigan,2013-2014,Age,35 Months,90.9,86.4 to 94.4,490
≥1 Dose Varicella,,States/Local Areas,Michigan,2016,Age,35 Months,95.2,89.6 to 98.3,291
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2017,Age,35 Months,95.2,92.0 to 97.4,693
Hep B,≥2 Doses,States/Local Areas,Michigan,2018,Age,7 Months,93.5,89.2 to 96.2,415
Hep B,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,94.1,91.5 to 96.0,790
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2019,Age,0-2 Days,81.1,74.0 to 86.7,375
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2018,Age,0-2 Days,82.5,76.8 to 87.0,415
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2018-2019,Age,0-2 Days,81.8,77.4 to 85.5,790
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2017,Age,0-2 Days,78.8,72.7 to 83.9,402
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2017-2018,Age,0-2 Days,80.6,76.6 to 84.1,817
Hep B,≥3 Doses,States/Local Areas,Michigan,2018,Age,24 Months,95.9,92.6 to 98.0,415
Hep B,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,24 Months,95.5,93.3 to 97.1,790
PCV,≥3 Doses,States/Local Areas,Michigan,2015,Age,13 Months,84.5,76.8 to 90.0,236
PCV,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,86.1,81.5 to 89.7,527
PCV,≥3 Doses,States/Local Areas,Michigan,2014,Age,13 Months,83.9,77.1 to 89.0,250
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,84.2,79.3 to 88.1,486
Hep B,≥2 Doses,States/Local Areas,Michigan,2017,Age,7 Months,91.5,86.6 to 94.7,402
Hep B,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,92.5,89.4 to 94.7,817
PCV,≥3 Doses,States/Local Areas,Michigan,2013,Age,13 Months,83.5,79.7 to 86.7,240
PCV,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,83.7,81.7 to 85.5,490
Hep B,≥2 Doses,States/Local Areas,Michigan,2016,Age,7 Months,93.9,90.1 to 96.4,291
Hep B,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,92.7,89.8 to 94.9,693
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2016,Age,0-2 Days,78.3,71.7 to 83.7,291
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2016-2017,Age,0-2 Days,78.6,74.2 to 82.4,693
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2011,Age,0-2 Days,72.5,64.9 to 79.1,255
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2019,Age,0-1 Days,76.4,69.0 to 82.4,375
Hep B,≥2 Doses,States/Local Areas,Michigan,2013,Age,7 Months,90.7,84.6 to 94.5,240
Hep B,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,90.8,89.1 to 92.2,490
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2012,Age,0-2 Days,80.1,77.4 to 82.5,212
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2013,Age,0-2 Days,79.1,74.3 to 83.2,240
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2013-2014,Age,0-2 Days,78.0,76.2 to 79.8,490
PCV,≥3 Doses,States/Local Areas,Michigan,2011,Age,13 Months,83.0,76.6 to 87.9,255
PCV,≥3 Doses,States/Local Areas,Michigan,2019,Age,7 Months,70.6,63.4 to 77.0,375
PCV,≥3 Doses,States/Local Areas,Michigan,2018,Age,7 Months,70.6,63.9 to 76.6,415
PCV,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,70.6,65.8 to 75.1,790
Hep B,≥2 Doses,States/Local Areas,Michigan,2012,Age,7 Months,87.0,81.3 to 91.1,212
Hep B,≥2 Doses,States/Local Areas,Michigan,2015,Age,7 Months,89.6,83.2 to 93.8,236
Hep B,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,91.8,88.2 to 94.4,527
Hep B,≥2 Doses,States/Local Areas,Michigan,2014,Age,7 Months,90.9,85.7 to 94.3,250
Hep B,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,90.3,86.4 to 93.1,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2014,Age,24 Months,93.1,88.5 to 96.3,250
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,24 Months,91.8,88.3 to 94.6,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2015,Age,24 Months,90.6,84.8 to 94.9,236
Hep B,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,24 Months,91.4,87.8 to 94.3,527
Hep B,≥3 Doses,States/Local Areas,Michigan,2016,Age,24 Months,92.2,87.6 to 95.6,291
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,24 Months,92.2,88.8 to 94.9,693
PCV,≥3 Doses,States/Local Areas,Michigan,2012,Age,13 Months,78.7,69.9 to 85.4,212
≥1 Dose MMR,,States/Local Areas,Michigan,2016,Age,24 Months,90.9,86.4 to 94.4,291
≥1 Dose MMR,,States/Local Areas,Michigan,2016-2017,Age,24 Months,92.0,88.7 to 94.6,693
≥1 Dose MMR,,States/Local Areas,Michigan,2017,Age,24 Months,93.1,88.6 to 96.2,402
≥1 Dose MMR,,States/Local Areas,Michigan,2017-2018,Age,24 Months,93.3,90.2 to 95.7,817
PCV,≥4 Doses,States/Local Areas,Michigan,2018,Age,19 Months,83.1,76.9 to 87.9,415
PCV,≥4 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,84.4,80.0 to 88.0,624
PCV,≥4 Doses,States/Local Areas,Michigan,2017,Age,19 Months,76.9,70.1 to 82.5,402
PCV,≥4 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,80.0,75.5 to 83.8,817
≥1 Dose Varicella,,States/Local Areas,Michigan,2012,Age,35 Months,89.9,81.8 to 95.4,212
≥1 Dose Varicella,,States/Local Areas,Michigan,2011,Age,35 Months,91.8,85.6 to 96.1,255
≥1 Dose Varicella,,States/Local Areas,Michigan,2019,Age,24 Months,93.5,89.2 to 96.5,375
≥1 Dose MMR,,States/Local Areas,Michigan,2013,Age,24 Months,87.0,80.6 to 92.0,240
≥1 Dose MMR,,States/Local Areas,Michigan,2013-2014,Age,24 Months,88.9,84.3 to 92.6,490
≥1 Dose MMR,,States/Local Areas,Michigan,2014,Age,24 Months,90.8,85.2 to 94.9,250
≥1 Dose MMR,,States/Local Areas,Michigan,2014-2015,Age,24 Months,89.6,85.5 to 93.0,486
≥1 Dose MMR,,States/Local Areas,Michigan,2015,Age,24 Months,88.4,82.0 to 93.4,236
≥1 Dose MMR,,States/Local Areas,Michigan,2015-2016,Age,24 Months,89.7,85.9 to 92.9,527
≥1 Dose Varicella,,States/Local Areas,Michigan,2018,Age,24 Months,94.4,90.6 to 97.0,415
≥1 Dose Varicella,,States/Local Areas,Michigan,2018-2019,Age,24 Months,93.9,91.2 to 96.0,790
Hep B,≥3 Doses,States/Local Areas,Michigan,2011,Age,24 Months,88.5,83.4 to 92.6,255
Hep B,≥3 Doses,States/Local Areas,Michigan,2019,Age,19 Months,93.5,89.3 to 96.2,375
Hep B,≥3 Doses,States/Local Areas,Michigan,2013,Age,24 Months,90.4,85.0 to 94.4,240
Hep B,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,24 Months,91.7,87.8 to 94.8,490
Hep B,≥3 Doses,States/Local Areas,Michigan,2012,Age,24 Months,87.1,79.4 to 93.0,212
PCV,≥3 Doses,States/Local Areas,Michigan,2016,Age,7 Months,64.1,56.9 to 70.8,291
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,64.4,59.3 to 69.2,693
PCV,≥4 Doses,States/Local Areas,Michigan,2016,Age,19 Months,78.2,71.5 to 83.6,291
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,77.5,72.7 to 81.7,693
PCV,≥4 Doses,States/Local Areas,Michigan,2015,Age,19 Months,75.5,71.9 to 78.7,236
PCV,≥4 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,76.8,71.6 to 81.3,527
PCV,≥4 Doses,States/Local Areas,Michigan,2014,Age,19 Months,80.2,73.2 to 85.8,250
PCV,≥4 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,77.9,72.5 to 82.5,486
PCV,≥3 Doses,States/Local Areas,Michigan,2015,Age,7 Months,64.3,55.8 to 72.1,236
PCV,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,64.2,58.6 to 69.5,527
PCV,≥3 Doses,States/Local Areas,Michigan,2017,Age,7 Months,64.6,57.5 to 71.1,402
PCV,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,67.6,62.7 to 72.1,817
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2015,Age,0-1 Days,68.2,60.1 to 75.3,236
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2015-2016,Age,0-1 Days,70.5,65.3 to 75.3,527
Hep B,≥2 Doses,States/Local Areas,Michigan,2015,Age,5 Months,85.2,78.2 to 90.3,236
Hep B,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,5 Months,88.5,84.4 to 91.6,527
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2014,Age,0-1 Days,72.2,65.4 to 78.1,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2014-2015,Age,0-1 Days,70.2,65.0 to 75.0,486
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2013,Age,0-1 Days,65.4,60.5 to 69.9,240
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2013-2014,Age,0-1 Days,68.8,65.4 to 72.0,490
≥1 Dose Varicella,,States/Local Areas,Michigan,2013,Age,24 Months,87.9,81.8 to 92.7,240
≥1 Dose Varicella,,States/Local Areas,Michigan,2013-2014,Age,24 Months,89.0,84.4 to 92.7,490
≥1 Dose Varicella,,States/Local Areas,Michigan,2014,Age,24 Months,90.1,83.9 to 94.7,250
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2015,Age,24 Months,90.0,85.7 to 93.4,486
≥1 Dose Varicella,,States/Local Areas,Michigan,2019,Age,19 Months,90.5,85.2 to 94.0,375
Polio,≥2 Doses,States/Local Areas,Michigan,2019,Age,13 Months,96.1,93.6 to 97.7,375
Polio,≥2 Doses,States/Local Areas,Michigan,2018,Age,13 Months,97.8,94.8 to 99.1,415
Polio,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,97.0,95.2 to 98.1,790
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2012,Age,0-1 Days,76.6,71.9 to 80.7,212
Hep B,≥2 Doses,States/Local Areas,Michigan,2014,Age,5 Months,87.1,81.3 to 91.3,250
Hep B,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,5 Months,86.2,82.7 to 89.0,486
Hep B,≥2 Doses,States/Local Areas,Michigan,2016,Age,5 Months,91.7,86.9 to 94.8,291
Hep B,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,5 Months,89.5,86.1 to 92.2,693
Hep B,≥3 Doses,States/Local Areas,Michigan,2018,Age,19 Months,94.9,90.9 to 97.2,415
Hep B,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,91.6,88.6 to 93.9,790
Hep B,≥3 Doses,States/Local Areas,Michigan,2017,Age,19 Months,90.9,86.0 to 94.2,402
Hep B,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,92.9,89.9 to 95.0,817
PCV,≥3 Doses,States/Local Areas,Michigan,2012,Age,7 Months,53.8,43.1 to 64.1,212
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,85.2,81.2 to 89.3,414
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,91.9,87.4 to 96.4,316
PCV,≥3 Doses,States/Local Areas,Michigan,2014,Age,7 Months,60.1,52.4 to 67.3,250
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,62.2,56.5 to 67.6,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2016,Age,19 Months,92.2,87.1 to 95.4,291
Hep B,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,91.6,87.9 to 94.2,693
PCV,≥3 Doses,States/Local Areas,Michigan,2011,Age,7 Months,58.9,56.5 to 61.2,255
PCV,≥3 Doses,States/Local Areas,Michigan,2013,Age,7 Months,60.5,58.9 to 62.1,240
PCV,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,60.3,57.5 to 63.1,490
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2015,Age,0-2 Days,74.5,66.6 to 81.1,236
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2015-2016,Age,0-2 Days,76.4,71.3 to 80.8,527
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2014,Age,0-2 Days,76.9,70.3 to 82.4,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Michigan,2014-2015,Age,0-2 Days,75.7,70.7 to 80.1,486
≥1 Dose Varicella,,States/Local Areas,Michigan,2013,Age,35 Months,88.7,82.5 to 93.5,240
≥1 Dose Varicella,,States/Local Areas,Michigan,2013-2014,Age,35 Months,92.6,87.7 to 96.1,490
≥1 Dose MMR,,States/Local Areas,Michigan,2018,Age,24 Months,93.5,88.9 to 96.7,415
≥1 Dose MMR,,States/Local Areas,Michigan,2018-2019,Age,24 Months,93.8,90.9 to 96.0,790
PCV,≥4 Doses,States/Local Areas,Michigan,2019,Age,19 Months,83.0,76.9 to 87.7,375
≥1 Dose Varicella,,States/Local Areas,Michigan,2014,Age,35 Months,97.4,92.9 to 99.4,250
≥1 Dose Varicella,,States/Local Areas,Michigan,2014-2015,Age,35 Months,96.5,92.5 to 98.7,486
≥1 Dose Varicella,,States/Local Areas,Michigan,2015,Age,35 Months,95.7,87.8 to 99.1,236
≥1 Dose Varicella,,States/Local Areas,Michigan,2015-2016,Age,35 Months,95.2,90.6 to 98.0,527
PCV,≥4 Doses,States/Local Areas,Michigan,2011,Age,24 Months,77.3,70.1 to 83.8,255
Hep A,≥1 Dose,States/Local Areas,Michigan,2020,Age,35 Months,94.4,90.5 to 97.1,448
≥1 Dose Varicella,,States/Local Areas,Michigan,2017,Age,24 Months,92.0,87.2 to 95.4,402
≥1 Dose Varicella,,States/Local Areas,Michigan,2017-2018,Age,24 Months,93.2,90.2 to 95.5,817
≥1 Dose Varicella,,States/Local Areas,Michigan,2016,Age,24 Months,91.7,87.3 to 95.1,291
≥1 Dose Varicella,,States/Local Areas,Michigan,2016-2017,Age,24 Months,91.8,88.4 to 94.5,693
≥1 Dose Varicella,,States/Local Areas,Michigan,2015,Age,24 Months,89.8,83.5 to 94.4,236
≥1 Dose Varicella,,States/Local Areas,Michigan,2015-2016,Age,24 Months,90.8,87.0 to 93.8,527
≥1 Dose MMR,,States/Local Areas,Michigan,2012,Age,24 Months,82.4,73.4 to 89.7,212
≥1 Dose MMR,,States/Local Areas,Michigan,2011,Age,24 Months,88.4,83.1 to 92.6,255
≥1 Dose MMR,,States/Local Areas,Michigan,2019,Age,19 Months,91.7,86.7 to 94.9,375
≥1 Dose MMR,,States/Local Areas,Michigan,2018,Age,19 Months,90.0,84.6 to 93.6,415
≥1 Dose MMR,,States/Local Areas,Michigan,2018-2019,Age,19 Months,96.7,95.0 to 97.9,790
PCV,≥4 Doses,States/Local Areas,Michigan,2011,Age,19 Months,73.9,69.5 to 77.9,255
PCV,≥4 Doses,States/Local Areas,Michigan,2012,Age,19 Months,70.4,63.5 to 76.5,212
PCV,≥4 Doses,States/Local Areas,Michigan,2013,Age,19 Months,73.4,68.7 to 77.5,240
PCV,≥4 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,76.8,75.0 to 78.5,490
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2018,Age,0-1 Days,76.2,70.0 to 81.5,415
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2018-2019,Age,0-1 Days,76.3,71.6 to 80.4,790
Hep B,≥2 Doses,States/Local Areas,Michigan,2018,Age,5 Months,92.2,87.6 to 95.2,415
Hep B,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,5 Months,92.7,89.9 to 94.8,790
Hep B,≥2 Doses,States/Local Areas,Michigan,2017,Age,5 Months,87.3,81.8 to 91.3,402
Hep B,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,5 Months,89.7,86.3 to 92.4,817
Hep B,≥2 Doses,States/Local Areas,Michigan,2011,Age,7 Months,84.2,80.3 to 87.4,255
Hep B,≥2 Doses,States/Local Areas,Michigan,2019,Age,5 Months,93.3,89.3 to 95.9,375
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2017,Age,0-1 Days,75.1,68.8 to 80.5,402
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2017-2018,Age,0-1 Days,75.7,71.3 to 79.6,817
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2016,Age,0-1 Days,72.9,66.1 to 78.7,291
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Michigan,2016-2017,Age,0-1 Days,74.0,69.5 to 78.1,693
DTaP,≥4 Doses,States/Local Areas,Michigan,2018,Age,35 Months,94.6,87.9 to 98.2,415
DTaP,≥4 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,91.8,87.1 to 95.4,790
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.5,55.0 to 78.0,92
≥1 Dose MMR,,States/Local Areas,Michigan,2011,Age,19 Months,83.3,80.2 to 86.1,255
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,88.4,85.0 to 91.8,609
DTaP,≥4 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,76.0,70.3 to 81.7,359
DTaP,≥4 Doses,States/Local Areas,Michigan,2019,Age,35 Months,88.6,81.8 to 93.8,375
Influenza,,States/Local Areas,Michigan,2016,Age,24 Months,55.5,48.3 to 62.8,291
Influenza,,States/Local Areas,Michigan,2016-2017,Age,24 Months,57.9,52.8 to 63.1,693
Influenza,,States/Local Areas,Michigan,2014,Age,24 Months,59.6,52.0 to 67.3,250
Influenza,,States/Local Areas,Michigan,2014-2015,Age,24 Months,59.8,54.1 to 65.6,486
Influenza,,States/Local Areas,Michigan,2015,Age,24 Months,60.0,51.8 to 68.3,236
Influenza,,States/Local Areas,Michigan,2015-2016,Age,24 Months,57.7,52.3 to 63.3,527
Influenza,,States/Local Areas,Michigan,2012,Age,24 Months,58.6,49.5 to 68.0,212
Influenza,,States/Local Areas,Michigan,2011,Age,24 Months,52.0,44.0 to 60.6,255
Influenza,,States/Local Areas,Michigan,2013,Age,24 Months,48.4,40.4 to 57.2,240
Influenza,,States/Local Areas,Michigan,2013-2014,Age,24 Months,53.9,48.2 to 60.0,490
Influenza,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,48.3,41.8 to 54.8,359
Influenza,,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,71.1,66.5 to 75.7,609
Influenza,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",33.3,22.2 to 44.5,92
Influenza,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,64.5,52.5 to 76.4,90
Influenza,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.3,57.2 to 77.4,122
Influenza,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,66.3,60.7 to 72.0,481
Influenza,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,60.1,50.8 to 69.5,158
Influenza,,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",64.5,59.7 to 69.2,693
Influenza,,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,52.1,45.4 to 58.8,358
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.0,75.2 to 90.8,147
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.0,68.2 to 89.8,147
PCV,≥1 Dose,States/Local Areas,Michigan,2021,Age,3 Months,87.6,81.0 to 92.1,323
Hib,Full Series,States/Local Areas,Michigan,2020-2021,Age,24 Months,76.5,71.2 to 81.4,771
Influenza,,States/Local Areas,Michigan,2021,Age,24 Months,61.6,52.6 to 70.7,323
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,94.8,92.6 to 97.0,808
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,91.4,88.2 to 94.6,482
Hib,Full Series,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,88.4,85.2 to 91.6,808
Influenza,,States/Local Areas,Michigan,2014-2017,Overall,Overall,59.5,55.5 to 63.6,997
Influenza,,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,44.2,36.9 to 51.5,267
Influenza,,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,60.8,54.7 to 66.9,414
Influenza,,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,80.3,74.6 to 86.0,316
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.3,90.3 to 98.3,147
PCV,≥4 Doses,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,90.0,86.9 to 93.1,808
DTaP,≥3 Doses,States/Local Areas,Michigan,2020-2021,Age,7 Months,72.9,67.6 to 77.6,771
≥1 Dose Varicella,,States/Local Areas,Michigan,2020-2021,Age,13 Months,66.0,60.6 to 71.0,771
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,87.6 to 98.3,147
Hep A,≥2 Doses,States/Local Areas,Michigan,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.9,69.6 to 92.2,106
Influenza,,States/Local Areas,Michigan,2019,Age,24 Months,73.3,66.3 to 79.9,375
Influenza,,States/Local Areas,Michigan,2017,Age,24 Months,60.4,53.5 to 67.4,402
Influenza,,States/Local Areas,Michigan,2017-2018,Age,24 Months,61.3,56.4 to 66.3,817
Influenza,,States/Local Areas,Michigan,2018,Age,24 Months,62.2,55.5 to 69.0,415
Influenza,,States/Local Areas,Michigan,2018-2019,Age,24 Months,67.7,62.8 to 72.6,790
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Private Insurance Only,93.2,90.7 to 95.8,808
Hep A,≥1 Dose,States/Local Areas,Michigan,2016-2019,Insurance Coverage,Any Medicaid,89.9,86.4 to 93.4,482
Hep B,≥1 Dose,States/Local Areas,Michigan,2021,Age,3 Months,94.6,88.8 to 97.4,323
Polio,≥3 Doses,HHS Regions/National,Region 7,2014,Age,19 Months,91.5,89.1 to 93.5,977
Polio,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,19 Months,90.9,89.0 to 92.6,1868
Hib,≥3 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,70.7,67.0 to 74.1,1232
Hib,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,68.8,66.1 to 71.3,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,65.6,61.1 to 69.7,960
Hib,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,68.1,65.2 to 70.9,2192
Hib,≥3 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,71.4,67.1 to 75.4,891
Hib,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,68.5,65.4 to 71.5,1851
Polio,≥3 Doses,HHS Regions/National,Region 7,2017,Age,19 Months,91.8,89.3 to 93.7,1232
Polio,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,19 Months,92.7,91.1 to 94.1,2577
Polio,≥3 Doses,HHS Regions/National,Region 7,2016,Age,19 Months,89.9,86.9 to 92.3,960
Polio,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,19 Months,90.8,88.9 to 92.4,2192
Hib,≥3 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,66.8,63.0 to 70.4,1345
Hib,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,64.7,62.0 to 67.3,2614
Polio,≥3 Doses,HHS Regions/National,Region 7,2015,Age,19 Months,90.3,86.9 to 92.9,891
Polio,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,19 Months,90.1,87.9 to 92.0,1851
Hib,≥3 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,89.4,85.0 to 92.6,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,89.6,87.0 to 91.8,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,62.5,58.6 to 66.3,1269
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,91.1,88.4 to 93.3,1345
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,90.1,88.1 to 91.8,2614
DTaP,≥3 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,94.3,92.0 to 96.1,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,91.6,87.7 to 94.3,912
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,89.0,86.0 to 91.5,1269
Hib,≥3 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,44.5,40.7 to 48.3,1269
DTaP,≥3 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,91.3,88.2 to 93.6,977
Polio,≥3 Doses,HHS Regions/National,Region 7,2013,Age,19 Months,91.7,87.1 to 94.8,929
Polio,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,19 Months,91.6,89.4 to 93.4,1906
Polio,≥3 Doses,HHS Regions/National,Region 7,2012,Age,19 Months,93.1,91.0 to 94.7,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2012,Age,13 Months,75.9,71.6 to 79.7,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,82.0,78.1 to 85.4,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,75.4,71.7 to 78.8,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,73.4,70.5 to 76.1,1868
Polio,≥3 Doses,HHS Regions/National,Region 7,2011,Age,19 Months,90.2,86.4 to 93.1,912
Hib,≥3 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,72.8,68.9 to 76.4,929
Hib,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,74.1,70.9 to 77.1,1906
Hib,≥2 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,93.4,91.1 to 95.2,1232
Hib,≥2 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,94.2,92.7 to 95.4,2577
Hib,≥2 Doses,HHS Regions/National,Region 7,2018,Age,13 Months,95.0,92.9 to 96.5,1345
Hib,≥2 Doses,HHS Regions/National,Region 7,2018-2019,Age,13 Months,94.1,92.5 to 95.3,2614
Hib,≥2 Doses,HHS Regions/National,Region 7,2019,Age,13 Months,93.1,90.6 to 95.0,1269
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,89.8,87.0 to 92.0,977
DTaP,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,89.6,87.4 to 91.4,1868
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,90.0,86.7 to 92.6,929
DTaP,≥3 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,89.9,87.9 to 91.5,1906
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,89.4,86.0 to 92.1,891
DTaP,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,89.0,86.6 to 90.9,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017,Age,13 Months,89.1,86.3 to 91.5,1232
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,13 Months,90.1,88.2 to 91.8,2577
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,88.5,85.2 to 91.2,960
DTaP,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,88.8,86.7 to 90.6,2192
Hib,≥2 Doses,HHS Regions/National,Region 7,2014,Age,13 Months,93.7,91.5 to 95.4,977
Hib,≥2 Doses,HHS Regions/National,Region 7,2014-2015,Age,13 Months,92.9,91.1 to 94.4,1868
Hib,≥2 Doses,HHS Regions/National,Region 7,2016,Age,13 Months,92.2,89.5 to 94.3,960
Hib,≥2 Doses,HHS Regions/National,Region 7,2016-2017,Age,13 Months,92.8,91.1 to 94.2,2192
Hib,≥2 Doses,HHS Regions/National,Region 7,2015,Age,13 Months,92.1,89.0 to 94.4,891
Hib,≥2 Doses,HHS Regions/National,Region 7,2015-2016,Age,13 Months,92.1,90.1 to 93.8,1851
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,76.2,72.6 to 79.5,1345
DTaP,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,74.6,71.9 to 77.1,2614
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,68.7,64.9 to 72.2,1232
DTaP,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,72.4,69.8 to 74.9,2577
DTaP,≥3 Doses,HHS Regions/National,Region 7,2019,Age,7 Months,72.9,68.9 to 76.5,1269
Hib,Primary Series,HHS Regions/National,Region 7,2020,Age,24 Months,93.4,91.3 to 95.2,1280
DTaP,≥3 Doses,HHS Regions/National,Region 7,2011,Age,13 Months,89.7,86.6 to 92.2,912
PCV,≥3 Doses,HHS Regions/National,Region 7,2017,Age,35 Months,91.4,88.9 to 93.6,1232
PCV,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,35 Months,93.3,91.5 to 94.8,2577
Hib,≥2 Doses,HHS Regions/National,Region 7,2013,Age,13 Months,95.0,93.1 to 96.4,929
Hib,≥2 Doses,HHS Regions/National,Region 7,2013-2014,Age,13 Months,94.4,93.0 to 95.5,1906
Hib,≥3 Doses,HHS Regions/National,Region 7,2014,Age,7 Months,49.6,45.3 to 53.8,977
Hib,≥3 Doses,HHS Regions/National,Region 7,2014-2015,Age,7 Months,48.9,45.8 to 52.0,1868
PCV,≥3 Doses,HHS Regions/National,Region 7,2018,Age,35 Months,95.3,92.9 to 97.1,1345
PCV,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,35 Months,93.8,92.0 to 95.4,2614
Hib,≥3 Doses,HHS Regions/National,Region 7,2016,Age,7 Months,44.0,39.8 to 48.4,960
Hib,≥3 Doses,HHS Regions/National,Region 7,2016-2017,Age,7 Months,46.1,43.3 to 49.0,2192
Hib,≥3 Doses,HHS Regions/National,Region 7,2015,Age,7 Months,48.2,43.7 to 52.6,891
Hib,≥3 Doses,HHS Regions/National,Region 7,2015-2016,Age,7 Months,46.1,43.0 to 49.3,1851
Polio,≥1 Dose,HHS Regions/National,Region 7,2017,Age,3 Months,88.1,85.3 to 90.4,1232
Polio,≥1 Dose,HHS Regions/National,Region 7,2017-2018,Age,3 Months,89.2,87.3 to 90.9,2577
Polio,≥1 Dose,HHS Regions/National,Region 7,2018,Age,3 Months,90.3,87.6 to 92.5,1345
Polio,≥1 Dose,HHS Regions/National,Region 7,2018-2019,Age,3 Months,90.3,88.5 to 92.0,2614
Hib,≥3 Doses,HHS Regions/National,Region 7,2017,Age,7 Months,48.3,44.6 to 52.1,1232
Hib,≥3 Doses,HHS Regions/National,Region 7,2017-2018,Age,7 Months,47.0,44.3 to 49.7,2577
Hib,≥3 Doses,HHS Regions/National,Region 7,2018,Age,7 Months,45.6,41.8 to 49.4,1345
Hib,≥3 Doses,HHS Regions/National,Region 7,2018-2019,Age,7 Months,45.0,42.3 to 47.8,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2019,Age,35 Months,92.1,89.3 to 94.3,1269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2018,Age,0-3 Days,83.4,80.1 to 86.3,1345
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2018-2019,Age,0-3 Days,82.9,80.6 to 84.9,2614
Polio,≥1 Dose,HHS Regions/National,Region 7,2019,Age,3 Months,90.4,87.6 to 92.6,1269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2019,Age,0-3 Days,82.3,79.1 to 85.1,1269
Combined 7 Series,,HHS Regions/National,Region 7,2021,Age,24 Months,67.6,62.8 to 72.3,888
Hib,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,92.7,90.4 to 94.5,2168
Hep A,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,19 Months,85.7,83.4 to 87.7,2168
Rotavirus,,HHS Regions/National,Region 7,2020-2021,Age,8 Months,78.7,76.0 to 81.2,2168
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2020-2021,Age,0-1 Days,79.6,77.0 to 82.0,2168
Polio,≥3 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,91.5,88.5 to 93.7,888
Hib,Full Series,HHS Regions/National,Region 7,2020-2021,Age,19 Months,71.7,68.8 to 74.5,2168
≥1 Dose MMR,,HHS Regions/National,Region 7,2020-2021,Age,13 Months,65.2,62.1 to 68.1,2168
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2020-2021,Age,0-2 Days,81.8,79.3 to 84.1,2168
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,90.3,88.2 to 92.0,2168
Hib,Primary Series,HHS Regions/National,Region 7,2020-2021,Age,19 Months,92.2,90.4 to 93.7,2168
Hib,Full Series,HHS Regions/National,Region 7,2020-2021,Age,35 Months,80.4,77.4 to 83.2,2168
Hib,Primary Series,HHS Regions/National,Region 7,2020-2021,Age,35 Months,93.3,91.5 to 94.8,2168
PCV,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,73.6,70.7 to 76.4,2168
Hep A,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,31.9,29.2 to 34.7,2168
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,91.8,90.0 to 93.4,2168
Hep A,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,50.4,47.2 to 53.7,2168
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020-2021,Age,24 Months,90.8,88.9 to 92.5,2168
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,75.3,72.4 to 78.0,2168
DTaP,≥4 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,72.4,69.5 to 75.2,2168
Hib,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,87.9,85.7 to 89.9,2168
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020-2021,Age,19 Months,89.0,87.0 to 90.8,2168
Hep B,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,5 Months,91.3,89.5 to 92.8,2168
Hib,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,5 Months,77.2,74.4 to 79.7,2168
PCV,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,92.5,90.8 to 94.1,2168
Hib,≥3 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,65.8,61.2 to 70.1,888
Polio,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,91.8,90.0 to 93.4,2168
Combined 7 Series,,HHS Regions/National,Region 7,2020-2021,Age,35 Months,72.9,69.5 to 76.1,2168
DTaP,≥3 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,93.4,90.0 to 95.9,888
Polio,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,3 Months,89.6,87.7 to 91.3,2168
Polio,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,92.5,90.8 to 94.1,2168
Hib,Primary Series,HHS Regions/National,Region 7,2020-2021,Age,7 Months,76.3,73.5 to 78.8,2168
Hib,Primary Series,HHS Regions/National,Region 7,2021,Age,35 Months,92.6,89.8 to 94.8,888
Hib,≥2 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,92.8,90.0 to 94.8,888
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,92.5,90.7 to 94.0,2168
≥1 Dose MMR,,HHS Regions/National,Region 7,2020-2021,Age,19 Months,89.7,87.7 to 91.4,2168
Hep A,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,24 Months,87.9,85.7 to 89.9,2168
Hib,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,45.5,42.4 to 48.5,2168
≥1 Dose MMR,,HHS Regions/National,Region 7,2021,Age,13 Months,64.1,59.4 to 68.5,888
Rotavirus,,HHS Regions/National,Region 7,2021,Age,8 Months,78.4,74.1 to 82.1,888
Hep A,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,80.8,76.8 to 84.5,2168
PCV,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,90.0,87.9 to 91.7,2168
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020-2021,Age,13 Months,59.2,56.1 to 62.1,2168
Hib,Full Series,HHS Regions/National,Region 7,2020-2021,Age,24 Months,76.8,74.1 to 79.5,2168
Influenza,,HHS Regions/National,Region 7,2021,Age,24 Months,50.4,45.8 to 55.3,888
Hep B,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,3 Months,95.2,93.8 to 96.3,2168
Hib,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,90.2,88.2 to 91.9,2168
Hib,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,66.5,63.6 to 69.4,2168
DTaP,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,5 Months,81.9,79.3 to 84.3,2168
PCV,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,3 Months,88.9,86.9 to 90.7,2168
Hib,≥3 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,90.5,87.2 to 93.2,888
Hep B,≥1 Dose,HHS Regions/National,Region 7,2021,Age,3 Months,94.2,91.7 to 95.9,888
Polio,≥2 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,93.4,90.8 to 95.3,888
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2021,Age,0-3 Days,80.1,76.2 to 83.6,888
DTaP,≥3 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,92.3,89.6 to 94.5,888
Hep B,≥3 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,87.9,84.7 to 90.5,888
PCV,≥1 Dose,HHS Regions/National,Region 7,2021,Age,3 Months,89.0,85.7 to 91.6,888
Polio,≥2 Doses,HHS Regions/National,Region 7,2021,Age,5 Months,81.7,77.7 to 85.2,888
≥1 Dose Varicella,,HHS Regions/National,Region 7,2021,Age,13 Months,57.8,53.1 to 62.3,888
≥1 Dose MMR,,HHS Regions/National,Region 7,2021,Age,19 Months,90.0,86.9 to 92.4,888
Polio,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,93.6,92.1 to 94.9,2168
DTaP,≥2 Doses,HHS Regions/National,Region 7,2021,Age,5 Months,81.7,77.5 to 85.2,888
Influenza,,HHS Regions/National,Region 7,2019,Age,24 Months,59.7,55.7 to 63.6,1269
Influenza,,HHS Regions/National,Region 7,2016,Age,24 Months,54.5,50.0 to 59.0,960
Influenza,,HHS Regions/National,Region 7,2016-2017,Age,24 Months,55.5,52.5 to 58.5,2192
Influenza,,HHS Regions/National,Region 7,2017,Age,24 Months,56.5,52.8 to 60.4,1232
Influenza,,HHS Regions/National,Region 7,2017-2018,Age,24 Months,58.3,55.6 to 61.1,2577
Influenza,,HHS Regions/National,Region 7,2018,Age,24 Months,60.2,56.3 to 64.1,1345
Influenza,,HHS Regions/National,Region 7,2018-2019,Age,24 Months,60.0,57.2 to 62.8,2614
PCV,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,93.4,91.5 to 95.0,2168
Hep B,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,93.2,91.6 to 94.5,2168
Hib,Full Series,HHS Regions/National,Region 7,2021,Age,35 Months,78.5,74.0 to 82.7,888
Hib,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,3 Months,84.4,82.1 to 86.5,2168
≥1 Dose MMR,,HHS Regions/National,Region 7,2020-2021,Age,35 Months,94.4,92.3 to 96.1,2168
Combined 7 Series,,HHS Regions/National,Region 7,2020-2021,Age,24 Months,67.5,64.5 to 70.6,2168
Polio,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,94.0,92.1 to 95.6,2168
Hep B,≥3 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,92.4,88.5 to 95.3,888
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,72.3,69.5 to 74.9,2168
Influenza,,HHS Regions/National,Region 7,2020-2021,Age,24 Months,54.8,51.7 to 57.9,2168
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 7,2020-2021,Age,0-3 Days,82.4,79.9 to 84.6,2168
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,24 Months,92.9,91.2 to 94.4,2168
PCV,≥4 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,80.4,77.6 to 82.9,2168
PCV,≥4 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,85.9,83.2 to 88.3,2168
DTaP,≥4 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,85.9,81.4 to 89.8,888
PCV,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,19 Months,92.0,90.2 to 93.6,2168
Hib,Primary Series,HHS Regions/National,Region 7,2021,Age,13 Months,84.9,81.3 to 87.9,888
Polio,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,7 Months,90.9,89.0 to 92.5,2168
Polio,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,5 Months,81.7,79.1 to 84.1,2168
Hep B,≥2 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,93.9,91.4 to 95.7,888
≥1 Dose Varicella,,HHS Regions/National,Region 7,2021,Age,35 Months,95.6,91.3 to 98.2,888
Influenza,,HHS Regions/National,Region 7,2012,Age,24 Months,50.8,46.4 to 55.4,977
Influenza,,HHS Regions/National,Region 7,2011,Age,24 Months,55.0,50.4 to 59.7,912
Influenza,,HHS Regions/National,Region 7,2014,Age,24 Months,51.1,46.9 to 55.4,977
Influenza,,HHS Regions/National,Region 7,2014-2015,Age,24 Months,52.5,49.5 to 55.7,1868
Influenza,,HHS Regions/National,Region 7,2015,Age,24 Months,54.0,49.5 to 58.5,891
Influenza,,HHS Regions/National,Region 7,2015-2016,Age,24 Months,54.2,51.1 to 57.5,1851
Influenza,,HHS Regions/National,Region 7,2013,Age,24 Months,50.3,45.9 to 54.9,929
Influenza,,HHS Regions/National,Region 7,2013-2014,Age,24 Months,50.7,47.7 to 53.8,1906
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,93.0,89.2 to 95.5,403
Influenza,,States/Local Areas,New Hampshire,2011,Age,24 Months,68.0,60.3 to 75.5,244
Influenza,,States/Local Areas,New Hampshire,2012,Age,24 Months,68.5,60.6 to 76.2,225
Influenza,,States/Local Areas,New Hampshire,2015,Age,24 Months,66.3,58.7 to 73.7,223
Influenza,,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,61.3,55.8 to 66.8,454
Influenza,,States/Local Areas,New Hampshire,2014,Age,24 Months,56.6,48.9 to 64.7,219
Influenza,,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,61.5,56.0 to 67.0,442
Influenza,,States/Local Areas,New Hampshire,2013,Age,24 Months,64.6,56.6 to 72.5,222
Influenza,,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,60.7,55.1 to 66.4,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,94.3 to 100.0,72
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,84.2,78.8 to 89.7,275
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,92.6,86.5 to 98.7,67
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,91.2,84.7 to 97.7,67
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.8,96.3 to 100.0,72
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,84.0,73.1 to 94.9,67
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,94.7,89.7 to 97.4,126
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2021,Age,13 Months,69.6,59.6 to 78.1,126
Influenza,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,53.9,47.2 to 60.7,286
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,3 Months,93.8,88.3 to 96.8,126
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,78.9,70.4 to 86.4,315
Hib,Full Series,States/Local Areas,New Hampshire,2021,Age,35 Months,91.2,80.4 to 97.3,126
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,95.5,92.6 to 97.6,315
PCV,≥4 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,85.5,79.7 to 89.9,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,96.3,92.8 to 98.4,315
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2021,Age,35 Months,95.8,89.3 to 98.9,126
Hib,Primary Series,States/Local Areas,New Hampshire,2021,Age,13 Months,90.3,82.1 to 95.0,126
Hib,Full Series,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,81.8,75.4 to 86.8,315
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,97.4,91.2 to 99.6,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,97.3,95.1 to 98.6,315
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,90.7,85.8 to 94.0,315
Polio,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,94.2,88.9 to 97.5,126
Rotavirus,,States/Local Areas,New Hampshire,2020-2021,Age,8 Months,80.8,74.6 to 85.7,315
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,95.5,92.2 to 97.4,315
Hib,Primary Series,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,93.9,89.4 to 96.5,315
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,29.6,24.1 to 35.8,315
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,72.5,65.7 to 78.3,315
Hib,Primary Series,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,96.0,92.5 to 98.1,315
Hib,Full Series,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,88.7,82.7 to 93.3,315
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,91.5,86.5 to 94.8,315
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,3 Months,94.6,91.2 to 96.8,315
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,3 Months,94.0,90.4 to 96.3,315
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2020-2021,Age,0-2 Days,81.0,74.9 to 85.9,315
Polio,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,96.1,92.8 to 97.9,315
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,72.1,65.6 to 77.7,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,93.9,89.6 to 96.5,315
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,83.1,77.1 to 87.9,315
Influenza,,States/Local Areas,New Hampshire,2021,Age,24 Months,76.6,67.1 to 85.1,126
Hib,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,5 Months,82.8,73.5 to 89.3,126
Hib,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,5 Months,85.1,79.3 to 89.6,315
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,5 Months,90.3,81.9 to 95.0,126
PCV,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,90.2,82.1 to 94.9,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,91.0,82.6 to 95.5,126
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,5 Months,84.3,75.1 to 90.5,126
≥1 Dose MMR,,States/Local Areas,New Hampshire,2021,Age,19 Months,96.6,92.7 to 98.5,126
Polio,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,5 Months,83.7,74.5 to 90.0,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,78.3,73.0 to 82.8,403
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,96.2,93.6 to 98.8,394
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,94.6,91.6 to 96.6,403
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,88.9,84.6 to 93.2,275
Influenza,,States/Local Areas,New Hampshire,2019,Age,24 Months,71.7,63.9 to 79.2,214
Influenza,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.2,59.5 to 83.0,82
Influenza,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,48.6,33.5 to 63.6,60
Influenza,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,72.8,68.0 to 77.6,484
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,92.0,89.4 to 94.7,563
Influenza,,States/Local Areas,New Hampshire,2018,Age,24 Months,79.6,73.3 to 85.2,269
Influenza,,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,75.7,70.6 to 80.4,483
Influenza,,States/Local Areas,New Hampshire,2017,Age,24 Months,77.6,70.6 to 84.0,244
Influenza,,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,78.6,74.0 to 83.0,513
Hib,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,92.7,88.2 to 95.6,315
≥1 Dose MMR,,States/Local Areas,New Hampshire,2021,Age,13 Months,77.7,68.1 to 85.0,126
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.7,74.9 to 96.5,72
Influenza,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,56.9,47.0 to 66.8,145
Influenza,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.6,59.1 to 68.0,659
Influenza,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,62.2,55.9 to 68.4,344
Influenza,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,66.2,60.0 to 72.3,328
Influenza,,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,70.4,64.0 to 76.7,315
Influenza,,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,64.3,58.2 to 70.4,329
Influenza,,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,47.1,38.3 to 55.9,173
Influenza,,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,62.7,58.6 to 66.8,817
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,88.8,85.4 to 92.2,563
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,92.5,88.4 to 96.7,275
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.3 to 97.8,563
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,75.8 to 98.9,72
Influenza,,States/Local Areas,New Hampshire,2016,Age,24 Months,56.1,48.4 to 64.1,231
Influenza,,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,67.1,61.7 to 72.4,475
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,91.4,88.4 to 94.4,563
Hib,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,96.8,89.8 to 99.4,126
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,95.8,91.8 to 98.2,126
PCV,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,3 Months,92.0,85.4 to 95.8,126
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,79.3,72.9 to 84.5,315
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,92.0,87.5 to 95.0,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,75.8,69.1 to 81.4,315
Hib,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,94.2,88.2 to 97.3,126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2021,Age,0-3 Days,79.6,69.9 to 86.8,126
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,5 Months,87.6,82.0 to 91.6,315
PCV,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,3 Months,92.0,87.5 to 94.9,315
Hib,Primary Series,States/Local Areas,New Hampshire,2021,Age,35 Months,96.2,88.7 to 99.3,126
Polio,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,5 Months,86.5,80.8 to 90.7,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,92.8,87.7 to 95.9,315
Polio,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,96.5,93.6 to 98.3,315
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,44.1,37.4 to 51.3,315
Hib,Primary Series,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,78.3,71.9 to 83.6,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,86.9,77.6 to 92.7,126
Polio,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,96.5,93.6 to 98.3,315
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,92.0,87.4 to 95.3,315
Rotavirus,,States/Local Areas,New Hampshire,2021,Age,8 Months,80.0,70.5 to 87.0,126
Hib,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,3 Months,92.4,88.2 to 95.2,315
Hib,Primary Series,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,92.6,88.1 to 95.5,315
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,95.5,92.6 to 97.6,315
Combined 7 Series,,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,82.8,76.3 to 88.3,315
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,5 Months,92.0,87.3 to 95.1,315
PCV,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,5 Months,86.8,81.4 to 90.8,315
Polio,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,96.1,92.8 to 97.9,315
Polio,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,93.0,88.4 to 95.8,315
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,94.0,90.0 to 96.8,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,95.8,91.8 to 98.2,126
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,92.7,88.0 to 95.7,315
Combined 7 Series,,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,77.2,70.9 to 82.9,315
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,94.7,90.3 to 97.6,126
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,93.7,89.2 to 96.4,315
Influenza,,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,72.5,66.1 to 78.5,315
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2020-2021,Age,0-1 Days,78.1,71.8 to 83.3,315
PCV,≥4 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,89.0,83.5 to 93.3,315
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,96.1,91.0 to 98.7,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,7 Months,77.1,70.9 to 82.4,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2020-2021,Age,0-3 Days,81.4,75.3 to 86.2,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,97.3,95.1 to 98.6,315
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,89.4,84.4 to 93.4,315
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,89.9,86.9 to 92.9,484
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,89.8,86.2 to 93.4,315
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,77.3,68.5 to 86.0,145
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.7,82.4 to 88.9,659
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.2,67.4 to 89.0,82
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,77.1,63.7 to 90.4,60
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,76.5,70.5 to 82.4,286
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,84.8,79.8 to 89.7,329
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,69.8,61.2 to 78.4,173
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,83.3,80.2 to 86.5,817
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,82.3,77.2 to 87.3,344
Rotavirus,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.3,83.2 to 91.4,328
Rotavirus,,States/Local Areas,New Hampshire,2011,Age,8 Months,78.4,70.2 to 84.8,244
Rotavirus,,States/Local Areas,New Hampshire,2017,Age,8 Months,89.8,84.0 to 93.7,244
Rotavirus,,States/Local Areas,New Hampshire,2017-2018,Age,8 Months,87.8,83.9 to 90.8,513
Rotavirus,,States/Local Areas,New Hampshire,2019,Age,8 Months,79.4,71.7 to 85.5,214
Rotavirus,,States/Local Areas,New Hampshire,2018,Age,8 Months,85.7,79.9 to 90.0,269
Rotavirus,,States/Local Areas,New Hampshire,2018-2019,Age,8 Months,82.6,78.0 to 86.4,483
Rotavirus,,States/Local Areas,New Hampshire,2014,Age,8 Months,80.3,73.4 to 85.8,219
Rotavirus,,States/Local Areas,New Hampshire,2014-2015,Age,8 Months,81.2,76.3 to 85.3,442
Rotavirus,,States/Local Areas,New Hampshire,2012,Age,8 Months,77.3,69.5 to 83.5,225
Rotavirus,,States/Local Areas,New Hampshire,2013,Age,8 Months,77.6,70.1 to 83.6,222
Rotavirus,,States/Local Areas,New Hampshire,2013-2014,Age,8 Months,78.9,74.0 to 83.2,441
Rotavirus,,States/Local Areas,New Hampshire,2015,Age,8 Months,82.0,74.6 to 87.6,223
Rotavirus,,States/Local Areas,New Hampshire,2015-2016,Age,8 Months,80.9,75.8 to 85.2,454
Rotavirus,,States/Local Areas,New Hampshire,2016,Age,8 Months,79.7,72.1 to 85.7,231
Rotavirus,,States/Local Areas,New Hampshire,2016-2017,Age,8 Months,84.9,80.3 to 88.6,475
Hib,Full Series,States/Local Areas,New Hampshire,2017,Age,19 Months,88.5,82.5 to 92.6,244
Hib,Full Series,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,88.0,84.2 to 91.0,513
Hib,Full Series,States/Local Areas,New Hampshire,2015,Age,19 Months,85.9,82.0 to 89.1,223
Hib,Full Series,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,82.2,77.3 to 86.2,454
Hib,Full Series,States/Local Areas,New Hampshire,2014,Age,19 Months,86.0,79.9 to 90.5,219
Hib,Full Series,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,86.0,81.8 to 89.3,442
Hib,Full Series,States/Local Areas,New Hampshire,2019,Age,19 Months,74.8,66.8 to 81.4,214
Hib,Full Series,States/Local Areas,New Hampshire,2018,Age,19 Months,87.5,82.2 to 91.4,269
Hib,Full Series,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,96.9,94.7 to 98.2,483
Hib,Full Series,States/Local Areas,New Hampshire,2011,Age,24 Months,88.6,82.9 to 93.0,244
Hib,Full Series,States/Local Areas,New Hampshire,2012,Age,24 Months,89.8,84.1 to 94.0,225
Hib,Full Series,States/Local Areas,New Hampshire,2016,Age,19 Months,78.3,70.4 to 84.5,231
Hib,Full Series,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,83.5,78.7 to 87.4,475
Hib,Full Series,States/Local Areas,New Hampshire,2014,Age,24 Months,90.4,85.5 to 94.2,219
Hib,Full Series,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,89.7,86.3 to 92.7,442
Hib,Full Series,States/Local Areas,New Hampshire,2013,Age,24 Months,86.5,80.1 to 91.7,222
Hib,Full Series,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,88.4,84.4 to 91.7,441
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Principal City,73.7,64.7 to 82.7,145
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.8,70.1 to 81.4,328
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.9,75.1 to 82.7,659
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.2,60.1 to 84.2,82
Combined 7 Series,,States/Local Areas,New Hampshire,2015,Age,35 Months,83.4,76.1 to 89.5,223
Combined 7 Series,,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,83.3,76.9 to 88.8,454
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,66.2,57.4 to 75.1,173
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,78.2,72.8 to 83.6,344
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,76.3,72.7 to 79.9,817
Hib,Full Series,States/Local Areas,New Hampshire,2013,Age,19 Months,83.0,73.3 to 89.7,222
Hib,Full Series,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,84.5,77.9 to 89.4,441
Hib,Full Series,States/Local Areas,New Hampshire,2012,Age,19 Months,85.2,82.5 to 87.5,225
Hib,Full Series,States/Local Areas,New Hampshire,2011,Age,19 Months,86.7,84.8 to 88.4,244
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,80.6,75.2 to 86.0,315
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,78.0,72.6 to 83.4,329
Combined 7 Series,,States/Local Areas,New Hampshire,2018,Age,35 Months,83.7,77.3 to 89.0,269
Combined 7 Series,,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,81.3,76.3 to 85.8,483
Combined 7 Series,,States/Local Areas,New Hampshire,2019,Age,35 Months,78.8,70.8 to 85.8,214
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,70.4,64.1 to 76.7,286
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,81.0,76.5 to 85.4,484
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2017,Race and Ethnicity,Hispanic,67.3,52.7 to 81.8,60
Hib,Primary Series,States/Local Areas,New Hampshire,2018,Age,7 Months,83.0,76.8 to 87.9,269
Hib,Primary Series,States/Local Areas,New Hampshire,2018-2019,Age,7 Months,80.1,75.2 to 84.2,483
Hib,Primary Series,States/Local Areas,New Hampshire,2013,Age,13 Months,94.5,91.0 to 96.7,222
Hib,Primary Series,States/Local Areas,New Hampshire,2013-2014,Age,13 Months,94.2,92.2 to 95.7,441
Hib,Primary Series,States/Local Areas,New Hampshire,2012,Age,13 Months,95.2,91.6 to 97.3,225
Hib,Primary Series,States/Local Areas,New Hampshire,2011,Age,13 Months,94.6,89.5 to 97.3,244
Hib,Primary Series,States/Local Areas,New Hampshire,2014,Age,7 Months,75.1,67.8 to 81.1,219
Hib,Primary Series,States/Local Areas,New Hampshire,2014-2015,Age,7 Months,77.7,72.7 to 82.0,442
Hib,Primary Series,States/Local Areas,New Hampshire,2015,Age,7 Months,80.3,73.2 to 85.9,223
Hib,Primary Series,States/Local Areas,New Hampshire,2015-2016,Age,7 Months,78.7,73.6 to 83.0,454
Hib,Primary Series,States/Local Areas,New Hampshire,2019,Age,7 Months,77.0,69.2 to 83.2,214
Hib,Primary Series,States/Local Areas,New Hampshire,2016,Age,7 Months,77.0,69.5 to 83.1,231
Hib,Primary Series,States/Local Areas,New Hampshire,2016-2017,Age,7 Months,79.1,74.2 to 83.4,475
Hib,Primary Series,States/Local Areas,New Hampshire,2017,Age,7 Months,81.2,74.2 to 86.6,244
Hib,Primary Series,States/Local Areas,New Hampshire,2017-2018,Age,7 Months,82.1,77.6 to 85.9,513
Hib,Primary Series,States/Local Areas,New Hampshire,2012,Age,24 Months,96.3,91.9 to 98.7,225
Hib,Primary Series,States/Local Areas,New Hampshire,2011,Age,24 Months,95.5,91.2 to 98.1,244
Hib,Primary Series,States/Local Areas,New Hampshire,2013,Age,7 Months,69.2,65.0 to 73.1,222
Hib,Primary Series,States/Local Areas,New Hampshire,2013-2014,Age,7 Months,72.1,67.2 to 76.5,441
Hib,Primary Series,States/Local Areas,New Hampshire,2014,Age,13 Months,93.8,88.9 to 96.6,219
Hib,Primary Series,States/Local Areas,New Hampshire,2014-2015,Age,13 Months,92.6,88.9 to 95.2,442
Hib,Primary Series,States/Local Areas,New Hampshire,2015,Age,13 Months,91.5,85.1 to 95.3,223
Hib,Primary Series,States/Local Areas,New Hampshire,2015-2016,Age,13 Months,92.2,88.4 to 94.9,454
DTaP,≥3 Doses,States/Local Areas,Washington,2011,Age,19 Months,93.4,87.8 to 96.5,241
DTaP,≥3 Doses,States/Local Areas,Washington,2012,Age,19 Months,94.6,93.2 to 95.7,252
Hib,≥3 Doses,States/Local Areas,Washington,2016,Age,13 Months,78.3,70.1 to 84.7,280
Hib,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,80.9,76.1 to 84.8,747
Hib,≥3 Doses,States/Local Areas,Washington,2017,Age,13 Months,83.5,78.5 to 87.6,467
Hib,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,84.7,81.2 to 87.6,959
Polio,≥3 Doses,States/Local Areas,Washington,2014,Age,19 Months,88.7,82.8 to 92.8,304
Polio,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,19 Months,88.6,84.4 to 91.8,582
Hib,≥3 Doses,States/Local Areas,Washington,2015,Age,13 Months,79.0,70.9 to 85.3,278
Hib,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,78.6,73.0 to 83.3,558
DTaP,≥3 Doses,States/Local Areas,Washington,2016,Age,13 Months,86.6,78.8 to 91.9,280
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,88.2,83.9 to 91.5,747
DTaP,≥3 Doses,States/Local Areas,Washington,2015,Age,13 Months,85.5,77.8 to 90.9,278
DTaP,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,86.1,80.9 to 90.0,558
DTaP,≥3 Doses,States/Local Areas,Washington,2017,Age,13 Months,89.8,85.4 to 93.0,467
DTaP,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,92.5,90.0 to 94.5,959
Hib,≥3 Doses,States/Local Areas,Washington,2018,Age,13 Months,85.9,80.7 to 89.8,492
Hib,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,86.3,82.9 to 89.0,947
Hib,≥3 Doses,States/Local Areas,Washington,2012,Age,19 Months,91.6,88.1 to 94.1,252
Hib,≥3 Doses,States/Local Areas,Washington,2011,Age,19 Months,93.4,88.1 to 96.4,241
DTaP,≥3 Doses,States/Local Areas,Washington,2019,Age,13 Months,93.8,90.0 to 96.2,455
DTaP,≥3 Doses,States/Local Areas,Washington,2018,Age,13 Months,95.3,92.4 to 97.1,492
DTaP,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,94.6,92.3 to 96.2,947
Polio,≥3 Doses,States/Local Areas,Washington,2013,Age,19 Months,89.7,86.1 to 92.4,313
Polio,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,19 Months,89.2,85.3 to 92.1,617
Polio,≥3 Doses,States/Local Areas,Washington,2012,Age,19 Months,92.9,90.5 to 94.7,252
Polio,≥3 Doses,States/Local Areas,Washington,2015,Age,19 Months,88.5,87.3 to 89.5,278
Polio,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,19 Months,87.1,82.2 to 90.8,558
Polio,≥3 Doses,States/Local Areas,Washington,2016,Age,19 Months,85.7,77.8 to 91.1,280
Polio,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,19 Months,87.9,83.5 to 91.2,747
Polio,≥3 Doses,States/Local Areas,Washington,2017,Age,19 Months,90.1,85.8 to 93.2,467
Polio,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,19 Months,92.3,89.7 to 94.3,959
Hib,≥3 Doses,States/Local Areas,Washington,2011,Age,13 Months,90.1,87.3 to 92.3,241
Hib,≥3 Doses,States/Local Areas,Washington,2012,Age,13 Months,85.9,84.2 to 87.4,252
Hib,≥3 Doses,States/Local Areas,Washington,2014,Age,13 Months,85.2,78.9 to 89.8,304
Hib,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,82.1,77.1 to 86.2,582
Hib,≥3 Doses,States/Local Areas,Washington,2013,Age,13 Months,84.5,81.7 to 87.0,313
Hib,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,84.9,81.6 to 87.6,617
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,91.6,87.1 to 96.1,448
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,87.8,83.0 to 92.6,412
Polio,≥3 Doses,States/Local Areas,Washington,2011,Age,19 Months,90.8,85.6 to 94.2,241
PCV,≥1 Dose,States/Local Areas,Washington,2015,Age,3 Months,84.5,76.6 to 90.1,278
PCV,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,3 Months,84.6,79.4 to 88.7,558
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,89.4,85.8 to 93.0,679
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,93.6,85.6 to 100.0,52
Hib,≥2 Doses,States/Local Areas,Washington,2019,Age,5 Months,89.1,84.5 to 92.4,455
PCV,≥1 Dose,States/Local Areas,Washington,2016,Age,3 Months,84.7,77.2 to 90.1,280
PCV,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,3 Months,83.8,79.4 to 87.5,747
PCV,≥1 Dose,States/Local Areas,Washington,2017,Age,3 Months,82.9,77.4 to 87.3,467
PCV,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,3 Months,85.6,82.0 to 88.6,959
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,85.8,81.1 to 90.5,352
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2012,Age,0-3 Days,73.3,65.4 to 80.0,252
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,80.4,75.6 to 85.2,593
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,80.7,77.3 to 84.1,1097
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,77.6,66.9 to 88.3,113
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.9,76.5 to 87.4,391
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,79.4,73.6 to 85.2,412
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,73.6,66.5 to 80.7,237
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,88.2,83.4 to 92.9,448
Hib,≥2 Doses,States/Local Areas,Washington,2013,Age,7 Months,88.5,84.8 to 91.3,313
Hib,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,89.8,86.8 to 92.2,617
Hib,≥2 Doses,States/Local Areas,Washington,2014,Age,7 Months,91.1,86.4 to 94.3,304
Hib,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,88.7,84.6 to 91.9,582
Hib,≥2 Doses,States/Local Areas,Washington,2018,Age,5 Months,82.9,77.5 to 87.2,492
Hib,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,5 Months,86.0,82.5 to 88.8,947
PCV,≥3 Doses,States/Local Areas,Washington,2015,Age,24 Months,89.0,83.1 to 93.6,278
PCV,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,24 Months,88.3,83.8 to 91.9,558
Hib,≥2 Doses,States/Local Areas,Washington,2012,Age,7 Months,90.2,86.9 to 92.7,252
PCV,≥3 Doses,States/Local Areas,Washington,2016,Age,24 Months,87.4,80.5 to 92.8,280
PCV,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,24 Months,89.7,85.8 to 92.9,747
PCV,≥3 Doses,States/Local Areas,Washington,2017,Age,24 Months,91.9,88.2 to 94.9,467
PCV,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,24 Months,93.6,91.4 to 95.5,959
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,87.2,81.9 to 92.5,237
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,90.2,85.8 to 94.6,448
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,84.6,79.4 to 89.8,412
Hib,≥3 Doses,States/Local Areas,Washington,2011,Age,7 Months,67.4,61.1 to 73.1,241
Hib,≥3 Doses,States/Local Areas,Washington,2012,Age,7 Months,67.0,60.7 to 72.8,252
Hib,≥3 Doses,States/Local Areas,Washington,2013,Age,7 Months,62.1,56.9 to 67.0,313
Polio,≥1 Dose,States/Local Areas,Washington,2014,Age,3 Months,84.8,78.7 to 89.4,304
Polio,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,3 Months,86.2,81.7 to 89.7,582
Polio,≥1 Dose,States/Local Areas,Washington,2015,Age,3 Months,87.5,80.3 to 92.4,278
Polio,≥1 Dose,States/Local Areas,Washington,2015-2016,Age,3 Months,86.7,81.8 to 90.5,558
Polio,≥1 Dose,States/Local Areas,Washington,2016,Age,3 Months,85.9,78.4 to 91.1,280
Polio,≥1 Dose,States/Local Areas,Washington,2016-2017,Age,3 Months,84.6,80.2 to 88.2,747
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2017,Age,0-3 Days,73.4,64.4 to 80.7,235
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2017-2018,Age,0-3 Days,78.3,74.6 to 81.6,959
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016,Age,0-3 Days,74.0,65.7 to 80.8,280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2016-2017,Age,0-3 Days,75.2,70.3 to 79.5,747
Hib,≥2 Doses,States/Local Areas,Washington,2016,Age,7 Months,85.0,77.5 to 90.4,280
Hib,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,86.3,82.0 to 89.7,747
Hib,≥2 Doses,States/Local Areas,Washington,2017,Age,7 Months,87.5,82.7 to 91.2,467
Hib,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,90.2,87.0 to 92.6,959
PCV,≥3 Doses,States/Local Areas,Washington,2014,Age,35 Months,93.6,88.9 to 96.8,304
PCV,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,35 Months,91.6,87.8 to 94.5,582
PCV,≥3 Doses,States/Local Areas,Washington,2015,Age,35 Months,89.5,83.6 to 94.0,278
PCV,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,35 Months,88.5,84.1 to 92.2,558
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2013,Age,0-3 Days,73.9,67.5 to 79.5,313
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2013-2014,Age,0-3 Days,72.5,67.9 to 76.7,617
Polio,≥1 Dose,States/Local Areas,Washington,2013,Age,3 Months,87.3,85.8 to 88.7,313
Polio,≥1 Dose,States/Local Areas,Washington,2013-2014,Age,3 Months,86.1,84.0 to 87.9,617
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,87.3,84.4 to 90.2,1097
Polio,≥1 Dose,States/Local Areas,Washington,2012,Age,3 Months,86.0,82.3 to 89.0,252
Polio,≥1 Dose,States/Local Areas,Washington,2011,Age,3 Months,88.9,83.2 to 92.8,241
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014,Age,0-3 Days,71.1,64.2 to 77.2,304
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2015,Age,0-3 Days,72.6,67.5 to 77.2,582
PCV,≥1 Dose,States/Local Areas,Washington,2018,Age,3 Months,88.3,83.2 to 92.0,492
PCV,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,3 Months,90.3,87.2 to 92.8,947
DTaP,≥3 Doses,States/Local Areas,Washington,2013,Age,7 Months,68.4,62.9 to 73.4,313
DTaP,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,69.6,65.3 to 73.6,617
DTaP,≥3 Doses,States/Local Areas,Washington,2012,Age,7 Months,75.7,73.1 to 78.1,252
DTaP,≥3 Doses,States/Local Areas,Washington,2011,Age,7 Months,71.2,66.9 to 75.1,241
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,87.1,83.0 to 91.2,593
PCV,≥1 Dose,States/Local Areas,Washington,2012,Age,3 Months,86.0,83.7 to 88.1,252
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.7,75.0 to 84.5,651
PCV,≥4 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,80.5 to 93.4,211
PCV,≥1 Dose,States/Local Areas,Washington,2014,Age,3 Months,85.5,79.4 to 90.1,304
PCV,≥1 Dose,States/Local Areas,Washington,2014-2015,Age,3 Months,85.0,80.2 to 88.8,582
Hib,≥2 Doses,States/Local Areas,Washington,2017,Age,5 Months,79.1,73.5 to 83.8,467
Hib,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,5 Months,81.0,77.2 to 84.3,959
Hib,≥2 Doses,States/Local Areas,Washington,2011,Age,7 Months,88.9,78.0 to 94.8,241
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.2,81.0 to 89.5,651
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.9,83.3 to 92.5,391
PCV,≥3 Doses,States/Local Areas,Washington,2012,Age,35 Months,95.2,90.2 to 98.2,252
PCV,≥3 Doses,States/Local Areas,Washington,2019,Age,24 Months,95.7,92.9 to 97.6,455
PCV,≥3 Doses,States/Local Areas,Washington,2011,Age,35 Months,93.6,88.3 to 97.0,241
PCV,≥3 Doses,States/Local Areas,Washington,2013,Age,35 Months,92.9,88.5 to 96.1,313
PCV,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,35 Months,93.2,90.2 to 95.6,617
Hib,≥2 Doses,States/Local Areas,Washington,2015,Age,7 Months,86.4,79.1 to 91.4,278
Hib,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,85.7,80.7 to 89.6,558
PCV,≥3 Doses,States/Local Areas,Washington,2018,Age,24 Months,95.3,92.6 to 97.3,492
PCV,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,24 Months,95.5,93.6 to 96.9,947
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,86.4,77.8 to 95.0,113
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,86.6,80.3 to 93.0,210
Hep B,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,88.2 to 97.1,211
Hib,≥2 Doses,States/Local Areas,Washington,2012,Age,13 Months,90.8,88.1 to 93.0,252
Hib,≥2 Doses,States/Local Areas,Washington,2011,Age,13 Months,95.1,90.1 to 97.6,241
Hib,≥2 Doses,States/Local Areas,Washington,2018,Age,7 Months,92.9,88.2 to 95.8,492
Hib,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,93.5,90.8 to 95.5,947
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2015,Age,0-3 Days,74.1,66.2 to 80.7,278
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2015-2016,Age,0-3 Days,74.0,68.5 to 78.9,558
DTaP,≥3 Doses,States/Local Areas,Washington,2016,Age,7 Months,75.4,67.4 to 82.0,280
DTaP,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,72.6,67.7 to 77.1,747
DTaP,≥3 Doses,States/Local Areas,Washington,2015,Age,7 Months,73.5,65.3 to 80.3,278
DTaP,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,74.4,68.9 to 79.3,558
DTaP,≥3 Doses,States/Local Areas,Washington,2014,Age,7 Months,70.9,63.4 to 77.3,304
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,72.2,66.8 to 77.0,582
Polio,≥1 Dose,States/Local Areas,Washington,2017,Age,3 Months,83.4,77.9 to 87.7,467
Polio,≥1 Dose,States/Local Areas,Washington,2017-2018,Age,3 Months,87.0,83.5 to 89.8,959
Hib,≥3 Doses,States/Local Areas,Washington,2015,Age,7 Months,59.4,50.8 to 67.4,278
Hib,≥3 Doses,States/Local Areas,Washington,2015-2016,Age,7 Months,62.8,56.8 to 68.4,558
Hib,≥3 Doses,States/Local Areas,Washington,2014,Age,7 Months,65.3,57.9 to 72.1,304
Hib,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,7 Months,62.4,56.7 to 67.7,582
PCV,≥3 Doses,States/Local Areas,Washington,2018,Age,35 Months,95.7,93.0 to 97.6,492
PCV,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,35 Months,96.2,94.4 to 97.6,947
Hib,≥2 Doses,States/Local Areas,Washington,2013,Age,13 Months,93.1,88.5 to 96.0,313
Hib,≥2 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,92.6,89.0 to 95.2,617
PCV,≥3 Doses,States/Local Areas,Washington,2017,Age,35 Months,93.4,89.8 to 96.1,467
PCV,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,35 Months,94.7,92.5 to 96.4,959
DTaP,≥3 Doses,States/Local Areas,Washington,2018,Age,7 Months,79.6,74.2 to 84.1,492
DTaP,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,80.3,76.5 to 83.5,947
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2019,Age,0-3 Days,83.8,78.8 to 87.8,455
DTaP,≥3 Doses,States/Local Areas,Washington,2017,Age,7 Months,69.8,63.7 to 75.3,467
DTaP,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,74.7,70.6 to 78.3,959
PCV,≥3 Doses,States/Local Areas,Washington,2019,Age,35 Months,96.8,94.1 to 98.5,455
PCV,≥3 Doses,States/Local Areas,Washington,2016,Age,35 Months,87.4,80.5 to 92.8,280
PCV,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,35 Months,90.6,86.8 to 93.8,747
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,91.2,81.7 to 100.0,52
Hib,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,7 Months,63.7,59.4 to 67.8,617
Hib,≥2 Doses,States/Local Areas,Washington,2019,Age,7 Months,94.2,90.7 to 96.4,455
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,69.9,53.6 to 86.3,52
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,73.5,68.8 to 78.2,679
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,73.1,67.2 to 78.9,352
Polio,≥1 Dose,States/Local Areas,Washington,2019,Age,3 Months,93.8,90.2 to 96.2,455
Hib,Full Series,States/Local Areas,Washington,2020,Age,24 Months,83.8,78.6 to 88.4,445
Polio,≥1 Dose,States/Local Areas,Washington,2018,Age,3 Months,90.6,85.9 to 93.9,492
Polio,≥1 Dose,States/Local Areas,Washington,2018-2019,Age,3 Months,92.2,89.4 to 94.4,947
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2018,Age,0-3 Days,80.3,75.2 to 84.6,492
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2018-2019,Age,0-3 Days,82.0,78.5 to 85.1,947
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,89.1,83.3 to 94.9,210
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,87.2 to 97.8,211
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,86.4,81.6 to 91.1,352
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,92.9,89.8 to 96.0,679
DTaP,≥3 Doses,States/Local Areas,Washington,2019,Age,7 Months,80.9,75.5 to 85.4,455
Hib,≥3 Doses,States/Local Areas,Washington,2017,Age,7 Months,62.3,56.1 to 68.1,467
Hib,≥3 Doses,States/Local Areas,Washington,2017-2018,Age,7 Months,64.5,60.3 to 68.6,959
Hib,≥2 Doses,States/Local Areas,Washington,2014,Age,13 Months,92.2,87.5 to 95.2,304
Hib,≥2 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,92.3,88.8 to 94.8,582
Hib,≥2 Doses,States/Local Areas,Washington,2015,Age,13 Months,92.4,86.4 to 95.9,278
Hib,≥2 Doses,States/Local Areas,Washington,2015-2016,Age,13 Months,90.0,85.4 to 93.3,558
Hib,≥2 Doses,States/Local Areas,Washington,2016,Age,13 Months,87.6,80.1 to 92.6,280
Hib,≥2 Doses,States/Local Areas,Washington,2016-2017,Age,13 Months,90.0,85.9 to 93.0,747
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,88.1,82.7 to 93.5,237
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Overall,Overall,89.2,86.4 to 92.0,1097
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.0,83.2 to 92.9,391
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,92.4,85.4 to 99.4,113
Hib,≥2 Doses,States/Local Areas,Washington,2019,Age,13 Months,97.5,95.1 to 98.8,455
Hib,≥2 Doses,States/Local Areas,Washington,2018,Age,13 Months,96.0,93.2 to 97.7,492
Hib,≥2 Doses,States/Local Areas,Washington,2018-2019,Age,13 Months,96.8,95.0 to 97.9,947
Hib,≥2 Doses,States/Local Areas,Washington,2017,Age,13 Months,92.5,88.5 to 95.1,467
Hib,≥2 Doses,States/Local Areas,Washington,2017-2018,Age,13 Months,94.2,91.9 to 95.9,959
Hib,≥3 Doses,States/Local Areas,Washington,2016,Age,7 Months,66.2,57.8 to 73.7,280
Hib,≥3 Doses,States/Local Areas,Washington,2016-2017,Age,7 Months,64.3,59.1 to 69.1,747
Hib,≥3 Doses,States/Local Areas,Washington,2018,Age,7 Months,66.8,60.8 to 72.3,492
Hib,≥3 Doses,States/Local Areas,Washington,2018-2019,Age,7 Months,69.3,65.2 to 73.1,947
Hib,≥3 Doses,States/Local Areas,Washington,2019,Age,7 Months,71.8,66.0 to 77.0,455
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Overall,Overall,72.4,68.7 to 76.1,1097
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,71.6,60.4 to 82.8,113
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,72.4,67.4 to 77.4,593
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.6,66.4 to 78.8,391
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.9,63.7 to 74.0,651
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.1,71.0 to 85.2,211
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,74.9,67.1 to 82.7,210
DTaP,≥3 Doses,States/Local Areas,Washington,2013,Age,13 Months,90.0,86.1 to 92.8,313
DTaP,≥3 Doses,States/Local Areas,Washington,2013-2014,Age,13 Months,89.6,85.5 to 92.7,617
DTaP,≥3 Doses,States/Local Areas,Washington,2014,Age,13 Months,89.3,83.5 to 93.3,304
DTaP,≥3 Doses,States/Local Areas,Washington,2014-2015,Age,13 Months,87.4,82.8 to 90.9,582
PCV,≥1 Dose,States/Local Areas,Washington,2019,Age,3 Months,92.4,88.4 to 95.1,455
DTaP,≥3 Doses,States/Local Areas,Washington,2012,Age,13 Months,92.5,87.8 to 95.5,252
DTaP,≥3 Doses,States/Local Areas,Washington,2011,Age,13 Months,89.7,85.3 to 93.0,241
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,85.6 to 93.2,593
PCV,≥3 Doses,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.0,84.0 to 92.1,651
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,77.2,70.6 to 83.8,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,74.8,69.1 to 80.6,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,65.8,59.3 to 72.3,412
Rotavirus,,States/Local Areas,Washington,2019,Age,8 Months,79.6,74.1 to 84.3,455
Rotavirus,,States/Local Areas,Washington,2017,Age,8 Months,71.5,65.4 to 76.9,467
Rotavirus,,States/Local Areas,Washington,2017-2018,Age,8 Months,76.9,72.9 to 80.5,959
Rotavirus,,States/Local Areas,Washington,2018,Age,8 Months,82.4,77.1 to 86.8,492
Rotavirus,,States/Local Areas,Washington,2018-2019,Age,8 Months,81.0,77.3 to 84.3,947
Hep B,≥3 Doses,States/Local Areas,Washington,2021,Age,13 Months,90.9,85.1 to 94.6,262
Hib,≥2 Doses,States/Local Areas,Washington,2021,Age,5 Months,79.1,71.6 to 85.1,262
≥1 Dose MMR,,States/Local Areas,Washington,2021,Age,19 Months,90.1,83.8 to 94.2,262
Hib,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,94.0,90.5 to 96.5,707
Rotavirus,,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,83.8,78.6 to 89.0,448
Polio,≥3 Doses,States/Local Areas,Washington,2021,Age,19 Months,92.8,87.0 to 96.1,262
DTaP,≥2 Doses,States/Local Areas,Washington,2021,Age,5 Months,81.1,73.7 to 86.8,262
Hib,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,90.7,87.1 to 93.3,707
≥1 Dose Varicella,,States/Local Areas,Washington,2021,Age,13 Months,66.5,58.4 to 73.8,262
Combined 7 Series,,States/Local Areas,Washington,2021,Age,24 Months,70.8,62.9 to 78.3,262
DTaP,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,92.5,89.2 to 94.9,707
Hep A,≥2 Doses,States/Local Areas,Washington,2021,Age,19 Months,27.5,21.0 to 35.1,262
Polio,≥2 Doses,States/Local Areas,Washington,2021,Age,5 Months,81.1,73.7 to 86.8,262
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Washington,2020-2021,Age,0-2 Days,83.3,79.3 to 86.6,707
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Washington,2020-2021,Age,0-1 Days,82.0,78.0 to 85.5,707
Hib,Full Series,States/Local Areas,Washington,2020-2021,Age,35 Months,87.1,82.6 to 91.0,707
≥1 Dose Varicella,,States/Local Areas,Washington,2021,Age,35 Months,98.5,91.7 to 99.9,262
Polio,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,93.6,90.3 to 95.8,707
DTaP,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,91.5,88.1 to 94.0,707
PCV,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,69.9,64.9 to 74.5,707
PCV,≥1 Dose,States/Local Areas,Washington,2021,Age,3 Months,91.4,85.7 to 95.0,262
Rotavirus,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,69.4,61.0 to 77.7,210
Rotavirus,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,64.8,58.3 to 71.3,352
Rotavirus,,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,66.8,59.1 to 74.5,237
Rotavirus,,States/Local Areas,Washington,2014-2017,Overall,Overall,73.4,69.6 to 77.1,1097
Rotavirus,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.9,65.6 to 78.1,391
Rotavirus,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,67.5,55.2 to 79.9,113
Rotavirus,,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,69.0,62.6 to 75.5,412
Rotavirus,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,83.4,79.3 to 87.4,679
Rotavirus,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,63.0,44.7 to 81.2,52
Rotavirus,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,75.5,70.4 to 80.6,593
Rotavirus,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.0,69.0 to 79.0,651
Rotavirus,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.0,67.5 to 84.6,211
≥1 Dose Varicella,,States/Local Areas,Washington,2019-2020,Age,19 Months,89.4,86.3 to 91.9,900
Influenza,,States/Local Areas,Washington,2011,Age,24 Months,54.9,46.4 to 63.8,241
Influenza,,States/Local Areas,Washington,2012,Age,24 Months,59.5,51.4 to 67.8,252
Influenza,,States/Local Areas,Washington,2015,Age,24 Months,65.8,57.7 to 73.7,278
Influenza,,States/Local Areas,Washington,2015-2016,Age,24 Months,65.2,59.5 to 70.9,558
Influenza,,States/Local Areas,Washington,2014,Age,24 Months,57.0,49.6 to 64.7,304
Influenza,,States/Local Areas,Washington,2014-2015,Age,24 Months,61.4,55.9 to 67.0,582
Influenza,,States/Local Areas,Washington,2013,Age,24 Months,61.4,54.4 to 68.4,313
Influenza,,States/Local Areas,Washington,2013-2014,Age,24 Months,59.2,54.0 to 64.4,617
Influenza,,States/Local Areas,Washington,2019,Age,24 Months,74.7,69.1 to 79.9,455
Influenza,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Private Insurance Only,72.7,67.9 to 77.5,679
Influenza,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Other,64.1,45.9 to 82.3,52
PCV,≥4 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,89.8,86.7 to 92.9,963
Polio,≥2 Doses,States/Local Areas,Washington,2021,Age,13 Months,95.0,89.5 to 97.7,262
Hib,Full Series,States/Local Areas,Washington,2020-2021,Age,24 Months,82.6,78.2 to 86.5,707
≥1 Dose MMR,,States/Local Areas,Washington,2021,Age,35 Months,98.4,91.3 to 99.9,262
Hep B,≥1 Dose,States/Local Areas,Washington,2021,Age,3 Months,94.6,89.2 to 97.4,262
Influenza,,States/Local Areas,Washington,2014-2017,Overall,Overall,63.2,59.1 to 67.2,1097
Hib,Full Series,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,88.3,84.9 to 91.7,963
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Race and Ethnicity,Hispanic,88.6,83.1 to 94.2,298
Hib,Full Series,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.0,73.2 to 86.9,317
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,95.3,92.7 to 97.8,963
PCV,≥3 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,86.9 to 97.0,317
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,69.2 to 86.7,317
Influenza,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Principal City,65.5,60.1 to 71.0,593
Influenza,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"White, Non-Hispanic",59.2,53.7 to 64.7,651
Influenza,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a MSA Non-Principal City,63.9,57.1 to 70.7,391
Influenza,,States/Local Areas,Washington,2014-2017,Urbanicity,Living In a Non-MSA,48.2,35.7 to 60.7,113
Influenza,,States/Local Areas,Washington,2014-2017,Insurance Coverage,Any Medicaid,53.9,47.2 to 60.7,352
Influenza,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,Hispanic,62.9,54.3 to 71.5,210
Influenza,,States/Local Areas,Washington,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.8,66.5 to 83.1,211
Influenza,,States/Local Areas,Washington,2017,Age,24 Months,69.2,63.4 to 74.8,467
Influenza,,States/Local Areas,Washington,2017-2018,Age,24 Months,71.9,68.0 to 75.8,959
Influenza,,States/Local Areas,Washington,2018,Age,24 Months,74.7,69.4 to 79.8,492
Influenza,,States/Local Areas,Washington,2018-2019,Age,24 Months,74.8,70.9 to 78.5,947
Influenza,,States/Local Areas,Washington,2016,Age,24 Months,64.5,56.3 to 72.5,280
Influenza,,States/Local Areas,Washington,2016-2017,Age,24 Months,66.8,61.8 to 71.7,747
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.7,56.3 to 93.1,44
Hep A,≥2 Doses,States/Local Areas,Washington,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.3,67.5 to 79.2,885
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Insurance Coverage,Any Medicaid,86.0,81.9 to 90.2,512
Hep A,≥1 Dose,States/Local Areas,Washington,2016-2019,Insurance Coverage,Private Insurance Only,90.5,87.4 to 93.6,963
Influenza,,States/Local Areas,Washington,2014-2017,Poverty,133% to <400% FPL,55.3,48.6 to 62.0,412
Influenza,,States/Local Areas,Washington,2014-2017,Poverty,<133% FPL,53.9,45.7 to 62.2,237
Influenza,,States/Local Areas,Washington,2014-2017,Poverty,>400% FPL,79.8,74.2 to 85.5,448
DTaP,≥4 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,80.1,75.5 to 84.3,707
Hep B,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,3 Months,94.3,91.2 to 96.4,707
Hib,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,89.3,85.5 to 92.1,707
≥1 Dose MMR,,States/Local Areas,Washington,2021,Age,13 Months,71.0,63.0 to 77.8,262
PCV,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,3 Months,87.7,84.0 to 90.6,707
Hib,≥3 Doses,States/Local Areas,Washington,2021,Age,35 Months,95.9,86.4 to 99.4,262
Hib,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,83.8,79.6 to 87.3,707
≥1 Dose Varicella,,States/Local Areas,Washington,2020-2021,Age,13 Months,65.8,60.8 to 70.6,707
Influenza,,States/Local Areas,Washington,2021,Age,24 Months,65.2,57.0 to 73.3,262
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2021,Age,0-3 Days,86.8,80.7 to 91.1,262
Hib,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,63.9,58.8 to 68.8,707
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Washington,2020-2021,Age,0-3 Days,84.2,80.3 to 87.5,707
DTaP,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,93.1,90.1 to 95.5,707
PCV,≥4 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,80.1,75.5 to 84.1,707
≥1 Dose MMR,,States/Local Areas,Washington,2020-2021,Age,19 Months,89.6,85.8 to 92.5,707
Rotavirus,,States/Local Areas,Washington,2020-2021,Age,8 Months,76.8,72.1 to 80.9,707
Hib,Full Series,States/Local Areas,Washington,2020-2021,Age,19 Months,76.6,71.7 to 80.9,707
Hep A,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,24 Months,90.9,87.6 to 93.6,707
DTaP,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,5 Months,81.5,77.0 to 85.2,707
Hep B,≥3 Doses,States/Local Areas,Washington,2021,Age,35 Months,92.5,87.3 to 96.2,262
DTaP,≥4 Doses,States/Local Areas,Washington,2021,Age,35 Months,94.9,84.2 to 99.2,262
Polio,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,5 Months,80.9,76.4 to 84.7,707
Polio,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,91.2,87.8 to 93.7,707
PCV,≥4 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,87.1,82.3 to 91.0,707
Hib,Primary Series,States/Local Areas,Washington,2020-2021,Age,19 Months,93.2,90.2 to 95.3,707
Hib,Primary Series,States/Local Areas,Washington,2021,Age,13 Months,90.2,84.2 to 94.1,262
PCV,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,92.1,88.7 to 94.5,707
Influenza,,States/Local Areas,Washington,2020-2021,Age,24 Months,67.7,62.7 to 72.7,707
≥1 Dose MMR,,States/Local Areas,Washington,2020-2021,Age,35 Months,92.8,89.3 to 95.5,707
Hep B,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,93.2,89.9 to 95.4,707
PCV,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,93.1,90.0 to 95.5,707
Combined 7 Series,,States/Local Areas,Washington,2020-2021,Age,24 Months,72.4,67.6 to 77.0,707
DTaP,≥3 Doses,States/Local Areas,Washington,2021,Age,35 Months,93.9,88.1 to 97.5,262
Hib,≥3 Doses,States/Local Areas,Washington,2021,Age,13 Months,84.8,77.8 to 89.8,262
PCV,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,92.3,89.1 to 94.8,707
≥1 Dose Varicella,,States/Local Areas,Washington,2020-2021,Age,19 Months,89.7,85.9 to 92.5,707
Hib,Full Series,States/Local Areas,Washington,2021,Age,35 Months,93.5,81.2 to 98.8,262
Polio,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,94.1,90.4 to 96.7,707
Hep A,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,79.0,73.2 to 84.2,707
Polio,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,3 Months,87.9,84.1 to 90.9,707
Polio,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,92.4,89.3 to 94.9,707
Hib,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,5 Months,80.2,75.7 to 84.1,707
Hep B,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,5 Months,91.2,87.7 to 93.7,707
DTaP,≥4 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,72.0,67.0 to 76.5,707
DTaP,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,71.9,66.9 to 76.5,707
Hib,Primary Series,States/Local Areas,Washington,2021,Age,35 Months,94.2,89.6 to 97.2,262
Hib,Primary Series,States/Local Areas,Washington,2020-2021,Age,7 Months,73.6,68.6 to 78.0,707
PCV,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,13 Months,89.5,85.9 to 92.3,707
DTaP,≥4 Doses,States/Local Areas,Washington,2020-2021,Age,35 Months,88.7,84.2 to 92.3,707
Hep B,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,93.1,90.1 to 95.5,707
Hib,≥2 Doses,States/Local Areas,Washington,2021,Age,13 Months,94.3,88.6 to 97.2,262
Rotavirus,,States/Local Areas,Washington,2021,Age,8 Months,78.1,70.5 to 84.3,262
Hib,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,3 Months,87.7,84.0 to 90.7,707
Hep B,≥2 Doses,States/Local Areas,Washington,2021,Age,13 Months,95.0,89.6 to 97.7,262
Hep A,≥2 Doses,States/Local Areas,Washington,2020-2021,Age,24 Months,48.6,43.5 to 54.1,707
≥1 Dose Varicella,,States/Local Areas,Washington,2020-2021,Age,24 Months,91.7,88.4 to 94.4,707
Hib,Primary Series,States/Local Areas,Washington,2020-2021,Age,35 Months,94.5,91.4 to 96.8,707
Hep B,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,7 Months,68.5,63.4 to 73.2,707
Hep A,≥1 Dose,States/Local Areas,Washington,2020-2021,Age,19 Months,88.2,84.4 to 91.2,707
Hep B,≥3 Doses,States/Local Areas,Washington,2020-2021,Age,19 Months,92.0,88.6 to 94.5,707
DTaP,≥3 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,86.3,82.1 to 89.6,231
Hib,≥3 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,73.5,66.9 to 79.2,281
Hib,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,76.0,71.5 to 79.9,577
DTaP,≥3 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,89.5,86.5 to 91.8,254
DTaP,≥3 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,92.2,90.0 to 93.9,231
Polio,≥3 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,91.4,85.8 to 94.9,259
Polio,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,93.0,89.9 to 95.3,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,92.2,87.8 to 95.1,296
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,91.8,88.5 to 94.2,555
Polio,≥3 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,91.9,84.1 to 96.1,281
Polio,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,92.1,89.1 to 94.3,577
Hib,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,74.4,69.6 to 78.7,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,75.3,68.1 to 81.3,259
Hib,≥3 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,78.5,72.6 to 83.5,296
Hib,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,76.9,72.4 to 80.9,555
Polio,≥3 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,94.8,91.4 to 96.9,268
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,93.4,90.7 to 95.3,549
Polio,≥3 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,86.9,83.3 to 89.9,254
Polio,≥3 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,85.0,83.1 to 86.8,243
Polio,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,89.9,85.2 to 93.2,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,91.1,86.1 to 94.4,252
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,87.9,83.7 to 91.2,453
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,84.8,77.4 to 90.0,201
Hib,≥2 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,91.6,85.9 to 95.2,259
Hib,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,93.4,90.0 to 95.8,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,95.3,90.6 to 97.7,252
Hib,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,93.7,90.4 to 95.9,453
Hib,≥2 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,92.2,86.6 to 95.5,201
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,92.8,90.1 to 95.6,386
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.3,91.3 to 97.3,335
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,93.3,91.6 to 95.1,1023
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,92.2,89.5 to 95.0,410
PCV,≥1 Dose,States/Local Areas,West Virginia,2019,Age,3 Months,84.5,76.8 to 90.0,201
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.9,73.4 to 84.3,335
Hib,≥2 Doses,States/Local Areas,West Virginia,2020,Age,13 Months,87.3,80.7 to 91.9,271
DTaP,≥3 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,86.8,82.8 to 89.9,254
Hib,≥3 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,73.5,66.8 to 79.3,252
Hib,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,71.1,65.9 to 75.8,453
Hib,≥3 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,92.5,90.1 to 94.4,231
Hib,≥3 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,88.0,83.2 to 91.6,254
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,90.0,84.9 to 93.5,296
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,88.9,85.2 to 91.8,555
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,87.8,81.8 to 92.1,259
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,89.4,85.7 to 92.3,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,91.7,87.2 to 94.7,281
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,90.9,87.7 to 93.3,577
Polio,≥3 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,89.8,86.2 to 92.5,231
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,93.7,90.9 to 96.6,418
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,95.8,92.6 to 99.0,195
Hib,≥3 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,77.2,75.0 to 79.3,243
Hib,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,76.1,72.6 to 79.2,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,74.8,68.2 to 80.5,268
Hib,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,74.2,69.6 to 78.3,549
Hib,≥3 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,81.6,77.7 to 85.0,254
Hib,≥3 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,85.2,81.6 to 88.2,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.7,89.6 to 93.8,872
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,84.5 to 93.3,302
Hib,≥3 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,57.3,49.7 to 64.6,259
Hib,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,60.0,54.7 to 65.0,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,67.2,58.8 to 74.6,201
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,87.5,81.8 to 91.6,268
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,89.6,86.1 to 92.3,549
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,85.8,83.8 to 87.6,243
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,86.7,84.6 to 88.5,511
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,77.7,61.9 to 93.4,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.9,59.6 to 82.2,87
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.6,69.1 to 76.0,872
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.9,69.4 to 80.4,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,66.2,59.8 to 72.6,302
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,76.1,71.3 to 80.9,386
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Overall,Overall,72.7,69.5 to 75.9,1023
Hib,≥3 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,49.3,41.2 to 57.5,201
Hib,≥3 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,62.7,55.6 to 69.3,252
Hib,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,56.1,50.6 to 61.4,453
Hib,≥3 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,61.7,55.0 to 68.0,296
Hib,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,59.5,54.4 to 64.4,555
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,69.0,63.8 to 74.2,418
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,80.2,74.0 to 86.4,195
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,73.2,68.2 to 78.1,410
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,92.0 to 95.7,872
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,89.4 to 96.2,302
Hib,≥2 Doses,States/Local Areas,West Virginia,2018,Age,5 Months,79.0,72.4 to 84.4,252
Hib,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,5 Months,75.8,70.7 to 80.3,453
PCV,≥3 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,93.4,89.2 to 96.4,281
PCV,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,92.6,89.5 to 95.1,577
Hib,≥2 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,85.7,83.8 to 87.5,254
PCV,≥3 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,91.8,87.3 to 95.1,296
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,91.8,88.6 to 94.4,555
PCV,≥3 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,91.9,87.1 to 95.4,259
PCV,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,91.9,88.8 to 94.4,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,93.4,89.2 to 96.4,281
PCV,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,93.0,89.8 to 95.5,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,95.1,92.0 to 97.2,268
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,94.3,91.8 to 96.2,549
Hib,≥2 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,86.5,80.1 to 91.1,259
Hib,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,88.9,85.0 to 91.9,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,91.0,86.0 to 94.3,296
Hib,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,88.7,84.9 to 91.7,555
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016,Age,0-3 Days,73.6,66.8 to 79.5,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2016-2017,Age,0-3 Days,77.1,72.5 to 81.1,555
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2017,Age,0-3 Days,78.0,68.9 to 85.0,175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2017-2018,Age,0-3 Days,82.5,78.4 to 85.9,511
Polio,≥1 Dose,States/Local Areas,West Virginia,2016,Age,3 Months,86.8,81.2 to 90.9,296
Polio,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,3 Months,85.4,81.3 to 88.7,555
Polio,≥1 Dose,States/Local Areas,West Virginia,2015,Age,3 Months,87.5,82.1 to 91.4,281
Polio,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,3 Months,87.2,83.4 to 90.2,577
Polio,≥1 Dose,States/Local Areas,West Virginia,2014,Age,3 Months,84.9,78.8 to 89.5,268
Polio,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,3 Months,86.2,82.3 to 89.4,549
Hib,≥3 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,61.9,58.2 to 65.5,254
Hib,≥3 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,61.5,53.0 to 69.3,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,92.7,89.7 to 95.8,418
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,94.1,90.5 to 97.7,195
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,89.3,86.0 to 92.6,410
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.7,84.1 to 97.3,87
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,92.0,82.9 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,90.9,87.7 to 94.1,386
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.9,91.0 to 96.8,335
Hib,≥2 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,91.3,86.2 to 94.7,252
Hib,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,88.9,85.0 to 91.9,453
Hib,≥2 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,94.8,91.2 to 97.0,231
Hib,≥2 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,92.0,87.4 to 95.0,254
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2015,Age,0-3 Days,68.3,61.5 to 74.4,281
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2015-2016,Age,0-3 Days,70.9,66.1 to 75.2,577
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,69.7,63.0 to 75.7,296
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,68.7,63.8 to 73.3,555
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,62.1,54.7 to 68.9,268
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,64.8,59.8 to 69.5,549
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,67.5,60.6 to 73.7,281
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,68.6,63.8 to 72.9,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,93.5,88.2 to 96.9,259
PCV,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,93.9,90.5 to 96.4,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,93.6,91.0 to 95.5,243
Hib,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,94.0,92.4 to 95.3,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,94.4,90.1 to 97.2,252
PCV,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,92.7,89.0 to 95.6,453
Hib,≥3 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,51.3,44.1 to 58.5,268
Hib,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,49.6,44.6 to 54.6,549
Hib,≥3 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,47.9,41.0 to 54.8,281
Hib,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,54.5,49.6 to 59.4,577
Polio,≥1 Dose,States/Local Areas,West Virginia,2017,Age,3 Months,83.9,77.5 to 88.7,259
Polio,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,3 Months,87.1,83.1 to 90.2,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,94.4,90.3 to 96.8,296
Hib,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,93.0,89.7 to 95.3,555
Hib,≥2 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,92.9,88.4 to 95.8,281
Hib,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,93.6,90.8 to 95.7,577
Hib,≥2 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,94.4,90.4 to 96.8,268
Hib,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,93.7,90.9 to 95.7,549
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.1 to 97.2,432
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,93.3,90.9 to 95.7,500
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,83.6 to 97.9,87
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,89.6,79.5 to 99.7,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2018,Age,0-3 Days,84.5,79.0 to 88.7,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2018-2019,Age,0-3 Days,82.0,77.3 to 85.9,453
Polio,≥1 Dose,States/Local Areas,West Virginia,2018,Age,3 Months,90.3,84.9 to 94.0,252
Polio,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,3 Months,89.0,84.7 to 92.2,453
Polio,≥1 Dose,States/Local Areas,West Virginia,2019,Age,3 Months,87.7,80.3 to 92.5,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,72.7,68.2 to 77.2,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,73.4,68.6 to 78.2,432
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,75.0,63.3 to 86.8,67
Hib,≥2 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,86.4,79.9 to 91.1,201
Hib,≥3 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,51.8,49.3 to 54.3,243
Hib,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,51.6,47.8 to 55.3,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2020,Age,24 Months,88.4,82.5 to 92.9,271
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,91.5,84.1 to 98.8,67
PCV,≥3 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,92.3,87.7 to 95.6,296
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,92.8,89.5 to 95.4,555
PCV,≥3 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,90.1,84.1 to 94.5,201
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,67.7,60.2 to 74.4,259
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,72.6,67.6 to 77.0,511
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2019,Age,0-3 Days,79.5,71.6 to 85.7,201
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,77.5,70.9 to 83.0,252
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,72.4,67.1 to 77.1,453
PCV,≥4 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,82.6,76.1 to 88.2,268
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,85.3,81.0 to 89.0,549
PCV,≥4 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,87.8,82.0 to 92.4,281
PCV,≥4 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,86.4,82.3 to 89.9,577
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.4,77.0 to 93.8,87
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,70.6,54.5 to 86.8,39
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,84.0,80.2 to 87.7,500
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,92.6,89.8 to 95.4,432
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,95.0,91.6 to 97.4,252
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,95.5,92.6 to 97.5,453
PCV,≥3 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,94.4,90.9 to 96.6,268
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,93.4,90.7 to 95.4,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,95.9,91.2 to 98.5,201
≥1 Dose MMR,,States/Local Areas,West Virginia,2012,Age,24 Months,92.9,87.6 to 96.5,254
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017,Age,24 Months,91.3,86.8 to 94.8,259
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017-2018,Age,24 Months,90.3,87.0 to 93.1,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019,Age,24 Months,89.4,83.2 to 94.0,201
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,48.5,25.7 to 71.2,39
PCV,≥4 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,73.4,65.3 to 80.1,201
PCV,≥4 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,84.4,77.0 to 90.5,243
PCV,≥4 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,83.6,78.8 to 87.8,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,90.5,85.8 to 93.8,254
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,98.2,94.1 to 99.7,259
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,96.9,94.0 to 98.6,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,77.3,70.7 to 83.2,252
PCV,≥4 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,78.2,73.4 to 82.7,453
PCV,≥4 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,79.7,72.4 to 86.1,201
PCV,≥4 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,88.0,78.8 to 94.5,254
PCV,≥4 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,85.7,75.6 to 93.1,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,87.6,82.0 to 92.1,296
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,93.3,89.2 to 96.3,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,93.4,89.0 to 96.4,281
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,90.4,87.0 to 93.3,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,90.0,88.1 to 91.6,243
PCV,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,92.2,89.4 to 94.2,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,89.9,85.1 to 93.3,231
Hep B,≥2 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,96.0,92.7 to 97.8,268
Hep B,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,94.3,91.6 to 96.1,549
Hib,≥1 Dose,States/Local Areas,West Virginia,2014,Age,3 Months,84.7,78.5 to 89.3,268
Hib,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,3 Months,85.2,81.2 to 88.5,549
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2019,Age,0-2 Days,79.1,71.2 to 85.3,201
Hep B,≥2 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,95.4,93.1 to 96.9,243
Hep B,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,95.7,94.7 to 96.4,511
Hep B,≥2 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,92.5,87.9 to 95.5,281
Hep B,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,93.2,90.2 to 95.3,577
Hib,≥1 Dose,States/Local Areas,West Virginia,2011,Age,3 Months,86.3,82.0 to 89.7,231
Hib,≥1 Dose,States/Local Areas,West Virginia,2012,Age,3 Months,82.0,79.0 to 84.7,254
Hib,≥1 Dose,States/Local Areas,West Virginia,2013,Age,3 Months,82.1,77.8 to 85.7,243
Hib,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,3 Months,83.4,78.7 to 87.2,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,74.0,58.1 to 89.8,39
PCV,≥3 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,87.4,81.9 to 91.4,296
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,87.5,83.6 to 90.5,555
Hep B,≥2 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,94.4,89.5 to 97.0,201
PCV,≥3 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,85.6,79.4 to 90.2,252
PCV,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,84.0,79.2 to 87.8,453
Hib,Full Series,States/Local Areas,West Virginia,2020,Age,24 Months,72.1,64.8 to 79.0,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2018,Age,0-2 Days,84.4,78.9 to 88.6,252
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2018-2019,Age,0-2 Days,81.8,77.1 to 85.7,453
Hep B,≥2 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,95.2,91.9 to 97.2,252
Hep B,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,94.8,92.1 to 96.6,453
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,93.3,87.5 to 97.1,243
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,94.2,91.1 to 96.5,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,95.3,92.1 to 97.4,268
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,94.3,91.7 to 96.2,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,88.5,82.0 to 93.5,254
PCV,≥3 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,87.5,81.6 to 91.7,259
PCV,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,86.6,82.5 to 89.8,511
Hep B,≥2 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,92.8,82.8 to 97.2,254
Hep B,≥2 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,95.7,90.5 to 98.1,231
PCV,≥4 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,80.7,75.0 to 85.8,296
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,82.1,78.1 to 85.8,555
PCV,≥4 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,83.6,77.9 to 88.6,259
PCV,≥4 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,80.5,76.2 to 84.4,511
≥1 Dose MMR,,States/Local Areas,West Virginia,2014,Age,35 Months,92.4,87.4 to 96.0,268
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2015,Age,35 Months,92.5,88.8 to 95.3,549
≥1 Dose MMR,,States/Local Areas,West Virginia,2015,Age,35 Months,92.4,86.4 to 96.4,281
≥1 Dose MMR,,States/Local Areas,West Virginia,2015-2016,Age,35 Months,91.5,87.7 to 94.5,577
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018,Age,35 Months,95.3,89.1 to 98.5,252
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018-2019,Age,35 Months,92.8,88.7 to 95.9,453
PCV,≥4 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,84.2,78.7 to 88.9,281
PCV,≥4 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,82.4,78.4 to 86.1,577
≥1 Dose MMR,,States/Local Areas,West Virginia,2016,Age,35 Months,90.4,85.4 to 94.2,296
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2017,Age,35 Months,92.6,89.1 to 95.4,555
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019,Age,35 Months,90.8,84.4 to 95.4,201
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,90.9,87.6 to 94.2,432
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,86.9,83.5 to 90.2,500
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.8,86.3 to 91.3,872
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,84.5 to 93.4,302
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,90.8,86.2 to 95.5,195
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,89.7,86.1 to 93.2,418
Hib,≥1 Dose,States/Local Areas,West Virginia,2017,Age,3 Months,82.7,76.2 to 87.7,259
Hib,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,3 Months,84.4,80.0 to 87.9,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,82.3,74.6 to 88.0,201
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,82.1,70.5 to 93.7,67
PCV,≥3 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,88.4,81.7 to 92.8,201
PCV,≥3 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,90.9,84.9 to 95.2,254
PCV,≥3 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,90.4,84.8 to 94.6,243
PCV,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,92.7,89.6 to 95.2,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,95.1,92.0 to 97.2,268
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,94.3,91.8 to 96.2,549
PCV,≥1 Dose,States/Local Areas,West Virginia,2013,Age,3 Months,84.4,75.5 to 90.5,243
PCV,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,3 Months,84.1,79.9 to 87.5,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,76.5,72.1 to 80.9,500
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,74.8,62.3 to 87.3,67
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,66.4,49.6 to 83.3,39
Hib,≥2 Doses,States/Local Areas,West Virginia,2016,Age,5 Months,73.1,66.5 to 78.8,296
Hib,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,5 Months,73.5,68.6 to 77.8,555
Hib,≥2 Doses,States/Local Areas,West Virginia,2015,Age,5 Months,75.8,69.4 to 81.2,281
Hib,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,5 Months,74.5,70.0 to 78.5,577
Hib,≥2 Doses,States/Local Areas,West Virginia,2014,Age,5 Months,68.7,61.2 to 75.2,268
Hib,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,5 Months,72.2,63.8 to 79.3,549
PCV,≥3 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,90.7,85.3 to 94.2,259
PCV,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,91.2,87.9 to 93.8,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2013,Age,5 Months,69.4,64.2 to 74.2,243
Hib,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,5 Months,69.1,62.0 to 75.3,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2011,Age,5 Months,76.6,73.5 to 79.5,231
Hib,≥2 Doses,States/Local Areas,West Virginia,2012,Age,5 Months,77.6,73.3 to 81.4,254
Hib,≥1 Dose,States/Local Areas,West Virginia,2019,Age,3 Months,84.4,76.8 to 89.8,201
Hib,≥1 Dose,States/Local Areas,West Virginia,2018,Age,3 Months,86.0,79.8 to 90.6,252
Hib,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,3 Months,85.2,80.5 to 88.9,453
PCV,≥4 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,82.3,74.9 to 88.6,201
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,88.8,85.5 to 92.2,432
PCV,≥3 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,91.7,86.1 to 95.7,231
PCV,≥3 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,91.8,87.1 to 94.9,252
PCV,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,84.0,79.2 to 87.8,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.7,83.5 to 91.8,335
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,84.8,80.6 to 88.9,386
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Overall,Overall,87.0,84.5 to 89.4,1023
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,83.6,79.4 to 87.8,410
PCV,≥1 Dose,States/Local Areas,West Virginia,2011,Age,3 Months,82.8,77.8 to 86.9,231
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,88.6,85.1 to 92.0,418
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,93.0,88.9 to 97.2,195
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,79.9,74.3 to 85.5,302
PCV,≥1 Dose,States/Local Areas,West Virginia,2017,Age,3 Months,83.1,76.7 to 88.0,259
PCV,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,3 Months,84.5,80.2 to 88.0,511
PCV,≥1 Dose,States/Local Areas,West Virginia,2016,Age,3 Months,87.0,81.7 to 91.0,296
PCV,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,3 Months,85.0,81.0 to 88.3,555
Hib,≥2 Doses,States/Local Areas,West Virginia,2019,Age,5 Months,72.6,64.5 to 79.4,201
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,89.2,80.0 to 98.3,67
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.4 to 96.4,432
PCV,≥1 Dose,States/Local Areas,West Virginia,2015,Age,3 Months,85.3,79.6 to 89.6,281
PCV,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,3 Months,86.1,82.4 to 89.2,577
PCV,≥4 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,83.5,76.8 to 89.1,252
PCV,≥4 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,83.0,78.0 to 87.4,453
PCV,≥4 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,84.9,79.1 to 89.8,296
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,86.4,82.3 to 90.0,555
Hep B,≥2 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,95.2,90.7 to 97.6,201
PCV,≥4 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,88.2,81.8 to 93.1,259
PCV,≥4 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,85.8,81.3 to 89.7,511
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2011,Age,0-3 Days,72.9,63.4 to 80.7,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,90.5,87.7 to 93.4,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2012,Age,0-3 Days,69.6,61.3 to 76.7,254
Hib,≥2 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,85.6,79.5 to 90.0,268
Hib,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,87.3,83.5 to 90.3,549
Hib,≥2 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,83.0,78.6 to 86.7,243
Hib,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,84.3,81.8 to 86.5,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.4,79.7 to 89.2,335
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,76.9,71.9 to 81.9,386
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,80.3,77.3 to 83.2,1023
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,92.4,88.4 to 96.4,195
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,73.4,68.5 to 78.4,410
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,83.9,79.6 to 88.1,418
Hib,≥2 Doses,States/Local Areas,West Virginia,2017,Age,5 Months,73.8,66.5 to 80.0,259
Hib,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,5 Months,76.4,71.5 to 80.7,511
Hib,≥2 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,88.8,87.8 to 89.7,231
PCV,≥1 Dose,States/Local Areas,West Virginia,2012,Age,3 Months,78.4,73.7 to 82.5,254
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.7,66.3 to 87.0,87
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.7,78.6 to 84.8,872
PCV,≥1 Dose,States/Local Areas,West Virginia,2014,Age,3 Months,83.7,77.6 to 88.5,268
PCV,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,3 Months,84.5,80.5 to 87.9,549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2013,Age,0-3 Days,74.2,67.1 to 80.2,243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2013-2014,Age,0-3 Days,74.3,69.5 to 78.5,511
Polio,≥1 Dose,States/Local Areas,West Virginia,2013,Age,3 Months,86.6,80.8 to 90.9,243
Polio,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,3 Months,85.8,82.7 to 88.3,511
Polio,≥1 Dose,States/Local Areas,West Virginia,2011,Age,3 Months,86.6,82.5 to 89.9,231
Polio,≥1 Dose,States/Local Areas,West Virginia,2012,Age,3 Months,82.6,78.7 to 85.9,254
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,91.3,89.3 to 93.3,1023
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014,Age,0-3 Days,74.3,67.6 to 80.1,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,West Virginia,2014-2015,Age,0-3 Days,71.3,66.6 to 75.6,549
PCV,≥1 Dose,States/Local Areas,West Virginia,2018,Age,3 Months,85.9,79.6 to 90.5,252
PCV,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,3 Months,85.2,80.5 to 89.0,453
DTaP,≥3 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,65.2,58.2 to 71.6,231
DTaP,≥3 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,66.8,62.8 to 70.5,254
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,61.6,58.3 to 64.8,243
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,61.8,57.8 to 65.7,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,91.8,87.5 to 95.1,252
PCV,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,90.7,87.2 to 93.6,453
Hib,≥2 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,89.0,84.0 to 92.5,281
Hib,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,89.9,86.6 to 92.5,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,96.2,90.7 to 98.9,243
PCV,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,95.4,92.6 to 97.4,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,92.8,87.1 to 96.5,231
PCV,≥3 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,89.7,83.7 to 94.1,201
PCV,≥3 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,93.0,87.5 to 96.7,254
≥1 Dose MMR,,States/Local Areas,West Virginia,2013,Age,13 Months,45.6,36.8 to 54.7,243
≥1 Dose MMR,,States/Local Areas,West Virginia,2013-2014,Age,13 Months,44.5,37.3 to 51.8,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018,Age,13 Months,57.2,49.8 to 64.2,252
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018-2019,Age,13 Months,50.7,45.3 to 56.2,453
≥1 Dose Varicella,,States/Local Areas,West Virginia,2012,Age,19 Months,84.9,82.1 to 87.3,254
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,91.2,88.3 to 94.1,418
≥1 Dose Varicella,,States/Local Areas,West Virginia,2011,Age,19 Months,77.9,73.8 to 81.6,231
DTaP,≥4 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,92.4,85.7 to 96.8,231
≥1 Dose MMR,,States/Local Areas,West Virginia,2014,Age,13 Months,43.3,36.4 to 50.5,268
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2015,Age,13 Months,44.3,39.5 to 49.3,549
≥1 Dose MMR,,States/Local Areas,West Virginia,2015,Age,13 Months,45.3,38.5 to 52.4,281
≥1 Dose MMR,,States/Local Areas,West Virginia,2015-2016,Age,13 Months,48.0,43.1 to 52.9,577
Hep A,≥2 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,81.7,72.6 to 89.2,252
Hep A,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,81.4,75.0 to 87.0,453
Hep A,≥2 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,79.0,71.1 to 86.0,259
Hep A,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,80.2,74.4 to 85.5,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,84.8,78.9 to 89.3,268
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,86.7,83.0 to 89.7,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,86.5,84.1 to 88.5,243
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,85.7,83.1 to 87.9,511
DTaP,≥4 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,86.3,77.6 to 92.8,243
DTaP,≥4 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,87.2,82.2 to 91.3,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,84.8,75.3 to 91.0,254
Hep A,≥2 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,81.2,72.4 to 88.6,201
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,87.9,81.9 to 92.6,268
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,89.6,85.6 to 92.8,549
DTaP,≥4 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,82.5,72.9 to 90.2,254
Polio,≥2 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,85.9,79.9 to 90.3,268
Polio,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,87.5,83.8 to 90.5,549
Polio,≥2 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,86.4,82.7 to 89.4,243
Polio,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,86.2,84.0 to 88.1,511
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Overall,Overall,87.1,84.7 to 89.5,1023
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,83.1,79.0 to 87.3,410
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,63.8,55.7 to 71.3,201
Hep B,≥3 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,85.1,80.4 to 88.8,231
Polio,≥2 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,89.2,84.2 to 92.7,281
Polio,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,89.8,86.4 to 92.4,577
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017,Age,13 Months,56.3,48.8 to 63.6,259
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017-2018,Age,13 Months,56.7,51.5 to 61.8,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016,Age,13 Months,49.3,42.3 to 56.2,296
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2017,Age,13 Months,52.8,47.7 to 57.8,555
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.8,79.2 to 94.5,87
Hib,≥3 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,95.2,90.4 to 98.1,252
Hib,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,93.0,89.4 to 95.7,453
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,93.8,92.1 to 95.5,1023
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,43.5,36.6 to 51.1,268
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,47.5,42.5 to 52.8,549
Polio,≥2 Doses,States/Local Areas,West Virginia,2014,Age,5 Months,70.0,62.5 to 76.5,268
Polio,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,5 Months,73.3,65.0 to 80.2,549
Polio,≥2 Doses,States/Local Areas,West Virginia,2013,Age,5 Months,75.0,72.1 to 77.8,243
Polio,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,5 Months,72.5,67.1 to 77.3,511
Hep A,≥1 Dose,States/Local Areas,West Virginia,2012,Age,35 Months,87.0,80.2 to 92.4,254
Polio,≥2 Doses,States/Local Areas,West Virginia,2011,Age,5 Months,76.7,73.6 to 79.5,231
Polio,≥2 Doses,States/Local Areas,West Virginia,2012,Age,5 Months,79.4,73.5 to 84.3,254
Hep A,≥2 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,52.6,45.3 to 60.3,259
Hep A,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,52.5,47.3 to 58.0,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,51.6,44.5 to 59.2,281
Hep A,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,48.2,43.4 to 53.4,577
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,44.4,37.8 to 51.4,296
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,48.5,43.5 to 53.7,555
DTaP,≥4 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,74.6,66.6 to 82.0,243
DTaP,≥4 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,72.8,67.7 to 77.7,511
DTaP,≥4 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,72.3,64.2 to 79.9,254
DTaP,≥4 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,79.8,72.1 to 86.4,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,55.7,44.1 to 66.7,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,60.4,53.9 to 66.6,254
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,94.3,91.6 to 97.1,418
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,96.5,93.4 to 99.6,195
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,92.5,89.8 to 95.2,410
Hib,≥3 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,90.4,84.9 to 94.6,201
DTaP,≥4 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,72.9,66.1 to 78.8,252
DTaP,≥4 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,95.1,92.2 to 97.0,453
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015,Age,13 Months,45.6,38.7 to 52.7,281
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015-2016,Age,13 Months,47.4,42.5 to 52.3,577
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,82.9,78.7 to 87.2,386
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.5,85.7 to 93.3,335
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.4,86.0 to 90.8,872
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,89.5,85.3 to 93.6,302
≥1 Dose MMR,,States/Local Areas,West Virginia,2011,Age,13 Months,39.8,31.9 to 48.3,231
DTaP,≥4 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,78.5,72.2 to 84.2,252
DTaP,≥4 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,77.4,72.5 to 82.0,453
DTaP,≥4 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,81.7,75.6 to 87.0,259
DTaP,≥4 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,80.2,75.9 to 84.1,511
DTaP,≥4 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,76.9,69.3 to 83.8,201
Polio,≥2 Doses,States/Local Areas,West Virginia,2019,Age,5 Months,76.6,68.6 to 83.0,201
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,73.2,66.7 to 78.8,252
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,68.5,63.3 to 73.3,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2016,Age,13 Months,50.8,43.8 to 57.7,296
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2017,Age,13 Months,51.6,46.5 to 56.7,555
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014,Age,19 Months,81.5,75.3 to 86.4,268
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2015,Age,19 Months,82.9,78.8 to 86.3,549
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015,Age,19 Months,84.3,81.4 to 86.8,281
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015-2016,Age,19 Months,84.3,80.2 to 87.6,577
Polio,≥2 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,94.8,91.2 to 97.0,231
Polio,≥2 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,94.2,88.0 to 97.3,254
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013,Age,19 Months,78.9,76.1 to 81.5,243
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013-2014,Age,19 Months,80.2,75.1 to 84.5,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,88.0,82.0 to 92.2,259
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,89.3,85.6 to 92.2,511
≥1 Dose MMR,,States/Local Areas,West Virginia,2018,Age,13 Months,63.0,55.8 to 69.6,252
≥1 Dose MMR,,States/Local Areas,West Virginia,2018-2019,Age,13 Months,58.2,52.6 to 63.5,453
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,81.1,71.9 to 90.4,410
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,82.7,77.7 to 87.7,1023
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,83.7,73.3 to 94.1,386
≥1 Dose MMR,,States/Local Areas,West Virginia,2012,Age,13 Months,40.4,35.2 to 45.9,254
≥1 Dose MMR,,States/Local Areas,West Virginia,2017,Age,13 Months,52.4,45.0 to 59.8,259
≥1 Dose MMR,,States/Local Areas,West Virginia,2017-2018,Age,13 Months,57.7,52.5 to 62.7,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.1,78.3 to 91.9,335
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.2,78.9 to 89.6,872
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,80.7,74.0 to 87.5,302
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.3,67.0 to 89.6,87
Hep B,≥1 Dose,States/Local Areas,West Virginia,2016,Age,3 Months,96.1,91.7 to 98.2,296
Hep B,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,3 Months,96.7,94.4 to 98.1,555
Hep B,≥1 Dose,States/Local Areas,West Virginia,2015,Age,3 Months,95.0,91.3 to 97.2,281
Hep B,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,3 Months,95.5,93.0 to 97.2,577
Hep B,≥1 Dose,States/Local Areas,West Virginia,2014,Age,3 Months,94.9,90.0 to 97.5,268
Hep B,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,3 Months,94.9,92.2 to 96.8,549
Polio,≥2 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,93.8,91.3 to 95.5,243
Polio,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,93.9,92.2 to 95.2,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,86.3,80.0 to 90.8,259
Polio,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,90.5,86.9 to 93.2,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,90.4,85.4 to 93.8,296
Polio,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,88.3,84.5 to 91.3,555
Hep B,≥1 Dose,States/Local Areas,West Virginia,2011,Age,3 Months,95.9,89.8 to 98.4,231
Hep B,≥1 Dose,States/Local Areas,West Virginia,2012,Age,3 Months,93.0,83.0 to 97.3,254
Hep B,≥1 Dose,States/Local Areas,West Virginia,2013,Age,3 Months,96.2,94.5 to 97.3,243
Hep B,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,3 Months,95.6,93.5 to 97.0,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,94.9,90.8 to 97.2,252
Polio,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,90.8,87.1 to 93.4,453
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019,Age,13 Months,44.2,36.4 to 52.4,201
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,89.9,85.2 to 94.6,195
Hep B,≥1 Dose,States/Local Areas,West Virginia,2019,Age,3 Months,94.9,88.0 to 97.9,201
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,76.4,62.0 to 90.9,39
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.3,63.3 to 85.2,87
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.4,74.1 to 80.8,872
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.6,75.5 to 85.7,335
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,74.2,68.1 to 80.3,302
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,75.3,70.2 to 80.3,386
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Overall,Overall,76.7,73.6 to 79.8,1023
≥1 Dose MMR,,States/Local Areas,West Virginia,2014,Age,19 Months,83.2,77.0 to 87.9,268
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2015,Age,19 Months,82.8,78.6 to 86.3,549
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,69.5,64.3 to 74.7,410
≥1 Dose Varicella,,States/Local Areas,West Virginia,2012,Age,24 Months,89.5,83.6 to 93.9,254
≥1 Dose Varicella,,States/Local Areas,West Virginia,2011,Age,24 Months,87.7,81.3 to 92.7,231
≥1 Dose MMR,,States/Local Areas,West Virginia,2016,Age,19 Months,83.5,77.8 to 88.0,296
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2017,Age,19 Months,83.6,79.4 to 87.1,555
≥1 Dose MMR,,States/Local Areas,West Virginia,2015,Age,19 Months,82.4,80.4 to 84.3,281
≥1 Dose MMR,,States/Local Areas,West Virginia,2015-2016,Age,19 Months,82.9,78.8 to 86.4,577
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,92.6,88.2 to 95.5,268
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,91.8,88.7 to 94.0,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,90.9,83.9 to 95.0,281
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,88.7,85.1 to 91.5,577
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,89.6,87.8 to 91.1,243
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,91.1,88.8 to 92.9,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,83.8,76.0 to 91.7,195
Hep B,≥2 Doses,States/Local Areas,West Virginia,2013,Age,5 Months,86.1,83.4 to 88.3,243
Hep B,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,5 Months,86.2,82.7 to 89.0,511
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2011,Age,0-1 Days,59.3,52.4 to 65.8,231
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,84.1,78.3 to 89.8,418
Hep B,≥2 Doses,States/Local Areas,West Virginia,2011,Age,5 Months,87.5,79.1 to 92.8,231
Hep B,≥2 Doses,States/Local Areas,West Virginia,2012,Age,5 Months,83.0,73.6 to 89.5,254
Polio,≥2 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,94.0,89.9 to 96.4,268
Polio,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,93.6,90.8 to 95.6,549
Hep B,≥1 Dose,States/Local Areas,West Virginia,2018,Age,3 Months,98.8,96.7 to 99.6,252
Hep B,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,3 Months,96.9,93.4 to 98.5,453
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,91.0,77.7 to 100.0,67
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,85.3,80.6 to 90.0,432
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,79.5,73.0 to 86.0,500
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,84.8,78.7 to 89.4,296
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,86.4,82.3 to 89.7,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,88.6,83.7 to 92.2,281
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,86.8,83.0 to 89.8,577
DTaP,≥4 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,91.1,85.5 to 95.1,281
DTaP,≥4 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,87.1,82.9 to 90.6,577
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,82.9,76.6 to 88.4,296
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,85.5,81.0 to 89.5,555
DTaP,≥4 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,88.5,81.5 to 93.7,259
DTaP,≥4 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,87.6,82.8 to 91.6,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,86.1,78.9 to 91.2,201
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,90.6,85.6 to 94.0,252
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,88.4,84.1 to 91.6,453
Polio,≥2 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,86.6,80.2 to 91.1,201
Hep B,≥3 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,87.1,79.3 to 92.2,254
Hep B,≥3 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,89.4,86.7 to 91.6,231
≥1 Dose MMR,,States/Local Areas,West Virginia,2011,Age,19 Months,78.9,75.2 to 82.2,231
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,73.2,59.9 to 86.6,67
DTaP,≥4 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,83.9,76.5 to 90.0,201
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,85.8,82.0 to 89.7,432
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,72.6,68.0 to 77.1,500
DTaP,≥4 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,86.9,80.0 to 92.4,252
DTaP,≥4 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,85.8,80.6 to 90.1,453
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017,Age,19 Months,85.3,78.8 to 90.1,259
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017-2018,Age,19 Months,85.7,81.7 to 89.0,511
≥1 Dose MMR,,States/Local Areas,West Virginia,2012,Age,19 Months,85.3,82.4 to 87.8,254
≥1 Dose MMR,,States/Local Areas,West Virginia,2013,Age,19 Months,79.9,76.8 to 82.6,243
≥1 Dose MMR,,States/Local Areas,West Virginia,2013-2014,Age,19 Months,81.5,77.4 to 85.0,511
Hep B,≥1 Dose,States/Local Areas,West Virginia,2017,Age,3 Months,97.3,94.7 to 98.6,259
Hep B,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,3 Months,98.0,96.6 to 98.9,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,94.2,90.0 to 96.7,296
Polio,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,92.8,89.5 to 95.2,555
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018,Age,19 Months,86.1,80.6 to 90.3,252
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018-2019,Age,19 Months,50.7,45.3 to 56.2,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2019,Age,13 Months,53.3,45.0 to 61.4,201
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016,Age,19 Months,84.2,78.5 to 88.6,296
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2017,Age,19 Months,84.8,80.6 to 88.2,555
Polio,≥2 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,93.2,88.8 to 96.0,281
Polio,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,93.7,90.8 to 95.7,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,59.6,52.2 to 66.5,268
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,62.1,57.1 to 66.9,549
PCV,≥3 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,61.5,56.7 to 66.0,254
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,80.8,76.3 to 85.3,418
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,88.9,83.8 to 93.9,195
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,86.3,80.3 to 90.7,296
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,89.2,85.3 to 92.1,555
PCV,≥3 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,57.1,48.5 to 65.2,231
PCV,≥3 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,57.5,53.9 to 61.0,243
PCV,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,58.5,54.8 to 62.1,511
Hep B,≥2 Doses,States/Local Areas,West Virginia,2014,Age,5 Months,86.3,80.4 to 90.7,268
Hep B,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,5 Months,87.6,83.2 to 91.0,549
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2012,Age,0-1 Days,62.2,57.0 to 67.1,254
Hep B,≥2 Doses,States/Local Areas,West Virginia,2016,Age,5 Months,82.6,76.1 to 87.7,296
Hep B,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,5 Months,86.4,82.3 to 89.7,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,92.0,86.7 to 95.4,259
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,93.0,89.9 to 95.2,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,91.5,85.6 to 95.1,259
Polio,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,93.8,90.4 to 96.0,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013,Age,24 Months,81.5,74.2 to 87.7,243
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013-2014,Age,24 Months,83.8,79.5 to 87.7,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,96.1,92.0 to 98.2,252
Polio,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,95.1,92.2 to 97.0,453
≥1 Dose Varicella,,States/Local Areas,West Virginia,2019,Age,19 Months,83.8,76.7 to 89.1,201
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2014,Age,0-1 Days,64.9,57.8 to 71.3,268
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2014-2015,Age,0-1 Days,62.5,57.6 to 67.3,549
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2013,Age,0-1 Days,68.4,58.6 to 76.8,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2013-2014,Age,0-1 Days,66.7,62.1 to 70.9,511
Hep B,≥2 Doses,States/Local Areas,West Virginia,2015,Age,5 Months,88.9,84.0 to 92.4,281
Hep B,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,5 Months,85.9,82.0 to 89.1,577
≥1 Dose Varicella,,States/Local Areas,West Virginia,2011,Age,35 Months,93.9,86.4 to 98.0,231
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018,Age,24 Months,89.0,83.9 to 93.0,252
≥1 Dose Varicella,,States/Local Areas,West Virginia,2018-2019,Age,24 Months,89.2,85.3 to 92.4,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2014,Age,24 Months,86.6,81.3 to 91.0,268
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2015,Age,24 Months,85.9,82.0 to 89.3,549
≥1 Dose MMR,,States/Local Areas,West Virginia,2013,Age,24 Months,83.2,76.1 to 89.2,243
≥1 Dose MMR,,States/Local Areas,West Virginia,2013-2014,Age,24 Months,84.9,80.6 to 88.7,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,76.3,70.2 to 81.5,296
PCV,≥4 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,77.5,73.1 to 81.3,555
PCV,≥4 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,76.6,76.0 to 77.3,281
PCV,≥4 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,76.5,72.0 to 80.4,577
PCV,≥4 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,67.1,59.7 to 73.7,268
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,71.9,67.0 to 76.3,549
PCV,≥3 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,64.8,57.9 to 71.1,281
PCV,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,64.7,59.9 to 69.2,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,64.6,58.0 to 70.7,296
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,64.2,59.3 to 68.9,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,87.1,80.7 to 92.2,254
Hep B,≥2 Doses,States/Local Areas,West Virginia,2018,Age,5 Months,93.9,90.1 to 96.2,252
Hep B,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,5 Months,90.9,87.0 to 93.8,453
Hep B,≥2 Doses,States/Local Areas,West Virginia,2019,Age,5 Months,88.0,80.7 to 92.7,201
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,89.8,84.1 to 94.1,243
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,92.0,88.7 to 94.6,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,91.5,85.9 to 95.5,231
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2018,Age,0-1 Days,80.1,74.1 to 84.9,252
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2018-2019,Age,0-1 Days,78.9,74.1 to 83.0,453
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,91.4,86.2 to 94.8,201
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2011,Age,0-2 Days,70.4,60.7 to 78.6,231
Hep B,≥2 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,92.7,90.3 to 94.6,243
Hep B,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,91.5,89.1 to 93.3,511
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2012,Age,0-2 Days,68.6,64.1 to 72.8,254
Hep B,≥2 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,90.1,84.5 to 93.9,268
Hep B,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,90.3,86.8 to 93.0,549
Hep B,≥2 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,87.9,82.6 to 91.8,254
PCV,≥3 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,63.8,56.3 to 70.7,259
PCV,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,65.9,60.8 to 70.7,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2018,Age,7 Months,68.0,60.8 to 74.5,252
PCV,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,7 Months,64.1,58.6 to 69.3,453
PCV,≥3 Doses,States/Local Areas,West Virginia,2011,Age,13 Months,82.9,78.1 to 86.7,231
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,94.2,90.5 to 96.8,268
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,93.0,90.2 to 95.2,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,91.8,87.4 to 95.1,281
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,89.1,85.7 to 92.0,577
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,86.3,80.7 to 91.0,296
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,89.7,86.1 to 92.7,555
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2019,Age,0-1 Days,77.7,69.8 to 84.1,201
Hep A,≥1 Dose,States/Local Areas,West Virginia,2020,Age,35 Months,93.4,86.6 to 97.5,271
Hep B,≥2 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,91.1,86.5 to 94.2,231
PCV,≥3 Doses,States/Local Areas,West Virginia,2012,Age,13 Months,86.6,81.4 to 90.4,254
≥1 Dose MMR,,States/Local Areas,West Virginia,2016,Age,24 Months,88.7,83.8 to 92.6,296
≥1 Dose MMR,,States/Local Areas,West Virginia,2016-2017,Age,24 Months,89.7,86.4 to 92.5,555
≥1 Dose MMR,,States/Local Areas,West Virginia,2017,Age,24 Months,90.5,85.7 to 94.2,259
≥1 Dose MMR,,States/Local Areas,West Virginia,2017-2018,Age,24 Months,90.3,87.0 to 93.2,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,74.4,67.5 to 80.2,252
PCV,≥4 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,76.1,70.1 to 81.2,362
PCV,≥4 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,78.6,72.0 to 84.0,259
PCV,≥4 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,76.5,71.9 to 80.6,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,94.1,89.0 to 96.9,201
≥1 Dose MMR,,States/Local Areas,West Virginia,2017,Age,19 Months,83.7,77.0 to 88.8,259
≥1 Dose MMR,,States/Local Areas,West Virginia,2017-2018,Age,19 Months,85.8,81.6 to 89.1,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2011,Age,19 Months,65.4,59.3 to 71.0,231
PCV,≥4 Doses,States/Local Areas,West Virginia,2012,Age,19 Months,70.0,64.2 to 75.3,254
PCV,≥4 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,72.9,66.2 to 78.7,243
PCV,≥4 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,70.1,64.1 to 75.4,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015,Age,24 Months,86.9,81.6 to 91.3,281
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015-2016,Age,24 Months,87.9,84.2 to 91.0,577
≥1 Dose MMR,,States/Local Areas,West Virginia,2018,Age,19 Months,87.9,82.6 to 91.7,252
≥1 Dose MMR,,States/Local Areas,West Virginia,2018-2019,Age,19 Months,93.7,90.4 to 95.9,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2011,Age,24 Months,86.5,79.9 to 91.8,231
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016,Age,24 Months,89.0,84.2 to 92.9,296
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2017,Age,24 Months,90.3,87.1 to 92.9,555
≥1 Dose MMR,,States/Local Areas,West Virginia,2019,Age,19 Months,83.5,76.3 to 88.8,201
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014,Age,24 Months,86.2,81.0 to 90.6,268
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2015,Age,24 Months,86.6,82.9 to 89.8,549
Hep B,≥2 Doses,States/Local Areas,West Virginia,2017,Age,5 Months,90.3,84.7 to 93.9,259
Hep B,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,5 Months,92.0,88.8 to 94.4,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,93.9,90.1 to 96.3,252
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,88.4,84.1 to 91.6,453
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2015,Age,0-1 Days,60.2,53.1 to 66.8,281
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2015-2016,Age,0-1 Days,62.5,57.6 to 67.2,577
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2017,Age,0-1 Days,67.9,60.6 to 74.5,259
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2017-2018,Age,0-1 Days,74.0,69.2 to 78.2,511
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2016,Age,0-1 Days,65.1,58.1 to 71.4,296
Hep B,"≥1 Dose, 1 Day",States/Local Areas,West Virginia,2016-2017,Age,0-1 Days,66.5,61.5 to 71.2,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,94.3,90.9 to 96.8,252
Hep B,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,93.5,90.8 to 95.7,453
Hep B,≥2 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,90.5,85.6 to 93.8,281
Hep B,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,90.2,86.8 to 92.8,577
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2013,Age,0-2 Days,72.7,64.3 to 79.7,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2013-2014,Age,0-2 Days,72.1,67.7 to 76.1,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2014,Age,13 Months,84.4,78.3 to 89.0,268
PCV,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,13 Months,87.4,83.7 to 90.3,549
PCV,≥3 Doses,States/Local Areas,West Virginia,2015,Age,13 Months,90.4,85.6 to 93.7,281
PCV,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,13 Months,89.0,85.3 to 91.8,577
≥1 Dose MMR,,States/Local Areas,West Virginia,2018,Age,24 Months,89.7,84.8 to 93.5,252
≥1 Dose MMR,,States/Local Areas,West Virginia,2018-2019,Age,24 Months,88.9,85.1 to 92.2,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2019,Age,24 Months,88.1,81.9 to 92.9,201
≥1 Dose MMR,,States/Local Areas,West Virginia,2012,Age,35 Months,93.3,88.1 to 96.8,254
≥1 Dose MMR,,States/Local Areas,West Virginia,2011,Age,35 Months,93.6,85.8 to 97.9,231
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016,Age,35 Months,90.8,85.9 to 94.4,296
≥1 Dose Varicella,,States/Local Areas,West Virginia,2016-2017,Age,35 Months,92.4,89.1 to 95.0,555
≥1 Dose MMR,,States/Local Areas,West Virginia,2013,Age,35 Months,89.5,82.2 to 94.7,243
≥1 Dose MMR,,States/Local Areas,West Virginia,2013-2014,Age,35 Months,91.0,86.7 to 94.3,511
PCV,≥4 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,74.3,67.4 to 80.6,268
PCV,≥4 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,79.2,74.8 to 83.3,549
PCV,≥4 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,79.3,72.1 to 85.6,243
PCV,≥4 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,76.8,71.8 to 81.5,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,93.0,88.2 to 96.4,259
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,93.7,90.8 to 95.9,511
Hep B,≥3 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,92.7,88.2 to 96.0,201
PCV,≥4 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,79.6,72.5 to 85.9,254
Hep B,≥3 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,91.5,85.9 to 95.5,231
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2017,Age,0-2 Days,79.0,72.4 to 84.4,259
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2017-2018,Age,0-2 Days,81.7,77.5 to 85.2,511
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2016,Age,0-2 Days,71.9,65.0 to 77.9,296
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2016-2017,Age,0-2 Days,75.4,70.8 to 79.6,555
PCV,≥4 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,74.8,66.5 to 82.4,231
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2014,Age,0-2 Days,71.5,64.6 to 77.5,268
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2014-2015,Age,0-2 Days,68.9,64.1 to 73.4,549
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2015,Age,0-2 Days,66.4,59.4 to 72.7,281
Hep B,"≥1 Dose, 2 Day",States/Local Areas,West Virginia,2015-2016,Age,0-2 Days,69.0,64.2 to 73.5,577
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014,Age,35 Months,93.7,89.2 to 96.7,268
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2015,Age,35 Months,92.6,89.1 to 95.3,549
≥1 Dose MMR,,States/Local Areas,West Virginia,2015,Age,24 Months,85.0,79.2 to 89.9,281
≥1 Dose MMR,,States/Local Areas,West Virginia,2015-2016,Age,24 Months,86.7,83.0 to 90.0,577
≥1 Dose Varicella,,States/Local Areas,West Virginia,2012,Age,35 Months,89.8,84.0 to 94.2,254
PCV,≥3 Doses,States/Local Areas,West Virginia,2019,Age,7 Months,60.2,51.7 to 68.1,201
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013,Age,35 Months,90.0,82.3 to 95.3,243
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013-2014,Age,35 Months,91.9,87.6 to 95.1,511
Hep B,≥2 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,93.8,89.2 to 96.6,259
Hep B,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,94.5,91.9 to 96.3,511
PCV,≥3 Doses,States/Local Areas,West Virginia,2013,Age,13 Months,85.1,82.5 to 87.4,243
PCV,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,13 Months,84.8,82.7 to 86.6,511
Hep B,≥2 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,89.8,84.5 to 93.5,296
Hep B,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,91.8,88.5 to 94.3,555
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017,Age,35 Months,93.7,88.9 to 96.9,259
≥1 Dose Varicella,,States/Local Areas,West Virginia,2017-2018,Age,35 Months,94.1,90.5 to 96.7,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015,Age,35 Months,91.6,86.1 to 95.6,281
≥1 Dose Varicella,,States/Local Areas,West Virginia,2015-2016,Age,35 Months,91.3,87.5 to 94.2,577
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,85.1,80.9 to 89.3,386
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.4,85.5 to 93.3,335
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Overall,Overall,87.4,85.0 to 89.9,1023
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,84.5,80.4 to 88.6,410
≥1 Dose MMR,,States/Local Areas,West Virginia,2018,Age,35 Months,93.5,87.8 to 97.2,252
≥1 Dose MMR,,States/Local Areas,West Virginia,2018-2019,Age,35 Months,91.9,87.9 to 95.0,453
≥1 Dose MMR,,States/Local Areas,West Virginia,2017,Age,35 Months,94.2,88.8 to 97.5,259
≥1 Dose MMR,,States/Local Areas,West Virginia,2017-2018,Age,35 Months,94.0,90.3 to 96.6,511
≥1 Dose MMR,,States/Local Areas,West Virginia,2019,Age,35 Months,90.4,84.0 to 95.0,201
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.1,77.8 to 94.5,87
≥1 Dose MMR,,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,87.8,78.4 to 97.2,67
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.8,86.3 to 91.3,872
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,88.0,83.5 to 92.6,302
Hep B,≥2 Doses,States/Local Areas,West Virginia,2017,Age,13 Months,96.3,91.9 to 98.4,259
Hep B,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,13 Months,96.6,94.2 to 98.0,511
Hib,≥1 Dose,States/Local Areas,West Virginia,2016,Age,3 Months,87.7,82.2 to 91.7,296
Hib,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,3 Months,85.2,81.1 to 88.6,555
Hib,≥1 Dose,States/Local Areas,West Virginia,2015,Age,3 Months,85.8,80.2 to 90.0,281
Hib,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,3 Months,86.7,82.9 to 89.8,577
PCV,≥3 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,90.6,85.6 to 94.0,296
PCV,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,90.7,87.2 to 93.3,555
PCV,≥3 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,92.5,87.7 to 95.5,281
PCV,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,91.6,88.1 to 94.1,577
Hep B,≥2 Doses,States/Local Areas,West Virginia,2016,Age,13 Months,93.9,89.4 to 96.5,296
Hep B,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,13 Months,95.1,92.2 to 96.9,555
Hep B,≥2 Doses,States/Local Areas,West Virginia,2018,Age,13 Months,96.9,94.1 to 98.4,252
Hep B,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,13 Months,96.0,93.6 to 97.5,453
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,75.6,70.5 to 80.6,386
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Overall,Overall,76.7,73.5 to 79.8,1023
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Poverty,<133% FPL,68.8,63.6 to 74.0,410
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Poverty,133% to <400% FPL,81.2,76.6 to 85.7,418
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013,Age,13 Months,47.9,42.7 to 53.2,243
≥1 Dose Varicella,,States/Local Areas,West Virginia,2013-2014,Age,13 Months,44.9,41.0 to 48.8,511
≥1 Dose Varicella,,States/Local Areas,West Virginia,2011,Age,13 Months,42.1,33.7 to 51.0,231
Hep A,≥1 Dose,States/Local Areas,West Virginia,2017,Age,35 Months,94.6,89.5 to 97.7,259
Hep A,≥1 Dose,States/Local Areas,West Virginia,2017-2018,Age,35 Months,95.1,91.4 to 97.5,511
Hep A,≥1 Dose,States/Local Areas,West Virginia,2015,Age,35 Months,90.4,84.7 to 94.7,281
Hep A,≥1 Dose,States/Local Areas,West Virginia,2015-2016,Age,35 Months,89.6,85.7 to 92.8,577
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,76.7,70.4 to 82.6,296
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,79.2,74.8 to 83.3,555
DTaP,≥4 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,81.2,75.2 to 86.5,281
DTaP,≥4 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,79.0,74.7 to 83.0,577
Hep A,≥2 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,52.5,45.3 to 60.1,252
Hep A,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,53.2,47.8 to 58.9,453
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013,Age,7 Months,59.7,56.0 to 63.4,243
Hep B,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,7 Months,58.4,55.7 to 61.1,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,54.0,45.8 to 62.7,201
Polio,≥2 Doses,States/Local Areas,West Virginia,2015,Age,5 Months,76.6,70.2 to 82.0,281
Polio,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,5 Months,75.2,70.6 to 79.2,577
Hep A,≥2 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,73.3,64.0 to 81.9,243
Hep A,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,74.6,68.3 to 80.5,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,80.1,68.2 to 89.7,254
Hep A,≥2 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,72.9,63.2 to 81.9,231
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016,Age,35 Months,88.3,83.0 to 92.6,296
Hep A,≥1 Dose,States/Local Areas,West Virginia,2016-2017,Age,35 Months,91.9,88.3 to 94.8,555
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014,Age,7 Months,57.1,49.9 to 64.1,268
Hep B,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,7 Months,58.4,53.4 to 63.3,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015,Age,7 Months,59.7,52.8 to 66.3,281
Hep B,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,7 Months,58.3,53.5 to 63.1,577
Polio,≥2 Doses,States/Local Areas,West Virginia,2017,Age,5 Months,74.9,67.6 to 81.0,259
Polio,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,5 Months,78.4,73.6 to 82.5,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2016,Age,5 Months,73.6,66.9 to 79.3,296
Polio,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,5 Months,74.3,69.4 to 78.5,555
PCV,≥2 Doses,States/Local Areas,West Virginia,2017,Age,5 Months,73.8,66.6 to 80.0,259
PCV,≥2 Doses,States/Local Areas,West Virginia,2017-2018,Age,5 Months,74.9,69.9 to 79.3,511
PCV,≥2 Doses,States/Local Areas,West Virginia,2018,Age,5 Months,76.0,68.9 to 81.9,252
PCV,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,5 Months,74.7,69.4 to 79.3,453
PCV,≥2 Doses,States/Local Areas,West Virginia,2019,Age,5 Months,73.4,65.3 to 80.2,201
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,84.3 to 98.4,87
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,89.6,79.5 to 99.7,39
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a Non-MSA,93.2,90.5 to 95.8,386
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.4,92.7 to 98.1,335
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.4,92.6 to 96.1,872
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,89.2 to 96.1,302
DTaP,≥4 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,71.5,64.2 to 77.9,259
DTaP,≥4 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,72.2,67.3 to 76.6,511
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,69.6,62.8 to 75.6,296
DTaP,≥4 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,70.5,65.6 to 75.0,555
Hep A,≥2 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,47.1,39.4 to 55.4,243
Hep A,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,45.3,40.0 to 51.0,511
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014,Age,35 Months,93.7,89.3 to 96.7,268
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2015,Age,35 Months,92.1,88.6 to 94.9,549
Hep A,≥1 Dose,States/Local Areas,West Virginia,2013,Age,35 Months,91.1,82.9 to 96.4,243
Hep A,≥1 Dose,States/Local Areas,West Virginia,2013-2014,Age,35 Months,92.5,88.1 to 95.7,511
Hep A,≥2 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,44.0,36.0 to 53.0,254
DTaP,≥4 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,62.4,54.1 to 70.1,201
Hib,Primary Series,States/Local Areas,West Virginia,2011,Age,7 Months,65.9,60.7 to 70.7,231
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Poverty,>400% FPL,89.9,85.2 to 94.6,195
Hep A,≥1 Dose,States/Local Areas,West Virginia,2018,Age,35 Months,96.3,90.9 to 98.9,252
Hep A,≥1 Dose,States/Local Areas,West Virginia,2018-2019,Age,35 Months,94.3,90.6 to 96.9,453
≥1 Dose Varicella,,States/Local Areas,West Virginia,2012,Age,13 Months,42.1,37.8 to 46.6,254
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014,Age,13 Months,41.7,34.9 to 48.9,268
≥1 Dose Varicella,,States/Local Areas,West Virginia,2014-2015,Age,13 Months,43.7,38.8 to 48.7,549
Hep A,≥1 Dose,States/Local Areas,West Virginia,2019,Age,35 Months,92.8,87.0 to 96.6,201
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,90.4,87.3 to 93.5,432
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,86.2,82.9 to 89.6,500
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,79.5,67.4 to 91.6,67
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017,Age,7 Months,63.4,56.0 to 70.3,259
Hep B,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,7 Months,68.3,63.3 to 72.8,511
Polio,≥2 Doses,States/Local Areas,West Virginia,2018,Age,5 Months,81.9,75.3 to 87.0,252
Polio,≥2 Doses,States/Local Areas,West Virginia,2018-2019,Age,5 Months,79.2,74.2 to 83.5,453
Hep A,≥1 Dose,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,71.9,56.3 to 87.6,39
Polio,≥2 Doses,States/Local Areas,West Virginia,2011,Age,7 Months,88.8,87.3 to 90.1,231
Polio,≥2 Doses,States/Local Areas,West Virginia,2012,Age,7 Months,87.4,85.2 to 89.3,254
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,71.7,63.3 to 79.5,296
Hep A,≥2 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,75.5,69.7 to 80.9,555
Hep A,≥2 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,83.1,76.0 to 89.2,281
Hep A,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,78.3,72.7 to 83.5,577
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,75.8,67.5 to 83.4,268
Hep A,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,79.6,74.2 to 84.6,549
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016,Age,7 Months,56.9,50.0 to 63.4,296
Hep B,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,7 Months,60.1,55.1 to 65.0,555
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,70.8,64.0 to 77.3,268
DTaP,≥4 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,76.0,71.4 to 80.3,549
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.2,64.7 to 85.6,87
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,85.3,73.3 to 97.3,39
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.8,73.4 to 80.2,872
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,75.6,69.7 to 81.4,302
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,93.9,91.2 to 96.7,432
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,93.0,90.6 to 95.4,500
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,91.5,84.1 to 98.8,67
Polio,≥3 Doses,States/Local Areas,West Virginia,2011,Age,35 Months,95.7,91.6 to 98.2,231
Polio,≥3 Doses,States/Local Areas,West Virginia,2019,Age,35 Months,92.5,87.1 to 96.3,201
Hib,Full Series,States/Local Areas,West Virginia,2016,Age,35 Months,87.6,81.5 to 92.4,296
Hib,Full Series,States/Local Areas,West Virginia,2016-2017,Age,35 Months,86.9,82.6 to 90.6,555
Hib,Full Series,States/Local Areas,West Virginia,2014,Age,35 Months,79.9,72.4 to 86.4,268
Hib,Full Series,States/Local Areas,West Virginia,2014-2015,Age,35 Months,83.7,79.0 to 87.9,549
Hib,Full Series,States/Local Areas,West Virginia,2015,Age,35 Months,87.3,81.2 to 92.2,281
Hib,Full Series,States/Local Areas,West Virginia,2015-2016,Age,35 Months,87.5,83.3 to 91.1,577
Polio,≥3 Doses,States/Local Areas,West Virginia,2017,Age,35 Months,95.5,88.8 to 98.7,259
Polio,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,35 Months,95.7,92.3 to 97.8,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2018,Age,35 Months,95.8,92.4 to 98.0,252
Polio,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,35 Months,94.2,91.1 to 96.5,453
Hib,Full Series,States/Local Areas,West Virginia,2017,Age,35 Months,86.0,79.7 to 91.2,259
Hib,Full Series,States/Local Areas,West Virginia,2017-2018,Age,35 Months,84.0,79.3 to 88.2,511
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Private Insurance Only,85.5,81.5 to 89.5,432
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Any Medicaid,71.9,67.3 to 76.5,500
Hib,Full Series,States/Local Areas,West Virginia,2014-2017,Insurance Coverage,Other,75.6,62.5 to 88.7,67
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,82.5 to 97.3,87
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,Hispanic,86.0,74.2 to 97.9,39
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,92.0 to 95.6,872
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2017,Urbanicity,Living In a MSA Principal City,92.5,89.0 to 96.0,302
Hib,Full Series,States/Local Areas,West Virginia,2019,Age,35 Months,76.8,67.9 to 84.7,201
Polio,≥3 Doses,States/Local Areas,West Virginia,2016,Age,35 Months,92.8,88.7 to 95.8,296
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,35 Months,94.0,90.7 to 96.4,555
Hib,Full Series,States/Local Areas,West Virginia,2018,Age,35 Months,82.2,75.0 to 88.4,252
Hib,Full Series,States/Local Areas,West Virginia,2018-2019,Age,35 Months,79.8,74.1 to 85.0,453
Polio,≥3 Doses,States/Local Areas,West Virginia,2015,Age,35 Months,92.8,88.6 to 95.9,281
Polio,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,35 Months,92.8,89.9 to 95.0,577
DTaP,≥2 Doses,States/Local Areas,West Virginia,2011,Age,5 Months,77.1,74.0 to 79.9,231
DTaP,≥2 Doses,States/Local Areas,West Virginia,2012,Age,5 Months,79.7,73.8 to 84.5,254
DTaP,≥2 Doses,States/Local Areas,West Virginia,2013,Age,5 Months,75.6,73.2 to 77.9,243
DTaP,≥2 Doses,States/Local Areas,West Virginia,2013-2014,Age,5 Months,72.9,67.2 to 77.9,511
DTaP,≥2 Doses,States/Local Areas,West Virginia,2014,Age,5 Months,70.1,62.7 to 76.6,268
DTaP,≥2 Doses,States/Local Areas,West Virginia,2014-2015,Age,5 Months,73.7,65.0 to 80.8,549
DTaP,≥2 Doses,States/Local Areas,West Virginia,2015,Age,5 Months,77.2,70.9 to 82.5,281
DTaP,≥2 Doses,States/Local Areas,West Virginia,2015-2016,Age,5 Months,75.4,70.9 to 79.4,577
Hib,Full Series,States/Local Areas,West Virginia,2013,Age,35 Months,80.1,72.5 to 86.6,243
Hib,Full Series,States/Local Areas,West Virginia,2013-2014,Age,35 Months,80.1,74.8 to 84.9,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2014,Age,35 Months,95.2,92.1 to 97.3,268
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,35 Months,94.0,91.4 to 96.0,549
Polio,≥3 Doses,States/Local Areas,West Virginia,2013,Age,35 Months,94.3,87.2 to 98.1,243
Polio,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,35 Months,94.4,90.9 to 96.9,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2012,Age,35 Months,93.3,87.3 to 97.2,254
Hib,Full Series,States/Local Areas,West Virginia,2018,Age,24 Months,73.0,66.2 to 79.4,252
Hib,Full Series,States/Local Areas,West Virginia,2018-2019,Age,24 Months,71.5,66.3 to 76.5,453
Hib,Full Series,States/Local Areas,West Virginia,2019,Age,24 Months,69.9,61.8 to 77.6,201
Hib,Full Series,States/Local Areas,West Virginia,2012,Age,35 Months,80.9,72.9 to 87.8,254
Hib,Full Series,States/Local Areas,West Virginia,2011,Age,35 Months,88.1,79.2 to 94.4,231
Hib,Full Series,States/Local Areas,West Virginia,2014,Age,24 Months,70.9,64.1 to 77.4,268
Hib,Full Series,States/Local Areas,West Virginia,2014-2015,Age,24 Months,75.0,70.4 to 79.3,549
DTaP,≥3 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,92.2,86.4 to 95.6,201
Hep A,≥1 Dose,States/Local Areas,West Virginia,2020-2021,Age,24 Months,86.9,82.0 to 91.1,428
DTaP,≥3 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,95.0,90.7 to 97.8,231
DTaP,≥3 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,94.0,88.9 to 97.3,254
Polio,≥3 Doses,States/Local Areas,West Virginia,2018,Age,24 Months,95.0,91.7 to 97.3,252
Polio,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,24 Months,93.8,90.7 to 96.1,453
Polio,≥3 Doses,States/Local Areas,West Virginia,2019,Age,24 Months,92.5,87.1 to 96.3,201
Polio,≥3 Doses,States/Local Areas,West Virginia,2017,Age,24 Months,93.5,88.5 to 96.8,259
Polio,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,24 Months,94.3,91.4 to 96.5,511
Hib,Full Series,States/Local Areas,West Virginia,2017,Age,24 Months,82.5,76.4 to 87.7,259
Hib,Full Series,States/Local Areas,West Virginia,2017-2018,Age,24 Months,77.8,73.3 to 82.0,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2016,Age,24 Months,92.2,88.2 to 95.3,296
Polio,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,24 Months,92.8,89.7 to 95.2,555
Hib,≥3 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,89.2,83.0 to 93.4,201
Hib,≥3 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,94.6,89.5 to 97.7,231
Hib,≥3 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,90.2,84.1 to 94.7,254
Hib,≥3 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,90.2,84.6 to 94.5,243
Hib,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,90.9,87.4 to 93.8,511
Hib,Full Series,States/Local Areas,West Virginia,2016,Age,24 Months,79.2,73.1 to 84.7,296
Hib,Full Series,States/Local Areas,West Virginia,2016-2017,Age,24 Months,80.8,76.6 to 84.7,555
Hib,Full Series,States/Local Areas,West Virginia,2015,Age,24 Months,79.1,73.0 to 84.6,281
Hib,Full Series,States/Local Areas,West Virginia,2015-2016,Age,24 Months,79.1,74.9 to 83.1,577
Hib,≥3 Doses,States/Local Areas,West Virginia,2019,Age,13 Months,68.7,60.4 to 75.9,201
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,95.4,92.1 to 97.4,268
DTaP,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,94.5,91.9 to 96.3,549
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,93.5,87.4 to 96.7,281
DTaP,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,93.4,90.5 to 95.4,577
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,89.6,87.5 to 91.4,243
DTaP,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,92.5,89.9 to 94.5,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2014,Age,19 Months,90.4,85.4 to 93.8,268
Hib,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,19 Months,90.1,86.7 to 92.8,549
Hib,≥3 Doses,States/Local Areas,West Virginia,2013,Age,19 Months,87.3,84.2 to 89.8,243
Hib,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,19 Months,88.8,85.5 to 91.5,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2012,Age,24 Months,91.5,85.5 to 95.7,254
Polio,≥3 Doses,States/Local Areas,West Virginia,2011,Age,24 Months,94.8,90.6 to 97.6,231
Hib,≥3 Doses,States/Local Areas,West Virginia,2015,Age,19 Months,89.9,87.5 to 91.9,281
Hib,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,19 Months,89.7,86.3 to 92.4,577
Polio,≥3 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,94.7,91.1 to 96.9,252
Polio,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,58.2,52.6 to 63.5,453
Polio,≥3 Doses,States/Local Areas,West Virginia,2019,Age,19 Months,89.3,83.1 to 93.4,201
Polio,≥3 Doses,States/Local Areas,West Virginia,2014,Age,24 Months,95.0,91.9 to 97.2,268
Polio,≥3 Doses,States/Local Areas,West Virginia,2014-2015,Age,24 Months,93.9,91.4 to 95.9,549
Polio,≥3 Doses,States/Local Areas,West Virginia,2015,Age,24 Months,92.8,88.6 to 95.9,281
Polio,≥3 Doses,States/Local Areas,West Virginia,2015-2016,Age,24 Months,92.4,89.6 to 94.7,577
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,93.3,89.0 to 96.0,296
DTaP,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,92.8,89.6 to 95.1,555
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,92.3,86.9 to 95.6,259
DTaP,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,93.5,90.4 to 95.6,511
Polio,≥3 Doses,States/Local Areas,West Virginia,2013,Age,24 Months,87.0,80.4 to 92.2,243
Polio,≥3 Doses,States/Local Areas,West Virginia,2013-2014,Age,24 Months,91.0,87.3 to 93.9,511
Hib,≥3 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,91.4,86.8 to 94.5,252
Hib,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,71.1,65.9 to 75.8,453
Hib,≥3 Doses,States/Local Areas,West Virginia,2016,Age,19 Months,89.5,84.6 to 93.0,296
Hib,≥3 Doses,States/Local Areas,West Virginia,2016-2017,Age,19 Months,89.0,85.3 to 91.8,555
Hib,≥3 Doses,States/Local Areas,West Virginia,2017,Age,19 Months,88.5,82.6 to 92.6,259
Hib,≥3 Doses,States/Local Areas,West Virginia,2017-2018,Age,19 Months,89.9,86.4 to 92.7,511
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018,Age,19 Months,94.7,91.1 to 96.9,252
DTaP,≥3 Doses,States/Local Areas,West Virginia,2018-2019,Age,19 Months,87.9,83.7 to 91.2,453
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2012,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2011,Age,0-3 Days,NA,,
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,81.2,75.4 to 86.3,589
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,92.8,88.9 to 95.7,589
Combined 7 Series,,States/Local Areas,TX-Rest of state,2011,Age,35 Months,71.7,65.4 to 77.8,702
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2021,Age,0-1 Days,82.2,71.9 to 89.2,207
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,94.7,91.0 to 97.3,589
Rotavirus,,States/Local Areas,TX-Rest of state,2019-2020,Age,8 Months,74.4,69.3 to 79.0,878
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,3 Months,80.1,72.5 to 86.0,382
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,3 Months,83.0,75.6 to 88.5,382
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,64.0,55.8 to 71.5,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,67.2,58.7 to 74.6,382
Hib,Primary Series,States/Local Areas,TX-Rest of state,2021,Age,24 Months,92.3,84.3 to 97.2,207
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,90.1,84.8 to 93.7,589
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2021,Age,0-2 Days,82.3,72.0 to 89.3,207
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,92.8,86.1 to 96.4,207
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,95.5,91.9 to 97.8,589
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,3 Months,85.2,79.2 to 89.6,589
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2021,Age,24 Months,98.3,95.4 to 99.6,207
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,92.3,84.2 to 97.1,207
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,24 Months,94.6,89.0 to 97.9,207
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,87.0,78.6 to 93.3,207
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,3 Months,86.6,76.0 to 93.0,207
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,93.7,89.3 to 96.7,589
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,94.1,90.9 to 96.5,589
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,79.0,64.3 to 90.6,207
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,94.7,88.6 to 98.1,207
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,96.3,92.2 to 98.5,207
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2021,Age,24 Months,97.7,94.6 to 99.2,207
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,93.2,89.7 to 95.9,878
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,84.4,79.3 to 88.9,878
Combined 7 Series,,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,67.4,62.3 to 72.5,878
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,94.4,90.9 to 96.8,878
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,69.6,64.4 to 74.4,878
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,86.1,81.6 to 89.5,878
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,93.2,90.0 to 95.4,878
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,87.5,83.7 to 90.5,878
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,72.3,67.0 to 77.1,878
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,88.1,83.9 to 91.4,878
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,5 Months,78.0,72.9 to 82.4,878
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,5 Months,87.8,83.7 to 90.9,878
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,85.4,81.2 to 88.7,878
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,91.5,87.9 to 94.1,878
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,80.6,76.1 to 84.5,878
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,91.3,87.6 to 93.9,878
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,70.7,65.5 to 75.5,878
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,5 Months,78.5,73.5 to 82.7,878
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,5 Months,80.2,75.3 to 84.3,878
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,5 Months,80.6,75.7 to 84.7,878
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,13 Months,87.6,83.5 to 90.7,878
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,3 Months,84.8,80.1 to 88.5,878
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,3 Months,95.8,93.2 to 97.4,878
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,89.6,86.0 to 92.6,878
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,91.3,87.8 to 94.1,878
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,78.1,73.3 to 82.6,878
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,90.7,87.3 to 93.6,878
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,82.5,77.9 to 86.7,878
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,90.4,86.6 to 93.6,878
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,93.5,89.5 to 96.4,878
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,93.5,89.8 to 96.2,878
Hib,Full Series,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,80.8,76.2 to 85.0,878
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,92.2,88.7 to 94.9,878
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,92.0,88.6 to 94.8,878
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,92.9,88.9 to 95.9,878
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,89.9,86.2 to 92.6,878
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,90.1,86.5 to 92.9,878
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,87.8,83.9 to 90.9,878
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,33.2,28.4 to 38.3,878
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,89.6,86.1 to 92.6,878
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,89.1,85.3 to 92.3,878
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,80.9,76.3 to 85.1,878
Hib,Full Series,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,78.8,74.2 to 83.1,878
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,89.5,86.0 to 92.4,878
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,63.8,58.4 to 68.8,878
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,69.3,63.8 to 74.2,878
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2019-2020,Age,0-2 Days,83.5,79.4 to 86.9,878
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2019-2020,Age,0-1 Days,81.6,77.2 to 85.2,878
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,88.8,84.7 to 91.9,878
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,79.1,74.2 to 83.2,878
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,85.7,81.7 to 88.9,878
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,88.0,84.1 to 91.0,878
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,88.2,84.5 to 91.2,878
Hib,Full Series,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,74.9,70.0 to 79.2,878
Combined 7 Series,,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,72.9,67.1 to 78.3,878
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,87.9,83.7 to 91.2,878
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,90.5,87.1 to 93.4,878
Influenza,,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,53.6,48.2 to 59.1,878
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,90.3,86.9 to 93.2,878
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,93.8,89.9 to 96.6,878
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,55.2,49.8 to 60.7,878
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,35 Months,82.1,76.0 to 87.5,878
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,24 Months,89.7,86.2 to 92.6,878
Combined 7 Series,,States/Local Areas,TX-Rest of state,2020,Age,35 Months,71.8,62.4 to 80.6,382
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020,Age,13 Months,73.0,65.1 to 79.7,382
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,78.3,68.7 to 86.7,382
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,19 Months,85.3,79.1 to 89.9,382
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,31.1,24.1 to 39.2,382
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2020,Age,0-2 Days,85.2,79.1 to 89.8,382
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2020,Age,0-1 Days,83.4,76.8 to 88.4,382
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,84.1,76.9 to 89.4,382
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,84.7,77.4 to 89.9,382
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020,Age,7 Months,69.8,61.6 to 76.9,382
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,64.3,55.9 to 71.8,382
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,90.5,85.0 to 94.6,382
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,5 Months,72.7,64.4 to 79.7,382
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,89.0,82.7 to 93.2,382
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,76.6,68.8 to 83.7,382
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020,Age,24 Months,89.5,83.8 to 93.8,382
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,90.4,84.9 to 94.6,382
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020,Age,35 Months,91.9,85.7 to 96.1,382
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,89.5,84.0 to 93.8,382
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020,Age,35 Months,90.0,84.5 to 94.2,382
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,89.8,84.3 to 94.0,382
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,92.4,86.7 to 96.2,382
Hib,Full Series,States/Local Areas,TX-Rest of state,2020,Age,35 Months,79.2,71.9 to 85.6,382
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020,Age,19 Months,89.4,83.4 to 93.4,382
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020,Age,35 Months,92.2,85.9 to 96.4,382
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,88.8,83.1 to 92.8,382
Hib,Full Series,States/Local Areas,TX-Rest of state,2020,Age,19 Months,73.4,65.6 to 79.9,382
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,90.8,85.2 to 94.9,382
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020,Age,19 Months,87.8,81.6 to 92.1,382
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,90.7,85.2 to 94.8,382
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,84.2,75.4 to 91.2,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,86.3,79.2 to 91.2,382
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,77.0,69.2 to 83.2,382
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,89.7,83.6 to 93.7,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,88.0,81.4 to 93.1,382
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,81.1,74.1 to 86.6,382
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020,Age,13 Months,84.0,77.2 to 89.0,382
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,91.7,86.1 to 95.2,382
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,88.2,82.4 to 92.2,382
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020,Age,13 Months,71.7,63.8 to 78.6,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,83.5,76.3 to 88.9,382
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,7 Months,71.2,62.9 to 78.3,382
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,90.1,84.1 to 94.1,382
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,68.4,60.1 to 75.6,382
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,90.0,84.0 to 94.0,382
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020,Age,19 Months,88.5,82.4 to 92.7,382
Combined 7 Series,,States/Local Areas,TX-Rest of state,2020,Age,24 Months,64.4,56.4 to 72.4,382
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,19 Months,89.2,83.1 to 93.2,382
Influenza,,States/Local Areas,TX-Rest of state,2020,Age,24 Months,52.9,44.8 to 61.5,382
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020,Age,24 Months,88.5,82.8 to 93.1,382
Rotavirus,,States/Local Areas,TX-Rest of state,2020,Age,8 Months,73.9,65.8 to 80.7,382
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2020,Age,0-3 Days,86.6,80.8 to 90.8,382
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,78.7,71.4 to 85.2,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,86.5,80.0 to 91.8,382
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,51.8,43.6 to 60.6,382
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,24 Months,90.3,84.9 to 94.4,382
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,3 Months,81.2,73.3 to 87.1,382
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,3 Months,95.2,90.9 to 97.5,382
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,5 Months,76.5,68.5 to 83.0,382
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,5 Months,75.9,67.9 to 82.4,382
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,5 Months,73.7,65.7 to 80.5,382
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,3 Months,83.7,76.3 to 89.1,382
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,5 Months,84.9,77.8 to 90.0,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,90.7,87.6 to 93.7,709
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.0,80.0 to 94.0,159
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.3 to 93.6,919
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",56.3,51.5 to 61.2,919
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",49.2,38.6 to 59.7,159
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,83.3,79.8 to 86.8,913
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,60.5,48.2 to 72.8,133
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.2,62.8 to 81.5,159
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.5,79.6 to 87.4,919
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,77.3,73.4 to 81.3,913
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,78.4,68.5 to 88.4,133
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,78.2,68.4 to 88.0,133
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,69.3,64.9 to 73.7,913
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.7,47.3 to 68.1,159
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.4,64.8 to 74.1,919
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,74.7,70.3 to 79.1,709
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,51.9,39.5 to 64.3,133
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,77.1,66.8 to 87.4,111
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,84.2,80.8 to 87.7,913
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.4,74.1 to 82.7,919
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,80.9,69.4 to 92.4,111
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,39.7,26.8 to 52.7,133
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,46.1,40.9 to 51.3,709
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,36.8,23.6 to 50.0,111
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,62.1,58.1 to 66.1,1353
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.9,71.1 to 84.7,315
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,81.9,78.8 to 85.0,1353
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,40.9,29.0 to 52.8,133
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,93.4,91.4 to 95.5,1353
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,78.8,69.1 to 88.6,133
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,86.6,78.3 to 94.8,111
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,69.4 to 82.8,315
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,90.4,88.0 to 92.8,1353
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,88.5,85.5 to 91.6,913
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,87.4 to 95.4,315
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.0,75.2 to 90.9,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,72.3,60.8 to 83.9,133
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,78.9,67.9 to 89.8,111
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,79.5,76.2 to 82.7,1353
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,81.4,77.3 to 85.4,709
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.9,64.4 to 83.4,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.1,73.6 to 86.7,315
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,74.8,71.2 to 78.3,1353
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.5,73.3 to 81.7,919
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.2,65.3 to 83.1,159
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.3,88.6 to 94.1,919
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.0,76.4 to 91.6,159
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,86.7 to 95.5,315
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.0,87.1 to 92.9,919
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,87.8,84.7 to 90.9,913
Hib,Full Series,States/Local Areas,TX-Rest of state,2021,Age,19 Months,76.1,65.0 to 84.5,207
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,93.9,86.8 to 97.3,207
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,92.5,88.3 to 95.2,589
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,93.3,89.2 to 95.9,589
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,89.0,83.9 to 92.6,589
Hib,Primary Series,States/Local Areas,TX-Rest of state,2021,Age,7 Months,65.6,53.8 to 75.7,207
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,72.1,60.6 to 81.4,207
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,90.9,86.3 to 94.5,589
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,90.1,80.3 to 95.3,207
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,93.3,90.9 to 95.7,801
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,87.6,84.3 to 91.0,811
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,86.6,83.2 to 90.0,838
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,88.7,86.8 to 90.6,2450
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,93.1,89.4 to 95.9,485
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,93.3,90.9 to 95.2,1101
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,88.4,84.1 to 91.9,538
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,91.0,88.3 to 93.3,1023
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,3 Months,87.5,83.6 to 90.6,705
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,3 Months,86.6,83.6 to 89.1,1243
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,3 Months,88.0,85.3 to 90.3,1257
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,3 Months,87.8,85.8 to 89.6,2463
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,3 Months,86.0,82.8 to 88.6,1030
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,3 Months,86.4,83.7 to 88.7,1397
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,3 Months,88.5,85.2 to 91.2,953
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,3 Months,87.2,85.0 to 89.2,1983
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,86.4 to 95.2,315
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,3 Months,80.1,68.7 to 88.1,207
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,3 Months,87.6,81.0 to 92.2,702
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,3 Months,86.4,84.6 to 87.9,867
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,5 Months,79.6,75.2 to 83.5,705
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,5 Months,78.0,74.5 to 81.1,1243
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.1,87.9 to 92.4,1351
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,86.0,80.2 to 91.8,266
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,91.8,88.7 to 94.4,705
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,90.1,87.5 to 92.4,1243
Hib,Primary Series,States/Local Areas,TX-Rest of state,2021,Age,19 Months,91.8,82.5 to 96.4,207
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,91.1,86.5 to 94.6,589
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,82.9,77.5 to 87.7,589
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,86.9,80.0 to 92.4,589
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,5 Months,70.9,58.9 to 80.6,207
Combined 7 Series,,States/Local Areas,TX-Rest of state,2021,Age,35 Months,70.1,59.4 to 80.1,207
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,5 Months,76.2,64.7 to 84.9,207
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,94.7,88.6 to 98.1,207
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,90.1,80.4 to 95.3,207
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,96.3,92.2 to 98.5,207
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2021,Age,35 Months,98.3,95.4 to 99.6,207
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,84.5,73.0 to 91.7,207
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,94.1,87.0 to 97.4,207
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,63.8,58.8 to 68.8,709
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,91.2,88.3 to 94.2,709
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,69.6,64.7 to 74.5,816
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,81.6,79.2 to 84.0,2306
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,76.4,71.6 to 81.1,643
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,91.6,89.0 to 94.3,816
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,72.1,67.1 to 77.1,643
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,74.7,70.2 to 79.1,847
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,87.4,83.7 to 91.2,643
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,88.1,85.0 to 91.2,816
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,90.4,87.5 to 93.2,847
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,90.3,87.4 to 93.1,816
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,90.5,87.6 to 93.3,847
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,85.5,81.5 to 89.4,643
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,85.4,81.3 to 89.4,643
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,89.8,86.9 to 92.7,847
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,41.7,36.3 to 47.2,643
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,49.9,44.8 to 54.9,847
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,91.9,89.2 to 94.5,816
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,87.6,85.5 to 89.6,2306
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,91.4,89.7 to 93.1,2306
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,88.7,85.0 to 92.3,643
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,92.3,89.7 to 95.0,816
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,78.8,72.1 to 85.6,643
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,81.7,76.1 to 87.3,847
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,78.8,74.5 to 83.2,816
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,80.9,77.0 to 84.9,847
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,89.4,86.4 to 92.4,816
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,89.5,86.5 to 92.5,799
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,72.2,67.4 to 77.1,643
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,75.6,71.3 to 79.9,847
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,91.9,89.4 to 94.4,799
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.6,88.0 to 93.1,1282
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,88.1,81.9 to 94.3,225
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,3 Months,85.7,81.2 to 89.3,878
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,3 Months,84.1,79.5 to 87.8,878
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2019-2020,Age,0-3 Days,84.3,80.3 to 87.6,878
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,90.2,86.6 to 93.0,878
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2019-2020,Age,3 Months,86.4,82.0 to 89.9,878
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,63.3,57.9 to 68.4,878
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,70.4,65.1 to 75.1,878
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,19 Months,90.8,87.1 to 93.5,878
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,54.8,43.5 to 65.7,207
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,68.1,56.3 to 79.9,111
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.4,59.5 to 75.2,315
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,81.9 to 92.9,315
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,82.8,78.9 to 86.6,799
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,91.3,86.6 to 96.1,225
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.1,77.7 to 84.4,1282
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,80.1,72.7 to 87.5,225
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,53.5,48.1 to 58.9,799
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,65.0,56.1 to 73.9,225
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.9,65.0 to 72.7,1282
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,80.0,76.0 to 84.0,799
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,86.1 to 92.4,799
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.1,84.3 to 90.0,1282
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,88.0 to 93.7,799
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,75.1,67.1 to 83.0,225
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.1,73.6 to 80.7,1282
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,79.1,71.8 to 86.5,225
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,77.4,72.9 to 81.9,799
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,75.9,65.3 to 86.4,225
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,91.7,87.0 to 96.4,225
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,88.3 to 93.7,799
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,52.9,48.9 to 56.9,1282
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,43.6,33.5 to 53.6,225
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,67.1,62.1 to 72.2,799
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.1,87.5 to 92.7,1282
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,89.9,84.8 to 95.0,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,80.0,75.7 to 84.3,799
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.6,85.8 to 91.4,1282
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.1,75.9 to 82.3,1282
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,87.1,81.2 to 93.1,225
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,94.3,92.2 to 96.5,816
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,83.8,76.1 to 91.4,225
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,77.4,74.8 to 80.0,2306
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,61.9,56.5 to 67.2,643
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,88.6,85.6 to 91.6,847
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,81.1,77.3 to 84.9,847
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,90.4,87.4 to 93.5,816
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,64.9,60.0 to 69.8,847
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,91.7,89.2 to 94.3,847
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,76.9,74.3 to 79.5,2306
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,80.1,76.1 to 84.1,816
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,88.8,86.8 to 90.7,2306
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,94.6,92.5 to 96.7,816
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,84.4,80.3 to 88.5,643
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,87.9,85.9 to 89.9,2306
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,79.8,77.4 to 82.3,2306
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,67.9,65.0 to 70.8,2306
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,81.6,78.1 to 85.1,2306
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,79.3,74.7 to 83.8,643
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,91.4,88.8 to 94.0,847
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,52.3,49.2 to 55.3,2306
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,88.1,84.5 to 91.7,643
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,86.1,82.1 to 90.0,816
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,87.1,83.7 to 90.4,847
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,86.0,82.0 to 90.0,643
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,89.1,87.2 to 91.1,2306
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,<133% FPL,73.4,68.4 to 78.4,643
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,91.1,89.4 to 92.8,2306
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,90.4,88.6 to 92.2,2306
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,85.0,81.4 to 88.5,816
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,50.2,45.5 to 54.9,913
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Overall,Overall,79.5,76.9 to 82.0,2306
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,79.2,69.6 to 88.8,111
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,87.6,84.2 to 91.0,709
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,91.4,89.0 to 93.7,1353
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,93.2,87.9 to 98.5,111
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,80.4,76.6 to 84.2,913
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.2,73.7 to 86.8,315
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,88.6,80.8 to 96.4,111
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,78.4,68.6 to 88.2,133
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,84.2,80.5 to 87.8,1353
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,29.8,18.9 to 40.7,133
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,84.7,78.5 to 90.9,709
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.8,60.2 to 79.3,159
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,85.2 to 94.4,315
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,85.1,82.2 to 88.1,1353
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.3,83.9 to 90.7,919
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,92.1,89.5 to 94.6,913
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,88.7 to 94.4,919
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.1,81.4 to 94.8,159
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.9,76.8 to 85.0,919
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,88.6,79.9 to 97.2,111
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,73.8,62.7 to 85.0,133
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,89.0,85.7 to 92.2,709
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,74.4,63.7 to 85.0,133
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,89.7,86.5 to 92.9,709
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,92.9,90.7 to 95.0,1353
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,74.7,70.0 to 79.3,709
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,76.4,66.1 to 86.7,111
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,49.5,37.1 to 61.9,133
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,91.6,85.1 to 98.2,111
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,76.1,71.6 to 80.6,709
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,78.8,68.5 to 89.1,111
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,57.2,44.9 to 69.5,133
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,86.6,83.0 to 90.1,709
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.7,74.8 to 90.5,159
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,85.6 to 92.0,919
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,88.8,81.3 to 96.4,111
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,89.5,86.9 to 92.0,1353
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.0,80.0 to 94.0,159
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,88.3 to 94.0,919
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Other,88.6,80.8 to 96.4,111
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Uninsured,74.8,64.3 to 85.3,133
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,88.8,85.7 to 91.8,913
Influenza,,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",53.1,44.7 to 61.6,315
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.6,80.7 to 94.5,159
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.3,71.7 to 78.9,1282
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,86.5,80.4 to 92.5,225
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,87.5,81.7 to 93.3,225
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,74.8,66.8 to 82.8,225
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,88.6 to 93.7,1282
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,89.2 to 94.2,799
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,79.5,75.1 to 83.8,799
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.5,85.8 to 91.3,1282
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.2,76.8 to 83.6,1282
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,87.6,84.2 to 91.0,799
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,93.9,87.8 to 97.5,207
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,85.9,76.7 to 91.9,207
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,19 Months,93.0,86.5 to 96.5,207
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,84.1,79.2 to 89.0,799
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.6,75.6 to 85.6,1282
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,35.6,25.7 to 47.0,207
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,85.6,76.6 to 92.4,207
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,88.8,80.1 to 94.8,207
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,94.7,87.5 to 97.9,207
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,3 Months,86.6,76.0 to 93.0,207
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.5,84.7 to 90.2,1282
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,70.2,58.6 to 79.7,207
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,5 Months,74.5,67.3 to 80.6,589
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,45.2,34.6 to 57.2,207
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,7 Months,72.5,61.1 to 81.6,207
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,84.8,79.0 to 89.2,589
Hib,Full Series,States/Local Areas,TX-Rest of state,2021,Age,24 Months,79.3,69.2 to 87.9,207
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,92.7,84.5 to 96.8,207
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2021,Age,19 Months,96.4,92.0 to 98.5,207
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,80.5,70.5 to 87.7,207
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,96.2,91.6 to 98.4,207
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,35 Months,96.4,90.8 to 99.0,207
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2013-2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2011,Age,8 Months,NA,,
Hib,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,3 Months,78.0,58.9 to 89.8,35
Hep B,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,3 Months,94.1,87.2 to 97.4,93
PCV,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,3 Months,86.1,76.6 to 92.1,93
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,57.2,41.9 to 73.5,93
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,24 Months,79.1,65.4 to 90.0,93
Hep B,"≥1 Dose, 2 Day",States/Local Areas,U.S. Virgin Islands,2019-2020,Age,0-2 Days,54.0,38.1 to 69.1,93
Hib,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,3 Months,81.2,66.8 to 90.2,93
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,56.2,38.0 to 72.9,58
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,87.2,73.3 to 94.4,58
DTaP,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,5 Months,63.3,39.1 to 82.2,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,70.4,50.6 to 84.7,58
Polio,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,3 Months,88.6,79.5 to 94.0,93
Hep B,"≥1 Dose, 2 Day",States/Local Areas,U.S. Virgin Islands,2020-2021,Age,0-2 Days,51.4,34.8 to 67.8,58
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,5 Months,60.9,37.4 to 80.3,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,83.1,66.2 to 92.5,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,5 Months,53.7,31.6 to 74.4,35
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,75.6,50.9 to 90.3,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,75.7,51.4 to 90.1,35
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,89.0,72.0 to 96.2,35
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,81.2,66.4 to 90.5,58
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,83.4,66.4 to 92.7,58
Hib,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,3 Months,80.1,65.2 to 89.7,58
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,55.5,37.1 to 72.4,58
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,74.8,57.4 to 86.8,58
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,84.3,70.8 to 93.9,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,84.3,70.8 to 93.9,58
PCV,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,3 Months,75.1,53.3 to 88.8,35
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,19 Months,75.4,51.2 to 89.9,35
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,76.5,58.7 to 88.2,58
DTaP,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,5 Months,66.5,46.9 to 81.8,58
Hep A,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,77.3,61.9 to 89.8,58
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,86.4,70.8 to 96.1,35
PCV,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,3 Months,85.5,72.4 to 92.9,58
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,35.3,22.0 to 51.4,58
PCV,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,5 Months,53.7,35.9 to 70.6,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,78.2,57.9 to 90.4,58
Hep B,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,3 Months,94.0,84.9 to 97.7,58
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,63.9,44.0 to 83.3,58
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,78.1,62.3 to 90.6,58
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,83.4,68.8 to 93.7,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,86.9,69.9 to 95.0,35
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,50.6,34.0 to 67.0,58
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,71.0,51.5 to 84.9,58
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,70.0,49.8 to 87.8,58
Hep A,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,44.5,23.6 to 72.3,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,60.4,41.8 to 76.4,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,86.4,70.8 to 96.0,35
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2021,Age,0-3 Days,51.0,29.5 to 72.1,35
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2021,Age,8 Months,49.7,28.5 to 71.1,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,68.5,49.0 to 83.1,58
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,45.1,30.3 to 60.8,58
Hib,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,5 Months,55.0,36.9 to 71.8,58
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,5 Months,80.9,62.7 to 91.4,58
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,82.2,67.8 to 92.8,58
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,13 Months,70.9,51.8 to 84.6,58
Hep A,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,60.0,36.9 to 83.9,58
Polio,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,3 Months,90.9,81.8 to 95.7,58
Polio,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,84.2,69.7 to 94.3,58
Hib,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,77.6,58.5 to 89.5,35
Combined 7 Series,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,35.6,22.4 to 53.3,58
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,85.9,72.5 to 94.9,58
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,77.5,59.6 to 88.9,58
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,66.4,45.7 to 85.7,35
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,78.7,57.4 to 94.0,35
Hep B,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,89.2,75.1 to 95.8,58
PCV,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,85.3,69.8 to 93.6,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,79.2,59.9 to 90.6,35
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,77.1,61.3 to 89.9,58
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,5 Months,64.0,44.7 to 79.7,58
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,7 Months,78.8,58.3 to 90.8,58
Hib,Primary Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,81.5,66.6 to 90.7,58
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,35 Months,59.7,41.8 to 78.3,58
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,59.0,35.0 to 84.1,35
Hep B,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,79.3,57.8 to 94.3,35
PCV,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,55.1,37.1 to 72.0,58
DTaP,≥3 Doses,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,83.7,69.1 to 93.9,58
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2020-2021,Age,0-3 Days,60.0,42.0 to 75.7,58
Rotavirus,,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,8 Months,50.1,32.4 to 67.7,58
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,19 Months,65.8,48.2 to 79.9,58
Hep B,≥1 Dose,States/Local Areas,U.S. Virgin Islands,2021,Age,3 Months,90.1,72.7 to 96.9,35
≥1 Dose MMR,,States/Local Areas,U.S. Virgin Islands,2021,Age,35 Months,75.6,54.4 to 92.1,35
Polio,≥2 Doses,States/Local Areas,U.S. Virgin Islands,2021,Age,13 Months,86.9,69.9 to 95.0,35
Hib,Full Series,States/Local Areas,U.S. Virgin Islands,2020-2021,Age,24 Months,67.3,51.1 to 82.5,58
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2014,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2013,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,U.S. Virgin Islands,2013-2014,Age,0-3 Days,NA,,
≥1 Dose Varicella,,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,68.6,52.2 to 81.4,93
DTaP,≥4 Doses,States/Local Areas,U.S. Virgin Islands,2019-2020,Age,19 Months,50.2,34.1 to 66.2,93
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,24.1,20.8 to 27.7,1030
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,26.2,23.3 to 29.4,1397
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,72.0,68.6 to 75.1,867
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,63.1,59.2 to 66.8,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,88.8,84.5 to 92.3,538
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,93.8,89.2 to 96.9,1023
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,19 Months,86.4,81.1 to 90.3,496
Combined 7 Series,,States/Local Areas,TX-Rest of state,2013,Age,24 Months,65.3,60.9 to 69.6,953
Combined 7 Series,,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,66.3,63.4 to 69.2,1983
Combined 7 Series,,States/Local Areas,TX-Rest of state,2012,Age,24 Months,68.6,63.9 to 73.3,867
Combined 7 Series,,States/Local Areas,TX-Rest of state,2011,Age,24 Months,66.3,60.4 to 72.2,702
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013,Age,35 Months,92.6,89.5 to 95.0,953
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,92.2,90.2 to 94.0,1983
Hib,Primary Series,States/Local Areas,TX-Rest of state,2011,Age,35 Months,93.4,89.9 to 96.1,702
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019,Age,24 Months,92.0,88.0 to 95.1,496
Hib,Primary Series,States/Local Areas,TX-Rest of state,2012,Age,35 Months,93.0,89.9 to 95.4,867
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016,Age,35 Months,91.1,87.5 to 94.0,705
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,91.3,88.5 to 93.7,1243
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015,Age,35 Months,93.8,91.3 to 95.8,1257
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,93.2,91.3 to 94.8,2463
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014,Age,24 Months,91.1,88.4 to 93.4,1030
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,91.4,89.2 to 93.2,1397
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015,Age,24 Months,92.0,89.8 to 94.0,1257
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,91.6,89.9 to 93.1,2463
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013,Age,24 Months,90.6,87.6 to 93.1,953
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,90.8,88.8 to 92.5,1983
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017,Age,24 Months,89.3,85.2 to 92.6,538
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,91.4,88.7 to 93.7,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018,Age,24 Months,93.1,89.2 to 96.0,485
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,92.6,90.0 to 94.6,1101
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016,Age,24 Months,90.4,87.1 to 93.3,705
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,89.9,87.3 to 92.1,1243
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017,Age,35 Months,91.9,86.9 to 95.5,538
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,92.3,89.5 to 94.6,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019,Age,35 Months,95.2,91.7 to 97.5,496
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018,Age,35 Months,93.2,89.3 to 96.0,485
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,94.1,91.8 to 96.0,1101
Combined 7 Series,,States/Local Areas,TX-Rest of state,2015,Age,24 Months,64.4,60.7 to 68.0,1257
Combined 7 Series,,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,65.5,62.9 to 68.2,2463
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014,Age,24 Months,67.4,63.4 to 71.3,1030
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,66.0,62.6 to 69.3,1397
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014,Age,35 Months,92.0,89.1 to 94.3,1030
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,92.9,90.5 to 94.8,1397
Hib,Primary Series,States/Local Areas,TX-Rest of state,2011,Age,24 Months,93.4,89.8 to 96.0,702
Hib,Primary Series,States/Local Areas,TX-Rest of state,2012,Age,24 Months,92.4,89.3 to 94.9,867
Combined 7 Series,,States/Local Areas,TX-Rest of state,2019,Age,24 Months,71.1,64.8 to 77.2,496
Combined 7 Series,,States/Local Areas,TX-Rest of state,2013,Age,35 Months,70.4,65.8 to 74.9,953
Combined 7 Series,,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,72.4,69.2 to 75.4,1983
Combined 7 Series,,States/Local Areas,TX-Rest of state,2012,Age,35 Months,73.5,68.7 to 78.1,867
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016,Age,24 Months,67.5,62.6 to 72.2,705
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,67.9,64.2 to 71.6,1243
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014,Age,35 Months,74.0,69.9 to 78.0,1030
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,74.6,70.4 to 78.6,1397
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016,Age,35 Months,71.1,66.1 to 75.9,705
Combined 7 Series,,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,72.4,68.5 to 76.3,1243
Combined 7 Series,,States/Local Areas,TX-Rest of state,2017,Age,35 Months,74.4,67.9 to 80.5,538
Combined 7 Series,,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,73.0,68.6 to 77.3,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016,Age,19 Months,90.0,86.4 to 92.8,705
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,89.7,87.0 to 91.8,1243
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015,Age,19 Months,90.9,88.2 to 93.1,1257
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,90.7,88.9 to 92.2,2463
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017,Age,19 Months,89.3,85.0 to 92.5,538
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,90.8,88.0 to 93.1,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019,Age,19 Months,91.5,87.3 to 94.5,496
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018,Age,19 Months,92.1,87.8 to 94.9,485
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,87.5,84.3 to 90.1,1101
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017,Age,13 Months,85.5,80.8 to 89.3,538
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,86.0,82.5 to 88.9,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016,Age,13 Months,83.7,79.4 to 87.2,705
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,84.6,81.5 to 87.3,1243
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014,Age,7 Months,67.0,63.0 to 70.7,1030
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,69.9,66.6 to 73.0,1397
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015,Age,7 Months,70.8,67.3 to 74.1,1257
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,70.1,67.6 to 72.6,2463
Hib,Primary Series,States/Local Areas,TX-Rest of state,2011,Age,13 Months,88.0,80.9 to 92.7,702
Hib,Primary Series,States/Local Areas,TX-Rest of state,2012,Age,13 Months,86.4,84.1 to 88.4,867
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013,Age,13 Months,85.4,83.0 to 87.4,953
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,84.7,83.0 to 86.3,1983
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,91.8,88.7 to 94.4,705
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,90.3,87.7 to 92.5,1243
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,94.9,92.5 to 96.7,1257
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,93.8,92.0 to 95.3,2463
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,5 Months,74.3,64.0 to 82.4,702
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,5 Months,74.2,71.9 to 76.5,867
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,5 Months,75.7,72.2 to 78.9,953
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,5 Months,75.6,72.6 to 78.4,1983
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,24 Months,87.9,84.4 to 90.9,867
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,24 Months,86.2,82.9 to 89.2,953
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,87.0,84.9 to 89.0,1983
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,24 Months,85.8,81.1 to 89.8,702
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,5 Months,85.4,79.8 to 89.6,496
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,93.4,89.8 to 96.0,702
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,20.3,15.2 to 26.7,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,94.1,91.4 to 96.2,1030
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,94.6,92.4 to 96.4,1397
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,95.2,92.0 to 97.5,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,93.2,90.3 to 95.5,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,93.4,90.5 to 95.7,953
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,93.8,91.8 to 95.4,1983
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,91.4,87.2 to 94.6,485
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,91.8,89.2 to 94.0,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,88.3,84.1 to 91.8,538
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,90.0,87.1 to 92.5,1023
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,91.8,87.9 to 94.9,496
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,25.4,21.1 to 30.3,867
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,25.4,21.0 to 30.3,953
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,24.7,21.9 to 27.7,1983
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,19 Months,82.9,78.6 to 86.5,705
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,83.1,80.0 to 85.8,1243
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,19 Months,85.4,80.7 to 89.1,485
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,86.2,82.9 to 89.0,964
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,19 Months,83.2,78.5 to 87.1,538
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,84.4,81.2 to 87.2,1023
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,92.2,89.2 to 94.6,1030
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,93.4,90.9 to 95.4,1397
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,92.3,89.3 to 94.8,953
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,92.3,90.2 to 94.0,1983
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,31.9,27.4 to 36.8,705
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,32.9,29.2 to 36.9,1243
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,27.6,25.0 to 30.3,1257
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,28.7,26.3 to 31.1,2463
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,94.3,91.7 to 96.3,1257
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,93.4,91.4 to 95.1,2463
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,92.5,89.3 to 95.1,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,96.6,92.9 to 98.7,496
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,5 Months,76.1,71.4 to 80.2,705
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,5 Months,77.2,73.8 to 80.2,1257
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,5 Months,75.9,73.4 to 78.2,2463
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,24 Months,91.1,87.1 to 94.3,485
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,90.1,87.3 to 92.5,1101
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,35 Months,91.4,86.0 to 95.3,702
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,24 Months,88.7,84.1 to 92.5,496
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,36.0,29.7 to 42.8,496
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,5 Months,75.9,72.3 to 79.1,1243
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,24 Months,86.3,81.9 to 90.1,538
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,88.9,86.0 to 91.4,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,77.1,66.9 to 87.3,138
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,34.0,28.3 to 40.2,538
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,28.7,24.9 to 32.8,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,88.2,85.0 to 91.4,859
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,93.4,91.4 to 95.4,1322
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,69.3,66.4 to 72.0,1257
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,70.6,68.1 to 73.0,2463
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,66.0,62.0 to 69.9,1030
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,68.6,65.2 to 71.8,1397
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,70.1,65.9 to 74.0,953
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,68.1,64.9 to 71.1,1983
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,90.0,85.6 to 93.4,538
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,91.2,88.2 to 93.6,1023
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,90.3,86.5 to 93.3,705
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,90.3,87.4 to 92.7,1243
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,24.3,19.5 to 29.9,485
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,32.5,28.1 to 37.1,964
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,46.7,40.6 to 53.3,702
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,19 Months,84.9,81.6 to 87.7,867
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,3 Months,89.9,84.9 to 93.4,496
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,86.6,80.1 to 91.2,382
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,3 Months,88.6,84.0 to 92.1,532
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,3 Months,89.4,86.2 to 91.9,1101
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,91.5,88.6 to 93.9,953
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,91.9,90.1 to 93.5,1983
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,19 Months,79.9,71.9 to 86.1,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,92.4,89.9 to 94.5,1030
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,92.6,90.6 to 94.4,1397
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,3 Months,85.7,80.8 to 89.4,538
DTaP,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,3 Months,87.2,83.8 to 89.9,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,92.8,90.5 to 94.7,1257
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,92.3,90.6 to 93.7,2463
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,19 Months,81.9,78.5 to 84.8,1030
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,83.5,80.8 to 86.0,1397
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,19 Months,85.3,83.5 to 86.9,1257
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,84.6,82.5 to 86.4,2463
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,5 Months,75.5,71.9 to 78.8,1030
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,5 Months,76.6,72.4 to 80.3,1397
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,24 Months,86.4,82.5 to 89.7,705
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,86.3,83.4 to 88.9,1243
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,24 Months,87.8,85.0 to 90.4,1030
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,87.7,85.3 to 90.0,1397
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,24 Months,88.6,86.0 to 90.9,1257
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,88.0,86.1 to 89.7,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,95.9,91.4 to 98.5,485
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,96.6,94.0 to 98.3,1101
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,90.2,82.5 to 98.0,131
Combined 7 Series,,States/Local Areas,TX-Rest of state,2018,Age,24 Months,66.5,60.5 to 72.4,485
Combined 7 Series,,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,68.5,64.3 to 72.6,1101
Combined 7 Series,,States/Local Areas,TX-Rest of state,2017,Age,24 Months,68.4,62.7 to 74.0,538
Combined 7 Series,,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,67.4,63.2 to 71.5,1023
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,19 Months,81.5,78.7 to 84.1,953
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,81.7,79.9 to 83.4,1983
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,90.1,87.3 to 92.6,1030
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,90.6,88.3 to 92.6,1397
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,5 Months,85.3,80.4 to 89.1,532
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,5 Months,84.8,81.3 to 87.8,1101
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2020,Age,13 Months,90.0,83.9 to 94.0,382
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,89.6,86.0 to 92.5,705
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,88.9,86.2 to 91.3,1243
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,91.5,89.1 to 93.5,1257
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,91.0,89.3 to 92.5,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,92.9,89.1 to 95.7,496
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,5 Months,76.3,70.7 to 81.1,538
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,5 Months,81.1,77.4 to 84.4,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014,Age,19 Months,88.7,85.6 to 91.2,1030
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,89.8,87.5 to 91.8,1397
Hib,Primary Series,States/Local Areas,TX-Rest of state,2012,Age,19 Months,91.6,89.6 to 93.2,867
Hib,Primary Series,States/Local Areas,TX-Rest of state,2011,Age,19 Months,92.5,87.0 to 95.7,702
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013,Age,19 Months,90.2,87.8 to 92.3,953
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,89.5,87.3 to 91.3,1983
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018,Age,13 Months,87.0,82.1 to 90.8,532
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,87.5,84.3 to 90.1,1101
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019,Age,13 Months,87.7,82.9 to 91.4,496
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019,Age,7 Months,74.1,67.6 to 79.7,496
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018,Age,7 Months,78.1,72.8 to 82.7,532
Hib,Primary Series,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,75.0,70.9 to 78.7,1101
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014,Age,13 Months,84.1,80.7 to 87.0,1030
Hib,Primary Series,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,84.3,81.5 to 86.7,1397
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015,Age,13 Months,86.1,83.3 to 88.6,1257
Hib,Primary Series,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,85.0,82.9 to 86.9,2463
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017,Age,7 Months,70.5,64.8 to 75.7,538
Hib,Primary Series,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,74.8,70.8 to 78.4,1023
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016,Age,7 Months,72.3,67.6 to 76.6,705
Hib,Primary Series,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,71.4,67.7 to 74.9,1243
Hib,Primary Series,States/Local Areas,TX-Rest of state,2012,Age,7 Months,66.1,62.3 to 69.6,867
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013,Age,7 Months,66.9,61.4 to 72.0,953
Hib,Primary Series,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,66.9,63.8 to 69.9,1983
Hib,Full Series,States/Local Areas,TX-Rest of state,2012,Age,24 Months,77.9,73.5 to 82.1,867
Hib,Full Series,States/Local Areas,TX-Rest of state,2011,Age,24 Months,78.6,73.2 to 83.6,702
Hib,Full Series,States/Local Areas,TX-Rest of state,2013,Age,24 Months,77.1,73.1 to 80.8,953
Hib,Full Series,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,77.6,75.0 to 80.2,1983
Hib,Full Series,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,71.1,68.8 to 73.4,1983
Hib,Full Series,States/Local Areas,TX-Rest of state,2014,Age,19 Months,69.8,65.8 to 73.5,1030
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,71.5,68.3 to 74.6,1397
Hib,Full Series,States/Local Areas,TX-Rest of state,2015,Age,19 Months,73.4,71.2 to 75.5,1257
Hib,Full Series,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,72.8,70.3 to 75.2,2463
Hib,Full Series,States/Local Areas,TX-Rest of state,2018,Age,19 Months,70.5,64.5 to 75.9,485
Hib,Full Series,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,94.9,92.7 to 96.5,1101
Hib,Full Series,States/Local Areas,TX-Rest of state,2019,Age,19 Months,76.8,70.7 to 82.0,496
Hib,Full Series,States/Local Areas,TX-Rest of state,2016,Age,19 Months,72.9,68.2 to 77.2,705
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,72.5,68.8 to 76.0,1243
Hib,Full Series,States/Local Areas,TX-Rest of state,2017,Age,19 Months,72.1,66.3 to 77.3,538
Hib,Full Series,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,71.2,67.1 to 75.1,1023
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,66.0,61.8 to 70.2,1034
Combined 7 Series,,States/Local Areas,TX-Rest of state,2015,Age,35 Months,73.6,68.3 to 78.6,1257
Combined 7 Series,,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,72.4,69.2 to 75.6,2463
Combined 7 Series,,States/Local Areas,TX-Rest of state,2018,Age,35 Months,72.0,65.8 to 77.9,485
Combined 7 Series,,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,73.6,69.2 to 77.9,1101
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,63.3,58.7 to 67.9,859
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,72.1,68.6 to 75.6,1322
Combined 7 Series,,States/Local Areas,TX-Rest of state,2019,Age,35 Months,75.3,68.7 to 81.4,496
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,67.9,56.4 to 79.3,131
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,39.8,28.5 to 51.1,138
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,76.7,72.4 to 80.9,801
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,64.1,59.2 to 68.9,811
Hib,Full Series,States/Local Areas,TX-Rest of state,2011,Age,19 Months,67.6,61.9 to 72.9,702
Hib,Full Series,States/Local Areas,TX-Rest of state,2012,Age,19 Months,73.1,70.6 to 75.5,867
Hib,Full Series,States/Local Areas,TX-Rest of state,2013,Age,19 Months,72.5,68.7 to 75.9,953
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,61.3,56.6 to 66.0,838
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",57.2,46.2 to 68.2,136
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,66.1,61.1 to 71.0,833
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.0,63.4 to 70.6,1351
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.1,63.9 to 72.3,989
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.2,63.0 to 77.4,291
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,66.3,63.6 to 69.1,2450
Combined 7 Series,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,63.0,54.9 to 71.2,266
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,90.8,87.2 to 93.4,878
Hib,Primary Series,States/Local Areas,TX-Rest of state,2019-2020,Age,7 Months,70.9,65.7 to 75.7,878
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,79.6,75.8 to 83.5,913
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,>400% FPL,94.7,92.6 to 96.8,816
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,71.7,64.4 to 78.0,589
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,91.0,88.4 to 93.7,913
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,83.5,78.6 to 88.4,913
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,79.3,75.1 to 83.6,709
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Poverty,133% to <400% FPL,77.4,73.2 to 81.6,847
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,82.2 to 93.3,315
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,92.0,89.5 to 94.5,913
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",64.1,54.0 to 74.2,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.5,70.2 to 78.8,919
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,77.6,70.8 to 83.2,589
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,92.8,89.3 to 95.3,589
Rotavirus,,States/Local Areas,TX-Rest of state,2011,Age,8 Months,67.4,61.5 to 72.8,702
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,3 Months,96.9,94.7 to 98.3,589
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,92.3,84.2 to 97.1,207
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,3 Months,84.8,78.9 to 89.3,589
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,92.6,88.7 to 95.5,589
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,3 Months,83.7,77.7 to 88.3,589
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,88.2,83.5 to 91.7,589
Rotavirus,,States/Local Areas,TX-Rest of state,2014,Age,8 Months,71.2,67.3 to 74.8,1030
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2015,Age,8 Months,72.9,69.6 to 75.9,1397
Rotavirus,,States/Local Areas,TX-Rest of state,2016,Age,8 Months,75.8,71.1 to 79.9,705
Rotavirus,,States/Local Areas,TX-Rest of state,2016-2017,Age,8 Months,73.2,69.5 to 76.6,1243
Rotavirus,,States/Local Areas,TX-Rest of state,2015,Age,8 Months,73.9,70.5 to 77.1,1257
Rotavirus,,States/Local Areas,TX-Rest of state,2015-2016,Age,8 Months,73.3,70.8 to 75.7,2463
Rotavirus,,States/Local Areas,TX-Rest of state,2017,Age,8 Months,70.6,64.8 to 75.8,538
Rotavirus,,States/Local Areas,TX-Rest of state,2017-2018,Age,8 Months,74.5,70.5 to 78.1,1023
Rotavirus,,States/Local Areas,TX-Rest of state,2019,Age,8 Months,77.3,71.3 to 82.4,496
Rotavirus,,States/Local Areas,TX-Rest of state,2018,Age,8 Months,77.6,71.9 to 82.5,485
Rotavirus,,States/Local Areas,TX-Rest of state,2018-2019,Age,8 Months,78.2,74.3 to 81.6,1101
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.6,68.7 to 82.5,291
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,73.6,69.0 to 78.3,833
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.7,70.7 to 78.6,989
Rotavirus,,States/Local Areas,TX-Rest of state,2013,Age,8 Months,71.8,67.4 to 75.7,953
Rotavirus,,States/Local Areas,TX-Rest of state,2013-2014,Age,8 Months,71.5,68.6 to 74.2,1983
Rotavirus,,States/Local Areas,TX-Rest of state,2012,Age,8 Months,70.3,65.7 to 74.6,867
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,65.6,61.1 to 70.1,838
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,72.5,69.9 to 75.1,2450
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.2,68.8 to 75.6,1351
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,70.3,62.5 to 78.0,266
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,73.7,69.3 to 78.0,811
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,81.6,77.6 to 85.5,801
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,79.6,76.4 to 82.7,1322
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,67.8,56.2 to 79.4,131
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,72.1,68.2 to 76.0,1034
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,67.5,63.2 to 71.9,859
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",63.0,52.2 to 73.7,136
Rotavirus,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,56.0,44.0 to 68.1,138
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,3 Months,98.7,96.4 to 99.5,207
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,40.5,35.9 to 45.1,859
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",43.6,32.8 to 54.3,136
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,43.4,39.1 to 47.8,1034
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",54.0,46.1 to 62.0,291
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,24.2,14.7 to 33.8,138
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,49.6,44.4 to 54.7,833
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",56.9,52.5 to 61.3,989
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,51.0,47.3 to 54.7,1351
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,36.9,28.4 to 45.4,266
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,49.1,46.3 to 51.9,2450
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,Hispanic,88.5,85.4 to 91.5,913
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,83.2,80.2 to 86.2,1353
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,93.7,91.8 to 95.6,1353
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,86.4 to 95.3,315
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.6,71.9 to 87.2,315
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.3,70.4 to 84.2,315
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,61.3,57.5 to 65.1,1322
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,39.0,27.9 to 50.1,131
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,87.0,83.4 to 90.6,709
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.4,74.6 to 86.3,919
Influenza,,States/Local Areas,TX-Rest of state,2016,Age,24 Months,48.4,43.5 to 53.6,705
Influenza,,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,50.5,46.6 to 54.6,1243
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,66.2,61.4 to 71.1,801
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,48.6,43.7 to 53.5,811
Influenza,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,38.4,33.8 to 42.9,838
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,86.3,83.5 to 89.1,1353
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,24 Months,94.7,88.6 to 98.1,207
Influenza,,States/Local Areas,TX-Rest of state,2021,Age,24 Months,47.2,36.6 to 59.1,207
Hib,Full Series,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,79.1,72.9 to 84.6,589
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,71.8,65.1 to 77.6,589
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,79.3,70.8 to 86.7,589
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,93.0,84.7 to 96.9,207
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,59.5,52.1 to 66.5,589
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2021,Age,13 Months,75.8,64.6 to 84.3,207
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,92.5,88.8 to 95.4,589
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,5 Months,77.4,70.3 to 83.3,589
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,84.3,78.0 to 89.1,589
Rotavirus,,States/Local Areas,TX-Rest of state,2020-2021,Age,8 Months,76.8,70.4 to 82.2,589
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2020-2021,Age,0-3 Days,84.4,78.8 to 88.8,589
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,92.6,88.8 to 95.6,589
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,83.4,78.0 to 88.1,589
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,87.4,81.9 to 91.4,589
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,94.7,88.6 to 98.1,207
Hib,Full Series,States/Local Areas,TX-Rest of state,2021,Age,35 Months,79.4,69.3 to 88.0,207
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,91.5,87.2 to 94.5,589
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,92.1,88.3 to 95.1,589
Combined 7 Series,,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,67.4,60.8 to 73.8,589
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,95.4,91.9 to 97.7,589
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,3 Months,80.1,73.6 to 85.3,589
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,5 Months,77.1,69.9 to 83.0,589
Combined 7 Series,,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,73.2,65.0 to 80.8,589
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,92.2,88.5 to 94.7,589
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,92.4,88.2 to 95.2,589
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,91.5,87.6 to 94.5,589
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,5 Months,86.5,80.7 to 90.7,589
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,5 Months,72.3,64.9 to 78.7,589
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,74.2,62.6 to 83.1,207
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2021,Age,0-3 Days,82.3,72.1 to 89.4,207
Rotavirus,,States/Local Areas,TX-Rest of state,2021,Age,8 Months,79.6,68.8 to 87.4,207
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,90.5,80.5 to 95.6,207
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,92.0,88.1 to 94.9,589
Hib,Primary Series,States/Local Areas,TX-Rest of state,2021,Age,35 Months,92.3,84.3 to 97.2,207
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,92.7,88.8 to 95.6,589
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,74.5,68.2 to 79.9,589
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,93.3,90.0 to 95.8,589
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,48.9,42.2 to 56.1,589
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,89.6,84.4 to 93.2,589
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,67.7,60.2 to 74.3,589
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,90.0,87.6 to 92.4,1353
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.1,64.4 to 87.9,159
Influenza,,States/Local Areas,TX-Rest of state,2019,Age,24 Months,54.2,47.5 to 61.2,496
Influenza,,States/Local Areas,TX-Rest of state,2018,Age,24 Months,53.6,47.5 to 60.0,485
Influenza,,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,54.7,50.3 to 59.2,1101
Influenza,,States/Local Areas,TX-Rest of state,2017,Age,24 Months,52.7,46.8 to 58.9,538
Influenza,,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,53.2,48.9 to 57.7,1023
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,80.6,75.5 to 84.8,538
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,80.5,76.8 to 83.8,1023
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,75.9,71.1 to 80.2,705
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,78.2,74.7 to 81.3,1243
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,89.1,86.1 to 91.4,953
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,88.8,87.3 to 90.2,1983
Combined 7 Series,,States/Local Areas,TX-Rest of state,2021,Age,24 Months,70.0,59.3 to 80.0,207
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,90.6,85.6 to 94.0,589
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,76.8,72.8 to 80.9,838
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,78.6,74.5 to 82.7,801
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,76.0,71.8 to 80.2,811
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,71.5,66.0 to 76.5,532
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,68.0,63.8 to 72.0,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,62.4,58.5 to 66.2,1243
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,87.7,83.9 to 91.5,833
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.4,87.5 to 93.3,989
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,90.1,85.9 to 93.2,538
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,91.7,88.9 to 93.9,1023
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,86.7,83.4 to 90.1,838
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,89.5,87.6 to 91.3,2450
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.0,88.8 to 93.1,1351
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,86.2,80.3 to 92.0,266
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,93.3,89.4 to 95.8,532
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,94.1,91.7 to 95.8,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,66.0,59.2 to 72.2,496
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,94.2,90.5 to 96.5,496
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,88.1,82.5 to 92.1,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,86.8,85.0 to 88.4,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,89.8,85.0 to 93.2,496
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,81.6,76.4 to 85.9,532
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,81.7,78.1 to 84.9,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,81.2,75.4 to 85.9,496
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,91.8,85.6 to 95.4,702
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,90.9,89.4 to 92.2,867
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,87.0,82.4 to 90.6,538
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,89.8,86.9 to 92.2,1023
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,89.7,86.1 to 92.4,705
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,88.4,85.5 to 90.7,1243
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,90.3,87.3 to 92.7,1257
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,90.0,88.2 to 91.6,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,89.7,85.2 to 92.9,532
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,89.9,86.9 to 92.2,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,80.6,77.4 to 83.4,1257
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,79.2,76.9 to 81.4,2463
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,88.6,85.7 to 91.0,1030
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,89.3,86.9 to 91.3,1397
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,89.9,87.4 to 91.9,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,91.8,88.9 to 94.0,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,92.8,87.8 to 95.8,702
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.4,85.6 to 91.2,989
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.9,86.6 to 91.2,1351
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,83.0,76.6 to 89.3,266
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,3 Months,84.7,82.5 to 86.6,867
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.7,78.2 to 85.3,989
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.0,72.4 to 85.6,291
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,3 Months,84.0,80.7 to 86.8,1030
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,3 Months,84.6,81.8 to 86.9,1397
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,3 Months,85.1,82.1 to 87.6,1257
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,3 Months,85.2,83.1 to 87.1,2463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2013,Age,0-3 Days,75.8,71.8 to 79.5,953
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2013-2014,Age,0-3 Days,76.3,73.6 to 78.8,1983
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,3 Months,87.2,83.5 to 90.1,953
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,3 Months,86.3,84.1 to 88.3,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,87.5,85.6 to 89.5,2450
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,3 Months,86.9,80.0 to 91.7,702
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,3 Months,84.8,83.4 to 86.2,867
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,88.8,86.1 to 91.4,1034
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.9,81.6 to 92.1,291
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.4,69.5 to 89.3,136
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,92.8,89.8 to 95.2,867
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,87.7,83.1 to 91.1,538
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,89.3,86.2 to 91.8,1023
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,87.4,83.4 to 90.5,705
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,87.5,84.6 to 89.9,1243
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,91.9,88.1 to 94.9,705
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,91.6,88.6 to 94.1,1243
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,93.6,91.2 to 95.4,1257
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,92.8,90.8 to 94.5,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,92.9,90.2 to 95.1,1030
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,93.1,90.9 to 95.0,1397
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016,Age,0-3 Days,77.2,72.7 to 81.2,705
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2016-2017,Age,0-3 Days,75.4,71.6 to 78.9,1243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2017,Age,0-3 Days,72.7,64.5 to 79.5,367
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2017-2018,Age,0-3 Days,78.9,74.9 to 82.4,1023
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,3 Months,86.5,82.6 to 89.7,705
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,3 Months,85.5,82.4 to 88.1,1243
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,3 Months,87.5,84.8 to 89.9,1257
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,3 Months,87.1,85.1 to 88.9,2463
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,3 Months,85.5,82.3 to 88.2,1030
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,3 Months,86.0,83.3 to 88.2,1397
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,59.2,53.3 to 64.8,953
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,59.8,55.5 to 64.0,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,86.3,82.9 to 89.6,838
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,92.1,89.5 to 94.8,801
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,85.3,81.8 to 88.8,811
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,61.6,58.1 to 64.9,867
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,65.2,58.5 to 71.3,702
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,92.7,88.5 to 95.4,496
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,91.1,86.8 to 94.1,532
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,92.0,89.3 to 94.0,1101
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,93.4,89.5 to 95.9,702
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,93.0,92.0 to 94.0,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,74.8,70.2 to 78.9,705
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,73.6,70.0 to 76.9,1243
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2015,Age,0-3 Days,80.7,77.7 to 83.4,1257
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2015-2016,Age,0-3 Days,79.4,77.1 to 81.5,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,69.0,65.0 to 72.8,1030
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,72.2,68.9 to 75.3,1397
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,72.7,69.2 to 75.9,1257
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,72.2,69.7 to 74.6,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,91.2,86.2 to 94.9,538
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,93.8,89.9 to 96.6,1023
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,91.8,89.7 to 93.5,953
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,91.8,90.2 to 93.1,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,95.1,90.7 to 97.9,485
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,94.7,92.0 to 96.7,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,60.5,56.4 to 64.4,1030
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,61.2,57.8 to 64.6,1397
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,61.3,56.2 to 66.2,705
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,63.2,59.5 to 66.7,1257
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,62.0,59.3 to 64.6,2463
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,3 Months,84.4,79.5 to 88.3,538
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,3 Months,86.6,83.3 to 89.4,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,72.3,66.6 to 77.4,538
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,76.2,72.3 to 79.7,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,75.6,69.1 to 81.1,496
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020,Age,24 Months,89.7,84.2 to 94.0,382
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,79.1,73.8 to 83.5,532
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,76.9,72.9 to 80.5,1101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,69.6,58.3 to 81.0,138
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,3 Months,89.2,84.0 to 92.8,496
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,3 Months,88.3,83.6 to 91.8,532
Polio,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,3 Months,88.8,85.5 to 91.4,1101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2019,Age,0-3 Days,82.6,76.8 to 87.2,496
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2018,Age,0-3 Days,83.2,78.0 to 87.4,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2018-2019,Age,0-3 Days,82.9,79.3 to 86.0,1101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,84.6,77.4 to 91.8,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,75.1,71.7 to 78.4,1322
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,79.1,75.2 to 83.0,859
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.7,65.3 to 84.1,136
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,91.9,85.5 to 98.2,131
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,93.8,90.2 to 96.4,496
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,63.6,57.7 to 69.1,538
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,67.7,63.5 to 71.6,1023
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,90.7,88.3 to 93.0,1034
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,83.6 to 93.7,291
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.1,71.4 to 90.7,136
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,75.9,65.5 to 86.4,138
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,86.9,83.6 to 90.2,859
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,93.2,91.2 to 95.2,1322
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,91.7,89.0 to 93.8,1030
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,92.3,90.1 to 94.1,1397
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,91.8,88.4 to 94.3,705
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,91.0,88.4 to 93.0,1243
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,92.9,90.6 to 94.7,1257
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,92.4,90.7 to 93.8,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,87.5,83.7 to 90.6,705
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,87.2,84.2 to 89.6,1243
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,86.8,82.1 to 90.4,538
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,88.1,84.9 to 90.7,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,88.4,85.6 to 90.7,1257
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,87.4,85.5 to 89.2,2463
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,78.9,75.3 to 82.2,1030
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,77.3,74.2 to 80.1,1397
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,82.9,80.3 to 85.3,867
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,85.4,77.7 to 90.8,702
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,93.7,91.4 to 96.1,801
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,89.4,86.2 to 92.5,811
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,89.8,84.7 to 93.3,702
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,80.2,77.6 to 82.5,953
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,79.6,77.5 to 81.5,1983
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,86.5,83.3 to 89.2,1030
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,87.5,84.9 to 89.7,1397
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,87.4,85.2 to 89.3,953
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,87.0,85.6 to 88.2,1983
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,77.0,74.6 to 79.5,2450
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,74.3,66.2 to 82.4,266
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,73.4 to 82.1,833
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.1,74.0 to 80.2,1351
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",69.8,65.7 to 74.0,989
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,72.3 to 85.0,291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,82.4,78.9 to 85.9,1034
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,87.1,83.9 to 89.8,1030
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,87.6,85.0 to 89.9,1397
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,86.3,83.6 to 88.6,953
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,86.7,85.2 to 88.1,1983
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,81.1,77.1 to 85.0,811
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,77.1,73.0 to 81.2,838
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,86.2,82.8 to 89.6,801
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,84.9,82.1 to 87.6,1322
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,87.9,82.3 to 92.5,496
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,5 Months,76.9,67.8 to 84.0,702
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,5 Months,74.5,71.6 to 77.1,867
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,3 Months,84.9,80.0 to 88.7,538
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,3 Months,85.2,81.7 to 88.1,1023
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,3 Months,86.1,82.2 to 89.3,705
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,3 Months,85.5,82.5 to 88.1,1243
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,5 Months,82.5,77.3 to 86.7,532
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,5 Months,82.7,79.0 to 85.8,1101
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,91.2,84.8 to 97.5,131
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,90.0,87.7 to 92.3,1322
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,80.8,78.5 to 83.1,2450
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,77.6,70.5 to 84.6,266
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.7,79.8 to 85.5,1351
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,76.2,66.0 to 86.5,138
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,5 Months,83.7,78.1 to 88.1,496
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,5 Months,76.0,70.5 to 80.8,538
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,5 Months,79.4,75.5 to 82.8,1023
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,91.1,84.2 to 95.1,702
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,89.3,85.7 to 92.4,705
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,89.6,86.9 to 91.9,1243
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,92.0,89.8 to 93.9,1257
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,90.5,88.7 to 92.1,2463
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,87.0,85.4 to 88.4,867
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,89.8,85.8 to 93.0,538
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,91.5,88.8 to 93.7,1023
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,3 Months,89.3,84.3 to 92.9,496
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,3 Months,85.4,80.4 to 89.4,532
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,3 Months,87.7,84.4 to 90.4,1101
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2020,Age,35 Months,92.9,87.2 to 96.7,382
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014,Age,0-3 Days,76.8,73.2 to 80.0,1030
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2014-2015,Age,0-3 Days,77.7,74.7 to 80.4,1397
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,69.0,62.1 to 75.2,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,65.6,62.0 to 69.1,867
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,68.5,63.3 to 73.2,953
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,68.8,65.8 to 71.6,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,92.8,89.0 to 95.7,485
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,93.0,90.6 to 94.9,1101
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,89.0,86.4 to 91.2,1257
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,87.9,85.9 to 89.7,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,92.4,89.2 to 94.9,953
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,92.6,90.6 to 94.3,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,92.1,88.2 to 95.1,702
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,92.5,88.7 to 95.4,496
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,86.5,82.7 to 90.4,833
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,94.2,92.1 to 95.8,1030
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,93.1,91.2 to 94.6,1397
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,3 Months,84.5,81.2 to 87.3,1030
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,3 Months,85.4,82.7 to 87.7,1397
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,93.9,92.6 to 95.0,953
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,94.1,93.2 to 94.9,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,93.4,91.4 to 95.0,1257
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,93.1,91.6 to 94.4,2463
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,88.8,86.0 to 91.5,1034
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,88.6,80.5 to 96.7,131
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,68.8,57.2 to 80.3,138
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.9,67.7 to 88.0,136
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,92.1,88.0 to 94.9,496
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,92.3,89.3 to 94.8,867
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,90.9,87.9 to 93.4,953
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,91.3,89.3 to 93.0,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,91.6,89.1 to 93.8,1030
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,91.9,89.8 to 93.7,1397
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,82.4,79.1 to 85.7,1034
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.8,61.4 to 82.1,136
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,78.6,74.6 to 82.5,859
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,80.0,70.7 to 89.4,131
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,64.4,52.7 to 76.2,138
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,3 Months,86.2,80.7 to 90.3,953
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,3 Months,85.1,81.7 to 87.9,1983
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,5 Months,76.4,72.7 to 79.7,1030
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,5 Months,77.5,74.7 to 80.1,1397
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,5 Months,76.6,72.0 to 80.7,705
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,5 Months,76.3,72.8 to 79.5,1243
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,5 Months,78.7,75.4 to 81.6,1257
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,5 Months,76.9,74.5 to 79.2,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,92.0,88.2 to 95.0,702
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,85.1,79.9 to 89.5,485
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,87.4,83.8 to 90.5,1101
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,82.7,78.3 to 86.7,705
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,83.1,79.6 to 86.3,1243
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,94.8,91.3 to 97.0,496
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020,Age,24 Months,90.2,84.9 to 94.2,382
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,92.4,88.2 to 95.2,485
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,90.5,87.5 to 92.8,1101
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,3 Months,88.9,83.8 to 92.5,496
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,84.2,77.9 to 89.5,538
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,84.6,80.8 to 87.9,1023
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,89.7,85.5 to 92.8,538
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,91.2,88.4 to 93.4,1023
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,5 Months,75.0,70.8 to 78.8,953
Hib,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,5 Months,75.7,73.1 to 78.1,1983
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,3 Months,87.3,82.4 to 91.0,532
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,3 Months,88.3,85.0 to 90.9,1101
Hib,Full Series,States/Local Areas,TX-Rest of state,2020,Age,24 Months,78.5,71.3 to 85.0,382
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,84.5,80.9 to 88.1,838
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,87.7,85.8 to 89.7,2450
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.1,86.7 to 91.4,1351
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,82.9,76.1 to 89.8,266
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,92.3,89.7 to 94.9,801
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,88.2,85.0 to 91.4,811
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,3 Months,84.2,78.3 to 88.7,702
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2011,Age,0-3 Days,79.1,74.1 to 83.4,702
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,86.1,82.8 to 89.4,859
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Rest of state,2012,Age,0-3 Days,77.8,73.3 to 81.8,867
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,78.4,73.9 to 82.9,833
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,88.9,84.5 to 92.6,485
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,89.9,87.0 to 92.3,1101
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,91.3,89.1 to 93.1,1257
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,90.9,89.2 to 92.3,2463
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2013,Age,0-2 Days,75.5,71.9 to 78.9,953
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2013-2014,Age,0-2 Days,75.4,73.2 to 77.5,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,84.8,81.5 to 87.6,1030
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,85.8,83.0 to 88.1,1397
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,86.6,83.6 to 89.0,1257
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,85.3,83.1 to 87.2,2463
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017,Age,35 Months,93.9,88.8 to 97.2,538
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,93.3,90.5 to 95.5,1023
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015,Age,35 Months,91.3,88.3 to 93.7,1257
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,91.5,89.5 to 93.3,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,73.6,67.0 to 79.3,496
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013,Age,35 Months,90.4,87.2 to 93.1,953
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,92.1,90.0 to 93.9,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,88.4,83.8 to 91.9,538
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,91.2,88.3 to 93.4,1023
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,85.5,83.2 to 87.6,953
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,85.2,83.9 to 86.4,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,91.5,88.1 to 94.0,705
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,90.0,87.2 to 92.2,1243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2017,Age,0-2 Days,73.3,67.1 to 78.7,538
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2017-2018,Age,0-2 Days,78.6,74.7 to 82.1,1023
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2016,Age,0-2 Days,75.4,70.7 to 79.5,705
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2016-2017,Age,0-2 Days,74.3,70.5 to 77.8,1243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2018,Age,0-2 Days,82.2,77.2 to 86.3,532
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2018-2019,Age,0-2 Days,82.7,79.1 to 85.8,1101
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,78.9,73.5 to 83.8,702
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018,Age,24 Months,91.9,88.0 to 94.9,485
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,90.8,88.1 to 93.1,1101
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019,Age,24 Months,89.6,85.0 to 93.2,496
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2012,Age,35 Months,93.3,90.4 to 95.6,867
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2011,Age,35 Months,91.6,87.1 to 95.0,702
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016,Age,35 Months,92.4,89.1 to 95.0,705
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,92.9,90.2 to 95.1,1243
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013,Age,35 Months,91.0,88.1 to 93.5,953
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,91.7,89.6 to 93.4,1983
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,82.5,79.3 to 85.6,1030
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,82.2,79.4 to 84.8,1397
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,78.2,74.3 to 81.9,953
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,80.3,77.8 to 82.8,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,84.2,79.4 to 88.3,538
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,86.8,83.6 to 89.6,1023
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,89.5,84.9 to 93.1,496
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,80.7,76.6 to 84.5,867
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,86.9,82.5 to 90.7,702
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,84.3,80.6 to 88.0,838
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,86.9,84.8 to 88.9,2450
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.2,85.7 to 90.7,1351
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,82.4,75.5 to 89.2,266
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018,Age,35 Months,93.0,89.1 to 95.8,485
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,92.9,90.1 to 95.2,1101
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017,Age,35 Months,91.7,86.8 to 95.3,538
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,92.1,89.3 to 94.4,1023
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,85.7,81.8 to 89.7,833
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,82.9 to 89.5,989
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,92.9,88.1 to 97.7,131
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,83.9 to 94.1,291
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019,Age,35 Months,93.3,87.6 to 97.0,496
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,91.7,87.6 to 94.5,538
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,93.2,90.6 to 95.1,1023
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,3 Months,84.7,80.5 to 88.1,705
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,3 Months,84.3,81.1 to 87.0,1243
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,3 Months,87.1,84.3 to 89.4,1257
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,3 Months,85.9,83.8 to 87.8,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,88.7,84.8 to 91.7,705
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,89.2,86.4 to 91.4,1243
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,91.1,89.0 to 92.9,1257
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,89.7,87.8 to 91.3,2463
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,92.5,89.3 to 94.8,705
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,92.1,89.6 to 94.0,1243
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,94.5,91.0 to 96.7,532
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,94.9,92.7 to 96.5,1101
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,84.9,81.6 to 87.9,1030
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,85.1,82.3 to 87.7,1397
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,85.6,82.4 to 88.6,1257
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,83.9,81.5 to 86.2,2463
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,91.1,88.9 to 93.3,1322
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,84.7,81.2 to 88.2,859
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,89.5,86.9 to 92.0,1034
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,83.8 to 93.6,291
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.0,69.1 to 88.9,136
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,78.1,68.1 to 88.1,138
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,89.1,84.7 to 92.8,485
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,91.4,88.5 to 93.8,1101
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,89.5,86.7 to 91.9,1030
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,90.3,88.0 to 92.2,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,92.4,87.7 to 95.8,496
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,3 Months,83.9,79.0 to 87.8,538
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,3 Months,85.5,82.0 to 88.4,1023
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,81.6,77.4 to 85.3,953
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,83.2,80.6 to 85.7,1983
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,87.7,84.5 to 90.9,811
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,89.9,86.7 to 93.0,801
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,86.8,83.0 to 90.6,833
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.6,84.5 to 90.8,989
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,3 Months,87.2,80.9 to 91.6,702
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,3 Months,85.8,84.1 to 87.2,867
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,3 Months,85.5,80.8 to 89.2,953
Hib,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,3 Months,85.0,82.5 to 87.2,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,88.0,84.3 to 91.1,705
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,88.5,85.3 to 91.3,1243
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,91.2,88.5 to 93.5,1257
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,89.8,87.9 to 91.6,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,89.4,87.1 to 91.4,953
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,89.5,88.1 to 90.7,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,90.1,82.8 to 94.5,702
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,81.4,76.3 to 86.0,485
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,83.1,79.7 to 86.3,1101
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,83.9,78.6 to 88.5,496
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,83.4,79.3 to 87.1,867
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,84.8,79.3 to 89.6,702
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,90.1,84.0 to 94.6,538
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,89.3,85.8 to 92.3,1023
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,91.4,89.0 to 93.4,867
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,90.8,86.5 to 93.8,532
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,90.5,87.5 to 92.8,1101
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,90.1,85.4 to 93.5,496
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,84.5,80.2 to 87.9,705
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,86.2,83.2 to 88.7,1243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2019,Age,0-2 Days,82.4,76.6 to 87.0,496
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,92.5,88.3 to 95.3,496
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,93.5,89.6 to 95.9,532
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,93.2,90.7 to 95.1,1101
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,90.2,87.0 to 93.0,953
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,90.3,88.1 to 92.2,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,90.2,87.2 to 92.8,1030
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,91.0,88.5 to 93.2,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,90.9,87.6 to 93.7,867
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,87.9,83.4 to 91.2,538
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,89.3,86.2 to 91.7,1023
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,94.4,92.9 to 95.6,867
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,93.4,89.5 to 95.9,702
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,81.0,76.7 to 85.0,705
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,80.5,77.1 to 83.6,1243
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,79.8,74.7 to 84.4,538
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,80.7,77.1 to 84.0,1023
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014,Age,35 Months,92.2,89.3 to 94.6,1030
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,91.8,89.3 to 93.9,1397
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015,Age,35 Months,92.0,89.3 to 94.3,1257
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,91.5,89.7 to 93.2,2463
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018,Age,35 Months,93.5,89.8 to 96.2,485
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,93.5,90.6 to 95.7,1101
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,81.3,78.2 to 84.2,1257
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,80.4,78.0 to 82.6,2463
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016,Age,35 Months,91.6,88.4 to 94.2,705
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,91.4,88.8 to 93.6,1243
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,86.2,82.7 to 89.6,859
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,89.5,87.1 to 91.9,1322
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019,Age,35 Months,94.3,87.8 to 98.0,496
PCV,≥1 Dose,States/Local Areas,TX-Rest of state,2021,Age,3 Months,86.1,76.0 to 92.4,207
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,89.2,85.0 to 92.3,589
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,91.1,86.4 to 94.6,589
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2020-2021,Age,0-1 Days,82.8,76.9 to 87.4,589
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,91.5,86.9 to 94.6,589
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2021,Age,13 Months,71.8,60.3 to 81.0,207
Hib,Primary Series,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,91.2,86.6 to 94.7,589
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,74.4,67.9 to 80.0,589
Hib,Full Series,States/Local Areas,TX-Rest of state,2020-2021,Age,35 Months,79.5,73.4 to 85.1,589
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,5 Months,78.3,66.5 to 86.8,207
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,5 Months,78.3,66.5 to 86.8,207
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,5 Months,88.0,77.6 to 94.0,207
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2021,Age,19 Months,97.1,92.5 to 98.9,207
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,69.9,62.6 to 76.2,589
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,19 Months,94.7,87.5 to 97.9,207
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,33.4,27.0 to 40.4,589
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,89.8,80.3 to 95.0,207
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2020-2021,Age,0-2 Days,83.7,78.0 to 88.2,589
Hib,Full Series,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,74.7,68.2 to 80.3,589
Influenza,,States/Local Areas,TX-Rest of state,2014,Age,24 Months,44.1,40.2 to 48.2,1030
Influenza,,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,51.0,47.5 to 54.5,1397
Influenza,,States/Local Areas,TX-Rest of state,2015,Age,24 Months,54.7,51.0 to 58.4,1257
Influenza,,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,52.3,49.6 to 55.0,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,13 Months,89.7,85.0 to 93.1,589
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,91.4,87.3 to 94.2,589
Influenza,,States/Local Areas,TX-Rest of state,2012,Age,24 Months,48.1,43.3 to 53.2,867
Influenza,,States/Local Areas,TX-Rest of state,2011,Age,24 Months,45.5,39.7 to 51.7,702
Influenza,,States/Local Areas,TX-Rest of state,2013,Age,24 Months,44.2,39.9 to 48.7,953
Influenza,,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,44.1,41.2 to 47.2,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2021,Age,13 Months,94.9,87.6 to 98.0,207
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2021,Age,35 Months,98.3,94.9 to 99.6,207
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,81.5,75.7 to 86.1,589
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,19 Months,91.3,87.2 to 94.2,589
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,93.9,87.8 to 97.5,207
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2021,Age,35 Months,87.1,77.7 to 93.9,207
Hib,Primary Series,States/Local Areas,TX-Rest of state,2021,Age,13 Months,85.6,75.5 to 92.0,207
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2020-2021,Age,7 Months,67.1,60.0 to 73.6,589
Influenza,,States/Local Areas,TX-Rest of state,2020-2021,Age,24 Months,50.2,43.4 to 57.4,589
Hep A,≥1 Dose,HHS Regions/National,United States,2021,Age,35 Months,90.1,88.3 to 91.7,11281
≥1 Dose Varicella,,HHS Regions/National,United States,2020-2021,Age,35 Months,93.3,92.4 to 94.1,28668
Hep A,≥2 Doses,HHS Regions/National,United States,2021,Age,35 Months,78.1,73.9 to 82.1,11281
PCV,≥4 Doses,HHS Regions/National,United States,2021,Age,19 Months,77.3,75.5 to 78.9,11281
Hib,Primary Series,HHS Regions/National,United States,2021,Age,7 Months,68.5,66.6 to 70.4,11281
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,Hispanic,68.0,65.9 to 70.0,11789
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Other,67.4,63.9 to 70.9,2246
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Uninsured,47.9,43.7 to 52.1,1692
Combined 7 Series,,HHS Regions/National,United States,2019,Age,35 Months,76.0,74.5 to 77.4,17265
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Any Medicaid,65.1,63.7 to 66.4,21000
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Insurance Coverage,Private Insurance Only,75.1,74.0 to 76.2,31919
Combined 7 Series,,HHS Regions/National,United States,2018,Age,35 Months,76.1,74.7 to 77.5,18826
Combined 7 Series,,HHS Regions/National,United States,2018-2019,Age,35 Months,76.1,75.0 to 77.1,36091
Hib,Full Series,HHS Regions/National,United States,2017,Age,19 Months,74.4,73.0 to 75.7,17804
Hib,Full Series,HHS Regions/National,United States,2017-2018,Age,19 Months,74.5,73.6 to 75.4,36630
Hib,Full Series,HHS Regions/National,United States,2018,Age,19 Months,74.7,73.4 to 75.9,18826
Hib,Full Series,HHS Regions/National,United States,2018-2019,Age,19 Months,95.4,94.9 to 95.8,36091
Hib,Full Series,HHS Regions/National,United States,2014,Age,19 Months,73.4,71.9 to 74.8,15333
Hib,Full Series,HHS Regions/National,United States,2014-2015,Age,19 Months,73.5,72.5 to 74.6,30796
Hib,Full Series,HHS Regions/National,United States,2014,Age,24 Months,79.5,78.2 to 80.9,15333
Hib,Full Series,HHS Regions/National,United States,2014-2015,Age,24 Months,79.6,78.6 to 80.6,30796
Hib,Full Series,HHS Regions/National,United States,2013,Age,24 Months,80.8,79.6 to 82.1,14872
Hib,Full Series,HHS Regions/National,United States,2013-2014,Age,24 Months,80.2,79.3 to 81.1,30205
Hib,Full Series,HHS Regions/National,United States,2015,Age,19 Months,73.7,72.1 to 75.2,15463
Hib,Full Series,HHS Regions/National,United States,2015-2016,Age,19 Months,74.2,73.1 to 75.2,31419
Hib,Full Series,HHS Regions/National,United States,2016,Age,19 Months,74.6,73.0 to 76.1,15956
Hib,Full Series,HHS Regions/National,United States,2016-2017,Age,19 Months,74.5,73.4 to 75.5,33760
Hib,Full Series,HHS Regions/National,United States,2019,Age,19 Months,74.7,73.4 to 75.9,17265
Combined 7 Series,,HHS Regions/National,United States,2015,Age,35 Months,74.9,73.3 to 76.5,15463
Combined 7 Series,,HHS Regions/National,United States,2015-2016,Age,35 Months,75.1,73.9 to 76.2,31419
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a Non-MSA,66.1,64.3 to 68.0,10389
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Overall,Overall,69.3,68.5 to 70.1,56857
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.2,68.9 to 71.5,21757
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Urbanicity,Living In a MSA Principal City,69.2,68.0 to 70.5,24711
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.2,70.2 to 72.2,33203
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.2,68.0 to 72.4,7674
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.2,61.8 to 66.5,4191
Hib,Full Series,HHS Regions/National,United States,2013,Age,19 Months,74.7,73.5 to 76.0,14872
Hib,Full Series,HHS Regions/National,United States,2013-2014,Age,19 Months,74.0,73.2 to 74.9,30205
Hib,Full Series,HHS Regions/National,United States,2012,Age,19 Months,73.1,71.8 to 74.4,15039
Hib,Full Series,HHS Regions/National,United States,2011,Age,19 Months,72.6,71.3 to 73.9,14513
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Poverty,>400% FPL,79.3,77.9 to 80.6,18707
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Poverty,133% to <400% FPL,68.4,67.0 to 69.8,21077
Combined 7 Series,,HHS Regions/National,United States,2014-2017,Poverty,<133% FPL,63.1,61.6 to 64.6,17073
Hib,Full Series,HHS Regions/National,United States,2011,Age,24 Months,79.9,78.5 to 81.3,14513
Hib,Full Series,HHS Regions/National,United States,2012,Age,24 Months,80.2,78.8 to 81.5,15039
Hib,Primary Series,HHS Regions/National,United States,2012,Age,19 Months,92.4,91.5 to 93.1,15039
Hib,Primary Series,HHS Regions/National,United States,2012,Age,24 Months,93.6,92.8 to 94.2,15039
Hib,Primary Series,HHS Regions/National,United States,2011,Age,24 Months,92.8,91.8 to 93.8,14513
Hib,Primary Series,HHS Regions/National,United States,2019,Age,19 Months,93.1,92.3 to 93.7,17265
Hib,Primary Series,HHS Regions/National,United States,2016,Age,19 Months,91.8,90.8 to 92.8,15956
Hib,Primary Series,HHS Regions/National,United States,2016-2017,Age,19 Months,91.5,90.8 to 92.2,33760
Hib,Primary Series,HHS Regions/National,United States,2018,Age,13 Months,88.3,87.3 to 89.2,18826
Hib,Primary Series,HHS Regions/National,United States,2018-2019,Age,13 Months,88.2,87.5 to 88.9,36091
Hib,Primary Series,HHS Regions/National,United States,2017,Age,13 Months,87.0,85.9 to 88.1,17804
Hib,Primary Series,HHS Regions/National,United States,2017-2018,Age,13 Months,87.6,86.9 to 88.3,36630
Hib,Primary Series,HHS Regions/National,United States,2019,Age,13 Months,88.2,87.2 to 89.1,17265
Hib,Primary Series,HHS Regions/National,United States,2014,Age,7 Months,70.0,68.5 to 71.6,15333
Hib,Primary Series,HHS Regions/National,United States,2014-2015,Age,7 Months,69.4,68.2 to 70.5,30796
Hib,Primary Series,HHS Regions/National,United States,2015,Age,7 Months,68.7,66.9 to 70.4,15463
Hib,Primary Series,HHS Regions/National,United States,2015-2016,Age,7 Months,70.3,69.1 to 71.5,31419
Hib,Primary Series,HHS Regions/National,United States,2013,Age,7 Months,68.7,67.3 to 70.1,14872
Hib,Primary Series,HHS Regions/National,United States,2013-2014,Age,7 Months,69.4,68.3 to 70.4,30205
Hib,Primary Series,HHS Regions/National,United States,2018,Age,19 Months,93.0,92.2 to 93.7,18826
Hib,Primary Series,HHS Regions/National,United States,2018-2019,Age,19 Months,88.2,87.5 to 88.9,36091
Hib,Primary Series,HHS Regions/National,United States,2017,Age,19 Months,91.2,90.2 to 92.1,17804
Hib,Primary Series,HHS Regions/National,United States,2017-2018,Age,19 Months,92.1,91.5 to 92.7,36630
Hib,Primary Series,HHS Regions/National,United States,2015,Age,19 Months,92.1,91.4 to 92.7,15463
Hib,Primary Series,HHS Regions/National,United States,2015-2016,Age,19 Months,92.0,91.3 to 92.6,31419
Hib,Primary Series,HHS Regions/National,United States,2014,Age,19 Months,90.9,89.9 to 91.9,15333
Hib,Primary Series,HHS Regions/National,United States,2014-2015,Age,19 Months,91.5,90.8 to 92.1,30796
Hib,Primary Series,HHS Regions/National,United States,2013,Age,19 Months,92.7,92.0 to 93.4,14872
Hib,Primary Series,HHS Regions/National,United States,2013-2014,Age,19 Months,91.8,91.2 to 92.4,30205
Hib,Primary Series,HHS Regions/National,United States,2011,Age,19 Months,92.1,91.0 to 93.1,14513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,United States,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,76.1 to 77.8,37179
Hib,Full Series,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.6,71.5 to 75.8,4715
Polio,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,92.2,91.2 to 93.2,12650
Hep A,≥2 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,78.6,76.4 to 80.8,12650
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,91.8,90.8 to 92.9,12650
Hep A,≥1 Dose,HHS Regions/National,United States,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.5,84.8 to 88.3,8905
DTaP,≥4 Doses,HHS Regions/National,United States,2016-2019,Poverty,133% to <400% FPL,81.1,80.0 to 82.2,24430
Combined 7 Series,,HHS Regions/National,United States,2019,Age,24 Months,70.1,68.7 to 71.5,17265
Hib,Primary Series,HHS Regions/National,United States,2019,Age,35 Months,94.9,94.2 to 95.5,17265
Combined 7 Series,,HHS Regions/National,United States,2016,Age,24 Months,69.7,68.0 to 71.3,15956
Combined 7 Series,,HHS Regions/National,United States,2016-2017,Age,24 Months,69.8,68.6 to 70.9,33760
Hep B,≥3 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,62.8,61.8 to 63.8,34652
PCV,≥3 Doses,HHS Regions/National,United States,2016-2019,Poverty,>400% FPL,96.5,96.0 to 97.1,22558
Hib,Full Series,HHS Regions/National,United States,2016-2019,Race and Ethnicity,Hispanic,78.2,76.5 to 79.9,12650
Hep B,≥2 Doses,HHS Regions/National,United States,2019-2020,Age,7 Months,92.1,91.5 to 92.7,34652
Hib,Primary Series,HHS Regions/National,United States,2018,Age,35 Months,94.5,93.7 to 95.2,18826
Hib,Primary Series,HHS Regions/National,United States,2018-2019,Age,35 Months,94.7,94.2 to 95.2,36091
Combined 7 Series,,HHS Regions/National,United States,2015,Age,24 Months,68.3,66.7 to 69.9,15463
Combined 7 Series,,HHS Regions/National,United States,2015-2016,Age,24 Months,69.0,67.8 to 70.1,31419
Combined 7 Series,,HHS Regions/National,United States,2014,Age,24 Months,68.5,67.0 to 70.1,15333
Combined 7 Series,,HHS Regions/National,United States,2014-2015,Age,24 Months,68.4,67.3 to 69.5,30796
Hib,Primary Series,HHS Regions/National,United States,2014,Age,35 Months,92.7,91.7 to 93.6,15333
Hib,Primary Series,HHS Regions/National,United States,2014-2015,Age,35 Months,93.5,92.8 to 94.1,30796
Hib,Primary Series,HHS Regions/National,United States,2012,Age,35 Months,94.4,93.6 to 95.0,15039
Hib,Primary Series,HHS Regions/National,United States,2019,Age,24 Months,94.0,93.3 to 94.6,17265
Hib,Primary Series,HHS Regions/National,United States,2011,Age,35 Months,93.7,92.7 to 94.6,14513
Hib,Primary Series,HHS Regions/National,United States,2013,Age,35 Months,94.8,94.1 to 95.5,14872
Hib,Primary Series,HHS Regions/National,United States,2013-2014,Age,35 Months,93.7,93.1 to 94.3,30205
Hib,Primary Series,HHS Regions/National,United States,2016,Age,35 Months,93.4,92.5 to 94.3,15956
Hib,Primary Series,HHS Regions/National,United States,2016-2017,Age,35 Months,93.2,92.5 to 93.8,33760
Hib,Primary Series,HHS Regions/National,United States,2017,Age,35 Months,92.9,92.0 to 93.7,17804
Hib,Primary Series,HHS Regions/National,United States,2017-2018,Age,35 Months,93.7,93.1 to 94.3,36630
Combined 7 Series,,HHS Regions/National,United States,2018,Age,24 Months,70.1,68.8 to 71.5,18826
Combined 7 Series,,HHS Regions/National,United States,2018-2019,Age,24 Months,70.1,69.2 to 71.1,36091
Combined 7 Series,,HHS Regions/National,United States,2017,Age,24 Months,69.8,68.4 to 71.3,17804
Combined 7 Series,,HHS Regions/National,United States,2017-2018,Age,24 Months,70.0,69.0 to 71.0,36630
Combined 7 Series,,HHS Regions/National,United States,2014,Age,35 Months,74.1,72.5 to 75.7,15333
Combined 7 Series,,HHS Regions/National,United States,2014-2015,Age,35 Months,74.4,73.3 to 75.6,30796
Combined 7 Series,,HHS Regions/National,United States,2012,Age,35 Months,75.9,74.3 to 77.5,15039
Combined 7 Series,,HHS Regions/National,United States,2017,Age,35 Months,74.9,73.3 to 76.4,17804
Combined 7 Series,,HHS Regions/National,United States,2017-2018,Age,35 Months,75.5,74.4 to 76.5,36630
Combined 7 Series,,HHS Regions/National,United States,2016,Age,35 Months,75.3,73.6 to 77.0,15956
Combined 7 Series,,HHS Regions/National,United States,2016-2017,Age,35 Months,75.1,73.9 to 76.2,33760
Hib,Primary Series,HHS Regions/National,United States,2016,Age,13 Months,87.3,85.9 to 88.5,15956
Hib,Primary Series,HHS Regions/National,United States,2016-2017,Age,13 Months,87.2,86.3 to 88.0,33760
Combined 7 Series,,HHS Regions/National,United States,2011,Age,35 Months,74.4,72.6 to 76.1,14513
Hib,Primary Series,HHS Regions/National,United States,2013,Age,24 Months,93.5,92.7 to 94.2,14872
Hib,Primary Series,HHS Regions/National,United States,2013-2014,Age,24 Months,92.7,92.1 to 93.3,30205
Hib,Primary Series,HHS Regions/National,United States,2013,Age,13 Months,88.3,87.2 to 89.3,14872
Hib,Primary Series,HHS Regions/National,United States,2013-2014,Age,13 Months,87.7,86.9 to 88.5,30205
Hib,Primary Series,HHS Regions/National,United States,2012,Age,13 Months,88.5,87.5 to 89.4,15039
Hib,Primary Series,HHS Regions/National,United States,2011,Age,13 Months,88.7,87.5 to 89.7,14513
Hib,Primary Series,HHS Regions/National,United States,2016,Age,7 Months,72.0,70.3 to 73.5,15956
Hib,Primary Series,HHS Regions/National,United States,2016-2017,Age,7 Months,72.1,71.0 to 73.2,33760
Hib,Primary Series,HHS Regions/National,United States,2017,Age,7 Months,72.2,70.8 to 73.6,17804
Hib,Primary Series,HHS Regions/National,United States,2017-2018,Age,7 Months,73.0,72.0 to 73.9,36630
Hib,Primary Series,HHS Regions/National,United States,2019,Age,7 Months,72.5,71.1 to 73.8,17265
Hib,Primary Series,HHS Regions/National,United States,2014,Age,13 Months,87.2,86.0 to 88.2,15333
Hib,Primary Series,HHS Regions/National,United States,2014-2015,Age,13 Months,87.5,86.7 to 88.2,30796
Hib,Primary Series,HHS Regions/National,United States,2015,Age,13 Months,87.8,86.6 to 88.8,15463
Hib,Primary Series,HHS Regions/National,United States,2015-2016,Age,13 Months,87.5,86.7 to 88.4,31419
Hib,Primary Series,HHS Regions/National,United States,2017,Age,24 Months,92.0,91.1 to 92.9,17804
Hib,Primary Series,HHS Regions/National,United States,2017-2018,Age,24 Months,92.8,92.2 to 93.4,36630
Hib,Primary Series,HHS Regions/National,United States,2018,Age,7 Months,73.7,72.4 to 75.0,18826
Hib,Primary Series,HHS Regions/National,United States,2018-2019,Age,7 Months,73.1,72.1 to 74.0,36091
Hib,Primary Series,HHS Regions/National,United States,2014,Age,24 Months,91.9,90.9 to 92.8,15333
Hib,Primary Series,HHS Regions/National,United States,2014-2015,Age,24 Months,92.3,91.7 to 93.0,30796
Hib,Primary Series,HHS Regions/National,United States,2015,Age,24 Months,92.8,91.9 to 93.6,15463
Hib,Primary Series,HHS Regions/National,United States,2015-2016,Age,24 Months,92.7,92.1 to 93.4,31419
Combined 7 Series,,HHS Regions/National,United States,2013,Age,24 Months,68.3,66.8 to 69.7,14872
Combined 7 Series,,HHS Regions/National,United States,2013-2014,Age,24 Months,68.4,67.3 to 69.5,30205
Combined 7 Series,,HHS Regions/National,United States,2011,Age,24 Months,67.7,66.1 to 69.3,14513
Combined 7 Series,,HHS Regions/National,United States,2012,Age,24 Months,69.0,67.4 to 70.5,15039
Hib,Primary Series,HHS Regions/National,United States,2015,Age,35 Months,94.3,93.4 to 95.1,15463
Hib,Primary Series,HHS Regions/National,United States,2015-2016,Age,35 Months,93.8,93.2 to 94.4,31419
Combined 7 Series,,HHS Regions/National,United States,2013,Age,35 Months,74.8,73.3 to 76.3,14872
Combined 7 Series,,HHS Regions/National,United States,2013-2014,Age,35 Months,74.4,73.3 to 75.5,30205
Hib,Primary Series,HHS Regions/National,United States,2016,Age,24 Months,92.7,91.7 to 93.6,15956
Hib,Primary Series,HHS Regions/National,United States,2016-2017,Age,24 Months,92.4,91.7 to 93.0,33760
Hib,Primary Series,HHS Regions/National,United States,2018,Age,24 Months,93.6,92.8 to 94.3,18826
Hib,Primary Series,HHS Regions/National,United States,2018-2019,Age,24 Months,93.8,93.3 to 94.3,36091
Influenza,,States/Local Areas,Utah,2012,Age,24 Months,46.8,38.8 to 55.5,260
Influenza,,States/Local Areas,Utah,2011,Age,24 Months,50.0,42.4 to 58.3,266
Influenza,,States/Local Areas,Utah,2014,Age,24 Months,51.2,43.9 to 58.9,258
Influenza,,States/Local Areas,Utah,2014-2015,Age,24 Months,53.5,48.1 to 59.1,499
Influenza,,States/Local Areas,Utah,2015,Age,24 Months,55.8,48.0 to 63.9,241
Influenza,,States/Local Areas,Utah,2015-2016,Age,24 Months,52.1,46.7 to 57.8,534
Influenza,,States/Local Areas,Utah,2013,Age,24 Months,50.3,42.4 to 58.7,250
Influenza,,States/Local Areas,Utah,2013-2014,Age,24 Months,50.8,45.3 to 56.4,508
Polio,≥3 Doses,States/Local Areas,Utah,2013,Age,24 Months,89.4,83.4 to 94.0,250
Polio,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,90.2,86.4 to 93.3,508
Hib,≥3 Doses,States/Local Areas,Utah,2016,Age,19 Months,90.9,86.2 to 94.2,293
Hib,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,90.9,86.9 to 93.7,520
Hib,≥3 Doses,States/Local Areas,Utah,2017,Age,19 Months,90.8,83.7 to 95.0,227
Hib,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,92.9,89.1 to 95.4,525
Polio,≥3 Doses,States/Local Areas,Utah,2014,Age,24 Months,90.8,85.8 to 94.6,258
Polio,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,24 Months,90.1,86.3 to 93.2,499
Polio,≥3 Doses,States/Local Areas,Utah,2015,Age,24 Months,89.4,83.4 to 94.0,241
Polio,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,24 Months,90.8,87.2 to 93.7,534
DTaP,≥3 Doses,States/Local Areas,Utah,2018,Age,19 Months,95.6,92.1 to 97.6,298
DTaP,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,94.2,91.4 to 96.1,628
Polio,≥3 Doses,States/Local Areas,Utah,2019,Age,19 Months,95.4,91.0 to 97.7,330
Hib,≥3 Doses,States/Local Areas,Utah,2018,Age,19 Months,95.0,91.4 to 97.2,298
Hib,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,85.1,81.2 to 88.4,628
DTaP,≥3 Doses,States/Local Areas,Utah,2016,Age,19 Months,92.2,87.4 to 95.2,293
DTaP,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,19 Months,93.2,89.8 to 95.5,520
DTaP,≥3 Doses,States/Local Areas,Utah,2017,Age,19 Months,94.3,88.4 to 97.2,227
DTaP,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,19 Months,94.9,91.8 to 96.9,525
Hib,≥3 Doses,States/Local Areas,Utah,2019,Age,13 Months,83.6,77.4 to 88.4,330
DTaP,≥3 Doses,States/Local Areas,Utah,2013,Age,19 Months,89.2,85.5 to 92.0,250
DTaP,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,90.1,87.3 to 92.4,508
Hib,≥3 Doses,States/Local Areas,Utah,2014,Age,19 Months,88.2,82.2 to 92.4,258
Hib,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,87.3,83.0 to 90.6,499
Hib,≥3 Doses,States/Local Areas,Utah,2013,Age,19 Months,85.2,81.5 to 88.3,250
Hib,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,19 Months,86.7,83.7 to 89.3,508
Polio,≥3 Doses,States/Local Areas,Utah,2012,Age,24 Months,93.0,88.1 to 96.4,260
Polio,≥3 Doses,States/Local Areas,Utah,2011,Age,24 Months,91.8,86.6 to 95.6,266
Hib,≥3 Doses,States/Local Areas,Utah,2015,Age,19 Months,86.4,77.9 to 91.9,241
Hib,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,88.6,84.6 to 91.7,534
Polio,≥3 Doses,States/Local Areas,Utah,2018,Age,19 Months,95.6,92.1 to 97.6,298
Polio,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,19 Months,72.1,67.3 to 76.4,628
Polio,≥2 Doses,States/Local Areas,Utah,2020,Age,13 Months,94.8,91.0 to 97.0,333
Polio,≥3 Doses,States/Local Areas,Utah,2011,Age,35 Months,91.8,86.6 to 95.6,266
DTaP,≥3 Doses,States/Local Areas,Utah,2014,Age,19 Months,91.1,85.6 to 94.6,258
DTaP,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,19 Months,90.3,86.3 to 93.2,499
DTaP,≥3 Doses,States/Local Areas,Utah,2015,Age,19 Months,89.6,81.8 to 94.3,241
DTaP,≥3 Doses,States/Local Areas,Utah,2015-2016,Age,19 Months,90.8,87.0 to 93.6,534
Hib,Full Series,States/Local Areas,Utah,2017,Age,24 Months,83.9,77.2 to 89.6,227
Hib,Full Series,States/Local Areas,Utah,2017-2018,Age,24 Months,83.7,79.2 to 87.7,525
Polio,≥3 Doses,States/Local Areas,Utah,2016,Age,24 Months,92.2,87.8 to 95.5,293
Polio,≥3 Doses,States/Local Areas,Utah,2016-2017,Age,24 Months,93.2,90.0 to 95.6,520
Hib,≥3 Doses,States/Local Areas,Utah,2019,Age,19 Months,94.6,90.3 to 97.0,330
Hib,Full Series,States/Local Areas,Utah,2016,Age,24 Months,81.3,75.3 to 86.6,293
Hib,Full Series,States/Local Areas,Utah,2016-2017,Age,24 Months,82.8,78.4 to 86.8,520
Hib,≥3 Doses,States/Local Areas,Utah,2011,Age,24 Months,92.2,87.0 to 95.8,266
Hib,≥3 Doses,States/Local Areas,Utah,2012,Age,24 Months,91.1,85.9 to 94.9,260
Hib,≥3 Doses,States/Local Areas,Utah,2013,Age,24 Months,88.6,82.1 to 93.6,250
Hib,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,24 Months,88.3,84.2 to 91.8,508
Hib,Full Series,States/Local Areas,Utah,2014,Age,24 Months,78.5,72.2 to 84.3,258
Hib,Full Series,States/Local Areas,Utah,2014-2015,Age,24 Months,78.7,74.1 to 83.0,499
Hib,Full Series,States/Local Areas,Utah,2015,Age,24 Months,78.8,71.9 to 85.1,241
Hib,Full Series,States/Local Areas,Utah,2015-2016,Age,24 Months,80.1,75.5 to 84.3,534
Polio,≥3 Doses,States/Local Areas,Utah,2018,Age,24 Months,95.6,92.4 to 97.7,298
Polio,≥3 Doses,States/Local Areas,Utah,2018-2019,Age,24 Months,95.9,93.6 to 97.5,628
Polio,≥3 Doses,States/Local Areas,Utah,2019,Age,24 Months,96.1,92.4 to 98.3,330
Polio,≥3 Doses,States/Local Areas,Utah,2017,Age,24 Months,94.1,89.0 to 97.3,227
Polio,≥3 Doses,States/Local Areas,Utah,2017-2018,Age,24 Months,94.8,91.9 to 96.9,525
DTaP,≥3 Doses,States/Local Areas,Utah,2012,Age,24 Months,93.9,89.0 to 97.1,260
DTaP,≥3 Doses,States/Local Areas,Utah,2011,Age,24 Months,93.3,88.2 to 96.7,266
DTaP,≥3 Doses,States/Local Areas,Utah,2019,Age,19 Months,95.6,91.2 to 97.9,330
Hib,Full Series,States/Local Areas,Utah,2013,Age,35 Months,81.1,73.2 to 87.8,250
Hib,Full Series,States/Local Areas,Utah,2013-2014,Age,35 Months,82.6,77.5 to 87.1,508
Polio,≥3 Doses,States/Local Areas,Utah,2012,Age,35 Months,94.1,89.1 to 97.3,260
DTaP,≥2 Doses,States/Local Areas,Utah,2011,Age,5 Months,82.1,77.4 to 85.9,266
DTaP,≥2 Doses,States/Local Areas,Utah,2012,Age,5 Months,80.9,71.8 to 87.5,260
DTaP,≥2 Doses,States/Local Areas,Utah,2013,Age,5 Months,82.3,76.6 to 86.9,250
DTaP,≥2 Doses,States/Local Areas,Utah,2013-2014,Age,5 Months,81.4,79.2 to 83.4,508
Polio,≥3 Doses,States/Local Areas,Utah,2014,Age,35 Months,90.8,85.8 to 94.6,258
Polio,≥3 Doses,States/Local Areas,Utah,2014-2015,Age,35 Months,90.2,86.4 to 93.3,499
Polio,≥3 Doses,States/Local Areas,Utah,2013,Age,35 Months,95.3,87.1 to 99.0,250
Polio,≥3 Doses,States/Local Areas,Utah,2013-2014,Age,35 Months,94.4,88.5 to 97.9,508
≥1 Dose MMR,,States/Local Areas,Utah,2021,Age,19 Months,89.0,81.7 to 93.6,226
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Utah,2020-2021,Age,0-1 Days,81.4,76.7 to 85.3,559
≥1 Dose Varicella,,States/Local Areas,Utah,2021,Age,35 Months,91.2,84.7 to 95.7,226
Hib,Full Series,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,83.9,76.2 to 91.5,154
Hep B,≥2 Doses,States/Local Areas,Utah,2019-2020,Age,7 Months,93.5,90.8 to 95.5,663
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Poverty,>400% FPL,94.3,90.6 to 97.9,222
Hib,Primary Series,States/Local Areas,Utah,2019-2020,Age,7 Months,78.1,73.9 to 81.8,663
Hep A,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,19 Months,86.5,82.0 to 90.0,559
Hib,≥2 Doses,States/Local Areas,Utah,2021,Age,5 Months,82.3,74.4 to 88.1,226
Polio,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,93.6,88.8 to 98.4,154
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,82.4 to 98.6,87
DTaP,≥4 Doses,States/Local Areas,Utah,2016-2019,Poverty,133% to <400% FPL,83.7,79.9 to 87.6,597
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.6,80.2 to 86.9,782
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,93.9,89.2 to 98.7,154
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,92.9,80.7 to 100.0,154
Rotavirus,,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,81.1,74.6 to 87.6,171
Influenza,,States/Local Areas,Utah,2014-2017,Poverty,>400% FPL,62.5,53.5 to 71.5,171
Influenza,,States/Local Areas,Utah,2014-2017,Poverty,<133% FPL,47.2,39.1 to 55.4,224
Influenza,,States/Local Areas,Utah,2014-2017,Poverty,133% to <400% FPL,53.9,49.0 to 58.9,550
PCV,≥4 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,86.2,83.0 to 89.4,751
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.5,42.9 to 76.1,87
Influenza,,States/Local Areas,Utah,2021,Age,24 Months,58.9,50.2 to 67.8,226
≥1 Dose Varicella,,States/Local Areas,Utah,2020-2021,Age,13 Months,62.7,57.1 to 68.0,559
≥1 Dose MMR,,States/Local Areas,Utah,2021,Age,13 Months,66.5,57.3 to 74.6,226
Hib,≥3 Doses,States/Local Areas,Utah,2021,Age,35 Months,93.7,90.0 to 96.4,226
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2021,Age,0-3 Days,85.9,78.9 to 90.8,226
PCV,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,3 Months,89.2,85.1 to 92.3,559
Hib,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,91.6,88.3 to 94.0,559
Hep B,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,3 Months,95.6,93.1 to 97.2,559
Hep A,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,24 Months,91.6,88.3 to 94.3,559
Hib,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,70.9,65.5 to 75.7,559
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.6,90.2 to 100.0,87
PCV,≥3 Doses,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,94.6,92.4 to 96.7,751
Hib,Full Series,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.9,73.8 to 94.0,87
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Race and Ethnicity,Hispanic,94.3,90.2 to 98.3,154
Hib,Full Series,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,82.6,79.0 to 86.2,751
Influenza,,States/Local Areas,Utah,2014-2017,Overall,Overall,53.5,49.6 to 57.4,945
Hep B,≥1 Dose,States/Local Areas,Utah,2021,Age,3 Months,95.6,91.2 to 97.9,226
Hib,Full Series,States/Local Areas,Utah,2020-2021,Age,24 Months,82.8,78.4 to 86.7,559
Polio,≥2 Doses,States/Local Areas,Utah,2021,Age,13 Months,95.7,91.9 to 97.7,226
Hep A,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,82.8,77.2 to 87.7,559
Influenza,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Private Insurance Only,60.7,56.2 to 65.2,651
Influenza,,States/Local Areas,Utah,2016,Age,24 Months,48.4,41.2 to 56.2,293
Influenza,,States/Local Areas,Utah,2016-2017,Age,24 Months,52.7,47.0 to 58.7,520
Influenza,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",43.8,29.7 to 57.8,74
Influenza,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,Hispanic,49.2,39.4 to 59.0,134
Influenza,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Any Medicaid,45.4,37.4 to 53.3,222
Influenza,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a Non-MSA,30.9,19.2 to 42.6,88
Influenza,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Non-Principal City,54.0,48.8 to 59.2,520
Influenza,,States/Local Areas,Utah,2014-2017,Race and Ethnicity,"White, Non-Hispanic",55.3,50.9 to 59.6,729
Influenza,,States/Local Areas,Utah,2014-2017,Urbanicity,Living In a MSA Principal City,56.9,50.4 to 63.4,337
Influenza,,States/Local Areas,Utah,2014-2017,Insurance Coverage,Uninsured,25.1,9.0 to 41.2,45
Influenza,,States/Local Areas,Utah,2018,Age,24 Months,75.6,69.1 to 81.6,298
Influenza,,States/Local Areas,Utah,2018-2019,Age,24 Months,73.7,69.1 to 78.2,628
Influenza,,States/Local Areas,Utah,2017,Age,24 Months,57.1,48.5 to 66.2,227
Influenza,,States/Local Areas,Utah,2017-2018,Age,24 Months,66.2,60.6 to 71.8,525
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Insurance Coverage,Private Insurance Only,91.4,88.9 to 94.0,751
Hep A,≥1 Dose,States/Local Areas,Utah,2016-2019,Insurance Coverage,Any Medicaid,89.6,84.6 to 94.6,205
Hep A,≥2 Doses,States/Local Areas,Utah,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.9,76.6 to 85.2,782
Influenza,,States/Local Areas,Utah,2019,Age,24 Months,71.9,65.1 to 78.3,330
DTaP,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,94.4,92.0 to 96.3,559
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Utah,2020-2021,Age,0-3 Days,83.8,79.3 to 87.5,559
DTaP,≥2 Doses,States/Local Areas,Utah,2021,Age,5 Months,84.0,76.1 to 89.6,226
PCV,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,74.1,68.6 to 78.9,559
Polio,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,95.2,92.8 to 96.9,559
DTaP,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,92.9,90.2 to 95.0,559
DTaP,≥4 Doses,States/Local Areas,Utah,2021,Age,35 Months,92.2,85.9 to 96.4,226
PCV,≥4 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,81.8,76.9 to 85.9,559
Polio,≥2 Doses,States/Local Areas,Utah,2021,Age,5 Months,83.7,75.8 to 89.4,226
PCV,≥1 Dose,States/Local Areas,Utah,2021,Age,3 Months,88.0,80.7 to 92.8,226
Hep B,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,92.1,89.1 to 94.3,559
Hep B,≥3 Doses,States/Local Areas,Utah,2021,Age,13 Months,93.2,89.1 to 95.9,226
Polio,≥3 Doses,States/Local Areas,Utah,2021,Age,19 Months,94.0,90.0 to 96.5,226
Hib,Full Series,States/Local Areas,Utah,2020-2021,Age,35 Months,87.0,83.0 to 90.4,559
≥1 Dose Varicella,,States/Local Areas,Utah,2021,Age,13 Months,62.6,53.5 to 70.9,226
Hib,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,93.2,90.5 to 95.2,559
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Utah,2020-2021,Age,0-2 Days,83.2,78.7 to 86.9,559
Hib,Full Series,States/Local Areas,Utah,2020-2021,Age,19 Months,75.8,70.7 to 80.2,559
Hep A,≥2 Doses,States/Local Areas,Utah,2021,Age,19 Months,33.9,26.4 to 42.4,226
Hib,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,93.9,91.4 to 95.9,559
Hib,Primary Series,States/Local Areas,Utah,2020-2021,Age,35 Months,94.1,91.6 to 96.0,559
Combined 7 Series,,States/Local Areas,Utah,2021,Age,24 Months,74.9,65.7 to 83.3,226
Hep B,≥2 Doses,States/Local Areas,Utah,2021,Age,13 Months,95.8,92.0 to 97.8,226
≥1 Dose Varicella,,States/Local Areas,Utah,2020-2021,Age,24 Months,90.2,86.6 to 93.2,559
Hep A,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,48.6,42.9 to 54.7,559
≥1 Dose MMR,,States/Local Areas,Utah,2020-2021,Age,19 Months,90.0,85.9 to 93.0,559
Hib,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,87.6,84.1 to 90.4,559
DTaP,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,5 Months,84.7,80.2 to 88.3,559
Hib,≥2 Doses,States/Local Areas,Utah,2021,Age,13 Months,94.7,90.7 to 97.0,226
Hep B,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,92.1,89.3 to 94.4,559
Hib,Primary Series,States/Local Areas,Utah,2021,Age,35 Months,93.8,90.0 to 96.5,226
Rotavirus,,States/Local Areas,Utah,2021,Age,8 Months,76.1,67.5 to 83.0,226
PCV,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,13 Months,90.0,86.2 to 92.9,559
Polio,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,94.1,91.7 to 96.0,559
Hib,Primary Series,States/Local Areas,Utah,2020-2021,Age,7 Months,77.6,72.8 to 81.7,559
Hib,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,5 Months,83.3,78.7 to 87.0,559
Hep B,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,5 Months,90.6,87.1 to 93.2,559
Polio,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,94.1,91.7 to 96.0,559
Polio,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,3 Months,91.3,87.7 to 94.0,559
Hep B,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,93.4,90.7 to 95.4,559
≥1 Dose Varicella,,States/Local Areas,Utah,2020-2021,Age,19 Months,89.1,85.1 to 92.1,559
PCV,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,24 Months,92.7,89.6 to 95.2,559
Hib,≥3 Doses,States/Local Areas,Utah,2021,Age,13 Months,90.3,85.4 to 93.6,226
Polio,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,94.0,91.4 to 95.8,559
DTaP,≥4 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,75.3,70.0 to 79.8,559
DTaP,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,77.2,72.2 to 81.6,559
Combined 7 Series,,States/Local Areas,Utah,2020-2021,Age,35 Months,78.1,72.7 to 83.0,559
DTaP,≥3 Doses,States/Local Areas,Utah,2021,Age,35 Months,94.9,91.4 to 97.3,226
Hib,Full Series,States/Local Areas,Utah,2021,Age,35 Months,90.2,83.7 to 95.0,226
Combined 7 Series,,States/Local Areas,Utah,2020-2021,Age,24 Months,74.0,68.7 to 79.0,559
Influenza,,States/Local Areas,Utah,2020-2021,Age,24 Months,62.1,56.6 to 67.7,559
PCV,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,19 Months,91.3,87.6 to 94.0,559
Hep B,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,71.1,65.8 to 75.9,559
Hep B,≥3 Doses,States/Local Areas,Utah,2021,Age,35 Months,94.7,91.2 to 97.2,226
Hib,Primary Series,States/Local Areas,Utah,2021,Age,13 Months,90.8,85.9 to 94.1,226
≥1 Dose MMR,,States/Local Areas,Utah,2020-2021,Age,35 Months,93.1,89.4 to 95.8,559
Hib,≥1 Dose,States/Local Areas,Utah,2020-2021,Age,3 Months,90.0,86.3 to 92.8,559
PCV,≥3 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,92.7,89.6 to 95.2,559
Polio,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,7 Months,92.2,89.0 to 94.6,559
Polio,≥2 Doses,States/Local Areas,Utah,2020-2021,Age,5 Months,84.3,79.8 to 88.0,559
PCV,≥4 Doses,States/Local Areas,Utah,2020-2021,Age,35 Months,84.8,80.2 to 88.9,559
Rotavirus,,States/Local Areas,Utah,2020-2021,Age,8 Months,76.4,71.1 to 81.0,559
Hib,Primary Series,States/Local Areas,Massachusetts,2016,Age,24 Months,95.3,90.4 to 98.1,267
Hib,Primary Series,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,96.6,93.0 to 98.6,597
Hib,Primary Series,States/Local Areas,Massachusetts,2017,Age,24 Months,98.1,94.5 to 99.6,330
Hib,Primary Series,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,97.6,95.2 to 99.0,695
Hib,Primary Series,States/Local Areas,Massachusetts,2015,Age,35 Months,96.5,93.0 to 98.5,292
Hib,Primary Series,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,95.9,93.0 to 97.8,559
Hib,Primary Series,States/Local Areas,Massachusetts,2016,Age,35 Months,95.3,90.4 to 98.1,267
Hib,Primary Series,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.6,93.0 to 98.6,597
Combined 7 Series,,States/Local Areas,Massachusetts,2012,Age,24 Months,69.1,61.3 to 76.6,260
Combined 7 Series,,States/Local Areas,Massachusetts,2013,Age,24 Months,77.5,70.5 to 83.8,303
Combined 7 Series,,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,77.2,72.2 to 81.9,594
Hib,Primary Series,States/Local Areas,Massachusetts,2011,Age,35 Months,98.0,94.1 to 99.5,237
Hib,Primary Series,States/Local Areas,Massachusetts,2014,Age,35 Months,99.2,96.7 to 99.9,291
Hib,Primary Series,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,97.8,95.9 to 99.0,583
Hib,Primary Series,States/Local Areas,Massachusetts,2012,Age,35 Months,95.0,90.5 to 97.8,260
Combined 7 Series,,States/Local Areas,Massachusetts,2011,Age,24 Months,75.2,66.6 to 83.0,237
Hib,Primary Series,States/Local Areas,Massachusetts,2019,Age,24 Months,97.5,94.1 to 99.2,295
Hib,Primary Series,States/Local Areas,Massachusetts,2013,Age,35 Months,96.5,92.4 to 98.7,303
Hib,Primary Series,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,97.8,95.6 to 99.0,594
Hib,Primary Series,States/Local Areas,Massachusetts,2019,Age,13 Months,94.7,90.2 to 97.2,295
Hib,Primary Series,States/Local Areas,Massachusetts,2012,Age,19 Months,94.7,89.8 to 97.3,260
Hib,Primary Series,States/Local Areas,Massachusetts,2017,Age,19 Months,97.4,92.4 to 99.2,330
Hib,Primary Series,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,97.3,94.5 to 98.7,695
Hib,Primary Series,States/Local Areas,Massachusetts,2016,Age,13 Months,91.9,85.6 to 95.6,267
Hib,Primary Series,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,94.4,90.4 to 96.8,597
Hib,Primary Series,States/Local Areas,Massachusetts,2017,Age,13 Months,97.0,92.2 to 98.8,330
Hib,Primary Series,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,95.6,92.5 to 97.5,695
Hib,Primary Series,States/Local Areas,Massachusetts,2013,Age,19 Months,94.6,93.4 to 95.6,303
Hib,Primary Series,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,96.8,94.2 to 98.2,594
Hib,Primary Series,States/Local Areas,Massachusetts,2018,Age,19 Months,97.2,93.2 to 98.9,365
Hib,Primary Series,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,94.4,91.3 to 96.5,660
Hib,Primary Series,States/Local Areas,Massachusetts,2019,Age,7 Months,80.7,72.9 to 86.7,295
Hib,Primary Series,States/Local Areas,Massachusetts,2011,Age,19 Months,96.3,92.7 to 98.2,237
Hib,Primary Series,States/Local Areas,Massachusetts,2018,Age,13 Months,94.2,89.0 to 97.0,365
Hib,Primary Series,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,94.4,91.3 to 96.5,660
Hib,Primary Series,States/Local Areas,Massachusetts,2014,Age,19 Months,98.9,96.0 to 99.7,291
Hib,Primary Series,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,97.7,95.6 to 98.8,583
Hib,Primary Series,States/Local Areas,Massachusetts,2019,Age,19 Months,97.5,93.4 to 99.1,295
Hib,Primary Series,States/Local Areas,Massachusetts,2014,Age,7 Months,78.4,70.6 to 84.7,291
Hib,Primary Series,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,81.6,76.5 to 85.8,583
Hib,Primary Series,States/Local Areas,Massachusetts,2015,Age,7 Months,84.8,77.8 to 89.9,292
Hib,Primary Series,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,81.0,75.4 to 85.6,559
Hib,Primary Series,States/Local Areas,Massachusetts,2012,Age,24 Months,95.0,90.5 to 97.8,260
Hib,Primary Series,States/Local Areas,Massachusetts,2011,Age,24 Months,98.0,94.1 to 99.5,237
Hib,Primary Series,States/Local Areas,Massachusetts,2013,Age,24 Months,95.0,90.8 to 97.7,303
Hib,Primary Series,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,97.1,94.8 to 98.6,594
Hib,Primary Series,States/Local Areas,Massachusetts,2015,Age,19 Months,96.5,90.0 to 98.8,292
Hib,Primary Series,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,95.2,91.9 to 97.2,559
Hib,Primary Series,States/Local Areas,Massachusetts,2016,Age,19 Months,94.0,88.0 to 97.1,267
Hib,Primary Series,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,95.7,91.7 to 97.8,597
Hib,Primary Series,States/Local Areas,Massachusetts,2016,Age,7 Months,77.3,68.1 to 84.4,267
Hib,Primary Series,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,78.1,71.7 to 83.3,597
Hib,Primary Series,States/Local Areas,Massachusetts,2017,Age,7 Months,78.9,70.8 to 85.3,330
Hib,Primary Series,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,79.2,73.6 to 83.9,695
Hib,Primary Series,States/Local Areas,Massachusetts,2018,Age,7 Months,79.6,71.3 to 86.0,365
Hib,Primary Series,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,80.1,74.6 to 84.7,660
Hib,Primary Series,States/Local Areas,Massachusetts,2014,Age,13 Months,95.4,90.7 to 97.8,291
Hib,Primary Series,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,95.9,93.1 to 97.5,583
Hib,Primary Series,States/Local Areas,Massachusetts,2015,Age,13 Months,96.3,92.4 to 98.3,292
Hib,Primary Series,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,94.1,90.6 to 96.3,559
Hib,Primary Series,States/Local Areas,Massachusetts,2013,Age,7 Months,77.6,71.1 to 83.0,303
Hib,Primary Series,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,78.0,72.1 to 83.0,594
Hib,Primary Series,States/Local Areas,Massachusetts,2013,Age,13 Months,93.7,91.5 to 95.4,303
Hib,Primary Series,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,94.5,92.2 to 96.2,594
Hib,Primary Series,States/Local Areas,Massachusetts,2012,Age,13 Months,91.2,82.6 to 95.7,260
Hib,Primary Series,States/Local Areas,Massachusetts,2011,Age,13 Months,95.2,88.1 to 98.2,237
Hib,Primary Series,States/Local Areas,Massachusetts,2017,Age,35 Months,98.1,94.5 to 99.6,330
Hib,Primary Series,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,98.0,95.7 to 99.2,695
Combined 7 Series,,States/Local Areas,Massachusetts,2014,Age,24 Months,76.9,69.4 to 83.7,291
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,78.6,73.4 to 83.3,583
Hib,Primary Series,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,78.5,72.9 to 83.3,563
Polio,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,3 Months,94.2,90.8 to 96.3,563
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,3 Months,94.5,91.2 to 96.6,563
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,96.6,93.3 to 98.6,563
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,94.2,89.0 to 97.5,563
Polio,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,96.7,93.2 to 98.7,563
Combined 7 Series,,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,80.7,75.6 to 85.4,563
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,97.2,93.0 to 99.2,563
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,95.6,92.3 to 97.6,563
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,92.7,88.6 to 95.3,563
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,90.0,85.7 to 93.1,563
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,55.8,49.8 to 61.6,563
Hib,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,94.2,90.7 to 96.5,563
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,80.4,75.0 to 85.0,563
Polio,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,94.0,90.3 to 96.3,563
PCV,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,5 Months,87.1,82.1 to 90.8,563
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,5 Months,93.7,90.0 to 96.1,563
Hib,Primary Series,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,93.2,89.5 to 95.6,563
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,95.6,92.3 to 97.5,563
Hib,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,95.5,92.4 to 97.4,563
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,91.6,87.7 to 94.4,563
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,70.0,64.0 to 75.3,563
Polio,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,95.5,92.4 to 97.4,563
Hib,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,5 Months,87.0,82.1 to 90.8,563
Polio,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,5 Months,88.4,83.6 to 91.8,563
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,5 Months,88.8,84.1 to 92.2,563
PCV,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,3 Months,92.7,88.6 to 95.4,563
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.0,91.7 to 97.3,563
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,3 Months,97.8,96.0 to 98.8,563
Polio,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.5,92.6 to 97.5,563
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,86.4,81.7 to 90.4,563
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.7,92.7 to 97.7,563
PCV,≥4 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,93.7,88.8 to 96.9,563
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,95.6,92.6 to 97.7,563
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,96.5,93.4 to 98.4,563
Hib,Primary Series,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,95.7,92.9 to 97.7,563
Hib,Full Series,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,94.6,89.7 to 97.6,563
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,95.7,92.7 to 97.7,563
Hib,Full Series,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,79.5,74.1 to 84.1,563
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,95.7,92.9 to 97.7,563
Hib,Primary Series,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,95.7,92.6 to 97.6,563
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,95.7,92.6 to 97.5,563
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,93.5,89.7 to 95.9,563
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,31.8,26.7 to 37.4,563
PCV,≥4 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,88.4,83.8 to 92.2,563
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.5,92.5 to 97.6,563
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2019-2020,Age,0-3 Days,86.3,81.9 to 89.8,563
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.1,92.2 to 97.2,563
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,94.9,91.6 to 97.1,563
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2019-2020,Age,0-2 Days,86.2,81.7 to 89.7,563
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,88.8,84.4 to 92.1,563
Combined 7 Series,,States/Local Areas,Massachusetts,2017,Age,35 Months,92.4,82.4 to 97.8,330
Combined 7 Series,,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,91.4,84.2 to 96.2,695
Combined 7 Series,,States/Local Areas,Massachusetts,2016,Age,35 Months,83.9,76.6 to 89.9,267
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,86.6,80.6 to 91.5,597
Hib,Primary Series,States/Local Areas,Massachusetts,2018,Age,24 Months,97.2,93.8 to 99.0,365
Hib,Primary Series,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,97.4,95.1 to 98.7,660
Hib,Primary Series,States/Local Areas,Massachusetts,2019,Age,35 Months,97.5,94.1 to 99.2,295
Combined 7 Series,,States/Local Areas,Massachusetts,2016,Age,24 Months,83.9,76.6 to 89.9,267
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,82.4,77.5 to 86.8,597
Hib,Primary Series,States/Local Areas,Massachusetts,2018,Age,35 Months,97.8,94.6 to 99.4,365
Hib,Primary Series,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,97.6,95.5 to 98.9,660
Combined 7 Series,,States/Local Areas,Massachusetts,2015,Age,24 Months,80.2,73.1 to 86.5,292
Combined 7 Series,,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,82.1,77.0 to 86.5,559
Combined 7 Series,,States/Local Areas,Massachusetts,2011,Age,35 Months,78.2,69.3 to 86.0,237
Combined 7 Series,,States/Local Areas,Massachusetts,2012,Age,35 Months,79.3,71.2 to 86.4,260
Combined 7 Series,,States/Local Areas,Massachusetts,2013,Age,35 Months,85.9,74.9 to 93.8,303
Combined 7 Series,,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,85.2,78.3 to 90.9,594
Combined 7 Series,,States/Local Areas,Massachusetts,2014,Age,35 Months,85.1,75.4 to 92.5,291
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,86.4,81.3 to 90.7,583
Combined 7 Series,,States/Local Areas,Massachusetts,2018,Age,24 Months,77.1,69.6 to 83.9,365
Combined 7 Series,,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,78.0,72.8 to 82.9,660
Combined 7 Series,,States/Local Areas,Massachusetts,2017,Age,24 Months,80.9,74.2 to 86.7,330
Combined 7 Series,,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,79.0,74.1 to 83.6,695
Hib,Primary Series,States/Local Areas,Massachusetts,2014,Age,24 Months,99.2,96.7 to 99.9,291
Hib,Primary Series,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,97.8,95.9 to 99.0,583
Hib,Primary Series,States/Local Areas,Massachusetts,2015,Age,24 Months,96.5,93.0 to 98.5,292
Hib,Primary Series,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,95.9,93.0 to 97.8,559
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2021,Age,0-1 Days,85.0,74.0 to 91.9,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,97.2,95.0 to 98.7,443
Hib,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,96.1,92.9 to 97.9,443
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,96.3,93.4 to 99.1,240
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,87.9,82.0 to 93.8,240
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,93.3 to 97.6,914
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,93.3,87.4 to 96.5,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,75.7,67.2 to 82.5,268
Rotavirus,,States/Local Areas,Massachusetts,2019-2020,Age,8 Months,83.8,78.9 to 87.8,563
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,85.8,82.4 to 89.2,895
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.0,90.8 to 99.2,206
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.4,92.6 to 98.2,728
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.1,81.8 to 92.5,914
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,97.7,95.3 to 100.0,240
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.7,94.7 to 98.7,914
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,92.0,87.3 to 96.8,240
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.3,84.7 to 91.9,914
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,92.1 to 99.8,240
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,97.6,95.2 to 100.0,240
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.6,94.6 to 98.6,914
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,83.3,77.0 to 89.7,240
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,81.2,74.0 to 88.4,240
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,97.3,93.9 to 100.0,257
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,98.6,97.2 to 100.0,735
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.1,82.6 to 89.6,914
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,79.9,76.3 to 83.6,1165
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,88.6,85.7 to 91.5,1165
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,93.1,88.0 to 98.2,257
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,97.0,94.9 to 99.0,735
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,89.3,84.0 to 94.6,173
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,67.2,58.4 to 76.0,173
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,97.6,94.3 to 100.0,257
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,77.4,69.2 to 85.5,257
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,98.6,97.2 to 100.0,735
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,95.4,93.6 to 97.1,1165
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,87.7,84.0 to 91.4,735
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,84.0,80.4 to 87.5,1165
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,86.7,82.3 to 91.1,1165
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,95.1,91.9 to 98.4,173
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Overall,Overall,85.3,82.2 to 88.4,1165
Influenza,,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,82.1,78.7 to 85.4,1165
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,94.1,90.5 to 97.6,173
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,95.6,91.3 to 100.0,257
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,93.0,84.2 to 100.0,257
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,89.5,85.0 to 94.0,735
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,89.3,84.1 to 94.5,173
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,89.9,87.1 to 92.7,1165
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,92.2,87.1 to 97.3,257
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,96.0,94.4 to 97.6,1165
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,82.5,75.3 to 89.8,173
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,96.3,94.7 to 98.0,1165
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,88.7,84.9 to 92.6,735
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,93.0,90.9 to 95.2,1165
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,96.9,95.2 to 98.5,1165
Influenza,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,82.0,75.1 to 88.9,187
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,89.1,86.1 to 92.1,1165
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,95.0,91.6 to 98.4,187
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,92.3,88.0 to 96.6,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,97.5,96.1 to 98.9,895
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.8,74.8 to 90.9,206
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.1,72.3 to 99.9,44
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,87.0,81.0 to 93.1,187
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.6,87.8 to 97.4,206
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,96.6,94.8 to 98.3,895
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,81.7,73.2 to 90.2,237
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,91.1,86.2 to 95.9,895
Hib,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,3 Months,89.8,83.3 to 94.0,268
Polio,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,3 Months,92.0,86.3 to 95.5,268
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,68.5,60.3 to 75.7,268
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,95.0,90.5 to 97.8,268
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,3 Months,96.6,93.3 to 98.3,268
Combined 7 Series,,States/Local Areas,Massachusetts,2020,Age,35 Months,89.3,82.6 to 94.2,268
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020,Age,13 Months,72.6,64.0 to 79.7,268
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2020,Age,0-1 Days,79.2,71.3 to 85.4,268
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,35.1,27.7 to 43.2,268
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,3 Months,92.3,86.6 to 95.7,268
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2020,Age,0-2 Days,84.2,76.9 to 89.5,268
Hib,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,93.7,88.5 to 96.6,268
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,75.6,67.0 to 82.5,268
Hib,Primary Series,States/Local Areas,Massachusetts,2020,Age,7 Months,77.1,68.8 to 83.8,268
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,94.1,88.9 to 96.9,268
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,94.5,89.5 to 97.7,268
Polio,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,95.1,90.6 to 97.9,268
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,86.1,79.2 to 91.6,268
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020,Age,24 Months,95.5,90.3 to 98.4,268
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,94.3,89.7 to 97.3,268
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,94.3,89.7 to 97.3,268
Hib,Primary Series,States/Local Areas,Massachusetts,2020,Age,24 Months,94.3,89.7 to 97.3,268
Hib,Full Series,States/Local Areas,Massachusetts,2020,Age,35 Months,96.0,90.7 to 98.8,268
Hib,Primary Series,States/Local Areas,Massachusetts,2020,Age,35 Months,94.3,89.7 to 97.3,268
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,95.3,90.9 to 98.0,268
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020,Age,35 Months,98.0,95.1 to 99.4,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,94.0,88.8 to 97.3,268
Hib,Full Series,States/Local Areas,Massachusetts,2020,Age,19 Months,80.8,73.0 to 86.7,268
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,91.5,87.4 to 94.4,563
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,95.0,91.8 to 97.0,563
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2019-2020,Age,0-1 Days,82.2,77.3 to 86.3,563
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,77.0,71.3 to 81.8,563
Combined 7 Series,,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,90.3,84.6 to 94.5,563
Hib,Full Series,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,86.4,81.5 to 90.5,563
Hib,Primary Series,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.7,92.9 to 97.7,563
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,95.7,92.9 to 97.7,563
Influenza,,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,77.2,71.6 to 82.3,563
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,91.7,85.8 to 95.8,563
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,35 Months,97.9,93.3 to 99.6,563
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,93.4,89.9 to 96.0,563
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,24 Months,48.1,42.1 to 54.4,563
Polio,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,94.7,89.5 to 97.4,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,78.6,73.0 to 83.4,563
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,13 Months,94.5,91.1 to 96.6,563
Polio,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,95.5,92.3 to 97.4,563
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,78.6,73.3 to 83.1,563
PCV,≥4 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,85.9,81.0 to 89.8,563
Combined 7 Series,,States/Local Areas,Massachusetts,2019,Age,24 Months,78.9,71.5 to 85.5,295
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,95.5,92.3 to 98.7,187
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.1,93.4 to 100.0,44
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,95.0,89.9 to 97.6,268
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020,Age,19 Months,89.2,82.4 to 93.6,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,92.9,86.6 to 96.4,268
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,91.6,85.3 to 95.9,268
Polio,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,97.5,91.8 to 99.6,268
PCV,≥4 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,86.3,79.2 to 91.2,268
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020,Age,35 Months,98.7,95.4 to 99.8,268
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,91.0,84.6 to 94.9,268
PCV,≥4 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,92.6,86.2 to 96.7,268
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,19 Months,88.7,81.8 to 93.1,268
Hib,Primary Series,States/Local Areas,Massachusetts,2020,Age,13 Months,92.5,86.8 to 95.9,268
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,94.9,89.6 to 97.6,268
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,93.5,88.3 to 96.5,268
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020,Age,13 Months,53.2,44.7 to 61.5,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,90.6,84.0 to 94.6,268
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,78.4,70.1 to 84.9,268
PCV,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,5 Months,87.0,79.9 to 91.9,268
Polio,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,7 Months,94.3,89.1 to 97.1,268
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,94.5,88.7 to 97.4,268
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,78.1,70.3 to 84.3,268
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020,Age,19 Months,93.2,87.1 to 96.5,268
Polio,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,95.1,89.9 to 97.7,268
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,19 Months,94.3,89.1 to 97.1,268
Hib,Primary Series,States/Local Areas,Massachusetts,2020,Age,19 Months,94.3,89.1 to 97.1,268
Influenza,,States/Local Areas,Massachusetts,2020,Age,24 Months,68.1,59.6 to 76.3,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2020,Age,0-3 Days,84.2,76.9 to 89.5,268
Rotavirus,,States/Local Areas,Massachusetts,2020,Age,8 Months,84.7,77.5 to 89.9,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,94.0,88.8 to 97.3,268
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,99.2,95.0 to 100.0,268
PCV,≥4 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,89.2,82.8 to 94.0,268
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,24 Months,92.6,87.0 to 96.4,268
Combined 7 Series,,States/Local Areas,Massachusetts,2020,Age,24 Months,82.9,75.8 to 89.0,268
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,24 Months,49.6,41.4 to 58.5,268
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,5 Months,89.6,83.1 to 93.8,268
PCV,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,3 Months,91.6,85.4 to 95.3,268
Polio,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,5 Months,89.6,83.1 to 93.8,268
Hib,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,5 Months,86.9,79.9 to 91.7,268
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,5 Months,93.5,88.2 to 96.5,268
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,92.2,89.3 to 95.2,895
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",98.0,95.0 to 100.0,44
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,96.0,93.0 to 99.0,187
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.5,92.7 to 100.0,206
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.3,95.1 to 99.6,728
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,88.9 to 96.1,728
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,92.3,87.6 to 97.0,237
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,98.8,97.7 to 99.9,895
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,87.4 to 94.7,728
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,82.9,76.3 to 89.4,237
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.4,85.5 to 100.0,44
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,93.7,89.8 to 97.5,187
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,92.7,88.3 to 97.1,237
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,83.4,76.7 to 90.0,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",98.0,94.9 to 100.0,44
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.5 to 98.5,895
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.6,95.6 to 99.6,728
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,95.0,91.6 to 98.3,187
Influenza,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,84.9,81.1 to 88.7,895
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",98.0,94.9 to 100.0,44
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.2,94.9 to 99.4,728
Influenza,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.2,63.9 to 92.4,44
Influenza,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,66.4 to 85.8,206
Influenza,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.5,80.4 to 88.7,728
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.7,76.8 to 98.5,44
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,86.5,80.4 to 92.6,187
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.4,88.9 to 95.9,728
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,73.5 to 91.2,206
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,80.7,73.3 to 88.2,187
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.5,66.3 to 84.8,206
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.9,57.9 to 91.8,44
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.3,78.7 to 88.0,728
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,77.5,70.0 to 85.1,187
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.8,77.5 to 100.0,44
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,80.3,73.5 to 87.1,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.6,81.3 to 93.9,206
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,84.8,78.4 to 91.2,187
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,96.0,93.0 to 99.0,187
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,80.5 to 94.9,206
Influenza,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,76.8,69.8 to 83.8,237
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,92.6,87.9 to 97.2,237
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,87.0,83.2 to 90.7,895
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,98.8,97.7 to 99.9,895
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,92.2,88.1 to 96.4,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,90.5 to 99.2,206
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.1,93.5 to 100.0,44
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,94.3,90.6 to 98.0,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,83.6,77.0 to 90.2,237
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,90.5 to 96.3,728
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.4,78.1 to 98.7,44
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.4,66.7 to 94.1,44
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,84.9,81.2 to 88.7,895
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",98.0,95.0 to 100.0,44
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,93.7 to 98.2,728
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.4,81.7 to 91.1,728
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.0,95.1 to 98.8,728
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.2,82.8 to 93.6,728
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,71.9,64.1 to 79.7,237
Influenza,,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,85.9,81.7 to 90.0,735
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,80.2,72.8 to 87.7,173
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,95.3,93.2 to 97.5,735
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,88.2,81.5 to 94.8,257
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,78.8,71.6 to 86.1,173
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,93.6,90.8 to 96.4,735
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,92.9,88.2 to 97.6,173
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,93.1,89.1 to 97.0,173
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,86.6,79.5 to 93.7,257
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,93.8,91.1 to 96.6,735
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,92.4,88.5 to 96.4,173
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,95.8,92.1 to 99.5,257
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,96.6,94.5 to 98.7,735
Influenza,,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,73.5,65.4 to 81.7,173
Influenza,,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,83.0,76.3 to 89.7,257
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,95.5,93.7 to 97.4,1165
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Overall,Overall,97.0,95.3 to 98.6,1165
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,92.9,88.2 to 97.6,173
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,96.9,93.4 to 100.0,257
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,97.1,95.3 to 98.8,735
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,77.3,67.1 to 87.5,173
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,79.9,72.5 to 87.3,257
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,86.2,82.2 to 90.2,735
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,89.9,83.5 to 96.2,257
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,94.9,92.3 to 97.4,735
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Poverty,133% to <400% FPL,82.9,75.7 to 90.1,257
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,89.5 to 97.7,240
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Poverty,<133% FPL,75.4,66.4 to 84.5,173
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,95.1,91.0 to 99.1,240
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.7,94.8 to 98.5,914
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,93.9 to 97.7,914
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,87.1 to 93.5,914
Influenza,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,87.3,81.5 to 93.1,240
Combined 7 Series,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.5,75.3 to 83.7,914
Influenza,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.5,76.4 to 84.5,914
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.7,79.5 to 87.8,914
Rotavirus,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,85.1,78.2 to 92.1,240
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,89.1 to 97.7,240
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.0,90.5 to 95.5,914
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,86.2 to 95.7,240
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.7,84.2 to 91.2,914
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,94.0 to 97.8,914
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Urbanicity,Living In a MSA Principal City,86.5,79.3 to 93.8,240
DTaP,≥3 Doses,States/Local Areas,Michigan,2020,Age,13 Months,87.9,82.1 to 92.0,448
DTaP,≥3 Doses,States/Local Areas,Michigan,2011,Age,13 Months,84.9,79.4 to 89.1,255
DTaP,≥3 Doses,States/Local Areas,Michigan,2017,Age,13 Months,82.7,76.1 to 87.8,402
DTaP,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,88.6,84.7 to 91.6,817
DTaP,≥3 Doses,States/Local Areas,Michigan,2016,Age,13 Months,89.6,83.9 to 93.4,291
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,86.1,81.7 to 89.6,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2012,Age,13 Months,83.3,75.7 to 88.9,212
DTaP,≥3 Doses,States/Local Areas,Michigan,2015,Age,13 Months,86.5,79.0 to 91.6,236
DTaP,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,88.0,83.6 to 91.4,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2017,Age,7 Months,66.5,59.4 to 72.9,402
DTaP,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,68.8,64.0 to 73.2,817
DTaP,≥3 Doses,States/Local Areas,Michigan,2019,Age,7 Months,74.3,67.3 to 80.2,375
DTaP,≥3 Doses,States/Local Areas,Michigan,2018,Age,7 Months,71.1,64.5 to 76.9,415
DTaP,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,72.7,67.9 to 76.9,790
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,81.1,76.3 to 85.9,359
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.6,73.0 to 90.3,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,76.3,72.1 to 80.6,609
Hib,Primary Series,States/Local Areas,Michigan,2020,Age,24 Months,92.1,87.6 to 95.4,448
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2019,Age,0-3 Days,82.1,74.9 to 87.6,375
Polio,≥1 Dose,States/Local Areas,Michigan,2019,Age,3 Months,92.4,88.1 to 95.3,375
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2018,Age,0-3 Days,83.7,78.1 to 88.1,415
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2018-2019,Age,0-3 Days,82.9,78.5 to 86.6,790
PCV,≥3 Doses,States/Local Areas,Michigan,2019,Age,35 Months,96.7,94.1 to 98.4,375
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,91.8 to 96.0,693
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,89.6,85.3 to 93.9,358
Hib,≥3 Doses,States/Local Areas,Michigan,2019,Age,7 Months,50.7,43.2 to 58.1,375
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,74.2,68.7 to 79.7,414
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,74.9,68.8 to 81.0,316
Polio,≥3 Doses,States/Local Areas,Michigan,2012,Age,19 Months,83.2,73.3 to 89.9,212
Hib,≥3 Doses,States/Local Areas,Michigan,2012,Age,13 Months,65.0,55.3 to 73.6,212
Hib,≥3 Doses,States/Local Areas,Michigan,2011,Age,13 Months,73.9,67.8 to 79.2,255
Hib,≥3 Doses,States/Local Areas,Michigan,2014,Age,13 Months,68.1,60.5 to 74.9,250
Hib,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,66.7,61.0 to 71.9,486
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,93.2,90.5 to 95.9,414
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,96.3,93.1 to 99.5,316
Polio,≥3 Doses,States/Local Areas,Michigan,2011,Age,19 Months,88.5,84.4 to 91.6,255
Hib,≥3 Doses,States/Local Areas,Michigan,2013,Age,13 Months,65.8,61.4 to 69.9,240
Hib,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,67.0,64.5 to 69.4,490
Hib,≥2 Doses,States/Local Areas,Michigan,2019,Age,7 Months,92.2,87.7 to 95.1,375
DTaP,≥3 Doses,States/Local Areas,Michigan,2016,Age,7 Months,66.7,59.5 to 73.2,291
DTaP,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,66.6,61.5 to 71.3,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2014,Age,7 Months,63.4,55.8 to 70.4,250
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,66.0,60.3 to 71.2,486
DTaP,≥3 Doses,States/Local Areas,Michigan,2015,Age,7 Months,68.5,60.0 to 76.0,236
DTaP,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,67.6,62.1 to 72.7,527
Polio,≥1 Dose,States/Local Areas,Michigan,2018,Age,3 Months,88.8,83.4 to 92.6,415
Polio,≥1 Dose,States/Local Areas,Michigan,2018-2019,Age,3 Months,90.6,87.3 to 93.1,790
Polio,≥1 Dose,States/Local Areas,Michigan,2017,Age,3 Months,85.6,80.1 to 89.8,402
Polio,≥1 Dose,States/Local Areas,Michigan,2017-2018,Age,3 Months,87.2,83.5 to 90.1,817
Hib,≥3 Doses,States/Local Areas,Michigan,2016,Age,7 Months,45.9,38.9 to 53.1,291
Hib,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,42.2,37.3 to 47.2,693
Hib,≥3 Doses,States/Local Areas,Michigan,2015,Age,7 Months,41.4,33.8 to 49.4,236
Hib,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,43.7,38.4 to 49.1,527
Hib,≥3 Doses,States/Local Areas,Michigan,2014,Age,7 Months,40.7,33.5 to 48.5,250
Hib,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,7 Months,41.1,35.7 to 46.7,486
PCV,≥3 Doses,States/Local Areas,Michigan,2018,Age,35 Months,97.9,95.6 to 99.2,415
PCV,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,35 Months,97.3,95.7 to 98.4,790
PCV,≥3 Doses,States/Local Areas,Michigan,2017,Age,35 Months,93.8,89.6 to 96.7,402
PCV,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,35 Months,96.0,93.6 to 97.7,817
Hib,≥2 Doses,States/Local Areas,Michigan,2013,Age,13 Months,90.5,83.2 to 94.9,240
Hib,≥2 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,91.5,88.6 to 93.7,490
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Private Insurance Only,95.0,92.8 to 97.2,609
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Insurance Coverage,Any Medicaid,90.3,86.6 to 94.1,359
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.0,75.2 to 92.7,92
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,93.6,87.2 to 100.0,90
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.3,91.8 to 98.8,122
Hib,≥3 Doses,States/Local Areas,Michigan,2018,Age,7 Months,49.1,42.3 to 55.8,415
Hib,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,49.9,44.8 to 54.9,790
Hib,≥3 Doses,States/Local Areas,Michigan,2017,Age,7 Months,38.3,32.0 to 45.1,402
Hib,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,43.7,38.9 to 48.5,817
Hib,≥2 Doses,States/Local Areas,Michigan,2014,Age,13 Months,92.4,87.2 to 95.6,250
Hib,≥2 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,91.2,87.1 to 94.2,486
Hib,≥2 Doses,States/Local Areas,Michigan,2016,Age,13 Months,93.1,88.2 to 96.1,291
Hib,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,93.2,90.1 to 95.4,693
Hib,≥2 Doses,States/Local Areas,Michigan,2015,Age,13 Months,90.1,82.8 to 94.4,236
Hib,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,91.6,87.5 to 94.4,527
Hib,≥2 Doses,States/Local Areas,Michigan,2011,Age,13 Months,89.5,85.8 to 92.2,255
Hib,≥2 Doses,States/Local Areas,Michigan,2012,Age,13 Months,87.8,82.6 to 91.6,212
Hib,≥2 Doses,States/Local Areas,Michigan,2017,Age,7 Months,87.0,81.3 to 91.2,402
Hib,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,7 Months,89.7,86.2 to 92.4,817
Hib,≥2 Doses,States/Local Areas,Michigan,2016,Age,7 Months,90.4,85.3 to 93.9,291
Hib,≥2 Doses,States/Local Areas,Michigan,2016-2017,Age,7 Months,88.7,84.8 to 91.8,693
Hib,≥2 Doses,States/Local Areas,Michigan,2018,Age,7 Months,92.4,87.8 to 95.4,415
Hib,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,7 Months,92.3,89.3 to 94.5,790
PCV,≥3 Doses,States/Local Areas,Michigan,2014,Age,35 Months,93.2,88.7 to 96.4,250
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,35 Months,92.2,88.5 to 95.0,486
PCV,≥3 Doses,States/Local Areas,Michigan,2016,Age,35 Months,94.4,90.5 to 97.1,291
PCV,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,35 Months,94.1,91.3 to 96.2,693
PCV,≥3 Doses,States/Local Areas,Michigan,2015,Age,35 Months,91.2,85.2 to 95.5,236
PCV,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,35 Months,92.8,89.3 to 95.5,527
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016,Age,0-3 Days,79.5,72.9 to 84.8,291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2016-2017,Age,0-3 Days,80.6,76.3 to 84.2,693
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2017,Age,0-3 Days,78.0,69.0 to 84.9,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2017-2018,Age,0-3 Days,82.7,78.8 to 86.0,817
Polio,≥1 Dose,States/Local Areas,Michigan,2016,Age,3 Months,87.0,81.4 to 91.1,291
Polio,≥1 Dose,States/Local Areas,Michigan,2016-2017,Age,3 Months,86.3,82.5 to 89.4,693
Polio,≥1 Dose,States/Local Areas,Michigan,2015,Age,3 Months,84.6,77.4 to 89.8,236
Polio,≥1 Dose,States/Local Areas,Michigan,2015-2016,Age,3 Months,85.8,81.3 to 89.3,527
Polio,≥1 Dose,States/Local Areas,Michigan,2014,Age,3 Months,83.6,77.3 to 88.4,250
Polio,≥1 Dose,States/Local Areas,Michigan,2014-2015,Age,3 Months,84.1,79.4 to 87.8,486
Hib,≥3 Doses,States/Local Areas,Michigan,2013,Age,7 Months,40.9,36.5 to 45.4,240
Hib,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,40.8,37.9 to 43.8,490
Hib,≥3 Doses,States/Local Areas,Michigan,2011,Age,7 Months,52.4,47.8 to 56.9,255
Hib,≥3 Doses,States/Local Areas,Michigan,2012,Age,7 Months,38.4,28.8 to 49.1,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,133% to <400% FPL,91.1,87.8 to 94.5,414
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,>400% FPL,94.1,90.1 to 98.0,316
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,89.8,84.9 to 94.6,267
PCV,≥3 Doses,States/Local Areas,Michigan,2012,Age,35 Months,86.6,78.7 to 92.6,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,87.1,77.5 to 96.6,90
Hib,≥2 Doses,States/Local Areas,Michigan,2015,Age,7 Months,84.0,76.0 to 89.6,236
Hib,≥2 Doses,States/Local Areas,Michigan,2015-2016,Age,7 Months,87.2,82.6 to 90.7,527
PCV,≥3 Doses,States/Local Areas,Michigan,2013,Age,35 Months,89.7,82.8 to 94.7,240
PCV,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,35 Months,91.6,87.1 to 95.0,490
PCV,≥3 Doses,States/Local Areas,Michigan,2011,Age,35 Months,90.0,84.6 to 94.2,255
PCV,≥3 Doses,States/Local Areas,Michigan,2019,Age,24 Months,95.7,92.8 to 97.7,375
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2013,Age,0-3 Days,80.5,73.0 to 86.3,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2013-2014,Age,0-3 Days,79.4,74.6 to 83.4,490
Polio,≥1 Dose,States/Local Areas,Michigan,2013,Age,3 Months,81.7,74.2 to 87.4,240
Polio,≥1 Dose,States/Local Areas,Michigan,2013-2014,Age,3 Months,82.7,79.2 to 85.7,490
Polio,≥1 Dose,States/Local Areas,Michigan,2011,Age,3 Months,85.4,82.7 to 87.7,255
Polio,≥1 Dose,States/Local Areas,Michigan,2012,Age,3 Months,77.9,70.4 to 83.9,212
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,91.3,88.9 to 93.8,997
PCV,≥1 Dose,States/Local Areas,Michigan,2019,Age,3 Months,89.5,84.2 to 93.1,375
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014,Age,0-3 Days,78.3,71.7 to 83.7,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2015,Age,0-3 Days,77.4,72.5 to 81.7,486
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,88.8 to 96.9,122
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,90.2 to 95.8,481
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,89.9,84.1 to 95.8,158
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,91.1 to 95.8,693
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2015,Age,0-3 Days,76.6,68.8 to 83.0,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2015-2016,Age,0-3 Days,78.1,73.1 to 82.3,527
DTaP,≥3 Doses,States/Local Areas,Michigan,2011,Age,7 Months,62.1,59.1 to 65.0,255
DTaP,≥3 Doses,States/Local Areas,Michigan,2012,Age,7 Months,55.6,44.8 to 65.9,212
DTaP,≥3 Doses,States/Local Areas,Michigan,2013,Age,7 Months,61.9,57.9 to 65.7,240
DTaP,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,7 Months,62.6,59.5 to 65.7,490
Hep B,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,90.0,85.5 to 94.6,358
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,84.7,79.7 to 89.6,267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Race and Ethnicity,Hispanic,76.8,65.4 to 88.2,90
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,68.8 to 86.2,122
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.9,74.0 to 81.7,693
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.5,76.1 to 84.9,481
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Principal City,75.3,69.8 to 80.8,358
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Overall,Overall,78.3,75.1 to 81.5,997
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,80.7,73.6 to 87.7,158
DTaP,≥3 Doses,States/Local Areas,Michigan,2014,Age,13 Months,87.1,81.0 to 91.5,250
DTaP,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,13 Months,86.8,82.2 to 90.3,486
DTaP,≥3 Doses,States/Local Areas,Michigan,2013,Age,13 Months,86.5,81.1 to 90.6,240
DTaP,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,13 Months,86.8,83.9 to 89.3,490
Hib,≥3 Doses,States/Local Areas,Michigan,2015,Age,13 Months,65.2,56.7 to 72.8,236
Hib,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,13 Months,67.1,61.6 to 72.1,527
Hib,≥3 Doses,States/Local Areas,Michigan,2017,Age,13 Months,60.9,53.7 to 67.6,402
Hib,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,66.7,61.8 to 71.2,817
Hib,≥3 Doses,States/Local Areas,Michigan,2016,Age,13 Months,68.9,61.9 to 75.1,291
Hib,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,13 Months,64.9,59.9 to 69.6,693
DTaP,≥3 Doses,States/Local Areas,Michigan,2012,Age,19 Months,85.9,77.6 to 91.5,212
DTaP,≥3 Doses,States/Local Areas,Michigan,2013,Age,19 Months,88.2,82.4 to 92.2,240
DTaP,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,89.6,87.7 to 91.3,490
DTaP,≥3 Doses,States/Local Areas,Michigan,2011,Age,19 Months,89.2,85.4 to 92.2,255
DTaP,≥3 Doses,States/Local Areas,Michigan,2019,Age,13 Months,91.0,86.2 to 94.2,375
DTaP,≥3 Doses,States/Local Areas,Michigan,2018,Age,13 Months,94.6,90.6 to 97.0,415
DTaP,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,92.8,89.9 to 94.9,790
Hib,≥2 Doses,States/Local Areas,Michigan,2019,Age,13 Months,95.9,93.2 to 97.5,375
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,92.8 to 97.1,481
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Urbanicity,Living In a Non-MSA,91.5,86.5 to 96.4,158
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Overall,Overall,92.2,90.0 to 94.4,997
PCV,≥3 Doses,States/Local Areas,Michigan,2014-2017,Poverty,<133% FPL,88.6,84.0 to 93.2,267
Hib,≥2 Doses,States/Local Areas,Michigan,2017,Age,13 Months,93.3,88.8 to 96.0,402
Hib,≥2 Doses,States/Local Areas,Michigan,2017-2018,Age,13 Months,95.4,92.9 to 97.1,817
Hib,≥2 Doses,States/Local Areas,Michigan,2018,Age,13 Months,97.6,94.6 to 98.9,415
Hib,≥2 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,96.7,95.0 to 97.9,790
Polio,≥3 Doses,States/Local Areas,Michigan,2013,Age,19 Months,85.9,79.8 to 90.3,240
Polio,≥3 Doses,States/Local Areas,Michigan,2013-2014,Age,19 Months,87.9,85.9 to 89.7,490
Polio,≥3 Doses,States/Local Areas,Michigan,2015,Age,19 Months,90.0,85.5 to 93.3,236
Polio,≥3 Doses,States/Local Areas,Michigan,2015-2016,Age,19 Months,91.2,87.3 to 94.0,527
Polio,≥3 Doses,States/Local Areas,Michigan,2014,Age,19 Months,90.0,84.5 to 93.7,250
Polio,≥3 Doses,States/Local Areas,Michigan,2014-2015,Age,19 Months,90.0,85.9 to 93.0,486
Polio,≥3 Doses,States/Local Areas,Michigan,2018,Age,19 Months,96.1,92.5 to 98.0,415
Polio,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,19 Months,69.0,64.1 to 73.5,790
Hib,≥3 Doses,States/Local Areas,Michigan,2018,Age,13 Months,72.6,66.3 to 78.1,415
Hib,≥3 Doses,States/Local Areas,Michigan,2018-2019,Age,13 Months,71.9,67.3 to 76.1,790
Polio,≥3 Doses,States/Local Areas,Michigan,2017,Age,19 Months,88.0,82.2 to 92.1,402
Polio,≥3 Doses,States/Local Areas,Michigan,2017-2018,Age,19 Months,92.0,88.7 to 94.4,817
Polio,≥3 Doses,States/Local Areas,Michigan,2016,Age,19 Months,92.4,87.6 to 95.4,291
Polio,≥3 Doses,States/Local Areas,Michigan,2016-2017,Age,19 Months,90.2,86.3 to 93.1,693
Hib,≥3 Doses,States/Local Areas,Michigan,2011,Age,19 Months,85.2,81.2 to 88.5,255
Hib,≥3 Doses,States/Local Areas,Michigan,2012,Age,19 Months,81.6,75.8 to 86.2,212
Hib,≥3 Doses,States/Local Areas,Michigan,2019,Age,13 Months,71.2,64.3 to 77.3,375
Hib,≥2 Doses,States/Local Areas,Michigan,2020,Age,13 Months,93.2,88.6 to 96.1,448
Hib,≥1 Dose,States/Local Areas,Massachusetts,2019-2020,Age,3 Months,91.9,87.8 to 94.8,563
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,56.6,49.7 to 63.1,443
Hib,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,95.0,90.5 to 97.8,260
Hib,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,98.0,94.1 to 99.5,237
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,77.8,66.0 to 86.4,260
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,81.1,73.7 to 86.8,237
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,29.1,23.6 to 35.3,292
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,31.7,26.0 to 37.9,559
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,34.2,25.5 to 44.1,267
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,32.5,26.8 to 38.8,597
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,96.3,92.3 to 98.6,303
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,97.2,94.7 to 98.7,594
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,98.0,94.1 to 99.5,291
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,97.2,94.9 to 98.7,583
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,96.5,93.0 to 98.5,292
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,95.9,93.0 to 97.8,559
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,30.8,24.1 to 38.5,330
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,30.5,25.4 to 36.0,695
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,35 Months,90.1,84.0 to 94.5,260
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,19 Months,88.3,81.1 to 93.0,267
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,89.8,85.2 to 93.1,597
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,19 Months,89.4,83.1 to 93.6,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,24 Months,75.9,67.7 to 83.4,237
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,24 Months,85.8,80.1 to 90.6,303
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,84.4,79.8 to 88.4,594
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,24 Months,82.9,75.6 to 89.0,291
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,87.5,83.2 to 91.1,583
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,24 Months,85.5,79.1 to 90.8,260
PCV,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,5 Months,85.6,82.7 to 88.1,303
PCV,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,5 Months,88.1,83.3 to 91.7,594
PCV,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,5 Months,81.4,73.1 to 87.6,260
PCV,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,5 Months,83.7,77.9 to 88.2,237
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,97.0,93.6 to 98.8,292
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,96.2,93.4 to 98.0,559
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,95.4,90.5 to 98.2,267
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.6,93.0 to 98.6,597
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,98.1,94.5 to 99.6,330
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.4,94.8 to 98.9,695
Hib,Primary Series,States/Local Areas,Massachusetts,2021,Age,19 Months,97.8,92.3 to 99.4,175
Hib,Full Series,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,91.1,86.6 to 94.6,443
Hib,Full Series,States/Local Areas,Massachusetts,2021,Age,19 Months,89.1,80.9 to 94.0,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,98.5,96.5 to 99.4,175
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,91.8,87.3 to 95.1,443
Hib,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,97.8,92.3 to 99.4,175
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2021,Age,19 Months,96.4,90.1 to 98.7,175
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,19 Months,79.1,71.4 to 85.2,291
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,83.6,78.7 to 87.5,583
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,19 Months,88.0,81.4 to 92.5,292
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,88.2,83.6 to 91.6,559
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,19 Months,82.4,79.1 to 85.3,303
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,80.8,77.0 to 84.1,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,98.1,94.5 to 99.6,330
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,97.4,94.8 to 98.9,695
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,96.9,93.0 to 98.9,365
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,97.0,94.6 to 98.5,660
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,98.2,96.4 to 100.0,606
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,95.1,91.2 to 99.0,264
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,97.5,95.2 to 99.8,164
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,97.2,95.7 to 98.7,1034
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,5 Months,90.8,85.0 to 94.5,365
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,5 Months,90.3,86.3 to 93.2,660
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,5 Months,85.7,77.5 to 91.2,330
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,5 Months,88.2,83.4 to 91.8,695
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,96.5,93.0 to 98.5,292
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,95.9,93.0 to 97.8,559
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,95.3,90.4 to 98.1,267
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,96.6,93.0 to 98.6,597
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,97.2,93.7 to 99.0,295
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,98.1,94.5 to 99.6,330
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,97.6,95.2 to 99.0,695
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,24 Months,92.1,87.5 to 95.5,292
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,92.1,88.7 to 94.7,559
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,24 Months,92.2,86.9 to 95.9,267
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,93.1,89.3 to 95.9,597
PCV,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,5 Months,90.6,85.3 to 94.1,291
PCV,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,5 Months,91.5,87.8 to 94.2,583
PCV,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,5 Months,92.4,86.9 to 95.7,292
PCV,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,5 Months,90.6,86.1 to 93.7,559
PCV,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,5 Months,88.8,81.2 to 93.5,267
PCV,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,5 Months,86.5,80.6 to 90.9,597
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,96.9,93.0 to 98.9,365
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,97.1,94.7 to 98.6,660
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,97.3,93.8 to 99.0,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,24 Months,93.9,89.1 to 97.1,330
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,92.2,88.7 to 94.9,695
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,24 Months,90.4,85.1 to 94.5,365
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,92.6,89.3 to 95.2,660
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,24 Months,95.1,90.8 to 97.8,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,35 Months,87.8,77.5 to 94.8,237
PCV,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,5 Months,84.3,76.3 to 90.0,330
PCV,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,5 Months,84.1,78.9 to 88.2,695
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,97.8,94.6 to 99.4,365
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,97.6,95.5 to 98.9,660
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,41.7,34.1 to 50.2,260
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.3,93.6 to 100.0,53
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,76.3,71.8 to 80.2,303
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,79.4,73.4 to 84.3,594
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,82.5,75.6 to 87.7,291
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,81.9,77.1 to 85.8,583
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,81.2,73.9 to 86.9,292
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,80.4,74.9 to 85.0,559
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,96.8,93.7 to 99.8,219
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,98.1,96.7 to 99.6,780
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,95.3,90.4 to 98.1,267
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.6,93.0 to 98.6,597
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,98.1,94.5 to 99.6,330
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,98.0,95.7 to 99.2,695
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,30.1,22.9 to 38.4,365
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,26.7,20.9 to 33.5,565
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,28.8,21.9 to 36.9,295
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,43.5,35.1 to 52.8,237
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,99.6,97.9 to 99.9,303
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,99.6,98.6 to 99.9,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,99.0,96.7 to 99.8,260
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,98.0,94.1 to 99.5,237
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,99.8,99.4 to 100.0,291
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,98.4,96.6 to 99.3,583
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,26.0,22.3 to 30.1,237
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,5 Months,89.8,83.5 to 93.9,295
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,31.0,27.1 to 35.1,303
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,27.5,22.8 to 32.8,594
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,24.0,18.0 to 31.3,291
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,26.6,21.8 to 31.9,583
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,29.1,21.3 to 38.5,260
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,97.2,93.8 to 99.0,365
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,97.4,95.1 to 98.7,660
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,97.5,94.1 to 99.2,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,19 Months,91.3,85.7 to 94.8,330
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,89.0,84.9 to 92.1,695
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,19 Months,86.7,80.0 to 91.4,365
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,86.8,80.9 to 91.0,565
Hib,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,96.6,90.9 to 98.8,175
PCV,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,5 Months,88.3,80.2 to 93.4,175
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,86.4,78.2 to 91.8,175
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,98.8,96.3 to 99.6,175
Hib,Primary Series,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,96.1,93.2 to 98.0,443
PCV,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,97.4,91.9 to 99.5,175
PCV,≥4 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,89.1,77.6 to 95.0,175
Hib,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,84.4,76.1 to 90.1,175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.3,79.9 to 88.7,728
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,3 Months,94.3,87.4 to 97.5,260
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,3 Months,95.7,92.6 to 97.5,237
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,3 Months,95.6,94.1 to 96.8,303
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,3 Months,95.6,93.8 to 96.9,594
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,3 Months,95.6,89.9 to 98.1,291
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,3 Months,94.9,91.6 to 97.0,583
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,3 Months,94.2,89.2 to 97.0,292
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,3 Months,94.4,90.9 to 96.6,559
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,3 Months,94.5,88.7 to 97.4,267
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,3 Months,93.3,87.5 to 96.5,597
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,3 Months,92.0,83.7 to 96.3,330
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,3 Months,93.1,88.3 to 96.0,695
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,99.8,99.4 to 100.0,291
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,98.4,96.6 to 99.3,583
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,97.0,93.6 to 98.8,292
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,96.2,93.4 to 98.0,559
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,3 Months,94.2,87.9 to 97.3,365
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,3 Months,95.6,92.2 to 97.5,660
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,95.4,90.5 to 98.2,267
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,96.6,93.0 to 98.6,597
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,3 Months,97.0,93.0 to 98.7,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,19 Months,74.6,68.4 to 79.9,237
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,19 Months,80.4,69.9 to 87.9,260
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,90.6,83.2 to 95.7,175
Polio,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,99.1,97.6 to 99.7,175
Polio,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,3 Months,97.7,93.9 to 99.1,175
≥1 Dose MMR,,States/Local Areas,Massachusetts,2021,Age,24 Months,94.6,88.1 to 98.2,175
Hib,Primary Series,States/Local Areas,Massachusetts,2021,Age,24 Months,97.8,93.4 to 99.5,175
Hib,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,3 Months,94.6,87.6 to 97.7,175
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,93.9,89.7 to 96.8,443
Hib,Full Series,States/Local Areas,Massachusetts,2021,Age,24 Months,93.1,86.2 to 97.3,175
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,81.0,69.9 to 88.7,175
Hib,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,97.8,93.4 to 99.5,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,98.5,96.8 to 99.4,175
PCV,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,97.4,90.2 to 99.3,175
Hib,Primary Series,States/Local Areas,Massachusetts,2021,Age,7 Months,85.5,77.4 to 91.1,175
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,98.0,95.4 to 99.3,443
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,96.2,92.8 to 98.0,443
Combined 7 Series,,States/Local Areas,Massachusetts,2021,Age,35 Months,94.0,87.4 to 97.8,175
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,95.2,80.7 to 99.6,175
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,97.2,94.6 to 98.6,443
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,35 Months,90.9,83.6 to 95.8,175
Polio,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,99.1,97.3 to 99.7,175
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,96.1,93.2 to 98.0,443
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,94.2,90.7 to 96.4,443
≥1 Dose MMR,,States/Local Areas,Massachusetts,2021,Age,35 Months,95.5,89.4 to 98.6,175
PCV,≥4 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,89.4,83.6 to 93.8,443
Polio,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,98.2,94.4 to 99.5,175
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2021,Age,0-2 Days,86.0,74.7 to 92.7,175
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2021,Age,24 Months,96.8,91.5 to 99.2,175
PCV,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,97.4,91.9 to 99.5,175
PCV,≥4 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,89.8,79.8 to 96.1,175
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,24 Months,90.9,83.6 to 95.8,175
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,93.3,89.5 to 95.8,443
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,49.3,40.1 to 59.4,175
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,97.8,92.3 to 99.4,175
PCV,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,82.2,73.4 to 88.6,175
Combined 7 Series,,States/Local Areas,Massachusetts,2021,Age,24 Months,83.4,73.3 to 91.2,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,7 Months,78.1,69.8 to 84.6,175
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,95.7,92.4 to 97.9,443
Polio,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,99.4,98.1 to 99.8,175
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,97.8,92.3 to 99.4,175
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,19 Months,85.9,76.8 to 91.9,175
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,3 Months,96.4,90.8 to 98.7,175
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,19 Months,31.9,23.4 to 41.8,175
PCV,≥4 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,96.8,90.8 to 99.3,175
Rotavirus,,States/Local Areas,Florida,2011,Age,8 Months,60.4,51.1 to 68.9,236
Rotavirus,,States/Local Areas,Florida,2016,Age,8 Months,71.5,63.5 to 78.4,349
Rotavirus,,States/Local Areas,Florida,2016-2017,Age,8 Months,69.9,64.5 to 74.9,723
Rotavirus,,States/Local Areas,Florida,2015,Age,8 Months,67.5,59.4 to 74.7,309
Rotavirus,,States/Local Areas,Florida,2015-2016,Age,8 Months,69.5,63.9 to 74.6,658
Hep A,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,39.8,34.2 to 46.0,666
Rotavirus,,States/Local Areas,Florida,2017,Age,8 Months,68.3,60.5 to 75.2,374
Rotavirus,,States/Local Areas,Florida,2017-2018,Age,8 Months,69.4,63.2 to 74.9,698
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2020-2021,Age,0-3 Days,76.3,71.1 to 80.8,666
Hib,Primary Series,States/Local Areas,Florida,2020-2021,Age,35 Months,92.1,88.4 to 94.9,666
Hep B,≥3 Doses,States/Local Areas,Florida,2021,Age,13 Months,86.1,78.5 to 91.3,276
≥1 Dose Varicella,,States/Local Areas,Florida,2021,Age,13 Months,67.0,58.1 to 74.9,276
Hib,Primary Series,States/Local Areas,Florida,2021,Age,35 Months,92.3,86.2 to 96.4,276
Influenza,,States/Local Areas,Florida,2021,Age,24 Months,41.4,33.0 to 50.9,276
Polio,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,91.8,87.9 to 94.6,666
Hib,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,5 Months,75.4,69.9 to 80.2,666
≥1 Dose MMR,,States/Local Areas,Florida,2020-2021,Age,13 Months,69.9,64.2 to 74.9,666
Hep B,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,89.4,85.2 to 92.6,666
DTaP,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,88.8,84.5 to 92.0,666
Hep B,≥2 Doses,States/Local Areas,Florida,2021,Age,5 Months,87.1,80.0 to 92.0,276
Hep A,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,23.2,18.7 to 28.5,666
≥1 Dose MMR,,States/Local Areas,Florida,2021,Age,19 Months,88.5,81.4 to 93.2,276
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2020-2021,Age,0-2 Days,75.8,70.6 to 80.3,666
Hib,Full Series,States/Local Areas,Florida,2020-2021,Age,35 Months,80.9,75.1 to 86.0,666
DTaP,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,3 Months,86.3,81.7 to 90.0,666
Hep B,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,3 Months,94.6,91.4 to 96.7,666
PCV,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,91.3,87.3 to 94.4,666
≥1 Dose Varicella,,States/Local Areas,Florida,2020-2021,Age,19 Months,87.9,83.4 to 91.3,666
PCV,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,66.1,60.3 to 71.5,666
Rotavirus,,States/Local Areas,Florida,2019,Age,8 Months,69.6,61.5 to 76.7,333
Rotavirus,,States/Local Areas,Florida,2018,Age,8 Months,70.4,60.8 to 78.5,324
Rotavirus,,States/Local Areas,Florida,2018-2019,Age,8 Months,70.0,63.9 to 75.6,657
Rotavirus,,States/Local Areas,Florida,2013,Age,8 Months,63.6,55.4 to 71.2,272
Rotavirus,,States/Local Areas,Florida,2013-2014,Age,8 Months,66.3,60.3 to 71.8,546
Rotavirus,,States/Local Areas,Florida,2014,Age,8 Months,68.9,60.4 to 76.2,274
Rotavirus,,States/Local Areas,Florida,2014-2015,Age,8 Months,68.2,62.4 to 73.5,583
Rotavirus,,States/Local Areas,Florida,2012,Age,8 Months,61.2,52.3 to 69.5,240
Rotavirus,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,48.8,26.7 to 70.9,39
Rotavirus,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.0,56.2 to 77.8,157
Rotavirus,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,72.8,66.7 to 79.0,340
Rotavirus,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.8,55.5 to 78.1,106
Rotavirus,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,66.1,60.5 to 71.8,490
Rotavirus,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,81.4,77.0 to 85.8,628
Rotavirus,,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,75.3,69.8 to 80.8,467
Rotavirus,,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,64.6,58.0 to 71.3,340
Rotavirus,,States/Local Areas,Florida,2014-2017,Overall,Overall,71.7,67.9 to 75.5,1171
Rotavirus,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.2,66.3 to 78.1,469
Rotavirus,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,82.1,65.8 to 98.3,30
Rotavirus,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,70.7,65.6 to 75.9,672
Rotavirus,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.4,68.7 to 80.0,568
Rotavirus,,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,80.8,74.7 to 86.9,364
Hep A,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,24 Months,83.0,78.2 to 87.4,666
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,77.8 to 94.6,154
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,78.1,72.9 to 83.4,510
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,77.6,71.0 to 84.1,335
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,87.3,83.0 to 91.7,671
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.8,56.7 to 83.0,154
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,79.8 to 96.4,154
Hib,Full Series,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,79.0,72.7 to 85.4,408
Hep B,≥1 Dose,States/Local Areas,Florida,2021,Age,3 Months,95.4,89.6 to 98.0,276
Influenza,,States/Local Areas,Florida,2013,Age,24 Months,44.3,36.6 to 52.9,272
Influenza,,States/Local Areas,Florida,2013-2014,Age,24 Months,40.6,35.1 to 46.7,546
Influenza,,States/Local Areas,Florida,2012,Age,24 Months,44.9,36.8 to 53.9,240
Influenza,,States/Local Areas,Florida,2011,Age,24 Months,31.4,23.6 to 41.0,236
Influenza,,States/Local Areas,Florida,2015,Age,24 Months,38.2,31.0 to 46.5,309
Influenza,,States/Local Areas,Florida,2015-2016,Age,24 Months,36.1,31.0 to 41.8,658
Influenza,,States/Local Areas,Florida,2014,Age,24 Months,37.0,29.4 to 45.8,274
Influenza,,States/Local Areas,Florida,2014-2015,Age,24 Months,37.7,32.3 to 43.7,583
Influenza,,States/Local Areas,Florida,2016,Age,24 Months,34.0,27.2 to 41.9,349
Influenza,,States/Local Areas,Florida,2016-2017,Age,24 Months,38.1,32.9 to 43.7,723
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,78.2,72.9 to 83.5,510
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.8,65.0 to 90.7,88
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,83.7,78.6 to 88.8,671
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,70.3,60.5 to 80.1,408
Influenza,,States/Local Areas,Florida,2019,Age,24 Months,46.1,38.2 to 54.8,333
Influenza,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,19.2,0.2 to 38.2,39
Influenza,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,41.8,36.2 to 47.4,672
Influenza,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",44.5,38.2 to 50.8,568
Influenza,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,38.4,32.1 to 44.7,469
Influenza,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,24.5,6.6 to 42.5,30
Influenza,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",30.0,18.8 to 41.3,106
Influenza,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",35.9,25.6 to 46.1,157
Influenza,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,41.4,34.3 to 48.6,340
Influenza,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,31.1,25.6 to 36.7,490
Influenza,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,54.6,48.4 to 60.7,628
Hib,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,86.7,82.1 to 90.3,666
Influenza,,States/Local Areas,Florida,2018,Age,24 Months,48.4,39.5 to 58.2,324
Influenza,,States/Local Areas,Florida,2018-2019,Age,24 Months,47.3,41.2 to 53.8,657
Influenza,,States/Local Areas,Florida,2017,Age,24 Months,42.1,34.9 to 50.1,374
Influenza,,States/Local Areas,Florida,2017-2018,Age,24 Months,45.2,39.3 to 51.6,698
Hib,Full Series,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,64.1 to 86.6,154
PCV,≥1 Dose,States/Local Areas,Florida,2021,Age,3 Months,82.7,74.5 to 88.6,276
Hep B,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,90.6,86.7 to 93.7,666
Influenza,,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,57.0,48.9 to 65.2,364
Influenza,,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,41.4,34.8 to 48.1,467
Influenza,,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,30.7,24.3 to 37.2,340
Influenza,,States/Local Areas,Florida,2014-2017,Overall,Overall,39.9,35.8 to 44.0,1171
Hib,Full Series,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,77.4,72.1 to 82.6,510
Hib,Full Series,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,88.1,83.7 to 92.6,671
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.4 to 94.2,510
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,95.2,92.4 to 98.0,671
≥1 Dose Varicella,,States/Local Areas,Florida,2020-2021,Age,13 Months,66.1,60.4 to 71.5,666
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.1,64.2 to 86.0,154
DTaP,≥3 Doses,States/Local Areas,Florida,2021,Age,24 Months,92.3,86.2 to 96.4,276
DTaP,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,5 Months,78.4,73.2 to 82.8,666
Hib,≥2 Doses,States/Local Areas,Florida,2021,Age,13 Months,92.5,85.7 to 96.2,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2021,Age,0-3 Days,75.4,67.0 to 82.2,276
Polio,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,91.6,87.9 to 94.5,666
Hib,≥3 Doses,States/Local Areas,Florida,2021,Age,35 Months,91.9,85.8 to 96.1,276
Hep A,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,76.1,67.0 to 84.2,666
Polio,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,3 Months,85.3,80.4 to 89.1,666
PCV,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,3 Months,83.8,79.0 to 87.8,666
≥1 Dose MMR,,States/Local Areas,Florida,2021,Age,13 Months,68.0,59.0 to 75.8,276
Hib,Full Series,States/Local Areas,Florida,2020-2021,Age,19 Months,71.4,65.4 to 76.6,666
PCV,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,86.1,81.5 to 89.7,666
DTaP,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,68.9,63.1 to 74.1,666
≥1 Dose MMR,,States/Local Areas,Florida,2020-2021,Age,19 Months,89.1,84.9 to 92.2,666
Hib,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,57.0,51.1 to 62.8,666
DTaP,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,94.7,90.3 to 97.5,666
DTaP,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,92.1,88.5 to 95.0,666
Rotavirus,,States/Local Areas,Florida,2020-2021,Age,8 Months,70.9,65.3 to 75.9,666
Hib,Primary Series,States/Local Areas,Florida,2020-2021,Age,19 Months,91.5,87.7 to 94.3,666
≥1 Dose Varicella,,States/Local Areas,Florida,2021,Age,35 Months,94.8,88.5 to 98.3,276
DTaP,≥4 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,80.1,75.0 to 84.8,666
Hep A,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,19 Months,77.6,72.2 to 82.3,666
Hep B,≥2 Doses,States/Local Areas,Florida,2021,Age,13 Months,92.4,85.5 to 96.2,276
Polio,≥3 Doses,States/Local Areas,Florida,2021,Age,35 Months,92.4,86.3 to 96.5,276
Combined 7 Series,,States/Local Areas,Florida,2021,Age,24 Months,71.2,62.0 to 79.7,276
PCV,≥4 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,73.4,67.7 to 78.3,666
Hep B,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,54.6,48.8 to 60.3,666
Hib,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,91.2,87.3 to 94.2,666
DTaP,≥4 Doses,States/Local Areas,Florida,2021,Age,35 Months,85.7,76.3 to 92.7,276
Influenza,,States/Local Areas,Florida,2020-2021,Age,24 Months,42.1,36.5 to 48.1,666
Hib,Primary Series,States/Local Areas,Florida,2021,Age,13 Months,82.5,73.8 to 88.7,276
PCV,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,90.3,86.1 to 93.3,666
PCV,≥4 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,81.3,76.3 to 85.8,666
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2020-2021,Age,0-1 Days,71.2,65.7 to 76.2,666
Hep B,≥3 Doses,States/Local Areas,Florida,2021,Age,35 Months,98.8,94.8 to 99.9,276
≥1 Dose MMR,,States/Local Areas,Florida,2020-2021,Age,35 Months,93.3,89.6 to 96.0,666
DTaP,≥3 Doses,States/Local Areas,Florida,2021,Age,35 Months,99.2,95.0 to 100.0,276
Hib,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,3 Months,82.5,77.2 to 86.7,666
Hep B,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,89.4,85.2 to 92.5,666
Hib,Primary Series,States/Local Areas,Florida,2020-2021,Age,13 Months,84.0,78.8 to 88.2,666
Combined 7 Series,,States/Local Areas,Florida,2020-2021,Age,24 Months,67.3,61.5 to 72.9,666
Hib,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,90.4,86.3 to 93.3,666
Polio,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,7 Months,86.4,81.5 to 90.1,666
Hib,Full Series,States/Local Areas,Florida,2021,Age,35 Months,79.1,70.0 to 87.0,276
PCV,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,90.6,86.7 to 93.7,666
Polio,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,90.7,86.6 to 93.6,666
Hib,Primary Series,States/Local Areas,Florida,2020-2021,Age,7 Months,69.0,63.0 to 74.3,666
Polio,≥2 Doses,States/Local Areas,Florida,2021,Age,5 Months,76.9,68.3 to 83.7,276
DTaP,≥4 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,67.7,61.8 to 73.1,666
Hib,≥3 Doses,States/Local Areas,Florida,2021,Age,13 Months,74.4,65.4 to 81.8,276
Polio,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,5 Months,76.8,71.4 to 81.4,666
Combined 7 Series,,States/Local Areas,Florida,2020-2021,Age,35 Months,73.4,67.4 to 79.1,666
≥1 Dose MMR,,States/Local Areas,Florida,2020-2021,Age,24 Months,90.8,87.2 to 93.8,666
Hep B,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,5 Months,86.3,81.9 to 89.8,666
Polio,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,92.2,88.5 to 95.1,666
≥1 Dose Varicella,,States/Local Areas,Florida,2020-2021,Age,24 Months,90.9,87.2 to 94.0,666
Rotavirus,,States/Local Areas,Florida,2021,Age,8 Months,69.6,60.5 to 77.3,276
DTaP,≥2 Doses,States/Local Areas,Florida,2021,Age,5 Months,79.1,70.8 to 85.5,276
Hep A,≥1 Dose,States/Local Areas,Florida,2012,Age,19 Months,70.8,62.3 to 78.0,240
Hep A,≥1 Dose,States/Local Areas,Florida,2011,Age,19 Months,61.7,55.3 to 67.8,236
DTaP,≥1 Dose,States/Local Areas,Florida,2019,Age,3 Months,88.8,82.5 to 93.0,333
DTaP,≥3 Doses,States/Local Areas,Florida,2016,Age,24 Months,92.4,87.6 to 95.9,349
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,93.2,90.2 to 95.6,723
DTaP,≥1 Dose,States/Local Areas,Florida,2018,Age,3 Months,87.6,79.8 to 92.7,324
DTaP,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,3 Months,88.2,83.5 to 91.7,657
DTaP,≥3 Doses,States/Local Areas,Florida,2015,Age,24 Months,93.5,89.6 to 96.3,309
DTaP,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,93.0,90.0 to 95.3,658
DTaP,≥3 Doses,States/Local Areas,Florida,2014,Age,24 Months,90.3,84.3 to 94.7,274
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,24 Months,91.9,88.5 to 94.6,583
DTaP,≥1 Dose,States/Local Areas,Florida,2017,Age,3 Months,82.7,76.0 to 87.8,374
DTaP,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,3 Months,85.1,80.1 to 89.1,698
Hib,Primary Series,States/Local Areas,Florida,2016,Age,13 Months,84.7,77.7 to 89.8,349
Hib,Primary Series,States/Local Areas,Florida,2016-2017,Age,13 Months,85.7,81.2 to 89.2,723
Hib,Primary Series,States/Local Areas,Florida,2017,Age,13 Months,86.7,80.4 to 91.2,374
Hib,Primary Series,States/Local Areas,Florida,2017-2018,Age,13 Months,84.2,79.1 to 88.2,698
Hib,Primary Series,States/Local Areas,Florida,2018,Age,13 Months,81.6,72.9 to 88.0,324
Hib,Primary Series,States/Local Areas,Florida,2018-2019,Age,13 Months,84.5,79.3 to 88.6,657
Hib,Primary Series,States/Local Areas,Florida,2019,Age,19 Months,90.6,84.6 to 94.4,333
Hib,Primary Series,States/Local Areas,Florida,2018,Age,19 Months,89.2,81.7 to 93.8,324
Hib,Primary Series,States/Local Areas,Florida,2018-2019,Age,19 Months,84.5,79.3 to 88.6,657
Hib,Primary Series,States/Local Areas,Florida,2013,Age,19 Months,96.1,90.5 to 98.5,272
Hib,Primary Series,States/Local Areas,Florida,2013-2014,Age,19 Months,92.0,85.7 to 95.6,546
Hib,Primary Series,States/Local Areas,Florida,2012,Age,19 Months,94.9,92.0 to 96.7,240
Hib,Primary Series,States/Local Areas,Florida,2014,Age,19 Months,87.9,80.9 to 92.6,274
Hib,Primary Series,States/Local Areas,Florida,2014-2015,Age,19 Months,89.7,85.6 to 92.7,583
≥1 Dose MMR,,States/Local Areas,Florida,2020,Age,13 Months,71.8,64.9 to 77.8,390
Hib,Primary Series,States/Local Areas,Florida,2011,Age,19 Months,90.9,84.6 to 94.8,236
Hib,Primary Series,States/Local Areas,Florida,2019,Age,13 Months,87.5,81.0 to 92.0,333
Hib,Full Series,States/Local Areas,Florida,2016,Age,19 Months,68.7,60.3 to 75.9,349
Hib,Full Series,States/Local Areas,Florida,2016-2017,Age,19 Months,72.2,66.8 to 77.1,723
Combined 7 Series,,States/Local Areas,Florida,2019,Age,24 Months,71.1,63.2 to 78.7,333
Hib,Primary Series,States/Local Areas,Florida,2019,Age,35 Months,94.2,89.9 to 97.0,333
Combined 7 Series,,States/Local Areas,Florida,2016,Age,24 Months,71.4,63.7 to 78.7,349
Combined 7 Series,,States/Local Areas,Florida,2016-2017,Age,24 Months,69.6,64.3 to 74.8,723
Hib,Primary Series,States/Local Areas,Florida,2018,Age,35 Months,91.7,84.5 to 96.4,324
Hib,Primary Series,States/Local Areas,Florida,2018-2019,Age,35 Months,93.2,88.9 to 96.2,657
Combined 7 Series,,States/Local Areas,Florida,2015,Age,24 Months,69.6,62.0 to 77.0,309
Combined 7 Series,,States/Local Areas,Florida,2015-2016,Age,24 Months,70.5,65.1 to 75.8,658
Combined 7 Series,,States/Local Areas,Florida,2014,Age,24 Months,68.8,60.6 to 76.6,274
Combined 7 Series,,States/Local Areas,Florida,2014-2015,Age,24 Months,69.2,63.7 to 74.6,583
Hib,Primary Series,States/Local Areas,Florida,2015,Age,13 Months,89.4,83.4 to 93.4,309
Hib,Primary Series,States/Local Areas,Florida,2015-2016,Age,13 Months,87.1,82.6 to 90.5,658
Hib,Primary Series,States/Local Areas,Florida,2014-2015,Age,13 Months,86.2,81.5 to 89.9,583
Hib,Full Series,States/Local Areas,Florida,2019,Age,19 Months,77.6,70.4 to 83.5,333
Combined 7 Series,,States/Local Areas,Florida,2011,Age,35 Months,78.9,68.6 to 87.6,236
Combined 7 Series,,States/Local Areas,Florida,2018,Age,24 Months,69.6,60.9 to 77.9,324
Combined 7 Series,,States/Local Areas,Florida,2018-2019,Age,24 Months,70.3,64.4 to 76.0,657
Combined 7 Series,,States/Local Areas,Florida,2017,Age,24 Months,67.8,60.4 to 75.0,374
Combined 7 Series,,States/Local Areas,Florida,2017-2018,Age,24 Months,68.7,63.1 to 74.1,698
Hib,Primary Series,States/Local Areas,Florida,2014,Age,13 Months,83.0,75.2 to 88.7,274
Hib,Primary Series,States/Local Areas,Florida,2013,Age,13 Months,92.7,84.3 to 96.8,272
Hib,Primary Series,States/Local Areas,Florida,2013-2014,Age,13 Months,87.8,82.0 to 91.9,546
Hib,Primary Series,States/Local Areas,Florida,2012,Age,13 Months,90.2,87.6 to 92.2,240
Hib,Primary Series,States/Local Areas,Florida,2011,Age,13 Months,86.2,82.9 to 89.0,236
Hib,Primary Series,States/Local Areas,Florida,2019,Age,7 Months,66.3,57.6 to 74.0,333
Hib,Primary Series,States/Local Areas,Florida,2015,Age,7 Months,65.6,57.2 to 73.1,309
Hib,Primary Series,States/Local Areas,Florida,2015-2016,Age,7 Months,68.4,62.6 to 73.6,658
Hib,Primary Series,States/Local Areas,Florida,2014,Age,7 Months,67.2,58.4 to 74.9,274
Hib,Primary Series,States/Local Areas,Florida,2014-2015,Age,7 Months,66.4,60.4 to 71.9,583
Hib,Primary Series,States/Local Areas,Florida,2013,Age,7 Months,69.8,66.6 to 72.8,272
Hib,Primary Series,States/Local Areas,Florida,2013-2014,Age,7 Months,68.4,63.6 to 72.9,546
Hib,Primary Series,States/Local Areas,Florida,2017,Age,19 Months,92.4,87.4 to 95.5,374
Hib,Primary Series,States/Local Areas,Florida,2017-2018,Age,19 Months,90.8,86.6 to 93.8,698
Hib,Primary Series,States/Local Areas,Florida,2016,Age,19 Months,91.1,85.1 to 94.8,349
Hib,Primary Series,States/Local Areas,Florida,2016-2017,Age,19 Months,91.7,88.2 to 94.3,723
Hib,Primary Series,States/Local Areas,Florida,2013,Age,24 Months,96.1,92.3 to 98.3,272
Hib,Primary Series,States/Local Areas,Florida,2013-2014,Age,24 Months,92.2,88.4 to 95.1,546
Hib,Primary Series,States/Local Areas,Florida,2012,Age,24 Months,95.6,90.9 to 98.3,240
Hib,Primary Series,States/Local Areas,Florida,2011,Age,24 Months,91.4,85.4 to 95.6,236
Hib,Primary Series,States/Local Areas,Florida,2018,Age,7 Months,63.8,54.1 to 72.5,324
Hib,Primary Series,States/Local Areas,Florida,2018-2019,Age,7 Months,65.0,58.6 to 71.0,657
Hib,Primary Series,States/Local Areas,Florida,2015,Age,19 Months,91.4,89.8 to 92.8,309
Hib,Primary Series,States/Local Areas,Florida,2015-2016,Age,19 Months,91.3,87.5 to 93.9,658
Hep A,≥1 Dose,States/Local Areas,Florida,2013,Age,19 Months,71.5,66.9 to 75.7,272
Hep A,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,19 Months,72.0,69.5 to 74.3,546
Hep A,≥1 Dose,States/Local Areas,Florida,2016,Age,19 Months,68.7,60.3 to 76.0,349
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,19 Months,69.6,63.9 to 74.8,723
Hep A,≥1 Dose,States/Local Areas,Florida,2015,Age,19 Months,70.2,66.7 to 73.5,309
Hep A,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,19 Months,69.5,63.8 to 74.6,658
Hep A,≥1 Dose,States/Local Areas,Florida,2014,Age,19 Months,72.4,64.1 to 79.4,274
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,19 Months,71.3,65.7 to 76.3,583
DTaP,≥2 Doses,States/Local Areas,Florida,2019,Age,5 Months,75.5,66.8 to 82.5,333
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,100.0,,30
DTaP,≥2 Doses,States/Local Areas,Florida,2018,Age,5 Months,80.7,72.2 to 87.1,324
DTaP,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,5 Months,78.1,72.2 to 83.0,657
DTaP,≥2 Doses,States/Local Areas,Florida,2017,Age,5 Months,75.0,67.4 to 81.3,374
DTaP,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,5 Months,77.8,72.2 to 82.6,698
DTaP,≥3 Doses,States/Local Areas,Florida,2018,Age,24 Months,91.0,84.7 to 95.4,324
DTaP,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,92.0,88.1 to 94.9,657
DTaP,≥3 Doses,States/Local Areas,Florida,2017,Age,24 Months,94.1,90.0 to 96.9,374
DTaP,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,92.5,88.9 to 95.3,698
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,94.9,92.2 to 97.6,364
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,92.0,88.8 to 95.2,467
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,87.7,83.3 to 92.2,340
Polio,≥3 Doses,States/Local Areas,Florida,2014-2017,Overall,Overall,90.7,88.4 to 93.1,1171
Hep B,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,89.2,85.3 to 92.1,723
Hep B,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,52.6,47.1 to 58.1,723
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,95.2,92.0 to 98.3,404
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Poverty,<133% FPL,67.9,61.3 to 74.5,340
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Principal City,70.3,65.1 to 75.5,672
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.8,67.0 to 78.7,469
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.3,66.6 to 78.0,568
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.8,55.1 to 78.5,157
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Overall,Overall,71.4,67.6 to 75.2,1171
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Urbanicity,Living In a Non-MSA,74.2,51.4 to 96.9,30
Hib,Full Series,States/Local Areas,Florida,2013,Age,19 Months,74.4,67.7 to 80.2,272
Hib,Full Series,States/Local Areas,Florida,2013-2014,Age,19 Months,76.4,72.9 to 79.6,546
Hib,Full Series,States/Local Areas,Florida,2012,Age,19 Months,75.0,68.8 to 80.4,240
Hib,Full Series,States/Local Areas,Florida,2011,Age,19 Months,72.7,62.6 to 80.8,236
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Poverty,>400% FPL,78.3,72.0 to 84.6,364
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Poverty,133% to <400% FPL,71.8,65.8 to 77.7,467
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,69.0,63.4 to 74.6,490
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,75.6,70.6 to 80.6,628
Combined 7 Series,,States/Local Areas,Florida,2019,Age,35 Months,78.4,69.1 to 86.4,333
Combined 7 Series,,States/Local Areas,Florida,2018,Age,35 Months,72.9,63.9 to 81.2,324
Combined 7 Series,,States/Local Areas,Florida,2018-2019,Age,35 Months,75.4,69.0 to 81.4,657
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.7,63.0 to 84.3,106
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,59.8,37.6 to 82.0,39
Combined 7 Series,,States/Local Areas,Florida,2014-2017,Race and Ethnicity,Hispanic,70.7,64.2 to 77.2,340
Hib,Primary Series,States/Local Areas,Florida,2018,Age,24 Months,89.2,82.4 to 94.2,324
Hib,Primary Series,States/Local Areas,Florida,2018-2019,Age,24 Months,91.6,87.7 to 94.7,657
Hib,Primary Series,States/Local Areas,Florida,2017,Age,24 Months,93.7,89.7 to 96.6,374
Hib,Primary Series,States/Local Areas,Florida,2017-2018,Age,24 Months,91.5,87.6 to 94.5,698
Hib,Full Series,States/Local Areas,Florida,2018,Age,19 Months,72.5,63.0 to 80.3,324
Hib,Full Series,States/Local Areas,Florida,2018-2019,Age,19 Months,93.5,89.9 to 95.8,657
Hib,Full Series,States/Local Areas,Florida,2017,Age,19 Months,75.7,68.3 to 81.9,374
Hib,Full Series,States/Local Areas,Florida,2017-2018,Age,19 Months,74.1,68.3 to 79.2,698
Hib,Full Series,States/Local Areas,Florida,2015,Age,19 Months,74.4,68.4 to 79.5,309
Hib,Full Series,States/Local Areas,Florida,2015-2016,Age,19 Months,71.5,65.9 to 76.5,658
Hib,Full Series,States/Local Areas,Florida,2014,Age,19 Months,78.4,70.7 to 84.5,274
Hib,Full Series,States/Local Areas,Florida,2014-2015,Age,19 Months,76.3,71.0 to 81.0,583
Hib,Primary Series,States/Local Areas,Florida,2017,Age,7 Months,70.8,63.1 to 77.5,374
Hib,Primary Series,States/Local Areas,Florida,2017-2018,Age,7 Months,67.3,61.2 to 73.0,698
Hib,Primary Series,States/Local Areas,Florida,2016,Age,7 Months,71.3,63.1 to 78.2,349
Hib,Primary Series,States/Local Areas,Florida,2016-2017,Age,7 Months,71.0,65.4 to 76.1,723
Combined 7 Series,,States/Local Areas,Florida,2015,Age,35 Months,71.9,64.1 to 79.2,309
Combined 7 Series,,States/Local Areas,Florida,2015-2016,Age,35 Months,74.7,69.1 to 80.0,658
Combined 7 Series,,States/Local Areas,Florida,2014,Age,35 Months,77.1,68.7 to 84.6,274
Combined 7 Series,,States/Local Areas,Florida,2014-2015,Age,35 Months,74.8,69.1 to 80.3,583
Combined 7 Series,,States/Local Areas,Florida,2013,Age,35 Months,70.6,61.9 to 78.9,272
Combined 7 Series,,States/Local Areas,Florida,2013-2014,Age,35 Months,74.1,68.0 to 79.9,546
Combined 7 Series,,States/Local Areas,Florida,2012,Age,35 Months,69.4,61.2 to 77.3,240
Combined 7 Series,,States/Local Areas,Florida,2017,Age,35 Months,73.2,65.6 to 80.4,374
Combined 7 Series,,States/Local Areas,Florida,2017-2018,Age,35 Months,73.0,67.3 to 78.5,698
Combined 7 Series,,States/Local Areas,Florida,2016,Age,35 Months,77.7,69.3 to 85.1,349
Combined 7 Series,,States/Local Areas,Florida,2016-2017,Age,35 Months,75.1,69.7 to 80.3,723
Hib,Primary Series,States/Local Areas,Florida,2019,Age,24 Months,94.2,89.9 to 97.0,333
Hib,Primary Series,States/Local Areas,Florida,2014,Age,35 Months,88.4,82.0 to 93.4,274
Hib,Primary Series,States/Local Areas,Florida,2014-2015,Age,35 Months,90.5,86.6 to 93.6,583
Hib,Primary Series,States/Local Areas,Florida,2012,Age,35 Months,95.6,90.9 to 98.3,240
Hib,Primary Series,States/Local Areas,Florida,2013,Age,35 Months,96.8,93.1 to 98.9,272
Hib,Primary Series,States/Local Areas,Florida,2013-2014,Age,35 Months,92.7,89.1 to 95.4,546
Hib,Primary Series,States/Local Areas,Florida,2011,Age,35 Months,91.4,85.4 to 95.6,236
Combined 7 Series,,States/Local Areas,Florida,2012,Age,24 Months,67.8,59.6 to 75.8,240
Combined 7 Series,,States/Local Areas,Florida,2013,Age,24 Months,63.5,55.8 to 71.2,272
Combined 7 Series,,States/Local Areas,Florida,2013-2014,Age,24 Months,66.1,60.5 to 71.6,546
Combined 7 Series,,States/Local Areas,Florida,2011,Age,24 Months,67.2,58.0 to 76.2,236
Hib,Primary Series,States/Local Areas,Florida,2016,Age,35 Months,93.5,88.9 to 96.6,349
Hib,Primary Series,States/Local Areas,Florida,2016-2017,Age,35 Months,94.0,91.0 to 96.2,723
Hib,Primary Series,States/Local Areas,Florida,2015,Age,35 Months,92.8,88.1 to 96.1,309
Hib,Primary Series,States/Local Areas,Florida,2015-2016,Age,35 Months,93.1,90.0 to 95.5,658
Hib,Primary Series,States/Local Areas,Florida,2017,Age,35 Months,94.6,90.1 to 97.4,374
Hib,Primary Series,States/Local Areas,Florida,2017-2018,Age,35 Months,93.2,89.0 to 96.2,698
Hib,Full Series,States/Local Areas,Florida,2014,Age,24 Months,81.3,74.4 to 87.3,274
Hib,Full Series,States/Local Areas,Florida,2014-2015,Age,24 Months,80.0,75.2 to 84.5,583
Hib,Full Series,States/Local Areas,Florida,2013,Age,24 Months,79.8,72.9 to 85.9,272
Hib,Full Series,States/Local Areas,Florida,2013-2014,Age,24 Months,80.6,75.8 to 85.0,546
Hib,Full Series,States/Local Areas,Florida,2012,Age,24 Months,82.9,75.6 to 89.0,240
Hib,Full Series,States/Local Areas,Florida,2011,Age,24 Months,78.3,70.3 to 85.5,236
Hib,Primary Series,States/Local Areas,Florida,2016,Age,24 Months,93.5,88.9 to 96.6,349
Hib,Primary Series,States/Local Areas,Florida,2016-2017,Age,24 Months,93.6,90.7 to 95.9,723
Hib,Primary Series,States/Local Areas,Florida,2015,Age,24 Months,91.4,86.6 to 95.0,309
Hib,Primary Series,States/Local Areas,Florida,2015-2016,Age,24 Months,92.5,89.4 to 95.0,658
Hib,Primary Series,States/Local Areas,Florida,2014,Age,24 Months,88.4,82.0 to 93.4,274
Hib,Primary Series,States/Local Areas,Florida,2014-2015,Age,24 Months,90.0,86.1 to 93.1,583
Polio,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,91.5,88.9 to 93.5,3492
Hib,Full Series,HHS Regions/National,Region 6,2020-2021,Age,19 Months,72.4,68.6 to 75.9,3492
PCV,≥1 Dose,HHS Regions/National,Region 6,2021,Age,3 Months,86.3,80.7 to 90.4,1286
Hib,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,5 Months,73.5,69.2 to 77.4,3492
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020-2021,Age,19 Months,89.2,87.0 to 91.0,3492
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,90.3,88.0 to 92.3,3492
PCV,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,68.1,63.9 to 72.1,3492
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 6,2020-2021,Age,0-1 Days,79.1,75.7 to 82.1,3492
Rotavirus,,HHS Regions/National,Region 6,2020-2021,Age,8 Months,75.7,72.0 to 79.1,3492
Hib,Primary Series,HHS Regions/National,Region 6,2020-2021,Age,35 Months,91.5,88.8 to 93.8,3492
Hib,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,90.8,88.1 to 93.1,3492
Hib,Full Series,HHS Regions/National,Region 6,2020-2021,Age,35 Months,81.3,77.5 to 84.8,3492
Influenza,,HHS Regions/National,Region 6,2019,Age,24 Months,54.3,50.1 to 58.5,2266
Hep B,≥3 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,89.1,84.1 to 92.7,1286
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 6,2020-2021,Age,0-2 Days,80.7,77.4 to 83.6,3492
Hib,Primary Series,HHS Regions/National,Region 6,2020-2021,Age,19 Months,90.5,87.7 to 92.7,3492
Hep A,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,19 Months,86.2,83.7 to 88.3,3492
DTaP,≥2 Doses,HHS Regions/National,Region 6,2021,Age,5 Months,77.4,70.8 to 82.9,1286
Influenza,,HHS Regions/National,Region 6,2021,Age,24 Months,45.9,39.4 to 53.0,1286
Hib,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,85.6,82.0 to 88.6,3492
Hib,Full Series,HHS Regions/National,Region 6,2020-2021,Age,24 Months,77.9,74.2 to 81.3,3492
Influenza,,HHS Regions/National,Region 6,2018,Age,24 Months,53.8,50.4 to 57.4,2533
Influenza,,HHS Regions/National,Region 6,2018-2019,Age,24 Months,54.0,51.3 to 56.8,4799
Influenza,,HHS Regions/National,Region 6,2017,Age,24 Months,49.9,46.9 to 53.0,2732
Influenza,,HHS Regions/National,Region 6,2017-2018,Age,24 Months,51.9,49.6 to 54.2,5265
Influenza,,HHS Regions/National,Region 6,2016,Age,24 Months,50.5,47.8 to 53.2,2855
Influenza,,HHS Regions/National,Region 6,2016-2017,Age,24 Months,50.2,48.2 to 52.3,5587
Polio,≥2 Doses,HHS Regions/National,Region 6,2021,Age,5 Months,77.1,70.5 to 82.6,1286
≥1 Dose Varicella,,HHS Regions/National,Region 6,2021,Age,13 Months,67.4,60.9 to 73.4,1286
≥1 Dose MMR,,HHS Regions/National,Region 6,2020-2021,Age,13 Months,70.2,66.4 to 73.7,3492
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,89.0,86.3 to 91.2,3492
≥1 Dose MMR,,HHS Regions/National,Region 6,2021,Age,19 Months,92.1,89.6 to 94.1,1286
Hep A,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,19 Months,31.0,27.1 to 35.1,3492
Hep B,≥2 Doses,HHS Regions/National,Region 6,2021,Age,5 Months,87.9,82.4 to 91.9,1286
Polio,≥3 Doses,HHS Regions/National,Region 6,2021,Age,19 Months,92.4,88.9 to 94.9,1286
Combined 7 Series,,HHS Regions/National,Region 6,2021,Age,24 Months,68.6,62.2 to 74.8,1286
Rotavirus,,HHS Regions/National,Region 6,2018,Age,8 Months,77.1,74.1 to 79.9,2533
Rotavirus,,HHS Regions/National,Region 6,2018-2019,Age,8 Months,76.5,74.1 to 78.6,4799
Rotavirus,,HHS Regions/National,Region 6,2019,Age,8 Months,75.8,72.1 to 79.1,2266
Rotavirus,,HHS Regions/National,Region 6,2017,Age,8 Months,70.0,67.1 to 72.8,2732
Rotavirus,,HHS Regions/National,Region 6,2017-2018,Age,8 Months,73.5,71.5 to 75.5,5265
Rotavirus,,HHS Regions/National,Region 6,2013,Age,8 Months,70.2,67.3 to 72.9,2273
Rotavirus,,HHS Regions/National,Region 6,2013-2014,Age,8 Months,70.6,68.7 to 72.4,4660
Rotavirus,,HHS Regions/National,Region 6,2012,Age,8 Months,69.8,66.9 to 72.6,2367
Rotavirus,,HHS Regions/National,Region 6,2011,Age,8 Months,67.2,63.7 to 70.6,2229
Rotavirus,,HHS Regions/National,Region 6,2014,Age,8 Months,71.0,68.4 to 73.5,2387
Rotavirus,,HHS Regions/National,Region 6,2014-2015,Age,8 Months,72.1,70.4 to 73.8,5094
Rotavirus,,HHS Regions/National,Region 6,2016,Age,8 Months,72.7,70.2 to 75.1,2855
Rotavirus,,HHS Regions/National,Region 6,2016-2017,Age,8 Months,71.4,69.5 to 73.2,5587
Rotavirus,,HHS Regions/National,Region 6,2015,Age,8 Months,73.2,70.8 to 75.5,2707
Rotavirus,,HHS Regions/National,Region 6,2015-2016,Age,8 Months,73.0,71.2 to 74.6,5562
≥1 Dose Varicella,,HHS Regions/National,Region 6,2020-2021,Age,13 Months,67.7,63.9 to 71.4,3492
≥1 Dose MMR,,HHS Regions/National,Region 6,2020-2021,Age,19 Months,89.5,87.4 to 91.3,3492
Hep B,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,3 Months,96.1,94.8 to 97.0,3492
≥1 Dose MMR,,HHS Regions/National,Region 6,2021,Age,13 Months,70.8,64.5 to 76.5,1286
Hep A,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,24 Months,90.3,88.1 to 92.2,3492
Hib,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,57.3,52.9 to 61.5,3492
PCV,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,3 Months,83.8,80.4 to 86.7,3492
PCV,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,13 Months,87.3,84.6 to 89.6,3492
Hib,≥2 Doses,HHS Regions/National,Region 6,2021,Age,13 Months,91.0,85.8 to 94.5,1286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 6,2021,Age,0-3 Days,81.2,75.5 to 85.8,1286
Rotavirus,,HHS Regions/National,Region 6,2021,Age,8 Months,77.3,71.2 to 82.4,1286
Hep A,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,35 Months,78.3,73.5 to 82.7,3492
Polio,≥1 Dose,HHS Regions/National,Region 6,2020-2021,Age,3 Months,84.8,81.4 to 87.6,3492
Hib,≥3 Doses,HHS Regions/National,Region 6,2021,Age,35 Months,91.3,86.7 to 94.7,1286
DTaP,≥3 Doses,HHS Regions/National,Region 6,2021,Age,24 Months,93.3,90.0 to 95.8,1286
DTaP,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,7 Months,70.7,66.5 to 74.6,3492
Hep B,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,91.2,88.9 to 93.1,3492
DTaP,≥2 Doses,HHS Regions/National,Region 6,2020-2021,Age,5 Months,77.2,73.1 to 80.8,3492
Hib,Primary Series,HHS Regions/National,Region 6,2021,Age,35 Months,92.0,87.4 to 95.4,1286
Hib,Primary Series,HHS Regions/National,Region 6,2020-2021,Age,7 Months,68.4,64.1 to 72.4,3492
Polio,≥3 Doses,HHS Regions/National,Region 6,2020-2021,Age,24 Months,91.8,89.6 to 93.7,3492
Hep B,≥2 Doses,HHS Regions/National,Region 6,2019-2020,Age,7 Months,90.6,88.6 to 92.4,4472
Combined 7 Series,,HHS Regions/National,Region 6,2019,Age,24 Months,69.5,65.6 to 73.3,2266
Hib,Primary Series,HHS Regions/National,Region 6,2018,Age,35 Months,93.1,91.1 to 94.9,2533
Hib,Primary Series,HHS Regions/National,Region 6,2018-2019,Age,35 Months,93.8,92.3 to 95.0,4799
Combined 7 Series,,HHS Regions/National,Region 6,2015,Age,24 Months,66.1,63.6 to 68.6,2707
Combined 7 Series,,HHS Regions/National,Region 6,2015-2016,Age,24 Months,66.8,65.0 to 68.6,5562
Combined 7 Series,,HHS Regions/National,Region 6,2014,Age,24 Months,67.8,65.1 to 70.5,2387
Combined 7 Series,,HHS Regions/National,Region 6,2014-2015,Age,24 Months,67.0,65.1 to 68.8,5094
Hib,Primary Series,HHS Regions/National,Region 6,2019,Age,35 Months,94.6,92.4 to 96.3,2266
Combined 7 Series,,HHS Regions/National,Region 6,2016,Age,24 Months,67.5,64.9 to 70.1,2855
Combined 7 Series,,HHS Regions/National,Region 6,2016-2017,Age,24 Months,67.3,65.3 to 69.2,5587
Hib,Primary Series,HHS Regions/National,Region 6,2017,Age,35 Months,90.7,88.6 to 92.6,2732
Hib,Primary Series,HHS Regions/National,Region 6,2017-2018,Age,35 Months,91.9,90.5 to 93.2,5265
Hib,Primary Series,HHS Regions/National,Region 6,2017,Age,19 Months,89.1,87.0 to 91.0,2732
Hib,Primary Series,HHS Regions/National,Region 6,2017-2018,Age,19 Months,90.6,89.1 to 91.9,5265
Hib,Primary Series,HHS Regions/National,Region 6,2015,Age,19 Months,92.2,90.4 to 93.6,2707
Hib,Primary Series,HHS Regions/National,Region 6,2015-2016,Age,19 Months,91.4,90.2 to 92.4,5562
Hib,Primary Series,HHS Regions/National,Region 6,2014,Age,19 Months,89.7,87.7 to 91.3,2387
Hib,Primary Series,HHS Regions/National,Region 6,2014-2015,Age,19 Months,90.9,89.7 to 92.0,5094
Hib,Primary Series,HHS Regions/National,Region 6,2013,Age,19 Months,90.5,89.0 to 91.9,2273
Hib,Primary Series,HHS Regions/National,Region 6,2013-2014,Age,19 Months,90.1,88.7 to 91.3,4660
Hib,Primary Series,HHS Regions/National,Region 6,2011,Age,19 Months,92.1,89.1 to 94.4,2229
Hib,Primary Series,HHS Regions/National,Region 6,2018,Age,13 Months,87.6,84.9 to 89.8,2533
Hib,Primary Series,HHS Regions/National,Region 6,2018-2019,Age,13 Months,87.6,85.7 to 89.3,4799
Hib,Primary Series,HHS Regions/National,Region 6,2017,Age,13 Months,84.6,82.2 to 86.8,2732
Hib,Primary Series,HHS Regions/National,Region 6,2017-2018,Age,13 Months,86.1,84.3 to 87.7,5265
Hib,Primary Series,HHS Regions/National,Region 6,2019,Age,13 Months,87.7,84.8 to 90.1,2266
Hib,Primary Series,HHS Regions/National,Region 6,2014,Age,7 Months,67.1,64.4 to 69.7,2387
Hib,Primary Series,HHS Regions/National,Region 6,2014-2015,Age,7 Months,68.9,67.1 to 70.6,5094
Hib,Primary Series,HHS Regions/National,Region 6,2015,Age,7 Months,70.7,68.2 to 73.0,2707
Hib,Primary Series,HHS Regions/National,Region 6,2015-2016,Age,7 Months,69.5,67.7 to 71.2,5562
Hib,Primary Series,HHS Regions/National,Region 6,2013,Age,7 Months,65.4,61.6 to 69.1,2273
Hib,Primary Series,HHS Regions/National,Region 6,2013-2014,Age,7 Months,66.3,64.1 to 68.3,4660
Hib,Primary Series,HHS Regions/National,Region 6,2013,Age,13 Months,85.5,83.6 to 87.1,2273
Hib,Primary Series,HHS Regions/National,Region 6,2013-2014,Age,13 Months,85.4,84.0 to 86.6,4660
Hib,Primary Series,HHS Regions/National,Region 6,2012,Age,13 Months,86.8,85.2 to 88.3,2367
Hib,Primary Series,HHS Regions/National,Region 6,2011,Age,13 Months,88.0,84.2 to 91.0,2229
Hib,Primary Series,HHS Regions/National,Region 6,2016,Age,13 Months,85.2,83.0 to 87.1,2855
Hib,Primary Series,HHS Regions/National,Region 6,2016-2017,Age,13 Months,84.9,83.3 to 86.4,5587
Hib,Primary Series,HHS Regions/National,Region 6,2018,Age,7 Months,74.4,71.2 to 77.3,2533
Hib,Primary Series,HHS Regions/National,Region 6,2018-2019,Age,7 Months,73.6,71.1 to 75.9,4799
Hib,Primary Series,HHS Regions/National,Region 6,2013,Age,24 Months,91.0,89.1 to 92.6,2273
Hib,Primary Series,HHS Regions/National,Region 6,2013-2014,Age,24 Months,91.1,89.9 to 92.3,4660
Hib,Primary Series,HHS Regions/National,Region 6,2014,Age,13 Months,85.3,83.1 to 87.2,2387
Hib,Primary Series,HHS Regions/National,Region 6,2014-2015,Age,13 Months,86.6,85.2 to 87.9,5094
Hib,Primary Series,HHS Regions/National,Region 6,2015,Age,13 Months,87.9,86.1 to 89.5,2707
Hib,Primary Series,HHS Regions/National,Region 6,2015-2016,Age,13 Months,86.5,85.2 to 87.8,5562
Hib,Primary Series,HHS Regions/National,Region 6,2016,Age,7 Months,68.2,65.6 to 70.7,2855
Hib,Primary Series,HHS Regions/National,Region 6,2016-2017,Age,7 Months,69.0,67.1 to 70.9,5587
Hib,Primary Series,HHS Regions/National,Region 6,2017,Age,7 Months,69.9,67.0 to 72.6,2732
Hib,Primary Series,HHS Regions/National,Region 6,2017-2018,Age,7 Months,72.1,70.0 to 74.1,5265
Hib,Primary Series,HHS Regions/National,Region 6,2019,Age,7 Months,72.8,68.9 to 76.3,2266
Hib,Primary Series,HHS Regions/National,Region 6,2017,Age,24 Months,89.7,87.6 to 91.5,2732
Hib,Primary Series,HHS Regions/National,Region 6,2017-2018,Age,24 Months,91.2,89.8 to 92.5,5265
Hib,Primary Series,HHS Regions/National,Region 6,2014,Age,24 Months,91.3,89.6 to 92.9,2387
Hib,Primary Series,HHS Regions/National,Region 6,2014-2015,Age,24 Months,92.2,91.1 to 93.2,5094
Hib,Primary Series,HHS Regions/National,Region 6,2015,Age,24 Months,93.1,91.7 to 94.3,2707
Hib,Primary Series,HHS Regions/National,Region 6,2015-2016,Age,24 Months,92.2,91.1 to 93.2,5562
Combined 7 Series,,HHS Regions/National,Region 6,2013,Age,24 Months,65.6,62.7 to 68.4,2273
Combined 7 Series,,HHS Regions/National,Region 6,2013-2014,Age,24 Months,66.7,64.7 to 68.6,4660
Combined 7 Series,,HHS Regions/National,Region 6,2011,Age,24 Months,66.3,62.7 to 69.8,2229
Combined 7 Series,,HHS Regions/National,Region 6,2012,Age,24 Months,68.5,65.5 to 71.5,2367
Hib,Primary Series,HHS Regions/National,Region 6,2015,Age,35 Months,94.6,93.1 to 95.9,2707
Hib,Primary Series,HHS Regions/National,Region 6,2015-2016,Age,35 Months,93.6,92.5 to 94.7,5562
Combined 7 Series,,HHS Regions/National,Region 6,2013,Age,35 Months,70.8,67.8 to 73.7,2273
Combined 7 Series,,HHS Regions/National,Region 6,2013-2014,Age,35 Months,72.6,70.6 to 74.7,4660
Hib,Primary Series,HHS Regions/National,Region 6,2016,Age,35 Months,92.6,90.8 to 94.2,2855
Hib,Primary Series,HHS Regions/National,Region 6,2016-2017,Age,35 Months,91.7,90.3 to 93.0,5587
Combined 7 Series,,HHS Regions/National,Region 6,2018,Age,24 Months,65.6,62.2 to 69.0,2533
Combined 7 Series,,HHS Regions/National,Region 6,2018-2019,Age,24 Months,67.6,65.0 to 70.1,4799
Combined 7 Series,,HHS Regions/National,Region 6,2017,Age,24 Months,67.0,64.1 to 70.0,2732
Combined 7 Series,,HHS Regions/National,Region 6,2017-2018,Age,24 Months,66.3,64.1 to 68.6,5265
Combined 7 Series,,HHS Regions/National,Region 6,2014,Age,35 Months,74.4,71.6 to 77.2,2387
Combined 7 Series,,HHS Regions/National,Region 6,2014-2015,Age,35 Months,74.3,72.2 to 76.4,5094
Combined 7 Series,,HHS Regions/National,Region 6,2012,Age,35 Months,74.2,71.1 to 77.2,2367
Hib,Primary Series,HHS Regions/National,Region 6,2016,Age,24 Months,91.3,89.5 to 92.8,2855
Hib,Primary Series,HHS Regions/National,Region 6,2016-2017,Age,24 Months,90.5,89.1 to 91.7,5587
Hib,Primary Series,HHS Regions/National,Region 6,2018,Age,24 Months,92.8,90.8 to 94.5,2533
Hib,Primary Series,HHS Regions/National,Region 6,2018-2019,Age,24 Months,92.4,90.9 to 93.7,4799
Hib,Primary Series,HHS Regions/National,Region 6,2014,Age,35 Months,92.3,90.5 to 93.9,2387
Hib,Primary Series,HHS Regions/National,Region 6,2014-2015,Age,35 Months,93.5,92.3 to 94.5,5094
Hib,Primary Series,HHS Regions/National,Region 6,2012,Age,35 Months,93.7,91.8 to 95.4,2367
Hib,Primary Series,HHS Regions/National,Region 6,2019,Age,24 Months,92.0,89.6 to 94.0,2266
Hib,Primary Series,HHS Regions/National,Region 6,2011,Age,35 Months,93.5,91.4 to 95.2,2229
Hib,Primary Series,HHS Regions/National,Region 6,2013,Age,35 Months,92.9,91.0 to 94.5,2273
Hib,Primary Series,HHS Regions/National,Region 6,2013-2014,Age,35 Months,92.6,91.3 to 93.8,4660
Combined 7 Series,,HHS Regions/National,Region 6,2017,Age,35 Months,71.7,68.6 to 74.8,2732
Combined 7 Series,,HHS Regions/National,Region 6,2017-2018,Age,35 Months,71.7,69.3 to 74.1,5265
Combined 7 Series,,HHS Regions/National,Region 6,2016,Age,35 Months,73.2,70.5 to 75.8,2855
Combined 7 Series,,HHS Regions/National,Region 6,2016-2017,Age,35 Months,72.5,70.4 to 74.5,5587
Hib,Full Series,HHS Regions/National,Region 6,2014,Age,24 Months,78.4,76.0 to 80.8,2387
Hib,Full Series,HHS Regions/National,Region 6,2014-2015,Age,24 Months,79.0,77.4 to 80.6,5094
Hib,Full Series,HHS Regions/National,Region 6,2013,Age,24 Months,77.5,74.9 to 79.9,2273
Hib,Primary Series,HHS Regions/National,Region 6,2019,Age,19 Months,91.3,88.8 to 93.3,2266
Hib,Primary Series,HHS Regions/National,Region 6,2012,Age,24 Months,92.7,90.8 to 94.3,2367
Hib,Primary Series,HHS Regions/National,Region 6,2011,Age,24 Months,92.9,90.9 to 94.7,2229
Hib,Primary Series,HHS Regions/National,Region 6,2016,Age,19 Months,90.6,88.8 to 92.1,2855
Hib,Primary Series,HHS Regions/National,Region 6,2016-2017,Age,19 Months,89.9,88.5 to 91.1,5587
Hib,Primary Series,HHS Regions/National,Region 6,2012,Age,19 Months,91.5,90.1 to 92.6,2367
Combined 7 Series,,HHS Regions/National,Region 6,2011,Age,35 Months,72.2,68.3 to 76.0,2229
Hib,Primary Series,HHS Regions/National,Region 6,2018,Age,19 Months,92.0,89.9 to 93.8,2533
Hib,Primary Series,HHS Regions/National,Region 6,2018-2019,Age,19 Months,87.6,85.7 to 89.3,4799
Influenza,,States/Local Areas,Alabama,2011,Age,24 Months,45.1,36.5 to 54.6,218
Influenza,,States/Local Areas,Alabama,2012,Age,24 Months,40.4,32.1 to 50.0,233
Influenza,,States/Local Areas,Alabama,2014,Age,24 Months,47.1,39.6 to 55.2,276
Influenza,,States/Local Areas,Alabama,2014-2015,Age,24 Months,44.8,39.4 to 50.6,563
Influenza,,States/Local Areas,Alabama,2015,Age,24 Months,42.4,35.0 to 50.8,287
Influenza,,States/Local Areas,Alabama,2015-2016,Age,24 Months,39.6,34.5 to 45.2,596
Influenza,,States/Local Areas,Alabama,2016,Age,24 Months,36.8,30.1 to 44.4,309
Influenza,,States/Local Areas,Alabama,2016-2017,Age,24 Months,35.9,31.0 to 41.5,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2019,Age,19 Months,95.7,91.4 to 97.9,227
Influenza,,States/Local Areas,Alabama,2013,Age,24 Months,41.5,34.0 to 49.8,260
Influenza,,States/Local Areas,Alabama,2013-2014,Age,24 Months,44.3,38.9 to 50.1,536
Hep B,≥1 Dose,States/Local Areas,Alabama,2021,Age,3 Months,96.4,88.7 to 98.9,160
DTaP,≥3 Doses,States/Local Areas,Alabama,2016,Age,13 Months,89.3,83.6 to 93.1,309
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,91.8,88.5 to 94.2,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2017,Age,13 Months,94.3,90.2 to 96.8,259
DTaP,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,90.8,86.5 to 93.8,491
Polio,≥3 Doses,States/Local Areas,Alabama,2016,Age,19 Months,89.6,84.0 to 93.4,309
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,91.6,87.9 to 94.2,568
Polio,≥3 Doses,States/Local Areas,Alabama,2017,Age,19 Months,93.6,88.0 to 96.7,259
Polio,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,92.6,87.9 to 95.5,491
Polio,≥3 Doses,States/Local Areas,Alabama,2018,Age,19 Months,91.5,85.1 to 95.4,232
Polio,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,63.7,57.5 to 69.5,459
Hib,≥3 Doses,States/Local Areas,Alabama,2018,Age,13 Months,70.7,61.5 to 78.5,232
Hib,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,75.1,69.2 to 80.3,459
Hib,≥3 Doses,States/Local Areas,Alabama,2019,Age,13 Months,79.5,71.8 to 85.5,227
Hib,≥3 Doses,States/Local Areas,Alabama,2011,Age,19 Months,91.4,87.7 to 94.1,218
Hib,≥3 Doses,States/Local Areas,Alabama,2012,Age,19 Months,93.3,86.3 to 96.9,233
Hib,≥3 Doses,States/Local Areas,Alabama,2013,Age,19 Months,92.0,85.8 to 95.6,260
Hib,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,93.4,88.4 to 96.3,536
Polio,≥3 Doses,States/Local Areas,Alabama,2012,Age,19 Months,92.3,87.8 to 95.2,233
Polio,≥3 Doses,States/Local Areas,Alabama,2013,Age,19 Months,91.2,84.6 to 95.1,260
Polio,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,92.1,86.7 to 95.4,536
Polio,≥3 Doses,States/Local Areas,Alabama,2014,Age,19 Months,93.0,88.2 to 96.0,276
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,92.7,89.3 to 95.0,563
DTaP,≥3 Doses,States/Local Areas,Alabama,2019,Age,13 Months,92.1,86.3 to 95.5,227
DTaP,≥3 Doses,States/Local Areas,Alabama,2011,Age,19 Months,91.5,87.6 to 94.2,218
DTaP,≥3 Doses,States/Local Areas,Alabama,2012,Age,19 Months,96.1,90.0 to 98.5,233
DTaP,≥3 Doses,States/Local Areas,Alabama,2013,Age,19 Months,93.6,88.3 to 96.6,260
DTaP,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,94.5,90.3 to 96.9,536
DTaP,≥3 Doses,States/Local Areas,Alabama,2018,Age,13 Months,87.2,79.4 to 92.4,232
DTaP,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,89.7,85.0 to 93.0,459
Polio,≥3 Doses,States/Local Areas,Alabama,2015,Age,19 Months,92.3,89.2 to 94.6,287
Polio,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,91.0,87.3 to 93.6,596
Hib,≥3 Doses,States/Local Areas,Alabama,2016,Age,13 Months,76.6,69.8 to 82.2,309
Hib,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,79.7,74.9 to 83.8,568
Hib,≥3 Doses,States/Local Areas,Alabama,2017,Age,13 Months,82.9,75.7 to 88.3,259
Hib,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,76.9,70.8 to 82.0,491
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,96.5,93.8 to 99.1,500
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,94.0,91.5 to 96.4,453
Hib,≥2 Doses,States/Local Areas,Alabama,2017,Age,13 Months,95.1,89.5 to 97.8,259
Hib,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,93.5,88.6 to 96.4,491
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.2,91.3 to 99.1,132
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,96.2,92.6 to 99.8,106
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,85.2 to 99.6,103
Hib,≥3 Doses,States/Local Areas,Alabama,2017,Age,7 Months,66.8,58.3 to 74.4,259
Hib,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,60.5,54.2 to 66.5,491
Hib,≥3 Doses,States/Local Areas,Alabama,2018,Age,7 Months,54.0,45.2 to 62.7,232
Hib,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,57.5,51.3 to 63.4,459
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,90.8 to 96.0,701
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,93.9,91.0 to 96.8,432
Hib,≥3 Doses,States/Local Areas,Alabama,2019,Age,7 Months,60.9,52.5 to 68.6,227
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.3,89.8 to 96.8,401
Hib,≥3 Doses,States/Local Areas,Alabama,2011,Age,13 Months,86.5,81.5 to 90.3,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.3,74.0 to 92.7,103
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.9,78.2 to 85.6,701
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,82.7,77.7 to 87.6,432
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.6,75.8 to 85.4,401
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,81.6,74.3 to 89.0,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Overall,Overall,81.7,78.6 to 84.8,1042
DTaP,≥3 Doses,States/Local Areas,Alabama,2013,Age,13 Months,88.7,84.9 to 91.6,260
DTaP,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,90.9,86.3 to 94.1,536
DTaP,≥3 Doses,States/Local Areas,Alabama,2014,Age,13 Months,93.2,88.4 to 96.1,276
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,92.3,88.9 to 94.7,563
DTaP,≥3 Doses,States/Local Areas,Alabama,2012,Age,13 Months,95.2,90.3 to 97.7,233
DTaP,≥3 Doses,States/Local Areas,Alabama,2015,Age,13 Months,91.4,86.0 to 94.8,287
DTaP,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,90.3,86.7 to 93.1,596
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,95.7,92.5 to 98.9,209
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,94.1,92.2 to 96.0,1042
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,92.4,89.2 to 95.6,370
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,94.3,91.1 to 97.6,415
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,98.1,96.6 to 99.6,257
Polio,≥3 Doses,States/Local Areas,Alabama,2011,Age,19 Months,90.2,87.6 to 92.3,218
Hib,≥3 Doses,States/Local Areas,Alabama,2013,Age,13 Months,78.4,72.8 to 83.1,260
Hib,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,81.4,77.6 to 84.8,536
Hib,≥3 Doses,States/Local Areas,Alabama,2014,Age,13 Months,84.5,78.1 to 89.2,276
Hib,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,81.8,77.3 to 85.6,563
Hib,≥3 Doses,States/Local Areas,Alabama,2012,Age,13 Months,87.9,83.6 to 91.1,233
Hib,≥3 Doses,States/Local Areas,Alabama,2015,Age,13 Months,79.2,72.2 to 84.8,287
Hib,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,77.9,73.2 to 82.0,596
Hib,≥2 Doses,States/Local Areas,Alabama,2015,Age,13 Months,94.5,90.1 to 97.0,287
Hib,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,93.6,90.5 to 95.7,596
Hib,≥2 Doses,States/Local Areas,Alabama,2016,Age,13 Months,92.7,87.8 to 95.7,309
Hib,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,93.9,90.6 to 96.1,568
Hib,≥2 Doses,States/Local Areas,Alabama,2019,Age,7 Months,89.5,82.9 to 93.7,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,78.8,73.6 to 84.1,370
Hib,≥2 Doses,States/Local Areas,Alabama,2018,Age,13 Months,91.9,84.7 to 95.9,232
Hib,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,93.9,90.0 to 96.4,459
Hib,≥2 Doses,States/Local Areas,Alabama,2019,Age,13 Months,96.0,91.7 to 98.1,227
Hib,≥2 Doses,States/Local Areas,Alabama,2020,Age,13 Months,92.8,87.1 to 96.1,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,83.0,78.2 to 87.9,415
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,86.7,81.9 to 91.4,257
Hib,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,89.4,86.4 to 91.9,536
Hib,≥2 Doses,States/Local Areas,Alabama,2014,Age,7 Months,91.2,85.0 to 95.0,276
Hib,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,90.4,86.5 to 93.3,563
Hib,≥2 Doses,States/Local Areas,Alabama,2015,Age,7 Months,89.7,84.1 to 93.5,287
Hib,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,88.9,85.2 to 91.8,596
Hib,≥2 Doses,States/Local Areas,Alabama,2016,Age,7 Months,88.2,82.5 to 92.2,309
Hib,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,88.8,84.7 to 92.0,568
PCV,≥3 Doses,States/Local Areas,Alabama,2019,Age,24 Months,97.6,95.1 to 99.0,227
PCV,≥3 Doses,States/Local Areas,Alabama,2011,Age,35 Months,91.5,84.3 to 96.2,218
PCV,≥3 Doses,States/Local Areas,Alabama,2013,Age,35 Months,94.8,90.4 to 97.6,260
PCV,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,96.2,93.5 to 98.1,536
PCV,≥3 Doses,States/Local Areas,Alabama,2012,Age,35 Months,95.9,90.3 to 98.8,233
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,91.1,84.1 to 98.2,106
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,92.4,90.3 to 94.5,1042
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,89.5,85.6 to 93.5,370
PCV,≥1 Dose,States/Local Areas,Alabama,2019,Age,3 Months,93.7,89.3 to 96.3,227
Polio,≥1 Dose,States/Local Areas,Alabama,2011,Age,3 Months,87.4,81.2 to 91.8,218
Polio,≥1 Dose,States/Local Areas,Alabama,2012,Age,3 Months,91.0,89.7 to 92.1,233
Polio,≥1 Dose,States/Local Areas,Alabama,2013,Age,3 Months,87.6,82.2 to 91.5,260
Polio,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,3 Months,87.5,82.3 to 91.3,536
Polio,≥1 Dose,States/Local Areas,Alabama,2014,Age,3 Months,87.4,81.0 to 91.8,276
Polio,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,3 Months,86.5,82.1 to 90.0,563
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014,Age,0-3 Days,88.1,82.1 to 92.2,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2015,Age,0-3 Days,83.2,78.8 to 86.9,563
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2015,Age,0-3 Days,78.4,71.5 to 84.1,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2015-2016,Age,0-3 Days,78.8,74.1 to 82.9,596
DTaP,≥3 Doses,States/Local Areas,Alabama,2011,Age,7 Months,74.0,67.1 to 80.0,218
DTaP,≥3 Doses,States/Local Areas,Alabama,2012,Age,7 Months,78.9,75.9 to 81.6,233
DTaP,≥3 Doses,States/Local Areas,Alabama,2013,Age,7 Months,69.5,61.8 to 76.3,260
DTaP,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,72.4,67.5 to 76.8,536
Hib,≥2 Doses,States/Local Areas,Alabama,2018,Age,7 Months,81.8,72.7 to 88.3,232
Hib,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,85.6,80.2 to 89.8,459
PCV,≥3 Doses,States/Local Areas,Alabama,2014,Age,35 Months,97.9,93.7 to 99.5,276
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,97.0,94.3 to 98.6,563
PCV,≥3 Doses,States/Local Areas,Alabama,2015,Age,35 Months,95.2,91.4 to 97.7,287
PCV,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,94.0,91.0 to 96.2,596
PCV,≥3 Doses,States/Local Areas,Alabama,2016,Age,35 Months,92.6,87.8 to 96.0,309
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,94.4,91.6 to 96.5,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2014,Age,7 Months,75.2,68.0 to 81.3,276
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,72.3,67.1 to 77.0,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,94.7,92.4 to 97.1,415
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,95.3,92.8 to 97.7,257
Hib,≥3 Doses,States/Local Areas,Alabama,2011,Age,7 Months,71.3,64.5 to 77.3,218
Hib,≥3 Doses,States/Local Areas,Alabama,2012,Age,7 Months,73.0,65.7 to 79.2,233
Hib,≥3 Doses,States/Local Areas,Alabama,2013,Age,7 Months,57.3,52.3 to 62.0,260
Hib,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,62.4,59.3 to 65.3,536
Polio,≥1 Dose,States/Local Areas,Alabama,2015,Age,3 Months,85.7,79.0 to 90.5,287
Polio,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,3 Months,86.0,81.8 to 89.4,596
Polio,≥1 Dose,States/Local Areas,Alabama,2016,Age,3 Months,86.4,80.6 to 90.7,309
Polio,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,3 Months,85.8,81.0 to 89.6,568
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016,Age,0-3 Days,79.3,72.8 to 84.5,309
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2017,Age,0-3 Days,80.7,76.0 to 84.7,568
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2017,Age,0-3 Days,84.4,75.6 to 90.4,170
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2017-2018,Age,0-3 Days,79.8,74.4 to 84.3,491
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2018,Age,0-3 Days,77.4,69.2 to 83.9,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2018-2019,Age,0-3 Days,80.4,75.0 to 84.9,459
DTaP,≥3 Doses,States/Local Areas,Alabama,2015,Age,7 Months,69.4,61.5 to 76.3,287
DTaP,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,69.5,64.0 to 74.5,596
DTaP,≥3 Doses,States/Local Areas,Alabama,2016,Age,7 Months,69.7,62.1 to 76.3,309
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,71.5,65.9 to 76.5,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2017,Age,7 Months,73.4,64.8 to 80.5,259
DTaP,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,68.5,62.1 to 74.3,491
Hib,≥2 Doses,States/Local Areas,Alabama,2011,Age,13 Months,90.8,85.7 to 94.2,218
Hib,≥2 Doses,States/Local Areas,Alabama,2012,Age,13 Months,96.3,92.1 to 98.3,233
Hib,≥2 Doses,States/Local Areas,Alabama,2013,Age,13 Months,96.4,91.6 to 98.5,260
Hib,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,96.7,93.6 to 98.3,536
PCV,≥3 Doses,States/Local Areas,Alabama,2017,Age,35 Months,96.1,92.9 to 98.1,259
PCV,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,96.1,91.7 to 98.5,491
PCV,≥3 Doses,States/Local Areas,Alabama,2018,Age,35 Months,95.1,88.2 to 98.6,232
PCV,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.6,93.1 to 98.6,459
Hib,≥3 Doses,States/Local Areas,Alabama,2014,Age,7 Months,67.5,59.9 to 74.2,276
Hib,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,61.7,56.2 to 66.9,563
Hib,≥3 Doses,States/Local Areas,Alabama,2015,Age,7 Months,55.9,47.9 to 63.6,287
Hib,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,54.8,49.3 to 60.3,596
Hib,≥3 Doses,States/Local Areas,Alabama,2016,Age,7 Months,53.8,46.3 to 61.1,309
Hib,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,60.3,54.6 to 65.7,568
Polio,≥1 Dose,States/Local Areas,Alabama,2017,Age,3 Months,85.2,76.9 to 90.9,259
Polio,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,3 Months,86.4,80.7 to 90.6,491
Polio,≥1 Dose,States/Local Areas,Alabama,2018,Age,3 Months,87.6,80.2 to 92.5,232
Polio,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,3 Months,90.7,86.5 to 93.7,459
PCV,≥3 Doses,States/Local Areas,Alabama,2019,Age,35 Months,97.6,95.1 to 99.0,227
Hib,≥2 Doses,States/Local Areas,Alabama,2014,Age,13 Months,97.0,93.5 to 98.7,276
Hib,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,95.8,93.2 to 97.4,563
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,96.9,92.2 to 100.0,67
Polio,≥1 Dose,States/Local Areas,Alabama,2019,Age,3 Months,93.8,89.4 to 96.5,227
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,68.5,57.7 to 79.3,209
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.0 to 97.2,103
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,91.1 to 95.7,701
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,91.9,88.5 to 95.2,432
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.3,87.7 to 95.0,401
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,95.5,92.6 to 98.5,209
Hib,≥2 Doses,States/Local Areas,Alabama,2017,Age,7 Months,89.5,82.6 to 93.9,259
Hib,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,85.7,79.8 to 90.1,491
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2019,Age,0-3 Days,83.4,75.7 to 89.1,227
≥1 Dose Varicella,,States/Local Areas,Alabama,2020,Age,24 Months,94.4,90.8 to 96.9,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,87.6,78.1 to 97.1,67
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,84.0,79.8 to 88.1,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,79.4,74.7 to 84.2,453
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.5,75.2 to 89.7,132
DTaP,≥3 Doses,States/Local Areas,Alabama,2018,Age,7 Months,63.5,54.3 to 71.8,232
DTaP,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,68.6,62.4 to 74.1,459
DTaP,≥3 Doses,States/Local Areas,Alabama,2019,Age,7 Months,73.6,65.5 to 80.4,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,77.5,67.2 to 87.8,106
DTaP,≥3 Doses,States/Local Areas,Alabama,2011,Age,13 Months,89.7,85.2 to 93.0,218
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.7,72.8 to 84.7,701
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,74.6,64.1 to 85.0,432
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.1,74.6 to 87.7,401
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2016,Age,0-1 Days,77.1,70.6 to 82.5,309
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2016-2017,Age,0-1 Days,77.6,72.6 to 81.9,568
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2017,Age,0-1 Days,78.1,70.0 to 84.4,259
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2017-2018,Age,0-1 Days,74.0,68.2 to 79.1,491
PCV,≥4 Doses,States/Local Areas,Alabama,2017,Age,19 Months,79.7,71.9 to 85.8,259
PCV,≥4 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,78.0,71.7 to 83.1,491
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,76.3,70.3 to 82.2,1042
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,76.5,66.4 to 86.5,370
Hep B,≥3 Doses,States/Local Areas,Alabama,2018,Age,13 Months,89.7,82.9 to 94.0,232
Hep B,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,88.1,83.7 to 91.5,459
Hep B,≥3 Doses,States/Local Areas,Alabama,2019,Age,13 Months,86.5,80.1 to 91.1,227
Hep B,≥3 Doses,States/Local Areas,Alabama,2011,Age,19 Months,87.5,84.0 to 90.2,218
Hep B,≥3 Doses,States/Local Areas,Alabama,2012,Age,19 Months,90.7,87.2 to 93.2,233
Hep B,≥3 Doses,States/Local Areas,Alabama,2013,Age,19 Months,90.7,87.2 to 93.4,260
Hep B,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,91.2,88.7 to 93.3,536
PCV,≥3 Doses,States/Local Areas,Alabama,2016,Age,13 Months,88.7,82.8 to 92.8,309
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,90.3,86.5 to 93.2,568
Hep B,≥3 Doses,States/Local Areas,Alabama,2018,Age,24 Months,92.8,87.1 to 96.6,232
Hep B,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,92.8,89.2 to 95.6,459
Hep B,≥3 Doses,States/Local Areas,Alabama,2019,Age,24 Months,92.7,87.7 to 96.3,227
Hep B,≥3 Doses,States/Local Areas,Alabama,2011,Age,35 Months,87.5,80.4 to 93.0,218
PCV,≥4 Doses,States/Local Areas,Alabama,2012,Age,24 Months,84.4,76.3 to 90.9,233
PCV,≥4 Doses,States/Local Areas,Alabama,2013,Age,24 Months,79.6,72.3 to 86.1,260
PCV,≥4 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,82.8,78.0 to 87.0,536
PCV,≥4 Doses,States/Local Areas,Alabama,2014,Age,24 Months,85.9,79.6 to 91.0,276
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,85.0,80.7 to 88.8,563
PCV,≥4 Doses,States/Local Areas,Alabama,2015,Age,24 Months,84.3,78.0 to 89.5,287
PCV,≥4 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,83.3,79.0 to 87.3,596
≥1 Dose MMR,,States/Local Areas,Alabama,2019,Age,24 Months,95.8,91.3 to 98.4,227
≥1 Dose MMR,,States/Local Areas,Alabama,2011,Age,35 Months,89.4,81.2 to 95.1,218
≥1 Dose MMR,,States/Local Areas,Alabama,2012,Age,35 Months,96.4,91.5 to 98.9,233
≥1 Dose MMR,,States/Local Areas,Alabama,2013,Age,35 Months,96.0,92.2 to 98.2,260
≥1 Dose MMR,,States/Local Areas,Alabama,2013-2014,Age,35 Months,94.8,91.6 to 97.0,536
≥1 Dose Varicella,,States/Local Areas,Alabama,2016,Age,35 Months,94.5,90.1 to 97.4,309
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2017,Age,35 Months,94.8,92.0 to 96.9,568
≥1 Dose Varicella,,States/Local Areas,Alabama,2017,Age,35 Months,95.1,91.1 to 97.7,259
≥1 Dose Varicella,,States/Local Areas,Alabama,2017-2018,Age,35 Months,96.3,92.4 to 98.5,491
≥1 Dose Varicella,,States/Local Areas,Alabama,2018,Age,35 Months,99.4,95.9 to 100.0,232
≥1 Dose Varicella,,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.1,92.3 to 98.4,459
≥1 Dose MMR,,States/Local Areas,Alabama,2014,Age,35 Months,93.4,88.2 to 96.9,276
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2015,Age,35 Months,94.4,91.4 to 96.7,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2012,Age,35 Months,94.4,87.0 to 98.3,233
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2019,Age,0-2 Days,83.2,75.5 to 88.9,227
Hep B,≥2 Doses,States/Local Areas,Alabama,2019,Age,7 Months,90.7,84.9 to 94.4,227
Hep B,≥2 Doses,States/Local Areas,Alabama,2011,Age,13 Months,93.2,90.0 to 95.4,218
Hep B,≥2 Doses,States/Local Areas,Alabama,2012,Age,13 Months,95.7,90.5 to 98.1,233
Hep B,≥2 Doses,States/Local Areas,Alabama,2013,Age,13 Months,94.6,88.4 to 97.6,260
Hep B,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,95.4,92.3 to 97.3,536
PCV,≥3 Doses,States/Local Areas,Alabama,2017,Age,13 Months,92.0,86.4 to 95.4,259
PCV,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,89.5,84.4 to 93.0,491
PCV,≥3 Doses,States/Local Areas,Alabama,2018,Age,13 Months,86.9,79.1 to 92.1,232
PCV,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,89.3,84.7 to 92.6,459
Hib,Full Series,States/Local Areas,Alabama,2020,Age,24 Months,71.0,62.7 to 78.9,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2013,Age,35 Months,92.4,86.0 to 96.6,260
Hep B,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,93.2,89.3 to 96.1,536
Hep B,≥3 Doses,States/Local Areas,Alabama,2014,Age,35 Months,94.2,89.4 to 97.3,276
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,94.2,91.0 to 96.6,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2015,Age,35 Months,93.9,89.9 to 96.7,287
Hep B,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,92.6,89.5 to 95.0,596
PCV,≥4 Doses,States/Local Areas,Alabama,2016,Age,24 Months,82.3,75.9 to 87.8,309
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,84.1,79.6 to 88.1,568
PCV,≥4 Doses,States/Local Areas,Alabama,2017,Age,24 Months,85.9,79.2 to 91.3,259
PCV,≥4 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,84.5,79.1 to 89.2,491
PCV,≥4 Doses,States/Local Areas,Alabama,2018,Age,24 Months,83.1,75.3 to 89.6,232
PCV,≥4 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,84.3,79.2 to 88.7,459
≥1 Dose MMR,,States/Local Areas,Alabama,2015,Age,35 Months,95.1,92.2 to 97.2,287
≥1 Dose MMR,,States/Local Areas,Alabama,2015-2016,Age,35 Months,94.1,91.4 to 96.1,596
≥1 Dose MMR,,States/Local Areas,Alabama,2016,Age,35 Months,92.8,88.2 to 96.1,309
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2017,Age,35 Months,93.9,90.9 to 96.1,568
≥1 Dose MMR,,States/Local Areas,Alabama,2017,Age,35 Months,94.7,90.8 to 97.4,259
≥1 Dose MMR,,States/Local Areas,Alabama,2017-2018,Age,35 Months,96.4,93.0 to 98.4,491
≥1 Dose Varicella,,States/Local Areas,Alabama,2019,Age,35 Months,95.9,91.3 to 98.4,227
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,94.9,92.3 to 97.5,500
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,93.0,90.4 to 95.7,453
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,95.7,90.1 to 100.0,67
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.7,92.0 to 99.4,132
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,93.2,88.6 to 97.7,106
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,85.4 to 98.5,103
Hib,≥1 Dose,States/Local Areas,Alabama,2011,Age,3 Months,87.6,81.6 to 91.8,218
Hib,≥1 Dose,States/Local Areas,Alabama,2012,Age,3 Months,90.2,88.7 to 91.6,233
Hib,≥1 Dose,States/Local Areas,Alabama,2013,Age,3 Months,87.7,78.4 to 93.3,260
Hib,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,3 Months,87.9,81.9 to 92.1,536
Hib,≥1 Dose,States/Local Areas,Alabama,2014,Age,3 Months,88.1,82.0 to 92.4,276
Hib,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,3 Months,86.8,82.5 to 90.2,563
Hep B,≥2 Doses,States/Local Areas,Alabama,2014,Age,13 Months,96.3,91.9 to 98.3,276
Hep B,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,95.7,92.9 to 97.4,563
Hep B,≥2 Doses,States/Local Areas,Alabama,2015,Age,13 Months,95.0,90.8 to 97.4,287
Hep B,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,95.5,93.0 to 97.1,596
Hib,≥1 Dose,States/Local Areas,Alabama,2015,Age,3 Months,85.5,78.8 to 90.3,287
Hib,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,3 Months,85.6,81.4 to 89.1,596
Hep B,≥2 Doses,States/Local Areas,Alabama,2016,Age,13 Months,95.9,92.5 to 97.8,309
Hep B,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,96.8,94.8 to 98.0,568
PCV,≥3 Doses,States/Local Areas,Alabama,2019,Age,13 Months,91.7,85.9 to 95.2,227
PCV,≥3 Doses,States/Local Areas,Alabama,2011,Age,19 Months,90.6,87.3 to 93.1,218
PCV,≥3 Doses,States/Local Areas,Alabama,2013,Age,19 Months,92.3,85.2 to 96.1,260
PCV,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,93.6,89.7 to 96.1,536
PCV,≥3 Doses,States/Local Areas,Alabama,2014,Age,19 Months,95.0,89.9 to 97.6,276
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,94.3,91.1 to 96.4,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2016,Age,35 Months,91.3,86.5 to 94.9,309
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,92.6,89.3 to 95.2,568
Hep B,≥3 Doses,States/Local Areas,Alabama,2017,Age,35 Months,93.8,88.8 to 97.0,259
Hep B,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,96.1,91.5 to 98.6,491
PCV,≥3 Doses,States/Local Areas,Alabama,2012,Age,19 Months,95.7,89.4 to 98.3,233
Hep B,≥2 Doses,States/Local Areas,Alabama,2017,Age,5 Months,83.5,76.1 to 88.9,259
Hep B,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,5 Months,82.6,77.2 to 86.9,491
Hep B,≥3 Doses,States/Local Areas,Alabama,2017,Age,19 Months,89.5,82.4 to 93.9,259
Hep B,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,91.1,86.6 to 94.2,491
Hep B,≥3 Doses,States/Local Areas,Alabama,2018,Age,19 Months,92.8,86.3 to 96.3,232
Hep B,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,88.1,83.7 to 91.5,459
PCV,≥3 Doses,States/Local Areas,Alabama,2013,Age,7 Months,64.3,59.0 to 69.2,260
PCV,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,68.8,65.2 to 72.1,536
PCV,≥3 Doses,States/Local Areas,Alabama,2014,Age,7 Months,73.3,66.0 to 79.5,276
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,70.6,65.4 to 75.4,563
PCV,≥3 Doses,States/Local Areas,Alabama,2012,Age,7 Months,77.6,73.7 to 81.2,233
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,79.1,73.2 to 85.0,415
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,95.5,92.0 to 99.0,257
PCV,≥4 Doses,States/Local Areas,Alabama,2011,Age,19 Months,82.4,75.2 to 87.9,218
PCV,≥4 Doses,States/Local Areas,Alabama,2012,Age,19 Months,80.4,76.1 to 84.0,233
PCV,≥4 Doses,States/Local Areas,Alabama,2013,Age,19 Months,74.6,67.8 to 80.5,260
PCV,≥4 Doses,States/Local Areas,Alabama,2013-2014,Age,19 Months,79.3,76.1 to 82.2,536
≥1 Dose MMR,,States/Local Areas,Alabama,2018,Age,19 Months,87.6,79.7 to 92.7,232
≥1 Dose MMR,,States/Local Areas,Alabama,2018-2019,Age,19 Months,93.9,90.0 to 96.4,459
PCV,≥4 Doses,States/Local Areas,Alabama,2014,Age,19 Months,84.0,77.4 to 89.0,276
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,81.6,76.8 to 85.5,563
≥1 Dose MMR,,States/Local Areas,Alabama,2019,Age,19 Months,94.4,89.1 to 97.2,227
≥1 Dose MMR,,States/Local Areas,Alabama,2011,Age,24 Months,85.5,77.8 to 91.6,218
PCV,≥3 Doses,States/Local Areas,Alabama,2015,Age,7 Months,68.0,60.1 to 74.9,287
PCV,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,67.8,62.3 to 72.9,596
≥1 Dose MMR,,States/Local Areas,Alabama,2012,Age,24 Months,91.5,85.1 to 95.9,233
≥1 Dose Varicella,,States/Local Areas,Alabama,2015,Age,24 Months,93.3,89.4 to 96.1,287
≥1 Dose Varicella,,States/Local Areas,Alabama,2015-2016,Age,24 Months,93.1,90.3 to 95.3,596
≥1 Dose Varicella,,States/Local Areas,Alabama,2016,Age,24 Months,93.0,88.7 to 96.1,309
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2017,Age,24 Months,93.3,90.4 to 95.5,568
≥1 Dose Varicella,,States/Local Areas,Alabama,2017,Age,24 Months,93.5,89.4 to 96.5,259
≥1 Dose Varicella,,States/Local Areas,Alabama,2017-2018,Age,24 Months,92.9,89.7 to 95.5,491
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2018,Age,0-1 Days,69.9,61.2 to 77.4,232
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2018-2019,Age,0-1 Days,75.7,69.9 to 80.6,459
Hep B,≥2 Doses,States/Local Areas,Alabama,2018,Age,5 Months,81.7,73.4 to 87.8,232
Hep B,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,5 Months,84.8,79.8 to 88.8,459
Hep B,≥2 Doses,States/Local Areas,Alabama,2019,Age,5 Months,88.0,81.7 to 92.3,227
Hep B,≥2 Doses,States/Local Areas,Alabama,2011,Age,7 Months,92.2,88.8 to 94.6,218
Hep B,≥3 Doses,States/Local Areas,Alabama,2019,Age,19 Months,90.1,84.0 to 94.0,227
Hep B,≥3 Doses,States/Local Areas,Alabama,2011,Age,24 Months,87.5,80.3 to 92.9,218
Hep B,≥3 Doses,States/Local Areas,Alabama,2013,Age,24 Months,91.1,85.5 to 95.2,260
Hep B,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,91.6,88.0 to 94.5,536
Hep B,≥3 Doses,States/Local Areas,Alabama,2012,Age,24 Months,91.0,83.4 to 96.0,233
Hep B,≥3 Doses,States/Local Areas,Alabama,2014,Age,24 Months,92.1,87.1 to 95.7,276
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,92.5,89.4 to 95.0,563
PCV,≥3 Doses,States/Local Areas,Alabama,2016,Age,7 Months,67.7,60.1 to 74.5,309
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,69.9,64.3 to 75.0,568
PCV,≥3 Doses,States/Local Areas,Alabama,2017,Age,7 Months,72.1,63.6 to 79.3,259
PCV,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,66.9,60.5 to 72.7,491
PCV,≥4 Doses,States/Local Areas,Alabama,2015,Age,19 Months,79.1,75.8 to 82.0,287
PCV,≥4 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,77.6,72.6 to 81.9,596
PCV,≥4 Doses,States/Local Areas,Alabama,2016,Age,19 Months,76.0,68.9 to 81.9,309
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,77.9,72.7 to 82.3,568
≥1 Dose MMR,,States/Local Areas,Alabama,2013,Age,24 Months,93.5,88.6 to 96.8,260
≥1 Dose MMR,,States/Local Areas,Alabama,2013-2014,Age,24 Months,92.2,88.7 to 94.9,536
≥1 Dose MMR,,States/Local Areas,Alabama,2014,Age,24 Months,90.8,85.4 to 94.8,276
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2015,Age,24 Months,92.7,89.7 to 95.1,563
≥1 Dose MMR,,States/Local Areas,Alabama,2015,Age,24 Months,94.7,91.7 to 96.8,287
≥1 Dose MMR,,States/Local Areas,Alabama,2015-2016,Age,24 Months,92.6,89.9 to 94.8,596
≥1 Dose Varicella,,States/Local Areas,Alabama,2018,Age,24 Months,92.2,86.8 to 95.9,232
≥1 Dose Varicella,,States/Local Areas,Alabama,2018-2019,Age,24 Months,94.1,90.8 to 96.5,459
≥1 Dose Varicella,,States/Local Areas,Alabama,2019,Age,24 Months,95.9,91.3 to 98.4,227
≥1 Dose Varicella,,States/Local Areas,Alabama,2011,Age,35 Months,91.0,83.1 to 96.2,218
≥1 Dose Varicella,,States/Local Areas,Alabama,2012,Age,35 Months,94.6,89.1 to 97.8,233
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2019,Age,0-1 Days,81.4,73.5 to 87.4,227
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2011,Age,0-2 Days,81.2,73.1 to 87.2,218
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2012,Age,0-2 Days,87.7,84.7 to 90.1,233
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2013,Age,0-2 Days,78.6,75.5 to 81.5,260
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2013-2014,Age,0-2 Days,82.8,78.1 to 86.7,536
Hep B,≥2 Doses,States/Local Areas,Alabama,2013,Age,7 Months,91.9,87.2 to 95.0,260
Hep B,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,92.5,90.6 to 94.1,536
Hep B,≥2 Doses,States/Local Areas,Alabama,2014,Age,7 Months,93.1,87.4 to 96.3,276
Hep B,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,91.1,87.4 to 93.8,563
Hep B,≥2 Doses,States/Local Areas,Alabama,2012,Age,7 Months,91.5,82.5 to 96.1,233
Hep B,≥2 Doses,States/Local Areas,Alabama,2015,Age,7 Months,89.2,83.7 to 93.0,287
Hep B,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,91.0,87.6 to 93.5,596
PCV,≥3 Doses,States/Local Areas,Alabama,2018,Age,7 Months,61.5,52.4 to 69.9,232
PCV,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,66.5,60.4 to 72.1,459
PCV,≥3 Doses,States/Local Areas,Alabama,2019,Age,7 Months,71.5,63.2 to 78.5,227
PCV,≥3 Doses,States/Local Areas,Alabama,2011,Age,13 Months,89.5,85.3 to 92.6,218
PCV,≥3 Doses,States/Local Areas,Alabama,2013,Age,13 Months,86.5,80.9 to 90.7,260
PCV,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,89.7,86.3 to 92.3,536
Hep B,≥3 Doses,States/Local Areas,Alabama,2015,Age,24 Months,93.0,88.8 to 96.0,287
Hep B,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,92.0,88.9 to 94.5,596
Hep B,≥3 Doses,States/Local Areas,Alabama,2016,Age,24 Months,91.0,86.2 to 94.7,309
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,91.6,88.0 to 94.4,568
PCV,≥3 Doses,States/Local Areas,Alabama,2012,Age,13 Months,92.8,91.5 to 93.9,233
Hep A,≥1 Dose,States/Local Areas,Alabama,2020,Age,35 Months,92.2,87.3 to 95.6,240
Hep B,≥3 Doses,States/Local Areas,Alabama,2017,Age,24 Months,92.1,86.5 to 96.0,259
Hep B,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,92.7,88.7 to 95.6,491
PCV,≥4 Doses,States/Local Areas,Alabama,2018,Age,19 Months,76.1,67.0 to 83.4,232
PCV,≥4 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,77.1,69.8 to 83.0,372
≥1 Dose MMR,,States/Local Areas,Alabama,2016,Age,24 Months,90.5,85.9 to 94.1,309
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2017,Age,24 Months,92.3,89.4 to 94.7,568
≥1 Dose MMR,,States/Local Areas,Alabama,2017,Age,24 Months,94.1,90.2 to 96.8,259
≥1 Dose MMR,,States/Local Areas,Alabama,2017-2018,Age,24 Months,94.1,90.9 to 96.4,491
PCV,≥4 Doses,States/Local Areas,Alabama,2019,Age,19 Months,82.2,74.5 to 87.9,227
≥1 Dose MMR,,States/Local Areas,Alabama,2018,Age,24 Months,94.0,89.0 to 97.3,232
≥1 Dose MMR,,States/Local Areas,Alabama,2018-2019,Age,24 Months,94.9,91.7 to 97.1,459
≥1 Dose Varicella,,States/Local Areas,Alabama,2013,Age,35 Months,95.4,90.9 to 98.1,260
≥1 Dose Varicella,,States/Local Areas,Alabama,2013-2014,Age,35 Months,94.4,91.0 to 96.8,536
≥1 Dose Varicella,,States/Local Areas,Alabama,2014,Age,35 Months,93.3,87.8 to 96.9,276
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2015,Age,35 Months,93.5,90.3 to 96.0,563
PCV,≥4 Doses,States/Local Areas,Alabama,2011,Age,24 Months,84.8,77.0 to 91.0,218
≥1 Dose Varicella,,States/Local Areas,Alabama,2015,Age,35 Months,93.6,89.7 to 96.5,287
≥1 Dose Varicella,,States/Local Areas,Alabama,2015-2016,Age,35 Months,94.1,91.2 to 96.3,596
Hep B,≥3 Doses,States/Local Areas,Alabama,2018,Age,35 Months,97.6,90.8 to 99.7,232
Hep B,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.2,92.1 to 98.5,459
PCV,≥4 Doses,States/Local Areas,Alabama,2019,Age,24 Months,85.6,78.9 to 91.1,227
PCV,≥4 Doses,States/Local Areas,Alabama,2011,Age,35 Months,89.6,82.0 to 95.0,218
PCV,≥4 Doses,States/Local Areas,Alabama,2012,Age,35 Months,86.5,78.2 to 92.8,233
≥1 Dose MMR,,States/Local Areas,Alabama,2018,Age,35 Months,98.8,94.0 to 99.9,232
≥1 Dose MMR,,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.4,93.1 to 98.4,459
PCV,≥4 Doses,States/Local Areas,Alabama,2013,Age,35 Months,85.5,76.6 to 92.3,260
PCV,≥4 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,86.8,81.6 to 91.2,536
≥1 Dose MMR,,States/Local Areas,Alabama,2019,Age,35 Months,95.8,91.3 to 98.4,227
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,95.0,89.6 to 100.0,67
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,92.8,89.7 to 95.8,500
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,89.3 to 94.5,701
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,93.4,90.3 to 96.4,432
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.5 to 96.5,401
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,92.2,88.2 to 96.3,209
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Overall,Overall,93.2,91.3 to 95.1,1042
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,91.8,88.4 to 95.1,370
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,93.4,90.6 to 96.2,415
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2016,Age,0-2 Days,79.1,72.7 to 84.4,309
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2016-2017,Age,0-2 Days,79.9,75.0 to 84.0,568
Hep B,≥2 Doses,States/Local Areas,Alabama,2016,Age,7 Months,92.8,88.1 to 95.8,309
Hep B,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,92.0,88.5 to 94.4,568
Hep B,≥2 Doses,States/Local Areas,Alabama,2017,Age,7 Months,91.1,85.5 to 94.7,259
Hep B,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,89.8,85.4 to 92.9,491
Hep B,≥2 Doses,States/Local Areas,Alabama,2018,Age,7 Months,88.4,81.2 to 93.1,232
Hep B,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,89.5,85.2 to 92.7,459
PCV,≥3 Doses,States/Local Areas,Alabama,2014,Age,13 Months,92.8,87.3 to 96.0,276
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,90.5,86.7 to 93.3,563
PCV,≥3 Doses,States/Local Areas,Alabama,2015,Age,13 Months,88.2,82.0 to 92.5,287
PCV,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,88.5,84.4 to 91.6,596
Hib,≥1 Dose,States/Local Areas,Alabama,2016,Age,3 Months,85.8,79.8 to 90.2,309
Hib,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,3 Months,85.5,80.6 to 89.3,568
Hib,≥1 Dose,States/Local Areas,Alabama,2017,Age,3 Months,85.2,76.9 to 90.9,259
Hib,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,3 Months,85.5,79.6 to 89.9,491
Hep B,≥2 Doses,States/Local Areas,Alabama,2017,Age,13 Months,97.6,95.1 to 98.9,259
Hep B,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,95.5,92.1 to 97.5,491
Hep B,≥2 Doses,States/Local Areas,Alabama,2018,Age,13 Months,93.4,86.8 to 96.8,232
Hep B,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,94.0,90.1 to 96.4,459
Hep B,≥2 Doses,States/Local Areas,Alabama,2019,Age,13 Months,94.6,89.3 to 97.3,227
PCV,≥3 Doses,States/Local Areas,Alabama,2015,Age,19 Months,93.6,90.8 to 95.7,287
PCV,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,91.6,88.0 to 94.2,596
PCV,≥3 Doses,States/Local Areas,Alabama,2016,Age,19 Months,89.5,83.6 to 93.5,309
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,92.8,89.4 to 95.1,568
PCV,≥3 Doses,States/Local Areas,Alabama,2017,Age,19 Months,96.1,92.5 to 98.0,259
PCV,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,94.3,90.8 to 96.6,491
Hep B,≥3 Doses,States/Local Areas,Alabama,2019,Age,35 Months,94.4,89.8 to 97.4,227
PCV,≥4 Doses,States/Local Areas,Alabama,2014,Age,35 Months,88.5,81.9 to 93.5,276
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,87.3,82.7 to 91.1,563
PCV,≥4 Doses,States/Local Areas,Alabama,2015,Age,35 Months,85.6,79.3 to 90.7,287
PCV,≥4 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,85.6,81.2 to 89.5,596
PCV,≥4 Doses,States/Local Areas,Alabama,2016,Age,35 Months,85.1,78.8 to 90.3,309
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,87.5,82.8 to 91.5,568
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,92.3,89.4 to 95.2,453
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.6,90.4 to 98.8,132
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,93.5,89.1 to 98.0,106
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.8,79.7 to 95.8,103
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.8,88.0 to 93.6,701
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,92.3,89.0 to 95.6,432
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,88.3 to 95.2,401
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,96.6,94.4 to 98.9,257
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2017,Age,0-2 Days,80.7,72.9 to 86.6,259
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2017-2018,Age,0-2 Days,78.9,73.4 to 83.5,491
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2018,Age,0-2 Days,77.1,68.9 to 83.6,232
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2018-2019,Age,0-2 Days,80.2,74.8 to 84.6,459
Hib,≥1 Dose,States/Local Areas,Alabama,2018,Age,3 Months,85.8,77.7 to 91.3,232
Hib,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,3 Months,89.0,84.3 to 92.5,459
Hib,≥1 Dose,States/Local Areas,Alabama,2019,Age,3 Months,92.2,86.6 to 95.6,227
Hib,≥2 Doses,States/Local Areas,Alabama,2011,Age,5 Months,80.4,74.3 to 85.3,218
Hib,≥2 Doses,States/Local Areas,Alabama,2012,Age,5 Months,82.8,74.5 to 88.8,233
Hib,≥2 Doses,States/Local Areas,Alabama,2013,Age,5 Months,74.6,68.6 to 79.9,260
Hib,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,5 Months,76.1,72.3 to 79.6,536
Hib,≥2 Doses,States/Local Areas,Alabama,2014,Age,5 Months,77.6,70.3 to 83.6,276
Hib,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,5 Months,76.6,74.3 to 78.7,563
PCV,≥3 Doses,States/Local Areas,Alabama,2018,Age,19 Months,92.5,85.8 to 96.2,232
PCV,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,89.3,84.7 to 92.6,459
PCV,≥3 Doses,States/Local Areas,Alabama,2019,Age,19 Months,94.5,89.3 to 97.2,227
PCV,≥3 Doses,States/Local Areas,Alabama,2011,Age,24 Months,90.6,83.6 to 95.4,218
PCV,≥3 Doses,States/Local Areas,Alabama,2012,Age,24 Months,95.9,90.3 to 98.8,233
PCV,≥4 Doses,States/Local Areas,Alabama,2017,Age,35 Months,90.7,82.6 to 96.1,259
PCV,≥4 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,88.3,82.6 to 92.9,491
PCV,≥4 Doses,States/Local Areas,Alabama,2018,Age,35 Months,86.6,78.5 to 92.8,232
PCV,≥4 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,87.1,82.0 to 91.3,459
PCV,≥4 Doses,States/Local Areas,Alabama,2019,Age,35 Months,87.9,81.2 to 93.1,227
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,91.3,87.1 to 95.5,209
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Overall,Overall,91.9,89.8 to 94.0,1042
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,90.9,87.2 to 94.5,370
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,92.3,89.4 to 95.2,415
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,94.1,90.5 to 97.8,257
PCV,≥1 Dose,States/Local Areas,Alabama,2011,Age,3 Months,86.8,81.5 to 90.7,218
PCV,≥1 Dose,States/Local Areas,Alabama,2012,Age,3 Months,90.3,88.2 to 92.1,233
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,90.4,86.7 to 94.1,500
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,81.4,76.8 to 85.9,453
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,92.5,85.8 to 99.2,67
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.8,78.0 to 91.6,132
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,81.2,71.8 to 90.7,106
PCV,≥1 Dose,States/Local Areas,Alabama,2013,Age,3 Months,87.0,81.5 to 91.1,260
PCV,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,3 Months,87.9,84.6 to 90.6,536
PCV,≥1 Dose,States/Local Areas,Alabama,2014,Age,3 Months,88.8,82.9 to 92.8,276
PCV,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,3 Months,87.4,83.1 to 90.7,563
PCV,≥1 Dose,States/Local Areas,Alabama,2015,Age,3 Months,86.0,79.3 to 90.8,287
PCV,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,3 Months,86.5,82.3 to 89.8,596
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.8,66.9 to 88.8,103
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.5,81.8 to 89.1,701
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,82.9,78.0 to 87.7,432
Hib,≥2 Doses,States/Local Areas,Alabama,2015,Age,5 Months,75.6,68.1 to 81.9,287
Hib,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,5 Months,73.9,68.7 to 78.5,596
Hib,≥2 Doses,States/Local Areas,Alabama,2016,Age,5 Months,72.1,64.7 to 78.5,309
Hib,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,5 Months,74.7,69.3 to 79.6,568
Hib,≥2 Doses,States/Local Areas,Alabama,2017,Age,5 Months,77.4,68.9 to 84.1,259
Hib,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,5 Months,71.9,65.4 to 77.7,491
PCV,≥3 Doses,States/Local Areas,Alabama,2013,Age,24 Months,93.9,89.4 to 97.0,260
PCV,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,94.5,91.5 to 96.7,536
PCV,≥3 Doses,States/Local Areas,Alabama,2014,Age,24 Months,95.0,90.5 to 97.8,276
PCV,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,94.9,92.2 to 97.0,563
PCV,≥3 Doses,States/Local Areas,Alabama,2015,Age,24 Months,94.9,91.1 to 97.5,287
PCV,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,93.2,90.1 to 95.5,596
Hib,≥2 Doses,States/Local Areas,Alabama,2018,Age,5 Months,66.3,56.8 to 74.6,232
Hib,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,5 Months,74.3,68.2 to 79.6,459
Hib,≥2 Doses,States/Local Areas,Alabama,2019,Age,5 Months,82.2,75.1 to 87.7,227
Hib,≥2 Doses,States/Local Areas,Alabama,2011,Age,7 Months,89.6,84.6 to 93.1,218
Hib,≥2 Doses,States/Local Areas,Alabama,2012,Age,7 Months,92.4,89.9 to 94.3,233
Hib,≥2 Doses,States/Local Areas,Alabama,2013,Age,7 Months,87.7,84.1 to 90.5,260
PCV,≥3 Doses,States/Local Areas,Alabama,2016,Age,24 Months,91.3,86.2 to 95.1,309
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,93.7,90.7 to 96.0,568
PCV,≥3 Doses,States/Local Areas,Alabama,2017,Age,24 Months,96.1,92.9 to 98.1,259
PCV,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,94.3,91.0 to 96.7,491
PCV,≥3 Doses,States/Local Areas,Alabama,2018,Age,24 Months,92.5,86.6 to 96.5,232
PCV,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,95.3,92.2 to 97.4,459
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2014,Age,0-2 Days,87.0,81.0 to 91.3,276
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2014-2015,Age,0-2 Days,81.9,77.4 to 85.7,563
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2015,Age,0-2 Days,76.9,69.7 to 82.8,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2015-2016,Age,0-2 Days,78.0,73.2 to 82.1,596
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,92.9,85.7 to 100.0,67
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,94.8,92.5 to 97.1,500
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.4,86.3 to 96.5,132
PCV,≥1 Dose,States/Local Areas,Alabama,2016,Age,3 Months,87.0,81.2 to 91.2,309
PCV,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,3 Months,85.8,80.9 to 89.6,568
PCV,≥1 Dose,States/Local Areas,Alabama,2017,Age,3 Months,84.6,76.3 to 90.4,259
PCV,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,3 Months,85.9,80.2 to 90.2,491
PCV,≥1 Dose,States/Local Areas,Alabama,2018,Age,3 Months,87.3,79.9 to 92.3,232
PCV,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,3 Months,90.5,86.3 to 93.5,459
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,91.6,88.5 to 94.7,453
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2011,Age,0-3 Days,82.7,74.5 to 88.6,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2012,Age,0-3 Days,88.0,80.9 to 92.7,233
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2013,Age,0-3 Days,79.9,72.3 to 85.8,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2013-2014,Age,0-3 Days,84.0,79.3 to 87.8,536
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.8,81.0 to 90.6,401
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,84.1,77.5 to 90.6,209
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,84.1,81.1 to 87.2,1042
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,81.0,76.0 to 85.9,370
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,81.7,76.5 to 87.0,415
PCV,≥4 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,96.7,94.4 to 99.0,257
Hib,Full Series,States/Local Areas,Alabama,2016,Age,24 Months,77.9,71.5 to 83.8,309
Hib,Full Series,States/Local Areas,Alabama,2016-2017,Age,24 Months,81.1,76.3 to 85.4,568
Hib,Full Series,States/Local Areas,Alabama,2017,Age,24 Months,84.2,77.1 to 90.1,259
Hib,Full Series,States/Local Areas,Alabama,2017-2018,Age,24 Months,79.8,73.9 to 85.1,491
Hib,Full Series,States/Local Areas,Alabama,2018,Age,24 Months,74.7,65.9 to 82.7,232
Hib,Full Series,States/Local Areas,Alabama,2018-2019,Age,24 Months,77.0,71.3 to 82.3,459
PCV,≥2 Doses,States/Local Areas,Alabama,2018,Age,5 Months,66.7,57.3 to 75.0,232
PCV,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,5 Months,75.8,69.8 to 80.9,459
PCV,≥2 Doses,States/Local Areas,Alabama,2019,Age,5 Months,84.8,78.1 to 89.7,227
Polio,≥2 Doses,States/Local Areas,Alabama,2011,Age,5 Months,80.3,74.1 to 85.3,218
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,97.7,95.6 to 99.9,106
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.4,91.3 to 99.6,103
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.1,90.5 to 95.7,701
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,94.7,92.1 to 97.3,432
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.6,91.5 to 97.7,401
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,95.0,91.6 to 98.3,209
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,94.0,91.3 to 96.7,370
DTaP,≥4 Doses,States/Local Areas,Alabama,2017,Age,19 Months,68.3,59.9 to 75.7,259
DTaP,≥4 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,65.0,58.5 to 71.0,491
DTaP,≥4 Doses,States/Local Areas,Alabama,2018,Age,19 Months,61.6,52.3 to 70.2,232
DTaP,≥4 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,95.1,91.9 to 97.1,459
Hep A,≥2 Doses,States/Local Areas,Alabama,2013,Age,24 Months,41.0,33.2 to 49.8,260
Hep A,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,45.2,39.6 to 51.2,536
Hep A,≥2 Doses,States/Local Areas,Alabama,2014,Age,24 Months,49.3,41.7 to 57.6,276
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,48.5,42.9 to 54.4,563
Hep A,≥2 Doses,States/Local Areas,Alabama,2015,Age,24 Months,47.6,39.7 to 56.3,287
Hep A,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,47.2,41.7 to 53.0,596
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,94.7,93.0 to 96.5,1042
Hib,≥3 Doses,States/Local Areas,Alabama,2019,Age,35 Months,96.6,93.0 to 98.6,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2015,Age,35 Months,90.8,85.6 to 94.6,287
Hep A,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,35 Months,90.4,86.8 to 93.3,596
Polio,≥2 Doses,States/Local Areas,Alabama,2012,Age,5 Months,83.8,77.0 to 88.9,233
Polio,≥2 Doses,States/Local Areas,Alabama,2013,Age,5 Months,76.0,69.7 to 81.3,260
Polio,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,5 Months,76.9,73.1 to 80.3,536
Polio,≥2 Doses,States/Local Areas,Alabama,2014,Age,5 Months,77.8,70.5 to 83.7,276
Polio,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,5 Months,77.0,75.0 to 78.8,563
Polio,≥2 Doses,States/Local Areas,Alabama,2015,Age,5 Months,76.2,68.7 to 82.4,287
Polio,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,5 Months,75.4,70.3 to 79.9,596
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,94.0,90.7 to 97.3,415
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,98.3,96.8 to 99.7,257
Hep B,≥3 Doses,States/Local Areas,Alabama,2011,Age,7 Months,51.6,44.3 to 58.9,218
Hep B,≥3 Doses,States/Local Areas,Alabama,2012,Age,7 Months,61.8,55.5 to 67.7,233
Hep B,≥3 Doses,States/Local Areas,Alabama,2013,Age,7 Months,58.6,49.2 to 67.4,260
Hep B,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,59.6,55.5 to 63.6,536
DTaP,≥4 Doses,States/Local Areas,Alabama,2019,Age,19 Months,70.0,61.2 to 77.5,227
DTaP,≥4 Doses,States/Local Areas,Alabama,2011,Age,24 Months,83.6,75.6 to 90.2,218
DTaP,≥4 Doses,States/Local Areas,Alabama,2012,Age,24 Months,84.4,76.7 to 90.7,233
DTaP,≥4 Doses,States/Local Areas,Alabama,2013,Age,24 Months,76.6,68.8 to 83.7,260
DTaP,≥4 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,79.8,74.7 to 84.6,536
Hep A,≥2 Doses,States/Local Areas,Alabama,2016,Age,24 Months,46.8,39.4 to 54.8,309
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,43.4,37.8 to 49.5,568
Hep A,≥2 Doses,States/Local Areas,Alabama,2017,Age,24 Months,40.0,31.8 to 49.3,259
Hep A,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,37.4,31.5 to 43.9,491
DTaP,≥4 Doses,States/Local Areas,Alabama,2014,Age,24 Months,82.7,75.9 to 88.5,276
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,82.4,77.7 to 86.5,563
Hep A,≥2 Doses,States/Local Areas,Alabama,2018,Age,24 Months,34.7,27.0 to 43.8,232
Hep A,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,36.5,31.0 to 42.7,459
Polio,≥2 Doses,States/Local Areas,Alabama,2018,Age,5 Months,67.0,57.6 to 75.2,232
Polio,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,5 Months,75.4,69.5 to 80.5,459
Hep A,≥2 Doses,States/Local Areas,Alabama,2019,Age,24 Months,38.3,30.8 to 47.0,227
Hep A,≥2 Doses,States/Local Areas,Alabama,2011,Age,35 Months,65.4,55.0 to 75.6,218
Hep A,≥2 Doses,States/Local Areas,Alabama,2012,Age,35 Months,73.3,62.7 to 82.9,233
Hep A,≥2 Doses,States/Local Areas,Alabama,2013,Age,35 Months,87.4,74.9 to 95.5,260
Hep A,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,79.2,71.3 to 86.2,536
DTaP,≥4 Doses,States/Local Areas,Alabama,2015,Age,24 Months,81.6,75.0 to 87.3,287
DTaP,≥4 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,81.7,77.3 to 85.8,596
DTaP,≥4 Doses,States/Local Areas,Alabama,2016,Age,24 Months,81.4,75.2 to 87.0,309
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,82.3,77.6 to 86.6,568
Hep A,≥2 Doses,States/Local Areas,Alabama,2014,Age,35 Months,73.9,65.2 to 81.9,276
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,76.5,70.2 to 82.3,563
DTaP,≥4 Doses,States/Local Areas,Alabama,2017,Age,24 Months,83.2,75.9 to 89.3,259
DTaP,≥4 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,81.3,75.4 to 86.6,491
DTaP,≥3 Doses,States/Local Areas,Alabama,2011,Age,24 Months,91.5,84.4 to 96.2,218
DTaP,≥3 Doses,States/Local Areas,Alabama,2013,Age,24 Months,95.1,90.7 to 97.8,260
DTaP,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,95.9,93.3 to 97.7,536
Hib,Full Series,States/Local Areas,Alabama,2015,Age,24 Months,79.2,72.7 to 85.2,287
Hib,Full Series,States/Local Areas,Alabama,2015-2016,Age,24 Months,78.8,74.2 to 83.0,596
DTaP,≥3 Doses,States/Local Areas,Alabama,2012,Age,24 Months,96.1,90.4 to 98.9,233
Polio,≥3 Doses,States/Local Areas,Alabama,2017,Age,24 Months,93.9,88.9 to 97.1,259
Polio,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,24 Months,92.9,88.7 to 96.0,491
Polio,≥3 Doses,States/Local Areas,Alabama,2018,Age,24 Months,92.0,86.1 to 96.0,232
Polio,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,94.8,91.7 to 97.1,459
Polio,≥3 Doses,States/Local Areas,Alabama,2019,Age,24 Months,97.6,95.0 to 99.0,227
Hib,≥3 Doses,States/Local Areas,Alabama,2019,Age,19 Months,92.1,86.5 to 95.6,227
Hib,≥3 Doses,States/Local Areas,Alabama,2011,Age,24 Months,91.8,84.7 to 96.4,218
Hib,≥3 Doses,States/Local Areas,Alabama,2012,Age,24 Months,93.3,87.4 to 97.1,233
Hib,≥3 Doses,States/Local Areas,Alabama,2013,Age,24 Months,94.3,89.8 to 97.2,260
Hib,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,94.7,91.8 to 96.8,536
Hib,≥3 Doses,States/Local Areas,Alabama,2014,Age,24 Months,95.1,91.0 to 97.7,276
Hib,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,94.3,91.5 to 96.4,563
Polio,≥3 Doses,States/Local Areas,Alabama,2011,Age,35 Months,90.5,83.4 to 95.5,218
Polio,≥3 Doses,States/Local Areas,Alabama,2014,Age,24 Months,95.2,91.1 to 97.9,276
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,24 Months,94.6,91.9 to 96.7,563
Polio,≥3 Doses,States/Local Areas,Alabama,2015,Age,24 Months,94.0,89.8 to 96.9,287
Polio,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,24 Months,92.9,89.9 to 95.3,596
Polio,≥3 Doses,States/Local Areas,Alabama,2016,Age,24 Months,91.7,87.0 to 95.2,309
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,24 Months,92.8,89.5 to 95.4,568
Hib,≥3 Doses,States/Local Areas,Alabama,2017,Age,19 Months,90.8,84.7 to 94.6,259
Hib,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,88.3,82.8 to 92.2,491
Hib,≥3 Doses,States/Local Areas,Alabama,2018,Age,19 Months,85.7,77.1 to 91.4,232
Hib,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,75.1,69.2 to 80.3,459
DTaP,≥3 Doses,States/Local Areas,Alabama,2016,Age,19 Months,91.4,86.2 to 94.8,309
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,93.8,90.8 to 95.8,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2017,Age,19 Months,96.2,92.6 to 98.1,259
DTaP,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,19 Months,94.7,91.4 to 96.8,491
DTaP,≥3 Doses,States/Local Areas,Alabama,2018,Age,19 Months,93.2,87.0 to 96.6,232
DTaP,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,19 Months,89.7,85.0 to 93.0,459
Polio,≥3 Doses,States/Local Areas,Alabama,2019,Age,19 Months,95.3,91.0 to 97.6,227
Polio,≥3 Doses,States/Local Areas,Alabama,2011,Age,24 Months,90.5,83.4 to 95.4,218
Polio,≥3 Doses,States/Local Areas,Alabama,2012,Age,24 Months,92.8,86.3 to 97.0,233
Polio,≥3 Doses,States/Local Areas,Alabama,2013,Age,24 Months,93.7,89.0 to 96.9,260
Polio,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,24 Months,94.4,91.5 to 96.6,536
Hib,≥3 Doses,States/Local Areas,Alabama,2014,Age,19 Months,94.7,90.1 to 97.2,276
Hib,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,93.4,90.2 to 95.6,563
Hib,≥3 Doses,States/Local Areas,Alabama,2015,Age,19 Months,92.1,90.3 to 93.6,287
Hib,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,90.1,86.5 to 92.9,596
Hib,≥3 Doses,States/Local Areas,Alabama,2016,Age,19 Months,88.1,82.5 to 92.1,309
Hib,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,89.5,85.6 to 92.4,568
≥1 Dose Varicella,,States/Local Areas,Alabama,2013,Age,13 Months,61.6,54.4 to 68.4,260
≥1 Dose Varicella,,States/Local Areas,Alabama,2013-2014,Age,13 Months,62.5,58.1 to 66.6,536
≥1 Dose Varicella,,States/Local Areas,Alabama,2014,Age,13 Months,63.3,55.5 to 70.5,276
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2015,Age,13 Months,65.9,60.4 to 71.0,563
≥1 Dose Varicella,,States/Local Areas,Alabama,2012,Age,13 Months,71.2,64.8 to 76.9,233
≥1 Dose Varicella,,States/Local Areas,Alabama,2015,Age,13 Months,68.5,60.8 to 75.4,287
≥1 Dose Varicella,,States/Local Areas,Alabama,2015-2016,Age,13 Months,63.4,58.1 to 68.4,596
Hep A,≥1 Dose,States/Local Areas,Alabama,2019,Age,35 Months,89.9,83.6 to 94.5,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,88.1,84.3 to 91.9,500
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,87.9,84.1 to 91.6,453
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,86.7,75.5 to 97.8,67
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.7,81.4 to 93.9,132
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,90.9,85.3 to 96.5,106
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,83.1 to 97.3,103
Polio,≥2 Doses,States/Local Areas,Alabama,2019,Age,5 Months,83.8,77.1 to 88.8,227
Polio,≥2 Doses,States/Local Areas,Alabama,2011,Age,7 Months,89.2,84.5 to 92.6,218
Polio,≥2 Doses,States/Local Areas,Alabama,2012,Age,7 Months,92.4,89.9 to 94.3,233
Hep B,≥3 Doses,States/Local Areas,Alabama,2017,Age,7 Months,57.2,48.7 to 65.3,259
Hep B,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,58.6,52.4 to 64.6,491
Hep B,≥3 Doses,States/Local Areas,Alabama,2018,Age,7 Months,60.1,51.3 to 68.2,232
Hep B,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,60.6,54.7 to 66.2,459
Polio,≥2 Doses,States/Local Areas,Alabama,2013,Age,7 Months,88.3,83.9 to 91.6,260
Polio,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,7 Months,89.3,85.6 to 92.2,536
Hep B,≥3 Doses,States/Local Areas,Alabama,2019,Age,7 Months,61.1,53.0 to 68.6,227
Hep A,≥2 Doses,States/Local Areas,Alabama,2015,Age,35 Months,79.3,70.3 to 87.1,287
Hep A,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,77.3,70.7 to 83.3,596
Hep A,≥2 Doses,States/Local Areas,Alabama,2016,Age,35 Months,75.3,66.0 to 83.7,309
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,73.0,65.9 to 79.7,568
Hep A,≥2 Doses,States/Local Areas,Alabama,2017,Age,35 Months,71.4,59.7 to 82.1,259
DTaP,≥4 Doses,States/Local Areas,Alabama,2018,Age,24 Months,79.2,70.4 to 86.9,232
DTaP,≥4 Doses,States/Local Areas,Alabama,2018-2019,Age,24 Months,79.7,74.0 to 84.9,459
DTaP,≥4 Doses,States/Local Areas,Alabama,2019,Age,24 Months,80.4,73.1 to 86.8,227
DTaP,≥4 Doses,States/Local Areas,Alabama,2011,Age,35 Months,89.5,81.2 to 95.2,218
≥1 Dose Varicella,,States/Local Areas,Alabama,2011,Age,13 Months,67.4,62.5 to 71.8,218
Hep A,≥1 Dose,States/Local Areas,Alabama,2018,Age,35 Months,99.5,96.9 to 100.0,232
Hep A,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,35 Months,95.2,90.5 to 98.0,459
Polio,≥2 Doses,States/Local Areas,Alabama,2016,Age,5 Months,74.7,67.4 to 80.8,309
Polio,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,5 Months,75.8,70.4 to 80.6,568
Polio,≥2 Doses,States/Local Areas,Alabama,2017,Age,5 Months,77.0,68.5 to 83.7,259
Polio,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,5 Months,72.1,65.6 to 77.7,491
Hep B,≥3 Doses,States/Local Areas,Alabama,2014,Age,7 Months,60.6,53.0 to 67.8,276
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,60.6,55.1 to 65.8,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2015,Age,7 Months,60.5,52.7 to 67.8,287
Hep B,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,60.0,54.5 to 65.2,596
Hep B,≥3 Doses,States/Local Areas,Alabama,2016,Age,7 Months,59.5,52.0 to 66.6,309
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,58.3,52.7 to 63.8,568
Hep A,≥1 Dose,States/Local Areas,Alabama,2013,Age,35 Months,90.6,85.0 to 94.8,260
Hep A,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,35 Months,90.3,86.4 to 93.4,536
Hep A,≥1 Dose,States/Local Areas,Alabama,2014,Age,35 Months,89.8,84.1 to 94.1,276
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,35 Months,90.2,86.4 to 93.4,563
≥1 Dose MMR,,States/Local Areas,Alabama,2011,Age,13 Months,55.6,51.8 to 59.3,218
≥1 Dose MMR,,States/Local Areas,Alabama,2012,Age,13 Months,58.2,55.3 to 61.0,233
≥1 Dose MMR,,States/Local Areas,Alabama,2013,Age,13 Months,52.2,42.7 to 61.6,260
≥1 Dose MMR,,States/Local Areas,Alabama,2013-2014,Age,13 Months,54.0,48.0 to 59.9,536
≥1 Dose Varicella,,States/Local Areas,Alabama,2016,Age,13 Months,58.2,50.7 to 65.4,309
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2017,Age,13 Months,62.7,57.1 to 68.1,568
≥1 Dose Varicella,,States/Local Areas,Alabama,2017,Age,13 Months,67.2,58.8 to 74.7,259
≥1 Dose Varicella,,States/Local Areas,Alabama,2017-2018,Age,13 Months,63.4,57.3 to 69.2,491
≥1 Dose Varicella,,States/Local Areas,Alabama,2018,Age,13 Months,59.5,50.5 to 68.0,232
≥1 Dose Varicella,,States/Local Areas,Alabama,2018-2019,Age,13 Months,64.2,58.0 to 69.9,459
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.7,82.3 to 89.0,701
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,87.7,83.6 to 91.9,432
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.8,85.0 to 92.6,401
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,83.0,76.3 to 89.7,209
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Overall,Overall,87.3,84.6 to 89.9,1042
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,85.6,81.1 to 90.1,370
Polio,≥2 Doses,States/Local Areas,Alabama,2014,Age,7 Months,90.4,84.0 to 94.4,276
Polio,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,7 Months,90.1,86.1 to 93.0,563
Polio,≥2 Doses,States/Local Areas,Alabama,2015,Age,7 Months,89.8,84.2 to 93.5,287
Polio,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,7 Months,89.2,85.4 to 92.0,596
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,87.1,83.1 to 91.1,415
Polio,≥2 Doses,States/Local Areas,Alabama,2016,Age,7 Months,88.5,82.8 to 92.5,309
Polio,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,7 Months,89.0,84.8 to 92.2,568
Hep B,≥3 Doses,States/Local Areas,Alabama,2011,Age,13 Months,84.8,79.9 to 88.7,218
Hep B,≥3 Doses,States/Local Areas,Alabama,2013,Age,13 Months,86.7,82.3 to 90.1,260
Hep B,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,88.6,84.7 to 91.5,536
Hep B,≥3 Doses,States/Local Areas,Alabama,2014,Age,13 Months,90.4,84.9 to 94.0,276
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,89.6,85.9 to 92.4,563
Hep A,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,69.3,61.6 to 76.8,491
Hep A,≥2 Doses,States/Local Areas,Alabama,2018,Age,35 Months,68.0,57.4 to 78.1,232
Hep A,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,70.5,62.9 to 77.8,459
Hep B,≥3 Doses,States/Local Areas,Alabama,2012,Age,13 Months,86.8,80.2 to 91.4,233
Hep A,≥2 Doses,States/Local Areas,Alabama,2019,Age,35 Months,73.8,62.3 to 84.0,227
DTaP,≥4 Doses,States/Local Areas,Alabama,2013,Age,35 Months,87.0,77.2 to 94.0,260
DTaP,≥4 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,87.8,82.0 to 92.4,536
DTaP,≥4 Doses,States/Local Areas,Alabama,2014,Age,35 Months,88.5,81.5 to 93.7,276
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,89.3,84.3 to 93.3,563
DTaP,≥4 Doses,States/Local Areas,Alabama,2012,Age,35 Months,89.4,81.9 to 94.8,233
DTaP,≥4 Doses,States/Local Areas,Alabama,2015,Age,35 Months,90.3,83.2 to 95.3,287
DTaP,≥4 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,88.7,84.3 to 92.3,596
Hep B,≥3 Doses,States/Local Areas,Alabama,2015,Age,13 Months,88.9,83.3 to 92.7,287
Hep B,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,87.6,83.6 to 90.7,596
≥1 Dose MMR,,States/Local Areas,Alabama,2016,Age,13 Months,49.0,41.7 to 56.3,309
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2017,Age,13 Months,53.2,47.5 to 58.8,568
≥1 Dose Varicella,,States/Local Areas,Alabama,2019,Age,13 Months,68.8,60.3 to 76.2,227
≥1 Dose Varicella,,States/Local Areas,Alabama,2011,Age,19 Months,87.6,84.0 to 90.4,218
≥1 Dose Varicella,,States/Local Areas,Alabama,2012,Age,19 Months,92.8,89.4 to 95.1,233
≥1 Dose Varicella,,States/Local Areas,Alabama,2013,Age,19 Months,92.0,87.4 to 95.1,260
≥1 Dose Varicella,,States/Local Areas,Alabama,2013-2014,Age,19 Months,91.6,88.4 to 93.9,536
Hep B,≥1 Dose,States/Local Areas,Alabama,2011,Age,3 Months,94.1,89.9 to 96.6,218
Hep B,≥1 Dose,States/Local Areas,Alabama,2012,Age,3 Months,95.8,89.7 to 98.4,233
Hep B,≥1 Dose,States/Local Areas,Alabama,2013,Age,3 Months,95.0,93.0 to 96.4,260
Hep B,≥1 Dose,States/Local Areas,Alabama,2013-2014,Age,3 Months,96.1,94.6 to 97.2,536
Hep B,≥1 Dose,States/Local Areas,Alabama,2014,Age,3 Months,97.2,93.2 to 98.9,276
Hep B,≥1 Dose,States/Local Areas,Alabama,2014-2015,Age,3 Months,95.8,93.4 to 97.4,563
Polio,≥2 Doses,States/Local Areas,Alabama,2017,Age,7 Months,89.5,82.6 to 93.9,259
Polio,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,7 Months,87.0,81.3 to 91.1,491
Polio,≥2 Doses,States/Local Areas,Alabama,2018,Age,7 Months,84.4,75.7 to 90.3,232
Polio,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,7 Months,87.5,82.5 to 91.3,459
Hep A,≥1 Dose,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,91.6,87.0 to 96.2,257
Hep A,≥1 Dose,States/Local Areas,Alabama,2016,Age,35 Months,89.9,84.8 to 93.9,309
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,35 Months,90.5,86.7 to 93.6,568
Hep A,≥1 Dose,States/Local Areas,Alabama,2017,Age,35 Months,91.3,85.2 to 95.6,259
Hep A,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,35 Months,95.0,89.9 to 98.0,491
≥1 Dose MMR,,States/Local Areas,Alabama,2014,Age,13 Months,55.8,48.1 to 63.3,276
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2015,Age,13 Months,57.1,51.6 to 62.4,563
≥1 Dose MMR,,States/Local Areas,Alabama,2015,Age,13 Months,58.4,50.5 to 65.8,287
≥1 Dose MMR,,States/Local Areas,Alabama,2015-2016,Age,13 Months,53.7,48.4 to 59.0,596
Polio,≥2 Doses,States/Local Areas,Alabama,2019,Age,7 Months,90.7,84.9 to 94.4,227
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,84.3,72.3 to 96.4,67
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,73.4,66.1 to 80.6,500
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,77.4,69.3 to 85.5,453
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.4,62.3 to 88.5,132
Hep B,≥3 Doses,States/Local Areas,Alabama,2016,Age,13 Months,86.3,80.1 to 90.8,309
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,86.9,82.5 to 90.4,568
Hep B,≥3 Doses,States/Local Areas,Alabama,2017,Age,13 Months,87.5,80.4 to 92.3,259
Hep B,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,88.6,83.9 to 92.1,491
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,81.8,66.6 to 96.9,106
DTaP,≥4 Doses,States/Local Areas,Alabama,2016,Age,35 Months,88.1,82.1 to 92.7,309
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,88.6,83.9 to 92.4,568
DTaP,≥4 Doses,States/Local Areas,Alabama,2017,Age,35 Months,89.8,80.9 to 95.7,259
DTaP,≥4 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,88.2,81.9 to 93.1,491
DTaP,≥4 Doses,States/Local Areas,Alabama,2018,Age,35 Months,87.0,77.6 to 93.8,232
DTaP,≥4 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,91.0,84.8 to 95.4,459
≥1 Dose MMR,,States/Local Areas,Alabama,2017,Age,13 Months,57.4,48.9 to 65.5,259
≥1 Dose MMR,,States/Local Areas,Alabama,2017-2018,Age,13 Months,58.8,52.6 to 64.7,491
≥1 Dose MMR,,States/Local Areas,Alabama,2018,Age,13 Months,60.2,51.2 to 68.6,232
≥1 Dose MMR,,States/Local Areas,Alabama,2018-2019,Age,13 Months,63.7,57.5 to 69.5,459
≥1 Dose MMR,,States/Local Areas,Alabama,2019,Age,13 Months,67.3,58.6 to 74.9,227
≥1 Dose Varicella,,States/Local Areas,Alabama,2014,Age,19 Months,91.1,85.0 to 94.8,276
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2015,Age,19 Months,91.3,87.5 to 93.9,563
≥1 Dose Varicella,,States/Local Areas,Alabama,2015,Age,19 Months,91.5,89.1 to 93.3,287
≥1 Dose Varicella,,States/Local Areas,Alabama,2015-2016,Age,19 Months,89.4,85.9 to 92.2,596
≥1 Dose Varicella,,States/Local Areas,Alabama,2016,Age,19 Months,87.4,81.8 to 91.4,309
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2017,Age,19 Months,88.9,85.3 to 91.7,568
Polio,≥2 Doses,States/Local Areas,Alabama,2011,Age,13 Months,90.4,85.7 to 93.7,218
Polio,≥2 Doses,States/Local Areas,Alabama,2012,Age,13 Months,96.3,92.1 to 98.3,233
Polio,≥2 Doses,States/Local Areas,Alabama,2013,Age,13 Months,95.7,93.2 to 97.3,260
Polio,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,13 Months,96.0,92.5 to 97.9,536
Polio,≥2 Doses,States/Local Areas,Alabama,2014,Age,13 Months,96.2,91.9 to 98.3,276
Polio,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,13 Months,95.3,92.5 to 97.1,563
Hep B,≥1 Dose,States/Local Areas,Alabama,2015,Age,3 Months,94.4,90.7 to 96.7,287
Hep B,≥1 Dose,States/Local Areas,Alabama,2015-2016,Age,3 Months,95.5,93.3 to 97.0,596
Hep B,≥1 Dose,States/Local Areas,Alabama,2016,Age,3 Months,96.6,93.7 to 98.2,309
Hep B,≥1 Dose,States/Local Areas,Alabama,2016-2017,Age,3 Months,95.8,92.7 to 97.6,568
Hep B,≥1 Dose,States/Local Areas,Alabama,2017,Age,3 Months,94.9,88.7 to 97.8,259
Hep B,≥1 Dose,States/Local Areas,Alabama,2017-2018,Age,3 Months,95.2,91.4 to 97.3,491
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,56.5 to 82.5,103
DTaP,≥4 Doses,States/Local Areas,Alabama,2019,Age,35 Months,96.8,91.9 to 99.1,227
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,88.6,84.6 to 92.6,500
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,78.4,73.5 to 83.3,453
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,84.1,71.7 to 96.4,67
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.4,78.3 to 92.6,132
≥1 Dose MMR,,States/Local Areas,Alabama,2011,Age,19 Months,84.7,78.3 to 89.4,218
≥1 Dose MMR,,States/Local Areas,Alabama,2013,Age,19 Months,90.3,79.1 to 95.8,260
≥1 Dose MMR,,States/Local Areas,Alabama,2013-2014,Age,19 Months,89.7,83.4 to 93.8,536
≥1 Dose MMR,,States/Local Areas,Alabama,2012,Age,19 Months,91.0,86.4 to 94.1,233
≥1 Dose MMR,,States/Local Areas,Alabama,2014,Age,19 Months,89.1,83.0 to 93.2,276
≥1 Dose MMR,,States/Local Areas,Alabama,2014-2015,Age,19 Months,90.7,87.1 to 93.4,563
≥1 Dose Varicella,,States/Local Areas,Alabama,2017,Age,19 Months,90.5,85.3 to 94.0,259
≥1 Dose Varicella,,States/Local Areas,Alabama,2017-2018,Age,19 Months,89.1,84.5 to 92.4,491
≥1 Dose Varicella,,States/Local Areas,Alabama,2018,Age,19 Months,87.6,79.6 to 92.8,232
≥1 Dose Varicella,,States/Local Areas,Alabama,2018-2019,Age,19 Months,64.2,58.0 to 69.9,459
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,75.5,65.2 to 85.8,106
Polio,≥2 Doses,States/Local Areas,Alabama,2015,Age,13 Months,94.4,90.0 to 97.0,287
Polio,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,13 Months,93.7,90.6 to 95.8,596
Polio,≥2 Doses,States/Local Areas,Alabama,2016,Age,13 Months,93.0,88.0 to 96.0,309
Polio,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,13 Months,94.0,90.6 to 96.2,568
Polio,≥2 Doses,States/Local Areas,Alabama,2017,Age,13 Months,95.0,89.4 to 97.7,259
Polio,≥2 Doses,States/Local Areas,Alabama,2017-2018,Age,13 Months,94.7,90.2 to 97.2,491
Hep B,≥1 Dose,States/Local Areas,Alabama,2018,Age,3 Months,95.4,90.0 to 98.0,232
Hep B,≥1 Dose,States/Local Areas,Alabama,2018-2019,Age,3 Months,95.9,93.0 to 97.6,459
≥1 Dose Varicella,,States/Local Areas,Alabama,2019,Age,19 Months,93.5,88.3 to 96.5,227
Hep B,≥1 Dose,States/Local Areas,Alabama,2019,Age,3 Months,96.4,92.8 to 98.2,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2011,Age,0-1 Days,78.7,70.3 to 85.2,218
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2012,Age,0-1 Days,80.3,76.3 to 83.8,233
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,71.7,63.6 to 79.7,415
Hep B,≥2 Doses,States/Local Areas,Alabama,2011,Age,5 Months,83.9,77.4 to 88.7,218
Hep B,≥2 Doses,States/Local Areas,Alabama,2012,Age,5 Months,88.3,79.0 to 93.8,233
Hep B,≥2 Doses,States/Local Areas,Alabama,2013,Age,5 Months,82.4,76.2 to 87.3,260
Hep B,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,5 Months,85.2,82.1 to 87.8,536
Hep A,≥2 Doses,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,83.3,76.4 to 90.3,257
Hep B,≥2 Doses,States/Local Areas,Alabama,2014,Age,5 Months,87.9,81.9 to 92.2,276
Hep B,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,5 Months,85.5,81.3 to 88.9,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2014,Age,19 Months,91.7,86.3 to 95.2,276
Hep B,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,92.1,88.8 to 94.5,563
Hep B,≥3 Doses,States/Local Areas,Alabama,2015,Age,19 Months,92.5,89.1 to 94.9,287
Hep B,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,90.8,87.4 to 93.4,596
Hep B,≥3 Doses,States/Local Areas,Alabama,2016,Age,19 Months,89.2,83.6 to 93.0,309
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,19 Months,89.3,85.1 to 92.5,568
PCV,≥3 Doses,States/Local Areas,Alabama,2011,Age,7 Months,73.3,66.4 to 79.2,218
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.8,62.3 to 85.3,103
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.1,77.0 to 85.3,701
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,83.4,78.4 to 88.3,432
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.2,75.4 to 86.9,401
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,76.6,68.6 to 84.6,209
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Overall,Overall,81.3,77.9 to 84.7,1042
≥1 Dose MMR,,States/Local Areas,Alabama,2015,Age,19 Months,92.4,90.6 to 93.9,287
≥1 Dose MMR,,States/Local Areas,Alabama,2015-2016,Age,19 Months,89.2,85.7 to 91.9,596
≥1 Dose MMR,,States/Local Areas,Alabama,2016,Age,19 Months,85.9,80.2 to 90.1,309
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2017,Age,19 Months,88.5,84.8 to 91.3,568
DTaP,≥4 Doses,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,77.4,71.9 to 82.8,370
≥1 Dose MMR,,States/Local Areas,Alabama,2017,Age,19 Months,91.1,86.1 to 94.4,259
≥1 Dose MMR,,States/Local Areas,Alabama,2017-2018,Age,19 Months,89.4,84.9 to 92.6,491
≥1 Dose Varicella,,States/Local Areas,Alabama,2011,Age,24 Months,87.6,80.0 to 93.3,218
≥1 Dose Varicella,,States/Local Areas,Alabama,2012,Age,24 Months,91.7,85.5 to 96.0,233
≥1 Dose Varicella,,States/Local Areas,Alabama,2013,Age,24 Months,94.5,90.0 to 97.4,260
≥1 Dose Varicella,,States/Local Areas,Alabama,2013-2014,Age,24 Months,93.6,90.3 to 96.1,536
≥1 Dose Varicella,,States/Local Areas,Alabama,2014,Age,24 Months,92.7,87.3 to 96.4,276
≥1 Dose Varicella,,States/Local Areas,Alabama,2014-2015,Age,24 Months,93.0,89.8 to 95.5,563
Polio,≥2 Doses,States/Local Areas,Alabama,2018,Age,13 Months,94.5,88.8 to 97.4,232
Polio,≥2 Doses,States/Local Areas,Alabama,2018-2019,Age,13 Months,95.1,91.9 to 97.1,459
Polio,≥2 Doses,States/Local Areas,Alabama,2019,Age,13 Months,95.7,91.4 to 97.9,227
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2013,Age,0-1 Days,73.9,70.5 to 77.0,260
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2013-2014,Age,0-1 Days,79.1,75.0 to 82.7,536
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2014,Age,0-1 Days,84.3,78.1 to 89.0,276
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2014-2015,Age,0-1 Days,77.3,72.5 to 81.5,563
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2015,Age,0-1 Days,70.3,62.7 to 77.0,287
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2015-2016,Age,0-1 Days,73.7,68.6 to 78.2,596
Hep B,≥2 Doses,States/Local Areas,Alabama,2015,Age,5 Months,83.1,76.9 to 87.9,287
Hep B,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,5 Months,83.9,79.6 to 87.4,596
Hep B,≥2 Doses,States/Local Areas,Alabama,2016,Age,5 Months,84.6,78.2 to 89.4,309
Hep B,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,5 Months,84.1,79.4 to 87.9,568
DTaP,≥3 Doses,States/Local Areas,Alabama,2014,Age,19 Months,95.4,91.2 to 97.7,276
DTaP,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,19 Months,94.7,91.7 to 96.7,563
DTaP,≥3 Doses,States/Local Areas,Alabama,2015,Age,19 Months,94.0,91.1 to 96.1,287
DTaP,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,19 Months,92.7,89.4 to 95.1,596
DTaP,≥2 Doses,States/Local Areas,Alabama,2015,Age,5 Months,76.7,69.2 to 82.9,287
DTaP,≥2 Doses,States/Local Areas,Alabama,2015-2016,Age,5 Months,75.9,70.8 to 80.4,596
DTaP,≥2 Doses,States/Local Areas,Alabama,2016,Age,5 Months,75.1,67.8 to 81.2,309
DTaP,≥2 Doses,States/Local Areas,Alabama,2016-2017,Age,5 Months,76.8,71.5 to 81.4,568
Hib,Full Series,States/Local Areas,Alabama,2020-2021,Age,24 Months,71.6,64.9 to 77.9,400
Polio,≥3 Doses,States/Local Areas,Alabama,2016,Age,35 Months,93.0,88.6 to 96.2,309
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2017,Age,35 Months,94.1,90.9 to 96.5,568
Polio,≥3 Doses,States/Local Areas,Alabama,2017,Age,35 Months,95.2,89.9 to 98.3,259
Polio,≥3 Doses,States/Local Areas,Alabama,2017-2018,Age,35 Months,95.8,90.7 to 98.5,491
Hib,Full Series,States/Local Areas,Alabama,2019,Age,24 Months,79.4,72.0 to 85.9,227
Hib,Full Series,States/Local Areas,Alabama,2011,Age,35 Months,88.3,80.2 to 94.2,218
Hib,Full Series,States/Local Areas,Alabama,2012,Age,35 Months,81.4,72.7 to 88.7,233
Hib,Full Series,States/Local Areas,Alabama,2013,Age,35 Months,86.5,77.8 to 93.0,260
Hib,Full Series,States/Local Areas,Alabama,2013-2014,Age,35 Months,88.0,83.0 to 92.1,536
Hib,Full Series,States/Local Areas,Alabama,2014,Age,35 Months,89.7,83.5 to 94.3,276
Hib,Full Series,States/Local Areas,Alabama,2014-2015,Age,35 Months,89.4,84.6 to 93.2,563
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,95.3,92.4 to 98.2,500
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,94.4,92.2 to 96.6,453
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,96.2,91.3 to 100.0,67
DTaP,≥2 Doses,States/Local Areas,Alabama,2011,Age,5 Months,80.6,74.4 to 85.5,218
DTaP,≥2 Doses,States/Local Areas,Alabama,2012,Age,5 Months,84.7,79.4 to 88.8,233
DTaP,≥2 Doses,States/Local Areas,Alabama,2013,Age,5 Months,77.7,70.6 to 83.5,260
DTaP,≥2 Doses,States/Local Areas,Alabama,2013-2014,Age,5 Months,78.2,74.7 to 81.4,536
DTaP,≥2 Doses,States/Local Areas,Alabama,2014,Age,5 Months,78.8,71.6 to 84.6,276
DTaP,≥2 Doses,States/Local Areas,Alabama,2014-2015,Age,5 Months,77.8,75.3 to 80.1,563
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,88.8,84.9 to 92.7,500
Polio,≥3 Doses,States/Local Areas,Alabama,2019,Age,35 Months,97.9,95.4 to 99.3,227
Polio,≥3 Doses,States/Local Areas,Alabama,2018,Age,35 Months,95.2,88.4 to 98.6,232
Polio,≥3 Doses,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.7,93.1 to 98.8,459
Polio,≥3 Doses,States/Local Areas,Alabama,2013,Age,35 Months,94.4,89.3 to 97.6,260
Polio,≥3 Doses,States/Local Areas,Alabama,2013-2014,Age,35 Months,95.3,92.1 to 97.5,536
Polio,≥3 Doses,States/Local Areas,Alabama,2014,Age,35 Months,96.3,92.0 to 98.7,276
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2015,Age,35 Months,95.3,92.6 to 97.3,563
Polio,≥3 Doses,States/Local Areas,Alabama,2012,Age,35 Months,93.2,86.5 to 97.3,233
Polio,≥3 Doses,States/Local Areas,Alabama,2015,Age,35 Months,94.3,90.2 to 97.1,287
Polio,≥3 Doses,States/Local Areas,Alabama,2015-2016,Age,35 Months,93.8,90.9 to 96.0,596
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.2,92.8 to 99.7,132
Hib,Full Series,States/Local Areas,Alabama,2017,Age,35 Months,89.0,80.6 to 94.9,259
Hib,Full Series,States/Local Areas,Alabama,2017-2018,Age,35 Months,83.2,76.9 to 88.5,491
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,92.2,84.9 to 99.5,67
Hib,Full Series,States/Local Areas,Alabama,2015,Age,35 Months,90.2,82.6 to 95.5,287
Hib,Full Series,States/Local Areas,Alabama,2015-2016,Age,35 Months,85.9,81.3 to 89.9,596
Hib,Full Series,States/Local Areas,Alabama,2016,Age,35 Months,83.5,77.2 to 88.9,309
Hib,Full Series,States/Local Areas,Alabama,2016-2017,Age,35 Months,85.9,81.1 to 90.0,568
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.1,89.7 to 96.5,401
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,94.6,90.0 to 99.2,106
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,88.1 to 99.0,103
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,89.8 to 95.1,701
Polio,≥3 Doses,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,94.6,92.0 to 97.2,432
Hib,Full Series,States/Local Areas,Alabama,2018,Age,35 Months,77.4,68.3 to 85.5,232
Hib,Full Series,States/Local Areas,Alabama,2018-2019,Age,35 Months,79.9,74.1 to 85.2,459
Hib,Full Series,States/Local Areas,Alabama,2019,Age,35 Months,82.5,74.9 to 88.9,227
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,76.3,71.4 to 81.2,453
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.4,76.1 to 90.7,132
Hib,Primary Series,States/Local Areas,Alabama,2011,Age,7 Months,76.3,70.8 to 81.0,218
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,95.5,93.2 to 97.9,257
Hib,Primary Series,States/Local Areas,Alabama,2012,Age,7 Months,77.1,71.5 to 81.9,233
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,77.6,69.7 to 85.5,209
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Overall,Overall,80.7,77.4 to 84.0,1042
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,74.9,69.4 to 80.5,370
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,80.7,75.0 to 86.4,415
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,68.8,57.8 to 79.7,106
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.5,63.0 to 86.0,103
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.7,78.9 to 86.4,701
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,81.9,77.1 to 86.8,432
Hib,Full Series,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.9,75.2 to 86.5,401
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,96.1,89.1 to 98.7,252
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,96.8,93.6 to 98.4,497
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,94.4,89.9 to 96.9,237
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,90.9,86.9 to 93.7,462
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,97.0,94.6 to 98.6,250
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,96.6,94.5 to 98.1,487
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,91.1,86.3 to 94.4,250
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,92.7,89.7 to 94.9,487
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,88.1,84.4 to 91.1,248
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,89.7,86.1 to 92.4,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,87.3,80.9 to 91.8,225
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,24.1,19.6 to 29.4,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,95.9,91.7 to 98.0,237
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,96.9,94.5 to 98.3,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,97.4,94.7 to 98.7,250
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,96.6,94.4 to 98.0,487
Polio,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,96.2,92.4 to 98.4,248
Polio,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,96.6,94.5 to 98.0,498
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,97.6,94.9 to 99.0,245
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,96.9,94.7 to 98.3,493
Polio,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,97.5,93.9 to 99.0,225
Polio,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,77.9,72.9 to 82.2,502
Polio,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,96.8,91.3 to 98.8,277
Polio,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,97.0,93.9 to 98.7,221
Polio,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,98.2,96.1 to 99.3,233
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,90.0,83.7 to 94.0,245
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,89.0,85.1 to 92.1,493
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,88.6,81.7 to 93.1,252
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,89.3,85.5 to 92.2,497
Polio,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,95.6,92.1 to 97.8,252
Polio,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,96.6,94.5 to 98.0,497
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,98.0,94.3 to 99.3,225
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,95.9,92.8 to 97.7,502
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.7,82.6 to 88.9,641
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,98.9,96.8 to 99.7,233
Hib,Full Series,States/Local Areas,Rhode Island,2015,Age,24 Months,80.5,74.0 to 86.2,248
Hib,Full Series,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,83.7,79.6 to 87.4,498
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,97.2,91.6 to 99.1,277
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,98.0,95.2 to 99.4,221
Polio,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,98.5,96.3 to 99.5,233
Polio,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,98.7,94.9 to 99.8,221
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,89.2,83.0 to 93.3,277
Polio,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,96.8,92.3 to 99.0,277
Polio,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,97.5,94.4 to 99.1,225
Polio,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,97.2,94.7 to 98.7,502
Polio,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,96.3,92.3 to 98.5,237
Polio,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,96.9,94.6 to 98.4,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,97.6,94.3 to 99.0,245
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,97.5,95.5 to 98.6,493
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,97.4,94.4 to 98.8,248
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,97.4,95.5 to 98.5,498
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,5 Months,88.2,81.7 to 92.5,245
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,5 Months,87.0,82.6 to 90.3,493
Hib,Full Series,States/Local Areas,Rhode Island,2017,Age,24 Months,86.0,80.2 to 90.8,237
Hib,Full Series,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,87.8,83.7 to 91.3,462
Hib,Full Series,States/Local Areas,Rhode Island,2016,Age,24 Months,86.9,81.4 to 91.4,250
Hib,Full Series,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,86.4,82.5 to 89.8,487
Polio,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,97.8,94.1 to 99.4,248
Polio,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,97.1,95.0 to 98.5,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,91.7,86.6 to 95.3,252
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,93.0,89.6 to 95.5,497
Hib,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,94.1,89.3 to 97.2,233
Hib,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,94.0,89.1 to 97.2,221
Polio,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,99.3,95.5 to 100.0,237
Polio,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,99.3,97.2 to 99.9,462
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,97.0,94.6 to 98.6,250
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,97.5,94.9 to 98.9,487
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,5 Months,85.8,79.3 to 90.5,248
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,5 Months,86.5,82.3 to 89.8,498
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,5 Months,86.9,80.2 to 91.6,252
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,5 Months,87.5,82.6 to 91.2,497
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,5 Months,87.6,84.1 to 90.4,233
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,5 Months,83.3,78.7 to 87.0,221
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,99.1,97.5 to 99.7,245
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,98.3,96.4 to 99.3,493
Polio,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,96.0,92.6 to 98.1,252
Polio,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,97.4,95.5 to 98.6,497
Hib,Full Series,States/Local Areas,Rhode Island,2019,Age,24 Months,88.5,83.1 to 92.8,277
Hib,Full Series,States/Local Areas,Rhode Island,2018,Age,24 Months,89.8,83.9 to 94.2,225
Hib,Full Series,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,89.2,85.3 to 92.4,502
Hib,Full Series,States/Local Areas,Rhode Island,2011,Age,35 Months,90.2,84.1 to 94.7,221
Hib,Full Series,States/Local Areas,Rhode Island,2012,Age,35 Months,87.7,81.2 to 92.7,233
Hib,Full Series,States/Local Areas,Rhode Island,2013,Age,35 Months,86.8,80.7 to 91.7,252
Hib,Full Series,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,88.7,84.6 to 92.1,497
Hib,Full Series,States/Local Areas,Rhode Island,2015,Age,35 Months,84.2,77.3 to 89.9,248
Hib,Full Series,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,87.3,82.7 to 91.1,498
Hib,Full Series,States/Local Areas,Rhode Island,2017,Age,35 Months,86.3,80.5 to 91.1,237
Hib,Full Series,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,88.3,84.2 to 91.8,462
Polio,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,99.4,96.7 to 100.0,225
Polio,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,97.8,95.0 to 99.2,502
Hib,Full Series,States/Local Areas,Rhode Island,2014,Age,35 Months,90.9,85.0 to 95.1,245
Hib,Full Series,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,87.4,82.9 to 91.2,493
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,97.5,96.2 to 98.9,525
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,95.2,92.8 to 97.6,361
Hib,Full Series,States/Local Areas,Rhode Island,2016,Age,35 Months,90.3,84.2 to 94.8,250
Hib,Full Series,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,88.4,84.2 to 92.0,487
Polio,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,96.8,92.3 to 99.0,277
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,86.4,83.0 to 89.8,525
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,83.9,79.4 to 88.4,361
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.6,73.6 to 97.6,38
Hib,Full Series,States/Local Areas,Rhode Island,2018,Age,35 Months,90.6,84.7 to 94.9,225
Hib,Full Series,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,90.3,86.4 to 93.4,502
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,96.2,93.9 to 98.4,258
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.9,91.4 to 100.0,94
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.2,94.4 to 98.1,523
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,94.8,92.0 to 97.6,272
Hib,Full Series,States/Local Areas,Rhode Island,2019,Age,35 Months,89.9,84.6 to 94.0,277
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.0,91.1 to 100.0,38
Hib,Primary Series,States/Local Areas,Rhode Island,2011,Age,7 Months,89.0,85.2 to 91.8,221
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,88.6,85.0 to 92.3,358
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,49.9,41.5 to 59.0,233
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,95.4,92.9 to 98.0,279
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,92.2,87.0 to 95.8,245
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,89.7,86.1 to 92.7,493
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,83.7,77.4 to 89.0,250
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,86.7,82.6 to 90.2,487
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,87.2,81.8 to 91.5,248
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,85.4,81.4 to 89.0,498
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,35 Months,98.7,93.5 to 99.9,250
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,96.4,92.2 to 98.7,487
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,83.1,77.6 to 88.5,258
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,71.8 to 90.1,94
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.8,83.3 to 90.2,523
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,83.3,78.0 to 88.6,272
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,85.0,82.2 to 87.7,913
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,81.3,76.0 to 86.6,279
Hib,Full Series,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,85.5,80.6 to 90.4,276
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014,Age,13 Months,65.4,56.8 to 73.1,245
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,64.7,59.1 to 70.0,493
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015,Age,13 Months,64.0,56.5 to 71.0,248
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,62.3,57.1 to 67.2,498
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,35 Months,93.3,89.1 to 96.3,252
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,98.2,92.4 to 99.8,497
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,35 Months,92.8,86.8 to 96.8,245
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,99.0,94.3 to 99.9,493
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,35 Months,96.8,91.7 to 99.1,248
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,97.5,93.9 to 99.2,498
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,35 Months,94.8,90.4 to 97.6,237
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,96.4,92.9 to 98.4,462
Polio,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,5 Months,87.2,81.4 to 91.4,250
Polio,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,5 Months,86.8,82.5 to 90.1,487
Polio,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,5 Months,86.3,79.4 to 91.2,237
Polio,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,5 Months,87.3,82.6 to 90.9,462
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,89.1,82.8 to 93.3,245
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,89.6,85.7 to 92.5,493
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,90.1,84.8 to 93.7,248
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,89.4,85.8 to 92.2,498
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,67.3,59.5 to 74.8,237
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,61.8,56.0 to 67.6,462
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,51.3,44.1 to 59.0,250
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,59.2,53.9 to 64.6,487
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,87.3,81.3 to 92.1,252
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,89.7,85.8 to 92.9,497
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,72.4,64.9 to 78.9,277
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,83.6,77.2 to 88.4,252
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,86.2,83.2 to 88.8,497
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,87.6,80.7 to 92.8,221
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,88.2,82.4 to 92.7,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,7 Months,90.2,83.6 to 94.3,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,7 Months,85.1,80.0 to 89.2,221
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,96.7,94.7 to 98.8,276
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,98.0,96.4 to 99.5,358
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,96.0,90.8 to 98.7,225
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,95.3,91.9 to 97.5,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,96.7,95.4 to 97.9,913
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,56.2,48.7 to 63.8,248
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,53.7,48.5 to 59.1,498
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,51.6,43.3 to 60.4,245
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,53.9,48.3 to 59.8,493
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2011,Age,13 Months,55.9,44.4 to 66.7,221
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013,Age,13 Months,51.4,46.2 to 56.6,252
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,55.1,51.1 to 59.0,497
Polio,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,5 Months,88.4,81.8 to 92.7,225
Polio,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,5 Months,87.7,83.3 to 91.0,502
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.7,84.6 to 100.0,38
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,35 Months,98.5,94.5 to 99.8,277
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,93.3,91.0 to 95.6,525
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,92.7,89.8 to 95.6,361
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,35 Months,97.7,91.9 to 99.6,225
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,99.0,95.6 to 99.9,502
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2012,Age,13 Months,57.7,49.3 to 65.6,233
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014,Age,13 Months,58.9,50.5 to 66.8,245
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,61.4,55.9 to 66.7,493
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,90.0,84.2 to 93.8,277
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,84.1,75.5 to 91.0,245
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,83.8,77.8 to 88.9,493
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,87.2,80.1 to 92.7,250
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,88.3,83.2 to 92.4,487
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,82.8,74.7 to 89.5,248
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,85.5,80.2 to 90.1,498
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,91.3,85.5 to 94.9,225
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,90.7,86.8 to 93.5,502
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,91.1,85.3 to 94.8,237
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,91.2,87.4 to 94.0,462
Polio,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,5 Months,86.9,80.5 to 91.5,277
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,91.7,88.0 to 95.4,258
Polio,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,7 Months,96.9,90.5 to 99.0,233
Polio,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,7 Months,95.3,92.8 to 96.9,221
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,56.4,48.0 to 65.1,225
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,57.6,51.9 to 63.4,502
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,58.9,51.4 to 66.6,277
Polio,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,5 Months,86.3,79.8 to 90.9,248
Polio,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,5 Months,86.8,82.6 to 90.0,498
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,88.7,83.3 to 92.5,250
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,89.9,86.2 to 92.7,487
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,70.3,56.9 to 82.7,221
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,79.8,71.3 to 87.1,233
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,84.7,76.6 to 91.2,252
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,84.3,78.6 to 89.2,497
Polio,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,96.6,91.6 to 98.6,252
Polio,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,97.8,95.4 to 98.9,497
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,3 Months,95.9,91.5 to 98.1,245
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,3 Months,96.0,93.4 to 97.6,493
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,3 Months,96.2,92.3 to 98.1,248
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,3 Months,97.1,95.0 to 98.3,498
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,3 Months,98.0,95.5 to 99.1,250
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,3 Months,97.8,95.6 to 98.9,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018,Age,13 Months,78.7,71.2 to 84.6,225
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,77.9,72.9 to 82.2,502
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016,Age,13 Months,60.6,53.2 to 67.4,250
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,64.6,59.4 to 69.5,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017,Age,13 Months,68.8,61.1 to 75.6,237
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,73.7,68.3 to 78.5,462
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014,Age,19 Months,94.3,89.2 to 97.1,245
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,93.1,89.7 to 95.4,493
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015,Age,19 Months,91.8,86.7 to 95.1,248
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,91.3,87.9 to 93.8,498
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013,Age,19 Months,89.8,84.5 to 93.4,252
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,92.0,89.9 to 93.7,497
Polio,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,98.9,97.3 to 99.6,233
Polio,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,98.8,96.4 to 99.6,221
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,87.3,81.5 to 92.0,277
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,95.8,90.3 to 98.7,221
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016,Age,13 Months,58.7,51.3 to 65.6,250
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,63.1,57.9 to 68.0,487
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017,Age,13 Months,67.6,60.0 to 74.4,237
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,70.5,65.1 to 75.3,462
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015,Age,13 Months,63.9,56.6 to 70.7,248
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,61.3,56.1 to 66.2,498
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.4,89.4 to 99.4,94
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.6,90.0 to 95.2,523
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,90.7,86.9 to 94.4,272
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.4,91.2 to 95.6,641
Polio,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,98.0,96.2 to 99.0,245
Polio,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,97.0,95.1 to 98.1,493
Polio,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,93.0,84.5 to 97.0,252
Polio,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,95.4,91.4 to 97.6,497
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,92.6,90.7 to 94.5,913
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,91.1,87.6 to 94.7,279
Polio,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,95.9,92.4 to 97.8,248
Polio,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,95.4,93.0 to 97.0,498
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,94.7,88.1 to 97.8,221
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,87.6,79.4 to 93.7,225
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,88.9,83.9 to 92.9,502
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,88.8,81.2 to 94.4,237
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,88.4,82.9 to 92.8,462
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,94.3,87.8 to 97.4,252
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,94.6,92.3 to 96.2,497
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,94.9,90.4 to 97.3,245
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,95.3,92.5 to 97.1,493
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,89.7,83.3 to 94.4,277
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,97.6,94.3 to 99.0,233
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,88.9,82.9 to 93.4,252
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,94.9,88.0 to 98.5,497
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,92.3,86.8 to 96.1,233
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,94.6,88.5 to 98.1,245
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,97.6,92.4 to 99.5,493
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018,Age,13 Months,73.4,65.5 to 80.0,225
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,73.1,67.9 to 77.7,502
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013,Age,13 Months,55.1,48.6 to 61.5,252
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,60.1,55.4 to 64.7,497
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,85.1,80.6 to 89.6,525
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,85.3,78.5 to 92.0,361
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.2,60.9 to 100.0,38
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.5,79.9 to 89.2,523
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,82.9,76.6 to 89.2,272
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,87.6,81.7 to 92.3,225
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,87.4,83.4 to 90.9,502
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,89.7,84.2 to 93.9,237
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,88.7,84.6 to 92.1,462
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,86.4,77.5 to 95.3,258
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",100.0,,94
≥1 Dose MMR,,States/Local Areas,Rhode Island,2012,Age,13 Months,57.5,51.8 to 63.1,233
≥1 Dose MMR,,States/Local Areas,Rhode Island,2011,Age,13 Months,57.4,47.9 to 66.4,221
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,35 Months,95.3,89.9 to 98.4,301
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019,Age,13 Months,72.7,65.7 to 78.8,277
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2011,Age,19 Months,91.1,87.3 to 93.8,221
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2012,Age,19 Months,89.2,85.6 to 92.0,233
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,93.7,90.5 to 96.9,276
Polio,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,5 Months,86.8,83.2 to 89.8,233
Polio,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,5 Months,82.4,77.2 to 86.6,221
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,35 Months,95.2,90.5 to 98.0,233
Polio,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,5 Months,85.5,76.9 to 91.2,252
Polio,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,5 Months,86.4,81.0 to 90.4,497
Polio,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,5 Months,87.4,81.0 to 91.8,245
Polio,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,5 Months,86.8,83.3 to 89.7,493
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,72.8,65.0 to 79.4,225
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,97.9,95.2 to 99.1,502
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,51.0,43.0 to 59.5,252
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,51.3,45.5 to 57.4,497
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,70.7,63.5 to 77.0,250
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,74.6,69.6 to 79.1,487
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,78.6,71.5 to 84.4,237
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,75.7,70.4 to 80.3,462
PCV,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,5 Months,87.2,80.8 to 91.7,277
PCV,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,5 Months,86.4,79.5 to 91.2,237
PCV,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,5 Months,86.7,81.9 to 90.3,462
PCV,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,5 Months,87.0,80.4 to 91.6,225
PCV,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,5 Months,87.1,82.7 to 90.5,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.0,91.1 to 100.0,38
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,96.6,94.4 to 98.8,258
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.7,92.5 to 100.0,94
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.7,95.0 to 98.3,523
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,95.6,93.0 to 98.1,272
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.2,95.8 to 98.6,641
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,94.7,89.7 to 97.7,277
Hib,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,5 Months,83.1,79.2 to 86.3,233
Hib,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,5 Months,81.4,75.0 to 86.4,221
Hib,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,5 Months,85.0,76.4 to 90.9,252
Hib,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,5 Months,84.9,79.2 to 89.3,497
Hib,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,5 Months,84.9,78.0 to 89.9,245
Hib,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,5 Months,84.6,81.5 to 87.2,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,96.8,93.0 to 98.6,237
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,97.2,94.9 to 98.5,462
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,95.8,90.5 to 98.2,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,97.6,94.8 to 99.1,221
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,97.6,94.2 to 99.1,225
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,95.4,92.3 to 97.3,502
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,98.0,93.9 to 99.4,277
PCV,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,3 Months,93.8,89.8 to 96.3,221
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,93.6,89.9 to 97.2,276
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,96.8,94.9 to 98.7,358
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.3,93.4 to 97.2,641
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,95.1,93.5 to 96.7,913
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,94.6,91.8 to 97.4,279
Hib,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,5 Months,84.3,77.8 to 89.2,248
Hib,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,5 Months,84.1,79.7 to 87.7,498
Hib,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,5 Months,83.9,77.4 to 88.8,250
Hib,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,5 Months,85.1,80.6 to 88.7,487
PCV,≥4 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,90.6,84.7 to 94.8,237
PCV,≥4 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,91.1,87.1 to 94.3,462
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,89.6,84.4 to 93.6,250
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,90.1,86.2 to 93.2,487
PCV,≥4 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,91.9,86.5 to 95.7,225
PCV,≥4 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,92.3,88.8 to 95.0,502
PCV,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,3 Months,92.0,86.2 to 95.5,252
PCV,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,3 Months,91.1,87.2 to 93.8,497
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,88.8,85.1 to 92.4,361
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,88.6,84.1 to 93.1,258
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.5,80.3 to 98.7,38
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,96.2,91.7 to 98.7,245
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,96.5,94.0 to 98.1,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,99.1,96.9 to 99.8,233
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,97.1,93.8 to 98.9,252
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,96.7,94.1 to 98.4,497
Hib,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,3 Months,92.5,86.3 to 96.1,277
Hib,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,3 Months,91.8,86.3 to 95.2,225
Hib,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,3 Months,92.2,88.3 to 94.8,502
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.8,92.5 to 97.1,523
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,94.6,91.6 to 97.6,272
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,97.1,95.2 to 98.9,358
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,96.2,91.9 to 98.6,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,96.2,90.9 to 98.5,245
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,96.5,93.8 to 98.1,493
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,99.7,98.2 to 100.0,225
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,97.9,95.6 to 99.2,502
PCV,≥4 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,86.7,80.8 to 91.5,252
PCV,≥4 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,90.0,86.2 to 93.1,497
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.0,91.1 to 100.0,38
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,94.6,91.8 to 97.3,258
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.6,92.0 to 100.0,94
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,94.7,92.2 to 97.2,361
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,96.6,94.9 to 98.2,525
PCV,≥4 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,93.6,89.2 to 96.6,248
PCV,≥4 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,91.6,88.3 to 94.2,498
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,93.5,88.3 to 96.9,245
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,93.4,90.2 to 95.9,493
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,99.1,96.3 to 99.8,225
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,98.5,96.5 to 99.4,502
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,97.4,94.7 to 98.7,250
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,97.8,96.1 to 98.8,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,96.8,93.9 to 98.3,248
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,95.8,93.5 to 97.3,498
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,94.9,91.1 to 97.2,250
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,95.9,93.4 to 97.4,487
Hib,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,3 Months,91.8,86.7 to 95.1,248
Hib,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,3 Months,93.1,90.0 to 95.4,498
Hib,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,3 Months,94.5,89.9 to 97.0,250
Hib,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,3 Months,93.9,90.7 to 96.1,487
Hib,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,3 Months,93.3,87.9 to 96.4,237
Hib,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,3 Months,92.6,89.1 to 95.0,462
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,98.3,95.5 to 99.3,237
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,98.7,97.1 to 99.4,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018,Age,35 Months,98.1,94.3 to 99.6,225
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,98.1,95.0 to 99.5,502
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017,Age,35 Months,95.4,90.5 to 98.2,237
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,96.7,93.9 to 98.5,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019,Age,35 Months,98.0,92.3 to 99.8,277
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.3,91.4 to 100.0,94
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,91.5 to 96.2,523
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,91.8,88.2 to 95.5,272
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.6,80.1 to 100.0,38
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019,Age,35 Months,98.6,95.2 to 99.7,277
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,95.3,93.3 to 97.2,525
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,93.9,91.3 to 96.6,361
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018,Age,35 Months,97.4,93.5 to 99.2,225
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,97.9,95.5 to 99.2,502
PCV,≥4 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,92.1,87.9 to 95.2,248
PCV,≥4 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,90.1,86.9 to 92.9,498
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016,Age,35 Months,95.1,91.0 to 97.7,250
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,95.2,92.2 to 97.3,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014,Age,35 Months,99.7,98.2 to 100.0,245
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,98.3,95.6 to 99.5,493
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015,Age,35 Months,95.2,91.0 to 97.8,248
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,95.3,92.4 to 97.3,498
PCV,≥4 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,90.2,84.4 to 94.5,237
PCV,≥4 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,90.9,86.8 to 94.1,462
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,88.3,83.0 to 92.5,250
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,89.2,85.3 to 92.5,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,95.5,90.9 to 97.8,225
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,95.4,92.3 to 97.3,502
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,94.2,89.6 to 96.9,237
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,94.8,91.9 to 96.7,462
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,96.4,91.3 to 98.6,277
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,98.2,95.2 to 99.4,221
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,98.6,96.4 to 99.4,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,98.3,96.4 to 99.3,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,97.0,92.8 to 99.0,245
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,97.2,94.3 to 98.8,493
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,95.5,92.0 to 97.8,252
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,96.4,93.8 to 98.1,497
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,91.8,87.1 to 94.8,250
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,93.0,89.9 to 95.1,487
Hib,Full Series,States/Local Areas,Rhode Island,2020,Age,24 Months,86.1,80.3 to 90.9,301
PCV,≥4 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,91.7,86.4 to 95.5,225
PCV,≥4 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,91.5,88.0 to 94.3,502
PCV,≥4 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,91.6,86.6 to 95.2,277
PCV,≥4 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,93.5,89.3 to 96.4,221
PCV,≥4 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,94.7,90.4 to 97.5,233
PCV,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,97.7,95.6 to 98.8,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,97.4,93.9 to 99.2,237
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,99.4,97.4 to 99.9,462
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,95.3,90.0 to 97.8,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,97.6,95.0 to 98.8,221
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,96.0,91.7 to 98.1,252
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,96.1,93.3 to 97.8,497
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,96.9,93.1 to 98.9,248
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,96.6,94.4 to 98.1,498
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,96.4,93.6 to 98.2,250
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,96.9,94.9 to 98.3,487
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,94.1,91.1 to 97.1,258
Hib,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,3 Months,92.8,88.7 to 95.5,252
Hib,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,3 Months,92.3,89.7 to 94.2,497
Hib,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,3 Months,91.3,87.4 to 94.0,233
Hib,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,3 Months,93.0,90.2 to 95.1,221
Hib,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,3 Months,91.7,85.4 to 95.4,245
Hib,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,3 Months,91.8,88.0 to 94.4,493
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,97.8,95.0 to 99.1,245
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,97.8,96.0 to 98.8,493
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,97.8,94.7 to 99.1,248
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,97.6,95.8 to 98.6,498
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,96.6,92.3 to 98.5,252
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,97.2,95.4 to 98.3,497
PCV,≥4 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,92.9,87.9 to 96.3,277
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,93.2,90.9 to 95.6,525
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,91.2,87.4 to 95.0,276
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,94.0,92.2 to 95.7,913
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,93.3,90.1 to 96.4,279
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,93.1 to 96.8,641
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,99.1,96.3 to 99.8,225
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,97.8,95.2 to 99.0,502
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2019,Age,0-2 Days,76.8,69.6 to 82.8,277
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2018,Age,0-2 Days,78.4,71.6 to 84.0,225
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2018-2019,Age,0-2 Days,77.7,72.8 to 81.9,502
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2017,Age,0-2 Days,71.7,63.7 to 78.6,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2017-2018,Age,0-2 Days,75.1,69.8 to 79.7,462
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,96.2,91.9 to 98.6,277
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,97.1,93.7 to 98.9,237
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,97.8,95.9 to 99.0,462
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,96.2,92.8 to 98.3,221
PCV,≥4 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,91.8,86.7 to 95.4,233
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,93.2,88.1 to 96.7,245
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,92.6,89.5 to 95.1,493
PCV,≥4 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,86.2,80.3 to 91.0,252
PCV,≥4 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,89.6,85.8 to 92.8,497
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019,Age,24 Months,95.8,91.3 to 98.4,277
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018,Age,24 Months,97.2,93.6 to 99.0,225
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,96.5,93.9 to 98.2,502
≥1 Dose MMR,,States/Local Areas,Rhode Island,2011,Age,35 Months,95.8,90.9 to 98.5,221
≥1 Dose MMR,,States/Local Areas,Rhode Island,2012,Age,35 Months,95.6,91.4 to 98.1,233
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016,Age,35 Months,97.0,91.2 to 99.4,250
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,97.3,92.6 to 99.3,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013,Age,35 Months,94.6,90.7 to 97.3,252
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,99.2,96.6 to 99.9,497
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,98.6,96.2 to 99.6,225
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,97.4,95.1 to 98.8,502
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,97.0,93.8 to 98.6,248
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,97.2,95.3 to 98.3,498
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,93.9,88.2 to 97.0,245
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,94.0,90.8 to 96.1,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,94.1,90.0 to 96.6,248
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,92.9,90.0 to 95.0,498
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2014,Age,0-2 Days,64.7,56.2 to 72.3,245
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2014-2015,Age,0-2 Days,70.0,64.6 to 75.0,493
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2015,Age,0-2 Days,75.4,68.5 to 81.1,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2015-2016,Age,0-2 Days,75.5,70.9 to 79.7,498
PCV,≥4 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,86.6,80.2 to 91.2,225
PCV,≥4 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,87.8,82.8 to 91.4,374
PCV,≥4 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,88.0,81.6 to 92.4,237
PCV,≥4 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,87.3,82.7 to 90.8,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017,Age,24 Months,94.6,90.3 to 97.4,237
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,95.9,93.2 to 97.7,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016,Age,24 Months,93.6,89.3 to 96.6,250
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,94.1,91.2 to 96.3,487
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,7 Months,97.5,95.5 to 98.7,221
PCV,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,96.7,94.2 to 98.1,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,96.4,93.6 to 98.2,250
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,96.8,94.7 to 98.2,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,96.9,93.1 to 98.9,248
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,96.6,94.4 to 98.1,498
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,95.3,91.3 to 97.8,245
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,96.0,93.4 to 97.8,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,78.9,72.3 to 84.3,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,95.6,92.0 to 97.6,221
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,81.2,74.3 to 86.5,225
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,80.1,75.4 to 84.0,502
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,97.6,94.8 to 98.9,245
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,97.3,95.4 to 98.4,493
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,7 Months,97.8,94.3 to 99.1,233
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2019,Age,0-1 Days,70.1,62.6 to 76.7,277
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2011,Age,0-2 Days,69.0,63.9 to 73.6,221
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2018,Age,0-1 Days,72.0,64.3 to 78.5,225
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2018-2019,Age,0-1 Days,71.1,65.8 to 75.8,502
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2013,Age,0-2 Days,73.1,70.0 to 76.0,252
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2013-2014,Age,0-2 Days,69.0,66.2 to 71.7,497
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2012,Age,0-2 Days,69.7,63.5 to 75.2,233
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,94.3,88.7 to 97.2,252
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,95.9,93.3 to 97.5,497
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,96.2,91.2 to 98.5,277
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,96.0,92.7 to 98.1,221
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,94.4,90.7 to 97.0,252
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,94.9,92.2 to 96.8,497
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,75.6,68.5 to 81.5,250
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,78.7,73.9 to 82.8,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,24 Months,98.3,96.4 to 99.3,233
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,81.9,75.1 to 87.1,237
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,81.5,76.8 to 85.5,462
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,81.7,75.3 to 86.8,248
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,78.6,74.0 to 82.7,498
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,91.0,85.0 to 94.8,245
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,89.8,86.0 to 92.6,493
PCV,≥4 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,88.5,86.0 to 90.6,248
PCV,≥4 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,86.4,82.5 to 89.6,498
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,84.3,78.2 to 89.0,250
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,86.1,81.8 to 89.6,487
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018,Age,24 Months,96.5,92.7 to 98.7,225
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,95.5,92.7 to 97.5,502
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015,Age,24 Months,95.2,91.0 to 97.8,248
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,94.3,91.4 to 96.5,498
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014,Age,24 Months,96.3,91.7 to 98.7,245
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,95.7,92.8 to 97.7,493
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013,Age,24 Months,94.6,90.7 to 97.3,252
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,95.5,92.7 to 97.5,497
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019,Age,24 Months,94.5,89.8 to 97.5,277
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017,Age,24 Months,94.6,90.5 to 97.3,237
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,95.5,92.9 to 97.4,462
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2016,Age,0-2 Days,75.7,69.1 to 81.3,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2016-2017,Age,0-2 Days,73.8,68.6 to 78.3,487
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,97.4,94.7 to 98.7,250
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,97.5,95.7 to 98.6,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,92.4,86.2 to 96.0,252
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,93.1,89.7 to 95.5,497
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,97.7,94.5 to 99.0,237
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,98.4,96.6 to 99.2,462
PCV,≥4 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,86.6,80.3 to 91.1,277
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013,Age,35 Months,96.7,92.9 to 98.8,252
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,99.2,96.5 to 99.9,497
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2012,Age,35 Months,95.7,92.0 to 98.1,233
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015,Age,35 Months,94.4,90.4 to 97.1,248
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,95.9,92.4 to 98.0,498
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014,Age,35 Months,99.1,96.4 to 99.9,245
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,97.4,94.2 to 99.0,493
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017,Age,35 Months,96.4,90.8 to 99.0,237
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,96.6,93.7 to 98.3,462
PCV,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,3 Months,92.7,88.4 to 95.5,233
PCV,≥4 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,93.2,89.0 to 96.2,221
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2011,Age,35 Months,96.4,91.9 to 98.8,221
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2015,Age,0-1 Days,62.5,55.2 to 69.4,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2015-2016,Age,0-1 Days,62.3,57.1 to 67.1,498
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,5 Months,98.6,95.6 to 99.5,225
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,5 Months,95.7,92.6 to 97.5,502
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,5 Months,92.6,86.8 to 96.0,277
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,5 Months,93.0,86.6 to 96.5,237
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,5 Months,95.8,92.4 to 97.7,462
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014,Age,24 Months,95.3,90.6 to 98.1,245
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,94.7,91.8 to 96.9,493
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2016,Age,0-1 Days,62.0,54.8 to 68.7,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2016-2017,Age,0-1 Days,62.5,57.2 to 67.5,487
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2017,Age,0-1 Days,63.0,55.0 to 70.4,237
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2017-2018,Age,0-1 Days,67.5,61.9 to 72.6,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017,Age,19 Months,92.7,86.6 to 96.1,237
≥1 Dose MMR,,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,94.5,91.1 to 96.6,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019,Age,19 Months,94.5,89.2 to 97.3,277
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018,Age,19 Months,96.3,92.3 to 98.3,225
≥1 Dose MMR,,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,96.6,93.6 to 98.2,502
PCV,≥4 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,83.4,75.3 to 89.2,252
PCV,≥4 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,87.1,83.8 to 89.8,497
PCV,≥4 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,83.1,74.3 to 89.3,233
PCV,≥4 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,88.1,83.2 to 91.7,221
≥1 Dose MMR,,States/Local Areas,Rhode Island,2011,Age,24 Months,95.8,90.9 to 98.5,221
≥1 Dose MMR,,States/Local Areas,Rhode Island,2012,Age,24 Months,94.1,90.0 to 97.0,233
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015,Age,24 Months,94.1,90.1 to 96.8,248
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,93.3,90.4 to 95.6,498
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016,Age,24 Months,92.5,88.1 to 95.8,250
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,93.6,90.7 to 95.8,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,98.6,95.7 to 99.6,225
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,97.3,94.7 to 98.6,502
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,97.1,93.2 to 98.8,237
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,97.8,95.7 to 98.9,462
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,5 Months,95.0,91.2 to 97.2,250
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,5 Months,94.0,90.6 to 96.2,487
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,5 Months,92.6,87.2 to 95.9,245
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,5 Months,94.5,91.4 to 96.5,493
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2012,Age,0-1 Days,59.2,50.9 to 67.1,233
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,74.7,70.7 to 78.3,252
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,76.0,72.1 to 79.5,497
PCV,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,7 Months,75.4,72.0 to 78.4,221
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,96.4,93.3 to 98.1,250
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,96.8,94.6 to 98.1,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,77.3,69.5 to 83.6,245
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,79.5,74.6 to 83.7,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,7 Months,72.3,69.5 to 74.9,233
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,88.9,84.5 to 93.3,276
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,91.6,88.5 to 94.8,358
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019,Age,13 Months,77.1,70.0 to 82.9,277
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,89.5,81.0 to 95.3,301
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016,Age,19 Months,90.7,85.7 to 94.1,250
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,90.4,86.6 to 93.2,487
Polio,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,97.4,94.2 to 98.8,248
Polio,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,97.1,95.2 to 98.3,498
Polio,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,96.9,94.0 to 98.4,250
Polio,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,96.8,94.5 to 98.1,487
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,3 Months,97.6,92.8 to 99.3,237
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,3 Months,98.4,96.0 to 99.4,462
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018,Age,19 Months,95.8,91.2 to 98.0,225
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,73.1,67.9 to 77.7,502
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017,Age,19 Months,90.0,83.6 to 94.1,237
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,92.9,89.2 to 95.4,462
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013,Age,19 Months,92.1,86.9 to 95.4,252
≥1 Dose MMR,,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,93.7,90.8 to 95.7,497
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014,Age,19 Months,95.4,90.1 to 97.9,245
≥1 Dose MMR,,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,93.9,90.4 to 96.2,493
≥1 Dose MMR,,States/Local Areas,Rhode Island,2012,Age,19 Months,91.5,84.5 to 95.5,233
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,91.4,85.4 to 95.6,225
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,93.1,89.3 to 95.9,502
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019,Age,19 Months,93.5,88.1 to 96.5,277
Polio,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,97.2,91.6 to 99.1,277
Polio,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,98.6,95.7 to 99.6,225
Polio,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,97.9,95.2 to 99.1,502
Polio,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,96.7,92.5 to 98.6,237
Polio,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,97.6,95.4 to 98.8,462
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013,Age,24 Months,94.0,89.9 to 96.8,252
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,94.7,91.7 to 96.8,497
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2013,Age,0-1 Days,59.7,51.1 to 67.7,252
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2013-2014,Age,0-1 Days,53.5,45.7 to 61.2,497
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2014,Age,0-1 Days,47.0,39.0 to 55.2,245
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2014-2015,Age,0-1 Days,54.8,49.3 to 60.2,493
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,5 Months,96.3,92.9 to 98.1,248
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,5 Months,95.6,93.3 to 97.2,498
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,94.2,89.2 to 97.3,277
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,91.6,89.0 to 94.2,525
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,84.5,80.2 to 88.7,361
≥1 Dose MMR,,States/Local Areas,Rhode Island,2011,Age,19 Months,92.6,88.8 to 95.2,221
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.8,65.9 to 93.8,38
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,95.9,90.9 to 98.2,277
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,96.0,93.1 to 97.7,221
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,98.6,95.7 to 99.6,225
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,97.3,94.7 to 98.6,502
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,98.3,95.9 to 99.3,233
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,3 Months,98.1,94.4 to 99.4,277
Polio,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,99.0,97.7 to 99.6,245
Polio,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,98.2,96.6 to 99.1,493
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,3 Months,99.2,96.2 to 99.8,225
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,3 Months,98.6,96.7 to 99.5,502
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2011,Age,0-1 Days,59.4,50.2 to 68.1,221
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,87.1,80.1 to 94.0,276
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,5 Months,94.0,90.0 to 96.5,233
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,5 Months,91.9,87.3 to 95.0,221
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,5 Months,93.2,88.8 to 95.9,252
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,5 Months,92.9,90.5 to 94.8,497
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,94.4,87.9 to 97.6,252
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,94.9,92.4 to 96.5,497
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,85.9,80.7 to 91.1,358
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,95.3,90.7 to 97.7,245
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,95.7,92.8 to 97.5,493
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,96.1,89.8 to 98.6,248
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,96.3,93.9 to 97.8,498
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,87.3,83.0 to 91.6,272
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.7,84.7 to 90.7,641
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,87.6,85.1 to 90.1,913
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.5,81.2 to 95.9,94
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.0,87.1 to 93.0,523
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,84.3,79.2 to 89.5,258
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015,Age,19 Months,92.5,87.5 to 95.5,248
≥1 Dose MMR,,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,92.3,88.8 to 94.7,498
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016,Age,19 Months,92.1,87.3 to 95.2,250
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,92.4,88.8 to 94.9,487
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2011,Age,24 Months,94.2,88.9 to 97.5,221
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2012,Age,24 Months,94.6,90.8 to 97.2,233
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,83.0,78.1 to 87.9,279
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,90.9,85.4 to 94.9,237
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,91.2,87.0 to 94.5,462
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,90.4,84.2 to 94.9,250
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,92.7,87.3 to 96.3,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,95.8,92.5 to 97.7,250
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,96.1,93.7 to 97.6,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,95.8,91.3 to 98.0,248
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,95.8,93.3 to 97.4,498
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,91.2,85.2 to 95.5,248
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,94.5,88.1 to 98.1,498
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,96.4,92.3 to 98.4,237
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,97.5,95.3 to 98.7,462
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,93.1,90.2 to 96.0,358
Polio,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,95.6,91.3 to 97.9,225
Polio,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,95.7,92.4 to 97.6,502
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,3 Months,96.2,90.3 to 98.6,252
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,3 Months,96.1,93.6 to 97.6,497
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,3 Months,97.1,94.4 to 98.6,233
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,3 Months,98.6,96.3 to 99.5,221
Polio,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,94.9,91.1 to 97.2,250
Polio,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,95.0,92.3 to 96.8,487
Polio,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,95.1,90.5 to 97.5,237
Polio,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,95.4,92.5 to 97.2,462
Polio,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,95.7,89.7 to 98.3,277
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,85.3,81.3 to 89.4,913
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,84.7,77.0 to 92.4,279
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,81.0 to 90.8,641
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,96.6,94.7 to 97.8,233
Hib,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,91.5,86.3 to 94.9,250
Hib,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,92.7,89.3 to 95.0,487
Hib,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,93.8,88.9 to 96.7,237
Hib,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,93.8,90.7 to 96.0,462
Hib,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,93.8,89.0 to 96.6,225
Hib,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,93.5,90.1 to 95.9,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,84.8,78.6 to 89.5,248
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,81.9,77.4 to 85.7,498
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,81.9,74.6 to 87.5,245
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,83.4,78.8 to 87.2,493
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2015,Age,0-3 Days,79.2,72.8 to 84.4,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2015-2016,Age,0-3 Days,78.5,74.0 to 82.4,498
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,79.0,72.1 to 84.6,250
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,80.6,75.8 to 84.7,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,96.2,91.7 to 98.7,245
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,96.7,94.2 to 98.3,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,97.3,94.2 to 99.0,248
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,99.1,95.3 to 99.9,498
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,98.9,94.8 to 99.9,250
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,98.4,95.3 to 99.6,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,96.2,94.0 to 98.4,276
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,96.5,94.4 to 98.6,358
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,95.1,92.2 to 98.0,279
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,11.0,6.4 to 18.1,252
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,13.1,10.9 to 15.8,497
Polio,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,3 Months,91.7,85.5 to 95.4,245
Polio,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,3 Months,92.5,88.8 to 95.1,493
Polio,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,3 Months,93.3,88.3 to 96.3,248
Polio,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,3 Months,94.7,92.0 to 96.6,498
Polio,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,3 Months,96.2,92.9 to 98.0,250
Polio,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,3 Months,94.1,90.7 to 96.3,487
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2017,Age,0-3 Days,73.2,62.6 to 81.7,165
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2017-2018,Age,0-3 Days,77.8,72.7 to 82.2,462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016,Age,0-3 Days,77.7,71.2 to 83.1,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2017,Age,0-3 Days,76.7,71.7 to 81.1,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,98.7,96.3 to 99.7,225
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,97.9,95.5 to 99.2,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,95.1,91.4 to 97.2,250
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,94.8,92.1 to 96.6,487
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,94.6,89.9 to 97.1,237
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,95.1,92.1 to 97.0,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,96.2,92.8 to 98.1,248
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,95.7,93.4 to 97.2,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,34.2,30.8 to 37.8,233
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,96.3,93.8 to 97.8,221
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,80.2,73.6 to 85.4,277
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,82.2,75.3 to 87.5,237
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,81.7,76.9 to 85.7,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,81.2,74.4 to 86.5,225
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,80.7,76.1 to 84.6,502
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2019,Age,0-3 Days,77.3,70.1 to 83.2,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,75.8,70.6 to 80.9,361
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.1,53.5 to 86.6,38
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,74.4,70.1 to 78.6,525
Polio,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,3 Months,94.1,87.9 to 97.2,277
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2018,Age,0-3 Days,79.9,73.3 to 85.2,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2018-2019,Age,0-3 Days,78.6,73.8 to 82.7,502
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,97.0,92.4 to 99.1,277
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,7 Months,8.4,4.8 to 14.2,225
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,7 Months,7.5,5.2 to 10.8,502
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,7 Months,7.5,4.2 to 13.2,237
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,7 Months,8.0,5.3 to 11.7,462
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,97.2,95.7 to 98.7,525
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,95.1,92.7 to 97.5,361
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,97.0,94.7 to 99.3,258
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.0,92.9 to 100.0,94
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.5,83.0 to 99.9,38
Hib,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,96.0,92.5 to 97.9,248
Hib,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,96.4,94.4 to 97.8,498
Hib,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,96.9,94.0 to 98.4,250
Hib,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,96.8,94.5 to 98.1,487
Hib,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,97.6,93.7 to 99.1,245
Hib,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,96.8,94.5 to 98.1,493
Polio,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,3 Months,93.7,88.8 to 96.6,225
Polio,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,3 Months,93.9,90.3 to 96.2,502
Polio,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,3 Months,92.0,85.6 to 95.7,237
Polio,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,3 Months,92.8,89.1 to 95.3,462
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,9.3,5.6 to 15.0,248
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,9.1,6.5 to 12.6,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,7 Months,8.8,5.5 to 13.8,250
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,7 Months,8.2,5.7 to 11.7,487
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,99.0,96.2 to 99.9,225
PCV,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,98.0,95.6 to 99.3,502
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,15.4,10.0 to 23.0,245
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,12.3,8.9 to 16.9,493
Hib,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,95.8,91.4 to 98.0,252
Hib,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,96.6,94.0 to 98.2,497
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,96.8,93.5 to 98.7,237
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,97.9,96.0 to 99.1,462
Hib,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,7 Months,94.0,90.0 to 96.4,248
Hib,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,7 Months,92.7,89.6 to 94.9,498
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,97.0,92.4 to 99.1,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,98.2,95.4 to 99.5,221
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,98.5,95.9 to 99.6,252
PCV,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,97.5,94.9 to 98.9,497
Hib,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,93.2,87.4 to 96.5,277
Hib,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,13 Months,96.3,93.7 to 97.8,233
Hib,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,98.3,95.7 to 99.4,221
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020,Age,24 Months,96.6,93.4 to 98.5,301
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.0,91.1 to 100.0,38
PCV,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,3 Months,91.4,85.9 to 94.9,225
PCV,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,3 Months,92.6,88.8 to 95.2,502
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,95.9,94.4 to 97.3,913
PCV,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,3 Months,93.8,87.7 to 97.0,277
Polio,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,3 Months,94.4,90.3 to 96.9,233
Polio,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,3 Months,92.9,89.7 to 95.2,221
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2013,Age,0-3 Days,80.7,74.1 to 86.0,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2013-2014,Age,0-3 Days,74.8,69.5 to 79.4,497
Polio,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,3 Months,92.9,88.4 to 95.7,252
Polio,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,3 Months,92.3,88.7 to 94.8,497
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014,Age,0-3 Days,68.5,60.2 to 75.7,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2015,Age,0-3 Days,73.9,68.7 to 78.5,493
PCV,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,99.1,96.9 to 99.8,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,97.0,94.6 to 99.3,258
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,89.6 to 99.7,94
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.4,93.4 to 97.4,523
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,78.8,76.0 to 81.4,252
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,80.3,77.6 to 82.8,497
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,7 Months,79.9,76.8 to 82.8,233
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,7 Months,77.1,73.4 to 80.3,221
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,87.1 to 99.1,94
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.8,88.1 to 93.6,523
PCV,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,3 Months,90.1,83.1 to 94.4,245
PCV,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,3 Months,90.9,86.9 to 93.8,493
PCV,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,3 Months,91.7,86.6 to 95.0,248
PCV,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,3 Months,93.0,90.0 to 95.2,498
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,96.8,93.5 to 98.7,237
PCV,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,97.8,95.9 to 99.0,462
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,96.2,93.3 to 98.1,250
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,96.6,94.5 to 98.0,487
Hib,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,7 Months,94.4,92.9 to 95.5,233
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,96.8,93.8 to 98.5,248
PCV,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,96.5,94.5 to 97.9,498
Hib,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,5 Months,84.9,78.4 to 89.7,277
Hib,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,7 Months,94.4,90.8 to 96.7,221
Hib,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,5 Months,87.9,81.4 to 92.3,225
Hib,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,5 Months,86.4,82.0 to 89.9,502
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,95.0,92.0 to 97.9,272
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.3,94.7 to 97.9,641
Hib,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,5 Months,86.4,79.5 to 91.2,237
Hib,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,5 Months,87.1,82.4 to 90.7,462
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,96.1,94.3 to 98.0,525
PCV,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,3 Months,94.3,90.3 to 96.7,250
PCV,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,3 Months,93.9,90.8 to 96.0,487
PCV,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,3 Months,93.4,88.0 to 96.5,237
PCV,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,3 Months,92.4,88.9 to 94.9,462
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,87.6,83.1 to 92.1,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2012,Age,0-3 Days,72.1,64.5 to 78.6,233
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,95.6,93.2 to 98.0,361
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2011,Age,0-3 Days,70.0,61.1 to 77.6,221
Hib,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,7 Months,91.1,82.2 to 95.8,252
Hib,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,7 Months,93.7,89.8 to 96.2,497
Hib,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,7 Months,96.5,92.4 to 98.4,245
Hib,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,7 Months,95.2,92.7 to 96.9,493
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,94.7,92.1 to 97.3,358
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,88.0,83.7 to 92.3,279
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,88.5,84.3 to 92.6,276
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,89.2 to 94.1,641
PCV,≥4 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,90.4,88.2 to 92.6,913
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,94.1,90.8 to 96.3,542
Polio,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,97.7,96.4 to 98.6,233
Polio,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,94.4,85.5 to 98.0,252
Polio,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,95.9,91.8 to 98.0,497
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,13 Months,26.4,20.5 to 33.2,248
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,13 Months,29.8,25.2 to 34.7,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,13 Months,33.1,26.5 to 40.4,250
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,13 Months,31.9,27.1 to 37.1,487
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,30.7,24.0 to 38.3,237
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,26.9,22.1 to 32.2,462
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,97.4,94.4 to 98.8,245
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,96.5,94.0 to 97.9,493
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,25.3,19.1 to 32.6,277
Hib,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,89.4,83.5 to 93.4,233
Hib,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,88.0,84.5 to 90.8,221
Polio,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,95.5,90.0 to 98.0,248
Polio,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,96.3,93.9 to 97.7,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,23.0,16.7 to 30.8,225
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,24.1,19.6 to 29.4,502
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,97.0,94.3 to 98.5,250
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,96.0,93.7 to 97.5,487
Polio,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,95.0,90.6 to 97.4,237
Polio,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,96.3,93.7 to 97.8,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,95.5,89.5 to 98.2,252
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,96.0,93.3 to 97.7,497
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,96.6,93.1 to 98.3,245
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,96.4,94.2 to 97.8,493
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,Hispanic,78.0,72.1 to 83.9,258
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.0,62.9 to 83.1,94
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.1,69.8 to 78.4,523
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,77.3,71.5 to 83.0,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.9,69.9 to 77.8,641
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Overall,Overall,74.9,71.6 to 78.2,913
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,96.2,91.0 to 98.4,277
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,98.0,96.6 to 98.9,221
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,98.1,96.7 to 98.9,233
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,95.6,90.9 to 97.9,225
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,95.9,92.8 to 97.7,502
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,7 Months,6.6,4.1 to 10.5,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.9,93.9 to 97.8,523
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Principal City,94.0,90.9 to 97.1,272
Hib,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,96.9,92.4 to 98.8,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,78.7,73.1 to 84.3,279
Hib,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,13 Months,95.1,89.7 to 97.7,277
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,96.0,94.6 to 97.4,913
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,94.2,91.3 to 97.2,279
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.9,95.5 to 98.4,641
Hib,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,13 Months,98.0,94.3 to 99.3,225
Hib,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,13 Months,96.6,93.6 to 98.2,502
Hib,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,13 Months,96.6,92.3 to 98.5,237
Hib,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,13 Months,97.3,94.8 to 98.6,462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,69.7,63.4 to 76.0,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,75.2,70.1 to 80.3,358
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,13 Months,30.9,21.5 to 42.3,252
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,13 Months,30.9,26.7 to 35.5,497
Polio,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,96.2,92.4 to 98.2,221
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,96.3,94.0 to 98.6,276
PCV,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,97.7,96.0 to 99.3,358
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,13 Months,31.0,23.8 to 39.2,245
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,13 Months,28.7,23.9 to 33.9,493
Hib,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,13 Months,27.2,21.1 to 34.3,221
DTaP,≥4 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,69.3,61.5 to 76.8,808
Hib,≥3 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,47.4,39.9 to 55.0,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2021,Age,19 Months,85.9,79.9 to 90.3,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,89.6,86.0 to 92.7,2037
Hep A,≥1 Dose,HHS Regions/National,Region 9,2021,Age,35 Months,84.6,75.4 to 91.8,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,88.3,81.9 to 92.6,808
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2021,Age,0-2 Days,72.9,65.6 to 79.2,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2021,Age,24 Months,86.9,81.7 to 91.3,808
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020-2021,Age,35 Months,92.2,88.1 to 95.3,2037
PCV,≥3 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,83.6,76.8 to 88.7,808
Hep B,≥2 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,83.9,76.8 to 89.2,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,90.6,85.3 to 94.6,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,92.3,89.2 to 94.7,2037
PCV,≥4 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,74.1,66.7 to 81.0,808
Hep A,≥1 Dose,HHS Regions/National,Region 9,2021,Age,24 Months,81.0,73.6 to 87.4,808
Hep A,≥2 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,43.5,36.2 to 51.5,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,60.1,52.4 to 67.4,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,55.4,47.7 to 62.9,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2021,Age,13 Months,85.7,79.3 to 90.3,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,87.8,82.2 to 92.3,808
Hib,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,90.9,87.9 to 93.3,2037
Hep A,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,25.1,21.6 to 29.0,2037
DTaP,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,3 Months,83.1,79.2 to 86.4,2037
PCV,≥4 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,69.8,62.0 to 76.6,808
Hep A,≥1 Dose,HHS Regions/National,Region 9,2020-2021,Age,35 Months,88.2,83.2 to 92.2,2037
Hep A,≥1 Dose,HHS Regions/National,Region 9,2021,Age,19 Months,76.1,68.2 to 82.6,808
PCV,≥4 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,81.6,70.1 to 90.8,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,90.4,85.0 to 94.0,808
Polio,≥3 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,89.1,83.6 to 93.4,808
DTaP,≥1 Dose,HHS Regions/National,Region 9,2021,Age,3 Months,81.5,74.7 to 86.8,808
≥1 Dose MMR,,HHS Regions/National,Region 9,2021,Age,24 Months,88.8,83.7 to 92.9,808
Hib,≥3 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,87.8,82.3 to 92.2,808
Hib,Primary Series,HHS Regions/National,Region 9,2021,Age,24 Months,89.2,84.2 to 93.2,808
Hib,Primary Series,HHS Regions/National,Region 9,2020-2021,Age,13 Months,83.9,80.1 to 87.1,2037
Polio,≥1 Dose,HHS Regions/National,Region 9,2021,Age,3 Months,81.4,74.6 to 86.7,808
Hib,Full Series,HHS Regions/National,Region 9,2021,Age,24 Months,70.7,63.3 to 77.7,808
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,68.2,61.3 to 75.2,236
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,71.9,65.5 to 78.4,259
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Overall,Overall,76.6,73.2 to 80.0,850
Hib,Full Series,States/Local Areas,Nebraska,2013,Age,19 Months,81.3,76.4 to 85.4,225
Hib,Full Series,States/Local Areas,Nebraska,2013-2014,Age,19 Months,76.8,71.4 to 81.4,476
Hib,Full Series,States/Local Areas,Nebraska,2012,Age,19 Months,75.0,69.5 to 79.7,232
Hib,Full Series,States/Local Areas,Nebraska,2011,Age,19 Months,78.7,71.5 to 84.6,243
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,85.6,80.0 to 91.2,221
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,77.4,72.4 to 82.3,393
Hib,Full Series,States/Local Areas,Nebraska,2014,Age,19 Months,72.3,64.3 to 79.1,251
Hib,Full Series,States/Local Areas,Nebraska,2014-2015,Age,19 Months,76.1,71.0 to 80.6,489
Hib,Full Series,States/Local Areas,Nebraska,2016,Age,19 Months,79.8,72.2 to 85.7,223
Hib,Full Series,States/Local Areas,Nebraska,2016-2017,Age,19 Months,80.4,75.6 to 84.4,489
Hib,Full Series,States/Local Areas,Nebraska,2015,Age,19 Months,80.0,75.8 to 83.6,238
Hib,Full Series,States/Local Areas,Nebraska,2015-2016,Age,19 Months,79.9,75.0 to 84.0,461
Hib,Full Series,States/Local Areas,Nebraska,2019,Age,19 Months,70.1,62.5 to 76.8,259
Hib,Full Series,States/Local Areas,Nebraska,2018,Age,19 Months,72.9,66.0 to 78.9,279
Hib,Full Series,States/Local Areas,Nebraska,2018-2019,Age,19 Months,95.5,93.0 to 97.2,538
Hib,Full Series,States/Local Areas,Nebraska,2017,Age,19 Months,81.0,74.7 to 86.0,266
Hib,Full Series,States/Local Areas,Nebraska,2017-2018,Age,19 Months,77.0,72.3 to 81.1,545
Hib,Full Series,States/Local Areas,Nebraska,2014,Age,24 Months,79.9,72.5 to 86.4,251
Hib,Full Series,States/Local Areas,Nebraska,2014-2015,Age,24 Months,82.5,77.8 to 86.7,489
Hib,Full Series,States/Local Areas,Nebraska,2013,Age,24 Months,89.4,84.5 to 93.3,225
Hib,Full Series,States/Local Areas,Nebraska,2013-2014,Age,24 Months,84.6,80.0 to 88.5,476
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,73.0,65.3 to 80.6,168
DTaP,≥4 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,72.9,65.6 to 79.2,243
DTaP,≥4 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,72.4,69.1 to 75.4,232
Combined 7 Series,,States/Local Areas,Nebraska,2015,Age,35 Months,82.3,75.7 to 87.9,238
Combined 7 Series,,States/Local Areas,Nebraska,2015-2016,Age,35 Months,82.0,76.7 to 86.6,461
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,78.0,73.4 to 82.7,435
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.2,70.4 to 86.1,156
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,75.2 to 83.2,580
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.8,61.5 to 84.2,80
Combined 7 Series,,States/Local Areas,Nebraska,2018,Age,35 Months,78.6,71.9 to 84.6,279
Combined 7 Series,,States/Local Areas,Nebraska,2018-2019,Age,35 Months,75.2,70.3 to 79.9,538
Combined 7 Series,,States/Local Areas,Nebraska,2019,Age,35 Months,71.6,64.3 to 78.5,259
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,70.1,63.7 to 76.6,284
Combined 7 Series,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,81.9,78.1 to 85.7,527
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,97.8,94.9 to 99.3,266
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,97.2,95.0 to 98.6,545
PCV,≥2 Doses,States/Local Areas,Nebraska,2013,Age,5 Months,81.8,79.3 to 84.0,225
PCV,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,5 Months,79.3,76.7 to 81.7,476
PCV,≥2 Doses,States/Local Areas,Nebraska,2012,Age,5 Months,78.9,76.0 to 81.6,232
PCV,≥2 Doses,States/Local Areas,Nebraska,2011,Age,5 Months,84.7,80.3 to 88.2,243
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,98.2,94.1 to 99.7,238
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,96.6,93.3 to 98.6,461
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,95.0,89.4 to 98.2,223
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,96.4,93.6 to 98.3,489
Hep A,≥1 Dose,States/Local Areas,Nebraska,2019,Age,19 Months,88.4,82.5 to 92.6,259
Hep A,≥1 Dose,States/Local Areas,Nebraska,2011,Age,24 Months,87.5,81.9 to 92.0,243
Hep A,≥1 Dose,States/Local Areas,Nebraska,2013,Age,24 Months,91.2,86.2 to 94.9,225
Hep A,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,24 Months,87.1,82.9 to 90.7,476
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014,Age,24 Months,83.1,76.2 to 88.9,251
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,24 Months,85.4,81.0 to 89.3,489
Hep A,≥1 Dose,States/Local Areas,Nebraska,2012,Age,24 Months,88.5,83.5 to 92.5,232
Hep A,≥1 Dose,States/Local Areas,Nebraska,2017,Age,19 Months,90.9,86.1 to 94.1,266
Hep A,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,19 Months,90.3,87.2 to 92.7,545
Hep A,≥1 Dose,States/Local Areas,Nebraska,2018,Age,19 Months,89.7,85.2 to 93.0,279
Hep A,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,19 Months,89.0,84.4 to 92.4,444
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,97.8,93.9 to 99.4,225
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,95.6,92.1 to 97.8,476
DTaP,≥3 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,96.7,93.0 to 98.7,232
DTaP,≥3 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,96.3,92.4 to 98.5,243
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,93.3,87.3 to 97.1,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,95.5,92.1 to 97.7,489
Hep A,≥2 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,34.1,28.5 to 40.2,243
DTaP,≥2 Doses,States/Local Areas,Nebraska,2019,Age,5 Months,89.0,83.4 to 92.8,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,42.7,38.2 to 47.3,225
Hep A,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,38.9,34.4 to 43.5,476
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,35.0,28.2 to 42.5,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,38.9,33.8 to 44.3,489
Hep A,≥2 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,28.3,25.1 to 31.6,232
Hib,≥3 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,93.9,90.1 to 96.6,279
Hib,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,94.6,92.2 to 96.5,538
Hib,≥3 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,95.3,92.1 to 97.5,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,42.8,37.8 to 48.1,238
Hep A,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,40.4,34.9 to 46.0,461
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,37.8,30.3 to 46.0,223
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,38.6,33.5 to 44.0,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,96.5,92.3 to 98.7,225
Hib,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,93.5,89.7 to 96.3,476
Hib,≥3 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,90.5,83.8 to 95.2,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,92.8,89.0 to 95.6,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,95.2,91.2 to 97.7,238
Hib,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,93.9,90.6 to 96.4,461
Hep A,≥2 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,39.5,32.8 to 46.6,266
Hep A,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,39.1,34.2 to 44.3,545
Hep A,≥1 Dose,States/Local Areas,Nebraska,2015,Age,24 Months,87.7,81.8 to 92.4,238
Hep A,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,24 Months,86.3,81.9 to 90.0,461
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016,Age,24 Months,84.8,78.1 to 90.4,223
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,24 Months,88.7,84.7 to 92.0,489
PCV,≥2 Doses,States/Local Areas,Nebraska,2014,Age,5 Months,76.9,69.1 to 83.1,251
PCV,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,5 Months,81.1,79.7 to 82.5,489
PCV,≥2 Doses,States/Local Areas,Nebraska,2015,Age,5 Months,85.4,79.5 to 89.9,238
PCV,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,5 Months,84.8,80.4 to 88.4,461
PCV,≥2 Doses,States/Local Areas,Nebraska,2016,Age,5 Months,84.2,77.2 to 89.3,223
PCV,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,5 Months,84.3,79.7 to 88.0,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,97.0,93.0 to 99.0,279
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,97.1,94.6 to 98.7,538
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,97.2,93.8 to 99.0,259
Hep A,≥1 Dose,States/Local Areas,Nebraska,2018,Age,24 Months,91.4,87.4 to 94.6,279
Hep A,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,24 Months,90.6,87.4 to 93.3,538
Hep A,≥1 Dose,States/Local Areas,Nebraska,2019,Age,24 Months,89.8,84.4 to 93.9,259
Hep A,≥1 Dose,States/Local Areas,Nebraska,2011,Age,35 Months,90.7,85.0 to 94.9,243
PCV,≥2 Doses,States/Local Areas,Nebraska,2017,Age,5 Months,84.4,77.8 to 89.3,266
PCV,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,5 Months,83.9,79.5 to 87.5,545
Hib,≥3 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,96.3,92.6 to 98.4,232
Hib,≥3 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,98.9,94.2 to 99.9,243
Hep A,≥1 Dose,States/Local Areas,Nebraska,2017,Age,24 Months,92.6,88.6 to 95.6,266
Hep A,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,24 Months,92.0,89.3 to 94.3,545
Hib,≥3 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,93.9,90.1 to 96.6,279
Hib,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,95.3,93.0 to 97.0,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,48.4,40.0 to 57.5,232
DTaP,≥4 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,78.3,71.4 to 83.9,225
DTaP,≥4 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,74.2,67.8 to 79.8,476
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,70.3,62.0 to 77.4,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,74.4,69.1 to 79.1,489
DTaP,≥4 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,78.6,75.1 to 81.7,238
DTaP,≥4 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,76.9,71.8 to 81.4,461
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,92.5,88.2 to 96.9,284
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.8 to 99.0,527
Hib,≥3 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,92.5,86.8 to 96.4,223
Hib,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,94.4,91.3 to 96.7,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,96.3,93.1 to 98.2,266
Hib,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,95.1,92.7 to 96.9,545
Hep A,≥2 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,38.7,31.7 to 46.3,279
Hep A,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,38.1,32.3 to 44.4,444
Hep A,≥2 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,40.7,33.5 to 48.4,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,55.6,47.5 to 64.0,243
Hib,Full Series,States/Local Areas,Nebraska,2011,Age,24 Months,86.2,79.5 to 91.7,243
Hib,Full Series,States/Local Areas,Nebraska,2012,Age,24 Months,80.2,73.2 to 86.4,232
Hib,Primary Series,States/Local Areas,Nebraska,2019,Age,13 Months,84.5,78.1 to 89.2,259
Hib,Primary Series,States/Local Areas,Nebraska,2012,Age,19 Months,95.3,90.9 to 97.6,232
Hib,Primary Series,States/Local Areas,Nebraska,2017,Age,19 Months,96.3,92.6 to 98.2,266
Hib,Primary Series,States/Local Areas,Nebraska,2017-2018,Age,19 Months,94.7,92.1 to 96.5,545
Hib,Primary Series,States/Local Areas,Nebraska,2016,Age,13 Months,92.0,85.2 to 95.8,223
Hib,Primary Series,States/Local Areas,Nebraska,2016-2017,Age,13 Months,92.2,88.3 to 94.9,489
Hib,Primary Series,States/Local Areas,Nebraska,2017,Age,13 Months,92.4,87.3 to 95.6,266
Hib,Primary Series,States/Local Areas,Nebraska,2017-2018,Age,13 Months,88.7,85.0 to 91.6,545
Hib,Primary Series,States/Local Areas,Nebraska,2011,Age,19 Months,95.5,89.3 to 98.2,243
Hib,Primary Series,States/Local Areas,Nebraska,2018,Age,13 Months,84.9,78.9 to 89.4,279
Hib,Primary Series,States/Local Areas,Nebraska,2018-2019,Age,13 Months,84.7,80.4 to 88.1,538
Hib,Primary Series,States/Local Areas,Nebraska,2013,Age,19 Months,95.3,86.0 to 98.5,225
Hib,Primary Series,States/Local Areas,Nebraska,2013-2014,Age,19 Months,91.7,85.5 to 95.4,476
Hib,Primary Series,States/Local Areas,Nebraska,2018,Age,19 Months,93.0,88.7 to 95.8,279
Hib,Primary Series,States/Local Areas,Nebraska,2018-2019,Age,19 Months,84.7,80.4 to 88.1,538
Hib,Primary Series,States/Local Areas,Nebraska,2014,Age,7 Months,75.1,67.3 to 81.6,251
Hib,Primary Series,States/Local Areas,Nebraska,2014-2015,Age,7 Months,78.7,73.7 to 82.9,489
Hib,Primary Series,States/Local Areas,Nebraska,2015,Age,7 Months,82.2,75.7 to 87.3,238
Hib,Primary Series,States/Local Areas,Nebraska,2015-2016,Age,7 Months,81.5,76.7 to 85.4,461
Hib,Primary Series,States/Local Areas,Nebraska,2014,Age,19 Months,88.2,80.7 to 93.0,251
Hib,Primary Series,States/Local Areas,Nebraska,2014-2015,Age,19 Months,91.9,87.7 to 94.7,489
Hib,Primary Series,States/Local Areas,Nebraska,2019,Age,19 Months,95.2,91.8 to 97.2,259
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,96.3,92.9 to 98.1,251
Hib,Primary Series,States/Local Areas,Nebraska,2019,Age,7 Months,77.6,70.6 to 83.4,259
Hib,Primary Series,States/Local Areas,Nebraska,2018,Age,24 Months,93.8,90.0 to 96.6,279
Hib,Primary Series,States/Local Areas,Nebraska,2018-2019,Age,24 Months,94.8,92.4 to 96.5,538
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,94.4,90.9 to 97.9,176
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,83.1,76.9 to 89.3,176
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.4,90.1 to 100.0,90
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,79.4,70.8 to 88.0,176
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.9,87.8 to 100.0,90
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,85.2,80.5 to 89.8,300
Hib,Primary Series,States/Local Areas,Nebraska,2018,Age,35 Months,94.8,90.9 to 97.4,279
Hib,Primary Series,States/Local Areas,Nebraska,2018-2019,Age,35 Months,96.0,93.7 to 97.6,538
Combined 7 Series,,States/Local Areas,Nebraska,2015,Age,24 Months,78.0,71.5 to 83.9,238
Combined 7 Series,,States/Local Areas,Nebraska,2015-2016,Age,24 Months,77.7,72.7 to 82.3,461
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,97.5,95.5 to 99.4,266
Hib,Primary Series,States/Local Areas,Nebraska,2019-2020,Age,7 Months,73.6,68.2 to 78.5,510
Combined 7 Series,,States/Local Areas,Nebraska,2014,Age,24 Months,71.4,63.8 to 78.6,251
Combined 7 Series,,States/Local Areas,Nebraska,2014-2015,Age,24 Months,74.7,69.7 to 79.5,489
Hib,Primary Series,States/Local Areas,Nebraska,2019,Age,35 Months,97.1,94.5 to 98.7,259
Combined 7 Series,,States/Local Areas,Nebraska,2016,Age,24 Months,77.4,69.7 to 84.3,223
Combined 7 Series,,States/Local Areas,Nebraska,2016-2017,Age,24 Months,79.1,74.3 to 83.6,489
Combined 7 Series,,States/Local Areas,Nebraska,2018,Age,24 Months,73.7,67.0 to 79.9,279
Combined 7 Series,,States/Local Areas,Nebraska,2018-2019,Age,24 Months,71.8,66.9 to 76.5,538
Combined 7 Series,,States/Local Areas,Nebraska,2017,Age,24 Months,80.8,74.9 to 86.0,266
Combined 7 Series,,States/Local Areas,Nebraska,2017-2018,Age,24 Months,77.3,72.9 to 81.4,545
Combined 7 Series,,States/Local Areas,Nebraska,2017,Age,35 Months,84.8,79.4 to 89.4,266
Combined 7 Series,,States/Local Areas,Nebraska,2017-2018,Age,35 Months,81.6,77.4 to 85.5,545
Combined 7 Series,,States/Local Areas,Nebraska,2016,Age,35 Months,81.7,73.3 to 88.7,223
Combined 7 Series,,States/Local Areas,Nebraska,2016-2017,Age,35 Months,83.2,78.3 to 87.5,489
Combined 7 Series,,States/Local Areas,Nebraska,2019,Age,24 Months,69.9,62.6 to 77.0,259
Hep B,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,96.1,93.6 to 97.6,510
Hib,Primary Series,States/Local Areas,Nebraska,2017,Age,24 Months,96.8,93.7 to 98.6,266
Hib,Primary Series,States/Local Areas,Nebraska,2017-2018,Age,24 Months,95.3,93.0 to 97.1,545
Hib,Primary Series,States/Local Areas,Nebraska,2013,Age,35 Months,96.9,92.9 to 99.0,225
Hib,Primary Series,States/Local Areas,Nebraska,2013-2014,Age,35 Months,93.8,90.1 to 96.5,476
Hib,Primary Series,States/Local Areas,Nebraska,2011,Age,35 Months,98.9,94.2 to 99.9,243
Hib,Primary Series,States/Local Areas,Nebraska,2014,Age,35 Months,90.7,84.0 to 95.3,251
Hib,Primary Series,States/Local Areas,Nebraska,2014-2015,Age,35 Months,95.2,91.4 to 97.7,489
Hib,Primary Series,States/Local Areas,Nebraska,2012,Age,35 Months,96.4,92.7 to 98.6,232
Hib,Primary Series,States/Local Areas,Nebraska,2019,Age,24 Months,95.7,92.9 to 97.7,259
Combined 7 Series,,States/Local Areas,Nebraska,2012,Age,24 Months,68.6,60.8 to 76.2,232
Combined 7 Series,,States/Local Areas,Nebraska,2013,Age,24 Months,79.6,73.0 to 85.4,225
Combined 7 Series,,States/Local Areas,Nebraska,2013-2014,Age,24 Months,75.4,70.4 to 80.2,476
Hib,Primary Series,States/Local Areas,Nebraska,2017,Age,35 Months,97.2,94.1 to 98.9,266
Hib,Primary Series,States/Local Areas,Nebraska,2017-2018,Age,35 Months,96.0,93.7 to 97.6,545
Combined 7 Series,,States/Local Areas,Nebraska,2011,Age,24 Months,77.8,70.4 to 84.3,243
Hib,Primary Series,States/Local Areas,Nebraska,2015,Age,35 Months,98.8,95.7 to 99.8,238
Hib,Primary Series,States/Local Areas,Nebraska,2015-2016,Age,35 Months,97.1,93.7 to 98.9,461
Combined 7 Series,,States/Local Areas,Nebraska,2014,Age,35 Months,77.8,70.1 to 84.6,251
Combined 7 Series,,States/Local Areas,Nebraska,2014-2015,Age,35 Months,80.0,75.0 to 84.5,489
Combined 7 Series,,States/Local Areas,Nebraska,2012,Age,35 Months,75.5,67.6 to 82.7,232
Combined 7 Series,,States/Local Areas,Nebraska,2013,Age,35 Months,84.0,76.1 to 90.4,225
Combined 7 Series,,States/Local Areas,Nebraska,2013-2014,Age,35 Months,80.9,75.4 to 85.7,476
Hib,Primary Series,States/Local Areas,Nebraska,2016,Age,35 Months,94.6,89.7 to 97.6,223
Hib,Primary Series,States/Local Areas,Nebraska,2016-2017,Age,35 Months,96.0,93.2 to 97.8,489
Hib,Primary Series,States/Local Areas,Nebraska,2015,Age,19 Months,95.6,91.8 to 97.7,238
Hib,Primary Series,States/Local Areas,Nebraska,2015-2016,Age,19 Months,94.9,91.7 to 97.0,461
Hib,Primary Series,States/Local Areas,Nebraska,2016,Age,19 Months,94.3,88.8 to 97.2,223
Hib,Primary Series,States/Local Areas,Nebraska,2016-2017,Age,19 Months,95.3,92.2 to 97.2,489
Hib,Primary Series,States/Local Areas,Nebraska,2016,Age,7 Months,80.7,73.2 to 86.5,223
Hib,Primary Series,States/Local Areas,Nebraska,2016-2017,Age,7 Months,81.0,76.1 to 85.0,489
Hib,Primary Series,States/Local Areas,Nebraska,2017,Age,7 Months,81.2,74.6 to 86.4,266
Hib,Primary Series,States/Local Areas,Nebraska,2017-2018,Age,7 Months,78.3,73.6 to 82.3,545
Hib,Primary Series,States/Local Areas,Nebraska,2012,Age,24 Months,96.4,92.7 to 98.6,232
Hib,Primary Series,States/Local Areas,Nebraska,2011,Age,24 Months,96.0,92.2 to 98.3,243
Hib,Primary Series,States/Local Areas,Nebraska,2013,Age,24 Months,96.0,92.1 to 98.3,225
Hib,Primary Series,States/Local Areas,Nebraska,2013-2014,Age,24 Months,92.4,88.5 to 95.4,476
Hib,Primary Series,States/Local Areas,Nebraska,2013,Age,7 Months,76.1,73.4 to 78.6,225
Hib,Primary Series,States/Local Areas,Nebraska,2013-2014,Age,7 Months,75.6,73.0 to 78.1,476
Hib,Primary Series,States/Local Areas,Nebraska,2018,Age,7 Months,75.3,68.3 to 81.1,279
Hib,Primary Series,States/Local Areas,Nebraska,2018-2019,Age,7 Months,76.4,71.6 to 80.7,538
Hib,Primary Series,States/Local Areas,Nebraska,2014,Age,24 Months,89.0,82.2 to 94.0,251
Hib,Primary Series,States/Local Areas,Nebraska,2014-2015,Age,24 Months,92.7,88.9 to 95.6,489
Hib,Primary Series,States/Local Areas,Nebraska,2015,Age,24 Months,96.3,92.4 to 98.5,238
Hib,Primary Series,States/Local Areas,Nebraska,2015-2016,Age,24 Months,95.5,92.6 to 97.5,461
Hib,Primary Series,States/Local Areas,Nebraska,2013,Age,13 Months,92.7,84.6 to 96.7,225
Hib,Primary Series,States/Local Areas,Nebraska,2013-2014,Age,13 Months,88.5,81.4 to 93.1,476
Hib,Primary Series,States/Local Areas,Nebraska,2012,Age,13 Months,93.4,91.8 to 94.8,232
Hib,Primary Series,States/Local Areas,Nebraska,2011,Age,13 Months,93.5,88.1 to 96.5,243
Hib,Primary Series,States/Local Areas,Nebraska,2014,Age,13 Months,84.4,76.7 to 89.8,251
Hib,Primary Series,States/Local Areas,Nebraska,2014-2015,Age,13 Months,88.3,83.8 to 91.7,489
Hib,Primary Series,States/Local Areas,Nebraska,2015,Age,13 Months,92.3,87.2 to 95.4,238
Hib,Primary Series,States/Local Areas,Nebraska,2015-2016,Age,13 Months,92.1,88.2 to 94.8,461
Hib,Primary Series,States/Local Areas,Nebraska,2016,Age,24 Months,94.6,89.7 to 97.6,223
Hib,Primary Series,States/Local Areas,Nebraska,2016-2017,Age,24 Months,95.7,93.0 to 97.6,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,94.4,91.8 to 96.3,510
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.2,93.2 to 97.1,640
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.8,92.8 to 100.0,90
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,87.0,83.4 to 90.5,460
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,80.5,75.0 to 86.1,307
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.7,73.3 to 88.2,166
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.5,90.2 to 98.9,166
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,74.4,68.4 to 80.5,307
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,94.0,90.9 to 97.2,307
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,86.6,81.5 to 91.7,460
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.8,65.5 to 86.0,90
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.3 to 96.6,640
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,94.7,91.5 to 98.0,176
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.3,67.5 to 87.2,166
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,97.3,95.8 to 98.9,460
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,81.5,75.9 to 87.1,307
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,91.9 to 99.9,166
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,94.4,91.4 to 97.4,307
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,89.1,85.8 to 92.4,460
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.0,76.7 to 91.3,166
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,92.3 to 96.9,460
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,95.6,93.5 to 97.8,460
≥1 Dose MMR,,States/Local Areas,Nebraska,2020,Age,19 Months,94.8,90.3 to 97.3,251
Polio,≥3 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,97.2,94.8 to 98.5,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,97.2,95.5 to 98.3,510
PCV,≥3 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,94.0,88.2 to 97.5,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.7,87.4 to 98.0,166
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,82.5,76.9 to 88.0,307
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.9,81.1 to 94.7,166
Influenza,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,81.4,77.0 to 85.8,460
Influenza,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.3,67.9 to 84.7,166
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,73.5,67.4 to 79.7,307
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.7,64.0 to 81.4,166
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,85.0,81.1 to 88.9,460
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.0,82.0 to 94.0,166
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,91.1 to 96.2,460
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,83.6,78.4 to 88.7,307
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,85.1 to 96.5,166
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,73.2,64.6 to 81.9,307
Influenza,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,59.0,52.0 to 66.0,307
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,96.5,94.8 to 98.3,460
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,91.9 to 99.9,166
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,93.9,90.7 to 97.0,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,85.2,81.4 to 89.0,460
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,81.1,76.9 to 85.4,460
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,81.0,75.5 to 86.6,307
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Overall,Overall,77.3,74.0 to 80.6,933
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,96.2,94.1 to 98.3,427
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,97.5,95.5 to 99.5,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,92.8,89.3 to 96.3,307
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.6,79.8 to 93.3,166
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Overall,Overall,84.0,81.1 to 86.8,933
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,94.8,92.2 to 97.5,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,83.9,78.7 to 89.2,240
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,95.1,92.2 to 97.9,266
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,73.6,67.1 to 80.2,240
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,97.0,95.1 to 98.9,427
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,77.0,72.1 to 81.9,427
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,98.2,96.4 to 100.0,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Overall,Overall,93.8,91.9 to 95.6,933
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Overall,Overall,82.3,79.3 to 85.3,933
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,80.8,76.6 to 84.9,933
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,82.2,76.4 to 88.0,266
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,94.0,90.9 to 97.1,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Overall,Overall,84.2,81.3 to 87.0,933
Influenza,,States/Local Areas,Nebraska,2016-2019,Overall,Overall,73.7,70.2 to 77.3,933
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,92.8,89.2 to 96.3,240
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,96.1,93.9 to 98.3,427
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,83.9,78.1 to 89.6,427
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Overall,Overall,90.1,87.8 to 92.4,933
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,82.4,75.2 to 89.7,266
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,86.1,80.9 to 91.4,240
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,87.0,84.3 to 89.7,933
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,91.3,88.2 to 94.3,427
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Overall,Overall,94.5,92.8 to 96.2,933
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,79.8,73.9 to 85.8,240
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,95.4,93.8 to 96.9,933
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,93.3,90.1 to 96.5,266
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,95.6,94.2 to 97.1,933
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,85.9,83.1 to 88.7,933
Influenza,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,74.1,66.3 to 81.8,176
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,93.1,90.0 to 96.2,300
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.8 to 97.7,597
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.2,76.8 to 93.7,90
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,86.5,80.9 to 92.0,176
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.4 to 97.5,597
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,89.7 to 100.0,90
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,79.9,73.2 to 86.6,300
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,81.9,76.4 to 87.4,597
Polio,≥1 Dose,States/Local Areas,Nebraska,2020,Age,3 Months,94.7,90.3 to 97.2,251
Hib,≥1 Dose,States/Local Areas,Nebraska,2020,Age,3 Months,77.9,70.0 to 84.2,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,81.1,76.4 to 85.1,510
DTaP,≥4 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,80.5,75.6 to 84.5,510
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,96.5,94.5 to 97.8,510
Polio,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,97.2,95.2 to 98.5,510
DTaP,≥4 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,92.2,88.9 to 94.8,510
Combined 7 Series,,States/Local Areas,Nebraska,2019-2020,Age,24 Months,66.1,60.5 to 71.7,510
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,97.6,95.7 to 98.7,510
PCV,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,94.3,91.6 to 96.2,510
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019-2020,Age,13 Months,77.9,72.9 to 82.2,510
Hep B,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,96.7,94.4 to 98.1,510
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,90.5,87.1 to 93.0,510
Polio,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,95.0,92.4 to 96.7,510
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,82.0,77.3 to 85.9,510
PCV,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,5 Months,88.3,84.2 to 91.4,510
Hep B,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,5 Months,94.3,91.3 to 96.3,510
Hib,Primary Series,States/Local Areas,Nebraska,2019-2020,Age,13 Months,81.7,76.8 to 85.8,510
Hib,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,5 Months,76.8,71.5 to 81.4,510
≥1 Dose MMR,,States/Local Areas,Nebraska,2019-2020,Age,13 Months,79.0,74.0 to 83.3,510
Hib,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,96.3,94.0 to 97.8,510
Hib,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,13 Months,67.5,61.8 to 72.7,510
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,75.8,70.1 to 81.5,300
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,94.8,92.2 to 97.5,300
Influenza,,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,88.6,84.3 to 92.9,266
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,81.8,76.0 to 87.6,240
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,92.9,89.2 to 96.6,266
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,80.9,75.2 to 86.7,240
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,83.4,79.2 to 87.6,427
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,88.7,83.7 to 93.6,266
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,93.3,90.0 to 96.6,240
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,92.0,88.4 to 95.7,240
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,86.1,82.0 to 90.1,427
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,92.8,88.7 to 96.8,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,90.8,86.7 to 95.0,240
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,94.7,92.1 to 97.2,427
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,95.8,93.0 to 98.6,266
Influenza,,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,62.7,55.2 to 70.1,240
Influenza,,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,72.8,67.4 to 78.1,427
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,94.6,93.0 to 96.3,933
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Overall,Overall,96.2,94.8 to 97.6,933
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,94.8,92.3 to 97.4,427
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,93.6,90.3 to 96.9,240
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,97.1,95.0 to 99.2,266
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,73.9,66.2 to 81.6,240
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,83.6,79.1 to 88.1,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,85.5,80.5 to 90.4,266
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,87.1,83.2 to 91.1,427
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Poverty,>400% FPL,92.9,89.0 to 96.8,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,92.2 to 96.9,460
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Poverty,<133% FPL,72.8,66.0 to 79.6,240
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Poverty,133% to <400% FPL,82.6,78.4 to 86.8,427
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,96.0,94.0 to 97.9,460
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,94.0,90.9 to 97.0,307
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,91.9 to 99.9,166
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a Non-MSA,92.9,89.6 to 96.2,307
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,87.9,84.6 to 91.3,597
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,95.3,92.3 to 98.4,176
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.8,95.2 to 98.3,640
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.4,82.9 to 89.8,640
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,94.6,92.0 to 97.3,300
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.8 to 98.2,597
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,81.1,76.0 to 86.3,300
Hib,Full Series,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.4,80.9 to 87.9,640
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,91.0,85.9 to 96.1,176
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,94.8,92.3 to 97.4,300
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,83.1,78.1 to 88.0,300
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,94.7,92.4 to 96.9,597
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.3,94.6 to 97.9,640
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,92.1,87.7 to 96.5,176
Influenza,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.7,50.5 to 74.8,90
Influenza,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,79.9,75.8 to 84.0,597
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,94.3 to 97.7,640
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,93.9 to 100.0,90
Influenza,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.0,72.8 to 81.2,640
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,86.6,81.0 to 92.3,176
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.2,61.1 to 83.4,90
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.7,84.4 to 91.0,640
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,79.5,72.4 to 86.5,176
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.1,74.0 to 82.1,640
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,76.2,69.0 to 83.4,176
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,76.5,70.8 to 82.2,300
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,78.9 to 95.1,90
Influenza,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,64.8,58.2 to 71.5,300
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,84.5,78.1 to 90.9,176
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,95.0,91.8 to 98.2,176
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,79.9 to 95.4,90
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,86.4,83.1 to 89.8,597
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,97.3,95.8 to 98.9,597
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,91.4,87.8 to 95.0,300
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,93.7 to 100.0,90
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,Hispanic,93.6,89.9 to 97.3,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Any Medicaid,85.3,80.6 to 89.9,300
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.0,87.3 to 92.8,640
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,84.0,80.3 to 87.7,597
Combined 7 Series,,States/Local Areas,Nebraska,2016-2019,Insurance Coverage,Private Insurance Only,79.1,75.0 to 83.2,597
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,92.6 to 96.7,640
Rotavirus,,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.1,82.9 to 89.3,640
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,93.9 to 100.0,90
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.4,76.4 to 86.4,640
Hib,≥3 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,93.3,88.5 to 96.1,251
Combined 7 Series,,States/Local Areas,Nebraska,2020,Age,24 Months,63.2,54.9 to 71.5,251
Influenza,,States/Local Areas,Nebraska,2020,Age,24 Months,76.4,68.8 to 83.2,251
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2020,Age,0-3 Days,85.8,78.2 to 91.0,251
Rotavirus,,States/Local Areas,Nebraska,2020,Age,8 Months,79.9,71.9 to 86.0,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020,Age,24 Months,95.9,92.8 to 98.0,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,97.3,95.1 to 98.6,251
PCV,≥4 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,92.0,87.5 to 95.4,251
Hep A,≥1 Dose,States/Local Areas,Nebraska,2020,Age,24 Months,94.2,90.3 to 96.9,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,67.6,59.4 to 75.6,251
PCV,≥1 Dose,States/Local Areas,Nebraska,2020,Age,3 Months,94.8,90.3 to 97.2,251
Hep B,≥1 Dose,States/Local Areas,Nebraska,2020,Age,3 Months,96.0,91.6 to 98.2,251
DTaP,≥2 Doses,States/Local Areas,Nebraska,2020,Age,5 Months,89.4,83.4 to 93.4,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2020,Age,5 Months,89.2,83.2 to 93.2,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2020,Age,5 Months,72.3,64.0 to 79.2,251
Hep B,≥2 Doses,States/Local Areas,Nebraska,2020,Age,5 Months,94.6,90.3 to 97.1,251
DTaP,≥1 Dose,States/Local Areas,Nebraska,2020,Age,3 Months,94.7,90.3 to 97.2,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,83.8,75.2 to 90.7,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2020,Age,13 Months,80.0,72.4 to 85.9,251
Combined 7 Series,,States/Local Areas,Nebraska,2020,Age,35 Months,65.3,57.0 to 73.6,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,46.6,38.3 to 55.1,251
Hep A,≥1 Dose,States/Local Areas,Nebraska,2020,Age,19 Months,93.3,88.9 to 96.0,251
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2020,Age,0-1 Days,84.9,77.2 to 90.3,251
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2020,Age,0-2 Days,84.9,77.2 to 90.3,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,95.0,91.1 to 97.3,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,92.7,87.8 to 95.7,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,52.2,43.6 to 60.7,251
Hib,Primary Series,States/Local Areas,Nebraska,2020,Age,7 Months,70.3,61.9 to 77.6,251
Hep B,≥2 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,96.1,91.9 to 98.2,251
PCV,≥2 Doses,States/Local Areas,Nebraska,2020,Age,5 Months,89.3,83.3 to 93.3,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,90.7,85.6 to 94.5,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,97.4,95.3 to 98.7,251
Polio,≥3 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,97.2,95.0 to 98.6,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2020,Age,24 Months,95.6,91.5 to 98.1,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,93.8,89.6 to 96.7,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2020,Age,35 Months,97.2,93.3 to 99.1,251
Hib,Primary Series,States/Local Areas,Nebraska,2020,Age,35 Months,95.1,91.5 to 97.6,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,93.8,89.6 to 96.7,251
Hib,Full Series,States/Local Areas,Nebraska,2020,Age,35 Months,70.2,62.1 to 77.9,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,96.6,93.2 to 98.5,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020,Age,35 Months,98.3,96.3 to 99.3,251
Hib,Primary Series,States/Local Areas,Nebraska,2020,Age,19 Months,95.1,91.0 to 97.4,251
Hib,Full Series,States/Local Areas,Nebraska,2020,Age,19 Months,66.0,57.5 to 73.6,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,96.3,92.6 to 98.2,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020,Age,19 Months,95.2,91.6 to 97.2,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,97.8,95.9 to 99.0,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,95.3,91.4 to 97.8,251
PCV,≥4 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,88.0,82.2 to 92.1,251
Polio,≥3 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,97.2,95.0 to 98.6,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,97.3,94.9 to 98.5,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,96.1,91.9 to 98.1,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,97.6,95.7 to 98.9,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,66.8,58.3 to 74.3,251
Hib,Primary Series,States/Local Areas,Nebraska,2020,Age,13 Months,79.3,71.4 to 85.4,251
Hep B,≥2 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,96.8,93.0 to 98.6,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,91.7,86.9 to 94.9,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020,Age,13 Months,78.0,70.4 to 84.2,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,95.1,91.2 to 97.3,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,83.3,76.4 to 88.5,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,97.4,95.1 to 98.7,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2020,Age,19 Months,83.7,77.0 to 88.7,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,5 Months,88.5,84.4 to 91.6,510
DTaP,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,5 Months,88.8,84.7 to 91.9,510
PCV,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,3 Months,94.6,91.5 to 96.6,510
Hep B,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,3 Months,96.1,93.2 to 97.8,510
Hib,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,3 Months,83.6,78.8 to 87.6,510
≥1 Dose MMR,,States/Local Areas,Nebraska,2019-2020,Age,24 Months,93.8,90.8 to 96.0,510
Polio,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,96.2,94.3 to 97.6,510
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,96.5,94.6 to 97.8,510
DTaP,≥4 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,87.9,84.1 to 91.2,510
PCV,≥4 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,90.9,87.6 to 93.7,510
PCV,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,97.3,95.7 to 98.4,510
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019-2020,Age,35 Months,96.6,94.2 to 98.2,510
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,96.0,93.6 to 97.6,510
Hib,Primary Series,States/Local Areas,Nebraska,2019-2020,Age,35 Months,96.1,94.0 to 97.7,510
Hib,Full Series,States/Local Areas,Nebraska,2019-2020,Age,35 Months,73.3,67.8 to 78.5,510
≥1 Dose MMR,,States/Local Areas,Nebraska,2019-2020,Age,35 Months,95.9,93.0 to 97.8,510
Hib,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,95.1,92.6 to 96.9,510
Hib,Primary Series,States/Local Areas,Nebraska,2019-2020,Age,19 Months,95.0,92.4 to 96.7,510
Hib,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,93.0,90.0 to 95.2,510
Hep A,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,43.5,37.9 to 49.3,510
Polio,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,96.2,94.2 to 97.5,510
≥1 Dose MMR,,States/Local Areas,Nebraska,2019-2020,Age,19 Months,92.8,89.5 to 95.1,510
PCV,≥4 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,90.2,86.8 to 93.1,510
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019-2020,Age,24 Months,94.3,91.7 to 96.3,510
PCV,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,96.7,95.0 to 98.0,510
PCV,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,81.2,76.3 to 85.3,510
Hib,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,54.8,49.0 to 60.5,510
Hib,Full Series,States/Local Areas,Nebraska,2019-2020,Age,24 Months,73.0,67.5 to 78.2,510
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,95.5,93.1 to 97.3,510
Hep A,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,19 Months,90.5,86.8 to 93.2,510
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2019-2020,Age,0-1 Days,82.9,77.9 to 87.0,510
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2019-2020,Age,0-2 Days,84.3,79.4 to 88.2,510
PCV,≥4 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,86.7,82.6 to 89.9,510
PCV,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,96.7,94.9 to 97.9,510
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019-2020,Age,19 Months,93.6,90.8 to 95.6,510
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,19 Months,94.8,92.0 to 96.6,510
Hib,Full Series,States/Local Areas,Nebraska,2019-2020,Age,19 Months,67.8,62.0 to 73.0,510
Combined 7 Series,,States/Local Areas,Nebraska,2019-2020,Age,35 Months,68.1,62.4 to 73.6,510
Hib,Primary Series,States/Local Areas,Nebraska,2019-2020,Age,24 Months,95.4,93.1 to 97.1,510
Hib,≥3 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,94.5,91.9 to 96.4,510
Hib,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,7 Months,93.5,90.5 to 95.6,510
Hep A,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,24 Months,62.0,56.3 to 67.8,510
Influenza,,States/Local Areas,Nebraska,2019-2020,Age,24 Months,76.5,71.3 to 81.3,510
Hep A,≥2 Doses,States/Local Areas,Nebraska,2019-2020,Age,35 Months,80.0,73.9 to 85.4,510
Hep A,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,35 Months,94.1,90.8 to 96.5,510
Hep A,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,24 Months,91.8,88.5 to 94.4,510
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2019-2020,Age,0-3 Days,84.7,79.9 to 88.6,510
DTaP,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,3 Months,95.1,92.1 to 97.0,510
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,95.5,92.2 to 97.4,422
Hep B,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,97.0,94.2 to 98.4,422
Polio,≥3 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,92.1,86.1 to 96.2,171
≥1 Dose MMR,,States/Local Areas,Nebraska,2021,Age,35 Months,94.4,84.6 to 98.9,171
Hib,≥2 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,90.1,82.6 to 94.6,171
Hep B,≥2 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,94.9,88.8 to 97.8,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,89.3,81.2 to 94.1,171
DTaP,≥4 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,93.3,88.6 to 96.5,422
Hib,Full Series,States/Local Areas,Nebraska,2021,Age,19 Months,59.1,48.5 to 68.9,171
PCV,≥4 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,90.0,85.6 to 93.5,422
Hep A,≥1 Dose,States/Local Areas,Nebraska,2011,Age,19 Months,86.0,79.4 to 90.7,243
DTaP,≥1 Dose,States/Local Areas,Nebraska,2017,Age,3 Months,96.0,92.4 to 98.0,266
DTaP,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,3 Months,94.0,91.2 to 96.0,545
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,91.6,85.2 to 95.9,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,94.0,90.4 to 96.6,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,96.5,92.6 to 98.6,238
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,95.5,92.4 to 97.5,461
DTaP,≥1 Dose,States/Local Areas,Nebraska,2018,Age,3 Months,92.0,87.2 to 95.1,279
DTaP,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,3 Months,94.0,91.1 to 96.0,538
Hib,Primary Series,States/Local Areas,Nebraska,2021,Age,19 Months,91.8,84.1 to 95.9,171
Hib,Primary Series,States/Local Areas,Nebraska,2020-2021,Age,24 Months,93.5,89.8 to 96.2,422
Hep B,≥3 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,92.5,85.5 to 96.2,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,95.2,91.2 to 97.7,238
Hib,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,93.9,90.6 to 96.4,461
Hib,≥3 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,92.5,86.8 to 96.4,223
Hib,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,94.2,91.0 to 96.5,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,95.7,92.6 to 97.8,259
Hib,≥3 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,95.8,92.6 to 97.9,266
Hib,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,94.8,92.5 to 96.7,545
DTaP,≥2 Doses,States/Local Areas,Nebraska,2017,Age,5 Months,85.5,78.9 to 90.2,266
DTaP,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,5 Months,85.2,80.9 to 88.7,545
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,92.3,88.6 to 96.0,259
DTaP,≥2 Doses,States/Local Areas,Nebraska,2018,Age,5 Months,85.0,78.8 to 89.6,279
DTaP,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,5 Months,87.0,83.0 to 90.1,538
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,96.9,93.8 to 98.7,266
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,96.2,94.0 to 97.8,545
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,95.6,92.0 to 97.9,279
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,95.6,93.4 to 97.3,538
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,95.7,92.7 to 98.7,221
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,94.7,91.7 to 97.7,393
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,91.6,87.4 to 95.9,236
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,94.0,92.0 to 96.1,850
Hep A,≥1 Dose,States/Local Areas,Nebraska,2013,Age,19 Months,90.1,82.0 to 94.8,225
Hep A,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,19 Months,85.7,78.4 to 90.8,476
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014,Age,19 Months,81.3,74.0 to 87.0,251
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,19 Months,83.6,78.9 to 87.4,489
Hep A,≥1 Dose,States/Local Areas,Nebraska,2015,Age,19 Months,85.9,82.2 to 88.9,238
Hep A,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,19 Months,84.2,79.5 to 88.0,461
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016,Age,19 Months,82.5,75.1 to 88.1,223
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,19 Months,86.6,82.3 to 90.0,489
Hep A,≥1 Dose,States/Local Areas,Nebraska,2012,Age,19 Months,84.2,77.5 to 89.1,232
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,94.1,89.0 to 97.4,223
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,95.5,92.6 to 97.5,489
DTaP,≥1 Dose,States/Local Areas,Nebraska,2019,Age,3 Months,96.0,92.1 to 98.1,259
DTaP,≥1 Dose,States/Local Areas,Nebraska,2012,Age,3 Months,89.7,86.8 to 92.1,232
DTaP,≥1 Dose,States/Local Areas,Nebraska,2011,Age,3 Months,90.1,83.1 to 94.4,243
DTaP,≥1 Dose,States/Local Areas,Nebraska,2013,Age,3 Months,90.8,87.2 to 93.4,225
DTaP,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,3 Months,88.7,87.5 to 89.9,476
DTaP,≥1 Dose,States/Local Areas,Nebraska,2014,Age,3 Months,86.7,79.4 to 91.7,251
DTaP,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,3 Months,89.7,85.4 to 92.8,489
DTaP,≥1 Dose,States/Local Areas,Nebraska,2015,Age,3 Months,92.6,87.3 to 95.8,238
DTaP,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,3 Months,91.6,87.8 to 94.3,461
DTaP,≥1 Dose,States/Local Areas,Nebraska,2016,Age,3 Months,90.5,84.3 to 94.4,223
DTaP,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,3 Months,93.2,89.8 to 95.5,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,87.2,82.4 to 90.8,422
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.6,80.0 to 87.1,640
Hib,≥1 Dose,States/Local Areas,Nebraska,2021,Age,3 Months,71.8,61.0 to 80.5,171
Hep A,≥2 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,76.4,65.1 to 86.2,171
Combined 7 Series,,States/Local Areas,Nebraska,2021,Age,35 Months,59.6,49.5 to 70.1,171
Polio,≥2 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,91.4,84.9 to 95.3,171
Hib,Primary Series,States/Local Areas,Nebraska,2021,Age,7 Months,66.5,55.8 to 75.7,171
Combined 7 Series,,States/Local Areas,Nebraska,2011,Age,35 Months,85.6,78.2 to 91.5,243
Hib,≥2 Doses,States/Local Areas,Nebraska,2021,Age,5 Months,66.1,55.4 to 75.3,171
≥1 Dose MMR,,States/Local Areas,Nebraska,2020-2021,Age,24 Months,93.6,89.5 to 96.5,422
PCV,≥2 Doses,States/Local Areas,Nebraska,2021,Age,5 Months,86.1,78.1 to 91.5,171
DTaP,≥3 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,80.9,71.4 to 87.7,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,92.5,88.7 to 95.5,422
Rotavirus,,States/Local Areas,Nebraska,2019-2020,Age,8 Months,80.3,75.3 to 84.6,510
≥1 Dose MMR,,States/Local Areas,Nebraska,2020-2021,Age,13 Months,74.4,68.0 to 79.9,422
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Principal City,89.5,86.2 to 92.8,460
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.9,90.7 to 99.1,166
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,83.0,76.3 to 88.1,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2020,Age,7 Months,83.0,76.0 to 88.3,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2020-2021,Age,24 Months,88.2,83.4 to 92.2,422
Hep A,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,35 Months,93.9,89.9 to 96.7,422
PCV,≥3 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,92.2,85.7 to 95.8,171
DTaP,≥1 Dose,States/Local Areas,Nebraska,2020-2021,Age,3 Months,94.2,90.4 to 96.6,422
Hep B,≥2 Doses,States/Local Areas,Nebraska,2021,Age,5 Months,93.4,87.3 to 96.7,171
Hib,Primary Series,States/Local Areas,Nebraska,2020-2021,Age,13 Months,74.9,68.2 to 80.5,422
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,95.9,91.9 to 98.3,422
Hep A,≥1 Dose,States/Local Areas,Nebraska,2021,Age,35 Months,90.2,82.8 to 95.3,171
PCV,≥3 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,93.6,87.1 to 97.0,171
Hib,Primary Series,States/Local Areas,Nebraska,2021,Age,24 Months,91.8,85.0 to 96.3,171
Hib,Full Series,States/Local Areas,Nebraska,2021,Age,24 Months,64.0,53.7 to 74.3,171
DTaP,≥4 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,80.5,71.3 to 87.3,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2021,Age,19 Months,88.3,80.1 to 93.4,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,46.4,36.4 to 56.7,171
Hep A,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,19 Months,49.2,42.7 to 55.8,422
Hep A,≥2 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,68.5,58.3 to 78.3,171
Hep B,≥3 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,72.4,63.0 to 80.1,171
PCV,≥3 Doses,States/Local Areas,Nebraska,2021,Age,7 Months,78.9,69.4 to 86.1,171
DTaP,≥3 Doses,States/Local Areas,Nebraska,2021,Age,13 Months,93.2,86.7 to 96.7,171
Hep B,≥3 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,92.5,86.3 to 96.5,171
PCV,≥4 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,86.3,77.9 to 91.9,171
Hep A,≥1 Dose,States/Local Areas,Nebraska,2021,Age,19 Months,88.9,80.7 to 93.9,171
Hep A,≥2 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,51.8,41.6 to 62.0,171
DTaP,≥3 Doses,States/Local Areas,Nebraska,2021,Age,19 Months,93.5,87.0 to 96.9,171
PCV,≥4 Doses,States/Local Areas,Nebraska,2021,Age,35 Months,87.8,80.0 to 93.6,171
DTaP,≥4 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,85.6,77.3 to 92.1,171
DTaP,≥1 Dose,States/Local Areas,Nebraska,2021,Age,3 Months,93.7,86.5 to 97.2,171
Polio,≥3 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,92.1,86.1 to 96.2,171
≥1 Dose MMR,,States/Local Areas,Nebraska,2021,Age,24 Months,91.6,84.2 to 96.4,171
Hib,≥3 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,91.3,84.4 to 95.9,171
Polio,≥1 Dose,States/Local Areas,Nebraska,2021,Age,3 Months,93.2,86.0 to 96.8,171
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2021,Age,0-2 Days,76.8,66.4 to 84.7,171
PCV,≥3 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,94.0,88.2 to 97.5,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2021,Age,24 Months,89.9,82.4 to 95.2,171
≥1 Dose Varicella,,States/Local Areas,Nebraska,2020-2021,Age,35 Months,96.5,91.9 to 98.8,422
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2021,Age,0-1 Days,76.3,65.9 to 84.2,171
PCV,≥4 Doses,States/Local Areas,Nebraska,2021,Age,24 Months,87.8,80.0 to 93.6,171
Hep A,≥1 Dose,States/Local Areas,Nebraska,2021,Age,24 Months,90.0,82.6 to 95.2,171
Hib,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,13 Months,95.0,91.5 to 97.1,422
DTaP,≥3 Doses,States/Local Areas,Nebraska,2020-2021,Age,35 Months,95.8,92.9 to 97.8,422
PCV,≥2 Doses,States/Local Areas,Nebraska,2020-2021,Age,5 Months,87.7,83.1 to 91.2,422
Polio,≥3 Doses,States/Local Areas,Nevada,2017,Age,19 Months,87.2,81.2 to 91.5,344
Polio,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,90.5,87.0 to 93.2,722
Polio,≥3 Doses,States/Local Areas,Nevada,2016,Age,19 Months,87.2,81.6 to 91.3,327
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,87.2,83.2 to 90.4,671
Hib,≥3 Doses,States/Local Areas,Nevada,2018,Age,13 Months,70.7,64.1 to 76.6,378
Hib,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,69.6,64.9 to 73.9,718
Polio,≥3 Doses,States/Local Areas,Nevada,2018,Age,19 Months,93.9,89.4 to 96.6,378
Polio,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,64.6,59.7 to 69.3,718
Hib,≥3 Doses,States/Local Areas,Nevada,2011,Age,19 Months,87.7,82.6 to 91.4,293
Hib,≥3 Doses,States/Local Areas,Nevada,2012,Age,19 Months,84.4,80.2 to 87.8,272
Hib,≥3 Doses,States/Local Areas,Nevada,2019,Age,13 Months,68.4,61.5 to 74.6,340
PCV,≥2 Doses,States/Local Areas,Nevada,2020-2021,Age,5 Months,73.5,67.7 to 78.6,560
Polio,≥1 Dose,States/Local Areas,Nebraska,2019-2020,Age,3 Months,94.9,91.9 to 96.8,510
Influenza,,States/Local Areas,North Carolina,2011,Age,24 Months,55.1,46.4 to 64.2,252
Influenza,,States/Local Areas,North Carolina,2012,Age,24 Months,56.2,48.0 to 64.9,271
Influenza,,States/Local Areas,North Carolina,2015,Age,24 Months,58.7,51.4 to 66.2,320
Influenza,,States/Local Areas,North Carolina,2015-2016,Age,24 Months,58.3,53.1 to 63.6,672
Influenza,,States/Local Areas,North Carolina,2014,Age,24 Months,56.8,48.9 to 65.0,287
Influenza,,States/Local Areas,North Carolina,2014-2015,Age,24 Months,57.8,52.3 to 63.3,607
Influenza,,States/Local Areas,North Carolina,2013,Age,24 Months,62.4,55.0 to 69.7,271
Influenza,,States/Local Areas,North Carolina,2013-2014,Age,24 Months,59.6,54.1 to 65.1,558
Hep B,≥1 Dose,States/Local Areas,North Carolina,2021,Age,3 Months,97.1,93.0 to 98.8,305
Hib,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,43.1,37.8 to 48.5,764
PCV,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,91.9,88.6 to 94.3,764
PCV,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,3 Months,87.7,83.6 to 90.9,764
Polio,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,3 Months,88.5,84.4 to 91.6,764
Hep A,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,24 Months,86.3,82.4 to 89.7,764
≥1 Dose MMR,,States/Local Areas,North Carolina,2021,Age,13 Months,71.5,63.3 to 78.5,305
Hep A,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,76.5,70.5 to 82.0,764
≥1 Dose MMR,,States/Local Areas,North Carolina,2020-2021,Age,19 Months,93.0,90.1 to 95.1,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,72.2,67.2 to 76.8,764
Hib,≥3 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,94.4,90.7 to 96.9,305
DTaP,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,5 Months,81.7,77.1 to 85.6,764
Hep A,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,40.5,35.2 to 46.2,764
Hib,Primary Series,States/Local Areas,North Carolina,2021,Age,35 Months,96.4,93.5 to 98.2,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,88.5,84.7 to 92.2,656
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.4,61.2 to 91.7,109
Influenza,,States/Local Areas,North Carolina,2018,Age,24 Months,73.4,65.0 to 81.2,271
Influenza,,States/Local Areas,North Carolina,2018-2019,Age,24 Months,71.5,65.5 to 77.3,585
Influenza,,States/Local Areas,North Carolina,2017,Age,24 Months,71.5,63.8 to 78.8,292
Influenza,,States/Local Areas,North Carolina,2017-2018,Age,24 Months,72.4,66.7 to 77.8,563
Influenza,,States/Local Areas,North Carolina,2016,Age,24 Months,58.0,50.8 to 65.3,352
Influenza,,States/Local Areas,North Carolina,2016-2017,Age,24 Months,64.8,59.4 to 70.1,644
Influenza,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,70.2,65.2 to 75.2,673
Influenza,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,63.3,43.5 to 83.0,34
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,67.5 to 88.5,143
Influenza,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,53.7,43.8 to 63.7,180
Influenza,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,57.1,50.9 to 63.2,469
Influenza,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,65.3,59.4 to 71.2,506
Influenza,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.2,58.4 to 68.1,703
PCV,≥1 Dose,States/Local Areas,North Carolina,2021,Age,3 Months,88.9,82.0 to 93.4,305
Influenza,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,51.6,45.5 to 57.7,419
Influenza,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",51.3,40.6 to 62.0,125
Influenza,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.3,48.2 to 72.4,129
Influenza,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,62.6,53.7 to 71.6,198
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,91.2,88.1 to 94.3,656
Influenza,,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,61.7,55.4 to 68.0,474
Influenza,,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,46.4,39.3 to 53.6,302
Influenza,,States/Local Areas,North Carolina,2014-2017,Overall,Overall,60.4,56.4 to 64.3,1155
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,90.3,87.1 to 93.5,656
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Private Insurance Only,96.6,94.6 to 98.6,656
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.8,48.3 to 81.2,143
Influenza,,States/Local Areas,North Carolina,2021,Age,24 Months,46.3,38.5 to 54.9,305
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020-2021,Age,13 Months,67.7,62.4 to 72.6,764
Influenza,,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Uninsured,56.5,34.1 to 78.9,30
Influenza,,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,80.4,75.2 to 85.7,379
DTaP,≥3 Doses,States/Local Areas,North Carolina,2021,Age,24 Months,96.8,94.0 to 98.5,305
Hib,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,90.6,86.9 to 93.3,764
Hib,≥2 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,96.4,93.0 to 98.2,305
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2021,Age,0-3 Days,85.5,79.1 to 90.2,305
PCV,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,19 Months,95.6,93.2 to 97.2,773
Influenza,,States/Local Areas,North Carolina,2019,Age,24 Months,69.6,61.0 to 77.8,314
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,83.9,78.7 to 89.1,379
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.9,76.8 to 91.1,640
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,91.9,86.2 to 97.6,194
Hib,Full Series,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,87.5,80.6 to 94.4,194
Hep A,≥2 Doses,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,Hispanic,64.4,53.3 to 75.6,194
Polio,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,96.3,94.3 to 97.7,764
Hib,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,5 Months,76.4,71.4 to 80.7,764
Hep A,≥1 Dose,States/Local Areas,North Carolina,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.4,73.5 to 93.3,143
PCV,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Insurance Coverage,Any Medicaid,84.2,79.3 to 89.0,379
DTaP,≥4 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,133% to <400% FPL,86.0,80.7 to 91.3,427
DTaP,≥2 Doses,States/Local Areas,North Carolina,2021,Age,5 Months,82.6,75.2 to 88.2,305
Hep B,≥2 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,95.3,93.2 to 96.8,773
PCV,≥3 Doses,States/Local Areas,North Carolina,2016-2019,Poverty,>400% FPL,97.8,96.0 to 99.6,403
Hep B,≥3 Doses,States/Local Areas,North Carolina,2019-2020,Age,7 Months,64.0,58.6 to 69.1,773
Hib,Full Series,States/Local Areas,North Carolina,2020-2021,Age,24 Months,80.9,76.6 to 84.9,764
Polio,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,96.6,94.9 to 97.9,764
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,94.1,91.5 to 96.0,764
Hib,Primary Series,States/Local Areas,North Carolina,2020-2021,Age,7 Months,73.4,68.3 to 77.9,764
Hep B,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,5 Months,92.1,89.2 to 94.3,764
Rotavirus,,States/Local Areas,North Carolina,2021,Age,8 Months,84.1,77.1 to 89.3,305
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020-2021,Age,24 Months,93.1,90.2 to 95.3,764
Polio,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,96.7,95.0 to 97.9,764
Polio,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,5 Months,80.8,76.1 to 84.8,764
Combined 7 Series,,States/Local Areas,North Carolina,2020-2021,Age,35 Months,74.7,69.6 to 79.5,764
≥1 Dose MMR,,States/Local Areas,North Carolina,2020-2021,Age,24 Months,94.1,91.6 to 96.1,764
Polio,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,95.6,93.2 to 97.2,764
PCV,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,94.2,91.4 to 96.4,764
Combined 7 Series,,States/Local Areas,North Carolina,2020-2021,Age,24 Months,69.7,64.7 to 74.5,764
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Carolina,2020-2021,Age,0-1 Days,83.6,79.5 to 86.9,764
PCV,≥4 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,89.8,86.0 to 92.8,764
DTaP,≥4 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,71.3,66.2 to 75.9,764
Hib,≥3 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,62.5,54.3 to 70.0,305
Hib,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,90.3,86.8 to 93.0,764
Hib,Full Series,States/Local Areas,North Carolina,2021,Age,35 Months,80.7,73.7 to 86.8,305
Hib,Primary Series,States/Local Areas,North Carolina,2020-2021,Age,13 Months,89.6,86.0 to 92.4,764
Hep B,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,93.4,90.6 to 95.3,764
Hib,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,3 Months,84.0,79.4 to 87.7,764
Polio,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,91.3,87.7 to 94.0,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,96.8,94.0 to 98.5,305
≥1 Dose MMR,,States/Local Areas,North Carolina,2020-2021,Age,35 Months,95.3,92.9 to 97.2,764
PCV,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,94.1,91.0 to 96.1,764
Influenza,,States/Local Areas,North Carolina,2020-2021,Age,24 Months,49.5,44.3 to 54.9,764
DTaP,≥4 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,89.7,82.6 to 94.7,305
Hep B,≥3 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,97.2,94.6 to 98.8,305
Hib,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,95.0,92.8 to 96.7,764
PCV,≥4 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,84.2,79.8 to 87.8,764
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,65.8,60.6 to 70.6,764
Hib,Primary Series,States/Local Areas,North Carolina,2021,Age,13 Months,88.7,82.5 to 92.9,305
Hep B,≥2 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,97.1,94.3 to 98.5,305
Hep A,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,19 Months,83.6,79.3 to 87.2,764
Rotavirus,,States/Local Areas,North Carolina,2020-2021,Age,8 Months,80.0,75.4 to 83.9,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,97.1,95.5 to 98.3,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,97.1,95.5 to 98.3,764
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Carolina,2020-2021,Age,0-3 Days,84.9,80.9 to 88.2,764
Combined 7 Series,,States/Local Areas,North Carolina,2021,Age,24 Months,72.8,65.3 to 79.8,305
DTaP,≥4 Doses,States/Local Areas,North Carolina,2020-2021,Age,24 Months,81.4,77.1 to 85.4,764
≥1 Dose Varicella,,States/Local Areas,North Carolina,2021,Age,35 Months,96.9,93.9 to 98.7,305
Polio,≥3 Doses,States/Local Areas,North Carolina,2021,Age,35 Months,96.5,93.6 to 98.3,305
Hib,Primary Series,States/Local Areas,North Carolina,2020-2021,Age,19 Months,95.4,92.9 to 97.1,764
PCV,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,7 Months,70.5,65.4 to 75.1,764
DTaP,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,3 Months,89.4,85.5 to 92.4,764
Hib,Primary Series,States/Local Areas,North Carolina,2020-2021,Age,35 Months,96.2,94.3 to 97.6,764
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Carolina,2020-2021,Age,0-2 Days,84.6,80.5 to 87.9,764
Hib,Full Series,States/Local Areas,North Carolina,2020-2021,Age,35 Months,84.1,79.5 to 88.2,764
Hep B,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,93.8,91.1 to 95.7,764
PCV,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,35 Months,95.2,92.6 to 97.1,764
Hep B,≥1 Dose,States/Local Areas,North Carolina,2020-2021,Age,3 Months,96.7,94.4 to 98.1,764
≥1 Dose Varicella,,States/Local Areas,North Carolina,2020-2021,Age,19 Months,93.1,90.1 to 95.2,764
≥1 Dose MMR,,States/Local Areas,North Carolina,2020-2021,Age,13 Months,71.4,66.3 to 76.1,764
DTaP,≥3 Doses,States/Local Areas,North Carolina,2020-2021,Age,13 Months,92.5,89.4 to 94.8,764
Hep B,≥2 Doses,States/Local Areas,North Carolina,2021,Age,5 Months,93.7,89.2 to 96.4,305
≥1 Dose MMR,,States/Local Areas,North Carolina,2021,Age,19 Months,96.1,93.0 to 97.9,305
Hep A,≥2 Doses,States/Local Areas,North Carolina,2020-2021,Age,19 Months,23.9,19.7 to 28.7,764
Polio,≥3 Doses,States/Local Areas,North Carolina,2021,Age,19 Months,95.0,90.5 to 97.4,305
Hib,Full Series,States/Local Areas,North Carolina,2020-2021,Age,19 Months,74.7,69.7 to 79.1,764
Hep B,≥3 Doses,States/Local Areas,North Carolina,2021,Age,13 Months,92.9,88.3 to 95.8,305
≥1 Dose Varicella,,States/Local Areas,North Carolina,2021,Age,13 Months,65.0,56.6 to 72.5,305
Polio,≥2 Doses,States/Local Areas,North Carolina,2021,Age,5 Months,81.3,73.7 to 87.2,305
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a Non-MSA,75.5,67.4 to 83.6,180
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.7,73.5 to 83.9,469
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Poverty,<133% FPL,68.8,62.3 to 75.4,302
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Overall,Overall,77.6,74.1 to 81.0,1155
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Poverty,133% to <400% FPL,78.2,72.7 to 83.8,474
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Uninsured,63.8,42.5 to 85.1,34
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Private Insurance Only,84.5,80.3 to 88.7,673
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,Hispanic,73.8,66.0 to 81.6,198
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.7,62.8 to 82.6,125
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Insurance Coverage,Any Medicaid,72.6,67.2 to 78.0,419
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.0,64.1 to 85.8,129
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Urbanicity,Living In a MSA Principal City,77.5,72.0 to 82.9,506
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.4,77.4 to 85.4,703
Rotavirus,,States/Local Areas,North Carolina,2011,Age,8 Months,75.0,66.5 to 82.0,252
Rotavirus,,States/Local Areas,North Carolina,2017,Age,8 Months,75.3,66.9 to 82.1,292
Rotavirus,,States/Local Areas,North Carolina,2017-2018,Age,8 Months,78.0,72.3 to 82.8,563
Rotavirus,,States/Local Areas,North Carolina,2019,Age,8 Months,88.0,82.1 to 92.1,314
Rotavirus,,States/Local Areas,North Carolina,2012,Age,8 Months,84.9,78.8 to 89.5,271
Rotavirus,,States/Local Areas,North Carolina,2013,Age,8 Months,73.4,65.9 to 79.7,271
Rotavirus,,States/Local Areas,North Carolina,2013-2014,Age,8 Months,75.8,70.5 to 80.4,558
Rotavirus,,States/Local Areas,North Carolina,2014,Age,8 Months,78.3,70.6 to 84.4,287
Rotavirus,,States/Local Areas,North Carolina,2014-2015,Age,8 Months,78.4,73.5 to 82.7,607
Rotavirus,,States/Local Areas,North Carolina,2016,Age,8 Months,76.5,69.5 to 82.3,352
Rotavirus,,States/Local Areas,North Carolina,2016-2017,Age,8 Months,75.9,70.5 to 80.6,644
Rotavirus,,States/Local Areas,North Carolina,2015,Age,8 Months,78.6,71.8 to 84.2,320
Rotavirus,,States/Local Areas,North Carolina,2015-2016,Age,8 Months,77.6,72.7 to 81.8,672
Rotavirus,,States/Local Areas,North Carolina,2018,Age,8 Months,80.8,72.7 to 86.9,271
Rotavirus,,States/Local Areas,North Carolina,2018-2019,Age,8 Months,84.4,79.5 to 88.3,585
Rotavirus,,States/Local Areas,North Carolina,2014-2017,Poverty,>400% FPL,90.2,86.4 to 94.0,379
DTaP,≥3 Doses,States/Local Areas,Nevada,2016,Age,19 Months,86.9,81.2 to 91.1,327
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,88.0,84.1 to 91.1,671
DTaP,≥4 Doses,States/Local Areas,Nevada,2020-2021,Age,24 Months,72.1,66.2 to 77.8,560
≥1 Dose Varicella,,States/Local Areas,Nevada,2019-2020,Age,19 Months,82.3,77.4 to 86.3,663
Influenza,,States/Local Areas,Nevada,2013,Age,24 Months,49.9,42.1 to 58.3,234
Influenza,,States/Local Areas,Nevada,2013-2014,Age,24 Months,44.8,39.0 to 51.1,420
Influenza,,States/Local Areas,Nevada,2014,Age,24 Months,39.8,31.6 to 49.4,186
Influenza,,States/Local Areas,Nevada,2014-2015,Age,24 Months,42.5,36.8 to 48.6,439
Influenza,,States/Local Areas,Nevada,2015,Age,24 Months,45.1,37.7 to 53.2,253
Influenza,,States/Local Areas,Nevada,2015-2016,Age,24 Months,45.1,40.0 to 50.5,580
Influenza,,States/Local Areas,Nevada,2012,Age,24 Months,41.6,34.5 to 49.5,272
Influenza,,States/Local Areas,Nevada,2011,Age,24 Months,44.1,37.1 to 51.8,293
Hib,≥3 Doses,States/Local Areas,Nevada,2015,Age,19 Months,86.4,75.8 to 92.8,253
Hib,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,83.9,79.8 to 87.3,580
DTaP,≥3 Doses,States/Local Areas,Nevada,2015,Age,19 Months,90.1,86.8 to 92.6,253
DTaP,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,88.5,84.9 to 91.4,580
DTaP,≥3 Doses,States/Local Areas,Nevada,2014,Age,19 Months,86.7,79.2 to 91.7,186
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,88.4,84.1 to 91.6,439
Polio,≥2 Doses,States/Local Areas,Nevada,2020,Age,13 Months,87.7,80.0 to 92.7,323
Polio,≥3 Doses,States/Local Areas,Nevada,2014,Age,24 Months,90.9,85.2 to 95.0,186
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,90.3,86.7 to 93.3,439
Polio,≥3 Doses,States/Local Areas,Nevada,2015,Age,24 Months,89.9,85.2 to 93.7,253
Polio,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,88.9,85.5 to 91.9,580
Polio,≥3 Doses,States/Local Areas,Nevada,2013,Age,24 Months,93.1,88.5 to 96.4,234
Polio,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,91.9,88.4 to 94.7,420
Hib,≥3 Doses,States/Local Areas,Nevada,2013,Age,19 Months,90.8,85.2 to 94.4,234
Hib,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,86.1,81.0 to 90.0,420
Hib,≥3 Doses,States/Local Areas,Nevada,2014,Age,19 Months,81.4,73.1 to 87.6,186
Hib,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,83.9,79.0 to 87.8,439
Polio,≥3 Doses,States/Local Areas,Nevada,2012,Age,24 Months,88.7,83.2 to 93.1,272
Polio,≥3 Doses,States/Local Areas,Nevada,2011,Age,24 Months,92.7,88.4 to 95.8,293
Polio,≥3 Doses,States/Local Areas,Nevada,2019,Age,19 Months,90.5,85.0 to 94.1,340
Hib,≥3 Doses,States/Local Areas,Nevada,2016,Age,19 Months,81.4,75.2 to 86.4,327
Hib,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,83.5,79.3 to 87.0,671
Polio,≥3 Doses,States/Local Areas,Nevada,2016,Age,24 Months,87.9,82.7 to 92.2,327
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,88.6,84.9 to 91.7,671
Hib,≥3 Doses,States/Local Areas,Nevada,2017,Age,19 Months,85.5,79.6 to 90.0,344
Hib,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,88.0,84.2 to 91.0,722
Hib,≥3 Doses,States/Local Areas,Nevada,2018,Age,19 Months,90.5,85.3 to 94.0,378
Hib,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,69.6,64.9 to 73.9,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2017,Age,19 Months,89.1,83.4 to 93.0,344
DTaP,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,92.7,89.5 to 95.0,722
DTaP,≥3 Doses,States/Local Areas,Nevada,2018,Age,19 Months,96.3,93.0 to 98.1,378
DTaP,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,89.8,86.2 to 92.5,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2019,Age,19 Months,90.6,85.1 to 94.2,340
Hib,Full Series,States/Local Areas,Nevada,2015,Age,24 Months,74.7,67.9 to 81.1,253
Hib,Full Series,States/Local Areas,Nevada,2015-2016,Age,24 Months,74.1,69.3 to 78.6,580
DTaP,≥3 Doses,States/Local Areas,Nevada,2013,Age,24 Months,94.6,90.2 to 97.4,234
DTaP,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,92.6,89.2 to 95.3,420
Polio,≥3 Doses,States/Local Areas,Nevada,2011,Age,35 Months,96.6,92.9 to 98.6,293
DTaP,≥3 Doses,States/Local Areas,Nevada,2011,Age,24 Months,93.6,89.3 to 96.6,293
Polio,≥3 Doses,States/Local Areas,Nevada,2017,Age,24 Months,89.1,83.9 to 93.2,344
Polio,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,92.1,89.0 to 94.6,722
Hib,≥3 Doses,States/Local Areas,Nevada,2019,Age,19 Months,85.8,79.8 to 90.2,340
Polio,≥3 Doses,States/Local Areas,Nevada,2019,Age,24 Months,91.1,86.1 to 94.9,340
Polio,≥3 Doses,States/Local Areas,Nevada,2018,Age,24 Months,95.0,91.4 to 97.4,378
Polio,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,93.1,90.1 to 95.5,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2012,Age,24 Months,88.5,82.6 to 93.2,272
Hib,Full Series,States/Local Areas,Nevada,2017,Age,24 Months,75.9,69.2 to 82.1,344
Hib,Full Series,States/Local Areas,Nevada,2017-2018,Age,24 Months,77.7,73.2 to 81.9,722
Hib,Full Series,States/Local Areas,Nevada,2018,Age,24 Months,79.5,73.5 to 84.9,378
Hib,Full Series,States/Local Areas,Nevada,2018-2019,Age,24 Months,78.3,73.9 to 82.4,718
Hib,Full Series,States/Local Areas,Nevada,2016,Age,24 Months,73.4,66.6 to 79.7,327
Hib,Full Series,States/Local Areas,Nevada,2016-2017,Age,24 Months,74.7,69.9 to 79.2,671
Polio,≥3 Doses,States/Local Areas,Nevada,2012,Age,35 Months,91.0,85.4 to 95.0,272
Hib,≥3 Doses,States/Local Areas,Nevada,2014,Age,24 Months,89.2,83.1 to 93.8,186
Hib,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,88.5,84.7 to 91.8,439
Hib,≥3 Doses,States/Local Areas,Nevada,2011,Age,24 Months,90.3,85.3 to 94.1,293
Hib,≥3 Doses,States/Local Areas,Nevada,2012,Age,24 Months,87.8,82.1 to 92.3,272
Hib,≥3 Doses,States/Local Areas,Nevada,2013,Age,24 Months,91.6,86.7 to 95.2,234
Hib,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,90.2,86.4 to 93.3,420
Polio,≥3 Doses,States/Local Areas,Nevada,2015,Age,35 Months,91.5,87.1 to 94.9,253
Polio,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,91.9,88.6 to 94.5,580
DTaP,≥2 Doses,States/Local Areas,Nevada,2015,Age,5 Months,72.6,65.1 to 79.0,253
DTaP,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,5 Months,74.1,69.1 to 78.5,580
DTaP,≥2 Doses,States/Local Areas,Nevada,2016,Age,5 Months,75.6,68.8 to 81.3,327
DTaP,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,5 Months,74.1,69.2 to 78.5,671
Polio,≥3 Doses,States/Local Areas,Nevada,2016,Age,35 Months,92.6,87.6 to 96.1,327
Polio,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,91.9,88.4 to 94.7,671
Polio,≥3 Doses,States/Local Areas,Nevada,2017,Age,35 Months,91.3,86.3 to 95.1,344
Polio,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,94.0,91.0 to 96.2,722
DTaP,≥2 Doses,States/Local Areas,Nevada,2014,Age,5 Months,74.5,65.8 to 81.6,186
DTaP,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,5 Months,73.5,69.9 to 76.9,439
Hib,Full Series,States/Local Areas,Nevada,2012,Age,35 Months,83.2,75.6 to 89.5,272
Hib,Full Series,States/Local Areas,Nevada,2011,Age,35 Months,82.7,75.7 to 88.7,293
Hib,Full Series,States/Local Areas,Nevada,2013,Age,35 Months,88.8,82.6 to 93.5,234
Hib,Full Series,States/Local Areas,Nevada,2013-2014,Age,35 Months,85.0,79.7 to 89.5,420
Polio,≥3 Doses,States/Local Areas,Nevada,2013,Age,35 Months,96.5,92.7 to 98.6,234
Polio,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,95.5,91.8 to 97.8,420
Polio,≥3 Doses,States/Local Areas,Nevada,2014,Age,35 Months,94.8,87.4 to 98.5,186
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,93.0,88.4 to 96.3,439
Hib,Full Series,States/Local Areas,Nevada,2019,Age,24 Months,76.9,70.5 to 82.8,340
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,79.9,75.1 to 84.6,520
Polio,≥3 Doses,States/Local Areas,Nevada,2018,Age,35 Months,96.8,93.4 to 98.7,378
Polio,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,94.9,92.0 to 97.0,718
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,91.8,88.7 to 94.9,520
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,87.0,83.0 to 90.9,374
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,90.4,81.3 to 99.5,52
DTaP,≥2 Doses,States/Local Areas,Nevada,2011,Age,5 Months,68.1,59.3 to 75.8,293
DTaP,≥2 Doses,States/Local Areas,Nevada,2012,Age,5 Months,65.7,58.8 to 72.0,272
DTaP,≥2 Doses,States/Local Areas,Nevada,2013,Age,5 Months,80.6,76.0 to 84.4,234
DTaP,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,5 Months,77.5,73.4 to 81.1,420
Hib,Full Series,States/Local Areas,Nevada,2017,Age,35 Months,83.0,76.3 to 88.8,344
Hib,Full Series,States/Local Areas,Nevada,2017-2018,Age,35 Months,82.4,77.9 to 86.4,722
Polio,≥3 Doses,States/Local Areas,Nevada,2019,Age,35 Months,93.1,88.1 to 96.5,340
Hib,Full Series,States/Local Areas,Nevada,2016,Age,35 Months,79.1,71.8 to 85.6,327
Hib,Full Series,States/Local Areas,Nevada,2016-2017,Age,35 Months,81.3,76.3 to 85.7,671
Hib,Full Series,States/Local Areas,Nevada,2015,Age,35 Months,80.6,74.4 to 86.1,253
Hib,Full Series,States/Local Areas,Nevada,2015-2016,Age,35 Months,80.0,75.3 to 84.4,580
Hib,Full Series,States/Local Areas,Nevada,2014,Age,35 Months,80.5,72.3 to 87.5,186
Hib,Full Series,States/Local Areas,Nevada,2014-2015,Age,35 Months,80.6,75.5 to 85.2,439
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,71.4,65.7 to 77.0,374
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.9,53.4 to 80.4,66
Hib,Full Series,States/Local Areas,Nevada,2019,Age,35 Months,80.0,73.3 to 85.9,340
Hib,Full Series,States/Local Areas,Nevada,2018,Age,35 Months,81.7,75.7 to 87.0,378
Hib,Full Series,States/Local Areas,Nevada,2018-2019,Age,35 Months,80.9,76.5 to 85.0,718
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,90.0,86.1 to 94.0,326
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,83.9 to 95.2,151
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,86.4 to 93.4,430
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,88.6,85.7 to 91.6,692
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,86.6 to 96.7,172
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.9,68.7 to 91.2,66
Hib,Primary Series,States/Local Areas,Nevada,2011,Age,7 Months,60.9,54.0 to 67.3,293
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,83.4,76.7 to 90.1,243
Hib,Primary Series,States/Local Areas,Nevada,2012,Age,7 Months,61.7,53.2 to 69.6,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2011,Age,13 Months,56.8,50.1 to 63.3,293
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.3,67.9 to 84.6,172
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,71.3,65.1 to 77.6,326
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,77.1 to 91.8,151
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.0,70.7 to 81.3,430
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,74.5,70.2 to 78.8,692
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Overall,Overall,74.3,70.6 to 77.9,973
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,67.1,55.3 to 79.0,109
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,68.7,62.5 to 74.9,341
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,76.2,70.7 to 81.6,389
Hib,Full Series,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,74.0,57.9 to 90.1,52
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,77.9,72.0 to 83.8,692
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.7,65.1 to 86.3,151
Hib,Full Series,States/Local Areas,Nevada,2020,Age,24 Months,71.4,63.5 to 78.9,323
≥1 Dose MMR,,States/Local Areas,Nevada,2011,Age,13 Months,55.5,53.2 to 57.8,293
≥1 Dose MMR,,States/Local Areas,Nevada,2012,Age,13 Months,57.6,54.2 to 60.9,272
≥1 Dose MMR,,States/Local Areas,Nevada,2013,Age,13 Months,60.4,56.2 to 64.4,234
≥1 Dose MMR,,States/Local Areas,Nevada,2013-2014,Age,13 Months,60.7,57.5 to 63.8,420
Hib,≥3 Doses,States/Local Areas,Nevada,2019,Age,35 Months,89.9,84.7 to 94.0,340
Hep A,≥2 Doses,States/Local Areas,Nevada,2014,Age,24 Months,41.7,33.2 to 51.5,186
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,45.6,39.8 to 51.9,439
Hep A,≥2 Doses,States/Local Areas,Nevada,2015,Age,24 Months,49.5,42.0 to 57.6,253
Hep A,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,47.4,42.3 to 52.9,580
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,89.1,86.6 to 91.6,973
Hep A,≥1 Dose,States/Local Areas,Nevada,2014,Age,35 Months,90.6,83.6 to 95.5,186
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,35 Months,90.4,86.3 to 93.7,439
Hep A,≥1 Dose,States/Local Areas,Nevada,2013,Age,35 Months,92.7,87.9 to 96.1,234
Hep A,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,35 Months,91.6,87.6 to 94.7,420
DTaP,≥4 Doses,States/Local Areas,Nevada,2012,Age,24 Months,75.3,67.8 to 82.2,272
DTaP,≥4 Doses,States/Local Areas,Nevada,2011,Age,24 Months,78.3,71.8 to 84.2,293
DTaP,≥4 Doses,States/Local Areas,Nevada,2019,Age,19 Months,70.7,63.7 to 76.9,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2013,Age,7 Months,70.6,65.3 to 75.4,234
Hep B,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,67.9,61.0 to 74.0,420
Hep B,≥3 Doses,States/Local Areas,Nevada,2011,Age,7 Months,56.5,51.3 to 61.5,293
Hep B,≥3 Doses,States/Local Areas,Nevada,2012,Age,7 Months,65.8,55.5 to 74.8,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,88.4,84.3 to 92.5,389
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,92.3,87.7 to 97.0,243
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,88.3,84.3 to 92.3,341
Polio,≥2 Doses,States/Local Areas,Nevada,2014,Age,5 Months,72.9,64.3 to 80.2,186
Polio,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,5 Months,71.6,67.4 to 75.5,439
Polio,≥2 Doses,States/Local Areas,Nevada,2013,Age,5 Months,79.1,74.7 to 82.9,234
Polio,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,5 Months,76.0,71.0 to 80.3,420
Hep A,≥1 Dose,States/Local Areas,Nevada,2012,Age,35 Months,94.3,82.7 to 99.1,272
Polio,≥2 Doses,States/Local Areas,Nevada,2011,Age,5 Months,66.7,58.7 to 73.9,293
Polio,≥2 Doses,States/Local Areas,Nevada,2012,Age,5 Months,64.5,57.4 to 70.9,272
Hep A,≥1 Dose,States/Local Areas,Nevada,2015,Age,35 Months,90.8,86.0 to 94.5,253
Hep A,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,35 Months,91.2,87.8 to 94.0,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2013,Age,24 Months,82.6,76.1 to 88.2,234
DTaP,≥4 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,78.9,73.7 to 83.8,420
Hep A,≥2 Doses,States/Local Areas,Nevada,2016,Age,24 Months,45.3,38.4 to 52.8,327
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,51.0,45.8 to 56.4,671
Hep A,≥2 Doses,States/Local Areas,Nevada,2017,Age,24 Months,56.4,49.0 to 64.0,344
Hep A,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,57.4,52.3 to 62.7,722
Hep A,≥2 Doses,States/Local Areas,Nevada,2018,Age,24 Months,58.9,51.8 to 66.0,378
Hep A,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,55.0,49.9 to 60.2,718
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,80.0,74.9 to 85.0,341
Hib,≥2 Doses,States/Local Areas,Nevada,2019,Age,7 Months,85.9,80.1 to 90.2,340
PCV,≥3 Doses,States/Local Areas,Nevada,2016,Age,35 Months,90.3,84.6 to 94.6,327
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,89.0,84.9 to 92.4,671
PCV,≥3 Doses,States/Local Areas,Nevada,2015,Age,35 Months,91.2,86.6 to 94.7,253
PCV,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,90.5,86.9 to 93.4,580
PCV,≥3 Doses,States/Local Areas,Nevada,2014,Age,35 Months,90.3,84.6 to 94.5,186
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,90.7,87.2 to 93.6,439
Hib,≥2 Doses,States/Local Areas,Nevada,2018,Age,7 Months,90.2,85.2 to 93.7,378
Hib,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,88.1,84.4 to 91.0,718
PCV,≥3 Doses,States/Local Areas,Nevada,2012,Age,35 Months,91.6,86.0 to 95.5,272
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,89.3,85.1 to 93.5,326
DTaP,≥3 Doses,States/Local Areas,Nevada,2011,Age,13 Months,88.9,86.1 to 91.2,293
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,83.0 to 94.6,151
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.0,82.9 to 95.2,172
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,89.1,82.1 to 96.2,109
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.3,86.9 to 93.8,430
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,88.8,85.9 to 91.7,692
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016,Age,0-3 Days,78.0,71.8 to 83.2,327
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2016-2017,Age,0-3 Days,76.9,72.4 to 80.8,671
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2017,Age,0-3 Days,78.1,68.6 to 85.4,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2017-2018,Age,0-3 Days,79.5,75.3 to 83.1,722
Polio,≥1 Dose,States/Local Areas,Nevada,2016,Age,3 Months,83.6,77.3 to 88.4,327
Polio,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,3 Months,82.8,78.4 to 86.5,671
Polio,≥1 Dose,States/Local Areas,Nevada,2015,Age,3 Months,80.7,73.7 to 86.2,253
Polio,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,3 Months,82.1,77.6 to 85.9,580
Polio,≥1 Dose,States/Local Areas,Nevada,2014,Age,3 Months,80.5,72.3 to 86.7,186
Polio,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,3 Months,80.6,75.4 to 84.9,439
Hib,≥3 Doses,States/Local Areas,Nevada,2013,Age,7 Months,45.4,35.9 to 55.3,234
Hib,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,42.9,33.8 to 52.5,420
Hib,≥3 Doses,States/Local Areas,Nevada,2011,Age,7 Months,44.3,40.2 to 48.6,293
Hib,≥3 Doses,States/Local Areas,Nevada,2012,Age,7 Months,44.0,35.0 to 53.4,272
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,87.8,83.8 to 91.9,389
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,94.4,90.7 to 98.1,243
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,87.4,83.1 to 91.7,341
Hib,≥2 Doses,States/Local Areas,Nevada,2017,Age,7 Months,84.7,78.4 to 89.4,344
Hib,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,87.5,83.6 to 90.5,722
Hib,≥2 Doses,States/Local Areas,Nevada,2016,Age,7 Months,83.5,77.2 to 88.3,327
Hib,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,84.1,79.8 to 87.7,671
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,75.2,61.6 to 88.8,52
DTaP,≥3 Doses,States/Local Areas,Nevada,2017,Age,7 Months,60.4,52.8 to 67.6,344
DTaP,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,67.1,62.1 to 71.8,722
DTaP,≥3 Doses,States/Local Areas,Nevada,2019,Age,7 Months,72.7,66.0 to 78.4,340
DTaP,≥3 Doses,States/Local Areas,Nevada,2018,Age,7 Months,73.8,67.5 to 79.3,378
DTaP,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,73.2,68.8 to 77.3,718
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,78.9,74.0 to 83.7,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.5,59.9 to 85.1,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,74.9,69.9 to 79.8,520
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2019,Age,0-3 Days,83.3,77.6 to 87.7,340
Polio,≥1 Dose,States/Local Areas,Nevada,2019,Age,3 Months,88.4,82.8 to 92.3,340
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2018,Age,0-3 Days,83.3,77.9 to 87.5,378
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2018-2019,Age,0-3 Days,83.3,79.5 to 86.5,718
PCV,≥3 Doses,States/Local Areas,Nevada,2019,Age,35 Months,91.3,86.0 to 95.2,340
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,88.6,84.7 to 92.4,520
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,86.6,82.7 to 90.6,374
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,88.5,84.2 to 92.7,326
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,83.7 to 94.9,151
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.5,62.1 to 87.0,66
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,89.6,80.1 to 99.0,52
Hib,≥3 Doses,States/Local Areas,Nevada,2018,Age,7 Months,47.6,41.0 to 54.4,378
Hib,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,46.8,42.1 to 51.7,718
Hib,≥3 Doses,States/Local Areas,Nevada,2017,Age,7 Months,43.8,36.6 to 51.2,344
Hib,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,45.7,40.8 to 50.8,722
Hib,≥2 Doses,States/Local Areas,Nevada,2014,Age,13 Months,89.1,82.7 to 93.3,186
Hib,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,90.3,86.5 to 93.1,439
Hib,≥2 Doses,States/Local Areas,Nevada,2016,Age,13 Months,87.8,82.1 to 91.9,327
Hib,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,89.1,85.3 to 92.0,671
Hib,≥2 Doses,States/Local Areas,Nevada,2015,Age,13 Months,91.5,86.6 to 94.7,253
Hib,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,89.7,86.1 to 92.4,580
Polio,≥1 Dose,States/Local Areas,Nevada,2018,Age,3 Months,89.0,84.0 to 92.6,378
Polio,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,3 Months,88.7,85.1 to 91.5,718
Polio,≥1 Dose,States/Local Areas,Nevada,2017,Age,3 Months,82.1,75.6 to 87.1,344
Polio,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,3 Months,85.5,81.5 to 88.8,722
Hib,≥3 Doses,States/Local Areas,Nevada,2016,Age,7 Months,39.1,32.5 to 46.1,327
Hib,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,41.5,36.5 to 46.6,671
Hib,≥3 Doses,States/Local Areas,Nevada,2015,Age,7 Months,34.3,27.5 to 41.8,253
Hib,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,36.7,31.9 to 41.8,580
Hib,≥3 Doses,States/Local Areas,Nevada,2014,Age,7 Months,40.4,31.8 to 49.5,186
Hib,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,37.3,31.8 to 43.2,439
PCV,≥3 Doses,States/Local Areas,Nevada,2018,Age,35 Months,94.8,90.7 to 97.4,378
PCV,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,93.1,89.9 to 95.6,718
PCV,≥3 Doses,States/Local Areas,Nevada,2017,Age,35 Months,87.6,82.0 to 92.1,344
PCV,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,91.1,87.8 to 93.9,722
Hib,≥2 Doses,States/Local Areas,Nevada,2013,Age,13 Months,94.3,90.3 to 96.7,234
Hib,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,91.7,86.6 to 95.0,420
DTaP,≥3 Doses,States/Local Areas,Nevada,2016,Age,7 Months,65.9,58.8 to 72.4,327
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,63.1,57.9 to 68.1,671
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2015,Age,0-3 Days,76.9,69.4 to 83.0,253
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2015-2016,Age,0-3 Days,77.4,72.7 to 81.6,580
DTaP,≥3 Doses,States/Local Areas,Nevada,2014,Age,7 Months,68.2,59.3 to 75.9,186
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,63.1,57.2 to 68.6,439
DTaP,≥3 Doses,States/Local Areas,Nevada,2015,Age,7 Months,58.0,50.3 to 65.3,253
DTaP,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,61.9,56.7 to 66.9,580
Hib,≥2 Doses,States/Local Areas,Nevada,2011,Age,13 Months,94.6,93.2 to 95.8,293
Hib,≥2 Doses,States/Local Areas,Nevada,2012,Age,13 Months,91.0,88.7 to 92.9,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2017,Age,13 Months,85.5,79.3 to 90.1,344
DTaP,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,88.4,84.7 to 91.4,722
DTaP,≥3 Doses,States/Local Areas,Nevada,2016,Age,13 Months,81.9,75.4 to 86.9,327
DTaP,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,83.7,79.3 to 87.3,671
Hib,≥3 Doses,States/Local Areas,Nevada,2015,Age,13 Months,63.8,56.4 to 70.6,253
Hib,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,62.8,57.7 to 67.6,580
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.9,85.2 to 92.5,430
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,87.6,84.5 to 90.7,692
Hib,≥3 Doses,States/Local Areas,Nevada,2019,Age,7 Months,46.0,39.0 to 53.2,340
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,71.6,65.8 to 77.3,389
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,79.7,73.3 to 86.1,243
Hib,≥2 Doses,States/Local Areas,Nevada,2019,Age,13 Months,91.7,86.2 to 95.1,340
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.0,81.8 to 94.2,172
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,83.0,73.2 to 92.8,109
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,87.4,84.7 to 90.1,973
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,85.8,81.5 to 90.2,341
Hib,≥2 Doses,States/Local Areas,Nevada,2017,Age,13 Months,90.3,84.9 to 94.0,344
Hib,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,92.5,89.2 to 94.8,722
Hib,≥2 Doses,States/Local Areas,Nevada,2018,Age,13 Months,94.6,90.4 to 97.0,378
Hib,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,93.2,89.9 to 95.4,718
DTaP,≥3 Doses,States/Local Areas,Nevada,2012,Age,13 Months,84.8,78.3 to 89.5,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2015,Age,13 Months,86.8,80.8 to 91.1,253
DTaP,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,84.3,80.1 to 87.8,580
Hib,≥3 Doses,States/Local Areas,Nevada,2012,Age,13 Months,70.1,61.0 to 77.8,272
Hib,≥3 Doses,States/Local Areas,Nevada,2011,Age,13 Months,73.1,69.4 to 76.4,293
Hib,≥3 Doses,States/Local Areas,Nevada,2014,Age,13 Months,63.8,55.0 to 71.8,186
Hib,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,63.8,58.1 to 69.1,439
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,86.7,82.3 to 91.1,389
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,92.3,87.6 to 97.0,243
Polio,≥3 Doses,States/Local Areas,Nevada,2011,Age,19 Months,90.2,89.3 to 91.0,293
Hib,≥3 Doses,States/Local Areas,Nevada,2013,Age,13 Months,72.1,64.7 to 78.5,234
Hib,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,67.9,61.6 to 73.7,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,80.5,75.3 to 85.6,326
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,67.6 to 84.8,151
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.8,68.4 to 79.2,430
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.3,63.4 to 81.1,172
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,77.7,73.9 to 81.4,692
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Overall,Overall,76.8,73.5 to 80.1,973
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,80.4,71.2 to 89.6,109
DTaP,≥3 Doses,States/Local Areas,Nevada,2014,Age,13 Months,86.3,78.9 to 91.4,186
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,86.6,82.0 to 90.1,439
DTaP,≥3 Doses,States/Local Areas,Nevada,2013,Age,13 Months,92.4,88.6 to 95.0,234
DTaP,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,89.3,85.7 to 92.2,420
Polio,≥3 Doses,States/Local Areas,Nevada,2015,Age,19 Months,89.8,85.8 to 92.7,253
Polio,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,88.5,84.9 to 91.4,580
Polio,≥3 Doses,States/Local Areas,Nevada,2012,Age,19 Months,85.6,80.2 to 89.7,272
Polio,≥3 Doses,States/Local Areas,Nevada,2014,Age,19 Months,86.8,79.4 to 91.9,186
Polio,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,88.3,84.0 to 91.6,439
Polio,≥3 Doses,States/Local Areas,Nevada,2013,Age,19 Months,92.3,88.5 to 94.9,234
Polio,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,89.5,85.8 to 92.4,420
Hib,≥3 Doses,States/Local Areas,Nevada,2017,Age,13 Months,68.6,61.4 to 74.9,344
Hib,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,69.6,64.8 to 74.0,722
Hib,≥3 Doses,States/Local Areas,Nevada,2016,Age,13 Months,61.8,54.7 to 68.5,327
Hib,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,65.2,60.2 to 70.0,671
DTaP,≥3 Doses,States/Local Areas,Nevada,2012,Age,19 Months,88.3,84.2 to 91.5,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2013,Age,19 Months,94.4,90.2 to 96.9,234
DTaP,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,90.5,86.2 to 93.6,420
DTaP,≥3 Doses,States/Local Areas,Nevada,2011,Age,19 Months,92.0,90.1 to 93.6,293
DTaP,≥3 Doses,States/Local Areas,Nevada,2019,Age,13 Months,88.2,82.5 to 92.2,340
DTaP,≥3 Doses,States/Local Areas,Nevada,2018,Age,13 Months,91.4,86.6 to 94.6,378
DTaP,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,89.8,86.2 to 92.5,718
Polio,≥1 Dose,States/Local Areas,Nevada,2011,Age,3 Months,81.9,77.0 to 86.0,293
Polio,≥1 Dose,States/Local Areas,Nevada,2012,Age,3 Months,76.0,72.1 to 79.6,272
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,88.9,86.4 to 91.4,973
PCV,≥1 Dose,States/Local Areas,Nevada,2019,Age,3 Months,88.0,82.5 to 91.9,340
Polio,≥1 Dose,States/Local Areas,Nevada,2013,Age,3 Months,83.2,78.4 to 87.0,234
Polio,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,3 Months,81.8,76.7 to 86.1,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2013,Age,0-3 Days,70.7,63.0 to 77.4,234
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2013-2014,Age,0-3 Days,71.3,65.6 to 76.4,420
DTaP,≥3 Doses,States/Local Areas,Nevada,2011,Age,7 Months,58.7,54.6 to 62.6,293
DTaP,≥3 Doses,States/Local Areas,Nevada,2012,Age,7 Months,62.5,54.9 to 69.5,272
DTaP,≥3 Doses,States/Local Areas,Nevada,2013,Age,7 Months,68.0,60.2 to 74.9,234
DTaP,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,68.1,62.0 to 73.6,420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014,Age,0-3 Days,71.9,63.2 to 79.3,186
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2014-2015,Age,0-3 Days,74.4,68.8 to 79.3,439
PCV,≥1 Dose,States/Local Areas,Nevada,2015,Age,3 Months,79.3,72.2 to 85.0,253
PCV,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,3 Months,80.0,75.3 to 84.0,580
PCV,≥1 Dose,States/Local Areas,Nevada,2014,Age,3 Months,78.1,69.4 to 84.8,186
PCV,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,3 Months,78.7,73.3 to 83.2,439
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.6,74.6 to 90.7,151
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.5,74.5 to 84.5,430
PCV,≥3 Doses,States/Local Areas,Nevada,2018,Age,24 Months,94.8,90.7 to 97.4,378
PCV,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,92.5,89.4 to 95.0,718
PCV,≥3 Doses,States/Local Areas,Nevada,2017,Age,24 Months,87.3,81.7 to 91.8,344
PCV,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,91.0,87.7 to 93.8,722
Hib,≥2 Doses,States/Local Areas,Nevada,2012,Age,7 Months,81.9,80.1 to 83.7,272
PCV,≥3 Doses,States/Local Areas,Nevada,2016,Age,24 Months,85.4,79.8 to 90.1,327
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,86.4,82.5 to 89.8,671
Hib,≥2 Doses,States/Local Areas,Nevada,2011,Age,7 Months,86.7,81.8 to 90.4,293
Hib,≥2 Doses,States/Local Areas,Nevada,2019,Age,5 Months,77.1,70.5 to 82.5,340
Hib,≥2 Doses,States/Local Areas,Nevada,2018,Age,5 Months,80.9,75.0 to 85.7,378
Hib,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,5 Months,79.0,74.7 to 82.7,718
PCV,≥3 Doses,States/Local Areas,Nevada,2013,Age,35 Months,94.8,89.9 to 97.8,234
PCV,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,93.2,89.0 to 96.1,420
PCV,≥3 Doses,States/Local Areas,Nevada,2011,Age,35 Months,90.5,85.3 to 94.4,293
PCV,≥3 Doses,States/Local Areas,Nevada,2019,Age,24 Months,90.3,85.2 to 94.2,340
Hib,≥2 Doses,States/Local Areas,Nevada,2015,Age,7 Months,84.7,78.4 to 89.5,253
Hib,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,84.1,79.8 to 87.6,580
PCV,≥1 Dose,States/Local Areas,Nevada,2017,Age,3 Months,81.2,74.7 to 86.4,344
PCV,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,3 Months,84.1,80.1 to 87.5,722
PCV,≥1 Dose,States/Local Areas,Nevada,2016,Age,3 Months,80.7,74.3 to 85.8,327
PCV,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,3 Months,81.0,76.5 to 84.8,671
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,91.7,88.6 to 94.8,520
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.1,71.1 to 93.0,66
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.5,67.2 to 83.7,172
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,91.6,82.2 to 100.0,52
Hep B,≥3 Doses,States/Local Areas,Nevada,2020,Age,24 Months,88.7,81.7 to 94.0,323
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,75.8,72.3 to 79.4,973
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,70.2,58.5 to 81.8,109
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,70.1,64.1 to 76.2,341
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,77.4,72.0 to 82.8,389
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,85.9,79.7 to 92.1,243
Hib,≥2 Doses,States/Local Areas,Nevada,2011,Age,5 Months,67.1,57.6 to 75.3,293
Hib,≥2 Doses,States/Local Areas,Nevada,2012,Age,5 Months,65.7,58.8 to 71.9,272
PCV,≥3 Doses,States/Local Areas,Nevada,2017,Age,19 Months,85.2,78.9 to 89.9,344
PCV,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,89.3,85.5 to 92.2,722
Hib,≥2 Doses,States/Local Areas,Nevada,2014,Age,5 Months,73.9,65.2 to 81.0,186
Hib,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,5 Months,73.2,69.5 to 76.7,439
Hib,≥2 Doses,States/Local Areas,Nevada,2013,Age,5 Months,76.8,72.0 to 81.0,234
Hib,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,5 Months,75.4,71.6 to 78.8,420
PCV,≥3 Doses,States/Local Areas,Nevada,2011,Age,24 Months,89.3,84.2 to 93.3,293
PCV,≥3 Doses,States/Local Areas,Nevada,2019,Age,19 Months,90.2,84.7 to 93.9,340
PCV,≥3 Doses,States/Local Areas,Nevada,2018,Age,19 Months,93.3,88.6 to 96.2,378
PCV,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,88.8,85.1 to 91.7,718
PCV,≥1 Dose,States/Local Areas,Nevada,2012,Age,3 Months,75.2,70.8 to 79.1,272
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Overall,Overall,88.7,86.0 to 91.4,973
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,87.4,82.7 to 92.1,341
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,80.6,70.3 to 90.8,109
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,89.8,85.9 to 93.6,389
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,89.6,84.3 to 94.9,243
PCV,≥1 Dose,States/Local Areas,Nevada,2011,Age,3 Months,80.0,74.6 to 84.4,293
PCV,≥4 Doses,States/Local Areas,Nevada,2019,Age,35 Months,82.7,76.5 to 88.0,340
PCV,≥4 Doses,States/Local Areas,Nevada,2018,Age,35 Months,82.3,76.3 to 87.6,378
PCV,≥4 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,82.5,78.2 to 86.4,718
PCV,≥4 Doses,States/Local Areas,Nevada,2017,Age,35 Months,79.4,72.3 to 85.6,344
PCV,≥4 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,81.1,76.4 to 85.3,722
Hib,≥2 Doses,States/Local Areas,Nevada,2016,Age,5 Months,73.8,67.0 to 79.7,327
Hib,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,5 Months,73.2,68.3 to 77.6,671
Hib,≥2 Doses,States/Local Areas,Nevada,2015,Age,5 Months,72.6,65.2 to 78.9,253
Hib,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,5 Months,73.2,68.3 to 77.6,580
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,76.6,72.4 to 80.7,692
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2012,Age,0-3 Days,80.7,73.7 to 86.1,272
Hib,≥2 Doses,States/Local Areas,Nevada,2014,Age,7 Months,84.1,76.5 to 89.6,186
Hib,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,84.4,79.7 to 88.2,439
Hib,≥2 Doses,States/Local Areas,Nevada,2013,Age,7 Months,88.4,84.0 to 91.7,234
Hib,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,86.3,83.0 to 89.0,420
PCV,≥3 Doses,States/Local Areas,Nevada,2013,Age,24 Months,92.0,87.2 to 95.5,234
PCV,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,91.0,87.5 to 93.9,420
Hib,≥2 Doses,States/Local Areas,Nevada,2017,Age,5 Months,72.6,65.2 to 78.9,344
Hib,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,5 Months,76.7,72.1 to 80.8,722
PCV,≥3 Doses,States/Local Areas,Nevada,2012,Age,24 Months,89.8,84.3 to 94.0,272
PCV,≥3 Doses,States/Local Areas,Nevada,2014,Age,24 Months,90.3,84.6 to 94.5,186
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,90.2,86.7 to 93.2,439
PCV,≥3 Doses,States/Local Areas,Nevada,2015,Age,24 Months,90.3,85.8 to 93.9,253
PCV,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,87.9,84.3 to 90.9,580
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,72.9,67.4 to 78.5,374
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,84.2,72.6 to 95.8,52
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,74.3,68.3 to 80.3,326
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.3,47.7 to 74.9,66
PCV,≥1 Dose,States/Local Areas,Nevada,2013,Age,3 Months,81.6,76.4 to 85.8,234
PCV,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,3 Months,79.8,76.7 to 82.6,420
PCV,≥1 Dose,States/Local Areas,Nevada,2018,Age,3 Months,87.1,81.7 to 91.0,378
PCV,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,3 Months,87.5,83.8 to 90.5,718
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nevada,2011,Age,0-3 Days,77.7,71.4 to 82.9,293
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,79.8,74.9 to 84.6,520
PCV,≥3 Doses,States/Local Areas,Nevada,2016,Age,19 Months,84.8,78.8 to 89.3,327
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,85.0,80.8 to 88.4,671
PCV,≥3 Doses,States/Local Areas,Nevada,2015,Age,19 Months,90.3,84.7 to 94.0,253
PCV,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,87.6,83.8 to 90.5,580
Hep B,≥2 Doses,States/Local Areas,Nevada,2019,Age,13 Months,94.4,89.8 to 97.0,340
Hep B,≥2 Doses,States/Local Areas,Nevada,2018,Age,13 Months,97.4,95.2 to 98.6,378
Hep B,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,95.9,93.5 to 97.5,718
Hep B,≥2 Doses,States/Local Areas,Nevada,2017,Age,13 Months,91.8,87.0 to 94.9,344
Hep B,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,94.6,92.1 to 96.4,722
Hib,≥1 Dose,States/Local Areas,Nevada,2017,Age,3 Months,83.5,77.1 to 88.3,344
Hib,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,3 Months,86.2,82.3 to 89.4,722
Hib,≥1 Dose,States/Local Areas,Nevada,2016,Age,3 Months,82.6,76.3 to 87.5,327
Hib,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,3 Months,83.0,78.7 to 86.7,671
Hib,≥1 Dose,States/Local Areas,Nevada,2015,Age,3 Months,83.1,76.4 to 88.1,253
Hib,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,3 Months,82.8,78.4 to 86.5,580
≥1 Dose MMR,,States/Local Areas,Nevada,2017,Age,35 Months,93.4,88.3 to 96.8,344
≥1 Dose MMR,,States/Local Areas,Nevada,2017-2018,Age,35 Months,94.1,90.8 to 96.5,722
≥1 Dose MMR,,States/Local Areas,Nevada,2018,Age,35 Months,94.9,90.4 to 97.7,378
≥1 Dose MMR,,States/Local Areas,Nevada,2018-2019,Age,35 Months,93.7,90.5 to 96.1,718
PCV,≥4 Doses,States/Local Areas,Nevada,2013,Age,35 Months,88.4,81.5 to 93.6,234
PCV,≥4 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,85.5,80.2 to 90.0,420
≥1 Dose MMR,,States/Local Areas,Nevada,2019,Age,35 Months,92.5,87.5 to 96.0,340
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,83.1 to 96.1,151
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.3,86.0 to 92.7,430
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,89.0,85.8 to 92.2,692
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,96.4,92.5 to 100.0,52
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.3,73.4 to 95.2,66
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,87.3,83.3 to 91.4,520
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.3 to 94.1,374
≥1 Dose Varicella,,States/Local Areas,Nevada,2019,Age,35 Months,92.6,87.6 to 96.1,340
≥1 Dose MMR,,States/Local Areas,Nevada,2016,Age,35 Months,92.1,87.3 to 95.6,327
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2017,Age,35 Months,92.7,89.3 to 95.3,671
PCV,≥4 Doses,States/Local Areas,Nevada,2015,Age,24 Months,74.0,66.9 to 80.5,253
PCV,≥4 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,73.9,69.1 to 78.5,580
PCV,≥4 Doses,States/Local Areas,Nevada,2016,Age,24 Months,73.8,67.2 to 80.1,327
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,74.8,70.1 to 79.3,671
PCV,≥4 Doses,States/Local Areas,Nevada,2017,Age,24 Months,75.7,69.0 to 82.0,344
PCV,≥4 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,78.2,73.8 to 82.4,722
≥1 Dose MMR,,States/Local Areas,Nevada,2015,Age,35 Months,92.7,88.1 to 96.0,253
≥1 Dose MMR,,States/Local Areas,Nevada,2015-2016,Age,35 Months,92.4,89.2 to 94.9,580
≥1 Dose MMR,,States/Local Areas,Nevada,2014,Age,35 Months,92.6,85.5 to 97.0,186
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2015,Age,35 Months,92.6,88.8 to 95.5,439
PCV,≥3 Doses,States/Local Areas,Nevada,2016,Age,13 Months,79.9,73.4 to 85.2,327
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,80.8,76.2 to 84.7,671
Hep B,≥3 Doses,States/Local Areas,Nevada,2013,Age,35 Months,92.8,87.8 to 96.3,234
Hep B,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,92.3,87.9 to 95.6,420
Hep B,≥3 Doses,States/Local Areas,Nevada,2014,Age,35 Months,93.0,83.5 to 98.0,186
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,91.7,86.9 to 95.3,439
Hep B,≥3 Doses,States/Local Areas,Nevada,2015,Age,35 Months,92.0,87.7 to 95.2,253
Hep B,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,91.8,88.6 to 94.3,580
Hep B,≥3 Doses,States/Local Areas,Nevada,2012,Age,35 Months,90.7,85.1 to 94.9,272
PCV,≥3 Doses,States/Local Areas,Nevada,2018,Age,13 Months,90.4,85.4 to 93.8,378
PCV,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,88.8,85.1 to 91.7,718
PCV,≥3 Doses,States/Local Areas,Nevada,2017,Age,13 Months,81.6,74.8 to 86.9,344
PCV,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,86.0,81.9 to 89.3,722
Hep B,≥2 Doses,States/Local Areas,Nevada,2012,Age,13 Months,93.1,89.2 to 95.6,272
Hep B,≥2 Doses,States/Local Areas,Nevada,2013,Age,13 Months,94.3,90.6 to 96.6,234
Hep B,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,92.6,88.2 to 95.4,420
Hep B,≥2 Doses,States/Local Areas,Nevada,2011,Age,13 Months,95.7,94.1 to 96.8,293
Hep B,≥2 Doses,States/Local Areas,Nevada,2019,Age,7 Months,92.2,87.3 to 95.3,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2017,Age,35 Months,91.8,86.7 to 95.4,344
Hep B,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,93.9,90.9 to 96.1,722
PCV,≥3 Doses,States/Local Areas,Nevada,2012,Age,19 Months,88.3,84.7 to 91.2,272
PCV,≥4 Doses,States/Local Areas,Nevada,2012,Age,35 Months,85.1,78.6 to 90.5,272
PCV,≥4 Doses,States/Local Areas,Nevada,2011,Age,35 Months,83.8,76.4 to 90.0,293
PCV,≥4 Doses,States/Local Areas,Nevada,2018,Age,24 Months,80.7,74.7 to 86.1,378
PCV,≥4 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,80.7,76.5 to 84.6,718
PCV,≥4 Doses,States/Local Areas,Nevada,2019,Age,24 Months,80.7,74.7 to 86.1,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2016,Age,35 Months,92.1,87.0 to 95.7,327
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,92.0,88.5 to 94.8,671
PCV,≥3 Doses,States/Local Areas,Nevada,2014,Age,19 Months,86.2,78.8 to 91.3,186
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,88.3,84.0 to 91.5,439
PCV,≥3 Doses,States/Local Areas,Nevada,2013,Age,19 Months,91.7,88.0 to 94.3,234
PCV,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,88.9,85.5 to 91.6,420
PCV,≥3 Doses,States/Local Areas,Nevada,2011,Age,19 Months,86.9,84.2 to 89.3,293
PCV,≥3 Doses,States/Local Areas,Nevada,2019,Age,13 Months,87.1,81.2 to 91.4,340
Hep B,≥2 Doses,States/Local Areas,Nevada,2016,Age,13 Months,91.8,86.8 to 95.1,327
Hep B,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,91.8,88.5 to 94.2,671
Hep B,≥2 Doses,States/Local Areas,Nevada,2015,Age,13 Months,94.4,90.5 to 96.7,253
Hep B,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,93.1,90.1 to 95.2,580
Hep B,≥2 Doses,States/Local Areas,Nevada,2014,Age,13 Months,90.8,84.8 to 94.6,186
Hep B,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,92.6,89.2 to 95.0,439
Hib,≥1 Dose,States/Local Areas,Nevada,2014,Age,3 Months,80.9,72.7 to 87.1,186
Hib,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,3 Months,82.0,76.9 to 86.1,439
Hib,≥1 Dose,States/Local Areas,Nevada,2011,Age,3 Months,85.0,81.8 to 87.7,293
Hib,≥1 Dose,States/Local Areas,Nevada,2012,Age,3 Months,76.6,72.9 to 79.9,272
Hib,≥1 Dose,States/Local Areas,Nevada,2013,Age,3 Months,80.4,75.9 to 84.2,234
Hib,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,3 Months,80.7,76.0 to 84.6,420
Hep B,≥3 Doses,States/Local Areas,Nevada,2019,Age,35 Months,93.3,88.4 to 96.6,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2018,Age,35 Months,95.9,92.5 to 98.1,378
Hep B,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,94.7,91.8 to 96.8,718
PCV,≥4 Doses,States/Local Areas,Nevada,2014,Age,35 Months,82.3,74.4 to 88.9,186
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,80.1,75.0 to 84.8,439
PCV,≥4 Doses,States/Local Areas,Nevada,2015,Age,35 Months,77.8,71.1 to 83.9,253
PCV,≥4 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,79.9,75.1 to 84.2,580
PCV,≥4 Doses,States/Local Areas,Nevada,2016,Age,35 Months,81.7,74.9 to 87.6,327
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,80.5,75.6 to 84.9,671
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,89.2,85.2 to 93.2,374
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,88.6,84.8 to 92.4,520
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,88.7,84.0 to 93.4,326
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,78.7 to 93.3,151
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.6,78.7 to 98.5,66
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,95.7,89.8 to 100.0,52
Hib,≥1 Dose,States/Local Areas,Nevada,2019,Age,3 Months,88.2,82.8 to 92.1,340
Hib,≥1 Dose,States/Local Areas,Nevada,2018,Age,3 Months,89.0,84.1 to 92.5,378
Hib,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,3 Months,88.6,85.1 to 91.4,718
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.7,86.4 to 93.0,430
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,88.9,85.7 to 92.1,692
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.1,85.7 to 96.5,172
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,90.1,84.9 to 95.2,243
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.7,83.9 to 95.6,172
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,81.5,71.4 to 91.6,109
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Overall,Overall,88.6,85.9 to 91.3,973
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,87.7,83.0 to 92.3,341
PCV,≥4 Doses,States/Local Areas,Nevada,2012,Age,24 Months,80.1,73.1 to 86.2,272
Hep B,≥3 Doses,States/Local Areas,Nevada,2011,Age,35 Months,90.8,85.9 to 94.5,293
Hep B,≥3 Doses,States/Local Areas,Nevada,2017,Age,24 Months,88.9,83.6 to 93.1,344
Hep B,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,91.9,88.9 to 94.4,722
Hep B,≥3 Doses,States/Local Areas,Nevada,2019,Age,24 Months,90.3,85.3 to 94.2,340
PCV,≥4 Doses,States/Local Areas,Nevada,2013,Age,24 Months,80.2,73.7 to 86.0,234
PCV,≥4 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,79.4,74.2 to 84.2,420
PCV,≥4 Doses,States/Local Areas,Nevada,2014,Age,24 Months,78.2,70.2 to 85.3,186
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,76.1,70.8 to 81.1,439
≥1 Dose MMR,,States/Local Areas,Nevada,2019,Age,24 Months,89.3,84.3 to 93.2,340
≥1 Dose MMR,,States/Local Areas,Nevada,2012,Age,35 Months,92.5,87.0 to 96.2,272
≥1 Dose MMR,,States/Local Areas,Nevada,2011,Age,35 Months,93.5,89.2 to 96.5,293
≥1 Dose MMR,,States/Local Areas,Nevada,2013,Age,35 Months,97.5,94.6 to 99.1,234
≥1 Dose MMR,,States/Local Areas,Nevada,2013-2014,Age,35 Months,95.3,91.8 to 97.7,420
≥1 Dose Varicella,,States/Local Areas,Nevada,2016,Age,35 Months,91.8,86.8 to 95.4,327
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2017,Age,35 Months,91.9,88.4 to 94.6,671
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,88.9,84.8 to 92.9,389
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,87.5,83.6 to 91.3,374
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,88.6,83.9 to 93.4,326
Hep B,≥2 Doses,States/Local Areas,Nevada,2018,Age,7 Months,95.8,92.6 to 97.6,378
Hep B,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,94.0,91.2 to 95.9,718
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2019,Age,0-2 Days,82.5,76.8 to 87.0,340
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2018,Age,0-2 Days,81.2,75.5 to 85.9,378
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2018-2019,Age,0-2 Days,81.8,77.9 to 85.2,718
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2017,Age,0-2 Days,74.3,67.5 to 80.1,344
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2017-2018,Age,0-2 Days,77.8,73.4 to 81.6,722
≥1 Dose Varicella,,States/Local Areas,Nevada,2017,Age,35 Months,92.1,87.0 to 95.8,344
≥1 Dose Varicella,,States/Local Areas,Nevada,2017-2018,Age,35 Months,93.8,90.6 to 96.2,722
Hep B,≥3 Doses,States/Local Areas,Nevada,2018,Age,24 Months,94.9,91.8 to 97.1,378
Hep B,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,92.7,89.7 to 95.0,718
PCV,≥3 Doses,States/Local Areas,Nevada,2015,Age,13 Months,84.8,78.5 to 89.4,253
PCV,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,82.4,78.0 to 86.0,580
PCV,≥3 Doses,States/Local Areas,Nevada,2014,Age,13 Months,84.8,77.4 to 90.1,186
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,84.8,80.2 to 88.5,439
Hep B,≥2 Doses,States/Local Areas,Nevada,2017,Age,7 Months,89.9,84.6 to 93.5,344
Hep B,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,92.8,89.9 to 95.0,722
PCV,≥3 Doses,States/Local Areas,Nevada,2013,Age,13 Months,89.8,86.4 to 92.5,234
PCV,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,87.3,84.0 to 90.0,420
Hep B,≥2 Doses,States/Local Areas,Nevada,2016,Age,7 Months,88.4,82.7 to 92.4,327
Hep B,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,89.2,85.4 to 92.1,671
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2016,Age,0-2 Days,76.3,69.8 to 81.7,327
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2016-2017,Age,0-2 Days,75.3,70.7 to 79.4,671
≥1 Dose Varicella,,States/Local Areas,Nevada,2013,Age,35 Months,96.6,92.6 to 98.8,234
≥1 Dose Varicella,,States/Local Areas,Nevada,2013-2014,Age,35 Months,94.8,91.1 to 97.3,420
≥1 Dose MMR,,States/Local Areas,Nevada,2018,Age,24 Months,92.2,87.7 to 95.5,378
≥1 Dose MMR,,States/Local Areas,Nevada,2018-2019,Age,24 Months,90.8,87.5 to 93.5,718
PCV,≥4 Doses,States/Local Areas,Nevada,2019,Age,19 Months,77.5,71.0 to 82.9,340
≥1 Dose Varicella,,States/Local Areas,Nevada,2014,Age,35 Months,91.8,84.8 to 96.4,186
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2015,Age,35 Months,92.4,88.7 to 95.2,439
≥1 Dose Varicella,,States/Local Areas,Nevada,2015,Age,35 Months,93.0,88.9 to 96.0,253
≥1 Dose Varicella,,States/Local Areas,Nevada,2015-2016,Age,35 Months,92.4,89.3 to 94.8,580
PCV,≥4 Doses,States/Local Areas,Nevada,2011,Age,24 Months,73.3,66.7 to 79.6,293
Hib,Primary Series,States/Local Areas,Nevada,2020,Age,24 Months,88.2,81.2 to 93.5,323
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2015,Age,0-2 Days,75.8,68.2 to 82.0,253
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2015-2016,Age,0-2 Days,76.0,71.2 to 80.3,580
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2014,Age,0-2 Days,70.3,61.3 to 77.9,186
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2014-2015,Age,0-2 Days,73.0,67.3 to 78.1,439
Hep B,≥3 Doses,States/Local Areas,Nevada,2014,Age,24 Months,87.5,81.0 to 92.6,186
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,89.4,85.5 to 92.5,439
Hep B,≥3 Doses,States/Local Areas,Nevada,2015,Age,24 Months,91.2,86.8 to 94.6,253
Hep B,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,90.3,87.0 to 93.0,580
Hep B,≥3 Doses,States/Local Areas,Nevada,2016,Age,24 Months,89.4,84.3 to 93.3,327
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,89.2,85.6 to 92.2,671
PCV,≥3 Doses,States/Local Areas,Nevada,2012,Age,13 Months,84.6,78.7 to 89.1,272
≥1 Dose MMR,,States/Local Areas,Nevada,2016,Age,24 Months,87.8,82.5 to 92.1,327
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2017,Age,24 Months,89.4,85.9 to 92.3,671
≥1 Dose MMR,,States/Local Areas,Nevada,2017,Age,24 Months,90.8,86.0 to 94.5,344
≥1 Dose MMR,,States/Local Areas,Nevada,2017-2018,Age,24 Months,91.5,88.4 to 94.1,722
PCV,≥4 Doses,States/Local Areas,Nevada,2018,Age,19 Months,78.3,71.9 to 83.6,378
PCV,≥4 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,78.7,73.8 to 83.0,594
PCV,≥4 Doses,States/Local Areas,Nevada,2017,Age,19 Months,70.8,63.5 to 77.2,344
PCV,≥4 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,74.6,69.8 to 78.8,722
PCV,≥3 Doses,States/Local Areas,Nevada,2011,Age,13 Months,82.2,79.1 to 84.9,293
PCV,≥3 Doses,States/Local Areas,Nevada,2019,Age,7 Months,67.3,60.3 to 73.6,340
PCV,≥3 Doses,States/Local Areas,Nevada,2018,Age,7 Months,70.4,64.0 to 76.2,378
PCV,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,68.9,64.2 to 73.2,718
Hep B,≥2 Doses,States/Local Areas,Nevada,2012,Age,7 Months,90.6,85.1 to 94.2,272
Hep B,≥2 Doses,States/Local Areas,Nevada,2015,Age,7 Months,91.3,86.4 to 94.6,253
Hep B,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,89.9,86.3 to 92.6,580
Hep B,≥2 Doses,States/Local Areas,Nevada,2014,Age,7 Months,86.9,79.5 to 91.9,186
Hep B,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,89.1,84.9 to 92.3,439
Hep B,≥2 Doses,States/Local Areas,Nevada,2013,Age,7 Months,90.3,85.8 to 93.4,234
Hep B,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,88.6,83.2 to 92.4,420
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2012,Age,0-2 Days,80.1,73.6 to 85.4,272
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2013,Age,0-2 Days,70.7,62.4 to 77.8,234
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2013-2014,Age,0-2 Days,70.5,64.5 to 75.9,420
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nevada,2011,Age,0-2 Days,77.0,67.6 to 84.3,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2019,Age,0-1 Days,79.3,73.5 to 84.2,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2011,Age,24 Months,88.6,83.3 to 92.8,293
Hep B,≥3 Doses,States/Local Areas,Nevada,2019,Age,19 Months,89.5,84.0 to 93.3,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2013,Age,24 Months,89.4,83.7 to 93.8,234
Hep B,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,88.5,84.3 to 92.0,420
Hep B,≥3 Doses,States/Local Areas,Nevada,2012,Age,24 Months,89.3,83.6 to 93.7,272
PCV,≥3 Doses,States/Local Areas,Nevada,2016,Age,7 Months,62.3,55.1 to 69.1,327
PCV,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,61.0,55.7 to 66.0,671
PCV,≥4 Doses,States/Local Areas,Nevada,2016,Age,19 Months,71.2,64.2 to 77.3,327
PCV,≥4 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,71.0,66.0 to 75.5,671
PCV,≥4 Doses,States/Local Areas,Nevada,2015,Age,19 Months,70.6,64.1 to 76.4,253
PCV,≥4 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,70.9,65.9 to 75.5,580
PCV,≥4 Doses,States/Local Areas,Nevada,2014,Age,19 Months,68.4,59.1 to 76.5,186
PCV,≥4 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,69.5,63.7 to 74.8,439
PCV,≥3 Doses,States/Local Areas,Nevada,2015,Age,7 Months,52.8,45.2 to 60.4,253
PCV,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,57.6,52.3 to 62.7,580
PCV,≥3 Doses,States/Local Areas,Nevada,2017,Age,7 Months,59.6,52.0 to 66.8,344
PCV,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,65.0,60.0 to 69.7,722
≥1 Dose MMR,,States/Local Areas,Nevada,2013,Age,24 Months,93.8,89.4 to 96.9,234
≥1 Dose MMR,,States/Local Areas,Nevada,2013-2014,Age,24 Months,92.0,88.5 to 94.8,420
≥1 Dose MMR,,States/Local Areas,Nevada,2014,Age,24 Months,90.1,84.4 to 94.4,186
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2015,Age,24 Months,89.9,86.2 to 92.9,439
≥1 Dose MMR,,States/Local Areas,Nevada,2015,Age,24 Months,89.5,84.5 to 93.4,253
≥1 Dose MMR,,States/Local Areas,Nevada,2015-2016,Age,24 Months,88.6,85.1 to 91.7,580
≥1 Dose Varicella,,States/Local Areas,Nevada,2018,Age,24 Months,92.8,88.5 to 95.9,378
≥1 Dose Varicella,,States/Local Areas,Nevada,2018-2019,Age,24 Months,91.1,87.9 to 93.7,718
≥1 Dose Varicella,,States/Local Areas,Nevada,2012,Age,35 Months,91.1,85.2 to 95.4,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2011,Age,35 Months,97.9,92.2 to 99.7,293
≥1 Dose Varicella,,States/Local Areas,Nevada,2019,Age,24 Months,89.3,84.4 to 93.2,340
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2015,Age,0-1 Days,74.1,66.5 to 80.4,253
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2015-2016,Age,0-1 Days,74.1,69.2 to 78.5,580
Hep B,≥2 Doses,States/Local Areas,Nevada,2015,Age,5 Months,85.9,79.9 to 90.3,253
Hep B,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,5 Months,85.3,81.2 to 88.6,580
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2014,Age,0-1 Days,65.8,56.6 to 74.0,186
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2014-2015,Age,0-1 Days,70.0,64.1 to 75.3,439
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2013,Age,0-1 Days,68.1,58.3 to 76.5,234
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2013-2014,Age,0-1 Days,67.0,61.3 to 72.1,420
≥1 Dose Varicella,,States/Local Areas,Nevada,2013,Age,24 Months,92.1,87.0 to 95.8,234
≥1 Dose Varicella,,States/Local Areas,Nevada,2013-2014,Age,24 Months,90.8,87.1 to 93.8,420
≥1 Dose Varicella,,States/Local Areas,Nevada,2014,Age,24 Months,89.4,83.6 to 93.8,186
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2015,Age,24 Months,89.8,86.2 to 92.9,439
≥1 Dose Varicella,,States/Local Areas,Nevada,2019,Age,19 Months,84.8,78.9 to 89.3,340
Polio,≥2 Doses,States/Local Areas,Nevada,2019,Age,13 Months,91.5,86.0 to 95.0,340
Polio,≥2 Doses,States/Local Areas,Nevada,2018,Age,13 Months,94.5,89.9 to 97.1,378
Polio,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,93.0,89.6 to 95.3,718
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2012,Age,0-1 Days,79.0,72.3 to 84.4,272
Hep B,≥2 Doses,States/Local Areas,Nevada,2014,Age,5 Months,81.2,72.9 to 87.4,186
Hep B,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,5 Months,83.5,77.1 to 88.4,439
Hep B,≥2 Doses,States/Local Areas,Nevada,2016,Age,5 Months,84.7,78.7 to 89.2,327
Hep B,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,5 Months,85.6,81.5 to 88.9,671
Hep B,≥3 Doses,States/Local Areas,Nevada,2018,Age,19 Months,94.8,91.4 to 96.9,378
Hep B,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,90.3,86.8 to 92.9,718
Hep B,≥3 Doses,States/Local Areas,Nevada,2017,Age,19 Months,87.5,81.6 to 91.6,344
Hep B,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,91.1,87.8 to 93.6,722
PCV,≥3 Doses,States/Local Areas,Nevada,2012,Age,7 Months,57.9,53.0 to 62.7,272
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,74.7,69.1 to 80.3,389
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,83.3,76.6 to 90.1,243
PCV,≥3 Doses,States/Local Areas,Nevada,2014,Age,7 Months,61.9,52.8 to 70.3,186
PCV,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,57.3,51.4 to 63.1,439
Hep B,≥3 Doses,States/Local Areas,Nevada,2016,Age,19 Months,89.2,83.8 to 93.0,327
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,88.3,84.5 to 91.3,671
PCV,≥3 Doses,States/Local Areas,Nevada,2011,Age,7 Months,53.3,49.5 to 57.1,293
PCV,≥3 Doses,States/Local Areas,Nevada,2013,Age,7 Months,62.0,53.5 to 69.9,234
PCV,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,62.0,56.5 to 67.1,420
≥1 Dose Varicella,,States/Local Areas,Nevada,2017,Age,24 Months,90.5,85.6 to 94.3,344
≥1 Dose Varicella,,States/Local Areas,Nevada,2017-2018,Age,24 Months,91.6,88.5 to 94.2,722
≥1 Dose Varicella,,States/Local Areas,Nevada,2016,Age,24 Months,87.5,82.2 to 91.8,327
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2017,Age,24 Months,89.0,85.5 to 92.1,671
≥1 Dose Varicella,,States/Local Areas,Nevada,2015,Age,24 Months,90.1,85.3 to 93.8,253
≥1 Dose Varicella,,States/Local Areas,Nevada,2015-2016,Age,24 Months,88.8,85.3 to 91.8,580
≥1 Dose MMR,,States/Local Areas,Nevada,2012,Age,24 Months,86.8,80.7 to 91.8,272
≥1 Dose MMR,,States/Local Areas,Nevada,2011,Age,24 Months,90.0,85.2 to 93.7,293
≥1 Dose MMR,,States/Local Areas,Nevada,2019,Age,19 Months,84.4,78.4 to 88.9,340
≥1 Dose MMR,,States/Local Areas,Nevada,2018,Age,19 Months,89.1,83.7 to 92.9,378
≥1 Dose MMR,,States/Local Areas,Nevada,2018-2019,Age,19 Months,93.2,89.9 to 95.4,718
PCV,≥4 Doses,States/Local Areas,Nevada,2011,Age,19 Months,68.1,65.7 to 70.4,293
PCV,≥4 Doses,States/Local Areas,Nevada,2012,Age,19 Months,72.6,62.9 to 80.5,272
PCV,≥4 Doses,States/Local Areas,Nevada,2013,Age,19 Months,76.6,72.9 to 79.9,234
PCV,≥4 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,72.5,66.6 to 77.7,420
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2018,Age,0-1 Days,78.1,72.3 to 83.0,378
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2018-2019,Age,0-1 Days,78.7,74.7 to 82.3,718
Hep B,≥2 Doses,States/Local Areas,Nevada,2018,Age,5 Months,93.7,90.2 to 96.0,378
Hep B,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,5 Months,90.4,87.1 to 93.0,718
Hep B,≥2 Doses,States/Local Areas,Nevada,2017,Age,5 Months,86.6,80.6 to 90.9,344
Hep B,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,5 Months,90.1,86.8 to 92.7,722
PCV,≥4 Doses,States/Local Areas,Nevada,2020,Age,35 Months,80.7,72.5 to 87.8,323
Hep B,≥2 Doses,States/Local Areas,Nevada,2011,Age,7 Months,93.2,90.4 to 95.3,293
Hep B,≥2 Doses,States/Local Areas,Nevada,2019,Age,5 Months,87.1,81.2 to 91.4,340
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2017,Age,0-1 Days,70.5,63.5 to 76.7,344
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2017-2018,Age,0-1 Days,74.3,69.8 to 78.4,722
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2016,Age,0-1 Days,74.2,67.7 to 79.9,327
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2016-2017,Age,0-1 Days,72.4,67.6 to 76.7,671
Polio,≥2 Doses,States/Local Areas,Nevada,2017,Age,13 Months,90.7,85.3 to 94.3,344
Polio,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,92.6,89.3 to 95.0,722
Polio,≥2 Doses,States/Local Areas,Nevada,2016,Age,13 Months,88.2,82.4 to 92.2,327
Polio,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,89.5,85.7 to 92.3,671
Polio,≥2 Doses,States/Local Areas,Nevada,2015,Age,13 Months,92.5,88.0 to 95.4,253
Polio,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,90.3,86.9 to 93.0,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,73.8,67.6 to 79.9,326
≥1 Dose Varicella,,States/Local Areas,Nevada,2018,Age,19 Months,90.4,85.4 to 93.8,378
≥1 Dose Varicella,,States/Local Areas,Nevada,2018-2019,Age,19 Months,64.2,59.4 to 68.8,718
≥1 Dose Varicella,,States/Local Areas,Nevada,2017,Age,19 Months,85.3,79.1 to 89.9,344
≥1 Dose Varicella,,States/Local Areas,Nevada,2017-2018,Age,19 Months,87.8,84.0 to 90.9,722
≥1 Dose MMR,,States/Local Areas,Nevada,2012,Age,19 Months,83.5,74.9 to 89.6,272
≥1 Dose MMR,,States/Local Areas,Nevada,2014,Age,19 Months,79.5,70.3 to 86.3,186
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2015,Age,19 Months,82.9,77.7 to 87.2,439
≥1 Dose MMR,,States/Local Areas,Nevada,2013,Age,19 Months,90.5,85.7 to 93.9,234
≥1 Dose MMR,,States/Local Areas,Nevada,2013-2014,Age,19 Months,85.0,79.6 to 89.1,420
≥1 Dose MMR,,States/Local Areas,Nevada,2011,Age,19 Months,86.0,83.7 to 88.0,293
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,74.1,57.7 to 90.5,52
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.8,52.4 to 79.1,66
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,78.1,73.1 to 83.0,520
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,74.7,69.3 to 80.1,374
DTaP,≥4 Doses,States/Local Areas,Nevada,2019,Age,35 Months,81.6,75.0 to 87.4,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2015,Age,19 Months,90.9,84.6 to 94.8,253
Hep B,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,19 Months,90.0,86.6 to 92.7,580
Hep B,≥3 Doses,States/Local Areas,Nevada,2014,Age,19 Months,86.7,79.5 to 91.6,186
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,19 Months,88.8,84.7 to 91.9,439
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,84.4,74.1 to 94.8,243
Hep B,≥3 Doses,States/Local Areas,Nevada,2013,Age,19 Months,88.3,81.8 to 92.7,234
Hep B,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,19 Months,87.5,80.1 to 92.4,420
Hep B,≥2 Doses,States/Local Areas,Nevada,2013,Age,5 Months,86.7,83.4 to 89.5,234
Hep B,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,5 Months,83.9,78.8 to 88.0,420
Hep B,≥2 Doses,States/Local Areas,Nevada,2011,Age,5 Months,85.4,80.5 to 89.3,293
Hep B,≥2 Doses,States/Local Areas,Nevada,2012,Age,5 Months,87.0,83.1 to 90.2,272
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nevada,2011,Age,0-1 Days,73.7,62.5 to 82.4,293
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,79.9,72.5 to 87.2,389
Hep B,≥1 Dose,States/Local Areas,Nevada,2019,Age,3 Months,97.3,93.6 to 98.9,340
Hep B,≥1 Dose,States/Local Areas,Nevada,2018,Age,3 Months,97.3,95.1 to 98.5,378
Hep B,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,3 Months,97.3,95.3 to 98.5,718
≥1 Dose Varicella,,States/Local Areas,Nevada,2012,Age,24 Months,85.1,78.8 to 90.4,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2011,Age,24 Months,89.2,84.1 to 93.2,293
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,72.3,66.3 to 78.3,341
≥1 Dose MMR,,States/Local Areas,Nevada,2017,Age,19 Months,84.6,78.5 to 89.3,344
≥1 Dose MMR,,States/Local Areas,Nevada,2017-2018,Age,19 Months,86.9,82.9 to 90.0,722
≥1 Dose MMR,,States/Local Areas,Nevada,2016,Age,19 Months,86.3,80.5 to 90.6,327
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2017,Age,19 Months,85.5,81.4 to 88.8,671
≥1 Dose MMR,,States/Local Areas,Nevada,2015,Age,19 Months,86.4,82.5 to 89.5,253
≥1 Dose MMR,,States/Local Areas,Nevada,2015-2016,Age,19 Months,86.3,82.4 to 89.5,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.9,67.5 to 84.3,172
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,76.4,72.2 to 80.7,692
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,75.3,71.7 to 78.9,973
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,64.1,52.0 to 76.2,109
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.0,77.9 to 92.1,151
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.8,70.6 to 81.1,430
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,76.2,69.7 to 82.6,520
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,82.4,74.5 to 90.3,374
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.2,54.2 to 90.2,66
≥1 Dose Varicella,,States/Local Areas,Nevada,2018,Age,35 Months,95.7,91.4 to 98.2,378
≥1 Dose Varicella,,States/Local Areas,Nevada,2018-2019,Age,35 Months,94.1,91.0 to 96.5,718
DTaP,≥4 Doses,States/Local Areas,Nevada,2018,Age,35 Months,88.7,82.1 to 93.6,378
DTaP,≥4 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,85.4,80.6 to 89.6,718
Hep B,≥3 Doses,States/Local Areas,Nevada,2011,Age,19 Months,87.1,83.5 to 90.1,293
Hep B,≥3 Doses,States/Local Areas,Nevada,2019,Age,13 Months,88.0,82.2 to 92.0,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2018,Age,13 Months,92.5,88.2 to 95.3,378
Hep B,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,13 Months,90.3,86.8 to 92.9,718
Hep B,≥3 Doses,States/Local Areas,Nevada,2012,Age,19 Months,87.6,81.6 to 91.8,272
Polio,≥2 Doses,States/Local Areas,Nevada,2018,Age,7 Months,89.5,84.3 to 93.1,378
Polio,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,87.7,83.9 to 90.7,718
Polio,≥2 Doses,States/Local Areas,Nevada,2017,Age,7 Months,84.6,78.2 to 89.4,344
Polio,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,87.1,83.1 to 90.2,722
Polio,≥2 Doses,States/Local Areas,Nevada,2016,Age,7 Months,83.8,77.6 to 88.6,327
Polio,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,84.2,79.9 to 87.8,671
Hep B,≥1 Dose,States/Local Areas,Nevada,2014,Age,3 Months,89.6,82.6 to 94.0,186
Hep B,≥1 Dose,States/Local Areas,Nevada,2014-2015,Age,3 Months,92.2,88.3 to 94.9,439
Hep B,≥1 Dose,States/Local Areas,Nevada,2011,Age,3 Months,95.6,88.0 to 98.5,293
Hep B,≥1 Dose,States/Local Areas,Nevada,2012,Age,3 Months,95.3,91.0 to 97.6,272
Hep B,≥1 Dose,States/Local Areas,Nevada,2013,Age,3 Months,94.2,90.6 to 96.4,234
Hep B,≥1 Dose,States/Local Areas,Nevada,2013-2014,Age,3 Months,91.9,89.3 to 93.9,420
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,79.1,71.1 to 87.1,326
Hep B,≥1 Dose,States/Local Areas,Nevada,2017,Age,3 Months,91.6,86.4 to 94.9,344
Hep B,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,3 Months,94.4,91.7 to 96.3,722
Hep B,≥1 Dose,States/Local Areas,Nevada,2016,Age,3 Months,95.4,91.3 to 97.6,327
Hep B,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,3 Months,93.5,90.3 to 95.6,671
Hep B,≥1 Dose,States/Local Areas,Nevada,2015,Age,3 Months,94.8,90.0 to 97.4,253
Hep B,≥1 Dose,States/Local Areas,Nevada,2015-2016,Age,3 Months,95.1,92.2 to 96.9,580
Polio,≥2 Doses,States/Local Areas,Nevada,2014,Age,13 Months,90.4,84.2 to 94.3,186
Polio,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,91.5,87.9 to 94.1,439
Polio,≥2 Doses,States/Local Areas,Nevada,2013,Age,13 Months,94.3,90.3 to 96.7,234
Polio,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,92.3,88.4 to 95.0,420
Polio,≥2 Doses,States/Local Areas,Nevada,2011,Age,13 Months,94.0,91.8 to 95.6,293
Polio,≥2 Doses,States/Local Areas,Nevada,2012,Age,13 Months,91.1,88.5 to 93.2,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2016,Age,19 Months,85.5,79.5 to 89.9,327
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2017,Age,19 Months,85.4,81.2 to 88.8,671
≥1 Dose Varicella,,States/Local Areas,Nevada,2013-2014,Age,19 Months,84.4,76.6 to 90.0,420
≥1 Dose Varicella,,States/Local Areas,Nevada,2015,Age,19 Months,86.8,82.4 to 90.2,253
≥1 Dose Varicella,,States/Local Areas,Nevada,2015-2016,Age,19 Months,86.1,82.2 to 89.3,580
≥1 Dose Varicella,,States/Local Areas,Nevada,2014,Age,19 Months,78.1,69.0 to 85.1,186
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2015,Age,19 Months,82.5,77.2 to 86.7,439
≥1 Dose MMR,,States/Local Areas,Nevada,2019,Age,13 Months,65.0,58.0 to 71.5,340
≥1 Dose MMR,,States/Local Areas,Nevada,2018,Age,13 Months,64.3,57.4 to 70.6,378
≥1 Dose MMR,,States/Local Areas,Nevada,2018-2019,Age,13 Months,64.6,59.7 to 69.3,718
≥1 Dose MMR,,States/Local Areas,Nevada,2017,Age,13 Months,62.9,55.5 to 69.8,344
≥1 Dose MMR,,States/Local Areas,Nevada,2017-2018,Age,13 Months,63.6,58.6 to 68.3,722
Hep B,≥3 Doses,States/Local Areas,Nevada,2011,Age,13 Months,85.3,80.6 to 89.0,293
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Poverty,133% to <400% FPL,86.8,82.4 to 91.1,389
Polio,≥2 Doses,States/Local Areas,Nevada,2015,Age,7 Months,83.7,77.0 to 88.7,253
Polio,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,83.8,79.3 to 87.4,580
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Overall,Overall,85.5,82.5 to 88.5,973
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,84.4,79.3 to 89.5,341
Polio,≥2 Doses,States/Local Areas,Nevada,2013,Age,7 Months,88.8,84.5 to 92.1,234
Polio,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,7 Months,86.7,83.4 to 89.5,420
Polio,≥2 Doses,States/Local Areas,Nevada,2014,Age,7 Months,84.6,77.0 to 90.0,186
Polio,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,84.2,79.3 to 88.0,439
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.7,82.7 to 94.7,172
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,84.0,74.7 to 93.4,109
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.2,83.3 to 91.0,430
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,84.8,81.1 to 88.4,692
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.1,77.4 to 92.7,151
≥1 Dose Varicella,,States/Local Areas,Nevada,2015,Age,13 Months,60.4,52.7 to 67.6,253
≥1 Dose Varicella,,States/Local Areas,Nevada,2015-2016,Age,13 Months,60.4,55.2 to 65.5,580
≥1 Dose Varicella,,States/Local Areas,Nevada,2017,Age,13 Months,64.7,57.3 to 71.5,344
≥1 Dose Varicella,,States/Local Areas,Nevada,2017-2018,Age,13 Months,64.4,59.4 to 69.0,722
≥1 Dose Varicella,,States/Local Areas,Nevada,2016,Age,13 Months,60.4,53.2 to 67.3,327
≥1 Dose Varicella,,States/Local Areas,Nevada,2016-2017,Age,13 Months,62.6,57.4 to 67.5,671
DTaP,≥4 Doses,States/Local Areas,Nevada,2017,Age,24 Months,75.9,69.1 to 82.2,344
DTaP,≥4 Doses,States/Local Areas,Nevada,2017-2018,Age,24 Months,79.5,75.1 to 83.6,722
DTaP,≥4 Doses,States/Local Areas,Nevada,2018,Age,24 Months,83.2,77.5 to 88.2,378
DTaP,≥4 Doses,States/Local Areas,Nevada,2018-2019,Age,24 Months,80.5,76.2 to 84.5,718
DTaP,≥4 Doses,States/Local Areas,Nevada,2011,Age,35 Months,90.6,84.5 to 95.0,293
DTaP,≥4 Doses,States/Local Areas,Nevada,2019,Age,24 Months,77.7,71.3 to 83.6,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2017,Age,13 Months,86.9,81.0 to 91.1,344
Hep B,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,13 Months,89.7,86.2 to 92.4,722
Hep B,≥3 Doses,States/Local Areas,Nevada,2015,Age,13 Months,87.5,81.8 to 91.6,253
Hep B,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,13 Months,85.6,81.5 to 88.9,580
Hep B,≥3 Doses,States/Local Areas,Nevada,2016,Age,13 Months,83.6,77.4 to 88.4,327
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,13 Months,85.3,81.1 to 88.6,671
DTaP,≥4 Doses,States/Local Areas,Nevada,2016,Age,35 Months,84.1,76.8 to 90.1,327
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,86.7,81.8 to 90.8,671
DTaP,≥4 Doses,States/Local Areas,Nevada,2017,Age,35 Months,88.7,82.0 to 93.8,344
DTaP,≥4 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,88.8,84.2 to 92.6,722
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Poverty,>400% FPL,85.4,79.3 to 91.5,243
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,78.2,59.5 to 96.9,52
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.1,71.2 to 94.9,172
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,75.6,61.3 to 89.8,109
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Poverty,<133% FPL,76.0,67.6 to 84.3,341
Hep A,≥1 Dose,States/Local Areas,Nevada,2020,Age,35 Months,88.3,79.9 to 94.3,323
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Overall,Overall,78.8,73.7 to 83.8,973
Polio,≥2 Doses,States/Local Areas,Nevada,2019,Age,7 Months,85.8,80.0 to 90.2,340
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.5,73.0 to 88.1,430
Hep A,≥2 Doses,States/Local Areas,Nevada,2017,Age,35 Months,78.8,70.7 to 86.0,344
Hep A,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,35 Months,79.4,73.8 to 84.5,722
Hep A,≥2 Doses,States/Local Areas,Nevada,2018,Age,35 Months,80.1,72.4 to 86.8,378
Hep A,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,35 Months,75.3,69.7 to 80.5,718
Hep B,≥3 Doses,States/Local Areas,Nevada,2014,Age,13 Months,84.4,76.5 to 90.0,186
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,13 Months,86.0,81.3 to 89.6,439
Hep B,≥3 Doses,States/Local Areas,Nevada,2013,Age,13 Months,85.6,77.7 to 91.0,234
Hep B,≥3 Doses,States/Local Areas,Nevada,2013-2014,Age,13 Months,85.0,78.4 to 89.8,420
DTaP,≥4 Doses,States/Local Areas,Nevada,2013,Age,35 Months,90.1,83.6 to 94.8,234
DTaP,≥4 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,87.9,82.6 to 92.1,420
Hep B,≥3 Doses,States/Local Areas,Nevada,2012,Age,13 Months,83.1,78.6 to 86.8,272
Hep A,≥2 Doses,States/Local Areas,Nevada,2019,Age,35 Months,70.7,62.7 to 78.3,340
DTaP,≥4 Doses,States/Local Areas,Nevada,2014,Age,35 Months,85.8,77.4 to 92.3,186
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,84.6,79.5 to 89.1,439
DTaP,≥4 Doses,States/Local Areas,Nevada,2015,Age,35 Months,83.6,77.4 to 88.9,253
DTaP,≥4 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,84.1,79.3 to 88.3,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2012,Age,35 Months,83.9,76.4 to 90.1,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2018,Age,13 Months,64.0,57.3 to 70.2,378
≥1 Dose Varicella,,States/Local Areas,Nevada,2018-2019,Age,13 Months,64.2,59.4 to 68.8,718
≥1 Dose MMR,,States/Local Areas,Nevada,2016,Age,13 Months,59.9,52.6 to 66.8,327
≥1 Dose MMR,,States/Local Areas,Nevada,2016-2017,Age,13 Months,61.4,56.2 to 66.4,671
≥1 Dose Varicella,,States/Local Areas,Nevada,2012,Age,19 Months,81.4,72.0 to 88.2,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2013,Age,19 Months,90.9,82.2 to 95.6,234
≥1 Dose Varicella,,States/Local Areas,Nevada,2011,Age,19 Months,85.3,81.6 to 88.4,293
≥1 Dose Varicella,,States/Local Areas,Nevada,2019,Age,13 Months,64.5,57.4 to 71.0,340
≥1 Dose MMR,,States/Local Areas,Nevada,2015,Age,13 Months,60.1,52.4 to 67.4,253
≥1 Dose MMR,,States/Local Areas,Nevada,2015-2016,Age,13 Months,60.0,54.8 to 65.1,580
≥1 Dose MMR,,States/Local Areas,Nevada,2014,Age,13 Months,61.0,51.7 to 69.6,186
≥1 Dose MMR,,States/Local Areas,Nevada,2014-2015,Age,13 Months,60.6,54.6 to 66.3,439
≥1 Dose Varicella,,States/Local Areas,Nevada,2013,Age,13 Months,61.5,57.9 to 65.0,234
≥1 Dose Varicella,,States/Local Areas,Nevada,2013-2014,Age,13 Months,57.2,55.6 to 58.8,420
Polio,≥2 Doses,States/Local Areas,Nevada,2018,Age,5 Months,81.2,75.3 to 86.1,378
Polio,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,5 Months,79.7,75.4 to 83.4,718
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Uninsured,95.5,91.5 to 99.5,52
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.1,71.8 to 94.4,66
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Private Insurance Only,84.0,79.6 to 88.3,520
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Insurance Coverage,Any Medicaid,86.7,82.2 to 91.2,374
Hep A,≥1 Dose,States/Local Areas,Nevada,2019,Age,35 Months,93.5,88.2 to 96.9,340
≥1 Dose Varicella,,States/Local Areas,Nevada,2012,Age,13 Months,56.0,49.2 to 62.5,272
≥1 Dose Varicella,,States/Local Areas,Nevada,2014,Age,13 Months,53.0,43.9 to 61.9,186
≥1 Dose Varicella,,States/Local Areas,Nevada,2014-2015,Age,13 Months,56.7,50.7 to 62.6,439
Hep A,≥2 Doses,States/Local Areas,Nevada,2014,Age,35 Months,83.5,71.7 to 92.4,186
Hep A,≥2 Doses,States/Local Areas,Nevada,2014-2015,Age,35 Months,78.4,71.3 to 84.7,439
Hep B,≥3 Doses,States/Local Areas,Nevada,2019,Age,7 Months,70.7,63.9 to 76.7,340
Hep A,≥2 Doses,States/Local Areas,Nevada,2015,Age,35 Months,74.4,66.0 to 82.1,253
Hep A,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,35 Months,79.3,73.4 to 84.7,580
Hep A,≥2 Doses,States/Local Areas,Nevada,2016,Age,35 Months,83.6,75.7 to 90.1,327
Hep A,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,35 Months,81.4,75.5 to 86.7,671
Hep B,≥3 Doses,States/Local Areas,Nevada,2018,Age,7 Months,75.9,69.8 to 81.0,378
Hep B,≥3 Doses,States/Local Areas,Nevada,2018-2019,Age,7 Months,73.3,68.8 to 77.4,718
Hep B,≥3 Doses,States/Local Areas,Nevada,2017,Age,7 Months,67.3,60.0 to 73.9,344
Hep B,≥3 Doses,States/Local Areas,Nevada,2017-2018,Age,7 Months,71.6,66.9 to 75.9,722
Polio,≥2 Doses,States/Local Areas,Nevada,2011,Age,7 Months,86.3,81.2 to 90.1,293
Polio,≥2 Doses,States/Local Areas,Nevada,2012,Age,7 Months,83.7,79.9 to 87.0,272
Hep A,≥1 Dose,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,84.8,79.5 to 90.0,326
Polio,≥2 Doses,States/Local Areas,Nevada,2019,Age,5 Months,78.2,71.7 to 83.5,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2015,Age,7 Months,62.7,55.1 to 69.7,253
Hep B,≥3 Doses,States/Local Areas,Nevada,2015-2016,Age,7 Months,63.7,58.5 to 68.6,580
Hep B,≥3 Doses,States/Local Areas,Nevada,2014,Age,7 Months,65.2,56.1 to 73.3,186
Hep B,≥3 Doses,States/Local Areas,Nevada,2014-2015,Age,7 Months,63.9,58.0 to 69.5,439
Polio,≥2 Doses,States/Local Areas,Nevada,2017,Age,5 Months,71.1,63.6 to 77.5,344
Polio,≥2 Doses,States/Local Areas,Nevada,2017-2018,Age,5 Months,76.1,71.4 to 80.3,722
Polio,≥2 Doses,States/Local Areas,Nevada,2016,Age,5 Months,75.3,68.5 to 81.1,327
Polio,≥2 Doses,States/Local Areas,Nevada,2016-2017,Age,5 Months,73.2,68.2 to 77.6,671
Hep A,≥1 Dose,States/Local Areas,Nevada,2018,Age,35 Months,96.6,92.5 to 98.8,378
Hep A,≥1 Dose,States/Local Areas,Nevada,2018-2019,Age,35 Months,95.0,91.6 to 97.4,718
Hep A,≥1 Dose,States/Local Areas,Nevada,2017,Age,35 Months,89.3,83.7 to 93.6,344
Hep A,≥1 Dose,States/Local Areas,Nevada,2017-2018,Age,35 Months,93.5,89.1 to 96.5,722
Hep A,≥1 Dose,States/Local Areas,Nevada,2016,Age,35 Months,92.0,86.9 to 95.6,327
Hep A,≥1 Dose,States/Local Areas,Nevada,2016-2017,Age,35 Months,90.3,86.5 to 93.4,671
Hep A,≥2 Doses,States/Local Areas,Nevada,2013,Age,35 Months,71.8,63.5 to 79.6,234
Hep A,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,35 Months,76.6,69.6 to 83.0,420
Hep A,≥2 Doses,States/Local Areas,Nevada,2012,Age,35 Months,73.7,62.5 to 83.7,272
Hep A,≥2 Doses,States/Local Areas,Nevada,2011,Age,35 Months,77.6,69.5 to 84.8,293
Hep A,≥2 Doses,States/Local Areas,Nevada,2019,Age,24 Months,51.2,44.2 to 58.7,340
Hep B,≥3 Doses,States/Local Areas,Nevada,2016,Age,7 Months,64.6,57.4 to 71.2,327
Hep B,≥3 Doses,States/Local Areas,Nevada,2016-2017,Age,7 Months,66.0,60.9 to 70.7,671
Polio,≥2 Doses,States/Local Areas,Nevada,2015,Age,5 Months,70.3,62.7 to 76.9,253
Polio,≥2 Doses,States/Local Areas,Nevada,2015-2016,Age,5 Months,72.8,67.8 to 77.3,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2015,Age,24 Months,75.3,68.5 to 81.6,253
DTaP,≥4 Doses,States/Local Areas,Nevada,2015-2016,Age,24 Months,73.6,68.8 to 78.2,580
DTaP,≥4 Doses,States/Local Areas,Nevada,2016,Age,24 Months,71.9,65.0 to 78.5,327
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2017,Age,24 Months,73.9,69.1 to 78.6,671
DTaP,≥4 Doses,States/Local Areas,Nevada,2014,Age,24 Months,75.3,67.1 to 82.8,186
DTaP,≥4 Doses,States/Local Areas,Nevada,2014-2015,Age,24 Months,75.3,70.0 to 80.3,439
Hep A,≥2 Doses,States/Local Areas,Nevada,2013,Age,24 Months,51.4,43.4 to 59.9,234
Hep A,≥2 Doses,States/Local Areas,Nevada,2013-2014,Age,24 Months,46.4,40.3 to 52.9,420
DTaP,≥4 Doses,States/Local Areas,Nevada,2018,Age,19 Months,73.5,67.1 to 79.1,378
DTaP,≥4 Doses,States/Local Areas,Nevada,2018-2019,Age,19 Months,93.0,89.6 to 95.3,718
DTaP,≥4 Doses,States/Local Areas,Nevada,2017,Age,19 Months,64.0,56.5 to 70.8,344
DTaP,≥4 Doses,States/Local Areas,Nevada,2017-2018,Age,19 Months,68.7,63.8 to 73.2,722
DTaP,≥4 Doses,States/Local Areas,Nevada,2016,Age,19 Months,66.9,59.7 to 73.3,327
DTaP,≥4 Doses,States/Local Areas,Nevada,2016-2017,Age,19 Months,65.4,60.3 to 70.2,671
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,Hispanic,90.6,86.8 to 94.4,326
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,83.9 to 95.2,151
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.3,66.6 to 90.1,66
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.7,85.2 to 96.3,172
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a Non-MSA,84.8,75.3 to 94.4,109
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.1,86.6 to 93.6,430
DTaP,≥3 Doses,States/Local Areas,Nevada,2014-2017,Urbanicity,Living In a MSA Principal City,89.1,86.2 to 92.0,692
PCV,≥2 Doses,States/Local Areas,Nevada,2019,Age,5 Months,76.3,69.6 to 81.8,340
PCV,≥2 Doses,States/Local Areas,Nevada,2018,Age,5 Months,80.0,74.0 to 84.9,378
PCV,≥2 Doses,States/Local Areas,Nevada,2018-2019,Age,5 Months,78.2,73.8 to 82.0,718
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,83.8,79.9 to 87.6,757
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2021,Age,13 Months,59.4,50.1 to 68.1,218
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,83.8,78.8 to 87.9,560
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,65.4,59.5 to 70.9,560
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,55.6,49.7 to 61.4,560
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,84.5,79.4 to 88.6,560
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,3 Months,82.0,76.6 to 86.3,560
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,68.7,59.9 to 77.1,560
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,92.0,87.8 to 95.1,560
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,89.5,81.7 to 94.9,218
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,94.4,88.0 to 97.5,218
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,5 Months,72.0,66.0 to 77.3,560
Hib,Primary Series,States/Local Areas,NY-City of New York,2021,Age,35 Months,90.3,83.4 to 95.2,218
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,91.9,88.2 to 94.8,560
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,90.0,85.3 to 93.3,560
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,3 Months,78.0,72.4 to 82.7,560
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,5 Months,71.8,65.8 to 77.2,560
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,32.5,27.1 to 38.8,560
Hib,Primary Series,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,67.0,61.1 to 72.4,560
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,87.4,82.8 to 91.3,560
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,60.0,56.2 to 63.9,1046
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",51.6,45.0 to 58.3,391
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",53.5,43.1 to 63.8,117
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,66.9 to 81.4,226
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,64.7,58.1 to 71.4,312
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,82.7 to 92.0,341
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.1,74.2 to 91.9,341
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,70.5,65.3 to 75.6,524
Influenza,,States/Local Areas,NY-City of New York,2016,Age,24 Months,56.5,49.0 to 64.2,303
Influenza,,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,59.6,54.5 to 64.7,706
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,53.6,47.6 to 59.6,393
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,48.4,36.8 to 59.9,120
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,70.4,64.3 to 76.5,398
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,52.8,44.9 to 60.8,248
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,57.8,51.9 to 63.7,400
Influenza,,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,60.0,56.2 to 63.9,1046
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,86.1,82.4 to 89.8,757
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,94.9,92.7 to 97.2,757
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,89.3,85.9 to 92.7,478
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,3 Months,77.8,68.5 to 84.9,218
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,24 Months,89.0,81.5 to 94.4,218
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,88.4,83.7 to 91.8,560
Influenza,,States/Local Areas,NY-City of New York,2018,Age,24 Months,70.9,64.9 to 76.7,451
Influenza,,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,68.7,64.4 to 73.0,863
Influenza,,States/Local Areas,NY-City of New York,2017,Age,24 Months,62.9,56.4 to 69.5,403
Influenza,,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,66.8,62.3 to 71.2,854
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,81.6,77.4 to 85.8,757
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,77.6,72.9 to 82.4,478
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.0,64.3 to 85.8,154
Influenza,,States/Local Areas,NY-City of New York,2019,Age,24 Months,66.4,60.1 to 72.6,412
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,90.4,86.8 to 93.1,754
Influenza,,States/Local Areas,NY-City of New York,2011,Age,24 Months,59.0,51.3 to 67.0,249
Influenza,,States/Local Areas,NY-City of New York,2012,Age,24 Months,64.6,56.9 to 72.3,243
Influenza,,States/Local Areas,NY-City of New York,2015,Age,24 Months,61.1,53.4 to 68.9,249
Influenza,,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,58.9,53.4 to 64.4,552
Influenza,,States/Local Areas,NY-City of New York,2014,Age,24 Months,58.4,51.8 to 65.1,305
Influenza,,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,59.7,54.6 to 64.9,554
Influenza,,States/Local Areas,NY-City of New York,2013,Age,24 Months,61.5,54.3 to 68.7,279
Influenza,,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,59.9,55.0 to 64.9,584
Combined 7 Series,,States/Local Areas,NY-City of New York,2017,Age,35 Months,72.9,66.6 to 78.8,403
Combined 7 Series,,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,74.7,70.3 to 79.0,854
Combined 7 Series,,States/Local Areas,NY-City of New York,2016,Age,35 Months,65.4,57.5 to 73.3,303
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,69.0,63.9 to 74.0,706
Combined 7 Series,,States/Local Areas,NY-City of New York,2018,Age,24 Months,70.4,64.4 to 76.2,451
Combined 7 Series,,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,70.2,65.8 to 74.4,863
Combined 7 Series,,States/Local Areas,NY-City of New York,2017,Age,24 Months,68.7,62.4 to 74.7,403
Combined 7 Series,,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,69.5,65.2 to 73.7,854
Combined 7 Series,,States/Local Areas,NY-City of New York,2019,Age,24 Months,69.8,63.6 to 75.9,412
Hib,Primary Series,States/Local Areas,NY-City of New York,2016,Age,35 Months,89.6,83.6 to 94.1,303
Hib,Primary Series,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,90.9,87.2 to 93.9,706
Hib,Primary Series,States/Local Areas,NY-City of New York,2017,Age,35 Months,92.1,87.7 to 95.4,403
Hib,Primary Series,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,91.3,88.3 to 93.8,854
Hib,Primary Series,States/Local Areas,NY-City of New York,2015,Age,35 Months,89.6,83.5 to 94.2,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,89.8,85.6 to 93.2,552
Combined 7 Series,,States/Local Areas,NY-City of New York,2011,Age,24 Months,68.4,60.8 to 75.8,249
Combined 7 Series,,States/Local Areas,NY-City of New York,2012,Age,24 Months,65.1,57.5 to 72.6,243
Combined 7 Series,,States/Local Areas,NY-City of New York,2013,Age,24 Months,68.1,61.2 to 74.8,279
Combined 7 Series,,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,65.8,61.0 to 70.6,584
Hib,Primary Series,States/Local Areas,NY-City of New York,2013,Age,35 Months,94.9,90.3 to 97.7,279
Hib,Primary Series,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,93.9,90.9 to 96.1,584
Hib,Primary Series,States/Local Areas,NY-City of New York,2019,Age,24 Months,92.6,88.3 to 95.8,412
Hib,Primary Series,States/Local Areas,NY-City of New York,2011,Age,35 Months,91.5,85.7 to 95.6,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2014,Age,35 Months,92.9,88.7 to 95.9,305
Hib,Primary Series,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,91.3,87.7 to 94.3,554
Hib,Primary Series,States/Local Areas,NY-City of New York,2012,Age,35 Months,96.4,92.6 to 98.6,243
Hib,Primary Series,States/Local Areas,NY-City of New York,2018,Age,35 Months,90.4,86.0 to 93.9,451
Hib,Primary Series,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,91.5,88.5 to 94.0,863
Combined 7 Series,,States/Local Areas,NY-City of New York,2015,Age,24 Months,65.0,57.2 to 72.8,249
Combined 7 Series,,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,62.4,56.9 to 67.9,552
Combined 7 Series,,States/Local Areas,NY-City of New York,2014,Age,24 Months,63.5,56.9 to 70.1,305
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,64.2,59.1 to 69.3,554
Hib,Primary Series,States/Local Areas,NY-City of New York,2019,Age,35 Months,92.6,88.3 to 95.8,412
Combined 7 Series,,States/Local Areas,NY-City of New York,2016,Age,24 Months,60.0,52.5 to 67.6,303
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,64.2,59.2 to 69.1,706
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,91.6,88.5 to 93.9,754
Hib,Primary Series,States/Local Areas,NY-City of New York,2019,Age,19 Months,91.6,86.7 to 94.8,412
Hib,Primary Series,States/Local Areas,NY-City of New York,2018,Age,19 Months,90.1,85.3 to 93.4,451
Hib,Primary Series,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,84.9,81.1 to 88.1,863
Hib,Primary Series,States/Local Areas,NY-City of New York,2014,Age,7 Months,67.0,60.3 to 73.1,305
Hib,Primary Series,States/Local Areas,NY-City of New York,2014-2015,Age,7 Months,63.7,58.4 to 68.6,554
Hib,Primary Series,States/Local Areas,NY-City of New York,2015,Age,7 Months,60.3,52.1 to 68.0,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2015-2016,Age,7 Months,61.0,55.5 to 66.3,552
Hib,Primary Series,States/Local Areas,NY-City of New York,2018,Age,7 Months,68.4,62.3 to 73.9,451
Hib,Primary Series,States/Local Areas,NY-City of New York,2018-2019,Age,7 Months,65.5,61.1 to 69.7,863
Hib,Primary Series,States/Local Areas,NY-City of New York,2016,Age,24 Months,88.8,82.8 to 93.4,303
Hib,Primary Series,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,90.4,86.7 to 93.4,706
Hib,Primary Series,States/Local Areas,NY-City of New York,2016,Age,7 Months,61.7,54.0 to 68.9,303
Hib,Primary Series,States/Local Areas,NY-City of New York,2016-2017,Age,7 Months,64.6,59.5 to 69.3,706
Hib,Primary Series,States/Local Areas,NY-City of New York,2017,Age,7 Months,67.6,61.1 to 73.5,403
Hib,Primary Series,States/Local Areas,NY-City of New York,2017-2018,Age,7 Months,68.0,63.6 to 72.1,854
Hib,Primary Series,States/Local Areas,NY-City of New York,2012,Age,24 Months,95.6,91.8 to 97.9,243
Hib,Primary Series,States/Local Areas,NY-City of New York,2011,Age,24 Months,91.5,85.7 to 95.6,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2013,Age,7 Months,60.7,56.1 to 65.2,279
Hib,Primary Series,States/Local Areas,NY-City of New York,2013-2014,Age,7 Months,63.9,60.9 to 66.7,584
Hib,Primary Series,States/Local Areas,NY-City of New York,2013,Age,13 Months,84.2,81.2 to 86.7,279
Hib,Primary Series,States/Local Areas,NY-City of New York,2013-2014,Age,13 Months,84.1,80.5 to 87.2,584
Hib,Primary Series,States/Local Areas,NY-City of New York,2012,Age,13 Months,87.0,84.0 to 89.6,243
Hib,Primary Series,States/Local Areas,NY-City of New York,2011,Age,13 Months,89.4,82.4 to 93.9,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2019,Age,7 Months,62.5,56.0 to 68.7,412
Hib,Primary Series,States/Local Areas,NY-City of New York,2018,Age,24 Months,90.4,86.0 to 93.9,451
Hib,Primary Series,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,91.5,88.5 to 94.0,863
Hib,Primary Series,States/Local Areas,NY-City of New York,2014,Age,13 Months,84.1,78.5 to 88.4,305
Hib,Primary Series,States/Local Areas,NY-City of New York,2014-2015,Age,13 Months,84.0,79.7 to 87.5,554
Hib,Primary Series,States/Local Areas,NY-City of New York,2015,Age,13 Months,83.9,76.8 to 89.1,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2015-2016,Age,13 Months,82.0,77.0 to 86.1,552
Hib,Primary Series,States/Local Areas,NY-City of New York,2013,Age,24 Months,93.5,89.3 to 96.5,279
Hib,Primary Series,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,92.7,89.9 to 95.0,584
Hib,Primary Series,States/Local Areas,NY-City of New York,2014,Age,24 Months,92.0,88.0 to 95.1,305
Hib,Primary Series,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,90.8,87.2 to 93.7,554
Hib,Primary Series,States/Local Areas,NY-City of New York,2015,Age,24 Months,89.6,83.5 to 94.2,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,89.2,85.1 to 92.6,552
Hib,Primary Series,States/Local Areas,NY-City of New York,2017,Age,24 Months,92.1,87.7 to 95.4,403
Hib,Primary Series,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,91.3,88.3 to 93.8,854
Combined 7 Series,,States/Local Areas,NY-City of New York,2014,Age,35 Months,69.2,62.4 to 75.8,305
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,70.7,65.3 to 75.9,554
Combined 7 Series,,States/Local Areas,NY-City of New York,2012,Age,35 Months,75.6,66.8 to 83.7,243
Combined 7 Series,,States/Local Areas,NY-City of New York,2013,Age,35 Months,72.9,65.6 to 79.7,279
Combined 7 Series,,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,71.0,66.0 to 75.9,584
Combined 7 Series,,States/Local Areas,NY-City of New York,2011,Age,35 Months,78.4,70.2 to 85.6,249
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,52.4,47.5 to 57.3,754
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,95.3,92.4 to 98.3,577
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,59.7,53.7 to 65.3,560
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.7,78.5 to 88.8,341
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,73.4,68.2 to 78.6,478
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,76.2,70.5 to 81.9,410
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,90.3,86.4 to 94.2,410
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.8,90.5 to 97.2,341
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,77.1,69.4 to 84.8,410
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2021,Age,13 Months,57.7,48.3 to 66.5,218
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2021,Age,3 Months,83.8,74.5 to 90.1,218
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,76.8,68.1 to 83.8,218
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,5 Months,84.1,78.9 to 88.2,560
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,90.9,86.5 to 94.4,560
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,93.0,88.7 to 96.1,560
Hib,Primary Series,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,87.2,82.5 to 90.7,560
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,3 Months,80.4,74.9 to 84.9,560
Combined 7 Series,,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,75.0,68.3 to 81.3,560
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,86.7,82.1 to 90.6,560
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,90.8,86.3 to 94.0,560
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,89.6,85.1 to 92.9,560
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,89.0,81.5 to 94.4,218
Rotavirus,,States/Local Areas,NY-City of New York,2021,Age,8 Months,68.4,58.8 to 76.7,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2021,Age,0-3 Days,66.4,56.9 to 74.8,218
Combined 7 Series,,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,68.0,62.1 to 73.8,560
Hib,Full Series,States/Local Areas,NY-City of New York,2021,Age,35 Months,81.0,71.5 to 88.8,218
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,90.9,86.7 to 93.9,560
Hib,Primary Series,States/Local Areas,NY-City of New York,2021,Age,13 Months,85.8,77.6 to 91.3,218
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,94.6,90.4 to 97.4,560
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,89.1,84.3 to 92.5,560
Influenza,,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,62.2,56.2 to 68.2,560
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2020-2021,Age,0-1 Days,68.4,62.6 to 73.6,560
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,82.1,75.8 to 87.5,560
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,91.5,83.8 to 95.7,218
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,83.9,74.2 to 91.5,218
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,52.8,47.0 to 58.6,560
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,71.1,65.3 to 76.2,560
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,92.2,87.8 to 95.4,560
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,84.0,78.3 to 88.8,560
Hib,Full Series,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,72.6,67.0 to 77.6,560
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,90.7,84.0 to 95.4,218
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,80.7,75.2 to 85.6,560
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,92.9,88.7 to 96.0,560
Rotavirus,,States/Local Areas,NY-City of New York,2020-2021,Age,8 Months,73.3,67.5 to 78.4,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2020-2021,Age,0-3 Days,72.8,67.1 to 77.8,560
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,91.7,87.7 to 94.4,560
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,70.1,64.3 to 75.3,560
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,89.0,81.5 to 94.4,218
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2021,Age,35 Months,93.3,86.3 to 97.5,218
Hib,Primary Series,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,92.1,87.9 to 94.9,560
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,92.0,87.8 to 95.1,560
Hib,Full Series,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,84.6,79.2 to 89.3,560
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,7 Months,58.8,52.8 to 64.5,560
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,3 Months,89.2,84.1 to 92.8,560
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,85.8,80.8 to 89.7,560
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,3 Months,82.3,76.9 to 86.6,560
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2020-2021,Age,0-2 Days,71.7,66.1 to 76.8,560
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,62.4,56.5 to 67.9,560
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,18.6,14.5 to 23.5,560
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,5 Months,80.3,71.2 to 87.1,218
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2021,Age,19 Months,84.3,75.7 to 90.2,218
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,70.7,64.9 to 75.9,560
Influenza,,States/Local Areas,NY-City of New York,2021,Age,24 Months,54.2,44.9 to 64.0,218
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,5 Months,70.7,64.7 to 76.1,560
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,13 Months,87.6,79.3 to 92.8,218
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,5 Months,73.9,64.2 to 81.7,218
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,5 Months,72.7,63.0 to 80.6,218
Hib,Primary Series,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,92.8,88.9 to 95.6,560
Rotavirus,,States/Local Areas,NY-City of New York,2018,Age,8 Months,78.9,73.3 to 83.6,451
Rotavirus,,States/Local Areas,NY-City of New York,2018-2019,Age,8 Months,77.0,72.9 to 80.6,863
Rotavirus,,States/Local Areas,NY-City of New York,2017,Age,8 Months,72.1,65.7 to 77.8,403
Rotavirus,,States/Local Areas,NY-City of New York,2017-2018,Age,8 Months,75.5,71.3 to 79.2,854
Rotavirus,,States/Local Areas,NY-City of New York,2019,Age,8 Months,74.9,68.7 to 80.2,412
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,71.8,65.6 to 78.0,312
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.3,58.5 to 78.1,117
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,63.5,57.8 to 69.3,393
Rotavirus,,States/Local Areas,NY-City of New York,2015,Age,8 Months,66.7,58.7 to 73.9,249
Rotavirus,,States/Local Areas,NY-City of New York,2015-2016,Age,8 Months,64.9,59.3 to 70.1,552
Rotavirus,,States/Local Areas,NY-City of New York,2014,Age,8 Months,67.2,60.5 to 73.3,305
Rotavirus,,States/Local Areas,NY-City of New York,2014-2015,Age,8 Months,67.0,61.8 to 71.7,554
Rotavirus,,States/Local Areas,NY-City of New York,2016,Age,8 Months,63.1,55.3 to 70.3,303
Rotavirus,,States/Local Areas,NY-City of New York,2016-2017,Age,8 Months,67.5,62.3 to 72.2,706
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,76.4,71.5 to 81.3,524
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,52.5,41.1 to 63.9,120
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,88.1,83.4 to 91.6,560
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,94.8,91.4 to 96.9,560
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.8,69.5 to 84.1,226
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,67.4,63.8 to 71.1,1046
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",57.9,51.3 to 64.4,391
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,80.5,75.0 to 86.0,398
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,63.9,58.2 to 69.5,400
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,67.4,63.8 to 71.1,1046
Rotavirus,,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,59.4,51.5 to 67.2,248
Rotavirus,,States/Local Areas,NY-City of New York,2011,Age,8 Months,67.6,59.8 to 74.5,249
Rotavirus,,States/Local Areas,NY-City of New York,2012,Age,8 Months,63.0,54.9 to 70.4,243
Rotavirus,,States/Local Areas,NY-City of New York,2013,Age,8 Months,71.2,64.3 to 77.3,279
Rotavirus,,States/Local Areas,NY-City of New York,2013-2014,Age,8 Months,69.2,64.4 to 73.6,584
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.5,70.6 to 82.4,341
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.6,79.2 to 89.9,515
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,90.5 to 94.5,1420
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,76.6 to 83.0,1420
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,88.2,85.7 to 90.8,1420
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,94.6,90.2 to 97.5,560
Rotavirus,,States/Local Areas,NY-City of New York,2019-2020,Age,8 Months,76.4,71.9 to 80.4,754
Hib,Primary Series,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,93.0,89.9 to 95.1,754
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,89.7,81.9 to 94.3,218
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,53.9,44.7 to 62.9,218
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,89.2,84.8 to 93.5,410
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.2,84.5 to 95.8,154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,74.5,70.0 to 79.1,757
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,87.6 to 95.3,341
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,64.2,58.6 to 69.7,478
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,56.6,45.8 to 67.3,174
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,92.4,89.4 to 95.3,478
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,78.4,73.0 to 83.9,577
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,74.1,69.1 to 79.2,462
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,81.7,76.8 to 86.7,577
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,73.6,67.0 to 80.2,381
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,75.7,70.8 to 80.7,462
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,87.1,82.6 to 91.6,577
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,91.2,88.1 to 94.4,462
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,89.9,86.4 to 93.3,462
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,73.5,66.5 to 80.5,381
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,88.9,84.5 to 93.4,577
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,84.8,79.3 to 90.4,381
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,88.8,85.3 to 92.2,462
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,93.6,90.4 to 96.9,577
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,61.1,55.4 to 66.7,462
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,55.2,47.9 to 62.5,381
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,92.5,90.5 to 94.5,1420
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,88.2,85.7 to 90.8,1420
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,92.8,90.0 to 95.7,462
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,85.8,80.6 to 91.1,381
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,94.3,91.0 to 97.6,577
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,71.7,64.8 to 78.5,462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,72.0,65.5 to 78.6,381
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,71.1,64.2 to 78.0,381
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,70.9,65.3 to 76.4,577
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,84.3,79.6 to 89.1,577
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,86.9 to 91.6,1420
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,65.1,58.1 to 72.1,381
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,70.8,65.6 to 76.0,462
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,88.0 to 92.5,1420
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,64.7,61.1 to 68.2,1420
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,72.8,69.4 to 76.1,1420
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,78.1,74.9 to 81.2,1420
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,78.6,75.5 to 81.8,1420
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,70.2,65.5 to 75.0,1420
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,5 Months,87.8,82.2 to 91.8,342
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,3 Months,83.1,76.6 to 88.0,342
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,89.5,84.0 to 93.2,342
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,57.2,49.9 to 64.3,342
Hib,Primary Series,States/Local Areas,NY-City of New York,2020,Age,7 Months,70.2,63.0 to 76.6,342
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,92.1,87.6 to 95.1,342
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,94.9,90.9 to 97.5,342
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,83.3,77.1 to 88.7,342
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,94.9,91.0 to 97.4,342
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020,Age,24 Months,86.4,80.9 to 91.0,342
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,93.4,89.3 to 96.4,342
Hib,Primary Series,States/Local Areas,NY-City of New York,2020,Age,24 Months,94.6,90.7 to 97.3,342
Hib,Full Series,States/Local Areas,NY-City of New York,2020,Age,35 Months,87.1,81.1 to 91.9,342
Hib,Primary Series,States/Local Areas,NY-City of New York,2020,Age,35 Months,95.0,91.0 to 97.6,342
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,94.3,89.9 to 97.2,342
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,94.3,90.0 to 97.2,342
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020,Age,35 Months,95.3,90.2 to 98.2,342
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,95.6,90.4 to 98.4,342
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,92.6,88.4 to 95.4,342
Hib,Full Series,States/Local Areas,NY-City of New York,2020,Age,19 Months,74.4,67.4 to 80.4,342
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,90.8,84.9 to 94.5,342
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020,Age,19 Months,87.4,81.6 to 91.6,342
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,91.3,85.1 to 95.7,342
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,96.4,92.1 to 98.7,342
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020,Age,35 Months,95.0,90.2 to 97.9,342
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,73.5,66.4 to 79.6,342
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,85.1,78.1 to 90.8,342
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,19 Months,73.9,67.0 to 79.9,342
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,77.1,70.5 to 82.6,342
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,93.7,89.3 to 96.4,342
Hib,Primary Series,States/Local Areas,NY-City of New York,2020,Age,13 Months,88.5,83.0 to 92.4,342
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,88.5,83.0 to 92.4,342
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,68.5,61.2 to 74.9,342
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,88.1,82.0 to 92.3,342
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2020,Age,13 Months,61.6,54.2 to 68.5,342
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,5 Months,67.8,60.1 to 74.7,342
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,92.4,87.8 to 95.4,342
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,94.2,89.6 to 96.8,342
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,71.9,64.7 to 78.1,342
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,92.9,88.0 to 95.9,342
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020,Age,19 Months,83.4,77.0 to 88.3,342
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,92.7,88.0 to 95.6,342
Hib,Primary Series,States/Local Areas,NY-City of New York,2020,Age,19 Months,93.8,89.3 to 96.5,342
Influenza,,States/Local Areas,NY-City of New York,2020,Age,24 Months,69.9,62.9 to 76.6,342
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,35 Months,96.2,91.9 to 98.6,342
Rotavirus,,States/Local Areas,NY-City of New York,2020,Age,8 Months,78.1,71.3 to 83.6,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2020,Age,0-3 Days,78.9,72.8 to 84.0,342
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,92.8,87.8 to 96.3,342
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,80.3,73.7 to 86.1,342
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,24 Months,81.1,74.9 to 86.5,342
Combined 7 Series,,States/Local Areas,NY-City of New York,2020,Age,24 Months,72.0,65.1 to 78.6,342
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,35.0,28.3 to 42.9,342
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,5 Months,70.1,62.4 to 76.9,342
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,3 Months,78.2,71.4 to 83.8,342
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,5 Months,70.9,63.2 to 77.7,342
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,5 Months,69.6,61.8 to 76.3,342
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,88.6,85.2 to 92.1,757
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,92.9,89.6 to 96.2,410
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.7,86.4 to 97.0,154
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,91.7 to 98.1,341
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,80.1,71.1 to 89.2,174
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,87.0 to 95.4,515
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.2,67.9 to 80.6,515
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,88.9,85.2 to 92.7,478
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.7 to 97.5,757
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,65.0,54.6 to 75.5,174
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,76.0,71.1 to 81.0,478
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.8,67.7 to 80.0,515
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,75.8,65.7 to 85.9,174
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.4,75.8 to 91.1,154
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,84.3,79.5 to 89.1,410
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,68.9,58.4 to 79.4,174
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,66.8,56.0 to 77.6,174
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,88.5,84.9 to 92.0,478
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,75.7,70.4 to 81.0,478
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,92.3,89.3 to 95.2,757
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.6,82.5 to 94.7,154
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.2,84.6 to 93.8,515
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,88.8,84.9 to 92.6,410
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,80.7,71.5 to 89.8,174
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,75.1,70.3 to 79.8,757
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.0,84.2 to 95.7,154
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,84.1 to 93.4,515
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",56.7,47.1 to 66.4,154
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.9,90.4 to 97.3,341
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.1,67.8 to 80.3,341
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,79.4,70.0 to 88.9,174
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",62.5,55.9 to 69.1,515
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.3,69.0 to 85.6,154
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,77.4,71.7 to 83.1,410
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.2,63.0 to 75.4,515
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.3,76.8 to 87.8,341
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,75.8,70.3 to 81.3,410
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.3,63.4 to 81.2,154
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",59.3,52.8 to 65.8,515
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,65.3,58.9 to 71.6,410
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,56.7,46.1 to 67.3,174
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.7,74.4 to 89.0,154
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,69.6,64.3 to 74.8,478
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,54.2,40.5 to 67.9,174
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.8,70.7 to 83.0,341
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,49.5,38.9 to 60.1,174
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,82.9,78.4 to 87.4,410
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,90.7,86.7 to 94.6,410
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,59.3,53.7 to 64.9,478
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,80.9 to 90.7,341
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,81.1,76.8 to 85.4,757
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,90.4 to 96.7,341
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,96.8,95.2 to 98.4,757
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,88.7,85.2 to 92.2,478
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,59.3,48.8 to 69.8,174
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.7,85.1 to 96.2,154
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,88.5,84.3 to 92.7,410
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,77.6,72.9 to 82.2,478
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.5,59.1 to 72.0,515
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,73.2,68.5 to 78.0,757
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.4,65.6 to 83.1,154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.9,73.3 to 88.5,154
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.8,83.6 to 96.0,154
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.2,82.4 to 92.0,515
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",63.0,56.6 to 69.5,515
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.5,84.9 to 94.0,515
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",54.1,45.8 to 62.4,515
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,87.9 to 92.4,1420
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,76.4,73.2 to 79.6,1420
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,88.3 to 92.8,1420
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,66.8,63.3 to 70.4,1420
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Urbanicity,Living In a MSA Principal City,73.4,70.2 to 76.7,1420
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,85.1,79.5 to 90.7,381
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,94.5,91.3 to 97.6,577
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,78.6,75.5 to 81.8,1420
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,66.8,63.3 to 70.4,1420
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,83.8,77.9 to 89.7,381
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,90.9,86.9 to 95.0,577
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,65.3,59.8 to 70.8,462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,76.2,71.3 to 81.1,462
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,88.4,83.5 to 93.3,381
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,60.6,53.3 to 67.9,381
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,95.7,92.8 to 98.7,577
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,89.2,86.9 to 91.6,1420
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,72.8,69.4 to 76.1,1420
Combined 7 Series,,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,74.6,69.0 to 80.2,577
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,70.2,65.5 to 75.0,1420
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,89.1,85.7 to 92.6,462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,73.4,70.2 to 76.7,1420
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,64.7,61.1 to 68.2,1420
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,89.7,86.3 to 93.1,462
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,65.8,56.4 to 75.1,381
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,85.5,80.0 to 90.9,381
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,78.1,74.9 to 81.2,1420
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,72.1,63.2 to 81.0,577
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,78.6,73.9 to 83.2,462
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,76.4,73.2 to 79.6,1420
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2019,Poverty,133% to <400% FPL,73.3,66.4 to 80.1,381
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,90.1,87.9 to 92.4,1420
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Poverty,<133% FPL,77.2,72.2 to 82.3,462
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,90.2,88.0 to 92.5,1420
Rotavirus,,States/Local Areas,NY-City of New York,2016-2019,Poverty,>400% FPL,82.1,77.0 to 87.2,577
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,90.5,88.3 to 92.8,1420
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,64.0,53.4 to 74.6,174
Influenza,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,65.8,59.6 to 72.0,410
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Overall,Overall,79.8,76.6 to 83.0,1420
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,83.0,74.6 to 91.4,174
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,88.4,84.6 to 92.2,478
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,94.2,91.9 to 96.6,757
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Other,80.7,71.5 to 89.9,174
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.1,84.4 to 93.8,341
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,Hispanic,78.4,72.6 to 84.2,410
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.8,74.2 to 89.5,154
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,89.3 to 96.4,341
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.4 to 95.8,757
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Any Medicaid,72.4,65.5 to 79.3,478
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2019,Insurance Coverage,Private Insurance Only,74.4,67.8 to 80.9,757
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,3 Months,82.4,75.9 to 87.4,342
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,3 Months,79.8,72.9 to 85.3,342
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,24 Months,93.1,89.2 to 95.9,342
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2020,Age,3 Months,94.4,89.7 to 97.1,342
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,55.5,48.2 to 62.6,342
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,89.7,84.2 to 93.4,342
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2020,Age,7 Months,62.5,55.2 to 69.3,342
Combined 7 Series,,States/Local Areas,NY-City of New York,2015,Age,35 Months,72.5,63.9 to 80.6,249
Combined 7 Series,,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,68.6,62.8 to 74.4,552
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Urbanicity,Living In a MSA Principal City,63.7,59.9 to 67.6,1046
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",58.5,51.9 to 65.2,391
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.0,60.0 to 76.0,226
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,63.7,59.9 to 67.6,1046
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,62.6,56.8 to 68.4,400
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.5,51.0 to 72.0,117
Hib,Full Series,States/Local Areas,NY-City of New York,2015,Age,19 Months,68.8,66.3 to 71.2,249
Hib,Full Series,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,69.4,63.9 to 74.4,552
Hib,Full Series,States/Local Areas,NY-City of New York,2016,Age,19 Months,69.9,62.3 to 76.7,303
Hib,Full Series,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,72.0,67.0 to 76.5,706
Hib,Full Series,States/Local Areas,NY-City of New York,2014,Age,19 Months,66.1,59.3 to 72.2,305
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,67.5,62.3 to 72.2,554
Hib,Full Series,States/Local Areas,NY-City of New York,2013,Age,19 Months,70.8,61.9 to 78.4,279
Hib,Full Series,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,68.5,62.3 to 74.0,584
Hib,Full Series,States/Local Areas,NY-City of New York,2012,Age,19 Months,65.9,57.9 to 73.1,243
Hib,Full Series,States/Local Areas,NY-City of New York,2011,Age,19 Months,73.0,66.2 to 78.9,249
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,72.2,66.0 to 78.3,398
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,56.9,48.9 to 64.9,248
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,51.3,39.8 to 62.8,120
Combined 7 Series,,States/Local Areas,NY-City of New York,2018,Age,35 Months,77.4,70.7 to 83.4,451
Combined 7 Series,,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,76.4,71.7 to 80.8,863
Combined 7 Series,,States/Local Areas,NY-City of New York,2019,Age,35 Months,75.0,68.5 to 81.0,412
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,62.3,56.4 to 68.2,393
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,69.6,64.3 to 74.9,524
Hib,Full Series,States/Local Areas,NY-City of New York,2018,Age,19 Months,70.8,64.8 to 76.1,451
Hib,Full Series,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,93.4,90.6 to 95.4,863
Hib,Full Series,States/Local Areas,NY-City of New York,2019,Age,19 Months,69.0,62.5 to 74.7,412
Hib,Full Series,States/Local Areas,NY-City of New York,2017,Age,19 Months,74.2,67.9 to 79.7,403
Hib,Full Series,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,72.5,68.2 to 76.4,854
Hib,Full Series,States/Local Areas,NY-City of New York,2014,Age,24 Months,78.6,72.5 to 84.1,305
Hib,Full Series,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,76.6,71.8 to 81.1,554
Hib,Full Series,States/Local Areas,NY-City of New York,2013,Age,24 Months,78.0,71.8 to 83.7,279
Hib,Full Series,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,78.3,73.9 to 82.3,584
Hib,Full Series,States/Local Areas,NY-City of New York,2011,Age,24 Months,83.6,77.3 to 88.9,249
Hib,Full Series,States/Local Areas,NY-City of New York,2012,Age,24 Months,78.0,70.7 to 84.5,243
Hib,Primary Series,States/Local Areas,NY-City of New York,2016,Age,13 Months,80.1,72.6 to 86.0,303
Hib,Primary Series,States/Local Areas,NY-City of New York,2016-2017,Age,13 Months,82.8,78.2 to 86.7,706
Hib,Primary Series,States/Local Areas,NY-City of New York,2018,Age,13 Months,85.0,79.6 to 89.1,451
Hib,Primary Series,States/Local Areas,NY-City of New York,2018-2019,Age,13 Months,84.9,81.1 to 88.1,863
Hib,Primary Series,States/Local Areas,NY-City of New York,2019,Age,13 Months,84.8,79.0 to 89.2,412
Hib,Primary Series,States/Local Areas,NY-City of New York,2017,Age,13 Months,85.8,80.2 to 90.0,403
Hib,Primary Series,States/Local Areas,NY-City of New York,2017-2018,Age,13 Months,85.4,81.7 to 88.5,854
Hib,Primary Series,States/Local Areas,NY-City of New York,2014,Age,19 Months,90.0,85.5 to 93.2,305
Hib,Primary Series,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,89.5,85.7 to 92.4,554
Hib,Primary Series,States/Local Areas,NY-City of New York,2013,Age,19 Months,91.6,87.9 to 94.2,279
Hib,Primary Series,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,90.8,89.2 to 92.2,584
Hib,Primary Series,States/Local Areas,NY-City of New York,2011,Age,19 Months,91.4,84.8 to 95.3,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2012,Age,19 Months,91.3,89.5 to 92.8,243
Hib,Primary Series,States/Local Areas,NY-City of New York,2015,Age,19 Months,89.0,86.3 to 91.2,249
Hib,Primary Series,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,87.9,83.4 to 91.3,552
Hib,Primary Series,States/Local Areas,NY-City of New York,2016,Age,19 Months,86.9,80.2 to 91.5,303
Hib,Primary Series,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,88.6,84.6 to 91.7,706
Hib,Primary Series,States/Local Areas,NY-City of New York,2017,Age,19 Months,90.5,85.4 to 94.0,403
Hib,Primary Series,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,90.3,87.0 to 92.8,854
Combined 7 Series,,States/Local Areas,NY-City of New York,2014-2017,Race and Ethnicity,Hispanic,68.0,61.5 to 74.6,312
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,94.2,90.3 to 96.9,403
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,94.9,92.3 to 96.9,854
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,5 Months,67.5,55.7 to 77.4,279
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,5 Months,67.2,60.8 to 73.1,584
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,5 Months,65.7,62.9 to 68.3,243
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,5 Months,68.6,59.3 to 76.6,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,91.2,85.2 to 95.5,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,92.2,88.2 to 95.2,552
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,92.2,86.8 to 96.0,303
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,93.4,90.1 to 95.9,706
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2020,Age,13 Months,65.2,57.9 to 71.9,342
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,96.5,92.7 to 98.6,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,91.5,85.7 to 95.6,249
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,19 Months,78.9,73.5 to 83.5,412
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,24 Months,75.1,68.0 to 81.7,249
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,24 Months,82.4,76.6 to 87.4,279
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,24 Months,79.7,75.5 to 83.5,584
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,24 Months,74.5,66.9 to 81.5,243
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,19 Months,74.7,68.6 to 79.9,403
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,73.9,69.7 to 77.8,854
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,19 Months,73.2,67.2 to 78.4,451
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,74.0,69.2 to 78.3,712
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,97.0,93.4 to 98.9,279
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,96.4,93.7 to 98.2,584
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2012,Age,35 Months,97.8,94.8 to 99.3,243
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2011,Age,35 Months,96.2,92.1 to 98.5,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,95.6,91.2 to 98.2,305
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,94.0,89.9 to 96.8,554
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,11.9,9.1 to 15.3,249
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,5 Months,76.4,70.2 to 81.6,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,16.5,12.5 to 21.5,279
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,16.4,13.3 to 20.0,584
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,16.3,12.0 to 21.7,305
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,16.3,12.8 to 20.4,554
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,15.3,11.9 to 19.4,243
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,89.9,85.4 to 93.5,451
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,91.1,88.0 to 93.6,863
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,92.3,88.0 to 95.5,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,16.2,13.2 to 19.7,249
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,14.3,11.1 to 18.2,552
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,19 Months,12.4,8.8 to 17.2,303
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,14.6,11.6 to 18.1,706
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013,Age,35 Months,94.3,89.5 to 97.4,279
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,35 Months,93.0,89.8 to 95.5,584
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,35 Months,91.5,86.8 to 95.1,305
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,35 Months,90.7,86.9 to 93.8,554
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,35 Months,89.6,83.5 to 94.2,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,35 Months,89.7,85.5 to 93.2,552
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,19 Months,17.0,12.6 to 22.4,403
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,19 Months,18.0,14.8 to 21.7,854
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,24 Months,76.9,70.9 to 82.4,305
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,77.0,72.5 to 81.3,554
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,24 Months,77.1,70.1 to 83.4,249
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,72.4,67.3 to 77.3,552
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,24 Months,67.9,60.6 to 75.1,303
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,74.8,70.0 to 79.3,706
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2014,Age,5 Months,67.0,60.3 to 73.0,305
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,5 Months,67.0,60.8 to 72.6,554
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2015,Age,5 Months,67.0,59.0 to 74.1,249
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,5 Months,66.4,60.9 to 71.5,552
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,5 Months,65.8,58.0 to 72.8,303
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,5 Months,67.9,62.8 to 72.6,706
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,95.9,91.8 to 98.3,451
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,95.0,92.4 to 97.0,863
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Other,82.6,73.7 to 91.5,120
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,35 Months,94.3,90.3 to 97.0,412
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,24 Months,79.5,74.0 to 84.5,451
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,81.8,78.2 to 85.2,863
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,24 Months,84.2,79.3 to 88.5,412
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,35 Months,88.4,79.6 to 94.7,249
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,5 Months,70.2,63.8 to 76.0,403
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,5 Months,73.0,68.7 to 76.9,854
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,19 Months,63.0,55.3 to 70.0,303
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,19 Months,68.6,63.6 to 73.2,706
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,24 Months,82.2,76.8 to 87.1,403
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,81.0,77.2 to 84.6,854
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2011,Age,19 Months,69.7,66.1 to 73.1,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2012,Age,19 Months,60.9,53.7 to 67.7,243
Combined 7 Series,,States/Local Areas,NY-City of New York,2020,Age,35 Months,80.0,72.6 to 86.5,342
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2020,Age,0-1 Days,75.2,68.8 to 80.7,342
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,19 Months,19.7,14.6 to 26.1,342
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2020,Age,0-2 Days,78.1,72.0 to 83.3,342
Hep B,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,3 Months,95.0,92.2 to 96.8,754
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,89.8,86.6 to 92.6,754
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,92.8,89.9 to 95.1,754
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,82.8,78.6 to 86.5,754
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,94.1,91.5 to 96.2,754
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,84.8,80.3 to 88.7,754
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,95.6,91.4 to 98.1,754
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,95.7,92.6 to 97.7,754
Hib,Primary Series,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,94.1,91.4 to 96.2,754
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,92.6,89.5 to 95.1,754
Hib,Full Series,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,85.4,81.2 to 89.0,754
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,93.7,90.9 to 95.8,754
Hib,Full Series,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,72.2,67.5 to 76.4,754
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,91.4,88.2 to 93.8,754
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,17.9,14.5 to 21.9,754
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,87.5,83.7 to 90.4,754
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,79.5,75.2 to 83.6,754
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,92.4,89.3 to 94.9,754
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,59.7,54.8 to 64.5,754
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2019-2020,Age,0-3 Days,79.2,75.2 to 82.8,754
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,91.4,88.5 to 93.9,754
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,90.8,87.7 to 93.4,754
Hep B,"≥1 Dose, 2 Day",States/Local Areas,NY-City of New York,2019-2020,Age,0-2 Days,77.1,73.0 to 80.8,754
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,76.7,72.4 to 80.5,754
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,72.4,67.7 to 76.7,754
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,90.7,87.6 to 93.1,754
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,88.5,84.9 to 91.2,754
Hep B,"≥1 Dose, 1 Day",States/Local Areas,NY-City of New York,2019-2020,Age,0-1 Days,73.9,69.6 to 77.8,754
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,52.9,48.0 to 57.7,754
Combined 7 Series,,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,77.8,72.7 to 82.5,754
Hib,Primary Series,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,93.9,91.2 to 96.0,754
Hib,Full Series,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,80.4,76.1 to 84.3,754
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,93.2,90.4 to 95.4,754
Influenza,,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,68.3,63.6 to 72.9,754
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,88.6,84.8 to 91.9,754
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,76.4,69.4 to 82.9,754
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,82.7,78.9 to 86.3,754
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,37.2,32.4 to 42.4,754
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2020,Age,13 Months,94.9,90.9 to 97.2,342
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,3 Months,86.9,83.1 to 90.0,754
Polio,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,3 Months,85.6,81.6 to 88.8,754
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,89.4,85.8 to 92.2,754
Hib,Primary Series,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,65.9,61.0 to 70.4,754
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,91.7,88.4 to 94.1,754
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,71.4,66.7 to 75.6,754
Hib,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,3 Months,83.9,79.8 to 87.3,754
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,5 Months,71.9,62.2 to 79.9,218
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,87.2,78.6 to 92.7,218
Hib,Primary Series,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,92.5,88.7 to 95.4,560
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,94.3,91.1 to 96.6,754
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,94.3,91.3 to 96.5,754
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,89.1,85.1 to 92.5,754
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,35 Months,95.4,92.7 to 97.3,754
Combined 7 Series,,States/Local Areas,NY-City of New York,2019-2020,Age,24 Months,70.6,65.9 to 75.1,754
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,19 Months,93.7,90.8 to 95.7,754
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,87.0,83.1 to 90.1,754
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,88.1,84.4 to 91.0,754
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,59.6,54.7 to 64.3,754
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,86.4,82.7 to 89.5,754
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,89.4,85.8 to 92.1,754
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,7 Months,65.9,61.0 to 70.4,754
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,5 Months,71.0,66.1 to 75.4,754
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,5 Months,88.5,85.0 to 91.3,754
Hep B,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,93.9,91.1 to 95.8,754
Hib,Primary Series,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,86.9,83.1 to 89.9,754
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,93.1,90.1 to 95.2,754
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,76.5,72.1 to 80.4,754
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,65.2,60.3 to 69.7,754
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,13 Months,93.5,90.5 to 95.6,754
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,5 Months,72.0,67.1 to 76.4,754
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,5 Months,73.3,68.4 to 77.7,754
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2019-2020,Age,5 Months,73.8,68.9 to 78.1,754
PCV,≥1 Dose,States/Local Areas,NY-City of New York,2019-2020,Age,3 Months,81.6,77.3 to 85.2,754
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,90.7,83.2 to 95.0,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,NY-City of New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",57.8,51.3 to 64.3,515
Combined 7 Series,,States/Local Areas,NY-City of New York,2021,Age,35 Months,68.6,57.1 to 79.5,218
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,35 Months,88.3,82.4 to 92.9,560
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,3 Months,87.9,85.0 to 90.3,243
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,3 Months,85.4,81.7 to 88.6,249
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,3 Months,85.7,79.7 to 90.2,279
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,3 Months,85.8,81.1 to 89.5,584
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,3 Months,85.8,80.3 to 90.0,305
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,3 Months,85.4,81.1 to 88.8,554
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,3 Months,84.9,78.0 to 89.9,249
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,3 Months,82.9,78.1 to 86.9,552
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2016,Age,3 Months,81.0,73.8 to 86.6,303
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2016-2017,Age,3 Months,84.8,80.5 to 88.4,706
Polio,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,86.7,78.3 to 92.2,218
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,19 Months,88.7,80.4 to 93.8,218
PCV,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,5 Months,68.1,58.4 to 76.4,218
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,62.3,52.7 to 71.0,218
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,19 Months,91.6,87.1 to 94.6,560
Hep B,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,13 Months,88.1,83.4 to 91.5,560
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,91.5,87.2 to 94.8,560
PCV,≥4 Doses,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,76.8,71.3 to 81.9,560
Hib,≥2 Doses,States/Local Areas,NY-City of New York,2021,Age,7 Months,87.3,78.9 to 92.6,218
≥1 Dose MMR,,States/Local Areas,NY-City of New York,2021,Age,35 Months,94.2,86.6 to 98.3,218
PCV,≥3 Doses,States/Local Areas,NY-City of New York,2021,Age,35 Months,89.0,81.3 to 94.5,218
Hib,Primary Series,States/Local Areas,NY-City of New York,2021,Age,19 Months,90.3,82.6 to 94.8,218
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,35 Months,90.5,86.0 to 94.1,451
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,35 Months,91.5,88.4 to 94.0,863
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2012,Age,24 Months,33.7,26.2 to 42.6,243
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2013,Age,19 Months,70.4,57.1 to 80.9,279
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,66.5,56.7 to 75.0,584
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014,Age,19 Months,62.6,55.9 to 68.9,305
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,64.2,59.1 to 68.9,554
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2015,Age,19 Months,65.8,62.4 to 69.0,249
DTaP,≥4 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,65.0,59.5 to 70.1,552
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Any Medicaid,92.0,88.9 to 95.0,393
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.4 to 97.0,524
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,35 Months,89.4,83.4 to 93.9,303
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,35 Months,90.1,86.4 to 93.2,706
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,35 Months,90.7,86.0 to 94.3,403
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,35 Months,90.6,87.4 to 93.2,854
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,19 Months,19.1,14.8 to 24.2,451
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,19 Months,16.7,13.3 to 20.7,712
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2019,Age,19 Months,15.3,11.3 to 20.4,412
Hep A,≥2 Doses,States/Local Areas,NY-City of New York,2011,Age,24 Months,32.0,25.2 to 40.0,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,89.6,83.5 to 94.2,249
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,89.1,85.0 to 92.6,552
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,88.5,82.6 to 93.2,303
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,89.6,85.9 to 92.7,706
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2019,Age,24 Months,92.9,88.9 to 95.9,412
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,90.7,86.0 to 94.3,403
Hib,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,90.3,87.2 to 93.0,854
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2017,Age,5 Months,77.1,70.8 to 82.4,403
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,5 Months,79.1,75.1 to 82.7,854
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2016,Age,5 Months,74.0,66.5 to 80.3,303
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,5 Months,75.5,70.6 to 79.7,706
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2018,Age,5 Months,81.2,75.7 to 85.7,451
DTaP,≥2 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,5 Months,78.9,74.8 to 82.4,863
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017,Age,24 Months,94.2,90.3 to 96.9,403
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2017-2018,Age,24 Months,94.2,91.6 to 96.2,854
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018,Age,24 Months,94.2,90.4 to 96.9,451
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2018-2019,Age,24 Months,93.6,90.9 to 95.7,863
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,>400% FPL,94.2,90.9 to 97.5,398
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,133% to <400% FPL,84.5,78.6 to 90.4,248
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Poverty,<133% FPL,90.4,87.2 to 93.7,400
Polio,≥3 Doses,States/Local Areas,NY-City of New York,2014-2017,Overall,Overall,89.9,87.5 to 92.2,1046
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2013,Age,19 Months,71.8,64.7 to 77.9,279
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2013-2014,Age,19 Months,68.8,63.4 to 73.6,584
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2012,Age,19 Months,64.6,60.2 to 68.8,243
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016,Age,24 Months,90.0,84.4 to 94.3,303
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2016-2017,Age,24 Months,92.0,88.7 to 94.7,706
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2019,Age,3 Months,89.7,84.6 to 93.2,412
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2011,Age,19 Months,66.4,63.5 to 69.2,249
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2017,Age,3 Months,88.9,83.9 to 92.6,403
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2017-2018,Age,3 Months,88.4,85.0 to 91.1,854
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014,Age,24 Months,92.2,88.2 to 95.2,305
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2014-2015,Age,24 Months,91.7,88.3 to 94.4,554
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015,Age,24 Months,91.2,85.2 to 95.5,249
DTaP,≥3 Doses,States/Local Areas,NY-City of New York,2015-2016,Age,24 Months,90.7,86.7 to 93.8,552
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2018,Age,3 Months,87.8,82.7 to 91.5,451
DTaP,≥1 Dose,States/Local Areas,NY-City of New York,2018-2019,Age,3 Months,88.7,85.3 to 91.4,863
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014,Age,19 Months,65.7,58.9 to 71.9,305
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2014-2015,Age,19 Months,69.0,64.0 to 73.5,554
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2015,Age,19 Months,72.2,65.7 to 78.0,249
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2015-2016,Age,19 Months,67.5,62.2 to 72.4,552
Hib,Full Series,States/Local Areas,NY-City of New York,2021,Age,19 Months,70.8,61.6 to 78.5,218
Hib,Full Series,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,79.4,74.1 to 84.3,560
Hep A,≥1 Dose,States/Local Areas,NY-City of New York,2020-2021,Age,24 Months,77.2,71.8 to 82.2,560
≥1 Dose Varicella,,States/Local Areas,NY-City of New York,2021,Age,19 Months,84.2,75.3 to 90.2,218
DTaP,≥1 Dose,States/Local Areas,Montana,2019,Age,3 Months,91.1,83.4 to 95.5,187
DTaP,≥3 Doses,States/Local Areas,Montana,2016,Age,24 Months,89.9,84.5 to 94.1,257
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,91.1,87.6 to 93.9,522
DTaP,≥1 Dose,States/Local Areas,Montana,2018,Age,3 Months,88.7,81.9 to 93.2,233
DTaP,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,3 Months,89.9,85.2 to 93.3,420
DTaP,≥3 Doses,States/Local Areas,Montana,2015,Age,24 Months,91.2,85.0 to 95.6,256
DTaP,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,90.6,86.6 to 93.8,513
DTaP,≥3 Doses,States/Local Areas,Montana,2014,Age,24 Months,93.2,88.6 to 96.4,225
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,24 Months,92.1,88.3 to 95.1,481
DTaP,≥1 Dose,States/Local Areas,Montana,2017,Age,3 Months,88.0,82.3 to 92.0,265
DTaP,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,3 Months,88.4,84.2 to 91.5,498
Hep A,≥1 Dose,States/Local Areas,Montana,2013,Age,19 Months,62.9,55.5 to 69.7,249
Hep A,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,19 Months,68.3,64.6 to 71.9,474
Hep A,≥1 Dose,States/Local Areas,Montana,2015,Age,19 Months,72.6,63.0 to 80.4,256
Hep A,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,19 Months,71.1,65.8 to 75.8,513
Hep A,≥1 Dose,States/Local Areas,Montana,2014,Age,19 Months,73.6,66.0 to 80.1,225
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,19 Months,73.1,67.8 to 77.8,481
Combined 7 Series,,States/Local Areas,Montana,2019,Age,24 Months,70.1,61.1 to 78.7,187
Combined 7 Series,,States/Local Areas,Montana,2011,Age,35 Months,68.0,60.2 to 75.6,250
Combined 7 Series,,States/Local Areas,Montana,2014,Age,35 Months,73.4,65.8 to 80.4,225
Combined 7 Series,,States/Local Areas,Montana,2014-2015,Age,35 Months,70.1,64.7 to 75.3,481
Combined 7 Series,,States/Local Areas,Montana,2013,Age,35 Months,63.1,55.0 to 71.2,249
Combined 7 Series,,States/Local Areas,Montana,2013-2014,Age,35 Months,68.3,62.6 to 73.9,474
Combined 7 Series,,States/Local Areas,Montana,2012,Age,35 Months,72.7,64.3 to 80.6,219
Combined 7 Series,,States/Local Areas,Montana,2016,Age,35 Months,64.0,56.3 to 71.8,257
Combined 7 Series,,States/Local Areas,Montana,2016-2017,Age,35 Months,69.5,63.8 to 75.1,522
Combined 7 Series,,States/Local Areas,Montana,2017,Age,35 Months,74.7,66.7 to 82.0,265
Combined 7 Series,,States/Local Areas,Montana,2017-2018,Age,35 Months,74.3,68.9 to 79.5,498
DTaP,≥2 Doses,States/Local Areas,Montana,2017,Age,5 Months,79.0,72.1 to 84.6,265
DTaP,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,5 Months,81.0,76.1 to 85.1,498
DTaP,≥2 Doses,States/Local Areas,Montana,2018,Age,5 Months,82.9,75.5 to 88.5,233
DTaP,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,5 Months,84.5,79.4 to 88.6,420
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Urbanicity,Living In a Non-MSA,92.1,89.5 to 94.6,608
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Overall,Overall,91.5,89.2 to 93.7,910
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,<133% FPL,86.8,81.7 to 91.9,242
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,133% to <400% FPL,93.8,91.5 to 96.1,443
Polio,≥3 Doses,States/Local Areas,Montana,2014-2017,Poverty,>400% FPL,94.6,90.8 to 98.4,225
DTaP,≥3 Doses,States/Local Areas,Montana,2018,Age,24 Months,95.9,92.3 to 98.1,233
DTaP,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,94.5,91.0 to 97.0,420
DTaP,≥3 Doses,States/Local Areas,Montana,2017,Age,24 Months,92.3,87.8 to 95.6,265
DTaP,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,94.1,91.4 to 96.3,498
DTaP,≥1 Dose,States/Local Areas,Montana,2016,Age,3 Months,85.4,78.4 to 90.5,257
DTaP,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,3 Months,86.7,82.3 to 90.1,522
DTaP,≥1 Dose,States/Local Areas,Montana,2015,Age,3 Months,83.0,75.5 to 88.6,256
DTaP,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,3 Months,84.2,79.1 to 88.3,513
DTaP,≥1 Dose,States/Local Areas,Montana,2014,Age,3 Months,84.7,77.6 to 89.9,225
DTaP,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,3 Months,83.9,78.9 to 87.9,481
DTaP,≥1 Dose,States/Local Areas,Montana,2013,Age,3 Months,82.4,76.8 to 86.9,249
DTaP,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,3 Months,83.6,81.5 to 85.5,474
DTaP,≥1 Dose,States/Local Areas,Montana,2011,Age,3 Months,86.2,81.6 to 89.9,250
DTaP,≥1 Dose,States/Local Areas,Montana,2012,Age,3 Months,88.4,83.9 to 91.8,219
Hib,≥3 Doses,States/Local Areas,Montana,2017,Age,24 Months,81.9,75.5 to 87.5,265
Hib,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,24 Months,85.7,81.5 to 89.4,498
DTaP,≥3 Doses,States/Local Areas,Montana,2019,Age,24 Months,93.1,86.6 to 97.2,187
Hib,≥3 Doses,States/Local Areas,Montana,2016,Age,24 Months,82.3,75.8 to 87.9,257
Hib,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,24 Months,82.1,77.5 to 86.2,522
Hib,≥3 Doses,States/Local Areas,Montana,2015,Age,24 Months,86.0,79.3 to 91.3,256
Hib,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,24 Months,84.1,79.5 to 88.1,513
Hep A,≥1 Dose,States/Local Areas,Montana,2012,Age,19 Months,67.9,63.1 to 72.2,219
Hep A,≥1 Dose,States/Local Areas,Montana,2011,Age,19 Months,73.7,71.4 to 75.9,250
Hib,≥1 Dose,States/Local Areas,Montana,2021,Age,3 Months,82.4,73.9 to 88.5,127
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.5,70.9 to 78.2,730
≥1 Dose MMR,,States/Local Areas,Montana,2021,Age,35 Months,85.5,78.3 to 91.3,127
Hep B,≥3 Doses,States/Local Areas,Montana,2021,Age,19 Months,85.8,78.0 to 91.1,127
PCV,≥4 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,70.9,64.4 to 77.0,347
Hib,Full Series,States/Local Areas,Montana,2021,Age,19 Months,67.0,56.7 to 75.9,127
DTaP,≥4 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,80.3,73.5 to 86.3,347
Hep B,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,83.7,78.5 to 87.8,347
Hib,Primary Series,States/Local Areas,Montana,2020-2021,Age,24 Months,90.0,85.8 to 93.4,347
Hib,Primary Series,States/Local Areas,Montana,2021,Age,19 Months,87.4,79.9 to 92.4,127
Hib,≥3 Doses,States/Local Areas,Montana,2021,Age,19 Months,77.1,67.5 to 84.6,127
PCV,≥3 Doses,States/Local Areas,Montana,2021,Age,35 Months,88.3,81.4 to 93.4,127
Hib,≥2 Doses,States/Local Areas,Montana,2021,Age,7 Months,84.8,77.0 to 90.3,127
Hib,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,83.5,77.9 to 88.4,347
Polio,≥2 Doses,States/Local Areas,Montana,2021,Age,7 Months,85.7,78.0 to 91.0,127
Polio,≥3 Doses,States/Local Areas,Montana,2021,Age,35 Months,88.6,80.9 to 94.1,127
Hep B,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,87.6,83.0 to 91.1,347
DTaP,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,88.3,83.7 to 91.7,347
PCV,≥2 Doses,States/Local Areas,Montana,2021,Age,5 Months,72.6,62.0 to 81.2,127
≥1 Dose MMR,,States/Local Areas,Montana,2020-2021,Age,24 Months,86.3,81.6 to 90.4,347
Combined 7 Series,,States/Local Areas,Montana,2017,Age,24 Months,64.1,56.8 to 71.3,265
Combined 7 Series,,States/Local Areas,Montana,2017-2018,Age,24 Months,66.6,61.3 to 71.8,498
Combined 7 Series,,States/Local Areas,Montana,2018,Age,24 Months,69.2,61.6 to 76.5,233
Combined 7 Series,,States/Local Areas,Montana,2018-2019,Age,24 Months,69.6,63.8 to 75.2,420
Combined 7 Series,,States/Local Areas,Montana,2016,Age,24 Months,60.2,52.8 to 67.8,257
Combined 7 Series,,States/Local Areas,Montana,2016-2017,Age,24 Months,62.1,56.8 to 67.4,522
Hib,Primary Series,States/Local Areas,Montana,2019,Age,35 Months,93.0,86.5 to 97.1,187
Combined 7 Series,,States/Local Areas,Montana,2014,Age,24 Months,67.9,60.4 to 75.1,225
Combined 7 Series,,States/Local Areas,Montana,2014-2015,Age,24 Months,66.3,61.0 to 71.5,481
Combined 7 Series,,States/Local Areas,Montana,2015,Age,24 Months,64.6,57.0 to 72.1,256
Combined 7 Series,,States/Local Areas,Montana,2015-2016,Age,24 Months,62.5,57.0 to 67.9,513
Hib,Primary Series,States/Local Areas,Montana,2018,Age,35 Months,95.5,91.5 to 98.0,233
Hib,Primary Series,States/Local Areas,Montana,2018-2019,Age,35 Months,94.5,91.1 to 97.0,420
Hib,Primary Series,States/Local Areas,Montana,2017,Age,24 Months,91.7,87.1 to 95.1,265
Hib,Primary Series,States/Local Areas,Montana,2017-2018,Age,24 Months,92.5,89.4 to 95.0,498
Hib,Primary Series,States/Local Areas,Montana,2016,Age,24 Months,91.6,86.5 to 95.3,257
Hib,Primary Series,States/Local Areas,Montana,2016-2017,Age,24 Months,91.7,88.3 to 94.4,522
Hib,Primary Series,States/Local Areas,Montana,2018,Age,24 Months,93.3,88.7 to 96.5,233
Hib,Primary Series,States/Local Areas,Montana,2018-2019,Age,24 Months,93.1,89.4 to 95.9,420
Hib,Primary Series,States/Local Areas,Montana,2021,Age,7 Months,75.9,66.1 to 83.5,127
PCV,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,5 Months,73.2,66.7 to 78.8,347
Hep A,≥1 Dose,States/Local Areas,Montana,2016,Age,19 Months,69.6,62.0 to 76.2,257
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,19 Months,73.7,68.8 to 78.2,522
Hep A,≥1 Dose,States/Local Areas,Montana,2018,Age,19 Months,76.3,68.4 to 82.8,233
Hep A,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,19 Months,81.3,75.6 to 85.9,367
Hep A,≥1 Dose,States/Local Areas,Montana,2017,Age,19 Months,78.0,71.4 to 83.4,265
Hep A,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,19 Months,77.1,72.1 to 81.5,498
Hib,≥3 Doses,States/Local Areas,Montana,2019,Age,24 Months,87.3,79.7 to 93.0,187
Hib,≥3 Doses,States/Local Areas,Montana,2018,Age,24 Months,89.5,84.0 to 93.8,233
Hib,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,24 Months,88.3,83.8 to 92.1,420
Hep A,≥2 Doses,States/Local Areas,Montana,2014,Age,19 Months,13.5,8.9 to 20.0,225
Hep A,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,12.4,9.3 to 16.4,481
Hep A,≥2 Doses,States/Local Areas,Montana,2013,Age,19 Months,15.7,12.2 to 20.0,249
Hep A,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,14.6,12.8 to 16.6,474
DTaP,≥2 Doses,States/Local Areas,Montana,2019,Age,5 Months,86.1,78.3 to 91.4,187
Hep A,≥2 Doses,States/Local Areas,Montana,2011,Age,19 Months,18.0,11.5 to 27.2,250
DTaP,≥3 Doses,States/Local Areas,Montana,2014,Age,35 Months,93.2,88.6 to 96.4,225
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,92.9,89.2 to 95.7,481
DTaP,≥3 Doses,States/Local Areas,Montana,2011,Age,35 Months,94.9,90.0 to 97.9,250
DTaP,≥3 Doses,States/Local Areas,Montana,2012,Age,35 Months,95.8,91.2 to 98.4,219
DTaP,≥3 Doses,States/Local Areas,Montana,2013,Age,35 Months,92.5,86.5 to 96.5,249
DTaP,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,92.7,88.6 to 95.7,474
Combined 7 Series,,States/Local Areas,Montana,2021,Age,35 Months,61.5,50.4 to 72.7,127
Hep A,≥2 Doses,States/Local Areas,Montana,2021,Age,35 Months,65.4,47.4 to 82.6,127
Hib,≥3 Doses,States/Local Areas,Montana,2011,Age,35 Months,93.7,88.5 to 97.1,250
Hib,≥3 Doses,States/Local Areas,Montana,2012,Age,35 Months,93.0,87.5 to 96.7,219
DTaP,≥3 Doses,States/Local Areas,Montana,2017,Age,35 Months,96.1,91.5 to 98.6,265
DTaP,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,96.9,94.6 to 98.4,498
DTaP,≥4 Doses,States/Local Areas,Montana,2011,Age,19 Months,69.1,65.2 to 72.8,250
DTaP,≥4 Doses,States/Local Areas,Montana,2012,Age,19 Months,62.0,55.2 to 68.4,219
DTaP,≥3 Doses,States/Local Areas,Montana,2016,Age,35 Months,95.8,88.9 to 99.0,257
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,95.8,92.1 to 98.1,522
DTaP,≥3 Doses,States/Local Areas,Montana,2015,Age,35 Months,93.0,86.9 to 96.9,256
DTaP,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,95.0,90.1 to 97.9,513
PCV,≥2 Doses,States/Local Areas,Montana,2011,Age,5 Months,78.5,75.6 to 81.2,250
PCV,≥2 Doses,States/Local Areas,Montana,2012,Age,5 Months,75.7,67.2 to 82.5,219
PCV,≥2 Doses,States/Local Areas,Montana,2013,Age,5 Months,67.7,63.0 to 72.0,249
PCV,≥2 Doses,States/Local Areas,Montana,2013-2014,Age,5 Months,69.5,66.5 to 72.3,474
Hep A,≥2 Doses,States/Local Areas,Montana,2011,Age,24 Months,29.8,22.4 to 38.9,250
Hep A,≥2 Doses,States/Local Areas,Montana,2019,Age,19 Months,21.4,15.0 to 29.6,187
Hep A,≥2 Doses,States/Local Areas,Montana,2018,Age,19 Months,21.9,16.2 to 28.9,233
Hep A,≥2 Doses,States/Local Areas,Montana,2018-2019,Age,19 Months,19.6,15.1 to 25.0,367
Hib,≥3 Doses,States/Local Areas,Montana,2017,Age,35 Months,87.7,80.9 to 93.0,265
Hib,≥3 Doses,States/Local Areas,Montana,2017-2018,Age,35 Months,91.8,88.0 to 94.8,498
Hib,≥3 Doses,States/Local Areas,Montana,2016,Age,35 Months,84.7,78.0 to 90.2,257
Hib,≥3 Doses,States/Local Areas,Montana,2016-2017,Age,35 Months,86.2,81.5 to 90.2,522
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.3 to 97.0,453
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Any Medicaid,92.5,89.3 to 95.6,375
DTaP,≥4 Doses,States/Local Areas,Montana,2015,Age,19 Months,64.7,56.9 to 71.9,256
DTaP,≥4 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,64.4,58.9 to 69.6,513
DTaP,≥4 Doses,States/Local Areas,Montana,2014,Age,19 Months,64.9,57.1 to 72.0,225
DTaP,≥4 Doses,States/Local Areas,Montana,2014-2015,Age,19 Months,64.8,59.3 to 69.9,481
DTaP,≥4 Doses,States/Local Areas,Montana,2013,Age,19 Months,58.8,54.6 to 62.8,249
DTaP,≥4 Doses,States/Local Areas,Montana,2013-2014,Age,19 Months,61.9,59.0 to 64.6,474
Hep A,≥2 Doses,States/Local Areas,Montana,2012,Age,24 Months,26.8,19.3 to 36.4,219
Hib,≥3 Doses,States/Local Areas,Montana,2018,Age,35 Months,95.6,91.9 to 97.9,233
Hib,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,92.7,88.5 to 95.9,420
PCV,≥2 Doses,States/Local Areas,Montana,2017,Age,5 Months,77.0,69.9 to 82.8,265
PCV,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,5 Months,79.6,74.7 to 83.8,498
Hep A,≥1 Dose,States/Local Areas,Montana,2011,Age,35 Months,86.9,80.2 to 92.2,250
Hep A,≥1 Dose,States/Local Areas,Montana,2019,Age,24 Months,87.0,80.0 to 92.4,187
Hep A,≥1 Dose,States/Local Areas,Montana,2018,Age,24 Months,84.3,78.0 to 89.5,233
Hep A,≥1 Dose,States/Local Areas,Montana,2018-2019,Age,24 Months,85.7,81.2 to 89.7,420
DTaP,≥3 Doses,States/Local Areas,Montana,2019,Age,35 Months,93.8,87.6 to 97.6,187
DTaP,≥3 Doses,States/Local Areas,Montana,2014-2017,Insurance Coverage,Other,88.6,78.6 to 98.6,59
DTaP,≥3 Doses,States/Local Areas,Montana,2018,Age,35 Months,97.8,95.1 to 99.2,233
DTaP,≥3 Doses,States/Local Areas,Montana,2018-2019,Age,35 Months,96.5,93.5 to 98.4,420
PCV,≥2 Doses,States/Local Areas,Montana,2016,Age,5 Months,76.1,68.5 to 82.4,257
PCV,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,5 Months,76.6,71.4 to 81.0,522
PCV,≥2 Doses,States/Local Areas,Montana,2015,Age,5 Months,75.1,67.4 to 81.5,256
PCV,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,5 Months,75.6,70.2 to 80.3,513
PCV,≥2 Doses,States/Local Areas,Montana,2014,Age,5 Months,71.3,63.3 to 78.2,225
PCV,≥2 Doses,States/Local Areas,Montana,2014-2015,Age,5 Months,73.2,70.1 to 76.2,481
Hep A,≥1 Dose,States/Local Areas,Montana,2016,Age,24 Months,71.6,64.3 to 78.5,257
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2017,Age,24 Months,77.2,72.5 to 81.6,522
Hep A,≥1 Dose,States/Local Areas,Montana,2015,Age,24 Months,78.7,71.7 to 84.9,256
Hep A,≥1 Dose,States/Local Areas,Montana,2015-2016,Age,24 Months,75.1,70.2 to 79.9,513
Hep A,≥1 Dose,States/Local Areas,Montana,2012,Age,24 Months,72.7,64.7 to 80.2,219
Hep A,≥1 Dose,States/Local Areas,Montana,2014,Age,24 Months,76.5,69.3 to 83.0,225
Hep A,≥1 Dose,States/Local Areas,Montana,2014-2015,Age,24 Months,77.6,72.6 to 82.2,481
Hep A,≥1 Dose,States/Local Areas,Montana,2013,Age,24 Months,65.7,58.1 to 73.3,249
Hep A,≥1 Dose,States/Local Areas,Montana,2013-2014,Age,24 Months,71.2,65.9 to 76.3,474
Hep A,≥1 Dose,States/Local Areas,Montana,2011,Age,24 Months,80.2,73.5 to 86.1,250
Hep A,≥1 Dose,States/Local Areas,Montana,2019,Age,19 Months,84.9,77.3 to 90.3,187
Hep A,≥1 Dose,States/Local Areas,Montana,2017,Age,24 Months,82.8,77.0 to 87.8,265
Hep A,≥1 Dose,States/Local Areas,Montana,2017-2018,Age,24 Months,83.5,79.3 to 87.3,498
DTaP,≥3 Doses,States/Local Areas,Montana,2021,Age,7 Months,61.6,50.8 to 71.4,127
Hep A,≥1 Dose,States/Local Areas,Montana,2012,Age,35 Months,82.9,75.5 to 89.2,219
Hep A,≥2 Doses,States/Local Areas,Montana,2017,Age,19 Months,18.0,13.1 to 24.2,265
Hep A,≥2 Doses,States/Local Areas,Montana,2017-2018,Age,19 Months,19.9,16.1 to 24.5,498
Hib,≥3 Doses,States/Local Areas,Montana,2015,Age,35 Months,89.8,83.4 to 94.5,256
Hib,≥3 Doses,States/Local Areas,Montana,2015-2016,Age,35 Months,87.0,82.5 to 90.9,513
Hib,≥3 Doses,States/Local Areas,Montana,2014,Age,35 Months,88.5,82.6 to 93.1,225
Hib,≥3 Doses,States/Local Areas,Montana,2014-2015,Age,35 Months,89.1,84.8 to 92.7,481
Hib,≥3 Doses,States/Local Areas,Montana,2013,Age,35 Months,83.9,76.5 to 89.9,249
Hib,≥3 Doses,States/Local Areas,Montana,2013-2014,Age,35 Months,86.2,81.5 to 90.3,474
Hep A,≥2 Doses,States/Local Areas,Montana,2016,Age,19 Months,24.0,18.2 to 30.9,257
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2017,Age,19 Months,21.0,17.1 to 25.5,522
Hep A,≥2 Doses,States/Local Areas,Montana,2015,Age,19 Months,11.3,8.6 to 14.8,256
Hep A,≥2 Doses,States/Local Areas,Montana,2015-2016,Age,19 Months,17.6,13.9 to 22.0,513
Hep A,≥1 Dose,States/Local Areas,Montana,2021,Age,35 Months,78.2,69.2 to 86.1,127
PCV,≥3 Doses,States/Local Areas,Montana,2021,Age,19 Months,87.3,79.8 to 92.3,127
Hib,≥3 Doses,States/Local Areas,Montana,2021,Age,7 Months,13.8,8.5 to 21.5,127
≥1 Dose Varicella,,States/Local Areas,Montana,2021,Age,19 Months,84.8,76.9 to 90.3,127
DTaP,≥4 Doses,States/Local Areas,Montana,2021,Age,19 Months,63.0,52.5 to 72.5,127
Hib,Primary Series,States/Local Areas,Montana,2020-2021,Age,13 Months,83.0,77.6 to 87.3,347
Hep B,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,88.0,83.4 to 91.9,347
Hib,Full Series,States/Local Areas,Montana,2021,Age,24 Months,70.0,60.4 to 79.2,127
Hib,Primary Series,States/Local Areas,Montana,2021,Age,24 Months,87.4,80.5 to 92.7,127
Polio,≥1 Dose,States/Local Areas,Montana,2021,Age,3 Months,82.3,73.4 to 88.7,127
Hib,≥3 Doses,States/Local Areas,Montana,2021,Age,24 Months,80.7,71.8 to 88.3,127
≥1 Dose MMR,,States/Local Areas,Montana,2021,Age,24 Months,85.5,78.3 to 91.3,127
DTaP,≥1 Dose,States/Local Areas,Montana,2021,Age,3 Months,85.8,77.8 to 91.2,127
DTaP,≥4 Doses,States/Local Areas,Montana,2021,Age,24 Months,67.9,57.8 to 77.5,127
PCV,≥4 Doses,States/Local Areas,Montana,2021,Age,35 Months,73.4,62.6 to 83.2,127
DTaP,≥3 Doses,States/Local Areas,Montana,2021,Age,19 Months,87.4,79.9 to 92.4,127
Polio,≥3 Doses,States/Local Areas,Montana,2021,Age,24 Months,88.6,80.9 to 94.1,127
Hep A,≥1 Dose,States/Local Areas,Montana,2021,Age,19 Months,76.8,66.9 to 84.4,127
Hep B,≥3 Doses,States/Local Areas,Montana,2021,Age,7 Months,79.9,70.7 to 86.7,127
Hep A,≥2 Doses,States/Local Areas,Montana,2021,Age,24 Months,30.1,21.9 to 40.5,127
Hep A,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,19 Months,24.7,19.6 to 30.6,347
PCV,≥4 Doses,States/Local Areas,Montana,2021,Age,19 Months,68.7,57.9 to 77.8,127
Hep B,≥3 Doses,States/Local Areas,Montana,2021,Age,24 Months,85.8,78.7 to 91.5,127
PCV,≥3 Doses,States/Local Areas,Montana,2021,Age,7 Months,62.5,51.7 to 72.2,127
DTaP,≥3 Doses,States/Local Areas,Montana,2021,Age,13 Months,84.5,76.2 to 90.2,127
Hep A,≥1 Dose,States/Local Areas,Montana,2021,Age,24 Months,78.2,69.2 to 86.1,127
DTaP,≥3 Doses,States/Local Areas,Montana,2020-2021,Age,35 Months,90.5,86.3 to 93.8,347
DTaP,≥4 Doses,States/Local Areas,Montana,2020-2021,Age,24 Months,69.6,63.2 to 75.7,347
≥1 Dose Varicella,,States/Local Areas,Montana,2021,Age,24 Months,85.0,77.8 to 90.9,127
PCV,≥3 Doses,States/Local Areas,Montana,2021,Age,24 Months,88.3,81.4 to 93.4,127
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2021,Age,0-2 Days,67.4,56.9 to 76.4,127
Hep B,≥2 Doses,States/Local Areas,Montana,2021,Age,7 Months,87.2,79.9 to 92.1,127
Hib,≥2 Doses,States/Local Areas,Montana,2020-2021,Age,13 Months,87.1,82.4 to 90.7,347
PCV,≥4 Doses,States/Local Areas,Montana,2021,Age,24 Months,71.1,60.9 to 80.6,127
PCV,≥3 Doses,States/Local Areas,Montana,2021,Age,13 Months,85.3,77.2 to 90.9,127
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2021,Age,0-1 Days,65.8,55.2 to 74.9,127
≥1 Dose Varicella,,States/Local Areas,Montana,2020-2021,Age,35 Months,86.4,81.2 to 90.7,347
DTaP,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,3 Months,84.8,79.7 to 88.8,347
Hep A,≥1 Dose,States/Local Areas,Montana,2020-2021,Age,35 Months,84.5,78.3 to 89.8,347
Hep B,≥2 Doses,States/Local Areas,Montana,2021,Age,5 Months,82.5,73.6 to 88.9,127
Rotavirus,,States/Local Areas,Montana,2019-2020,Age,8 Months,73.2,67.4 to 78.3,407
Hib,Primary Series,States/Local Areas,Montana,2020-2021,Age,19 Months,88.1,83.6 to 91.5,347
≥1 Dose MMR,,States/Local Areas,Montana,2020-2021,Age,13 Months,58.6,51.8 to 65.1,347
PCV,≥3 Doses,States/Local Areas,Montana,2020,Age,7 Months,68.4,60.5 to 75.4,220
Hep B,≥3 Doses,States/Local Areas,Montana,2020,Age,7 Months,76.7,69.1 to 82.9,220
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,83.5,78.0 to 89.1,259
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,88.7,83.8 to 93.6,259
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,92.9,90.4 to 95.4,590
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,90.8 to 97.3,259
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.8,65.1 to 92.6,48
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,76.2,71.9 to 80.6,590
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,73.5,66.8 to 80.3,259
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,89.2,86.2 to 92.2,590
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,98.3,95.0 to 100.0,48
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,88.4 to 96.4,259
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,75.9 to 100.0,48
Rotavirus,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,71.4,67.0 to 75.9,590
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,86.3 to 99.9,48
Hib,Full Series,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.9,64.0 to 91.7,48
Hib,Full Series,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,79.4,75.5 to 83.4,590
Hib,Full Series,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,72.5,66.0 to 79.1,259
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,59.5,53.4 to 65.6,590
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.1,83.9 to 98.3,48
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,79.3,75.3 to 83.3,590
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,82.9,77.4 to 88.4,259
Rotavirus,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,75.4,69.2 to 81.6,259
Rotavirus,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.5,62.7 to 96.2,48
Influenza,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.0,58.3 to 85.6,48
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.1,52.4 to 83.8,48
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,64.9,60.1 to 69.7,590
Influenza,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,67.5,60.6 to 74.3,259
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.3,65.7 to 92.9,48
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,79.3,75.2 to 83.4,590
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.5,87.1 to 99.9,48
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,91.1,88.4 to 93.9,590
Hib,≥1 Dose,States/Local Areas,Montana,2020,Age,3 Months,82.7,75.7 to 88.1,220
Hep B,≥2 Doses,States/Local Areas,Montana,2020,Age,7 Months,84.6,77.6 to 89.6,220
Polio,≥1 Dose,States/Local Areas,Montana,2020,Age,3 Months,82.3,74.9 to 87.8,220
DTaP,≥1 Dose,States/Local Areas,Montana,2020,Age,3 Months,83.8,76.8 to 89.0,220
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,74.1,68.4 to 79.8,493
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,68.0,58.0 to 78.0,338
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,90.1,86.8 to 93.5,493
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,81.4 to 95.1,109
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,73.3,58.4 to 88.2,52
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.0,59.0 to 81.1,109
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,91.7,88.7 to 94.7,493
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,85.8,74.4 to 97.2,43
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,89.3,85.4 to 93.2,338
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,84.3,72.7 to 96.0,43
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,75.5,71.9 to 79.1,897
Influenza,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,55.4,39.0 to 71.7,52
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,75.3,61.3 to 89.2,43
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,92.2,90.0 to 94.3,897
Rotavirus,,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,78.5,72.1 to 85.0,248
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,91.7,89.6 to 93.8,897
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,65.9,58.0 to 73.9,202
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Overall,Overall,89.4,86.9 to 91.9,897
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,82.6,78.3 to 86.8,447
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,80.8,77.6 to 84.0,897
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,75.9,69.2 to 82.7,202
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,70.2,61.6 to 78.8,248
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Overall,Overall,81.4,78.3 to 84.5,897
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,68.7,62.5 to 74.9,447
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,91.9,89.1 to 94.7,447
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,91.8,87.4 to 96.1,202
Influenza,,States/Local Areas,Montana,2016-2019,Overall,Overall,64.2,60.4 to 68.0,897
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Overall,Overall,74.1,70.7 to 77.5,897
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,92.9,88.8 to 96.9,202
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,69.0,63.2 to 74.8,897
Rotavirus,,States/Local Areas,Montana,2016-2019,Overall,Overall,73.3,69.8 to 76.9,897
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,69.6,62.5 to 76.6,248
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Overall,Overall,86.2,83.4 to 89.0,897
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,92.8,88.6 to 97.0,248
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,65.8,60.4 to 71.2,447
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,93.6,91.1 to 96.2,447
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,58.2,50.0 to 66.4,202
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,78.2,71.4 to 85.0,202
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,92.7,88.8 to 96.7,248
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,91.7,88.7 to 94.6,447
Hib,Full Series,States/Local Areas,Montana,2016-2019,Overall,Overall,77.0,73.6 to 80.4,897
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Overall,Overall,64.4,60.5 to 68.3,897
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.9,63.5 to 90.3,48
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,86.3,82.9 to 89.6,590
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,92.5,88.3 to 96.7,248
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,92.9,90.3 to 95.6,447
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,72.6,68.4 to 76.7,590
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,62.7,55.6 to 69.9,259
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,76.2,70.0 to 82.5,259
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,92.2,89.7 to 94.8,590
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,98.3,95.0 to 100.0,48
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,86.6 to 95.4,259
Influenza,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,61.5,56.7 to 66.3,590
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,84.2 to 100.0,48
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.7,86.9 to 92.5,730
Rotavirus,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.9,70.9 to 78.8,730
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.5,83.3 to 89.6,730
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,70.9,66.0 to 75.9,493
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.7,79.4 to 86.0,730
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,76.5,71.3 to 81.8,338
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,84.2,73.1 to 95.3,52
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,63.6,47.1 to 80.1,43
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.6,84.6 to 96.6,109
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,85.6,81.2 to 90.0,338
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,95.4,93.3 to 97.6,493
Rotavirus,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,78.5,74.0 to 83.1,493
Influenza,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,60.3,54.2 to 66.4,338
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.2,69.2 to 87.3,109
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,91.4,81.1 to 100.0,52
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,78.2,65.8 to 90.7,52
Influenza,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,52.8,35.2 to 70.4,43
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.8,61.4 to 82.2,109
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,50.1,29.4 to 70.9,43
Rotavirus,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,70.2,64.5 to 75.9,338
Rotavirus,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,76.5,62.9 to 90.2,43
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,58.8,42.9 to 74.7,52
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.9,61.7 to 70.1,730
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.5,50.8 to 74.2,109
Rotavirus,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,66.2,50.4 to 81.9,52
Rotavirus,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,61.0 to 80.7,109
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.4,78.9 to 85.9,730
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,72.9,58.3 to 87.6,52
Influenza,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.1,61.0 to 69.3,730
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,82.6,70.4 to 94.9,43
Influenza,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.2,51.4 to 72.9,109
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.4 to 96.8,109
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.7,90.3 to 95.0,730
Influenza,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,72.0,67.2 to 76.7,493
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,84.9,73.4 to 96.4,43
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,80.6,66.9 to 94.2,52
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.7,89.3 to 94.2,730
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.1 to 96.1,493
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,71.3,65.4 to 77.3,338
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,93.3,90.3 to 96.3,338
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,77.5,63.7 to 91.2,43
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,76.0,61.8 to 90.1,52
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,70.4,55.0 to 85.8,43
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,84.4,72.7 to 96.1,43
Hib,Full Series,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,76.4,71.0 to 81.8,338
Hib,Full Series,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.1,74.4 to 81.8,730
Hib,Full Series,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,74.8,60.4 to 89.2,43
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,94.7,92.4 to 97.0,493
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,92.7,89.4 to 96.0,338
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.1,73.2 to 81.0,730
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,91.1 to 95.7,730
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,68.9,52.7 to 85.1,43
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.4 to 96.8,109
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,96.7,93.2 to 100.0,52
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,83.1,78.9 to 87.4,493
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,Hispanic,95.5,91.4 to 99.6,52
DTaP,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,91.5,87.7 to 94.2,407
DTaP,≥4 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,64.9,58.8 to 70.5,407
Hep B,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,80.7,75.6 to 85.0,407
Hib,≥2 Doses,States/Local Areas,Montana,2020,Age,5 Months,75.7,68.3 to 81.9,220
Polio,≥2 Doses,States/Local Areas,Montana,2020,Age,5 Months,75.8,68.2 to 82.1,220
DTaP,≥2 Doses,States/Local Areas,Montana,2020,Age,5 Months,77.3,70.0 to 83.3,220
Hep B,≥1 Dose,States/Local Areas,Montana,2020,Age,3 Months,87.9,81.4 to 92.3,220
PCV,≥1 Dose,States/Local Areas,Montana,2020,Age,3 Months,79.9,72.4 to 85.7,220
Hep A,≥2 Doses,States/Local Areas,Montana,2020,Age,24 Months,37.3,30.1 to 45.6,220
Hep A,≥1 Dose,States/Local Areas,Montana,2020,Age,24 Months,77.9,70.7 to 84.4,220
PCV,≥4 Doses,States/Local Areas,Montana,2020,Age,24 Months,70.4,62.7 to 77.8,220
PCV,≥3 Doses,States/Local Areas,Montana,2020,Age,24 Months,87.4,81.5 to 92.2,220
≥1 Dose Varicella,,States/Local Areas,Montana,2020,Age,24 Months,79.9,72.9 to 86.1,220
Rotavirus,,States/Local Areas,Montana,2020,Age,8 Months,68.5,60.5 to 75.5,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2020,Age,0-3 Days,74.8,67.0 to 81.3,220
Influenza,,States/Local Areas,Montana,2020,Age,24 Months,57.1,49.4 to 65.0,220
Combined 7 Series,,States/Local Areas,Montana,2020,Age,24 Months,57.7,49.9 to 65.7,220
Hib,≥3 Doses,States/Local Areas,Montana,2020,Age,19 Months,77.5,69.6 to 83.8,220
Polio,≥3 Doses,States/Local Areas,Montana,2020,Age,19 Months,88.5,82.7 to 92.5,220
≥1 Dose MMR,,States/Local Areas,Montana,2020,Age,19 Months,81.3,74.0 to 86.9,220
DTaP,≥4 Doses,States/Local Areas,Montana,2020,Age,19 Months,62.3,54.3 to 69.8,220
DTaP,≥3 Doses,States/Local Areas,Montana,2020,Age,19 Months,89.2,83.5 to 93.1,220
Hep B,≥2 Doses,States/Local Areas,Montana,2020,Age,5 Months,81.0,73.7 to 86.7,220
DTaP,≥3 Doses,States/Local Areas,Montana,2020,Age,7 Months,72.5,64.9 to 79.0,220
PCV,≥3 Doses,States/Local Areas,Montana,2020,Age,13 Months,79.6,72.0 to 85.6,220
≥1 Dose Varicella,,States/Local Areas,Montana,2020,Age,13 Months,50.4,42.6 to 58.3,220
PCV,≥2 Doses,States/Local Areas,Montana,2020,Age,5 Months,73.7,66.0 to 80.2,220
Hep B,≥3 Doses,States/Local Areas,Montana,2020,Age,13 Months,83.0,75.9 to 88.3,220
Hep B,≥2 Doses,States/Local Areas,Montana,2020,Age,13 Months,86.6,79.9 to 91.3,220
Hib,Primary Series,States/Local Areas,Montana,2020,Age,13 Months,83.1,76.3 to 88.2,220
Hib,≥3 Doses,States/Local Areas,Montana,2020,Age,13 Months,47.0,39.3 to 55.0,220
PCV,≥3 Doses,States/Local Areas,Montana,2020,Age,35 Months,89.8,83.8 to 94.3,220
Hib,≥2 Doses,States/Local Areas,Montana,2020,Age,13 Months,87.2,81.0 to 91.6,220
PCV,≥3 Doses,States/Local Areas,Montana,2020,Age,19 Months,86.8,80.3 to 91.3,220
Polio,≥3 Doses,States/Local Areas,Montana,2020,Age,35 Months,90.5,85.8 to 94.2,220
PCV,≥4 Doses,States/Local Areas,Montana,2020,Age,19 Months,67.5,59.3 to 74.7,220
DTaP,≥4 Doses,States/Local Areas,Montana,2020,Age,35 Months,80.9,73.3 to 87.4,220
DTaP,≥3 Doses,States/Local Areas,Montana,2020,Age,35 Months,92.1,87.7 to 95.4,220
≥1 Dose Varicella,,States/Local Areas,Montana,2020,Age,19 Months,76.2,68.4 to 82.5,220
Hep B,≥3 Doses,States/Local Areas,Montana,2020,Age,19 Months,86.4,79.7 to 91.1,220
Hib,Full Series,States/Local Areas,Montana,2020,Age,19 Months,69.5,61.4 to 76.5,220
Hib,Primary Series,States/Local Areas,Montana,2020,Age,19 Months,88.8,83.1 to 92.8,220
≥1 Dose Varicella,,States/Local Areas,Montana,2020,Age,35 Months,85.6,79.0 to 91.0,220
Hep B,≥3 Doses,States/Local Areas,Montana,2020,Age,35 Months,89.4,83.6 to 93.8,220
Hib,Full Series,States/Local Areas,Montana,2020,Age,35 Months,77.2,69.8 to 83.8,220
Hib,≥3 Doses,States/Local Areas,Montana,2020,Age,35 Months,87.3,81.0 to 92.3,220
Hib,Primary Series,States/Local Areas,Montana,2020,Age,35 Months,92.0,87.4 to 95.3,220
≥1 Dose MMR,,States/Local Areas,Montana,2020,Age,35 Months,87.2,81.3 to 91.9,220
Hib,≥3 Doses,States/Local Areas,Montana,2020,Age,24 Months,84.6,78.1 to 90.0,220
≥1 Dose MMR,,States/Local Areas,Montana,2020,Age,24 Months,86.0,80.1 to 90.9,220
Polio,≥3 Doses,States/Local Areas,Montana,2020,Age,24 Months,90.5,85.8 to 94.2,220
DTaP,≥3 Doses,States/Local Areas,Montana,2020,Age,24 Months,91.7,87.2 to 95.1,220
DTaP,≥4 Doses,States/Local Areas,Montana,2020,Age,24 Months,70.7,63.2 to 77.9,220
Hib,Primary Series,States/Local Areas,Montana,2020,Age,7 Months,74.6,67.3 to 80.8,220
Hib,≥3 Doses,States/Local Areas,Montana,2020,Age,7 Months,20.6,14.6 to 28.2,220
Hib,≥2 Doses,States/Local Areas,Montana,2020,Age,7 Months,82.2,75.3 to 87.5,220
Polio,≥2 Doses,States/Local Areas,Montana,2020,Age,7 Months,84.2,77.4 to 89.3,220
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2020,Age,0-2 Days,73.5,65.6 to 80.1,220
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2020,Age,0-1 Days,71.3,63.4 to 78.0,220
Hep A,≥1 Dose,States/Local Areas,Montana,2020,Age,19 Months,75.2,67.3 to 81.8,220
Hep A,≥2 Doses,States/Local Areas,Montana,2020,Age,19 Months,23.3,17.2 to 30.7,220
Combined 7 Series,,States/Local Areas,Montana,2020,Age,35 Months,62.6,54.7 to 70.6,220
≥1 Dose MMR,,States/Local Areas,Montana,2020,Age,13 Months,62.9,54.7 to 70.3,220
Hep A,≥2 Doses,States/Local Areas,Montana,2020,Age,35 Months,61.5,52.3 to 70.8,220
Hep A,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,24 Months,83.0,78.2 to 87.2,407
Hep A,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,35 Months,88.7,83.9 to 92.6,407
Hep A,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,69.7,61.0 to 78.0,407
Influenza,,States/Local Areas,Montana,2019-2020,Age,24 Months,65.8,60.2 to 71.4,407
Hep A,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,36.5,30.8 to 43.0,407
Hib,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,86.4,81.7 to 90.4,407
Hib,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,87.0,82.4 to 90.5,407
Hib,Primary Series,States/Local Areas,Montana,2019-2020,Age,24 Months,92.9,89.7 to 95.5,407
Combined 7 Series,,States/Local Areas,Montana,2019-2020,Age,35 Months,68.9,63.0 to 74.7,407
Hib,Full Series,States/Local Areas,Montana,2019-2020,Age,19 Months,72.7,67.0 to 77.7,407
Hep B,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,89.1,84.8 to 92.3,407
≥1 Dose Varicella,,States/Local Areas,Montana,2019-2020,Age,19 Months,81.5,76.3 to 85.8,407
PCV,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,89.9,85.7 to 93.0,407
PCV,≥4 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,74.8,69.1 to 79.7,407
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Montana,2019-2020,Age,0-2 Days,72.7,67.0 to 77.8,407
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Montana,2019-2020,Age,0-1 Days,69.5,63.6 to 74.8,407
Hep A,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,19 Months,80.5,75.3 to 84.8,407
Hep B,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,90.7,86.9 to 93.8,407
Hib,Full Series,States/Local Areas,Montana,2019-2020,Age,24 Months,76.1,70.7 to 81.1,407
Hib,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,19.7,15.3 to 25.1,407
PCV,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,73.3,67.6 to 78.4,407
≥1 Dose Varicella,,States/Local Areas,Montana,2019-2020,Age,24 Months,84.8,80.0 to 88.9,407
PCV,≥4 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,76.7,71.3 to 81.7,407
PCV,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,90.9,87.1 to 94.0,407
Polio,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,91.2,87.3 to 93.9,407
Hep A,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,22.3,17.7 to 27.6,407
Hib,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,19 Months,82.0,76.6 to 86.3,407
≥1 Dose MMR,,States/Local Areas,Montana,2019-2020,Age,19 Months,86.1,81.3 to 89.8,407
Hib,Primary Series,States/Local Areas,Montana,2019-2020,Age,19 Months,91.5,87.6 to 94.2,407
Hib,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,88.7,84.0 to 92.4,407
≥1 Dose MMR,,States/Local Areas,Montana,2019-2020,Age,35 Months,89.7,85.6 to 93.0,407
Hib,Full Series,States/Local Areas,Montana,2019-2020,Age,35 Months,79.6,74.4 to 84.4,407
Hib,Primary Series,States/Local Areas,Montana,2019-2020,Age,35 Months,93.3,90.0 to 95.8,407
Hep B,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,91.4,87.6 to 94.3,407
≥1 Dose Varicella,,States/Local Areas,Montana,2019-2020,Age,35 Months,89.4,85.1 to 92.8,407
PCV,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,92.3,88.4 to 95.2,407
PCV,≥4 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,79.9,74.5 to 84.7,407
DTaP,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,93.2,89.9 to 95.7,407
Polio,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,92.6,89.3 to 95.2,407
DTaP,≥4 Doses,States/Local Areas,Montana,2019-2020,Age,24 Months,73.5,67.8 to 78.9,407
≥1 Dose MMR,,States/Local Areas,Montana,2019-2020,Age,24 Months,88.8,84.7 to 92.2,407
Hib,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,3 Months,86.5,81.8 to 90.1,407
Hep B,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,3 Months,92.4,88.9 to 94.9,407
PCV,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,3 Months,86.0,81.2 to 89.8,407
DTaP,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,5 Months,81.7,76.7 to 85.9,407
Polio,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,5 Months,81.0,75.8 to 85.2,407
DTaP,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,88.1,83.7 to 91.5,407
Polio,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,90.8,86.8 to 93.7,407
Hib,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,90.5,86.5 to 93.5,407
≥1 Dose MMR,,States/Local Areas,Montana,2019-2020,Age,13 Months,67.1,61.2 to 72.6,407
Hib,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,5 Months,80.1,75.0 to 84.4,407
Hib,Primary Series,States/Local Areas,Montana,2019-2020,Age,13 Months,86.9,82.5 to 90.3,407
Hib,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,48.2,42.2 to 54.3,407
Hep B,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,5 Months,86.4,81.8 to 90.0,407
PCV,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,5 Months,79.9,74.7 to 84.3,407
DTaP,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,75.5,69.9 to 80.4,407
Polio,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,7 Months,88.4,83.9 to 91.8,407
Hep B,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,87.1,82.6 to 90.6,407
Hep B,≥2 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,90.7,86.9 to 93.5,407
≥1 Dose Varicella,,States/Local Areas,Montana,2019-2020,Age,13 Months,52.2,46.2 to 58.2,407
PCV,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,13 Months,85.7,80.9 to 89.4,407
DTaP,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,93.6,90.4 to 96.0,407
Combined 7 Series,,States/Local Areas,Montana,2019-2020,Age,24 Months,63.2,57.3 to 69.1,407
DTaP,≥4 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,81.9,76.3 to 86.8,407
Polio,≥3 Doses,States/Local Areas,Montana,2019-2020,Age,35 Months,92.8,89.4 to 95.3,407
Polio,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,3 Months,87.2,82.4 to 90.8,407
DTaP,≥1 Dose,States/Local Areas,Montana,2019-2020,Age,3 Months,87.9,83.3 to 91.4,407
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2019-2020,Age,0-3 Days,73.6,67.9 to 78.6,407
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,82.1,71.8 to 92.4,259
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,86.7 to 97.5,109
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Insurance Coverage,Private Insurance Only,73.3,68.6 to 77.9,493
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.8,63.9 to 75.7,730
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.3,88.7 to 100.0,48
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a Non-MSA,91.1,88.5 to 93.8,590
PCV,≥3 Doses,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,88.1 to 96.1,259
Rotavirus,,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,64.8,56.9 to 72.6,202
Rotavirus,,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,76.1,71.5 to 80.8,447
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Urbanicity,Living In a MSA Principal City,84.6,79.0 to 90.2,259
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,86.1,80.8 to 91.4,248
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,83.4,79.2 to 87.7,447
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,75.6,69.3 to 81.9,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,70.8,65.9 to 75.6,447
Hep A,≥2 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,68.3,53.2 to 83.4,202
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,92.2,88.1 to 96.3,248
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,89.3,85.8 to 92.8,447
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,92.4,88.0 to 96.8,202
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,93.1,91.0 to 95.1,897
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Overall,Overall,92.3,90.2 to 94.3,897
Influenza,,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,64.7,59.4 to 70.0,447
Influenza,,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,53.4,45.5 to 61.4,202
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,89.9,85.1 to 94.8,248
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,86.6,82.7 to 90.5,447
≥1 Dose Varicella,,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,82.7,76.7 to 88.8,202
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,78.5,71.9 to 85.2,248
DTaP,≥4 Doses,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,80.3,75.6 to 84.9,447
≥1 Dose MMR,,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,87.2,82.0 to 92.5,202
Polio,≥3 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,90.8,85.9 to 95.6,202
Hib,Full Series,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,80.9,74.8 to 87.0,248
Hib,Full Series,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,72.9,65.7 to 80.1,202
Hib,Full Series,States/Local Areas,Montana,2016-2019,Poverty,133% to <400% FPL,77.7,73.0 to 82.3,447
Hep A,≥1 Dose,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,86.0,80.5 to 91.4,248
PCV,≥4 Doses,States/Local Areas,Montana,2016-2019,Poverty,<133% FPL,72.4,65.0 to 79.7,202
Influenza,,States/Local Areas,Montana,2016-2019,Poverty,>400% FPL,76.8,70.3 to 83.3,248
DTaP,≥3 Doses,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,93.7,90.7 to 96.7,338
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Other,53.4,35.8 to 70.9,43
Combined 7 Series,,States/Local Areas,Montana,2016-2019,Insurance Coverage,Any Medicaid,62.1,55.9 to 68.4,338
Hep B,≥3 Doses,States/Local Areas,Montana,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.3,89.9 to 94.6,730
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014,Age,24 Months,91.2,85.0 to 95.5,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2015,Age,24 Months,92.3,88.6 to 95.2,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013,Age,24 Months,93.8,89.5 to 96.8,225
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013-2014,Age,24 Months,92.5,88.8 to 95.3,476
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2013,Age,0-1 Days,72.9,66.9 to 78.2,225
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2013-2014,Age,0-1 Days,71.9,67.6 to 75.8,476
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2014,Age,0-1 Days,70.9,63.4 to 77.4,251
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2014-2015,Age,0-1 Days,77.6,72.6 to 81.9,489
Hep B,≥2 Doses,States/Local Areas,Nebraska,2015,Age,5 Months,93.0,87.5 to 96.1,238
Hep B,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,5 Months,92.0,88.3 to 94.7,461
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2015,Age,0-1 Days,84.3,77.9 to 89.0,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2015-2016,Age,0-1 Days,82.6,78.0 to 86.4,461
PCV,≥4 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,81.9,77.5 to 85.6,225
PCV,≥4 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,79.2,74.4 to 83.3,476
PCV,≥4 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,77.8,75.6 to 79.9,232
PCV,≥4 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,85.7,78.3 to 90.9,243
≥1 Dose MMR,,States/Local Areas,Nebraska,2018,Age,19 Months,92.9,88.8 to 95.5,279
≥1 Dose MMR,,States/Local Areas,Nebraska,2018-2019,Age,19 Months,96.0,93.8 to 97.4,538
≥1 Dose MMR,,States/Local Areas,Nebraska,2019,Age,19 Months,91.5,86.7 to 94.7,259
≥1 Dose MMR,,States/Local Areas,Nebraska,2011,Age,24 Months,93.9,89.5 to 96.9,243
≥1 Dose MMR,,States/Local Areas,Nebraska,2012,Age,24 Months,92.1,86.7 to 95.9,232
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015,Age,24 Months,93.5,88.9 to 96.7,238
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015-2016,Age,24 Months,92.4,88.8 to 95.2,461
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016,Age,24 Months,91.3,85.3 to 95.5,223
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2017,Age,24 Months,92.7,89.2 to 95.4,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017,Age,24 Months,94.0,90.0 to 96.8,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017-2018,Age,24 Months,93.7,91.1 to 95.8,545
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019,Age,24 Months,92.9,88.6 to 96.0,259
≥1 Dose Varicella,,States/Local Areas,Nebraska,2011,Age,35 Months,95.2,90.8 to 97.9,243
≥1 Dose Varicella,,States/Local Areas,Nebraska,2012,Age,35 Months,93.8,89.2 to 96.9,232
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018,Age,24 Months,93.4,89.7 to 96.2,279
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018-2019,Age,24 Months,93.2,90.4 to 95.3,538
≥1 Dose MMR,,States/Local Areas,Nebraska,2015,Age,24 Months,94.6,90.3 to 97.4,238
≥1 Dose MMR,,States/Local Areas,Nebraska,2015-2016,Age,24 Months,94.3,91.1 to 96.6,461
≥1 Dose MMR,,States/Local Areas,Nebraska,2014,Age,24 Months,93.0,87.2 to 96.8,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2015,Age,24 Months,93.7,90.2 to 96.3,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2013,Age,24 Months,95.7,91.8 to 98.2,225
≥1 Dose MMR,,States/Local Areas,Nebraska,2013-2014,Age,24 Months,94.3,90.9 to 96.7,476
PCV,≥3 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,75.7,68.6 to 81.6,266
PCV,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,75.4,70.6 to 79.6,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,79.0,72.1 to 84.5,238
PCV,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,79.6,74.7 to 83.7,461
PCV,≥4 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,76.5,68.6 to 83.0,251
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,79.8,74.7 to 84.0,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,83.0,80.0 to 85.6,238
PCV,≥4 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,82.0,77.1 to 86.1,461
PCV,≥4 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,81.0,73.1 to 87.0,223
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,82.3,77.5 to 86.3,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,80.2,72.8 to 86.0,223
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,78.0,73.0 to 82.3,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,94.0,89.9 to 96.9,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,95.0,90.4 to 97.8,225
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,92.8,89.2 to 95.6,476
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,93.3,88.7 to 96.2,259
Hep B,≥3 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,91.8,87.2 to 95.2,243
Polio,≥2 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,95.2,91.3 to 97.4,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,79.0,74.6 to 83.5,850
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,74.5,65.3 to 83.7,236
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,71.2,60.8 to 81.5,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.1,67.1 to 87.1,156
Hep B,≥3 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,93.8,90.9 to 95.8,232
Hep A,≥1 Dose,States/Local Areas,Nebraska,2020,Age,35 Months,96.3,92.5 to 98.5,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,86.1,80.3 to 90.4,279
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,87.7,84.0 to 90.6,538
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,89.4,84.3 to 92.9,259
Hep B,≥3 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,90.8,87.1 to 93.6,243
DTaP,≥4 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,90.2,84.3 to 94.5,279
DTaP,≥4 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,89.6,85.8 to 92.8,538
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2016,Age,0-1 Days,80.9,73.7 to 86.5,223
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2016-2017,Age,0-1 Days,79.7,74.8 to 83.9,489
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2017,Age,0-1 Days,78.5,71.4 to 84.2,266
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2017-2018,Age,0-1 Days,82.8,78.3 to 86.5,545
Hep B,≥2 Doses,States/Local Areas,Nebraska,2019,Age,5 Months,94.3,90.1 to 96.8,259
Hep B,≥2 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,94.2,89.5 to 96.9,243
Hep B,≥2 Doses,States/Local Areas,Nebraska,2017,Age,5 Months,92.3,87.0 to 95.6,266
Hep B,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,5 Months,92.2,89.0 to 94.5,545
Hep B,≥2 Doses,States/Local Areas,Nebraska,2018,Age,5 Months,92.1,87.7 to 95.0,279
Hep B,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,5 Months,93.2,90.4 to 95.2,538
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2018,Age,0-1 Days,87.2,81.3 to 91.4,279
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2018-2019,Age,0-1 Days,84.6,80.2 to 88.1,538
PCV,≥3 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,72.1,68.4 to 75.5,225
PCV,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,71.6,68.6 to 74.4,476
PCV,≥3 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,74.3,69.1 to 78.8,243
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,92.6,86.9 to 95.9,223
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,93.9,90.7 to 96.1,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,71.1,63.3 to 77.9,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,75.0,69.9 to 79.6,489
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,92.1,87.8 to 96.4,221
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,84.0,79.5 to 88.5,393
PCV,≥3 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,73.5,71.8 to 75.1,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,95.3,91.4 to 97.5,266
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,94.2,91.5 to 96.1,545
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,93.0,88.6 to 95.8,279
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,87.7,84.0 to 90.6,538
Hep B,≥2 Doses,States/Local Areas,Nebraska,2016,Age,5 Months,91.1,85.1 to 94.8,223
Hep B,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,5 Months,91.7,88.0 to 94.3,489
Hep B,≥2 Doses,States/Local Areas,Nebraska,2014,Age,5 Months,85.2,78.0 to 90.4,251
Hep B,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,5 Months,89.1,85.4 to 91.9,489
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2012,Age,0-1 Days,68.5,59.6 to 76.2,232
Polio,≥2 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,95.1,91.3 to 97.3,279
Polio,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,95.9,93.7 to 97.3,538
Polio,≥2 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,96.7,93.8 to 98.3,259
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019,Age,19 Months,92.3,87.6 to 95.3,259
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2019,Age,0-1 Days,81.8,75.0 to 87.1,259
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2011,Age,0-2 Days,84.3,78.3 to 88.8,243
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2013,Age,0-2 Days,76.4,70.8 to 81.2,225
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2013-2014,Age,0-2 Days,75.3,72.1 to 78.3,476
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2012,Age,0-2 Days,73.2,62.4 to 81.8,232
Hep B,≥2 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,92.3,89.8 to 94.3,225
Hep B,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,90.8,88.8 to 92.5,476
Hep B,≥2 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,89.3,82.0 to 93.8,251
Hep B,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,92.0,87.8 to 94.9,489
Hep B,≥2 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,94.8,89.7 to 97.5,238
Hep B,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,93.7,90.2 to 96.0,461
Hep B,≥2 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,94.9,92.9 to 96.3,232
PCV,≥3 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,75.1,68.2 to 80.9,279
PCV,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,77.8,73.1 to 81.9,538
PCV,≥3 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,80.6,73.9 to 85.9,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,92.1,85.5 to 95.8,243
PCV,≥4 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,83.6,77.5 to 88.3,266
PCV,≥4 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,83.8,79.6 to 87.4,545
PCV,≥4 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,84.1,78.2 to 88.6,279
PCV,≥4 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,85.8,81.1 to 89.5,444
≥1 Dose MMR,,States/Local Areas,Nebraska,2017,Age,24 Months,94.9,91.2 to 97.5,266
≥1 Dose MMR,,States/Local Areas,Nebraska,2017-2018,Age,24 Months,94.7,92.2 to 96.6,545
≥1 Dose MMR,,States/Local Areas,Nebraska,2016,Age,24 Months,94.1,88.8 to 97.4,223
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2017,Age,24 Months,94.3,91.3 to 96.6,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,93.9,91.8 to 95.4,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,93.4,88.3 to 96.8,223
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,95.2,92.3 to 97.2,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,94.6,90.0 to 97.5,238
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,94.1,90.8 to 96.5,461
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,90.9,85.2 to 95.1,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,92.7,89.2 to 95.4,489
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2014,Age,0-2 Days,74.3,66.7 to 80.6,251
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2014-2015,Age,0-2 Days,79.7,74.8 to 83.9,489
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2015,Age,0-2 Days,85.1,78.8 to 89.8,238
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2015-2016,Age,0-2 Days,83.6,79.0 to 87.3,461
PCV,≥4 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,88.0,81.8 to 92.8,243
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015,Age,35 Months,96.2,91.8 to 98.6,238
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015-2016,Age,35 Months,94.5,90.7 to 97.1,461
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014,Age,35 Months,95.6,90.5 to 98.4,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2015,Age,35 Months,95.8,92.6 to 97.9,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,86.1,80.3 to 90.5,259
≥1 Dose MMR,,States/Local Areas,Nebraska,2018,Age,24 Months,94.5,91.0 to 97.0,279
≥1 Dose MMR,,States/Local Areas,Nebraska,2018-2019,Age,24 Months,93.6,91.0 to 95.7,538
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013,Age,35 Months,94.1,89.8 to 97.1,225
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013-2014,Age,35 Months,94.6,91.1 to 97.0,476
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2016,Age,0-2 Days,81.9,74.8 to 87.4,223
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2016-2017,Age,0-2 Days,81.5,76.7 to 85.5,489
Hep B,≥2 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,92.5,86.7 to 95.9,223
Hep B,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,94.2,90.9 to 96.3,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,91.7,88.5 to 94.1,225
PCV,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,88.9,84.7 to 92.0,476
Hep B,≥2 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,95.9,92.0 to 97.9,266
Hep B,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,94.7,92.1 to 96.5,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,86.0,78.5 to 91.2,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,88.8,84.3 to 92.0,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,91.5,86.3 to 94.8,238
PCV,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,91.4,87.4 to 94.2,461
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,93.2,89.1 to 96.1,279
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,93.9,91.2 to 96.0,538
Hib,≥1 Dose,States/Local Areas,Nebraska,2013,Age,3 Months,90.3,86.8 to 92.9,225
Hib,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,3 Months,87.1,85.2 to 88.8,476
Hib,≥1 Dose,States/Local Areas,Nebraska,2012,Age,3 Months,89.5,86.4 to 92.0,232
Hib,≥1 Dose,States/Local Areas,Nebraska,2011,Age,3 Months,90.6,84.4 to 94.5,243
Hib,≥1 Dose,States/Local Areas,Nebraska,2014,Age,3 Months,84.0,76.6 to 89.4,251
Hib,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,3 Months,87.7,83.2 to 91.1,489
Hep B,≥2 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,91.1,84.0 to 95.2,251
Hep B,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,93.6,89.7 to 96.1,489
Hep B,≥2 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,96.2,91.8 to 98.3,238
Hep B,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,95.6,92.4 to 97.5,461
Hep B,≥2 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,95.0,89.4 to 97.7,223
Hep B,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,96.3,93.4 to 98.0,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,94.1,90.2 to 96.5,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2011,Age,19 Months,95.3,89.7 to 97.9,243
PCV,≥3 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,95.2,86.0 to 98.4,225
PCV,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,91.6,85.3 to 95.3,476
PCV,≥3 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,88.0,80.6 to 92.9,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,90.8,86.5 to 93.8,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,94.2,89.0 to 97.5,223
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,95.8,92.9 to 97.7,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,89.4,84.6 to 93.3,259
PCV,≥4 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,87.3,82.2 to 91.5,279
PCV,≥4 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,88.3,84.9 to 91.3,538
PCV,≥4 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,92.9,87.2 to 96.7,243
PCV,≥4 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,87.3,81.1 to 92.3,232
PCV,≥3 Doses,States/Local Areas,Nebraska,2012,Age,19 Months,95.7,93.2 to 97.3,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,97.2,94.3 to 98.9,266
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,95.6,93.3 to 97.3,545
Hep B,≥2 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,96.1,92.6 to 98.0,259
Hep B,≥2 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,95.5,91.9 to 97.5,243
Hep B,≥2 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,95.5,93.0 to 97.2,225
Hep B,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,93.3,90.5 to 95.3,476
Hep B,≥2 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,97.3,95.9 to 98.2,232
PCV,≥3 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,92.8,87.7 to 96.0,266
PCV,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,91.4,88.1 to 93.9,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,89.9,84.9 to 93.4,279
PCV,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,92.0,88.9 to 94.2,538
Hep B,≥3 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,95.4,91.6 to 97.8,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,96.1,91.4 to 98.6,238
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,95.3,91.9 to 97.5,461
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,90.9,85.2 to 95.1,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,93.8,90.2 to 96.4,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,95.5,90.8 to 98.2,225
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,93.1,89.5 to 95.9,476
PCV,≥3 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,91.3,84.4 to 95.3,223
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,92.1,88.1 to 94.8,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2014,Age,35 Months,96.2,91.5 to 98.7,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2015,Age,35 Months,96.1,92.9 to 98.1,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2015,Age,35 Months,96.2,91.7 to 98.6,238
≥1 Dose MMR,,States/Local Areas,Nebraska,2015-2016,Age,35 Months,95.1,91.8 to 97.4,461
PCV,≥4 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,87.4,82.1 to 91.7,266
PCV,≥4 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,87.4,83.8 to 90.5,545
PCV,≥4 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,84.5,77.1 to 90.6,223
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,85.9,81.5 to 89.8,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,86.7,81.2 to 91.3,238
PCV,≥4 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,85.6,81.1 to 89.5,461
≥1 Dose MMR,,States/Local Areas,Nebraska,2016,Age,35 Months,94.1,88.9 to 97.4,223
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2017,Age,35 Months,94.3,91.3 to 96.6,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019,Age,35 Months,94.6,90.5 to 97.3,259
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,90.0,85.1 to 94.9,284
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,95.6,93.5 to 97.7,527
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,85.1,80.7 to 89.6,393
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,77.2,70.9 to 83.6,236
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,80.2,74.4 to 86.1,259
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Overall,Overall,84.2,81.2 to 87.2,850
≥1 Dose Varicella,,States/Local Areas,Nebraska,2011,Age,13 Months,65.8,63.3 to 68.2,243
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,81.1,73.8 to 87.3,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,83.7,79.2 to 87.7,489
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,81.8,74.3 to 88.2,223
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,84.6,80.0 to 88.6,489
DTaP,≥4 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,86.3,80.8 to 90.9,238
DTaP,≥4 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,84.1,79.5 to 88.1,461
Polio,≥2 Doses,States/Local Areas,Nebraska,2015,Age,5 Months,85.5,79.5 to 90.0,238
Polio,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,5 Months,84.8,80.4 to 88.4,461
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,74.8,67.1 to 81.2,223
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,74.3,69.2 to 78.8,489
Hep A,≥2 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,57.2,49.4 to 65.3,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,82.8,74.1 to 90.0,243
Hep A,≥2 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,82.5,74.6 to 89.1,232
Hep A,≥2 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,85.5,76.5 to 92.4,225
Hep A,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,80.0,73.8 to 85.6,476
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016,Age,35 Months,88.8,82.6 to 93.6,223
Hep A,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,35 Months,91.6,88.0 to 94.5,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2016,Age,5 Months,84.2,77.2 to 89.3,223
Polio,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,5 Months,84.7,80.1 to 88.3,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2017,Age,5 Months,85.2,78.6 to 90.0,266
Polio,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,5 Months,84.5,80.2 to 88.1,545
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,68.6,60.6 to 75.7,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,71.4,66.1 to 76.3,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,74.3,67.0 to 80.4,238
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,74.5,69.4 to 79.1,461
Polio,≥2 Doses,States/Local Areas,Nebraska,2019,Age,5 Months,88.6,83.1 to 92.5,259
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,93.0,89.0 to 97.0,168
Polio,≥2 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,94.9,93.1 to 96.2,232
Polio,≥2 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,93.2,86.2 to 96.8,243
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,73.7,66.8 to 79.7,266
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,73.1,68.2 to 77.5,545
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,72.5,65.4 to 78.6,279
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,76.2,71.4 to 80.4,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,73.1,63.7 to 81.8,223
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,78.3,72.3 to 83.8,489
Hep A,≥2 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,82.8,75.5 to 89.0,238
Hep A,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,78.2,72.3 to 83.6,461
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019,Age,7 Months,80.0,73.4 to 85.3,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,74.9,66.2 to 82.9,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,78.9,73.3 to 84.1,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014,Age,13 Months,69.4,61.7 to 76.2,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2015,Age,13 Months,73.8,68.7 to 78.4,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2012,Age,13 Months,72.5,69.0 to 75.8,232
Hep A,≥1 Dose,States/Local Areas,Nebraska,2019,Age,35 Months,92.2,86.6 to 96.1,259
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,83.1,77.4 to 88.7,284
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,89.8,86.9 to 92.8,527
Polio,≥2 Doses,States/Local Areas,Nebraska,2018,Age,5 Months,83.9,77.7 to 88.6,279
Polio,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,5 Months,86.2,82.2 to 89.5,538
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013,Age,13 Months,68.2,61.9 to 74.0,225
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013-2014,Age,13 Months,68.8,66.9 to 70.7,476
≥1 Dose MMR,,States/Local Areas,Nebraska,2014,Age,13 Months,70.9,63.1 to 77.7,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2015,Age,13 Months,74.8,69.7 to 79.3,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2015,Age,13 Months,78.7,71.9 to 84.2,238
≥1 Dose MMR,,States/Local Areas,Nebraska,2015-2016,Age,13 Months,77.0,72.0 to 81.3,461
≥1 Dose Varicella,,States/Local Areas,Nebraska,2019,Age,13 Months,78.5,71.8 to 84.0,259
≥1 Dose Varicella,,States/Local Areas,Nebraska,2011,Age,19 Months,91.5,87.3 to 94.4,243
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013,Age,19 Months,93.5,88.7 to 96.4,225
≥1 Dose Varicella,,States/Local Areas,Nebraska,2013-2014,Age,19 Months,90.5,85.9 to 93.7,476
≥1 Dose Varicella,,States/Local Areas,Nebraska,2012,Age,19 Months,90.1,87.5 to 92.3,232
PCV,≥4 Doses,States/Local Areas,Nebraska,2020,Age,35 Months,92.0,87.5 to 95.4,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2016,Age,13 Months,75.2,67.6 to 81.5,223
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2017,Age,13 Months,75.5,70.5 to 80.0,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018,Age,13 Months,75.1,68.1 to 81.0,279
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018-2019,Age,13 Months,76.8,72.0 to 80.9,538
DTaP,≥4 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,90.5,82.9 to 95.6,232
DTaP,≥4 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,95.2,90.0 to 98.2,238
DTaP,≥4 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,92.1,87.3 to 95.6,461
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,88.4,81.5 to 93.5,251
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,92.1,87.6 to 95.5,489
Hep A,≥2 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,77.1,68.6 to 84.6,259
Hep B,≥3 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,83.5,80.9 to 85.8,232
DTaP,≥4 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,93.3,86.9 to 97.3,225
DTaP,≥4 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,90.7,86.1 to 94.2,476
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,86.9,80.0 to 91.6,225
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,85.7,82.0 to 88.8,476
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,84.5,76.7 to 90.1,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,86.9,82.1 to 90.5,489
Hep A,≥2 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,81.0,74.1 to 87.0,279
Hep A,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,79.0,73.6 to 84.0,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,82.7,75.3 to 88.9,266
Hep A,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,82.7,77.3 to 87.4,545
DTaP,≥4 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,85.8,80.2 to 90.5,259
DTaP,≥4 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,90.9,84.0 to 95.6,243
DTaP,≥4 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,85.0,79.3 to 89.9,279
DTaP,≥4 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,85.4,81.5 to 88.9,538
DTaP,≥4 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,87.3,82.1 to 91.6,266
DTaP,≥4 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,86.2,82.5 to 89.5,545
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016,Age,13 Months,75.1,67.2 to 81.5,223
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2017,Age,13 Months,75.7,70.6 to 80.2,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017,Age,13 Months,76.4,69.5 to 82.1,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017-2018,Age,13 Months,75.7,71.0 to 79.9,545
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015,Age,13 Months,78.2,71.4 to 83.8,238
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015-2016,Age,13 Months,76.7,71.6 to 81.0,461
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,80.7 to 97.2,80
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,90.3,86.6 to 94.1,435
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.3,82.8 to 89.7,580
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,76.3,70.3 to 82.4,259
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.1,83.1 to 95.0,156
Polio,≥2 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,86.9,79.2 to 92.0,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,89.5,85.0 to 92.8,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,91.8,88.1 to 94.4,225
Polio,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,89.3,85.6 to 92.1,476
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,84.1,78.5 to 89.7,236
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Overall,Overall,86.8,84.0 to 89.6,850
Polio,≥2 Doses,States/Local Areas,Nebraska,2015,Age,7 Months,92.2,86.9 to 95.5,238
Polio,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,7 Months,92.3,88.7 to 94.9,461
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,85.9,81.6 to 90.3,393
Hep B,≥3 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,82.1,72.9 to 88.7,243
≥1 Dose MMR,,States/Local Areas,Nebraska,2017,Age,13 Months,75.8,68.9 to 81.6,266
≥1 Dose MMR,,States/Local Areas,Nebraska,2017-2018,Age,13 Months,75.2,70.4 to 79.5,545
≥1 Dose MMR,,States/Local Areas,Nebraska,2018,Age,13 Months,74.6,67.6 to 80.6,279
≥1 Dose MMR,,States/Local Areas,Nebraska,2018-2019,Age,13 Months,76.9,72.2 to 81.1,538
≥1 Dose MMR,,States/Local Areas,Nebraska,2019,Age,13 Months,79.3,72.6 to 84.7,259
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014,Age,19 Months,87.5,80.3 to 92.3,251
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2015,Age,19 Months,89.4,85.2 to 92.5,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015,Age,19 Months,91.3,88.2 to 93.7,238
≥1 Dose Varicella,,States/Local Areas,Nebraska,2015-2016,Age,19 Months,89.9,85.8 to 92.9,461
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016,Age,19 Months,88.4,81.6 to 92.9,223
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2017,Age,19 Months,90.4,86.5 to 93.3,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2012,Age,13 Months,96.7,93.5 to 98.3,232
Polio,≥2 Doses,States/Local Areas,Nebraska,2011,Age,13 Months,96.0,90.1 to 98.5,243
Polio,≥2 Doses,States/Local Areas,Nebraska,2013,Age,13 Months,96.4,91.2 to 98.6,225
Polio,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,13 Months,93.9,89.7 to 96.5,476
Polio,≥2 Doses,States/Local Areas,Nebraska,2014,Age,13 Months,91.5,84.4 to 95.5,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,13 Months,93.4,89.5 to 96.0,489
Hep B,≥1 Dose,States/Local Areas,Nebraska,2015,Age,3 Months,97.6,94.1 to 99.1,238
Hep B,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,3 Months,97.4,95.1 to 98.7,461
Hep B,≥1 Dose,States/Local Areas,Nebraska,2016,Age,3 Months,97.2,93.1 to 98.9,223
Hep B,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,3 Months,98.1,96.0 to 99.1,489
Hep B,≥1 Dose,States/Local Areas,Nebraska,2017,Age,3 Months,99.1,96.8 to 99.7,266
Hep B,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,3 Months,99.0,97.8 to 99.5,545
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,76.4 to 99.9,80
≥1 Dose MMR,,States/Local Areas,Nebraska,2013,Age,13 Months,68.7,63.1 to 73.8,225
≥1 Dose MMR,,States/Local Areas,Nebraska,2013-2014,Age,13 Months,69.8,68.4 to 71.3,476
≥1 Dose MMR,,States/Local Areas,Nebraska,2012,Age,13 Months,68.5,63.8 to 72.8,232
≥1 Dose MMR,,States/Local Areas,Nebraska,2011,Age,13 Months,63.1,59.4 to 66.6,243
Hep A,≥1 Dose,States/Local Areas,Nebraska,2017,Age,35 Months,94.4,90.5 to 97.0,266
Hep A,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,35 Months,93.6,90.9 to 95.7,545
Hep A,≥1 Dose,States/Local Areas,Nebraska,2018,Age,35 Months,92.7,88.7 to 95.6,279
Hep A,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,35 Months,92.4,89.1 to 94.9,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,83.5,77.9 to 89.1,435
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.0,71.7 to 82.3,580
DTaP,≥4 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,91.7,87.3 to 95.0,266
DTaP,≥4 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,90.5,87.1 to 93.4,545
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,88.7,80.9 to 94.4,223
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,90.1,85.8 to 93.5,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,84.6,77.4 to 89.9,223
Hep B,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,87.0,82.7 to 90.3,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,89.2,83.3 to 93.1,238
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,86.9,82.5 to 90.4,461
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,89.3,84.6 to 92.8,266
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,87.7,84.1 to 90.6,545
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,85.3,78.2 to 92.5,168
Hep B,≥1 Dose,States/Local Areas,Nebraska,2013,Age,3 Months,95.4,92.8 to 97.1,225
Hep B,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,3 Months,94.9,93.2 to 96.2,476
Hep B,≥1 Dose,States/Local Areas,Nebraska,2012,Age,3 Months,96.5,94.1 to 98.0,232
Hep B,≥1 Dose,States/Local Areas,Nebraska,2011,Age,3 Months,95.2,90.5 to 97.6,243
Hep B,≥1 Dose,States/Local Areas,Nebraska,2014,Age,3 Months,94.4,90.2 to 96.9,251
Hep B,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,3 Months,96.0,93.6 to 97.6,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2016,Age,7 Months,92.5,86.6 to 95.9,223
Polio,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,7 Months,92.9,89.3 to 95.4,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2017,Age,7 Months,93.4,88.3 to 96.3,266
Polio,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,7 Months,92.8,89.7 to 95.0,545
Polio,≥2 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,92.2,87.9 to 95.0,279
Polio,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,93.7,91.0 to 95.6,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,75.9,67.6 to 84.1,284
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,81.6,76.2 to 86.9,527
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.4,83.0 to 89.9,580
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,72.5 to 92.3,80
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,81.1,75.4 to 86.9,259
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,84.4,81.4 to 87.4,850
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,85.6,81.5 to 89.6,435
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.1,78.3 to 92.0,156
≥1 Dose MMR,,States/Local Areas,Nebraska,2015,Age,19 Months,91.7,88.1 to 94.3,238
≥1 Dose MMR,,States/Local Areas,Nebraska,2015-2016,Age,19 Months,90.8,87.0 to 93.5,461
≥1 Dose MMR,,States/Local Areas,Nebraska,2016,Age,19 Months,89.8,83.6 to 93.8,223
≥1 Dose MMR,,States/Local Areas,Nebraska,2016-2017,Age,19 Months,92.3,88.8 to 94.8,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2017,Age,19 Months,94.9,90.7 to 97.3,266
≥1 Dose MMR,,States/Local Areas,Nebraska,2017-2018,Age,19 Months,93.9,91.2 to 95.8,545
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,78.7,72.5 to 84.9,236
≥1 Dose Varicella,,States/Local Areas,Nebraska,2011,Age,24 Months,93.6,89.2 to 96.6,243
≥1 Dose Varicella,,States/Local Areas,Nebraska,2012,Age,24 Months,91.8,87.1 to 95.3,232
Hep B,≥1 Dose,States/Local Areas,Nebraska,2018,Age,3 Months,98.8,97.3 to 99.5,279
Hep B,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,3 Months,97.7,95.8 to 98.8,538
Hep B,≥1 Dose,States/Local Areas,Nebraska,2019,Age,3 Months,96.6,92.5 to 98.5,259
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,78.3,71.9 to 84.7,393
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Nebraska,2011,Age,0-1 Days,82.4,77.0 to 86.7,243
Hep B,≥2 Doses,States/Local Areas,Nebraska,2012,Age,5 Months,89.3,86.5 to 91.6,232
Hep B,≥2 Doses,States/Local Areas,Nebraska,2011,Age,5 Months,91.8,87.7 to 94.6,243
Hep B,≥2 Doses,States/Local Areas,Nebraska,2013,Age,5 Months,87.3,85.2 to 89.2,225
Hep B,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,5 Months,86.3,84.2 to 88.1,476
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,92.6,88.6 to 95.2,225
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,90.8,88.0 to 93.0,476
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,85.7,78.7 to 92.6,221
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,89.1,82.3 to 93.5,251
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,91.5,87.5 to 94.4,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,93.9,90.1 to 96.3,238
Hep B,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,93.3,89.7 to 95.6,461
DTaP,≥4 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,89.6,84.4 to 93.6,259
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,78.9,73.0 to 84.8,284
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,88.8,85.7 to 92.0,527
≥1 Dose MMR,,States/Local Areas,Nebraska,2011,Age,19 Months,92.8,87.6 to 95.9,243
≥1 Dose MMR,,States/Local Areas,Nebraska,2013,Age,19 Months,94.5,91.1 to 96.7,225
≥1 Dose MMR,,States/Local Areas,Nebraska,2013-2014,Age,19 Months,92.1,88.3 to 94.8,476
≥1 Dose MMR,,States/Local Areas,Nebraska,2014,Age,19 Months,89.8,82.8 to 94.1,251
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2015,Age,19 Months,90.7,86.7 to 93.6,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2012,Age,19 Months,89.4,83.0 to 93.5,232
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017,Age,19 Months,92.5,87.7 to 95.5,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017-2018,Age,19 Months,92.6,89.6 to 94.8,545
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018,Age,19 Months,92.7,88.6 to 95.4,279
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018-2019,Age,19 Months,76.8,72.0 to 80.9,538
DTaP,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,81.7,75.0 to 88.3,168
Polio,≥2 Doses,States/Local Areas,Nebraska,2015,Age,13 Months,95.4,90.8 to 97.8,238
Polio,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,13 Months,94.9,91.7 to 97.0,461
Polio,≥2 Doses,States/Local Areas,Nebraska,2016,Age,13 Months,94.5,88.9 to 97.3,223
Polio,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,13 Months,95.9,92.8 to 97.6,489
Polio,≥2 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,97.3,93.7 to 98.9,266
Polio,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,96.2,93.9 to 97.7,545
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016,Age,35 Months,92.4,86.4 to 96.4,223
≥1 Dose Varicella,,States/Local Areas,Nebraska,2016-2017,Age,35 Months,93.5,90.1 to 96.0,489
≥1 Dose MMR,,States/Local Areas,Nebraska,2013,Age,35 Months,96.0,92.0 to 98.4,225
≥1 Dose MMR,,States/Local Areas,Nebraska,2013-2014,Age,35 Months,95.9,92.7 to 97.9,476
≥1 Dose MMR,,States/Local Areas,Nebraska,2011,Age,35 Months,95.3,91.0 to 97.9,243
≥1 Dose MMR,,States/Local Areas,Nebraska,2012,Age,35 Months,94.5,89.0 to 97.8,232
≥1 Dose MMR,,States/Local Areas,Nebraska,2019,Age,24 Months,92.6,88.4 to 95.7,259
PCV,≥4 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,82.5,75.2 to 88.6,251
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,84.6,80.1 to 88.5,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,89.6,84.4 to 93.7,225
PCV,≥4 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,85.9,81.4 to 89.8,476
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,94.7,90.8 to 97.3,259
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,96.8,93.8 to 98.6,266
Hep B,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,95.0,92.6 to 96.8,545
Hep B,≥3 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,93.6,88.8 to 96.9,243
PCV,≥4 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,82.4,75.6 to 88.2,232
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017,Age,35 Months,94.5,90.6 to 97.2,266
≥1 Dose Varicella,,States/Local Areas,Nebraska,2017-2018,Age,35 Months,95.0,92.5 to 97.0,545
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2017,Age,0-2 Days,81.0,74.0 to 86.4,266
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2017-2018,Age,0-2 Days,84.7,80.4 to 88.2,545
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2018,Age,0-2 Days,88.5,83.1 to 92.4,279
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2018-2019,Age,0-2 Days,86.3,82.2 to 89.6,538
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Nebraska,2019,Age,0-2 Days,84.0,77.4 to 88.9,259
Hep B,≥2 Doses,States/Local Areas,Nebraska,2018,Age,7 Months,93.5,89.4 to 96.1,279
Hep B,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,7 Months,94.8,92.3 to 96.5,538
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018,Age,35 Months,97.4,93.1 to 99.3,279
≥1 Dose Varicella,,States/Local Areas,Nebraska,2018-2019,Age,35 Months,95.9,92.9 to 97.9,538
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,93.0,88.7 to 97.3,168
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,92.4,89.1 to 95.7,435
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.2,91.7 to 96.7,580
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,83.9 to 98.7,80
≥1 Dose MMR,,States/Local Areas,Nebraska,2019,Age,35 Months,95.1,90.7 to 97.9,259
PCV,≥4 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,89.6,84.4 to 93.7,225
PCV,≥4 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,88.1,83.7 to 91.8,476
≥1 Dose MMR,,States/Local Areas,Nebraska,2018,Age,35 Months,96.4,92.7 to 98.6,279
≥1 Dose MMR,,States/Local Areas,Nebraska,2018-2019,Age,35 Months,96.6,93.2 to 98.5,538
≥1 Dose MMR,,States/Local Areas,Nebraska,2017,Age,35 Months,94.9,91.2 to 97.5,266
≥1 Dose MMR,,States/Local Areas,Nebraska,2017-2018,Age,35 Months,95.5,93.0 to 97.3,545
Hib,≥1 Dose,States/Local Areas,Nebraska,2015,Age,3 Months,91.4,85.9 to 94.8,238
Hib,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,3 Months,89.2,85.0 to 92.4,461
Hib,≥1 Dose,States/Local Areas,Nebraska,2016,Age,3 Months,87.1,80.0 to 91.9,223
Hib,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,3 Months,90.7,86.6 to 93.7,489
Hib,≥1 Dose,States/Local Areas,Nebraska,2017,Age,3 Months,94.4,90.7 to 96.7,266
Hib,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,3 Months,90.4,87.0 to 93.0,545
Hep B,≥2 Doses,States/Local Areas,Nebraska,2017,Age,13 Months,97.7,94.5 to 99.0,266
Hep B,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,13 Months,96.1,93.7 to 97.6,545
Hep B,≥2 Doses,States/Local Areas,Nebraska,2018,Age,13 Months,94.5,90.3 to 96.9,279
Hep B,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,13 Months,95.5,93.0 to 97.2,538
Hep B,≥2 Doses,States/Local Areas,Nebraska,2019,Age,13 Months,96.6,93.2 to 98.4,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,93.6,88.9 to 96.4,238
PCV,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,93.7,90.3 to 96.0,461
PCV,≥3 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,93.9,88.1 to 97.0,223
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,94.9,91.7 to 96.9,489
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,90.1,85.3 to 95.0,236
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Overall,Overall,92.8,90.5 to 95.1,850
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,91.7,87.5 to 95.9,259
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.2,90.7 to 99.6,156
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,91.7,87.4 to 96.0,221
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,93.5,90.2 to 96.7,393
Hib,≥1 Dose,States/Local Areas,Nebraska,2018,Age,3 Months,86.3,80.4 to 90.6,279
Hib,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,3 Months,87.9,84.0 to 91.0,538
Hib,≥1 Dose,States/Local Areas,Nebraska,2019,Age,3 Months,89.6,83.7 to 93.5,259
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.0,88.7 to 99.4,80
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,95.3,92.0 to 98.7,168
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,96.2,94.2 to 98.1,527
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,92.6,88.1 to 97.1,284
PCV,≥4 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,90.1,82.4 to 95.4,223
PCV,≥4 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,89.8,85.5 to 93.2,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,88.7,83.2 to 93.1,238
PCV,≥4 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,89.5,84.9 to 93.2,461
PCV,≥4 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,86.4,79.3 to 92.0,251
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,87.5,83.1 to 91.2,489
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,94.0,90.0 to 96.8,279
Hep B,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,94.6,92.0 to 96.6,538
Hep B,≥3 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,95.3,91.5 to 97.7,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,94.3,90.0 to 97.2,238
PCV,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,94.3,91.1 to 96.6,461
PCV,≥3 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,88.8,82.0 to 93.9,251
PCV,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,91.6,87.7 to 94.7,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,95.7,91.9 to 98.1,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2020,Age,24 Months,96.6,93.2 to 98.5,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2017,Age,5 Months,84.0,77.5 to 88.9,266
Hib,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,5 Months,81.2,76.6 to 85.0,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,95.2,91.1 to 97.8,225
PCV,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,92.0,88.1 to 95.0,476
≥1 Dose Varicella,,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,95.0,91.4 to 98.5,221
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.7,94.5 to 100.0,156
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,92.6,89.4 to 95.8,435
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.6,92.2 to 97.0,580
Hib,≥2 Doses,States/Local Areas,Nebraska,2015,Age,5 Months,86.2,80.3 to 90.6,238
Hib,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,5 Months,83.8,79.1 to 87.6,461
Hib,≥2 Doses,States/Local Areas,Nebraska,2016,Age,5 Months,81.3,73.7 to 87.1,223
Hib,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,5 Months,82.6,77.7 to 86.7,489
PCV,≥4 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,89.6,84.9 to 93.4,266
PCV,≥4 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,89.8,86.4 to 92.6,545
PCV,≥4 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,90.3,85.2 to 94.1,279
PCV,≥4 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,90.5,87.1 to 93.3,538
PCV,≥4 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,90.8,86.1 to 94.4,259
Hib,Full Series,States/Local Areas,Nebraska,2020,Age,24 Months,70.2,62.1 to 77.9,251
PCV,≥1 Dose,States/Local Areas,Nebraska,2011,Age,3 Months,89.6,83.2 to 93.8,243
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,96.5,93.6 to 99.3,221
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,93.9,90.6 to 97.1,393
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,93.7,90.1 to 97.3,259
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,91.9,87.5 to 96.3,236
≥1 Dose MMR,,States/Local Areas,Nebraska,2014-2017,Overall,Overall,93.9,91.8 to 96.0,850
PCV,≥1 Dose,States/Local Areas,Nebraska,2012,Age,3 Months,89.3,86.7 to 91.4,232
PCV,≥3 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,93.0,88.7 to 95.8,279
PCV,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,92.0,88.9 to 94.2,538
PCV,≥3 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,96.3,93.2 to 98.0,259
PCV,≥3 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,95.7,91.8 to 98.1,243
Hib,≥2 Doses,States/Local Areas,Nebraska,2013,Age,5 Months,83.1,79.0 to 86.5,225
Hib,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,5 Months,79.7,77.7 to 81.6,476
Hib,≥2 Doses,States/Local Areas,Nebraska,2014,Age,5 Months,76.4,68.7 to 82.8,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,5 Months,81.3,78.2 to 84.1,489
PCV,≥3 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,95.9,92.0 to 98.0,266
PCV,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,94.5,91.8 to 96.3,545
Hib,≥2 Doses,States/Local Areas,Nebraska,2012,Age,5 Months,80.8,79.5 to 82.0,232
Hib,≥2 Doses,States/Local Areas,Nebraska,2011,Age,5 Months,85.4,81.5 to 88.6,243
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,91.9,87.5 to 96.3,221
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,88.3,84.2 to 92.4,393
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,76.1,69.7 to 82.6,236
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,82.4,77.0 to 87.9,259
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,85.5,82.6 to 88.5,850
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.1,81.3 to 94.8,156
Hib,≥2 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,92.4,88.9 to 94.8,225
Hib,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,89.3,84.8 to 92.6,476
Hib,≥2 Doses,States/Local Areas,Nebraska,2014,Age,7 Months,86.3,78.6 to 91.5,251
Hib,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,7 Months,89.6,85.1 to 92.9,489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2012,Age,0-3 Days,75.8,67.6 to 82.5,232
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,86.0,82.0 to 90.1,435
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Nebraska,2011,Age,0-3 Days,85.3,79.1 to 89.9,243
PCV,≥1 Dose,States/Local Areas,Nebraska,2018,Age,3 Months,91.5,86.6 to 94.7,279
PCV,≥1 Dose,States/Local Areas,Nebraska,2018-2019,Age,3 Months,93.2,90.2 to 95.4,538
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,91.3,86.6 to 96.0,284
Hep B,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,95.3,93.1 to 97.4,527
PCV,≥1 Dose,States/Local Areas,Nebraska,2016,Age,3 Months,89.9,83.7 to 93.9,223
PCV,≥1 Dose,States/Local Areas,Nebraska,2016-2017,Age,3 Months,92.5,89.0 to 94.9,489
PCV,≥1 Dose,States/Local Areas,Nebraska,2017,Age,3 Months,95.2,91.3 to 97.4,266
PCV,≥1 Dose,States/Local Areas,Nebraska,2017-2018,Age,3 Months,93.4,90.5 to 95.4,545
Hib,≥2 Doses,States/Local Areas,Nebraska,2018,Age,5 Months,78.2,71.3 to 83.9,279
Hib,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,5 Months,80.0,75.3 to 84.0,538
Hib,≥2 Doses,States/Local Areas,Nebraska,2019,Age,5 Months,81.8,75.1 to 87.0,259
Hib,≥2 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,93.0,86.5 to 96.5,243
PCV,≥3 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,94.1,89.0 to 97.4,223
PCV,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,95.0,92.1 to 97.1,489
Hib,≥2 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,95.3,92.8 to 96.9,232
PCV,≥3 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,95.9,92.5 to 98.1,266
PCV,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,94.9,92.4 to 96.7,545
PCV,≥3 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,93.8,90.0 to 96.6,279
PCV,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,95.0,92.7 to 96.8,538
PCV,≥1 Dose,States/Local Areas,Nebraska,2013,Age,3 Months,89.0,85.9 to 91.4,225
PCV,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,3 Months,87.0,85.3 to 88.5,476
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,83.7,77.4 to 90.0,168
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,79.3,73.4 to 85.2,284
PCV,≥4 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,91.0,88.1 to 94.0,527
Polio,≥3 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,96.9,93.4 to 98.8,259
Hib,Primary Series,States/Local Areas,Nebraska,2020,Age,24 Months,95.1,91.5 to 97.6,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,61.2,53.8 to 68.6,279
Hep A,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,59.3,53.9 to 64.8,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,58.4,51.1 to 65.8,266
Hep A,≥2 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,59.7,54.6 to 64.9,545
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,51.4,43.4 to 60.0,223
Hep A,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,55.0,49.5 to 60.6,489
DTaP,≥4 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,88.4,82.7 to 92.9,225
DTaP,≥4 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,84.7,80.1 to 88.7,476
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.7,80.1 to 93.2,156
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,85.0,80.8 to 89.1,435
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,82.7 to 89.7,580
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.8,70.8 to 90.9,80
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,83.6,77.2 to 90.0,168
Hep A,≥1 Dose,States/Local Areas,Nebraska,2015,Age,35 Months,91.3,85.4 to 95.5,238
Hep A,≥1 Dose,States/Local Areas,Nebraska,2015-2016,Age,35 Months,90.0,85.8 to 93.4,461
Polio,≥2 Doses,States/Local Areas,Nebraska,2012,Age,5 Months,80.3,78.1 to 82.4,232
Polio,≥2 Doses,States/Local Areas,Nebraska,2011,Age,5 Months,85.9,81.3 to 89.5,243
Hep A,≥1 Dose,States/Local Areas,Nebraska,2012,Age,35 Months,89.9,85.0 to 93.8,232
Polio,≥2 Doses,States/Local Areas,Nebraska,2013,Age,5 Months,82.7,78.4 to 86.3,225
Polio,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,5 Months,80.4,77.3 to 83.1,476
Polio,≥2 Doses,States/Local Areas,Nebraska,2014,Age,5 Months,78.1,70.3 to 84.3,251
Polio,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,5 Months,81.8,80.0 to 83.5,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,<133% FPL,92.3,88.1 to 96.5,236
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,97.8,95.7 to 99.8,221
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Poverty,133% to <400% FPL,95.3,92.5 to 98.2,393
Hep B,≥3 Doses,States/Local Areas,Nebraska,2012,Age,7 Months,54.9,49.9 to 59.7,232
Hep B,≥3 Doses,States/Local Areas,Nebraska,2011,Age,7 Months,49.3,42.3 to 56.2,243
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013,Age,7 Months,69.0,66.9 to 71.1,225
Hep B,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,7 Months,68.8,66.3 to 71.2,476
DTaP,≥4 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,78.2,71.2 to 83.9,259
DTaP,≥4 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,85.6,78.6 to 91.3,243
DTaP,≥4 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,82.6,75.6 to 88.6,232
Hep A,≥1 Dose,States/Local Areas,Nebraska,2013,Age,35 Months,94.3,89.4 to 97.4,225
Hep A,≥1 Dose,States/Local Areas,Nebraska,2013-2014,Age,35 Months,92.0,88.0 to 95.1,476
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014,Age,35 Months,90.0,83.4 to 94.8,251
Hep A,≥1 Dose,States/Local Areas,Nebraska,2014-2015,Age,35 Months,90.5,86.2 to 93.9,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Overall,Overall,95.1,93.2 to 97.0,850
Hep A,≥2 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,61.3,53.6 to 69.0,238
Hep A,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,56.5,50.8 to 62.4,461
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,50.9,43.2 to 59.1,251
Hep A,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,56.1,50.6 to 61.7,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2019,Age,35 Months,96.6,93.7 to 98.3,259
PCV,≥2 Doses,States/Local Areas,Nebraska,2018,Age,5 Months,83.3,77.0 to 88.2,279
PCV,≥2 Doses,States/Local Areas,Nebraska,2018-2019,Age,5 Months,85.7,81.6 to 89.0,538
PCV,≥2 Doses,States/Local Areas,Nebraska,2019,Age,5 Months,88.1,82.5 to 92.1,259
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,94.6,91.7 to 97.5,435
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.1,94.0 to 98.2,580
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a Non-MSA,93.9,90.6 to 97.2,259
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,98.0,95.3 to 100.0,156
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.3,90.5 to 100.0,80
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,95.4,92.1 to 98.7,168
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,75.3,67.2 to 82.0,223
DTaP,≥4 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,75.7,70.6 to 80.2,489
DTaP,≥4 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,76.2,69.6 to 81.8,266
DTaP,≥4 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,76.0,71.3 to 80.2,545
DTaP,≥4 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,75.8,69.2 to 81.4,279
DTaP,≥4 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,95.9,93.7 to 97.3,538
Hep A,≥2 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,60.1,52.2 to 68.1,225
Hep A,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,55.4,49.8 to 61.2,476
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.3,94.3 to 100.0,156
Hib,Primary Series,States/Local Areas,Nebraska,2012,Age,7 Months,78.9,75.0 to 82.3,232
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Poverty,>400% FPL,91.2,86.7 to 95.6,221
Hib,Primary Series,States/Local Areas,Nebraska,2011,Age,7 Months,76.5,71.1 to 81.1,243
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Urbanicity,Living In a MSA Principal City,93.6,90.6 to 96.6,435
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.8,92.4 to 97.1,580
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,89.7 to 99.6,80
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Race and Ethnicity,Hispanic,95.1,91.7 to 98.5,168
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,77.4,71.4 to 83.5,284
Hib,Full Series,States/Local Areas,Nebraska,2019,Age,24 Months,76.4,69.2 to 82.9,259
Hib,Full Series,States/Local Areas,Nebraska,2018,Age,35 Months,83.0,76.7 to 88.4,279
Hib,Full Series,States/Local Areas,Nebraska,2018-2019,Age,35 Months,80.3,75.6 to 84.5,538
Hib,Full Series,States/Local Areas,Nebraska,2019,Age,35 Months,77.1,70.0 to 83.5,259
Hib,Full Series,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,89.4,86.4 to 92.5,527
Hib,Full Series,States/Local Areas,Nebraska,2014,Age,35 Months,85.2,78.0 to 91.1,251
Hib,Full Series,States/Local Areas,Nebraska,2014-2015,Age,35 Months,86.2,81.7 to 90.1,489
Hib,Full Series,States/Local Areas,Nebraska,2015,Age,35 Months,87.1,81.4 to 91.7,238
Hib,Full Series,States/Local Areas,Nebraska,2015-2016,Age,35 Months,88.2,83.6 to 91.9,461
Hib,Full Series,States/Local Areas,Nebraska,2016,Age,35 Months,88.6,81.3 to 94.0,223
Hib,Full Series,States/Local Areas,Nebraska,2016-2017,Age,35 Months,89.3,85.1 to 92.7,489
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Any Medicaid,92.0,87.5 to 96.4,284
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2017,Insurance Coverage,Private Insurance Only,96.0,94.0 to 97.9,527
DTaP,≥2 Doses,States/Local Areas,Nebraska,2013,Age,5 Months,83.5,79.5 to 87.0,225
DTaP,≥2 Doses,States/Local Areas,Nebraska,2013-2014,Age,5 Months,81.0,78.1 to 83.5,476
DTaP,≥2 Doses,States/Local Areas,Nebraska,2012,Age,5 Months,81.0,79.5 to 82.4,232
DTaP,≥2 Doses,States/Local Areas,Nebraska,2011,Age,5 Months,85.6,80.1 to 89.8,243
Polio,≥3 Doses,States/Local Areas,Nebraska,2018,Age,35 Months,94.9,90.8 to 97.6,279
Polio,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,35 Months,96.0,93.4 to 97.8,538
Hib,Full Series,States/Local Areas,Nebraska,2017,Age,35 Months,90.0,85.4 to 93.7,266
Hib,Full Series,States/Local Areas,Nebraska,2017-2018,Age,35 Months,86.5,82.6 to 89.9,545
Hib,Full Series,States/Local Areas,Nebraska,2013,Age,35 Months,90.0,85.0 to 93.9,225
Hib,Full Series,States/Local Areas,Nebraska,2013-2014,Age,35 Months,87.7,83.2 to 91.4,476
Hib,Full Series,States/Local Areas,Nebraska,2011,Age,35 Months,90.9,84.5 to 95.4,243
Hib,Full Series,States/Local Areas,Nebraska,2012,Age,35 Months,87.9,81.2 to 93.0,232
Polio,≥3 Doses,States/Local Areas,Nebraska,2014,Age,35 Months,95.3,90.0 to 98.3,251
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,35 Months,95.3,92.0 to 97.5,489
Polio,≥3 Doses,States/Local Areas,Nebraska,2013,Age,35 Months,97.5,93.5 to 99.3,225
Polio,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,35 Months,96.4,93.2 to 98.4,476
Polio,≥3 Doses,States/Local Areas,Nebraska,2012,Age,35 Months,96.5,92.8 to 98.6,232
Polio,≥3 Doses,States/Local Areas,Nebraska,2015,Age,35 Months,95.5,91.3 to 98.0,238
Polio,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,35 Months,95.0,91.8 to 97.3,461
DTaP,≥2 Doses,States/Local Areas,Nebraska,2014,Age,5 Months,78.4,70.7 to 84.6,251
DTaP,≥2 Doses,States/Local Areas,Nebraska,2014-2015,Age,5 Months,82.8,80.7 to 84.8,489
Polio,≥3 Doses,States/Local Areas,Nebraska,2011,Age,35 Months,95.7,91.8 to 98.1,243
DTaP,≥2 Doses,States/Local Areas,Nebraska,2016,Age,5 Months,84.3,77.3 to 89.4,223
DTaP,≥2 Doses,States/Local Areas,Nebraska,2016-2017,Age,5 Months,84.9,80.3 to 88.5,489
DTaP,≥2 Doses,States/Local Areas,Nebraska,2015,Age,5 Months,87.2,81.4 to 91.4,238
DTaP,≥2 Doses,States/Local Areas,Nebraska,2015-2016,Age,5 Months,85.8,81.4 to 89.2,461
Polio,≥3 Doses,States/Local Areas,Nebraska,2017,Age,35 Months,97.7,94.8 to 99.2,266
Polio,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,35 Months,96.3,93.9 to 97.9,545
Polio,≥3 Doses,States/Local Areas,Nebraska,2016,Age,35 Months,94.5,88.8 to 97.9,223
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,35 Months,96.1,93.2 to 98.0,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,95.4,91.3 to 98.0,225
Hib,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,92.0,88.1 to 95.1,476
Hib,≥3 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,95.7,92.1 to 98.0,232
Hib,≥3 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,96.0,92.2 to 98.3,243
Hib,≥3 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,88.8,82.0 to 93.8,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,92.1,88.2 to 95.0,489
Hib,Full Series,States/Local Areas,Nebraska,2016,Age,24 Months,85.5,78.7 to 91.1,223
Hib,Full Series,States/Local Areas,Nebraska,2016-2017,Age,24 Months,86.2,82.0 to 89.9,489
Hib,Full Series,States/Local Areas,Nebraska,2018,Age,24 Months,78.4,72.0 to 84.2,279
Hib,Full Series,States/Local Areas,Nebraska,2018-2019,Age,24 Months,77.4,72.6 to 81.8,538
Hib,Full Series,States/Local Areas,Nebraska,2017,Age,24 Months,86.9,81.6 to 91.3,266
Hib,Full Series,States/Local Areas,Nebraska,2017-2018,Age,24 Months,82.7,78.7 to 86.4,545
DTaP,≥3 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,96.7,93.0 to 98.7,232
Polio,≥3 Doses,States/Local Areas,Nebraska,2018,Age,24 Months,94.0,89.9 to 96.8,279
Polio,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,24 Months,94.6,92.2 to 96.5,538
Polio,≥3 Doses,States/Local Areas,Nebraska,2019,Age,24 Months,95.3,92.2 to 97.5,259
Hib,≥3 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,92.9,88.6 to 95.7,259
Polio,≥3 Doses,States/Local Areas,Nebraska,2017,Age,24 Months,96.8,93.6 to 98.6,266
Polio,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,24 Months,95.4,93.0 to 97.1,545
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,97.3,93.4 to 99.2,225
DTaP,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,94.4,90.8 to 97.0,476
Hib,Full Series,States/Local Areas,Nebraska,2015,Age,24 Months,85.2,79.3 to 90.1,238
Hib,Full Series,States/Local Areas,Nebraska,2015-2016,Age,24 Months,85.3,80.9 to 89.1,461
DTaP,≥3 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,96.3,92.4 to 98.5,243
DTaP,≥3 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,95.7,92.2 to 97.6,259
Polio,≥2 Doses,States/Local Areas,Nebraska,2020,Age,13 Months,97.9,95.7 to 99.0,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,93.7,89.5 to 96.3,279
DTaP,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,91.9,88.8 to 94.2,538
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,96.9,93.3 to 98.6,266
DTaP,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,95.3,92.8 to 97.0,545
Polio,≥3 Doses,States/Local Areas,Nebraska,2015,Age,24 Months,94.3,90.1 to 97.1,238
Polio,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,24 Months,94.0,90.8 to 96.3,461
Polio,≥3 Doses,States/Local Areas,Nebraska,2014,Age,24 Months,91.3,84.9 to 95.7,251
Polio,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,24 Months,92.8,89.1 to 95.6,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,89.1,81.7 to 93.8,251
DTaP,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,92.0,87.8 to 94.8,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,94.8,90.7 to 97.2,238
DTaP,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,94.4,91.0 to 96.6,461
Hib,≥3 Doses,States/Local Areas,Nebraska,2015,Age,19 Months,93.9,87.0 to 97.3,238
Hib,≥3 Doses,States/Local Areas,Nebraska,2015-2016,Age,19 Months,92.9,89.2 to 95.4,461
Hib,≥3 Doses,States/Local Areas,Nebraska,2018,Age,19 Months,91.8,87.4 to 94.8,279
Hib,≥3 Doses,States/Local Areas,Nebraska,2018-2019,Age,19 Months,72.2,67.1 to 76.8,538
Hib,≥3 Doses,States/Local Areas,Nebraska,2017,Age,19 Months,95.3,91.6 to 97.4,266
Hib,≥3 Doses,States/Local Areas,Nebraska,2017-2018,Age,19 Months,93.6,90.9 to 95.5,545
Polio,≥3 Doses,States/Local Areas,Nebraska,2016,Age,24 Months,93.5,88.4 to 96.9,223
Polio,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,24 Months,95.1,92.2 to 97.2,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,91.9,85.6 to 95.6,223
Hib,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,93.6,90.1 to 95.9,489
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016,Age,19 Months,93.9,88.1 to 97.0,223
DTaP,≥3 Doses,States/Local Areas,Nebraska,2016-2017,Age,19 Months,95.4,92.2 to 97.3,489
Polio,≥3 Doses,States/Local Areas,Nebraska,2019,Age,19 Months,95.3,91.8 to 97.4,259
Polio,≥3 Doses,States/Local Areas,Nebraska,2011,Age,24 Months,95.7,91.8 to 98.1,243
Polio,≥3 Doses,States/Local Areas,Nebraska,2012,Age,24 Months,95.1,91.2 to 97.7,232
Hib,≥3 Doses,States/Local Areas,Nebraska,2014,Age,19 Months,87.8,80.4 to 92.6,251
Hib,≥3 Doses,States/Local Areas,Nebraska,2014-2015,Age,19 Months,90.8,86.6 to 93.8,489
Hib,≥3 Doses,States/Local Areas,Nebraska,2013,Age,19 Months,94.5,86.9 to 97.8,225
Hib,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,19 Months,91.1,85.5 to 94.7,476
Polio,≥3 Doses,States/Local Areas,Nebraska,2013,Age,24 Months,96.9,93.1 to 98.9,225
Polio,≥3 Doses,States/Local Areas,Nebraska,2013-2014,Age,24 Months,94.1,90.5 to 96.7,476
≥1 Dose MMR,,States/Local Areas,Hawaii,2020-2021,Age,13 Months,70.0,63.6 to 75.7,353
Rotavirus,,States/Local Areas,Hawaii,2019-2020,Age,8 Months,76.7,71.4 to 81.3,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,86.5 to 95.1,287
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,90.2,85.1 to 95.3,175
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,89.5 to 95.5,426
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.5,71.0 to 81.9,426
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,78.6,70.9 to 86.4,175
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,86.6,80.5 to 92.7,175
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,88.0 to 95.7,287
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.2,85.0 to 95.5,176
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,61.4,49.3 to 73.6,175
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,87.2,82.1 to 92.4,287
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,81.4,75.3 to 87.5,287
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.1,85.6 to 92.6,426
Hep A,≥2 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,64.6,53.6 to 75.4,201
≥1 Dose MMR,,States/Local Areas,Hawaii,2020,Age,13 Months,63.3,54.3 to 71.5,201
Hep A,≥1 Dose,States/Local Areas,Hawaii,2015,Age,24 Months,89.4,84.3 to 93.4,240
Hep A,≥1 Dose,States/Local Areas,Hawaii,2015-2016,Age,24 Months,87.6,83.4 to 91.1,470
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,90.1,84.9 to 95.3,167
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.5,85.3 to 91.8,541
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.2,82.9 to 91.5,426
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,81.6,75.7 to 87.5,287
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.7,74.6 to 84.7,426
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,76.2,68.1 to 84.3,175
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,68.9,59.9 to 77.9,175
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.1,64.4 to 75.8,426
Influenza,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,68.9,62.4 to 75.5,287
Influenza,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,59.9,54.0 to 65.8,426
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,74.9,68.8 to 80.9,287
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.6,71.6 to 81.7,426
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,82.0,74.4 to 89.6,175
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,86.3,80.9 to 91.6,287
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.3,81.0 to 89.7,426
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,80.1,74.0 to 86.1,287
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.4,73.4 to 83.4,426
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,77.4,69.2 to 85.5,175
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.1,84.1 to 92.1,426
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,68.6,59.6 to 77.6,175
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,79.7,71.8 to 87.6,287
Influenza,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,48.6,38.7 to 58.5,175
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,89.9,85.5 to 94.3,287
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,88.4 to 94.8,426
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,87.9,82.2 to 93.6,175
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,74.4,68.0 to 80.8,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,85.3,80.5 to 90.1,287
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,87.8,83.8 to 91.8,379
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,95.4,92.9 to 97.8,328
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Overall,Overall,71.1,67.2 to 75.0,888
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.6,75.7 to 85.4,426
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,83.0,77.0 to 89.0,175
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,85.4,78.9 to 91.9,175
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Overall,Overall,78.7,75.2 to 82.2,888
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,87.8,83.8 to 91.8,379
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,91.7,88.3 to 95.1,328
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,87.2,81.6 to 92.9,181
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,57.9,49.0 to 66.7,181
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,72.2,66.4 to 78.0,379
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,89.8,86.1 to 93.6,379
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,95.5,93.2 to 97.9,328
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Overall,Overall,86.6,83.6 to 89.6,888
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,72.6,67.7 to 77.6,888
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,80.0,74.7 to 85.4,328
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,88.8,83.5 to 94.0,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Overall,Overall,82.5,79.4 to 85.5,888
Influenza,,States/Local Areas,Hawaii,2016-2019,Overall,Overall,60.2,56.0 to 64.3,888
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,88.7,83.4 to 94.1,181
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,87.3,83.0 to 91.5,379
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,72.9,65.0 to 80.8,379
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,77.8,70.2 to 85.5,328
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,81.5,74.4 to 88.7,181
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,82.9,77.8 to 88.0,379
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,79.4,75.9 to 82.9,888
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,89.6,87.2 to 92.1,888
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Overall,Overall,87.5,84.7 to 90.3,888
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,79.4,74.0 to 84.8,328
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Overall,Overall,84.9,81.8 to 88.1,888
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,90.3,88.0 to 92.7,888
Influenza,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,53.1,43.7 to 62.6,167
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,89.7,84.4 to 95.1,167
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,87.4,82.9 to 92.0,323
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,88.5,85.1 to 91.9,535
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.3,73.6 to 83.0,541
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,72.5,63.9 to 81.2,167
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,87.4,83.8 to 90.9,535
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,67.9,60.3 to 75.6,323
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,83.7 to 91.1,541
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,77.5,70.6 to 84.3,535
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,88.1,84.7 to 91.5,535
DTaP,≥1 Dose,States/Local Areas,Hawaii,2020,Age,3 Months,81.0,72.7 to 87.1,201
Polio,≥1 Dose,States/Local Areas,Hawaii,2020,Age,3 Months,80.2,72.0 to 86.4,201
Hep B,≥2 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,87.6,81.1 to 92.0,201
Hib,≥1 Dose,States/Local Areas,Hawaii,2020,Age,3 Months,83.3,75.5 to 88.9,201
PCV,≥3 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,68.0,58.9 to 75.8,201
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,62.4,53.6 to 70.5,201
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,88.4,84.6 to 91.6,447
Hib,Full Series,States/Local Areas,Hawaii,2019-2020,Age,24 Months,77.1,72.1 to 81.8,447
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2019-2020,Age,0-2 Days,82.4,78.0 to 86.1,447
Hep A,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,19 Months,80.7,75.8 to 84.8,447
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2019-2020,Age,0-1 Days,80.9,76.3 to 84.8,447
PCV,≥4 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,77.8,72.6 to 82.3,447
PCV,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,88.4,84.3 to 91.6,447
Hib,Full Series,States/Local Areas,Hawaii,2019-2020,Age,19 Months,72.9,67.5 to 77.7,447
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,88.0,84.0 to 91.1,447
Combined 7 Series,,States/Local Areas,Hawaii,2019-2020,Age,35 Months,74.7,69.3 to 79.9,447
Hib,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,87.9,83.7 to 91.1,447
Hib,Primary Series,States/Local Areas,Hawaii,2019-2020,Age,24 Months,90.5,86.7 to 93.5,447
Hib,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,87.5,83.3 to 91.1,447
Hep A,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,43.9,38.4 to 49.8,447
Influenza,,States/Local Areas,Hawaii,2019-2020,Age,24 Months,64.8,59.3 to 70.3,447
Hep A,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,35 Months,88.2,84.1 to 91.7,447
Hep A,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,68.8,61.8 to 75.6,447
Hep A,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,24 Months,85.8,81.6 to 89.4,447
Hib,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,58.0,52.3 to 63.5,447
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,65.3,59.7 to 70.5,447
DTaP,≥4 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,71.8,66.3 to 76.7,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,89.1,85.0 to 92.2,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,90.1 to 98.3,176
Influenza,,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,66.9,60.0 to 73.9,328
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,68.1,59.7 to 76.5,181
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Overall,Overall,74.4,70.8 to 78.0,888
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,90.9,87.3 to 94.5,328
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,64.8,56.2 to 73.3,181
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,78.4,73.0 to 83.8,379
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,90.3,86.6 to 93.9,328
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,88.4,82.8 to 93.9,181
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,78.4,74.8 to 82.0,888
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,82.9,75.8 to 89.9,181
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,80.2,74.9 to 85.5,379
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,88.7,84.6 to 92.8,328
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,82.0,74.2 to 89.7,181
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,86.1,81.6 to 90.6,379
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,91.0,87.6 to 94.4,328
Influenza,,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,53.0,44.1 to 61.8,181
Influenza,,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,59.4,53.2 to 65.6,379
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,89.3,86.8 to 91.7,888
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Overall,Overall,91.5,89.3 to 93.8,888
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,89.4,84.2 to 94.6,181
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,88.3,84.1 to 92.4,379
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,90.4,86.8 to 93.9,328
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,65.8,55.7 to 75.8,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,76.9,71.8 to 82.0,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,86.2,81.3 to 91.0,328
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,79.9,74.5 to 85.3,379
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Poverty,>400% FPL,87.7,83.5 to 91.9,328
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,86.1,80.9 to 91.4,287
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Poverty,133% to <400% FPL,75.6,70.3 to 80.9,379
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Poverty,<133% FPL,66.2,57.7 to 74.7,181
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,89.3,84.0 to 94.6,175
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Principal City,89.4,84.8 to 94.1,287
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.9,86.3 to 93.4,426
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a Non-MSA,86.1,80.2 to 92.0,175
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,73.0,66.6 to 79.4,323
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,83.7,79.7 to 87.7,535
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,88.4 to 94.3,541
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,90.2,85.0 to 95.4,167
DTaP,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.8,79.4 to 92.2,176
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,91.3,87.7 to 94.8,323
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,90.3,87.2 to 93.5,535
Hib,Full Series,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.6,78.1 to 91.1,176
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,83.0,75.6 to 90.4,167
Hep B,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,91.8,88.5 to 95.2,323
PCV,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.5,84.7 to 96.4,176
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,83.7,76.4 to 91.1,167
Influenza,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,63.4,58.1 to 68.7,535
Influenza,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",61.6,56.4 to 66.9,541
Influenza,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.7,56.6 to 74.9,176
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.8,71.0 to 86.6,176
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,88.4 to 97.4,176
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,77.5,69.7 to 85.3,167
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.0,69.3 to 78.6,541
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,74.7,66.4 to 83.0,167
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.9,65.9 to 75.9,541
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,70.2,61.5 to 78.9,167
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,69.8,63.6 to 76.0,323
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.8,64.1 to 81.5,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.9,83.6 to 90.1,541
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,80.1,72.0 to 88.2,167
Polio,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,88.4,82.6 to 94.1,167
PCV,≥4 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.2,75.7 to 84.8,541
Influenza,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,56.1,49.4 to 62.8,323
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,79.3,75.2 to 83.5,535
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,91.9,88.4 to 95.4,323
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,91.7,88.7 to 94.6,535
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,85.2,80.1 to 90.3,323
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,84.4 to 91.7,541
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,Hispanic,83.4,76.6 to 90.1,167
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,87.0,82.9 to 91.0,323
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.9,82.2 to 93.6,176
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Any Medicaid,66.8,60.2 to 73.4,323
Combined 7 Series,,States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,75.3,70.7 to 80.0,535
Rotavirus,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.9,69.3 to 84.4,176
≥1 Dose Varicella,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.0,80.9 to 93.2,176
≥1 Dose MMR,,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.6,85.6 to 95.7,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2016-2019,Insurance Coverage,Private Insurance Only,80.0,75.5 to 84.4,535
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.5,67.3 to 89.6,176
≥1 Dose MMR,,States/Local Areas,Hawaii,2020,Age,19 Months,80.3,72.2 to 86.5,201
Influenza,,States/Local Areas,Hawaii,2020,Age,24 Months,63.6,55.1 to 72.1,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2020,Age,0-3 Days,81.0,73.7 to 86.7,201
Rotavirus,,States/Local Areas,Hawaii,2020,Age,8 Months,73.3,64.6 to 80.5,201
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020,Age,24 Months,85.6,79.2 to 90.9,201
PCV,≥3 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,86.4,79.6 to 91.8,201
PCV,≥4 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,77.8,69.8 to 85.0,201
Hep A,≥2 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,38.1,30.4 to 47.1,201
Hep A,≥1 Dose,States/Local Areas,Hawaii,2020,Age,24 Months,82.3,75.4 to 88.2,201
Hep B,≥1 Dose,States/Local Areas,Hawaii,2020,Age,3 Months,92.7,88.3 to 95.6,201
PCV,≥1 Dose,States/Local Areas,Hawaii,2020,Age,3 Months,82.7,74.9 to 88.4,201
DTaP,≥2 Doses,States/Local Areas,Hawaii,2020,Age,5 Months,79.5,71.2 to 85.9,201
Polio,≥2 Doses,States/Local Areas,Hawaii,2020,Age,5 Months,77.9,69.5 to 84.5,201
Hib,≥2 Doses,States/Local Areas,Hawaii,2020,Age,5 Months,78.6,70.3 to 85.1,201
Combined 7 Series,,States/Local Areas,Hawaii,2020,Age,35 Months,74.0,65.5 to 81.7,201
Hep A,≥1 Dose,States/Local Areas,Hawaii,2020,Age,19 Months,79.3,71.4 to 85.5,201
Hep A,≥2 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,29.4,22.4 to 37.6,201
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2020,Age,0-2 Days,80.8,73.5 to 86.4,201
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2020,Age,0-1 Days,79.9,72.5 to 85.7,201
Polio,≥2 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,85.5,78.1 to 90.7,201
Hib,≥2 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,85.6,78.2 to 90.8,201
Hib,≥3 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,53.5,44.7 to 62.1,201
Hib,Primary Series,States/Local Areas,Hawaii,2020,Age,7 Months,73.5,65.0 to 80.6,201
DTaP,≥4 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,78.0,70.6 to 84.7,201
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,87.0,80.2 to 92.4,201
Polio,≥3 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,86.5,79.7 to 91.9,201
≥1 Dose MMR,,States/Local Areas,Hawaii,2020,Age,24 Months,84.9,78.2 to 90.5,201
Hib,≥3 Doses,States/Local Areas,Hawaii,2020,Age,24 Months,84.9,77.7 to 90.7,201
≥1 Dose MMR,,States/Local Areas,Hawaii,2020,Age,35 Months,88.7,82.0 to 93.8,201
Hib,≥3 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,88.6,81.5 to 93.9,201
Hib,Primary Series,States/Local Areas,Hawaii,2020,Age,35 Months,88.6,81.6 to 93.8,201
Hib,Full Series,States/Local Areas,Hawaii,2020,Age,35 Months,81.3,73.5 to 88.0,201
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,87.0,80.0 to 92.4,201
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020,Age,35 Months,88.3,81.7 to 93.3,201
Hib,Primary Series,States/Local Areas,Hawaii,2020,Age,19 Months,85.8,78.3 to 91.0,201
Hib,Full Series,States/Local Areas,Hawaii,2020,Age,19 Months,71.7,62.9 to 79.0,201
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020,Age,19 Months,82.4,74.5 to 88.2,201
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,84.9,77.6 to 90.1,201
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,90.2,83.0 to 95.2,201
DTaP,≥4 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,79.5,71.9 to 86.1,201
Polio,≥3 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,88.9,81.9 to 94.1,201
PCV,≥3 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,85.2,77.7 to 90.5,201
PCV,≥4 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,77.2,68.7 to 84.0,201
Hib,≥2 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,87.7,80.6 to 92.4,201
PCV,≥3 Doses,States/Local Areas,Hawaii,2020,Age,35 Months,88.8,81.8 to 94.1,201
Hib,Primary Series,States/Local Areas,Hawaii,2020,Age,13 Months,84.0,76.6 to 89.5,201
Hib,≥3 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,68.0,59.2 to 75.6,201
Hep B,≥2 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,88.8,82.6 to 93.0,201
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,84.3,77.0 to 89.6,201
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020,Age,13 Months,63.6,54.6 to 71.8,201
PCV,≥2 Doses,States/Local Areas,Hawaii,2020,Age,5 Months,78.5,70.2 to 85.0,201
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020,Age,7 Months,69.7,60.6 to 77.4,201
Hep B,≥2 Doses,States/Local Areas,Hawaii,2020,Age,5 Months,86.9,80.4 to 91.5,201
PCV,≥3 Doses,States/Local Areas,Hawaii,2020,Age,13 Months,85.2,77.7 to 90.5,201
DTaP,≥4 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,72.6,64.0 to 79.8,201
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,85.8,78.3 to 91.0,201
Polio,≥3 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,85.3,77.8 to 90.6,201
Combined 7 Series,,States/Local Areas,Hawaii,2020,Age,24 Months,70.2,62.0 to 78.0,201
Hib,≥3 Doses,States/Local Areas,Hawaii,2020,Age,19 Months,82.1,73.9 to 88.2,201
DTaP,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,3 Months,85.5,80.9 to 89.2,447
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Hawaii,2019-2020,Age,0-3 Days,83.2,78.8 to 86.8,447
Hep A,≥1 Dose,States/Local Areas,Hawaii,2018,Age,24 Months,84.4,77.9 to 89.8,268
Hep A,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,24 Months,86.7,82.8 to 90.2,514
Hep A,≥1 Dose,States/Local Areas,Hawaii,2019,Age,24 Months,89.0,84.3 to 92.8,246
Hep A,≥1 Dose,States/Local Areas,Hawaii,2011,Age,35 Months,81.2,73.7 to 87.7,244
PCV,≥2 Doses,States/Local Areas,Hawaii,2017,Age,5 Months,73.6,66.1 to 80.0,229
PCV,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,5 Months,79.4,74.5 to 83.5,497
Hep A,≥1 Dose,States/Local Areas,Hawaii,2012,Age,35 Months,91.2,86.2 to 95.0,270
DTaP,≥3 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,92.5,86.6 to 96.5,152
Hib,≥3 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,93.2,88.8 to 96.3,270
Hib,≥3 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,93.3,88.5 to 96.6,244
Hep A,≥1 Dose,States/Local Areas,Hawaii,2019,Age,19 Months,81.6,75.4 to 86.6,246
Hep A,≥1 Dose,States/Local Areas,Hawaii,2011,Age,24 Months,74.8,67.3 to 81.7,244
Hep A,≥1 Dose,States/Local Areas,Hawaii,2013,Age,24 Months,83.8,77.9 to 88.9,261
Hep A,≥1 Dose,States/Local Areas,Hawaii,2013-2014,Age,24 Months,82.8,78.5 to 86.6,509
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014,Age,24 Months,81.7,75.3 to 87.3,248
Hep A,≥1 Dose,States/Local Areas,Hawaii,2014-2015,Age,24 Months,85.5,81.4 to 89.1,488
Hep A,≥1 Dose,States/Local Areas,Hawaii,2012,Age,24 Months,86.5,81.2 to 90.9,270
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016,Age,24 Months,85.7,78.9 to 91.2,230
Hep A,≥1 Dose,States/Local Areas,Hawaii,2016-2017,Age,24 Months,86.4,82.1 to 90.1,459
PCV,≥2 Doses,States/Local Areas,Hawaii,2014,Age,5 Months,75.5,68.3 to 81.4,248
PCV,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,5 Months,76.8,73.0 to 80.2,488
PCV,≥2 Doses,States/Local Areas,Hawaii,2015,Age,5 Months,78.1,71.0 to 83.9,240
PCV,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,5 Months,73.3,68.0 to 78.0,470
PCV,≥2 Doses,States/Local Areas,Hawaii,2016,Age,5 Months,68.7,60.6 to 75.7,230
PCV,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,5 Months,71.0,65.5 to 75.9,459
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,93.8,90.0 to 96.5,268
DTaP,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,93.4,90.8 to 95.6,514
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019,Age,35 Months,93.0,89.0 to 95.9,246
Hep A,≥1 Dose,States/Local Areas,Hawaii,2017,Age,24 Months,87.5,81.8 to 92.1,229
Hep A,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,24 Months,86.0,81.8 to 89.6,497
DTaP,≥4 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,67.5,63.0 to 71.6,261
DTaP,≥4 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,71.0,65.4 to 76.0,509
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,74.5,67.5 to 80.5,248
DTaP,≥4 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,74.0,68.8 to 78.5,488
DTaP,≥4 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,73.4,67.4 to 78.7,240
DTaP,≥4 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,72.4,67.0 to 77.2,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Any Medicaid,90.3,86.3 to 94.3,293
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2017,Insurance Coverage,Private Insurance Only,92.2,89.4 to 95.1,522
Hep A,≥2 Doses,States/Local Areas,Hawaii,2018,Age,19 Months,31.0,23.9 to 39.2,268
Hep A,≥2 Doses,States/Local Areas,Hawaii,2018-2019,Age,19 Months,32.5,26.5 to 39.1,428
Hep A,≥2 Doses,States/Local Areas,Hawaii,2019,Age,19 Months,34.9,28.3 to 42.1,246
Hep A,≥2 Doses,States/Local Areas,Hawaii,2011,Age,24 Months,36.0,28.6 to 44.6,244
Hib,≥3 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,90.7,85.1 to 94.9,230
Hib,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,91.8,87.8 to 94.8,459
Hib,≥3 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,93.8,87.6 to 97.5,229
Hib,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,92.6,88.8 to 95.4,497
Hib,≥3 Doses,States/Local Areas,Hawaii,2018,Age,35 Months,91.8,86.9 to 95.3,268
Hib,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,35 Months,91.0,87.6 to 93.8,514
Hep A,≥2 Doses,States/Local Areas,Hawaii,2012,Age,24 Months,40.7,33.5 to 48.7,270
Hib,≥3 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,92.0,85.2 to 95.9,152
Hep A,≥1 Dose,States/Local Areas,Hawaii,2017,Age,19 Months,85.2,79.0 to 89.8,229
Hep A,≥1 Dose,States/Local Areas,Hawaii,2017-2018,Age,19 Months,83.0,78.5 to 86.7,497
Hep A,≥1 Dose,States/Local Areas,Hawaii,2018,Age,19 Months,80.8,73.8 to 86.4,268
Hep A,≥1 Dose,States/Local Areas,Hawaii,2018-2019,Age,19 Months,79.4,73.6 to 84.3,428
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,94.5,90.5 to 97.2,261
DTaP,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,94.1,91.1 to 96.4,509
DTaP,≥3 Doses,States/Local Areas,Hawaii,2012,Age,35 Months,96.1,92.7 to 98.2,270
DTaP,≥3 Doses,States/Local Areas,Hawaii,2011,Age,35 Months,92.4,87.1 to 96.1,244
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,93.8,88.8 to 97.1,248
DTaP,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,93.2,89.8 to 95.8,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,18.6,13.3 to 25.3,244
Hep A,≥2 Doses,States/Local Areas,Hawaii,2013,Age,19 Months,18.5,15.4 to 22.1,261
Hep A,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,19 Months,19.7,16.3 to 23.7,509
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014,Age,19 Months,20.9,15.6 to 27.5,248
Hep A,≥2 Doses,States/Local Areas,Hawaii,2014-2015,Age,19 Months,24.8,20.5 to 29.7,488
Hep A,≥2 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,21.3,17.6 to 25.7,270
Hib,≥3 Doses,States/Local Areas,Hawaii,2018,Age,24 Months,89.7,84.2 to 94.0,268
Hib,≥3 Doses,States/Local Areas,Hawaii,2018-2019,Age,24 Months,90.0,86.4 to 92.9,514
Hib,≥3 Doses,States/Local Areas,Hawaii,2019,Age,24 Months,90.2,85.4 to 93.9,246
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017,Age,35 Months,95.3,90.4 to 98.1,229
DTaP,≥3 Doses,States/Local Areas,Hawaii,2017-2018,Age,35 Months,94.5,91.6 to 96.6,497
DTaP,≥4 Doses,States/Local Areas,Hawaii,2011,Age,19 Months,68.0,61.1 to 74.3,244
DTaP,≥4 Doses,States/Local Areas,Hawaii,2012,Age,19 Months,73.6,64.7 to 80.9,270
PCV,≥2 Doses,States/Local Areas,Hawaii,2013,Age,5 Months,72.0,66.7 to 76.8,261
PCV,≥2 Doses,States/Local Areas,Hawaii,2013-2014,Age,5 Months,73.7,70.0 to 77.2,509
PCV,≥2 Doses,States/Local Areas,Hawaii,2012,Age,5 Months,72.5,69.1 to 75.8,270
PCV,≥2 Doses,States/Local Areas,Hawaii,2011,Age,5 Months,73.8,69.1 to 78.1,244
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,92.3,87.1 to 95.9,240
DTaP,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,92.8,89.5 to 95.4,470
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016,Age,35 Months,93.1,88.5 to 96.4,230
DTaP,≥3 Doses,States/Local Areas,Hawaii,2016-2017,Age,35 Months,94.2,90.8 to 96.6,459
Hep A,≥2 Doses,States/Local Areas,Hawaii,2015,Age,19 Months,28.7,23.6 to 34.3,240
Hep A,≥2 Doses,States/Local Areas,Hawaii,2015-2016,Age,19 Months,26.2,21.6 to 31.3,470
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016,Age,19 Months,23.8,17.8 to 30.9,230
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2017,Age,19 Months,27.5,22.9 to 32.7,459
Hib,≥3 Doses,States/Local Areas,Hawaii,2013,Age,35 Months,94.3,90.2 to 97.1,261
Hib,≥3 Doses,States/Local Areas,Hawaii,2013-2014,Age,35 Months,92.7,89.6 to 95.2,509
Hib,≥3 Doses,States/Local Areas,Hawaii,2014,Age,35 Months,91.4,86.2 to 95.2,248
Hib,≥3 Doses,States/Local Areas,Hawaii,2014-2015,Age,35 Months,91.7,87.5 to 95.0,488
Hib,≥3 Doses,States/Local Areas,Hawaii,2015,Age,35 Months,92.0,85.2 to 96.4,240
Hib,≥3 Doses,States/Local Areas,Hawaii,2015-2016,Age,35 Months,91.4,87.0 to 94.8,470
Hep A,≥2 Doses,States/Local Areas,Hawaii,2017,Age,19 Months,31.8,24.9 to 39.5,229
Hep A,≥2 Doses,States/Local Areas,Hawaii,2017-2018,Age,19 Months,31.4,26.3 to 36.9,497
Polio,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,90.6,86.6 to 93.8,447
DTaP,≥4 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,80.3,75.3 to 84.9,447
Combined 7 Series,,States/Local Areas,Hawaii,2019-2020,Age,24 Months,70.9,65.6 to 76.1,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,92.0,88.0 to 95.1,447
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019-2020,Age,13 Months,67.0,61.3 to 72.2,447
PCV,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,87.6,83.4 to 90.8,447
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,87.0,82.9 to 90.2,447
Hep B,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,90.6,87.1 to 93.2,447
Polio,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,87.7,83.6 to 90.9,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,74.9,69.5 to 79.7,447
PCV,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,5 Months,81.5,76.5 to 85.6,447
Hep B,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,5 Months,88.8,85.1 to 91.6,447
Hib,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,69.8,64.3 to 74.8,447
Hib,Primary Series,States/Local Areas,Hawaii,2019-2020,Age,13 Months,88.1,84.0 to 91.2,447
Hib,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,5 Months,81.4,76.4 to 85.5,447
≥1 Dose MMR,,States/Local Areas,Hawaii,2019-2020,Age,13 Months,68.2,62.5 to 73.4,447
Hib,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,90.7,87.0 to 93.5,447
Polio,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,90.6,86.8 to 93.3,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,13 Months,88.5,84.3 to 91.6,447
Polio,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,5 Months,80.8,75.8 to 84.9,447
DTaP,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,5 Months,82.7,77.8 to 86.7,447
PCV,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,3 Months,85.8,81.4 to 89.2,447
Hep B,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,3 Months,93.1,90.3 to 95.2,447
Hib,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,3 Months,86.5,82.1 to 89.9,447
Polio,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,89.2,85.4 to 92.4,447
≥1 Dose MMR,,States/Local Areas,Hawaii,2019-2020,Age,24 Months,86.4,82.2 to 90.0,447
DTaP,≥4 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,78.4,73.5 to 83.0,447
DTaP,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,90.1,86.3 to 93.2,447
PCV,≥4 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,81.9,76.9 to 86.4,447
PCV,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,91.3,87.3 to 94.4,447
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019-2020,Age,35 Months,90.5,86.4 to 93.8,447
Hep B,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,90.4,86.5 to 93.5,447
Hib,Primary Series,States/Local Areas,Hawaii,2019-2020,Age,35 Months,91.3,87.5 to 94.3,447
Hib,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,35 Months,89.7,85.4 to 93.1,447
Hib,Full Series,States/Local Areas,Hawaii,2019-2020,Age,35 Months,80.0,74.9 to 84.6,447
≥1 Dose MMR,,States/Local Areas,Hawaii,2019-2020,Age,35 Months,89.0,84.7 to 92.5,447
Hib,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,85.1,80.4 to 88.9,447
Hib,Primary Series,States/Local Areas,Hawaii,2019-2020,Age,19 Months,89.5,85.5 to 92.5,447
≥1 Dose MMR,,States/Local Areas,Hawaii,2019-2020,Age,19 Months,83.2,78.3 to 87.2,447
Polio,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,88.0,83.8 to 91.2,447
Hep A,≥2 Doses,States/Local Areas,Hawaii,2019-2020,Age,19 Months,32.6,27.6 to 38.1,447
PCV,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,89.4,85.6 to 92.5,447
PCV,≥4 Doses,States/Local Areas,Hawaii,2019-2020,Age,24 Months,79.8,74.8 to 84.3,447
≥1 Dose Varicella,,States/Local Areas,Hawaii,2019-2020,Age,24 Months,88.5,84.6 to 91.8,447
PCV,≥3 Doses,States/Local Areas,Hawaii,2019-2020,Age,7 Months,73.4,68.0 to 78.2,447
Polio,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,88.2,83.3 to 91.8,353
Hep A,≥2 Doses,States/Local Areas,Hawaii,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.3,66.5 to 80.2,426
PCV,≥3 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,88.3,80.7 to 93.2,152
Hib,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,13 Months,91.3,87.2 to 94.2,353
Hep B,≥2 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,92.5,86.5 to 96.0,152
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Hawaii,2021,Age,0-2 Days,85.8,78.0 to 91.2,152
≥1 Dose Varicella,,States/Local Areas,Hawaii,2020-2021,Age,35 Months,89.2,84.6 to 92.9,353
PCV,≥4 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,77.3,68.7 to 85.0,152
Polio,≥1 Dose,States/Local Areas,Hawaii,2019-2020,Age,3 Months,84.6,80.0 to 88.3,447
Hep A,≥1 Dose,States/Local Areas,Hawaii,2021,Age,35 Months,89.9,83.5 to 94.6,152
PCV,≥3 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,90.9,83.8 to 95.1,152
Hib,Primary Series,States/Local Areas,Hawaii,2021,Age,24 Months,92.7,86.7 to 96.6,152
DTaP,≥3 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,91.1,84.1 to 95.2,152
Hib,Full Series,States/Local Areas,Hawaii,2021,Age,24 Months,78.2,69.8 to 85.6,152
≥1 Dose MMR,,States/Local Areas,Hawaii,2021,Age,24 Months,90.2,83.7 to 94.8,152
Hib,≥3 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,92.0,86.0 to 96.2,152
Hib,Primary Series,States/Local Areas,Hawaii,2020-2021,Age,13 Months,84.4,79.1 to 88.5,353
≥1 Dose Varicella,,States/Local Areas,Hawaii,2021,Age,19 Months,89.2,82.2 to 93.6,152
Hib,≥3 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,70.5,60.8 to 78.6,152
Hep B,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,90.7,86.4 to 94.0,353
PCV,≥4 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,86.2,75.4 to 93.9,152
DTaP,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,3 Months,86.1,81.1 to 90.0,353
DTaP,≥4 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,85.3,77.7 to 91.4,152
DTaP,≥1 Dose,States/Local Areas,Hawaii,2021,Age,3 Months,91.4,85.2 to 95.2,152
Polio,≥3 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,91.1,84.8 to 95.5,152
Polio,≥1 Dose,States/Local Areas,Hawaii,2021,Age,3 Months,90.5,84.1 to 94.5,152
Hep A,≥1 Dose,States/Local Areas,Hawaii,2021,Age,24 Months,89.9,83.5 to 94.6,152
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Hawaii,2021,Age,0-1 Days,85.1,77.2 to 90.5,152
PCV,≥3 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,90.9,84.6 to 95.4,152
≥1 Dose Varicella,,States/Local Areas,Hawaii,2021,Age,24 Months,89.2,82.7 to 94.0,152
Hep B,≥3 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,71.6,62.9 to 79.0,152
Hep A,≥2 Doses,States/Local Areas,Hawaii,2020-2021,Age,19 Months,30.6,25.0 to 36.7,353
DTaP,≥3 Doses,States/Local Areas,Hawaii,2021,Age,13 Months,88.9,81.3 to 93.6,152
Hep A,≥2 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,45.3,36.0 to 55.7,152
PCV,≥3 Doses,States/Local Areas,Hawaii,2021,Age,7 Months,77.1,67.8 to 84.4,152
Hep B,≥3 Doses,States/Local Areas,Hawaii,2021,Age,24 Months,94.0,89.5 to 97.0,152
PCV,≥4 Doses,States/Local Areas,Hawaii,2021,Age,19 Months,75.5,66.3 to 82.9,152
Hep A,≥1 Dose,States/Local Areas,Hawaii,2021,Age,19 Months,89.3,82.2 to 93.8,152
PCV,≥3 Doses,States/Local Areas,Hawaii,2021,Age,35 Months,91.4,85.0 to 95.8,152
DTaP,≥3 Doses,States/Local Areas,Hawaii,2020-2021,Age,35 Months,92.1,87.3 to 95.5,353
Hep A,≥1 Dose,States/Local Areas,Hawaii,2020-2021,Age,35 Months,88.0,83.4 to 91.8,353
Hib,Primary Series,States/Local Areas,Idaho,2011,Age,7 Months,69.5,66.4 to 72.4,246
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,87.8,81.4 to 94.2,114
Hib,Primary Series,States/Local Areas,Idaho,2012,Age,7 Months,75.1,71.7 to 78.2,223
Hep A,≥1 Dose,States/Local Areas,Idaho,2014,Age,35 Months,90.1,83.5 to 94.9,201
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,35 Months,89.9,85.4 to 93.5,415
Hep A,≥1 Dose,States/Local Areas,Idaho,2013,Age,35 Months,87.8,81.9 to 92.5,224
Hep A,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,35 Months,89.0,84.8 to 92.5,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2014,Age,24 Months,48.4,40.0 to 57.7,201
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,47.5,41.5 to 53.9,415
Hep A,≥2 Doses,States/Local Areas,Idaho,2015,Age,24 Months,46.5,38.4 to 55.3,214
Hep A,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,49.5,43.3 to 56.0,404
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,91.8,89.3 to 94.3,726
Hib,≥3 Doses,States/Local Areas,Idaho,2019,Age,35 Months,92.0,86.0 to 96.1,306
Hep A,≥2 Doses,States/Local Areas,Idaho,2013,Age,24 Months,45.3,37.4 to 54.0,224
Hep A,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,46.9,41.0 to 53.2,425
DTaP,≥4 Doses,States/Local Areas,Idaho,2018,Age,19 Months,72.2,66.3 to 77.4,443
DTaP,≥4 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,93.7,90.7 to 95.8,749
DTaP,≥4 Doses,States/Local Areas,Idaho,2017,Age,19 Months,75.6,70.3 to 80.2,499
DTaP,≥4 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,73.9,70.0 to 77.5,942
DTaP,≥4 Doses,States/Local Areas,Idaho,2016,Age,19 Months,71.8,63.3 to 79.0,190
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,73.7,68.8 to 78.1,689
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,85.8,77.5 to 94.2,104
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.4,74.9 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,Idaho,2020,Age,24 Months,92.7,87.5 to 96.3,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,91.0,86.7 to 95.3,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.3,87.8 to 96.9,236
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.7,91.5 to 95.9,581
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,87.8 to 96.2,244
PCV,≥2 Doses,States/Local Areas,Idaho,2019,Age,5 Months,81.6,75.0 to 86.8,306
PCV,≥2 Doses,States/Local Areas,Idaho,2018,Age,5 Months,87.6,83.1 to 91.0,443
PCV,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,5 Months,84.5,80.6 to 87.8,749
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.8,74.6 to 87.0,236
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,74.9,65.1 to 84.6,104
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,65.0 to 96.9,39
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.5,75.5 to 83.4,581
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,78.9,72.7 to 85.2,244
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,76.4,69.7 to 83.1,246
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Overall,Overall,78.7,75.1 to 82.4,726
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,74.0,66.9 to 81.1,230
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,79.7,74.9 to 84.6,382
Polio,≥3 Doses,States/Local Areas,Idaho,2012,Age,35 Months,91.2,84.3 to 95.8,223
Polio,≥3 Doses,States/Local Areas,Idaho,2013,Age,35 Months,90.5,85.5 to 94.3,224
Polio,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,92.4,89.1 to 94.9,425
Polio,≥3 Doses,States/Local Areas,Idaho,2014,Age,35 Months,94.2,89.7 to 97.2,201
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,91.4,87.5 to 94.4,415
DTaP,≥4 Doses,States/Local Areas,Idaho,2013,Age,24 Months,79.7,72.8 to 85.8,224
DTaP,≥4 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,82.0,77.1 to 86.4,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2016,Age,24 Months,52.4,43.4 to 62.1,190
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,52.3,46.9 to 58.0,689
Hep A,≥2 Doses,States/Local Areas,Idaho,2017,Age,24 Months,52.3,46.4 to 58.4,499
Hep A,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,54.4,50.1 to 58.8,942
DTaP,≥4 Doses,States/Local Areas,Idaho,2014,Age,24 Months,84.0,76.9 to 89.8,201
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,77.9,72.4 to 83.1,415
Hep A,≥2 Doses,States/Local Areas,Idaho,2018,Age,24 Months,56.6,50.4 to 63.1,443
Hep A,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,55.8,50.8 to 60.9,749
DTaP,≥4 Doses,States/Local Areas,Idaho,2012,Age,24 Months,75.7,67.8 to 82.8,223
DTaP,≥4 Doses,States/Local Areas,Idaho,2011,Age,24 Months,72.7,65.4 to 79.6,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2019,Age,19 Months,73.5,66.2 to 79.7,306
Hep B,≥3 Doses,States/Local Areas,Idaho,2013,Age,7 Months,75.5,72.8 to 78.0,224
Hep B,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,73.5,69.6 to 77.1,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2011,Age,7 Months,63.6,61.5 to 65.6,246
Hep B,≥3 Doses,States/Local Areas,Idaho,2012,Age,7 Months,76.0,71.5 to 79.9,223
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,93.1,90.1 to 96.1,382
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,97.2,94.6 to 99.8,114
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,88.0,82.5 to 93.4,230
Polio,≥2 Doses,States/Local Areas,Idaho,2014,Age,5 Months,74.6,66.1 to 81.6,201
Polio,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,5 Months,75.0,72.4 to 77.5,415
Polio,≥2 Doses,States/Local Areas,Idaho,2013,Age,5 Months,71.9,67.9 to 75.5,224
Polio,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,5 Months,73.3,69.3 to 76.9,425
Polio,≥2 Doses,States/Local Areas,Idaho,2011,Age,5 Months,77.8,71.2 to 83.2,246
Polio,≥2 Doses,States/Local Areas,Idaho,2012,Age,5 Months,75.4,68.7 to 81.0,223
Hep A,≥2 Doses,States/Local Areas,Idaho,2019,Age,24 Months,54.9,47.3 to 62.8,306
Hep B,≥3 Doses,States/Local Areas,Idaho,2016,Age,7 Months,83.1,76.6 to 88.1,190
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,80.3,76.1 to 83.9,689
Polio,≥2 Doses,States/Local Areas,Idaho,2015,Age,5 Months,75.5,66.9 to 82.4,214
Polio,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,5 Months,78.4,72.7 to 83.1,404
Hep B,≥3 Doses,States/Local Areas,Idaho,2015,Age,7 Months,75.0,66.8 to 81.8,214
Hep B,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,79.1,73.8 to 83.5,404
Hep B,≥3 Doses,States/Local Areas,Idaho,2014,Age,7 Months,71.6,63.1 to 78.9,201
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,73.3,67.6 to 78.4,415
Polio,≥2 Doses,States/Local Areas,Idaho,2017,Age,5 Months,74.6,68.8 to 79.6,499
Polio,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,5 Months,81.2,77.5 to 84.4,942
Polio,≥2 Doses,States/Local Areas,Idaho,2016,Age,5 Months,81.3,73.5 to 87.2,190
Polio,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,5 Months,78.0,73.3 to 82.1,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2011,Age,13 Months,55.6,50.8 to 60.3,246
Hep A,≥1 Dose,States/Local Areas,Idaho,2015,Age,35 Months,89.5,83.0 to 94.2,214
Hep A,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.8,89.3 to 95.5,404
DTaP,≥4 Doses,States/Local Areas,Idaho,2015,Age,24 Months,71.8,63.4 to 79.7,214
DTaP,≥4 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,76.1,70.5 to 81.3,404
DTaP,≥4 Doses,States/Local Areas,Idaho,2016,Age,24 Months,80.5,73.5 to 86.7,190
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,81.5,77.3 to 85.3,689
Hep A,≥1 Dose,States/Local Areas,Idaho,2018,Age,35 Months,97.3,93.2 to 99.2,443
Hep A,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,35 Months,93.2,89.7 to 95.8,749
Hep A,≥1 Dose,States/Local Areas,Idaho,2017,Age,35 Months,94.3,90.7 to 96.8,499
Hep A,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,35 Months,95.6,93.2 to 97.4,942
Hep A,≥1 Dose,States/Local Areas,Idaho,2016,Age,35 Months,96.1,93.3 to 98.0,190
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,35 Months,95.2,93.0 to 96.9,689
Hep A,≥2 Doses,States/Local Areas,Idaho,2014,Age,35 Months,79.8,71.0 to 87.4,201
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,76.0,69.8 to 81.8,415
Hep B,≥3 Doses,States/Local Areas,Idaho,2019,Age,7 Months,79.7,72.6 to 85.3,306
Polio,≥2 Doses,States/Local Areas,Idaho,2013,Age,7 Months,85.5,83.6 to 87.1,224
Polio,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,87.3,84.6 to 89.5,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2015,Age,35 Months,72.0,63.3 to 80.3,214
Hep A,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,73.7,67.3 to 79.8,404
Hep A,≥2 Doses,States/Local Areas,Idaho,2016,Age,35 Months,75.3,65.8 to 83.8,190
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,79.6,74.3 to 84.5,689
Hep B,≥3 Doses,States/Local Areas,Idaho,2018,Age,7 Months,82.6,77.3 to 87.0,443
Hep B,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,81.1,76.7 to 84.9,749
Hep B,≥3 Doses,States/Local Areas,Idaho,2017,Age,7 Months,77.4,71.9 to 82.1,499
Hep B,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,80.0,76.2 to 83.3,942
Polio,≥2 Doses,States/Local Areas,Idaho,2011,Age,7 Months,88.1,83.2 to 91.7,246
Polio,≥2 Doses,States/Local Areas,Idaho,2012,Age,7 Months,91.6,90.1 to 92.9,223
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,82.9,74.0 to 91.7,104
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,77.3 to 100.0,39
Polio,≥2 Doses,States/Local Areas,Idaho,2019,Age,5 Months,80.1,73.2 to 85.6,306
≥1 Dose Varicella,,States/Local Areas,Idaho,2013,Age,13 Months,55.4,48.8 to 61.8,224
≥1 Dose Varicella,,States/Local Areas,Idaho,2013-2014,Age,13 Months,56.0,52.7 to 59.2,425
Polio,≥2 Doses,States/Local Areas,Idaho,2018,Age,5 Months,87.9,83.5 to 91.3,443
Polio,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,5 Months,83.9,79.8 to 87.3,749
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,91.4,88.4 to 94.4,377
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,86.4,81.8 to 91.1,303
Hep A,≥1 Dose,States/Local Areas,Idaho,2019,Age,35 Months,89.9,84.3 to 94.2,306
≥1 Dose Varicella,,States/Local Areas,Idaho,2012,Age,13 Months,50.8,42.7 to 58.8,223
≥1 Dose Varicella,,States/Local Areas,Idaho,2015,Age,13 Months,62.9,54.5 to 70.7,214
≥1 Dose Varicella,,States/Local Areas,Idaho,2015-2016,Age,13 Months,64.3,58.2 to 70.0,404
≥1 Dose Varicella,,States/Local Areas,Idaho,2014,Age,13 Months,56.6,47.7 to 65.1,201
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2015,Age,13 Months,59.8,53.7 to 65.5,415
DTaP,≥4 Doses,States/Local Areas,Idaho,2011,Age,35 Months,86.5,77.4 to 93.2,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2019,Age,24 Months,80.4,73.7 to 86.2,306
Hep A,≥2 Doses,States/Local Areas,Idaho,2013,Age,35 Months,70.8,62.2 to 78.8,224
Hep A,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,75.9,69.7 to 81.6,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2012,Age,35 Months,79.6,69.7 to 88.0,223
Hep A,≥2 Doses,States/Local Areas,Idaho,2011,Age,35 Months,73.0,63.1 to 82.0,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2017,Age,24 Months,82.5,77.7 to 86.8,499
DTaP,≥4 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,82.5,79.0 to 85.7,942
DTaP,≥4 Doses,States/Local Areas,Idaho,2018,Age,24 Months,82.5,77.3 to 87.1,443
DTaP,≥4 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,81.4,77.2 to 85.2,749
≥1 Dose MMR,,States/Local Areas,Idaho,2011,Age,13 Months,55.5,51.5 to 59.4,246
≥1 Dose MMR,,States/Local Areas,Idaho,2012,Age,13 Months,55.8,43.4 to 67.5,223
≥1 Dose MMR,,States/Local Areas,Idaho,2013,Age,13 Months,57.9,52.9 to 62.7,224
≥1 Dose MMR,,States/Local Areas,Idaho,2013-2014,Age,13 Months,58.3,55.6 to 61.0,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2011,Age,13 Months,85.9,81.4 to 89.5,246
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,91.2,88.0 to 94.4,382
Polio,≥2 Doses,States/Local Areas,Idaho,2016,Age,7 Months,90.9,85.7 to 94.3,190
Polio,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,88.8,85.4 to 91.5,689
Polio,≥2 Doses,States/Local Areas,Idaho,2015,Age,7 Months,88.5,81.6 to 93.0,214
Polio,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,89.7,85.6 to 92.8,404
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Overall,Overall,88.4,85.5 to 91.2,726
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,83.1,77.0 to 89.2,230
Polio,≥2 Doses,States/Local Areas,Idaho,2014,Age,7 Months,89.0,82.7 to 93.1,201
Polio,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,88.7,84.3 to 92.0,415
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,84.7,79.0 to 90.3,246
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.9,86.2 to 95.7,236
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.6,86.8 to 92.4,581
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,84.9 to 93.6,244
≥1 Dose Varicella,,States/Local Areas,Idaho,2017,Age,13 Months,61.1,55.3 to 66.7,499
≥1 Dose Varicella,,States/Local Areas,Idaho,2017-2018,Age,13 Months,60.7,56.4 to 64.7,942
≥1 Dose Varicella,,States/Local Areas,Idaho,2016,Age,13 Months,65.8,56.8 to 73.7,190
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2017,Age,13 Months,63.5,58.2 to 68.4,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2018,Age,13 Months,60.2,54.0 to 66.1,443
≥1 Dose Varicella,,States/Local Areas,Idaho,2018-2019,Age,13 Months,60.2,55.2 to 65.0,749
≥1 Dose MMR,,States/Local Areas,Idaho,2016,Age,13 Months,70.3,61.5 to 77.9,190
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2017,Age,13 Months,68.0,62.8 to 72.8,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2012,Age,19 Months,82.4,72.4 to 89.3,223
≥1 Dose Varicella,,States/Local Areas,Idaho,2013,Age,19 Months,81.3,78.5 to 83.8,224
≥1 Dose Varicella,,States/Local Areas,Idaho,2013-2014,Age,19 Months,82.9,78.1 to 86.8,425
≥1 Dose Varicella,,States/Local Areas,Idaho,2011,Age,19 Months,83.3,80.6 to 85.7,246
≥1 Dose Varicella,,States/Local Areas,Idaho,2019,Age,13 Months,60.2,52.3 to 67.5,306
≥1 Dose MMR,,States/Local Areas,Idaho,2015,Age,13 Months,64.8,56.5 to 72.4,214
≥1 Dose MMR,,States/Local Areas,Idaho,2015-2016,Age,13 Months,67.6,61.5 to 73.1,404
≥1 Dose MMR,,States/Local Areas,Idaho,2014,Age,13 Months,58.8,49.8 to 67.2,201
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2015,Age,13 Months,61.8,55.7 to 67.5,415
Hep A,≥2 Doses,States/Local Areas,Idaho,2017,Age,35 Months,83.4,77.6 to 88.4,499
Hep A,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,83.7,78.4 to 88.4,942
Hep A,≥2 Doses,States/Local Areas,Idaho,2018,Age,35 Months,84.0,73.0 to 92.3,443
Hep A,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,80.9,74.5 to 86.5,749
Hep B,≥3 Doses,States/Local Areas,Idaho,2014,Age,13 Months,87.7,80.5 to 92.5,201
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,87.9,83.2 to 91.4,415
Hep B,≥3 Doses,States/Local Areas,Idaho,2013,Age,13 Months,86.5,82.5 to 89.6,224
Hep B,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,87.1,86.2 to 88.0,425
DTaP,≥4 Doses,States/Local Areas,Idaho,2013,Age,35 Months,83.6,76.4 to 89.7,224
DTaP,≥4 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,85.9,80.8 to 90.3,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2012,Age,13 Months,89.6,87.0 to 91.7,223
Hep A,≥2 Doses,States/Local Areas,Idaho,2019,Age,35 Months,79.1,70.9 to 86.3,306
DTaP,≥4 Doses,States/Local Areas,Idaho,2014,Age,35 Months,87.9,80.2 to 93.6,201
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,85.2,79.6 to 90.0,415
DTaP,≥4 Doses,States/Local Areas,Idaho,2015,Age,35 Months,82.2,73.6 to 89.4,214
DTaP,≥4 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,83.2,77.7 to 88.0,404
DTaP,≥4 Doses,States/Local Areas,Idaho,2012,Age,35 Months,82.6,73.7 to 89.8,223
DTaP,≥4 Doses,States/Local Areas,Idaho,2016,Age,35 Months,84.2,77.2 to 90.0,190
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,86.7,82.5 to 90.3,689
DTaP,≥4 Doses,States/Local Areas,Idaho,2017,Age,35 Months,89.0,84.1 to 93.0,499
DTaP,≥4 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,90.0,86.4 to 93.0,942
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,60.0,47.6 to 72.3,104
Hep B,≥3 Doses,States/Local Areas,Idaho,2017,Age,13 Months,88.5,84.0 to 91.9,499
Hep B,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,92.2,89.7 to 94.2,942
Hep B,≥3 Doses,States/Local Areas,Idaho,2015,Age,13 Months,88.0,81.2 to 92.6,214
Hep B,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,89.1,85.0 to 92.2,404
Hep B,≥3 Doses,States/Local Areas,Idaho,2016,Age,13 Months,90.2,84.9 to 93.8,190
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,89.4,86.0 to 92.0,689
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,77.2,71.2 to 83.3,377
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,76.0,68.7 to 83.3,303
Polio,≥2 Doses,States/Local Areas,Idaho,2018,Age,7 Months,91.9,87.7 to 94.7,443
Polio,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,90.3,86.8 to 93.0,749
Polio,≥2 Doses,States/Local Areas,Idaho,2017,Age,7 Months,86.6,81.7 to 90.3,499
Polio,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,89.2,86.1 to 91.7,942
Hep B,≥1 Dose,States/Local Areas,Idaho,2014,Age,3 Months,91.6,85.3 to 95.3,201
Hep B,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,3 Months,92.6,88.6 to 95.3,415
Hep B,≥1 Dose,States/Local Areas,Idaho,2011,Age,3 Months,92.2,90.8 to 93.5,246
Hep B,≥1 Dose,States/Local Areas,Idaho,2012,Age,3 Months,95.6,94.1 to 96.7,223
Hep B,≥1 Dose,States/Local Areas,Idaho,2013,Age,3 Months,91.9,90.1 to 93.3,224
Hep B,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,3 Months,91.7,90.1 to 93.1,425
≥1 Dose MMR,,States/Local Areas,Idaho,2019,Age,13 Months,72.5,65.0 to 78.9,306
≥1 Dose MMR,,States/Local Areas,Idaho,2018,Age,13 Months,74.8,69.1 to 79.9,443
≥1 Dose MMR,,States/Local Areas,Idaho,2018-2019,Age,13 Months,73.6,69.0 to 77.8,749
≥1 Dose MMR,,States/Local Areas,Idaho,2017,Age,13 Months,65.6,59.8 to 71.0,499
≥1 Dose MMR,,States/Local Areas,Idaho,2017-2018,Age,13 Months,70.2,66.1 to 73.9,942
Polio,≥2 Doses,States/Local Areas,Idaho,2011,Age,13 Months,95.1,90.5 to 97.6,246
Polio,≥2 Doses,States/Local Areas,Idaho,2012,Age,13 Months,94.7,91.6 to 96.7,223
≥1 Dose Varicella,,States/Local Areas,Idaho,2016,Age,19 Months,86.0,79.1 to 90.8,190
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2017,Age,19 Months,86.9,82.9 to 90.0,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2015,Age,19 Months,86.4,79.2 to 91.4,214
≥1 Dose Varicella,,States/Local Areas,Idaho,2015-2016,Age,19 Months,86.2,81.4 to 89.9,404
≥1 Dose Varicella,,States/Local Areas,Idaho,2014,Age,19 Months,84.5,77.1 to 89.8,201
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2015,Age,19 Months,85.4,80.4 to 89.3,415
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,70.0,61.6 to 78.5,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2018,Age,35 Months,91.6,85.6 to 95.8,443
DTaP,≥4 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,89.2,84.7 to 92.8,749
Polio,≥3 Doses,States/Local Areas,Idaho,2018,Age,35 Months,96.3,92.8 to 98.5,443
Polio,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,94.2,90.8 to 96.7,749
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,92.6,88.1 to 97.2,114
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,72.9,64.7 to 81.0,230
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,75.5,70.8 to 80.2,726
Polio,≥2 Doses,States/Local Areas,Idaho,2019,Age,7 Months,88.9,82.8 to 93.0,306
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.1,74.2 to 84.0,581
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.6,70.9 to 88.2,236
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,78.0,70.7 to 85.4,244
Hep B,≥1 Dose,States/Local Areas,Idaho,2017,Age,3 Months,93.6,89.8 to 96.0,499
Hep B,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,3 Months,94.6,92.4 to 96.2,942
Hep B,≥1 Dose,States/Local Areas,Idaho,2016,Age,3 Months,95.0,91.1 to 97.3,190
Hep B,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,3 Months,94.3,91.8 to 96.1,689
Hep B,≥1 Dose,States/Local Areas,Idaho,2015,Age,3 Months,93.7,87.6 to 96.9,214
Hep B,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,3 Months,94.3,91.0 to 96.5,404
Polio,≥2 Doses,States/Local Areas,Idaho,2014,Age,13 Months,94.9,90.1 to 97.4,201
Polio,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,92.8,89.0 to 95.4,415
Polio,≥2 Doses,States/Local Areas,Idaho,2013,Age,13 Months,89.3,86.9 to 91.3,224
Polio,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,92.1,91.0 to 93.2,425
≥1 Dose Varicella,,States/Local Areas,Idaho,2015,Age,24 Months,88.0,81.5 to 93.0,214
≥1 Dose Varicella,,States/Local Areas,Idaho,2015-2016,Age,24 Months,89.1,85.1 to 92.4,404
≥1 Dose MMR,,States/Local Areas,Idaho,2012,Age,24 Months,87.6,80.4 to 93.1,223
≥1 Dose MMR,,States/Local Areas,Idaho,2011,Age,24 Months,87.6,81.7 to 92.3,246
≥1 Dose Varicella,,States/Local Areas,Idaho,2016,Age,24 Months,90.1,85.1 to 94.0,190
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2017,Age,24 Months,88.7,85.4 to 91.6,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2017,Age,24 Months,87.3,82.7 to 91.3,499
≥1 Dose Varicella,,States/Local Areas,Idaho,2017-2018,Age,24 Months,89.9,86.9 to 92.5,942
Hep B,≥2 Doses,States/Local Areas,Idaho,2017,Age,5 Months,87.5,82.9 to 91.1,499
Hep B,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,5 Months,90.2,87.3 to 92.5,942
Hep B,≥2 Doses,States/Local Areas,Idaho,2016,Age,5 Months,90.7,85.6 to 94.1,190
Hep B,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,5 Months,89.1,85.8 to 91.7,689
Hep B,≥3 Doses,States/Local Areas,Idaho,2018,Age,19 Months,96.9,94.6 to 98.2,443
Hep B,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,93.4,90.5 to 95.4,749
Hep B,≥3 Doses,States/Local Areas,Idaho,2017,Age,19 Months,90.9,86.7 to 93.9,499
Hep B,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,93.9,91.5 to 95.6,942
PCV,≥3 Doses,States/Local Areas,Idaho,2012,Age,7 Months,65.3,61.6 to 68.9,223
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,83.3,78.7 to 87.9,382
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,87.4,80.6 to 94.2,114
PCV,≥3 Doses,States/Local Areas,Idaho,2014,Age,7 Months,67.7,58.9 to 75.3,201
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,67.5,61.6 to 73.0,415
Hep B,≥3 Doses,States/Local Areas,Idaho,2016,Age,19 Months,92.3,87.4 to 95.4,190
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,91.6,88.6 to 93.9,689
PCV,≥3 Doses,States/Local Areas,Idaho,2011,Age,7 Months,67.8,62.4 to 72.7,246
PCV,≥3 Doses,States/Local Areas,Idaho,2013,Age,7 Months,69.4,64.0 to 74.4,224
PCV,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,68.5,65.9 to 71.1,425
≥1 Dose Varicella,,States/Local Areas,Idaho,2012,Age,24 Months,86.9,80.1 to 92.3,223
≥1 Dose Varicella,,States/Local Areas,Idaho,2011,Age,24 Months,85.4,79.3 to 90.5,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,69.4,62.0 to 76.9,230
≥1 Dose MMR,,States/Local Areas,Idaho,2017,Age,19 Months,87.8,83.0 to 91.3,499
≥1 Dose MMR,,States/Local Areas,Idaho,2017-2018,Age,19 Months,90.2,87.2 to 92.5,942
≥1 Dose MMR,,States/Local Areas,Idaho,2016,Age,19 Months,91.0,86.0 to 94.3,190
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2017,Age,19 Months,89.4,86.1 to 92.0,689
≥1 Dose MMR,,States/Local Areas,Idaho,2015,Age,19 Months,86.1,84.7 to 87.4,214
≥1 Dose MMR,,States/Local Areas,Idaho,2015-2016,Age,19 Months,88.6,84.2 to 91.8,404
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.1,74.7 to 87.6,236
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,77.6,71.1 to 84.1,244
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,77.7,71.0 to 84.4,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,78.8,75.0 to 82.6,726
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.3,68.3 to 98.3,39
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.1,74.9 to 83.3,581
Hep B,≥3 Doses,States/Local Areas,Idaho,2015,Age,19 Months,89.5,88.6 to 90.3,214
Hep B,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,90.9,87.0 to 93.7,404
Hep B,≥3 Doses,States/Local Areas,Idaho,2014,Age,19 Months,90.0,83.7 to 94.1,201
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,89.8,85.4 to 92.9,415
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,80.1,70.7 to 89.5,114
Hep B,≥2 Doses,States/Local Areas,Idaho,2014,Age,5 Months,85.5,77.9 to 90.8,201
Hep B,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,5 Months,85.7,82.2 to 88.7,415
Hep B,≥3 Doses,States/Local Areas,Idaho,2013,Age,19 Months,89.9,84.5 to 93.6,224
Hep B,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,90.0,87.4 to 92.1,425
Hep B,≥2 Doses,States/Local Areas,Idaho,2013,Age,5 Months,82.3,79.5 to 84.9,224
Hep B,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,5 Months,84.0,81.1 to 86.5,425
Hep B,≥2 Doses,States/Local Areas,Idaho,2011,Age,5 Months,82.0,78.1 to 85.4,246
Hep B,≥2 Doses,States/Local Areas,Idaho,2012,Age,5 Months,87.9,86.9 to 88.8,223
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2011,Age,0-1 Days,71.2,66.7 to 75.2,246
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,76.3,69.5 to 83.0,382
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2012,Age,0-1 Days,65.1,61.1 to 68.9,223
Hep B,≥1 Dose,States/Local Areas,Idaho,2019,Age,3 Months,96.9,93.4 to 98.6,306
≥1 Dose Varicella,,States/Local Areas,Idaho,2019,Age,19 Months,88.8,83.0 to 92.8,306
Hep B,≥1 Dose,States/Local Areas,Idaho,2018,Age,3 Months,95.7,92.8 to 97.5,443
Hep B,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,3 Months,96.3,94.3 to 97.7,749
Polio,≥2 Doses,States/Local Areas,Idaho,2017,Age,13 Months,92.5,88.6 to 95.1,499
Polio,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,94.2,91.9 to 95.9,942
Polio,≥2 Doses,States/Local Areas,Idaho,2016,Age,13 Months,93.5,89.1 to 96.2,190
Polio,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,93.0,90.2 to 95.0,689
Polio,≥2 Doses,States/Local Areas,Idaho,2015,Age,13 Months,90.8,84.1 to 94.8,214
Polio,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,92.2,88.3 to 94.8,404
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,75.7,65.7 to 85.6,104
≥1 Dose Varicella,,States/Local Areas,Idaho,2018,Age,19 Months,90.4,85.9 to 93.6,443
≥1 Dose Varicella,,States/Local Areas,Idaho,2018-2019,Age,19 Months,60.2,55.2 to 65.0,749
≥1 Dose Varicella,,States/Local Areas,Idaho,2017,Age,19 Months,87.7,83.1 to 91.2,499
≥1 Dose Varicella,,States/Local Areas,Idaho,2017-2018,Age,19 Months,89.1,86.0 to 91.5,942
≥1 Dose MMR,,States/Local Areas,Idaho,2012,Age,19 Months,82.8,72.4 to 89.8,223
≥1 Dose MMR,,States/Local Areas,Idaho,2014,Age,19 Months,87.4,80.4 to 92.1,201
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2015,Age,19 Months,86.7,81.9 to 90.5,415
≥1 Dose MMR,,States/Local Areas,Idaho,2013,Age,19 Months,86.0,84.1 to 87.7,224
≥1 Dose MMR,,States/Local Areas,Idaho,2013-2014,Age,19 Months,86.7,82.5 to 89.9,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2011,Age,19 Months,91.3,84.5 to 95.2,246
Hep B,≥3 Doses,States/Local Areas,Idaho,2019,Age,13 Months,90.9,85.5 to 94.4,306
Hep B,≥3 Doses,States/Local Areas,Idaho,2018,Age,13 Months,96.1,93.5 to 97.6,443
Hep B,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,93.4,90.5 to 95.4,749
Hep B,≥3 Doses,States/Local Areas,Idaho,2012,Age,19 Months,91.7,89.7 to 93.3,223
Hep A,≥1 Dose,States/Local Areas,Idaho,2020,Age,35 Months,90.5,84.5 to 94.9,286
≥1 Dose MMR,,States/Local Areas,Idaho,2011,Age,19 Months,83.9,79.4 to 87.6,246
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,85.7,81.4 to 90.0,377
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,74.6,68.5 to 80.7,303
DTaP,≥4 Doses,States/Local Areas,Idaho,2019,Age,35 Months,87.6,80.9 to 92.9,306
≥1 Dose MMR,,States/Local Areas,Idaho,2013,Age,24 Months,89.6,84.6 to 93.5,224
≥1 Dose MMR,,States/Local Areas,Idaho,2013-2014,Age,24 Months,88.7,84.8 to 92.0,425
≥1 Dose MMR,,States/Local Areas,Idaho,2014,Age,24 Months,87.7,81.3 to 92.8,201
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2015,Age,24 Months,87.6,83.0 to 91.4,415
≥1 Dose MMR,,States/Local Areas,Idaho,2015,Age,24 Months,87.4,80.6 to 92.7,214
≥1 Dose MMR,,States/Local Areas,Idaho,2015-2016,Age,24 Months,90.7,86.8 to 93.8,404
≥1 Dose Varicella,,States/Local Areas,Idaho,2018,Age,24 Months,92.6,88.4 to 95.6,443
≥1 Dose Varicella,,States/Local Areas,Idaho,2018-2019,Age,24 Months,91.1,87.8 to 93.8,749
Hep B,≥3 Doses,States/Local Areas,Idaho,2011,Age,24 Months,92.4,87.5 to 95.8,246
Hep B,≥3 Doses,States/Local Areas,Idaho,2019,Age,19 Months,92.7,87.8 to 95.7,306
Hep B,≥3 Doses,States/Local Areas,Idaho,2013,Age,24 Months,89.9,85.0 to 93.8,224
Hep B,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,90.6,87.0 to 93.5,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2014,Age,24 Months,91.2,85.8 to 95.1,201
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,90.5,86.6 to 93.7,415
PCV,≥4 Doses,States/Local Areas,Idaho,2020,Age,35 Months,84.3,77.8 to 89.8,286
Hep B,≥3 Doses,States/Local Areas,Idaho,2012,Age,24 Months,92.2,87.4 to 95.7,223
PCV,≥3 Doses,States/Local Areas,Idaho,2016,Age,7 Months,69.6,60.6 to 77.4,190
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,67.2,61.8 to 72.1,689
PCV,≥4 Doses,States/Local Areas,Idaho,2016,Age,19 Months,85.2,78.4 to 90.2,190
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,82.6,78.5 to 86.1,689
PCV,≥4 Doses,States/Local Areas,Idaho,2015,Age,19 Months,73.5,70.9 to 75.9,214
PCV,≥4 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,79.3,73.9 to 83.9,404
PCV,≥3 Doses,States/Local Areas,Idaho,2015,Age,7 Months,67.4,58.8 to 75.1,214
PCV,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,68.5,62.3 to 74.1,404
PCV,≥3 Doses,States/Local Areas,Idaho,2017,Age,7 Months,64.7,58.7 to 70.2,499
PCV,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,68.5,64.3 to 72.4,942
Hep B,≥3 Doses,States/Local Areas,Idaho,2015,Age,24 Months,89.9,83.8 to 94.4,214
Hep B,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,91.5,87.9 to 94.4,404
PCV,≥3 Doses,States/Local Areas,Idaho,2013,Age,13 Months,87.4,85.0 to 89.4,224
PCV,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,89.0,87.2 to 90.6,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2016,Age,24 Months,93.2,89.0 to 96.2,190
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,92.7,90.0 to 94.9,689
Hep B,≥3 Doses,States/Local Areas,Idaho,2017,Age,24 Months,92.3,88.6 to 95.1,499
Hep B,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,94.6,92.5 to 96.2,942
PCV,≥3 Doses,States/Local Areas,Idaho,2012,Age,13 Months,88.1,83.3 to 91.7,223
≥1 Dose MMR,,States/Local Areas,Idaho,2016,Age,24 Months,93.7,89.8 to 96.5,190
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2017,Age,24 Months,91.9,89.0 to 94.2,689
≥1 Dose MMR,,States/Local Areas,Idaho,2017,Age,24 Months,89.9,85.6 to 93.4,499
≥1 Dose MMR,,States/Local Areas,Idaho,2017-2018,Age,24 Months,92.1,89.4 to 94.4,942
PCV,≥4 Doses,States/Local Areas,Idaho,2018,Age,19 Months,83.9,78.7 to 88.0,443
PCV,≥4 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,83.0,78.2 to 86.8,641
PCV,≥4 Doses,States/Local Areas,Idaho,2017,Age,19 Months,80.0,74.7 to 84.4,499
PCV,≥4 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,81.9,78.3 to 85.0,942
PCV,≥3 Doses,States/Local Areas,Idaho,2011,Age,13 Months,86.0,77.6 to 91.7,246
PCV,≥3 Doses,States/Local Areas,Idaho,2019,Age,7 Months,75.8,68.8 to 81.7,306
PCV,≥3 Doses,States/Local Areas,Idaho,2018,Age,7 Months,72.4,66.5 to 77.6,443
PCV,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,74.1,69.6 to 78.2,749
Hep B,≥2 Doses,States/Local Areas,Idaho,2012,Age,7 Months,91.6,89.9 to 93.1,223
Hep B,≥2 Doses,States/Local Areas,Idaho,2015,Age,7 Months,91.4,84.6 to 95.4,214
Hep B,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,92.1,88.2 to 94.8,404
Hep B,≥2 Doses,States/Local Areas,Idaho,2014,Age,7 Months,91.8,86.4 to 95.2,201
Hep B,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,91.6,87.6 to 94.5,415
Hep B,≥2 Doses,States/Local Areas,Idaho,2013,Age,7 Months,87.1,83.9 to 89.8,224
Hep B,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,89.5,87.1 to 91.6,425
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2012,Age,0-2 Days,66.4,62.3 to 70.2,223
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2013,Age,0-2 Days,70.7,68.5 to 72.7,224
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2013-2014,Age,0-2 Days,71.1,69.3 to 72.9,425
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2011,Age,0-2 Days,74.5,71.2 to 77.5,246
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2019,Age,0-1 Days,72.7,65.4 to 79.0,306
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2018,Age,0-1 Days,75.7,69.9 to 80.6,443
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2018-2019,Age,0-1 Days,74.2,69.5 to 78.3,749
Hep B,≥2 Doses,States/Local Areas,Idaho,2018,Age,5 Months,92.9,89.2 to 95.5,443
Hep B,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,5 Months,91.2,87.9 to 93.7,749
Hep B,≥2 Doses,States/Local Areas,Idaho,2011,Age,7 Months,90.1,87.9 to 91.9,246
Hep B,≥2 Doses,States/Local Areas,Idaho,2019,Age,5 Months,89.6,83.9 to 93.5,306
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2017,Age,0-1 Days,65.9,59.9 to 71.5,499
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2017-2018,Age,0-1 Days,70.7,66.6 to 74.6,942
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2016,Age,0-1 Days,73.8,65.3 to 80.9,190
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2016-2017,Age,0-1 Days,69.9,64.8 to 74.6,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2013,Age,24 Months,85.9,79.8 to 91.0,224
≥1 Dose Varicella,,States/Local Areas,Idaho,2013-2014,Age,24 Months,86.0,81.6 to 89.7,425
≥1 Dose Varicella,,States/Local Areas,Idaho,2014,Age,24 Months,85.9,79.3 to 91.3,201
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2015,Age,24 Months,87.0,82.5 to 90.8,415
Polio,≥2 Doses,States/Local Areas,Idaho,2019,Age,13 Months,91.4,85.9 to 94.9,306
Polio,≥2 Doses,States/Local Areas,Idaho,2018,Age,13 Months,96.1,93.1 to 97.8,443
Polio,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,93.7,90.7 to 95.8,749
Hep B,≥2 Doses,States/Local Areas,Idaho,2015,Age,5 Months,85.9,78.4 to 91.1,214
Hep B,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,5 Months,88.3,83.9 to 91.6,404
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2015,Age,0-1 Days,65.3,56.9 to 72.9,214
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2015-2016,Age,0-1 Days,69.6,63.6 to 74.9,404
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2014,Age,0-1 Days,69.4,60.7 to 76.9,201
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2014-2015,Age,0-1 Days,67.4,61.2 to 72.9,415
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2013,Age,0-1 Days,67.8,64.9 to 70.5,224
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2013-2014,Age,0-1 Days,68.6,65.0 to 72.0,425
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2019,Age,0-2 Days,76.1,69.0 to 82.0,306
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2018,Age,0-2 Days,78.1,72.5 to 82.8,443
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2018-2019,Age,0-2 Days,77.1,72.6 to 81.0,749
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2017,Age,0-2 Days,66.7,60.6 to 72.3,499
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2017-2018,Age,0-2 Days,72.3,68.2 to 76.1,942
PCV,≥4 Doses,States/Local Areas,Idaho,2012,Age,24 Months,85.3,78.7 to 90.7,223
Hep B,≥3 Doses,States/Local Areas,Idaho,2011,Age,35 Months,95.6,89.8 to 98.6,246
Hep B,≥3 Doses,States/Local Areas,Idaho,2019,Age,24 Months,92.7,88.2 to 95.9,306
PCV,≥4 Doses,States/Local Areas,Idaho,2013,Age,24 Months,81.0,74.2 to 86.9,224
PCV,≥4 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,82.7,78.0 to 86.9,425
PCV,≥4 Doses,States/Local Areas,Idaho,2014,Age,24 Months,84.3,77.7 to 89.9,201
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,80.7,75.6 to 85.3,415
PCV,≥4 Doses,States/Local Areas,Idaho,2015,Age,24 Months,77.0,69.4 to 83.9,214
PCV,≥4 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,81.4,76.4 to 85.9,404
≥1 Dose MMR,,States/Local Areas,Idaho,2019,Age,24 Months,88.7,83.0 to 93.2,306
≥1 Dose MMR,,States/Local Areas,Idaho,2012,Age,35 Months,87.9,80.7 to 93.4,223
≥1 Dose MMR,,States/Local Areas,Idaho,2011,Age,35 Months,93.6,87.3 to 97.5,246
≥1 Dose MMR,,States/Local Areas,Idaho,2013,Age,35 Months,91.4,86.1 to 95.3,224
≥1 Dose MMR,,States/Local Areas,Idaho,2013-2014,Age,35 Months,91.3,87.4 to 94.4,425
≥1 Dose Varicella,,States/Local Areas,Idaho,2016,Age,35 Months,93.1,88.5 to 96.3,190
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2017,Age,35 Months,91.8,88.8 to 94.3,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2013,Age,35 Months,87.4,81.1 to 92.5,224
≥1 Dose Varicella,,States/Local Areas,Idaho,2013-2014,Age,35 Months,87.9,83.5 to 91.5,425
≥1 Dose MMR,,States/Local Areas,Idaho,2018,Age,24 Months,94.4,90.7 to 96.9,443
≥1 Dose MMR,,States/Local Areas,Idaho,2018-2019,Age,24 Months,91.5,88.1 to 94.2,749
PCV,≥4 Doses,States/Local Areas,Idaho,2019,Age,19 Months,82.9,76.2 to 88.0,306
≥1 Dose Varicella,,States/Local Areas,Idaho,2014,Age,35 Months,88.6,82.1 to 93.6,201
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2015,Age,35 Months,89.8,85.5 to 93.3,415
≥1 Dose Varicella,,States/Local Areas,Idaho,2015,Age,35 Months,90.9,84.8 to 95.3,214
≥1 Dose Varicella,,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.1,88.5 to 94.9,404
PCV,≥4 Doses,States/Local Areas,Idaho,2011,Age,24 Months,79.5,72.7 to 85.6,246
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2015,Age,0-2 Days,70.5,62.3 to 77.6,214
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2015-2016,Age,0-2 Days,73.0,67.2 to 78.1,404
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2014,Age,0-2 Days,71.6,62.9 to 78.9,201
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2014-2015,Age,0-2 Days,71.1,65.1 to 76.4,415
≥1 Dose MMR,,States/Local Areas,Idaho,2019,Age,19 Months,88.1,81.9 to 92.4,306
PCV,≥4 Doses,States/Local Areas,Idaho,2014,Age,19 Months,83.4,76.3 to 88.7,201
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,78.4,73.0 to 83.0,415
≥1 Dose MMR,,States/Local Areas,Idaho,2018,Age,19 Months,92.6,88.6 to 95.3,443
≥1 Dose MMR,,States/Local Areas,Idaho,2018-2019,Age,19 Months,94.1,91.4 to 96.0,749
PCV,≥4 Doses,States/Local Areas,Idaho,2011,Age,19 Months,74.7,67.1 to 81.1,246
PCV,≥4 Doses,States/Local Areas,Idaho,2012,Age,19 Months,82.1,73.7 to 88.2,223
PCV,≥4 Doses,States/Local Areas,Idaho,2013,Age,19 Months,77.4,76.2 to 78.6,224
PCV,≥4 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,80.5,76.9 to 83.6,425
≥1 Dose Varicella,,States/Local Areas,Idaho,2012,Age,35 Months,86.9,80.1 to 92.3,223
≥1 Dose Varicella,,States/Local Areas,Idaho,2011,Age,35 Months,92.7,86.0 to 97.0,246
≥1 Dose Varicella,,States/Local Areas,Idaho,2019,Age,24 Months,89.6,84.3 to 93.8,306
PCV,≥3 Doses,States/Local Areas,Idaho,2016,Age,13 Months,91.1,86.2 to 94.4,190
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,89.2,85.9 to 91.8,689
Hep B,≥3 Doses,States/Local Areas,Idaho,2018,Age,24 Months,96.9,94.8 to 98.3,443
Hep B,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,94.7,92.3 to 96.6,749
PCV,≥3 Doses,States/Local Areas,Idaho,2015,Age,13 Months,84.7,76.9 to 90.1,214
PCV,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,87.9,83.4 to 91.3,404
PCV,≥3 Doses,States/Local Areas,Idaho,2014,Age,13 Months,90.6,84.7 to 94.3,201
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,87.6,82.9 to 91.1,415
Hep B,≥2 Doses,States/Local Areas,Idaho,2018,Age,7 Months,94.2,90.7 to 96.5,443
Hep B,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,93.1,90.2 to 95.3,749
Hep B,≥2 Doses,States/Local Areas,Idaho,2017,Age,7 Months,91.8,87.8 to 94.6,499
Hep B,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,93.0,90.5 to 94.9,942
Hep B,≥2 Doses,States/Local Areas,Idaho,2016,Age,7 Months,92.7,87.9 to 95.7,190
Hep B,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,92.3,89.3 to 94.5,689
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2016,Age,0-2 Days,75.6,67.1 to 82.5,190
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2016-2017,Age,0-2 Days,71.2,66.0 to 75.9,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2017,Age,35 Months,90.6,86.2 to 94.1,499
≥1 Dose Varicella,,States/Local Areas,Idaho,2017-2018,Age,35 Months,93.6,90.8 to 95.8,942
≥1 Dose Varicella,,States/Local Areas,Idaho,2018,Age,35 Months,97.7,94.0 to 99.4,443
≥1 Dose Varicella,,States/Local Areas,Idaho,2018-2019,Age,35 Months,94.0,90.4 to 96.5,749
Hib,Primary Series,States/Local Areas,Idaho,2020,Age,24 Months,93.0,88.2 to 96.3,286
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,86.9,79.0 to 94.8,104
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,75.4 to 100.0,39
Hib,≥1 Dose,States/Local Areas,Idaho,2011,Age,3 Months,87.9,78.3 to 93.6,246
Hib,≥1 Dose,States/Local Areas,Idaho,2012,Age,3 Months,87.0,86.0 to 87.9,223
Hib,≥1 Dose,States/Local Areas,Idaho,2013,Age,3 Months,82.3,79.4 to 84.8,224
Hib,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,3 Months,84.9,82.2 to 87.3,425
Hep B,≥2 Doses,States/Local Areas,Idaho,2014,Age,13 Months,95.0,90.5 to 97.4,201
Hep B,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,93.5,89.7 to 96.0,415
Hib,≥1 Dose,States/Local Areas,Idaho,2014,Age,3 Months,87.5,81.0 to 92.0,201
Hib,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,3 Months,87.5,83.0 to 91.0,415
Hep B,≥2 Doses,States/Local Areas,Idaho,2015,Age,13 Months,92.1,85.2 to 95.9,214
Hep B,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,93.3,89.6 to 95.8,404
Hep B,≥2 Doses,States/Local Areas,Idaho,2016,Age,13 Months,94.6,90.5 to 96.9,190
Hep B,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,94.0,91.4 to 95.8,689
Hep B,≥3 Doses,States/Local Areas,Idaho,2017,Age,35 Months,93.1,89.4 to 95.8,499
Hep B,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,95.1,92.9 to 96.7,942
PCV,≥3 Doses,States/Local Areas,Idaho,2012,Age,19 Months,90.3,87.8 to 92.3,223
Hep B,≥3 Doses,States/Local Areas,Idaho,2018,Age,35 Months,96.9,94.8 to 98.3,443
Hep B,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,94.9,92.4 to 96.8,749
PCV,≥4 Doses,States/Local Areas,Idaho,2012,Age,35 Months,87.4,80.3 to 92.9,223
PCV,≥4 Doses,States/Local Areas,Idaho,2011,Age,35 Months,86.5,78.6 to 92.6,246
PCV,≥4 Doses,States/Local Areas,Idaho,2019,Age,24 Months,85.6,79.7 to 90.6,306
Hep B,≥3 Doses,States/Local Areas,Idaho,2016,Age,35 Months,94.7,90.8 to 97.3,190
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,93.9,91.3 to 95.9,689
PCV,≥3 Doses,States/Local Areas,Idaho,2014,Age,19 Months,91.7,85.9 to 95.2,201
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,90.2,85.9 to 93.3,415
PCV,≥3 Doses,States/Local Areas,Idaho,2013,Age,19 Months,91.1,88.2 to 93.4,224
PCV,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,91.4,88.8 to 93.5,425
PCV,≥3 Doses,States/Local Areas,Idaho,2011,Age,19 Months,91.5,89.4 to 93.2,246
PCV,≥3 Doses,States/Local Areas,Idaho,2019,Age,13 Months,88.1,82.0 to 92.4,306
Hep B,≥3 Doses,States/Local Areas,Idaho,2013,Age,35 Months,89.9,85.0 to 93.8,224
Hep B,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,90.8,87.3 to 93.7,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2014,Age,35 Months,91.9,86.5 to 95.7,201
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,90.8,86.9 to 94.0,415
Hep B,≥3 Doses,States/Local Areas,Idaho,2015,Age,35 Months,89.9,83.8 to 94.4,214
Hep B,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.4,88.8 to 95.1,404
Hep B,≥3 Doses,States/Local Areas,Idaho,2012,Age,35 Months,92.8,88.0 to 96.2,223
PCV,≥3 Doses,States/Local Areas,Idaho,2018,Age,13 Months,92.6,88.9 to 95.2,443
PCV,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,90.3,86.8 to 93.0,749
PCV,≥3 Doses,States/Local Areas,Idaho,2017,Age,13 Months,87.2,82.5 to 90.8,499
PCV,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,89.9,87.0 to 92.2,942
Hep B,≥2 Doses,States/Local Areas,Idaho,2012,Age,13 Months,94.2,90.1 to 96.7,223
Hep B,≥2 Doses,States/Local Areas,Idaho,2013,Age,13 Months,89.7,84.7 to 93.3,224
Hep B,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,92.4,91.4 to 93.3,425
Hep B,≥2 Doses,States/Local Areas,Idaho,2011,Age,13 Months,95.8,92.0 to 97.8,246
Hep B,≥2 Doses,States/Local Areas,Idaho,2019,Age,7 Months,92.1,87.0 to 95.3,306
PCV,≥4 Doses,States/Local Areas,Idaho,2016,Age,24 Months,85.8,79.5 to 91.0,190
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,84.2,80.3 to 87.7,689
PCV,≥4 Doses,States/Local Areas,Idaho,2017,Age,24 Months,82.5,77.7 to 86.9,499
PCV,≥4 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,84.7,81.4 to 87.8,942
≥1 Dose MMR,,States/Local Areas,Idaho,2015,Age,35 Months,90.7,84.2 to 95.3,214
≥1 Dose MMR,,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.7,89.1 to 95.5,404
PCV,≥4 Doses,States/Local Areas,Idaho,2018,Age,24 Months,87.1,82.5 to 91.1,443
PCV,≥4 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,86.4,82.6 to 89.6,749
≥1 Dose MMR,,States/Local Areas,Idaho,2014,Age,35 Months,91.4,85.0 to 95.8,201
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2015,Age,35 Months,91.0,86.7 to 94.4,415
≥1 Dose MMR,,States/Local Areas,Idaho,2016,Age,35 Months,94.7,90.8 to 97.3,190
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2017,Age,35 Months,93.9,91.2 to 96.0,689
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,91.8,88.9 to 94.7,377
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,86.5,81.9 to 91.1,303
≥1 Dose Varicella,,States/Local Areas,Idaho,2019,Age,35 Months,90.8,85.3 to 94.8,306
PCV,≥4 Doses,States/Local Areas,Idaho,2014,Age,35 Months,88.2,81.8 to 93.2,201
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,83.7,78.8 to 88.1,415
PCV,≥4 Doses,States/Local Areas,Idaho,2015,Age,35 Months,79.5,71.8 to 86.3,214
PCV,≥4 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,83.3,78.3 to 87.7,404
PCV,≥4 Doses,States/Local Areas,Idaho,2016,Age,35 Months,87.3,81.0 to 92.3,190
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,85.2,81.3 to 88.6,689
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,87.7,83.3 to 92.1,303
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,86.9,79.1 to 94.7,104
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,77.3 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,Idaho,2019,Age,35 Months,93.0,88.5 to 96.2,306
PCV,≥3 Doses,States/Local Areas,Idaho,2017,Age,19 Months,90.9,86.6 to 93.9,499
PCV,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,93.3,90.7 to 95.2,942
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.2,88.7 to 93.8,581
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,90.0,85.8 to 94.2,244
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,88.2 to 97.0,236
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,93.5,89.0 to 98.0,114
≥1 Dose MMR,,States/Local Areas,Idaho,2017,Age,35 Months,93.0,89.0 to 95.9,499
≥1 Dose MMR,,States/Local Areas,Idaho,2017-2018,Age,35 Months,95.2,92.7 to 97.0,942
≥1 Dose MMR,,States/Local Areas,Idaho,2018,Age,35 Months,97.6,94.3 to 99.2,443
≥1 Dose MMR,,States/Local Areas,Idaho,2018-2019,Age,35 Months,94.2,90.9 to 96.7,749
PCV,≥4 Doses,States/Local Areas,Idaho,2013,Age,35 Months,83.3,76.6 to 89.0,224
PCV,≥4 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,85.7,81.2 to 89.6,425
≥1 Dose MMR,,States/Local Areas,Idaho,2019,Age,35 Months,91.3,85.8 to 95.3,306
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,94.8,92.5 to 97.0,377
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.8,86.0 to 91.7,581
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,90.2,86.1 to 94.4,244
PCV,≥3 Doses,States/Local Areas,Idaho,2016,Age,19 Months,92.5,87.7 to 95.5,190
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,91.7,88.7 to 94.0,689
PCV,≥3 Doses,States/Local Areas,Idaho,2015,Age,19 Months,88.8,86.4 to 90.9,214
PCV,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,90.6,86.5 to 93.6,404
Hep B,≥2 Doses,States/Local Areas,Idaho,2019,Age,13 Months,93.5,88.7 to 96.4,306
Hep B,≥2 Doses,States/Local Areas,Idaho,2018,Age,13 Months,97.1,94.9 to 98.4,443
Hep B,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,95.3,92.7 to 97.0,749
Hep B,≥2 Doses,States/Local Areas,Idaho,2017,Age,13 Months,93.4,89.7 to 95.9,499
Hep B,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,95.3,93.2 to 96.7,942
Hib,≥1 Dose,States/Local Areas,Idaho,2017,Age,3 Months,87.2,82.8 to 90.7,499
Hib,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,3 Months,88.6,85.6 to 91.0,942
Hib,≥1 Dose,States/Local Areas,Idaho,2016,Age,3 Months,86.7,79.0 to 91.8,190
Hib,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,3 Months,87.0,82.7 to 90.3,689
Hib,≥1 Dose,States/Local Areas,Idaho,2015,Age,3 Months,87.6,80.6 to 92.3,214
Hib,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,3 Months,87.1,82.2 to 90.9,404
PCV,≥4 Doses,States/Local Areas,Idaho,2017,Age,35 Months,83.0,78.1 to 87.4,499
PCV,≥4 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,86.7,83.4 to 89.6,942
Hib,≥1 Dose,States/Local Areas,Idaho,2019,Age,3 Months,86.9,80.8 to 91.3,306
Hib,≥1 Dose,States/Local Areas,Idaho,2018,Age,3 Months,89.9,85.7 to 93.0,443
Hib,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,3 Months,88.4,84.7 to 91.2,749
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,90.8,87.6 to 94.0,382
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,85.7,80.4 to 90.9,246
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.4,84.5 to 94.4,236
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Overall,Overall,88.5,85.7 to 91.3,726
≥1 Dose Varicella,,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,83.5,77.6 to 89.3,230
PCV,≥4 Doses,States/Local Areas,Idaho,2019,Age,35 Months,87.2,81.2 to 92.0,306
PCV,≥4 Doses,States/Local Areas,Idaho,2018,Age,35 Months,91.7,86.8 to 95.3,443
PCV,≥4 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,89.2,85.3 to 92.4,749
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,88.3,83.4 to 93.2,246
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Overall,Overall,90.3,87.7 to 93.0,726
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,85.8,80.3 to 91.4,230
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,91.7,88.6 to 94.9,382
≥1 Dose MMR,,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,97.3,94.8 to 99.7,114
PCV,≥1 Dose,States/Local Areas,Idaho,2011,Age,3 Months,86.1,76.4 to 92.2,246
PCV,≥1 Dose,States/Local Areas,Idaho,2012,Age,3 Months,86.3,85.4 to 87.1,223
Hib,≥2 Doses,States/Local Areas,Idaho,2014,Age,5 Months,74.2,65.6 to 81.2,201
Hib,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,5 Months,73.6,70.9 to 76.2,415
Hib,≥2 Doses,States/Local Areas,Idaho,2013,Age,5 Months,72.8,68.9 to 76.4,224
Hib,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,5 Months,73.5,69.5 to 77.2,425
PCV,≥3 Doses,States/Local Areas,Idaho,2011,Age,24 Months,93.5,89.0 to 96.6,246
PCV,≥3 Doses,States/Local Areas,Idaho,2019,Age,19 Months,91.7,86.1 to 95.1,306
PCV,≥3 Doses,States/Local Areas,Idaho,2018,Age,19 Months,95.8,92.5 to 97.7,443
PCV,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,90.3,86.8 to 93.0,749
Hib,≥2 Doses,States/Local Areas,Idaho,2011,Age,5 Months,78.2,71.2 to 84.0,246
Hib,≥2 Doses,States/Local Areas,Idaho,2012,Age,5 Months,76.8,72.8 to 80.4,223
PCV,≥3 Doses,States/Local Areas,Idaho,2012,Age,24 Months,90.3,84.5 to 94.7,223
PCV,≥3 Doses,States/Local Areas,Idaho,2013,Age,24 Months,91.1,86.3 to 94.8,224
PCV,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,91.6,88.1 to 94.3,425
Hib,≥2 Doses,States/Local Areas,Idaho,2017,Age,5 Months,74.5,68.8 to 79.5,499
Hib,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,5 Months,80.6,76.9 to 83.8,942
PCV,≥3 Doses,States/Local Areas,Idaho,2014,Age,24 Months,92.0,86.8 to 95.7,201
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,90.9,86.9 to 94.0,415
PCV,≥3 Doses,States/Local Areas,Idaho,2015,Age,24 Months,89.7,83.4 to 94.4,214
PCV,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,92.0,88.3 to 94.9,404
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,77.0,71.3 to 82.8,303
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,75.4,65.6 to 85.3,104
PCV,≥1 Dose,States/Local Areas,Idaho,2013,Age,3 Months,79.7,77.4 to 81.9,224
PCV,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,3 Months,83.5,80.9 to 85.9,425
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,87.3,83.3 to 91.3,377
Hib,≥2 Doses,States/Local Areas,Idaho,2016,Age,5 Months,81.2,73.3 to 87.1,190
Hib,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,5 Months,77.9,73.2 to 82.0,689
Hib,≥2 Doses,States/Local Areas,Idaho,2015,Age,5 Months,73.1,64.5 to 80.2,214
Hib,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,5 Months,77.1,71.4 to 82.0,404
Hib,≥2 Doses,States/Local Areas,Idaho,2014,Age,7 Months,88.3,82.0 to 92.6,201
Hib,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,88.4,84.0 to 91.7,415
Hib,≥2 Doses,States/Local Areas,Idaho,2013,Age,7 Months,85.3,82.8 to 87.5,224
Hib,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,86.8,83.5 to 89.6,425
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.0,78.0 to 90.0,236
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,75.9,69.2 to 82.7,246
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,81.0,77.4 to 84.5,726
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,74.3,67.4 to 81.2,230
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,82.6,77.9 to 87.2,382
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,92.8,87.4 to 98.3,114
PCV,≥3 Doses,States/Local Areas,Idaho,2018,Age,24 Months,96.1,93.1 to 98.1,443
PCV,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,93.8,90.9 to 96.0,749
PCV,≥3 Doses,States/Local Areas,Idaho,2017,Age,24 Months,91.7,87.7 to 94.7,499
PCV,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,93.8,91.4 to 95.8,942
Hib,≥2 Doses,States/Local Areas,Idaho,2012,Age,7 Months,93.1,91.6 to 94.3,223
PCV,≥3 Doses,States/Local Areas,Idaho,2016,Age,24 Months,94.2,90.2 to 96.9,190
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,92.9,90.2 to 95.1,689
Hib,≥2 Doses,States/Local Areas,Idaho,2011,Age,7 Months,87.4,80.8 to 91.9,246
Hib,≥2 Doses,States/Local Areas,Idaho,2019,Age,5 Months,80.1,73.3 to 85.6,306
Hib,≥2 Doses,States/Local Areas,Idaho,2018,Age,5 Months,86.8,82.2 to 90.4,443
Hib,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,5 Months,83.4,79.3 to 86.8,749
PCV,≥1 Dose,States/Local Areas,Idaho,2017,Age,3 Months,87.4,82.8 to 91.0,499
PCV,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,3 Months,88.9,85.9 to 91.4,942
PCV,≥1 Dose,States/Local Areas,Idaho,2016,Age,3 Months,87.1,79.6 to 92.1,190
PCV,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,3 Months,87.2,83.1 to 90.5,689
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.6 to 96.1,377
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,82.5,76.8 to 88.2,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2012,Age,0-3 Days,69.6,60.9 to 77.1,223
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,90.9,87.2 to 94.6,303
PCV,≥1 Dose,States/Local Areas,Idaho,2018,Age,3 Months,90.5,86.3 to 93.5,443
PCV,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,3 Months,89.2,85.8 to 91.9,749
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2011,Age,0-3 Days,75.1,67.6 to 81.3,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014,Age,0-3 Days,72.2,63.5 to 79.5,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2015,Age,0-3 Days,72.0,66.0 to 77.3,415
DTaP,≥3 Doses,States/Local Areas,Idaho,2011,Age,7 Months,68.8,62.4 to 74.5,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2012,Age,7 Months,65.6,60.8 to 70.2,223
DTaP,≥3 Doses,States/Local Areas,Idaho,2013,Age,7 Months,70.7,65.0 to 75.9,224
DTaP,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,69.6,66.8 to 72.3,425
Polio,≥1 Dose,States/Local Areas,Idaho,2011,Age,3 Months,88.2,81.0 to 92.9,246
Polio,≥1 Dose,States/Local Areas,Idaho,2012,Age,3 Months,88.2,86.0 to 90.1,223
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,91.6,89.3 to 93.9,726
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,90.7,86.4 to 95.1,230
PCV,≥1 Dose,States/Local Areas,Idaho,2019,Age,3 Months,88.1,82.3 to 92.1,306
Polio,≥1 Dose,States/Local Areas,Idaho,2013,Age,3 Months,82.2,79.7 to 84.5,224
Polio,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,3 Months,84.8,82.9 to 86.5,425
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2013,Age,0-3 Days,70.7,62.8 to 77.5,224
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2013-2014,Age,0-3 Days,71.4,65.7 to 76.6,425
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,90.9,86.7 to 95.2,246
PCV,≥1 Dose,States/Local Areas,Idaho,2015,Age,3 Months,88.3,81.4 to 92.8,214
PCV,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,3 Months,87.7,82.8 to 91.3,404
PCV,≥1 Dose,States/Local Areas,Idaho,2014,Age,3 Months,87.2,80.7 to 91.7,201
PCV,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,3 Months,87.7,83.2 to 91.1,415
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,63.7 to 96.0,39
PCV,≥4 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.5,78.8 to 86.2,581
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2015,Age,0-3 Days,71.7,63.6 to 78.7,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2015-2016,Age,0-3 Days,73.9,68.2 to 79.0,404
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.5,57.9 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.0 to 96.9,236
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,89.4 to 94.3,581
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,90.2,85.9 to 94.6,244
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,88.9,81.7 to 96.1,104
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.9,90.9 to 100.0,39
PCV,≥3 Doses,States/Local Areas,Idaho,2012,Age,35 Months,90.6,84.7 to 94.9,223
PCV,≥3 Doses,States/Local Areas,Idaho,2013,Age,35 Months,91.4,86.5 to 95.1,224
PCV,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,92.0,88.6 to 94.8,425
PCV,≥3 Doses,States/Local Areas,Idaho,2011,Age,35 Months,97.6,92.9 to 99.5,246
PCV,≥3 Doses,States/Local Areas,Idaho,2019,Age,24 Months,91.7,86.7 to 95.4,306
Hib,≥2 Doses,States/Local Areas,Idaho,2015,Age,7 Months,88.5,81.7 to 93.1,214
Hib,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,90.0,85.9 to 93.0,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016,Age,0-3 Days,76.1,67.6 to 82.9,190
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2017,Age,0-3 Days,72.5,67.4 to 77.1,689
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2017,Age,0-3 Days,70.1,58.9 to 79.3,119
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2017-2018,Age,0-3 Days,73.6,69.5 to 77.3,942
Polio,≥1 Dose,States/Local Areas,Idaho,2016,Age,3 Months,87.1,79.4 to 92.2,190
Polio,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,3 Months,87.6,83.4 to 90.9,689
Polio,≥1 Dose,States/Local Areas,Idaho,2015,Age,3 Months,88.0,81.1 to 92.6,214
Polio,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,3 Months,87.5,82.7 to 91.2,404
Polio,≥1 Dose,States/Local Areas,Idaho,2014,Age,3 Months,87.2,80.7 to 91.8,201
Polio,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,3 Months,87.6,83.1 to 91.0,415
Hib,≥3 Doses,States/Local Areas,Idaho,2013,Age,7 Months,42.0,37.1 to 47.0,224
Hib,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,7 Months,37.2,30.9 to 44.0,425
Hib,≥3 Doses,States/Local Areas,Idaho,2011,Age,7 Months,47.7,41.9 to 53.6,246
Hib,≥3 Doses,States/Local Areas,Idaho,2012,Age,7 Months,49.3,45.3 to 53.3,223
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,91.4,88.2 to 94.7,382
Hep B,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,94.5,90.5 to 98.5,114
DTaP,≥3 Doses,States/Local Areas,Idaho,2014,Age,7 Months,68.6,59.8 to 76.2,201
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,68.7,62.8 to 74.1,415
PCV,≥3 Doses,States/Local Areas,Idaho,2016,Age,35 Months,94.2,90.2 to 96.9,190
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,93.9,91.4 to 96.0,689
PCV,≥3 Doses,States/Local Areas,Idaho,2015,Age,35 Months,89.7,83.4 to 94.4,214
PCV,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.0,88.3 to 94.9,404
PCV,≥3 Doses,States/Local Areas,Idaho,2014,Age,35 Months,92.8,87.5 to 96.4,201
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,91.2,87.2 to 94.4,415
Hib,≥2 Doses,States/Local Areas,Idaho,2018,Age,7 Months,91.3,87.1 to 94.3,443
Hib,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,90.7,87.3 to 93.2,749
Hib,≥2 Doses,States/Local Areas,Idaho,2017,Age,7 Months,85.3,80.3 to 89.3,499
Hib,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,88.3,85.1 to 90.9,942
Hib,≥2 Doses,States/Local Areas,Idaho,2016,Age,7 Months,91.4,86.4 to 94.7,190
Hib,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,88.4,85.0 to 91.2,689
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,94.0,91.3 to 96.8,377
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,88.6,84.4 to 92.9,303
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,86.6,78.5 to 94.7,104
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.4,74.9 to 100.0,39
Hib,≥3 Doses,States/Local Areas,Idaho,2018,Age,7 Months,30.8,25.2 to 37.1,443
Hib,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,32.2,27.8 to 37.0,749
Hib,≥3 Doses,States/Local Areas,Idaho,2017,Age,7 Months,34.2,28.7 to 40.1,499
Hib,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,32.5,28.5 to 36.8,942
Hib,≥2 Doses,States/Local Areas,Idaho,2016,Age,13 Months,94.1,89.8 to 96.6,190
Hib,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,92.6,89.8 to 94.7,689
Hib,≥2 Doses,States/Local Areas,Idaho,2015,Age,13 Months,91.6,84.9 to 95.5,214
Hib,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,92.8,89.0 to 95.4,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,76.5,67.3 to 85.7,104
DTaP,≥3 Doses,States/Local Areas,Idaho,2011,Age,13 Months,87.2,80.4 to 91.9,246
Hib,Full Series,States/Local Areas,Idaho,2019,Age,24 Months,80.7,74.2 to 86.5,306
Hib,Full Series,States/Local Areas,Idaho,2012,Age,35 Months,82.5,74.9 to 88.9,223
Hib,Full Series,States/Local Areas,Idaho,2011,Age,35 Months,81.6,73.8 to 88.3,246
Hib,Full Series,States/Local Areas,Idaho,2013,Age,35 Months,82.7,76.0 to 88.5,224
Hib,Full Series,States/Local Areas,Idaho,2013-2014,Age,35 Months,82.6,77.8 to 86.9,425
DTaP,≥2 Doses,States/Local Areas,Idaho,2011,Age,5 Months,78.2,71.2 to 84.0,246
DTaP,≥2 Doses,States/Local Areas,Idaho,2012,Age,5 Months,74.0,68.3 to 79.1,223
DTaP,≥2 Doses,States/Local Areas,Idaho,2013,Age,5 Months,74.8,72.0 to 77.4,224
DTaP,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,5 Months,74.7,71.6 to 77.6,425
DTaP,≥2 Doses,States/Local Areas,Idaho,2014,Age,5 Months,74.6,66.1 to 81.6,201
DTaP,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,5 Months,75.4,72.3 to 78.3,415
DTaP,≥2 Doses,States/Local Areas,Idaho,2016,Age,5 Months,81.9,74.1 to 87.7,190
DTaP,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,5 Months,78.6,73.9 to 82.6,689
Polio,≥3 Doses,States/Local Areas,Idaho,2016,Age,35 Months,95.6,91.7 to 98.0,190
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,94.7,92.1 to 96.6,689
Polio,≥3 Doses,States/Local Areas,Idaho,2017,Age,35 Months,93.7,89.9 to 96.5,499
Polio,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,95.0,92.5 to 96.9,942
DTaP,≥2 Doses,States/Local Areas,Idaho,2015,Age,5 Months,76.2,67.7 to 83.0,214
DTaP,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,5 Months,79.0,73.4 to 83.7,404
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,95.5,93.1 to 97.9,377
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,88.6,84.3 to 92.8,303
Polio,≥3 Doses,States/Local Areas,Idaho,2019,Age,35 Months,92.4,86.7 to 96.2,306
Polio,≥3 Doses,States/Local Areas,Idaho,2015,Age,35 Months,88.5,82.1 to 93.4,214
Polio,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.1,88.4 to 95.0,404
Hib,Full Series,States/Local Areas,Idaho,2017,Age,35 Months,83.2,78.3 to 87.5,499
Hib,Full Series,States/Local Areas,Idaho,2017-2018,Age,35 Months,85.9,82.5 to 89.0,942
Hib,Full Series,States/Local Areas,Idaho,2014,Age,35 Months,82.2,74.9 to 88.5,201
Hib,Full Series,States/Local Areas,Idaho,2014-2015,Age,35 Months,80.3,74.7 to 85.3,415
Hib,Full Series,States/Local Areas,Idaho,2016,Age,35 Months,88.8,82.4 to 93.6,190
Hib,Full Series,States/Local Areas,Idaho,2016-2017,Age,35 Months,86.0,82.1 to 89.4,689
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,84.0,79.8 to 88.3,377
Hib,Full Series,States/Local Areas,Idaho,2019,Age,35 Months,86.5,79.6 to 92.0,306
Hib,Full Series,States/Local Areas,Idaho,2018,Age,35 Months,89.5,84.0 to 93.7,443
Hib,Full Series,States/Local Areas,Idaho,2018-2019,Age,35 Months,87.9,83.5 to 91.6,749
Hib,Full Series,States/Local Areas,Idaho,2015,Age,35 Months,77.7,69.4 to 85.2,214
Hib,Full Series,States/Local Areas,Idaho,2015-2016,Age,35 Months,83.3,78.0 to 87.9,404
Hib,Full Series,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,75.3,69.4 to 81.2,303
Hib,Full Series,States/Local Areas,Idaho,2016,Age,24 Months,85.6,79.2 to 90.8,190
Hib,Full Series,States/Local Areas,Idaho,2016-2017,Age,24 Months,82.5,78.5 to 86.2,689
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,84.4,76.0 to 92.9,104
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.4,74.9 to 100.0,39
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.0,90.6 to 95.3,581
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,89.3,84.7 to 94.0,244
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.9,88.5 to 97.4,236
Hib,Full Series,States/Local Areas,Idaho,2018,Age,24 Months,84.2,79.1 to 88.6,443
Hib,Full Series,States/Local Areas,Idaho,2018-2019,Age,24 Months,82.4,78.3 to 86.1,749
Hib,Full Series,States/Local Areas,Idaho,2017,Age,24 Months,79.4,74.3 to 84.0,499
Hib,Full Series,States/Local Areas,Idaho,2017-2018,Age,24 Months,81.7,78.2 to 85.0,942
Polio,≥3 Doses,States/Local Areas,Idaho,2011,Age,35 Months,95.7,90.2 to 98.6,246
Hib,≥3 Doses,States/Local Areas,Idaho,2014,Age,24 Months,90.4,84.6 to 94.7,201
Hib,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,89.2,84.8 to 92.8,415
Hib,≥3 Doses,States/Local Areas,Idaho,2011,Age,24 Months,92.3,87.4 to 95.9,246
Hib,≥3 Doses,States/Local Areas,Idaho,2012,Age,24 Months,90.0,84.1 to 94.3,223
Hib,≥3 Doses,States/Local Areas,Idaho,2013,Age,24 Months,89.6,84.5 to 93.6,224
Hib,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,90.4,86.7 to 93.4,425
Hib,≥3 Doses,States/Local Areas,Idaho,2019,Age,19 Months,85.2,78.3 to 90.2,306
Polio,≥3 Doses,States/Local Areas,Idaho,2019,Age,24 Months,90.2,84.7 to 94.4,306
Polio,≥3 Doses,States/Local Areas,Idaho,2018,Age,24 Months,94.9,91.9 to 97.1,443
Polio,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,92.5,89.4 to 95.0,749
DTaP,≥3 Doses,States/Local Areas,Idaho,2012,Age,24 Months,89.0,82.7 to 93.8,223
Polio,≥3 Doses,States/Local Areas,Idaho,2017,Age,24 Months,91.3,87.2 to 94.6,499
Polio,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,93.2,90.6 to 95.2,942
Hib,Full Series,States/Local Areas,Idaho,2015,Age,24 Months,70.4,62.1 to 78.2,214
Hib,Full Series,States/Local Areas,Idaho,2015-2016,Age,24 Months,77.9,72.5 to 82.9,404
DTaP,≥3 Doses,States/Local Areas,Idaho,2013,Age,24 Months,91.4,86.5 to 95.0,224
DTaP,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,92.9,89.7 to 95.3,425
Polio,≥2 Doses,States/Local Areas,Idaho,2020,Age,13 Months,94.1,88.9 to 96.9,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2011,Age,24 Months,94.6,90.3 to 97.3,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2019,Age,19 Months,91.0,85.0 to 94.7,306
DTaP,≥3 Doses,States/Local Areas,Idaho,2018,Age,19 Months,97.1,94.5 to 98.5,443
DTaP,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,90.7,87.2 to 93.3,749
DTaP,≥3 Doses,States/Local Areas,Idaho,2017,Age,19 Months,91.9,87.6 to 94.8,499
DTaP,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,94.5,92.0 to 96.2,942
DTaP,≥3 Doses,States/Local Areas,Idaho,2016,Age,19 Months,93.4,88.7 to 96.2,190
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,92.7,89.7 to 94.8,689
Polio,≥3 Doses,States/Local Areas,Idaho,2014,Age,24 Months,93.6,89.1 to 96.7,201
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,91.0,87.2 to 94.1,415
Polio,≥3 Doses,States/Local Areas,Idaho,2015,Age,24 Months,88.5,82.1 to 93.4,214
Polio,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,91.4,87.6 to 94.4,404
Polio,≥3 Doses,States/Local Areas,Idaho,2016,Age,24 Months,94.3,90.3 to 97.0,190
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,92.8,90.0 to 95.1,689
Hib,≥3 Doses,States/Local Areas,Idaho,2017,Age,19 Months,86.4,81.8 to 90.0,499
Hib,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,88.5,85.5 to 90.9,942
Hib,≥3 Doses,States/Local Areas,Idaho,2018,Age,19 Months,90.6,86.6 to 93.5,443
Hib,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,53.8,48.8 to 58.7,749
DTaP,≥3 Doses,States/Local Areas,Idaho,2015,Age,19 Months,89.8,87.7 to 91.6,214
DTaP,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,91.6,87.5 to 94.4,404
DTaP,≥3 Doses,States/Local Areas,Idaho,2014,Age,19 Months,93.6,88.6 to 96.5,201
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,91.7,87.6 to 94.5,415
Hib,≥3 Doses,States/Local Areas,Idaho,2016,Age,19 Months,89.5,82.8 to 93.8,190
Hib,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,88.0,84.2 to 91.0,689
Hib,≥3 Doses,States/Local Areas,Idaho,2015,Age,19 Months,87.2,85.0 to 89.2,214
Hib,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,88.4,83.5 to 91.9,404
Polio,≥3 Doses,States/Local Areas,Idaho,2013,Age,24 Months,90.5,85.5 to 94.3,224
Polio,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,24 Months,92.1,88.9 to 94.7,425
Hib,≥3 Doses,States/Local Areas,Idaho,2014,Age,19 Months,87.2,79.8 to 92.2,201
Hib,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,87.2,82.2 to 91.0,415
Polio,≥3 Doses,States/Local Areas,Idaho,2012,Age,24 Months,89.0,82.9 to 93.7,223
Polio,≥3 Doses,States/Local Areas,Idaho,2011,Age,24 Months,93.5,89.0 to 96.6,246
Polio,≥3 Doses,States/Local Areas,Idaho,2019,Age,19 Months,90.2,84.1 to 94.2,306
DTaP,≥3 Doses,States/Local Areas,Idaho,2016,Age,13 Months,92.0,87.1 to 95.1,190
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,13 Months,90.2,87.0 to 92.7,689
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,75.2,68.4 to 81.9,230
Hib,≥2 Doses,States/Local Areas,Idaho,2019,Age,13 Months,93.3,88.7 to 96.2,306
Hib,≥2 Doses,States/Local Areas,Idaho,2017,Age,13 Months,91.1,86.9 to 94.1,499
Hib,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,93.0,90.4 to 94.9,942
Hib,≥2 Doses,States/Local Areas,Idaho,2018,Age,13 Months,94.9,91.6 to 97.0,443
Hib,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,94.1,91.4 to 96.0,749
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,70.9,65.3 to 76.4,382
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,77.7,68.9 to 86.5,114
Polio,≥3 Doses,States/Local Areas,Idaho,2012,Age,19 Months,89.0,86.3 to 91.3,223
DTaP,≥3 Doses,States/Local Areas,Idaho,2018,Age,13 Months,93.1,89.4 to 95.5,443
DTaP,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,13 Months,90.7,87.2 to 93.3,749
DTaP,≥3 Doses,States/Local Areas,Idaho,2017,Age,13 Months,88.5,83.8 to 91.9,499
DTaP,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,13 Months,90.7,87.9 to 93.0,942
Hib,≥3 Doses,States/Local Areas,Idaho,2012,Age,13 Months,77.3,74.4 to 80.0,223
Hib,≥3 Doses,States/Local Areas,Idaho,2011,Age,13 Months,73.1,67.2 to 78.3,246
Hib,≥3 Doses,States/Local Areas,Idaho,2014,Age,13 Months,64.2,55.4 to 72.2,201
Hib,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,64.4,58.2 to 70.1,415
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,91.7,88.4 to 94.9,382
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,96.4,93.3 to 99.5,114
Polio,≥3 Doses,States/Local Areas,Idaho,2011,Age,19 Months,91.6,89.3 to 93.5,246
Hib,≥3 Doses,States/Local Areas,Idaho,2013,Age,13 Months,69.7,66.1 to 73.1,224
Hib,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,66.9,60.6 to 72.6,425
DTaP,≥3 Doses,States/Local Areas,Idaho,2019,Age,7 Months,77.1,70.2 to 82.8,306
DTaP,≥3 Doses,States/Local Areas,Idaho,2018,Age,7 Months,73.6,67.8 to 78.7,443
DTaP,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,7 Months,75.4,70.9 to 79.4,749
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,73.0,66.9 to 79.0,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,75.7,70.6 to 80.7,377
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2019,Age,0-3 Days,76.1,69.0 to 82.0,306
Hib,Full Series,States/Local Areas,Idaho,2020,Age,24 Months,83.8,77.7 to 89.0,286
Polio,≥1 Dose,States/Local Areas,Idaho,2019,Age,3 Months,89.0,83.0 to 93.0,306
Hib,≥2 Doses,States/Local Areas,Idaho,2014,Age,13 Months,94.9,90.1 to 97.4,201
Hib,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,93.2,89.4 to 95.7,415
PCV,≥3 Doses,States/Local Areas,Idaho,2019,Age,35 Months,93.7,88.5 to 97.1,306
Polio,≥1 Dose,States/Local Areas,Idaho,2018,Age,3 Months,91.6,87.6 to 94.4,443
Polio,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,3 Months,90.3,86.8 to 92.9,749
Polio,≥1 Dose,States/Local Areas,Idaho,2017,Age,3 Months,88.1,83.6 to 91.5,499
Polio,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,3 Months,89.8,86.9 to 92.1,942
Hib,≥3 Doses,States/Local Areas,Idaho,2016,Age,7 Months,38.2,29.8 to 47.4,190
Hib,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,36.2,31.1 to 41.7,689
Hib,≥3 Doses,States/Local Areas,Idaho,2015,Age,7 Months,37.7,30.2 to 46.0,214
Hib,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,38.0,32.2 to 44.1,404
Hib,≥3 Doses,States/Local Areas,Idaho,2014,Age,7 Months,32.7,25.3 to 41.0,201
Hib,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,7 Months,35.2,29.9 to 40.9,415
PCV,≥3 Doses,States/Local Areas,Idaho,2018,Age,35 Months,96.1,93.1 to 98.1,443
PCV,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,95.2,91.9 to 97.4,749
PCV,≥3 Doses,States/Local Areas,Idaho,2017,Age,35 Months,93.7,90.0 to 96.3,499
PCV,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,95.2,92.8 to 97.0,942
Hib,≥2 Doses,States/Local Areas,Idaho,2013,Age,13 Months,89.5,87.6 to 91.1,224
Hib,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,92.2,90.9 to 93.4,425
DTaP,≥3 Doses,States/Local Areas,Idaho,2017,Age,7 Months,66.9,60.9 to 72.3,499
DTaP,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,7 Months,70.2,66.1 to 74.0,942
DTaP,≥3 Doses,States/Local Areas,Idaho,2016,Age,7 Months,73.0,64.2 to 80.2,190
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,7 Months,69.9,64.7 to 74.7,689
DTaP,≥3 Doses,States/Local Areas,Idaho,2015,Age,7 Months,68.9,60.2 to 76.4,214
DTaP,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,7 Months,70.9,64.8 to 76.3,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2018,Age,0-3 Days,78.5,73.0 to 83.2,443
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2018-2019,Age,0-3 Days,77.3,72.9 to 81.2,749
Hib,≥2 Doses,States/Local Areas,Idaho,2011,Age,13 Months,95.4,90.3 to 97.9,246
Hib,≥2 Doses,States/Local Areas,Idaho,2012,Age,13 Months,95.2,90.3 to 97.7,223
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,89.4 to 94.4,581
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,85.1 to 94.5,244
Hib,≥3 Doses,States/Local Areas,Idaho,2019,Age,7 Months,33.6,27.0 to 40.9,306
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.8,72.8 to 84.8,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,72.8,66.1 to 79.5,244
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,68.1,60.7 to 75.5,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Overall,Overall,73.4,69.5 to 77.3,726
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.7,62.8 to 94.6,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.8,67.3 to 76.3,581
Hib,≥2 Doses,States/Local Areas,Idaho,2019,Age,7 Months,90.0,84.2 to 93.9,306
DTaP,≥3 Doses,States/Local Areas,Idaho,2014,Age,13 Months,91.3,85.5 to 94.9,201
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,13 Months,88.6,83.9 to 92.0,415
DTaP,≥3 Doses,States/Local Areas,Idaho,2013,Age,13 Months,88.9,85.9 to 91.2,224
DTaP,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,13 Months,90.1,88.3 to 91.7,425
DTaP,≥3 Doses,States/Local Areas,Idaho,2012,Age,13 Months,85.2,78.4 to 90.1,223
DTaP,≥3 Doses,States/Local Areas,Idaho,2015,Age,13 Months,85.8,78.0 to 91.2,214
DTaP,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,13 Months,88.9,84.4 to 92.2,404
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,90.1,85.8 to 94.5,246
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.9,87.4 to 96.5,236
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,90.6,88.0 to 93.3,726
PCV,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,87.1,81.6 to 92.5,230
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,Hispanic,73.6,63.0 to 84.2,84
Hib,Full Series,States/Local Areas,Iowa,2018,Age,19 Months,87.0,80.4 to 91.6,255
Hib,Full Series,States/Local Areas,Iowa,2018-2019,Age,19 Months,95.4,91.6 to 97.5,505
Combined 7 Series,,States/Local Areas,Iowa,2015,Age,35 Months,80.4,72.9 to 86.9,238
Combined 7 Series,,States/Local Areas,Iowa,2015-2016,Age,35 Months,81.9,76.5 to 86.6,436
Combined 7 Series,,States/Local Areas,Iowa,2018,Age,35 Months,87.7,79.9 to 93.5,255
Combined 7 Series,,States/Local Areas,Iowa,2018-2019,Age,35 Months,87.2,82.0 to 91.6,505
Combined 7 Series,,States/Local Areas,Iowa,2019,Age,35 Months,86.9,79.1 to 92.8,250
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,62.6,55.8 to 69.4,297
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,80.5,76.6 to 84.5,472
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.5,47.2 to 83.8,37
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,79.7,66.8 to 92.5,49
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Overall,Overall,71.7,68.0 to 75.4,838
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,69.1,62.9 to 75.4,326
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,61.3,53.6 to 69.1,222
Hib,Full Series,States/Local Areas,Iowa,2013,Age,19 Months,81.2,78.0 to 84.0,265
Hib,Full Series,States/Local Areas,Iowa,2013-2014,Age,19 Months,80.5,77.8 to 82.9,542
Hib,Full Series,States/Local Areas,Iowa,2012,Age,19 Months,79.8,68.4 to 87.8,247
Hib,Full Series,States/Local Areas,Iowa,2011,Age,19 Months,68.8,60.8 to 75.9,220
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,79.7,74.0 to 85.3,238
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,74.7,69.5 to 80.0,378
Hib,Full Series,States/Local Areas,Iowa,2014,Age,24 Months,84.5,78.8 to 89.3,277
Hib,Full Series,States/Local Areas,Iowa,2014-2015,Age,24 Months,84.2,80.0 to 88.0,515
Hib,Full Series,States/Local Areas,Iowa,2013,Age,24 Months,84.2,78.4 to 89.1,265
Hib,Full Series,States/Local Areas,Iowa,2013-2014,Age,24 Months,84.3,80.3 to 87.9,542
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Principal City,74.4,68.3 to 80.5,274
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.9,65.1 to 78.8,238
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.9,67.7 to 76.2,642
Combined 7 Series,,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.6,58.6 to 84.5,75
Hib,Full Series,States/Local Areas,Iowa,2011,Age,24 Months,78.7,70.4 to 86.0,220
Hib,Full Series,States/Local Areas,Iowa,2012,Age,24 Months,86.2,80.8 to 90.8,247
Hib,Full Series,States/Local Areas,Iowa,2017,Age,19 Months,74.1,66.1 to 80.8,228
Hib,Full Series,States/Local Areas,Iowa,2017-2018,Age,19 Months,80.5,75.4 to 84.7,483
Hib,Full Series,States/Local Areas,Iowa,2019,Age,19 Months,82.7,75.1 to 88.4,250
Hib,Full Series,States/Local Areas,Iowa,2016,Age,19 Months,78.6,70.3 to 85.1,198
Hib,Full Series,States/Local Areas,Iowa,2016-2017,Age,19 Months,76.4,70.9 to 81.1,426
Hib,Full Series,States/Local Areas,Iowa,2014,Age,19 Months,79.8,73.5 to 84.9,277
Hib,Full Series,States/Local Areas,Iowa,2014-2015,Age,19 Months,78.6,74.0 to 82.6,515
Hib,Full Series,States/Local Areas,Iowa,2015,Age,19 Months,77.4,71.5 to 82.5,238
Hib,Full Series,States/Local Areas,Iowa,2015-2016,Age,19 Months,78.0,72.6 to 82.6,436
Combined 7 Series,,States/Local Areas,Iowa,2014,Age,24 Months,70.7,63.9 to 77.1,277
Combined 7 Series,,States/Local Areas,Iowa,2014-2015,Age,24 Months,72.8,68.0 to 77.4,515
Hib,Primary Series,States/Local Areas,Iowa,2019,Age,35 Months,95.3,89.9 to 98.3,250
Combined 7 Series,,States/Local Areas,Iowa,2016,Age,24 Months,73.5,65.2 to 81.1,198
Combined 7 Series,,States/Local Areas,Iowa,2016-2017,Age,24 Months,71.5,65.8 to 77.0,426
Hib,Primary Series,States/Local Areas,Iowa,2018,Age,35 Months,95.9,90.9 to 98.6,255
Hib,Primary Series,States/Local Areas,Iowa,2018-2019,Age,35 Months,95.6,92.2 to 97.8,505
Combined 7 Series,,States/Local Areas,Iowa,2015,Age,24 Months,75.0,68.0 to 81.5,238
Combined 7 Series,,States/Local Areas,Iowa,2015-2016,Age,24 Months,74.2,68.7 to 79.3,436
Hep A,≥2 Doses,States/Local Areas,Iowa,2020,Age,35 Months,83.3,73.3 to 91.2,271
≥1 Dose MMR,,States/Local Areas,Iowa,2020,Age,13 Months,54.2,45.2 to 62.9,271
Combined 7 Series,,States/Local Areas,Iowa,2020,Age,35 Months,72.5,63.6 to 80.7,271
Hep A,≥1 Dose,States/Local Areas,Iowa,2020,Age,19 Months,86.2,78.9 to 91.2,271
Hep A,≥2 Doses,States/Local Areas,Iowa,2020,Age,19 Months,34.5,26.8 to 43.1,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2020,Age,0-2 Days,85.7,79.1 to 90.4,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2020,Age,0-1 Days,82.7,75.9 to 88.0,271
Hib,≥2 Doses,States/Local Areas,Iowa,2020,Age,7 Months,90.6,84.6 to 94.4,271
Polio,≥2 Doses,States/Local Areas,Iowa,2020,Age,7 Months,90.8,84.8 to 94.6,271
Hib,≥3 Doses,States/Local Areas,Iowa,2020,Age,7 Months,31.5,24.2 to 39.8,271
Hib,Primary Series,States/Local Areas,Iowa,2020,Age,7 Months,77.7,69.0 to 84.5,271
Hep B,≥2 Doses,States/Local Areas,Iowa,2020,Age,7 Months,95.4,91.4 to 97.5,271
PCV,≥2 Doses,States/Local Areas,Iowa,2020,Age,5 Months,85.2,78.1 to 90.3,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2019-2020,Age,0-2 Days,85.4,80.9 to 89.0,521
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2019-2020,Age,0-1 Days,80.6,75.6 to 84.8,521
Hep A,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,19 Months,88.6,84.2 to 91.9,521
PCV,≥4 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,86.7,81.8 to 90.4,521
PCV,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,93.4,89.8 to 95.8,521
≥1 Dose Varicella,,States/Local Areas,Iowa,2019-2020,Age,19 Months,90.5,86.4 to 93.5,521
Hep B,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,94.1,90.6 to 96.4,521
Hib,Full Series,States/Local Areas,Iowa,2019-2020,Age,19 Months,79.1,73.5 to 83.8,521
Combined 7 Series,,States/Local Areas,Iowa,2019-2020,Age,35 Months,79.7,73.9 to 84.9,521
Hib,Primary Series,States/Local Areas,Iowa,2019-2020,Age,24 Months,94.6,91.3 to 96.9,521
Hib,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,92.4,88.5 to 95.0,521
Hib,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,92.5,89.1 to 95.2,521
Influenza,,States/Local Areas,Iowa,2019-2020,Age,24 Months,50.7,44.9 to 56.8,521
Hep A,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,82.8,76.4 to 88.3,521
Hep A,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,35 Months,92.6,88.8 to 95.5,521
Hep A,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,57.1,51.0 to 63.4,521
Hep A,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,24 Months,91.3,87.5 to 94.2,521
Hep A,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,35.9,30.3 to 41.8,521
PCV,≥4 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,88.7,84.3 to 92.2,521
PCV,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,93.8,90.4 to 96.2,521
PCV,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,75.8,69.8 to 80.9,521
Hib,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,35.3,29.8 to 41.3,521
≥1 Dose Varicella,,States/Local Areas,Iowa,2019-2020,Age,24 Months,92.4,88.6 to 95.2,521
Hib,Full Series,States/Local Areas,Iowa,2019-2020,Age,24 Months,84.2,79.1 to 88.6,521
Hep B,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,94.3,91.1 to 96.7,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,97.1,93.5 to 100.0,91
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.5,76.1 to 98.8,30
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,87.2 to 100.0,83
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.7,82.0 to 89.4,618
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,93.1,86.3 to 99.9,62
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,94.2,90.8 to 97.6,282
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,97.6,96.1 to 99.0,469
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.9,84.5 to 91.3,618
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,89.1,81.0 to 97.3,62
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,92.8,87.1 to 98.4,91
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.6,73.4 to 99.4,30
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,88.4,77.7 to 99.1,62
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,98.6,96.0 to 100.0,62
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,95.0,92.1 to 98.0,282
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,81.8,68.9 to 94.7,62
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,79.0,73.0 to 85.1,282
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.5,76.1 to 98.8,30
Influenza,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,53.5,47.9 to 59.0,469
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.6,94.7 to 98.6,618
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,94.9,90.4 to 99.4,91
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.0,95.4 to 98.6,618
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.5,76.1 to 98.8,30
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,98.3,95.6 to 100.0,62
Influenza,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",28.8,9.5 to 48.0,30
Influenza,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",40.1,27.4 to 52.7,83
Influenza,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",52.0,47.0 to 56.9,618
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,91.3,83.4 to 99.2,62
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,89.2,82.4 to 96.0,91
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.0,67.2 to 94.7,30
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.9,86.6 to 93.1,618
Rotavirus,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.6,66.8 to 88.4,83
Rotavirus,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,72.0,61.0 to 83.0,91
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.5,67.8 to 91.1,83
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.4,74.2 to 82.6,618
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.0,49.5 to 86.6,30
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,75.6,65.8 to 85.5,91
Rotavirus,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,70.7,64.4 to 77.0,282
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.6,66.6 to 94.6,30
Rotavirus,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,75.4,62.1 to 88.6,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.9,72.3 to 93.6,83
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,87.9,71.7 to 100.0,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,85.6,78.2 to 93.0,91
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,97.1,93.5 to 100.0,91
Influenza,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,38.5,23.9 to 53.2,62
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.5,75.1 to 95.8,83
Influenza,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,45.1,37.9 to 52.3,282
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,94.2,90.8 to 97.6,282
Rotavirus,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,91.0,88.0 to 93.9,469
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,98.0,96.7 to 99.3,469
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,92.9,89.0 to 96.7,282
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,87.7 to 100.0,83
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,97.3,94.1 to 100.0,91
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.3,75.3 to 99.4,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,82.5,71.8 to 93.2,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,84.1,79.1 to 89.0,282
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.6,86.7 to 92.5,618
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,85.1,81.4 to 88.9,469
Rotavirus,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.2,54.2 to 88.2,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.8,73.9 to 97.7,30
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,91.3 to 96.3,618
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.3,75.3 to 99.4,30
Rotavirus,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.6,78.8 to 86.4,618
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.2 to 96.8,618
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.1,71.7 to 82.5,618
DTaP,≥4 Doses,States/Local Areas,Iowa,2020,Age,24 Months,80.2,72.6 to 86.8,271
DTaP,≥3 Doses,States/Local Areas,Iowa,2020,Age,24 Months,93.2,88.4 to 96.5,271
Polio,≥3 Doses,States/Local Areas,Iowa,2020,Age,24 Months,93.0,88.3 to 96.3,271
≥1 Dose MMR,,States/Local Areas,Iowa,2020,Age,24 Months,90.3,84.1 to 94.8,271
≥1 Dose MMR,,States/Local Areas,Iowa,2020,Age,35 Months,94.0,87.4 to 97.8,271
Hib,≥3 Doses,States/Local Areas,Iowa,2020,Age,24 Months,90.4,85.3 to 94.3,271
Hib,≥3 Doses,States/Local Areas,Iowa,2020,Age,35 Months,92.8,87.7 to 96.4,271
Hib,Primary Series,States/Local Areas,Iowa,2020,Age,35 Months,93.7,89.0 to 96.8,271
Hib,Full Series,States/Local Areas,Iowa,2020,Age,35 Months,79.6,71.0 to 87.0,271
Hep B,≥3 Doses,States/Local Areas,Iowa,2020,Age,35 Months,95.4,90.2 to 98.3,271
≥1 Dose Varicella,,States/Local Areas,Iowa,2020,Age,35 Months,94.6,89.0 to 97.9,271
Hib,Primary Series,States/Local Areas,Iowa,2020,Age,19 Months,93.7,88.5 to 96.6,271
Hib,Full Series,States/Local Areas,Iowa,2020,Age,19 Months,74.9,66.1 to 82.0,271
Hep B,≥3 Doses,States/Local Areas,Iowa,2020,Age,19 Months,93.6,88.4 to 96.5,271
≥1 Dose Varicella,,States/Local Areas,Iowa,2020,Age,19 Months,89.4,82.9 to 93.6,271
DTaP,≥3 Doses,States/Local Areas,Iowa,2020,Age,35 Months,96.2,91.3 to 98.8,271
DTaP,≥4 Doses,States/Local Areas,Iowa,2020,Age,35 Months,86.9,79.7 to 92.6,271
PCV,≥4 Doses,States/Local Areas,Iowa,2020,Age,19 Months,84.0,76.6 to 89.3,271
Polio,≥3 Doses,States/Local Areas,Iowa,2020,Age,35 Months,96.7,91.8 to 99.0,271
PCV,≥3 Doses,States/Local Areas,Iowa,2020,Age,19 Months,92.3,87.0 to 95.6,271
Hib,≥2 Doses,States/Local Areas,Iowa,2020,Age,13 Months,93.6,88.4 to 96.5,271
PCV,≥3 Doses,States/Local Areas,Iowa,2020,Age,35 Months,95.0,90.4 to 97.9,271
Hib,Primary Series,States/Local Areas,Iowa,2020,Age,13 Months,88.4,80.8 to 93.3,271
Hib,≥3 Doses,States/Local Areas,Iowa,2020,Age,13 Months,62.2,53.2 to 70.4,271
Hep B,≥2 Doses,States/Local Areas,Iowa,2020,Age,13 Months,95.9,92.1 to 98.0,271
Hep B,≥3 Doses,States/Local Areas,Iowa,2020,Age,13 Months,92.9,87.7 to 96.0,271
≥1 Dose Varicella,,States/Local Areas,Iowa,2020,Age,13 Months,48.2,39.5 to 57.0,271
DTaP,≥3 Doses,States/Local Areas,Iowa,2020,Age,7 Months,76.9,68.2 to 83.7,271
PCV,≥3 Doses,States/Local Areas,Iowa,2020,Age,13 Months,89.7,83.1 to 93.9,271
DTaP,≥3 Doses,States/Local Areas,Iowa,2020,Age,19 Months,92.8,87.5 to 95.9,271
DTaP,≥4 Doses,States/Local Areas,Iowa,2020,Age,19 Months,76.4,67.7 to 83.3,271
≥1 Dose MMR,,States/Local Areas,Iowa,2020,Age,19 Months,88.9,81.9 to 93.4,271
Polio,≥3 Doses,States/Local Areas,Iowa,2020,Age,19 Months,92.6,87.3 to 95.8,271
Hib,≥3 Doses,States/Local Areas,Iowa,2020,Age,19 Months,89.0,83.1 to 93.0,271
Combined 7 Series,,States/Local Areas,Iowa,2020,Age,24 Months,69.4,60.7 to 77.6,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2020,Age,0-3 Days,85.8,79.2 to 90.5,271
Rotavirus,,States/Local Areas,Iowa,2020,Age,8 Months,81.2,73.4 to 87.1,271
Influenza,,States/Local Areas,Iowa,2020,Age,24 Months,44.6,36.5 to 53.5,271
≥1 Dose Varicella,,States/Local Areas,Iowa,2020,Age,24 Months,91.0,85.3 to 95.1,271
PCV,≥3 Doses,States/Local Areas,Iowa,2020,Age,24 Months,92.7,87.9 to 96.1,271
PCV,≥4 Doses,States/Local Areas,Iowa,2020,Age,24 Months,86.0,79.4 to 91.3,271
Hep A,≥2 Doses,States/Local Areas,Iowa,2020,Age,24 Months,50.6,42.3 to 59.5,271
Hep A,≥1 Dose,States/Local Areas,Iowa,2020,Age,24 Months,88.9,82.6 to 93.8,271
Hep B,≥1 Dose,States/Local Areas,Iowa,2020,Age,3 Months,96.7,93.6 to 98.3,271
PCV,≥1 Dose,States/Local Areas,Iowa,2020,Age,3 Months,91.7,86.4 to 95.0,271
DTaP,≥2 Doses,States/Local Areas,Iowa,2020,Age,5 Months,86.4,79.3 to 91.4,271
Polio,≥2 Doses,States/Local Areas,Iowa,2020,Age,5 Months,86.0,78.9 to 91.0,271
Hib,≥2 Doses,States/Local Areas,Iowa,2020,Age,5 Months,84.5,77.0 to 89.9,271
Hep B,≥2 Doses,States/Local Areas,Iowa,2020,Age,5 Months,94.7,90.7 to 97.0,271
DTaP,≥1 Dose,States/Local Areas,Iowa,2020,Age,3 Months,92.1,86.8 to 95.4,271
PCV,≥2 Doses,States/Local Areas,Iowa,2021,Age,5 Months,79.1,68.2 to 86.9,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,91.2,86.1 to 94.5,455
DTaP,≥3 Doses,States/Local Areas,Iowa,2021,Age,7 Months,77.9,67.2 to 85.8,184
Polio,≥3 Doses,States/Local Areas,Iowa,2021,Age,35 Months,92.4,84.8 to 97.0,184
Hep B,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,94.2,89.9 to 96.7,455
Hep B,≥2 Doses,States/Local Areas,Iowa,2021,Age,7 Months,92.4,84.1 to 96.6,184
Hib,≥2 Doses,States/Local Areas,Iowa,2021,Age,7 Months,89.8,80.2 to 95.1,184
≥1 Dose MMR,,States/Local Areas,Iowa,2021,Age,35 Months,93.0,85.1 to 97.5,184
Hib,≥3 Doses,States/Local Areas,Iowa,2021,Age,7 Months,37.6,28.2 to 48.1,184
PCV,≥3 Doses,States/Local Areas,Iowa,2021,Age,35 Months,89.4,80.9 to 95.3,184
Hep A,≥1 Dose,States/Local Areas,Iowa,2016,Age,19 Months,83.8,76.0 to 89.4,198
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,19 Months,84.5,79.8 to 88.3,426
Hep A,≥1 Dose,States/Local Areas,Iowa,2017,Age,19 Months,85.3,79.3 to 89.8,228
Hep A,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,19 Months,86.6,82.4 to 89.9,483
Hep A,≥1 Dose,States/Local Areas,Iowa,2018,Age,19 Months,87.8,81.3 to 92.3,255
Hep A,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,19 Months,90.4,85.5 to 93.8,396
DTaP,≥3 Doses,States/Local Areas,Iowa,2013,Age,35 Months,97.9,94.4 to 99.4,265
DTaP,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,97.4,95.3 to 98.6,542
DTaP,≥3 Doses,States/Local Areas,Iowa,2012,Age,35 Months,96.4,91.9 to 98.7,247
DTaP,≥3 Doses,States/Local Areas,Iowa,2011,Age,35 Months,96.8,91.6 to 99.2,220
DTaP,≥3 Doses,States/Local Areas,Iowa,2014,Age,35 Months,96.8,93.8 to 98.6,277
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,96.8,94.3 to 98.4,515
Hep A,≥2 Doses,States/Local Areas,Iowa,2011,Age,19 Months,23.7,15.4 to 34.6,220
Hep A,≥2 Doses,States/Local Areas,Iowa,2013,Age,19 Months,26.0,20.4 to 32.5,265
Hep A,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,27.8,27.2 to 28.5,542
Hep A,≥2 Doses,States/Local Areas,Iowa,2014,Age,19 Months,29.6,23.9 to 36.1,277
Hep A,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,33.1,28.2 to 38.3,515
Hep A,≥2 Doses,States/Local Areas,Iowa,2012,Age,19 Months,34.6,32.7 to 36.5,247
Hib,≥3 Doses,States/Local Areas,Iowa,2018,Age,24 Months,92.9,87.0 to 96.7,255
Hib,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,93.7,89.9 to 96.4,505
Hib,≥3 Doses,States/Local Areas,Iowa,2019,Age,24 Months,94.5,88.8 to 97.9,250
DTaP,≥3 Doses,States/Local Areas,Iowa,2017,Age,35 Months,97.2,93.3 to 99.1,228
DTaP,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,97.9,95.8 to 99.0,483
DTaP,≥4 Doses,States/Local Areas,Iowa,2011,Age,19 Months,64.8,54.9 to 73.5,220
DTaP,≥4 Doses,States/Local Areas,Iowa,2012,Age,19 Months,73.2,63.2 to 81.4,247
PCV,≥2 Doses,States/Local Areas,Iowa,2013,Age,5 Months,80.3,78.5 to 81.9,265
PCV,≥2 Doses,States/Local Areas,Iowa,2013-2014,Age,5 Months,80.1,75.5 to 84.1,542
PCV,≥2 Doses,States/Local Areas,Iowa,2012,Age,5 Months,73.9,70.0 to 77.4,247
PCV,≥2 Doses,States/Local Areas,Iowa,2011,Age,5 Months,74.9,69.5 to 79.6,220
DTaP,≥3 Doses,States/Local Areas,Iowa,2015,Age,35 Months,96.5,92.1 to 98.8,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,97.5,95.0 to 99.0,436
DTaP,≥3 Doses,States/Local Areas,Iowa,2016,Age,35 Months,99.0,95.9 to 99.9,198
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,97.8,95.6 to 99.1,426
Hep A,≥2 Doses,States/Local Areas,Iowa,2015,Age,19 Months,36.5,33.0 to 40.2,238
Hep A,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,36.4,30.8 to 42.3,436
Hep A,≥2 Doses,States/Local Areas,Iowa,2016,Age,19 Months,36.3,28.5 to 44.9,198
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,19 Months,29.4,24.4 to 34.9,426
Hib,≥3 Doses,States/Local Areas,Iowa,2013,Age,35 Months,95.0,90.9 to 97.6,265
Hib,≥3 Doses,States/Local Areas,Iowa,2013-2014,Age,35 Months,94.6,91.6 to 96.9,542
Hib,≥3 Doses,States/Local Areas,Iowa,2014,Age,35 Months,95.4,88.4 to 98.7,277
Hib,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,35 Months,95.2,90.2 to 98.1,515
Hib,≥3 Doses,States/Local Areas,Iowa,2015,Age,35 Months,93.7,88.4 to 97.1,238
Hib,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,35 Months,96.4,93.4 to 98.3,436
Hep A,≥2 Doses,States/Local Areas,Iowa,2017,Age,19 Months,22.4,16.7 to 29.3,228
Hep A,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,19 Months,29.2,24.5 to 34.5,483
Hep A,≥1 Dose,States/Local Areas,Iowa,2015,Age,24 Months,82.8,75.9 to 88.6,238
Hep A,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,24 Months,85.1,80.4 to 89.2,436
Hep A,≥1 Dose,States/Local Areas,Iowa,2016,Age,24 Months,87.1,80.4 to 92.4,198
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,24 Months,86.9,82.7 to 90.5,426
PCV,≥2 Doses,States/Local Areas,Iowa,2014,Age,5 Months,80.0,73.8 to 85.0,277
PCV,≥2 Doses,States/Local Areas,Iowa,2014-2015,Age,5 Months,79.7,74.7 to 84.0,515
PCV,≥2 Doses,States/Local Areas,Iowa,2015,Age,5 Months,79.5,72.1 to 85.4,238
PCV,≥2 Doses,States/Local Areas,Iowa,2015-2016,Age,5 Months,81.7,76.3 to 86.1,436
PCV,≥2 Doses,States/Local Areas,Iowa,2016,Age,5 Months,83.9,75.5 to 89.9,198
PCV,≥2 Doses,States/Local Areas,Iowa,2016-2017,Age,5 Months,82.8,77.5 to 87.0,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2018,Age,35 Months,98.5,96.3 to 99.5,255
DTaP,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,97.0,94.2 to 98.7,505
DTaP,≥3 Doses,States/Local Areas,Iowa,2019,Age,35 Months,95.1,89.8 to 98.2,250
Hep A,≥1 Dose,States/Local Areas,Iowa,2017,Age,24 Months,86.6,81.2 to 91.1,228
Hep A,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,24 Months,88.6,84.7 to 91.8,483
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Other,97.8,93.6 to 100.0,49
Hep A,≥1 Dose,States/Local Areas,Iowa,2018,Age,24 Months,90.5,84.7 to 94.8,255
Hep A,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,24 Months,91.9,88.3 to 94.8,505
Hep A,≥1 Dose,States/Local Areas,Iowa,2019,Age,24 Months,93.3,88.7 to 96.5,250
Hep A,≥1 Dose,States/Local Areas,Iowa,2011,Age,35 Months,89.8,83.2 to 94.7,220
PCV,≥2 Doses,States/Local Areas,Iowa,2017,Age,5 Months,81.6,74.3 to 87.2,228
PCV,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,5 Months,85.2,80.5 to 88.9,483
Hib,≥3 Doses,States/Local Areas,Iowa,2018,Age,35 Months,97.4,93.9 to 99.1,255
Hib,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,35 Months,96.0,92.6 to 98.1,505
Hep A,≥2 Doses,States/Local Areas,Iowa,2012,Age,24 Months,53.9,45.7 to 62.7,247
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.7,76.4 to 100.0,37
DTaP,≥4 Doses,States/Local Areas,Iowa,2013,Age,19 Months,74.3,71.3 to 77.0,265
DTaP,≥4 Doses,States/Local Areas,Iowa,2013-2014,Age,19 Months,73.1,71.1 to 75.0,542
DTaP,≥4 Doses,States/Local Areas,Iowa,2014,Age,19 Months,72.0,65.3 to 77.8,277
DTaP,≥4 Doses,States/Local Areas,Iowa,2014-2015,Age,19 Months,72.9,68.0 to 77.3,515
DTaP,≥4 Doses,States/Local Areas,Iowa,2015,Age,19 Months,73.8,70.4 to 76.9,238
DTaP,≥4 Doses,States/Local Areas,Iowa,2015-2016,Age,19 Months,75.0,69.4 to 79.9,436
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Any Medicaid,92.5,89.0 to 96.1,297
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2017,Insurance Coverage,Private Insurance Only,98.4,97.4 to 99.5,472
Hib,≥3 Doses,States/Local Areas,Iowa,2016,Age,35 Months,99.5,97.4 to 100.0,198
Hib,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,35 Months,96.3,92.8 to 98.4,426
Hib,≥3 Doses,States/Local Areas,Iowa,2017,Age,35 Months,93.1,87.1 to 97.0,228
Hib,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,35 Months,95.4,91.9 to 97.7,483
Hep A,≥2 Doses,States/Local Areas,Iowa,2018,Age,19 Months,36.3,28.9 to 44.4,255
Hep A,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,19 Months,38.8,32.1 to 45.9,396
Hep A,≥2 Doses,States/Local Areas,Iowa,2019,Age,19 Months,37.0,29.4 to 45.4,250
Hep A,≥2 Doses,States/Local Areas,Iowa,2011,Age,24 Months,43.4,34.8 to 53.2,220
Hib,≥3 Doses,States/Local Areas,Iowa,2012,Age,35 Months,92.4,87.8 to 95.8,247
Hib,≥3 Doses,States/Local Areas,Iowa,2011,Age,35 Months,92.9,86.5 to 97.0,220
Hep A,≥1 Dose,States/Local Areas,Iowa,2019,Age,19 Months,90.6,84.5 to 94.4,250
Hep A,≥1 Dose,States/Local Areas,Iowa,2011,Age,24 Months,74.0,66.3 to 81.2,220
Hep A,≥1 Dose,States/Local Areas,Iowa,2013,Age,24 Months,82.8,76.8 to 88.0,265
Hep A,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,24 Months,82.5,78.4 to 86.3,542
Hep A,≥1 Dose,States/Local Areas,Iowa,2014,Age,24 Months,82.4,76.6 to 87.5,277
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,24 Months,82.6,78.2 to 86.6,515
Hep A,≥1 Dose,States/Local Areas,Iowa,2012,Age,24 Months,80.7,74.3 to 86.4,247
Hep A,≥1 Dose,States/Local Areas,Iowa,2012,Age,35 Months,82.5,76.2 to 88.0,247
Hib,≥3 Doses,States/Local Areas,Iowa,2021,Age,19 Months,89.0,79.3 to 94.5,184
Polio,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,3 Months,92.7,89.0 to 95.2,521
Hib,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,3 Months,91.9,87.9 to 94.7,521
DTaP,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,3 Months,92.7,89.0 to 95.2,521
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2019-2020,Age,0-3 Days,85.6,81.1 to 89.2,521
Polio,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,96.3,93.1 to 98.3,521
DTaP,≥4 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,90.0,85.3 to 93.7,521
Combined 7 Series,,States/Local Areas,Iowa,2019-2020,Age,24 Months,76.4,70.7 to 81.7,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,96.0,92.8 to 98.1,521
PCV,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,91.4,87.1 to 94.3,521
≥1 Dose Varicella,,States/Local Areas,Iowa,2019-2020,Age,13 Months,49.9,43.9 to 56.0,521
Hep B,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,93.0,89.3 to 95.6,521
Hep B,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,95.0,91.5 to 97.1,521
Polio,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,92.5,88.6 to 95.1,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,77.8,71.9 to 82.8,521
PCV,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,5 Months,86.0,81.1 to 89.8,521
Hep B,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,5 Months,93.5,89.9 to 95.9,521
Hib,Primary Series,States/Local Areas,Iowa,2019-2020,Age,13 Months,91.7,87.2 to 94.7,521
Hib,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,5 Months,86.1,81.2 to 90.0,521
Hib,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,94.5,91.0 to 96.7,521
Hib,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,62.0,55.9 to 67.7,521
≥1 Dose MMR,,States/Local Areas,Iowa,2019-2020,Age,13 Months,57.4,51.2 to 63.3,521
Polio,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,94.5,91.0 to 96.7,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,13 Months,92.0,87.9 to 94.7,521
Polio,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,5 Months,86.9,82.1 to 90.6,521
DTaP,≥2 Doses,States/Local Areas,Iowa,2019-2020,Age,5 Months,87.1,82.3 to 90.8,521
PCV,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,3 Months,92.1,88.2 to 94.8,521
Hep B,≥1 Dose,States/Local Areas,Iowa,2019-2020,Age,3 Months,96.0,92.9 to 97.8,521
≥1 Dose MMR,,States/Local Areas,Iowa,2019-2020,Age,24 Months,92.6,89.0 to 95.5,521
Polio,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,93.8,90.5 to 96.3,521
DTaP,≥4 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,84.5,79.6 to 88.8,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,24 Months,94.0,90.7 to 96.4,521
PCV,≥4 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,89.1,84.8 to 92.7,521
PCV,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,95.1,91.9 to 97.3,521
≥1 Dose Varicella,,States/Local Areas,Iowa,2019-2020,Age,35 Months,94.2,90.5 to 96.9,521
Hep B,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,95.5,92.0 to 97.8,521
Hib,Primary Series,States/Local Areas,Iowa,2019-2020,Age,35 Months,94.6,91.3 to 96.9,521
Hib,Full Series,States/Local Areas,Iowa,2019-2020,Age,35 Months,85.7,80.5 to 90.1,521
≥1 Dose MMR,,States/Local Areas,Iowa,2019-2020,Age,35 Months,94.7,91.2 to 97.2,521
Hib,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,35 Months,93.9,90.5 to 96.4,521
Hib,Primary Series,States/Local Areas,Iowa,2019-2020,Age,19 Months,94.4,90.9 to 96.6,521
Hib,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,89.3,85.1 to 92.5,521
≥1 Dose MMR,,States/Local Areas,Iowa,2019-2020,Age,19 Months,90.6,86.4 to 93.7,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2016,Age,24 Months,98.1,95.4 to 99.4,198
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,96.4,94.0 to 98.0,426
DTaP,≥1 Dose,States/Local Areas,Iowa,2019,Age,3 Months,93.2,86.8 to 96.6,250
Hep A,≥1 Dose,States/Local Areas,Iowa,2011,Age,19 Months,73.5,68.9 to 77.5,220
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,>400% FPL,97.8,95.7 to 99.8,238
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,133% to <400% FPL,97.3,95.7 to 98.9,378
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Poverty,<133% FPL,90.0,85.4 to 94.7,222
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Overall,Overall,95.1,93.4 to 96.8,838
DTaP,≥2 Doses,States/Local Areas,Iowa,2017,Age,5 Months,80.5,72.9 to 86.3,228
DTaP,≥2 Doses,States/Local Areas,Iowa,2017-2018,Age,5 Months,85.8,81.2 to 89.4,483
DTaP,≥2 Doses,States/Local Areas,Iowa,2019,Age,5 Months,87.3,79.7 to 92.4,250
Polio,≥3 Doses,States/Local Areas,Iowa,2014-2017,Urbanicity,Living In a Non-MSA,94.7,91.8 to 97.7,326
DTaP,≥2 Doses,States/Local Areas,Iowa,2018,Age,5 Months,91.3,85.7 to 94.8,255
DTaP,≥2 Doses,States/Local Areas,Iowa,2018-2019,Age,5 Months,89.3,84.8 to 92.6,505
DTaP,≥3 Doses,States/Local Areas,Iowa,2017,Age,24 Months,95.0,90.8 to 97.6,228
DTaP,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,96.0,93.3 to 97.8,483
DTaP,≥3 Doses,States/Local Areas,Iowa,2018,Age,24 Months,97.0,93.0 to 99.0,255
DTaP,≥3 Doses,States/Local Areas,Iowa,2018-2019,Age,24 Months,95.8,92.6 to 97.9,505
DTaP,≥1 Dose,States/Local Areas,Iowa,2017,Age,3 Months,87.7,81.5 to 92.0,228
DTaP,≥1 Dose,States/Local Areas,Iowa,2017-2018,Age,3 Months,91.5,87.8 to 94.1,483
DTaP,≥3 Doses,States/Local Areas,Iowa,2014,Age,24 Months,95.6,92.2 to 97.8,277
DTaP,≥3 Doses,States/Local Areas,Iowa,2014-2015,Age,24 Months,95.7,93.1 to 97.5,515
DTaP,≥3 Doses,States/Local Areas,Iowa,2015,Age,24 Months,95.9,91.5 to 98.4,238
DTaP,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,96.9,94.2 to 98.5,436
DTaP,≥1 Dose,States/Local Areas,Iowa,2018,Age,3 Months,95.3,90.9 to 97.7,255
DTaP,≥1 Dose,States/Local Areas,Iowa,2018-2019,Age,3 Months,94.3,90.7 to 96.5,505
Hep A,≥1 Dose,States/Local Areas,Iowa,2014,Age,19 Months,77.4,70.8 to 82.9,277
Hep A,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,19 Months,79.6,74.9 to 83.7,515
Hep A,≥1 Dose,States/Local Areas,Iowa,2015,Age,19 Months,81.8,80.9 to 82.7,238
Hep A,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,19 Months,82.8,77.6 to 86.9,436
Hep A,≥1 Dose,States/Local Areas,Iowa,2013,Age,19 Months,79.8,77.1 to 82.2,265
Hep A,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,19 Months,78.6,76.3 to 80.7,542
Hib,Full Series,States/Local Areas,Iowa,2021,Age,19 Months,75.1,64.1 to 83.6,184
Hib,≥3 Doses,States/Local Areas,Iowa,2015,Age,24 Months,93.2,87.8 to 96.7,238
Hib,≥3 Doses,States/Local Areas,Iowa,2015-2016,Age,24 Months,93.3,89.5 to 96.1,436
Hib,≥3 Doses,States/Local Areas,Iowa,2016,Age,24 Months,93.4,87.5 to 97.2,198
Hib,≥3 Doses,States/Local Areas,Iowa,2016-2017,Age,24 Months,92.6,88.6 to 95.6,426
DTaP,≥3 Doses,States/Local Areas,Iowa,2019,Age,24 Months,94.6,89.0 to 97.9,250
Hib,≥3 Doses,States/Local Areas,Iowa,2017,Age,24 Months,91.7,85.8 to 95.8,228
Hib,≥3 Doses,States/Local Areas,Iowa,2017-2018,Age,24 Months,92.4,88.4 to 95.3,483
Hep A,≥1 Dose,States/Local Areas,Iowa,2012,Age,19 Months,78.2,69.7 to 84.9,247
Hib,Primary Series,States/Local Areas,Iowa,2020-2021,Age,24 Months,92.2,87.5 to 95.7,455
Hib,Primary Series,States/Local Areas,Iowa,2021,Age,19 Months,90.8,80.9 to 95.9,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2021,Age,19 Months,89.8,80.1 to 95.1,184
DTaP,≥4 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,86.2,79.9 to 91.3,455
PCV,≥4 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,85.0,79.4 to 89.7,455
Hib,≥2 Doses,States/Local Areas,Iowa,2021,Age,5 Months,79.0,68.2 to 86.8,184
DTaP,≥1 Dose,States/Local Areas,Iowa,2013,Age,3 Months,91.2,87.6 to 93.8,265
DTaP,≥1 Dose,States/Local Areas,Iowa,2013-2014,Age,3 Months,90.7,87.7 to 93.0,542
DTaP,≥1 Dose,States/Local Areas,Iowa,2014,Age,3 Months,90.2,85.5 to 93.5,277
DTaP,≥1 Dose,States/Local Areas,Iowa,2014-2015,Age,3 Months,90.8,87.3 to 93.5,515
DTaP,≥1 Dose,States/Local Areas,Iowa,2015,Age,3 Months,91.4,85.4 to 95.1,238
DTaP,≥1 Dose,States/Local Areas,Iowa,2015-2016,Age,3 Months,93.1,89.5 to 95.6,436
DTaP,≥1 Dose,States/Local Areas,Iowa,2016,Age,3 Months,94.8,90.0 to 97.4,198
DTaP,≥1 Dose,States/Local Areas,Iowa,2016-2017,Age,3 Months,91.3,87.5 to 94.0,426
Combined 7 Series,,States/Local Areas,Iowa,2021,Age,35 Months,83.0,67.7 to 93.7,184
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,81.9 to 88.6,618
Hib,≥1 Dose,States/Local Areas,Iowa,2021,Age,3 Months,84.0,73.7 to 90.8,184
DTaP,≥1 Dose,States/Local Areas,Iowa,2012,Age,3 Months,84.8,79.6 to 88.8,247
DTaP,≥1 Dose,States/Local Areas,Iowa,2011,Age,3 Months,88.7,85.1 to 91.5,220
Hib,Primary Series,States/Local Areas,Iowa,2021,Age,7 Months,78.9,68.6 to 86.6,184
DTaP,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,19 Months,91.7,86.5 to 95.0,455
Hib,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,90.0,85.2 to 93.8,455
Polio,≥2 Doses,States/Local Areas,Iowa,2021,Age,7 Months,93.8,87.5 to 97.0,184
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,97.7,95.7 to 99.7,276
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,89.2 to 96.8,284
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,88.7,83.9 to 93.4,284
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,93.2 to 98.4,262
Hep B,≥2 Doses,States/Local Areas,Iowa,2021,Age,5 Months,90.2,82.1 to 94.9,184
Hep A,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,35 Months,93.6,87.9 to 97.2,455
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.5,70.5 to 86.5,262
Hib,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,13 Months,92.2,87.0 to 95.4,455
PCV,≥3 Doses,States/Local Areas,Iowa,2021,Age,13 Months,88.2,78.7 to 93.7,184
≥1 Dose Varicella,,States/Local Areas,Iowa,2020-2021,Age,35 Months,95.4,90.6 to 98.2,455
DTaP,≥1 Dose,States/Local Areas,Iowa,2020-2021,Age,3 Months,90.5,85.4 to 94.0,455
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Iowa,2021,Age,0-1 Days,78.5,68.6 to 85.8,184
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Iowa,2021,Age,0-2 Days,80.0,70.3 to 87.1,184
≥1 Dose Varicella,,States/Local Areas,Iowa,2021,Age,24 Months,89.7,82.1 to 95.0,184
PCV,≥4 Doses,States/Local Areas,Iowa,2021,Age,24 Months,84.1,74.8 to 91.4,184
Hep A,≥1 Dose,States/Local Areas,Iowa,2021,Age,24 Months,86.7,79.0 to 92.6,184
PCV,≥2 Doses,States/Local Areas,Iowa,2020-2021,Age,5 Months,82.1,75.7 to 87.0,455
Hep B,≥3 Doses,States/Local Areas,Iowa,2021,Age,7 Months,76.8,67.2 to 84.2,184
PCV,≥3 Doses,States/Local Areas,Iowa,2021,Age,7 Months,76.1,65.6 to 84.2,184
DTaP,≥3 Doses,States/Local Areas,Iowa,2021,Age,13 Months,89.3,79.7 to 94.7,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2021,Age,24 Months,89.8,81.3 to 95.5,184
PCV,≥4 Doses,States/Local Areas,Iowa,2021,Age,19 Months,82.6,72.2 to 89.7,184
Hep A,≥1 Dose,States/Local Areas,Iowa,2021,Age,19 Months,84.3,74.7 to 90.7,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,96.5,92.8 to 100.0,91
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.7,95.2 to 98.2,618
Rotavirus,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,77.9,71.6 to 84.2,276
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,80.3,72.1 to 88.6,276
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,94.7,91.3 to 98.0,284
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.7,94.1 to 99.2,262
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,94.5,91.1 to 97.9,276
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,86.9,81.6 to 92.3,276
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.2,78.4 to 90.1,262
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,94.9,91.8 to 98.0,284
DTaP,≥4 Doses,States/Local Areas,Iowa,2020-2021,Age,24 Months,80.4,74.1 to 85.9,455
Hep B,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,7 Months,81.4,76.2 to 85.7,521
Polio,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,93.5,90.0 to 95.9,521
DTaP,≥4 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,77.4,71.7 to 82.3,521
DTaP,≥3 Doses,States/Local Areas,Iowa,2019-2020,Age,19 Months,93.6,90.0 to 96.0,521
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,91.0,88.0 to 93.9,469
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.5,80.7 to 100.0,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,86.3,82.6 to 90.0,469
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,87.2 to 100.0,83
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.9,90.4 to 97.4,262
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,83.5,78.1 to 89.0,284
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.4,80.8 to 92.0,262
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,91.1,87.0 to 95.2,276
Influenza,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,42.7,35.6 to 49.9,284
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.3,72.0 to 84.7,262
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,79.8,73.8 to 85.8,276
Influenza,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,50.4,43.2 to 57.6,262
Rotavirus,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.2,77.6 to 88.8,262
Rotavirus,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,79.2,73.3 to 85.0,284
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,86.7 to 95.0,284
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,86.5 to 95.0,262
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,86.9,82.0 to 91.9,276
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,88.3,83.5 to 93.1,284
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.7,81.3 to 92.1,262
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,92.8 to 98.8,262
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,86.9,82.2 to 91.6,276
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,78.8,69.8 to 87.8,284
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,70.8,64.2 to 77.5,282
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,70.7,56.7 to 84.8,62
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.3,95.8 to 98.9,618
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,98.3,95.6 to 100.0,62
Rotavirus,,States/Local Areas,Iowa,2016-2019,Overall,Overall,80.0,76.6 to 83.5,822
Influenza,,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,53.1,45.7 to 60.6,239
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,82.2,75.5 to 88.9,194
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,89.7,85.2 to 94.1,239
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,86.4,82.2 to 90.6,389
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,82.7,76.1 to 89.3,194
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,95.4,92.0 to 98.8,239
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,92.4,87.8 to 97.0,194
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,84.7,81.5 to 88.0,822
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,89.9,84.4 to 95.4,194
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,86.9,82.7 to 91.0,389
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,92.8,88.8 to 96.9,239
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,89.5,83.9 to 95.1,194
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,94.1,91.3 to 96.8,389
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,97.2,94.8 to 99.7,239
Influenza,,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,42.1,33.6 to 50.6,194
Influenza,,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,49.7,43.3 to 56.0,389
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,96.0,94.4 to 97.5,822
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,96.2,94.6 to 97.9,822
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,92.4,87.8 to 97.0,194
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,95.4,93.0 to 97.7,389
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,97.7,95.7 to 99.6,239
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,82.7,69.2 to 96.2,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,83.9,79.3 to 88.4,389
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,88.4,83.6 to 93.3,239
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,89.7,85.9 to 93.5,389
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,94.8,90.7 to 98.9,239
Rotavirus,,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,83.5,78.7 to 88.2,389
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,91.2,87.1 to 95.4,284
Rotavirus,,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,66.1,58.4 to 73.8,194
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.5,91.0 to 97.9,262
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,89.6 to 97.2,284
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,96.8,94.5 to 99.1,276
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,97.5,95.5 to 99.6,276
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,94.5,91.1 to 97.9,284
Influenza,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,53.3,45.6 to 61.1,276
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.7,94.1 to 99.2,262
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,97.2,95.1 to 99.4,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,81.9,76.6 to 87.2,284
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Principal City,75.3,69.0 to 81.6,284
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,96.7,94.7 to 98.8,389
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,99.1,98.0 to 100.0,239
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,95.9,92.8 to 98.9,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a Non-MSA,85.7,80.4 to 90.9,276
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.6,84.6 to 92.6,262
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Overall,Overall,77.5,73.9 to 81.2,822
Hib,Full Series,States/Local Areas,Iowa,2016-2019,Overall,Overall,87.4,84.5 to 90.3,822
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,96.9,95.0 to 98.7,389
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,97.7,95.8 to 99.5,239
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,85.0,79.5 to 90.5,194
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,68.4,60.2 to 76.7,194
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,97.2,95.2 to 99.1,389
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,79.0,74.0 to 84.0,389
DTaP,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,99.1,98.0 to 100.0,239
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Overall,Overall,93.5,91.3 to 95.6,822
Combined 7 Series,,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,85.9,80.5 to 91.2,239
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,79.5,74.4 to 84.6,822
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,93.2,89.0 to 97.4,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Iowa,2016-2019,Overall,Overall,85.1,82.2 to 88.0,822
Influenza,,States/Local Areas,Iowa,2016-2019,Overall,Overall,48.3,44.0 to 52.5,822
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,89.3,84.0 to 94.6,194
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,96.5,94.3 to 98.7,389
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,78.3,71.4 to 85.2,389
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,84.0,77.0 to 91.0,239
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Poverty,<133% FPL,87.3,81.5 to 93.0,194
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,88.6,85.8 to 91.5,822
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Poverty,133% to <400% FPL,91.2,87.7 to 94.6,389
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Overall,Overall,94.4,92.3 to 96.4,822
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,94.8,92.9 to 96.8,822
Rotavirus,,States/Local Areas,Iowa,2016-2019,Poverty,>400% FPL,90.5,86.2 to 94.8,239
Hep A,≥1 Dose,States/Local Areas,Iowa,2016-2019,Overall,Overall,89.7,87.1 to 92.2,822
Polio,≥3 Doses,States/Local Areas,Iowa,2016-2019,Overall,Overall,96.0,94.4 to 97.7,822
Influenza,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,45.4,33.3 to 57.5,91
PCV,≥4 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,82.0,71.0 to 93.0,62
PCV,≥3 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,91.9,85.6 to 98.1,91
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Other,96.7,92.9 to 100.0,62
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,93.2,89.3 to 97.0,282
≥1 Dose MMR,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,96.1,94.2 to 98.0,469
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,73.7 to 94.9,83
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,Hispanic,86.4,78.4 to 94.3,91
DTaP,≥4 Doses,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.3,54.4 to 90.2,30
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,86.1 to 100.0,83
≥1 Dose Varicella,,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,95.1,92.8 to 97.4,469
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Any Medicaid,74.7,64.7 to 84.8,282
Hep A,≥2 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,82.5,76.7 to 88.3,469
Hep B,≥3 Doses,States/Local Areas,Iowa,2016-2019,Insurance Coverage,Private Insurance Only,96.7,95.0 to 98.4,469
Polio,≥1 Dose,States/Local Areas,Iowa,2020,Age,3 Months,92.1,86.8 to 95.4,271
Hib,≥1 Dose,States/Local Areas,Iowa,2020,Age,3 Months,90.4,84.3 to 94.3,271
Hep B,≥3 Doses,States/Local Areas,Iowa,2020,Age,7 Months,80.5,72.9 to 86.3,271
PCV,≥3 Doses,States/Local Areas,Iowa,2020,Age,7 Months,74.3,65.5 to 81.5,271
Hep A,≥1 Dose,States/Local Areas,Iowa,2021,Age,35 Months,95.7,85.1 to 99.4,184
PCV,≥3 Doses,States/Local Areas,Iowa,2021,Age,19 Months,89.0,79.4 to 94.4,184
≥1 Dose MMR,,States/Local Areas,Iowa,2020-2021,Age,24 Months,90.2,85.2 to 94.0,455
Hep A,≥2 Doses,States/Local Areas,Iowa,2021,Age,35 Months,80.9,59.9 to 95.0,184
Hib,Primary Series,States/Local Areas,Iowa,2021,Age,24 Months,90.8,82.2 to 96.3,184
Hib,Full Series,States/Local Areas,Iowa,2021,Age,24 Months,81.1,71.0 to 89.3,184
Hib,Primary Series,States/Local Areas,Iowa,2020-2021,Age,13 Months,87.6,81.6 to 91.8,455
≥1 Dose MMR,,States/Local Areas,Iowa,2021,Age,24 Months,90.1,81.9 to 95.6,184
≥1 Dose Varicella,,States/Local Areas,Iowa,2021,Age,19 Months,89.2,80.7 to 94.2,184
DTaP,≥4 Doses,States/Local Areas,Iowa,2021,Age,19 Months,73.0,62.0 to 81.8,184
Hep B,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,92.9,87.7 to 96.5,455
PCV,≥3 Doses,States/Local Areas,Iowa,2021,Age,24 Months,89.4,80.9 to 95.3,184
DTaP,≥3 Doses,States/Local Areas,Iowa,2020-2021,Age,35 Months,94.7,90.1 to 97.6,455
Hep A,≥2 Doses,States/Local Areas,Iowa,2021,Age,19 Months,36.2,27.0 to 46.6,184
PCV,≥4 Doses,States/Local Areas,Iowa,2021,Age,35 Months,86.7,78.0 to 93.2,184
DTaP,≥3 Doses,States/Local Areas,Iowa,2021,Age,19 Months,90.6,80.7 to 95.7,184
DTaP,≥1 Dose,States/Local Areas,Iowa,2021,Age,3 Months,89.0,79.4 to 94.4,184
DTaP,≥4 Doses,States/Local Areas,Iowa,2021,Age,24 Months,80.9,70.5 to 89.4,184
Hep A,≥2 Doses,States/Local Areas,Iowa,2021,Age,24 Months,44.2,34.4 to 55.5,184
Rotavirus,,States/Local Areas,Iowa,2019-2020,Age,8 Months,82.7,77.5 to 86.9,521
Polio,≥3 Doses,States/Local Areas,Iowa,2021,Age,24 Months,92.4,84.8 to 97.0,184
Hib,≥3 Doses,States/Local Areas,Iowa,2021,Age,24 Months,89.7,81.0 to 95.5,184
Polio,≥1 Dose,States/Local Areas,Iowa,2021,Age,3 Months,91.0,82.6 to 95.6,184
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,92.6,87.7 to 97.5,174
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,80.7 to 98.2,84
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,89.4 to 95.0,612
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,92.1,88.4 to 95.9,320
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Other,79.5,70.3 to 88.7,134
Combined 7 Series,,States/Local Areas,Iowa,2017-2018,Age,24 Months,75.5,70.2 to 80.4,483
Polio,≥3 Doses,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.9,89.1 to 96.8,270
Hib,Primary Series,States/Local Areas,Kansas,2011,Age,7 Months,70.2,63.7 to 75.9,221
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Poverty,>400% FPL,90.0,85.4 to 94.6,236
Hib,Primary Series,States/Local Areas,Kansas,2012,Age,7 Months,72.0,67.0 to 76.5,224
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.7,74.2 to 87.2,270
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,Hispanic,78.4,70.0 to 86.7,174
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.9,65.8 to 89.9,84
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.3,78.2 to 86.4,612
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a MSA Principal City,80.9,75.2 to 86.5,320
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Urbanicity,Living In a Non-MSA,79.8,73.9 to 85.7,315
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Overall,Overall,80.5,77.0 to 84.0,905
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Poverty,<133% FPL,70.5,63.0 to 78.0,256
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Poverty,133% to <400% FPL,82.3,77.5 to 87.2,413
Hib,Full Series,States/Local Areas,Kansas,2014-2017,Insurance Coverage,Uninsured,46.0,24.0 to 68.0,35
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,5 Months,98.3,96.5 to 99.2,301
Hib,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,5 Months,90.2,84.1 to 94.1,301
Polio,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,5 Months,91.4,85.8 to 94.9,301
PCV,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,3 Months,97.6,95.3 to 98.8,301
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,5 Months,91.4,85.8 to 94.9,301
Combined 7 Series,,States/Local Areas,Rhode Island,2020,Age,24 Months,77.0,70.5 to 82.9,301
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,57.8,50.2 to 65.6,301
PCV,≥4 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,94.0,90.1 to 96.8,301
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,24 Months,92.5,87.3 to 96.1,301
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,98.7,96.3 to 99.7,301
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,99.1,97.9 to 99.7,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2020,Age,0-3 Days,83.0,77.0 to 87.7,301
Rotavirus,,States/Local Areas,Rhode Island,2020,Age,8 Months,91.9,86.7 to 95.1,301
Hib,Primary Series,States/Local Areas,Rhode Island,2020,Age,19 Months,95.9,90.5 to 98.3,301
Influenza,,States/Local Areas,Rhode Island,2020,Age,24 Months,84.8,79.2 to 89.5,301
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,86.5,80.0 to 91.2,301
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020,Age,19 Months,96.4,93.5 to 98.0,301
Polio,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,98.5,95.7 to 99.5,301
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,75.9,68.7 to 81.9,301
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,98.5,95.7 to 99.5,301
PCV,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,5 Months,91.2,85.7 to 94.7,301
Polio,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,96.9,93.1 to 98.6,301
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,81.2,74.3 to 86.6,301
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,97.5,94.5 to 98.9,301
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020,Age,13 Months,69.6,62.1 to 76.2,301
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,98.1,95.4 to 99.2,301
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,99.4,98.0 to 99.8,301
Hib,Primary Series,States/Local Areas,Rhode Island,2020,Age,13 Months,91.2,85.5 to 94.8,301
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,20.4,15.0 to 27.1,301
PCV,≥4 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,95.5,91.6 to 98.0,301
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,19 Months,89.1,82.6 to 93.3,301
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020,Age,35 Months,98.0,95.6 to 99.3,301
PCV,≥4 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,90.4,85.2 to 93.9,301
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,95.4,89.7 to 98.4,301
Polio,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,98.5,96.1 to 99.5,301
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,99.1,97.8 to 99.6,301
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020,Age,19 Months,95.4,91.5 to 97.5,301
Hib,Full Series,States/Local Areas,Rhode Island,2020,Age,19 Months,82.1,75.4 to 87.2,301
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,99.1,97.7 to 99.7,301
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,99.3,98.2 to 99.8,301
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,99.1,97.9 to 99.7,301
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020,Age,35 Months,97.1,94.0 to 98.9,301
Hib,Primary Series,States/Local Areas,Rhode Island,2020,Age,35 Months,97.0,93.2 to 99.0,301
Hib,Full Series,States/Local Areas,Rhode Island,2020,Age,35 Months,91.2,85.3 to 95.4,301
Hib,Primary Series,States/Local Areas,Rhode Island,2020,Age,24 Months,97.0,93.2 to 99.0,301
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,35 Months,96.0,91.0 to 98.7,301
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020,Age,24 Months,97.5,95.5 to 98.8,301
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,91.5,86.3 to 95.3,301
Polio,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,98.5,96.1 to 99.5,301
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,88.6,83.3 to 92.8,301
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,99.0,97.6 to 99.6,301
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,98.7,96.3 to 99.7,301
Hib,Primary Series,States/Local Areas,Rhode Island,2020,Age,7 Months,88.7,82.8 to 92.8,301
Hib,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,95.9,91.0 to 98.2,301
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,3 Months,97.2,94.3 to 98.7,301
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2020,Age,0-2 Days,82.3,76.2 to 87.1,301
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,19 Months,37.4,30.4 to 44.8,301
Combined 7 Series,,States/Local Areas,Rhode Island,2020,Age,35 Months,84.9,77.8 to 90.7,301
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,79.9,73.0 to 85.4,301
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,97.1,93.9 to 98.6,301
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,91.7,86.6 to 94.9,301
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,3 Months,99.0,97.4 to 99.7,301
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,24 Months,99.1,97.9 to 99.7,301
Polio,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,3 Months,97.2,94.3 to 98.7,301
Hib,≥1 Dose,States/Local Areas,Rhode Island,2020,Age,3 Months,95.2,90.9 to 97.5,301
Rotavirus,,States/Local Areas,Rhode Island,2019-2020,Age,8 Months,91.2,87.6 to 93.9,578
Hib,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,96.8,93.9 to 98.3,542
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2021,Age,0-1 Days,76.2,67.9 to 82.8,241
Influenza,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.6,75.9 to 95.2,86
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",100.0,,86
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,94.4,91.0 to 97.9,237
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.9,95.0 to 98.7,504
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.0 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,97.3,96.0 to 98.7,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,96.7,94.3 to 99.0,349
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,84.4,79.4 to 89.3,349
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.0,85.5 to 100.0,39
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.5,93.3 to 97.6,504
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,85.6,80.7 to 90.5,349
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,97.4,95.9 to 98.8,487
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,92.5,88.9 to 96.0,349
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,96.6,94.3 to 98.8,349
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.6,85.0 to 92.2,504
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,97.1,94.7 to 99.4,237
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.0,95.2 to 98.8,504
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.0 to 100.0,39
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,91.4,88.2 to 94.5,487
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.0 to 100.0,39
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,97.2,94.6 to 98.8,542
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,24 Months,92.1,86.5 to 96.1,241
PCV,≥4 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,89.8,83.6 to 94.4,241
PCV,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,96.3,93.3 to 98.2,542
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2021,Age,24 Months,93.6,88.0 to 97.2,241
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,92.4,86.8 to 95.8,241
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2021,Age,0-2 Days,79.5,71.3 to 85.8,241
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020,Age,7 Months,8.9,5.3 to 14.6,301
PCV,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,93.4,87.9 to 97.0,241
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,57.9,49.5 to 66.5,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,94.4,88.0 to 97.4,241
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,19 Months,89.6,83.3 to 93.7,241
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,3 Months,97.0,92.1 to 98.9,241
Polio,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,97.6,92.5 to 99.2,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,13 Months,93.7,87.4 to 96.9,241
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,40.3,32.5 to 48.6,241
PCV,≥4 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,90.5,84.1 to 95.1,241
Combined 7 Series,,States/Local Areas,Rhode Island,2021,Age,24 Months,78.6,71.0 to 85.4,241
PCV,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,76.1,67.8 to 82.7,241
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,97.2,94.6 to 98.8,542
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,22.2,17.9 to 27.2,542
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,98.3,95.9 to 99.3,542
Hib,Primary Series,States/Local Areas,Rhode Island,2021,Age,7 Months,81.8,74.0 to 87.6,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,19 Months,96.4,93.1 to 98.1,542
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,95.4,92.2 to 97.5,542
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,35 Months,92.1,86.5 to 96.1,241
PCV,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,93.4,87.1 to 96.7,241
Combined 7 Series,,States/Local Areas,Rhode Island,2011,Age,35 Months,82.2,73.8 to 89.2,221
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,95.4,90.3 to 98.3,241
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,72.0,63.3 to 79.3,241
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2020-2021,Age,35 Months,94.5,88.7 to 97.8,542
Hib,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,3 Months,95.5,90.8 to 97.8,241
Hib,Full Series,States/Local Areas,Rhode Island,2021,Age,24 Months,86.3,79.4 to 91.8,241
Hib,Primary Series,States/Local Areas,Rhode Island,2021,Age,24 Months,93.4,87.9 to 97.0,241
Hib,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,92.9,86.8 to 96.9,241
≥1 Dose MMR,,States/Local Areas,Rhode Island,2021,Age,24 Months,94.2,89.1 to 97.4,241
Polio,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,94.2,88.7 to 97.6,241
Polio,≥1 Dose,States/Local Areas,Rhode Island,2021,Age,3 Months,97.0,92.1 to 98.9,241
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2021,Age,24 Months,88.1,81.3 to 93.3,241
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,84.8,73.3 to 93.2,241
PCV,≥4 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,85.3,78.2 to 90.4,241
Hib,Primary Series,States/Local Areas,Rhode Island,2017,Age,24 Months,97.1,93.7 to 98.9,237
Hib,Primary Series,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,96.8,94.5 to 98.3,462
Hib,Primary Series,States/Local Areas,Rhode Island,2014,Age,24 Months,97.8,94.4 to 99.3,245
Hib,Primary Series,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,97.5,95.5 to 98.8,493
Hib,Primary Series,States/Local Areas,Rhode Island,2015,Age,24 Months,97.2,94.4 to 98.9,248
Hib,Primary Series,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,97.3,95.6 to 98.5,498
Hib,Primary Series,States/Local Areas,Rhode Island,2013,Age,24 Months,96.2,91.8 to 98.6,252
Hib,Primary Series,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,96.9,94.4 to 98.5,497
Combined 7 Series,,States/Local Areas,Rhode Island,2013,Age,24 Months,71.6,64.4 to 78.5,252
Combined 7 Series,,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,75.5,70.4 to 80.3,497
Combined 7 Series,,States/Local Areas,Rhode Island,2012,Age,24 Months,75.8,68.5 to 82.4,233
Combined 7 Series,,States/Local Areas,Rhode Island,2011,Age,24 Months,75.2,67.3 to 82.4,221
Hib,Primary Series,States/Local Areas,Rhode Island,2015,Age,35 Months,97.2,94.4 to 98.9,248
Hib,Primary Series,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,97.3,95.6 to 98.5,498
Hib,Primary Series,States/Local Areas,Rhode Island,2016,Age,35 Months,97.4,95.0 to 98.8,250
Hib,Primary Series,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,97.2,95.3 to 98.5,487
Hib,Primary Series,States/Local Areas,Rhode Island,2016,Age,24 Months,97.4,95.0 to 98.8,250
Hib,Primary Series,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,97.2,95.3 to 98.5,487
Hib,Primary Series,States/Local Areas,Rhode Island,2018,Age,24 Months,96.5,92.4 to 98.7,225
Hib,Primary Series,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,96.3,93.4 to 98.1,502
Hib,Primary Series,States/Local Areas,Rhode Island,2014,Age,35 Months,97.8,94.4 to 99.3,245
Hib,Primary Series,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,97.5,95.5 to 98.8,493
Hib,Primary Series,States/Local Areas,Rhode Island,2012,Age,35 Months,99.4,97.2 to 99.9,233
Hib,Primary Series,States/Local Areas,Rhode Island,2019,Age,24 Months,96.1,91.5 to 98.6,277
Hib,Primary Series,States/Local Areas,Rhode Island,2011,Age,35 Months,98.7,96.2 to 99.7,221
Hib,Primary Series,States/Local Areas,Rhode Island,2013,Age,35 Months,96.2,91.8 to 98.6,252
Hib,Primary Series,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,96.9,94.4 to 98.5,497
Combined 7 Series,,States/Local Areas,Rhode Island,2017,Age,35 Months,78.4,71.4 to 84.7,237
Combined 7 Series,,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,79.3,74.3 to 84.0,462
Combined 7 Series,,States/Local Areas,Rhode Island,2016,Age,35 Months,79.4,72.1 to 85.8,250
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,79.4,74.2 to 84.2,487
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,94.3,91.1 to 96.7,578
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,89.1,84.1 to 93.1,578
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,99.4,97.3 to 99.9,578
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,92.6,89.2 to 95.2,578
Influenza,,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,83.3,79.1 to 87.1,578
Hib,Full Series,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,87.4,83.6 to 90.7,578
Hib,Primary Series,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,96.6,93.8 to 98.3,578
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,7.7,5.4 to 11.0,578
Combined 7 Series,,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,84.8,80.2 to 88.9,578
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2019-2020,Age,0-1 Days,75.5,70.7 to 79.8,578
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,97.7,95.2 to 98.9,578
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,94.4,91.4 to 96.4,578
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,90.3,86.3 to 93.3,578
PCV,≥4 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,88.4,84.5 to 91.5,578
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Rhode Island,2019-2020,Age,0-2 Days,79.5,74.9 to 83.5,578
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2019-2020,Age,0-3 Days,80.1,75.5 to 84.0,578
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,95.5,92.8 to 97.4,578
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,97.7,95.5 to 99.0,578
PCV,≥4 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,92.8,89.7 to 95.2,578
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,98.1,95.8 to 99.3,578
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,37.8,32.8 to 43.0,578
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,95.5,92.7 to 97.2,578
Hib,Primary Series,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,95.9,92.6 to 97.7,578
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,87.9,83.6 to 91.2,578
Hib,Full Series,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,82.8,78.3 to 86.6,578
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,95.4,91.9 to 97.7,578
Hib,Primary Series,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,96.6,93.8 to 98.3,578
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,97.7,95.5 to 99.0,578
Hib,Full Series,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,90.5,86.5 to 93.6,578
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,98.4,95.9 to 99.5,578
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,98.1,95.8 to 99.3,578
PCV,≥4 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,94.1,91.1 to 96.4,578
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,98.0,95.6 to 99.2,578
Polio,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,97.6,95.3 to 99.0,578
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,88.1,84.2 to 91.3,578
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,96.7,94.3 to 98.2,578
Hep B,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,3 Months,98.5,96.4 to 99.4,578
PCV,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,3 Months,95.7,92.5 to 97.5,578
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,5 Months,89.0,84.9 to 92.1,578
Hib,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,5 Months,87.5,83.2 to 90.8,578
Polio,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,5 Months,89.1,85.0 to 92.2,578
Polio,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,98.0,95.2 to 99.1,578
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,77.4,72.5 to 81.6,578
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,22.7,18.5 to 27.6,578
Hib,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,96.0,92.9 to 97.7,578
Hib,Primary Series,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,91.8,88.1 to 94.4,578
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,98.6,96.5 to 99.5,578
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,5 Months,95.4,92.4 to 97.3,578
PCV,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,5 Months,89.1,85.1 to 92.2,578
Polio,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,96.3,93.2 to 98.0,578
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,80.6,76.0 to 84.5,578
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,71.1,65.9 to 75.7,578
Hib,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,94.5,91.1 to 96.7,578
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,97.0,94.4 to 98.4,578
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,97.8,95.1 to 99.1,578
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,96.4,93.7 to 98.0,578
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,98.0,95.6 to 99.2,578
Combined 7 Series,,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,78.4,73.9 to 82.6,578
Polio,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,97.6,95.3 to 99.0,578
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,94.9,91.5 to 97.3,578
≥1 Dose MMR,,States/Local Areas,Rhode Island,2019-2020,Age,35 Months,98.4,95.5 to 99.6,578
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,74.1,69.0 to 78.7,578
Polio,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,19 Months,97.6,95.0 to 98.9,578
Hib,Primary Series,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,87.7,83.5 to 90.9,578
PCV,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,7 Months,79.4,74.7 to 83.4,578
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019-2020,Age,13 Months,96.6,93.9 to 98.1,578
Polio,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,3 Months,95.6,92.4 to 97.5,578
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,3 Months,95.5,92.3 to 97.4,578
Hib,≥1 Dose,States/Local Areas,Rhode Island,2019-2020,Age,3 Months,93.8,90.3 to 96.1,578
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,91.1,86.8 to 95.3,487
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,86.4,80.4 to 92.3,349
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,85.5 to 100.0,86
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.2,67.8 to 94.7,39
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,84.6,78.4 to 90.9,237
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.1,90.2 to 100.0,86
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,97.2,95.7 to 98.7,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,93.1,89.7 to 96.6,349
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.2,89.9 to 100.0,86
Influenza,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,76.4,70.2 to 82.6,237
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,87.7,84.8 to 90.5,866
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,97.0,95.6 to 98.3,866
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,91.6,88.2 to 95.0,329
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,96.9,95.4 to 98.3,866
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,83.8,78.0 to 89.5,249
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,95.1,93.3 to 96.9,866
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,95.9,93.2 to 98.5,288
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,93.3,89.7 to 97.0,249
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,92.6,88.4 to 96.7,329
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,92.7,87.1 to 98.4,288
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,97.2,94.8 to 99.5,288
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,95.4,92.3 to 98.5,249
Influenza,,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,81.0,77.9 to 84.2,866
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Overall,Overall,77.5,74.1 to 80.9,866
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,95.0,93.3 to 96.8,866
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,97.0,94.5 to 99.4,249
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,79.6,73.8 to 85.4,249
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,88.8,85.3 to 92.4,866
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,75.9,72.2 to 79.6,866
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,94.3,92.3 to 96.3,866
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,98.2,96.7 to 99.7,329
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,74.4,67.4 to 81.5,288
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,88.7,86.0 to 91.3,866
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,86.1,81.9 to 90.3,329
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,96.8,94.3 to 99.3,288
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,97.4,95.7 to 99.1,329
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,67.4,60.3 to 74.4,249
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,97.1,94.7 to 99.5,288
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,87.2,84.3 to 90.1,866
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,97.2,95.4 to 99.1,329
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,79.5,73.4 to 85.6,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.6,72.5 to 80.6,606
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,74.6,67.7 to 81.4,260
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,93.2 to 98.5,260
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.4,95.9 to 98.9,606
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,95.7,92.9 to 98.6,260
≥1 Dose MMR,,States/Local Areas,Rhode Island,2020,Age,13 Months,78.0,71.0 to 83.7,301
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Rhode Island,2020,Age,0-1 Days,81.2,75.0 to 86.0,301
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2019-2020,Age,24 Months,58.3,52.9 to 63.8,578
Polio,≥2 Doses,States/Local Areas,Rhode Island,2020,Age,13 Months,98.7,95.8 to 99.6,301
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.0,68.8 to 89.3,86
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",100.0,,86
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.5,70.9 to 100.0,39
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.8,93.6 to 98.0,504
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.3,94.2 to 98.3,504
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,81.6,77.3 to 85.9,487
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.2,87.1 to 93.2,504
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.8,73.3 to 96.3,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,58.9 to 82.6,86
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.1,59.1 to 91.1,39
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,78.6,74.3 to 82.9,487
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,75.3,69.7 to 80.9,349
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.5,76.4 to 100.0,39
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.2 to 98.4,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,93.6,90.0 to 97.3,237
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,93.1 to 100.0,86
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,98.0,96.8 to 99.3,487
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,82.4 to 99.4,86
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,91.5,88.6 to 94.3,487
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,85.0 to 100.0,86
Influenza,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Private Insurance Only,85.8,82.0 to 89.6,487
Influenza,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,75.5,70.2 to 80.8,349
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,96.8,94.5 to 99.2,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,79.9,73.9 to 85.9,237
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.8,83.6 to 92.0,504
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,85.9,81.2 to 90.6,349
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.4,80.1 to 98.8,39
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,69.9,62.7 to 77.2,237
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",64.5,46.9 to 82.2,39
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.9,75.1 to 84.6,504
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,85.9,80.1 to 91.7,237
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,86.5,80.6 to 92.3,237
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,88.4 to 94.5,504
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.0,78.4 to 99.5,39
Influenza,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.0,78.9 to 87.1,504
Influenza,,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.3,65.6 to 95.0,39
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.6,94.7 to 98.5,504
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,89.0 to 100.0,39
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,96.3,93.9 to 98.6,349
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,85.1,79.0 to 91.2,260
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,94.8,91.7 to 97.9,260
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.2,85.0 to 91.4,606
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,87.2 to 93.5,606
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,93.8,90.4 to 97.2,260
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.7,93.7 to 97.6,606
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,85.1,80.3 to 90.0,260
Influenza,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.4,79.9 to 87.0,606
Influenza,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,75.9,69.6 to 82.3,260
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.5,72.2 to 80.8,606
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,87.7,82.8 to 92.7,260
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.1,88.0 to 94.2,606
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,94.3,90.9 to 97.7,260
PCV,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,98.0,96.7 to 99.4,606
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,93.2 to 97.6,606
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,90.5,86.6 to 94.5,288
Rotavirus,,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,84.0,78.1 to 89.9,249
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,91.9,87.9 to 96.0,260
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,93.9,90.8 to 97.0,329
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,91.0,87.0 to 95.1,288
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,77.5,72.1 to 83.0,329
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,75.3,69.0 to 81.6,288
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,81.6,73.7 to 89.4,249
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,97.4,95.6 to 99.2,329
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,96.6,94.2 to 99.0,249
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,97.2,95.9 to 98.5,866
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,97.1,95.9 to 98.4,866
Influenza,,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,80.5,75.0 to 86.0,288
Influenza,,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,73.8,67.5 to 80.2,249
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,97.4,95.6 to 99.2,329
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,96.1,93.3 to 98.8,288
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,89.6,84.9 to 94.3,249
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,90.8,86.5 to 95.2,249
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,97.2,94.5 to 99.8,288
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,92.3,88.9 to 95.7,329
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,97.3,95.0 to 99.6,288
Polio,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,96.6,94.2 to 99.0,249
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,92.3,89.2 to 95.4,329
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Poverty,133% to <400% FPL,84.6,78.3 to 90.9,288
Hib,Full Series,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,84.5,79.3 to 89.7,249
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,95.9,93.6 to 98.2,329
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Poverty,<133% FPL,85.3,79.5 to 91.0,249
PCV,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Overall,Overall,90.0,87.3 to 92.7,866
Influenza,,States/Local Areas,Rhode Island,2016-2019,Poverty,>400% FPL,89.0,84.9 to 93.0,329
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,96.6,94.3 to 98.8,349
Combined 7 Series,,States/Local Areas,Rhode Island,2016-2019,Insurance Coverage,Any Medicaid,71.4,65.3 to 77.5,349
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,Hispanic,97.1,94.7 to 99.5,237
Polio,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,94.2,87.9 to 97.4,241
Hib,Primary Series,States/Local Areas,Rhode Island,2021,Age,19 Months,93.4,87.1 to 96.7,241
Hib,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,88.2,81.3 to 92.8,241
Hib,Primary Series,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,95.2,91.9 to 97.4,542
PCV,≥4 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,91.9,88.2 to 94.7,542
Polio,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,95.4,90.6 to 97.8,241
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,96.3,93.2 to 98.0,542
Hib,≥3 Doses,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,92.2,88.5 to 95.1,542
≥1 Dose MMR,,States/Local Areas,Rhode Island,2021,Age,35 Months,94.2,89.1 to 97.4,241
Combined 7 Series,,States/Local Areas,Rhode Island,2021,Age,35 Months,80.3,72.4 to 87.1,241
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,3 Months,95.0,91.1 to 97.3,233
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,3 Months,93.6,89.6 to 96.1,221
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,3 Months,93.6,90.5 to 95.7,252
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,3 Months,93.5,91.5 to 95.1,497
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,3 Months,93.4,87.6 to 96.6,245
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,3 Months,93.1,89.5 to 95.5,493
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,3 Months,92.8,87.7 to 95.9,248
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,3 Months,94.5,91.7 to 96.4,498
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,3 Months,96.2,92.9 to 98.0,250
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,3 Months,94.8,91.9 to 96.7,487
≥1 Dose MMR,,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.3,93.0 to 97.5,606
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,88.1,83.7 to 92.6,260
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.5,83.9 to 91.2,606
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,93.2 to 98.5,260
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.8,96.5 to 99.2,606
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,83.8 to 94.6,260
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.8,96.5 to 99.1,606
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.7,84.2 to 93.3,606
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.0,95.3 to 98.7,504
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",99.3,97.9 to 100.0,86
PCV,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,35 Months,93.4,87.9 to 97.0,241
Hib,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,94.5,89.7 to 97.1,241
Hib,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,96.5,92.3 to 98.7,233
Hib,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,95.7,90.7 to 98.4,221
Hib,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,9.6,5.7 to 15.6,241
Hep B,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,96.3,91.5 to 98.4,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,7 Months,77.9,69.8 to 84.3,241
PCV,≥2 Doses,States/Local Areas,Rhode Island,2021,Age,5 Months,89.0,82.7 to 93.2,241
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2021,Age,19 Months,92.1,85.8 to 95.8,241
≥1 Dose Varicella,,States/Local Areas,Rhode Island,2020-2021,Age,13 Months,71.5,66.1 to 76.3,542
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,92.3,88.7 to 95.2,542
Hep B,≥3 Doses,States/Local Areas,Rhode Island,2021,Age,19 Months,94.5,88.7 to 97.5,241
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,3 Months,93.8,88.8 to 96.7,225
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,3 Months,93.8,90.2 to 96.1,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,97.4,94.6 to 98.9,248
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,97.4,95.7 to 98.5,498
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,3 Months,93.4,88.0 to 96.5,237
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,3 Months,93.6,90.3 to 95.9,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,97.7,94.9 to 99.2,245
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,97.6,95.7 to 98.7,493
DTaP,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,3 Months,93.8,87.7 to 97.0,277
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,19 Months,77.4,72.9 to 81.4,221
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,24 Months,97.4,94.2 to 99.1,252
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,97.7,95.6 to 98.9,497
Hib,Full Series,States/Local Areas,Rhode Island,2020-2021,Age,24 Months,86.2,81.8 to 90.0,542
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,19 Months,82.9,80.1 to 85.4,233
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,19 Months,85.0,78.2 to 89.9,245
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,86.8,82.6 to 90.1,493
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,19 Months,88.6,79.3 to 94.0,248
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,89.7,86.2 to 92.4,498
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,5 Months,86.3,79.4 to 91.2,237
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,5 Months,87.4,82.7 to 91.0,462
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,5 Months,88.5,81.9 to 92.8,225
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,5 Months,87.6,83.2 to 90.9,502
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,5 Months,87.2,81.4 to 91.4,250
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,5 Months,86.8,82.5 to 90.1,487
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.8,95.4 to 98.3,641
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,98.0,94.9 to 99.4,225
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,97.6,95.1 to 99.0,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,96.1,92.4 to 98.3,237
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,97.0,94.8 to 98.5,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,97.4,95.0 to 98.8,250
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,96.7,94.7 to 98.2,487
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Overall,Overall,96.2,94.9 to 97.6,913
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,<133% FPL,95.0,92.2 to 97.8,279
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,133% to <400% FPL,96.5,94.2 to 98.7,276
Polio,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Poverty,>400% FPL,97.6,95.9 to 99.2,358
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,19 Months,83.2,79.1 to 86.6,252
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,84.0,79.4 to 87.8,497
Hib,Full Series,States/Local Areas,Rhode Island,2021,Age,19 Months,81.4,73.8 to 87.2,241
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,97.2,92.6 to 99.3,277
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,24 Months,94.4,89.6 to 97.5,245
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,93.7,90.7 to 96.0,493
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,19 Months,38.4,31.4 to 45.9,277
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,24 Months,30.7,23.6 to 39.4,221
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2018,Age,19 Months,36.8,29.0 to 45.5,225
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,37.2,30.7 to 44.1,374
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,95.3,91.3 to 97.8,250
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,95.6,92.9 to 97.5,487
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,95.6,91.6 to 98.0,237
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,96.1,92.8 to 98.1,462
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,71.2,68.0 to 74.2,252
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,77.5,74.9 to 79.9,497
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,84.2,77.6 to 89.1,245
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,77.4,72.6 to 81.6,493
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,70.7,66.4 to 74.7,248
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,70.7,65.7 to 75.2,498
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2017,Age,19 Months,41.0,33.6 to 48.8,237
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,38.9,33.4 to 44.7,462
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Private Insurance Only,97.8,96.6 to 99.1,525
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2017,Insurance Coverage,Any Medicaid,96.0,93.8 to 98.1,361
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,24 Months,93.1,89.0 to 96.0,248
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,93.5,90.7 to 95.7,498
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,24 Months,93.8,89.7 to 96.7,250
Hib,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,94.5,91.8 to 96.6,487
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,24 Months,94.2,89.8 to 97.2,237
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,94.4,91.3 to 96.7,462
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,24 Months,95.6,91.0 to 98.2,277
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,35 Months,94.5,89.6 to 97.6,221
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,24 Months,94.9,89.8 to 97.9,225
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,95.2,92.0 to 97.4,502
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,35 Months,97.2,92.6 to 99.3,277
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,35 Months,99.5,97.2 to 100.0,225
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,35 Months,98.2,95.5 to 99.4,502
PCV,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,5 Months,84.2,77.7 to 89.0,248
PCV,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,5 Months,84.1,79.8 to 87.7,498
PCV,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,5 Months,84.1,77.8 to 88.9,250
PCV,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,5 Months,85.2,80.8 to 88.8,487
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014,Age,24 Months,88.7,82.8 to 93.3,245
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2014-2015,Age,24 Months,91.4,87.8 to 94.2,493
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2015,Age,24 Months,94.1,90.1 to 96.8,248
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2015-2016,Age,24 Months,94.0,91.2 to 96.1,498
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,24 Months,93.8,89.7 to 96.6,250
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,24 Months,93.9,91.1 to 96.1,487
PCV,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,5 Months,82.5,75.1 to 88.0,245
PCV,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,5 Months,83.3,78.9 to 87.0,493
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,94.7,90.8 to 97.4,248
Hib,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,95.1,92.4 to 97.1,498
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2015,Age,19 Months,31.5,25.9 to 37.8,248
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2015-2016,Age,19 Months,33.9,29.3 to 38.8,498
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016,Age,19 Months,36.2,29.7 to 43.4,250
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,38.6,33.6 to 43.9,487
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,93.0,88.0 to 96.4,252
Hib,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,94.2,90.9 to 96.6,497
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,95.5,90.6 to 98.3,245
Hib,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,95.2,92.1 to 97.4,493
Hib,≥3 Doses,States/Local Areas,Rhode Island,2019,Age,24 Months,93.6,88.6 to 96.9,277
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,24 Months,95.2,91.4 to 97.7,237
Hib,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,24 Months,94.7,91.7 to 96.8,462
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018,Age,24 Months,94.2,89.3 to 97.4,225
Hib,≥3 Doses,States/Local Areas,Rhode Island,2018-2019,Age,24 Months,93.8,90.5 to 96.3,502
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,19 Months,29.5,26.3 to 33.0,252
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,19 Months,32.2,30.0 to 34.5,497
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,25.9,23.6 to 28.3,233
DTaP,≥2 Doses,States/Local Areas,Rhode Island,2019,Age,5 Months,86.7,80.3 to 91.2,277
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,21.0,14.2 to 29.9,221
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014,Age,35 Months,99.9,99.1 to 100.0,245
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2014-2015,Age,35 Months,99.6,98.2 to 99.9,493
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013,Age,35 Months,97.4,94.2 to 99.1,252
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2013-2014,Age,35 Months,98.8,96.8 to 99.7,497
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2012,Age,35 Months,98.9,96.8 to 99.7,233
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2011,Age,35 Months,98.8,95.4 to 99.8,221
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2018,Age,19 Months,89.4,83.0 to 93.6,225
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2018-2019,Age,19 Months,91.5,87.1 to 94.5,374
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2017,Age,19 Months,91.8,86.2 to 95.2,237
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2017-2018,Age,19 Months,90.6,86.4 to 93.6,462
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016,Age,19 Months,90.9,86.2 to 94.1,250
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2016-2017,Age,19 Months,91.3,87.9 to 93.8,487
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2012,Age,24 Months,89.4,83.8 to 93.8,233
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2019,Age,19 Months,91.5,85.9 to 95.0,277
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2011,Age,24 Months,87.1,80.7 to 92.3,221
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2013,Age,24 Months,91.9,87.4 to 95.3,252
Hep A,≥1 Dose,States/Local Areas,Rhode Island,2013-2014,Age,24 Months,90.4,86.8 to 93.4,497
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017,Age,35 Months,99.1,94.9 to 100.0,237
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2017-2018,Age,35 Months,99.3,97.2 to 99.9,462
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2011,Age,19 Months,72.3,69.9 to 74.5,221
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014,Age,19 Months,35.0,27.6 to 43.2,245
Hep A,≥2 Doses,States/Local Areas,Rhode Island,2014-2015,Age,19 Months,33.3,28.3 to 38.6,493
DTaP,≥4 Doses,States/Local Areas,Rhode Island,2012,Age,19 Months,74.0,68.1 to 79.2,233
PCV,≥2 Doses,States/Local Areas,Rhode Island,2013,Age,5 Months,85.6,77.4 to 91.2,252
PCV,≥2 Doses,States/Local Areas,Rhode Island,2013-2014,Age,5 Months,84.1,77.1 to 89.2,497
PCV,≥2 Doses,States/Local Areas,Rhode Island,2012,Age,5 Months,81.5,76.6 to 85.6,233
PCV,≥2 Doses,States/Local Areas,Rhode Island,2011,Age,5 Months,82.3,77.6 to 86.2,221
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015,Age,35 Months,98.8,95.9 to 99.8,248
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2015-2016,Age,35 Months,97.9,96.2 to 98.9,498
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016,Age,35 Months,97.4,95.0 to 98.8,250
DTaP,≥3 Doses,States/Local Areas,Rhode Island,2016-2017,Age,35 Months,97.7,94.6 to 99.3,487
Hep A,≥1 Dose,States/Local Areas,Florida,2020-2021,Age,35 Months,88.0,83.2 to 92.0,666
Hib,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,92.0,88.1 to 94.6,666
Rotavirus,,States/Local Areas,Florida,2019-2020,Age,8 Months,71.0,65.7 to 75.7,723
≥1 Dose Varicella,,States/Local Areas,Florida,2020-2021,Age,35 Months,93.1,89.4 to 95.9,666
PCV,≥3 Doses,States/Local Areas,Florida,2020,Age,7 Months,69.0,61.9 to 75.3,390
DTaP,≥3 Doses,States/Local Areas,Florida,2020,Age,13 Months,89.6,84.4 to 93.2,390
Hep B,≥3 Doses,States/Local Areas,Florida,2020,Age,24 Months,90.3,85.8 to 93.9,390
Hep B,≥1 Dose,States/Local Areas,Florida,2020,Age,3 Months,93.8,89.4 to 96.4,390
Hep B,≥3 Doses,States/Local Areas,Florida,2020,Age,7 Months,56.1,48.8 to 63.1,390
Hib,≥1 Dose,States/Local Areas,Florida,2020,Age,3 Months,83.4,77.2 to 88.2,390
Polio,≥1 Dose,States/Local Areas,Florida,2020,Age,3 Months,86.1,80.0 to 90.6,390
Hep B,≥2 Doses,States/Local Areas,Florida,2020,Age,5 Months,85.4,79.5 to 89.8,390
Hib,≥2 Doses,States/Local Areas,Florida,2020,Age,5 Months,75.2,68.2 to 81.1,390
Polio,≥2 Doses,States/Local Areas,Florida,2020,Age,5 Months,76.7,69.7 to 82.5,390
DTaP,≥2 Doses,States/Local Areas,Florida,2020,Age,5 Months,77.6,70.6 to 83.2,390
PCV,≥1 Dose,States/Local Areas,Florida,2020,Age,3 Months,85.1,79.2 to 89.5,390
Combined 7 Series,,States/Local Areas,Florida,2020,Age,24 Months,64.4,57.4 to 71.3,390
Hep A,≥2 Doses,States/Local Areas,Florida,2020,Age,24 Months,37.3,30.7 to 44.9,390
Hep A,≥1 Dose,States/Local Areas,Florida,2020,Age,24 Months,81.9,75.8 to 87.3,390
PCV,≥4 Doses,States/Local Areas,Florida,2020,Age,24 Months,80.8,74.6 to 86.2,390
DTaP,≥3 Doses,States/Local Areas,Florida,2020,Age,35 Months,92.4,87.9 to 95.7,390
PCV,≥3 Doses,States/Local Areas,Florida,2020,Age,24 Months,91.6,87.3 to 94.9,390
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2020,Age,0-3 Days,77.3,70.8 to 82.7,390
Rotavirus,,States/Local Areas,Florida,2020,Age,8 Months,72.3,65.3 to 78.3,390
Influenza,,States/Local Areas,Florida,2020,Age,24 Months,42.7,35.9 to 50.1,390
Hib,≥3 Doses,States/Local Areas,Florida,2020,Age,19 Months,89.5,84.1 to 93.2,390
Polio,≥3 Doses,States/Local Areas,Florida,2020,Age,19 Months,90.2,85.1 to 93.7,390
≥1 Dose MMR,,States/Local Areas,Florida,2020,Age,19 Months,89.7,84.6 to 93.2,390
DTaP,≥4 Doses,States/Local Areas,Florida,2020,Age,19 Months,71.1,64.0 to 77.3,390
DTaP,≥3 Doses,States/Local Areas,Florida,2020,Age,19 Months,91.4,86.6 to 94.6,390
PCV,≥2 Doses,States/Local Areas,Florida,2020,Age,5 Months,78.1,71.4 to 83.6,390
DTaP,≥3 Doses,States/Local Areas,Florida,2020,Age,7 Months,71.4,64.2 to 77.6,390
PCV,≥3 Doses,States/Local Areas,Florida,2020,Age,13 Months,87.8,82.6 to 91.6,390
≥1 Dose Varicella,,States/Local Areas,Florida,2020,Age,13 Months,65.2,57.9 to 71.9,390
Hep B,≥3 Doses,States/Local Areas,Florida,2020,Age,13 Months,86.6,80.9 to 90.7,390
Hep B,≥2 Doses,States/Local Areas,Florida,2020,Age,13 Months,92.4,87.6 to 95.4,390
Hib,≥3 Doses,States/Local Areas,Florida,2020,Age,13 Months,75.2,68.4 to 81.1,390
Hib,Primary Series,States/Local Areas,Florida,2020,Age,13 Months,85.6,79.9 to 90.0,390
PCV,≥4 Doses,States/Local Areas,Florida,2020,Age,35 Months,82.4,76.3 to 87.6,390
PCV,≥4 Doses,States/Local Areas,Florida,2020,Age,19 Months,75.1,68.2 to 80.9,390
Polio,≥3 Doses,States/Local Areas,Florida,2020,Age,35 Months,91.6,86.7 to 95.2,390
DTaP,≥4 Doses,States/Local Areas,Florida,2020,Age,35 Months,88.7,82.4 to 93.6,390
≥1 Dose Varicella,,States/Local Areas,Florida,2020,Age,19 Months,88.2,82.9 to 92.0,390
PCV,≥3 Doses,States/Local Areas,Florida,2020,Age,19 Months,91.1,86.4 to 94.3,390
Hep B,≥3 Doses,States/Local Areas,Florida,2020,Age,19 Months,89.3,84.0 to 93.0,390
Hib,Full Series,States/Local Areas,Florida,2020,Age,19 Months,73.5,66.6 to 79.5,390
Hib,Primary Series,States/Local Areas,Florida,2020,Age,19 Months,91.3,86.5 to 94.5,390
PCV,≥3 Doses,States/Local Areas,Florida,2020,Age,35 Months,92.0,87.6 to 95.3,390
≥1 Dose Varicella,,States/Local Areas,Florida,2020,Age,35 Months,92.2,87.5 to 95.7,390
Hep B,≥3 Doses,States/Local Areas,Florida,2020,Age,35 Months,91.3,86.7 to 94.8,390
Hib,Full Series,States/Local Areas,Florida,2020,Age,35 Months,81.8,75.3 to 87.5,390
Hib,Primary Series,States/Local Areas,Florida,2020,Age,35 Months,91.7,87.2 to 95.1,390
Hib,≥3 Doses,States/Local Areas,Florida,2020,Age,35 Months,90.2,85.1 to 94.1,390
≥1 Dose MMR,,States/Local Areas,Florida,2020,Age,35 Months,92.7,88.1 to 96.0,390
Hib,Primary Series,States/Local Areas,Florida,2020,Age,24 Months,91.5,87.0 to 94.9,390
Hib,≥3 Doses,States/Local Areas,Florida,2020,Age,24 Months,89.7,84.7 to 93.6,390
≥1 Dose MMR,,States/Local Areas,Florida,2020,Age,24 Months,90.7,86.0 to 94.3,390
DTaP,≥4 Doses,States/Local Areas,Florida,2020,Age,24 Months,77.8,71.3 to 83.8,390
Polio,≥3 Doses,States/Local Areas,Florida,2020,Age,24 Months,90.7,86.0 to 94.4,390
DTaP,≥3 Doses,States/Local Areas,Florida,2020,Age,24 Months,91.9,87.5 to 95.2,390
Hep B,≥2 Doses,States/Local Areas,Florida,2020,Age,7 Months,89.9,85.0 to 93.4,390
Hib,Primary Series,States/Local Areas,Florida,2020,Age,7 Months,70.5,63.5 to 76.6,390
Hib,≥3 Doses,States/Local Areas,Florida,2020,Age,7 Months,57.8,50.6 to 64.8,390
Hib,≥2 Doses,States/Local Areas,Florida,2020,Age,7 Months,88.8,83.7 to 92.5,390
DTaP,≥1 Dose,States/Local Areas,Florida,2020,Age,3 Months,86.0,79.9 to 90.5,390
Polio,≥2 Doses,States/Local Areas,Florida,2020,Age,7 Months,89.0,83.7 to 92.7,390
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2020,Age,0-2 Days,76.4,69.9 to 81.8,390
Hep A,≥2 Doses,States/Local Areas,Florida,2020,Age,19 Months,23.0,17.7 to 29.2,390
Hep A,≥1 Dose,States/Local Areas,Florida,2020,Age,19 Months,79.0,72.4 to 84.3,390
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2020,Age,0-1 Days,73.7,67.0 to 79.4,390
Combined 7 Series,,States/Local Areas,Florida,2020,Age,35 Months,72.6,65.4 to 79.3,390
Hep A,≥2 Doses,States/Local Areas,Florida,2020,Age,35 Months,76.8,67.4 to 85.1,390
Hep A,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,43.2,37.7 to 49.2,723
Polio,≥2 Doses,States/Local Areas,Florida,2020,Age,13 Months,90.7,85.5 to 94.1,390
Hep A,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,24 Months,83.6,79.4 to 87.4,723
Hep A,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,35 Months,91.2,86.6 to 94.7,723
Hep A,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,76.7,70.2 to 82.7,723
Influenza,,States/Local Areas,Florida,2019-2020,Age,24 Months,44.6,39.2 to 50.3,723
Hib,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,91.8,88.6 to 94.4,723
Hib,Primary Series,States/Local Areas,Florida,2019-2020,Age,24 Months,92.8,89.8 to 95.1,723
Hib,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,54.4,48.8 to 59.8,723
Combined 7 Series,,States/Local Areas,Florida,2019-2020,Age,35 Months,75.3,69.6 to 80.7,723
Hep B,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,90.1,86.5 to 92.8,723
≥1 Dose Varicella,,States/Local Areas,Florida,2019-2020,Age,19 Months,88.9,85.1 to 91.9,723
PCV,≥4 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,77.2,72.2 to 81.5,723
Hep A,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,19 Months,80.2,75.6 to 84.1,723
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2019-2020,Age,0-2 Days,74.3,69.3 to 78.8,723
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2019-2020,Age,0-1 Days,70.7,65.5 to 75.4,723
Hep B,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,91.3,88.2 to 93.9,723
≥1 Dose Varicella,,States/Local Areas,Florida,2019-2020,Age,24 Months,90.5,87.0 to 93.5,723
PCV,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,66.8,61.2 to 71.9,723
Hib,Full Series,States/Local Areas,Florida,2019-2020,Age,24 Months,81.1,76.7 to 85.1,723
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2019-2020,Age,0-3 Days,75.1,70.2 to 79.5,723
PCV,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,92.0,88.7 to 94.6,723
PCV,≥4 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,81.4,76.8 to 85.6,723
Hep A,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,25.9,21.3 to 31.1,723
≥1 Dose MMR,,States/Local Areas,Florida,2019-2020,Age,19 Months,91.0,87.6 to 93.6,723
Hib,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,89.9,86.2 to 92.8,723
Hib,Primary Series,States/Local Areas,Florida,2019-2020,Age,19 Months,90.9,87.3 to 93.6,723
Hib,Full Series,States/Local Areas,Florida,2019-2020,Age,19 Months,75.3,70.4 to 79.6,723
≥1 Dose MMR,,States/Local Areas,Florida,2019-2020,Age,35 Months,94.0,91.1 to 96.3,723
Hib,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,92.2,88.9 to 94.7,723
Hib,Primary Series,States/Local Areas,Florida,2019-2020,Age,35 Months,92.9,89.9 to 95.3,723
Hib,Full Series,States/Local Areas,Florida,2019-2020,Age,35 Months,85.7,81.0 to 89.7,723
Hep B,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,92.0,88.9 to 94.6,723
≥1 Dose Varicella,,States/Local Areas,Florida,2019-2020,Age,35 Months,94.5,90.8 to 97.0,723
PCV,≥4 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,84.0,79.0 to 88.3,723
PCV,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,92.2,88.9 to 94.8,723
DTaP,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,92.4,89.2 to 94.9,723
DTaP,≥4 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,80.3,75.6 to 84.6,723
Polio,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,24 Months,90.8,87.2 to 93.7,723
≥1 Dose MMR,,States/Local Areas,Florida,2019-2020,Age,24 Months,93.1,90.2 to 95.4,723
Hep B,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,3 Months,93.6,90.3 to 95.8,723
PCV,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,3 Months,85.0,80.6 to 88.5,723
DTaP,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,5 Months,76.6,71.3 to 81.3,723
Polio,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,5 Months,76.3,70.9 to 80.9,723
Hib,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,5 Months,74.2,68.8 to 79.0,723
Polio,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,91.3,87.7 to 93.9,723
≥1 Dose MMR,,States/Local Areas,Florida,2019-2020,Age,13 Months,71.7,66.5 to 76.3,723
Hib,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,77.3,72.3 to 81.6,723
Hib,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,92.4,89.2 to 94.7,723
Hib,Primary Series,States/Local Areas,Florida,2019-2020,Age,13 Months,86.6,82.5 to 89.9,723
Hep B,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,92.8,89.6 to 95.1,723
Hep B,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,5 Months,84.6,80.1 to 88.2,723
PCV,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,5 Months,75.2,69.8 to 80.0,723
DTaP,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,69.9,64.4 to 74.9,723
Polio,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,87.6,83.4 to 90.8,723
Hib,≥2 Doses,States/Local Areas,Florida,2019-2020,Age,7 Months,89.3,85.7 to 92.1,723
Hep B,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,87.9,83.9 to 90.9,723
PCV,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,86.6,82.4 to 90.0,723
DTaP,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,91.5,88.0 to 94.1,723
≥1 Dose Varicella,,States/Local Areas,Florida,2019-2020,Age,13 Months,66.6,61.2 to 71.6,723
Combined 7 Series,,States/Local Areas,Florida,2019-2020,Age,24 Months,67.7,62.5 to 72.9,723
DTaP,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,94.6,90.9 to 97.1,723
DTaP,≥4 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,88.3,83.8 to 92.0,723
Polio,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,35 Months,91.2,87.6 to 94.0,723
Hep A,≥1 Dose,States/Local Areas,Florida,2021,Age,24 Months,84.6,76.6 to 91.1,276
PCV,≥4 Doses,States/Local Areas,Florida,2021,Age,24 Months,79.0,71.0 to 85.9,276
Hib,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,74.8,69.1 to 79.8,666
DTaP,≥3 Doses,States/Local Areas,Florida,2021,Age,19 Months,92.3,85.4 to 96.1,276
PCV,≥3 Doses,States/Local Areas,Florida,2021,Age,24 Months,89.6,82.9 to 94.5,276
≥1 Dose Varicella,,States/Local Areas,Florida,2021,Age,24 Months,93.1,86.7 to 97.1,276
Hep A,≥2 Doses,States/Local Areas,Florida,2021,Age,24 Months,41.8,33.1 to 51.9,276
Hep B,≥3 Doses,States/Local Areas,Florida,2021,Age,7 Months,53.2,44.0 to 62.2,276
PCV,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,5 Months,76.6,71.3 to 81.2,666
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Florida,2021,Age,0-2 Days,75.2,66.8 to 82.0,276
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Florida,2021,Age,0-1 Days,68.9,60.0 to 76.5,276
Polio,≥2 Doses,States/Local Areas,Florida,2021,Age,13 Months,93.0,86.1 to 96.6,276
Hep A,≥1 Dose,States/Local Areas,Florida,2021,Age,19 Months,76.4,67.4 to 83.5,276
Hib,≥3 Doses,States/Local Areas,Florida,2021,Age,24 Months,91.9,85.8 to 96.1,276
≥1 Dose MMR,,States/Local Areas,Florida,2021,Age,24 Months,91.2,85.5 to 95.3,276
Polio,≥1 Dose,States/Local Areas,Florida,2021,Age,3 Months,84.5,76.3 to 90.2,276
Polio,≥3 Doses,States/Local Areas,Florida,2021,Age,24 Months,92.4,86.3 to 96.5,276
DTaP,≥4 Doses,States/Local Areas,Florida,2021,Age,24 Months,83.6,75.1 to 90.5,276
PCV,≥4 Doses,States/Local Areas,Florida,2021,Age,35 Months,79.9,71.8 to 87.0,276
Hep A,≥2 Doses,States/Local Areas,Florida,2021,Age,19 Months,23.5,16.6 to 32.2,276
DTaP,≥1 Dose,States/Local Areas,Florida,2021,Age,3 Months,86.7,79.0 to 91.9,276
Hep B,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,92.9,89.1 to 95.8,666
DTaP,≥3 Doses,States/Local Areas,Florida,2021,Age,13 Months,88.0,80.7 to 92.8,276
Hep B,≥3 Doses,States/Local Areas,Florida,2021,Age,24 Months,92.0,84.0 to 96.9,276
PCV,≥3 Doses,States/Local Areas,Florida,2021,Age,7 Months,63.3,53.9 to 71.7,276
Hep A,≥1 Dose,States/Local Areas,Florida,2021,Age,35 Months,90.4,82.5 to 95.8,276
Hib,Primary Series,States/Local Areas,Florida,2021,Age,7 Months,67.5,58.1 to 75.7,276
PCV,≥3 Doses,States/Local Areas,Florida,2021,Age,19 Months,89.5,82.1 to 94.0,276
DTaP,≥4 Doses,States/Local Areas,Florida,2021,Age,19 Months,64.5,55.0 to 72.9,276
Hib,Full Series,States/Local Areas,Florida,2021,Age,24 Months,76.4,67.9 to 84.2,276
Hib,Primary Series,States/Local Areas,Florida,2021,Age,24 Months,92.3,86.2 to 96.4,276
DTaP,≥3 Doses,States/Local Areas,Florida,2017,Age,35 Months,94.8,90.4 to 97.6,374
DTaP,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,93.0,89.3 to 95.7,698
DTaP,≥4 Doses,States/Local Areas,Florida,2011,Age,19 Months,67.8,57.1 to 76.9,236
DTaP,≥4 Doses,States/Local Areas,Florida,2012,Age,19 Months,67.1,63.9 to 70.0,240
Hep A,≥2 Doses,States/Local Areas,Florida,2021,Age,35 Months,65.7,53.4 to 77.7,276
Hep A,≥2 Doses,States/Local Areas,Florida,2017,Age,19 Months,23.0,17.5 to 29.7,374
Hep A,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,19 Months,22.9,18.3 to 28.2,698
Hib,≥3 Doses,States/Local Areas,Florida,2015,Age,35 Months,92.9,88.3 to 96.1,309
Hib,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,92.8,89.5 to 95.3,658
Hib,≥3 Doses,States/Local Areas,Florida,2014,Age,35 Months,88.3,81.9 to 93.2,274
Hib,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,90.5,86.6 to 93.6,583
Hib,≥3 Doses,States/Local Areas,Florida,2013,Age,35 Months,96.7,92.9 to 98.8,272
Hib,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,92.5,88.9 to 95.3,546
Hep A,≥2 Doses,States/Local Areas,Florida,2016,Age,19 Months,24.7,18.3 to 32.5,349
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,19 Months,23.9,19.5 to 28.9,723
Hep A,≥2 Doses,States/Local Areas,Florida,2015,Age,19 Months,24.7,20.8 to 28.9,309
Hep A,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,24.7,20.0 to 30.0,658
Hib,≥3 Doses,States/Local Areas,Florida,2018,Age,35 Months,91.6,84.5 to 96.3,324
Hib,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,93.1,88.8 to 96.2,657
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.3,86.2 to 98.5,106
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Uninsured,84.3,70.2 to 98.3,39
Hep A,≥2 Doses,States/Local Areas,Florida,2012,Age,24 Months,39.8,31.6 to 49.3,240
Hib,≥3 Doses,States/Local Areas,Florida,2017,Age,35 Months,93.1,88.1 to 96.4,374
Hib,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,35 Months,92.4,88.2 to 95.6,698
Hib,≥3 Doses,States/Local Areas,Florida,2016,Age,35 Months,92.7,87.5 to 96.2,349
Hib,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,92.9,89.5 to 95.5,723
Hep A,≥2 Doses,States/Local Areas,Florida,2011,Age,24 Months,34.2,26.0 to 44.0,236
Hep A,≥2 Doses,States/Local Areas,Florida,2019,Age,19 Months,28.7,21.5 to 37.2,333
Hep A,≥2 Doses,States/Local Areas,Florida,2018,Age,19 Months,22.8,16.1 to 31.2,324
Hep A,≥2 Doses,States/Local Areas,Florida,2018-2019,Age,19 Months,25.8,19.2 to 33.7,505
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Any Medicaid,91.5,88.5 to 94.4,490
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2017,Insurance Coverage,Private Insurance Only,95.1,92.0 to 98.2,628
DTaP,≥4 Doses,States/Local Areas,Florida,2015,Age,19 Months,75.1,65.7 to 82.6,309
DTaP,≥4 Doses,States/Local Areas,Florida,2015-2016,Age,19 Months,71.7,66.2 to 76.6,658
DTaP,≥4 Doses,States/Local Areas,Florida,2014,Age,19 Months,69.0,60.3 to 76.5,274
DTaP,≥4 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,72.1,66.4 to 77.1,583
DTaP,≥4 Doses,States/Local Areas,Florida,2013,Age,19 Months,69.6,65.4 to 73.6,272
DTaP,≥4 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,69.3,66.2 to 72.2,546
Hep A,≥1 Dose,States/Local Areas,Florida,2017,Age,24 Months,76.5,69.2 to 83.1,374
Hep A,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,24 Months,76.6,71.0 to 81.8,698
Hib,≥2 Doses,States/Local Areas,Florida,2020,Age,13 Months,91.4,86.5 to 94.6,390
Hep A,≥1 Dose,States/Local Areas,Florida,2011,Age,35 Months,78.7,68.6 to 87.4,236
Hep A,≥1 Dose,States/Local Areas,Florida,2019,Age,24 Months,85.4,79.2 to 90.5,333
Hep A,≥1 Dose,States/Local Areas,Florida,2018,Age,24 Months,76.9,68.2 to 84.7,324
Hep A,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,24 Months,81.1,75.7 to 85.9,657
DTaP,≥3 Doses,States/Local Areas,Florida,2019,Age,35 Months,97.5,92.8 to 99.4,333
DTaP,≥3 Doses,States/Local Areas,Florida,2018,Age,35 Months,91.2,84.8 to 95.6,324
DTaP,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,35 Months,93.9,89.6 to 96.8,657
PCV,≥2 Doses,States/Local Areas,Florida,2016,Age,5 Months,74.6,66.7 to 81.2,349
PCV,≥2 Doses,States/Local Areas,Florida,2016-2017,Age,5 Months,72.4,67.0 to 77.3,723
PCV,≥2 Doses,States/Local Areas,Florida,2015,Age,5 Months,77.3,70.0 to 83.2,309
PCV,≥2 Doses,States/Local Areas,Florida,2015-2016,Age,5 Months,76.0,70.7 to 80.5,658
PCV,≥2 Doses,States/Local Areas,Florida,2014,Age,5 Months,74.1,65.6 to 81.1,274
PCV,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,5 Months,75.7,71.9 to 79.1,583
Hep A,≥1 Dose,States/Local Areas,Florida,2016,Age,24 Months,76.0,68.4 to 83.0,349
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,24 Months,76.3,70.9 to 81.2,723
Hep A,≥1 Dose,States/Local Areas,Florida,2015,Age,24 Months,75.9,68.6 to 82.5,309
Hep A,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,24 Months,76.0,70.8 to 80.9,658
DTaP,≥3 Doses,States/Local Areas,Florida,2016,Age,35 Months,94.2,89.7 to 97.1,349
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,35 Months,94.5,91.6 to 96.7,723
DTaP,≥3 Doses,States/Local Areas,Florida,2015,Age,35 Months,95.0,91.0 to 97.6,309
DTaP,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,35 Months,94.7,91.8 to 96.8,658
PCV,≥2 Doses,States/Local Areas,Florida,2013,Age,5 Months,72.0,60.9 to 80.9,272
PCV,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,5 Months,73.0,65.9 to 79.2,546
PCV,≥2 Doses,States/Local Areas,Florida,2012,Age,5 Months,67.1,58.0 to 75.1,240
PCV,≥2 Doses,States/Local Areas,Florida,2011,Age,5 Months,65.6,61.8 to 69.1,236
PCV,≥2 Doses,States/Local Areas,Florida,2017,Age,5 Months,70.3,62.5 to 77.1,374
PCV,≥2 Doses,States/Local Areas,Florida,2017-2018,Age,5 Months,73.8,68.0 to 78.8,698
Hep A,≥1 Dose,States/Local Areas,Florida,2012,Age,35 Months,82.0,74.5 to 88.4,240
Hib,≥3 Doses,States/Local Areas,Florida,2012,Age,35 Months,95.0,89.7 to 98.1,240
Hib,≥3 Doses,States/Local Areas,Florida,2011,Age,35 Months,90.0,83.6 to 94.6,236
Hep A,≥1 Dose,States/Local Areas,Florida,2014,Age,24 Months,74.4,66.6 to 81.6,274
Hep A,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,24 Months,75.1,69.8 to 80.1,583
Hep A,≥1 Dose,States/Local Areas,Florida,2012,Age,24 Months,75.2,67.5 to 82.2,240
Hep A,≥1 Dose,States/Local Areas,Florida,2013,Age,24 Months,74.2,67.5 to 80.6,272
Hep A,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,24 Months,74.3,69.1 to 79.3,546
Hep A,≥1 Dose,States/Local Areas,Florida,2011,Age,24 Months,70.3,61.2 to 78.9,236
Hep A,≥1 Dose,States/Local Areas,Florida,2019,Age,19 Months,81.2,74.3 to 86.6,333
Hep B,≥2 Doses,States/Local Areas,Florida,2021,Age,7 Months,88.9,81.6 to 93.5,276
DTaP,≥3 Doses,States/Local Areas,Florida,2021,Age,7 Months,66.5,57.2 to 74.6,276
Combined 7 Series,,States/Local Areas,Florida,2021,Age,35 Months,73.6,64.2 to 82.3,276
Hep A,≥1 Dose,States/Local Areas,Florida,2018,Age,19 Months,75.2,65.8 to 82.7,324
Hep A,≥1 Dose,States/Local Areas,Florida,2018-2019,Age,19 Months,79.4,72.5 to 84.9,505
Hep A,≥1 Dose,States/Local Areas,Florida,2017,Age,19 Months,70.6,62.7 to 77.3,374
Hep A,≥1 Dose,States/Local Areas,Florida,2017-2018,Age,19 Months,72.8,66.9 to 78.1,698
Hib,≥3 Doses,States/Local Areas,Florida,2019,Age,24 Months,93.9,89.7 to 96.8,333
Hib,≥3 Doses,States/Local Areas,Florida,2018,Age,24 Months,89.0,82.2 to 94.0,324
Hib,≥3 Doses,States/Local Areas,Florida,2018-2019,Age,24 Months,91.4,87.5 to 94.5,657
Hep A,≥2 Doses,States/Local Areas,Florida,2014,Age,19 Months,18.2,12.3 to 26.0,274
Hep A,≥2 Doses,States/Local Areas,Florida,2014-2015,Age,19 Months,21.4,16.8 to 27.0,583
Hep A,≥2 Doses,States/Local Areas,Florida,2012,Age,19 Months,17.8,12.0 to 25.5,240
Hep A,≥2 Doses,States/Local Areas,Florida,2013,Age,19 Months,26.0,19.7 to 33.5,272
Hep A,≥2 Doses,States/Local Areas,Florida,2013-2014,Age,19 Months,22.0,15.9 to 29.8,546
Hep A,≥2 Doses,States/Local Areas,Florida,2011,Age,19 Months,19.1,13.8 to 25.9,236
DTaP,≥3 Doses,States/Local Areas,Florida,2014,Age,35 Months,93.0,86.7 to 97.0,274
DTaP,≥3 Doses,States/Local Areas,Florida,2014-2015,Age,35 Months,93.9,90.3 to 96.6,583
DTaP,≥3 Doses,States/Local Areas,Florida,2013,Age,35 Months,98.0,94.4 to 99.5,272
DTaP,≥3 Doses,States/Local Areas,Florida,2013-2014,Age,35 Months,95.4,92.0 to 97.7,546
DTaP,≥3 Doses,States/Local Areas,Florida,2012,Age,35 Months,95.6,90.9 to 98.2,240
DTaP,≥3 Doses,States/Local Areas,Florida,2011,Age,35 Months,93.1,87.2 to 97.0,236
PCV,≥2 Doses,States/Local Areas,Florida,2021,Age,5 Months,75.1,66.5 to 82.1,276
DTaP,≥4 Doses,States/Local Areas,Florida,2020-2021,Age,35 Months,88.6,83.0 to 93.0,666
Polio,≥2 Doses,States/Local Areas,Florida,2021,Age,7 Months,83.8,75.3 to 89.8,276
Hib,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,90.8,87.1 to 93.9,666
Polio,≥3 Doses,States/Local Areas,Florida,2021,Age,19 Months,91.1,84.0 to 95.2,276
Hep B,≥2 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,92.4,88.5 to 95.0,666
DTaP,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,19 Months,91.9,88.0 to 94.6,666
PCV,≥4 Doses,States/Local Areas,Florida,2021,Age,19 Months,71.7,62.5 to 79.4,276
Hib,≥1 Dose,States/Local Areas,Florida,2021,Age,3 Months,81.6,72.6 to 88.1,276
Hib,Full Series,States/Local Areas,Florida,2021,Age,19 Months,69.3,59.8 to 77.4,276
≥1 Dose Varicella,,States/Local Areas,Florida,2021,Age,19 Months,87.6,79.8 to 92.7,276
Hep B,≥3 Doses,States/Local Areas,Florida,2021,Age,19 Months,89.6,82.2 to 94.1,276
Hib,≥3 Doses,States/Local Areas,Florida,2017,Age,24 Months,92.4,87.7 to 95.7,374
Hib,≥3 Doses,States/Local Areas,Florida,2017-2018,Age,24 Months,90.7,86.7 to 93.9,698
DTaP,≥3 Doses,States/Local Areas,Florida,2019,Age,24 Months,93.0,88.1 to 96.3,333
Hib,≥3 Doses,States/Local Areas,Florida,2016,Age,24 Months,91.2,86.0 to 95.0,349
Hib,≥3 Doses,States/Local Areas,Florida,2016-2017,Age,24 Months,91.8,88.4 to 94.5,723
Hib,≥3 Doses,States/Local Areas,Florida,2015,Age,24 Months,91.5,86.8 to 95.1,309
Hib,≥3 Doses,States/Local Areas,Florida,2015-2016,Age,24 Months,91.4,88.1 to 94.2,658
DTaP,≥1 Dose,States/Local Areas,Florida,2016,Age,3 Months,89.8,84.0 to 93.7,349
DTaP,≥1 Dose,States/Local Areas,Florida,2016-2017,Age,3 Months,86.2,82.0 to 89.6,723
DTaP,≥1 Dose,States/Local Areas,Florida,2015,Age,3 Months,85.3,78.6 to 90.2,309
DTaP,≥1 Dose,States/Local Areas,Florida,2015-2016,Age,3 Months,87.5,83.3 to 90.8,658
DTaP,≥1 Dose,States/Local Areas,Florida,2014,Age,3 Months,85.5,78.1 to 90.6,274
DTaP,≥1 Dose,States/Local Areas,Florida,2014-2015,Age,3 Months,85.4,80.7 to 89.1,583
DTaP,≥1 Dose,States/Local Areas,Florida,2013,Age,3 Months,88.1,85.2 to 90.4,272
DTaP,≥1 Dose,States/Local Areas,Florida,2013-2014,Age,3 Months,86.8,82.3 to 90.2,546
DTaP,≥1 Dose,States/Local Areas,Florida,2012,Age,3 Months,88.3,84.4 to 91.3,240
DTaP,≥1 Dose,States/Local Areas,Florida,2011,Age,3 Months,83.2,75.8 to 88.7,236
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",64.0,57.1 to 70.8,579
Hib,Primary Series,States/Local Areas,Florida,2021,Age,19 Months,91.8,84.9 to 95.7,276
Hib,≥3 Doses,States/Local Areas,Florida,2021,Age,19 Months,91.2,84.4 to 95.2,276
Hib,≥2 Doses,States/Local Areas,Florida,2021,Age,5 Months,75.6,66.7 to 82.7,276
Hib,Primary Series,States/Local Areas,Florida,2020-2021,Age,24 Months,91.9,88.3 to 94.8,666
Hib,≥3 Doses,States/Local Areas,Florida,2021,Age,7 Months,56.3,47.0 to 65.1,276
PCV,≥3 Doses,States/Local Areas,Florida,2021,Age,35 Months,90.6,83.5 to 95.6,276
≥1 Dose MMR,,States/Local Areas,Florida,2021,Age,35 Months,95.4,89.3 to 98.5,276
Hib,≥2 Doses,States/Local Areas,Florida,2021,Age,7 Months,84.6,76.5 to 90.3,276
Hep B,≥3 Doses,States/Local Areas,Florida,2020-2021,Age,13 Months,86.3,81.8 to 89.8,666
PCV,≥4 Doses,States/Local Areas,Florida,2020-2021,Age,24 Months,80.0,75.0 to 84.5,666
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,88.6 to 95.7,579
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,90.4 to 95.7,703
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,79.0,73.9 to 84.1,703
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.3 to 95.8,502
DTaP,≥4 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,71.5,66.2 to 76.2,723
Polio,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,19 Months,89.9,86.1 to 92.8,723
DTaP,≥3 Doses,States/Local Areas,Florida,2019-2020,Age,13 Months,89.4,85.7 to 92.3,723
Hib,Primary Series,States/Local Areas,Florida,2019-2020,Age,7 Months,68.2,62.7 to 73.3,723
DTaP,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,3 Months,87.4,83.3 to 90.6,723
Polio,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,3 Months,85.9,81.5 to 89.4,723
Hib,≥1 Dose,States/Local Areas,Florida,2019-2020,Age,3 Months,85.0,80.7 to 88.5,723
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,79.1,73.8 to 84.4,510
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,90.0 to 100.0,88
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,87.9,83.9 to 92.0,671
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,79.2 to 95.7,154
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,92.3,88.4 to 96.1,408
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,80.5 to 90.1,579
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,71.2,48.3 to 94.1,30
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.3 to 94.3,510
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,94.7,91.9 to 97.5,671
Hib,Full Series,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.0,79.2 to 88.7,579
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,51.3,26.9 to 75.8,30
Hib,Full Series,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,45.9,22.2 to 69.5,30
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,79.9,73.9 to 85.9,408
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.9,75.9 to 93.9,88
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,79.4,62.5 to 96.2,30
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,92.2,89.0 to 95.3,510
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,58.6,33.5 to 83.7,30
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.0,89.7 to 100.0,88
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,79.4,62.5 to 96.2,30
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,89.6 to 96.5,579
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.1,77.7 to 94.5,154
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,90.1,85.8 to 94.4,408
Influenza,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,61.8,55.0 to 68.6,671
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,90.0 to 100.0,88
Influenza,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",44.4,30.5 to 58.3,154
Influenza,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",38.6,26.0 to 51.3,88
Influenza,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",47.4,40.0 to 54.7,579
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.6,69.6 to 89.7,88
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.6,87.9 to 95.2,579
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,42.9,19.3 to 66.5,30
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,77.2,70.8 to 83.7,408
Rotavirus,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.2,51.5 to 74.9,154
Rotavirus,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,71.7,65.1 to 78.3,408
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.9,60.8 to 83.1,88
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.7,54.5 to 78.8,154
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,67.8,60.6 to 75.0,408
Rotavirus,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,67.1,61.0 to 73.2,510
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.7,69.9 to 81.5,579
Rotavirus,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,43.6,20.4 to 66.8,30
Hib,Full Series,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.6,69.2 to 89.9,88
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,34.5,11.9 to 57.1,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.4,54.4 to 78.5,154
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,64.5,57.8 to 71.3,408
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,91.8,88.0 to 95.7,408
Influenza,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,28.1,8.7 to 47.5,30
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,67.0 to 88.0,154
Influenza,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,34.7,28.5 to 40.9,510
Rotavirus,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,80.3,75.1 to 85.6,671
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,91.1,87.7 to 94.5,510
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,79.4,62.5 to 96.2,30
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.0 to 99.0,671
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,91.8,88.4 to 95.1,510
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.9,76.2 to 93.6,154
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,90.0 to 100.0,88
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,91.6,87.6 to 95.6,408
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,47.6,24.2 to 70.9,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,66.3,60.5 to 72.1,510
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.7,71.3 to 84.1,579
Rotavirus,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.6,59.8 to 83.4,88
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.0,57.8 to 80.1,88
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,68.7,62.9 to 74.5,510
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,76.9,71.4 to 82.5,671
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.3,90.0 to 100.0,88
Rotavirus,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.3,65.6 to 79.0,579
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,90.1 to 96.8,579
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,88.6 to 95.6,579
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,64.6,58.2 to 70.9,671
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.8,56.0 to 75.5,579
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,42.1,18.6 to 65.6,30
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,90.1 to 96.9,579
Influenza,,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,61.6,53.0 to 70.1,404
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,75.3,68.8 to 81.7,335
Rotavirus,,States/Local Areas,Florida,2016-2019,Overall,Overall,71.1,66.8 to 75.3,1229
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,80.9,74.2 to 87.6,404
Hib,Full Series,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,72.9,66.1 to 79.7,335
Hib,Full Series,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,83.4,78.1 to 88.8,490
Hib,Full Series,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,90.9,87.0 to 94.7,404
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,89.1,84.6 to 93.7,335
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,82.2,78.6 to 85.7,1229
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,89.8,85.3 to 94.3,335
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,83.3,77.8 to 88.8,490
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,89.6,85.3 to 93.9,404
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,89.1,84.4 to 93.7,335
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,94.4,91.6 to 97.2,490
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,94.1,90.9 to 97.2,404
Influenza,,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,35.6,28.1 to 43.1,335
Influenza,,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,46.2,38.5 to 53.9,490
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,92.3,90.0 to 94.5,1229
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,92.9,90.7 to 95.2,1229
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,89.5,85.0 to 94.1,335
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,93.0,89.9 to 96.0,490
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,94.4,91.2 to 97.7,404
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,65.8,55.6 to 76.1,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,69.5,63.2 to 75.9,490
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,60.8,52.7 to 68.9,404
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,83.2,77.5 to 89.0,490
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,86.8,81.1 to 92.4,404
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.7 to 95.4,703
Rotavirus,,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,72.9,66.1 to 79.7,490
Rotavirus,,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,65.5,58.3 to 72.7,335
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,93.5,90.9 to 96.1,703
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,86.1 to 94.6,502
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.1,87.0 to 95.3,502
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,79.5,74.4 to 84.6,703
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.3,75.8 to 86.9,502
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.4,68.4 to 80.4,502
Influenza,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,45.9,39.6 to 52.1,703
Influenza,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,45.5,38.2 to 52.7,502
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,67.3 to 82.9,703
PCV,≥3 Doses,States/Local Areas,Florida,2021,Age,13 Months,84.4,76.4 to 90.1,276
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,92.9,89.7 to 96.0,408
Rotavirus,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,70.5,64.8 to 76.3,703
Rotavirus,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.5,63.8 to 77.1,502
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,82.6,78.1 to 87.2,703
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.5,70.2 to 82.7,502
Hib,Full Series,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,81.0,76.1 to 85.9,703
Hib,Full Series,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.8,74.2 to 85.5,502
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.2,86.0 to 94.4,502
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,66.2,58.0 to 74.4,502
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.4,88.4 to 100.0,88
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.3,77.5 to 95.0,154
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,91.5 to 96.6,703
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.2,87.1 to 95.3,502
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.2,80.1 to 90.3,502
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,92.3,89.4 to 95.1,703
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,90.3 to 95.6,703
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,86.5 to 95.0,502
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,68.7,62.9 to 74.4,703
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Principal City,61.5,55.5 to 67.4,703
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,94.0,91.2 to 96.9,490
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,94.9,91.9 to 98.0,404
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Overall,Overall,71.2,67.0 to 75.3,1229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Urbanicity,Living In a MSA Non-Principal City,71.5,65.6 to 77.4,502
Hib,Full Series,States/Local Areas,Florida,2016-2019,Overall,Overall,80.5,76.9 to 84.2,1229
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,94.2,91.4 to 97.0,490
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,92.2,88.3 to 96.1,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,64.2,57.1 to 71.3,335
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,66.0,58.9 to 73.1,335
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,73.8,67.2 to 80.3,490
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,95.2,92.7 to 97.7,490
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,95.9,93.0 to 98.8,404
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Overall,Overall,92.0,89.7 to 94.4,1229
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,70.8,64.9 to 76.6,1229
Combined 7 Series,,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,77.3,70.4 to 84.2,404
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,90.6,86.4 to 94.9,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Florida,2016-2019,Overall,Overall,65.4,61.2 to 69.6,1229
Influenza,,States/Local Areas,Florida,2016-2019,Overall,Overall,45.0,40.3 to 49.6,1229
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,88.4,83.8 to 93.1,335
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,95.1,92.6 to 97.6,490
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,75.7,67.0 to 84.3,490
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,72.2,62.8 to 81.6,404
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Poverty,<133% FPL,74.5,67.6 to 81.4,335
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Poverty,133% to <400% FPL,85.1,80.6 to 89.7,490
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,80.5,76.9 to 84.2,1229
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,92.3,90.0 to 94.6,1229
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Overall,Overall,92.0,89.6 to 94.3,1229
Rotavirus,,States/Local Areas,Florida,2016-2019,Poverty,>400% FPL,79.3,72.4 to 86.1,404
Hep A,≥1 Dose,States/Local Areas,Florida,2016-2019,Overall,Overall,79.7,76.0 to 83.4,1229
Polio,≥3 Doses,States/Local Areas,Florida,2016-2019,Overall,Overall,92.1,89.8 to 94.5,1229
Influenza,,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,46.3,38.9 to 53.7,408
PCV,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.2,80.4 to 90.1,579
PCV,≥3 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,91.4,87.4 to 95.4,408
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,83.5,65.0 to 100.0,30
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.9 to 94.6,510
≥1 Dose MMR,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,93.5,90.5 to 96.5,671
DTaP,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Uninsured,79.4,62.5 to 96.2,30
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,69.8 to 89.9,154
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,Hispanic,79.3,72.7 to 85.8,408
DTaP,≥4 Doses,States/Local Areas,Florida,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.9,73.6 to 92.2,88
≥1 Dose Varicella,,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,93.7,90.6 to 96.7,671
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Any Medicaid,70.7,62.5 to 78.9,510
Hep A,≥2 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,74.4,65.7 to 83.2,671
Hep B,≥3 Doses,States/Local Areas,Florida,2016-2019,Insurance Coverage,Private Insurance Only,93.0,90.0 to 96.1,671
PCV,≥1 Dose,States/Local Areas,Georgia,2012,Age,3 Months,85.1,78.8 to 89.8,270
PCV,≥3 Doses,States/Local Areas,Georgia,2015,Age,24 Months,92.4,88.1 to 95.7,306
PCV,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,92.6,89.5 to 95.1,640
PCV,≥3 Doses,States/Local Areas,Georgia,2014,Age,24 Months,90.7,85.9 to 94.4,284
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,91.6,88.5 to 94.2,590
Hib,≥2 Doses,States/Local Areas,Georgia,2017,Age,5 Months,76.1,67.9 to 82.8,292
Hib,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,5 Months,72.3,66.0 to 77.8,574
PCV,≥3 Doses,States/Local Areas,Georgia,2013,Age,24 Months,97.3,94.2 to 99.0,276
PCV,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,94.0,91.2 to 96.1,560
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,73.8 to 90.9,148
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.8,79.3 to 88.3,535
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,79.9,74.3 to 85.6,418
PCV,≥1 Dose,States/Local Areas,Georgia,2014,Age,3 Months,84.2,77.9 to 89.0,284
PCV,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,3 Months,86.1,82.0 to 89.4,590
PCV,≥1 Dose,States/Local Areas,Georgia,2015,Age,3 Months,88.0,82.2 to 92.0,306
PCV,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,3 Months,88.4,84.5 to 91.4,640
Hib,≥2 Doses,States/Local Areas,Georgia,2018,Age,5 Months,68.4,59.3 to 76.2,282
Hib,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,5 Months,73.7,67.5 to 79.1,555
Hib,≥2 Doses,States/Local Areas,Georgia,2019,Age,5 Months,79.1,70.3 to 85.7,273
Hib,≥2 Doses,States/Local Areas,Georgia,2011,Age,7 Months,91.5,83.2 to 95.9,219
Hib,≥2 Doses,States/Local Areas,Georgia,2012,Age,7 Months,87.6,85.0 to 89.9,270
PCV,≥3 Doses,States/Local Areas,Georgia,2016,Age,24 Months,92.9,87.9 to 96.3,334
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,91.4,87.6 to 94.4,626
PCV,≥3 Doses,States/Local Areas,Georgia,2017,Age,24 Months,90.0,83.9 to 94.5,292
PCV,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,90.7,86.1 to 94.2,574
PCV,≥3 Doses,States/Local Areas,Georgia,2018,Age,24 Months,91.3,85.1 to 95.6,282
PCV,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,91.9,87.8 to 95.1,555
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,86.0,81.7 to 90.3,576
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,75.6,61.2 to 90.1,50
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,84.7,74.4 to 95.0,68
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,79.4,74.4 to 84.5,396
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,84.2,78.2 to 90.2,215
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.0,72.1 to 86.0,192
PCV,≥1 Dose,States/Local Areas,Georgia,2013,Age,3 Months,89.1,86.2 to 91.4,276
PCV,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,3 Months,86.6,81.6 to 90.5,560
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2011,Age,0-3 Days,83.8,75.5 to 89.8,219
PCV,≥1 Dose,States/Local Areas,Georgia,2018,Age,3 Months,90.1,83.3 to 94.3,282
PCV,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,3 Months,89.1,84.3 to 92.5,555
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,93.3,90.4 to 96.3,396
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Georgia,2012,Age,0-3 Days,76.0,68.0 to 82.5,270
PCV,≥3 Doses,States/Local Areas,Georgia,2012,Age,24 Months,91.7,86.2 to 95.6,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,92.8,90.2 to 95.4,576
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,91.3,82.9 to 99.7,68
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.8,90.0 to 97.5,192
PCV,≥1 Dose,States/Local Areas,Georgia,2016,Age,3 Months,88.9,83.0 to 92.9,334
PCV,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,3 Months,87.3,82.7 to 90.8,626
PCV,≥1 Dose,States/Local Areas,Georgia,2017,Age,3 Months,85.7,78.2 to 90.9,292
PCV,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,3 Months,87.9,83.1 to 91.4,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,94.6,89.2 to 100.0,50
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.0,79.8 to 88.1,564
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,81.2,71.9 to 90.6,108
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,82.2,79.0 to 85.3,1090
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,77.9,72.6 to 83.2,372
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,80.7,74.9 to 86.4,376
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,93.1,89.7 to 96.5,342
Hib,≥2 Doses,States/Local Areas,Georgia,2015,Age,7 Months,89.0,83.0 to 93.0,306
Hib,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,89.1,84.9 to 92.2,640
PCV,≥3 Doses,States/Local Areas,Georgia,2019,Age,24 Months,92.6,86.5 to 96.6,273
PCV,≥3 Doses,States/Local Areas,Georgia,2011,Age,35 Months,92.4,86.3 to 96.4,219
PCV,≥3 Doses,States/Local Areas,Georgia,2013,Age,35 Months,97.3,94.2 to 99.0,276
PCV,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,94.4,91.6 to 96.6,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,95.9,92.8 to 98.9,108
Hib,≥2 Doses,States/Local Areas,Georgia,2013,Age,7 Months,92.5,87.3 to 95.7,276
Hib,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,89.6,83.6 to 93.6,560
Hib,≥2 Doses,States/Local Areas,Georgia,2014,Age,7 Months,86.8,80.7 to 91.1,284
Hib,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,87.9,83.8 to 91.0,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.1,89.3 to 94.9,564
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,88.8 to 94.9,535
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,93.5,90.4 to 96.5,418
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,95.1,91.9 to 98.3,215
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,86.5 to 97.5,148
PCV,≥3 Doses,States/Local Areas,Georgia,2012,Age,35 Months,92.5,87.0 to 96.3,270
Polio,≥3 Doses,States/Local Areas,Georgia,2011,Age,35 Months,90.5,83.7 to 95.2,219
DTaP,≥4 Doses,States/Local Areas,Georgia,2019,Age,35 Months,81.9,73.3 to 89.0,273
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,80.7,75.9 to 85.6,576
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,78.3,73.1 to 83.6,396
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,68.3,51.8 to 84.8,50
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,76.0,63.2 to 88.7,68
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.2,67.8 to 82.6,192
≥1 Dose MMR,,States/Local Areas,Georgia,2011,Age,19 Months,87.2,83.0 to 90.5,219
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.9,77.8 to 90.1,564
PCV,≥4 Doses,States/Local Areas,Georgia,2017,Age,19 Months,76.8,68.5 to 83.5,292
PCV,≥4 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,74.7,68.6 to 79.9,574
Hib,≥1 Dose,States/Local Areas,Georgia,2018,Age,3 Months,87.9,80.6 to 92.8,282
Hib,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,3 Months,88.3,83.4 to 91.9,555
Hib,≥1 Dose,States/Local Areas,Georgia,2019,Age,3 Months,88.7,81.3 to 93.4,273
PCV,≥4 Doses,States/Local Areas,Georgia,2014,Age,35 Months,83.1,76.7 to 88.6,284
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,82.1,77.4 to 86.3,590
PCV,≥4 Doses,States/Local Areas,Georgia,2015,Age,35 Months,81.0,74.0 to 87.1,306
PCV,≥4 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,83.9,79.3 to 88.0,640
PCV,≥4 Doses,States/Local Areas,Georgia,2016,Age,35 Months,86.8,80.6 to 91.7,334
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,83.5,78.5 to 87.9,626
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,91.5,88.1 to 94.9,396
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,93.0,88.9 to 97.1,215
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,80.3 to 95.2,148
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,73.5,58.1 to 88.9,50
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.9,86.5 to 95.3,192
PCV,≥3 Doses,States/Local Areas,Georgia,2017,Age,19 Months,89.8,83.1 to 94.0,292
PCV,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,89.4,84.4 to 93.0,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2019,Age,35 Months,92.8,86.9 to 96.7,273
≥1 Dose MMR,,States/Local Areas,Georgia,2018,Age,35 Months,95.6,86.8 to 99.2,282
≥1 Dose MMR,,States/Local Areas,Georgia,2018-2019,Age,35 Months,95.9,89.8 to 98.9,555
≥1 Dose MMR,,States/Local Areas,Georgia,2017,Age,35 Months,92.3,86.0 to 96.4,292
≥1 Dose MMR,,States/Local Areas,Georgia,2017-2018,Age,35 Months,93.5,88.6 to 96.8,574
PCV,≥4 Doses,States/Local Areas,Georgia,2013,Age,35 Months,89.7,82.3 to 94.9,276
PCV,≥4 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,86.5,81.8 to 90.6,560
≥1 Dose MMR,,States/Local Areas,Georgia,2019,Age,35 Months,94.2,87.4 to 98.0,273
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,92.4,89.4 to 95.5,576
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,89.6,80.7 to 98.5,68
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.9,87.4 to 94.4,535
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,88.7,84.5 to 93.0,418
Hib,≥1 Dose,States/Local Areas,Georgia,2015,Age,3 Months,87.7,81.9 to 91.8,306
Hib,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,3 Months,88.8,84.9 to 91.7,640
Hib,≥1 Dose,States/Local Areas,Georgia,2016,Age,3 Months,89.9,84.1 to 93.7,334
Hib,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,3 Months,89.0,84.7 to 92.2,626
Hib,≥1 Dose,States/Local Areas,Georgia,2017,Age,3 Months,88.2,81.2 to 92.9,292
Hib,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,3 Months,88.1,83.3 to 91.6,574
Hep B,≥2 Doses,States/Local Areas,Georgia,2017,Age,13 Months,93.5,87.4 to 96.7,292
Hep B,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,94.5,91.0 to 96.7,574
Hep B,≥2 Doses,States/Local Areas,Georgia,2018,Age,13 Months,95.6,90.8 to 98.0,282
Hep B,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,94.8,91.0 to 97.1,555
Hep B,≥2 Doses,States/Local Areas,Georgia,2019,Age,13 Months,94.0,87.1 to 97.3,273
PCV,≥3 Doses,States/Local Areas,Georgia,2015,Age,19 Months,91.3,89.1 to 93.1,306
PCV,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,92.0,88.4 to 94.5,640
PCV,≥3 Doses,States/Local Areas,Georgia,2016,Age,19 Months,92.6,87.2 to 95.9,334
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,91.2,87.1 to 94.0,626
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.0,87.5 to 94.6,535
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,85.3 to 93.6,418
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.8,88.7 to 94.8,564
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,95.6,92.9 to 98.4,342
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,88.6,84.1 to 93.1,376
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,92.7,87.4 to 98.0,108
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,88.7 to 94.6,564
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Overall,Overall,90.7,88.4 to 93.0,1090
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,89.8,86.2 to 93.5,372
PCV,≥4 Doses,States/Local Areas,Georgia,2017,Age,35 Months,80.2,72.3 to 87.1,292
PCV,≥4 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,80.6,74.9 to 85.8,574
PCV,≥4 Doses,States/Local Areas,Georgia,2018,Age,35 Months,81.0,72.9 to 87.9,282
PCV,≥4 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,82.6,77.0 to 87.5,555
PCV,≥4 Doses,States/Local Areas,Georgia,2019,Age,35 Months,84.2,76.0 to 90.9,273
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,92.7,87.4 to 98.0,108
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Overall,Overall,91.0,88.7 to 93.3,1090
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,89.9,86.1 to 93.7,372
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,89.8,85.6 to 93.9,376
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,95.0,91.8 to 98.1,342
PCV,≥1 Dose,States/Local Areas,Georgia,2011,Age,3 Months,81.9,71.0 to 89.4,219
PCV,≥3 Doses,States/Local Areas,Georgia,2018,Age,19 Months,89.1,81.6 to 93.8,282
PCV,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,88.9,83.9 to 92.5,555
PCV,≥3 Doses,States/Local Areas,Georgia,2019,Age,19 Months,92.5,85.7 to 96.2,273
PCV,≥3 Doses,States/Local Areas,Georgia,2011,Age,24 Months,92.4,86.3 to 96.4,219
Hib,≥2 Doses,States/Local Areas,Georgia,2013,Age,5 Months,79.1,75.4 to 82.3,276
Hib,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,5 Months,76.6,70.9 to 81.5,560
Hib,≥2 Doses,States/Local Areas,Georgia,2014,Age,5 Months,74.1,66.7 to 80.4,284
Hib,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,5 Months,74.6,69.2 to 79.4,590
Hib,≥2 Doses,States/Local Areas,Georgia,2011,Age,5 Months,73.7,62.2 to 82.7,219
Hib,≥2 Doses,States/Local Areas,Georgia,2012,Age,5 Months,78.7,72.1 to 84.1,270
Hib,≥2 Doses,States/Local Areas,Georgia,2015,Age,5 Months,75.2,67.9 to 81.2,306
Hib,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,5 Months,76.2,71.1 to 80.7,640
Hib,≥2 Doses,States/Local Areas,Georgia,2016,Age,5 Months,77.3,69.8 to 83.4,334
Hib,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,5 Months,76.7,71.3 to 81.4,626
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2019,Age,0-1 Days,66.9,57.4 to 75.1,273
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2011,Age,0-2 Days,82.5,73.9 to 88.8,219
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2012,Age,0-2 Days,75.0,67.1 to 81.5,270
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2013,Age,0-2 Days,77.7,75.6 to 79.7,276
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2013-2014,Age,0-2 Days,75.1,72.4 to 77.5,560
Hep B,≥2 Doses,States/Local Areas,Georgia,2013,Age,7 Months,97.0,94.0 to 98.5,276
Hep B,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,95.0,91.0 to 97.3,560
Hep B,≥2 Doses,States/Local Areas,Georgia,2014,Age,7 Months,93.1,88.4 to 95.9,284
Hep B,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,91.9,88.4 to 94.4,590
Hep B,≥2 Doses,States/Local Areas,Georgia,2012,Age,7 Months,92.8,90.0 to 94.8,270
Hep B,≥2 Doses,States/Local Areas,Georgia,2015,Age,7 Months,90.8,85.0 to 94.4,306
Hep B,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,92.7,89.2 to 95.1,640
PCV,≥3 Doses,States/Local Areas,Georgia,2018,Age,7 Months,66.2,57.2 to 74.1,282
PCV,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,69.0,62.8 to 74.7,555
PCV,≥3 Doses,States/Local Areas,Georgia,2019,Age,7 Months,71.8,62.8 to 79.4,273
PCV,≥3 Doses,States/Local Areas,Georgia,2011,Age,13 Months,90.4,85.5 to 93.8,219
PCV,≥3 Doses,States/Local Areas,Georgia,2013,Age,13 Months,92.7,89.5 to 95.0,276
PCV,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,90.7,85.7 to 94.0,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2015,Age,24 Months,90.7,86.0 to 94.4,306
Hep B,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,92.7,89.8 to 95.0,640
Hep B,≥3 Doses,States/Local Areas,Georgia,2016,Age,24 Months,94.7,91.2 to 97.0,334
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,93.6,90.5 to 95.9,626
PCV,≥3 Doses,States/Local Areas,Georgia,2012,Age,13 Months,88.1,86.6 to 89.4,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2017,Age,24 Months,92.5,87.0 to 96.3,292
Hep B,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,92.6,89.0 to 95.3,574
PCV,≥4 Doses,States/Local Areas,Georgia,2018,Age,19 Months,72.4,63.4 to 80.0,282
PCV,≥4 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,72.5,64.9 to 79.0,441
≥1 Dose MMR,,States/Local Areas,Georgia,2016,Age,24 Months,92.6,87.9 to 96.0,334
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2017,Age,24 Months,90.4,86.5 to 93.5,626
≥1 Dose MMR,,States/Local Areas,Georgia,2017,Age,24 Months,88.3,81.9 to 93.2,292
≥1 Dose MMR,,States/Local Areas,Georgia,2017-2018,Age,24 Months,89.1,84.4 to 92.9,574
PCV,≥4 Doses,States/Local Areas,Georgia,2011,Age,19 Months,77.4,69.6 to 83.7,219
PCV,≥4 Doses,States/Local Areas,Georgia,2012,Age,19 Months,75.7,71.5 to 79.4,270
PCV,≥4 Doses,States/Local Areas,Georgia,2013,Age,19 Months,82.6,78.1 to 86.3,276
PCV,≥4 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,80.1,76.6 to 83.2,560
≥1 Dose MMR,,States/Local Areas,Georgia,2018,Age,19 Months,83.9,75.8 to 89.6,282
≥1 Dose MMR,,States/Local Areas,Georgia,2018-2019,Age,19 Months,92.6,88.3 to 95.4,555
PCV,≥4 Doses,States/Local Areas,Georgia,2014,Age,19 Months,77.6,70.8 to 83.3,284
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,76.6,71.7 to 80.9,590
≥1 Dose MMR,,States/Local Areas,Georgia,2019,Age,19 Months,90.0,82.3 to 94.6,273
≥1 Dose MMR,,States/Local Areas,Georgia,2011,Age,24 Months,88.2,81.7 to 93.2,219
≥1 Dose MMR,,States/Local Areas,Georgia,2012,Age,24 Months,90.0,84.3 to 94.3,270
≥1 Dose Varicella,,States/Local Areas,Georgia,2015,Age,24 Months,90.1,85.0 to 94.0,306
≥1 Dose Varicella,,States/Local Areas,Georgia,2015-2016,Age,24 Months,91.5,88.2 to 94.2,640
≥1 Dose Varicella,,States/Local Areas,Georgia,2016,Age,24 Months,93.1,88.5 to 96.3,334
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2017,Age,24 Months,92.0,88.4 to 94.8,626
≥1 Dose Varicella,,States/Local Areas,Georgia,2017,Age,24 Months,90.9,85.0 to 95.1,292
≥1 Dose Varicella,,States/Local Areas,Georgia,2017-2018,Age,24 Months,89.1,84.3 to 92.9,574
≥1 Dose Varicella,,States/Local Areas,Georgia,2017,Age,35 Months,95.5,89.7 to 98.6,292
≥1 Dose Varicella,,States/Local Areas,Georgia,2017-2018,Age,35 Months,95.1,90.0 to 98.0,574
≥1 Dose Varicella,,States/Local Areas,Georgia,2018,Age,35 Months,94.7,85.7 to 98.8,282
≥1 Dose Varicella,,States/Local Areas,Georgia,2018-2019,Age,35 Months,95.5,89.2 to 98.6,555
≥1 Dose MMR,,States/Local Areas,Georgia,2014,Age,35 Months,94.7,89.3 to 97.9,284
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2015,Age,35 Months,94.9,91.4 to 97.3,590
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2017,Age,0-2 Days,75.4,67.8 to 81.7,292
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2017-2018,Age,0-2 Days,77.1,71.8 to 81.7,574
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2018,Age,0-2 Days,78.8,71.0 to 85.0,282
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2018-2019,Age,0-2 Days,78.3,72.6 to 83.0,555
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2019,Age,0-2 Days,77.7,69.1 to 84.4,273
≥1 Dose Varicella,,States/Local Areas,Georgia,2019,Age,24 Months,91.9,85.2 to 96.3,273
≥1 Dose Varicella,,States/Local Areas,Georgia,2011,Age,35 Months,98.7,95.2 to 99.8,219
≥1 Dose Varicella,,States/Local Areas,Georgia,2012,Age,35 Months,93.2,88.6 to 96.4,270
≥1 Dose MMR,,States/Local Areas,Georgia,2013,Age,24 Months,92.9,87.8 to 96.3,276
≥1 Dose MMR,,States/Local Areas,Georgia,2013-2014,Age,24 Months,91.3,88.0 to 94.0,560
≥1 Dose MMR,,States/Local Areas,Georgia,2014,Age,24 Months,89.8,85.1 to 93.5,284
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2015,Age,24 Months,89.4,85.8 to 92.3,590
≥1 Dose MMR,,States/Local Areas,Georgia,2015,Age,24 Months,88.8,83.3 to 93.1,306
≥1 Dose MMR,,States/Local Areas,Georgia,2015-2016,Age,24 Months,90.6,87.0 to 93.5,640
≥1 Dose Varicella,,States/Local Areas,Georgia,2018,Age,24 Months,87.2,80.1 to 92.7,282
≥1 Dose Varicella,,States/Local Areas,Georgia,2018-2019,Age,24 Months,89.5,84.8 to 93.2,555
Hep B,≥3 Doses,States/Local Areas,Georgia,2019,Age,19 Months,92.1,85.4 to 95.8,273
Hep B,≥3 Doses,States/Local Areas,Georgia,2011,Age,24 Months,92.0,86.7 to 95.8,219
Hep B,≥3 Doses,States/Local Areas,Georgia,2013,Age,24 Months,98.2,96.7 to 99.2,276
Hep B,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,95.1,92.6 to 97.0,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2012,Age,24 Months,93.1,87.8 to 96.7,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2014,Age,24 Months,92.0,87.4 to 95.5,284
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,91.4,88.2 to 94.0,590
PCV,≥3 Doses,States/Local Areas,Georgia,2016,Age,7 Months,68.8,61.1 to 75.5,334
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,67.9,62.2 to 73.0,626
PCV,≥3 Doses,States/Local Areas,Georgia,2017,Age,7 Months,66.9,58.4 to 74.5,292
PCV,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,66.6,60.3 to 72.3,574
PCV,≥3 Doses,States/Local Areas,Georgia,2015,Age,7 Months,63.2,55.7 to 70.2,306
PCV,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,66.0,60.7 to 70.9,640
PCV,≥4 Doses,States/Local Areas,Georgia,2015,Age,19 Months,75.6,70.9 to 79.7,306
PCV,≥4 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,77.8,72.9 to 82.1,640
PCV,≥4 Doses,States/Local Areas,Georgia,2016,Age,19 Months,80.1,73.1 to 85.7,334
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,78.5,73.2 to 83.0,626
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.2,74.5 to 83.9,564
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,77.0,71.1 to 82.9,418
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,81.9,73.3 to 90.4,108
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,78.7,75.2 to 82.1,1090
≥1 Dose MMR,,States/Local Areas,Georgia,2015,Age,19 Months,84.7,80.1 to 88.4,306
≥1 Dose MMR,,States/Local Areas,Georgia,2015-2016,Age,19 Months,86.7,82.6 to 90.0,640
≥1 Dose MMR,,States/Local Areas,Georgia,2016,Age,19 Months,88.8,82.9 to 92.8,334
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2017,Age,19 Months,87.7,83.3 to 91.0,626
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,76.2,70.6 to 81.8,372
≥1 Dose MMR,,States/Local Areas,Georgia,2017,Age,19 Months,86.6,79.6 to 91.5,292
≥1 Dose MMR,,States/Local Areas,Georgia,2017-2018,Age,19 Months,85.3,79.9 to 89.4,574
≥1 Dose Varicella,,States/Local Areas,Georgia,2011,Age,24 Months,89.7,83.2 to 94.4,219
≥1 Dose Varicella,,States/Local Areas,Georgia,2012,Age,24 Months,91.9,87.4 to 95.3,270
Hep B,≥1 Dose,States/Local Areas,Georgia,2018,Age,3 Months,96.4,91.8 to 98.5,282
Hep B,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,3 Months,96.4,93.5 to 98.0,555
≥1 Dose Varicella,,States/Local Areas,Georgia,2019,Age,19 Months,89.8,82.0 to 94.4,273
Hep B,≥1 Dose,States/Local Areas,Georgia,2019,Age,3 Months,96.3,91.7 to 98.4,273
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2011,Age,0-1 Days,74.6,65.0 to 82.3,219
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2012,Age,0-1 Days,67.3,65.0 to 69.4,270
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,80.1,72.0 to 88.3,376
Hep B,≥2 Doses,States/Local Areas,Georgia,2011,Age,5 Months,87.1,78.3 to 92.7,219
Hep B,≥2 Doses,States/Local Areas,Georgia,2012,Age,5 Months,90.7,87.0 to 93.5,270
Hep B,≥2 Doses,States/Local Areas,Georgia,2013,Age,5 Months,93.0,90.2 to 95.1,276
Hep B,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,5 Months,88.9,82.6 to 93.1,560
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,90.6,85.5 to 95.6,342
Hep B,≥2 Doses,States/Local Areas,Georgia,2014,Age,5 Months,84.8,78.2 to 89.7,284
Hep B,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,5 Months,86.0,81.7 to 89.5,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2014,Age,19 Months,91.0,86.0 to 94.4,284
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,90.8,87.4 to 93.4,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2015,Age,19 Months,90.6,85.7 to 93.9,306
Hep B,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,92.6,89.6 to 94.8,640
Hep B,≥3 Doses,States/Local Areas,Georgia,2019,Age,24 Months,92.3,86.3 to 96.3,273
Hep B,≥3 Doses,States/Local Areas,Georgia,2011,Age,35 Months,94.3,89.2 to 97.4,219
PCV,≥4 Doses,States/Local Areas,Georgia,2012,Age,24 Months,81.3,74.0 to 87.6,270
PCV,≥4 Doses,States/Local Areas,Georgia,2013,Age,24 Months,85.2,78.5 to 90.7,276
PCV,≥4 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,82.9,78.5 to 86.9,560
PCV,≥4 Doses,States/Local Areas,Georgia,2014,Age,24 Months,80.6,74.3 to 86.3,284
PCV,≥4 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,79.7,75.1 to 84.0,590
PCV,≥4 Doses,States/Local Areas,Georgia,2015,Age,24 Months,78.8,72.0 to 85.0,306
PCV,≥4 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,81.8,77.2 to 86.0,640
≥1 Dose MMR,,States/Local Areas,Georgia,2019,Age,24 Months,91.7,85.1 to 96.1,273
≥1 Dose MMR,,States/Local Areas,Georgia,2011,Age,35 Months,98.7,94.4 to 99.8,219
≥1 Dose MMR,,States/Local Areas,Georgia,2012,Age,35 Months,95.1,90.8 to 97.8,270
≥1 Dose MMR,,States/Local Areas,Georgia,2013,Age,35 Months,95.4,90.4 to 98.2,276
≥1 Dose MMR,,States/Local Areas,Georgia,2013-2014,Age,35 Months,94.7,91.1 to 97.2,560
≥1 Dose Varicella,,States/Local Areas,Georgia,2016,Age,35 Months,93.3,88.7 to 96.5,334
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2017,Age,35 Months,95.0,91.2 to 97.5,626
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2014,Age,0-2 Days,72.4,65.3 to 78.6,284
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2014-2015,Age,0-2 Days,74.2,69.3 to 78.6,590
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2015,Age,0-2 Days,76.0,69.1 to 81.8,306
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2015-2016,Age,0-2 Days,77.2,72.5 to 81.2,640
PCV,≥4 Doses,States/Local Areas,Georgia,2019,Age,19 Months,76.2,67.1 to 83.4,273
≥1 Dose MMR,,States/Local Areas,Georgia,2018,Age,24 Months,89.9,83.6 to 94.6,282
≥1 Dose MMR,,States/Local Areas,Georgia,2018-2019,Age,24 Months,90.8,86.4 to 94.2,555
≥1 Dose Varicella,,States/Local Areas,Georgia,2013,Age,35 Months,97.6,93.0 to 99.5,276
≥1 Dose Varicella,,States/Local Areas,Georgia,2013-2014,Age,35 Months,95.7,92.4 to 97.8,560
≥1 Dose Varicella,,States/Local Areas,Georgia,2014,Age,35 Months,94.7,90.1 to 97.6,284
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2015,Age,35 Months,95.1,92.3 to 97.2,590
PCV,≥4 Doses,States/Local Areas,Georgia,2011,Age,24 Months,80.9,72.9 to 87.8,219
≥1 Dose Varicella,,States/Local Areas,Georgia,2015,Age,35 Months,95.6,91.4 to 98.1,306
≥1 Dose Varicella,,States/Local Areas,Georgia,2015-2016,Age,35 Months,94.7,91.7 to 96.9,640
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2016,Age,0-2 Days,78.3,71.8 to 83.7,334
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Georgia,2016-2017,Age,0-2 Days,76.9,72.0 to 81.2,626
Hep B,≥2 Doses,States/Local Areas,Georgia,2016,Age,7 Months,94.7,89.9 to 97.3,334
Hep B,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,92.3,88.5 to 95.0,626
Hep B,≥2 Doses,States/Local Areas,Georgia,2017,Age,7 Months,90.0,83.3 to 94.2,292
Hep B,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,91.1,86.8 to 94.1,574
Hep B,≥2 Doses,States/Local Areas,Georgia,2018,Age,7 Months,92.3,85.8 to 95.9,282
Hep B,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,92.8,88.5 to 95.5,555
PCV,≥3 Doses,States/Local Areas,Georgia,2014,Age,13 Months,88.6,82.9 to 92.6,284
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,87.9,83.9 to 91.0,590
PCV,≥3 Doses,States/Local Areas,Georgia,2015,Age,13 Months,87.1,80.9 to 91.5,306
PCV,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,89.1,85.2 to 92.1,640
Hep B,≥3 Doses,States/Local Areas,Georgia,2018,Age,24 Months,92.7,87.5 to 96.2,282
Hep B,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,92.5,88.7 to 95.3,555
PCV,≥3 Doses,States/Local Areas,Georgia,2016,Age,13 Months,91.1,85.6 to 94.6,334
PCV,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,87.9,83.2 to 91.4,626
Hep B,≥2 Doses,States/Local Areas,Georgia,2016,Age,13 Months,97.9,95.2 to 99.0,334
Hep B,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,95.6,92.5 to 97.5,626
Hep B,≥2 Doses,States/Local Areas,Georgia,2015,Age,13 Months,95.2,91.3 to 97.4,306
Hep B,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,96.5,94.4 to 97.9,640
Hib,≥1 Dose,States/Local Areas,Georgia,2014,Age,3 Months,85.0,78.7 to 89.7,284
Hib,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,3 Months,86.3,82.2 to 89.6,590
Hep B,≥2 Doses,States/Local Areas,Georgia,2014,Age,13 Months,94.6,90.0 to 97.2,284
Hep B,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,94.9,92.2 to 96.8,590
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,91.7,87.3 to 96.0,215
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.7,83.0 to 96.5,148
Hib,≥1 Dose,States/Local Areas,Georgia,2011,Age,3 Months,83.4,71.3 to 91.1,219
Hib,≥1 Dose,States/Local Areas,Georgia,2012,Age,3 Months,85.9,80.2 to 90.2,270
Hib,≥1 Dose,States/Local Areas,Georgia,2013,Age,3 Months,90.7,89.3 to 92.0,276
Hib,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,3 Months,87.8,83.0 to 91.4,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2018,Age,35 Months,93.8,88.6 to 97.2,282
Hep B,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,93.3,89.6 to 96.1,555
PCV,≥3 Doses,States/Local Areas,Georgia,2012,Age,19 Months,91.3,89.5 to 92.8,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2017,Age,35 Months,93.3,87.7 to 97.0,292
Hep B,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,93.6,89.9 to 96.2,574
PCV,≥4 Doses,States/Local Areas,Georgia,2019,Age,24 Months,81.8,73.6 to 88.7,273
PCV,≥4 Doses,States/Local Areas,Georgia,2011,Age,35 Months,90.7,78.9 to 97.4,219
PCV,≥4 Doses,States/Local Areas,Georgia,2012,Age,35 Months,86.1,79.1 to 91.7,270
PCV,≥3 Doses,States/Local Areas,Georgia,2019,Age,13 Months,91.8,85.0 to 95.7,273
PCV,≥3 Doses,States/Local Areas,Georgia,2011,Age,19 Months,91.9,87.0 to 95.1,219
PCV,≥3 Doses,States/Local Areas,Georgia,2013,Age,19 Months,95.1,91.5 to 97.2,276
PCV,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,92.7,87.3 to 96.0,560
PCV,≥3 Doses,States/Local Areas,Georgia,2014,Age,19 Months,90.4,85.2 to 94.0,284
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,90.9,87.3 to 93.5,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2016,Age,35 Months,96.0,92.6 to 98.1,334
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,94.6,91.4 to 96.9,626
Hep B,≥2 Doses,States/Local Areas,Georgia,2019,Age,7 Months,93.3,86.5 to 96.8,273
Hep B,≥2 Doses,States/Local Areas,Georgia,2011,Age,13 Months,94.2,87.1 to 97.5,219
Hep B,≥2 Doses,States/Local Areas,Georgia,2012,Age,13 Months,93.9,89.7 to 96.4,270
Hep B,≥2 Doses,States/Local Areas,Georgia,2013,Age,13 Months,98.1,97.1 to 98.8,276
Hep B,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,96.4,92.7 to 98.2,560
PCV,≥3 Doses,States/Local Areas,Georgia,2017,Age,13 Months,84.7,76.8 to 90.3,292
PCV,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,85.3,79.7 to 89.6,574
PCV,≥3 Doses,States/Local Areas,Georgia,2018,Age,13 Months,86.0,77.8 to 91.5,282
PCV,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,88.9,83.9 to 92.5,555
Hep B,≥3 Doses,States/Local Areas,Georgia,2013,Age,35 Months,98.4,96.8 to 99.3,276
Hep B,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,96.3,93.7 to 98.0,560
Hib,Full Series,States/Local Areas,Georgia,2020,Age,24 Months,71.4,63.5 to 78.8,338
Hep B,≥3 Doses,States/Local Areas,Georgia,2014,Age,35 Months,94.2,89.3 to 97.3,284
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,94.9,91.9 to 97.0,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2015,Age,35 Months,96.0,92.3 to 98.2,306
Hep B,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,96.0,93.5 to 97.7,640
Hep B,≥3 Doses,States/Local Areas,Georgia,2012,Age,35 Months,93.5,88.1 to 96.9,270
PCV,≥4 Doses,States/Local Areas,Georgia,2016,Age,24 Months,84.9,78.6 to 90.2,334
PCV,≥4 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,82.1,77.1 to 86.6,626
PCV,≥4 Doses,States/Local Areas,Georgia,2017,Age,24 Months,79.4,71.5 to 86.2,292
PCV,≥4 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,78.6,72.9 to 83.8,574
PCV,≥4 Doses,States/Local Areas,Georgia,2018,Age,24 Months,77.9,69.8 to 85.0,282
PCV,≥4 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,79.8,74.2 to 84.9,555
≥1 Dose MMR,,States/Local Areas,Georgia,2015,Age,35 Months,95.0,90.1 to 97.9,306
≥1 Dose MMR,,States/Local Areas,Georgia,2015-2016,Age,35 Months,94.4,91.0 to 96.8,640
≥1 Dose MMR,,States/Local Areas,Georgia,2016,Age,35 Months,93.7,89.1 to 96.8,334
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2017,Age,35 Months,93.2,89.3 to 96.1,626
≥1 Dose Varicella,,States/Local Areas,Georgia,2019,Age,35 Months,94.3,87.5 to 98.1,273
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,91.5,88.2 to 94.8,576
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,91.6,88.3 to 94.9,396
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,71.7,55.3 to 88.0,50
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,91.9,84.9 to 99.0,68
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.2,85.7 to 94.8,192
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.8,80.6 to 93.0,535
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,84.0,75.8 to 92.1,418
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,83.8,73.8 to 93.8,108
Polio,≥2 Doses,States/Local Areas,Georgia,2019,Age,7 Months,92.0,85.1 to 95.9,273
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,84.1,79.6 to 88.6,1090
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,83.4,76.2 to 90.6,372
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2016,Age,0-1 Days,69.8,62.7 to 76.0,334
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2016-2017,Age,0-1 Days,69.6,64.4 to 74.4,626
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2017,Age,0-1 Days,69.5,61.6 to 76.4,292
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2017-2018,Age,0-1 Days,71.5,66.0 to 76.5,574
Hep B,≥2 Doses,States/Local Areas,Georgia,2019,Age,5 Months,90.7,84.0 to 94.8,273
Hep B,≥2 Doses,States/Local Areas,Georgia,2011,Age,7 Months,91.0,85.3 to 94.7,219
Hep B,≥2 Doses,States/Local Areas,Georgia,2018,Age,5 Months,86.9,79.4 to 92.0,282
Hep B,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,5 Months,88.8,84.1 to 92.3,555
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2018,Age,0-1 Days,73.6,65.6 to 80.4,282
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2018-2019,Age,0-1 Days,70.3,64.1 to 75.8,555
≥1 Dose MMR,,States/Local Areas,Georgia,2017,Age,13 Months,55.9,47.5 to 64.0,292
≥1 Dose MMR,,States/Local Areas,Georgia,2017-2018,Age,13 Months,55.4,49.3 to 61.3,574
≥1 Dose MMR,,States/Local Areas,Georgia,2018,Age,13 Months,54.9,46.1 to 63.4,282
≥1 Dose MMR,,States/Local Areas,Georgia,2018-2019,Age,13 Months,60.9,54.5 to 67.0,555
≥1 Dose MMR,,States/Local Areas,Georgia,2019,Age,13 Months,67.0,57.5 to 75.3,273
≥1 Dose Varicella,,States/Local Areas,Georgia,2014,Age,19 Months,86.6,81.2 to 90.6,284
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2015,Age,19 Months,85.7,81.8 to 88.9,590
≥1 Dose Varicella,,States/Local Areas,Georgia,2015,Age,19 Months,84.9,81.9 to 87.5,306
≥1 Dose Varicella,,States/Local Areas,Georgia,2015-2016,Age,19 Months,86.8,82.7 to 90.1,640
≥1 Dose Varicella,,States/Local Areas,Georgia,2016,Age,19 Months,88.8,83.0 to 92.7,334
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2017,Age,19 Months,88.9,84.8 to 92.0,626
Polio,≥2 Doses,States/Local Areas,Georgia,2011,Age,13 Months,95.3,91.0 to 97.6,219
Polio,≥2 Doses,States/Local Areas,Georgia,2012,Age,13 Months,92.4,88.7 to 95.0,270
Polio,≥2 Doses,States/Local Areas,Georgia,2013,Age,13 Months,96.0,92.9 to 97.7,276
Polio,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,94.3,89.7 to 97.0,560
Polio,≥2 Doses,States/Local Areas,Georgia,2014,Age,13 Months,92.7,87.6 to 95.9,284
Polio,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,93.2,90.0 to 95.4,590
Hep B,≥1 Dose,States/Local Areas,Georgia,2015,Age,3 Months,95.6,92.4 to 97.5,306
Hep B,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,3 Months,96.9,95.2 to 98.1,640
Hep B,≥1 Dose,States/Local Areas,Georgia,2016,Age,3 Months,98.3,96.2 to 99.3,334
Hep B,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,3 Months,97.5,95.4 to 98.6,626
Hep B,≥1 Dose,States/Local Areas,Georgia,2017,Age,3 Months,96.6,92.5 to 98.5,292
Hep B,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,3 Months,96.5,93.8 to 98.1,574
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.0,59.1 to 84.8,148
≥1 Dose Varicella,,States/Local Areas,Georgia,2013,Age,24 Months,94.7,89.7 to 97.7,276
≥1 Dose Varicella,,States/Local Areas,Georgia,2013-2014,Age,24 Months,91.6,88.4 to 94.2,560
≥1 Dose Varicella,,States/Local Areas,Georgia,2014,Age,24 Months,88.6,83.8 to 92.5,284
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2015,Age,24 Months,89.4,86.0 to 92.3,590
Polio,≥2 Doses,States/Local Areas,Georgia,2018,Age,13 Months,92.4,85.9 to 96.0,282
Polio,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,93.2,88.9 to 95.9,555
Polio,≥2 Doses,States/Local Areas,Georgia,2019,Age,13 Months,94.0,87.1 to 97.3,273
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2013,Age,0-1 Days,72.1,65.8 to 77.6,276
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2013-2014,Age,0-1 Days,68.4,65.0 to 71.6,560
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2014,Age,0-1 Days,64.7,57.1 to 71.6,284
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2014-2015,Age,0-1 Days,65.7,60.5 to 70.5,590
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2015,Age,0-1 Days,66.7,59.3 to 73.3,306
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Georgia,2015-2016,Age,0-1 Days,68.2,63.1 to 72.9,640
Hep B,≥2 Doses,States/Local Areas,Georgia,2015,Age,5 Months,87.3,81.2 to 91.6,306
Hep B,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,5 Months,89.1,85.3 to 92.1,640
PCV,≥3 Doses,States/Local Areas,Georgia,2013,Age,7 Months,68.3,61.7 to 74.3,276
PCV,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,68.0,62.9 to 72.6,560
PCV,≥3 Doses,States/Local Areas,Georgia,2011,Age,7 Months,66.3,55.8 to 75.4,219
PCV,≥3 Doses,States/Local Areas,Georgia,2014,Age,7 Months,67.6,60.1 to 74.3,284
PCV,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,65.4,60.2 to 70.3,590
PCV,≥3 Doses,States/Local Areas,Georgia,2012,Age,7 Months,63.1,57.0 to 68.7,270
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,77.9,72.0 to 83.8,376
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,85.1,79.4 to 90.8,342
Hep B,≥3 Doses,States/Local Areas,Georgia,2017,Age,19 Months,91.2,85.0 to 95.0,292
Hep B,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,91.1,87.0 to 94.0,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2018,Age,19 Months,91.0,84.6 to 94.9,282
Hep B,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,89.3,84.6 to 92.7,555
Hep B,≥2 Doses,States/Local Areas,Georgia,2016,Age,5 Months,91.0,85.7 to 94.5,334
Hep B,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,5 Months,89.9,85.9 to 92.9,626
Hep B,≥2 Doses,States/Local Areas,Georgia,2017,Age,5 Months,88.8,82.2 to 93.2,292
Hep B,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,5 Months,87.9,83.1 to 91.4,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2012,Age,19 Months,92.9,89.6 to 95.2,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2013,Age,19 Months,98.2,97.6 to 98.6,276
Hep B,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,19 Months,94.6,88.3 to 97.6,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2018,Age,13 Months,86.8,79.3 to 91.8,282
Hep B,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,13 Months,89.3,84.6 to 92.7,555
Hep B,≥3 Doses,States/Local Areas,Georgia,2019,Age,13 Months,91.8,85.2 to 95.7,273
Hep B,≥3 Doses,States/Local Areas,Georgia,2011,Age,19 Months,91.8,84.6 to 95.8,219
≥1 Dose MMR,,States/Local Areas,Georgia,2013,Age,19 Months,88.9,83.9 to 92.5,276
≥1 Dose MMR,,States/Local Areas,Georgia,2013-2014,Age,19 Months,88.7,85.8 to 91.0,560
≥1 Dose MMR,,States/Local Areas,Georgia,2012,Age,19 Months,81.6,77.4 to 85.2,270
≥1 Dose MMR,,States/Local Areas,Georgia,2014,Age,19 Months,88.5,83.4 to 92.1,284
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2015,Age,19 Months,86.6,82.6 to 89.7,590
≥1 Dose Varicella,,States/Local Areas,Georgia,2017,Age,19 Months,89.0,82.4 to 93.3,292
≥1 Dose Varicella,,States/Local Areas,Georgia,2017-2018,Age,19 Months,85.0,79.5 to 89.2,574
≥1 Dose Varicella,,States/Local Areas,Georgia,2018,Age,19 Months,80.8,72.3 to 87.2,282
≥1 Dose Varicella,,States/Local Areas,Georgia,2018-2019,Age,19 Months,54.0,47.6 to 60.2,555
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,85.4,79.3 to 91.4,215
Polio,≥2 Doses,States/Local Areas,Georgia,2015,Age,13 Months,93.6,89.0 to 96.4,306
Polio,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,94.9,92.0 to 96.8,640
Polio,≥2 Doses,States/Local Areas,Georgia,2016,Age,13 Months,96.2,91.8 to 98.3,334
Polio,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,94.2,90.5 to 96.5,626
Polio,≥2 Doses,States/Local Areas,Georgia,2017,Age,13 Months,92.2,85.5 to 96.0,292
Polio,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,92.3,88.1 to 95.1,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2016,Age,19 Months,94.7,90.9 to 96.9,334
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,92.9,89.4 to 95.3,626
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.8,67.8 to 85.8,148
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,74.2 to 84.2,535
Hib,Primary Series,States/Local Areas,Georgia,2011,Age,7 Months,66.2,56.2 to 75.0,219
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,89.8,85.8 to 93.9,342
Hib,Primary Series,States/Local Areas,Georgia,2012,Age,7 Months,68.4,61.1 to 74.9,270
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,73.8,56.6 to 90.9,68
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,83.4,77.5 to 89.2,576
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,86.1,79.6 to 92.5,396
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.5,78.7 to 96.4,192
≥1 Dose MMR,,States/Local Areas,Georgia,2014,Age,13 Months,58.0,50.5 to 65.2,284
≥1 Dose MMR,,States/Local Areas,Georgia,2014-2015,Age,13 Months,54.7,49.3 to 60.0,590
≥1 Dose MMR,,States/Local Areas,Georgia,2015,Age,13 Months,51.3,43.9 to 58.8,306
≥1 Dose MMR,,States/Local Areas,Georgia,2015-2016,Age,13 Months,55.4,50.1 to 60.6,640
≥1 Dose MMR,,States/Local Areas,Georgia,2016,Age,13 Months,59.5,51.9 to 66.7,334
≥1 Dose MMR,,States/Local Areas,Georgia,2016-2017,Age,13 Months,57.7,52.1 to 63.2,626
Hep B,≥1 Dose,States/Local Areas,Georgia,2011,Age,3 Months,95.2,89.1 to 98.0,219
Hep B,≥1 Dose,States/Local Areas,Georgia,2012,Age,3 Months,93.7,91.1 to 95.6,270
Hep B,≥1 Dose,States/Local Areas,Georgia,2013,Age,3 Months,98.8,98.2 to 99.2,276
Hep B,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,3 Months,96.4,93.5 to 98.1,560
Hep B,≥1 Dose,States/Local Areas,Georgia,2014,Age,3 Months,94.1,89.7 to 96.6,284
Hep B,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,3 Months,94.8,92.3 to 96.5,590
Polio,≥2 Doses,States/Local Areas,Georgia,2017,Age,7 Months,85.5,77.7 to 91.0,292
Polio,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,86.2,80.7 to 90.4,574
Polio,≥2 Doses,States/Local Areas,Georgia,2018,Age,7 Months,87.0,79.2 to 92.1,282
Polio,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,89.5,84.6 to 92.9,555
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,95.7,93.1 to 98.3,342
Hep A,≥1 Dose,States/Local Areas,Georgia,2020,Age,35 Months,88.3,81.8 to 93.3,338
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Overall,Overall,88.8,86.4 to 91.3,1090
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,87.5,83.5 to 91.5,372
Polio,≥2 Doses,States/Local Areas,Georgia,2014,Age,7 Months,87.4,81.4 to 91.7,284
Polio,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,88.9,84.9 to 91.9,590
Polio,≥2 Doses,States/Local Areas,Georgia,2015,Age,7 Months,90.3,84.6 to 94.1,306
Polio,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,90.3,86.3 to 93.2,640
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,86.0,81.2 to 90.9,376
Polio,≥2 Doses,States/Local Areas,Georgia,2016,Age,7 Months,90.2,83.9 to 94.2,334
Polio,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,87.8,83.0 to 91.4,626
Hep B,≥3 Doses,States/Local Areas,Georgia,2011,Age,13 Months,88.0,81.6 to 92.3,219
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,64.8,38.6 to 91.1,50
DTaP,≥4 Doses,States/Local Areas,Georgia,2018,Age,35 Months,85.4,76.4 to 92.3,282
DTaP,≥4 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,84.1,77.8 to 89.4,555
DTaP,≥4 Doses,States/Local Areas,Georgia,2016,Age,35 Months,85.6,78.7 to 91.1,334
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,83.3,78.0 to 87.9,626
DTaP,≥4 Doses,States/Local Areas,Georgia,2017,Age,35 Months,81.0,72.8 to 88.0,292
DTaP,≥4 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,83.5,77.2 to 88.9,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2016,Age,13 Months,92.0,87.2 to 95.1,334
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,13 Months,90.6,86.6 to 93.5,626
Hep B,≥3 Doses,States/Local Areas,Georgia,2015,Age,13 Months,87.9,82.1 to 92.0,306
Hep B,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,13 Months,89.9,86.3 to 92.7,640
Hep B,≥3 Doses,States/Local Areas,Georgia,2017,Age,13 Months,89.2,82.5 to 93.5,292
Hep B,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,13 Months,88.0,83.3 to 91.5,574
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,77.9,67.9 to 87.9,215
≥1 Dose Varicella,,States/Local Areas,Georgia,2018,Age,13 Months,48.9,40.3 to 57.5,282
≥1 Dose Varicella,,States/Local Areas,Georgia,2018-2019,Age,13 Months,54.0,47.6 to 60.2,555
≥1 Dose Varicella,,States/Local Areas,Georgia,2019,Age,13 Months,59.1,49.6 to 67.9,273
≥1 Dose Varicella,,States/Local Areas,Georgia,2011,Age,19 Months,89.7,84.5 to 93.3,219
≥1 Dose Varicella,,States/Local Areas,Georgia,2012,Age,19 Months,85.5,83.4 to 87.4,270
≥1 Dose Varicella,,States/Local Areas,Georgia,2013,Age,19 Months,90.2,83.6 to 94.3,276
≥1 Dose Varicella,,States/Local Areas,Georgia,2013-2014,Age,19 Months,88.4,84.3 to 91.5,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2013,Age,13 Months,95.4,93.6 to 96.8,276
Hep B,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,13 Months,92.7,88.1 to 95.6,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2014,Age,13 Months,90.0,84.9 to 93.5,284
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,13 Months,89.0,85.3 to 91.8,590
Hep A,≥2 Doses,States/Local Areas,Georgia,2017,Age,35 Months,69.3,59.8 to 78.4,292
Hep A,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,72.3,64.8 to 79.4,574
Hep A,≥2 Doses,States/Local Areas,Georgia,2018,Age,35 Months,75.7,63.9 to 86.0,282
Hep A,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,78.0,70.0 to 85.0,555
Hep B,≥3 Doses,States/Local Areas,Georgia,2012,Age,13 Months,91.1,88.1 to 93.4,270
Hep A,≥2 Doses,States/Local Areas,Georgia,2019,Age,35 Months,79.7,69.6 to 88.1,273
DTaP,≥4 Doses,States/Local Areas,Georgia,2013,Age,35 Months,97.8,90.1 to 99.8,276
DTaP,≥4 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,91.0,86.3 to 94.6,560
DTaP,≥4 Doses,States/Local Areas,Georgia,2014,Age,35 Months,87.3,80.9 to 92.4,284
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,86.9,82.0 to 91.0,590
DTaP,≥4 Doses,States/Local Areas,Georgia,2012,Age,35 Months,86.3,78.6 to 92.3,270
DTaP,≥4 Doses,States/Local Areas,Georgia,2015,Age,35 Months,86.7,78.5 to 92.9,306
DTaP,≥4 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,86.1,81.0 to 90.4,640
DTaP,≥4 Doses,States/Local Areas,Georgia,2019,Age,24 Months,78.1,69.6 to 85.6,273
DTaP,≥4 Doses,States/Local Areas,Georgia,2011,Age,35 Months,92.3,80.6 to 98.2,219
DTaP,≥4 Doses,States/Local Areas,Georgia,2018,Age,24 Months,74.9,66.6 to 82.5,282
DTaP,≥4 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,76.5,70.6 to 82.0,555
≥1 Dose MMR,,States/Local Areas,Georgia,2011,Age,13 Months,53.7,47.1 to 60.2,219
≥1 Dose MMR,,States/Local Areas,Georgia,2012,Age,13 Months,47.9,45.8 to 50.0,270
≥1 Dose MMR,,States/Local Areas,Georgia,2013,Age,13 Months,52.2,48.6 to 55.8,276
≥1 Dose MMR,,States/Local Areas,Georgia,2013-2014,Age,13 Months,55.1,49.3 to 60.8,560
≥1 Dose Varicella,,States/Local Areas,Georgia,2016,Age,13 Months,59.2,51.7 to 66.3,334
≥1 Dose Varicella,,States/Local Areas,Georgia,2016-2017,Age,13 Months,59.0,53.4 to 64.4,626
≥1 Dose Varicella,,States/Local Areas,Georgia,2017,Age,13 Months,58.7,50.3 to 66.7,292
≥1 Dose Varicella,,States/Local Areas,Georgia,2017-2018,Age,13 Months,53.9,47.8 to 59.8,574
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,87.6,80.9 to 94.4,108
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.1,85.6 to 92.6,564
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.1,84.1 to 92.1,535
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,88.8,84.7 to 92.9,418
Hep A,≥1 Dose,States/Local Areas,Georgia,2013,Age,35 Months,95.0,88.1 to 98.5,276
Hep A,≥1 Dose,States/Local Areas,Georgia,2013-2014,Age,35 Months,91.8,87.8 to 95.0,560
Hep A,≥1 Dose,States/Local Areas,Georgia,2014,Age,35 Months,89.1,83.0 to 93.7,284
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2015,Age,35 Months,90.9,86.9 to 94.1,590
Hep A,≥2 Doses,States/Local Areas,Georgia,2014,Age,24 Months,43.4,36.0 to 51.6,284
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,43.8,38.5 to 49.6,590
Hep A,≥2 Doses,States/Local Areas,Georgia,2015,Age,24 Months,44.2,37.0 to 52.2,306
Hep A,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,41.9,36.8 to 47.4,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Overall,Overall,94.1,92.1 to 96.0,1090
Hib,≥3 Doses,States/Local Areas,Georgia,2019,Age,35 Months,88.9,81.6 to 94.3,273
PCV,≥2 Doses,States/Local Areas,Georgia,2018,Age,5 Months,70.5,61.6 to 78.2,282
PCV,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,5 Months,74.5,68.3 to 79.8,555
PCV,≥2 Doses,States/Local Areas,Georgia,2019,Age,5 Months,78.4,69.6 to 85.2,273
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,95.9,92.6 to 99.1,215
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.9 to 99.9,148
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,97.0,94.7 to 99.3,108
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.1,91.5 to 96.7,564
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,92.2 to 97.7,535
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,93.2,89.5 to 96.9,418
DTaP,≥4 Doses,States/Local Areas,Georgia,2016,Age,19 Months,67.1,59.6 to 73.9,334
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,66.1,60.5 to 71.3,626
DTaP,≥4 Doses,States/Local Areas,Georgia,2017,Age,19 Months,65.2,56.7 to 72.8,292
DTaP,≥4 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,64.1,57.9 to 69.8,574
DTaP,≥4 Doses,States/Local Areas,Georgia,2018,Age,19 Months,62.9,53.9 to 71.1,282
DTaP,≥4 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,93.2,88.9 to 95.9,555
Hep A,≥2 Doses,States/Local Areas,Georgia,2013,Age,24 Months,49.5,41.5 to 58.2,276
Hep A,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,46.5,41.0 to 52.3,560
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a Non-MSA,79.2,68.8 to 89.6,108
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Overall,Overall,79.4,76.1 to 82.7,1090
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,77.1,71.6 to 82.5,372
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,75.5,69.3 to 81.6,376
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,80.5,73.2 to 87.7,215
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,71.5 to 88.1,148
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.7,75.9 to 85.4,535
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,79.2,73.5 to 84.8,418
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.6,75.1 to 84.1,564
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,68.0,52.7 to 83.3,50
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,83.2,78.8 to 87.5,576
Hep A,≥1 Dose,States/Local Areas,Georgia,2018,Age,35 Months,95.8,88.1 to 99.1,282
Hep A,≥1 Dose,States/Local Areas,Georgia,2018-2019,Age,35 Months,96.4,91.2 to 99.0,555
Polio,≥2 Doses,States/Local Areas,Georgia,2016,Age,5 Months,78.1,70.7 to 84.0,334
Polio,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,5 Months,77.1,71.7 to 81.7,626
Polio,≥2 Doses,States/Local Areas,Georgia,2017,Age,5 Months,76.2,68.0 to 82.8,292
Polio,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,5 Months,72.6,66.3 to 78.1,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2014,Age,7 Months,61.8,54.4 to 68.8,284
Hep B,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,7 Months,61.4,56.2 to 66.4,590
Hep B,≥3 Doses,States/Local Areas,Georgia,2015,Age,7 Months,61.0,53.5 to 68.0,306
Hep B,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,7 Months,63.6,58.4 to 68.5,640
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,88.0,82.6 to 93.4,215
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.2,77.3 to 93.1,148
Polio,≥2 Doses,States/Local Areas,Georgia,2019,Age,5 Months,78.8,69.9 to 85.6,273
Polio,≥2 Doses,States/Local Areas,Georgia,2011,Age,7 Months,90.6,80.1 to 95.8,219
Polio,≥2 Doses,States/Local Areas,Georgia,2012,Age,7 Months,87.4,84.8 to 89.5,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2017,Age,7 Months,61.0,52.6 to 68.7,292
Hep B,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,7 Months,62.3,56.2 to 68.1,574
Hep B,≥3 Doses,States/Local Areas,Georgia,2018,Age,7 Months,63.7,55.0 to 71.6,282
Hep B,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,7 Months,68.1,62.0 to 73.6,555
Polio,≥2 Doses,States/Local Areas,Georgia,2013,Age,7 Months,92.0,87.2 to 95.1,276
Polio,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,89.7,84.1 to 93.5,560
Hep B,≥3 Doses,States/Local Areas,Georgia,2019,Age,7 Months,72.4,63.9 to 79.6,273
Hep A,≥2 Doses,States/Local Areas,Georgia,2014,Age,35 Months,81.8,72.8 to 89.3,284
Hep A,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,81.4,75.7 to 86.6,590
Hep A,≥2 Doses,States/Local Areas,Georgia,2015,Age,35 Months,82.3,74.0 to 89.2,306
Hep A,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,83.8,78.0 to 88.8,640
Hep A,≥2 Doses,States/Local Areas,Georgia,2016,Age,35 Months,85.8,76.9 to 92.5,334
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,77.5,70.7 to 83.6,626
≥1 Dose Varicella,,States/Local Areas,Georgia,2014,Age,13 Months,53.3,45.8 to 60.7,284
≥1 Dose Varicella,,States/Local Areas,Georgia,2014-2015,Age,13 Months,53.5,48.1 to 58.8,590
≥1 Dose Varicella,,States/Local Areas,Georgia,2012,Age,13 Months,57.4,52.1 to 62.6,270
≥1 Dose Varicella,,States/Local Areas,Georgia,2015,Age,13 Months,53.7,46.2 to 61.0,306
≥1 Dose Varicella,,States/Local Areas,Georgia,2015-2016,Age,13 Months,56.4,51.1 to 61.6,640
Hep A,≥1 Dose,States/Local Areas,Georgia,2019,Age,35 Months,95.0,88.4 to 98.4,273
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,90.1,86.5 to 93.7,576
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,88.6,84.8 to 92.3,396
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,81.4,68.8 to 94.0,50
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,88.9,79.7 to 98.2,68
Hep A,≥1 Dose,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.6,87.4 to 95.8,192
Polio,≥2 Doses,States/Local Areas,Georgia,2018,Age,5 Months,68.9,59.9 to 76.7,282
Polio,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,5 Months,73.9,67.6 to 79.3,555
≥1 Dose Varicella,,States/Local Areas,Georgia,2020,Age,24 Months,86.6,80.2 to 91.7,338
DTaP,≥4 Doses,States/Local Areas,Georgia,2013,Age,24 Months,87.4,80.4 to 92.7,276
DTaP,≥4 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,83.4,78.8 to 87.4,560
Hep A,≥2 Doses,States/Local Areas,Georgia,2016,Age,24 Months,39.5,32.6 to 47.3,334
Hep A,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,36.7,31.5 to 42.3,626
Hep A,≥2 Doses,States/Local Areas,Georgia,2017,Age,24 Months,33.8,26.6 to 42.2,292
Hep A,≥2 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,37.1,31.5 to 43.3,574
DTaP,≥4 Doses,States/Local Areas,Georgia,2014,Age,24 Months,79.4,72.8 to 85.3,284
DTaP,≥4 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,78.5,73.7 to 83.0,590
Hep A,≥2 Doses,States/Local Areas,Georgia,2018,Age,24 Months,40.4,32.4 to 49.5,282
Hep A,≥2 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,46.5,40.2 to 53.1,555
Hep A,≥1 Dose,States/Local Areas,Georgia,2015,Age,35 Months,92.9,87.1 to 96.7,306
Hep A,≥1 Dose,States/Local Areas,Georgia,2015-2016,Age,35 Months,92.8,89.1 to 95.6,640
Polio,≥2 Doses,States/Local Areas,Georgia,2011,Age,5 Months,73.7,62.1 to 82.7,219
Polio,≥2 Doses,States/Local Areas,Georgia,2012,Age,5 Months,78.8,73.4 to 83.4,270
Polio,≥2 Doses,States/Local Areas,Georgia,2013,Age,5 Months,80.4,76.6 to 83.7,276
Polio,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,5 Months,78.1,71.8 to 83.3,560
Polio,≥2 Doses,States/Local Areas,Georgia,2014,Age,5 Months,75.8,68.5 to 81.9,284
Polio,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,5 Months,76.3,70.4 to 81.3,590
Polio,≥2 Doses,States/Local Areas,Georgia,2015,Age,5 Months,76.7,69.5 to 82.6,306
Polio,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,5 Months,77.4,72.4 to 81.7,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,<133% FPL,92.7,89.2 to 96.1,372
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,133% to <400% FPL,93.8,90.4 to 97.2,376
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2017,Poverty,>400% FPL,97.3,95.1 to 99.5,342
Hep B,≥3 Doses,States/Local Areas,Georgia,2011,Age,7 Months,53.9,43.2 to 64.2,219
Hep B,≥3 Doses,States/Local Areas,Georgia,2012,Age,7 Months,56.7,46.3 to 66.6,270
Hep B,≥3 Doses,States/Local Areas,Georgia,2013,Age,7 Months,67.5,63.9 to 70.9,276
Hep B,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,7 Months,64.7,57.4 to 71.3,560
DTaP,≥4 Doses,States/Local Areas,Georgia,2019,Age,19 Months,71.7,62.5 to 79.5,273
DTaP,≥4 Doses,States/Local Areas,Georgia,2011,Age,24 Months,79.6,71.4 to 86.6,219
DTaP,≥4 Doses,States/Local Areas,Georgia,2012,Age,24 Months,77.2,69.1 to 84.6,270
DTaP,≥4 Doses,States/Local Areas,Georgia,2017,Age,24 Months,77.1,69.3 to 84.1,292
DTaP,≥4 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,76.0,70.1 to 81.4,574
DTaP,≥4 Doses,States/Local Areas,Georgia,2015,Age,24 Months,77.6,70.5 to 84.0,306
DTaP,≥4 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,77.5,72.6 to 82.1,640
DTaP,≥4 Doses,States/Local Areas,Georgia,2016,Age,24 Months,77.4,70.5 to 83.8,334
DTaP,≥4 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,77.2,72.1 to 82.0,626
Hep B,≥3 Doses,States/Local Areas,Georgia,2016,Age,7 Months,66.2,58.8 to 72.9,334
Hep B,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,7 Months,63.6,58.0 to 68.8,626
Hep A,≥2 Doses,States/Local Areas,Georgia,2019,Age,24 Months,52.6,43.4 to 62.5,273
Hep A,≥2 Doses,States/Local Areas,Georgia,2011,Age,35 Months,75.0,64.4 to 84.5,219
Hep A,≥2 Doses,States/Local Areas,Georgia,2012,Age,35 Months,76.1,64.8 to 86.0,270
Hep A,≥2 Doses,States/Local Areas,Georgia,2013,Age,35 Months,82.1,74.2 to 88.8,276
Hep A,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,81.5,75.8 to 86.6,560
Hep A,≥1 Dose,States/Local Areas,Georgia,2016,Age,35 Months,93.1,88.1 to 96.5,334
Hep A,≥1 Dose,States/Local Areas,Georgia,2016-2017,Age,35 Months,92.7,88.8 to 95.6,626
Hep A,≥1 Dose,States/Local Areas,Georgia,2017,Age,35 Months,92.1,85.6 to 96.4,292
Hep A,≥1 Dose,States/Local Areas,Georgia,2017-2018,Age,35 Months,94.0,88.9 to 97.3,574
≥1 Dose Varicella,,States/Local Areas,Georgia,2011,Age,13 Months,59.5,53.7 to 65.2,219
≥1 Dose Varicella,,States/Local Areas,Georgia,2013,Age,13 Months,61.2,57.0 to 65.3,276
≥1 Dose Varicella,,States/Local Areas,Georgia,2013-2014,Age,13 Months,57.3,53.4 to 61.0,560
Polio,≥3 Doses,States/Local Areas,Georgia,2013,Age,35 Months,98.7,96.4 to 99.6,276
Polio,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,35 Months,95.2,92.4 to 97.2,560
Polio,≥3 Doses,States/Local Areas,Georgia,2014,Age,35 Months,92.0,87.0 to 95.6,284
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,35 Months,94.0,90.9 to 96.3,590
Polio,≥3 Doses,States/Local Areas,Georgia,2012,Age,35 Months,92.7,87.2 to 96.4,270
Polio,≥3 Doses,States/Local Areas,Georgia,2015,Age,35 Months,96.5,93.3 to 98.4,306
Polio,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,35 Months,96.1,93.6 to 97.8,640
Polio,≥3 Doses,States/Local Areas,Georgia,2016,Age,35 Months,95.6,91.8 to 98.0,334
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,35 Months,94.2,90.7 to 96.6,626
Polio,≥3 Doses,States/Local Areas,Georgia,2017,Age,35 Months,92.8,86.8 to 96.7,292
Polio,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,35 Months,92.0,87.5 to 95.4,574
Hib,Full Series,States/Local Areas,Georgia,2019,Age,24 Months,74.7,65.8 to 82.9,273
Hib,Full Series,States/Local Areas,Georgia,2011,Age,35 Months,88.5,77.6 to 95.6,219
Hib,Full Series,States/Local Areas,Georgia,2012,Age,35 Months,85.7,78.6 to 91.4,270
Hib,Full Series,States/Local Areas,Georgia,2013,Age,35 Months,86.8,79.7 to 92.4,276
Hib,Full Series,States/Local Areas,Georgia,2013-2014,Age,35 Months,85.3,80.7 to 89.3,560
Hib,Full Series,States/Local Areas,Georgia,2014,Age,35 Months,83.4,77.3 to 88.6,284
Hib,Full Series,States/Local Areas,Georgia,2014-2015,Age,35 Months,81.2,76.6 to 85.5,590
DTaP,≥2 Doses,States/Local Areas,Georgia,2011,Age,5 Months,74.7,64.5 to 82.7,219
DTaP,≥2 Doses,States/Local Areas,Georgia,2012,Age,5 Months,80.1,75.4 to 84.1,270
DTaP,≥2 Doses,States/Local Areas,Georgia,2013,Age,5 Months,81.1,77.4 to 84.4,276
DTaP,≥2 Doses,States/Local Areas,Georgia,2013-2014,Age,5 Months,78.8,72.4 to 84.0,560
DTaP,≥2 Doses,States/Local Areas,Georgia,2014,Age,5 Months,76.4,69.1 to 82.5,284
DTaP,≥2 Doses,States/Local Areas,Georgia,2014-2015,Age,5 Months,77.2,71.9 to 81.7,590
DTaP,≥2 Doses,States/Local Areas,Georgia,2015,Age,5 Months,78.0,70.8 to 83.8,306
DTaP,≥2 Doses,States/Local Areas,Georgia,2015-2016,Age,5 Months,78.3,73.3 to 82.6,640
DTaP,≥2 Doses,States/Local Areas,Georgia,2016,Age,5 Months,78.7,71.4 to 84.6,334
DTaP,≥2 Doses,States/Local Areas,Georgia,2016-2017,Age,5 Months,77.6,72.2 to 82.1,626
Hib,Full Series,States/Local Areas,Georgia,2017,Age,35 Months,77.1,68.9 to 84.4,292
Hib,Full Series,States/Local Areas,Georgia,2017-2018,Age,35 Months,78.1,71.6 to 83.9,574
Hib,Full Series,States/Local Areas,Georgia,2020-2021,Age,24 Months,68.8,62.9 to 74.6,593
Polio,≥3 Doses,States/Local Areas,Georgia,2018,Age,35 Months,91.2,84.9 to 95.6,282
Polio,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,35 Months,92.4,88.1 to 95.6,555
Polio,≥3 Doses,States/Local Areas,Georgia,2019,Age,35 Months,93.5,87.3 to 97.4,273
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Private Insurance Only,94.1,91.7 to 96.5,576
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Uninsured,95.1,89.8 to 100.0,50
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,89.6,80.8 to 98.4,68
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,92.4,89.2 to 95.7,396
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.8,88.7 to 96.9,192
Hib,Full Series,States/Local Areas,Georgia,2015,Age,35 Months,79.1,71.9 to 85.5,306
Hib,Full Series,States/Local Areas,Georgia,2015-2016,Age,35 Months,82.3,77.3 to 86.8,640
Hib,Full Series,States/Local Areas,Georgia,2016,Age,35 Months,85.6,78.2 to 91.4,334
Hib,Full Series,States/Local Areas,Georgia,2016-2017,Age,35 Months,81.5,75.9 to 86.5,626
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,Hispanic,93.9,90.3 to 97.6,215
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,86.0 to 97.3,148
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.2,90.3 to 96.2,535
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,89.4 to 96.2,418
Hib,Full Series,States/Local Areas,Georgia,2018,Age,35 Months,78.5,69.3 to 86.6,282
Hib,Full Series,States/Local Areas,Georgia,2018-2019,Age,35 Months,78.7,72.2 to 84.6,555
Hib,Full Series,States/Local Areas,Georgia,2019,Age,35 Months,78.3,69.3 to 86.2,273
DTaP,≥3 Doses,States/Local Areas,Georgia,2012,Age,24 Months,92.8,87.3 to 96.5,270
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Other,81.2,69.6 to 92.8,68
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.4,89.6 to 95.2,564
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Insurance Coverage,Any Medicaid,77.2,71.9 to 82.5,396
Hib,Full Series,States/Local Areas,Georgia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.1,70.0 to 84.2,192
Hib,Full Series,States/Local Areas,Georgia,2016,Age,24 Months,81.3,74.8 to 87.0,334
Hib,Full Series,States/Local Areas,Georgia,2016-2017,Age,24 Months,78.1,72.9 to 82.8,626
Hib,Full Series,States/Local Areas,Georgia,2017,Age,24 Months,74.9,66.9 to 82.2,292
Hib,Full Series,States/Local Areas,Georgia,2017-2018,Age,24 Months,72.0,66.0 to 77.7,574
Hib,Full Series,States/Local Areas,Georgia,2018,Age,24 Months,69.2,60.6 to 77.4,282
Hib,Full Series,States/Local Areas,Georgia,2018-2019,Age,24 Months,71.9,65.8 to 77.8,555
Hib,≥3 Doses,States/Local Areas,Georgia,2011,Age,24 Months,92.5,86.4 to 96.5,219
Hib,≥3 Doses,States/Local Areas,Georgia,2012,Age,24 Months,92.0,86.4 to 95.9,270
Hib,≥3 Doses,States/Local Areas,Georgia,2013,Age,24 Months,94.8,89.4 to 97.9,276
Hib,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,92.0,88.4 to 94.8,560
Hib,≥3 Doses,States/Local Areas,Georgia,2014,Age,24 Months,89.1,83.7 to 93.3,284
Hib,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,88.7,84.8 to 91.9,590
DTaP,≥3 Doses,States/Local Areas,Georgia,2019,Age,19 Months,93.0,86.0 to 96.6,273
Polio,≥3 Doses,States/Local Areas,Georgia,2018,Age,24 Months,90.2,83.9 to 94.8,282
Polio,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,24 Months,91.2,87.0 to 94.5,555
Polio,≥3 Doses,States/Local Areas,Georgia,2019,Age,24 Months,92.2,86.0 to 96.3,273
Hib,≥3 Doses,States/Local Areas,Georgia,2019,Age,19 Months,86.9,78.7 to 92.3,273
Polio,≥3 Doses,States/Local Areas,Georgia,2017,Age,24 Months,92.0,86.2 to 96.0,292
Polio,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,24 Months,91.1,86.6 to 94.6,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2013,Age,24 Months,97.9,95.8 to 99.1,276
DTaP,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,95.2,92.6 to 97.1,560
Hib,Full Series,States/Local Areas,Georgia,2015,Age,24 Months,76.0,69.1 to 82.3,306
Hib,Full Series,States/Local Areas,Georgia,2015-2016,Age,24 Months,78.6,74.0 to 83.0,640
DTaP,≥3 Doses,States/Local Areas,Georgia,2011,Age,24 Months,91.0,84.3 to 95.6,219
DTaP,≥3 Doses,States/Local Areas,Georgia,2017,Age,19 Months,91.6,85.1 to 95.4,292
DTaP,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,91.1,86.2 to 94.4,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2018,Age,19 Months,90.6,83.6 to 94.8,282
DTaP,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,89.5,84.5 to 92.9,555
Polio,≥3 Doses,States/Local Areas,Georgia,2014,Age,24 Months,91.3,86.4 to 94.9,284
Polio,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,24 Months,91.7,88.5 to 94.3,590
Polio,≥3 Doses,States/Local Areas,Georgia,2015,Age,24 Months,92.1,87.6 to 95.4,306
Polio,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,24 Months,92.8,89.8 to 95.1,640
Hib,≥3 Doses,States/Local Areas,Georgia,2018,Age,19 Months,86.4,79.0 to 91.5,282
Hib,≥3 Doses,States/Local Areas,Georgia,2018-2019,Age,19 Months,67.6,61.2 to 73.3,555
Polio,≥3 Doses,States/Local Areas,Georgia,2016,Age,24 Months,93.5,89.1 to 96.5,334
Polio,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,24 Months,92.7,89.2 to 95.4,626
Hib,≥3 Doses,States/Local Areas,Georgia,2017,Age,19 Months,86.2,79.1 to 91.1,292
Hib,≥3 Doses,States/Local Areas,Georgia,2017-2018,Age,19 Months,86.3,81.1 to 90.2,574
DTaP,≥3 Doses,States/Local Areas,Georgia,2016,Age,19 Months,92.6,87.2 to 95.8,334
DTaP,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,92.1,88.2 to 94.8,626
Hib,≥3 Doses,States/Local Areas,Georgia,2015,Age,19 Months,83.6,81.8 to 85.3,306
Hib,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,86.3,81.9 to 89.7,640
Hib,≥3 Doses,States/Local Areas,Georgia,2016,Age,19 Months,88.9,83.1 to 93.0,334
Hib,≥3 Doses,States/Local Areas,Georgia,2016-2017,Age,19 Months,87.5,83.1 to 90.9,626
Polio,≥3 Doses,States/Local Areas,Georgia,2013,Age,24 Months,96.9,93.9 to 98.7,276
Polio,≥3 Doses,States/Local Areas,Georgia,2013-2014,Age,24 Months,94.1,91.3 to 96.2,560
Hib,≥3 Doses,States/Local Areas,Georgia,2014,Age,19 Months,88.6,82.8 to 92.6,284
Hib,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,86.1,81.8 to 89.5,590
Polio,≥3 Doses,States/Local Areas,Georgia,2011,Age,24 Months,90.5,83.7 to 95.2,219
Polio,≥3 Doses,States/Local Areas,Georgia,2012,Age,24 Months,92.3,86.9 to 96.1,270
Polio,≥3 Doses,States/Local Areas,Georgia,2019,Age,19 Months,91.0,83.8 to 95.2,273
DTaP,≥3 Doses,States/Local Areas,Georgia,2014,Age,19 Months,91.6,86.4 to 95.0,284
DTaP,≥3 Doses,States/Local Areas,Georgia,2014-2015,Age,19 Months,91.9,88.4 to 94.4,590
DTaP,≥3 Doses,States/Local Areas,Georgia,2015,Age,19 Months,92.1,89.9 to 93.9,306
DTaP,≥3 Doses,States/Local Areas,Georgia,2015-2016,Age,19 Months,92.4,88.8 to 94.9,640
Hep A,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,19 Months,75.2,68.9 to 80.5,293
Hep A,≥1 Dose,States/Local Areas,Guam,2015,Age,19 Months,72.8,67.8 to 77.2,242
Hep A,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,19 Months,76.5,71.2 to 81.1,460
Hep A,≥1 Dose,States/Local Areas,Guam,2014,Age,19 Months,75.2,68.6 to 80.7,293
Hep A,≥1 Dose,States/Local Areas,Guam,2014-2015,Age,19 Months,74.0,69.1 to 78.3,535
Hep B,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,67.4,56.5 to 76.7,161
Hib,Primary Series,States/Local Areas,Guam,2021,Age,19 Months,74.6,57.2 to 86.6,64
Hib,Primary Series,States/Local Areas,Guam,2020-2021,Age,24 Months,70.2,59.6 to 80.1,161
DTaP,≥2 Doses,States/Local Areas,Guam,2017,Age,5 Months,58.6,48.0 to 68.5,155
DTaP,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,5 Months,61.0,53.5 to 68.0,295
Hib,≥3 Doses,States/Local Areas,Guam,2017,Age,24 Months,76.9,67.8 to 84.9,155
Hib,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,76.7,70.2 to 82.7,295
DTaP,≥3 Doses,States/Local Areas,Guam,2019,Age,24 Months,81.7,71.1 to 90.1,97
Hib,≥3 Doses,States/Local Areas,Guam,2016,Age,24 Months,85.4,78.7 to 90.9,218
Hib,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,81.4,75.9 to 86.3,373
Hib,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,82.0,77.0 to 86.4,460
DTaP,≥3 Doses,States/Local Areas,Guam,2018,Age,24 Months,78.7,69.8 to 86.4,140
DTaP,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,80.1,73.3 to 86.1,237
DTaP,≥3 Doses,States/Local Areas,Guam,2017,Age,24 Months,79.3,70.6 to 86.8,155
DTaP,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,79.0,72.6 to 84.7,295
DTaP,≥2 Doses,States/Local Areas,Guam,2018,Age,5 Months,63.4,53.0 to 72.7,140
DTaP,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,5 Months,63.7,55.8 to 70.9,237
DTaP,≥2 Doses,States/Local Areas,Guam,2019,Age,5 Months,64.0,51.8 to 74.6,97
Hep A,≥1 Dose,States/Local Areas,Guam,2016,Age,19 Months,79.8,72.3 to 85.7,218
Hep A,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,19 Months,77.4,71.4 to 82.5,373
DTaP,≥1 Dose,States/Local Areas,Guam,2018,Age,3 Months,75.0,65.4 to 82.7,140
DTaP,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,3 Months,74.9,67.5 to 81.0,237
DTaP,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,86.3,81.8 to 90.1,460
DTaP,≥3 Doses,States/Local Areas,Guam,2014,Age,24 Months,86.1,81.0 to 90.5,293
DTaP,≥1 Dose,States/Local Areas,Guam,2017,Age,3 Months,68.8,58.3 to 77.7,155
DTaP,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,3 Months,71.9,64.7 to 78.1,295
DTaP,≥1 Dose,States/Local Areas,Guam,2019,Age,3 Months,74.7,62.9 to 83.7,97
DTaP,≥3 Doses,States/Local Areas,Guam,2016,Age,24 Months,87.3,80.8 to 92.4,218
DTaP,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,83.5,78.2 to 88.1,373
Hep A,≥1 Dose,States/Local Areas,Guam,2018,Age,19 Months,68.5,58.5 to 77.1,140
Hep A,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,19 Months,64.4,54.7 to 73.1,194
Hep A,≥1 Dose,States/Local Areas,Guam,2017,Age,19 Months,74.8,64.8 to 82.6,155
Hep A,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,19 Months,71.7,64.8 to 77.7,295
Hib,≥3 Doses,States/Local Areas,Guam,2021,Age,19 Months,69.8,53.0 to 82.5,64
DTaP,≥3 Doses,States/Local Areas,Guam,2021,Age,24 Months,72.4,57.0 to 85.9,64
Hib,≥2 Doses,States/Local Areas,Guam,2021,Age,7 Months,66.7,49.7 to 80.2,64
≥1 Dose MMR,,States/Local Areas,Guam,2020-2021,Age,24 Months,77.3,67.6 to 85.8,161
Hep B,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,78.9,68.7 to 86.4,161
Polio,≥3 Doses,States/Local Areas,Guam,2021,Age,35 Months,72.4,57.0 to 85.9,64
DTaP,≥3 Doses,States/Local Areas,Guam,2021,Age,7 Months,49.7,35.0 to 64.4,64
PCV,≥2 Doses,States/Local Areas,Guam,2021,Age,5 Months,48.3,33.9 to 63.0,64
Hep B,≥2 Doses,States/Local Areas,Guam,2021,Age,5 Months,62.1,45.9 to 76.0,64
Hib,Primary Series,States/Local Areas,Guam,2021,Age,7 Months,44.5,30.7 to 59.1,64
DTaP,≥4 Doses,States/Local Areas,Guam,2021,Age,19 Months,50.9,36.1 to 65.6,64
Combined 7 Series,,States/Local Areas,Guam,2021,Age,35 Months,36.5,24.1 to 52.6,64
Polio,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,69.9,58.8 to 79.0,161
Hep A,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,35 Months,74.1,63.9 to 83.3,161
Hib,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,67.9,57.4 to 78.0,161
DTaP,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,3 Months,59.7,48.5 to 70.0,161
DTaP,≥1 Dose,States/Local Areas,Guam,2016,Age,3 Months,71.4,63.2 to 78.5,218
DTaP,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,3 Months,70.2,63.7 to 76.0,373
DTaP,≥1 Dose,States/Local Areas,Guam,2015,Age,3 Months,75.5,68.2 to 81.7,242
DTaP,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,3 Months,73.4,67.9 to 78.2,460
DTaP,≥1 Dose,States/Local Areas,Guam,2014,Age,3 Months,76.8,70.6 to 82.0,293
DTaP,≥1 Dose,States/Local Areas,Guam,2014-2015,Age,3 Months,76.2,71.5 to 80.3,535
DTaP,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,3 Months,76.8,71.3 to 81.5,293
Hep A,≥2 Doses,States/Local Areas,Guam,2021,Age,35 Months,40.9,27.4 to 57.9,64
≥1 Dose Varicella,,States/Local Areas,Guam,2021,Age,35 Months,77.0,62.4 to 89.1,64
Hep B,≥3 Doses,States/Local Areas,Guam,2021,Age,19 Months,66.1,50.0 to 79.2,64
Hib,Full Series,States/Local Areas,Guam,2021,Age,19 Months,50.3,35.6 to 65.0,64
PCV,≥4 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,57.5,47.2 to 68.2,161
PCV,≥2 Doses,States/Local Areas,Guam,2017,Age,5 Months,54.0,43.6 to 64.2,155
PCV,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,5 Months,57.5,50.0 to 64.7,295
Hep A,≥1 Dose,States/Local Areas,Guam,2019,Age,24 Months,75.0,62.8 to 85.7,97
Hep A,≥1 Dose,States/Local Areas,Guam,2018,Age,24 Months,73.1,63.7 to 81.7,140
Hep A,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,24 Months,74.2,66.5 to 81.3,237
≥1 Dose MMR,,States/Local Areas,Guam,2020-2021,Age,13 Months,54.9,44.5 to 64.8,161
PCV,≥3 Doses,States/Local Areas,Guam,2021,Age,13 Months,68.3,51.6 to 81.3,64
Hep A,≥1 Dose,States/Local Areas,Guam,2021,Age,24 Months,77.4,62.5 to 89.5,64
Hep B,≥3 Doses,States/Local Areas,Guam,2021,Age,7 Months,48.3,33.8 to 63.0,64
≥1 Dose Varicella,,States/Local Areas,Guam,2020-2021,Age,35 Months,77.2,67.5 to 85.7,161
Hib,≥3 Doses,States/Local Areas,Guam,2018,Age,35 Months,76.6,67.5 to 84.6,140
Hib,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,80.5,73.5 to 86.6,237
Hib,≥3 Doses,States/Local Areas,Guam,2017,Age,35 Months,77.4,68.3 to 85.4,155
Hib,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,77.1,70.5 to 83.1,295
Hib,≥3 Doses,States/Local Areas,Guam,2016,Age,35 Months,86.7,79.9 to 92.1,218
Hib,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,82.2,76.7 to 87.1,373
Hep A,≥2 Doses,States/Local Areas,Guam,2019,Age,19 Months,27.1,18.3 to 38.1,97
Hep A,≥2 Doses,States/Local Areas,Guam,2018,Age,19 Months,25.5,17.3 to 35.8,140
Hep A,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,20.9,14.7 to 28.8,194
DTaP,≥4 Doses,States/Local Areas,Guam,2015,Age,19 Months,56.7,51.7 to 61.6,242
DTaP,≥4 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,55.4,49.7 to 61.1,460
DTaP,≥4 Doses,States/Local Areas,Guam,2014,Age,19 Months,57.2,50.4 to 63.8,293
DTaP,≥4 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,57.0,51.7 to 62.1,535
DTaP,≥4 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,57.2,51.1 to 63.1,293
Hep A,≥1 Dose,States/Local Areas,Guam,2017,Age,24 Months,76.1,66.9 to 84.3,155
Hep A,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,24 Months,74.6,68.1 to 80.6,295
DTaP,≥3 Doses,States/Local Areas,Guam,2019,Age,35 Months,84.0,73.2 to 92.1,97
DTaP,≥3 Doses,States/Local Areas,Guam,2018,Age,35 Months,78.7,69.8 to 86.4,140
DTaP,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,81.5,74.6 to 87.5,237
PCV,≥2 Doses,States/Local Areas,Guam,2016,Age,5 Months,65.2,56.8 to 72.7,218
PCV,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,5 Months,59.9,53.2 to 66.3,373
PCV,≥2 Doses,States/Local Areas,Guam,2015,Age,5 Months,52.4,44.6 to 60.0,242
PCV,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,5 Months,59.1,53.4 to 64.6,460
PCV,≥2 Doses,States/Local Areas,Guam,2014,Age,5 Months,61.0,54.2 to 67.3,293
PCV,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,5 Months,56.7,51.2 to 62.0,535
Hep A,≥1 Dose,States/Local Areas,Guam,2016,Age,24 Months,81.2,74.1 to 87.3,218
Hep A,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,24 Months,78.8,73.1 to 84.0,373
Hep A,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,24 Months,80.2,75.2 to 84.8,460
Hep A,≥2 Doses,States/Local Areas,Guam,2017,Age,19 Months,22.6,15.7 to 31.4,155
Hep A,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,24.1,18.5 to 30.7,295
Hib,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,85.3,80.2 to 89.7,460
Hib,≥3 Doses,States/Local Areas,Guam,2014,Age,35 Months,86.6,80.6 to 91.4,293
Hib,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,86.6,80.6 to 91.4,293
Hep A,≥2 Doses,States/Local Areas,Guam,2016,Age,19 Months,25.7,19.5 to 33.1,218
Hep A,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,24.3,19.4 to 29.8,373
Hep A,≥2 Doses,States/Local Areas,Guam,2015,Age,19 Months,20.3,14.6 to 27.7,242
Hep A,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,23.2,18.9 to 28.0,460
DTaP,≥3 Doses,States/Local Areas,Guam,2016,Age,35 Months,88.2,81.8 to 93.2,218
DTaP,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,86.0,80.5 to 90.6,373
DTaP,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,88.5,84.1 to 92.2,460
PCV,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,5 Months,61.0,55.5 to 66.2,293
DTaP,≥3 Doses,States/Local Areas,Guam,2017,Age,35 Months,83.1,73.7 to 90.6,155
DTaP,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,81.3,74.4 to 87.2,295
Hep B,≥2 Doses,States/Local Areas,Guam,2021,Age,7 Months,70.0,53.3 to 82.7,64
Hib,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,76.6,65.8 to 84.8,161
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2021,Age,0-1 Days,84.4,72.4 to 91.8,64
PCV,≥3 Doses,States/Local Areas,Guam,2021,Age,24 Months,70.2,54.9 to 84.1,64
≥1 Dose Varicella,,States/Local Areas,Guam,2021,Age,24 Months,77.0,62.4 to 89.1,64
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2021,Age,0-2 Days,84.4,72.4 to 91.8,64
Hep B,≥3 Doses,States/Local Areas,Guam,2021,Age,24 Months,66.1,51.2 to 80.3,64
≥1 Dose MMR,,States/Local Areas,Guam,2020,Age,13 Months,51.7,37.8 to 65.3,97
Hep A,≥1 Dose,States/Local Areas,Guam,2014,Age,24 Months,79.2,73.1 to 84.8,293
Hep A,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,24 Months,79.2,73.1 to 84.8,293
Hep A,≥1 Dose,States/Local Areas,Guam,2019,Age,19 Months,64.1,51.4 to 75.0,97
Hib,≥3 Doses,States/Local Areas,Guam,2019,Age,24 Months,81.7,71.1 to 90.1,97
Hib,≥3 Doses,States/Local Areas,Guam,2018,Age,24 Months,76.6,67.5 to 84.6,140
Hib,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,79.0,72.2 to 85.1,237
Hep A,≥2 Doses,States/Local Areas,Guam,2014,Age,19 Months,18.4,14.2 to 23.5,293
Hep A,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,19.4,15.9 to 23.4,535
Hep A,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,18.4,16.3 to 20.7,293
DTaP,≥3 Doses,States/Local Areas,Guam,2014,Age,35 Months,90.8,85.0 to 95.0,293
DTaP,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,90.8,85.0 to 95.0,293
Polio,≥2 Doses,States/Local Areas,Guam,2021,Age,7 Months,65.7,48.9 to 79.3,64
Hep A,≥1 Dose,States/Local Areas,Guam,2021,Age,35 Months,77.4,62.5 to 89.5,64
PCV,≥3 Doses,States/Local Areas,Guam,2021,Age,19 Months,70.2,53.4 to 82.9,64
Hep B,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,71.4,61.4 to 80.7,161
Hib,Primary Series,States/Local Areas,Guam,2020-2021,Age,13 Months,65.3,54.3 to 74.9,161
Combined 7 Series,,States/Local Areas,Guam,2015-2016,Age,35 Months,61.3,54.2 to 68.4,460
Hib,Full Series,States/Local Areas,Guam,2013-2014,Age,19 Months,56.6,50.4 to 62.7,293
Hib,≥3 Doses,States/Local Areas,Guam,2021,Age,7 Months,36.9,24.5 to 51.3,64
≥1 Dose Varicella,,States/Local Areas,Guam,2021,Age,19 Months,77.0,60.6 to 88.0,64
Hib,Full Series,States/Local Areas,Guam,2021,Age,24 Months,52.3,38.1 to 68.1,64
DTaP,≥3 Doses,States/Local Areas,Guam,2021,Age,19 Months,72.4,55.4 to 84.7,64
Hib,Primary Series,States/Local Areas,Guam,2021,Age,24 Months,74.6,59.1 to 87.9,64
DTaP,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,78.4,61.6 to 91.4,161
Polio,≥1 Dose,States/Local Areas,Guam,2021,Age,3 Months,58.7,42.6 to 73.0,64
Hib,≥3 Doses,States/Local Areas,Guam,2021,Age,24 Months,70.6,55.2 to 84.5,64
≥1 Dose MMR,,States/Local Areas,Guam,2021,Age,24 Months,79.8,65.1 to 91.3,64
Combined 7 Series,,States/Local Areas,Guam,2020-2021,Age,35 Months,43.7,34.0 to 54.7,161
Polio,≥3 Doses,States/Local Areas,Guam,2021,Age,24 Months,72.4,57.0 to 85.9,64
DTaP,≥1 Dose,States/Local Areas,Guam,2021,Age,3 Months,56.1,40.5 to 70.7,64
DTaP,≥4 Doses,States/Local Areas,Guam,2021,Age,24 Months,55.3,40.8 to 71.0,64
PCV,≥4 Doses,States/Local Areas,Guam,2021,Age,35 Months,59.5,44.8 to 74.7,64
PCV,≥3 Doses,States/Local Areas,Guam,2021,Age,35 Months,70.2,54.9 to 84.1,64
Hep A,≥1 Dose,States/Local Areas,Guam,2021,Age,19 Months,75.4,59.2 to 86.7,64
PCV,≥4 Doses,States/Local Areas,Guam,2021,Age,19 Months,57.3,41.9 to 71.4,64
PCV,≥3 Doses,States/Local Areas,Guam,2021,Age,7 Months,50.0,35.3 to 64.7,64
DTaP,≥3 Doses,States/Local Areas,Guam,2021,Age,13 Months,70.5,53.7 to 83.1,64
Hep A,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,30.0,21.6 to 39.9,161
Hep A,≥2 Doses,States/Local Areas,Guam,2021,Age,24 Months,38.4,25.6 to 54.7,64
PCV,≥4 Doses,States/Local Areas,Guam,2021,Age,24 Months,59.5,44.8 to 74.7,64
Combined 7 Series,,States/Local Areas,Guam,2019,Age,35 Months,52.6,38.6 to 68.1,97
Combined 7 Series,,States/Local Areas,Guam,2018,Age,35 Months,55.7,45.4 to 66.5,140
Combined 7 Series,,States/Local Areas,Guam,2018-2019,Age,35 Months,55.1,45.6 to 65.1,237
Hib,≥1 Dose,States/Local Areas,Guam,2021,Age,3 Months,54.3,39.0 to 68.9,64
Rotavirus,,States/Local Areas,Guam,2019-2020,Age,8 Months,45.0,36.1 to 54.2,194
Hep B,≥3 Doses,States/Local Areas,Guam,2020,Age,7 Months,47.8,34.3 to 61.7,97
PCV,≥3 Doses,States/Local Areas,Guam,2020,Age,7 Months,36.6,24.8 to 50.2,97
Hib,≥1 Dose,States/Local Areas,Guam,2020,Age,3 Months,62.9,47.9 to 75.8,97
Hep B,≥2 Doses,States/Local Areas,Guam,2020,Age,7 Months,76.0,61.4 to 86.3,97
Polio,≥1 Dose,States/Local Areas,Guam,2020,Age,3 Months,62.9,47.9 to 75.8,97
DTaP,≥1 Dose,States/Local Areas,Guam,2020,Age,3 Months,62.9,47.9 to 75.8,97
Hib,≥2 Doses,States/Local Areas,Guam,2020,Age,5 Months,52.4,38.4 to 66.1,97
Polio,≥2 Doses,States/Local Areas,Guam,2020,Age,5 Months,48.0,34.5 to 61.7,97
DTaP,≥2 Doses,States/Local Areas,Guam,2020,Age,5 Months,51.7,37.8 to 65.5,97
PCV,≥1 Dose,States/Local Areas,Guam,2020,Age,3 Months,58.9,44.4 to 72.1,97
Hep B,≥1 Dose,States/Local Areas,Guam,2020,Age,3 Months,90.5,78.5 to 96.2,97
Hep A,≥1 Dose,States/Local Areas,Guam,2020,Age,24 Months,69.7,55.9 to 82.5,97
Hep A,≥2 Doses,States/Local Areas,Guam,2020,Age,24 Months,41.8,29.4 to 56.8,97
PCV,≥4 Doses,States/Local Areas,Guam,2020,Age,24 Months,55.6,42.3 to 70.0,97
PCV,≥3 Doses,States/Local Areas,Guam,2020,Age,24 Months,69.0,55.0 to 82.1,97
Rotavirus,,States/Local Areas,Guam,2020,Age,8 Months,46.3,33.1 to 60.0,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2020,Age,0-3 Days,84.5,71.5 to 92.2,97
≥1 Dose Varicella,,States/Local Areas,Guam,2020,Age,24 Months,75.3,62.7 to 86.2,97
Influenza,,States/Local Areas,Guam,2020,Age,24 Months,54.2,41.1 to 68.4,97
≥1 Dose MMR,,States/Local Areas,Guam,2020,Age,19 Months,70.8,56.8 to 81.8,97
Hib,≥3 Doses,States/Local Areas,Guam,2020,Age,19 Months,65.5,50.5 to 78.0,97
Combined 7 Series,,States/Local Areas,Guam,2020,Age,24 Months,50.1,37.0 to 64.8,97
DTaP,≥4 Doses,States/Local Areas,Guam,2020,Age,19 Months,50.2,36.4 to 63.9,97
Polio,≥3 Doses,States/Local Areas,Guam,2020,Age,19 Months,67.6,53.0 to 79.4,97
DTaP,≥3 Doses,States/Local Areas,Guam,2020,Age,19 Months,68.6,54.1 to 80.3,97
PCV,≥3 Doses,States/Local Areas,Guam,2020,Age,13 Months,61.2,46.7 to 73.9,97
Hep B,≥2 Doses,States/Local Areas,Guam,2020,Age,5 Months,70.1,55.5 to 81.5,97
DTaP,≥3 Doses,States/Local Areas,Guam,2020,Age,7 Months,43.4,30.6 to 57.2,97
PCV,≥2 Doses,States/Local Areas,Guam,2020,Age,5 Months,48.3,34.9 to 61.9,97
≥1 Dose Varicella,,States/Local Areas,Guam,2020,Age,13 Months,47.4,33.9 to 61.2,97
Hep B,≥3 Doses,States/Local Areas,Guam,2020,Age,13 Months,72.6,58.0 to 83.5,97
Hep B,≥2 Doses,States/Local Areas,Guam,2020,Age,13 Months,80.4,66.8 to 89.3,97
Hib,≥3 Doses,States/Local Areas,Guam,2020,Age,13 Months,63.6,48.9 to 76.2,97
Hib,Primary Series,States/Local Areas,Guam,2020,Age,13 Months,64.3,49.5 to 76.8,97
PCV,≥4 Doses,States/Local Areas,Guam,2020,Age,19 Months,53.6,39.7 to 66.9,97
PCV,≥3 Doses,States/Local Areas,Guam,2020,Age,35 Months,75.7,61.2 to 88.0,97
Hib,≥2 Doses,States/Local Areas,Guam,2020,Age,13 Months,78.4,64.4 to 88.0,97
PCV,≥3 Doses,States/Local Areas,Guam,2020,Age,19 Months,65.0,50.1 to 77.5,97
Polio,≥3 Doses,States/Local Areas,Guam,2020,Age,35 Months,81.1,59.0 to 95.6,97
DTaP,≥4 Doses,States/Local Areas,Guam,2020,Age,35 Months,60.3,45.6 to 75.4,97
DTaP,≥3 Doses,States/Local Areas,Guam,2020,Age,35 Months,77.5,58.3 to 92.2,97
Hep B,≥3 Doses,States/Local Areas,Guam,2020,Age,19 Months,75.6,61.2 to 85.9,97
≥1 Dose Varicella,,States/Local Areas,Guam,2020,Age,19 Months,71.5,57.6 to 82.3,97
Hib,Full Series,States/Local Areas,Guam,2020,Age,19 Months,55.8,41.6 to 69.1,97
Hib,Primary Series,States/Local Areas,Guam,2020,Age,19 Months,66.2,51.1 to 78.6,97
≥1 Dose Varicella,,States/Local Areas,Guam,2020,Age,35 Months,76.6,64.0 to 87.4,97
Hep B,≥3 Doses,States/Local Areas,Guam,2020,Age,35 Months,76.1,62.9 to 87.3,97
Hib,Full Series,States/Local Areas,Guam,2020,Age,35 Months,57.9,44.3 to 72.2,97
Hib,Primary Series,States/Local Areas,Guam,2020,Age,35 Months,79.5,57.3 to 94.8,97
Hib,≥3 Doses,States/Local Areas,Guam,2020,Age,35 Months,79.1,56.6 to 94.7,97
≥1 Dose MMR,,States/Local Areas,Guam,2020,Age,35 Months,76.3,63.4 to 87.2,97
Hib,≥3 Doses,States/Local Areas,Guam,2020,Age,24 Months,65.5,51.7 to 79.0,97
≥1 Dose MMR,,States/Local Areas,Guam,2020,Age,24 Months,74.9,62.2 to 86.0,97
Polio,≥3 Doses,States/Local Areas,Guam,2020,Age,24 Months,68.0,54.5 to 80.8,97
DTaP,≥3 Doses,States/Local Areas,Guam,2020,Age,24 Months,69.0,55.6 to 81.6,97
DTaP,≥4 Doses,States/Local Areas,Guam,2020,Age,24 Months,54.6,41.2 to 69.1,97
Hib,Primary Series,States/Local Areas,Guam,2020,Age,7 Months,41.9,29.2 to 55.7,97
Hib,≥3 Doses,States/Local Areas,Guam,2020,Age,7 Months,34.0,22.4 to 47.7,97
Hib,≥2 Doses,States/Local Areas,Guam,2020,Age,7 Months,65.5,51.0 to 77.6,97
Polio,≥2 Doses,States/Local Areas,Guam,2020,Age,7 Months,65.9,51.3 to 78.0,97
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2020,Age,0-1 Days,84.5,71.5 to 92.2,97
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2020,Age,0-2 Days,84.5,71.5 to 92.2,97
Hep A,≥2 Doses,States/Local Areas,Guam,2020,Age,19 Months,29.7,18.5 to 44.0,97
Hep A,≥1 Dose,States/Local Areas,Guam,2020,Age,19 Months,65.4,50.6 to 77.7,97
Combined 7 Series,,States/Local Areas,Guam,2020,Age,35 Months,50.1,37.0 to 64.8,97
Hep A,≥2 Doses,States/Local Areas,Guam,2020,Age,35 Months,55.4,37.0 to 75.6,97
DTaP,≥3 Doses,States/Local Areas,Guam,2020,Age,13 Months,63.3,49.1 to 75.5,97
Hep A,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,24 Months,71.3,62.0 to 80.0,194
Hep A,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,58.4,45.5 to 71.9,194
Hep A,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,35 Months,76.8,67.3 to 85.1,194
Influenza,,States/Local Areas,Guam,2019-2020,Age,24 Months,49.6,40.6 to 59.4,194
≥1 Dose MMR,,States/Local Areas,Guam,2019-2020,Age,24 Months,73.6,64.7 to 81.7,194
Hep A,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,40.1,31.6 to 49.8,194
Hib,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,72.2,63.1 to 80.6,194
Hib,Primary Series,States/Local Areas,Guam,2019-2020,Age,24 Months,72.5,63.4 to 80.9,194
Hib,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,69.5,60.0 to 77.6,194
Combined 7 Series,,States/Local Areas,Guam,2019-2020,Age,35 Months,50.0,40.3 to 60.6,194
Hib,Full Series,States/Local Areas,Guam,2019-2020,Age,19 Months,53.2,43.8 to 62.4,194
Hep B,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,72.8,63.3 to 80.6,194
PCV,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,69.7,59.9 to 78.0,194
PCV,≥4 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,51.2,42.1 to 60.3,194
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2019-2020,Age,0-1 Days,85.3,77.4 to 90.7,194
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2019-2020,Age,0-2 Days,85.3,77.4 to 90.7,194
Hib,Full Series,States/Local Areas,Guam,2019-2020,Age,24 Months,59.2,49.9 to 68.7,194
Hep B,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,73.2,64.3 to 81.4,194
PCV,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,41.6,33.0 to 50.8,194
≥1 Dose Varicella,,States/Local Areas,Guam,2019-2020,Age,24 Months,73.4,64.6 to 81.5,194
PCV,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,73.6,64.5 to 81.9,194
Hep A,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,19 Months,63.1,53.3 to 71.9,194
≥1 Dose MMR,,States/Local Areas,Guam,2019-2020,Age,19 Months,66.9,57.3 to 75.2,194
Polio,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,72.5,63.1 to 80.3,194
Hib,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,71.9,62.2 to 79.9,194
Hib,Primary Series,States/Local Areas,Guam,2019-2020,Age,19 Months,72.2,62.5 to 80.2,194
≥1 Dose MMR,,States/Local Areas,Guam,2019-2020,Age,35 Months,77.5,68.3 to 85.6,194
Hib,Full Series,States/Local Areas,Guam,2019-2020,Age,35 Months,64.9,55.1 to 74.6,194
Hib,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,82.3,66.5 to 93.6,194
Hib,Primary Series,States/Local Areas,Guam,2019-2020,Age,35 Months,82.5,66.8 to 93.7,194
Hep B,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,73.3,64.4 to 81.5,194
≥1 Dose Varicella,,States/Local Areas,Guam,2019-2020,Age,35 Months,77.4,68.4 to 85.4,194
PCV,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,79.3,69.5 to 87.6,194
PCV,≥4 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,62.7,52.6 to 72.8,194
DTaP,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,73.9,65.0 to 82.0,194
DTaP,≥4 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,58.5,49.2 to 68.0,194
Hep A,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,27.4,20.1 to 36.1,194
Polio,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,73.2,64.3 to 81.4,194
Hib,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,3 Months,69.6,60.0 to 77.8,194
Hep B,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,3 Months,92.9,86.7 to 96.4,194
DTaP,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,5 Months,57.1,47.6 to 66.1,194
PCV,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,3 Months,68.3,58.8 to 76.5,194
Polio,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,5 Months,55.2,45.9 to 64.3,194
DTaP,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,70.0,60.6 to 77.9,194
Polio,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,81.4,72.7 to 87.8,194
Hib,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,68.4,58.9 to 76.6,194
Hib,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,82.6,73.9 to 88.8,194
≥1 Dose MMR,,States/Local Areas,Guam,2019-2020,Age,13 Months,51.9,42.6 to 61.1,194
Hib,Primary Series,States/Local Areas,Guam,2019-2020,Age,13 Months,69.9,60.3 to 78.0,194
Hib,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,5 Months,57.4,47.9 to 66.4,194
Hep B,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,5 Months,73.5,64.0 to 81.3,194
PCV,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,5 Months,56.3,46.9 to 65.2,194
DTaP,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,44.4,35.6 to 53.6,194
Polio,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,69.7,60.1 to 77.8,194
Hep B,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,86.6,78.7 to 91.8,194
Hep B,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,69.6,60.1 to 77.7,194
PCV,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,13 Months,66.7,57.1 to 75.1,194
≥1 Dose Varicella,,States/Local Areas,Guam,2019-2020,Age,13 Months,49.0,39.8 to 58.3,194
Combined 7 Series,,States/Local Areas,Guam,2019-2020,Age,24 Months,44.7,36.1 to 54.5,194
DTaP,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,80.6,67.6 to 90.7,194
DTaP,≥4 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,69.0,58.3 to 79.2,194
Polio,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,35 Months,83.2,67.4 to 94.2,194
DTaP,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,73.4,64.0 to 81.1,194
DTaP,≥4 Doses,States/Local Areas,Guam,2019-2020,Age,19 Months,49.8,40.6 to 59.0,194
PCV,≥4 Doses,States/Local Areas,Guam,2019-2020,Age,24 Months,55.4,46.2 to 65.0,194
Hep B,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,46.0,37.0 to 55.2,194
Hib,≥3 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,35.1,27.0 to 44.1,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2019-2020,Age,0-3 Days,86.0,78.1 to 91.4,194
DTaP,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,3 Months,69.0,59.5 to 77.2,194
Polio,≥1 Dose,States/Local Areas,Guam,2019-2020,Age,3 Months,68.8,59.2 to 77.0,194
Hib,Full Series,States/Local Areas,Guam,2014,Age,24 Months,63.2,56.5 to 69.8,293
Hib,Full Series,States/Local Areas,Guam,2013-2014,Age,24 Months,63.2,56.5 to 69.8,293
Hib,Full Series,States/Local Areas,Guam,2019,Age,19 Months,53.9,41.8 to 65.6,97
Hib,Full Series,States/Local Areas,Guam,2018,Age,19 Months,59.1,48.7 to 68.7,140
Hib,Full Series,States/Local Areas,Guam,2018-2019,Age,19 Months,89.6,84.1 to 93.4,237
Hib,Full Series,States/Local Areas,Guam,2017,Age,19 Months,50.7,40.5 to 61.0,155
Hib,Full Series,States/Local Areas,Guam,2017-2018,Age,19 Months,54.9,47.5 to 62.1,295
Hib,Primary Series,States/Local Areas,Guam,2017,Age,24 Months,77.5,68.5 to 85.5,155
Hib,Primary Series,States/Local Areas,Guam,2017-2018,Age,24 Months,77.1,70.5 to 83.1,295
Combined 7 Series,,States/Local Areas,Guam,2013-2014,Age,35 Months,56.4,49.1 to 64.0,293
Combined 7 Series,,States/Local Areas,Guam,2014,Age,35 Months,56.4,49.1 to 64.0,293
Hib,Full Series,States/Local Areas,Guam,2016,Age,19 Months,57.3,48.9 to 65.3,218
Hib,Full Series,States/Local Areas,Guam,2016-2017,Age,19 Months,54.2,47.6 to 60.6,373
Hib,Full Series,States/Local Areas,Guam,2015,Age,19 Months,56.6,51.8 to 61.3,242
Hib,Full Series,States/Local Areas,Guam,2015-2016,Age,19 Months,57.0,51.2 to 62.6,460
Hib,Full Series,States/Local Areas,Guam,2014,Age,19 Months,56.6,49.9 to 63.2,293
Hib,Full Series,States/Local Areas,Guam,2014-2015,Age,19 Months,56.6,51.4 to 61.7,535
Combined 7 Series,,States/Local Areas,Guam,2017,Age,35 Months,49.9,39.0 to 61.9,155
Combined 7 Series,,States/Local Areas,Guam,2017-2018,Age,35 Months,53.1,45.3 to 61.2,295
Combined 7 Series,,States/Local Areas,Guam,2016,Age,35 Months,65.5,56.1 to 74.7,218
Combined 7 Series,,States/Local Areas,Guam,2016-2017,Age,35 Months,57.9,50.4 to 65.5,373
Combined 7 Series,,States/Local Areas,Guam,2018,Age,24 Months,51.7,41.9 to 62.3,140
Combined 7 Series,,States/Local Areas,Guam,2018-2019,Age,24 Months,47.2,39.7 to 55.4,237
Combined 7 Series,,States/Local Areas,Guam,2017,Age,24 Months,40.6,31.0 to 51.8,155
Combined 7 Series,,States/Local Areas,Guam,2017-2018,Age,24 Months,46.2,39.1 to 53.9,295
Hib,Primary Series,States/Local Areas,Guam,2019,Age,35 Months,84.0,73.2 to 92.1,97
Combined 7 Series,,States/Local Areas,Guam,2016,Age,24 Months,56.3,48.0 to 64.9,218
Combined 7 Series,,States/Local Areas,Guam,2016-2017,Age,24 Months,48.8,42.3 to 55.8,373
Hib,Primary Series,States/Local Areas,Guam,2018,Age,35 Months,76.6,67.5 to 84.6,140
Hib,Primary Series,States/Local Areas,Guam,2018-2019,Age,35 Months,80.5,73.5 to 86.6,237
Combined 7 Series,,States/Local Areas,Guam,2015-2016,Age,24 Months,52.3,46.6 to 58.4,460
Combined 7 Series,,States/Local Areas,Guam,2014,Age,24 Months,50.8,44.1 to 57.9,293
Hib,Primary Series,States/Local Areas,Guam,2017,Age,35 Months,78.1,69.0 to 86.0,155
Hib,Primary Series,States/Local Areas,Guam,2017-2018,Age,35 Months,77.4,70.8 to 83.4,295
Hib,Primary Series,States/Local Areas,Guam,2016,Age,35 Months,86.8,80.0 to 92.2,218
Hib,Primary Series,States/Local Areas,Guam,2016-2017,Age,35 Months,82.6,77.0 to 87.5,373
Hib,Primary Series,States/Local Areas,Guam,2015-2016,Age,35 Months,85.7,80.6 to 90.0,460
Combined 7 Series,,States/Local Areas,Guam,2013-2014,Age,24 Months,50.8,44.1 to 57.9,293
Combined 7 Series,,States/Local Areas,Guam,2019,Age,24 Months,42.2,31.5 to 54.8,97
Hib,Primary Series,States/Local Areas,Guam,2014,Age,35 Months,88.0,82.3 to 92.6,293
Hib,Primary Series,States/Local Areas,Guam,2013-2014,Age,35 Months,88.0,82.3 to 92.6,293
Hib,Primary Series,States/Local Areas,Guam,2019,Age,24 Months,81.7,71.1 to 90.1,97
Hib,Primary Series,States/Local Areas,Guam,2018,Age,24 Months,76.6,67.5 to 84.6,140
Hib,Primary Series,States/Local Areas,Guam,2018-2019,Age,24 Months,79.0,72.2 to 85.1,237
Hib,Primary Series,States/Local Areas,Guam,2016,Age,24 Months,85.5,78.8 to 91.0,218
Hib,Primary Series,States/Local Areas,Guam,2016-2017,Age,24 Months,81.7,76.2 to 86.6,373
Hib,Primary Series,States/Local Areas,Guam,2015-2016,Age,24 Months,82.4,77.5 to 86.8,460
Hib,Primary Series,States/Local Areas,Guam,2014,Age,24 Months,84.2,78.9 to 88.8,293
Hib,Primary Series,States/Local Areas,Guam,2016,Age,13 Months,80.6,72.9 to 86.5,218
Hib,Primary Series,States/Local Areas,Guam,2016-2017,Age,13 Months,74.1,67.7 to 79.6,373
Hib,Primary Series,States/Local Areas,Guam,2013-2014,Age,19 Months,81.7,77.5 to 85.2,293
Hib,Primary Series,States/Local Areas,Guam,2019,Age,13 Months,78.1,66.6 to 86.5,97
Hib,Primary Series,States/Local Areas,Guam,2018,Age,13 Months,74.9,65.1 to 82.7,140
Hib,Primary Series,States/Local Areas,Guam,2018-2019,Age,13 Months,76.5,69.2 to 82.5,237
Hib,Primary Series,States/Local Areas,Guam,2017,Age,13 Months,67.0,56.3 to 76.1,155
Hib,Primary Series,States/Local Areas,Guam,2017-2018,Age,13 Months,70.9,63.6 to 77.3,295
Hib,Primary Series,States/Local Areas,Guam,2014,Age,19 Months,81.7,75.9 to 86.3,293
Hib,Primary Series,States/Local Areas,Guam,2014-2015,Age,19 Months,80.2,75.5 to 84.2,535
Hib,Primary Series,States/Local Areas,Guam,2015,Age,19 Months,78.7,73.8 to 82.9,242
Hib,Primary Series,States/Local Areas,Guam,2015-2016,Age,19 Months,82.3,77.1 to 86.5,460
Hib,Primary Series,States/Local Areas,Guam,2016,Age,19 Months,85.5,78.2 to 90.7,218
Hib,Primary Series,States/Local Areas,Guam,2016-2017,Age,19 Months,81.7,75.9 to 86.4,373
Hib,Primary Series,States/Local Areas,Guam,2017,Age,19 Months,77.5,67.8 to 85.0,155
Hib,Primary Series,States/Local Areas,Guam,2017-2018,Age,19 Months,77.1,70.1 to 82.8,295
Hib,Primary Series,States/Local Areas,Guam,2013-2014,Age,24 Months,84.2,78.9 to 88.8,293
Hib,Primary Series,States/Local Areas,Guam,2019,Age,19 Months,80.7,69.1 to 88.7,97
Hib,Primary Series,States/Local Areas,Guam,2018,Age,19 Months,76.6,66.8 to 84.1,140
Hib,Primary Series,States/Local Areas,Guam,2018-2019,Age,19 Months,76.5,69.2 to 82.5,237
Rotavirus,,States/Local Areas,Guam,2018,Age,8 Months,63.6,53.4 to 72.6,140
Rotavirus,,States/Local Areas,Guam,2018-2019,Age,8 Months,54.8,47.0 to 62.5,237
Rotavirus,,States/Local Areas,Guam,2019,Age,8 Months,45.6,34.1 to 57.5,97
Hib,Primary Series,States/Local Areas,Guam,2019-2020,Age,7 Months,42.5,33.9 to 51.6,194
Hep B,≥2 Doses,States/Local Areas,Guam,2019-2020,Age,7 Months,82.1,73.5 to 88.3,194
Hib,Primary Series,States/Local Areas,Guam,2018,Age,7 Months,50.5,40.3 to 60.6,140
Hib,Primary Series,States/Local Areas,Guam,2018-2019,Age,7 Months,48.5,40.7 to 56.3,237
Hib,Primary Series,States/Local Areas,Guam,2013-2014,Age,13 Months,76.6,70.8 to 81.5,293
Hib,Primary Series,States/Local Areas,Guam,2019,Age,7 Months,46.3,34.9 to 58.2,97
Hib,Primary Series,States/Local Areas,Guam,2017,Age,7 Months,51.4,41.0 to 61.6,155
Hib,Primary Series,States/Local Areas,Guam,2017-2018,Age,7 Months,50.9,43.6 to 58.2,295
Hib,Primary Series,States/Local Areas,Guam,2016,Age,7 Months,58.0,49.7 to 65.8,218
Hib,Primary Series,States/Local Areas,Guam,2016-2017,Age,7 Months,54.8,48.2 to 61.3,373
Hib,Primary Series,States/Local Areas,Guam,2015,Age,13 Months,73.6,65.6 to 80.4,242
Hib,Primary Series,States/Local Areas,Guam,2015-2016,Age,13 Months,77.3,71.9 to 81.9,460
Hib,Primary Series,States/Local Areas,Guam,2014,Age,13 Months,76.6,70.6 to 81.7,293
Hib,Primary Series,States/Local Areas,Guam,2014-2015,Age,13 Months,75.1,70.3 to 79.4,535
Hib,Primary Series,States/Local Areas,Guam,2015,Age,7 Months,46.4,38.9 to 54.1,242
Hib,Primary Series,States/Local Areas,Guam,2015-2016,Age,7 Months,52.5,46.8 to 58.1,460
Hib,Primary Series,States/Local Areas,Guam,2014,Age,7 Months,49.6,42.9 to 56.2,293
Hib,Primary Series,States/Local Areas,Guam,2014-2015,Age,7 Months,48.0,43.0 to 53.0,535
Hib,Primary Series,States/Local Areas,Guam,2013-2014,Age,7 Months,49.6,39.6 to 59.6,293
Rotavirus,,States/Local Areas,Guam,2011,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Guam,2017,Age,8 Months,45.9,36.0 to 56.2,155
Rotavirus,,States/Local Areas,Guam,2017-2018,Age,8 Months,54.7,47.3 to 61.9,295
Rotavirus,,States/Local Areas,Guam,2016,Age,8 Months,61.5,53.1 to 69.3,218
Rotavirus,,States/Local Areas,Guam,2016-2017,Age,8 Months,54.1,47.5 to 60.6,373
Rotavirus,,States/Local Areas,Guam,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Guam,2014,Age,8 Months,52.8,46.1 to 59.4,293
Rotavirus,,States/Local Areas,Guam,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,Guam,2013-2014,Age,8 Months,52.8,46.1 to 59.4,293
PCV,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,5 Months,48.3,38.1 to 58.7,161
DTaP,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,70.4,59.4 to 79.4,161
Combined 7 Series,,States/Local Areas,Guam,2021,Age,24 Months,36.5,24.1 to 52.6,64
Hep A,≥2 Doses,States/Local Areas,Guam,2021,Age,19 Months,30.2,18.4 to 45.4,64
Polio,≥2 Doses,States/Local Areas,Guam,2021,Age,5 Months,50.5,35.7 to 65.2,64
DTaP,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,66.7,55.8 to 76.1,161
Polio,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,76.2,65.4 to 84.4,161
PCV,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,42.9,33.2 to 53.3,161
Hib,Full Series,States/Local Areas,Guam,2020-2021,Age,35 Months,55.2,45.0 to 66.0,161
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2020-2021,Age,0-1 Days,84.4,76.1 to 90.3,161
Hep B,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,48.0,38.2 to 58.0,161
Hep A,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,19 Months,70.1,59.2 to 79.2,161
Hib,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,67.5,56.4 to 77.0,161
Hep B,≥3 Doses,States/Local Areas,Guam,2021,Age,13 Months,61.6,45.5 to 75.5,64
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2020-2021,Age,0-2 Days,84.4,76.1 to 90.3,161
Hep B,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,71.1,60.5 to 79.9,161
Hib,Primary Series,States/Local Areas,Guam,2020-2021,Age,35 Months,81.7,62.1 to 94.9,161
Hib,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,80.3,59.7 to 94.5,161
Hib,Full Series,States/Local Areas,Guam,2020-2021,Age,19 Months,53.2,42.7 to 63.5,161
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2020-2021,Age,0-3 Days,84.4,76.1 to 90.3,161
Rotavirus,,States/Local Areas,Guam,2020-2021,Age,8 Months,48.2,38.4 to 58.2,161
PCV,≥4 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,55.3,44.7 to 65.5,161
PCV,≥4 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,57.5,47.2 to 68.2,161
Hib,Primary Series,States/Local Areas,Guam,2020-2021,Age,19 Months,70.2,58.9 to 79.5,161
Polio,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,5 Months,49.2,38.8 to 59.6,161
Polio,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,65.8,55.0 to 75.1,161
PCV,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,67.5,56.3 to 76.9,161
Influenza,,States/Local Areas,Guam,2020-2021,Age,24 Months,52.6,42.5 to 63.4,161
Hib,Primary Series,States/Local Areas,Guam,2021,Age,13 Months,66.5,50.2 to 79.6,64
≥1 Dose MMR,,States/Local Areas,Guam,2020-2021,Age,35 Months,78.3,68.5 to 86.7,161
Hep B,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,73.2,62.3 to 81.8,161
Hep B,≥3 Doses,States/Local Areas,Guam,2021,Age,35 Months,66.1,51.2 to 80.3,64
DTaP,≥4 Doses,States/Local Areas,Guam,2021,Age,35 Months,55.3,40.8 to 71.0,64
PCV,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,75.9,63.7 to 86.4,161
Combined 7 Series,,States/Local Areas,Guam,2020-2021,Age,24 Months,43.7,34.0 to 54.7,161
Hib,Full Series,States/Local Areas,Guam,2021,Age,35 Months,52.3,38.1 to 68.1,64
Hib,≥3 Doses,States/Local Areas,Guam,2021,Age,13 Months,60.6,45.0 to 74.4,64
DTaP,≥3 Doses,States/Local Areas,Guam,2021,Age,35 Months,72.4,57.0 to 85.9,64
Polio,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,82.1,61.7 to 95.5,161
PCV,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,69.6,59.1 to 79.5,161
Hep A,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,40.2,31.2 to 50.8,161
Hib,Primary Series,States/Local Areas,Guam,2020-2021,Age,7 Months,43.1,33.4 to 53.4,161
Hib,Primary Series,States/Local Areas,Guam,2021,Age,35 Months,74.6,59.1 to 87.9,64
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2021,Age,0-3 Days,84.4,72.4 to 91.8,64
Rotavirus,,States/Local Areas,Guam,2021,Age,8 Months,50.4,35.6 to 65.1,64
DTaP,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,46.4,36.3 to 56.8,161
DTaP,≥4 Doses,States/Local Areas,Guam,2020-2021,Age,19 Months,50.5,40.1 to 61.0,161
Hep B,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,5 Months,66.3,55.5 to 75.7,161
Hib,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,5 Months,49.5,39.1 to 59.9,161
Hib,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,62.2,51.4 to 71.9,161
Polio,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,3 Months,60.9,49.6 to 71.1,161
Hep A,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,54.0,35.7 to 74.6,161
≥1 Dose Varicella,,States/Local Areas,Guam,2020-2021,Age,24 Months,76.2,66.6 to 84.8,161
≥1 Dose Varicella,,States/Local Areas,Guam,2020-2021,Age,19 Months,74.1,63.6 to 82.4,161
Polio,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,70.1,59.8 to 79.8,161
Hib,≥2 Doses,States/Local Areas,Guam,2021,Age,13 Months,74.6,57.2 to 86.6,64
Hep B,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,71.3,61.3 to 80.6,161
DTaP,≥4 Doses,States/Local Areas,Guam,2020-2021,Age,35 Months,60.6,47.9 to 73.5,161
PCV,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,13 Months,64.5,53.5 to 74.2,161
≥1 Dose MMR,,States/Local Areas,Guam,2020-2021,Age,19 Months,75.1,64.5 to 83.3,161
Hib,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,35.3,26.5 to 45.3,161
DTaP,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,5 Months,50.0,39.5 to 60.4,161
Hep A,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,24 Months,73.4,63.2 to 82.7,161
≥1 Dose MMR,,States/Local Areas,Guam,2021,Age,13 Months,58.4,42.6 to 72.6,64
PCV,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,3 Months,57.4,46.4 to 67.8,161
Hib,≥3 Doses,States/Local Areas,Guam,2021,Age,35 Months,70.6,55.2 to 84.5,64
DTaP,≥4 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,55.0,44.7 to 65.8,161
Influenza,,States/Local Areas,Guam,2021,Age,24 Months,50.8,36.7 to 66.6,64
≥1 Dose Varicella,,States/Local Areas,Guam,2020-2021,Age,13 Months,49.3,39.3 to 59.3,161
Hib,Full Series,States/Local Areas,Guam,2020-2021,Age,24 Months,55.2,45.0 to 66.0,161
Polio,≥2 Doses,States/Local Areas,Guam,2021,Age,13 Months,73.7,56.4 to 85.8,64
Influenza,,States/Local Areas,Guam,2019,Age,24 Months,45.2,34.1 to 58.0,97
Influenza,,States/Local Areas,Guam,2018,Age,24 Months,55.5,45.6 to 65.9,140
Influenza,,States/Local Areas,Guam,2018-2019,Age,24 Months,50.4,42.7 to 58.7,237
Influenza,,States/Local Areas,Guam,2017,Age,24 Months,43.7,34.3 to 54.5,155
Influenza,,States/Local Areas,Guam,2017-2018,Age,24 Months,49.4,42.3 to 57.0,295
DTaP,≥2 Doses,States/Local Areas,Guam,2021,Age,5 Months,48.0,33.7 to 62.7,64
Polio,≥3 Doses,States/Local Areas,Guam,2021,Age,19 Months,72.4,55.4 to 84.7,64
Hib,≥2 Doses,States/Local Areas,Guam,2020-2021,Age,7 Months,66.0,55.3 to 75.4,161
Hep B,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,3 Months,89.9,82.2 to 94.5,161
≥1 Dose MMR,,States/Local Areas,Guam,2021,Age,35 Months,79.8,65.1 to 91.3,64
Hep B,≥1 Dose,States/Local Areas,Guam,2021,Age,3 Months,89.2,77.2 to 95.3,64
PCV,≥1 Dose,States/Local Areas,Guam,2021,Age,3 Months,55.8,40.2 to 70.3,64
Hep B,≥2 Doses,States/Local Areas,Guam,2021,Age,13 Months,77.2,60.7 to 88.2,64
Hib,≥2 Doses,States/Local Areas,Guam,2021,Age,5 Months,46.2,32.2 to 60.9,64
≥1 Dose MMR,,States/Local Areas,Guam,2021,Age,19 Months,79.8,63.0 to 90.2,64
≥1 Dose Varicella,,States/Local Areas,Guam,2021,Age,13 Months,51.4,36.5 to 66.1,64
Hib,≥1 Dose,States/Local Areas,Guam,2020-2021,Age,3 Months,58.9,47.8 to 69.1,161
DTaP,≥3 Doses,States/Local Areas,Guam,2020-2021,Age,24 Months,70.6,60.3 to 80.2,161
Influenza,,States/Local Areas,Guam,2013-2014,Age,24 Months,50.0,43.3 to 57.2,293
Hib,Full Series,States/Local Areas,Guam,2019,Age,35 Months,73.9,60.5 to 85.6,97
Hib,Full Series,States/Local Areas,Guam,2018,Age,35 Months,64.8,54.7 to 74.7,140
Hib,Full Series,States/Local Areas,Guam,2018-2019,Age,35 Months,70.8,61.5 to 79.6,237
Influenza,,States/Local Areas,Guam,2015-2016,Age,24 Months,56.2,50.3 to 62.2,460
Influenza,,States/Local Areas,Guam,2014,Age,24 Months,50.0,43.3 to 57.2,293
Influenza,,States/Local Areas,Guam,2016,Age,24 Months,58.8,50.4 to 67.3,218
Influenza,,States/Local Areas,Guam,2016-2017,Age,24 Months,51.5,45.1 to 58.3,373
≥1 Dose Varicella,,States/Local Areas,Guam,2019-2020,Age,19 Months,67.0,57.4 to 75.3,194
DTaP,≥3 Doses,States/Local Areas,Guam,2016,Age,19 Months,87.0,80.0 to 91.8,218
DTaP,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,83.3,77.7 to 87.7,373
DTaP,≥3 Doses,States/Local Areas,Guam,2015,Age,19 Months,84.0,80.9 to 86.6,242
DTaP,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,85.5,80.8 to 89.3,460
DTaP,≥3 Doses,States/Local Areas,Guam,2014,Age,19 Months,84.2,78.6 to 88.6,293
DTaP,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,84.1,79.8 to 87.6,535
Hib,≥3 Doses,States/Local Areas,Guam,2017,Age,19 Months,76.7,67.1 to 84.2,155
Hib,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,76.7,69.7 to 82.4,295
Polio,≥3 Doses,States/Local Areas,Guam,2016,Age,24 Months,87.2,81.1 to 92.1,218
Polio,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,82.4,77.1 to 87.0,373
Hib,≥3 Doses,States/Local Areas,Guam,2018,Age,19 Months,76.6,66.8 to 84.1,140
Hib,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,73.2,65.9 to 79.5,237
Polio,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,83.6,79.0 to 87.7,460
Polio,≥3 Doses,States/Local Areas,Guam,2014,Age,24 Months,82.4,77.0 to 87.1,293
Polio,≥3 Doses,States/Local Areas,Guam,2019,Age,19 Months,79.8,68.2 to 87.9,97
Hib,≥3 Doses,States/Local Areas,Guam,2014,Age,19 Months,79.8,73.8 to 84.6,293
Hib,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,78.8,74.1 to 82.9,535
Polio,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,82.4,77.0 to 87.1,293
Hib,≥3 Doses,States/Local Areas,Guam,2016,Age,19 Months,85.1,77.8 to 90.3,218
Hib,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,81.1,75.3 to 85.8,373
Hib,≥3 Doses,States/Local Areas,Guam,2015,Age,19 Months,77.8,74.2 to 81.1,242
Hib,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,81.7,76.5 to 85.9,460
Hib,Full Series,States/Local Areas,Guam,2018,Age,24 Months,62.6,52.7 to 72.6,140
Hib,Full Series,States/Local Areas,Guam,2018-2019,Age,24 Months,62.8,55.0 to 70.7,237
Hib,Full Series,States/Local Areas,Guam,2017,Age,24 Months,54.3,44.2 to 65.0,155
Hib,Full Series,States/Local Areas,Guam,2017-2018,Age,24 Months,58.4,51.2 to 65.8,295
Hib,Full Series,States/Local Areas,Guam,2016,Age,24 Months,64.8,56.5 to 73.1,218
Hib,Full Series,States/Local Areas,Guam,2016-2017,Age,24 Months,59.8,53.2 to 66.4,373
Polio,≥3 Doses,States/Local Areas,Guam,2018,Age,35 Months,77.2,68.2 to 85.2,140
Polio,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,80.5,73.5 to 86.6,237
Hib,Full Series,States/Local Areas,Guam,2016,Age,35 Months,73.4,64.2 to 82.0,218
Hib,Full Series,States/Local Areas,Guam,2016-2017,Age,35 Months,67.1,59.9 to 74.2,373
Hib,Full Series,States/Local Areas,Guam,2015-2016,Age,35 Months,72.7,65.8 to 79.3,460
Hib,≥3 Doses,States/Local Areas,Guam,2014,Age,24 Months,82.5,77.1 to 87.3,293
Polio,≥2 Doses,States/Local Areas,Guam,2020,Age,13 Months,78.4,64.4 to 88.0,97
Hib,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,82.5,77.1 to 87.3,293
Polio,≥3 Doses,States/Local Areas,Guam,2017,Age,24 Months,77.1,68.3 to 84.9,155
Polio,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,77.1,70.7 to 83.0,295
Hib,≥3 Doses,States/Local Areas,Guam,2019,Age,19 Months,80.7,69.1 to 88.7,97
Polio,≥3 Doses,States/Local Areas,Guam,2019,Age,24 Months,81.1,70.6 to 89.7,97
Polio,≥3 Doses,States/Local Areas,Guam,2018,Age,24 Months,77.2,68.2 to 85.2,140
Polio,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,79.1,72.3 to 85.2,237
Hib,Full Series,States/Local Areas,Guam,2015-2016,Age,24 Months,63.4,57.5 to 69.2,460
DTaP,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,86.1,81.0 to 90.5,293
DTaP,≥3 Doses,States/Local Areas,Guam,2019,Age,19 Months,80.7,69.1 to 88.7,97
DTaP,≥3 Doses,States/Local Areas,Guam,2018,Age,19 Months,77.6,68.0 to 85.0,140
DTaP,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,77.9,70.7 to 83.8,237
DTaP,≥3 Doses,States/Local Areas,Guam,2017,Age,19 Months,79.3,69.9 to 86.3,155
DTaP,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,78.4,71.7 to 83.9,295
Polio,≥3 Doses,States/Local Areas,Guam,2019,Age,35 Months,83.4,72.7 to 91.6,97
Hep B,≥3 Doses,States/Local Areas,Guam,2016,Age,19 Months,85.3,78.6 to 90.2,218
Hep B,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,79.3,73.4 to 84.2,373
PCV,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,3 Months,75.1,70.7 to 79.0,293
Polio,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,86.2,81.5 to 90.2,460
Hib,Full Series,States/Local Areas,Guam,2017,Age,35 Months,60.9,50.1 to 71.8,155
Hib,Full Series,States/Local Areas,Guam,2017-2018,Age,35 Months,63.1,55.5 to 70.7,295
Polio,≥3 Doses,States/Local Areas,Guam,2017,Age,35 Months,80.9,71.2 to 88.9,155
Polio,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,79.6,72.4 to 85.9,295
Polio,≥3 Doses,States/Local Areas,Guam,2016,Age,35 Months,88.2,82.2 to 93.0,218
Polio,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,84.7,79.2 to 89.4,373
Polio,≥3 Doses,States/Local Areas,Guam,2014,Age,35 Months,87.6,81.7 to 92.2,293
Polio,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,87.6,81.7 to 92.2,293
Hib,Full Series,States/Local Areas,Guam,2014,Age,35 Months,68.2,61.0 to 75.2,293
Hib,Full Series,States/Local Areas,Guam,2013-2014,Age,35 Months,68.2,61.0 to 75.2,293
Hib,Full Series,States/Local Areas,Guam,2019,Age,24 Months,62.6,50.7 to 74.5,97
DTaP,≥2 Doses,States/Local Areas,Guam,2014,Age,5 Months,62.8,56.1 to 69.1,293
DTaP,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,5 Months,58.6,52.6 to 64.4,535
DTaP,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,5 Months,62.8,55.1 to 70.0,293
DTaP,≥2 Doses,States/Local Areas,Guam,2016,Age,5 Months,67.2,58.8 to 74.7,218
DTaP,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,5 Months,63.1,56.5 to 69.4,373
DTaP,≥2 Doses,States/Local Areas,Guam,2015,Age,5 Months,54.4,46.5 to 62.0,242
DTaP,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,5 Months,61.1,55.4 to 66.6,460
Hep A,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,32.2,26.4 to 38.9,293
DTaP,≥4 Doses,States/Local Areas,Guam,2018,Age,19 Months,53.8,43.6 to 63.7,140
DTaP,≥4 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,84.6,78.2 to 89.4,237
DTaP,≥4 Doses,States/Local Areas,Guam,2017,Age,19 Months,49.7,39.5 to 60.0,155
DTaP,≥4 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,51.8,44.4 to 59.0,295
DTaP,≥4 Doses,States/Local Areas,Guam,2016,Age,19 Months,54.2,45.9 to 62.3,218
DTaP,≥4 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,52.1,45.5 to 58.6,373
PCV,≥2 Doses,States/Local Areas,Guam,2019,Age,5 Months,66.1,54.1 to 76.4,97
PCV,≥2 Doses,States/Local Areas,Guam,2018,Age,5 Months,61.0,50.6 to 70.4,140
PCV,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,5 Months,63.5,55.7 to 70.7,237
Hib,≥3 Doses,States/Local Areas,Guam,2019,Age,35 Months,84.0,73.2 to 92.1,97
Hep A,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,42.7,36.8 to 49.1,460
Hep A,≥2 Doses,States/Local Areas,Guam,2014,Age,24 Months,32.2,26.4 to 38.9,293
Hep A,≥1 Dose,States/Local Areas,Guam,2014,Age,35 Months,84.6,78.3 to 90.0,293
Hep A,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,35 Months,84.6,78.3 to 90.0,293
Hep B,≥2 Doses,States/Local Areas,Guam,2017,Age,5 Months,76.2,66.1 to 84.1,155
Hep B,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,5 Months,75.8,68.4 to 81.9,295
Hep B,≥2 Doses,States/Local Areas,Guam,2016,Age,5 Months,81.4,74.0 to 87.1,218
Hep B,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,5 Months,79.0,72.9 to 84.0,373
Hep B,≥3 Doses,States/Local Areas,Guam,2018,Age,19 Months,71.1,60.9 to 79.6,140
Hep B,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,67.8,59.9 to 74.8,237
Hep B,≥3 Doses,States/Local Areas,Guam,2017,Age,19 Months,72.7,62.4 to 81.0,155
Hep B,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,71.9,64.6 to 78.2,295
PCV,≥3 Doses,States/Local Areas,Guam,2014,Age,7 Months,47.6,41.0 to 54.2,293
PCV,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,45.4,40.5 to 50.5,535
PCV,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,47.6,37.9 to 57.4,293
Hep B,≥2 Doses,States/Local Areas,Guam,2015,Age,5 Months,83.5,76.9 to 88.5,242
Hep B,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,5 Months,82.4,77.6 to 86.4,460
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2015,Age,0-1 Days,89.0,83.3 to 92.9,242
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2015-2016,Age,0-1 Days,91.6,88.4 to 94.0,460
Polio,≥2 Doses,States/Local Areas,Guam,2016,Age,7 Months,78.5,70.6 to 84.8,218
Polio,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,74.3,67.9 to 79.8,373
Polio,≥2 Doses,States/Local Areas,Guam,2015,Age,7 Months,78.2,70.6 to 84.3,242
Polio,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,78.4,73.0 to 82.9,460
Polio,≥2 Doses,States/Local Areas,Guam,2014,Age,7 Months,76.6,70.5 to 81.8,293
Polio,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,77.4,72.7 to 81.5,535
≥1 Dose Varicella,,States/Local Areas,Guam,2017,Age,13 Months,47.3,37.2 to 57.5,155
≥1 Dose Varicella,,States/Local Areas,Guam,2017-2018,Age,13 Months,51.7,44.4 to 58.9,295
≥1 Dose Varicella,,States/Local Areas,Guam,2016,Age,13 Months,51.8,43.6 to 60.0,218
≥1 Dose Varicella,,States/Local Areas,Guam,2016-2017,Age,13 Months,49.7,43.1 to 56.2,373
≥1 Dose MMR,,States/Local Areas,Guam,2013-2014,Age,13 Months,52.9,46.9 to 58.8,293
Polio,≥2 Doses,States/Local Areas,Guam,2018,Age,7 Months,76.4,66.9 to 83.8,140
Polio,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,76.2,68.9 to 82.2,237
Polio,≥2 Doses,States/Local Areas,Guam,2017,Age,7 Months,69.6,59.1 to 78.4,155
Polio,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,73.0,65.8 to 79.1,295
Hep B,≥1 Dose,States/Local Areas,Guam,2014,Age,3 Months,97.0,93.7 to 98.6,293
Hep B,≥1 Dose,States/Local Areas,Guam,2014-2015,Age,3 Months,95.9,93.1 to 97.6,535
Hep B,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,3 Months,97.0,93.0 to 98.8,293
Hep B,≥3 Doses,States/Local Areas,Guam,2017,Age,13 Months,66.9,56.4 to 75.9,155
Hep B,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,66.9,59.5 to 73.5,295
Hep B,≥3 Doses,States/Local Areas,Guam,2015,Age,13 Months,80.0,73.0 to 85.5,242
Hep B,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,80.2,75.3 to 84.4,460
Hep B,≥3 Doses,States/Local Areas,Guam,2016,Age,13 Months,80.5,73.0 to 86.3,218
Hep B,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,74.0,67.7 to 79.5,373
DTaP,≥4 Doses,States/Local Areas,Guam,2017,Age,35 Months,63.8,52.2 to 75.4,155
DTaP,≥4 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,64.6,56.3 to 72.8,295
DTaP,≥4 Doses,States/Local Areas,Guam,2016,Age,35 Months,72.3,63.1 to 80.8,218
DTaP,≥4 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,68.4,60.8 to 75.8,373
DTaP,≥4 Doses,States/Local Areas,Guam,2018,Age,35 Months,63.9,53.5 to 74.1,140
DTaP,≥4 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,71.8,62.5 to 80.6,237
DTaP,≥4 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,73.8,66.9 to 80.2,460
DTaP,≥4 Doses,States/Local Areas,Guam,2014,Age,35 Months,75.2,68.0 to 81.9,293
DTaP,≥4 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,75.2,68.0 to 81.9,293
Hep A,≥2 Doses,States/Local Areas,Guam,2019,Age,35 Months,62.0,47.3 to 76.9,97
Hep A,≥2 Doses,States/Local Areas,Guam,2018,Age,35 Months,49.4,38.8 to 61.1,140
Hep A,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,56.9,47.2 to 67.0,237
Hep A,≥2 Doses,States/Local Areas,Guam,2017,Age,35 Months,54.4,42.6 to 66.9,155
Hep A,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,52.8,44.4 to 61.7,295
Hep B,≥3 Doses,States/Local Areas,Guam,2014,Age,13 Months,76.2,70.0 to 81.5,293
Hep B,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,78.1,73.5 to 82.0,535
Hep B,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,76.2,74.8 to 77.6,293
≥1 Dose Varicella,,States/Local Areas,Guam,2013-2014,Age,19 Months,67.3,56.6 to 76.4,293
≥1 Dose Varicella,,States/Local Areas,Guam,2019,Age,13 Months,53.5,41.5 to 65.2,97
≥1 Dose Varicella,,States/Local Areas,Guam,2018,Age,13 Months,56.1,46.0 to 65.7,140
≥1 Dose Varicella,,States/Local Areas,Guam,2018-2019,Age,13 Months,54.9,47.0 to 62.5,237
≥1 Dose MMR,,States/Local Areas,Guam,2016,Age,13 Months,55.2,46.8 to 63.3,218
≥1 Dose MMR,,States/Local Areas,Guam,2016-2017,Age,13 Months,53.5,46.9 to 60.1,373
≥1 Dose MMR,,States/Local Areas,Guam,2015,Age,13 Months,46.9,39.4 to 54.6,242
≥1 Dose MMR,,States/Local Areas,Guam,2015-2016,Age,13 Months,51.3,45.6 to 56.9,460
≥1 Dose MMR,,States/Local Areas,Guam,2014,Age,13 Months,52.9,46.1 to 59.5,293
≥1 Dose MMR,,States/Local Areas,Guam,2014-2015,Age,13 Months,49.9,44.8 to 55.1,535
DTaP,≥4 Doses,States/Local Areas,Guam,2019,Age,35 Months,76.7,63.4 to 87.9,97
≥1 Dose Varicella,,States/Local Areas,Guam,2018,Age,19 Months,69.4,59.3 to 77.9,140
≥1 Dose Varicella,,States/Local Areas,Guam,2018-2019,Age,19 Months,54.9,47.0 to 62.5,237
≥1 Dose Varicella,,States/Local Areas,Guam,2017,Age,19 Months,73.4,63.4 to 81.4,155
≥1 Dose Varicella,,States/Local Areas,Guam,2017-2018,Age,19 Months,71.4,64.5 to 77.4,295
≥1 Dose MMR,,States/Local Areas,Guam,2014,Age,19 Months,80.1,73.9 to 85.1,293
≥1 Dose MMR,,States/Local Areas,Guam,2014-2015,Age,19 Months,77.0,72.2 to 81.2,535
≥1 Dose MMR,,States/Local Areas,Guam,2013-2014,Age,19 Months,80.1,73.5 to 85.3,293
Hep B,≥3 Doses,States/Local Areas,Guam,2019,Age,13 Months,68.8,56.3 to 79.1,97
Hep B,≥3 Doses,States/Local Areas,Guam,2018,Age,13 Months,66.8,56.6 to 75.7,140
Hep B,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,67.8,59.9 to 74.8,237
Hep A,≥1 Dose,States/Local Areas,Guam,2020,Age,35 Months,70.8,57.0 to 83.4,97
Polio,≥2 Doses,States/Local Areas,Guam,2019,Age,7 Months,76.0,64.3 to 84.7,97
Hep B,≥1 Dose,States/Local Areas,Guam,2017,Age,3 Months,94.8,87.7 to 97.9,155
Hep B,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,3 Months,95.0,91.1 to 97.2,295
Hep B,≥1 Dose,States/Local Areas,Guam,2016,Age,3 Months,98.0,95.6 to 99.1,218
Hep B,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,3 Months,96.5,93.2 to 98.2,373
Hep B,≥1 Dose,States/Local Areas,Guam,2015,Age,3 Months,94.8,89.5 to 97.5,242
Hep B,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,3 Months,96.5,93.9 to 98.0,460
Polio,≥2 Doses,States/Local Areas,Guam,2014,Age,13 Months,87.1,82.1 to 90.8,293
Polio,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,87.7,83.9 to 90.7,535
Polio,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,87.1,85.3 to 88.7,293
≥1 Dose Varicella,,States/Local Areas,Guam,2016,Age,19 Months,75.6,67.8 to 82.0,218
≥1 Dose Varicella,,States/Local Areas,Guam,2016-2017,Age,19 Months,74.5,68.4 to 79.8,373
≥1 Dose Varicella,,States/Local Areas,Guam,2015,Age,19 Months,67.3,56.2 to 76.7,242
≥1 Dose Varicella,,States/Local Areas,Guam,2015-2016,Age,19 Months,71.7,66.3 to 76.5,460
≥1 Dose Varicella,,States/Local Areas,Guam,2014,Age,19 Months,67.3,60.5 to 73.4,293
≥1 Dose Varicella,,States/Local Areas,Guam,2014-2015,Age,19 Months,67.3,62.3 to 71.9,535
≥1 Dose MMR,,States/Local Areas,Guam,2019,Age,13 Months,55.2,43.1 to 66.8,97
≥1 Dose MMR,,States/Local Areas,Guam,2018,Age,13 Months,55.3,45.0 to 65.1,140
≥1 Dose MMR,,States/Local Areas,Guam,2018-2019,Age,13 Months,55.3,47.3 to 62.9,237
≥1 Dose MMR,,States/Local Areas,Guam,2017,Age,13 Months,51.7,41.3 to 61.9,155
≥1 Dose MMR,,States/Local Areas,Guam,2017-2018,Age,13 Months,53.5,46.1 to 60.7,295
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2014,Age,0-1 Days,84.1,78.5 to 88.5,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2014-2015,Age,0-1 Days,86.6,82.7 to 89.7,535
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2013-2014,Age,0-1 Days,84.1,79.8 to 87.7,293
Polio,≥2 Doses,States/Local Areas,Guam,2019,Age,13 Months,86.9,76.6 to 93.0,97
Polio,≥2 Doses,States/Local Areas,Guam,2018,Age,13 Months,82.6,73.6 to 88.9,140
Polio,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,84.6,78.2 to 89.4,237
≥1 Dose Varicella,,States/Local Areas,Guam,2014,Age,24 Months,76.3,70.1 to 82.0,293
≥1 Dose Varicella,,States/Local Areas,Guam,2013-2014,Age,24 Months,76.3,70.1 to 82.0,293
≥1 Dose Varicella,,States/Local Areas,Guam,2017,Age,24 Months,74.6,65.3 to 83.0,155
≥1 Dose Varicella,,States/Local Areas,Guam,2017-2018,Age,24 Months,73.3,66.6 to 79.6,295
≥1 Dose Varicella,,States/Local Areas,Guam,2016,Age,24 Months,77.4,70.0 to 84.1,218
≥1 Dose Varicella,,States/Local Areas,Guam,2016-2017,Age,24 Months,76.1,70.2 to 81.5,373
≥1 Dose Varicella,,States/Local Areas,Guam,2015-2016,Age,24 Months,75.8,70.5 to 80.7,460
≥1 Dose MMR,,States/Local Areas,Guam,2019,Age,19 Months,66.8,53.9 to 77.5,97
PCV,≥4 Doses,States/Local Areas,Guam,2014,Age,19 Months,59.2,52.4 to 65.7,293
PCV,≥4 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,57.9,52.6 to 63.0,535
≥1 Dose MMR,,States/Local Areas,Guam,2018,Age,19 Months,67.2,56.7 to 76.1,140
≥1 Dose MMR,,States/Local Areas,Guam,2018-2019,Age,19 Months,85.1,78.7 to 89.9,237
PCV,≥4 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,59.2,52.4 to 65.8,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2018,Age,0-1 Days,83.6,73.9 to 90.2,140
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2018-2019,Age,0-1 Days,84.7,77.8 to 89.7,237
Hep B,≥2 Doses,States/Local Areas,Guam,2018,Age,5 Months,75.3,64.8 to 83.5,140
Hep B,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,5 Months,76.2,68.3 to 82.7,237
Hep B,≥2 Doses,States/Local Areas,Guam,2019,Age,5 Months,77.2,64.4 to 86.4,97
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2017,Age,0-1 Days,85.4,76.5 to 91.3,155
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2017-2018,Age,0-1 Days,84.5,78.3 to 89.2,295
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2016,Age,0-1 Days,94.0,90.1 to 96.4,218
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2016-2017,Age,0-1 Days,89.9,85.3 to 93.2,373
DTaP,≥4 Doses,States/Local Areas,Guam,2018,Age,24 Months,59.4,49.5 to 69.5,140
DTaP,≥4 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,61.9,54.0 to 69.8,237
DTaP,≥4 Doses,States/Local Areas,Guam,2019,Age,24 Months,63.9,51.9 to 75.8,97
≥1 Dose Varicella,,States/Local Areas,Guam,2013-2014,Age,13 Months,43.5,35.6 to 51.8,293
Polio,≥2 Doses,States/Local Areas,Guam,2018,Age,5 Months,61.6,51.3 to 71.0,140
Polio,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,5 Months,62.8,54.9 to 70.0,237
Hep A,≥1 Dose,States/Local Areas,Guam,2019,Age,35 Months,86.0,72.8 to 94.8,97
≥1 Dose Varicella,,States/Local Areas,Guam,2015,Age,13 Months,41.0,33.8 to 48.7,242
≥1 Dose Varicella,,States/Local Areas,Guam,2015-2016,Age,13 Months,46.7,41.2 to 52.3,460
≥1 Dose Varicella,,States/Local Areas,Guam,2014,Age,13 Months,43.5,37.1 to 50.2,293
≥1 Dose Varicella,,States/Local Areas,Guam,2014-2015,Age,13 Months,42.3,37.4 to 47.4,535
Hep A,≥2 Doses,States/Local Areas,Guam,2016,Age,35 Months,65.3,55.4 to 75.0,218
Hep A,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,60.0,52.1 to 68.1,373
Hep A,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,60.6,53.3 to 68.0,460
Hep A,≥2 Doses,States/Local Areas,Guam,2014,Age,35 Months,64.1,52.6 to 75.5,293
Hep B,≥3 Doses,States/Local Areas,Guam,2019,Age,7 Months,47.1,35.5 to 59.1,97
Polio,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,76.6,71.5 to 81.1,293
Hep B,≥3 Doses,States/Local Areas,Guam,2018,Age,7 Months,47.7,37.7 to 57.9,140
Hep B,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,47.4,39.7 to 55.3,237
Hep B,≥3 Doses,States/Local Areas,Guam,2017,Age,7 Months,46.8,36.9 to 57.1,155
Hep B,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,47.3,40.1 to 54.6,295
Polio,≥2 Doses,States/Local Areas,Guam,2019,Age,5 Months,64.0,51.8 to 74.6,97
Hep B,≥3 Doses,States/Local Areas,Guam,2015,Age,7 Months,49.1,41.5 to 56.8,242
Hep B,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,54.4,48.7 to 59.9,460
Hep B,≥3 Doses,States/Local Areas,Guam,2014,Age,7 Months,48.1,41.5 to 54.8,293
Hep B,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,48.6,43.6 to 53.7,535
Polio,≥2 Doses,States/Local Areas,Guam,2017,Age,5 Months,59.2,48.6 to 69.0,155
Polio,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,5 Months,60.4,52.9 to 67.4,295
Polio,≥2 Doses,States/Local Areas,Guam,2016,Age,5 Months,68.4,60.0 to 75.7,218
Polio,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,5 Months,64.0,57.3 to 70.2,373
Hep A,≥1 Dose,States/Local Areas,Guam,2018,Age,35 Months,76.7,66.9 to 85.4,140
Hep A,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,35 Months,82.2,73.7 to 89.3,237
Hep A,≥1 Dose,States/Local Areas,Guam,2017,Age,35 Months,81.8,71.0 to 90.5,155
Hep A,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,35 Months,79.5,72.3 to 85.8,295
Hep A,≥1 Dose,States/Local Areas,Guam,2016,Age,35 Months,84.9,77.8 to 90.6,218
Hep A,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,35 Months,83.3,77.3 to 88.5,373
Hep A,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,64.1,52.6 to 75.5,293
Hep A,≥2 Doses,States/Local Areas,Guam,2019,Age,24 Months,41.1,30.2 to 54.0,97
Hep B,≥3 Doses,States/Local Areas,Guam,2016,Age,7 Months,59.1,50.8 to 66.9,218
Hep B,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,53.3,46.7 to 59.7,373
Polio,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,5 Months,62.2,56.5 to 67.6,460
DTaP,≥4 Doses,States/Local Areas,Guam,2016,Age,24 Months,63.0,54.6 to 71.4,218
DTaP,≥4 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,58.4,51.7 to 65.2,373
DTaP,≥4 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,62.4,56.5 to 68.2,460
DTaP,≥4 Doses,States/Local Areas,Guam,2017,Age,24 Months,53.4,43.3 to 64.1,155
DTaP,≥4 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,56.3,49.1 to 63.8,295
DTaP,≥4 Doses,States/Local Areas,Guam,2019,Age,19 Months,52.2,40.3 to 64.0,97
Hep B,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,48.1,39.2 to 57.2,293
Polio,≥2 Doses,States/Local Areas,Guam,2015,Age,5 Months,55.4,47.5 to 63.0,242
Polio,≥2 Doses,States/Local Areas,Guam,2014,Age,5 Months,61.8,55.0 to 68.1,293
Polio,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,5 Months,58.6,53.0 to 64.0,535
Polio,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,5 Months,61.8,55.0 to 68.1,293
Hep A,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,35 Months,86.3,81.3 to 90.6,460
Hep A,≥2 Doses,States/Local Areas,Guam,2018,Age,24 Months,39.4,30.0 to 50.6,140
Hep A,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,40.4,33.0 to 48.8,237
DTaP,≥4 Doses,States/Local Areas,Guam,2014,Age,24 Months,64.9,58.2 to 71.6,293
Hep A,≥2 Doses,States/Local Areas,Guam,2017,Age,24 Months,36.4,27.0 to 47.7,155
Hep A,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,38.0,31.1 to 45.8,295
Hep A,≥2 Doses,States/Local Areas,Guam,2016,Age,24 Months,48.0,39.3 to 57.5,218
Hep A,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,42.4,35.8 to 49.7,373
DTaP,≥4 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,64.9,58.2 to 71.6,293
Hep B,≥3 Doses,States/Local Areas,Guam,2020,Age,24 Months,76.0,62.8 to 87.2,97
Polio,≥2 Doses,States/Local Areas,Guam,2017,Age,13 Months,78.2,68.5 to 85.6,155
Polio,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,80.4,73.7 to 85.7,295
Polio,≥2 Doses,States/Local Areas,Guam,2016,Age,13 Months,87.6,80.3 to 92.4,218
Polio,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,83.1,77.4 to 87.7,373
Polio,≥2 Doses,States/Local Areas,Guam,2015,Age,13 Months,88.2,82.0 to 92.5,242
Polio,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,87.9,83.3 to 91.3,460
Hep B,≥1 Dose,States/Local Areas,Guam,2019,Age,3 Months,95.4,88.7 to 98.2,97
≥1 Dose Varicella,,States/Local Areas,Guam,2019,Age,19 Months,66.0,53.2 to 76.8,97
Hep B,≥1 Dose,States/Local Areas,Guam,2018,Age,3 Months,95.2,90.2 to 97.7,140
Hep B,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,3 Months,95.3,91.7 to 97.4,237
≥1 Dose MMR,,States/Local Areas,Guam,2017,Age,19 Months,79.3,70.2 to 86.3,155
≥1 Dose MMR,,States/Local Areas,Guam,2017-2018,Age,19 Months,73.3,66.5 to 79.1,295
≥1 Dose MMR,,States/Local Areas,Guam,2016,Age,19 Months,79.7,72.1 to 85.6,218
≥1 Dose MMR,,States/Local Areas,Guam,2016-2017,Age,19 Months,79.5,73.8 to 84.2,373
≥1 Dose MMR,,States/Local Areas,Guam,2015,Age,19 Months,73.9,66.5 to 80.1,242
≥1 Dose MMR,,States/Local Areas,Guam,2015-2016,Age,19 Months,76.9,71.6 to 81.5,460
≥1 Dose Varicella,,States/Local Areas,Guam,2016,Age,35 Months,80.7,73.2 to 87.2,218
≥1 Dose Varicella,,States/Local Areas,Guam,2016-2017,Age,35 Months,79.8,73.7 to 85.3,373
≥1 Dose MMR,,States/Local Areas,Guam,2013-2014,Age,35 Months,87.0,81.3 to 91.7,293
≥1 Dose MMR,,States/Local Areas,Guam,2019,Age,24 Months,75.2,63.2 to 85.6,97
PCV,≥4 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,61.5,55.7 to 67.4,460
PCV,≥4 Doses,States/Local Areas,Guam,2014,Age,24 Months,65.1,58.5 to 71.7,293
PCV,≥4 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,65.1,58.5 to 71.7,293
Hep B,≥3 Doses,States/Local Areas,Guam,2019,Age,24 Months,72.8,61.2 to 83.4,97
Hep B,≥3 Doses,States/Local Areas,Guam,2015,Age,19 Months,82.2,79.1 to 85.0,242
Hep B,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,83.9,79.2 to 87.6,460
Hep B,≥3 Doses,States/Local Areas,Guam,2014,Age,19 Months,81.8,75.9 to 86.5,293
Hep B,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,82.0,77.6 to 85.6,535
Hep B,≥2 Doses,States/Local Areas,Guam,2014,Age,5 Months,81.7,75.8 to 86.4,293
Hep B,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,5 Months,82.6,80.2 to 84.7,535
Hep B,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,81.8,79.3 to 84.0,293
Hep B,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,5 Months,81.7,77.5 to 85.1,293
PCV,≥4 Doses,States/Local Areas,Guam,2019,Age,35 Months,74.6,59.2 to 87.7,97
PCV,≥4 Doses,States/Local Areas,Guam,2018,Age,35 Months,64.1,53.8 to 74.3,140
PCV,≥4 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,70.5,60.4 to 79.9,237
PCV,≥4 Doses,States/Local Areas,Guam,2017,Age,35 Months,58.4,47.3 to 69.8,155
PCV,≥4 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,61.5,53.7 to 69.4,295
≥1 Dose Varicella,,States/Local Areas,Guam,2015-2016,Age,35 Months,81.8,76.3 to 86.7,460
≥1 Dose Varicella,,States/Local Areas,Guam,2014,Age,35 Months,80.6,74.4 to 86.1,293
≥1 Dose Varicella,,States/Local Areas,Guam,2013-2014,Age,35 Months,80.6,74.4 to 86.1,293
≥1 Dose MMR,,States/Local Areas,Guam,2018,Age,24 Months,71.0,61.2 to 80.1,140
≥1 Dose MMR,,States/Local Areas,Guam,2018-2019,Age,24 Months,73.1,65.4 to 80.3,237
PCV,≥4 Doses,States/Local Areas,Guam,2019,Age,19 Months,52.9,40.9 to 64.6,97
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2015,Age,0-2 Days,90.1,84.5 to 93.8,242
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2015-2016,Age,0-2 Days,92.5,89.4 to 94.8,460
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2014,Age,0-2 Days,84.9,79.3 to 89.1,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2014-2015,Age,0-2 Days,87.5,83.7 to 90.5,535
PCV,≥4 Doses,States/Local Areas,Guam,2016,Age,19 Months,54.7,46.4 to 62.8,218
PCV,≥4 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,49.7,43.3 to 56.1,373
PCV,≥4 Doses,States/Local Areas,Guam,2015,Age,19 Months,56.5,52.2 to 60.7,242
PCV,≥4 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,55.6,49.8 to 61.2,460
PCV,≥3 Doses,States/Local Areas,Guam,2015,Age,7 Months,43.3,35.9 to 51.0,242
PCV,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,49.3,43.7 to 54.9,460
PCV,≥3 Doses,States/Local Areas,Guam,2017,Age,7 Months,43.4,33.8 to 53.5,155
PCV,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,49.9,42.6 to 57.1,295
PCV,≥3 Doses,States/Local Areas,Guam,2016,Age,7 Months,54.7,46.5 to 62.7,218
PCV,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,49.4,42.9 to 55.8,373
Hep B,≥3 Doses,States/Local Areas,Guam,2014,Age,24 Months,84.1,78.6 to 88.7,293
Hep B,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,84.1,78.6 to 88.7,293
Hep B,≥3 Doses,States/Local Areas,Guam,2019,Age,19 Months,71.9,59.3 to 81.8,97
≥1 Dose Varicella,,States/Local Areas,Guam,2018,Age,24 Months,72.0,62.1 to 81.2,140
≥1 Dose Varicella,,States/Local Areas,Guam,2018-2019,Age,24 Months,73.1,65.3 to 80.3,237
≥1 Dose MMR,,States/Local Areas,Guam,2015-2016,Age,24 Months,80.2,75.2 to 84.8,460
≥1 Dose MMR,,States/Local Areas,Guam,2014,Age,24 Months,83.1,77.4 to 88.0,293
≥1 Dose MMR,,States/Local Areas,Guam,2013-2014,Age,24 Months,83.1,77.4 to 88.0,293
≥1 Dose Varicella,,States/Local Areas,Guam,2019,Age,24 Months,74.1,62.1 to 84.7,97
PCV,≥4 Doses,States/Local Areas,Guam,2017,Age,19 Months,44.1,34.5 to 54.2,155
Hep B,≥3 Doses,States/Local Areas,Guam,2019,Age,35 Months,72.8,61.2 to 83.4,97
PCV,≥3 Doses,States/Local Areas,Guam,2017,Age,19 Months,76.2,65.9 to 84.1,155
PCV,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,75.3,68.2 to 81.3,295
PCV,≥4 Doses,States/Local Areas,Guam,2016,Age,35 Months,71.0,61.7 to 79.7,218
PCV,≥4 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,64.7,57.3 to 71.9,373
PCV,≥4 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,70.4,63.7 to 76.9,460
PCV,≥4 Doses,States/Local Areas,Guam,2014,Age,35 Months,72.6,64.6 to 80.0,293
Hib,≥1 Dose,States/Local Areas,Guam,2019,Age,3 Months,76.5,64.7 to 85.3,97
Hib,≥1 Dose,States/Local Areas,Guam,2018,Age,3 Months,75.5,65.9 to 83.1,140
Hib,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,3 Months,76.0,68.7 to 82.1,237
Hep B,≥2 Doses,States/Local Areas,Guam,2014,Age,13 Months,92.5,88.3 to 95.3,293
Hep B,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,91.9,88.7 to 94.3,535
Hib,≥1 Dose,States/Local Areas,Guam,2014,Age,3 Months,76.6,70.4 to 81.8,293
Hib,≥1 Dose,States/Local Areas,Guam,2014-2015,Age,3 Months,76.4,71.7 to 80.5,535
Hep B,≥2 Doses,States/Local Areas,Guam,2015,Age,13 Months,91.3,85.8 to 94.9,242
Hep B,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,92.5,88.8 to 95.0,460
Hep B,≥2 Doses,States/Local Areas,Guam,2016,Age,13 Months,93.5,87.8 to 96.6,218
Hep B,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,87.6,82.2 to 91.5,373
PCV,≥3 Doses,States/Local Areas,Guam,2016,Age,13 Months,77.6,69.9 to 83.7,218
PCV,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,70.1,63.5 to 76.0,373
Hep B,≥3 Doses,States/Local Areas,Guam,2018,Age,24 Months,72.3,62.7 to 81.2,140
Hep B,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,72.5,65.0 to 79.6,237
PCV,≥3 Doses,States/Local Areas,Guam,2015,Age,13 Months,72.1,64.2 to 78.8,242
PCV,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,75.0,69.6 to 79.7,460
PCV,≥3 Doses,States/Local Areas,Guam,2014,Age,13 Months,77.2,71.2 to 82.3,293
PCV,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,74.7,69.8 to 78.9,535
Hep B,≥2 Doses,States/Local Areas,Guam,2018,Age,7 Months,83.0,74.2 to 89.2,140
Hep B,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,85.2,79.0 to 89.9,237
Hep B,≥2 Doses,States/Local Areas,Guam,2017,Age,7 Months,77.1,67.0 to 84.8,155
Hep B,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,80.0,73.2 to 85.4,295
Hep B,≥2 Doses,States/Local Areas,Guam,2016,Age,7 Months,87.4,80.8 to 92.0,218
Hep B,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,82.5,76.6 to 87.2,373
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2016,Age,0-2 Days,94.7,91.0 to 96.9,218
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2016-2017,Age,0-2 Days,90.6,86.0 to 93.8,373
Hib,Primary Series,States/Local Areas,Guam,2020,Age,24 Months,66.2,52.3 to 79.6,97
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2019,Age,0-2 Days,85.8,74.7 to 92.5,97
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2018,Age,0-2 Days,86.3,78.0 to 91.7,140
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2018-2019,Age,0-2 Days,86.1,79.6 to 90.7,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2017,Age,0-2 Days,86.0,77.0 to 91.9,155
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2017-2018,Age,0-2 Days,86.2,80.4 to 90.4,295
≥1 Dose MMR,,States/Local Areas,Guam,2014,Age,35 Months,87.0,81.3 to 91.7,293
≥1 Dose Varicella,,States/Local Areas,Guam,2018,Age,35 Months,72.3,62.4 to 81.5,140
≥1 Dose Varicella,,States/Local Areas,Guam,2018-2019,Age,35 Months,78.1,69.4 to 85.8,237
≥1 Dose Varicella,,States/Local Areas,Guam,2017,Age,35 Months,79.0,68.8 to 87.6,155
≥1 Dose Varicella,,States/Local Areas,Guam,2017-2018,Age,35 Months,75.9,68.8 to 82.5,295
≥1 Dose MMR,,States/Local Areas,Guam,2017,Age,24 Months,80.7,72.3 to 87.9,155
≥1 Dose MMR,,States/Local Areas,Guam,2017-2018,Age,24 Months,75.8,69.5 to 81.8,295
≥1 Dose MMR,,States/Local Areas,Guam,2016,Age,24 Months,80.6,73.5 to 86.8,218
≥1 Dose MMR,,States/Local Areas,Guam,2016-2017,Age,24 Months,80.7,75.3 to 85.6,373
PCV,≥4 Doses,States/Local Areas,Guam,2018,Age,19 Months,55.8,45.5 to 65.6,140
PCV,≥4 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,50.8,41.5 to 60.1,194
PCV,≥4 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,49.9,42.7 to 57.2,295
Hep B,≥3 Doses,States/Local Areas,Guam,2017,Age,24 Months,72.7,63.1 to 81.6,155
Hep B,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,72.4,65.5 to 79.0,295
Hep B,≥3 Doses,States/Local Areas,Guam,2016,Age,24 Months,86.3,80.0 to 91.4,218
Hep B,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,79.8,74.1 to 84.9,373
Hep B,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,85.2,80.9 to 89.0,460
PCV,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,77.2,71.9 to 81.7,293
PCV,≥3 Doses,States/Local Areas,Guam,2019,Age,7 Months,49.6,37.9 to 61.3,97
PCV,≥3 Doses,States/Local Areas,Guam,2018,Age,7 Months,56.3,46.1 to 66.0,140
PCV,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,53.1,45.2 to 60.8,237
Hep B,≥2 Doses,States/Local Areas,Guam,2015,Age,7 Months,87.4,81.2 to 91.8,242
Hep B,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,87.4,83.1 to 90.8,460
Hep B,≥2 Doses,States/Local Areas,Guam,2014,Age,7 Months,88.6,83.7 to 92.2,293
Hep B,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,88.0,84.2 to 91.0,535
Hep B,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,88.6,82.8 to 92.6,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Guam,2013-2014,Age,0-2 Days,84.9,79.1 to 89.2,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Guam,2019,Age,0-1 Days,85.8,74.7 to 92.5,97
PCV,≥4 Doses,States/Local Areas,Guam,2020,Age,35 Months,55.6,42.3 to 70.0,97
Hib,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,79.8,77.1 to 82.2,293
Hib,≥3 Doses,States/Local Areas,Guam,2019,Age,13 Months,75.5,64.0 to 84.2,97
Hib,≥3 Doses,States/Local Areas,Guam,2017,Age,13 Months,63.7,53.1 to 73.0,155
Hib,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,67.4,60.1 to 73.9,295
Hib,≥3 Doses,States/Local Areas,Guam,2016,Age,13 Months,77.8,70.1 to 84.0,218
Hib,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,71.1,64.6 to 76.8,373
Hib,≥3 Doses,States/Local Areas,Guam,2015,Age,13 Months,70.7,62.7 to 77.7,242
Hib,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,74.4,69.0 to 79.2,460
Polio,≥3 Doses,States/Local Areas,Guam,2015,Age,19 Months,78.1,72.2 to 83.0,242
Polio,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,82.9,78.1 to 86.8,460
Polio,≥3 Doses,States/Local Areas,Guam,2014,Age,19 Months,80.8,75.1 to 85.5,293
Polio,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,79.5,74.9 to 83.4,535
Polio,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,80.8,78.1 to 83.3,293
DTaP,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,84.2,79.8 to 87.9,293
DTaP,≥3 Doses,States/Local Areas,Guam,2019,Age,13 Months,79.1,67.5 to 87.3,97
Polio,≥3 Doses,States/Local Areas,Guam,2017,Age,19 Months,75.9,66.3 to 83.4,155
Polio,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,19 Months,76.0,69.1 to 81.7,295
Polio,≥3 Doses,States/Local Areas,Guam,2016,Age,19 Months,87.2,80.6 to 91.8,218
Polio,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,81.8,76.2 to 86.3,373
Hib,≥3 Doses,States/Local Areas,Guam,2018,Age,13 Months,71.1,61.2 to 79.4,140
Hib,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,73.2,65.9 to 79.5,237
Polio,≥3 Doses,States/Local Areas,Guam,2018,Age,19 Months,76.1,66.4 to 83.7,140
Polio,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,55.3,47.3 to 62.9,237
DTaP,≥3 Doses,States/Local Areas,Guam,2018,Age,13 Months,76.8,67.2 to 84.3,140
DTaP,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,77.9,70.7 to 83.8,237
DTaP,≥3 Doses,States/Local Areas,Guam,2017,Age,13 Months,66.2,55.5 to 75.4,155
DTaP,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,71.5,64.2 to 77.8,295
DTaP,≥3 Doses,States/Local Areas,Guam,2016,Age,13 Months,81.7,74.3 to 87.4,218
DTaP,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,74.3,67.9 to 79.8,373
Hib,≥3 Doses,States/Local Areas,Guam,2014,Age,13 Months,72.6,66.3 to 78.1,293
Hib,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,71.7,66.7 to 76.1,535
Hib,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,72.6,67.6 to 77.0,293
DTaP,≥3 Doses,States/Local Areas,Guam,2014,Age,13 Months,78.5,72.5 to 83.4,293
DTaP,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,77.4,72.6 to 81.5,535
DTaP,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,78.5,73.0 to 83.0,293
Hib,≥3 Doses,States/Local Areas,Guam,2019,Age,7 Months,39.6,28.7 to 51.7,97
Polio,≥1 Dose,States/Local Areas,Guam,2018,Age,3 Months,73.4,63.7 to 81.3,140
Polio,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,3 Months,73.7,66.4 to 80.0,237
Polio,≥1 Dose,States/Local Areas,Guam,2017,Age,3 Months,69.4,58.9 to 78.2,155
Polio,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,3 Months,71.4,64.2 to 77.6,295
Hib,≥3 Doses,States/Local Areas,Guam,2016,Age,7 Months,49.1,41.0 to 57.3,218
Hib,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,46.9,40.5 to 53.5,373
Hib,≥3 Doses,States/Local Areas,Guam,2015,Age,7 Months,41.5,34.2 to 49.2,242
Hib,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,45.5,39.9 to 51.2,460
Hib,≥3 Doses,States/Local Areas,Guam,2014,Age,7 Months,40.8,34.4 to 47.4,293
Hib,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,41.1,36.3 to 46.1,535
PCV,≥3 Doses,States/Local Areas,Guam,2018,Age,35 Months,74.4,65.3 to 82.7,140
PCV,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,79.2,72.2 to 85.4,237
PCV,≥3 Doses,States/Local Areas,Guam,2017,Age,35 Months,77.3,67.6 to 85.7,155
PCV,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,75.9,69.1 to 82.2,295
Hib,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,87.6,85.3 to 89.7,293
DTaP,≥3 Doses,States/Local Areas,Guam,2017,Age,7 Months,51.5,41.2 to 61.7,155
DTaP,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,56.2,48.8 to 63.3,295
DTaP,≥3 Doses,States/Local Areas,Guam,2016,Age,7 Months,62.0,53.6 to 69.6,218
DTaP,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,57.0,50.3 to 63.5,373
DTaP,≥3 Doses,States/Local Areas,Guam,2015,Age,7 Months,49.6,41.9 to 57.3,242
DTaP,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,56.1,50.4 to 61.6,460
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2018,Age,0-3 Days,86.4,78.1 to 91.9,140
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2018-2019,Age,0-3 Days,86.8,80.4 to 91.4,237
DTaP,≥3 Doses,States/Local Areas,Guam,2019,Age,7 Months,48.1,36.4 to 60.0,97
DTaP,≥3 Doses,States/Local Areas,Guam,2018,Age,7 Months,60.9,50.7 to 70.2,140
DTaP,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,54.7,46.8 to 62.4,237
Hib,Full Series,States/Local Areas,Guam,2020,Age,24 Months,57.9,44.3 to 72.2,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2019,Age,0-3 Days,87.3,76.1 to 93.7,97
Polio,≥1 Dose,States/Local Areas,Guam,2019,Age,3 Months,74.1,62.3 to 83.2,97
Hib,≥2 Doses,States/Local Areas,Guam,2014,Age,13 Months,87.6,82.7 to 91.3,293
Hib,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,13 Months,88.2,84.5 to 91.1,535
PCV,≥3 Doses,States/Local Areas,Guam,2019,Age,35 Months,83.5,72.8 to 91.8,97
Hib,≥3 Doses,States/Local Areas,Guam,2018,Age,7 Months,41.5,31.8 to 51.9,140
Hib,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,40.6,33.1 to 48.5,237
Hib,≥3 Doses,States/Local Areas,Guam,2017,Age,7 Months,44.5,34.6 to 54.9,155
Hib,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,43.0,36.0 to 50.4,295
Hib,≥2 Doses,States/Local Areas,Guam,2016,Age,13 Months,87.6,80.3 to 92.4,218
Hib,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,13 Months,83.7,78.0 to 88.1,373
Hib,≥2 Doses,States/Local Areas,Guam,2015,Age,13 Months,88.7,82.6 to 92.9,242
Hib,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,88.1,83.6 to 91.5,460
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2017,Age,0-3 Days,90.3,77.6 to 96.2,88
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2017-2018,Age,0-3 Days,86.2,80.4 to 90.5,295
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2016,Age,0-3 Days,94.7,91.0 to 96.9,218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2016-2017,Age,0-3 Days,90.6,86.0 to 93.8,373
Polio,≥1 Dose,States/Local Areas,Guam,2016,Age,3 Months,72.2,64.0 to 79.1,218
Polio,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,3 Months,70.9,64.4 to 76.6,373
Polio,≥1 Dose,States/Local Areas,Guam,2015,Age,3 Months,75.7,68.3 to 81.8,242
Polio,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,3 Months,73.9,68.4 to 78.6,460
Polio,≥1 Dose,States/Local Areas,Guam,2014,Age,3 Months,75.7,69.4 to 81.1,293
Polio,≥1 Dose,States/Local Areas,Guam,2014-2015,Age,3 Months,75.7,71.0 to 79.9,535
Hib,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,40.8,31.1 to 51.2,293
DTaP,≥3 Doses,States/Local Areas,Guam,2014,Age,7 Months,54.2,47.5 to 60.8,293
DTaP,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,51.9,46.9 to 56.9,535
PCV,≥3 Doses,States/Local Areas,Guam,2016,Age,35 Months,83.1,75.8 to 89.3,218
PCV,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,80.2,74.3 to 85.6,373
PCV,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,83.5,78.6 to 87.9,460
PCV,≥3 Doses,States/Local Areas,Guam,2014,Age,35 Months,87.8,81.9 to 92.5,293
Hib,≥2 Doses,States/Local Areas,Guam,2018,Age,7 Months,77.3,67.9 to 84.6,140
Hib,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,7 Months,76.7,69.4 to 82.6,237
Hib,≥2 Doses,States/Local Areas,Guam,2019,Age,13 Months,88.3,77.9 to 94.2,97
Hib,≥2 Doses,States/Local Areas,Guam,2017,Age,13 Months,79.4,69.7 to 86.5,155
Hib,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,80.8,74.1 to 86.0,295
Hib,≥2 Doses,States/Local Areas,Guam,2018,Age,13 Months,82.1,73.0 to 88.7,140
Hib,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,85.1,78.7 to 89.9,237
DTaP,≥3 Doses,States/Local Areas,Guam,2015,Age,13 Months,76.2,68.3 to 82.7,242
DTaP,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,13 Months,79.1,73.8 to 83.6,460
Hib,≥2 Doses,States/Local Areas,Guam,2019,Age,7 Months,76.0,64.3 to 84.7,97
Hib,≥2 Doses,States/Local Areas,Guam,2017,Age,7 Months,70.6,60.2 to 79.3,155
Hib,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,7 Months,74.0,66.9 to 80.0,295
Hib,≥2 Doses,States/Local Areas,Guam,2016,Age,7 Months,78.3,70.3 to 84.6,218
Hib,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,7 Months,74.6,68.2 to 80.1,373
PCV,≥1 Dose,States/Local Areas,Guam,2019,Age,3 Months,78.1,66.7 to 86.4,97
Polio,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,3 Months,75.7,71.2 to 79.8,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2013,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2013-2014,Age,0-3 Days,84.9,79.3 to 89.1,293
DTaP,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,54.2,43.2 to 64.9,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2014,Age,0-3 Days,84.9,79.3 to 89.1,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2015-2016,Age,0-3 Days,92.8,89.8 to 95.0,460
PCV,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,87.8,81.9 to 92.5,293
PCV,≥3 Doses,States/Local Areas,Guam,2019,Age,24 Months,80.9,70.4 to 89.5,97
Hib,≥2 Doses,States/Local Areas,Guam,2015,Age,7 Months,77.6,70.0 to 83.8,242
Hib,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,7 Months,78.0,72.6 to 82.5,460
Hib,≥2 Doses,States/Local Areas,Guam,2014,Age,7 Months,77.1,70.9 to 82.2,293
Hib,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,7 Months,77.3,72.6 to 81.4,535
Hib,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,7 Months,77.1,71.1 to 82.1,293
PCV,≥3 Doses,States/Local Areas,Guam,2018,Age,24 Months,74.4,65.3 to 82.7,140
PCV,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,77.6,70.7 to 83.8,237
PCV,≥3 Doses,States/Local Areas,Guam,2017,Age,24 Months,76.2,66.7 to 84.7,155
PCV,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,75.3,68.6 to 81.6,295
PCV,≥3 Doses,States/Local Areas,Guam,2016,Age,24 Months,81.2,74.0 to 87.4,218
PCV,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,78.8,73.0 to 84.2,373
Hib,≥2 Doses,States/Local Areas,Guam,2019,Age,5 Months,64.0,51.8 to 74.6,97
Hib,≥2 Doses,States/Local Areas,Guam,2018,Age,5 Months,60.0,49.6 to 69.6,140
Hib,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,5 Months,61.9,54.0 to 69.3,237
PCV,≥1 Dose,States/Local Areas,Guam,2017,Age,3 Months,65.5,54.8 to 74.8,155
PCV,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,3 Months,69.0,61.7 to 75.5,295
PCV,≥1 Dose,States/Local Areas,Guam,2016,Age,3 Months,70.0,61.8 to 77.1,218
PCV,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,3 Months,67.9,61.3 to 73.8,373
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2012,Age,0-3 Days,NA,,
PCV,≥1 Dose,States/Local Areas,Guam,2018,Age,3 Months,72.6,62.9 to 80.6,140
PCV,≥1 Dose,States/Local Areas,Guam,2018-2019,Age,3 Months,75.3,68.1 to 81.3,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Guam,2011,Age,0-3 Days,NA,,
PCV,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,24 Months,84.1,78.8 to 88.7,293
Hib,≥2 Doses,States/Local Areas,Guam,2017,Age,5 Months,59.5,48.9 to 69.3,155
Hib,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,5 Months,59.8,52.3 to 66.8,295
PCV,≥3 Doses,States/Local Areas,Guam,2014,Age,24 Months,84.1,78.8 to 88.7,293
PCV,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,24 Months,81.2,76.3 to 85.6,460
PCV,≥1 Dose,States/Local Areas,Guam,2015,Age,3 Months,73.2,65.8 to 79.5,242
PCV,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,3 Months,71.5,66.1 to 76.4,460
PCV,≥1 Dose,States/Local Areas,Guam,2014,Age,3 Months,75.1,68.8 to 80.5,293
PCV,≥1 Dose,States/Local Areas,Guam,2014-2015,Age,3 Months,74.2,69.4 to 78.4,535
Hib,≥2 Doses,States/Local Areas,Guam,2016,Age,5 Months,67.4,59.0 to 74.8,218
Hib,≥2 Doses,States/Local Areas,Guam,2016-2017,Age,5 Months,63.6,57.0 to 69.8,373
Hib,≥2 Doses,States/Local Areas,Guam,2015,Age,5 Months,54.4,46.5 to 62.1,242
Hib,≥2 Doses,States/Local Areas,Guam,2015-2016,Age,5 Months,61.2,55.5 to 66.7,460
Hib,≥2 Doses,States/Local Areas,Guam,2014,Age,5 Months,62.4,55.8 to 68.7,293
Hib,≥2 Doses,States/Local Areas,Guam,2014-2015,Age,5 Months,58.4,52.2 to 64.4,535
Hib,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,5 Months,62.4,54.4 to 69.8,293
PCV,≥3 Doses,States/Local Areas,Guam,2019,Age,19 Months,78.2,66.3 to 86.7,97
PCV,≥3 Doses,States/Local Areas,Guam,2018,Age,19 Months,74.4,64.6 to 82.2,140
PCV,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,19 Months,74.8,67.4 to 81.0,237
PCV,≥3 Doses,States/Local Areas,Guam,2016,Age,19 Months,81.2,73.5 to 87.0,218
PCV,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,19 Months,78.8,72.7 to 83.9,373
PCV,≥3 Doses,States/Local Areas,Guam,2015,Age,19 Months,78.7,75.5 to 81.6,242
PCV,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,19 Months,80.0,74.9 to 84.3,460
Hep B,≥2 Doses,States/Local Areas,Guam,2019,Age,13 Months,93.0,84.0 to 97.1,97
Hep B,≥2 Doses,States/Local Areas,Guam,2018,Age,13 Months,86.5,78.2 to 91.9,140
Hep B,≥2 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,89.6,84.1 to 93.4,237
Hep B,≥2 Doses,States/Local Areas,Guam,2017,Age,13 Months,81.1,71.4 to 88.1,155
Hep B,≥2 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,83.8,77.7 to 88.4,295
Hib,≥1 Dose,States/Local Areas,Guam,2017,Age,3 Months,68.7,58.2 to 77.5,155
Hib,≥1 Dose,States/Local Areas,Guam,2017-2018,Age,3 Months,72.1,64.9 to 78.3,295
Hib,≥1 Dose,States/Local Areas,Guam,2016,Age,3 Months,72.3,64.1 to 79.2,218
Hib,≥1 Dose,States/Local Areas,Guam,2016-2017,Age,3 Months,70.6,64.1 to 76.3,373
Hib,≥1 Dose,States/Local Areas,Guam,2015,Age,3 Months,76.2,68.8 to 82.2,242
Hib,≥1 Dose,States/Local Areas,Guam,2015-2016,Age,3 Months,74.1,68.7 to 78.9,460
≥1 Dose MMR,,States/Local Areas,Guam,2019,Age,35 Months,83.6,69.6 to 93.6,97
PCV,≥4 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,72.6,64.6 to 80.0,293
≥1 Dose MMR,,States/Local Areas,Guam,2017,Age,35 Months,83.6,74.7 to 90.7,155
≥1 Dose MMR,,States/Local Areas,Guam,2017-2018,Age,35 Months,77.5,70.9 to 83.5,295
≥1 Dose MMR,,States/Local Areas,Guam,2018,Age,35 Months,71.3,61.5 to 80.4,140
≥1 Dose MMR,,States/Local Areas,Guam,2018-2019,Age,35 Months,78.4,69.2 to 86.4,237
≥1 Dose Varicella,,States/Local Areas,Guam,2019,Age,35 Months,81.7,69.2 to 91.4,97
≥1 Dose MMR,,States/Local Areas,Guam,2016,Age,35 Months,83.6,76.3 to 89.7,218
≥1 Dose MMR,,States/Local Areas,Guam,2016-2017,Age,35 Months,83.7,78.1 to 88.5,373
≥1 Dose MMR,,States/Local Areas,Guam,2015-2016,Age,35 Months,84.8,79.7 to 89.2,460
PCV,≥4 Doses,States/Local Areas,Guam,2018,Age,24 Months,60.1,50.2 to 70.2,140
PCV,≥4 Doses,States/Local Areas,Guam,2018-2019,Age,24 Months,59.7,51.8 to 67.7,237
PCV,≥4 Doses,States/Local Areas,Guam,2017,Age,24 Months,50.3,40.2 to 61.3,155
PCV,≥4 Doses,States/Local Areas,Guam,2017-2018,Age,24 Months,55.2,47.9 to 62.8,295
PCV,≥4 Doses,States/Local Areas,Guam,2016,Age,24 Months,62.2,53.8 to 70.6,218
PCV,≥4 Doses,States/Local Areas,Guam,2016-2017,Age,24 Months,56.5,49.8 to 63.4,373
Hep B,≥3 Doses,States/Local Areas,Guam,2015-2016,Age,35 Months,86.8,82.4 to 90.6,460
Hep B,≥3 Doses,States/Local Areas,Guam,2014,Age,35 Months,85.5,80.0 to 90.1,293
Hep B,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,35 Months,85.5,80.0 to 90.1,293
PCV,≥3 Doses,States/Local Areas,Guam,2018,Age,13 Months,73.6,63.9 to 81.5,140
PCV,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,13 Months,74.8,67.4 to 81.0,237
PCV,≥3 Doses,States/Local Areas,Guam,2017,Age,13 Months,61.9,51.2 to 71.6,155
PCV,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,13 Months,67.8,60.4 to 74.4,295
Hep B,≥2 Doses,States/Local Areas,Guam,2013-2014,Age,13 Months,92.5,88.2 to 95.4,293
Hep B,≥2 Doses,States/Local Areas,Guam,2019,Age,7 Months,87.7,77.7 to 93.6,97
Hep B,≥3 Doses,States/Local Areas,Guam,2016,Age,35 Months,87.8,81.4 to 92.8,218
Hep B,≥3 Doses,States/Local Areas,Guam,2016-2017,Age,35 Months,81.7,75.9 to 86.9,373
PCV,≥3 Doses,States/Local Areas,Guam,2014,Age,19 Months,82.4,76.7 to 87.0,293
PCV,≥3 Doses,States/Local Areas,Guam,2014-2015,Age,19 Months,80.6,76.1 to 84.4,535
PCV,≥3 Doses,States/Local Areas,Guam,2013-2014,Age,19 Months,82.4,78.9 to 85.5,293
PCV,≥3 Doses,States/Local Areas,Guam,2019,Age,13 Months,76.0,64.2 to 84.8,97
PCV,≥4 Doses,States/Local Areas,Guam,2019,Age,24 Months,58.9,47.0 to 71.2,97
Hep B,≥3 Doses,States/Local Areas,Guam,2017,Age,35 Months,74.9,65.0 to 83.9,155
Hep B,≥3 Doses,States/Local Areas,Guam,2017-2018,Age,35 Months,74.2,67.0 to 80.9,295
Hep B,≥3 Doses,States/Local Areas,Guam,2018,Age,35 Months,73.0,63.4 to 81.9,140
Hep B,≥3 Doses,States/Local Areas,Guam,2018-2019,Age,35 Months,72.8,65.3 to 79.9,237
Hib,≥1 Dose,States/Local Areas,Guam,2013-2014,Age,3 Months,76.6,70.8 to 81.5,293
Polio,≥3 Doses,States/Local Areas,Georgia,2021,Age,24 Months,92.9,87.4 to 96.6,255
Polio,≥1 Dose,States/Local Areas,Georgia,2021,Age,3 Months,87.2,79.2 to 92.4,255
≥1 Dose MMR,,States/Local Areas,Georgia,2021,Age,24 Months,83.2,75.2 to 89.8,255
Hib,≥3 Doses,States/Local Areas,Georgia,2021,Age,24 Months,89.7,83.6 to 94.3,255
Hib,Primary Series,States/Local Areas,Georgia,2021,Age,24 Months,92.7,87.2 to 96.4,255
Hib,Full Series,States/Local Areas,Georgia,2021,Age,24 Months,66.4,57.4 to 75.1,255
DTaP,≥4 Doses,States/Local Areas,Georgia,2021,Age,19 Months,67.6,58.5 to 75.5,255
PCV,≥3 Doses,States/Local Areas,Georgia,2021,Age,19 Months,92.0,85.7 to 95.7,255
Hep A,≥1 Dose,States/Local Areas,Georgia,2021,Age,35 Months,82.5,74.3 to 89.3,255
Hep A,≥2 Doses,States/Local Areas,Georgia,2021,Age,35 Months,68.0,55.6 to 79.8,255
Polio,≥3 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,93.1,87.9 to 96.6,323
DTaP,≥4 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,90.6,84.8 to 94.9,323
PCV,≥3 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,88.2,82.3 to 92.3,323
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,93.2,88.0 to 96.6,323
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020,Age,19 Months,87.5,81.8 to 91.7,323
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,88.7,83.0 to 92.6,323
Hib,Full Series,States/Local Areas,Arkansas,2020,Age,19 Months,71.2,63.9 to 77.6,323
Hib,Primary Series,States/Local Areas,Arkansas,2020,Age,19 Months,88.8,83.0 to 92.8,323
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020,Age,35 Months,95.3,90.8 to 98.0,323
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,92.6,87.4 to 96.2,323
Hib,Full Series,States/Local Areas,Arkansas,2020,Age,35 Months,82.6,76.2 to 88.1,323
Hib,Primary Series,States/Local Areas,Arkansas,2020,Age,35 Months,90.3,85.0 to 94.3,323
Hib,≥3 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,90.2,84.9 to 94.2,323
≥1 Dose MMR,,States/Local Areas,Arkansas,2020,Age,35 Months,93.6,88.3 to 97.1,323
Hib,≥3 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,88.8,83.4 to 93.1,323
≥1 Dose MMR,,States/Local Areas,Arkansas,2020,Age,24 Months,90.8,85.8 to 94.5,323
Polio,≥3 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,90.3,85.2 to 94.2,323
DTaP,≥4 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,76.0,69.1 to 82.3,323
Hep B,≥2 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,91.2,85.8 to 94.6,323
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,90.4,85.3 to 94.3,323
PCV,≥2 Doses,States/Local Areas,Arkansas,2020,Age,5 Months,72.8,65.5 to 79.0,323
Hib,Primary Series,States/Local Areas,Arkansas,2020,Age,7 Months,71.9,64.5 to 78.2,323
Hib,≥3 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,43.9,36.4 to 51.7,323
Polio,≥2 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,86.3,80.4 to 90.7,323
Hib,≥2 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,85.7,79.6 to 90.2,323
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2020,Age,0-1 Days,81.9,75.7 to 86.8,323
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2020,Age,0-2 Days,83.2,77.1 to 87.9,323
Hep A,≥2 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,31.0,24.1 to 38.9,323
Hep A,≥1 Dose,States/Local Areas,Arkansas,2020,Age,19 Months,80.3,73.4 to 85.8,323
Combined 7 Series,,States/Local Areas,Arkansas,2020,Age,35 Months,73.8,66.3 to 80.7,323
Hep A,≥2 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,80.3,71.8 to 87.5,323
≥1 Dose MMR,,States/Local Areas,Arkansas,2020,Age,13 Months,66.9,59.4 to 73.6,323
Hep A,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,44.5,39.3 to 50.0,680
Polio,≥2 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,91.8,86.6 to 95.1,323
Hep A,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,24 Months,85.8,81.9 to 89.3,680
Hep A,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,35 Months,92.2,88.3 to 95.2,680
Hep A,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,75.1,68.2 to 81.4,680
Influenza,,States/Local Areas,Arkansas,2019-2020,Age,24 Months,44.9,39.9 to 50.2,680
Hib,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,88.0,84.2 to 91.2,680
Hib,Primary Series,States/Local Areas,Arkansas,2019-2020,Age,24 Months,88.5,84.8 to 91.7,680
Hib,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,85.4,81.2 to 88.8,680
Hib,Full Series,States/Local Areas,Arkansas,2019-2020,Age,19 Months,69.5,64.5 to 74.2,680
Combined 7 Series,,States/Local Areas,Arkansas,2019-2020,Age,35 Months,75.6,70.4 to 80.6,680
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,88.6,84.8 to 91.5,680
PCV,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,87.9,83.9 to 91.0,680
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019-2020,Age,19 Months,84.8,80.7 to 88.2,680
PCV,≥4 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,71.8,66.8 to 76.3,680
Hep A,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,19 Months,77.8,73.1 to 81.9,680
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2019-2020,Age,0-1 Days,79.4,75.0 to 83.2,680
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2019-2020,Age,0-2 Days,80.8,76.4 to 84.4,680
PCV,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,63.2,57.9 to 68.1,680
Hib,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,45.6,40.4 to 50.9,680
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2019-2020,Age,0-3 Days,80.8,76.4 to 84.4,680
Hib,Full Series,States/Local Areas,Arkansas,2019-2020,Age,24 Months,78.1,73.6 to 82.4,680
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,89.3,85.7 to 92.3,680
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019-2020,Age,24 Months,90.2,86.9 to 93.0,680
PCV,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,88.7,85.0 to 91.8,680
PCV,≥4 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,76.8,72.2 to 81.1,680
Hep A,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,28.2,23.6 to 33.3,680
≥1 Dose MMR,,States/Local Areas,Arkansas,2019-2020,Age,19 Months,84.5,80.4 to 87.9,680
Hib,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,84.8,80.6 to 88.2,680
Hib,Primary Series,States/Local Areas,Arkansas,2019-2020,Age,19 Months,88.2,84.3 to 91.2,680
≥1 Dose MMR,,States/Local Areas,Arkansas,2019-2020,Age,35 Months,94.1,90.3 to 96.7,680
Hib,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,90.9,86.8 to 94.1,680
Hib,Primary Series,States/Local Areas,Arkansas,2019-2020,Age,35 Months,90.2,86.0 to 93.6,680
Hib,Full Series,States/Local Areas,Arkansas,2019-2020,Age,35 Months,83.0,78.5 to 87.1,680
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,92.9,89.1 to 95.8,680
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019-2020,Age,35 Months,95.5,92.0 to 97.8,680
PCV,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,91.4,87.1 to 94.8,680
PCV,≥4 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,80.6,76.0 to 84.9,680
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,89.5,85.9 to 92.5,680
DTaP,≥4 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,76.0,71.2 to 80.5,680
Polio,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,24 Months,89.3,85.7 to 92.4,680
≥1 Dose MMR,,States/Local Areas,Arkansas,2019-2020,Age,24 Months,89.4,86.0 to 92.4,680
Hep B,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,3 Months,97.6,96.0 to 98.5,680
PCV,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,3 Months,81.8,77.4 to 85.5,680
DTaP,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,5 Months,73.2,68.2 to 77.7,680
Polio,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,5 Months,72.3,67.3 to 76.9,680
Hib,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,5 Months,71.1,66.0 to 75.7,680
Polio,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,91.8,88.4 to 94.3,680
≥1 Dose MMR,,States/Local Areas,Arkansas,2019-2020,Age,13 Months,59.6,54.4 to 64.6,680
Hib,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,90.8,87.3 to 93.4,680
Hib,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,66.7,61.6 to 71.4,680
Hib,Primary Series,States/Local Areas,Arkansas,2019-2020,Age,13 Months,84.4,80.2 to 87.9,680
Hep B,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,92.8,89.5 to 95.2,680
Hep B,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,5 Months,88.3,84.3 to 91.3,680
PCV,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,5 Months,72.2,67.2 to 76.8,680
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,64.5,59.3 to 69.4,680
Polio,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,86.2,82.2 to 89.5,680
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,86.5,82.5 to 89.7,680
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019-2020,Age,13 Months,60.9,55.6 to 65.9,680
PCV,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,83.7,79.4 to 87.2,680
Combined 7 Series,,States/Local Areas,Arkansas,2019-2020,Age,24 Months,66.6,61.6 to 71.6,680
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,92.2,88.2 to 95.3,680
DTaP,≥4 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,87.9,83.0 to 91.9,680
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,88.3,84.4 to 91.3,680
Polio,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,35 Months,92.1,88.0 to 95.2,680
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,86.6,80.7 to 90.9,323
Hep B,≥2 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,92.2,87.1 to 95.4,323
Hib,Primary Series,States/Local Areas,Arkansas,2020,Age,13 Months,84.7,78.4 to 89.4,323
Hib,≥3 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,63.2,55.5 to 70.2,323
PCV,≥3 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,91.9,86.1 to 95.9,323
PCV,≥4 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,73.8,66.8 to 79.9,323
PCV,≥3 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,64.3,56.8 to 71.3,323
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,73.2,66.0 to 79.4,323
Hib,≥1 Dose,States/Local Areas,Arkansas,2020,Age,3 Months,81.1,74.6 to 86.3,323
Polio,≥1 Dose,States/Local Areas,Arkansas,2020,Age,3 Months,81.9,75.3 to 87.1,323
Hib,≥2 Doses,States/Local Areas,Arkansas,2020,Age,5 Months,71.9,64.6 to 78.3,323
DTaP,≥1 Dose,States/Local Areas,Arkansas,2020,Age,3 Months,83.4,77.1 to 88.3,323
Hep B,≥2 Doses,States/Local Areas,Arkansas,2020,Age,5 Months,89.0,83.5 to 92.8,323
Polio,≥2 Doses,States/Local Areas,Arkansas,2020,Age,5 Months,72.1,64.7 to 78.5,323
DTaP,≥2 Doses,States/Local Areas,Arkansas,2020,Age,5 Months,73.8,66.6 to 80.0,323
PCV,≥1 Dose,States/Local Areas,Arkansas,2020,Age,3 Months,80.2,73.6 to 85.5,323
Hep B,≥1 Dose,States/Local Areas,Arkansas,2020,Age,3 Months,97.0,94.3 to 98.4,323
Hep A,≥1 Dose,States/Local Areas,Arkansas,2020,Age,24 Months,86.9,81.2 to 91.6,323
Hep A,≥2 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,50.5,42.8 to 58.7,323
PCV,≥4 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,75.8,69.2 to 82.0,323
PCV,≥3 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,88.9,83.5 to 93.2,323
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020,Age,24 Months,91.5,86.7 to 95.0,323
Influenza,,States/Local Areas,Arkansas,2020,Age,24 Months,39.4,32.5 to 47.1,323
Rotavirus,,States/Local Areas,Arkansas,2020,Age,8 Months,77.9,71.1 to 83.5,323
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2020,Age,0-3 Days,83.2,77.1 to 87.9,323
Hib,≥3 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,85.0,78.8 to 89.6,323
Combined 7 Series,,States/Local Areas,Arkansas,2020,Age,24 Months,65.0,57.7 to 72.2,323
Polio,≥3 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,89.4,83.8 to 93.2,323
≥1 Dose MMR,,States/Local Areas,Arkansas,2020,Age,19 Months,87.8,82.0 to 91.9,323
DTaP,≥4 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,64.2,56.6 to 71.2,323
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020,Age,19 Months,89.5,83.9 to 93.4,323
PCV,≥3 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,83.5,77.2 to 88.4,323
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020,Age,7 Months,65.9,58.4 to 72.7,323
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020,Age,13 Months,67.8,60.4 to 74.4,323
Polio,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,3 Months,82.8,78.4 to 86.5,680
Hib,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,3 Months,81.9,77.4 to 85.6,680
DTaP,≥1 Dose,States/Local Areas,Arkansas,2019-2020,Age,3 Months,83.7,79.3 to 87.2,680
DTaP,≥4 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,62.1,56.8 to 67.0,680
Polio,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,19 Months,87.9,84.0 to 91.0,680
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,72.9,67.9 to 77.3,680
Hib,Primary Series,States/Local Areas,Arkansas,2019-2020,Age,7 Months,69.2,64.1 to 73.8,680
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019-2020,Age,13 Months,85.5,81.4 to 88.9,680
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2021,Age,0-1 Days,82.5,72.9 to 89.1,190
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020-2021,Age,35 Months,91.7,86.3 to 95.6,513
Hep A,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,35 Months,90.4,85.3 to 94.3,513
PCV,≥4 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,73.0,62.7 to 82.5,190
DTaP,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,3 Months,84.0,78.7 to 88.2,513
PCV,≥3 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,81.0,70.3 to 88.4,190
Hib,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,89.7,84.5 to 93.3,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2021,Age,0-2 Days,82.6,73.1 to 89.3,190
PCV,≥3 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,83.3,73.6 to 90.9,190
≥1 Dose Varicella,,States/Local Areas,Arkansas,2021,Age,24 Months,82.1,72.1 to 90.1,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2021,Age,24 Months,80.5,70.7 to 88.7,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2021,Age,35 Months,86.9,77.8 to 93.6,190
PCV,≥3 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,83.0,72.4 to 90.1,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,92.0,87.5 to 95.4,513
≥1 Dose Varicella,,States/Local Areas,Arkansas,2021,Age,19 Months,76.4,64.9 to 85.0,190
DTaP,≥4 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,60.4,49.0 to 70.7,190
Hib,Full Series,States/Local Areas,Arkansas,2021,Age,24 Months,71.6,61.1 to 81.3,190
Hib,Primary Series,States/Local Areas,Arkansas,2021,Age,24 Months,85.8,76.9 to 92.5,190
Hib,≥3 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,82.0,72.3 to 89.9,190
≥1 Dose MMR,,States/Local Areas,Arkansas,2020-2021,Age,24 Months,86.6,80.9 to 91.2,513
≥1 Dose MMR,,States/Local Areas,Arkansas,2021,Age,24 Months,82.4,72.4 to 90.4,190
DTaP,≥4 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,70.7,60.1 to 80.7,190
Polio,≥3 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,82.9,73.2 to 90.6,190
DTaP,≥1 Dose,States/Local Areas,Arkansas,2021,Age,3 Months,84.5,75.3 to 90.7,190
PCV,≥4 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,73.5,63.1 to 82.9,190
Hep A,≥2 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,17.8,11.2 to 27.0,190
Polio,≥1 Dose,States/Local Areas,Arkansas,2021,Age,3 Months,84.5,75.2 to 90.7,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2021,Age,19 Months,71.7,60.2 to 80.9,190
Polio,≥2 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,89.4,79.8 to 94.8,190
PCV,≥4 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,64.4,52.9 to 74.4,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,84.8,75.7 to 91.8,190
DTaP,≥3 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,80.6,70.0 to 88.1,190
PCV,≥3 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,56.8,45.8 to 67.2,190
Hep A,≥2 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,42.4,32.0 to 54.4,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,65.5,54.5 to 75.0,190
PCV,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,5 Months,70.2,63.6 to 76.0,513
DTaP,≥3 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,82.9,72.3 to 90.1,190
Hep B,≥2 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,91.5,82.7 to 96.0,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2012,Age,19 Months,68.7,60.8 to 75.7,236
DTaP,≥1 Dose,States/Local Areas,Arkansas,2018,Age,3 Months,82.6,76.5 to 87.4,426
DTaP,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,3 Months,83.5,79.2 to 87.1,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,92.3,87.6 to 95.7,265
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,93.4,90.0 to 95.9,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,92.7,88.1 to 96.0,239
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,92.5,89.4 to 95.0,504
DTaP,≥1 Dose,States/Local Areas,Arkansas,2017,Age,3 Months,80.1,73.7 to 85.3,390
DTaP,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,3 Months,81.3,77.0 to 85.0,816
Hep A,≥1 Dose,States/Local Areas,Arkansas,2011,Age,19 Months,54.2,49.0 to 59.4,230
DTaP,≥1 Dose,States/Local Areas,Arkansas,2019,Age,3 Months,84.5,78.4 to 89.1,357
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,94.2,89.0 to 97.5,272
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,92.8,89.4 to 95.4,662
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,95.2,91.8 to 98.5,198
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,89.7,85.6 to 93.8,387
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,92.4,89.3 to 95.5,423
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,92.0,89.8 to 94.2,1008
DTaP,≥2 Doses,States/Local Areas,Arkansas,2018,Age,5 Months,73.7,67.1 to 79.3,426
DTaP,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,5 Months,73.4,68.6 to 77.7,783
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,92.4,88.9 to 95.8,331
DTaP,≥2 Doses,States/Local Areas,Arkansas,2019,Age,5 Months,73.1,66.0 to 79.2,357
DTaP,≥2 Doses,States/Local Areas,Arkansas,2017,Age,5 Months,68.6,61.7 to 74.9,390
DTaP,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,5 Months,71.1,66.4 to 75.5,816
Hep A,≥1 Dose,States/Local Areas,Arkansas,2015,Age,19 Months,82.6,76.6 to 87.3,265
Hep A,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,19 Months,82.3,77.4 to 86.3,537
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014,Age,19 Months,79.7,71.9 to 85.8,239
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,19 Months,81.2,76.1 to 85.3,504
Hep A,≥1 Dose,States/Local Areas,Arkansas,2013,Age,19 Months,79.7,73.5 to 84.7,212
Hep A,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,19 Months,79.7,75.1 to 83.6,451
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016,Age,19 Months,82.0,74.5 to 87.7,272
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,19 Months,82.2,77.6 to 86.1,662
PCV,≥2 Doses,States/Local Areas,Arkansas,2021,Age,5 Months,67.6,56.2 to 77.2,190
Combined 7 Series,,States/Local Areas,Arkansas,2021,Age,35 Months,64.8,53.5 to 75.9,190
Hib,Primary Series,States/Local Areas,Arkansas,2021,Age,7 Months,63.2,52.2 to 73.0,190
DTaP,≥1 Dose,States/Local Areas,Arkansas,2016,Age,3 Months,84.1,77.6 to 89.0,272
DTaP,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,3 Months,82.1,77.7 to 85.8,662
DTaP,≥1 Dose,States/Local Areas,Arkansas,2015,Age,3 Months,82.8,76.8 to 87.4,265
DTaP,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,3 Months,83.4,79.2 to 86.9,537
DTaP,≥1 Dose,States/Local Areas,Arkansas,2014,Age,3 Months,79.2,71.6 to 85.1,239
DTaP,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,3 Months,81.0,76.3 to 84.9,504
DTaP,≥1 Dose,States/Local Areas,Arkansas,2013,Age,3 Months,81.6,75.8 to 86.3,212
DTaP,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,3 Months,80.4,74.8 to 85.0,451
DTaP,≥1 Dose,States/Local Areas,Arkansas,2012,Age,3 Months,84.3,77.3 to 89.4,236
DTaP,≥1 Dose,States/Local Areas,Arkansas,2011,Age,3 Months,80.6,75.7 to 84.7,230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.6,74.8 to 82.4,866
Hib,≥1 Dose,States/Local Areas,Arkansas,2021,Age,3 Months,82.6,72.9 to 89.3,190
Hib,≥2 Doses,States/Local Areas,Arkansas,2021,Age,5 Months,67.3,56.0 to 76.9,190
DTaP,≥3 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,57.4,46.3 to 67.7,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,84.3,74.2 to 90.9,190
DTaP,≥4 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,89.2,82.8 to 94.0,513
PCV,≥4 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,74.5,68.4 to 80.2,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,87.6,82.1 to 92.0,390
Hib,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,88.4,84.9 to 91.5,816
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,88.8,83.6 to 93.0,357
Hib,≥3 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,92.4,87.1 to 96.1,272
Hib,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,90.1,86.4 to 93.1,662
Hib,≥3 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,87.2,81.6 to 91.7,265
Hib,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,89.9,86.1 to 93.0,537
Hib,Full Series,States/Local Areas,Arkansas,2021,Age,19 Months,65.6,54.3 to 75.4,190
Hib,Primary Series,States/Local Areas,Arkansas,2021,Age,19 Months,85.6,75.7 to 91.8,190
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,91.8,87.3 to 95.2,426
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,90.4,87.0 to 93.2,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,91.3,86.4 to 94.9,390
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,91.6,88.4 to 94.2,816
Polio,≥2 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,84.1,74.4 to 90.6,190
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,86.2,80.3 to 90.5,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,85.3,79.7 to 90.0,513
Hep B,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,92.2,87.6 to 95.2,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,80.6,70.0 to 88.2,190
PCV,≥3 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,87.3,77.6 to 94.2,190
≥1 Dose MMR,,States/Local Areas,Arkansas,2021,Age,35 Months,86.9,76.7 to 94.1,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,85.4,79.8 to 89.6,513
Hib,≥2 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,81.7,71.6 to 88.8,190
Hib,≥3 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,87.6,82.3 to 91.9,357
Hib,≥3 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,89.3,84.6 to 93.2,426
Hib,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,88.5,85.0 to 91.5,783
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,20.7,15.0 to 27.8,239
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,22.7,18.5 to 27.5,504
Hep A,≥2 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,16.6,14.0 to 19.7,236
Hep A,≥2 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,17.7,15.8 to 19.8,212
Hep A,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,19.2,17.6 to 20.9,451
Hep A,≥2 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,11.4,9.1 to 14.2,230
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,93.4,88.8 to 96.6,265
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,93.8,90.4 to 96.3,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,92.7,88.1 to 96.0,239
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,93.0,89.9 to 95.4,504
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,98.9,93.7 to 99.9,212
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,95.0,91.5 to 97.4,451
DTaP,≥3 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,97.2,91.8 to 99.4,236
DTaP,≥3 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,94.5,89.6 to 97.6,230
Hep A,≥1 Dose,States/Local Areas,Arkansas,2018,Age,19 Months,84.7,79.1 to 89.0,426
Hep A,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,19 Months,81.5,76.5 to 85.7,662
Hep A,≥1 Dose,States/Local Areas,Arkansas,2017,Age,19 Months,82.4,76.4 to 87.2,390
Hep A,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,19 Months,83.5,79.6 to 86.9,816
Hib,≥3 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,94.3,89.5 to 97.4,236
Hib,≥3 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,91.7,85.5 to 95.9,230
Hib,Primary Series,States/Local Areas,Arkansas,2020-2021,Age,24 Months,87.5,82.4 to 91.7,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2021,Age,7 Months,44.2,33.6 to 55.3,190
Hib,≥3 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,91.7,86.8 to 95.3,426
Hib,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,91.7,87.8 to 94.7,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,78.0,64.1 to 92.0,53
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.6,92.7 to 100.0,94
Hep A,≥2 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,35.8,28.4 to 44.5,236
Hib,≥3 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,88.4,82.9 to 92.8,390
Hib,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,90.0,86.5 to 93.0,816
Hib,≥3 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,92.4,87.1 to 96.1,272
Hib,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,90.5,86.8 to 93.5,662
Hep A,≥2 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,31.8,23.7 to 42.0,230
Hep A,≥2 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,26.0,20.1 to 32.8,357
Hep A,≥2 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,27.8,21.9 to 34.5,426
Hep A,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,26.7,21.9 to 32.1,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,67.9,59.8 to 75.0,272
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,64.7,59.4 to 69.7,662
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,95.5,93.5 to 97.5,426
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,93.8,90.3 to 97.3,387
DTaP,≥4 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,61.8,56.9 to 66.5,265
DTaP,≥4 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,64.9,59.4 to 70.0,537
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,62.8,54.7 to 70.2,239
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,62.3,56.8 to 67.5,504
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,90.9,84.8 to 97.0,142
Hep A,≥1 Dose,States/Local Areas,Arkansas,2017,Age,24 Months,85.5,79.9 to 90.2,390
Hep A,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,24 Months,86.3,82.7 to 89.6,816
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,92.2,84.9 to 96.8,357
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,93.8,89.5 to 96.8,426
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,93.1,89.2 to 96.0,783
PCV,≥2 Doses,States/Local Areas,Arkansas,2016,Age,5 Months,72.3,64.7 to 78.7,272
PCV,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,5 Months,70.6,65.5 to 75.2,662
PCV,≥2 Doses,States/Local Areas,Arkansas,2015,Age,5 Months,66.3,58.9 to 73.1,265
PCV,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,5 Months,69.3,64.0 to 74.1,537
PCV,≥2 Doses,States/Local Areas,Arkansas,2014,Age,5 Months,61.5,53.5 to 69.0,239
PCV,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,5 Months,63.9,58.6 to 68.9,504
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016,Age,24 Months,85.7,78.9 to 91.2,272
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,24 Months,85.7,81.3 to 89.4,662
Hep A,≥1 Dose,States/Local Areas,Arkansas,2015,Age,24 Months,89.3,84.0 to 93.5,265
Hep A,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,24 Months,87.4,83.1 to 91.1,537
Hep A,≥2 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,22.3,17.5 to 28.1,390
Hep A,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,25.0,21.1 to 29.4,816
Hib,≥3 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,94.6,89.1 to 97.8,265
Hib,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,93.0,88.9 to 96.0,537
Hib,≥3 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,90.2,84.5 to 94.5,239
Hib,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,92.0,88.0 to 95.1,504
Hib,≥3 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,95.5,89.7 to 98.6,212
Hib,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,92.0,88.0 to 95.1,451
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,21.5,15.9 to 28.4,272
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,21.9,18.1 to 26.3,662
Hep A,≥2 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,24.7,18.1 to 32.7,265
Hep A,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,23.1,18.9 to 27.9,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,94.2,89.0 to 97.5,272
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,93.0,89.6 to 95.6,662
PCV,≥2 Doses,States/Local Areas,Arkansas,2013,Age,5 Months,70.2,67.9 to 72.5,212
PCV,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,5 Months,65.9,61.0 to 70.5,451
PCV,≥2 Doses,States/Local Areas,Arkansas,2012,Age,5 Months,69.6,60.6 to 77.2,236
PCV,≥2 Doses,States/Local Areas,Arkansas,2011,Age,5 Months,65.3,56.2 to 73.4,230
DTaP,≥4 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,66.8,65.0 to 68.6,212
DTaP,≥4 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,64.8,62.4 to 67.1,451
DTaP,≥4 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,60.3,58.1 to 62.4,236
DTaP,≥4 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,56.4,52.4 to 60.3,230
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,91.6,86.7 to 95.3,390
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,92.7,89.4 to 95.2,816
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,76.4,71.2 to 81.7,521
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.5,67.1 to 80.0,366
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.4,82.1 to 92.8,366
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,85.2,80.5 to 89.9,437
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,75.9,70.3 to 81.5,437
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.4,70.0 to 84.9,366
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,86.7 to 93.8,521
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,87.6 to 95.6,366
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,69.7,61.6 to 77.8,437
Hib,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,65.1,58.5 to 71.1,513
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014,Age,24 Months,87.5,81.2 to 92.4,239
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,24 Months,88.4,84.4 to 91.8,504
Hep A,≥1 Dose,States/Local Areas,Arkansas,2012,Age,24 Months,77.4,69.6 to 84.5,236
Hep A,≥1 Dose,States/Local Areas,Arkansas,2013,Age,24 Months,86.0,79.8 to 91.0,212
Hep A,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,24 Months,86.9,82.6 to 90.6,451
Hep A,≥1 Dose,States/Local Areas,Arkansas,2011,Age,24 Months,67.3,58.4 to 75.9,230
Hep A,≥1 Dose,States/Local Areas,Arkansas,2019,Age,19 Months,74.9,68.1 to 80.7,357
Influenza,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,48.9,39.5 to 58.3,189
Influenza,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",41.9,30.3 to 53.4,144
Influenza,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",47.1,42.4 to 51.9,866
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,88.5,81.8 to 95.3,181
Influenza,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",38.3,28.2 to 48.4,125
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.2,83.4 to 96.9,125
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,88.3 to 94.0,866
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.4,70.7 to 88.0,144
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,84.6,78.7 to 90.6,189
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.6,67.3 to 85.9,125
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.9,63.0 to 82.7,144
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,78.4,71.4 to 85.5,189
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.2,65.9 to 84.6,144
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,70.9,62.5 to 79.4,189
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.9,57.3 to 78.4,125
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,72.8,67.9 to 77.6,559
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,63.6,46.5 to 80.8,56
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",64.5,59.9 to 69.2,866
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,72.5,63.5 to 81.5,181
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,47.5,25.7 to 69.4,56
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.2,72.8 to 89.6,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.1,66.6 to 85.6,144
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,91.8,86.4 to 97.2,189
Influenza,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,27.6,12.7 to 42.6,56
Influenza,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,32.0,22.6 to 41.3,181
Influenza,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,40.3,34.9 to 45.7,559
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,83.7,78.6 to 88.7,528
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,79.4,65.8 to 93.0,56
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,93.4,90.8 to 96.0,559
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,94.2,90.8 to 97.7,528
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,91.4,88.4 to 94.4,559
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,84.0 to 96.8,144
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,92.1,87.8 to 96.4,189
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.9,85.9 to 97.9,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,86.0,76.5 to 95.5,56
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,82.0,74.4 to 89.6,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,79.5,75.2 to 83.7,559
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,84.6,77.6 to 91.5,189
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,66.4,61.1 to 71.7,559
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.7,74.9 to 90.6,125
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,75.1,69.5 to 80.7,528
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.3,58.2 to 78.5,125
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.6,73.6 to 81.5,866
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",92.4,86.6 to 98.2,125
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.8,84.6 to 91.1,866
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.3,85.0 to 91.6,866
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,78.7,73.2 to 84.2,528
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.6,68.9 to 80.4,866
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,83.7,79.0 to 88.5,528
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,87.5 to 98.6,144
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,95.4,92.0 to 98.9,189
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.6,85.5 to 97.6,125
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.4,69.1 to 77.8,866
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.4,63.3 to 83.6,125
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,72.3,56.5 to 88.0,56
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,87.7,80.7 to 94.6,181
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,89.0,82.2 to 95.7,181
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,91.4,88.3 to 94.5,559
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,94.0,90.5 to 97.5,528
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,59.1,41.9 to 76.3,56
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,74.2,65.4 to 82.9,181
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,66.5,48.9 to 84.1,56
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.6,71.3 to 79.9,866
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,84.1,77.2 to 91.0,189
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,90.5,81.7 to 99.2,56
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,91.4,86.7 to 96.2,181
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.7,81.7 to 95.6,125
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,93.7,91.3 to 96.0,559
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,56.5,37.8 to 75.3,56
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,67.7,58.2 to 77.3,181
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,79.4,65.8 to 93.0,56
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.8,83.4 to 96.2,125
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.5,87.4 to 93.6,866
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,85.7 to 97.9,144
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,93.0,89.0 to 97.0,189
Influenza,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,63.5,57.2 to 69.7,528
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,62.2,52.5 to 72.0,181
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.7,88.8 to 94.5,866
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,89.0,82.2 to 95.7,181
Influenza,,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,69.2,60.6 to 77.8,261
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,75.2,70.4 to 79.9,517
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Overall,Overall,75.5,72.2 to 78.8,1324
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,91.5,87.6 to 95.4,261
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,77.3,72.8 to 81.8,517
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,78.0,72.5 to 83.5,546
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,87.7,82.6 to 92.7,261
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,90.5,87.2 to 93.8,517
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,74.7,71.3 to 78.2,1324
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,91.1,88.1 to 94.2,517
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,76.4,70.7 to 82.0,546
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,90.3,86.0 to 94.6,261
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,91.6,88.6 to 94.5,517
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,86.1,81.4 to 90.9,546
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,93.8,90.3 to 97.3,261
Influenza,,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,36.3,30.9 to 41.8,517
Influenza,,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,48.8,42.8 to 54.8,546
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,93.0,91.2 to 94.8,1324
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,92.3,90.2 to 94.4,1324
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,91.9,88.8 to 94.9,517
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,86.2,81.5 to 90.9,546
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,94.0,90.4 to 97.6,261
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,73.7,67.0 to 80.4,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,78.6,73.8 to 83.5,546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,83.6,77.4 to 89.7,261
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,76.7,71.0 to 82.3,546
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,91.6,87.7 to 95.6,261
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,72.7,67.8 to 77.7,517
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,94.4,91.6 to 97.2,437
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,78.9,73.8 to 84.1,521
Influenza,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,32.9,26.7 to 39.0,437
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,89.6,85.7 to 93.5,521
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,87.5 to 95.7,366
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,92.7,89.1 to 96.3,437
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,69.4,63.6 to 75.2,521
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,63.0,56.0 to 70.0,366
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,81.1,76.5 to 85.7,521
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.6,69.6 to 81.6,366
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,89.6,85.5 to 93.7,437
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,82.0,77.0 to 87.0,437
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,86.5 to 93.7,521
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,90.6,86.6 to 94.6,546
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,95.1,91.8 to 98.4,261
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Overall,Overall,67.3,63.7 to 70.9,1324
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Overall,Overall,78.9,75.8 to 82.0,1324
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,91.0,87.3 to 94.7,546
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,96.6,94.0 to 99.2,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,79.9,75.5 to 84.4,517
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,62.9,57.4 to 68.3,517
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,67.1,61.1 to 73.2,546
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,91.6,87.9 to 95.3,546
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,95.4,92.2 to 98.6,261
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Overall,Overall,90.0,87.6 to 92.3,1324
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,74.4,69.8 to 79.0,1324
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,84.4,78.9 to 89.9,261
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,93.4,91.1 to 95.7,517
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2019,Overall,Overall,80.0,77.0 to 82.9,1324
Influenza,,States/Local Areas,Arkansas,2016-2019,Overall,Overall,45.2,41.5 to 48.9,1324
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,90.7,87.6 to 93.9,517
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,90.5,86.3 to 94.7,546
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,95.3,92.1 to 98.5,261
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,70.2,63.2 to 77.3,546
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,84.1,76.6 to 91.7,261
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,86.3,82.5 to 90.1,517
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,84.0,79.0 to 89.0,546
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,77.9,74.7 to 81.1,1324
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,91.3,89.1 to 93.6,1324
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Poverty,133% to <400% FPL,76.3,70.8 to 81.8,546
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Overall,Overall,89.8,87.4 to 92.1,1324
Rotavirus,,States/Local Areas,Arkansas,2016-2019,Poverty,>400% FPL,83.6,76.9 to 90.3,261
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Overall,Overall,86.2,83.5 to 88.9,1324
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Overall,Overall,91.3,89.0 to 93.5,1324
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,57.0,39.8 to 74.2,56
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.1,71.8 to 80.4,866
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,74.4,65.5 to 83.2,181
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,72.3,56.5 to 88.0,56
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,95.6,92.1 to 99.0,189
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,88.1,81.3 to 94.8,181
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,90.9,87.9 to 94.0,559
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,79.4,65.8 to 93.0,56
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,91.6,87.8 to 95.5,528
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,73.1 to 89.8,144
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,76.3,68.4 to 84.1,189
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,91.6,87.8 to 95.5,528
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,71.3,58.4 to 84.1,181
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,73.6,67.1 to 80.1,559
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,82.3,75.1 to 89.5,528
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.4,81.9 to 89.0,866
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,93.0,89.4 to 96.6,528
PCV,≥2 Doses,States/Local Areas,Arkansas,2017,Age,5 Months,68.8,61.9 to 75.0,390
PCV,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,5 Months,71.0,66.2 to 75.3,816
Hep A,≥1 Dose,States/Local Areas,Arkansas,2012,Age,35 Months,86.5,78.7 to 92.6,236
Rotavirus,,States/Local Areas,Arkansas,2019-2020,Age,8 Months,76.6,71.9 to 80.7,680
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,73.5,68.5 to 78.4,559
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,88.6 to 98.6,125
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,95.7,92.6 to 98.8,189
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.9,88.1 to 97.6,144
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Uninsured,45.9,29.0 to 62.8,56
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,89.6 to 94.6,866
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.0,85.5 to 94.5,366
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,89.5,85.5 to 93.5,521
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.2 to 96.2,366
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,92.8,89.3 to 96.3,437
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,75.7,70.3 to 81.0,521
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.6,70.3 to 83.0,366
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,77.6,72.2 to 83.0,437
Combined 7 Series,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,68.0,61.9 to 74.2,437
Influenza,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,50.1,44.2 to 56.1,521
Influenza,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,53.8,46.5 to 61.1,366
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,78.1,70.1 to 86.0,521
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,72.8 to 83.1,521
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.3,75.8 to 86.7,366
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,78.2,72.8 to 83.5,437
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.7,85.1 to 94.3,366
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,86.2,82.1 to 90.3,521
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,89.2,85.1 to 93.3,437
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.7,66.9 to 80.5,366
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,74.4,68.6 to 80.3,437
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,91.5,88.1 to 94.9,521
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,89.2 to 97.0,366
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a Non-MSA,92.7,89.1 to 96.3,437
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,89.9 to 95.5,521
Hep A,≥1 Dose,States/Local Areas,Arkansas,2011,Age,35 Months,78.8,66.7 to 88.8,230
Hep A,≥1 Dose,States/Local Areas,Arkansas,2019,Age,24 Months,84.7,78.9 to 89.6,357
Hep A,≥1 Dose,States/Local Areas,Arkansas,2018,Age,24 Months,87.1,82.1 to 91.3,426
Hep A,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,24 Months,85.9,82.1 to 89.2,783
Hib,Primary Series,States/Local Areas,Wyoming,2020,Age,7 Months,78.3,71.6 to 83.8,296
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,89.7,84.7 to 93.6,296
DTaP,≥4 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,75.4,68.0 to 82.2,296
≥1 Dose MMR,,States/Local Areas,Wyoming,2020,Age,24 Months,87.9,81.8 to 92.7,296
Polio,≥3 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,88.7,83.4 to 92.9,296
≥1 Dose MMR,,States/Local Areas,Wyoming,2020,Age,35 Months,89.8,83.5 to 94.5,296
Hib,≥3 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,88.1,82.8 to 92.3,296
Hib,≥3 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,90.0,84.8 to 94.0,296
Hib,Primary Series,States/Local Areas,Wyoming,2020,Age,35 Months,91.5,86.6 to 95.2,296
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,89.8,84.5 to 93.9,296
Hib,Full Series,States/Local Areas,Wyoming,2020,Age,35 Months,80.6,73.7 to 86.7,296
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020,Age,35 Months,87.9,81.4 to 93.0,296
Hib,Primary Series,States/Local Areas,Wyoming,2020,Age,19 Months,90.5,85.1 to 94.0,296
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,88.4,82.7 to 92.4,296
Hib,Full Series,States/Local Areas,Wyoming,2020,Age,19 Months,74.0,66.3 to 80.4,296
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020,Age,19 Months,83.6,76.6 to 88.8,296
DTaP,≥4 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,82.8,74.8 to 89.4,296
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,92.2,87.3 to 95.7,296
PCV,≥4 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,73.3,65.6 to 79.7,296
PCV,≥3 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,87.8,82.1 to 91.9,296
Polio,≥3 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,91.8,86.6 to 95.5,296
PCV,≥3 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,89.4,84.1 to 93.5,296
Hib,≥2 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,91.7,86.9 to 94.9,296
Hib,Primary Series,States/Local Areas,Wyoming,2020,Age,13 Months,88.8,83.5 to 92.6,296
Hib,≥3 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,58.0,50.3 to 65.4,296
Hep B,≥2 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,91.8,86.4 to 95.2,296
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,87.3,81.5 to 91.5,296
PCV,≥2 Doses,States/Local Areas,Wyoming,2020,Age,5 Months,77.6,70.6 to 83.3,296
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020,Age,13 Months,60.2,52.3 to 67.7,296
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,72.3,64.9 to 78.6,296
Hep B,≥2 Doses,States/Local Areas,Wyoming,2020,Age,5 Months,88.3,82.2 to 92.5,296
PCV,≥3 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,86.4,80.6 to 90.7,296
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,89.0,83.5 to 92.8,296
DTaP,≥4 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,66.2,58.1 to 73.4,296
Polio,≥3 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,87.9,82.1 to 92.0,296
≥1 Dose MMR,,States/Local Areas,Wyoming,2020,Age,19 Months,85.7,79.0 to 90.5,296
Combined 7 Series,,States/Local Areas,Wyoming,2020,Age,24 Months,66.9,59.3 to 74.3,296
Hib,≥3 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,87.4,81.6 to 91.5,296
Rotavirus,,States/Local Areas,Wyoming,2020,Age,8 Months,76.8,69.6 to 82.7,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2020,Age,0-3 Days,77.6,70.2 to 83.6,296
Influenza,,States/Local Areas,Wyoming,2020,Age,24 Months,54.2,46.5 to 62.3,296
≥1 Dose Varicella,,States/Local Areas,Wyoming,2020,Age,24 Months,86.2,80.0 to 91.4,296
PCV,≥4 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,77.6,70.6 to 83.9,296
PCV,≥3 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,88.6,83.3 to 92.8,296
Hep A,≥2 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,42.9,35.4 to 51.3,296
Hep A,≥1 Dose,States/Local Areas,Wyoming,2020,Age,24 Months,79.7,72.8 to 85.7,296
Hep B,≥1 Dose,States/Local Areas,Wyoming,2020,Age,3 Months,92.4,86.4 to 95.8,296
≥1 Dose MMR,,States/Local Areas,Wyoming,2020,Age,13 Months,60.0,52.1 to 67.5,296
Hep A,≥1 Dose,States/Local Areas,Wyoming,2020,Age,19 Months,76.1,68.6 to 82.3,296
Hep A,≥2 Doses,States/Local Areas,Wyoming,2020,Age,19 Months,29.1,22.6 to 36.5,296
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2020,Age,0-2 Days,77.6,70.2 to 83.6,296
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2020,Age,0-1 Days,77.6,70.2 to 83.6,296
Hib,≥2 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,88.9,83.5 to 92.7,296
Polio,≥2 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,88.9,83.5 to 92.7,296
Hib,≥3 Doses,States/Local Areas,Wyoming,2020,Age,7 Months,39.2,31.8 to 47.2,296
Hep A,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,71.8,64.1 to 79.0,556
Hep A,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,35 Months,87.5,83.1 to 91.1,556
Hep A,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,24 Months,83.3,78.9 to 87.2,556
Combined 7 Series,,States/Local Areas,Wyoming,2020,Age,35 Months,72.2,64.0 to 79.9,296
Hep A,≥2 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,61.7,52.8 to 70.6,296
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,85.3,80.4 to 90.3,289
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,77.9,73.8 to 82.0,640
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,91.9 to 97.4,289
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,74.9,70.7 to 79.1,640
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,76.7,70.8 to 82.7,289
Influenza,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,60.9,53.9 to 67.8,289
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,81.9,76.6 to 87.3,289
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,66.9,62.2 to 71.5,640
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,81.1,77.3 to 84.9,640
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,85.8,80.8 to 90.7,289
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,90.4,87.5 to 93.3,640
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,94.3,91.4 to 97.1,289
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,91.5,88.8 to 94.2,640
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,80.0,74.2 to 85.8,289
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,94.7,92.0 to 97.5,289
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,76.8,72.6 to 81.1,640
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,77.5,73.4 to 81.6,640
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,90.2,87.2 to 93.2,640
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,67.3,56.8 to 77.9,289
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.8,90.5 to 95.0,744
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,68.4,62.0 to 74.7,640
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,69.7,52.5 to 87.0,40
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.6,57.3 to 81.9,66
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,94.5,90.7 to 98.2,141
DTaP,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,3 Months,90.1,86.2 to 93.0,556
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2019-2020,Age,0-3 Days,80.9,75.9 to 85.0,556
PCV,≥1 Dose,States/Local Areas,Wyoming,2020,Age,3 Months,85.8,79.7 to 90.4,296
DTaP,≥2 Doses,States/Local Areas,Wyoming,2020,Age,5 Months,80.9,74.1 to 86.2,296
Polio,≥2 Doses,States/Local Areas,Wyoming,2020,Age,5 Months,79.8,72.9 to 85.3,296
Hib,≥2 Doses,States/Local Areas,Wyoming,2020,Age,5 Months,79.5,72.6 to 85.0,296
Polio,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,3 Months,88.9,84.7 to 92.1,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,94.4,90.3 to 97.2,231
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,93.6,90.7 to 95.9,518
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,94.4,90.4 to 97.1,283
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,94.4,91.7 to 96.5,514
PCV,≥2 Doses,States/Local Areas,Wyoming,2011,Age,5 Months,68.6,65.6 to 71.5,214
PCV,≥2 Doses,States/Local Areas,Wyoming,2012,Age,5 Months,76.3,71.6 to 80.5,217
DTaP,≥4 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,64.8,61.1 to 68.3,214
DTaP,≥4 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,61.2,55.4 to 66.7,217
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,18.6,13.2 to 25.5,265
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,20.5,16.5 to 25.1,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,90.4,85.5 to 94.2,280
Hib,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,90.6,87.0 to 93.6,540
Hib,≥3 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,90.3,86.1 to 93.7,287
Hib,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,90.4,87.3 to 93.0,567
Hib,≥3 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,90.8,85.2 to 94.9,260
Hep A,≥2 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,14.4,13.2 to 15.7,217
Hep A,≥2 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,19.3,17.0 to 21.9,215
Hep A,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,19.0,16.8 to 21.4,480
DTaP,≥3 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,93.8,86.9 to 97.8,214
DTaP,≥3 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,94.1,88.0 to 97.7,217
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,95.3,90.8 to 98.0,215
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,93.2,90.2 to 95.4,480
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,90.9,86.5 to 94.3,265
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,92.7,89.9 to 95.0,548
Hep A,≥2 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,9.7,8.3 to 11.3,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,79.7,74.8 to 83.8,556
DTaP,≥4 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,70.9,65.4 to 75.8,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,91.0,87.4 to 93.6,556
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,82.5,78.6 to 86.4,573
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,81.5 to 97.7,66
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,67.6,56.4 to 78.9,276
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,68.6,62.2 to 75.1,573
Influenza,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,44.5,29.7 to 59.2,68
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.5,68.8 to 92.2,66
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,77.3,68.7 to 85.9,141
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,97.8,95.2 to 100.0,40
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,86.0,76.8 to 95.2,68
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,90.7,86.8 to 94.6,276
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,93.0,85.1 to 100.0,40
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,93.2,90.7 to 95.7,573
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,76.5,70.3 to 82.8,276
Influenza,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,56.0,46.2 to 65.9,141
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,94.2,87.7 to 100.0,40
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,84.7,78.7 to 90.7,213
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,92.7,90.7 to 94.7,957
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,78.1,74.7 to 81.4,957
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,91.8,89.7 to 93.9,957
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,70.9,64.0 to 77.8,256
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,78.3,73.7 to 82.9,488
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,73.6,66.2 to 80.9,213
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,93.4,89.0 to 97.8,213
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,63.5,54.2 to 72.8,213
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,78.7,72.4 to 85.0,256
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,86.2,81.7 to 90.8,256
Influenza,,States/Local Areas,Wyoming,2016-2019,Overall,Overall,58.7,54.7 to 62.6,957
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,94.6,92.1 to 97.1,488
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,82.1,76.3 to 87.9,256
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Overall,Overall,70.3,66.7 to 73.9,957
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,66.3,53.7 to 78.8,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Overall,Overall,75.9,72.6 to 79.3,957
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,93.8,91.3 to 96.4,488
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,89.8,85.7 to 94.0,256
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Overall,Overall,77.4,74.1 to 80.8,957
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Overall,Overall,91.9,89.8 to 93.9,957
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,95.3,91.5 to 99.1,213
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Overall,Overall,91.3,89.2 to 93.4,957
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,67.6,62.1 to 73.0,957
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Overall,Overall,77.0,73.7 to 80.3,957
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,73.1,68.3 to 77.9,488
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,74.1,66.5 to 81.7,213
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,94.9,91.3 to 98.6,213
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,70.9,65.8 to 76.0,488
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,63.4,56.2 to 70.6,256
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Overall,Overall,80.6,77.5 to 83.7,957
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,79.5,75.8 to 83.2,640
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,93.8,89.5 to 98.1,213
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,89.5,86.6 to 92.5,640
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,71.7,65.5 to 78.0,289
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,92.1,89.4 to 94.9,640
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,75.4,69.5 to 81.4,289
Influenza,,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,57.3,52.5 to 62.2,640
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,90.6 to 96.7,289
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a Non-MSA,93.9,91.5 to 96.2,640
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,95.7,93.2 to 98.1,289
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,89.8,85.6 to 94.0,276
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,68.7,55.1 to 82.3,68
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,95.3,93.3 to 97.3,573
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,73.5,66.7 to 80.3,276
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,75.8,60.0 to 91.7,40
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,75.5,69.3 to 81.8,276
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,93.5,84.9 to 100.0,40
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,78.8,61.5 to 96.1,40
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,94.0,91.6 to 96.3,573
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.8,87.7 to 99.9,66
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,67.3,54.0 to 80.5,68
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,91.4,87.4 to 95.3,276
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,90.2,86.1 to 94.3,276
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,96.6,92.3 to 100.0,40
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,84.4,74.5 to 94.4,68
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.3,74.5 to 82.1,744
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,91.5 to 95.8,744
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,95.2,91.6 to 98.9,141
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,91.8 to 97.3,289
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,77.3,72.7 to 82.0,488
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,84.9,78.7 to 91.1,213
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,71.3,64.7 to 77.9,256
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,78.2,71.4 to 84.9,213
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,70.2,63.1 to 77.3,488
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,92.3,88.2 to 96.5,213
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,91.6,88.1 to 95.1,256
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,95.3,92.9 to 97.6,488
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,94.1,92.4 to 95.9,957
Influenza,,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,74.2,66.7 to 81.7,213
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,92.9,90.9 to 94.8,957
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,91.8,87.4 to 96.2,213
Influenza,,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,48.2,40.9 to 55.6,256
Influenza,,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,58.6,52.9 to 64.3,488
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,92.4,89.6 to 95.2,488
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,89.1,84.9 to 93.3,256
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,89.4,85.3 to 93.4,256
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,80.7,73.5 to 88.0,213
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,93.1,90.3 to 96.0,488
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Poverty,>400% FPL,82.4,75.8 to 89.1,213
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,90.1,86.1 to 94.1,256
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,94.0,91.4 to 96.6,488
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,83.6,79.6 to 87.6,488
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,74.7,68.2 to 81.2,256
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,133% to <400% FPL,87.2,83.6 to 90.8,488
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Overall,Overall,82.8,79.8 to 85.7,957
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Poverty,<133% FPL,74.5,68.1 to 80.9,256
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,92.7,89.1 to 96.3,276
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,66.2,59.3 to 73.2,276
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.1,79.4 to 98.7,66
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.9,88.5 to 93.4,744
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,88.9 to 100.0,66
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.4,74.8 to 82.1,744
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.1,71.2 to 79.0,744
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,74.5,70.1 to 78.9,573
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.4,60.4 to 86.3,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,73.7,69.1 to 78.2,573
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,77.2,71.1 to 83.3,276
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.9,89.5 to 94.3,744
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,87.5,77.2 to 97.7,40
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,79.2,67.9 to 90.5,68
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.9,79.0 to 96.7,66
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,93.2,88.7 to 97.7,141
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,92.4,89.9 to 94.9,573
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,58.0 to 83.7,66
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,97.8,95.2 to 100.0,40
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.9 to 97.7,573
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,82.2,78.4 to 85.9,573
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,86.1,76.7 to 95.5,68
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.9,66.2 to 89.7,66
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,58.6,44.7 to 72.5,68
Influenza,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Private Insurance Only,64.0,59.1 to 68.9,573
Influenza,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,53.6,46.1 to 61.2,276
Influenza,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,57.2,37.7 to 76.7,40
Hib,Full Series,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.1,77.5 to 84.6,744
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,76.6,57.3 to 95.9,40
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,78.9,71.1 to 86.7,141
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,70.1,63.4 to 76.7,276
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,54.0,33.5 to 74.6,68
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Other,81.6,69.0 to 94.1,40
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,68.5,55.8 to 81.3,68
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.6,66.5 to 74.7,744
Combined 7 Series,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,70.4,61.3 to 79.5,141
Rotavirus,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,75.4,67.3 to 83.6,141
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,85.8,76.4 to 95.2,68
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.0,80.8 to 87.2,744
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,85.1,75.3 to 94.9,68
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,Hispanic,81.3,73.8 to 88.8,141
Influenza,,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",59.0,54.5 to 63.5,744
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,89.7 to 94.5,744
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Uninsured,65.0,51.5 to 78.5,68
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2019,Insurance Coverage,Any Medicaid,88.4,84.0 to 92.9,276
Polio,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,93.3,89.7 to 96.0,556
DTaP,≥4 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,86.2,79.9 to 91.4,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,94.7,91.6 to 96.9,556
Combined 7 Series,,States/Local Areas,Wyoming,2019-2020,Age,24 Months,69.8,64.5 to 75.0,556
PCV,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,89.0,85.2 to 91.9,556
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019-2020,Age,13 Months,65.4,59.9 to 70.5,556
Hep B,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,93.8,90.4 to 96.1,556
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,90.0,86.2 to 92.8,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,73.2,67.9 to 77.8,556
Polio,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,89.7,85.8 to 92.6,556
PCV,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,5 Months,80.4,75.7 to 84.4,556
Hep B,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,5 Months,90.7,87.0 to 93.5,556
Hib,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,5 Months,80.4,75.5 to 84.4,556
Hib,Primary Series,States/Local Areas,Wyoming,2019-2020,Age,13 Months,88.4,84.4 to 91.4,556
Hib,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,57.2,51.6 to 62.7,556
≥1 Dose MMR,,States/Local Areas,Wyoming,2019-2020,Age,13 Months,64.8,59.2 to 70.1,556
Hib,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,92.5,89.0 to 95.0,556
Polio,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,92.3,88.6 to 94.9,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,13 Months,89.9,86.2 to 92.6,556
DTaP,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,5 Months,82.7,78.1 to 86.5,556
Polio,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,5 Months,80.9,76.1 to 84.9,556
PCV,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,3 Months,87.6,83.3 to 90.9,556
Hep B,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,3 Months,94.5,90.9 to 96.7,556
≥1 Dose MMR,,States/Local Areas,Wyoming,2019-2020,Age,24 Months,89.9,85.9 to 93.1,556
Polio,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,90.7,87.0 to 93.7,556
Hib,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,3 Months,88.5,84.3 to 91.7,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,92.1,88.8 to 94.7,556
DTaP,≥4 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,77.8,72.7 to 82.5,556
PCV,≥4 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,82.5,77.8 to 86.7,556
PCV,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,91.5,88.1 to 94.3,556
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019-2020,Age,35 Months,91.8,87.8 to 94.9,556
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,93.2,89.9 to 95.7,556
Hib,Full Series,States/Local Areas,Wyoming,2019-2020,Age,35 Months,81.6,76.8 to 86.0,556
Hib,Primary Series,States/Local Areas,Wyoming,2019-2020,Age,35 Months,92.0,88.4 to 94.8,556
Hib,Primary Series,States/Local Areas,Wyoming,2019-2020,Age,19 Months,91.0,87.2 to 93.7,556
Hib,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,35 Months,90.5,86.7 to 93.6,556
≥1 Dose MMR,,States/Local Areas,Wyoming,2019-2020,Age,35 Months,93.3,89.4 to 96.1,556
Hib,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,87.9,83.9 to 91.1,556
≥1 Dose MMR,,States/Local Areas,Wyoming,2019-2020,Age,19 Months,88.1,83.9 to 91.4,556
Polio,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,89.3,85.3 to 92.3,556
Hep A,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,31.8,26.7 to 37.4,556
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019-2020,Age,24 Months,88.5,84.4 to 91.9,556
PCV,≥4 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,81.4,76.7 to 85.7,556
PCV,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,91.0,87.6 to 93.9,556
Hib,Full Series,States/Local Areas,Wyoming,2019-2020,Age,24 Months,80.2,75.4 to 84.6,556
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,91.7,88.3 to 94.5,556
Hib,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,36.2,30.9 to 41.8,556
PCV,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,71.4,66.1 to 76.2,556
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2019-2020,Age,0-2 Days,80.6,75.6 to 84.7,556
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2019-2020,Age,0-1 Days,80.3,75.4 to 84.5,556
Hep A,≥1 Dose,States/Local Areas,Wyoming,2019-2020,Age,19 Months,81.1,76.3 to 85.1,556
PCV,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,90.3,86.6 to 93.0,556
PCV,≥4 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,77.9,72.8 to 82.3,556
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,19 Months,91.2,87.5 to 93.8,556
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019-2020,Age,19 Months,86.6,82.2 to 90.1,556
Hib,Full Series,States/Local Areas,Wyoming,2019-2020,Age,19 Months,76.1,70.9 to 80.7,556
Combined 7 Series,,States/Local Areas,Wyoming,2019-2020,Age,35 Months,74.3,68.7 to 79.6,556
Hib,≥3 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,89.2,85.5 to 92.4,556
Hib,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,7 Months,89.5,85.7 to 92.4,556
Hib,Primary Series,States/Local Areas,Wyoming,2019-2020,Age,24 Months,91.4,87.8 to 94.2,556
Influenza,,States/Local Areas,Wyoming,2019-2020,Age,24 Months,58.8,53.2 to 64.6,556
Hep A,≥2 Doses,States/Local Areas,Wyoming,2019-2020,Age,24 Months,48.4,42.8 to 54.4,556
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,94.9,90.2 to 97.8,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,93.3,89.1 to 96.4,231
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,93.0,90.0 to 95.3,518
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,91.1,89.1 to 93.0,949
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,87.7,83.5 to 91.8,247
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,91.5,88.8 to 94.2,514
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,95.3,91.7 to 98.9,188
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,95.0,91.6 to 97.4,280
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,94.9,92.1 to 97.0,540
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,92.5,88.1 to 95.7,287
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,93.6,90.9 to 95.7,567
DTaP,≥2 Doses,States/Local Areas,Wyoming,2016,Age,5 Months,76.6,69.4 to 82.5,231
DTaP,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,5 Months,79.9,75.3 to 83.8,518
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,90.2,87.7 to 92.8,630
DTaP,≥2 Doses,States/Local Areas,Wyoming,2017,Age,5 Months,83.7,77.6 to 88.3,287
DTaP,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,5 Months,82.9,78.6 to 86.5,567
Hep A,≥1 Dose,States/Local Areas,Wyoming,2013,Age,19 Months,70.5,65.1 to 75.4,215
Hep A,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,19 Months,65.2,59.9 to 70.2,480
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014,Age,19 Months,59.8,52.3 to 66.8,265
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,19 Months,62.7,57.6 to 67.5,548
Hep A,≥1 Dose,States/Local Areas,Wyoming,2015,Age,19 Months,65.6,63.6 to 67.4,283
Hep A,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,19 Months,65.8,60.6 to 70.6,514
DTaP,≥2 Doses,States/Local Areas,Wyoming,2018,Age,5 Months,82.0,75.4 to 87.2,280
DTaP,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,5 Months,83.4,78.9 to 87.0,540
Hib,≥3 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,83.6,77.9 to 88.5,265
Hib,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,85.4,81.5 to 88.8,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,89.2,84.2 to 93.2,231
Hib,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,89.8,86.5 to 92.5,518
Hib,≥3 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,87.1,81.7 to 91.5,283
Hib,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,88.2,84.5 to 91.3,514
Hep A,≥1 Dose,States/Local Areas,Wyoming,2013,Age,24 Months,70.5,62.3 to 78.3,215
Hep A,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,24 Months,67.6,62.2 to 72.9,480
Hep A,≥1 Dose,States/Local Areas,Wyoming,2011,Age,24 Months,55.6,47.0 to 64.6,214
Hep A,≥1 Dose,States/Local Areas,Wyoming,2012,Age,24 Months,64.6,55.5 to 73.7,217
Hep A,≥1 Dose,States/Local Areas,Wyoming,2019,Age,19 Months,85.9,79.8 to 90.4,260
DTaP,≥2 Doses,States/Local Areas,Wyoming,2019,Age,5 Months,84.6,78.0 to 89.5,260
Hib,≥3 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,88.3,81.4 to 93.5,214
Hep A,≥1 Dose,States/Local Areas,Wyoming,2018,Age,24 Months,78.8,72.5 to 84.6,280
Hep A,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,24 Months,83.1,78.9 to 86.9,540
Hep A,≥1 Dose,States/Local Areas,Wyoming,2011,Age,35 Months,57.4,48.6 to 66.5,214
Hep A,≥1 Dose,States/Local Areas,Wyoming,2019,Age,24 Months,87.0,81.3 to 91.6,260
Hep A,≥2 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,35.3,27.7 to 43.7,260
PCV,≥2 Doses,States/Local Areas,Wyoming,2016,Age,5 Months,76.6,69.6 to 82.5,231
PCV,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,5 Months,79.2,74.5 to 83.2,518
Hep A,≥1 Dose,States/Local Areas,Wyoming,2017,Age,24 Months,77.5,71.4 to 83.1,287
Hep A,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,24 Months,78.1,73.7 to 82.2,567
Hep A,≥2 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,21.4,15.9 to 28.1,287
Hep A,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,24.7,20.4 to 29.6,567
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,94.9,93.1 to 96.7,595
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,90.5,86.5 to 94.4,258
DTaP,≥4 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,65.5,62.9 to 68.1,283
DTaP,≥4 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,67.5,62.4 to 72.2,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,59.0,51.5 to 66.1,265
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,62.3,57.1 to 67.1,548
DTaP,≥4 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,70.9,63.1 to 77.5,215
DTaP,≥4 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,65.0,60.1 to 69.6,480
Hib,≥3 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,91.7,87.6 to 94.9,287
Hib,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,92.9,89.4 to 95.6,567
Hib,≥3 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,89.8,84.7 to 93.7,231
Hib,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,90.6,87.4 to 93.3,518
Hep A,≥2 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,28.4,22.2 to 35.6,280
Hep A,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,32.3,26.5 to 38.7,439
Hep A,≥2 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,17.8,12.3 to 25.4,214
PCV,≥2 Doses,States/Local Areas,Wyoming,2014,Age,5 Months,69.2,62.0 to 75.7,265
PCV,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,5 Months,72.7,70.6 to 74.6,548
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016,Age,24 Months,73.4,66.4 to 79.9,231
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,24 Months,75.3,70.6 to 79.7,518
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014,Age,24 Months,64.3,57.2 to 71.3,265
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,24 Months,67.4,62.5 to 72.2,548
Hep A,≥1 Dose,States/Local Areas,Wyoming,2015,Age,24 Months,70.3,63.6 to 76.8,283
Hep A,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,24 Months,71.9,67.0 to 76.5,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,95.6,92.1 to 97.8,280
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,97.1,94.2 to 98.8,540
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,97.6,93.6 to 99.3,260
PCV,≥2 Doses,States/Local Areas,Wyoming,2013,Age,5 Months,79.7,73.8 to 84.6,215
PCV,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,5 Months,74.6,68.9 to 79.5,480
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,91.8,84.1 to 99.4,37
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,92.5,88.1 to 95.7,287
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,93.8,91.1 to 96.0,567
PCV,≥2 Doses,States/Local Areas,Wyoming,2015,Age,5 Months,76.0,69.3 to 81.7,283
PCV,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,5 Months,76.4,71.6 to 80.5,514
Hib,≥3 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,85.2,79.6 to 90.0,265
Hib,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,87.5,83.7 to 90.8,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,94.3,88.8 to 97.7,215
Hib,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,89.7,85.9 to 92.9,480
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,23.8,17.9 to 30.9,231
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,22.7,18.5 to 27.5,518
Hep A,≥2 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,22.4,20.6 to 24.3,283
Hep A,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,23.1,18.9 to 27.8,514
Hib,≥3 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,93.6,87.5 to 97.3,217
Hep A,≥1 Dose,States/Local Areas,Wyoming,2017,Age,19 Months,70.9,64.2 to 76.8,287
Hep A,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,19 Months,72.0,67.2 to 76.4,567
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016,Age,19 Months,66.0,58.3 to 72.9,231
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,19 Months,68.3,63.2 to 73.0,518
Hep A,≥1 Dose,States/Local Areas,Wyoming,2018,Age,19 Months,73.3,66.1 to 79.4,280
Hep A,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,19 Months,78.5,73.1 to 83.0,439
Hib,≥3 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,89.6,84.1 to 93.8,283
Hib,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,89.8,86.1 to 92.9,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,77.9,66.7 to 89.1,59
DTaP,≥3 Doses,States/Local Areas,Wyoming,2021,Age,24 Months,92.0,84.7 to 96.7,201
Hib,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,88.1,83.4 to 92.0,497
Hib,≥2 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,90.2,81.9 to 94.9,201
PCV,≥3 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,98.6,91.2 to 99.9,201
Hib,≥3 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,83.9,74.1 to 90.5,201
Polio,≥2 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,91.7,83.4 to 96.1,201
≥1 Dose MMR,,States/Local Areas,Wyoming,2020-2021,Age,24 Months,89.6,84.8 to 93.4,497
DTaP,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,19 Months,89.8,85.1 to 93.1,497
Hep B,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,92.6,88.3 to 95.5,497
Polio,≥3 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,92.7,85.0 to 97.3,201
Hep B,≥2 Doses,States/Local Areas,Wyoming,2021,Age,5 Months,84.7,75.1 to 91.0,201
Hib,Primary Series,States/Local Areas,Wyoming,2021,Age,7 Months,77.9,67.7 to 85.5,201
PCV,≥2 Doses,States/Local Areas,Wyoming,2020-2021,Age,5 Months,77.8,71.8 to 82.7,497
DTaP,≥4 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,76.1,70.0 to 81.7,497
DTaP,≥3 Doses,States/Local Areas,Wyoming,2021,Age,7 Months,64.0,53.2 to 73.5,201
Combined 7 Series,,States/Local Areas,Wyoming,2021,Age,35 Months,72.9,59.2 to 85.1,201
Hep A,≥2 Doses,States/Local Areas,Wyoming,2021,Age,35 Months,80.3,63.8 to 92.6,201
DTaP,≥4 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,70.3,59.8 to 78.9,201
≥1 Dose MMR,,States/Local Areas,Wyoming,2021,Age,35 Months,91.1,83.3 to 96.2,201
Hep B,≥3 Doses,States/Local Areas,Wyoming,2021,Age,19 Months,89.8,81.1 to 94.8,201
Hib,Primary Series,States/Local Areas,Wyoming,2020-2021,Age,24 Months,91.5,87.4 to 94.7,497
Hib,Primary Series,States/Local Areas,Wyoming,2021,Age,19 Months,91.1,82.6 to 95.7,201
DTaP,≥1 Dose,States/Local Areas,Wyoming,2016,Age,3 Months,88.5,82.5 to 92.6,231
DTaP,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,3 Months,89.2,85.4 to 92.1,518
DTaP,≥1 Dose,States/Local Areas,Wyoming,2015,Age,3 Months,88.1,82.7 to 92.0,283
DTaP,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,3 Months,88.3,84.5 to 91.3,514
DTaP,≥1 Dose,States/Local Areas,Wyoming,2014,Age,3 Months,82.7,76.2 to 87.7,265
DTaP,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,3 Months,85.4,81.3 to 88.8,548
DTaP,≥1 Dose,States/Local Areas,Wyoming,2013,Age,3 Months,90.9,83.5 to 95.2,215
DTaP,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,3 Months,86.9,81.5 to 90.9,480
Hib,≥1 Dose,States/Local Areas,Wyoming,2021,Age,3 Months,90.7,82.8 to 95.2,201
DTaP,≥1 Dose,States/Local Areas,Wyoming,2011,Age,3 Months,80.1,75.8 to 83.8,214
DTaP,≥1 Dose,States/Local Areas,Wyoming,2012,Age,3 Months,87.8,85.1 to 90.1,217
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,90.0,85.8 to 93.5,265
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,91.9,89.1 to 94.2,548
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,93.7,89.7 to 96.5,283
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,93.5,90.7 to 95.7,514
DTaP,≥1 Dose,States/Local Areas,Wyoming,2019,Age,3 Months,92.5,86.8 to 95.8,260
DTaP,≥1 Dose,States/Local Areas,Wyoming,2018,Age,3 Months,89.5,84.1 to 93.1,280
DTaP,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,3 Months,91.0,87.4 to 93.7,540
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,95.3,90.8 to 98.0,215
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,92.7,89.8 to 95.0,480
Hep A,≥1 Dose,States/Local Areas,Wyoming,2011,Age,19 Months,47.7,42.6 to 53.0,214
DTaP,≥1 Dose,States/Local Areas,Wyoming,2017,Age,3 Months,90.1,84.8 to 93.6,287
DTaP,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,3 Months,89.8,86.2 to 92.5,567
PCV,≥2 Doses,States/Local Areas,Wyoming,2021,Age,5 Months,77.9,67.9 to 85.5,201
PCV,≥4 Doses,States/Local Areas,Wyoming,2020-2021,Age,24 Months,78.3,72.6 to 83.5,497
Hib,Full Series,States/Local Areas,Wyoming,2021,Age,19 Months,75.6,65.4 to 83.5,201
DTaP,≥4 Doses,States/Local Areas,Wyoming,2020-2021,Age,35 Months,85.4,78.5 to 90.9,497
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020-2021,Age,13 Months,88.1,83.3 to 91.7,497
Hep A,≥1 Dose,States/Local Areas,Wyoming,2012,Age,19 Months,57.3,48.7 to 65.5,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",71.2,64.5 to 78.0,682
Hib,≥3 Doses,States/Local Areas,California,2015,Age,24 Months,92.4,86.0 to 96.6,293
Hib,≥3 Doses,States/Local Areas,California,2015-2016,Age,24 Months,90.1,85.5 to 93.7,599
Hib,≥3 Doses,States/Local Areas,California,2016,Age,24 Months,88.0,80.9 to 93.4,306
Hib,≥3 Doses,States/Local Areas,California,2016-2017,Age,24 Months,89.5,85.1 to 93.1,724
DTaP,≥3 Doses,States/Local Areas,California,2019,Age,24 Months,95.5,92.0 to 97.7,537
Hib,≥3 Doses,States/Local Areas,California,2017,Age,24 Months,91.1,85.6 to 95.1,418
Hib,≥3 Doses,States/Local Areas,California,2017-2018,Age,24 Months,92.4,89.1 to 94.9,977
Hib,Full Series,States/Local Areas,California,2021,Age,19 Months,64.8,54.8 to 73.7,253
DTaP,≥4 Doses,States/Local Areas,California,2020-2021,Age,35 Months,82.3,75.3 to 88.3,687
Hep B,≥3 Doses,States/Local Areas,California,2021,Age,19 Months,87.4,79.4 to 92.6,253
Hep A,≥1 Dose,States/Local Areas,California,2013,Age,19 Months,79.8,73.3 to 85.1,319
Hep A,≥1 Dose,States/Local Areas,California,2013-2014,Age,19 Months,80.6,78.0 to 83.1,674
Hep A,≥1 Dose,States/Local Areas,California,2012,Age,19 Months,76.6,73.4 to 79.5,320
DTaP,≥3 Doses,States/Local Areas,California,2016,Age,24 Months,93.7,88.2 to 97.2,306
DTaP,≥3 Doses,States/Local Areas,California,2016-2017,Age,24 Months,93.4,89.9 to 96.0,724
DTaP,≥1 Dose,States/Local Areas,California,2019,Age,3 Months,93.3,89.6 to 95.8,537
Hep A,≥1 Dose,States/Local Areas,California,2011,Age,19 Months,81.8,74.2 to 87.6,298
DTaP,≥1 Dose,States/Local Areas,California,2017,Age,3 Months,83.6,76.4 to 88.9,418
DTaP,≥1 Dose,States/Local Areas,California,2017-2018,Age,3 Months,87.3,83.1 to 90.5,977
DTaP,≥3 Doses,States/Local Areas,California,2014,Age,24 Months,92.0,86.0 to 96.1,355
DTaP,≥3 Doses,States/Local Areas,California,2014-2015,Age,24 Months,93.5,89.7 to 96.3,648
DTaP,≥3 Doses,States/Local Areas,California,2015,Age,24 Months,94.8,89.8 to 97.8,293
DTaP,≥3 Doses,States/Local Areas,California,2015-2016,Age,24 Months,94.2,90.7 to 96.7,599
DTaP,≥1 Dose,States/Local Areas,California,2018,Age,3 Months,91.1,86.6 to 94.2,559
DTaP,≥1 Dose,States/Local Areas,California,2018-2019,Age,3 Months,92.2,89.4 to 94.3,1096
Hep A,≥1 Dose,States/Local Areas,California,2016,Age,19 Months,80.4,71.2 to 87.2,306
Hep A,≥1 Dose,States/Local Areas,California,2016-2017,Age,19 Months,81.0,75.4 to 85.5,724
Hep A,≥1 Dose,States/Local Areas,California,2014,Age,19 Months,81.5,73.5 to 87.5,355
Hep A,≥1 Dose,States/Local Areas,California,2014-2015,Age,19 Months,83.6,78.0 to 88.0,648
Hep A,≥1 Dose,States/Local Areas,California,2015,Age,19 Months,85.7,83.4 to 87.8,293
Hep A,≥1 Dose,States/Local Areas,California,2015-2016,Age,19 Months,83.1,77.1 to 87.7,599
DTaP,≥2 Doses,States/Local Areas,California,2017,Age,5 Months,72.3,64.1 to 79.2,418
DTaP,≥2 Doses,States/Local Areas,California,2017-2018,Age,5 Months,75.9,70.7 to 80.4,977
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Overall,Overall,90.3,87.2 to 93.3,1141
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,87.9,82.2 to 93.6,215
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,86.2,79.5 to 92.9,343
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,96.2,93.7 to 98.7,583
DTaP,≥3 Doses,States/Local Areas,California,2017,Age,24 Months,93.1,88.0 to 96.6,418
DTaP,≥3 Doses,States/Local Areas,California,2017-2018,Age,24 Months,94.5,91.7 to 96.6,977
DTaP,≥3 Doses,States/Local Areas,California,2018,Age,24 Months,96.0,93.4 to 97.8,559
DTaP,≥3 Doses,States/Local Areas,California,2018-2019,Age,24 Months,95.8,93.7 to 97.3,1096
DTaP,≥1 Dose,States/Local Areas,California,2011,Age,3 Months,89.6,84.2 to 93.3,298
DTaP,≥1 Dose,States/Local Areas,California,2012,Age,3 Months,86.5,80.6 to 90.8,320
DTaP,≥1 Dose,States/Local Areas,California,2013,Age,3 Months,89.5,87.6 to 91.2,319
DTaP,≥1 Dose,States/Local Areas,California,2013-2014,Age,3 Months,86.2,83.1 to 88.8,674
DTaP,≥1 Dose,States/Local Areas,California,2014,Age,3 Months,82.8,75.2 to 88.4,355
DTaP,≥1 Dose,States/Local Areas,California,2014-2015,Age,3 Months,86.6,81.5 to 90.5,648
DTaP,≥1 Dose,States/Local Areas,California,2015,Age,3 Months,90.5,82.8 to 94.9,293
DTaP,≥1 Dose,States/Local Areas,California,2015-2016,Age,3 Months,88.2,82.9 to 92.0,599
DTaP,≥1 Dose,States/Local Areas,California,2016,Age,3 Months,86.0,77.6 to 91.6,306
DTaP,≥1 Dose,States/Local Areas,California,2016-2017,Age,3 Months,84.8,79.5 to 88.9,724
Hib,Primary Series,States/Local Areas,California,2020-2021,Age,24 Months,89.1,84.9 to 92.6,687
Hib,Primary Series,States/Local Areas,California,2021,Age,19 Months,88.5,81.0 to 93.3,253
Hep B,≥3 Doses,States/Local Areas,California,2020-2021,Age,13 Months,84.4,79.2 to 88.6,687
DTaP,≥4 Doses,States/Local Areas,California,2021,Age,19 Months,55.1,45.1 to 64.6,253
DTaP,≥4 Doses,States/Local Areas,California,2020-2021,Age,24 Months,72.4,66.1 to 78.5,687
DTaP,≥2 Doses,States/Local Areas,California,2019,Age,5 Months,82.2,76.6 to 86.7,537
DTaP,≥2 Doses,States/Local Areas,California,2018,Age,5 Months,79.6,73.5 to 84.6,559
DTaP,≥2 Doses,States/Local Areas,California,2018-2019,Age,5 Months,80.9,76.9 to 84.4,1096
Hep A,≥2 Doses,States/Local Areas,California,2021,Age,35 Months,77.6,56.6 to 93.1,253
Combined 7 Series,,States/Local Areas,California,2021,Age,35 Months,60.3,48.8 to 72.1,253
PCV,≥4 Doses,States/Local Areas,California,2020-2021,Age,24 Months,74.9,68.8 to 80.6,687
Hep B,≥2 Doses,States/Local Areas,California,2021,Age,5 Months,80.5,70.8 to 87.5,253
Hib,Primary Series,States/Local Areas,California,2021,Age,7 Months,55.6,45.9 to 65.0,253
≥1 Dose MMR,,States/Local Areas,California,2020-2021,Age,24 Months,88.6,84.3 to 92.2,687
PCV,≥2 Doses,States/Local Areas,California,2021,Age,5 Months,71.7,62.0 to 79.7,253
DTaP,≥3 Doses,States/Local Areas,California,2021,Age,7 Months,55.5,45.7 to 64.9,253
Hep B,≥2 Doses,States/Local Areas,California,2020-2021,Age,13 Months,89.9,85.2 to 93.2,687
Polio,≥2 Doses,States/Local Areas,California,2021,Age,7 Months,83.1,74.1 to 89.4,253
Hib,≥3 Doses,States/Local Areas,California,2020-2021,Age,24 Months,88.2,83.8 to 91.8,687
Hib,≥2 Doses,States/Local Areas,California,2021,Age,7 Months,85.0,76.6 to 90.7,253
Hep A,≥1 Dose,States/Local Areas,California,2017,Age,19 Months,81.6,74.7 to 87.0,418
Hep A,≥1 Dose,States/Local Areas,California,2017-2018,Age,19 Months,84.7,80.6 to 88.1,977
Hep A,≥1 Dose,States/Local Areas,California,2018,Age,19 Months,88.0,83.2 to 91.6,559
Hep A,≥1 Dose,States/Local Areas,California,2018-2019,Age,19 Months,86.6,82.5 to 89.8,920
DTaP,≥3 Doses,States/Local Areas,California,2011,Age,35 Months,93.9,86.9 to 97.9,298
DTaP,≥3 Doses,States/Local Areas,California,2012,Age,35 Months,97.7,94.5 to 99.3,320
DTaP,≥3 Doses,States/Local Areas,California,2013,Age,35 Months,95.8,91.3 to 98.3,319
DTaP,≥3 Doses,States/Local Areas,California,2013-2014,Age,35 Months,94.8,91.4 to 97.2,674
DTaP,≥3 Doses,States/Local Areas,California,2014,Age,35 Months,93.7,88.3 to 97.1,355
DTaP,≥3 Doses,States/Local Areas,California,2014-2015,Age,35 Months,94.7,91.0 to 97.2,648
DTaP,≥3 Doses,States/Local Areas,California,2015,Age,35 Months,94.8,89.8 to 97.8,293
DTaP,≥3 Doses,States/Local Areas,California,2015-2016,Age,35 Months,94.2,90.7 to 96.7,599
Hep A,≥2 Doses,States/Local Areas,California,2011,Age,19 Months,21.9,17.7 to 26.7,298
Hep A,≥2 Doses,States/Local Areas,California,2013,Age,19 Months,21.3,13.7 to 31.5,319
Hep A,≥2 Doses,States/Local Areas,California,2013-2014,Age,19 Months,25.3,18.4 to 33.6,674
Hep A,≥2 Doses,States/Local Areas,California,2012,Age,19 Months,21.0,16.6 to 26.1,320
Hep A,≥2 Doses,States/Local Areas,California,2014,Age,19 Months,29.3,21.8 to 38.0,355
Hep A,≥2 Doses,States/Local Areas,California,2014-2015,Age,19 Months,25.2,19.9 to 31.4,648
Hib,≥3 Doses,States/Local Areas,California,2018,Age,24 Months,93.6,89.9 to 96.3,559
Hib,≥3 Doses,States/Local Areas,California,2018-2019,Age,24 Months,93.9,91.3 to 95.9,1096
Hib,≥3 Doses,States/Local Areas,California,2019,Age,24 Months,94.1,90.2 to 96.8,537
DTaP,≥3 Doses,States/Local Areas,California,2021,Age,24 Months,91.0,84.5 to 95.5,253
Hib,≥3 Doses,States/Local Areas,California,2011,Age,35 Months,93.5,86.4 to 97.6,298
Hib,≥3 Doses,States/Local Areas,California,2012,Age,35 Months,97.2,93.7 to 99.0,320
Hep A,≥1 Dose,States/Local Areas,California,2015,Age,24 Months,89.7,82.8 to 94.7,293
Hep A,≥1 Dose,States/Local Areas,California,2015-2016,Age,24 Months,87.9,82.8 to 92.0,599
Hep A,≥1 Dose,States/Local Areas,California,2016,Age,24 Months,86.1,78.4 to 92.1,306
Hep A,≥1 Dose,States/Local Areas,California,2016-2017,Age,24 Months,86.4,81.6 to 90.4,724
PCV,≥2 Doses,States/Local Areas,California,2014,Age,5 Months,66.9,58.0 to 74.7,355
PCV,≥2 Doses,States/Local Areas,California,2014-2015,Age,5 Months,68.7,65.1 to 72.1,648
PCV,≥2 Doses,States/Local Areas,California,2015,Age,5 Months,70.5,60.6 to 78.8,293
PCV,≥2 Doses,States/Local Areas,California,2015-2016,Age,5 Months,72.8,65.8 to 78.9,599
PCV,≥2 Doses,States/Local Areas,California,2016,Age,5 Months,75.1,64.7 to 83.3,306
PCV,≥2 Doses,States/Local Areas,California,2016-2017,Age,5 Months,72.6,66.1 to 78.2,724
DTaP,≥3 Doses,States/Local Areas,California,2018,Age,35 Months,96.8,94.2 to 98.5,559
DTaP,≥3 Doses,States/Local Areas,California,2018-2019,Age,35 Months,96.3,94.1 to 97.9,1096
DTaP,≥3 Doses,States/Local Areas,California,2019,Age,35 Months,95.7,92.1 to 98.0,537
Hep A,≥1 Dose,States/Local Areas,California,2017,Age,24 Months,86.8,80.8 to 91.6,418
Hep A,≥1 Dose,States/Local Areas,California,2017-2018,Age,24 Months,89.2,85.7 to 92.2,977
DTaP,≥4 Doses,States/Local Areas,California,2014,Age,19 Months,63.7,54.8 to 71.8,355
DTaP,≥4 Doses,States/Local Areas,California,2014-2015,Age,19 Months,67.1,60.3 to 73.3,648
DTaP,≥4 Doses,States/Local Areas,California,2015,Age,19 Months,70.7,64.4 to 76.2,293
DTaP,≥4 Doses,States/Local Areas,California,2015-2016,Age,19 Months,66.5,59.0 to 73.3,599
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,96.5,93.8 to 99.2,820
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,90.3,85.7 to 94.8,283
DTaP,≥4 Doses,States/Local Areas,California,2016,Age,19 Months,62.4,51.8 to 71.9,306
DTaP,≥4 Doses,States/Local Areas,California,2016-2017,Age,19 Months,65.3,58.6 to 71.4,724
Hep A,≥2 Doses,States/Local Areas,California,2018,Age,19 Months,27.4,21.9 to 33.7,559
Hep A,≥2 Doses,States/Local Areas,California,2018-2019,Age,19 Months,30.2,25.5 to 35.3,920
Hep A,≥2 Doses,States/Local Areas,California,2019,Age,19 Months,29.8,24.6 to 35.6,537
Hep A,≥2 Doses,States/Local Areas,California,2011,Age,24 Months,48.0,39.3 to 57.5,298
Hib,≥3 Doses,States/Local Areas,California,2016,Age,35 Months,92.7,83.7 to 97.7,306
Hib,≥3 Doses,States/Local Areas,California,2016-2017,Age,35 Months,91.7,87.0 to 95.2,724
Hib,≥3 Doses,States/Local Areas,California,2017,Age,35 Months,91.3,85.7 to 95.3,418
Hib,≥3 Doses,States/Local Areas,California,2017-2018,Age,35 Months,92.6,89.4 to 95.2,977
Hep A,≥2 Doses,States/Local Areas,California,2012,Age,24 Months,43.8,35.7 to 52.9,320
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.1,77.3 to 100.0,41
Hib,≥3 Doses,States/Local Areas,California,2018,Age,35 Months,94.0,90.2 to 96.7,559
Hib,≥3 Doses,States/Local Areas,California,2018-2019,Age,35 Months,94.4,91.8 to 96.4,1096
Polio,≥3 Doses,States/Local Areas,California,2019-2020,Age,35 Months,94.1,91.2 to 96.4,971
DTaP,≥4 Doses,States/Local Areas,California,2019-2020,Age,35 Months,87.6,82.7 to 91.6,971
DTaP,≥3 Doses,States/Local Areas,California,2019-2020,Age,35 Months,94.4,91.5 to 96.6,971
Combined 7 Series,,States/Local Areas,California,2019-2020,Age,24 Months,66.6,61.8 to 71.4,971
PCV,≥3 Doses,States/Local Areas,California,2019-2020,Age,13 Months,87.9,84.1 to 90.9,971
≥1 Dose Varicella,,States/Local Areas,California,2019-2020,Age,13 Months,58.0,53.2 to 62.6,971
Hep B,≥3 Doses,States/Local Areas,California,2019-2020,Age,13 Months,88.0,84.1 to 91.1,971
Hep B,≥2 Doses,States/Local Areas,California,2019-2020,Age,13 Months,94.7,92.1 to 96.5,971
Polio,≥2 Doses,States/Local Areas,California,2019-2020,Age,7 Months,91.4,88.3 to 93.8,971
DTaP,≥3 Doses,States/Local Areas,California,2019-2020,Age,7 Months,67.1,62.2 to 71.6,971
PCV,≥2 Doses,States/Local Areas,California,2019-2020,Age,5 Months,77.5,73.2 to 81.3,971
Hep B,≥2 Doses,States/Local Areas,California,2019-2020,Age,5 Months,88.1,84.3 to 91.1,971
Hib,≥2 Doses,States/Local Areas,California,2019-2020,Age,5 Months,77.5,73.2 to 81.3,971
Hib,Primary Series,States/Local Areas,California,2019-2020,Age,13 Months,87.5,83.7 to 90.4,971
Hib,≥3 Doses,States/Local Areas,California,2019-2020,Age,13 Months,80.6,76.4 to 84.2,971
Hib,≥2 Doses,States/Local Areas,California,2019-2020,Age,13 Months,94.3,91.4 to 96.2,971
≥1 Dose MMR,,States/Local Areas,California,2019-2020,Age,13 Months,62.4,57.6 to 67.0,971
Polio,≥2 Doses,States/Local Areas,California,2019-2020,Age,13 Months,95.4,93.0 to 97.0,971
DTaP,≥3 Doses,States/Local Areas,California,2019-2020,Age,13 Months,89.4,85.7 to 92.2,971
Polio,≥2 Doses,States/Local Areas,California,2019-2020,Age,5 Months,78.1,73.9 to 81.9,971
DTaP,≥2 Doses,States/Local Areas,California,2019-2020,Age,5 Months,79.1,74.9 to 82.8,971
PCV,≥1 Dose,States/Local Areas,California,2019-2020,Age,3 Months,87.9,84.3 to 90.7,971
Hep B,≥1 Dose,States/Local Areas,California,2019-2020,Age,3 Months,94.7,92.2 to 96.5,971
Hib,≥1 Dose,States/Local Areas,California,2019-2020,Age,3 Months,87.3,83.7 to 90.2,971
≥1 Dose MMR,,States/Local Areas,California,2019-2020,Age,24 Months,89.4,85.7 to 92.5,971
Polio,≥3 Doses,States/Local Areas,California,2019-2020,Age,24 Months,92.8,89.9 to 95.2,971
DTaP,≥4 Doses,States/Local Areas,California,2019-2020,Age,24 Months,77.5,72.8 to 81.9,971
DTaP,≥3 Doses,States/Local Areas,California,2019-2020,Age,24 Months,93.1,90.2 to 95.5,971
PCV,≥4 Doses,States/Local Areas,California,2019-2020,Age,35 Months,84.3,79.6 to 88.5,971
PCV,≥3 Doses,States/Local Areas,California,2019-2020,Age,35 Months,92.8,89.6 to 95.3,971
≥1 Dose Varicella,,States/Local Areas,California,2019-2020,Age,35 Months,92.4,88.4 to 95.4,971
Hep B,≥3 Doses,States/Local Areas,California,2019-2020,Age,35 Months,94.0,90.6 to 96.5,971
Hib,Full Series,States/Local Areas,California,2019-2020,Age,35 Months,82.3,77.9 to 86.3,971
Hib,≥3 Doses,States/Local Areas,California,2019-2020,Age,35 Months,92.8,89.6 to 95.2,971
Hib,Primary Series,States/Local Areas,California,2019-2020,Age,35 Months,94.1,91.2 to 96.3,971
≥1 Dose MMR,,States/Local Areas,California,2019-2020,Age,35 Months,92.3,88.3 to 95.4,971
Hib,Primary Series,States/Local Areas,California,2019-2020,Age,19 Months,92.5,89.4 to 94.8,971
Hib,≥3 Doses,States/Local Areas,California,2019-2020,Age,19 Months,90.7,87.3 to 93.2,971
≥1 Dose MMR,,States/Local Areas,California,2019-2020,Age,19 Months,86.8,82.7 to 90.1,971
Polio,≥3 Doses,States/Local Areas,California,2019-2020,Age,19 Months,92.3,89.0 to 94.6,971
Hep A,≥2 Doses,States/Local Areas,California,2019-2020,Age,19 Months,28.1,24.4 to 32.2,971
PCV,≥3 Doses,States/Local Areas,California,2019-2020,Age,24 Months,91.9,88.8 to 94.4,971
PCV,≥4 Doses,States/Local Areas,California,2019-2020,Age,24 Months,79.6,75.0 to 83.7,971
≥1 Dose Varicella,,States/Local Areas,California,2019-2020,Age,24 Months,88.2,84.4 to 91.5,971
Hep B,≥3 Doses,States/Local Areas,California,2019-2020,Age,24 Months,92.2,89.0 to 94.8,971
Hib,Full Series,States/Local Areas,California,2019-2020,Age,24 Months,77.2,72.9 to 81.3,971
PCV,≥3 Doses,States/Local Areas,California,2019-2020,Age,7 Months,64.6,59.7 to 69.1,971
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2019-2020,Age,0-2 Days,76.6,72.3 to 80.5,971
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2019-2020,Age,0-1 Days,74.4,70.0 to 78.3,971
Hep A,≥1 Dose,States/Local Areas,California,2019-2020,Age,19 Months,84.8,80.6 to 88.2,971
PCV,≥4 Doses,States/Local Areas,California,2019-2020,Age,19 Months,76.0,71.4 to 80.2,971
PCV,≥3 Doses,States/Local Areas,California,2019-2020,Age,19 Months,91.2,87.8 to 93.7,971
Hib,Full Series,States/Local Areas,California,2019-2020,Age,19 Months,72.5,68.0 to 76.6,971
Hep B,≥3 Doses,States/Local Areas,California,2019-2020,Age,19 Months,90.9,87.3 to 93.6,971
Combined 7 Series,,States/Local Areas,California,2019-2020,Age,35 Months,72.4,67.4 to 77.3,971
Hib,Primary Series,States/Local Areas,California,2019-2020,Age,24 Months,92.6,89.7 to 94.9,971
Hib,≥2 Doses,States/Local Areas,California,2019-2020,Age,7 Months,90.6,87.3 to 93.1,971
Hib,≥3 Doses,States/Local Areas,California,2019-2020,Age,24 Months,91.2,88.0 to 93.8,971
Hep A,≥2 Doses,States/Local Areas,California,2019-2020,Age,24 Months,53.9,49.0 to 58.9,971
Influenza,,States/Local Areas,California,2019-2020,Age,24 Months,69.0,64.3 to 73.5,971
Hep A,≥1 Dose,States/Local Areas,California,2019-2020,Age,35 Months,92.0,87.9 to 95.1,971
Hep A,≥2 Doses,States/Local Areas,California,2019-2020,Age,35 Months,77.7,72.2 to 82.7,971
Hep A,≥1 Dose,States/Local Areas,California,2019-2020,Age,24 Months,88.0,84.2 to 91.3,971
≥1 Dose MMR,,States/Local Areas,California,2020,Age,13 Months,56.9,49.6 to 63.9,434
Hep A,≥2 Doses,States/Local Areas,California,2020,Age,35 Months,76.7,68.7 to 83.9,434
Combined 7 Series,,States/Local Areas,California,2020,Age,35 Months,71.4,64.1 to 78.4,434
Hep A,≥1 Dose,States/Local Areas,California,2020,Age,19 Months,84.0,76.9 to 89.2,434
Hep A,≥2 Doses,States/Local Areas,California,2020,Age,19 Months,26.1,21.0 to 32.0,434
Rotavirus,,States/Local Areas,California,2020,Age,8 Months,73.3,65.9 to 79.6,434
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2020,Age,0-2 Days,72.7,65.9 to 78.7,434
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2020,Age,0-1 Days,71.6,64.7 to 77.5,434
Polio,≥2 Doses,States/Local Areas,California,2020,Age,7 Months,90.0,84.7 to 93.5,434
Hib,≥2 Doses,States/Local Areas,California,2020,Age,7 Months,88.0,82.3 to 92.0,434
Hib,≥3 Doses,States/Local Areas,California,2020,Age,7 Months,53.7,46.6 to 60.6,434
Hib,Primary Series,States/Local Areas,California,2020,Age,7 Months,68.2,61.3 to 74.4,434
DTaP,≥4 Doses,States/Local Areas,California,2020,Age,24 Months,77.1,69.8 to 83.7,434
DTaP,≥3 Doses,States/Local Areas,California,2020,Age,24 Months,90.6,85.6 to 94.5,434
Polio,≥3 Doses,States/Local Areas,California,2020,Age,24 Months,90.5,85.5 to 94.4,434
≥1 Dose MMR,,States/Local Areas,California,2020,Age,24 Months,88.2,82.0 to 93.1,434
Hib,≥3 Doses,States/Local Areas,California,2020,Age,24 Months,88.2,82.8 to 92.5,434
≥1 Dose MMR,,States/Local Areas,California,2020,Age,35 Months,91.4,85.1 to 95.8,434
Hib,≥3 Doses,States/Local Areas,California,2020,Age,35 Months,90.5,85.4 to 94.4,434
Hib,Primary Series,States/Local Areas,California,2020,Age,35 Months,90.5,85.4 to 94.4,434
Hib,Full Series,States/Local Areas,California,2020,Age,35 Months,81.1,74.8 to 86.7,434
Hep B,≥3 Doses,States/Local Areas,California,2020,Age,35 Months,90.6,84.5 to 95.0,434
≥1 Dose Varicella,,States/Local Areas,California,2020,Age,35 Months,91.7,85.3 to 96.1,434
Hib,Primary Series,States/Local Areas,California,2020,Age,19 Months,88.3,82.5 to 92.4,434
Hib,Full Series,States/Local Areas,California,2020,Age,19 Months,73.2,66.4 to 79.1,434
Hep B,≥3 Doses,States/Local Areas,California,2020,Age,19 Months,87.6,80.7 to 92.3,434
≥1 Dose Varicella,,States/Local Areas,California,2020,Age,19 Months,85.2,78.3 to 90.2,434
DTaP,≥3 Doses,States/Local Areas,California,2020,Age,35 Months,92.7,87.9 to 96.0,434
DTaP,≥4 Doses,States/Local Areas,California,2020,Age,35 Months,86.3,78.7 to 92.3,434
PCV,≥3 Doses,States/Local Areas,California,2020,Age,19 Months,89.4,83.7 to 93.3,434
Polio,≥3 Doses,States/Local Areas,California,2020,Age,35 Months,92.6,87.9 to 96.0,434
PCV,≥4 Doses,States/Local Areas,California,2020,Age,19 Months,72.9,65.4 to 79.3,434
PCV,≥3 Doses,States/Local Areas,California,2020,Age,35 Months,91.9,86.8 to 95.5,434
Hib,≥2 Doses,States/Local Areas,California,2020,Age,13 Months,91.3,86.0 to 94.7,434
Hib,≥3 Doses,States/Local Areas,California,2020,Age,13 Months,77.7,71.0 to 83.2,434
Hib,Primary Series,States/Local Areas,California,2020,Age,13 Months,84.5,78.2 to 89.2,434
Hep B,≥2 Doses,States/Local Areas,California,2020,Age,13 Months,91.8,86.8 to 95.1,434
Hep B,≥3 Doses,States/Local Areas,California,2020,Age,13 Months,84.1,76.9 to 89.3,434
≥1 Dose Varicella,,States/Local Areas,California,2020,Age,13 Months,53.1,46.0 to 60.1,434
PCV,≥2 Doses,States/Local Areas,California,2020,Age,5 Months,74.2,67.5 to 79.9,434
DTaP,≥3 Doses,States/Local Areas,California,2020,Age,7 Months,63.8,56.3 to 70.6,434
PCV,≥3 Doses,States/Local Areas,California,2020,Age,13 Months,85.4,79.1 to 90.1,434
Hep B,≥2 Doses,States/Local Areas,California,2020,Age,5 Months,83.9,77.0 to 89.0,434
DTaP,≥3 Doses,States/Local Areas,California,2020,Age,19 Months,90.4,84.9 to 94.0,434
DTaP,≥4 Doses,States/Local Areas,California,2020,Age,19 Months,68.1,60.5 to 74.9,434
Polio,≥3 Doses,States/Local Areas,California,2020,Age,19 Months,89.5,83.8 to 93.4,434
Combined 7 Series,,States/Local Areas,California,2020,Age,24 Months,67.8,60.6 to 74.9,434
Hib,≥3 Doses,States/Local Areas,California,2020,Age,19 Months,88.1,82.3 to 92.1,434
≥1 Dose MMR,,States/Local Areas,California,2020,Age,19 Months,85.4,78.3 to 90.5,434
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2020,Age,0-3 Days,73.4,66.5 to 79.3,434
Influenza,,States/Local Areas,California,2020,Age,24 Months,66.8,59.8 to 73.7,434
≥1 Dose Varicella,,States/Local Areas,California,2020,Age,24 Months,87.4,81.3 to 92.3,434
PCV,≥3 Doses,States/Local Areas,California,2020,Age,24 Months,90.3,85.2 to 94.2,434
PCV,≥4 Doses,States/Local Areas,California,2020,Age,24 Months,76.5,69.3 to 83.0,434
Hep A,≥2 Doses,States/Local Areas,California,2020,Age,24 Months,56.0,48.9 to 63.4,434
Hep A,≥1 Dose,States/Local Areas,California,2020,Age,24 Months,87.5,81.2 to 92.5,434
Hep B,≥1 Dose,States/Local Areas,California,2020,Age,3 Months,92.4,87.7 to 95.4,434
PCV,≥1 Dose,States/Local Areas,California,2020,Age,3 Months,84.4,78.3 to 89.1,434
DTaP,≥2 Doses,States/Local Areas,California,2020,Age,5 Months,75.8,69.1 to 81.4,434
Polio,≥2 Doses,States/Local Areas,California,2020,Age,5 Months,75.3,68.6 to 80.9,434
Hib,≥2 Doses,States/Local Areas,California,2020,Age,5 Months,74.4,67.7 to 80.1,434
DTaP,≥1 Dose,States/Local Areas,California,2020,Age,3 Months,85.8,79.7 to 90.3,434
Polio,≥1 Dose,States/Local Areas,California,2020,Age,3 Months,86.3,80.5 to 90.5,434
Hep B,≥2 Doses,States/Local Areas,California,2020,Age,7 Months,90.2,83.6 to 94.3,434
Hib,≥1 Dose,States/Local Areas,California,2020,Age,3 Months,84.1,78.0 to 88.8,434
Hep B,≥3 Doses,States/Local Areas,California,2020,Age,7 Months,62.3,55.1 to 69.0,434
PCV,≥3 Doses,States/Local Areas,California,2020,Age,7 Months,61.6,54.3 to 68.4,434
Hep A,≥1 Dose,States/Local Areas,California,2012,Age,35 Months,89.6,82.0 to 94.9,320
PCV,≥2 Doses,States/Local Areas,California,2017,Age,5 Months,69.9,61.7 to 77.0,418
PCV,≥2 Doses,States/Local Areas,California,2017-2018,Age,5 Months,73.7,68.6 to 78.3,977
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,92.8,90.0 to 95.6,1171
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.9,80.6 to 93.2,682
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,77.7,71.7 to 83.6,1171
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,75.8,67.5 to 84.2,421
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,83.4,58.4 to 100.0,36
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,91.6,88.3 to 94.9,1171
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,78.3,72.0 to 84.7,494
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.4,73.0 to 89.9,413
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,93.1,89.8 to 96.3,1171
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,87.5,82.6 to 92.3,421
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Insurance Coverage,Other,85.8,65.3 to 100.0,36
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,92.4,88.9 to 95.9,494
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,75.6,47.2 to 100.0,36
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.9,76.8 to 89.1,682
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Overall,Overall,92.6,90.1 to 95.0,1649
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Overall,Overall,88.0,84.8 to 91.1,1649
Rotavirus,,States/Local Areas,California,2016-2019,Poverty,>400% FPL,88.4,84.1 to 92.7,883
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Overall,Overall,90.0,87.1 to 92.9,1649
Rotavirus,,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,74.4,67.0 to 81.7,461
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Overall,Overall,91.7,89.1 to 94.3,1649
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Overall,Overall,80.3,76.3 to 84.3,1649
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,85.8,79.0 to 92.5,461
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Poverty,<133% FPL,87.8,82.9 to 92.8,305
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,77.8,71.0 to 84.7,883
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,73.6,63.3 to 83.9,461
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,95.7,93.3 to 98.2,883
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,90.0,84.3 to 95.8,461
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,89.2,84.2 to 94.2,305
Influenza,,States/Local Areas,California,2016-2019,Overall,Overall,66.0,61.6 to 70.3,1649
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Overall,Overall,73.9,69.9 to 77.8,1649
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,89.3,84.2 to 94.4,305
Combined 7 Series,,States/Local Areas,California,2016-2019,Poverty,>400% FPL,77.7,71.6 to 83.8,883
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Overall,Overall,75.9,70.8 to 81.0,1649
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Overall,Overall,89.1,86.2 to 92.0,1649
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,96.2,93.8 to 98.5,883
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,95.7,91.6 to 99.8,461
Combined 7 Series,,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,62.6,54.3 to 70.9,461
Combined 7 Series,,States/Local Areas,California,2016-2019,Poverty,<133% FPL,58.7,50.1 to 67.2,305
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Poverty,<133% FPL,72.7,65.2 to 80.1,305
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,93.5,90.6 to 96.4,883
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,89.4,83.8 to 95.0,461
Hib,Full Series,States/Local Areas,California,2016-2019,Overall,Overall,78.3,74.2 to 82.4,1649
Combined 7 Series,,States/Local Areas,California,2016-2019,Overall,Overall,66.4,61.9 to 71.0,1649
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,95.8,93.4 to 98.1,883
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,91.8,86.8 to 96.8,461
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,88.5,84.5 to 92.4,859
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,54.9,24.3 to 85.5,30
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,90.0,79.5 to 100.0,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.2,72.8 to 83.6,760
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,71.0,65.3 to 76.7,859
Combined 7 Series,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.1,61.7 to 74.6,760
Combined 7 Series,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,65.6,59.2 to 72.1,859
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,94.4,86.4 to 100.0,30
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.3 to 95.7,760
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,93.1,89.8 to 96.4,859
Influenza,,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,49.2,18.4 to 79.9,30
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,79.9,74.0 to 85.7,859
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.4,88.8 to 96.0,760
DTaP,≥3 Doses,States/Local Areas,California,2017,Age,35 Months,93.1,88.0 to 96.6,418
DTaP,≥3 Doses,States/Local Areas,California,2017-2018,Age,35 Months,94.8,91.9 to 96.9,977
DTaP,≥4 Doses,States/Local Areas,California,2011,Age,19 Months,75.4,70.9 to 79.4,298
DTaP,≥4 Doses,States/Local Areas,California,2012,Age,19 Months,67.6,60.5 to 73.9,320
DTaP,≥4 Doses,States/Local Areas,California,2013,Age,19 Months,73.1,66.3 to 78.9,319
DTaP,≥4 Doses,States/Local Areas,California,2013-2014,Age,19 Months,68.4,65.0 to 71.6,674
PCV,≥2 Doses,States/Local Areas,California,2011,Age,5 Months,74.7,70.3 to 78.6,298
PCV,≥2 Doses,States/Local Areas,California,2012,Age,5 Months,75.1,73.2 to 76.9,320
PCV,≥2 Doses,States/Local Areas,California,2013,Age,5 Months,73.0,69.4 to 76.3,319
PCV,≥2 Doses,States/Local Areas,California,2013-2014,Age,5 Months,69.9,66.1 to 73.5,674
DTaP,≥3 Doses,States/Local Areas,California,2016,Age,35 Months,93.7,88.2 to 97.2,306
DTaP,≥3 Doses,States/Local Areas,California,2016-2017,Age,35 Months,93.4,89.9 to 96.0,724
Hep A,≥2 Doses,States/Local Areas,California,2015,Age,19 Months,21.1,16.7 to 26.3,293
Hep A,≥2 Doses,States/Local Areas,California,2015-2016,Age,19 Months,24.6,19.2 to 31.0,599
Hep A,≥2 Doses,States/Local Areas,California,2016,Age,19 Months,28.2,20.3 to 37.7,306
Hep A,≥2 Doses,States/Local Areas,California,2016-2017,Age,19 Months,28.1,22.8 to 34.1,724
Hib,≥3 Doses,States/Local Areas,California,2013,Age,35 Months,95.3,90.3 to 98.1,319
Hib,≥3 Doses,States/Local Areas,California,2013-2014,Age,35 Months,93.2,89.3 to 96.1,674
Hib,≥3 Doses,States/Local Areas,California,2014,Age,35 Months,91.4,85.2 to 95.7,355
Hib,≥3 Doses,States/Local Areas,California,2014-2015,Age,35 Months,94.3,89.8 to 97.2,648
Hib,≥3 Doses,States/Local Areas,California,2015,Age,35 Months,98.8,95.3 to 99.8,293
Hib,≥3 Doses,States/Local Areas,California,2015-2016,Age,35 Months,95.6,89.7 to 98.6,599
Hep A,≥2 Doses,States/Local Areas,California,2017,Age,19 Months,28.1,21.6 to 35.6,418
Hep A,≥2 Doses,States/Local Areas,California,2017-2018,Age,19 Months,27.7,23.4 to 32.6,977
Hep A,≥1 Dose,States/Local Areas,California,2019,Age,19 Months,85.8,80.7 to 89.7,537
Hep A,≥1 Dose,States/Local Areas,California,2011,Age,24 Months,85.5,78.3 to 91.3,298
Hep A,≥1 Dose,States/Local Areas,California,2013,Age,24 Months,84.2,77.4 to 89.9,319
Hep A,≥1 Dose,States/Local Areas,California,2013-2014,Age,24 Months,84.1,79.3 to 88.4,674
Hep A,≥1 Dose,States/Local Areas,California,2012,Age,24 Months,87.2,79.9 to 92.8,320
Hep A,≥1 Dose,States/Local Areas,California,2014,Age,24 Months,84.2,77.1 to 90.1,355
Hep A,≥1 Dose,States/Local Areas,California,2014-2015,Age,24 Months,86.8,82.0 to 90.9,648
Hib,≥3 Doses,States/Local Areas,California,2021,Age,19 Months,87.0,79.0 to 92.3,253
Hep A,≥1 Dose,States/Local Areas,California,2018,Age,24 Months,91.7,87.8 to 94.8,559
Hep A,≥1 Dose,States/Local Areas,California,2018-2019,Age,24 Months,90.2,87.3 to 92.8,1096
Hep A,≥1 Dose,States/Local Areas,California,2019,Age,24 Months,88.9,84.1 to 92.8,537
Hep A,≥1 Dose,States/Local Areas,California,2011,Age,35 Months,90.1,81.8 to 95.7,298
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,97.2,91.7 to 100.0,30
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.4,90.0 to 96.7,760
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,94.4,91.3 to 97.6,859
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,87.8,76.4 to 99.2,30
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,90.0,79.5 to 100.0,30
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.8,75.0 to 86.6,760
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,88.1,84.0 to 92.3,859
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.2,85.8 to 94.6,760
Hib,Full Series,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,70.5,38.6 to 100.0,30
Hib,Full Series,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.5,75.1 to 85.9,760
Hib,Full Series,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,76.8,70.8 to 82.8,859
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,49.1,17.4 to 80.9,30
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,89.5,85.7 to 93.3,859
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,89.4,85.4 to 93.3,859
Polio,≥3 Doses,States/Local Areas,California,2021,Age,35 Months,91.6,82.9 to 97.0,253
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.5,67.4 to 81.6,760
Rotavirus,,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,44.3,15.7 to 73.0,30
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,67.1,35.6 to 98.7,30
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.0,84.4 to 93.5,760
Rotavirus,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.8,70.0 to 81.6,760
Rotavirus,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,77.2,71.3 to 83.1,859
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,78.7,71.3 to 86.0,859
Influenza,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.6,59.2 to 71.9,760
Influenza,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,67.1,61.1 to 73.2,859
Combined 7 Series,,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,52.3,21.4 to 83.2,30
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,62.0,30.7 to 93.3,30
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.9,76.5 to 87.3,760
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,79.8,73.9 to 85.7,859
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,76.8,43.9 to 100.0,30
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,89.3 to 96.3,760
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Principal City,91.4,87.8 to 95.1,859
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.5,85.1 to 93.9,760
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Urbanicity,Living In a Non-MSA,91.7,79.6 to 100.0,30
Rotavirus,,States/Local Areas,California,2016-2019,Poverty,<133% FPL,64.4,56.0 to 72.8,305
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,89.2,84.7 to 93.6,883
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,79.0,72.0 to 86.0,461
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Poverty,>400% FPL,75.6,69.8 to 81.4,883
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,73.3,66.2 to 80.5,461
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,76.1,66.9 to 85.3,305
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Poverty,>400% FPL,95.1,91.8 to 98.4,883
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,89.2,83.2 to 95.3,461
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,90.6,85.8 to 95.3,305
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Overall,Overall,93.9,91.7 to 96.2,1649
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Overall,Overall,90.8,88.1 to 93.5,1649
Influenza,,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,61.8,53.4 to 70.2,461
Influenza,,States/Local Areas,California,2016-2019,Poverty,<133% FPL,56.1,48.1 to 64.1,305
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Poverty,>400% FPL,92.9,89.3 to 96.6,883
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,88.7,82.7 to 94.7,461
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Poverty,<133% FPL,85.6,80.3 to 90.9,305
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Poverty,>400% FPL,86.8,81.2 to 92.4,883
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,81.8,74.8 to 88.9,461
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Poverty,<133% FPL,85.5,80.2 to 90.9,305
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Overall,Overall,80.4,76.4 to 84.5,1649
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,90.1,85.3 to 94.9,305
Hib,Full Series,States/Local Areas,California,2016-2019,Poverty,>400% FPL,84.7,79.4 to 89.9,883
Hib,Full Series,States/Local Areas,California,2016-2019,Poverty,133% to <400% FPL,80.3,73.6 to 87.0,461
Hib,Full Series,States/Local Areas,California,2016-2019,Poverty,<133% FPL,70.4,62.2 to 78.6,305
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Poverty,>400% FPL,89.7,85.1 to 94.3,883
Rotavirus,,States/Local Areas,California,2016-2019,Overall,Overall,75.8,71.6 to 79.9,1649
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,72.7,64.6 to 80.9,305
Influenza,,States/Local Areas,California,2016-2019,Poverty,>400% FPL,79.5,73.7 to 85.4,883
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,99.6,98.7 to 100.0,36
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.4,95.1 to 99.7,682
Combined 7 Series,,States/Local Areas,California,2016-2019,Insurance Coverage,Other,74.8,46.2 to 100.0,36
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.7,90.4 to 96.9,682
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,74.8,69.8 to 79.8,1171
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.8,85.3 to 96.3,682
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.6,84.2 to 95.1,682
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.7,59.0 to 98.4,60
Rotavirus,,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.1,74.5 to 87.8,682
Rotavirus,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",55.8,32.1 to 79.4,60
Combined 7 Series,,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,73.0,67.5 to 78.4,1171
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.7,36.3 to 83.1,60
Combined 7 Series,,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,59.8,52.4 to 67.2,421
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,76.4,70.7 to 82.1,494
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,73.4,67.0 to 79.7,421
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Insurance Coverage,Other,69.7,41.0 to 98.3,36
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.1,67.1 to 100.0,60
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,89.4,85.5 to 93.3,494
≥1 Dose MMR,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.9,84.4 to 97.4,413
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,87.1,82.2 to 91.9,421
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.1 to 98.9,1171
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,91.2,87.2 to 95.2,421
Rotavirus,,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,84.9,80.3 to 89.4,1171
Influenza,,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,56.4,49.3 to 63.5,421
Influenza,,States/Local Areas,California,2016-2019,Insurance Coverage,Other,61.1,31.1 to 91.1,36
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,93.4,90.1 to 96.7,494
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.7,64.5 to 82.8,413
Hib,Full Series,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",72.5,52.6 to 92.4,60
Rotavirus,,States/Local Areas,California,2016-2019,Insurance Coverage,Other,84.3,63.4 to 100.0,36
Combined 7 Series,,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.4,57.5 to 73.4,682
Rotavirus,,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,66.5,59.4 to 73.5,421
Combined 7 Series,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.8,34.4 to 81.3,60
Combined 7 Series,,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,65.7,58.9 to 72.6,494
Combined 7 Series,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.8,62.8 to 80.7,413
Rotavirus,,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,73.6,67.1 to 80.0,494
Rotavirus,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.5,70.0 to 86.9,413
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.5,39.2 to 85.9,60
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,79.4,73.3 to 85.6,494
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.1,75.1 to 91.2,413
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.5,94.1 to 98.9,682
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.9,47.0 to 92.8,60
Influenza,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",53.8,30.1 to 77.6,60
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,99.6,98.7 to 100.0,36
Influenza,,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.7,68.9 to 82.4,682
Influenza,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.0,57.2 to 76.8,413
Influenza,,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,61.6,55.0 to 68.1,494
Influenza,,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,76.6,71.3 to 81.9,1171
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,89.8,85.9 to 93.7,494
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.2,81.4 to 95.1,413
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,88.8 to 98.1,682
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.9,58.6 to 97.3,60
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,75.0,46.5 to 100.0,36
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,88.7,84.0 to 93.4,421
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",66.3,43.5 to 89.1,60
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,99.5,98.6 to 100.0,36
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,92.0,88.4 to 95.7,494
Hib,Full Series,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.8,70.6 to 85.1,682
Hib,Full Series,States/Local Areas,California,2016-2019,Insurance Coverage,Other,75.6,47.2 to 100.0,36
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,95.3,92.9 to 97.7,1171
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,89.9,85.6 to 94.2,421
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Other,99.5,98.6 to 100.0,36
≥1 Dose Varicella,,States/Local Areas,California,2016-2019,Insurance Coverage,Other,96.4,90.1 to 100.0,36
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.9,54.1 to 93.7,60
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.8,79.6 to 92.0,682
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",79.3,60.0 to 98.6,60
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,94.7,91.6 to 97.8,494
DTaP,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,83.9 to 97.1,413
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,85.5,80.8 to 90.1,1171
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.9,45.1 to 90.7,60
Hib,≥1 Dose,States/Local Areas,California,2021,Age,3 Months,76.3,67.5 to 83.3,253
Hib,≥3 Doses,States/Local Areas,California,2021,Age,7 Months,44.8,35.4 to 54.6,253
Hep B,≥3 Doses,States/Local Areas,California,2020-2021,Age,35 Months,90.2,85.5 to 93.9,687
≥1 Dose Varicella,,States/Local Areas,California,2021,Age,19 Months,85.6,77.8 to 91.0,253
Hep A,≥1 Dose,States/Local Areas,California,2021,Age,35 Months,83.4,71.5 to 92.3,253
PCV,≥3 Doses,States/Local Areas,California,2021,Age,19 Months,88.4,79.7 to 93.6,253
DTaP,≥1 Dose,States/Local Areas,California,2021,Age,3 Months,79.9,71.0 to 86.5,253
≥1 Dose MMR,,States/Local Areas,California,2021,Age,24 Months,88.8,82.2 to 93.9,253
Hib,≥3 Doses,States/Local Areas,California,2021,Age,24 Months,88.2,81.2 to 93.5,253
Polio,≥1 Dose,States/Local Areas,California,2021,Age,3 Months,79.9,71.0 to 86.5,253
Hib,Primary Series,States/Local Areas,California,2021,Age,24 Months,89.9,83.4 to 94.7,253
Hib,Primary Series,States/Local Areas,California,2020-2021,Age,13 Months,84.2,79.3 to 88.2,687
Hib,Full Series,States/Local Areas,California,2021,Age,24 Months,70.2,60.8 to 79.1,253
DTaP,≥3 Doses,States/Local Areas,California,2021,Age,19 Months,90.7,83.4 to 94.9,253
≥1 Dose MMR,,States/Local Areas,California,2020-2021,Age,13 Months,58.1,52.2 to 63.9,687
Polio,≥1 Dose,States/Local Areas,California,2019-2020,Age,3 Months,89.5,86.2 to 92.1,971
DTaP,≥1 Dose,States/Local Areas,California,2019-2020,Age,3 Months,89.6,86.2 to 92.3,971
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2019-2020,Age,0-3 Days,77.6,73.4 to 81.4,971
Hep B,≥3 Doses,States/Local Areas,California,2019-2020,Age,7 Months,62.8,58.1 to 67.3,971
Hib,≥3 Doses,States/Local Areas,California,2019-2020,Age,7 Months,56.2,51.3 to 60.8,971
DTaP,≥4 Doses,States/Local Areas,California,2019-2020,Age,19 Months,68.6,63.8 to 73.1,971
DTaP,≥3 Doses,States/Local Areas,California,2019-2020,Age,19 Months,93.0,89.9 to 95.2,971
Polio,≥3 Doses,States/Local Areas,California,2020-2021,Age,19 Months,89.3,84.7 to 92.6,687
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,83.3 to 96.6,413
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.6,60.5 to 78.8,682
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,76.4,69.7 to 83.2,421
Hep B,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,91.4,87.6 to 95.2,494
Rotavirus,,States/Local Areas,California,2019-2020,Age,8 Months,74.7,70.0 to 78.9,971
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2021,Age,0-1 Days,69.5,60.1 to 77.6,253
≥1 Dose Varicella,,States/Local Areas,California,2020-2021,Age,35 Months,92.4,87.2 to 96.0,687
≥1 Dose Varicella,,States/Local Areas,California,2021,Age,24 Months,86.1,79.2 to 91.5,253
PCV,≥3 Doses,States/Local Areas,California,2021,Age,24 Months,91.2,84.1 to 95.9,253
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2021,Age,0-2 Days,70.9,61.5 to 78.9,253
PCV,≥3 Doses,States/Local Areas,California,2021,Age,13 Months,83.7,74.7 to 89.9,253
Hep B,≥2 Doses,States/Local Areas,California,2021,Age,7 Months,83.5,74.1 to 89.9,253
DTaP,≥3 Doses,States/Local Areas,California,2020-2021,Age,35 Months,92.9,88.9 to 95.8,687
PCV,≥4 Doses,States/Local Areas,California,2021,Age,24 Months,73.4,63.9 to 82.1,253
Hep A,≥1 Dose,States/Local Areas,California,2021,Age,24 Months,79.1,69.6 to 87.2,253
Hep A,≥2 Doses,States/Local Areas,California,2020-2021,Age,19 Months,24.3,19.9 to 29.3,687
Hep A,≥2 Doses,States/Local Areas,California,2021,Age,24 Months,43.9,34.7 to 54.3,253
PCV,≥3 Doses,States/Local Areas,California,2021,Age,7 Months,53.2,43.5 to 62.7,253
DTaP,≥3 Doses,States/Local Areas,California,2021,Age,13 Months,85.7,77.2 to 91.4,253
Hep B,≥3 Doses,States/Local Areas,California,2021,Age,24 Months,87.8,80.6 to 93.3,253
PCV,≥4 Doses,States/Local Areas,California,2021,Age,19 Months,68.8,58.8 to 77.4,253
Hep A,≥1 Dose,States/Local Areas,California,2021,Age,19 Months,74.4,64.1 to 82.5,253
Hep A,≥1 Dose,States/Local Areas,California,2020-2021,Age,35 Months,87.8,81.4 to 92.8,687
PCV,≥3 Doses,States/Local Areas,California,2021,Age,35 Months,97.8,90.8 to 99.8,253
DTaP,≥1 Dose,States/Local Areas,California,2020-2021,Age,3 Months,82.8,77.8 to 87.0,687
PCV,≥4 Doses,States/Local Areas,California,2021,Age,35 Months,80.7,67.4 to 91.1,253
Hib,≥2 Doses,States/Local Areas,California,2020-2021,Age,13 Months,91.7,87.7 to 94.5,687
Hep B,≥3 Doses,States/Local Areas,California,2021,Age,7 Months,58.8,48.9 to 68.0,253
DTaP,≥4 Doses,States/Local Areas,California,2021,Age,24 Months,67.5,57.6 to 77.0,253
Polio,≥3 Doses,States/Local Areas,California,2021,Age,24 Months,89.0,81.8 to 94.3,253
Influenza,,States/Local Areas,New Mexico,2011,Age,24 Months,59.7,51.7 to 67.8,268
Influenza,,States/Local Areas,New Mexico,2012,Age,24 Months,60.1,51.7 to 68.7,263
Influenza,,States/Local Areas,New Mexico,2015,Age,24 Months,61.7,54.0 to 69.4,253
Influenza,,States/Local Areas,New Mexico,2015-2016,Age,24 Months,60.4,55.1 to 65.7,648
Influenza,,States/Local Areas,New Mexico,2014,Age,24 Months,51.9,44.5 to 59.7,247
Influenza,,States/Local Areas,New Mexico,2014-2015,Age,24 Months,56.7,51.4 to 62.2,500
Influenza,,States/Local Areas,New Mexico,2013,Age,24 Months,53.7,46.1 to 61.7,250
Influenza,,States/Local Areas,New Mexico,2013-2014,Age,24 Months,52.8,47.5 to 58.4,497
Hep B,≥1 Dose,States/Local Areas,New Mexico,2021,Age,3 Months,93.1,86.5 to 96.6,238
Influenza,,States/Local Areas,New Mexico,2019,Age,24 Months,67.2,60.5 to 73.8,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,93.9,91.3 to 96.6,555
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,88.7,85.9 to 91.5,900
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.2,77.5 to 92.9,454
Influenza,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",61.0,48.6 to 73.3,129
Influenza,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,55.0,50.0 to 60.0,644
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.0,75.4 to 90.6,164
Influenza,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,59.3,53.5 to 65.0,525
Influenza,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",57.8,50.7 to 64.9,382
Influenza,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,58.4,50.0 to 66.9,261
Influenza,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,50.1,43.4 to 56.7,379
Influenza,,States/Local Areas,New Mexico,2016,Age,24 Months,58.9,51.8 to 66.2,395
Influenza,,States/Local Areas,New Mexico,2016-2017,Age,24 Months,56.5,51.7 to 61.4,824
Influenza,,States/Local Areas,New Mexico,2018,Age,24 Months,63.0,56.8 to 69.2,447
Influenza,,States/Local Areas,New Mexico,2018-2019,Age,24 Months,65.1,60.5 to 69.6,821
Influenza,,States/Local Areas,New Mexico,2017,Age,24 Months,53.8,47.6 to 60.2,429
Influenza,,States/Local Areas,New Mexico,2017-2018,Age,24 Months,58.3,53.9 to 62.8,876
Influenza,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,52.9,48.0 to 57.9,707
Influenza,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,67.5,61.4 to 73.6,418
Hib,Full Series,States/Local Areas,New Mexico,2020-2021,Age,24 Months,78.6,73.3 to 83.5,595
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,87.3,83.2 to 91.5,555
Influenza,,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,76.9,68.8 to 84.9,197
Influenza,,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,57.1,50.7 to 63.6,462
Influenza,,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,49.8,44.2 to 55.5,506
Influenza,,States/Local Areas,New Mexico,2014-2017,Overall,Overall,56.2,52.3 to 60.1,1165
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,87.7,83.6 to 91.8,555
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.2 to 98.8,555
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,63.9 to 90.0,164
DTaP,≥3 Doses,States/Local Areas,New Mexico,2021,Age,24 Months,86.6,78.9 to 92.6,238
Hib,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,87.2,82.9 to 90.6,595
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2021,Age,0-3 Days,70.7,62.1 to 78.1,238
Hib,≥3 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,85.1,77.3 to 91.3,238
Influenza,,States/Local Areas,New Mexico,2021,Age,24 Months,50.2,41.7 to 59.4,238
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020-2021,Age,13 Months,60.3,54.5 to 65.8,595
Hep B,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,3 Months,94.4,91.1 to 96.6,595
PCV,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,3 Months,86.4,82.2 to 89.7,595
DTaP,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,5 Months,75.8,70.4 to 80.5,595
≥1 Dose MMR,,States/Local Areas,New Mexico,2021,Age,13 Months,62.1,53.0 to 70.4,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,24 Months,87.6,83.1 to 91.4,595
Hib,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,44.9,39.4 to 50.6,595
Polio,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,3 Months,87.0,82.8 to 90.3,595
Hep A,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,77.4,70.7 to 83.5,595
Polio,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,90.1,85.9 to 93.5,595
PCV,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,86.5,81.9 to 90.1,595
≥1 Dose MMR,,States/Local Areas,New Mexico,2020-2021,Age,19 Months,86.7,81.7 to 90.5,595
Hib,Primary Series,States/Local Areas,New Mexico,2020-2021,Age,7 Months,67.5,61.8 to 72.8,595
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,88.4,83.8 to 92.1,595
Hib,≥2 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,89.5,82.4 to 93.9,238
Rotavirus,,States/Local Areas,New Mexico,2021,Age,8 Months,71.1,62.1 to 78.7,238
Hib,Primary Series,States/Local Areas,New Mexico,2021,Age,35 Months,86.6,78.9 to 92.6,238
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020-2021,Age,24 Months,89.7,85.2 to 93.3,595
Hep A,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,54.7,48.6 to 61.1,595
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,64.9,59.1 to 70.3,595
Hep B,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,5 Months,86.7,82.0 to 90.2,595
Hib,≥3 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,68.2,59.6 to 75.7,238
Polio,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,88.8,84.2 to 92.2,595
Hib,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,5 Months,74.2,68.7 to 79.0,595
DTaP,≥4 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,66.8,61.1 to 72.1,595
Hib,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,87.1,82.5 to 90.7,595
Polio,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,91.7,87.4 to 94.9,595
PCV,≥4 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,85.2,79.1 to 90.3,595
Hib,Full Series,States/Local Areas,New Mexico,2021,Age,35 Months,78.5,69.1 to 86.7,238
DTaP,≥3 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,87.0,79.2 to 92.9,238
Combined 7 Series,,States/Local Areas,New Mexico,2020-2021,Age,35 Months,75.1,67.7 to 81.9,595
PCV,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,90.0,85.6 to 93.1,595
Hib,Primary Series,States/Local Areas,New Mexico,2021,Age,13 Months,83.4,75.1 to 89.3,238
DTaP,≥4 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,77.2,66.7 to 86.4,238
Hep B,≥3 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,84.3,76.2 to 90.8,238
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,67.7,61.9 to 73.0,595
Influenza,,States/Local Areas,New Mexico,2020-2021,Age,24 Months,55.4,49.7 to 61.3,595
Combined 7 Series,,States/Local Areas,New Mexico,2020-2021,Age,24 Months,68.2,62.5 to 73.7,595
Hep B,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,90.6,86.4 to 93.5,595
Hib,Primary Series,States/Local Areas,New Mexico,2020-2021,Age,13 Months,86.7,82.1 to 90.3,595
≥1 Dose MMR,,States/Local Areas,New Mexico,2020-2021,Age,35 Months,90.1,85.6 to 93.6,595
Hib,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,3 Months,86.1,81.7 to 89.5,595
Polio,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,88.1,83.9 to 91.3,595
PCV,≥4 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,76.3,70.9 to 81.1,595
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2020-2021,Age,0-3 Days,74.4,69.1 to 79.1,595
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,91.3,87.0 to 94.6,595
Combined 7 Series,,States/Local Areas,New Mexico,2021,Age,24 Months,62.4,53.7 to 71.1,238
Hep B,≥2 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,90.9,83.7 to 95.1,238
PCV,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,90.5,86.4 to 93.7,595
PCV,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,91.3,87.1 to 94.5,595
Polio,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,5 Months,75.0,69.6 to 79.7,595
≥1 Dose Varicella,,States/Local Areas,New Mexico,2021,Age,35 Months,87.6,79.4 to 93.6,238
Rotavirus,,States/Local Areas,New Mexico,2020-2021,Age,8 Months,75.1,69.6 to 79.9,595
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,90.7,86.4 to 94.0,595
DTaP,≥4 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,76.7,71.1 to 81.8,595
Hib,≥3 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,73.1,66.4 to 78.8,374
Hib,≥3 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,91.2,89.0 to 93.0,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,89.5,87.2 to 91.5,268
Hib,≥3 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,78.0,71.1 to 83.7,253
Hib,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,77.2,72.8 to 81.1,648
Polio,≥3 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,92.9,88.3 to 95.8,447
Polio,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,73.3,68.9 to 77.2,821
Hib,≥3 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,74.5,68.9 to 79.3,447
Hib,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,73.8,69.5 to 77.6,821
Polio,≥3 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,93.5,89.9 to 95.8,395
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,91.8,88.9 to 94.0,824
Polio,≥3 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,90.1,85.1 to 93.5,429
Polio,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,91.5,88.3 to 93.9,876
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,71.5,66.6 to 76.4,506
Hib,≥3 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,49.8,42.8 to 56.8,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,90.1 to 95.8,525
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.5,89.2 to 95.8,382
Hib,≥3 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,76.3,70.5 to 81.3,395
Hib,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,73.9,69.8 to 77.7,824
Hib,≥3 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,71.3,65.2 to 76.7,429
Hib,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,72.9,68.8 to 76.6,876
Polio,≥3 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,89.4,86.5 to 91.8,250
Polio,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,90.2,88.6 to 91.6,497
Polio,≥3 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,90.9,86.4 to 94.1,247
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,92.8,89.7 to 95.0,500
Polio,≥3 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,93.3,87.7 to 96.4,263
Polio,≥3 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,94.6,92.8 to 96.0,253
Polio,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,94.0,91.3 to 96.0,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,92.0,87.6 to 95.0,447
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,92.6,89.7 to 94.7,821
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,93.1,88.9 to 95.8,374
DTaP,≥3 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,91.4,88.8 to 93.5,268
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,93.7,89.9 to 96.2,250
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,93.3,90.4 to 95.4,497
DTaP,≥3 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,95.7,94.6 to 96.6,263
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,89.5,85.3 to 92.7,250
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,90.4,88.0 to 92.4,497
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,91.3,87.0 to 94.3,247
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,91.2,87.8 to 93.7,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Overall,Overall,70.0,66.5 to 73.4,1165
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,75.9,70.1 to 81.7,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,63.5,58.1 to 68.9,525
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.9,69.1 to 82.7,261
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",58.5,51.4 to 65.6,382
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.7,65.2 to 84.2,129
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,74.1,69.9 to 78.4,644
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,63.6,54.2 to 73.0,197
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,70.4,64.7 to 76.1,462
Hib,≥3 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,74.3,64.3 to 82.3,250
Hib,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,74.4,69.2 to 79.0,497
Polio,≥3 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,89.9,86.8 to 92.3,268
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,96.1,92.6 to 99.7,197
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,94.4,91.8 to 97.0,462
Hib,≥3 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,74.5,67.6 to 80.4,247
Hib,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,76.3,71.5 to 80.5,500
Hib,≥3 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,84.3,82.9 to 85.7,268
Hib,≥3 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,81.5,79.0 to 83.7,263
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,91.0,85.2 to 94.7,253
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,91.3,88.0 to 93.8,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,91.7,85.5 to 95.4,263
Hib,≥2 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,95.2,91.6 to 97.3,447
Hib,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,96.2,94.1 to 97.6,821
Hib,≥2 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,91.8,87.0 to 95.0,429
Hib,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,93.5,90.7 to 95.5,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,90.5,87.3 to 93.7,506
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,92.6,90.7 to 94.6,1165
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.8,86.3 to 95.3,261
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,93.4,90.3 to 96.5,379
Hib,≥2 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,97.3,94.6 to 98.7,374
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,91.6,87.7 to 94.3,395
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,90.7,87.7 to 93.0,824
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,89.7,84.7 to 93.2,429
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,90.9,87.7 to 93.3,876
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,91.9,89.0 to 94.7,644
Hib,≥2 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,96.0,92.9 to 97.8,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,96.1,93.3 to 98.0,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2018,Age,0-3 Days,72.9,66.8 to 78.2,447
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2018-2019,Age,0-3 Days,74.1,69.6 to 78.1,821
Polio,≥1 Dose,States/Local Areas,New Mexico,2019,Age,3 Months,96.3,93.9 to 97.8,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2019,Age,0-3 Days,75.3,68.4 to 81.1,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,68.1,62.0 to 74.2,418
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,70.8,66.5 to 75.1,707
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,74.9,68.6 to 80.3,447
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,74.7,70.1 to 78.7,821
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,74.4,67.5 to 80.3,374
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,67.9,61.6 to 73.6,429
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,71.4,67.0 to 75.4,876
DTaP,≥3 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,90.6,88.1 to 92.6,268
Hib,Primary Series,States/Local Areas,New Mexico,2020,Age,24 Months,92.4,88.0 to 95.6,357
Hib,≥2 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,93.1,89.3 to 95.6,447
Hib,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,94.5,92.2 to 96.2,821
PCV,≥3 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,93.3,89.6 to 96.1,247
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,95.6,92.8 to 97.6,500
PCV,≥3 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,98.0,94.5 to 99.5,253
PCV,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,96.4,93.7 to 98.1,648
PCV,≥3 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,94.8,91.4 to 97.2,395
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,94.6,91.6 to 96.8,824
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,94.1,91.2 to 97.0,379
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.0,93.8 to 100.0,129
PCV,≥3 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,95.8,91.1 to 98.4,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,46.9,40.7 to 53.2,429
Hib,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,48.4,44.0 to 52.8,876
Hib,≥3 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,49.9,43.7 to 56.1,447
Hib,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,49.9,45.2 to 54.5,821
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.6,93.1 to 100.0,129
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,92.2,89.5 to 94.9,644
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,92.3,89.7 to 94.8,707
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,95.2,92.6 to 97.9,418
Hib,≥2 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,91.0,87.0 to 93.9,395
Hib,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,89.4,86.2 to 91.9,824
Hib,≥2 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,87.6,82.2 to 91.5,429
Hib,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,90.3,87.1 to 92.8,876
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,90.7,87.3 to 94.0,506
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,92.9,88.3 to 97.5,197
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,93.4,90.4 to 96.3,462
Hib,≥3 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,52.9,47.5 to 58.2,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,62.8,58.0 to 67.4,268
Hib,≥3 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,51.8,45.2 to 58.4,250
Hib,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,50.9,47.8 to 54.0,497
Polio,≥1 Dose,States/Local Areas,New Mexico,2014,Age,3 Months,88.9,84.0 to 92.5,247
Polio,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,3 Months,89.5,86.0 to 92.3,500
Polio,≥1 Dose,States/Local Areas,New Mexico,2015,Age,3 Months,90.2,84.4 to 94.0,253
Polio,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,3 Months,89.5,85.7 to 92.4,648
Polio,≥1 Dose,States/Local Areas,New Mexico,2016,Age,3 Months,88.8,83.1 to 92.7,395
Polio,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,3 Months,87.8,84.1 to 90.8,824
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2017,Age,0-3 Days,78.7,70.4 to 85.2,269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2017-2018,Age,0-3 Days,74.5,70.5 to 78.1,876
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016,Age,0-3 Days,67.8,61.3 to 73.7,395
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2017,Age,0-3 Days,71.7,67.5 to 75.6,824
Hib,≥2 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,94.3,89.0 to 97.1,263
Hib,≥2 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,94.1,93.1 to 95.0,268
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,65.4,57.3 to 72.6,253
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,68.3,63.0 to 73.2,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,69.8,62.6 to 76.1,247
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,67.6,62.3 to 72.5,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2015,Age,0-3 Days,70.4,62.9 to 77.0,253
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2015-2016,Age,0-3 Days,69.2,64.2 to 73.7,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,71.4,64.2 to 77.6,395
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,69.7,65.0 to 74.0,824
Hib,≥2 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,91.7,89.5 to 93.5,250
Hib,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,92.9,91.8 to 93.9,497
PCV,≥3 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,94.0,89.4 to 97.1,429
PCV,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,95.3,92.5 to 97.2,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,96.7,93.1 to 98.8,447
PCV,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,96.7,94.3 to 98.2,821
Hib,≥3 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,49.9,42.4 to 57.4,247
Hib,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,48.1,42.6 to 53.5,500
Hib,≥3 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,46.2,38.5 to 54.0,253
Hib,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,48.4,43.1 to 53.7,648
Hib,≥3 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,50.7,43.5 to 57.8,395
Hib,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,48.9,44.1 to 53.7,824
Polio,≥1 Dose,States/Local Areas,New Mexico,2017,Age,3 Months,86.8,81.6 to 90.8,429
Polio,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,3 Months,88.2,84.6 to 91.1,876
Polio,≥1 Dose,States/Local Areas,New Mexico,2018,Age,3 Months,89.6,84.0 to 93.4,447
Polio,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,3 Months,92.9,89.9 to 95.1,821
Hib,≥2 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,95.6,90.8 to 97.9,253
Hib,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,94.9,92.2 to 96.7,648
Hib,≥2 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,94.2,90.6 to 96.5,395
Hib,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,93.1,90.3 to 95.1,824
Hib,≥2 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,94.2,90.3 to 96.6,247
Hib,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,94.9,92.1 to 96.7,500
DTaP,≥4 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,91.3,85.4 to 95.5,374
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,81.8,78.0 to 85.5,707
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,87.5,83.3 to 91.8,418
≥1 Dose MMR,,States/Local Areas,New Mexico,2011,Age,19 Months,83.8,80.3 to 86.8,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2013,Age,19 Months,81.4,73.4 to 87.4,250
≥1 Dose MMR,,States/Local Areas,New Mexico,2013-2014,Age,19 Months,86.4,84.2 to 88.3,497
≥1 Dose MMR,,States/Local Areas,New Mexico,2014,Age,19 Months,91.5,87.2 to 94.4,247
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2015,Age,19 Months,89.3,85.4 to 92.3,500
≥1 Dose MMR,,States/Local Areas,New Mexico,2012,Age,19 Months,88.7,83.6 to 92.4,263
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017,Age,19 Months,89.2,84.4 to 92.6,429
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017-2018,Age,19 Months,90.4,87.3 to 92.7,876
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018,Age,19 Months,91.6,87.4 to 94.5,447
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018-2019,Age,19 Months,69.0,64.4 to 73.3,821
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,83.4,79.7 to 87.1,644
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016,Age,19 Months,89.3,84.5 to 92.7,395
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2017,Age,19 Months,89.2,86.0 to 91.7,824
Polio,≥2 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,96.0,91.3 to 98.2,253
Polio,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,95.3,92.6 to 97.0,648
Polio,≥2 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,94.5,90.9 to 96.7,395
Polio,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,93.5,90.8 to 95.5,824
Hep B,≥1 Dose,States/Local Areas,New Mexico,2017,Age,3 Months,95.3,92.1 to 97.3,429
Hep B,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,3 Months,95.5,93.0 to 97.1,876
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2016,Age,0-1 Days,58.5,51.3 to 65.3,395
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2016-2017,Age,0-1 Days,62.3,57.6 to 66.8,824
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2017,Age,0-1 Days,66.5,60.5 to 72.1,429
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2017-2018,Age,0-1 Days,65.3,61.1 to 69.4,876
Hep B,≥2 Doses,States/Local Areas,New Mexico,2019,Age,5 Months,93.3,87.3 to 96.6,374
Hep B,≥2 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,86.5,83.5 to 89.0,268
Hep B,≥2 Doses,States/Local Areas,New Mexico,2017,Age,5 Months,84.4,78.8 to 88.7,429
Hep B,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,5 Months,87.6,84.1 to 90.5,876
PCV,≥4 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,85.7,79.7 to 90.7,357
Hep B,≥2 Doses,States/Local Areas,New Mexico,2018,Age,5 Months,90.9,86.1 to 94.2,447
Hep B,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,5 Months,92.1,88.6 to 94.6,821
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2018,Age,0-1 Days,64.1,58.0 to 69.7,447
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2018-2019,Age,0-1 Days,65.8,61.1 to 70.1,821
PCV,≥4 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,69.6,63.8 to 74.9,250
PCV,≥4 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,73.9,71.0 to 76.5,497
PCV,≥4 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,81.3,75.5 to 86.0,263
PCV,≥4 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,71.9,67.5 to 75.9,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2018,Age,19 Months,94.5,90.9 to 96.7,447
≥1 Dose MMR,,States/Local Areas,New Mexico,2018-2019,Age,19 Months,96.2,94.1 to 97.6,821
≥1 Dose MMR,,States/Local Areas,New Mexico,2019,Age,19 Months,91.4,86.9 to 94.4,374
≥1 Dose MMR,,States/Local Areas,New Mexico,2011,Age,24 Months,89.9,84.8 to 93.9,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2012,Age,24 Months,91.9,86.4 to 95.7,263
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015,Age,24 Months,87.8,81.5 to 92.8,253
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015-2016,Age,24 Months,88.9,85.0 to 92.1,648
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016,Age,24 Months,89.9,85.4 to 93.6,395
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2017,Age,24 Months,90.4,87.4 to 93.0,824
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017,Age,24 Months,90.9,86.8 to 94.2,429
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017-2018,Age,24 Months,92.6,90.0 to 94.7,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,62.3,59.9 to 64.7,250
PCV,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,63.8,59.8 to 67.6,497
PCV,≥3 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,65.9,62.0 to 69.5,268
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,92.4,88.7 to 95.0,395
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,90.6,87.5 to 93.0,824
PCV,≥3 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,65.3,57.9 to 71.9,247
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,63.0,57.6 to 68.0,500
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,90.6,85.1 to 96.1,197
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,85.3,81.1 to 89.5,462
PCV,≥3 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,71.0,63.2 to 77.8,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,88.6,83.2 to 92.4,429
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,90.4,87.0 to 92.9,876
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,92.2,87.7 to 95.2,447
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,90.9,87.8 to 93.3,821
Hep B,≥2 Doses,States/Local Areas,New Mexico,2016,Age,5 Months,89.2,84.9 to 92.3,395
Hep B,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,5 Months,86.9,83.5 to 89.7,824
Hep B,≥2 Doses,States/Local Areas,New Mexico,2014,Age,5 Months,90.2,84.9 to 93.8,247
Hep B,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,5 Months,90.9,87.5 to 93.5,500
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2012,Age,0-1 Days,51.9,45.7 to 58.1,263
Polio,≥2 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,94.1,89.4 to 96.8,447
Polio,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,95.5,93.0 to 97.2,821
Polio,≥2 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,97.0,94.3 to 98.4,374
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019,Age,19 Months,89.8,84.9 to 93.3,374
Polio,≥2 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,92.4,87.7 to 95.4,429
Polio,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,93.3,90.2 to 95.4,876
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014,Age,24 Months,92.2,88.1 to 95.3,247
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2015,Age,24 Months,90.0,86.3 to 93.1,500
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013,Age,24 Months,84.1,77.4 to 89.7,250
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013-2014,Age,24 Months,88.2,84.2 to 91.6,497
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2013,Age,0-1 Days,58.6,54.7 to 62.3,250
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2013-2014,Age,0-1 Days,56.5,53.3 to 59.6,497
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2014,Age,0-1 Days,54.3,46.8 to 61.6,247
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2014-2015,Age,0-1 Days,55.9,50.5 to 61.1,500
Hep B,≥2 Doses,States/Local Areas,New Mexico,2015,Age,5 Months,91.7,86.8 to 94.9,253
Hep B,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,5 Months,90.5,87.4 to 92.9,648
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2015,Age,0-1 Days,57.5,49.6 to 65.0,253
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2015-2016,Age,0-1 Days,58.0,52.7 to 63.1,648
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019,Age,24 Months,91.3,86.9 to 94.7,374
≥1 Dose Varicella,,States/Local Areas,New Mexico,2011,Age,35 Months,88.5,82.7 to 93.0,268
≥1 Dose Varicella,,States/Local Areas,New Mexico,2012,Age,35 Months,95.0,87.9 to 98.5,263
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018,Age,24 Months,94.5,91.0 to 96.9,447
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018-2019,Age,24 Months,92.9,90.2 to 95.1,821
≥1 Dose MMR,,States/Local Areas,New Mexico,2015,Age,24 Months,90.5,84.7 to 94.8,253
≥1 Dose MMR,,States/Local Areas,New Mexico,2015-2016,Age,24 Months,90.9,87.4 to 93.7,648
≥1 Dose MMR,,States/Local Areas,New Mexico,2014,Age,24 Months,93.3,89.5 to 96.1,247
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2015,Age,24 Months,91.9,88.6 to 94.6,500
≥1 Dose MMR,,States/Local Areas,New Mexico,2013,Age,24 Months,87.7,81.9 to 92.3,250
≥1 Dose MMR,,States/Local Areas,New Mexico,2013-2014,Age,24 Months,90.5,87.0 to 93.3,497
PCV,≥3 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,64.8,58.5 to 70.6,429
PCV,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,67.5,63.1 to 71.6,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,60.6,52.7 to 67.9,253
PCV,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,64.2,58.9 to 69.1,648
PCV,≥4 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,78.2,71.6 to 83.7,247
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,76.2,71.2 to 80.5,500
PCV,≥4 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,74.0,65.0 to 81.4,253
PCV,≥4 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,77.9,73.2 to 82.1,648
PCV,≥4 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,82.1,76.5 to 86.5,395
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,79.0,75.0 to 82.5,824
PCV,≥3 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,67.9,60.8 to 74.3,395
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,66.4,61.7 to 70.8,824
Hep B,≥3 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,90.0,84.1 to 94.3,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,91.1,86.8 to 94.5,250
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,91.1,88.0 to 93.7,497
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,95.3,92.2 to 97.2,374
Hep B,≥3 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,90.2,85.0 to 94.1,268
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2019,Age,0-1 Days,67.5,60.2 to 74.0,374
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2011,Age,0-2 Days,63.9,55.5 to 71.4,268
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2013,Age,0-2 Days,67.9,62.6 to 72.8,250
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2013-2014,Age,0-2 Days,65.2,60.5 to 69.7,497
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2012,Age,0-2 Days,60.6,55.4 to 65.6,263
Hep B,≥2 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,92.1,88.9 to 94.4,250
Hep B,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,92.4,90.2 to 94.1,497
Hep B,≥2 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,92.7,87.9 to 95.7,247
Hep B,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,94.0,90.9 to 96.1,500
Hep B,≥2 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,93.6,89.8 to 96.1,263
PCV,≥3 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,70.2,63.9 to 75.9,447
PCV,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,71.2,66.8 to 75.3,821
PCV,≥3 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,72.3,65.9 to 77.9,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,86.9,80.6 to 91.4,268
PCV,≥4 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,75.7,69.7 to 80.8,429
PCV,≥4 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,76.7,72.7 to 80.3,876
PCV,≥4 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,77.7,72.1 to 82.5,447
PCV,≥4 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,80.4,75.7 to 84.3,671
≥1 Dose MMR,,States/Local Areas,New Mexico,2017,Age,24 Months,93.2,89.5 to 95.9,429
≥1 Dose MMR,,States/Local Areas,New Mexico,2017-2018,Age,24 Months,94.8,92.5 to 96.5,876
≥1 Dose MMR,,States/Local Areas,New Mexico,2016,Age,24 Months,91.3,87.1 to 94.5,395
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2017,Age,24 Months,92.2,89.4 to 94.4,824
PCV,≥3 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,89.8,83.6 to 93.9,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,92.9,89.5 to 95.6,395
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,91.7,89.0 to 94.0,824
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,95.1,90.6 to 97.9,253
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,94.0,91.4 to 96.1,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,91.1,86.4 to 94.7,247
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,93.1,90.0 to 95.5,500
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2014,Age,0-2 Days,62.4,54.9 to 69.4,247
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2014-2015,Age,0-2 Days,63.8,58.4 to 68.9,500
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2015,Age,0-2 Days,65.2,57.4 to 72.3,253
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2015-2016,Age,0-2 Days,64.7,59.5 to 69.5,648
PCV,≥4 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,78.7,71.4 to 85.2,268
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015,Age,35 Months,89.9,82.7 to 95.0,253
≥1 Dose Varicella,,States/Local Areas,New Mexico,2015-2016,Age,35 Months,92.4,88.1 to 95.6,648
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014,Age,35 Months,94.1,89.6 to 97.1,247
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2015,Age,35 Months,91.9,88.0 to 94.9,500
PCV,≥4 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,81.7,75.8 to 86.4,374
≥1 Dose MMR,,States/Local Areas,New Mexico,2018,Age,24 Months,96.4,93.6 to 98.2,447
≥1 Dose MMR,,States/Local Areas,New Mexico,2018-2019,Age,24 Months,94.4,92.1 to 96.3,821
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013,Age,35 Months,89.4,82.8 to 94.4,250
≥1 Dose Varicella,,States/Local Areas,New Mexico,2013-2014,Age,35 Months,91.7,87.8 to 94.8,497
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2016,Age,0-2 Days,64.1,57.4 to 70.3,395
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2016-2017,Age,0-2 Days,68.1,63.6 to 72.3,824
Hep B,≥2 Doses,States/Local Areas,New Mexico,2016,Age,7 Months,93.1,89.4 to 95.5,395
Hep B,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,7 Months,91.7,88.8 to 93.9,824
PCV,≥3 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,85.7,82.0 to 88.8,250
PCV,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,86.8,83.6 to 89.5,497
Hep B,≥2 Doses,States/Local Areas,New Mexico,2017,Age,7 Months,90.3,85.3 to 93.7,429
Hep B,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,7 Months,91.7,88.5 to 94.1,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,88.0,82.9 to 91.7,247
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,87.6,83.7 to 90.7,500
PCV,≥3 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,87.3,80.7 to 91.9,253
PCV,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,89.2,85.5 to 92.1,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,94.5,91.1 to 96.9,447
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,95.3,93.2 to 96.9,821
Hep B,≥2 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,95.3,90.6 to 97.7,253
Hep B,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,94.2,91.5 to 96.1,648
Hib,≥1 Dose,States/Local Areas,New Mexico,2013,Age,3 Months,85.6,82.1 to 88.4,250
Hib,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,3 Months,86.4,83.5 to 88.9,497
Hib,≥1 Dose,States/Local Areas,New Mexico,2012,Age,3 Months,86.5,74.5 to 93.3,263
Hib,≥1 Dose,States/Local Areas,New Mexico,2011,Age,3 Months,86.6,80.4 to 91.0,268
Hib,≥1 Dose,States/Local Areas,New Mexico,2014,Age,3 Months,87.3,81.8 to 91.4,247
Hib,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,3 Months,87.9,84.1 to 90.9,500
Hep B,≥2 Doses,States/Local Areas,New Mexico,2014,Age,13 Months,93.3,88.4 to 96.2,247
Hep B,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,13 Months,95.0,91.9 to 96.9,500
Hep B,≥2 Doses,States/Local Areas,New Mexico,2015,Age,13 Months,96.7,91.6 to 98.8,253
Hep B,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,13 Months,95.3,92.6 to 97.0,648
Hep B,≥2 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,93.8,90.2 to 96.1,395
Hep B,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,93.4,90.8 to 95.4,824
PCV,≥3 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,93.2,89.1 to 95.8,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,90.3,86.0 to 93.4,268
PCV,≥3 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,87.9,84.3 to 90.7,250
PCV,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,90.1,87.6 to 92.2,497
PCV,≥3 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,92.5,88.2 to 95.3,247
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,92.3,88.9 to 94.7,500
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,93.8,90.2 to 96.3,395
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,93.5,90.8 to 95.6,824
PCV,≥4 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,85.1,79.8 to 89.6,374
PCV,≥4 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,82.3,77.0 to 87.0,447
PCV,≥4 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,83.7,80.0 to 87.0,821
PCV,≥4 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,81.9,73.5 to 89.0,268
PCV,≥4 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,90.4,81.4 to 96.2,263
PCV,≥3 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,93.4,89.9 to 95.7,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,93.3,89.0 to 96.3,429
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,94.8,92.1 to 96.8,876
Hep B,≥2 Doses,States/Local Areas,New Mexico,2019,Age,7 Months,96.9,94.1 to 98.4,374
Hep B,≥2 Doses,States/Local Areas,New Mexico,2011,Age,13 Months,92.4,90.9 to 93.7,268
Hep B,≥2 Doses,States/Local Areas,New Mexico,2013,Age,13 Months,93.2,89.3 to 95.7,250
Hep B,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,13 Months,93.2,90.4 to 95.3,497
Hep B,≥2 Doses,States/Local Areas,New Mexico,2012,Age,13 Months,93.8,89.9 to 96.3,263
PCV,≥3 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,87.5,82.3 to 91.3,429
PCV,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,88.9,85.6 to 91.5,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,90.4,85.9 to 93.5,447
PCV,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,91.7,88.9 to 93.9,821
Hep B,≥3 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,93.0,86.9 to 96.9,263
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,95.1,90.6 to 97.9,253
Hep B,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,94.5,91.8 to 96.5,648
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,91.7,87.0 to 95.2,247
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,93.4,90.3 to 95.8,500
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,91.6,87.3 to 94.9,250
Hep B,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,91.6,88.6 to 94.2,497
PCV,≥3 Doses,States/Local Areas,New Mexico,2016,Age,13 Months,91.3,87.5 to 94.0,395
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,13 Months,89.5,86.4 to 91.9,824
≥1 Dose MMR,,States/Local Areas,New Mexico,2014,Age,35 Months,94.2,90.5 to 96.8,247
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2015,Age,35 Months,93.2,89.8 to 95.8,500
≥1 Dose MMR,,States/Local Areas,New Mexico,2015,Age,35 Months,92.7,85.8 to 97.0,253
≥1 Dose MMR,,States/Local Areas,New Mexico,2015-2016,Age,35 Months,94.3,90.1 to 97.2,648
PCV,≥4 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,78.8,73.2 to 84.0,429
PCV,≥4 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,80.5,76.7 to 84.1,876
PCV,≥4 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,84.8,79.9 to 89.1,395
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,82.0,78.3 to 85.3,824
PCV,≥4 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,78.5,71.3 to 84.9,253
PCV,≥4 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,81.6,77.1 to 85.6,648
≥1 Dose MMR,,States/Local Areas,New Mexico,2016,Age,35 Months,95.4,90.7 to 98.2,395
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2017,Age,35 Months,94.8,92.0 to 96.8,824
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019,Age,35 Months,95.9,92.2 to 98.2,374
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,90.0,86.9 to 93.1,707
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,91.7,88.2 to 95.1,418
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016,Age,35 Months,94.2,89.4 to 97.3,395
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2017,Age,35 Months,94.1,91.2 to 96.2,824
≥1 Dose MMR,,States/Local Areas,New Mexico,2013,Age,35 Months,92.9,87.5 to 96.5,250
≥1 Dose MMR,,States/Local Areas,New Mexico,2013-2014,Age,35 Months,93.5,90.3 to 95.8,497
≥1 Dose MMR,,States/Local Areas,New Mexico,2011,Age,35 Months,90.8,85.8 to 94.6,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2012,Age,35 Months,93.3,87.6 to 97.0,263
≥1 Dose MMR,,States/Local Areas,New Mexico,2019,Age,24 Months,92.4,88.4 to 95.4,374
PCV,≥4 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,83.8,78.1 to 88.7,247
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,81.1,76.5 to 85.3,500
PCV,≥4 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,77.3,70.3 to 83.7,250
PCV,≥4 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,80.5,76.0 to 84.7,497
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,96.0,93.3 to 97.8,374
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,90.4,85.8 to 94.0,429
Hep B,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,92.4,89.6 to 94.7,876
Hep B,≥3 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,90.9,85.9 to 94.7,268
PCV,≥4 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,82.7,75.9 to 88.5,263
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017,Age,35 Months,94.1,90.4 to 96.7,429
≥1 Dose Varicella,,States/Local Areas,New Mexico,2017-2018,Age,35 Months,95.0,92.7 to 96.8,876
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2017,Age,0-2 Days,72.5,66.7 to 77.6,429
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2017-2018,Age,0-2 Days,71.1,66.9 to 74.9,876
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2018,Age,0-2 Days,69.6,63.5 to 75.1,447
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2018-2019,Age,0-2 Days,71.6,67.0 to 75.7,821
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2019,Age,0-2 Days,73.6,66.5 to 79.5,374
Hep B,≥2 Doses,States/Local Areas,New Mexico,2018,Age,7 Months,93.2,88.6 to 96.0,447
Hep B,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,7 Months,95.0,92.5 to 96.7,821
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018,Age,35 Months,96.4,93.3 to 98.3,447
≥1 Dose Varicella,,States/Local Areas,New Mexico,2018-2019,Age,35 Months,96.2,93.9 to 97.8,821
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,89.8,86.5 to 93.0,644
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,88.4,84.4 to 92.4,525
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.1,86.1 to 94.1,382
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,85.5 to 98.0,129
≥1 Dose MMR,,States/Local Areas,New Mexico,2019,Age,35 Months,95.3,91.4 to 97.8,374
PCV,≥4 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,82.3,75.6 to 88.2,250
PCV,≥4 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,83.6,79.3 to 87.5,497
≥1 Dose MMR,,States/Local Areas,New Mexico,2018,Age,35 Months,97.8,95.7 to 99.1,447
≥1 Dose MMR,,States/Local Areas,New Mexico,2018-2019,Age,35 Months,96.6,94.4 to 98.1,821
≥1 Dose MMR,,States/Local Areas,New Mexico,2017,Age,35 Months,94.3,90.6 to 96.9,429
≥1 Dose MMR,,States/Local Areas,New Mexico,2017-2018,Age,35 Months,96.0,93.9 to 97.6,876
Hib,≥1 Dose,States/Local Areas,New Mexico,2015,Age,3 Months,88.6,82.8 to 92.6,253
Hib,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,3 Months,87.5,83.6 to 90.6,648
Hib,≥1 Dose,States/Local Areas,New Mexico,2016,Age,3 Months,86.5,80.7 to 90.7,395
Hib,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,3 Months,85.9,82.1 to 89.0,824
Hib,≥1 Dose,States/Local Areas,New Mexico,2017,Age,3 Months,85.3,80.0 to 89.4,429
Hib,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,3 Months,87.0,83.4 to 89.9,876
Hep B,≥2 Doses,States/Local Areas,New Mexico,2017,Age,13 Months,93.0,88.5 to 95.9,429
Hep B,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,13 Months,94.4,91.5 to 96.3,876
Hep B,≥2 Doses,States/Local Areas,New Mexico,2018,Age,13 Months,95.7,91.3 to 98.0,447
Hep B,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,13 Months,97.0,94.6 to 98.3,821
Hep B,≥2 Doses,States/Local Areas,New Mexico,2019,Age,13 Months,98.3,96.0 to 99.3,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,92.1,83.5 to 96.4,253
PCV,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,92.7,89.4 to 95.0,648
PCV,≥3 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,93.3,89.7 to 95.7,395
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,91.9,89.1 to 94.1,824
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,86.9,82.9 to 90.9,506
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Overall,Overall,90.2,87.8 to 92.5,1165
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.4,84.7 to 94.1,261
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,93.3,90.3 to 96.4,379
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,94.0,89.5 to 98.5,197
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.3,85.7 to 94.8,261
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,91.0,87.6 to 94.5,525
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.0,88.6 to 95.5,382
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.6,89.4 to 99.9,129
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,90.9,88.0 to 93.9,644
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,94.7,92.1 to 97.3,418
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,91.0,88.2 to 93.8,707
PCV,≥4 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,89.5,83.5 to 94.1,395
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,85.5,81.6 to 88.9,824
PCV,≥4 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,84.5,76.3 to 91.0,253
PCV,≥4 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,86.9,81.9 to 91.1,648
PCV,≥4 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,84.6,78.9 to 89.4,247
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,84.7,79.7 to 89.0,500
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,96.5,92.6 to 98.7,447
Hep B,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,96.9,94.4 to 98.4,821
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,97.0,94.3 to 98.6,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,92.1,86.7 to 95.8,253
PCV,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,93.0,89.9 to 95.4,648
PCV,≥3 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,93.3,89.6 to 96.1,247
PCV,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,92.7,89.6 to 95.2,500
PCV,≥3 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,93.7,89.1 to 96.8,263
Hib,≥2 Doses,States/Local Areas,New Mexico,2017,Age,5 Months,75.3,69.2 to 80.5,429
Hib,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,5 Months,79.2,75.0 to 82.8,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2013,Age,24 Months,90.0,84.8 to 94.1,250
PCV,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,24 Months,91.7,88.5 to 94.2,497
Hib,≥1 Dose,States/Local Areas,New Mexico,2018,Age,3 Months,88.7,83.5 to 92.4,447
Hib,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,3 Months,92.3,89.5 to 94.5,821
Hib,≥1 Dose,States/Local Areas,New Mexico,2019,Age,3 Months,96.1,93.6 to 97.6,374
≥1 Dose Varicella,,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,93.3,90.7 to 96.0,462
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,86.9,82.6 to 91.2,418
Hib,≥2 Doses,States/Local Areas,New Mexico,2015,Age,5 Months,79.2,72.6 to 84.6,253
Hib,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,5 Months,78.2,73.6 to 82.2,648
Hib,≥2 Doses,States/Local Areas,New Mexico,2016,Age,5 Months,77.1,70.3 to 82.7,395
Hib,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,5 Months,76.3,71.8 to 80.2,824
PCV,≥4 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,81.8,76.1 to 86.8,429
PCV,≥4 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,83.7,79.8 to 87.3,876
PCV,≥4 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,86.3,80.3 to 91.1,447
PCV,≥4 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,86.5,82.7 to 89.9,821
PCV,≥4 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,86.9,81.8 to 91.2,374
PCV,≥1 Dose,States/Local Areas,New Mexico,2011,Age,3 Months,81.9,76.7 to 86.2,268
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,96.1,92.5 to 99.6,197
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,95.3,93.2 to 97.3,462
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,88.1,84.4 to 91.8,506
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Overall,Overall,91.7,89.6 to 93.9,1165
≥1 Dose MMR,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,93.8,90.8 to 96.7,379
PCV,≥1 Dose,States/Local Areas,New Mexico,2012,Age,3 Months,87.8,78.9 to 93.2,263
PCV,≥3 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,94.0,90.0 to 96.4,447
PCV,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,91.7,88.9 to 93.9,821
PCV,≥3 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,96.1,92.9 to 97.9,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,90.8,85.8 to 94.6,268
Hib,≥2 Doses,States/Local Areas,New Mexico,2013,Age,5 Months,78.7,74.2 to 82.6,250
Hib,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,5 Months,79.6,78.5 to 80.8,497
Hib,≥2 Doses,States/Local Areas,New Mexico,2014,Age,5 Months,80.6,74.0 to 85.8,247
Hib,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,5 Months,79.9,77.5 to 82.1,500
PCV,≥3 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,90.4,85.5 to 93.8,429
PCV,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,92.2,89.2 to 94.4,876
Hib,≥2 Doses,States/Local Areas,New Mexico,2012,Age,5 Months,76.6,71.8 to 80.8,263
Hib,≥2 Doses,States/Local Areas,New Mexico,2011,Age,5 Months,76.3,70.4 to 81.3,268
Hib,Full Series,States/Local Areas,New Mexico,2020,Age,24 Months,82.7,76.8 to 87.8,357
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,91.7,86.1 to 97.4,197
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,86.9,83.0 to 90.9,462
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,74.1,69.1 to 79.1,506
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,81.1,78.1 to 84.2,1165
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,82.8,77.7 to 88.0,379
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.9,65.8 to 80.0,261
Hib,≥2 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,89.3,86.9 to 91.2,250
Hib,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,89.3,87.3 to 91.1,497
Hib,≥2 Doses,States/Local Areas,New Mexico,2014,Age,7 Months,89.4,84.3 to 93.0,247
Hib,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,7 Months,90.5,87.1 to 93.1,500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2012,Age,0-3 Days,66.5,57.8 to 74.2,263
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,83.5,79.2 to 87.9,525
PCV,≥1 Dose,States/Local Areas,New Mexico,2013,Age,3 Months,84.0,78.5 to 88.3,250
PCV,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,3 Months,84.9,81.4 to 87.9,497
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,81.6,77.7 to 85.6,644
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,79.8,75.8 to 83.8,707
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2011,Age,0-3 Days,65.4,57.0 to 72.9,268
PCV,≥1 Dose,States/Local Areas,New Mexico,2018,Age,3 Months,87.8,82.5 to 91.7,447
PCV,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,3 Months,90.6,87.5 to 93.0,821
Hib,≥2 Doses,States/Local Areas,New Mexico,2018,Age,5 Months,83.1,77.2 to 87.7,447
Hib,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,5 Months,84.3,80.2 to 87.7,821
Hib,≥2 Doses,States/Local Areas,New Mexico,2019,Age,5 Months,85.6,79.4 to 90.2,374
Hib,≥2 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,87.2,83.6 to 90.1,268
PCV,≥3 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,94.0,90.7 to 96.4,395
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,92.6,89.9 to 94.8,824
Hib,≥2 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,89.6,83.3 to 93.8,263
PCV,≥3 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,91.0,86.5 to 94.5,429
PCV,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,92.6,89.7 to 94.9,876
PCV,≥3 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,94.1,90.4 to 96.7,447
PCV,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,95.1,92.8 to 96.8,821
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,91.9,88.3 to 95.5,418
PCV,≥1 Dose,States/Local Areas,New Mexico,2016,Age,3 Months,88.0,82.3 to 92.0,395
PCV,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,3 Months,86.9,83.2 to 89.9,824
PCV,≥1 Dose,States/Local Areas,New Mexico,2017,Age,3 Months,85.8,80.5 to 89.8,429
PCV,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,3 Months,86.8,83.2 to 89.7,876
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.0,75.4 to 86.6,382
PCV,≥4 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.4,70.2 to 88.7,129
PCV,≥1 Dose,States/Local Areas,New Mexico,2014,Age,3 Months,85.8,80.4 to 90.0,247
PCV,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,3 Months,87.4,83.6 to 90.4,500
PCV,≥1 Dose,States/Local Areas,New Mexico,2015,Age,3 Months,89.0,83.1 to 93.1,253
PCV,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,3 Months,88.5,84.6 to 91.5,648
Hep A,≥1 Dose,States/Local Areas,New Mexico,2020,Age,35 Months,92.0,87.4 to 95.5,357
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014,Age,0-3 Days,64.7,57.1 to 71.6,247
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2014-2015,Age,0-3 Days,67.5,62.2 to 72.4,500
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013,Age,7 Months,67.9,63.8 to 71.8,250
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,7 Months,68.8,65.7 to 71.8,497
DTaP,≥3 Doses,States/Local Areas,New Mexico,2012,Age,7 Months,68.6,63.5 to 73.3,263
DTaP,≥3 Doses,States/Local Areas,New Mexico,2011,Age,7 Months,71.9,66.6 to 76.6,268
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2013,Age,0-3 Days,69.1,61.8 to 75.6,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2013-2014,Age,0-3 Days,66.9,61.7 to 71.8,497
Polio,≥1 Dose,States/Local Areas,New Mexico,2013,Age,3 Months,86.5,82.7 to 89.6,250
Polio,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,3 Months,87.7,84.8 to 90.1,497
PCV,≥1 Dose,States/Local Areas,New Mexico,2019,Age,3 Months,93.4,90.0 to 95.7,374
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,91.9,89.8 to 94.0,1165
Polio,≥1 Dose,States/Local Areas,New Mexico,2012,Age,3 Months,85.3,76.0 to 91.4,263
Polio,≥1 Dose,States/Local Areas,New Mexico,2011,Age,3 Months,86.5,83.3 to 89.1,268
Hib,≥2 Doses,States/Local Areas,New Mexico,2015,Age,7 Months,91.6,86.6 to 94.9,253
Hib,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,7 Months,91.3,88.3 to 93.6,648
PCV,≥3 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,96.1,93.3 to 98.0,374
PCV,≥3 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,93.4,86.6 to 97.4,268
PCV,≥3 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,94.3,89.8 to 97.2,250
PCV,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,93.8,90.9 to 96.0,497
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,87.9 to 94.6,525
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,92.2,89.6 to 94.8,707
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.5,86.7 to 94.3,382
Hep B,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.4,85.8 to 94.9,261
Influenza,,States/Local Areas,Connecticut,2017,Age,24 Months,74.8,65.6 to 83.1,184
Influenza,,States/Local Areas,Connecticut,2017-2018,Age,24 Months,77.0,71.3 to 82.2,492
Influenza,,States/Local Areas,Connecticut,2018,Age,24 Months,78.8,72.3 to 84.7,308
Influenza,,States/Local Areas,Connecticut,2018-2019,Age,24 Months,81.8,77.5 to 85.7,619
Influenza,,States/Local Areas,Connecticut,2019,Age,24 Months,84.7,79.0 to 89.6,311
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,83.8,76.8 to 90.8,200
Influenza,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,63.2,50.5 to 75.9,92
Influenza,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,79.7,75.0 to 84.4,474
Influenza,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,70.3,62.6 to 77.9,186
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,93.9,91.0 to 96.7,595
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.1,52.2 to 94.0,50
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,94.9,91.9 to 98.0,186
Influenza,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,73.0,65.2 to 80.9,182
Influenza,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.3,69.8 to 88.8,115
Influenza,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.9,45.6 to 84.3,44
Influenza,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.1,68.6 to 79.5,421
Influenza,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,74.2,67.3 to 81.2,261
Influenza,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.0,67.6 to 78.5,478
PCV,≥1 Dose,States/Local Areas,Connecticut,2021,Age,3 Months,88.7,78.4 to 94.5,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,96.9,92.8 to 99.0,164
DTaP,≥3 Doses,States/Local Areas,Connecticut,2021,Age,24 Months,98.6,96.5 to 99.5,164
≥1 Dose MMR,,States/Local Areas,Connecticut,2021,Age,13 Months,73.6,63.0 to 82.0,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,97.4,95.8 to 99.0,595
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,94.8,91.6 to 98.1,186
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.4 to 95.9,595
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,88.5,83.7 to 93.2,186
Influenza,,States/Local Areas,Connecticut,2014-2017,Overall,Overall,73.7,69.5 to 77.9,762
Influenza,,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,68.8,60.4 to 77.2,178
Influenza,,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,62.8,54.7 to 71.0,246
Influenza,,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,85.9,81.0 to 90.8,338
PCV,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,94.4,90.7 to 96.7,412
Hib,Primary Series,States/Local Areas,Connecticut,2021,Age,35 Months,96.2,91.8 to 98.6,164
DTaP,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,5 Months,90.1,85.1 to 93.6,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2021,Age,0-3 Days,83.7,74.0 to 90.2,164
Hib,≥2 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,98.2,95.6 to 99.3,164
Hib,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,94.2,90.5 to 96.5,412
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,96.2,93.0 to 98.0,412
Polio,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,96.9,93.6 to 98.8,412
Hep A,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,59.0,51.6 to 66.5,412
Polio,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,5 Months,88.3,82.7 to 92.2,412
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,80.4,74.2 to 85.3,412
PCV,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,3 Months,89.4,83.5 to 93.3,412
Hib,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,59.2,52.3 to 65.7,412
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,95.1,91.5 to 97.4,412
Polio,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,95.4,91.4 to 97.9,412
Rotavirus,,States/Local Areas,Connecticut,2021,Age,8 Months,85.5,76.8 to 91.3,164
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020-2021,Age,24 Months,95.6,91.6 to 98.0,412
Hib,Primary Series,States/Local Areas,Connecticut,2020-2021,Age,7 Months,76.0,69.6 to 81.4,412
≥1 Dose MMR,,States/Local Areas,Connecticut,2020-2021,Age,24 Months,94.4,90.4 to 97.2,412
Combined 7 Series,,States/Local Areas,Connecticut,2020-2021,Age,35 Months,89.7,80.2 to 95.9,412
Hib,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,3 Months,91.2,86.2 to 94.5,412
Hib,Primary Series,States/Local Areas,Connecticut,2020-2021,Age,13 Months,91.0,86.7 to 94.0,412
PCV,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,5 Months,86.3,80.4 to 90.6,412
Hep B,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,5 Months,93.8,89.9 to 96.3,412
Polio,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,93.9,89.4 to 96.5,412
Polio,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,95.2,91.6 to 97.3,412
Hib,≥3 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,71.5,61.3 to 79.9,164
DTaP,≥3 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,98.6,96.5 to 99.5,164
Hib,Full Series,States/Local Areas,Connecticut,2021,Age,35 Months,98.0,88.9 to 99.9,164
Combined 7 Series,,States/Local Areas,Connecticut,2020-2021,Age,24 Months,76.7,70.5 to 82.5,412
Hep B,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,94.7,91.0 to 97.0,412
PCV,≥4 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,94.8,89.6 to 97.9,412
PCV,≥4 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,86.1,80.6 to 90.2,412
Hib,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,95.1,91.7 to 97.4,412
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2020-2021,Age,0-1 Days,79.9,73.7 to 84.9,412
Influenza,,States/Local Areas,Connecticut,2020-2021,Age,24 Months,79.8,73.7 to 85.3,412
PCV,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,96.1,93.3 to 98.0,412
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,64.7,58.2 to 70.7,412
≥1 Dose MMR,,States/Local Areas,Connecticut,2020-2021,Age,35 Months,96.2,91.5 to 98.7,412
Hib,Primary Series,States/Local Areas,Connecticut,2021,Age,13 Months,92.1,85.9 to 95.7,164
PCV,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,95.7,92.5 to 97.6,412
Hep B,≥3 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,96.2,91.1 to 98.8,164
DTaP,≥4 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,93.4,85.4 to 97.9,164
≥1 Dose Varicella,,States/Local Areas,Connecticut,2021,Age,35 Months,95.5,89.1 to 98.7,164
Polio,≥3 Doses,States/Local Areas,Connecticut,2021,Age,35 Months,97.3,91.4 to 99.5,164
Hep A,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,35 Months,97.8,94.5 to 99.4,412
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,97.7,95.2 to 99.1,412
Hib,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,94.5,90.9 to 96.8,412
Hep A,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,19 Months,91.1,86.1 to 94.4,412
Hep B,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,94.5,90.6 to 96.9,412
Rotavirus,,States/Local Areas,Connecticut,2020-2021,Age,8 Months,84.5,78.9 to 88.9,412
DTaP,≥4 Doses,States/Local Areas,Connecticut,2020-2021,Age,24 Months,86.7,81.2 to 91.3,412
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,35 Months,97.7,95.2 to 99.1,412
Hep A,≥1 Dose,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,90.4 to 99.5,134
Hep B,≥2 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,97.5,91.8 to 99.3,164
Hib,Full Series,States/Local Areas,Connecticut,2020-2021,Age,19 Months,79.4,73.4 to 84.4,412
PCV,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,19 Months,95.0,91.7 to 97.0,559
DTaP,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,94.8,91.1 to 97.0,412
Polio,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,13 Months,96.3,93.1 to 98.0,412
≥1 Dose MMR,,States/Local Areas,Connecticut,2020-2021,Age,13 Months,72.7,66.0 to 78.5,412
Hib,≥2 Doses,States/Local Areas,Connecticut,2021,Age,5 Months,85.7,76.2 to 91.8,164
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Connecticut,2021,Age,0-1 Days,79.4,69.3 to 86.8,164
≥1 Dose MMR,,States/Local Areas,Connecticut,2021,Age,19 Months,92.1,83.5 to 96.4,164
DTaP,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,3 Months,93.2,88.6 to 96.0,412
Hib,Full Series,States/Local Areas,Connecticut,2020-2021,Age,35 Months,94.2,87.1 to 98.1,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Connecticut,2020-2021,Age,0-3 Days,83.9,78.1 to 88.3,412
Hib,Primary Series,States/Local Areas,Connecticut,2020-2021,Age,35 Months,95.1,91.8 to 97.4,412
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Connecticut,2020-2021,Age,0-2 Days,82.8,77.0 to 87.4,412
Influenza,,States/Local Areas,Connecticut,2021,Age,24 Months,76.4,66.8 to 84.9,164
DTaP,≥4 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,75.7,69.5 to 81.1,412
PCV,≥3 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,95.3,90.1 to 97.8,164
Hep B,≥2 Doses,States/Local Areas,Connecticut,2021,Age,5 Months,96.9,91.3 to 98.9,164
Hep B,≥3 Doses,States/Local Areas,Connecticut,2021,Age,13 Months,94.7,88.7 to 97.6,164
≥1 Dose Varicella,,States/Local Areas,Connecticut,2021,Age,13 Months,65.7,55.2 to 74.8,164
DTaP,≥2 Doses,States/Local Areas,Connecticut,2021,Age,5 Months,90.8,82.0 to 95.5,164
Polio,≥2 Doses,States/Local Areas,Connecticut,2021,Age,5 Months,87.3,77.6 to 93.2,164
Influenza,,States/Local Areas,Connecticut,2013,Age,24 Months,79.4,72.3 to 85.7,255
Influenza,,States/Local Areas,Connecticut,2013-2014,Age,24 Months,73.5,68.4 to 78.3,518
Hib,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,5 Months,87.2,81.6 to 91.2,412
Hib,Primary Series,States/Local Areas,Connecticut,2020-2021,Age,19 Months,95.0,91.4 to 97.2,412
Hep A,≥2 Doses,States/Local Areas,Connecticut,2020-2021,Age,19 Months,33.0,27.3 to 39.3,412
PCV,≥3 Doses,States/Local Areas,Connecticut,2020-2021,Age,7 Months,80.2,74.0 to 85.2,412
≥1 Dose Varicella,,States/Local Areas,Connecticut,2020-2021,Age,19 Months,93.2,88.3 to 96.1,412
Hep B,≥1 Dose,States/Local Areas,Connecticut,2020-2021,Age,3 Months,96.5,93.1 to 98.2,412
Influenza,,States/Local Areas,Connecticut,2011,Age,24 Months,71.8,64.6 to 78.6,243
Influenza,,States/Local Areas,Connecticut,2012,Age,24 Months,74.1,66.5 to 81.2,245
Influenza,,States/Local Areas,Connecticut,2014,Age,24 Months,67.5,60.2 to 74.7,263
Influenza,,States/Local Areas,Connecticut,2014-2015,Age,24 Months,70.3,64.8 to 75.6,479
Influenza,,States/Local Areas,Connecticut,2015,Age,24 Months,73.0,64.8 to 80.6,216
Influenza,,States/Local Areas,Connecticut,2015-2016,Age,24 Months,75.6,69.6 to 81.2,398
Influenza,,States/Local Areas,Connecticut,2016,Age,24 Months,77.9,69.0 to 85.8,182
Influenza,,States/Local Areas,Connecticut,2016-2017,Age,24 Months,76.4,70.0 to 82.3,366
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Poverty,>400% FPL,88.7,84.5 to 92.8,338
Rotavirus,,States/Local Areas,Connecticut,2015,Age,8 Months,81.0,73.2 to 86.9,216
Rotavirus,,States/Local Areas,Connecticut,2015-2016,Age,8 Months,80.7,74.7 to 85.5,398
Rotavirus,,States/Local Areas,Connecticut,2016,Age,8 Months,80.3,70.7 to 87.4,182
Rotavirus,,States/Local Areas,Connecticut,2016-2017,Age,8 Months,80.2,73.7 to 85.4,366
Rotavirus,,States/Local Areas,Connecticut,2017,Age,8 Months,80.1,70.5 to 87.1,184
Rotavirus,,States/Local Areas,Connecticut,2017-2018,Age,8 Months,84.1,78.8 to 88.3,492
Rotavirus,,States/Local Areas,Connecticut,2012,Age,8 Months,69.3,60.6 to 76.8,245
Rotavirus,,States/Local Areas,Connecticut,2014,Age,8 Months,75.1,67.4 to 81.5,263
Rotavirus,,States/Local Areas,Connecticut,2014-2015,Age,8 Months,78.0,72.7 to 82.6,479
Rotavirus,,States/Local Areas,Connecticut,2013,Age,8 Months,83.7,76.5 to 89.0,255
Rotavirus,,States/Local Areas,Connecticut,2013-2014,Age,8 Months,79.4,74.3 to 83.8,518
Rotavirus,,States/Local Areas,Connecticut,2011,Age,8 Months,85.8,80.4 to 90.0,243
Rotavirus,,States/Local Areas,Connecticut,2018,Age,8 Months,88.2,83.0 to 91.9,308
Rotavirus,,States/Local Areas,Connecticut,2018-2019,Age,8 Months,85.5,81.6 to 88.6,619
Rotavirus,,States/Local Areas,Connecticut,2019,Age,8 Months,82.8,76.7 to 87.5,311
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Other,84.6,74.9 to 94.2,92
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Private Insurance Only,88.6,85.2 to 92.0,474
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Insurance Coverage,Any Medicaid,73.6,66.5 to 80.8,186
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.3,57.0 to 85.7,44
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,Hispanic,80.7,74.1 to 87.3,182
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,75.2 to 91.3,115
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,82.0 to 90.4,421
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Principal City,77.9,71.7 to 84.2,261
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.6,81.8 to 89.4,478
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Overall,Overall,82.8,79.5 to 86.1,762
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Poverty,<133% FPL,73.7,66.4 to 81.0,178
Rotavirus,,States/Local Areas,Connecticut,2014-2017,Poverty,133% to <400% FPL,84.1,78.2 to 89.9,246
Hep B,≥1 Dose,States/Local Areas,Connecticut,2021,Age,3 Months,97.5,91.8 to 99.3,164
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,Hispanic,83.9,77.5 to 90.4,200
Polio,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.9,92.9 to 100.0,134
Hep A,≥2 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,83.4 to 98.9,134
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Private Insurance Only,94.6,92.1 to 97.1,595
DTaP,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,<133% FPL,84.7,78.8 to 90.6,176
PCV,≥4 Doses,States/Local Areas,Connecticut,2016-2019,Insurance Coverage,Any Medicaid,89.5,84.7 to 94.3,186
Hib,Full Series,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,87.3 to 98.1,134
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Poverty,>400% FPL,98.3,96.7 to 99.9,428
Hep B,≥3 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,59.9,54.5 to 65.1,559
Hep B,≥2 Doses,States/Local Areas,Connecticut,2019-2020,Age,7 Months,94.0,90.6 to 96.3,559
PCV,≥3 Doses,States/Local Areas,Connecticut,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,91.3 to 99.8,134
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.7,72.9 to 90.6,90
Hep B,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,61.2,55.5 to 66.7,467
Hep B,≥2 Doses,States/Local Areas,Alabama,2019-2020,Age,7 Months,91.9,88.3 to 94.5,467
Polio,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,89.5,83.7 to 93.5,400
Hib,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,5 Months,75.3,68.5 to 81.0,400
≥1 Dose Varicella,,States/Local Areas,Alabama,2021,Age,13 Months,59.9,48.7 to 70.2,160
Hep B,≥3 Doses,States/Local Areas,Alabama,2021,Age,13 Months,74.1,62.9 to 82.8,160
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,71.2,58.5 to 84.0,84
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.4,91.4 to 99.4,90
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,88.2 to 98.1,90
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.2,47.1 to 79.3,90
Hep A,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,24 Months,88.2,83.4 to 92.2,400
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,89.1,84.8 to 93.5,454
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,75.1,68.8 to 81.4,308
Rotavirus,,States/Local Areas,Alabama,2015,Age,8 Months,71.7,63.8 to 78.4,287
Rotavirus,,States/Local Areas,Alabama,2015-2016,Age,8 Months,71.6,66.4 to 76.3,596
Rotavirus,,States/Local Areas,Alabama,2016,Age,8 Months,71.6,64.1 to 78.0,309
Rotavirus,,States/Local Areas,Alabama,2016-2017,Age,8 Months,74.7,69.5 to 79.3,568
Rotavirus,,States/Local Areas,Alabama,2013,Age,8 Months,72.7,64.8 to 79.3,260
Rotavirus,,States/Local Areas,Alabama,2013-2014,Age,8 Months,76.3,71.1 to 80.8,536
Rotavirus,,States/Local Areas,Alabama,2014,Age,8 Months,79.9,73.1 to 85.4,276
Rotavirus,,States/Local Areas,Alabama,2014-2015,Age,8 Months,75.8,70.7 to 80.3,563
Rotavirus,,States/Local Areas,Alabama,2011,Age,8 Months,78.4,69.9 to 84.9,218
Rotavirus,,States/Local Areas,Alabama,2018,Age,8 Months,67.6,58.5 to 75.5,232
Rotavirus,,States/Local Areas,Alabama,2018-2019,Age,8 Months,73.4,67.5 to 78.5,459
Rotavirus,,States/Local Areas,Alabama,2019,Age,8 Months,79.1,71.7 to 85.0,227
Rotavirus,,States/Local Areas,Alabama,2017,Age,8 Months,77.9,70.2 to 84.1,259
Rotavirus,,States/Local Areas,Alabama,2017-2018,Age,8 Months,72.8,66.9 to 78.0,491
Rotavirus,,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,92.7,89.1 to 96.4,257
Rotavirus,,States/Local Areas,Alabama,2012,Age,8 Months,79.9,71.1 to 86.6,233
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2020-2021,Age,0-3 Days,76.7,70.3 to 82.1,400
DTaP,≥4 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,79.7,73.6 to 85.2,400
Influenza,,States/Local Areas,Alabama,2020-2021,Age,24 Months,33.4,27.2 to 40.5,400
PCV,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,66.0,59.0 to 72.4,400
Hib,Primary Series,States/Local Areas,Alabama,2020-2021,Age,35 Months,90.5,85.2 to 94.5,400
DTaP,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,3 Months,86.9,80.9 to 91.2,400
Hib,Full Series,States/Local Areas,Alabama,2020-2021,Age,35 Months,76.5,69.4 to 82.9,400
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Alabama,2020-2021,Age,0-2 Days,75.7,69.3 to 81.2,400
Hep B,≥2 Doses,States/Local Areas,Alabama,2021,Age,5 Months,76.9,65.9 to 85.2,160
≥1 Dose MMR,,States/Local Areas,Alabama,2021,Age,19 Months,80.2,69.5 to 87.8,160
Hep A,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,23.1,18.1 to 29.1,400
DTaP,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,84.5,78.5 to 89.2,400
Hep B,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,3 Months,96.7,93.2 to 98.4,400
≥1 Dose Varicella,,States/Local Areas,Alabama,2020-2021,Age,19 Months,86.4,80.7 to 90.6,400
Hep B,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,85.1,79.2 to 89.6,400
≥1 Dose MMR,,States/Local Areas,Alabama,2020-2021,Age,13 Months,63.7,56.6 to 70.2,400
Influenza,,States/Local Areas,Alabama,2021,Age,24 Months,34.4,24.7 to 46.5,160
Hib,Full Series,States/Local Areas,Alabama,2020-2021,Age,19 Months,62.9,56.0 to 69.4,400
DTaP,≥2 Doses,States/Local Areas,Alabama,2021,Age,5 Months,74.5,63.3 to 83.2,160
Polio,≥2 Doses,States/Local Areas,Alabama,2021,Age,5 Months,74.5,63.3 to 83.2,160
Hib,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,3 Months,83.7,77.5 to 88.5,400
Polio,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,86.1,79.8 to 90.6,400
DTaP,≥4 Doses,States/Local Areas,Alabama,2021,Age,35 Months,83.5,73.1 to 91.6,160
PCV,≥4 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,71.4,64.6 to 77.4,400
Hep B,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,55.3,48.2 to 62.2,400
Hib,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,89.4,84.0 to 93.6,400
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Alabama,2020-2021,Age,0-1 Days,72.5,65.9 to 78.2,400
PCV,≥4 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,80.6,74.3 to 86.3,400
Hib,Primary Series,States/Local Areas,Alabama,2021,Age,13 Months,76.1,64.8 to 84.6,160
Hep B,≥3 Doses,States/Local Areas,Alabama,2021,Age,35 Months,81.9,71.9 to 90.0,160
PCV,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,88.4,82.8 to 92.3,400
Hep B,≥2 Doses,States/Local Areas,Alabama,2021,Age,13 Months,92.0,83.2 to 96.4,160
Combined 7 Series,,States/Local Areas,Alabama,2021,Age,24 Months,63.7,52.4 to 74.8,160
Hib,Primary Series,States/Local Areas,Alabama,2020-2021,Age,13 Months,79.6,72.9 to 84.9,400
≥1 Dose MMR,,States/Local Areas,Alabama,2020-2021,Age,35 Months,91.2,85.9 to 95.1,400
Polio,≥3 Doses,States/Local Areas,Alabama,2021,Age,35 Months,86.3,76.6 to 93.4,160
≥1 Dose Varicella,,States/Local Areas,Alabama,2021,Age,35 Months,87.5,77.9 to 94.3,160
Hep A,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,19 Months,81.8,75.7 to 86.6,400
DTaP,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,91.1,86.2 to 94.7,400
DTaP,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,92.1,87.2 to 95.6,400
Rotavirus,,States/Local Areas,Alabama,2020-2021,Age,8 Months,69.8,62.6 to 76.1,400
Hib,Primary Series,States/Local Areas,Alabama,2020-2021,Age,19 Months,87.2,81.2 to 91.5,400
Hep B,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,85.4,79.9 to 90.1,400
Hib,Primary Series,States/Local Areas,Alabama,2020-2021,Age,7 Months,67.3,60.1 to 73.7,400
Hep A,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,39.9,33.1 to 47.6,400
Hib,≥3 Doses,States/Local Areas,Alabama,2021,Age,35 Months,85.4,75.6 to 92.7,160
Polio,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,89.2,83.8 to 93.4,400
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2021,Age,0-3 Days,74.0,63.4 to 82.4,160
Rotavirus,,States/Local Areas,Alabama,2021,Age,8 Months,62.7,51.2 to 73.0,160
≥1 Dose Varicella,,States/Local Areas,Alabama,2020-2021,Age,24 Months,90.4,85.4 to 94.3,400
Hib,Primary Series,States/Local Areas,Alabama,2021,Age,35 Months,86.4,76.7 to 93.5,160
Polio,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,89.7,84.3 to 93.9,400
Hep B,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,5 Months,81.6,75.2 to 86.6,400
Polio,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,5 Months,79.0,72.4 to 84.4,400
Hib,≥3 Doses,States/Local Areas,Alabama,2021,Age,13 Months,71.1,59.8 to 80.2,160
PCV,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,24 Months,91.1,86.3 to 94.8,400
Polio,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,86.3,80.3 to 90.7,400
Hib,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,84.8,78.8 to 89.4,400
Combined 7 Series,,States/Local Areas,Alabama,2020-2021,Age,24 Months,62.6,55.7 to 69.5,400
Combined 7 Series,,States/Local Areas,Alabama,2020-2021,Age,35 Months,68.5,61.1 to 75.6,400
≥1 Dose MMR,,States/Local Areas,Alabama,2020-2021,Age,24 Months,89.8,84.6 to 93.8,400
Hib,Full Series,States/Local Areas,Alabama,2021,Age,35 Months,74.1,63.2 to 83.9,160
DTaP,≥3 Doses,States/Local Areas,Alabama,2021,Age,35 Months,89.6,80.6 to 95.6,160
DTaP,≥4 Doses,States/Local Areas,Alabama,2020-2021,Age,19 Months,65.0,58.0 to 71.4,400
Hep B,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,89.8,84.2 to 93.5,400
Hib,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,84.0,77.6 to 88.8,400
PCV,≥1 Dose,States/Local Areas,Alabama,2021,Age,3 Months,80.9,70.3 to 88.4,160
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,77.4 to 94.1,90
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,83.1,78.4 to 87.8,404
≥1 Dose MMR,,States/Local Areas,Alabama,2020-2021,Age,19 Months,84.4,78.2 to 89.1,400
Hib,≥2 Doses,States/Local Areas,Alabama,2021,Age,13 Months,85.0,74.2 to 91.8,160
DTaP,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,68.7,61.6 to 75.1,400
Hib,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,7 Months,57.8,50.6 to 64.6,400
PCV,≥3 Doses,States/Local Areas,Alabama,2020-2021,Age,13 Months,84.6,78.5 to 89.2,400
PCV,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,3 Months,84.9,78.9 to 89.5,400
Polio,≥1 Dose,States/Local Areas,Alabama,2020-2021,Age,3 Months,85.7,79.4 to 90.3,400
≥1 Dose MMR,,States/Local Areas,Alabama,2021,Age,13 Months,61.2,50.0 to 71.3,160
Hep A,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,35 Months,75.3,66.9 to 82.9,400
DTaP,≥2 Doses,States/Local Areas,Alabama,2020-2021,Age,5 Months,79.0,72.4 to 84.4,400
DTaP,≥3 Doses,States/Local Areas,Alabama,2021,Age,24 Months,87.7,78.9 to 94.1,160
≥1 Dose Varicella,,States/Local Areas,Alabama,2020-2021,Age,13 Months,64.1,57.0 to 70.6,400
Influenza,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",35.2,25.9 to 44.4,132
Influenza,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,42.0,30.1 to 53.9,106
Influenza,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",33.5,22.4 to 44.6,103
Influenza,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",45.4,40.6 to 50.2,701
Influenza,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,37.9,32.0 to 43.8,432
Influenza,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,45.3,38.6 to 52.1,401
Influenza,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,40.3,31.4 to 49.1,209
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,95.7,92.6 to 98.7,454
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,94.4,91.8 to 97.0,404
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,89.1,84.8 to 93.4,454
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,76.5,71.2 to 81.7,404
Influenza,,States/Local Areas,Alabama,2014-2017,Overall,Overall,41.1,37.1 to 45.1,1042
Influenza,,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,31.4,25.6 to 37.3,370
Influenza,,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,41.8,35.0 to 48.5,415
Influenza,,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,65.1,57.0 to 73.1,257
Influenza,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,51.4,32.5 to 70.2,67
Influenza,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,56.8,50.9 to 62.7,500
Influenza,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,32.0,26.5 to 37.6,453
Influenza,,States/Local Areas,Alabama,2017,Age,24 Months,35.1,28.0 to 43.4,259
Influenza,,States/Local Areas,Alabama,2017-2018,Age,24 Months,36.7,31.2 to 42.8,491
Influenza,,States/Local Areas,Alabama,2018,Age,24 Months,38.2,30.4 to 47.3,232
Influenza,,States/Local Areas,Alabama,2018-2019,Age,24 Months,39.9,34.3 to 46.0,459
Influenza,,States/Local Areas,Alabama,2019,Age,24 Months,41.5,33.9 to 50.0,227
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,89.1,85.2 to 93.0,454
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,88.6,85.0 to 92.2,404
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,82.3,70.7 to 94.0,68
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.9,60.7 to 87.2,134
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,75.4,54.5 to 96.3,84
PCV,≥3 Doses,States/Local Areas,Alabama,2019-2020,Age,19 Months,93.4,89.8 to 95.8,467
Combined 7 Series,,States/Local Areas,Alabama,2014,Age,24 Months,73.5,66.1 to 80.4,276
Combined 7 Series,,States/Local Areas,Alabama,2014-2015,Age,24 Months,71.5,66.3 to 76.6,563
Combined 7 Series,,States/Local Areas,Alabama,2015,Age,24 Months,69.5,62.0 to 76.7,287
Combined 7 Series,,States/Local Areas,Alabama,2015-2016,Age,24 Months,71.0,65.9 to 75.9,596
Hib,Primary Series,States/Local Areas,Alabama,2018,Age,35 Months,94.9,87.0 to 98.7,232
Hib,Primary Series,States/Local Areas,Alabama,2018-2019,Age,35 Months,96.5,92.4 to 98.8,459
Combined 7 Series,,States/Local Areas,Alabama,2016,Age,24 Months,72.3,65.4 to 78.8,309
Combined 7 Series,,States/Local Areas,Alabama,2016-2017,Age,24 Months,73.5,68.2 to 78.5,568
Hib,Primary Series,States/Local Areas,Alabama,2019,Age,35 Months,97.8,95.3 to 99.2,227
Hib,Primary Series,States/Local Areas,Alabama,2017,Age,35 Months,95.2,90.1 to 98.1,259
Hib,Primary Series,States/Local Areas,Alabama,2017-2018,Age,35 Months,95.7,90.2 to 98.6,491
Hib,Primary Series,States/Local Areas,Alabama,2015,Age,35 Months,94.5,90.4 to 97.3,287
Hib,Primary Series,States/Local Areas,Alabama,2015-2016,Age,35 Months,94.5,92.0 to 96.5,596
Hib,Primary Series,States/Local Areas,Alabama,2016,Age,35 Months,94.3,90.9 to 96.8,309
Hib,Primary Series,States/Local Areas,Alabama,2016-2017,Age,35 Months,94.8,91.9 to 96.9,568
Hib,Primary Series,States/Local Areas,Alabama,2011,Age,35 Months,91.9,84.7 to 96.5,218
Hib,Primary Series,States/Local Areas,Alabama,2013,Age,35 Months,96.0,92.5 to 98.1,260
Hib,Primary Series,States/Local Areas,Alabama,2013-2014,Age,35 Months,96.5,94.2 to 98.1,536
Hib,Primary Series,States/Local Areas,Alabama,2012,Age,35 Months,95.2,89.8 to 98.3,233
Hib,Primary Series,States/Local Areas,Alabama,2014,Age,35 Months,97.3,93.4 to 99.2,276
Hib,Primary Series,States/Local Areas,Alabama,2014-2015,Age,35 Months,96.0,93.4 to 97.8,563
Combined 7 Series,,States/Local Areas,Alabama,2011,Age,24 Months,74.0,65.6 to 81.8,218
Combined 7 Series,,States/Local Areas,Alabama,2013,Age,24 Months,65.9,57.9 to 73.8,260
Combined 7 Series,,States/Local Areas,Alabama,2013-2014,Age,24 Months,69.8,64.3 to 75.1,536
Combined 7 Series,,States/Local Areas,Alabama,2012,Age,24 Months,70.4,61.2 to 79.1,233
Hib,Primary Series,States/Local Areas,Alabama,2019,Age,24 Months,97.8,95.3 to 99.2,227
Hib,Primary Series,States/Local Areas,Alabama,2013,Age,7 Months,71.2,66.8 to 75.3,260
Hib,Primary Series,States/Local Areas,Alabama,2013-2014,Age,7 Months,75.1,72.5 to 77.5,536
Hib,Primary Series,States/Local Areas,Alabama,2014,Age,7 Months,79.0,72.1 to 84.5,276
Hib,Primary Series,States/Local Areas,Alabama,2014-2015,Age,7 Months,74.7,69.6 to 79.2,563
Hib,Primary Series,States/Local Areas,Alabama,2015,Age,7 Months,70.5,62.6 to 77.3,287
Hib,Primary Series,States/Local Areas,Alabama,2015-2016,Age,7 Months,70.6,65.2 to 75.5,596
Hib,Primary Series,States/Local Areas,Alabama,2019,Age,13 Months,90.1,84.1 to 94.1,227
Hib,Primary Series,States/Local Areas,Alabama,2011,Age,19 Months,91.4,87.7 to 94.1,218
Combined 7 Series,,States/Local Areas,Alabama,2016,Age,35 Months,77.3,70.4 to 83.6,309
Combined 7 Series,,States/Local Areas,Alabama,2016-2017,Age,35 Months,79.6,74.2 to 84.5,568
Combined 7 Series,,States/Local Areas,Alabama,2017,Age,35 Months,82.5,73.3 to 89.9,259
Combined 7 Series,,States/Local Areas,Alabama,2017-2018,Age,35 Months,77.0,70.4 to 83.0,491
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,94.8,92.5 to 97.0,396
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,97.1,93.5 to 100.0,174
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.7,87.6 to 95.7,370
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,94.8,92.1 to 97.4,396
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,78.5,69.5 to 87.6,174
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.0,72.5 to 85.4,370
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,91.5,86.3 to 96.7,174
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.4 to 95.5,370
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,89.7,86.0 to 93.4,396
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,80.1,71.5 to 88.7,174
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.2,70.8 to 83.7,370
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,81.1,75.7 to 86.4,396
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,60.7,48.5 to 73.0,174
Combined 7 Series,,States/Local Areas,Alabama,2011,Age,35 Months,81.5,72.9 to 88.6,218
Rotavirus,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,73.5,64.2 to 82.8,174
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,86.6,80.0 to 93.2,174
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.0,82.6 to 91.4,370
Rotavirus,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.8,68.6 to 80.9,370
Rotavirus,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,74.5,68.6 to 80.4,396
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,76.9,66.6 to 87.2,396
Influenza,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,36.8,30.2 to 43.5,370
Influenza,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,42.4,35.8 to 48.9,396
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,71.3,61.9 to 80.6,174
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,81.1,72.8 to 89.3,174
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.1,77.4 to 88.8,370
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,83.7,78.7 to 88.7,396
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,96.0,91.3 to 100.0,174
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,87.9 to 96.0,370
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,94.5,91.8 to 97.2,396
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,93.7,88.5 to 98.9,174
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,86.7 to 94.6,370
Rotavirus,,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,64.9,58.1 to 71.6,308
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,95.7,92.9 to 98.6,237
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,84.4,79.2 to 89.6,395
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,81.4,74.0 to 88.7,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,80.1,74.8 to 85.5,395
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,72.5,60.9 to 84.1,308
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,93.1,89.2 to 97.0,237
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,93.8,91.0 to 96.7,395
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,92.2,88.7 to 95.6,308
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,94.1,92.1 to 96.1,940
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,92.9,90.6 to 95.2,940
Influenza,,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,37.8,31.1 to 44.5,395
Influenza,,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,26.7,20.6 to 32.9,308
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,95.9,92.9 to 98.9,237
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,94.4,91.6 to 97.2,395
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,91.2,87.6 to 94.8,308
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,96.5,94.0 to 99.0,237
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,80.2,74.0 to 86.3,395
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,92.9,89.7 to 96.0,308
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,81.0,77.3 to 84.7,940
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,91.2,87.3 to 95.2,308
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,94.5,90.7 to 98.3,237
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,79.4,73.2 to 85.6,395
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,73.1,66.7 to 79.4,308
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,94.4,91.2 to 97.5,237
Rotavirus,,States/Local Areas,Alabama,2016-2019,Overall,Overall,74.4,70.5 to 78.3,940
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,78.3,72.3 to 84.4,308
Influenza,,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,62.9,54.4 to 71.5,237
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,89.3,79.4 to 99.1,68
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,89.9 to 95.9,632
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,69.3,53.7 to 84.8,68
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,90.4 to 95.8,632
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,94.6,91.8 to 97.4,454
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.1,83.7 to 90.5,632
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,75.7,68.7 to 82.8,454
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,73.6,64.3 to 83.0,404
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,75.8,60.5 to 91.2,68
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,93.5,90.3 to 96.7,454
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,74.6,61.8 to 87.4,84
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,72.1 to 90.8,90
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,91.9,88.4 to 95.4,454
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,95.1,93.0 to 97.1,404
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,88.0,77.7 to 98.3,68
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,93.7,86.7 to 100.0,84
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,82.9,71.0 to 94.7,68
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.7,79.5 to 87.8,632
Influenza,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",42.3,28.8 to 55.8,90
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,93.4,91.2 to 95.6,940
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Overall,Overall,88.2,85.6 to 90.8,940
Rotavirus,,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,87.1,80.8 to 93.5,237
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Overall,Overall,93.2,91.3 to 95.1,940
Rotavirus,,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,79.3,73.7 to 84.9,395
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,93.8,91.7 to 95.9,940
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,83.9,80.5 to 87.2,940
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,87.7,83.3 to 92.0,395
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,86.0,81.5 to 90.6,308
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,92.7,87.1 to 98.3,237
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,67.4,58.7 to 76.1,395
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,98.5,96.9 to 100.0,237
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,94.2,90.7 to 97.6,395
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,91.7,88.0 to 95.5,308
Influenza,,States/Local Areas,Alabama,2016-2019,Overall,Overall,37.6,33.5 to 41.8,940
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Overall,Overall,81.0,77.6 to 84.4,940
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,89.1,84.5 to 93.7,308
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,88.2,83.1 to 93.2,237
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Overall,Overall,73.8,67.7 to 79.8,940
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Overall,Overall,93.3,91.3 to 95.3,940
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,98.5,96.9 to 100.0,237
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,94.4,90.9 to 97.8,395
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,73.6,67.1 to 80.1,395
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,61.2,54.2 to 68.2,308
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Poverty,<133% FPL,81.5,76.0 to 86.9,308
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,96.9,94.7 to 99.1,237
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,95.5,93.2 to 97.8,395
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Overall,Overall,79.5,75.7 to 83.2,940
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Overall,Overall,70.9,66.8 to 75.0,940
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,>400% FPL,97.8,95.7 to 99.9,237
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Poverty,133% to <400% FPL,93.9,90.4 to 97.4,395
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,95.3,93.1 to 97.6,396
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,80.0,71.9 to 88.0,174
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,92.7,87.8 to 97.7,174
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.8,73.2 to 84.3,370
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,83.2,78.1 to 88.2,396
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,67.6,60.6 to 74.5,370
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,73.5,67.4 to 79.5,396
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,96.2,92.4 to 100.0,174
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.9,86.8 to 95.1,370
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,94.2,91.0 to 97.4,396
Influenza,,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a Non-MSA,28.0,19.7 to 36.2,174
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,85.6,80.9 to 90.3,396
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.3 to 96.1,370
Combined 7 Series,,States/Local Areas,Alabama,2012,Age,35 Months,75.2,65.8 to 83.7,233
Combined 7 Series,,States/Local Areas,Alabama,2013,Age,35 Months,73.6,63.2 to 83.1,260
Combined 7 Series,,States/Local Areas,Alabama,2013-2014,Age,35 Months,77.3,71.2 to 82.9,536
Combined 7 Series,,States/Local Areas,Alabama,2014,Age,35 Months,81.1,73.4 to 87.8,276
Combined 7 Series,,States/Local Areas,Alabama,2014-2015,Age,35 Months,80.4,74.7 to 85.6,563
Combined 7 Series,,States/Local Areas,Alabama,2015,Age,35 Months,79.8,71.0 to 87.3,287
Combined 7 Series,,States/Local Areas,Alabama,2015-2016,Age,35 Months,78.1,72.8 to 83.1,596
Combined 7 Series,,States/Local Areas,Alabama,2017,Age,24 Months,74.7,66.6 to 82.1,259
Combined 7 Series,,States/Local Areas,Alabama,2017-2018,Age,24 Months,70.5,64.2 to 76.5,491
Combined 7 Series,,States/Local Areas,Alabama,2018,Age,24 Months,65.7,56.6 to 74.6,232
Combined 7 Series,,States/Local Areas,Alabama,2018-2019,Age,24 Months,65.1,58.9 to 71.2,459
Combined 7 Series,,States/Local Areas,Alabama,2019,Age,24 Months,64.7,56.4 to 73.0,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,79.6,74.4 to 84.9,454
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.0,89.3 to 94.7,632
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.7,88.8 to 94.5,632
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.5,95.2 to 99.8,134
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,92.0,83.8 to 100.0,84
Rotavirus,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.8,74.3 to 83.3,632
Rotavirus,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.0,61.0 to 79.1,134
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,81.7,76.7 to 86.6,454
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,67.4,61.6 to 73.3,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.7,75.5 to 90.0,134
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,81.4,70.2 to 92.7,84
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,82.0,77.3 to 86.7,404
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,74.4,60.3 to 88.5,68
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.6,95.4 to 99.8,134
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,93.8,87.1 to 100.0,84
≥1 Dose MMR,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,77.7 to 94.3,90
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,94.5,92.2 to 96.8,404
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,95.9,92.8 to 98.9,454
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,94.9,92.6 to 97.3,404
Rotavirus,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,83.0,77.9 to 88.2,454
Rotavirus,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,70.6,65.1 to 76.2,404
Influenza,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,28.7,23.2 to 34.3,404
Influenza,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,41.7,24.5 to 58.9,68
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,95.4,88.9 to 100.0,84
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.1,72.6 to 91.6,90
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.2,69.4 to 86.9,134
Rotavirus,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,79.9,66.8 to 93.0,68
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.6,67.8 to 77.4,632
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.0,61.4 to 80.7,134
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,56.4,42.6 to 70.2,84
Combined 7 Series,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.0,65.8 to 86.2,90
Rotavirus,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,68.7,56.0 to 81.3,84
Rotavirus,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.5,58.2 to 82.9,90
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.2,74.0 to 90.4,134
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,84.9,74.7 to 95.1,84
PCV,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,82.0 to 95.5,90
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,89.4 to 95.5,632
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.6,90.1 to 99.1,134
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,90.9,81.4 to 100.0,68
Influenza,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",40.5,35.5 to 45.4,632
Influenza,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",31.3,21.9 to 40.8,134
Influenza,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,36.3,23.8 to 48.7,84
Influenza,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,52.7,46.5 to 58.9,454
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,82.3 to 96.5,90
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.0,90.0 to 96.0,632
PCV,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.0,90.8 to 99.1,134
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,81.3,68.6 to 94.1,68
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,93.6,90.6 to 96.5,404
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,88.0,78.0 to 98.0,68
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.7,84.0 to 95.4,134
Hep A,≥1 Dose,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,91.9,84.7 to 99.2,84
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.5,77.1 to 85.8,632
Hib,Full Series,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,80.0,66.4 to 93.7,68
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,95.4,92.2 to 98.5,454
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,94.0,91.2 to 96.8,404
Polio,≥3 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,88.6,78.7 to 98.6,68
≥1 Dose Varicella,,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Other,89.2,79.0 to 99.4,68
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.6,79.4 to 87.7,632
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.6,69.8 to 87.3,134
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.9,92.4 to 99.4,134
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,95.4,88.9 to 100.0,84
DTaP,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.3,89.9 to 98.7,90
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Private Insurance Only,88.8,84.4 to 93.2,454
DTaP,≥4 Doses,States/Local Areas,Alabama,2016-2019,Insurance Coverage,Any Medicaid,78.6,73.5 to 83.8,404
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.8,88.6 to 99.0,134
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,63.3,57.0 to 69.7,370
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Principal City,93.2,89.9 to 96.6,396
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.3,68.2 to 84.5,370
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,88.6 to 97.9,90
Hep B,≥3 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,Hispanic,90.3,81.3 to 99.4,84
Hep A,≥2 Doses,States/Local Areas,Alabama,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.2,69.3 to 81.1,632
Rotavirus,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,87.8,76.9 to 98.8,67
Rotavirus,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,86.7,82.5 to 90.9,500
Rotavirus,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,66.9,61.4 to 72.3,453
Rotavirus,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.9,60.1 to 77.8,132
Rotavirus,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,63.7,52.1 to 75.4,106
Rotavirus,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,63.5 to 84.9,103
Rotavirus,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.5,74.3 to 82.7,701
Rotavirus,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,72.3,66.4 to 78.2,432
Rotavirus,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.5,71.9 to 83.0,401
Rotavirus,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,70.7,62.5 to 79.0,209
Rotavirus,,States/Local Areas,Alabama,2014-2017,Overall,Overall,73.9,70.2 to 77.5,1042
Rotavirus,,States/Local Areas,Alabama,2014-2017,Poverty,<133% FPL,62.1,55.9 to 68.3,370
Rotavirus,,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,79.9,74.5 to 85.2,415
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.5,53.5 to 77.4,103
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.4,70.0 to 78.7,701
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Principal City,72.0,66.1 to 77.9,432
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.0,65.8 to 78.1,401
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,Hispanic,56.1,44.2 to 68.0,106
Combined 7 Series,,States/Local Areas,Alabama,2018,Age,35 Months,71.7,62.1 to 80.6,232
Combined 7 Series,,States/Local Areas,Alabama,2018-2019,Age,35 Months,70.9,64.4 to 77.1,459
Combined 7 Series,,States/Local Areas,Alabama,2019,Age,35 Months,70.4,61.5 to 78.8,227
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Private Insurance Only,81.6,77.1 to 86.1,500
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Any Medicaid,66.5,60.9 to 72.1,453
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Insurance Coverage,Other,73.4,58.6 to 88.1,67
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.9,64.1 to 81.6,132
Hib,Full Series,States/Local Areas,Alabama,2014,Age,19 Months,80.1,73.1 to 85.7,276
Hib,Full Series,States/Local Areas,Alabama,2014-2015,Age,19 Months,76.9,71.9 to 81.2,563
Hib,Full Series,States/Local Areas,Alabama,2015,Age,19 Months,73.7,69.1 to 77.8,287
Hib,Full Series,States/Local Areas,Alabama,2015-2016,Age,19 Months,71.8,66.7 to 76.5,596
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Poverty,133% to <400% FPL,73.0,66.8 to 79.2,415
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Poverty,>400% FPL,88.5,83.6 to 93.4,257
Hib,Full Series,States/Local Areas,Alabama,2011,Age,19 Months,77.9,74.6 to 80.8,218
Hib,Full Series,States/Local Areas,Alabama,2012,Age,19 Months,72.9,67.8 to 77.4,233
Hib,Full Series,States/Local Areas,Alabama,2013,Age,19 Months,74.6,72.1 to 77.0,260
Hib,Full Series,States/Local Areas,Alabama,2013-2014,Age,19 Months,77.4,75.5 to 79.2,536
Hib,Primary Series,States/Local Areas,Alabama,2017,Age,24 Months,93.9,89.0 to 97.2,259
Hib,Primary Series,States/Local Areas,Alabama,2017-2018,Age,24 Months,92.3,87.7 to 95.6,491
Hib,Primary Series,States/Local Areas,Alabama,2018,Age,24 Months,90.6,83.9 to 95.3,232
Hib,Primary Series,States/Local Areas,Alabama,2018-2019,Age,24 Months,94.3,90.7 to 96.9,459
Hib,Primary Series,States/Local Areas,Alabama,2014,Age,24 Months,95.9,92.1 to 98.2,276
Hib,Primary Series,States/Local Areas,Alabama,2014-2015,Age,24 Months,95.2,92.5 to 97.1,563
Hib,Primary Series,States/Local Areas,Alabama,2015,Age,24 Months,94.5,90.4 to 97.3,287
Hib,Primary Series,States/Local Areas,Alabama,2015-2016,Age,24 Months,93.7,91.0 to 95.9,596
Hib,Primary Series,States/Local Areas,Alabama,2016,Age,24 Months,93.0,88.9 to 95.9,309
Hib,Primary Series,States/Local Areas,Alabama,2016-2017,Age,24 Months,93.4,90.4 to 95.8,568
Hib,Primary Series,States/Local Areas,Alabama,2015,Age,13 Months,89.3,83.5 to 93.2,287
Hib,Primary Series,States/Local Areas,Alabama,2015-2016,Age,13 Months,89.2,85.5 to 92.0,596
Hib,Primary Series,States/Local Areas,Alabama,2017,Age,13 Months,92.5,87.0 to 95.8,259
Hib,Primary Series,States/Local Areas,Alabama,2017-2018,Age,13 Months,87.4,82.0 to 91.4,491
Hib,Primary Series,States/Local Areas,Alabama,2016,Age,7 Months,70.8,63.4 to 77.3,309
Hib,Primary Series,States/Local Areas,Alabama,2016-2017,Age,7 Months,74.1,68.7 to 78.8,568
Hib,Primary Series,States/Local Areas,Alabama,2017,Age,7 Months,77.4,69.3 to 83.9,259
Hib,Primary Series,States/Local Areas,Alabama,2017-2018,Age,7 Months,71.9,65.7 to 77.4,491
Hib,Primary Series,States/Local Areas,Alabama,2018,Age,7 Months,66.3,57.3 to 74.2,232
Hib,Primary Series,States/Local Areas,Alabama,2018-2019,Age,7 Months,70.2,64.2 to 75.5,459
Hib,Primary Series,States/Local Areas,Alabama,2019,Age,7 Months,74.1,66.2 to 80.7,227
Hib,Primary Series,States/Local Areas,Alabama,2011,Age,13 Months,89.6,85.2 to 92.8,218
Hib,Primary Series,States/Local Areas,Alabama,2012,Age,13 Months,89.8,86.0 to 92.7,233
Hib,Primary Series,States/Local Areas,Alabama,2013,Age,13 Months,87.3,83.3 to 90.5,260
Hib,Primary Series,States/Local Areas,Alabama,2013-2014,Age,13 Months,90.7,87.3 to 93.2,536
Hib,Primary Series,States/Local Areas,Alabama,2014,Age,13 Months,94.1,89.8 to 96.6,276
Hib,Primary Series,States/Local Areas,Alabama,2014-2015,Age,13 Months,91.7,88.3 to 94.1,563
Hib,Primary Series,States/Local Areas,Alabama,2012,Age,19 Months,95.2,88.8 to 98.1,233
Hib,Primary Series,States/Local Areas,Alabama,2013,Age,19 Months,94.3,86.5 to 97.7,260
Hib,Primary Series,States/Local Areas,Alabama,2013-2014,Age,19 Months,95.0,89.9 to 97.6,536
Hib,Primary Series,States/Local Areas,Alabama,2014,Age,19 Months,95.6,91.4 to 97.9,276
Hib,Primary Series,States/Local Areas,Alabama,2014-2015,Age,19 Months,95.0,92.1 to 96.8,563
Hib,Primary Series,States/Local Areas,Alabama,2016,Age,13 Months,89.0,83.8 to 92.7,309
Hib,Primary Series,States/Local Areas,Alabama,2016-2017,Age,13 Months,90.7,87.2 to 93.4,568
≥1 Dose MMR,,States/Local Areas,Alabama,2020,Age,13 Months,66.2,57.9 to 73.6,240
Hib,Primary Series,States/Local Areas,Alabama,2018,Age,13 Months,82.2,73.7 to 88.4,232
Hib,Primary Series,States/Local Areas,Alabama,2018-2019,Age,13 Months,86.2,81.1 to 90.1,459
Hib,Primary Series,States/Local Areas,Alabama,2015,Age,19 Months,94.3,92.9 to 95.5,287
Hib,Primary Series,States/Local Areas,Alabama,2015-2016,Age,19 Months,93.2,90.3 to 95.3,596
Hib,Primary Series,States/Local Areas,Alabama,2017,Age,19 Months,93.9,88.4 to 96.9,259
Hib,Primary Series,States/Local Areas,Alabama,2017-2018,Age,19 Months,92.1,87.1 to 95.3,491
Hib,Primary Series,States/Local Areas,Alabama,2016,Age,19 Months,92.1,87.7 to 95.1,309
Hib,Primary Series,States/Local Areas,Alabama,2016-2017,Age,19 Months,93.0,89.8 to 95.3,568
Hib,Primary Series,States/Local Areas,Alabama,2011,Age,24 Months,91.8,84.7 to 96.4,218
Hib,Primary Series,States/Local Areas,Alabama,2012,Age,24 Months,95.2,89.8 to 98.3,233
Hib,Primary Series,States/Local Areas,Alabama,2013,Age,24 Months,96.0,92.5 to 98.1,260
Hib,Primary Series,States/Local Areas,Alabama,2013-2014,Age,24 Months,95.9,93.5 to 97.6,536
Hib,Full Series,States/Local Areas,Alabama,2019,Age,19 Months,72.4,63.7 to 79.7,227
Hib,Full Series,States/Local Areas,Alabama,2016,Age,19 Months,70.0,62.8 to 76.3,309
Hib,Full Series,States/Local Areas,Alabama,2016-2017,Age,19 Months,70.0,64.4 to 75.0,568
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Urbanicity,Living In a Non-MSA,68.4,59.7 to 77.1,209
Combined 7 Series,,States/Local Areas,Alabama,2014-2017,Overall,Overall,71.3,67.5 to 75.1,1042
Hib,Primary Series,States/Local Areas,Alabama,2019,Age,19 Months,95.9,91.9 to 98.0,227
Hib,Primary Series,States/Local Areas,Alabama,2018,Age,19 Months,90.2,82.8 to 94.7,232
Hib,Primary Series,States/Local Areas,Alabama,2018-2019,Age,19 Months,86.2,81.1 to 90.1,459
Hib,Full Series,States/Local Areas,Alabama,2011,Age,24 Months,82.1,74.2 to 88.8,218
Hib,Full Series,States/Local Areas,Alabama,2012,Age,24 Months,79.2,70.6 to 86.6,233
Hib,Full Series,States/Local Areas,Alabama,2013,Age,24 Months,80.7,73.2 to 87.2,260
Hib,Full Series,States/Local Areas,Alabama,2013-2014,Age,24 Months,82.8,78.0 to 87.2,536
Hib,Full Series,States/Local Areas,Alabama,2014,Age,24 Months,85.0,78.5 to 90.3,276
Hib,Full Series,States/Local Areas,Alabama,2014-2015,Age,24 Months,82.2,77.7 to 86.3,563
Hib,Full Series,States/Local Areas,Alabama,2017,Age,19 Months,69.9,61.3 to 77.3,259
Hib,Full Series,States/Local Areas,Alabama,2017-2018,Age,19 Months,66.8,60.3 to 72.7,491
Hib,Full Series,States/Local Areas,Alabama,2018,Age,19 Months,63.6,54.3 to 72.0,232
Hib,Full Series,States/Local Areas,Alabama,2018-2019,Age,19 Months,94.0,90.1 to 96.4,459
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,95.7,91.0 to 98.4,485
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,95.1,92.2 to 97.1,1101
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,94.3,90.1 to 97.1,496
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,86.9,83.6 to 90.2,859
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,88.7,80.7 to 96.7,131
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,76.3,66.0 to 86.5,138
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,92.0,89.8 to 94.1,1322
Hib,Full Series,States/Local Areas,TX-Rest of state,2014,Age,35 Months,83.2,79.5 to 86.5,1030
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,84.2,80.9 to 87.2,1397
Hib,Full Series,States/Local Areas,TX-Rest of state,2015,Age,35 Months,85.1,81.2 to 88.6,1257
Hib,Full Series,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,83.2,80.5 to 85.7,2463
Hib,Full Series,States/Local Areas,TX-Rest of state,2016,Age,35 Months,80.4,75.8 to 84.7,705
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,80.0,76.2 to 83.4,1243
Hib,Full Series,States/Local Areas,TX-Rest of state,2017,Age,35 Months,79.1,73.5 to 84.2,538
Hib,Full Series,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,79.5,75.4 to 83.3,1023
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,5 Months,77.6,74.0 to 80.8,1030
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,5 Months,79.1,76.1 to 81.7,1397
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,5 Months,80.6,77.4 to 83.4,1257
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,5 Months,79.1,76.8 to 81.3,2463
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,87.0,83.1 to 90.8,833
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.0,85.9 to 92.1,989
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,90.2,87.8 to 92.6,1034
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,84.4 to 94.2,291
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,76.0,65.6 to 86.4,131
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,35 Months,91.7,88.3 to 94.4,705
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,93.1,90.4 to 95.2,1243
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,35 Months,95.1,90.2 to 98.0,538
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,93.7,90.7 to 95.9,1023
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,35 Months,92.2,89.7 to 94.3,1257
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,91.9,90.1 to 93.5,2463
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,61.9,57.9 to 65.8,1030
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,64.9,61.6 to 68.2,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,66.3,62.7 to 69.7,1257
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,65.3,62.7 to 67.9,2463
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,5 Months,76.2,70.7 to 81.0,538
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,5 Months,81.1,77.4 to 84.4,1023
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,5 Months,79.1,74.7 to 82.9,705
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,5 Months,77.7,74.2 to 80.8,1243
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,45.9,39.6 to 52.6,485
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,51.9,47.5 to 56.6,1101
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,65.1,59.3 to 70.6,953
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,63.5,59.4 to 67.4,1983
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,58.3,51.5 to 65.2,496
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,5 Months,79.7,76.5 to 82.6,1257
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,5 Months,78.5,76.2 to 80.7,2463
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,78.0,72.6 to 82.9,953
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,77.4,73.9 to 80.8,1983
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,75.4,69.7 to 80.8,867
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,79.8,73.1 to 85.8,702
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,79.5,75.9 to 82.8,1030
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,79.2,76.2 to 82.1,1397
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,79.8,75.4 to 83.8,705
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,80.1,76.8 to 83.2,1243
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,78.4,75.1 to 81.5,1257
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,78.7,76.3 to 80.9,2463
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,35 Months,92.8,88.9 to 95.7,485
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,93.7,90.6 to 96.1,1101
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2012,Age,13 Months,62.7,56.6 to 68.5,867
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014,Age,13 Months,61.1,57.0 to 65.0,1030
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,63.0,59.5 to 66.3,1397
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,84.4,80.8 to 87.9,859
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,88.6,86.1 to 91.1,1322
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,35 Months,95.3,87.8 to 98.8,496
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,90.3,83.3 to 97.4,131
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,71.7,60.9 to 82.6,138
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.7,66.9 to 86.5,136
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,61.6,55.7 to 67.1,538
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,66.2,62.0 to 70.1,1023
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,5 Months,84.9,80.0 to 88.8,532
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,5 Months,84.5,81.0 to 87.5,1101
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,87.6,84.8 to 90.4,1034
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,90.7,84.2 to 94.7,702
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,87.6,85.9 to 89.2,867
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,77.9,71.7 to 83.6,705
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,77.9,73.3 to 82.2,1243
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,81.1,76.5 to 85.4,1257
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,80.6,77.2 to 83.7,2463
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,76.7,72.0 to 81.2,1030
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,79.0,74.7 to 83.0,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,68.2,63.3 to 72.6,705
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,64.9,61.1 to 68.5,1243
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,73.8,67.4 to 79.4,496
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,5 Months,84.5,78.9 to 88.8,496
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,72.8,67.0 to 77.8,485
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,94.3,92.0 to 96.0,1101
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,46.7,40.8 to 53.0,538
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,46.3,41.9 to 51.0,1023
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,48.8,45.1 to 52.8,1257
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,48.9,46.2 to 51.8,2463
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,49.2,44.1 to 54.5,705
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,47.9,44.0 to 52.0,1243
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,78.1,74.2 to 81.9,953
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,78.7,76.1 to 81.3,1983
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,5 Months,77.0,73.4 to 80.3,1030
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,5 Months,78.2,75.4 to 80.8,1397
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,5 Months,76.5,73.1 to 79.6,953
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,5 Months,76.8,75.2 to 78.3,1983
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,35 Months,93.0,89.4 to 95.7,867
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,5 Months,76.7,67.1 to 84.2,702
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,5 Months,73.9,70.4 to 77.1,867
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,79.9,75.6 to 83.8,867
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,76.3,70.6 to 81.5,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,87.7,84.4 to 91.1,838
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,93.7,91.3 to 96.2,801
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,90.1,87.1 to 93.2,811
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,60.3,55.5 to 64.9,702
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,64.4,58.0 to 70.3,867
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,35 Months,93.6,90.7 to 95.9,1030
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,92.7,90.3 to 94.7,1397
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,35 Months,90.6,87.2 to 93.3,953
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,92.2,90.0 to 94.1,1983
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,46.9,41.9 to 52.1,867
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.1,70.3 to 89.9,136
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,74.7,70.5 to 78.8,859
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.9,59.4 to 80.4,136
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,82.2,79.2 to 85.1,1322
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013,Age,13 Months,61.1,57.5 to 64.6,953
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,61.1,58.8 to 63.3,1983
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2011,Age,13 Months,58.7,50.9 to 66.0,702
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,92.1,87.9 to 95.3,485
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,93.6,91.2 to 95.6,1101
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,90.1,88.3 to 91.9,2450
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,44.5,40.4 to 48.8,1030
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,45.7,42.2 to 49.4,1397
Hib,Full Series,States/Local Areas,TX-Rest of state,2018,Age,35 Months,79.5,73.7 to 84.7,485
Hib,Full Series,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,80.7,76.8 to 84.3,1101
Hib,Full Series,States/Local Areas,TX-Rest of state,2019,Age,35 Months,83.1,77.3 to 88.2,496
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,94.3,91.8 to 96.2,1257
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,92.9,91.0 to 94.5,2463
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,90.2,86.9 to 93.1,705
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,89.4,86.6 to 91.7,1243
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,88.6,84.1 to 92.3,538
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,93.6,88.8 to 96.8,1023
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,92.4,89.6 to 94.7,1030
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,93.5,91.0 to 95.5,1397
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,92.8,89.8 to 95.2,953
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,92.6,90.6 to 94.3,1983
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,92.4,89.2 to 94.9,867
Hib,Full Series,States/Local Areas,TX-Rest of state,2018,Age,24 Months,75.4,69.6 to 80.8,485
Hib,Full Series,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,77.3,73.5 to 81.0,1101
Hib,Full Series,States/Local Areas,TX-Rest of state,2019,Age,24 Months,79.6,74.0 to 84.8,496
Hib,Full Series,States/Local Areas,TX-Rest of state,2012,Age,35 Months,81.9,77.4 to 86.0,867
Hib,Full Series,States/Local Areas,TX-Rest of state,2011,Age,35 Months,83.9,78.3 to 88.8,702
Hib,Full Series,States/Local Areas,TX-Rest of state,2013,Age,35 Months,81.7,77.5 to 85.6,953
Hib,Full Series,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,82.5,79.8 to 85.1,1983
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,5 Months,77.4,68.0 to 84.7,702
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,5 Months,75.6,72.4 to 78.5,867
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,5 Months,78.2,75.5 to 80.7,953
DTaP,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,5 Months,77.9,76.3 to 79.4,1983
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,94.7,91.5 to 97.0,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,92.2,88.1 to 95.0,496
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,91.3,87.0 to 94.2,496
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,92.8,89.8 to 95.1,867
Hib,Full Series,States/Local Areas,TX-Rest of state,2014,Age,24 Months,78.2,74.6 to 81.6,1030
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,77.9,74.9 to 80.8,1397
Hib,Full Series,States/Local Areas,TX-Rest of state,2015,Age,24 Months,78.5,75.3 to 81.6,1257
Hib,Full Series,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,78.0,75.7 to 80.3,2463
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,93.3,89.8 to 96.0,702
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,91.8,88.6 to 94.4,867
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,90.1,87.1 to 92.7,953
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,90.1,88.0 to 91.9,1983
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,92.9,89.1 to 95.8,485
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,92.6,90.1 to 94.7,1101
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,91.7,87.5 to 94.9,496
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,87.1,82.7 to 90.8,538
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,90.3,87.6 to 92.7,1023
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,54.1,42.0 to 66.3,138
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,92.3,88.1 to 95.1,485
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,89.9,86.9 to 92.2,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,90.4,85.8 to 93.6,485
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,81.7,78.1 to 84.9,1101
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,90.1,87.1 to 92.7,953
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,90.5,88.6 to 92.3,1983
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,88.3,84.5 to 91.3,705
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,88.2,85.3 to 90.5,1243
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,88.0,83.6 to 91.4,538
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,89.3,86.3 to 91.8,1023
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,91.0,88.4 to 93.2,1030
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,91.0,88.8 to 92.9,1397
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,91.5,89.1 to 93.5,1257
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,90.9,89.2 to 92.4,2463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Travis County,2013,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Travis County,2014,Age,0-3 Days,NA,,
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.0,74.9 to 81.2,1351
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,76.5,72.3 to 80.7,811
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,71.8,67.5 to 76.2,838
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,77.1,74.6 to 79.5,2450
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,76.7,69.3 to 84.1,266
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,91.1,87.7 to 93.7,705
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,89.8,87.0 to 92.0,1243
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,88.4,83.9 to 91.7,538
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,90.5,87.6 to 92.8,1023
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,91.0,86.6 to 94.1,496
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,92.1,87.9 to 94.9,485
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,71.4,67.2 to 75.3,1101
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,87.1,83.9 to 89.7,1030
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,88.3,85.7 to 90.4,1397
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,89.1,86.8 to 91.0,953
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,88.1,86.1 to 89.8,1983
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,91.2,88.1 to 93.8,867
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,91.3,87.5 to 94.3,702
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,90.5,87.8 to 92.8,1030
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,91.2,88.9 to 93.0,1397
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,91.4,88.7 to 93.5,1257
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,91.3,89.5 to 92.7,2463
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,90.3,87.9 to 92.3,953
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,90.4,88.9 to 91.8,1983
Hib,Full Series,States/Local Areas,TX-Rest of state,2016,Age,24 Months,78.1,73.7 to 82.3,705
Hib,Full Series,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,77.0,73.5 to 80.4,1243
Hib,Full Series,States/Local Areas,TX-Rest of state,2017,Age,24 Months,75.9,70.4 to 81.0,538
Hib,Full Series,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,75.7,71.7 to 79.5,1023
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,90.0,86.9 to 92.4,1257
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,89.6,87.7 to 91.2,2463
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,91.5,87.7 to 94.5,702
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,90.2,86.9 to 93.1,705
Polio,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,88.7,86.0 to 91.1,1243
Influenza,,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,51.7,41.7 to 62.6,150
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,92.6,85.4 to 97.0,162
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,92.5,86.9 to 96.3,222
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,97.6,92.2 to 99.6,41
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,86.6,76.3 to 94.0,150
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,81.1,66.0 to 92.3,60
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,90.0,81.0 to 95.9,101
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,79.3,70.4 to 87.0,162
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,79.8,72.2 to 86.5,222
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,87.6,68.7 to 95.8,60
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,93.4,82.3 to 97.7,101
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,86.6,77.1 to 93.6,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,84.5,75.3 to 90.7,162
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,85.5,77.6 to 90.9,222
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,98.0,89.9 to 99.9,60
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,99.0,94.6 to 99.9,101
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.1,95.7 to 99.9,41
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,88.5,79.7 to 94.7,162
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,90.8,83.9 to 95.5,222
Hib,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,3 Months,87.1,78.0 to 92.8,150
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,90.9,81.4 to 95.8,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,85.6,75.1 to 92.1,150
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.1,96.6 to 99.9,41
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,76.6,66.2 to 85.6,150
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,94.0,85.7 to 97.6,162
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,95.3,89.4 to 98.0,222
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,89.8,81.3 to 94.6,162
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,92.0,85.8 to 95.6,222
Hib,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,3 Months,88.6,80.3 to 93.7,162
Hib,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,3 Months,90.2,83.9 to 94.3,222
Hib,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,3 Months,94.1,82.0 to 98.2,60
Hib,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,3 Months,96.7,90.3 to 98.9,101
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,98.2,92.7 to 99.6,60
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,98.8,96.1 to 99.6,101
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,92.2,83.8 to 97.2,60
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,94.6,89.9 to 97.5,101
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,96.6,91.0 to 99.2,41
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,94.2,84.8 to 98.6,60
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,96.8,92.1 to 99.1,101
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,5 Months,73.8,63.7 to 81.9,162
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,5 Months,76.5,68.1 to 83.3,222
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,5 Months,83.0,65.6 to 92.6,60
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,5 Months,87.5,75.6 to 94.0,101
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,54.6,43.8 to 65.0,150
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,79.1,70.8 to 86.3,162
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,79.9,72.8 to 86.2,222
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,72.5,61.9 to 82.3,150
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,43.5,24.3 to 69.0,41
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,54.1,43.9 to 63.9,162
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,52.2,43.4 to 60.8,222
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,70.8,59.1 to 81.8,150
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,92.0,74.8 to 99.0,162
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,88.2,76.6 to 95.7,222
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,47.6,31.1 to 64.7,60
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,63.9,49.9 to 75.9,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,52.3,41.4 to 62.9,150
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,98.4,94.0 to 99.8,41
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,67.2,57.1 to 76.0,162
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,68.7,60.1 to 76.1,222
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,72.0,54.6 to 84.6,60
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,76.4,62.5 to 86.2,101
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,87.0,77.8 to 92.8,150
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,54.5,27.0 to 79.5,34
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,97.7,93.6 to 99.4,121
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,61.0,34.3 to 87.9,34
Hib,Full Series,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,82.0,60.0 to 96.0,41
DTaP,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,5 Months,77.6,69.8 to 83.9,150
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,90.7,75.5 to 98.2,60
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,95.0,86.3 to 98.9,101
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,93.0,86.2 to 97.2,162
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,92.2,85.9 to 96.4,222
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,81.1,66.0 to 92.3,60
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,92.6,83.1 to 97.8,101
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,83.9,74.0 to 91.6,162
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,82.4,74.4 to 89.1,222
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.1,95.7 to 99.9,41
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,97.1,90.8 to 99.1,60
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,98.2,95.0 to 99.4,101
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,85.6,76.2 to 92.7,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,99.4,95.3 to 99.9,41
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,5 Months,74.1,64.0 to 82.1,162
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,5 Months,76.8,68.3 to 83.5,222
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,5 Months,75.7,68.0 to 82.0,150
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,86.3,77.1 to 92.2,150
PCV,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,3 Months,86.5,77.2 to 92.4,150
Polio,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,3 Months,87.1,78.0 to 92.8,150
Polio,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,3 Months,90.1,82.0 to 94.8,162
Polio,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,3 Months,91.3,85.1 to 95.0,222
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Tarrant County,2017,Age,0-3 Days,69.2,48.3 to 84.4,48
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Tarrant County,2017-2018,Age,0-3 Days,76.8,62.9 to 86.6,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Tarrant County,2016,Age,0-3 Days,73.5,62.8 to 82.0,162
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Tarrant County,2016-2017,Age,0-3 Days,73.1,63.9 to 80.6,222
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,88.5,78.8 to 95.1,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,91.0,83.5 to 96.0,162
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,92.8,87.3 to 96.5,222
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,85.2,75.6 to 91.5,162
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,85.6,77.5 to 91.2,222
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,86.7,67.8 to 95.3,60
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,92.3,81.4 to 97.1,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Tarrant County,2014-2015,Age,0-3 Days,86.8,78.0 to 92.4,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.4,96.6 to 99.9,41
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,93.3,85.3 to 97.1,162
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,94.7,89.1 to 97.5,222
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,90.2,80.8 to 95.2,150
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,81.0,64.0 to 91.1,60
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,82.4,69.2 to 90.8,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Tarrant County,2018,Age,0-3 Days,81.6,58.9 to 93.2,41
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,82.5,65.5 to 92.1,60
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,83.3,70.0 to 91.4,101
Polio,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,3 Months,94.1,82.0 to 98.2,60
Polio,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,3 Months,93.9,83.3 to 97.9,101
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,65.3,54.9 to 74.4,162
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,70.0,61.3 to 77.5,222
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,55.3,44.3 to 65.8,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.4,96.6 to 99.9,41
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,97.1,92.1 to 99.3,60
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,98.2,95.5 to 99.5,101
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,59.4,48.2 to 69.7,150
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,68.3,57.7 to 77.2,162
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,72.5,63.8 to 79.8,222
PCV,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,3 Months,85.5,76.6 to 91.5,162
PCV,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,3 Months,86.8,79.5 to 91.7,222
PCV,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,3 Months,89.6,73.1 to 96.5,60
PCV,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,3 Months,91.0,78.2 to 96.6,101
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,97.1,92.1 to 99.3,60
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,98.2,95.5 to 99.5,101
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,99.2,95.8 to 99.9,41
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,90.5,83.0 to 95.6,162
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,92.5,87.0 to 96.3,222
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,98.1,92.8 to 99.5,60
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,98.7,96.1 to 99.6,101
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,80.2,69.4 to 87.8,150
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,83.9,74.6 to 90.3,162
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,85.9,78.2 to 91.2,222
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,90.6,71.2 to 97.4,60
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,94.9,83.9 to 98.5,101
Influenza,,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,67.8,58.5 to 76.7,162
Influenza,,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,66.5,58.4 to 74.5,222
Influenza,,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,63.8,47.9 to 79.4,60
Influenza,,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,66.1,52.7 to 79.1,101
Influenza,,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,68.5,46.6 to 88.1,41
Rotavirus,,States/Local Areas,TX-Tarrant County,2016,Age,8 Months,67.6,56.9 to 76.7,162
Rotavirus,,States/Local Areas,TX-Tarrant County,2016-2017,Age,8 Months,69.2,60.1 to 77.0,222
Rotavirus,,States/Local Areas,TX-Tarrant County,2014-2015,Age,8 Months,71.0,60.0 to 80.0,150
Rotavirus,,States/Local Areas,TX-Tarrant County,2018,Age,8 Months,84.8,61.0 to 95.3,41
Rotavirus,,States/Local Areas,TX-Tarrant County,2017,Age,8 Months,72.9,54.4 to 85.8,60
Rotavirus,,States/Local Areas,TX-Tarrant County,2017-2018,Age,8 Months,78.8,64.8 to 88.2,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Travis County,2012,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Travis County,2011,Age,0-3 Days,NA,,
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,60.4,49.3 to 70.6,150
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,82.1,71.7 to 89.2,150
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,97.1,90.8 to 99.1,60
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,98.1,95.0 to 99.3,101
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,93.5,86.5 to 97.0,162
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,94.6,89.6 to 97.2,222
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,99.2,95.8 to 99.9,41
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,82.4,72.9 to 89.1,162
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,83.9,75.9 to 89.6,222
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,87.3,68.6 to 95.6,60
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,92.6,81.9 to 97.2,101
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,85.9,75.4 to 92.4,150
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,95.5,89.4 to 98.6,162
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,98.0,93.4 to 99.7,222
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,86.6,77.2 to 93.5,150
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,94.8,88.7 to 98.2,162
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,95.5,91.1 to 98.1,222
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.2,96.7 to 99.9,41
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,97.1,92.1 to 99.3,60
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,98.3,95.5 to 99.5,101
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,87.6,78.1 to 94.3,150
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,63.1,52.6 to 73.6,150
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.2,96.7 to 99.9,41
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,98.9,94.7 to 99.9,60
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,99.3,96.9 to 99.9,101
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,71.5,56.0 to 85.4,60
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,75.8,63.0 to 86.7,101
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,80.1,58.6 to 94.8,41
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,65.4,55.5 to 75.1,162
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,67.3,58.8 to 75.5,222
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,75.3,58.8 to 89.0,60
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,81.0,67.5 to 91.4,101
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,72.9,61.5 to 83.2,162
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,73.0,63.8 to 81.5,222
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,83.3,73.0 to 90.2,150
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,80.4,70.6 to 87.4,162
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,82.4,74.3 to 88.4,222
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,87.3,68.6 to 95.6,60
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,92.6,81.9 to 97.2,101
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,92.1,84.3 to 96.2,162
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,91.7,84.7 to 95.7,222
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,90.7,71.1 to 97.5,60
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,95.0,83.9 to 98.6,101
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,5 Months,83.0,65.6 to 92.6,60
Hib,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,5 Months,89.7,79.5 to 95.2,101
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,87.6,65.7 to 98.3,41
Hib,Full Series,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,71.6,61.7 to 79.8,162
Hib,Full Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,72.5,64.0 to 79.7,222
Hib,Full Series,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,71.2,44.2 to 88.6,41
Hib,Full Series,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,74.8,56.8 to 87.0,60
Hib,Full Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,73.0,57.0 to 84.7,101
Combined 7 Series,,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,66.3,55.5 to 76.8,150
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,95.5,89.4 to 98.6,162
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,98.0,93.4 to 99.7,222
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,98.9,94.7 to 99.9,60
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,99.3,96.9 to 99.9,101
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,60.3,49.1 to 70.5,150
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,53.1,36.1 to 69.4,60
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,43.9,30.4 to 58.4,101
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,91.5,82.8 to 96.8,60
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,94.5,89.8 to 97.4,101
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,97.5,93.2 to 99.4,41
PCV,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,5 Months,73.4,63.3 to 81.5,162
PCV,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,5 Months,74.9,66.3 to 82.0,222
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.4,96.6 to 99.9,41
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,82.8,72.9 to 90.7,150
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,92.3,85.8 to 96.5,162
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,92.2,87.0 to 95.9,222
PCV,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,5 Months,76.4,72.2 to 80.2,150
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,26.2,18.7 to 35.5,162
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,34.3,26.3 to 43.3,222
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,86.8,77.2 to 93.7,150
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,94.4,87.8 to 98.0,162
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,97.6,92.3 to 99.6,222
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,98.9,94.7 to 99.9,60
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,99.3,96.8 to 99.9,101
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,25.7,17.8 to 35.5,150
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,81.1,70.7 to 88.3,150
Hib,Full Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,66.3,54.9 to 76.0,150
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,67.4,57.0 to 76.3,162
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,71.5,62.8 to 78.8,222
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,81.0,64.0 to 91.1,60
Hib,Primary Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,82.5,69.2 to 90.8,101
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,97.1,92.1 to 99.3,60
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,98.3,95.5 to 99.5,101
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.2,96.7 to 99.9,41
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,87.6,77.1 to 94.8,150
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,89.9,79.4 to 95.3,60
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,93.6,88.2 to 96.7,101
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,97.5,92.1 to 99.2,41
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,88.0,79.9 to 93.1,162
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,88.5,82.4 to 92.7,222
DTaP,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,3 Months,87.2,78.1 to 92.9,150
DTaP,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,3 Months,89.8,81.8 to 94.6,162
DTaP,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,3 Months,92.1,86.3 to 95.6,222
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,97.1,92.1 to 99.3,60
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,98.2,95.5 to 99.5,101
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.4,96.6 to 99.9,41
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,93.6,87.0 to 97.5,162
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,94.6,89.9 to 97.6,222
DTaP,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,5 Months,73.9,63.7 to 82.0,162
DTaP,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,5 Months,77.6,69.2 to 84.2,222
DTaP,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,5 Months,86.3,69.0 to 94.7,60
DTaP,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,5 Months,91.9,82.1 to 96.6,101
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,94.8,88.7 to 98.2,162
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,95.5,91.1 to 98.1,222
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,85.2,75.8 to 92.3,150
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,79.3,68.4 to 87.1,150
DTaP,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,3 Months,97.3,91.5 to 99.2,60
DTaP,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,3 Months,98.3,95.4 to 99.4,101
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,84.1,74.3 to 91.7,150
Rotavirus,,States/Local Areas,TX-Travis County,2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Travis County,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Travis County,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Travis County,2011,Age,8 Months,NA,,
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,85.8,82.4 to 89.3,801
Hib,Primary Series,States/Local Areas,TX-Rest of state,2011,Age,7 Months,67.7,60.9 to 73.8,702
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,75.4,70.8 to 80.0,833
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.8,73.9 to 81.6,989
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,77.9,74.3 to 81.5,1034
Hib,Full Series,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,71.0 to 84.0,291
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2011,Age,35 Months,84.3,78.2 to 89.6,702
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2019,Age,24 Months,79.8,74.0 to 85.0,496
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,88.5,85.5 to 91.0,1030
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,88.0,85.5 to 90.2,1397
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,83.7,80.0 to 87.4,838
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,86.0,83.9 to 88.0,2450
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,87.0,83.9 to 89.6,953
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,87.8,86.3 to 89.1,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,81.7,76.8 to 85.7,702
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,89.2,86.6 to 91.4,1257
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,88.1,86.1 to 89.8,2463
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017,Age,13 Months,65.8,60.0 to 71.2,538
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,67.3,63.1 to 71.2,1023
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016,Age,13 Months,67.3,62.4 to 71.9,705
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,66.6,62.8 to 70.1,1243
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,86.7,82.9 to 90.5,833
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.3,83.0 to 89.5,989
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.3,83.7 to 88.9,1351
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,81.7,74.7 to 88.8,266
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,80.3 to 91.8,291
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015,Age,13 Months,62.5,58.8 to 66.1,1257
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,64.2,61.5 to 66.8,2463
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,64.0,57.1 to 70.4,496
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013,Age,13 Months,61.6,58.1 to 65.0,953
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,61.5,59.0 to 63.9,1983
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018,Age,13 Months,69.5,63.9 to 74.6,532
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,68.5,64.2 to 72.4,1101
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,85.5,82.0 to 89.0,811
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2012,Age,19 Months,87.8,83.0 to 91.4,867
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2011,Age,19 Months,87.1,80.7 to 91.7,702
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014,Age,13 Months,61.3,57.3 to 65.2,1030
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,64.5,61.1 to 67.8,1397
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015,Age,13 Months,64.9,61.3 to 68.4,1257
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,65.9,63.3 to 68.4,2463
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014,Age,35 Months,85.9,82.2 to 89.3,1030
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,87.7,84.2 to 90.7,1397
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2012,Age,35 Months,84.1,79.8 to 87.9,867
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2013,Age,35 Months,84.6,80.3 to 88.4,953
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,35 Months,85.3,82.5 to 87.9,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,86.3,82.9 to 89.1,867
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,85.2,77.6 to 91.3,496
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,83.7,77.0 to 89.4,485
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,83.8,78.9 to 88.2,1101
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,77.5,70.6 to 83.8,538
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,81.6,76.4 to 86.2,1023
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,83.1,79.8 to 86.0,1030
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,84.7,82.0 to 87.1,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,84.1,80.4 to 87.2,953
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,83.6,81.4 to 85.6,1983
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017,Age,13 Months,67.4,61.6 to 72.7,538
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,70.3,66.3 to 74.1,1023
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016,Age,13 Months,69.3,64.5 to 73.7,705
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,68.3,64.6 to 71.9,1243
Hib,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,95.0,91.6 to 97.4,496
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,5 Months,75.7,70.1 to 80.5,538
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,5 Months,78.6,74.6 to 82.0,1023
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,87.3,83.4 to 91.1,833
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.7,87.8 to 93.6,989
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.1,90.0 to 94.1,1351
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,87.7,82.1 to 93.3,266
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,91.8,89.5 to 94.0,1034
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,85.1 to 94.8,291
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,5 Months,81.4,76.1 to 85.8,532
PCV,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,5 Months,82.7,79.0 to 85.8,1101
DTaP,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",80.1,70.3 to 89.9,136
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,76.0,70.7 to 80.6,538
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,74.2,70.3 to 77.8,1023
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,73.6,69.0 to 77.8,705
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,74.8,71.3 to 78.0,1243
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,46.9,42.5 to 51.5,953
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,45.6,42.6 to 48.8,1983
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014,Age,19 Months,86.2,83.1 to 88.8,1030
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,87.2,84.6 to 89.4,1397
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015,Age,19 Months,87.2,85.6 to 88.7,1257
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,86.9,84.8 to 88.7,2463
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,93.4,89.3 to 96.0,702
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,93.2,91.0 to 94.8,867
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013,Age,19 Months,86.5,84.1 to 88.5,953
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,86.3,85.4 to 87.2,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,81.6,76.4 to 85.9,538
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,84.7,81.2 to 87.6,1023
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018,Age,13 Months,73.3,67.9 to 78.2,532
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,71.4,67.2 to 75.3,1101
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,76.9,70.6 to 83.2,838
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,78.5,74.9 to 82.2,2450
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.2,73.0 to 83.5,1351
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2018,Age,24 Months,79.4,74.1 to 84.3,485
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,79.4,75.6 to 82.9,1101
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2017,Age,24 Months,80.4,75.4 to 85.0,538
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,79.9,76.2 to 83.3,1023
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,5 Months,85.2,79.7 to 89.5,496
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,70.8,65.2 to 75.9,532
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,66.9,62.6 to 71.0,1101
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2011,Age,13 Months,60.9,54.0 to 67.4,702
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2012,Age,13 Months,63.3,57.5 to 68.8,867
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,70.5,60.1 to 80.9,266
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,82.6,77.1 to 88.1,1034
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2016,Age,3 Months,94.6,91.8 to 96.4,705
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2016-2017,Age,3 Months,94.2,92.1 to 95.9,1243
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2015,Age,3 Months,94.9,93.1 to 96.2,1257
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2015-2016,Age,3 Months,94.8,93.5 to 95.9,2463
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2014,Age,3 Months,95.6,93.6 to 97.0,1030
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2015,Age,3 Months,94.4,92.7 to 95.8,1397
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,13 Months,91.4,88.8 to 93.5,953
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,13 Months,92.1,90.6 to 93.3,1983
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016,Age,35 Months,86.5,82.0 to 90.3,705
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,35 Months,85.7,82.2 to 88.8,1243
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2017,Age,35 Months,84.4,79.1 to 89.0,538
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,35 Months,84.1,80.4 to 87.4,1023
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.7,69.2 to 86.2,291
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,81.9,76.2 to 87.5,833
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.5,72.0 to 83.0,989
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,50.5,35.1 to 65.9,138
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,Hispanic,79.9,76.5 to 83.4,1034
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.7,74.9 to 82.6,989
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,75.6 to 88.2,291
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Overall,Overall,78.5,76.1 to 80.9,2450
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,75.0,67.4 to 82.7,266
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,77.2,72.6 to 81.8,833
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.8,76.8 to 82.9,1351
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014,Age,19 Months,85.3,82.2 to 88.0,1030
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,86.6,84.0 to 88.9,1397
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,<133% FPL,73.9,69.6 to 78.2,838
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2012,Age,24 Months,90.6,87.3 to 93.3,867
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2011,Age,24 Months,91.2,87.1 to 94.4,702
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016,Age,19 Months,86.6,82.8 to 89.6,705
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,86.4,83.5 to 88.9,1243
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015,Age,19 Months,87.1,85.7 to 88.3,1257
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,87.0,85.0 to 88.8,2463
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,87.0,84.0 to 89.5,1030
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,87.5,85.0 to 89.7,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,88.6,86.5 to 90.5,1257
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,88.0,86.1 to 89.7,2463
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,82.3,76.9 to 87.6,801
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,86.7,84.1 to 89.0,953
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,86.8,85.2 to 88.3,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,5 Months,85.1,82.0 to 87.8,953
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,5 Months,85.3,82.8 to 87.5,1983
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019,Age,13 Months,69.6,62.9 to 75.7,496
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018,Age,19 Months,89.2,84.7 to 92.4,485
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,68.5,64.2 to 72.4,1101
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2019,Age,3 Months,96.8,93.7 to 98.4,496
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,77.1,71.0 to 83.2,811
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2011,Age,0-1 Days,73.8,69.5 to 77.7,702
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,5 Months,86.5,83.4 to 89.1,702
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,5 Months,87.1,85.2 to 88.8,867
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,13 Months,92.8,90.3 to 94.6,1030
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,13 Months,92.7,90.6 to 94.3,1397
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2018,Age,3 Months,95.3,91.5 to 97.5,532
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2018-2019,Age,3 Months,96.3,94.2 to 97.6,1101
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2018,Age,35 Months,83.8,78.4 to 88.4,485
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,35 Months,85.2,81.3 to 88.7,1101
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,85.4,81.4 to 88.6,705
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,83.5,80.3 to 86.2,1243
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,86.1,83.3 to 88.6,1257
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,85.4,83.3 to 87.2,2463
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2015,Age,35 Months,88.6,84.5 to 92.0,1257
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,35 Months,87.5,84.8 to 90.0,2463
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,86.3,81.6 to 89.9,538
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,89.3,86.3 to 91.7,1023
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,87.8,84.0 to 90.9,705
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,87.1,84.2 to 89.5,1243
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2011,Age,3 Months,94.2,91.2 to 96.3,702
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2012,Age,3 Months,95.1,93.4 to 96.5,867
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2013,Age,3 Months,94.7,93.5 to 95.7,953
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2013-2014,Age,3 Months,95.2,94.3 to 96.0,1983
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019,Age,13 Months,68.2,61.5 to 74.3,496
Hep A,≥1 Dose,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,89.9,86.9 to 92.9,801
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,82.5,76.7 to 88.2,859
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,78.2,73.6 to 82.8,1322
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.8,48.2 to 75.4,136
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,87.1,82.0 to 90.9,496
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,87.8,83.2 to 91.3,532
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,87.5,84.3 to 90.1,1101
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,7 Months,92.5,88.1 to 95.4,496
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,88.8,85.8 to 91.3,867
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,85.5,80.6 to 89.4,702
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017,Age,19 Months,85.7,81.1 to 89.3,538
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,87.6,84.6 to 90.2,1023
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2012,Age,19 Months,88.7,83.7 to 92.3,867
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013,Age,19 Months,86.3,82.8 to 89.2,953
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,85.8,84.2 to 87.3,1983
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2017,Age,3 Months,93.9,90.2 to 96.3,538
Hep B,≥1 Dose,States/Local Areas,TX-Rest of state,2017-2018,Age,3 Months,94.6,92.0 to 96.4,1023
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,13 Months,91.7,88.4 to 94.1,705
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,13 Months,90.2,87.6 to 92.4,1243
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016,Age,19 Months,85.6,81.7 to 88.9,705
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,85.7,82.7 to 88.2,1243
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,13 Months,92.9,90.6 to 94.7,1257
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,13 Months,92.4,90.7 to 93.7,2463
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2017,Age,0-1 Days,71.3,65.1 to 76.7,538
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2017-2018,Age,0-1 Days,75.2,71.1 to 78.9,1023
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2016,Age,0-1 Days,69.7,64.8 to 74.2,705
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2016-2017,Age,0-1 Days,70.5,66.6 to 74.1,1243
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015,Age,24 Months,88.0,85.2 to 90.5,1257
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,88.3,86.4 to 90.1,2463
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2011,Age,24 Months,89.6,85.4 to 93.1,702
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017,Age,19 Months,86.2,81.6 to 89.9,538
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,87.7,84.6 to 90.3,1023
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2020,Age,35 Months,78.8,71.4 to 85.3,382
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2011,Age,19 Months,71.1,64.9 to 76.6,702
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2012,Age,19 Months,76.7,71.1 to 81.5,867
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2013,Age,19 Months,75.6,72.1 to 78.8,953
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,19 Months,75.3,73.8 to 76.8,1983
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,64.8,60.7 to 68.7,1030
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,68.2,64.8 to 71.4,1397
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,>400% FPL,87.4,84.0 to 90.7,801
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Poverty,133% to <400% FPL,77.0,72.8 to 81.2,811
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,64.5,60.2 to 68.6,867
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,87.2,83.4 to 90.2,705
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,85.6,82.6 to 88.2,1243
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,63.6,55.1 to 71.4,702
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,65.3,60.0 to 70.3,953
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,65.1,61.5 to 68.5,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,5 Months,85.5,82.3 to 88.1,1030
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,5 Months,85.7,83.8 to 87.4,1397
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2012,Age,0-1 Days,74.2,69.5 to 78.3,867
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2016,Age,5 Months,87.5,83.7 to 90.6,705
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,5 Months,86.1,83.0 to 88.6,1243
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,84.0,79.0 to 88.0,538
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,86.4,83.0 to 89.1,1023
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2014,Age,0-1 Days,71.4,67.6 to 74.9,1030
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2014-2015,Age,0-1 Days,70.4,67.1 to 73.4,1397
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2013,Age,0-1 Days,72.6,68.6 to 76.3,953
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2013-2014,Age,0-1 Days,72.0,69.1 to 74.7,1983
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,5 Months,90.5,86.0 to 93.7,496
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2018,Age,0-1 Days,78.0,72.7 to 82.5,532
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2018-2019,Age,0-1 Days,79.5,75.8 to 82.8,1101
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2011,Age,0-2 Days,78.5,73.5 to 82.8,702
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2013,Age,7 Months,90.8,88.8 to 92.6,953
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,7 Months,91.2,89.6 to 92.6,1983
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2012,Age,0-2 Days,76.8,73.0 to 80.2,867
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2014,Age,7 Months,91.6,89.1 to 93.6,1030
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,7 Months,91.2,89.1 to 92.9,1397
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2012,Age,7 Months,92.7,90.8 to 94.2,867
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,74.1,68.5 to 79.0,532
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,73.6,69.4 to 77.4,1101
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,13 Months,85.0,76.1 to 91.0,702
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014,Age,24 Months,88.2,85.4 to 90.7,1030
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,88.8,86.5 to 90.9,1397
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,24 Months,89.4,86.8 to 91.6,1257
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,88.7,86.8 to 90.4,2463
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,24 Months,87.6,84.0 to 90.7,705
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,85.9,83.0 to 88.5,1243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2019,Age,0-1 Days,79.8,73.8 to 84.7,496
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2011,Age,7 Months,90.1,87.0 to 92.5,702
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,13 Months,87.0,84.5 to 89.2,867
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016,Age,24 Months,89.0,85.6 to 91.8,705
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,88.7,86.1 to 91.0,1243
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017,Age,24 Months,88.4,84.2 to 91.9,538
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,90.3,87.6 to 92.7,1023
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,78.3,72.8 to 82.9,485
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,81.4,77.6 to 84.7,964
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2017,Age,19 Months,77.6,72.3 to 82.2,538
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,19 Months,78.0,74.2 to 81.3,1023
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017,Age,24 Months,86.8,82.4 to 90.5,538
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2017-2018,Age,24 Months,89.8,87.0 to 92.2,1023
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019,Age,24 Months,90.1,85.6 to 93.6,496
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,80.3,69.9 to 90.6,131
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Uninsured,59.1,47.1 to 71.2,138
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.1,56.4 to 77.8,136
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2011,Age,19 Months,86.5,81.2 to 90.5,702
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,75.9,71.8 to 80.0,859
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,83.0,80.0 to 85.9,1322
DTaP,≥4 Doses,States/Local Areas,TX-Rest of state,2019,Age,35 Months,85.7,79.8 to 90.6,496
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018,Age,19 Months,88.9,84.4 to 92.3,485
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,94.1,91.7 to 95.8,1101
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2019,Age,19 Months,87.9,82.8 to 91.6,496
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014,Age,24 Months,90.6,88.0 to 92.9,1030
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,88.6,86.1 to 90.7,1397
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,5 Months,84.6,79.6 to 88.5,538
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,5 Months,87.0,83.8 to 89.7,1023
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018,Age,19 Months,88.2,83.5 to 91.8,485
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,19 Months,87.5,84.3 to 90.1,1101
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2015,Age,0-1 Days,73.2,69.8 to 76.4,1257
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Rest of state,2015-2016,Age,0-1 Days,72.8,70.3 to 75.2,2463
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016,Age,24 Months,88.2,84.6 to 91.3,705
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2016-2017,Age,24 Months,87.5,84.7 to 90.0,1243
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2019,Age,13 Months,93.5,89.5 to 96.1,496
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,13 Months,94.6,91.2 to 96.7,532
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,13 Months,94.3,92.0 to 96.0,1101
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2015,Age,5 Months,87.0,84.3 to 89.2,1257
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,5 Months,86.9,85.0 to 88.7,2463
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2017,Age,13 Months,88.7,84.3 to 92.0,538
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,13 Months,91.8,89.2 to 93.9,1023
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013,Age,24 Months,87.8,84.5 to 90.6,953
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,89.2,87.1 to 91.0,1983
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2019,Age,19 Months,88.4,83.5 to 92.1,496
Hep A,≥2 Doses,States/Local Areas,TX-Rest of state,2014-2017,Insurance Coverage,Other,78.0,62.2 to 93.7,131
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,7 Months,92.2,88.1 to 95.0,532
Polio,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,7 Months,92.5,89.7 to 94.5,1101
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2011,Age,35 Months,93.1,88.8 to 96.2,702
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2012,Age,24 Months,91.3,88.2 to 93.8,867
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018,Age,24 Months,92.3,88.6 to 95.2,485
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2018-2019,Age,24 Months,91.1,88.3 to 93.4,1101
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015,Age,24 Months,89.0,86.3 to 91.3,1257
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2015-2016,Age,24 Months,89.0,87.2 to 90.7,2463
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014,Age,24 Months,89.3,86.5 to 91.7,1030
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2014-2015,Age,24 Months,88.6,86.1 to 90.7,1397
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013,Age,24 Months,88.9,85.9 to 91.6,953
≥1 Dose MMR,,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,89.1,87.1 to 90.9,1983
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016,Age,19 Months,76.9,72.2 to 81.0,705
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,19 Months,77.2,73.7 to 80.4,1243
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2015,Age,19 Months,78.2,76.6 to 79.7,1257
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,19 Months,76.9,74.5 to 79.2,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017,Age,7 Months,72.1,66.5 to 77.1,538
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2017-2018,Age,7 Months,73.1,69.0 to 76.8,1023
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014,Age,19 Months,75.0,71.3 to 78.5,1030
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2014-2015,Age,19 Months,78.2,75.1 to 80.9,1397
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015,Age,7 Months,68.7,65.1 to 72.1,1257
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2015-2016,Age,7 Months,68.8,66.2 to 71.3,2463
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016,Age,7 Months,72.3,67.5 to 76.6,705
PCV,≥3 Doses,States/Local Areas,TX-Rest of state,2016-2017,Age,7 Months,72.2,68.6 to 75.6,1243
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2012,Age,24 Months,89.4,86.1 to 92.2,867
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2018,Age,5 Months,89.4,85.1 to 92.6,532
Hep B,≥2 Doses,States/Local Areas,TX-Rest of state,2018-2019,Age,5 Months,90.2,87.4 to 92.5,1101
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,88.1,83.1 to 91.8,496
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013,Age,24 Months,88.0,84.7 to 90.8,953
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2013-2014,Age,24 Months,88.1,86.0 to 90.1,1983
Hep B,≥3 Doses,States/Local Areas,TX-Rest of state,2011,Age,24 Months,86.9,82.5 to 90.7,702
PCV,≥4 Doses,States/Local Areas,TX-Rest of state,2019,Age,19 Months,82.2,76.4 to 86.8,496
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2014,Age,0-2 Days,75.3,71.6 to 78.6,1030
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2014-2015,Age,0-2 Days,75.7,72.6 to 78.5,1397
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2015,Age,0-2 Days,78.6,75.4 to 81.5,1257
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Rest of state,2015-2016,Age,0-2 Days,77.5,75.2 to 79.7,2463
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014,Age,35 Months,93.6,90.9 to 95.7,1030
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2014-2015,Age,35 Months,91.9,89.4 to 94.0,1397
≥1 Dose Varicella,,States/Local Areas,TX-Rest of state,2012,Age,35 Months,92.9,89.7 to 95.4,867
PCV,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,3 Months,98.1,87.2 to 99.7,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2015,Age,0-3 Days,82.9,76.3 to 87.9,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,93.7,91.4 to 96.1,508
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2013,Age,0-3 Days,NA,,
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,80.2,68.7 to 88.2,117
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,74.5,61.8 to 84.0,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,65.4,40.2 to 84.1,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,89.4,85.2 to 93.6,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,71.3,51.6 to 90.9,35
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2018,Age,0-3 Days,92.4,78.2 to 97.6,32
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,75.4,67.2 to 83.5,169
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,95.3,81.6 to 98.9,32
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,96.3,89.2 to 100.0,35
Polio,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,3 Months,93.6,79.2 to 98.3,32
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,69.0,56.4 to 79.4,117
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,64.7,52.2 to 75.5,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.2,85.5 to 100.0,40
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.0,88.5 to 100.0,42
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,93.6,91.2 to 96.1,468
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,93.9,83.4 to 98.7,32
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,92.1,87.2 to 97.0,169
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,92.4,87.9 to 97.0,283
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,92.8,89.4 to 96.2,437
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,92.7,75.7 to 98.1,89
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,94.5,88.4 to 97.5,206
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,95.1,91.3 to 97.3,332
Polio,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,3 Months,89.9,81.6 to 94.7,117
Polio,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,3 Months,91.3,84.9 to 95.2,149
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,50.3,35.4 to 65.1,89
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,63.1,52.8 to 72.3,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,93.9,83.4 to 98.7,32
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,56.5,48.8 to 64.0,332
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,93.0,86.4 to 97.1,117
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,93.3,88.0 to 96.8,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,69.8,62.3 to 76.4,332
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,60.1,43.8 to 74.4,89
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,73.8,64.0 to 81.7,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.7,80.8 to 100.0,40
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,92.7,89.5 to 95.8,508
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,92.2,87.6 to 96.8,283
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,95.4,88.7 to 98.2,117
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,96.4,91.8 to 98.5,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,89.7,83.4 to 93.8,332
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,85.5,81.6 to 89.5,437
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.3,69.7 to 94.9,42
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.8,77.0 to 100.0,40
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,82.7,78.6 to 86.8,468
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,83.2,79.3 to 87.2,508
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.6,94.2 to 100.0,42
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,89.5 to 96.0,468
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,57.8,34.3 to 78.2,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,87.6,71.7 to 95.2,89
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,92.1,85.7 to 95.8,206
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,98.1,87.2 to 99.7,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,94.2,87.5 to 97.4,117
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,94.1,88.4 to 97.0,149
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,92.5,87.6 to 97.3,164
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,96.0,91.4 to 100.0,61
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,81.1,73.2 to 87.1,332
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,79.4,71.7 to 87.2,164
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,84.9,75.5 to 94.3,61
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,85.0,79.9 to 90.0,283
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,90.6,84.4 to 94.5,332
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,84.3,68.6 to 93.0,89
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,83.7,74.6 to 90.0,206
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,83.4,71.3 to 91.0,117
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,84.1,74.9 to 90.4,149
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,90.4,74.6 to 96.8,89
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,93.2,87.1 to 96.6,206
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.6,88.0 to 97.6,117
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,94.3,88.7 to 97.2,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,93.9,80.4 to 98.3,32
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,82.6,71.3 to 94.0,60
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,32.0,25.7 to 38.3,283
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,47.0,37.9 to 56.1,164
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,67.3,53.2 to 81.4,61
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,90.9,83.1 to 98.8,60
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,85.2,75.6 to 94.8,60
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,91.8,87.2 to 96.4,178
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,40.4,35.4 to 45.4,508
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,34.7,14.4 to 55.0,35
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,56.7,47.7 to 65.6,169
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,85.4,68.2 to 94.1,32
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,38.6,33.3 to 44.0,437
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,33.5,27.2 to 39.7,283
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,56.7,37.3 to 76.1,40
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",55.0,37.6 to 72.5,42
Influenza,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,39.2,34.0 to 44.3,468
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,89.0,80.6 to 97.4,60
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,91.8,85.8 to 97.8,113
Influenza,,States/Local Areas,TX-El Paso County,2016,Age,24 Months,36.1,23.9 to 52.0,89
Influenza,,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,39.7,30.2 to 50.9,206
Influenza,,States/Local Areas,TX-El Paso County,2018,Age,24 Months,61.5,41.9 to 81.4,32
Influenza,,States/Local Areas,TX-El Paso County,2017,Age,24 Months,41.3,29.1 to 56.3,117
Influenza,,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,49.4,37.7 to 62.6,149
Influenza,,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,38.9,31.9 to 46.9,332
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,85.7,79.3 to 92.1,178
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,81.4,70.8 to 92.0,60
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,89.0,81.3 to 96.7,113
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,95.5,92.6 to 98.5,178
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,89.0,80.4 to 97.6,178
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,95.3,92.1 to 98.5,178
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,89.7,82.7 to 96.7,61
Rotavirus,,States/Local Areas,TX-El Paso County,2017,Age,8 Months,83.8,73.9 to 90.5,117
Rotavirus,,States/Local Areas,TX-El Paso County,2017-2018,Age,8 Months,83.1,74.5 to 89.3,149
Rotavirus,,States/Local Areas,TX-El Paso County,2018,Age,8 Months,82.0,64.1 to 92.1,32
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.1,66.4 to 95.7,42
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,75.3,70.4 to 80.2,468
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,75.9,67.9 to 84.0,164
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.3,63.1 to 95.4,40
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,75.6,71.0 to 80.3,508
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,72.9,66.4 to 79.4,283
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,75.7,57.2 to 94.3,35
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,79.2,72.2 to 86.3,169
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,73.3,66.7 to 79.8,283
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,75.9,70.9 to 80.9,437
Rotavirus,,States/Local Areas,TX-El Paso County,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-El Paso County,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-El Paso County,2016,Age,8 Months,67.0,49.9 to 80.6,89
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2017,Age,8 Months,78.5,69.3 to 85.5,206
Rotavirus,,States/Local Areas,TX-El Paso County,2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-El Paso County,2014-2015,Age,8 Months,75.6,68.8 to 81.2,332
Rotavirus,,States/Local Areas,TX-El Paso County,2011,Age,8 Months,NA,,
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,64.2,55.2 to 73.2,164
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,78.5,66.5 to 90.6,61
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,71.8,64.9 to 78.6,283
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,70.1,65.1 to 75.2,508
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.3,46.7 to 79.9,42
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.1,58.1 to 90.1,40
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,69.8,64.5 to 75.1,468
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,72.2,66.8 to 77.6,437
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,64.7,55.8 to 73.6,169
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,71.5,64.7 to 78.3,283
Combined 7 Series,,States/Local Areas,TX-El Paso County,2018,Age,35 Months,81.7,49.1 to 98.6,32
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,84.3,69.8 to 98.7,35
Hib,Full Series,States/Local Areas,TX-El Paso County,2016,Age,19 Months,71.7,54.0 to 84.6,89
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,81.1,72.5 to 87.4,206
Hib,Full Series,States/Local Areas,TX-El Paso County,2018,Age,19 Months,70.7,47.5 to 86.5,32
Hib,Full Series,States/Local Areas,TX-El Paso County,2017,Age,19 Months,85.4,76.7 to 91.3,117
Hib,Full Series,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,79.8,69.1 to 87.4,149
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,74.5,67.5 to 80.5,332
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,81.5,75.0 to 87.2,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,67.9,60.3 to 74.6,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2018,Age,7 Months,58.4,34.8 to 78.8,32
Hib,Primary Series,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,89.3,82.9 to 93.4,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.9,88.2 to 97.8,117
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,93.4,86.7 to 96.9,149
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016,Age,19 Months,92.7,75.7 to 98.1,89
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,94.2,88.0 to 97.2,206
Hib,Primary Series,States/Local Areas,TX-El Paso County,2018,Age,19 Months,91.1,74.3 to 97.3,32
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016,Age,13 Months,89.1,72.6 to 96.1,89
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,91.2,84.5 to 95.2,206
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017,Age,13 Months,92.2,84.7 to 96.2,117
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,90.9,83.9 to 95.0,149
Hib,Primary Series,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,93.3,87.2 to 96.6,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2018,Age,13 Months,88.8,72.4 to 96.0,32
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016,Age,35 Months,99.5,97.4 to 100.0,89
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,98.8,95.2 to 99.8,206
Hib,Primary Series,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,93.3,87.9 to 96.8,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016,Age,24 Months,92.7,79.6 to 98.6,89
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,94.2,88.8 to 97.5,206
Hib,Primary Series,States/Local Areas,TX-El Paso County,2018,Age,24 Months,95.0,84.5 to 99.2,32
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017,Age,24 Months,94.9,89.2 to 98.1,117
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,95.1,90.2 to 98.0,149
Hib,Primary Series,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,95.7,92.6 to 97.7,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2018,Age,35 Months,95.0,84.5 to 99.2,32
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,69.1,61.3 to 76.6,332
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017,Age,35 Months,94.9,89.2 to 98.1,117
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,95.1,90.2 to 98.0,149
Combined 7 Series,,States/Local Areas,TX-El Paso County,2018,Age,24 Months,46.1,26.3 to 71.4,32
Combined 7 Series,,States/Local Areas,TX-El Paso County,2017,Age,24 Months,79.7,69.2 to 88.5,117
Combined 7 Series,,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,67.3,54.9 to 79.2,149
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016,Age,7 Months,63.3,46.6 to 77.2,89
Hib,Primary Series,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,74.5,65.3 to 82.0,206
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017,Age,7 Months,79.8,69.5 to 87.3,117
Hib,Primary Series,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,71.6,59.1 to 81.5,149
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016,Age,24 Months,79.0,64.7 to 90.4,89
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,79.3,70.9 to 86.6,206
Combined 7 Series,,States/Local Areas,TX-El Paso County,2017,Age,35 Months,84.2,73.2 to 92.4,117
Combined 7 Series,,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,85.4,67.4 to 96.3,149
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016,Age,35 Months,82.7,67.8 to 93.4,89
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,83.6,74.9 to 90.6,206
Combined 7 Series,,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,77.5,67.7 to 86.0,332
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,92.5,87.6 to 97.5,178
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,96.9,93.2 to 100.0,60
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,97.3,94.5 to 100.0,113
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,89.3,81.7 to 96.9,113
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,85.1,76.7 to 93.6,113
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,91.6,84.4 to 98.7,60
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,98.2,95.7 to 100.0,113
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,92.8,86.4 to 99.2,113
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,96.1,93.3 to 98.9,178
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,80.8,70.0 to 91.6,60
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,87.9,77.3 to 98.6,113
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,82.8,67.7 to 97.9,60
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,87.4,81.4 to 93.3,178
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,92.3,84.2 to 100.0,60
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,94.3,88.9 to 99.6,113
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,85.0,79.1 to 90.8,201
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,40.8,32.5 to 49.1,178
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,95.0,92.0 to 98.1,201
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,94.5,91.3 to 97.7,201
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,89.0,82.4 to 95.5,118
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,93.1,88.8 to 97.3,201
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,92.6,87.9 to 97.3,118
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,88.8,80.1 to 97.5,60
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,95.8,92.4 to 99.1,118
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,43.9,35.9 to 51.8,201
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,95.6,90.4 to 100.0,60
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,84.4,76.5 to 92.4,118
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,86.2,77.8 to 94.5,201
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,73.5,65.9 to 81.1,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,85.3,79.5 to 91.1,201
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,90.6,86.0 to 95.2,201
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,97.4,94.3 to 100.0,118
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,93.2,88.9 to 97.6,201
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,79.2,72.3 to 86.0,201
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,96.8,92.2 to 100.0,60
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,76.8,64.6 to 89.0,60
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,86.2,76.5 to 95.9,60
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,96.8,92.2 to 100.0,60
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,73.3,63.2 to 83.4,118
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,84.3,78.2 to 90.4,201
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,84.7,78.5 to 90.9,184
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,72.4,64.3 to 80.5,184
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,91.3 to 97.9,184
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,96.3,93.6 to 99.0,184
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,83.6,77.1 to 90.1,184
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,93.1,88.7 to 97.6,184
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,85.6 to 95.3,184
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,78.6,71.4 to 85.9,184
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,42.4,34.1 to 50.7,184
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,85.0,78.5 to 91.4,184
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,90.6 to 97.5,184
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,85.1,73.8 to 96.4,60
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,74.4,64.7 to 84.1,118
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,93.3,88.7 to 97.9,184
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,87.5,77.7 to 97.4,60
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,79.1,65.1 to 93.1,60
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,92.3,84.2 to 100.0,118
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,96.0,92.7 to 99.4,118
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,96.2,93.7 to 98.8,201
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,96.6,94.1 to 99.1,201
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,50.4,35.4 to 65.4,60
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,36.0,26.0 to 45.9,118
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,96.8,92.2 to 100.0,60
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,92.9,87.4 to 98.4,118
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,94.4,90.1 to 98.6,118
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,92.9,85.9 to 99.8,60
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,93.7,86.2 to 100.0,60
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,96.7,93.5 to 99.9,118
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Poverty,133% to <400% FPL,88.0,79.6 to 96.4,60
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,84.7,76.8 to 92.6,118
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Poverty,<133% FPL,87.4,80.0 to 94.8,118
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Overall,Overall,85.5,79.5 to 91.5,201
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,97.2,94.4 to 100.0,113
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,76.3,66.1 to 86.5,113
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,96.5,93.8 to 99.3,178
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,70.5,57.0 to 84.1,60
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,91.1,85.6 to 96.6,113
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,78.9,65.5 to 92.2,60
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,92.6,87.9 to 97.3,178
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,95.5,90.1 to 100.0,60
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,96.4,92.2 to 100.0,60
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,88.3,80.3 to 96.3,60
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Private Insurance Only,58.8,43.7 to 73.8,60
Influenza,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,38.4,28.3 to 48.4,113
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,88.5,83.3 to 93.7,178
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,75.3,65.2 to 85.3,113
Combined 7 Series,,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,75.5,67.5 to 83.5,178
Rotavirus,,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,78.5,70.9 to 86.1,178
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Race and Ethnicity,Hispanic,86.7,80.3 to 93.1,178
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Insurance Coverage,Any Medicaid,96.9,94.0 to 99.8,113
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,99.6,97.7 to 100.0,89
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,98.9,96.1 to 99.8,206
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,94.3,88.6 to 97.7,117
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,94.8,89.9 to 97.8,149
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,41.4,20.6 to 65.7,32
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,72.0,64.6 to 78.4,332
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,36.0,23.6 to 50.6,117
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,38.0,26.5 to 51.2,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,93.3,88.6 to 98.0,169
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,95.8,93.2 to 98.4,283
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,24 Months,94.7,89.4 to 97.9,117
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,90.8,82.1 to 96.3,149
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,24 Months,83.6,63.1 to 96.3,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,96.3,89.2 to 100.0,35
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,95.0,84.5 to 99.2,32
PCV,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,5 Months,70.1,52.3 to 83.3,89
PCV,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,5 Months,79.9,70.8 to 86.8,206
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,91.1,85.4 to 95.2,332
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,24 Months,91.9,84.3 to 96.7,89
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,93.9,89.7 to 96.7,206
PCV,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,5 Months,74.6,71.8 to 77.2,332
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,20.1,11.4 to 33.1,89
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,30.9,21.7 to 42.0,206
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,97.3,93.5 to 99.1,332
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,98.1,92.7 to 99.7,89
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,97.2,93.3 to 99.1,206
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,95.1,89.4 to 98.3,117
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,95.1,90.2 to 98.0,149
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,29.6,23.1 to 37.2,332
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,94.3,88.6 to 97.7,117
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,94.8,89.9 to 97.8,149
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,95.0,84.5 to 99.2,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,96.1,93.5 to 97.9,332
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,19 Months,83.6,58.4 to 94.9,32
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,19 Months,92.9,86.7 to 96.4,117
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,89.4,79.1 to 94.9,149
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,19 Months,89.1,78.4 to 94.8,89
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,91.7,86.6 to 95.0,206
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,84.8,78.5 to 91.0,184
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,93.2 to 98.7,184
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2019,Urbanicity,Living In a MSA Principal City,84.7,75.5 to 93.8,184
DTaP,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,3 Months,89.9,84.0 to 93.7,332
DTaP,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,3 Months,86.8,71.1 to 94.6,89
DTaP,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,3 Months,89.1,81.8 to 93.7,206
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,93.4,91.0 to 95.9,508
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,94.9,91.8 to 98.1,283
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,90.8,85.5 to 96.0,164
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,96.4,92.2 to 100.0,61
DTaP,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,5 Months,73.7,46.1 to 90.2,32
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.6,87.2 to 100.0,40
DTaP,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,5 Months,70.1,52.3 to 83.3,89
DTaP,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,5 Months,82.5,73.4 to 88.9,206
DTaP,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,5 Months,88.2,78.9 to 93.8,117
DTaP,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,5 Months,82.6,69.7 to 90.8,149
DTaP,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,3 Months,96.9,87.3 to 99.3,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,95.0,84.5 to 99.2,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,95.1,89.4 to 98.3,117
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,95.1,90.2 to 98.0,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,92.7,79.6 to 98.6,89
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,94.3,89.0 to 97.6,206
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,91.4,78.3 to 98.1,89
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,93.7,88.1 to 97.2,206
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,85.7,78.9 to 90.6,332
DTaP,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,3 Months,90.2,81.9 to 95.0,117
DTaP,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,3 Months,92.8,87.1 to 96.1,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,95.8,93.2 to 97.6,332
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,61.4,31.2 to 84.8,34
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,90.9,82.4 to 95.5,132
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,78.5,56.5 to 91.1,160
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,60.9,30.9 to 84.4,34
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,83.6,74.5 to 89.9,132
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,73.3,53.9 to 86.6,160
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,92.6,85.4 to 96.4,121
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,91.6,86.0 to 95.6,332
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,81.4,71.0 to 91.8,98
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.4,81.8 to 100.0,30
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,87.9,79.7 to 93.1,121
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,69.2,57.7 to 78.7,132
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,61.2,45.1 to 75.1,160
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,66.7,53.6 to 77.7,121
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,61.4,34.5 to 88.2,34
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,62.6,50.0 to 73.7,121
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,61.1,49.9 to 71.2,132
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,55.4,40.7 to 69.2,160
Polio,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,3 Months,73.2,42.9 to 90.8,34
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,95.5,90.1 to 98.0,121
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,96.1,90.4 to 98.4,132
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,82.0,57.7 to 93.8,160
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2013,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2014,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2014-2015,Age,0-3 Days,89.1,79.2 to 94.6,121
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,7 Months,66.3,33.8 to 88.4,34
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,88.4,79.7 to 93.7,132
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,76.8,55.8 to 89.7,160
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,95.5,89.8 to 98.5,132
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,82.8,61.6 to 96.1,160
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,96.2,91.2 to 98.7,121
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2016,Age,0-3 Days,90.7,80.9 to 95.7,132
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2016-2017,Age,0-3 Days,93.3,86.1 to 96.9,160
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2017-2018,Age,0-3 Days,78.2,48.4 to 93.3,34
Polio,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,3 Months,84.8,74.4 to 91.4,132
Polio,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,3 Months,83.9,70.5 to 91.9,160
Polio,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,3 Months,83.6,67.9 to 92.5,121
PCV,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,3 Months,83.2,67.6 to 92.2,121
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Hidalgo County,2014-2015,Age,0-2 Days,88.5,78.7 to 94.2,121
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,94.0,88.3 to 97.6,121
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,7 Months,79.4,51.5 to 93.3,34
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,91.7,82.8 to 96.1,132
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,88.7,74.6 to 95.5,160
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,91.9,85.1 to 95.8,121
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,62.8,35.4 to 89.2,34
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Hidalgo County,2017-2018,Age,0-2 Days,78.2,48.4 to 93.3,34
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Hidalgo County,2016,Age,0-2 Days,90.7,80.9 to 95.7,132
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Hidalgo County,2016-2017,Age,0-2 Days,93.3,86.1 to 96.9,160
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,92.2,85.2 to 96.7,132
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,80.0,60.5 to 93.8,160
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,86.9,78.9 to 92.9,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,61.4,34.5 to 88.2,34
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,62.8,35.4 to 89.2,34
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,91.9,85.6 to 96.1,121
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,79.2,69.3 to 86.6,132
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,69.9,51.6 to 83.5,160
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,81.9,72.0 to 88.8,121
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,68.3,56.9 to 78.0,132
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,60.2,44.4 to 74.2,160
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,93.4,86.3 to 96.9,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,89.2,81.0 to 94.9,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,91.2,83.8 to 96.1,132
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,78.7,59.8 to 92.8,160
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,87.7,80.3 to 93.4,132
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,75.9,57.8 to 90.4,160
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,60.6,33.9 to 87.7,34
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,60.0,30.4 to 83.8,34
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,62.8,31.9 to 85.9,34
Hep B,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,3 Months,94.7,69.9 to 99.3,34
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,96.6,91.0 to 98.8,132
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,82.4,57.8 to 94.1,160
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,90.2,81.9 to 95.0,132
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,78.8,56.7 to 91.4,160
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,89.6,81.5 to 94.4,121
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,85.6,77.1 to 91.3,132
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,74.5,54.6 to 87.7,160
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,89.2,79.9 to 94.4,121
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,95.5,90.1 to 98.0,121
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Hidalgo County,2017-2018,Age,0-1 Days,78.2,48.4 to 93.3,34
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Hidalgo County,2016,Age,0-1 Days,90.1,80.5 to 95.3,132
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Hidalgo County,2016-2017,Age,0-1 Days,92.9,85.8 to 96.6,160
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,93.4,87.7 to 97.1,121
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,5 Months,79.4,51.5 to 93.3,34
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,92.2,85.2 to 96.7,132
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,80.0,60.5 to 93.8,160
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,60.6,30.7 to 84.2,34
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,64.3,51.5 to 75.3,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,91.2,82.7 to 95.7,132
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,78.7,56.6 to 91.3,160
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,5 Months,88.3,79.7 to 93.6,121
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,5 Months,90.5,81.9 to 95.3,132
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,5 Months,88.0,74.2 to 94.9,160
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,61.4,31.2 to 84.8,34
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Hidalgo County,2014-2015,Age,0-1 Days,87.7,77.8 to 93.6,121
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,66.3,33.8 to 88.4,34
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,55.9,27.9 to 80.7,34
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,61.3,50.1 to 71.5,132
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,55.5,40.7 to 69.3,160
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,91.1,83.4 to 95.5,121
Hep B,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,3 Months,95.3,87.9 to 98.3,132
Hep B,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,3 Months,96.8,91.4 to 98.9,160
Hep B,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,3 Months,96.3,89.4 to 98.8,121
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,85.2,74.7 to 93.0,132
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,68.5,51.0 to 84.6,160
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,53.1,28.5 to 81.9,34
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,61.4,31.2 to 84.8,34
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,88.6,79.7 to 93.9,132
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,77.0,55.8 to 89.8,160
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,7 Months,66.3,33.8 to 88.4,34
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,89.0,80.3 to 94.2,132
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,77.2,56.0 to 90.1,160
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,63.9,51.1 to 75.0,121
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,85.9,77.4 to 92.5,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,88.2,78.8 to 93.8,121
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,53.1,28.5 to 81.9,34
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,61.4,31.2 to 84.8,34
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,87.0,78.2 to 92.6,132
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,75.9,55.3 to 88.9,160
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,90.9,83.3 to 95.3,121
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,66.3,33.8 to 88.4,34
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,61.4,34.5 to 88.2,34
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2011,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Hidalgo County,2012,Age,0-3 Days,NA,,
PCV,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,3 Months,72.5,42.5 to 90.4,34
PCV,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,3 Months,80.9,68.6 to 89.2,132
PCV,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,3 Months,80.9,67.2 to 89.8,160
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,89.9,81.7 to 94.6,121
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,5 Months,73.1,64.3 to 80.4,121
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,5 Months,72.0,60.4 to 81.2,132
Hib,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,5 Months,63.3,46.7 to 77.3,160
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,94.1,88.7 to 97.4,121
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,61.4,31.2 to 84.8,34
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,90.4,75.4 to 98.0,132
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,75.6,55.7 to 91.3,160
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,60.7,34.0 to 87.7,34
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,60.6,33.9 to 87.7,34
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,80.7,52.3 to 94.1,34
Hib,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,3 Months,73.2,42.9 to 90.8,34
Hib,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,3 Months,80.2,67.9 to 88.5,132
Hib,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,3 Months,80.8,67.1 to 89.6,160
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,94.5,87.8 to 97.6,132
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,81.0,57.5 to 93.0,160
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,94.8,86.7 to 98.1,132
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,91.6,75.9 to 97.4,160
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,88.2,80.5 to 93.9,121
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,93.5,87.4 to 96.8,121
Hep B,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,96.7,91.8 to 98.7,121
Hib,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,3 Months,82.1,66.9 to 91.2,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,93.4,84.9 to 98.0,132
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,79.9,60.1 to 93.9,160
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,61.4,34.5 to 88.2,34
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,88.8,80.0 to 94.0,132
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,77.1,55.9 to 89.9,160
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,91.6,83.2 to 96.7,121
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,61.4,31.2 to 84.8,34
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,81.4,72.4 to 88.9,132
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,71.7,54.8 to 86.6,160
PCV,≥4 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,60.7,34.0 to 87.7,34
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,91.9,85.6 to 96.1,121
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,89.9,82.0 to 95.3,132
≥1 Dose MMR,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,76.7,57.9 to 91.4,160
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,90.8,82.6 to 95.3,121
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,58.1,29.2 to 82.3,34
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,65.5,54.0 to 75.4,132
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,59.5,43.8 to 73.4,160
≥1 Dose Varicella,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,63.2,50.5 to 74.4,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,7 Months,60.4,30.6 to 84.0,34
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,91.6,71.9 to 99.2,132
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,66.6,44.7 to 86.9,160
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,79.8,69.2 to 88.7,121
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,79.9,69.8 to 87.3,132
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,70.5,52.0 to 84.1,160
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,83.1,74.3 to 90.3,121
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,77.0,68.0 to 85.0,132
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,64.7,49.0 to 80.0,160
Hep B,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,68.6,57.5 to 77.9,121
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,5 Months,73.3,61.7 to 82.4,132
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,5 Months,64.3,47.3 to 78.2,160
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,68.0,39.0 to 92.8,34
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,92.3,85.8 to 96.5,132
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,79.7,60.3 to 93.6,160
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,62.8,52.2 to 73.4,132
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,53.7,39.5 to 69.3,160
Polio,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,5 Months,74.6,66.8 to 81.0,121
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,93.0,87.1 to 96.9,121
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,54.4,42.7 to 66.8,121
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,52.3,25.7 to 77.7,34
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,73.6,64.0 to 81.5,132
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,62.1,45.8 to 76.1,160
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,96.9,91.6 to 99.2,121
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,60.1,33.6 to 87.2,34
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,86.5,78.2 to 92.8,121
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,87.1,78.2 to 93.7,132
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,74.8,56.5 to 89.8,160
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,83.6,75.7 to 90.1,132
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,73.0,55.9 to 87.7,160
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,60.1,33.6 to 87.2,34
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,90.9,83.4 to 95.9,132
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,78.5,59.6 to 92.6,160
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,61.4,34.5 to 88.2,34
Influenza,,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,40.0,30.6 to 51.0,132
Influenza,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,34.3,24.5 to 46.6,160
Influenza,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,43.7,32.7 to 56.6,121
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,93.9,87.2 to 97.2,132
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,80.3,57.3 to 92.5,160
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,60.9,30.9 to 84.4,34
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,95.5,90.0 to 98.5,121
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,94.2,87.6 to 97.4,132
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,80.8,57.4 to 92.9,160
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,61.4,31.2 to 84.8,34
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,94.2,88.6 to 97.2,121
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,94.3,88.6 to 97.2,121
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,81.3,69.4 to 90.7,132
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,65.3,48.3 to 81.6,160
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,53.1,28.5 to 81.9,34
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,71.7,62.1 to 80.7,132
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,61.2,46.2 to 76.4,160
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,53.1,28.5 to 81.9,34
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,61.4,34.5 to 88.2,34
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,68.4,58.1 to 78.3,121
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,97.0,92.7 to 99.1,121
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,61.4,34.5 to 88.2,34
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,96.1,90.8 to 98.8,132
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,81.9,61.7 to 95.2,160
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,94.8,89.9 to 97.8,121
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,96.1,90.8 to 98.8,132
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,81.9,61.7 to 95.2,160
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,94.3,88.7 to 97.2,121
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,13 Months,61.4,31.2 to 84.8,34
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016,Age,13 Months,86.4,77.6 to 92.1,132
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,13 Months,75.5,55.1 to 88.5,160
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,93.9,87.2 to 97.2,132
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,80.5,57.4 to 92.7,160
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,61.4,31.2 to 84.8,34
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,13 Months,89.8,81.9 to 94.5,121
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,7 Months,64.2,51.4 to 75.2,121
Rotavirus,,States/Local Areas,TX-Hidalgo County,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Hidalgo County,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Hidalgo County,2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,8 Months,79.0,69.1 to 86.4,121
Rotavirus,,States/Local Areas,TX-Hidalgo County,2016,Age,8 Months,68.2,57.2 to 77.4,132
Rotavirus,,States/Local Areas,TX-Hidalgo County,2016-2017,Age,8 Months,53.7,39.3 to 67.6,160
Rotavirus,,States/Local Areas,TX-Hidalgo County,2011,Age,8 Months,NA,,
Combined 7 Series,,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,70.1,59.8 to 79.8,121
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,93.4,84.3 to 98.1,132
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,79.7,59.9 to 93.8,160
Polio,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,61.4,34.5 to 88.2,34
DTaP,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,5 Months,74.6,66.8 to 81.0,121
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,95.5,89.8 to 98.5,132
PCV,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,81.5,61.5 to 95.0,160
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016,Age,7 Months,67.4,56.0 to 77.1,132
Hib,Primary Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,7 Months,59.9,44.2 to 73.9,160
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,96.6,92.4 to 98.8,121
DTaP,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,3 Months,73.2,42.9 to 90.8,34
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,89.8,81.8 to 94.6,121
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,94.7,89.9 to 97.7,121
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,96.1,90.8 to 98.8,132
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,81.7,61.6 to 95.1,160
DTaP,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,5 Months,73.3,61.7 to 82.4,132
DTaP,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,5 Months,64.3,47.3 to 78.2,160
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,95.6,89.9 to 98.6,132
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,81.6,61.5 to 95.0,160
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,61.4,34.5 to 88.2,34
DTaP,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,3 Months,84.8,74.4 to 91.4,132
DTaP,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,3 Months,83.9,70.5 to 91.9,160
DTaP,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,3 Months,83.6,67.9 to 92.5,121
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,88.6,80.9 to 93.4,132
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,77.7,56.3 to 90.4,160
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,27.1,18.5 to 37.9,121
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,61.4,34.5 to 88.2,34
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,95.6,89.9 to 98.6,132
DTaP,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,82.8,61.6 to 96.1,160
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,35 Months,96.9,92.6 to 99.1,121
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,40.5,30.2 to 51.8,132
Hep A,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,37.9,26.3 to 51.1,160
PCV,≥2 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,5 Months,71.9,62.3 to 79.9,121
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016,Age,24 Months,92.3,85.8 to 96.5,132
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2016-2017,Age,24 Months,79.7,60.3 to 93.6,160
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,93.0,87.1 to 96.9,121
PCV,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,5 Months,72.5,60.9 to 81.7,132
PCV,≥2 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,5 Months,63.4,46.7 to 77.3,160
Hep A,≥1 Dose,States/Local Areas,TX-Hidalgo County,2017-2018,Age,24 Months,68.0,39.0 to 92.8,34
DTaP,≥4 Doses,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,71.9,60.8 to 80.8,121
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2017-2018,Age,35 Months,61.0,34.3 to 87.9,34
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016,Age,35 Months,96.1,90.8 to 98.8,132
Hib,≥3 Doses,States/Local Areas,TX-Hidalgo County,2016-2017,Age,35 Months,81.7,61.6 to 95.1,160
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,82.3,71.5 to 89.7,150
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,24 Months,84.1,75.6 to 90.8,121
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2014-2015,Age,19 Months,78.9,68.8 to 86.4,121
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2017-2018,Age,19 Months,59.9,30.4 to 83.7,34
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2016,Age,19 Months,82.4,73.8 to 88.6,132
Hib,Full Series,States/Local Areas,TX-Hidalgo County,2016-2017,Age,19 Months,72.1,53.2 to 85.5,160
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,84.5,74.1 to 91.2,150
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,99.4,95.3 to 99.9,41
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,97.1,90.8 to 99.1,60
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,98.2,95.0 to 99.4,101
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,92.7,85.2 to 96.6,162
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,94.0,88.7 to 96.9,222
DTaP,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,99.4,95.3 to 99.9,41
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,84.8,75.5 to 92.0,150
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,97.1,90.8 to 99.1,60
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,98.1,95.0 to 99.3,101
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,93.5,86.5 to 97.0,162
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,94.6,89.6 to 97.2,222
Hib,Full Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,75.0,64.7 to 84.1,150
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,90.7,75.5 to 98.2,60
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,95.0,86.3 to 98.9,101
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.4,96.6 to 99.9,41
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,92.4,85.6 to 96.8,162
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,91.9,85.7 to 96.2,222
Hib,Full Series,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,80.9,65.9 to 92.2,60
Hib,Full Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,81.5,68.5 to 91.5,101
Hib,Full Series,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,74.9,65.8 to 83.1,162
Hib,Full Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,76.7,69.0 to 83.7,222
Hib,Full Series,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,80.4,70.6 to 88.6,162
Hib,Full Series,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,83.2,75.4 to 89.7,222
Hib,Full Series,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,79.0,68.3 to 88.0,150
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.4,96.6 to 99.9,41
Hib,Full Series,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,90.3,77.1 to 97.5,60
Hib,Full Series,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,88.0,75.3 to 96.0,101
Hib,Full Series,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,88.7,67.2 to 98.6,41
Polio,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,87.1,77.5 to 94.0,150
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,75.4,66.0 to 82.9,162
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,76.0,67.9 to 82.6,222
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,77.5,59.7 to 88.9,60
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,74.2,58.4 to 85.5,101
PCV,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,5 Months,78.6,60.0 to 90.0,60
PCV,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,5 Months,87.5,76.1 to 93.8,101
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,41.4,31.8 to 52.6,150
Hib,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,99.2,96.7 to 99.9,41
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,86.7,76.3 to 94.0,150
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,5 Months,77.5,69.5 to 83.9,150
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,42.7,33.2 to 53.6,162
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,48.2,39.6 to 57.7,222
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,60.7,45.2 to 76.6,60
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,52.5,38.8 to 67.6,101
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,70.9,44.0 to 88.3,41
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,93.6,87.2 to 97.4,162
Hep A,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,94.9,89.1 to 98.1,222
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,82.1,67.7 to 92.8,60
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,82.0,69.3 to 91.7,101
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,81.8,59.8 to 95.9,41
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,84.7,74.4 to 91.3,150
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,87.9,75.3 to 95.9,60
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,82.1,66.8 to 93.2,101
Hep A,≥2 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,77.5,53.3 to 94.6,41
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,77.1,66.0 to 86.6,150
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,59.1,47.9 to 69.4,150
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,84.2,74.5 to 90.7,162
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,85.9,77.8 to 91.4,222
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,89.9,70.4 to 97.1,60
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,94.6,83.4 to 98.4,101
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,81.1,70.9 to 88.3,162
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,84.3,76.4 to 89.9,222
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,92.1,81.3 to 97.9,60
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,92.1,81.0 to 98.0,101
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,87.4,78.6 to 93.7,162
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,88.7,81.9 to 93.8,222
Hep B,≥1 Dose,States/Local Areas,TX-Tarrant County,2014-2015,Age,3 Months,95.3,86.1 to 98.5,150
Hep B,≥1 Dose,States/Local Areas,TX-Tarrant County,2016,Age,3 Months,95.5,86.9 to 98.5,162
Hep B,≥1 Dose,States/Local Areas,TX-Tarrant County,2016-2017,Age,3 Months,95.9,90.0 to 98.4,222
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,91.7,78.7 to 97.0,60
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,95.3,88.4 to 98.2,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,77.6,65.9 to 86.1,150
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,68.8,58.5 to 77.5,162
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,68.3,59.6 to 75.9,222
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,67.3,49.6 to 81.1,60
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,74.0,60.0 to 84.3,101
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,13 Months,98.1,92.8 to 99.5,60
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,13 Months,98.7,96.1 to 99.6,101
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Tarrant County,2014-2015,Age,0-1 Days,85.1,76.0 to 91.1,150
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,91.8,78.8 to 97.1,60
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,95.4,88.4 to 98.3,101
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,5 Months,85.2,75.0 to 91.7,162
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,5 Months,87.4,79.6 to 92.5,222
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,5 Months,88.0,84.0 to 91.1,150
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,87.4,77.6 to 93.3,162
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,88.7,81.3 to 93.5,222
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,61.3,50.1 to 71.5,150
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,87.8,72.8 to 95.1,60
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,91.5,83.6 to 95.8,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,90.9,83.6 to 95.9,162
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,91.2,85.6 to 95.3,222
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,5 Months,92.5,79.1 to 97.6,60
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,5 Months,95.4,88.4 to 98.3,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,81.0,70.2 to 89.8,150
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,99.1,95.8 to 99.8,41
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,95.3,88.0 to 98.2,41
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Tarrant County,2016,Age,0-1 Days,70.5,59.9 to 79.3,162
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Tarrant County,2016-2017,Age,0-1 Days,67.2,58.0 to 75.2,222
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Tarrant County,2017,Age,0-1 Days,59.4,41.2 to 75.3,60
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Tarrant County,2017-2018,Age,0-1 Days,70.3,56.1 to 81.5,101
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,90.2,80.8 to 95.2,150
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,96.2,89.2 to 98.7,41
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,85.8,75.4 to 92.3,150
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,89.6,80.6 to 94.7,162
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,89.0,82.0 to 93.6,222
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,79.8,68.5 to 87.8,150
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,88.4,79.7 to 93.7,162
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,88.0,81.1 to 92.7,222
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,13 Months,92.2,83.9 to 96.4,162
Polio,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,13 Months,93.9,88.1 to 97.0,222
Hep B,≥1 Dose,States/Local Areas,TX-Tarrant County,2017,Age,3 Months,97.1,87.0 to 99.4,60
Hep B,≥1 Dose,States/Local Areas,TX-Tarrant County,2017-2018,Age,3 Months,98.2,93.3 to 99.5,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,87.1,72.4 to 94.6,60
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,91.6,83.7 to 95.9,101
DTaP,≥4 Doses,States/Local Areas,TX-Tarrant County,2018,Age,35 Months,93.4,74.7 to 99.5,41
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2017,Age,19 Months,80.9,63.6 to 91.1,60
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,19 Months,88.7,78.7 to 94.3,101
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2018,Age,19 Months,96.7,91.4 to 98.8,41
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,92.2,83.8 to 97.2,60
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,94.6,89.9 to 97.5,101
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,91.9,84.5 to 96.7,162
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,92.2,86.5 to 96.1,222
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,24 Months,87.7,79.0 to 94.0,162
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,24 Months,88.9,82.2 to 94.0,222
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,85.8,76.5 to 92.8,150
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,7 Months,88.0,78.9 to 93.4,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,62.7,52.1 to 72.2,162
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,65.3,56.2 to 73.3,222
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,19 Months,66.9,55.8 to 76.3,150
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,71.4,53.1 to 84.6,60
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,77.7,63.8 to 87.3,101
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2016,Age,19 Months,77.3,67.7 to 84.7,162
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,19 Months,78.4,70.3 to 84.7,222
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,83.8,73.9 to 91.5,150
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,97.6,92.2 to 99.6,41
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,91.6,83.2 to 96.8,60
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,94.7,90.1 to 97.6,101
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017,Age,24 Months,91.8,81.1 to 97.7,60
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,24 Months,95.4,89.6 to 98.5,101
PCV,≥4 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,24 Months,74.6,64.5 to 83.7,150
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016,Age,35 Months,90.9,83.6 to 95.9,162
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2016-2017,Age,35 Months,91.2,85.6 to 95.3,222
≥1 Dose MMR,,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,96.6,91.0 to 99.2,41
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Tarrant County,2016,Age,0-2 Days,72.8,62.1 to 81.3,162
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Tarrant County,2016-2017,Age,0-2 Days,69.4,60.1 to 77.4,222
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Tarrant County,2017,Age,0-2 Days,61.6,43.1 to 77.3,60
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Tarrant County,2017-2018,Age,0-2 Days,71.5,57.1 to 82.5,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017,Age,35 Months,91.6,83.2 to 96.8,60
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2017-2018,Age,35 Months,95.8,91.0 to 98.5,101
PCV,≥3 Doses,States/Local Areas,TX-Tarrant County,2014-2015,Age,13 Months,83.6,73.2 to 90.4,150
Hep B,≥3 Doses,States/Local Areas,TX-Tarrant County,2018,Age,24 Months,99.1,96.6 to 99.9,41
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2016,Age,7 Months,88.7,78.9 to 94.3,162
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2016-2017,Age,7 Months,90.9,83.7 to 95.1,222
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2017,Age,7 Months,96.0,86.5 to 98.9,60
Hep B,≥2 Doses,States/Local Areas,TX-Tarrant County,2017-2018,Age,7 Months,97.5,92.8 to 99.2,101
≥1 Dose Varicella,,States/Local Areas,TX-Tarrant County,2014-2015,Age,35 Months,84.4,73.0 to 92.8,150
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Tarrant County,2014-2015,Age,0-2 Days,85.6,76.6 to 91.5,150
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.6,59.9 to 87.2,86
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,92.0,88.3 to 95.7,335
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.6,93.6 to 99.6,166
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.4,89.2 to 99.6,86
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,93.7,89.7 to 97.7,286
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,80.9,65.2 to 96.6,34
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,99.0,97.1 to 100.0,42
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,88.4,84.0 to 92.8,311
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,77.1,70.9 to 83.3,311
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,63.6,44.8 to 82.4,34
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,75.1,62.2 to 88.1,42
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.4,81.5 to 99.3,86
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,96.8,93.0 to 100.0,42
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.4,91.3 to 99.5,166
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,87.5,73.8 to 100.0,42
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,75.5,69.5 to 81.5,311
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,71.9,54.1 to 89.7,34
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,85.8,75.3 to 96.3,42
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,95.5,92.2 to 98.8,286
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,90.4,86.3 to 94.4,311
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,84.1,70.7 to 97.4,34
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,89.6,85.0 to 94.1,311
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,90.6 to 98.5,166
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,86.6,74.0 to 99.2,34
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,96.3,90.5 to 100.0,42
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,91.7,87.9 to 95.4,335
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.0,94.1 to 99.9,166
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.4,89.2 to 99.6,86
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.2,82.7 to 97.6,86
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,90.2,84.4 to 94.5,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,13 Months,93.4,84.4 to 97.4,126
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,93.3,88.2 to 96.3,339
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2021,Age,0-2 Days,83.5,72.2 to 90.8,126
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,3 Months,84.5,77.3 to 89.6,339
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,70.7,61.1 to 78.7,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,70.7,61.2 to 78.6,213
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,3 Months,82.4,73.1 to 89.0,213
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,3 Months,81.7,72.5 to 88.3,213
Rotavirus,,States/Local Areas,TX-City of Houston,2019-2020,Age,8 Months,74.0,67.6 to 79.6,409
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,5 Months,86.9,78.5 to 92.4,213
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,3 Months,82.1,72.8 to 88.7,213
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,5 Months,80.8,72.1 to 87.3,213
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,5 Months,81.6,72.9 to 88.0,213
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,5 Months,81.3,72.5 to 87.7,213
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,3 Months,92.0,84.5 to 96.1,213
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,3 Months,83.7,74.3 to 90.0,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,24 Months,87.2,80.0 to 92.7,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,56.1,46.7 to 65.9,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,90.6,83.9 to 95.3,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,81.3,73.2 to 88.1,213
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2020,Age,0-3 Days,75.9,67.0 to 83.1,213
Rotavirus,,States/Local Areas,TX-City of Houston,2020,Age,8 Months,73.3,63.7 to 81.1,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020,Age,24 Months,87.3,80.0 to 93.0,213
Influenza,,States/Local Areas,TX-City of Houston,2020,Age,24 Months,58.1,49.0 to 67.5,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,89.8,82.2 to 94.4,213
Combined 7 Series,,States/Local Areas,TX-City of Houston,2020,Age,24 Months,70.8,61.9 to 79.3,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020,Age,19 Months,85.6,77.3 to 91.2,213
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,88.9,80.7 to 93.9,213
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,70.7,61.3 to 78.6,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,90.5,82.9 to 94.9,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,72.2,62.6 to 80.1,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,87.6,79.4 to 92.9,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020,Age,13 Months,65.8,56.3 to 74.2,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,87.3,79.1 to 92.6,213
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,91.5,83.8 to 95.7,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020,Age,13 Months,87.3,79.2 to 92.6,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,86.4,78.3 to 91.8,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,91.4,84.7 to 95.9,213
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,91.5,84.0 to 95.7,213
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,80.3,71.7 to 86.8,213
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,89.5,81.8 to 94.2,213
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,81.0,71.2 to 89.1,213
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,90.2,83.0 to 95.2,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020,Age,19 Months,86.3,78.0 to 91.8,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,91.5,85.0 to 96.0,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2020,Age,19 Months,78.2,69.6 to 84.9,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,87.3,79.1 to 92.6,213
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2020,Age,35 Months,89.5,81.9 to 94.9,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020,Age,19 Months,90.3,82.6 to 94.8,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2020,Age,35 Months,84.3,75.6 to 91.2,213
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,90.7,83.7 to 95.6,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,90.9,84.2 to 95.5,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020,Age,35 Months,91.3,84.7 to 95.8,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,90.9,84.2 to 95.5,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020,Age,35 Months,88.4,80.8 to 93.9,213
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,90.0,82.8 to 95.0,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020,Age,24 Months,86.6,79.3 to 92.4,213
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,76.1,67.2 to 84.0,213
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,5 Months,81.8,72.9 to 88.2,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,24 Months,91.5,85.0 to 96.0,213
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,89.8,81.7 to 94.6,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020,Age,7 Months,72.1,62.5 to 80.0,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,70.7,61.1 to 78.7,213
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,89.5,81.4 to 94.3,213
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,7 Months,89.6,81.4 to 94.4,213
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2020,Age,0-1 Days,72.5,63.5 to 79.9,213
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2020,Age,0-2 Days,74.3,65.3 to 81.6,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,19 Months,35.1,26.8 to 44.4,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2020,Age,19 Months,82.8,74.3 to 88.9,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,35 Months,73.9,63.7 to 83.1,213
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2020,Age,13 Months,68.9,59.3 to 77.2,213
Combined 7 Series,,States/Local Areas,TX-City of Houston,2020,Age,35 Months,76.3,66.1 to 85.2,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,88.6,83.9 to 92.4,409
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,80.4,72.8 to 87.0,409
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,55.1,48.4 to 62.2,409
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,93.2,89.0 to 96.2,409
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,90.2,85.5 to 93.9,409
Influenza,,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,60.7,54.2 to 67.3,409
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,91.1,86.5 to 94.6,409
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,90.3,85.1 to 93.8,409
Combined 7 Series,,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,74.3,67.2 to 80.9,409
Hib,Full Series,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,76.9,71.0 to 82.0,409
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,86.2,80.7 to 90.4,409
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,85.1,79.5 to 89.3,409
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,80.0,74.0 to 84.8,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,88.8,83.6 to 92.5,409
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-City of Houston,2019-2020,Age,0-1 Days,73.9,67.7 to 79.2,409
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,84.5,79.0 to 88.8,409
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-City of Houston,2019-2020,Age,0-2 Days,75.7,69.5 to 80.9,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,69.5,62.8 to 75.5,409
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,69.3,62.6 to 75.3,409
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,87.2,82.1 to 91.4,409
Hib,Full Series,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,79.0,73.4 to 84.1,409
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,80.7,75.1 to 85.8,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,89.7,84.9 to 93.5,409
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,87.1,82.0 to 91.3,409
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,32.3,26.5 to 38.8,409
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,85.1,79.5 to 89.3,409
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,90.2,85.2 to 93.6,409
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,89.3,84.2 to 92.9,409
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,90.5,85.4 to 94.4,409
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,90.3,85.7 to 94.0,409
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,91.1,86.5 to 94.6,409
Hib,Full Series,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,84.7,78.4 to 89.9,409
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,90.9,85.4 to 95.0,409
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,89.4,84.4 to 93.4,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,91.8,86.6 to 95.6,409
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,83.1,77.4 to 88.2,409
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,90.0,85.2 to 93.7,409
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,76.6,70.6 to 82.2,409
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,91.2,86.7 to 94.7,409
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,87.0,81.9 to 91.1,409
PCV,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,3 Months,83.9,78.0 to 88.5,409
Hep B,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,3 Months,92.0,87.3 to 95.0,409
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,5 Months,80.7,74.8 to 85.5,409
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,86.9,81.4 to 91.0,409
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,5 Months,80.8,74.9 to 85.5,409
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,5 Months,80.6,74.7 to 85.4,409
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,69.9,63.2 to 75.8,409
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,91.6,86.6 to 94.8,409
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,91.5,84.0 to 95.6,213
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,84.4,78.7 to 88.8,409
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,91.6,86.7 to 94.9,409
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020,Age,13 Months,87.9,79.7 to 93.0,213
Hib,Primary Series,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,87.2,82.0 to 91.1,409
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,5 Months,85.9,80.3 to 90.1,409
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,5 Months,79.8,73.8 to 84.7,409
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,90.4,85.2 to 93.9,409
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,71.4,64.7 to 77.2,409
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,85.1,79.5 to 89.4,409
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,91.1,86.0 to 94.4,409
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,86.1,80.5 to 90.3,409
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2019-2020,Age,13 Months,64.3,57.6 to 70.4,409
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,91.2,86.7 to 94.7,409
Combined 7 Series,,States/Local Areas,TX-City of Houston,2019-2020,Age,24 Months,68.1,61.8 to 74.3,409
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,83.8,76.9 to 89.6,409
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,35 Months,90.5,85.7 to 94.2,409
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,70.6,64.1 to 76.3,409
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,90.3,85.3 to 93.7,409
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,19 Months,89.1,83.8 to 92.7,409
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2019-2020,Age,7 Months,70.1,63.7 to 75.9,409
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,3 Months,83.5,77.6 to 88.1,409
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2019-2020,Age,0-3 Days,76.5,70.3 to 81.7,409
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,3 Months,83.5,77.6 to 88.0,409
Polio,≥1 Dose,States/Local Areas,TX-City of Houston,2019-2020,Age,3 Months,83.4,77.5 to 88.0,409
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,73.9,66.2 to 81.0,339
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,87.2,81.7 to 92.8,286
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,90.4 to 98.7,166
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,75.9,68.6 to 83.2,311
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,89.6,83.7 to 95.4,286
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,36.5,17.2 to 55.7,34
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.0,57.0 to 81.0,86
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,77.9 to 99.3,86
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,78.9,73.4 to 84.4,335
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,65.2 to 90.9,86
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,87.8,75.4 to 100.0,34
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,99.0,97.1 to 100.0,42
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,93.8,89.5 to 98.1,286
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,90.3,85.9 to 94.7,311
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,94.1,87.0 to 100.0,42
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,77.1 to 99.1,86
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,92.0,84.6 to 99.4,42
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,79.6,75.5 to 83.7,673
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,54.9,48.5 to 61.4,335
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,92.5,89.9 to 95.1,673
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,90.5,85.7 to 95.3,202
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,91.9,89.2 to 94.6,673
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,74.7,68.5 to 81.0,302
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,91.1,88.2 to 94.1,673
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,90.5,86.1 to 94.9,302
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,87.2,79.7 to 94.7,169
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,90.8,83.6 to 98.0,202
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,89.3,85.0 to 93.6,302
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,60.2,55.4 to 65.0,673
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,92.5,87.7 to 97.3,169
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,83.4,74.9 to 92.0,169
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,82.5,77.2 to 87.8,302
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,81.2,76.4 to 86.1,673
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,71.2,66.6 to 75.7,673
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,82.2,78.4 to 86.1,673
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,91.0,87.9 to 94.1,673
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,88.7,84.3 to 93.1,302
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,91.5,88.5 to 94.4,673
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,98.1,96.4 to 99.8,202
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,76.9,72.8 to 81.1,673
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,85.4,77.9 to 92.8,202
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,92.8,88.0 to 97.5,169
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,68.5,59.7 to 77.3,169
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,97.1,94.7 to 99.4,202
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,89.7,83.7 to 95.6,169
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,66.8,60.1 to 73.4,302
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,79.9,75.8 to 84.0,673
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,98.1,96.4 to 99.8,202
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,82.2,78.4 to 86.1,673
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,71.2,66.6 to 75.7,673
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.9 to 95.1,673
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,90.7,87.9 to 93.6,673
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,93.9,89.4 to 96.9,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,93.3,88.7 to 96.5,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,79.9,75.8 to 84.0,673
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,91.1,88.2 to 94.1,673
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,87.9 to 94.1,673
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,76.9,72.8 to 81.1,673
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,60.2,55.4 to 65.0,673
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,83.3,79.7 to 87.0,673
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,91.9,89.2 to 94.6,673
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,76.9,68.9 to 84.9,169
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,71.7,65.4 to 77.9,302
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,91.5,88.5 to 94.4,673
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,84.3,77.4 to 91.2,169
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,94.5,90.7 to 98.3,202
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,82.6,74.3 to 90.9,202
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,81.3,73.9 to 88.7,169
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,77.1,69.7 to 84.5,302
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,95.9,92.1 to 99.6,202
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,91.0,86.9 to 95.1,302
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,93.0,90.4 to 95.5,673
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,90.7,87.9 to 93.6,673
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,56.9,47.0 to 66.7,169
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,51.5,44.6 to 58.4,302
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,97.4,95.5 to 99.4,202
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,89.2,83.0 to 95.4,169
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,90.2,85.7 to 94.7,302
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,90.1,85.7 to 94.6,302
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,92.1,87.3 to 97.0,169
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,95.1,92.1 to 98.0,202
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,88.8,82.6 to 95.0,169
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,91.2,84.5 to 97.9,202
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,90.4,86.2 to 94.5,302
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Poverty,133% to <400% FPL,81.4,74.1 to 88.7,169
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,74.8,68.7 to 80.9,302
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,97.1,95.2 to 99.1,202
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Poverty,<133% FPL,78.7,73.0 to 84.4,302
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Overall,Overall,83.3,79.7 to 87.0,673
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,91.0,87.0 to 95.0,311
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Poverty,>400% FPL,86.9,80.6 to 93.1,202
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,68.3,61.7 to 74.8,311
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,69.0,55.2 to 82.9,42
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,90.2,86.2 to 94.1,335
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.7,50.7 to 80.6,86
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.1,94.2 to 100.0,166
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.5,80.7 to 98.3,86
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.4,79.8 to 100.0,86
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,90.3 to 98.7,166
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,78.6,71.7 to 85.6,286
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.3,74.5 to 92.2,166
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.6,56.1 to 79.1,86
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,67.7 to 94.0,86
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.4,66.0 to 86.8,86
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,81.5,76.2 to 86.8,311
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,81.2,74.6 to 87.7,286
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.1,80.2 to 98.0,86
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,90.3,78.9 to 100.0,42
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,87.1,72.2 to 100.0,34
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,91.1,87.3 to 94.8,335
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,75.2 to 98.9,86
≥1 Dose Varicella,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,94.9,91.1 to 98.6,286
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,87.8,75.4 to 100.0,34
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,95.9,92.8 to 99.1,286
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.7,70.1 to 93.2,86
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,99.0,97.1 to 100.0,42
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,89.6,85.4 to 93.9,286
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,58.8,39.5 to 78.1,34
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Private Insurance Only,81.6,75.3 to 87.9,286
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,67.0 to 92.6,86
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,51.0,44.3 to 57.7,311
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,50.7,31.5 to 69.9,42
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,85.9,81.3 to 90.5,335
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.1,82.0 to 96.2,166
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,79.3,53.4 to 100.0,34
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,87.4,74.9 to 99.9,42
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,69.1,62.8 to 75.4,311
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.6,67.4 to 87.9,86
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Other,83.3,72.6 to 94.1,42
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,74.1,56.7 to 91.5,34
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",60.8,48.3 to 73.2,86
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.8,72.7 to 88.9,166
Combined 7 Series,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,73.0,67.1 to 79.0,335
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,90.0,78.2 to 100.0,34
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,80.8,65.0 to 96.5,34
Rotavirus,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,77.3,71.8 to 82.7,335
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Uninsured,72.2,55.0 to 89.5,34
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,Hispanic,83.0,78.1 to 87.9,335
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.2,67.7 to 88.7,86
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,87.8 to 97.3,166
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.6,73.7 to 89.6,166
Influenza,,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",48.2,35.1 to 61.3,86
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.1,94.2 to 100.0,166
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.4,89.2 to 99.6,86
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Insurance Coverage,Any Medicaid,89.9,85.8 to 94.1,311
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,30.1,22.5 to 38.9,196
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,54.0,44.2 to 64.6,213
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,30.8,23.4 to 39.4,223
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,32.7,26.3 to 39.9,334
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,95.6,90.7 to 98.3,168
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,92.8,88.7 to 95.9,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,90.5,83.9 to 95.2,171
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,90.6,86.2 to 94.1,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,69.9,64.0 to 75.2,205
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,69.9,64.3 to 75.1,359
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,70.0,59.9 to 78.5,154
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,70.3,63.0 to 76.7,295
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,70.5,64.7 to 75.7,141
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,71.6,64.3 to 77.9,309
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,29.5,21.5 to 39.0,171
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,30.2,24.6 to 36.4,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,96.7,94.3 to 99.2,203
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,90.9,86.9 to 95.0,296
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,24 Months,91.3,84.4 to 95.9,171
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,91.1,86.7 to 94.5,394
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,24 Months,89.9,83.1 to 94.8,196
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,35 Months,90.7,80.4 to 96.9,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,24 Months,90.9,85.0 to 95.2,223
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,90.3,86.0 to 93.8,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,100.0,,32
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,90.8,83.8 to 95.6,196
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,94.4,89.6 to 97.5,223
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,92.7,88.6 to 95.7,419
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,5 Months,84.2,75.5 to 90.2,141
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,5 Months,81.2,75.2 to 86.1,309
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,5 Months,78.1,69.1 to 85.1,168
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,5 Months,77.2,71.0 to 82.4,339
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,24 Months,89.4,82.4 to 94.5,154
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,91.8,87.5 to 95.1,295
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,24 Months,93.7,87.9 to 97.3,141
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,92.6,88.2 to 95.8,309
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,24 Months,90.8,84.0 to 95.5,168
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,91.2,86.6 to 94.7,339
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,5 Months,80.9,72.4 to 87.2,154
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,5 Months,82.6,78.1 to 86.3,295
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,93.8,89.0 to 97.0,244
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,96.8,92.6 to 98.9,141
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,96.5,93.1 to 98.5,309
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,30.1,16.9 to 47.7,141
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,28.9,22.7 to 36.0,309
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,27.6,20.1 to 36.7,168
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,28.6,22.9 to 35.0,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,94.5,88.9 to 97.8,205
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,92.8,88.8 to 95.8,359
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,90.8,84.4 to 95.3,154
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,93.8,90.2 to 96.4,295
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,5 Months,75.6,71.0 to 79.7,205
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,5 Months,78.3,73.5 to 82.5,359
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,5 Months,77.0,73.4 to 80.2,244
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,5 Months,72.8,64.6 to 79.6,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,99.3,96.5 to 99.9,141
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,98.6,96.5 to 99.5,309
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,97.3,93.6 to 99.1,168
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,94.4,90.6 to 97.0,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,91.6,85.4 to 95.9,171
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,93.0,89.2 to 95.8,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,76.4,67.7 to 83.4,244
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,23.8,16.6 to 32.8,154
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,27.0,21.1 to 33.9,295
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,67.7,64.6 to 70.7,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,24 Months,89.7,83.7 to 94.2,244
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,19 Months,85.5,77.3 to 91.1,196
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,24 Months,85.8,77.7 to 92.1,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,24 Months,88.3,82.1 to 93.1,205
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,88.9,84.4 to 92.6,359
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,89.5,82.3 to 94.7,196
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,90.5,83.9 to 95.2,171
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,90.6,86.2 to 94.1,394
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,90.7,84.3 to 95.2,223
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,90.1,85.5 to 93.7,419
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,31.6,25.2 to 38.8,205
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,27.5,23.9 to 31.5,359
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,19 Months,27.6,24.1 to 31.4,244
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,5 Months,79.4,70.5 to 86.2,196
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,19 Months,22.5,18.5 to 27.2,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,90.3,83.2 to 95.3,154
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,95.4,91.7 to 97.7,295
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,97.2,92.3 to 99.3,205
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,94.0,90.0 to 96.8,359
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,94.1,89.6 to 97.2,244
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,95.4,88.0 to 98.8,213
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,93.5,85.0 to 97.3,126
≥1 Dose MMR,,States/Local Areas,TX-City of Houston,2021,Age,35 Months,88.8,79.6 to 95.1,126
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,92.1,81.3 to 96.9,126
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,79.6,75.5 to 83.7,673
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,90.4 to 95.5,673
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2019,Urbanicity,Living In a MSA Principal City,81.2,76.4 to 86.1,673
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,95.0,87.4 to 98.7,213
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,19 Months,87.5,80.9 to 92.0,223
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,87.9,82.2 to 92.0,334
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,19 Months,85.7,77.3 to 91.3,171
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,86.6,81.5 to 90.4,394
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,19 Months,87.3,79.3 to 92.6,168
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,86.5,81.0 to 90.6,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,62.7,49.3 to 74.4,126
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,92.1,80.7 to 97.0,126
PCV,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,97.1,94.5 to 98.7,126
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,78.5 to 99.8,86
Polio,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,89.1,77.3 to 95.1,126
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,91.5,86.1 to 95.4,339
Hep B,≥2 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,92.7,87.5 to 95.8,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,19 Months,92.6,87.5 to 95.8,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,35 Months,92.5,82.8 to 97.8,126
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,7 Months,71.9,58.4 to 82.3,126
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,5 Months,79.7,67.1 to 88.3,126
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,3 Months,89.8,84.2 to 93.6,205
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,3 Months,85.2,82.3 to 87.7,359
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,3 Months,80.9,72.2 to 87.4,154
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,3 Months,86.0,80.2 to 90.2,295
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,3 Months,90.8,82.0 to 95.5,141
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,3 Months,91.2,85.9 to 94.7,309
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2016,Age,3 Months,91.7,84.0 to 95.9,168
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2016-2017,Age,3 Months,89.8,84.8 to 93.3,339
Combined 7 Series,,States/Local Areas,TX-City of Houston,2021,Age,35 Months,70.8,53.5 to 86.1,126
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,3 Months,84.3,78.1 to 89.0,244
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,3 Months,87.2,82.1 to 91.0,213
Hib,≥1 Dose,States/Local Areas,TX-City of Houston,2021,Age,3 Months,86.1,74.6 to 92.9,126
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,78.2 to 99.8,86
Hib,Primary Series,States/Local Areas,TX-City of Houston,2021,Age,7 Months,65.5,52.1 to 76.8,126
Hib,≥2 Doses,States/Local Areas,TX-City of Houston,2021,Age,5 Months,74.9,61.7 to 84.6,126
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,35 Months,88.8,77.1 to 96.1,339
PCV,≥4 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,81.3,74.5 to 87.2,339
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2021,Age,19 Months,91.2,81.5 to 96.0,126
Hib,Primary Series,States/Local Areas,TX-City of Houston,2020-2021,Age,24 Months,93.0,88.4 to 96.3,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,94.4,89.6 to 97.5,223
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,92.7,88.6 to 95.7,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,91.6,85.4 to 95.9,171
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,93.0,89.2 to 95.8,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,92.7,85.9 to 97.0,168
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,92.1,87.7 to 95.4,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,92.0,89.3 to 94.8,560
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,89.9,85.8 to 93.9,319
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,94.7,90.4 to 99.0,107
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,96.6,93.6 to 99.6,134
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,5 Months,83.8,75.9 to 89.5,223
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,5 Months,81.7,75.9 to 86.3,419
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2016,Age,5 Months,80.5,71.5 to 87.2,168
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,5 Months,80.9,75.1 to 85.7,339
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,5 Months,81.4,73.1 to 87.6,171
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,5 Months,82.6,77.1 to 87.0,394
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,96.8,92.6 to 98.9,141
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,94.4,90.7 to 97.0,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,92.1,85.5 to 96.4,168
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,91.3,86.8 to 94.7,339
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,90.8,83.8 to 95.6,196
Hep B,≥3 Doses,States/Local Areas,TX-City of Houston,2020-2021,Age,13 Months,89.2,83.4 to 93.1,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2021,Age,19 Months,94.8,85.7 to 98.2,126
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,90.8,84.4 to 95.3,154
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,93.8,90.2 to 96.4,295
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,19 Months,87.4,79.3 to 92.6,154
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,87.6,82.0 to 91.6,295
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2015,Age,19 Months,87.8,85.4 to 89.9,141
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,87.6,82.0 to 91.6,309
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2018,Age,3 Months,88.0,80.3 to 92.9,223
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2018-2019,Age,3 Months,86.1,80.7 to 90.2,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,97.2,92.9 to 99.2,141
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,94.9,91.1 to 97.5,309
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2017,Age,3 Months,87.8,80.1 to 92.8,171
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2017-2018,Age,3 Months,87.9,82.8 to 91.6,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,90.3,83.2 to 95.3,154
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,93.7,89.7 to 96.5,295
DTaP,≥1 Dose,States/Local Areas,TX-City of Houston,2019,Age,3 Months,84.2,75.6 to 90.2,196
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2011,Age,19 Months,83.6,75.2 to 89.5,213
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,95.4,90.3 to 98.2,205
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,92.8,88.7 to 95.9,359
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2012,Age,19 Months,86.9,84.4 to 89.0,244
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,19 Months,84.3,81.7 to 86.6,205
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,85.9,82.1 to 89.0,359
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,86.1,76.0 to 92.4,137
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,87.3,77.9 to 93.0,178
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,86.5,76.2 to 92.7,118
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,86.3,79.4 to 91.1,255
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,88.0,60.2 to 97.3,41
Hib,Full Series,States/Local Areas,TX-City of Houston,2021,Age,19 Months,65.7,52.3 to 77.0,126
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,76.8,66.4 to 84.7,137
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,80.0,70.6 to 86.9,178
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,79.5,68.6 to 87.3,118
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,77.9,70.6 to 83.9,255
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,91.5,86.5 to 94.7,287
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,89.5,60.1 to 98.0,41
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,78.6,71.8 to 85.3,209
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,72.2,63.2 to 81.3,125
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,78.6,70.4 to 86.8,130
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,86.8,81.0 to 91.0,287
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,96.0,92.4 to 99.5,125
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,90.8,84.9 to 96.8,130
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,94.2,91.3 to 97.1,331
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.4,88.7 to 98.2,132
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,77.4,72.8 to 82.0,464
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,79.7,74.6 to 84.8,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.1,62.6 to 81.6,133
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.3,64.6 to 82.0,132
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,64.1 to 88.2,48
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,82.1,75.8 to 88.5,214
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,88.9,83.3 to 92.7,287
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,83.5,73.2 to 90.3,137
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,85.2,75.8 to 91.4,178
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,83.5,72.8 to 90.5,118
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,83.5,76.4 to 88.8,255
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,91.8,83.2 to 96.2,137
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,93.8,87.5 to 97.1,178
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,99.0,95.1 to 99.8,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,90.5,85.9 to 95.0,209
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,91.6,88.6 to 94.7,464
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.7,78.3 to 93.1,133
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,65.1,53.2 to 75.3,118
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,68.5,60.7 to 75.4,255
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,71.4,64.8 to 77.2,287
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,88.9,80.4 to 94.9,137
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,91.8,85.4 to 96.1,178
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,68.6,62.0 to 74.6,287
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,99.0,96.1 to 99.8,41
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,56.2,44.6 to 67.1,118
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,60.5,52.6 to 67.9,255
Polio,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,3 Months,81.7,70.8 to 89.2,137
Polio,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,3 Months,82.5,72.2 to 89.5,178
Polio,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,3 Months,84.3,55.7 to 95.8,41
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,91.6,86.4 to 94.9,287
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,88.8,78.9 to 94.4,118
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,90.5,84.6 to 94.3,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.9,70.3 to 99.5,48
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,93.4,89.8 to 97.0,214
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.1,82.3 to 99.9,70
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,91.5,87.1 to 96.0,214
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,93.7,89.8 to 97.5,195
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,63.7,53.0 to 73.2,137
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,63.5,53.1 to 72.7,178
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,62.9,38.4 to 82.2,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,93.2,86.0 to 100.0,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2018,Age,0-3 Days,84.5,59.6 to 95.3,41
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,74.4,67.5 to 81.3,195
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,87.3,77.2 to 97.4,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,76.9,70.1 to 83.7,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.3,56.5 to 82.0,70
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,77.8,51.2 to 92.1,41
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,71.1,60.4 to 79.8,137
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,73.0,62.9 to 81.1,178
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2013,Age,0-3 Days,NA,,
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,86.9,83.1 to 90.7,464
PCV,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,3 Months,84.3,55.7 to 95.8,41
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2014-2015,Age,0-3 Days,76.6,70.5 to 81.7,287
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,84.4,74.9 to 90.8,137
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,86.1,77.1 to 91.9,178
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,83.8,73.2 to 90.7,118
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,84.1,77.4 to 89.2,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,83.2,72.0 to 91.8,118
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,86.9,80.0 to 92.3,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,94.0,89.8 to 96.8,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016,Age,0-3 Days,80.8,70.7 to 88.1,118
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2017,Age,0-3 Days,79.3,72.6 to 84.7,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2017,Age,0-3 Days,78.5,67.9 to 86.3,119
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2017-2018,Age,0-3 Days,80.0,71.2 to 86.6,178
Polio,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,3 Months,84.4,73.6 to 91.4,118
Polio,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,3 Months,82.9,75.4 to 88.4,255
Polio,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,3 Months,88.2,83.0 to 92.0,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,84.3,78.3 to 90.2,209
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,87.8,80.6 to 94.9,125
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,91.8,86.7 to 97.0,130
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,90.1,59.5 to 98.2,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,99.0,96.1 to 99.8,41
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,87.0 to 94.2,331
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.5,78.2 to 92.8,132
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.2,69.0 to 87.4,133
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,67.6 to 94.3,48
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,88.2,82.8 to 93.7,214
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.5,73.5 to 89.5,132
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.3,51.0 to 81.7,48
PCV,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,3 Months,82.4,76.6 to 87.0,287
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,5 Months,69.9,59.1 to 78.9,137
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,5 Months,72.3,62.1 to 80.6,178
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,5 Months,78.3,51.6 to 92.4,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,80.7,70.0 to 89.4,118
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,85.1,78.6 to 90.5,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,88.4,80.1 to 94.3,137
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,91.4,85.2 to 95.7,178
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2011,Age,0-3 Days,NA,,
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,85.4,79.8 to 91.1,214
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2012,Age,0-3 Days,NA,,
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,80.2,74.8 to 85.7,331
PCV,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,3 Months,82.8,72.5 to 89.8,137
PCV,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,3 Months,83.3,73.3 to 90.0,178
PCV,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,3 Months,82.8,71.3 to 90.3,118
PCV,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,3 Months,82.8,75.5 to 88.3,255
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,92.1,84.5 to 99.7,30
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,88.6,83.0 to 94.2,195
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,79.5,74.8 to 84.1,464
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.7,68.5 to 86.8,133
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,75.7,66.5 to 84.8,130
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,77.9,71.1 to 84.7,209
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,88.8,82.6 to 95.1,125
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.7,78.9 to 96.5,70
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,88.9,83.5 to 92.7,287
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,5 Months,79.9,73.6 to 85.0,287
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,5 Months,71.5,60.2 to 80.6,118
Hib,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,5 Months,70.6,62.8 to 77.3,255
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,82.1,75.8 to 88.4,214
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.8,63.5 to 88.1,70
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,77.5,70.8 to 84.1,214
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,81.0,60.4 to 100.0,30
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,84.7,78.9 to 90.6,195
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,94.0,89.8 to 96.8,287
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,87.6,82.5 to 92.7,209
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,89.1,85.6 to 92.5,464
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.4,78.1 to 92.6,133
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,93.6,88.7 to 98.5,125
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,88.7,81.8 to 95.6,130
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,90.1,67.9 to 99.1,41
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,75.7,62.1 to 87.3,118
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,77.2,66.6 to 86.3,255
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,74.5,63.6 to 84.2,137
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,78.6,69.2 to 86.6,178
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,88.5,83.5 to 93.5,209
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,89.1,85.5 to 92.7,464
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.8,80.9 to 94.7,133
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,89.6,85.5 to 93.8,331
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.7,81.5 to 95.9,132
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.6,66.3 to 93.0,48
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,85.2,67.9 to 100.0,30
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017,Age,35 Months,84.7,75.1 to 92.1,137
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,89.0,81.6 to 94.3,178
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2018,Age,35 Months,98.0,94.0 to 99.6,41
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,89.7,80.6 to 94.8,137
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,92.4,85.6 to 96.1,178
Hib,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,3 Months,85.5,75.3 to 91.9,137
Hib,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,3 Months,85.0,75.1 to 91.5,178
Hib,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,3 Months,82.1,71.0 to 89.6,118
Hib,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,3 Months,84.1,76.9 to 89.3,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,79.9,68.1 to 88.1,118
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,84.8,77.8 to 89.9,255
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,89.5,79.3 to 95.0,118
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,89.7,83.4 to 93.7,255
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,99.0,95.1 to 99.8,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,88.4,79.1 to 93.8,137
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,88.9,79.9 to 94.1,178
Hib,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,3 Months,83.9,55.7 to 95.6,41
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,88.7,82.0 to 93.7,287
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,90.7,85.7 to 95.7,195
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,90.0,85.5 to 94.5,214
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.3,66.1 to 92.6,48
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,89.9,85.1 to 94.7,214
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.9,81.8 to 98.0,70
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,95.8,92.6 to 97.6,287
Hib,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,3 Months,86.6,81.1 to 90.7,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,85.8,76.7 to 92.7,118
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,83.9,77.4 to 89.4,255
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,82.6,73.3 to 90.2,137
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,87.3,80.1 to 92.9,178
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,90.1,67.9 to 99.1,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,79.0,67.3 to 87.3,118
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,81.4,73.9 to 87.0,255
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,89.1,84.1 to 93.0,287
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,83.1,72.8 to 90.0,137
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,85.1,75.7 to 91.3,178
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,90.1,59.5 to 98.2,41
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,69.0,57.7 to 79.8,118
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,71.2,63.6 to 78.4,255
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,72.8,62.6 to 82.0,137
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,77.7,68.7 to 85.6,178
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,95.4,90.2 to 98.3,287
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016,Age,35 Months,85.0,75.3 to 92.3,118
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,84.5,78.0 to 90.0,255
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2018,Age,35 Months,99.0,96.1 to 99.8,41
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,90.8,86.5 to 95.2,214
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,91.1,86.0 to 96.2,195
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,84.1,66.8 to 100.0,30
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.1,78.9 to 97.4,70
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,89.0,82.0 to 95.9,130
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,90.4,82.7 to 98.1,125
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,90.6,86.7 to 94.4,331
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.0,84.4 to 97.5,132
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,99.0,96.1 to 99.8,41
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,91.2,86.3 to 94.5,287
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,91.4,86.7 to 96.1,214
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Dallas County,2014-2015,Age,0-2 Days,74.9,68.7 to 80.3,287
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,97.4,93.0 to 99.4,287
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,84.1,73.6 to 90.9,137
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,87.3,79.2 to 92.5,178
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,83.4,72.4 to 90.5,118
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,83.8,76.6 to 89.1,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,84.1,78.0 to 88.8,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,99.0,96.1 to 99.8,41
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017,Age,35 Months,83.2,73.2 to 91.0,137
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,88.3,80.6 to 94.0,178
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Dallas County,2017,Age,0-2 Days,78.0,68.6 to 85.3,137
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Dallas County,2017-2018,Age,0-2 Days,79.9,71.1 to 86.5,178
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Dallas County,2018,Age,0-2 Days,84.5,59.6 to 95.3,41
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,95.3,85.4 to 98.6,41
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Dallas County,2016,Age,0-2 Days,79.0,68.6 to 86.6,118
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Dallas County,2016-2017,Age,0-2 Days,78.4,71.7 to 84.0,255
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016,Age,35 Months,85.2,75.7 to 92.4,118
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,83.7,77.0 to 89.4,255
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2018,Age,24 Months,98.0,94.0 to 99.6,41
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,82.5,76.6 to 87.6,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,82.6,73.3 to 90.2,137
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,87.3,80.1 to 92.9,178
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017,Age,24 Months,82.0,72.4 to 89.8,137
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,87.6,80.0 to 93.3,178
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,91.5,87.4 to 94.7,287
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2018,Age,24 Months,99.0,96.1 to 99.8,41
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,64.6,52.7 to 75.0,118
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,68.6,60.7 to 75.6,255
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,73.8,67.2 to 79.5,287
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,69.1,58.5 to 78.0,137
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,70.6,60.5 to 78.9,178
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,63.1,51.4 to 73.5,118
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,66.6,58.8 to 73.6,255
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Dallas County,2018,Age,0-1 Days,84.3,59.6 to 95.1,41
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,91.8,87.4 to 94.7,287
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,74.1,48.8 to 89.6,41
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,87.8,83.0 to 91.8,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,85.5,76.4 to 92.4,118
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,83.8,77.3 to 89.3,255
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016,Age,24 Months,85.0,75.3 to 92.3,118
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,84.0,77.6 to 89.5,255
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017,Age,24 Months,83.5,74.4 to 90.8,137
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,88.2,81.1 to 93.6,178
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,71.5,60.7 to 80.3,137
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,76.8,67.2 to 84.3,178
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,86.4,60.2 to 96.4,41
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,74.5,46.1 to 100.0,30
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.2,60.1 to 86.3,70
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,77.5,70.8 to 84.2,214
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,77.8,70.1 to 85.6,195
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,81.0,58.0 to 95.8,41
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017,Age,19 Months,80.2,69.7 to 87.7,137
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,83.0,73.5 to 89.6,178
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hep B,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,3 Months,91.1,81.8 to 95.9,137
Hep B,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,3 Months,93.5,86.5 to 97.0,178
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,88.3,78.5 to 94.0,118
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,88.3,81.7 to 92.8,255
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016,Age,19 Months,84.3,74.0 to 91.0,118
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,81.9,74.8 to 87.4,255
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,76.5,69.4 to 83.6,214
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.6,70.3 to 88.9,132
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.8,59.1 to 88.4,48
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,76.3,71.3 to 81.4,464
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,79.4,73.7 to 85.1,331
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.3,59.0 to 79.6,133
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,86.6,81.3 to 90.5,287
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,74.9,67.6 to 82.2,209
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016,Age,19 Months,83.7,73.0 to 90.7,118
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,82.5,75.5 to 87.8,255
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,87.3,82.0 to 91.1,287
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,82.2,69.2 to 95.3,125
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,86.5,75.7 to 97.3,130
Hep B,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,3 Months,99.2,94.6 to 99.9,41
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,92.9,88.1 to 95.8,287
Influenza,,States/Local Areas,TX-Dallas County,2017,Age,24 Months,45.8,35.5 to 57.4,137
Influenza,,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,47.1,37.4 to 57.9,178
Influenza,,States/Local Areas,TX-Dallas County,2018,Age,24 Months,50.7,30.3 to 75.1,41
Influenza,,States/Local Areas,TX-Dallas County,2016,Age,24 Months,44.1,33.8 to 55.8,118
Influenza,,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,44.9,37.5 to 53.1,255
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,49.4,42.8 to 55.9,331
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.5,56.6 to 76.4,132
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,45.8,35.3 to 56.3,133
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,44.3,36.5 to 52.0,214
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",39.7,26.5 to 52.9,70
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",51.4,34.8 to 68.0,48
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,44.3,36.4 to 52.3,214
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,62.3,54.1 to 70.6,195
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,36.4,14.3 to 58.5,30
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,48.2,42.7 to 53.8,464
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,86.9,78.8 to 95.1,92
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,74.7,63.2 to 86.3,98
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,95.2,90.8 to 99.5,98
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,66.6,55.5 to 77.7,125
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,52.2,41.5 to 62.8,130
Influenza,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,40.4,32.6 to 48.1,209
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,84.7,76.2 to 93.1,98
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016,Age,24 Months,85.2,75.7 to 92.4,118
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,83.3,76.6 to 88.9,255
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2018,Age,19 Months,89.1,60.4 to 97.8,41
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017,Age,19 Months,81.5,71.6 to 88.6,137
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,83.7,74.6 to 90.0,178
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,87.3,79.7 to 94.9,125
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,71.4,61.5 to 81.2,130
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,62.9,56.0 to 69.2,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,83.7,73.2 to 90.7,118
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,82.9,76.0 to 88.1,255
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,5 Months,85.1,76.3 to 91.0,287
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,5 Months,81.4,70.4 to 88.9,118
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,5 Months,81.1,73.9 to 86.7,255
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,82.2,72.0 to 89.3,137
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,84.5,75.1 to 90.8,178
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Dallas County,2014-2015,Age,0-1 Days,69.3,62.8 to 75.1,287
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,88.3,78.3 to 94.1,137
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,91.4,83.8 to 95.6,178
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,13 Months,99.0,95.1 to 99.8,41
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017,Age,13 Months,55.1,44.3 to 65.4,137
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,62.6,52.5 to 71.8,178
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016,Age,13 Months,59.7,48.4 to 70.0,118
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,57.0,49.3 to 64.4,255
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2018,Age,13 Months,81.4,54.5 to 94.1,41
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,87.7,82.5 to 91.5,287
Hep B,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,3 Months,92.5,83.5 to 96.8,118
Hep B,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,3 Months,91.7,85.7 to 95.3,255
Hep B,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,3 Months,96.8,93.8 to 98.3,287
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.4,62.0 to 96.9,48
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Dallas County,2017,Age,0-1 Days,74.5,65.0 to 82.2,137
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Dallas County,2017-2018,Age,0-1 Days,77.3,68.5 to 84.3,178
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Dallas County,2016,Age,0-1 Days,77.6,67.2 to 85.4,118
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Dallas County,2016-2017,Age,0-1 Days,75.8,69.0 to 81.6,255
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,93.1,89.1 to 96.0,287
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,5 Months,80.9,70.5 to 88.2,137
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,5 Months,84.1,76.0 to 89.8,178
Hep B,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,5 Months,92.1,80.9 to 97.0,41
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,77.9,67.5 to 88.3,214
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,79.3,71.3 to 87.2,331
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,73.2,64.2 to 82.1,209
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,78.3,71.3 to 85.2,464
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.0,62.2 to 85.8,133
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,81.6,69.6 to 91.0,118
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,79.0,69.2 to 87.3,255
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,70.5,60.3 to 80.1,137
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,73.5,63.9 to 82.2,178
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,13 Months,80.6,70.3 to 87.9,137
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,82.3,72.9 to 88.9,178
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,13 Months,79.2,68.1 to 87.1,118
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,80.0,72.9 to 85.6,255
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,82.6,72.3 to 89.6,137
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,84.7,75.3 to 91.0,178
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,84.1,73.6 to 90.9,118
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,83.2,76.1 to 88.5,255
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,90.1,59.5 to 98.2,41
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,89.5,83.6 to 95.4,125
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,81.8,72.5 to 91.1,214
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,75.1,65.3 to 84.9,195
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.8,56.9 to 88.7,70
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,60.1,28.8 to 91.3,30
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2018,Age,13 Months,73.9,50.0 to 88.9,41
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,85.7,78.6 to 92.8,130
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,59.3,52.4 to 65.9,287
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,89.2,81.0 to 95.0,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,82.0,76.0 to 86.7,287
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,74.0,58.3 to 87.4,137
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,69.7,56.2 to 82.2,178
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,65.4,39.7 to 89.2,41
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,87.8,82.5 to 93.0,209
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,87.6,84.0 to 91.2,464
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,91.4,86.5 to 94.6,287
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,88.3,84.1 to 92.5,331
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.8,80.6 to 93.0,132
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,78.8 to 93.0,133
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,62.7 to 91.0,48
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017,Age,13 Months,50.6,40.0 to 61.2,137
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,57.3,47.2 to 66.8,178
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016,Age,13 Months,61.6,50.1 to 71.9,118
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,55.3,47.5 to 62.7,255
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,60.0,53.0 to 66.6,287
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,35 Months,96.6,89.5 to 99.4,41
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,90.6,86.1 to 95.1,214
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,86.0,80.1 to 91.9,195
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,5 Months,80.8,53.0 to 94.0,41
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,84.0,66.6 to 100.0,30
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.9,73.3 to 94.4,70
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,91.3,86.8 to 95.7,214
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,7 Months,58.4,47.6 to 68.3,137
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,56.8,46.6 to 66.4,178
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,7 Months,52.9,30.5 to 74.2,41
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,75.6,63.1 to 86.4,118
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,77.1,66.6 to 86.2,255
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,81.5,73.4 to 88.3,287
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,7 Months,51.9,40.6 to 63.0,118
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,55.6,47.9 to 63.1,255
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,79.2,73.0 to 84.7,287
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,71.1,59.8 to 81.5,118
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,71.0,63.3 to 78.4,255
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,42.8,23.3 to 69.0,41
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,59.8,53.0 to 66.2,287
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,5 Months,69.6,58.5 to 78.9,137
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,5 Months,72.8,62.4 to 81.2,178
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,5 Months,76.4,65.4 to 84.7,118
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,5 Months,72.5,64.6 to 79.2,255
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,35 Months,81.5,72.0 to 89.3,137
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,85.9,78.5 to 91.7,178
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,35 Months,85.1,75.2 to 92.6,118
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,83.9,76.9 to 89.7,255
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,50.4,39.1 to 62.8,118
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,42.7,35.1 to 51.2,255
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,36.5,26.6 to 48.6,137
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,38.4,28.9 to 49.8,178
Polio,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,5 Months,80.9,75.9 to 85.2,287
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,92.3,88.0 to 96.5,209
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,95.9,92.4 to 99.4,125
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,94.8,90.8 to 98.8,130
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,97.7,94.0 to 99.4,287
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,46.6,39.7 to 54.1,287
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,93.6,90.9 to 96.3,464
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,90.1,67.9 to 99.1,41
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,96.0,93.7 to 98.3,331
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.9,90.5 to 99.3,132
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.0,81.0 to 95.0,133
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.5,78.3 to 100.0,48
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,93.8,90.3 to 97.3,214
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.5,88.6 to 100.0,70
PCV,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,5 Months,80.8,53.0 to 94.0,41
PCV,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,5 Months,70.2,59.4 to 79.2,137
PCV,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,5 Months,73.3,63.1 to 81.5,178
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,66.7,55.9 to 76.1,137
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,70.5,60.3 to 79.0,178
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,59.3,47.6 to 69.9,118
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,63.6,55.6 to 70.9,255
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,79.8,52.7 to 93.4,41
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,70.5,60.3 to 80.1,137
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,73.5,63.9 to 82.2,178
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,81.0,58.0 to 95.8,41
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,89.4,80.3 to 95.4,118
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,88.0,81.4 to 93.1,255
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,86.8,77.4 to 93.7,137
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,90.3,83.2 to 95.3,178
DTaP,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,5 Months,81.5,76.6 to 85.5,287
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,94.6,90.5 to 97.3,287
Hib,Full Series,States/Local Areas,TX-Dallas County,2018,Age,24 Months,68.3,45.9 to 88.3,41
Hib,Full Series,States/Local Areas,TX-Dallas County,2017,Age,35 Months,71.4,60.5 to 81.6,137
Hib,Full Series,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,69.9,59.8 to 79.4,178
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,83.5,77.1 to 88.8,287
Hib,Full Series,States/Local Areas,TX-Dallas County,2016,Age,35 Months,81.6,68.8 to 91.5,118
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,78.7,67.9 to 87.8,255
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,92.6,88.6 to 96.6,214
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,93.0,85.7 to 100.0,30
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,95.3,92.2 to 98.5,195
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,99.0,96.1 to 99.8,41
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,77.3,70.7 to 83.9,214
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.3,65.0 to 89.6,70
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,78.3,70.7 to 86.0,195
Hib,Full Series,States/Local Areas,TX-Dallas County,2018,Age,35 Months,68.3,45.9 to 88.3,41
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,95.5,93.1 to 97.8,331
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.1,88.2 to 98.0,132
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.5,75.3 to 97.7,48
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,92.8,88.8 to 96.8,214
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,75.2,53.7 to 96.7,30
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.1,86.8 to 100.0,70
Influenza,,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,47.7,41.2 to 54.6,287
Rotavirus,,States/Local Areas,TX-Dallas County,2011,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Dallas County,2014,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2015,Age,8 Months,70.0,63.4 to 75.8,287
Rotavirus,,States/Local Areas,TX-Dallas County,2016,Age,8 Months,67.0,55.0 to 77.1,118
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2017,Age,8 Months,66.0,58.1 to 73.1,255
Rotavirus,,States/Local Areas,TX-Dallas County,2013,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Dallas County,2012,Age,8 Months,NA,,
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,69.7,62.3 to 77.1,214
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,68.6,61.4 to 75.8,214
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.1,61.0 to 85.2,70
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,76.8,69.5 to 84.0,195
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,64.8,43.0 to 86.5,30
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,68.6,61.5 to 75.8,209
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,70.1,65.1 to 75.2,464
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,65.1,55.3 to 74.9,133
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,66.4,56.2 to 76.6,130
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",51.0,34.5 to 67.5,48
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,72.2,66.3 to 78.1,331
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.7,70.3 to 87.0,132
Rotavirus,,States/Local Areas,TX-Dallas County,2018,Age,8 Months,87.3,60.4 to 96.9,41
Rotavirus,,States/Local Areas,TX-Dallas County,2017,Age,8 Months,65.3,54.4 to 74.8,137
Rotavirus,,States/Local Areas,TX-Dallas County,2017-2018,Age,8 Months,71.6,61.8 to 79.7,178
Rotavirus,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,80.3,71.6 to 88.9,125
Hib,Full Series,States/Local Areas,TX-Dallas County,2016,Age,24 Months,72.7,61.3 to 83.0,118
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,71.0,63.3 to 78.3,255
Hib,Full Series,States/Local Areas,TX-Dallas County,2017,Age,24 Months,69.7,59.4 to 79.3,137
Hib,Full Series,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,69.2,59.3 to 78.6,178
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,86.5,77.3 to 93.3,118
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,86.3,79.9 to 91.4,255
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,86.1,77.1 to 93.0,137
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,89.8,82.9 to 94.8,178
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,99.0,96.1 to 99.8,41
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,87.0,76.7 to 93.2,118
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,87.4,81.0 to 91.9,255
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,87.8,78.5 to 93.4,137
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,88.4,79.5 to 93.8,178
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,92.0,87.0 to 95.2,287
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,90.9,85.2 to 96.6,125
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.5,59.4 to 79.5,133
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,80.9,75.6 to 86.2,331
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.2,68.7 to 87.7,132
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.6,58.9 to 88.3,48
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,78.0,71.3 to 84.8,214
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,72.3,62.4 to 82.2,130
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,75.5,68.6 to 82.5,209
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,77.5,72.7 to 82.3,464
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,73.1,62.7 to 83.4,89
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,71.6,56.3 to 86.8,60
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,93.0,88.8 to 96.0,287
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,87.0,76.7 to 93.2,118
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,87.0,80.3 to 91.6,255
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,87.0,77.3 to 92.9,137
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,87.9,78.7 to 93.4,178
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,89.1,83.3 to 93.0,287
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.4,72.6 to 92.2,132
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.7,41.1 to 100.0,30
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.3,61.9 to 96.7,66
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,87.4,80.0 to 94.9,89
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,82.8,72.7 to 93.0,98
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.1,66.1 to 88.1,66
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.1,55.9 to 94.3,30
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,89.8,82.6 to 97.0,92
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,76.2,65.9 to 86.4,92
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,95.9,91.2 to 100.0,71
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,87.0,77.9 to 96.1,92
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,70.8,57.1 to 84.5,92
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,72.3,64.8 to 79.4,287
Combined 7 Series,,States/Local Areas,TX-Dallas County,2017,Age,24 Months,59.6,49.2 to 70.4,137
Combined 7 Series,,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,59.5,49.5 to 69.8,178
Combined 7 Series,,States/Local Areas,TX-Dallas County,2018,Age,24 Months,59.6,38.0 to 82.1,41
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017,Age,35 Months,88.4,79.8 to 94.5,137
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,88.7,80.6 to 94.5,178
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,65.1,58.4 to 71.8,287
Hib,Primary Series,States/Local Areas,TX-Dallas County,2018,Age,35 Months,90.1,67.9 to 99.1,41
Hib,Primary Series,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,93.6,88.7 to 96.8,287
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017,Age,24 Months,87.8,79.5 to 93.8,137
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,88.4,80.4 to 94.2,178
Hib,Primary Series,States/Local Areas,TX-Dallas County,2018,Age,24 Months,90.1,67.9 to 99.1,41
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016,Age,24 Months,87.0,77.8 to 93.7,118
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,87.4,81.5 to 92.2,255
Hib,Primary Series,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,93.6,88.7 to 96.8,287
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016,Age,35 Months,88.8,79.7 to 95.1,118
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,88.6,82.4 to 93.3,255
Hib,Primary Series,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,89.2,83.5 to 93.2,287
Hib,Primary Series,States/Local Areas,TX-Dallas County,2018,Age,13 Months,88.0,60.2 to 97.3,41
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017,Age,13 Months,79.5,69.2 to 87.0,137
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017-2018,Age,13 Months,82.0,72.6 to 88.6,178
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016,Age,13 Months,84.3,73.9 to 91.1,118
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016-2017,Age,13 Months,81.5,74.4 to 87.0,255
Hib,Primary Series,States/Local Areas,TX-Dallas County,2018,Age,19 Months,90.1,59.5 to 98.2,41
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016,Age,19 Months,87.0,76.7 to 93.2,118
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,87.4,81.0 to 91.9,255
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017,Age,19 Months,87.8,78.5 to 93.4,137
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,88.4,79.5 to 93.8,178
Hib,Primary Series,States/Local Areas,TX-Dallas County,2014-2015,Age,13 Months,87.0,81.2 to 91.2,287
Hib,Primary Series,States/Local Areas,TX-Dallas County,2018,Age,7 Months,63.0,38.4 to 82.3,41
Hib,Primary Series,States/Local Areas,TX-Dallas County,2014-2015,Age,7 Months,69.4,62.7 to 75.3,287
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017,Age,7 Months,68.4,57.8 to 77.4,137
Hib,Primary Series,States/Local Areas,TX-Dallas County,2017-2018,Age,7 Months,66.8,56.4 to 75.8,178
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016,Age,7 Months,60.7,49.0 to 71.2,118
Hib,Primary Series,States/Local Areas,TX-Dallas County,2016-2017,Age,7 Months,65.1,57.3 to 72.2,255
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016,Age,35 Months,66.9,54.9 to 78.6,118
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,64.8,56.1 to 73.4,255
Combined 7 Series,,States/Local Areas,TX-Dallas County,2017,Age,35 Months,61.3,50.3 to 72.5,137
Combined 7 Series,,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,60.2,50.0 to 70.6,178
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,79.3,73.3 to 84.8,287
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016,Age,24 Months,57.7,46.5 to 69.4,118
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,58.9,51.0 to 66.9,255
Hib,Full Series,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,71.6,65.1 to 77.4,287
Hib,Full Series,States/Local Areas,TX-Dallas County,2017,Age,19 Months,68.0,57.1 to 77.2,137
Hib,Full Series,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,68.1,57.6 to 77.0,178
Hib,Full Series,States/Local Areas,TX-Dallas County,2018,Age,19 Months,68.3,42.9 to 86.0,41
Hib,Full Series,States/Local Areas,TX-Dallas County,2016,Age,19 Months,65.7,53.7 to 75.9,118
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,67.0,59.0 to 74.1,255
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Principal City,65.5,59.0 to 71.9,331
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,53.6,42.8 to 64.4,133
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.0,52.4 to 73.5,132
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",61.0,44.7 to 77.3,48
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,61.9,56.3 to 67.5,464
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.4,45.5 to 73.3,70
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,58.2,50.1 to 66.3,209
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,94.0,89.9 to 96.8,287
DTaP,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,3 Months,83.7,73.3 to 90.6,137
DTaP,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,3 Months,83.8,73.8 to 90.4,178
DTaP,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,3 Months,83.8,55.7 to 95.5,41
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,50.8,27.7 to 73.9,30
Combined 7 Series,,States/Local Areas,TX-Dallas County,2018,Age,35 Months,59.6,38.0 to 82.1,41
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,62.1,54.4 to 69.8,214
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,66.2,57.8 to 74.7,195
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Race and Ethnicity,Hispanic,62.6,54.6 to 70.7,214
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,71.2,60.8 to 81.7,125
Combined 7 Series,,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,63.1,52.8 to 73.4,130
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,83.6,78.3 to 87.8,287
DTaP,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,5 Months,71.4,60.5 to 80.2,137
DTaP,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,5 Months,73.9,63.7 to 82.1,178
DTaP,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,5 Months,76.7,65.5 to 85.0,118
DTaP,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,5 Months,73.6,65.9 to 80.1,255
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.0,77.0 to 93.0,133
DTaP,≥2 Doses,States/Local Areas,TX-Dallas County,2018,Age,5 Months,80.3,52.8 to 93.7,41
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,>400% FPL,92.4,85.0 to 99.7,125
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,133% to <400% FPL,95.9,92.6 to 99.2,130
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Poverty,<133% FPL,90.5,86.1 to 95.0,209
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Overall,Overall,92.4,89.4 to 95.3,464
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,93.4,88.5 to 96.7,287
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,87.0,77.8 to 93.7,118
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,87.4,81.5 to 92.2,255
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,24 Months,87.0,77.8 to 93.7,118
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,87.6,81.4 to 92.5,255
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,87.9,79.1 to 94.2,137
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,91.1,84.4 to 95.7,178
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,99.0,96.1 to 99.8,41
DTaP,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,3 Months,87.1,76.4 to 93.4,118
DTaP,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,3 Months,85.2,78.0 to 90.3,255
DTaP,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,3 Months,88.3,83.1 to 92.1,287
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,22.7,17.3 to 29.1,287
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,88.7,79.5 to 95.0,137
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,91.6,84.8 to 96.2,178
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,88.8,79.7 to 95.1,118
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,88.7,82.4 to 93.6,255
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,93.4,88.5 to 96.7,287
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,19 Months,22.6,15.2 to 32.2,118
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,22.3,16.8 to 29.0,255
PCV,≥2 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,5 Months,76.7,74.3 to 78.9,287
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,24 Months,82.7,73.0 to 90.4,118
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,24 Months,82.0,75.3 to 87.8,255
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2014-2015,Age,24 Months,90.4,86.3 to 93.7,287
PCV,≥2 Doses,States/Local Areas,TX-Dallas County,2016,Age,5 Months,71.1,59.5 to 80.5,118
PCV,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,5 Months,70.6,62.7 to 77.4,255
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,35 Months,99.0,96.1 to 99.8,41
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Other,97.5,92.9 to 100.0,30
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,24 Months,96.6,89.5 to 99.4,41
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,24 Months,81.5,72.0 to 89.3,137
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,85.9,78.5 to 91.7,178
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Any Medicaid,93.7,89.9 to 97.5,214
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2017,Insurance Coverage,Private Insurance Only,94.6,90.8 to 98.4,195
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2017,Age,19 Months,22.0,14.6 to 31.7,137
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,27.0,18.6 to 37.6,178
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,19 Months,64.7,57.8 to 71.0,287
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,35 Months,88.4,79.8 to 94.5,137
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,35 Months,88.7,80.6 to 94.5,178
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016,Age,35 Months,88.8,79.7 to 95.1,118
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2017,Age,35 Months,88.6,82.4 to 93.3,255
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,85.4,77.1 to 93.8,89
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.6,93.8 to 100.0,30
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.3,83.9 to 98.6,66
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",35.0,14.3 to 55.6,30
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.5,61.1 to 85.9,66
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.3,71.1 to 91.5,66
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.4,43.3 to 83.4,30
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,79.1,69.4 to 88.8,92
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,71.6,61.0 to 82.2,92
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,64.4,52.3 to 76.4,92
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",61.1,46.6 to 75.7,66
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",51.4,30.2 to 72.7,30
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,69.5,58.7 to 80.4,89
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.2,57.8 to 86.5,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,85.7,78.0 to 93.3,92
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,38.1,26.3 to 49.9,89
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,67.3,55.8 to 78.9,98
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,74.5,63.3 to 85.6,98
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,94.8,89.3 to 100.0,98
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,93.0,87.1 to 98.9,98
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,88.5,80.9 to 96.1,92
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.8,63.9 to 97.6,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,88.8,83.0 to 94.7,98
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,75.5,65.4 to 85.5,89
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.5,48.5 to 86.5,30
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.0,55.0 to 90.9,30
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",67.2,52.8 to 81.6,66
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,71.6,59.8 to 83.4,98
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,84.6 to 98.4,66
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.8,63.9 to 97.6,30
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.3,76.7 to 99.9,66
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,87.2,79.0 to 95.4,92
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,59.3,47.4 to 71.2,89
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,68.2,52.9 to 83.5,71
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,89.3,82.4 to 96.2,89
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,76.5,69.5 to 83.5,212
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,73.3,62.3 to 84.2,81
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,89.8,81.3 to 98.3,71
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,72.3,61.0 to 83.5,81
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,68.5,52.2 to 84.7,60
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,88.9,81.4 to 96.5,81
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,87.6,78.4 to 96.8,71
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,84.6,71.2 to 98.1,60
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,89.1,80.2 to 98.0,71
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,94.3,88.4 to 100.0,60
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,83.2,74.2 to 92.3,81
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,82.0,72.4 to 91.6,81
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,88.2,76.5 to 99.9,60
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,86.2,73.7 to 98.6,71
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,30.5,18.8 to 42.1,81
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,60.4,44.9 to 75.8,60
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,88.3,83.3 to 93.2,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,81.3,70.1 to 92.5,60
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,92.2,87.9 to 96.4,212
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,89.9,82.5 to 97.4,81
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,93.0,85.9 to 100.0,71
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,63.3,45.8 to 80.8,81
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,85.5,77.2 to 93.7,71
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,88.9,80.4 to 97.3,71
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,69.7,54.7 to 84.6,60
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,85.0,77.3 to 92.6,144
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,69.5,58.4 to 80.6,81
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,66.4,51.3 to 81.5,60
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,90.8,84.6 to 96.9,144
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.4,79.2 to 95.7,68
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.1,74.2 to 96.0,68
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,74.0,64.9 to 83.2,144
PCV,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.0,71.1 to 90.9,68
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,51.3,41.3 to 61.4,144
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,60.5,45.9 to 75.1,68
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,72.1,63.2 to 80.9,144
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,85.3,77.7 to 92.9,144
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.0,69.8 to 92.2,68
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,84.9,77.1 to 92.7,144
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.0,60.5 to 85.4,68
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,76.5,67.5 to 85.6,144
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,75.7,62.9 to 88.6,144
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,89.6 to 98.7,144
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,45.0,30.0 to 60.0,68
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,63.5,53.5 to 73.5,144
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.2,73.1 to 95.2,68
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,81.1,73.6 to 88.5,144
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.8,70.3 to 91.2,68
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,90.0,78.5 to 100.0,71
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,75.2,67.8 to 82.6,212
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,56.7,43.6 to 69.8,81
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,91.1,82.6 to 99.5,60
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,93.5,87.8 to 99.2,71
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,59.1,43.2 to 75.0,60
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,92.2,84.3 to 100.0,60
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,75.5,61.9 to 89.0,71
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,71.1,63.8 to 78.4,212
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,95.9,91.2 to 100.0,71
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,85.0,78.8 to 91.3,212
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,83.5,74.5 to 92.4,81
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,83.9,77.6 to 90.2,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,81.0,74.9 to 87.0,212
Combined 7 Series,,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,62.5,54.2 to 70.8,212
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,73.1,62.5 to 83.8,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,78.1,67.8 to 88.4,81
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,81.2,64.9 to 97.4,60
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,89.5,79.8 to 99.2,60
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,49.1,40.7 to 57.5,212
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,86.0,77.5 to 94.5,81
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,85.1,69.8 to 100.0,71
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Poverty,133% to <400% FPL,81.6,68.6 to 94.6,60
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,81.7,71.5 to 91.8,81
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,86.3,80.4 to 92.2,212
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Poverty,<133% FPL,70.5,58.7 to 82.3,81
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,89.6,84.7 to 94.5,212
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Poverty,>400% FPL,79.1,67.8 to 90.4,71
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,90.7,85.8 to 95.6,212
Influenza,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,42.3,30.1 to 54.4,92
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Overall,Overall,75.7,68.4 to 83.1,212
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,86.7,79.2 to 94.1,89
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,90.5,82.2 to 98.7,98
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,73.2,62.2 to 84.3,92
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.1,55.9 to 94.3,30
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,77.8,62.2 to 93.4,98
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,73.1,59.0 to 87.1,89
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.0,78.4 to 95.6,66
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016,Age,19 Months,80.0,69.4 to 87.5,118
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2017,Age,19 Months,79.6,72.5 to 85.3,255
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2017,Age,19 Months,79.4,69.1 to 86.8,137
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2017-2018,Age,19 Months,81.4,72.1 to 88.1,178
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2018,Age,19 Months,86.6,60.4 to 96.4,41
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2014-2015,Age,35 Months,94.8,90.7 to 97.4,287
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2018,Age,24 Months,90.1,67.9 to 99.1,41
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017,Age,24 Months,87.8,79.5 to 93.8,137
Hib,≥3 Doses,States/Local Areas,TX-Dallas County,2017-2018,Age,24 Months,88.4,80.4 to 94.2,178
Rotavirus,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.3,56.3 to 82.2,68
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,88.6 to 98.7,144
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.4,81.6 to 97.1,68
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,78.9,70.1 to 87.6,144
≥1 Dose MMR,,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.0,80.7 to 97.3,68
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.4,57.1 to 83.7,68
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,75.3 to 93.8,68
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",97.6,93.8 to 100.0,30
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.3,88.2 to 100.0,66
DTaP,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,88.6,80.9 to 96.3,92
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.7,72.1 to 93.2,66
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,85.4,77.4 to 93.3,89
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,89.3,82.4 to 96.2,89
Polio,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,97.1,93.7 to 100.0,98
Hib,Full Series,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,75.5,65.5 to 85.4,89
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.9,76.5 to 95.2,66
Hep A,≥1 Dose,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.4,54.9 to 94.0,30
DTaP,≥4 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,73.9,63.4 to 84.3,89
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Any Medicaid,83.8,75.4 to 92.2,89
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Insurance Coverage,Private Insurance Only,93.9,89.1 to 98.8,98
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.5,73.7 to 100.0,30
PCV,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,84.1 to 98.7,66
≥1 Dose Varicella,,States/Local Areas,TX-Dallas County,2016-2019,Race and Ethnicity,Hispanic,83.9,74.2 to 93.6,92
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,80.6,76.2 to 85.1,508
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,79.9,73.6 to 86.2,283
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,80.3,73.0 to 87.6,164
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,81.5,76.8 to 86.3,437
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.4,64.2 to 92.6,42
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,80.7,76.0 to 85.4,468
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.5,64.7 to 94.3,40
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,86.0,75.4 to 96.7,61
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,93.8,87.9 to 97.0,332
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,91.6,85.3 to 95.3,332
Hep A,≥2 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,67.8,49.8 to 85.9,68
Hep B,≥3 Doses,States/Local Areas,TX-Dallas County,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,84.4 to 96.0,144
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,93.9,80.4 to 98.3,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,95.0,81.0 to 98.8,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.9,88.2 to 97.8,117
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,94.9,89.3 to 97.7,149
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,92.7,75.7 to 98.1,89
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,94.2,88.0 to 97.2,206
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,93.8,90.1 to 96.4,332
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.3,87.7 to 97.5,117
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,92.9,86.2 to 96.4,149
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,88.6,72.9 to 95.8,89
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,92.5,86.2 to 96.1,206
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,93.9,83.4 to 98.7,32
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,94.8,89.1 to 98.1,117
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,94.4,89.5 to 97.5,149
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,92.6,79.3 to 98.6,89
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,94.2,88.8 to 97.5,206
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,87.6,74.0 to 100.0,35
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,93.9,91.3 to 96.4,437
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,86.6 to 100.0,42
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,93.2,90.6 to 95.8,468
Hib,Full Series,States/Local Areas,TX-El Paso County,2018,Age,35 Months,71.9,51.5 to 89.2,32
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,82.0,75.1 to 88.9,169
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,79.1,72.8 to 85.5,283
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,93.9,83.4 to 98.7,32
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,90.5,85.1 to 95.8,169
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,94.5,86.6 to 100.0,35
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,95.3,92.3 to 98.4,283
Hib,Full Series,States/Local Areas,TX-El Paso County,2016,Age,35 Months,87.5,72.7 to 96.4,89
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,90.2,83.3 to 95.1,206
Hib,Full Series,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,87.7,79.5 to 93.7,332
Hib,Full Series,States/Local Areas,TX-El Paso County,2017,Age,35 Months,91.1,84.0 to 96.0,117
Hib,Full Series,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,84.0,74.5 to 91.4,149
Hib,Full Series,States/Local Areas,TX-El Paso County,2018,Age,24 Months,71.9,51.5 to 89.2,32
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,94.3,90.6 to 96.9,332
Hib,Full Series,States/Local Areas,TX-El Paso County,2017,Age,24 Months,90.3,83.3 to 95.2,117
Hib,Full Series,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,83.5,74.0 to 91.0,149
Hib,Full Series,States/Local Areas,TX-El Paso County,2016,Age,24 Months,84.9,70.8 to 94.5,89
Hib,Full Series,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,88.5,82.1 to 93.4,206
DTaP,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,5 Months,76.4,73.3 to 79.2,332
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,95.9,90.2 to 98.8,117
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,95.1,90.1 to 98.0,149
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,99.2,97.0 to 99.9,89
Polio,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,98.7,95.5 to 99.8,206
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,72.1,54.8 to 84.7,89
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,78.4,69.9 to 85.1,206
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,81.4,71.9 to 88.2,117
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,76.5,64.2 to 85.5,149
PCV,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,5 Months,84.5,74.8 to 91.0,117
PCV,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,5 Months,80.3,67.7 to 88.9,149
PCV,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,5 Months,73.6,46.0 to 90.1,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,95.0,92.9 to 97.2,437
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.6,87.2 to 100.0,40
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",99.2,97.5 to 100.0,42
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,94.5,92.2 to 96.8,468
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,35 Months,95.4,90.1 to 98.3,117
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,91.5,83.1 to 96.7,149
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,5 Months,70.1,52.3 to 83.3,89
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,5 Months,80.7,71.5 to 87.4,206
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,5 Months,85.6,75.9 to 91.8,117
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,5 Months,79.8,67.0 to 88.4,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,74.4,67.4 to 80.3,332
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,48.9,28.2 to 74.2,32
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,88.6,76.0 to 96.4,89
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,88.4,82.0 to 93.3,206
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,81.1,74.2 to 87.1,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,61.9,45.4 to 76.1,89
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,75.7,66.6 to 82.9,206
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,78.2,69.9 to 85.6,332
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,89.3,77.4 to 96.6,89
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,92.1,85.3 to 96.6,206
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,82.1,72.6 to 88.9,117
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,79.3,68.9 to 86.9,149
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,90.5,87.1 to 93.9,437
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,5 Months,70.3,43.7 to 87.9,32
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,93.4,84.4 to 100.0,35
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,85.2,78.3 to 92.1,169
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,91.5,87.5 to 95.4,283
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,35 Months,83.6,63.1 to 96.3,32
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,64.0,56.5 to 70.8,332
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,95.0,84.5 to 99.2,32
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,94.6,92.4 to 96.8,508
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,58.5,50.8 to 66.4,332
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,92.3,86.6 to 96.2,332
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,92.3,87.2 to 97.3,164
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,97.2,93.2 to 100.0,61
DTaP,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,95.9,93.5 to 98.3,283
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,68.6,42.7 to 86.5,32
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,5 Months,75.5,71.6 to 79.1,332
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,63.6,49.7 to 77.4,117
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,59.8,47.0 to 73.0,149
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,48.3,33.3 to 65.8,89
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,58.5,47.8 to 69.5,206
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016,Age,13 Months,55.8,40.4 to 70.2,89
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,61.6,51.1 to 71.2,206
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017,Age,13 Months,64.4,50.7 to 76.0,117
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,58.9,46.3 to 70.4,149
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.2,76.7 to 99.8,40
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,75.9 to 96.6,42
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,86.4 to 93.2,468
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,91.4,85.4 to 95.1,332
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,89.7,86.5 to 93.0,508
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,92.2,88.5 to 95.9,283
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,74.9,51.4 to 89.3,32
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,92.2,72.8 to 99.3,32
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,93.4,84.1 to 98.2,117
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,94.7,86.4 to 98.7,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,89.3,84.5 to 92.8,332
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,90.8,82.5 to 96.2,332
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,63.7,56.2 to 70.6,332
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,85.1,78.2 to 92.1,164
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,89.5,72.3 to 100.0,35
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,73.0,62.6 to 83.4,169
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,83.9,75.7 to 92.1,283
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,90.4,80.9 to 100.0,61
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2018,Age,13 Months,50.2,28.2 to 72.1,32
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,98.1,87.2 to 99.7,32
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,88.6,73.5 to 95.6,89
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,90.8,83.9 to 95.0,206
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,91.9,84.0 to 96.0,117
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,94.2,88.9 to 97.1,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,97.0,91.1 to 99.0,89
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,92.8,87.3 to 96.0,206
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,90.8,82.8 to 95.3,117
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,91.1,84.3 to 95.2,149
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,92.3,84.9 to 96.9,117
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,95.3,85.9 to 99.2,149
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,98.6,95.8 to 99.7,89
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,96.3,90.5 to 99.0,206
Hib,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,90.5,74.1 to 96.9,32
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,35 Months,94.0,86.8 to 98.0,89
Hep A,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,95.2,91.1 to 97.8,206
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,69.6,46.6 to 89.6,32
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,88.2,80.5 to 93.9,117
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,81.2,69.5 to 90.5,149
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,81.9,75.6 to 88.2,508
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,84.1,76.1 to 92.1,283
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",61.7,39.4 to 84.0,42
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.2,88.6 to 100.0,40
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,80.6,73.8 to 87.4,468
Hep B,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,3 Months,98.8,97.4 to 99.4,332
Hep B,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,3 Months,99.2,96.7 to 99.8,89
Hep B,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,3 Months,98.5,96.2 to 99.4,206
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,87.0,80.0 to 91.8,332
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016,Age,13 Months,53.1,37.8 to 67.8,89
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,62.5,52.0 to 71.9,206
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017,Age,13 Months,66.9,53.2 to 78.2,117
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,64.7,52.4 to 75.3,149
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,98.1,87.2 to 99.7,32
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,95.4,88.7 to 98.2,117
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,96.4,91.8 to 98.5,149
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-El Paso County,2014-2015,Age,0-1 Days,80.5,73.9 to 85.8,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.9,89.0 to 97.7,117
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,93.7,87.5 to 96.9,149
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,5 Months,94.9,84.4 to 98.4,89
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,5 Months,92.8,87.0 to 96.1,206
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,5 Months,91.6,89.0 to 93.6,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,97.2,91.2 to 99.2,89
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,95.7,91.6 to 97.8,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,69.0,61.5 to 75.6,332
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,78.1,70.6 to 85.7,164
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,86.2,75.5 to 96.8,61
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.0,88.2 to 97.1,117
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,90.4,79.9 to 95.7,149
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016,Age,24 Months,95.4,89.4 to 98.6,89
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,96.7,93.8 to 98.5,206
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,95.4,91.9 to 97.4,332
Hep B,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,3 Months,98.1,87.2 to 99.7,32
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,83.3,67.8 to 98.8,164
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2018,Age,19 Months,73.9,45.6 to 90.6,32
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,80.1,65.8 to 94.4,61
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,93.2,89.7 to 95.7,332
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016,Age,19 Months,93.3,84.1 to 97.4,89
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,93.8,89.3 to 96.5,206
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,83.1,77.2 to 89.0,283
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,86.3,79.4 to 91.2,332
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.4,65.6 to 95.2,40
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,81.8,77.3 to 86.4,468
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,81.8,77.5 to 86.1,508
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.3,60.9 to 89.7,42
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,83.1,78.5 to 87.7,437
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016,Age,19 Months,95.4,88.2 to 98.3,89
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,94.5,90.3 to 96.9,206
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,97.5,91.2 to 99.3,89
Polio,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,96.1,91.6 to 98.2,206
Hep B,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,3 Months,98.1,94.6 to 99.4,117
Hep B,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,3 Months,98.1,94.8 to 99.3,149
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017,Age,19 Months,94.0,88.2 to 97.1,117
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,86.3,72.8 to 93.7,149
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,95.4,77.9 to 99.8,32
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,79.6,72.4 to 86.8,169
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,82.4,76.4 to 88.4,283
DTaP,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,84.3,69.8 to 98.7,35
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,91.7,75.3 to 97.5,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2018,Age,13 Months,61.2,37.9 to 80.2,32
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,69.0,42.9 to 86.8,32
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,81.4,70.2 to 89.0,117
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,76.6,63.9 to 85.8,149
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017,Age,24 Months,97.2,93.7 to 99.0,117
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,93.4,85.4 to 97.8,149
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016,Age,24 Months,93.3,85.6 to 97.7,89
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,95.9,92.6 to 98.1,206
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,97.2,92.4 to 99.3,89
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,97.9,95.4 to 99.2,206
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-El Paso County,2018,Age,0-1 Days,92.4,78.2 to 97.6,32
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,93.6,90.4 to 96.1,332
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,65.3,40.1 to 84.1,32
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,96.2,93.4 to 97.8,332
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,58.8,42.7 to 73.2,89
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,71.5,61.8 to 79.6,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,77.5,65.9 to 86.0,117
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,72.8,60.3 to 82.5,149
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,77.1,70.1 to 82.8,332
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,79.1,63.9 to 89.0,89
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,80.7,72.0 to 87.1,206
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2018,Age,24 Months,73.9,49.7 to 92.8,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,92.2,86.6 to 96.1,332
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017,Age,24 Months,97.2,93.7 to 99.0,117
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,90.5,80.0 to 96.8,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,98.2,95.1 to 99.5,117
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,95.9,90.7 to 98.6,149
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,84.6,78.5 to 89.7,332
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2018,Age,24 Months,84.5,63.6 to 96.7,32
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016,Age,35 Months,99.3,96.0 to 100.0,89
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,99.2,96.8 to 99.9,206
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-El Paso County,2016,Age,0-2 Days,81.0,63.7 to 91.3,89
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-El Paso County,2016-2017,Age,0-2 Days,83.8,74.4 to 90.3,206
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-El Paso County,2018,Age,0-2 Days,92.4,78.2 to 97.6,32
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-El Paso County,2017,Age,0-2 Days,85.1,73.0 to 92.4,117
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-El Paso County,2017-2018,Age,0-2 Days,87.9,79.2 to 93.3,149
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017,Age,35 Months,97.7,94.2 to 99.3,117
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,91.5,81.4 to 97.3,149
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,5 Months,91.8,83.9 to 96.0,117
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,5 Months,92.7,86.5 to 96.2,149
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,93.0,87.5 to 96.7,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,91.7,75.3 to 97.5,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2018,Age,19 Months,84.5,58.6 to 95.4,32
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,5 Months,94.1,79.5 to 98.5,32
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-El Paso County,2016,Age,0-1 Days,80.0,62.9 to 90.4,89
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-El Paso County,2016-2017,Age,0-1 Days,83.0,73.6 to 89.5,206
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-El Paso County,2017,Age,0-1 Days,84.4,72.4 to 91.8,117
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-El Paso County,2017-2018,Age,0-1 Days,87.5,78.8 to 92.9,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,91.7,78.8 to 98.1,32
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,88.9,82.7 to 93.0,332
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,98.9,95.1 to 99.8,89
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,95.2,90.2 to 97.7,206
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,93.4,86.2 to 97.0,117
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,95.2,90.2 to 97.7,149
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,94.0,88.5 to 97.4,332
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-El Paso County,2014-2015,Age,0-2 Days,81.9,75.3 to 87.0,332
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,88.3,81.8 to 94.9,169
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,95.4,92.5 to 98.2,283
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2018,Age,35 Months,73.9,49.7 to 92.8,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016,Age,35 Months,96.2,87.7 to 99.4,89
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,97.7,93.7 to 99.4,206
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,93.4,87.8 to 97.0,332
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,86.0,76.0 to 93.3,117
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,79.6,67.8 to 89.3,149
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,84.1,70.2 to 93.9,89
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,85.2,77.3 to 91.4,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,92.3,84.7 to 96.3,117
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,92.5,86.4 to 95.9,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,94.4,91.1 to 96.7,332
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,84.1,68.6 to 92.7,89
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,89.7,82.8 to 94.0,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,92.7,79.4 to 97.7,32
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,7 Months,98.1,87.2 to 99.7,32
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2018,Age,24 Months,69.0,46.1 to 89.1,32
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,98.2,95.1 to 99.5,117
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,95.9,90.7 to 98.6,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,97.2,92.4 to 99.3,89
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,97.9,95.4 to 99.2,206
Hib,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,3 Months,87.4,81.4 to 91.7,332
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,13 Months,97.2,94.9 to 98.4,332
Hep A,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,84.3,77.9 to 90.8,437
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.9,21.0 to 100.0,9
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,95.0,86.0 to 100.0,35
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,19 Months,92.2,86.2 to 95.8,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,91.7,78.8 to 98.1,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.8,89.2 to 100.0,42
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,91.7,88.5 to 94.8,468
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,92.6,83.2 to 100.0,61
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,87.3,80.7 to 94.0,164
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,13 Months,98.9,95.1 to 99.8,89
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,13 Months,98.3,95.9 to 99.3,206
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,13 Months,98.1,87.2 to 99.7,32
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,19 Months,92.7,75.7 to 98.1,89
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,19 Months,92.9,86.4 to 96.4,206
Hib,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,3 Months,86.8,71.1 to 94.6,89
Hib,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,3 Months,88.3,81.0 to 93.0,206
Hib,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,3 Months,88.9,80.6 to 94.0,117
Hib,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,3 Months,92.4,86.8 to 95.8,149
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,13 Months,98.0,94.4 to 99.3,117
Hep B,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,13 Months,98.0,94.8 to 99.3,149
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2018,Age,35 Months,84.5,63.6 to 96.7,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017,Age,35 Months,97.7,94.2 to 99.3,117
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,94.1,86.4 to 98.2,149
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,90.3,79.0 to 100.0,35
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.8,89.2 to 100.0,42
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,92.9,90.0 to 95.8,468
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,83.3 to 100.0,40
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,93.0,90.3 to 95.8,508
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,96.6,94.4 to 98.7,283
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,91.8,88.6 to 95.0,437
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,94.1,90.7 to 97.4,283
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,86.9,80.1 to 93.7,169
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,85.6,79.2 to 90.8,332
≥1 Dose Varicella,,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,93.7,91.0 to 96.5,437
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2017,Age,35 Months,88.2,78.2 to 95.1,117
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,35 Months,96.1,84.5 to 99.6,149
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,86.7,72.0 to 95.9,89
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,87.9,79.3 to 94.2,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2018,Age,19 Months,93.9,80.5 to 98.3,32
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2018,Age,35 Months,95.3,77.4 to 99.8,32
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,86.6,79.8 to 93.4,164
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,90.2,80.0 to 100.0,61
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.6,78.7 to 100.0,40
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,91.6,88.6 to 94.6,508
≥1 Dose MMR,,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,94.8,91.8 to 97.7,283
Hib,≥1 Dose,States/Local Areas,TX-El Paso County,2018,Age,3 Months,98.1,87.2 to 99.7,32
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,19 Months,93.0,85.4 to 96.8,117
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,19 Months,93.3,87.4 to 96.6,149
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,92.7,83.0 to 100.0,35
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,83.1,77.2 to 89.1,283
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,84.5,80.0 to 89.0,437
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,5 Months,71.1,53.2 to 84.2,89
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,5 Months,81.1,72.0 to 87.7,206
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,5 Months,75.2,71.2 to 78.7,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,90.5,85.2 to 95.8,169
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Other,96.3,89.2 to 100.0,35
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2018,Age,5 Months,72.0,44.9 to 89.1,32
PCV,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,3 Months,86.8,71.1 to 94.6,89
PCV,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,3 Months,87.5,80.1 to 92.3,206
PCV,≥1 Dose,States/Local Areas,TX-El Paso County,2017,Age,3 Months,87.8,79.3 to 93.0,117
PCV,≥1 Dose,States/Local Areas,TX-El Paso County,2017-2018,Age,3 Months,91.7,86.0 to 95.2,149
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Principal City,83.1,78.7 to 87.5,468
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2012,Age,0-3 Days,NA,,
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Any Medicaid,95.7,93.1 to 98.4,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2011,Age,0-3 Days,NA,,
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017,Age,24 Months,93.0,86.4 to 97.1,117
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,24 Months,93.3,88.0 to 96.8,149
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,24 Months,92.7,79.6 to 98.6,89
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,24 Months,92.9,87.2 to 96.7,206
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,5 Months,85.7,76.0 to 91.9,117
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,5 Months,80.5,67.7 to 89.0,149
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,89.7,84.3 to 95.0,164
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,95.4,90.7 to 100.0,61
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,95.9,93.2 to 98.6,283
Polio,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,3 Months,87.9,81.9 to 92.1,332
Polio,≥1 Dose,States/Local Areas,TX-El Paso County,2016,Age,3 Months,86.8,71.1 to 94.6,89
Polio,≥1 Dose,States/Local Areas,TX-El Paso County,2016-2017,Age,3 Months,88.9,81.6 to 93.6,206
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2017,Age,0-3 Days,82.9,70.9 to 90.6,101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2017-2018,Age,0-3 Days,87.9,79.2 to 93.3,149
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016,Age,0-3 Days,81.4,63.9 to 91.6,89
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-El Paso County,2016-2017,Age,0-3 Days,84.0,74.5 to 90.4,206
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,35 Months,94.3,90.7 to 96.8,332
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016,Age,35 Months,99.5,97.4 to 100.0,89
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,35 Months,98.5,94.0 to 99.8,206
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2016,Age,7 Months,89.9,74.3 to 96.5,89
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2016-2017,Age,7 Months,91.3,84.7 to 95.2,206
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2017,Age,7 Months,91.9,84.1 to 96.1,117
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2017-2018,Age,7 Months,93.2,87.3 to 96.5,149
PCV,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,24 Months,92.2,86.8 to 96.0,332
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Insurance Coverage,Private Insurance Only,80.8,73.6 to 88.0,169
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,>400% FPL,88.1,78.0 to 98.2,61
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,<133% FPL,85.0,79.3 to 90.8,283
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Poverty,133% to <400% FPL,78.1,70.3 to 85.9,164
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.0,65.0 to 95.0,40
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Overall,Overall,82.9,78.6 to 87.2,508
PCV,≥1 Dose,States/Local Areas,TX-El Paso County,2014-2015,Age,3 Months,88.1,82.2 to 92.2,332
PCV,≥4 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.0,58.1 to 89.8,42
Hib,≥2 Doses,States/Local Areas,TX-El Paso County,2014-2015,Age,7 Months,91.3,85.3 to 95.0,332
Hep B,≥3 Doses,States/Local Areas,TX-El Paso County,2014-2017,Race and Ethnicity,Hispanic,94.2,91.9 to 96.5,437
≥1 Dose Varicella,,HHS Regions/National,Region 5,2020,Age,24 Months,90.7,89.0 to 92.3,2239
Polio,≥3 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,95.0,93.3 to 96.5,2023
Polio,≥3 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,90.7,88.8 to 92.4,1726
Polio,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,90.0,88.5 to 91.2,3461
Hib,≥3 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,69.3,66.4 to 72.0,2019
Hib,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,69.2,67.2 to 71.0,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,70.8,67.8 to 73.5,1835
Hib,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,70.0,68.0 to 72.0,3854
Hib,≥3 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,69.3,66.3 to 72.2,1735
Hib,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,70.0,68.0 to 72.1,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,89.0,87.0 to 90.7,2239
Polio,≥3 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,90.5,88.2 to 92.3,2019
Polio,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,91.0,89.6 to 92.2,4223
Polio,≥3 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,92.8,91.0 to 94.3,1835
Polio,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,91.7,90.2 to 92.9,3854
Hib,≥3 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,69.1,66.4 to 71.6,2204
Hib,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,68.7,66.8 to 70.6,4227
Hib,≥3 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,90.1,87.8 to 92.0,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,89.0,85.7 to 91.6,1752
Hib,≥3 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,68.3,65.5 to 71.0,2023
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,89.3,87.4 to 91.0,2204
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,89.8,88.4 to 91.0,4227
DTaP,≥3 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,91.5,88.4 to 93.8,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,92.3,90.4 to 93.8,1771
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,90.3,88.1 to 92.0,2023
Hib,≥3 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,48.9,45.9 to 51.8,2023
Polio,≥3 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,90.8,88.6 to 92.6,1730
Polio,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,90.7,89.2 to 92.1,3456
Polio,≥3 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,89.2,86.0 to 91.7,1735
Polio,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,91.0,89.6 to 92.2,3570
Polio,≥3 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,89.5,86.0 to 92.3,1752
Hib,≥2 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,93.6,91.6 to 95.1,2019
Hib,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,94.0,92.8 to 95.0,4223
Hib,≥2 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,94.5,93.1 to 95.6,2204
Hib,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,94.4,93.3 to 95.2,4227
Hib,≥2 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,94.2,92.7 to 95.5,2023
Hib,≥2 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,92.9,91.1 to 94.4,1771
Hib,≥2 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,91.7,89.1 to 93.7,1752
Hib,≥2 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,89.4,87.3 to 91.2,2023
DTaP,≥3 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,88.4,85.5 to 90.7,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,89.5,87.4 to 91.3,1726
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,87.9,86.3 to 89.3,3461
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,89.8,87.7 to 91.5,1730
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,89.6,88.0 to 91.1,3456
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,86.2,83.7 to 88.3,1735
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,88.6,87.0 to 90.0,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,89.0,86.7 to 91.0,2019
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,89.2,87.7 to 90.5,4223
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,91.0,89.0 to 92.7,1835
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,90.0,88.5 to 91.4,3854
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,70.4,67.6 to 73.0,2204
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,70.1,68.1 to 72.0,4227
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,71.6,68.7 to 74.4,2019
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,71.0,69.0 to 72.9,4223
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,69.8,66.8 to 72.6,2023
DTaP,≥3 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,88.5,86.0 to 90.5,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,76.8,72.4 to 80.8,1752
Hib,≥3 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,79.7,76.3 to 82.8,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,73.5,70.8 to 76.1,1726
Hib,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,71.4,69.4 to 73.4,3461
Polio,≥3 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,91.2,89.4 to 92.7,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,76.4,72.5 to 80.0,1730
Hib,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,75.0,71.7 to 78.0,3456
Hib,≥2 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,88.9,86.9 to 90.6,2204
Hib,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,89.2,87.7 to 90.4,4227
Hib,≥2 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,89.2,86.9 to 91.2,2019
Hib,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,89.1,87.6 to 90.4,4223
Hib,≥2 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,90.0,87.9 to 91.9,1835
Hib,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,89.6,88.1 to 91.0,3854
Hib,≥2 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,92.7,90.9 to 94.2,1726
Hib,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,92.1,90.7 to 93.2,3461
Hib,≥2 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,94.4,92.8 to 95.7,1835
Hib,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,94.0,92.7 to 95.0,3854
Hib,≥2 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,91.4,89.4 to 93.1,1735
Hib,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,92.9,91.6 to 94.0,3570
Hib,≥3 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,50.6,47.6 to 53.6,2019
Hib,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,50.6,48.6 to 52.7,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,50.7,47.9 to 53.5,2204
Hib,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,49.8,47.7 to 51.8,4227
PCV,≥3 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,94.2,92.5 to 95.6,2023
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2018,Age,0-3 Days,81.4,79.1 to 83.6,2204
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2018-2019,Age,0-3 Days,81.9,80.2 to 83.5,4227
Polio,≥1 Dose,HHS Regions/National,Region 5,2019,Age,3 Months,89.4,87.3 to 91.3,2023
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2019,Age,0-3 Days,82.4,79.9 to 84.7,2023
PCV,≥3 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,92.7,91.1 to 94.2,2204
PCV,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,93.1,91.9 to 94.1,4227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2016,Age,0-3 Days,78.9,76.2 to 81.3,1835
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2016-2017,Age,0-3 Days,79.5,77.6 to 81.2,3854
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2017,Age,0-3 Days,79.7,75.8 to 83.2,1118
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2017-2018,Age,0-3 Days,80.8,79.0 to 82.4,4223
Polio,≥1 Dose,HHS Regions/National,Region 5,2016,Age,3 Months,88.0,85.8 to 89.9,1835
Polio,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,3 Months,87.3,85.7 to 88.8,3854
Polio,≥1 Dose,HHS Regions/National,Region 5,2015,Age,3 Months,84.5,82.0 to 86.7,1735
Polio,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,3 Months,86.3,84.6 to 87.7,3570
Polio,≥1 Dose,HHS Regions/National,Region 5,2014,Age,3 Months,85.3,83.0 to 87.4,1726
Polio,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,3 Months,84.9,83.2 to 86.5,3461
Hib,≥3 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,52.4,48.3 to 56.5,1730
Hib,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,52.5,49.2 to 55.7,3456
Hib,≥3 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,60.7,56.0 to 65.1,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,55.4,50.3 to 60.3,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,93.8,92.1 to 95.3,1835
PCV,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,93.6,92.3 to 94.7,3854
PCV,≥3 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,92.1,90.0 to 93.9,1735
PCV,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,92.9,91.6 to 94.1,3570
PCV,≥3 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,92.1,90.3 to 93.7,1726
PCV,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,92.0,90.7 to 93.2,3461
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,69.5,66.4 to 72.4,1835
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,70.6,68.4 to 72.6,3854
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2015,Age,0-3 Days,74.0,71.0 to 76.8,1735
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2015-2016,Age,0-3 Days,76.4,74.5 to 78.3,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,68.7,65.7 to 71.6,1726
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,67.9,65.7 to 70.0,3461
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,67.0,63.9 to 70.0,1735
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,68.3,66.1 to 70.4,3570
PCV,≥3 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,93.3,91.3 to 95.0,2019
PCV,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,93.7,92.4 to 94.9,4223
Hib,≥2 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,94.1,91.8 to 95.7,1730
Hib,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,93.4,91.8 to 94.6,3456
Hib,≥3 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,52.5,49.4 to 55.6,1726
Hib,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,50.1,47.9 to 52.3,3461
PCV,≥3 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,94.0,92.3 to 95.5,2204
PCV,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,94.1,93.0 to 95.2,4227
Hib,≥3 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,49.9,46.8 to 53.0,1835
Hib,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,50.3,48.1 to 52.4,3854
Hib,≥3 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,47.7,44.6 to 50.8,1735
Hib,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,48.8,46.6 to 51.0,3570
Polio,≥1 Dose,HHS Regions/National,Region 5,2017,Age,3 Months,86.6,84.2 to 88.7,2019
Polio,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,3 Months,87.3,85.8 to 88.8,4223
Polio,≥1 Dose,HHS Regions/National,Region 5,2018,Age,3 Months,88.0,85.9 to 89.9,2204
Polio,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,3 Months,88.7,87.3 to 90.1,4227
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017,Age,35 Months,92.5,90.3 to 94.3,2019
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017-2018,Age,35 Months,93.4,91.9 to 94.6,4223
Hep B,≥3 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,89.2,86.7 to 91.3,1752
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,89.2,87.3 to 90.9,2204
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,89.3,87.9 to 90.6,4227
Hep B,≥3 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,87.6,86.1 to 88.9,1771
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,89.4,87.3 to 91.2,2023
≥1 Dose MMR,,HHS Regions/National,Region 5,2011,Age,19 Months,85.8,82.7 to 88.4,1771
DTaP,≥4 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,89.0,86.0 to 91.5,2023
Hep B,≥2 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,93.5,91.7 to 95.0,1730
Hep B,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,94.0,92.9 to 94.9,3456
Hep B,≥2 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,92.6,90.8 to 94.0,1735
Hep B,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,93.8,92.7 to 94.7,3570
Hep B,≥2 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,94.4,92.9 to 95.6,1726
Hep B,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,93.5,92.4 to 94.5,3461
Hib,≥1 Dose,HHS Regions/National,Region 5,2014,Age,3 Months,85.0,82.7 to 87.1,1726
Hib,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,3 Months,84.9,83.2 to 86.4,3461
Hib,≥1 Dose,HHS Regions/National,Region 5,2011,Age,3 Months,86.8,84.6 to 88.8,1771
Hib,≥1 Dose,HHS Regions/National,Region 5,2012,Age,3 Months,84.7,81.9 to 87.2,1752
Hib,≥1 Dose,HHS Regions/National,Region 5,2013,Age,3 Months,82.7,79.3 to 85.7,1730
Hib,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,3 Months,83.9,81.4 to 86.1,3456
≥1 Dose MMR,,HHS Regions/National,Region 5,2019,Age,35 Months,94.3,92.3 to 95.9,2023
≥1 Dose MMR,,HHS Regions/National,Region 5,2017,Age,35 Months,92.8,90.6 to 94.6,2019
≥1 Dose MMR,,HHS Regions/National,Region 5,2017-2018,Age,35 Months,93.6,92.1 to 94.9,4223
≥1 Dose MMR,,HHS Regions/National,Region 5,2018,Age,35 Months,94.3,92.3 to 96.0,2204
≥1 Dose MMR,,HHS Regions/National,Region 5,2018-2019,Age,35 Months,94.3,92.9 to 95.5,4227
Hep B,≥2 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,94.0,92.1 to 95.4,2019
Hep B,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,94.9,93.8 to 95.8,4223
Hib,≥1 Dose,HHS Regions/National,Region 5,2017,Age,3 Months,86.5,84.0 to 88.5,2019
Hib,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,3 Months,86.7,85.1 to 88.2,4223
Hib,≥1 Dose,HHS Regions/National,Region 5,2016,Age,3 Months,87.6,85.4 to 89.5,1835
Hib,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,3 Months,87.0,85.4 to 88.5,3854
Hib,≥1 Dose,HHS Regions/National,Region 5,2015,Age,3 Months,84.7,82.2 to 86.9,1735
Hib,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,3 Months,86.2,84.5 to 87.7,3570
PCV,≥3 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,92.2,90.2 to 93.7,1835
PCV,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,91.6,90.1 to 92.8,3854
PCV,≥3 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,88.9,86.5 to 90.9,1735
PCV,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,90.5,89.1 to 91.8,3570
Hep B,≥2 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,95.0,93.5 to 96.1,1835
Hep B,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,94.5,93.3 to 95.4,3854
Hep B,≥2 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,95.8,94.6 to 96.7,2204
Hep B,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,95.6,94.7 to 96.3,4227
PCV,≥4 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,84.2,81.4 to 86.7,1726
PCV,≥4 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,82.6,80.6 to 84.5,3461
PCV,≥4 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,81.1,78.0 to 83.9,1735
PCV,≥4 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,83.1,81.2 to 84.9,3570
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2017,Age,0-2 Days,77.8,75.1 to 80.3,2019
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2017-2018,Age,0-2 Days,78.9,77.1 to 80.5,4223
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2018,Age,0-2 Days,80.0,77.6 to 82.1,2204
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2018-2019,Age,0-2 Days,80.7,79.0 to 82.3,4227
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2019,Age,0-2 Days,81.5,79.0 to 83.8,2023
Hep B,≥2 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,92.7,91.1 to 94.0,2204
Hep B,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,93.1,92.0 to 94.1,4227
≥1 Dose Varicella,,HHS Regions/National,Region 5,2011,Age,35 Months,91.5,89.1 to 93.5,1771
PCV,≥4 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,79.2,76.4 to 81.9,1771
Hib,Full Series,HHS Regions/National,Region 5,2020,Age,24 Months,78.7,76.3 to 81.1,2239
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,95.5,93.8 to 96.9,2204
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,95.1,93.9 to 96.2,4227
PCV,≥3 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,90.3,88.3 to 92.0,1726
PCV,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,89.6,88.1 to 90.9,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,94.5,92.7 to 96.0,2023
PCV,≥4 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,84.2,81.4 to 86.9,1730
PCV,≥4 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,84.2,82.2 to 86.1,3456
Hib,≥1 Dose,HHS Regions/National,Region 5,2018,Age,3 Months,87.0,84.8 to 88.9,2204
Hib,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,3 Months,87.4,85.8 to 88.7,4227
Hib,≥1 Dose,HHS Regions/National,Region 5,2019,Age,3 Months,87.8,85.5 to 89.7,2023
PCV,≥3 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,92.1,90.1 to 93.8,1730
PCV,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,91.9,90.5 to 93.1,3456
Hib,≥2 Doses,HHS Regions/National,Region 5,2017,Age,5 Months,78.8,76.0 to 81.3,2019
Hib,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,5 Months,78.3,76.4 to 80.0,4223
PCV,≥3 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,90.7,88.6 to 92.6,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,91.6,89.8 to 93.2,1726
PCV,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,91.1,89.8 to 92.3,3461
PCV,≥4 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,86.5,84.0 to 88.9,2023
Hib,≥2 Doses,HHS Regions/National,Region 5,2016,Age,5 Months,79.4,76.6 to 81.9,1835
Hib,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,5 Months,79.1,77.1 to 80.9,3854
Hib,≥2 Doses,HHS Regions/National,Region 5,2015,Age,5 Months,74.5,71.6 to 77.3,1735
Hib,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,5 Months,76.9,74.9 to 78.8,3570
PCV,≥1 Dose,HHS Regions/National,Region 5,2013,Age,3 Months,81.7,78.8 to 84.3,1730
PCV,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,3 Months,82.8,80.4 to 84.9,3456
PCV,≥4 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,86.6,83.9 to 89.0,2204
PCV,≥4 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,86.6,84.7 to 88.3,4227
PCV,≥4 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,85.3,82.8 to 87.5,1835
PCV,≥4 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,84.6,82.8 to 86.3,3854
PCV,≥4 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,83.8,81.2 to 86.3,2019
PCV,≥4 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,85.2,83.3 to 86.9,4223
PCV,≥1 Dose,HHS Regions/National,Region 5,2012,Age,3 Months,83.4,80.3 to 86.1,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,91.0,88.8 to 92.8,2019
PCV,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,91.2,89.8 to 92.4,4223
Hib,≥2 Doses,HHS Regions/National,Region 5,2014,Age,5 Months,76.8,74.0 to 79.3,1726
Hib,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,5 Months,75.7,73.3 to 77.9,3461
Hib,≥2 Doses,HHS Regions/National,Region 5,2013,Age,5 Months,73.4,70.5 to 76.0,1730
Hib,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,5 Months,75.1,72.8 to 77.2,3456
Hib,≥2 Doses,HHS Regions/National,Region 5,2011,Age,5 Months,76.9,72.8 to 80.4,1771
Hib,≥2 Doses,HHS Regions/National,Region 5,2012,Age,5 Months,76.4,73.0 to 79.5,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,91.4,89.6 to 92.9,2204
PCV,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,88.9,87.4 to 90.2,4227
PCV,≥3 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,91.1,89.0 to 93.0,1771
PCV,≥3 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,91.9,90.0 to 93.4,2023
Hib,≥2 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,88.1,85.9 to 90.0,1726
Hib,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,87.0,85.4 to 88.5,3461
Hib,≥2 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,88.5,85.5 to 91.0,1730
Hib,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,88.3,86.3 to 90.1,3456
PCV,≥1 Dose,HHS Regions/National,Region 5,2011,Age,3 Months,84.6,81.9 to 87.0,1771
Hep B,≥2 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,95.5,94.1 to 96.5,2023
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2012,Age,0-3 Days,76.0,73.0 to 78.8,1752
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2011,Age,0-3 Days,73.7,70.7 to 76.5,1771
Hib,≥2 Doses,HHS Regions/National,Region 5,2018,Age,5 Months,77.8,75.3 to 80.2,2204
Hib,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,5 Months,78.4,76.5 to 80.1,4227
Hib,≥2 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,88.5,86.0 to 90.5,1771
Hib,≥2 Doses,HHS Regions/National,Region 5,2019,Age,5 Months,78.9,76.2 to 81.4,2023
PCV,≥3 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,90.6,88.6 to 92.4,1735
PCV,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,92.0,90.6 to 93.2,3570
Hib,≥2 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,87.2,83.1 to 90.4,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,93.3,91.6 to 94.8,1835
PCV,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,92.3,91.0 to 93.5,3854
PCV,≥3 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,91.2,89.1 to 93.1,2019
PCV,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,92.0,90.7 to 93.2,4223
PCV,≥1 Dose,HHS Regions/National,Region 5,2017,Age,3 Months,85.4,83.0 to 87.6,2019
PCV,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,3 Months,86.2,84.6 to 87.7,4223
PCV,≥1 Dose,HHS Regions/National,Region 5,2016,Age,3 Months,87.8,85.6 to 89.6,1835
PCV,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,3 Months,86.6,85.0 to 88.1,3854
PCV,≥1 Dose,HHS Regions/National,Region 5,2015,Age,3 Months,82.2,79.5 to 84.6,1735
PCV,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,3 Months,85.0,83.3 to 86.5,3570
PCV,≥1 Dose,HHS Regions/National,Region 5,2014,Age,3 Months,83.8,81.4 to 86.0,1726
PCV,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,3 Months,83.0,81.2 to 84.7,3461
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2014,Age,0-3 Days,74.9,72.1 to 77.5,1726
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2014-2015,Age,0-3 Days,74.4,72.4 to 76.4,3461
Polio,≥1 Dose,HHS Regions/National,Region 5,2013,Age,3 Months,83.6,80.8 to 86.0,1730
Polio,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,3 Months,84.4,82.4 to 86.3,3456
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2013,Age,0-3 Days,74.5,71.7 to 77.2,1730
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 5,2013-2014,Age,0-3 Days,74.7,72.7 to 76.6,3456
Polio,≥1 Dose,HHS Regions/National,Region 5,2011,Age,3 Months,86.4,84.3 to 88.3,1771
Polio,≥1 Dose,HHS Regions/National,Region 5,2012,Age,3 Months,85.1,82.0 to 87.8,1752
PCV,≥1 Dose,HHS Regions/National,Region 5,2019,Age,3 Months,88.4,86.2 to 90.3,2023
PCV,≥1 Dose,HHS Regions/National,Region 5,2018,Age,3 Months,87.0,84.8 to 88.9,2204
PCV,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,3 Months,87.7,86.2 to 89.1,4227
PCV,≥3 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,91.5,89.4 to 93.3,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,70.0,65.8 to 74.0,1771
DTaP,≥3 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,67.7,63.4 to 71.7,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,67.1,62.1 to 71.6,1730
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,67.9,65.0 to 70.6,3456
PCV,≥3 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,93.9,92.0 to 95.5,1730
PCV,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,92.9,91.6 to 94.1,3456
PCV,≥3 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,92.3,90.2 to 94.1,1771
PCV,≥3 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,93.5,91.8 to 94.9,2023
Hib,≥2 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,85.9,83.5 to 88.1,1735
Hib,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,88.0,86.4 to 89.4,3570
Hep A,≥1 Dose,HHS Regions/National,Region 5,2016,Age,35 Months,90.9,88.7 to 92.8,1835
Hep A,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,35 Months,90.4,88.8 to 91.9,3854
DTaP,≥4 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,77.5,74.6 to 80.2,1735
DTaP,≥4 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,79.9,78.0 to 81.7,3570
DTaP,≥4 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,82.3,79.8 to 84.8,1835
DTaP,≥4 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,81.5,79.7 to 83.3,3854
DTaP,≥4 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,80.4,77.8 to 83.0,1726
DTaP,≥4 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,78.9,77.0 to 80.8,3461
Hep A,≥1 Dose,HHS Regions/National,Region 5,2014,Age,35 Months,88.6,85.9 to 91.0,1726
Hep A,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,35 Months,88.3,86.3 to 90.2,3461
Hep A,≥1 Dose,HHS Regions/National,Region 5,2013,Age,35 Months,87.3,84.6 to 89.8,1730
Hep A,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,35 Months,88.0,86.0 to 89.8,3456
Hep A,≥2 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,40.6,37.3 to 44.2,1752
Hep A,≥2 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,71.7,67.9 to 75.5,1730
Hep A,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,72.2,69.5 to 74.9,3456
Hep A,≥2 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,74.8,71.0 to 78.5,1752
Hep A,≥2 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,69.9,66.0 to 73.7,1771
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,60.3,57.2 to 63.3,1835
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,61.5,59.3 to 63.6,3854
Polio,≥2 Doses,HHS Regions/National,Region 5,2015,Age,5 Months,75.3,72.4 to 78.0,1735
Polio,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,5 Months,77.3,75.3 to 79.1,3570
Hep A,≥2 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,49.3,46.2 to 52.6,2023
Hep A,≥2 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,47.3,44.5 to 50.2,2204
Hep A,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,48.3,46.1 to 50.4,4227
Polio,≥2 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,88.6,86.2 to 90.6,1771
Polio,≥2 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,86.9,83.2 to 89.9,1752
Polio,≥2 Doses,HHS Regions/National,Region 5,2019,Age,5 Months,80.7,78.0 to 83.1,2023
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,62.7,59.7 to 65.5,2019
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,62.2,60.1 to 64.1,4223
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,61.6,58.9 to 64.3,2204
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,62.7,60.7 to 64.7,4227
Hep A,≥2 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,72.1,68.2 to 76.0,1735
Hep A,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,74.7,72.0 to 77.3,3570
Hep A,≥2 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,77.3,73.7 to 80.7,1835
Hep A,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,77.7,75.3 to 80.1,3854
Hep A,≥2 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,72.7,68.8 to 76.5,1726
Hep A,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,72.4,69.6 to 75.1,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,63.8,60.8 to 66.6,2023
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014,Age,13 Months,55.9,52.8 to 59.0,1726
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014-2015,Age,13 Months,54.8,52.6 to 57.1,3461
≥1 Dose Varicella,,HHS Regions/National,Region 5,2012,Age,13 Months,55.7,52.3 to 59.0,1752
Hep A,≥1 Dose,HHS Regions/National,Region 5,2018,Age,35 Months,92.3,90.1 to 94.2,2204
Hep A,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,35 Months,92.2,90.6 to 93.6,4227
Hep A,≥1 Dose,HHS Regions/National,Region 5,2019,Age,35 Months,91.8,89.7 to 93.6,2023
Polio,≥2 Doses,HHS Regions/National,Region 5,2018,Age,5 Months,78.2,75.6 to 80.5,2204
Polio,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,5 Months,79.4,77.6 to 81.1,4227
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013,Age,13 Months,54.4,50.9 to 57.8,1730
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013-2014,Age,13 Months,55.2,52.1 to 58.1,3456
≥1 Dose Varicella,,HHS Regions/National,Region 5,2011,Age,13 Months,53.2,49.2 to 57.3,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,93.4,91.6 to 95.0,2023
PCV,≥2 Doses,HHS Regions/National,Region 5,2018,Age,5 Months,77.2,74.6 to 79.6,2204
PCV,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,5 Months,78.4,76.6 to 80.2,4227
PCV,≥2 Doses,HHS Regions/National,Region 5,2017,Age,5 Months,77.6,74.8 to 80.1,2019
PCV,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,5 Months,77.4,75.5 to 79.2,4223
PCV,≥2 Doses,HHS Regions/National,Region 5,2019,Age,5 Months,79.7,76.9 to 82.1,2023
DTaP,≥4 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,71.6,68.6 to 74.3,2019
DTaP,≥4 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,70.8,68.8 to 72.7,4223
DTaP,≥4 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,72.4,69.4 to 75.1,1835
DTaP,≥4 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,72.0,69.9 to 73.9,3854
Hep A,≥2 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,44.9,41.6 to 48.2,1730
Hep A,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,43.8,41.5 to 46.2,3456
DTaP,≥4 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,69.9,67.2 to 72.6,2204
DTaP,≥4 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,94.4,93.3 to 95.3,4227
Polio,≥2 Doses,HHS Regions/National,Region 5,2014,Age,5 Months,77.6,74.9 to 80.1,1726
Polio,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,5 Months,76.5,74.2 to 78.6,3461
Polio,≥2 Doses,HHS Regions/National,Region 5,2013,Age,5 Months,73.2,70.1 to 76.2,1730
Polio,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,5 Months,75.4,73.0 to 77.7,3456
Hep A,≥1 Dose,HHS Regions/National,Region 5,2012,Age,35 Months,88.0,85.1 to 90.5,1752
Polio,≥2 Doses,HHS Regions/National,Region 5,2011,Age,5 Months,77.1,73.2 to 80.5,1771
Polio,≥2 Doses,HHS Regions/National,Region 5,2012,Age,5 Months,75.8,72.3 to 79.1,1752
Hep A,≥1 Dose,HHS Regions/National,Region 5,2015,Age,35 Months,88.2,85.4 to 90.8,1735
Hep A,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,35 Months,89.5,87.7 to 91.1,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,52.1,48.1 to 56.0,1771
Hep B,≥3 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,57.9,53.4 to 62.1,1752
DTaP,≥4 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,81.2,78.3 to 83.8,1752
DTaP,≥4 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,80.8,78.1 to 83.3,1771
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,58.4,53.0 to 63.5,1730
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,59.5,55.9 to 63.0,3456
DTaP,≥4 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,72.4,69.5 to 75.1,2023
DTaP,≥4 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,80.9,78.1 to 83.5,1730
DTaP,≥4 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,80.6,78.7 to 82.5,3456
Hep A,≥2 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,47.3,44.1 to 50.6,1835
Hep A,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,47.1,44.9 to 49.3,3854
Hep A,≥2 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,46.8,43.8 to 50.0,2019
Hep A,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,47.1,45.0 to 49.2,4223
≥1 Dose MMR,,HHS Regions/National,Region 5,2015,Age,13 Months,57.7,54.5 to 60.8,1735
≥1 Dose MMR,,HHS Regions/National,Region 5,2015-2016,Age,13 Months,60.0,57.8 to 62.2,3570
≥1 Dose MMR,,HHS Regions/National,Region 5,2014,Age,13 Months,59.8,56.7 to 62.8,1726
≥1 Dose MMR,,HHS Regions/National,Region 5,2014-2015,Age,13 Months,58.7,56.5 to 60.9,3461
≥1 Dose Varicella,,HHS Regions/National,Region 5,2012,Age,19 Months,84.8,82.4 to 87.0,1752
≥1 Dose Varicella,,HHS Regions/National,Region 5,2011,Age,19 Months,84.4,81.0 to 87.3,1771
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019,Age,13 Months,57.6,54.5 to 60.5,2023
≥1 Dose MMR,,HHS Regions/National,Region 5,2013,Age,13 Months,53.1,48.6 to 57.4,1730
≥1 Dose MMR,,HHS Regions/National,Region 5,2013-2014,Age,13 Months,56.4,52.9 to 59.8,3456
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018,Age,13 Months,61.6,58.7 to 64.3,2204
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018-2019,Age,13 Months,59.6,57.5 to 61.6,4227
DTaP,≥4 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,86.9,84.2 to 89.4,1726
DTaP,≥4 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,85.7,83.7 to 87.7,3461
DTaP,≥4 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,87.2,84.3 to 89.8,1752
DTaP,≥4 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,88.2,85.6 to 90.6,1730
DTaP,≥4 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,87.5,85.6 to 89.3,3456
Hep B,≥3 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,85.6,82.7 to 88.1,1752
Hep A,≥2 Doses,HHS Regions/National,Region 5,2019,Age,35 Months,82.9,79.5 to 86.0,2023
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,88.5,86.4 to 90.3,1726
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,86.0,84.4 to 87.5,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,87.9,85.7 to 89.9,1730
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,88.2,86.7 to 89.6,3456
Hep A,≥2 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,78.1,74.8 to 81.3,2019
Hep A,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,79.2,76.9 to 81.5,4223
Hep A,≥2 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,80.6,77.1 to 83.9,2204
Hep A,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,81.7,79.3 to 84.0,4227
Hep B,≥3 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,82.8,80.5 to 84.9,1771
Polio,≥2 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,87.1,84.7 to 89.1,1735
Polio,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,88.6,87.1 to 90.0,3570
Polio,≥2 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,87.9,84.8 to 90.3,1730
Polio,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,88.2,86.2 to 89.9,3456
Polio,≥2 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,88.5,86.3 to 90.3,1726
Polio,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,87.8,86.2 to 89.2,3461
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015,Age,13 Months,53.8,50.6 to 56.9,1735
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015-2016,Age,13 Months,55.9,53.7 to 58.2,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017,Age,13 Months,57.6,54.5 to 60.6,2019
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017-2018,Age,13 Months,59.6,57.5 to 61.6,4223
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016,Age,13 Months,58.1,55.0 to 61.2,1835
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016-2017,Age,13 Months,57.9,55.7 to 60.0,3854
≥1 Dose MMR,,HHS Regions/National,Region 5,2011,Age,13 Months,52.7,49.5 to 55.9,1771
≥1 Dose MMR,,HHS Regions/National,Region 5,2012,Age,13 Months,54.8,50.6 to 59.0,1752
Hep A,≥2 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,42.8,39.6 to 46.1,1726
Hep A,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,41.8,39.5 to 44.1,3461
Hep A,≥2 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,40.8,37.7 to 44.1,1735
Hep A,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,44.0,41.8 to 46.3,3570
DTaP,≥4 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,80.6,78.0 to 83.2,2019
DTaP,≥4 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,80.2,78.4 to 82.0,4223
DTaP,≥4 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,79.8,77.2 to 82.2,2204
DTaP,≥4 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,80.7,78.9 to 82.5,4227
≥1 Dose MMR,,HHS Regions/National,Region 5,2018,Age,13 Months,68.4,65.6 to 71.1,2204
≥1 Dose MMR,,HHS Regions/National,Region 5,2018-2019,Age,13 Months,66.1,64.0 to 68.1,4227
Hep B,≥1 Dose,HHS Regions/National,Region 5,2016,Age,3 Months,95.5,94.1 to 96.5,1835
Hep B,≥1 Dose,HHS Regions/National,Region 5,2016-2017,Age,3 Months,95.5,94.6 to 96.3,3854
Hep B,≥1 Dose,HHS Regions/National,Region 5,2015,Age,3 Months,93.7,92.1 to 95.0,1735
Hep B,≥1 Dose,HHS Regions/National,Region 5,2015-2016,Age,3 Months,94.6,93.6 to 95.5,3570
Hep B,≥1 Dose,HHS Regions/National,Region 5,2014,Age,3 Months,94.1,92.6 to 95.3,1726
Hep B,≥1 Dose,HHS Regions/National,Region 5,2014-2015,Age,3 Months,93.9,92.8 to 94.8,3461
Polio,≥2 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,93.6,91.6 to 95.2,1730
Polio,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,93.2,91.7 to 94.4,3456
Polio,≥2 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,89.2,87.1 to 91.1,2023
Polio,≥2 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,89.1,86.7 to 91.0,2019
Polio,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,89.2,87.7 to 90.5,4223
Polio,≥2 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,90.2,88.0 to 92.0,1835
Polio,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,89.6,88.1 to 91.0,3854
Hep B,≥1 Dose,HHS Regions/National,Region 5,2011,Age,3 Months,94.3,93.0 to 95.3,1771
Hep B,≥1 Dose,HHS Regions/National,Region 5,2012,Age,3 Months,93.2,91.1 to 94.8,1752
Hep B,≥1 Dose,HHS Regions/National,Region 5,2013,Age,3 Months,94.5,92.9 to 95.8,1730
Hep B,≥1 Dose,HHS Regions/National,Region 5,2013-2014,Age,3 Months,94.3,93.4 to 95.1,3456
Polio,≥2 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,89.3,87.4 to 91.0,2204
Polio,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,89.3,87.9 to 90.6,4227
DTaP,≥4 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,87.6,84.8 to 90.1,1771
DTaP,≥4 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,81.7,79.1 to 84.2,2023
Polio,≥2 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,93.0,91.0 to 94.6,1771
Polio,≥2 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,91.8,89.3 to 93.8,1752
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013,Age,19 Months,85.9,83.2 to 88.3,1730
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013-2014,Age,19 Months,86.2,84.4 to 87.9,3456
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015,Age,19 Months,83.3,80.2 to 86.0,1735
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015-2016,Age,19 Months,86.0,84.3 to 87.5,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014,Age,19 Months,86.5,84.1 to 88.5,1726
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014-2015,Age,19 Months,84.9,83.1 to 86.5,3461
≥1 Dose MMR,,HHS Regions/National,Region 5,2017,Age,13 Months,61.0,57.9 to 63.9,2019
≥1 Dose MMR,,HHS Regions/National,Region 5,2017-2018,Age,13 Months,64.7,62.6 to 66.7,4223
≥1 Dose MMR,,HHS Regions/National,Region 5,2016,Age,13 Months,62.4,59.3 to 65.4,1835
≥1 Dose MMR,,HHS Regions/National,Region 5,2016-2017,Age,13 Months,61.7,59.5 to 63.8,3854
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,88.2,85.9 to 90.2,2019
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,88.7,87.3 to 90.0,4223
DTaP,≥4 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,84.6,81.5 to 87.5,1735
DTaP,≥4 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,86.6,84.6 to 88.5,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,83.6,81.0 to 85.8,1735
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,86.4,84.8 to 87.9,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,89.2,87.2 to 91.0,1835
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,88.7,87.2 to 90.1,3854
DTaP,≥4 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,88.6,86.0 to 90.8,1835
DTaP,≥4 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,88.0,86.2 to 89.7,3854
DTaP,≥4 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,87.4,84.7 to 89.8,2019
DTaP,≥4 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,88.4,86.6 to 90.1,4223
≥1 Dose Varicella,,HHS Regions/National,Region 5,2012,Age,24 Months,88.1,85.7 to 90.2,1752
≥1 Dose Varicella,,HHS Regions/National,Region 5,2011,Age,24 Months,87.0,84.7 to 89.1,1771
≥1 Dose MMR,,HHS Regions/National,Region 5,2016,Age,19 Months,89.0,86.8 to 90.8,1835
≥1 Dose MMR,,HHS Regions/National,Region 5,2016-2017,Age,19 Months,88.0,86.4 to 89.5,3854
≥1 Dose MMR,,HHS Regions/National,Region 5,2015,Age,19 Months,83.5,80.8 to 85.9,1735
≥1 Dose MMR,,HHS Regions/National,Region 5,2015-2016,Age,19 Months,86.2,84.5 to 87.7,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,87.9,85.3 to 90.1,1735
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,90.0,88.6 to 91.3,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,91.5,89.7 to 93.1,1726
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,89.7,88.3 to 91.0,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,91.2,89.0 to 92.9,1730
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,91.4,90.0 to 92.5,3456
Hep B,≥2 Doses,HHS Regions/National,Region 5,2013,Age,5 Months,86.7,84.1 to 88.9,1730
Hep B,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,5 Months,87.6,86.2 to 88.9,3456
Hep B,≥2 Doses,HHS Regions/National,Region 5,2011,Age,5 Months,86.6,84.6 to 88.4,1771
Hep B,≥2 Doses,HHS Regions/National,Region 5,2012,Age,5 Months,86.2,84.4 to 87.8,1752
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2011,Age,0-1 Days,63.3,59.6 to 66.9,1771
Hep B,≥1 Dose,HHS Regions/National,Region 5,2018,Age,3 Months,96.4,95.2 to 97.3,2204
Hep B,≥1 Dose,HHS Regions/National,Region 5,2018-2019,Age,3 Months,96.4,95.5 to 97.1,4227
Polio,≥2 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,92.8,91.0 to 94.2,1726
Polio,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,92.4,91.2 to 93.5,3461
Hep B,≥1 Dose,HHS Regions/National,Region 5,2019,Age,3 Months,96.4,95.1 to 97.4,2023
DTaP,≥4 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,89.6,86.9 to 91.9,2204
DTaP,≥4 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,89.3,87.4 to 91.0,4227
≥1 Dose MMR,,HHS Regions/National,Region 5,2012,Age,19 Months,85.8,82.8 to 88.3,1752
≥1 Dose MMR,,HHS Regions/National,Region 5,2014,Age,19 Months,87.5,85.2 to 89.4,1726
≥1 Dose MMR,,HHS Regions/National,Region 5,2014-2015,Age,19 Months,85.5,83.7 to 87.0,3461
≥1 Dose MMR,,HHS Regions/National,Region 5,2013,Age,19 Months,86.5,84.0 to 88.6,1730
≥1 Dose MMR,,HHS Regions/National,Region 5,2013-2014,Age,19 Months,87.0,85.2 to 88.5,3456
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017,Age,19 Months,86.4,83.8 to 88.6,2019
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017-2018,Age,19 Months,86.8,85.1 to 88.3,4223
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018,Age,19 Months,87.2,84.9 to 89.2,2204
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018-2019,Age,19 Months,59.6,57.5 to 61.6,4227
Hep B,≥1 Dose,HHS Regions/National,Region 5,2017,Age,3 Months,95.5,94.2 to 96.5,2019
Hep B,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,3 Months,95.9,95.1 to 96.6,4223
Polio,≥2 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,94.2,92.6 to 95.5,1835
Polio,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,93.8,92.5 to 94.8,3854
Polio,≥2 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,92.1,90.2 to 93.7,1735
Polio,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,93.2,92.0 to 94.2,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016,Age,19 Months,88.7,86.5 to 90.5,1835
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016-2017,Age,19 Months,87.5,85.9 to 89.0,3854
≥1 Dose MMR,,HHS Regions/National,Region 5,2019,Age,13 Months,63.7,60.6 to 66.7,2023
PCV,≥3 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,64.5,60.5 to 68.2,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,64.0,60.9 to 67.0,1726
PCV,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,63.5,61.3 to 65.7,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,92.1,90.3 to 93.7,1835
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,91.4,90.0 to 92.6,3854
PCV,≥3 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,65.7,61.2 to 69.9,1771
PCV,≥3 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,63.5,59.0 to 67.9,1730
PCV,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,63.8,61.3 to 66.2,3456
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2012,Age,0-1 Days,66.1,61.5 to 70.3,1752
Hep B,≥2 Doses,HHS Regions/National,Region 5,2014,Age,5 Months,88.5,86.4 to 90.2,1726
Hep B,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,5 Months,86.8,85.6 to 87.8,3461
Hep B,≥2 Doses,HHS Regions/National,Region 5,2016,Age,5 Months,89.1,87.0 to 91.0,1835
Hep B,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,5 Months,88.8,87.3 to 90.2,3854
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,90.6,88.4 to 92.4,2019
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,91.2,89.9 to 92.4,4223
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,91.9,90.2 to 93.3,2204
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,89.3,87.9 to 90.6,4227
Hep B,≥2 Doses,HHS Regions/National,Region 5,2015,Age,5 Months,85.0,82.7 to 87.1,1735
Hep B,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,5 Months,87.1,85.5 to 88.5,3570
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2014,Age,0-1 Days,65.9,62.9 to 68.8,1726
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2014-2015,Age,0-1 Days,65.1,62.9 to 67.2,3461
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2013,Age,0-1 Days,64.5,61.7 to 67.1,1730
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2013-2014,Age,0-1 Days,65.2,63.3 to 67.0,3456
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013,Age,24 Months,89.5,87.2 to 91.6,1730
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013-2014,Age,24 Months,89.5,88.0 to 90.9,3456
Polio,≥2 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,93.3,91.3 to 94.9,2019
Polio,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,94.1,93.0 to 95.1,4223
Polio,≥2 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,95.0,93.6 to 96.0,2204
Polio,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,94.4,93.3 to 95.3,4227
Polio,≥2 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,93.8,92.1 to 95.2,2023
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019,Age,19 Months,87.7,85.4 to 89.6,2023
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016,Age,24 Months,91.0,89.0 to 92.7,1835
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016-2017,Age,24 Months,90.2,88.7 to 91.6,3854
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015,Age,24 Months,87.6,85.3 to 89.7,1735
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015-2016,Age,24 Months,89.3,87.8 to 90.7,3570
≥1 Dose MMR,,HHS Regions/National,Region 5,2012,Age,24 Months,89.6,87.4 to 91.6,1752
≥1 Dose MMR,,HHS Regions/National,Region 5,2011,Age,24 Months,89.6,87.5 to 91.4,1771
PCV,≥4 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,74.3,70.7 to 77.6,1771
PCV,≥4 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,77.3,73.7 to 80.5,1752
PCV,≥4 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,76.2,73.9 to 78.4,1730
PCV,≥4 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,76.8,74.8 to 78.7,3456
≥1 Dose MMR,,HHS Regions/National,Region 5,2018,Age,19 Months,87.2,84.9 to 89.2,2204
≥1 Dose MMR,,HHS Regions/National,Region 5,2018-2019,Age,19 Months,94.4,93.3 to 95.2,4227
≥1 Dose MMR,,HHS Regions/National,Region 5,2019,Age,19 Months,88.1,85.9 to 90.0,2023
≥1 Dose MMR,,HHS Regions/National,Region 5,2017,Age,19 Months,87.0,84.5 to 89.2,2019
≥1 Dose MMR,,HHS Regions/National,Region 5,2017-2018,Age,19 Months,87.1,85.4 to 88.6,4223
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017,Age,24 Months,89.4,87.0 to 91.4,2019
≥1 Dose Varicella,,HHS Regions/National,Region 5,2017-2018,Age,24 Months,89.6,88.1 to 91.0,4223
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019,Age,24 Months,90.8,88.8 to 92.6,2023
≥1 Dose MMR,,HHS Regions/National,Region 5,2013,Age,24 Months,89.4,87.1 to 91.4,1730
≥1 Dose MMR,,HHS Regions/National,Region 5,2013-2014,Age,24 Months,89.8,88.2 to 91.2,3456
≥1 Dose MMR,,HHS Regions/National,Region 5,2014,Age,24 Months,90.2,88.1 to 92.0,1726
≥1 Dose MMR,,HHS Regions/National,Region 5,2014-2015,Age,24 Months,89.2,87.7 to 90.6,3461
≥1 Dose MMR,,HHS Regions/National,Region 5,2015,Age,24 Months,88.3,86.0 to 90.3,1735
≥1 Dose MMR,,HHS Regions/National,Region 5,2015-2016,Age,24 Months,89.8,88.3 to 91.1,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018,Age,24 Months,89.8,87.7 to 91.7,2204
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018-2019,Age,24 Months,90.3,88.9 to 91.6,4227
PCV,≥4 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,80.3,77.7 to 82.7,1835
PCV,≥4 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,79.6,77.7 to 81.4,3854
PCV,≥4 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,72.4,69.5 to 75.1,1735
PCV,≥4 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,76.4,74.3 to 78.3,3570
PCV,≥4 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,77.4,74.5 to 80.0,1726
PCV,≥4 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,74.9,72.8 to 76.8,3461
PCV,≥3 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,63.1,59.9 to 66.1,1735
PCV,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,65.2,63.0 to 67.3,3570
PCV,≥3 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,68.9,66.0 to 71.7,2019
PCV,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,68.6,66.6 to 70.5,4223
Hep B,≥3 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,90.3,88.3 to 92.1,1752
PCV,≥3 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,67.3,64.2 to 70.2,1835
PCV,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,68.1,65.9 to 70.2,3854
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,91.8,89.9 to 93.5,1730
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,92.3,91.0 to 93.4,3456
Hep B,≥3 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,89.8,87.7 to 91.7,1771
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,92.3,90.5 to 93.8,2023
Hep B,≥2 Doses,HHS Regions/National,Region 5,2013,Age,7 Months,90.6,88.4 to 92.5,1730
Hep B,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,7 Months,91.3,90.1 to 92.4,3456
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2012,Age,0-2 Days,74.4,71.2 to 77.3,1752
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2013,Age,0-2 Days,72.6,68.8 to 76.1,1730
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2013-2014,Age,0-2 Days,72.5,70.3 to 74.7,3456
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2018,Age,0-1 Days,76.2,73.6 to 78.5,2204
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2018-2019,Age,0-1 Days,76.8,74.9 to 78.5,4227
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2011,Age,0-2 Days,71.6,67.2 to 75.6,1771
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2019,Age,0-1 Days,77.4,74.7 to 79.9,2023
Hep B,≥2 Doses,HHS Regions/National,Region 5,2012,Age,7 Months,89.7,87.7 to 91.5,1752
Hep B,≥2 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,92.0,90.3 to 93.4,1726
Hep B,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,90.4,89.1 to 91.6,3461
PCV,≥3 Doses,HHS Regions/National,Region 5,2018,Age,7 Months,68.2,65.4 to 70.9,2204
PCV,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,7 Months,67.8,65.7 to 69.8,4227
PCV,≥3 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,86.1,83.3 to 88.6,1771
PCV,≥3 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,67.3,64.3 to 70.2,2023
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,92.6,91.0 to 94.1,1726
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,90.9,89.6 to 92.1,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,89.1,87.0 to 91.0,1735
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,90.7,89.4 to 92.0,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,92.4,90.6 to 94.0,1835
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,91.8,90.4 to 93.0,3854
PCV,≥3 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,86.0,82.7 to 88.8,1752
≥1 Dose MMR,,HHS Regions/National,Region 5,2016,Age,24 Months,91.3,89.4 to 93.0,1835
≥1 Dose MMR,,HHS Regions/National,Region 5,2016-2017,Age,24 Months,90.7,89.2 to 92.0,3854
≥1 Dose MMR,,HHS Regions/National,Region 5,2017,Age,24 Months,90.0,87.7 to 92.0,2019
≥1 Dose MMR,,HHS Regions/National,Region 5,2017-2018,Age,24 Months,89.9,88.4 to 91.4,4223
PCV,≥4 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,78.9,76.2 to 81.5,2019
PCV,≥4 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,78.4,76.5 to 80.2,4223
PCV,≥4 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,77.9,75.3 to 80.3,2204
PCV,≥4 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,78.8,76.6 to 80.8,3417
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2015,Age,0-2 Days,72.3,69.3 to 75.1,1735
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2015-2016,Age,0-2 Days,74.5,72.5 to 76.4,3570
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2014,Age,0-2 Days,72.5,69.6 to 75.2,1726
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2014-2015,Age,0-2 Days,72.4,70.3 to 74.4,3461
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2017,Age,0-1 Days,72.0,69.1 to 74.6,2019
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2017-2018,Age,0-1 Days,74.0,72.2 to 75.8,4223
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2016,Age,0-1 Days,70.1,67.2 to 73.0,1835
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2016-2017,Age,0-1 Days,71.0,69.0 to 73.0,3854
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014,Age,24 Months,89.5,87.4 to 91.4,1726
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014-2015,Age,24 Months,88.6,87.0 to 90.0,3461
Hep B,≥2 Doses,HHS Regions/National,Region 5,2017,Age,5 Months,88.5,86.3 to 90.4,2019
Hep B,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,5 Months,89.4,88.0 to 90.7,4223
Hep B,≥2 Doses,HHS Regions/National,Region 5,2011,Age,7 Months,90.1,87.9 to 91.9,1771
Hep B,≥2 Doses,HHS Regions/National,Region 5,2019,Age,5 Months,90.9,89.1 to 92.5,2023
Hep B,≥2 Doses,HHS Regions/National,Region 5,2018,Age,5 Months,90.3,88.5 to 91.9,2204
Hep B,≥2 Doses,HHS Regions/National,Region 5,2018-2019,Age,5 Months,90.6,89.4 to 91.8,4227
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2015,Age,0-1 Days,64.3,61.2 to 67.4,1735
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 5,2015-2016,Age,0-1 Days,67.2,65.1 to 69.3,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014,Age,35 Months,91.6,89.6 to 93.4,1726
≥1 Dose Varicella,,HHS Regions/National,Region 5,2014-2015,Age,35 Months,91.4,89.8 to 92.8,3461
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015,Age,35 Months,91.2,88.8 to 93.3,1735
≥1 Dose Varicella,,HHS Regions/National,Region 5,2015-2016,Age,35 Months,92.5,91.0 to 93.9,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2012,Age,35 Months,92.9,90.9 to 94.7,1752
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013,Age,35 Months,92.2,89.8 to 94.2,1730
≥1 Dose Varicella,,HHS Regions/National,Region 5,2013-2014,Age,35 Months,91.9,90.4 to 93.3,3456
PCV,≥4 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,79.5,76.8 to 82.0,2023
Hep B,≥2 Doses,HHS Regions/National,Region 5,2017,Age,7 Months,91.5,89.5 to 93.2,2019
Hep B,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,7 Months,92.1,90.8 to 93.2,4223
PCV,≥3 Doses,HHS Regions/National,Region 5,2013,Age,13 Months,88.0,86.0 to 89.8,1730
PCV,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,13 Months,87.4,85.9 to 88.8,3456
Hep B,≥2 Doses,HHS Regions/National,Region 5,2016,Age,7 Months,92.8,91.1 to 94.3,1835
Hep B,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,7 Months,92.2,90.9 to 93.3,3854
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2016,Age,0-2 Days,76.7,73.9 to 79.2,1835
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 5,2016-2017,Age,0-2 Days,77.2,75.3 to 79.0,3854
PCV,≥3 Doses,HHS Regions/National,Region 5,2015,Age,13 Months,84.0,81.4 to 86.3,1735
PCV,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,13 Months,86.5,84.8 to 88.0,3570
PCV,≥3 Doses,HHS Regions/National,Region 5,2014,Age,13 Months,86.8,84.4 to 88.8,1726
PCV,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,13 Months,85.4,83.7 to 87.0,3461
Hep B,≥2 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,88.8,86.7 to 90.7,1735
Hep B,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,90.8,89.5 to 92.0,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,93.3,91.8 to 94.7,2204
Hep B,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,93.1,92.0 to 94.1,4227
≥1 Dose MMR,,HHS Regions/National,Region 5,2013,Age,35 Months,91.8,89.5 to 93.8,1730
≥1 Dose MMR,,HHS Regions/National,Region 5,2013-2014,Age,35 Months,92.0,90.5 to 93.4,3456
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016,Age,35 Months,93.8,91.9 to 95.4,1835
≥1 Dose Varicella,,HHS Regions/National,Region 5,2016-2017,Age,35 Months,93.2,91.7 to 94.4,3854
≥1 Dose MMR,,HHS Regions/National,Region 5,2012,Age,35 Months,93.9,92.0 to 95.5,1752
≥1 Dose MMR,,HHS Regions/National,Region 5,2011,Age,35 Months,93.5,91.2 to 95.3,1771
≥1 Dose MMR,,HHS Regions/National,Region 5,2018,Age,24 Months,89.9,87.7 to 91.8,2204
≥1 Dose MMR,,HHS Regions/National,Region 5,2018-2019,Age,24 Months,90.1,88.7 to 91.5,4227
≥1 Dose MMR,,HHS Regions/National,Region 5,2019,Age,24 Months,90.4,88.4 to 92.2,2023
PCV,≥4 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,80.5,77.8 to 83.2,1730
PCV,≥4 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,80.7,78.7 to 82.5,3456
PCV,≥4 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,80.8,78.1 to 83.3,1726
PCV,≥4 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,79.0,77.1 to 80.9,3461
PCV,≥4 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,81.0,78.3 to 83.7,1752
Hep B,≥3 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,91.3,89.3 to 93.1,1771
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,91.2,89.1 to 93.0,2019
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,92.2,91.0 to 93.4,4223
Hep B,≥3 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,92.8,91.1 to 94.3,2023
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,93.1,91.4 to 94.6,1835
Hep B,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,92.7,91.3 to 93.9,3854
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,91.5,89.2 to 93.4,1735
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,92.2,90.8 to 93.4,3570
PCV,≥3 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,91.0,88.8 to 92.8,1730
PCV,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,90.7,89.3 to 91.9,3456
PCV,≥3 Doses,HHS Regions/National,Region 5,2011,Age,19 Months,89.8,87.8 to 91.4,1771
PCV,≥3 Doses,HHS Regions/National,Region 5,2019,Age,13 Months,88.9,86.7 to 90.8,2023
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,92.2,90.2 to 94.0,2019
Hep B,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,94.0,92.6 to 95.1,4223
PCV,≥3 Doses,HHS Regions/National,Region 5,2012,Age,19 Months,89.7,86.1 to 92.5,1752
PCV,≥4 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,83.4,80.5 to 86.1,1752
PCV,≥4 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,82.8,79.9 to 85.6,1771
PCV,≥4 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,83.1,80.5 to 85.5,2023
PCV,≥4 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,82.2,79.7 to 84.5,2204
PCV,≥4 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,82.6,80.9 to 84.3,4227
Hep A,≥1 Dose,HHS Regions/National,Region 5,2020,Age,35 Months,93.2,91.5 to 94.7,2239
PCV,≥3 Doses,HHS Regions/National,Region 5,2016,Age,13 Months,89.0,86.8 to 90.8,1835
PCV,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,13 Months,88.4,86.8 to 89.9,3854
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,93.0,91.1 to 94.6,1730
Hep B,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,93.4,92.1 to 94.5,3456
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,93.7,92.1 to 95.1,1726
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,92.6,91.2 to 93.8,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,92.2,90.3 to 94.0,1752
Hep B,≥2 Doses,HHS Regions/National,Region 5,2012,Age,13 Months,92.8,90.9 to 94.4,1752
Hep B,≥2 Doses,HHS Regions/National,Region 5,2011,Age,13 Months,92.7,91.1 to 94.0,1771
Hep B,≥2 Doses,HHS Regions/National,Region 5,2019,Age,7 Months,93.5,91.9 to 94.9,2023
PCV,≥3 Doses,HHS Regions/National,Region 5,2017,Age,13 Months,87.9,85.5 to 90.0,2019
PCV,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,13 Months,88.4,86.8 to 89.8,4223
PCV,≥3 Doses,HHS Regions/National,Region 5,2018,Age,13 Months,88.8,86.8 to 90.6,2204
PCV,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,13 Months,88.9,87.4 to 90.2,4227
PCV,≥4 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,83.4,80.9 to 85.7,1835
PCV,≥4 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,82.5,80.7 to 84.2,3854
PCV,≥4 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,81.6,78.9 to 84.1,2019
PCV,≥4 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,81.9,80.1 to 83.6,4223
≥1 Dose MMR,,HHS Regions/National,Region 5,2015,Age,35 Months,92.9,90.5 to 94.8,1735
≥1 Dose MMR,,HHS Regions/National,Region 5,2015-2016,Age,35 Months,92.9,91.4 to 94.2,3570
≥1 Dose MMR,,HHS Regions/National,Region 5,2014,Age,35 Months,92.3,90.2 to 94.0,1726
≥1 Dose MMR,,HHS Regions/National,Region 5,2014-2015,Age,35 Months,92.5,91.0 to 93.8,3461
≥1 Dose MMR,,HHS Regions/National,Region 5,2016,Age,35 Months,93.1,91.2 to 94.7,1835
≥1 Dose MMR,,HHS Regions/National,Region 5,2016-2017,Age,35 Months,92.9,91.5 to 94.2,3854
PCV,≥4 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,77.3,74.4 to 80.0,1735
PCV,≥4 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,80.3,78.4 to 82.1,3570
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018,Age,35 Months,94.1,92.2 to 95.7,2204
≥1 Dose Varicella,,HHS Regions/National,Region 5,2018-2019,Age,35 Months,94.4,93.0 to 95.6,4227
≥1 Dose Varicella,,HHS Regions/National,Region 5,2019,Age,35 Months,94.6,92.5 to 96.2,2023
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015,Age,7 Months,56.3,53.2 to 59.5,1735
Hep B,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,7 Months,58.3,56.1 to 60.5,3570
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014,Age,7 Months,60.6,57.6 to 63.6,1726
Hep B,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,7 Months,58.5,56.3 to 60.7,3461
Polio,≥2 Doses,HHS Regions/National,Region 5,2017,Age,5 Months,79.1,76.4 to 81.6,2019
Polio,≥2 Doses,HHS Regions/National,Region 5,2017-2018,Age,5 Months,78.6,76.8 to 80.4,4223
Polio,≥2 Doses,HHS Regions/National,Region 5,2016,Age,5 Months,79.2,76.5 to 81.7,1835
Polio,≥2 Doses,HHS Regions/National,Region 5,2016-2017,Age,5 Months,79.2,77.2 to 81.0,3854
Hep A,≥1 Dose,HHS Regions/National,Region 5,2017,Age,35 Months,90.0,87.6 to 92.1,2019
Hep A,≥1 Dose,HHS Regions/National,Region 5,2017-2018,Age,35 Months,91.1,89.5 to 92.6,4223
Hib,Primary Series,HHS Regions/National,Region 5,2011,Age,7 Months,70.1,65.5 to 74.3,1771
Hib,Primary Series,HHS Regions/National,Region 5,2012,Age,7 Months,68.3,64.2 to 72.0,1752
Hib,Full Series,HHS Regions/National,Region 5,2019,Age,35 Months,83.5,80.8 to 86.0,2023
Hib,Full Series,HHS Regions/National,Region 5,2018,Age,35 Months,83.9,81.1 to 86.6,2204
Hib,Full Series,HHS Regions/National,Region 5,2018-2019,Age,35 Months,83.8,81.8 to 85.7,4227
Polio,≥3 Doses,HHS Regions/National,Region 5,2018,Age,35 Months,93.9,92.2 to 95.4,2204
Polio,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,35 Months,94.5,93.2 to 95.5,4227
Hib,Full Series,HHS Regions/National,Region 5,2016,Age,35 Months,84.8,82.3 to 87.2,1835
Hib,Full Series,HHS Regions/National,Region 5,2016-2017,Age,35 Months,84.5,82.5 to 86.4,3854
Hib,Full Series,HHS Regions/National,Region 5,2014,Age,35 Months,83.0,80.4 to 85.5,1726
Hib,Full Series,HHS Regions/National,Region 5,2014-2015,Age,35 Months,81.2,79.2 to 83.2,3461
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,92.3,90.5 to 93.7,2204
DTaP,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,89.8,88.4 to 91.0,4227
Polio,≥3 Doses,HHS Regions/National,Region 5,2012,Age,35 Months,92.6,90.6 to 94.4,1752
Hib,Full Series,HHS Regions/National,Region 5,2019,Age,24 Months,79.6,77.0 to 82.2,2023
Polio,≥3 Doses,HHS Regions/National,Region 5,2013,Age,35 Months,94.0,92.2 to 95.6,1730
Polio,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,35 Months,93.7,92.3 to 94.9,3456
Polio,≥3 Doses,HHS Regions/National,Region 5,2014,Age,35 Months,93.4,91.6 to 95.0,1726
Polio,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,35 Months,93.3,92.0 to 94.4,3461
Hib,Full Series,HHS Regions/National,Region 5,2017,Age,35 Months,84.1,81.0 to 86.9,2019
Hib,Full Series,HHS Regions/National,Region 5,2017-2018,Age,35 Months,84.0,81.9 to 85.9,4223
Hib,Full Series,HHS Regions/National,Region 5,2015,Age,35 Months,79.4,76.3 to 82.3,1735
Hib,Full Series,HHS Regions/National,Region 5,2015-2016,Age,35 Months,82.1,80.1 to 84.0,3570
Hib,Full Series,HHS Regions/National,Region 5,2013,Age,35 Months,83.8,81.0 to 86.3,1730
Hib,Full Series,HHS Regions/National,Region 5,2013-2014,Age,35 Months,83.4,81.5 to 85.2,3456
Hib,Full Series,HHS Regions/National,Region 5,2012,Age,35 Months,82.2,79.3 to 85.0,1752
Hib,Full Series,HHS Regions/National,Region 5,2011,Age,35 Months,84.9,81.9 to 87.7,1771
Hib,Full Series,HHS Regions/National,Region 5,2018,Age,24 Months,78.3,75.8 to 80.8,2204
Hib,Full Series,HHS Regions/National,Region 5,2018-2019,Age,24 Months,79.0,77.1 to 80.7,4227
Hib,≥2 Doses,HHS Regions/National,Region 5,2020,Age,13 Months,92.5,90.8 to 93.9,2239
DTaP,≥2 Doses,HHS Regions/National,Region 5,2011,Age,5 Months,78.8,74.6 to 82.4,1771
DTaP,≥2 Doses,HHS Regions/National,Region 5,2012,Age,5 Months,77.6,74.2 to 80.7,1752
DTaP,≥2 Doses,HHS Regions/National,Region 5,2013,Age,5 Months,74.9,71.3 to 78.2,1730
DTaP,≥2 Doses,HHS Regions/National,Region 5,2013-2014,Age,5 Months,76.8,74.2 to 79.3,3456
Polio,≥3 Doses,HHS Regions/National,Region 5,2015,Age,35 Months,93.3,91.4 to 94.8,1735
Polio,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,35 Months,93.8,92.6 to 94.8,3570
DTaP,≥2 Doses,HHS Regions/National,Region 5,2015,Age,5 Months,76.5,73.6 to 79.2,1735
DTaP,≥2 Doses,HHS Regions/National,Region 5,2015-2016,Age,5 Months,78.2,76.2 to 80.0,3570
Polio,≥3 Doses,HHS Regions/National,Region 5,2016,Age,35 Months,94.4,92.8 to 95.7,1835
Polio,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,35 Months,93.8,92.5 to 94.9,3854
Polio,≥3 Doses,HHS Regions/National,Region 5,2017,Age,35 Months,93.3,91.3 to 95.0,2019
Polio,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,35 Months,93.6,92.3 to 94.8,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,92.1,90.2 to 93.8,1771
Hib,≥3 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,89.8,87.6 to 91.8,1752
Hib,≥3 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,92.5,90.7 to 94.1,1730
Hib,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,91.6,90.2 to 92.8,3456
DTaP,≥2 Doses,HHS Regions/National,Region 5,2014,Age,5 Months,78.7,76.0 to 81.2,1726
DTaP,≥2 Doses,HHS Regions/National,Region 5,2014-2015,Age,5 Months,77.6,75.2 to 79.8,3461
Hib,Full Series,HHS Regions/National,Region 5,2016,Age,24 Months,82.4,79.8 to 84.8,1835
Hib,Full Series,HHS Regions/National,Region 5,2016-2017,Age,24 Months,81.1,79.2 to 82.9,3854
Hib,Full Series,HHS Regions/National,Region 5,2017,Age,24 Months,79.8,77.1 to 82.3,2019
Hib,Full Series,HHS Regions/National,Region 5,2017-2018,Age,24 Months,79.1,77.2 to 80.9,4223
Polio,≥3 Doses,HHS Regions/National,Region 5,2011,Age,35 Months,94.0,92.2 to 95.5,1771
Polio,≥3 Doses,HHS Regions/National,Region 5,2017,Age,24 Months,91.3,89.2 to 93.1,2019
Polio,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,24 Months,92.0,90.7 to 93.2,4223
Polio,≥3 Doses,HHS Regions/National,Region 5,2018,Age,24 Months,92.7,91.1 to 94.1,2204
Polio,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,24 Months,93.0,91.8 to 94.0,4227
Polio,≥3 Doses,HHS Regions/National,Region 5,2019,Age,24 Months,93.2,91.5 to 94.7,2023
Hib,≥3 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,88.5,86.4 to 90.4,2023
DTaP,≥3 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,92.2,90.2 to 93.9,1752
DTaP,≥3 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,93.5,91.7 to 95.1,1771
DTaP,≥3 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,92.9,91.1 to 94.3,2023
Hib,Full Series,HHS Regions/National,Region 5,2015,Age,24 Months,75.0,72.1 to 77.9,1735
Hib,Full Series,HHS Regions/National,Region 5,2015-2016,Age,24 Months,78.7,76.7 to 80.6,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,94.0,92.3 to 95.5,1730
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,93.7,92.5 to 94.8,3456
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,94.0,92.2 to 95.5,2383
Hib,≥3 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,88.6,86.6 to 90.3,2204
Hib,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,68.7,66.8 to 70.6,4227
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,93.8,92.0 to 95.1,1835
DTaP,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,92.6,91.2 to 93.8,3854
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,91.5,89.3 to 93.3,2019
DTaP,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,91.9,90.5 to 93.1,4223
Hib,≥3 Doses,HHS Regions/National,Region 5,2016,Age,19 Months,90.6,88.6 to 92.3,1835
Hib,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,19 Months,89.0,87.4 to 90.4,3854
Polio,≥3 Doses,HHS Regions/National,Region 5,2016,Age,24 Months,93.9,92.3 to 95.3,1835
Polio,≥3 Doses,HHS Regions/National,Region 5,2016-2017,Age,24 Months,92.6,91.3 to 93.8,3854
Hib,≥3 Doses,HHS Regions/National,Region 5,2017,Age,19 Months,87.4,84.9 to 89.5,2019
Hib,≥3 Doses,HHS Regions/National,Region 5,2017-2018,Age,19 Months,88.0,86.4 to 89.4,4223
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,90.8,88.0 to 93.0,1735
DTaP,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,92.3,91.0 to 93.4,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,91.9,89.9 to 93.4,1726
DTaP,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,91.3,90.0 to 92.5,3461
Hep B,≥3 Doses,HHS Regions/National,Region 5,2020,Age,24 Months,91.0,89.3 to 92.6,2239
Hib,≥3 Doses,HHS Regions/National,Region 5,2015,Age,19 Months,86.4,83.6 to 88.8,1735
Hib,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,19 Months,88.5,86.9 to 89.9,3570
Polio,≥3 Doses,HHS Regions/National,Region 5,2013,Age,24 Months,92.4,90.4 to 94.0,1730
Polio,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,24 Months,92.3,91.0 to 93.5,3456
Hib,≥3 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,90.4,88.2 to 92.2,1730
Hib,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,89.5,88.1 to 90.7,3456
Hib,≥3 Doses,HHS Regions/National,Region 5,2014,Age,19 Months,88.5,86.4 to 90.4,1726
Hib,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,19 Months,87.5,85.9 to 88.9,3461
Polio,≥3 Doses,HHS Regions/National,Region 5,2012,Age,24 Months,91.1,89.0 to 92.9,1752
Polio,≥3 Doses,HHS Regions/National,Region 5,2011,Age,24 Months,92.5,90.7 to 94.1,1771
Polio,≥3 Doses,HHS Regions/National,Region 5,2019,Age,19 Months,91.9,90.0 to 93.5,2023
Polio,≥3 Doses,HHS Regions/National,Region 5,2018,Age,19 Months,91.5,89.8 to 93.0,2204
Polio,≥3 Doses,HHS Regions/National,Region 5,2018-2019,Age,19 Months,66.1,64.0 to 68.1,4227
Polio,≥3 Doses,HHS Regions/National,Region 5,2014,Age,24 Months,92.2,90.5 to 93.8,1726
Polio,≥3 Doses,HHS Regions/National,Region 5,2014-2015,Age,24 Months,91.8,90.5 to 93.0,3461
Polio,≥3 Doses,HHS Regions/National,Region 5,2015,Age,24 Months,91.4,89.6 to 93.1,1735
Polio,≥3 Doses,HHS Regions/National,Region 5,2015-2016,Age,24 Months,92.7,91.4 to 93.8,3570
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013,Age,19 Months,92.9,91.1 to 94.3,1730
DTaP,≥3 Doses,HHS Regions/National,Region 5,2013-2014,Age,19 Months,92.4,90.9 to 93.6,3456
Hib,≥3 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,94.5,92.4 to 96.1,1991
Hib,≥3 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,92.1,89.7 to 94.1,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2012,Age,24 Months,80.3,77.3 to 83.0,1991
Hep A,≥1 Dose,HHS Regions/National,Region 4,2019,Age,19 Months,83.8,81.2 to 86.2,2383
Hep A,≥1 Dose,HHS Regions/National,Region 4,2011,Age,24 Months,77.9,74.6 to 81.0,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2013,Age,24 Months,81.2,78.6 to 83.7,2020
Hep A,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,24 Months,80.2,78.3 to 82.1,4120
Hep A,≥2 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,20.9,18.5 to 23.5,1848
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,93.4,90.9 to 95.5,2100
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,94.8,93.4 to 96.0,4318
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,96.1,94.6 to 97.3,2020
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,94.8,93.4 to 95.9,4120
DTaP,≥3 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,95.2,93.4 to 96.7,1991
DTaP,≥3 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,93.8,91.7 to 95.6,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2018,Age,19 Months,80.2,76.8 to 83.3,2317
Hep A,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,19 Months,82.3,79.8 to 84.6,3710
Hep A,≥1 Dose,HHS Regions/National,Region 4,2017,Age,19 Months,78.7,75.7 to 81.5,2369
Hep A,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,19 Months,79.5,77.2 to 81.6,4686
Hep A,≥1 Dose,HHS Regions/National,Region 4,2016,Age,19 Months,77.3,74.1 to 80.1,2341
Hep A,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,19 Months,78.0,75.8 to 80.0,4710
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,94.2,92.3 to 95.7,2369
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,94.2,92.7 to 95.4,4686
DTaP,≥4 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,68.6,65.0 to 72.1,1848
DTaP,≥4 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,67.7,65.0 to 70.2,1991
PCV,≥2 Doses,HHS Regions/National,Region 4,2013,Age,5 Months,74.8,70.5 to 78.6,2020
PCV,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,5 Months,75.5,72.9 to 77.9,4120
PCV,≥2 Doses,HHS Regions/National,Region 4,2012,Age,5 Months,74.5,69.8 to 78.7,1991
PCV,≥2 Doses,HHS Regions/National,Region 4,2011,Age,5 Months,73.6,69.5 to 77.4,1848
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,96.4,95.1 to 97.5,2218
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,96.0,94.9 to 96.9,4559
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,95.6,93.8 to 97.0,2341
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,94.8,93.6 to 95.9,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,91.3,89.4 to 93.0,2218
Hib,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,91.6,90.2 to 92.8,4559
Hib,≥3 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,91.8,89.8 to 93.5,2341
Hib,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,91.1,89.6 to 92.4,4710
Hep A,≥1 Dose,HHS Regions/National,Region 4,2017,Age,24 Months,83.7,80.9 to 86.2,2369
Hep A,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,24 Months,83.7,81.5 to 85.7,4686
Hep A,≥1 Dose,HHS Regions/National,Region 4,2019,Age,24 Months,88.3,86.0 to 90.5,2383
Hep A,≥1 Dose,HHS Regions/National,Region 4,2011,Age,35 Months,86.0,82.3 to 89.3,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2018,Age,24 Months,83.7,80.5 to 86.7,2317
Hep A,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,24 Months,86.0,84.0 to 87.9,4700
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,96.2,94.1 to 97.8,2383
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,94.1,91.8 to 95.9,2317
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,95.1,93.5 to 96.4,4700
PCV,≥2 Doses,HHS Regions/National,Region 4,2015,Age,5 Months,76.6,73.7 to 79.3,2218
PCV,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,5 Months,76.6,74.5 to 78.5,4559
PCV,≥2 Doses,HHS Regions/National,Region 4,2016,Age,5 Months,76.5,73.4 to 79.3,2341
PCV,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,5 Months,75.6,73.5 to 77.7,4710
Hep A,≥1 Dose,HHS Regions/National,Region 4,2014,Age,24 Months,79.2,76.3 to 82.0,2100
Hep A,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,24 Months,80.6,78.6 to 82.5,4318
Hep A,≥1 Dose,HHS Regions/National,Region 4,2015,Age,24 Months,82.0,79.3 to 84.6,2218
Hep A,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,24 Months,82.7,80.8 to 84.6,4559
Hep A,≥1 Dose,HHS Regions/National,Region 4,2016,Age,24 Months,83.4,80.6 to 86.0,2341
Hep A,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,24 Months,83.6,81.6 to 85.4,4710
PCV,≥2 Doses,HHS Regions/National,Region 4,2014,Age,5 Months,76.2,73.1 to 79.1,2100
PCV,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,5 Months,76.4,74.5 to 78.3,4318
Hib,≥3 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,93.0,91.2 to 94.6,2218
Hib,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,93.3,92.0 to 94.5,4559
Hep A,≥2 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,24.5,22.4 to 26.7,2218
Hep A,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,24.0,22.1 to 26.0,4559
Hep A,≥2 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,23.4,20.7 to 26.4,2341
Hep A,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,23.6,21.7 to 25.6,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,94.1,92.4 to 95.6,2020
Hib,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,92.0,90.5 to 93.3,4120
Hib,≥3 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,89.9,87.5 to 92.0,2100
Hib,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,91.4,89.9 to 92.7,4318
Hib,≥3 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,92.4,90.4 to 94.0,2383
Hib,≥3 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,90.3,88.2 to 92.2,2369
Hib,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,90.4,88.7 to 91.8,4686
Hib,≥3 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,90.4,87.9 to 92.6,2317
Hib,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,91.4,89.8 to 92.8,4700
Hep A,≥2 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,24.3,21.2 to 27.7,2020
Hep A,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,22.8,20.4 to 25.5,4120
Hep A,≥2 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,21.4,18.7 to 24.3,2100
Hep A,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,23.0,21.0 to 25.0,4318
Hep A,≥2 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,20.1,17.5 to 23.0,1991
DTaP,≥2 Doses,HHS Regions/National,Region 4,2019,Age,5 Months,80.2,77.0 to 83.1,2383
PCV,≥4 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,80.9,78.9 to 82.9,4478
DTaP,≥3 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,69.6,65.9 to 73.0,1813
Hib,≥2 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,86.6,83.6 to 89.2,1813
Hep B,≥2 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,90.8,88.3 to 92.9,1813
DTaP,≥1 Dose,HHS Regions/National,Region 4,2012,Age,3 Months,88.2,86.2 to 89.9,1991
DTaP,≥1 Dose,HHS Regions/National,Region 4,2011,Age,3 Months,86.5,83.0 to 89.4,1848
DTaP,≥1 Dose,HHS Regions/National,Region 4,2013,Age,3 Months,89.2,87.5 to 90.6,2020
DTaP,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,3 Months,88.3,86.7 to 89.8,4120
DTaP,≥1 Dose,HHS Regions/National,Region 4,2014,Age,3 Months,87.5,84.9 to 89.7,2100
DTaP,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,3 Months,87.2,85.5 to 88.8,4318
DTaP,≥1 Dose,HHS Regions/National,Region 4,2015,Age,3 Months,87.0,84.5 to 89.2,2218
DTaP,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,3 Months,88.6,87.0 to 90.0,4559
DTaP,≥1 Dose,HHS Regions/National,Region 4,2016,Age,3 Months,90.2,88.1 to 92.0,2341
DTaP,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,3 Months,88.6,86.9 to 90.0,4710
Combined 7 Series,,HHS Regions/National,Region 4,2021,Age,35 Months,70.2,66.3 to 74.0,1813
Hib,≥1 Dose,HHS Regions/National,Region 4,2021,Age,3 Months,83.5,80.3 to 86.4,1813
≥1 Dose Varicella,,HHS Regions/National,Region 4,2021,Age,19 Months,87.0,84.1 to 89.4,1813
Hib,Primary Series,HHS Regions/National,Region 4,2021,Age,7 Months,68.0,64.3 to 71.6,1813
PCV,≥4 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,76.0,72.5 to 79.3,1813
Hib,Full Series,HHS Regions/National,Region 4,2020-2021,Age,24 Months,74.7,72.5 to 76.9,4478
Hib,Full Series,HHS Regions/National,Region 4,2021,Age,19 Months,68.1,64.3 to 71.6,1813
DTaP,≥1 Dose,HHS Regions/National,Region 4,2018,Age,3 Months,89.3,86.6 to 91.5,2317
DTaP,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,3 Months,90.2,88.5 to 91.7,4700
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,94.7,93.2 to 95.9,2218
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,94.3,93.1 to 95.3,4559
DTaP,≥1 Dose,HHS Regions/National,Region 4,2017,Age,3 Months,86.9,84.4 to 89.1,2369
DTaP,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,3 Months,88.1,86.3 to 89.7,4686
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,92.1,89.8 to 93.9,2100
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,93.4,92.1 to 94.5,4318
DTaP,≥1 Dose,HHS Regions/National,Region 4,2019,Age,3 Months,91.0,88.8 to 92.9,2383
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,93.9,92.1 to 95.4,2341
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,93.5,92.2 to 94.6,4710
Hep A,≥1 Dose,HHS Regions/National,Region 4,2011,Age,19 Months,71.6,67.3 to 75.6,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2014,Age,19 Months,75.7,72.6 to 78.5,2100
Hep A,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,19 Months,76.2,74.1 to 78.2,4318
Hep A,≥1 Dose,HHS Regions/National,Region 4,2015,Age,19 Months,76.8,72.7 to 80.4,2218
Hep A,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,19 Months,77.0,74.9 to 79.0,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,90.1,87.5 to 92.1,1813
DTaP,≥4 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,86.9,84.6 to 89.0,4478
Hep A,≥1 Dose,HHS Regions/National,Region 4,2012,Age,19 Months,74.9,71.3 to 78.2,1991
Hep A,≥1 Dose,HHS Regions/National,Region 4,2013,Age,19 Months,78.0,74.3 to 81.4,2020
Hep A,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,19 Months,76.8,73.9 to 79.5,4120
DTaP,≥2 Doses,HHS Regions/National,Region 4,2017,Age,5 Months,77.1,74.1 to 79.9,2369
DTaP,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,5 Months,77.9,75.7 to 80.0,4686
DTaP,≥2 Doses,HHS Regions/National,Region 4,2018,Age,5 Months,78.7,75.5 to 81.6,2317
DTaP,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,5 Months,79.5,77.3 to 81.6,4700
DTaP,≥2 Doses,HHS Regions/National,Region 4,2016,Age,5 Months,79.2,76.3 to 81.9,2341
DTaP,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,5 Months,78.2,76.1 to 80.1,4710
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,93.3,91.2 to 95.1,2317
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,93.7,92.3 to 94.9,4700
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,93.1,91.2 to 94.7,2369
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,93.2,91.8 to 94.5,4686
Hib,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,90.3,88.8 to 91.7,4318
Hep A,≥2 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,29.9,26.8 to 33.3,2383
Hep A,≥2 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,37.6,34.1 to 41.5,1848
Hep A,≥2 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,23.8,21.0 to 26.9,2317
Hep A,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,27.3,24.5 to 30.2,3710
Hib,≥3 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,93.6,91.6 to 95.2,2341
Hib,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,92.7,91.3 to 94.0,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,91.9,89.8 to 93.7,2369
Hib,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,92.4,90.6 to 93.9,4686
DTaP,≥4 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,70.3,67.7 to 72.7,2020
DTaP,≥4 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,69.3,67.3 to 71.3,4120
DTaP,≥4 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,68.4,65.1 to 71.6,2100
DTaP,≥4 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,70.1,67.9 to 72.2,4318
DTaP,≥4 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,71.8,67.6 to 75.5,2218
DTaP,≥4 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,70.2,68.0 to 72.3,4559
Hep A,≥2 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,23.8,21.2 to 26.5,2369
Hep A,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,23.8,21.8 to 25.8,4686
Hib,≥3 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,92.8,90.0 to 95.0,2317
Hib,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,93.3,91.6 to 94.8,4700
Hib,Primary Series,HHS Regions/National,Region 4,2021,Age,19 Months,91.3,88.9 to 93.2,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,92.7,90.3 to 94.8,1813
≥1 Dose MMR,,HHS Regions/National,Region 4,2021,Age,35 Months,93.1,90.3 to 95.3,1813
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,87.7,86.0 to 89.2,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,50.2,46.4 to 54.0,1813
Hib,Primary Series,HHS Regions/National,Region 4,2020-2021,Age,24 Months,92.3,90.9 to 93.5,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,88.4,85.9 to 90.6,1813
Hib,≥2 Doses,HHS Regions/National,Region 4,2021,Age,5 Months,75.4,71.9 to 78.6,1813
Polio,≥2 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,86.9,83.8 to 89.5,1813
Hib,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,90.3,88.8 to 91.7,4478
Polio,≥3 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,91.0,88.5 to 92.9,1813
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,92.1,90.6 to 93.3,4478
Hep B,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,93.9,92.6 to 95.0,4478
PCV,≥2 Doses,HHS Regions/National,Region 4,2021,Age,5 Months,77.2,73.7 to 80.3,1813
PCV,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,19 Months,90.5,86.6 to 93.4,620
Influenza,,States/Local Areas,District of Columbia,2013,Age,24 Months,58.5,51.3 to 65.9,293
Influenza,,States/Local Areas,District of Columbia,2013-2014,Age,24 Months,60.0,54.7 to 65.3,589
Influenza,,States/Local Areas,District of Columbia,2016,Age,24 Months,72.3,65.0 to 79.2,293
Influenza,,States/Local Areas,District of Columbia,2016-2017,Age,24 Months,68.7,63.5 to 73.8,607
Influenza,,States/Local Areas,District of Columbia,2014,Age,24 Months,61.7,54.2 to 69.2,296
Influenza,,States/Local Areas,District of Columbia,2014-2015,Age,24 Months,65.7,60.2 to 71.1,596
Influenza,,States/Local Areas,District of Columbia,2015,Age,24 Months,69.6,61.8 to 77.0,300
Influenza,,States/Local Areas,District of Columbia,2015-2016,Age,24 Months,71.1,65.8 to 76.2,593
Influenza,,States/Local Areas,District of Columbia,2011,Age,24 Months,59.6,51.1 to 68.4,261
Influenza,,States/Local Areas,District of Columbia,2012,Age,24 Months,64.9,57.4 to 72.3,315
Hib,Primary Series,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,71.7,64.4 to 77.9,463
Rotavirus,,States/Local Areas,District of Columbia,2021,Age,8 Months,76.7,65.5 to 85.1,170
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,87.6,82.1 to 92.0,463
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,53.5,46.0 to 61.4,463
Hib,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,84.1,74.2 to 90.7,170
Polio,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,90.1,85.2 to 94.0,463
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,90.2,85.2 to 94.1,463
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,88.4,83.0 to 92.7,463
Combined 7 Series,,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,73.7,66.7 to 80.3,463
Hib,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,3 Months,87.7,82.2 to 91.6,463
Polio,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,5 Months,79.3,72.5 to 84.7,463
Hib,Primary Series,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,87.2,81.6 to 91.2,463
Polio,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,89.7,84.3 to 93.4,463
Polio,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,88.6,83.0 to 92.5,463
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,5 Months,87.8,82.3 to 91.7,463
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,88.9,80.0 to 95.1,170
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,88.5,83.0 to 92.4,463
Hib,Full Series,States/Local Areas,District of Columbia,2021,Age,35 Months,79.4,69.4 to 87.9,170
Combined 7 Series,,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,71.2,64.3 to 77.9,463
PCV,≥4 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,86.2,80.5 to 91.0,463
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,90.6,80.9 to 95.6,170
Hib,Primary Series,States/Local Areas,District of Columbia,2021,Age,13 Months,86.1,76.2 to 92.3,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,89.8,84.3 to 93.5,463
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,87.8,79.0 to 94.2,170
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,88.4,83.0 to 92.7,463
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,89.8,84.5 to 93.4,463
Influenza,,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,67.9,60.5 to 75.2,463
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,78.3,67.3 to 87.7,170
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,90.2,85.1 to 94.1,463
PCV,≥4 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,82.2,75.6 to 87.3,463
Hib,Full Series,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,74.9,67.9 to 80.8,463
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,90.1,84.8 to 94.1,463
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,67.8,60.5 to 74.3,463
Polio,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,88.8,79.9 to 95.0,170
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2021,Age,35 Months,86.7,77.5 to 93.4,170
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,90.4,85.4 to 94.2,463
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,87.9,82.1 to 92.0,463
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,80.3,73.7 to 86.1,463
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,90.4,85.4 to 94.2,463
Hib,Primary Series,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,89.6,84.2 to 93.3,463
Hep B,"≥1 Dose, 1 Day",States/Local Areas,District of Columbia,2020-2021,Age,0-1 Days,67.8,60.4 to 74.5,463
Rotavirus,,States/Local Areas,District of Columbia,2020-2021,Age,8 Months,75.9,69.0 to 81.6,463
≥1 Dose MMR,,States/Local Areas,District of Columbia,2021,Age,13 Months,73.5,62.1 to 82.5,170
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,87.7,81.8 to 91.9,463
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,73.2,66.1 to 79.3,463
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,88.4,82.8 to 92.3,463
Hib,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,65.3,57.9 to 72.1,463
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,74.5,64.8 to 83.3,463
PCV,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,3 Months,85.4,78.9 to 90.1,463
Polio,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,3 Months,88.6,83.3 to 92.4,463
Hib,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,35 Months,88.8,79.9 to 95.0,170
Polio,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,90.1,85.2 to 94.0,463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2021,Age,0-3 Days,78.4,67.1 to 86.6,170
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,5 Months,79.5,72.8 to 84.9,463
Hib,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,88.8,78.7 to 94.4,170
Hib,Primary Series,States/Local Areas,District of Columbia,2021,Age,35 Months,88.9,80.0 to 95.1,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,95.2,93.2 to 97.1,792
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.2 to 94.5,347
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,85.3,82.0 to 88.6,792
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,75.6,70.1 to 81.1,347
Influenza,,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,67.6,63.5 to 71.6,1071
Influenza,,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,54.1,46.9 to 61.2,288
Influenza,,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,60.7,49.8 to 71.6,137
Influenza,,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,82.9,78.7 to 87.0,646
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,71.2,64.1 to 77.4,463
Influenza,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,83.6,79.9 to 87.4,702
Influenza,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,52.5,46.0 to 59.0,353
Rotavirus,,States/Local Areas,District of Columbia,2017,Age,8 Months,82.3,76.1 to 87.1,314
Rotavirus,,States/Local Areas,District of Columbia,2017-2018,Age,8 Months,80.6,76.4 to 84.3,664
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Poverty,>400% FPL,84.6,81.0 to 88.3,646
Rotavirus,,States/Local Areas,District of Columbia,2015,Age,8 Months,71.0,62.8 to 78.1,300
Rotavirus,,States/Local Areas,District of Columbia,2015-2016,Age,8 Months,72.2,66.6 to 77.1,593
Rotavirus,,States/Local Areas,District of Columbia,2016,Age,8 Months,73.1,65.4 to 79.7,293
Rotavirus,,States/Local Areas,District of Columbia,2016-2017,Age,8 Months,77.4,72.4 to 81.7,607
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,24 Months,88.6,83.6 to 92.7,463
PCV,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,3 Months,86.1,74.4 to 92.9,170
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,24 Months,88.9,80.0 to 95.1,170
Influenza,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,78.4,70.9 to 85.9,222
Influenza,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.1,61.7 to 82.5,132
Influenza,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",51.3,44.0 to 58.6,249
Influenza,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.6,82.9 to 90.3,468
Influenza,,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,67.6,63.5 to 71.6,1071
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,84.8 to 97.7,134
Hib,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,88.0,82.3 to 92.0,463
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.0,73.9 to 92.0,134
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,92.1,89.7 to 94.5,792
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",80.3,71.7 to 88.9,268
Hep A,≥1 Dose,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,88.8,84.5 to 93.1,347
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,83.0,74.1 to 91.9,228
Influenza,,States/Local Areas,District of Columbia,2017,Age,24 Months,64.6,57.2 to 71.9,314
Influenza,,States/Local Areas,District of Columbia,2017-2018,Age,24 Months,67.3,62.3 to 72.2,664
Influenza,,States/Local Areas,District of Columbia,2018,Age,24 Months,70.1,63.6 to 76.4,350
Influenza,,States/Local Areas,District of Columbia,2018-2019,Age,24 Months,72.1,67.2 to 76.9,677
Influenza,,States/Local Areas,District of Columbia,2019,Age,24 Months,74.1,66.7 to 81.0,327
PCV,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,7 Months,67.0,59.4 to 73.8,463
Hib,Full Series,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,82.0,75.7 to 87.5,463
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,86.1,79.7 to 90.6,463
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,3 Months,93.5,89.0 to 96.3,463
DTaP,≥1 Dose,States/Local Areas,District of Columbia,2020-2021,Age,3 Months,89.0,83.6 to 92.7,463
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,District of Columbia,2020-2021,Age,0-3 Days,78.2,71.6 to 83.6,463
Hib,Primary Series,States/Local Areas,District of Columbia,2020-2021,Age,35 Months,90.0,85.1 to 93.9,463
Hep B,"≥1 Dose, 2 Day",States/Local Areas,District of Columbia,2020-2021,Age,0-2 Days,74.8,68.0 to 80.6,463
≥1 Dose MMR,,States/Local Areas,District of Columbia,2021,Age,19 Months,88.0,78.0 to 93.8,170
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,29.3,23.2 to 36.2,463
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,5 Months,87.8,78.1 to 93.6,170
DTaP,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,88.7,83.1 to 92.5,463
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,88.2,82.8 to 92.1,463
≥1 Dose MMR,,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,73.6,66.6 to 79.5,463
Hib,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,5 Months,78.3,71.5 to 83.8,463
Polio,≥2 Doses,States/Local Areas,District of Columbia,2020-2021,Age,13 Months,90.3,85.0 to 93.9,463
Influenza,,States/Local Areas,District of Columbia,2021,Age,24 Months,67.9,55.9 to 79.3,170
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2020-2021,Age,19 Months,73.3,65.9 to 79.6,463
≥1 Dose Varicella,,States/Local Areas,District of Columbia,2021,Age,13 Months,70.3,58.5 to 79.9,170
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2021,Age,13 Months,86.3,76.5 to 92.4,170
DTaP,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,5 Months,79.4,68.3 to 87.3,170
Polio,≥2 Doses,States/Local Areas,District of Columbia,2021,Age,5 Months,79.4,68.3 to 87.3,170
Rotavirus,,States/Local Areas,District of Columbia,2013,Age,8 Months,70.0,62.6 to 76.4,293
Rotavirus,,States/Local Areas,District of Columbia,2013-2014,Age,8 Months,69.8,64.6 to 74.6,589
Rotavirus,,States/Local Areas,District of Columbia,2014,Age,8 Months,69.7,62.1 to 76.4,296
Rotavirus,,States/Local Areas,District of Columbia,2014-2015,Age,8 Months,70.4,64.9 to 75.4,596
Rotavirus,,States/Local Areas,District of Columbia,2012,Age,8 Months,74.7,67.7 to 80.6,315
Rotavirus,,States/Local Areas,District of Columbia,2018,Age,8 Months,78.9,72.7 to 84.0,350
Rotavirus,,States/Local Areas,District of Columbia,2018-2019,Age,8 Months,77.5,72.7 to 81.6,677
Rotavirus,,States/Local Areas,District of Columbia,2019,Age,8 Months,76.0,68.6 to 82.2,327
Rotavirus,,States/Local Areas,District of Columbia,2011,Age,8 Months,60.8,52.2 to 68.9,261
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Private Insurance Only,82.6,78.7 to 86.5,702
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Insurance Coverage,Any Medicaid,68.4,62.5 to 74.3,353
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.2,61.7 to 74.7,249
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,Hispanic,79.2,72.0 to 86.3,222
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,60.4 to 81.2,132
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.8,81.9 to 89.8,468
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Urbanicity,Living In a MSA Principal City,75.0,71.5 to 78.6,1071
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Overall,Overall,75.0,71.5 to 78.6,1071
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Poverty,<133% FPL,68.5,62.1 to 74.9,288
Rotavirus,,States/Local Areas,District of Columbia,2014-2017,Poverty,133% to <400% FPL,66.3,55.8 to 76.7,137
Hib,Full Series,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,Hispanic,80.4,74.3 to 86.5,228
Polio,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.8,86.1 to 97.5,134
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Private Insurance Only,88.8,85.9 to 91.8,792
DTaP,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,<133% FPL,76.0,69.4 to 82.6,274
PCV,≥4 Doses,States/Local Areas,District of Columbia,2016-2019,Insurance Coverage,Any Medicaid,79.1,73.8 to 84.4,347
Hep A,≥2 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.6,79.6 to 99.6,134
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,85.3 to 96.9,134
Hep B,≥1 Dose,States/Local Areas,District of Columbia,2021,Age,3 Months,93.2,84.7 to 97.2,170
PCV,≥3 Doses,States/Local Areas,District of Columbia,2016-2019,Poverty,>400% FPL,95.1,93.1 to 97.1,725
Hep B,≥3 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,71.2,65.8 to 76.1,620
Hep B,≥2 Doses,States/Local Areas,District of Columbia,2019-2020,Age,7 Months,90.4,86.5 to 93.3,620
Influenza,,States/Local Areas,Indiana,2020-2021,Age,24 Months,50.5,44.0 to 57.4,369
Hep B,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,64.7,57.9 to 71.0,369
Hep B,≥3 Doses,States/Local Areas,Indiana,2021,Age,35 Months,92.8,84.0 to 97.7,137
DTaP,≥4 Doses,States/Local Areas,Indiana,2021,Age,35 Months,84.8,73.1 to 93.3,137
Combined 7 Series,,States/Local Areas,Indiana,2021,Age,24 Months,70.4,60.0 to 80.2,137
DTaP,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,94.6,90.7 to 97.2,369
Rotavirus,,States/Local Areas,Indiana,2020-2021,Age,8 Months,72.7,65.9 to 78.5,369
DTaP,≥4 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,81.7,75.8 to 86.9,369
≥1 Dose Varicella,,States/Local Areas,Indiana,2021,Age,35 Months,92.3,85.1 to 96.8,137
Polio,≥3 Doses,States/Local Areas,Indiana,2021,Age,35 Months,93.7,86.8 to 97.7,137
Influenza,,States/Local Areas,Indiana,2013,Age,24 Months,48.2,40.0 to 57.0,218
Influenza,,States/Local Areas,Indiana,2013-2014,Age,24 Months,48.8,43.2 to 54.7,476
Hib,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,92.3,87.7 to 95.6,369
Hep B,≥1 Dose,States/Local Areas,Indiana,2021,Age,3 Months,95.8,87.5 to 98.7,137
Influenza,,States/Local Areas,Indiana,2014,Age,24 Months,49.4,42.0 to 57.3,258
Influenza,,States/Local Areas,Indiana,2014-2015,Age,24 Months,53.2,47.4 to 59.2,509
Influenza,,States/Local Areas,Indiana,2015,Age,24 Months,56.8,48.4 to 65.5,251
Influenza,,States/Local Areas,Indiana,2015-2016,Age,24 Months,52.0,46.4 to 58.0,536
Influenza,,States/Local Areas,Indiana,2012,Age,24 Months,48.5,41.5 to 56.0,306
Influenza,,States/Local Areas,Indiana,2011,Age,24 Months,48.4,41.0 to 56.3,271
Influenza,,States/Local Areas,Indiana,2016,Age,24 Months,47.0,39.9 to 54.7,285
Influenza,,States/Local Areas,Indiana,2016-2017,Age,24 Months,53.2,48.1 to 58.5,589
Hep B,≥2 Doses,States/Local Areas,Indiana,2021,Age,13 Months,93.9,84.2 to 97.8,137
PCV,≥4 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,80.0,73.8 to 85.1,369
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Indiana,2020-2021,Age,0-1 Days,77.7,71.1 to 83.2,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,94.6,90.7 to 97.2,369
Hib,Primary Series,States/Local Areas,Indiana,2021,Age,13 Months,88.1,78.8 to 93.7,137
PCV,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,93.0,88.4 to 95.8,369
PCV,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,93.3,89.1 to 96.3,369
PCV,≥4 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,85.8,80.1 to 90.5,369
≥1 Dose MMR,,States/Local Areas,Indiana,2020-2021,Age,35 Months,93.4,88.9 to 96.6,369
Hep B,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,90.5,85.4 to 93.9,369
Polio,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,5 Months,74.2,67.4 to 79.9,369
≥1 Dose MMR,,States/Local Areas,Indiana,2020-2021,Age,24 Months,91.9,87.7 to 95.1,369
Polio,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,88.5,83.1 to 92.3,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2021,Age,35 Months,94.5,87.5 to 98.2,137
Hib,Full Series,States/Local Areas,Indiana,2021,Age,35 Months,82.0,71.8 to 90.1,137
Hib,Primary Series,States/Local Areas,Indiana,2020-2021,Age,13 Months,89.0,83.8 to 92.7,369
Hib,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,3 Months,84.3,78.8 to 88.5,369
Combined 7 Series,,States/Local Areas,Indiana,2020-2021,Age,24 Months,71.7,65.3 to 77.8,369
Polio,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,93.5,89.5 to 96.4,369
Hib,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,90.0,84.5 to 93.7,369
≥1 Dose Varicella,,States/Local Areas,Indiana,2020-2021,Age,24 Months,91.6,87.4 to 94.8,369
PCV,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,93.3,89.1 to 96.3,369
Polio,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,92.1,87.3 to 95.2,369
DTaP,≥4 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,72.8,66.3 to 78.6,369
Hib,≥3 Doses,States/Local Areas,Indiana,2021,Age,13 Months,66.3,55.3 to 75.8,137
Hib,Primary Series,States/Local Areas,Indiana,2021,Age,35 Months,93.3,86.2 to 97.6,137
Hep B,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,91.5,86.7 to 95.1,369
Hib,≥2 Doses,States/Local Areas,Indiana,2021,Age,13 Months,93.4,85.3 to 97.2,137
Rotavirus,,States/Local Areas,Indiana,2021,Age,8 Months,71.4,60.0 to 80.6,137
Combined 7 Series,,States/Local Areas,Indiana,2020-2021,Age,35 Months,75.6,69.1 to 81.6,369
Hep A,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,58.3,51.4 to 65.3,369
Hib,Primary Series,States/Local Areas,Indiana,2020-2021,Age,7 Months,72.7,66.2 to 78.3,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,64.7,57.7 to 71.2,369
Hep B,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,5 Months,85.6,79.8 to 89.9,369
DTaP,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,5 Months,75.0,68.2 to 80.7,369
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2021,Age,0-3 Days,82.5,72.3 to 89.5,137
Hib,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,88.4,83.1 to 92.2,369
Polio,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,24 Months,93.5,89.5 to 96.4,369
Hep A,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,80.1,70.1 to 88.4,369
Polio,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,3 Months,83.3,77.4 to 87.9,369
Hep A,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,24 Months,92.4,88.6 to 95.3,369
≥1 Dose MMR,,States/Local Areas,Indiana,2021,Age,13 Months,61.5,50.6 to 71.4,137
PCV,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,3 Months,85.0,79.6 to 89.1,369
Hib,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,50.7,44.0 to 57.4,369
PCV,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,88.6,83.4 to 92.3,369
≥1 Dose MMR,,States/Local Areas,Indiana,2020-2021,Age,19 Months,88.2,83.0 to 92.0,369
Hib,≥3 Doses,States/Local Areas,Indiana,2021,Age,35 Months,90.8,83.0 to 96.0,137
DTaP,≥3 Doses,States/Local Areas,Indiana,2021,Age,24 Months,94.5,87.5 to 98.2,137
PCV,≥1 Dose,States/Local Areas,Indiana,2021,Age,3 Months,86.9,77.8 to 92.6,137
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,74.9,62.5 to 87.2,150
Influenza,,States/Local Areas,Indiana,2021,Age,24 Months,48.9,38.6 to 60.3,137
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,96.1,94.1 to 98.1,519
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,89.6,86.0 to 93.2,440
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,84.7,80.8 to 88.6,519
Influenza,,States/Local Areas,Indiana,2014-2017,Overall,Overall,52.1,48.1 to 56.0,975
Influenza,,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,46.3,39.6 to 53.0,337
Influenza,,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,50.3,44.2 to 56.4,405
Influenza,,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,68.0,60.3 to 75.6,233
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,82.3 to 98.4,115
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,87.7,84.0 to 91.3,519
≥1 Dose Varicella,,States/Local Areas,Indiana,2020-2021,Age,13 Months,61.1,54.3 to 67.4,369
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,74.6,69.4 to 79.8,440
Influenza,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,52.6,45.5 to 59.6,316
Influenza,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,44.5,36.0 to 53.0,207
Influenza,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",54.7,49.9 to 59.6,650
Influenza,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,55.0,49.1 to 60.9,452
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.0,67.2 to 86.8,115
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.0,64.2 to 89.8,115
Influenza,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,62.4,56.9 to 67.8,483
Influenza,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,47.3,41.5 to 53.1,434
Influenza,,States/Local Areas,Indiana,2017,Age,24 Months,59.4,52.6 to 66.4,304
Influenza,,States/Local Areas,Indiana,2017-2018,Age,24 Months,61.4,56.2 to 66.6,576
Influenza,,States/Local Areas,Indiana,2018,Age,24 Months,63.3,55.7 to 70.9,272
Influenza,,States/Local Areas,Indiana,2018-2019,Age,24 Months,61.8,55.7 to 67.8,481
Polio,≥2 Doses,States/Local Areas,Indiana,2021,Age,5 Months,76.0,65.0 to 84.4,137
DTaP,≥2 Doses,States/Local Areas,Indiana,2021,Age,5 Months,77.6,66.4 to 85.8,137
Influenza,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,21.0,7.2 to 34.9,44
Influenza,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",44.7,30.7 to 58.8,66
Influenza,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,42.6,32.4 to 52.8,150
Influenza,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",52.6,40.9 to 64.4,109
Influenza,,States/Local Areas,Indiana,2019,Age,24 Months,59.9,50.7 to 69.3,209
Hep A,≥2 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.2,45.5 to 78.8,78
Hep B,≥3 Doses,States/Local Areas,Indiana,2021,Age,13 Months,85.4,74.7 to 92.0,137
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.3 to 95.9,519
Hep A,≥1 Dose,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,87.1,83.1 to 91.1,440
Polio,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,87.2 to 98.2,115
≥1 Dose Varicella,,States/Local Areas,Indiana,2021,Age,13 Months,61.3,50.4 to 71.1,137
≥1 Dose MMR,,States/Local Areas,Indiana,2020-2021,Age,13 Months,64.8,58.1 to 71.1,369
Polio,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,93.7,89.2 to 96.4,369
Hib,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,5 Months,76.1,69.6 to 81.5,369
Hib,Full Series,States/Local Areas,Indiana,2020-2021,Age,19 Months,75.6,69.3 to 80.9,369
≥1 Dose MMR,,States/Local Areas,Indiana,2021,Age,19 Months,88.9,79.8 to 94.2,137
PCV,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,7 Months,63.1,56.2 to 69.6,369
Hep A,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,33.2,27.4 to 39.6,369
Hep A,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,19 Months,87.8,82.8 to 91.4,369
Hib,Full Series,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,Hispanic,77.7,68.8 to 86.5,150
Hib,Primary Series,States/Local Areas,Indiana,2020-2021,Age,19 Months,93.4,88.7 to 96.2,369
≥1 Dose Varicella,,States/Local Areas,Indiana,2020-2021,Age,19 Months,86.7,81.1 to 90.8,369
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Indiana,2020-2021,Age,0-3 Days,81.4,75.2 to 86.3,369
Hib,Primary Series,States/Local Areas,Indiana,2020-2021,Age,35 Months,93.5,89.3 to 96.5,369
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,82.4 to 97.5,115
Hep B,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,19 Months,91.2,86.0 to 94.6,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,90.5,85.3 to 93.9,369
Hib,Full Series,States/Local Areas,Indiana,2020-2021,Age,35 Months,84.6,78.9 to 89.4,369
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Indiana,2020-2021,Age,0-2 Days,80.7,74.5 to 85.7,369
Hep B,≥2 Doses,States/Local Areas,Indiana,2021,Age,5 Months,84.5,74.7 to 91.0,137
Polio,≥3 Doses,States/Local Areas,Indiana,2021,Age,19 Months,92.5,84.3 to 96.6,137
DTaP,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,3 Months,83.8,78.0 to 88.4,369
Hep B,≥1 Dose,States/Local Areas,Indiana,2020-2021,Age,3 Months,95.9,92.2 to 97.9,369
PCV,≥4 Doses,States/Local Areas,Indiana,2016-2019,Insurance Coverage,Any Medicaid,75.6,70.5 to 80.7,440
DTaP,≥4 Doses,States/Local Areas,Indiana,2016-2019,Poverty,<133% FPL,70.0,63.7 to 76.4,318
Hib,Full Series,States/Local Areas,Indiana,2020-2021,Age,24 Months,81.0,75.3 to 86.1,369
Rotavirus,,States/Local Areas,Indiana,2019,Age,8 Months,75.3,67.0 to 82.0,209
Rotavirus,,States/Local Areas,Indiana,2017,Age,8 Months,79.0,72.8 to 84.1,304
Rotavirus,,States/Local Areas,Indiana,2017-2018,Age,8 Months,75.4,70.7 to 79.6,576
Rotavirus,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.1,68.0 to 80.2,316
Rotavirus,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,65.5,57.5 to 73.6,207
Rotavirus,,States/Local Areas,Indiana,2014-2017,Overall,Overall,73.7,70.2 to 77.2,975
Rotavirus,,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,68.0,61.8 to 74.2,337
Rotavirus,,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,72.1,66.6 to 77.6,405
Rotavirus,,States/Local Areas,Indiana,2018,Age,8 Months,71.9,64.5 to 78.2,272
Rotavirus,,States/Local Areas,Indiana,2018-2019,Age,8 Months,73.6,68.2 to 78.3,481
Rotavirus,,States/Local Areas,Indiana,2015,Age,8 Months,69.5,60.9 to 76.8,251
Rotavirus,,States/Local Areas,Indiana,2015-2016,Age,8 Months,71.0,65.5 to 76.0,536
Rotavirus,,States/Local Areas,Indiana,2016,Age,8 Months,72.6,65.2 to 79.0,285
Rotavirus,,States/Local Areas,Indiana,2016-2017,Age,8 Months,75.8,71.0 to 80.0,589
Rotavirus,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,83.4,79.4 to 87.4,483
Rotavirus,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,64.4,46.6 to 82.1,44
Rotavirus,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",52.4,38.4 to 66.3,66
Rotavirus,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,67.3,61.9 to 72.8,434
Rotavirus,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,74.7,65.9 to 83.5,150
Rotavirus,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,64.6 to 83.9,109
Rotavirus,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.6,72.4 to 80.7,650
Rotavirus,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,76.8,71.7 to 81.9,452
Rotavirus,,States/Local Areas,Indiana,2013,Age,8 Months,74.3,65.8 to 81.3,218
Rotavirus,,States/Local Areas,Indiana,2013-2014,Age,8 Months,73.6,68.0 to 78.5,476
Rotavirus,,States/Local Areas,Indiana,2012,Age,8 Months,70.5,63.6 to 76.6,307
Rotavirus,,States/Local Areas,Indiana,2014,Age,8 Months,72.9,65.3 to 79.3,258
Rotavirus,,States/Local Areas,Indiana,2014-2015,Age,8 Months,71.2,65.6 to 76.2,509
Rotavirus,,States/Local Areas,Indiana,2011,Age,8 Months,63.5,55.8 to 70.6,271
Rotavirus,,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,88.9,84.4 to 93.5,233
PCV,≥3 Doses,States/Local Areas,Indiana,2016-2019,Poverty,>400% FPL,98.4,97.0 to 99.7,240
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Poverty,133% to <400% FPL,65.1,59.2 to 71.0,405
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Poverty,>400% FPL,80.5,74.0 to 87.1,233
Hib,Full Series,States/Local Areas,Indiana,2011,Age,19 Months,69.0,66.2 to 71.8,271
Hib,Full Series,States/Local Areas,Indiana,2012,Age,19 Months,70.3,63.9 to 75.9,307
Hib,Full Series,States/Local Areas,Indiana,2013,Age,19 Months,78.5,75.4 to 81.3,218
Hib,Full Series,States/Local Areas,Indiana,2013-2014,Age,19 Months,73.3,66.3 to 79.2,476
Hep B,≥2 Doses,States/Local Areas,Indiana,2019-2020,Age,7 Months,92.8,89.2 to 95.3,441
Polio,≥2 Doses,States/Local Areas,Indiana,2021,Age,13 Months,94.1,85.9 to 97.7,137
Hep B,≥3 Doses,States/Local Areas,Indiana,2021,Age,7 Months,65.4,54.4 to 75.0,137
Hib,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,13 Months,69.5,62.6 to 75.5,369
PCV,≥2 Doses,States/Local Areas,Indiana,2020-2021,Age,5 Months,75.9,69.4 to 81.3,369
DTaP,≥3 Doses,States/Local Areas,Indiana,2021,Age,19 Months,93.3,84.9 to 97.2,137
Hib,Primary Series,States/Local Areas,Indiana,2021,Age,24 Months,93.3,86.2 to 97.6,137
Hib,≥3 Doses,States/Local Areas,Indiana,2021,Age,24 Months,90.8,83.0 to 96.0,137
≥1 Dose MMR,,States/Local Areas,Indiana,2021,Age,24 Months,92.1,84.8 to 96.7,137
Polio,≥3 Doses,States/Local Areas,Indiana,2021,Age,24 Months,93.7,86.8 to 97.7,137
DTaP,≥4 Doses,States/Local Areas,Indiana,2021,Age,24 Months,80.6,70.4 to 89.0,137
DTaP,≥1 Dose,States/Local Areas,Indiana,2021,Age,3 Months,84.4,74.2 to 91.1,137
PCV,≥4 Doses,States/Local Areas,Indiana,2021,Age,35 Months,85.8,75.5 to 93.3,137
Hep A,≥2 Doses,States/Local Areas,Indiana,2021,Age,19 Months,29.9,21.6 to 39.9,137
Hep A,≥1 Dose,States/Local Areas,Indiana,2021,Age,19 Months,91.4,84.6 to 95.3,137
Hep B,≥3 Doses,States/Local Areas,Indiana,2021,Age,24 Months,91.4,83.0 to 96.7,137
PCV,≥4 Doses,States/Local Areas,Indiana,2021,Age,19 Months,81.1,70.9 to 88.4,137
DTaP,≥3 Doses,States/Local Areas,Indiana,2021,Age,13 Months,88.2,78.9 to 93.8,137
PCV,≥3 Doses,States/Local Areas,Indiana,2021,Age,7 Months,64.4,53.1 to 74.3,137
Hep A,≥2 Doses,States/Local Areas,Indiana,2021,Age,24 Months,56.7,45.4 to 68.6,137
Hib,Primary Series,States/Local Areas,Indiana,2013,Age,24 Months,95.6,91.1 to 98.2,218
Hib,Primary Series,States/Local Areas,Indiana,2013-2014,Age,24 Months,93.1,89.8 to 95.7,476
Hib,Primary Series,States/Local Areas,Indiana,2011,Age,24 Months,93.4,88.2 to 96.8,271
Hib,Primary Series,States/Local Areas,Indiana,2012,Age,24 Months,89.3,84.0 to 93.4,307
Hib,Primary Series,States/Local Areas,Indiana,2018,Age,19 Months,90.7,85.5 to 94.2,272
Hib,Primary Series,States/Local Areas,Indiana,2018-2019,Age,19 Months,86.7,82.1 to 90.2,481
Polio,≥1 Dose,States/Local Areas,Indiana,2021,Age,3 Months,83.4,73.3 to 90.2,137
Hib,Primary Series,States/Local Areas,Indiana,2019,Age,19 Months,93.0,86.6 to 96.5,209
PCV,≥3 Doses,States/Local Areas,Indiana,2021,Age,19 Months,93.1,84.8 to 97.0,137
Hep A,≥1 Dose,States/Local Areas,Indiana,2021,Age,35 Months,92.5,86.1 to 96.6,137
Hep A,≥2 Doses,States/Local Areas,Indiana,2021,Age,35 Months,79.7,60.2 to 93.6,137
Hep B,≥3 Doses,States/Local Areas,Indiana,2020-2021,Age,35 Months,92.3,87.5 to 95.7,369
DTaP,≥4 Doses,States/Local Areas,Indiana,2021,Age,19 Months,74.5,63.7 to 82.9,137
≥1 Dose Varicella,,States/Local Areas,Indiana,2021,Age,19 Months,87.3,77.8 to 93.1,137
Hib,Full Series,States/Local Areas,Indiana,2021,Age,24 Months,79.2,69.8 to 87.3,137
Hib,Primary Series,States/Local Areas,Indiana,2015,Age,19 Months,84.7,79.5 to 88.8,251
Hib,Primary Series,States/Local Areas,Indiana,2015-2016,Age,19 Months,86.7,81.9 to 90.4,536
Hib,Primary Series,States/Local Areas,Indiana,2016,Age,19 Months,88.7,82.6 to 92.9,285
Hib,Primary Series,States/Local Areas,Indiana,2016-2017,Age,19 Months,90.6,87.0 to 93.4,589
Hib,Primary Series,States/Local Areas,Indiana,2013,Age,19 Months,95.6,93.1 to 97.2,218
Hib,Primary Series,States/Local Areas,Indiana,2013-2014,Age,19 Months,92.8,88.1 to 95.8,476
Hib,Primary Series,States/Local Areas,Indiana,2014,Age,19 Months,90.1,84.2 to 93.9,258
Hib,Primary Series,States/Local Areas,Indiana,2014-2015,Age,19 Months,87.4,82.7 to 90.9,509
Hib,Primary Series,States/Local Areas,Indiana,2017,Age,19 Months,92.6,87.8 to 95.5,304
Hib,Primary Series,States/Local Areas,Indiana,2017-2018,Age,19 Months,91.6,88.3 to 94.1,576
Hib,Primary Series,States/Local Areas,Indiana,2012,Age,19 Months,89.0,83.5 to 92.8,307
Hib,Primary Series,States/Local Areas,Indiana,2018,Age,13 Months,85.2,78.7 to 90.0,272
Hib,Primary Series,States/Local Areas,Indiana,2018-2019,Age,13 Months,86.7,82.1 to 90.2,481
Hib,Primary Series,States/Local Areas,Indiana,2011,Age,19 Months,89.8,84.3 to 93.5,271
Hib,Primary Series,States/Local Areas,Indiana,2013,Age,7 Months,72.5,68.0 to 76.6,218
Hib,Primary Series,States/Local Areas,Indiana,2013-2014,Age,7 Months,70.4,66.1 to 74.4,476
Hib,Primary Series,States/Local Areas,Indiana,2011,Age,13 Months,81.0,75.7 to 85.4,271
Hib,Primary Series,States/Local Areas,Indiana,2012,Age,13 Months,87.5,82.0 to 91.5,307
Hib,Primary Series,States/Local Areas,Indiana,2013,Age,13 Months,92.6,88.4 to 95.3,218
Hib,Primary Series,States/Local Areas,Indiana,2013-2014,Age,13 Months,88.8,82.7 to 93.0,476
Hib,Primary Series,States/Local Areas,Indiana,2019,Age,13 Months,88.2,81.0 to 92.9,209
Hib,Primary Series,States/Local Areas,Indiana,2017,Age,13 Months,87.8,82.3 to 91.8,304
Hib,Primary Series,States/Local Areas,Indiana,2017-2018,Age,13 Months,86.5,82.4 to 89.8,576
Hib,Primary Series,States/Local Areas,Indiana,2019,Age,7 Months,69.1,60.6 to 76.4,209
Hib,Primary Series,States/Local Areas,Indiana,2015,Age,13 Months,79.1,70.6 to 85.7,251
Hib,Primary Series,States/Local Areas,Indiana,2015-2016,Age,13 Months,81.2,75.9 to 85.5,536
Hib,Primary Series,States/Local Areas,Indiana,2014,Age,13 Months,85.1,78.4 to 89.9,258
Hib,Primary Series,States/Local Areas,Indiana,2014-2015,Age,13 Months,82.1,76.9 to 86.4,509
Hib,Primary Series,States/Local Areas,Indiana,2016,Age,13 Months,83.3,76.5 to 88.4,285
Hib,Primary Series,States/Local Areas,Indiana,2016-2017,Age,13 Months,85.6,81.3 to 88.9,589
Hib,Primary Series,States/Local Areas,Indiana,2018,Age,7 Months,68.4,60.7 to 75.2,272
Hib,Primary Series,States/Local Areas,Indiana,2018-2019,Age,7 Months,68.7,63.1 to 73.9,481
Hib,Primary Series,States/Local Areas,Indiana,2017,Age,7 Months,71.0,64.1 to 77.0,304
Hib,Primary Series,States/Local Areas,Indiana,2017-2018,Age,7 Months,69.7,64.6 to 74.3,576
Hib,Primary Series,States/Local Areas,Indiana,2016,Age,7 Months,66.8,59.3 to 73.6,285
Hib,Primary Series,States/Local Areas,Indiana,2016-2017,Age,7 Months,68.9,63.9 to 73.6,589
Combined 7 Series,,States/Local Areas,Indiana,2011,Age,24 Months,60.1,52.5 to 67.8,271
Hib,Primary Series,States/Local Areas,Indiana,2015,Age,7 Months,59.5,50.6 to 67.7,251
Hib,Primary Series,States/Local Areas,Indiana,2015-2016,Age,7 Months,63.1,57.3 to 68.6,536
Hib,Primary Series,States/Local Areas,Indiana,2014,Age,7 Months,68.3,60.3 to 75.4,258
Hib,Primary Series,States/Local Areas,Indiana,2014-2015,Age,7 Months,63.9,58.0 to 69.4,509
Combined 7 Series,,States/Local Areas,Indiana,2013,Age,35 Months,72.4,64.0 to 80.2,218
Combined 7 Series,,States/Local Areas,Indiana,2013-2014,Age,35 Months,70.5,64.9 to 76.0,476
Combined 7 Series,,States/Local Areas,Indiana,2012,Age,35 Months,73.8,65.9 to 81.0,307
Hib,Primary Series,States/Local Areas,Indiana,2016,Age,35 Months,91.4,86.0 to 95.3,285
Hib,Primary Series,States/Local Areas,Indiana,2016-2017,Age,35 Months,94.5,91.4 to 96.8,589
Combined 7 Series,,States/Local Areas,Indiana,2011,Age,35 Months,70.2,61.7 to 78.3,271
Combined 7 Series,,States/Local Areas,Indiana,2016,Age,35 Months,69.2,61.7 to 76.4,285
Combined 7 Series,,States/Local Areas,Indiana,2016-2017,Age,35 Months,73.0,67.9 to 77.9,589
Combined 7 Series,,States/Local Areas,Indiana,2017,Age,35 Months,76.9,70.1 to 83.2,304
Combined 7 Series,,States/Local Areas,Indiana,2017-2018,Age,35 Months,72.2,67.2 to 77.1,576
Combined 7 Series,,States/Local Areas,Indiana,2014,Age,35 Months,68.7,61.1 to 76.1,258
Combined 7 Series,,States/Local Areas,Indiana,2014-2015,Age,35 Months,65.9,59.8 to 71.8,509
Combined 7 Series,,States/Local Areas,Indiana,2019,Age,24 Months,68.3,58.8 to 77.5,209
Hib,Primary Series,States/Local Areas,Indiana,2017,Age,35 Months,97.4,94.1 to 99.1,304
Hib,Primary Series,States/Local Areas,Indiana,2017-2018,Age,35 Months,95.6,92.5 to 97.6,576
Combined 7 Series,,States/Local Areas,Indiana,2017,Age,24 Months,71.1,64.6 to 77.2,304
Combined 7 Series,,States/Local Areas,Indiana,2017-2018,Age,24 Months,67.9,62.9 to 72.8,576
Combined 7 Series,,States/Local Areas,Indiana,2018,Age,24 Months,64.8,57.4 to 72.2,272
Combined 7 Series,,States/Local Areas,Indiana,2018-2019,Age,24 Months,66.3,60.4 to 72.2,481
Combined 7 Series,,States/Local Areas,Indiana,2015,Age,24 Months,56.7,48.1 to 65.7,251
Combined 7 Series,,States/Local Areas,Indiana,2015-2016,Age,24 Months,60.6,54.9 to 66.4,536
Hib,Primary Series,States/Local Areas,Indiana,2018,Age,35 Months,93.0,87.8 to 96.5,272
Hib,Primary Series,States/Local Areas,Indiana,2018-2019,Age,35 Months,93.8,90.2 to 96.5,481
Combined 7 Series,,States/Local Areas,Indiana,2016,Age,24 Months,64.6,57.4 to 71.8,285
Combined 7 Series,,States/Local Areas,Indiana,2016-2017,Age,24 Months,67.8,63.0 to 72.6,589
Hib,Primary Series,States/Local Areas,Indiana,2019,Age,35 Months,94.3,88.8 to 97.7,209
Hib,Primary Series,States/Local Areas,Indiana,2015,Age,35 Months,90.8,85.3 to 94.9,251
Hib,Primary Series,States/Local Areas,Indiana,2015-2016,Age,35 Months,91.1,87.3 to 94.1,536
Combined 7 Series,,States/Local Areas,Indiana,2014,Age,24 Months,67.4,59.8 to 74.8,258
Combined 7 Series,,States/Local Areas,Indiana,2014-2015,Age,24 Months,62.1,56.3 to 67.9,509
Hib,Primary Series,States/Local Areas,Indiana,2012,Age,35 Months,91.9,86.6 to 95.7,307
Hib,Primary Series,States/Local Areas,Indiana,2014,Age,35 Months,90.8,85.3 to 94.8,258
Hib,Primary Series,States/Local Areas,Indiana,2014-2015,Age,35 Months,90.8,87.1 to 93.9,509
Combined 7 Series,,States/Local Areas,Indiana,2013,Age,24 Months,70.7,62.4 to 78.6,218
Combined 7 Series,,States/Local Areas,Indiana,2013-2014,Age,24 Months,69.0,63.4 to 74.5,476
Combined 7 Series,,States/Local Areas,Indiana,2012,Age,24 Months,67.4,60.4 to 74.3,307
Hib,Primary Series,States/Local Areas,Indiana,2013,Age,35 Months,96.3,92.1 to 98.6,218
Hib,Primary Series,States/Local Areas,Indiana,2013-2014,Age,35 Months,93.5,90.1 to 96.0,476
Hib,Primary Series,States/Local Areas,Indiana,2019,Age,24 Months,94.3,88.8 to 97.7,209
Hib,Primary Series,States/Local Areas,Indiana,2011,Age,35 Months,94.3,88.9 to 97.6,271
Hib,Primary Series,States/Local Areas,Indiana,2016,Age,24 Months,89.4,83.9 to 93.7,285
Hib,Primary Series,States/Local Areas,Indiana,2016-2017,Age,24 Months,91.2,87.8 to 94.0,589
Hib,Primary Series,States/Local Areas,Indiana,2018,Age,24 Months,91.0,86.2 to 94.6,272
Hib,Primary Series,States/Local Areas,Indiana,2018-2019,Age,24 Months,92.6,89.1 to 95.2,481
Hib,Primary Series,States/Local Areas,Indiana,2015,Age,24 Months,89.6,84.0 to 93.9,251
Hib,Primary Series,States/Local Areas,Indiana,2015-2016,Age,24 Months,89.5,85.7 to 92.7,536
Hib,Primary Series,States/Local Areas,Indiana,2014,Age,24 Months,90.6,85.2 to 94.7,258
Hib,Primary Series,States/Local Areas,Indiana,2014-2015,Age,24 Months,90.1,86.3 to 93.2,509
Hib,Primary Series,States/Local Areas,Indiana,2017,Age,24 Months,93.0,88.6 to 96.1,304
Hib,Primary Series,States/Local Areas,Indiana,2017-2018,Age,24 Months,92.0,88.9 to 94.5,576
≥1 Dose MMR,,States/Local Areas,Indiana,2020,Age,13 Months,68.3,60.0 to 75.5,232
Hib,Full Series,States/Local Areas,Indiana,2019,Age,19 Months,72.6,64.1 to 79.7,209
Hib,Full Series,States/Local Areas,Indiana,2018,Age,19 Months,69.8,62.4 to 76.3,272
Hib,Full Series,States/Local Areas,Indiana,2018-2019,Age,19 Months,95.7,93.0 to 97.4,481
Hib,Full Series,States/Local Areas,Indiana,2013,Age,24 Months,84.9,78.3 to 90.3,218
Hib,Full Series,States/Local Areas,Indiana,2013-2014,Age,24 Months,79.8,74.8 to 84.3,476
Hib,Full Series,States/Local Areas,Indiana,2014,Age,24 Months,74.6,67.2 to 81.5,258
Hib,Full Series,States/Local Areas,Indiana,2014-2015,Age,24 Months,71.6,65.9 to 77.0,509
Hib,Full Series,States/Local Areas,Indiana,2012,Age,24 Months,77.2,70.8 to 83.0,307
Hib,Full Series,States/Local Areas,Indiana,2011,Age,24 Months,76.8,69.9 to 83.1,271
Hib,Full Series,States/Local Areas,Indiana,2017,Age,19 Months,74.3,67.7 to 79.9,304
Hib,Full Series,States/Local Areas,Indiana,2017-2018,Age,19 Months,72.0,67.1 to 76.5,576
Hib,Full Series,States/Local Areas,Indiana,2015,Age,19 Months,61.4,45.0 to 75.6,251
Hib,Full Series,States/Local Areas,Indiana,2015-2016,Age,19 Months,65.3,59.4 to 70.7,536
Hib,Full Series,States/Local Areas,Indiana,2016,Age,19 Months,69.2,61.7 to 75.9,285
Hib,Full Series,States/Local Areas,Indiana,2016-2017,Age,19 Months,71.8,66.8 to 76.2,589
Combined 7 Series,,States/Local Areas,Indiana,2015,Age,35 Months,62.8,53.6 to 72.0,251
Combined 7 Series,,States/Local Areas,Indiana,2015-2016,Age,35 Months,66.1,60.0 to 72.1,536
Hib,Full Series,States/Local Areas,Indiana,2014,Age,19 Months,68.0,60.1 to 74.9,258
Hib,Full Series,States/Local Areas,Indiana,2014-2015,Age,19 Months,64.7,58.8 to 70.2,509
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,Hispanic,61.4,51.2 to 71.6,150
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Private Insurance Only,76.3,71.6 to 81.0,483
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Any Medicaid,60.5,54.8 to 66.1,434
Combined 7 Series,,States/Local Areas,Indiana,2019,Age,35 Months,74.7,64.7 to 83.7,209
Combined 7 Series,,States/Local Areas,Indiana,2018,Age,35 Months,68.0,60.4 to 75.3,272
Combined 7 Series,,States/Local Areas,Indiana,2018-2019,Age,35 Months,70.9,64.8 to 76.7,481
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",53.5,39.5 to 67.5,66
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Insurance Coverage,Uninsured,28.8,13.2 to 44.4,44
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.2,54.0 to 76.4,109
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.6,63.1 to 72.2,650
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.8,65.4 to 78.3,316
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a MSA Principal City,64.7,59.1 to 70.3,452
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Urbanicity,Living In a Non-MSA,56.6,48.2 to 65.0,207
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Overall,Overall,65.2,61.4 to 69.0,975
Combined 7 Series,,States/Local Areas,Indiana,2014-2017,Poverty,<133% FPL,58.0,51.5 to 64.4,337
Rotavirus,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,73.5,67.4 to 79.5,303
Rotavirus,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,75.9,66.2 to 85.6,104
Rotavirus,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.2,58.4 to 92.1,39
Rotavirus,,States/Local Areas,Idaho,2018,Age,8 Months,83.7,78.5 to 87.8,443
Rotavirus,,States/Local Areas,Idaho,2018-2019,Age,8 Months,80.4,76.1 to 84.1,749
Rotavirus,,States/Local Areas,Idaho,2019,Age,8 Months,77.2,70.3 to 82.9,306
Rotavirus,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.3,75.2 to 83.3,581
Rotavirus,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,81.0,75.0 to 87.0,244
Rotavirus,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,84.9,80.6 to 89.1,377
Rotavirus,,States/Local Areas,Idaho,2011,Age,8 Months,69.5,61.7 to 76.3,246
Rotavirus,,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,80.8,76.0 to 85.6,382
Rotavirus,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,75.8,69.2 to 82.4,246
Rotavirus,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.3,71.7 to 85.0,236
Rotavirus,,States/Local Areas,Idaho,2014-2017,Overall,Overall,78.4,74.7 to 82.2,726
Rotavirus,,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,70.7,63.5 to 77.9,230
Rotavirus,,States/Local Areas,Idaho,2016,Age,8 Months,81.0,72.8 to 87.1,190
Rotavirus,,States/Local Areas,Idaho,2016-2017,Age,8 Months,77.8,73.0 to 82.0,689
Rotavirus,,States/Local Areas,Idaho,2017,Age,8 Months,74.6,69.0 to 79.5,499
Rotavirus,,States/Local Areas,Idaho,2017-2018,Age,8 Months,79.1,75.3 to 82.4,942
Rotavirus,,States/Local Areas,Idaho,2014,Age,8 Months,78.8,71.4 to 84.8,201
Rotavirus,,States/Local Areas,Idaho,2014-2015,Age,8 Months,77.6,72.1 to 82.3,415
Rotavirus,,States/Local Areas,Idaho,2012,Age,8 Months,79.2,71.2 to 85.3,223
Rotavirus,,States/Local Areas,Idaho,2013,Age,8 Months,72.6,64.7 to 79.2,224
Rotavirus,,States/Local Areas,Idaho,2013-2014,Age,8 Months,75.8,70.4 to 80.4,425
Rotavirus,,States/Local Areas,Idaho,2015,Age,8 Months,76.4,68.0 to 83.1,214
Rotavirus,,States/Local Areas,Idaho,2015-2016,Age,8 Months,78.7,72.9 to 83.5,404
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,95.2,91.8 to 98.6,250
Hep B,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,92.3,88.7 to 94.8,592
Hib,Primary Series,States/Local Areas,Idaho,2015,Age,7 Months,70.5,61.9 to 77.9,214
Hib,Primary Series,States/Local Areas,Idaho,2015-2016,Age,7 Months,75.1,69.3 to 80.1,404
Hib,Primary Series,States/Local Areas,Idaho,2014,Age,7 Months,74.4,66.3 to 81.1,201
Hib,Primary Series,States/Local Areas,Idaho,2014-2015,Age,7 Months,72.5,66.8 to 77.5,415
Hib,Primary Series,States/Local Areas,Idaho,2019-2020,Age,7 Months,78.8,73.9 to 83.0,592
Hib,Primary Series,States/Local Areas,Idaho,2017,Age,7 Months,73.4,67.7 to 78.5,499
Hib,Primary Series,States/Local Areas,Idaho,2017-2018,Age,7 Months,77.1,73.2 to 80.6,942
Hib,Primary Series,States/Local Areas,Idaho,2016,Age,7 Months,79.8,72.0 to 85.8,190
Hib,Primary Series,States/Local Areas,Idaho,2016-2017,Age,7 Months,76.6,71.9 to 80.8,689
Hib,Primary Series,States/Local Areas,Idaho,2015,Age,13 Months,85.2,77.5 to 90.6,214
Hib,Primary Series,States/Local Areas,Idaho,2015-2016,Age,13 Months,88.6,84.0 to 92.0,404
Hib,Primary Series,States/Local Areas,Idaho,2014,Age,13 Months,88.4,82.0 to 92.7,201
Hib,Primary Series,States/Local Areas,Idaho,2014-2015,Age,13 Months,86.8,82.0 to 90.5,415
Hib,Primary Series,States/Local Areas,Idaho,2014,Age,19 Months,92.5,87.1 to 95.7,201
Hib,Primary Series,States/Local Areas,Idaho,2014-2015,Age,19 Months,91.0,86.9 to 93.9,415
Hib,Primary Series,States/Local Areas,Idaho,2019,Age,13 Months,89.7,84.2 to 93.5,306
Hib,Primary Series,States/Local Areas,Idaho,2018,Age,13 Months,90.2,85.9 to 93.3,443
Hib,Primary Series,States/Local Areas,Idaho,2018-2019,Age,13 Months,90.0,86.6 to 92.5,749
Hib,Primary Series,States/Local Areas,Idaho,2011,Age,19 Months,93.8,91.8 to 95.3,246
Hib,Primary Series,States/Local Areas,Idaho,2012,Age,19 Months,91.4,89.0 to 93.4,223
Hib,Primary Series,States/Local Areas,Idaho,2013,Age,19 Months,90.9,87.5 to 93.4,224
Hib,Primary Series,States/Local Areas,Idaho,2013-2014,Age,19 Months,91.7,89.8 to 93.3,425
Hib,Primary Series,States/Local Areas,Idaho,2017,Age,13 Months,87.6,82.9 to 91.2,499
Hib,Primary Series,States/Local Areas,Idaho,2017-2018,Age,13 Months,88.9,85.8 to 91.4,942
Hib,Primary Series,States/Local Areas,Idaho,2019,Age,7 Months,79.1,72.2 to 84.6,306
Hib,Primary Series,States/Local Areas,Idaho,2011,Age,13 Months,91.1,88.2 to 93.3,246
Hib,Primary Series,States/Local Areas,Idaho,2012,Age,13 Months,89.0,85.1 to 91.9,223
Hib,Primary Series,States/Local Areas,Idaho,2013,Age,13 Months,88.0,85.9 to 89.8,224
Hib,Primary Series,States/Local Areas,Idaho,2013-2014,Age,13 Months,88.2,86.9 to 89.4,425
Hib,Primary Series,States/Local Areas,Idaho,2018,Age,7 Months,80.8,75.3 to 85.3,443
Hib,Primary Series,States/Local Areas,Idaho,2018-2019,Age,7 Months,79.9,75.6 to 83.6,749
Hib,Full Series,States/Local Areas,Idaho,2012,Age,24 Months,79.0,71.9 to 85.3,223
Hib,Full Series,States/Local Areas,Idaho,2011,Age,24 Months,73.4,66.1 to 80.2,246
Hib,Full Series,States/Local Areas,Idaho,2019,Age,19 Months,76.5,69.3 to 82.4,306
Hib,Full Series,States/Local Areas,Idaho,2018,Age,19 Months,77.9,72.3 to 82.7,443
Hib,Full Series,States/Local Areas,Idaho,2018-2019,Age,19 Months,95.3,92.7 to 97.0,749
Combined 7 Series,,States/Local Areas,Idaho,2013,Age,35 Months,71.5,63.7 to 78.9,224
Combined 7 Series,,States/Local Areas,Idaho,2013-2014,Age,35 Months,72.7,67.1 to 78.1,425
Combined 7 Series,,States/Local Areas,Idaho,2012,Age,35 Months,75.0,65.6 to 83.5,223
Hib,Full Series,States/Local Areas,Idaho,2017,Age,19 Months,76.4,71.0 to 81.0,499
Hib,Full Series,States/Local Areas,Idaho,2017-2018,Age,19 Months,77.1,73.3 to 80.5,942
Hib,Full Series,States/Local Areas,Idaho,2016,Age,19 Months,80.6,72.5 to 86.7,190
Hib,Full Series,States/Local Areas,Idaho,2016-2017,Age,19 Months,78.5,73.8 to 82.5,689
Hib,Full Series,States/Local Areas,Idaho,2015,Age,19 Months,68.3,62.9 to 73.2,214
Hib,Full Series,States/Local Areas,Idaho,2015-2016,Age,19 Months,74.4,68.5 to 79.5,404
Hib,Full Series,States/Local Areas,Idaho,2014,Age,19 Months,75.5,67.0 to 82.3,201
Hib,Full Series,States/Local Areas,Idaho,2014-2015,Age,19 Months,71.9,66.0 to 77.1,415
Combined 7 Series,,States/Local Areas,Idaho,2019,Age,24 Months,72.7,65.7 to 79.4,306
Combined 7 Series,,States/Local Areas,Idaho,2015,Age,24 Months,58.3,50.0 to 66.8,214
Combined 7 Series,,States/Local Areas,Idaho,2015-2016,Age,24 Months,66.2,60.4 to 72.0,404
Hib,Primary Series,States/Local Areas,Idaho,2018,Age,35 Months,96.6,93.2 to 98.6,443
Hib,Primary Series,States/Local Areas,Idaho,2018-2019,Age,35 Months,94.9,92.0 to 96.9,749
Combined 7 Series,,States/Local Areas,Idaho,2016,Age,24 Months,74.3,66.8 to 81.3,190
Combined 7 Series,,States/Local Areas,Idaho,2016-2017,Age,24 Months,72.9,68.3 to 77.5,689
Hib,Primary Series,States/Local Areas,Idaho,2019,Age,35 Months,93.4,88.9 to 96.6,306
Combined 7 Series,,States/Local Areas,Idaho,2017,Age,24 Months,71.6,66.0 to 76.9,499
Combined 7 Series,,States/Local Areas,Idaho,2017-2018,Age,24 Months,73.2,69.3 to 77.0,942
Combined 7 Series,,States/Local Areas,Idaho,2018,Age,24 Months,75.0,69.4 to 80.3,443
Combined 7 Series,,States/Local Areas,Idaho,2018-2019,Age,24 Months,73.8,69.3 to 78.2,749
Combined 7 Series,,States/Local Areas,Idaho,2014,Age,24 Months,69.8,61.7 to 77.6,201
Combined 7 Series,,States/Local Areas,Idaho,2014-2015,Age,24 Months,64.1,58.2 to 70.0,415
Combined 7 Series,,States/Local Areas,Idaho,2016,Age,35 Months,75.7,68.2 to 82.6,190
Combined 7 Series,,States/Local Areas,Idaho,2016-2017,Age,35 Months,75.8,71.1 to 80.2,689
Combined 7 Series,,States/Local Areas,Idaho,2017,Age,35 Months,75.6,70.2 to 80.7,499
Combined 7 Series,,States/Local Areas,Idaho,2017-2018,Age,35 Months,78.3,74.4 to 82.1,942
Combined 7 Series,,States/Local Areas,Idaho,2014,Age,35 Months,73.7,65.4 to 81.4,201
Combined 7 Series,,States/Local Areas,Idaho,2014-2015,Age,35 Months,70.8,64.6 to 76.8,415
Hib,Primary Series,States/Local Areas,Idaho,2017,Age,35 Months,91.7,87.6 to 94.8,499
Hib,Primary Series,States/Local Areas,Idaho,2017-2018,Age,35 Months,93.8,91.3 to 95.8,942
Hib,Primary Series,States/Local Areas,Idaho,2016,Age,35 Months,94.3,90.5 to 97.0,190
Hib,Primary Series,States/Local Areas,Idaho,2016-2017,Age,35 Months,93.0,90.3 to 95.2,689
Combined 7 Series,,States/Local Areas,Idaho,2012,Age,24 Months,67.1,58.9 to 75.0,223
Combined 7 Series,,States/Local Areas,Idaho,2011,Age,24 Months,58.8,51.0 to 66.7,246
Hib,Primary Series,States/Local Areas,Idaho,2016,Age,24 Months,94.3,90.5 to 97.0,190
Hib,Primary Series,States/Local Areas,Idaho,2016-2017,Age,24 Months,92.8,90.1 to 95.0,689
Hib,Primary Series,States/Local Areas,Idaho,2015,Age,35 Months,89.6,83.2 to 94.3,214
Hib,Primary Series,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.0,88.3 to 94.9,404
Hib,Primary Series,States/Local Areas,Idaho,2012,Age,35 Months,92.3,86.8 to 96.2,223
Hib,Primary Series,States/Local Areas,Idaho,2014,Age,35 Months,93.7,89.2 to 96.7,201
Hib,Primary Series,States/Local Areas,Idaho,2014-2015,Age,35 Months,91.6,87.8 to 94.6,415
Combined 7 Series,,States/Local Areas,Idaho,2013,Age,24 Months,67.8,60.0 to 75.3,224
Combined 7 Series,,States/Local Areas,Idaho,2013-2014,Age,24 Months,68.9,63.3 to 74.4,425
Hib,Primary Series,States/Local Areas,Idaho,2011,Age,35 Months,98.6,95.5 to 99.7,246
Hib,Primary Series,States/Local Areas,Idaho,2013,Age,35 Months,91.2,86.3 to 94.9,224
Hib,Primary Series,States/Local Areas,Idaho,2013-2014,Age,35 Months,92.5,89.3 to 95.0,425
Hib,Primary Series,States/Local Areas,Idaho,2019,Age,24 Months,92.3,87.5 to 95.8,306
Hib,Primary Series,States/Local Areas,Idaho,2018,Age,24 Months,95.6,92.4 to 97.7,443
Hib,Primary Series,States/Local Areas,Idaho,2018-2019,Age,24 Months,93.8,91.0 to 96.0,749
Hib,Primary Series,States/Local Areas,Idaho,2019,Age,19 Months,92.3,87.0 to 95.5,306
Hib,Primary Series,States/Local Areas,Idaho,2013,Age,7 Months,71.9,65.4 to 77.7,224
Hib,Primary Series,States/Local Areas,Idaho,2013-2014,Age,7 Months,73.2,70.9 to 75.4,425
Hib,Primary Series,States/Local Areas,Idaho,2017,Age,24 Months,91.3,87.2 to 94.5,499
Hib,Primary Series,States/Local Areas,Idaho,2017-2018,Age,24 Months,93.3,90.8 to 95.4,942
Hib,Primary Series,States/Local Areas,Idaho,2016,Age,19 Months,93.1,88.4 to 96.0,190
Hib,Primary Series,States/Local Areas,Idaho,2016-2017,Age,19 Months,91.9,88.9 to 94.2,689
Hib,Primary Series,States/Local Areas,Idaho,2013,Age,24 Months,90.9,86.0 to 94.6,224
Hib,Primary Series,States/Local Areas,Idaho,2013-2014,Age,24 Months,92.3,89.1 to 94.8,425
Hib,Primary Series,States/Local Areas,Idaho,2011,Age,24 Months,95.8,92.1 to 98.1,246
Hib,Primary Series,States/Local Areas,Idaho,2012,Age,24 Months,92.3,86.8 to 96.2,223
Hib,Primary Series,States/Local Areas,Idaho,2015,Age,24 Months,89.6,83.2 to 94.3,214
Hib,Primary Series,States/Local Areas,Idaho,2015-2016,Age,24 Months,92.0,88.3 to 94.9,404
Hib,Primary Series,States/Local Areas,Idaho,2014,Age,24 Months,93.7,89.2 to 96.7,201
Hib,Primary Series,States/Local Areas,Idaho,2014-2015,Age,24 Months,91.6,87.8 to 94.6,415
Hib,Primary Series,States/Local Areas,Idaho,2018,Age,19 Months,94.9,91.4 to 97.0,443
Hib,Primary Series,States/Local Areas,Idaho,2018-2019,Age,19 Months,90.0,86.6 to 92.5,749
Hib,Primary Series,States/Local Areas,Idaho,2015,Age,19 Months,89.5,87.4 to 91.3,214
Hib,Primary Series,States/Local Areas,Idaho,2015-2016,Age,19 Months,91.3,87.3 to 94.2,404
Hib,Primary Series,States/Local Areas,Idaho,2017,Age,19 Months,90.7,86.2 to 93.8,499
Hib,Primary Series,States/Local Areas,Idaho,2017-2018,Age,19 Months,92.7,90.0 to 94.8,942
Hib,Primary Series,States/Local Areas,Idaho,2016,Age,13 Months,92.0,86.8 to 95.2,190
Hib,Primary Series,States/Local Areas,Idaho,2016-2017,Age,13 Months,89.8,86.5 to 92.4,689
Combined 7 Series,,States/Local Areas,Idaho,2015,Age,35 Months,67.8,58.6 to 76.6,214
Combined 7 Series,,States/Local Areas,Idaho,2015-2016,Age,35 Months,71.9,65.8 to 77.7,404
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,Hispanic,66.2,55.4 to 76.9,104
Hep A,≥2 Doses,States/Local Areas,Idaho,2011,Age,24 Months,42.8,35.2 to 51.4,246
Hep A,≥2 Doses,States/Local Areas,Idaho,2019,Age,19 Months,39.4,32.1 to 47.2,306
Hep A,≥2 Doses,States/Local Areas,Idaho,2018,Age,19 Months,32.3,26.9 to 38.3,443
Hep A,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,19 Months,37.2,31.7 to 43.1,641
Hib,≥3 Doses,States/Local Areas,Idaho,2017,Age,35 Months,89.7,85.4 to 93.2,499
Hib,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,92.2,89.5 to 94.4,942
Hib,≥3 Doses,States/Local Areas,Idaho,2016,Age,35 Months,94.3,90.3 to 97.0,190
Hib,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,92.0,89.2 to 94.4,689
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,95.5,93.1 to 97.9,377
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.1 to 94.2,303
DTaP,≥4 Doses,States/Local Areas,Idaho,2015,Age,19 Months,64.9,62.6 to 67.0,214
DTaP,≥4 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,68.3,62.2 to 73.9,404
DTaP,≥4 Doses,States/Local Areas,Idaho,2014,Age,19 Months,76.6,68.1 to 83.4,201
DTaP,≥4 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,70.7,64.7 to 76.1,415
DTaP,≥4 Doses,States/Local Areas,Idaho,2013,Age,19 Months,65.4,62.5 to 68.2,224
DTaP,≥4 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,71.1,65.4 to 76.3,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2012,Age,24 Months,41.1,33.1 to 50.2,223
Hib,≥3 Doses,States/Local Areas,Idaho,2018,Age,35 Months,94.9,91.6 to 97.2,443
Hib,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,93.8,90.1 to 96.4,749
Hep A,≥2 Doses,States/Local Areas,Idaho,2017,Age,19 Months,34.5,29.1 to 40.3,499
Hep A,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,19 Months,33.4,29.5 to 37.6,942
Hib,≥3 Doses,States/Local Areas,Idaho,2015,Age,35 Months,91.2,84.2 to 96.0,214
Hib,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.8,88.8 to 95.7,404
Hib,≥3 Doses,States/Local Areas,Idaho,2014,Age,35 Months,92.6,86.7 to 96.5,201
Hib,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,92.0,87.6 to 95.3,415
Hib,≥3 Doses,States/Local Areas,Idaho,2013,Age,35 Months,90.0,84.9 to 94.0,224
Hib,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,91.4,87.8 to 94.3,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2016,Age,19 Months,34.0,25.9 to 43.2,190
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,19 Months,34.3,29.2 to 39.6,689
Hep A,≥2 Doses,States/Local Areas,Idaho,2015,Age,19 Months,24.2,17.2 to 32.8,214
Hep A,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,19 Months,29.1,23.9 to 35.0,404
DTaP,≥3 Doses,States/Local Areas,Idaho,2016,Age,35 Months,95.2,91.4 to 97.7,190
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,35 Months,95.0,92.5 to 96.9,689
DTaP,≥3 Doses,States/Local Areas,Idaho,2015,Age,35 Months,89.9,83.6 to 94.5,214
DTaP,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,35 Months,92.6,88.9 to 95.4,404
PCV,≥2 Doses,States/Local Areas,Idaho,2011,Age,5 Months,75.6,71.4 to 79.3,246
PCV,≥2 Doses,States/Local Areas,Idaho,2012,Age,5 Months,76.1,71.3 to 80.3,223
PCV,≥2 Doses,States/Local Areas,Idaho,2013,Age,5 Months,72.5,69.5 to 75.3,224
PCV,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,5 Months,74.2,70.5 to 77.6,425
DTaP,≥4 Doses,States/Local Areas,Idaho,2012,Age,19 Months,64.7,53.9 to 74.2,223
DTaP,≥4 Doses,States/Local Areas,Idaho,2011,Age,19 Months,59.9,56.6 to 63.1,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2017,Age,35 Months,94.8,91.1 to 97.2,499
DTaP,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,35 Months,96.2,94.0 to 97.7,942
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Private Insurance Only,73.7,68.5 to 78.9,377
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Insurance Coverage,Any Medicaid,64.0,57.4 to 70.5,303
Combined 7 Series,,States/Local Areas,Idaho,2019,Age,35 Months,78.3,70.9 to 84.9,306
Combined 7 Series,,States/Local Areas,Idaho,2018,Age,35 Months,82.3,75.6 to 88.0,443
Combined 7 Series,,States/Local Areas,Idaho,2018-2019,Age,35 Months,80.1,75.2 to 84.5,749
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,59.2,51.5 to 66.9,230
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,62.9,55.3 to 70.6,246
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Overall,Overall,67.8,63.6 to 72.0,726
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,56.4 to 90.6,39
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.5,62.8 to 72.1,581
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.2,65.2 to 79.2,236
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a MSA Principal City,67.8,60.8 to 74.7,244
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,70.9,65.4 to 76.3,382
Combined 7 Series,,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,79.5,71.2 to 87.8,114
Hib,Full Series,States/Local Areas,Idaho,2011,Age,19 Months,66.2,61.8 to 70.3,246
Hib,Full Series,States/Local Areas,Idaho,2012,Age,19 Months,77.0,69.6 to 83.0,223
Hib,Full Series,States/Local Areas,Idaho,2013,Age,19 Months,70.7,69.0 to 72.4,224
Hib,Full Series,States/Local Areas,Idaho,2013-2014,Age,19 Months,73.1,68.5 to 77.3,425
Hib,Full Series,States/Local Areas,Idaho,2013,Age,24 Months,80.9,74.3 to 86.8,224
Hib,Full Series,States/Local Areas,Idaho,2013-2014,Age,24 Months,80.7,75.9 to 85.0,425
Hib,Full Series,States/Local Areas,Idaho,2014,Age,24 Months,80.1,72.9 to 86.4,201
Hib,Full Series,States/Local Areas,Idaho,2014-2015,Age,24 Months,75.2,69.7 to 80.4,415
Hib,≥3 Doses,States/Local Areas,Idaho,2011,Age,35 Months,97.0,90.9 to 99.4,246
Hib,≥3 Doses,States/Local Areas,Idaho,2012,Age,35 Months,90.0,84.1 to 94.3,223
Hib,≥3 Doses,States/Local Areas,Idaho,2021,Age,19 Months,78.9,67.9 to 86.9,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2021,Age,24 Months,86.7,77.2 to 93.6,171
Hib,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,84.6,78.8 to 89.6,457
Polio,≥2 Doses,States/Local Areas,Idaho,2021,Age,7 Months,84.1,73.4 to 91.1,171
Hep A,≥1 Dose,States/Local Areas,Idaho,2012,Age,35 Months,93.5,86.6 to 97.5,223
PCV,≥2 Doses,States/Local Areas,Idaho,2017,Age,5 Months,73.6,67.8 to 78.7,499
PCV,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,5 Months,80.5,76.8 to 83.8,942
Hep A,≥1 Dose,States/Local Areas,Idaho,2011,Age,35 Months,92.5,87.2 to 96.1,246
Hep A,≥1 Dose,States/Local Areas,Idaho,2019,Age,24 Months,88.9,83.3 to 93.3,306
Hep A,≥1 Dose,States/Local Areas,Idaho,2018,Age,24 Months,93.8,89.9 to 96.6,443
Hep A,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,24 Months,91.3,88.0 to 94.1,749
Hep A,≥1 Dose,States/Local Areas,Idaho,2017,Age,24 Months,89.9,85.6 to 93.3,499
Hep A,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,24 Months,91.8,89.0 to 94.1,942
DTaP,≥3 Doses,States/Local Areas,Idaho,2019,Age,35 Months,94.2,89.3 to 97.4,306
DTaP,≥3 Doses,States/Local Areas,Idaho,2018,Age,35 Months,97.1,94.7 to 98.5,443
DTaP,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,35 Months,95.9,92.9 to 97.9,749
PCV,≥2 Doses,States/Local Areas,Idaho,2016,Age,5 Months,79.0,70.6 to 85.4,190
PCV,≥2 Doses,States/Local Areas,Idaho,2016-2017,Age,5 Months,76.3,71.4 to 80.6,689
PCV,≥2 Doses,States/Local Areas,Idaho,2015,Age,5 Months,73.8,65.2 to 80.8,214
PCV,≥2 Doses,States/Local Areas,Idaho,2015-2016,Age,5 Months,76.3,70.5 to 81.3,404
PCV,≥2 Doses,States/Local Areas,Idaho,2014,Age,5 Months,75.7,67.3 to 82.6,201
PCV,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,5 Months,74.8,71.7 to 77.6,415
Hep A,≥1 Dose,States/Local Areas,Idaho,2016,Age,24 Months,92.4,88.4 to 95.4,190
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,24 Months,91.1,88.3 to 93.5,689
Hep A,≥1 Dose,States/Local Areas,Idaho,2012,Age,24 Months,86.8,80.1 to 92.0,223
Hep A,≥1 Dose,States/Local Areas,Idaho,2014,Age,24 Months,87.0,80.3 to 92.3,201
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,24 Months,85.6,80.9 to 89.7,415
Hep A,≥1 Dose,States/Local Areas,Idaho,2013,Age,24 Months,85.3,79.4 to 90.3,224
Hep A,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,24 Months,86.2,81.9 to 89.9,425
Hep A,≥1 Dose,States/Local Areas,Idaho,2011,Age,24 Months,88.4,83.0 to 92.7,246
Hep A,≥1 Dose,States/Local Areas,Idaho,2019,Age,19 Months,87.3,81.2 to 91.6,306
Hib,≥3 Doses,States/Local Areas,Idaho,2019,Age,24 Months,87.7,81.6 to 92.5,306
Hib,≥3 Doses,States/Local Areas,Idaho,2018,Age,24 Months,94.5,91.2 to 96.8,443
Hib,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,90.9,87.4 to 93.7,749
Hep A,≥2 Doses,States/Local Areas,Idaho,2012,Age,19 Months,23.3,19.3 to 27.8,223
Hep A,≥2 Doses,States/Local Areas,Idaho,2014,Age,19 Months,32.9,25.3 to 41.4,201
Hep A,≥2 Doses,States/Local Areas,Idaho,2014-2015,Age,19 Months,28.5,23.6 to 34.0,415
Hep A,≥2 Doses,States/Local Areas,Idaho,2013,Age,19 Months,25.8,18.8 to 34.5,224
Hep A,≥2 Doses,States/Local Areas,Idaho,2013-2014,Age,19 Months,29.4,23.7 to 35.9,425
Hep A,≥2 Doses,States/Local Areas,Idaho,2011,Age,19 Months,19.7,17.2 to 22.5,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2014,Age,35 Months,94.9,90.5 to 97.7,201
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,35 Months,92.5,88.7 to 95.3,415
DTaP,≥3 Doses,States/Local Areas,Idaho,2011,Age,35 Months,98.6,95.3 to 99.7,246
DTaP,≥3 Doses,States/Local Areas,Idaho,2012,Age,35 Months,90.3,83.8 to 94.9,223
DTaP,≥3 Doses,States/Local Areas,Idaho,2013,Age,35 Months,91.4,86.5 to 95.0,224
DTaP,≥3 Doses,States/Local Areas,Idaho,2013-2014,Age,35 Months,93.1,90.0 to 95.6,425
Hep A,≥1 Dose,States/Local Areas,Idaho,2015,Age,24 Months,84.3,77.2 to 90.1,214
Hep A,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,24 Months,88.3,84.2 to 91.8,404
Hep A,≥1 Dose,States/Local Areas,Idaho,2018,Age,19 Months,90.8,86.2 to 94.0,443
Hep A,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,19 Months,90.4,86.4 to 93.4,641
Hep A,≥1 Dose,States/Local Areas,Idaho,2017,Age,19 Months,87.0,82.4 to 90.6,499
Hep A,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,19 Months,88.9,85.8 to 91.4,942
Hib,≥2 Doses,States/Local Areas,Idaho,2021,Age,7 Months,84.1,73.4 to 91.0,171
Hep B,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,92.4,87.7 to 95.3,457
≥1 Dose MMR,,States/Local Areas,Idaho,2020-2021,Age,24 Months,88.9,84.0 to 92.8,457
Polio,≥3 Doses,States/Local Areas,Idaho,2021,Age,35 Months,90.8,80.7 to 96.9,171
PCV,≥2 Doses,States/Local Areas,Idaho,2021,Age,5 Months,77.9,67.1 to 85.9,171
Combined 7 Series,,States/Local Areas,Idaho,2021,Age,35 Months,73.7,62.7 to 83.6,171
DTaP,≥4 Doses,States/Local Areas,Idaho,2021,Age,19 Months,72.7,61.9 to 81.4,171
Hep A,≥2 Doses,States/Local Areas,Idaho,2021,Age,35 Months,70.4,55.2 to 84.3,171
DTaP,≥1 Dose,States/Local Areas,Idaho,2016,Age,3 Months,87.6,79.9 to 92.6,190
DTaP,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,3 Months,88.1,83.9 to 91.3,689
DTaP,≥1 Dose,States/Local Areas,Idaho,2015,Age,3 Months,89.2,82.2 to 93.6,214
DTaP,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,3 Months,88.4,83.5 to 92.0,404
DTaP,≥1 Dose,States/Local Areas,Idaho,2014,Age,3 Months,87.2,80.7 to 91.8,201
DTaP,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,3 Months,88.2,83.7 to 91.6,415
DTaP,≥1 Dose,States/Local Areas,Idaho,2013,Age,3 Months,84.0,80.8 to 86.8,224
DTaP,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,3 Months,85.6,83.2 to 87.8,425
DTaP,≥1 Dose,States/Local Areas,Idaho,2011,Age,3 Months,88.9,81.3 to 93.6,246
DTaP,≥1 Dose,States/Local Areas,Idaho,2012,Age,3 Months,86.7,85.1 to 88.1,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.6,68.5 to 76.6,1017
DTaP,≥3 Doses,States/Local Areas,Idaho,2021,Age,7 Months,74.2,63.1 to 82.9,171
Hep B,≥2 Doses,States/Local Areas,Idaho,2021,Age,5 Months,87.2,77.6 to 93.0,171
Hib,Primary Series,States/Local Areas,Idaho,2021,Age,7 Months,71.7,60.3 to 80.9,171
DTaP,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,3 Months,87.3,81.8 to 91.3,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2021,Age,19 Months,86.4,75.8 to 92.8,171
Combined 7 Series,,States/Local Areas,Idaho,2011,Age,35 Months,74.1,64.2 to 83.1,246
Hib,≥1 Dose,States/Local Areas,Idaho,2021,Age,3 Months,84.2,74.5 to 90.6,171
Hib,Full Series,States/Local Areas,Idaho,2021,Age,19 Months,72.9,62.0 to 81.6,171
PCV,≥4 Doses,States/Local Areas,Idaho,2020-2021,Age,24 Months,82.6,76.8 to 87.6,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,88.6,82.8 to 92.7,457
Hib,Primary Series,States/Local Areas,Idaho,2021,Age,19 Months,87.9,78.2 to 93.6,171
Hib,≥3 Doses,States/Local Areas,Idaho,2017,Age,24 Months,88.1,83.8 to 91.8,499
Hib,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,91.1,88.4 to 93.4,942
DTaP,≥3 Doses,States/Local Areas,Idaho,2019,Age,24 Months,92.1,87.1 to 95.7,306
Hib,≥3 Doses,States/Local Areas,Idaho,2016,Age,24 Months,93.6,89.6 to 96.5,190
Hib,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,90.9,88.0 to 93.3,689
Hib,≥3 Doses,States/Local Areas,Idaho,2015,Age,24 Months,87.9,80.9 to 93.2,214
Hib,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,90.7,86.7 to 94.0,404
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Overall,Overall,91.0,88.4 to 93.6,726
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,<133% FPL,87.0,81.5 to 92.5,230
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,133% to <400% FPL,92.1,88.9 to 95.2,382
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Poverty,>400% FPL,97.4,95.1 to 99.8,114
DTaP,≥3 Doses,States/Local Areas,Idaho,2018,Age,24 Months,97.1,94.7 to 98.5,443
DTaP,≥3 Doses,States/Local Areas,Idaho,2018-2019,Age,24 Months,94.5,91.8 to 96.6,749
DTaP,≥3 Doses,States/Local Areas,Idaho,2017,Age,24 Months,92.8,88.9 to 95.7,499
DTaP,≥3 Doses,States/Local Areas,Idaho,2017-2018,Age,24 Months,94.9,92.7 to 96.7,942
DTaP,≥2 Doses,States/Local Areas,Idaho,2018,Age,5 Months,88.2,83.8 to 91.6,443
DTaP,≥2 Doses,States/Local Areas,Idaho,2018-2019,Age,5 Months,84.5,80.4 to 87.9,749
Polio,≥3 Doses,States/Local Areas,Idaho,2014-2017,Urbanicity,Living In a Non-MSA,90.5,86.1 to 94.9,246
DTaP,≥2 Doses,States/Local Areas,Idaho,2019,Age,5 Months,81.0,74.1 to 86.4,306
Hib,≥2 Doses,States/Local Areas,Illinois,2018,Age,13 Months,94.6,91.7 to 96.6,542
Hib,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,94.2,92.0 to 95.9,1090
Hib,≥2 Doses,States/Local Areas,Illinois,2017,Age,13 Months,95.3,92.4 to 97.1,502
Hib,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,95.0,93.0 to 96.4,1044
Hib,≥2 Doses,States/Local Areas,Illinois,2019,Age,13 Months,93.8,90.1 to 96.2,548
DTaP,≥3 Doses,States/Local Areas,Illinois,2016,Age,13 Months,93.1,89.2 to 95.7,484
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,92.9,90.4 to 94.8,986
DTaP,≥3 Doses,States/Local Areas,Illinois,2017,Age,13 Months,92.7,89.0 to 95.2,502
DTaP,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,91.5,88.8 to 93.5,1044
DTaP,≥3 Doses,States/Local Areas,Illinois,2018,Age,13 Months,90.2,86.0 to 93.2,542
DTaP,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,90.6,87.8 to 92.8,1090
Hib,≥3 Doses,States/Local Areas,Illinois,2013,Age,13 Months,81.0,76.1 to 85.2,537
Hib,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,79.3,76.0 to 82.3,1030
Polio,≥3 Doses,States/Local Areas,Illinois,2011,Age,19 Months,93.4,90.9 to 95.2,583
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,98.1,96.6 to 99.6,686
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,91.6,88.7 to 94.5,519
Hib,≥3 Doses,States/Local Areas,Illinois,2014,Age,13 Months,77.6,72.6 to 81.9,493
Hib,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,75.5,71.9 to 78.8,960
Hib,≥3 Doses,States/Local Areas,Illinois,2011,Age,13 Months,85.1,82.0 to 87.7,583
Hib,≥3 Doses,States/Local Areas,Illinois,2012,Age,13 Months,78.1,75.4 to 80.6,543
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,92.9,90.1 to 95.6,515
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,94.3,92.8 to 95.7,1720
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.8,91.7 to 95.8,850
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,96.5,93.6 to 99.4,119
DTaP,≥3 Doses,States/Local Areas,Illinois,2015,Age,13 Months,89.6,85.1 to 92.9,467
DTaP,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,91.4,88.4 to 93.6,951
DTaP,≥3 Doses,States/Local Areas,Illinois,2012,Age,13 Months,86.5,83.5 to 89.0,543
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.1,69.6 to 76.6,930
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.0,62.5 to 77.4,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Overall,Overall,74.2,71.7 to 76.8,1720
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,73.6,64.0 to 83.1,119
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,76.7,72.9 to 80.6,751
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.5,68.9 to 76.0,850
Hib,≥3 Doses,States/Local Areas,Illinois,2019,Age,7 Months,55.5,49.8 to 61.0,548
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,94.4,92.2 to 96.7,751
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.4,94.9 to 97.9,930
Hib,≥2 Doses,States/Local Areas,Illinois,2012,Age,13 Months,91.0,86.8 to 94.0,543
Hib,≥2 Doses,States/Local Areas,Illinois,2011,Age,13 Months,95.7,94.0 to 97.0,583
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2018,Age,0-3 Days,79.4,74.6 to 83.6,542
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2018-2019,Age,0-3 Days,80.2,76.9 to 83.1,1090
DTaP,≥3 Doses,States/Local Areas,Illinois,2015,Age,7 Months,71.2,65.4 to 76.4,467
DTaP,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,72.9,68.9 to 76.6,951
DTaP,≥3 Doses,States/Local Areas,Illinois,2016,Age,7 Months,74.7,68.9 to 79.7,484
DTaP,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,76.2,72.4 to 79.7,986
DTaP,≥3 Doses,States/Local Areas,Illinois,2017,Age,7 Months,77.9,72.8 to 82.2,502
DTaP,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,75.8,72.2 to 79.1,1044
Hib,≥2 Doses,States/Local Areas,Illinois,2013,Age,13 Months,96.0,94.5 to 97.1,537
Hib,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,95.6,93.3 to 97.2,1030
PCV,≥3 Doses,States/Local Areas,Illinois,2017,Age,35 Months,94.6,91.8 to 96.7,502
PCV,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,94.2,92.0 to 95.9,1044
PCV,≥3 Doses,States/Local Areas,Illinois,2018,Age,35 Months,93.7,90.2 to 96.3,542
PCV,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,93.6,90.9 to 95.7,1090
Hib,≥3 Doses,States/Local Areas,Illinois,2014,Age,7 Months,61.0,55.5 to 66.2,493
Hib,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,58.4,54.3 to 62.3,960
Hib,≥3 Doses,States/Local Areas,Illinois,2015,Age,7 Months,55.7,49.8 to 61.5,467
Hib,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,57.9,53.6 to 62.0,951
Hib,≥3 Doses,States/Local Areas,Illinois,2016,Age,7 Months,60.0,53.9 to 65.7,484
Hib,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,61.4,57.2 to 65.4,986
Polio,≥1 Dose,States/Local Areas,Illinois,2017,Age,3 Months,88.4,84.4 to 91.5,502
Polio,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,3 Months,87.7,84.8 to 90.1,1044
Polio,≥1 Dose,States/Local Areas,Illinois,2018,Age,3 Months,86.9,82.6 to 90.3,542
Polio,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,3 Months,88.0,85.0 to 90.5,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2019,Age,35 Months,93.5,89.2 to 96.5,548
Hib,≥2 Doses,States/Local Areas,Illinois,2014,Age,13 Months,95.3,92.2 to 97.2,493
Hib,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,95.0,92.8 to 96.5,960
Polio,≥1 Dose,States/Local Areas,Illinois,2019,Age,3 Months,89.1,84.5 to 92.4,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2019,Age,0-3 Days,81.0,76.2 to 84.9,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,72.4,68.9 to 75.8,1043
≥1 Dose Varicella,,States/Local Areas,Illinois,2020,Age,24 Months,91.9,88.2 to 94.8,549
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,77.0,73.2 to 80.9,624
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.2,62.9 to 79.4,151
DTaP,≥3 Doses,States/Local Areas,Illinois,2018,Age,7 Months,73.8,68.5 to 78.5,542
DTaP,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,72.2,68.4 to 75.7,1090
DTaP,≥3 Doses,States/Local Areas,Illinois,2019,Age,7 Months,70.6,65.1 to 75.6,548
Hib,≥3 Doses,States/Local Areas,Illinois,2017,Age,7 Months,63.0,57.3 to 68.4,502
Hib,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,61.2,57.3 to 65.1,1044
Hib,≥3 Doses,States/Local Areas,Illinois,2018,Age,7 Months,59.4,53.9 to 64.7,542
Hib,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,57.5,53.6 to 61.3,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.6,88.8 to 96.5,231
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,93.4,90.5 to 96.3,408
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.5,83.5 to 95.4,151
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,84.3,71.5 to 97.0,34
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,92.5,90.0 to 95.0,624
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,96.2,94.6 to 97.7,1043
Hib,≥2 Doses,States/Local Areas,Illinois,2015,Age,13 Months,94.7,91.2 to 96.9,467
Hib,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,95.6,93.5 to 97.1,951
Hib,≥2 Doses,States/Local Areas,Illinois,2016,Age,13 Months,96.5,93.4 to 98.2,484
Hib,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,95.9,94.0 to 97.3,986
Hib,≥2 Doses,States/Local Areas,Illinois,2018,Age,7 Months,88.2,83.9 to 91.5,542
Hib,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,7 Months,88.3,85.3 to 90.8,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2014,Age,35 Months,93.2,90.0 to 95.6,493
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,35 Months,94.3,92.0 to 96.2,960
PCV,≥3 Doses,States/Local Areas,Illinois,2015,Age,35 Months,95.6,91.9 to 97.9,467
PCV,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,35 Months,95.5,93.2 to 97.1,951
PCV,≥3 Doses,States/Local Areas,Illinois,2016,Age,35 Months,95.0,91.5 to 97.4,484
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,35 Months,94.9,92.7 to 96.6,986
DTaP,≥3 Doses,States/Local Areas,Illinois,2014,Age,7 Months,77.3,72.3 to 81.6,493
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,74.2,70.4 to 77.7,960
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,95.9,94.3 to 97.5,686
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,91.2,88.3 to 94.1,519
Hib,≥3 Doses,States/Local Areas,Illinois,2012,Age,7 Months,58.3,55.1 to 61.4,543
Hib,≥3 Doses,States/Local Areas,Illinois,2011,Age,7 Months,70.1,65.5 to 74.4,583
Hib,≥3 Doses,States/Local Areas,Illinois,2013,Age,7 Months,58.7,53.3 to 63.9,537
Hib,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,59.8,55.5 to 64.0,1030
Polio,≥1 Dose,States/Local Areas,Illinois,2014,Age,3 Months,89.1,85.4 to 92.0,493
Polio,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,3 Months,87.6,84.7 to 90.0,960
Polio,≥1 Dose,States/Local Areas,Illinois,2015,Age,3 Months,86.0,81.6 to 89.6,467
Polio,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,3 Months,86.9,83.7 to 89.6,951
Polio,≥1 Dose,States/Local Areas,Illinois,2016,Age,3 Months,87.8,82.8 to 91.5,484
Polio,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,3 Months,88.1,84.9 to 90.7,986
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2017,Age,0-3 Days,81.9,75.0 to 87.2,273
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2017-2018,Age,0-3 Days,78.8,75.3 to 81.9,1044
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016,Age,0-3 Days,76.1,70.6 to 80.8,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2016-2017,Age,0-3 Days,77.1,73.4 to 80.4,986
Hib,≥2 Doses,States/Local Areas,Illinois,2015,Age,7 Months,90.0,85.5 to 93.2,467
Hib,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,7 Months,90.7,87.6 to 93.1,951
DTaP,≥3 Doses,States/Local Areas,Illinois,2013,Age,13 Months,92.8,91.6 to 93.9,537
DTaP,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,13 Months,93.3,91.5 to 94.8,1030
DTaP,≥3 Doses,States/Local Areas,Illinois,2014,Age,13 Months,93.9,90.6 to 96.1,493
DTaP,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,13 Months,91.8,89.1 to 93.8,960
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,75.9,71.5 to 80.3,515
Hib,≥2 Doses,States/Local Areas,Illinois,2019,Age,7 Months,88.5,83.8 to 91.9,548
DTaP,≥3 Doses,States/Local Areas,Illinois,2011,Age,13 Months,92.4,89.9 to 94.3,583
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,80.7,76.3 to 85.2,408
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,70.8,51.9 to 89.6,34
Hib,≥2 Doses,States/Local Areas,Illinois,2016,Age,7 Months,91.5,86.7 to 94.6,484
Hib,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,7 Months,91.9,89.1 to 94.1,986
Hib,≥2 Doses,States/Local Areas,Illinois,2017,Age,7 Months,92.4,88.9 to 94.9,502
Hib,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,7 Months,90.3,87.7 to 92.5,1044
PCV,≥3 Doses,States/Local Areas,Illinois,2019,Age,24 Months,91.6,87.6 to 94.7,548
PCV,≥3 Doses,States/Local Areas,Illinois,2011,Age,35 Months,93.6,90.4 to 96.1,583
PCV,≥3 Doses,States/Local Areas,Illinois,2013,Age,35 Months,95.1,91.7 to 97.4,537
PCV,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,93.8,91.6 to 95.7,1030
PCV,≥3 Doses,States/Local Areas,Illinois,2012,Age,35 Months,90.7,86.7 to 93.9,543
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,86.5 to 95.2,231
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,95.7,93.4 to 98.0,408
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,93.9,91.9 to 95.9,751
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.4,92.7 to 96.1,930
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2013,Age,0-3 Days,69.3,63.8 to 74.2,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2013-2014,Age,0-3 Days,71.3,67.6 to 74.8,1030
Polio,≥1 Dose,States/Local Areas,Illinois,2013,Age,3 Months,85.2,81.5 to 88.3,537
Polio,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,3 Months,87.2,83.9 to 89.9,1030
PCV,≥1 Dose,States/Local Areas,Illinois,2019,Age,3 Months,87.9,83.2 to 91.4,548
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,92.9,90.4 to 95.5,515
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,93.4,92.0 to 94.8,1720
Polio,≥1 Dose,States/Local Areas,Illinois,2012,Age,3 Months,84.2,79.7 to 87.9,543
Polio,≥1 Dose,States/Local Areas,Illinois,2011,Age,3 Months,88.1,84.0 to 91.3,583
DTaP,≥3 Doses,States/Local Areas,Illinois,2013,Age,7 Months,73.4,70.4 to 76.2,537
DTaP,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,75.3,73.2 to 77.3,1030
DTaP,≥3 Doses,States/Local Areas,Illinois,2012,Age,7 Months,67.4,64.5 to 70.1,543
DTaP,≥3 Doses,States/Local Areas,Illinois,2011,Age,7 Months,77.2,71.6 to 81.9,583
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014,Age,0-3 Days,73.5,68.4 to 78.0,493
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2015,Age,0-3 Days,72.4,68.7 to 75.9,960
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,87.6 to 92.2,930
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.7,77.9 to 89.4,231
PCV,≥1 Dose,States/Local Areas,Illinois,2014,Age,3 Months,89.9,86.2 to 92.6,493
PCV,≥1 Dose,States/Local Areas,Illinois,2014-2015,Age,3 Months,87.5,84.5 to 90.0,960
PCV,≥1 Dose,States/Local Areas,Illinois,2015,Age,3 Months,85.1,80.3 to 89.0,467
PCV,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,3 Months,86.9,83.5 to 89.6,951
Hib,≥2 Doses,States/Local Areas,Illinois,2018,Age,5 Months,79.5,74.6 to 83.6,542
Hib,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,5 Months,78.3,74.7 to 81.5,1090
Hib,≥2 Doses,States/Local Areas,Illinois,2019,Age,5 Months,77.1,71.7 to 81.8,548
Hib,≥2 Doses,States/Local Areas,Illinois,2011,Age,7 Months,93.3,90.8 to 95.1,583
PCV,≥3 Doses,States/Local Areas,Illinois,2016,Age,24 Months,94.7,91.1 to 97.1,484
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,24 Months,94.2,92.0 to 96.0,986
Hib,≥2 Doses,States/Local Areas,Illinois,2012,Age,7 Months,85.8,81.7 to 89.1,543
PCV,≥3 Doses,States/Local Areas,Illinois,2017,Age,24 Months,93.8,90.7 to 96.1,502
PCV,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,24 Months,93.2,90.9 to 95.2,1044
PCV,≥3 Doses,States/Local Areas,Illinois,2018,Age,24 Months,92.7,89.0 to 95.5,542
PCV,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,24 Months,92.2,89.6 to 94.4,1090
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.5,90.3 to 94.6,850
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,97.1,94.5 to 99.7,119
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2015,Age,0-3 Days,71.4,65.8 to 76.4,467
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2015-2016,Age,0-3 Days,73.8,69.9 to 77.3,951
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2011,Age,0-3 Days,67.3,61.5 to 72.6,583
PCV,≥1 Dose,States/Local Areas,Illinois,2018,Age,3 Months,86.9,82.6 to 90.3,542
PCV,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,3 Months,87.4,84.3 to 89.9,1090
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,93.0,90.7 to 95.3,624
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2012,Age,0-3 Days,71.9,66.5 to 76.7,543
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,83.4,79.9 to 86.9,751
Hib,≥3 Doses,States/Local Areas,Illinois,2015,Age,13 Months,73.5,68.0 to 78.3,467
Hib,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,13 Months,75.2,71.4 to 78.7,951
Polio,≥3 Doses,States/Local Areas,Illinois,2012,Age,19 Months,88.1,83.5 to 91.6,543
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,72.5,68.2 to 76.9,686
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,74.1,69.7 to 78.6,519
DTaP,≥3 Doses,States/Local Areas,Illinois,2020,Age,13 Months,88.6,84.4 to 91.9,549
Polio,≥3 Doses,States/Local Areas,Illinois,2013,Age,19 Months,92.1,90.4 to 93.5,537
Polio,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,92.8,90.9 to 94.4,1030
Polio,≥3 Doses,States/Local Areas,Illinois,2014,Age,19 Months,93.6,90.3 to 95.9,493
Polio,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,19 Months,93.0,90.6 to 94.8,960
Polio,≥3 Doses,States/Local Areas,Illinois,2015,Age,19 Months,92.4,89.1 to 94.8,467
Polio,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,93.1,90.5 to 95.0,951
Hib,≥3 Doses,States/Local Areas,Illinois,2016,Age,13 Months,77.0,71.6 to 81.6,484
Hib,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,13 Months,77.4,73.7 to 80.7,986
Hib,≥3 Doses,States/Local Areas,Illinois,2017,Age,13 Months,77.9,72.6 to 82.4,502
Hib,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,76.3,72.7 to 79.6,1044
DTaP,≥3 Doses,States/Local Areas,Illinois,2019,Age,13 Months,91.0,86.8 to 94.0,548
DTaP,≥3 Doses,States/Local Areas,Illinois,2011,Age,19 Months,95.1,92.7 to 96.7,583
DTaP,≥3 Doses,States/Local Areas,Illinois,2013,Age,19 Months,94.5,93.3 to 95.4,537
DTaP,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,94.7,92.8 to 96.2,1030
DTaP,≥3 Doses,States/Local Areas,Illinois,2012,Age,19 Months,89.8,86.5 to 92.5,543
Hib,≥3 Doses,States/Local Areas,Illinois,2019,Age,13 Months,73.7,68.4 to 78.4,548
Hib,≥2 Doses,States/Local Areas,Illinois,2020,Age,13 Months,93.4,90.1 to 95.7,549
Hib,≥3 Doses,States/Local Areas,Illinois,2012,Age,19 Months,88.8,85.8 to 91.2,543
Hib,≥3 Doses,States/Local Areas,Illinois,2011,Age,19 Months,93.7,91.3 to 95.5,583
Hib,≥3 Doses,States/Local Areas,Illinois,2013,Age,19 Months,93.5,92.4 to 94.4,537
Hib,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,19 Months,92.1,90.6 to 93.4,1030
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,80.4 to 98.5,91
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,78.3,74.3 to 82.4,741
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.5,78.3 to 86.7,1017
Rotavirus,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,77.6,71.4 to 83.8,331
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.4,87.3 to 95.5,482
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,81.0,75.1 to 87.0,331
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.7,75.1 to 86.2,482
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,82.6,77.8 to 87.3,519
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,86.4 to 95.0,482
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,93.5,90.8 to 96.2,519
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,91.1,87.2 to 94.9,331
Rotavirus,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.1,73.2 to 84.9,482
Rotavirus,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,78.8,73.8 to 83.8,519
Influenza,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,62.3,55.7 to 68.9,482
Influenza,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,64.2,58.3 to 70.0,519
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.4,68.5 to 80.4,482
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,69.0,61.8 to 76.2,331
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,84.4,78.8 to 90.0,331
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.0,78.7 to 89.3,482
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,81.6,76.9 to 86.3,519
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,94.6,91.8 to 97.3,331
Polio,≥3 Doses,States/Local Areas,Illinois,2018,Age,19 Months,90.9,86.8 to 93.8,542
Polio,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,69.4,65.6 to 73.0,1090
Hib,≥3 Doses,States/Local Areas,Illinois,2018,Age,13 Months,74.6,69.5 to 79.2,542
Hib,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,74.2,70.5 to 77.5,1090
Polio,≥3 Doses,States/Local Areas,Illinois,2016,Age,19 Months,93.7,89.7 to 96.2,484
Polio,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,93.7,91.2 to 95.5,986
Polio,≥3 Doses,States/Local Areas,Illinois,2017,Age,19 Months,93.6,90.1 to 96.0,502
Polio,≥3 Doses,States/Local Areas,Illinois,2017-2018,Age,19 Months,92.3,89.7 to 94.2,1044
PCV,≥1 Dose,States/Local Areas,Illinois,2016,Age,3 Months,88.6,83.6 to 92.2,484
PCV,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,3 Months,88.0,84.7 to 90.6,986
PCV,≥1 Dose,States/Local Areas,Illinois,2017,Age,3 Months,87.3,83.0 to 90.7,502
PCV,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,3 Months,87.1,84.1 to 89.6,1044
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,92.6,89.9 to 95.2,686
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,82.0,78.2 to 85.8,519
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,79.6,75.4 to 83.8,515
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Overall,Overall,84.7,82.5 to 86.8,1720
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,87.3,80.6 to 94.0,119
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.2,82.3 to 88.1,850
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,94.1,92.4 to 95.8,1043
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.3,82.8 to 93.8,151
Hep B,≥3 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,86.5,74.5 to 98.6,34
Hib,≥2 Doses,States/Local Areas,Illinois,2013,Age,7 Months,90.5,87.1 to 93.2,537
Hib,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,7 Months,91.8,88.6 to 94.1,1030
Hib,≥2 Doses,States/Local Areas,Illinois,2014,Age,7 Months,93.0,89.6 to 95.4,493
Hib,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,7 Months,91.5,88.8 to 93.6,960
Hib,≥2 Doses,States/Local Areas,Illinois,2015,Age,5 Months,79.8,74.5 to 84.2,467
Hib,≥2 Doses,States/Local Areas,Illinois,2015-2016,Age,5 Months,80.1,76.3 to 83.3,951
Hib,≥2 Doses,States/Local Areas,Illinois,2016,Age,5 Months,80.3,74.8 to 84.9,484
Hib,≥2 Doses,States/Local Areas,Illinois,2016-2017,Age,5 Months,82.0,78.4 to 85.1,986
PCV,≥3 Doses,States/Local Areas,Illinois,2015,Age,24 Months,93.7,90.1 to 96.3,467
PCV,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,24 Months,94.2,91.7 to 96.1,951
PCV,≥3 Doses,States/Local Areas,Illinois,2014,Age,24 Months,93.1,89.9 to 95.6,493
PCV,≥3 Doses,States/Local Areas,Illinois,2014-2015,Age,24 Months,93.4,91.1 to 95.3,960
Hib,≥2 Doses,States/Local Areas,Illinois,2017,Age,5 Months,83.7,79.2 to 87.4,502
Hib,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,5 Months,81.6,78.4 to 84.5,1044
PCV,≥3 Doses,States/Local Areas,Illinois,2013,Age,24 Months,91.6,87.5 to 94.8,537
PCV,≥3 Doses,States/Local Areas,Illinois,2013-2014,Age,24 Months,92.3,89.8 to 94.4,1030
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,89.1,86.6 to 91.6,1043
PCV,≥1 Dose,States/Local Areas,Illinois,2013,Age,3 Months,82.8,78.3 to 86.6,537
PCV,≥1 Dose,States/Local Areas,Illinois,2013-2014,Age,3 Months,86.3,82.9 to 89.1,1030
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,Hispanic,82.4,78.2 to 86.7,408
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.3,62.8 to 79.9,151
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Any Medicaid,79.9,76.2 to 83.6,624
PCV,≥4 Doses,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Uninsured,69.0,50.7 to 87.3,34
PCV,≥4 Doses,States/Local Areas,Illinois,2017,Age,35 Months,85.4,80.7 to 89.5,502
PCV,≥4 Doses,States/Local Areas,Illinois,2017-2018,Age,35 Months,86.1,82.7 to 89.1,1044
Hib,≥1 Dose,States/Local Areas,Illinois,2015,Age,3 Months,87.9,83.5 to 91.3,467
Hib,≥1 Dose,States/Local Areas,Illinois,2015-2016,Age,3 Months,87.8,84.6 to 90.4,951
Hib,≥1 Dose,States/Local Areas,Illinois,2016,Age,3 Months,87.7,82.6 to 91.4,484
Hib,≥1 Dose,States/Local Areas,Illinois,2016-2017,Age,3 Months,88.1,84.8 to 90.7,986
Hib,≥1 Dose,States/Local Areas,Illinois,2017,Age,3 Months,88.6,84.5 to 91.6,502
Hib,≥1 Dose,States/Local Areas,Illinois,2017-2018,Age,3 Months,87.3,84.4 to 89.7,1044
Hep B,≥2 Doses,States/Local Areas,Illinois,2017,Age,13 Months,95.5,92.7 to 97.2,502
Hep B,≥2 Doses,States/Local Areas,Illinois,2017-2018,Age,13 Months,95.7,93.9 to 97.0,1044
Hep B,≥2 Doses,States/Local Areas,Illinois,2018,Age,13 Months,95.9,93.3 to 97.6,542
Hep B,≥2 Doses,States/Local Areas,Illinois,2018-2019,Age,13 Months,95.6,93.7 to 97.0,1090
Hep B,≥2 Doses,States/Local Areas,Illinois,2019,Age,13 Months,95.3,92.1 to 97.3,548
PCV,≥3 Doses,States/Local Areas,Illinois,2015,Age,19 Months,92.4,89.3 to 94.6,467
PCV,≥3 Doses,States/Local Areas,Illinois,2015-2016,Age,19 Months,92.9,90.0 to 95.0,951
PCV,≥3 Doses,States/Local Areas,Illinois,2016,Age,19 Months,93.4,89.2 to 96.1,484
PCV,≥3 Doses,States/Local Areas,Illinois,2016-2017,Age,19 Months,93.4,90.9 to 95.3,986
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,93.6,91.3 to 95.8,751
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.1,91.0 to 95.1,930
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Insurance Coverage,Private Insurance Only,93.5,91.5 to 95.6,1043
≥1 Dose MMR,,States/Local Areas,Illinois,2019,Age,35 Months,93.2,88.9 to 96.3,548
PCV,≥4 Doses,States/Local Areas,Illinois,2013,Age,35 Months,86.9,82.2 to 90.8,537
PCV,≥4 Doses,States/Local Areas,Illinois,2013-2014,Age,35 Months,85.7,82.5 to 88.6,1030
≥1 Dose MMR,,States/Local Areas,Illinois,2018,Age,35 Months,94.3,90.9 to 96.7,542
≥1 Dose MMR,,States/Local Areas,Illinois,2018-2019,Age,35 Months,93.7,91.1 to 95.7,1090
≥1 Dose MMR,,States/Local Areas,Illinois,2017,Age,35 Months,93.5,90.0 to 96.0,502
≥1 Dose MMR,,States/Local Areas,Illinois,2017-2018,Age,35 Months,93.8,91.5 to 95.7,1044
PCV,≥1 Dose,States/Local Areas,Illinois,2012,Age,3 Months,83.0,79.1 to 86.3,543
PCV,≥1 Dose,States/Local Areas,Illinois,2011,Age,3 Months,86.7,82.3 to 90.2,583
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,96.5,94.8 to 98.3,686
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,89.4,86.2 to 92.6,519
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,91.7,88.8 to 94.6,515
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Overall,Overall,92.6,91.0 to 94.2,1720
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,93.0,87.8 to 98.1,119
PCV,≥4 Doses,States/Local Areas,Illinois,2018,Age,35 Months,87.0,82.0 to 91.2,542
PCV,≥4 Doses,States/Local Areas,Illinois,2018-2019,Age,35 Months,86.3,82.6 to 89.6,1090
PCV,≥4 Doses,States/Local Areas,Illinois,2019,Age,35 Months,85.8,79.6 to 90.8,548
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Poverty,<133% FPL,92.6,89.9 to 95.3,515
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Overall,Overall,92.9,91.3 to 94.4,1720
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.4,90.1 to 94.6,850
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a Non-MSA,92.6,86.9 to 98.2,119
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Poverty,133% to <400% FPL,90.1,86.9 to 93.3,519
PCV,≥3 Doses,States/Local Areas,Illinois,2018,Age,19 Months,91.8,87.7 to 94.6,542
PCV,≥3 Doses,States/Local Areas,Illinois,2018-2019,Age,19 Months,89.5,86.6 to 91.9,1090
PCV,≥3 Doses,States/Local Areas,Illinois,2019,Age,19 Months,90.9,86.6 to 93.9,548
PCV,≥3 Doses,States/Local Areas,Illinois,2011,Age,24 Months,92.9,89.7 to 95.4,583
Hib,≥2 Doses,States/Local Areas,Illinois,2013,Age,5 Months,77.3,76.0 to 78.5,537
Hib,≥2 Doses,States/Local Areas,Illinois,2013-2014,Age,5 Months,79.2,76.4 to 81.7,1030
Hib,≥2 Doses,States/Local Areas,Illinois,2014,Age,5 Months,81.1,76.4 to 85.0,493
Hib,≥2 Doses,States/Local Areas,Illinois,2014-2015,Age,5 Months,80.4,76.8 to 83.6,960
Hib,≥1 Dose,States/Local Areas,Illinois,2018,Age,3 Months,86.0,81.5 to 89.6,542
Hib,≥1 Dose,States/Local Areas,Illinois,2018-2019,Age,3 Months,87.0,84.0 to 89.6,1090
Hib,≥1 Dose,States/Local Areas,Illinois,2019,Age,3 Months,88.1,83.6 to 91.5,548
Hib,≥2 Doses,States/Local Areas,Illinois,2012,Age,5 Months,76.1,72.6 to 79.4,543
Hib,≥2 Doses,States/Local Areas,Illinois,2011,Age,5 Months,83.6,79.9 to 86.7,583
≥1 Dose Varicella,,States/Local Areas,Illinois,2014-2017,Poverty,>400% FPL,95.7,93.7 to 97.6,686
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.3,89.0 to 93.6,850
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Urbanicity,Living In a MSA Principal City,94.3,92.1 to 96.5,751
≥1 Dose MMR,,States/Local Areas,Illinois,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.2,91.3 to 95.2,930
PCV,≥3 Doses,States/Local Areas,Illinois,2012,Age,24 Months,89.5,85.4 to 92.9,543
DTaP,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,91.6,87.9 to 94.3,592
DTaP,≥4 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,73.6,68.3 to 78.3,592
Hep B,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,81.4,76.5 to 85.5,592
PCV,≥4 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,84.6,80.2 to 88.4,592
Hib,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,33.6,28.7 to 38.9,592
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2019-2020,Age,0-3 Days,79.7,75.1 to 83.7,592
DTaP,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,3 Months,89.4,85.4 to 92.5,592
Polio,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,3 Months,87.8,83.4 to 91.1,592
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,87.3 to 95.8,482
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,90.3 to 96.8,519
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,92.7,89.1 to 96.2,331
Rotavirus,,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,73.1,66.6 to 79.7,386
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,88.5 to 94.9,519
Rotavirus,,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,79.8,75.5 to 84.1,696
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.8,84.3 to 93.3,482
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,89.9,84.7 to 95.1,250
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,85.3,81.3 to 89.2,696
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,75.1,67.6 to 82.6,250
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,73.7,68.8 to 78.6,696
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,83.1,72.6 to 93.5,386
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,96.3,93.4 to 99.2,250
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,92.8,90.2 to 95.3,696
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,91.5,86.8 to 96.1,386
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,93.6,91.5 to 95.7,1332
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,93.7,91.9 to 95.5,1332
Influenza,,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,59.8,54.4 to 65.2,696
Influenza,,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,54.3,47.3 to 61.4,386
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,93.8,89.8 to 97.9,250
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,91.0,88.2 to 93.7,696
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,87.7,82.7 to 92.7,386
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,84.1,77.8 to 90.4,250
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,83.6,79.6 to 87.7,696
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,89.1,84.4 to 93.9,386
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,81.0,77.9 to 84.2,1332
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,90.7,86.0 to 95.4,386
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,79.6,72.5 to 86.7,250
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,78.4,72.3 to 84.4,386
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,84.2,80.2 to 88.2,696
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,92.9,88.8 to 97.1,250
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,78.9,72.9 to 84.9,386
Influenza,,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,78.6,71.9 to 85.3,250
Rotavirus,,States/Local Areas,Idaho,2016-2019,Overall,Overall,78.6,75.3 to 81.8,1332
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.3,93.7 to 97.0,1017
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,88.2,71.3 to 100.0,30
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,68.1,44.5 to 91.6,30
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,69.7,64.1 to 75.4,521
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,31.8,12.5 to 51.1,40
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.0,92.2 to 95.8,1017
Hep A,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,19 Months,86.2,81.8 to 89.7,592
Hib,≥2 Doses,States/Local Areas,Idaho,2020,Age,5 Months,76.2,68.5 to 82.5,286
Polio,≥2 Doses,States/Local Areas,Idaho,2020,Age,5 Months,78.1,70.4 to 84.2,286
DTaP,≥2 Doses,States/Local Areas,Idaho,2020,Age,5 Months,79.3,71.8 to 85.2,286
PCV,≥1 Dose,States/Local Areas,Idaho,2020,Age,3 Months,86.7,79.9 to 91.4,286
Hep B,≥1 Dose,States/Local Areas,Idaho,2020,Age,3 Months,94.1,88.7 to 97.0,286
Hep A,≥1 Dose,States/Local Areas,Idaho,2020,Age,24 Months,89.5,83.5 to 94.0,286
Hep A,≥2 Doses,States/Local Areas,Idaho,2020,Age,24 Months,53.2,45.5 to 61.2,286
PCV,≥4 Doses,States/Local Areas,Idaho,2020,Age,24 Months,83.6,77.0 to 89.2,286
PCV,≥3 Doses,States/Local Areas,Idaho,2020,Age,24 Months,92.3,87.2 to 95.9,286
≥1 Dose Varicella,,States/Local Areas,Idaho,2020,Age,24 Months,86.6,80.3 to 91.6,286
Influenza,,States/Local Areas,Idaho,2020,Age,24 Months,57.0,49.3 to 65.0,286
Rotavirus,,States/Local Areas,Idaho,2020,Age,8 Months,78.7,71.5 to 84.5,286
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2020,Age,0-3 Days,83.5,77.2 to 88.4,286
≥1 Dose MMR,,States/Local Areas,Idaho,2020,Age,19 Months,87.3,80.9 to 91.8,286
Hib,≥3 Doses,States/Local Areas,Idaho,2020,Age,19 Months,87.8,81.7 to 92.1,286
Combined 7 Series,,States/Local Areas,Idaho,2020,Age,24 Months,70.0,62.5 to 77.2,286
DTaP,≥4 Doses,States/Local Areas,Idaho,2020,Age,19 Months,74.9,67.3 to 81.2,286
Polio,≥3 Doses,States/Local Areas,Idaho,2020,Age,19 Months,89.1,82.5 to 93.4,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2020,Age,19 Months,92.4,87.2 to 95.6,286
PCV,≥3 Doses,States/Local Areas,Idaho,2020,Age,13 Months,90.1,84.2 to 93.9,286
Hep B,≥2 Doses,States/Local Areas,Idaho,2020,Age,5 Months,91.8,85.9 to 95.3,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2020,Age,7 Months,72.5,64.6 to 79.2,286
PCV,≥2 Doses,States/Local Areas,Idaho,2020,Age,5 Months,77.4,69.8 to 83.6,286
≥1 Dose Varicella,,States/Local Areas,Idaho,2020,Age,13 Months,54.0,46.1 to 61.7,286
Hep B,≥3 Doses,States/Local Areas,Idaho,2020,Age,13 Months,92.4,86.6 to 95.8,286
Hep B,≥2 Doses,States/Local Areas,Idaho,2020,Age,13 Months,93.3,87.5 to 96.6,286
Hib,≥3 Doses,States/Local Areas,Idaho,2020,Age,13 Months,59.2,51.5 to 66.5,286
Hib,Primary Series,States/Local Areas,Idaho,2020,Age,13 Months,90.6,85.3 to 94.1,286
PCV,≥3 Doses,States/Local Areas,Idaho,2020,Age,35 Months,96.0,90.2 to 98.8,286
Hib,≥2 Doses,States/Local Areas,Idaho,2020,Age,13 Months,93.3,88.0 to 96.4,286
PCV,≥4 Doses,States/Local Areas,Idaho,2020,Age,19 Months,81.3,74.1 to 86.9,286
PCV,≥3 Doses,States/Local Areas,Idaho,2020,Age,19 Months,91.5,85.9 to 95.1,286
Polio,≥3 Doses,States/Local Areas,Idaho,2020,Age,35 Months,92.5,84.7 to 97.2,286
DTaP,≥4 Doses,States/Local Areas,Idaho,2020,Age,35 Months,86.6,77.6 to 93.3,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2020,Age,35 Months,94.9,89.1 to 98.1,286
Hep B,≥3 Doses,States/Local Areas,Idaho,2020,Age,19 Months,92.7,86.9 to 96.0,286
≥1 Dose Varicella,,States/Local Areas,Idaho,2020,Age,19 Months,83.9,76.8 to 89.1,286
Hib,Full Series,States/Local Areas,Idaho,2020,Age,19 Months,79.9,73.0 to 85.4,286
Hib,Primary Series,States/Local Areas,Idaho,2020,Age,19 Months,93.0,87.7 to 96.1,286
≥1 Dose Varicella,,States/Local Areas,Idaho,2020,Age,35 Months,92.8,84.0 to 97.7,286
Hep B,≥3 Doses,States/Local Areas,Idaho,2020,Age,35 Months,92.7,87.5 to 96.3,286
Hib,Full Series,States/Local Areas,Idaho,2020,Age,35 Months,87.6,80.1 to 93.3,286
Hib,Primary Series,States/Local Areas,Idaho,2020,Age,35 Months,94.9,89.1 to 98.2,286
Hib,≥3 Doses,States/Local Areas,Idaho,2020,Age,35 Months,93.6,86.8 to 97.6,286
≥1 Dose MMR,,States/Local Areas,Idaho,2020,Age,35 Months,91.3,84.5 to 96.0,286
Hib,≥3 Doses,States/Local Areas,Idaho,2020,Age,24 Months,90.5,85.3 to 94.4,286
≥1 Dose MMR,,States/Local Areas,Idaho,2020,Age,24 Months,89.0,83.2 to 93.5,286
Polio,≥3 Doses,States/Local Areas,Idaho,2020,Age,24 Months,89.6,83.7 to 94.1,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2020,Age,24 Months,92.9,88.3 to 96.2,286
DTaP,≥4 Doses,States/Local Areas,Idaho,2020,Age,24 Months,79.6,72.9 to 85.6,286
Hib,Primary Series,States/Local Areas,Idaho,2020,Age,7 Months,79.1,71.7 to 85.0,286
Hib,≥3 Doses,States/Local Areas,Idaho,2020,Age,7 Months,33.8,26.8 to 41.6,286
Hib,≥2 Doses,States/Local Areas,Idaho,2020,Age,7 Months,87.6,80.9 to 92.1,286
Polio,≥2 Doses,States/Local Areas,Idaho,2020,Age,7 Months,88.0,81.2 to 92.5,286
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2020,Age,0-1 Days,81.7,75.2 to 86.7,286
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2020,Age,0-2 Days,83.5,77.1 to 88.3,286
Hep A,≥2 Doses,States/Local Areas,Idaho,2020,Age,19 Months,38.2,31.0 to 45.9,286
Hep A,≥1 Dose,States/Local Areas,Idaho,2020,Age,19 Months,85.5,78.5 to 90.4,286
Combined 7 Series,,States/Local Areas,Idaho,2020,Age,35 Months,74.2,65.8 to 82.0,286
≥1 Dose MMR,,States/Local Areas,Idaho,2020,Age,13 Months,69.3,61.3 to 76.3,286
Hep A,≥2 Doses,States/Local Areas,Idaho,2020,Age,35 Months,82.8,73.3 to 90.4,286
DTaP,≥3 Doses,States/Local Areas,Idaho,2020,Age,13 Months,92.0,86.8 to 95.3,286
Hep A,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,24 Months,89.2,85.2 to 92.5,592
Hep A,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,80.2,73.9 to 85.7,592
Hep A,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,35 Months,90.2,86.2 to 93.4,592
Influenza,,States/Local Areas,Idaho,2019-2020,Age,24 Months,62.5,57.0 to 68.0,592
Hep A,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,53.7,48.2 to 59.4,592
Hib,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,88.8,84.9 to 92.1,592
Hib,Primary Series,States/Local Areas,Idaho,2019-2020,Age,24 Months,92.6,89.3 to 95.1,592
Hib,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,88.8,84.7 to 92.0,592
Combined 7 Series,,States/Local Areas,Idaho,2019-2020,Age,35 Months,76.3,70.6 to 81.6,592
Hib,Full Series,States/Local Areas,Idaho,2019-2020,Age,19 Months,77.8,72.9 to 82.1,592
Hep B,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,92.7,89.1 to 95.1,592
PCV,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,91.4,87.6 to 94.1,592
PCV,≥4 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,82.2,77.5 to 86.1,592
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2019-2020,Age,0-1 Days,77.1,72.3 to 81.3,592
Hib,Full Series,States/Local Areas,Idaho,2019-2020,Age,24 Months,81.9,77.4 to 86.0,592
Hep B,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,92.7,89.4 to 95.3,592
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2019-2020,Age,0-2 Days,79.7,75.0 to 83.7,592
PCV,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,74.0,68.8 to 78.6,592
≥1 Dose Varicella,,States/Local Areas,Idaho,2019-2020,Age,24 Months,88.1,84.0 to 91.5,592
PCV,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,91.8,88.2 to 94.6,592
Hep A,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,38.6,33.4 to 44.1,592
Polio,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,89.6,85.4 to 92.7,592
≥1 Dose MMR,,States/Local Areas,Idaho,2019-2020,Age,19 Months,87.6,83.3 to 91.0,592
Hib,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,19 Months,86.4,82.0 to 89.9,592
≥1 Dose MMR,,States/Local Areas,Idaho,2019-2020,Age,35 Months,90.8,86.7 to 94.0,592
Hib,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,92.7,88.4 to 95.8,592
Hib,Primary Series,States/Local Areas,Idaho,2019-2020,Age,19 Months,92.6,89.1 to 95.0,592
Hib,Full Series,States/Local Areas,Idaho,2019-2020,Age,35 Months,86.8,81.8 to 91.0,592
Hib,Primary Series,States/Local Areas,Idaho,2019-2020,Age,35 Months,93.7,90.4 to 96.2,592
Hep B,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,92.9,89.6 to 95.4,592
≥1 Dose Varicella,,States/Local Areas,Idaho,2019-2020,Age,35 Months,90.2,85.8 to 93.8,592
PCV,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,94.0,90.2 to 96.7,592
PCV,≥4 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,85.7,81.4 to 89.5,592
DTaP,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,92.4,89.1 to 95.1,592
DTaP,≥4 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,79.4,74.6 to 83.9,592
Polio,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,24 Months,89.9,85.9 to 93.1,592
Hib,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,3 Months,86.7,82.5 to 90.1,592
≥1 Dose MMR,,States/Local Areas,Idaho,2019-2020,Age,24 Months,88.8,84.7 to 92.2,592
Hep B,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,3 Months,95.5,92.5 to 97.4,592
PCV,≥1 Dose,States/Local Areas,Idaho,2019-2020,Age,3 Months,87.3,83.1 to 90.6,592
DTaP,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,5 Months,79.8,74.8 to 84.0,592
Polio,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,5 Months,78.8,73.7 to 83.1,592
DTaP,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,90.1,86.2 to 93.0,592
Polio,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,92.7,89.3 to 95.2,592
Hib,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,93.3,90.1 to 95.6,592
≥1 Dose MMR,,States/Local Areas,Idaho,2019-2020,Age,13 Months,71.0,65.7 to 75.8,592
Hib,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,5 Months,77.8,72.7 to 82.2,592
Hib,Primary Series,States/Local Areas,Idaho,2019-2020,Age,13 Months,90.2,86.6 to 92.9,592
Hib,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,56.8,51.3 to 62.2,592
Hep B,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,5 Months,90.6,86.8 to 93.5,592
PCV,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,5 Months,79.2,74.2 to 83.4,592
DTaP,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,74.8,69.6 to 79.3,592
Polio,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,7 Months,88.4,84.1 to 91.6,592
Hep B,≥2 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,93.4,89.9 to 95.7,592
Hep B,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,91.7,88.0 to 94.3,592
PCV,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,13 Months,89.0,85.0 to 92.1,592
≥1 Dose Varicella,,States/Local Areas,Idaho,2019-2020,Age,13 Months,57.3,51.8 to 62.7,592
DTaP,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,94.3,90.7 to 96.8,592
Combined 7 Series,,States/Local Areas,Idaho,2019-2020,Age,24 Months,70.9,65.7 to 75.9,592
DTaP,≥4 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,86.3,81.1 to 90.7,592
Polio,≥3 Doses,States/Local Areas,Idaho,2019-2020,Age,35 Months,91.9,87.6 to 95.2,592
Hep B,≥3 Doses,States/Local Areas,Idaho,2020,Age,7 Months,83.2,76.0 to 88.6,286
PCV,≥3 Doses,States/Local Areas,Idaho,2020,Age,7 Months,72.6,64.8 to 79.2,286
Hib,≥1 Dose,States/Local Areas,Idaho,2020,Age,3 Months,86.8,80.3 to 91.3,286
Hep B,≥2 Doses,States/Local Areas,Idaho,2020,Age,7 Months,92.5,86.5 to 95.9,286
Polio,≥1 Dose,States/Local Areas,Idaho,2020,Age,3 Months,87.0,80.0 to 91.7,286
DTaP,≥1 Dose,States/Local Areas,Idaho,2020,Age,3 Months,89.5,83.3 to 93.5,286
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,94.9,92.9 to 96.9,741
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,81.4,76.6 to 86.3,741
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,83.7,75.0 to 92.4,521
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,92.6,90.1 to 95.2,741
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.5,70.6 to 96.4,91
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,79.3,71.5 to 87.2,215
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.1,58.5 to 87.7,91
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,95.3,93.3 to 97.3,741
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,72.7,46.7 to 98.8,40
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,89.7,86.1 to 93.3,521
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,91.1,84.9 to 97.4,215
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,96.7,90.3 to 100.0,30
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,78.0,56.1 to 99.9,30
Influenza,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,61.3,52.6 to 70.1,215
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,92.4,90.2 to 94.6,1332
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Overall,Overall,91.8,89.6 to 93.9,1332
Rotavirus,,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,86.1,80.2 to 92.1,250
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,92.6,90.4 to 94.8,1332
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Overall,Overall,92.1,90.0 to 94.3,1332
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,92.7,90.1 to 95.2,696
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,83.8,80.9 to 86.8,1332
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,89.9,85.2 to 94.6,386
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,81.9,73.6 to 90.1,250
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,80.8,75.3 to 86.3,696
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,92.9,90.1 to 95.7,696
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,90.8,86.2 to 95.5,386
Influenza,,States/Local Areas,Idaho,2016-2019,Overall,Overall,61.1,57.2 to 64.9,1332
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Overall,Overall,74.7,71.3 to 78.1,1332
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,94.1,90.9 to 97.4,386
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Overall,Overall,81.6,76.8 to 86.5,1332
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,73.5,65.8 to 81.1,250
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Overall,Overall,90.3,88.0 to 92.6,1332
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,95.9,92.8 to 99.0,250
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,73.6,68.8 to 78.4,696
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,94.3,91.9 to 96.7,696
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,69.3,62.6 to 75.9,386
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Poverty,<133% FPL,75.9,70.0 to 81.9,386
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,92.3,87.5 to 97.0,250
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,93.8,91.4 to 96.1,696
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Overall,Overall,81.4,78.3 to 84.5,1332
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Overall,Overall,72.1,68.5 to 75.6,1332
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,90.6,86.7 to 94.6,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,74.6,67.9 to 81.3,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.9,71.3 to 82.4,482
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,>400% FPL,93.7,89.4 to 98.1,250
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Poverty,133% to <400% FPL,93.2,90.6 to 95.8,696
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,72.6,67.0 to 78.1,519
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,72.1,66.7 to 77.5,519
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,93.9,90.8 to 97.0,331
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.0 to 96.4,482
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,91.5,87.8 to 95.1,519
Influenza,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,55.7,48.0 to 63.4,331
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.2,91.2 to 97.2,482
Rotavirus,,States/Local Areas,Idaho,2019-2020,Age,8 Months,77.8,73.0 to 82.0,592
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,93.2,89.9 to 96.5,331
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.1,73.4 to 84.9,482
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,83.2,77.3 to 89.0,331
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.1,87.9 to 96.3,482
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,94.8,92.0 to 97.5,331
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,94.2,91.1 to 97.3,519
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a Non-MSA,82.1,72.5 to 91.7,331
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,83.1,78.5 to 87.7,519
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,88.8 to 95.5,519
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,92.3,88.9 to 95.7,519
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Principal City,82.4,76.5 to 88.3,519
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.6,72.4 to 86.8,482
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,92.2 to 95.9,1017
Rotavirus,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.3,75.6 to 83.0,1017
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.8,89.6 to 94.0,1017
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,76.8,72.4 to 81.2,741
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.7,90.7 to 94.8,1017
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,72.0,66.4 to 77.6,521
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,89.6,83.4 to 95.7,215
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,59.5,32.8 to 86.2,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,71.0,51.1 to 90.8,40
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,66.5 to 94.2,91
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,88.8,85.0 to 92.6,521
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.6 to 98.0,741
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,72.7,46.7 to 98.8,40
Rotavirus,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,85.0,81.5 to 88.6,741
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,92.3,88.8 to 95.8,521
Influenza,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,54.9,48.8 to 61.0,521
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.6,58.0 to 87.2,91
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,90.8,84.5 to 97.0,215
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,77.9,70.4 to 85.4,215
Influenza,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,46.5,20.7 to 72.3,30
Influenza,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,39.2,17.0 to 61.4,40
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,83.3,61.5 to 100.0,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.0,73.1 to 94.9,91
Hep A,≥2 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,68.3,39.3 to 97.3,40
Rotavirus,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,59.4,34.2 to 84.6,40
Rotavirus,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,78.0,56.1 to 99.9,30
Rotavirus,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,72.8,67.2 to 78.3,521
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,69.8,61.2 to 78.4,215
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.3,69.3 to 77.2,1017
Combined 7 Series,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.0,50.1 to 80.0,91
≥1 Dose MMR,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,70.7,44.9 to 96.5,40
Rotavirus,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,78.6,70.8 to 86.4,215
Rotavirus,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.6,53.6 to 83.7,91
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.0,81.8 to 88.2,1017
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,61.2,36.0 to 86.4,40
PCV,≥4 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,83.4,76.0 to 90.7,215
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,88.2,71.3 to 100.0,30
Influenza,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",61.8,57.5 to 66.2,1017
Influenza,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",50.5,33.5 to 67.5,91
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,80.6,58.8 to 100.0,30
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.7 to 96.3,1017
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,87.3,80.8 to 93.7,215
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,92.1 to 96.0,1017
Influenza,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,68.9,64.1 to 73.6,741
PCV,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,72.7,46.7 to 98.8,40
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,78.9,73.7 to 84.0,521
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,93.5,90.5 to 96.4,521
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,74.7,52.3 to 97.0,30
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,40.0,18.4 to 61.6,40
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,96.7,90.3 to 100.0,30
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,90.8,84.6 to 96.9,215
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,79.6,57.8 to 100.0,30
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,89.0,78.5 to 99.4,40
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,72.7,46.7 to 98.8,40
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.6,80.3 to 86.9,1017
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,73.3,50.7 to 96.0,30
Hib,Full Series,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,60.9,35.7 to 86.1,40
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,95.8,94.0 to 97.6,741
Polio,≥3 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.1 to 94.5,521
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.4,78.9 to 85.9,1017
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Other,95.2,88.0 to 100.0,30
≥1 Dose Varicella,,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Uninsured,69.4,43.8 to 95.0,40
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.8,68.2 to 95.4,91
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,91.7,85.6 to 97.8,215
DTaP,≥4 Doses,States/Local Areas,Idaho,2016-2019,Insurance Coverage,Private Insurance Only,85.9,82.3 to 89.5,741
Hep B,≥3 Doses,States/Local Areas,Idaho,2016-2019,Race and Ethnicity,Hispanic,93.7,88.7 to 98.7,215
DTaP,≥2 Doses,States/Local Areas,Idaho,2017,Age,5 Months,75.2,69.5 to 80.2,499
DTaP,≥2 Doses,States/Local Areas,Idaho,2017-2018,Age,5 Months,81.6,78.0 to 84.8,942
Hib,Primary Series,States/Local Areas,Idaho,2020-2021,Age,24 Months,90.5,85.6 to 94.2,457
Hep A,≥1 Dose,States/Local Areas,Idaho,2013,Age,19 Months,80.0,77.3 to 82.4,224
Hep A,≥1 Dose,States/Local Areas,Idaho,2013-2014,Age,19 Months,82.5,79.2 to 85.4,425
Hep A,≥1 Dose,States/Local Areas,Idaho,2016,Age,19 Months,90.3,85.4 to 93.7,190
Hep A,≥1 Dose,States/Local Areas,Idaho,2016-2017,Age,19 Months,88.7,85.4 to 91.3,689
DTaP,≥1 Dose,States/Local Areas,Idaho,2018,Age,3 Months,91.8,87.8 to 94.6,443
DTaP,≥1 Dose,States/Local Areas,Idaho,2018-2019,Age,3 Months,90.8,87.5 to 93.4,749
DTaP,≥3 Doses,States/Local Areas,Idaho,2015,Age,24 Months,89.9,83.6 to 94.5,214
DTaP,≥3 Doses,States/Local Areas,Idaho,2015-2016,Age,24 Months,92.3,88.6 to 95.1,404
DTaP,≥3 Doses,States/Local Areas,Idaho,2014,Age,24 Months,94.4,89.9 to 97.3,201
DTaP,≥3 Doses,States/Local Areas,Idaho,2014-2015,Age,24 Months,92.1,88.4 to 95.0,415
DTaP,≥1 Dose,States/Local Areas,Idaho,2017,Age,3 Months,88.5,84.1 to 91.9,499
DTaP,≥1 Dose,States/Local Areas,Idaho,2017-2018,Age,3 Months,90.2,87.3 to 92.5,942
Hep A,≥1 Dose,States/Local Areas,Idaho,2011,Age,19 Months,83.1,80.1 to 85.7,246
DTaP,≥1 Dose,States/Local Areas,Idaho,2019,Age,3 Months,89.9,84.1 to 93.7,306
DTaP,≥3 Doses,States/Local Areas,Idaho,2016,Age,24 Months,94.6,90.8 to 97.2,190
DTaP,≥3 Doses,States/Local Areas,Idaho,2016-2017,Age,24 Months,93.7,91.1 to 95.8,689
Hep A,≥1 Dose,States/Local Areas,Idaho,2015,Age,19 Months,80.7,75.9 to 84.7,214
Hep A,≥1 Dose,States/Local Areas,Idaho,2015-2016,Age,19 Months,85.5,80.7 to 89.2,404
Hep A,≥1 Dose,States/Local Areas,Idaho,2014,Age,19 Months,85.0,77.5 to 90.3,201
Hep A,≥1 Dose,States/Local Areas,Idaho,2014-2015,Age,19 Months,82.9,77.6 to 87.1,415
Hep A,≥1 Dose,States/Local Areas,Idaho,2012,Age,19 Months,82.3,77.5 to 86.3,223
PCV,≥3 Doses,States/Local Areas,Idaho,2021,Age,19 Months,85.6,74.9 to 92.2,171
Hep A,≥1 Dose,States/Local Areas,Idaho,2021,Age,35 Months,89.2,81.1 to 94.9,171
Hib,Primary Series,States/Local Areas,Idaho,2020-2021,Age,13 Months,86.5,80.7 to 90.7,457
Hib,≥3 Doses,States/Local Areas,Idaho,2021,Age,7 Months,36.8,27.2 to 47.6,171
≥1 Dose Varicella,,States/Local Areas,Idaho,2021,Age,19 Months,82.8,72.6 to 89.7,171
Hib,Full Series,States/Local Areas,Idaho,2021,Age,24 Months,73.5,63.4 to 82.8,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2021,Age,19 Months,86.4,75.8 to 92.8,171
Hib,Primary Series,States/Local Areas,Idaho,2021,Age,24 Months,88.1,79.4 to 94.3,171
Hep B,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,91.9,86.2 to 95.9,457
Polio,≥1 Dose,States/Local Areas,Idaho,2021,Age,3 Months,84.8,75.2 to 91.2,171
≥1 Dose MMR,,States/Local Areas,Idaho,2021,Age,24 Months,88.7,80.5 to 94.5,171
Hib,≥3 Doses,States/Local Areas,Idaho,2021,Age,24 Months,79.2,69.1 to 87.8,171
Polio,≥3 Doses,States/Local Areas,Idaho,2021,Age,24 Months,86.4,77.0 to 93.4,171
DTaP,≥1 Dose,States/Local Areas,Idaho,2021,Age,3 Months,85.3,75.6 to 91.5,171
DTaP,≥4 Doses,States/Local Areas,Idaho,2021,Age,24 Months,74.7,64.6 to 83.9,171
Hep A,≥1 Dose,States/Local Areas,Idaho,2020-2021,Age,35 Months,89.8,84.9 to 93.7,457
PCV,≥3 Doses,States/Local Areas,Idaho,2021,Age,35 Months,85.6,76.1 to 92.8,171
PCV,≥4 Doses,States/Local Areas,Idaho,2021,Age,35 Months,82.1,72.4 to 89.9,171
Hep A,≥1 Dose,States/Local Areas,Idaho,2021,Age,19 Months,84.3,74.0 to 91.1,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,35 Months,94.2,87.6 to 97.9,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2021,Age,24 Months,86.6,77.2 to 93.5,171
PCV,≥3 Doses,States/Local Areas,Idaho,2021,Age,7 Months,73.3,62.2 to 82.0,171
Hep A,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,37.2,31.1 to 43.8,457
Hep A,≥2 Doses,States/Local Areas,Idaho,2021,Age,24 Months,50.4,39.9 to 62.0,171
Hep A,≥1 Dose,States/Local Areas,Idaho,2021,Age,24 Months,89.2,81.1 to 94.9,171
PCV,≥4 Doses,States/Local Areas,Idaho,2021,Age,24 Months,81.6,72.0 to 89.5,171
≥1 Dose Varicella,,States/Local Areas,Idaho,2020-2021,Age,35 Months,91.3,83.1 to 96.5,457
Polio,≥3 Doses,States/Local Areas,Idaho,2020-2021,Age,19 Months,87.5,81.6 to 91.7,457
Hep B,≥3 Doses,States/Local Areas,Idaho,2021,Age,7 Months,78.7,67.7 to 86.7,171
≥1 Dose Varicella,,States/Local Areas,Idaho,2021,Age,24 Months,85.5,76.6 to 92.4,171
PCV,≥3 Doses,States/Local Areas,Idaho,2021,Age,24 Months,85.6,76.1 to 92.8,171
PCV,≥3 Doses,States/Local Areas,Idaho,2021,Age,13 Months,84.3,73.9 to 91.1,171
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Idaho,2021,Age,0-2 Days,84.1,74.8 to 90.4,171
Hep B,≥2 Doses,States/Local Areas,Idaho,2021,Age,7 Months,87.7,78.0 to 93.5,171
Hib,≥2 Doses,States/Local Areas,Idaho,2020-2021,Age,13 Months,89.3,83.4 to 93.2,457
PCV,≥4 Doses,States/Local Areas,Idaho,2021,Age,19 Months,78.9,68.0 to 86.9,171
DTaP,≥3 Doses,States/Local Areas,Idaho,2021,Age,13 Months,84.8,74.2 to 91.5,171
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Idaho,2021,Age,0-1 Days,84.1,74.8 to 90.4,171
≥1 Dose MMR,,States/Local Areas,Idaho,2020-2021,Age,13 Months,68.4,61.6 to 74.5,457
Rotavirus,,States/Local Areas,Arkansas,2014,Age,8 Months,71.4,63.7 to 78.0,239
Rotavirus,,States/Local Areas,Arkansas,2014-2015,Age,8 Months,72.0,66.9 to 76.7,504
Rotavirus,,States/Local Areas,Arkansas,2013,Age,8 Months,69.6,60.4 to 77.5,212
Rotavirus,,States/Local Areas,Arkansas,2013-2014,Age,8 Months,70.5,64.7 to 75.7,451
Rotavirus,,States/Local Areas,Arkansas,2011,Age,8 Months,59.8,50.5 to 68.6,230
Rotavirus,,States/Local Areas,Arkansas,2012,Age,8 Months,71.1,62.7 to 78.2,236
Rotavirus,,States/Local Areas,Arkansas,2016,Age,8 Months,74.1,66.1 to 80.8,272
Rotavirus,,States/Local Areas,Arkansas,2016-2017,Age,8 Months,72.3,67.0 to 77.0,662
Rotavirus,,States/Local Areas,Arkansas,2015,Age,8 Months,72.7,65.5 to 78.9,265
Rotavirus,,States/Local Areas,Arkansas,2015-2016,Age,8 Months,73.4,68.2 to 78.1,537
Hib,Full Series,States/Local Areas,Arkansas,2014,Age,24 Months,76.1,68.5 to 83.1,239
Hib,Full Series,States/Local Areas,Arkansas,2014-2015,Age,24 Months,75.9,70.7 to 80.7,504
Hib,Full Series,States/Local Areas,Arkansas,2013,Age,24 Months,80.6,73.4 to 86.9,212
Hib,Full Series,States/Local Areas,Arkansas,2013-2014,Age,24 Months,78.4,73.2 to 83.2,451
Hep B,≥2 Doses,States/Local Areas,Arkansas,2019-2020,Age,7 Months,91.6,88.0 to 94.2,680
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,44.8,28.7 to 60.8,53
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,62.1,51.7 to 72.4,142
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.1,46.2 to 70.1,94
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,72.6,63.0 to 82.3,130
Hib,Full Series,States/Local Areas,Arkansas,2016,Age,19 Months,77.5,70.0 to 83.6,272
Hib,Full Series,States/Local Areas,Arkansas,2016-2017,Age,19 Months,74.9,70.0 to 79.3,662
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,61.4,53.7 to 69.1,279
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,67.9,61.6 to 74.1,398
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.2,62.4 to 72.0,669
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.2,62.1 to 82.4,115
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,63.8,58.0 to 69.7,426
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,80.1,74.6 to 85.5,387
Combined 7 Series,,States/Local Areas,Arkansas,2019,Age,35 Months,77.9,70.4 to 84.7,357
Combined 7 Series,,States/Local Areas,Arkansas,2018,Age,35 Months,71.1,64.2 to 77.7,426
Combined 7 Series,,States/Local Areas,Arkansas,2018-2019,Age,35 Months,74.2,69.1 to 79.1,783
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Overall,Overall,66.9,63.0 to 70.9,1008
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,70.2,63.9 to 76.6,331
Hib,Full Series,States/Local Areas,Arkansas,2013,Age,19 Months,76.9,68.7 to 83.5,212
Hib,Full Series,States/Local Areas,Arkansas,2013-2014,Age,19 Months,72.3,69.1 to 75.2,451
Hib,Full Series,States/Local Areas,Arkansas,2012,Age,19 Months,67.4,64.3 to 70.3,236
Hib,Full Series,States/Local Areas,Arkansas,2011,Age,19 Months,60.8,55.8 to 65.6,230
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,86.2,80.8 to 91.5,198
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,66.0,59.4 to 72.6,387
Hib,Full Series,States/Local Areas,Arkansas,2015,Age,19 Months,66.3,63.3 to 69.2,265
Hib,Full Series,States/Local Areas,Arkansas,2015-2016,Age,19 Months,72.0,66.7 to 76.7,537
Hib,Full Series,States/Local Areas,Arkansas,2014,Age,19 Months,67.5,59.4 to 74.7,239
Hib,Full Series,States/Local Areas,Arkansas,2014-2015,Age,19 Months,66.9,61.4 to 72.0,504
Hib,Full Series,States/Local Areas,Arkansas,2018,Age,19 Months,74.9,68.5 to 80.4,426
Hib,Full Series,States/Local Areas,Arkansas,2018-2019,Age,19 Months,94.3,91.3 to 96.3,783
Hib,Full Series,States/Local Areas,Arkansas,2017,Age,19 Months,72.3,65.6 to 78.1,390
Hib,Full Series,States/Local Areas,Arkansas,2017-2018,Age,19 Months,73.6,69.0 to 77.7,816
Combined 7 Series,,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,62.7,56.9 to 68.5,423
Hib,Full Series,States/Local Areas,Arkansas,2019,Age,19 Months,68.3,61.2 to 74.7,357
Hib,Full Series,States/Local Areas,Arkansas,2012,Age,24 Months,74.5,66.5 to 81.9,236
Hib,Full Series,States/Local Areas,Arkansas,2011,Age,24 Months,71.1,62.3 to 79.3,230
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.7,72.6 to 88.7,144
Combined 7 Series,,States/Local Areas,Arkansas,2011,Age,35 Months,68.1,55.6 to 80.1,230
Hib,Primary Series,States/Local Areas,Arkansas,2015,Age,13 Months,84.3,77.8 to 89.2,265
Hib,Primary Series,States/Local Areas,Arkansas,2015-2016,Age,13 Months,86.6,82.3 to 90.0,537
Hib,Primary Series,States/Local Areas,Arkansas,2018,Age,13 Months,88.1,82.9 to 91.9,426
Hib,Primary Series,States/Local Areas,Arkansas,2018-2019,Age,13 Months,86.4,82.5 to 89.5,783
Hib,Primary Series,States/Local Areas,Arkansas,2018,Age,19 Months,91.8,86.9 to 94.9,426
Hib,Primary Series,States/Local Areas,Arkansas,2018-2019,Age,19 Months,86.4,82.5 to 89.5,783
Hib,Primary Series,States/Local Areas,Arkansas,2019,Age,19 Months,88.0,82.4 to 92.0,357
Hib,Primary Series,States/Local Areas,Arkansas,2013,Age,24 Months,91.6,86.5 to 95.3,212
Hib,Primary Series,States/Local Areas,Arkansas,2013-2014,Age,24 Months,90.5,86.9 to 93.5,451
Hib,Primary Series,States/Local Areas,Arkansas,2012,Age,24 Months,93.0,88.3 to 96.3,236
Hib,Primary Series,States/Local Areas,Arkansas,2011,Age,24 Months,93.3,88.1 to 96.8,230
Hib,Primary Series,States/Local Areas,Arkansas,2017,Age,13 Months,84.1,78.2 to 88.7,390
Hib,Primary Series,States/Local Areas,Arkansas,2017-2018,Age,13 Months,86.1,82.2 to 89.3,816
Hib,Primary Series,States/Local Areas,Arkansas,2016,Age,13 Months,88.8,82.7 to 93.0,272
Hib,Primary Series,States/Local Areas,Arkansas,2016-2017,Age,13 Months,86.5,82.4 to 89.8,662
Hib,Primary Series,States/Local Areas,Arkansas,2011,Age,19 Months,90.9,86.9 to 93.7,230
Hib,Primary Series,States/Local Areas,Arkansas,2019,Age,13 Months,84.7,78.7 to 89.2,357
Hib,Primary Series,States/Local Areas,Arkansas,2014,Age,19 Months,87.7,81.2 to 92.2,239
Hib,Primary Series,States/Local Areas,Arkansas,2014-2015,Age,19 Months,88.4,84.2 to 91.6,504
Hib,Primary Series,States/Local Areas,Arkansas,2013,Age,19 Months,91.3,89.2 to 93.0,212
Hib,Primary Series,States/Local Areas,Arkansas,2013-2014,Age,19 Months,89.5,85.5 to 92.5,451
Hib,Primary Series,States/Local Areas,Arkansas,2012,Age,19 Months,88.8,86.4 to 90.8,236
Hep A,≥2 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,72.0,57.9 to 84.7,190
Hib,Primary Series,States/Local Areas,Arkansas,2016,Age,19 Months,91.3,85.2 to 95.1,272
Hib,Primary Series,States/Local Areas,Arkansas,2016-2017,Age,19 Months,89.7,85.7 to 92.6,662
Hib,Primary Series,States/Local Areas,Arkansas,2017,Age,19 Months,88.0,82.3 to 92.0,390
Hib,Primary Series,States/Local Areas,Arkansas,2017-2018,Age,19 Months,89.9,86.3 to 92.6,816
Hib,Primary Series,States/Local Areas,Arkansas,2015,Age,19 Months,89.1,85.0 to 92.1,265
Hib,Primary Series,States/Local Areas,Arkansas,2015-2016,Age,19 Months,90.2,86.2 to 93.1,537
Hib,Primary Series,States/Local Areas,Arkansas,2015,Age,7 Months,65.1,57.6 to 71.9,265
Hib,Primary Series,States/Local Areas,Arkansas,2015-2016,Age,7 Months,63.2,57.6 to 68.5,537
Hib,Primary Series,States/Local Areas,Arkansas,2014,Age,7 Months,57.1,49.0 to 64.9,239
Hib,Primary Series,States/Local Areas,Arkansas,2014-2015,Age,7 Months,61.1,55.6 to 66.4,504
Hib,Primary Series,States/Local Areas,Arkansas,2013,Age,7 Months,67.6,63.9 to 71.1,212
Hib,Primary Series,States/Local Areas,Arkansas,2013-2014,Age,7 Months,62.4,55.8 to 68.6,451
Hib,Primary Series,States/Local Areas,Arkansas,2014,Age,13 Months,82.1,74.3 to 87.8,239
Hib,Primary Series,States/Local Areas,Arkansas,2014-2015,Age,13 Months,83.2,78.3 to 87.2,504
Hib,Primary Series,States/Local Areas,Arkansas,2013,Age,13 Months,89.0,86.2 to 91.4,212
Hib,Primary Series,States/Local Areas,Arkansas,2013-2014,Age,13 Months,85.6,81.4 to 89.0,451
Hib,Primary Series,States/Local Areas,Arkansas,2012,Age,13 Months,84.6,80.7 to 87.9,236
Hib,Primary Series,States/Local Areas,Arkansas,2011,Age,13 Months,84.2,78.4 to 88.6,230
Hib,Primary Series,States/Local Areas,Arkansas,2019,Age,7 Months,66.9,59.6 to 73.4,357
Hib,Primary Series,States/Local Areas,Arkansas,2018,Age,7 Months,67.3,60.6 to 73.4,426
Hib,Primary Series,States/Local Areas,Arkansas,2018-2019,Age,7 Months,67.1,62.2 to 71.7,783
Hib,Primary Series,States/Local Areas,Arkansas,2017,Age,7 Months,64.4,57.4 to 70.8,390
Hib,Primary Series,States/Local Areas,Arkansas,2017-2018,Age,7 Months,65.9,61.0 to 70.4,816
Hib,Primary Series,States/Local Areas,Arkansas,2016,Age,7 Months,61.3,53.0 to 69.0,272
Hib,Primary Series,States/Local Areas,Arkansas,2016-2017,Age,7 Months,62.8,57.4 to 67.9,662
Combined 7 Series,,States/Local Areas,Arkansas,2014,Age,35 Months,71.6,63.2 to 79.5,239
Combined 7 Series,,States/Local Areas,Arkansas,2014-2015,Age,35 Months,73.7,68.0 to 79.2,504
Combined 7 Series,,States/Local Areas,Arkansas,2015,Age,35 Months,76.6,68.5 to 83.8,265
Combined 7 Series,,States/Local Areas,Arkansas,2015-2016,Age,35 Months,74.3,68.5 to 79.8,537
Combined 7 Series,,States/Local Areas,Arkansas,2013,Age,35 Months,70.5,61.1 to 79.3,212
Combined 7 Series,,States/Local Areas,Arkansas,2013-2014,Age,35 Months,71.3,65.0 to 77.4,451
Combined 7 Series,,States/Local Areas,Arkansas,2012,Age,35 Months,68.5,59.8 to 76.8,236
Combined 7 Series,,States/Local Areas,Arkansas,2019,Age,24 Months,68.8,61.8 to 75.5,357
Combined 7 Series,,States/Local Areas,Arkansas,2018,Age,24 Months,64.8,58.3 to 71.2,426
Combined 7 Series,,States/Local Areas,Arkansas,2018-2019,Age,24 Months,66.6,61.8 to 71.4,783
Combined 7 Series,,States/Local Areas,Arkansas,2017,Age,24 Months,65.0,58.2 to 71.8,390
Combined 7 Series,,States/Local Areas,Arkansas,2017-2018,Age,24 Months,64.9,60.1 to 69.7,816
Hib,Primary Series,States/Local Areas,Arkansas,2019,Age,35 Months,90.9,83.7 to 95.8,357
Combined 7 Series,,States/Local Areas,Arkansas,2016,Age,24 Months,69.7,61.9 to 77.2,272
Combined 7 Series,,States/Local Areas,Arkansas,2016-2017,Age,24 Months,67.4,62.2 to 72.5,662
Hib,Primary Series,States/Local Areas,Arkansas,2018,Age,35 Months,93.9,89.5 to 96.9,426
Hib,Primary Series,States/Local Areas,Arkansas,2018-2019,Age,35 Months,92.6,88.5 to 95.6,783
Combined 7 Series,,States/Local Areas,Arkansas,2015,Age,24 Months,64.1,56.6 to 71.5,265
Combined 7 Series,,States/Local Areas,Arkansas,2015-2016,Age,24 Months,67.0,61.5 to 72.3,537
Combined 7 Series,,States/Local Areas,Arkansas,2014,Age,24 Months,63.6,55.5 to 71.6,239
Combined 7 Series,,States/Local Areas,Arkansas,2014-2015,Age,24 Months,63.8,58.3 to 69.2,504
Combined 7 Series,,States/Local Areas,Arkansas,2017,Age,35 Months,73.6,66.0 to 80.6,390
Combined 7 Series,,States/Local Areas,Arkansas,2017-2018,Age,35 Months,72.3,67.2 to 77.3,816
Combined 7 Series,,States/Local Areas,Arkansas,2016,Age,35 Months,72.9,64.7 to 80.5,272
Combined 7 Series,,States/Local Areas,Arkansas,2016-2017,Age,35 Months,73.1,67.5 to 78.4,662
Hib,Primary Series,States/Local Areas,Arkansas,2016,Age,24 Months,93.6,88.3 to 97.0,272
Hib,Primary Series,States/Local Areas,Arkansas,2016-2017,Age,24 Months,91.6,88.1 to 94.4,662
Hib,Primary Series,States/Local Areas,Arkansas,2015,Age,24 Months,90.8,85.8 to 94.6,265
Hib,Primary Series,States/Local Areas,Arkansas,2015-2016,Age,24 Months,92.3,88.8 to 95.1,537
Hib,Primary Series,States/Local Areas,Arkansas,2014,Age,24 Months,89.5,83.9 to 93.7,239
Hib,Primary Series,States/Local Areas,Arkansas,2014-2015,Age,24 Months,90.1,86.5 to 93.1,504
Hib,Primary Series,States/Local Areas,Arkansas,2018,Age,24 Months,91.9,87.4 to 95.2,426
Hib,Primary Series,States/Local Areas,Arkansas,2018-2019,Age,24 Months,89.9,86.6 to 92.8,783
Hib,Primary Series,States/Local Areas,Arkansas,2017,Age,24 Months,89.5,84.4 to 93.6,390
Hib,Primary Series,States/Local Areas,Arkansas,2017-2018,Age,24 Months,90.7,87.4 to 93.4,816
Hib,Primary Series,States/Local Areas,Arkansas,2019,Age,24 Months,88.0,82.7 to 92.2,357
Hib,Primary Series,States/Local Areas,Arkansas,2014,Age,35 Months,90.0,84.4 to 94.2,239
Hib,Primary Series,States/Local Areas,Arkansas,2014-2015,Age,35 Months,91.8,87.7 to 94.9,504
Hib,Primary Series,States/Local Areas,Arkansas,2012,Age,35 Months,96.0,92.0 to 98.3,236
Hib,Primary Series,States/Local Areas,Arkansas,2013,Age,35 Months,96.7,92.2 to 99.0,212
Hib,Primary Series,States/Local Areas,Arkansas,2013-2014,Age,35 Months,92.9,89.2 to 95.7,451
Hib,Primary Series,States/Local Areas,Arkansas,2011,Age,35 Months,93.3,88.1 to 96.8,230
Combined 7 Series,,States/Local Areas,Arkansas,2012,Age,24 Months,62.6,54.2 to 71.1,236
Combined 7 Series,,States/Local Areas,Arkansas,2013,Age,24 Months,68.0,58.9 to 76.8,212
Combined 7 Series,,States/Local Areas,Arkansas,2013-2014,Age,24 Months,65.8,59.5 to 71.9,451
Combined 7 Series,,States/Local Areas,Arkansas,2011,Age,24 Months,61.4,52.4 to 70.5,230
Hib,Primary Series,States/Local Areas,Arkansas,2016,Age,35 Months,93.6,88.3 to 97.0,272
Hib,Primary Series,States/Local Areas,Arkansas,2016-2017,Age,35 Months,91.7,88.2 to 94.5,662
Hib,Primary Series,States/Local Areas,Arkansas,2015,Age,35 Months,94.5,87.9 to 98.2,265
Hib,Primary Series,States/Local Areas,Arkansas,2015-2016,Age,35 Months,93.6,89.4 to 96.5,537
Hib,Primary Series,States/Local Areas,Arkansas,2017,Age,35 Months,89.7,84.6 to 93.7,390
Hib,Primary Series,States/Local Areas,Arkansas,2017-2018,Age,35 Months,91.7,88.4 to 94.4,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,87.0 to 98.1,144
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,77.2,72.6 to 81.8,559
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Poverty,<133% FPL,69.5,64.2 to 74.7,517
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,84.5,79.3 to 89.6,528
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.7,61.2 to 88.1,144
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.7 to 98.6,144
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,87.1,82.0 to 92.2,189
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,86.4,79.8 to 93.0,198
Rotavirus,,States/Local Areas,Arkansas,2017,Age,8 Months,70.4,63.2 to 76.7,390
Rotavirus,,States/Local Areas,Arkansas,2017-2018,Age,8 Months,73.9,69.2 to 78.1,816
Rotavirus,,States/Local Areas,Arkansas,2019,Age,8 Months,75.6,69.0 to 81.2,357
Rotavirus,,States/Local Areas,Arkansas,2018,Age,8 Months,77.5,71.4 to 82.5,426
Rotavirus,,States/Local Areas,Arkansas,2018-2019,Age,8 Months,76.5,72.1 to 80.5,783
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.9,55.6 to 78.1,115
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,80.5,72.7 to 88.3,130
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.3,58.5 to 80.0,94
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,71.4,66.1 to 76.7,426
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,82.3,76.9 to 87.8,387
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,71.5,62.0 to 81.1,142
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,60.8,44.8 to 76.8,53
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,70.6,64.5 to 76.8,387
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,72.7,67.6 to 77.9,423
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Overall,Overall,73.8,70.3 to 77.4,1008
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,71.9,65.9 to 77.8,331
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.6,66.7 to 80.5,279
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,75.7,69.9 to 81.5,398
Rotavirus,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.3,71.1 to 79.6,669
Influenza,,States/Local Areas,Arkansas,2019,Age,24 Months,50.7,43.6 to 58.3,357
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,90.2,86.3 to 94.1,528
Influenza,,States/Local Areas,Arkansas,2015,Age,24 Months,41.4,34.3 to 49.3,265
Influenza,,States/Local Areas,Arkansas,2015-2016,Age,24 Months,40.0,34.8 to 45.7,537
Influenza,,States/Local Areas,Arkansas,2014,Age,24 Months,27.2,20.9 to 35.0,239
Influenza,,States/Local Areas,Arkansas,2014-2015,Age,24 Months,34.3,29.4 to 39.8,504
Influenza,,States/Local Areas,Arkansas,2016,Age,24 Months,38.6,31.3 to 46.9,272
Influenza,,States/Local Areas,Arkansas,2016-2017,Age,24 Months,39.7,34.7 to 45.1,662
Influenza,,States/Local Areas,Arkansas,2012,Age,24 Months,30.4,23.4 to 38.9,236
Influenza,,States/Local Areas,Arkansas,2011,Age,24 Months,27.8,20.8 to 36.6,230
Influenza,,States/Local Areas,Arkansas,2018,Age,24 Months,47.2,40.7 to 54.2,426
Influenza,,States/Local Areas,Arkansas,2018-2019,Age,24 Months,49.0,44.1 to 54.1,783
Influenza,,States/Local Areas,Arkansas,2017,Age,24 Months,40.8,34.4 to 47.9,390
Influenza,,States/Local Areas,Arkansas,2017-2018,Age,24 Months,44.0,39.3 to 48.9,816
Influenza,,States/Local Areas,Arkansas,2013,Age,24 Months,42.7,33.8 to 52.8,212
Influenza,,States/Local Areas,Arkansas,2013-2014,Age,24 Months,35.0,29.4 to 41.4,451
Hep B,≥1 Dose,States/Local Areas,Arkansas,2021,Age,3 Months,98.0,94.1 to 99.3,190
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,Hispanic,71.9,60.0 to 83.8,189
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Other,83.9,76.3 to 91.5,181
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,86.6,82.8 to 90.4,559
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.5,61.2 to 87.8,125
Influenza,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,53.3,46.5 to 60.0,387
Influenza,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,22.8,14.5 to 31.1,142
Hib,Full Series,States/Local Areas,Arkansas,2020-2021,Age,24 Months,74.8,68.5 to 80.6,513
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020-2021,Age,13 Months,64.6,57.8 to 70.9,513
Influenza,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,35.3,29.4 to 41.2,426
Influenza,,States/Local Areas,Arkansas,2021,Age,24 Months,41.5,31.6 to 53.1,190
Hep A,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,79.4,71.2 to 86.6,513
Polio,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,3 Months,83.2,77.9 to 87.5,513
PCV,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,3 Months,82.5,77.1 to 86.8,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,44.1,37.6 to 50.7,513
≥1 Dose MMR,,States/Local Areas,Arkansas,2021,Age,13 Months,59.6,48.3 to 69.9,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,24 Months,83.8,78.2 to 88.6,513
Hep B,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,3 Months,97.5,95.5 to 98.6,513
PCV,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,82.2,76.3 to 87.0,513
DTaP,≥3 Doses,States/Local Areas,Arkansas,2021,Age,24 Months,83.7,74.0 to 91.3,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,82.0 to 95.3,144
Influenza,,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,64.4,55.5 to 73.3,198
Influenza,,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,40.4,33.7 to 47.1,387
Influenza,,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,29.7,24.3 to 35.2,423
Influenza,,States/Local Areas,Arkansas,2014-2017,Overall,Overall,38.1,34.2 to 42.0,1008
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,80.4,76.2 to 84.6,559
Hib,Full Series,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,82.3,77.1 to 87.5,528
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Any Medicaid,92.8,90.1 to 95.4,559
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2019,Insurance Coverage,Private Insurance Only,92.3,88.0 to 96.6,528
Influenza,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,28.1,13.7 to 42.4,53
Influenza,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,22.6,16.6 to 28.7,331
Influenza,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,37.8,30.2 to 45.4,279
Influenza,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,51.9,45.4 to 58.3,398
Influenza,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",38.7,33.8 to 43.6,669
Influenza,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",28.5,17.8 to 39.2,94
Influenza,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",45.6,33.6 to 57.5,115
Influenza,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,40.8,30.6 to 51.0,130
Hep B,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,5 Months,87.3,82.2 to 91.1,513
Hib,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,5 Months,69.6,63.0 to 75.5,513
Hib,Primary Series,States/Local Areas,Arkansas,2020-2021,Age,7 Months,67.5,60.8 to 73.5,513
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,86.7,81.6 to 91.0,513
Polio,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,86.5,81.0 to 91.1,513
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,61.6,54.8 to 67.9,513
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020-2021,Age,24 Months,86.8,81.1 to 91.4,513
DTaP,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,5 Months,70.5,63.9 to 76.3,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2021,Age,0-3 Days,82.6,73.1 to 89.3,190
Hib,≥3 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,86.1,76.5 to 93.2,190
Hib,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,83.7,78.0 to 88.1,513
≥1 Dose MMR,,States/Local Areas,Arkansas,2020-2021,Age,19 Months,82.2,75.7 to 87.2,513
DTaP,≥4 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,62.3,55.4 to 68.7,513
Hib,Primary Series,States/Local Areas,Arkansas,2020-2021,Age,35 Months,89.9,85.0 to 93.8,513
Polio,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,85.7,79.8 to 90.1,513
PCV,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,86.0,80.5 to 90.6,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,67.0,56.0 to 76.4,190
Hib,Primary Series,States/Local Areas,Arkansas,2021,Age,35 Months,89.4,80.7 to 95.3,190
Rotavirus,,States/Local Areas,Arkansas,2021,Age,8 Months,69.0,58.1 to 78.1,190
Hib,≥2 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,88.6,78.9 to 94.1,190
Hib,Full Series,States/Local Areas,Arkansas,2021,Age,35 Months,73.0,62.5 to 82.6,190
Combined 7 Series,,States/Local Areas,Arkansas,2020-2021,Age,24 Months,62.0,55.4 to 68.6,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,82.8,76.8 to 87.5,513
Polio,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,90.6,85.2 to 94.6,513
Hep A,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,46.5,39.8 to 53.7,513
≥1 Dose Varicella,,States/Local Areas,Arkansas,2020-2021,Age,19 Months,81.9,75.4 to 87.0,513
Hib,Primary Series,States/Local Areas,Arkansas,2020-2021,Age,19 Months,87.1,81.7 to 91.1,513
Polio,≥3 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,86.6,77.0 to 93.6,190
Combined 7 Series,,States/Local Areas,Arkansas,2021,Age,24 Months,58.9,48.1 to 70.0,190
Hep A,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,19 Months,75.9,69.3 to 81.5,513
Hib,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,88.1,82.7 to 92.4,513
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2020-2021,Age,0-1 Days,82.2,76.8 to 86.6,513
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2020-2021,Age,0-3 Days,82.9,77.5 to 87.3,513
Rotavirus,,States/Local Areas,Arkansas,2020-2021,Age,8 Months,73.4,67.1 to 78.9,513
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,91.1,85.8 to 95.0,513
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,87.0,81.5 to 91.5,513
≥1 Dose Varicella,,States/Local Areas,Arkansas,2021,Age,35 Months,86.6,76.4 to 93.9,190
DTaP,≥4 Doses,States/Local Areas,Arkansas,2020-2021,Age,24 Months,73.4,67.0 to 79.5,513
Hep B,≥2 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,92.2,83.2 to 96.6,190
PCV,≥4 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,69.0,62.3 to 75.1,513
PCV,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,85.6,79.7 to 90.0,513
Hib,Primary Series,States/Local Areas,Arkansas,2021,Age,13 Months,82.7,72.9 to 89.5,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,69.3,62.7 to 75.2,513
Influenza,,States/Local Areas,Arkansas,2020-2021,Age,24 Months,40.4,34.0 to 47.5,513
Hep B,≥3 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,90.8,83.0 to 95.9,190
DTaP,≥4 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,82.1,70.8 to 90.9,190
PCV,≥4 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,76.7,70.6 to 82.3,513
PCV,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,35 Months,90.7,84.5 to 95.1,513
≥1 Dose MMR,,States/Local Areas,Arkansas,2020-2021,Age,35 Months,90.4,84.8 to 94.6,513
Hib,≥1 Dose,States/Local Areas,Arkansas,2020-2021,Age,3 Months,81.9,76.3 to 86.4,513
Hep B,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,91.3,86.7 to 94.5,513
DTaP,≥3 Doses,States/Local Areas,Arkansas,2021,Age,35 Months,87.6,78.0 to 94.4,190
Polio,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,85.2,79.8 to 89.4,513
Combined 7 Series,,States/Local Areas,Arkansas,2020-2021,Age,35 Months,70.0,63.2 to 76.7,513
Polio,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,5 Months,69.6,63.0 to 75.4,513
Hib,Primary Series,States/Local Areas,Arkansas,2020-2021,Age,13 Months,83.7,78.1 to 88.1,513
Combined 7 Series,,States/Local Areas,TX-Bexar County,2011,Age,35 Months,71.3,63.8 to 78.5,280
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,52.9,44.2 to 62.1,244
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2013,Age,35 Months,95.9,90.3 to 98.7,205
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,94.5,90.9 to 97.0,359
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014,Age,35 Months,93.0,87.2 to 96.8,154
Hep A,≥1 Dose,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,94.5,90.8 to 97.1,295
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,71.2,62.0 to 79.0,196
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,35 Months,91.6,85.4 to 95.9,171
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,92.6,88.7 to 95.6,394
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,35 Months,97.3,93.7 to 99.1,168
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,94.5,90.8 to 97.1,339
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2015,Age,5 Months,86.4,77.6 to 92.1,141
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,5 Months,83.5,77.5 to 88.2,309
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,5 Months,79.3,70.4 to 86.0,154
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,5 Months,82.9,78.9 to 86.3,295
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,35 Months,99.3,96.9 to 99.9,141
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,98.4,96.4 to 99.4,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,90.7,84.3 to 95.2,223
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,90.3,85.7 to 93.9,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,92.8,90.2 to 95.5,560
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,58.5,48.1 to 69.3,154
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,55.2,47.7 to 62.9,295
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,72.3,53.7 to 88.2,113
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,87.7,81.7 to 93.7,203
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.1,63.4 to 86.7,62
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,75.1,69.0 to 81.1,296
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,90.6,83.5 to 95.5,196
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,35 Months,93.3,88.0 to 96.9,223
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,92.0,87.8 to 95.2,419
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Private Insurance Only,95.6,92.7 to 98.5,203
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,100.0,,32
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.0 to 94.3,296
Hib,Full Series,States/Local Areas,TX-City of Houston,2016,Age,35 Months,81.0,72.0 to 88.6,168
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2017,Age,35 Months,80.4,74.2 to 85.9,339
Hib,Full Series,States/Local Areas,TX-City of Houston,2014,Age,35 Months,85.3,77.2 to 91.7,154
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,85.8,80.3 to 90.4,295
Hib,Full Series,States/Local Areas,TX-City of Houston,2015,Age,35 Months,86.0,78.3 to 92.1,141
Hib,Full Series,States/Local Areas,TX-City of Houston,2015-2016,Age,35 Months,83.9,77.9 to 89.1,309
Hib,Full Series,States/Local Areas,TX-City of Houston,2017,Age,35 Months,79.8,71.1 to 87.3,171
Hib,Full Series,States/Local Areas,TX-City of Houston,2017-2018,Age,35 Months,82.7,77.1 to 87.6,394
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,72.7,63.5 to 80.3,223
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,93.1,88.5 to 96.0,419
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,50.8,42.3 to 60.0,205
Hep A,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,54.4,47.6 to 61.5,359
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,72.7,62.4 to 81.0,168
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,69.9,63.0 to 76.0,339
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,67.0,57.3 to 75.4,171
DTaP,≥4 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,69.8,63.3 to 75.6,394
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2019,Age,5 Months,77.5,68.5 to 84.5,196
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2017,Age,5 Months,76.2,67.2 to 83.3,171
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,5 Months,79.3,73.3 to 84.2,394
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2018,Age,5 Months,82.5,74.1 to 88.6,223
PCV,≥2 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,5 Months,80.0,74.1 to 84.9,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.1,91.2 to 100.0,62
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,93.1,89.4 to 96.8,303
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.8,79.9 to 99.7,66
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.9,86.1 to 97.6,129
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,90.2 to 95.5,560
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,35 Months,89.9,82.6 to 95.0,196
Hib,Full Series,States/Local Areas,TX-City of Houston,2019,Age,24 Months,77.4,69.3 to 84.7,196
Hib,Full Series,States/Local Areas,TX-City of Houston,2018,Age,24 Months,83.9,76.7 to 89.9,223
Hib,Full Series,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,80.7,75.4 to 85.5,419
Hib,Full Series,States/Local Areas,TX-City of Houston,2011,Age,35 Months,83.9,74.7 to 91.2,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2012,Age,35 Months,85.1,78.0 to 91.0,244
Hib,Full Series,States/Local Areas,TX-City of Houston,2013,Age,35 Months,85.3,77.9 to 91.2,205
Hib,Full Series,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,85.4,80.1 to 90.0,359
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2013,Age,5 Months,79.2,74.5 to 83.2,205
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,5 Months,79.2,75.8 to 82.3,359
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2012,Age,5 Months,77.1,69.6 to 83.2,244
DTaP,≥2 Doses,States/Local Areas,TX-City of Houston,2011,Age,5 Months,78.9,70.3 to 85.6,213
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,35 Months,93.7,89.1 to 96.8,244
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,35 Months,94.0,87.4 to 97.8,154
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,35 Months,97.0,94.0 to 98.7,295
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,35 Months,95.2,89.6 to 98.3,205
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,35 Months,94.2,90.1 to 96.9,359
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.6,90.5 to 100.0,62
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Insurance Coverage,Other,91.4,82.6 to 100.0,32
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,92.9,89.2 to 96.6,303
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.1,75.5 to 96.7,66
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.9,84.9 to 96.9,129
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,89.3 to 94.8,560
Hib,Full Series,States/Local Areas,TX-City of Houston,2019,Age,35 Months,84.1,75.0 to 91.3,196
Hib,Full Series,States/Local Areas,TX-City of Houston,2018,Age,35 Months,85.6,78.3 to 91.4,223
Hib,Full Series,States/Local Areas,TX-City of Houston,2018-2019,Age,35 Months,85.7,79.7 to 90.7,419
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,92.4,86.5 to 96.4,205
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,91.6,87.5 to 94.9,359
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,91.5,85.9 to 95.6,244
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,93.5,87.6 to 97.2,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2017,Age,24 Months,78.3,69.7 to 85.8,171
Hib,Full Series,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,81.1,75.5 to 86.0,394
Hib,Full Series,States/Local Areas,TX-City of Houston,2016,Age,24 Months,75.9,67.1 to 83.8,168
Hib,Full Series,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,77.1,71.0 to 82.7,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,35 Months,93.2,87.2 to 97.1,213
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,70.0,56.8 to 80.6,113
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,88.7,81.5 to 94.1,313
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,86.4,81.1 to 90.8,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,87.1,75.6 to 93.6,113
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,35 Months,98.4,91.6 to 99.9,113
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,Hispanic,79.2,73.5 to 85.0,303
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.7,67.4 to 94.0,66
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.3,73.9 to 90.6,129
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Urbanicity,Living In a MSA Principal City,79.3,75.1 to 83.5,560
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,94.4,88.9 to 97.3,223
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,88.6,83.7 to 92.2,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,91.0,83.9 to 95.1,171
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,92.7,88.5 to 95.4,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,91.0,83.2 to 95.4,168
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,91.0,86.1 to 94.3,339
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,24 Months,96.0,91.7 to 98.4,141
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,94.1,90.3 to 96.8,309
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,24 Months,90.0,82.9 to 95.0,154
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,24 Months,92.9,88.9 to 95.8,295
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,19 Months,88.4,80.4 to 93.4,171
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,19 Months,89.5,84.5 to 93.0,394
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,19 Months,91.5,84.1 to 95.6,168
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,19 Months,90.0,84.9 to 93.5,339
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,90.7,83.6 to 94.9,223
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,83.2,77.6 to 87.6,419
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,89.9,82.0 to 94.6,196
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,94.0,88.2 to 97.6,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2015,Age,24 Months,84.8,77.3 to 90.9,141
Hib,Full Series,States/Local Areas,TX-City of Houston,2015-2016,Age,24 Months,80.4,74.6 to 85.6,309
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,88.7,80.7 to 93.6,196
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,24 Months,89.8,82.8 to 94.8,196
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,24 Months,93.3,88.0 to 96.9,223
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,24 Months,91.6,87.4 to 94.8,419
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2017,Age,24 Months,90.5,84.0 to 95.2,171
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2017-2018,Age,24 Months,91.9,87.9 to 95.0,394
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,94.0,89.4 to 97.0,244
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016,Age,24 Months,92.4,85.6 to 96.7,168
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2016-2017,Age,24 Months,91.4,86.9 to 94.9,339
Hib,Primary Series,States/Local Areas,TX-City of Houston,2011,Age,7 Months,67.3,61.7 to 72.4,213
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Poverty,>400% FPL,90.2,82.4 to 97.9,134
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,88.5,80.6 to 93.5,154
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,92.9,88.6 to 95.7,295
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,97.2,96.0 to 98.0,141
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,94.2,89.9 to 96.7,309
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,94.0,90.7 to 96.1,205
DTaP,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,91.2,88.1 to 93.5,359
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2018,Age,19 Months,93.3,87.3 to 96.6,223
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2018-2019,Age,19 Months,72.2,66.1 to 77.6,419
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2019,Age,19 Months,88.9,81.1 to 93.8,196
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2011,Age,24 Months,92.9,87.1 to 96.8,213
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2012,Age,24 Months,93.6,89.0 to 96.7,244
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014,Age,19 Months,90.0,82.8 to 94.4,154
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2014-2015,Age,19 Months,93.3,89.3 to 95.9,295
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,19 Months,90.8,88.4 to 92.8,205
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,19 Months,90.4,86.1 to 93.5,359
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2013,Age,24 Months,93.4,87.7 to 97.1,205
Polio,≥3 Doses,States/Local Areas,TX-City of Houston,2013-2014,Age,24 Months,91.6,87.2 to 94.9,359
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015,Age,19 Months,96.5,95.2 to 97.4,141
Hib,≥3 Doses,States/Local Areas,TX-City of Houston,2015-2016,Age,19 Months,94.0,89.9 to 96.5,309
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Overall,Overall,79.3,75.1 to 83.5,560
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Poverty,<133% FPL,73.3,67.4 to 79.1,319
Hib,Full Series,States/Local Areas,TX-City of Houston,2014-2017,Poverty,133% to <400% FPL,89.6,82.7 to 96.5,107
Hib,Primary Series,States/Local Areas,TX-Bexar County,2021,Age,24 Months,87.2,77.1 to 94.3,113
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,3 Months,85.6,74.8 to 92.2,113
Hib,Full Series,States/Local Areas,TX-Bexar County,2021,Age,24 Months,75.1,62.9 to 85.8,113
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,87.1,77.0 to 94.2,113
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2021,Age,19 Months,86.7,77.2 to 92.6,113
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,75.7,64.2 to 85.8,113
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,24 Months,86.0,75.7 to 93.4,113
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2021,Age,24 Months,89.2,80.8 to 95.1,113
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,54.2,40.7 to 67.1,113
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,5 Months,71.4,63.4 to 78.3,313
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,28.5,18.6 to 42.2,113
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,55.2,41.5 to 68.1,113
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,84.9,73.2 to 92.0,113
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,19 Months,81.0,68.6 to 89.3,113
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,94.2,78.6 to 99.5,113
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,87.2,75.7 to 93.7,113
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,3 Months,84.9,73.1 to 92.0,113
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,86.4,76.0 to 93.9,113
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,74.8,62.3 to 84.2,113
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,23.4,14.2 to 35.9,113
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,79.8,68.6 to 89.0,113
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,87.9,78.5 to 94.4,113
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2021,Age,24 Months,89.4,81.1 to 95.1,113
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,87.1,77.0 to 94.2,113
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2021,Age,0-2 Days,74.8,61.5 to 84.6,113
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,87.8,81.4 to 92.1,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,85.4,74.1 to 92.3,113
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,3 Months,85.5,78.9 to 90.3,313
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,92.4,86.5 to 96.4,313
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2021,Age,0-1 Days,68.3,54.7 to 79.4,113
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,89.0,83.4 to 93.4,313
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,79.4,73.7 to 85.0,376
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.9,75.2 to 100.0,38
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,93.4,88.3 to 96.8,313
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,3 Months,85.2,80.3 to 89.0,427
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,3 Months,82.9,77.9 to 87.0,427
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,86.2,81.3 to 90.0,427
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2019-2020,Age,0-3 Days,76.8,71.3 to 81.5,427
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,3 Months,85.8,80.9 to 89.6,427
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,60.9,54.8 to 66.7,427
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,89.1,84.6 to 92.4,427
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,89.9,85.6 to 93.1,427
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,68.8,62.8 to 74.4,427
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,89.7,85.5 to 93.1,427
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,84.5,78.5 to 89.7,427
Combined 7 Series,,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,63.5,57.5 to 69.5,427
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,91.2,87.2 to 94.4,427
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,62.4,56.3 to 68.2,427
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,85.5,80.5 to 89.4,427
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,91.2,87.0 to 94.2,427
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,85.0,80.3 to 88.7,427
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,70.9,64.9 to 76.2,427
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,87.4,82.6 to 91.0,427
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,5 Months,74.8,69.0 to 79.9,427
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,5 Months,85.2,80.4 to 89.0,427
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,84.8,79.8 to 88.7,427
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,85.9,78.5 to 91.1,200
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,90.7,86.4 to 93.7,427
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,82.0,77.0 to 86.2,427
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,88.0,80.5 to 92.8,200
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,90.3,85.9 to 93.4,427
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019-2020,Age,13 Months,64.8,58.6 to 70.4,427
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,5 Months,77.1,71.4 to 81.9,427
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,5 Months,75.6,69.8 to 80.5,427
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,5 Months,78.0,72.3 to 82.8,427
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,3 Months,95.7,92.1 to 97.7,427
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,3 Months,83.4,78.3 to 87.4,427
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,85.8,81.0 to 90.0,427
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,90.1,86.0 to 93.5,427
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,74.3,68.6 to 79.7,427
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,89.4,85.1 to 92.8,427
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,81.8,76.3 to 86.7,427
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,89.7,85.5 to 93.1,427
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,89.4,84.5 to 93.2,427
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,89.2,84.4 to 93.0,427
Hib,Full Series,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,81.0,75.3 to 86.2,427
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,91.3,86.4 to 94.9,427
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,91.4,86.5 to 95.1,427
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,89.6,84.7 to 93.5,427
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,88.7,84.2 to 92.0,427
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,89.1,84.7 to 92.4,427
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,82.0,76.5 to 86.4,427
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,27.7,22.7 to 33.3,427
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,84.8,79.8 to 89.0,427
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,89.3,85.1 to 92.8,427
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,77.5,72.0 to 82.6,427
Hib,Full Series,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,74.1,68.4 to 79.4,427
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,87.7,83.4 to 91.3,427
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,64.7,58.6 to 70.3,427
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,67.4,61.3 to 73.0,427
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2019-2020,Age,0-2 Days,75.1,69.5 to 79.9,427
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,80.9,75.6 to 85.3,427
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2019-2020,Age,0-1 Days,73.2,67.5 to 78.1,427
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,71.9,66.0 to 77.2,427
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,88.4,83.7 to 91.9,427
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,81.1,75.6 to 85.6,427
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,86.8,82.2 to 90.3,427
Hib,Full Series,States/Local Areas,TX-Bexar County,2019-2020,Age,19 Months,69.2,63.1 to 74.7,427
Combined 7 Series,,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,72.0,65.7 to 78.0,427
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,86.6,81.7 to 90.4,427
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,89.4,85.2 to 92.8,427
Influenza,,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,52.8,46.8 to 59.1,427
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,89.1,84.9 to 92.6,427
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,91.8,87.1 to 95.3,427
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,45.1,39.1 to 51.6,427
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,35 Months,74.4,66.9 to 81.2,427
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2019-2020,Age,24 Months,85.9,81.4 to 89.8,427
Combined 7 Series,,States/Local Areas,TX-Bexar County,2020,Age,35 Months,65.9,56.9 to 74.7,200
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020,Age,13 Months,64.8,55.9 to 72.9,200
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,73.9,63.4 to 83.4,200
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,19 Months,81.6,73.9 to 87.4,200
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,24.0,17.4 to 32.1,200
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2020,Age,0-2 Days,69.7,60.7 to 77.4,200
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2020,Age,0-1 Days,67.3,58.4 to 75.1,200
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,84.8,77.1 to 90.2,200
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,85.8,78.3 to 91.0,200
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,61.8,52.8 to 70.0,200
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020,Age,7 Months,70.6,61.7 to 78.2,200
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,86.6,79.1 to 91.7,200
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,88.7,82.0 to 93.7,200
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,5 Months,73.8,65.0 to 81.0,200
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,74.1,66.0 to 81.5,200
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020,Age,24 Months,83.6,76.3 to 89.7,200
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,88.5,81.8 to 93.6,200
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020,Age,35 Months,86.9,79.1 to 92.9,200
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,86.8,80.0 to 92.2,200
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020,Age,35 Months,89.8,82.0 to 95.1,200
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,89.9,82.2 to 95.2,200
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,88.2,80.3 to 94.0,200
Hib,Full Series,States/Local Areas,TX-Bexar County,2020,Age,35 Months,79.3,70.7 to 86.7,200
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020,Age,19 Months,87.0,79.5 to 92.0,200
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020,Age,35 Months,87.9,80.2 to 93.5,200
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,84.8,77.4 to 90.0,200
Hib,Full Series,States/Local Areas,TX-Bexar County,2020,Age,19 Months,68.1,59.3 to 75.9,200
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,90.1,83.7 to 94.8,200
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020,Age,19 Months,81.5,73.3 to 87.6,200
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,88.5,81.8 to 93.6,200
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,84.6,75.7 to 91.6,200
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,87.2,79.7 to 92.2,200
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,69.2,60.5 to 76.7,200
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,87.2,80.3 to 92.5,200
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,80.0,72.2 to 86.0,200
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020,Age,13 Months,84.2,76.7 to 89.6,200
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,89.4,82.2 to 93.9,200
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,82.1,74.5 to 87.8,200
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020,Age,13 Months,61.3,52.3 to 69.6,200
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,85.1,77.6 to 90.4,200
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,70.8,61.7 to 78.4,200
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,88.5,81.1 to 93.2,200
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,69.0,60.2 to 76.6,200
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,88.0,80.7 to 92.7,200
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020,Age,19 Months,81.4,73.2 to 87.5,200
Combined 7 Series,,States/Local Areas,TX-Bexar County,2020,Age,24 Months,60.5,51.9 to 69.3,200
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,19 Months,86.4,78.9 to 91.5,200
Influenza,,States/Local Areas,TX-Bexar County,2020,Age,24 Months,49.3,40.8 to 58.5,200
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020,Age,24 Months,84.3,77.2 to 90.2,200
Rotavirus,,States/Local Areas,TX-Bexar County,2020,Age,8 Months,73.4,64.7 to 80.5,200
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2020,Age,0-3 Days,71.9,63.1 to 79.4,200
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,74.4,66.4 to 81.7,200
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,87.2,80.3 to 92.5,200
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,40.2,32.0 to 49.7,200
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,24 Months,84.5,77.8 to 90.1,200
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,3 Months,82.9,75.1 to 88.7,200
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,3 Months,94.6,88.5 to 97.6,200
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,13 Months,89.0,81.8 to 93.5,200
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,5 Months,77.2,68.4 to 84.1,200
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,5 Months,75.6,66.7 to 82.7,200
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,5 Months,72.5,63.6 to 79.9,200
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,3 Months,86.2,78.4 to 91.5,200
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2020,Age,5 Months,81.8,73.8 to 87.7,200
Rotavirus,,States/Local Areas,TX-Bexar County,2019-2020,Age,8 Months,73.5,67.6 to 78.6,427
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,3 Months,81.4,73.5 to 87.3,200
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,3 Months,85.1,77.4 to 90.6,200
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,62.2,53.4 to 70.2,200
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,7 Months,67.8,58.8 to 75.7,200
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,91.9,89.6 to 94.2,754
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,68.7,64.6 to 72.8,754
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,82.2 to 99.4,69
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.4,59.4 to 87.4,69
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,78.9,75.3 to 82.4,754
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,97.4,94.7 to 100.0,187
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,76.7,73.0 to 80.3,823
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,62.7,56.5 to 68.9,321
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,90.7,87.1 to 94.3,315
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,96.6,93.7 to 99.5,187
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,68.5,62.0 to 75.0,315
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,92.7,89.4 to 96.0,315
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,77.5,68.8 to 86.3,187
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,74.2,70.4 to 77.9,823
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,97.6,95.1 to 100.0,187
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,90.0,87.4 to 92.7,823
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,90.7,86.8 to 94.6,321
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,88.1,85.4 to 90.8,823
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,78.4,74.9 to 81.8,823
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,67.4,63.4 to 71.4,823
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,77.9,72.6 to 83.2,823
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,82.3,77.3 to 87.3,321
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,79.9,71.8 to 87.9,315
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,93.1,89.8 to 96.3,315
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,59.1,54.9 to 63.3,823
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,89.0,85.0 to 93.1,321
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,83.4,73.0 to 93.8,187
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,90.3,86.5 to 94.1,315
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,86.4,82.1 to 90.7,321
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,90.9,88.4 to 93.4,823
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,73.0,67.3 to 78.8,321
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,92.0,89.7 to 94.3,823
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,85.4,77.8 to 93.0,187
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,91.7,89.4 to 93.9,823
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,58.5,53.4 to 63.5,544
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,77.1,73.5 to 80.8,823
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,81.4,66.0 to 96.8,47
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,78.0 to 97.4,66
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,91.8,83.5 to 100.0,47
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,90.1,86.4 to 93.8,360
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,92.1,88.6 to 95.6,376
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,90.9,82.5 to 99.3,47
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,90.5,81.2 to 99.7,40
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.7,55.7 to 83.8,66
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,77.8,73.4 to 82.2,544
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.6,71.6 to 93.6,66
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.4,52.1 to 88.7,38
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,45.5,27.1 to 64.0,40
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,73.4,65.9 to 80.9,376
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,82.0,75.0 to 89.0,360
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,5 Months,68.1,59.6 to 75.6,229
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,5 Months,70.6,68.3 to 72.7,471
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,24 Months,90.8,85.9 to 94.5,229
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,89.4,85.5 to 92.6,449
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,24 Months,92.5,87.4 to 96.1,242
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,91.7,88.3 to 94.4,471
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,24 Months,91.2,84.9 to 95.6,229
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,91.8,88.0 to 94.8,471
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,5 Months,73.1,65.2 to 79.8,229
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,5 Months,72.4,66.7 to 77.4,449
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,5 Months,73.0,65.4 to 79.4,242
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,5 Months,73.0,67.7 to 77.8,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,95.7,91.9 to 98.0,237
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,93.7,90.4 to 96.2,464
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,91.8,85.9 to 95.8,227
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,98.0,94.4 to 100.0,44
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,24 Months,85.7,79.8 to 90.6,237
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,86.3,82.0 to 89.9,464
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,35 Months,95.3,90.2 to 98.2,280
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,24 Months,87.1,80.6 to 92.2,227
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,24 Months,88.0,81.6 to 92.9,220
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,86.8,82.6 to 90.5,457
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,94.0,88.9 to 97.3,248
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,93.4,88.0 to 97.0,280
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,24 Months,84.7,77.1 to 90.8,217
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,88.0,83.2 to 91.9,446
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,24 Months,85.9,80.5 to 90.5,280
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,19 Months,80.6,72.9 to 86.5,227
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,24 Months,92.7,88.7 to 95.7,248
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,63.6,54.4 to 71.9,280
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,26.8,20.4 to 34.3,229
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,28.4,23.6 to 33.7,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,69.5,62.7 to 75.6,248
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,94.3,89.1 to 97.5,220
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,95.3,92.1 to 97.5,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,93.2,90.8 to 95.7,544
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,78.9,73.5 to 84.3,754
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.2,85.5 to 100.0,38
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,86.3 to 96.5,175
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,93.0,90.4 to 95.6,544
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,84.4,70.2 to 98.6,47
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,88.7,78.0 to 99.4,40
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.1,72.9 to 87.3,175
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,90.3,86.6 to 94.0,360
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,87.4,76.3 to 98.4,40
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,88.9,85.2 to 92.6,360
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.6 to 98.1,376
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,88.4,78.9 to 97.9,47
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,76.9,62.2 to 91.5,40
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,74.0,68.5 to 79.4,360
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,91.8,83.5 to 100.0,47
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.7,83.4 to 94.1,175
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,94.1,88.9 to 99.3,47
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.9,78.2 to 100.0,38
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,87.7,78.2 to 97.2,47
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,80.8,66.3 to 95.3,40
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,74.3,68.8 to 79.7,360
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,91.0,87.4 to 94.7,360
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,91.8,83.5 to 100.0,47
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,90.5,81.2 to 99.7,40
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,93.2,90.2 to 96.1,376
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.2,85.5 to 100.0,38
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,85.9 to 96.2,175
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,90.5,87.4 to 93.7,544
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.4,76.5 to 96.4,66
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",47.1,32.2 to 62.0,66
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,80.4 to 97.4,69
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,90.5 to 94.9,754
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,70.5,55.5 to 85.4,69
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,77.8,74.0 to 81.5,754
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,82.0 to 98.5,69
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.1,62.7 to 89.6,69
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.7,84.3 to 100.0,69
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,91.8,89.5 to 94.2,754
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.4,82.7 to 94.1,175
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,76.9,70.1 to 83.0,313
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,91.1,87.6 to 94.5,373
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.6 to 99.2,379
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,30.4,23.6 to 38.3,220
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,26.9,22.4 to 32.0,457
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,71.2,62.3 to 78.7,242
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,73.3,68.0 to 78.0,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,70.8,62.4 to 77.9,229
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,71.0,65.6 to 75.9,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,65.0,57.8 to 71.5,217
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,67.9,62.8 to 72.6,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,90.3,83.9 to 94.9,220
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,91.7,87.9 to 94.8,457
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,94.8,90.0 to 97.8,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,92.8,88.9 to 95.7,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,23.3,17.7 to 29.9,237
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,30.1,23.9 to 37.1,374
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,48.6,41.1 to 56.6,280
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,31.7,24.5 to 39.8,227
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,90.9,82.5 to 99.3,47
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,89.0,85.2 to 92.8,360
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.2,85.5 to 100.0,38
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.9,86.1 to 95.7,175
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",47.8,29.3 to 66.3,38
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.8,65.3 to 82.2,175
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.7,76.8 to 90.6,175
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.3,65.0 to 97.6,38
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,80.2,75.9 to 84.4,544
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,80.5,66.5 to 94.5,40
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,73.8,69.3 to 78.3,544
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,88.4,76.5 to 100.0,40
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,87.4,76.6 to 98.2,40
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,68.6,63.8 to 73.4,544
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.8,64.9 to 80.8,175
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",51.1,32.1 to 70.0,38
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,69.4,49.7 to 89.0,40
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,73.7,57.0 to 90.5,47
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",66.8,47.3 to 86.2,38
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,66.8,61.1 to 72.4,360
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,80.1,65.3 to 94.9,47
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,44.0,22.5 to 65.5,40
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.0,72.7 to 87.3,175
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,81.1,77.2 to 85.0,544
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,79.9,67.1 to 92.8,47
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,48.6,42.5 to 54.8,360
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,63.8 to 90.0,66
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,72.5,66.7 to 78.2,376
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,72.2,55.2 to 89.1,40
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,85.3,81.1 to 89.6,376
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.1,55.5 to 82.8,66
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.0 to 98.5,376
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,90.5,81.2 to 99.7,40
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,90.5,86.6 to 94.4,376
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.5,73.6 to 95.3,66
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,91.8,89.0 to 94.7,544
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Uninsured,80.1,67.0 to 93.1,40
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,65.2,48.8 to 81.5,47
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,82.0 to 100.0,38
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,74.4,68.6 to 80.2,376
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,82.4,77.7 to 87.1,360
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.2,47.6 to 82.7,38
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.5,59.0 to 86.1,66
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.4,54.8 to 87.9,38
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.7,71.9 to 87.5,175
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,69.7,63.6 to 75.8,376
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.5,86.8 to 96.1,175
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,78.0 to 97.4,66
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.5,78.1 to 100.0,38
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,83.3 to 94.3,175
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",58.0,44.1 to 72.0,66
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.9,77.2 to 96.7,66
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,94.0,88.9 to 97.3,280
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,99.0,96.2 to 99.8,248
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,87.5,80.4 to 93.0,217
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,90.9,86.3 to 94.5,446
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,94.1,87.3 to 97.9,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,96.3,92.7 to 98.4,471
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,22.2,18.1 to 26.9,280
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,5 Months,78.1,70.4 to 84.3,227
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,22.4,18.2 to 27.1,248
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,29.5,24.7 to 34.9,217
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,28.1,25.1 to 31.4,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,91.7,87.1 to 95.1,237
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,91.1,87.7 to 94.0,464
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,89.0,82.8 to 93.7,220
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,90.3,86.6 to 93.3,457
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,90.6,85.0 to 94.8,227
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,94.7,89.8 to 97.7,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,94.5,91.1 to 96.9,449
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,98.6,96.0 to 99.7,242
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,96.7,93.8 to 98.5,471
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,5 Months,67.9,62.0 to 73.2,280
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,5 Months,69.4,58.2 to 78.8,248
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,5 Months,68.0,55.2 to 78.6,217
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,5 Months,68.1,59.9 to 75.3,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,93.9,87.0 to 97.9,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,94.6,91.0 to 97.1,471
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,86.5,79.4 to 92.0,217
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,90.3,85.6 to 94.0,446
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,32.3,25.5 to 39.8,229
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,31.4,26.5 to 36.7,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,30.0,28.6 to 31.4,242
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,31.1,26.3 to 36.4,471
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,95.3,91.9 to 97.5,242
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,95.4,92.4 to 97.6,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Other,68.6,50.7 to 86.6,47
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,65.4,59.6 to 71.3,360
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,77.6,69.5 to 85.7,187
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,89.9,86.4 to 93.5,360
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,80.5,77.0 to 84.0,823
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,74.9,69.2 to 80.6,321
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,88.3,81.5 to 95.1,187
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,71.7,65.8 to 77.5,321
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,78.9,73.3 to 84.5,315
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,89.3,85.4 to 93.2,321
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,85.4,77.7 to 93.0,187
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,91.4,87.4 to 95.3,315
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,86.2,78.9 to 93.6,187
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,91.8,88.3 to 95.2,315
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,90.2,86.4 to 94.0,321
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,90.2,86.4 to 94.0,321
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,89.8,85.4 to 94.2,315
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,89.8,83.4 to 96.3,187
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,50.4,43.9 to 56.9,321
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,61.0,54.2 to 67.9,315
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,91.8,89.5 to 94.1,823
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Overall,Overall,92.4,90.2 to 94.6,823
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,90.1,86.4 to 93.9,321
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,91.3,85.7 to 97.0,187
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,73.4,65.3 to 81.5,321
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,71.8,65.8 to 77.8,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,80.7,73.0 to 88.3,187
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,86.9,79.2 to 94.7,187
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,84.9,79.8 to 90.0,315
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,90.0,87.2 to 92.8,754
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,<133% FPL,66.0,59.9 to 72.1,321
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,79.3,74.0 to 84.6,315
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,82.0 to 98.5,69
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.9,74.4 to 95.3,69
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,90.4 to 94.9,754
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.7,54.8 to 84.6,69
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,81.6,78.0 to 85.1,754
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,54.3,38.7 to 69.9,69
Influenza,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,57.5,53.1 to 61.9,754
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,75.1,71.2 to 78.9,754
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.6,80.1 to 97.2,69
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,88.0,85.2 to 90.9,754
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.1,50.3 to 79.9,69
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,61.0,46.1 to 75.9,69
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,90.9,88.3 to 93.5,754
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Principal City,78.2,74.5 to 81.9,754
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Urbanicity,Living In a MSA Non-Principal City,69.6,48.8 to 90.5,69
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,66.8,53.0 to 78.2,113
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,87.9,78.5 to 94.4,113
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,87.8,81.6 to 92.2,313
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,88.7,82.5 to 92.9,313
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,87.0,81.2 to 91.7,313
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,84.4,72.4 to 91.8,113
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2021,Age,35 Months,98.4,91.4 to 99.9,113
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,88.0,76.7 to 94.2,113
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,61.8,48.3 to 73.8,113
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,87.1,77.0 to 94.2,113
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,87.1,75.6 to 93.6,113
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,19 Months,89.1,83.7 to 92.9,229
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,85.8,81.3 to 89.4,449
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,19 Months,82.5,74.8 to 88.2,220
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,81.9,76.9 to 86.0,457
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,19 Months,81.2,74.2 to 86.7,237
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,80.5,74.2 to 85.5,374
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,5 Months,69.1,55.4 to 80.1,113
Combined 7 Series,,States/Local Areas,TX-Bexar County,2021,Age,35 Months,92.6,73.5 to 99.4,113
Hib,Primary Series,States/Local Areas,TX-Bexar County,2021,Age,7 Months,65.8,52.0 to 77.3,113
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,7 Months,84.4,72.4 to 91.8,113
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,62.7,56.8 to 68.6,352
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,90.9,85.3 to 95.0,227
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,19 Months,86.8,83.6 to 89.5,242
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,87.9,84.1 to 90.9,471
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,19 Months,85.4,78.2 to 90.6,229
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,86.1,81.7 to 89.6,471
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,5 Months,72.6,64.3 to 79.7,220
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,5 Months,77.8,72.5 to 82.2,457
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,100.0,,66
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,5 Months,75.1,67.3 to 81.5,229
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,5 Months,73.9,68.3 to 78.8,449
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,5 Months,83.0,76.7 to 87.8,237
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,5 Months,80.6,75.7 to 84.6,464
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,96.0,92.6 to 99.4,205
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,93.8,90.9 to 96.7,276
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,91.2,87.7 to 94.8,352
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,92.8,90.7 to 95.0,833
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,92.1,87.5 to 95.5,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,90.9,87.2 to 93.9,449
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,89.7,83.5 to 94.3,220
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,92.2,88.7 to 95.0,457
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,94.8,91.1 to 97.3,237
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,92.9,89.6 to 95.4,464
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,87.2,81.4 to 91.9,313
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,92.4,87.8 to 95.7,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,90.7,86.9 to 93.7,449
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,94.9,91.5 to 97.2,242
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,93.6,90.9 to 95.8,471
Hib,Full Series,States/Local Areas,TX-Bexar County,2021,Age,19 Months,71.2,57.8 to 81.7,113
Hib,Primary Series,States/Local Areas,TX-Bexar County,2021,Age,19 Months,87.2,75.7 to 93.7,113
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,82.7,75.8 to 87.9,313
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,83.2,70.7 to 91.1,113
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,75.0,68.1 to 81.4,313
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,88.4,80.5 to 94.1,313
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,5 Months,73.1,59.4 to 83.5,113
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,3 Months,87.6,81.4 to 91.9,229
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,3 Months,84.0,79.2 to 87.9,449
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,3 Months,88.6,82.8 to 92.6,242
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,3 Months,88.1,84.1 to 91.2,471
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,3 Months,84.8,77.1 to 90.2,229
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,3 Months,86.7,82.1 to 90.3,471
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,3 Months,76.4,65.5 to 84.6,217
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,3 Months,80.6,73.0 to 86.5,446
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,3 Months,84.7,72.9 to 91.9,113
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,3 Months,82.1,79.8 to 84.2,280
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,3 Months,84.1,71.4 to 91.9,248
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",46.2,28.6 to 63.7,47
Combined 7 Series,,States/Local Areas,TX-Bexar County,2015,Age,35 Months,79.2,70.6 to 86.6,242
Combined 7 Series,,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,77.3,72.0 to 82.3,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,70.0,66.1 to 73.9,833
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,70.8,66.0 to 75.6,514
Hib,Full Series,States/Local Areas,TX-Bexar County,2014,Age,19 Months,72.5,64.1 to 79.5,229
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,75.3,70.0 to 79.9,471
Hib,Full Series,States/Local Areas,TX-Bexar County,2016,Age,19 Months,74.6,66.9 to 81.1,229
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,69.2,63.5 to 74.4,449
Hib,Full Series,States/Local Areas,TX-Bexar County,2015,Age,19 Months,78.1,73.9 to 81.8,242
Hib,Full Series,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,76.4,71.3 to 80.8,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.5,68.3 to 92.7,66
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,69.2,65.1 to 73.3,767
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.2,70.5 to 83.9,196
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.8,49.9 to 77.6,76
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,19 Months,83.2,79.3 to 86.5,248
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,86.5,79.5 to 92.1,217
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,88.7,84.0 to 92.6,446
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,19 Months,79.1,67.6 to 87.3,280
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,3 Months,84.7,77.8 to 89.8,227
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,90.7,83.9 to 95.5,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,93.6,89.9 to 96.3,471
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,3 Months,80.4,72.5 to 86.5,220
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,3 Months,85.1,80.3 to 88.9,457
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,96.4,93.3 to 98.3,242
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,94.3,91.6 to 96.3,471
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,3 Months,89.9,84.8 to 93.4,237
DTaP,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,3 Months,87.3,83.1 to 90.6,464
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,85.2,78.5 to 91.9,205
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,74.0,67.6 to 80.3,276
Hib,Full Series,States/Local Areas,TX-Bexar County,2011,Age,19 Months,66.8,57.0 to 75.3,280
Hib,Full Series,States/Local Areas,TX-Bexar County,2012,Age,19 Months,66.4,61.1 to 71.4,248
Hib,Full Series,States/Local Areas,TX-Bexar County,2013,Age,19 Months,63.9,59.3 to 68.2,217
Hib,Full Series,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,68.2,64.3 to 71.9,446
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,19 Months,79.7,75.1 to 83.7,217
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,82.6,76.7 to 87.3,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,90.5,83.6 to 95.3,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.7,89.0 to 95.5,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2018,Age,35 Months,75.2,65.1 to 84.2,237
Combined 7 Series,,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,75.6,69.4 to 81.5,464
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,64.1,58.3 to 70.0,373
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,78.9,73.7 to 84.1,379
Combined 7 Series,,States/Local Areas,TX-Bexar County,2019,Age,35 Months,76.4,67.6 to 84.3,227
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,71.9,56.2 to 87.7,44
Hib,Full Series,States/Local Areas,TX-Bexar County,2018,Age,19 Months,68.2,60.7 to 74.9,237
Hib,Full Series,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,94.4,91.1 to 96.5,464
Hib,Full Series,States/Local Areas,TX-Bexar County,2019,Age,19 Months,69.8,61.1 to 77.3,227
Hib,Full Series,States/Local Areas,TX-Bexar County,2017,Age,19 Months,63.8,55.4 to 71.4,220
Hib,Full Series,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,66.0,60.4 to 71.2,457
Hib,Full Series,States/Local Areas,TX-Bexar County,2013,Age,24 Months,72.1,63.6 to 80.1,217
Hib,Full Series,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,74.1,68.3 to 79.6,446
Hib,Full Series,States/Local Areas,TX-Bexar County,2014,Age,24 Months,76.2,68.2 to 83.5,229
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,79.2,74.2 to 83.8,471
Hib,Full Series,States/Local Areas,TX-Bexar County,2012,Age,24 Months,76.7,69.7 to 83.1,248
Hib,Full Series,States/Local Areas,TX-Bexar County,2011,Age,24 Months,76.7,70.0 to 82.8,280
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016,Age,13 Months,86.0,79.7 to 90.6,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,86.1,81.6 to 89.6,449
Hib,Primary Series,States/Local Areas,TX-Bexar County,2012,Age,7 Months,62.0,58.9 to 64.9,248
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013,Age,7 Months,56.7,46.9 to 66.0,217
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,59.9,55.6 to 64.0,446
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017,Age,7 Months,66.8,58.5 to 74.3,220
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,70.0,64.5 to 75.1,457
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016,Age,7 Months,65.2,57.1 to 72.4,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,66.0,60.2 to 71.3,449
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015,Age,7 Months,65.2,57.3 to 72.4,242
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,65.2,59.6 to 70.4,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014,Age,7 Months,63.0,54.6 to 70.6,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,64.1,58.4 to 69.4,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2011,Age,13 Months,86.4,80.4 to 90.7,280
Hib,Primary Series,States/Local Areas,TX-Bexar County,2012,Age,13 Months,85.2,83.2 to 87.0,248
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013,Age,13 Months,80.2,65.6 to 89.6,217
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,82.1,76.0 to 86.9,446
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018,Age,7 Months,73.3,66.0 to 79.6,237
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,72.5,67.2 to 77.3,464
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019,Age,7 Months,71.7,63.4 to 78.8,227
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015,Age,13 Months,87.0,81.1 to 91.3,242
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,86.5,82.4 to 89.8,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014,Age,13 Months,83.9,76.0 to 89.5,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,85.4,80.7 to 89.2,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016,Age,19 Months,91.7,86.7 to 95.0,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,91.1,87.3 to 93.8,449
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015,Age,19 Months,94.9,89.8 to 97.5,242
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,93.3,90.4 to 95.4,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017,Age,19 Months,90.4,84.1 to 94.4,220
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,92.1,88.4 to 94.7,457
Hib,Primary Series,States/Local Areas,TX-Bexar County,2011,Age,24 Months,91.7,86.7 to 95.3,280
Hib,Primary Series,States/Local Areas,TX-Bexar County,2012,Age,24 Months,92.7,87.7 to 96.2,248
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019,Age,19 Months,90.5,84.3 to 94.4,227
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018,Age,19 Months,93.8,89.2 to 96.5,237
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,86.5,82.0 to 90.1,464
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018,Age,13 Months,88.5,82.5 to 92.6,237
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,86.5,82.0 to 90.1,464
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019,Age,13 Months,84.6,77.2 to 89.9,227
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017,Age,13 Months,86.1,79.2 to 91.0,220
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,87.3,83.0 to 90.7,457
Hib,Primary Series,States/Local Areas,TX-Bexar County,2012,Age,19 Months,91.7,89.4 to 93.5,248
Hib,Primary Series,States/Local Areas,TX-Bexar County,2011,Age,19 Months,90.2,86.5 to 92.9,280
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013,Age,19 Months,86.4,73.9 to 93.5,217
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,87.3,82.0 to 91.2,446
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014,Age,19 Months,88.1,80.6 to 92.9,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,91.5,87.5 to 94.3,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2013,Age,24 Months,55.4,46.9 to 64.3,217
Combined 7 Series,,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,60.5,54.6 to 66.5,446
Combined 7 Series,,States/Local Areas,TX-Bexar County,2012,Age,24 Months,70.4,63.0 to 77.4,248
Combined 7 Series,,States/Local Areas,TX-Bexar County,2011,Age,24 Months,67.6,60.3 to 74.7,280
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015,Age,35 Months,95.6,92.4 to 97.8,242
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,95.7,92.6 to 97.8,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016,Age,35 Months,94.8,90.0 to 97.8,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,93.7,89.9 to 96.4,449
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013,Age,35 Months,87.2,80.1 to 92.6,217
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,90.8,86.1 to 94.4,446
Hib,Primary Series,States/Local Areas,TX-Bexar County,2011,Age,35 Months,93.4,87.9 to 97.0,280
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019,Age,24 Months,90.9,85.3 to 95.0,227
Hib,Primary Series,States/Local Areas,TX-Bexar County,2012,Age,35 Months,94.5,89.4 to 97.6,248
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015,Age,24 Months,95.2,92.0 to 97.4,242
Hib,Primary Series,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,93.8,91.1 to 95.9,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014,Age,24 Months,90.6,83.7 to 95.4,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.9,89.2 to 95.7,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013,Age,24 Months,86.8,79.8 to 92.3,217
Hib,Primary Series,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,88.8,84.1 to 92.6,446
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018,Age,24 Months,93.8,89.7 to 96.7,237
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,92.3,89.0 to 95.0,464
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016,Age,24 Months,92.4,87.8 to 95.7,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,91.5,88.0 to 94.4,449
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017,Age,24 Months,90.7,84.9 to 94.9,220
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,92.2,88.8 to 94.9,457
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017,Age,35 Months,92.1,86.2 to 96.1,220
Hib,Primary Series,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,93.2,89.7 to 95.9,457
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016,Age,24 Months,72.9,65.6 to 79.7,229
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,67.9,62.5 to 73.3,449
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019,Age,35 Months,91.8,85.9 to 95.8,227
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014,Age,24 Months,65.6,57.5 to 73.5,229
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,67.9,62.5 to 73.2,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2015,Age,24 Months,70.1,62.8 to 77.2,242
Combined 7 Series,,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,71.5,66.3 to 76.6,471
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018,Age,35 Months,94.1,90.0 to 97.0,237
Hib,Primary Series,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,93.0,89.6 to 95.6,464
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014,Age,35 Months,94.1,87.1 to 98.0,229
Hib,Primary Series,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,94.9,91.3 to 97.4,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2019,Age,24 Months,65.3,57.0 to 73.5,227
Combined 7 Series,,States/Local Areas,TX-Bexar County,2017,Age,24 Months,62.9,54.7 to 71.1,220
Combined 7 Series,,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,64.5,59.0 to 70.0,457
Combined 7 Series,,States/Local Areas,TX-Bexar County,2018,Age,24 Months,66.2,58.8 to 73.4,237
Combined 7 Series,,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,65.7,60.2 to 71.2,464
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016,Age,35 Months,76.4,69.0 to 83.1,229
Combined 7 Series,,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,70.7,65.2 to 76.1,449
Combined 7 Series,,States/Local Areas,TX-Bexar County,2017,Age,35 Months,65.1,56.8 to 73.3,220
Combined 7 Series,,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,69.7,63.4 to 75.7,457
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,89.0,84.6 to 92.2,427
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014,Age,35 Months,73.2,64.5 to 81.2,229
Combined 7 Series,,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,76.0,70.0 to 81.6,471
Combined 7 Series,,States/Local Areas,TX-Bexar County,2013,Age,35 Months,61.5,52.2 to 70.8,217
Combined 7 Series,,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,67.3,61.0 to 73.6,446
Combined 7 Series,,States/Local Areas,TX-Bexar County,2012,Age,35 Months,74.4,66.9 to 81.3,248
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,78.1,73.8 to 82.3,544
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,>400% FPL,97.3,94.8 to 99.9,187
Hib,Primary Series,States/Local Areas,TX-Bexar County,2019-2020,Age,7 Months,71.7,65.8 to 77.0,427
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,81.8,75.1 to 87.0,313
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,92.2,89.6 to 94.9,544
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,77.6,71.3 to 84.0,544
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.4,64.7 to 82.0,175
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,92.5,89.7 to 95.2,544
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.2,73.2 to 95.1,66
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,77.1,71.8 to 82.5,360
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Poverty,133% to <400% FPL,78.0,72.0 to 84.0,315
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.5,62.2 to 88.9,66
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,64.1,58.2 to 70.0,352
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,72.6,68.7 to 76.4,833
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,82.0,76.5 to 87.4,276
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,85.3,81.3 to 89.3,379
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,71.6,55.5 to 87.7,44
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,72.3,67.5 to 77.1,514
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,65.4,59.7 to 71.2,373
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",63.4,46.8 to 80.1,47
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.3,55.1 to 81.5,76
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,72.3,68.3 to 76.3,767
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.7,71.5 to 86.0,196
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,82.6,75.4 to 89.8,205
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,5 Months,73.1,59.4 to 83.5,113
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,83.2,70.7 to 91.1,113
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,65.3,57.3 to 72.6,313
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2020-2021,Age,0-2 Days,72.2,64.5 to 78.9,313
Hib,Full Series,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,69.7,61.7 to 76.6,313
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,87.3,80.9 to 91.7,313
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,84.0,77.2 to 89.1,313
Rotavirus,,States/Local Areas,TX-Bexar County,2011,Age,8 Months,73.2,66.3 to 79.2,280
Rotavirus,,States/Local Areas,TX-Bexar County,2014,Age,8 Months,68.5,60.1 to 75.8,229
Rotavirus,,States/Local Areas,TX-Bexar County,2014-2015,Age,8 Months,71.3,65.8 to 76.2,471
Rotavirus,,States/Local Areas,TX-Bexar County,2016,Age,8 Months,78.0,70.6 to 84.0,229
Rotavirus,,States/Local Areas,TX-Bexar County,2016-2017,Age,8 Months,73.5,68.0 to 78.4,449
Rotavirus,,States/Local Areas,TX-Bexar County,2015,Age,8 Months,74.0,66.9 to 80.1,242
Rotavirus,,States/Local Areas,TX-Bexar County,2015-2016,Age,8 Months,76.0,70.9 to 80.5,471
Rotavirus,,States/Local Areas,TX-Bexar County,2013,Age,8 Months,66.3,57.6 to 74.0,217
Rotavirus,,States/Local Areas,TX-Bexar County,2013-2014,Age,8 Months,67.4,61.5 to 72.8,446
Rotavirus,,States/Local Areas,TX-Bexar County,2012,Age,8 Months,69.8,61.9 to 76.7,248
Rotavirus,,States/Local Areas,TX-Bexar County,2018,Age,8 Months,75.4,68.5 to 81.2,237
Rotavirus,,States/Local Areas,TX-Bexar County,2018-2019,Age,8 Months,74.3,69.0 to 79.0,464
Rotavirus,,States/Local Areas,TX-Bexar County,2017,Age,8 Months,68.9,60.5 to 76.3,220
Rotavirus,,States/Local Areas,TX-Bexar County,2017-2018,Age,8 Months,72.1,66.6 to 77.0,457
Rotavirus,,States/Local Areas,TX-Bexar County,2019,Age,8 Months,73.3,65.0 to 80.2,227
Combined 7 Series,,States/Local Areas,TX-Bexar County,2021,Age,24 Months,64.2,51.6 to 76.7,113
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2020-2021,Age,0-3 Days,73.4,65.7 to 80.0,313
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,88.0,82.2 to 92.6,313
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,90.3,84.1 to 94.8,227
Hib,Primary Series,States/Local Areas,TX-Bexar County,2021,Age,13 Months,84.2,72.1 to 91.7,113
Rotavirus,,States/Local Areas,TX-Bexar County,2020-2021,Age,8 Months,73.1,65.4 to 79.6,313
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,89.8,82.7 to 94.8,313
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,81.3,74.4 to 86.7,313
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,89.9,83.0 to 94.9,313
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2020-2021,Age,0-1 Days,67.8,59.8 to 74.9,313
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,87.1,80.8 to 91.6,313
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,84.1,78.2 to 88.6,313
Hib,Full Series,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,84.6,77.2 to 90.6,313
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,85.4,79.0 to 90.1,313
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,5 Months,78.5,64.8 to 87.9,113
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2021,Age,19 Months,86.8,77.4 to 92.7,113
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,19 Months,85.3,73.6 to 92.4,113
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,23.7,17.7 to 30.9,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,61.4,53.1 to 69.1,313
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2021,Age,13 Months,65.2,51.7 to 76.6,113
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,3 Months,82.5,70.3 to 90.3,113
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,5 Months,71.7,58.0 to 82.2,113
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,58.2,50.0 to 65.9,313
Influenza,,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,47.7,40.0 to 56.2,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,87.2,80.8 to 91.6,313
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,86.4,76.0 to 93.9,113
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,96.8,83.5 to 99.9,113
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,85.1,78.4 to 90.0,313
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,5 Months,73.6,65.7 to 80.3,313
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,72.0,64.7 to 78.4,313
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,88.0,76.7 to 94.2,113
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2021,Age,35 Months,98.4,91.4 to 99.9,113
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,84.2,77.6 to 89.2,313
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,92.2,86.0 to 96.3,313
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,3 Months,83.0,76.4 to 88.1,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,87.2,81.3 to 91.9,313
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,80.8,72.8 to 87.7,313
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,68.2,60.1 to 75.3,313
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,86.0,80.1 to 90.9,313
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,86.6,75.1 to 93.2,113
Hib,Primary Series,States/Local Areas,TX-Bexar County,2021,Age,35 Months,87.2,77.1 to 94.3,113
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,86.6,81.4 to 91.0,313
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,34.4,27.4 to 42.5,313
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,5 Months,80.1,72.5 to 86.1,313
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,5 Months,72.8,64.9 to 79.5,313
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,86.6,80.2 to 91.2,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,87.2,81.3 to 91.9,313
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,83.5,71.5 to 91.1,113
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,69.5,61.8 to 76.2,313
Rotavirus,,States/Local Areas,TX-Bexar County,2021,Age,8 Months,72.9,59.7 to 83.0,113
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2021,Age,0-3 Days,74.9,61.7 to 84.7,113
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,86.7,80.4 to 91.2,313
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,88.2,82.8 to 92.6,313
Hib,Full Series,States/Local Areas,TX-Bexar County,2021,Age,35 Months,97.1,85.2 to 99.9,113
Combined 7 Series,,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,62.3,54.5 to 70.1,313
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,87.2,77.1 to 94.3,113
Combined 7 Series,,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,72.6,63.4 to 81.1,313
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,87.3,81.1 to 91.7,313
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,35 Months,73.5,63.7 to 82.4,313
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,35 Months,87.1,77.0 to 94.2,113
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,5 Months,75.1,67.2 to 81.7,313
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,88.2,82.8 to 92.6,313
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,85.2,79.0 to 89.9,313
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,3 Months,85.4,79.1 to 90.0,313
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2020-2021,Age,19 Months,84.1,78.3 to 88.6,313
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,68.8,60.7 to 75.8,313
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,46.3,40.3 to 52.2,373
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",34.5,19.1 to 50.0,47
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",56.5,42.3 to 70.6,76
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,55.4,50.2 to 60.5,514
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,69.2,63.6 to 74.8,379
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,80.8,69.2 to 92.5,44
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,56.2,52.1 to 60.4,833
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,Hispanic,88.2,85.0 to 91.5,544
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,79.1,73.5 to 84.7,376
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,96.4,94.3 to 98.6,376
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.9,54.4 to 89.3,66
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2021,Age,13 Months,86.6,75.1 to 93.2,113
Hib,Full Series,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,73.4,65.9 to 80.4,313
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2020-2021,Age,13 Months,63.3,55.1 to 70.7,313
Influenza,,States/Local Areas,TX-Bexar County,2021,Age,24 Months,46.2,34.0 to 60.4,113
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2021,Age,24 Months,87.2,77.1 to 94.3,113
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,67.1,58.5 to 75.6,205
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,62.7,55.6 to 69.7,276
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,49.1,43.1 to 55.2,352
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,85.4,80.5 to 90.3,376
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,84.6,77.9 to 89.5,313
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,3 Months,93.4,88.0 to 96.5,313
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,3 Months,82.7,75.8 to 87.9,313
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2020-2021,Age,7 Months,61.8,53.8 to 69.2,313
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2021,Age,13 Months,65.8,52.5 to 77.0,113
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2020-2021,Age,24 Months,85.2,79.4 to 90.1,313
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.5,49.6 to 77.4,66
Influenza,,States/Local Areas,TX-Bexar County,2019,Age,24 Months,56.1,47.9 to 64.8,227
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.6,57.5 to 95.7,38
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.7,71.3 to 90.2,175
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Any Medicaid,87.5,83.7 to 91.3,360
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2019,Insurance Coverage,Private Insurance Only,88.4,84.0 to 92.9,376
Influenza,,States/Local Areas,TX-Bexar County,2017,Age,24 Months,52.6,44.4 to 61.3,220
Influenza,,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,58.7,53.1 to 64.3,457
Influenza,,States/Local Areas,TX-Bexar County,2018,Age,24 Months,64.8,57.7 to 71.9,237
Influenza,,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,60.5,54.9 to 66.2,464
Influenza,,States/Local Areas,TX-Bexar County,2016,Age,24 Months,58.8,51.1 to 66.7,229
Influenza,,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,55.7,50.0 to 61.6,449
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,58.9,43.8 to 73.9,66
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,56.0,51.7 to 60.3,767
Influenza,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.2,59.1 to 75.4,196
Influenza,,States/Local Areas,TX-Bexar County,2013,Age,24 Months,44.2,36.3 to 53.1,217
Influenza,,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,47.0,41.3 to 53.1,446
Influenza,,States/Local Areas,TX-Bexar County,2014,Age,24 Months,49.7,41.8 to 58.2,229
Influenza,,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,56.2,50.6 to 61.9,471
Influenza,,States/Local Areas,TX-Bexar County,2015,Age,24 Months,62.5,54.9 to 70.1,242
Influenza,,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,60.7,55.2 to 66.3,471
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2021,Age,3 Months,92.2,81.9 to 96.9,113
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,93.3,88.6 to 96.6,248
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,84.5,79.4 to 89.6,276
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,71.5,65.8 to 77.1,352
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,78.4,74.8 to 82.0,833
Influenza,,States/Local Areas,TX-Bexar County,2012,Age,24 Months,49.1,41.5 to 57.4,248
Influenza,,States/Local Areas,TX-Bexar County,2011,Age,24 Months,41.8,34.9 to 49.4,280
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,94.8,90.7 to 97.1,237
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,88.3,84.0 to 91.5,464
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,74.0 to 81.5,767
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.8,78.0 to 89.7,196
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,60.9 to 87.5,76
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,78.8,74.3 to 83.2,514
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,90.6,83.8 to 95.4,229
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.9,89.2 to 95.7,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,95.3,92.0 to 97.5,242
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,93.4,90.6 to 95.5,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,91.1,86.0 to 94.5,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,90.3,86.3 to 93.2,449
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,89.5,82.7 to 93.8,220
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,92.1,88.3 to 94.7,457
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,86.1,74.5 to 92.9,217
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,88.0,82.8 to 91.7,446
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,95.9,90.2 to 98.3,242
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,93.5,90.6 to 95.6,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,89.8,82.2 to 94.3,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,92.8,88.9 to 95.5,471
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,89.8,83.5 to 96.1,205
Hib,Primary Series,States/Local Areas,TX-Bexar County,2011,Age,7 Months,62.5,56.3 to 68.4,280
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.0,75.3 to 98.7,66
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,91.4,86.7 to 95.0,229
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,90.1,86.2 to 93.2,449
Hib,Full Series,States/Local Areas,TX-Bexar County,2015,Age,24 Months,82.2,76.2 to 87.4,242
Hib,Full Series,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,81.8,77.4 to 85.8,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,92.4,87.7 to 95.8,280
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,90.7,84.5 to 94.6,227
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,91.7,86.7 to 94.9,237
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,84.0,79.4 to 87.8,464
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,91.6,86.6 to 94.8,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,90.2,86.2 to 93.1,449
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,88.7,81.9 to 93.2,220
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,90.2,86.2 to 93.1,457
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,94.5,90.7 to 96.8,242
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,93.1,90.1 to 95.2,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,85.0,77.7 to 91.0,217
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,87.9,83.0 to 91.9,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,85.6,74.6 to 92.4,217
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,86.8,81.7 to 90.6,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,88.0,80.5 to 92.8,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,91.3,87.3 to 94.1,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,91.9,87.1 to 95.4,248
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,89.8,84.7 to 93.8,280
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,89.4,82.8 to 93.7,227
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,93.5,89.1 to 96.2,237
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,64.3,58.6 to 69.7,464
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,91.8,86.0 to 95.8,280
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,91.7,86.8 to 95.3,280
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,92.0,87.0 to 95.6,248
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,86.1,79.1 to 91.7,217
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,88.4,83.6 to 92.3,446
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,88.8,82.4 to 93.6,220
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,91.1,87.4 to 94.1,457
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,93.5,89.5 to 96.4,237
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,91.5,88.0 to 94.3,464
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,89.4,83.4 to 94.0,227
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,90.2,84.0 to 94.1,227
Hib,Full Series,States/Local Areas,TX-Bexar County,2018,Age,35 Months,81.6,72.4 to 89.2,237
Hib,Full Series,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,81.5,75.8 to 86.6,464
Hib,Full Series,States/Local Areas,TX-Bexar County,2019,Age,35 Months,81.7,73.5 to 88.5,227
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,92.3,90.0 to 94.6,767
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.7,91.4 to 98.0,196
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,79.7 to 98.7,76
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,93.7,91.0 to 96.3,514
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,86.9,77.0 to 96.8,44
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.1,69.8 to 94.4,47
Hib,Full Series,States/Local Areas,TX-Bexar County,2016,Age,24 Months,81.4,75.0 to 87.0,229
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,76.1,70.9 to 81.0,449
Hib,Full Series,States/Local Areas,TX-Bexar County,2017,Age,24 Months,70.7,62.5 to 78.4,220
Hib,Full Series,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,72.8,67.5 to 77.9,457
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,72.3,66.8 to 77.9,373
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.9,43.8 to 82.1,47
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,85.7,81.1 to 90.3,379
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,84.9,70.5 to 99.3,44
Hib,Full Series,States/Local Areas,TX-Bexar County,2017,Age,35 Months,73.2,64.9 to 81.0,220
Hib,Full Series,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,77.1,71.2 to 82.6,457
Hib,Full Series,States/Local Areas,TX-Bexar County,2015,Age,35 Months,91.6,84.8 to 96.2,242
Hib,Full Series,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,86.0,81.8 to 89.7,471
Hib,Full Series,States/Local Areas,TX-Bexar County,2014,Age,35 Months,80.4,71.8 to 87.7,229
Hib,Full Series,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,85.5,80.0 to 90.2,471
Hib,Full Series,States/Local Areas,TX-Bexar County,2016,Age,35 Months,82.1,75.7 to 87.6,229
Hib,Full Series,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,77.7,72.5 to 82.5,449
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,90.2,86.6 to 93.7,373
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,100.0,,44
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,96.5,94.5 to 98.5,379
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,95.7,91.9 to 98.0,237
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,92.9,89.3 to 95.7,464
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,5 Months,76.7,69.2 to 82.8,242
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,5 Months,75.9,70.7 to 80.4,471
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,5 Months,71.8,63.2 to 79.1,229
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,5 Months,74.3,71.7 to 76.7,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,97.5,94.8 to 99.0,242
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,96.1,93.2 to 98.0,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,94.6,89.5 to 97.7,229
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,93.6,89.9 to 96.4,449
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,92.4,86.4 to 96.4,220
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,94.2,90.7 to 96.7,457
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,86.5,79.1 to 92.3,217
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,90.3,85.5 to 94.0,446
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,94.0,87.2 to 97.8,229
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,95.7,92.2 to 98.0,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,98.6,95.0 to 99.8,248
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,5 Months,71.9,65.7 to 77.4,280
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,5 Months,69.7,59.2 to 78.5,248
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,5 Months,69.5,53.4 to 81.9,217
DTaP,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,5 Months,70.7,61.0 to 78.8,446
Hib,Full Series,States/Local Areas,TX-Bexar County,2013,Age,35 Months,75.2,66.2 to 83.4,217
Hib,Full Series,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,77.7,71.6 to 83.3,446
Hib,Full Series,States/Local Areas,TX-Bexar County,2012,Age,35 Months,79.8,72.7 to 86.1,248
Hib,Full Series,States/Local Areas,TX-Bexar County,2011,Age,35 Months,79.3,72.4 to 85.4,280
Hib,Full Series,States/Local Areas,TX-Bexar County,2018,Age,24 Months,75.0,68.2 to 81.4,237
Hib,Full Series,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,75.0,69.8 to 80.0,464
Hib,Full Series,States/Local Areas,TX-Bexar County,2019,Age,24 Months,75.1,67.0 to 82.5,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2011,Age,13 Months,65.8,61.3 to 70.0,280
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2012,Age,13 Months,67.5,58.0 to 75.8,248
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,35 Months,96.0,90.7 to 98.7,229
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,93.5,89.5 to 96.3,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,43.8,36.1 to 52.4,229
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,48.1,42.5 to 54.0,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,93.8,91.8 to 95.9,833
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,93.7,88.4 to 97.1,237
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,92.6,89.0 to 95.5,464
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,91.9,86.0 to 96.0,227
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,100.0,,66
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,93.3,91.1 to 95.5,767
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.6,92.6 to 98.7,196
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.5,82.5 to 100.0,76
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,94.6,92.1 to 97.0,514
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",82.1,69.8 to 94.4,47
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,5 Months,79.6,72.8 to 85.0,237
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,5 Months,77.6,72.4 to 82.0,464
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,5 Months,71.6,63.2 to 78.7,220
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,5 Months,75.5,70.1 to 80.2,457
PCV,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,5 Months,75.6,67.4 to 82.3,227
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,61.0,52.4 to 68.9,220
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,62.9,57.3 to 68.2,457
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,75.3,67.6 to 81.8,229
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,68.2,62.4 to 73.5,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,46.4,38.1 to 55.5,217
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,45.1,39.4 to 51.3,446
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,64.9,57.2 to 71.9,237
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,93.3,89.8 to 95.7,464
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,83.4,72.3 to 91.9,237
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,83.1,77.0 to 88.4,464
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2012,Age,19 Months,86.8,82.2 to 90.4,248
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013,Age,19 Months,82.7,68.1 to 91.4,217
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,85.6,77.5 to 91.2,446
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017,Age,19 Months,81.8,73.9 to 87.7,220
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,84.3,79.4 to 88.2,457
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018,Age,19 Months,86.8,80.4 to 91.4,237
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,62.9,57.2 to 68.3,464
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,3 Months,94.5,88.0 to 97.6,220
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,3 Months,95.7,92.4 to 97.7,457
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,93.4,88.9 to 96.2,229
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,91.8,88.1 to 94.5,449
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,95.4,91.8 to 97.5,242
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,94.4,91.7 to 96.3,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016,Age,19 Months,91.7,86.3 to 95.1,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,86.8,82.2 to 90.3,449
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019,Age,13 Months,64.6,56.1 to 72.3,227
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,80.2,75.9 to 84.5,514
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.3,78.6 to 89.9,196
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.9,60.6 to 87.2,76
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,79.3,75.8 to 82.8,833
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.4,75.0 to 97.9,66
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,78.8,75.1 to 82.4,767
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014,Age,19 Months,88.5,81.2 to 93.2,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,89.9,85.7 to 93.0,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,72.6,67.1 to 78.1,352
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2012,Age,24 Months,95.7,92.5 to 97.8,248
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2011,Age,24 Months,90.9,86.4 to 94.3,280
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016,Age,19 Months,92.3,87.3 to 95.4,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,88.7,84.4 to 92.0,449
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015,Age,19 Months,91.3,83.8 to 95.5,242
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,91.8,88.4 to 94.2,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,91.9,89.4 to 93.9,242
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,91.8,88.5 to 94.2,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,88.9,81.6 to 93.5,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,90.4,86.3 to 93.4,471
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,86.0,78.7 to 93.4,205
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,82.0,75.0 to 87.4,217
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,85.5,79.6 to 89.9,446
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,5 Months,78.9,72.5 to 84.2,217
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,5 Months,82.5,76.0 to 87.6,446
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,5 Months,85.9,81.8 to 89.2,280
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,5 Months,86.1,79.3 to 90.9,248
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,84.9,76.6 to 93.2,276
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2011,Age,0-1 Days,57.3,53.0 to 61.5,280
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,3 Months,97.0,93.5 to 98.7,237
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,3 Months,96.8,93.8 to 98.4,464
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,89.6,82.1 to 94.2,229
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,92.5,88.5 to 95.2,471
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,3 Months,96.6,90.5 to 98.8,227
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016,Age,24 Months,91.9,87.0 to 95.5,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,90.6,86.9 to 93.7,449
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015,Age,24 Months,93.8,89.3 to 96.8,242
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,92.7,89.5 to 95.2,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2011,Age,24 Months,89.6,84.8 to 93.4,280
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2020,Age,35 Months,76.7,68.7 to 83.9,200
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,77.8,72.3 to 82.6,280
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,76.5,73.3 to 79.4,248
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,69.3,57.7 to 78.9,217
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,74.6,66.4 to 81.3,446
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018,Age,19 Months,85.9,79.2 to 90.7,237
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,93.1,89.6 to 95.5,464
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019,Age,19 Months,82.6,74.9 to 88.3,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017,Age,19 Months,85.1,77.5 to 90.5,220
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,85.5,80.7 to 89.3,457
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,90.0,83.7 to 96.2,205
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,85.3,80.3 to 90.2,276
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,60.0,54.1 to 65.5,248
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,59.6,51.2 to 67.4,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,60.9,55.2 to 66.3,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,91.7,86.6 to 94.9,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,90.0,86.0 to 92.9,449
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,57.3,53.1 to 61.3,280
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,53.0,46.0 to 59.9,217
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,56.3,53.3 to 59.3,446
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2012,Age,0-1 Days,58.3,52.9 to 63.6,248
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,5 Months,86.0,78.3 to 91.3,229
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,5 Months,87.5,83.6 to 90.6,471
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,5 Months,88.7,82.7 to 92.8,229
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,5 Months,84.5,79.8 to 88.2,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,88.2,81.6 to 92.7,220
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,91.1,87.3 to 93.9,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,94.1,89.7 to 96.7,237
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,88.9,85.0 to 91.9,464
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2017,Age,0-2 Days,69.0,60.6 to 76.2,220
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2017-2018,Age,0-2 Days,75.1,69.8 to 79.7,457
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2018,Age,0-2 Days,81.3,74.5 to 86.6,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2018-2019,Age,0-2 Days,80.5,75.8 to 84.5,464
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2019,Age,0-2 Days,79.8,72.8 to 85.3,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,95.6,91.5 to 97.7,237
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,93.2,89.8 to 95.5,464
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,88.8,83.7 to 92.5,248
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,90.9,85.7 to 94.3,237
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,88.9,85.0 to 91.9,464
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,87.1,83.5 to 90.1,280
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,87.0,80.5 to 91.6,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2011,Age,19 Months,88.0,85.0 to 90.6,280
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,86.0,75.9 to 96.1,44
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.4,41.8 to 77.1,47
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,74.4,69.0 to 79.7,373
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,86.1,81.6 to 90.6,379
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,83.2,75.1 to 89.9,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,5 Months,89.0,83.7 to 92.7,242
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,5 Months,88.8,85.0 to 91.7,471
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2014,Age,0-1 Days,66.9,58.7 to 74.1,229
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2014-2015,Age,0-1 Days,66.7,61.2 to 71.8,471
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2013,Age,0-1 Days,65.6,60.3 to 70.5,217
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2013-2014,Age,0-1 Days,66.2,62.4 to 69.9,446
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013,Age,24 Months,85.2,78.4 to 90.9,217
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,88.6,84.1 to 92.2,446
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,90.2,83.7 to 94.3,220
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,92.4,88.7 to 95.0,457
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,94.7,90.3 to 97.1,237
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,93.3,89.8 to 95.7,464
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,91.9,85.8 to 95.5,227
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019,Age,19 Months,81.1,73.3 to 87.0,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017,Age,13 Months,60.9,52.3 to 68.8,220
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,62.4,56.8 to 67.8,457
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016,Age,13 Months,65.9,58.0 to 73.1,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,63.4,57.6 to 68.9,449
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018,Age,13 Months,64.1,56.3 to 71.1,237
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,64.3,58.6 to 69.7,464
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,91.7,85.5 to 95.4,280
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,94.1,90.7 to 96.3,248
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013,Age,19 Months,83.6,71.6 to 91.2,217
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,86.1,78.2 to 91.5,446
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015,Age,19 Months,88.4,81.1 to 93.1,242
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,90.0,86.4 to 92.8,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014,Age,19 Months,88.6,81.3 to 93.3,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,88.5,84.2 to 91.7,471
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,3 Months,96.9,93.5 to 98.6,229
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,3 Months,95.7,92.4 to 97.6,449
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,3 Months,94.0,89.6 to 96.6,242
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,3 Months,95.4,92.9 to 97.1,471
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,3 Months,93.3,86.8 to 96.8,229
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,3 Months,93.7,90.1 to 96.0,471
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,89.9,81.0 to 94.9,217
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,89.7,86.8 to 92.1,446
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.8,64.5 to 97.2,76
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2017,Age,0-1 Days,65.3,56.9 to 72.9,220
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2017-2018,Age,0-1 Days,71.4,66.1 to 76.3,457
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2016,Age,0-1 Days,72.3,64.9 to 78.6,229
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2016-2017,Age,0-1 Days,68.8,63.3 to 73.9,449
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014,Age,24 Months,91.9,85.6 to 96.1,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.8,89.1 to 95.6,471
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,5 Months,80.2,72.6 to 86.1,220
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,5 Months,86.5,82.0 to 90.0,457
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,5 Months,87.9,81.6 to 92.3,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,5 Months,92.9,88.3 to 95.7,237
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,5 Months,90.4,86.7 to 93.2,464
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2015,Age,0-1 Days,66.5,58.9 to 73.4,242
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2015-2016,Age,0-1 Days,69.4,64.1 to 74.1,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2012,Age,24 Months,93.8,89.2 to 96.9,248
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2011,Age,35 Months,95.8,91.7 to 98.2,280
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,82.5,76.2 to 88.7,514
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,82.1,76.8 to 87.5,767
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,85.8,79.8 to 90.8,229
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,83.2,77.9 to 87.9,449
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,80.6,71.7 to 88.1,220
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,81.9,75.3 to 87.6,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,83.0,75.8 to 88.5,220
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,86.9,82.6 to 90.3,457
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,89.7,82.0 to 95.1,242
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,87.1,82.7 to 90.8,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,87.6,81.9 to 91.6,242
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,88.5,84.7 to 91.4,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,89.4,83.7 to 93.2,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,86.2,81.8 to 89.7,449
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,85.7,78.6 to 90.7,220
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,88.5,84.3 to 91.6,457
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,90.1,84.8 to 93.7,229
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,87.9,83.5 to 91.2,449
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,3 Months,94.4,91.8 to 96.2,280
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,3 Months,93.9,86.9 to 97.2,248
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,3 Months,90.2,86.3 to 93.1,217
Hep B,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,3 Months,91.8,87.5 to 94.7,446
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,91.3,86.4 to 94.5,237
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,89.9,85.9 to 92.9,464
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,95.6,91.8 to 99.5,205
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013,Age,13 Months,57.9,42.0 to 72.2,217
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,60.2,51.1 to 68.6,446
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018,Age,13 Months,61.9,54.3 to 69.1,237
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,62.9,57.2 to 68.3,464
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,92.7,89.3 to 96.0,276
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2012,Age,19 Months,88.4,85.4 to 90.8,248
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2011,Age,19 Months,89.2,83.8 to 93.0,280
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019,Age,13 Months,63.9,55.5 to 71.6,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015,Age,13 Months,64.8,57.1 to 71.9,242
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,65.4,59.9 to 70.5,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014,Age,13 Months,62.5,54.2 to 70.1,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,63.7,58.0 to 68.9,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,85.2,78.7 to 90.6,248
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,83.0,74.2 to 90.1,229
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,85.9,80.2 to 90.7,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,77.7,68.6 to 85.7,217
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,80.0,73.9 to 85.6,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,87.1,80.0 to 91.9,248
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,75.4,65.3 to 84.5,227
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,84.7,76.9 to 90.2,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,86.1,81.5 to 89.8,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,76.6,67.3 to 83.8,217
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,80.7,74.9 to 85.4,446
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,76.2,65.4 to 85.6,220
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,72.8,65.6 to 79.5,457
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,69.5,59.8 to 78.8,237
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,72.5,65.4 to 79.2,464
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.7,72.9 to 88.5,196
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.9,62.6 to 95.2,66
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,79.7,71.1 to 88.3,352
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,82.1,76.9 to 87.4,833
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,88.5,81.4 to 93.1,227
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,82.0,73.8 to 90.2,373
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,84.4,77.3 to 91.5,379
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.3,43.0 to 97.7,47
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,81.1,73.9 to 87.3,280
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,73.5,65.3 to 81.2,227
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,73.5,65.2 to 81.1,220
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,74.0,68.6 to 79.1,457
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,74.6,67.5 to 81.1,237
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,74.0,68.6 to 79.2,464
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,84.2,77.5 to 89.2,280
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,89.9,84.3 to 93.6,242
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,90.0,86.3 to 92.7,471
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,90.1,86.5 to 93.7,352
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,91.9,89.7 to 94.2,833
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,84.1,72.0 to 91.6,217
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,84.7,78.8 to 89.2,446
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,85.2,77.6 to 90.6,229
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,87.6,83.0 to 91.0,471
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,84.7 to 100.0,66
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,91.9,89.5 to 94.2,767
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.6,88.6 to 96.5,196
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,80.1 to 99.6,76
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015,Age,13 Months,62.8,55.1 to 70.0,242
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,64.0,58.4 to 69.1,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017,Age,13 Months,57.9,49.4 to 66.0,220
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,59.9,54.2 to 65.3,457
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016,Age,13 Months,65.1,57.1 to 72.3,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,61.5,55.7 to 67.1,449
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013,Age,13 Months,59.4,44.9 to 72.4,217
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,60.1,52.3 to 67.4,446
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2011,Age,13 Months,68.0,63.6 to 72.1,280
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014,Age,13 Months,60.7,52.4 to 68.5,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,61.8,56.1 to 67.1,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2012,Age,13 Months,68.4,60.2 to 75.6,248
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,35 Months,91.1,82.9 to 96.3,237
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,91.9,86.4 to 95.8,464
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,90.7,87.4 to 94.0,373
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,93.2,89.9 to 96.4,379
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,35 Months,93.2,85.1 to 97.8,227
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,5 Months,81.8,75.3 to 86.9,237
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,5 Months,79.9,75.0 to 84.1,464
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,97.3,92.4 to 100.0,44
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.9,87.7 to 100.0,47
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,87.0,81.9 to 90.9,280
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,86.1,81.0 to 89.9,248
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,91.9,89.1 to 94.6,514
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,5 Months,78.0,70.2 to 84.2,227
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,60.6,52.3 to 68.2,220
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,62.6,57.1 to 67.8,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,64.7,57.3 to 71.5,237
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,61.8,56.2 to 67.1,464
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,84.8,75.6 to 92.0,242
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,83.6,77.4 to 88.9,471
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,82.8,74.3 to 89.8,229
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,80.0,73.3 to 85.9,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,73.1,62.9 to 82.5,229
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,78.9,71.9 to 85.1,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,68.2,60.7 to 74.9,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,64.4,58.9 to 69.6,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,58.8,50.3 to 66.9,227
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,74.8,66.9 to 82.1,229
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,77.5,72.4 to 82.2,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,80.0,73.6 to 85.8,242
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,81.7,77.2 to 85.8,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,83.4,77.2 to 88.6,229
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,78.4,73.3 to 83.1,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,74.8,64.1 to 84.3,217
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,74.0,66.6 to 80.8,446
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,83.1,72.5 to 91.3,248
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,79.6,70.8 to 87.1,280
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,5 Months,75.0,67.5 to 81.2,242
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,5 Months,74.2,69.0 to 78.9,471
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,50.4,41.9 to 59.5,227
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,40.4,33.4 to 48.3,237
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,45.3,39.7 to 51.3,464
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,52.5,45.3 to 59.5,217
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,56.2,51.5 to 60.8,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,65.8,58.3 to 72.7,242
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,67.0,61.7 to 71.9,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,59.9,51.6 to 67.6,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,62.9,57.3 to 68.1,471
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,5 Months,71.5,63.1 to 78.6,220
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,5 Months,76.6,71.2 to 81.2,457
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,5 Months,73.5,65.7 to 80.0,229
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,5 Months,72.5,66.8 to 77.5,449
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,35 Months,91.0,84.7 to 95.5,220
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,91.2,86.3 to 94.9,457
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,35 Months,96.6,92.5 to 98.8,242
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,96.4,93.2 to 98.3,471
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,70.3,61.9 to 78.4,217
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,72.6,66.8 to 78.0,446
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,54.5,46.6 to 62.7,229
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,55.2,49.2 to 61.4,449
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,56.1,47.2 to 65.4,220
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,48.1,42.2 to 54.2,457
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,52.3,44.5 to 60.5,242
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,53.3,47.7 to 59.2,471
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,5 Months,70.1,61.6 to 77.5,229
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,5 Months,72.6,70.0 to 75.0,471
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,5 Months,70.6,55.6 to 82.1,217
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,5 Months,70.4,61.8 to 77.7,446
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,35 Months,97.1,93.9 to 98.8,248
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,5 Months,70.5,64.7 to 75.7,280
Polio,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,5 Months,70.6,61.6 to 78.3,248
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,91.8,88.4 to 95.3,352
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,96.5,93.2 to 99.8,205
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,95.8,93.6 to 98.0,276
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,61.8,56.5 to 66.9,280
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,60.8,55.9 to 65.6,248
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,80.6,73.9 to 86.4,248
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,77.9,70.9 to 84.2,280
DTaP,≥4 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,68.5,59.7 to 76.1,227
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,35 Months,94.2,87.2 to 98.1,229
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,95.4,91.4 to 97.9,471
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,35 Months,88.7,81.1 to 94.3,217
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,91.8,86.7 to 95.4,446
Hep A,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,47.6,39.7 to 56.2,248
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,92.3,87.3 to 95.5,280
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,93.4,88.8 to 96.2,248
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,87.7,80.5 to 92.5,227
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,90.6,85.6 to 94.1,237
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,89.2,85.1 to 92.3,464
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,87.1,82.8 to 90.5,248
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,91.6,85.4 to 95.3,220
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,93.0,89.4 to 95.4,457
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,94.4,89.9 to 97.0,237
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,93.1,89.6 to 95.5,464
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,98.6,96.4 to 100.0,66
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,91.0,87.4 to 94.6,352
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,93.3,91.1 to 95.4,833
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,91.7,85.7 to 95.4,227
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,90.5 to 95.1,767
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.8,90.2 to 97.4,196
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,66.7,58.4 to 74.1,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,75.3,71.8 to 78.8,833
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.0,64.4 to 89.6,66
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,75.1,71.5 to 78.8,767
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.2,62.0 to 78.3,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.5,48.9 to 76.0,76
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,78.4,74.3 to 82.5,514
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,86.2,78.4 to 91.5,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,87.1,82.5 to 90.7,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,82.2,66.2 to 91.5,217
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,84.2,77.0 to 89.5,446
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2015,Age,0-3 Days,77.0,70.5 to 82.5,242
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2015-2016,Age,0-3 Days,77.3,72.6 to 81.4,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,65.7,57.6 to 73.0,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,66.4,60.5 to 71.8,449
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,63.8,55.4 to 71.5,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,65.2,59.5 to 70.5,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,66.5,58.7 to 73.6,242
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,66.1,60.5 to 71.4,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,90.5,83.9 to 95.2,220
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,92.8,88.8 to 95.7,457
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,88.3,76.6 to 94.6,217
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,88.6,84.4 to 91.8,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,55.6,47.4 to 63.5,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,57.6,51.9 to 63.0,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,95.0,90.8 to 97.7,237
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,93.3,89.8 to 95.9,464
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,54.8,46.7 to 62.7,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,56.7,50.8 to 62.4,449
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,59.5,51.6 to 66.9,242
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,57.2,51.5 to 62.7,471
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,3 Months,81.7,73.9 to 87.6,220
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,3 Months,85.5,80.7 to 89.2,457
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,3 Months,89.2,84.0 to 92.9,237
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,3 Months,86.9,82.7 to 90.2,464
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,58.5,50.0 to 66.6,220
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,63.3,57.6 to 68.6,457
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,68.1,60.7 to 74.7,237
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,67.4,62.0 to 72.4,464
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,91.6,85.8 to 95.7,227
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,100.0,,44
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2018,Age,0-3 Days,83.0,76.3 to 88.0,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2018-2019,Age,0-3 Days,81.9,77.3 to 85.8,464
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,3 Months,84.6,77.6 to 89.6,227
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,74.4,69.0 to 79.7,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,69.5,55.4 to 83.6,44
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,77.1,72.2 to 82.0,373
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.9,52.2 to 85.6,47
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2019,Age,0-3 Days,80.8,73.9 to 86.3,227
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,75.3,68.2 to 81.2,237
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,72.8,67.5 to 77.5,464
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,67.0,58.5 to 74.6,220
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,71.1,65.5 to 76.1,457
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,70.2,61.9 to 77.4,227
Hib,Primary Series,States/Local Areas,TX-Bexar County,2020,Age,24 Months,87.2,80.3 to 92.5,200
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,88.7,86.0 to 91.0,280
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,88.9,81.4 to 93.6,229
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,92.5,88.5 to 95.2,471
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,93.6,89.1 to 96.3,229
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,92.6,89.0 to 95.1,449
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,96.0,92.5 to 97.9,242
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,94.8,92.2 to 96.6,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.0,76.9 to 97.1,76
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,94.6,92.0 to 97.1,514
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.5,71.4 to 95.6,47
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,90.4,86.9 to 93.9,373
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,96.8,94.8 to 98.9,379
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2013,Age,0-3 Days,73.6,65.2 to 80.6,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2013-2014,Age,0-3 Days,72.3,66.6 to 77.4,446
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,3 Months,76.3,66.9 to 83.7,217
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,3 Months,80.1,73.0 to 85.7,446
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,3 Months,81.9,79.7 to 83.9,280
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,3 Months,82.8,69.2 to 91.2,248
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,3 Months,83.5,76.4 to 88.7,227
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,93.0,90.9 to 95.2,833
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,3 Months,88.2,82.6 to 92.1,237
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,3 Months,85.8,81.5 to 89.3,464
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014,Age,0-3 Days,71.0,62.9 to 78.0,229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2015,Age,0-3 Days,74.0,68.9 to 78.6,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,93.8,89.7 to 96.6,237
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,92.2,88.9 to 94.9,464
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,89.9,84.4 to 93.6,242
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,89.5,85.8 to 92.3,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,87.9,81.4 to 92.9,217
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,90.9,86.4 to 94.4,446
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,91.8,86.0 to 95.9,280
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,90.7,85.1 to 94.8,227
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.3,85.0 to 100.0,66
Hep A,≥1 Dose,States/Local Areas,TX-Bexar County,2020,Age,35 Months,90.2,83.5 to 95.0,200
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,62.0,56.9 to 66.8,280
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,65.0,60.6 to 69.1,248
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,57.1,48.1 to 65.6,217
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,60.5,56.8 to 64.1,446
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,81.0,78.5 to 83.2,248
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,90.8 to 95.3,767
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,86.5,79.6 to 91.3,220
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,88.5,84.3 to 91.8,457
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,89.0,83.5 to 92.9,229
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,87.8,83.5 to 91.0,449
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,94.9,90.1 to 97.8,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,93.0,89.0 to 96.0,449
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,96.6,92.6 to 98.7,242
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,95.8,92.7 to 97.8,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,93.9,87.0 to 97.9,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,95.3,91.2 to 97.8,471
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016,Age,0-3 Days,77.7,70.5 to 83.5,229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2016-2017,Age,0-3 Days,75.1,69.8 to 79.8,449
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2017,Age,0-3 Days,79.2,68.8 to 86.7,133
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2017-2018,Age,0-3 Days,77.7,72.5 to 82.1,457
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,3 Months,87.0,80.8 to 91.4,229
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,3 Months,84.4,79.6 to 88.2,449
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,3 Months,87.1,81.3 to 91.4,242
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,3 Months,87.1,83.0 to 90.2,471
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,3 Months,83.7,76.1 to 89.3,229
Polio,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,3 Months,85.4,80.8 to 89.1,471
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,53.7,45.1 to 62.0,217
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,54.6,50.4 to 58.8,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,92.1,88.7 to 95.5,352
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,95.8,92.4 to 99.2,205
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,92.5,89.0 to 96.0,276
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,56.6,53.3 to 59.9,248
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,59.8,54.2 to 65.2,280
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,3 Months,82.7,72.3 to 89.7,248
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.2,80.7 to 91.7,196
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.3,64.5 to 90.2,76
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,3 Months,87.2,81.4 to 91.4,242
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,3 Months,86.9,82.8 to 90.1,471
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,3 Months,83.7,76.0 to 89.3,229
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,3 Months,85.5,80.8 to 89.1,471
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,88.1,81.1 to 92.8,220
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,90.8,86.8 to 93.6,457
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,90.3,85.1 to 93.8,229
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,89.2,85.1 to 92.3,449
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,84.9,78.7 to 89.6,237
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,84.0,79.4 to 87.8,464
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,93.9,88.9 to 96.7,242
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,92.1,89.1 to 94.4,471
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,90.0,86.3 to 92.8,280
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,91.0,88.9 to 92.7,248
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,83.1,75.7 to 88.6,227
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,82.2,75.8 to 87.1,242
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,82.3,77.7 to 86.1,471
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,82.8,75.0 to 88.6,220
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,83.9,79.1 to 87.7,457
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,82.4,75.5 to 87.7,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,82.6,77.6 to 86.7,449
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,89.0,81.5 to 93.7,229
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,91.5,87.5 to 94.3,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,90.6,85.6 to 94.0,237
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,88.3,84.0 to 91.5,464
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,90.6,87.7 to 92.9,248
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,91.0,88.9 to 92.7,280
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,85.9,78.6 to 91.0,227
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,84.7,80.8 to 87.8,217
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,86.9,83.7 to 89.5,446
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,90.2,85.2 to 93.6,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,76.8,71.7 to 81.8,352
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,78.1,70.9 to 85.3,205
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,70.4,64.0 to 76.8,276
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,85.3,79.5 to 89.7,280
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,80.0,72.1 to 86.1,229
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,81.1,76.2 to 85.2,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,96.7,93.4 to 100.0,205
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,95.5,93.2 to 97.9,276
Polio,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,88.9,84.3 to 92.3,280
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,78.2,67.2 to 86.3,217
Hib,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,79.1,75.0 to 82.8,446
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,88.1,82.1 to 92.2,242
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,87.8,83.8 to 91.0,471
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,86.3,79.2 to 91.3,220
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,88.4,84.2 to 91.6,457
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,87.6,81.5 to 91.9,229
DTaP,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,87.0,82.5 to 90.4,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,86.8 to 95.4,196
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.1,82.1 to 100.0,76
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,94.4,92.0 to 96.8,514
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,93.1,88.4 to 96.4,248
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,5 Months,71.9,63.6 to 79.0,220
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,5 Months,77.3,72.0 to 81.8,457
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,5 Months,82.8,76.4 to 87.7,237
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,5 Months,80.4,75.5 to 84.5,464
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,87.3,82.2 to 91.1,280
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,5 Months,78.0,70.2 to 84.2,227
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,94.4,90.8 to 96.8,242
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,93.4,90.7 to 95.6,471
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,86.3,84.6 to 87.9,248
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,92.5,88.0 to 95.8,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,90.9,87.0 to 94.0,449
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,89.2,82.8 to 94.1,220
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,91.5,87.7 to 94.5,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.2,67.9 to 98.5,47
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2011,Age,0-3 Days,74.2,66.9 to 80.3,280
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,91.9,88.6 to 95.3,373
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,TX-Bexar County,2012,Age,0-3 Days,68.6,60.7 to 75.5,248
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,81.9,78.4 to 85.3,767
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,3 Months,80.0,72.1 to 86.2,220
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,3 Months,84.1,79.2 to 88.0,457
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,3 Months,86.5,80.1 to 91.1,229
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,3 Months,83.3,78.4 to 87.3,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,96.2,91.4 to 100.0,44
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,94.5,91.7 to 97.2,379
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,82.3,79.0 to 85.6,833
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.1,76.9 to 99.3,66
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,86.6,81.9 to 91.3,276
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,77.3,72.0 to 82.5,352
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,90.4,84.7 to 96.2,205
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,85.0,77.2 to 90.4,229
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,87.5,82.9 to 90.9,471
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,81.0,68.8 to 89.2,217
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,83.0,76.7 to 87.9,446
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,5 Months,72.1,64.2 to 78.8,229
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,5 Months,72.0,66.4 to 77.0,449
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,5 Months,74.7,67.2 to 80.9,242
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,5 Months,73.4,68.1 to 78.1,471
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,89.0,84.8 to 93.1,379
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,86.0,77.8 to 92.3,227
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,82.8,78.8 to 86.9,514
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.8,53.9 to 87.8,47
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,77.9,72.9 to 83.0,373
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,85.4,74.7 to 96.0,44
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,3 Months,74.1,67.5 to 79.8,217
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,3 Months,79.0,72.6 to 84.2,446
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,90.5,83.6 to 95.3,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.4,88.7 to 95.3,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,87.9,81.4 to 92.9,217
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,89.2,84.6 to 92.9,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2020,Age,24 Months,85.3,78.5 to 90.9,200
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,93.0,88.2 to 96.3,248
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,93.8,89.3 to 96.5,237
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,88.2,83.8 to 91.6,464
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,89.1,84.1 to 93.1,280
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,88.8,81.7 to 93.3,227
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,88.5,81.4 to 93.1,220
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,91.1,87.1 to 94.0,457
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,5 Months,65.0,56.4 to 72.7,229
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,5 Months,69.8,66.7 to 72.8,471
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,5 Months,65.9,50.0 to 78.9,217
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,5 Months,65.4,56.4 to 73.5,446
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,5 Months,70.1,64.7 to 75.1,280
Hib,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,5 Months,69.6,61.2 to 76.8,248
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,90.2,86.4 to 94.0,352
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,92.8,90.6 to 95.1,833
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.5,86.4 to 100.0,66
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,95.8,92.1 to 99.5,205
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,95.8,93.4 to 98.1,276
PCV,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,3 Months,81.3,79.9 to 82.7,280
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,86.6,76.0 to 94.1,237
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,86.0,79.9 to 91.0,464
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,82.6,76.0 to 88.2,229
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,80.0,74.9 to 84.6,449
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,77.3,69.3 to 84.4,220
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,81.2,75.2 to 86.5,457
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.7,84.4 to 100.0,66
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,<133% FPL,90.6,87.0 to 94.3,352
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Overall,Overall,92.6,90.3 to 94.9,833
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,92.6,90.2 to 95.0,767
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.2,89.3 to 97.0,196
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,79.6 to 98.9,76
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,100.0,,44
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019,Age,35 Months,92.0,85.3 to 96.4,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017,Age,35 Months,93.1,87.2 to 96.9,220
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,92.5,88.4 to 95.5,457
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018,Age,35 Months,91.6,85.4 to 95.8,237
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,91.8,87.2 to 95.3,464
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,91.0,84.6 to 94.9,220
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,93.6,90.1 to 96.0,457
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2017,Age,3 Months,80.2,72.3 to 86.3,220
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2017-2018,Age,3 Months,84.5,79.7 to 88.4,457
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2016,Age,3 Months,84.4,77.7 to 89.3,229
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2016-2017,Age,3 Months,82.3,77.3 to 86.4,449
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2015,Age,3 Months,87.1,81.3 to 91.3,242
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2015-2016,Age,3 Months,85.8,81.6 to 89.1,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,92.5,87.5 to 95.6,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,90.5,86.4 to 93.5,449
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,93.0,88.0 to 96.0,242
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,92.8,89.8 to 94.9,471
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,96.5,93.3 to 98.2,229
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,93.8,90.4 to 96.0,449
Hib,Full Series,States/Local Areas,TX-Bexar County,2020,Age,24 Months,71.7,63.5 to 79.4,200
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,92.5,86.6 to 95.9,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,96.3,92.5 to 98.2,237
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,94.4,91.1 to 96.5,464
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2019,Age,3 Months,83.5,76.4 to 88.7,227
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,133% to <400% FPL,93.8,90.4 to 97.2,276
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Poverty,>400% FPL,95.9,92.3 to 99.6,205
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,90.3 to 95.0,767
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.9,90.5 to 97.2,196
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2011,Age,3 Months,82.1,80.0 to 84.1,280
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2012,Age,3 Months,82.2,66.7 to 91.4,248
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2013,Age,3 Months,76.3,64.1 to 85.3,217
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2013-2014,Age,3 Months,79.0,71.6 to 84.9,446
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,90.6,86.2 to 93.7,217
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,91.9,88.6 to 94.3,446
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,95.9,92.3 to 97.8,242
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,96.2,94.0 to 97.6,471
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,93.2,86.4 to 96.7,229
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,94.6,91.0 to 96.8,471
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2014,Age,3 Months,81.7,73.9 to 87.5,229
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2014-2015,Age,3 Months,84.4,79.7 to 88.2,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,35 Months,92.7,88.2 to 95.9,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,92.8,89.4 to 95.4,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,93.3,88.7 to 96.4,242
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,93.0,89.9 to 95.4,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,19 Months,87.5,79.2 to 92.8,217
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,19 Months,88.2,84.3 to 91.3,446
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,19 Months,89.0,82.8 to 93.1,280
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,13 Months,85.2,77.5 to 90.6,227
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,35 Months,92.5,87.4 to 96.1,220
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,94.0,90.7 to 96.4,457
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,19 Months,92.5,89.1 to 94.9,248
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,84.6,78.2 to 90.0,248
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,83.8,77.8 to 89.0,280
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,79.9,72.0 to 86.7,227
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,78.6,72.2 to 84.4,237
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,79.3,74.3 to 84.0,464
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,13 Months,86.9,80.3 to 91.4,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,13 Months,85.2,80.4 to 88.9,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,83.7,76.2 to 89.9,217
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,88.7,84.1 to 92.6,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,94.3,88.0 to 97.9,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,93.8,90.1 to 96.4,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,35 Months,97.3,92.2 to 99.4,248
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,93.9,90.3 to 96.3,248
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,93.5,91.3 to 95.2,280
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,90.8,84.9 to 94.5,227
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,13 Months,83.4,75.9 to 89.0,220
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,13 Months,87.3,82.8 to 90.7,457
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,13 Months,91.2,86.1 to 94.6,237
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,13 Months,88.2,83.8 to 91.6,464
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,82.6,76.0 to 88.2,229
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,79.7,74.6 to 84.4,449
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,76.7,68.7 to 83.9,220
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,77.7,72.6 to 82.5,457
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015,Age,35 Months,97.9,94.4 to 99.5,242
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,96.2,93.3 to 98.1,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014,Age,35 Months,92.3,85.8 to 96.6,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,95.0,91.1 to 97.6,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016,Age,35 Months,94.8,90.3 to 97.6,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,94.0,90.5 to 96.6,449
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,81.3,74.8 to 87.0,242
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,82.0,77.3 to 86.2,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018,Age,35 Months,93.5,86.1 to 97.7,237
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,91.7,87.0 to 95.2,464
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,91.6,88.3 to 94.9,373
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,94.7,91.9 to 97.5,379
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019,Age,35 Months,90.3,83.7 to 95.1,227
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014,Age,35 Months,86.4,79.0 to 92.2,229
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,87.1,82.4 to 91.1,471
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2015,Age,35 Months,87.7,81.5 to 92.7,242
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,85.1,80.7 to 89.0,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Private Insurance Only,95.0,92.2 to 97.7,379
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Any Medicaid,91.2,87.8 to 94.7,373
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,82.5 to 100.0,76
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,92.6,89.8 to 95.4,514
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.4,90.9 to 100.0,47
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2013,Age,35 Months,76.5,67.5 to 84.6,217
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,81.7,75.9 to 86.8,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,35 Months,94.6,90.6 to 97.3,237
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,35 Months,92.0,88.5 to 94.7,464
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,89.0,81.4 to 93.7,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,91.0,87.0 to 93.9,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,35 Months,89.3,83.4 to 93.9,227
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2018,Age,3 Months,89.0,83.7 to 92.7,237
Hib,≥1 Dose,States/Local Areas,TX-Bexar County,2018-2019,Age,3 Months,86.2,82.0 to 89.6,464
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,Hispanic,92.7,89.9 to 95.5,514
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2015,Age,0-2 Days,76.4,69.9 to 81.9,242
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2015-2016,Age,0-2 Days,76.3,71.5 to 80.5,471
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2014,Age,0-2 Days,69.2,61.0 to 76.4,229
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2014-2015,Age,0-2 Days,72.9,67.6 to 77.5,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014,Age,35 Months,94.0,87.3 to 97.9,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2015,Age,35 Months,96.0,92.0 to 98.3,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2012,Age,35 Months,97.7,93.8 to 99.4,248
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013,Age,35 Months,89.0,82.2 to 94.1,217
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,91.7,87.1 to 95.2,446
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,74.9,66.5 to 81.7,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,84.1,76.7 to 89.5,220
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,89.8,85.6 to 92.9,457
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,13 Months,79.5,67.0 to 88.1,217
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,13 Months,81.9,75.8 to 86.7,446
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,94.1,89.6 to 96.7,229
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,89.2,84.9 to 92.3,449
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2016,Age,0-2 Days,76.1,68.9 to 82.1,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,13 Months,86.5,80.7 to 90.8,242
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,13 Months,86.7,82.5 to 90.0,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,13 Months,84.2,76.2 to 89.9,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,13 Months,85.4,80.6 to 89.1,471
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,92.9,88.4 to 95.7,242
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,93.5,90.5 to 95.6,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,24 Months,94.2,90.3 to 97.0,237
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,91.8,88.3 to 94.6,464
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Insurance Coverage,Other,92.4,79.3 to 100.0,44
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.6,91.4 to 100.0,47
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017,Age,35 Months,92.4,86.5 to 96.4,220
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017-2018,Age,35 Months,92.8,88.6 to 95.9,457
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015,Age,35 Months,98.3,94.9 to 99.6,242
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2015-2016,Age,35 Months,96.6,93.6 to 98.4,471
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,80.1,74.2 to 85.5,280
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2016-2017,Age,0-2 Days,72.5,67.1 to 77.4,449
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013,Age,35 Months,88.5,81.2 to 93.9,217
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013-2014,Age,35 Months,90.4,85.7 to 94.1,446
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016,Age,35 Months,95.5,90.7 to 98.2,229
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2016-2017,Age,35 Months,93.9,90.4 to 96.5,449
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2012,Age,35 Months,96.2,91.6 to 98.7,248
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2011,Age,35 Months,93.1,88.0 to 96.5,280
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018,Age,24 Months,89.3,83.8 to 93.6,237
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,88.3,83.9 to 91.9,464
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2019,Age,24 Months,87.3,80.2 to 92.8,227
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,73.5,65.2 to 81.2,217
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,77.3,71.8 to 82.4,446
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,81.0,73.6 to 87.4,229
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,81.2,76.3 to 85.6,471
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,82.7,76.1 to 88.3,248
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,35 Months,89.8,84.3 to 94.0,280
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,24 Months,89.2,83.2 to 93.8,220
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,91.7,88.2 to 94.5,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,24 Months,89.3,83.4 to 93.9,227
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017,Age,24 Months,89.4,83.3 to 94.0,220
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,89.6,85.6 to 92.9,457
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2019,Age,24 Months,84.9,77.7 to 90.7,227
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013,Age,24 Months,84.5,77.0 to 90.6,217
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,87.9,83.1 to 91.9,446
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014,Age,24 Months,91.3,84.8 to 95.8,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.8,89.0 to 95.6,471
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015,Age,24 Months,94.2,89.9 to 97.1,242
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,93.5,90.6 to 95.8,471
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018,Age,24 Months,89.7,84.1 to 94.0,237
≥1 Dose Varicella,,States/Local Areas,TX-Bexar County,2018-2019,Age,24 Months,87.3,82.9 to 91.0,464
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016,Age,19 Months,78.5,70.8 to 84.6,229
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,19 Months,74.7,69.1 to 79.6,449
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2015,Age,19 Months,75.7,74.5 to 76.8,242
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,19 Months,77.1,71.9 to 81.6,471
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014,Age,19 Months,79.6,71.7 to 85.8,229
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,19 Months,77.7,72.5 to 82.1,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,7 Months,62.2,54.3 to 69.5,242
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,7 Months,63.9,58.2 to 69.2,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017,Age,7 Months,65.0,56.5 to 72.7,220
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,7 Months,68.9,63.3 to 74.0,457
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,24 Months,92.4,87.4 to 95.9,248
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,7 Months,65.6,57.4 to 72.9,229
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,7 Months,65.3,59.4 to 70.7,449
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013,Age,24 Months,83.1,75.7 to 89.3,217
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,24 Months,88.3,83.6 to 92.1,446
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,24 Months,87.5,82.2 to 91.9,280
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,19 Months,88.0,81.4 to 92.4,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2013,Age,7 Months,86.6,79.6 to 91.5,217
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2013-2014,Age,7 Months,88.9,83.8 to 92.6,446
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2012,Age,0-2 Days,67.1,61.6 to 72.1,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2013,Age,0-2 Days,72.9,65.2 to 79.4,217
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2013-2014,Age,0-2 Days,71.0,67.1 to 74.7,446
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2018,Age,0-1 Days,77.7,70.7 to 83.4,237
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2018-2019,Age,0-1 Days,77.9,73.1 to 82.1,464
Hep B,"≥1 Dose, 2 Day",States/Local Areas,TX-Bexar County,2011,Age,0-2 Days,71.8,66.8 to 76.2,280
Hep B,"≥1 Dose, 1 Day",States/Local Areas,TX-Bexar County,2019,Age,0-1 Days,78.2,71.1 to 84.0,227
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2012,Age,7 Months,90.8,86.1 to 94.1,248
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2014,Age,7 Months,91.2,84.0 to 95.3,229
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,7 Months,92.0,88.1 to 94.7,471
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018,Age,7 Months,72.9,65.6 to 79.1,237
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,7 Months,69.8,64.2 to 74.8,464
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2011,Age,13 Months,85.8,82.2 to 88.7,280
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2019,Age,7 Months,66.6,58.1 to 74.2,227
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014,Age,24 Months,93.5,87.4 to 97.3,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2014-2015,Age,24 Months,92.9,89.3 to 95.6,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015,Age,24 Months,92.3,87.8 to 95.6,242
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2015-2016,Age,24 Months,92.4,89.4 to 94.8,471
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016,Age,24 Months,92.5,88.1 to 95.8,229
Hep B,≥3 Doses,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,90.8,87.2 to 93.8,449
PCV,≥3 Doses,States/Local Areas,TX-Bexar County,2012,Age,13 Months,86.3,82.7 to 89.3,248
Hep B,≥2 Doses,States/Local Areas,TX-Bexar County,2011,Age,7 Months,89.7,85.0 to 93.1,280
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016,Age,24 Months,92.9,88.5 to 96.1,229
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2016-2017,Age,24 Months,92.2,88.7 to 94.9,449
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017,Age,24 Months,91.5,85.6 to 95.6,220
≥1 Dose MMR,,States/Local Areas,TX-Bexar County,2017-2018,Age,24 Months,90.4,86.6 to 93.6,457
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2017,Age,19 Months,70.8,62.4 to 78.0,220
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2017-2018,Age,19 Months,72.8,67.3 to 77.6,457
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2018,Age,19 Months,74.7,67.6 to 80.8,237
PCV,≥4 Doses,States/Local Areas,TX-Bexar County,2018-2019,Age,19 Months,75.7,69.2 to 81.1,374
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,19 Months,95.0,91.4 to 97.1,563
Influenza,,States/Local Areas,Massachusetts,2015,Age,24 Months,75.6,67.9 to 82.6,292
Influenza,,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,78.6,73.5 to 83.4,559
Influenza,,States/Local Areas,Massachusetts,2014,Age,24 Months,73.0,65.6 to 79.9,291
Influenza,,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,74.3,69.0 to 79.3,583
Influenza,,States/Local Areas,Massachusetts,2011,Age,24 Months,76.0,67.8 to 83.4,237
Influenza,,States/Local Areas,Massachusetts,2012,Age,24 Months,75.6,68.4 to 82.3,260
Influenza,,States/Local Areas,Massachusetts,2016,Age,24 Months,81.6,74.7 to 87.6,267
Influenza,,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,83.0,78.4 to 87.1,597
Influenza,,States/Local Areas,Massachusetts,2013,Age,24 Months,76.5,69.5 to 82.9,303
Influenza,,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,74.8,69.7 to 79.5,594
Influenza,,States/Local Areas,Massachusetts,2018,Age,24 Months,79.6,72.3 to 86.0,365
Influenza,,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,82.8,77.8 to 87.3,660
Influenza,,States/Local Areas,Massachusetts,2017,Age,24 Months,84.4,78.3 to 89.6,330
Influenza,,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,82.0,77.3 to 86.3,695
Influenza,,States/Local Areas,Massachusetts,2019,Age,24 Months,86.0,78.8 to 91.8,295
Influenza,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,78.5,74.2 to 82.9,780
Influenza,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.8,62.2 to 83.4,152
Influenza,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,81.0,73.3 to 88.8,157
Influenza,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.7,51.9 to 85.5,53
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,88.5,83.6 to 92.4,443
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,99.5,96.4 to 100.0,443
Polio,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,97.1,94.8 to 98.6,443
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2021,Age,0-3 Days,86.1,74.8 to 92.9,175
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,5 Months,90.4,86.0 to 93.6,443
Hib,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,97.8,92.3 to 99.4,175
Polio,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,99.1,97.6 to 99.7,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,96.8,94.2 to 98.2,443
Rotavirus,,States/Local Areas,Massachusetts,2020-2021,Age,8 Months,89.4,85.1 to 92.6,443
Combined 7 Series,,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,83.1,77.0 to 88.4,443
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,87.3,81.9 to 91.3,443
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,93.1,88.9 to 95.9,443
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,80.0,74.3 to 84.8,443
PCV,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,3 Months,92.7,88.3 to 95.5,443
Hib,Primary Series,States/Local Areas,Massachusetts,2021,Age,35 Months,97.8,93.4 to 99.5,175
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,82.5,76.9 to 87.0,443
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,49.5,43.2 to 56.2,443
Polio,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,5 Months,91.1,86.9 to 94.0,443
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,96.1,92.9 to 97.9,443
Influenza,,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,81.5,76.8 to 86.2,606
Influenza,,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,71.4,63.7 to 79.1,264
Influenza,,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,79.0,71.1 to 86.9,164
Influenza,,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,78.0,74.3 to 81.7,1034
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,93.1,90.6 to 95.6,895
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,92.7,88.3 to 97.1,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.5 to 99.4,895
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,24 Months,97.8,93.4 to 99.5,175
Hib,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,97.8,93.4 to 99.5,175
PCV,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,3 Months,93.8,86.1 to 97.3,175
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,94.4,92.1 to 96.7,895
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.7,85.1 to 96.3,206
Hib,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,95.2,91.8 to 97.2,443
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,96.8,94.5 to 98.3,443
Polio,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,98.5,95.2 to 99.7,443
Rotavirus,,States/Local Areas,Massachusetts,2021,Age,8 Months,94.0,88.6 to 96.9,175
Hib,Primary Series,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,81.4,75.8 to 86.0,443
Hib,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,95.6,90.5 to 98.0,175
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,96.1,92.7 to 98.2,443
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,95.7,92.4 to 97.9,443
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,5 Months,95.7,92.9 to 97.4,443
PCV,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,5 Months,87.7,82.6 to 91.4,443
Hib,Primary Series,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,94.7,91.3 to 96.8,443
Hib,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,3 Months,92.2,88.0 to 95.1,443
Combined 7 Series,,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,92.0,87.5 to 95.3,443
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,94.9,91.0 to 97.5,443
Polio,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,97.1,94.5 to 98.5,443
Polio,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,96.3,93.4 to 97.9,443
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,96.5,93.8 to 98.0,443
PCV,≥4 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,94.9,90.7 to 97.6,443
Influenza,,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,72.4,65.7 to 78.8,443
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2020-2021,Age,0-1 Days,82.2,75.9 to 87.1,443
Hib,Full Series,States/Local Areas,Massachusetts,2021,Age,35 Months,96.5,89.8 to 99.3,175
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,97.6,93.9 to 99.3,443
Hib,Primary Series,States/Local Areas,Massachusetts,2021,Age,13 Months,96.7,92.0 to 98.7,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,99.0,97.4 to 99.7,175
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,95.2,91.3 to 97.4,443
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,97.8,93.4 to 99.5,175
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2021,Age,35 Months,96.1,89.4 to 99.1,175
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,73.4,67.6 to 78.4,443
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,99.4,98.1 to 99.8,175
Hib,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,96.1,93.2 to 98.0,443
PCV,≥4 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,87.7,81.6 to 92.0,443
Hib,Full Series,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,85.0,79.7 to 89.1,443
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,99.6,96.8 to 100.0,443
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,24 Months,96.2,93.2 to 98.1,443
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2021,Age,35 Months,97.7,92.7 to 99.6,175
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,87.9,83.7 to 92.0,606
Hib,Full Series,States/Local Areas,Massachusetts,2014,Age,19 Months,85.0,77.9 to 90.1,291
Hib,Full Series,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,85.7,81.2 to 89.2,583
Hib,Full Series,States/Local Areas,Massachusetts,2016,Age,19 Months,87.9,80.9 to 92.6,267
Hib,Full Series,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,85.1,80.3 to 88.9,597
Hib,Full Series,States/Local Areas,Massachusetts,2017,Age,19 Months,82.3,75.4 to 87.6,330
Hib,Full Series,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,82.3,77.5 to 86.2,695
Hib,Full Series,States/Local Areas,Massachusetts,2019,Age,19 Months,79.2,71.2 to 85.4,295
Hib,Full Series,States/Local Areas,Massachusetts,2015,Age,19 Months,86.4,80.6 to 90.6,292
Hib,Full Series,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,87.2,82.7 to 90.6,559
Hib,Full Series,States/Local Areas,Massachusetts,2018,Age,19 Months,82.3,75.2 to 87.7,365
Hib,Full Series,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,96.5,93.6 to 98.1,660
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.5,48.3 to 82.7,53
Combined 7 Series,,States/Local Areas,Massachusetts,2018,Age,35 Months,86.9,80.4 to 92.0,365
Combined 7 Series,,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,89.8,84.6 to 93.8,660
Combined 7 Series,,States/Local Areas,Massachusetts,2019,Age,35 Months,90.8,83.1 to 95.9,295
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,72.3,64.2 to 80.4,219
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,84.3,80.6 to 88.0,780
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,78.2,69.8 to 86.7,157
Hib,Full Series,States/Local Areas,Massachusetts,2014,Age,24 Months,89.6,83.5 to 94.2,291
Hib,Full Series,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,91.4,87.8 to 94.3,583
Hib,Full Series,States/Local Areas,Massachusetts,2013,Age,24 Months,84.9,78.1 to 90.5,303
Hib,Full Series,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,87.3,82.9 to 91.1,594
Hib,Full Series,States/Local Areas,Massachusetts,2011,Age,24 Months,86.5,78.5 to 92.6,237
Hib,Full Series,States/Local Areas,Massachusetts,2012,Age,24 Months,86.1,79.3 to 91.5,260
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,79.3,75.6 to 83.0,1034
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,73.2,64.6 to 81.8,164
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,74.8,65.7 to 83.9,212
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.6,76.5 to 84.6,807
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.1,77.8 to 86.4,672
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.5,70.0 to 88.9,152
Hib,Full Series,States/Local Areas,Massachusetts,2013,Age,19 Months,76.6,74.0 to 79.0,303
Hib,Full Series,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,80.8,77.3 to 83.9,594
Hib,Full Series,States/Local Areas,Massachusetts,2012,Age,19 Months,80.4,72.4 to 86.6,260
Hib,Full Series,States/Local Areas,Massachusetts,2011,Age,19 Months,82.8,76.2 to 87.9,237
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,86.9,82.9 to 90.9,606
Combined 7 Series,,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,72.3,64.3 to 80.3,264
Combined 7 Series,,States/Local Areas,Massachusetts,2015,Age,35 Months,88.4,82.6 to 93.0,292
Combined 7 Series,,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,86.5,81.9 to 90.4,559
Rotavirus,,States/Local Areas,Massachusetts,2015,Age,8 Months,81.8,74.0 to 87.7,292
Rotavirus,,States/Local Areas,Massachusetts,2015-2016,Age,8 Months,83.6,78.4 to 87.7,559
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,80.3,71.7 to 88.8,212
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.4,77.3 to 87.4,672
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.4,65.9 to 87.0,152
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,80.2,72.0 to 88.5,157
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.7,55.9 to 87.5,53
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,73.4,65.4 to 81.4,219
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,85.3,81.5 to 89.2,780
Rotavirus,,States/Local Areas,Massachusetts,2017,Age,8 Months,82.4,74.1 to 88.4,330
Rotavirus,,States/Local Areas,Massachusetts,2017-2018,Age,8 Months,81.9,76.5 to 86.3,695
Rotavirus,,States/Local Areas,Massachusetts,2019,Age,8 Months,84.5,77.8 to 89.4,295
Rotavirus,,States/Local Areas,Massachusetts,2018,Age,8 Months,81.4,73.7 to 87.2,365
Rotavirus,,States/Local Areas,Massachusetts,2018-2019,Age,8 Months,82.9,78.0 to 86.9,660
Rotavirus,,States/Local Areas,Massachusetts,2013,Age,8 Months,83.4,76.7 to 88.4,303
Rotavirus,,States/Local Areas,Massachusetts,2013-2014,Age,8 Months,81.3,76.4 to 85.3,594
Rotavirus,,States/Local Areas,Massachusetts,2012,Age,8 Months,80.0,72.7 to 85.8,260
Rotavirus,,States/Local Areas,Massachusetts,2014,Age,8 Months,79.2,71.7 to 85.0,291
Rotavirus,,States/Local Areas,Massachusetts,2014-2015,Age,8 Months,80.5,75.3 to 84.8,583
Rotavirus,,States/Local Areas,Massachusetts,2011,Age,8 Months,83.3,74.8 to 89.4,237
Rotavirus,,States/Local Areas,Massachusetts,2016,Age,8 Months,85.3,78.0 to 90.5,267
Rotavirus,,States/Local Areas,Massachusetts,2016-2017,Age,8 Months,83.9,78.0 to 88.4,597
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,79.6,72.7 to 86.5,264
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,67.2,57.2 to 77.1,164
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,80.1,76.2 to 84.0,1034
Rotavirus,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.7,75.2 to 84.2,807
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,86.6,80.7 to 92.5,187
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,88.5 to 98.7,206
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,Hispanic,86.2,78.9 to 93.4,187
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,94.2,90.5 to 96.5,563
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,94.9,89.0 to 97.7,175
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,82.0,75.2 to 88.7,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2020-2021,Age,0-2 Days,85.1,78.8 to 89.7,443
Polio,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,97.1,94.5 to 98.5,443
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,73.7,67.3 to 79.2,443
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,13 Months,95.6,92.2 to 97.5,443
Influenza,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,79.1,72.3 to 85.9,219
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.5,92.6 to 100.0,206
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,79.6,73.1 to 84.8,443
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2019,Poverty,>400% FPL,98.0,96.2 to 99.8,735
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019-2020,Age,7 Months,67.6,61.9 to 72.8,563
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,93.8,83.7 to 98.6,443
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2021,Age,3 Months,99.4,98.1 to 99.8,175
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Any Medicaid,88.8,83.6 to 94.0,237
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2019,Insurance Coverage,Private Insurance Only,95.1,93.1 to 97.1,895
Hib,Primary Series,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,96.1,92.9 to 97.9,443
PCV,≥3 Doses,States/Local Areas,Massachusetts,2020-2021,Age,7 Months,79.0,73.1 to 83.9,443
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,33.5,27.7 to 39.8,443
Hib,Primary Series,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,96.1,93.2 to 98.0,443
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2020-2021,Age,0-3 Days,85.2,78.9 to 89.8,443
Hib,Full Series,States/Local Areas,Massachusetts,2020-2021,Age,35 Months,96.7,92.6 to 98.9,443
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,92.9,88.7 to 95.5,443
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,3 Months,98.0,96.4 to 99.0,443
DTaP,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,3 Months,94.4,90.8 to 96.6,443
≥1 Dose MMR,,States/Local Areas,Massachusetts,2021,Age,13 Months,74.8,65.0 to 82.5,175
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.6,72.3 to 98.9,206
Influenza,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,77.7,69.4 to 86.0,212
Influenza,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.6,75.2 to 84.0,672
Influenza,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.3,74.1 to 82.4,807
Hib,Full Series,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.9,76.0 to 91.9,206
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.8,55.9 to 93.7,44
Hib,≥2 Doses,States/Local Areas,Massachusetts,2020-2021,Age,5 Months,88.2,83.3 to 91.8,443
Influenza,,States/Local Areas,Massachusetts,2021,Age,24 Months,76.7,66.0 to 85.9,175
Hib,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,5 Months,89.3,81.6 to 94.1,175
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,5 Months,97.8,94.9 to 99.0,175
PCV,≥3 Doses,States/Local Areas,Massachusetts,2021,Age,13 Months,95.6,88.2 to 98.5,175
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2021,Age,13 Months,59.8,49.0 to 69.7,175
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,5 Months,91.2,84.3 to 95.3,175
≥1 Dose MMR,,States/Local Areas,Massachusetts,2021,Age,19 Months,94.6,86.8 to 97.9,175
Polio,≥2 Doses,States/Local Areas,Massachusetts,2021,Age,5 Months,92.5,86.3 to 96.0,175
Combined 7 Series,,HHS Regions/National,Region 8,2019,Age,35 Months,79.0,75.1 to 82.6,1623
Combined 7 Series,,HHS Regions/National,Region 8,2018,Age,35 Months,77.5,73.3 to 81.4,1790
Combined 7 Series,,HHS Regions/National,Region 8,2018-2019,Age,35 Months,78.2,75.3 to 80.9,3413
Combined 7 Series,,HHS Regions/National,Region 8,2015,Age,35 Months,76.7,72.1 to 81.0,1488
Combined 7 Series,,HHS Regions/National,Region 8,2015-2016,Age,35 Months,76.1,73.0 to 79.1,2978
Hib,≥2 Doses,HHS Regions/National,Region 8,2021,Age,5 Months,74.4,69.4 to 78.9,1062
Hib,Full Series,HHS Regions/National,Region 8,2017,Age,19 Months,78.2,74.0 to 81.9,1643
Hib,Full Series,HHS Regions/National,Region 8,2017-2018,Age,19 Months,77.5,74.6 to 80.1,3433
Hib,Full Series,HHS Regions/National,Region 8,2018,Age,19 Months,76.7,72.7 to 80.3,1790
Hib,Full Series,HHS Regions/National,Region 8,2018-2019,Age,19 Months,95.4,94.1 to 96.5,3413
Hib,Full Series,HHS Regions/National,Region 8,2014,Age,19 Months,75.3,71.5 to 78.7,1484
Hib,Full Series,HHS Regions/National,Region 8,2014-2015,Age,19 Months,75.3,72.6 to 77.7,2972
Hib,Full Series,HHS Regions/National,Region 8,2014,Age,24 Months,80.3,76.7 to 83.6,1484
Hib,Full Series,HHS Regions/National,Region 8,2014-2015,Age,24 Months,81.0,78.6 to 83.3,2972
Hib,Full Series,HHS Regions/National,Region 8,2013,Age,24 Months,79.5,76.0 to 82.8,1423
Hib,Full Series,HHS Regions/National,Region 8,2013-2014,Age,24 Months,79.9,77.4 to 82.2,2907
Hib,Full Series,HHS Regions/National,Region 8,2015,Age,19 Months,75.3,70.9 to 79.2,1488
Hib,Full Series,HHS Regions/National,Region 8,2015-2016,Age,19 Months,75.3,72.5 to 77.8,2978
Hib,Full Series,HHS Regions/National,Region 8,2016,Age,19 Months,75.3,71.2 to 78.9,1490
Hib,Full Series,HHS Regions/National,Region 8,2016-2017,Age,19 Months,76.7,73.9 to 79.4,3133
Hib,Full Series,HHS Regions/National,Region 8,2011,Age,24 Months,80.3,76.6 to 83.7,1500
Hib,Full Series,HHS Regions/National,Region 8,2012,Age,24 Months,80.4,76.9 to 83.7,1498
Hib,Full Series,HHS Regions/National,Region 8,2013,Age,19 Months,73.4,68.4 to 77.8,1423
Hib,Full Series,HHS Regions/National,Region 8,2013-2014,Age,19 Months,74.3,70.8 to 77.6,2907
Hib,Full Series,HHS Regions/National,Region 8,2012,Age,19 Months,73.2,69.3 to 76.7,1498
Hib,Full Series,HHS Regions/National,Region 8,2011,Age,19 Months,73.8,69.6 to 77.6,1500
PCV,≥3 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,87.7,83.5 to 91.0,1062
Hep A,≥1 Dose,HHS Regions/National,Region 8,2021,Age,35 Months,86.3,81.7 to 90.3,1062
Hib,≥3 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,55.0,49.9 to 60.0,1062
DTaP,≥4 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,69.0,63.9 to 73.8,1062
≥1 Dose Varicella,,HHS Regions/National,Region 8,2021,Age,19 Months,85.4,81.1 to 88.8,1062
Hib,Full Series,HHS Regions/National,Region 8,2021,Age,24 Months,76.0,71.2 to 80.6,1062
Hib,Primary Series,HHS Regions/National,Region 8,2020-2021,Age,13 Months,87.0,84.5 to 89.1,2759
Polio,≥1 Dose,HHS Regions/National,Region 8,2021,Age,3 Months,84.7,80.1 to 88.4,1062
Hib,Primary Series,HHS Regions/National,Region 8,2021,Age,24 Months,88.5,84.5 to 91.9,1062
Hib,≥3 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,87.3,83.3 to 90.8,1062
≥1 Dose MMR,,HHS Regions/National,Region 8,2021,Age,24 Months,86.4,82.1 to 90.1,1062
DTaP,≥1 Dose,HHS Regions/National,Region 8,2021,Age,3 Months,84.5,79.8 to 88.3,1062
DTaP,≥4 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,77.6,72.8 to 82.1,1062
Hep A,≥2 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,29.6,25.4 to 34.2,1062
Hep A,≥1 Dose,HHS Regions/National,Region 8,2021,Age,19 Months,81.3,76.5 to 85.2,1062
Polio,≥3 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,88.8,85.0 to 92.0,1062
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,91.5,89.1 to 93.5,2759
DTaP,≥3 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,88.0,83.8 to 91.2,1062
PCV,≥4 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,78.9,74.1 to 83.0,1062
Hep B,≥3 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,89.4,85.6 to 92.5,1062
PCV,≥4 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,80.3,75.7 to 84.6,1062
PCV,≥3 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,67.3,62.1 to 72.2,1062
DTaP,≥3 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,86.8,82.6 to 90.1,1062
Hep B,≥3 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,71.1,65.9 to 75.9,1062
Hep A,≥2 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,46.3,40.8 to 52.0,1062
Hep A,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,29.8,27.1 to 32.7,2759
PCV,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,5 Months,78.4,75.4 to 81.1,2759
PCV,≥4 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,79.7,75.1 to 83.9,1062
PCV,≥3 Doses,HHS Regions/National,Region 8,2021,Age,24 Months,89.1,85.1 to 92.3,1062
Hib,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,91.0,88.7 to 92.9,2759
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,91.9,89.7 to 93.8,2759
Hep A,≥1 Dose,HHS Regions/National,Region 8,2021,Age,24 Months,84.5,80.0 to 88.5,1062
≥1 Dose Varicella,,HHS Regions/National,Region 8,2021,Age,24 Months,86.0,81.9 to 89.6,1062
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2021,Age,0-1 Days,79.5,75.0 to 83.3,1062
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2021,Age,0-2 Days,80.9,76.5 to 84.7,1062
DTaP,≥3 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,71.0,65.9 to 75.6,1062
PCV,≥2 Doses,HHS Regions/National,Region 8,2021,Age,5 Months,76.2,71.2 to 80.6,1062
Hib,Primary Series,HHS Regions/National,Region 8,2021,Age,7 Months,73.0,68.0 to 77.5,1062
Hib,≥2 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,85.7,81.3 to 89.3,1062
Hep B,≥2 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,90.6,87.2 to 93.2,1062
Polio,≥2 Doses,HHS Regions/National,Region 8,2021,Age,7 Months,86.7,82.4 to 90.1,1062
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,19 Months,90.1,87.8 to 92.0,2759
Hep B,≥2 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,92.7,90.8 to 94.2,2759
Polio,≥3 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,89.5,85.7 to 92.7,1062
≥1 Dose MMR,,HHS Regions/National,Region 8,2020-2021,Age,24 Months,88.4,85.9 to 90.6,2759
Combined 7 Series,,HHS Regions/National,Region 8,2021,Age,35 Months,71.5,65.8 to 76.9,1062
Hep A,≥2 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,77.0,69.8 to 83.4,1062
Hib,≥1 Dose,HHS Regions/National,Region 8,2021,Age,3 Months,81.6,76.8 to 85.6,1062
DTaP,≥1 Dose,HHS Regions/National,Region 8,2012,Age,3 Months,87.1,83.2 to 90.1,1498
DTaP,≥1 Dose,HHS Regions/National,Region 8,2011,Age,3 Months,88.7,85.9 to 91.0,1500
DTaP,≥1 Dose,HHS Regions/National,Region 8,2013,Age,3 Months,86.5,84.1 to 88.5,1423
DTaP,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,3 Months,87.2,85.8 to 88.5,2907
DTaP,≥1 Dose,HHS Regions/National,Region 8,2014,Age,3 Months,88.0,85.0 to 90.5,1484
DTaP,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,3 Months,87.9,85.8 to 89.7,2972
DTaP,≥1 Dose,HHS Regions/National,Region 8,2015,Age,3 Months,87.8,84.7 to 90.3,1488
DTaP,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,3 Months,88.5,86.4 to 90.3,2978
DTaP,≥1 Dose,HHS Regions/National,Region 8,2016,Age,3 Months,89.3,86.2 to 91.8,1490
DTaP,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,3 Months,90.0,87.8 to 91.8,3133
≥1 Dose MMR,,HHS Regions/National,Region 8,2021,Age,35 Months,87.7,83.4 to 91.4,1062
DTaP,≥4 Doses,HHS Regions/National,Region 8,2020-2021,Age,35 Months,86.1,83.0 to 88.9,2759
PCV,≥4 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,80.3,77.5 to 82.9,2759
Hib,Full Series,HHS Regions/National,Region 8,2021,Age,19 Months,71.1,66.1 to 75.7,1062
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,13 Months,87.3,84.8 to 89.5,2759
Hep B,≥3 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,89.3,85.3 to 92.3,1062
Hib,Primary Series,HHS Regions/National,Region 8,2021,Age,19 Months,87.7,83.5 to 91.0,1062
DTaP,≥1 Dose,HHS Regions/National,Region 8,2018,Age,3 Months,91.9,89.3 to 93.8,1790
DTaP,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,3 Months,91.7,89.9 to 93.2,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,91.9,89.4 to 94.1,1488
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,92.7,91.1 to 94.1,2978
DTaP,≥1 Dose,HHS Regions/National,Region 8,2017,Age,3 Months,90.6,87.4 to 93.1,1643
DTaP,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,3 Months,91.2,89.2 to 92.9,3433
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,94.3,92.2 to 95.9,1484
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,93.1,91.5 to 94.5,2972
DTaP,≥1 Dose,HHS Regions/National,Region 8,2019,Age,3 Months,91.4,88.7 to 93.6,1623
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,93.5,91.3 to 95.2,1490
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,94.0,92.4 to 95.3,3133
Hep A,≥1 Dose,HHS Regions/National,Region 8,2011,Age,19 Months,75.1,66.6 to 81.9,1500
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,69.9,66.2 to 73.4,1697
PCV,≥3 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,72.0,68.4 to 75.4,1697
PCV,≥3 Doses,HHS Regions/National,Region 8,2021,Age,35 Months,89.5,85.5 to 92.8,1062
Hib,≥3 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,89.0,86.7 to 91.1,2759
Hep A,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,35 Months,89.9,87.0 to 92.3,2759
Hib,≥3 Doses,HHS Regions/National,Region 8,2021,Age,19 Months,85.5,81.2 to 88.9,1062
Rotavirus,,HHS Regions/National,Region 8,2019-2020,Age,8 Months,78.8,76.4 to 81.0,3320
Hib,≥1 Dose,HHS Regions/National,Region 8,2020,Age,3 Months,88.1,85.4 to 90.3,1697
Polio,≥1 Dose,HHS Regions/National,Region 8,2020,Age,3 Months,88.2,85.5 to 90.5,1697
≥1 Dose MMR,,HHS Regions/National,Region 8,2020-2021,Age,13 Months,67.0,63.8 to 70.1,2759
Hib,≥2 Doses,HHS Regions/National,Region 8,2020,Age,5 Months,80.6,77.4 to 83.4,1697
DTaP,≥1 Dose,HHS Regions/National,Region 8,2020,Age,3 Months,89.4,86.8 to 91.5,1697
Hep B,≥2 Doses,HHS Regions/National,Region 8,2020,Age,5 Months,87.8,85.0 to 90.1,1697
Polio,≥2 Doses,HHS Regions/National,Region 8,2020,Age,5 Months,80.5,77.2 to 83.4,1697
DTaP,≥2 Doses,HHS Regions/National,Region 8,2020,Age,5 Months,81.7,78.6 to 84.5,1697
Hep B,≥1 Dose,HHS Regions/National,Region 8,2020,Age,3 Months,93.8,91.5 to 95.5,1697
PCV,≥1 Dose,HHS Regions/National,Region 8,2020,Age,3 Months,87.2,84.4 to 89.5,1697
Hep A,≥2 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,46.9,43.1 to 50.9,1697
Hep A,≥1 Dose,HHS Regions/National,Region 8,2020,Age,24 Months,86.7,83.9 to 89.3,1697
PCV,≥3 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,91.6,89.3 to 93.6,1697
PCV,≥4 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,80.8,77.6 to 83.8,1697
Rotavirus,,HHS Regions/National,Region 8,2020,Age,8 Months,74.7,71.2 to 77.9,1697
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020,Age,24 Months,88.2,85.5 to 90.6,1697
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2020,Age,0-3 Days,80.9,77.6 to 83.8,1697
Influenza,,HHS Regions/National,Region 8,2020,Age,24 Months,65.9,62.2 to 69.5,1697
Combined 7 Series,,HHS Regions/National,Region 8,2020,Age,24 Months,67.8,64.2 to 71.4,1697
Hib,≥3 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,88.9,86.4 to 91.1,1697
≥1 Dose MMR,,HHS Regions/National,Region 8,2020,Age,19 Months,87.9,85.1 to 90.2,1697
Polio,≥3 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,91.3,88.9 to 93.2,1697
DTaP,≥4 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,70.7,67.1 to 74.0,1697
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,92.3,90.1 to 94.0,1697
PCV,≥3 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,87.5,84.7 to 89.8,1697
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,74.0,70.5 to 77.3,1697
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020,Age,13 Months,59.0,55.2 to 62.7,1697
Hep B,≥2 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,93.0,90.9 to 94.7,1697
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,88.4,85.7 to 90.6,1697
Hib,≥3 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,74.9,71.7 to 77.9,1697
Hib,Primary Series,HHS Regions/National,Region 8,2020,Age,13 Months,89.1,86.7 to 91.2,1697
Hib,≥2 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,93.1,91.0 to 94.8,1697
PCV,≥3 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,92.8,90.5 to 94.7,1697
Polio,≥3 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,93.1,91.0 to 94.9,1697
PCV,≥3 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,90.6,88.1 to 92.6,1697
PCV,≥4 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,78.0,74.6 to 81.0,1697
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,94.2,92.3 to 95.8,1697
DTaP,≥4 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,87.2,83.9 to 90.1,1697
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020,Age,19 Months,85.9,83.0 to 88.4,1697
Hib,Full Series,HHS Regions/National,Region 8,2020,Age,19 Months,74.2,70.8 to 77.4,1697
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,89.4,86.7 to 91.5,1697
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020,Age,35 Months,91.7,89.1 to 93.9,1697
Hib,Primary Series,HHS Regions/National,Region 8,2020,Age,19 Months,92.6,90.4 to 94.3,1697
Hib,Full Series,HHS Regions/National,Region 8,2020,Age,35 Months,83.5,80.1 to 86.5,1697
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,91.9,89.4 to 94.0,1697
Hib,≥3 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,91.9,89.4 to 94.0,1697
Hib,Primary Series,HHS Regions/National,Region 8,2020,Age,35 Months,93.6,91.5 to 95.3,1697
Hib,≥3 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,90.7,88.4 to 92.8,1697
≥1 Dose MMR,,HHS Regions/National,Region 8,2020,Age,35 Months,92.6,90.0 to 94.8,1697
Polio,≥3 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,92.5,90.3 to 94.3,1697
≥1 Dose MMR,,HHS Regions/National,Region 8,2020,Age,24 Months,90.2,87.7 to 92.4,1697
DTaP,≥4 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,79.3,76.1 to 82.3,1697
DTaP,≥3 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,93.6,91.7 to 95.2,1697
PCV,≥2 Doses,HHS Regions/National,Region 8,2020,Age,5 Months,80.6,77.5 to 83.5,1697
Hep B,≥2 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,91.1,88.7 to 93.0,1697
Hib,Primary Series,HHS Regions/National,Region 8,2020,Age,7 Months,76.7,73.4 to 79.7,1697
Hib,≥3 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,57.0,53.3 to 60.6,1697
Hib,≥2 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,89.2,86.6 to 91.3,1697
Polio,≥2 Doses,HHS Regions/National,Region 8,2020,Age,7 Months,89.5,86.9 to 91.7,1697
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2020,Age,0-2 Days,80.5,77.2 to 83.4,1697
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2020,Age,0-1 Days,78.6,75.2 to 81.7,1697
Hep A,≥1 Dose,HHS Regions/National,Region 8,2020,Age,19 Months,83.9,80.8 to 86.5,1697
Hep A,≥2 Doses,HHS Regions/National,Region 8,2020,Age,19 Months,30.0,26.7 to 33.5,1697
≥1 Dose MMR,,HHS Regions/National,Region 8,2020,Age,13 Months,69.2,65.6 to 72.6,1697
Hep A,≥2 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,78.7,74.2 to 82.9,1697
Combined 7 Series,,HHS Regions/National,Region 8,2020,Age,35 Months,74.4,70.5 to 78.2,1697
Hep A,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,24 Months,87.8,85.8 to 89.6,3320
Hep A,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,79.1,75.8 to 82.3,3320
Hep A,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,35 Months,91.5,89.6 to 93.3,3320
Hep A,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,45.9,43.0 to 48.9,3320
Influenza,,HHS Regions/National,Region 8,2019-2020,Age,24 Months,70.3,67.7 to 72.9,3320
Hib,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,90.8,89.1 to 92.2,3320
Hib,Primary Series,HHS Regions/National,Region 8,2019-2020,Age,24 Months,94.1,92.8 to 95.3,3320
Hib,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,91.8,90.2 to 93.2,3320
Hib,Full Series,HHS Regions/National,Region 8,2019-2020,Age,19 Months,75.4,72.9 to 77.7,3320
Combined 7 Series,,HHS Regions/National,Region 8,2019-2020,Age,35 Months,76.7,74.0 to 79.4,3320
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019-2020,Age,19 Months,88.1,86.2 to 89.8,3320
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,91.7,90.1 to 93.1,3320
PCV,≥4 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,81.0,78.7 to 83.1,3320
PCV,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,92.0,90.4 to 93.4,3320
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2019-2020,Age,0-2 Days,81.5,79.1 to 83.7,3320
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2019-2020,Age,0-1 Days,79.9,77.5 to 82.2,3320
Hep A,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,19 Months,85.3,83.2 to 87.2,3320
PCV,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,75.7,73.2 to 78.1,3320
Hib,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,59.1,56.4 to 61.9,3320
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,92.6,91.1 to 93.9,3320
Hib,Full Series,HHS Regions/National,Region 8,2019-2020,Age,24 Months,79.8,77.5 to 82.1,3320
PCV,≥4 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,83.6,81.4 to 85.6,3320
PCV,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,93.0,91.5 to 94.3,3320
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019-2020,Age,24 Months,90.3,88.5 to 91.9,3320
Hep A,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,30.4,27.8 to 33.1,3320
≥1 Dose MMR,,HHS Regions/National,Region 8,2019-2020,Age,19 Months,89.8,87.9 to 91.3,3320
Polio,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,92.9,91.4 to 94.1,3320
Hib,Primary Series,HHS Regions/National,Region 8,2019-2020,Age,19 Months,93.4,92.0 to 94.6,3320
Hib,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,90.3,88.5 to 91.7,3320
≥1 Dose MMR,,HHS Regions/National,Region 8,2019-2020,Age,35 Months,93.9,92.2 to 95.3,3320
Hib,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,93.0,91.4 to 94.5,3320
Hib,Primary Series,HHS Regions/National,Region 8,2019-2020,Age,35 Months,94.6,93.3 to 95.7,3320
Hib,Full Series,HHS Regions/National,Region 8,2019-2020,Age,35 Months,84.3,81.9 to 86.5,3320
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,93.7,92.2 to 95.0,3320
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019-2020,Age,35 Months,93.3,91.6 to 94.7,3320
PCV,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,94.1,92.6 to 95.3,3320
PCV,≥4 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,85.5,83.3 to 87.5,3320
DTaP,≥4 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,81.0,78.7 to 83.1,3320
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,94.6,93.4 to 95.7,3320
Polio,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,24 Months,93.9,92.5 to 95.1,3320
≥1 Dose MMR,,HHS Regions/National,Region 8,2019-2020,Age,24 Months,91.9,90.3 to 93.4,3320
Hib,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,3 Months,88.2,86.3 to 90.0,3320
Hep B,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,3 Months,95.4,94.1 to 96.5,3320
PCV,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,3 Months,89.0,87.1 to 90.7,3320
Polio,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,5 Months,83.6,81.4 to 85.6,3320
DTaP,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,5 Months,84.4,82.3 to 86.3,3320
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,91.4,89.9 to 92.8,3320
Polio,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,94.2,92.8 to 95.3,3320
Hib,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,94.0,92.6 to 95.2,3320
≥1 Dose MMR,,HHS Regions/National,Region 8,2019-2020,Age,13 Months,70.0,67.3 to 72.6,3320
Hib,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,76.3,73.9 to 78.5,3320
Hib,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,5 Months,82.3,80.0 to 84.3,3320
Hib,Primary Series,HHS Regions/National,Region 8,2019-2020,Age,13 Months,89.2,87.4 to 90.7,3320
Hep B,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,5 Months,89.9,88.1 to 91.5,3320
PCV,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,5 Months,83.5,81.4 to 85.5,3320
Polio,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,91.1,89.4 to 92.6,3320
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,76.9,74.4 to 79.2,3320
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,90.1,88.3 to 91.6,3320
Hep B,≥2 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,94.5,93.3 to 95.6,3320
PCV,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,13 Months,90.1,88.4 to 91.6,3320
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019-2020,Age,13 Months,61.4,58.6 to 64.2,3320
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,95.4,94.2 to 96.4,3320
Combined 7 Series,,HHS Regions/National,Region 8,2019-2020,Age,24 Months,70.4,67.8 to 73.0,3320
DTaP,≥4 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,88.4,86.1 to 90.4,3320
Polio,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,35 Months,94.8,93.4 to 95.9,3320
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,93.5,92.1 to 94.7,3320
DTaP,≥4 Doses,HHS Regions/National,Region 8,2019-2020,Age,19 Months,73.2,70.7 to 75.6,3320
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019-2020,Age,7 Months,71.4,68.7 to 74.0,3320
DTaP,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,3 Months,90.3,88.5 to 91.9,3320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2019-2020,Age,0-3 Days,82.0,79.6 to 84.1,3320
Polio,≥1 Dose,HHS Regions/National,Region 8,2019-2020,Age,3 Months,89.6,87.7 to 91.2,3320
PCV,≥3 Doses,HHS Regions/National,Region 8,2021,Age,13 Months,86.2,82.0 to 89.6,1062
≥1 Dose Varicella,,HHS Regions/National,Region 8,2020-2021,Age,35 Months,90.2,87.7 to 92.5,2759
DTaP,≥1 Dose,HHS Regions/National,Region 8,2020-2021,Age,3 Months,86.9,84.2 to 89.2,2759
DTaP,≥4 Doses,HHS Regions/National,Region 8,2020-2021,Age,24 Months,78.5,75.6 to 81.2,2759
Hep B,≥2 Doses,HHS Regions/National,Region 8,2021,Age,5 Months,86.5,82.3 to 89.8,1062
Polio,≥3 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,90.1,85.5 to 93.3,1269
Polio,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,92.4,89.8 to 94.3,2758
Polio,≥3 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,91.0,85.7 to 94.5,1120
Polio,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,90.6,87.3 to 93.1,2389
Hib,≥3 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,83.1,79.0 to 86.5,1489
Hib,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,82.0,79.2 to 84.6,2847
Polio,≥3 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,90.4,83.5 to 94.6,1034
Polio,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,90.7,87.1 to 93.4,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,89.1,84.8 to 92.2,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,92.1,87.9 to 94.9,1139
Polio,≥3 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,84.4,78.1 to 89.1,1048
Polio,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,87.4,83.3 to 90.6,2082
Hib,≥3 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,79.1,73.5 to 83.7,1269
Hib,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,81.1,77.7 to 84.0,2758
Hib,≥3 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,76.4,68.6 to 82.7,1120
Hib,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,77.7,73.0 to 81.8,2389
Hib,≥3 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,79.2,72.6 to 84.6,1034
Hib,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,77.8,72.8 to 82.1,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,85.5,80.9 to 89.1,1139
Polio,≥3 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,90.0,86.8 to 92.5,1078
Polio,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,87.2,82.2 to 90.9,2126
Polio,≥3 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,92.6,88.8 to 95.2,1139
Hib,≥3 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,57.9,52.8 to 62.8,1358
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,92.9,90.0 to 95.0,1489
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,92.3,90.1 to 94.0,2847
DTaP,≥3 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,93.3,89.8 to 95.7,1139
DTaP,≥3 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,89.9,85.3 to 93.2,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,91.7,88.2 to 94.2,1358
Hib,≥2 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,93.1,89.2 to 95.6,1269
Hib,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,94.1,91.7 to 95.8,2758
Hib,≥2 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,95.1,92.0 to 97.1,1489
Hib,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,95.5,93.7 to 96.7,2847
Hib,≥2 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,95.8,93.8 to 97.2,1358
Hib,≥2 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,91.8,88.4 to 94.3,1101
Hib,≥2 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,95.4,93.5 to 96.8,1139
Hib,≥2 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,91.6,88.5 to 94.0,1358
DTaP,≥3 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,90.5,87.4 to 92.9,1139
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,86.1,80.0 to 90.5,1048
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,87.4,83.4 to 90.6,2082
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,90.4,86.9 to 93.0,1078
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,88.2,83.7 to 91.6,2126
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,88.8,83.0 to 92.8,1034
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,87.6,83.2 to 91.1,2154
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,89.4,84.9 to 92.7,1269
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,91.1,88.5 to 93.2,2758
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,86.4,79.0 to 91.5,1120
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,87.9,83.7 to 91.1,2389
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,74.2,69.3 to 78.6,1489
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,72.6,69.1 to 75.8,2847
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,63.2,56.7 to 69.2,1269
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,68.6,64.4 to 72.4,2758
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,71.0,66.0 to 75.5,1358
DTaP,≥3 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,86.9,82.3 to 90.5,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,83.9,79.5 to 87.5,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,80.0,74.0 to 85.0,1048
Hib,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,79.6,75.3 to 83.4,2082
Polio,≥3 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,88.3,84.3 to 91.3,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,82.7,78.7 to 86.1,1078
Hib,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,81.4,76.9 to 85.1,2126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2014,Age,0-3 Days,62.3,54.6 to 69.3,1048
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2014-2015,Age,0-3 Days,63.7,57.9 to 69.0,2082
Polio,≥1 Dose,HHS Regions/National,Region 9,2013,Age,3 Months,85.7,83.6 to 87.5,1078
Polio,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,3 Months,84.0,81.3 to 86.4,2126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2013,Age,0-3 Days,70.5,64.1 to 76.1,1078
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2013-2014,Age,0-3 Days,66.4,61.3 to 71.0,2126
Polio,≥1 Dose,HHS Regions/National,Region 9,2011,Age,3 Months,86.9,82.7 to 90.3,1101
Polio,≥1 Dose,HHS Regions/National,Region 9,2012,Age,3 Months,85.0,80.0 to 89.0,1139
PCV,≥1 Dose,HHS Regions/National,Region 9,2019,Age,3 Months,90.3,87.1 to 92.8,1358
PCV,≥1 Dose,HHS Regions/National,Region 9,2018,Age,3 Months,88.5,84.8 to 91.4,1489
PCV,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,3 Months,89.4,87.0 to 91.4,2847
PCV,≥3 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,93.6,88.1 to 97.1,1139
PCV,≥1 Dose,HHS Regions/National,Region 9,2012,Age,3 Months,81.9,79.3 to 84.3,1139
DTaP,≥3 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,70.7,64.8 to 76.0,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,65.7,59.5 to 71.5,1139
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,69.5,66.8 to 72.0,1078
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,65.4,62.1 to 68.5,2126
PCV,≥3 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,94.7,91.4 to 97.0,1078
PCV,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,91.9,88.7 to 94.5,2126
PCV,≥3 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,91.0,85.6 to 95.0,1101
PCV,≥3 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,92.8,89.8 to 95.3,1358
Hib,≥2 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,88.2,82.2 to 92.3,1034
Hib,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,87.9,83.3 to 91.4,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,95.8,93.8 to 97.3,1489
PCV,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,94.3,92.5 to 95.8,2847
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2016,Age,0-3 Days,72.8,65.0 to 79.5,1120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2016-2017,Age,0-3 Days,74.8,69.9 to 79.0,2389
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2017,Age,0-3 Days,77.2,67.0 to 85.0,677
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2017-2018,Age,0-3 Days,75.7,71.9 to 79.1,2758
Polio,≥1 Dose,HHS Regions/National,Region 9,2016,Age,3 Months,84.6,77.9 to 89.6,1120
Polio,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,3 Months,83.7,79.5 to 87.2,2389
Polio,≥1 Dose,HHS Regions/National,Region 9,2015,Age,3 Months,85.1,78.2 to 90.1,1034
Polio,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,3 Months,84.9,80.3 to 88.6,2154
Polio,≥1 Dose,HHS Regions/National,Region 9,2014,Age,3 Months,82.4,76.5 to 87.0,1048
Polio,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,3 Months,83.7,79.4 to 87.3,2082
Hib,≥3 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,59.8,54.7 to 64.6,1078
Hib,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,57.3,54.3 to 60.3,2126
Hib,≥3 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,66.2,60.0 to 71.9,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,58.7,52.8 to 64.4,1139
PCV,≥3 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,91.7,86.6 to 95.5,1120
PCV,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,91.3,88.1 to 93.9,2389
PCV,≥3 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,95.4,90.5 to 98.2,1034
PCV,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,93.7,89.4 to 96.7,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,89.6,84.3 to 93.8,1048
PCV,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,91.6,87.9 to 94.6,2082
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,70.0,61.8 to 77.1,1120
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,66.7,61.5 to 71.4,2389
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2015,Age,0-3 Days,65.1,56.5 to 72.8,1034
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2015-2016,Age,0-3 Days,69.0,63.2 to 74.2,2154
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,61.3,54.1 to 68.0,1048
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,61.1,55.6 to 66.3,2082
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,60.9,52.5 to 68.8,1034
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,65.5,59.6 to 70.9,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,91.0,86.7 to 94.3,1269
PCV,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,93.5,91.2 to 95.5,2758
Hib,≥2 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,94.3,92.8 to 95.5,1078
Hib,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,93.3,92.4 to 94.2,2126
Hib,≥3 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,54.8,47.8 to 61.7,1048
Hib,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,51.1,45.7 to 56.5,2082
PCV,≥3 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,96.3,94.3 to 97.8,1489
PCV,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,94.7,92.9 to 96.2,2847
Hib,≥3 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,58.1,50.0 to 65.7,1120
Hib,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,55.8,50.7 to 60.9,2389
Hib,≥3 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,47.3,39.3 to 55.4,1034
Hib,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,52.7,46.9 to 58.4,2154
Polio,≥1 Dose,HHS Regions/National,Region 9,2017,Age,3 Months,82.8,77.2 to 87.3,1269
Polio,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,3 Months,86.4,83.1 to 89.1,2758
Polio,≥1 Dose,HHS Regions/National,Region 9,2018,Age,3 Months,90.1,86.6 to 92.8,1489
Polio,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,3 Months,90.8,88.6 to 92.6,2847
Hib,≥2 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,91.4,88.0 to 94.0,1489
Hib,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,91.5,89.3 to 93.3,2847
Hib,≥2 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,88.0,82.9 to 91.7,1269
Hib,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,89.7,86.7 to 92.1,2758
Hib,≥2 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,87.7,80.0 to 92.7,1120
Hib,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,87.8,83.5 to 91.2,2389
Hib,≥2 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,92.4,88.0 to 95.2,1048
Hib,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,93.4,90.3 to 95.5,2082
Hib,≥2 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,92.3,86.7 to 95.6,1120
Hib,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,92.7,89.5 to 95.0,2389
Hib,≥2 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,94.4,89.5 to 97.1,1034
Hib,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,93.3,89.9 to 95.7,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,53.5,47.1 to 59.7,1269
Hib,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,57.6,53.5 to 61.7,2758
Hib,≥3 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,61.9,56.7 to 66.9,1489
Hib,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,59.9,56.3 to 63.5,2847
PCV,≥3 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,93.0,89.9 to 95.5,1358
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2018,Age,0-3 Days,74.6,69.4 to 79.2,1489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2018-2019,Age,0-3 Days,77.9,74.6 to 80.9,2847
Polio,≥1 Dose,HHS Regions/National,Region 9,2019,Age,3 Months,91.5,88.6 to 93.8,1358
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2019,Age,0-3 Days,81.3,77.1 to 84.9,1358
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,91.3,86.0 to 95.2,1120
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,92.0,88.6 to 94.7,2389
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,91.8,86.0 to 95.8,1034
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,91.5,87.6 to 94.5,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,92.1,90.0 to 93.8,1078
PCV,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,89.4,86.2 to 91.9,2126
PCV,≥3 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,87.3,83.9 to 90.0,1101
PCV,≥3 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,89.5,85.9 to 92.3,1358
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,92.4,88.1 to 95.6,1269
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,93.1,90.5 to 95.2,2758
PCV,≥3 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,90.6,88.2 to 92.6,1139
PCV,≥4 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,87.7,81.6 to 92.6,1139
PCV,≥4 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,80.8,74.4 to 86.4,1101
PCV,≥4 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,82.0,77.5 to 86.0,1358
PCV,≥4 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,86.6,82.9 to 89.7,1489
PCV,≥4 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,84.3,81.5 to 86.9,2847
PCV,≥3 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,84.9,77.3 to 90.2,1120
PCV,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,85.3,80.8 to 88.8,2389
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,93.3,89.7 to 96.0,1078
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,90.6,87.4 to 93.4,2126
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,88.3,82.8 to 92.7,1048
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,89.9,86.1 to 93.1,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,94.9,91.8 to 97.1,1139
Hep B,≥2 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,94.5,91.4 to 96.5,1139
Hep B,≥2 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,93.4,89.5 to 96.0,1101
Hep B,≥2 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,94.8,92.5 to 96.3,1358
PCV,≥3 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,85.7,80.5 to 89.6,1269
PCV,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,89.0,86.1 to 91.4,2758
PCV,≥3 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,92.5,89.5 to 94.6,1489
PCV,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,91.0,88.8 to 92.8,2847
PCV,≥4 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,77.3,69.9 to 84.0,1120
PCV,≥4 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,76.9,72.2 to 81.3,2389
PCV,≥4 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,76.4,70.5 to 81.8,1269
PCV,≥4 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,81.3,77.9 to 84.6,2758
≥1 Dose MMR,,HHS Regions/National,Region 9,2015,Age,35 Months,94.2,90.7 to 96.7,1034
≥1 Dose MMR,,HHS Regions/National,Region 9,2015-2016,Age,35 Months,93.3,90.4 to 95.6,2154
≥1 Dose MMR,,HHS Regions/National,Region 9,2014,Age,35 Months,92.3,87.0 to 95.9,1048
≥1 Dose MMR,,HHS Regions/National,Region 9,2014-2015,Age,35 Months,93.1,89.7 to 95.7,2082
≥1 Dose MMR,,HHS Regions/National,Region 9,2016,Age,35 Months,92.3,87.5 to 95.8,1120
≥1 Dose MMR,,HHS Regions/National,Region 9,2016-2017,Age,35 Months,90.3,86.8 to 93.1,2389
PCV,≥4 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,80.7,74.1 to 86.6,1034
PCV,≥4 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,78.9,74.0 to 83.5,2154
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018,Age,35 Months,91.6,88.1 to 94.4,1489
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018-2019,Age,35 Months,92.3,89.8 to 94.3,2847
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019,Age,35 Months,93.1,89.3 to 95.9,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2019,Age,35 Months,93.0,89.3 to 95.8,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2017,Age,35 Months,88.7,83.7 to 92.8,1269
≥1 Dose MMR,,HHS Regions/National,Region 9,2017-2018,Age,35 Months,91.6,88.7 to 94.0,2758
≥1 Dose MMR,,HHS Regions/National,Region 9,2018,Age,35 Months,94.8,91.9 to 96.9,1489
≥1 Dose MMR,,HHS Regions/National,Region 9,2018-2019,Age,35 Months,93.9,91.6 to 95.7,2847
Hep B,≥2 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,93.1,88.9 to 95.8,1269
Hep B,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,94.1,91.7 to 95.9,2758
Hib,≥1 Dose,HHS Regions/National,Region 9,2017,Age,3 Months,83.6,78.0 to 87.9,1269
Hib,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,3 Months,86.1,82.8 to 88.8,2758
Hib,≥1 Dose,HHS Regions/National,Region 9,2016,Age,3 Months,84.3,77.6 to 89.3,1120
Hib,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,3 Months,83.9,79.7 to 87.4,2389
Hib,≥1 Dose,HHS Regions/National,Region 9,2015,Age,3 Months,86.3,79.7 to 91.0,1034
Hib,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,3 Months,85.3,80.8 to 88.9,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,89.7,84.0 to 93.5,1120
PCV,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,89.5,85.9 to 92.2,2389
PCV,≥3 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,89.0,85.1 to 92.0,1034
PCV,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,89.4,85.4 to 92.4,2154
Hep B,≥2 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,94.6,89.4 to 97.3,1120
Hep B,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,93.9,90.8 to 95.9,2389
Hep B,≥2 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,95.2,92.3 to 97.1,1489
Hep B,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,96.0,94.4 to 97.1,2847
PCV,≥4 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,81.2,74.7 to 87.0,1048
PCV,≥4 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,81.9,77.3 to 86.1,2082
PCV,≥4 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,83.0,76.4 to 88.7,1034
PCV,≥4 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,83.2,77.9 to 87.8,2154
Hep B,≥2 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,95.0,91.7 to 97.0,1078
Hep B,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,92.5,88.8 to 95.1,2126
Hep B,≥2 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,92.9,87.1 to 96.2,1034
Hep B,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,93.7,90.2 to 96.1,2154
Hep B,≥2 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,90.0,84.7 to 93.6,1048
Hep B,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,91.4,87.8 to 94.1,2082
Hib,≥1 Dose,HHS Regions/National,Region 9,2014,Age,3 Months,81.5,75.6 to 86.3,1048
Hib,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,3 Months,83.9,79.6 to 87.4,2082
Hib,≥1 Dose,HHS Regions/National,Region 9,2011,Age,3 Months,87.5,82.8 to 91.0,1101
Hib,≥1 Dose,HHS Regions/National,Region 9,2012,Age,3 Months,84.9,80.9 to 88.1,1139
Hib,≥1 Dose,HHS Regions/National,Region 9,2013,Age,3 Months,85.9,83.1 to 88.3,1078
Hib,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,3 Months,83.7,82.1 to 85.2,2126
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,93.7,90.5 to 96.2,1489
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,95.2,93.3 to 96.6,2847
PCV,≥3 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,86.7,80.4 to 91.1,1048
PCV,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,87.8,83.6 to 91.1,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,96.7,94.8 to 98.1,1358
PCV,≥4 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,86.2,80.6 to 90.8,1078
PCV,≥4 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,83.5,79.1 to 87.4,2126
Hib,≥1 Dose,HHS Regions/National,Region 9,2018,Age,3 Months,88.6,84.8 to 91.6,1489
Hib,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,3 Months,89.1,86.6 to 91.2,2847
Hib,≥1 Dose,HHS Regions/National,Region 9,2019,Age,3 Months,89.6,86.2 to 92.2,1358
PCV,≥3 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,92.5,88.8 to 95.3,1078
PCV,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,91.0,87.8 to 93.6,2126
PCV,≥3 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,92.5,87.7 to 96.0,1139
PCV,≥3 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,89.4,84.1 to 93.6,1048
PCV,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,90.1,86.4 to 93.1,2082
PCV,≥4 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,85.2,80.6 to 89.1,1358
Hib,≥2 Doses,HHS Regions/National,Region 9,2016,Age,5 Months,74.7,66.6 to 81.4,1120
Hib,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,5 Months,73.0,67.9 to 77.6,2389
Hib,≥2 Doses,HHS Regions/National,Region 9,2015,Age,5 Months,71.9,64.3 to 78.5,1034
Hib,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,5 Months,73.3,67.9 to 78.2,2154
PCV,≥1 Dose,HHS Regions/National,Region 9,2013,Age,3 Months,87.1,84.8 to 89.0,1078
PCV,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,3 Months,82.5,78.3 to 86.1,2126
PCV,≥4 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,89.4,85.6 to 92.5,1489
PCV,≥4 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,87.3,84.3 to 89.9,2847
PCV,≥4 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,83.1,75.0 to 89.7,1120
PCV,≥4 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,80.7,76.0 to 85.0,2389
PCV,≥4 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,79.1,73.2 to 84.4,1269
PCV,≥4 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,83.9,80.4 to 87.1,2758
PCV,≥1 Dose,HHS Regions/National,Region 9,2011,Age,3 Months,85.6,80.4 to 89.6,1101
PCV,≥3 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,89.2,84.4 to 92.7,1269
PCV,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,92.3,89.7 to 94.3,2758
Hib,≥2 Doses,HHS Regions/National,Region 9,2014,Age,5 Months,72.3,65.4 to 78.3,1048
Hib,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,5 Months,72.1,69.3 to 74.8,2082
Hib,≥2 Doses,HHS Regions/National,Region 9,2013,Age,5 Months,71.0,65.6 to 75.9,1078
Hib,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,5 Months,71.7,69.2 to 74.0,2126
Hib,≥2 Doses,HHS Regions/National,Region 9,2011,Age,5 Months,78.0,74.7 to 80.9,1101
Hib,≥2 Doses,HHS Regions/National,Region 9,2012,Age,5 Months,75.6,72.1 to 78.9,1139
PCV,≥3 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,95.5,93.3 to 97.0,1489
PCV,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,91.0,88.8 to 92.8,2847
PCV,≥3 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,88.3,82.9 to 92.6,1101
PCV,≥3 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,92.4,89.1 to 94.7,1358
Hib,≥2 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,86.7,80.7 to 91.0,1048
Hib,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,87.4,83.4 to 90.6,2082
Hib,≥2 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,88.4,84.6 to 91.3,1078
Hib,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,87.6,85.2 to 89.6,2126
PCV,≥4 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,78.9,72.7 to 84.5,1101
Hep B,≥2 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,96.7,95.2 to 97.8,1358
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2012,Age,0-3 Days,69.8,63.4 to 75.6,1139
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2011,Age,0-3 Days,71.9,65.3 to 77.7,1101
Hib,≥2 Doses,HHS Regions/National,Region 9,2018,Age,5 Months,79.2,74.3 to 83.3,1489
Hib,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,5 Months,79.6,76.3 to 82.5,2847
Hib,≥2 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,88.1,85.8 to 90.0,1101
Hib,≥2 Doses,HHS Regions/National,Region 9,2019,Age,5 Months,80.0,75.5 to 83.8,1358
PCV,≥3 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,90.7,85.3 to 94.7,1034
PCV,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,90.9,87.4 to 93.7,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,88.2,83.6 to 92.0,1229
Hib,≥2 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,91.6,89.4 to 93.3,1139
PCV,≥3 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,91.0,86.2 to 94.7,1120
PCV,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,90.8,87.6 to 93.4,2389
PCV,≥3 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,90.5,86.3 to 93.9,1269
PCV,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,93.1,90.8 to 95.0,2758
PCV,≥1 Dose,HHS Regions/National,Region 9,2017,Age,3 Months,82.4,76.8 to 86.9,1269
PCV,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,3 Months,85.4,82.1 to 88.2,2758
PCV,≥1 Dose,HHS Regions/National,Region 9,2016,Age,3 Months,83.8,77.1 to 88.9,1120
PCV,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,3 Months,83.1,78.9 to 86.6,2389
Hib,≥2 Doses,HHS Regions/National,Region 9,2017,Age,5 Months,71.3,64.8 to 77.0,1269
Hib,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,5 Months,75.2,71.1 to 78.8,2758
PCV,≥1 Dose,HHS Regions/National,Region 9,2015,Age,3 Months,86.1,79.9 to 90.7,1034
PCV,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,3 Months,85.0,80.6 to 88.5,2154
PCV,≥1 Dose,HHS Regions/National,Region 9,2014,Age,3 Months,78.0,71.5 to 83.4,1048
PCV,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,3 Months,82.0,77.6 to 85.7,2082
≥1 Dose Varicella,,HHS Regions/National,Region 9,2011,Age,35 Months,91.0,85.3 to 95.2,1101
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017,Age,35 Months,90.9,86.3 to 94.5,1269
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017-2018,Age,35 Months,91.4,88.6 to 93.8,2758
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2017,Age,0-2 Days,75.4,69.7 to 80.4,1269
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2017-2018,Age,0-2 Days,74.3,70.5 to 77.8,2758
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2018,Age,0-2 Days,73.2,68.0 to 77.8,1489
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2018-2019,Age,0-2 Days,76.6,73.2 to 79.7,2847
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2019,Age,0-2 Days,80.1,75.7 to 83.8,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,92.2,88.7 to 94.7,1489
Hep B,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,93.5,91.5 to 95.0,2847
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014,Age,35 Months,94.7,87.1 to 98.5,1048
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014-2015,Age,35 Months,95.3,89.6 to 98.4,2082
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015,Age,35 Months,94.2,90.6 to 96.7,1034
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015-2016,Age,35 Months,94.3,91.3 to 96.5,2154
≥1 Dose Varicella,,HHS Regions/National,Region 9,2012,Age,35 Months,96.5,94.0 to 98.1,1139
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013,Age,35 Months,93.6,89.3 to 96.6,1078
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013-2014,Age,35 Months,94.6,89.2 to 97.8,2126
PCV,≥4 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,78.7,74.1 to 82.6,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,89.9,85.1 to 93.3,1269
Hep B,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,91.1,88.2 to 93.3,2758
PCV,≥3 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,87.8,84.4 to 90.5,1078
PCV,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,85.4,80.6 to 89.2,2126
Hep B,≥2 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,89.1,82.8 to 93.3,1120
Hep B,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,89.5,85.7 to 92.4,2389
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2016,Age,0-2 Days,72.2,64.3 to 78.8,1120
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2016-2017,Age,0-2 Days,73.8,68.9 to 78.1,2389
PCV,≥3 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,86.3,80.0 to 90.8,1034
PCV,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,85.6,80.9 to 89.3,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,83.1,76.7 to 88.1,1048
PCV,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,84.7,80.3 to 88.2,2082
Hep B,≥2 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,88.2,81.6 to 92.6,1034
Hep B,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,88.7,84.3 to 91.9,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,92.0,88.7 to 94.6,1489
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,93.1,91.1 to 94.7,2847
≥1 Dose MMR,,HHS Regions/National,Region 9,2013,Age,35 Months,94.8,90.7 to 97.5,1078
≥1 Dose MMR,,HHS Regions/National,Region 9,2013-2014,Age,35 Months,93.3,89.8 to 95.9,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016,Age,35 Months,93.8,89.3 to 96.9,1120
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016-2017,Age,35 Months,92.2,89.0 to 94.7,2389
≥1 Dose MMR,,HHS Regions/National,Region 9,2012,Age,35 Months,95.5,92.7 to 97.5,1139
≥1 Dose MMR,,HHS Regions/National,Region 9,2011,Age,35 Months,91.2,85.4 to 95.3,1101
≥1 Dose MMR,,HHS Regions/National,Region 9,2018,Age,24 Months,93.7,90.8 to 96.0,1489
≥1 Dose MMR,,HHS Regions/National,Region 9,2018-2019,Age,24 Months,92.2,90.0 to 94.1,2847
≥1 Dose MMR,,HHS Regions/National,Region 9,2019,Age,24 Months,90.8,87.2 to 93.6,1358
PCV,≥4 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,82.0,76.2 to 87.0,1078
PCV,≥4 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,79.8,75.6 to 83.7,2126
PCV,≥4 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,78.0,71.7 to 83.6,1048
PCV,≥4 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,79.0,74.6 to 83.2,2082
PCV,≥4 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,85.2,79.8 to 89.9,1139
Hep B,≥3 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,90.1,84.7 to 94.2,1101
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,90.4,86.3 to 93.7,1269
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,91.2,88.6 to 93.4,2758
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,94.2,92.1 to 95.9,1358
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017,Age,24 Months,88.0,83.2 to 91.9,1269
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017-2018,Age,24 Months,89.4,86.5 to 91.9,2758
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019,Age,24 Months,89.7,85.9 to 92.9,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2013,Age,24 Months,90.0,85.2 to 93.8,1078
≥1 Dose MMR,,HHS Regions/National,Region 9,2013-2014,Age,24 Months,89.2,85.9 to 92.1,2126
≥1 Dose MMR,,HHS Regions/National,Region 9,2014,Age,24 Months,88.6,83.6 to 92.6,1048
≥1 Dose MMR,,HHS Regions/National,Region 9,2014-2015,Age,24 Months,90.0,86.9 to 92.7,2082
≥1 Dose MMR,,HHS Regions/National,Region 9,2015,Age,24 Months,91.8,87.8 to 94.9,1034
≥1 Dose MMR,,HHS Regions/National,Region 9,2015-2016,Age,24 Months,91.4,88.3 to 94.0,2154
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018,Age,24 Months,90.9,87.5 to 93.8,1489
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018-2019,Age,24 Months,90.3,87.8 to 92.5,2847
PCV,≥4 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,73.5,65.5 to 80.2,1120
PCV,≥4 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,72.3,67.3 to 76.8,2389
PCV,≥4 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,73.9,69.3 to 78.0,1034
PCV,≥4 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,73.7,68.4 to 78.4,2154
PCV,≥4 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,72.3,65.4 to 78.3,1048
PCV,≥4 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,73.1,68.1 to 77.6,2082
PCV,≥3 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,53.7,45.4 to 61.8,1034
PCV,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,59.1,53.3 to 64.8,2154
PCV,≥3 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,58.2,51.8 to 64.4,1269
PCV,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,64.0,59.8 to 68.0,2758
Hep B,≥3 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,92.6,89.4 to 95.1,1139
PCV,≥3 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,64.6,56.3 to 72.1,1120
PCV,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,61.5,56.3 to 66.5,2389
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,90.8,86.9 to 94.0,1078
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,88.8,85.5 to 91.7,2126
Hep B,≥3 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,88.7,83.7 to 92.7,1101
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,92.9,90.6 to 94.7,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,89.6,86.9 to 91.8,1078
Hep B,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,87.6,84.6 to 90.0,2126
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2012,Age,0-2 Days,68.2,58.6 to 76.5,1139
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2013,Age,0-2 Days,68.2,62.5 to 73.4,1078
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2013-2014,Age,0-2 Days,64.8,58.3 to 70.9,2126
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2018,Age,0-1 Days,68.8,63.4 to 73.7,1489
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2018-2019,Age,0-1 Days,73.1,69.6 to 76.3,2847
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2011,Age,0-2 Days,70.6,66.3 to 74.5,1101
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2019,Age,0-1 Days,77.4,73.0 to 81.4,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,92.3,89.4 to 94.4,1139
Hep B,≥2 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,85.5,79.5 to 90.0,1048
Hep B,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,86.8,82.6 to 90.2,2082
PCV,≥3 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,70.0,64.9 to 74.6,1489
PCV,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,68.9,65.4 to 72.3,2847
PCV,≥3 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,83.3,80.0 to 86.1,1101
PCV,≥3 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,67.9,62.8 to 72.6,1358
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,86.7,81.4 to 91.2,1048
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,87.5,83.6 to 90.9,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,88.2,82.4 to 92.8,1034
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,89.5,85.7 to 92.6,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,90.7,85.4 to 94.6,1120
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,90.6,87.3 to 93.3,2389
PCV,≥3 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,88.3,83.9 to 91.6,1139
Hep B,≥2 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,88.6,85.2 to 91.2,1101
≥1 Dose MMR,,HHS Regions/National,Region 9,2016,Age,24 Months,90.9,85.9 to 94.6,1120
≥1 Dose MMR,,HHS Regions/National,Region 9,2016-2017,Age,24 Months,88.9,85.4 to 91.9,2389
≥1 Dose MMR,,HHS Regions/National,Region 9,2017,Age,24 Months,87.0,81.9 to 91.2,1269
≥1 Dose MMR,,HHS Regions/National,Region 9,2017-2018,Age,24 Months,90.3,87.4 to 92.8,2758
PCV,≥4 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,71.1,64.8 to 76.7,1269
PCV,≥4 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,76.2,72.4 to 79.7,2758
PCV,≥4 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,81.5,77.2 to 85.1,1489
PCV,≥4 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,79.8,76.1 to 82.9,2372
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2015,Age,0-2 Days,63.5,54.9 to 71.3,1034
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2015-2016,Age,0-2 Days,67.8,62.0 to 73.1,2154
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2014,Age,0-2 Days,61.4,53.8 to 68.5,1048
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2014-2015,Age,0-2 Days,62.4,56.7 to 67.8,2082
≥1 Dose Varicella,,HHS Regions/National,Region 9,2012,Age,24 Months,92.5,89.5 to 94.9,1139
≥1 Dose Varicella,,HHS Regions/National,Region 9,2011,Age,24 Months,88.3,83.0 to 92.6,1101
≥1 Dose MMR,,HHS Regions/National,Region 9,2016,Age,19 Months,85.9,79.3 to 90.6,1120
≥1 Dose MMR,,HHS Regions/National,Region 9,2016-2017,Age,19 Months,84.4,80.3 to 87.8,2389
≥1 Dose MMR,,HHS Regions/National,Region 9,2015,Age,19 Months,87.6,84.4 to 90.2,1034
≥1 Dose MMR,,HHS Regions/National,Region 9,2015-2016,Age,19 Months,86.7,82.6 to 90.0,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,86.7,83.3 to 89.5,1034
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,88.5,84.3 to 91.6,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,84.2,78.1 to 88.9,1048
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,85.5,81.1 to 89.0,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,90.3,88.4 to 91.9,1078
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,87.3,82.6 to 90.9,2126
Hep B,≥2 Doses,HHS Regions/National,Region 9,2013,Age,5 Months,83.8,80.5 to 86.7,1078
Hep B,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,5 Months,81.9,79.1 to 84.4,2126
Hep B,≥2 Doses,HHS Regions/National,Region 9,2011,Age,5 Months,82.8,79.5 to 85.6,1101
Hep B,≥2 Doses,HHS Regions/National,Region 9,2012,Age,5 Months,86.1,81.3 to 89.8,1139
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2011,Age,0-1 Days,63.9,57.7 to 69.6,1101
Hep B,≥1 Dose,HHS Regions/National,Region 9,2018,Age,3 Months,95.8,93.0 to 97.5,1489
Hep B,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,3 Months,96.1,94.4 to 97.2,2847
Polio,≥2 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,91.9,87.5 to 94.9,1048
Polio,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,92.5,89.2 to 94.9,2082
Hep B,≥1 Dose,HHS Regions/National,Region 9,2019,Age,3 Months,96.4,94.3 to 97.7,1358
DTaP,≥4 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,91.4,87.9 to 94.2,1489
DTaP,≥4 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,89.4,86.5 to 91.9,2847
≥1 Dose MMR,,HHS Regions/National,Region 9,2012,Age,19 Months,87.3,85.2 to 89.1,1139
≥1 Dose MMR,,HHS Regions/National,Region 9,2014,Age,19 Months,86.5,80.9 to 90.6,1048
≥1 Dose MMR,,HHS Regions/National,Region 9,2014-2015,Age,19 Months,87.0,83.3 to 90.1,2082
≥1 Dose MMR,,HHS Regions/National,Region 9,2013,Age,19 Months,86.4,82.3 to 89.7,1078
≥1 Dose MMR,,HHS Regions/National,Region 9,2013-2014,Age,19 Months,86.4,84.1 to 88.5,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017,Age,19 Months,83.2,77.7 to 87.5,1269
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017-2018,Age,19 Months,86.6,83.4 to 89.3,2758
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018,Age,19 Months,90.1,86.5 to 92.8,1489
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018-2019,Age,19 Months,62.2,58.6 to 65.7,2847
Hep B,≥1 Dose,HHS Regions/National,Region 9,2017,Age,3 Months,93.5,89.8 to 96.0,1269
Hep B,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,3 Months,94.6,92.4 to 96.2,2758
Polio,≥2 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,91.7,86.0 to 95.2,1120
Polio,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,92.4,89.2 to 94.8,2389
Polio,≥2 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,93.1,87.5 to 96.3,1034
Polio,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,92.4,88.7 to 95.0,2154
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016,Age,19 Months,85.0,78.4 to 89.8,1120
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016-2017,Age,19 Months,84.1,80.0 to 87.5,2389
≥1 Dose MMR,,HHS Regions/National,Region 9,2019,Age,13 Months,67.6,62.6 to 72.3,1358
PCV,≥3 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,61.8,57.1 to 66.3,1139
PCV,≥3 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,55.8,48.7 to 62.7,1048
PCV,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,54.8,49.3 to 60.1,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,90.2,84.5 to 94.0,1120
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,90.2,86.8 to 92.8,2389
PCV,≥3 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,61.0,58.3 to 63.7,1101
PCV,≥3 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,66.3,64.1 to 68.6,1078
PCV,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,61.1,56.8 to 65.2,2126
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2012,Age,0-1 Days,61.6,52.6 to 69.8,1139
Hep B,≥2 Doses,HHS Regions/National,Region 9,2014,Age,5 Months,80.0,73.5 to 85.2,1048
Hep B,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,5 Months,80.9,77.8 to 83.7,2082
Hep B,≥2 Doses,HHS Regions/National,Region 9,2016,Age,5 Months,84.6,76.6 to 90.2,1120
Hep B,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,5 Months,84.9,80.3 to 88.6,2389
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,90.2,85.8 to 93.3,1269
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,90.8,88.1 to 92.9,2758
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,91.4,87.8 to 94.0,1489
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,89.7,87.4 to 91.6,2847
DTaP,≥4 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,80.9,75.4 to 85.8,1269
DTaP,≥4 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,84.5,81.3 to 87.5,2758
DTaP,≥4 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,88.3,85.0 to 91.3,1489
DTaP,≥4 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,83.5,80.5 to 86.2,2847
Hep A,≥1 Dose,HHS Regions/National,Region 9,2020,Age,35 Months,90.7,85.5 to 94.6,1229
Hep B,≥3 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,91.6,88.6 to 93.9,1139
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,89.2,85.4 to 92.0,1489
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,89.7,87.4 to 91.6,2847
Hep B,≥3 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,87.6,83.4 to 90.8,1101
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,90.2,87.2 to 92.6,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2011,Age,19 Months,86.6,81.4 to 90.5,1101
DTaP,≥4 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,87.8,83.1 to 91.7,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2015,Age,5 Months,81.9,74.7 to 87.4,1034
Hep B,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,5 Months,83.2,78.1 to 87.3,2154
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2014,Age,0-1 Days,56.3,48.9 to 63.4,1048
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2014-2015,Age,0-1 Days,56.4,50.8 to 61.8,2082
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2013,Age,0-1 Days,59.5,53.5 to 65.1,1078
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2013-2014,Age,0-1 Days,57.9,51.6 to 63.9,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013,Age,24 Months,88.1,83.1 to 92.2,1078
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013-2014,Age,24 Months,87.3,83.8 to 90.4,2126
Polio,≥2 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,93.2,89.3 to 95.8,1269
Polio,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,94.4,92.2 to 96.1,2758
Polio,≥2 Doses,HHS Regions/National,Region 9,2018,Age,13 Months,95.7,93.1 to 97.3,1489
Polio,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,13 Months,96.1,94.7 to 97.1,2847
Polio,≥2 Doses,HHS Regions/National,Region 9,2019,Age,13 Months,96.5,95.0 to 97.6,1358
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019,Age,19 Months,87.6,83.6 to 90.7,1358
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016,Age,24 Months,90.4,85.4 to 94.3,1120
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016-2017,Age,24 Months,89.2,85.8 to 92.0,2389
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015,Age,24 Months,92.2,88.2 to 95.2,1034
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015-2016,Age,24 Months,91.4,88.2 to 94.0,2154
≥1 Dose MMR,,HHS Regions/National,Region 9,2012,Age,24 Months,91.8,88.5 to 94.5,1139
≥1 Dose MMR,,HHS Regions/National,Region 9,2011,Age,24 Months,88.9,83.6 to 93.1,1101
PCV,≥4 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,74.0,70.7 to 77.1,1101
PCV,≥4 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,78.4,72.2 to 83.6,1139
PCV,≥4 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,76.3,72.2 to 80.0,1078
PCV,≥4 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,74.3,70.9 to 77.5,2126
≥1 Dose MMR,,HHS Regions/National,Region 9,2018,Age,19 Months,92.2,88.9 to 94.5,1489
≥1 Dose MMR,,HHS Regions/National,Region 9,2018-2019,Age,19 Months,95.5,93.7 to 96.7,2847
≥1 Dose MMR,,HHS Regions/National,Region 9,2019,Age,19 Months,88.5,84.6 to 91.5,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2017,Age,19 Months,82.9,77.3 to 87.4,1269
≥1 Dose MMR,,HHS Regions/National,Region 9,2017-2018,Age,19 Months,87.5,84.2 to 90.1,2758
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2017,Age,0-1 Days,70.2,64.2 to 75.6,1269
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2017-2018,Age,0-1 Days,69.5,65.5 to 73.2,2758
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2016,Age,0-1 Days,67.2,59.4 to 74.2,1120
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2016-2017,Age,0-1 Days,68.7,63.8 to 73.2,2389
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014,Age,24 Months,86.7,81.4 to 91.2,1048
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014-2015,Age,24 Months,89.2,85.9 to 92.1,2082
PCV,≥4 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,81.3,75.6 to 86.5,1229
Hep B,≥2 Doses,HHS Regions/National,Region 9,2017,Age,5 Months,85.2,80.0 to 89.3,1269
Hep B,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,5 Months,87.3,84.1 to 89.8,2758
Hep B,≥2 Doses,HHS Regions/National,Region 9,2019,Age,5 Months,91.2,88.3 to 93.4,1358
Hep B,≥2 Doses,HHS Regions/National,Region 9,2018,Age,5 Months,89.3,85.6 to 92.2,1489
Hep B,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,5 Months,90.3,88.0 to 92.2,2847
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2015,Age,0-1 Days,56.5,48.1 to 64.5,1034
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2015-2016,Age,0-1 Days,61.8,56.1 to 67.3,2154
Hib,Full Series,HHS Regions/National,Region 9,2019,Age,35 Months,82.9,77.8 to 87.3,1358
Hib,Full Series,HHS Regions/National,Region 9,2018,Age,35 Months,84.5,80.1 to 88.3,1489
Hib,Full Series,HHS Regions/National,Region 9,2018-2019,Age,35 Months,83.5,80.3 to 86.5,2847
Hep A,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,35 Months,92.9,89.0 to 95.8,2154
Hep A,≥1 Dose,HHS Regions/National,Region 9,2016,Age,35 Months,91.4,85.1 to 95.8,1120
Hep A,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,35 Months,90.8,87.3 to 93.7,2389
DTaP,≥4 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,84.8,78.9 to 89.8,1034
DTaP,≥4 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,81.3,76.6 to 85.7,2154
DTaP,≥4 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,77.9,70.4 to 84.6,1120
DTaP,≥4 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,79.3,74.7 to 83.6,2389
DTaP,≥4 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,75.1,68.6 to 81.1,1048
DTaP,≥4 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,79.7,75.3 to 83.8,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,56.0,47.7 to 64.0,1034
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,56.6,50.8 to 62.3,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,54.6,47.7 to 61.3,1048
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,55.3,49.8 to 60.6,2082
Polio,≥2 Doses,HHS Regions/National,Region 9,2017,Age,5 Months,71.0,64.7 to 76.7,1269
Polio,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,5 Months,75.5,71.4 to 79.1,2758
Polio,≥2 Doses,HHS Regions/National,Region 9,2016,Age,5 Months,74.9,66.7 to 81.6,1120
Polio,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,5 Months,73.0,67.9 to 77.5,2389
Hep A,≥1 Dose,HHS Regions/National,Region 9,2017,Age,35 Months,90.7,86.3 to 94.1,1269
Hep A,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,35 Months,91.9,89.3 to 94.1,2758
Hep A,≥2 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,78.6,69.7 to 86.3,1078
Hep A,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,77.6,71.9 to 82.8,2126
Hep A,≥2 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,72.3,63.7 to 80.4,1139
Hep A,≥2 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,75.6,67.6 to 82.8,1101
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,57.3,49.1 to 65.0,1120
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,57.3,52.1 to 62.3,2389
Polio,≥2 Doses,HHS Regions/National,Region 9,2015,Age,5 Months,69.0,61.1 to 76.0,1034
Polio,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,5 Months,72.0,66.4 to 76.9,2154
Hep A,≥2 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,50.2,45.0 to 55.7,1358
Hep A,≥2 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,55.0,49.7 to 60.5,1489
Hep A,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,52.7,49.0 to 56.6,2847
Polio,≥2 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,87.4,85.0 to 89.6,1101
Polio,≥2 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,91.8,89.9 to 93.3,1139
Polio,≥2 Doses,HHS Regions/National,Region 9,2019,Age,5 Months,80.6,76.1 to 84.4,1358
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,57.3,50.9 to 63.4,1269
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,61.3,57.2 to 65.2,2758
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,65.4,60.3 to 70.1,1489
Hep B,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,63.8,60.2 to 67.3,2847
Hep A,≥2 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,81.0,70.1 to 89.9,1034
Hep A,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,77.8,70.8 to 84.2,2154
Hep A,≥2 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,74.1,65.4 to 82.1,1120
Hep A,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,77.8,72.5 to 82.7,2389
Hep A,≥2 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,77.5,69.9 to 84.4,1048
Hep A,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,79.1,72.7 to 84.8,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,62.2,57.1 to 67.0,1358
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014,Age,13 Months,58.4,51.2 to 65.3,1048
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014-2015,Age,13 Months,56.6,51.2 to 61.9,2082
≥1 Dose Varicella,,HHS Regions/National,Region 9,2012,Age,13 Months,55.2,52.3 to 58.1,1139
Hep A,≥1 Dose,HHS Regions/National,Region 9,2018,Age,35 Months,93.2,90.1 to 95.6,1489
Hep A,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,35 Months,93.0,90.7 to 94.9,2847
Hep A,≥1 Dose,HHS Regions/National,Region 9,2019,Age,35 Months,93.1,89.4 to 95.9,1358
Polio,≥2 Doses,HHS Regions/National,Region 9,2018,Age,5 Months,80.0,75.2 to 84.1,1489
Polio,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,5 Months,80.3,77.1 to 83.2,2847
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013,Age,13 Months,55.8,50.2 to 61.1,1078
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013-2014,Age,13 Months,57.1,54.6 to 59.5,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2011,Age,13 Months,59.6,50.2 to 68.3,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,93.7,90.6 to 96.0,1358
PCV,≥2 Doses,HHS Regions/National,Region 9,2018,Age,5 Months,78.9,74.1 to 83.0,1489
PCV,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,5 Months,79.5,76.3 to 82.4,2847
PCV,≥2 Doses,HHS Regions/National,Region 9,2017,Age,5 Months,70.4,64.0 to 76.1,1269
PCV,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,5 Months,74.6,70.5 to 78.2,2758
PCV,≥2 Doses,HHS Regions/National,Region 9,2019,Age,5 Months,80.1,75.6 to 84.0,1358
DTaP,≥4 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,68.4,62.2 to 74.1,1269
DTaP,≥4 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,73.3,69.4 to 76.8,2758
DTaP,≥4 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,64.7,56.3 to 72.3,1120
DTaP,≥4 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,66.5,61.3 to 71.4,2389
Hep A,≥2 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,44.8,38.0 to 52.2,1078
Hep A,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,49.2,44.1 to 54.5,2126
DTaP,≥4 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,78.3,73.7 to 82.2,1489
DTaP,≥4 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,96.1,94.7 to 97.1,2847
Polio,≥2 Doses,HHS Regions/National,Region 9,2014,Age,5 Months,72.6,65.7 to 78.5,1048
Polio,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,5 Months,70.8,68.5 to 73.1,2082
Polio,≥2 Doses,HHS Regions/National,Region 9,2013,Age,5 Months,71.1,67.6 to 74.3,1078
Polio,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,5 Months,71.8,69.2 to 74.3,2126
Hep A,≥1 Dose,HHS Regions/National,Region 9,2012,Age,35 Months,89.8,83.7 to 94.3,1139
Polio,≥2 Doses,HHS Regions/National,Region 9,2011,Age,5 Months,77.8,74.4 to 80.8,1101
Polio,≥2 Doses,HHS Regions/National,Region 9,2012,Age,5 Months,75.1,72.2 to 77.9,1139
Hep A,≥1 Dose,HHS Regions/National,Region 9,2015,Age,35 Months,94.4,90.2 to 97.2,1034
Hep B,≥3 Doses,HHS Regions/National,Region 9,2011,Age,7 Months,53.2,51.2 to 55.3,1101
Hep B,≥3 Doses,HHS Regions/National,Region 9,2012,Age,7 Months,60.9,55.0 to 66.5,1139
DTaP,≥4 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,82.6,77.3 to 87.4,1139
DTaP,≥4 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,79.8,73.8 to 85.2,1101
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,62.6,59.3 to 65.8,1078
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,58.6,54.1 to 63.0,2126
DTaP,≥4 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,70.0,65.0 to 74.6,1358
DTaP,≥4 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,81.2,75.2 to 86.5,1078
DTaP,≥4 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,78.0,73.6 to 82.1,2126
Hep A,≥2 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,52.1,44.1 to 60.7,1120
Hep A,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,52.6,47.4 to 58.0,2389
Hep A,≥2 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,52.9,46.5 to 59.5,1269
Hep A,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,53.9,49.7 to 58.3,2758
≥1 Dose MMR,,HHS Regions/National,Region 9,2015,Age,13 Months,59.3,51.1 to 67.0,1034
≥1 Dose MMR,,HHS Regions/National,Region 9,2015-2016,Age,13 Months,61.4,55.8 to 66.7,2154
≥1 Dose MMR,,HHS Regions/National,Region 9,2014,Age,13 Months,62.6,55.3 to 69.4,1048
≥1 Dose MMR,,HHS Regions/National,Region 9,2014-2015,Age,13 Months,61.0,55.5 to 66.2,2082
≥1 Dose Varicella,,HHS Regions/National,Region 9,2012,Age,19 Months,86.6,81.7 to 90.3,1139
≥1 Dose Varicella,,HHS Regions/National,Region 9,2011,Age,19 Months,86.6,80.4 to 91.1,1101
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019,Age,13 Months,63.1,58.1 to 67.9,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2013,Age,13 Months,56.6,53.8 to 59.3,1078
≥1 Dose MMR,,HHS Regions/National,Region 9,2013-2014,Age,13 Months,59.6,56.7 to 62.5,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018,Age,13 Months,61.3,56.0 to 66.3,1489
≥1 Dose Varicella,,HHS Regions/National,Region 9,2018-2019,Age,13 Months,62.2,58.6 to 65.7,2847
DTaP,≥4 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,88.5,79.1 to 95.0,1048
DTaP,≥4 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,90.5,84.4 to 94.9,2082
DTaP,≥4 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,92.1,87.4 to 95.6,1139
DTaP,≥4 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,88.9,83.2 to 93.4,1078
DTaP,≥4 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,89.3,82.7 to 94.2,2126
Hep B,≥3 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,90.3,86.9 to 92.9,1139
Hep A,≥2 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,79.0,73.0 to 84.4,1358
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014,Age,13 Months,81.8,75.4 to 86.8,1048
Hep B,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,13 Months,82.8,78.2 to 86.6,2082
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,87.3,84.1 to 89.9,1078
Hep B,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,84.5,79.7 to 88.4,2126
Hep A,≥2 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,79.9,73.6 to 85.5,1269
Hep A,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,79.7,75.3 to 83.7,2758
Hep A,≥2 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,79.6,73.3 to 85.2,1489
Hep A,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,79.1,74.8 to 83.1,2847
Hep B,≥3 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,83.4,78.9 to 87.2,1101
Polio,≥2 Doses,HHS Regions/National,Region 9,2015,Age,7 Months,88.4,82.4 to 92.5,1034
Polio,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,7 Months,87.6,83.0 to 91.1,2154
Polio,≥2 Doses,HHS Regions/National,Region 9,2013,Age,7 Months,87.3,84.2 to 89.9,1078
Polio,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,7 Months,86.8,84.3 to 88.9,2126
Polio,≥2 Doses,HHS Regions/National,Region 9,2014,Age,7 Months,86.2,80.2 to 90.6,1048
Polio,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,7 Months,87.3,83.3 to 90.5,2082
Hep A,≥1 Dose,HHS Regions/National,Region 9,2014,Age,35 Months,87.3,81.4 to 92.0,1048
Hep A,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,35 Months,90.1,86.3 to 93.3,2082
Hep A,≥1 Dose,HHS Regions/National,Region 9,2013,Age,35 Months,89.9,84.8 to 93.8,1078
Hep A,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,35 Months,88.2,84.4 to 91.5,2126
Hep A,≥2 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,42.3,35.8 to 49.5,1139
Hep A,≥2 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,53.5,46.3 to 61.0,1048
Hep A,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,53.1,47.5 to 58.9,2082
Hep A,≥2 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,52.8,44.5 to 61.5,1034
Hep A,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,52.5,46.7 to 58.6,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,94.3,92.2 to 95.9,2847
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015,Age,13 Months,54.8,46.6 to 62.7,1034
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015-2016,Age,13 Months,57.8,52.2 to 63.2,2154
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017,Age,13 Months,61.3,55.0 to 67.2,1269
≥1 Dose Varicella,,HHS Regions/National,Region 9,2017-2018,Age,13 Months,61.3,57.1 to 65.3,2758
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016,Age,13 Months,60.8,53.2 to 67.9,1120
≥1 Dose Varicella,,HHS Regions/National,Region 9,2016-2017,Age,13 Months,61.0,56.1 to 65.7,2389
≥1 Dose MMR,,HHS Regions/National,Region 9,2011,Age,13 Months,58.2,49.8 to 66.1,1101
≥1 Dose MMR,,HHS Regions/National,Region 9,2012,Age,13 Months,50.0,45.3 to 54.7,1139
≥1 Dose MMR,,HHS Regions/National,Region 9,2018,Age,13 Months,66.7,61.5 to 71.5,1489
≥1 Dose MMR,,HHS Regions/National,Region 9,2018-2019,Age,13 Months,67.2,63.6 to 70.6,2847
Hep B,≥1 Dose,HHS Regions/National,Region 9,2016,Age,3 Months,93.0,86.8 to 96.5,1120
Hep B,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,3 Months,93.3,89.9 to 95.6,2389
Hep B,≥1 Dose,HHS Regions/National,Region 9,2015,Age,3 Months,90.3,83.9 to 94.3,1034
Hep B,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,3 Months,91.7,87.5 to 94.5,2154
Hep B,≥1 Dose,HHS Regions/National,Region 9,2014,Age,3 Months,90.0,84.5 to 93.7,1048
Hep B,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,3 Months,90.1,86.2 to 93.0,2082
Polio,≥2 Doses,HHS Regions/National,Region 9,2013,Age,13 Months,94.7,92.3 to 96.4,1078
Polio,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,13 Months,93.3,91.3 to 94.9,2126
Polio,≥2 Doses,HHS Regions/National,Region 9,2019,Age,7 Months,91.6,88.5 to 94.0,1358
Polio,≥2 Doses,HHS Regions/National,Region 9,2017,Age,7 Months,87.0,81.7 to 90.9,1269
Polio,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,7 Months,89.4,86.4 to 91.8,2758
Polio,≥2 Doses,HHS Regions/National,Region 9,2016,Age,7 Months,86.9,79.2 to 92.0,1120
Polio,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,7 Months,86.9,82.5 to 90.4,2389
Hep B,≥1 Dose,HHS Regions/National,Region 9,2011,Age,3 Months,93.7,90.2 to 96.0,1101
Hep B,≥1 Dose,HHS Regions/National,Region 9,2012,Age,3 Months,92.3,86.3 to 95.8,1139
Hep B,≥1 Dose,HHS Regions/National,Region 9,2013,Age,3 Months,94.4,93.1 to 95.6,1078
Hep B,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,3 Months,92.2,89.0 to 94.5,2126
Polio,≥2 Doses,HHS Regions/National,Region 9,2018,Age,7 Months,91.9,88.7 to 94.3,1489
Polio,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,7 Months,91.8,89.6 to 93.5,2847
Hib,Full Series,HHS Regions/National,Region 9,2020,Age,24 Months,75.9,70.9 to 80.6,1229
DTaP,≥4 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,85.3,78.7 to 90.7,1101
DTaP,≥4 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,78.4,73.6 to 82.8,1358
Polio,≥2 Doses,HHS Regions/National,Region 9,2011,Age,13 Months,91.4,87.7 to 94.1,1101
Polio,≥2 Doses,HHS Regions/National,Region 9,2012,Age,13 Months,95.4,93.5 to 96.8,1139
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013,Age,19 Months,85.2,81.5 to 88.2,1078
≥1 Dose Varicella,,HHS Regions/National,Region 9,2013-2014,Age,19 Months,85.7,83.4 to 87.8,2126
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015,Age,19 Months,87.8,85.1 to 90.1,1034
≥1 Dose Varicella,,HHS Regions/National,Region 9,2015-2016,Age,19 Months,86.4,82.3 to 89.7,2154
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014,Age,19 Months,86.3,80.8 to 90.5,1048
≥1 Dose Varicella,,HHS Regions/National,Region 9,2014-2015,Age,19 Months,87.1,83.3 to 90.1,2082
≥1 Dose MMR,,HHS Regions/National,Region 9,2017,Age,13 Months,64.1,57.8 to 69.9,1269
≥1 Dose MMR,,HHS Regions/National,Region 9,2017-2018,Age,13 Months,65.4,61.2 to 69.3,2758
≥1 Dose MMR,,HHS Regions/National,Region 9,2016,Age,13 Months,63.5,55.9 to 70.5,1120
≥1 Dose MMR,,HHS Regions/National,Region 9,2016-2017,Age,13 Months,63.8,58.9 to 68.4,2389
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017,Age,13 Months,87.1,82.3 to 90.7,1269
Hep B,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,13 Months,88.1,85.2 to 90.5,2758
DTaP,≥4 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,92.2,86.0 to 96.3,1034
DTaP,≥4 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,90.2,85.3 to 93.9,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015,Age,13 Months,83.9,77.0 to 89.0,1034
Hep B,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,13 Months,85.4,80.9 to 88.9,2154
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016,Age,13 Months,86.8,80.6 to 91.2,1120
Hep B,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,13 Months,86.9,83.2 to 90.0,2389
DTaP,≥4 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,87.9,80.3 to 93.5,1120
DTaP,≥4 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,86.7,82.2 to 90.6,2389
DTaP,≥4 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,86.2,80.5 to 90.9,1269
DTaP,≥4 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,88.6,85.2 to 91.5,2758
Hib,Primary Series,HHS Regions/National,Region 9,2011,Age,7 Months,70.0,65.0 to 74.5,1101
Hib,Full Series,HHS Regions/National,Region 8,2019,Age,19 Months,76.6,72.9 to 79.9,1623
Polio,≥3 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,94.4,91.7 to 96.5,1358
Hib,Full Series,HHS Regions/National,Region 9,2016,Age,35 Months,82.7,74.2 to 89.6,1120
Hib,Full Series,HHS Regions/National,Region 9,2016-2017,Age,35 Months,80.3,75.4 to 84.9,2389
Polio,≥3 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,96.7,94.5 to 98.2,1489
Polio,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,95.6,93.9 to 97.0,2847
Hib,Full Series,HHS Regions/National,Region 9,2014,Age,35 Months,84.5,74.7 to 92.0,1048
Hib,Full Series,HHS Regions/National,Region 9,2014-2015,Age,35 Months,85.8,78.7 to 91.5,2082
Polio,≥3 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,96.0,93.6 to 97.6,1139
Hib,Full Series,HHS Regions/National,Region 9,2017,Age,35 Months,78.4,72.0 to 84.1,1269
Hib,Full Series,HHS Regions/National,Region 9,2017-2018,Age,35 Months,81.4,77.5 to 85.0,2758
Hib,Full Series,HHS Regions/National,Region 9,2015,Age,35 Months,85.3,78.8 to 90.6,1034
Hib,Full Series,HHS Regions/National,Region 9,2015-2016,Age,35 Months,84.1,78.9 to 88.7,2154
Hib,Full Series,HHS Regions/National,Region 9,2013,Age,35 Months,89.6,84.6 to 93.5,1078
Hib,Full Series,HHS Regions/National,Region 9,2013-2014,Age,35 Months,86.8,80.9 to 91.6,2126
Hib,Full Series,HHS Regions/National,Region 9,2012,Age,35 Months,84.4,77.9 to 89.9,1139
Hib,Full Series,HHS Regions/National,Region 9,2011,Age,35 Months,82.8,76.0 to 88.5,1101
Hib,Full Series,HHS Regions/National,Region 9,2018,Age,24 Months,83.0,78.7 to 86.8,1489
Hib,Full Series,HHS Regions/National,Region 9,2018-2019,Age,24 Months,80.3,77.1 to 83.2,2847
Hib,Full Series,HHS Regions/National,Region 9,2019,Age,24 Months,77.5,72.8 to 82.0,1358
Polio,≥3 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,93.6,89.9 to 96.3,1078
Polio,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,92.8,89.5 to 95.3,2126
Polio,≥3 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,91.8,86.4 to 95.7,1048
Polio,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,93.0,89.4 to 95.7,2082
DTaP,≥2 Doses,HHS Regions/National,Region 9,2011,Age,5 Months,78.8,75.3 to 82.0,1101
DTaP,≥2 Doses,HHS Regions/National,Region 9,2012,Age,5 Months,76.8,73.4 to 79.9,1139
DTaP,≥2 Doses,HHS Regions/National,Region 9,2013,Age,5 Months,73.4,69.6 to 76.8,1078
DTaP,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,5 Months,73.5,71.0 to 75.8,2126
DTaP,≥2 Doses,HHS Regions/National,Region 9,2015,Age,5 Months,74.8,67.4 to 81.0,1034
DTaP,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,5 Months,75.8,70.4 to 80.4,2154
Polio,≥3 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,95.4,88.5 to 98.7,1120
Polio,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,93.5,90.2 to 96.0,2389
Polio,≥3 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,92.4,88.3 to 95.4,1269
Polio,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,94.3,92.0 to 96.2,2758
Polio,≥3 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,93.1,88.9 to 96.1,1034
Polio,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,94.8,90.5 to 97.6,2154
DTaP,≥2 Doses,HHS Regions/National,Region 9,2014,Age,5 Months,73.6,66.7 to 79.5,1048
DTaP,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,5 Months,74.2,72.1 to 76.2,2082
Hib,Full Series,HHS Regions/National,Region 9,2016,Age,24 Months,78.1,70.8 to 84.7,1120
Hib,Full Series,HHS Regions/National,Region 9,2016-2017,Age,24 Months,76.4,71.7 to 80.9,2389
Hib,Full Series,HHS Regions/National,Region 9,2017,Age,24 Months,74.5,68.5 to 80.2,1269
Hib,Full Series,HHS Regions/National,Region 9,2017-2018,Age,24 Months,78.6,74.9 to 82.2,2758
Hib,≥3 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,90.2,85.0 to 94.1,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,93.8,91.0 to 95.9,1139
Hib,≥3 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,92.4,88.7 to 95.3,1078
Hib,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,91.2,88.1 to 93.8,2126
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,95.8,93.6 to 97.3,1489
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,92.3,90.1 to 94.0,2847
Polio,≥3 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,93.1,87.4 to 96.8,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,94.7,91.9 to 96.7,1139
Polio,≥3 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,91.6,87.6 to 94.7,1269
Polio,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,93.5,91.3 to 95.4,2758
Polio,≥3 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,95.5,93.3 to 97.2,1489
Polio,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,94.8,93.2 to 96.2,2847
Polio,≥3 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,94.1,91.4 to 96.1,1358
Hib,≥3 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,92.0,88.9 to 94.3,1358
DTaP,≥3 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,91.0,85.8 to 94.9,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,94.4,91.6 to 96.3,1358
Hib,Full Series,HHS Regions/National,Region 9,2015,Age,24 Months,83.0,76.7 to 88.5,1034
Hib,Full Series,HHS Regions/National,Region 9,2015-2016,Age,24 Months,80.7,75.9 to 85.1,2154
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,94.3,90.9 to 96.7,1078
Polio,≥2 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,91.9,88.4 to 94.4,1229
Hib,≥3 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,93.1,90.1 to 95.3,1489
Hib,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,82.0,79.2 to 84.6,2847
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,93.2,88.7 to 96.0,1120
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,92.7,89.8 to 94.8,2389
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,92.1,88.0 to 94.9,1269
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,93.9,91.7 to 95.6,2758
Polio,≥3 Doses,HHS Regions/National,Region 9,2013,Age,24 Months,91.3,87.3 to 94.5,1078
Polio,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,89.5,86.2 to 92.3,2126
Hib,≥3 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,91.2,89.3 to 92.7,1078
Hib,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,89.6,87.8 to 91.1,2126
Hib,≥3 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,88.0,82.4 to 92.0,1048
Hib,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,88.6,84.7 to 91.6,2082
Polio,≥3 Doses,HHS Regions/National,Region 9,2012,Age,24 Months,94.3,91.6 to 96.4,1139
Polio,≥3 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,89.9,84.7 to 94.0,1101
Polio,≥3 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,93.7,90.9 to 95.7,1358
Polio,≥3 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,94.7,92.2 to 96.4,1489
Polio,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,67.2,63.6 to 70.6,2847
Polio,≥3 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,87.6,82.1 to 92.0,1048
Polio,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,90.0,86.6 to 92.9,2082
Polio,≥3 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,92.4,88.0 to 95.6,1034
Polio,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,91.8,88.6 to 94.4,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,89.2,86.2 to 91.6,1034
Hib,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,88.6,84.7 to 91.6,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,88.0,82.1 to 92.1,1120
Hib,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,88.3,84.7 to 91.2,2389
Polio,≥3 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,91.3,86.4 to 95.0,1120
Polio,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,91.4,88.3 to 94.0,2389
Hib,≥3 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,88.7,83.8 to 92.2,1269
Hib,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,90.9,88.1 to 93.1,2758
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,93.8,90.6 to 95.9,1034
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,93.5,90.7 to 95.5,2154
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,89.3,83.6 to 93.2,1048
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,91.5,88.1 to 94.0,2082
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,93.2,91.5 to 94.6,1078
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,91.3,89.2 to 93.0,2126
Hib,≥3 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,92.4,89.8 to 94.6,1498
Hib,≥3 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,92.0,89.3 to 94.2,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2017,Age,24 Months,87.7,84.6 to 90.4,1643
Hep A,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,24 Months,88.4,86.3 to 90.3,3433
Hep A,≥1 Dose,HHS Regions/National,Region 8,2019,Age,24 Months,88.7,85.8 to 91.3,1623
Hep A,≥1 Dose,HHS Regions/National,Region 8,2011,Age,35 Months,84.3,80.8 to 87.4,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2018,Age,24 Months,89.1,86.2 to 91.6,1790
Hep A,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,24 Months,88.9,86.9 to 90.7,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,96.6,94.9 to 97.8,1623
Hep A,≥1 Dose,HHS Regions/National,Region 8,2012,Age,24 Months,81.0,77.7 to 84.2,1498
Hep A,≥1 Dose,HHS Regions/National,Region 8,2019,Age,19 Months,86.6,83.5 to 89.3,1623
Hep A,≥1 Dose,HHS Regions/National,Region 8,2011,Age,24 Months,79.1,75.6 to 82.4,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2013,Age,24 Months,81.2,77.7 to 84.5,1423
Hep A,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,24 Months,82.5,80.1 to 84.8,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,94.9,92.4 to 96.7,1643
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,95.8,94.3 to 97.0,3433
DTaP,≥4 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,71.6,67.5 to 75.3,1500
Hep A,≥2 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,25.5,22.0 to 29.4,1484
Hep A,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,23.8,21.3 to 26.4,2972
DTaP,≥4 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,67.7,64.1 to 71.0,1498
PCV,≥2 Doses,HHS Regions/National,Region 8,2013,Age,5 Months,77.5,73.6 to 80.9,1423
PCV,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,5 Months,77.3,74.8 to 79.6,2907
PCV,≥2 Doses,HHS Regions/National,Region 8,2012,Age,5 Months,76.5,72.0 to 80.5,1498
PCV,≥2 Doses,HHS Regions/National,Region 8,2011,Age,5 Months,77.6,74.0 to 80.9,1500
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,92.3,89.7 to 94.4,1488
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,93.3,91.6 to 94.7,2978
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,94.3,92.0 to 96.1,1490
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,94.5,92.9 to 95.8,3133
Hib,Primary Series,HHS Regions/National,Region 8,2020-2021,Age,24 Months,90.9,88.7 to 92.9,2759
Hep A,≥1 Dose,HHS Regions/National,Region 8,2012,Age,19 Months,76.7,73.2 to 79.9,1498
Hep A,≥1 Dose,HHS Regions/National,Region 8,2014,Age,19 Months,80.8,77.3 to 83.9,1484
Hep A,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,19 Months,80.1,77.6 to 82.4,2972
Hep A,≥1 Dose,HHS Regions/National,Region 8,2015,Age,19 Months,79.5,75.2 to 83.1,1488
Hep A,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,19 Months,80.8,78.3 to 83.0,2978
DTaP,≥2 Doses,HHS Regions/National,Region 8,2017,Age,5 Months,86.3,83.1 to 89.0,1643
DTaP,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,5 Months,86.6,84.5 to 88.5,3433
DTaP,≥2 Doses,HHS Regions/National,Region 8,2018,Age,5 Months,86.9,83.9 to 89.5,1790
DTaP,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,5 Months,87.1,85.1 to 88.9,3413
DTaP,≥2 Doses,HHS Regions/National,Region 8,2016,Age,5 Months,80.9,77.0 to 84.3,1490
DTaP,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,5 Months,83.6,81.1 to 85.8,3133
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,96.2,94.3 to 97.6,1790
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,95.9,94.6 to 96.9,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,94.5,92.0 to 96.4,1643
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,95.3,93.8 to 96.6,3433
Hib,≥3 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,89.9,87.0 to 92.4,1484
Hib,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,89.7,87.7 to 91.5,2972
Hep A,≥2 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,31.2,27.2 to 35.4,1623
Hep A,≥2 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,36.8,32.7 to 41.2,1500
Hep A,≥2 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,29.7,26.0 to 33.7,1790
Hep A,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,29.1,25.8 to 32.5,2826
Hib,≥3 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,92.6,90.3 to 94.5,1490
Hib,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,93.0,91.3 to 94.5,3133
Hib,≥3 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,93.4,90.7 to 95.5,1643
Hib,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,94.1,92.3 to 95.5,3433
DTaP,≥4 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,67.2,62.9 to 71.2,1423
DTaP,≥4 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,70.9,67.8 to 73.8,2907
DTaP,≥4 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,74.5,70.8 to 77.9,1484
DTaP,≥4 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,71.8,69.0 to 74.4,2972
DTaP,≥4 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,69.0,64.7 to 73.0,1488
DTaP,≥4 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,69.5,66.5 to 72.3,2978
Hep A,≥2 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,27.4,23.3 to 31.8,1643
Hep A,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,28.5,25.7 to 31.5,3433
Hib,≥3 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,94.7,92.3 to 96.6,1790
Hib,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,94.5,92.9 to 95.8,3413
Hep A,≥1 Dose,HHS Regions/National,Region 8,2013,Age,19 Months,76.4,72.9 to 79.6,1423
Hep A,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,19 Months,78.6,76.0 to 81.1,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,95.6,93.8 to 97.0,1623
Hib,≥3 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,89.5,86.7 to 91.9,1488
Hib,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,90.1,88.2 to 91.8,2978
Hib,≥3 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,90.7,88.1 to 92.9,1490
Hib,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,91.5,89.6 to 93.1,3133
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,96.8,94.9 to 98.1,1790
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,96.7,95.4 to 97.7,3413
PCV,≥2 Doses,HHS Regions/National,Region 8,2015,Age,5 Months,79.9,76.2 to 83.1,1488
PCV,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,5 Months,79.2,76.5 to 81.6,2978
PCV,≥2 Doses,HHS Regions/National,Region 8,2016,Age,5 Months,78.5,74.5 to 82.0,1490
PCV,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,5 Months,81.5,78.9 to 83.9,3133
Hep A,≥1 Dose,HHS Regions/National,Region 8,2014,Age,24 Months,83.8,80.5 to 86.9,1484
Hep A,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,24 Months,83.4,81.0 to 85.6,2972
Hep A,≥1 Dose,HHS Regions/National,Region 8,2015,Age,24 Months,82.9,79.5 to 86.1,1488
Hep A,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,24 Months,83.9,81.6 to 86.2,2978
Hep A,≥1 Dose,HHS Regions/National,Region 8,2016,Age,24 Months,85.0,81.7 to 87.9,1490
Hep A,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,24 Months,86.3,84.0 to 88.3,3133
PCV,≥2 Doses,HHS Regions/National,Region 8,2014,Age,5 Months,77.1,73.2 to 80.6,1484
PCV,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,5 Months,78.5,76.4 to 80.5,2972
Hib,≥3 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,90.4,87.7 to 92.8,1488
Hib,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,91.6,89.8 to 93.2,2978
Hep A,≥2 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,22.1,17.0 to 28.3,1488
Hep A,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,24.1,21.6 to 26.8,2978
Hep A,≥2 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,26.2,22.5 to 30.2,1490
Hep A,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,26.8,24.0 to 29.7,3133
Hib,≥3 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,92.4,89.2 to 94.9,1423
Hib,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,92.3,90.0 to 94.3,2907
Hib,≥3 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,91.5,88.7 to 93.9,1484
Hib,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,91.1,89.1 to 92.8,2972
Hib,≥3 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,93.0,90.8 to 94.8,1623
Hib,≥3 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,92.3,89.5 to 94.5,1643
Hib,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,93.1,91.3 to 94.6,3433
Hib,≥3 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,93.9,91.5 to 95.7,1790
Hib,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,93.4,91.9 to 94.8,3413
Hep A,≥2 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,23.5,21.0 to 26.1,1423
Hep A,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,24.5,22.2 to 26.9,2907
Hep A,≥2 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,18.6,16.0 to 21.5,1498
DTaP,≥2 Doses,HHS Regions/National,Region 8,2019,Age,5 Months,87.3,84.4 to 89.8,1623
Hep A,≥2 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,20.7,17.3 to 24.6,1500
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,94.9,92.9 to 96.5,1484
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,93.7,92.1 to 95.1,2972
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,94.7,91.8 to 96.8,1423
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,95.0,93.1 to 96.5,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,95.0,92.6 to 96.9,1498
DTaP,≥3 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,93.8,91.2 to 95.8,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2018,Age,19 Months,85.3,81.8 to 88.2,1790
Hep A,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,19 Months,86.1,83.4 to 88.4,2826
Hep A,≥1 Dose,HHS Regions/National,Region 8,2017,Age,19 Months,84.8,81.4 to 87.7,1643
Hep A,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,19 Months,85.1,82.7 to 87.1,3433
Hep A,≥1 Dose,HHS Regions/National,Region 8,2016,Age,19 Months,82.1,78.6 to 85.2,1490
Hep A,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,19 Months,83.5,81.0 to 85.6,3133
Combined 7 Series,,States/Local Areas,Oregon,2011,Age,35 Months,68.8,60.0 to 77.3,266
Combined 7 Series,,States/Local Areas,Oregon,2013,Age,35 Months,73.6,65.3 to 81.3,208
Combined 7 Series,,States/Local Areas,Oregon,2013-2014,Age,35 Months,70.7,65.0 to 76.3,478
Combined 7 Series,,States/Local Areas,Oregon,2014,Age,35 Months,67.9,59.8 to 75.8,270
Combined 7 Series,,States/Local Areas,Oregon,2014-2015,Age,35 Months,70.6,65.0 to 76.1,513
Hib,Primary Series,States/Local Areas,Oregon,2019,Age,35 Months,94.3,89.2 to 97.5,264
Combined 7 Series,,States/Local Areas,Oregon,2016,Age,24 Months,67.5,57.6 to 77.0,177
Combined 7 Series,,States/Local Areas,Oregon,2016-2017,Age,24 Months,68.9,62.5 to 75.1,372
Combined 7 Series,,States/Local Areas,Oregon,2012,Age,35 Months,66.6,57.5 to 75.4,229
Combined 7 Series,,States/Local Areas,Oregon,2019,Age,24 Months,73.0,65.2 to 80.3,264
Combined 7 Series,,States/Local Areas,Oregon,2018,Age,24 Months,71.3,64.2 to 78.0,290
Combined 7 Series,,States/Local Areas,Oregon,2018-2019,Age,24 Months,72.1,66.9 to 77.1,554
Combined 7 Series,,States/Local Areas,Oregon,2017,Age,24 Months,70.2,62.1 to 77.9,195
Combined 7 Series,,States/Local Areas,Oregon,2017-2018,Age,24 Months,70.8,65.4 to 75.9,485
Combined 7 Series,,States/Local Areas,Oregon,2017,Age,35 Months,74.2,66.0 to 81.8,195
Combined 7 Series,,States/Local Areas,Oregon,2017-2018,Age,35 Months,73.8,68.4 to 78.9,485
Combined 7 Series,,States/Local Areas,Oregon,2016,Age,35 Months,68.8,58.9 to 78.3,177
Combined 7 Series,,States/Local Areas,Oregon,2016-2017,Age,35 Months,71.5,65.1 to 77.6,372
Hib,Primary Series,States/Local Areas,Oregon,2016,Age,24 Months,90.3,82.4 to 95.6,177
Hib,Primary Series,States/Local Areas,Oregon,2016-2017,Age,24 Months,90.0,85.1 to 93.8,372
PCV,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,85.8,80.6 to 89.8,484
≥1 Dose Varicella,,States/Local Areas,Oregon,2019-2020,Age,13 Months,58.6,52.8 to 64.1,484
Hep B,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,94.1,90.8 to 96.3,484
Hep B,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,88.1,83.5 to 91.5,484
Polio,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,89.0,84.6 to 92.3,484
DTaP,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,72.6,66.9 to 77.7,484
PCV,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,5 Months,78.9,73.4 to 83.5,484
Hep B,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,5 Months,87.0,82.4 to 90.5,484
Hib,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,75.9,70.3 to 80.7,484
Hib,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,5 Months,78.7,73.2 to 83.3,484
Hib,Primary Series,States/Local Areas,Oregon,2019-2020,Age,13 Months,86.7,81.6 to 90.5,484
≥1 Dose MMR,,States/Local Areas,Oregon,2019-2020,Age,13 Months,65.9,60.2 to 71.2,484
Hib,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,92.8,88.9 to 95.4,484
Polio,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,92.8,89.0 to 95.4,484
DTaP,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,13 Months,87.9,83.0 to 91.6,484
Polio,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,5 Months,79.2,73.7 to 83.8,484
DTaP,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,5 Months,80.4,75.0 to 84.9,484
PCV,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,3 Months,86.2,81.3 to 90.0,484
Hep B,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,3 Months,92.7,88.9 to 95.3,484
Hep A,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,32.3,27.3 to 37.8,484
≥1 Dose MMR,,States/Local Areas,Oregon,2019-2020,Age,24 Months,88.1,83.8 to 91.7,484
Hib,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,3 Months,86.1,81.1 to 90.0,484
Polio,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,91.3,87.3 to 94.5,484
DTaP,≥4 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,79.4,74.1 to 84.2,484
DTaP,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,92.5,88.6 to 95.4,484
PCV,≥4 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,81.9,76.7 to 86.6,484
PCV,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,92.1,87.6 to 95.5,484
≥1 Dose Varicella,,States/Local Areas,Oregon,2019-2020,Age,35 Months,92.5,87.8 to 95.9,484
Hep B,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,91.0,87.3 to 94.0,484
Hib,Primary Series,States/Local Areas,Oregon,2019-2020,Age,35 Months,92.3,87.9 to 95.5,484
Hib,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,91.8,87.2 to 95.2,484
Hib,Full Series,States/Local Areas,Oregon,2019-2020,Age,35 Months,82.1,76.9 to 86.7,484
≥1 Dose MMR,,States/Local Areas,Oregon,2019-2020,Age,35 Months,91.4,87.2 to 94.7,484
Hib,Primary Series,States/Local Areas,Oregon,2019-2020,Age,19 Months,90.2,85.8 to 93.3,484
Hib,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,88.8,84.3 to 92.1,484
≥1 Dose MMR,,States/Local Areas,Oregon,2019-2020,Age,19 Months,87.2,82.6 to 90.7,484
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2020,Age,0-1 Days,83.1,75.8 to 88.6,220
Polio,≥2 Doses,States/Local Areas,Oregon,2020,Age,7 Months,87.2,79.7 to 92.2,220
Hib,≥2 Doses,States/Local Areas,Oregon,2020,Age,7 Months,85.6,77.6 to 91.0,220
Hib,≥3 Doses,States/Local Areas,Oregon,2020,Age,7 Months,53.1,44.9 to 61.2,220
Hib,Primary Series,States/Local Areas,Oregon,2020,Age,7 Months,71.2,62.7 to 78.4,220
DTaP,≥4 Doses,States/Local Areas,Oregon,2020,Age,24 Months,77.9,70.1 to 84.9,220
DTaP,≥3 Doses,States/Local Areas,Oregon,2020,Age,24 Months,91.1,84.7 to 95.5,220
Polio,≥3 Doses,States/Local Areas,Oregon,2020,Age,24 Months,89.5,82.8 to 94.4,220
≥1 Dose MMR,,States/Local Areas,Oregon,2020,Age,24 Months,89.6,83.0 to 94.4,220
Hib,≥3 Doses,States/Local Areas,Oregon,2020,Age,24 Months,87.8,80.9 to 93.1,220
≥1 Dose MMR,,States/Local Areas,Oregon,2020,Age,35 Months,89.6,83.0 to 94.4,220
Hib,Primary Series,States/Local Areas,Oregon,2020,Age,35 Months,89.3,82.5 to 94.3,220
Hib,≥3 Doses,States/Local Areas,Oregon,2020,Age,35 Months,87.8,80.9 to 93.1,220
Hep B,≥3 Doses,States/Local Areas,Oregon,2020,Age,35 Months,87.9,81.2 to 93.0,220
Hib,Full Series,States/Local Areas,Oregon,2020,Age,35 Months,79.5,71.7 to 86.3,220
≥1 Dose Varicella,,States/Local Areas,Oregon,2020,Age,35 Months,90.4,83.9 to 95.1,220
Hib,Full Series,States/Local Areas,Oregon,2020,Age,19 Months,70.3,62.0 to 77.4,220
Hib,Primary Series,States/Local Areas,Oregon,2020,Age,19 Months,88.7,81.2 to 93.4,220
≥1 Dose Varicella,,States/Local Areas,Oregon,2020,Age,19 Months,87.4,80.4 to 92.1,220
Hep B,≥3 Doses,States/Local Areas,Oregon,2020,Age,19 Months,87.4,80.0 to 92.3,220
DTaP,≥3 Doses,States/Local Areas,Oregon,2020,Age,35 Months,91.1,84.7 to 95.5,220
DTaP,≥4 Doses,States/Local Areas,Oregon,2020,Age,35 Months,79.9,72.0 to 86.8,220
PCV,≥3 Doses,States/Local Areas,Oregon,2020,Age,19 Months,89.0,81.6 to 93.6,220
Polio,≥3 Doses,States/Local Areas,Oregon,2020,Age,35 Months,89.5,82.8 to 94.4,220
Polio,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,90.3,86.0 to 93.4,484
PCV,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,90.9,86.6 to 94.3,484
≥1 Dose Varicella,,States/Local Areas,Oregon,2019-2020,Age,24 Months,89.0,84.6 to 92.6,484
PCV,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,71.4,65.7 to 76.5,484
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2019-2020,Age,0-2 Days,85.5,81.1 to 89.0,484
Hib,Full Series,States/Local Areas,Oregon,2019-2020,Age,24 Months,79.7,74.5 to 84.4,484
Hep B,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,90.8,87.1 to 93.8,484
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2019-2020,Age,0-1 Days,83.4,78.8 to 87.1,484
PCV,≥4 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,78.5,73.1 to 83.1,484
PCV,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,90.7,86.0 to 93.9,484
Hib,Full Series,States/Local Areas,Oregon,2019-2020,Age,19 Months,75.5,70.0 to 80.3,484
Hep B,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,90.6,86.6 to 93.4,484
Combined 7 Series,,States/Local Areas,Oregon,2019-2020,Age,35 Months,72.6,66.7 to 78.2,484
Hib,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,88.8,84.3 to 92.2,484
Hib,Primary Series,States/Local Areas,Oregon,2019-2020,Age,24 Months,90.8,86.7 to 94.0,484
Hib,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,89.6,85.5 to 93.0,484
Hep A,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,50.5,44.8 to 56.5,484
Influenza,,States/Local Areas,Oregon,2019-2020,Age,24 Months,67.7,62.2 to 73.1,484
Hep A,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,35 Months,91.7,87.5 to 94.9,484
Hep A,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,77.3,70.2 to 83.7,484
Hep A,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,24 Months,87.4,83.1 to 91.0,484
DTaP,≥3 Doses,States/Local Areas,Oregon,2020,Age,13 Months,85.6,77.8 to 91.0,220
Hep A,≥2 Doses,States/Local Areas,Oregon,2020,Age,35 Months,79.4,68.7 to 88.3,220
Combined 7 Series,,States/Local Areas,Oregon,2020,Age,35 Months,66.2,57.7 to 74.5,220
Hep A,≥2 Doses,States/Local Areas,Oregon,2020,Age,19 Months,32.6,25.6 to 40.4,220
Hep A,≥1 Dose,States/Local Areas,Oregon,2020,Age,19 Months,85.0,77.5 to 90.4,220
Polio,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,3 Months,86.7,81.7 to 90.5,484
Hep A,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,19 Months,85.5,80.9 to 89.2,484
Polio,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,92.4,88.4 to 95.4,484
DTaP,≥4 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,82.3,76.9 to 87.1,484
DTaP,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,35 Months,93.4,89.7 to 96.2,484
Combined 7 Series,,States/Local Areas,Oregon,2019-2020,Age,24 Months,69.1,63.4 to 74.6,484
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.1,52.2 to 74.1,150
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,89.7,82.7 to 96.7,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2019-2020,Age,0-3 Days,86.7,82.5 to 90.0,484
DTaP,≥1 Dose,States/Local Areas,Oregon,2019-2020,Age,3 Months,87.6,82.7 to 91.3,484
Hib,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,56.9,51.1 to 62.5,484
PCV,≥4 Doses,States/Local Areas,Oregon,2019-2020,Age,24 Months,80.1,74.9 to 84.8,484
Hep B,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,72.2,66.8 to 77.1,484
DTaP,≥4 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,68.3,62.6 to 73.5,484
DTaP,≥3 Doses,States/Local Areas,Oregon,2019-2020,Age,19 Months,91.5,87.4 to 94.4,484
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,63.2,56.5 to 69.9,342
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,90.9,87.0 to 94.7,342
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,80.6,76.9 to 84.3,848
Influenza,,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,86.5,81.6 to 91.5,301
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,71.4,63.2 to 79.7,198
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,93.8,90.0 to 97.6,301
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,70.8,62.4 to 79.3,198
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,77.2,71.4 to 83.0,349
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,89.5,84.9 to 94.1,301
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,86.9,81.0 to 92.7,198
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,88.3,83.2 to 93.4,198
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,86.7,80.5 to 92.8,301
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,90.1,85.4 to 94.7,198
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,90.3,86.2 to 94.5,349
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,93.9,90.6 to 97.2,301
Influenza,,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,52.2,43.4 to 61.1,198
Influenza,,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,60.9,54.2 to 67.7,349
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,90.5,87.7 to 93.3,848
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,94.2,92.0 to 96.3,848
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,94.6,91.5 to 97.6,349
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,86.9,81.0 to 92.7,198
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,94.8,91.6 to 98.0,301
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,69.7,59.8 to 79.6,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,84.5,79.9 to 89.2,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,79.6,73.7 to 85.5,301
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,80.3,74.8 to 85.9,349
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,91.1,87.1 to 95.2,301
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,93.9,91.2 to 96.5,485
Rotavirus,,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,63.8,55.2 to 72.4,198
Rotavirus,,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,76.2,70.3 to 82.0,349
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,84.8,76.1 to 93.5,127
Influenza,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,41.7,30.0 to 53.5,127
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,88.3 to 96.7,236
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,94.7,92.1 to 97.3,485
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,87.1,78.3 to 95.9,127
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,72.2,66.8 to 77.5,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,84.2,80.1 to 88.3,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,87.8,80.3 to 95.3,127
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.8,71.2 to 84.5,236
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,94.9,91.9 to 97.8,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,77.1,66.4 to 87.8,127
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,96.7,94.2 to 99.2,301
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Overall,Overall,78.5,74.6 to 82.3,848
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,93.2,89.5 to 96.9,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,77.8,70.4 to 85.2,198
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,91.6,86.1 to 97.2,301
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,60.0,51.2 to 68.9,198
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,96.3,93.6 to 99.0,349
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,79.2,72.3 to 86.0,301
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,69.0,62.4 to 75.5,349
Rotavirus,,States/Local Areas,Oregon,2016-2019,Overall,Overall,75.5,71.5 to 79.5,848
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,98.6,97.4 to 99.8,301
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Overall,Overall,91.2,88.7 to 93.7,848
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Overall,Overall,68.9,64.6 to 73.3,848
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,79.3,74.4 to 84.2,848
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,85.7,79.8 to 91.5,198
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Overall,Overall,90.4,87.7 to 93.0,848
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Overall,Overall,81.3,77.9 to 84.7,848
Influenza,,States/Local Areas,Oregon,2016-2019,Overall,Overall,65.0,60.6 to 69.4,848
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,82.8,76.0 to 89.6,198
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,93.8,90.4 to 97.1,349
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,80.7,73.2 to 88.1,349
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,87.3,80.8 to 93.7,301
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,88.2,82.8 to 93.6,198
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,89.8,85.7 to 93.9,349
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Overall,Overall,92.7,90.5 to 94.9,848
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Poverty,<133% FPL,66.5,57.6 to 75.4,198
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,91.4,88.8 to 94.1,848
Rotavirus,,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,87.5,81.8 to 93.2,301
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,93.0,90.8 to 95.3,848
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Overall,Overall,77.8,73.7 to 81.9,848
Influenza,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,63.2,53.0 to 73.4,131
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,89.9,86.2 to 93.6,342
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,95.3,92.7 to 97.9,486
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.6,77.5 to 93.7,150
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.3,61.9 to 82.7,150
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,79.2,70.2 to 88.3,131
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,82.1 to 95.5,150
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,76.3,68.9 to 83.6,342
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,84.0,77.9 to 90.2,486
DTaP,≥1 Dose,States/Local Areas,Oregon,2020,Age,3 Months,82.9,74.4 to 88.9,220
Polio,≥1 Dose,States/Local Areas,Oregon,2020,Age,3 Months,81.9,73.3 to 88.2,220
Hep B,≥2 Doses,States/Local Areas,Oregon,2020,Age,7 Months,88.0,80.2 to 93.0,220
Hib,≥1 Dose,States/Local Areas,Oregon,2020,Age,3 Months,81.4,72.8 to 87.7,220
Hep B,≥3 Doses,States/Local Areas,Oregon,2020,Age,7 Months,72.3,64.2 to 79.2,220
PCV,≥3 Doses,States/Local Areas,Oregon,2020,Age,7 Months,66.9,58.3 to 74.5,220
PCV,≥4 Doses,States/Local Areas,Oregon,2020,Age,19 Months,75.3,67.0 to 82.0,220
PCV,≥3 Doses,States/Local Areas,Oregon,2020,Age,35 Months,89.4,82.7 to 94.4,220
Hib,≥2 Doses,States/Local Areas,Oregon,2020,Age,13 Months,90.8,83.7 to 95.0,220
Hib,≥3 Doses,States/Local Areas,Oregon,2020,Age,13 Months,74.2,66.0 to 80.9,220
Hib,Primary Series,States/Local Areas,Oregon,2020,Age,13 Months,85.6,77.9 to 91.0,220
Hep B,≥2 Doses,States/Local Areas,Oregon,2020,Age,13 Months,92.4,85.8 to 96.1,220
Hep B,≥3 Doses,States/Local Areas,Oregon,2020,Age,13 Months,86.4,79.0 to 91.4,220
≥1 Dose Varicella,,States/Local Areas,Oregon,2020,Age,13 Months,64.0,55.6 to 71.6,220
PCV,≥2 Doses,States/Local Areas,Oregon,2020,Age,5 Months,76.0,67.4 to 82.9,220
PCV,≥3 Doses,States/Local Areas,Oregon,2020,Age,13 Months,83.0,74.7 to 88.9,220
Hep B,≥2 Doses,States/Local Areas,Oregon,2020,Age,5 Months,83.9,76.0 to 89.6,220
DTaP,≥3 Doses,States/Local Areas,Oregon,2020,Age,7 Months,69.3,60.8 to 76.7,220
DTaP,≥3 Doses,States/Local Areas,Oregon,2020,Age,19 Months,90.2,83.1 to 94.5,220
DTaP,≥4 Doses,States/Local Areas,Oregon,2020,Age,19 Months,64.9,56.6 to 72.3,220
Polio,≥3 Doses,States/Local Areas,Oregon,2020,Age,19 Months,88.5,81.1 to 93.2,220
Combined 7 Series,,States/Local Areas,Oregon,2020,Age,24 Months,64.0,55.7 to 72.2,220
Hib,≥3 Doses,States/Local Areas,Oregon,2020,Age,19 Months,86.6,79.1 to 91.7,220
≥1 Dose MMR,,States/Local Areas,Oregon,2020,Age,19 Months,87.7,80.6 to 92.5,220
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2020,Age,0-3 Days,85.4,78.3 to 90.4,220
Rotavirus,,States/Local Areas,Oregon,2020,Age,8 Months,70.6,62.0 to 78.0,220
≥1 Dose Varicella,,States/Local Areas,Oregon,2020,Age,24 Months,90.4,83.9 to 95.1,220
Influenza,,States/Local Areas,Oregon,2020,Age,24 Months,67.0,59.0 to 74.7,220
PCV,≥3 Doses,States/Local Areas,Oregon,2020,Age,24 Months,89.4,82.7 to 94.4,220
PCV,≥4 Doses,States/Local Areas,Oregon,2020,Age,24 Months,78.0,70.1 to 85.0,220
Hep A,≥2 Doses,States/Local Areas,Oregon,2020,Age,24 Months,52.7,44.5 to 61.3,220
Hep A,≥1 Dose,States/Local Areas,Oregon,2020,Age,24 Months,88.2,81.3 to 93.4,220
PCV,≥1 Dose,States/Local Areas,Oregon,2020,Age,3 Months,80.9,72.3 to 87.3,220
Hep B,≥1 Dose,States/Local Areas,Oregon,2020,Age,3 Months,90.9,83.9 to 95.1,220
Polio,≥2 Doses,States/Local Areas,Oregon,2020,Age,5 Months,77.0,68.4 to 83.7,220
DTaP,≥2 Doses,States/Local Areas,Oregon,2020,Age,5 Months,78.4,70.0 to 85.0,220
Hib,≥2 Doses,States/Local Areas,Oregon,2020,Age,5 Months,75.6,67.0 to 82.5,220
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,85.7,80.8 to 90.6,486
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,95.0,90.6 to 99.4,131
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,89.6,85.9 to 93.2,342
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.0,93.8 to 98.2,556
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.4,74.3 to 84.4,556
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,90.3,86.4 to 94.2,342
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,96.9,95.0 to 98.9,486
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,74.6,68.7 to 80.6,342
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.4,87.0 to 93.7,556
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,93.4,88.8 to 98.0,131
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,88.5,84.3 to 92.7,342
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,70.8,64.3 to 77.3,342
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,92.7,88.9 to 96.5,486
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.8,89.5 to 96.1,556
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,93.9,89.3 to 98.4,131
Influenza,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.8,52.8 to 74.9,150
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,85.7,80.9 to 90.6,342
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,92.1 to 97.1,556
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.2,79.6 to 94.9,150
Influenza,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",66.5,60.9 to 72.1,556
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,84.9,77.6 to 92.2,131
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.7,74.7 to 84.8,556
Rotavirus,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,77.3,68.2 to 86.5,131
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.9,63.2 to 74.6,556
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,74.2,64.6 to 83.8,131
Rotavirus,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,67.7,61.2 to 74.2,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.6,75.3 to 91.9,150
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.2,72.0 to 82.4,556
Influenza,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,54.8,48.0 to 61.7,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,87.8,81.4 to 94.2,131
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,94.0,89.2 to 98.8,131
Influenza,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,77.8,72.2 to 83.4,486
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,68.4 to 86.6,150
Rotavirus,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.0,62.8 to 83.3,150
Rotavirus,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,82.2,77.1 to 87.3,486
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,98.2,96.7 to 99.7,486
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.7,83.5 to 95.8,150
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,92.9,89.5 to 96.3,486
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,94.9,90.8 to 98.9,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,80.8,75.5 to 86.1,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,81.2,76.6 to 85.7,486
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,75.3,69.3 to 81.4,486
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.9,87.6 to 94.2,556
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.5,79.9 to 95.2,150
Rotavirus,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.5,70.4 to 80.7,556
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.2,90.4 to 96.0,556
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,86.8 to 98.6,150
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2020,Age,0-2 Days,84.1,76.7 to 89.5,220
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.7,87.2 to 94.2,556
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,81.6,76.8 to 86.3,485
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.9,65.0 to 82.8,236
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,90.5 to 98.0,236
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,95.7,93.2 to 98.1,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,64.3,51.2 to 77.4,127
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.0,69.1 to 84.9,236
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,81.4,76.5 to 86.2,485
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,91.1,87.5 to 94.8,485
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,91.4,85.1 to 97.7,127
Rotavirus,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,62.1,49.9 to 74.4,127
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,82.9,77.1 to 88.8,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,87.4,78.7 to 96.1,127
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.9,87.1 to 96.7,236
≥1 Dose MMR,,States/Local Areas,Oregon,2020-2021,Age,13 Months,71.3,64.9 to 77.0,351
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.7,82.3 to 93.1,236
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,81.9,72.3 to 91.5,127
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.5,83.9 to 95.1,236
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,92.0 to 97.3,485
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,65.5,53.7 to 77.2,127
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.0,71.8 to 86.3,236
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,84.9,80.5 to 89.3,485
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,68.4,60.1 to 76.7,236
Combined 7 Series,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,56.0,43.1 to 69.0,127
Influenza,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,73.3,68.0 to 78.7,485
Influenza,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,59.4,50.9 to 67.9,236
Rotavirus,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,78.2,73.1 to 83.4,485
Rotavirus,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.2,69.0 to 83.4,236
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,85.1,76.0 to 94.2,127
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.1,82.8 to 93.3,236
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,90.0 to 95.8,485
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.3,86.9 to 95.8,236
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Principal City,93.9,91.2 to 96.6,485
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,68.0,56.3 to 79.8,127
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a MSA Non-Principal City,77.1,69.5 to 84.6,236
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Urbanicity,Living In a Non-MSA,81.6,65.2 to 98.0,127
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2021,Age,0-1 Days,80.5,71.4 to 87.2,131
Hib,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,90.7,85.7 to 94.0,351
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2021,Age,0-2 Days,80.9,71.8 to 87.6,131
Hep B,≥3 Doses,States/Local Areas,Oregon,2021,Age,24 Months,90.3,83.1 to 95.4,131
≥1 Dose Varicella,,States/Local Areas,Oregon,2020-2021,Age,35 Months,90.3,85.4 to 94.2,351
≥1 Dose Varicella,,States/Local Areas,Oregon,2021,Age,24 Months,88.4,80.6 to 94.1,131
PCV,≥3 Doses,States/Local Areas,Oregon,2021,Age,24 Months,87.8,79.9 to 93.7,131
Polio,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,89.4,84.2 to 93.0,351
PCV,≥4 Doses,States/Local Areas,Oregon,2021,Age,24 Months,73.7,63.9 to 82.7,131
PCV,≥3 Doses,States/Local Areas,Oregon,2021,Age,13 Months,83.7,74.9 to 89.9,131
Hep A,≥1 Dose,States/Local Areas,Oregon,2021,Age,24 Months,87.0,78.6 to 93.4,131
Hep B,≥2 Doses,States/Local Areas,Oregon,2021,Age,7 Months,90.8,82.6 to 95.4,131
Hep B,≥3 Doses,States/Local Areas,Oregon,2021,Age,7 Months,75.5,65.9 to 83.1,131
Hep A,≥2 Doses,States/Local Areas,Oregon,2021,Age,24 Months,47.8,36.7 to 60.3,131
Hep A,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,31.1,25.4 to 37.5,351
PCV,≥3 Doses,States/Local Areas,Oregon,2021,Age,7 Months,72.8,62.8 to 80.8,131
DTaP,≥3 Doses,States/Local Areas,Oregon,2021,Age,13 Months,90.2,81.9 to 94.9,131
PCV,≥4 Doses,States/Local Areas,Oregon,2021,Age,19 Months,72.0,61.5 to 80.5,131
PCV,≥3 Doses,States/Local Areas,Oregon,2021,Age,35 Months,87.8,79.9 to 93.7,131
Hep A,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,35 Months,89.9,84.6 to 93.9,351
PCV,≥4 Doses,States/Local Areas,Oregon,2021,Age,35 Months,79.9,69.6 to 88.5,131
DTaP,≥1 Dose,States/Local Areas,Oregon,2021,Age,3 Months,87.0,78.3 to 92.5,131
Polio,≥3 Doses,States/Local Areas,Oregon,2021,Age,24 Months,91.6,83.9 to 96.5,131
DTaP,≥4 Doses,States/Local Areas,Oregon,2021,Age,24 Months,76.1,65.8 to 85.2,131
≥1 Dose MMR,,States/Local Areas,Oregon,2021,Age,24 Months,88.6,80.9 to 94.2,131
Hib,≥3 Doses,States/Local Areas,Oregon,2021,Age,24 Months,85.7,76.5 to 92.7,131
Polio,≥1 Dose,States/Local Areas,Oregon,2021,Age,3 Months,87.1,78.4 to 92.6,131
DTaP,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,91.6,87.0 to 95.1,351
Hib,Full Series,States/Local Areas,Oregon,2021,Age,24 Months,75.8,65.9 to 84.5,131
DTaP,≥3 Doses,States/Local Areas,Oregon,2021,Age,19 Months,90.9,82.6 to 95.5,131
Hib,Primary Series,States/Local Areas,Oregon,2021,Age,24 Months,90.8,83.6 to 95.7,131
Hep A,≥1 Dose,States/Local Areas,Oregon,2021,Age,19 Months,84.1,75.1 to 90.3,131
≥1 Dose Varicella,,States/Local Areas,Oregon,2021,Age,19 Months,86.3,77.8 to 91.9,131
Hib,≥3 Doses,States/Local Areas,Oregon,2021,Age,7 Months,59.7,48.9 to 69.6,131
Hib,Primary Series,States/Local Areas,Oregon,2020-2021,Age,13 Months,85.6,80.0 to 89.8,351
Hep A,≥1 Dose,States/Local Areas,Oregon,2021,Age,35 Months,88.4,79.6 to 94.6,131
PCV,≥3 Doses,States/Local Areas,Oregon,2021,Age,19 Months,86.6,78.0 to 92.1,131
DTaP,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,3 Months,84.9,79.2 to 89.3,351
Hep B,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,89.1,84.4 to 92.9,351
Hep A,≥2 Doses,States/Local Areas,Oregon,2021,Age,35 Months,86.9,61.7 to 98.7,131
Hib,Primary Series,States/Local Areas,Oregon,2021,Age,7 Months,76.4,66.6 to 84.0,131
Polio,≥3 Doses,States/Local Areas,Oregon,2021,Age,35 Months,91.6,83.9 to 96.5,131
Hep B,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,91.6,86.8 to 94.8,351
≥1 Dose MMR,,States/Local Areas,Oregon,2020-2021,Age,24 Months,89.0,84.1 to 92.9,351
DTaP,≥4 Doses,States/Local Areas,Oregon,2021,Age,19 Months,68.8,57.8 to 78.1,131
Combined 7 Series,,States/Local Areas,Oregon,2021,Age,35 Months,72.4,60.8 to 82.9,131
Hep B,≥2 Doses,States/Local Areas,Oregon,2021,Age,5 Months,86.3,77.8 to 92.0,131
PCV,≥2 Doses,States/Local Areas,Oregon,2021,Age,5 Months,76.4,66.7 to 83.9,131
DTaP,≥3 Doses,States/Local Areas,Oregon,2021,Age,7 Months,76.0,66.3 to 83.6,131
Rotavirus,,States/Local Areas,Oregon,2019-2020,Age,8 Months,76.2,70.6 to 81.0,484
DTaP,≥4 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,77.1,70.7 to 83.0,351
PCV,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,5 Months,76.2,69.9 to 81.5,351
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,78.7 to 94.8,150
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,74.7,68.8 to 80.6,342
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2019,Poverty,133% to <400% FPL,80.0,74.2 to 85.9,349
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,92.8,87.9 to 97.7,131
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,84.5,74.7 to 94.4,131
Hib,Primary Series,States/Local Areas,Oregon,2019-2020,Age,7 Months,74.6,69.0 to 79.5,484
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,Hispanic,86.3,79.5 to 93.2,131
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Poverty,>400% FPL,97.2,94.8 to 99.6,301
Hep B,≥2 Doses,States/Local Areas,Oregon,2019-2020,Age,7 Months,90.6,86.4 to 93.6,484
Rotavirus,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,79.2,73.7 to 84.7,428
Rotavirus,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,75.8,66.9 to 84.7,133
Rotavirus,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,63.3,56.7 to 69.9,314
Rotavirus,,States/Local Areas,Oregon,2018,Age,8 Months,73.7,66.1 to 80.1,290
Rotavirus,,States/Local Areas,Oregon,2018-2019,Age,8 Months,77.3,71.9 to 81.9,554
Rotavirus,,States/Local Areas,Oregon,2017,Age,8 Months,76.0,67.8 to 82.6,195
Rotavirus,,States/Local Areas,Oregon,2017-2018,Age,8 Months,74.8,69.4 to 79.6,485
Rotavirus,,States/Local Areas,Oregon,2019,Age,8 Months,81.1,73.4 to 87.0,264
Rotavirus,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,55.1,44.1 to 66.2,138
Rotavirus,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.2,64.5 to 79.8,217
Rotavirus,,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,59.8,52.1 to 67.6,221
Rotavirus,,States/Local Areas,Oregon,2014-2017,Overall,Overall,70.8,66.6 to 75.0,780
Rotavirus,,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,72.9,66.6 to 79.3,308
Rotavirus,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.5,57.6 to 79.5,118
Rotavirus,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,74.7,69.3 to 80.2,425
Rotavirus,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.1,64.9 to 75.4,520
Rotavirus,,States/Local Areas,Oregon,2016,Age,8 Months,74.4,64.2 to 82.4,177
Rotavirus,,States/Local Areas,Oregon,2016-2017,Age,8 Months,75.2,68.8 to 80.6,372
Rotavirus,,States/Local Areas,Oregon,2015,Age,8 Months,73.8,66.0 to 80.4,243
Rotavirus,,States/Local Areas,Oregon,2015-2016,Age,8 Months,74.1,67.8 to 79.5,420
Rotavirus,,States/Local Areas,Oregon,2013,Age,8 Months,70.8,62.1 to 78.2,208
Rotavirus,,States/Local Areas,Oregon,2013-2014,Age,8 Months,69.6,64.0 to 74.7,478
Rotavirus,,States/Local Areas,Oregon,2012,Age,8 Months,69.8,61.6 to 76.8,229
Rotavirus,,States/Local Areas,Oregon,2011,Age,8 Months,60.7,53.0 to 68.0,266
Rotavirus,,States/Local Areas,Oregon,2014,Age,8 Months,68.4,60.9 to 75.0,270
Rotavirus,,States/Local Areas,Oregon,2014-2015,Age,8 Months,71.1,65.8 to 75.9,513
Hib,Full Series,States/Local Areas,Oregon,2018,Age,19 Months,76.1,68.9 to 82.1,290
Hib,Full Series,States/Local Areas,Oregon,2018-2019,Age,19 Months,94.9,92.7 to 96.5,554
Hib,Full Series,States/Local Areas,Oregon,2019,Age,19 Months,80.1,72.1 to 86.2,264
Hib,Full Series,States/Local Areas,Oregon,2017,Age,19 Months,68.4,60.2 to 75.7,195
Hib,Full Series,States/Local Areas,Oregon,2017-2018,Age,19 Months,72.2,66.8 to 77.0,485
Hib,Full Series,States/Local Areas,Oregon,2014,Age,19 Months,70.7,63.7 to 76.9,270
Hib,Full Series,States/Local Areas,Oregon,2014-2015,Age,19 Months,72.4,67.4 to 76.9,513
Hib,Full Series,States/Local Areas,Oregon,2015,Age,19 Months,74.1,72.2 to 76.0,243
Hib,Full Series,States/Local Areas,Oregon,2015-2016,Age,19 Months,74.0,67.9 to 79.4,420
Hib,Full Series,States/Local Areas,Oregon,2016,Age,19 Months,73.9,63.9 to 82.0,177
Hib,Full Series,States/Local Areas,Oregon,2016-2017,Age,19 Months,71.2,64.8 to 76.8,372
Combined 7 Series,,States/Local Areas,Oregon,2015,Age,35 Months,73.4,65.5 to 80.8,243
Combined 7 Series,,States/Local Areas,Oregon,2015-2016,Age,35 Months,71.0,64.7 to 77.1,420
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,61.3,51.2 to 71.4,133
Combined 7 Series,,States/Local Areas,Oregon,2018,Age,35 Months,73.3,66.2 to 79.9,290
Combined 7 Series,,States/Local Areas,Oregon,2018-2019,Age,35 Months,75.5,70.1 to 80.6,554
Combined 7 Series,,States/Local Areas,Oregon,2019,Age,35 Months,77.8,69.2 to 85.4,264
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,57.3,50.6 to 64.0,314
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,68.0,61.6 to 74.4,428
Hib,Full Series,States/Local Areas,Oregon,2011,Age,24 Months,71.4,64.0 to 78.5,266
Hib,Full Series,States/Local Areas,Oregon,2012,Age,24 Months,72.3,64.4 to 79.8,229
Hib,Full Series,States/Local Areas,Oregon,2014,Age,24 Months,75.2,68.9 to 81.1,270
Hib,Full Series,States/Local Areas,Oregon,2014-2015,Age,24 Months,78.1,73.6 to 82.3,513
Hib,Full Series,States/Local Areas,Oregon,2013,Age,24 Months,81.9,75.2 to 87.7,208
Hib,Full Series,States/Local Areas,Oregon,2013-2014,Age,24 Months,78.6,74.1 to 82.9,478
Hib,Primary Series,States/Local Areas,Oregon,2016,Age,13 Months,84.3,74.5 to 90.8,177
Hib,Primary Series,States/Local Areas,Oregon,2016-2017,Age,13 Months,84.2,78.3 to 88.7,372
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,53.0,45.2 to 60.8,221
Hib,Full Series,States/Local Areas,Oregon,2013,Age,19 Months,76.6,72.2 to 80.5,208
Hib,Full Series,States/Local Areas,Oregon,2013-2014,Age,19 Months,73.7,71.9 to 75.5,478
Hib,Full Series,States/Local Areas,Oregon,2012,Age,19 Months,66.4,59.2 to 72.9,229
Hib,Full Series,States/Local Areas,Oregon,2011,Age,19 Months,64.5,58.8 to 69.9,266
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,74.1,66.5 to 81.7,251
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,61.4,54.4 to 68.5,308
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,62.7,54.2 to 71.2,217
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,64.1,58.3 to 70.0,425
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",62.2,56.5 to 67.9,520
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.1,48.8 to 71.4,118
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,49.7,39.1 to 60.2,138
Combined 7 Series,,States/Local Areas,Oregon,2014-2017,Overall,Overall,61.5,57.0 to 65.9,780
Hib,Primary Series,States/Local Areas,Oregon,2018,Age,35 Months,94.9,90.8 to 97.5,290
Hib,Primary Series,States/Local Areas,Oregon,2018-2019,Age,35 Months,94.6,91.6 to 96.9,554
Combined 7 Series,,States/Local Areas,Oregon,2015,Age,24 Months,67.7,59.9 to 75.2,243
Combined 7 Series,,States/Local Areas,Oregon,2015-2016,Age,24 Months,67.6,61.3 to 73.7,420
Combined 7 Series,,States/Local Areas,Oregon,2014,Age,24 Months,58.9,51.8 to 66.2,270
Combined 7 Series,,States/Local Areas,Oregon,2014-2015,Age,24 Months,63.3,58.0 to 68.5,513
Hib,Primary Series,States/Local Areas,Oregon,2014,Age,24 Months,89.9,85.3 to 93.6,270
Hib,Primary Series,States/Local Areas,Oregon,2014-2015,Age,24 Months,90.9,87.8 to 93.5,513
Hib,Primary Series,States/Local Areas,Oregon,2015,Age,24 Months,91.9,87.3 to 95.3,243
Hib,Primary Series,States/Local Areas,Oregon,2015-2016,Age,24 Months,91.2,86.7 to 94.6,420
Hib,Primary Series,States/Local Areas,Oregon,2018,Age,24 Months,94.9,90.8 to 97.5,290
Hib,Primary Series,States/Local Areas,Oregon,2018-2019,Age,24 Months,93.6,90.5 to 96.0,554
Hib,Primary Series,States/Local Areas,Oregon,2013,Age,35 Months,95.3,91.9 to 97.6,208
Hib,Primary Series,States/Local Areas,Oregon,2013-2014,Age,35 Months,93.3,90.5 to 95.5,478
Hib,Primary Series,States/Local Areas,Oregon,2019,Age,24 Months,92.3,87.1 to 95.9,264
Hib,Primary Series,States/Local Areas,Oregon,2011,Age,35 Months,87.4,81.1 to 92.4,266
Hib,Primary Series,States/Local Areas,Oregon,2014,Age,35 Months,91.3,86.5 to 94.8,270
Hib,Primary Series,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.5,89.2 to 95.1,513
Hib,Primary Series,States/Local Areas,Oregon,2012,Age,35 Months,93.9,89.2 to 97.1,229
Hib,Primary Series,States/Local Areas,Oregon,2013,Age,24 Months,94.4,90.9 to 96.9,208
Hib,Primary Series,States/Local Areas,Oregon,2013-2014,Age,24 Months,92.2,89.4 to 94.5,478
Hib,Primary Series,States/Local Areas,Oregon,2017,Age,24 Months,89.5,83.3 to 94.2,195
Hib,Primary Series,States/Local Areas,Oregon,2017-2018,Age,24 Months,92.1,88.5 to 95.0,485
Combined 7 Series,,States/Local Areas,Oregon,2013,Age,24 Months,67.5,59.3 to 75.4,208
Combined 7 Series,,States/Local Areas,Oregon,2013-2014,Age,24 Months,63.3,57.9 to 68.7,478
Combined 7 Series,,States/Local Areas,Oregon,2011,Age,24 Months,58.5,50.9 to 66.2,266
Combined 7 Series,,States/Local Areas,Oregon,2012,Age,24 Months,58.7,50.4 to 67.2,229
Hib,Primary Series,States/Local Areas,Oregon,2015,Age,35 Months,94.0,88.6 to 97.4,243
Hib,Primary Series,States/Local Areas,Oregon,2015-2016,Age,35 Months,92.6,87.8 to 96.1,420
Hib,Primary Series,States/Local Areas,Oregon,2014,Age,7 Months,63.2,55.7 to 70.1,270
Hib,Primary Series,States/Local Areas,Oregon,2014-2015,Age,7 Months,69.8,64.6 to 74.6,513
Hib,Primary Series,States/Local Areas,Oregon,2015,Age,7 Months,76.4,69.0 to 82.5,243
Hib,Primary Series,States/Local Areas,Oregon,2015-2016,Age,7 Months,73.5,67.2 to 79.0,420
Hib,Primary Series,States/Local Areas,Oregon,2013,Age,7 Months,70.8,67.2 to 74.1,208
Hib,Primary Series,States/Local Areas,Oregon,2013-2014,Age,7 Months,67.0,63.7 to 70.2,478
Hib,Primary Series,States/Local Areas,Oregon,2016,Age,35 Months,91.0,83.2 to 96.2,177
Hib,Primary Series,States/Local Areas,Oregon,2016-2017,Age,35 Months,90.5,85.6 to 94.2,372
Hib,Primary Series,States/Local Areas,Oregon,2017,Age,35 Months,89.5,83.3 to 94.2,195
Hib,Primary Series,States/Local Areas,Oregon,2017-2018,Age,35 Months,92.1,88.5 to 95.0,485
Hib,Primary Series,States/Local Areas,Oregon,2016,Age,7 Months,70.6,60.0 to 79.3,177
Hib,Primary Series,States/Local Areas,Oregon,2016-2017,Age,7 Months,71.9,65.3 to 77.6,372
Hib,Primary Series,States/Local Areas,Oregon,2017,Age,7 Months,73.1,64.8 to 80.1,195
Hib,Primary Series,States/Local Areas,Oregon,2017-2018,Age,7 Months,75.4,70.0 to 80.1,485
Hib,Primary Series,States/Local Areas,Oregon,2012,Age,19 Months,90.5,82.5 to 95.0,229
Hib,Primary Series,States/Local Areas,Oregon,2016,Age,19 Months,87.6,77.6 to 93.5,177
Hib,Primary Series,States/Local Areas,Oregon,2016-2017,Age,19 Months,87.3,81.6 to 91.5,372
Hib,Primary Series,States/Local Areas,Oregon,2017,Age,19 Months,87.1,79.8 to 92.0,195
Hib,Primary Series,States/Local Areas,Oregon,2017-2018,Age,19 Months,90.1,85.8 to 93.2,485
Hib,Primary Series,States/Local Areas,Oregon,2013,Age,13 Months,87.9,83.5 to 91.3,208
Hib,Primary Series,States/Local Areas,Oregon,2013-2014,Age,13 Months,86.1,84.2 to 87.8,478
Hib,Primary Series,States/Local Areas,Oregon,2012,Age,13 Months,87.5,84.9 to 89.7,229
Hib,Primary Series,States/Local Areas,Oregon,2011,Age,13 Months,82.6,76.5 to 87.3,266
Hib,Primary Series,States/Local Areas,Oregon,2019,Age,7 Months,77.9,70.0 to 84.2,264
Hib,Primary Series,States/Local Areas,Oregon,2018,Age,7 Months,77.7,70.5 to 83.5,290
Hib,Primary Series,States/Local Areas,Oregon,2018-2019,Age,7 Months,77.8,72.5 to 82.3,554
Hib,Primary Series,States/Local Areas,Oregon,2014,Age,13 Months,84.3,78.1 to 88.9,270
Hib,Primary Series,States/Local Areas,Oregon,2014-2015,Age,13 Months,86.2,82.1 to 89.4,513
Hib,Primary Series,States/Local Areas,Oregon,2015,Age,13 Months,88.1,82.1 to 92.2,243
Hib,Primary Series,States/Local Areas,Oregon,2015-2016,Age,13 Months,86.2,80.7 to 90.3,420
Hib,Primary Series,States/Local Areas,Oregon,2019,Age,19 Months,91.7,86.0 to 95.2,264
Hib,Primary Series,States/Local Areas,Oregon,2018,Age,19 Months,93.3,88.2 to 96.3,290
Hib,Primary Series,States/Local Areas,Oregon,2018-2019,Age,19 Months,88.4,83.9 to 91.8,554
Hib,Primary Series,States/Local Areas,Oregon,2017,Age,13 Months,84.1,76.6 to 89.5,195
Hib,Primary Series,States/Local Areas,Oregon,2017-2018,Age,13 Months,86.7,82.1 to 90.2,485
Hib,Primary Series,States/Local Areas,Oregon,2013,Age,19 Months,94.4,93.1 to 95.5,208
Hib,Primary Series,States/Local Areas,Oregon,2013-2014,Age,19 Months,91.9,87.9 to 94.6,478
Hib,Primary Series,States/Local Areas,Oregon,2011,Age,19 Months,85.3,79.5 to 89.7,266
Hib,Primary Series,States/Local Areas,Oregon,2015,Age,19 Months,91.9,90.5 to 93.1,243
Hib,Primary Series,States/Local Areas,Oregon,2015-2016,Age,19 Months,89.7,84.5 to 93.4,420
Hib,Primary Series,States/Local Areas,Oregon,2012,Age,24 Months,92.8,88.1 to 96.2,229
Hib,Primary Series,States/Local Areas,Oregon,2011,Age,24 Months,86.8,80.6 to 91.8,266
Hib,Primary Series,States/Local Areas,Oregon,2014,Age,19 Months,89.3,84.1 to 92.9,270
Hib,Primary Series,States/Local Areas,Oregon,2014-2015,Age,19 Months,90.6,87.2 to 93.1,513
Hib,Primary Series,States/Local Areas,Oregon,2018,Age,13 Months,89.3,83.5 to 93.3,290
Hib,Primary Series,States/Local Areas,Oregon,2018-2019,Age,13 Months,88.4,83.9 to 91.8,554
Hib,Primary Series,States/Local Areas,Oregon,2019,Age,13 Months,87.5,79.8 to 92.5,264
Rotavirus,,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,83.3,76.5 to 90.1,251
Hib,≥1 Dose,States/Local Areas,Oregon,2021,Age,3 Months,86.3,77.7 to 92.0,131
PCV,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,90.8,88.6 to 92.7,1808
Polio,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,90.9,88.3 to 92.9,1462
Combined 7 Series,,HHS Regions/National,Region 2,2020-2021,Age,24 Months,67.5,64.0 to 71.1,1462
DTaP,≥3 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,92.8,89.0 to 95.7,570
Hib,Full Series,HHS Regions/National,Region 2,2021,Age,35 Months,83.6,77.8 to 88.7,570
DTaP,≥4 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,88.2,82.7 to 92.6,570
Influenza,,HHS Regions/National,Region 2,2020-2021,Age,24 Months,62.0,58.4 to 65.7,1462
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2020-2021,Age,0-1 Days,73.6,70.3 to 76.7,1462
Hep B,≥3 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,93.1,88.2 to 96.4,570
PCV,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,90.2,87.5 to 92.4,1462
Hib,Primary Series,HHS Regions/National,Region 2,2021,Age,13 Months,84.9,79.9 to 88.8,570
Rotavirus,,HHS Regions/National,Region 2,2020-2021,Age,8 Months,74.8,71.4 to 77.9,1462
Hep A,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,35 Months,89.5,84.8 to 93.3,1462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2020-2021,Age,0-3 Days,78.0,74.8 to 80.9,1462
PCV,≥4 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,74.2,70.7 to 77.4,1462
DTaP,≥4 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,82.1,78.8 to 85.1,1462
Hep A,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,19 Months,73.9,70.5 to 77.0,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,92.8,90.4 to 94.8,1462
Hep B,≥2 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,93.6,89.6 to 96.1,570
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,47.7,44.1 to 51.4,1462
PCV,≥4 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,84.5,81.1 to 87.6,1462
Influenza,,HHS Regions/National,Region 2,2013,Age,24 Months,63.5,59.2 to 67.8,797
Influenza,,HHS Regions/National,Region 2,2013-2014,Age,24 Months,62.6,59.6 to 65.6,1723
Influenza,,HHS Regions/National,Region 2,2015,Age,24 Months,65.7,61.4 to 70.0,818
Influenza,,HHS Regions/National,Region 2,2015-2016,Age,24 Months,62.3,59.0 to 65.6,1622
Influenza,,HHS Regions/National,Region 2,2014,Age,24 Months,61.7,57.7 to 65.8,926
Influenza,,HHS Regions/National,Region 2,2014-2015,Age,24 Months,63.7,60.8 to 66.7,1744
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,95.1,92.6 to 96.9,1462
Influenza,,HHS Regions/National,Region 2,2011,Age,24 Months,58.7,53.9 to 63.6,730
Influenza,,HHS Regions/National,Region 2,2012,Age,24 Months,64.3,60.0 to 68.7,780
Polio,≥3 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,92.3,88.4 to 95.3,570
≥1 Dose Varicella,,HHS Regions/National,Region 2,2021,Age,35 Months,91.2,86.0 to 95.1,570
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,91.5,89.1 to 93.4,1462
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,93.7,91.5 to 95.5,1462
Hib,Full Series,HHS Regions/National,Region 2,2020-2021,Age,19 Months,70.4,66.8 to 73.7,1462
Hib,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,5 Months,75.6,72.2 to 78.7,1462
Hib,Full Series,HHS Regions/National,Region 2,2020-2021,Age,35 Months,84.6,81.1 to 87.7,1462
Hib,Primary Series,HHS Regions/National,Region 2,2020-2021,Age,35 Months,93.9,91.6 to 95.9,1462
Hep A,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,18.1,15.5 to 21.0,1462
PCV,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,63.8,60.2 to 67.3,1462
Hib,Primary Series,HHS Regions/National,Region 2,2020-2021,Age,19 Months,91.8,89.4 to 93.8,1462
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2020-2021,Age,0-2 Days,76.5,73.3 to 79.5,1462
Hep B,≥2 Doses,HHS Regions/National,Region 2,2021,Age,5 Months,86.7,82.1 to 90.2,570
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,89.2,86.5 to 91.5,1462
DTaP,≥4 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,69.4,65.8 to 72.7,1462
DTaP,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,3 Months,86.4,83.6 to 88.7,1462
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020-2021,Age,19 Months,84.9,81.9 to 87.6,1462
Hep B,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,3 Months,93.0,90.7 to 94.8,1462
DTaP,≥2 Doses,HHS Regions/National,Region 2,2021,Age,5 Months,79.4,74.0 to 83.9,570
≥1 Dose MMR,,HHS Regions/National,Region 2,2021,Age,19 Months,84.4,79.3 to 88.4,570
≥1 Dose Varicella,,HHS Regions/National,Region 2,2021,Age,13 Months,50.0,44.4 to 55.6,570
Influenza,,HHS Regions/National,Region 2,2018,Age,24 Months,73.0,69.0 to 76.9,1002
Influenza,,HHS Regions/National,Region 2,2018-2019,Age,24 Months,70.7,67.7 to 73.7,1918
Influenza,,HHS Regions/National,Region 2,2017,Age,24 Months,64.7,60.2 to 69.1,911
Influenza,,HHS Regions/National,Region 2,2017-2018,Age,24 Months,68.8,65.8 to 71.8,1913
Influenza,,HHS Regions/National,Region 2,2016,Age,24 Months,59.0,54.1 to 63.9,804
Influenza,,HHS Regions/National,Region 2,2016-2017,Age,24 Months,61.8,58.4 to 65.1,1715
Influenza,,HHS Regions/National,Region 2,2019,Age,24 Months,68.3,63.6 to 72.9,916
Hib,Primary Series,HHS Regions/National,Region 2,2020-2021,Age,13 Months,85.7,82.8 to 88.2,1462
Polio,≥2 Doses,HHS Regions/National,Region 2,2021,Age,5 Months,79.0,73.7 to 83.5,570
Hib,≥2 Doses,HHS Regions/National,Region 2,2021,Age,5 Months,77.0,71.6 to 81.7,570
Hep B,≥3 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,88.0,83.3 to 91.4,570
Polio,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,93.7,91.4 to 95.5,1462
Influenza,,HHS Regions/National,Region 2,2021,Age,24 Months,60.5,54.7 to 66.5,570
≥1 Dose MMR,,HHS Regions/National,Region 2,2020-2021,Age,13 Months,60.2,56.6 to 63.8,1462
Polio,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,89.9,87.2 to 92.1,1462
≥1 Dose MMR,,HHS Regions/National,Region 2,2020-2021,Age,35 Months,94.1,91.2 to 96.4,1462
PCV,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,92.1,89.6 to 94.2,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,78.6,73.3 to 83.1,570
Polio,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,95.2,92.7 to 97.0,1462
Hep A,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,32.7,29.3 to 36.5,1462
Hep B,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,5 Months,86.7,83.9 to 89.1,1462
Hib,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,3 Months,83.2,80.3 to 85.9,1462
≥1 Dose MMR,,HHS Regions/National,Region 2,2020-2021,Age,24 Months,89.6,86.8 to 92.0,1462
Combined 7 Series,,HHS Regions/National,Region 2,2020-2021,Age,35 Months,73.9,70.0 to 77.7,1462
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020-2021,Age,24 Months,89.5,86.7 to 91.9,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,90.3,87.6 to 92.4,1462
Hib,Primary Series,HHS Regions/National,Region 2,2021,Age,35 Months,92.0,87.9 to 95.0,570
Hib,≥2 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,92.7,88.4 to 95.6,570
Hib,Primary Series,HHS Regions/National,Region 2,2020-2021,Age,7 Months,70.2,66.8 to 73.4,1462
Polio,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,5 Months,77.4,74.1 to 80.4,1462
DTaP,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,5 Months,77.7,74.3 to 80.7,1462
Polio,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,92.8,90.5 to 94.7,1462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2021,Age,0-3 Days,75.7,70.5 to 80.3,570
Rotavirus,,HHS Regions/National,Region 2,2021,Age,8 Months,73.4,67.8 to 78.3,570
Hep A,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,73.7,68.5 to 78.7,1462
PCV,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,3 Months,81.6,78.5 to 84.3,1462
Polio,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,3 Months,85.5,82.7 to 87.9,1462
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,71.3,67.8 to 74.5,1462
PCV,≥1 Dose,HHS Regions/National,Region 2,2021,Age,3 Months,82.1,77.0 to 86.2,570
Hib,≥3 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,91.2,87.0 to 94.5,570
DTaP,≥3 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,92.8,89.0 to 95.7,570
Hib,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,88.0,85.1 to 90.4,1462
≥1 Dose MMR,,HHS Regions/National,Region 2,2021,Age,13 Months,57.3,51.5 to 62.9,570
Hib,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,61.1,57.5 to 64.6,1462
PCV,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,86.5,83.5 to 88.9,1462
Hep B,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,7 Months,90.6,88.0 to 92.6,1462
Rotavirus,,HHS Regions/National,Region 2,2019,Age,8 Months,74.9,70.3 to 79.0,916
Rotavirus,,HHS Regions/National,Region 2,2017,Age,8 Months,72.1,67.7 to 76.2,911
Rotavirus,,HHS Regions/National,Region 2,2017-2018,Age,8 Months,75.5,72.6 to 78.2,1913
Rotavirus,,HHS Regions/National,Region 2,2011,Age,8 Months,68.0,63.3 to 72.4,730
Rotavirus,,HHS Regions/National,Region 2,2018,Age,8 Months,79.0,75.2 to 82.3,1002
Rotavirus,,HHS Regions/National,Region 2,2018-2019,Age,8 Months,77.0,74.1 to 79.7,1918
Rotavirus,,HHS Regions/National,Region 2,2013,Age,8 Months,72.9,68.8 to 76.7,797
Rotavirus,,HHS Regions/National,Region 2,2013-2014,Age,8 Months,73.5,70.7 to 76.1,1723
Rotavirus,,HHS Regions/National,Region 2,2012,Age,8 Months,67.7,63.3 to 71.8,780
Rotavirus,,HHS Regions/National,Region 2,2014,Age,8 Months,74.0,70.3 to 77.4,926
Rotavirus,,HHS Regions/National,Region 2,2014-2015,Age,8 Months,72.9,70.2 to 75.6,1744
Rotavirus,,HHS Regions/National,Region 2,2016,Age,8 Months,70.3,65.5 to 74.6,804
Rotavirus,,HHS Regions/National,Region 2,2016-2017,Age,8 Months,71.2,67.9 to 74.2,1715
Rotavirus,,HHS Regions/National,Region 2,2015,Age,8 Months,71.9,67.6 to 75.7,818
Rotavirus,,HHS Regions/National,Region 2,2015-2016,Age,8 Months,71.0,67.9 to 74.0,1622
≥1 Dose MMR,,HHS Regions/National,Region 2,2020-2021,Age,19 Months,85.3,82.3 to 87.9,1462
Hep B,≥1 Dose,HHS Regions/National,Region 2,2021,Age,3 Months,91.6,87.6 to 94.4,570
Combined 7 Series,,HHS Regions/National,Region 2,2019,Age,24 Months,66.5,61.6 to 71.2,916
Combined 7 Series,,HHS Regions/National,Region 2,2017,Age,35 Months,75.5,70.9 to 79.9,911
Combined 7 Series,,HHS Regions/National,Region 2,2017-2018,Age,35 Months,75.9,72.7 to 78.9,1913
Combined 7 Series,,HHS Regions/National,Region 2,2016,Age,35 Months,70.2,65.2 to 75.1,804
Combined 7 Series,,HHS Regions/National,Region 2,2016-2017,Age,35 Months,72.9,69.5 to 76.3,1715
Combined 7 Series,,HHS Regions/National,Region 2,2018,Age,24 Months,70.2,66.1 to 74.2,1002
Combined 7 Series,,HHS Regions/National,Region 2,2018-2019,Age,24 Months,68.4,65.2 to 71.5,1918
Combined 7 Series,,HHS Regions/National,Region 2,2017,Age,24 Months,69.2,64.8 to 73.4,911
Combined 7 Series,,HHS Regions/National,Region 2,2017-2018,Age,24 Months,69.7,66.7 to 72.6,1913
Combined 7 Series,,HHS Regions/National,Region 2,2014,Age,35 Months,73.3,69.3 to 77.2,926
Combined 7 Series,,HHS Regions/National,Region 2,2014-2015,Age,35 Months,74.2,71.2 to 77.1,1744
Combined 7 Series,,HHS Regions/National,Region 2,2012,Age,35 Months,77.7,72.7 to 82.3,780
Hib,Primary Series,HHS Regions/National,Region 2,2018,Age,35 Months,93.9,91.5 to 95.9,1002
Hib,Primary Series,HHS Regions/National,Region 2,2018-2019,Age,35 Months,93.9,91.8 to 95.6,1918
Combined 7 Series,,HHS Regions/National,Region 2,2015,Age,24 Months,68.4,64.1 to 72.6,818
Combined 7 Series,,HHS Regions/National,Region 2,2015-2016,Age,24 Months,67.0,63.7 to 70.2,1622
Combined 7 Series,,HHS Regions/National,Region 2,2014,Age,24 Months,67.1,63.1 to 71.0,926
Combined 7 Series,,HHS Regions/National,Region 2,2014-2015,Age,24 Months,67.8,64.8 to 70.6,1744
Hib,Primary Series,HHS Regions/National,Region 2,2019,Age,35 Months,93.6,90.2 to 96.2,916
Combined 7 Series,,HHS Regions/National,Region 2,2016,Age,24 Months,65.6,60.7 to 70.4,804
Combined 7 Series,,HHS Regions/National,Region 2,2016-2017,Age,24 Months,67.3,64.0 to 70.6,1715
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,46.0,42.7 to 49.3,1808
Hep B,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,91.4,89.3 to 93.1,1808
Combined 7 Series,,HHS Regions/National,Region 2,2011,Age,35 Months,74.6,69.8 to 79.2,730
Hib,Primary Series,HHS Regions/National,Region 2,2013,Age,24 Months,95.0,92.8 to 96.7,797
Hib,Primary Series,HHS Regions/National,Region 2,2013-2014,Age,24 Months,94.1,92.6 to 95.4,1723
Hib,Primary Series,HHS Regions/National,Region 2,2014,Age,7 Months,69.7,65.7 to 73.4,926
Hib,Primary Series,HHS Regions/National,Region 2,2014-2015,Age,7 Months,68.0,65.1 to 70.9,1744
Hib,Primary Series,HHS Regions/National,Region 2,2015,Age,7 Months,66.4,62.0 to 70.6,818
Hib,Primary Series,HHS Regions/National,Region 2,2015-2016,Age,7 Months,65.7,62.4 to 68.9,1622
Hib,Primary Series,HHS Regions/National,Region 2,2013,Age,7 Months,61.6,57.7 to 65.4,797
Hib,Primary Series,HHS Regions/National,Region 2,2013-2014,Age,7 Months,65.6,62.5 to 68.7,1723
Hib,Primary Series,HHS Regions/National,Region 2,2013,Age,13 Months,89.2,86.0 to 91.8,797
Hib,Primary Series,HHS Regions/National,Region 2,2013-2014,Age,13 Months,88.9,86.4 to 90.9,1723
Hib,Primary Series,HHS Regions/National,Region 2,2012,Age,13 Months,90.5,88.3 to 92.4,780
Hib,Primary Series,HHS Regions/National,Region 2,2011,Age,13 Months,89.3,84.9 to 92.5,730
Hib,Primary Series,HHS Regions/National,Region 2,2014,Age,13 Months,88.5,85.7 to 90.8,926
Hib,Primary Series,HHS Regions/National,Region 2,2014-2015,Age,13 Months,88.5,86.5 to 90.3,1744
Hib,Primary Series,HHS Regions/National,Region 2,2015,Age,13 Months,88.5,85.4 to 91.1,818
Hib,Primary Series,HHS Regions/National,Region 2,2015-2016,Age,13 Months,87.0,84.5 to 89.2,1622
Hib,Primary Series,HHS Regions/National,Region 2,2016,Age,7 Months,65.0,60.0 to 69.7,804
Hib,Primary Series,HHS Regions/National,Region 2,2016-2017,Age,7 Months,67.2,63.9 to 70.4,1715
Hib,Primary Series,HHS Regions/National,Region 2,2017,Age,7 Months,69.5,65.0 to 73.7,911
Hib,Primary Series,HHS Regions/National,Region 2,2017-2018,Age,7 Months,70.7,67.7 to 73.5,1913
Hib,Primary Series,HHS Regions/National,Region 2,2019,Age,7 Months,66.9,62.1 to 71.3,916
Hib,Primary Series,HHS Regions/National,Region 2,2017,Age,24 Months,93.2,90.4 to 95.4,911
Hib,Primary Series,HHS Regions/National,Region 2,2017-2018,Age,24 Months,93.2,91.4 to 94.7,1913
Hib,Primary Series,HHS Regions/National,Region 2,2014,Age,24 Months,93.3,91.0 to 95.2,926
Hib,Primary Series,HHS Regions/National,Region 2,2014-2015,Age,24 Months,93.1,91.4 to 94.6,1744
Hib,Primary Series,HHS Regions/National,Region 2,2015,Age,24 Months,92.9,90.3 to 95.1,818
Hib,Primary Series,HHS Regions/National,Region 2,2015-2016,Age,24 Months,92.2,90.1 to 94.0,1622
Hib,Primary Series,HHS Regions/National,Region 2,2018,Age,7 Months,71.8,67.8 to 75.5,1002
Hib,Primary Series,HHS Regions/National,Region 2,2018-2019,Age,7 Months,69.4,66.2 to 72.3,1918
Hib,Primary Series,HHS Regions/National,Region 2,2014,Age,35 Months,94.8,92.4 to 96.6,926
Hib,Primary Series,HHS Regions/National,Region 2,2014-2015,Age,35 Months,93.9,92.2 to 95.4,1744
Hib,Primary Series,HHS Regions/National,Region 2,2012,Age,35 Months,95.4,93.3 to 97.0,780
Hib,Primary Series,HHS Regions/National,Region 2,2019,Age,24 Months,92.6,89.5 to 95.1,916
Hib,Primary Series,HHS Regions/National,Region 2,2011,Age,35 Months,94.2,91.3 to 96.4,730
Hib,Primary Series,HHS Regions/National,Region 2,2013,Age,35 Months,96.2,94.0 to 97.8,797
Hib,Primary Series,HHS Regions/National,Region 2,2013-2014,Age,35 Months,95.5,93.9 to 96.8,1723
Hib,Primary Series,HHS Regions/National,Region 2,2016,Age,24 Months,91.3,88.0 to 94.1,804
Hib,Primary Series,HHS Regions/National,Region 2,2016-2017,Age,24 Months,92.2,90.1 to 94.1,1715
Hib,Primary Series,HHS Regions/National,Region 2,2018,Age,24 Months,93.2,90.9 to 95.2,1002
Hib,Primary Series,HHS Regions/National,Region 2,2018-2019,Age,24 Months,92.9,91.0 to 94.5,1918
Combined 7 Series,,HHS Regions/National,Region 2,2013,Age,24 Months,69.2,65.0 to 73.3,797
Combined 7 Series,,HHS Regions/National,Region 2,2013-2014,Age,24 Months,68.2,65.3 to 71.0,1723
Combined 7 Series,,HHS Regions/National,Region 2,2011,Age,24 Months,66.6,62.0 to 71.2,730
Combined 7 Series,,HHS Regions/National,Region 2,2012,Age,24 Months,65.6,61.3 to 69.9,780
Hib,Primary Series,HHS Regions/National,Region 2,2015,Age,35 Months,92.9,90.3 to 95.1,818
Hib,Primary Series,HHS Regions/National,Region 2,2015-2016,Age,35 Months,92.7,90.6 to 94.5,1622
Combined 7 Series,,HHS Regions/National,Region 2,2013,Age,35 Months,77.2,72.6 to 81.5,797
Combined 7 Series,,HHS Regions/National,Region 2,2013-2014,Age,35 Months,75.2,72.2 to 78.2,1723
Hib,Primary Series,HHS Regions/National,Region 2,2016,Age,35 Months,92.3,88.9 to 94.9,804
Hib,Primary Series,HHS Regions/National,Region 2,2016-2017,Age,35 Months,93.0,90.9 to 94.8,1715
Hib,Primary Series,HHS Regions/National,Region 2,2017,Age,35 Months,93.8,91.1 to 95.9,911
Hib,Primary Series,HHS Regions/National,Region 2,2017-2018,Age,35 Months,93.9,92.1 to 95.4,1913
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,94.2,92.3 to 95.7,2020
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,92.5,90.9 to 93.9,4120
Hib,≥3 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,88.4,85.7 to 90.6,2317
Hib,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,69.2,66.8 to 71.5,4700
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,90.8,88.5 to 92.7,2100
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,92.4,91.0 to 93.5,4318
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,93.9,92.8 to 94.8,2218
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,93.2,91.9 to 94.2,4559
Hib,≥3 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,88.1,85.8 to 90.0,2369
Hib,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,88.2,86.5 to 89.8,4686
Polio,≥3 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,93.3,91.6 to 94.8,2341
Polio,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,92.6,91.2 to 93.8,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,88.4,86.0 to 90.4,2341
Hib,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,88.2,86.6 to 89.7,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,88.8,86.7 to 90.7,2218
Hib,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,88.6,87.0 to 90.0,4559
DTaP,≥3 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,94.6,92.8 to 96.0,1991
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,92.2,90.1 to 93.9,2369
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,92.3,90.7 to 93.6,4686
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,92.4,90.4 to 94.0,2341
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,92.3,90.9 to 93.5,4710
Polio,≥3 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,93.5,91.9 to 94.9,2218
Polio,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,93.4,92.3 to 94.5,4559
Polio,≥3 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,90.3,87.9 to 92.3,2100
Polio,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,91.9,90.5 to 93.2,4318
Polio,≥3 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,91.2,88.6 to 93.2,2317
Polio,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,67.2,64.8 to 69.6,4700
Polio,≥3 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,91.9,89.7 to 93.7,2383
Polio,≥3 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,91.3,88.5 to 93.6,1848
Polio,≥3 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,93.6,91.9 to 95.1,1991
Hib,≥3 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,87.1,84.6 to 89.3,2100
Hib,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,88.0,86.4 to 89.4,4318
Hib,≥3 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,91.3,88.4 to 93.6,2020
Hib,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,89.2,87.1 to 91.0,4120
Polio,≥3 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,93.9,92.2 to 95.3,2020
Polio,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,92.1,90.6 to 93.4,4120
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,92.4,90.0 to 94.3,2317
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,90.3,88.7 to 91.8,4700
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,93.3,91.2 to 94.9,2383
DTaP,≥3 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,92.7,90.5 to 94.5,1848
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,95.3,93.9 to 96.5,2020
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,93.7,92.4 to 94.9,4120
Hib,Full Series,HHS Regions/National,Region 4,2015,Age,24 Months,78.6,75.8 to 81.2,2218
Hib,Full Series,HHS Regions/National,Region 4,2015-2016,Age,24 Months,79.2,77.2 to 81.1,4559
Polio,≥3 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,95.7,94.3 to 96.9,2218
Polio,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,95.6,94.2 to 96.7,4559
Hib,≥3 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,89.2,86.8 to 91.4,2100
Polio,≥3 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,92.8,90.2 to 94.9,1848
Hib,≥3 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,89.4,87.1 to 91.4,2383
Polio,≥3 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,93.1,91.0 to 94.8,2383
Polio,≥3 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,92.4,90.1 to 94.3,2317
Polio,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,92.7,91.2 to 94.1,4700
Polio,≥3 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,91.8,89.7 to 93.6,2369
Polio,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,92.1,90.6 to 93.5,4686
Hib,Full Series,HHS Regions/National,Region 4,2017,Age,24 Months,79.6,76.7 to 82.4,2369
Hib,Full Series,HHS Regions/National,Region 4,2017-2018,Age,24 Months,78.6,76.4 to 80.7,4686
Hib,Full Series,HHS Regions/National,Region 4,2016,Age,24 Months,79.8,77.0 to 82.5,2341
Hib,Full Series,HHS Regions/National,Region 4,2016-2017,Age,24 Months,79.7,77.7 to 81.7,4710
Hib,Full Series,HHS Regions/National,Region 4,2018,Age,24 Months,77.6,74.3 to 80.7,2317
DTaP,≥2 Doses,HHS Regions/National,Region 4,2014,Age,5 Months,77.5,74.3 to 80.4,2100
DTaP,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,5 Months,78.2,76.7 to 79.6,4318
Hib,≥3 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,93.1,91.3 to 94.5,2020
Hib,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,91.1,89.6 to 92.5,4120
Hib,≥3 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,92.6,90.6 to 94.3,1991
Hib,≥3 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,91.1,88.8 to 93.2,1848
Polio,≥3 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,93.1,91.0 to 94.9,2369
Polio,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,93.1,91.5 to 94.5,4686
Polio,≥3 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,95.5,93.2 to 97.3,2341
Polio,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,94.3,92.7 to 95.6,4710
DTaP,≥2 Doses,HHS Regions/National,Region 4,2015,Age,5 Months,78.9,76.0 to 81.5,2218
DTaP,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,5 Months,79.0,77.0 to 80.9,4559
DTaP,≥2 Doses,HHS Regions/National,Region 4,2013,Age,5 Months,78.4,75.4 to 81.2,2020
DTaP,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,5 Months,78.0,75.8 to 80.0,4120
DTaP,≥2 Doses,HHS Regions/National,Region 4,2012,Age,5 Months,78.3,75.5 to 80.9,1991
DTaP,≥2 Doses,HHS Regions/National,Region 4,2011,Age,5 Months,77.3,72.1 to 81.9,1848
Polio,≥3 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,94.6,92.7 to 96.1,1991
Polio,≥3 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,93.2,90.8 to 95.1,2317
Polio,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,93.5,91.9 to 94.8,4700
Hib,Full Series,HHS Regions/National,Region 4,2018-2019,Age,24 Months,79.3,77.1 to 81.3,4700
Hib,Full Series,HHS Regions/National,Region 4,2011,Age,35 Months,86.1,82.8 to 89.1,1848
Hib,Full Series,HHS Regions/National,Region 4,2012,Age,35 Months,86.2,83.1 to 89.0,1991
Hib,Full Series,HHS Regions/National,Region 4,2013,Age,35 Months,84.0,81.1 to 86.6,2020
Hib,Full Series,HHS Regions/National,Region 4,2013-2014,Age,35 Months,83.1,81.2 to 85.0,4120
Polio,≥3 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,92.4,89.8 to 94.6,2100
Polio,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,94.0,92.5 to 95.3,4318
Polio,≥3 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,95.0,93.3 to 96.4,2020
Polio,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,93.7,92.2 to 95.1,4120
Hib,Full Series,HHS Regions/National,Region 4,2019,Age,24 Months,81.0,78.2 to 83.6,2383
Hib,Full Series,HHS Regions/National,Region 4,2015,Age,35 Months,82.1,79.3 to 84.8,2218
Hib,Full Series,HHS Regions/National,Region 4,2015-2016,Age,35 Months,83.5,81.4 to 85.4,4559
Hib,Full Series,HHS Regions/National,Region 4,2017,Age,35 Months,82.9,79.9 to 85.7,2369
Hib,Full Series,HHS Regions/National,Region 4,2017-2018,Age,35 Months,82.6,80.3 to 84.7,4686
Hib,Full Series,HHS Regions/National,Region 4,2014,Age,35 Months,82.4,79.6 to 85.1,2100
Hib,Full Series,HHS Regions/National,Region 4,2014-2015,Age,35 Months,82.2,80.3 to 84.1,4318
Hib,Full Series,HHS Regions/National,Region 4,2018,Age,35 Months,82.2,78.8 to 85.3,2317
Hib,Full Series,HHS Regions/National,Region 4,2018-2019,Age,35 Months,83.6,81.4 to 85.7,4700
Hib,Full Series,HHS Regions/National,Region 4,2016,Age,35 Months,84.8,81.8 to 87.5,2341
Hib,Full Series,HHS Regions/National,Region 4,2016-2017,Age,35 Months,83.8,81.7 to 85.8,4710
Hib,Full Series,HHS Regions/National,Region 4,2019,Age,35 Months,85.1,82.2 to 87.7,2383
Hib,Primary Series,HHS Regions/National,Region 4,2012,Age,7 Months,71.5,67.0 to 75.6,1991
Hib,Primary Series,HHS Regions/National,Region 4,2011,Age,7 Months,69.6,66.2 to 72.9,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2017,Age,35 Months,88.3,85.5 to 90.8,2369
Hep A,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,35 Months,89.2,87.0 to 91.2,4686
Polio,≥2 Doses,HHS Regions/National,Region 4,2016,Age,5 Months,77.7,74.7 to 80.4,2341
Polio,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,5 Months,77.0,74.9 to 79.0,4710
Polio,≥2 Doses,HHS Regions/National,Region 4,2017,Age,5 Months,76.4,73.3 to 79.2,2369
Polio,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,5 Months,77.0,74.7 to 79.1,4686
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,59.8,56.4 to 63.1,2100
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,59.3,56.9 to 61.6,4318
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,58.7,55.4 to 62.0,2218
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,59.8,57.4 to 62.1,4559
Polio,≥3 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,93.8,91.7 to 95.6,2383
≥1 Dose MMR,,HHS Regions/National,Region 4,2012,Age,13 Months,52.1,48.6 to 55.5,1991
≥1 Dose MMR,,HHS Regions/National,Region 4,2011,Age,13 Months,51.5,47.4 to 55.6,1848
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016,Age,13 Months,60.2,56.9 to 63.4,2341
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016-2017,Age,13 Months,59.5,57.2 to 61.8,4710
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017,Age,13 Months,58.8,55.5 to 62.1,2369
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017-2018,Age,13 Months,59.7,57.2 to 62.1,4686
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015,Age,13 Months,60.0,56.7 to 63.2,2218
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015-2016,Age,13 Months,60.1,57.8 to 62.4,4559
Hep A,≥2 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,38.9,35.7 to 42.2,2218
Hep A,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,38.7,36.4 to 41.0,4559
Hep A,≥2 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,39.9,36.5 to 43.5,2100
Hep A,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,39.4,37.0 to 41.9,4318
Hep A,≥2 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,38.0,34.5 to 41.6,1991
Hep A,≥1 Dose,HHS Regions/National,Region 4,2013,Age,35 Months,86.4,83.6 to 89.0,2020
Hep A,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,35 Months,85.3,83.3 to 87.2,4120
Hep A,≥1 Dose,HHS Regions/National,Region 4,2014,Age,35 Months,84.2,81.2 to 87.0,2100
Hep A,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,35 Months,86.0,84.0 to 87.9,4318
DTaP,≥4 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,80.0,77.0 to 82.8,2100
DTaP,≥4 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,80.9,78.9 to 82.8,4318
DTaP,≥4 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,80.9,78.2 to 83.6,2341
DTaP,≥4 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,80.5,78.5 to 82.4,4710
DTaP,≥4 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,81.7,79.1 to 84.2,2218
DTaP,≥4 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,81.3,79.4 to 83.2,4559
Hep A,≥1 Dose,HHS Regions/National,Region 4,2016,Age,35 Months,88.4,85.6 to 90.8,2341
Hep A,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,35 Months,88.3,86.4 to 90.1,4710
≥1 Dose MMR,,HHS Regions/National,Region 4,2016,Age,13 Months,58.0,54.7 to 61.2,2341
≥1 Dose MMR,,HHS Regions/National,Region 4,2016-2017,Age,13 Months,57.7,55.4 to 60.0,4710
≥1 Dose MMR,,HHS Regions/National,Region 4,2017,Age,13 Months,57.4,54.1 to 60.6,2369
≥1 Dose MMR,,HHS Regions/National,Region 4,2017-2018,Age,13 Months,61.1,58.6 to 63.4,4686
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014,Age,19 Months,86.2,83.7 to 88.4,2100
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014-2015,Age,19 Months,87.3,85.6 to 88.8,4318
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015,Age,19 Months,88.3,85.8 to 90.4,2218
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015-2016,Age,19 Months,87.5,85.8 to 89.0,4559
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013,Age,19 Months,89.0,86.8 to 90.8,2020
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013-2014,Age,19 Months,87.6,85.8 to 89.2,4120
Polio,≥2 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,94.7,93.1 to 95.9,1991
Polio,≥2 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,93.3,91.0 to 95.0,1848
DTaP,≥4 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,83.0,80.1 to 85.7,2383
DTaP,≥4 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,89.3,85.9 to 92.2,1848
DTaP,≥4 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,89.2,86.4 to 91.7,2383
≥1 Dose MMR,,HHS Regions/National,Region 4,2011,Age,19 Months,87.1,84.8 to 89.1,1848
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,90.1,87.8 to 92.0,2383
Hep B,≥3 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,89.4,86.6 to 91.7,1848
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,87.7,84.7 to 90.1,2317
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,88.9,87.0 to 90.5,4700
Hep B,≥3 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,91.3,88.5 to 93.5,1991
DTaP,≥4 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,80.6,77.5 to 83.5,2317
DTaP,≥4 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,81.8,79.7 to 83.8,4700
DTaP,≥4 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,80.1,77.2 to 82.8,2369
DTaP,≥4 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,80.3,78.2 to 82.4,4686
Polio,≥2 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,86.9,84.2 to 89.2,2100
Polio,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,88.5,86.8 to 90.0,4318
Polio,≥2 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,90.2,88.6 to 91.6,2020
Polio,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,88.6,86.7 to 90.2,4120
Polio,≥2 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,90.1,87.9 to 92.0,2218
Polio,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,89.8,88.3 to 91.2,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,84.2,81.1 to 86.9,1848
Hep A,≥2 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,74.2,69.3 to 78.8,2317
Hep A,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,76.0,72.9 to 79.0,4700
Hep A,≥2 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,73.0,69.1 to 76.8,2369
Hep A,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,73.6,70.5 to 76.6,4686
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,88.1,85.6 to 90.2,2020
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,87.0,84.8 to 89.0,4120
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,86.0,83.4 to 88.2,2100
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,86.4,84.6 to 88.0,4318
Hep A,≥2 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,77.8,73.9 to 81.4,2383
Hep B,≥3 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,88.4,86.1 to 90.4,1991
DTaP,≥4 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,89.0,86.3 to 91.4,2020
DTaP,≥4 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,87.7,85.7 to 89.6,4120
DTaP,≥4 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,87.2,84.1 to 90.0,1991
DTaP,≥4 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,86.6,83.7 to 89.3,2100
DTaP,≥4 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,87.4,85.4 to 89.2,4318
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018,Age,13 Months,60.5,56.8 to 64.0,2317
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018-2019,Age,13 Months,62.5,60.0 to 64.9,4700
≥1 Dose MMR,,HHS Regions/National,Region 4,2013,Age,13 Months,51.4,47.6 to 55.1,2020
≥1 Dose MMR,,HHS Regions/National,Region 4,2013-2014,Age,13 Months,54.2,51.5 to 57.0,4120
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019,Age,13 Months,64.4,61.0 to 67.7,2383
≥1 Dose Varicella,,HHS Regions/National,Region 4,2011,Age,19 Months,87.8,85.4 to 89.7,1848
≥1 Dose Varicella,,HHS Regions/National,Region 4,2012,Age,19 Months,86.7,83.8 to 89.1,1991
≥1 Dose MMR,,HHS Regions/National,Region 4,2014,Age,13 Months,57.1,53.7 to 60.4,2100
≥1 Dose MMR,,HHS Regions/National,Region 4,2014-2015,Age,13 Months,57.6,55.3 to 59.9,4318
≥1 Dose MMR,,HHS Regions/National,Region 4,2015,Age,13 Months,58.2,54.9 to 61.4,2218
≥1 Dose MMR,,HHS Regions/National,Region 4,2015-2016,Age,13 Months,58.1,55.8 to 60.4,4559
Hep A,≥2 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,40.8,37.5 to 44.2,2369
Hep A,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,42.0,39.5 to 44.5,4686
Hep A,≥2 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,38.5,35.3 to 41.8,2341
Hep A,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,39.6,37.4 to 42.0,4710
DTaP,≥4 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,81.8,79.2 to 84.4,2020
DTaP,≥4 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,80.9,78.9 to 82.8,4120
DTaP,≥4 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,73.1,69.9 to 76.1,2383
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,60.3,54.1 to 66.2,2020
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,60.0,55.3 to 64.7,4120
DTaP,≥4 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,81.1,78.1 to 84.0,1848
DTaP,≥4 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,80.6,77.6 to 83.4,1991
Hep B,≥3 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,58.8,53.5 to 63.9,1991
Hep B,≥3 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,52.3,46.2 to 58.2,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2015,Age,35 Months,87.9,85.3 to 90.3,2218
Hep A,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,35 Months,88.1,86.2 to 89.9,4559
Polio,≥2 Doses,HHS Regions/National,Region 4,2012,Age,5 Months,77.6,75.0 to 80.1,1991
Polio,≥2 Doses,HHS Regions/National,Region 4,2011,Age,5 Months,76.3,70.7 to 81.1,1848
Hep A,≥1 Dose,HHS Regions/National,Region 4,2012,Age,35 Months,86.6,83.7 to 89.2,1991
Polio,≥2 Doses,HHS Regions/National,Region 4,2013,Age,5 Months,77.6,74.3 to 80.5,2020
Polio,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,5 Months,76.8,74.6 to 78.9,4120
Polio,≥2 Doses,HHS Regions/National,Region 4,2014,Age,5 Months,76.1,72.8 to 79.1,2100
Polio,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,5 Months,77.2,75.6 to 78.8,4318
DTaP,≥4 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,68.0,64.4 to 71.4,2317
DTaP,≥4 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,94.3,93.0 to 95.4,4700
Hep A,≥2 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,40.7,37.4 to 44.1,2020
Hep A,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,40.3,37.9 to 42.7,4120
DTaP,≥4 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,68.6,65.4 to 71.7,2341
DTaP,≥4 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,69.7,67.5 to 71.8,4710
DTaP,≥4 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,70.7,67.6 to 73.7,2369
DTaP,≥4 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,69.4,67.0 to 71.7,4686
PCV,≥2 Doses,HHS Regions/National,Region 4,2019,Age,5 Months,78.7,75.4 to 81.7,2383
PCV,≥2 Doses,HHS Regions/National,Region 4,2017,Age,5 Months,74.8,71.6 to 77.7,2369
PCV,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,5 Months,75.6,73.3 to 77.8,4686
PCV,≥2 Doses,HHS Regions/National,Region 4,2018,Age,5 Months,76.4,73.1 to 79.4,2317
PCV,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,5 Months,77.6,75.3 to 79.7,4700
Hib,≥3 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,93.7,91.8 to 95.3,2383
≥1 Dose Varicella,,HHS Regions/National,Region 4,2011,Age,13 Months,57.7,55.0 to 60.5,1848
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013,Age,13 Months,60.5,56.1 to 64.7,2020
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013-2014,Age,13 Months,59.0,56.0 to 61.9,4120
Polio,≥2 Doses,HHS Regions/National,Region 4,2018,Age,5 Months,77.6,74.3 to 80.6,2317
Polio,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,5 Months,78.6,76.3 to 80.7,4700
Hep A,≥1 Dose,HHS Regions/National,Region 4,2019,Age,35 Months,93.3,90.8 to 95.4,2383
Hep A,≥1 Dose,HHS Regions/National,Region 4,2018,Age,35 Months,90.1,86.6 to 93.0,2317
Hep A,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,35 Months,91.7,89.5 to 93.6,4700
≥1 Dose Varicella,,HHS Regions/National,Region 4,2012,Age,13 Months,60.1,57.3 to 62.8,1991
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014,Age,13 Months,57.4,54.0 to 60.8,2100
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014-2015,Age,13 Months,58.7,56.3 to 61.0,4318
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,62.0,58.5 to 65.4,2383
Hep A,≥2 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,71.4,67.3 to 75.4,2100
Hep A,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,72.3,69.4 to 75.0,4318
Hep A,≥2 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,74.3,70.1 to 78.3,2341
Hep A,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,73.6,70.7 to 76.4,4710
Hep A,≥2 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,73.3,69.4 to 77.0,2218
Hep A,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,73.8,71.0 to 76.5,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,62.2,58.4 to 65.8,2317
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,62.1,59.5 to 64.6,4700
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,58.2,54.8 to 61.4,2369
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,60.1,57.7 to 62.6,4686
Polio,≥2 Doses,HHS Regions/National,Region 4,2019,Age,5 Months,79.6,76.4 to 82.5,2383
Polio,≥2 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,90.2,88.5 to 91.6,1991
Polio,≥2 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,88.3,85.3 to 90.9,1848
Hep A,≥2 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,43.1,39.5 to 46.9,2317
Hep A,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,45.0,42.4 to 47.6,4700
Hep A,≥2 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,46.9,43.3 to 50.6,2383
Polio,≥2 Doses,HHS Regions/National,Region 4,2015,Age,5 Months,78.3,75.5 to 81.0,2218
Polio,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,5 Months,78.0,76.0 to 79.9,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,60.8,57.5 to 64.1,2341
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,59.5,57.1 to 61.8,4710
Hep A,≥2 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,66.9,61.6 to 72.1,1848
Hep A,≥2 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,68.7,64.4 to 73.0,1991
Hep A,≥2 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,72.8,68.9 to 76.6,2020
Hep A,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,72.1,69.2 to 74.9,4120
Hib,≥2 Doses,HHS Regions/National,Region 4,2012,Age,5 Months,77.3,74.2 to 80.0,1991
Hib,≥2 Doses,HHS Regions/National,Region 4,2011,Age,5 Months,76.3,71.4 to 80.6,1848
Hib,≥2 Doses,HHS Regions/National,Region 4,2013,Age,5 Months,76.9,74.0 to 79.6,2020
Hib,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,5 Months,76.5,74.6 to 78.3,4120
Hib,≥2 Doses,HHS Regions/National,Region 4,2014,Age,5 Months,76.1,72.9 to 79.0,2100
Hib,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,5 Months,76.7,75.0 to 78.3,4318
PCV,≥3 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,90.3,87.9 to 92.2,2369
PCV,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,91.2,89.5 to 92.6,4686
PCV,≥3 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,92.6,90.4 to 94.3,2383
PCV,≥3 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,92.0,89.7 to 93.9,1848
PCV,≥3 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,92.1,89.7 to 94.0,2317
PCV,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,88.8,87.0 to 90.4,4700
Hep B,≥2 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,94.8,93.1 to 96.2,2383
PCV,≥1 Dose,HHS Regions/National,Region 4,2011,Age,3 Months,83.8,80.5 to 86.7,1848
PCV,≥4 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,82.6,79.6 to 85.3,2369
PCV,≥4 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,83.5,81.3 to 85.5,4686
Hib,≥2 Doses,HHS Regions/National,Region 4,2015,Age,5 Months,77.2,74.3 to 79.9,2218
Hib,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,5 Months,77.6,75.5 to 79.5,4559
Hib,≥2 Doses,HHS Regions/National,Region 4,2016,Age,5 Months,77.9,75.0 to 80.6,2341
Hib,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,5 Months,76.9,74.8 to 78.9,4710
PCV,≥1 Dose,HHS Regions/National,Region 4,2013,Age,3 Months,86.8,84.7 to 88.7,2020
PCV,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,3 Months,86.2,84.2 to 87.9,4120
PCV,≥3 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,90.7,88.4 to 92.7,2100
PCV,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,91.8,90.3 to 93.1,4318
PCV,≥3 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,93.2,91.4 to 94.8,1991
Hib,≥2 Doses,HHS Regions/National,Region 4,2017,Age,5 Months,75.9,72.8 to 78.7,2369
Hib,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,5 Months,76.2,73.9 to 78.3,4686
PCV,≥3 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,93.5,91.7 to 95.0,2020
PCV,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,92.1,90.6 to 93.4,4120
Hib,≥1 Dose,HHS Regions/National,Region 4,2019,Age,3 Months,89.3,86.9 to 91.3,2383
Hib,≥1 Dose,HHS Regions/National,Region 4,2018,Age,3 Months,87.4,84.6 to 89.8,2317
Hib,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,3 Months,88.4,86.5 to 90.0,4700
PCV,≥4 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,85.4,82.7 to 87.9,2341
PCV,≥4 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,83.9,81.9 to 85.8,4710
PCV,≥4 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,84.4,81.4 to 87.2,2317
PCV,≥4 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,86.1,84.0 to 88.1,4700
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,93.8,91.9 to 95.4,2383
PCV,≥3 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,89.6,87.2 to 91.6,2100
PCV,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,90.9,89.4 to 92.2,4318
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,93.5,91.2 to 95.3,2317
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,93.7,92.2 to 94.9,4700
PCV,≥4 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,84.2,81.6 to 86.6,2218
PCV,≥4 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,84.8,82.9 to 86.5,4559
PCV,≥4 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,83.3,80.4 to 86.0,2100
PCV,≥4 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,83.7,81.8 to 85.6,4318
Hep B,≥2 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,95.5,93.7 to 96.8,2317
Hep B,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,95.2,94.0 to 96.1,4700
Hep B,≥2 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,95.4,94.0 to 96.5,2341
Hep B,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,94.9,93.8 to 95.8,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,92.2,90.9 to 93.3,2218
PCV,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,91.9,90.5 to 93.1,4559
PCV,≥3 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,91.7,89.6 to 93.4,2341
PCV,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,91.0,89.5 to 92.3,4710
Hib,≥1 Dose,HHS Regions/National,Region 4,2015,Age,3 Months,86.3,83.8 to 88.5,2218
Hib,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,3 Months,87.7,86.0 to 89.2,4559
Hib,≥1 Dose,HHS Regions/National,Region 4,2016,Age,3 Months,89.0,86.8 to 90.9,2341
Hib,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,3 Months,87.5,85.9 to 89.0,4710
Hib,≥1 Dose,HHS Regions/National,Region 4,2017,Age,3 Months,86.0,83.4 to 88.3,2369
Hib,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,3 Months,86.7,84.8 to 88.4,4686
Hep B,≥2 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,94.4,92.7 to 95.8,2369
Hep B,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,95.0,93.8 to 95.9,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2018,Age,35 Months,94.4,91.9 to 96.3,2317
≥1 Dose MMR,,HHS Regions/National,Region 4,2018-2019,Age,35 Months,95.0,93.5 to 96.2,4700
≥1 Dose MMR,,HHS Regions/National,Region 4,2017,Age,35 Months,92.8,90.7 to 94.5,2369
≥1 Dose MMR,,HHS Regions/National,Region 4,2017-2018,Age,35 Months,93.6,92.0 to 94.9,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2019,Age,35 Months,95.4,93.8 to 96.8,2383
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019,Age,35 Months,96.6,94.3 to 98.2,2383
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018,Age,35 Months,94.1,91.4 to 96.2,2317
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018-2019,Age,35 Months,95.2,93.4 to 96.7,4700
PCV,≥4 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,81.9,79.3 to 84.4,2218
PCV,≥4 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,82.1,80.3 to 83.9,4559
≥1 Dose MMR,,HHS Regions/National,Region 4,2016,Age,35 Months,93.4,91.6 to 95.0,2341
≥1 Dose MMR,,HHS Regions/National,Region 4,2016-2017,Age,35 Months,93.1,91.7 to 94.3,4710
≥1 Dose MMR,,HHS Regions/National,Region 4,2014,Age,35 Months,93.3,90.4 to 95.5,2100
≥1 Dose MMR,,HHS Regions/National,Region 4,2014-2015,Age,35 Months,93.7,91.9 to 95.2,4318
≥1 Dose MMR,,HHS Regions/National,Region 4,2015,Age,35 Months,93.9,92.2 to 95.4,2218
≥1 Dose MMR,,HHS Regions/National,Region 4,2015-2016,Age,35 Months,93.7,92.4 to 94.8,4559
PCV,≥4 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,80.9,78.0 to 83.7,2369
PCV,≥4 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,81.4,79.3 to 83.4,4686
PCV,≥4 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,82.3,79.7 to 84.9,2341
PCV,≥4 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,81.6,79.7 to 83.5,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,87.7,84.9 to 90.0,2317
PCV,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,88.8,87.0 to 90.4,4700
PCV,≥3 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,86.1,83.3 to 88.4,2369
PCV,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,86.9,84.9 to 88.6,4686
Hep B,≥2 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,92.3,90.1 to 94.1,2383
Hep B,≥2 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,93.5,91.4 to 95.1,1848
Hep B,≥2 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,95.1,93.7 to 96.2,1991
Hep B,≥3 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,93.9,91.9 to 95.6,1991
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,93.2,90.7 to 95.2,2100
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,93.4,91.8 to 94.8,4318
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,93.6,91.6 to 95.2,2020
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,93.5,91.9 to 94.8,4120
PCV,≥3 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,89.2,86.9 to 91.1,2341
PCV,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,87.6,85.9 to 89.2,4710
Hib,Full Series,HHS Regions/National,Region 4,2020,Age,24 Months,75.6,72.8 to 78.2,2665
PCV,≥4 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,81.9,78.9 to 84.7,2317
PCV,≥4 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,83.6,81.6 to 85.5,4700
PCV,≥4 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,85.2,82.4 to 87.8,2383
PCV,≥4 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,85.6,82.1 to 88.7,1848
PCV,≥4 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,84.9,81.9 to 87.6,1991
PCV,≥3 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,92.4,90.5 to 93.9,1991
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,93.5,91.5 to 95.1,2369
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,93.5,92.1 to 94.8,4686
PCV,≥3 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,89.9,87.4 to 91.9,2383
PCV,≥3 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,91.0,88.3 to 93.2,1848
PCV,≥3 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,92.7,90.4 to 94.4,2020
PCV,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,91.1,89.3 to 92.6,4120
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,93.6,91.6 to 95.3,2218
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,94.7,93.1 to 96.0,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,95.7,93.3 to 97.5,2341
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,94.5,93.0 to 95.8,4710
Hib,≥1 Dose,HHS Regions/National,Region 4,2013,Age,3 Months,88.1,86.0 to 89.9,2020
Hib,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,3 Months,87.1,85.3 to 88.8,4120
Hib,≥1 Dose,HHS Regions/National,Region 4,2012,Age,3 Months,87.5,85.8 to 89.0,1991
Hib,≥1 Dose,HHS Regions/National,Region 4,2011,Age,3 Months,86.1,82.6 to 88.9,1848
Hib,≥1 Dose,HHS Regions/National,Region 4,2014,Age,3 Months,86.2,83.6 to 88.5,2100
Hib,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,3 Months,86.2,84.5 to 87.9,4318
Hep B,≥2 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,93.0,90.9 to 94.6,2100
Hep B,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,93.5,92.2 to 94.7,4318
Hep B,≥2 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,94.1,92.3 to 95.5,2218
Hep B,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,94.8,93.6 to 95.7,4559
Hep B,≥2 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,95.2,93.9 to 96.2,2020
Hep B,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,94.1,92.8 to 95.1,4120
PCV,≥4 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,87.8,84.8 to 90.5,2383
PCV,≥4 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,85.2,82.5 to 87.7,2020
PCV,≥4 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,84.2,82.2 to 86.1,4120
Hep B,≥2 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,93.0,90.8 to 94.7,2317
Hep B,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,92.7,91.2 to 93.9,4700
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2019,Age,0-2 Days,78.6,75.6 to 81.3,2383
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2018,Age,0-2 Days,73.9,70.4 to 77.2,2317
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2018-2019,Age,0-2 Days,76.3,73.9 to 78.4,4700
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2017,Age,0-2 Days,70.6,67.5 to 73.6,2369
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2017-2018,Age,0-2 Days,72.3,69.9 to 74.5,4686
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,92.9,91.0 to 94.5,2383
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,92.2,90.3 to 93.9,2369
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,92.4,91.0 to 93.7,4686
Hep B,≥3 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,92.3,90.1 to 94.1,1848
PCV,≥4 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,81.9,79.0 to 84.6,1991
PCV,≥4 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,81.2,78.3 to 83.8,2100
PCV,≥4 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,81.5,79.6 to 83.4,4318
PCV,≥4 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,82.4,79.8 to 84.9,2020
PCV,≥4 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,81.8,79.8 to 83.6,4120
≥1 Dose MMR,,HHS Regions/National,Region 4,2019,Age,24 Months,94.0,92.3 to 95.5,2383
≥1 Dose MMR,,HHS Regions/National,Region 4,2018-2019,Age,24 Months,92.9,91.5 to 94.2,4700
≥1 Dose MMR,,HHS Regions/National,Region 4,2011,Age,35 Months,94.1,91.5 to 96.2,1848
≥1 Dose MMR,,HHS Regions/National,Region 4,2012,Age,35 Months,94.7,92.9 to 96.2,1991
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016,Age,35 Months,94.0,92.3 to 95.5,2341
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016-2017,Age,35 Months,93.8,92.4 to 95.0,4710
≥1 Dose MMR,,HHS Regions/National,Region 4,2013,Age,35 Months,93.1,90.8 to 94.9,2020
≥1 Dose MMR,,HHS Regions/National,Region 4,2013-2014,Age,35 Months,93.2,91.3 to 94.9,4120
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,92.6,90.5 to 94.5,2317
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,92.8,91.4 to 94.0,4700
Hep B,≥2 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,90.4,88.1 to 92.3,2218
Hep B,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,91.8,90.4 to 93.1,4559
PCV,≥3 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,85.8,83.1 to 88.2,2100
PCV,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,87.4,85.7 to 88.9,4318
PCV,≥3 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,88.9,86.7 to 90.9,2218
PCV,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,89.1,87.5 to 90.5,4559
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2014,Age,0-2 Days,70.4,67.1 to 73.4,2100
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2014-2015,Age,0-2 Days,70.6,68.4 to 72.8,4318
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2015,Age,0-2 Days,70.9,67.7 to 73.9,2218
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2015-2016,Age,0-2 Days,71.0,68.8 to 73.1,4559
PCV,≥4 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,78.5,75.3 to 81.3,2317
PCV,≥4 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,79.5,76.8 to 81.9,3710
PCV,≥4 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,77.2,74.2 to 80.0,2369
PCV,≥4 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,77.8,75.6 to 79.9,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2017,Age,24 Months,90.8,88.8 to 92.6,2369
≥1 Dose MMR,,HHS Regions/National,Region 4,2017-2018,Age,24 Months,91.3,89.8 to 92.7,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2016,Age,24 Months,91.6,89.8 to 93.3,2341
≥1 Dose MMR,,HHS Regions/National,Region 4,2016-2017,Age,24 Months,91.2,89.9 to 92.4,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,87.9,85.7 to 89.8,1991
Hep A,≥1 Dose,HHS Regions/National,Region 4,2020,Age,35 Months,88.5,86.2 to 90.6,2665
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,93.5,91.7 to 95.0,2341
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,92.8,91.5 to 94.0,4710
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,91.4,89.5 to 93.2,2218
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,92.4,91.1 to 93.6,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014,Age,24 Months,90.5,88.2 to 92.4,2100
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,24 Months,91.0,89.5 to 92.3,4318
PCV,≥3 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,69.6,66.1 to 72.9,2383
PCV,≥3 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,87.3,85.0 to 89.3,1848
PCV,≥3 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,68.4,64.8 to 71.8,2317
PCV,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,69.0,66.5 to 71.4,4700
Hep B,≥2 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,90.8,88.6 to 92.7,2100
Hep B,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,90.6,89.1 to 92.0,4318
Hep B,≥2 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,92.5,91.2 to 93.6,1991
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2019,Age,0-1 Days,73.9,70.7 to 77.0,2383
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2011,Age,0-2 Days,70.5,63.2 to 76.9,1848
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2018,Age,0-1 Days,70.0,66.4 to 73.4,2317
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2018-2019,Age,0-1 Days,72.0,69.6 to 74.3,4700
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2013,Age,0-2 Days,69.7,63.6 to 75.2,2020
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2013-2014,Age,0-2 Days,70.0,65.5 to 74.2,4120
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2012,Age,0-2 Days,71.4,65.0 to 77.1,1991
Hep B,≥2 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,92.5,90.5 to 94.2,2020
Hep B,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,91.7,90.1 to 93.0,4120
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,91.6,89.5 to 93.3,2383
Hep B,≥3 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,90.7,88.5 to 92.7,1848
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013,Age,24 Months,92.4,90.5 to 94.1,2020
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,24 Months,91.4,90.0 to 92.8,4120
PCV,≥3 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,68.4,65.1 to 71.5,2341
PCV,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,67.1,64.8 to 69.4,4710
Hep B,≥3 Doses,HHS Regions/National,Region 4,2012,Age,24 Months,92.2,90.2 to 93.9,1991
PCV,≥3 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,65.9,62.6 to 69.0,2369
PCV,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,67.1,64.6 to 69.5,4686
PCV,≥3 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,64.7,61.4 to 67.9,2218
PCV,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,66.6,64.2 to 68.8,4559
PCV,≥4 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,78.0,75.0 to 80.7,2100
PCV,≥4 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,78.2,76.2 to 80.1,4318
PCV,≥4 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,78.4,74.0 to 82.2,2218
PCV,≥4 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,77.4,75.3 to 79.3,4559
PCV,≥4 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,76.3,73.3 to 79.2,2341
PCV,≥4 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,76.8,74.7 to 78.8,4710
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018,Age,24 Months,91.2,88.9 to 93.1,2317
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018-2019,Age,24 Months,92.0,90.5 to 93.4,4700
≥1 Dose MMR,,HHS Regions/National,Region 4,2015,Age,24 Months,91.5,89.7 to 93.1,2218
≥1 Dose MMR,,HHS Regions/National,Region 4,2015-2016,Age,24 Months,91.6,90.3 to 92.7,4559
≥1 Dose MMR,,HHS Regions/National,Region 4,2014,Age,24 Months,88.3,85.9 to 90.4,2100
≥1 Dose MMR,,HHS Regions/National,Region 4,2014-2015,Age,24 Months,89.9,88.4 to 91.3,4318
≥1 Dose MMR,,HHS Regions/National,Region 4,2013,Age,24 Months,90.1,87.9 to 92.1,2020
≥1 Dose MMR,,HHS Regions/National,Region 4,2013-2014,Age,24 Months,89.2,87.6 to 90.7,4120
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019,Age,24 Months,92.9,90.7 to 94.6,2383
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017,Age,24 Months,90.8,88.7 to 92.7,2369
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017-2018,Age,24 Months,91.0,89.4 to 92.4,4686
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2016,Age,0-2 Days,71.1,68.0 to 74.0,2341
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2016-2017,Age,0-2 Days,70.9,68.6 to 73.0,4710
Hep B,≥2 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,93.2,91.5 to 94.6,2341
Hep B,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,91.6,90.2 to 92.8,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,90.1,87.2 to 92.4,2020
PCV,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,87.9,85.4 to 90.1,4120
Hep B,≥2 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,90.0,87.7 to 91.9,2369
Hep B,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,91.5,89.9 to 92.8,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2018,Age,24 Months,91.8,89.6 to 93.7,2317
PCV,≥4 Doses,HHS Regions/National,Region 4,2019,Age,19 Months,81.4,78.5 to 84.1,2383
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013,Age,35 Months,94.4,92.5 to 95.9,2020
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013-2014,Age,35 Months,93.9,92.2 to 95.3,4120
≥1 Dose Varicella,,HHS Regions/National,Region 4,2012,Age,35 Months,94.5,92.6 to 96.0,1991
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015,Age,35 Months,94.4,92.5 to 95.9,2218
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015-2016,Age,35 Months,94.2,92.9 to 95.3,4559
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014,Age,35 Months,93.1,90.6 to 95.2,2100
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014-2015,Age,35 Months,93.9,92.2 to 95.3,4318
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017,Age,35 Months,93.4,91.3 to 95.2,2369
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017-2018,Age,35 Months,93.8,92.1 to 95.2,4686
PCV,≥1 Dose,HHS Regions/National,Region 4,2012,Age,3 Months,85.1,82.5 to 87.4,1991
PCV,≥4 Doses,HHS Regions/National,Region 4,2011,Age,24 Months,81.6,78.4 to 84.5,1848
≥1 Dose Varicella,,HHS Regions/National,Region 4,2011,Age,35 Months,94.5,91.8 to 96.5,1848
Hep B,≥2 Doses,HHS Regions/National,Region 4,2018,Age,5 Months,88.0,85.2 to 90.4,2317
Hep B,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,5 Months,88.4,86.6 to 90.1,4700
Hep B,≥2 Doses,HHS Regions/National,Region 4,2019,Age,5 Months,88.9,86.3 to 91.0,2383
Hep B,≥2 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,90.0,87.5 to 92.0,1848
Hep B,≥2 Doses,HHS Regions/National,Region 4,2017,Age,5 Months,86.5,84.0 to 88.7,2369
Hep B,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,5 Months,87.3,85.4 to 89.0,4686
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014,Age,24 Months,88.3,86.0 to 90.5,2100
≥1 Dose Varicella,,HHS Regions/National,Region 4,2014-2015,Age,24 Months,89.9,88.4 to 91.3,4318
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2016,Age,0-1 Days,65.1,61.8 to 68.2,2341
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2016-2017,Age,0-1 Days,65.4,63.1 to 67.6,4710
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2017,Age,0-1 Days,65.7,62.5 to 68.8,2369
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2017-2018,Age,0-1 Days,67.9,65.4 to 70.2,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2017,Age,19 Months,88.0,85.7 to 90.0,2369
≥1 Dose MMR,,HHS Regions/National,Region 4,2017-2018,Age,19 Months,88.5,86.8 to 90.0,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2019,Age,19 Months,91.1,89.0 to 92.8,2383
≥1 Dose MMR,,HHS Regions/National,Region 4,2018,Age,19 Months,89.1,86.5 to 91.2,2317
≥1 Dose MMR,,HHS Regions/National,Region 4,2018-2019,Age,19 Months,94.2,93.0 to 95.3,4700
PCV,≥4 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,79.4,75.8 to 82.6,2020
PCV,≥4 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,78.7,76.4 to 80.8,4120
PCV,≥4 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,77.7,75.5 to 79.8,1991
PCV,≥4 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,77.6,74.3 to 80.6,1848
≥1 Dose MMR,,HHS Regions/National,Region 4,2011,Age,24 Months,90.2,87.9 to 92.2,1848
≥1 Dose MMR,,HHS Regions/National,Region 4,2012,Age,24 Months,89.5,87.2 to 91.6,1991
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015,Age,24 Months,91.5,89.5 to 93.2,2218
≥1 Dose Varicella,,HHS Regions/National,Region 4,2015-2016,Age,24 Months,91.7,90.4 to 92.9,4559
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016,Age,24 Months,91.9,90.1 to 93.6,2341
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016-2017,Age,24 Months,91.4,90.0 to 92.6,4710
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019,Age,19 Months,90.1,87.8 to 92.0,2383
Polio,≥2 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,94.1,92.1 to 95.6,2383
Polio,≥2 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,94.5,92.6 to 95.9,2317
Polio,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,94.3,93.0 to 95.4,4700
Polio,≥2 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,93.6,91.7 to 95.1,2369
Polio,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,94.0,92.7 to 95.1,4686
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013,Age,24 Months,91.9,89.9 to 93.6,2020
≥1 Dose Varicella,,HHS Regions/National,Region 4,2013-2014,Age,24 Months,90.1,88.6 to 91.5,4120
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2013,Age,0-1 Days,64.8,58.2 to 71.0,2020
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2013-2014,Age,0-1 Days,65.0,59.7 to 70.1,4120
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2014,Age,0-1 Days,65.2,61.8 to 68.5,2100
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2014-2015,Age,0-1 Days,64.6,62.2 to 66.9,4318
Hep B,≥2 Doses,HHS Regions/National,Region 4,2015,Age,5 Months,86.8,84.3 to 88.9,2218
Hep B,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,5 Months,88.2,86.6 to 89.6,4559
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2015,Age,0-1 Days,64.0,60.7 to 67.1,2218
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2015-2016,Age,0-1 Days,64.5,62.2 to 66.7,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018,Age,19 Months,92.0,89.7 to 93.9,2317
Hep B,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,19 Months,88.9,87.0 to 90.5,4700
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,90.9,88.8 to 92.7,2369
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,91.5,89.9 to 92.8,4686
Hep B,≥2 Doses,HHS Regions/National,Region 4,2016,Age,5 Months,89.7,87.6 to 91.4,2341
Hep B,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,5 Months,88.1,86.5 to 89.5,4710
Hep B,≥2 Doses,HHS Regions/National,Region 4,2014,Age,5 Months,86.0,83.3 to 88.3,2100
Hep B,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,5 Months,86.4,84.7 to 87.8,4318
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2012,Age,0-1 Days,65.7,59.3 to 71.6,1991
PCV,≥3 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,65.2,62.5 to 67.9,2020
PCV,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,65.6,63.5 to 67.7,4120
PCV,≥3 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,65.2,61.6 to 68.6,1848
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,91.8,89.6 to 93.5,2341
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,91.4,89.9 to 92.6,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,66.1,62.6 to 69.3,2100
PCV,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,65.4,63.0 to 67.7,4318
PCV,≥3 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,65.2,60.2 to 69.9,1991
≥1 Dose MMR,,HHS Regions/National,Region 4,2019,Age,13 Months,69.7,66.4 to 72.8,2383
Hep B,≥1 Dose,HHS Regions/National,Region 4,2019,Age,3 Months,95.8,94.0 to 97.0,2383
Polio,≥2 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,91.2,88.9 to 93.1,2100
Polio,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,92.5,91.0 to 93.7,4318
Hep B,≥1 Dose,HHS Regions/National,Region 4,2018,Age,3 Months,96.2,94.6 to 97.4,2317
Hep B,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,3 Months,96.0,94.9 to 96.9,4700
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2011,Age,0-1 Days,64.6,56.9 to 71.7,1848
Hep B,≥2 Doses,HHS Regions/National,Region 4,2012,Age,5 Months,87.8,85.6 to 89.8,1991
Hep B,≥2 Doses,HHS Regions/National,Region 4,2011,Age,5 Months,84.4,80.7 to 87.6,1848
Hep B,≥2 Doses,HHS Regions/National,Region 4,2013,Age,5 Months,87.2,84.3 to 89.6,2020
Hep B,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,5 Months,86.6,84.7 to 88.2,4120
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,91.4,89.1 to 93.3,2020
Hep B,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,90.4,88.7 to 91.9,4120
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,89.5,87.1 to 91.4,2100
Hep B,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,90.1,88.6 to 91.5,4318
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,90.8,88.9 to 92.4,2218
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,91.3,89.8 to 92.6,4559
≥1 Dose MMR,,HHS Regions/National,Region 4,2015,Age,19 Months,88.1,86.0 to 90.0,2218
≥1 Dose MMR,,HHS Regions/National,Region 4,2015-2016,Age,19 Months,87.5,85.8 to 88.9,4559
≥1 Dose MMR,,HHS Regions/National,Region 4,2016,Age,19 Months,86.8,84.3 to 88.9,2341
≥1 Dose MMR,,HHS Regions/National,Region 4,2016-2017,Age,19 Months,87.4,85.7 to 88.9,4710
≥1 Dose Varicella,,HHS Regions/National,Region 4,2011,Age,24 Months,90.6,88.3 to 92.7,1848
≥1 Dose Varicella,,HHS Regions/National,Region 4,2012,Age,24 Months,90.6,88.5 to 92.4,1991
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016,Age,19 Months,86.6,84.0 to 88.9,2341
≥1 Dose Varicella,,HHS Regions/National,Region 4,2016-2017,Age,19 Months,87.1,85.3 to 88.6,4710
Polio,≥2 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,93.8,91.8 to 95.2,2218
Polio,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,94.2,93.0 to 95.2,4559
Polio,≥2 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,94.7,93.1 to 95.9,2341
Polio,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,94.1,93.0 to 95.1,4710
Hep B,≥1 Dose,HHS Regions/National,Region 4,2017,Age,3 Months,94.2,92.3 to 95.7,2369
Hep B,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,3 Months,95.2,94.0 to 96.2,4686
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018,Age,19 Months,88.3,85.7 to 90.5,2317
≥1 Dose Varicella,,HHS Regions/National,Region 4,2018-2019,Age,19 Months,62.5,60.0 to 64.9,4700
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017,Age,19 Months,87.5,85.1 to 89.6,2369
≥1 Dose Varicella,,HHS Regions/National,Region 4,2017-2018,Age,19 Months,87.9,86.1 to 89.5,4686
≥1 Dose MMR,,HHS Regions/National,Region 4,2013,Age,19 Months,87.1,85.2 to 88.8,2020
≥1 Dose MMR,,HHS Regions/National,Region 4,2013-2014,Age,19 Months,86.5,85.0 to 87.9,4120
≥1 Dose MMR,,HHS Regions/National,Region 4,2014,Age,19 Months,85.9,83.4 to 88.1,2100
≥1 Dose MMR,,HHS Regions/National,Region 4,2014-2015,Age,19 Months,87.0,85.4 to 88.5,4318
≥1 Dose MMR,,HHS Regions/National,Region 4,2012,Age,19 Months,85.9,83.9 to 87.7,1991
DTaP,≥4 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,88.8,85.6 to 91.6,2317
DTaP,≥4 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,89.0,86.9 to 91.0,4700
DTaP,≥4 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,88.6,85.7 to 91.3,2369
DTaP,≥4 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,88.7,86.5 to 90.7,4686
DTaP,≥4 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,89.2,86.3 to 91.7,2341
DTaP,≥4 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,88.9,86.9 to 90.8,4710
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,88.1,85.5 to 90.3,2341
Hep B,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,87.8,86.1 to 89.4,4710
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,86.8,84.2 to 89.0,2218
Hep B,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,87.4,85.6 to 89.0,4559
DTaP,≥4 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,88.1,85.4 to 90.5,2218
DTaP,≥4 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,88.7,86.7 to 90.4,4559
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,87.6,85.2 to 89.7,2369
Hep B,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,87.6,85.8 to 89.3,4686
Polio,≥2 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,89.6,87.0 to 91.7,2317
Polio,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,89.9,88.2 to 91.4,4700
Hep B,≥1 Dose,HHS Regions/National,Region 4,2013,Age,3 Months,95.5,94.0 to 96.6,2020
Hep B,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,3 Months,95.1,94.2 to 95.8,4120
Hep B,≥1 Dose,HHS Regions/National,Region 4,2012,Age,3 Months,94.8,93.8 to 95.6,1991
Hep B,≥1 Dose,HHS Regions/National,Region 4,2011,Age,3 Months,93.0,90.3 to 94.9,1848
Polio,≥2 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,89.5,87.3 to 91.4,2341
Polio,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,88.2,86.5 to 89.7,4710
Polio,≥2 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,86.9,84.2 to 89.1,2369
Polio,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,88.2,86.3 to 89.9,4686
Polio,≥2 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,90.2,87.8 to 92.2,2383
Polio,≥2 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,95.0,93.5 to 96.1,2020
Polio,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,93.1,91.4 to 94.5,4120
Hep B,≥1 Dose,HHS Regions/National,Region 4,2014,Age,3 Months,94.7,93.1 to 95.9,2100
Hep B,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,3 Months,94.2,93.0 to 95.2,4318
Hep B,≥1 Dose,HHS Regions/National,Region 4,2015,Age,3 Months,93.8,91.9 to 95.3,2218
Hep B,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,3 Months,94.9,93.7 to 95.8,4559
Hep B,≥1 Dose,HHS Regions/National,Region 4,2016,Age,3 Months,96.0,94.6 to 97.1,2341
Hep B,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,3 Months,95.1,94.0 to 96.1,4710
≥1 Dose MMR,,HHS Regions/National,Region 4,2018,Age,13 Months,64.8,61.1 to 68.3,2317
≥1 Dose MMR,,HHS Regions/National,Region 4,2018-2019,Age,13 Months,67.2,64.8 to 69.6,4700
PCV,≥1 Dose,HHS Regions/National,Region 4,2016,Age,3 Months,88.1,85.7 to 90.1,2341
PCV,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,3 Months,86.3,84.5 to 87.9,4710
PCV,≥1 Dose,HHS Regions/National,Region 4,2017,Age,3 Months,84.5,81.7 to 86.9,2369
PCV,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,3 Months,86.2,84.3 to 88.0,4686
Hep B,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,93.7,92.2 to 95.0,3970
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2011,Age,0-3 Days,72.1,68.4 to 75.6,1848
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2012,Age,0-3 Days,72.5,69.2 to 75.5,1991
Hib,≥2 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,90.7,88.9 to 92.3,2020
Hib,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,89.0,87.2 to 90.7,4120
Hib,≥2 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,87.3,84.8 to 89.5,2100
Hib,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,88.5,86.8 to 90.0,4318
PCV,≥1 Dose,HHS Regions/National,Region 4,2014,Age,3 Months,85.6,82.8 to 87.9,2100
PCV,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,3 Months,85.4,83.5 to 87.0,4318
PCV,≥1 Dose,HHS Regions/National,Region 4,2015,Age,3 Months,85.2,82.6 to 87.5,2218
PCV,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,3 Months,86.6,84.9 to 88.2,4559
PCV,≥3 Doses,HHS Regions/National,Region 4,2017,Age,24 Months,91.1,88.9 to 93.0,2369
PCV,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,24 Months,91.9,90.4 to 93.3,4686
PCV,≥3 Doses,HHS Regions/National,Region 4,2016,Age,24 Months,92.8,91.0 to 94.4,2341
PCV,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,24 Months,92.0,90.6 to 93.2,4710
Hib,≥2 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,90.1,88.4 to 91.6,1991
PCV,≥3 Doses,HHS Regions/National,Region 4,2015,Age,24 Months,92.8,91.0 to 94.4,2218
PCV,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,24 Months,92.8,91.5 to 94.0,4559
Hib,≥2 Doses,HHS Regions/National,Region 4,2019,Age,5 Months,78.5,75.3 to 81.5,2383
Hib,≥2 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,87.7,84.6 to 90.3,1848
Hib,≥2 Doses,HHS Regions/National,Region 4,2018,Age,5 Months,76.5,73.1 to 79.5,2317
Hib,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,5 Months,77.5,75.2 to 79.6,4700
PCV,≥3 Doses,HHS Regions/National,Region 4,2014,Age,35 Months,91.5,89.1 to 93.5,2100
PCV,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,35 Months,92.9,91.4 to 94.2,4318
PCV,≥3 Doses,HHS Regions/National,Region 4,2015,Age,35 Months,94.5,92.8 to 96.0,2218
PCV,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,35 Months,94.1,92.9 to 95.2,4559
PCV,≥3 Doses,HHS Regions/National,Region 4,2016,Age,35 Months,93.8,92.0 to 95.3,2341
PCV,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,35 Months,93.2,91.8 to 94.4,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,54.0,50.5 to 57.5,1991
Hib,≥3 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,60.5,57.7 to 63.3,1848
Hib,≥3 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,48.6,43.8 to 53.5,2020
Hib,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,47.8,43.7 to 51.8,4120
Polio,≥1 Dose,HHS Regions/National,Region 4,2014,Age,3 Months,85.6,82.9 to 88.0,2100
Polio,≥1 Dose,HHS Regions/National,Region 4,2014-2015,Age,3 Months,85.8,84.0 to 87.5,4318
Polio,≥1 Dose,HHS Regions/National,Region 4,2015,Age,3 Months,86.0,83.4 to 88.2,2218
Polio,≥1 Dose,HHS Regions/National,Region 4,2015-2016,Age,3 Months,87.6,85.9 to 89.1,4559
Polio,≥1 Dose,HHS Regions/National,Region 4,2016,Age,3 Months,89.2,87.0 to 91.1,2341
Polio,≥1 Dose,HHS Regions/National,Region 4,2016-2017,Age,3 Months,87.6,85.9 to 89.1,4710
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2017,Age,0-3 Days,73.2,69.0 to 77.1,1376
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2017-2018,Age,0-3 Days,73.9,71.5 to 76.1,4686
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2016,Age,0-3 Days,72.5,69.4 to 75.4,2341
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2016-2017,Age,0-3 Days,72.4,70.2 to 74.4,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2018,Age,24 Months,92.8,90.6 to 94.7,2317
PCV,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,24 Months,93.4,92.0 to 94.6,4700
PCV,≥3 Doses,HHS Regions/National,Region 4,2012,Age,35 Months,94.0,92.0 to 95.6,1991
PCV,≥1 Dose,HHS Regions/National,Region 4,2018,Age,3 Months,88.0,85.3 to 90.3,2317
PCV,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,3 Months,88.7,86.9 to 90.2,4700
PCV,≥1 Dose,HHS Regions/National,Region 4,2019,Age,3 Months,89.3,86.8 to 91.4,2383
Polio,≥1 Dose,HHS Regions/National,Region 4,2012,Age,3 Months,87.7,86.0 to 89.2,1991
Polio,≥1 Dose,HHS Regions/National,Region 4,2011,Age,3 Months,86.3,82.6 to 89.2,1848
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2013,Age,0-3 Days,71.4,68.2 to 74.3,2020
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2013-2014,Age,0-3 Days,71.2,69.0 to 73.4,4120
Polio,≥1 Dose,HHS Regions/National,Region 4,2013,Age,3 Months,88.3,86.1 to 90.2,2020
Polio,≥1 Dose,HHS Regions/National,Region 4,2013-2014,Age,3 Months,87.0,84.9 to 88.7,4120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2014,Age,0-3 Days,71.1,67.8 to 74.2,2100
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2014-2015,Age,0-3 Days,71.6,69.4 to 73.8,4318
Hib,≥2 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,89.6,87.3 to 91.5,2218
Hib,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,89.7,88.1 to 91.1,4559
PCV,≥3 Doses,HHS Regions/National,Region 4,2019,Age,24 Months,94.0,92.0 to 95.6,2383
PCV,≥3 Doses,HHS Regions/National,Region 4,2011,Age,35 Months,92.9,90.7 to 94.8,1848
PCV,≥3 Doses,HHS Regions/National,Region 4,2013,Age,35 Months,94.4,92.7 to 95.8,2020
PCV,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,35 Months,92.9,91.5 to 94.2,4120
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013,Age,7 Months,68.2,65.7 to 70.7,2020
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,7 Months,68.1,65.6 to 70.5,4120
DTaP,≥3 Doses,HHS Regions/National,Region 4,2012,Age,7 Months,68.5,64.7 to 72.0,1991
DTaP,≥3 Doses,HHS Regions/National,Region 4,2011,Age,7 Months,68.8,65.1 to 72.2,1848
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,89.2,86.8 to 91.2,2341
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,88.7,87.0 to 90.2,4710
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,88.2,85.6 to 90.3,2369
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,88.8,87.0 to 90.4,4686
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,91.5,89.6 to 93.1,2218
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,90.4,88.9 to 91.7,4559
DTaP,≥3 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,90.4,88.6 to 92.0,1991
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020,Age,24 Months,89.5,87.4 to 91.3,2665
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2019,Age,0-3 Days,79.9,76.9 to 82.5,2383
Polio,≥1 Dose,HHS Regions/National,Region 4,2019,Age,3 Months,89.2,86.7 to 91.3,2383
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2018,Age,0-3 Days,75.6,72.0 to 78.8,2317
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2018-2019,Age,0-3 Days,77.7,75.4 to 79.8,4700
PCV,≥3 Doses,HHS Regions/National,Region 4,2019,Age,35 Months,94.4,92.5 to 96.0,2383
Hib,≥3 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,49.6,45.9 to 53.2,2317
Hib,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,49.9,47.3 to 52.4,4700
Hib,≥3 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,51.4,48.2 to 54.7,2369
Hib,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,50.5,48.0 to 53.0,4686
Hib,≥2 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,94.2,92.4 to 95.6,2383
Hib,≥2 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,94.3,92.4 to 95.8,2317
Hib,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,94.2,93.0 to 95.3,4700
Hib,≥2 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,93.4,91.5 to 94.9,2369
Hib,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,93.9,92.5 to 95.0,4686
Hib,≥3 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,73.9,66.5 to 80.1,2020
Hib,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,70.8,66.1 to 75.1,4120
Polio,≥3 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,90.1,86.1 to 93.0,1848
Hib,≥3 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,67.7,64.5 to 70.8,2100
Hib,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,69.9,67.7 to 71.9,4318
Hib,≥3 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,81.8,79.6 to 83.9,1848
Hib,≥3 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,77.8,74.0 to 81.2,1991
DTaP,≥3 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,88.2,85.4 to 90.5,1848
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,71.8,68.4 to 75.0,2383
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,68.8,65.5 to 71.8,2369
DTaP,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,70.1,67.6 to 72.4,4686
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,71.4,67.8 to 74.7,2317
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,71.6,69.2 to 73.9,4700
Hib,≥2 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,93.6,91.8 to 95.0,2218
Hib,≥2 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,94.2,93.0 to 95.1,4559
Hib,≥2 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,94.8,93.2 to 95.9,2341
Hib,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,94.1,92.9 to 95.1,4710
Hib,≥2 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,91.5,89.2 to 93.4,2100
Hib,≥2 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,92.6,91.1 to 93.8,4318
Polio,≥1 Dose,HHS Regions/National,Region 4,2018,Age,3 Months,88.7,86.0 to 91.0,2317
Polio,≥1 Dose,HHS Regions/National,Region 4,2018-2019,Age,3 Months,89.0,87.2 to 90.6,4700
Polio,≥1 Dose,HHS Regions/National,Region 4,2017,Age,3 Months,85.9,83.3 to 88.2,2369
Polio,≥1 Dose,HHS Regions/National,Region 4,2017-2018,Age,3 Months,87.3,85.4 to 89.0,4686
Hib,≥3 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,47.4,44.1 to 50.7,2218
Hib,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,48.5,46.2 to 50.9,4559
Hib,≥3 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,49.7,46.4 to 53.0,2341
Hib,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,50.6,48.2 to 52.9,4710
PCV,≥3 Doses,HHS Regions/National,Region 4,2018,Age,35 Months,93.5,91.3 to 95.4,2317
PCV,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,35 Months,94.0,92.5 to 95.3,4700
Hib,≥3 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,46.9,43.5 to 50.3,2100
Hib,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,47.2,44.8 to 49.5,4318
Hib,≥2 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,95.3,93.3 to 96.7,2020
Hib,≥2 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,93.4,91.5 to 94.9,4120
PCV,≥3 Doses,HHS Regions/National,Region 4,2017,Age,35 Months,92.5,90.3 to 94.4,2369
PCV,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,35 Months,93.0,91.5 to 94.4,4686
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015,Age,7 Months,68.0,64.8 to 71.1,2218
DTaP,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,7 Months,69.7,67.5 to 71.9,4559
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014,Age,7 Months,67.9,64.5 to 71.1,2100
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,7 Months,67.9,65.6 to 70.2,4318
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2015,Age,0-3 Days,72.1,69.0 to 75.1,2218
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2015-2016,Age,0-3 Days,72.3,70.1 to 74.4,4559
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,71.5,68.3 to 74.5,2341
DTaP,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,70.1,67.8 to 72.3,4710
Hib,≥2 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,90.7,88.5 to 92.5,2383
Hib,≥2 Doses,HHS Regions/National,Region 4,2012,Age,13 Months,94.8,93.3 to 96.0,1991
Hib,≥2 Doses,HHS Regions/National,Region 4,2011,Age,13 Months,92.9,90.9 to 94.5,1848
Hib,≥2 Doses,HHS Regions/National,Region 4,2016,Age,7 Months,89.8,87.5 to 91.6,2341
Hib,≥2 Doses,HHS Regions/National,Region 4,2016-2017,Age,7 Months,88.3,86.6 to 89.8,4710
Hib,≥2 Doses,HHS Regions/National,Region 4,2017,Age,7 Months,86.8,84.1 to 89.0,2369
Hib,≥2 Doses,HHS Regions/National,Region 4,2017-2018,Age,7 Months,87.7,85.8 to 89.4,4686
Hib,≥2 Doses,HHS Regions/National,Region 4,2018,Age,7 Months,88.7,86.0 to 91.0,2317
Hib,≥2 Doses,HHS Regions/National,Region 4,2018-2019,Age,7 Months,89.7,88.0 to 91.2,4700
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,91.3,89.1 to 93.1,2383
DTaP,≥3 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,92.0,88.9 to 94.3,1848
DTaP,≥3 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,94.1,92.6 to 95.3,1991
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,89.4,86.7 to 91.6,2317
DTaP,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,90.3,88.7 to 91.8,4700
Hib,≥3 Doses,HHS Regions/National,Region 4,2019,Age,7 Months,50.2,46.7 to 53.7,2383
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013,Age,13 Months,91.7,88.7 to 94.0,2020
DTaP,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,13 Months,89.4,86.8 to 91.6,4120
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014,Age,13 Months,87.2,84.5 to 89.4,2100
DTaP,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,13 Months,89.3,87.7 to 90.8,4318
Hib,≥3 Doses,HHS Regions/National,Region 4,2015,Age,13 Months,72.0,69.2 to 74.7,2218
Hib,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,13 Months,70.7,68.6 to 72.7,4559
Hib,≥3 Doses,HHS Regions/National,Region 4,2016,Age,13 Months,69.3,66.3 to 72.2,2341
Hib,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,13 Months,70.2,68.1 to 72.2,4710
Hib,≥3 Doses,HHS Regions/National,Region 4,2017,Age,13 Months,71.0,68.1 to 73.8,2369
Hib,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,13 Months,69.7,67.4 to 71.8,4686
Polio,≥3 Doses,HHS Regions/National,Region 4,2014,Age,19 Months,88.2,85.6 to 90.4,2100
Polio,≥3 Doses,HHS Regions/National,Region 4,2014-2015,Age,19 Months,90.5,89.0 to 91.8,4318
Polio,≥3 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,92.7,90.8 to 94.2,1991
Polio,≥3 Doses,HHS Regions/National,Region 4,2015,Age,19 Months,92.7,91.6 to 93.8,2218
Polio,≥3 Doses,HHS Regions/National,Region 4,2015-2016,Age,19 Months,92.3,91.0 to 93.4,4559
Polio,≥3 Doses,HHS Regions/National,Region 4,2013,Age,19 Months,92.0,90.5 to 93.3,2020
Polio,≥3 Doses,HHS Regions/National,Region 4,2013-2014,Age,19 Months,90.1,88.1 to 91.8,4120
Hib,≥3 Doses,HHS Regions/National,Region 4,2019,Age,13 Months,70.1,66.9 to 73.2,2383
Hib,≥2 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,92.8,91.1 to 94.3,2665
Hib,≥3 Doses,HHS Regions/National,Region 4,2012,Age,19 Months,91.1,89.2 to 92.7,1991
Hib,≥3 Doses,HHS Regions/National,Region 4,2011,Age,19 Months,90.3,87.5 to 92.6,1848
Hib,≥3 Doses,HHS Regions/National,Region 4,2018,Age,13 Months,68.3,64.8 to 71.6,2317
Hib,≥3 Doses,HHS Regions/National,Region 4,2018-2019,Age,13 Months,69.2,66.8 to 71.5,4700
Polio,≥3 Doses,HHS Regions/National,Region 4,2016,Age,19 Months,91.8,89.7 to 93.5,2341
Polio,≥3 Doses,HHS Regions/National,Region 4,2016-2017,Age,19 Months,90.8,89.3 to 92.2,4710
Polio,≥3 Doses,HHS Regions/National,Region 4,2017,Age,19 Months,89.9,87.5 to 91.9,2369
Polio,≥3 Doses,HHS Regions/National,Region 4,2017-2018,Age,19 Months,90.5,88.8 to 92.0,4686
PCV,≥3 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,91.2,88.6 to 93.3,1580
Hep A,≥1 Dose,HHS Regions/National,Region 3,2021,Age,35 Months,91.4,88.0 to 94.1,1580
Hib,Primary Series,HHS Regions/National,Region 3,2021,Age,7 Months,72.1,68.2 to 75.7,1580
Hep B,≥3 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,90.3,87.6 to 92.6,1580
PCV,≥4 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,80.4,76.8 to 83.5,1580
Hep A,≥2 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,79.4,74.1 to 84.2,1580
Polio,≥3 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,92.2,89.7 to 94.3,1580
≥1 Dose MMR,,HHS Regions/National,Region 3,2021,Age,24 Months,89.4,86.4 to 91.9,1580
Hib,≥3 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,90.7,88.1 to 93.0,1580
DTaP,≥4 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,80.3,76.7 to 83.7,1580
Polio,≥1 Dose,HHS Regions/National,Region 3,2021,Age,3 Months,89.2,86.5 to 91.4,1580
Hib,Full Series,HHS Regions/National,Region 3,2021,Age,24 Months,76.9,73.2 to 80.4,1580
Hib,≥1 Dose,HHS Regions/National,Region 3,2021,Age,3 Months,87.3,84.4 to 89.6,1580
Hib,Primary Series,HHS Regions/National,Region 3,2021,Age,24 Months,91.4,88.9 to 93.6,1580
DTaP,≥4 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,72.6,68.6 to 76.2,1580
≥1 Dose Varicella,,HHS Regions/National,Region 3,2021,Age,24 Months,90.1,87.3 to 92.6,1580
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2021,Age,0-2 Days,79.6,76.0 to 82.8,1580
PCV,≥3 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,92.6,90.1 to 94.6,1580
PCV,≥4 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,82.2,78.9 to 85.3,1580
PCV,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,92.5,90.9 to 93.9,3970
Hep B,≥3 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,56.6,52.4 to 60.7,1580
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,92.9,90.8 to 94.7,3970
Hep A,≥1 Dose,HHS Regions/National,Region 3,2021,Age,24 Months,87.7,84.6 to 90.5,1580
DTaP,≥3 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,90.8,88.1 to 93.0,1580
Hep A,≥2 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,41.2,37.1 to 45.5,1580
PCV,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,5 Months,80.0,77.6 to 82.2,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,75.4,72.9 to 77.8,3970
Combined 7 Series,,HHS Regions/National,Region 3,2021,Age,24 Months,68.9,65.0 to 72.8,1580
PCV,≥3 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,70.9,66.9 to 74.7,1580
DTaP,≥3 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,89.2,86.4 to 91.5,1580
Polio,≥2 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,92.5,90.0 to 94.4,1580
Hep A,≥1 Dose,HHS Regions/National,Region 3,2021,Age,19 Months,83.4,79.8 to 86.4,1580
Hep A,≥2 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,26.8,23.4 to 30.6,1580
DTaP,≥1 Dose,HHS Regions/National,Region 3,2021,Age,3 Months,89.4,86.8 to 91.5,1580
PCV,≥4 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,84.3,80.8 to 87.5,1580
Polio,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,94.8,93.0 to 96.3,4830
≥1 Dose MMR,,HHS Regions/National,Region 3,2019-2020,Age,35 Months,93.4,91.9 to 94.7,4830
DTaP,≥4 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,88.1,85.9 to 90.0,4830
Combined 7 Series,,HHS Regions/National,Region 3,2019-2020,Age,24 Months,71.3,69.0 to 73.6,4830
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,95.4,93.6 to 96.8,4830
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,92.6,91.1 to 93.9,4830
PCV,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,89.9,88.3 to 91.4,4830
Hib,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,89.3,87.6 to 90.9,4830
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019-2020,Age,13 Months,63.4,61.0 to 65.8,4830
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,89.0,87.3 to 90.6,4830
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,74.7,72.4 to 76.9,4830
Polio,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,89.9,88.1 to 91.4,4830
PCV,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,5 Months,81.2,79.1 to 83.1,4830
Hep B,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,5 Months,90.0,88.3 to 91.5,4830
Hib,Primary Series,HHS Regions/National,Region 3,2019-2020,Age,13 Months,86.8,85.0 to 88.4,4830
Hep B,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,95.1,93.8 to 96.1,4830
Hib,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,77.2,74.9 to 79.3,4830
Hib,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,93.5,92.1 to 94.7,4830
≥1 Dose MMR,,HHS Regions/National,Region 3,2019-2020,Age,13 Months,68.8,66.4 to 71.0,4830
Polio,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,93.9,92.4 to 95.0,4830
Polio,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,5 Months,81.7,79.5 to 83.6,4830
Hib,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,5 Months,78.8,76.6 to 80.9,4830
DTaP,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,5 Months,82.1,80.0 to 84.0,4830
PCV,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,3 Months,88.9,87.2 to 90.5,4830
Hep B,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,3 Months,96.2,95.0 to 97.1,4830
≥1 Dose MMR,,HHS Regions/National,Region 3,2019-2020,Age,24 Months,92.4,91.0 to 93.7,4830
DTaP,≥4 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,81.8,79.7 to 83.7,4830
Polio,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,93.0,91.6 to 94.3,4830
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,93.6,92.2 to 94.9,4830
PCV,≥4 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,87.1,84.8 to 89.1,4830
PCV,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,93.7,92.3 to 95.0,4830
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019-2020,Age,35 Months,93.6,92.1 to 94.9,4830
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,94.8,93.1 to 96.2,4830
Hib,Full Series,HHS Regions/National,Region 3,2019-2020,Age,35 Months,83.8,81.3 to 86.1,4830
Hib,Primary Series,HHS Regions/National,Region 3,2019-2020,Age,35 Months,93.8,92.4 to 95.1,4830
Hib,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,93.0,91.4 to 94.4,4830
Hib,Full Series,HHS Regions/National,Region 3,2019-2020,Age,19 Months,74.2,71.9 to 76.3,4830
Hib,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,90.3,88.7 to 91.7,4830
Hib,Primary Series,HHS Regions/National,Region 3,2019-2020,Age,19 Months,92.2,90.7 to 93.4,4830
Hep A,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,31.2,28.9 to 33.5,4830
≥1 Dose MMR,,HHS Regions/National,Region 3,2019-2020,Age,19 Months,89.3,87.7 to 90.8,4830
PCV,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,93.1,91.7 to 94.3,4830
PCV,≥4 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,84.3,82.4 to 86.1,4830
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,92.5,91.1 to 93.8,4830
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019-2020,Age,24 Months,91.6,90.1 to 93.0,4830
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2019-2020,Age,0-3 Days,81.6,79.5 to 83.4,4830
PCV,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,72.6,70.2 to 74.8,4830
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2019-2020,Age,0-2 Days,80.7,78.6 to 82.5,4830
Hep A,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,19 Months,85.3,83.4 to 87.0,4830
PCV,≥4 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,81.3,79.3 to 83.2,4830
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,91.6,90.0 to 92.9,4830
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019-2020,Age,19 Months,88.9,87.2 to 90.4,4830
Combined 7 Series,,HHS Regions/National,Region 3,2019-2020,Age,35 Months,76.7,74.2 to 79.1,4830
Hib,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,7 Months,61.6,59.1 to 64.0,4830
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2019-2020,Age,0-1 Days,77.0,74.9 to 79.0,4830
Hib,Full Series,HHS Regions/National,Region 3,2019-2020,Age,24 Months,78.7,76.6 to 80.8,4830
Hib,Primary Series,HHS Regions/National,Region 3,2019-2020,Age,24 Months,93.3,91.9 to 94.5,4830
Influenza,,HHS Regions/National,Region 3,2019-2020,Age,24 Months,67.8,65.4 to 70.1,4830
Hib,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,92.1,90.6 to 93.4,4830
Hep A,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,35 Months,92.5,90.7 to 94.0,4830
Hep A,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,35 Months,81.9,79.1 to 84.6,4830
Hep A,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,24 Months,89.1,87.4 to 90.7,4830
Polio,≥2 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,92.2,89.9 to 94.0,2390
Hep A,≥2 Doses,HHS Regions/National,Region 3,2019-2020,Age,24 Months,48.8,46.3 to 51.3,4830
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2020,Age,0-1 Days,75.0,71.9 to 77.8,2390
Combined 7 Series,,HHS Regions/National,Region 3,2020,Age,35 Months,74.9,71.2 to 78.5,2390
Hep A,≥2 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,29.2,26.2 to 32.3,2390
Hep A,≥1 Dose,HHS Regions/National,Region 3,2020,Age,19 Months,83.9,81.0 to 86.3,2390
DTaP,≥1 Dose,HHS Regions/National,Region 3,2020,Age,3 Months,87.0,84.3 to 89.3,2390
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2020,Age,0-2 Days,78.6,75.6 to 81.2,2390
Polio,≥2 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,87.4,84.6 to 89.8,2390
Hib,≥2 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,86.2,83.3 to 88.7,2390
Hib,≥3 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,59.2,55.7 to 62.5,2390
Hib,Primary Series,HHS Regions/National,Region 3,2020,Age,7 Months,70.0,66.6 to 73.2,2390
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,92.3,90.1 to 94.2,2390
Hep B,≥2 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,91.2,88.8 to 93.1,2390
Polio,≥3 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,92.1,89.9 to 93.9,2390
DTaP,≥4 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,80.5,77.5 to 83.3,2390
Hib,≥3 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,89.4,86.8 to 91.6,2390
≥1 Dose MMR,,HHS Regions/National,Region 3,2020,Age,24 Months,90.4,88.0 to 92.5,2390
Hib,Primary Series,HHS Regions/National,Region 3,2020,Age,24 Months,90.8,88.5 to 92.8,2390
Hib,Full Series,HHS Regions/National,Region 3,2020,Age,35 Months,80.2,76.7 to 83.5,2390
Hib,≥3 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,91.0,88.2 to 93.3,2390
Hib,Primary Series,HHS Regions/National,Region 3,2020,Age,35 Months,91.8,89.2 to 94.0,2390
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,93.6,91.1 to 95.6,2390
PCV,≥3 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,91.8,89.5 to 93.7,2390
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020,Age,35 Months,92.2,89.9 to 94.2,2390
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,90.5,88.3 to 92.4,2390
Hib,Full Series,HHS Regions/National,Region 3,2020,Age,19 Months,71.8,68.5 to 74.9,2390
PCV,≥3 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,90.4,88.0 to 92.4,2390
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020,Age,19 Months,87.9,85.4 to 90.1,2390
Polio,≥3 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,93.7,91.1 to 95.7,2390
DTaP,≥4 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,87.1,83.9 to 89.9,2390
PCV,≥4 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,78.7,75.5 to 81.5,2390
≥1 Dose MMR,,HHS Regions/National,Region 3,2020,Age,35 Months,91.5,89.0 to 93.6,2390
PCV,≥4 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,84.1,81.2 to 86.9,2390
Hib,Primary Series,HHS Regions/National,Region 3,2020,Age,13 Months,83.9,81.0 to 86.4,2390
Hep B,≥2 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,94.4,92.5 to 95.8,2390
Hib,≥3 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,73.8,70.5 to 76.9,2390
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,87.4,84.8 to 89.7,2390
PCV,≥3 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,88.1,85.5 to 90.3,2390
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,72.3,68.9 to 75.5,2390
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020,Age,13 Months,61.0,57.6 to 64.3,2390
PCV,≥2 Doses,HHS Regions/National,Region 3,2020,Age,5 Months,79.2,76.1 to 82.1,2390
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,90.9,88.5 to 92.9,2390
DTaP,≥4 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,71.8,68.5 to 74.9,2390
Polio,≥3 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,90.6,88.1 to 92.6,2390
≥1 Dose MMR,,HHS Regions/National,Region 3,2020,Age,19 Months,87.6,84.9 to 89.9,2390
Hib,≥3 Doses,HHS Regions/National,Region 3,2020,Age,19 Months,87.3,84.5 to 89.7,2390
Hib,Primary Series,HHS Regions/National,Region 3,2020,Age,19 Months,89.7,87.2 to 91.7,2390
Influenza,,HHS Regions/National,Region 3,2020,Age,24 Months,62.4,59.0 to 65.9,2390
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2020,Age,0-3 Days,79.6,76.7 to 82.2,2390
PCV,≥3 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,91.1,88.8 to 93.1,2390
Rotavirus,,HHS Regions/National,Region 3,2020,Age,8 Months,76.5,73.2 to 79.4,2390
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,94.1,91.4 to 96.1,2390
Hep A,≥1 Dose,HHS Regions/National,Region 3,2020,Age,24 Months,87.2,84.6 to 89.6,2390
PCV,≥4 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,82.3,79.4 to 85.1,2390
Hep A,≥2 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,47.6,44.2 to 51.2,2390
Combined 7 Series,,HHS Regions/National,Region 3,2020,Age,24 Months,69.0,65.7 to 72.3,2390
PCV,≥1 Dose,HHS Regions/National,Region 3,2020,Age,3 Months,86.6,83.9 to 88.8,2390
DTaP,≥2 Doses,HHS Regions/National,Region 3,2020,Age,5 Months,79.5,76.3 to 82.4,2390
Polio,≥2 Doses,HHS Regions/National,Region 3,2020,Age,5 Months,79.3,76.1 to 82.1,2390
Hep B,≥2 Doses,HHS Regions/National,Region 3,2020,Age,5 Months,88.7,86.2 to 90.9,2390
Hib,≥2 Doses,HHS Regions/National,Region 3,2020,Age,5 Months,75.8,72.5 to 78.8,2390
Polio,≥1 Dose,HHS Regions/National,Region 3,2020,Age,3 Months,86.5,83.8 to 88.9,2390
Hib,≥1 Dose,HHS Regions/National,Region 3,2020,Age,3 Months,82.6,79.7 to 85.2,2390
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,57.2,53.8 to 60.5,2390
Hep B,≥1 Dose,HHS Regions/National,Region 3,2020,Age,3 Months,95.0,93.1 to 96.4,2390
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020,Age,24 Months,91.5,89.5 to 93.4,2390
Rotavirus,,HHS Regions/National,Region 3,2019-2020,Age,8 Months,77.6,75.4 to 79.7,4830
PCV,≥3 Doses,HHS Regions/National,Region 3,2020,Age,7 Months,70.5,67.1 to 73.7,2390
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,88.8,86.2 to 90.9,2390
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020-2021,Age,35 Months,92.4,90.5 to 94.0,3970
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2021,Age,0-1 Days,77.5,73.8 to 80.8,1580
PCV,≥3 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,93.6,91.0 to 95.6,1580
≥1 Dose MMR,,HHS Regions/National,Region 3,2021,Age,35 Months,92.4,88.4 to 95.4,1580
Hib,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,90.1,88.3 to 91.7,3970
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,87.8,85.9 to 89.5,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,89.5,86.7 to 91.8,1580
Hib,≥2 Doses,HHS Regions/National,Region 3,2021,Age,5 Months,79.9,76.2 to 83.1,1580
Hib,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,3 Months,86.6,84.8 to 88.3,4830
DTaP,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,3 Months,90.0,88.3 to 91.5,4830
Polio,≥1 Dose,HHS Regions/National,Region 3,2019-2020,Age,3 Months,89.5,87.7 to 90.9,4830
Hib,Primary Series,HHS Regions/National,Region 3,2019-2020,Age,7 Months,72.2,69.9 to 74.4,4830
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,13 Months,90.8,89.2 to 92.2,4830
Polio,≥3 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,91.8,90.2 to 93.1,4830
DTaP,≥4 Doses,HHS Regions/National,Region 3,2019-2020,Age,19 Months,73.6,71.3 to 75.7,4830
Hib,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,91.8,90.1 to 93.2,3970
PCV,≥3 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,89.3,86.5 to 91.5,1580
Hib,≥3 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,62.6,58.4 to 66.6,1580
Combined 7 Series,,HHS Regions/National,Region 3,2021,Age,35 Months,73.0,68.7 to 77.3,1580
Polio,≥3 Doses,HHS Regions/National,Region 3,2021,Age,19 Months,90.8,88.1 to 93.0,1580
PCV,≥2 Doses,HHS Regions/National,Region 3,2021,Age,5 Months,80.7,77.0 to 84.0,1580
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,90.9,89.1 to 92.4,3970
DTaP,≥3 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,73.5,69.5 to 77.1,1580
Hep B,≥2 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,91.2,88.5 to 93.2,1580
Polio,≥2 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,89.9,87.2 to 92.1,1580
PCV,≥4 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,82.3,80.1 to 84.4,3970
Hib,≥2 Doses,HHS Regions/National,Region 3,2021,Age,7 Months,89.3,86.5 to 91.5,1580
Hib,Primary Series,HHS Regions/National,Region 3,2020-2021,Age,24 Months,91.1,89.4 to 92.6,3970
Hib,Primary Series,HHS Regions/National,Region 3,2021,Age,19 Months,90.4,87.6 to 92.5,1580
≥1 Dose Varicella,,States/Local Areas,Oregon,2019-2020,Age,19 Months,87.3,82.7 to 90.9,484
Influenza,,States/Local Areas,Oregon,2013,Age,24 Months,51.0,42.6 to 60.1,208
Influenza,,States/Local Areas,Oregon,2013-2014,Age,24 Months,50.2,44.6 to 56.1,478
Influenza,,States/Local Areas,Oregon,2015,Age,24 Months,57.5,49.6 to 65.5,243
Influenza,,States/Local Areas,Oregon,2015-2016,Age,24 Months,61.8,55.5 to 68.2,420
Influenza,,States/Local Areas,Oregon,2014,Age,24 Months,49.4,42.3 to 57.1,270
Influenza,,States/Local Areas,Oregon,2014-2015,Age,24 Months,53.4,48.1 to 59.0,513
Influenza,,States/Local Areas,Oregon,2011,Age,24 Months,43.7,36.7 to 51.4,266
Influenza,,States/Local Areas,Oregon,2012,Age,24 Months,54.9,46.7 to 63.4,229
Hib,≥2 Doses,States/Local Areas,Oregon,2021,Age,13 Months,90.5,82.3 to 95.2,131
Hep B,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,89.1,84.4 to 92.9,351
PCV,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,83.3,77.6 to 87.9,351
DTaP,≥4 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,81.7,75.3 to 87.3,351
≥1 Dose Varicella,,States/Local Areas,Oregon,2020-2021,Age,24 Months,89.4,84.5 to 93.3,351
Polio,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,90.6,85.7 to 94.3,351
Polio,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,3 Months,84.5,78.7 to 89.0,351
Hep A,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,80.7,70.4 to 89.2,351
Hib,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,5 Months,78.4,72.3 to 83.5,351
Hep B,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,5 Months,85.1,79.6 to 89.4,351
DTaP,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,72.7,66.3 to 78.2,351
Hep B,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,73.9,67.8 to 79.2,351
Hep A,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,19 Months,84.6,79.0 to 88.9,351
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2020-2021,Age,0-1 Days,81.8,76.2 to 86.4,351
Hib,Full Series,States/Local Areas,Oregon,2020-2021,Age,35 Months,80.2,74.1 to 85.7,351
Polio,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,90.7,85.7 to 94.1,351
DTaP,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,87.9,82.6 to 91.8,351
Hep B,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,88.6,83.5 to 92.3,351
Hib,Primary Series,States/Local Areas,Oregon,2020-2021,Age,35 Months,90.1,85.3 to 93.8,351
Hib,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,85.6,79.6 to 90.0,351
Hib,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,88.8,83.4 to 93.0,351
≥1 Dose Varicella,,States/Local Areas,Oregon,2021,Age,35 Months,90.4,82.3 to 95.8,131
Combined 7 Series,,States/Local Areas,Oregon,2021,Age,24 Months,64.6,53.8 to 75.2,131
Hib,≥2 Doses,States/Local Areas,Oregon,2021,Age,5 Months,81.2,71.9 to 88.0,131
≥1 Dose MMR,,States/Local Areas,Oregon,2021,Age,19 Months,86.1,77.7 to 91.7,131
Hep B,≥3 Doses,States/Local Areas,Oregon,2021,Age,13 Months,88.5,80.3 to 93.5,131
PCV,≥1 Dose,States/Local Areas,Oregon,2021,Age,3 Months,82.2,73.0 to 88.7,131
≥1 Dose MMR,,States/Local Areas,Oregon,2021,Age,35 Months,90.4,82.5 to 95.8,131
Hep B,≥1 Dose,States/Local Areas,Oregon,2021,Age,3 Months,90.8,82.7 to 95.4,131
PCV,≥4 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,87.2,82.4 to 92.0,486
Influenza,,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,75.3,68.5 to 82.0,251
Hib,Full Series,States/Local Areas,Oregon,2020-2021,Age,24 Months,76.2,70.0 to 82.0,351
Polio,≥2 Doses,States/Local Areas,Oregon,2021,Age,13 Months,90.2,81.9 to 94.9,131
Influenza,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,68.0,61.7 to 74.2,428
Influenza,,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,51.1,44.4 to 57.8,314
Influenza,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",57.4,45.8 to 69.0,118
Influenza,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,54.7,44.5 to 65.0,133
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.7,61.2 to 82.3,150
Influenza,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,43.8,33.8 to 53.8,138
Influenza,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,55.0,46.4 to 63.6,217
Influenza,,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,61.6,55.7 to 67.5,425
Influenza,,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",58.0,52.4 to 63.6,520
Influenza,,States/Local Areas,Oregon,2016,Age,24 Months,66.1,56.2 to 75.8,177
Influenza,,States/Local Areas,Oregon,2016-2017,Age,24 Months,61.9,55.2 to 68.5,372
Influenza,,States/Local Areas,Oregon,2018,Age,24 Months,70.0,62.8 to 76.9,290
Influenza,,States/Local Areas,Oregon,2018-2019,Age,24 Months,68.9,63.6 to 74.1,554
Influenza,,States/Local Areas,Oregon,2017,Age,24 Months,57.5,48.9 to 66.5,195
Influenza,,States/Local Areas,Oregon,2017-2018,Age,24 Months,63.7,57.9 to 69.4,485
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,92.6,89.3 to 95.8,486
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Any Medicaid,88.3,84.1 to 92.5,342
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"White, Non-Hispanic",80.2,74.1 to 86.3,556
Hib,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,3 Months,83.9,78.0 to 88.4,351
Influenza,,States/Local Areas,Oregon,2019,Age,24 Months,67.7,59.9 to 75.4,264
Hep B,≥2 Doses,States/Local Areas,Oregon,2021,Age,13 Months,90.8,82.6 to 95.4,131
Hep A,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,50.2,43.3 to 57.6,351
Hib,Primary Series,States/Local Areas,Oregon,2020-2021,Age,7 Months,73.8,67.5 to 79.3,351
Rotavirus,,States/Local Areas,Oregon,2021,Age,8 Months,72.7,62.1 to 81.2,131
Hib,Primary Series,States/Local Areas,Oregon,2021,Age,35 Months,90.8,83.6 to 95.7,131
PCV,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,88.6,83.6 to 92.6,351
Polio,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,90.6,85.7 to 94.3,351
Combined 7 Series,,States/Local Areas,Oregon,2020-2021,Age,24 Months,64.3,57.5 to 71.0,351
PCV,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,88.6,83.6 to 92.6,351
DTaP,≥3 Doses,States/Local Areas,Oregon,2021,Age,35 Months,92.2,84.7 to 96.9,131
Hib,≥3 Doses,States/Local Areas,Oregon,2021,Age,13 Months,74.1,63.5 to 82.4,131
≥1 Dose Varicella,,States/Local Areas,Oregon,2020-2021,Age,19 Months,86.8,81.6 to 90.7,351
Hib,Full Series,States/Local Areas,Oregon,2021,Age,35 Months,80.8,71.0 to 88.9,131
≥1 Dose MMR,,States/Local Areas,Oregon,2020-2021,Age,35 Months,89.9,85.0 to 93.8,351
Hib,Primary Series,States/Local Areas,Oregon,2021,Age,13 Months,85.6,76.7 to 91.5,131
PCV,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,87.8,82.4 to 91.6,351
Influenza,,States/Local Areas,Oregon,2020-2021,Age,24 Months,59.9,53.3 to 66.6,351
DTaP,≥4 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,66.9,60.1 to 73.0,351
Hep B,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,89.4,84.2 to 93.1,351
Polio,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,5 Months,78.9,72.8 to 84.0,351
Polio,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,88.3,83.1 to 92.1,351
Hep B,≥3 Doses,States/Local Areas,Oregon,2021,Age,35 Months,90.3,83.1 to 95.4,131
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2020-2021,Age,0-3 Days,83.1,77.6 to 87.5,351
DTaP,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,24 Months,91.6,87.0 to 95.1,351
PCV,≥4 Doses,States/Local Areas,Oregon,2020-2021,Age,35 Months,79.1,72.8 to 84.8,351
Combined 7 Series,,States/Local Areas,Oregon,2020-2021,Age,35 Months,69.0,62.0 to 75.8,351
Hib,Primary Series,States/Local Areas,Oregon,2020-2021,Age,19 Months,89.8,84.7 to 93.3,351
DTaP,≥4 Doses,States/Local Areas,Oregon,2021,Age,35 Months,83.7,73.2 to 91.7,131
Rotavirus,,States/Local Areas,Oregon,2020-2021,Age,8 Months,71.7,65.0 to 77.5,351
Hib,Full Series,States/Local Areas,Oregon,2020-2021,Age,19 Months,71.2,64.7 to 77.0,351
Hep B,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,3 Months,90.9,85.9 to 94.2,351
Hib,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,87.5,82.1 to 91.4,351
Hib,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,13 Months,74.1,67.7 to 79.7,351
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Oregon,2021,Age,0-3 Days,80.9,71.8 to 87.6,131
Hib,≥3 Doses,States/Local Areas,Oregon,2021,Age,35 Months,89.4,80.9 to 95.2,131
PCV,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,3 Months,81.5,75.5 to 86.3,351
≥1 Dose MMR,,States/Local Areas,Oregon,2021,Age,13 Months,72.2,62.2 to 80.4,131
Influenza,,States/Local Areas,Oregon,2021,Age,24 Months,53.1,42.7 to 64.3,131
PCV,≥4 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,73.6,67.1 to 79.2,351
≥1 Dose Varicella,,States/Local Areas,Oregon,2020-2021,Age,13 Months,63.6,56.9 to 69.7,351
Hib,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,56.4,49.7 to 63.0,351
DTaP,≥2 Doses,States/Local Areas,Oregon,2020-2021,Age,5 Months,79.8,73.7 to 84.8,351
Hep A,≥1 Dose,States/Local Areas,Oregon,2020-2021,Age,24 Months,87.5,82.3 to 91.8,351
≥1 Dose MMR,,States/Local Areas,Oregon,2020-2021,Age,19 Months,86.9,81.7 to 90.8,351
Influenza,,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,52.6,45.4 to 59.7,308
Influenza,,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,49.2,41.4 to 56.9,221
Influenza,,States/Local Areas,Oregon,2014-2017,Overall,Overall,56.8,52.4 to 61.2,780
Hib,Full Series,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,83.3,78.0 to 88.7,486
PCV,≥3 Doses,States/Local Areas,Oregon,2016-2019,Insurance Coverage,Private Insurance Only,97.6,95.8 to 99.4,486
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.9,56.4 to 81.3,150
Polio,≥2 Doses,States/Local Areas,Oregon,2021,Age,5 Months,80.8,71.5 to 87.6,131
Polio,≥3 Doses,States/Local Areas,Oregon,2021,Age,19 Months,90.2,81.9 to 94.9,131
DTaP,≥2 Doses,States/Local Areas,Oregon,2021,Age,5 Months,81.2,71.8 to 88.0,131
DTaP,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,19 Months,90.6,85.6 to 94.0,351
Hep A,≥2 Doses,States/Local Areas,Oregon,2021,Age,19 Months,29.6,21.1 to 39.9,131
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Oregon,2020-2021,Age,0-2 Days,82.5,76.8 to 87.0,351
≥1 Dose Varicella,,States/Local Areas,Oregon,2021,Age,13 Months,63.1,52.5 to 72.6,131
PCV,≥3 Doses,States/Local Areas,Oregon,2020-2021,Age,7 Months,69.9,63.4 to 75.6,351
Polio,≥3 Doses,States/Local Areas,Oregon,2019,Age,19 Months,92.2,86.6 to 95.5,264
Polio,≥3 Doses,States/Local Areas,Oregon,2018,Age,19 Months,94.2,89.8 to 96.8,290
Polio,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,70.4,65.1 to 75.3,554
Polio,≥3 Doses,States/Local Areas,Oregon,2011,Age,24 Months,86.4,80.3 to 91.3,266
Polio,≥3 Doses,States/Local Areas,Oregon,2012,Age,24 Months,91.0,85.6 to 95.0,229
Hib,≥3 Doses,States/Local Areas,Oregon,2014,Age,19 Months,85.5,80.1 to 89.7,270
Hib,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,86.5,82.6 to 89.7,513
Hib,≥3 Doses,States/Local Areas,Oregon,2013,Age,19 Months,92.1,88.8 to 94.6,208
Hib,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,88.9,84.7 to 92.0,478
Polio,≥3 Doses,States/Local Areas,Oregon,2013,Age,24 Months,90.9,85.6 to 94.8,208
Polio,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,90.1,86.7 to 93.0,478
Hib,≥3 Doses,States/Local Areas,Oregon,2015,Age,19 Months,87.5,83.1 to 90.9,243
Hib,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,86.2,80.6 to 90.4,420
Polio,≥3 Doses,States/Local Areas,Oregon,2015,Age,24 Months,90.3,85.0 to 94.3,243
Polio,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,90.1,85.8 to 93.6,420
Polio,≥3 Doses,States/Local Areas,Oregon,2014,Age,24 Months,89.4,84.6 to 93.2,270
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,89.8,86.4 to 92.7,513
DTaP,≥3 Doses,States/Local Areas,Oregon,2014,Age,19 Months,89.5,84.3 to 93.2,270
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,90.1,86.4 to 92.8,513
DTaP,≥3 Doses,States/Local Areas,Oregon,2015,Age,19 Months,90.6,89.1 to 91.9,243
DTaP,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,90.2,85.3 to 93.6,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2016,Age,19 Months,89.8,80.8 to 94.9,177
DTaP,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,90.3,85.2 to 93.8,372
Hib,≥3 Doses,States/Local Areas,Oregon,2017,Age,19 Months,84.9,77.4 to 90.1,195
Hib,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,88.8,84.4 to 92.0,485
Polio,≥3 Doses,States/Local Areas,Oregon,2016,Age,24 Months,89.9,82.7 to 95.0,177
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,91.1,86.7 to 94.6,372
Hib,≥3 Doses,States/Local Areas,Oregon,2016,Age,19 Months,84.9,75.0 to 91.3,177
Hib,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,84.9,79.0 to 89.3,372
Hib,≥3 Doses,States/Local Areas,Oregon,2018,Age,19 Months,92.8,87.7 to 95.9,290
Hib,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,77.5,72.3 to 82.0,554
DTaP,≥3 Doses,States/Local Areas,Oregon,2018,Age,19 Months,95.7,91.3 to 98.0,290
DTaP,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,91.4,87.4 to 94.3,554
DTaP,≥3 Doses,States/Local Areas,Oregon,2019,Age,19 Months,93.0,87.5 to 96.2,264
DTaP,≥3 Doses,States/Local Areas,Oregon,2017,Age,19 Months,90.9,84.4 to 94.8,195
DTaP,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,93.3,89.6 to 95.7,485
Hib,Full Series,States/Local Areas,Oregon,2018,Age,24 Months,79.2,72.5 to 85.1,290
Hib,Full Series,States/Local Areas,Oregon,2018-2019,Age,24 Months,80.5,75.6 to 84.9,554
Polio,≥3 Doses,States/Local Areas,Oregon,2011,Age,35 Months,91.3,84.9 to 95.7,266
DTaP,≥3 Doses,States/Local Areas,Oregon,2012,Age,24 Months,92.8,87.9 to 96.3,229
DTaP,≥3 Doses,States/Local Areas,Oregon,2013,Age,24 Months,93.9,90.2 to 96.5,208
DTaP,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,92.2,89.4 to 94.6,478
Hib,Full Series,States/Local Areas,Oregon,2015,Age,24 Months,81.1,74.4 to 86.9,243
Hib,Full Series,States/Local Areas,Oregon,2015-2016,Age,24 Months,79.1,73.5 to 84.3,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2011,Age,24 Months,87.7,81.7 to 92.5,266
Polio,≥2 Doses,States/Local Areas,Oregon,2020,Age,13 Months,91.2,84.2 to 95.3,220
Polio,≥3 Doses,States/Local Areas,Oregon,2018,Age,24 Months,94.7,90.7 to 97.4,290
Polio,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,94.0,90.9 to 96.2,554
Polio,≥3 Doses,States/Local Areas,Oregon,2019,Age,24 Months,93.2,88.2 to 96.5,264
Hib,≥3 Doses,States/Local Areas,Oregon,2019,Age,19 Months,90.8,84.9 to 94.5,264
Polio,≥3 Doses,States/Local Areas,Oregon,2017,Age,24 Months,92.2,86.4 to 96.1,195
Polio,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,93.3,90.0 to 95.9,485
Hib,Full Series,States/Local Areas,Oregon,2017,Age,24 Months,78.7,71.2 to 85.3,195
Hib,Full Series,States/Local Areas,Oregon,2017-2018,Age,24 Months,78.9,74.0 to 83.5,485
Hib,Full Series,States/Local Areas,Oregon,2016,Age,24 Months,77.2,68.0 to 85.3,177
Hib,Full Series,States/Local Areas,Oregon,2016-2017,Age,24 Months,78.0,72.2 to 83.4,372
Hib,≥3 Doses,States/Local Areas,Oregon,2013,Age,24 Months,92.8,87.9 to 96.2,208
Hib,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,89.8,86.5 to 92.7,478
Hib,≥3 Doses,States/Local Areas,Oregon,2012,Age,24 Months,90.3,84.6 to 94.6,229
Hib,≥3 Doses,States/Local Areas,Oregon,2011,Age,24 Months,84.2,77.6 to 89.8,266
DTaP,≥2 Doses,States/Local Areas,Oregon,2014,Age,5 Months,74.6,67.4 to 80.6,270
DTaP,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,5 Months,78.1,76.3 to 79.8,513
Polio,≥3 Doses,States/Local Areas,Oregon,2012,Age,35 Months,93.8,88.5 to 97.1,229
DTaP,≥2 Doses,States/Local Areas,Oregon,2015,Age,5 Months,81.7,74.6 to 87.1,243
DTaP,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,5 Months,77.9,71.6 to 83.1,420
Polio,≥3 Doses,States/Local Areas,Oregon,2015,Age,35 Months,94.8,88.3 to 98.3,243
Polio,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,94.8,90.2 to 97.6,420
Polio,≥3 Doses,States/Local Areas,Oregon,2014,Age,35 Months,90.8,85.8 to 94.5,270
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.4,88.6 to 95.2,513
Polio,≥3 Doses,States/Local Areas,Oregon,2013,Age,35 Months,91.7,86.5 to 95.5,208
Polio,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,91.3,87.8 to 94.1,478
Polio,≥3 Doses,States/Local Areas,Oregon,2017,Age,35 Months,92.2,86.4 to 96.1,195
Polio,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,93.7,90.4 to 96.2,485
Polio,≥3 Doses,States/Local Areas,Oregon,2016,Age,35 Months,94.7,87.6 to 98.4,177
Polio,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,94.2,89.5 to 97.3,372
DTaP,≥2 Doses,States/Local Areas,Oregon,2013,Age,5 Months,83.9,79.7 to 87.4,208
DTaP,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,5 Months,79.3,75.7 to 82.5,478
DTaP,≥2 Doses,States/Local Areas,Oregon,2012,Age,5 Months,80.6,77.0 to 83.7,229
DTaP,≥2 Doses,States/Local Areas,Oregon,2011,Age,5 Months,75.5,68.8 to 81.1,266
Hib,≥3 Doses,States/Local Areas,Oregon,2014,Age,24 Months,86.9,81.9 to 91.0,270
Hib,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,89.4,86.1 to 92.2,513
Hib,Full Series,States/Local Areas,Oregon,2011,Age,35 Months,79.0,70.9 to 86.1,266
Hib,Full Series,States/Local Areas,Oregon,2012,Age,35 Months,76.4,68.5 to 83.6,229
Hib,Full Series,States/Local Areas,Oregon,2019,Age,24 Months,81.7,74.5 to 87.9,264
Hib,Full Series,States/Local Areas,Oregon,2013,Age,35 Months,83.6,76.9 to 89.3,208
Hib,Full Series,States/Local Areas,Oregon,2013-2014,Age,35 Months,82.4,77.7 to 86.6,478
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,91.8,88.4 to 95.2,425
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.5,85.0 to 91.9,520
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,81.8 to 96.7,118
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,93.1,88.6 to 97.7,133
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,71.4,65.4 to 77.5,314
Hib,Full Series,States/Local Areas,Oregon,2018,Age,35 Months,80.0,73.3 to 86.0,290
Hib,Full Series,States/Local Areas,Oregon,2018-2019,Age,35 Months,82.0,77.1 to 86.4,554
Hib,Full Series,States/Local Areas,Oregon,2019,Age,35 Months,84.0,76.5 to 90.1,264
Hib,Full Series,States/Local Areas,Oregon,2015,Age,35 Months,82.5,75.7 to 88.3,243
Hib,Full Series,States/Local Areas,Oregon,2015-2016,Age,35 Months,80.3,74.6 to 85.4,420
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,81.8,76.3 to 87.2,428
Hib,Full Series,States/Local Areas,Oregon,2014,Age,35 Months,81.6,74.7 to 87.6,270
Hib,Full Series,States/Local Areas,Oregon,2014-2015,Age,35 Months,82.1,77.4 to 86.4,513
Hib,Full Series,States/Local Areas,Oregon,2016,Age,35 Months,78.2,68.9 to 86.2,177
Hib,Full Series,States/Local Areas,Oregon,2016-2017,Age,35 Months,79.9,74.0 to 85.2,372
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,76.7,71.4 to 82.0,425
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.3,69.2 to 79.4,520
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.8,63.8 to 85.8,118
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,78.5,70.0 to 87.0,133
Polio,≥3 Doses,States/Local Areas,Oregon,2019,Age,35 Months,94.8,90.3 to 97.6,264
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,86.9,82.7 to 91.1,314
Polio,≥3 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,94.4,91.4 to 97.3,428
Hib,Full Series,States/Local Areas,Oregon,2017,Age,35 Months,81.6,74.0 to 88.0,195
Hib,Full Series,States/Local Areas,Oregon,2017-2018,Age,35 Months,80.8,75.8 to 85.3,485
Polio,≥3 Doses,States/Local Areas,Oregon,2018,Age,35 Months,95.3,91.3 to 97.8,290
Polio,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,95.1,92.3 to 97.1,554
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,76.5,70.8 to 82.3,308
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,65.0,57.3 to 72.8,221
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,66.2,56.1 to 76.3,138
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Overall,Overall,75.1,71.1 to 79.1,780
Hib,Primary Series,States/Local Areas,Oregon,2012,Age,7 Months,71.1,63.5 to 77.7,229
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,87.4,81.7 to 93.1,251
Hib,Primary Series,States/Local Areas,Oregon,2011,Age,7 Months,68.7,65.8 to 71.4,266
Hib,Full Series,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.6,69.2 to 83.9,217
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,63.5,47.3 to 79.7,138
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.1,72.0 to 88.3,217
Hep A,≥1 Dose,States/Local Areas,Oregon,2016,Age,35 Months,94.9,90.6 to 97.7,177
Hep A,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,35 Months,94.6,91.5 to 96.8,372
Polio,≥2 Doses,States/Local Areas,Oregon,2012,Age,5 Months,79.0,75.4 to 82.2,229
Polio,≥2 Doses,States/Local Areas,Oregon,2011,Age,5 Months,71.6,64.6 to 77.7,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2012,Age,35 Months,87.0,80.2 to 92.4,229
Polio,≥2 Doses,States/Local Areas,Oregon,2013,Age,5 Months,79.2,75.0 to 82.8,208
Polio,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,5 Months,76.2,73.6 to 78.7,478
Polio,≥2 Doses,States/Local Areas,Oregon,2014,Age,5 Months,73.2,66.0 to 79.4,270
Polio,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,5 Months,77.0,74.9 to 78.9,513
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,85.7,80.4 to 91.1,221
≥1 Dose Varicella,,States/Local Areas,Oregon,2011,Age,13 Months,44.6,38.3 to 51.0,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2017,Age,35 Months,94.3,89.5 to 97.4,195
Hep A,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,35 Months,93.5,90.2 to 96.0,485
Hep A,≥1 Dose,States/Local Areas,Oregon,2018,Age,35 Months,92.8,87.8 to 96.3,290
Polio,≥2 Doses,States/Local Areas,Oregon,2016,Age,5 Months,73.9,63.3 to 82.3,177
Polio,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,5 Months,74.9,67.9 to 80.8,372
Polio,≥2 Doses,States/Local Areas,Oregon,2017,Age,5 Months,76.0,66.2 to 83.6,195
Polio,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,5 Months,79.2,73.4 to 84.0,485
Hep B,≥3 Doses,States/Local Areas,Oregon,2014,Age,7 Months,55.5,48.1 to 62.6,270
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,60.4,55.1 to 65.5,513
Hep B,≥3 Doses,States/Local Areas,Oregon,2015,Age,7 Months,65.4,57.6 to 72.4,243
Hep B,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,61.2,54.8 to 67.4,420
Polio,≥2 Doses,States/Local Areas,Oregon,2015,Age,5 Months,80.7,73.6 to 86.2,243
Polio,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,5 Months,77.3,71.1 to 82.5,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2016,Age,7 Months,57.1,46.8 to 66.8,177
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,62.8,56.2 to 69.1,372
Hep A,≥2 Doses,States/Local Areas,Oregon,2019,Age,24 Months,47.8,39.9 to 56.4,264
Hep A,≥2 Doses,States/Local Areas,Oregon,2011,Age,35 Months,66.5,56.6 to 76.1,266
Hep A,≥2 Doses,States/Local Areas,Oregon,2012,Age,35 Months,72.3,62.4 to 81.5,229
Hep A,≥2 Doses,States/Local Areas,Oregon,2013,Age,35 Months,77.9,69.2 to 85.6,208
Hep A,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,76.8,70.9 to 82.3,478
DTaP,≥4 Doses,States/Local Areas,Oregon,2016,Age,24 Months,72.7,62.9 to 81.8,177
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,78.1,71.9 to 83.7,372
DTaP,≥4 Doses,States/Local Areas,Oregon,2015,Age,24 Months,75.8,68.4 to 82.7,243
DTaP,≥4 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,74.3,68.1 to 80.0,420
DTaP,≥4 Doses,States/Local Areas,Oregon,2014,Age,24 Months,77.3,71.1 to 82.9,270
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,76.6,71.8 to 81.1,513
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,90.4,85.4 to 95.4,251
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,81.0,70.2 to 91.9,133
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,79.7,72.3 to 87.1,425
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.8,70.6 to 84.9,520
DTaP,≥4 Doses,States/Local Areas,Oregon,2018,Age,24 Months,83.5,77.7 to 88.5,290
DTaP,≥4 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,82.0,77.4 to 86.1,554
DTaP,≥4 Doses,States/Local Areas,Oregon,2017,Age,24 Months,83.4,76.2 to 89.5,195
DTaP,≥4 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,83.4,78.9 to 87.5,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2019,Age,24 Months,80.1,72.7 to 86.6,264
DTaP,≥4 Doses,States/Local Areas,Oregon,2011,Age,35 Months,81.1,72.7 to 88.2,266
Hep A,≥1 Dose,States/Local Areas,Oregon,2013,Age,35 Months,94.1,89.4 to 97.2,208
Hep A,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,35 Months,92.5,88.7 to 95.3,478
Hep A,≥1 Dose,States/Local Areas,Oregon,2014,Age,35 Months,90.9,84.5 to 95.4,270
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,35 Months,92.1,88.0 to 95.3,513
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,91.1,88.6 to 93.6,780
Hep A,≥2 Doses,States/Local Areas,Oregon,2015,Age,24 Months,43.4,35.5 to 52.2,243
Hep A,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,24 Months,45.1,38.6 to 52.2,420
Hep A,≥2 Doses,States/Local Areas,Oregon,2014,Age,24 Months,38.3,31.2 to 46.3,270
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,24 Months,40.9,35.5 to 46.7,513
Hib,≥3 Doses,States/Local Areas,Oregon,2019,Age,35 Months,94.3,89.2 to 97.5,264
PCV,≥2 Doses,States/Local Areas,Oregon,2018,Age,5 Months,80.8,74.2 to 86.0,290
PCV,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,5 Months,81.0,76.1 to 85.1,554
PCV,≥2 Doses,States/Local Areas,Oregon,2019,Age,5 Months,81.2,73.5 to 87.0,264
PCV,≥2 Doses,States/Local Areas,Oregon,2017,Age,5 Months,74.6,64.8 to 82.4,195
PCV,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,5 Months,77.7,71.8 to 82.6,485
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,80.9,72.5 to 89.3,138
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.6,87.6 to 95.7,217
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,90.7 to 96.9,425
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,86.7 to 93.2,520
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,83.2 to 97.8,118
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,95.1,91.0 to 99.2,133
Hep B,≥3 Doses,States/Local Areas,Oregon,2020,Age,24 Months,87.9,81.2 to 93.0,220
DTaP,≥4 Doses,States/Local Areas,Oregon,2016,Age,19 Months,63.8,53.3 to 73.1,177
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2017,Age,19 Months,65.1,58.5 to 71.2,372
DTaP,≥4 Doses,States/Local Areas,Oregon,2017,Age,19 Months,66.4,58.1 to 73.8,195
DTaP,≥4 Doses,States/Local Areas,Oregon,2017-2018,Age,19 Months,71.0,65.6 to 75.8,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2018,Age,19 Months,75.7,68.5 to 81.6,290
DTaP,≥4 Doses,States/Local Areas,Oregon,2018-2019,Age,19 Months,94.8,92.0 to 96.7,554
Hep A,≥2 Doses,States/Local Areas,Oregon,2013,Age,24 Months,37.4,29.7 to 46.3,208
Hep A,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,37.8,32.5 to 43.7,478
Hep A,≥1 Dose,States/Local Areas,Oregon,2015,Age,35 Months,93.2,87.5 to 96.8,243
Hep A,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,35 Months,93.8,90.5 to 96.3,420
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,94.7,90.6 to 98.8,251
DTaP,≥3 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,93.8,90.6 to 96.9,308
Hep B,≥3 Doses,States/Local Areas,Oregon,2012,Age,7 Months,57.7,52.8 to 62.3,229
Hep B,≥3 Doses,States/Local Areas,Oregon,2011,Age,7 Months,55.6,50.6 to 60.4,266
Hep B,≥3 Doses,States/Local Areas,Oregon,2013,Age,7 Months,62.0,56.3 to 67.4,208
Hep B,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,58.8,52.0 to 65.2,478
DTaP,≥4 Doses,States/Local Areas,Oregon,2019,Age,19 Months,71.1,63.1 to 77.9,264
DTaP,≥4 Doses,States/Local Areas,Oregon,2011,Age,24 Months,74.7,67.3 to 81.6,266
DTaP,≥4 Doses,States/Local Areas,Oregon,2012,Age,24 Months,76.4,68.7 to 83.3,229
Hep A,≥2 Doses,States/Local Areas,Oregon,2018,Age,24 Months,51.0,43.5 to 59.0,290
Hep A,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,24 Months,49.6,44.1 to 55.4,554
Hep A,≥2 Doses,States/Local Areas,Oregon,2017,Age,24 Months,48.0,39.7 to 57.0,195
Hep A,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,24 Months,49.5,43.8 to 55.4,485
Hep A,≥2 Doses,States/Local Areas,Oregon,2016,Age,24 Months,46.7,36.8 to 57.8,177
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,24 Months,47.4,40.8 to 54.4,372
DTaP,≥4 Doses,States/Local Areas,Oregon,2013,Age,24 Months,84.6,77.8 to 90.2,208
DTaP,≥4 Doses,States/Local Areas,Oregon,2013-2014,Age,24 Months,81.0,76.5 to 85.1,478
Polio,≥2 Doses,States/Local Areas,Oregon,2019,Age,5 Months,80.9,73.2 to 86.8,264
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,92.0,87.1 to 96.9,133
Polio,≥2 Doses,States/Local Areas,Oregon,2012,Age,7 Months,88.7,87.4 to 89.9,229
Polio,≥2 Doses,States/Local Areas,Oregon,2011,Age,7 Months,80.3,72.6 to 86.2,266
Hep B,≥3 Doses,States/Local Areas,Oregon,2017,Age,7 Months,68.6,60.3 to 75.8,195
Hep B,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,69.8,64.4 to 74.7,485
Hep B,≥3 Doses,States/Local Areas,Oregon,2018,Age,7 Months,71.1,63.9 to 77.3,290
Hep B,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,71.9,66.6 to 76.6,554
Hep A,≥2 Doses,States/Local Areas,Oregon,2016,Age,35 Months,84.6,74.2 to 92.5,177
Hep A,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,82.5,75.3 to 88.7,372
Hep A,≥2 Doses,States/Local Areas,Oregon,2015,Age,35 Months,75.9,65.1 to 85.5,243
Hep A,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,81.1,73.0 to 87.9,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2019,Age,7 Months,72.7,64.9 to 79.2,264
Hep A,≥2 Doses,States/Local Areas,Oregon,2014,Age,35 Months,75.9,67.5 to 83.5,270
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,75.7,69.1 to 81.9,513
≥1 Dose Varicella,,States/Local Areas,Oregon,2014,Age,13 Months,55.3,47.9 to 62.4,270
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2015,Age,13 Months,55.2,49.8 to 60.6,513
≥1 Dose Varicella,,States/Local Areas,Oregon,2012,Age,13 Months,51.2,44.7 to 57.7,229
Hep A,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,35 Months,92.3,88.6 to 95.2,554
Hep A,≥1 Dose,States/Local Areas,Oregon,2019,Age,35 Months,91.8,85.9 to 96.0,264
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,84.7,80.2 to 89.1,314
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,90.6,87.0 to 94.2,428
Polio,≥2 Doses,States/Local Areas,Oregon,2018,Age,5 Months,82.5,76.0 to 87.5,290
Polio,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,5 Months,81.7,76.9 to 85.7,554
≥1 Dose Varicella,,States/Local Areas,Oregon,2013,Age,13 Months,53.0,49.0 to 56.9,208
≥1 Dose Varicella,,States/Local Areas,Oregon,2013-2014,Age,13 Months,54.1,49.4 to 58.8,478
Polio,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,94.8,92.0 to 96.7,554
Polio,≥2 Doses,States/Local Areas,Oregon,2019,Age,13 Months,94.6,90.4 to 97.1,264
≥1 Dose Varicella,,States/Local Areas,Oregon,2019,Age,19 Months,87.0,79.7 to 91.9,264
Polio,≥2 Doses,States/Local Areas,Oregon,2017,Age,13 Months,90.3,83.4 to 94.5,195
Polio,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,92.6,88.7 to 95.2,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2014,Age,24 Months,85.3,79.9 to 89.9,270
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2015,Age,24 Months,87.3,83.4 to 90.6,513
≥1 Dose Varicella,,States/Local Areas,Oregon,2013,Age,24 Months,89.5,83.6 to 94.0,208
≥1 Dose Varicella,,States/Local Areas,Oregon,2013-2014,Age,24 Months,87.4,83.6 to 90.8,478
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2013,Age,0-1 Days,59.2,53.2 to 64.9,208
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2013-2014,Age,0-1 Days,60.7,58.0 to 63.4,478
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2014,Age,0-1 Days,62.3,54.9 to 69.1,270
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2014-2015,Age,0-1 Days,68.6,63.4 to 73.4,513
Hep B,≥2 Doses,States/Local Areas,Oregon,2015,Age,5 Months,86.3,80.0 to 90.9,243
Hep B,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,5 Months,83.4,77.5 to 88.0,420
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2015,Age,0-1 Days,75.0,67.5 to 81.2,243
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2015-2016,Age,0-1 Days,71.7,65.5 to 77.2,420
PCV,≥4 Doses,States/Local Areas,Oregon,2013,Age,19 Months,81.0,76.3 to 85.0,208
PCV,≥4 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,77.0,74.1 to 79.6,478
PCV,≥4 Doses,States/Local Areas,Oregon,2012,Age,19 Months,72.7,62.4 to 81.0,229
PCV,≥4 Doses,States/Local Areas,Oregon,2011,Age,19 Months,67.7,63.5 to 71.7,266
≥1 Dose MMR,,States/Local Areas,Oregon,2018,Age,19 Months,92.3,87.1 to 95.6,290
≥1 Dose MMR,,States/Local Areas,Oregon,2018-2019,Age,19 Months,95.1,92.2 to 97.0,554
≥1 Dose MMR,,States/Local Areas,Oregon,2019,Age,19 Months,86.3,79.5 to 91.1,264
≥1 Dose MMR,,States/Local Areas,Oregon,2011,Age,24 Months,81.3,74.6 to 87.2,266
≥1 Dose MMR,,States/Local Areas,Oregon,2012,Age,24 Months,84.9,77.9 to 90.6,229
≥1 Dose Varicella,,States/Local Areas,Oregon,2015,Age,24 Months,89.2,83.5 to 93.6,243
≥1 Dose Varicella,,States/Local Areas,Oregon,2015-2016,Age,24 Months,89.3,85.0 to 92.8,420
≥1 Dose Varicella,,States/Local Areas,Oregon,2016,Age,24 Months,89.3,82.4 to 94.4,177
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2017,Age,24 Months,91.5,87.4 to 94.7,372
≥1 Dose MMR,,States/Local Areas,Oregon,2013,Age,19 Months,87.1,82.9 to 90.4,208
≥1 Dose MMR,,States/Local Areas,Oregon,2013-2014,Age,19 Months,84.3,80.7 to 87.3,478
≥1 Dose MMR,,States/Local Areas,Oregon,2014,Age,19 Months,81.4,74.9 to 86.5,270
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2015,Age,19 Months,84.4,80.1 to 87.9,513
≥1 Dose MMR,,States/Local Areas,Oregon,2012,Age,19 Months,80.7,73.5 to 86.3,229
≥1 Dose Varicella,,States/Local Areas,Oregon,2017,Age,19 Months,86.2,79.0 to 91.1,195
≥1 Dose Varicella,,States/Local Areas,Oregon,2017-2018,Age,19 Months,87.4,82.9 to 90.8,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2018,Age,19 Months,88.6,82.6 to 92.7,290
≥1 Dose Varicella,,States/Local Areas,Oregon,2018-2019,Age,19 Months,59.9,54.4 to 65.2,554
≥1 Dose MMR,,States/Local Areas,Oregon,2019,Age,13 Months,61.5,53.2 to 69.1,264
≥1 Dose Varicella,,States/Local Areas,Oregon,2016,Age,19 Months,85.7,77.5 to 91.2,177
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2017,Age,19 Months,85.9,80.8 to 89.9,372
Polio,≥2 Doses,States/Local Areas,Oregon,2015,Age,13 Months,92.8,87.5 to 95.9,243
Polio,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,92.0,87.6 to 94.9,420
Polio,≥2 Doses,States/Local Areas,Oregon,2016,Age,13 Months,91.1,83.3 to 95.5,177
Polio,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,90.7,85.9 to 94.0,372
Hep B,≥1 Dose,States/Local Areas,Oregon,2017,Age,3 Months,93.7,88.1 to 96.8,195
Hep B,≥1 Dose,States/Local Areas,Oregon,2017-2018,Age,3 Months,94.3,91.1 to 96.3,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2019,Age,35 Months,83.8,75.9 to 90.3,264
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,71.4,65.2 to 77.5,314
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,81.1,75.6 to 86.7,428
≥1 Dose MMR,,States/Local Areas,Oregon,2011,Age,19 Months,77.9,73.7 to 81.5,266
Hep B,≥1 Dose,States/Local Areas,Oregon,2018,Age,3 Months,94.8,91.0 to 97.1,290
Hep B,≥1 Dose,States/Local Areas,Oregon,2018-2019,Age,3 Months,94.6,91.9 to 96.5,554
Polio,≥2 Doses,States/Local Areas,Oregon,2014,Age,13 Months,90.8,85.5 to 94.2,270
Polio,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,91.8,88.3 to 94.3,513
Hep B,≥1 Dose,States/Local Areas,Oregon,2019,Age,3 Months,94.4,89.8 to 96.9,264
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,81.8,73.5 to 90.0,308
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2011,Age,0-1 Days,49.7,41.8 to 57.5,266
Hep B,≥2 Doses,States/Local Areas,Oregon,2012,Age,5 Months,81.4,79.0 to 83.7,229
Hep B,≥2 Doses,States/Local Areas,Oregon,2011,Age,5 Months,78.6,73.9 to 82.7,266
Hep B,≥2 Doses,States/Local Areas,Oregon,2013,Age,5 Months,79.5,76.7 to 82.1,208
Hep B,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,5 Months,81.4,79.9 to 82.9,478
Hep B,≥3 Doses,States/Local Areas,Oregon,2013,Age,19 Months,87.3,83.2 to 90.5,208
Hep B,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,19 Months,86.6,82.9 to 89.6,478
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Poverty,>400% FPL,80.1,71.5 to 88.6,251
Hep B,≥3 Doses,States/Local Areas,Oregon,2014,Age,19 Months,85.9,80.4 to 90.0,270
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,19 Months,86.8,82.8 to 90.0,513
Hep B,≥3 Doses,States/Local Areas,Oregon,2015,Age,19 Months,87.7,81.8 to 91.9,243
Hep B,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,19 Months,89.2,84.9 to 92.4,420
≥1 Dose MMR,,States/Local Areas,Oregon,2015,Age,19 Months,87.3,85.6 to 88.9,243
≥1 Dose MMR,,States/Local Areas,Oregon,2015-2016,Age,19 Months,87.9,83.5 to 91.2,420
≥1 Dose MMR,,States/Local Areas,Oregon,2016,Age,19 Months,88.4,81.5 to 93.0,177
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2017,Age,19 Months,88.4,83.8 to 91.8,372
≥1 Dose MMR,,States/Local Areas,Oregon,2017,Age,19 Months,88.3,81.4 to 92.8,195
≥1 Dose MMR,,States/Local Areas,Oregon,2017-2018,Age,19 Months,90.3,86.2 to 93.2,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,66.8,59.3 to 74.2,221
≥1 Dose Varicella,,States/Local Areas,Oregon,2011,Age,24 Months,79.9,73.1 to 85.9,266
≥1 Dose Varicella,,States/Local Areas,Oregon,2012,Age,24 Months,81.8,74.5 to 88.0,229
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,Hispanic,77.5,68.9 to 86.2,133
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.7,68.6 to 78.9,520
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,66.6 to 87.3,118
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,61.6,50.9 to 72.4,138
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,74.8,70.7 to 78.9,780
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.4,66.9 to 82.0,217
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,78.8,73.6 to 84.1,425
Hep B,≥1 Dose,States/Local Areas,Oregon,2013,Age,3 Months,93.4,92.0 to 94.5,208
Hep B,≥1 Dose,States/Local Areas,Oregon,2013-2014,Age,3 Months,93.0,92.3 to 93.6,478
Hep B,≥1 Dose,States/Local Areas,Oregon,2012,Age,3 Months,91.7,89.3 to 93.6,229
Hep B,≥1 Dose,States/Local Areas,Oregon,2011,Age,3 Months,89.0,84.0 to 92.5,266
Polio,≥2 Doses,States/Local Areas,Oregon,2016,Age,7 Months,88.5,79.4 to 93.9,177
Polio,≥2 Doses,States/Local Areas,Oregon,2016-2017,Age,7 Months,88.0,82.6 to 91.8,372
Polio,≥2 Doses,States/Local Areas,Oregon,2017,Age,7 Months,87.4,80.4 to 92.2,195
Polio,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,7 Months,89.8,85.6 to 92.8,485
Polio,≥2 Doses,States/Local Areas,Oregon,2018,Age,7 Months,92.2,87.3 to 95.3,290
Polio,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,7 Months,91.5,88.1 to 94.0,554
Hep B,≥2 Doses,States/Local Areas,Oregon,2019,Age,5 Months,89.9,84.6 to 93.6,264
Hep B,≥2 Doses,States/Local Areas,Oregon,2011,Age,7 Months,83.2,77.9 to 87.4,266
Hep B,≥2 Doses,States/Local Areas,Oregon,2017,Age,5 Months,86.1,79.0 to 91.1,195
Hep B,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,5 Months,88.4,84.2 to 91.6,485
Hep B,≥2 Doses,States/Local Areas,Oregon,2018,Age,5 Months,90.7,85.7 to 94.1,290
Hep B,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,5 Months,90.3,86.9 to 92.9,554
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2016,Age,0-1 Days,68.4,58.3 to 77.0,177
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2016-2017,Age,0-1 Days,70.7,64.4 to 76.4,372
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2017,Age,0-1 Days,73.1,65.0 to 79.9,195
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Oregon,2017-2018,Age,0-1 Days,77.2,72.1 to 81.5,485
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Any Medicaid,76.7,69.1 to 84.3,314
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Insurance Coverage,Private Insurance Only,80.7,73.1 to 88.4,428
Hep B,≥3 Doses,States/Local Areas,Oregon,2016,Age,13 Months,83.5,74.3 to 89.8,177
Hep B,≥3 Doses,States/Local Areas,Oregon,2016-2017,Age,13 Months,83.4,77.7 to 87.8,372
Hep B,≥3 Doses,States/Local Areas,Oregon,2015,Age,13 Months,83.8,77.2 to 88.7,243
Hep B,≥3 Doses,States/Local Areas,Oregon,2015-2016,Age,13 Months,83.6,78.2 to 87.9,420
DTaP,≥4 Doses,States/Local Areas,Oregon,2015,Age,35 Months,83.0,75.6 to 89.3,243
DTaP,≥4 Doses,States/Local Areas,Oregon,2015-2016,Age,35 Months,78.6,72.5 to 84.2,420
Hep B,≥3 Doses,States/Local Areas,Oregon,2017,Age,13 Months,83.3,75.6 to 88.9,195
Hep B,≥3 Doses,States/Local Areas,Oregon,2017-2018,Age,13 Months,85.1,80.4 to 88.8,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2017,Age,35 Months,87.3,80.2 to 92.8,195
DTaP,≥4 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,88.1,83.7 to 91.8,485
DTaP,≥4 Doses,States/Local Areas,Oregon,2016,Age,35 Months,74.4,64.5 to 83.4,177
DTaP,≥4 Doses,States/Local Areas,Oregon,2016-2017,Age,35 Months,80.8,74.6 to 86.2,372
DTaP,≥4 Doses,States/Local Areas,Oregon,2018,Age,35 Months,88.6,82.9 to 93.0,290
DTaP,≥4 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,86.2,81.4 to 90.4,554
Hep B,≥3 Doses,States/Local Areas,Oregon,2018,Age,13 Months,87.0,81.0 to 91.3,290
Hep B,≥3 Doses,States/Local Areas,Oregon,2018-2019,Age,13 Months,88.3,84.1 to 91.5,554
Hep B,≥3 Doses,States/Local Areas,Oregon,2019,Age,13 Months,89.7,82.9 to 94.0,264
Hep B,≥3 Doses,States/Local Areas,Oregon,2011,Age,19 Months,81.1,77.3 to 84.3,266
Hep B,≥3 Doses,States/Local Areas,Oregon,2012,Age,19 Months,82.8,78.4 to 86.5,229
Hep A,≥1 Dose,States/Local Areas,Oregon,2020,Age,35 Months,91.2,84.5 to 95.7,220
Polio,≥2 Doses,States/Local Areas,Oregon,2013,Age,13 Months,91.4,90.3 to 92.4,208
Polio,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,91.1,88.6 to 93.1,478
Hep B,≥1 Dose,States/Local Areas,Oregon,2014,Age,3 Months,92.5,88.5 to 95.2,270
Hep B,≥1 Dose,States/Local Areas,Oregon,2014-2015,Age,3 Months,93.8,91.3 to 95.6,513
Hep B,≥1 Dose,States/Local Areas,Oregon,2015,Age,3 Months,95.1,91.4 to 97.3,243
Hep B,≥1 Dose,States/Local Areas,Oregon,2015-2016,Age,3 Months,95.7,93.1 to 97.4,420
Hep B,≥1 Dose,States/Local Areas,Oregon,2016,Age,3 Months,96.3,91.6 to 98.4,177
Hep B,≥1 Dose,States/Local Areas,Oregon,2016-2017,Age,3 Months,95.0,91.7 to 97.0,372
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.6,61.4 to 85.9,118
Polio,≥2 Doses,States/Local Areas,Oregon,2019,Age,7 Months,90.8,85.3 to 94.4,264
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Overall,Overall,77.4,72.0 to 82.9,780
Hep A,≥2 Doses,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,70.4,60.7 to 80.2,221
≥1 Dose Varicella,,States/Local Areas,Oregon,2014,Age,19 Months,79.3,72.8 to 84.6,270
≥1 Dose Varicella,,States/Local Areas,Oregon,2014-2015,Age,19 Months,82.6,78.1 to 86.3,513
≥1 Dose Varicella,,States/Local Areas,Oregon,2015,Age,19 Months,85.9,85.0 to 86.7,243
≥1 Dose Varicella,,States/Local Areas,Oregon,2015-2016,Age,19 Months,85.8,80.8 to 89.6,420
≥1 Dose Varicella,,States/Local Areas,Oregon,2013,Age,19 Months,85.2,83.0 to 87.1,208
≥1 Dose Varicella,,States/Local Areas,Oregon,2013-2014,Age,19 Months,82.3,76.1 to 87.1,478
Polio,≥2 Doses,States/Local Areas,Oregon,2012,Age,13 Months,91.5,89.7 to 93.0,229
Polio,≥2 Doses,States/Local Areas,Oregon,2011,Age,13 Months,84.4,77.4 to 89.5,266
≥1 Dose MMR,,States/Local Areas,Oregon,2016-2017,Age,13 Months,66.0,59.5 to 71.9,372
≥1 Dose MMR,,States/Local Areas,Oregon,2018,Age,13 Months,79.1,72.1 to 84.7,290
≥1 Dose MMR,,States/Local Areas,Oregon,2018-2019,Age,13 Months,70.4,65.1 to 75.3,554
≥1 Dose MMR,,States/Local Areas,Oregon,2017,Age,13 Months,65.2,56.8 to 72.8,195
≥1 Dose MMR,,States/Local Areas,Oregon,2017-2018,Age,13 Months,72.0,66.6 to 76.9,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2016,Age,13 Months,59.8,49.5 to 69.2,177
≥1 Dose Varicella,,States/Local Areas,Oregon,2016-2017,Age,13 Months,60.7,54.2 to 67.0,372
≥1 Dose Varicella,,States/Local Areas,Oregon,2017,Age,13 Months,61.7,53.3 to 69.5,195
≥1 Dose Varicella,,States/Local Areas,Oregon,2017-2018,Age,13 Months,63.9,58.3 to 69.2,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2015,Age,13 Months,55.2,47.1 to 63.0,243
≥1 Dose Varicella,,States/Local Areas,Oregon,2015-2016,Age,13 Months,57.5,51.0 to 63.7,420
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.8,78.5 to 95.2,118
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a Non-MSA,76.9,68.0 to 85.7,138
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Non-Principal City,87.6,82.8 to 92.3,217
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Urbanicity,Living In a MSA Principal City,89.6,86.0 to 93.3,425
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.2,81.4 to 88.9,520
Polio,≥2 Doses,States/Local Areas,Oregon,2014,Age,7 Months,84.3,78.2 to 89.0,270
Polio,≥2 Doses,States/Local Areas,Oregon,2014-2015,Age,7 Months,87.2,83.2 to 90.3,513
Polio,≥2 Doses,States/Local Areas,Oregon,2013,Age,7 Months,88.1,86.3 to 89.7,208
Polio,≥2 Doses,States/Local Areas,Oregon,2013-2014,Age,7 Months,86.2,83.3 to 88.7,478
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Poverty,<133% FPL,81.4,75.7 to 87.2,221
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Overall,Overall,87.0,84.1 to 89.9,780
Polio,≥2 Doses,States/Local Areas,Oregon,2015,Age,7 Months,90.0,84.4 to 93.7,243
Polio,≥2 Doses,States/Local Areas,Oregon,2015-2016,Age,7 Months,89.2,84.3 to 92.8,420
Hep A,≥1 Dose,States/Local Areas,Oregon,2014-2017,Poverty,133% to <400% FPL,89.7,85.8 to 93.6,308
Hep B,≥3 Doses,States/Local Areas,Oregon,2011,Age,13 Months,76.1,71.5 to 80.1,266
≥1 Dose MMR,,States/Local Areas,Oregon,2013,Age,13 Months,60.2,55.9 to 64.4,208
≥1 Dose MMR,,States/Local Areas,Oregon,2013-2014,Age,13 Months,59.6,54.1 to 64.9,478
≥1 Dose MMR,,States/Local Areas,Oregon,2012,Age,13 Months,52.2,44.2 to 60.1,229
≥1 Dose MMR,,States/Local Areas,Oregon,2011,Age,13 Months,49.2,43.3 to 55.2,266
DTaP,≥4 Doses,States/Local Areas,Oregon,2012,Age,35 Months,88.9,75.3 to 96.9,229
DTaP,≥4 Doses,States/Local Areas,Oregon,2014,Age,35 Months,84.7,78.1 to 90.2,270
DTaP,≥4 Doses,States/Local Areas,Oregon,2014-2015,Age,35 Months,84.2,79.2 to 88.5,513
Hep A,≥2 Doses,States/Local Areas,Oregon,2019,Age,35 Months,74.1,64.2 to 83.0,264
Hep B,≥3 Doses,States/Local Areas,Oregon,2012,Age,13 Months,79.7,77.2 to 82.0,229
DTaP,≥4 Doses,States/Local Areas,Oregon,2013,Age,35 Months,91.1,85.8 to 95.0,208
DTaP,≥4 Doses,States/Local Areas,Oregon,2013-2014,Age,35 Months,88.0,83.9 to 91.5,478
Hep B,≥3 Doses,States/Local Areas,Oregon,2013,Age,13 Months,83.2,78.7 to 86.9,208
Hep B,≥3 Doses,States/Local Areas,Oregon,2013-2014,Age,13 Months,82.9,79.7 to 85.7,478
Hep B,≥3 Doses,States/Local Areas,Oregon,2014,Age,13 Months,82.6,76.7 to 87.2,270
Hep B,≥3 Doses,States/Local Areas,Oregon,2014-2015,Age,13 Months,83.2,78.9 to 86.7,513
Hep A,≥2 Doses,States/Local Areas,Oregon,2018,Age,35 Months,81.0,73.4 to 87.5,290
Hep A,≥2 Doses,States/Local Areas,Oregon,2018-2019,Age,35 Months,77.9,71.7 to 83.5,554
Hep A,≥2 Doses,States/Local Areas,Oregon,2017,Age,35 Months,78.9,69.9 to 86.6,195
Hep A,≥2 Doses,States/Local Areas,Oregon,2017-2018,Age,35 Months,80.0,74.2 to 85.1,485
≥1 Dose Varicella,,States/Local Areas,Oregon,2019,Age,13 Months,53.4,45.4 to 61.3,264
≥1 Dose Varicella,,States/Local Areas,Oregon,2011,Age,19 Months,77.1,72.8 to 80.9,266
≥1 Dose Varicella,,States/Local Areas,Oregon,2012,Age,19 Months,76.5,69.0 to 82.7,229
≥1 Dose MMR,,States/Local Areas,Oregon,2016,Age,13 Months,66.8,56.8 to 75.5,177
≥1 Dose Varicella,,States/Local Areas,Oregon,2018,Age,13 Months,66.2,58.6 to 73.0,290
≥1 Dose Varicella,,States/Local Areas,Oregon,2018-2019,Age,13 Months,59.9,54.4 to 65.2,554
≥1 Dose MMR,,States/Local Areas,Oregon,2014,Age,13 Months,59.0,51.6 to 66.0,270
≥1 Dose MMR,,States/Local Areas,Oregon,2014-2015,Age,13 Months,59.3,53.9 to 64.5,513
≥1 Dose MMR,,States/Local Areas,Oregon,2015,Age,13 Months,59.6,51.5 to 67.1,243
≥1 Dose MMR,,States/Local Areas,Oregon,2015-2016,Age,13 Months,63.2,56.8 to 69.1,420
Influenza,,States/Local Areas,California,2016,Age,24 Months,63.7,54.1 to 73.2,306
Influenza,,States/Local Areas,California,2016-2017,Age,24 Months,61.6,55.3 to 67.9,724
Influenza,,States/Local Areas,California,2011,Age,24 Months,60.5,51.9 to 69.3,298
Influenza,,States/Local Areas,California,2012,Age,24 Months,59.4,50.9 to 68.2,320
Influenza,,States/Local Areas,California,2014,Age,24 Months,54.6,45.7 to 64.0,355
Influenza,,States/Local Areas,California,2014-2015,Age,24 Months,55.7,48.9 to 62.6,648
Influenza,,States/Local Areas,California,2015,Age,24 Months,56.5,46.9 to 66.6,293
Influenza,,States/Local Areas,California,2015-2016,Age,24 Months,60.1,53.3 to 67.1,599
Influenza,,States/Local Areas,California,2013,Age,24 Months,58.6,50.0 to 67.5,319
Influenza,,States/Local Areas,California,2013-2014,Age,24 Months,56.6,50.3 to 63.1,674
≥1 Dose Varicella,,States/Local Areas,California,2019-2020,Age,19 Months,85.9,81.8 to 89.3,971
Influenza,,States/Local Areas,California,2021,Age,24 Months,54.0,44.3 to 64.2,253
Hep B,≥1 Dose,States/Local Areas,California,2021,Age,3 Months,91.3,84.0 to 95.4,253
≥1 Dose Varicella,,States/Local Areas,California,2020-2021,Age,13 Months,53.2,47.3 to 59.1,687
Hep A,≥1 Dose,States/Local Areas,California,2020-2021,Age,24 Months,83.3,77.4 to 88.4,687
Polio,≥2 Doses,States/Local Areas,California,2021,Age,13 Months,90.0,82.0 to 94.7,253
Hib,≥3 Doses,States/Local Areas,California,2021,Age,35 Months,95.2,87.2 to 98.9,253
PCV,≥1 Dose,States/Local Areas,California,2020-2021,Age,3 Months,83.8,78.9 to 87.7,687
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2021,Age,0-3 Days,71.0,61.5 to 78.9,253
≥1 Dose MMR,,States/Local Areas,California,2021,Age,13 Months,59.4,49.6 to 68.5,253
DTaP,≥2 Doses,States/Local Areas,California,2020-2021,Age,5 Months,72.9,66.9 to 78.2,687
Hib,≥3 Doses,States/Local Areas,California,2020-2021,Age,13 Months,77.1,71.6 to 81.8,687
Hib,≥2 Doses,States/Local Areas,California,2020-2021,Age,7 Months,86.5,81.7 to 90.1,687
Hib,≥2 Doses,States/Local Areas,California,2021,Age,5 Months,65.6,55.9 to 74.1,253
Hib,≥3 Doses,States/Local Areas,California,2020-2021,Age,7 Months,49.3,43.3 to 55.2,687
≥1 Dose MMR,,States/Local Areas,California,2020-2021,Age,19 Months,85.7,80.8 to 89.6,687
PCV,≥3 Doses,States/Local Areas,California,2020-2021,Age,13 Months,84.6,79.4 to 88.6,687
Hib,≥2 Doses,States/Local Areas,California,2021,Age,13 Months,92.1,85.1 to 95.9,253
Hep B,≥3 Doses,States/Local Areas,California,2020-2021,Age,24 Months,88.5,84.0 to 92.3,687
Hep A,≥2 Doses,States/Local Areas,California,2020-2021,Age,35 Months,73.7,66.1 to 80.7,687
Rotavirus,,States/Local Areas,California,2021,Age,8 Months,73.0,63.5 to 80.7,253
Hib,Primary Series,States/Local Areas,California,2021,Age,35 Months,96.2,89.7 to 99.1,253
Polio,≥3 Doses,States/Local Areas,California,2020-2021,Age,24 Months,89.8,85.6 to 93.2,687
Polio,≥1 Dose,States/Local Areas,California,2020-2021,Age,3 Months,83.1,78.1 to 87.2,687
Hib,≥2 Doses,States/Local Areas,California,2020-2021,Age,5 Months,70.0,64.0 to 75.4,687
≥1 Dose Varicella,,States/Local Areas,California,2020-2021,Age,24 Months,87.0,82.6 to 90.7,687
Hep B,≥2 Doses,States/Local Areas,California,2020-2021,Age,5 Months,82.2,76.6 to 86.7,687
DTaP,≥4 Doses,States/Local Areas,California,2020-2021,Age,19 Months,61.6,55.1 to 67.7,687
PCV,≥3 Doses,States/Local Areas,California,2020-2021,Age,24 Months,90.8,86.7 to 94.0,687
Hib,Primary Series,States/Local Areas,California,2020-2021,Age,7 Months,61.9,55.9 to 67.7,687
Polio,≥3 Doses,States/Local Areas,California,2020-2021,Age,35 Months,92.1,87.8 to 95.3,687
Hep A,≥2 Doses,States/Local Areas,California,2020-2021,Age,24 Months,50.8,44.8 to 57.3,687
Hib,≥3 Doses,States/Local Areas,California,2021,Age,13 Months,76.5,67.4 to 83.6,253
DTaP,≥3 Doses,States/Local Areas,California,2020-2021,Age,7 Months,59.6,53.4 to 65.6,687
DTaP,≥3 Doses,States/Local Areas,California,2021,Age,35 Months,93.1,85.4 to 97.6,253
Hep B,≥2 Doses,States/Local Areas,California,2020-2021,Age,7 Months,86.8,81.4 to 90.8,687
Hib,Full Series,States/Local Areas,California,2021,Age,35 Months,77.6,66.7 to 86.9,253
Hib,≥1 Dose,States/Local Areas,California,2020-2021,Age,3 Months,80.2,75.1 to 84.5,687
PCV,≥3 Doses,States/Local Areas,California,2020-2021,Age,35 Months,92.9,88.7 to 96.0,687
Hep B,≥1 Dose,States/Local Areas,California,2020-2021,Age,3 Months,91.8,87.8 to 94.6,687
Hib,Full Series,States/Local Areas,California,2020-2021,Age,24 Months,73.7,67.8 to 79.2,687
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.2,75.9 to 92.5,413
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,93.1,89.7 to 96.6,1171
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,90.4,86.3 to 94.6,421
Hib,Full Series,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,81.9,77.1 to 86.8,1171
Hib,Full Series,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,75.4,68.7 to 82.1,421
Influenza,,States/Local Areas,California,2014-2017,Overall,Overall,58.8,53.6 to 63.9,1141
Influenza,,States/Local Areas,California,2014-2017,Poverty,<133% FPL,51.0,41.8 to 60.3,215
Influenza,,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,51.5,41.9 to 61.1,343
Influenza,,States/Local Areas,California,2014-2017,Poverty,>400% FPL,73.4,66.2 to 80.6,583
Influenza,,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,64.4,57.7 to 71.1,820
Influenza,,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,52.8,44.7 to 61.0,283
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,80.7,73.6 to 87.9,494
Influenza,,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,56.8,49.1 to 64.5,314
Influenza,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.3,51.0 to 75.7,255
Influenza,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",50.9,22.6 to 79.2,41
Influenza,,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",61.0,52.6 to 69.4,531
Influenza,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,62.3,55.0 to 69.6,588
Influenza,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,55.9,48.5 to 63.2,533
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,88.0,83.6 to 92.3,1171
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",60.0,34.2 to 85.7,60
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,88.3,83.6 to 93.0,421
Hep A,≥1 Dose,States/Local Areas,California,2016-2019,Insurance Coverage,Other,96.3,90.2 to 100.0,36
Influenza,,States/Local Areas,California,2017,Age,24 Months,59.3,51.5 to 67.3,418
Influenza,,States/Local Areas,California,2017-2018,Age,24 Months,64.1,58.8 to 69.3,977
Influenza,,States/Local Areas,California,2018,Age,24 Months,69.1,62.8 to 75.2,559
Influenza,,States/Local Areas,California,2018-2019,Age,24 Months,69.9,65.4 to 74.2,1096
Influenza,,States/Local Areas,California,2019,Age,24 Months,70.6,64.5 to 76.5,537
Polio,≥3 Doses,States/Local Areas,California,2021,Age,19 Months,89.0,81.0 to 93.9,253
Polio,≥2 Doses,States/Local Areas,California,2021,Age,5 Months,70.0,60.2 to 78.3,253
Combined 7 Series,,States/Local Areas,California,2021,Age,24 Months,50.9,41.6 to 60.9,253
≥1 Dose Varicella,,States/Local Areas,California,2021,Age,13 Months,53.3,43.6 to 62.7,253
Hib,≥3 Doses,States/Local Areas,California,2020-2021,Age,35 Months,91.7,87.6 to 94.8,687
DTaP,≥2 Doses,States/Local Areas,California,2021,Age,5 Months,70.0,60.2 to 78.3,253
Rotavirus,,States/Local Areas,California,2014-2017,Poverty,>400% FPL,80.8,73.6 to 88.0,583
Hib,Primary Series,States/Local Areas,California,2020-2021,Age,35 Months,92.3,88.5 to 95.2,687
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2020-2021,Age,0-3 Days,72.2,66.3 to 77.4,687
Hib,Full Series,States/Local Areas,California,2020-2021,Age,35 Months,78.2,72.6 to 83.3,687
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2020-2021,Age,0-1 Days,70.6,64.7 to 75.8,687
PCV,≥3 Doses,States/Local Areas,California,2020-2021,Age,7 Months,57.4,51.3 to 63.4,687
DTaP,≥3 Doses,States/Local Areas,California,2020-2021,Age,13 Months,86.0,81.0 to 89.8,687
Polio,≥2 Doses,States/Local Areas,California,2020-2021,Age,13 Months,91.5,87.1 to 94.4,687
PCV,≥4 Doses,States/Local Areas,California,2020-2021,Age,19 Months,70.9,64.5 to 76.5,687
Hep B,≥3 Doses,States/Local Areas,California,2020-2021,Age,7 Months,60.5,54.4 to 66.4,687
≥1 Dose Varicella,,States/Local Areas,California,2021,Age,35 Months,97.5,88.4 to 99.8,253
Combined 7 Series,,States/Local Areas,California,2020-2021,Age,24 Months,59.8,53.6 to 66.1,687
Rotavirus,,States/Local Areas,California,2020-2021,Age,8 Months,73.1,67.1 to 78.4,687
Hib,≥3 Doses,States/Local Areas,California,2020-2021,Age,19 Months,87.5,82.8 to 91.1,687
Hep A,≥1 Dose,States/Local Areas,California,2020-2021,Age,19 Months,79.2,72.9 to 84.4,687
≥1 Dose MMR,,States/Local Areas,California,2021,Age,19 Months,86.0,78.2 to 91.4,253
Hep B,≥3 Doses,States/Local Areas,California,2020-2021,Age,19 Months,87.5,82.6 to 91.2,687
Hep A,≥2 Doses,States/Local Areas,California,2021,Age,19 Months,22.4,15.8 to 30.9,253
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2020-2021,Age,0-2 Days,71.8,66.0 to 77.0,687
Hib,Full Series,States/Local Areas,California,2020-2021,Age,19 Months,69.0,62.8 to 74.6,687
DTaP,≥3 Doses,States/Local Areas,California,2020-2021,Age,19 Months,90.5,86.3 to 93.5,687
Hep B,≥3 Doses,States/Local Areas,California,2021,Age,13 Months,84.8,76.4 to 90.6,253
PCV,≥1 Dose,States/Local Areas,California,2021,Age,3 Months,83.1,74.8 to 89.1,253
≥1 Dose Varicella,,States/Local Areas,California,2020-2021,Age,19 Months,85.4,80.5 to 89.3,687
≥1 Dose MMR,,States/Local Areas,California,2020-2021,Age,35 Months,91.8,87.1 to 95.3,687
Hib,Primary Series,States/Local Areas,California,2021,Age,13 Months,84.0,75.9 to 89.7,253
Hep B,≥3 Doses,States/Local Areas,California,2021,Age,35 Months,90.3,81.9 to 95.9,253
PCV,≥3 Doses,States/Local Areas,California,2020-2021,Age,19 Months,88.9,84.1 to 92.4,687
Influenza,,States/Local Areas,California,2020-2021,Age,24 Months,60.6,54.5 to 66.8,687
Combined 7 Series,,States/Local Areas,California,2020-2021,Age,35 Months,65.5,59.1 to 71.8,687
PCV,≥4 Doses,States/Local Areas,California,2020-2021,Age,35 Months,80.7,74.2 to 86.5,687
Hib,Primary Series,States/Local Areas,California,2020-2021,Age,19 Months,88.4,83.9 to 91.8,687
Polio,≥2 Doses,States/Local Areas,California,2020-2021,Age,5 Months,72.7,66.6 to 78.0,687
Polio,≥2 Doses,States/Local Areas,California,2020-2021,Age,7 Months,86.6,81.6 to 90.3,687
DTaP,≥4 Doses,States/Local Areas,California,2021,Age,35 Months,77.7,63.4 to 89.4,253
DTaP,≥3 Doses,States/Local Areas,California,2020-2021,Age,24 Months,90.8,86.9 to 94.0,687
Hep B,≥2 Doses,States/Local Areas,California,2021,Age,13 Months,88.0,79.4 to 93.3,253
Rotavirus,,States/Local Areas,California,2015,Age,8 Months,66.4,55.5 to 75.8,293
Rotavirus,,States/Local Areas,California,2015-2016,Age,8 Months,70.2,62.7 to 76.7,599
Rotavirus,,States/Local Areas,California,2016,Age,8 Months,74.0,63.5 to 82.2,306
Rotavirus,,States/Local Areas,California,2016-2017,Age,8 Months,74.8,68.3 to 80.3,724
Rotavirus,,States/Local Areas,California,2017,Age,8 Months,75.6,67.7 to 82.1,418
Rotavirus,,States/Local Areas,California,2017-2018,Age,8 Months,77.2,72.4 to 81.4,977
Rotavirus,,States/Local Areas,California,2013,Age,8 Months,75.4,67.3 to 82.0,319
Rotavirus,,States/Local Areas,California,2013-2014,Age,8 Months,70.5,64.5 to 75.9,674
Rotavirus,,States/Local Areas,California,2014,Age,8 Months,65.6,56.7 to 73.6,355
Rotavirus,,States/Local Areas,California,2014-2015,Age,8 Months,66.0,59.0 to 72.4,648
Rotavirus,,States/Local Areas,California,2018,Age,8 Months,78.9,73.0 to 83.8,559
Rotavirus,,States/Local Areas,California,2018-2019,Age,8 Months,77.4,73.2 to 81.1,1096
Rotavirus,,States/Local Areas,California,2019,Age,8 Months,75.9,69.7 to 81.1,537
Rotavirus,,States/Local Areas,California,2012,Age,8 Months,71.7,63.1 to 79.0,320
Rotavirus,,States/Local Areas,California,2011,Age,8 Months,73.3,64.6 to 80.6,298
Rotavirus,,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,77.5,71.5 to 83.5,820
Rotavirus,,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,61.0,52.9 to 69.0,283
Rotavirus,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",60.3,31.1 to 89.5,41
Rotavirus,,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,65.8,58.3 to 73.3,314
Rotavirus,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.8,57.0 to 80.7,255
Rotavirus,,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.3,68.8 to 83.8,531
Rotavirus,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,70.8,63.5 to 78.0,588
Rotavirus,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.4,62.4 to 76.4,533
Rotavirus,,States/Local Areas,California,2014-2017,Overall,Overall,69.0,63.9 to 74.0,1141
Rotavirus,,States/Local Areas,California,2014-2017,Poverty,<133% FPL,58.8,49.8 to 67.9,215
Rotavirus,,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,67.9,58.9 to 77.0,343
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Private Insurance Only,85.5,81.1 to 89.9,1171
DTaP,≥4 Doses,States/Local Areas,California,2016-2019,Poverty,<133% FPL,73.1,65.2 to 81.0,305
PCV,≥4 Doses,States/Local Areas,California,2016-2019,Insurance Coverage,Any Medicaid,75.8,69.1 to 82.6,421
Hib,Full Series,States/Local Areas,California,2016-2019,Race and Ethnicity,Hispanic,77.7,71.5 to 83.8,494
Polio,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.9,83.2 to 96.5,413
Hib,Primary Series,States/Local Areas,California,2019,Age,7 Months,67.9,61.6 to 73.7,537
Hib,Primary Series,States/Local Areas,California,2011,Age,13 Months,86.2,81.3 to 90.0,298
Hib,Primary Series,States/Local Areas,California,2012,Age,13 Months,91.0,86.7 to 94.0,320
Hib,Primary Series,States/Local Areas,California,2013,Age,13 Months,88.9,85.0 to 91.8,319
Hib,Primary Series,States/Local Areas,California,2013-2014,Age,13 Months,88.2,84.3 to 91.3,674
Hib,Primary Series,States/Local Areas,California,2014,Age,13 Months,87.6,80.1 to 92.5,355
Hib,Primary Series,States/Local Areas,California,2014-2015,Age,13 Months,88.1,82.9 to 91.8,648
Hep A,≥2 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.3,66.7 to 88.0,413
Hib,Primary Series,States/Local Areas,California,2019-2020,Age,7 Months,68.1,63.5 to 72.4,971
Hib,Primary Series,States/Local Areas,California,2011,Age,24 Months,90.6,83.9 to 95.3,298
Hib,Primary Series,States/Local Areas,California,2012,Age,24 Months,95.7,92.1 to 98.0,320
Hib,Primary Series,States/Local Areas,California,2013,Age,24 Months,93.3,88.4 to 96.6,319
Hib,Primary Series,States/Local Areas,California,2013-2014,Age,24 Months,91.4,87.5 to 94.4,674
Hib,Full Series,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,73.7 to 90.0,413
Hep B,≥2 Doses,States/Local Areas,California,2019-2020,Age,7 Months,92.9,89.5 to 95.3,971
Hib,Primary Series,States/Local Areas,California,2013,Age,7 Months,69.3,62.8 to 75.1,319
Hib,Primary Series,States/Local Areas,California,2013-2014,Age,7 Months,67.5,62.7 to 72.0,674
Hib,Primary Series,States/Local Areas,California,2014,Age,7 Months,65.8,56.6 to 73.9,355
Hib,Primary Series,States/Local Areas,California,2014-2015,Age,7 Months,61.6,54.5 to 68.2,648
Hib,Primary Series,States/Local Areas,California,2015,Age,7 Months,57.2,46.6 to 67.3,293
Hib,Primary Series,States/Local Areas,California,2015-2016,Age,7 Months,63.5,56.0 to 70.3,599
Hib,Primary Series,States/Local Areas,California,2017,Age,19 Months,89.6,83.2 to 93.7,418
Hib,Primary Series,States/Local Areas,California,2017-2018,Age,19 Months,91.7,88.1 to 94.3,977
Hib,Primary Series,States/Local Areas,California,2015,Age,13 Months,88.6,80.7 to 93.5,293
Hib,Primary Series,States/Local Areas,California,2015-2016,Age,13 Months,86.4,80.3 to 90.8,599
Hib,Primary Series,States/Local Areas,California,2016,Age,7 Months,69.7,59.4 to 78.3,306
Hib,Primary Series,States/Local Areas,California,2016-2017,Age,7 Months,68.0,61.5 to 73.9,724
Hib,Primary Series,States/Local Areas,California,2017,Age,7 Months,66.3,58.1 to 73.6,418
Hib,Primary Series,States/Local Areas,California,2017-2018,Age,7 Months,68.7,63.6 to 73.4,977
Hib,Primary Series,States/Local Areas,California,2018,Age,7 Months,71.3,64.9 to 76.9,559
Hib,Primary Series,States/Local Areas,California,2018-2019,Age,7 Months,69.6,65.2 to 73.7,1096
Combined 7 Series,,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,65.6,58.0 to 73.2,314
Combined 7 Series,,States/Local Areas,California,2018,Age,35 Months,76.1,69.5 to 82.1,559
Combined 7 Series,,States/Local Areas,California,2018-2019,Age,35 Months,74.7,70.0 to 79.1,1096
Combined 7 Series,,States/Local Areas,California,2019,Age,35 Months,73.8,66.8 to 80.3,537
Combined 7 Series,,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,70.8,64.4 to 77.2,820
Combined 7 Series,,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,61.9,54.0 to 69.9,283
Combined 7 Series,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.7,51.3 to 96.2,41
Combined 7 Series,,States/Local Areas,California,2012,Age,35 Months,80.8,72.1 to 88.2,320
Combined 7 Series,,States/Local Areas,California,2013,Age,35 Months,78.7,70.2 to 86.2,319
Combined 7 Series,,States/Local Areas,California,2013-2014,Age,35 Months,71.7,65.5 to 77.6,674
Combined 7 Series,,States/Local Areas,California,2015,Age,35 Months,80.4,68.9 to 89.7,293
Combined 7 Series,,States/Local Areas,California,2015-2016,Age,35 Months,76.5,68.5 to 83.7,599
Combined 7 Series,,States/Local Areas,California,2014,Age,35 Months,66.2,57.4 to 74.8,355
Combined 7 Series,,States/Local Areas,California,2014-2015,Age,35 Months,72.2,65.4 to 78.5,648
Combined 7 Series,,States/Local Areas,California,2017,Age,24 Months,63.4,55.4 to 71.3,418
Combined 7 Series,,States/Local Areas,California,2017-2018,Age,24 Months,67.7,62.6 to 72.7,977
Combined 7 Series,,States/Local Areas,California,2018,Age,24 Months,72.1,65.9 to 78.0,559
Combined 7 Series,,States/Local Areas,California,2018-2019,Age,24 Months,68.6,64.1 to 73.0,1096
Combined 7 Series,,States/Local Areas,California,2019,Age,24 Months,65.2,58.7 to 71.6,537
Combined 7 Series,,States/Local Areas,California,2014,Age,24 Months,63.1,54.6 to 71.5,355
Combined 7 Series,,States/Local Areas,California,2014-2015,Age,24 Months,67.8,61.3 to 74.1,648
Combined 7 Series,,States/Local Areas,California,2015,Age,24 Months,73.6,63.5 to 82.7,293
Combined 7 Series,,States/Local Areas,California,2015-2016,Age,24 Months,68.1,61.0 to 75.0,599
Hib,Primary Series,States/Local Areas,California,2018,Age,35 Months,94.9,91.2 to 97.4,559
Hib,Primary Series,States/Local Areas,California,2018-2019,Age,35 Months,96.2,94.0 to 97.7,1096
Combined 7 Series,,States/Local Areas,California,2016,Age,24 Months,63.1,53.1 to 73.1,306
Combined 7 Series,,States/Local Areas,California,2016-2017,Age,24 Months,63.3,56.8 to 69.7,724
Hib,Primary Series,States/Local Areas,California,2019,Age,35 Months,97.8,95.2 to 99.2,537
Combined 7 Series,,States/Local Areas,California,2016,Age,35 Months,72.5,61.4 to 82.6,306
Combined 7 Series,,States/Local Areas,California,2016-2017,Age,35 Months,70.6,63.9 to 77.0,724
Combined 7 Series,,States/Local Areas,California,2017,Age,35 Months,69.2,60.9 to 77.1,418
Combined 7 Series,,States/Local Areas,California,2017-2018,Age,35 Months,72.5,67.2 to 77.5,977
Hib,Primary Series,States/Local Areas,California,2017,Age,35 Months,91.3,85.7 to 95.3,418
Hib,Primary Series,States/Local Areas,California,2017-2018,Age,35 Months,93.1,89.8 to 95.6,977
Hib,Primary Series,States/Local Areas,California,2015,Age,35 Months,98.8,95.1 to 99.8,293
Hib,Primary Series,States/Local Areas,California,2015-2016,Age,35 Months,95.8,89.3 to 98.8,599
Hib,Primary Series,States/Local Areas,California,2016,Age,35 Months,92.0,85.2 to 96.4,306
Hib,Primary Series,States/Local Areas,California,2016-2017,Age,35 Months,91.7,87.5 to 94.9,724
Hib,Primary Series,States/Local Areas,California,2019,Age,13 Months,90.2,85.7 to 93.4,537
Hib,Primary Series,States/Local Areas,California,2011,Age,19 Months,89.5,84.2 to 93.2,298
DTaP,≥3 Doses,States/Local Areas,California,2020,Age,13 Months,86.2,79.9 to 90.8,434
Combined 7 Series,,States/Local Areas,California,2011,Age,24 Months,70.0,61.6 to 78.1,298
Combined 7 Series,,States/Local Areas,California,2013,Age,24 Months,70.5,62.2 to 78.3,319
Combined 7 Series,,States/Local Areas,California,2013-2014,Age,24 Months,66.5,60.6 to 72.3,674
Combined 7 Series,,States/Local Areas,California,2012,Age,24 Months,73.0,64.9 to 80.6,320
Hib,Primary Series,States/Local Areas,California,2011,Age,35 Months,92.6,86.3 to 96.7,298
Hib,Primary Series,States/Local Areas,California,2013,Age,35 Months,95.7,90.6 to 98.5,319
Hib,Primary Series,States/Local Areas,California,2013-2014,Age,35 Months,93.2,89.3 to 96.1,674
Hib,Primary Series,States/Local Areas,California,2012,Age,35 Months,97.2,93.7 to 99.0,320
Hib,Primary Series,States/Local Areas,California,2014,Age,35 Months,91.3,85.2 to 95.6,355
Hib,Primary Series,States/Local Areas,California,2014-2015,Age,35 Months,94.3,89.9 to 97.2,648
Hib,Primary Series,States/Local Areas,California,2019,Age,24 Months,96.6,94.1 to 98.3,537
Hib,Primary Series,States/Local Areas,California,2017,Age,24 Months,91.1,85.6 to 95.2,418
Hib,Primary Series,States/Local Areas,California,2017-2018,Age,24 Months,92.8,89.6 to 95.3,977
Hib,Primary Series,States/Local Areas,California,2018,Age,24 Months,94.5,90.9 to 97.0,559
Hib,Primary Series,States/Local Areas,California,2018-2019,Age,24 Months,95.6,93.5 to 97.2,1096
Hib,Primary Series,States/Local Areas,California,2014,Age,24 Months,89.5,83.1 to 94.3,355
Hib,Primary Series,States/Local Areas,California,2014-2015,Age,24 Months,91.1,86.8 to 94.5,648
Hib,Primary Series,States/Local Areas,California,2015,Age,24 Months,92.8,86.6 to 96.8,293
Hib,Primary Series,States/Local Areas,California,2015-2016,Age,24 Months,91.8,87.4 to 95.1,599
Hib,Primary Series,States/Local Areas,California,2016,Age,24 Months,90.8,84.1 to 95.5,306
Hib,Primary Series,States/Local Areas,California,2016-2017,Age,24 Months,90.9,86.7 to 94.2,724
Hib,Primary Series,States/Local Areas,California,2012,Age,19 Months,94.1,89.5 to 96.8,320
Hib,Primary Series,States/Local Areas,California,2013,Age,19 Months,93.2,91.7 to 94.5,319
Hib,Primary Series,States/Local Areas,California,2013-2014,Age,19 Months,91.2,88.8 to 93.2,674
Hib,Primary Series,States/Local Areas,California,2014,Age,19 Months,89.2,82.1 to 93.7,355
Hib,Primary Series,States/Local Areas,California,2014-2015,Age,19 Months,90.9,86.3 to 94.1,648
Hib,Primary Series,States/Local Areas,California,2018,Age,13 Months,90.7,86.2 to 93.9,559
Hib,Primary Series,States/Local Areas,California,2018-2019,Age,13 Months,90.5,87.5 to 92.9,1096
Hib,Primary Series,States/Local Areas,California,2015,Age,19 Months,92.8,90.5 to 94.5,293
Hib,Primary Series,States/Local Areas,California,2015-2016,Age,19 Months,91.8,87.0 to 94.9,599
Hib,Primary Series,States/Local Areas,California,2016,Age,13 Months,84.2,74.2 to 90.8,306
Hib,Primary Series,States/Local Areas,California,2016-2017,Age,13 Months,84.8,78.9 to 89.3,724
Hib,Primary Series,States/Local Areas,California,2017,Age,13 Months,85.4,78.3 to 90.5,418
Hib,Primary Series,States/Local Areas,California,2017-2018,Age,13 Months,88.0,83.9 to 91.2,977
Hib,Primary Series,States/Local Areas,California,2016,Age,19 Months,90.8,83.2 to 95.1,306
Hib,Primary Series,States/Local Areas,California,2016-2017,Age,19 Months,90.2,85.6 to 93.4,724
Hib,Primary Series,States/Local Areas,California,2019,Age,19 Months,96.4,93.7 to 98.0,537
Hib,Primary Series,States/Local Areas,California,2018,Age,19 Months,94.0,90.0 to 96.4,559
Hib,Primary Series,States/Local Areas,California,2018-2019,Age,19 Months,90.5,87.5 to 92.9,1096
PCV,≥3 Doses,States/Local Areas,California,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.3,83.7 to 96.9,413
≥1 Dose MMR,,States/Local Areas,California,2021,Age,35 Months,93.0,84.7 to 97.7,253
Hib,Full Series,States/Local Areas,California,2013,Age,24 Months,84.1,77.2 to 89.8,319
Hib,Full Series,States/Local Areas,California,2013-2014,Age,24 Months,80.1,74.7 to 84.9,674
Hib,Full Series,States/Local Areas,California,2014,Age,24 Months,76.4,68.1 to 83.9,355
Hib,Full Series,States/Local Areas,California,2014-2015,Age,24 Months,80.8,75.0 to 86.1,648
Hib,Full Series,States/Local Areas,California,2011,Age,24 Months,79.1,71.2 to 86.0,298
Hib,Full Series,States/Local Areas,California,2012,Age,24 Months,81.4,73.6 to 88.0,320
Hib,Full Series,States/Local Areas,California,2019,Age,19 Months,72.3,66.0 to 77.8,537
Hib,Full Series,States/Local Areas,California,2016,Age,19 Months,73.6,63.3 to 81.9,306
Hib,Full Series,States/Local Areas,California,2016-2017,Age,19 Months,71.9,65.5 to 77.6,724
Combined 7 Series,,States/Local Areas,California,2014-2017,Poverty,<133% FPL,61.3,52.2 to 70.4,215
Hib,Full Series,States/Local Areas,California,2017,Age,19 Months,70.1,61.9 to 77.1,418
Hib,Full Series,States/Local Areas,California,2017-2018,Age,19 Months,74.3,69.3 to 78.7,977
Hib,Full Series,States/Local Areas,California,2018,Age,19 Months,78.6,72.6 to 83.7,559
Hib,Full Series,States/Local Areas,California,2018-2019,Age,19 Months,96.0,93.9 to 97.4,1096
Hib,Full Series,States/Local Areas,California,2014,Age,19 Months,70.6,61.5 to 78.2,355
Hib,Full Series,States/Local Areas,California,2014-2015,Age,19 Months,74.2,67.7 to 79.8,648
Hib,Full Series,States/Local Areas,California,2015,Age,19 Months,78.0,72.7 to 82.5,293
Hib,Full Series,States/Local Areas,California,2015-2016,Age,19 Months,75.8,68.9 to 81.6,599
Combined 7 Series,,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,59.3,49.9 to 68.8,343
Combined 7 Series,,States/Local Areas,California,2014-2017,Poverty,>400% FPL,78.5,71.7 to 85.2,583
Hib,Full Series,States/Local Areas,California,2011,Age,19 Months,73.0,69.5 to 76.2,298
Hib,Full Series,States/Local Areas,California,2012,Age,19 Months,70.8,65.8 to 75.3,320
Hib,Full Series,States/Local Areas,California,2013,Age,19 Months,76.9,69.7 to 82.8,319
Hib,Full Series,States/Local Areas,California,2013-2014,Age,19 Months,73.7,70.6 to 76.7,674
Combined 7 Series,,States/Local Areas,California,2011,Age,35 Months,73.2,64.5 to 81.2,298
Combined 7 Series,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.8,60.0 to 81.7,255
Combined 7 Series,,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",64.4,55.9 to 72.9,531
Combined 7 Series,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,67.9,60.7 to 75.1,588
Combined 7 Series,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,66.7,59.5 to 73.9,533
Combined 7 Series,,States/Local Areas,California,2014-2017,Overall,Overall,66.5,61.5 to 71.6,1141
Influenza,,States/Local Areas,Minnesota,2013,Age,24 Months,62.2,54.8 to 69.6,293
Influenza,,States/Local Areas,Minnesota,2013-2014,Age,24 Months,62.9,57.4 to 68.4,562
Influenza,,States/Local Areas,Minnesota,2011,Age,24 Months,66.7,57.5 to 75.7,208
Influenza,,States/Local Areas,Minnesota,2012,Age,24 Months,69.4,61.4 to 77.2,225
Influenza,,States/Local Areas,Minnesota,2015,Age,24 Months,61.1,51.2 to 71.2,227
Influenza,,States/Local Areas,Minnesota,2015-2016,Age,24 Months,65.8,58.9 to 72.6,444
Influenza,,States/Local Areas,Minnesota,2014,Age,24 Months,63.6,55.6 to 71.6,269
Influenza,,States/Local Areas,Minnesota,2014-2015,Age,24 Months,62.4,56.0 to 68.8,496
Influenza,,States/Local Areas,Minnesota,2016,Age,24 Months,70.6,61.1 to 79.5,217
Influenza,,States/Local Areas,Minnesota,2016-2017,Age,24 Months,75.0,69.1 to 80.5,507
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,76.6,69.2 to 84.1,251
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,92.7,85.2 to 100.0,73
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.2,85.3 to 99.1,123
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,74.4,56.7 to 92.1,73
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Poverty,>400% FPL,98.3,97.1 to 99.6,491
Hep B,≥3 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,80.6,75.5 to 84.9,522
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,Hispanic,75.5,62.8 to 88.1,73
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2020-2021,Age,0-3 Days,81.3,75.0 to 86.4,415
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020-2021,Age,19 Months,89.2,84.0 to 92.9,415
Hep B,≥3 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,92.9,86.0 to 96.6,176
Hep B,≥2 Doses,States/Local Areas,Minnesota,2019-2020,Age,7 Months,91.4,87.3 to 94.3,522
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,95.2,91.5 to 97.6,415
Hib,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,91.6,87.1 to 95.0,415
DTaP,≥4 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,82.0,75.9 to 87.4,415
≥1 Dose Varicella,,States/Local Areas,Minnesota,2021,Age,35 Months,92.4,84.5 to 97.2,176
Polio,≥3 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,92.5,85.2 to 97.0,176
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,94.2,90.7 to 96.7,415
Rotavirus,,States/Local Areas,Minnesota,2020-2021,Age,8 Months,77.2,70.7 to 82.6,415
Hep A,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,19 Months,86.2,80.8 to 90.3,415
Hib,Primary Series,States/Local Areas,Minnesota,2020-2021,Age,35 Months,93.1,89.1 to 96.0,415
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Minnesota,2020-2021,Age,0-1 Days,78.6,72.2 to 83.8,415
Hib,Primary Series,States/Local Areas,Minnesota,2020-2021,Age,19 Months,90.9,86.5 to 94.0,415
Hib,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,5 Months,77.2,70.5 to 82.7,415
≥1 Dose MMR,,States/Local Areas,Minnesota,2020-2021,Age,13 Months,66.7,59.6 to 73.1,415
PCV,≥1 Dose,States/Local Areas,Minnesota,2021,Age,3 Months,82.3,72.1 to 89.3,176
Hib,Full Series,States/Local Areas,Minnesota,2020-2021,Age,19 Months,68.7,61.8 to 74.8,415
Polio,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,91.7,87.1 to 94.8,415
≥1 Dose Varicella,,States/Local Areas,Minnesota,2021,Age,13 Months,58.1,47.5 to 67.9,176
Polio,≥2 Doses,States/Local Areas,Minnesota,2021,Age,5 Months,72.7,62.0 to 81.3,176
DTaP,≥2 Doses,States/Local Areas,Minnesota,2021,Age,5 Months,75.0,64.6 to 83.2,176
Hib,Full Series,States/Local Areas,Minnesota,2020-2021,Age,35 Months,75.8,69.4 to 81.8,415
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Minnesota,2020-2021,Age,0-2 Days,81.1,74.7 to 86.1,415
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,91.6,87.2 to 94.5,415
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,89.0,83.4 to 93.0,415
Polio,≥3 Doses,States/Local Areas,Minnesota,2021,Age,19 Months,89.9,81.1 to 94.9,176
Hep B,≥2 Doses,States/Local Areas,Minnesota,2021,Age,5 Months,91.1,81.9 to 95.9,176
≥1 Dose MMR,,States/Local Areas,Minnesota,2021,Age,19 Months,89.9,81.0 to 94.9,176
Hep A,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,27.2,22.1 to 33.0,415
PCV,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,67.8,60.8 to 74.1,415
Influenza,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,73.1,66.6 to 79.6,343
Influenza,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.6,63.1 to 74.1,605
Influenza,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,57.6,46.5 to 68.8,175
Influenza,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,65.4,57.4 to 73.4,315
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",65.4,45.5 to 85.2,56
Influenza,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.6,58.3 to 81.0,111
Influenza,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,68.3,52.6 to 83.9,66
Influenza,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",55.4,37.0 to 73.7,51
Influenza,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,59.3,50.3 to 68.2,221
Hep A,≥2 Doses,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.7,87.9 to 100.0,123
Influenza,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,73.3,68.0 to 78.7,582
Influenza,,States/Local Areas,Minnesota,2019,Age,24 Months,72.4,64.4 to 79.8,283
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020-2021,Age,13 Months,63.4,56.5 to 69.9,415
Influenza,,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,80.9,75.4 to 86.5,403
Influenza,,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,57.6,49.3 to 65.8,293
Influenza,,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,56.4,45.0 to 67.7,137
Influenza,,States/Local Areas,Minnesota,2014-2017,Overall,Overall,67.4,62.8 to 72.0,833
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,85.0,81.1 to 88.8,721
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,90.8,86.0 to 95.6,251
PCV,≥3 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,97.4,96.0 to 98.7,721
Influenza,,States/Local Areas,Minnesota,2021,Age,24 Months,69.8,60.1 to 79.1,176
Hib,Full Series,States/Local Areas,Minnesota,2020-2021,Age,24 Months,74.6,68.2 to 80.6,415
PCV,≥4 Doses,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,90.6,87.3 to 93.8,721
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.4,92.9 to 100.0,123
Hib,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,86.3,80.1 to 90.8,415
DTaP,≥3 Doses,States/Local Areas,Minnesota,2021,Age,24 Months,94.7,89.0 to 98.0,176
≥1 Dose MMR,,States/Local Areas,Minnesota,2020-2021,Age,19 Months,90.3,85.2 to 93.7,415
Hep B,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,3 Months,93.6,89.5 to 96.1,415
PCV,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,3 Months,85.8,79.4 to 90.4,415
Hep A,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,24 Months,90.2,85.7 to 93.7,415
≥1 Dose MMR,,States/Local Areas,Minnesota,2021,Age,13 Months,60.6,49.9 to 70.4,176
Polio,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,3 Months,85.5,79.2 to 90.1,415
Hep A,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,81.6,70.2 to 90.7,415
Influenza,,States/Local Areas,Minnesota,2018,Age,24 Months,74.5,67.6 to 80.9,328
Influenza,,States/Local Areas,Minnesota,2018-2019,Age,24 Months,73.4,68.2 to 78.4,611
Influenza,,States/Local Areas,Minnesota,2017,Age,24 Months,79.3,72.6 to 85.2,290
Influenza,,States/Local Areas,Minnesota,2017-2018,Age,24 Months,76.9,72.1 to 81.4,618
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Any Medicaid,84.6,77.9 to 91.2,251
Hep A,≥1 Dose,States/Local Areas,Minnesota,2016-2019,Insurance Coverage,Private Insurance Only,93.3,90.3 to 96.2,721
Hep B,≥1 Dose,States/Local Areas,Minnesota,2021,Age,3 Months,96.6,90.4 to 98.9,176
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Minnesota,2021,Age,0-3 Days,85.2,75.5 to 91.5,176
Hib,≥3 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,92.3,85.3 to 96.8,176
Hib,Full Series,States/Local Areas,Minnesota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,73.4 to 91.3,123
Hib,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,35.5,29.7 to 41.7,415
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,93.2,89.3 to 96.0,415
DTaP,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,5 Months,78.1,71.4 to 83.5,415
PCV,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,13 Months,85.4,79.2 to 90.0,415
Polio,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,92.8,88.6 to 95.9,415
Hep A,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,47.6,40.9 to 54.7,415
Hib,≥2 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,94.0,87.8 to 97.1,176
DTaP,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,69.2,62.2 to 75.5,415
Rotavirus,,States/Local Areas,Minnesota,2021,Age,8 Months,76.6,66.5 to 84.3,176
Hib,Primary Series,States/Local Areas,Minnesota,2021,Age,35 Months,93.8,88.4 to 97.2,176
≥1 Dose Varicella,,States/Local Areas,Minnesota,2020-2021,Age,24 Months,92.2,87.9 to 95.4,415
Hib,Primary Series,States/Local Areas,Minnesota,2020-2021,Age,7 Months,69.7,62.8 to 75.7,415
Hep B,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,5 Months,89.5,83.6 to 93.4,415
Hib,≥3 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,46.0,36.2 to 56.0,176
DTaP,≥4 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,74.2,67.4 to 80.0,415
Polio,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,90.0,84.9 to 93.5,415
PCV,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,24 Months,92.5,88.7 to 95.4,415
Polio,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,93.9,89.6 to 96.8,415
Hib,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,86.2,80.7 to 90.3,415
Hib,Full Series,States/Local Areas,Minnesota,2021,Age,35 Months,73.6,63.5 to 82.8,176
Hib,Primary Series,States/Local Areas,Minnesota,2020-2021,Age,13 Months,81.6,75.5 to 86.5,415
Combined 7 Series,,States/Local Areas,Minnesota,2020-2021,Age,24 Months,68.9,62.4 to 75.3,415
Polio,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,5 Months,76.9,70.1 to 82.5,415
Polio,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,86.6,80.2 to 91.2,415
Combined 7 Series,,States/Local Areas,Minnesota,2020-2021,Age,35 Months,70.8,64.2 to 77.2,415
PCV,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,92.5,88.7 to 95.4,415
PCV,≥4 Doses,States/Local Areas,Minnesota,2020-2021,Age,35 Months,83.4,77.1 to 88.7,415
Hib,Primary Series,States/Local Areas,Minnesota,2021,Age,13 Months,81.5,72.0 to 88.3,176
PCV,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,90.8,86.2 to 94.0,415
Hep B,≥3 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,95.3,90.4 to 98.1,176
DTaP,≥4 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,81.0,71.2 to 89.1,176
Influenza,,States/Local Areas,Minnesota,2020-2021,Age,24 Months,68.0,61.5 to 74.3,415
Hep B,≥3 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,79.1,72.5 to 84.4,415
PCV,≥4 Doses,States/Local Areas,Minnesota,2020-2021,Age,19 Months,76.7,70.0 to 82.2,415
Hib,≥1 Dose,States/Local Areas,Minnesota,2020-2021,Age,3 Months,86.1,79.9 to 90.6,415
DTaP,≥3 Doses,States/Local Areas,Minnesota,2021,Age,35 Months,94.7,89.0 to 98.0,176
Hep B,≥2 Doses,States/Local Areas,Minnesota,2020-2021,Age,7 Months,92.6,88.4 to 95.3,415
≥1 Dose MMR,,States/Local Areas,Minnesota,2020-2021,Age,35 Months,94.1,90.0 to 96.9,415
Hep B,≥2 Doses,States/Local Areas,Minnesota,2021,Age,13 Months,97.2,93.5 to 98.8,176
Combined 7 Series,,States/Local Areas,Minnesota,2021,Age,24 Months,64.8,54.8 to 74.8,176
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,82.8,78.2 to 87.5,582
Rotavirus,,States/Local Areas,Minnesota,2017,Age,8 Months,79.0,71.7 to 84.8,290
Rotavirus,,States/Local Areas,Minnesota,2017-2018,Age,8 Months,80.6,75.7 to 84.6,618
Rotavirus,,States/Local Areas,Minnesota,2019,Age,8 Months,83.2,75.6 to 88.9,283
Rotavirus,,States/Local Areas,Minnesota,2018,Age,8 Months,82.2,75.3 to 87.5,328
Rotavirus,,States/Local Areas,Minnesota,2018-2019,Age,8 Months,82.7,77.8 to 86.7,611
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,85.3,80.2 to 90.5,343
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.4,73.5 to 83.4,605
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.8,62.9 to 84.8,111
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,75.5,61.3 to 89.6,66
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.6,63.4 to 89.8,51
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,66.4,58.1 to 74.7,221
Rotavirus,,States/Local Areas,Minnesota,2015,Age,8 Months,63.8,53.4 to 73.1,227
Rotavirus,,States/Local Areas,Minnesota,2015-2016,Age,8 Months,74.9,68.1 to 80.6,444
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,67.5,59.4 to 75.5,293
Rotavirus,,States/Local Areas,Minnesota,2013,Age,8 Months,77.7,70.3 to 83.7,293
Rotavirus,,States/Local Areas,Minnesota,2013-2014,Age,8 Months,78.8,73.7 to 83.1,562
Rotavirus,,States/Local Areas,Minnesota,2012,Age,8 Months,81.5,72.5 to 88.1,225
Rotavirus,,States/Local Areas,Minnesota,2014,Age,8 Months,79.8,72.4 to 85.6,269
Rotavirus,,States/Local Areas,Minnesota,2014-2015,Age,8 Months,71.8,65.4 to 77.4,496
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,67.5,57.4 to 77.6,137
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Overall,Overall,77.1,73.0 to 81.3,833
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,67.1,56.4 to 77.7,175
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.9,64.5 to 79.2,315
Rotavirus,,States/Local Areas,Minnesota,2016,Age,8 Months,86.0,77.8 to 91.5,217
Rotavirus,,States/Local Areas,Minnesota,2016-2017,Age,8 Months,82.5,77.2 to 86.7,507
Rotavirus,,States/Local Areas,Minnesota,2011,Age,8 Months,70.2,60.4 to 78.5,208
Hib,Full Series,States/Local Areas,Minnesota,2018,Age,19 Months,75.1,67.9 to 81.1,328
Hib,Full Series,States/Local Areas,Minnesota,2018-2019,Age,19 Months,95.1,92.1 to 97.1,611
Hib,Full Series,States/Local Areas,Minnesota,2017,Age,19 Months,76.2,68.6 to 82.4,290
Hib,Full Series,States/Local Areas,Minnesota,2017-2018,Age,19 Months,75.6,70.5 to 80.1,618
Hib,Full Series,States/Local Areas,Minnesota,2011,Age,24 Months,81.2,73.4 to 87.9,208
Hib,Full Series,States/Local Areas,Minnesota,2012,Age,24 Months,80.8,73.3 to 87.3,225
Hib,Full Series,States/Local Areas,Minnesota,2014,Age,19 Months,78.0,71.0 to 83.6,269
Hib,Full Series,States/Local Areas,Minnesota,2014-2015,Age,19 Months,71.3,65.3 to 76.7,496
Rotavirus,,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,89.8,85.9 to 93.8,403
Hib,Full Series,States/Local Areas,Minnesota,2015,Age,19 Months,64.7,62.0 to 67.3,227
Hib,Full Series,States/Local Areas,Minnesota,2015-2016,Age,19 Months,74.2,67.8 to 79.8,444
Hib,Full Series,States/Local Areas,Minnesota,2019,Age,19 Months,73.8,65.9 to 80.4,283
Combined 7 Series,,States/Local Areas,Minnesota,2015,Age,35 Months,65.8,54.5 to 76.8,227
Combined 7 Series,,States/Local Areas,Minnesota,2015-2016,Age,35 Months,72.8,65.6 to 79.6,444
Hib,Full Series,States/Local Areas,Minnesota,2016,Age,19 Months,83.9,76.0 to 89.6,217
Hib,Full Series,States/Local Areas,Minnesota,2016-2017,Age,19 Months,80.0,74.7 to 84.5,507
Hib,Full Series,States/Local Areas,Minnesota,2014,Age,24 Months,81.0,74.6 to 86.7,269
Hib,Full Series,States/Local Areas,Minnesota,2014-2015,Age,24 Months,75.4,69.6 to 80.7,496
Hib,Full Series,States/Local Areas,Minnesota,2013,Age,24 Months,82.2,75.8 to 87.7,293
Hib,Full Series,States/Local Areas,Minnesota,2013-2014,Age,24 Months,81.5,77.1 to 85.6,562
Combined 7 Series,,States/Local Areas,Minnesota,2018,Age,35 Months,74.3,66.4 to 81.5,328
Combined 7 Series,,States/Local Areas,Minnesota,2018-2019,Age,35 Months,73.6,68.0 to 79.0,611
Combined 7 Series,,States/Local Areas,Minnesota,2019,Age,35 Months,72.8,64.9 to 80.2,283
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Any Medicaid,60.8,52.0 to 69.5,221
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Insurance Coverage,Private Insurance Only,73.2,68.0 to 78.5,582
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",43.6,26.7 to 60.5,51
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,Hispanic,67.8,52.7 to 83.0,66
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Poverty,<133% FPL,57.6,47.0 to 68.3,137
Hib,Full Series,States/Local Areas,Minnesota,2013,Age,19 Months,76.7,68.9 to 83.1,293
Hib,Full Series,States/Local Areas,Minnesota,2013-2014,Age,19 Months,77.4,73.6 to 80.7,562
Hib,Full Series,States/Local Areas,Minnesota,2012,Age,19 Months,78.4,74.0 to 82.2,225
Hib,Full Series,States/Local Areas,Minnesota,2011,Age,19 Months,77.1,71.3 to 82.0,208
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Poverty,>400% FPL,76.8,70.8 to 82.8,403
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Poverty,133% to <400% FPL,64.4,56.1 to 72.7,293
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a Non-MSA,67.5,57.0 to 78.1,175
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Overall,Overall,68.3,63.7 to 72.8,833
Hib,Primary Series,States/Local Areas,Minnesota,2018,Age,35 Months,94.0,89.5 to 97.1,328
Hib,Primary Series,States/Local Areas,Minnesota,2018-2019,Age,35 Months,94.4,90.9 to 96.9,611
Combined 7 Series,,States/Local Areas,Minnesota,2015,Age,24 Months,56.5,46.8 to 66.7,227
Combined 7 Series,,States/Local Areas,Minnesota,2015-2016,Age,24 Months,65.7,59.0 to 72.3,444
Hib,Primary Series,States/Local Areas,Minnesota,2016,Age,24 Months,97.2,93.3 to 99.1,217
Hib,Primary Series,States/Local Areas,Minnesota,2016-2017,Age,24 Months,95.9,93.2 to 97.7,507
Hib,Primary Series,States/Local Areas,Minnesota,2019,Age,24 Months,94.2,88.3 to 97.7,283
Hib,Primary Series,States/Local Areas,Minnesota,2011,Age,35 Months,93.5,87.9 to 97.1,208
Hib,Primary Series,States/Local Areas,Minnesota,2014,Age,35 Months,96.7,92.7 to 98.9,269
Hib,Primary Series,States/Local Areas,Minnesota,2014-2015,Age,35 Months,95.3,92.8 to 97.2,496
Hib,Primary Series,States/Local Areas,Minnesota,2012,Age,35 Months,95.7,91.7 to 98.2,225
Combined 7 Series,,States/Local Areas,Minnesota,2012,Age,24 Months,72.8,64.9 to 80.1,225
Combined 7 Series,,States/Local Areas,Minnesota,2013,Age,24 Months,70.6,63.3 to 77.7,293
Combined 7 Series,,States/Local Areas,Minnesota,2013-2014,Age,24 Months,68.8,63.4 to 74.1,562
Hib,Primary Series,States/Local Areas,Minnesota,2013,Age,35 Months,95.4,91.5 to 97.8,293
Hib,Primary Series,States/Local Areas,Minnesota,2013-2014,Age,35 Months,95.9,93.4 to 97.7,562
Combined 7 Series,,States/Local Areas,Minnesota,2011,Age,24 Months,71.1,62.5 to 79.2,208
Hib,Primary Series,States/Local Areas,Minnesota,2015,Age,35 Months,94.2,90.5 to 96.8,227
Hib,Primary Series,States/Local Areas,Minnesota,2015-2016,Age,35 Months,95.7,93.2 to 97.4,444
Hib,Primary Series,States/Local Areas,Minnesota,2017,Age,35 Months,94.6,90.4 to 97.3,290
Hib,Primary Series,States/Local Areas,Minnesota,2017-2018,Age,35 Months,94.3,91.4 to 96.5,618
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Principal City,72.2,65.8 to 78.7,343
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,62.9,54.9 to 70.8,315
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.4,68.2 to 78.6,605
Combined 7 Series,,States/Local Areas,Minnesota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.2,51.5 to 74.9,111
Hib,Primary Series,States/Local Areas,Minnesota,2016,Age,35 Months,97.2,93.3 to 99.1,217
Hib,Primary Series,States/Local Areas,Minnesota,2016-2017,Age,35 Months,95.9,93.2 to 97.7,507
Combined 7 Series,,States/Local Areas,Minnesota,2017,Age,35 Months,81.8,75.2 to 87.5,290
Combined 7 Series,,States/Local Areas,Minnesota,2017-2018,Age,35 Months,77.9,72.8 to 82.6,618
Combined 7 Series,,States/Local Areas,Minnesota,2016,Age,35 Months,80.3,71.3 to 88.0,217
Combined 7 Series,,States/Local Areas,Minnesota,2016-2017,Age,35 Months,80.6,75.2 to 85.5,507
Combined 7 Series,,States/Local Areas,Minnesota,2019,Age,24 Months,69.5,61.8 to 77.0,283
Hib,Primary Series,States/Local Areas,Minnesota,2018,Age,24 Months,93.7,89.2 to 96.8,328
Hib,Primary Series,States/Local Areas,Minnesota,2018-2019,Age,24 Months,94.0,90.5 to 96.5,611
Combined 7 Series,,States/Local Areas,Minnesota,2014,Age,24 Months,67.0,59.3 to 74.6,269
Combined 7 Series,,States/Local Areas,Minnesota,2014-2015,Age,24 Months,61.7,55.4 to 68.1,496
Hib,Primary Series,States/Local Areas,Minnesota,2019,Age,35 Months,94.7,88.8 to 98.1,283
Combined 7 Series,,States/Local Areas,Minnesota,2016,Age,24 Months,74.9,66.3 to 82.7,217
Combined 7 Series,,States/Local Areas,Minnesota,2016-2017,Age,24 Months,75.8,70.3 to 80.9,507
Combined 7 Series,,States/Local Areas,Minnesota,2018,Age,24 Months,66.6,59.3 to 73.7,328
Combined 7 Series,,States/Local Areas,Minnesota,2018-2019,Age,24 Months,68.0,62.6 to 73.2,611
Combined 7 Series,,States/Local Areas,Minnesota,2017,Age,24 Months,77.0,69.9 to 83.4,290
Combined 7 Series,,States/Local Areas,Minnesota,2017-2018,Age,24 Months,71.7,66.6 to 76.6,618
Hib,Primary Series,States/Local Areas,Minnesota,2014,Age,24 Months,96.7,92.7 to 98.9,269
Hib,Primary Series,States/Local Areas,Minnesota,2014-2015,Age,24 Months,95.3,92.8 to 97.2,496
Hib,Primary Series,States/Local Areas,Minnesota,2015,Age,24 Months,94.2,90.5 to 96.8,227
Hib,Primary Series,States/Local Areas,Minnesota,2015-2016,Age,24 Months,95.7,93.2 to 97.4,444
Hib,Primary Series,States/Local Areas,Minnesota,2017,Age,24 Months,94.6,90.4 to 97.3,290
Hib,Primary Series,States/Local Areas,Minnesota,2017-2018,Age,24 Months,94.2,91.3 to 96.4,618
Combined 7 Series,,States/Local Areas,Minnesota,2011,Age,35 Months,72.6,64.0 to 80.7,208
Hib,Primary Series,States/Local Areas,Minnesota,2014,Age,13 Months,92.1,87.1 to 95.3,269
Hib,Primary Series,States/Local Areas,Minnesota,2014-2015,Age,13 Months,88.9,84.5 to 92.1,496
Hib,Primary Series,States/Local Areas,Minnesota,2015,Age,13 Months,85.6,77.9 to 91.0,227
Hib,Primary Series,States/Local Areas,Minnesota,2015-2016,Age,13 Months,89.0,84.2 to 92.4,444
Hib,Primary Series,States/Local Areas,Minnesota,2013,Age,13 Months,90.6,85.4 to 94.1,293
Hib,Primary Series,States/Local Areas,Minnesota,2013-2014,Age,13 Months,91.4,89.3 to 93.1,562
Hib,Primary Series,States/Local Areas,Minnesota,2012,Age,13 Months,92.9,82.1 to 97.4,225
Hib,Primary Series,States/Local Areas,Minnesota,2011,Age,13 Months,86.8,80.2 to 91.4,208
Combined 7 Series,,States/Local Areas,Minnesota,2012,Age,35 Months,77.5,69.7 to 84.4,225
Combined 7 Series,,States/Local Areas,Minnesota,2013,Age,35 Months,77.8,70.2 to 84.5,293
Combined 7 Series,,States/Local Areas,Minnesota,2013-2014,Age,35 Months,77.5,71.3 to 83.2,562
Combined 7 Series,,States/Local Areas,Minnesota,2014,Age,35 Months,77.3,67.4 to 86.0,269
Combined 7 Series,,States/Local Areas,Minnesota,2014-2015,Age,35 Months,72.5,64.1 to 80.3,496
PCV,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,95.1,93.3 to 96.4,3211
Hep B,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,94.3,92.5 to 95.7,3211
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,67.9,64.8 to 70.8,3211
Hep B,≥1 Dose,HHS Regions/National,Region 1,2021,Age,3 Months,97.5,96.2 to 98.4,1042
Rotavirus,,HHS Regions/National,Region 1,2011,Age,8 Months,82.6,78.5 to 86.0,1422
Rotavirus,,HHS Regions/National,Region 1,2012,Age,8 Months,77.6,73.6 to 81.2,1457
Rotavirus,,HHS Regions/National,Region 1,2013,Age,8 Months,82.0,78.5 to 85.0,1537
Rotavirus,,HHS Regions/National,Region 1,2013-2014,Age,8 Months,80.2,77.6 to 82.5,3101
Rotavirus,,HHS Regions/National,Region 1,2015,Age,8 Months,81.4,77.3 to 84.9,1509
Rotavirus,,HHS Regions/National,Region 1,2015-2016,Age,8 Months,82.2,79.4 to 84.7,2930
Rotavirus,,HHS Regions/National,Region 1,2016,Age,8 Months,83.1,79.0 to 86.5,1421
Rotavirus,,HHS Regions/National,Region 1,2016-2017,Age,8 Months,82.5,79.4 to 85.2,3005
Rotavirus,,HHS Regions/National,Region 1,2014,Age,8 Months,78.3,74.3 to 81.8,1564
Rotavirus,,HHS Regions/National,Region 1,2014-2015,Age,8 Months,79.8,77.1 to 82.4,3073
Rotavirus,,HHS Regions/National,Region 1,2017,Age,8 Months,81.9,77.5 to 85.6,1584
Rotavirus,,HHS Regions/National,Region 1,2017-2018,Age,8 Months,83.0,80.1 to 85.5,3342
Rotavirus,,HHS Regions/National,Region 1,2019,Age,8 Months,83.0,79.6 to 86.0,1675
Rotavirus,,HHS Regions/National,Region 1,2018,Age,8 Months,84.1,80.3 to 87.3,1758
Rotavirus,,HHS Regions/National,Region 1,2018-2019,Age,8 Months,83.6,81.1 to 85.8,3433
Combined 7 Series,,HHS Regions/National,Region 1,2018,Age,35 Months,86.1,82.8 to 89.0,1758
Combined 7 Series,,HHS Regions/National,Region 1,2018-2019,Age,35 Months,86.7,84.2 to 89.0,3433
Combined 7 Series,,HHS Regions/National,Region 1,2019,Age,35 Months,87.1,83.2 to 90.4,1675
Combined 7 Series,,HHS Regions/National,Region 1,2015,Age,35 Months,84.6,80.9 to 87.9,1509
Combined 7 Series,,HHS Regions/National,Region 1,2015-2016,Age,35 Months,83.9,81.0 to 86.5,2930
Hib,Full Series,HHS Regions/National,Region 1,2011,Age,19 Months,82.6,79.0 to 85.6,1422
Hib,Full Series,HHS Regions/National,Region 1,2012,Age,19 Months,79.5,74.9 to 83.5,1457
Hib,Full Series,HHS Regions/National,Region 1,2013,Age,19 Months,79.0,76.8 to 81.1,1537
Hib,Full Series,HHS Regions/National,Region 1,2013-2014,Age,19 Months,80.6,78.6 to 82.4,3101
Hib,Full Series,HHS Regions/National,Region 1,2017,Age,19 Months,82.1,78.1 to 85.4,1584
Hib,Full Series,HHS Regions/National,Region 1,2017-2018,Age,19 Months,82.7,80.0 to 85.0,3342
Hib,Full Series,HHS Regions/National,Region 1,2016,Age,19 Months,84.0,80.0 to 87.3,1421
Hib,Full Series,HHS Regions/National,Region 1,2016-2017,Age,19 Months,83.0,80.2 to 85.5,3005
Hib,Full Series,HHS Regions/National,Region 1,2015,Age,19 Months,82.9,78.6 to 86.4,1509
Hib,Full Series,HHS Regions/National,Region 1,2015-2016,Age,19 Months,83.4,80.8 to 85.7,2930
Hib,Full Series,HHS Regions/National,Region 1,2014,Age,19 Months,82.1,78.4 to 85.3,1564
Hib,Full Series,HHS Regions/National,Region 1,2014-2015,Age,19 Months,82.5,80.0 to 84.7,3073
Hib,Full Series,HHS Regions/National,Region 1,2019,Age,19 Months,80.7,76.6 to 84.2,1675
Hib,Full Series,HHS Regions/National,Region 1,2018,Age,19 Months,83.3,79.7 to 86.3,1758
Hib,Full Series,HHS Regions/National,Region 1,2018-2019,Age,19 Months,96.4,95.0 to 97.4,3433
Hib,Full Series,HHS Regions/National,Region 1,2012,Age,24 Months,85.6,82.0 to 88.8,1457
Hib,Full Series,HHS Regions/National,Region 1,2011,Age,24 Months,87.5,83.7 to 90.8,1422
Hib,Primary Series,HHS Regions/National,Region 1,2016,Age,19 Months,94.8,91.9 to 96.7,1421
Hib,Primary Series,HHS Regions/National,Region 1,2016-2017,Age,19 Months,95.0,92.9 to 96.4,3005
Hib,Primary Series,HHS Regions/National,Region 1,2019,Age,19 Months,96.3,94.5 to 97.5,1675
Hib,Primary Series,HHS Regions/National,Region 1,2011,Age,24 Months,97.1,95.5 to 98.3,1422
Hib,Primary Series,HHS Regions/National,Region 1,2012,Age,24 Months,95.4,93.0 to 97.2,1457
Hib,Full Series,HHS Regions/National,Region 1,2013,Age,24 Months,85.7,82.2 to 88.9,1537
Hib,Full Series,HHS Regions/National,Region 1,2013-2014,Age,24 Months,86.8,84.5 to 89.0,3101
Hib,Full Series,HHS Regions/National,Region 1,2014,Age,24 Months,87.9,84.8 to 90.7,1564
Hib,Full Series,HHS Regions/National,Region 1,2014-2015,Age,24 Months,88.3,86.3 to 90.2,3073
Hib,Primary Series,HHS Regions/National,Region 1,2015,Age,19 Months,95.9,93.2 to 97.5,1509
Hib,Primary Series,HHS Regions/National,Region 1,2015-2016,Age,19 Months,95.3,93.7 to 96.6,2930
Hib,Primary Series,HHS Regions/National,Region 1,2017,Age,19 Months,95.1,92.5 to 96.9,1584
Hib,Primary Series,HHS Regions/National,Region 1,2017-2018,Age,19 Months,95.8,94.2 to 96.9,3342
Hib,Primary Series,HHS Regions/National,Region 1,2018,Age,19 Months,96.5,94.6 to 97.7,1758
Hib,Primary Series,HHS Regions/National,Region 1,2018-2019,Age,19 Months,93.5,92.0 to 94.8,3433
Hib,Primary Series,HHS Regions/National,Region 1,2012,Age,19 Months,94.5,91.3 to 96.6,1457
Hib,Primary Series,HHS Regions/National,Region 1,2016,Age,13 Months,92.4,89.1 to 94.7,1421
Hib,Primary Series,HHS Regions/National,Region 1,2016-2017,Age,13 Months,92.6,90.4 to 94.3,3005
Hib,Primary Series,HHS Regions/National,Region 1,2017,Age,13 Months,92.9,90.0 to 94.9,1584
Hib,Primary Series,HHS Regions/National,Region 1,2017-2018,Age,13 Months,93.3,91.5 to 94.7,3342
Hib,Primary Series,HHS Regions/National,Region 1,2018,Age,13 Months,93.7,91.3 to 95.5,1758
Hib,Primary Series,HHS Regions/National,Region 1,2018-2019,Age,13 Months,93.5,92.0 to 94.8,3433
Hib,Primary Series,HHS Regions/National,Region 1,2011,Age,19 Months,96.3,94.6 to 97.4,1422
Hib,Primary Series,HHS Regions/National,Region 1,2013,Age,19 Months,95.6,94.2 to 96.7,1537
Hib,Primary Series,HHS Regions/National,Region 1,2013-2014,Age,19 Months,96.2,95.0 to 97.2,3101
Hib,Primary Series,HHS Regions/National,Region 1,2014,Age,19 Months,96.9,95.5 to 97.8,1564
Hib,Primary Series,HHS Regions/National,Region 1,2014-2015,Age,19 Months,96.4,95.3 to 97.2,3073
Hib,Primary Series,HHS Regions/National,Region 1,2015,Age,7 Months,81.4,77.8 to 84.6,1509
Hib,Primary Series,HHS Regions/National,Region 1,2015-2016,Age,7 Months,80.3,77.3 to 82.9,2930
Hib,Primary Series,HHS Regions/National,Region 1,2014,Age,7 Months,77.7,73.6 to 81.4,1564
Hib,Primary Series,HHS Regions/National,Region 1,2014-2015,Age,7 Months,79.6,76.9 to 82.1,3073
Hib,Primary Series,HHS Regions/National,Region 1,2017,Age,24 Months,95.5,93.1 to 97.3,1584
Hib,Primary Series,HHS Regions/National,Region 1,2017-2018,Age,24 Months,96.1,94.7 to 97.3,3342
Hib,Primary Series,HHS Regions/National,Region 1,2019,Age,7 Months,79.9,75.9 to 83.4,1675
Hib,Primary Series,HHS Regions/National,Region 1,2015,Age,13 Months,93.5,91.3 to 95.1,1509
Hib,Primary Series,HHS Regions/National,Region 1,2015-2016,Age,13 Months,92.9,91.0 to 94.4,2930
Hib,Primary Series,HHS Regions/National,Region 1,2014,Age,13 Months,93.3,91.0 to 95.0,1564
Hib,Primary Series,HHS Regions/National,Region 1,2014-2015,Age,13 Months,93.4,91.9 to 94.6,3073
Hib,Primary Series,HHS Regions/National,Region 1,2018,Age,7 Months,80.8,76.7 to 84.4,1758
Hib,Primary Series,HHS Regions/National,Region 1,2018-2019,Age,7 Months,80.4,77.5 to 82.9,3433
Hib,Primary Series,HHS Regions/National,Region 1,2017,Age,7 Months,78.6,74.1 to 82.5,1584
Hib,Primary Series,HHS Regions/National,Region 1,2017-2018,Age,7 Months,79.7,76.7 to 82.4,3342
Hib,Primary Series,HHS Regions/National,Region 1,2016,Age,7 Months,79.1,74.3 to 83.2,1421
Hib,Primary Series,HHS Regions/National,Region 1,2016-2017,Age,7 Months,78.8,75.5 to 81.9,3005
Hib,Primary Series,HHS Regions/National,Region 1,2011,Age,13 Months,95.1,92.2 to 96.9,1422
Hib,Primary Series,HHS Regions/National,Region 1,2012,Age,13 Months,91.1,86.8 to 94.1,1457
Hib,Primary Series,HHS Regions/National,Region 1,2013,Age,13 Months,93.5,92.4 to 94.6,1537
Hib,Primary Series,HHS Regions/National,Region 1,2013-2014,Age,13 Months,93.4,92.0 to 94.6,3101
Combined 7 Series,,HHS Regions/National,Region 1,2014,Age,24 Months,76.0,71.9 to 79.8,1564
Combined 7 Series,,HHS Regions/National,Region 1,2014-2015,Age,24 Months,76.6,73.8 to 79.4,3073
Combined 7 Series,,HHS Regions/National,Region 1,2015,Age,24 Months,77.3,73.3 to 81.0,1509
Combined 7 Series,,HHS Regions/National,Region 1,2015-2016,Age,24 Months,78.2,75.3 to 80.9,2930
Hib,Primary Series,HHS Regions/National,Region 1,2018,Age,35 Months,97.2,95.5 to 98.3,1758
Hib,Primary Series,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.8,95.7 to 97.7,3433
Combined 7 Series,,HHS Regions/National,Region 1,2013,Age,35 Months,81.2,76.6 to 85.4,1537
Combined 7 Series,,HHS Regions/National,Region 1,2013-2014,Age,35 Months,81.5,78.3 to 84.4,3101
Combined 7 Series,,HHS Regions/National,Region 1,2016,Age,35 Months,83.1,78.8 to 87.0,1421
Combined 7 Series,,HHS Regions/National,Region 1,2016-2017,Age,35 Months,84.4,81.0 to 87.5,3005
Combined 7 Series,,HHS Regions/National,Region 1,2017,Age,35 Months,86.5,80.6 to 91.4,1584
Combined 7 Series,,HHS Regions/National,Region 1,2017-2018,Age,35 Months,86.4,82.9 to 89.5,3342
Combined 7 Series,,HHS Regions/National,Region 1,2011,Age,35 Months,79.1,74.5 to 83.5,1422
Hib,Primary Series,HHS Regions/National,Region 1,2017,Age,35 Months,96.3,94.0 to 97.9,1584
Hib,Primary Series,HHS Regions/National,Region 1,2017-2018,Age,35 Months,96.7,95.4 to 97.8,3342
Hib,Primary Series,HHS Regions/National,Region 1,2016,Age,35 Months,95.6,93.0 to 97.4,1421
Hib,Primary Series,HHS Regions/National,Region 1,2016-2017,Age,35 Months,95.9,94.1 to 97.3,3005
Hib,Primary Series,HHS Regions/National,Region 1,2015,Age,35 Months,96.5,94.8 to 97.8,1509
Hib,Primary Series,HHS Regions/National,Region 1,2015-2016,Age,35 Months,96.0,94.5 to 97.2,2930
Combined 7 Series,,HHS Regions/National,Region 1,2011,Age,24 Months,74.4,69.9 to 78.7,1422
Combined 7 Series,,HHS Regions/National,Region 1,2012,Age,24 Months,72.6,68.3 to 76.7,1457
Hib,Primary Series,HHS Regions/National,Region 1,2019,Age,13 Months,93.4,91.1 to 95.0,1675
Hib,Primary Series,HHS Regions/National,Region 1,2013,Age,35 Months,97.1,95.3 to 98.3,1537
Hib,Primary Series,HHS Regions/National,Region 1,2013-2014,Age,35 Months,97.2,96.2 to 98.0,3101
Hib,Primary Series,HHS Regions/National,Region 1,2011,Age,35 Months,97.1,95.5 to 98.3,1422
Hib,Primary Series,HHS Regions/National,Region 1,2019,Age,24 Months,96.5,94.8 to 97.8,1675
Hib,Primary Series,HHS Regions/National,Region 1,2012,Age,35 Months,95.5,93.1 to 97.3,1457
Hib,Primary Series,HHS Regions/National,Region 1,2014,Age,35 Months,97.4,96.2 to 98.3,1564
Hib,Primary Series,HHS Regions/National,Region 1,2014-2015,Age,35 Months,96.9,95.9 to 97.8,3073
Hib,Primary Series,HHS Regions/National,Region 1,2013,Age,24 Months,96.5,94.5 to 97.9,1537
Hib,Primary Series,HHS Regions/National,Region 1,2013-2014,Age,24 Months,96.9,95.8 to 97.8,3101
Hib,Primary Series,HHS Regions/National,Region 1,2018,Age,24 Months,96.7,95.0 to 97.9,1758
Hib,Primary Series,HHS Regions/National,Region 1,2018-2019,Age,24 Months,96.6,95.4 to 97.5,3433
Hib,Primary Series,HHS Regions/National,Region 1,2016,Age,24 Months,95.5,93.0 to 97.3,1421
Hib,Primary Series,HHS Regions/National,Region 1,2016-2017,Age,24 Months,95.5,93.6 to 97.0,3005
Combined 7 Series,,HHS Regions/National,Region 1,2013,Age,24 Months,75.8,72.0 to 79.5,1537
Combined 7 Series,,HHS Regions/National,Region 1,2013-2014,Age,24 Months,75.9,73.2 to 78.6,3101
Hib,Primary Series,HHS Regions/National,Region 1,2015,Age,24 Months,96.0,94.2 to 97.4,1509
Hib,Primary Series,HHS Regions/National,Region 1,2015-2016,Age,24 Months,95.8,94.3 to 97.0,2930
Hib,Primary Series,HHS Regions/National,Region 1,2014,Age,24 Months,97.3,96.1 to 98.3,1564
Hib,Primary Series,HHS Regions/National,Region 1,2014-2015,Age,24 Months,96.7,95.6 to 97.5,3073
Combined 7 Series,,HHS Regions/National,Region 1,2019,Age,24 Months,78.9,75.0 to 82.6,1675
Hib,Primary Series,HHS Regions/National,Region 1,2013,Age,7 Months,76.5,73.3 to 79.5,1537
Hib,Primary Series,HHS Regions/National,Region 1,2013-2014,Age,7 Months,77.1,74.1 to 79.8,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,94.9,92.3 to 96.8,1421
Hib,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,95.1,93.2 to 96.6,3005
Hib,≥3 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,95.0,92.9 to 96.6,1509
Hib,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,94.9,93.4 to 96.3,2930
Hep A,≥1 Dose,HHS Regions/National,Region 1,2013,Age,19 Months,83.1,80.3 to 85.6,1537
Hep A,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,19 Months,82.2,79.6 to 84.5,3101
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,95.7,93.2 to 97.5,1584
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,96.3,94.8 to 97.4,3342
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,96.9,95.0 to 98.2,1758
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,96.7,95.4 to 97.6,3433
DTaP,≥2 Doses,HHS Regions/National,Region 1,2016,Age,5 Months,87.0,83.1 to 90.1,1421
DTaP,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,5 Months,85.9,82.8 to 88.4,3005
DTaP,≥2 Doses,HHS Regions/National,Region 1,2018,Age,5 Months,89.7,86.8 to 92.0,1758
DTaP,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,5 Months,89.1,87.1 to 90.9,3433
DTaP,≥2 Doses,HHS Regions/National,Region 1,2017,Age,5 Months,84.7,80.4 to 88.2,1584
DTaP,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,5 Months,87.2,84.6 to 89.3,3342
Hep A,≥1 Dose,HHS Regions/National,Region 1,2011,Age,19 Months,77.9,72.9 to 82.2,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016,Age,24 Months,95.7,93.2 to 97.5,1421
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,24 Months,95.7,93.8 to 97.1,3005
DTaP,≥1 Dose,HHS Regions/National,Region 1,2019,Age,3 Months,95.0,93.1 to 96.4,1675
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014,Age,24 Months,97.9,97.0 to 98.6,1564
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,24 Months,97.0,95.9 to 97.8,3073
DTaP,≥1 Dose,HHS Regions/National,Region 1,2017,Age,3 Months,91.9,88.0 to 94.6,1584
DTaP,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,3 Months,93.0,90.7 to 94.8,3342
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015,Age,24 Months,96.0,94.1 to 97.4,1509
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,24 Months,95.9,94.3 to 97.1,2930
DTaP,≥1 Dose,HHS Regions/National,Region 1,2018,Age,3 Months,94.2,91.4 to 96.1,1758
DTaP,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,3 Months,94.6,93.0 to 95.8,3433
Hep A,≥1 Dose,HHS Regions/National,Region 1,2015,Age,19 Months,86.5,83.3 to 89.3,1509
Hep A,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,19 Months,86.7,84.2 to 88.8,2930
Hep A,≥1 Dose,HHS Regions/National,Region 1,2014,Age,19 Months,81.3,77.3 to 84.6,1564
Hep A,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,19 Months,83.9,81.4 to 86.1,3073
Hib,Full Series,HHS Regions/National,Region 1,2021,Age,19 Months,85.1,80.9 to 88.5,1042
PCV,≥2 Doses,HHS Regions/National,Region 1,2014,Age,5 Months,85.5,82.5 to 88.1,1564
PCV,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,5 Months,86.9,83.4 to 89.7,3073
Hep A,≥1 Dose,HHS Regions/National,Region 1,2016,Age,24 Months,89.9,86.7 to 92.6,1421
Hep A,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,24 Months,90.8,88.6 to 92.8,3005
Hep A,≥1 Dose,HHS Regions/National,Region 1,2015,Age,24 Months,90.5,87.9 to 92.7,1509
Hep A,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,24 Months,90.2,88.2 to 92.0,2930
Hep A,≥1 Dose,HHS Regions/National,Region 1,2014,Age,24 Months,84.9,81.2 to 88.2,1564
Hep A,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,24 Months,87.7,85.4 to 89.7,3073
PCV,≥2 Doses,HHS Regions/National,Region 1,2016,Age,5 Months,86.5,82.7 to 89.6,1421
PCV,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,5 Months,85.0,82.0 to 87.6,3005
PCV,≥2 Doses,HHS Regions/National,Region 1,2015,Age,5 Months,88.3,85.3 to 90.7,1509
PCV,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,5 Months,87.4,85.0 to 89.4,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,97.2,95.3 to 98.5,1758
DTaP,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.9,95.6 to 97.8,3433
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019,Age,35 Months,96.5,94.8 to 97.8,1675
Hep A,≥1 Dose,HHS Regions/National,Region 1,2018,Age,24 Months,91.9,89.2 to 94.2,1758
Hep A,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,24 Months,92.7,91.0 to 94.2,3433
Hep A,≥1 Dose,HHS Regions/National,Region 1,2011,Age,35 Months,89.1,83.9 to 93.2,1422
Hep A,≥1 Dose,HHS Regions/National,Region 1,2019,Age,24 Months,93.6,91.4 to 95.4,1675
Hep A,≥1 Dose,HHS Regions/National,Region 1,2017,Age,24 Months,91.7,88.8 to 94.1,1584
Hep A,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,24 Months,91.8,89.9 to 93.5,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2018,Age,35 Months,96.8,95.2 to 98.0,1758
Hib,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,35 Months,96.5,95.4 to 97.5,3433
Hep A,≥2 Doses,HHS Regions/National,Region 1,2017,Age,19 Months,33.9,29.7 to 38.2,1584
Hep A,≥2 Doses,HHS Regions/National,Region 1,2017-2018,Age,19 Months,33.3,30.3 to 36.4,3342
DTaP,≥4 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,76.6,70.9 to 81.4,1509
DTaP,≥4 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,76.3,73.3 to 79.1,2930
DTaP,≥4 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,79.4,75.7 to 82.7,1564
DTaP,≥4 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,78.0,75.3 to 80.5,3073
DTaP,≥4 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,75.9,73.2 to 78.3,1537
DTaP,≥4 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,77.6,74.9 to 80.1,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,96.1,93.8 to 97.7,1584
Hib,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,96.5,95.1 to 97.5,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,95.1,92.5 to 97.0,1421
Hib,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,95.5,93.7 to 96.9,3005
Hep A,≥2 Doses,HHS Regions/National,Region 1,2018,Age,19 Months,32.7,28.7 to 37.0,1758
Hep A,≥2 Doses,HHS Regions/National,Region 1,2018-2019,Age,19 Months,29.0,25.7 to 32.5,2825
Hep A,≥2 Doses,HHS Regions/National,Region 1,2011,Age,24 Months,42.0,37.4 to 47.0,1422
Hep A,≥2 Doses,HHS Regions/National,Region 1,2019,Age,19 Months,30.4,26.5 to 34.6,1675
Combined 7 Series,,HHS Regions/National,Region 1,2016,Age,24 Months,79.1,74.9 to 82.9,1421
Combined 7 Series,,HHS Regions/National,Region 1,2016-2017,Age,24 Months,79.1,76.3 to 81.9,3005
Hib,Primary Series,HHS Regions/National,Region 1,2019,Age,35 Months,96.5,94.8 to 97.8,1675
Hib,≥3 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,97.0,95.3 to 98.2,1422
Hib,≥3 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,95.3,92.9 to 97.1,1457
Hep A,≥1 Dose,HHS Regions/National,Region 1,2013,Age,24 Months,86.6,83.6 to 89.3,1537
Hep A,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,24 Months,85.8,83.4 to 87.9,3101
Hep A,≥1 Dose,HHS Regions/National,Region 1,2011,Age,24 Months,81.4,77.2 to 85.2,1422
Hep A,≥1 Dose,HHS Regions/National,Region 1,2019,Age,19 Months,89.6,86.5 to 92.1,1675
Hep A,≥1 Dose,HHS Regions/National,Region 1,2012,Age,24 Months,86.5,83.1 to 89.4,1457
Hep A,≥1 Dose,HHS Regions/National,Region 1,2016,Age,19 Months,86.8,83.0 to 89.9,1421
Hep A,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,19 Months,88.1,85.6 to 90.2,3005
Hep A,≥1 Dose,HHS Regions/National,Region 1,2017,Age,19 Months,89.4,86.2 to 92.0,1584
Hep A,≥1 Dose,HHS Regions/National,Region 1,2017-2018,Age,19 Months,89.1,86.8 to 90.9,3342
Hep A,≥1 Dose,HHS Regions/National,Region 1,2018,Age,19 Months,88.7,85.4 to 91.3,1758
Hep A,≥1 Dose,HHS Regions/National,Region 1,2018-2019,Age,19 Months,88.4,85.6 to 90.8,2825
DTaP,≥3 Doses,HHS Regions/National,Region 1,2011,Age,35 Months,98.0,96.3 to 99.0,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2012,Age,35 Months,98.1,96.3 to 99.1,1457
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,98.6,97.4 to 99.3,1537
DTaP,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,98.4,97.6 to 99.0,3101
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,98.3,97.3 to 98.9,1564
DTaP,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,97.4,96.4 to 98.2,3073
Hep A,≥2 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,24.8,21.6 to 28.2,1422
DTaP,≥2 Doses,HHS Regions/National,Region 1,2019,Age,5 Months,88.6,85.4 to 91.1,1675
Hep A,≥2 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,26.0,21.7 to 30.7,1457
Hep A,≥2 Doses,HHS Regions/National,Region 1,2014,Age,19 Months,27.8,24.1 to 31.8,1564
Hep A,≥2 Doses,HHS Regions/National,Region 1,2014-2015,Age,19 Months,27.8,25.1 to 30.7,3073
Hep A,≥2 Doses,HHS Regions/National,Region 1,2013,Age,19 Months,28.9,25.1 to 33.0,1537
Hep A,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,19 Months,28.3,25.2 to 31.7,3101
Hib,≥3 Doses,HHS Regions/National,Region 1,2018,Age,24 Months,96.3,94.6 to 97.6,1758
Hib,≥3 Doses,HHS Regions/National,Region 1,2018-2019,Age,24 Months,96.2,95.0 to 97.2,3433
Hib,≥3 Doses,HHS Regions/National,Region 1,2017,Age,24 Months,95.3,92.8 to 97.1,1584
Hib,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,24 Months,95.8,94.3 to 96.9,3342
Hib,≥3 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,96.1,94.4 to 97.4,1675
Hib,≥3 Doses,HHS Regions/National,Region 1,2014,Age,35 Months,96.7,95.0 to 97.9,1564
Hib,≥3 Doses,HHS Regions/National,Region 1,2014-2015,Age,35 Months,96.1,94.9 to 97.1,3073
Hib,≥3 Doses,HHS Regions/National,Region 1,2013,Age,35 Months,96.7,94.9 to 98.0,1537
Hib,≥3 Doses,HHS Regions/National,Region 1,2013-2014,Age,35 Months,96.7,95.5 to 97.6,3101
Hep A,≥2 Doses,HHS Regions/National,Region 1,2016,Age,19 Months,32.3,27.4 to 37.6,1421
Hep A,≥2 Doses,HHS Regions/National,Region 1,2016-2017,Age,19 Months,33.1,29.8 to 36.5,3005
Hep A,≥2 Doses,HHS Regions/National,Region 1,2015,Age,19 Months,27.8,24.0 to 31.8,1509
Hep A,≥2 Doses,HHS Regions/National,Region 1,2015-2016,Age,19 Months,30.0,26.9 to 33.4,2930
Hib,≥3 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,95.6,93.6 to 97.1,1509
Hib,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,95.3,93.7 to 96.6,2930
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016,Age,35 Months,95.8,93.2 to 97.6,1421
DTaP,≥3 Doses,HHS Regions/National,Region 1,2016-2017,Age,35 Months,96.2,94.3 to 97.5,3005
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015,Age,35 Months,96.6,94.7 to 98.0,1509
DTaP,≥3 Doses,HHS Regions/National,Region 1,2015-2016,Age,35 Months,96.1,94.6 to 97.3,2930
PCV,≥2 Doses,HHS Regions/National,Region 1,2011,Age,5 Months,84.8,81.4 to 87.6,1422
PCV,≥2 Doses,HHS Regions/National,Region 1,2012,Age,5 Months,81.5,77.1 to 85.2,1457
PCV,≥2 Doses,HHS Regions/National,Region 1,2013,Age,5 Months,82.2,78.8 to 85.3,1537
PCV,≥2 Doses,HHS Regions/National,Region 1,2013-2014,Age,5 Months,83.9,80.4 to 86.8,3101
DTaP,≥4 Doses,HHS Regions/National,Region 1,2012,Age,19 Months,74.9,68.2 to 80.6,1457
DTaP,≥4 Doses,HHS Regions/National,Region 1,2011,Age,19 Months,79.6,75.9 to 82.9,1422
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017,Age,35 Months,96.8,94.5 to 98.3,1584
DTaP,≥3 Doses,HHS Regions/National,Region 1,2017-2018,Age,35 Months,97.0,95.6 to 98.1,3342
Combined 7 Series,,HHS Regions/National,Region 1,2017,Age,24 Months,79.2,75.3 to 82.9,1584
Combined 7 Series,,HHS Regions/National,Region 1,2017-2018,Age,24 Months,79.5,76.8 to 82.2,3342
Combined 7 Series,,HHS Regions/National,Region 1,2018,Age,24 Months,79.8,75.9 to 83.4,1758
Combined 7 Series,,HHS Regions/National,Region 1,2018-2019,Age,24 Months,79.4,76.7 to 82.0,3433
Combined 7 Series,,HHS Regions/National,Region 1,2012,Age,35 Months,79.5,75.3 to 83.4,1457
Combined 7 Series,,HHS Regions/National,Region 1,2014,Age,35 Months,81.7,77.4 to 85.6,1564
Combined 7 Series,,HHS Regions/National,Region 1,2014-2015,Age,35 Months,83.0,80.2 to 85.6,3073
DTaP,≥1 Dose,HHS Regions/National,Region 1,2016,Age,3 Months,93.5,90.5 to 95.6,1421
DTaP,≥1 Dose,HHS Regions/National,Region 1,2016-2017,Age,3 Months,92.7,90.0 to 94.7,3005
DTaP,≥1 Dose,HHS Regions/National,Region 1,2015,Age,3 Months,92.6,90.0 to 94.6,1509
DTaP,≥1 Dose,HHS Regions/National,Region 1,2015-2016,Age,3 Months,93.1,91.2 to 94.6,2930
DTaP,≥1 Dose,HHS Regions/National,Region 1,2014,Age,3 Months,93.5,90.9 to 95.4,1564
DTaP,≥1 Dose,HHS Regions/National,Region 1,2014-2015,Age,3 Months,93.1,91.3 to 94.5,3073
DTaP,≥1 Dose,HHS Regions/National,Region 1,2013,Age,3 Months,94.6,93.5 to 95.5,1537
DTaP,≥1 Dose,HHS Regions/National,Region 1,2013-2014,Age,3 Months,94.1,92.8 to 95.1,3101
DTaP,≥1 Dose,HHS Regions/National,Region 1,2011,Age,3 Months,94.8,92.9 to 96.2,1422
DTaP,≥1 Dose,HHS Regions/National,Region 1,2012,Age,3 Months,93.3,90.1 to 95.5,1457
Hib,Full Series,HHS Regions/National,Region 1,2020-2021,Age,24 Months,88.0,85.5 to 90.3,2578
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020-2021,Age,13 Months,60.6,56.8 to 64.3,2578
PCV,≥3 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,96.8,94.4 to 98.4,1042
≥1 Dose Varicella,,HHS Regions/National,Region 1,2021,Age,19 Months,93.9,91.0 to 95.9,1042
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019,Age,24 Months,96.4,94.7 to 97.7,1675
Hep B,≥3 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,96.6,95.0 to 97.6,1042
Hep A,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,24 Months,91.7,89.4 to 93.7,2578
Combined 7 Series,,HHS Regions/National,Region 1,2021,Age,35 Months,93.9,84.9 to 98.4,1042
Hep A,≥1 Dose,HHS Regions/National,Region 1,2012,Age,19 Months,82.0,76.8 to 86.3,1457
Polio,≥1 Dose,HHS Regions/National,Region 1,2020-2021,Age,3 Months,93.5,91.7 to 95.0,2578
≥1 Dose MMR,,HHS Regions/National,Region 1,2020-2021,Age,19 Months,93.6,91.4 to 95.3,2578
Polio,≥3 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,96.3,94.3 to 97.6,1042
PCV,≥2 Doses,HHS Regions/National,Region 1,2021,Age,5 Months,86.2,81.8 to 89.6,1042
PCV,≥4 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,88.9,86.0 to 91.5,2578
Hep B,≥2 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,96.5,94.9 to 97.6,1042
Hep A,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,90.0,85.3 to 93.6,2578
DTaP,≥3 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,82.5,78.1 to 86.1,1042
Hib,≥2 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,95.2,92.8 to 96.8,1042
Hib,Primary Series,HHS Regions/National,Region 1,2020-2021,Age,24 Months,95.7,94.2 to 96.9,2578
≥1 Dose MMR,,HHS Regions/National,Region 1,2019-2020,Age,35 Months,96.3,94.8 to 97.5,3211
DTaP,≥4 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,93.9,91.5 to 95.7,3211
Polio,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,96.8,95.1 to 98.0,3211
Combined 7 Series,,HHS Regions/National,Region 1,2019-2020,Age,24 Months,79.1,76.3 to 81.7,3211
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,96.9,95.1 to 98.2,3211
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,95.6,94.0 to 96.8,3211
PCV,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,93.2,91.2 to 94.8,3211
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,91.3,89.2 to 93.1,3211
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019-2020,Age,13 Months,59.8,56.5 to 63.0,3211
Polio,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,94.2,92.4 to 95.6,3211
Hib,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,94.3,92.6 to 95.7,3211
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,80.0,77.1 to 82.6,3211
Hep B,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,5 Months,93.4,91.5 to 94.9,3211
PCV,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,5 Months,87.8,85.3 to 89.9,3211
Hib,Primary Series,HHS Regions/National,Region 1,2019-2020,Age,13 Months,92.6,90.7 to 94.1,3211
Hep B,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,95.5,93.9 to 96.7,3211
Hib,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,83.3,81.2 to 85.3,3211
Hib,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,95.6,94.0 to 96.8,3211
≥1 Dose MMR,,HHS Regions/National,Region 1,2019-2020,Age,13 Months,71.3,68.1 to 74.3,3211
Polio,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,95.8,94.2 to 96.9,3211
Polio,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,5 Months,88.2,85.8 to 90.3,3211
Hib,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,5 Months,87.4,84.9 to 89.5,3211
DTaP,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,5 Months,88.7,86.3 to 90.7,3211
PCV,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,3 Months,92.6,90.5 to 94.2,3211
Hep B,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,3 Months,97.2,96.2 to 98.0,3211
≥1 Dose MMR,,HHS Regions/National,Region 1,2019-2020,Age,24 Months,94.6,93.0 to 96.0,3211
Polio,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,95.9,94.4 to 97.1,3211
DTaP,≥4 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,86.6,84.1 to 88.8,3211
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,96.1,94.6 to 97.3,3211
PCV,≥4 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,92.8,90.4 to 94.7,3211
PCV,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,96.0,94.4 to 97.2,3211
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019-2020,Age,35 Months,96.7,95.2 to 97.8,3211
Hib,Primary Series,HHS Regions/National,Region 1,2019-2020,Age,35 Months,95.8,94.3 to 97.0,3211
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,95.6,94.1 to 96.8,3211
Hib,Full Series,HHS Regions/National,Region 1,2019-2020,Age,35 Months,91.8,89.3 to 93.9,3211
Hib,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,95.6,94.2 to 96.8,3211
Hib,Full Series,HHS Regions/National,Region 1,2019-2020,Age,19 Months,80.3,77.5 to 82.9,3211
Hib,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,94.6,93.0 to 95.8,3211
Hib,Primary Series,HHS Regions/National,Region 1,2019-2020,Age,19 Months,95.4,93.8 to 96.6,3211
≥1 Dose MMR,,HHS Regions/National,Region 1,2019-2020,Age,19 Months,93.3,91.4 to 94.8,3211
Hep A,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,31.9,29.0 to 34.9,3211
PCV,≥4 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,88.8,86.4 to 90.9,3211
PCV,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,95.6,94.1 to 96.9,3211
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2019-2020,Age,0-3 Days,85.1,82.7 to 87.2,3211
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,94.9,93.3 to 96.2,3211
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019-2020,Age,24 Months,94.6,92.9 to 95.9,3211
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2019-2020,Age,0-2 Days,84.3,81.9 to 86.4,3211
Hep A,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,19 Months,89.2,87.0 to 91.1,3211
PCV,≥4 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,86.1,83.6 to 88.4,3211
Hep B,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,94.7,93.0 to 96.0,3211
≥1 Dose Varicella,,HHS Regions/National,Region 1,2019-2020,Age,19 Months,92.3,90.3 to 94.0,3211
Combined 7 Series,,HHS Regions/National,Region 1,2019-2020,Age,35 Months,86.5,83.7 to 89.1,3211
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2019-2020,Age,0-1 Days,80.3,77.7 to 82.7,3211
Hib,Full Series,HHS Regions/National,Region 1,2019-2020,Age,24 Months,86.4,83.8 to 88.7,3211
Hib,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,68.2,65.2 to 71.1,3211
Hib,Primary Series,HHS Regions/National,Region 1,2019-2020,Age,24 Months,95.7,94.2 to 96.9,3211
Influenza,,HHS Regions/National,Region 1,2019-2020,Age,24 Months,78.4,75.4 to 81.2,3211
Hib,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,95.2,93.8 to 96.5,3211
Hep A,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,35 Months,96.9,94.8 to 98.3,3211
Hep A,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,35 Months,89.0,85.8 to 91.7,3211
Hep A,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,24 Months,92.6,90.8 to 94.2,3211
Hep A,≥2 Doses,HHS Regions/National,Region 1,2019-2020,Age,24 Months,51.0,47.7 to 54.4,3211
Polio,≥2 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,95.4,92.7 to 97.1,1536
≥1 Dose MMR,,HHS Regions/National,Region 1,2020,Age,13 Months,72.3,67.7 to 76.5,1536
Combined 7 Series,,HHS Regions/National,Region 1,2020,Age,35 Months,86.3,82.6 to 89.6,1536
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 1,2020,Age,0-1 Days,79.2,75.1 to 82.8,1536
Hep A,≥2 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,33.5,29.4 to 37.9,1536
DTaP,≥1 Dose,HHS Regions/National,Region 1,2020,Age,3 Months,92.2,89.2 to 94.5,1536
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2020,Age,0-2 Days,83.3,79.5 to 86.5,1536
Hib,≥2 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,94.1,91.4 to 96.0,1536
Hib,≥3 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,67.4,62.9 to 71.6,1536
Hib,Primary Series,HHS Regions/National,Region 1,2020,Age,7 Months,78.3,73.9 to 82.2,1536
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,96.1,93.6 to 97.8,1536
Hep B,≥2 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,94.0,91.3 to 95.9,1536
Polio,≥3 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,96.4,94.2 to 97.9,1536
DTaP,≥4 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,86.5,82.8 to 89.8,1536
≥1 Dose MMR,,HHS Regions/National,Region 1,2020,Age,24 Months,95.2,92.7 to 97.1,1536
Hib,≥3 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,94.5,92.0 to 96.4,1536
Hib,Primary Series,HHS Regions/National,Region 1,2020,Age,24 Months,94.9,92.5 to 96.8,1536
Hib,≥3 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,95.3,92.9 to 97.1,1536
Hib,Full Series,HHS Regions/National,Region 1,2020,Age,35 Months,92.1,89.2 to 94.6,1536
Hib,Primary Series,HHS Regions/National,Region 1,2020,Age,35 Months,95.2,92.8 to 97.0,1536
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020,Age,35 Months,97.9,96.0 to 99.0,1536
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,95.8,93.5 to 97.5,1536
PCV,≥3 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,95.6,93.0 to 97.4,1536
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,94.8,92.2 to 96.6,1536
Hib,Full Series,HHS Regions/National,Region 1,2020,Age,19 Months,80.3,76.2 to 84.0,1536
PCV,≥3 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,94.4,91.3 to 96.5,1536
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020,Age,19 Months,91.2,87.8 to 93.8,1536
DTaP,≥4 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,93.8,90.5 to 96.2,1536
Polio,≥3 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,97.9,95.2 to 99.3,1536
≥1 Dose MMR,,HHS Regions/National,Region 1,2020,Age,35 Months,97.3,95.1 to 98.6,1536
PCV,≥4 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,86.6,82.9 to 89.6,1536
Hib,≥3 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,82.6,79.2 to 85.5,1536
Hep A,≥1 Dose,HHS Regions/National,Region 1,2020,Age,19 Months,89.0,85.5 to 91.8,1536
PCV,≥4 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,92.6,89.5 to 95.1,1536
Hib,Primary Series,HHS Regions/National,Region 1,2020,Age,13 Months,92.2,89.2 to 94.4,1536
Hep B,≥2 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,94.9,92.3 to 96.7,1536
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,93.3,90.7 to 95.3,1536
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020,Age,13 Months,58.7,53.9 to 63.4,1536
PCV,≥3 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,92.6,89.3 to 94.9,1536
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,79.0,74.6 to 82.8,1536
PCV,≥2 Doses,HHS Regions/National,Region 1,2020,Age,5 Months,88.3,84.7 to 91.2,1536
Polio,≥2 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,94.4,91.8 to 96.3,1536
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,95.2,92.4 to 97.0,1536
DTaP,≥4 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,77.3,73.0 to 81.0,1536
Polio,≥3 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,95.5,92.9 to 97.2,1536
≥1 Dose MMR,,HHS Regions/National,Region 1,2020,Age,19 Months,93.6,90.6 to 95.7,1536
Hib,≥3 Doses,HHS Regions/National,Region 1,2020,Age,19 Months,93.8,91.2 to 95.7,1536
Hib,Primary Series,HHS Regions/National,Region 1,2020,Age,19 Months,94.7,92.0 to 96.5,1536
Influenza,,HHS Regions/National,Region 1,2020,Age,24 Months,73.8,69.1 to 78.2,1536
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 1,2020,Age,0-3 Days,83.9,80.1 to 87.1,1536
PCV,≥3 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,95.0,92.3 to 97.0,1536
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020,Age,35 Months,98.4,95.5 to 99.6,1536
Rotavirus,,HHS Regions/National,Region 1,2020,Age,8 Months,84.2,80.3 to 87.4,1536
PCV,≥4 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,88.9,85.5 to 91.9,1536
Hep A,≥1 Dose,HHS Regions/National,Region 1,2020,Age,24 Months,92.0,89.0 to 94.4,1536
Combined 7 Series,,HHS Regions/National,Region 1,2020,Age,24 Months,79.5,75.5 to 83.2,1536
Hep A,≥2 Doses,HHS Regions/National,Region 1,2020,Age,24 Months,52.5,47.8 to 57.4,1536
DTaP,≥2 Doses,HHS Regions/National,Region 1,2020,Age,5 Months,89.7,86.4 to 92.3,1536
PCV,≥1 Dose,HHS Regions/National,Region 1,2020,Age,3 Months,91.7,88.5 to 94.0,1536
Polio,≥2 Doses,HHS Regions/National,Region 1,2020,Age,5 Months,89.5,86.1 to 92.1,1536
Hib,≥2 Doses,HHS Regions/National,Region 1,2020,Age,5 Months,87.8,84.2 to 90.6,1536
Hep B,≥2 Doses,HHS Regions/National,Region 1,2020,Age,5 Months,93.0,90.3 to 95.1,1536
Polio,≥1 Dose,HHS Regions/National,Region 1,2020,Age,3 Months,91.8,88.8 to 94.0,1536
Hib,≥1 Dose,HHS Regions/National,Region 1,2020,Age,3 Months,90.4,87.1 to 93.0,1536
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,69.4,64.9 to 73.6,1536
Hep B,≥1 Dose,HHS Regions/National,Region 1,2020,Age,3 Months,96.3,94.4 to 97.5,1536
Rotavirus,,HHS Regions/National,Region 1,2019-2020,Age,8 Months,83.3,80.6 to 85.6,3211
PCV,≥3 Doses,HHS Regions/National,Region 1,2020,Age,7 Months,77.7,73.2 to 81.6,1536
DTaP,≥3 Doses,HHS Regions/National,Region 1,2020,Age,13 Months,93.9,90.9 to 95.9,1536
DTaP,≥4 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,89.0,85.0 to 92.4,1042
Hib,Primary Series,HHS Regions/National,Region 1,2021,Age,19 Months,96.2,94.0 to 97.6,1042
Polio,≥2 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,96.2,94.5 to 97.5,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,68.3,63.4 to 72.8,1042
Hib,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,3 Months,91.9,89.8 to 93.6,3211
DTaP,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,3 Months,93.6,91.8 to 95.0,3211
Polio,≥1 Dose,HHS Regions/National,Region 1,2019-2020,Age,3 Months,93.1,91.4 to 94.5,3211
Hib,Primary Series,HHS Regions/National,Region 1,2019-2020,Age,7 Months,79.0,76.0 to 81.7,3211
DTaP,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,13 Months,94.3,92.5 to 95.6,3211
PCV,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,7 Months,78.6,75.7 to 81.3,3211
Polio,≥3 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,95.2,93.6 to 96.4,3211
DTaP,≥4 Doses,HHS Regions/National,Region 1,2019-2020,Age,19 Months,77.2,74.3 to 79.8,3211
≥1 Dose MMR,,HHS Regions/National,Region 1,2021,Age,35 Months,95.1,91.9 to 97.3,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,24 Months,95.3,93.8 to 96.6,2578
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,93.6,91.7 to 95.0,2578
Influenza,,States/Local Areas,North Dakota,2013,Age,24 Months,58.9,51.3 to 66.7,237
Influenza,,States/Local Areas,North Dakota,2013-2014,Age,24 Months,60.0,54.4 to 65.6,467
Influenza,,States/Local Areas,North Dakota,2014,Age,24 Months,61.0,53.1 to 68.9,230
Influenza,,States/Local Areas,North Dakota,2014-2015,Age,24 Months,62.8,57.3 to 68.3,447
Influenza,,States/Local Areas,North Dakota,2015,Age,24 Months,64.8,57.0 to 72.4,217
Influenza,,States/Local Areas,North Dakota,2015-2016,Age,24 Months,68.5,63.1 to 73.7,444
Influenza,,States/Local Areas,North Dakota,2012,Age,24 Months,67.6,60.2 to 74.7,294
Influenza,,States/Local Areas,North Dakota,2011,Age,24 Months,60.5,53.3 to 67.7,299
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,87.1,82.8 to 91.4,267
Rotavirus,,States/Local Areas,North Dakota,2015,Age,8 Months,79.9,73.0 to 85.4,217
Rotavirus,,States/Local Areas,North Dakota,2015-2016,Age,8 Months,79.9,75.2 to 84.0,444
Rotavirus,,States/Local Areas,North Dakota,2016,Age,8 Months,80.0,73.3 to 85.3,227
Rotavirus,,States/Local Areas,North Dakota,2016-2017,Age,8 Months,79.8,75.2 to 83.7,525
Rotavirus,,States/Local Areas,North Dakota,2013,Age,8 Months,73.8,66.0 to 80.4,237
Rotavirus,,States/Local Areas,North Dakota,2013-2014,Age,8 Months,77.5,72.5 to 81.9,467
Rotavirus,,States/Local Areas,North Dakota,2012,Age,8 Months,76.6,69.8 to 82.2,294
Rotavirus,,States/Local Areas,North Dakota,2014,Age,8 Months,81.0,74.3 to 86.3,230
Rotavirus,,States/Local Areas,North Dakota,2014-2015,Age,8 Months,80.4,75.8 to 84.4,447
Rotavirus,,States/Local Areas,North Dakota,2019,Age,8 Months,82.6,75.9 to 87.8,263
Rotavirus,,States/Local Areas,North Dakota,2017,Age,8 Months,79.7,73.0 to 85.0,298
Rotavirus,,States/Local Areas,North Dakota,2017-2018,Age,8 Months,82.7,78.1 to 86.5,591
Rotavirus,,States/Local Areas,North Dakota,2011,Age,8 Months,74.0,67.1 to 79.9,299
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,72.2,65.3 to 79.0,209
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,78.5,64.7 to 92.3,48
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.0,79.6 to 86.3,637
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,83.9,79.0 to 88.8,285
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.0,64.2 to 81.7,123
Rotavirus,,States/Local Areas,North Dakota,2018,Age,8 Months,85.9,79.4 to 90.6,293
Rotavirus,,States/Local Areas,North Dakota,2018-2019,Age,8 Months,84.3,79.8 to 87.9,556
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,79.0,74.2 to 83.8,408
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Overall,Overall,80.2,77.0 to 83.3,830
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,73.7,66.1 to 81.3,155
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.7,69.4 to 86.0,124
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,77.8,73.1 to 82.4,421
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,73.7,58.7 to 88.6,42
Rotavirus,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,84.7,81.3 to 88.2,562
Hib,≥2 Doses,States/Local Areas,North Dakota,2021,Age,5 Months,79.1,68.8 to 86.6,143
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,90.8,82.8 to 98.8,43
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,92.6,85.5 to 99.7,43
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,80.8,65.5 to 96.1,43
Hib,Primary Series,States/Local Areas,North Dakota,2016,Age,13 Months,91.2,86.4 to 94.5,227
Hib,Primary Series,States/Local Areas,North Dakota,2016-2017,Age,13 Months,90.7,87.3 to 93.2,525
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,97.0,94.4 to 99.6,351
Hep B,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,93.8,90.5 to 96.0,511
Hib,Primary Series,States/Local Areas,North Dakota,2019-2020,Age,7 Months,78.5,73.4 to 82.8,511
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,79.2,74.3 to 84.1,497
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,79.3,72.8 to 85.8,236
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,77.7 to 93.9,120
Hib,Primary Series,States/Local Areas,North Dakota,2017,Age,13 Months,90.0,84.7 to 93.6,298
Hib,Primary Series,States/Local Areas,North Dakota,2017-2018,Age,13 Months,92.2,89.0 to 94.6,591
Hib,Primary Series,States/Local Areas,North Dakota,2011,Age,19 Months,92.1,90.2 to 93.6,299
Hib,Primary Series,States/Local Areas,North Dakota,2013,Age,19 Months,89.4,74.3 to 96.1,237
Hib,Primary Series,States/Local Areas,North Dakota,2013-2014,Age,19 Months,91.0,85.7 to 94.4,467
Hib,Primary Series,States/Local Areas,North Dakota,2019,Age,13 Months,90.5,85.0 to 94.1,263
Hib,Primary Series,States/Local Areas,North Dakota,2018,Age,13 Months,94.5,90.3 to 97.0,293
Hib,Primary Series,States/Local Areas,North Dakota,2018-2019,Age,13 Months,92.5,89.3 to 94.8,556
Hib,Primary Series,States/Local Areas,North Dakota,2017,Age,19 Months,93.1,88.6 to 95.9,298
Hib,Primary Series,States/Local Areas,North Dakota,2017-2018,Age,19 Months,94.5,91.6 to 96.4,591
Hib,Primary Series,States/Local Areas,North Dakota,2014,Age,19 Months,92.4,87.5 to 95.5,230
Hib,Primary Series,States/Local Areas,North Dakota,2014-2015,Age,19 Months,93.4,90.4 to 95.5,447
Hib,Primary Series,States/Local Areas,North Dakota,2012,Age,19 Months,93.0,90.4 to 94.9,294
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,89.5,82.8 to 93.8,248
Hib,Primary Series,States/Local Areas,North Dakota,2015,Age,7 Months,79.4,72.2 to 85.2,217
Hib,Primary Series,States/Local Areas,North Dakota,2015-2016,Age,7 Months,79.4,74.6 to 83.5,444
Hib,Primary Series,States/Local Areas,North Dakota,2014,Age,7 Months,79.0,71.9 to 84.6,230
Hib,Primary Series,States/Local Areas,North Dakota,2014-2015,Age,7 Months,79.2,74.3 to 83.3,447
Hib,Primary Series,States/Local Areas,North Dakota,2017,Age,7 Months,76.2,69.2 to 82.0,298
Hib,Primary Series,States/Local Areas,North Dakota,2017-2018,Age,7 Months,79.0,74.2 to 83.1,591
Hib,Primary Series,States/Local Areas,North Dakota,2016,Age,7 Months,79.4,72.8 to 84.7,227
Hib,Primary Series,States/Local Areas,North Dakota,2016-2017,Age,7 Months,77.8,73.1 to 82.0,525
Hib,Primary Series,States/Local Areas,North Dakota,2011,Age,24 Months,94.4,90.3 to 97.2,299
Hib,Primary Series,States/Local Areas,North Dakota,2012,Age,24 Months,94.2,89.9 to 97.1,294
Hib,Primary Series,States/Local Areas,North Dakota,2015,Age,19 Months,94.4,91.6 to 96.2,217
Hib,Primary Series,States/Local Areas,North Dakota,2015-2016,Age,19 Months,93.8,90.7 to 95.9,444
Hib,Primary Series,States/Local Areas,North Dakota,2016,Age,19 Months,93.1,88.6 to 95.9,227
Hib,Primary Series,States/Local Areas,North Dakota,2016-2017,Age,19 Months,93.1,90.2 to 95.3,525
Hib,Primary Series,States/Local Areas,North Dakota,2018,Age,19 Months,95.9,91.6 to 98.0,293
Hib,Primary Series,States/Local Areas,North Dakota,2018-2019,Age,19 Months,92.5,89.3 to 94.8,556
Hib,Primary Series,States/Local Areas,North Dakota,2019,Age,19 Months,94.4,89.8 to 97.0,263
Hib,Primary Series,States/Local Areas,North Dakota,2017,Age,35 Months,94.7,91.0 to 97.2,298
Hib,Primary Series,States/Local Areas,North Dakota,2017-2018,Age,35 Months,95.3,92.8 to 97.1,591
Hib,Primary Series,States/Local Areas,North Dakota,2016,Age,35 Months,94.9,91.1 to 97.5,227
Hib,Primary Series,States/Local Areas,North Dakota,2016-2017,Age,35 Months,94.8,92.2 to 96.7,525
Hib,Primary Series,States/Local Areas,North Dakota,2015,Age,35 Months,95.2,91.6 to 97.6,217
Hib,Primary Series,States/Local Areas,North Dakota,2015-2016,Age,35 Months,95.1,92.4 to 97.0,444
Combined 7 Series,,States/Local Areas,North Dakota,2011,Age,24 Months,72.0,65.0 to 78.6,299
Combined 7 Series,,States/Local Areas,North Dakota,2012,Age,24 Months,72.7,65.8 to 79.3,294
Hib,Primary Series,States/Local Areas,North Dakota,2018,Age,24 Months,95.9,92.1 to 98.1,293
Hib,Primary Series,States/Local Areas,North Dakota,2018-2019,Age,24 Months,95.7,93.4 to 97.4,556
Combined 7 Series,,States/Local Areas,North Dakota,2013,Age,24 Months,68.0,60.4 to 75.4,237
Combined 7 Series,,States/Local Areas,North Dakota,2013-2014,Age,24 Months,72.1,66.8 to 77.2,467
Hib,Primary Series,States/Local Areas,North Dakota,2017,Age,24 Months,94.7,91.0 to 97.2,298
Hib,Primary Series,States/Local Areas,North Dakota,2017-2018,Age,24 Months,95.3,92.8 to 97.1,591
Hib,Primary Series,States/Local Areas,North Dakota,2012,Age,35 Months,96.0,91.7 to 98.4,294
Hib,Primary Series,States/Local Areas,North Dakota,2014,Age,35 Months,92.8,88.3 to 96.0,230
Hib,Primary Series,States/Local Areas,North Dakota,2014-2015,Age,35 Months,94.0,91.2 to 96.1,447
Hib,Primary Series,States/Local Areas,North Dakota,2011,Age,35 Months,94.4,90.3 to 97.2,299
Hib,Primary Series,States/Local Areas,North Dakota,2019,Age,24 Months,95.6,92.3 to 97.8,263
Hib,Primary Series,States/Local Areas,North Dakota,2013,Age,35 Months,91.9,86.0 to 96.0,237
Hib,Primary Series,States/Local Areas,North Dakota,2013-2014,Age,35 Months,92.4,88.9 to 95.2,467
Hib,Primary Series,States/Local Areas,North Dakota,2016,Age,24 Months,94.1,90.2 to 96.8,227
Hib,Primary Series,States/Local Areas,North Dakota,2016-2017,Age,24 Months,94.4,91.8 to 96.3,525
Hib,Primary Series,States/Local Areas,North Dakota,2013,Age,24 Months,91.9,86.0 to 96.0,237
Hib,Primary Series,States/Local Areas,North Dakota,2013-2014,Age,24 Months,92.4,88.9 to 95.2,467
Hib,Primary Series,States/Local Areas,North Dakota,2013,Age,7 Months,72.2,58.1 to 83.0,237
Hib,Primary Series,States/Local Areas,North Dakota,2013-2014,Age,7 Months,75.7,69.3 to 81.1,467
Hib,Primary Series,States/Local Areas,North Dakota,2015,Age,13 Months,93.2,88.9 to 95.9,217
Hib,Primary Series,States/Local Areas,North Dakota,2015-2016,Age,13 Months,92.3,89.1 to 94.6,444
Hib,Primary Series,States/Local Areas,North Dakota,2014,Age,13 Months,90.8,85.1 to 94.4,230
Hib,Primary Series,States/Local Areas,North Dakota,2014-2015,Age,13 Months,92.0,88.7 to 94.4,447
Hib,Primary Series,States/Local Areas,North Dakota,2015,Age,24 Months,95.2,91.6 to 97.6,217
Hib,Primary Series,States/Local Areas,North Dakota,2015-2016,Age,24 Months,94.6,91.9 to 96.6,444
Hib,Primary Series,States/Local Areas,North Dakota,2014,Age,24 Months,92.8,88.3 to 96.0,230
Hib,Primary Series,States/Local Areas,North Dakota,2014-2015,Age,24 Months,94.0,91.2 to 96.1,447
Hib,Primary Series,States/Local Areas,North Dakota,2019,Age,7 Months,79.7,73.1 to 85.1,263
Hib,Primary Series,States/Local Areas,North Dakota,2020,Age,24 Months,93.3,88.2 to 96.7,248
Hib,Primary Series,States/Local Areas,North Dakota,2011,Age,13 Months,87.9,84.1 to 90.9,299
Hib,Primary Series,States/Local Areas,North Dakota,2012,Age,13 Months,86.8,81.7 to 90.7,294
Hib,Primary Series,States/Local Areas,North Dakota,2013,Age,13 Months,85.8,61.4 to 95.8,237
Hib,Primary Series,States/Local Areas,North Dakota,2013-2014,Age,13 Months,88.4,78.4 to 94.1,467
Hib,Primary Series,States/Local Areas,North Dakota,2018,Age,7 Months,82.0,75.1 to 87.3,293
Hib,Primary Series,States/Local Areas,North Dakota,2018-2019,Age,7 Months,80.9,76.2 to 84.8,556
Combined 7 Series,,States/Local Areas,North Dakota,2016,Age,35 Months,83.4,76.1 to 89.5,227
Combined 7 Series,,States/Local Areas,North Dakota,2016-2017,Age,35 Months,77.8,72.4 to 82.8,525
Combined 7 Series,,States/Local Areas,North Dakota,2017,Age,35 Months,72.4,64.6 to 79.7,298
Combined 7 Series,,States/Local Areas,North Dakota,2017-2018,Age,35 Months,80.3,74.9 to 85.2,591
Combined 7 Series,,States/Local Areas,North Dakota,2011,Age,35 Months,80.6,68.8 to 90.1,299
Combined 7 Series,,States/Local Areas,North Dakota,2013,Age,35 Months,70.4,62.7 to 77.8,237
Combined 7 Series,,States/Local Areas,North Dakota,2013-2014,Age,35 Months,77.4,72.2 to 82.3,467
Combined 7 Series,,States/Local Areas,North Dakota,2017,Age,24 Months,68.0,60.8 to 75.0,298
Combined 7 Series,,States/Local Areas,North Dakota,2017-2018,Age,24 Months,75.3,70.4 to 79.9,591
Combined 7 Series,,States/Local Areas,North Dakota,2018,Age,24 Months,83.1,77.1 to 88.3,293
Combined 7 Series,,States/Local Areas,North Dakota,2018-2019,Age,24 Months,80.1,75.6 to 84.2,556
Combined 7 Series,,States/Local Areas,North Dakota,2019,Age,24 Months,77.0,70.2 to 83.2,263
Combined 7 Series,,States/Local Areas,North Dakota,2012,Age,35 Months,77.0,69.9 to 83.5,294
Combined 7 Series,,States/Local Areas,North Dakota,2014,Age,35 Months,84.2,77.4 to 89.8,230
Combined 7 Series,,States/Local Areas,North Dakota,2014-2015,Age,35 Months,85.0,80.3 to 89.1,447
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Other,69.6,54.1 to 85.2,42
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Poverty,<133% FPL,69.9,61.6 to 78.2,155
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Private Insurance Only,80.8,76.6 to 85.0,562
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Insurance Coverage,Any Medicaid,67.3,59.9 to 74.8,209
Combined 7 Series,,States/Local Areas,North Dakota,2019,Age,35 Months,80.2,73.3 to 86.2,263
Combined 7 Series,,States/Local Areas,North Dakota,2018,Age,35 Months,88.5,81.9 to 93.5,293
Combined 7 Series,,States/Local Areas,North Dakota,2018-2019,Age,35 Months,84.3,79.6 to 88.4,556
Combined 7 Series,,States/Local Areas,North Dakota,2016,Age,24 Months,77.5,70.5 to 83.9,227
Combined 7 Series,,States/Local Areas,North Dakota,2016-2017,Age,24 Months,72.7,67.7 to 77.5,525
Hib,Primary Series,States/Local Areas,North Dakota,2019,Age,35 Months,96.2,92.9 to 98.2,263
Combined 7 Series,,States/Local Areas,North Dakota,2014,Age,24 Months,76.0,68.5 to 82.8,230
Combined 7 Series,,States/Local Areas,North Dakota,2014-2015,Age,24 Months,76.0,70.8 to 80.8,447
Combined 7 Series,,States/Local Areas,North Dakota,2015,Age,24 Months,75.9,68.8 to 82.4,217
Combined 7 Series,,States/Local Areas,North Dakota,2015-2016,Age,24 Months,76.7,71.7 to 81.3,444
Hib,Primary Series,States/Local Areas,North Dakota,2018,Age,35 Months,96.0,92.2 to 98.2,293
Hib,Primary Series,States/Local Areas,North Dakota,2018-2019,Age,35 Months,96.1,93.7 to 97.7,556
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,Hispanic,72.3,57.2 to 87.5,48
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.2,62.3 to 82.0,123
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.8,73.7 to 81.8,637
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,77.2,71.0 to 83.3,285
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.8,59.0 to 78.6,124
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Overall,Overall,75.4,71.7 to 79.0,830
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Urbanicity,Living In a Non-MSA,76.1,71.3 to 81.0,421
Hib,Full Series,States/Local Areas,North Dakota,2012,Age,24 Months,78.9,72.3 to 84.8,294
Hib,Full Series,States/Local Areas,North Dakota,2011,Age,24 Months,78.2,71.6 to 84.2,299
Hib,Full Series,States/Local Areas,North Dakota,2014,Age,19 Months,80.0,73.0 to 85.5,230
Hib,Full Series,States/Local Areas,North Dakota,2014-2015,Age,19 Months,79.4,74.7 to 83.4,447
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Poverty,133% to <400% FPL,73.9,68.4 to 79.3,408
Combined 7 Series,,States/Local Areas,North Dakota,2014-2017,Poverty,>400% FPL,82.1,76.9 to 87.4,267
Hib,Full Series,States/Local Areas,North Dakota,2011,Age,19 Months,68.0,63.3 to 72.4,299
Hib,Full Series,States/Local Areas,North Dakota,2012,Age,19 Months,66.9,60.0 to 73.2,294
Hib,Full Series,States/Local Areas,North Dakota,2013,Age,19 Months,73.0,55.6 to 85.5,237
Hib,Full Series,States/Local Areas,North Dakota,2013-2014,Age,19 Months,76.6,69.4 to 82.6,467
Combined 7 Series,,States/Local Areas,North Dakota,2015,Age,35 Months,85.7,79.0 to 91.2,217
Combined 7 Series,,States/Local Areas,North Dakota,2015-2016,Age,35 Months,84.7,79.8 to 89.0,444
Hib,Full Series,States/Local Areas,North Dakota,2013,Age,24 Months,77.3,70.1 to 83.9,237
Hib,Full Series,States/Local Areas,North Dakota,2013-2014,Age,24 Months,81.1,76.3 to 85.4,467
Hib,Full Series,States/Local Areas,North Dakota,2014,Age,24 Months,84.6,78.3 to 89.8,230
Hib,Full Series,States/Local Areas,North Dakota,2014-2015,Age,24 Months,85.7,81.6 to 89.3,447
Hib,Full Series,States/Local Areas,North Dakota,2016,Age,19 Months,77.7,70.5 to 83.5,227
Hib,Full Series,States/Local Areas,North Dakota,2016-2017,Age,19 Months,76.0,71.1 to 80.3,525
Hib,Full Series,States/Local Areas,North Dakota,2015,Age,19 Months,78.8,71.7 to 84.5,217
Hib,Full Series,States/Local Areas,North Dakota,2015-2016,Age,19 Months,78.3,73.4 to 82.4,444
Hib,Full Series,States/Local Areas,North Dakota,2017,Age,19 Months,74.3,67.2 to 80.3,298
Hib,Full Series,States/Local Areas,North Dakota,2017-2018,Age,19 Months,75.9,71.0 to 80.3,591
Hib,Full Series,States/Local Areas,North Dakota,2019,Age,19 Months,74.0,66.7 to 80.2,263
Hib,Full Series,States/Local Areas,North Dakota,2018,Age,19 Months,77.7,70.3 to 83.7,293
Hib,Full Series,States/Local Areas,North Dakota,2018-2019,Age,19 Months,96.7,94.5 to 98.0,556
PCV,≥3 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,89.8,82.3 to 94.4,143
Hep A,≥1 Dose,States/Local Areas,North Dakota,2021,Age,35 Months,90.0,78.2 to 96.9,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,96.0,92.4 to 98.3,391
Hib,≥3 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,51.6,40.3 to 62.7,143
DTaP,≥4 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,66.9,55.5 to 76.5,143
≥1 Dose Varicella,,States/Local Areas,North Dakota,2021,Age,19 Months,79.3,69.0 to 86.9,143
Hib,Primary Series,States/Local Areas,North Dakota,2020-2021,Age,13 Months,89.7,85.0 to 93.1,391
Hib,Full Series,States/Local Areas,North Dakota,2021,Age,24 Months,78.7,68.9 to 87.1,143
Hib,Primary Series,States/Local Areas,North Dakota,2021,Age,24 Months,89.8,83.0 to 94.7,143
Polio,≥1 Dose,States/Local Areas,North Dakota,2021,Age,3 Months,89.4,81.9 to 94.0,143
Hib,≥3 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,88.0,81.0 to 93.3,143
≥1 Dose MMR,,States/Local Areas,North Dakota,2021,Age,24 Months,85.6,76.8 to 92.3,143
DTaP,≥1 Dose,States/Local Areas,North Dakota,2021,Age,3 Months,89.4,81.9 to 94.0,143
Polio,≥3 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,89.4,82.6 to 94.4,143
DTaP,≥4 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,77.2,67.0 to 86.1,143
PCV,≥4 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,78.7,68.8 to 87.2,143
DTaP,≥3 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,89.4,81.9 to 94.1,143
PCV,≥4 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,77.2,66.5 to 85.3,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,89.1,82.3 to 94.2,143
Hep A,≥1 Dose,States/Local Areas,North Dakota,2021,Age,19 Months,79.7,69.4 to 87.2,143
DTaP,≥3 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,89.4,81.9 to 94.1,143
PCV,≥3 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,74.5,63.5 to 83.0,143
Hep B,≥3 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,77.3,66.7 to 85.2,143
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,35 Months,93.6,89.0 to 96.7,391
PCV,≥4 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,78.7,68.8 to 87.2,143
DTaP,≥4 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,77.3,70.9 to 83.1,391
PCV,≥3 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,89.8,83.0 to 94.7,143
Hep A,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,19 Months,33.8,27.5 to 40.8,391
Hep A,≥2 Doses,States/Local Areas,North Dakota,2021,Age,24 Months,54.9,43.4 to 67.1,143
Hep A,≥1 Dose,States/Local Areas,North Dakota,2021,Age,24 Months,81.9,72.3 to 89.7,143
≥1 Dose Varicella,,States/Local Areas,North Dakota,2021,Age,24 Months,84.2,75.4 to 91.2,143
DTaP,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,3 Months,87.2,82.1 to 91.0,391
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2021,Age,0-2 Days,84.1,74.9 to 90.4,143
Hep B,≥2 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,88.8,80.9 to 93.8,143
Hib,≥2 Doses,States/Local Areas,North Dakota,2020-2021,Age,13 Months,92.0,87.8 to 94.9,391
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020-2021,Age,35 Months,90.5,84.6 to 94.8,391
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2021,Age,0-1 Days,81.3,71.3 to 88.3,143
PCV,≥3 Doses,States/Local Areas,North Dakota,2021,Age,13 Months,87.5,78.7 to 93.0,143
Hep B,≥2 Doses,States/Local Areas,North Dakota,2021,Age,5 Months,87.5,79.5 to 92.7,143
Hep A,≥1 Dose,States/Local Areas,North Dakota,2020-2021,Age,35 Months,88.6,82.3 to 93.4,391
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,80.7,73.3 to 86.5,248
PCV,≥3 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,69.6,61.2 to 77.0,248
Hep B,≥2 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,91.8,85.5 to 95.5,248
Hib,≥1 Dose,States/Local Areas,North Dakota,2020,Age,3 Months,85.6,77.9 to 90.9,248
Polio,≥1 Dose,States/Local Areas,North Dakota,2020,Age,3 Months,85.1,77.3 to 90.5,248
DTaP,≥1 Dose,States/Local Areas,North Dakota,2020,Age,3 Months,85.0,77.3 to 90.4,248
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,86.8,81.0 to 92.6,695
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,76.8,67.8 to 85.7,236
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.9,76.6 to 93.1,120
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,86.1,74.4 to 97.8,43
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.0,56.2 to 77.8,120
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,92.2,81.4 to 100.0,30
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.3,87.6 to 99.0,120
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.9 to 97.9,695
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,90.9,86.5 to 95.4,236
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,86.9,73.5 to 100.0,30
Influenza,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,73.2,56.9 to 89.4,43
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,81.6,78.3 to 84.9,987
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,78.7,61.3 to 96.2,30
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,94.2,92.4 to 96.0,987
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,86.8,81.6 to 92.1,351
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,94.3,92.4 to 96.2,987
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,74.5,65.6 to 83.4,139
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Overall,Overall,93.5,91.5 to 95.5,987
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,88.9,85.2 to 92.6,497
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,86.0,83.1 to 88.9,987
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,89.8,83.8 to 95.9,139
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,91.5,84.9 to 98.0,351
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,80.8,74.0 to 87.5,497
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,93.1,90.1 to 96.1,497
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,93.0,88.3 to 97.7,139
Influenza,,States/Local Areas,North Dakota,2016-2019,Overall,Overall,71.5,67.6 to 75.4,987
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Overall,Overall,84.6,81.5 to 87.7,987
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Overall,Overall,89.9,87.4 to 92.5,987
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,93.4,88.7 to 98.0,139
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,81.9,76.9 to 86.9,987
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Overall,Overall,74.7,70.9 to 78.5,987
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Overall,Overall,81.5,78.3 to 84.7,987
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Overall,Overall,91.8,89.5 to 94.1,987
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,97.3,95.4 to 99.3,351
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,72.8,67.2 to 78.4,497
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,83.4,78.1 to 88.7,351
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,93.4,90.5 to 96.2,497
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,64.9,55.2 to 74.7,139
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,96.8,95.0 to 98.7,351
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,85.0,78.4 to 91.7,139
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,92.2,89.1 to 95.3,497
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Overall,Overall,83.8,80.5 to 87.1,987
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,96.8,94.7 to 98.9,351
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,85.6,81.6 to 89.5,489
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,92.8,89.9 to 95.7,497
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.4,76.9 to 91.9,164
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,89.5,85.7 to 93.3,489
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,83.2,77.1 to 89.3,334
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,77.1,70.6 to 83.6,334
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,93.0,90.1 to 95.9,489
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,95.2,92.3 to 98.1,334
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,92.7 to 98.9,164
Influenza,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,61.7,55.8 to 67.6,489
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.7,94.0 to 99.5,164
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.4,92.3 to 96.4,795
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.9,80.5 to 87.4,795
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,88.2 to 99.1,120
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,90.5 to 95.3,795
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,80.0,75.6 to 84.4,695
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,87.5,83.8 to 91.1,695
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,78.5,71.9 to 85.0,236
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,93.6,86.9 to 100.0,43
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,79.1,62.1 to 96.2,30
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,94.5,92.1 to 97.0,695
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,80.4 to 95.6,120
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.4 to 98.0,695
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,87.2,83.9 to 90.5,695
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.3,61.3 to 81.3,120
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.4,63.3 to 83.5,120
Influenza,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,76.2,71.7 to 80.6,695
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,91.2,83.5 to 98.8,43
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,71.7,54.7 to 88.6,43
Influenza,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,65.0,57.3 to 72.6,236
Influenza,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,58.4,35.4 to 81.5,30
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.6,81.0 to 88.3,795
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,64.5,41.9 to 87.2,30
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.9,77.9 to 93.9,120
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,72.0,64.8 to 79.2,236
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,70.0,51.1 to 89.0,30
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,84.4,72.4 to 96.3,43
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.3,73.2 to 81.4,795
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,78.4,65.2 to 91.5,43
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.5,85.5 to 91.4,795
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,91.6,83.3 to 99.8,43
Influenza,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.1,68.9 to 77.4,795
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,87.7 to 98.7,120
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.5 to 96.5,795
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,92.9,89.0 to 96.7,236
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,92.2,81.4 to 100.0,30
Influenza,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.0,53.6 to 76.5,120
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,93.6,86.9 to 100.0,43
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.4,92.2 to 96.6,795
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.7 to 97.4,695
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,76.8,70.0 to 83.6,236
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,92.2,81.4 to 100.0,30
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,91.1,86.7 to 95.5,236
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,67.7,48.4 to 87.1,30
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,90.1,82.2 to 98.0,43
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,85.1,71.3 to 98.9,30
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.3,87.5 to 93.1,795
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,92.2,81.4 to 100.0,30
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,78.0,71.4 to 84.6,236
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,79.1,62.5 to 95.7,30
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,95.6,93.8 to 97.5,695
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,92.7,88.9 to 96.6,236
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.2,80.8 to 87.6,795
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.6,92.6 to 96.6,795
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,84.9,71.1 to 98.8,30
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,88.3,83.3 to 93.4,236
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,92.6,85.5 to 99.7,43
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Private Insurance Only,85.9,82.3 to 89.5,695
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,81.6,77.1 to 86.0,497
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,72.1,63.2 to 81.0,139
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,93.5,90.1 to 96.9,334
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,92.4,88.7 to 96.2,351
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,85.3,81.1 to 89.5,497
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,84.4,79.0 to 89.8,351
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,84.6,80.0 to 89.1,497
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,64.7,52.5 to 76.9,139
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,96.7,94.8 to 98.6,351
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,92.7,88.0 to 97.5,139
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,92.3,89.2 to 95.4,497
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,94.5,92.7 to 96.3,987
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Overall,Overall,93.9,92.0 to 95.7,987
Influenza,,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,68.5,62.8 to 74.1,497
Influenza,,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,62.7,52.5 to 72.8,139
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,96.0,93.3 to 98.8,351
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,90.3,86.8 to 93.8,497
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,88.1,81.6 to 94.6,139
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,89.7,85.4 to 94.0,351
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,90.8,85.1 to 96.5,139
Polio,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,93.7,89.2 to 98.1,139
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,88.8,84.3 to 93.3,351
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Poverty,133% to <400% FPL,83.0,78.1 to 87.9,497
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,77.0,68.5 to 85.5,139
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,91.5,87.4 to 95.7,351
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Poverty,<133% FPL,76.7,68.4 to 85.0,139
Influenza,,States/Local Areas,North Dakota,2016-2019,Poverty,>400% FPL,81.6,76.1 to 87.1,351
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,92.5,88.6 to 96.5,236
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Any Medicaid,66.6,58.9 to 74.3,236
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,91.7 to 96.0,795
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,86.0,81.1 to 90.9,334
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.6,68.0 to 85.2,164
DTaP,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,80.1,75.2 to 85.0,489
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,95.5,92.7 to 98.4,334
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.4,93.5 to 99.2,164
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,90.4,83.3 to 97.5,334
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.2,78.5 to 92.0,164
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,82.4,77.7 to 87.1,489
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,94.3,91.1 to 97.4,334
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.3,94.7 to 100.0,164
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,88.6 to 96.1,334
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.3,87.4 to 97.2,164
Hep A,≥1 Dose,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,87.6,83.5 to 91.6,489
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.3,81.2 to 95.3,164
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,84.3,79.2 to 89.3,334
Influenza,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.3,70.3 to 88.2,164
Influenza,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,82.1,76.8 to 87.5,334
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,73.4,68.0 to 78.8,489
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.9,63.9 to 81.9,164
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,84.3 to 96.3,164
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,82.2,77.6 to 86.8,489
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,95.2,92.3 to 98.2,334
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,90.8 to 99.1,164
PCV,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,93.4,90.5 to 96.4,489
≥1 Dose Varicella,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.2,91.3 to 99.1,164
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,93.5,90.7 to 96.3,489
Rotavirus,,States/Local Areas,North Dakota,2019-2020,Age,8 Months,80.6,75.4 to 84.9,511
Hib,Primary Series,States/Local Areas,North Dakota,2020-2021,Age,19 Months,91.5,87.1 to 94.5,391
≥1 Dose MMR,,States/Local Areas,North Dakota,2020-2021,Age,13 Months,62.9,55.7 to 69.6,391
Polio,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,3 Months,89.3,85.1 to 92.5,511
Hib,≥3 Doses,States/Local Areas,North Dakota,2021,Age,19 Months,84.4,75.3 to 90.5,143
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Insurance Coverage,Other,63.4,43.7 to 83.0,30
Combined 7 Series,,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.0,48.8 to 71.2,120
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,87.0 to 98.3,120
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,92.4,88.6 to 95.1,511
DTaP,≥4 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,69.9,64.3 to 75.0,511
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,82.0,77.4 to 85.9,511
DTaP,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,3 Months,89.6,85.4 to 92.7,511
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2019-2020,Age,0-3 Days,88.0,83.6 to 91.4,511
PCV,≥4 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,89.6,85.5 to 93.8,334
DTaP,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,93.2,90.3 to 96.1,489
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,89.6 to 96.4,334
≥1 Dose MMR,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,91.7,88.4 to 94.9,489
Rotavirus,,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,77.4,72.5 to 82.3,489
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.7,72.6 to 92.9,164
Hib,Full Series,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a MSA Principal City,84.9,79.0 to 90.8,334
Hep A,≥2 Doses,States/Local Areas,North Dakota,2016-2019,Urbanicity,Living In a Non-MSA,76.5,69.5 to 83.5,489
Hep B,≥3 Doses,States/Local Areas,North Dakota,2016-2019,Race and Ethnicity,Hispanic,95.3,90.4 to 100.0,43
PCV,≥3 Doses,States/Local Areas,North Dakota,2021,Age,35 Months,89.8,83.0 to 94.7,143
Hib,≥2 Doses,States/Local Areas,North Dakota,2021,Age,7 Months,87.2,78.4 to 92.7,143
Hib,≥3 Doses,States/Local Areas,North Dakota,2020-2021,Age,24 Months,87.7,82.9 to 91.7,391
Hib,≥2 Doses,States/Local Areas,North Dakota,2020,Age,5 Months,78.1,69.8 to 84.5,248
DTaP,≥2 Doses,States/Local Areas,North Dakota,2020,Age,5 Months,78.5,70.2 to 84.9,248
Polio,≥2 Doses,States/Local Areas,North Dakota,2020,Age,5 Months,78.5,70.3 to 85.0,248
Hep B,≥1 Dose,States/Local Areas,North Dakota,2020,Age,3 Months,96.9,92.2 to 98.8,248
PCV,≥1 Dose,States/Local Areas,North Dakota,2020,Age,3 Months,83.6,75.6 to 89.4,248
Hep A,≥1 Dose,States/Local Areas,North Dakota,2020,Age,24 Months,86.8,80.2 to 92.1,248
Hep A,≥2 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,60.5,51.7 to 69.5,248
PCV,≥4 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,82.2,74.8 to 88.6,248
PCV,≥3 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,91.2,85.3 to 95.4,248
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020,Age,24 Months,89.1,82.3 to 94.2,248
Rotavirus,,States/Local Areas,North Dakota,2020,Age,8 Months,78.0,69.7 to 84.5,248
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,North Dakota,2020,Age,0-3 Days,89.8,83.6 to 93.8,248
Influenza,,States/Local Areas,North Dakota,2020,Age,24 Months,69.9,61.8 to 77.7,248
Hib,≥3 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,86.3,78.5 to 91.5,248
Combined 7 Series,,States/Local Areas,North Dakota,2020,Age,24 Months,72.2,63.7 to 80.2,248
≥1 Dose MMR,,States/Local Areas,North Dakota,2020,Age,19 Months,87.9,80.3 to 92.8,248
Polio,≥3 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,91.2,84.8 to 95.1,248
DTaP,≥4 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,70.9,62.2 to 78.3,248
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,91.2,84.8 to 95.1,248
Hep B,≥2 Doses,States/Local Areas,North Dakota,2020,Age,5 Months,91.0,84.7 to 94.9,248
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,71.9,63.6 to 79.0,248
PCV,≥3 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,87.3,80.1 to 92.2,248
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020,Age,13 Months,60.7,52.0 to 68.8,248
PCV,≥2 Doses,States/Local Areas,North Dakota,2020,Age,5 Months,75.4,67.0 to 82.2,248
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,93.0,87.8 to 96.2,248
Hep B,≥2 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,95.4,90.6 to 97.8,248
Hib,Primary Series,States/Local Areas,North Dakota,2020,Age,13 Months,91.0,84.5 to 94.9,248
Hib,≥3 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,60.2,51.5 to 68.3,248
Hib,≥2 Doses,States/Local Areas,North Dakota,2020,Age,13 Months,94.4,89.4 to 97.1,248
PCV,≥3 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,91.2,85.3 to 95.4,248
PCV,≥4 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,81.6,73.6 to 87.6,248
PCV,≥3 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,91.2,84.6 to 95.1,248
Polio,≥3 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,93.8,87.9 to 97.4,248
DTaP,≥4 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,93.4,80.5 to 98.9,248
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,93.8,87.9 to 97.4,248
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020,Age,19 Months,89.1,81.5 to 93.8,248
Hib,Full Series,States/Local Areas,North Dakota,2020,Age,19 Months,77.6,69.1 to 84.2,248
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,95.1,90.3 to 97.6,248
Hib,Primary Series,States/Local Areas,North Dakota,2020,Age,19 Months,93.3,87.6 to 96.5,248
≥1 Dose Varicella,,States/Local Areas,North Dakota,2020,Age,35 Months,92.3,85.2 to 96.8,248
Hib,Full Series,States/Local Areas,North Dakota,2020,Age,35 Months,90.1,75.7 to 97.7,248
Hep B,≥3 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,95.9,91.6 to 98.3,248
Hib,≥3 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,87.8,80.7 to 93.3,248
Hib,Primary Series,States/Local Areas,North Dakota,2020,Age,35 Months,93.6,88.5 to 97.0,248
≥1 Dose MMR,,States/Local Areas,North Dakota,2020,Age,35 Months,91.9,84.7 to 96.6,248
Hib,≥3 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,87.5,80.4 to 92.9,248
≥1 Dose MMR,,States/Local Areas,North Dakota,2020,Age,24 Months,88.6,81.8 to 93.8,248
Polio,≥3 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,91.2,85.4 to 95.4,248
DTaP,≥4 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,77.8,69.6 to 85.0,248
DTaP,≥3 Doses,States/Local Areas,North Dakota,2020,Age,24 Months,91.2,85.4 to 95.4,248
Hib,Primary Series,States/Local Areas,North Dakota,2020,Age,7 Months,76.8,68.5 to 83.3,248
Hib,≥3 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,42.4,34.3 to 51.0,248
Polio,≥2 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,87.6,80.3 to 92.5,248
Hib,≥2 Doses,States/Local Areas,North Dakota,2020,Age,7 Months,87.6,80.3 to 92.5,248
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2020,Age,0-1 Days,87.8,81.2 to 92.4,248
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2020,Age,0-2 Days,89.8,83.6 to 93.8,248
Hep A,≥1 Dose,States/Local Areas,North Dakota,2020,Age,19 Months,86.6,79.3 to 91.5,248
Hep A,≥2 Doses,States/Local Areas,North Dakota,2020,Age,19 Months,27.5,20.8 to 35.5,248
Combined 7 Series,,States/Local Areas,North Dakota,2020,Age,35 Months,83.9,68.8 to 94.3,248
≥1 Dose MMR,,States/Local Areas,North Dakota,2020,Age,13 Months,63.0,54.4 to 70.9,248
Hep A,≥2 Doses,States/Local Areas,North Dakota,2020,Age,35 Months,85.2,76.4 to 91.9,248
Hep A,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,24 Months,89.5,85.4 to 92.8,511
Hep A,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,85.9,80.0 to 90.9,511
Hep A,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,35 Months,90.7,86.5 to 94.0,511
Influenza,,States/Local Areas,North Dakota,2019-2020,Age,24 Months,73.6,68.3 to 78.7,511
Hib,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,89.4,85.1 to 92.9,511
Hep A,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,64.0,58.0 to 69.9,511
Hib,Primary Series,States/Local Areas,North Dakota,2019-2020,Age,24 Months,94.5,91.6 to 96.6,511
Hib,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,88.9,84.7 to 92.1,511
Hib,Full Series,States/Local Areas,North Dakota,2019-2020,Age,19 Months,76.0,70.6 to 80.7,511
Combined 7 Series,,States/Local Areas,North Dakota,2019-2020,Age,35 Months,81.1,74.1 to 87.2,511
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019-2020,Age,19 Months,88.8,84.3 to 92.1,511
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,95.8,93.2 to 97.4,511
PCV,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,91.7,87.6 to 94.5,511
PCV,≥4 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,83.1,78.0 to 87.1,511
Hep A,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,19 Months,89.0,84.6 to 92.2,511
Hep B,"≥1 Dose, 1 Day",States/Local Areas,North Dakota,2019-2020,Age,0-1 Days,86.5,81.9 to 90.1,511
Hep B,"≥1 Dose, 2 Day",States/Local Areas,North Dakota,2019-2020,Age,0-2 Days,88.0,83.6 to 91.4,511
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,96.1,93.7 to 97.7,511
Hib,Full Series,States/Local Areas,North Dakota,2019-2020,Age,24 Months,82.2,77.2 to 86.6,511
Hib,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,51.2,45.4 to 57.0,511
PCV,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,75.4,70.0 to 80.0,511
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019-2020,Age,24 Months,90.1,85.9 to 93.4,511
PCV,≥4 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,84.9,80.2 to 89.1,511
PCV,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,92.3,88.6 to 95.1,511
Polio,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,92.1,88.2 to 94.8,511
Hep A,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,34.1,28.8 to 39.8,511
Hib,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,19 Months,87.1,82.4 to 90.6,511
≥1 Dose MMR,,States/Local Areas,North Dakota,2019-2020,Age,19 Months,89.2,84.7 to 92.5,511
Hib,Primary Series,States/Local Areas,North Dakota,2019-2020,Age,19 Months,93.9,90.6 to 96.1,511
≥1 Dose MMR,,States/Local Areas,North Dakota,2019-2020,Age,35 Months,92.2,88.1 to 95.3,511
Hib,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,89.8,85.5 to 93.3,511
Hib,Full Series,States/Local Areas,North Dakota,2019-2020,Age,35 Months,87.0,80.5 to 92.2,511
Hib,Primary Series,States/Local Areas,North Dakota,2019-2020,Age,35 Months,95.0,92.1 to 97.1,511
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,96.2,93.8 to 97.8,511
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019-2020,Age,35 Months,91.6,87.5 to 94.8,511
PCV,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,93.5,89.6 to 96.3,511
PCV,≥4 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,85.4,80.7 to 89.5,511
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,93.6,90.2 to 96.2,511
Polio,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,93.5,90.1 to 96.1,511
DTaP,≥4 Doses,States/Local Areas,North Dakota,2019-2020,Age,24 Months,80.4,75.3 to 85.1,511
≥1 Dose MMR,,States/Local Areas,North Dakota,2019-2020,Age,24 Months,90.7,86.5 to 94.0,511
Hib,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,3 Months,89.7,85.5 to 92.8,511
Hep B,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,3 Months,97.8,95.5 to 98.9,511
PCV,≥1 Dose,States/Local Areas,North Dakota,2019-2020,Age,3 Months,89.5,85.1 to 92.7,511
DTaP,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,5 Months,82.4,77.4 to 86.5,511
Polio,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,5 Months,81.9,76.8 to 86.0,511
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,89.3,85.1 to 92.4,511
Polio,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,93.6,90.2 to 95.9,511
Hib,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,93.6,90.3 to 95.8,511
≥1 Dose MMR,,States/Local Areas,North Dakota,2019-2020,Age,13 Months,66.9,61.1 to 72.2,511
Hib,Primary Series,States/Local Areas,North Dakota,2019-2020,Age,13 Months,90.9,87.0 to 93.7,511
Hib,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,67.9,62.2 to 73.1,511
Hib,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,5 Months,81.8,76.8 to 86.0,511
Hep B,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,5 Months,93.1,89.8 to 95.4,511
PCV,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,5 Months,82.0,76.9 to 86.2,511
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,75.5,70.3 to 80.1,511
Polio,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,7 Months,89.2,84.9 to 92.4,511
Hep B,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,92.2,88.7 to 94.7,511
Hep B,≥2 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,96.6,94.1 to 98.0,511
≥1 Dose Varicella,,States/Local Areas,North Dakota,2019-2020,Age,13 Months,64.5,58.7 to 69.9,511
PCV,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,13 Months,89.1,84.7 to 92.3,511
Combined 7 Series,,States/Local Areas,North Dakota,2019-2020,Age,24 Months,75.0,69.6 to 80.1,511
DTaP,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,94.9,91.6 to 97.2,511
DTaP,≥4 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,92.3,84.4 to 97.1,511
Polio,≥3 Doses,States/Local Areas,North Dakota,2019-2020,Age,35 Months,95.0,91.6 to 97.3,511
Rotavirus,,States/Local Areas,Louisiana,2016,Age,8 Months,70.3,61.4 to 77.8,266
Rotavirus,,States/Local Areas,Louisiana,2016-2017,Age,8 Months,69.7,64.0 to 74.9,665
Rotavirus,,States/Local Areas,Louisiana,2011,Age,8 Months,68.5,60.6 to 75.5,257
Rotavirus,,States/Local Areas,Louisiana,2014,Age,8 Months,65.7,57.4 to 73.1,261
Rotavirus,,States/Local Areas,Louisiana,2014-2015,Age,8 Months,68.7,63.1 to 73.7,535
Rotavirus,,States/Local Areas,Louisiana,2012,Age,8 Months,65.8,57.5 to 73.2,249
Rotavirus,,States/Local Areas,Louisiana,2013,Age,8 Months,66.0,58.1 to 73.1,238
Rotavirus,,States/Local Areas,Louisiana,2013-2014,Age,8 Months,65.8,60.1 to 71.1,499
Rotavirus,,States/Local Areas,Louisiana,2015,Age,8 Months,71.6,64.0 to 78.2,274
Rotavirus,,States/Local Areas,Louisiana,2015-2016,Age,8 Months,70.9,65.2 to 76.1,540
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,81.7,76.9 to 86.5,447
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,77.0,69.2 to 84.7,256
Hib,Primary Series,States/Local Areas,Louisiana,2019-2020,Age,7 Months,65.0,59.7 to 70.0,844
Hib,Full Series,States/Local Areas,Louisiana,2014,Age,19 Months,72.9,65.1 to 79.5,261
Hib,Full Series,States/Local Areas,Louisiana,2014-2015,Age,19 Months,72.9,67.5 to 77.8,535
Hib,Full Series,States/Local Areas,Louisiana,2015,Age,19 Months,73.0,66.0 to 79.0,274
Hib,Full Series,States/Local Areas,Louisiana,2015-2016,Age,19 Months,68.9,63.0 to 74.3,540
Hib,Full Series,States/Local Areas,Louisiana,2016,Age,19 Months,64.9,55.7 to 73.1,266
Hib,Full Series,States/Local Areas,Louisiana,2016-2017,Age,19 Months,68.2,62.3 to 73.6,665
Hep B,≥2 Doses,States/Local Areas,Louisiana,2019-2020,Age,7 Months,90.2,86.4 to 93.0,844
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,>400% FPL,93.9,88.5 to 99.4,343
Hib,Full Series,States/Local Areas,Louisiana,2012,Age,24 Months,80.2,73.2 to 86.3,249
Hib,Full Series,States/Local Areas,Louisiana,2011,Age,24 Months,78.3,71.1 to 84.8,257
Hib,Full Series,States/Local Areas,Louisiana,2018,Age,19 Months,66.2,59.0 to 72.7,401
Hib,Full Series,States/Local Areas,Louisiana,2018-2019,Age,19 Months,95.8,92.9 to 97.5,812
Hib,Full Series,States/Local Areas,Louisiana,2019,Age,19 Months,67.5,59.9 to 74.2,411
Hib,Full Series,States/Local Areas,Louisiana,2017,Age,19 Months,71.7,64.3 to 78.2,399
Hib,Full Series,States/Local Areas,Louisiana,2017-2018,Age,19 Months,69.0,63.8 to 73.7,800
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,72.9,66.8 to 79.0,447
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,68.5,63.1 to 73.9,535
Combined 7 Series,,States/Local Areas,Louisiana,2019,Age,35 Months,70.6,62.7 to 78.2,411
Combined 7 Series,,States/Local Areas,Louisiana,2018,Age,35 Months,64.9,57.3 to 72.5,401
Combined 7 Series,,States/Local Areas,Louisiana,2018-2019,Age,35 Months,67.6,62.1 to 73.0,812
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.6,60.0 to 77.2,162
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,70.6,60.9 to 80.3,162
Hib,Primary Series,States/Local Areas,Louisiana,2013,Age,35 Months,93.1,88.2 to 96.5,238
Hib,Primary Series,States/Local Areas,Louisiana,2013-2014,Age,35 Months,94.6,91.4 to 96.9,499
Hib,Primary Series,States/Local Areas,Louisiana,2011,Age,35 Months,91.5,85.6 to 95.6,257
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,70.2,64.4 to 76.0,410
Combined 7 Series,,States/Local Areas,Louisiana,2015,Age,35 Months,72.2,64.4 to 79.6,274
Combined 7 Series,,States/Local Areas,Louisiana,2015-2016,Age,35 Months,72.9,66.8 to 78.6,540
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,62.6,51.2 to 74.0,152
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Overall,Overall,68.7,64.5 to 72.8,1012
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.8,65.6 to 86.0,92
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.9,61.4 to 72.4,596
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.2,64.1 to 76.2,448
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,69.9,63.6 to 76.2,412
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,69.4,62.0 to 76.7,346
Combined 7 Series,,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,62.9,53.4 to 72.5,256
Hib,Full Series,States/Local Areas,Louisiana,2011,Age,19 Months,69.1,61.4 to 75.8,257
Hib,Full Series,States/Local Areas,Louisiana,2012,Age,19 Months,74.1,68.8 to 78.8,249
Hib,Full Series,States/Local Areas,Louisiana,2013,Age,19 Months,72.5,68.5 to 76.2,238
Hib,Full Series,States/Local Areas,Louisiana,2013-2014,Age,19 Months,72.7,67.0 to 77.7,499
Hib,Full Series,States/Local Areas,Louisiana,2013,Age,24 Months,75.7,68.7 to 82.1,238
Hib,Full Series,States/Local Areas,Louisiana,2013-2014,Age,24 Months,78.5,73.5 to 83.2,499
Hib,Full Series,States/Local Areas,Louisiana,2014,Age,24 Months,81.5,74.5 to 87.5,261
Hib,Full Series,States/Local Areas,Louisiana,2014-2015,Age,24 Months,80.9,76.2 to 85.1,535
Combined 7 Series,,States/Local Areas,Louisiana,2011,Age,35 Months,86.8,71.9 to 96.1,257
Combined 7 Series,,States/Local Areas,Louisiana,2011,Age,24 Months,67.9,60.2 to 75.3,257
Combined 7 Series,,States/Local Areas,Louisiana,2014,Age,35 Months,75.6,67.9 to 82.6,261
Combined 7 Series,,States/Local Areas,Louisiana,2014-2015,Age,35 Months,73.9,68.5 to 79.1,535
Combined 7 Series,,States/Local Areas,Louisiana,2013,Age,35 Months,70.2,62.7 to 77.4,238
Combined 7 Series,,States/Local Areas,Louisiana,2013-2014,Age,35 Months,72.9,67.4 to 78.1,499
Combined 7 Series,,States/Local Areas,Louisiana,2012,Age,35 Months,78.6,70.8 to 85.5,249
Hib,Primary Series,States/Local Areas,Louisiana,2016,Age,35 Months,90.2,83.0 to 95.3,266
Hib,Primary Series,States/Local Areas,Louisiana,2016-2017,Age,35 Months,90.9,86.6 to 94.3,665
Combined 7 Series,,States/Local Areas,Louisiana,2014,Age,24 Months,69.3,61.7 to 76.6,261
Combined 7 Series,,States/Local Areas,Louisiana,2014-2015,Age,24 Months,67.9,62.5 to 73.2,535
Combined 7 Series,,States/Local Areas,Louisiana,2016,Age,35 Months,73.4,64.1 to 82.0,266
Combined 7 Series,,States/Local Areas,Louisiana,2016-2017,Age,35 Months,72.1,66.0 to 77.9,665
Combined 7 Series,,States/Local Areas,Louisiana,2017,Age,35 Months,70.8,62.9 to 78.4,399
Combined 7 Series,,States/Local Areas,Louisiana,2017-2018,Age,35 Months,67.8,62.3 to 73.3,800
Hib,Primary Series,States/Local Areas,Louisiana,2017,Age,24 Months,91.5,86.3 to 95.3,399
Hib,Primary Series,States/Local Areas,Louisiana,2017-2018,Age,24 Months,91.1,87.6 to 93.8,800
Hib,Primary Series,States/Local Areas,Louisiana,2016,Age,24 Months,90.2,83.0 to 95.3,266
Hib,Primary Series,States/Local Areas,Louisiana,2016-2017,Age,24 Months,90.9,86.6 to 94.3,665
Hib,Primary Series,States/Local Areas,Louisiana,2018,Age,24 Months,90.6,85.9 to 94.3,401
Hib,Primary Series,States/Local Areas,Louisiana,2018-2019,Age,24 Months,92.0,88.7 to 94.6,812
Hib,Primary Series,States/Local Areas,Louisiana,2015,Age,24 Months,95.5,92.4 to 97.5,274
Hib,Primary Series,States/Local Areas,Louisiana,2015-2016,Age,24 Months,92.8,88.9 to 95.7,540
Hib,Primary Series,States/Local Areas,Louisiana,2014,Age,24 Months,94.2,90.2 to 97.0,261
Hib,Primary Series,States/Local Areas,Louisiana,2014-2015,Age,24 Months,94.8,92.4 to 96.7,535
Hib,Primary Series,States/Local Areas,Louisiana,2017,Age,35 Months,91.5,86.3 to 95.3,399
Hib,Primary Series,States/Local Areas,Louisiana,2017-2018,Age,35 Months,91.9,88.5 to 94.6,800
Hib,Primary Series,States/Local Areas,Louisiana,2015,Age,35 Months,96.7,94.1 to 98.3,274
Hib,Primary Series,States/Local Areas,Louisiana,2015-2016,Age,35 Months,93.5,89.6 to 96.3,540
Hib,Primary Series,States/Local Areas,Louisiana,2019,Age,24 Months,93.4,88.4 to 96.8,411
Hib,Primary Series,States/Local Areas,Louisiana,2012,Age,35 Months,96.9,89.9 to 99.5,249
Hib,Primary Series,States/Local Areas,Louisiana,2014,Age,35 Months,95.7,91.4 to 98.2,261
Hib,Primary Series,States/Local Areas,Louisiana,2014-2015,Age,35 Months,96.2,93.9 to 97.8,535
Combined 7 Series,,States/Local Areas,Louisiana,2013,Age,24 Months,67.7,60.4 to 74.9,238
Combined 7 Series,,States/Local Areas,Louisiana,2013-2014,Age,24 Months,68.5,63.1 to 73.7,499
Combined 7 Series,,States/Local Areas,Louisiana,2012,Age,24 Months,70.6,62.9 to 77.9,249
Hib,Primary Series,States/Local Areas,Louisiana,2014,Age,19 Months,94.2,89.8 to 96.8,261
Hib,Primary Series,States/Local Areas,Louisiana,2014-2015,Age,19 Months,94.5,91.9 to 96.3,535
Hib,Primary Series,States/Local Areas,Louisiana,2018,Age,13 Months,85.2,79.3 to 89.6,401
Hib,Primary Series,States/Local Areas,Louisiana,2018-2019,Age,13 Months,85.8,81.7 to 89.2,812
Hib,Primary Series,States/Local Areas,Louisiana,2011,Age,19 Months,90.6,83.0 to 95.0,257
Hib,Primary Series,States/Local Areas,Louisiana,2012,Age,19 Months,89.7,83.3 to 93.8,249
Hib,Primary Series,States/Local Areas,Louisiana,2019,Age,13 Months,86.5,80.1 to 91.0,411
Hib,Primary Series,States/Local Areas,Louisiana,2017,Age,13 Months,86.7,80.2 to 91.3,399
Hib,Primary Series,States/Local Areas,Louisiana,2017-2018,Age,13 Months,86.0,81.8 to 89.3,800
Hib,Primary Series,States/Local Areas,Louisiana,2016,Age,13 Months,84.7,76.2 to 90.6,266
Hib,Primary Series,States/Local Areas,Louisiana,2016-2017,Age,13 Months,85.7,80.5 to 89.7,665
Hib,Primary Series,States/Local Areas,Louisiana,2011,Age,13 Months,86.6,81.0 to 90.7,257
Hib,Primary Series,States/Local Areas,Louisiana,2012,Age,13 Months,86.8,79.3 to 91.8,249
Hib,Primary Series,States/Local Areas,Louisiana,2013,Age,13 Months,81.9,78.2 to 85.1,238
Hib,Primary Series,States/Local Areas,Louisiana,2013-2014,Age,13 Months,84.8,81.6 to 87.6,499
Hib,Primary Series,States/Local Areas,Louisiana,2015,Age,7 Months,68.9,61.2 to 75.6,274
Hib,Primary Series,States/Local Areas,Louisiana,2015-2016,Age,7 Months,67.7,61.8 to 73.0,540
Hib,Primary Series,States/Local Areas,Louisiana,2014,Age,7 Months,68.3,60.4 to 75.3,261
Hib,Primary Series,States/Local Areas,Louisiana,2014-2015,Age,7 Months,68.6,63.2 to 73.5,535
Hib,Primary Series,States/Local Areas,Louisiana,2017,Age,7 Months,63.6,55.8 to 70.8,399
Hib,Primary Series,States/Local Areas,Louisiana,2017-2018,Age,7 Months,64.1,58.7 to 69.2,800
Hib,Primary Series,States/Local Areas,Louisiana,2016,Age,7 Months,66.5,57.5 to 74.4,266
Hib,Primary Series,States/Local Areas,Louisiana,2016-2017,Age,7 Months,65.1,59.2 to 70.5,665
Hib,Primary Series,States/Local Areas,Louisiana,2019,Age,7 Months,61.9,54.3 to 69.0,411
Hib,Primary Series,States/Local Areas,Louisiana,2018,Age,7 Months,64.6,57.3 to 71.3,401
Hib,Primary Series,States/Local Areas,Louisiana,2018-2019,Age,7 Months,63.3,58.0 to 68.2,812
Combined 7 Series,,States/Local Areas,Louisiana,2019,Age,24 Months,64.7,57.2 to 72.0,411
Combined 7 Series,,States/Local Areas,Louisiana,2015,Age,24 Months,66.5,58.7 to 74.1,274
Combined 7 Series,,States/Local Areas,Louisiana,2015-2016,Age,24 Months,67.0,61.2 to 72.8,540
Hib,Primary Series,States/Local Areas,Louisiana,2018,Age,35 Months,92.2,87.5 to 95.6,401
Hib,Primary Series,States/Local Areas,Louisiana,2018-2019,Age,35 Months,93.9,90.7 to 96.3,812
Combined 7 Series,,States/Local Areas,Louisiana,2016,Age,24 Months,67.6,58.7 to 76.1,266
Combined 7 Series,,States/Local Areas,Louisiana,2016-2017,Age,24 Months,67.1,61.3 to 72.8,665
Hib,Primary Series,States/Local Areas,Louisiana,2019,Age,35 Months,97.2,92.5 to 99.3,411
Hib,Primary Series,States/Local Areas,Louisiana,2015,Age,13 Months,91.9,87.7 to 94.7,274
Hib,Primary Series,States/Local Areas,Louisiana,2015-2016,Age,13 Months,88.3,83.6 to 91.7,540
Hib,Primary Series,States/Local Areas,Louisiana,2014,Age,13 Months,87.8,81.7 to 92.0,261
Hib,Primary Series,States/Local Areas,Louisiana,2014-2015,Age,13 Months,89.8,86.3 to 92.5,535
Combined 7 Series,,States/Local Areas,Louisiana,2017,Age,24 Months,66.6,59.2 to 73.8,399
Combined 7 Series,,States/Local Areas,Louisiana,2017-2018,Age,24 Months,63.7,58.5 to 68.9,800
Combined 7 Series,,States/Local Areas,Louisiana,2018,Age,24 Months,60.8,53.7 to 67.9,401
Combined 7 Series,,States/Local Areas,Louisiana,2018-2019,Age,24 Months,62.7,57.6 to 67.9,812
Hib,Primary Series,States/Local Areas,Louisiana,2016,Age,19 Months,90.1,81.9 to 94.8,266
Hib,Primary Series,States/Local Areas,Louisiana,2016-2017,Age,19 Months,90.2,85.5 to 93.5,665
Hib,Primary Series,States/Local Areas,Louisiana,2013,Age,19 Months,91.0,88.4 to 93.0,238
Hib,Primary Series,States/Local Areas,Louisiana,2013-2014,Age,19 Months,92.6,91.7 to 93.4,499
Hib,Primary Series,States/Local Areas,Louisiana,2013,Age,7 Months,58.7,54.5 to 62.8,238
Hib,Primary Series,States/Local Areas,Louisiana,2013-2014,Age,7 Months,63.5,59.2 to 67.6,499
Hib,Primary Series,States/Local Areas,Louisiana,2015,Age,19 Months,94.9,92.9 to 96.3,274
Hib,Primary Series,States/Local Areas,Louisiana,2015-2016,Age,19 Months,92.5,88.2 to 95.3,540
Hib,Primary Series,States/Local Areas,Louisiana,2017,Age,19 Months,90.3,84.3 to 94.2,399
Hib,Primary Series,States/Local Areas,Louisiana,2017-2018,Age,19 Months,89.8,86.1 to 92.7,800
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,82.9 to 97.1,126
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Louisiana,2020-2021,Age,0-2 Days,75.0,69.8 to 79.5,697
Hib,Full Series,States/Local Areas,Louisiana,2020-2021,Age,19 Months,67.0,61.4 to 72.2,697
≥1 Dose MMR,,States/Local Areas,Louisiana,2020-2021,Age,13 Months,61.2,55.5 to 66.7,697
PCV,≥1 Dose,States/Local Areas,Louisiana,2021,Age,3 Months,83.5,74.9 to 89.5,264
≥1 Dose MMR,,States/Local Areas,Louisiana,2021,Age,19 Months,88.9,81.7 to 93.4,264
Hep B,≥2 Doses,States/Local Areas,Louisiana,2021,Age,5 Months,91.3,85.3 to 95.0,264
Hep A,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,24.9,20.3 to 30.0,697
Polio,≥3 Doses,States/Local Areas,Louisiana,2021,Age,19 Months,92.3,85.6 to 96.1,264
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,89.7,85.6 to 92.7,697
PCV,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,66.4,60.7 to 71.7,697
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,92.9,89.6 to 95.1,697
Hib,Full Series,States/Local Areas,Louisiana,2020-2021,Age,35 Months,80.5,74.8 to 85.5,697
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020-2021,Age,19 Months,86.3,81.8 to 89.8,697
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2020-2021,Age,0-3 Days,76.8,71.8 to 81.2,697
Combined 7 Series,,States/Local Areas,Louisiana,2021,Age,24 Months,73.4,64.0 to 81.9,264
Hib,Primary Series,States/Local Areas,Louisiana,2020-2021,Age,19 Months,91.9,88.0 to 94.6,697
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Louisiana,2020-2021,Age,0-1 Days,72.1,66.7 to 77.0,697
Polio,≥2 Doses,States/Local Areas,Louisiana,2021,Age,5 Months,78.1,69.3 to 84.8,264
Rotavirus,,States/Local Areas,Louisiana,2021,Age,8 Months,74.7,65.8 to 81.9,264
Polio,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,93.1,89.7 to 95.6,697
Hep A,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,44.6,38.8 to 50.9,697
Hib,Primary Series,States/Local Areas,Louisiana,2021,Age,35 Months,92.3,86.3 to 96.3,264
DTaP,≥2 Doses,States/Local Areas,Louisiana,2021,Age,5 Months,79.8,71.0 to 86.4,264
≥1 Dose Varicella,,States/Local Areas,Louisiana,2021,Age,13 Months,64.0,54.9 to 72.1,264
Polio,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,92.1,88.2 to 94.7,697
Hib,Primary Series,States/Local Areas,Louisiana,2020-2021,Age,35 Months,92.4,88.8 to 95.2,697
Hib,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,91.2,87.5 to 94.2,697
Hep A,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,19 Months,80.0,74.9 to 84.4,697
Hib,Primary Series,States/Local Areas,Louisiana,2021,Age,13 Months,88.0,80.6 to 92.8,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,90.7,86.5 to 93.7,697
Influenza,,States/Local Areas,Louisiana,2020-2021,Age,24 Months,40.8,35.5 to 46.6,697
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,69.6,64.2 to 74.6,697
DTaP,≥4 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,93.2,82.5 to 98.4,264
Hep B,≥3 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,97.1,94.6 to 98.6,264
Polio,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,87.1,82.6 to 90.5,697
PCV,≥4 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,80.1,74.9 to 84.8,697
Hib,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,3 Months,83.5,78.6 to 87.4,697
≥1 Dose MMR,,States/Local Areas,Louisiana,2020-2021,Age,35 Months,93.0,89.5 to 95.7,697
Hib,Primary Series,States/Local Areas,Louisiana,2020-2021,Age,13 Months,86.9,82.4 to 90.3,697
PCV,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,92.5,88.7 to 95.5,697
DTaP,≥3 Doses,States/Local Areas,Louisiana,2021,Age,24 Months,95.0,89.7 to 98.1,264
Hep B,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,91.3,87.6 to 93.9,697
Combined 7 Series,,States/Local Areas,Louisiana,2020-2021,Age,35 Months,70.5,64.8 to 76.0,697
Polio,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,5 Months,78.2,72.9 to 82.7,697
Hib,Full Series,States/Local Areas,Louisiana,2021,Age,35 Months,82.8,74.7 to 89.4,264
DTaP,≥3 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,95.0,89.7 to 98.1,264
Combined 7 Series,,States/Local Areas,Louisiana,2020-2021,Age,24 Months,68.5,62.7 to 74.0,697
Hib,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,89.5,85.4 to 92.6,697
PCV,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,91.8,87.9 to 94.8,697
Polio,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,91.2,87.3 to 94.0,697
DTaP,≥4 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,68.4,62.8 to 73.5,697
Hib,≥3 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,79.7,71.4 to 86.0,264
Hib,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,5 Months,77.7,72.4 to 82.2,697
Hep B,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,5 Months,89.7,85.9 to 92.6,697
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020-2021,Age,24 Months,90.1,86.3 to 93.2,697
Hep B,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,93.9,91.3 to 96.0,697
Hib,Primary Series,States/Local Areas,Louisiana,2020-2021,Age,7 Months,71.3,65.8 to 76.3,697
Hep B,≥3 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,91.1,85.2 to 94.9,264
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,78.2,69.1 to 87.2,188
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,71.6,66.5 to 76.7,654
DTaP,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Poverty,<133% FPL,73.3,67.4 to 79.3,439
Influenza,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Private Insurance Only,57.5,50.6 to 64.5,447
Rotavirus,,States/Local Areas,Louisiana,2019,Age,8 Months,67.5,59.9 to 74.3,411
Rotavirus,,States/Local Areas,Louisiana,2017,Age,8 Months,69.2,61.6 to 75.9,399
Rotavirus,,States/Local Areas,Louisiana,2017-2018,Age,8 Months,67.1,61.8 to 72.1,800
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.5,67.4 to 77.6,596
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,72.8,66.8 to 78.9,412
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.9,60.8 to 76.9,162
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,67.5,62.2 to 72.8,535
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,69.1,58.5 to 79.8,162
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.2,63.8 to 84.7,92
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.4,65.6 to 77.2,448
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,66.6,55.9 to 77.4,152
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Overall,Overall,71.1,67.2 to 75.1,1012
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,65.3,59.3 to 71.3,410
Rotavirus,,States/Local Areas,Louisiana,2018,Age,8 Months,65.0,57.5 to 71.9,401
Rotavirus,,States/Local Areas,Louisiana,2018-2019,Age,8 Months,66.3,61.0 to 71.2,812
Rotavirus,,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,77.9,71.6 to 84.2,346
Influenza,,States/Local Areas,Louisiana,2013,Age,24 Months,50.5,42.9 to 58.6,238
Influenza,,States/Local Areas,Louisiana,2013-2014,Age,24 Months,42.3,36.9 to 48.0,499
Influenza,,States/Local Areas,Louisiana,2016,Age,24 Months,48.0,39.7 to 57.1,266
Influenza,,States/Local Areas,Louisiana,2016-2017,Age,24 Months,47.4,41.8 to 53.4,665
Influenza,,States/Local Areas,Louisiana,2012,Age,24 Months,48.8,40.9 to 57.3,249
Influenza,,States/Local Areas,Louisiana,2011,Age,24 Months,41.9,34.5 to 50.2,257
Influenza,,States/Local Areas,Louisiana,2014,Age,24 Months,34.0,27.1 to 42.2,261
Influenza,,States/Local Areas,Louisiana,2014-2015,Age,24 Months,38.7,33.5 to 44.5,535
Influenza,,States/Local Areas,Louisiana,2015,Age,24 Months,43.4,35.7 to 51.9,274
Influenza,,States/Local Areas,Louisiana,2015-2016,Age,24 Months,45.7,39.9 to 51.9,540
Hep B,≥1 Dose,States/Local Areas,Louisiana,2021,Age,3 Months,96.5,93.8 to 98.1,264
Influenza,,States/Local Areas,Louisiana,2014-2017,Insurance Coverage,Any Medicaid,36.1,30.6 to 41.5,535
Influenza,,States/Local Areas,Louisiana,2021,Age,24 Months,36.9,29.1 to 46.0,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,96.1,93.8 to 98.4,609
PCV,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,87.0,82.9 to 91.2,654
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,85.1,80.8 to 89.5,609
Influenza,,States/Local Areas,Louisiana,2014-2017,Overall,Overall,42.6,38.3 to 46.9,1012
Influenza,,States/Local Areas,Louisiana,2014-2017,Poverty,<133% FPL,38.2,32.0 to 44.3,410
Influenza,,States/Local Areas,Louisiana,2014-2017,Poverty,133% to <400% FPL,43.5,35.7 to 51.3,346
Influenza,,States/Local Areas,Louisiana,2014-2017,Poverty,>400% FPL,55.0,45.6 to 64.3,256
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.7,71.2 to 90.2,126
PCV,≥4 Doses,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,88.8,85.1 to 92.5,609
≥1 Dose Varicella,,States/Local Areas,Louisiana,2020-2021,Age,13 Months,62.6,56.8 to 67.9,697
Hib,Full Series,States/Local Areas,Louisiana,2020-2021,Age,24 Months,77.4,72.2 to 82.2,697
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,71.6,66.1 to 76.6,697
≥1 Dose MMR,,States/Local Areas,Louisiana,2020-2021,Age,19 Months,85.9,81.4 to 89.4,697
Hib,≥2 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,92.5,85.7 to 96.2,264
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Private Insurance Only,87.7,83.6 to 91.7,609
Hep A,≥1 Dose,States/Local Areas,Louisiana,2016-2019,Insurance Coverage,Any Medicaid,84.5,80.4 to 88.5,654
Polio,≥3 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,83.0 to 97.5,126
Influenza,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",34.1,25.6 to 42.5,162
Influenza,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,Hispanic,45.7,34.1 to 57.4,162
Influenza,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",43.0,29.2 to 56.8,92
Influenza,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Non-Principal City,43.9,37.4 to 50.4,448
Influenza,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a Non-MSA,37.1,26.6 to 47.6,152
Influenza,,States/Local Areas,Louisiana,2014-2017,Race and Ethnicity,"White, Non-Hispanic",47.9,42.2 to 53.6,596
Influenza,,States/Local Areas,Louisiana,2014-2017,Urbanicity,Living In a MSA Principal City,43.9,37.0 to 50.8,412
Hib,Full Series,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.2,65.4 to 85.0,126
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.4,49.8 to 77.0,126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Louisiana,2021,Age,0-3 Days,80.8,73.2 to 86.6,264
Hib,≥3 Doses,States/Local Areas,Louisiana,2021,Age,35 Months,91.9,85.9 to 96.0,264
Polio,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,93.0,89.6 to 95.5,697
Polio,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,3 Months,84.1,79.3 to 87.9,697
Hep A,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,72.6,65.0 to 79.7,697
Hep A,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,24 Months,87.1,83.0 to 90.6,697
≥1 Dose MMR,,States/Local Areas,Louisiana,2021,Age,13 Months,62.7,53.6 to 71.1,264
PCV,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,13 Months,85.2,80.4 to 89.0,697
Hib,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,60.1,54.3 to 65.6,697
Hep B,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,3 Months,95.7,93.4 to 97.2,697
Hib,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,7 Months,87.9,83.5 to 91.2,697
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,35 Months,94.5,91.3 to 96.8,697
Rotavirus,,States/Local Areas,Louisiana,2020-2021,Age,8 Months,74.3,68.9 to 79.1,697
DTaP,≥2 Doses,States/Local Areas,Louisiana,2020-2021,Age,5 Months,79.8,74.5 to 84.2,697
PCV,≥1 Dose,States/Local Areas,Louisiana,2020-2021,Age,3 Months,81.6,76.5 to 85.9,697
DTaP,≥3 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,94.5,91.3 to 96.8,697
DTaP,≥4 Doses,States/Local Areas,Louisiana,2020-2021,Age,24 Months,81.3,76.4 to 85.8,697
≥1 Dose Varicella,,States/Local Areas,Louisiana,2021,Age,35 Months,93.7,87.9 to 97.4,264
Hep B,≥2 Doses,States/Local Areas,Louisiana,2021,Age,13 Months,93.9,88.0 to 97.0,264
PCV,≥4 Doses,States/Local Areas,Louisiana,2020-2021,Age,19 Months,72.4,66.9 to 77.4,697
Influenza,,States/Local Areas,Louisiana,2019,Age,24 Months,47.5,40.4 to 55.2,411
Influenza,,States/Local Areas,Louisiana,2017,Age,24 Months,46.8,39.7 to 54.6,399
Influenza,,States/Local Areas,Louisiana,2017-2018,Age,24 Months,44.5,39.5 to 49.8,800
Influenza,,States/Local Areas,Louisiana,2018,Age,24 Months,41.9,35.4 to 49.2,401
Influenza,,States/Local Areas,Louisiana,2018-2019,Age,24 Months,44.7,39.8 to 50.0,812
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,Hispanic,68.1,55.5 to 80.7,188
Hep A,≥2 Doses,States/Local Areas,Louisiana,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.9,60.4 to 79.4,236
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,32.9,26.0 to 40.5,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2012,Age,0-3 Days,NA,,
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,66.8,59.1 to 73.7,319
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,76.3,69.2 to 82.1,296
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,72.4,67.3 to 77.0,615
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,68.4,60.8 to 75.2,319
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,73.6,66.5 to 79.7,296
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,66.8,61.5 to 71.7,615
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,59.7,51.9 to 67.0,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2014,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2013,Age,0-3 Days,NA,,
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2013-2014,Age,0-3 Days,NA,,
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,3 Months,69.7,62.3 to 76.3,319
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,70.3,63.0 to 77.4,319
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,81.4,75.4 to 86.8,296
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,76.0,71.2 to 80.5,615
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,75.0,67.9 to 81.0,296
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,71.0,65.8 to 75.7,615
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2011,Age,0-3 Days,NA,,
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,3 Months,75.6,68.4 to 81.5,296
PCV,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,3 Months,72.7,67.6 to 77.2,615
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,84.6,78.9 to 89.0,296
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,81.5,77.2 to 85.1,615
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,78.2,71.4 to 83.7,319
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,80.3,73.6 to 85.7,319
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,80.8,74.4 to 85.9,296
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,68.4,63.2 to 73.2,615
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,68.0,60.4 to 74.8,319
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,5 Months,57.8,50.0 to 65.3,296
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,5 Months,56.3,50.8 to 61.7,615
Hib,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,5 Months,54.7,46.9 to 62.2,319
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,82.0,75.9 to 87.4,296
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,77.4,72.5 to 81.9,615
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,3 Months,78.9,72.0 to 84.4,296
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,3 Months,76.8,72.0 to 81.0,615
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,45.2,37.6 to 53.0,296
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,39.1,33.9 to 44.6,615
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,72.6,65.0 to 79.8,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2018,Age,0-3 Days,71.4,63.9 to 77.9,296
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2018-2019,Age,0-3 Days,70.6,65.4 to 75.4,615
Polio,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,3 Months,74.7,67.6 to 80.7,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Puerto Rico,2019,Age,0-3 Days,69.9,62.4 to 76.4,319
Hib,Full Series,States/Local Areas,Puerto Rico,2020,Age,24 Months,62.0,54.8 to 69.2,337
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,46.5,38.8 to 54.3,296
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,40.9,35.7 to 46.4,615
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,35.2,28.2 to 42.8,319
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,38.1,30.8 to 45.9,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018,Age,24 Months,74.5,67.5 to 81.0,296
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,67.1,61.9 to 72.3,615
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,62.5,54.5 to 70.6,296
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,58.5,52.7 to 64.4,615
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,54.3,46.0 to 63.1,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019,Age,35 Months,67.3,58.9 to 75.5,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018,Age,35 Months,83.6,74.9 to 90.6,296
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,76.4,69.5 to 82.8,615
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,86.6,81.0 to 90.8,296
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,83.5,79.3 to 87.1,615
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,81.7,73.8 to 88.4,296
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,79.5,74.0 to 84.6,615
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,77.3,69.5 to 84.4,319
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,3 Months,77.5,70.6 to 83.2,296
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,3 Months,74.6,69.6 to 79.0,615
Hib,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,3 Months,71.6,64.2 to 78.0,319
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,77.8,71.4 to 83.7,296
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,75.6,70.7 to 80.2,615
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019,Age,24 Months,59.5,51.9 to 67.3,319
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,73.3,65.9 to 80.3,319
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2018,Age,0-2 Days,66.0,58.2 to 73.0,296
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2018-2019,Age,0-2 Days,65.5,60.1 to 70.6,615
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Puerto Rico,2019,Age,0-2 Days,65.1,57.2 to 72.2,319
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,84.4,78.3 to 89.0,296
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,80.4,75.8 to 84.3,615
Hib,Primary Series,States/Local Areas,Puerto Rico,2020,Age,24 Months,80.3,74.4 to 85.6,337
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,62.0,54.3 to 69.2,319
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,46.8,39.3 to 54.9,319
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,56.1,48.4 to 64.1,296
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,51.6,46.1 to 57.3,615
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,76.3,69.2 to 82.2,319
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,74.6,67.5 to 80.6,296
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,68.4,63.2 to 73.2,615
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018,Age,35 Months,85.8,77.8 to 92.1,296
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,80.3,73.7 to 86.1,615
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019,Age,35 Months,72.8,64.4 to 80.6,319
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,55.5,48.0 to 63.4,296
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,51.2,45.8 to 56.8,615
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,46.7,39.2 to 54.8,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018,Age,13 Months,40.1,32.8 to 47.8,296
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,32.9,28.0 to 38.1,615
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,68.3,60.7 to 75.1,319
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,77.5,70.6 to 83.1,296
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,73.0,67.9 to 77.5,615
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2020,Age,24 Months,73.2,66.4 to 79.5,337
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019,Age,13 Months,26.9,20.8 to 34.1,319
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018,Age,13 Months,40.9,33.6 to 48.7,296
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,34.1,29.2 to 39.3,615
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,48.0,38.7 to 58.2,319
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,49.4,40.2 to 59.3,296
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,49.0,42.3 to 56.0,615
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,3 Months,94.7,89.9 to 97.3,296
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,3 Months,93.4,90.2 to 95.6,615
Hep B,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,3 Months,92.0,87.1 to 95.1,319
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2020,Age,35 Months,82.7,76.5 to 88.1,337
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,74.6,67.3 to 80.7,296
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,71.1,65.9 to 75.9,615
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,67.5,59.7 to 74.5,319
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,57.5,48.6 to 66.7,319
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,63.4,55.2 to 71.7,296
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,60.5,54.4 to 66.7,615
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018,Age,19 Months,73.8,66.5 to 80.0,296
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,34.1,29.2 to 39.3,615
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019,Age,13 Months,25.4,19.4 to 32.5,319
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,77.8,71.0 to 83.4,296
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,71.1,65.9 to 75.9,615
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,13 Months,85.7,80.2 to 89.9,296
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,13 Months,82.7,78.6 to 86.2,615
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,13 Months,79.6,73.1 to 84.9,319
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019,Age,19 Months,55.3,47.5 to 62.9,319
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018,Age,19 Months,72.2,64.8 to 78.6,296
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,81.5,77.2 to 85.1,615
≥1 Dose MMR,,States/Local Areas,Puerto Rico,2019,Age,19 Months,55.0,47.2 to 62.5,319
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,5 Months,72.8,65.5 to 79.0,319
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,5 Months,77.1,70.0 to 82.9,296
Hep B,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,5 Months,75.0,70.0 to 79.3,615
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2019,Age,24 Months,65.3,57.5 to 72.9,319
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018,Age,24 Months,77.2,70.5 to 83.4,296
≥1 Dose Varicella,,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,71.3,66.2 to 76.3,615
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,71.1,63.3 to 77.8,319
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2018,Age,0-1 Days,59.3,51.4 to 66.7,296
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2018-2019,Age,0-1 Days,59.2,53.6 to 64.5,615
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2020,Age,35 Months,69.8,62.5 to 76.9,337
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Puerto Rico,2019,Age,0-1 Days,59.1,51.2 to 66.5,319
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,43.1,35.6 to 51.0,296
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,37.5,32.3 to 42.9,615
PCV,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,31.6,24.9 to 39.1,319
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,47.3,39.6 to 55.0,296
PCV,≥4 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,37.5,31.5 to 44.0,505
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,77.4,69.7 to 84.4,319
Hib,Full Series,States/Local Areas,Puerto Rico,2018,Age,35 Months,62.2,54.2 to 70.2,296
Hib,Full Series,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,58.8,52.8 to 64.8,615
Hib,Full Series,States/Local Areas,Puerto Rico,2019,Age,35 Months,55.5,46.6 to 64.8,319
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,35 Months,74.0,66.5 to 81.0,319
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,5 Months,57.3,49.4 to 64.8,296
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,5 Months,54.6,49.0 to 60.0,615
PCV,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,5 Months,51.8,44.1 to 59.4,319
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,51.2,43.5 to 58.9,296
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,82.7,78.6 to 86.2,615
DTaP,≥4 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,38.2,31.1 to 45.9,319
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,35.2,28.1 to 43.4,319
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,29.6,22.8 to 37.7,296
Hep A,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,32.3,27.3 to 38.0,615
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2019,Age,5 Months,57.0,49.3 to 64.4,319
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,7 Months,49.4,41.7 to 57.2,296
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,7 Months,47.4,42.0 to 52.9,615
Hep B,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,7 Months,45.4,37.8 to 53.2,319
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2018,Age,35 Months,79.6,71.6 to 86.5,296
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,77.7,71.7 to 83.1,615
Hep A,≥1 Dose,States/Local Areas,Puerto Rico,2019,Age,35 Months,75.4,67.1 to 83.0,319
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2018,Age,5 Months,59.3,51.4 to 66.7,296
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,5 Months,58.2,52.6 to 63.5,615
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,80.0,73.3 to 85.3,296
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,72.4,67.3 to 77.0,615
DTaP,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,72.4,64.9 to 78.8,319
Polio,≥2 Doses,States/Local Areas,Puerto Rico,2020,Age,13 Months,79.6,73.2 to 84.8,337
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,24 Months,80.8,74.8 to 86.2,296
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,76.8,72.1 to 81.3,615
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,24 Months,72.6,65.3 to 79.5,319
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,68.2,60.5 to 74.9,319
Hib,Full Series,States/Local Areas,Puerto Rico,2018,Age,24 Months,57.1,49.5 to 64.9,296
Hib,Full Series,States/Local Areas,Puerto Rico,2018-2019,Age,24 Months,51.8,46.4 to 57.4,615
Hib,Full Series,States/Local Areas,Puerto Rico,2019,Age,24 Months,46.3,38.9 to 54.4,319
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,35 Months,86.1,78.2 to 92.3,296
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,35 Months,82.3,76.3 to 87.5,615
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2019,Age,19 Months,70.6,62.9 to 77.2,319
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,79.4,72.7 to 84.8,296
Polio,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,32.9,28.0 to 38.1,615
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018,Age,19 Months,77.8,71.0 to 83.4,296
Hib,≥3 Doses,States/Local Areas,Puerto Rico,2018-2019,Age,19 Months,66.8,61.5 to 71.7,615
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,24 Months,87.6,81.2 to 92.7,356
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,87.7,83.4 to 91.3,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,95.0,91.2 to 97.6,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,93.9,89.7 to 96.8,331
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,91.5,84.3 to 96.3,299
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,93.3,89.3 to 96.3,653
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,89.0,82.5 to 93.8,342
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,90.4,85.8 to 94.1,641
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,95.9,91.6 to 98.4,325
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,92.5,88.7 to 95.4,667
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,37.9,30.5 to 45.8,354
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,37.1,31.9 to 42.6,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,32.1,26.2 to 38.6,299
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,35.0,29.5 to 40.9,653
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,93.4,87.6 to 97.1,356
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,92.8,89.2 to 95.6,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,96.3,92.5 to 98.5,406
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,92.3,87.3 to 95.9,426
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,94.3,91.3 to 96.6,832
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,28.2,23.8 to 33.1,331
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,26.0,19.8 to 33.3,342
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,29.0,23.9 to 34.7,641
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,28.5,24.6 to 32.7,325
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,27.2,22.7 to 32.3,667
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,5 Months,86.5,80.6 to 90.8,406
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,20.9,16.2 to 26.6,343
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,91.0,84.8 to 95.4,342
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,92.3,87.9 to 95.5,641
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,96.0,92.3 to 98.2,343
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,96.0,92.3 to 98.3,331
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,96.3,91.9 to 98.6,325
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,93.7,90.0 to 96.4,667
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,19 Months,86.8,80.4 to 91.4,426
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,89.4,85.3 to 92.5,699
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,19 Months,83.2,75.8 to 88.6,356
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,85.0,80.3 to 88.7,782
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,19 Months,82.8,75.2 to 88.4,354
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,83.0,77.9 to 87.1,710
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,35 Months,85.0,78.6 to 90.3,343
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,24 Months,93.1,88.6 to 96.3,406
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,24 Months,87.5,81.6 to 92.3,426
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,90.3,86.7 to 93.3,832
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,96.4,92.6 to 98.6,406
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,90.1,80.1 to 100.0,62
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,24 Months,80.9,73.3 to 87.4,331
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,24 Months,82.6,74.9 to 89.1,325
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,82.4,77.3 to 87.0,667
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,24 Months,82.2,76.0 to 87.7,343
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,19 Months,90.2,85.0 to 93.7,406
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.5,91.5 to 98.0,354
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,95.2,91.9 to 97.4,710
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,93.0,86.2 to 97.2,299
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,94.2,90.3 to 96.8,653
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,5 Months,83.1,73.7 to 89.6,343
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,5 Months,76.0,67.8 to 82.7,331
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,5 Months,82.2,78.5 to 85.3,325
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,5 Months,80.1,77.0 to 82.9,667
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,94.7,89.2 to 97.9,356
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,94.7,91.4 to 97.0,782
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,69.3,61.1 to 76.5,331
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,69.5,66.6 to 72.3,343
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,71.9,66.9 to 76.3,743
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,92.2,88.7 to 94.7,743
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,91.9,88.4 to 94.4,743
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,73.4,68.3 to 77.9,743
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,3 Months,89.4,85.6 to 92.3,743
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,3 Months,89.8,86.0 to 92.7,743
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,3 Months,86.3,82.1 to 89.6,743
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2021,Age,0-1 Days,82.1,75.0 to 87.6,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,95.2,87.1 to 100.0,51
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.5,92.1 to 96.8,1122
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,91.7,81.7 to 100.0,51
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.7,80.1 to 89.4,1122
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,81.8,65.3 to 98.3,51
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.8,92.4 to 97.2,947
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,73.6,59.7 to 87.6,74
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,87.7 to 99.2,206
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,91.0,85.5 to 94.5,238
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,5 Months,81.4,74.0 to 87.0,238
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,90.4,86.8 to 93.4,575
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,60.6,51.7 to 68.7,238
Hib,Primary Series,States/Local Areas,PA-Rest of state,2021,Age,19 Months,91.5,86.0 to 94.9,238
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2021,Age,35 Months,95.5,87.1 to 99.1,238
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,97.4,90.2 to 99.7,238
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,82.2,77.4 to 86.5,575
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,87.4,83.2 to 90.7,575
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,90.8,85.1 to 94.4,238
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,91.5,85.9 to 95.0,238
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,88.8,84.8 to 92.1,575
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,92.7,87.3 to 95.9,238
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,5 Months,80.6,73.0 to 86.5,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,90.7,86.9 to 93.5,575
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,74.0,65.6 to 80.9,238
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,91.8,86.4 to 95.2,238
Combined 7 Series,,States/Local Areas,PA-Rest of state,2021,Age,35 Months,73.1,62.5 to 82.7,238
Hib,Primary Series,States/Local Areas,PA-Rest of state,2021,Age,7 Months,75.9,68.1 to 82.2,238
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,93.4,90.1 to 95.7,575
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,3 Months,94.3,90.0 to 96.8,354
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,3 Months,92.0,88.2 to 94.7,710
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,3 Months,83.4,74.4 to 89.7,299
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,3 Months,88.8,83.9 to 92.4,653
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,3 Months,88.3,81.3 to 92.9,342
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,3 Months,85.9,80.4 to 90.0,641
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,3 Months,88.0,79.6 to 93.2,325
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,3 Months,88.1,83.3 to 91.7,667
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,3 Months,91.6,86.7 to 94.8,343
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,3 Months,90.9,86.1 to 94.2,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.7,83.6 to 89.7,947
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2021,Age,19 Months,87.0,79.8 to 91.9,238
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,3 Months,90.3,85.0 to 93.9,238
Hib,Full Series,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,74.0,68.8 to 79.0,575
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,84.6,78.5 to 89.8,575
Hib,Full Series,States/Local Areas,PA-Rest of state,2021,Age,19 Months,73.0,64.5 to 80.1,238
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,3 Months,89.4,83.8 to 93.3,426
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,3 Months,91.4,87.9 to 94.0,832
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,93.0,86.2 to 97.2,299
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,94.2,90.3 to 96.8,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,89.6,83.1 to 94.4,342
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,91.3,86.8 to 94.7,641
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,3 Months,89.7,82.8 to 94.0,356
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,3 Months,89.6,85.4 to 92.7,782
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,19 Months,76.6,71.8 to 80.7,343
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,3 Months,93.4,88.4 to 96.4,406
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,95.5,91.5 to 98.0,354
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,94.4,91.0 to 96.8,710
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,81.4,73.6 to 87.2,238
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,89.9,83.7 to 93.9,238
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,19 Months,75.4,72.6 to 78.1,331
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,19 Months,77.8,73.2 to 81.8,325
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,77.7,72.0 to 82.6,667
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,5 Months,82.8,75.1 to 88.4,356
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,5 Months,82.4,77.5 to 86.4,782
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,5 Months,82.1,75.3 to 87.3,426
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,5 Months,84.3,80.0 to 87.8,832
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,5 Months,86.5,79.9 to 91.2,354
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,5 Months,84.6,79.8 to 88.5,710
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,84.2,71.4 to 97.1,48
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.9,91.2 to 96.7,945
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,92.4,89.9 to 94.9,1184
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,86.6,80.3 to 92.9,225
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,92.4,88.3 to 96.6,381
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,97.0,95.1 to 98.9,578
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,19 Months,77.5,67.0 to 85.4,299
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,80.2,74.5 to 84.8,653
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,19 Months,77.7,69.7 to 84.0,342
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,77.6,71.8 to 82.5,641
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,94.7,90.3 to 97.5,426
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,95.6,92.8 to 97.5,832
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,93.3,87.5 to 97.0,356
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,94.0,90.5 to 96.5,782
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,96.4,92.6 to 98.6,406
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,94.9,90.9 to 97.5,354
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,94.1,90.8 to 96.6,710
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,91.5,84.3 to 96.3,299
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,93.1,89.1 to 96.1,653
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,40.5,34.0 to 47.7,343
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,39.6,32.6 to 47.0,406
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,32.4,26.2 to 39.3,426
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,35.9,30.5 to 41.8,699
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,94.8,89.4 to 98.0,356
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,93.6,90.1 to 96.2,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.3,91.2 to 97.9,354
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,95.1,91.9 to 97.3,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,36.4,29.3 to 44.1,356
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,34.4,29.6 to 39.5,782
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,98.1,97.1 to 99.1,797
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,91.2,87.0 to 95.5,301
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,65.4,56.5 to 73.2,299
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,71.9,65.8 to 77.3,653
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,71.2,62.8 to 78.4,342
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,68.3,62.0 to 74.0,641
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,70.0,61.2 to 77.6,325
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,70.6,63.9 to 76.6,667
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,92.4,87.4 to 95.9,426
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,94.3,91.3 to 96.6,832
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,94.7,90.4 to 97.5,426
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,95.6,92.8 to 97.5,832
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,5 Months,84.5,77.7 to 89.5,354
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,5 Months,82.7,77.8 to 86.8,710
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,5 Months,72.8,63.7 to 80.4,299
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,5 Months,78.6,73.0 to 83.3,653
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,5 Months,78.0,70.1 to 84.4,342
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,5 Months,75.4,68.5 to 81.3,641
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,24 Months,85.5,78.8 to 90.9,354
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,86.6,82.1 to 90.5,710
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,24 Months,84.2,76.3 to 90.5,299
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,84.6,79.5 to 89.0,653
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,24 Months,82.4,75.2 to 88.5,342
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,83.0,77.8 to 87.6,641
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,84.7,80.0 to 89.5,473
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,69.3,61.6 to 77.0,245
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,96.2,93.4 to 99.0,242
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,94.3,91.9 to 96.7,697
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,88.4,83.8 to 92.9,473
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,87.6,83.9 to 91.3,697
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,84.9,79.6 to 90.2,473
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,72.1,62.5 to 81.7,245
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,97.0,95.3 to 98.8,697
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,92.6,88.4 to 96.8,245
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,96.1,94.5 to 97.7,1415
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,94.5,92.6 to 96.4,1415
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,71.9,65.8 to 78.0,473
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,61.4,53.3 to 69.5,245
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,97.3,95.5 to 99.0,697
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,93.3,89.5 to 97.2,473
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,92.0,88.7 to 95.3,697
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,92.5,88.2 to 96.8,245
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,93.4,89.2 to 97.5,245
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,93.3,89.7 to 97.0,473
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,91.9,87.6 to 96.2,245
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,93.3,90.7 to 95.9,697
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,86.9,82.4 to 91.4,473
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,95.6,93.6 to 97.6,697
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,70.4,62.8 to 78.1,245
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,81.3,75.1 to 87.6,245
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,88.6,85.0 to 92.3,697
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,88.5,85.9 to 91.1,1415
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,94.9,92.0 to 97.8,383
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,71.1,64.8 to 77.4,383
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,96.7,94.0 to 99.4,170
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.0,62.1 to 81.8,206
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.4,93.0 to 97.7,947
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.9,82.3 to 89.4,947
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.0,96.2 to 99.8,206
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.8,80.8 to 98.9,92
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.0,92.5 to 97.5,947
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,83.9,80.2 to 87.6,941
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.8,49.7 to 77.9,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,86.1,82.3 to 89.9,941
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.0,80.8 to 95.3,206
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.9,77.3 to 94.5,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,85.6,81.0 to 90.1,383
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,95.2,91.5 to 98.9,170
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.7,82.1 to 99.3,92
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,91.5,85.3 to 97.7,74
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,96.7,95.0 to 98.3,941
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.5,90.1 to 99.0,206
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,98.1,96.8 to 99.4,941
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,90.5,87.7 to 93.3,941
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.5,73.9 to 91.1,206
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.7,78.8 to 94.6,206
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,83.4,79.6 to 87.1,941
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,83.1,72.7 to 93.6,170
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,95.3,91.8 to 98.8,170
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,64.7,58.0 to 71.4,383
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,78.1,66.4 to 89.9,74
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.3,81.6 to 89.0,947
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,63.6,44.4 to 82.8,74
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.0,57.8 to 84.2,92
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,75.0,68.9 to 81.0,383
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,80.1,68.3 to 91.9,74
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,82.6,74.6 to 90.6,170
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.8,74.6 to 83.0,947
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.5,54.2 to 80.8,92
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,82.1,74.2 to 90.0,170
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.8,86.6 to 92.9,947
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,89.8,84.4 to 95.2,170
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",78.9,67.5 to 90.3,92
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.1,70.7 to 79.5,947
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.5,90.4 to 100.0,206
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.8,50.0 to 77.6,92
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.4,83.7 to 99.1,92
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.8,93.6 to 98.0,947
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,94.3,91.2 to 97.3,383
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,88.9,79.2 to 98.6,74
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,94.5,90.6 to 98.4,170
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.2,71.8 to 88.6,206
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,93.5 to 97.9,947
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.9 to 97.8,941
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.4,83.7 to 99.1,92
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,81.8,76.3 to 87.2,383
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,89.2,79.6 to 98.8,74
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,94.6,91.3 to 98.0,383
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,78.4,65.0 to 91.8,74
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,83.7,71.9 to 95.5,74
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.5,75.2 to 95.8,92
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.5,87.3 to 93.7,947
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,89.1,79.6 to 98.6,74
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,78.1,72.3 to 84.0,383
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,82.8,71.9 to 93.7,74
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.6 to 99.3,941
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,93.8,90.5 to 97.1,383
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.2,82.5 to 90.0,947
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.4,94.3 to 98.5,947
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,93.4,87.7 to 99.2,74
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,93.8,90.3 to 97.4,383
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,96.1,93.0 to 99.3,170
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.4,83.7 to 99.1,92
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,90.7,87.6 to 93.8,941
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.7,81.9 to 99.4,92
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,5 Months,73.6,66.1 to 80.0,337
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,5 Months,88.3,82.0 to 92.6,337
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,5 Months,77.1,69.7 to 83.1,337
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,5 Months,76.8,69.5 to 82.9,337
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,3 Months,86.8,80.7 to 91.2,337
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,51.4,44.1 to 59.1,337
Combined 7 Series,,States/Local Areas,PA-Rest of state,2020,Age,24 Months,66.0,58.7 to 73.1,337
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,24 Months,84.9,78.8 to 90.0,337
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,80.8,74.3 to 86.6,337
Rotavirus,,States/Local Areas,PA-Rest of state,2020,Age,8 Months,77.1,69.8 to 83.1,337
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2020,Age,0-3 Days,82.5,76.1 to 87.4,337
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,90.1,84.6 to 94.3,337
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,89.5,84.1 to 93.7,337
Influenza,,States/Local Areas,PA-Rest of state,2020,Age,24 Months,62.0,54.6 to 69.4,337
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,83.0,76.1 to 88.3,337
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020,Age,19 Months,86.1,79.9 to 90.7,337
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,88.7,82.7 to 92.8,337
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,88.7,82.7 to 92.8,337
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,66.8,59.4 to 73.5,337
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,5 Months,77.4,70.1 to 83.3,337
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,70.3,62.7 to 76.9,337
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,87.3,81.1 to 91.7,337
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020,Age,13 Months,59.7,52.3 to 66.7,337
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,86.2,79.8 to 90.8,337
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,93.5,88.5 to 96.4,337
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020,Age,13 Months,82.6,75.8 to 87.8,337
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,64.7,57.1 to 71.5,337
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,81.9,75.4 to 87.5,337
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,77.8,70.8 to 83.5,337
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,90.7,85.3 to 94.7,337
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,83.6,76.4 to 89.6,337
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020,Age,19 Months,88.2,82.2 to 92.4,337
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,88.5,82.6 to 92.6,337
Hib,Full Series,States/Local Areas,PA-Rest of state,2020,Age,19 Months,67.9,60.4 to 74.5,337
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,90.4,84.9 to 94.0,337
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020,Age,35 Months,88.9,83.4 to 93.2,337
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020,Age,19 Months,88.1,82.0 to 92.3,337
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,89.6,84.2 to 93.8,337
Hib,Full Series,States/Local Areas,PA-Rest of state,2020,Age,35 Months,77.2,69.3 to 84.3,337
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,91.0,86.0 to 94.7,337
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020,Age,35 Months,89.0,83.3 to 93.4,337
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,87.1,80.9 to 92.1,337
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020,Age,35 Months,88.4,82.7 to 92.9,337
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020,Age,24 Months,88.7,83.1 to 93.1,337
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,85.8,79.5 to 90.9,337
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020,Age,24 Months,88.0,82.3 to 92.5,337
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,76.7,69.9 to 83.0,337
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,90.3,85.0 to 94.3,337
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,90.0,84.0 to 93.9,337
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,89.8,84.3 to 94.0,337
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020,Age,7 Months,70.8,63.3 to 77.3,337
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,52.9,45.6 to 60.0,337
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,84.1,77.0 to 89.3,337
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,85.2,78.4 to 90.2,337
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2020,Age,0-2 Days,81.5,75.2 to 86.6,337
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,3 Months,86.2,79.9 to 90.7,337
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,19 Months,84.2,77.6 to 89.1,337
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,19 Months,32.2,26.0 to 39.2,337
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2020,Age,0-1 Days,80.4,73.9 to 85.5,337
Combined 7 Series,,States/Local Areas,PA-Rest of state,2020,Age,35 Months,72.7,64.6 to 80.2,337
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,35 Months,76.1,67.8 to 83.7,337
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,54.1,48.8 to 59.6,743
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,90.4,84.6 to 94.2,337
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,89.0,85.3 to 92.1,743
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,80.4,74.6 to 85.6,743
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,92.1,88.4 to 95.0,743
Influenza,,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,69.9,64.8 to 74.9,743
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,91.1,87.5 to 94.1,743
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,92.6,89.3 to 95.2,743
Hib,Full Series,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,77.6,73.0 to 81.9,743
Combined 7 Series,,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,76.1,70.8 to 81.2,743
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,59.0,53.7 to 64.1,743
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,90.2,86.5 to 92.9,743
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,92.8,89.5 to 95.1,743
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,82.6,78.2 to 86.2,743
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,87.1,83.1 to 90.3,743
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2019-2020,Age,0-2 Days,84.4,80.3 to 87.9,743
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2019-2020,Age,0-1 Days,82.6,78.3 to 86.1,743
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,91.6,88.3 to 94.3,743
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,93.4,90.4 to 95.7,743
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2019-2020,Age,0-3 Days,85.4,81.3 to 88.8,743
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,74.0,69.0 to 78.5,743
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,92.9,89.7 to 95.4,743
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,85.0,80.9 to 88.6,743
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,89.9,86.2 to 92.6,743
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,36.0,31.2 to 41.1,743
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,89.6,85.7 to 92.6,743
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,92.1,88.6 to 94.6,743
Hib,Full Series,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,73.7,68.8 to 78.1,743
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,92.5,89.2 to 95.1,743
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,91.8,88.3 to 94.7,743
Hib,Full Series,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,83.0,78.0 to 87.5,743
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,92.7,89.4 to 95.3,743
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,93.8,90.8 to 96.1,743
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,93.1,89.9 to 95.6,743
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,92.3,89.0 to 94.9,743
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,87.0,82.8 to 90.6,743
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,93.2,90.0 to 95.7,743
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,80.3,75.7 to 84.5,743
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,93.0,89.9 to 95.5,743
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,92.2,88.9 to 94.8,743
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,3 Months,96.7,93.4 to 98.4,743
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2019-2020,Age,3 Months,90.1,86.4 to 92.9,743
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,5 Months,82.0,77.3 to 85.8,743
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,5 Months,81.8,77.2 to 85.7,743
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,5 Months,78.6,73.8 to 82.8,743
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,93.5,90.2 to 95.8,743
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,68.2,63.2 to 72.8,743
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,72.6,67.5 to 77.1,743
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,92.8,89.3 to 95.2,743
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,94.8,91.4 to 96.9,743
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,87.0,82.9 to 90.2,743
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,5 Months,91.2,87.2 to 94.0,743
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,5 Months,81.6,77.0 to 85.4,743
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,74.9,69.9 to 79.3,743
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,90.3,86.3 to 93.2,743
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,90.0,86.0 to 92.9,743
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,89.3,85.1 to 92.4,743
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,64.7,59.5 to 69.5,743
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,92.6,89.1 to 95.0,743
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,13 Months,91.3,87.7 to 93.9,743
Combined 7 Series,,States/Local Areas,PA-Rest of state,2019-2020,Age,24 Months,70.5,65.5 to 75.3,743
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,93.4,90.1 to 95.8,743
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,87.1,82.4 to 91.0,743
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,35 Months,93.2,90.0 to 95.7,743
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,91.7,88.1 to 94.5,575
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2021,Age,0-2 Days,84.6,77.6 to 89.7,238
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,90.8,86.9 to 93.6,575
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,89.5,85.3 to 92.9,575
Rotavirus,,States/Local Areas,PA-Rest of state,2019-2020,Age,8 Months,79.1,74.4 to 83.2,743
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,87.9,81.8 to 92.1,337
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,69.0,61.6 to 75.7,337
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,24 Months,90.8,85.9 to 94.6,337
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,3 Months,94.9,89.6 to 97.6,337
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020,Age,7 Months,59.5,52.2 to 66.4,337
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,3 Months,82.4,75.7 to 87.6,337
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,3 Months,85.5,79.2 to 90.2,337
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,89.2,85.4 to 93.0,941
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,79.8,72.0 to 87.6,383
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.2,92.1 to 100.0,206
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,85.5,78.0 to 93.1,170
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.1,69.8 to 92.5,92
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,78.2 to 93.4,206
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,95.6 to 99.6,206
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,90.8,81.8 to 99.9,74
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,96.4,94.7 to 98.0,941
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,94.0,90.5 to 97.5,383
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,94.9,90.0 to 99.7,74
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,75.2,65.4 to 84.9,170
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,85.7,82.7 to 88.6,1415
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Other,82.3,71.1 to 93.4,74
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,95.3,93.5 to 97.1,1415
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,92.0,88.8 to 95.2,697
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,95.3,93.7 to 97.0,1415
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,76.7,69.6 to 83.7,245
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,94.8,93.0 to 96.7,1415
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,87.8,82.9 to 92.6,473
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,86.0,80.1 to 91.8,245
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,84.1,77.6 to 90.6,473
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,91.1,87.1 to 95.1,697
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,91.8,87.4 to 96.2,245
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,96.4,94.0 to 98.9,473
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,74.9,71.4 to 78.5,1415
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,86.3,83.6 to 89.0,1415
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,90.2,87.6 to 92.7,1415
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,92.0,87.2 to 96.8,245
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,83.9,80.0 to 87.9,1415
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,77.4,74.0 to 80.8,1415
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,94.7,92.7 to 96.6,1415
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,97.9,96.3 to 99.5,697
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,83.0,79.9 to 86.0,1415
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,81.1,75.8 to 86.4,473
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,85.2,81.0 to 89.3,697
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,97.1,94.7 to 99.4,473
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,62.9,55.0 to 70.8,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Poverty,<133% FPL,86.4,81.2 to 91.6,245
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,94.7,91.9 to 97.4,697
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,96.4,94.0 to 98.8,473
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Overall,Overall,84.5,81.5 to 87.5,1415
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,97.4,95.6 to 99.3,697
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,95.9,92.9 to 98.9,473
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,84.8,79.3 to 90.4,242
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,91.9,81.9 to 100.0,51
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.3,84.1 to 90.6,1122
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,79.2,66.3 to 92.0,51
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,77.5,70.5 to 84.5,242
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,95.2,87.1 to 100.0,51
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,93.1 to 98.7,242
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.1,92.9 to 97.4,1122
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,64.3,46.6 to 81.9,51
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,94.7,91.4 to 97.9,242
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,91.9,86.4 to 95.3,238
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,85.1,78.9 to 91.3,242
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.9,83.5 to 90.3,1122
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,72.4,57.5 to 87.3,51
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,97.2,95.0 to 99.5,242
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.8,93.8 to 97.8,1122
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,76.2,60.7 to 91.7,51
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,81.5,73.8 to 89.3,242
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,85.4,79.6 to 91.2,242
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.6,81.0 to 88.2,1122
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,97.3,94.8 to 99.7,242
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.9 to 96.7,1122
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,79.7,65.5 to 93.9,51
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,90.6,85.9 to 95.4,242
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.8,87.9 to 93.8,1122
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.7,80.1 to 87.4,1122
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,81.2,66.3 to 96.0,51
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,82.2,75.9 to 88.6,242
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.9,71.7 to 80.0,1122
Influenza,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,74.5,67.0 to 82.0,242
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,69.9,54.9 to 84.9,51
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.0,73.9 to 82.0,1122
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,89.2,84.7 to 93.6,242
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.9,85.8 to 92.1,1122
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,80.8,66.9 to 94.7,51
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,96.0,93.2 to 98.7,242
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.4,93.3 to 97.4,1122
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,92.5,83.2 to 100.0,51
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.4,91.9 to 96.8,1122
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,94.9,86.8 to 100.0,51
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,90.0,79.8 to 96.3,238
Hib,Full Series,States/Local Areas,PA-Rest of state,2019,Age,19 Months,79.4,72.8 to 84.6,406
Hib,Full Series,States/Local Areas,PA-Rest of state,2018,Age,19 Months,81.1,74.5 to 86.3,426
Hib,Full Series,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,95.7,92.9 to 97.4,832
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,35 Months,95.5,83.7 to 99.5,238
Hib,Full Series,States/Local Areas,PA-Rest of state,2017,Age,19 Months,79.7,72.2 to 85.6,356
Hib,Full Series,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,80.4,75.6 to 84.5,782
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,89.9,84.3 to 94.1,238
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,71.2,62.5 to 78.5,238
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,92.4,87.0 to 95.7,238
Hib,Full Series,States/Local Areas,PA-Rest of state,2021,Age,24 Months,75.9,68.2 to 83.0,238
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,91.5,86.5 to 95.2,238
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2021,Age,24 Months,88.7,82.4 to 93.5,238
Hib,Primary Series,States/Local Areas,PA-Rest of state,2021,Age,24 Months,92.0,87.0 to 95.6,238
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,3 Months,92.3,87.8 to 95.3,238
Hib,Full Series,States/Local Areas,PA-Rest of state,2014,Age,19 Months,71.6,63.4 to 78.6,342
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,68.7,62.4 to 74.4,641
Hib,Full Series,States/Local Areas,PA-Rest of state,2016,Age,19 Months,79.8,72.0 to 85.8,354
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,79.7,74.5 to 84.1,710
Hib,Full Series,States/Local Areas,PA-Rest of state,2015,Age,19 Months,65.8,57.6 to 73.1,299
Hib,Full Series,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,72.7,66.6 to 78.1,653
Hib,Full Series,States/Local Areas,PA-Rest of state,2013,Age,24 Months,84.3,77.4 to 90.0,325
Hib,Full Series,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,81.5,76.4 to 86.0,667
Hib,Full Series,States/Local Areas,PA-Rest of state,2014,Age,24 Months,78.6,71.2 to 85.3,342
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,76.6,70.7 to 82.0,641
Hib,Full Series,States/Local Areas,PA-Rest of state,2012,Age,24 Months,81.6,74.5 to 87.8,331
Hib,Full Series,States/Local Areas,PA-Rest of state,2011,Age,24 Months,86.1,80.6 to 90.7,343
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",50.0,32.9 to 67.0,72
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,61.4,52.4 to 70.3,225
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,78.1,71.9 to 84.2,381
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,80.3,74.9 to 85.7,578
Hib,Full Series,States/Local Areas,PA-Rest of state,2011,Age,19 Months,78.5,75.1 to 81.5,343
Hib,Full Series,States/Local Areas,PA-Rest of state,2012,Age,19 Months,73.7,61.0 to 83.4,331
Hib,Full Series,States/Local Areas,PA-Rest of state,2013,Age,19 Months,77.3,73.0 to 81.1,325
Hib,Full Series,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,74.5,70.6 to 78.0,667
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,74.1,70.2 to 78.1,1184
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,67.4,51.5 to 83.3,48
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.5,65.3 to 85.7,172
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.8,71.1 to 80.5,813
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,71.1,62.2 to 80.0,191
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.8,71.2 to 80.4,945
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,92.7,87.8 to 96.1,238
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,79.4,71.5 to 86.2,238
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,3 Months,92.8,88.3 to 95.6,238
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,19 Months,80.3,72.0 to 86.6,238
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,90.5,86.9 to 93.5,575
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,93.0,87.6 to 96.1,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,91.7,86.2 to 95.1,238
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,85.1,77.8 to 91.1,238
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,71.9,63.3 to 79.1,238
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,5 Months,79.0,73.9 to 83.4,575
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,69.1,63.6 to 74.2,575
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,7 Months,60.3,51.6 to 68.4,238
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,26.3,19.6 to 34.4,238
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,38.9,30.7 to 48.3,238
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,24 Months,86.6,79.7 to 92.1,238
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,83.4,76.2 to 89.4,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,19 Months,92.7,87.3 to 95.9,238
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,92.4,87.6 to 95.9,238
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2021,Age,24 Months,88.5,82.1 to 93.5,238
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018,Age,24 Months,92.9,88.0 to 96.3,426
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,94.6,91.7 to 96.8,832
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,70.0,53.1 to 87.0,62
Combined 7 Series,,States/Local Areas,PA-Rest of state,2015,Age,35 Months,76.7,65.6 to 86.3,299
Combined 7 Series,,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,80.4,74.1 to 86.0,653
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,81.0,76.7 to 85.2,797
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,67.5,59.9 to 75.1,301
Combined 7 Series,,States/Local Areas,PA-Rest of state,2019,Age,35 Months,79.4,72.3 to 85.7,406
Combined 7 Series,,States/Local Areas,PA-Rest of state,2018,Age,35 Months,77.2,70.4 to 83.4,426
Combined 7 Series,,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,78.1,73.4 to 82.6,832
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,77.3,66.3 to 88.3,127
Combined 7 Series,,States/Local Areas,PA-Rest of state,2011,Age,35 Months,79.6,72.8 to 85.7,343
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016,Age,35 Months,84.7,77.4 to 90.6,354
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,83.6,78.6 to 87.9,710
Combined 7 Series,,States/Local Areas,PA-Rest of state,2017,Age,35 Months,82.6,75.5 to 88.7,356
Combined 7 Series,,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,80.0,75.1 to 84.4,782
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014,Age,35 Months,71.3,63.2 to 79.0,342
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,72.9,66.5 to 79.0,641
Combined 7 Series,,States/Local Areas,PA-Rest of state,2013,Age,35 Months,76.2,67.8 to 83.8,325
Combined 7 Series,,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,73.6,67.8 to 79.1,667
Combined 7 Series,,States/Local Areas,PA-Rest of state,2012,Age,35 Months,78.1,70.1 to 85.1,331
Combined 7 Series,,States/Local Areas,PA-Rest of state,2019,Age,24 Months,74.7,67.9 to 81.0,406
Combined 7 Series,,States/Local Areas,PA-Rest of state,2017,Age,24 Months,79.9,72.8 to 86.2,356
Combined 7 Series,,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,77.2,72.3 to 81.7,782
Combined 7 Series,,States/Local Areas,PA-Rest of state,2018,Age,24 Months,74.4,67.6 to 80.7,426
Combined 7 Series,,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,74.5,69.8 to 79.0,832
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017,Age,24 Months,93.3,87.6 to 97.0,356
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,93.1,89.6 to 95.8,782
Hib,Primary Series,States/Local Areas,PA-Rest of state,2011,Age,24 Months,95.0,91.2 to 97.6,343
Hib,Primary Series,States/Local Areas,PA-Rest of state,2012,Age,24 Months,94.2,90.0 to 97.1,331
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013,Age,7 Months,76.3,71.8 to 80.3,325
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,72.5,68.6 to 76.0,667
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016,Age,24 Months,78.5,71.4 to 84.9,354
Combined 7 Series,,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,79.3,74.3 to 83.8,710
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019,Age,35 Months,96.3,92.5 to 98.5,406
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014,Age,24 Months,70.3,62.3 to 78.0,342
Combined 7 Series,,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,69.3,63.2 to 75.3,641
Combined 7 Series,,States/Local Areas,PA-Rest of state,2015,Age,24 Months,68.7,59.4 to 77.7,299
Combined 7 Series,,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,73.6,67.6 to 79.2,653
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018,Age,35 Months,93.0,88.1 to 96.3,426
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,94.6,91.7 to 96.8,832
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016,Age,24 Months,95.2,91.2 to 97.8,354
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,94.3,90.9 to 96.7,710
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015,Age,24 Months,92.4,85.4 to 96.8,299
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,93.8,89.9 to 96.6,653
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014,Age,24 Months,88.5,81.8 to 93.5,342
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,90.5,86.0 to 94.1,641
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013,Age,24 Months,96.1,91.9 to 98.5,325
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,92.3,88.4 to 95.3,667
Hib,Primary Series,States/Local Areas,PA-Rest of state,2012,Age,35 Months,94.2,90.0 to 97.1,331
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014,Age,35 Months,89.9,83.5 to 94.5,342
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,91.5,87.1 to 94.9,641
Hib,Primary Series,States/Local Areas,PA-Rest of state,2011,Age,35 Months,95.0,91.2 to 97.6,343
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019,Age,24 Months,96.3,92.5 to 98.5,406
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013,Age,35 Months,96.1,91.9 to 98.5,325
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,93.1,89.3 to 95.9,667
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015,Age,7 Months,68.8,59.4 to 76.8,299
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,75.7,69.8 to 80.8,653
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014,Age,7 Months,68.6,60.2 to 76.0,342
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,68.7,62.4 to 74.3,641
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015,Age,35 Months,92.4,85.4 to 96.8,299
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,93.8,89.9 to 96.6,653
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017,Age,35 Months,94.8,89.3 to 98.0,356
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,93.9,90.5 to 96.4,782
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.2,91.2 to 97.8,354
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,95.0,91.8 to 97.3,710
Combined 7 Series,,States/Local Areas,PA-Rest of state,2013,Age,24 Months,69.3,61.1 to 77.2,325
Combined 7 Series,,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,69.9,64.1 to 75.4,667
Combined 7 Series,,States/Local Areas,PA-Rest of state,2012,Age,24 Months,71.8,63.9 to 79.2,331
Combined 7 Series,,States/Local Areas,PA-Rest of state,2011,Age,24 Months,74.0,67.1 to 80.4,343
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019,Age,7 Months,75.6,68.8 to 81.4,406
Hib,Primary Series,States/Local Areas,PA-Rest of state,2011,Age,13 Months,92.3,88.7 to 94.7,343
Hib,Primary Series,States/Local Areas,PA-Rest of state,2012,Age,13 Months,85.6,79.9 to 89.9,331
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013,Age,13 Months,90.5,86.7 to 93.3,325
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,87.4,80.9 to 91.9,667
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017,Age,7 Months,78.2,70.4 to 84.4,356
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,75.5,70.3 to 80.0,782
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016,Age,7 Months,82.7,75.6 to 88.1,354
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,80.5,75.4 to 84.7,710
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018,Age,7 Months,72.8,65.6 to 79.0,426
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,74.2,69.3 to 78.5,832
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017,Age,19 Months,92.7,86.2 to 96.3,356
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,92.6,88.7 to 95.2,782
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016,Age,19 Months,95.2,90.7 to 97.5,354
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,93.9,90.3 to 96.3,710
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015,Age,19 Months,92.4,88.3 to 95.1,299
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,93.8,89.5 to 96.4,653
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015,Age,13 Months,89.4,80.6 to 94.5,299
Hib,Primary Series,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,91.1,86.2 to 94.4,653
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014,Age,13 Months,84.3,76.7 to 89.7,342
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,86.8,81.4 to 90.8,641
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018,Age,19 Months,92.5,87.1 to 95.7,426
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,89.7,86.0 to 92.6,832
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019,Age,19 Months,96.1,91.8 to 98.2,406
Hib,Primary Series,States/Local Areas,PA-Rest of state,2012,Age,19 Months,91.6,87.3 to 94.5,331
Hib,Primary Series,States/Local Areas,PA-Rest of state,2011,Age,19 Months,95.0,92.5 to 96.8,343
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013,Age,19 Months,95.2,93.4 to 96.5,325
Hib,Primary Series,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,91.0,82.9 to 95.4,667
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014,Age,19 Months,86.7,79.3 to 91.8,342
Hib,Primary Series,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,89.5,84.5 to 93.1,641
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020,Age,13 Months,65.8,58.5 to 72.4,337
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017,Age,13 Months,87.6,80.5 to 92.4,356
Hib,Primary Series,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,88.0,83.6 to 91.4,782
Hib,Primary Series,States/Local Areas,PA-Rest of state,2019,Age,13 Months,91.1,86.0 to 94.5,406
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018,Age,13 Months,88.4,82.5 to 92.5,426
Hib,Primary Series,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,89.7,86.0 to 92.6,832
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016,Age,13 Months,92.8,87.2 to 96.1,354
Hib,Primary Series,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,90.2,85.9 to 93.3,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,90.0,79.8 to 100.0,170
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,94.0,89.7 to 98.2,170
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,86.7,79.5 to 93.9,170
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,63.2,58.1 to 68.0,743
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,>400% FPL,97.1,95.2 to 99.0,697
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,7 Months,92.9,89.1 to 95.4,743
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,3 Months,94.2,89.9 to 96.7,238
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,84.4,79.3 to 89.6,383
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Poverty,133% to <400% FPL,86.6,81.7 to 91.4,473
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,83.3 to 96.8,206
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019-2020,Age,19 Months,92.0,88.5 to 94.5,743
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,86.0,81.1 to 91.0,578
Rotavirus,,States/Local Areas,PA-Rest of state,2019,Age,8 Months,81.1,74.7 to 86.3,406
Rotavirus,,States/Local Areas,PA-Rest of state,2017,Age,8 Months,78.0,70.2 to 84.3,356
Rotavirus,,States/Local Areas,PA-Rest of state,2017-2018,Age,8 Months,78.8,73.8 to 83.1,782
Rotavirus,,States/Local Areas,PA-Rest of state,2018,Age,8 Months,79.6,72.8 to 85.0,426
Rotavirus,,States/Local Areas,PA-Rest of state,2018-2019,Age,8 Months,80.4,75.8 to 84.3,832
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,67.4,60.0 to 74.9,301
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",54.8,38.4 to 71.2,72
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,69.6,57.7 to 81.5,127
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,65.9,48.8 to 83.1,62
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,87.3,83.7 to 90.9,797
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,81.4,75.6 to 87.2,381
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,77.0,73.1 to 80.9,1184
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,60.0,51.1 to 68.8,225
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,73.3,57.7 to 89.0,48
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.9,73.4 to 82.4,945
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.8,76.3 to 85.3,813
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,75.4,66.7 to 84.2,191
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.9,66.4 to 87.4,172
Rotavirus,,States/Local Areas,PA-Rest of state,2015,Age,8 Months,71.5,62.1 to 79.3,299
Rotavirus,,States/Local Areas,PA-Rest of state,2015-2016,Age,8 Months,78.1,72.2 to 83.0,653
Rotavirus,,States/Local Areas,PA-Rest of state,2016,Age,8 Months,84.7,77.4 to 89.9,354
Rotavirus,,States/Local Areas,PA-Rest of state,2016-2017,Age,8 Months,81.4,76.2 to 85.6,710
Rotavirus,,States/Local Areas,PA-Rest of state,2014,Age,8 Months,71.1,62.5 to 78.4,342
Rotavirus,,States/Local Areas,PA-Rest of state,2014-2015,Age,8 Months,71.3,65.0 to 76.8,641
Rotavirus,,States/Local Areas,PA-Rest of state,2013,Age,8 Months,75.7,67.0 to 82.7,325
Rotavirus,,States/Local Areas,PA-Rest of state,2013-2014,Age,8 Months,73.4,67.4 to 78.6,667
Rotavirus,,States/Local Areas,PA-Rest of state,2012,Age,8 Months,75.4,67.4 to 81.9,331
Rotavirus,,States/Local Areas,PA-Rest of state,2011,Age,8 Months,78.0,71.2 to 83.6,343
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,92.5,87.0 to 95.7,238
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,97.4,90.0 to 99.7,238
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,91.6,88.1 to 94.4,575
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,3 Months,89.0,85.2 to 91.9,575
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,3 Months,88.1,84.0 to 91.2,575
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,56.8,51.0 to 62.3,575
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,89.6,85.7 to 92.6,575
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2021,Age,13 Months,61.4,52.3 to 69.7,238
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,78.7,71.3 to 85.3,575
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,72.2,66.6 to 77.1,575
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,86.8,82.3 to 90.2,575
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,87.5,83.1 to 90.8,575
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,97.7,96.3 to 99.0,941
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,90.8,87.9 to 93.7,941
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,62.7,58.5 to 66.9,1184
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,45.7,36.9 to 54.4,225
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,58.9,51.7 to 66.0,381
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,80.1,75.0 to 85.2,578
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,Hispanic,91.2,85.1 to 97.3,170
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,93.7,91.6 to 95.9,941
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",62.4,57.3 to 67.6,813
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,62.7,53.3 to 72.2,191
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,30.3,15.3 to 45.3,48
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,66.2,61.4 to 71.1,945
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.3,80.6 to 94.0,206
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2021,Age,3 Months,89.3,83.3 to 93.3,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,24 Months,92.7,87.8 to 96.1,238
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,61.6,55.9 to 67.1,575
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,59.8,47.0 to 72.5,127
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.3,62.9 to 83.7,172
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,49.9,42.1 to 57.6,301
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",52.3,35.6 to 68.9,72
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,74.2,69.5 to 78.8,797
Influenza,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,58.3,40.9 to 75.7,62
Influenza,,States/Local Areas,PA-Rest of state,2017,Age,24 Months,73.1,65.8 to 79.9,356
Influenza,,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,73.7,68.7 to 78.4,782
Influenza,,States/Local Areas,PA-Rest of state,2018,Age,24 Months,74.1,67.2 to 80.5,426
Influenza,,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,75.7,70.9 to 80.3,832
Influenza,,States/Local Areas,PA-Rest of state,2016,Age,24 Months,70.7,63.1 to 77.8,354
Influenza,,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,71.9,66.6 to 76.9,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.0,66.8 to 91.1,206
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",70.2,54.8 to 85.6,92
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,87.1,82.1 to 92.1,383
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,94.5,92.6 to 96.5,941
Influenza,,States/Local Areas,PA-Rest of state,2019,Age,24 Months,77.5,70.6 to 83.7,406
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.1,81.9 to 90.4,947
Influenza,,States/Local Areas,PA-Rest of state,2012,Age,24 Months,56.9,48.8 to 65.4,331
Influenza,,States/Local Areas,PA-Rest of state,2011,Age,24 Months,68.8,61.8 to 75.6,343
Influenza,,States/Local Areas,PA-Rest of state,2014,Age,24 Months,56.8,48.5 to 65.4,342
Influenza,,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,53.9,47.9 to 60.3,641
Influenza,,States/Local Areas,PA-Rest of state,2015,Age,24 Months,50.9,42.2 to 60.2,299
Influenza,,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,60.8,54.9 to 66.8,653
Influenza,,States/Local Areas,PA-Rest of state,2013,Age,24 Months,63.2,54.9 to 71.6,325
Influenza,,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,60.0,54.1 to 66.0,667
DTaP,≥4 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,71.9,65.4 to 77.5,268
DTaP,≥4 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,75.7,72.8 to 78.4,263
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,95.9,91.6 to 98.3,429
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,96.4,93.7 to 98.1,876
PCV,≥2 Doses,States/Local Areas,New Mexico,2013,Age,5 Months,79.1,73.5 to 83.7,250
PCV,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,5 Months,78.8,75.4 to 81.9,497
PCV,≥2 Doses,States/Local Areas,New Mexico,2012,Age,5 Months,79.1,73.6 to 83.8,263
PCV,≥2 Doses,States/Local Areas,New Mexico,2011,Age,5 Months,72.0,67.1 to 76.4,268
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,97.1,92.6 to 99.2,253
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,95.8,93.2 to 97.6,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,94.9,91.4 to 97.2,395
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,95.6,92.6 to 97.6,824
Hep A,≥1 Dose,States/Local Areas,New Mexico,2019,Age,19 Months,90.2,85.2 to 93.6,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2011,Age,24 Months,85.5,79.5 to 90.4,268
Hep A,≥1 Dose,States/Local Areas,New Mexico,2013,Age,24 Months,83.6,77.3 to 89.0,250
Hep A,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,24 Months,86.7,82.7 to 90.2,497
Hep A,≥1 Dose,States/Local Areas,New Mexico,2012,Age,24 Months,88.1,82.2 to 92.8,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,93.0,87.3 to 96.8,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,91.2,86.1 to 95.0,268
Hib,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,72.9,67.7 to 77.6,595
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016,Age,19 Months,87.4,82.6 to 91.0,395
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,19 Months,87.1,83.8 to 89.8,824
Hep A,≥1 Dose,States/Local Areas,New Mexico,2015,Age,24 Months,88.3,82.4 to 92.9,253
Hep A,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,24 Months,88.7,85.1 to 91.8,648
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016,Age,24 Months,89.2,84.8 to 92.7,395
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,24 Months,89.2,86.2 to 91.9,824
PCV,≥2 Doses,States/Local Areas,New Mexico,2014,Age,5 Months,78.6,72.1 to 83.9,247
PCV,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,5 Months,77.7,76.1 to 79.3,500
PCV,≥2 Doses,States/Local Areas,New Mexico,2015,Age,5 Months,76.8,69.9 to 82.5,253
PCV,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,5 Months,77.2,72.5 to 81.3,648
PCV,≥2 Doses,States/Local Areas,New Mexico,2016,Age,5 Months,77.5,70.8 to 83.1,395
PCV,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,5 Months,76.2,71.8 to 80.2,824
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,96.7,93.4 to 98.6,447
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,96.7,94.6 to 98.1,821
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019,Age,35 Months,96.5,93.7 to 98.3,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2018,Age,24 Months,91.5,87.3 to 94.7,447
Hep A,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,24 Months,91.2,88.2 to 93.6,821
Hep A,≥1 Dose,States/Local Areas,New Mexico,2019,Age,24 Months,90.9,86.3 to 94.5,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2011,Age,35 Months,87.4,81.5 to 92.2,268
PCV,≥2 Doses,States/Local Areas,New Mexico,2017,Age,5 Months,74.8,68.7 to 80.0,429
PCV,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,5 Months,77.9,73.7 to 81.6,876
Hep A,≥1 Dose,States/Local Areas,New Mexico,2017,Age,19 Months,86.9,81.9 to 90.6,429
Hep A,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,19 Months,87.4,84.1 to 90.1,876
Hep A,≥1 Dose,States/Local Areas,New Mexico,2018,Age,19 Months,88.0,83.2 to 91.6,447
Hep A,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,19 Months,89.1,85.4 to 92.0,671
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,95.8,92.3 to 98.1,250
DTaP,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,94.5,92.1 to 96.4,497
DTaP,≥3 Doses,States/Local Areas,New Mexico,2012,Age,35 Months,96.8,92.9 to 98.9,263
DTaP,≥3 Doses,States/Local Areas,New Mexico,2011,Age,35 Months,95.7,90.4 to 98.5,268
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,93.3,89.6 to 96.1,247
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,95.0,92.3 to 97.0,500
Hep A,≥2 Doses,States/Local Areas,New Mexico,2011,Age,19 Months,20.1,16.3 to 24.6,268
DTaP,≥2 Doses,States/Local Areas,New Mexico,2019,Age,5 Months,86.3,80.1 to 90.8,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,20.5,14.7 to 28.0,250
Hep A,≥2 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,25.1,22.6 to 27.8,497
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,29.8,23.1 to 37.4,247
Hep A,≥2 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,27.3,22.7 to 32.4,500
Hep A,≥2 Doses,States/Local Areas,New Mexico,2012,Age,19 Months,16.3,9.6 to 26.4,263
Hib,≥3 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,92.6,88.9 to 95.4,447
Hib,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,93.3,90.7 to 95.4,821
Hib,≥3 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,93.9,89.9 to 96.6,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,24.8,20.7 to 29.3,253
Hep A,≥2 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,26.8,22.5 to 31.5,648
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016,Age,19 Months,28.9,23.0 to 35.5,395
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,19 Months,28.5,24.5 to 33.0,824
Hib,≥3 Doses,States/Local Areas,New Mexico,2013,Age,35 Months,92.4,86.8 to 96.3,250
Hib,≥3 Doses,States/Local Areas,New Mexico,2013-2014,Age,35 Months,92.2,88.9 to 94.9,497
Hib,≥3 Doses,States/Local Areas,New Mexico,2014,Age,35 Months,91.9,87.7 to 95.1,247
Hib,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,35 Months,93.5,90.4 to 96.0,500
Hib,≥3 Doses,States/Local Areas,New Mexico,2015,Age,35 Months,95.5,90.2 to 98.4,253
Hib,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,35 Months,95.0,92.0 to 97.1,648
Hep A,≥2 Doses,States/Local Areas,New Mexico,2017,Age,19 Months,28.2,22.9 to 34.2,429
Hep A,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,19 Months,27.4,23.8 to 31.5,876
Hib,≥3 Doses,States/Local Areas,New Mexico,2018,Age,35 Months,93.4,89.7 to 96.1,447
Hib,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,35 Months,94.5,91.9 to 96.6,821
Hep A,≥2 Doses,States/Local Areas,New Mexico,2012,Age,24 Months,37.6,29.1 to 47.6,263
DTaP,≥4 Doses,States/Local Areas,New Mexico,2013,Age,19 Months,62.7,52.6 to 71.8,250
DTaP,≥4 Doses,States/Local Areas,New Mexico,2013-2014,Age,19 Months,67.8,64.3 to 71.0,497
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014,Age,19 Months,73.0,65.7 to 79.2,247
DTaP,≥4 Doses,States/Local Areas,New Mexico,2014-2015,Age,19 Months,75.2,70.2 to 79.7,500
DTaP,≥4 Doses,States/Local Areas,New Mexico,2015,Age,19 Months,77.5,73.8 to 80.9,253
DTaP,≥4 Doses,States/Local Areas,New Mexico,2015-2016,Age,19 Months,75.8,71.0 to 80.1,648
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,93.6,91.2 to 95.9,707
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,95.4,92.7 to 98.0,418
Hib,≥3 Doses,States/Local Areas,New Mexico,2016,Age,35 Months,94.6,90.9 to 97.1,395
Hib,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,35 Months,93.3,90.1 to 95.8,824
Hib,≥3 Doses,States/Local Areas,New Mexico,2017,Age,35 Months,91.6,86.3 to 95.4,429
Hib,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,35 Months,92.5,89.3 to 95.1,876
Hep A,≥2 Doses,States/Local Areas,New Mexico,2018,Age,19 Months,26.7,21.8 to 32.2,447
Hep A,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,19 Months,32.1,27.0 to 37.8,671
Hep A,≥2 Doses,States/Local Areas,New Mexico,2019,Age,19 Months,33.1,26.8 to 40.1,374
Hep A,≥2 Doses,States/Local Areas,New Mexico,2011,Age,24 Months,35.2,27.6 to 44.2,268
Hib,≥3 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,93.3,88.1 to 96.7,253
Hib,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,92.7,89.7 to 95.2,648
Hib,≥3 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,92.3,88.4 to 95.2,395
Hib,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,90.4,87.4 to 92.9,824
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019,Age,24 Months,96.5,93.7 to 98.3,374
Hib,≥3 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,88.3,83.4 to 92.3,429
Hib,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,90.4,87.4 to 92.9,876
DTaP,≥2 Doses,States/Local Areas,New Mexico,2017,Age,5 Months,77.9,71.9 to 82.9,429
DTaP,≥2 Doses,States/Local Areas,New Mexico,2017-2018,Age,5 Months,81.3,77.2 to 84.8,876
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.6,86.0 to 95.2,261
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,94.3,91.5 to 97.2,379
DTaP,≥2 Doses,States/Local Areas,New Mexico,2016,Age,5 Months,80.0,73.1 to 85.4,395
DTaP,≥2 Doses,States/Local Areas,New Mexico,2016-2017,Age,5 Months,79.0,74.5 to 82.8,824
DTaP,≥2 Doses,States/Local Areas,New Mexico,2018,Age,5 Months,84.7,78.8 to 89.2,447
DTaP,≥2 Doses,States/Local Areas,New Mexico,2018-2019,Age,5 Months,85.5,81.4 to 88.8,821
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017,Age,24 Months,91.5,87.0 to 94.9,429
DTaP,≥3 Doses,States/Local Areas,New Mexico,2017-2018,Age,24 Months,93.7,91.1 to 95.8,876
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018,Age,24 Months,95.9,93.0 to 97.9,447
DTaP,≥3 Doses,States/Local Areas,New Mexico,2018-2019,Age,24 Months,96.2,94.3 to 97.6,821
Polio,≥2 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,86.0,78.7 to 91.1,238
Hep B,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,92.7,88.9 to 95.2,595
DTaP,≥3 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,62.0,52.9 to 70.3,238
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,89.8,85.2 to 93.0,595
Hib,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,88.1,83.7 to 91.8,595
Hep B,≥2 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,87.8,80.3 to 92.7,238
Hib,≥2 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,85.8,78.5 to 90.9,238
≥1 Dose MMR,,States/Local Areas,New Mexico,2021,Age,35 Months,87.4,79.7 to 93.3,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2017,Age,24 Months,89.3,84.9 to 92.9,429
Hep A,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,24 Months,90.4,87.4 to 92.8,876
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,95.7,92.0 to 99.4,197
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,94.1,91.3 to 96.9,462
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,91.6,88.6 to 94.6,506
Polio,≥3 Doses,States/Local Areas,New Mexico,2014-2017,Overall,Overall,93.1,91.2 to 95.0,1165
Hep A,≥1 Dose,States/Local Areas,New Mexico,2013,Age,19 Months,78.3,71.1 to 84.0,250
Hep A,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,19 Months,81.5,77.8 to 84.7,497
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014,Age,19 Months,84.9,78.6 to 89.6,247
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,19 Months,84.9,80.4 to 88.6,500
Hep A,≥1 Dose,States/Local Areas,New Mexico,2015,Age,19 Months,85.0,79.5 to 89.2,253
Hep A,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,19 Months,86.1,82.0 to 89.4,648
Hep A,≥1 Dose,States/Local Areas,New Mexico,2012,Age,19 Months,84.0,76.5 to 89.4,263
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016,Age,24 Months,94.1,90.8 to 96.6,395
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2017,Age,24 Months,92.9,90.2 to 95.0,824
DTaP,≥1 Dose,States/Local Areas,New Mexico,2019,Age,3 Months,96.3,93.9 to 97.8,374
Hep A,≥1 Dose,States/Local Areas,New Mexico,2011,Age,19 Months,77.6,73.9 to 80.9,268
DTaP,≥1 Dose,States/Local Areas,New Mexico,2017,Age,3 Months,87.2,81.9 to 91.1,429
DTaP,≥1 Dose,States/Local Areas,New Mexico,2017-2018,Age,3 Months,88.4,84.8 to 91.3,876
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014,Age,24 Months,93.3,89.6 to 96.1,247
DTaP,≥3 Doses,States/Local Areas,New Mexico,2014-2015,Age,24 Months,94.3,91.6 to 96.4,500
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015,Age,24 Months,95.3,91.0 to 98.0,253
DTaP,≥3 Doses,States/Local Areas,New Mexico,2015-2016,Age,24 Months,94.7,92.2 to 96.7,648
DTaP,≥1 Dose,States/Local Areas,New Mexico,2018,Age,3 Months,89.7,84.1 to 93.5,447
DTaP,≥1 Dose,States/Local Areas,New Mexico,2018-2019,Age,3 Months,93.0,89.9 to 95.2,821
Hib,Full Series,States/Local Areas,New Mexico,2021,Age,19 Months,69.2,60.1 to 77.0,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014,Age,24 Months,89.8,84.8 to 93.7,247
Hep A,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,24 Months,89.1,85.3 to 92.3,500
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,84.4,79.3 to 88.4,595
DTaP,≥4 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,85.4,78.3 to 91.2,595
PCV,≥4 Doses,States/Local Areas,New Mexico,2020-2021,Age,24 Months,80.9,75.8 to 85.5,595
Hep B,≥3 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,82.6,73.5 to 89.0,238
Hib,≥2 Doses,States/Local Areas,New Mexico,2021,Age,5 Months,72.0,63.3 to 79.3,238
DTaP,≥1 Dose,States/Local Areas,New Mexico,2012,Age,3 Months,85.5,76.2 to 91.5,263
DTaP,≥1 Dose,States/Local Areas,New Mexico,2011,Age,3 Months,86.9,82.2 to 90.5,268
DTaP,≥1 Dose,States/Local Areas,New Mexico,2013,Age,3 Months,86.8,82.7 to 90.1,250
DTaP,≥1 Dose,States/Local Areas,New Mexico,2013-2014,Age,3 Months,88.0,85.2 to 90.4,497
DTaP,≥1 Dose,States/Local Areas,New Mexico,2014,Age,3 Months,89.3,84.4 to 92.8,247
DTaP,≥1 Dose,States/Local Areas,New Mexico,2014-2015,Age,3 Months,89.7,86.2 to 92.4,500
DTaP,≥1 Dose,States/Local Areas,New Mexico,2015,Age,3 Months,90.2,84.4 to 94.0,253
DTaP,≥1 Dose,States/Local Areas,New Mexico,2015-2016,Age,3 Months,89.6,85.8 to 92.5,648
DTaP,≥1 Dose,States/Local Areas,New Mexico,2016,Age,3 Months,89.0,83.3 to 92.9,395
DTaP,≥1 Dose,States/Local Areas,New Mexico,2016-2017,Age,3 Months,88.1,84.4 to 91.0,824
Hib,Primary Series,States/Local Areas,New Mexico,2021,Age,7 Months,64.5,55.5 to 72.5,238
Combined 7 Series,,States/Local Areas,New Mexico,2021,Age,35 Months,90.3,68.6 to 99.1,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",68.0,62.1 to 73.9,454
Hib,≥1 Dose,States/Local Areas,New Mexico,2021,Age,3 Months,85.3,78.0 to 90.5,238
PCV,≥2 Doses,States/Local Areas,New Mexico,2021,Age,5 Months,75.6,67.1 to 82.5,238
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,91.1,87.1 to 95.1,399
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,77.5,72.1 to 82.9,399
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.1,71.3 to 88.8,329
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,93.1,89.5 to 96.6,399
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,82.5,78.7 to 86.4,768
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.6,87.4 to 95.8,329
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.8,78.1 to 89.5,329
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,75.6,69.6 to 81.7,399
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.0 to 96.3,329
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,91.3 to 95.9,768
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,75.8,70.1 to 81.6,768
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,93.7,91.2 to 96.1,768
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,77.4,71.5 to 83.4,399
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.7,88.5 to 96.9,329
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,80.3,76.2 to 84.4,768
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.9,72.4 to 85.3,329
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.9 to 95.1,768
Polio,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,5 Months,82.4,78.0 to 86.1,731
Hib,Primary Series,States/Local Areas,New Mexico,2021,Age,19 Months,86.1,77.7 to 91.7,238
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.7,60.6 to 78.9,164
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,92.1,89.6 to 94.6,865
DTaP,≥2 Doses,States/Local Areas,New Mexico,2020,Age,5 Months,79.0,72.2 to 84.5,357
Hib,≥2 Doses,States/Local Areas,New Mexico,2020,Age,5 Months,76.3,69.3 to 82.1,357
DTaP,≥1 Dose,States/Local Areas,New Mexico,2020,Age,3 Months,89.8,85.1 to 93.2,357
Hep B,≥2 Doses,States/Local Areas,New Mexico,2020,Age,5 Months,91.2,86.5 to 94.3,357
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.2,71.9 to 84.5,329
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,76.7,70.7 to 82.8,399
Influenza,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,57.9,52.9 to 62.9,768
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,64.7,57.7 to 71.8,329
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,64.7,58.2 to 71.2,399
Influenza,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,63.7,56.1 to 71.2,329
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.2,65.7 to 80.7,329
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,78.6,74.1 to 83.2,768
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,90.2,87.2 to 93.2,768
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.5,83.8 to 93.3,329
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,88.3,83.9 to 92.6,399
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,80.1,76.1 to 84.2,768
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,84.1,76.1 to 92.1,399
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.6,88.0 to 95.2,454
Hep A,≥2 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,82.2,75.1 to 88.2,357
≥1 Dose MMR,,States/Local Areas,New Mexico,2020,Age,13 Months,68.7,61.4 to 75.1,357
Combined 7 Series,,States/Local Areas,New Mexico,2020,Age,35 Months,77.9,70.8 to 84.2,357
Hep A,≥2 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,28.1,22.3 to 34.9,357
Hib,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,5 Months,81.2,76.7 to 85.0,731
PCV,≥3 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,88.8,81.5 to 94.1,238
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,92.0,89.0 to 94.2,731
DTaP,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,3 Months,93.2,90.6 to 95.1,731
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,73.0,68.0 to 77.4,731
Polio,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,94.3,91.9 to 96.0,731
DTaP,≥4 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,73.2,68.3 to 77.6,731
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,64.3,60.1 to 68.5,900
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,92.6,90.2 to 95.0,900
Influenza,,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,80.9,74.3 to 87.5,287
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,73.5,68.8 to 78.2,582
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,93.2,89.1 to 97.4,287
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,75.1,70.4 to 79.7,582
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,82.4,78.0 to 86.9,627
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,86.7,80.7 to 92.6,287
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,90.4,87.3 to 93.6,582
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,89.7,86.5 to 93.0,582
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,85.6,79.4 to 91.8,287
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,88.1,84.6 to 91.6,582
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,92.9,90.2 to 95.6,627
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,93.4,89.1 to 97.6,287
Influenza,,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,52.5,47.1 to 58.0,582
Influenza,,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,56.1,50.4 to 61.9,627
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,92.2,90.3 to 94.1,1496
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,93.3,91.5 to 95.1,1496
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,94.7,92.5 to 97.0,627
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,90.7,87.5 to 93.9,582
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,95.8,92.4 to 99.2,287
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,71.7,65.2 to 78.3,582
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,74.7,69.9 to 79.5,627
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,67.1,59.4 to 74.8,287
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,83.3,78.8 to 87.8,627
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,90.7,85.7 to 95.7,287
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,91.1,88.4 to 93.8,768
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,72.1,67.2 to 77.1,582
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,78.3,73.0 to 83.6,627
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,90.9 to 95.8,768
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.7,87.2 to 96.3,329
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,91.2,87.1 to 95.3,399
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.7,86.1 to 95.2,329
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,92.1,88.5 to 95.7,399
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,92.6,89.9 to 95.3,768
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,88.3 to 96.7,329
Influenza,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,55.4,48.7 to 62.1,399
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,70.0,65.4 to 74.6,768
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,93.1,89.5 to 96.6,399
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,83.3,78.5 to 88.1,399
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,94.1,91.2 to 96.9,627
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,96.3,93.4 to 99.1,287
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.9,67.5 to 80.3,329
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a Non-MSA,90.0,85.9 to 94.1,399
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Urbanicity,Living In a MSA Principal City,67.6,63.1 to 72.1,768
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Overall,Overall,79.7,76.8 to 82.6,1496
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,94.3,91.7 to 96.8,627
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,74.5,70.1 to 78.9,582
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,93.2,89.3 to 97.1,287
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,62.4,57.3 to 67.4,582
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,77.7,70.7 to 84.7,287
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,94.9,92.3 to 97.6,627
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,69.0,63.5 to 74.4,627
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,97.0,94.4 to 99.6,287
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Overall,Overall,90.7,88.7 to 92.8,1496
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Overall,Overall,77.1,73.9 to 80.3,1496
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Overall,Overall,67.4,64.0 to 70.7,1496
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,79.3,75.1 to 83.6,1496
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,90.1,87.0 to 93.3,582
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Overall,Overall,73.4,70.4 to 76.4,1496
Influenza,,States/Local Areas,New Mexico,2016-2019,Overall,Overall,58.5,54.9 to 62.0,1496
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,90.1,86.8 to 93.3,582
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,93.3,90.2 to 96.4,627
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,86.5,80.4 to 92.7,627
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Overall,Overall,89.3,87.1 to 91.5,1496
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,81.9,73.8 to 90.1,287
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,85.5,81.7 to 89.3,582
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,79.9,77.0 to 82.9,1496
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,92.3,89.4 to 95.2,627
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Overall,Overall,92.6,90.7 to 94.4,1496
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,<133% FPL,74.7,69.9 to 79.5,582
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,92.4,90.4 to 94.4,1496
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,88.5,83.4 to 93.6,287
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,92.7,90.8 to 94.6,1496
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Overall,Overall,79.2,76.2 to 82.2,1496
Influenza,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,55.4,50.9 to 59.9,865
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,92.0,89.6 to 94.4,900
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,95.9,93.6 to 98.1,555
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.6,77.2 to 92.0,164
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,75.6,71.5 to 79.7,865
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,93.2,90.2 to 96.1,555
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,82.1 to 95.0,164
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,77.2,71.4 to 83.0,900
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,86.0,80.9 to 91.2,555
Polio,≥1 Dose,States/Local Areas,New Mexico,2020,Age,3 Months,89.7,84.9 to 93.0,357
Hib,≥1 Dose,States/Local Areas,New Mexico,2020,Age,3 Months,86.8,81.1 to 90.9,357
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,69.8,62.4 to 76.3,357
Hep A,≥1 Dose,States/Local Areas,New Mexico,2020,Age,19 Months,87.7,82.1 to 91.7,357
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2020,Age,0-1 Days,71.5,64.6 to 77.5,357
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2020,Age,0-2 Days,76.3,69.8 to 81.8,357
Hib,≥2 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,88.6,83.1 to 92.5,357
Polio,≥2 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,90.1,85.0 to 93.6,357
Hib,≥3 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,49.1,41.8 to 56.5,357
Hib,Primary Series,States/Local Areas,New Mexico,2020,Age,7 Months,70.4,63.1 to 76.9,357
Hep B,≥2 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,93.2,88.6 to 96.0,357
PCV,≥2 Doses,States/Local Areas,New Mexico,2020,Age,5 Months,74.9,67.7 to 80.8,357
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,94.5,91.0 to 96.9,357
DTaP,≥4 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,82.2,75.9 to 87.7,357
Polio,≥3 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,94.5,91.3 to 96.9,357
≥1 Dose MMR,,States/Local Areas,New Mexico,2020,Age,24 Months,91.8,87.1 to 95.3,357
Hib,≥3 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,91.2,86.7 to 94.6,357
≥1 Dose MMR,,States/Local Areas,New Mexico,2020,Age,35 Months,92.5,87.8 to 95.8,357
Hib,Primary Series,States/Local Areas,New Mexico,2020,Age,35 Months,93.2,88.9 to 96.2,357
Hib,≥3 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,92.0,87.6 to 95.3,357
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,93.4,89.4 to 96.3,357
Hib,Full Series,States/Local Areas,New Mexico,2020,Age,35 Months,85.8,79.9 to 90.6,357
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020,Age,35 Months,93.9,89.8 to 96.7,357
Hib,Primary Series,States/Local Areas,New Mexico,2020,Age,19 Months,91.7,86.8 to 94.8,357
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,91.2,86.4 to 94.4,357
Hib,Full Series,States/Local Areas,New Mexico,2020,Age,19 Months,76.5,69.6 to 82.2,357
PCV,≥3 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,91.4,86.6 to 94.6,357
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,95.3,92.1 to 97.5,357
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020,Age,19 Months,89.5,84.4 to 93.1,357
DTaP,≥4 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,89.4,82.5 to 94.4,357
Polio,≥3 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,95.5,92.4 to 97.6,357
PCV,≥4 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,78.4,71.6 to 84.0,357
PCV,≥3 Doses,States/Local Areas,New Mexico,2020,Age,35 Months,93.2,88.8 to 96.3,357
Hib,≥3 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,77.5,71.2 to 82.8,357
Hib,Primary Series,States/Local Areas,New Mexico,2020,Age,13 Months,89.9,85.0 to 93.3,357
Hep B,≥2 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,94.4,90.5 to 96.7,357
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,88.0,82.5 to 91.9,357
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020,Age,13 Months,65.5,58.2 to 72.1,357
PCV,≥3 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,87.6,81.9 to 91.7,357
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020,Age,7 Months,67.7,60.3 to 74.4,357
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,93.1,89.0 to 95.8,357
DTaP,≥4 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,71.3,64.0 to 77.7,357
Polio,≥3 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,92.4,88.2 to 95.2,357
≥1 Dose MMR,,States/Local Areas,New Mexico,2020,Age,19 Months,89.2,83.7 to 93.0,357
Hib,≥3 Doses,States/Local Areas,New Mexico,2020,Age,19 Months,90.1,85.1 to 93.5,357
Combined 7 Series,,States/Local Areas,New Mexico,2020,Age,24 Months,73.3,66.4 to 79.8,357
Influenza,,States/Local Areas,New Mexico,2020,Age,24 Months,60.1,52.9 to 67.5,357
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2020,Age,0-3 Days,78.0,71.5 to 83.3,357
Rotavirus,,States/Local Areas,New Mexico,2020,Age,8 Months,78.9,72.2 to 84.4,357
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020,Age,24 Months,93.1,88.9 to 96.1,357
PCV,≥3 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,92.2,87.9 to 95.4,357
PCV,≥4 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,82.9,76.8 to 88.1,357
Hep A,≥2 Doses,States/Local Areas,New Mexico,2020,Age,24 Months,56.0,48.4 to 63.9,357
Hep A,≥1 Dose,States/Local Areas,New Mexico,2020,Age,24 Months,91.0,86.2 to 94.6,357
PCV,≥1 Dose,States/Local Areas,New Mexico,2020,Age,3 Months,85.5,79.6 to 90.0,357
Hep B,≥1 Dose,States/Local Areas,New Mexico,2020,Age,3 Months,95.7,92.4 to 97.6,357
Polio,≥2 Doses,States/Local Areas,New Mexico,2020,Age,5 Months,78.3,71.5 to 83.8,357
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,87.9,83.7 to 92.2,555
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,92.8,90.4 to 95.3,865
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,90.8 to 97.5,454
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.9,80.9 to 90.8,454
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,91.9,89.4 to 94.4,900
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,95.8,93.4 to 98.3,555
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,77.0,73.2 to 80.8,900
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,87.8,84.8 to 90.8,865
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,91.9,89.5 to 94.3,900
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,76.1,72.2 to 80.0,900
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,94.0,91.2 to 96.8,555
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.9,90.5 to 97.2,454
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,90.5,87.8 to 93.2,865
Influenza,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.2,56.8 to 79.6,164
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,90.9,88.2 to 93.6,900
Influenza,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,73.2,68.0 to 78.3,555
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.9,90.5 to 97.2,454
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,88.7 to 98.3,164
Influenza,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",61.7,55.2 to 68.1,454
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,77.7,73.8 to 81.6,865
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.2,61.1 to 85.2,164
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.1,78.8 to 89.4,454
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,75.9,72.0 to 79.9,865
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",73.2,67.1 to 79.4,454
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,64.7,60.3 to 69.0,865
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,74.3,70.2 to 78.5,900
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,66.0 to 84.6,164
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.1,80.0 to 90.2,454
Influenza,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,53.2,48.7 to 57.8,900
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,75.1,71.3 to 78.8,865
Polio,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,92.2,89.6 to 94.7,865
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.1,76.9 to 91.3,164
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,84.3,79.6 to 89.1,555
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,96.3,94.0 to 98.5,555
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,90.4,87.9 to 93.0,900
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.4,88.6 to 98.3,164
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,91.6,89.0 to 94.1,865
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,73.6,69.9 to 77.3,900
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.4,87.7 to 95.1,454
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,72.3,67.0 to 77.5,555
Combined 7 Series,,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Private Insurance Only,75.5,70.1 to 80.8,555
≥1 Dose Varicella,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.6,89.3 to 96.0,454
Rotavirus,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.5,77.4 to 87.6,454
DTaP,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.5,89.9 to 99.0,164
≥1 Dose MMR,,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,91.9 to 97.5,454
Hep B,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.4,89.8 to 98.9,164
DTaP,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,5 Months,82.8,78.4 to 86.5,731
PCV,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,3 Months,89.7,86.4 to 92.2,731
Hep B,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,3 Months,97.1,95.4 to 98.2,731
≥1 Dose MMR,,States/Local Areas,New Mexico,2019-2020,Age,24 Months,92.2,89.2 to 94.7,731
Polio,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,95.4,93.3 to 96.9,731
DTaP,≥4 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,83.1,78.9 to 86.9,731
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,95.7,93.7 to 97.3,731
PCV,≥4 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,86.9,83.1 to 90.2,731
PCV,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,94.8,92.4 to 96.7,731
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019-2020,Age,35 Months,95.8,93.2 to 97.5,731
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,95.4,93.1 to 97.1,731
Hib,Primary Series,States/Local Areas,New Mexico,2019-2020,Age,35 Months,95.1,92.8 to 96.9,731
Hib,Full Series,States/Local Areas,New Mexico,2019-2020,Age,35 Months,89.1,85.6 to 92.1,731
Hib,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,94.1,91.3 to 96.2,731
≥1 Dose MMR,,States/Local Areas,New Mexico,2019-2020,Age,35 Months,94.5,91.7 to 96.7,731
Hib,Primary Series,States/Local Areas,New Mexico,2019-2020,Age,19 Months,94.3,91.7 to 96.2,731
Hib,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,90.9,87.6 to 93.4,731
Hep A,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,30.4,26.0 to 35.2,731
≥1 Dose MMR,,States/Local Areas,New Mexico,2019-2020,Age,19 Months,90.6,87.2 to 93.1,731
PCV,≥4 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,84.2,80.3 to 87.7,731
PCV,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,94.3,91.9 to 96.3,731
PCV,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,66.3,61.3 to 71.0,731
Hib,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,49.0,43.9 to 54.2,731
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Mexico,2019-2020,Age,0-3 Days,77.1,72.4 to 81.1,731
Hib,Full Series,States/Local Areas,New Mexico,2019-2020,Age,24 Months,85.3,81.5 to 88.7,731
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019-2020,Age,24 Months,92.4,89.5 to 94.8,731
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,94.5,92.2 to 96.3,731
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2019-2020,Age,0-2 Days,75.4,70.7 to 79.6,731
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2019-2020,Age,0-1 Days,70.1,65.2 to 74.7,731
Hep A,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,19 Months,89.2,85.7 to 91.9,731
PCV,≥4 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,80.4,76.1 to 84.1,731
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,93.6,91.0 to 95.5,731
PCV,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,94.0,91.3 to 95.9,731
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019-2020,Age,19 Months,90.0,86.7 to 92.6,731
Hib,Full Series,States/Local Areas,New Mexico,2019-2020,Age,19 Months,79.1,74.7 to 83.0,731
Combined 7 Series,,States/Local Areas,New Mexico,2019-2020,Age,35 Months,80.7,76.3 to 84.8,731
Hib,Primary Series,States/Local Areas,New Mexico,2019-2020,Age,24 Months,94.8,92.3 to 96.6,731
Hib,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,92.5,89.5 to 94.7,731
Hib,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,92.6,89.7 to 94.9,731
Influenza,,States/Local Areas,New Mexico,2019-2020,Age,24 Months,63.2,58.2 to 68.3,731
Hep A,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,24 Months,57.0,51.7 to 62.4,731
Hep A,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,35 Months,93.6,90.7 to 95.9,731
Hep A,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,83.9,79.1 to 88.2,731
Hep A,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,24 Months,91.2,88.0 to 93.8,731
Hib,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,3 Months,91.6,88.6 to 93.8,731
Polio,≥1 Dose,States/Local Areas,New Mexico,2019-2020,Age,3 Months,93.1,90.6 to 95.0,731
Polio,≥3 Doses,States/Local Areas,New Mexico,2021,Age,35 Months,87.1,79.0 to 93.1,238
Hib,≥3 Doses,States/Local Areas,New Mexico,2021,Age,7 Months,40.5,32.5 to 49.1,238
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,19 Months,94.9,92.6 to 96.5,731
Polio,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,96.4,94.4 to 97.8,731
DTaP,≥4 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,91.1,86.9 to 94.4,731
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,35 Months,96.1,94.2 to 97.6,731
Combined 7 Series,,States/Local Areas,New Mexico,2019-2020,Age,24 Months,75.8,71.3 to 80.1,731
PCV,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,90.4,87.1 to 93.0,731
≥1 Dose Varicella,,States/Local Areas,New Mexico,2019-2020,Age,13 Months,67.3,62.4 to 71.9,731
Hep B,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,96.5,94.4 to 97.8,731
Hep B,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,90.8,87.6 to 93.2,731
Polio,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,93.1,90.3 to 95.1,731
DTaP,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,70.4,65.3 to 75.1,731
PCV,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,5 Months,79.7,75.1 to 83.6,731
Hep B,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,5 Months,92.6,89.2 to 95.0,731
Polio,≥2 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,93.2,89.2 to 95.8,357
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020,Age,13 Months,90.5,85.6 to 93.8,357
Hib,Primary Series,States/Local Areas,New Mexico,2019-2020,Age,13 Months,92.1,89.2 to 94.2,731
Hib,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,95.0,92.5 to 96.7,731
Hib,≥3 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,75.4,70.9 to 79.4,731
≥1 Dose MMR,,States/Local Areas,New Mexico,2019-2020,Age,13 Months,70.7,65.8 to 75.1,731
Polio,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,13 Months,95.3,93.1 to 96.8,731
Hib,≥3 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,84.1,75.7 to 89.9,238
Hib,Primary Series,States/Local Areas,New Mexico,2020-2021,Age,24 Months,89.5,85.1 to 93.0,595
Rotavirus,,States/Local Areas,New Mexico,2017,Age,8 Months,73.5,67.5 to 78.8,429
Rotavirus,,States/Local Areas,New Mexico,2017-2018,Age,8 Months,77.3,73.1 to 81.0,876
Rotavirus,,States/Local Areas,New Mexico,2019,Age,8 Months,85.8,80.3 to 89.9,374
Rotavirus,,States/Local Areas,New Mexico,2018,Age,8 Months,81.1,75.1 to 85.9,447
Rotavirus,,States/Local Areas,New Mexico,2018-2019,Age,8 Months,83.4,79.5 to 86.7,821
DTaP,≥2 Doses,States/Local Areas,New Mexico,2021,Age,5 Months,72.5,63.8 to 79.8,238
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Mexico,2020-2021,Age,0-1 Days,67.7,62.2 to 72.7,595
Polio,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,91.5,87.7 to 94.2,595
Hib,Full Series,States/Local Areas,New Mexico,2020-2021,Age,19 Months,72.9,67.3 to 77.9,595
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Mexico,2020-2021,Age,0-2 Days,71.8,66.4 to 76.7,595
Hib,Full Series,States/Local Areas,New Mexico,2020-2021,Age,35 Months,82.7,77.1 to 87.6,595
Hep B,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,87.0,82.0 to 90.7,595
PCV,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,7 Months,61.8,56.0 to 67.4,595
DTaP,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,13 Months,87.0,82.3 to 90.6,595
Hep B,≥2 Doses,States/Local Areas,New Mexico,2021,Age,5 Months,81.9,73.6 to 88.0,238
≥1 Dose MMR,,States/Local Areas,New Mexico,2021,Age,19 Months,84.1,75.2 to 90.2,238
Hep A,≥2 Doses,States/Local Areas,New Mexico,2020-2021,Age,19 Months,27.5,23.0 to 32.6,595
Polio,≥3 Doses,States/Local Areas,New Mexico,2021,Age,19 Months,85.1,76.6 to 90.8,238
PCV,≥1 Dose,States/Local Areas,New Mexico,2021,Age,3 Months,87.3,80.7 to 91.9,238
Polio,≥2 Doses,States/Local Areas,New Mexico,2021,Age,5 Months,71.6,62.9 to 79.0,238
≥1 Dose Varicella,,States/Local Areas,New Mexico,2021,Age,13 Months,55.0,46.0 to 63.6,238
Hep A,≥1 Dose,States/Local Areas,New Mexico,2020-2021,Age,19 Months,84.4,79.3 to 88.4,595
Hib,≥3 Doses,States/Local Areas,New Mexico,2020-2021,Age,35 Months,88.7,84.2 to 92.4,595
Hib,Primary Series,States/Local Areas,New Mexico,2020-2021,Age,35 Months,90.1,85.7 to 93.6,595
Hib,Primary Series,States/Local Areas,New Mexico,2020-2021,Age,19 Months,89.0,84.3 to 92.3,595
≥1 Dose Varicella,,States/Local Areas,New Mexico,2020-2021,Age,19 Months,86.0,81.0 to 89.9,595
Hep B,≥3 Doses,States/Local Areas,New Mexico,2021,Age,13 Months,80.7,71.7 to 87.3,238
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.9,53.2 to 78.6,129
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,77.8,72.7 to 82.8,525
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.1,68.8 to 81.4,382
≥1 Dose MMR,,States/Local Areas,New Mexico,2020-2021,Age,13 Months,65.4,59.7 to 70.8,595
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,77.7,73.5 to 81.8,644
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,73.7,69.2 to 78.2,707
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,75.3,69.5 to 81.1,462
Rotavirus,,States/Local Areas,New Mexico,2011,Age,8 Months,74.2,66.5 to 80.6,268
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,72.0,66.8 to 77.1,506
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Overall,Overall,75.5,72.1 to 79.0,1165
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,64.6,56.3 to 72.9,261
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,79.6,74.5 to 84.7,379
Rotavirus,,States/Local Areas,New Mexico,2014,Age,8 Months,75.2,68.7 to 80.7,247
Rotavirus,,States/Local Areas,New Mexico,2014-2015,Age,8 Months,75.5,70.6 to 79.8,500
Rotavirus,,States/Local Areas,New Mexico,2012,Age,8 Months,78.6,71.1 to 84.7,263
Rotavirus,,States/Local Areas,New Mexico,2013,Age,8 Months,73.9,66.9 to 79.9,250
Rotavirus,,States/Local Areas,New Mexico,2013-2014,Age,8 Months,74.5,69.8 to 78.8,497
Rotavirus,,States/Local Areas,New Mexico,2015,Age,8 Months,75.8,68.2 to 82.1,253
Rotavirus,,States/Local Areas,New Mexico,2015-2016,Age,8 Months,75.2,70.0 to 79.8,648
Rotavirus,,States/Local Areas,New Mexico,2016,Age,8 Months,74.6,67.2 to 80.9,395
Rotavirus,,States/Local Areas,New Mexico,2016-2017,Age,8 Months,74.1,69.4 to 78.3,824
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,82.3,77.5 to 87.1,418
Rotavirus,,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,88.6,82.9 to 94.4,197
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,89.5 to 98.7,164
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,91.6,88.9 to 94.2,865
Hib,Full Series,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,77.2,73.2 to 81.1,865
Hep A,≥2 Doses,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,Hispanic,77.6,72.3 to 82.9,865
Hep A,≥1 Dose,States/Local Areas,New Mexico,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.5,87.2 to 97.8,164
PCV,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Insurance Coverage,Any Medicaid,77.7,73.9 to 81.5,900
DTaP,≥4 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,133% to <400% FPL,81.9,77.4 to 86.5,627
PCV,≥3 Doses,States/Local Areas,New Mexico,2016-2019,Poverty,>400% FPL,96.9,94.3 to 99.5,287
Combined 7 Series,,States/Local Areas,New Mexico,2014,Age,24 Months,69.9,62.7 to 76.8,247
Combined 7 Series,,States/Local Areas,New Mexico,2014-2015,Age,24 Months,71.1,65.9 to 76.1,500
Hib,Primary Series,States/Local Areas,New Mexico,2019,Age,35 Months,96.6,93.8 to 98.4,374
Combined 7 Series,,States/Local Areas,New Mexico,2016,Age,24 Months,67.9,61.4 to 74.2,395
Combined 7 Series,,States/Local Areas,New Mexico,2016-2017,Age,24 Months,66.3,61.8 to 70.8,824
Hep B,≥2 Doses,States/Local Areas,New Mexico,2019-2020,Age,7 Months,95.2,92.8 to 96.9,731
Hib,Primary Series,States/Local Areas,New Mexico,2018,Age,35 Months,94.5,91.1 to 96.9,447
Hib,Primary Series,States/Local Areas,New Mexico,2018-2019,Age,35 Months,95.6,93.4 to 97.2,821
Combined 7 Series,,States/Local Areas,New Mexico,2015,Age,24 Months,72.1,64.6 to 79.2,253
Combined 7 Series,,States/Local Areas,New Mexico,2015-2016,Age,24 Months,70.1,65.1 to 74.9,648
Combined 7 Series,,States/Local Areas,New Mexico,2017,Age,35 Months,70.1,63.6 to 76.4,429
Combined 7 Series,,States/Local Areas,New Mexico,2017-2018,Age,35 Months,74.2,69.6 to 78.5,876
Combined 7 Series,,States/Local Areas,New Mexico,2016,Age,35 Months,81.1,74.1 to 87.2,395
Combined 7 Series,,States/Local Areas,New Mexico,2016-2017,Age,35 Months,75.8,71.0 to 80.3,824
Combined 7 Series,,States/Local Areas,New Mexico,2018,Age,24 Months,71.9,66.0 to 77.7,447
Combined 7 Series,,States/Local Areas,New Mexico,2018-2019,Age,24 Months,74.8,70.5 to 78.8,821
Combined 7 Series,,States/Local Areas,New Mexico,2017,Age,24 Months,64.5,58.3 to 70.7,429
Combined 7 Series,,States/Local Areas,New Mexico,2017-2018,Age,24 Months,68.1,63.8 to 72.4,876
Combined 7 Series,,States/Local Areas,New Mexico,2019,Age,24 Months,77.6,71.6 to 83.1,374
Hib,Primary Series,States/Local Areas,New Mexico,2018,Age,7 Months,78.5,72.7 to 83.3,447
Hib,Primary Series,States/Local Areas,New Mexico,2018-2019,Age,7 Months,79.5,75.5 to 83.0,821
Hib,Primary Series,States/Local Areas,New Mexico,2019,Age,7 Months,80.6,74.7 to 85.3,374
Hib,Primary Series,States/Local Areas,New Mexico,2016,Age,24 Months,93.8,90.4 to 96.2,395
Hib,Primary Series,States/Local Areas,New Mexico,2016-2017,Age,24 Months,91.6,88.8 to 94.0,824
Hib,Primary Series,States/Local Areas,New Mexico,2018,Age,24 Months,94.2,90.8 to 96.6,447
Hib,Primary Series,States/Local Areas,New Mexico,2018-2019,Age,24 Months,95.4,93.3 to 97.0,821
Hib,Primary Series,States/Local Areas,New Mexico,2013,Age,13 Months,84.4,80.7 to 87.5,250
Hib,Primary Series,States/Local Areas,New Mexico,2013-2014,Age,13 Months,86.1,85.1 to 87.0,497
Hib,Primary Series,States/Local Areas,New Mexico,2012,Age,13 Months,90.0,81.2 to 94.9,263
Hib,Primary Series,States/Local Areas,New Mexico,2011,Age,13 Months,90.8,87.5 to 93.3,268
Hib,Primary Series,States/Local Areas,New Mexico,2014,Age,13 Months,87.8,82.4 to 91.7,247
Hib,Primary Series,States/Local Areas,New Mexico,2014-2015,Age,13 Months,88.7,85.0 to 91.6,500
Hib,Primary Series,States/Local Areas,New Mexico,2015,Age,13 Months,89.6,83.9 to 93.4,253
Hib,Primary Series,States/Local Areas,New Mexico,2015-2016,Age,13 Months,90.1,86.7 to 92.7,648
Hib,Primary Series,States/Local Areas,New Mexico,2013,Age,24 Months,92.4,87.9 to 95.7,250
Hib,Primary Series,States/Local Areas,New Mexico,2013-2014,Age,24 Months,92.6,89.7 to 94.9,497
Hib,Primary Series,States/Local Areas,New Mexico,2014,Age,24 Months,92.7,88.8 to 95.7,247
Hib,Primary Series,States/Local Areas,New Mexico,2014-2015,Age,24 Months,94.0,91.3 to 96.2,500
Hib,Primary Series,States/Local Areas,New Mexico,2015,Age,24 Months,95.3,91.0 to 98.0,253
Hib,Primary Series,States/Local Areas,New Mexico,2015-2016,Age,24 Months,94.6,92.0 to 96.5,648
Hib,Primary Series,States/Local Areas,New Mexico,2017,Age,24 Months,89.2,84.4 to 93.1,429
Hib,Primary Series,States/Local Areas,New Mexico,2017-2018,Age,24 Months,91.7,88.8 to 94.1,876
Hib,Primary Series,States/Local Areas,New Mexico,2013,Age,35 Months,94.7,90.3 to 97.6,250
Hib,Primary Series,States/Local Areas,New Mexico,2013-2014,Age,35 Months,93.8,91.0 to 96.0,497
Hib,Primary Series,States/Local Areas,New Mexico,2019,Age,24 Months,96.6,93.8 to 98.4,374
Hib,Primary Series,States/Local Areas,New Mexico,2011,Age,35 Months,92.8,88.4 to 96.0,268
Hib,Primary Series,States/Local Areas,New Mexico,2014,Age,35 Months,92.9,89.0 to 95.9,247
Hib,Primary Series,States/Local Areas,New Mexico,2014-2015,Age,35 Months,94.9,92.1 to 96.9,500
Hib,Primary Series,States/Local Areas,New Mexico,2012,Age,35 Months,92.9,87.3 to 96.7,263
Combined 7 Series,,States/Local Areas,New Mexico,2012,Age,24 Months,72.2,64.2 to 79.8,263
Combined 7 Series,,States/Local Areas,New Mexico,2013,Age,24 Months,62.7,55.0 to 70.5,250
Combined 7 Series,,States/Local Areas,New Mexico,2013-2014,Age,24 Months,66.4,61.1 to 71.7,497
Hib,Primary Series,States/Local Areas,New Mexico,2017,Age,35 Months,92.4,87.2 to 96.1,429
Hib,Primary Series,States/Local Areas,New Mexico,2017-2018,Age,35 Months,93.5,90.4 to 95.8,876
Combined 7 Series,,States/Local Areas,New Mexico,2011,Age,24 Months,66.1,58.3 to 73.7,268
Hib,Primary Series,States/Local Areas,New Mexico,2015,Age,35 Months,97.2,92.6 to 99.2,253
Hib,Primary Series,States/Local Areas,New Mexico,2015-2016,Age,35 Months,95.7,93.1 to 97.6,648
Combined 7 Series,,States/Local Areas,New Mexico,2012,Age,35 Months,84.8,73.0 to 93.3,263
Combined 7 Series,,States/Local Areas,New Mexico,2013,Age,35 Months,75.0,66.6 to 82.7,250
Combined 7 Series,,States/Local Areas,New Mexico,2013-2014,Age,35 Months,74.7,69.0 to 80.0,497
Hib,Primary Series,States/Local Areas,New Mexico,2019-2020,Age,7 Months,75.0,70.3 to 79.3,731
Combined 7 Series,,States/Local Areas,New Mexico,2011,Age,35 Months,73.4,64.8 to 81.4,268
Hib,Primary Series,States/Local Areas,New Mexico,2016,Age,35 Months,94.5,91.0 to 97.0,395
Hib,Primary Series,States/Local Areas,New Mexico,2016-2017,Age,35 Months,93.7,90.4 to 96.2,824
Combined 7 Series,,States/Local Areas,New Mexico,2015,Age,35 Months,80.2,71.6 to 87.5,253
Combined 7 Series,,States/Local Areas,New Mexico,2015-2016,Age,35 Months,80.7,75.2 to 85.6,648
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Overall,Overall,68.7,65.1 to 72.3,1165
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a Non-MSA,71.0,65.0 to 77.1,379
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Poverty,<133% FPL,62.4,57.0 to 67.9,506
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,Hispanic,68.7,64.0 to 73.4,644
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Principal City,69.9,64.5 to 75.4,525
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Urbanicity,Living In a MSA Non-Principal City,62.2,54.6 to 69.9,261
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"White, Non-Hispanic",68.7,62.0 to 75.4,382
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.1,57.9 to 78.4,129
Combined 7 Series,,States/Local Areas,New Mexico,2018,Age,35 Months,79.0,72.5 to 84.9,447
Combined 7 Series,,States/Local Areas,New Mexico,2018-2019,Age,35 Months,80.3,75.9 to 84.4,821
Combined 7 Series,,States/Local Areas,New Mexico,2019,Age,35 Months,81.6,75.6 to 86.9,374
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Any Medicaid,66.9,62.3 to 71.4,707
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Insurance Coverage,Private Insurance Only,74.7,68.8 to 80.6,418
Hib,Full Series,States/Local Areas,New Mexico,2014,Age,19 Months,74.4,67.4 to 80.3,247
Hib,Full Series,States/Local Areas,New Mexico,2014-2015,Age,19 Months,76.7,71.8 to 81.0,500
Hib,Full Series,States/Local Areas,New Mexico,2013,Age,19 Months,68.0,56.6 to 77.6,250
Hib,Full Series,States/Local Areas,New Mexico,2013-2014,Age,19 Months,71.2,68.6 to 73.6,497
Hib,Full Series,States/Local Areas,New Mexico,2012,Age,19 Months,80.1,76.8 to 83.1,263
Hib,Full Series,States/Local Areas,New Mexico,2011,Age,19 Months,76.9,70.4 to 82.3,268
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Poverty,>400% FPL,77.6,68.8 to 86.4,197
Combined 7 Series,,States/Local Areas,New Mexico,2014-2017,Poverty,133% to <400% FPL,74.1,68.8 to 79.3,462
Hib,Full Series,States/Local Areas,New Mexico,2016,Age,19 Months,78.0,71.6 to 83.2,395
Hib,Full Series,States/Local Areas,New Mexico,2016-2017,Age,19 Months,74.6,70.2 to 78.5,824
Hib,Full Series,States/Local Areas,New Mexico,2015,Age,19 Months,79.0,75.4 to 82.2,253
Hib,Full Series,States/Local Areas,New Mexico,2015-2016,Age,19 Months,78.5,73.8 to 82.6,648
Hib,Full Series,States/Local Areas,New Mexico,2019,Age,19 Months,81.2,75.1 to 86.1,374
Hib,Full Series,States/Local Areas,New Mexico,2018,Age,19 Months,77.0,71.4 to 81.8,447
Hib,Full Series,States/Local Areas,New Mexico,2018-2019,Age,19 Months,97.0,94.6 to 98.3,821
Hib,Full Series,States/Local Areas,New Mexico,2017,Age,19 Months,70.9,64.6 to 76.4,429
Hib,Full Series,States/Local Areas,New Mexico,2017-2018,Age,19 Months,73.9,69.8 to 77.7,876
Hib,Full Series,States/Local Areas,New Mexico,2011,Age,24 Months,82.6,76.2 to 88.1,268
Hib,Full Series,States/Local Areas,New Mexico,2012,Age,24 Months,85.6,78.7 to 91.2,263
Hib,Primary Series,States/Local Areas,New Mexico,2019,Age,13 Months,93.7,89.7 to 96.2,374
Hib,Full Series,States/Local Areas,New Mexico,2014,Age,24 Months,79.6,73.2 to 85.3,247
Hib,Full Series,States/Local Areas,New Mexico,2014-2015,Age,24 Months,82.6,78.3 to 86.6,500
Hib,Full Series,States/Local Areas,New Mexico,2013,Age,24 Months,76.6,69.7 to 82.8,250
Hib,Full Series,States/Local Areas,New Mexico,2013-2014,Age,24 Months,78.1,73.4 to 82.4,497
Hib,Primary Series,States/Local Areas,New Mexico,2011,Age,19 Months,92.4,90.4 to 94.0,268
Hib,Primary Series,States/Local Areas,New Mexico,2012,Age,19 Months,92.9,87.9 to 96.0,263
Hib,Primary Series,States/Local Areas,New Mexico,2018,Age,19 Months,94.1,90.4 to 96.4,447
Hib,Primary Series,States/Local Areas,New Mexico,2018-2019,Age,19 Months,92.7,90.0 to 94.7,821
Hib,Primary Series,States/Local Areas,New Mexico,2016,Age,13 Months,90.7,86.4 to 93.7,395
Hib,Primary Series,States/Local Areas,New Mexico,2016-2017,Age,13 Months,88.5,85.2 to 91.1,824
Hib,Primary Series,States/Local Areas,New Mexico,2017,Age,13 Months,86.0,80.6 to 90.1,429
Hib,Primary Series,States/Local Areas,New Mexico,2017-2018,Age,13 Months,88.9,85.6 to 91.5,876
Hib,Primary Series,States/Local Areas,New Mexico,2018,Age,13 Months,91.7,87.7 to 94.5,447
Hib,Primary Series,States/Local Areas,New Mexico,2018-2019,Age,13 Months,92.7,90.0 to 94.7,821
Hib,Primary Series,States/Local Areas,New Mexico,2013,Age,19 Months,91.2,89.7 to 92.5,250
Hib,Primary Series,States/Local Areas,New Mexico,2013-2014,Age,19 Months,91.1,90.3 to 91.9,497
Hib,Primary Series,States/Local Areas,New Mexico,2019,Age,19 Months,96.5,93.4 to 98.2,374
Hib,Primary Series,States/Local Areas,New Mexico,2014,Age,19 Months,91.1,85.9 to 94.5,247
Hib,Primary Series,States/Local Areas,New Mexico,2014-2015,Age,19 Months,92.5,89.1 to 94.9,500
Combined 7 Series,,States/Local Areas,New Mexico,2014,Age,35 Months,73.4,66.2 to 80.3,247
Combined 7 Series,,States/Local Areas,New Mexico,2014-2015,Age,35 Months,77.0,71.4 to 82.3,500
Hib,Primary Series,States/Local Areas,New Mexico,2014,Age,7 Months,67.2,59.7 to 73.9,247
Hib,Primary Series,States/Local Areas,New Mexico,2014-2015,Age,7 Months,69.5,64.1 to 74.3,500
Hib,Primary Series,States/Local Areas,New Mexico,2015,Age,7 Months,71.8,64.0 to 78.4,253
Hib,Primary Series,States/Local Areas,New Mexico,2015-2016,Age,7 Months,72.4,67.4 to 77.0,648
Hib,Primary Series,States/Local Areas,New Mexico,2015,Age,19 Months,93.9,90.1 to 96.3,253
Hib,Primary Series,States/Local Areas,New Mexico,2015-2016,Age,19 Months,93.8,90.9 to 95.9,648
Hib,Primary Series,States/Local Areas,New Mexico,2016,Age,19 Months,93.7,90.1 to 96.1,395
Hib,Primary Series,States/Local Areas,New Mexico,2016-2017,Age,19 Months,91.4,88.4 to 93.7,824
Hib,Primary Series,States/Local Areas,New Mexico,2017,Age,19 Months,88.9,83.7 to 92.6,429
Hib,Primary Series,States/Local Areas,New Mexico,2017-2018,Age,19 Months,91.5,88.4 to 93.8,876
Hib,Primary Series,States/Local Areas,New Mexico,2016,Age,7 Months,73.1,66.4 to 79.0,395
Hib,Primary Series,States/Local Areas,New Mexico,2016-2017,Age,7 Months,71.9,67.4 to 76.1,824
Hib,Primary Series,States/Local Areas,New Mexico,2017,Age,7 Months,70.6,64.3 to 76.2,429
Hib,Primary Series,States/Local Areas,New Mexico,2017-2018,Age,7 Months,74.5,70.3 to 78.3,876
Hib,Primary Series,States/Local Areas,New Mexico,2012,Age,24 Months,92.9,87.3 to 96.7,263
Hib,Primary Series,States/Local Areas,New Mexico,2011,Age,24 Months,92.8,88.4 to 96.0,268
Hib,Primary Series,States/Local Areas,New Mexico,2013,Age,7 Months,68.2,64.7 to 71.6,250
Hib,Primary Series,States/Local Areas,New Mexico,2013-2014,Age,7 Months,67.7,66.1 to 69.3,497
PCV,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,92.1,90.8 to 93.3,5048
Influenza,,HHS Regions/National,Region 4,2011,Age,24 Months,40.7,37.2 to 44.4,1848
Influenza,,HHS Regions/National,Region 4,2012,Age,24 Months,46.6,43.2 to 50.2,1991
Influenza,,HHS Regions/National,Region 4,2013,Age,24 Months,47.0,43.7 to 50.3,2020
Influenza,,HHS Regions/National,Region 4,2013-2014,Age,24 Months,45.8,43.4 to 48.1,4120
Influenza,,HHS Regions/National,Region 4,2015,Age,24 Months,45.6,42.4 to 48.9,2218
Influenza,,HHS Regions/National,Region 4,2015-2016,Age,24 Months,45.5,43.2 to 47.8,4559
Influenza,,HHS Regions/National,Region 4,2014,Age,24 Months,44.5,41.2 to 48.0,2100
Influenza,,HHS Regions/National,Region 4,2014-2015,Age,24 Months,45.1,42.7 to 47.5,4318
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020-2021,Age,24 Months,89.6,88.1 to 91.1,4478
Hib,Primary Series,HHS Regions/National,Region 4,2021,Age,35 Months,92.9,90.7 to 94.7,1813
Polio,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,5 Months,78.3,76.2 to 80.4,4478
Hep B,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,5 Months,88.2,86.6 to 89.7,4478
Combined 7 Series,,HHS Regions/National,Region 4,2020-2021,Age,35 Months,71.0,68.5 to 73.4,4478
≥1 Dose MMR,,HHS Regions/National,Region 4,2020-2021,Age,24 Months,89.7,88.2 to 91.2,4478
Polio,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,93.4,91.9 to 94.7,4478
Hib,Primary Series,HHS Regions/National,Region 4,2020-2021,Age,13 Months,83.5,81.5 to 85.3,4478
DTaP,≥3 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,95.7,92.1 to 97.9,1813
Polio,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,88.0,86.2 to 89.6,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,87.9,86.2 to 89.4,4478
Hib,Full Series,HHS Regions/National,Region 4,2021,Age,35 Months,76.4,72.7 to 79.9,1813
Combined 7 Series,,HHS Regions/National,Region 4,2020-2021,Age,24 Months,66.0,63.6 to 68.3,4478
DTaP,≥4 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,69.0,66.7 to 71.3,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,67.5,63.9 to 71.0,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,91.9,90.4 to 93.2,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,92.1,90.4 to 93.5,4478
DTaP,≥4 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,85.0,81.5 to 88.2,1813
Influenza,,HHS Regions/National,Region 4,2020-2021,Age,24 Months,43.0,40.6 to 45.4,4478
PCV,≥4 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,83.2,81.1 to 85.1,4478
PCV,≥4 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,76.4,74.2 to 78.5,4478
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,61.7,59.3 to 64.0,4478
Hep B,≥3 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,92.5,90.1 to 94.5,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,91.2,89.6 to 92.5,4478
Hib,Primary Series,HHS Regions/National,Region 4,2021,Age,13 Months,82.4,79.2 to 85.3,1813
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2020-2021,Age,0-1 Days,74.6,72.4 to 76.6,4478
≥1 Dose MMR,,HHS Regions/National,Region 4,2020-2021,Age,35 Months,92.6,91.0 to 94.0,4478
Hep B,≥2 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,93.9,91.7 to 95.5,1813
Hep B,≥1 Dose,HHS Regions/National,Region 4,2021,Age,3 Months,95.7,94.0 to 97.0,1813
Hib,Primary Series,HHS Regions/National,Region 4,2020-2021,Age,19 Months,91.3,89.8 to 92.6,4478
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,92.9,91.5 to 94.1,4478
DTaP,≥4 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,79.6,77.5 to 81.6,4478
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,94.5,92.9 to 95.9,4478
Rotavirus,,HHS Regions/National,Region 4,2020-2021,Age,8 Months,72.7,70.4 to 74.8,4478
Hib,Full Series,HHS Regions/National,Region 4,2020-2021,Age,19 Months,68.9,66.5 to 71.2,4478
≥1 Dose Varicella,,HHS Regions/National,Region 4,2021,Age,35 Months,93.1,90.3 to 95.3,1813
Hep A,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,19 Months,80.4,78.3 to 82.3,4478
Combined 7 Series,,HHS Regions/National,Region 4,2021,Age,24 Months,66.7,63.0 to 70.4,1813
Polio,≥3 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,92.8,90.6 to 94.7,1813
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2020-2021,Age,0-3 Days,78.5,76.5 to 80.5,4478
Hib,Full Series,HHS Regions/National,Region 4,2020-2021,Age,35 Months,78.3,75.9 to 80.6,4478
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020-2021,Age,19 Months,87.2,85.4 to 88.8,4478
Hib,Primary Series,HHS Regions/National,Region 4,2020-2021,Age,35 Months,93.2,91.8 to 94.5,4478
PCV,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,68.2,65.8 to 70.4,4478
DTaP,≥2 Doses,HHS Regions/National,Region 4,2021,Age,5 Months,79.5,76.2 to 82.4,1813
≥1 Dose Varicella,,HHS Regions/National,Region 4,2021,Age,13 Months,61.4,57.7 to 65.0,1813
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,70.3,67.9 to 72.5,4478
Influenza,,HHS Regions/National,Region 4,2018,Age,24 Months,52.0,48.3 to 55.7,2317
Influenza,,HHS Regions/National,Region 4,2018-2019,Age,24 Months,52.0,49.5 to 54.6,4700
Influenza,,HHS Regions/National,Region 4,2017,Age,24 Months,49.7,46.5 to 53.0,2369
Influenza,,HHS Regions/National,Region 4,2017-2018,Age,24 Months,50.8,48.4 to 53.4,4686
Influenza,,HHS Regions/National,Region 4,2016,Age,24 Months,45.4,42.2 to 48.7,2341
Influenza,,HHS Regions/National,Region 4,2016-2017,Age,24 Months,47.5,45.2 to 49.9,4710
Influenza,,HHS Regions/National,Region 4,2019,Age,24 Months,52.1,48.6 to 55.7,2383
Hep B,≥3 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,87.2,84.5 to 89.6,1813
Influenza,,HHS Regions/National,Region 4,2021,Age,24 Months,42.0,38.4 to 45.8,1813
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,88.5,86.8 to 90.0,4478
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,90.4,88.8 to 91.7,4478
Hep B,≥2 Doses,HHS Regions/National,Region 4,2021,Age,5 Months,88.3,85.6 to 90.5,1813
≥1 Dose MMR,,HHS Regions/National,Region 4,2021,Age,19 Months,87.0,84.3 to 89.4,1813
Hep A,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,25.9,23.9 to 28.1,4478
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2020-2021,Age,0-2 Days,77.6,75.5 to 79.5,4478
DTaP,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,3 Months,87.6,85.7 to 89.2,4478
DTaP,≥3 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,93.1,90.9 to 94.9,1813
Polio,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,93.0,91.6 to 94.2,4478
Hib,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,5 Months,75.8,73.6 to 77.9,4478
≥1 Dose MMR,,HHS Regions/National,Region 4,2020-2021,Age,13 Months,66.1,63.8 to 68.4,4478
Hep B,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,3 Months,95.7,94.6 to 96.5,4478
Hib,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,87.6,85.8 to 89.2,4478
PCV,≥1 Dose,HHS Regions/National,Region 4,2021,Age,3 Months,86.0,83.0 to 88.5,1813
Polio,≥2 Doses,HHS Regions/National,Region 4,2021,Age,5 Months,78.2,74.8 to 81.3,1813
PCV,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,3 Months,85.7,83.8 to 87.4,4478
Polio,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,3 Months,86.8,85.0 to 88.5,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,49.7,47.3 to 52.2,4478
PCV,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,87.2,85.4 to 88.8,4478
≥1 Dose MMR,,HHS Regions/National,Region 4,2020-2021,Age,19 Months,87.3,85.6 to 88.9,4478
Hib,≥3 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,91.4,89.1 to 93.5,1813
Polio,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,92.2,90.8 to 93.5,4478
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2021,Age,0-3 Days,77.6,74.4 to 80.6,1813
Rotavirus,,HHS Regions/National,Region 4,2021,Age,8 Months,73.4,69.8 to 76.6,1813
Hep A,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,76.3,73.0 to 79.5,4478
≥1 Dose MMR,,HHS Regions/National,Region 4,2021,Age,13 Months,66.9,63.2 to 70.3,1813
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020-2021,Age,13 Months,61.4,58.9 to 63.7,4478
Hib,≥2 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,92.9,90.6 to 94.7,1813
DTaP,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,5 Months,79.1,76.9 to 81.0,4478
Hep B,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,7 Months,91.4,89.9 to 92.7,4478
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,91.3,89.8 to 92.6,4478
Hep A,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,24 Months,42.7,40.3 to 45.3,4478
Polio,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,19 Months,91.1,89.6 to 92.5,4478
Hib,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,3 Months,84.0,81.9 to 85.8,4478
Hib,Primary Series,HHS Regions/National,Region 4,2020-2021,Age,7 Months,69.1,66.7 to 71.4,4478
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,90.4,87.6 to 92.7,1423
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,91.8,90.2 to 93.2,2907
Hib,≥3 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,92.1,89.6 to 94.0,1790
Hib,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,76.9,74.3 to 79.3,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,93.3,91.0 to 95.0,1484
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,92.5,90.8 to 93.9,2972
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,91.7,88.7 to 94.0,1488
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,92.1,90.4 to 93.5,2978
Hib,≥3 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,88.4,85.5 to 90.9,1488
Hib,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,88.7,86.7 to 90.4,2978
Polio,≥2 Doses,HHS Regions/National,Region 8,2020,Age,13 Months,93.0,90.9 to 94.7,1697
Polio,≥3 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,91.1,88.4 to 93.3,1488
Polio,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,91.6,89.9 to 93.2,2978
Polio,≥3 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,92.8,90.3 to 94.9,1484
Polio,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,92.0,90.2 to 93.5,2972
Polio,≥3 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,95.2,93.1 to 96.6,1790
Polio,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,71.1,68.2 to 73.8,3413
Polio,≥3 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,94.4,92.4 to 95.8,1623
Polio,≥3 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,90.5,87.6 to 92.9,1500
Polio,≥3 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,92.6,90.0 to 94.7,1498
Hib,≥3 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,88.8,85.8 to 91.2,1484
Hib,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,88.6,86.5 to 90.4,2972
Hib,≥3 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,86.6,83.5 to 89.2,1423
Hib,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,87.7,85.7 to 89.5,2907
Polio,≥3 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,89.9,87.0 to 92.4,1423
Polio,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,91.4,89.6 to 93.1,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,93.7,91.0 to 95.6,1643
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,94.4,92.8 to 95.7,3433
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,92.5,90.3 to 94.3,1490
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,93.1,91.4 to 94.5,3133
Hib,≥3 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,90.7,87.7 to 93.0,1643
Hib,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,91.4,89.5 to 92.9,3433
Polio,≥3 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,92.2,89.9 to 94.2,1490
Polio,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,93.0,91.4 to 94.5,3133
Hib,≥3 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,88.9,86.1 to 91.2,1490
Hib,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,89.8,87.8 to 91.5,3133
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,95.2,93.1 to 96.6,1790
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,93.1,91.6 to 94.3,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,91.5,88.9 to 93.7,1423
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,92.9,91.3 to 94.3,2907
Hib,Full Series,HHS Regions/National,Region 8,2015,Age,24 Months,81.8,78.5 to 84.9,1488
Hib,Full Series,HHS Regions/National,Region 8,2015-2016,Age,24 Months,80.9,78.4 to 83.3,2978
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,94.7,92.8 to 96.1,1623
DTaP,≥3 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,93.4,90.9 to 95.5,1500
Polio,≥3 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,92.0,89.1 to 94.4,1500
DTaP,≥3 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,94.0,91.6 to 95.9,1498
Hib,≥3 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,91.7,89.4 to 93.6,1623
Polio,≥3 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,95.3,93.5 to 96.7,1623
Polio,≥3 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,95.6,93.7 to 97.1,1790
Polio,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,95.4,94.2 to 96.5,3413
Polio,≥3 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,93.8,91.3 to 95.9,1643
Polio,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,94.7,93.1 to 96.0,3433
DTaP,≥2 Doses,HHS Regions/National,Region 8,2014,Age,5 Months,79.3,75.5 to 82.6,1484
DTaP,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,5 Months,80.2,78.2 to 82.0,2972
Hib,Full Series,HHS Regions/National,Region 8,2017,Age,24 Months,82.7,78.8 to 86.2,1643
Hib,Full Series,HHS Regions/National,Region 8,2017-2018,Age,24 Months,82.6,79.9 to 85.1,3433
Hib,Full Series,HHS Regions/National,Region 8,2016,Age,24 Months,80.0,76.2 to 83.5,1490
Hib,Full Series,HHS Regions/National,Region 8,2016-2017,Age,24 Months,81.3,78.6 to 83.8,3133
Polio,≥3 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,94.5,91.8 to 96.5,1498
Polio,≥3 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,91.7,89.0 to 93.9,1488
Polio,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,92.6,90.8 to 94.1,2978
Hib,≥3 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,89.3,86.4 to 91.8,1423
Hib,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,89.6,87.6 to 91.4,2907
Hib,≥3 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,91.4,88.8 to 93.7,1498
Hib,≥3 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,91.6,89.0 to 93.9,1500
Polio,≥3 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,94.5,91.9 to 96.4,1643
Polio,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,95.5,93.9 to 96.7,3433
Polio,≥3 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,93.5,91.1 to 95.5,1490
Polio,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,94.0,92.3 to 95.4,3133
DTaP,≥2 Doses,HHS Regions/National,Region 8,2015,Age,5 Months,81.1,77.5 to 84.2,1488
DTaP,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,5 Months,81.0,78.4 to 83.4,2978
DTaP,≥2 Doses,HHS Regions/National,Region 8,2013,Age,5 Months,80.0,76.8 to 83.0,1423
DTaP,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,5 Months,79.7,77.5 to 81.6,2907
DTaP,≥2 Doses,HHS Regions/National,Region 8,2012,Age,5 Months,78.6,74.2 to 82.4,1498
DTaP,≥2 Doses,HHS Regions/National,Region 8,2011,Age,5 Months,81.7,79.0 to 84.1,1500
Hib,Full Series,HHS Regions/National,Region 8,2014,Age,35 Months,83.3,79.7 to 86.5,1484
Hib,Full Series,HHS Regions/National,Region 8,2014-2015,Age,35 Months,84.3,81.8 to 86.6,2972
Hib,Full Series,HHS Regions/National,Region 8,2018,Age,24 Months,82.5,78.8 to 85.9,1790
Hib,Full Series,HHS Regions/National,Region 8,2018-2019,Age,24 Months,81.6,79.1 to 83.9,3413
Hib,Full Series,HHS Regions/National,Region 8,2011,Age,35 Months,82.8,79.0 to 86.3,1500
Hib,Full Series,HHS Regions/National,Region 8,2012,Age,35 Months,83.9,80.3 to 87.2,1498
Hib,Full Series,HHS Regions/National,Region 8,2013,Age,35 Months,83.5,80.0 to 86.7,1423
Hib,Full Series,HHS Regions/National,Region 8,2013-2014,Age,35 Months,83.4,80.9 to 85.7,2907
Polio,≥3 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,94.0,91.6 to 95.9,1484
Polio,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,92.9,91.2 to 94.5,2972
Polio,≥3 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,93.3,90.1 to 95.7,1423
Polio,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,93.9,91.8 to 95.6,2907
Hib,Full Series,HHS Regions/National,Region 8,2019,Age,24 Months,80.6,77.2 to 83.8,1623
Hib,Full Series,HHS Regions/National,Region 8,2015,Age,35 Months,85.7,82.0 to 88.9,1488
Hib,Full Series,HHS Regions/National,Region 8,2015-2016,Age,35 Months,84.1,81.5 to 86.5,2978
Hib,Full Series,HHS Regions/National,Region 8,2017,Age,35 Months,89.3,85.3 to 92.6,1643
Hib,Full Series,HHS Regions/National,Region 8,2017-2018,Age,35 Months,87.2,84.4 to 89.7,3433
Hib,Full Series,HHS Regions/National,Region 8,2016,Age,35 Months,82.8,79.0 to 86.2,1490
Hib,Full Series,HHS Regions/National,Region 8,2016-2017,Age,35 Months,85.9,83.1 to 88.5,3133
Hib,Full Series,HHS Regions/National,Region 8,2019,Age,35 Months,84.8,81.4 to 87.9,1623
Polio,≥3 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,96.4,94.5 to 97.8,1790
Polio,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,96.4,95.2 to 97.4,3413
Hib,Full Series,HHS Regions/National,Region 8,2018,Age,35 Months,85.3,81.5 to 88.6,1790
Hib,Full Series,HHS Regions/National,Region 8,2018-2019,Age,35 Months,85.0,82.5 to 87.3,3413
Polio,≥3 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,96.4,94.8 to 97.7,1623
Hib,Primary Series,HHS Regions/National,Region 8,2011,Age,7 Months,75.7,72.1 to 78.9,1500
≥1 Dose Varicella,,HHS Regions/National,Region 8,2011,Age,35 Months,89.4,86.0 to 92.2,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2017,Age,35 Months,89.7,86.7 to 92.3,1643
Hep A,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,35 Months,91.0,88.9 to 92.8,3433
Polio,≥2 Doses,HHS Regions/National,Region 8,2016,Age,5 Months,79.4,75.5 to 82.9,1490
Polio,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,5 Months,82.6,80.0 to 84.9,3133
Polio,≥2 Doses,HHS Regions/National,Region 8,2017,Age,5 Months,85.8,82.5 to 88.5,1643
Polio,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,5 Months,86.2,84.0 to 88.1,3433
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,70.7,66.6 to 74.4,1484
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,70.2,67.4 to 72.9,2972
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,69.8,65.8 to 73.6,1488
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,69.9,67.0 to 72.7,2978
Hep A,≥2 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,36.5,32.3 to 41.1,1498
Hep A,≥1 Dose,HHS Regions/National,Region 8,2013,Age,35 Months,88.4,85.2 to 91.2,1423
Hep A,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,35 Months,87.9,85.6 to 89.9,2907
Hep A,≥1 Dose,HHS Regions/National,Region 8,2014,Age,35 Months,87.5,84.3 to 90.3,1484
Hep A,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,35 Months,87.0,84.6 to 89.1,2972
DTaP,≥4 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,84.0,80.8 to 86.9,1484
DTaP,≥4 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,81.7,79.2 to 84.0,2972
DTaP,≥4 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,78.5,74.6 to 82.2,1490
DTaP,≥4 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,79.7,76.9 to 82.4,3133
DTaP,≥4 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,79.3,75.7 to 82.8,1488
DTaP,≥4 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,78.9,76.2 to 81.5,2978
Hep A,≥1 Dose,HHS Regions/National,Region 8,2016,Age,35 Months,89.5,86.3 to 92.3,1490
Hep A,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,35 Months,89.7,87.5 to 91.6,3133
DTaP,≥4 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,83.6,80.2 to 86.8,1790
DTaP,≥4 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,83.2,80.9 to 85.4,3413
DTaP,≥4 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,81.0,76.8 to 84.8,1643
DTaP,≥4 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,82.3,79.6 to 84.8,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2012,Age,13 Months,56.5,53.3 to 59.6,1498
≥1 Dose MMR,,HHS Regions/National,Region 8,2011,Age,13 Months,54.8,50.0 to 59.5,1500
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016,Age,13 Months,57.1,52.6 to 61.4,1490
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016-2017,Age,13 Months,58.7,55.5 to 61.9,3133
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017,Age,13 Months,60.4,55.6 to 65.0,1643
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017-2018,Age,13 Months,61.2,58.0 to 64.3,3433
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015,Age,13 Months,59.4,55.1 to 63.5,1488
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015-2016,Age,13 Months,58.2,55.1 to 61.2,2978
Hib,Primary Series,HHS Regions/National,Region 8,2020,Age,24 Months,93.3,91.3 to 95.0,1697
Hep A,≥2 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,39.6,35.4 to 44.1,1488
Hep A,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,39.9,36.8 to 43.1,2978
Hep A,≥2 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,44.2,39.9 to 48.8,1484
Hep A,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,41.9,38.9 to 45.1,2972
≥1 Dose Varicella,,HHS Regions/National,Region 8,2011,Age,13 Months,54.0,50.2 to 57.7,1500
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013,Age,13 Months,51.1,47.0 to 55.2,1423
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013-2014,Age,13 Months,55.2,52.6 to 57.7,2907
Polio,≥2 Doses,HHS Regions/National,Region 8,2018,Age,5 Months,86.6,83.5 to 89.1,1790
Polio,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,5 Months,86.8,84.7 to 88.6,3413
Hep A,≥1 Dose,HHS Regions/National,Region 8,2019,Age,35 Months,91.7,88.8 to 94.1,1623
Hep A,≥1 Dose,HHS Regions/National,Region 8,2018,Age,35 Months,92.3,89.4 to 94.7,1790
Hep A,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,35 Months,92.0,90.0 to 93.7,3413
≥1 Dose Varicella,,HHS Regions/National,Region 8,2012,Age,13 Months,55.4,52.7 to 58.0,1498
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014,Age,13 Months,59.2,54.9 to 63.4,1484
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014-2015,Age,13 Months,59.3,56.3 to 62.2,2972
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,72.8,68.7 to 76.5,1623
Hep A,≥2 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,75.1,70.2 to 79.8,1484
Hep A,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,74.2,70.5 to 77.8,2972
Hep A,≥2 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,75.2,69.3 to 80.8,1490
Hep A,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,77.1,73.4 to 80.5,3133
Hep A,≥2 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,73.3,67.6 to 78.7,1488
Hep A,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,74.4,70.3 to 78.3,2978
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,71.9,67.8 to 75.6,1790
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,72.3,69.5 to 75.0,3413
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,72.6,68.0 to 76.8,1643
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,72.2,69.2 to 75.1,3433
Polio,≥2 Doses,HHS Regions/National,Region 8,2019,Age,5 Months,87.0,84.0 to 89.4,1623
Polio,≥2 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,88.3,86.1 to 90.1,1498
Polio,≥2 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,87.3,83.7 to 90.2,1500
Hep A,≥2 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,45.4,41.2 to 49.9,1790
Hep A,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,45.4,42.4 to 48.6,3413
Hep A,≥2 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,45.4,41.1 to 49.9,1623
Polio,≥2 Doses,HHS Regions/National,Region 8,2015,Age,5 Months,80.8,77.2 to 83.9,1488
Polio,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,5 Months,80.1,77.5 to 82.5,2978
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,70.0,65.7 to 74.0,1490
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,71.3,68.2 to 74.2,3133
Hep A,≥2 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,65.8,60.7 to 70.8,1500
Hep A,≥2 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,70.7,65.7 to 75.6,1498
Hep A,≥2 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,72.2,67.1 to 77.2,1423
Hep A,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,73.7,70.2 to 77.2,2907
Polio,≥2 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,92.8,90.4 to 94.6,1790
Polio,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,92.8,91.3 to 94.2,3413
Hep B,≥1 Dose,HHS Regions/National,Region 8,2013,Age,3 Months,93.4,91.3 to 95.1,1423
Hep B,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,3 Months,93.8,92.6 to 94.9,2907
Hep B,≥1 Dose,HHS Regions/National,Region 8,2012,Age,3 Months,94.2,92.7 to 95.4,1498
Hep B,≥1 Dose,HHS Regions/National,Region 8,2011,Age,3 Months,92.4,90.1 to 94.2,1500
Polio,≥2 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,89.7,86.8 to 92.0,1490
Polio,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,90.8,88.9 to 92.4,3133
Polio,≥2 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,92.0,89.3 to 94.1,1643
Polio,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,92.4,90.7 to 93.8,3433
Polio,≥2 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,92.9,90.6 to 94.7,1623
Polio,≥2 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,92.0,89.8 to 93.7,1423
Polio,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,92.7,91.2 to 93.9,2907
Hep B,≥1 Dose,HHS Regions/National,Region 8,2014,Age,3 Months,94.2,92.0 to 95.8,1484
Hep B,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,3 Months,94.7,93.3 to 95.8,2972
Hep B,≥1 Dose,HHS Regions/National,Region 8,2015,Age,3 Months,95.2,93.3 to 96.6,1488
Hep B,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,3 Months,94.2,92.5 to 95.5,2978
Hep B,≥1 Dose,HHS Regions/National,Region 8,2016,Age,3 Months,93.1,90.1 to 95.3,1490
Hep B,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,3 Months,94.7,93.0 to 96.0,3133
≥1 Dose MMR,,HHS Regions/National,Region 8,2018,Age,13 Months,71.4,67.3 to 75.2,1790
≥1 Dose MMR,,HHS Regions/National,Region 8,2018-2019,Age,13 Months,71.1,68.2 to 73.8,3413
DTaP,≥4 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,90.8,87.0 to 93.8,1643
DTaP,≥4 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,89.8,87.2 to 92.1,3433
DTaP,≥4 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,86.1,82.5 to 89.3,1490
DTaP,≥4 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,88.5,85.7 to 90.9,3133
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,89.0,85.8 to 91.4,1490
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,89.6,87.3 to 91.5,3133
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,87.8,84.7 to 90.3,1488
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,88.4,86.2 to 90.2,2978
DTaP,≥4 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,87.8,83.9 to 91.2,1488
DTaP,≥4 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,86.9,84.3 to 89.3,2978
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,90.2,86.8 to 92.9,1643
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,90.5,88.4 to 92.3,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2016,Age,13 Months,63.7,59.3 to 67.9,1490
≥1 Dose MMR,,HHS Regions/National,Region 8,2016-2017,Age,13 Months,64.4,61.2 to 67.5,3133
≥1 Dose MMR,,HHS Regions/National,Region 8,2017,Age,13 Months,65.1,60.4 to 69.5,1643
≥1 Dose MMR,,HHS Regions/National,Region 8,2017-2018,Age,13 Months,68.2,65.1 to 71.1,3433
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014,Age,19 Months,88.2,85.5 to 90.5,1484
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014-2015,Age,19 Months,86.9,84.9 to 88.7,2972
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015,Age,19 Months,85.6,81.5 to 88.9,1488
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015-2016,Age,19 Months,85.7,83.4 to 87.6,2978
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013,Age,19 Months,83.6,80.5 to 86.3,1423
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013-2014,Age,19 Months,85.9,83.4 to 88.1,2907
Polio,≥2 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,93.5,92.3 to 94.6,1498
Polio,≥2 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,92.2,89.5 to 94.2,1500
DTaP,≥4 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,82.8,79.5 to 85.8,1623
DTaP,≥4 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,85.2,81.3 to 88.7,1500
Polio,≥2 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,89.7,86.8 to 92.1,1484
Polio,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,89.3,87.2 to 91.1,2972
Polio,≥2 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,86.3,84.3 to 88.1,1423
Polio,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,88.0,86.5 to 89.4,2907
Polio,≥2 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,88.9,85.8 to 91.5,1488
Polio,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,89.3,87.2 to 91.1,2978
Hep B,≥3 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,82.5,78.9 to 85.7,1500
Hep A,≥2 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,80.9,76.3 to 85.0,1790
Hep A,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,80.3,77.0 to 83.4,3413
Hep A,≥2 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,79.3,74.5 to 83.7,1643
Hep A,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,80.0,76.8 to 83.1,3433
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,87.0,84.7 to 89.0,1423
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,87.5,85.8 to 89.1,2907
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,88.1,85.0 to 90.5,1484
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,87.9,85.8 to 89.7,2972
Hep A,≥2 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,79.8,74.8 to 84.3,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,86.2,84.4 to 87.9,1498
DTaP,≥4 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,84.2,80.7 to 87.4,1423
DTaP,≥4 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,86.1,83.8 to 88.3,2907
DTaP,≥4 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,88.0,84.4 to 91.1,1498
DTaP,≥4 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,88.1,84.9 to 90.9,1484
DTaP,≥4 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,87.7,85.3 to 90.0,2972
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018,Age,13 Months,62.0,57.8 to 66.1,1790
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018-2019,Age,13 Months,62.9,59.9 to 65.8,3413
≥1 Dose MMR,,HHS Regions/National,Region 8,2013,Age,13 Months,51.9,47.4 to 56.4,1423
≥1 Dose MMR,,HHS Regions/National,Region 8,2013-2014,Age,13 Months,57.2,55.1 to 59.3,2907
PCV,≥4 Doses,HHS Regions/National,Region 8,2020,Age,35 Months,82.3,79.1 to 85.2,1697
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019,Age,13 Months,63.7,59.4 to 67.8,1623
≥1 Dose Varicella,,HHS Regions/National,Region 8,2011,Age,19 Months,84.5,80.8 to 87.6,1500
≥1 Dose Varicella,,HHS Regions/National,Region 8,2012,Age,19 Months,85.3,83.6 to 87.0,1498
≥1 Dose MMR,,HHS Regions/National,Region 8,2014,Age,13 Months,62.4,58.1 to 66.5,1484
≥1 Dose MMR,,HHS Regions/National,Region 8,2014-2015,Age,13 Months,61.9,58.9 to 64.8,2972
≥1 Dose MMR,,HHS Regions/National,Region 8,2015,Age,13 Months,61.5,57.2 to 65.5,1488
≥1 Dose MMR,,HHS Regions/National,Region 8,2015-2016,Age,13 Months,62.6,59.5 to 65.5,2978
Hep A,≥2 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,43.9,39.1 to 49.0,1643
Hep A,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,44.7,41.4 to 48.0,3433
Hep A,≥2 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,40.1,35.9 to 44.7,1490
Hep A,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,42.0,38.7 to 45.4,3133
DTaP,≥4 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,78.8,75.2 to 82.2,1423
DTaP,≥4 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,81.4,79.0 to 83.7,2907
DTaP,≥4 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,75.9,72.3 to 79.2,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,64.8,60.8 to 68.7,1423
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,67.8,65.1 to 70.3,2907
DTaP,≥4 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,80.3,76.6 to 83.7,1500
DTaP,≥4 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,80.3,76.7 to 83.6,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,66.3,62.0 to 70.3,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,63.4,59.2 to 67.4,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2015,Age,35 Months,86.5,82.9 to 89.6,1488
Hep A,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,35 Months,88.0,85.7 to 90.2,2978
Polio,≥2 Doses,HHS Regions/National,Region 8,2012,Age,5 Months,77.6,72.9 to 81.7,1498
Polio,≥2 Doses,HHS Regions/National,Region 8,2011,Age,5 Months,79.6,76.4 to 82.4,1500
Hep A,≥1 Dose,HHS Regions/National,Region 8,2012,Age,35 Months,87.2,83.9 to 90.1,1498
Polio,≥2 Doses,HHS Regions/National,Region 8,2013,Age,5 Months,77.5,73.5 to 81.1,1423
Polio,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,5 Months,78.2,75.9 to 80.4,2907
Polio,≥2 Doses,HHS Regions/National,Region 8,2014,Age,5 Months,79.0,75.2 to 82.3,1484
Polio,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,5 Months,79.9,78.0 to 81.6,2972
DTaP,≥4 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,74.9,71.0 to 78.5,1790
DTaP,≥4 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,95.7,94.5 to 96.7,3413
Hep A,≥2 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,40.2,35.8 to 44.9,1423
Hep A,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,42.2,39.1 to 45.5,2907
DTaP,≥4 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,69.9,65.7 to 73.9,1490
DTaP,≥4 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,71.3,68.3 to 74.2,3133
DTaP,≥4 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,72.8,68.2 to 76.9,1643
DTaP,≥4 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,73.8,70.9 to 76.6,3433
PCV,≥2 Doses,HHS Regions/National,Region 8,2019,Age,5 Months,86.7,83.6 to 89.2,1623
PCV,≥2 Doses,HHS Regions/National,Region 8,2017,Age,5 Months,84.6,81.2 to 87.5,1643
PCV,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,5 Months,85.4,83.2 to 87.4,3433
PCV,≥2 Doses,HHS Regions/National,Region 8,2018,Age,5 Months,86.3,83.2 to 88.9,1790
PCV,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,5 Months,86.5,84.4 to 88.3,3413
Hib,≥3 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,94.2,92.1 to 95.9,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,94.8,93.0 to 96.2,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,93.0,90.0 to 95.3,1643
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,93.2,91.3 to 94.8,3433
Hep B,≥3 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,87.9,84.7 to 90.8,1500
PCV,≥4 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,82.2,78.8 to 85.3,1498
PCV,≥4 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,83.8,80.5 to 86.8,1484
PCV,≥4 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,83.2,80.8 to 85.4,2972
PCV,≥4 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,81.1,77.4 to 84.5,1423
PCV,≥4 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,82.4,80.0 to 84.7,2907
≥1 Dose MMR,,HHS Regions/National,Region 8,2019,Age,24 Months,93.5,91.3 to 95.3,1623
≥1 Dose MMR,,HHS Regions/National,Region 8,2018,Age,24 Months,92.7,89.9 to 94.9,1790
≥1 Dose MMR,,HHS Regions/National,Region 8,2018-2019,Age,24 Months,93.1,91.4 to 94.6,3413
≥1 Dose MMR,,HHS Regions/National,Region 8,2011,Age,35 Months,89.9,86.6 to 92.7,1500
≥1 Dose MMR,,HHS Regions/National,Region 8,2012,Age,35 Months,92.2,89.2 to 94.7,1498
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016,Age,35 Months,92.9,90.3 to 95.1,1490
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016-2017,Age,35 Months,92.8,90.9 to 94.4,3133
≥1 Dose MMR,,HHS Regions/National,Region 8,2013,Age,35 Months,91.4,88.3 to 93.9,1423
≥1 Dose MMR,,HHS Regions/National,Region 8,2013-2014,Age,35 Months,91.9,90.0 to 93.6,2907
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,93.3,90.9 to 95.3,1790
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,94.1,92.6 to 95.3,3413
Hep B,≥2 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,90.0,87.1 to 92.3,1488
Hep B,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,90.2,88.1 to 91.9,2978
PCV,≥3 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,88.6,85.6 to 91.1,1484
PCV,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,88.5,86.4 to 90.3,2972
PCV,≥3 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,88.3,85.3 to 90.8,1488
PCV,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,88.9,86.9 to 90.7,2978
PCV,≥1 Dose,HHS Regions/National,Region 8,2013,Age,3 Months,83.9,81.1 to 86.5,1423
PCV,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,3 Months,84.8,82.9 to 86.6,2907
PCV,≥4 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,83.5,79.8 to 86.9,1423
PCV,≥4 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,84.8,82.4 to 87.1,2907
Hep B,≥2 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,92.3,89.7 to 94.3,1790
Hep B,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,93.6,92.1 to 94.8,3413
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2019,Age,0-2 Days,82.0,78.3 to 85.2,1623
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2018,Age,0-2 Days,82.7,79.5 to 85.4,1790
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2018-2019,Age,0-2 Days,82.4,80.0 to 84.5,3413
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2017,Age,0-2 Days,78.2,73.8 to 82.0,1643
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2017-2018,Age,0-2 Days,80.4,77.7 to 82.8,3433
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2016,Age,0-2 Days,76.8,72.8 to 80.4,1490
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2016-2017,Age,0-2 Days,77.5,74.6 to 80.2,3133
Hep B,≥2 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,90.4,87.2 to 92.8,1490
Hep B,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,91.2,89.1 to 93.0,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,86.3,82.5 to 89.5,1423
PCV,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,87.5,85.3 to 89.4,2907
Hep B,≥2 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,92.1,88.9 to 94.5,1643
Hep B,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,92.2,90.2 to 93.8,3433
PCV,≥4 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,84.1,80.8 to 87.0,1623
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013,Age,35 Months,89.6,86.4 to 92.4,1423
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013-2014,Age,35 Months,90.7,88.6 to 92.5,2907
≥1 Dose Varicella,,HHS Regions/National,Region 8,2012,Age,35 Months,92.1,89.2 to 94.5,1498
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015,Age,35 Months,90.3,87.2 to 92.9,1488
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015-2016,Age,35 Months,91.6,89.7 to 93.4,2978
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014,Age,35 Months,91.7,89.0 to 93.9,1484
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014-2015,Age,35 Months,91.0,89.0 to 92.7,2972
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2014,Age,0-2 Days,73.5,69.5 to 77.1,1484
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2014-2015,Age,0-2 Days,75.9,73.2 to 78.3,2972
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2015,Age,0-2 Days,78.2,74.7 to 81.4,1488
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2015-2016,Age,0-2 Days,77.5,74.9 to 80.0,2978
PCV,≥4 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,83.9,80.3 to 86.9,1790
PCV,≥4 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,83.9,80.9 to 86.4,2826
PCV,≥4 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,80.3,76.1 to 83.9,1643
PCV,≥4 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,82.0,79.3 to 84.4,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2017,Age,24 Months,92.2,89.5 to 94.5,1643
≥1 Dose MMR,,HHS Regions/National,Region 8,2017-2018,Age,24 Months,92.5,90.6 to 94.1,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2016,Age,24 Months,90.2,87.5 to 92.5,1490
≥1 Dose MMR,,HHS Regions/National,Region 8,2016-2017,Age,24 Months,91.2,89.3 to 92.8,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,89.2,87.9 to 90.3,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,92.2,89.8 to 94.3,1490
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,92.6,90.7 to 94.2,3133
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,89.8,87.1 to 92.2,1488
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,91.0,89.2 to 92.6,2978
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,91.4,88.9 to 93.5,1484
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,90.6,88.8 to 92.2,2972
PCV,≥3 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,79.5,75.9 to 82.7,1623
PCV,≥3 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,88.0,85.0 to 90.5,1500
PCV,≥3 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,76.9,73.0 to 80.3,1790
PCV,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,78.2,75.6 to 80.6,3413
Hep B,≥2 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,91.6,89.2 to 93.6,1484
Hep B,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,90.8,89.0 to 92.4,2972
Hep B,≥2 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,91.0,88.8 to 92.7,1498
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2019,Age,0-1 Days,81.0,77.3 to 84.2,1623
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2011,Age,0-2 Days,70.5,65.2 to 75.3,1500
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2018,Age,0-1 Days,81.3,78.1 to 84.1,1790
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2018-2019,Age,0-1 Days,81.1,78.7 to 83.3,3413
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2013,Age,0-2 Days,74.7,71.2 to 77.8,1423
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2013-2014,Age,0-2 Days,74.1,71.5 to 76.5,2907
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 8,2012,Age,0-2 Days,74.7,70.8 to 78.3,1498
Hep B,≥2 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,89.3,86.7 to 91.4,1423
Hep B,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,90.5,88.6 to 92.0,2907
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,94.0,92.0 to 95.5,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,86.8,83.6 to 89.7,1500
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,90.0,87.2 to 92.4,1423
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,90.7,88.9 to 92.3,2907
PCV,≥3 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,70.3,66.0 to 74.3,1490
PCV,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,73.8,70.9 to 76.6,3133
Hep B,≥3 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,90.5,87.6 to 93.0,1498
PCV,≥3 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,77.5,73.4 to 81.1,1643
PCV,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,77.2,74.4 to 79.7,3433
PCV,≥3 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,72.4,68.5 to 76.0,1488
PCV,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,71.4,68.5 to 74.1,2978
PCV,≥4 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,80.2,76.6 to 83.4,1484
PCV,≥4 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,79.8,77.3 to 82.1,2972
PCV,≥4 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,79.4,75.3 to 83.0,1488
PCV,≥4 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,80.0,77.4 to 82.3,2978
PCV,≥4 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,80.5,76.7 to 83.8,1490
PCV,≥4 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,80.4,77.7 to 82.9,3133
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018,Age,24 Months,91.5,88.5 to 94.0,1790
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018-2019,Age,24 Months,92.0,90.1 to 93.6,3413
≥1 Dose MMR,,HHS Regions/National,Region 8,2015,Age,24 Months,88.0,85.0 to 90.6,1488
≥1 Dose MMR,,HHS Regions/National,Region 8,2015-2016,Age,24 Months,89.1,87.1 to 90.8,2978
≥1 Dose MMR,,HHS Regions/National,Region 8,2014,Age,24 Months,90.7,88.1 to 92.9,1484
≥1 Dose MMR,,HHS Regions/National,Region 8,2014-2015,Age,24 Months,89.3,87.4 to 91.1,2972
≥1 Dose MMR,,HHS Regions/National,Region 8,2013,Age,24 Months,89.2,86.2 to 91.8,1423
≥1 Dose MMR,,HHS Regions/National,Region 8,2013-2014,Age,24 Months,89.9,88.0 to 91.7,2907
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019,Age,24 Months,92.4,90.1 to 94.4,1623
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017,Age,24 Months,90.0,86.9 to 92.6,1643
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017-2018,Age,24 Months,90.7,88.6 to 92.6,3433
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2015,Age,0-1 Days,74.1,70.3 to 77.5,1488
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2015-2016,Age,0-1 Days,73.0,70.2 to 75.6,2978
Hep B,≥2 Doses,HHS Regions/National,Region 8,2018,Age,5 Months,89.6,86.7 to 91.9,1790
Hep B,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,5 Months,90.8,88.9 to 92.3,3413
Hep B,≥2 Doses,HHS Regions/National,Region 8,2019,Age,5 Months,92.0,89.5 to 93.9,1623
Hep B,≥2 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,87.0,83.0 to 90.2,1500
Hep B,≥2 Doses,HHS Regions/National,Region 8,2017,Age,5 Months,88.4,84.5 to 91.4,1643
Hep B,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,5 Months,89.0,86.6 to 90.9,3433
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014,Age,24 Months,89.7,87.1 to 92.0,1484
≥1 Dose Varicella,,HHS Regions/National,Region 8,2014-2015,Age,24 Months,88.7,86.7 to 90.4,2972
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2016,Age,0-1 Days,71.9,67.7 to 75.7,1490
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2016-2017,Age,0-1 Days,73.3,70.3 to 76.2,3133
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2017,Age,0-1 Days,74.8,70.3 to 78.8,1643
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2017-2018,Age,0-1 Days,78.0,75.2 to 80.5,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2017,Age,19 Months,89.5,86.4 to 92.0,1643
≥1 Dose MMR,,HHS Regions/National,Region 8,2017-2018,Age,19 Months,89.9,87.8 to 91.7,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2019,Age,19 Months,91.6,89.0 to 93.6,1623
≥1 Dose MMR,,HHS Regions/National,Region 8,2018,Age,19 Months,90.3,87.2 to 92.7,1790
≥1 Dose MMR,,HHS Regions/National,Region 8,2018-2019,Age,19 Months,95.4,94.1 to 96.4,3413
PCV,≥4 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,75.3,71.4 to 78.8,1423
PCV,≥4 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,77.7,75.0 to 80.3,2907
PCV,≥4 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,79.0,76.1 to 81.6,1498
PCV,≥4 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,78.8,74.3 to 82.7,1500
≥1 Dose MMR,,HHS Regions/National,Region 8,2011,Age,24 Months,87.9,84.7 to 90.8,1500
≥1 Dose MMR,,HHS Regions/National,Region 8,2012,Age,24 Months,88.0,84.8 to 90.8,1498
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015,Age,24 Months,87.6,84.7 to 90.2,1488
≥1 Dose Varicella,,HHS Regions/National,Region 8,2015-2016,Age,24 Months,87.9,85.9 to 89.7,2978
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016,Age,24 Months,88.2,85.3 to 90.7,1490
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016-2017,Age,24 Months,89.0,86.9 to 90.9,3133
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,93.0,90.4 to 94.9,1790
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,91.3,89.6 to 92.8,3413
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,91.6,88.3 to 94.0,1643
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,92.3,90.3 to 93.9,3433
Hep B,≥2 Doses,HHS Regions/National,Region 8,2016,Age,5 Months,86.8,83.4 to 89.7,1490
Hep B,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,5 Months,87.6,85.1 to 89.7,3133
Hep B,≥2 Doses,HHS Regions/National,Region 8,2014,Age,5 Months,87.3,84.3 to 89.7,1484
Hep B,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,5 Months,86.7,85.0 to 88.3,2972
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2012,Age,0-1 Days,71.0,67.3 to 74.4,1498
PCV,≥3 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,66.4,61.8 to 70.6,1423
PCV,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,68.1,65.6 to 70.6,2907
PCV,≥3 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,70.8,66.6 to 74.7,1500
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,91.8,89.3 to 93.8,1490
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,91.7,89.7 to 93.3,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,69.9,65.8 to 73.7,1484
PCV,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,71.1,68.3 to 73.8,2972
PCV,≥3 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,68.7,63.1 to 73.8,1498
≥1 Dose MMR,,HHS Regions/National,Region 8,2019,Age,13 Months,70.7,66.6 to 74.6,1623
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016,Age,19 Months,85.7,82.4 to 88.4,1490
≥1 Dose Varicella,,HHS Regions/National,Region 8,2016-2017,Age,19 Months,86.5,84.2 to 88.5,3133
Polio,≥2 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,92.2,89.6 to 94.2,1488
Polio,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,92.6,90.9 to 93.9,2978
Polio,≥2 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,92.9,90.6 to 94.7,1490
Polio,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,93.5,91.8 to 94.9,3133
Hep B,≥1 Dose,HHS Regions/National,Region 8,2017,Age,3 Months,96.3,94.5 to 97.5,1643
Hep B,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,3 Months,96.2,95.1 to 97.0,3433
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018,Age,19 Months,88.9,85.8 to 91.5,1790
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018-2019,Age,19 Months,62.9,59.9 to 65.8,3413
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017,Age,19 Months,87.3,83.8 to 90.1,1643
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017-2018,Age,19 Months,88.1,85.8 to 90.1,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2013,Age,19 Months,85.8,82.9 to 88.3,1423
≥1 Dose MMR,,HHS Regions/National,Region 8,2013-2014,Age,19 Months,87.4,85.4 to 89.1,2907
≥1 Dose MMR,,HHS Regions/National,Region 8,2014,Age,19 Months,88.9,86.2 to 91.2,1484
≥1 Dose MMR,,HHS Regions/National,Region 8,2014-2015,Age,19 Months,87.1,85.0 to 88.9,2972
≥1 Dose MMR,,HHS Regions/National,Region 8,2012,Age,19 Months,84.7,82.5 to 86.7,1498
DTaP,≥4 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,89.1,85.7 to 92.0,1790
DTaP,≥4 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,89.4,87.1 to 91.4,3413
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019,Age,19 Months,90.4,87.8 to 92.5,1623
Polio,≥2 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,95.5,93.8 to 96.7,1623
Polio,≥2 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,96.0,94.0 to 97.3,1790
Polio,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,95.7,94.5 to 96.7,3413
Polio,≥2 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,94.1,91.4 to 96.0,1643
Polio,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,95.0,93.4 to 96.3,3433
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013,Age,24 Months,87.1,83.9 to 90.0,1423
≥1 Dose Varicella,,HHS Regions/National,Region 8,2013-2014,Age,24 Months,88.4,86.4 to 90.3,2907
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2013,Age,0-1 Days,71.9,68.3 to 75.2,1423
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2013-2014,Age,0-1 Days,71.0,68.2 to 73.6,2907
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2014,Age,0-1 Days,70.1,65.9 to 73.9,1484
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2014-2015,Age,0-1 Days,72.1,69.3 to 74.7,2972
Hep B,≥2 Doses,HHS Regions/National,Region 8,2015,Age,5 Months,86.2,83.0 to 88.9,1488
Hep B,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,5 Months,86.5,84.2 to 88.5,2978
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017,Age,35 Months,92.6,89.9 to 94.9,1643
≥1 Dose Varicella,,HHS Regions/National,Region 8,2017-2018,Age,35 Months,93.4,91.5 to 95.1,3433
DTaP,≥4 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,89.8,86.6 to 92.5,1623
≥1 Dose MMR,,HHS Regions/National,Region 8,2011,Age,19 Months,84.5,81.0 to 87.4,1500
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,91.9,89.5 to 93.8,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,85.8,82.7 to 88.5,1500
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,90.8,88.1 to 93.0,1790
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,91.3,89.6 to 92.8,3413
Hep B,≥3 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,89.7,88.1 to 91.1,1498
Hep A,≥1 Dose,HHS Regions/National,Region 8,2020,Age,35 Months,91.4,88.7 to 93.8,1697
Hep B,≥1 Dose,HHS Regions/National,Region 8,2019,Age,3 Months,97.0,95.3 to 98.1,1623
Polio,≥2 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,93.4,90.7 to 95.3,1484
Polio,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,92.8,91.0 to 94.2,2972
Hep B,≥1 Dose,HHS Regions/National,Region 8,2018,Age,3 Months,96.1,94.6 to 97.2,1790
Hep B,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,3 Months,96.5,95.5 to 97.3,3413
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 8,2011,Age,0-1 Days,66.8,61.4 to 71.8,1500
Hep B,≥2 Doses,HHS Regions/National,Region 8,2012,Age,5 Months,87.5,85.6 to 89.1,1498
Hep B,≥2 Doses,HHS Regions/National,Region 8,2011,Age,5 Months,82.9,79.5 to 85.8,1500
Hep B,≥2 Doses,HHS Regions/National,Region 8,2013,Age,5 Months,85.1,82.2 to 87.7,1423
Hep B,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,5 Months,86.2,84.2 to 88.0,2907
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,89.1,87.4 to 90.6,1423
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,90.1,88.5 to 91.4,2907
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,91.0,88.5 to 93.1,1484
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,90.2,88.4 to 91.8,2972
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,89.4,87.1 to 91.4,1488
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,90.6,88.7 to 92.2,2978
≥1 Dose MMR,,HHS Regions/National,Region 8,2015,Age,19 Months,85.2,81.2 to 88.5,1488
≥1 Dose MMR,,HHS Regions/National,Region 8,2015-2016,Age,19 Months,86.3,84.1 to 88.3,2978
≥1 Dose MMR,,HHS Regions/National,Region 8,2016,Age,19 Months,87.5,84.4 to 90.0,1490
≥1 Dose MMR,,HHS Regions/National,Region 8,2016-2017,Age,19 Months,88.5,86.3 to 90.3,3133
≥1 Dose Varicella,,HHS Regions/National,Region 8,2011,Age,24 Months,86.5,83.3 to 89.4,1500
≥1 Dose Varicella,,HHS Regions/National,Region 8,2012,Age,24 Months,88.2,85.2 to 90.8,1498
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,90.5,87.8 to 92.6,1490
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,91.0,89.1 to 92.6,3133
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,91.5,88.6 to 93.7,1643
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,92.1,90.3 to 93.6,3433
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,90.0,87.1 to 92.2,1488
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,90.2,88.3 to 91.9,2978
DTaP,≥3 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,89.3,86.3 to 91.7,1500
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,79.8,76.2 to 83.0,1623
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,79.5,75.5 to 83.1,1643
DTaP,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,78.7,76.0 to 81.2,3433
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,77.9,74.0 to 81.3,1790
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,78.8,76.2 to 81.2,3413
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2019,Age,0-3 Days,82.7,79.0 to 85.8,1623
Polio,≥1 Dose,HHS Regions/National,Region 8,2019,Age,3 Months,91.1,88.4 to 93.3,1623
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2018,Age,0-3 Days,83.3,80.2 to 86.0,1790
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2018-2019,Age,0-3 Days,83.0,80.6 to 85.1,3413
PCV,≥3 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,95.3,93.4 to 96.9,1623
Hib,≥3 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,58.1,53.9 to 62.3,1790
Hib,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,59.7,56.7 to 62.6,3413
Hib,≥3 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,62.5,57.9 to 66.8,1643
Hib,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,60.3,57.2 to 63.4,3433
Hib,≥2 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,95.1,93.3 to 96.4,1623
Hib,≥2 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,95.7,93.6 to 97.1,1790
Hib,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,95.4,94.1 to 96.4,3413
Hib,≥2 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,94.2,91.5 to 96.1,1643
Hib,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,94.9,93.3 to 96.2,3433
Hib,≥3 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,76.5,71.1 to 81.2,1423
Hib,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,75.7,71.5 to 79.4,2907
Polio,≥3 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,88.8,85.1 to 91.7,1500
Hib,≥3 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,74.9,71.2 to 78.3,1484
Hib,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,76.0,73.4 to 78.4,2972
Hib,≥3 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,83.6,79.0 to 87.3,1500
Hib,≥3 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,82.5,79.5 to 85.2,1498
DTaP,≥3 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,90.9,89.4 to 92.2,1498
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,86.9,83.3 to 89.9,1423
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,88.4,86.5 to 90.0,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,89.8,86.9 to 92.1,1484
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,89.9,87.9 to 91.6,2972
DTaP,≥3 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,93.4,91.3 to 95.0,1623
DTaP,≥3 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,91.6,88.8 to 93.8,1500
DTaP,≥3 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,93.3,91.9 to 94.4,1498
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,92.8,90.4 to 94.6,1790
DTaP,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,93.1,91.6 to 94.3,3413
Hib,≥3 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,61.2,57.0 to 65.2,1623
Hep A,≥2 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,84.2,74.0 to 92.0,888
Polio,≥3 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,91.6,89.9 to 93.0,1498
Polio,≥3 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,88.7,86.8 to 90.4,1423
Polio,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,89.9,88.6 to 91.1,2907
PCV,≥3 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,91.5,88.5 to 93.8,888
Hib,≥3 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,77.1,73.5 to 80.3,1488
Hib,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,75.7,73.1 to 78.2,2978
Hib,≥3 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,74.3,70.3 to 77.9,1490
Hib,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,77.0,74.3 to 79.4,3133
Hib,≥3 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,79.7,76.2 to 82.8,1643
Hib,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,78.0,75.4 to 80.3,3433
Polio,≥3 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,91.1,88.3 to 93.3,1484
Polio,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,90.8,88.9 to 92.5,2972
Polio,≥1 Dose,HHS Regions/National,Region 8,2018,Age,3 Months,91.4,88.9 to 93.5,1790
Polio,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,3 Months,91.3,89.5 to 92.8,3413
Polio,≥1 Dose,HHS Regions/National,Region 8,2017,Age,3 Months,90.4,87.2 to 92.9,1643
Polio,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,3 Months,90.9,88.9 to 92.6,3433
Hib,≥3 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,57.4,53.2 to 61.6,1488
Hib,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,55.5,52.4 to 58.5,2978
Hib,≥3 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,53.5,49.1 to 57.9,1490
Hib,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,57.9,54.7 to 61.0,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,96.0,94.1 to 97.5,1790
PCV,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,95.6,94.3 to 96.7,3413
Hib,≥3 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,55.7,51.4 to 59.9,1484
Hib,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,56.6,53.6 to 59.5,2972
Hib,≥2 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,91.6,89.3 to 93.4,1423
Hib,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,92.2,90.5 to 93.6,2907
PCV,≥3 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,94.1,91.6 to 96.0,1643
PCV,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,95.0,93.5 to 96.3,3433
Hib,≥2 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,92.1,89.4 to 94.1,1488
Hib,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,92.7,91.1 to 94.1,2978
Hib,≥2 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,93.4,91.2 to 95.1,1490
Hib,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,93.8,92.2 to 95.1,3133
Hib,≥2 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,92.7,90.0 to 94.8,1484
Hib,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,92.4,90.6 to 93.9,2972
Hib,≥2 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,92.5,90.1 to 94.3,1623
Hib,≥2 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,93.7,92.1 to 95.1,1498
Hib,≥2 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,93.3,90.2 to 95.4,1500
PCV,≥3 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,92.4,89.7 to 94.6,1484
PCV,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,92.0,90.1 to 93.6,2972
PCV,≥3 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,91.5,88.8 to 93.7,1488
PCV,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,92.2,90.6 to 93.7,2978
PCV,≥3 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,93.0,90.9 to 94.8,1490
PCV,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,93.5,92.0 to 94.9,3133
Hib,≥3 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,59.8,53.8 to 65.4,1498
Hib,≥3 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,65.6,59.7 to 71.1,1500
Hib,≥3 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,55.0,48.3 to 61.5,1423
Hib,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,55.3,50.6 to 60.0,2907
Polio,≥1 Dose,HHS Regions/National,Region 8,2014,Age,3 Months,86.9,83.8 to 89.5,1484
Polio,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,3 Months,87.0,84.9 to 88.9,2972
Polio,≥1 Dose,HHS Regions/National,Region 8,2015,Age,3 Months,87.1,84.0 to 89.7,1488
Polio,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,3 Months,87.7,85.5 to 89.5,2978
Polio,≥1 Dose,HHS Regions/National,Region 8,2016,Age,3 Months,88.2,85.0 to 90.8,1490
Polio,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,3 Months,89.3,87.1 to 91.1,3133
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2017,Age,0-3 Days,77.7,71.3 to 82.9,930
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2017-2018,Age,0-3 Days,81.5,78.8 to 83.8,3433
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2016,Age,0-3 Days,77.8,73.8 to 81.3,1490
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2016-2017,Age,0-3 Days,78.7,75.8 to 81.3,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,95.7,93.8 to 97.2,1790
PCV,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,95.0,93.7 to 96.2,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,74.5,70.7 to 78.0,1488
DTaP,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,73.6,70.8 to 76.2,2978
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,72.1,68.1 to 75.8,1484
DTaP,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,73.3,70.6 to 75.9,2972
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2015,Age,0-3 Days,78.6,75.1 to 81.8,1488
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2015-2016,Age,0-3 Days,78.2,75.6 to 80.6,2978
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,72.7,68.5 to 76.5,1490
DTaP,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,76.1,73.2 to 78.7,3133
Hib,≥2 Doses,HHS Regions/National,Region 8,2016,Age,7 Months,90.2,87.5 to 92.4,1490
Hib,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,7 Months,90.9,89.0 to 92.5,3133
Hib,≥2 Doses,HHS Regions/National,Region 8,2017,Age,7 Months,91.7,88.8 to 93.9,1643
Hib,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,7 Months,92.1,90.3 to 93.6,3433
Hib,≥2 Doses,HHS Regions/National,Region 8,2018,Age,7 Months,92.5,90.1 to 94.3,1790
Hib,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,7 Months,92.5,90.9 to 93.8,3413
Hib,≥2 Doses,HHS Regions/National,Region 8,2015,Age,7 Months,88.8,85.6 to 91.3,1488
Hib,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,7 Months,89.5,87.5 to 91.2,2978
PCV,≥3 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,94.3,92.3 to 96.0,1623
PCV,≥3 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,92.7,90.0 to 94.9,1500
PCV,≥3 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,93.1,90.2 to 95.4,1423
PCV,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,93.0,90.9 to 94.8,2907
PCV,≥3 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,93.6,91.2 to 95.6,1498
PCV,≥1 Dose,HHS Regions/National,Region 8,2018,Age,3 Months,91.0,88.3 to 93.1,1790
PCV,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,3 Months,91.0,89.2 to 92.6,3413
PCV,≥1 Dose,HHS Regions/National,Region 8,2019,Age,3 Months,91.1,88.3 to 93.2,1623
Polio,≥1 Dose,HHS Regions/National,Region 8,2012,Age,3 Months,86.6,82.7 to 89.8,1498
Polio,≥1 Dose,HHS Regions/National,Region 8,2011,Age,3 Months,86.5,83.5 to 88.9,1500
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2013,Age,0-3 Days,75.1,71.3 to 78.6,1423
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2013-2014,Age,0-3 Days,74.7,72.0 to 77.3,2907
Polio,≥1 Dose,HHS Regions/National,Region 8,2013,Age,3 Months,84.7,82.1 to 86.9,1423
Polio,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,3 Months,85.8,84.2 to 87.2,2907
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2014,Age,0-3 Days,74.4,70.4 to 78.0,1484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2014-2015,Age,0-3 Days,76.5,73.9 to 78.9,2972
PCV,≥1 Dose,HHS Regions/National,Region 8,2014,Age,3 Months,85.7,82.4 to 88.4,1484
PCV,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,3 Months,85.8,83.6 to 87.8,2972
PCV,≥1 Dose,HHS Regions/National,Region 8,2015,Age,3 Months,85.9,82.7 to 88.7,1488
PCV,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,3 Months,86.4,84.2 to 88.4,2978
PCV,≥3 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,93.7,91.2 to 95.7,1643
PCV,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,94.7,93.1 to 96.0,3433
PCV,≥3 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,93.0,90.9 to 94.7,1490
PCV,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,93.3,91.7 to 94.7,3133
Hib,≥2 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,88.2,86.2 to 90.0,1498
PCV,≥3 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,91.0,88.4 to 93.3,1488
PCV,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,92.0,90.3 to 93.5,2978
Hib,≥2 Doses,HHS Regions/National,Region 8,2019,Age,5 Months,84.3,81.1 to 87.0,1623
Hib,≥2 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,89.0,85.4 to 91.8,1500
Hib,≥2 Doses,HHS Regions/National,Region 8,2018,Age,5 Months,85.4,82.2 to 88.0,1790
Hib,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,5 Months,84.8,82.7 to 86.8,3413
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,69.9,65.3 to 74.1,1423
DTaP,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,71.0,68.4 to 73.5,2907
DTaP,≥3 Doses,HHS Regions/National,Region 8,2012,Age,7 Months,71.7,65.9 to 76.8,1498
DTaP,≥3 Doses,HHS Regions/National,Region 8,2011,Age,7 Months,75.5,72.1 to 78.7,1500
Hep B,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,93.5,91.6 to 95.2,2168
PCV,≥1 Dose,HHS Regions/National,Region 8,2012,Age,3 Months,84.7,80.1 to 88.4,1498
PCV,≥1 Dose,HHS Regions/National,Region 8,2016,Age,3 Months,87.0,83.7 to 89.7,1490
PCV,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,3 Months,88.0,85.8 to 90.0,3133
PCV,≥1 Dose,HHS Regions/National,Region 8,2017,Age,3 Months,89.2,85.9 to 91.8,1643
PCV,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,3 Months,90.0,88.0 to 91.8,3433
Hib,≥2 Doses,HHS Regions/National,Region 8,2013,Age,7 Months,85.9,83.1 to 88.2,1423
Hib,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,7 Months,87.8,85.8 to 89.6,2907
Hib,≥2 Doses,HHS Regions/National,Region 8,2014,Age,7 Months,89.7,86.8 to 92.0,1484
Hib,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,7 Months,89.3,87.1 to 91.1,2972
Hib,≥2 Doses,HHS Regions/National,Region 8,2012,Age,5 Months,76.8,72.1 to 81.0,1498
Hib,≥2 Doses,HHS Regions/National,Region 8,2011,Age,5 Months,79.8,76.6 to 82.7,1500
Hib,≥2 Doses,HHS Regions/National,Region 8,2013,Age,5 Months,76.9,73.0 to 80.4,1423
Hib,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,5 Months,77.3,75.1 to 79.4,2907
Hib,≥2 Doses,HHS Regions/National,Region 8,2014,Age,5 Months,77.7,73.9 to 81.1,1484
Hib,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,5 Months,78.8,76.9 to 80.7,2972
PCV,≥3 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,92.9,90.2 to 94.9,1643
PCV,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,94.0,92.3 to 95.3,3433
PCV,≥3 Doses,HHS Regions/National,Region 8,2019,Age,19 Months,93.5,91.4 to 95.2,1623
PCV,≥3 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,92.6,89.9 to 94.8,1500
PCV,≥3 Doses,HHS Regions/National,Region 8,2018,Age,19 Months,95.1,93.1 to 96.6,1790
PCV,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,19 Months,92.7,91.1 to 94.1,3413
Hib,Full Series,HHS Regions/National,Region 8,2020,Age,24 Months,79.0,75.8 to 82.1,1697
Hep B,≥2 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,95.9,94.2 to 97.2,1623
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2012,Age,0-3 Days,76.2,72.4 to 79.6,1498
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 8,2011,Age,0-3 Days,71.1,66.9 to 74.9,1500
PCV,≥1 Dose,HHS Regions/National,Region 8,2011,Age,3 Months,84.4,81.3 to 87.1,1500
Hib,≥2 Doses,HHS Regions/National,Region 8,2015,Age,5 Months,80.0,76.4 to 83.2,1488
Hib,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,5 Months,79.7,77.1 to 82.1,2978
Hib,≥2 Doses,HHS Regions/National,Region 8,2016,Age,5 Months,79.4,75.5 to 82.8,1490
Hib,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,5 Months,82.4,79.8 to 84.7,3133
PCV,≥4 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,86.1,82.7 to 89.1,1490
PCV,≥4 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,86.6,83.8 to 89.2,3133
PCV,≥4 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,89.2,86.0 to 92.0,1790
PCV,≥4 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,88.9,86.7 to 90.9,3413
PCV,≥4 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,86.8,82.5 to 90.4,1643
PCV,≥4 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,88.0,85.3 to 90.4,3433
PCV,≥4 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,88.6,85.6 to 91.3,1623
Hib,≥1 Dose,HHS Regions/National,Region 8,2018,Age,3 Months,90.2,87.5 to 92.4,1790
Hib,≥1 Dose,HHS Regions/National,Region 8,2018-2019,Age,3 Months,89.4,87.4 to 91.1,3413
≥1 Dose Varicella,,HHS Regions/National,Region 8,2019,Age,35 Months,94.8,92.5 to 96.5,1623
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018,Age,35 Months,94.2,91.1 to 96.5,1790
≥1 Dose Varicella,,HHS Regions/National,Region 8,2018-2019,Age,35 Months,94.5,92.7 to 96.0,3413
PCV,≥4 Doses,HHS Regions/National,Region 8,2015,Age,24 Months,82.5,79.1 to 85.6,1488
PCV,≥4 Doses,HHS Regions/National,Region 8,2015-2016,Age,24 Months,83.3,80.9 to 85.6,2978
≥1 Dose MMR,,HHS Regions/National,Region 8,2016,Age,35 Months,94.0,91.4 to 96.1,1490
≥1 Dose MMR,,HHS Regions/National,Region 8,2016-2017,Age,35 Months,93.8,92.0 to 95.3,3133
≥1 Dose MMR,,HHS Regions/National,Region 8,2014,Age,35 Months,92.5,89.9 to 94.6,1484
≥1 Dose MMR,,HHS Regions/National,Region 8,2014-2015,Age,35 Months,91.6,89.6 to 93.3,2972
≥1 Dose MMR,,HHS Regions/National,Region 8,2015,Age,35 Months,90.7,87.6 to 93.4,1488
≥1 Dose MMR,,HHS Regions/National,Region 8,2015-2016,Age,35 Months,92.4,90.4 to 94.2,2978
PCV,≥4 Doses,HHS Regions/National,Region 8,2017,Age,24 Months,82.4,78.5 to 86.0,1643
PCV,≥4 Doses,HHS Regions/National,Region 8,2017-2018,Age,24 Months,84.5,82.0 to 86.9,3433
PCV,≥4 Doses,HHS Regions/National,Region 8,2016,Age,24 Months,84.2,80.7 to 87.3,1490
PCV,≥4 Doses,HHS Regions/National,Region 8,2016-2017,Age,24 Months,83.3,80.7 to 85.7,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,92.7,90.2 to 94.6,1790
PCV,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,92.7,91.1 to 94.1,3413
PCV,≥3 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,90.7,87.8 to 93.0,1643
PCV,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,91.7,89.8 to 93.2,3433
Hep B,≥2 Doses,HHS Regions/National,Region 8,2019,Age,7 Months,94.9,93.0 to 96.3,1623
Hep B,≥2 Doses,HHS Regions/National,Region 8,2011,Age,13 Months,91.0,88.1 to 93.3,1500
Hep B,≥2 Doses,HHS Regions/National,Region 8,2012,Age,13 Months,93.4,92.0 to 94.5,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,91.8,88.9 to 94.3,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,91.6,89.2 to 93.7,1484
Hep B,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,91.6,89.7 to 93.2,2972
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013,Age,35 Months,91.3,88.5 to 93.6,1423
Hep B,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,35 Months,91.4,89.6 to 93.0,2907
PCV,≥3 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,89.6,86.8 to 91.8,1490
PCV,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,90.1,88.2 to 91.8,3133
PCV,≥4 Doses,HHS Regions/National,Region 8,2018,Age,24 Months,86.7,83.4 to 89.6,1790
PCV,≥4 Doses,HHS Regions/National,Region 8,2018-2019,Age,24 Months,86.6,84.3 to 88.7,3413
PCV,≥4 Doses,HHS Regions/National,Region 8,2019,Age,24 Months,86.5,83.4 to 89.2,1623
PCV,≥4 Doses,HHS Regions/National,Region 8,2011,Age,35 Months,85.2,81.7 to 88.2,1500
PCV,≥4 Doses,HHS Regions/National,Region 8,2012,Age,35 Months,85.9,82.6 to 88.9,1498
PCV,≥3 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,91.7,90.2 to 93.0,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017,Age,35 Months,93.5,90.5 to 95.8,1643
Hep B,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,35 Months,93.9,92.0 to 95.4,3433
PCV,≥3 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,92.8,90.6 to 94.5,1623
PCV,≥3 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,90.6,87.2 to 93.1,1500
PCV,≥3 Doses,HHS Regions/National,Region 8,2013,Age,19 Months,89.4,86.8 to 91.5,1423
PCV,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,19 Months,90.1,88.4 to 91.6,2907
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,91.5,88.6 to 93.9,1488
Hep B,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,92.5,90.5 to 94.3,2978
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016,Age,35 Months,93.6,90.8 to 95.8,1490
Hep B,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,35 Months,93.5,91.6 to 95.1,3133
PCV,≥4 Doses,HHS Regions/National,Region 8,2015,Age,35 Months,84.4,81.0 to 87.5,1488
PCV,≥4 Doses,HHS Regions/National,Region 8,2015-2016,Age,35 Months,85.3,82.9 to 87.5,2978
PCV,≥4 Doses,HHS Regions/National,Region 8,2014,Age,35 Months,86.3,83.0 to 89.2,1484
PCV,≥4 Doses,HHS Regions/National,Region 8,2014-2015,Age,35 Months,85.4,83.0 to 87.6,2972
Hep B,≥2 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,94.9,92.6 to 96.5,1790
Hep B,≥2 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,95.4,94.1 to 96.5,3413
Hep B,≥2 Doses,HHS Regions/National,Region 8,2016,Age,13 Months,93.7,91.1 to 95.5,1490
Hep B,≥2 Doses,HHS Regions/National,Region 8,2016-2017,Age,13 Months,93.7,91.9 to 95.1,3133
PCV,≥3 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,90.6,87.9 to 92.8,1488
PCV,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,91.3,89.6 to 92.8,2978
PCV,≥3 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,92.0,89.7 to 93.8,1490
PCV,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,92.4,90.7 to 93.8,3133
Hib,≥1 Dose,HHS Regions/National,Region 8,2015,Age,3 Months,87.1,84.0 to 89.6,1488
Hib,≥1 Dose,HHS Regions/National,Region 8,2015-2016,Age,3 Months,87.5,85.4 to 89.4,2978
Hib,≥1 Dose,HHS Regions/National,Region 8,2016,Age,3 Months,88.0,84.8 to 90.5,1490
Hib,≥1 Dose,HHS Regions/National,Region 8,2016-2017,Age,3 Months,88.9,86.7 to 90.8,3133
Hib,≥1 Dose,HHS Regions/National,Region 8,2017,Age,3 Months,89.8,86.5 to 92.4,1643
Hib,≥1 Dose,HHS Regions/National,Region 8,2017-2018,Age,3 Months,90.0,87.9 to 91.8,3433
Hep B,≥2 Doses,HHS Regions/National,Region 8,2017,Age,13 Months,93.7,90.8 to 95.8,1643
Hep B,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,13 Months,94.3,92.5 to 95.7,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2018,Age,35 Months,94.6,91.9 to 96.6,1790
≥1 Dose MMR,,HHS Regions/National,Region 8,2018-2019,Age,35 Months,94.7,93.1 to 96.1,3413
≥1 Dose MMR,,HHS Regions/National,Region 8,2017,Age,35 Months,93.7,91.0 to 95.8,1643
≥1 Dose MMR,,HHS Regions/National,Region 8,2017-2018,Age,35 Months,94.1,92.3 to 95.7,3433
≥1 Dose MMR,,HHS Regions/National,Region 8,2019,Age,35 Months,94.8,92.7 to 96.5,1623
PCV,≥3 Doses,HHS Regions/National,Region 8,2014,Age,24 Months,91.8,89.1 to 94.1,1484
PCV,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,24 Months,91.4,89.6 to 93.1,2972
PCV,≥3 Doses,HHS Regions/National,Region 8,2012,Age,24 Months,92.9,90.5 to 94.9,1498
Hep B,≥3 Doses,HHS Regions/National,Region 8,2020,Age,24 Months,90.4,87.9 to 92.5,1697
Hib,≥2 Doses,HHS Regions/National,Region 8,2017,Age,5 Months,85.4,82.1 to 88.2,1643
Hib,≥2 Doses,HHS Regions/National,Region 8,2017-2018,Age,5 Months,85.4,83.2 to 87.4,3433
PCV,≥3 Doses,HHS Regions/National,Region 8,2013,Age,24 Months,90.9,88.3 to 93.2,1423
PCV,≥3 Doses,HHS Regions/National,Region 8,2013-2014,Age,24 Months,91.4,89.5 to 93.0,2907
Hib,≥1 Dose,HHS Regions/National,Region 8,2019,Age,3 Months,88.6,85.6 to 91.1,1623
Hep B,≥3 Doses,HHS Regions/National,Region 8,2019,Age,35 Months,95.4,93.6 to 96.8,1623
PCV,≥3 Doses,HHS Regions/National,Region 8,2014,Age,19 Months,90.9,87.9 to 93.1,1484
PCV,≥3 Doses,HHS Regions/National,Region 8,2014-2015,Age,19 Months,90.8,88.8 to 92.4,2972
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018,Age,35 Months,94.3,91.9 to 96.2,1790
Hep B,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,35 Months,94.8,93.4 to 96.0,3413
Hib,≥1 Dose,HHS Regions/National,Region 8,2013,Age,3 Months,84.2,81.7 to 86.5,1423
Hib,≥1 Dose,HHS Regions/National,Region 8,2013-2014,Age,3 Months,85.2,83.7 to 86.5,2907
Hib,≥1 Dose,HHS Regions/National,Region 8,2012,Age,3 Months,85.8,81.4 to 89.2,1498
Hib,≥1 Dose,HHS Regions/National,Region 8,2011,Age,3 Months,87.0,84.0 to 89.5,1500
Hib,≥1 Dose,HHS Regions/National,Region 8,2014,Age,3 Months,86.1,82.9 to 88.7,1484
Hib,≥1 Dose,HHS Regions/National,Region 8,2014-2015,Age,3 Months,86.6,84.4 to 88.4,2972
Hep B,≥2 Doses,HHS Regions/National,Region 8,2014,Age,13 Months,93.4,91.1 to 95.2,1484
Hep B,≥2 Doses,HHS Regions/National,Region 8,2014-2015,Age,13 Months,92.8,91.1 to 94.1,2972
Hep B,≥2 Doses,HHS Regions/National,Region 8,2015,Age,13 Months,92.1,89.5 to 94.1,1488
Hep B,≥2 Doses,HHS Regions/National,Region 8,2015-2016,Age,13 Months,92.9,91.1 to 94.3,2978
Hep B,≥2 Doses,HHS Regions/National,Region 8,2013,Age,13 Months,92.8,91.2 to 94.1,1423
Hep B,≥2 Doses,HHS Regions/National,Region 8,2013-2014,Age,13 Months,93.1,92.0 to 94.1,2907
PCV,≥4 Doses,HHS Regions/National,Region 8,2011,Age,24 Months,83.6,80.1 to 86.7,1500
Hib,≥3 Doses,HHS Regions/National,Region 8,2019,Age,13 Months,77.7,74.1 to 80.8,1623
Hib,≥3 Doses,HHS Regions/National,Region 8,2012,Age,19 Months,90.7,88.5 to 92.5,1498
Hib,≥3 Doses,HHS Regions/National,Region 8,2011,Age,19 Months,90.0,86.1 to 92.9,1500
Polio,≥3 Doses,HHS Regions/National,Region 8,2015,Age,19 Months,90.5,88.0 to 92.6,1488
Polio,≥3 Doses,HHS Regions/National,Region 8,2015-2016,Age,19 Months,90.8,88.9 to 92.3,2978
Hib,≥3 Doses,HHS Regions/National,Region 8,2018,Age,13 Months,76.2,72.3 to 79.6,1790
Hib,≥3 Doses,HHS Regions/National,Region 8,2018-2019,Age,13 Months,76.9,74.3 to 79.3,3413
Polio,≥3 Doses,HHS Regions/National,Region 8,2016,Age,19 Months,91.0,88.6 to 93.0,1490
Polio,≥3 Doses,HHS Regions/National,Region 8,2016-2017,Age,19 Months,92.0,90.3 to 93.5,3133
Polio,≥3 Doses,HHS Regions/National,Region 8,2017,Age,19 Months,93.1,90.3 to 95.0,1643
Polio,≥3 Doses,HHS Regions/National,Region 8,2017-2018,Age,19 Months,94.1,92.5 to 95.4,3433
Hib,Primary Series,HHS Regions/National,Region 7,2021,Age,24 Months,92.2,89.4 to 94.4,888
≥1 Dose Varicella,,HHS Regions/National,Region 7,2021,Age,19 Months,89.4,86.4 to 91.8,888
DTaP,≥4 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,71.4,66.8 to 75.7,888
Hep A,≥1 Dose,HHS Regions/National,Region 7,2021,Age,35 Months,93.5,88.4 to 96.9,888
≥1 Dose MMR,,HHS Regions/National,Region 7,2020-2021,Age,24 Months,91.3,89.4 to 92.9,2168
DTaP,≥4 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,81.1,76.8 to 85.1,888
Polio,≥3 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,91.9,89.1 to 94.2,888
≥1 Dose MMR,,HHS Regions/National,Region 7,2021,Age,24 Months,91.6,88.7 to 94.0,888
Hib,≥3 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,90.0,86.7 to 92.7,888
Polio,≥1 Dose,HHS Regions/National,Region 7,2021,Age,3 Months,90.1,87.0 to 92.5,888
Hib,Primary Series,HHS Regions/National,Region 7,2020-2021,Age,13 Months,85.8,83.6 to 87.8,2168
Hib,Full Series,HHS Regions/National,Region 7,2021,Age,24 Months,77.3,73.0 to 81.4,888
Hep A,≥1 Dose,HHS Regions/National,Region 7,2021,Age,24 Months,87.7,84.4 to 90.5,888
PCV,≥4 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,84.3,80.4 to 87.8,888
PCV,≥3 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,91.8,88.9 to 94.2,888
DTaP,≥3 Doses,HHS Regions/National,Region 7,2020-2021,Age,35 Months,94.3,92.4 to 95.9,2168
Hep B,≥3 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,70.8,66.5 to 74.7,888
PCV,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,5 Months,80.6,77.9 to 83.0,2168
PCV,≥3 Doses,HHS Regions/National,Region 7,2021,Age,7 Months,72.2,67.7 to 76.3,888
Hep A,≥2 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,52.3,47.3 to 57.5,888
DTaP,≥3 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,89.3,85.9 to 92.0,888
Hep B,≥3 Doses,HHS Regions/National,Region 7,2021,Age,24 Months,90.9,88.0 to 93.4,888
Hep A,≥1 Dose,HHS Regions/National,Region 7,2021,Age,19 Months,85.4,81.9 to 88.3,888
PCV,≥4 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,80.4,76.1 to 84.0,888
Hep A,≥2 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,33.5,29.4 to 37.9,888
PCV,≥4 Doses,HHS Regions/National,Region 7,2021,Age,35 Months,85.6,81.6 to 89.1,888
DTaP,≥3 Doses,HHS Regions/National,Region 7,2021,Age,19 Months,91.5,88.5 to 93.8,888
DTaP,≥1 Dose,HHS Regions/National,Region 7,2021,Age,3 Months,89.4,86.0 to 92.1,888
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 7,2021,Age,0-1 Days,77.3,73.1 to 81.0,888
DTaP,≥1 Dose,HHS Regions/National,Region 7,2020-2021,Age,3 Months,89.5,87.4 to 91.2,2168
≥1 Dose Varicella,,HHS Regions/National,Region 7,2020-2021,Age,35 Months,94.8,92.7 to 96.4,2168
PCV,≥3 Doses,HHS Regions/National,Region 7,2021,Age,13 Months,89.4,86.2 to 91.9,888
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 7,2021,Age,0-2 Days,79.4,75.3 to 82.9,888
Hib,≥2 Doses,HHS Regions/National,Region 7,2020-2021,Age,13 Months,93.1,91.5 to 94.5,2168
≥1 Dose Varicella,,HHS Regions/National,Region 7,2021,Age,24 Months,90.8,87.9 to 93.2,888
Influenza,,States/Local Areas,Wyoming,2012,Age,24 Months,42.5,33.9 to 52.3,217
Influenza,,States/Local Areas,Wyoming,2011,Age,24 Months,34.8,27.5 to 43.5,214
Influenza,,States/Local Areas,Wyoming,2014,Age,24 Months,41.8,34.6 to 49.9,265
Influenza,,States/Local Areas,Wyoming,2014-2015,Age,24 Months,44.1,39.0 to 49.6,548
Influenza,,States/Local Areas,Wyoming,2015,Age,24 Months,46.4,39.5 to 53.8,283
Influenza,,States/Local Areas,Wyoming,2015-2016,Age,24 Months,49.3,44.1 to 54.8,514
Influenza,,States/Local Areas,Wyoming,2013,Age,24 Months,48.6,39.9 to 57.9,215
Influenza,,States/Local Areas,Wyoming,2013-2014,Age,24 Months,45.2,39.5 to 51.4,480
Polio,≥3 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,95.0,89.9 to 98.0,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,87.1,83.4 to 90.1,214
Polio,≥3 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,88.3,85.1 to 90.9,217
Polio,≥3 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,93.6,87.9 to 96.7,215
Polio,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,90.4,84.9 to 94.1,480
DTaP,≥3 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,90.0,85.9 to 93.1,217
DTaP,≥3 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,88.5,85.4 to 91.0,214
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,89.9,85.2 to 93.3,280
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,91.0,87.7 to 93.5,540
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,92.1,86.8 to 95.3,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,61.4,56.4 to 66.3,514
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,63.9,56.0 to 71.8,188
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,72.4,66.2 to 78.6,247
Hib,≥3 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,45.8,38.3 to 53.5,231
Hib,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,51.3,46.0 to 56.6,518
Hib,≥3 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,60.5,53.4 to 67.3,283
Hib,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,53.0,47.7 to 58.2,514
Polio,≥3 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,87.1,82.1 to 90.9,265
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,89.0,85.7 to 91.6,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,86.3,83.3 to 88.8,214
Hib,≥3 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,88.3,85.6 to 90.5,217
Hib,≥3 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,56.3,48.7 to 63.6,280
Hib,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,56.1,50.5 to 61.6,540
Polio,≥3 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,88.3,82.8 to 92.1,287
Polio,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,89.3,85.8 to 92.1,567
Polio,≥3 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,89.7,84.2 to 93.4,231
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,89.0,85.4 to 91.9,518
Polio,≥3 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,90.8,86.4 to 93.9,283
Polio,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,90.2,86.8 to 92.9,514
Hib,≥3 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,57.6,50.3 to 64.6,287
Hib,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,57.0,51.7 to 62.1,567
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,74.6,67.0 to 80.9,260
PCV,≥1 Dose,States/Local Areas,Wyoming,2019,Age,3 Months,90.1,83.7 to 94.1,260
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,87.5 to 92.3,754
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,91.3,87.9 to 94.8,291
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,82.5,76.4 to 87.2,265
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,86.0,82.1 to 89.1,548
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,89.5,86.7 to 91.7,215
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,86.0,83.0 to 88.6,480
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,76.3,67.9 to 84.7,117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",63.1,50.0 to 76.1,74
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",62.7,58.7 to 66.7,754
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,57.3,50.8 to 63.8,291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,70.7,66.6 to 74.8,630
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Overall,Overall,65.1,61.6 to 68.6,949
Hib,≥3 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,32.6,25.6 to 40.5,260
Hib,≥3 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,36.9,30.0 to 44.2,280
Hib,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,34.6,29.7 to 39.9,540
Hib,≥3 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,25.4,19.6 to 32.3,231
Hib,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,29.0,24.5 to 33.9,518
Polio,≥3 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,87.0,83.2 to 90.0,214
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,90.4,87.5 to 93.4,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,93.6,89.2 to 97.9,188
Hib,≥3 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,59.2,49.2 to 68.6,215
Hib,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,56.2,48.9 to 63.2,480
Hib,≥3 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,53.0,45.5 to 60.4,265
Hib,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,56.8,51.6 to 61.9,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,77.4,70.5 to 83.1,217
Hib,≥3 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,80.3,76.4 to 83.8,214
Hib,≥2 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,94.6,91.1 to 96.8,287
Hib,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,94.2,91.8 to 96.0,567
Hib,≥2 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,93.8,89.8 to 96.3,280
Hib,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,93.6,90.2 to 95.8,540
Hib,≥2 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,93.3,87.4 to 96.6,260
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,88.3,85.4 to 91.2,630
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,89.3,87.0 to 91.5,949
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,84.3,79.6 to 89.0,247
DTaP,≥3 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,87.4,84.6 to 89.7,217
PCV,≥1 Dose,States/Local Areas,Wyoming,2014,Age,3 Months,80.2,73.6 to 85.5,265
PCV,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,3 Months,82.8,78.5 to 86.3,548
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.9,57.9 to 81.9,74
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",80.9,77.6 to 84.1,754
PCV,≥1 Dose,States/Local Areas,Wyoming,2012,Age,3 Months,84.8,82.5 to 86.8,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,92.4,88.1 to 95.5,280
PCV,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,93.2,90.1 to 95.5,540
Hib,≥2 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,88.2,83.0 to 92.0,283
Hib,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,87.6,83.9 to 90.6,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,90.2,84.1 to 94.7,214
PCV,≥3 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,93.9,89.2 to 97.0,260
PCV,≥3 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,93.4,87.4 to 97.2,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,91.3,86.4 to 94.9,283
PCV,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,91.3,88.0 to 94.0,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,95.2,91.0 to 97.9,215
PCV,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,91.5,88.4 to 94.0,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,87.7,82.9 to 91.7,265
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,89.6,86.3 to 92.4,548
Hib,≥2 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,90.1,85.1 to 93.5,287
Hib,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,89.3,85.8 to 92.0,567
Hib,≥2 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,87.1,81.4 to 91.2,231
Hib,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,88.5,84.8 to 91.3,518
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,92.6,90.3 to 94.9,595
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,85.5,80.7 to 90.3,258
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,77.8,66.6 to 89.0,59
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.2,72.7 to 93.7,74
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,89.1,83.1 to 95.1,117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2018,Age,0-3 Days,77.9,70.8 to 83.7,280
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2018-2019,Age,0-3 Days,81.2,76.5 to 85.2,540
Polio,≥1 Dose,States/Local Areas,Wyoming,2018,Age,3 Months,87.8,81.9 to 92.0,280
Polio,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,3 Months,89.5,85.5 to 92.5,540
Polio,≥1 Dose,States/Local Areas,Wyoming,2019,Age,3 Months,91.1,84.8 to 95.0,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,71.4,65.2 to 77.7,258
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,60.7,56.1 to 65.3,595
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,72.1,56.8 to 87.4,37
Hib,≥2 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,90.2,84.1 to 94.1,260
Hib,≥3 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,39.6,29.2 to 51.1,215
Hib,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,33.8,24.9 to 44.0,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,91.8,84.1 to 99.4,37
PCV,≥3 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,91.2,86.4 to 94.8,231
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,91.2,88.0 to 93.8,518
PCV,≥3 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,94.1,89.3 to 97.2,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,73.1,66.2 to 79.1,287
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,72.5,67.5 to 76.9,567
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,68.4,55.7 to 81.0,59
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2019,Age,0-3 Days,84.3,77.4 to 89.3,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,71.7,64.4 to 78.1,280
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,73.2,68.1 to 77.8,540
PCV,≥4 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,82.5,75.4 to 87.9,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.0,90.2 to 99.8,74
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,91.6,86.8 to 96.4,117
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,90.2,87.6 to 92.8,630
Hib,≥2 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,89.9,84.6 to 93.5,231
Hib,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,92.1,89.0 to 94.4,518
Hib,≥2 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,92.5,88.2 to 95.4,283
Hib,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,91.2,87.9 to 93.6,514
Hib,≥2 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,88.2,83.0 to 91.9,265
Hib,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,90.4,87.2 to 92.8,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,91.3,86.8 to 94.7,287
PCV,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,91.7,88.7 to 94.2,567
Hib,≥2 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,94.2,88.8 to 97.1,215
Hib,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,91.2,87.6 to 93.9,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,92.4,88.1 to 95.5,280
PCV,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,93.3,90.2 to 95.6,540
Hib,≥3 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,27.7,21.8 to 34.5,265
Hib,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,32.1,27.5 to 37.1,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,36.5,29.8 to 43.6,283
Hib,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,30.8,26.3 to 35.7,514
Polio,≥1 Dose,States/Local Areas,Wyoming,2017,Age,3 Months,88.4,82.5 to 92.4,287
Polio,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,3 Months,88.1,84.1 to 91.2,567
Hib,≥2 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,88.4,82.9 to 92.4,280
Hib,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,89.3,85.5 to 92.3,540
Hib,≥2 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,89.9,88.4 to 91.3,214
Hib,≥2 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,92.4,87.5 to 95.4,217
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,58.8,51.2 to 66.1,265
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,63.1,57.9 to 68.0,548
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,67.3,60.2 to 73.7,283
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,66.6,61.3 to 71.4,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,65.8,58.0 to 72.9,231
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,69.2,64.0 to 74.0,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2015,Age,0-3 Days,61.7,54.6 to 68.3,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2015-2016,Age,0-3 Days,63.5,58.3 to 68.5,514
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.0,88.7 to 93.3,754
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,90.9 to 96.5,291
Hib,≥3 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,33.1,26.6 to 40.2,287
Hib,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,34.9,30.0 to 40.0,567
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,87.0,81.2 to 91.2,287
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,88.4,84.7 to 91.2,567
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,89.4,84.0 to 93.2,283
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,87.7,83.7 to 90.8,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,86.1,79.7 to 90.6,231
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,86.5,82.3 to 89.8,518
PCV,≥3 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,85.6,79.3 to 90.3,231
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,85.9,81.7 to 89.3,518
Hep B,≥2 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,95.3,90.1 to 97.8,260
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2018,Age,0-2 Days,77.6,70.4 to 83.4,280
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2018-2019,Age,0-2 Days,80.7,76.0 to 84.7,540
Hep B,≥2 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,91.2,85.3 to 94.9,280
Hep B,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,93.3,89.8 to 95.7,540
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,95.5,92.3 to 97.7,215
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,93.6,91.2 to 95.6,480
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,91.7,87.8 to 94.8,265
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,91.6,88.5 to 94.2,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,92.2,86.1 to 96.3,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,86.2,80.4 to 90.5,287
PCV,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,87.6,83.8 to 90.5,567
Hep B,≥2 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,92.7,89.4 to 95.0,217
Hep B,≥2 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,91.1,87.0 to 94.0,214
PCV,≥4 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,85.0,79.2 to 89.9,231
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,83.1,78.9 to 86.9,518
PCV,≥4 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,80.7,74.6 to 86.2,287
PCV,≥4 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,81.0,76.6 to 85.0,567
≥1 Dose MMR,,States/Local Areas,Wyoming,2014,Age,35 Months,90.1,85.6 to 93.7,265
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2015,Age,35 Months,89.8,86.4 to 92.6,548
≥1 Dose MMR,,States/Local Areas,Wyoming,2015,Age,35 Months,89.3,83.9 to 93.5,283
≥1 Dose MMR,,States/Local Areas,Wyoming,2015-2016,Age,35 Months,91.0,87.5 to 93.9,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018,Age,35 Months,96.1,88.0 to 99.3,280
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018-2019,Age,35 Months,95.1,91.3 to 97.6,540
PCV,≥4 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,78.3,72.0 to 84.1,283
PCV,≥4 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,81.8,77.5 to 85.6,514
≥1 Dose MMR,,States/Local Areas,Wyoming,2016,Age,35 Months,92.5,87.7 to 95.9,231
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2017,Age,35 Months,92.7,89.5 to 95.2,518
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019,Age,35 Months,95.3,91.0 to 97.9,260
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,89.6,86.9 to 92.4,595
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,84.7,79.8 to 89.6,258
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.3,85.6 to 90.9,754
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,90.9,87.4 to 94.5,291
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,91.7,87.3 to 96.1,188
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,87.3,84.0 to 90.7,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,69.0,55.3 to 82.6,59
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,88.6,79.6 to 97.5,37
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,93.4,89.2 to 96.4,231
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,92.4,89.3 to 94.9,518
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,91.6,86.5 to 95.3,283
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,92.6,89.3 to 95.1,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,93.3,87.5 to 96.5,215
PCV,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,90.0,85.6 to 93.2,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,88.7,87.1 to 90.1,214
PCV,≥4 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,81.2,74.8 to 86.8,280
PCV,≥4 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,83.3,78.9 to 87.2,540
PCV,≥4 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,85.3,78.8 to 90.7,260
PCV,≥4 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,85.2,78.1 to 90.9,217
PCV,≥4 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,76.3,67.9 to 83.9,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,91.0,86.2 to 94.6,287
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,92.8,89.1 to 95.6,567
PCV,≥3 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,90.0,87.4 to 92.2,217
Hep B,≥2 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,90.4,85.6 to 93.7,265
Hep B,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,92.0,89.0 to 94.2,548
Hib,≥1 Dose,States/Local Areas,Wyoming,2014,Age,3 Months,79.6,73.0 to 84.9,265
Hib,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,3 Months,83.3,79.1 to 86.8,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,89.1,84.1 to 92.7,280
PCV,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,90.6,87.2 to 93.1,540
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2019,Age,0-2 Days,83.6,76.8 to 88.8,260
Hep B,≥2 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,95.6,86.9 to 98.6,215
Hep B,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,93.0,86.7 to 96.5,480
Hep B,≥2 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,93.6,89.3 to 96.2,283
Hep B,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,93.3,90.4 to 95.4,514
Hib,≥1 Dose,States/Local Areas,Wyoming,2011,Age,3 Months,79.0,76.2 to 81.5,214
Hib,≥1 Dose,States/Local Areas,Wyoming,2012,Age,3 Months,86.9,83.3 to 89.8,217
Hib,≥1 Dose,States/Local Areas,Wyoming,2013,Age,3 Months,91.1,87.3 to 93.9,215
Hib,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,3 Months,85.5,80.1 to 89.6,480
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,88.2,81.8 to 94.7,117
PCV,≥1 Dose,States/Local Areas,Wyoming,2013,Age,3 Months,89.3,82.8 to 93.5,215
PCV,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,3 Months,84.9,79.0 to 89.3,480
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,74.1,68.0 to 80.3,258
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,64.7,51.2 to 78.2,59
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,79.9,67.1 to 92.7,37
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,76.3,67.7 to 85.0,117
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,84.2,80.8 to 87.6,595
PCV,≥4 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,85.3,78.8 to 90.7,260
Hib,≥1 Dose,States/Local Areas,Wyoming,2017,Age,3 Months,90.1,84.8 to 93.7,287
Hib,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,3 Months,89.5,86.0 to 92.2,567
PCV,≥3 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,94.5,90.2 to 97.3,215
PCV,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,90.8,87.7 to 93.4,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,91.3,85.1 to 95.7,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,93.1,87.9 to 96.1,260
Hib,≥2 Doses,States/Local Areas,Wyoming,2016,Age,5 Months,75.0,67.8 to 81.1,231
Hib,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,5 Months,78.4,73.7 to 82.5,518
Hib,≥2 Doses,States/Local Areas,Wyoming,2015,Age,5 Months,78.4,72.0 to 83.6,283
Hib,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,5 Months,76.7,72.0 to 80.8,514
Hib,≥2 Doses,States/Local Areas,Wyoming,2014,Age,5 Months,68.9,61.6 to 75.3,265
Hib,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,5 Months,73.6,70.9 to 76.2,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,91.2,86.3 to 94.4,280
PCV,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,90.6,87.2 to 93.1,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,86.8,83.7 to 89.9,630
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Overall,Overall,88.1,85.7 to 90.5,949
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,83.7,78.7 to 88.7,247
PCV,≥1 Dose,States/Local Areas,Wyoming,2011,Age,3 Months,76.8,71.2 to 81.6,214
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,88.3,85.0 to 91.6,514
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,94.3,90.5 to 98.1,188
PCV,≥4 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,85.2,77.5 to 91.2,280
PCV,≥4 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,85.1,80.3 to 89.2,540
PCV,≥4 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,88.0,82.1 to 92.6,231
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,85.7,81.5 to 89.4,518
Hep B,≥2 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,95.9,90.6 to 98.3,260
Hib,Full Series,States/Local Areas,Wyoming,2020,Age,24 Months,78.4,71.4 to 84.6,296
PCV,≥4 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,83.0,76.8 to 88.4,287
PCV,≥4 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,83.7,79.1 to 87.8,567
PCV,≥3 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,88.7,83.4 to 92.4,287
PCV,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,89.9,86.4 to 92.5,567
Hib,≥2 Doses,States/Local Areas,Wyoming,2013,Age,5 Months,79.3,71.2 to 85.6,215
Hib,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,5 Months,74.2,67.5 to 79.9,480
Hib,≥2 Doses,States/Local Areas,Wyoming,2011,Age,5 Months,70.7,67.6 to 73.7,214
Hib,≥2 Doses,States/Local Areas,Wyoming,2012,Age,5 Months,79.3,73.4 to 84.2,217
Hib,≥1 Dose,States/Local Areas,Wyoming,2019,Age,3 Months,90.3,84.0 to 94.3,260
Hib,≥1 Dose,States/Local Areas,Wyoming,2018,Age,3 Months,88.9,83.7 to 92.6,280
Hib,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,3 Months,89.6,85.8 to 92.5,540
PCV,≥1 Dose,States/Local Areas,Wyoming,2017,Age,3 Months,88.5,83.1 to 92.4,287
PCV,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,3 Months,88.2,84.6 to 91.1,567
PCV,≥1 Dose,States/Local Areas,Wyoming,2016,Age,3 Months,86.7,80.7 to 91.1,231
PCV,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,3 Months,87.6,83.7 to 90.7,518
Hib,≥2 Doses,States/Local Areas,Wyoming,2019,Age,5 Months,81.4,74.3 to 86.8,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2020,Age,24 Months,89.0,83.8 to 93.1,296
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,91.8,84.1 to 99.4,37
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,94.2,92.3 to 96.2,595
PCV,≥1 Dose,States/Local Areas,Wyoming,2015,Age,3 Months,85.3,79.4 to 89.7,283
PCV,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,3 Months,86.0,82.0 to 89.3,514
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,82.2,77.1 to 87.3,291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2012,Age,0-3 Days,73.9,64.6 to 81.5,217
Hib,≥2 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,79.4,73.0 to 84.6,265
Hib,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,83.9,79.9 to 87.2,548
Hib,≥2 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,92.4,87.8 to 95.4,215
Hib,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,86.1,80.8 to 90.0,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,87.0,82.2 to 91.1,265
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,88.6,85.2 to 91.5,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,89.1,83.1 to 93.7,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,89.5,85.4 to 93.6,258
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2011,Age,0-3 Days,68.4,59.8 to 75.9,214
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,90.6,85.2 to 95.9,188
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,74.2,68.1 to 80.3,247
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,78.3,74.1 to 82.4,514
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,77.8,66.6 to 89.0,59
Hib,≥2 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,85.8,82.3 to 88.8,214
Hib,≥2 Doses,States/Local Areas,Wyoming,2017,Age,5 Months,82.2,75.8 to 87.2,287
Hib,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,5 Months,81.8,77.2 to 85.5,567
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,77.8,74.0 to 81.6,630
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,79.4,76.4 to 82.4,949
PCV,≥3 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,90.6,86.2 to 94.1,287
PCV,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,91.4,88.4 to 93.9,567
PCV,≥3 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,91.2,86.4 to 94.8,231
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,90.9,87.8 to 93.6,518
Hib,≥2 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,89.1,86.1 to 91.6,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,90.1,85.1 to 94.0,283
PCV,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,90.7,87.3 to 93.4,514
Hib,≥2 Doses,States/Local Areas,Wyoming,2018,Age,5 Months,81.2,74.4 to 86.5,280
Hib,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,5 Months,81.3,76.6 to 85.2,540
Polio,≥1 Dose,States/Local Areas,Wyoming,2011,Age,3 Months,79.6,75.5 to 83.2,214
Polio,≥1 Dose,States/Local Areas,Wyoming,2012,Age,3 Months,87.8,85.1 to 90.1,217
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,91.5,89.5 to 93.4,949
Polio,≥1 Dose,States/Local Areas,Wyoming,2013,Age,3 Months,89.8,80.8 to 94.9,215
Polio,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,3 Months,85.6,79.1 to 90.4,480
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2013,Age,0-3 Days,63.3,54.6 to 71.2,215
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2013-2014,Age,0-3 Days,62.9,57.3 to 68.2,480
DTaP,≥3 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,61.6,55.5 to 67.4,214
DTaP,≥3 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,68.2,65.0 to 71.2,217
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,69.1,66.6 to 71.4,215
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,64.1,60.4 to 67.6,480
PCV,≥1 Dose,States/Local Areas,Wyoming,2018,Age,3 Months,87.9,82.5 to 91.7,280
PCV,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,3 Months,89.0,85.1 to 92.0,540
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014,Age,0-3 Days,62.5,55.1 to 69.3,265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2014-2015,Age,0-3 Days,62.1,57.0 to 66.9,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016,Age,0-3 Days,65.3,57.6 to 72.3,231
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2016-2017,Age,0-3 Days,72.4,67.3 to 76.9,518
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2017,Age,0-3 Days,73.3,63.1 to 81.6,170
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wyoming,2017-2018,Age,0-3 Days,79.2,74.7 to 83.2,567
Polio,≥1 Dose,States/Local Areas,Wyoming,2016,Age,3 Months,87.6,81.6 to 91.9,231
Polio,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,3 Months,88.0,83.9 to 91.1,518
Polio,≥1 Dose,States/Local Areas,Wyoming,2015,Age,3 Months,87.6,82.1 to 91.6,283
Polio,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,3 Months,87.6,83.7 to 90.7,514
Polio,≥1 Dose,States/Local Areas,Wyoming,2014,Age,3 Months,81.3,74.8 to 86.5,265
Polio,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,3 Months,84.5,80.3 to 87.9,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,54.0,50.9 to 57.1,217
Hib,≥3 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,55.0,48.0 to 61.7,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,91.7,88.9 to 94.4,514
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,95.2,91.8 to 98.5,188
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,88.8,84.9 to 92.7,247
Hep A,≥1 Dose,States/Local Areas,Wyoming,2017,Age,35 Months,87.6,81.8 to 92.3,287
Hep A,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,35 Months,88.4,83.7 to 92.2,567
Hep A,≥1 Dose,States/Local Areas,Wyoming,2015,Age,35 Months,75.7,68.7 to 82.2,283
Hep A,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,35 Months,76.9,72.0 to 81.5,514
Hib,≥3 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,94.8,88.3 to 98.3,280
Hib,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,92.7,88.5 to 95.8,540
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,92.2,90.3 to 94.0,949
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,31.7,25.0 to 39.7,265
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,32.1,27.4 to 37.4,548
Polio,≥3 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,93.5,89.3 to 96.4,283
Polio,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,93.5,90.7 to 95.8,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,75.6,68.1 to 81.9,260
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016,Age,35 Months,78.2,71.3 to 84.4,231
Hep A,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,35 Months,82.3,77.6 to 86.5,518
Polio,≥2 Doses,States/Local Areas,Wyoming,2014,Age,5 Months,70.3,63.1 to 76.7,265
Polio,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,5 Months,74.6,72.0 to 77.0,548
Polio,≥2 Doses,States/Local Areas,Wyoming,2013,Age,5 Months,78.2,74.2 to 81.6,215
Polio,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,5 Months,74.3,70.5 to 77.8,480
Hep A,≥1 Dose,States/Local Areas,Wyoming,2012,Age,35 Months,71.5,62.3 to 80.1,217
Polio,≥2 Doses,States/Local Areas,Wyoming,2011,Age,5 Months,70.8,69.1 to 72.4,214
Polio,≥2 Doses,States/Local Areas,Wyoming,2012,Age,5 Months,77.5,73.1 to 81.4,217
DTaP,≥4 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,73.5,64.1 to 82.1,217
DTaP,≥4 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,73.3,65.0 to 81.0,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,56.3,47.1 to 65.1,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,67.0,62.5 to 71.1,217
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,93.1,90.6 to 95.6,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,95.7,92.2 to 99.2,188
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,88.3,84.3 to 92.4,247
Hep A,≥2 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,35.5,28.6 to 43.4,287
Hep A,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,39.9,34.7 to 45.5,567
Hep A,≥2 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,32.6,26.4 to 39.8,283
Hep A,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,32.3,27.6 to 37.6,514
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,32.1,25.4 to 40.0,231
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,33.6,28.7 to 39.1,518
DTaP,≥4 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,77.0,69.0 to 84.2,215
DTaP,≥4 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,75.0,69.8 to 80.0,480
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,66.6,59.1 to 73.3,265
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,65.9,60.8 to 70.7,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,65.2,58.0 to 71.8,283
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,67.1,61.9 to 71.9,514
Polio,≥2 Doses,States/Local Areas,Wyoming,2017,Age,5 Months,82.2,75.8 to 87.2,287
Polio,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,5 Months,81.3,76.7 to 85.1,567
Polio,≥2 Doses,States/Local Areas,Wyoming,2016,Age,5 Months,76.3,69.1 to 82.2,231
Polio,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,5 Months,79.0,74.3 to 83.1,518
Hep A,≥2 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,44.8,37.5 to 52.8,280
Hep A,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,49.6,44.0 to 55.6,540
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,70.2,65.1 to 74.8,215
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,68.4,65.0 to 71.7,480
Hep A,≥2 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,54.1,46.0 to 62.7,260
Polio,≥2 Doses,States/Local Areas,Wyoming,2015,Age,5 Months,78.8,72.5 to 83.9,283
Polio,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,5 Months,77.5,72.9 to 81.6,514
Hep A,≥2 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,60.2,49.9 to 70.7,215
Hep A,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,57.4,50.9 to 64.2,480
Hep A,≥2 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,53.4,41.8 to 66.0,217
Hep A,≥2 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,37.2,27.1 to 49.6,214
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,80.1,73.5 to 85.9,231
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,79.1,74.5 to 83.3,518
DTaP,≥4 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,71.7,65.0 to 78.1,283
DTaP,≥4 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,76.0,71.3 to 80.4,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,72.9,66.0 to 79.3,265
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,72.3,67.5 to 76.9,548
PCV,≥2 Doses,States/Local Areas,Wyoming,2017,Age,5 Months,82.1,75.7 to 87.1,287
PCV,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,5 Months,81.0,76.4 to 84.8,567
PCV,≥2 Doses,States/Local Areas,Wyoming,2018,Age,5 Months,79.7,72.8 to 85.3,280
PCV,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,5 Months,81.9,77.3 to 85.7,540
PCV,≥2 Doses,States/Local Areas,Wyoming,2019,Age,5 Months,83.9,77.3 to 88.8,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.7,93.0 to 100.0,74
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,91.1,86.0 to 96.3,117
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,91.3,88.8 to 93.8,630
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,89.6 to 94.0,754
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,93.8,91.0 to 96.6,291
DTaP,≥4 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,67.2,60.0 to 73.6,287
DTaP,≥4 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,67.3,62.1 to 72.0,567
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,69.4,61.9 to 76.0,231
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,68.4,63.2 to 73.1,518
Hep A,≥2 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,34.5,26.8 to 43.8,215
Hep A,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,33.1,27.9 to 39.0,480
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014,Age,35 Months,70.5,63.3 to 77.4,265
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,35 Months,73.2,68.1 to 77.9,548
Hep A,≥1 Dose,States/Local Areas,Wyoming,2013,Age,35 Months,73.8,65.3 to 81.7,215
Hep A,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,35 Months,72.3,66.8 to 77.6,480
Hep A,≥2 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,23.0,16.1 to 32.2,217
Polio,≥3 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,93.6,89.3 to 96.7,231
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,93.3,90.4 to 95.6,518
Hib,Full Series,States/Local Areas,Wyoming,2019,Age,35 Months,82.3,75.3 to 88.3,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,75.7,68.9 to 81.5,287
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,77.1,72.4 to 81.2,567
Polio,≥2 Doses,States/Local Areas,Wyoming,2018,Age,5 Months,80.2,73.3 to 85.7,280
Polio,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,5 Months,81.2,76.5 to 85.2,540
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,75.4,66.9 to 84.0,117
Polio,≥2 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,85.9,80.9 to 89.8,214
Polio,≥2 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,88.8,85.1 to 91.7,217
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,62.1,53.1 to 71.2,231
Hep A,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,64.6,58.1 to 71.0,518
Hep A,≥2 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,54.2,45.9 to 62.9,283
Hep A,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,58.5,52.2 to 64.8,514
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,54.9,46.6 to 63.6,265
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,54.7,48.8 to 60.9,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,68.9,61.2 to 75.6,231
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,72.1,67.0 to 76.7,518
Hep A,≥1 Dose,States/Local Areas,Wyoming,2018,Age,35 Months,90.7,82.5 to 96.0,280
Hep A,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,35 Months,91.1,86.4 to 94.7,540
≥1 Dose Varicella,,States/Local Areas,Wyoming,2012,Age,13 Months,58.6,55.0 to 62.0,217
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014,Age,13 Months,57.9,50.4 to 65.1,265
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2015,Age,13 Months,59.5,54.3 to 64.4,548
Hep A,≥1 Dose,States/Local Areas,Wyoming,2019,Age,35 Months,91.5,86.2 to 95.4,260
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,70.1,65.9 to 74.4,595
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,73.2,66.7 to 79.6,258
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,48.3,34.0 to 62.5,59
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,48.3,28.1 to 68.5,37
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013,Age,13 Months,61.8,59.2 to 64.4,215
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013-2014,Age,13 Months,59.9,58.3 to 61.5,480
≥1 Dose Varicella,,States/Local Areas,Wyoming,2011,Age,13 Months,54.9,52.3 to 57.5,214
DTaP,≥2 Doses,States/Local Areas,Wyoming,2014,Age,5 Months,70.5,63.2 to 76.8,265
DTaP,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,5 Months,74.9,72.3 to 77.3,548
DTaP,≥2 Doses,States/Local Areas,Wyoming,2015,Age,5 Months,79.2,73.0 to 84.3,283
DTaP,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,5 Months,77.9,73.2 to 81.9,514
Polio,≥3 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,97.2,89.7 to 99.6,217
Hib,Full Series,States/Local Areas,Wyoming,2013,Age,35 Months,86.5,79.5 to 92.0,215
Hib,Full Series,States/Local Areas,Wyoming,2013-2014,Age,35 Months,82.0,77.3 to 86.3,480
DTaP,≥2 Doses,States/Local Areas,Wyoming,2011,Age,5 Months,71.8,69.4 to 74.1,214
DTaP,≥2 Doses,States/Local Areas,Wyoming,2012,Age,5 Months,79.6,73.3 to 84.7,217
DTaP,≥2 Doses,States/Local Areas,Wyoming,2013,Age,5 Months,81.6,75.6 to 86.3,215
DTaP,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,5 Months,76.1,70.4 to 81.0,480
Polio,≥3 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,90.2,85.7 to 93.8,265
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,91.9,88.9 to 94.3,548
Polio,≥3 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,94.1,89.1 to 97.3,215
Polio,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,92.1,89.0 to 94.7,480
Hib,Full Series,States/Local Areas,Wyoming,2014,Age,35 Months,77.6,71.2 to 83.4,265
Hib,Full Series,States/Local Areas,Wyoming,2014-2015,Age,35 Months,80.1,75.0 to 84.8,548
Hib,Full Series,States/Local Areas,Wyoming,2015,Age,35 Months,83.1,74.7 to 89.9,283
Hib,Full Series,States/Local Areas,Wyoming,2015-2016,Age,35 Months,84.0,78.9 to 88.5,514
Hib,Full Series,States/Local Areas,Wyoming,2016,Age,35 Months,84.9,79.3 to 89.7,231
Hib,Full Series,States/Local Areas,Wyoming,2016-2017,Age,35 Months,83.7,79.5 to 87.4,518
Hib,Full Series,States/Local Areas,Wyoming,2018,Age,24 Months,81.8,75.4 to 87.3,280
Hib,Full Series,States/Local Areas,Wyoming,2018-2019,Age,24 Months,81.8,77.3 to 86.0,540
Hib,Full Series,States/Local Areas,Wyoming,2019,Age,24 Months,81.9,75.0 to 87.9,260
Hib,Full Series,States/Local Areas,Wyoming,2012,Age,35 Months,94.4,80.8 to 99.3,217
Hib,Full Series,States/Local Areas,Wyoming,2011,Age,35 Months,74.2,65.7 to 82.1,214
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,93.5,91.5 to 95.6,595
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,88.9,84.8 to 93.1,258
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,80.1,69.5 to 90.7,59
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,91.8,84.1 to 99.4,37
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,75.6,60.5 to 90.6,37
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.9,91.9 to 99.8,74
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,90.4,85.2 to 95.7,117
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.6,88.3 to 92.9,754
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,92.5,89.5 to 95.6,291
Polio,≥3 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,92.9,88.9 to 95.8,287
Polio,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,93.4,90.5 to 95.7,567
Polio,≥3 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,94.0,89.5 to 97.0,280
Polio,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,94.7,91.2 to 97.1,540
Hib,Full Series,States/Local Areas,Wyoming,2017,Age,35 Months,82.3,75.9 to 87.8,287
Hib,Full Series,States/Local Areas,Wyoming,2017-2018,Age,35 Months,84.2,79.5 to 88.4,567
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,80.5,76.8 to 84.3,595
Hib,Full Series,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,72.7,66.3 to 79.0,258
Hib,Full Series,States/Local Areas,Wyoming,2018,Age,35 Months,86.8,79.2 to 92.6,280
Hib,Full Series,States/Local Areas,Wyoming,2018-2019,Age,35 Months,84.4,79.4 to 88.7,540
Hib,Full Series,States/Local Areas,Wyoming,2014,Age,24 Months,75.2,68.8 to 81.2,265
Hib,Full Series,States/Local Areas,Wyoming,2014-2015,Age,24 Months,75.5,71.0 to 79.8,548
DTaP,≥3 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,90.3,84.0 to 94.9,214
DTaP,≥3 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,93.4,88.2 to 96.4,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,92.1,85.8 to 96.3,217
Polio,≥3 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,93.3,88.9 to 96.4,280
Polio,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,93.1,89.8 to 95.7,540
Polio,≥3 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,93.0,87.6 to 96.7,260
Polio,≥3 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,91.1,86.5 to 94.6,287
Polio,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,92.1,89.0 to 94.5,567
Hib,Full Series,States/Local Areas,Wyoming,2017,Age,24 Months,79.8,73.4 to 85.4,287
Hib,Full Series,States/Local Areas,Wyoming,2017-2018,Age,24 Months,80.7,76.3 to 84.8,567
Polio,≥3 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,91.4,84.3 to 96.1,214
Hib,Full Series,States/Local Areas,Wyoming,2016,Age,24 Months,83.9,78.2 to 88.7,231
Hib,Full Series,States/Local Areas,Wyoming,2016-2017,Age,24 Months,82.0,77.8 to 85.8,518
Hib,Full Series,States/Local Areas,Wyoming,2015,Age,24 Months,75.9,69.4 to 81.9,283
Hib,Full Series,States/Local Areas,Wyoming,2015-2016,Age,24 Months,80.0,75.7 to 83.9,514
Polio,≥3 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,92.5,88.1 to 95.7,231
Polio,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,91.9,88.8 to 94.4,518
Hib,≥3 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,86.5,80.5 to 90.9,280
Hib,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,56.1,50.5 to 61.6,540
Hib,≥3 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,88.7,82.6 to 92.9,260
Hib,≥3 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,86.9,80.3 to 92.2,214
Hib,≥3 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,90.9,84.6 to 95.4,217
Hib,≥3 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,91.0,85.2 to 95.1,215
Hib,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,87.4,83.5 to 90.7,480
Hib,≥3 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,82.1,75.9 to 86.9,265
Hib,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,83.6,79.5 to 87.1,548
Hib,≥3 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,89.5,86.3 to 92.1,215
Hib,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,85.9,80.8 to 89.8,480
Polio,≥3 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,89.0,81.6 to 94.4,217
Polio,≥3 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,88.8,82.1 to 93.7,214
Hib,≥3 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,85.2,82.4 to 87.7,283
Hib,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,85.7,81.5 to 89.0,514
Polio,≥3 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,90.5,85.4 to 94.0,280
Polio,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,68.2,62.9 to 73.2,540
Polio,≥2 Doses,States/Local Areas,Wyoming,2020,Age,13 Months,90.9,85.6 to 94.4,296
Hib,≥3 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,56.0,47.8 to 63.9,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,95.3,88.5 to 98.1,215
DTaP,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,92.5,86.9 to 95.8,480
Polio,≥3 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,91.1,85.1 to 94.9,260
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,89.6,85.0 to 92.9,265
DTaP,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,91.0,87.9 to 93.4,548
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,92.4,90.1 to 94.1,283
DTaP,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,91.3,87.9 to 93.8,514
Hib,≥3 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,86.1,80.0 to 90.6,231
Hib,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,86.9,83.0 to 90.0,518
Hib,≥3 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,87.8,82.7 to 91.6,287
Hib,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,87.2,83.4 to 90.2,567
Polio,≥3 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,93.6,88.6 to 96.9,215
Polio,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,91.3,88.2 to 93.9,480
Polio,≥3 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,88.9,84.5 to 92.5,265
Polio,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,90.5,87.6 to 93.1,548
Polio,≥3 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,92.2,87.9 to 95.4,283
Polio,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,92.3,89.3 to 94.7,514
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,92.2,87.9 to 95.0,280
DTaP,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,91.0,87.7 to 93.5,540
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,90.3,84.9 to 94.0,231
DTaP,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,90.0,86.4 to 92.7,518
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,89.6,84.3 to 93.3,287
DTaP,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,90.8,87.5 to 93.3,567
≥1 Dose Varicella,,States/Local Areas,Wyoming,2012,Age,19 Months,84.6,79.5 to 88.6,217
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,69.5,64.8 to 74.1,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2011,Age,19 Months,78.6,73.5 to 82.9,214
≥1 Dose MMR,,States/Local Areas,Wyoming,2013,Age,13 Months,61.8,58.3 to 65.1,215
≥1 Dose MMR,,States/Local Areas,Wyoming,2013-2014,Age,13 Months,61.4,59.5 to 63.2,480
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018,Age,13 Months,64.5,56.8 to 71.4,280
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018-2019,Age,13 Months,67.6,62.3 to 72.5,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2014,Age,13 Months,60.9,53.4 to 68.0,265
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2015,Age,13 Months,61.2,56.1 to 66.1,548
≥1 Dose MMR,,States/Local Areas,Wyoming,2015,Age,13 Months,61.5,54.4 to 68.1,283
≥1 Dose MMR,,States/Local Areas,Wyoming,2015-2016,Age,13 Months,59.6,54.3 to 64.6,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,77.1,68.5 to 84.8,214
Hep A,≥2 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,70.1,60.0 to 79.7,280
Hep A,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,76.3,68.4 to 83.5,540
Hep A,≥2 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,67.2,58.3 to 75.8,287
Hep A,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,68.2,61.5 to 74.8,567
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,86.3,81.1 to 90.3,265
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,86.4,82.6 to 89.5,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,88.9,81.1 to 93.7,215
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,87.6,82.5 to 91.4,480
DTaP,≥4 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,87.0,79.5 to 92.7,215
DTaP,≥4 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,85.2,80.5 to 89.4,480
Hep B,≥3 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,88.6,85.1 to 91.3,217
Hep A,≥2 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,82.8,71.2 to 91.7,260
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,83.4,76.9 to 89.0,265
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,81.6,76.5 to 86.2,548
DTaP,≥4 Doses,States/Local Areas,Wyoming,2012,Age,35 Months,91.8,80.4 to 97.8,217
Polio,≥2 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,82.5,76.5 to 87.3,265
Polio,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,85.6,81.7 to 88.7,548
Polio,≥2 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,91.5,84.2 to 95.6,215
Polio,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,87.1,80.0 to 91.9,480
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Overall,Overall,68.7,65.2 to 72.2,949
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,68.3,61.5 to 75.2,247
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,81.8,74.8 to 87.3,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,84.0,76.1 to 89.6,214
Polio,≥2 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,88.6,83.4 to 92.3,283
Polio,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,88.6,85.0 to 91.4,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017,Age,13 Months,62.6,55.2 to 69.4,287
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017-2018,Age,13 Months,63.5,58.2 to 68.4,567
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016,Age,13 Months,57.4,49.6 to 64.8,231
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2017,Age,13 Months,59.8,54.4 to 64.9,518
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.2,52.7 to 77.8,74
Hib,≥3 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,91.3,85.5 to 95.4,260
DTaP,≥4 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,67.3,59.9 to 74.0,280
DTaP,≥4 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,93.0,89.4 to 95.5,540
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015,Age,13 Months,61.0,53.9 to 67.7,283
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015-2016,Age,13 Months,59.1,53.9 to 64.2,514
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,68.8,64.5 to 73.1,630
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.3,63.3 to 71.3,754
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,67.8,61.6 to 74.0,291
≥1 Dose MMR,,States/Local Areas,Wyoming,2011,Age,13 Months,49.1,45.3 to 53.0,214
DTaP,≥4 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,76.3,69.5 to 82.6,280
DTaP,≥4 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,78.4,73.5 to 82.9,540
DTaP,≥4 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,77.8,71.4 to 83.5,287
DTaP,≥4 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,77.1,72.5 to 81.5,567
DTaP,≥4 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,80.2,73.1 to 86.4,260
Polio,≥2 Doses,States/Local Areas,Wyoming,2019,Age,5 Months,82.1,75.1 to 87.5,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,78.7,71.9 to 84.2,280
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,80.3,75.6 to 84.3,540
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,87.1,81.1 to 91.4,287
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,88.7,84.8 to 91.7,567
≥1 Dose MMR,,States/Local Areas,Wyoming,2018,Age,13 Months,66.9,59.4 to 73.6,280
≥1 Dose MMR,,States/Local Areas,Wyoming,2018-2019,Age,13 Months,68.2,62.9 to 73.2,540
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,56.3,51.7 to 60.9,949
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,55.8,50.2 to 61.4,630
Hep B,≥1 Dose,States/Local Areas,Wyoming,2016,Age,3 Months,95.0,90.7 to 97.4,231
Hep B,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,3 Months,94.6,91.8 to 96.5,518
Hep B,≥1 Dose,States/Local Areas,Wyoming,2015,Age,3 Months,93.4,89.3 to 96.0,283
Hep B,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,3 Months,94.3,91.5 to 96.2,514
Hep B,≥1 Dose,States/Local Areas,Wyoming,2014,Age,3 Months,90.5,85.6 to 93.8,265
Hep B,≥1 Dose,States/Local Areas,Wyoming,2014-2015,Age,3 Months,92.0,89.0 to 94.2,548
Polio,≥2 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,94.7,86.6 to 98.0,215
Polio,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,92.0,86.0 to 95.6,480
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014,Age,19 Months,83.4,77.8 to 87.7,265
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2015,Age,19 Months,83.5,79.6 to 86.8,548
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015,Age,19 Months,83.6,78.4 to 87.8,283
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015-2016,Age,19 Months,84.3,80.2 to 87.7,514
Polio,≥2 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,91.5,87.7 to 94.2,214
Polio,≥2 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,92.4,87.5 to 95.4,217
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013,Age,19 Months,89.1,86.3 to 91.4,215
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013-2014,Age,19 Months,86.3,84.0 to 88.3,480
≥1 Dose MMR,,States/Local Areas,Wyoming,2016,Age,13 Months,57.7,49.9 to 65.1,231
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2017,Age,13 Months,60.8,55.5 to 65.9,518
≥1 Dose MMR,,States/Local Areas,Wyoming,2017,Age,13 Months,64.4,57.1 to 71.0,287
≥1 Dose MMR,,States/Local Areas,Wyoming,2017-2018,Age,13 Months,65.6,60.4 to 70.4,567
Polio,≥2 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,87.9,81.8 to 92.1,287
Polio,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,87.5,83.4 to 90.7,567
Polio,≥2 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,88.6,83.0 to 92.5,231
Polio,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,88.3,84.3 to 91.3,518
Hep B,≥1 Dose,States/Local Areas,Wyoming,2011,Age,3 Months,90.1,86.9 to 92.6,214
Hep B,≥1 Dose,States/Local Areas,Wyoming,2012,Age,3 Months,93.4,88.0 to 96.4,217
Hep B,≥1 Dose,States/Local Areas,Wyoming,2013,Age,3 Months,92.3,83.5 to 96.6,215
Hep B,≥1 Dose,States/Local Areas,Wyoming,2013-2014,Age,3 Months,91.4,84.9 to 95.3,480
Polio,≥2 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,87.0,80.9 to 91.4,280
Polio,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,88.8,84.8 to 91.9,540
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019,Age,13 Months,70.5,62.7 to 77.3,260
Hep A,≥1 Dose,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,67.0,59.0 to 75.1,188
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,90.6,86.4 to 93.6,265
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,89.7,86.4 to 92.3,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,88.9,86.7 to 90.7,283
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,89.7,86.1 to 92.5,514
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,94.7,85.7 to 98.2,215
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,92.7,87.4 to 95.9,480
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,61.7,51.8 to 71.6,188
Hep B,≥2 Doses,States/Local Areas,Wyoming,2013,Age,5 Months,88.0,75.8 to 94.5,215
Hep B,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,5 Months,84.4,74.9 to 90.7,480
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2011,Age,0-1 Days,65.8,61.4 to 70.0,214
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,56.7,50.8 to 62.7,514
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,52.1,42.3 to 61.8,247
Hep B,≥2 Doses,States/Local Areas,Wyoming,2011,Age,5 Months,84.5,78.8 to 88.9,214
Hep B,≥2 Doses,States/Local Areas,Wyoming,2012,Age,5 Months,87.4,84.4 to 89.9,217
Polio,≥2 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,89.2,84.4 to 92.6,265
Polio,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,90.8,87.7 to 93.2,548
Hep B,≥1 Dose,States/Local Areas,Wyoming,2018,Age,3 Months,96.4,92.0 to 98.4,280
Hep B,≥1 Dose,States/Local Areas,Wyoming,2018-2019,Age,3 Months,96.4,93.4 to 98.1,540
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,76.4,70.6 to 82.2,291
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,71.8,67.6 to 76.1,630
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Overall,Overall,73.6,70.2 to 77.0,949
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.8,54.1 to 79.5,74
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.1,71.3 to 78.8,754
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,69.2,59.6 to 78.9,117
Hep B,≥1 Dose,States/Local Areas,Wyoming,2019,Age,3 Months,96.5,91.1 to 98.7,260
≥1 Dose MMR,,States/Local Areas,Wyoming,2016,Age,19 Months,85.8,79.7 to 90.3,231
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2017,Age,19 Months,86.5,82.5 to 89.6,518
≥1 Dose MMR,,States/Local Areas,Wyoming,2015,Age,19 Months,85.2,81.5 to 88.2,283
≥1 Dose MMR,,States/Local Areas,Wyoming,2015-2016,Age,19 Months,85.5,81.4 to 88.8,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2012,Age,24 Months,90.5,85.1 to 94.6,217
≥1 Dose Varicella,,States/Local Areas,Wyoming,2011,Age,24 Months,84.5,77.6 to 90.3,214
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,67.1,60.3 to 74.0,247
≥1 Dose MMR,,States/Local Areas,Wyoming,2014,Age,19 Months,86.3,81.2 to 90.2,265
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2015,Age,19 Months,85.8,82.0 to 88.9,548
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017,Age,19 Months,83.4,77.0 to 88.3,287
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017-2018,Age,19 Months,85.1,80.8 to 88.6,567
≥1 Dose MMR,,States/Local Areas,Wyoming,2012,Age,19 Months,85.2,79.7 to 89.4,217
≥1 Dose MMR,,States/Local Areas,Wyoming,2013,Age,19 Months,92.2,90.3 to 93.7,215
≥1 Dose MMR,,States/Local Areas,Wyoming,2013-2014,Age,19 Months,89.3,86.7 to 91.4,480
Hep B,≥1 Dose,States/Local Areas,Wyoming,2017,Age,3 Months,94.1,89.7 to 96.7,287
Hep B,≥1 Dose,States/Local Areas,Wyoming,2017-2018,Age,3 Months,95.2,92.4 to 97.0,567
Polio,≥2 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,91.3,86.2 to 94.6,231
Polio,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,92.9,89.9 to 95.0,518
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018,Age,19 Months,87.0,80.9 to 91.4,280
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018-2019,Age,19 Months,67.6,62.3 to 72.5,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2019,Age,13 Months,69.5,61.4 to 76.5,260
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016,Age,19 Months,85.0,78.8 to 89.6,231
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2017,Age,19 Months,84.2,80.0 to 87.8,518
Polio,≥2 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,92.4,88.0 to 95.3,283
Polio,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,91.9,88.7 to 94.2,514
≥1 Dose MMR,,States/Local Areas,Wyoming,2011,Age,19 Months,81.6,77.8 to 84.9,214
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,54.8,40.3 to 69.3,59
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,65.8,48.1 to 83.4,37
DTaP,≥4 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,89.8,79.9 to 96.1,260
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,80.9,77.0 to 84.7,595
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,65.8,58.8 to 72.8,258
DTaP,≥4 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,87.3,79.5 to 93.2,280
DTaP,≥4 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,88.6,82.4 to 93.4,540
PCV,≥3 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,57.8,50.1 to 65.1,265
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,59.9,54.6 to 64.9,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,65.8,63.4 to 68.1,217
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,133% to <400% FPL,72.7,68.0 to 77.3,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2014-2017,Poverty,>400% FPL,86.0,79.5 to 92.6,188
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,90.6,85.2 to 94.1,231
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,90.1,86.5 to 92.8,518
PCV,≥3 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,59.5,53.1 to 65.6,214
PCV,≥3 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,66.8,64.0 to 69.5,215
PCV,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,62.4,58.5 to 66.1,480
Hep B,≥2 Doses,States/Local Areas,Wyoming,2014,Age,5 Months,80.6,74.0 to 85.8,265
Hep B,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,5 Months,82.3,79.3 to 85.0,548
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2012,Age,0-1 Days,72.1,68.8 to 75.2,217
Hep B,≥2 Doses,States/Local Areas,Wyoming,2016,Age,5 Months,84.2,77.6 to 89.1,231
Hep B,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,5 Months,86.6,82.5 to 89.9,518
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,89.5,84.0 to 93.3,287
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,90.4,86.7 to 93.1,567
Polio,≥2 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,94.7,91.2 to 96.8,287
Polio,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,93.5,90.7 to 95.5,567
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013,Age,24 Months,90.3,84.7 to 94.5,215
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013-2014,Age,24 Months,87.7,84.1 to 90.8,480
Polio,≥2 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,92.2,87.2 to 95.4,280
Polio,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,93.0,89.4 to 95.5,540
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019,Age,19 Months,89.6,83.5 to 93.6,260
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2014,Age,0-1 Days,61.8,54.5 to 68.7,265
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2014-2015,Age,0-1 Days,60.3,55.1 to 65.2,548
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2013,Age,0-1 Days,61.7,57.9 to 65.3,215
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2013-2014,Age,0-1 Days,61.8,58.4 to 65.0,480
Hep B,≥2 Doses,States/Local Areas,Wyoming,2015,Age,5 Months,84.0,77.9 to 88.7,283
Hep B,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,5 Months,84.1,79.8 to 87.7,514
Polio,≥2 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,93.8,87.7 to 96.9,260
≥1 Dose MMR,,States/Local Areas,Wyoming,2017,Age,19 Months,87.3,81.9 to 91.2,287
≥1 Dose MMR,,States/Local Areas,Wyoming,2017-2018,Age,19 Months,87.5,83.7 to 90.5,567
PCV,≥4 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,68.5,64.8 to 71.9,214
PCV,≥4 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,79.3,73.4 to 84.1,217
PCV,≥4 Doses,States/Local Areas,Wyoming,2013,Age,19 Months,80.4,78.3 to 82.4,215
PCV,≥4 Doses,States/Local Areas,Wyoming,2013-2014,Age,19 Months,75.8,72.3 to 78.9,480
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015,Age,24 Months,87.1,81.7 to 91.4,283
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015-2016,Age,24 Months,87.9,84.3 to 91.0,514
≥1 Dose MMR,,States/Local Areas,Wyoming,2018,Age,19 Months,87.8,81.9 to 92.0,280
≥1 Dose MMR,,States/Local Areas,Wyoming,2018-2019,Age,19 Months,93.6,90.2 to 95.8,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2011,Age,24 Months,88.0,81.5 to 93.1,214
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016,Age,24 Months,88.7,83.7 to 92.8,231
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2017,Age,24 Months,89.1,85.7 to 92.0,518
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2018,Age,0-1 Days,76.7,69.5 to 82.7,280
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2018-2019,Age,0-1 Days,80.1,75.3 to 84.1,540
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019,Age,19 Months,94.4,89.2 to 97.1,260
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2011,Age,0-2 Days,67.7,62.5 to 72.6,214
Hep B,≥2 Doses,States/Local Areas,Wyoming,2013,Age,7 Months,93.8,87.6 to 97.0,215
Hep B,≥2 Doses,States/Local Areas,Wyoming,2013-2014,Age,7 Months,91.2,85.0 to 95.0,480
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2012,Age,0-2 Days,73.6,71.5 to 75.6,217
Hep B,≥2 Doses,States/Local Areas,Wyoming,2014,Age,7 Months,88.5,83.4 to 92.1,265
Hep B,≥2 Doses,States/Local Areas,Wyoming,2014-2015,Age,7 Months,90.1,86.9 to 92.6,548
Hep B,≥2 Doses,States/Local Areas,Wyoming,2012,Age,7 Months,90.9,88.2 to 93.1,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,70.6,63.5 to 76.8,287
PCV,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,69.7,64.7 to 74.4,567
PCV,≥3 Doses,States/Local Areas,Wyoming,2018,Age,7 Months,68.7,61.3 to 75.4,280
PCV,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,7 Months,71.4,66.2 to 76.1,540
PCV,≥3 Doses,States/Local Areas,Wyoming,2011,Age,13 Months,84.2,81.3 to 86.7,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,91.2,87.3 to 94.2,265
Hep B,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,90.8,87.7 to 93.4,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015,Age,24 Months,90.4,85.4 to 94.3,283
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,24 Months,91.4,88.2 to 94.0,514
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016,Age,24 Months,92.3,88.0 to 95.5,231
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,24 Months,91.7,88.6 to 94.3,518
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2019,Age,0-1 Days,83.2,76.4 to 88.4,260
Hep B,≥2 Doses,States/Local Areas,Wyoming,2011,Age,7 Months,89.0,85.0 to 92.0,214
PCV,≥3 Doses,States/Local Areas,Wyoming,2012,Age,13 Months,88.0,85.1 to 90.4,217
≥1 Dose MMR,,States/Local Areas,Wyoming,2016,Age,24 Months,89.2,84.1 to 93.2,231
≥1 Dose MMR,,States/Local Areas,Wyoming,2016-2017,Age,24 Months,90.5,87.2 to 93.2,518
≥1 Dose MMR,,States/Local Areas,Wyoming,2017,Age,24 Months,92.2,87.7 to 95.4,287
≥1 Dose MMR,,States/Local Areas,Wyoming,2017-2018,Age,24 Months,91.8,88.5 to 94.4,567
PCV,≥4 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,77.7,70.6 to 83.4,280
PCV,≥4 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,79.7,74.1 to 84.3,439
PCV,≥4 Doses,States/Local Areas,Wyoming,2017,Age,19 Months,78.3,71.4 to 83.8,287
PCV,≥4 Doses,States/Local Areas,Wyoming,2017-2018,Age,19 Months,78.0,73.2 to 82.1,567
PCV,≥4 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,78.9,72.0 to 84.5,231
PCV,≥4 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,78.6,73.8 to 82.7,518
PCV,≥4 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,73.2,62.6 to 81.8,283
PCV,≥4 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,76.1,71.4 to 80.3,514
PCV,≥4 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,70.9,63.9 to 77.1,265
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,72.1,67.2 to 76.5,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,62.0,54.7 to 68.7,283
PCV,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,63.7,58.4 to 68.6,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,65.3,57.5 to 72.4,231
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,67.8,62.5 to 72.6,518
Hep B,≥3 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,89.8,83.5 to 94.4,217
Hep B,≥2 Doses,States/Local Areas,Wyoming,2018,Age,5 Months,87.6,81.3 to 92.0,280
Hep B,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,5 Months,90.6,86.8 to 93.3,540
Hep B,≥2 Doses,States/Local Areas,Wyoming,2019,Age,5 Months,93.3,88.1 to 96.4,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,95.0,91.8 to 97.3,215
Hep B,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,93.1,90.7 to 95.1,480
Hep B,≥3 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,88.9,83.0 to 93.5,214
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018,Age,24 Months,92.1,87.0 to 95.8,280
≥1 Dose Varicella,,States/Local Areas,Wyoming,2018-2019,Age,24 Months,91.6,87.9 to 94.5,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2014,Age,24 Months,87.8,83.2 to 91.6,265
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2015,Age,24 Months,87.9,84.4 to 90.9,548
≥1 Dose MMR,,States/Local Areas,Wyoming,2013,Age,24 Months,92.7,87.4 to 96.4,215
≥1 Dose MMR,,States/Local Areas,Wyoming,2013-2014,Age,24 Months,90.3,87.0 to 93.1,480
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017,Age,24 Months,89.8,85.0 to 93.6,287
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017-2018,Age,24 Months,90.9,87.5 to 93.7,567
≥1 Dose Varicella,,States/Local Areas,Wyoming,2019,Age,24 Months,90.8,85.2 to 94.9,260
Hep A,≥1 Dose,States/Local Areas,Wyoming,2020,Age,35 Months,83.5,76.6 to 89.3,296
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,33.1,11.9 to 54.4,37
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,59.0,53.3 to 64.8,595
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,57.8,48.7 to 67.0,258
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,87.0,80.8 to 91.4,231
Hep B,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,87.0,82.9 to 90.3,518
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,86.5,80.5 to 90.8,283
Hep B,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,86.7,82.7 to 90.0,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,80.2,72.2 to 87.2,283
DTaP,≥4 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,83.7,78.4 to 88.4,514
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016,Age,35 Months,86.4,80.0 to 91.6,231
DTaP,≥4 Doses,States/Local Areas,Wyoming,2016-2017,Age,35 Months,85.0,80.4 to 89.1,518
DTaP,≥4 Doses,States/Local Areas,Wyoming,2017,Age,35 Months,82.9,76.2 to 88.7,287
DTaP,≥4 Doses,States/Local Areas,Wyoming,2017-2018,Age,35 Months,85.1,80.0 to 89.4,567
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,40.5,25.2 to 55.8,59
≥1 Dose MMR,,States/Local Areas,Wyoming,2012,Age,13 Months,56.0,50.2 to 61.5,217
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",55.7,50.8 to 60.7,754
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,57.0,48.8 to 65.2,291
Hep B,≥3 Doses,States/Local Areas,Wyoming,2011,Age,19 Months,87.2,82.0 to 91.0,214
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,93.1,88.0 to 96.2,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,90.5,85.0 to 94.1,280
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,91.8,88.3 to 94.4,540
Polio,≥2 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,90.5,84.5 to 94.4,260
Hep B,≥3 Doses,States/Local Areas,Wyoming,2012,Age,19 Months,89.8,86.5 to 92.3,217
≥1 Dose MMR,,States/Local Areas,Wyoming,2019,Age,19 Months,90.6,84.5 to 94.4,260
PCV,≥4 Doses,States/Local Areas,Wyoming,2020,Age,35 Months,79.5,72.5 to 85.7,296
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014,Age,24 Months,84.9,79.9 to 89.3,265
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2015,Age,24 Months,86.0,82.5 to 89.2,548
Hep B,≥2 Doses,States/Local Areas,Wyoming,2017,Age,5 Months,89.4,84.0 to 93.1,287
Hep B,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,5 Months,88.5,84.7 to 91.5,567
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018,Age,19 Months,91.3,85.9 to 94.8,280
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,19 Months,91.8,88.3 to 94.4,540
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2015,Age,0-1 Days,58.7,51.5 to 65.6,283
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2015-2016,Age,0-1 Days,60.1,54.8 to 65.2,514
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2017,Age,0-1 Days,78.1,71.7 to 83.4,287
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2017-2018,Age,0-1 Days,77.5,72.8 to 81.6,567
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2016,Age,0-1 Days,61.5,53.7 to 68.7,231
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wyoming,2016-2017,Age,0-1 Days,69.3,64.1 to 74.0,518
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",47.0,27.8 to 66.2,74
Hep A,≥2 Doses,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,63.5,50.3 to 76.7,117
≥1 Dose Varicella,,States/Local Areas,Wyoming,2011,Age,35 Months,86.4,79.4 to 91.9,214
≥1 Dose MMR,,States/Local Areas,Wyoming,2012,Age,24 Months,91.7,86.8 to 95.3,217
Hep B,≥2 Doses,States/Local Areas,Wyoming,2017,Age,7 Months,91.3,85.9 to 94.7,287
Hep B,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,7 Months,91.2,87.5 to 93.9,567
PCV,≥3 Doses,States/Local Areas,Wyoming,2013,Age,13 Months,89.4,86.4 to 91.7,215
PCV,≥3 Doses,States/Local Areas,Wyoming,2013-2014,Age,13 Months,85.6,82.7 to 88.1,480
Hep B,≥2 Doses,States/Local Areas,Wyoming,2016,Age,7 Months,91.9,86.9 to 95.1,231
Hep B,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,7 Months,91.6,88.2 to 94.1,518
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018,Age,24 Months,92.1,87.3 to 95.6,280
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,24 Months,93.6,90.4 to 96.0,540
Hep B,≥2 Doses,States/Local Areas,Wyoming,2015,Age,7 Months,91.7,87.1 to 94.7,283
Hep B,≥2 Doses,States/Local Areas,Wyoming,2015-2016,Age,7 Months,91.8,88.6 to 94.1,514
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2013,Age,0-2 Days,63.0,59.5 to 66.4,215
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2013-2014,Age,0-2 Days,62.5,59.5 to 65.5,480
PCV,≥3 Doses,States/Local Areas,Wyoming,2014,Age,13 Months,81.7,75.6 to 86.5,265
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,13 Months,83.8,79.6 to 87.3,548
PCV,≥3 Doses,States/Local Areas,Wyoming,2015,Age,13 Months,85.9,79.7 to 90.4,283
PCV,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,13 Months,85.8,81.5 to 89.2,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014,Age,35 Months,87.0,82.1 to 91.1,265
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2015,Age,35 Months,87.7,84.2 to 90.8,548
≥1 Dose MMR,,States/Local Areas,Wyoming,2015,Age,24 Months,88.0,82.6 to 92.3,283
≥1 Dose MMR,,States/Local Areas,Wyoming,2015-2016,Age,24 Months,88.6,85.0 to 91.7,514
≥1 Dose Varicella,,States/Local Areas,Wyoming,2012,Age,35 Months,93.8,88.8 to 97.1,217
PCV,≥3 Doses,States/Local Areas,Wyoming,2019,Age,7 Months,73.8,66.3 to 80.2,260
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013,Age,35 Months,92.6,87.7 to 96.1,215
≥1 Dose Varicella,,States/Local Areas,Wyoming,2013-2014,Age,35 Months,89.9,86.6 to 92.7,480
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2014,Age,0-2 Days,62.0,54.7 to 68.9,265
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2014-2015,Age,0-2 Days,61.4,56.3 to 66.3,548
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2015,Age,0-2 Days,60.8,53.7 to 67.5,283
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2015-2016,Age,0-2 Days,62.3,57.0 to 67.3,514
≥1 Dose MMR,,States/Local Areas,Wyoming,2018,Age,24 Months,91.4,86.3 to 95.1,280
≥1 Dose MMR,,States/Local Areas,Wyoming,2018-2019,Age,24 Months,91.7,88.1 to 94.6,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2019,Age,24 Months,91.9,86.4 to 95.8,260
≥1 Dose MMR,,States/Local Areas,Wyoming,2012,Age,35 Months,94.3,89.6 to 97.4,217
≥1 Dose MMR,,States/Local Areas,Wyoming,2011,Age,35 Months,88.9,82.3 to 93.9,214
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016,Age,35 Months,92.3,87.3 to 95.9,231
≥1 Dose Varicella,,States/Local Areas,Wyoming,2016-2017,Age,35 Months,91.9,88.4 to 94.6,518
≥1 Dose MMR,,States/Local Areas,Wyoming,2013,Age,35 Months,94.5,90.1 to 97.4,215
≥1 Dose MMR,,States/Local Areas,Wyoming,2013-2014,Age,35 Months,92.3,89.3 to 94.7,480
PCV,≥4 Doses,States/Local Areas,Wyoming,2014,Age,24 Months,76.8,70.6 to 82.5,265
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2015,Age,24 Months,77.6,73.2 to 81.7,548
PCV,≥4 Doses,States/Local Areas,Wyoming,2013,Age,24 Months,82.1,74.8 to 88.4,215
PCV,≥4 Doses,States/Local Areas,Wyoming,2013-2014,Age,24 Months,79.6,74.9 to 83.9,480
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017,Age,24 Months,91.0,86.2 to 94.6,287
Hep B,≥3 Doses,States/Local Areas,Wyoming,2017-2018,Age,24 Months,91.5,88.3 to 94.2,567
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019,Age,24 Months,94.9,90.3 to 97.7,260
PCV,≥4 Doses,States/Local Areas,Wyoming,2012,Age,24 Months,83.4,76.2 to 89.5,217
Hep B,≥3 Doses,States/Local Areas,Wyoming,2011,Age,35 Months,90.1,84.1 to 94.5,214
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2017,Age,0-2 Days,80.2,74.1 to 85.2,287
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2017-2018,Age,0-2 Days,79.0,74.4 to 82.9,567
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2016,Age,0-2 Days,63.7,55.9 to 70.8,231
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wyoming,2016-2017,Age,0-2 Days,71.4,66.3 to 76.0,518
PCV,≥4 Doses,States/Local Areas,Wyoming,2011,Age,24 Months,74.5,66.3 to 82.1,214
Hep B,≥2 Doses,States/Local Areas,Wyoming,2017,Age,13 Months,94.2,89.9 to 96.7,287
Hep B,≥2 Doses,States/Local Areas,Wyoming,2017-2018,Age,13 Months,94.0,91.1 to 96.0,567
Hib,≥1 Dose,States/Local Areas,Wyoming,2016,Age,3 Months,86.4,80.3 to 90.8,231
Hib,≥1 Dose,States/Local Areas,Wyoming,2016-2017,Age,3 Months,88.1,84.2 to 91.2,518
Hib,≥1 Dose,States/Local Areas,Wyoming,2015,Age,3 Months,86.9,81.4 to 91.0,283
Hib,≥1 Dose,States/Local Areas,Wyoming,2015-2016,Age,3 Months,86.7,82.7 to 89.8,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2016,Age,19 Months,89.2,83.7 to 93.0,231
PCV,≥3 Doses,States/Local Areas,Wyoming,2016-2017,Age,19 Months,89.0,85.3 to 91.8,518
PCV,≥3 Doses,States/Local Areas,Wyoming,2015,Age,19 Months,89.5,86.5 to 91.9,283
PCV,≥3 Doses,States/Local Areas,Wyoming,2015-2016,Age,19 Months,89.3,85.6 to 92.2,514
Hep B,≥2 Doses,States/Local Areas,Wyoming,2016,Age,13 Months,93.0,88.4 to 95.9,231
Hep B,≥2 Doses,States/Local Areas,Wyoming,2016-2017,Age,13 Months,93.6,90.6 to 95.6,518
Hep B,≥2 Doses,States/Local Areas,Wyoming,2018,Age,13 Months,93.8,89.1 to 96.6,280
Hep B,≥2 Doses,States/Local Areas,Wyoming,2018-2019,Age,13 Months,94.9,91.8 to 96.9,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2018,Age,35 Months,95.1,87.6 to 98.7,280
≥1 Dose MMR,,States/Local Areas,Wyoming,2018-2019,Age,35 Months,95.3,91.6 to 97.7,540
≥1 Dose MMR,,States/Local Areas,Wyoming,2017,Age,35 Months,92.6,88.2 to 95.8,287
≥1 Dose MMR,,States/Local Areas,Wyoming,2017-2018,Age,35 Months,93.3,89.6 to 96.1,567
≥1 Dose MMR,,States/Local Areas,Wyoming,2019,Age,35 Months,96.4,92.4 to 98.6,260
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,85.5 to 98.3,74
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Other,82.3,70.0 to 94.5,37
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.6,82.7 to 88.4,754
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,85.3 to 93.0,291
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Urbanicity,Living In a Non-MSA,85.3,82.0 to 88.5,630
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Overall,Overall,86.5,84.1 to 89.0,949
≥1 Dose Varicella,,States/Local Areas,Wyoming,2014-2017,Poverty,<133% FPL,81.6,76.3 to 86.9,247
PCV,≥4 Doses,States/Local Areas,Wyoming,2014,Age,35 Months,78.5,72.2 to 84.2,265
PCV,≥4 Doses,States/Local Areas,Wyoming,2014-2015,Age,35 Months,79.3,74.9 to 83.4,548
PCV,≥4 Doses,States/Local Areas,Wyoming,2015,Age,35 Months,80.2,73.8 to 85.9,283
PCV,≥4 Doses,States/Local Areas,Wyoming,2015-2016,Age,35 Months,84.1,79.9 to 87.9,514
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Uninsured,74.5,62.2 to 86.9,59
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,82.1 to 96.5,74
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Race and Ethnicity,Hispanic,86.6,79.4 to 93.8,117
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Any Medicaid,85.8,81.0 to 90.6,258
≥1 Dose MMR,,States/Local Areas,Wyoming,2014-2017,Insurance Coverage,Private Insurance Only,91.5,88.9 to 94.1,595
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018,Age,35 Months,96.3,89.5 to 99.2,280
Hep B,≥3 Doses,States/Local Areas,Wyoming,2018-2019,Age,35 Months,97.2,93.3 to 99.1,540
PCV,≥3 Doses,States/Local Areas,Wyoming,2014,Age,19 Months,86.7,81.5 to 90.6,265
PCV,≥3 Doses,States/Local Areas,Wyoming,2014-2015,Age,19 Months,88.1,84.5 to 90.9,548
Hep B,≥3 Doses,States/Local Areas,Wyoming,2019,Age,35 Months,96.8,93.3 to 98.8,260
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017,Age,35 Months,91.3,86.4 to 94.9,287
≥1 Dose Varicella,,States/Local Areas,Wyoming,2017-2018,Age,35 Months,93.0,89.0 to 95.9,567
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015,Age,35 Months,88.4,83.1 to 92.7,283
≥1 Dose Varicella,,States/Local Areas,Wyoming,2015-2016,Age,35 Months,90.5,87.0 to 93.5,514
PCV,≥3 Doses,States/Local Areas,Wyoming,2019,Age,13 Months,92.0,86.7 to 95.2,260
PCV,≥4 Doses,States/Local Areas,Wyoming,2013,Age,35 Months,88.9,82.6 to 93.7,215
PCV,≥4 Doses,States/Local Areas,Wyoming,2013-2014,Age,35 Months,83.8,79.3 to 87.7,480
PCV,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,90.9,86.7 to 93.9,632
Influenza,,States/Local Areas,Mississippi,2012,Age,24 Months,28.8,21.9 to 37.3,230
Influenza,,States/Local Areas,Mississippi,2011,Age,24 Months,25.6,19.0 to 34.0,198
Influenza,,States/Local Areas,Mississippi,2014,Age,24 Months,29.8,23.2 to 37.9,239
Influenza,,States/Local Areas,Mississippi,2014-2015,Age,24 Months,31.9,27.2 to 37.1,511
Influenza,,States/Local Areas,Mississippi,2015,Age,24 Months,33.9,27.6 to 41.1,272
Influenza,,States/Local Areas,Mississippi,2015-2016,Age,24 Months,40.4,35.5 to 45.8,579
Influenza,,States/Local Areas,Mississippi,2016,Age,24 Months,46.9,39.7 to 54.8,307
Influenza,,States/Local Areas,Mississippi,2013,Age,24 Months,32.6,25.0 to 41.7,217
Influenza,,States/Local Areas,Mississippi,2013-2014,Age,24 Months,31.2,26.1 to 37.1,456
Hib,Full Series,States/Local Areas,Mississippi,2020-2021,Age,24 Months,71.6,65.0 to 77.8,505
Rotavirus,,States/Local Areas,Mississippi,2016,Age,8 Months,71.3,63.8 to 77.8,307
Rotavirus,,States/Local Areas,Mississippi,2016-2017,Age,8 Months,69.6,64.3 to 74.5,628
Rotavirus,,States/Local Areas,Mississippi,2013,Age,8 Months,69.4,60.5 to 77.0,217
Rotavirus,,States/Local Areas,Mississippi,2013-2014,Age,8 Months,69.2,63.3 to 74.6,456
Rotavirus,,States/Local Areas,Mississippi,2012,Age,8 Months,69.0,60.0 to 76.7,230
Rotavirus,,States/Local Areas,Mississippi,2014,Age,8 Months,69.0,60.9 to 76.1,239
Rotavirus,,States/Local Areas,Mississippi,2014-2015,Age,8 Months,67.4,62.0 to 72.3,511
Rotavirus,,States/Local Areas,Mississippi,2018,Age,8 Months,63.8,55.4 to 71.4,276
Rotavirus,,States/Local Areas,Mississippi,2018-2019,Age,8 Months,64.0,58.2 to 69.4,600
Rotavirus,,States/Local Areas,Mississippi,2019,Age,8 Months,64.1,56.1 to 71.5,324
Rotavirus,,States/Local Areas,Mississippi,2017,Age,8 Months,67.9,60.2 to 74.8,321
Rotavirus,,States/Local Areas,Mississippi,2017-2018,Age,8 Months,65.9,60.2 to 71.2,597
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",74.3,70.0 to 78.7,597
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,74.2,66.2 to 82.3,195
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,66.1,44.7 to 87.6,32
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,65.5,60.4 to 70.7,519
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.5,58.6 to 72.3,246
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,63.5,47.7 to 79.3,87
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",65.1,51.6 to 78.5,77
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,64.8,58.0 to 71.6,334
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,70.8,65.6 to 76.1,478
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Overall,Overall,69.4,65.7 to 73.2,1007
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,65.8,60.2 to 71.5,393
Rotavirus,,States/Local Areas,Mississippi,2011,Age,8 Months,63.9,54.5 to 72.2,198
Rotavirus,,States/Local Areas,Mississippi,2015,Age,8 Months,65.7,58.3 to 72.3,272
Rotavirus,,States/Local Areas,Mississippi,2015-2016,Age,8 Months,68.5,63.4 to 73.2,579
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,68.7,62.3 to 75.1,392
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,77.1,72.1 to 82.1,441
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,63.6,47.4 to 79.9,97
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,47.5,30.4 to 64.7,97
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.3,92.1 to 100.0,79
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,88.9,79.5 to 98.3,97
Hep B,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,91.3,87.3 to 94.2,632
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,75.6,70.1 to 80.3,632
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,95.5,92.4 to 98.7,281
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,77.4,72.5 to 82.4,519
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2020-2021,Age,0-3 Days,79.0,73.1 to 83.9,505
Hib,Primary Series,States/Local Areas,Mississippi,2020-2021,Age,35 Months,91.5,86.3 to 95.3,505
Hep B,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,5 Months,86.7,81.3 to 90.7,505
Rotavirus,,States/Local Areas,Mississippi,2021,Age,8 Months,57.8,47.4 to 67.6,197
Polio,≥2 Doses,States/Local Areas,Mississippi,2021,Age,5 Months,73.4,62.6 to 82.0,197
DTaP,≥2 Doses,States/Local Areas,Mississippi,2021,Age,5 Months,73.9,63.1 to 82.4,197
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020-2021,Age,24 Months,87.9,82.3 to 92.4,505
Polio,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,92.7,87.4 to 96.3,505
Hib,Primary Series,States/Local Areas,Mississippi,2021,Age,35 Months,94.4,87.5 to 98.2,197
≥1 Dose Varicella,,States/Local Areas,Mississippi,2021,Age,13 Months,60.9,50.3 to 70.5,197
Hep B,≥3 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,87.6,78.5 to 93.2,197
Hib,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,82.6,76.4 to 87.5,505
Hep A,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,28.3,22.4 to 35.3,505
Polio,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,92.4,87.8 to 95.4,505
Hib,Full Series,States/Local Areas,Mississippi,2020-2021,Age,19 Months,68.3,61.6 to 74.4,505
Hib,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,5 Months,70.9,64.0 to 77.0,505
Hep A,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,18.4,13.9 to 23.9,505
≥1 Dose MMR,,States/Local Areas,Mississippi,2021,Age,19 Months,85.4,75.6 to 91.8,197
Hep B,≥2 Doses,States/Local Areas,Mississippi,2021,Age,5 Months,86.9,77.9 to 92.6,197
Polio,≥3 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,83.9,73.6 to 90.7,197
PCV,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,66.6,59.7 to 72.9,505
≥1 Dose MMR,,States/Local Areas,Mississippi,2020-2021,Age,13 Months,61.3,54.5 to 67.6,505
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2020-2021,Age,0-2 Days,78.0,72.0 to 83.1,505
Hib,Full Series,States/Local Areas,Mississippi,2020-2021,Age,35 Months,75.6,68.5 to 82.2,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,83.2,76.8 to 88.0,505
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,87.8,82.4 to 91.7,505
DTaP,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,3 Months,87.7,82.1 to 91.7,505
Hep B,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,3 Months,95.9,92.6 to 97.8,505
PCV,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,93.4,88.4 to 96.7,505
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020-2021,Age,19 Months,83.9,77.8 to 88.5,505
Influenza,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,53.3,47.3 to 59.4,441
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2021,Age,0-3 Days,81.1,72.0 to 87.7,197
Hib,≥2 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,94.2,86.1 to 97.7,197
Polio,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,88.0,82.4 to 92.4,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,92.1,82.5 to 97.5,197
DTaP,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,5 Months,74.5,67.7 to 80.3,505
Hep A,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,54.7,44.8 to 65.3,505
≥1 Dose MMR,,States/Local Areas,Mississippi,2021,Age,13 Months,59.7,49.1 to 69.4,197
Hep A,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,24 Months,67.0,60.5 to 73.5,505
PCV,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,3 Months,86.3,80.6 to 90.5,505
Polio,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,3 Months,87.5,81.9 to 91.5,505
PCV,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,82.8,76.5 to 87.7,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,38.1,31.8 to 44.9,505
≥1 Dose MMR,,States/Local Areas,Mississippi,2020-2021,Age,19 Months,84.6,78.8 to 89.1,505
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,90.4,85.7 to 94.1,505
Influenza,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,29.8,25.0 to 34.7,519
Influenza,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,41.6,19.7 to 63.5,32
Influenza,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",33.8,26.9 to 40.6,246
Influenza,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,33.2,20.1 to 46.4,87
Influenza,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",28.8,16.7 to 40.9,77
PCV,≥1 Dose,States/Local Areas,Mississippi,2021,Age,3 Months,84.5,74.7 to 91.0,197
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020-2021,Age,13 Months,63.7,56.9 to 70.0,505
Influenza,,States/Local Areas,Mississippi,2021,Age,24 Months,17.7,12.4 to 24.9,197
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,95.7,93.9 to 97.6,541
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,93.4,90.7 to 96.2,519
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,84.3,80.3 to 88.2,541
Influenza,,States/Local Areas,Mississippi,2014-2017,Overall,Overall,38.0,34.2 to 41.8,1007
Influenza,,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,29.2,23.7 to 34.7,393
Influenza,,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,39.8,33.5 to 46.0,392
Influenza,,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,61.2,53.0 to 69.5,222
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",61.7,46.5 to 76.9,79
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,88.7,85.3 to 92.1,541
Influenza,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,41.3,34.6 to 47.9,334
Influenza,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,31.8,26.3 to 37.2,478
Influenza,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",43.8,38.7 to 48.9,597
Influenza,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,47.1,38.1 to 56.0,195
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.9,68.5 to 93.3,79
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",48.4,32.3 to 64.4,79
Influenza,,States/Local Areas,Mississippi,2016-2017,Age,24 Months,46.0,40.8 to 51.5,628
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",57.5,48.2 to 66.7,245
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,74.3,69.6 to 79.1,541
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,71.5,66.4 to 76.6,519
Influenza,,States/Local Areas,Mississippi,2017,Age,24 Months,45.1,38.0 to 52.9,321
Influenza,,States/Local Areas,Mississippi,2017-2018,Age,24 Months,43.6,38.3 to 49.3,597
Influenza,,States/Local Areas,Mississippi,2018,Age,24 Months,42.2,34.7 to 50.7,276
Influenza,,States/Local Areas,Mississippi,2018-2019,Age,24 Months,38.9,33.7 to 44.5,600
Influenza,,States/Local Areas,Mississippi,2019,Age,24 Months,35.6,28.9 to 43.3,324
Hep B,≥1 Dose,States/Local Areas,Mississippi,2021,Age,3 Months,96.0,89.6 to 98.5,197
DTaP,≥3 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,88.2,78.4 to 95.0,197
Hib,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,85.1,78.9 to 89.7,505
Hib,Primary Series,States/Local Areas,Mississippi,2020-2021,Age,19 Months,87.4,81.7 to 91.5,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,92.8,87.5 to 96.4,505
Rotavirus,,States/Local Areas,Mississippi,2020-2021,Age,8 Months,62.2,55.3 to 68.6,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,88.2,82.6 to 92.7,505
Polio,≥3 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,93.4,85.3 to 97.9,197
≥1 Dose Varicella,,States/Local Areas,Mississippi,2021,Age,35 Months,94.6,87.8 to 98.3,197
DTaP,≥4 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,74.3,67.7 to 80.5,505
Hep A,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,19 Months,65.8,59.0 to 72.1,505
Combined 7 Series,,States/Local Areas,Mississippi,2021,Age,24 Months,61.8,51.8 to 72.0,197
Influenza,,States/Local Areas,Mississippi,2020-2021,Age,24 Months,25.6,20.7 to 31.3,505
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,69.3,62.5 to 75.4,505
PCV,≥4 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,73.9,67.3 to 79.7,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,88.8,82.8 to 93.5,505
DTaP,≥4 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,81.8,69.5 to 91.4,197
Hep B,≥2 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,92.8,85.0 to 96.7,197
Hib,Primary Series,States/Local Areas,Mississippi,2021,Age,13 Months,78.3,68.3 to 85.8,197
PCV,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,87.1,81.2 to 91.4,505
Hep B,≥3 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,91.2,83.5 to 96.2,197
PCV,≥4 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,80.7,74.0 to 86.7,505
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2020-2021,Age,0-1 Days,75.4,69.2 to 80.8,505
≥1 Dose MMR,,States/Local Areas,Mississippi,2020-2021,Age,35 Months,93.5,89.3 to 96.5,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,67.5,60.6 to 73.8,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,94.1,85.9 to 98.3,197
Polio,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,85.5,79.4 to 90.1,505
Hib,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,3 Months,84.2,78.3 to 88.7,505
Hib,Primary Series,States/Local Areas,Mississippi,2020-2021,Age,13 Months,81.0,74.9 to 85.9,505
Hep B,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,7 Months,90.0,84.9 to 93.5,505
Combined 7 Series,,States/Local Areas,Mississippi,2020-2021,Age,24 Months,64.8,58.0 to 71.6,505
Hib,Full Series,States/Local Areas,Mississippi,2021,Age,35 Months,70.5,60.4 to 80.0,197
Polio,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,86.2,80.2 to 90.6,505
PCV,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,88.8,83.3 to 93.1,505
DTaP,≥4 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,67.9,60.9 to 74.1,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,54.7,44.4 to 64.7,197
Polio,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,5 Months,74.2,67.4 to 80.0,505
Combined 7 Series,,States/Local Areas,Mississippi,2020-2021,Age,35 Months,70.8,63.3 to 77.9,505
≥1 Dose MMR,,States/Local Areas,Mississippi,2020-2021,Age,24 Months,87.9,82.6 to 92.2,505
Hib,Primary Series,States/Local Areas,Mississippi,2020-2021,Age,7 Months,66.4,59.5 to 72.8,505
Rotavirus,,HHS Regions/National,Region 4,2014,Age,8 Months,72.3,69.1 to 75.3,2100
Rotavirus,,HHS Regions/National,Region 4,2014-2015,Age,8 Months,72.2,70.0 to 74.3,4318
Rotavirus,,HHS Regions/National,Region 4,2016,Age,8 Months,74.4,71.3 to 77.3,2341
Rotavirus,,HHS Regions/National,Region 4,2016-2017,Age,8 Months,73.1,70.9 to 75.2,4710
Rotavirus,,HHS Regions/National,Region 4,2015,Age,8 Months,72.1,69.0 to 75.1,2218
Rotavirus,,HHS Regions/National,Region 4,2015-2016,Age,8 Months,73.3,71.1 to 75.3,4559
Rotavirus,,HHS Regions/National,Region 4,2013,Age,8 Months,70.2,66.9 to 73.2,2020
Rotavirus,,HHS Regions/National,Region 4,2013-2014,Age,8 Months,71.2,68.9 to 73.4,4120
Rotavirus,,HHS Regions/National,Region 4,2012,Age,8 Months,71.2,67.7 to 74.3,1991
Rotavirus,,HHS Regions/National,Region 4,2011,Age,8 Months,69.1,65.4 to 72.5,1848
Rotavirus,,HHS Regions/National,Region 4,2018,Age,8 Months,73.4,69.8 to 76.6,2317
Rotavirus,,HHS Regions/National,Region 4,2018-2019,Age,8 Months,74.5,72.1 to 76.7,4700
Rotavirus,,HHS Regions/National,Region 4,2019,Age,8 Months,75.6,72.5 to 78.5,2383
Rotavirus,,HHS Regions/National,Region 4,2017,Age,8 Months,71.8,68.6 to 74.8,2369
Rotavirus,,HHS Regions/National,Region 4,2017-2018,Age,8 Months,72.6,70.2 to 74.9,4686
Hep A,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,24 Months,84.5,82.5 to 86.3,4478
Combined 7 Series,,HHS Regions/National,Region 4,2017,Age,35 Months,74.6,71.4 to 77.7,2369
Combined 7 Series,,HHS Regions/National,Region 4,2017-2018,Age,35 Months,74.5,72.1 to 76.9,4686
Combined 7 Series,,HHS Regions/National,Region 4,2016,Age,35 Months,78.6,75.3 to 81.7,2341
Combined 7 Series,,HHS Regions/National,Region 4,2016-2017,Age,35 Months,76.5,74.2 to 78.7,4710
Combined 7 Series,,HHS Regions/National,Region 4,2018,Age,24 Months,67.4,63.9 to 70.9,2317
Combined 7 Series,,HHS Regions/National,Region 4,2018-2019,Age,24 Months,69.6,67.2 to 72.0,4700
Combined 7 Series,,HHS Regions/National,Region 4,2017,Age,24 Months,70.3,67.1 to 73.4,2369
Combined 7 Series,,HHS Regions/National,Region 4,2017-2018,Age,24 Months,68.8,66.5 to 71.2,4686
Combined 7 Series,,HHS Regions/National,Region 4,2014,Age,35 Months,75.2,71.8 to 78.5,2100
Combined 7 Series,,HHS Regions/National,Region 4,2014-2015,Age,35 Months,74.8,72.4 to 77.1,4318
Combined 7 Series,,HHS Regions/National,Region 4,2012,Age,35 Months,76.2,72.8 to 79.5,1991
Hib,Primary Series,HHS Regions/National,Region 4,2018,Age,35 Months,93.6,90.9 to 95.7,2317
Hib,Primary Series,HHS Regions/National,Region 4,2018-2019,Age,35 Months,94.2,92.5 to 95.6,4700
Combined 7 Series,,HHS Regions/National,Region 4,2015,Age,24 Months,68.7,65.6 to 71.8,2218
Combined 7 Series,,HHS Regions/National,Region 4,2015-2016,Age,24 Months,70.3,68.2 to 72.5,4559
Combined 7 Series,,HHS Regions/National,Region 4,2014,Age,24 Months,68.5,65.2 to 71.7,2100
Combined 7 Series,,HHS Regions/National,Region 4,2014-2015,Age,24 Months,68.6,66.4 to 70.9,4318
Hib,Primary Series,HHS Regions/National,Region 4,2019,Age,35 Months,94.6,92.8 to 96.0,2383
Combined 7 Series,,HHS Regions/National,Region 4,2016,Age,24 Months,72.0,68.9 to 75.0,2341
Combined 7 Series,,HHS Regions/National,Region 4,2016-2017,Age,24 Months,71.1,69.0 to 73.3,4710
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,62.4,60.1 to 64.7,5048
Hep B,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,92.3,90.9 to 93.4,5048
Combined 7 Series,,HHS Regions/National,Region 4,2019,Age,24 Months,71.9,68.7 to 75.1,2383
Hib,Full Series,HHS Regions/National,Region 4,2014,Age,19 Months,73.9,70.9 to 76.7,2100
Hib,Full Series,HHS Regions/National,Region 4,2014-2015,Age,19 Months,73.4,71.3 to 75.4,4318
Hib,Full Series,HHS Regions/National,Region 4,2015,Age,19 Months,72.8,69.8 to 75.6,2218
Hib,Full Series,HHS Regions/National,Region 4,2015-2016,Age,19 Months,72.9,70.8 to 75.0,4559
Hib,Full Series,HHS Regions/National,Region 4,2016,Age,19 Months,73.0,69.9 to 76.0,2341
Hib,Full Series,HHS Regions/National,Region 4,2016-2017,Age,19 Months,73.8,71.6 to 75.9,4710
Hib,Full Series,HHS Regions/National,Region 4,2011,Age,24 Months,80.6,77.5 to 83.5,1848
Hib,Full Series,HHS Regions/National,Region 4,2012,Age,24 Months,81.2,78.3 to 84.0,1991
Hib,Primary Series,HHS Regions/National,Region 4,2012,Age,19 Months,94.0,92.5 to 95.2,1991
Hib,Full Series,HHS Regions/National,Region 4,2014,Age,24 Months,79.4,76.6 to 82.1,2100
Hib,Full Series,HHS Regions/National,Region 4,2014-2015,Age,24 Months,79.0,77.1 to 80.9,4318
Hib,Full Series,HHS Regions/National,Region 4,2013,Age,24 Months,80.5,77.7 to 83.1,2020
Hib,Full Series,HHS Regions/National,Region 4,2013-2014,Age,24 Months,80.0,78.0 to 81.8,4120
Hib,Primary Series,HHS Regions/National,Region 4,2012,Age,24 Months,94.6,92.9 to 96.0,1991
Hib,Primary Series,HHS Regions/National,Region 4,2011,Age,24 Months,92.4,90.2 to 94.2,1848
Hib,Primary Series,HHS Regions/National,Region 4,2019,Age,19 Months,92.4,90.3 to 94.2,2383
Hib,Primary Series,HHS Regions/National,Region 4,2016,Age,19 Months,92.2,90.2 to 93.9,2341
Hib,Primary Series,HHS Regions/National,Region 4,2016-2017,Age,19 Months,92.0,90.6 to 93.2,4710
≥1 Dose MMR,,HHS Regions/National,Region 4,2020,Age,13 Months,65.4,62.4 to 68.2,2665
Hib,Primary Series,HHS Regions/National,Region 4,2018,Age,19 Months,91.5,89.0 to 93.5,2317
Hib,Primary Series,HHS Regions/National,Region 4,2018-2019,Age,19 Months,86.2,84.3 to 87.9,4700
Hib,Primary Series,HHS Regions/National,Region 4,2017,Age,19 Months,91.8,89.8 to 93.4,2369
Hib,Primary Series,HHS Regions/National,Region 4,2017-2018,Age,19 Months,91.7,90.1 to 93.0,4686
Hib,Primary Series,HHS Regions/National,Region 4,2015,Age,19 Months,93.1,91.6 to 94.4,2218
Hib,Primary Series,HHS Regions/National,Region 4,2015-2016,Age,19 Months,92.7,91.3 to 93.8,4559
Hib,Primary Series,HHS Regions/National,Region 4,2014,Age,19 Months,90.2,87.8 to 92.2,2100
Hib,Primary Series,HHS Regions/National,Region 4,2014-2015,Age,19 Months,91.7,90.2 to 92.9,4318
Hib,Primary Series,HHS Regions/National,Region 4,2013,Age,19 Months,94.4,92.2 to 96.0,2020
Hib,Primary Series,HHS Regions/National,Region 4,2013-2014,Age,19 Months,92.3,90.3 to 93.9,4120
Hib,Primary Series,HHS Regions/National,Region 4,2011,Age,19 Months,92.0,89.6 to 93.9,1848
Hib,Primary Series,HHS Regions/National,Region 4,2018,Age,13 Months,85.4,82.3 to 88.0,2317
Hib,Primary Series,HHS Regions/National,Region 4,2018-2019,Age,13 Months,86.2,84.3 to 87.9,4700
Hib,Primary Series,HHS Regions/National,Region 4,2017,Age,13 Months,87.5,85.0 to 89.6,2369
Hib,Primary Series,HHS Regions/National,Region 4,2017-2018,Age,13 Months,86.4,84.5 to 88.2,4686
Hib,Primary Series,HHS Regions/National,Region 4,2019,Age,13 Months,87.1,84.6 to 89.2,2383
Hib,Primary Series,HHS Regions/National,Region 4,2014,Age,7 Months,70.8,67.4 to 73.9,2100
Hib,Primary Series,HHS Regions/National,Region 4,2014-2015,Age,7 Months,69.9,67.6 to 72.1,4318
Hib,Primary Series,HHS Regions/National,Region 4,2015,Age,7 Months,69.1,65.8 to 72.2,2218
Hib,Primary Series,HHS Regions/National,Region 4,2015-2016,Age,7 Months,71.1,68.8 to 73.3,4559
Hib,Primary Series,HHS Regions/National,Region 4,2013,Age,7 Months,70.6,68.8 to 72.4,2020
Hib,Primary Series,HHS Regions/National,Region 4,2013-2014,Age,7 Months,70.7,68.7 to 72.7,4120
Hib,Primary Series,HHS Regions/National,Region 4,2013,Age,13 Months,90.0,86.9 to 92.4,2020
Hib,Primary Series,HHS Regions/National,Region 4,2013-2014,Age,13 Months,87.6,85.3 to 89.5,4120
Hib,Primary Series,HHS Regions/National,Region 4,2012,Age,13 Months,90.0,88.4 to 91.5,1991
Hib,Primary Series,HHS Regions/National,Region 4,2011,Age,13 Months,88.8,86.7 to 90.6,1848
Hib,Primary Series,HHS Regions/National,Region 4,2016,Age,13 Months,87.9,85.5 to 90.0,2341
Hib,Primary Series,HHS Regions/National,Region 4,2016-2017,Age,13 Months,87.7,86.0 to 89.2,4710
Hib,Primary Series,HHS Regions/National,Region 4,2019,Age,7 Months,72.7,69.3 to 75.8,2383
Hib,Primary Series,HHS Regions/National,Region 4,2016,Age,7 Months,73.1,70.0 to 76.1,2341
Hib,Primary Series,HHS Regions/National,Region 4,2016-2017,Age,7 Months,72.8,70.6 to 75.0,4710
Hib,Primary Series,HHS Regions/National,Region 4,2017,Age,7 Months,72.6,69.4 to 75.5,2369
Hib,Primary Series,HHS Regions/National,Region 4,2017-2018,Age,7 Months,71.8,69.4 to 74.1,4686
Hib,Primary Series,HHS Regions/National,Region 4,2018,Age,7 Months,71.0,67.3 to 74.4,2317
Hib,Primary Series,HHS Regions/National,Region 4,2018-2019,Age,7 Months,71.8,69.3 to 74.2,4700
Hib,Primary Series,HHS Regions/National,Region 4,2014,Age,13 Months,85.2,82.5 to 87.6,2100
Hib,Primary Series,HHS Regions/National,Region 4,2014-2015,Age,13 Months,86.7,85.0 to 88.3,4318
Hib,Primary Series,HHS Regions/National,Region 4,2015,Age,13 Months,88.2,86.0 to 90.1,2218
Hib,Primary Series,HHS Regions/National,Region 4,2015-2016,Age,13 Months,88.1,86.4 to 89.5,4559
Hib,Primary Series,HHS Regions/National,Region 4,2017,Age,24 Months,92.7,90.9 to 94.3,2369
Hib,Primary Series,HHS Regions/National,Region 4,2017-2018,Age,24 Months,92.3,90.8 to 93.7,4686
Hib,Primary Series,HHS Regions/National,Region 4,2014,Age,24 Months,91.1,88.7 to 93.1,2100
Hib,Primary Series,HHS Regions/National,Region 4,2014-2015,Age,24 Months,92.3,90.9 to 93.6,4318
Hib,Primary Series,HHS Regions/National,Region 4,2015,Age,24 Months,93.5,91.8 to 95.0,2218
Hib,Primary Series,HHS Regions/National,Region 4,2015-2016,Age,24 Months,93.6,92.4 to 94.7,4559
Hib,Primary Series,HHS Regions/National,Region 4,2013,Age,24 Months,95.1,93.7 to 96.4,2020
Hib,Primary Series,HHS Regions/National,Region 4,2013-2014,Age,24 Months,93.1,91.7 to 94.3,4120
Combined 7 Series,,HHS Regions/National,Region 4,2013,Age,24 Months,67.8,64.6 to 70.9,2020
Combined 7 Series,,HHS Regions/National,Region 4,2013-2014,Age,24 Months,68.1,65.9 to 70.4,4120
Combined 7 Series,,HHS Regions/National,Region 4,2012,Age,24 Months,69.5,66.1 to 72.8,1991
Combined 7 Series,,HHS Regions/National,Region 4,2011,Age,24 Months,69.4,65.8 to 73.0,1848
Hib,Primary Series,HHS Regions/National,Region 4,2015,Age,35 Months,95.0,93.4 to 96.3,2218
Hib,Primary Series,HHS Regions/National,Region 4,2015-2016,Age,35 Months,94.5,93.4 to 95.6,4559
Hib,Primary Series,HHS Regions/National,Region 4,2016,Age,35 Months,94.2,92.5 to 95.7,2341
Hib,Primary Series,HHS Regions/National,Region 4,2016-2017,Age,35 Months,94.0,92.8 to 95.1,4710
Hib,Primary Series,HHS Regions/National,Region 4,2017,Age,35 Months,93.8,91.9 to 95.3,2369
Combined 7 Series,,HHS Regions/National,Region 4,2013,Age,35 Months,74.7,71.3 to 78.1,2020
Combined 7 Series,,HHS Regions/National,Region 4,2013-2014,Age,35 Months,74.9,72.5 to 77.3,4120
Hib,Primary Series,HHS Regions/National,Region 4,2017-2018,Age,35 Months,93.7,92.1 to 95.1,4686
Combined 7 Series,,HHS Regions/National,Region 4,2011,Age,35 Months,78.0,74.0 to 81.8,1848
Hib,Primary Series,HHS Regions/National,Region 4,2016,Age,24 Months,93.7,92.0 to 95.2,2341
Hib,Primary Series,HHS Regions/National,Region 4,2016-2017,Age,24 Months,93.2,92.0 to 94.4,4710
Hib,Primary Series,HHS Regions/National,Region 4,2018,Age,24 Months,92.0,89.6 to 94.0,2317
Hib,Primary Series,HHS Regions/National,Region 4,2018-2019,Age,24 Months,93.0,91.6 to 94.3,4700
Hib,Primary Series,HHS Regions/National,Region 4,2014,Age,35 Months,91.2,88.9 to 93.2,2100
Hib,Primary Series,HHS Regions/National,Region 4,2014-2015,Age,35 Months,93.0,91.6 to 94.2,4318
Hib,Primary Series,HHS Regions/National,Region 4,2012,Age,35 Months,94.9,93.2 to 96.3,1991
Hib,Primary Series,HHS Regions/National,Region 4,2019,Age,24 Months,94.1,92.4 to 95.6,2383
Hib,Primary Series,HHS Regions/National,Region 4,2011,Age,35 Months,93.0,90.7 to 94.8,1848
Hib,Primary Series,HHS Regions/National,Region 4,2013,Age,35 Months,95.6,94.1 to 96.8,2020
Hib,Primary Series,HHS Regions/National,Region 4,2013-2014,Age,35 Months,93.4,92.0 to 94.6,4120
Hib,Full Series,HHS Regions/National,Region 4,2019,Age,19 Months,75.0,71.9 to 77.9,2383
Combined 7 Series,,HHS Regions/National,Region 4,2015,Age,35 Months,74.2,71.0 to 77.2,2218
Combined 7 Series,,HHS Regions/National,Region 4,2015-2016,Age,35 Months,76.4,74.1 to 78.6,4559
Hib,Full Series,HHS Regions/National,Region 4,2013,Age,19 Months,74.9,72.2 to 77.4,2020
Hib,Full Series,HHS Regions/National,Region 4,2013-2014,Age,19 Months,74.4,72.3 to 76.4,4120
Hib,Full Series,HHS Regions/National,Region 4,2012,Age,19 Months,73.6,70.7 to 76.3,1991
Hib,Full Series,HHS Regions/National,Region 4,2011,Age,19 Months,73.2,69.6 to 76.6,1848
Combined 7 Series,,HHS Regions/National,Region 4,2019,Age,35 Months,77.7,74.2 to 81.0,2383
Combined 7 Series,,HHS Regions/National,Region 4,2018,Age,35 Months,74.4,70.6 to 78.1,2317
Combined 7 Series,,HHS Regions/National,Region 4,2018-2019,Age,35 Months,76.1,73.5 to 78.5,4700
Hib,Full Series,HHS Regions/National,Region 4,2018,Age,19 Months,71.2,67.6 to 74.5,2317
Hib,Full Series,HHS Regions/National,Region 4,2018-2019,Age,19 Months,95.2,94.0 to 96.1,4700
Hib,Full Series,HHS Regions/National,Region 4,2017,Age,19 Months,74.6,71.5 to 77.4,2369
Hib,Full Series,HHS Regions/National,Region 4,2017-2018,Age,19 Months,72.9,70.6 to 75.1,4686
Hep A,≥2 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,69.5,64.6 to 74.2,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,90.8,88.3 to 92.9,1813
Hep A,≥1 Dose,HHS Regions/National,Region 4,2021,Age,35 Months,88.7,85.2 to 91.6,1813
Hib,Full Series,HHS Regions/National,Region 4,2021,Age,24 Months,73.9,70.4 to 77.2,1813
Hib,Primary Series,HHS Regions/National,Region 4,2021,Age,24 Months,92.6,90.4 to 94.4,1813
Hib,≥3 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,90.5,88.2 to 92.6,1813
Polio,≥3 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,92.5,90.4 to 94.4,1813
≥1 Dose MMR,,HHS Regions/National,Region 4,2021,Age,24 Months,89.9,87.4 to 92.1,1813
DTaP,≥4 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,68.8,65.0 to 72.3,1813
Polio,≥1 Dose,HHS Regions/National,Region 4,2021,Age,3 Months,86.9,83.9 to 89.4,1813
DTaP,≥4 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,80.2,76.9 to 83.2,1813
DTaP,≥1 Dose,HHS Regions/National,Region 4,2021,Age,3 Months,88.0,85.1 to 90.3,1813
PCV,≥4 Doses,HHS Regions/National,Region 4,2021,Age,35 Months,82.8,79.4 to 86.0,1813
Hep A,≥2 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,26.9,23.7 to 30.4,1813
Polio,≥2 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,93.1,90.8 to 94.9,1813
Hep A,≥1 Dose,HHS Regions/National,Region 4,2021,Age,19 Months,79.7,76.3 to 82.7,1813
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,92.5,91.1 to 93.8,4478
PCV,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,35 Months,92.6,91.1 to 93.9,4478
Hep B,≥3 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,91.1,88.7 to 93.2,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,67.6,63.9 to 71.2,1813
DTaP,≥3 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,88.2,85.5 to 90.5,1813
Hib,≥3 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,67.3,64.9 to 69.5,4478
PCV,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,5 Months,77.3,75.1 to 79.3,4478
Hep A,≥2 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,42.3,38.5 to 46.4,1813
DTaP,≥3 Doses,HHS Regions/National,Region 4,2021,Age,19 Months,92.0,89.7 to 93.8,1813
Hep B,≥3 Doses,HHS Regions/National,Region 4,2021,Age,7 Months,60.6,56.9 to 64.3,1813
Hep A,≥1 Dose,HHS Regions/National,Region 4,2021,Age,24 Months,84.9,81.8 to 87.6,1813
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2021,Age,0-2 Days,76.4,73.2 to 79.4,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,91.8,89.4 to 93.8,1813
PCV,≥4 Doses,HHS Regions/National,Region 4,2021,Age,24 Months,80.8,77.6 to 83.8,1813
≥1 Dose Varicella,,HHS Regions/National,Region 4,2021,Age,24 Months,89.9,87.4 to 92.1,1813
DTaP,≥4 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,71.4,69.2 to 73.4,5048
Polio,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,91.6,90.2 to 92.9,5048
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,90.1,88.7 to 91.4,5048
Hib,Primary Series,HHS Regions/National,Region 4,2019-2020,Age,7 Months,71.4,69.2 to 73.6,5048
Polio,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,3 Months,88.1,86.4 to 89.6,5048
DTaP,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,3 Months,89.1,87.5 to 90.6,5048
Hib,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,3 Months,86.9,85.2 to 88.4,5048
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2021,Age,0-1 Days,73.1,69.6 to 76.3,1813
PCV,≥3 Doses,HHS Regions/National,Region 4,2021,Age,13 Months,86.8,83.8 to 89.3,1813
Hep A,≥1 Dose,HHS Regions/National,Region 4,2020-2021,Age,35 Months,88.5,86.6 to 90.2,4478
PCV,≥3 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,68.7,65.7 to 71.5,2665
Rotavirus,,HHS Regions/National,Region 4,2019-2020,Age,8 Months,73.8,71.7 to 75.9,5048
Hib,≥2 Doses,HHS Regions/National,Region 4,2020-2021,Age,13 Months,92.9,91.5 to 94.1,4478
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,88.8,86.7 to 90.6,2665
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,62.7,59.7 to 65.7,2665
Hep B,≥1 Dose,HHS Regions/National,Region 4,2020,Age,3 Months,95.6,94.2 to 96.7,2665
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,91.5,89.7 to 93.1,2665
Hib,≥1 Dose,HHS Regions/National,Region 4,2020,Age,3 Months,84.4,81.8 to 86.6,2665
Polio,≥1 Dose,HHS Regions/National,Region 4,2020,Age,3 Months,86.8,84.4 to 88.9,2665
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020-2021,Age,35 Months,92.5,90.9 to 93.9,4478
Hib,≥2 Doses,HHS Regions/National,Region 4,2020,Age,5 Months,76.2,73.4 to 78.8,2665
Hep B,≥2 Doses,HHS Regions/National,Region 4,2020,Age,5 Months,88.2,86.1 to 90.1,2665
Polio,≥2 Doses,HHS Regions/National,Region 4,2020,Age,5 Months,78.4,75.7 to 81.0,2665
DTaP,≥2 Doses,HHS Regions/National,Region 4,2020,Age,5 Months,78.6,75.9 to 81.2,2665
PCV,≥1 Dose,HHS Regions/National,Region 4,2020,Age,3 Months,85.4,83.0 to 87.6,2665
Combined 7 Series,,HHS Regions/National,Region 4,2020,Age,24 Months,65.4,62.4 to 68.4,2665
Hep A,≥2 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,43.0,40.0 to 46.1,2665
Hep A,≥1 Dose,HHS Regions/National,Region 4,2020,Age,24 Months,84.2,81.7 to 86.5,2665
PCV,≥4 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,81.1,78.5 to 83.5,2665
Rotavirus,,HHS Regions/National,Region 4,2020,Age,8 Months,71.9,69.0 to 74.7,2665
PCV,≥3 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,92.1,90.3 to 93.7,2665
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,93.9,92.1 to 95.4,2665
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2020,Age,0-3 Days,79.5,77.0 to 81.8,2665
Influenza,,HHS Regions/National,Region 4,2020,Age,24 Months,43.9,40.9 to 47.0,2665
Hib,≥3 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,87.4,85.1 to 89.3,2665
≥1 Dose MMR,,HHS Regions/National,Region 4,2020,Age,19 Months,87.6,85.4 to 89.5,2665
Polio,≥3 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,91.3,89.4 to 92.9,2665
DTaP,≥4 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,69.3,66.4 to 72.1,2665
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,92.1,90.3 to 93.6,2665
PCV,≥2 Doses,HHS Regions/National,Region 4,2020,Age,5 Months,77.4,74.6 to 80.0,2665
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,70.9,68.0 to 73.7,2665
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020,Age,13 Months,61.3,58.2 to 64.3,2665
PCV,≥3 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,87.6,85.4 to 89.5,2665
Hep B,≥2 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,93.9,92.3 to 95.2,2665
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,88.1,86.0 to 89.9,2665
Hib,≥3 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,67.0,64.1 to 69.8,2665
Hib,Primary Series,HHS Regions/National,Region 4,2020,Age,13 Months,84.6,82.2 to 86.7,2665
PCV,≥4 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,83.4,80.8 to 85.8,2665
Polio,≥3 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,93.6,91.7 to 95.2,2665
PCV,≥4 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,76.8,74.0 to 79.4,2665
DTaP,≥4 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,87.4,84.7 to 89.8,2665
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020,Age,19 Months,87.4,85.2 to 89.3,2665
PCV,≥3 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,91.5,89.6 to 93.1,2665
Hib,Full Series,HHS Regions/National,Region 4,2020,Age,19 Months,69.8,66.8 to 72.6,2665
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,90.7,88.7 to 92.3,2665
≥1 Dose Varicella,,HHS Regions/National,Region 4,2020,Age,35 Months,92.1,90.1 to 93.9,2665
PCV,≥3 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,92.6,90.8 to 94.1,2665
Hib,Primary Series,HHS Regions/National,Region 4,2020,Age,19 Months,91.3,89.3 to 92.9,2665
Hep B,≥3 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,92.6,90.8 to 94.1,2665
Hib,Full Series,HHS Regions/National,Region 4,2020,Age,35 Months,79.5,76.7 to 82.2,2665
Hib,≥3 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,92.3,90.2 to 94.0,2665
Hib,Primary Series,HHS Regions/National,Region 4,2020,Age,35 Months,93.3,91.5 to 94.8,2665
Hib,Primary Series,HHS Regions/National,Region 4,2020,Age,24 Months,92.0,90.3 to 93.6,2665
Hib,≥3 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,90.1,88.1 to 91.9,2665
≥1 Dose MMR,,HHS Regions/National,Region 4,2020,Age,35 Months,92.5,90.5 to 94.2,2665
≥1 Dose MMR,,HHS Regions/National,Region 4,2020,Age,24 Months,89.7,87.7 to 91.5,2665
DTaP,≥4 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,79.1,76.4 to 81.7,2665
DTaP,≥3 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,92.7,91.0 to 94.2,2665
Polio,≥3 Doses,HHS Regions/National,Region 4,2020,Age,24 Months,92.0,90.1 to 93.6,2665
Hep B,≥2 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,92.0,90.3 to 93.5,2665
Hib,Primary Series,HHS Regions/National,Region 4,2020,Age,7 Months,70.1,67.2 to 72.9,2665
Hib,≥3 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,49.2,46.1 to 52.2,2665
Hib,≥2 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,88.6,86.5 to 90.4,2665
DTaP,≥1 Dose,HHS Regions/National,Region 4,2020,Age,3 Months,87.1,84.7 to 89.2,2665
Polio,≥2 Doses,HHS Regions/National,Region 4,2020,Age,7 Months,89.2,87.0 to 91.0,2665
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2020,Age,0-2 Days,78.8,76.2 to 81.2,2665
Hep A,≥1 Dose,HHS Regions/National,Region 4,2020,Age,19 Months,81.1,78.5 to 83.4,2665
Hep A,≥2 Doses,HHS Regions/National,Region 4,2020,Age,19 Months,24.9,22.5 to 27.5,2665
Hep A,≥2 Doses,HHS Regions/National,Region 4,2020,Age,35 Months,77.7,74.0 to 81.3,2665
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2020,Age,0-1 Days,76.1,73.4 to 78.6,2665
Combined 7 Series,,HHS Regions/National,Region 4,2020,Age,35 Months,71.2,68.1 to 74.2,2665
Hep A,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,45.1,42.7 to 47.5,5048
Polio,≥2 Doses,HHS Regions/National,Region 4,2020,Age,13 Months,92.9,91.1 to 94.4,2665
Hep A,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,24 Months,86.4,84.8 to 88.0,5048
Hep A,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,77.9,75.2 to 80.4,5048
Hep A,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,35 Months,91.1,89.3 to 92.8,5048
Hib,Primary Series,HHS Regions/National,Region 4,2019-2020,Age,24 Months,93.2,91.9 to 94.3,5048
Hib,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,91.3,90.0 to 92.6,5048
Influenza,,HHS Regions/National,Region 4,2019-2020,Age,24 Months,48.1,45.8 to 50.5,5048
Hib,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,49.7,47.3 to 52.0,5048
Combined 7 Series,,HHS Regions/National,Region 4,2019-2020,Age,35 Months,74.6,72.3 to 76.9,5048
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019-2020,Age,19 Months,89.0,87.4 to 90.3,5048
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,91.2,89.8 to 92.4,5048
PCV,≥4 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,79.3,77.3 to 81.2,5048
Hep A,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,19 Months,82.7,80.8 to 84.4,5048
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 4,2019-2020,Age,0-2 Days,78.8,76.8 to 80.7,5048
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 4,2019-2020,Age,0-1 Days,75.2,73.1 to 77.2,5048
PCV,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,69.3,67.1 to 71.5,5048
Hib,Full Series,HHS Regions/National,Region 4,2019-2020,Age,24 Months,78.4,76.4 to 80.3,5048
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 4,2019-2020,Age,0-3 Days,79.8,77.9 to 81.6,5048
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019-2020,Age,24 Months,91.3,89.9 to 92.6,5048
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,92.3,91.0 to 93.4,5048
PCV,≥4 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,83.3,81.5 to 85.1,5048
Hep A,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,27.5,25.5 to 29.6,5048
PCV,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,93.1,91.8 to 94.2,5048
≥1 Dose MMR,,HHS Regions/National,Region 4,2019-2020,Age,19 Months,89.5,88.0 to 90.8,5048
Hib,Primary Series,HHS Regions/National,Region 4,2019-2020,Age,19 Months,92.0,90.6 to 93.2,5048
Hib,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,88.5,86.9 to 89.9,5048
Hib,Full Series,HHS Regions/National,Region 4,2019-2020,Age,19 Months,72.5,70.4 to 74.5,5048
≥1 Dose MMR,,HHS Regions/National,Region 4,2019-2020,Age,35 Months,94.1,92.8 to 95.2,5048
Hib,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,93.2,91.8 to 94.4,5048
Hib,Primary Series,HHS Regions/National,Region 4,2019-2020,Age,35 Months,94.1,92.8 to 95.1,5048
Hib,Full Series,HHS Regions/National,Region 4,2019-2020,Age,35 Months,82.4,80.4 to 84.3,5048
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,93.2,92.0 to 94.4,5048
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019-2020,Age,35 Months,94.4,92.7 to 95.8,5048
PCV,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,93.5,92.3 to 94.7,5048
PCV,≥4 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,85.7,83.8 to 87.6,5048
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,93.4,92.2 to 94.5,5048
Polio,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,92.6,91.3 to 93.8,5048
DTaP,≥4 Doses,HHS Regions/National,Region 4,2019-2020,Age,24 Months,81.2,79.2 to 83.1,5048
≥1 Dose MMR,,HHS Regions/National,Region 4,2019-2020,Age,24 Months,92.0,90.7 to 93.2,5048
Hep B,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,3 Months,95.7,94.7 to 96.6,5048
PCV,≥1 Dose,HHS Regions/National,Region 4,2019-2020,Age,3 Months,87.4,85.7 to 88.9,5048
DTaP,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,5 Months,79.5,77.5 to 81.5,5048
Hib,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,5 Months,77.5,75.4 to 79.5,5048
Polio,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,5 Months,79.1,77.0 to 81.1,5048
Polio,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,93.5,92.2 to 94.6,5048
≥1 Dose MMR,,HHS Regions/National,Region 4,2019-2020,Age,13 Months,67.7,65.5 to 69.8,5048
Hib,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,93.6,92.4 to 94.6,5048
Hib,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,68.6,66.5 to 70.7,5048
Hep B,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,5 Months,88.6,87.0 to 90.1,5048
Hep B,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,94.5,93.3 to 95.4,5048
Hib,Primary Series,HHS Regions/National,Region 4,2019-2020,Age,13 Months,86.0,84.3 to 87.5,5048
PCV,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,5 Months,78.2,76.1 to 80.2,5048
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,71.5,69.2 to 73.6,5048
Polio,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,89.7,88.2 to 91.1,5048
Hib,≥2 Doses,HHS Regions/National,Region 4,2019-2020,Age,7 Months,89.7,88.2 to 91.0,5048
Hep B,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,89.2,87.7 to 90.5,5048
PCV,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,13 Months,88.9,87.3 to 90.3,5048
≥1 Dose Varicella,,HHS Regions/National,Region 4,2019-2020,Age,13 Months,63.2,60.9 to 65.4,5048
Combined 7 Series,,HHS Regions/National,Region 4,2019-2020,Age,24 Months,68.8,66.6 to 71.0,5048
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,19 Months,92.8,91.5 to 93.9,5048
DTaP,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,95.1,93.7 to 96.2,5048
DTaP,≥4 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,88.4,86.5 to 90.2,5048
Polio,≥3 Doses,HHS Regions/National,Region 4,2019-2020,Age,35 Months,93.8,92.4 to 95.0,5048
DTaP,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,133% to <400% FPL,77.4,71.0 to 83.7,484
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,81.4 to 97.0,95
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,89.2,80.5 to 97.9,187
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,87.3,78.2 to 96.4,187
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",70.7,66.1 to 75.4,797
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.2,50.3 to 74.2,97
Hep B,≥2 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,93.4,90.2 to 95.6,759
≥1 Dose Varicella,,States/Local Areas,Tennessee,2021,Age,13 Months,65.1,55.7 to 73.3,216
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,74.1,60.7 to 87.5,187
Hib,Full Series,States/Local Areas,Tennessee,2020-2021,Age,24 Months,75.2,69.6 to 80.5,579
Rotavirus,,States/Local Areas,Tennessee,2015,Age,8 Months,67.5,58.4 to 75.4,241
Rotavirus,,States/Local Areas,Tennessee,2015-2016,Age,8 Months,72.4,66.3 to 77.7,459
Rotavirus,,States/Local Areas,Tennessee,2016,Age,8 Months,77.5,69.5 to 83.9,218
Rotavirus,,States/Local Areas,Tennessee,2016-2017,Age,8 Months,73.5,67.9 to 78.5,523
Rotavirus,,States/Local Areas,Tennessee,2014,Age,8 Months,70.0,62.0 to 77.0,243
Rotavirus,,States/Local Areas,Tennessee,2014-2015,Age,8 Months,68.8,62.7 to 74.2,484
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,68.4,57.9 to 78.9,134
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,63.0,56.1 to 70.0,331
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",56.6,41.6 to 71.6,61
Rotavirus,,States/Local Areas,Tennessee,2011,Age,8 Months,72.6,64.9 to 79.2,256
Rotavirus,,States/Local Areas,Tennessee,2018,Age,8 Months,80.0,74.1 to 84.9,410
Rotavirus,,States/Local Areas,Tennessee,2018-2019,Age,8 Months,75.7,71.2 to 79.6,806
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,70.9,63.9 to 77.8,342
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",57.5,42.8 to 72.2,70
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,70.0,63.8 to 76.3,413
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.4,72.9 to 81.8,564
Rotavirus,,States/Local Areas,Tennessee,2012,Age,8 Months,74.1,65.8 to 81.0,256
Rotavirus,,States/Local Areas,Tennessee,2013,Age,8 Months,78.7,71.4 to 84.5,227
Rotavirus,,States/Local Areas,Tennessee,2013-2014,Age,8 Months,74.3,69.0 to 79.1,470
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.5,68.7 to 82.3,268
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,65.8,55.6 to 76.1,148
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,65.2,58.1 to 72.3,298
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Overall,Overall,70.9,66.6 to 75.2,829
Rotavirus,,States/Local Areas,Tennessee,2017,Age,8 Months,69.7,61.5 to 76.8,305
Rotavirus,,States/Local Areas,Tennessee,2017-2018,Age,8 Months,74.9,69.8 to 79.4,715
Rotavirus,,States/Local Areas,Tennessee,2019,Age,8 Months,71.3,64.4 to 77.3,396
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,66.2,48.4 to 84.1,41
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,80.6,75.5 to 85.8,430
Rotavirus,,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,84.2,77.4 to 91.0,189
≥1 Dose MMR,,States/Local Areas,Tennessee,2020-2021,Age,35 Months,94.8,91.3 to 97.2,579
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Tennessee,2020-2021,Age,0-1 Days,68.5,62.5 to 73.9,579
PCV,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,70.6,64.6 to 76.0,579
Hib,Full Series,States/Local Areas,Tennessee,2020-2021,Age,35 Months,78.6,72.8 to 83.9,579
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Tennessee,2020-2021,Age,0-2 Days,72.2,66.4 to 77.4,579
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,93.4,89.7 to 95.8,579
Hib,Primary Series,States/Local Areas,Tennessee,2020-2021,Age,19 Months,93.2,89.3 to 95.7,579
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020-2021,Age,19 Months,89.4,84.9 to 92.7,579
PCV,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,95.4,92.1 to 97.6,579
Hep B,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,3 Months,97.0,94.4 to 98.4,579
DTaP,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,3 Months,91.9,88.1 to 94.5,579
Combined 7 Series,,States/Local Areas,Tennessee,2021,Age,24 Months,63.5,54.2 to 72.8,216
Rotavirus,,States/Local Areas,Tennessee,2020-2021,Age,8 Months,74.2,68.5 to 79.2,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,94.4,91.0 to 96.9,579
Hib,Primary Series,States/Local Areas,Tennessee,2020-2021,Age,35 Months,96.2,92.5 to 98.4,579
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2020-2021,Age,0-3 Days,73.0,67.1 to 78.2,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,97.8,93.7 to 99.5,579
Hib,Primary Series,States/Local Areas,Tennessee,2021,Age,13 Months,86.9,79.0 to 92.1,216
PCV,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,95.1,91.5 to 97.2,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,89.7,85.1 to 93.0,579
Hib,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,3 Months,87.4,82.9 to 90.9,579
Hep B,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,95.1,92.2 to 97.0,579
Hib,Primary Series,States/Local Areas,Tennessee,2020-2021,Age,13 Months,84.4,79.4 to 88.3,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,95.1,89.5 to 98.2,216
≥1 Dose MMR,,States/Local Areas,Tennessee,2020-2021,Age,24 Months,91.1,87.0 to 94.3,579
Polio,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,91.7,87.6 to 94.5,579
PCV,≥4 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,86.7,81.5 to 91.0,579
Influenza,,States/Local Areas,Tennessee,2020-2021,Age,24 Months,55.7,49.7 to 61.9,579
Hep B,≥3 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,93.5,87.9 to 97.1,216
DTaP,≥4 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,88.7,79.5 to 95.0,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,73.7,67.8 to 78.8,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,95.0,90.4 to 97.9,579
PCV,≥4 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,78.9,73.3 to 83.6,579
Hep B,≥2 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,96.5,92.2 to 98.5,216
Polio,≥3 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,94.0,88.6 to 97.5,216
≥1 Dose Varicella,,States/Local Areas,Tennessee,2021,Age,35 Months,97.7,92.6 to 99.6,216
DTaP,≥4 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,83.3,78.2 to 87.7,579
Hep A,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,19 Months,86.2,81.3 to 90.0,579
Hep B,≥3 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,91.2,83.7 to 95.5,216
DTaP,≥2 Doses,States/Local Areas,Tennessee,2021,Age,5 Months,80.0,70.7 to 86.9,216
Polio,≥2 Doses,States/Local Areas,Tennessee,2021,Age,5 Months,79.7,70.4 to 86.6,216
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,91.9,88.0 to 94.7,579
Hep B,≥2 Doses,States/Local Areas,Tennessee,2021,Age,5 Months,91.7,84.1 to 95.8,216
Hep A,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,30.8,25.3 to 36.9,579
≥1 Dose MMR,,States/Local Areas,Tennessee,2021,Age,19 Months,86.7,78.8 to 92.0,216
Polio,≥3 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,94.0,87.7 to 97.2,216
≥1 Dose MMR,,States/Local Areas,Tennessee,2020-2021,Age,13 Months,67.6,61.7 to 73.0,579
Hib,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,5 Months,75.5,69.6 to 80.6,579
Hib,Full Series,States/Local Areas,Tennessee,2020-2021,Age,19 Months,69.8,63.9 to 75.2,579
Polio,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,95.0,91.4 to 97.2,579
Hep B,≥3 Doses,States/Local Areas,Tennessee,2019-2020,Age,7 Months,71.1,66.2 to 75.5,759
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,65.6,54.9 to 76.3,187
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Poverty,>400% FPL,96.7,94.3 to 99.2,312
PCV,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,13 Months,91.1,86.9 to 94.0,579
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,Hispanic,86.4,76.8 to 95.9,187
PCV,≥4 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,89.3,85.4 to 93.2,612
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020-2021,Age,13 Months,60.2,54.2 to 65.9,579
Influenza,,States/Local Areas,Tennessee,2021,Age,24 Months,54.6,45.5 to 64.3,216
Hib,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,90.6,86.2 to 93.8,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2021,Age,24 Months,95.1,89.5 to 98.2,216
≥1 Dose MMR,,States/Local Areas,Tennessee,2020-2021,Age,19 Months,88.4,83.8 to 91.8,579
Polio,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,3 Months,91.6,87.8 to 94.2,579
PCV,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,3 Months,90.7,86.8 to 93.5,579
≥1 Dose MMR,,States/Local Areas,Tennessee,2021,Age,13 Months,71.5,62.5 to 79.2,216
Hep A,≥1 Dose,States/Local Areas,Tennessee,2020-2021,Age,24 Months,88.9,84.6 to 92.5,579
Hep A,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,83.9,74.6 to 91.2,579
Polio,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,93.9,90.5 to 96.5,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2021,Age,35 Months,92.8,85.4 to 97.2,216
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Tennessee,2021,Age,0-3 Days,75.0,65.6 to 82.5,216
Hib,≥2 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,95.5,88.8 to 98.3,216
DTaP,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,5 Months,78.6,72.8 to 83.4,579
Hib,Primary Series,States/Local Areas,Tennessee,2020-2021,Age,7 Months,70.2,64.2 to 75.6,579
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,72.0,66.0 to 77.4,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,7 Months,45.2,39.3 to 51.2,579
Hep B,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,93.6,90.3 to 96.2,579
Hep A,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,49.3,43.3 to 55.8,579
Hib,Primary Series,States/Local Areas,Tennessee,2021,Age,35 Months,95.5,89.8 to 98.5,216
Rotavirus,,States/Local Areas,Tennessee,2021,Age,8 Months,78.4,69.6 to 85.1,216
Polio,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,97.5,93.2 to 99.4,579
≥1 Dose Varicella,,States/Local Areas,Tennessee,2020-2021,Age,24 Months,91.5,87.5 to 94.6,579
Hep B,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,5 Months,90.2,85.7 to 93.4,579
Combined 7 Series,,States/Local Areas,Tennessee,2020-2021,Age,35 Months,70.0,63.6 to 76.1,579
Polio,≥2 Doses,States/Local Areas,Tennessee,2020-2021,Age,5 Months,78.6,72.8 to 83.4,579
Hib,≥3 Doses,States/Local Areas,Tennessee,2021,Age,13 Months,72.3,63.1 to 79.9,216
DTaP,≥4 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,73.0,67.3 to 78.1,579
PCV,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,24 Months,95.2,91.9 to 97.4,579
Polio,≥3 Doses,States/Local Areas,Tennessee,2020-2021,Age,19 Months,93.9,90.2 to 96.3,579
Hib,Full Series,States/Local Areas,Tennessee,2021,Age,35 Months,79.3,69.0 to 88.0,216
Combined 7 Series,,States/Local Areas,Tennessee,2020-2021,Age,24 Months,64.4,58.4 to 70.3,579
PCV,≥1 Dose,States/Local Areas,Tennessee,2021,Age,3 Months,94.6,90.0 to 97.2,216
Influenza,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,56.0,47.7 to 64.4,268
Influenza,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,44.7,34.6 to 54.8,148
Influenza,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,45.4,38.9 to 51.9,413
Influenza,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",53.8,48.3 to 59.4,564
Influenza,,States/Local Areas,Tennessee,2017,Age,24 Months,57.6,49.8 to 65.7,305
Influenza,,States/Local Areas,Tennessee,2017-2018,Age,24 Months,62.3,57.0 to 67.6,715
Influenza,,States/Local Areas,Tennessee,2018,Age,24 Months,66.8,60.4 to 73.2,410
Influenza,,States/Local Areas,Tennessee,2018-2019,Age,24 Months,64.2,59.5 to 68.8,806
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",85.4,70.3 to 100.0,97
Influenza,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",25.6,13.4 to 37.8,61
Influenza,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",49.0,34.1 to 63.9,70
Influenza,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,50.0,39.1 to 60.8,134
Influenza,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,60.3,54.0 to 66.6,430
Influenza,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,42.4,23.2 to 61.5,41
Influenza,,States/Local Areas,Tennessee,2014-2017,Overall,Overall,48.5,43.9 to 53.1,829
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.2,64.4 to 88.1,95
Hib,Full Series,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,83.0,78.4 to 87.7,612
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.0,82.4 to 97.6,95
PCV,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,96.9,95.1 to 98.7,612
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.0,68.3 to 93.6,95
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Any Medicaid,89.6,85.2 to 93.9,469
Influenza,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,39.7,32.7 to 46.7,331
Influenza,,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,64.2,55.3 to 73.1,189
Influenza,,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,51.4,44.0 to 58.8,342
Influenza,,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,39.0,31.9 to 46.1,298
Hep B,≥1 Dose,States/Local Areas,Tennessee,2021,Age,3 Months,97.1,92.5 to 98.9,216
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2019,Insurance Coverage,Private Insurance Only,94.6,92.2 to 96.9,612
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.0,81.5 to 92.4,797
Influenza,,States/Local Areas,Tennessee,2019,Age,24 Months,61.5,54.8 to 68.2,396
Influenza,,States/Local Areas,Tennessee,2016,Age,24 Months,56.9,48.1 to 66.0,218
Influenza,,States/Local Areas,Tennessee,2016-2017,Age,24 Months,57.2,51.3 to 63.3,523
Hib,Full Series,States/Local Areas,Tennessee,2012,Age,24 Months,80.1,71.3 to 87.6,256
Hib,Full Series,States/Local Areas,Tennessee,2011,Age,24 Months,82.3,75.7 to 88.0,256
Hib,Full Series,States/Local Areas,Tennessee,2013,Age,24 Months,83.2,76.1 to 89.2,227
Hib,Full Series,States/Local Areas,Tennessee,2013-2014,Age,24 Months,78.9,73.7 to 83.7,470
Hib,Full Series,States/Local Areas,Tennessee,2014,Age,24 Months,74.8,67.1 to 81.9,243
Hib,Full Series,States/Local Areas,Tennessee,2014-2015,Age,24 Months,78.5,73.4 to 83.1,484
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,77.9,69.9 to 85.9,189
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,64.9,57.5 to 72.3,342
Hib,Full Series,States/Local Areas,Tennessee,2011,Age,19 Months,70.3,64.2 to 75.7,256
Hib,Full Series,States/Local Areas,Tennessee,2012,Age,19 Months,73.0,69.2 to 76.4,256
Hib,Full Series,States/Local Areas,Tennessee,2013,Age,19 Months,76.6,72.7 to 80.2,227
Hib,Full Series,States/Local Areas,Tennessee,2013-2014,Age,19 Months,71.1,63.3 to 77.8,470
Hib,Full Series,States/Local Areas,Tennessee,2018,Age,19 Months,75.0,68.4 to 80.6,410
Hib,Full Series,States/Local Areas,Tennessee,2018-2019,Age,19 Months,96.2,93.8 to 97.7,806
Hib,Full Series,States/Local Areas,Tennessee,2017,Age,19 Months,70.7,62.6 to 77.8,305
Hib,Full Series,States/Local Areas,Tennessee,2017-2018,Age,19 Months,72.9,67.6 to 77.6,715
Combined 7 Series,,States/Local Areas,Tennessee,2015,Age,35 Months,83.0,75.7 to 89.1,241
Combined 7 Series,,States/Local Areas,Tennessee,2015-2016,Age,35 Months,80.1,73.3 to 86.1,459
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.2,60.0 to 76.4,268
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Principal City,66.1,59.8 to 72.4,413
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.5,67.5 to 77.5,564
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.1,52.4 to 79.9,70
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Overall,Overall,66.5,62.0 to 71.0,829
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,64.8,54.8 to 74.9,148
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,63.0,55.8 to 70.3,298
Hib,Full Series,States/Local Areas,Tennessee,2016,Age,19 Months,70.9,62.1 to 78.4,218
Hib,Full Series,States/Local Areas,Tennessee,2016-2017,Age,19 Months,70.8,64.9 to 76.1,523
Hib,Full Series,States/Local Areas,Tennessee,2015,Age,19 Months,73.3,66.2 to 79.3,241
Hib,Full Series,States/Local Areas,Tennessee,2015-2016,Age,19 Months,72.1,66.4 to 77.2,459
Hib,Full Series,States/Local Areas,Tennessee,2014,Age,19 Months,65.6,57.3 to 73.0,243
Hib,Full Series,States/Local Areas,Tennessee,2014-2015,Age,19 Months,69.4,63.8 to 74.5,484
Hib,Full Series,States/Local Areas,Tennessee,2019,Age,19 Months,70.5,63.7 to 76.5,396
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",54.5,39.1 to 69.9,61
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Race and Ethnicity,Hispanic,52.2,40.9 to 63.4,134
≥1 Dose MMR,,States/Local Areas,Tennessee,2020,Age,13 Months,63.6,55.9 to 70.6,363
Combined 7 Series,,States/Local Areas,Tennessee,2018,Age,35 Months,76.7,70.5 to 82.3,410
Combined 7 Series,,States/Local Areas,Tennessee,2018-2019,Age,35 Months,73.2,68.6 to 77.7,806
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,58.2,51.0 to 65.4,331
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,77.8,72.3 to 83.4,430
Combined 7 Series,,States/Local Areas,Tennessee,2019,Age,35 Months,69.4,62.5 to 76.1,396
Combined 7 Series,,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,62.9,44.7 to 81.1,41
Combined 7 Series,,States/Local Areas,Tennessee,2012,Age,35 Months,75.1,65.3 to 84.0,256
Combined 7 Series,,States/Local Areas,Tennessee,2014,Age,35 Months,71.5,63.2 to 79.3,243
Combined 7 Series,,States/Local Areas,Tennessee,2014-2015,Age,35 Months,76.9,71.4 to 82.0,484
Combined 7 Series,,States/Local Areas,Tennessee,2013,Age,35 Months,77.5,69.2 to 84.8,227
Combined 7 Series,,States/Local Areas,Tennessee,2013-2014,Age,35 Months,74.4,68.6 to 79.9,470
Combined 7 Series,,States/Local Areas,Tennessee,2016,Age,35 Months,77.5,66.4 to 87.0,218
Combined 7 Series,,States/Local Areas,Tennessee,2016-2017,Age,35 Months,71.4,65.0 to 77.6,523
Combined 7 Series,,States/Local Areas,Tennessee,2017,Age,35 Months,67.6,59.2 to 75.6,305
Combined 7 Series,,States/Local Areas,Tennessee,2017-2018,Age,35 Months,72.2,66.9 to 77.3,715
Combined 7 Series,,States/Local Areas,Tennessee,2011,Age,35 Months,78.7,69.3 to 86.8,256
Combined 7 Series,,States/Local Areas,Tennessee,2014,Age,24 Months,63.8,55.7 to 72.0,243
Combined 7 Series,,States/Local Areas,Tennessee,2014-2015,Age,24 Months,69.0,63.5 to 74.3,484
Combined 7 Series,,States/Local Areas,Tennessee,2015,Age,24 Months,73.9,66.7 to 80.6,241
Combined 7 Series,,States/Local Areas,Tennessee,2015-2016,Age,24 Months,71.5,65.8 to 76.9,459
Hib,Primary Series,States/Local Areas,Tennessee,2018,Age,35 Months,96.9,94.5 to 98.5,410
Hib,Primary Series,States/Local Areas,Tennessee,2018-2019,Age,35 Months,94.7,91.8 to 96.8,806
Hib,Primary Series,States/Local Areas,Tennessee,2014,Age,35 Months,89.4,83.3 to 94.0,243
Hib,Primary Series,States/Local Areas,Tennessee,2014-2015,Age,35 Months,93.0,89.6 to 95.6,484
Combined 7 Series,,States/Local Areas,Tennessee,2017,Age,24 Months,63.0,55.0 to 71.1,305
Combined 7 Series,,States/Local Areas,Tennessee,2017-2018,Age,24 Months,67.8,62.6 to 72.9,715
Combined 7 Series,,States/Local Areas,Tennessee,2018,Age,24 Months,72.3,65.9 to 78.3,410
Combined 7 Series,,States/Local Areas,Tennessee,2018-2019,Age,24 Months,68.3,63.7 to 72.8,806
Hib,Primary Series,States/Local Areas,Tennessee,2011,Age,24 Months,93.2,87.8 to 96.7,256
Hib,Primary Series,States/Local Areas,Tennessee,2012,Age,24 Months,95.9,92.7 to 98.0,256
Hib,Primary Series,States/Local Areas,Tennessee,2012,Age,19 Months,94.8,92.5 to 96.4,256
Hib,Primary Series,States/Local Areas,Tennessee,2016,Age,13 Months,88.8,82.4 to 93.0,218
Hib,Primary Series,States/Local Areas,Tennessee,2016-2017,Age,13 Months,86.3,81.7 to 90.0,523
Hib,Primary Series,States/Local Areas,Tennessee,2019,Age,13 Months,78.7,72.3 to 84.0,396
Hib,Primary Series,States/Local Areas,Tennessee,2016,Age,35 Months,93.5,89.0 to 96.6,218
Hib,Primary Series,States/Local Areas,Tennessee,2016-2017,Age,35 Months,92.7,89.0 to 95.5,523
Hib,Primary Series,States/Local Areas,Tennessee,2017,Age,13 Months,84.0,76.7 to 89.3,305
Hib,Primary Series,States/Local Areas,Tennessee,2017-2018,Age,13 Months,86.7,82.6 to 90.0,715
Hib,Primary Series,States/Local Areas,Tennessee,2018,Age,13 Months,89.5,84.9 to 92.8,410
Hib,Primary Series,States/Local Areas,Tennessee,2018-2019,Age,13 Months,84.1,80.3 to 87.4,806
Hib,Primary Series,States/Local Areas,Tennessee,2015,Age,35 Months,96.5,93.5 to 98.4,241
Hib,Primary Series,States/Local Areas,Tennessee,2015-2016,Age,35 Months,95.0,92.4 to 97.0,459
Combined 7 Series,,States/Local Areas,Tennessee,2011,Age,24 Months,70.1,62.8 to 77.1,256
Combined 7 Series,,States/Local Areas,Tennessee,2012,Age,24 Months,66.4,57.6 to 75.0,256
Hib,Primary Series,States/Local Areas,Tennessee,2017,Age,35 Months,91.6,85.6 to 95.8,305
Hib,Primary Series,States/Local Areas,Tennessee,2017-2018,Age,35 Months,94.3,91.1 to 96.6,715
Combined 7 Series,,States/Local Areas,Tennessee,2016,Age,24 Months,69.0,60.3 to 77.4,218
Combined 7 Series,,States/Local Areas,Tennessee,2016-2017,Age,24 Months,66.0,60.1 to 71.9,523
Hib,Primary Series,States/Local Areas,Tennessee,2019,Age,35 Months,92.2,86.8 to 96.0,396
Combined 7 Series,,States/Local Areas,Tennessee,2013,Age,24 Months,71.2,63.2 to 78.7,227
Combined 7 Series,,States/Local Areas,Tennessee,2013-2014,Age,24 Months,67.5,61.8 to 73.1,470
Hib,Primary Series,States/Local Areas,Tennessee,2013,Age,35 Months,97.1,93.8 to 98.9,227
Hib,Primary Series,States/Local Areas,Tennessee,2013-2014,Age,35 Months,93.2,89.8 to 95.8,470
Hib,Primary Series,States/Local Areas,Tennessee,2011,Age,35 Months,95.7,90.1 to 98.6,256
Hib,Primary Series,States/Local Areas,Tennessee,2019,Age,24 Months,91.1,86.0 to 94.8,396
Hib,Primary Series,States/Local Areas,Tennessee,2012,Age,35 Months,97.3,92.6 to 99.3,256
Hib,Primary Series,States/Local Areas,Tennessee,2013,Age,24 Months,97.1,93.8 to 98.9,227
Hib,Primary Series,States/Local Areas,Tennessee,2013-2014,Age,24 Months,93.0,89.5 to 95.6,470
Hib,Primary Series,States/Local Areas,Tennessee,2018,Age,24 Months,96.6,94.2 to 98.2,410
Hib,Primary Series,States/Local Areas,Tennessee,2018-2019,Age,24 Months,94.0,91.2 to 96.1,806
Hib,Primary Series,States/Local Areas,Tennessee,2016,Age,24 Months,93.5,89.0 to 96.6,218
Hib,Primary Series,States/Local Areas,Tennessee,2016-2017,Age,24 Months,92.2,88.6 to 95.1,523
Hib,Primary Series,States/Local Areas,Tennessee,2017,Age,24 Months,91.0,85.0 to 95.2,305
Hib,Primary Series,States/Local Areas,Tennessee,2017-2018,Age,24 Months,93.8,90.7 to 96.2,715
Hib,Primary Series,States/Local Areas,Tennessee,2015,Age,24 Months,96.5,93.5 to 98.4,241
Hib,Primary Series,States/Local Areas,Tennessee,2015-2016,Age,24 Months,95.0,92.4 to 97.0,459
Hib,Primary Series,States/Local Areas,Tennessee,2014,Age,24 Months,88.9,82.8 to 93.6,243
Hib,Primary Series,States/Local Areas,Tennessee,2014-2015,Age,24 Months,92.7,89.3 to 95.3,484
Hib,Primary Series,States/Local Areas,Tennessee,2019,Age,7 Months,71.0,64.3 to 77.0,396
Hib,Primary Series,States/Local Areas,Tennessee,2012,Age,7 Months,73.8,69.2 to 77.9,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,91.7,86.1 to 95.6,218
Hib,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,89.7,85.5 to 93.0,523
Hib,≥3 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,95.0,91.3 to 97.5,241
Hib,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,93.3,90.1 to 95.8,459
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,91.0,85.8 to 94.9,396
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,>400% FPL,96.0,91.8 to 100.0,189
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,133% to <400% FPL,91.4,87.2 to 95.7,342
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Poverty,<133% FPL,90.7,86.5 to 94.9,298
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Overall,Overall,92.0,89.4 to 94.6,829
Hib,≥3 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,95.1,89.0 to 98.3,256
Hib,≥3 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,97.4,92.9 to 99.3,256
PCV,≥2 Doses,States/Local Areas,Tennessee,2014,Age,5 Months,77.1,69.4 to 83.4,243
PCV,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,5 Months,75.5,72.9 to 77.9,484
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016,Age,24 Months,90.0,83.8 to 94.5,218
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,24 Months,90.0,85.9 to 93.3,523
Hep A,≥1 Dose,States/Local Areas,Tennessee,2015,Age,24 Months,88.9,83.0 to 93.4,241
Hep A,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,24 Months,89.4,85.3 to 92.8,459
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Any Medicaid,90.1,85.9 to 94.4,331
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Private Insurance Only,97.5,95.9 to 99.2,430
Hep A,≥2 Doses,States/Local Areas,Tennessee,2017,Age,19 Months,26.4,20.2 to 33.6,305
Hep A,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,19 Months,28.2,23.8 to 33.2,715
DTaP,≥4 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,72.8,60.9 to 82.1,241
DTaP,≥4 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,68.5,62.6 to 73.9,459
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,67.2,59.1 to 74.3,243
DTaP,≥4 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,70.0,64.5 to 74.9,484
DTaP,≥4 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,70.2,61.9 to 77.4,227
DTaP,≥4 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,68.7,59.8 to 76.4,470
Hib,≥3 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,89.9,83.8 to 94.5,305
Hib,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,93.2,89.8 to 95.8,715
Hib,≥3 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,95.9,90.9 to 98.6,218
Hib,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,92.5,88.6 to 95.4,523
Hep A,≥2 Doses,States/Local Areas,Tennessee,2018,Age,19 Months,30.1,24.1 to 36.8,410
Hep A,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,19 Months,32.0,26.9 to 37.6,651
Hep A,≥2 Doses,States/Local Areas,Tennessee,2011,Age,24 Months,38.4,30.7 to 47.3,256
Hep A,≥2 Doses,States/Local Areas,Tennessee,2019,Age,19 Months,31.9,26.0 to 38.4,396
Hib,≥3 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,87.0,80.4 to 92.2,243
Hib,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,91.0,87.3 to 94.0,484
DTaP,≥2 Doses,States/Local Areas,Tennessee,2019,Age,5 Months,80.2,73.7 to 85.5,396
Hep A,≥2 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,19.0,15.8 to 22.6,256
Hep A,≥2 Doses,States/Local Areas,Tennessee,2013,Age,19 Months,27.5,22.9 to 32.7,227
Hep A,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,19 Months,23.1,19.7 to 26.9,470
Hib,≥3 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,95.0,91.4 to 97.4,410
Hib,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,92.4,89.3 to 94.9,806
Hib,≥3 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,87.7,81.2 to 92.7,305
Hib,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,91.3,87.8 to 94.2,715
Hib,≥3 Doses,States/Local Areas,Tennessee,2019,Age,24 Months,89.5,84.2 to 93.6,396
Hib,≥3 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,88.7,82.1 to 93.7,243
Hib,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,92.8,89.1 to 95.6,484
Hib,≥3 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,95.4,90.8 to 98.1,227
Hib,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,92.0,88.1 to 95.1,470
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016,Age,19 Months,22.7,16.3 to 30.7,218
Hep A,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,19 Months,24.6,20.0 to 29.8,523
Hep A,≥2 Doses,States/Local Areas,Tennessee,2015,Age,19 Months,28.1,24.2 to 32.4,241
Hep A,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,19 Months,25.5,20.6 to 31.0,459
Hib,≥3 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,96.9,93.5 to 98.8,241
Hib,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,96.3,93.4 to 98.1,459
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014,Age,24 Months,82.6,75.8 to 88.4,243
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,24 Months,85.7,81.3 to 89.5,484
PCV,≥2 Doses,States/Local Areas,Tennessee,2016,Age,5 Months,77.7,69.7 to 84.1,218
PCV,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,5 Months,77.6,72.2 to 82.2,523
PCV,≥2 Doses,States/Local Areas,Tennessee,2015,Age,5 Months,73.9,64.9 to 81.3,241
PCV,≥2 Doses,States/Local Areas,Tennessee,2015-2016,Age,5 Months,75.8,69.8 to 80.9,459
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018,Age,35 Months,97.5,95.1 to 98.9,410
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,35 Months,95.5,92.7 to 97.4,806
DTaP,≥3 Doses,States/Local Areas,Tennessee,2019,Age,35 Months,93.6,88.0 to 97.2,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Insurance Coverage,Other,89.5,79.3 to 99.7,41
Hep A,≥1 Dose,States/Local Areas,Tennessee,2018,Age,24 Months,94.3,90.6 to 96.9,410
Hep A,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,24 Months,92.1,88.8 to 94.7,806
Hep A,≥1 Dose,States/Local Areas,Tennessee,2011,Age,35 Months,96.7,91.3 to 99.2,256
Hep A,≥1 Dose,States/Local Areas,Tennessee,2019,Age,24 Months,89.7,84.1 to 93.9,396
Hep A,≥1 Dose,States/Local Areas,Tennessee,2017,Age,24 Months,90.0,84.2 to 94.4,305
Hep A,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,24 Months,92.2,88.9 to 94.8,715
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016,Age,24 Months,92.4,86.9 to 96.2,218
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,24 Months,91.5,87.5 to 94.6,523
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017,Age,24 Months,90.6,84.3 to 95.1,305
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,24 Months,94.0,90.7 to 96.4,715
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018,Age,24 Months,97.3,94.9 to 98.7,410
DTaP,≥3 Doses,States/Local Areas,Tennessee,2018-2019,Age,24 Months,94.3,91.5 to 96.4,806
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.9,87.3 to 96.5,268
Polio,≥3 Doses,States/Local Areas,Tennessee,2014-2017,Urbanicity,Living In a Non-MSA,89.1,81.2 to 97.0,148
DTaP,≥2 Doses,States/Local Areas,Tennessee,2016,Age,5 Months,78.6,70.5 to 84.9,218
DTaP,≥2 Doses,States/Local Areas,Tennessee,2016-2017,Age,5 Months,78.3,72.9 to 82.9,523
DTaP,≥2 Doses,States/Local Areas,Tennessee,2018,Age,5 Months,80.9,74.7 to 85.8,410
DTaP,≥2 Doses,States/Local Areas,Tennessee,2018-2019,Age,5 Months,80.6,76.2 to 84.3,806
DTaP,≥2 Doses,States/Local Areas,Tennessee,2017,Age,5 Months,78.1,70.4 to 84.3,305
DTaP,≥2 Doses,States/Local Areas,Tennessee,2017-2018,Age,5 Months,79.5,74.5 to 83.7,715
Hep A,≥1 Dose,States/Local Areas,Tennessee,2013,Age,19 Months,79.5,76.3 to 82.4,227
Hep A,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,19 Months,78.9,75.8 to 81.7,470
Hep A,≥1 Dose,States/Local Areas,Tennessee,2015,Age,19 Months,83.9,75.6 to 89.8,241
Hep A,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,19 Months,84.4,79.7 to 88.2,459
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014,Age,19 Months,78.3,70.6 to 84.4,243
Hep A,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,19 Months,81.1,76.2 to 85.2,484
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013,Age,24 Months,96.0,91.4 to 98.5,227
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,24 Months,92.9,89.2 to 95.6,470
DTaP,≥3 Doses,States/Local Areas,Tennessee,2020,Age,13 Months,89.6,83.6 to 93.5,363
Hep A,≥1 Dose,States/Local Areas,Tennessee,2011,Age,19 Months,78.9,76.0 to 81.5,256
DTaP,≥1 Dose,States/Local Areas,Tennessee,2019,Age,3 Months,89.5,84.1 to 93.3,396
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014,Age,24 Months,89.8,83.8 to 94.3,243
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,24 Months,93.3,90.0 to 95.8,484
DTaP,≥1 Dose,States/Local Areas,Tennessee,2017,Age,3 Months,90.0,84.0 to 94.0,305
DTaP,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,3 Months,91.4,87.8 to 94.0,715
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015,Age,24 Months,96.7,94.0 to 98.5,241
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,24 Months,94.6,91.6 to 96.8,459
DTaP,≥1 Dose,States/Local Areas,Tennessee,2018,Age,3 Months,92.8,87.9 to 95.8,410
DTaP,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,3 Months,91.2,87.7 to 93.7,806
Hib,Full Series,States/Local Areas,Tennessee,2021,Age,19 Months,71.4,62.0 to 79.2,216
Hib,≥1 Dose,States/Local Areas,Tennessee,2021,Age,3 Months,89.8,82.8 to 94.1,216
DTaP,≥1 Dose,States/Local Areas,Tennessee,2016,Age,3 Months,90.1,84.2 to 93.9,218
DTaP,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,3 Months,90.1,86.1 to 93.0,523
DTaP,≥1 Dose,States/Local Areas,Tennessee,2015,Age,3 Months,83.4,74.3 to 89.7,241
DTaP,≥1 Dose,States/Local Areas,Tennessee,2015-2016,Age,3 Months,86.6,81.4 to 90.6,459
DTaP,≥1 Dose,States/Local Areas,Tennessee,2014,Age,3 Months,88.3,81.4 to 92.9,243
DTaP,≥1 Dose,States/Local Areas,Tennessee,2014-2015,Age,3 Months,85.8,80.3 to 90.0,484
DTaP,≥1 Dose,States/Local Areas,Tennessee,2013,Age,3 Months,92.3,85.0 to 96.2,227
DTaP,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,3 Months,90.3,88.9 to 91.5,470
Polio,≥3 Doses,States/Local Areas,Tennessee,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.2,82.0 to 98.4,95
DTaP,≥1 Dose,States/Local Areas,Tennessee,2011,Age,3 Months,91.9,83.7 to 96.1,256
DTaP,≥1 Dose,States/Local Areas,Tennessee,2012,Age,3 Months,87.3,83.1 to 90.6,256
DTaP,≥4 Doses,States/Local Areas,Tennessee,2020-2021,Age,35 Months,88.3,83.3 to 92.3,579
Combined 7 Series,,States/Local Areas,Tennessee,2021,Age,35 Months,71.5,60.1 to 82.0,216
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016,Age,35 Months,92.4,86.9 to 96.2,218
DTaP,≥3 Doses,States/Local Areas,Tennessee,2016-2017,Age,35 Months,93.3,89.2 to 96.2,523
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015,Age,35 Months,96.7,94.0 to 98.5,241
DTaP,≥3 Doses,States/Local Areas,Tennessee,2015-2016,Age,35 Months,94.6,91.6 to 96.8,459
PCV,≥2 Doses,States/Local Areas,Tennessee,2011,Age,5 Months,77.3,70.0 to 83.3,256
PCV,≥2 Doses,States/Local Areas,Tennessee,2012,Age,5 Months,74.4,68.4 to 79.5,256
PCV,≥2 Doses,States/Local Areas,Tennessee,2013,Age,5 Months,78.6,64.3 to 88.3,227
PCV,≥2 Doses,States/Local Areas,Tennessee,2013-2014,Age,5 Months,77.9,70.8 to 83.6,470
DTaP,≥4 Doses,States/Local Areas,Tennessee,2012,Age,19 Months,62.9,57.5 to 68.0,256
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014,Age,19 Months,18.7,13.5 to 25.4,243
Hep A,≥2 Doses,States/Local Areas,Tennessee,2014-2015,Age,19 Months,23.4,18.9 to 28.6,484
DTaP,≥4 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,66.1,59.9 to 71.9,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017,Age,35 Months,93.1,86.9 to 97.0,305
DTaP,≥3 Doses,States/Local Areas,Tennessee,2017-2018,Age,35 Months,95.3,92.1 to 97.5,715
Hep A,≥1 Dose,States/Local Areas,Tennessee,2013,Age,24 Months,86.7,79.6 to 92.3,227
Hep A,≥1 Dose,States/Local Areas,Tennessee,2013-2014,Age,24 Months,84.9,80.1 to 89.1,470
Hep A,≥1 Dose,States/Local Areas,Tennessee,2011,Age,24 Months,88.1,82.5 to 92.5,256
Hep A,≥1 Dose,States/Local Areas,Tennessee,2019,Age,19 Months,84.5,78.2 to 89.2,396
Hep A,≥1 Dose,States/Local Areas,Tennessee,2012,Age,24 Months,92.1,88.0 to 95.2,256
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016,Age,19 Months,85.0,77.7 to 90.2,218
Hep A,≥1 Dose,States/Local Areas,Tennessee,2016-2017,Age,19 Months,86.2,81.4 to 89.9,523
Hep A,≥1 Dose,States/Local Areas,Tennessee,2017,Age,19 Months,87.4,80.5 to 92.0,305
Hep A,≥1 Dose,States/Local Areas,Tennessee,2017-2018,Age,19 Months,87.9,83.9 to 91.1,715
Hep A,≥1 Dose,States/Local Areas,Tennessee,2018,Age,19 Months,88.5,83.4 to 92.2,410
Hep A,≥1 Dose,States/Local Areas,Tennessee,2018-2019,Age,19 Months,87.7,83.3 to 91.1,651
DTaP,≥3 Doses,States/Local Areas,Tennessee,2011,Age,35 Months,96.5,91.7 to 98.9,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2012,Age,35 Months,96.8,93.3 to 98.8,256
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013,Age,35 Months,96.0,91.4 to 98.5,227
DTaP,≥3 Doses,States/Local Areas,Tennessee,2013-2014,Age,35 Months,92.9,89.2 to 95.6,470
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014,Age,35 Months,89.8,83.8 to 94.3,243
DTaP,≥3 Doses,States/Local Areas,Tennessee,2014-2015,Age,35 Months,93.3,90.0 to 95.8,484
Hep A,≥2 Doses,States/Local Areas,Tennessee,2011,Age,19 Months,19.0,15.0 to 23.7,256
Hib,Primary Series,States/Local Areas,Tennessee,2017,Age,7 Months,70.9,62.7 to 77.9,305
Hib,Primary Series,States/Local Areas,Tennessee,2017-2018,Age,7 Months,73.4,68.2 to 78.1,715
Hib,Primary Series,States/Local Areas,Tennessee,2016,Age,7 Months,70.9,62.2 to 78.3,218
Hib,Primary Series,States/Local Areas,Tennessee,2016-2017,Age,7 Months,70.9,65.1 to 76.1,523
Hib,Primary Series,States/Local Areas,Tennessee,2018,Age,7 Months,75.9,69.4 to 81.4,410
Hib,Primary Series,States/Local Areas,Tennessee,2018-2019,Age,7 Months,73.5,68.9 to 77.6,806
Hib,Primary Series,States/Local Areas,Tennessee,2018,Age,19 Months,95.4,92.3 to 97.3,410
Hib,Primary Series,States/Local Areas,Tennessee,2018-2019,Age,19 Months,84.1,80.3 to 87.4,806
Hib,Primary Series,States/Local Areas,Tennessee,2015,Age,7 Months,72.8,64.6 to 79.7,241
Hib,Primary Series,States/Local Areas,Tennessee,2015-2016,Age,7 Months,71.9,66.0 to 77.1,459
Hib,Primary Series,States/Local Areas,Tennessee,2014,Age,7 Months,66.3,58.0 to 73.7,243
Hib,Primary Series,States/Local Areas,Tennessee,2014-2015,Age,7 Months,69.6,63.8 to 74.8,484
Hib,Primary Series,States/Local Areas,Tennessee,2011,Age,13 Months,89.3,85.1 to 92.5,256
Hib,Primary Series,States/Local Areas,Tennessee,2012,Age,13 Months,87.7,83.2 to 91.1,256
Hib,Primary Series,States/Local Areas,Tennessee,2013,Age,13 Months,92.2,89.4 to 94.3,227
Hib,Primary Series,States/Local Areas,Tennessee,2013-2014,Age,13 Months,86.5,80.9 to 90.6,470
Hib,Primary Series,States/Local Areas,Tennessee,2015,Age,13 Months,89.9,83.6 to 93.9,241
Hib,Primary Series,States/Local Areas,Tennessee,2015-2016,Age,13 Months,89.3,85.1 to 92.4,459
Hib,Primary Series,States/Local Areas,Tennessee,2014,Age,13 Months,80.8,72.8 to 86.8,243
Hib,Primary Series,States/Local Areas,Tennessee,2014-2015,Age,13 Months,85.3,80.5 to 89.1,484
Hib,Primary Series,States/Local Areas,Tennessee,2015,Age,19 Months,96.5,96.0 to 96.9,241
Hib,Primary Series,States/Local Areas,Tennessee,2015-2016,Age,19 Months,94.6,91.6 to 96.5,459
Hib,Primary Series,States/Local Areas,Tennessee,2017,Age,19 Months,89.0,82.4 to 93.3,305
Hib,Primary Series,States/Local Areas,Tennessee,2017-2018,Age,19 Months,92.2,88.7 to 94.7,715
Hib,Primary Series,States/Local Areas,Tennessee,2019,Age,19 Months,89.4,83.9 to 93.2,396
Hib,Primary Series,States/Local Areas,Tennessee,2011,Age,19 Months,92.7,87.3 to 96.0,256
Hib,Primary Series,States/Local Areas,Tennessee,2013,Age,19 Months,97.1,95.5 to 98.1,227
Hib,Primary Series,States/Local Areas,Tennessee,2013-2014,Age,19 Months,92.7,90.7 to 94.3,470
Hib,Primary Series,States/Local Areas,Tennessee,2014,Age,19 Months,88.4,81.7 to 92.8,243
Hib,Primary Series,States/Local Areas,Tennessee,2014-2015,Age,19 Months,92.4,88.8 to 94.9,484
Hib,Primary Series,States/Local Areas,Tennessee,2016,Age,19 Months,92.6,87.2 to 95.8,218
Hib,Primary Series,States/Local Areas,Tennessee,2016-2017,Age,19 Months,90.8,86.7 to 93.7,523
Hib,Primary Series,States/Local Areas,Tennessee,2013,Age,7 Months,74.3,65.4 to 81.6,227
Hib,Primary Series,States/Local Areas,Tennessee,2013-2014,Age,7 Months,70.3,64.7 to 75.3,470
Hep A,≥1 Dose,States/Local Areas,Tennessee,2012,Age,19 Months,85.8,84.8 to 86.7,256
PCV,≥4 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,80.5,71.5 to 87.1,216
Hib,Primary Series,States/Local Areas,Tennessee,2021,Age,7 Months,70.6,61.1 to 78.7,216
Hep B,≥3 Doses,States/Local Areas,Tennessee,2021,Age,19 Months,93.5,87.1 to 96.9,216
Combined 7 Series,,States/Local Areas,Tennessee,2019,Age,24 Months,64.0,57.3 to 70.6,396
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,99.6,98.6 to 99.9,291
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,98.1,96.1 to 99.1,583
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,96.6,89.5 to 99.0,292
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,96.0,92.9 to 97.8,559
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,95.4,89.7 to 98.0,267
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,96.4,92.4 to 98.3,597
Polio,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,96.2,91.7 to 98.3,295
Polio,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,95.0,89.6 to 98.2,237
Polio,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,95.1,91.4 to 97.6,260
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,97.7,93.1 to 99.3,291
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,97.1,94.5 to 98.5,583
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,94.5,93.2 to 95.5,303
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,96.1,92.0 to 98.1,594
Polio,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,96.3,92.7 to 98.5,303
Polio,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,97.3,95.3 to 98.6,594
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,96.5,90.0 to 98.8,292
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,95.2,91.9 to 97.2,559
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,97.4,92.4 to 99.2,330
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,97.1,94.2 to 98.6,695
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,97.1,93.1 to 98.8,295
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,97.4,92.4 to 99.2,330
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,97.3,94.5 to 98.7,695
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,95.4,90.5 to 98.2,267
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,96.6,93.0 to 98.6,597
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,94.0,88.0 to 97.1,267
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,95.7,91.7 to 97.8,597
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,97.2,93.2 to 98.9,365
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,93.5,90.3 to 95.7,660
Polio,≥1 Dose,States/Local Areas,Massachusetts,2020-2021,Age,3 Months,94.9,91.7 to 96.9,443
Polio,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,97.0,93.6 to 98.8,292
Polio,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,96.2,93.4 to 98.0,559
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,98.3,95.8 to 99.4,291
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,97.6,95.6 to 98.8,583
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,96.5,92.9 to 98.6,303
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,98.2,96.3 to 99.2,594
Hib,Full Series,States/Local Areas,Massachusetts,2015,Age,24 Months,93.0,88.7 to 96.1,292
Hib,Full Series,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,91.4,87.9 to 94.3,559
Polio,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,98.1,94.5 to 99.6,330
Polio,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,97.4,94.8 to 98.9,695
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,96.9,92.3 to 98.8,365
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,95.9,93.0 to 97.7,660
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,98.0,94.1 to 99.5,237
Polio,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,95.8,90.2 to 98.7,237
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,97.2,93.4 to 99.1,260
Polio,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,96.9,93.0 to 98.9,365
Polio,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,96.6,94.0 to 98.2,660
Polio,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,96.3,92.4 to 98.5,295
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,97.4,93.4 to 99.0,295
Hib,Full Series,States/Local Areas,Massachusetts,2016,Age,24 Months,89.8,84.0 to 94.2,267
Hib,Full Series,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,88.9,84.6 to 92.4,597
Hib,Full Series,States/Local Areas,Massachusetts,2018,Age,24 Months,91.1,86.0 to 95.0,365
Hib,Full Series,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,87.9,83.5 to 91.6,660
Hib,Full Series,States/Local Areas,Massachusetts,2017,Age,24 Months,88.0,81.8 to 92.8,330
Hib,Full Series,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,89.6,85.7 to 92.8,695
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,94.9,90.7 to 97.6,303
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,96.5,93.9 to 98.2,594
Hib,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,95.0,90.5 to 97.8,260
Hib,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,98.0,94.1 to 99.5,237
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,98.0,94.1 to 99.5,291
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,97.2,94.9 to 98.7,583
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,98.9,96.9 to 99.7,291
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,97.9,96.1 to 99.1,583
Polio,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,97.7,93.8 to 99.4,303
Polio,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,98.2,96.3 to 99.3,594
Polio,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,97.5,94.2 to 99.2,260
Hib,Full Series,States/Local Areas,Massachusetts,2019,Age,24 Months,84.6,77.2 to 90.6,295
Polio,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,97.0,93.6 to 98.8,292
Polio,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,96.2,93.4 to 98.0,559
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,5 Months,89.5,87.5 to 91.2,303
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,5 Months,90.7,86.6 to 93.6,594
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,5 Months,83.8,73.4 to 90.6,260
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,5 Months,86.9,78.3 to 92.5,237
Hib,Full Series,States/Local Areas,Massachusetts,2013,Age,35 Months,91.2,81.1 to 97.1,303
Hib,Full Series,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,93.1,87.5 to 96.7,594
Hib,Full Series,States/Local Areas,Massachusetts,2011,Age,35 Months,87.0,79.1 to 93.0,237
Hib,Full Series,States/Local Areas,Massachusetts,2012,Age,35 Months,92.4,86.5 to 96.4,260
Polio,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,98.1,94.5 to 99.6,330
Polio,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.4,94.8 to 98.9,695
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,95.4,90.5 to 98.2,267
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.6,93.1 to 98.6,597
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,5 Months,91.8,86.5 to 95.2,291
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,5 Months,92.6,88.2 to 95.4,583
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.2,95.4 to 98.9,807
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,5 Months,88.6,80.9 to 93.4,267
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,5 Months,87.1,81.2 to 91.4,597
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,5 Months,93.3,87.8 to 96.4,292
DTaP,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,5 Months,90.9,86.4 to 94.0,559
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,97.0,94.4 to 99.7,212
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.6,95.9 to 99.3,672
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.5,93.4 to 100.0,152
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,96.2,92.8 to 99.5,157
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,92.5,89.8 to 95.2,780
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,97.5,94.1 to 99.2,295
Hib,Full Series,States/Local Areas,Massachusetts,2018,Age,35 Months,93.7,89.0 to 96.8,365
Hib,Full Series,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,94.2,90.3 to 96.9,660
Hib,Full Series,States/Local Areas,Massachusetts,2019,Age,35 Months,93.8,87.4 to 97.6,295
Hib,Full Series,States/Local Areas,Massachusetts,2014,Age,35 Months,94.6,89.6 to 97.6,291
Hib,Full Series,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,94.2,91.1 to 96.5,583
Hib,Full Series,States/Local Areas,Massachusetts,2015,Age,35 Months,93.8,89.6 to 96.8,292
Hib,Full Series,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,91.8,88.3 to 94.6,559
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.3,72.6 to 100.0,53
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,83.0,75.9 to 90.1,219
Hib,Full Series,States/Local Areas,Massachusetts,2016,Age,35 Months,89.8,84.0 to 94.2,267
Hib,Full Series,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,90.9,86.4 to 94.5,597
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.6,85.1 to 92.1,807
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,96.3,93.1 to 99.5,219
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,97.8,96.3 to 99.3,780
Polio,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,96.9,93.0 to 98.9,365
Polio,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,96.6,94.1 to 98.3,660
Hib,Full Series,States/Local Areas,Massachusetts,2017,Age,35 Months,95.1,87.0 to 98.9,330
Hib,Full Series,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,94.3,89.8 to 97.3,695
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,89.4,83.7 to 95.1,264
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,79.9,71.9 to 87.9,164
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,88.5,85.4 to 91.6,1034
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.3,93.6 to 100.0,53
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,87.0,79.6 to 94.4,212
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.4,86.8 to 94.0,672
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.6,78.4 to 94.7,152
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,86.7,79.3 to 94.1,157
Hib,Primary Series,States/Local Areas,Massachusetts,2012,Age,7 Months,71.9,65.8 to 77.4,260
Hib,Full Series,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,93.0,89.8 to 96.2,606
Hib,Primary Series,States/Local Areas,Massachusetts,2011,Age,7 Months,81.2,77.4 to 84.4,237
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,92.4,87.5 to 95.9,365
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,89.8,85.7 to 93.1,660
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,87.2,80.9 to 92.3,330
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,89.9,86.0 to 93.1,695
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,86.9,79.9 to 92.3,295
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,94.7,89.1 to 98.0,237
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,35 Months,92.2,87.7 to 95.6,292
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,92.5,89.2 to 95.2,559
Polio,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,5 Months,82.1,73.1 to 88.6,260
Polio,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,5 Months,85.3,76.9 to 91.0,237
Polio,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,5 Months,87.1,83.4 to 90.1,303
Polio,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,5 Months,87.7,83.9 to 90.7,594
Polio,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,5 Months,88.3,82.0 to 92.6,291
Polio,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,5 Months,90.7,86.5 to 93.6,583
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,97.5,95.2 to 99.8,164
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,98.3,96.5 to 100.0,606
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,96.5,92.8 to 100.0,264
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,47.5,38.3 to 56.9,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,38.4,33.6 to 43.5,237
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,65.2,62.1 to 68.1,303
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,61.3,55.0 to 67.1,594
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,79.7,71.9 to 85.8,295
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,92.1,85.5 to 96.5,237
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,86.1,79.4 to 91.5,260
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,49.3,41.2 to 58.1,365
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,47.9,42.1 to 54.2,660
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,49.0,41.1 to 57.5,330
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,49.2,43.4 to 55.2,695
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,52.5,42.8 to 62.8,267
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,50.8,44.5 to 57.4,597
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,88.5,82.2 to 93.3,303
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,89.4,85.4 to 92.8,594
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,97.2,92.3 to 99.0,330
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,95.7,92.0 to 97.7,695
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,96.4,92.2 to 98.6,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,93.6,88.9 to 98.3,164
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,95.5,93.7 to 97.4,1034
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.5,93.2 to 97.7,807
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,91.7,87.3 to 96.0,264
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019,Age,35 Months,95.3,90.9 to 98.0,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,92.6,88.0 to 97.1,219
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,97.3,95.8 to 98.8,780
Hib,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,3 Months,91.9,90.3 to 93.3,303
Hib,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,3 Months,92.2,90.0 to 93.9,594
Hib,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,3 Months,92.0,82.5 to 96.5,260
Hib,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,3 Months,95.7,92.6 to 97.5,237
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018,Age,35 Months,97.2,93.8 to 99.0,365
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,96.7,93.9 to 98.4,660
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017,Age,35 Months,98.0,94.5 to 99.5,330
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.8,95.3 to 99.2,695
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2016,Age,0-2 Days,81.1,73.8 to 86.8,267
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2016-2017,Age,0-2 Days,83.9,79.0 to 87.7,597
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,94.4,88.9 to 97.3,267
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,95.5,91.6 to 97.6,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,95.0,93.8 to 96.0,303
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,94.9,93.5 to 96.1,594
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,96.5,91.8 to 98.6,330
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,95.8,92.6 to 97.6,695
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,94.9,89.9 to 97.5,291
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,94.8,91.7 to 96.8,583
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,94.7,90.0 to 97.2,292
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,93.2,89.6 to 95.6,559
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,92.5,87.4 to 96.1,365
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,94.1,91.0 to 96.5,660
PCV,≥4 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,90.0,82.7 to 95.1,237
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015,Age,35 Months,95.7,92.1 to 98.0,292
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,95.7,92.6 to 97.7,559
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014,Age,35 Months,94.3,88.1 to 97.9,291
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,95.0,91.6 to 97.3,583
PCV,≥4 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,86.7,79.4 to 91.7,295
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018,Age,24 Months,95.3,90.9 to 98.0,365
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,95.2,92.3 to 97.3,660
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013,Age,35 Months,98.5,94.2 to 99.8,303
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,97.7,93.3 to 99.5,594
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2014,Age,0-2 Days,71.8,63.7 to 78.7,291
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2014-2015,Age,0-2 Days,71.2,65.6 to 76.3,583
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2015,Age,0-2 Days,70.7,62.4 to 77.8,292
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2015-2016,Age,0-2 Days,76.0,70.5 to 80.7,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,88.8,82.6 to 93.0,330
PCV,≥4 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,85.5,80.7 to 89.3,695
PCV,≥4 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,82.1,74.5 to 87.9,365
PCV,≥4 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,83.8,77.5 to 88.6,565
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017,Age,24 Months,96.2,91.8 to 98.6,330
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,95.7,92.8 to 97.7,695
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016,Age,24 Months,94.9,90.1 to 97.9,267
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,95.5,92.0 to 97.8,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,91.4,83.8 to 95.6,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,95.8,91.4 to 98.4,267
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,96.3,93.0 to 98.3,597
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,95.2,91.0 to 97.8,292
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,95.5,92.7 to 97.5,559
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,94.8,91.7 to 97.0,583
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,94.4,88.6 to 97.3,291
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,94.1,90.5 to 96.3,583
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,93.8,88.5 to 96.7,292
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,94.1,90.6 to 96.3,559
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,88.8,81.5 to 93.5,260
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,73.8,65.2 to 80.8,365
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,78.4,72.8 to 83.1,660
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,83.0,75.7 to 88.4,295
PCV,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,93.6,91.0 to 95.5,237
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2013,Age,0-2 Days,68.6,64.1 to 72.9,303
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2013-2014,Age,0-2 Days,70.2,66.9 to 73.3,594
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2012,Age,0-2 Days,70.8,61.9 to 78.3,260
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,92.9,88.9 to 95.5,303
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,93.6,91.6 to 95.2,594
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2019,Age,0-1 Days,85.2,78.6 to 89.9,295
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2011,Age,0-2 Days,72.0,68.8 to 74.9,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,77.5,69.4 to 84.0,330
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,75.7,69.9 to 80.6,695
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,80.2,72.6 to 86.1,292
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,78.7,73.0 to 83.4,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,90.6,84.5 to 94.5,291
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,88.2,83.8 to 91.5,583
PCV,≥4 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,85.8,82.0 to 88.8,292
PCV,≥4 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,88.6,84.2 to 91.9,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,91.4,85.3 to 95.2,267
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,90.1,85.8 to 93.3,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,77.2,68.4 to 84.2,267
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,77.4,71.2 to 82.6,597
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,94.1,89.4 to 97.2,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,94.4,89.4 to 97.6,291
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,94.2,90.4 to 96.9,303
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,94.3,91.3 to 96.5,594
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,95.5,90.8 to 97.8,295
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,90.7,84.1 to 95.3,237
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018,Age,24 Months,93.7,88.5 to 97.0,365
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,94.3,91.1 to 96.6,660
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015,Age,24 Months,96.3,93.1 to 98.3,292
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,95.6,92.8 to 97.5,559
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014,Age,24 Months,93.7,88.2 to 97.2,291
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,95.0,92.0 to 97.2,583
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013,Age,24 Months,94.3,89.8 to 97.2,303
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,94.0,90.7 to 96.5,594
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019,Age,24 Months,94.7,90.3 to 97.5,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2011,Age,35 Months,95.5,89.3 to 98.7,237
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2012,Age,35 Months,94.9,89.8 to 97.9,260
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,77.2,69.9 to 83.2,303
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,76.7,70.3 to 82.0,594
PCV,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,79.3,77.3 to 81.1,237
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,95.3,90.3 to 97.8,267
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,95.8,92.1 to 97.8,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,76.1,68.1 to 82.7,291
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,78.2,72.7 to 82.8,583
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,93.0,89.8 to 96.2,606
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,80.1,72.5 to 87.7,264
PCV,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,68.7,57.8 to 77.9,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,96.3,91.7 to 98.4,330
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,93.7,90.3 to 96.0,695
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,91.1,85.3 to 94.8,365
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,82.0,77.3 to 85.9,660
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,5 Months,93.9,88.4 to 96.9,267
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,5 Months,93.9,89.3 to 96.6,597
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,5 Months,91.6,85.6 to 95.3,291
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,5 Months,91.6,88.2 to 94.2,583
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2012,Age,0-1 Days,54.6,49.0 to 60.0,260
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2013,Age,0-1 Days,54.4,48.7 to 59.9,303
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2013-2014,Age,0-1 Days,57.4,53.7 to 60.9,594
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2014,Age,0-1 Days,60.3,52.2 to 67.9,291
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2014-2015,Age,0-1 Days,56.6,50.8 to 62.3,583
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2015,Age,0-1 Days,52.9,44.4 to 61.2,292
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2015-2016,Age,0-1 Days,59.7,53.4 to 65.8,559
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,5 Months,91.6,86.1 to 95.1,292
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,5 Months,92.8,89.1 to 95.2,559
Polio,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,99.0,97.1 to 99.6,365
Polio,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,97.9,95.9 to 98.9,660
Polio,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,96.8,92.8 to 98.6,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019,Age,19 Months,94.6,89.6 to 97.3,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014,Age,24 Months,92.7,86.6 to 96.7,291
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,94.0,90.6 to 96.5,583
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013,Age,24 Months,93.5,89.1 to 96.6,303
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,93.0,89.5 to 95.7,594
PCV,≥4 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,86.2,85.0 to 87.3,303
PCV,≥4 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,88.4,85.7 to 90.6,594
PCV,≥4 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,80.9,65.5 to 90.4,260
PCV,≥4 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,88.2,85.3 to 90.5,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018,Age,19 Months,94.6,89.5 to 97.3,365
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,98.1,96.1 to 99.1,660
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019,Age,19 Months,94.5,89.5 to 97.2,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017,Age,24 Months,96.0,91.6 to 98.4,330
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,94.8,91.6 to 97.1,695
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016,Age,24 Months,94.2,89.1 to 97.4,267
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,95.1,91.5 to 97.5,597
≥1 Dose MMR,,States/Local Areas,Massachusetts,2011,Age,24 Months,97.5,93.8 to 99.2,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2012,Age,24 Months,92.7,87.2 to 96.4,260
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015,Age,24 Months,95.3,91.7 to 97.7,292
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,94.8,91.8 to 96.9,559
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,5 Months,94.8,89.6 to 97.5,295
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,88.1,83.9 to 91.3,237
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,5 Months,93.9,86.1 to 97.4,330
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,5 Months,94.1,89.9 to 96.6,695
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,5 Months,94.3,89.3 to 97.0,365
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,5 Months,94.5,91.3 to 96.6,660
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2018,Age,0-1 Days,73.1,65.1 to 79.9,365
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2018-2019,Age,0-1 Days,79.1,74.0 to 83.5,660
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013,Age,19 Months,92.5,88.5 to 95.1,303
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,92.7,88.4 to 95.5,594
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014,Age,19 Months,92.9,87.0 to 96.3,291
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,94.2,90.9 to 96.3,583
≥1 Dose MMR,,States/Local Areas,Massachusetts,2012,Age,19 Months,90.7,87.0 to 93.5,260
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017,Age,19 Months,95.4,90.4 to 97.8,330
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,93.5,90.0 to 95.9,695
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018,Age,19 Months,91.7,85.6 to 95.3,365
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,55.3,49.3 to 61.1,660
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,84.6,77.0 to 92.2,157
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,35 Months,93.3,81.7 to 98.6,268
Polio,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,96.6,92.7 to 98.5,292
Polio,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,96.5,93.6 to 98.1,559
Polio,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,96.4,91.1 to 98.6,267
Polio,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,97.2,93.1 to 98.9,597
Polio,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,98.0,92.3 to 99.5,330
Polio,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,98.5,95.9 to 99.4,695
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,95.7,88.7 to 98.9,295
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,83.2,76.3 to 90.0,219
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,91.0,87.9 to 94.1,780
≥1 Dose MMR,,States/Local Areas,Massachusetts,2011,Age,19 Months,95.8,93.2 to 97.4,237
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.3,71.9 to 98.7,53
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,3 Months,96.1,91.1 to 98.3,365
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,3 Months,97.7,95.2 to 98.9,660
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,3 Months,99.2,97.8 to 99.7,295
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,82.8,73.1 to 92.6,264
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2011,Age,0-1 Days,56.2,52.5 to 59.8,237
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,5 Months,85.5,76.7 to 91.4,260
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,5 Months,86.5,82.5 to 89.7,237
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,5 Months,90.8,89.0 to 92.3,303
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,5 Months,91.2,89.3 to 92.8,594
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,94.2,91.3 to 96.2,303
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,94.2,91.7 to 95.9,594
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,88.3,78.9 to 97.6,606
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,94.1,88.4 to 97.1,291
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,94.6,91.3 to 96.7,583
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,95.2,89.7 to 97.8,292
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,95.2,92.1 to 97.2,559
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015,Age,19 Months,95.5,93.7 to 96.8,292
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,95.2,92.2 to 97.1,559
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016,Age,19 Months,94.9,89.4 to 97.7,267
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,95.4,91.5 to 97.6,597
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017,Age,19 Months,95.9,90.8 to 98.2,330
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,95.2,92.0 to 97.2,695
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,88.9,82.7 to 95.1,164
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2011,Age,24 Months,90.8,83.9 to 95.6,237
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2012,Age,24 Months,91.8,86.0 to 95.8,260
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.6,87.1 to 94.0,672
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,81.3 to 96.1,152
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,88.4,85.4 to 91.5,1034
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,87.7,80.6 to 94.9,212
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.7,85.3 to 92.2,807
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,3 Months,94.7,93.4 to 95.8,303
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,3 Months,95.4,94.0 to 96.5,594
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,3 Months,92.9,82.7 to 97.3,260
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,3 Months,92.2,87.5 to 95.2,237
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,3 Months,96.1,90.1 to 98.5,291
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,3 Months,95.6,92.2 to 97.5,583
Polio,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,94.2,85.6 to 97.8,330
Polio,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,95.7,91.3 to 97.9,695
Polio,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,97.2,93.4 to 98.9,365
Polio,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,95.8,93.0 to 97.6,660
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2016,Age,0-1 Days,66.4,57.2 to 74.6,267
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2016-2017,Age,0-1 Days,68.3,62.3 to 73.7,597
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2017,Age,0-1 Days,70.1,62.6 to 76.7,330
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Massachusetts,2017-2018,Age,0-1 Days,71.6,66.2 to 76.5,695
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,95.8,91.9 to 98.2,365
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,95.9,92.2 to 98.2,660
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,76.3,69.0 to 82.3,365
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,82.0,77.3 to 85.9,660
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,87.8,81.1 to 92.3,295
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,89.7,88.5 to 90.8,237
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,92.0,87.0 to 95.1,260
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,93.4,90.9 to 95.9,780
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,92.7,87.1 to 98.3,157
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,92.2,89.0 to 95.4,606
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.1,52.1 to 90.0,53
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,72.2,61.5 to 82.8,219
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,88.2,80.2 to 96.1,780
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,92.9,87.2 to 96.1,267
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,94.3,90.4 to 96.6,597
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,93.6,88.1 to 96.6,292
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,93.2,89.6 to 95.6,559
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,95.6,91.1 to 97.9,330
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,86.1,81.9 to 89.4,695
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,79.9,68.6 to 91.2,157
Polio,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,97.1,96.1 to 97.9,303
Polio,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,98.2,97.1 to 98.8,594
Polio,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,99.2,97.4 to 99.7,291
Polio,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,97.9,95.9 to 98.9,583
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,3 Months,95.0,90.1 to 97.6,292
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,3 Months,95.7,92.5 to 97.5,559
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,3 Months,96.3,90.9 to 98.5,267
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,3 Months,97.0,93.0 to 98.8,597
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,3 Months,97.8,92.3 to 99.4,330
Hep B,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,3 Months,97.0,93.8 to 98.5,695
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.4,60.1 to 88.7,152
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,96.9,90.1 to 99.5,330
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.2,92.7 to 99.2,695
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,89.3,82.3 to 94.4,267
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,92.3,86.8 to 96.1,597
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,74.1,61.7 to 86.5,212
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.4,78.4 to 94.5,672
Polio,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,94.4,89.4 to 97.1,295
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,82.2,76.1 to 88.3,1034
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,69.6,57.0 to 82.2,164
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.9,78.5 to 91.3,807
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017,Age,13 Months,72.8,64.6 to 79.7,330
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,73.0,67.5 to 77.8,695
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016,Age,13 Months,64.3,54.9 to 72.8,267
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,64.0,57.6 to 70.0,597
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017,Age,13 Months,63.7,55.5 to 71.1,330
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,57.6,51.8 to 63.3,695
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015,Age,13 Months,59.7,51.2 to 67.7,292
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,62.0,55.7 to 68.0,559
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,84.9 to 97.7,152
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,87.8,80.6 to 95.0,212
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.4,88.2 to 94.6,672
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.4,88.6 to 94.1,807
Polio,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,96.1,90.2 to 98.5,291
Polio,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,95.6,92.3 to 97.6,583
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,90.1,83.8 to 96.3,164
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,90.6,88.0 to 93.3,1034
Polio,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,95.1,90.4 to 97.6,292
Polio,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,95.0,91.7 to 97.0,559
Polio,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,94.9,89.3 to 97.7,267
Polio,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,94.5,88.6 to 97.5,597
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,88.5,83.1 to 94.0,264
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,85.8,82.0 to 89.0,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013,Age,13 Months,52.5,42.8 to 61.9,303
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,58.1,50.2 to 65.7,594
≥1 Dose MMR,,States/Local Areas,Massachusetts,2012,Age,13 Months,50.7,46.8 to 54.7,260
≥1 Dose MMR,,States/Local Areas,Massachusetts,2011,Age,13 Months,55.8,49.3 to 62.0,237
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,92.0,85.7 to 96.3,260
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,94.5,90.2 to 97.3,292
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,92.2,88.3 to 95.2,559
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,96.9,93.8 to 98.7,291
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,95.6,93.1 to 97.4,583
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,92.1,85.7 to 96.4,295
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,86.9,76.3 to 93.2,260
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,89.4,82.7 to 94.3,303
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,93.4,89.7 to 96.2,594
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,93.6,91.3 to 95.3,303
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,92.8,89.4 to 95.2,594
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,92.1,85.8 to 95.7,291
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,92.8,89.0 to 95.4,583
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,87.4,79.2 to 93.5,365
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,89.9,84.6 to 93.9,660
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,87.2,78.0 to 93.8,330
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,86.9,80.7 to 91.9,695
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2019,Age,13 Months,59.1,50.7 to 67.0,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2011,Age,19 Months,92.3,87.9 to 95.2,237
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013,Age,19 Months,92.6,88.3 to 95.4,303
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,91.1,88.9 to 92.8,594
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2012,Age,19 Months,88.9,84.7 to 92.1,260
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016,Age,13 Months,65.6,56.2 to 74.0,267
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,69.2,62.8 to 75.0,597
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018,Age,13 Months,51.4,43.2 to 59.7,365
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,55.3,49.3 to 61.1,660
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2020,Age,35 Months,99.7,97.8 to 100.0,268
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014,Age,13 Months,63.8,55.8 to 71.1,291
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,65.7,60.0 to 71.0,583
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015,Age,13 Months,67.6,59.4 to 74.9,292
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,66.6,60.4 to 72.3,559
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014,Age,19 Months,89.6,82.8 to 93.9,291
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,91.1,87.3 to 93.9,583
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015,Age,19 Months,92.7,88.2 to 95.6,292
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,91.5,87.2 to 94.4,559
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016,Age,19 Months,90.3,82.4 to 94.9,267
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,92.8,88.1 to 95.8,597
Polio,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,96.1,93.1 to 97.8,260
Polio,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,97.3,96.2 to 98.1,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018,Age,13 Months,73.1,65.4 to 79.6,365
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,70.8,65.1 to 75.8,660
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019,Age,13 Months,68.4,59.9 to 75.8,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014,Age,13 Months,51.4,43.4 to 59.3,291
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,55.5,49.7 to 61.2,583
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2012,Age,13 Months,56.4,53.1 to 59.6,260
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,35 Months,97.1,92.3 to 99.3,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,89.2,83.7 to 94.6,219
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,91.3,88.2 to 94.3,780
Polio,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,5 Months,90.4,84.6 to 94.2,365
Polio,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,5 Months,89.6,85.6 to 92.7,660
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.9,87.8 to 99.9,53
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013,Age,13 Months,50.9,46.6 to 55.2,303
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,51.2,47.3 to 55.0,594
Polio,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,5 Months,88.9,82.4 to 93.2,295
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,87.1,79.8 to 94.3,157
Polio,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,92.4,85.9 to 96.1,260
Polio,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,92.7,85.9 to 96.3,237
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,60.2,51.9 to 67.9,330
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,59.9,54.1 to 65.4,695
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,59.6,51.4 to 67.2,365
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,63.3,57.6 to 68.7,660
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,81.7,71.7 to 89.8,267
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,84.5,78.0 to 90.0,597
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,86.4,76.7 to 93.5,292
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,84.0,77.0 to 89.9,559
Polio,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,94.8,92.6 to 96.4,303
Polio,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,95.5,94.0 to 96.6,594
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,67.1,59.0 to 74.2,295
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,72.2,63.3 to 80.5,291
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,78.9,72.2 to 84.9,583
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,35 Months,92.9,87.7 to 96.4,267
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,95.3,91.6 to 97.7,597
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,35 Months,98.5,94.9 to 99.8,330
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.8,94.4 to 99.4,695
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,35 Months,96.0,91.9 to 98.3,365
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,96.6,93.8 to 98.3,660
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2011,Age,13 Months,49.6,43.5 to 55.6,237
Polio,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,5 Months,89.3,81.6 to 94.0,267
Polio,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,5 Months,87.2,81.3 to 91.5,597
Polio,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,5 Months,85.2,77.1 to 90.8,330
Polio,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,5 Months,87.8,82.9 to 91.4,695
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,57.3,49.3 to 65.1,291
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,63.4,57.7 to 68.7,583
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,69.5,61.8 to 76.2,292
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,66.3,59.8 to 72.3,559
Polio,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,5 Months,93.0,87.6 to 96.2,292
Polio,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,5 Months,91.1,86.7 to 94.2,559
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,63.2,52.7 to 72.5,267
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,61.7,54.9 to 68.0,597
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,46.6,38.3 to 55.7,295
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,74.0,62.9 to 84.0,237
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,82.2,72.5 to 90.1,260
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,79.4,69.3 to 87.9,303
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,75.7,69.0 to 81.9,594
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,89.2,82.3 to 94.4,267
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,88.3,83.5 to 92.3,597
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,88.2,82.3 to 92.8,292
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,88.7,84.3 to 92.3,559
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,90.4,85.0 to 94.5,291
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,89.3,85.4 to 92.5,583
PCV,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,5 Months,83.9,76.6 to 89.3,365
PCV,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,5 Months,86.4,81.7 to 90.0,660
PCV,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,5 Months,88.9,82.2 to 93.2,295
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,97.1,94.4 to 99.8,212
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",98.3,96.7 to 99.8,672
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.7,96.0 to 99.3,807
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.5,93.5 to 100.0,152
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,96.2,92.8 to 99.5,157
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,79.6,70.6 to 86.3,267
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,79.4,73.8 to 84.0,597
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,79.1,72.0 to 84.8,330
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,79.7,74.8 to 83.9,695
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,80.3,73.1 to 86.0,365
DTaP,≥4 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,97.9,95.9 to 98.9,660
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,47.9,40.3 to 56.1,303
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,45.8,40.3 to 51.6,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,97.6,96.2 to 99.0,1034
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,42.3,34.5 to 50.9,292
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,47.3,41.1 to 54.1,559
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,43.8,36.0 to 52.4,291
Hep A,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,42.9,37.3 to 48.9,583
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,35 Months,86.2,80.4 to 90.9,303
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,88.8,84.6 to 92.3,594
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,35 Months,91.0,84.9 to 95.4,291
Hep A,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,91.8,88.0 to 94.8,583
Polio,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,96.4,92.4 to 98.6,295
Hep A,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,47.3,43.2 to 51.6,1108
Polio,≥2 Doses,States/Local Areas,Maryland,2020,Age,13 Months,95.7,92.1 to 97.7,494
Hep A,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,24 Months,89.9,87.1 to 92.3,1108
Hep A,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,35 Months,92.0,89.2 to 94.4,1108
Hep A,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,84.0,79.4 to 88.1,1108
Influenza,,States/Local Areas,Maryland,2019-2020,Age,24 Months,67.5,63.5 to 71.4,1108
Hib,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,93.8,91.5 to 95.6,1108
Hib,Primary Series,States/Local Areas,Maryland,2019-2020,Age,24 Months,95.0,93.0 to 96.6,1108
Hib,Full Series,States/Local Areas,Maryland,2019-2020,Age,24 Months,81.3,77.8 to 84.5,1108
Hib,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,64.8,60.6 to 68.8,1108
Combined 7 Series,,States/Local Areas,Maryland,2019-2020,Age,35 Months,80.0,76.0 to 83.8,1108
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2019-2020,Age,0-1 Days,74.2,70.2 to 77.7,1108
Hep B,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,92.4,89.8 to 94.4,1108
≥1 Dose Varicella,,States/Local Areas,Maryland,2019-2020,Age,19 Months,90.4,87.5 to 92.6,1108
≥1 Dose Varicella,,States/Local Areas,Maryland,2020,Age,35 Months,95.8,92.8 to 97.8,494
Hep B,≥3 Doses,States/Local Areas,Maryland,2020,Age,35 Months,98.0,94.9 to 99.5,494
Hib,Full Series,States/Local Areas,Maryland,2020,Age,35 Months,86.2,81.5 to 90.2,494
Hib,Primary Series,States/Local Areas,Maryland,2020,Age,35 Months,96.9,93.3 to 98.9,494
Hib,Primary Series,States/Local Areas,Maryland,2020,Age,24 Months,94.9,92.0 to 97.1,494
Hib,≥3 Doses,States/Local Areas,Maryland,2020,Age,35 Months,96.6,92.7 to 98.7,494
≥1 Dose MMR,,States/Local Areas,Maryland,2020,Age,35 Months,96.5,93.7 to 98.3,494
Hib,≥3 Doses,States/Local Areas,Maryland,2020,Age,24 Months,94.4,91.4 to 96.7,494
≥1 Dose MMR,,States/Local Areas,Maryland,2020,Age,24 Months,95.4,92.5 to 97.5,494
DTaP,≥4 Doses,States/Local Areas,Maryland,2020,Age,24 Months,87.6,83.2 to 91.3,494
Polio,≥3 Doses,States/Local Areas,Maryland,2020,Age,24 Months,96.1,93.3 to 98.0,494
DTaP,≥3 Doses,States/Local Areas,Maryland,2020,Age,24 Months,96.2,93.4 to 98.1,494
Hep B,≥2 Doses,States/Local Areas,Maryland,2020,Age,7 Months,93.4,89.6 to 95.9,494
Hib,Primary Series,States/Local Areas,Maryland,2020,Age,7 Months,76.0,70.3 to 80.9,494
Hib,≥3 Doses,States/Local Areas,Maryland,2020,Age,7 Months,67.7,61.8 to 73.1,494
Hib,≥2 Doses,States/Local Areas,Maryland,2020,Age,7 Months,91.3,86.9 to 94.3,494
Polio,≥2 Doses,States/Local Areas,Maryland,2020,Age,7 Months,93.5,89.6 to 96.0,494
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2020,Age,0-2 Days,79.5,74.1 to 84.1,494
DTaP,≥1 Dose,States/Local Areas,Maryland,2020,Age,3 Months,89.6,85.0 to 92.9,494
Hep A,≥1 Dose,States/Local Areas,Maryland,2020,Age,19 Months,86.8,82.2 to 90.3,494
Hep A,≥2 Doses,States/Local Areas,Maryland,2020,Age,19 Months,32.4,27.0 to 38.4,494
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2020,Age,0-1 Days,74.5,68.7 to 79.6,494
Hep A,≥2 Doses,States/Local Areas,Maryland,2020,Age,35 Months,85.9,79.8 to 90.9,494
Combined 7 Series,,States/Local Areas,Maryland,2020,Age,35 Months,82.8,77.4 to 87.5,494
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,83.4,80.6 to 86.1,1811
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,82.7,77.5 to 87.8,664
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,88.6,86.1 to 91.0,1811
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,96.7,90.3 to 100.0,35
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,89.0,84.9 to 93.0,664
Rotavirus,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,80.2,75.0 to 85.4,664
Rotavirus,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,80.1,77.0 to 83.1,1811
Influenza,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,63.5,59.9 to 67.1,1811
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,69.0,47.7 to 90.3,35
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,75.1,71.9 to 78.3,1811
Influenza,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,63.6,57.5 to 69.6,664
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,91.1,79.5 to 100.0,35
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.6,83.0 to 88.3,1811
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.4,90.3 to 94.5,1811
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,100.0,,35
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,85.0,80.3 to 89.8,664
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,95.8,93.5 to 98.2,664
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,99.7,99.2 to 100.0,35
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,95.5,93.1 to 97.9,664
Rotavirus,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,84.2,68.2 to 100.0,35
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,77.9,71.0 to 84.7,664
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,77.6,60.3 to 94.8,35
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,90.1 to 94.3,1811
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,87.9,72.0 to 100.0,35
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.7,89.9 to 97.5,382
Hep B,≥2 Doses,States/Local Areas,Maryland,2020,Age,5 Months,91.6,87.5 to 94.5,494
Hib,≥2 Doses,States/Local Areas,Maryland,2020,Age,5 Months,83.3,78.2 to 87.4,494
Polio,≥2 Doses,States/Local Areas,Maryland,2020,Age,5 Months,86.6,81.7 to 90.4,494
DTaP,≥2 Doses,States/Local Areas,Maryland,2020,Age,5 Months,86.3,81.3 to 90.1,494
PCV,≥1 Dose,States/Local Areas,Maryland,2020,Age,3 Months,89.3,84.7 to 92.6,494
Hep A,≥2 Doses,States/Local Areas,Maryland,2020,Age,24 Months,49.5,43.6 to 55.7,494
Combined 7 Series,,States/Local Areas,Maryland,2020,Age,24 Months,77.7,72.6 to 82.5,494
Hep A,≥1 Dose,States/Local Areas,Maryland,2020,Age,24 Months,91.2,87.5 to 94.2,494
PCV,≥4 Doses,States/Local Areas,Maryland,2020,Age,24 Months,88.2,83.8 to 91.8,494
DTaP,≥3 Doses,States/Local Areas,Maryland,2020,Age,35 Months,99.6,98.3 to 99.9,494
PCV,≥3 Doses,States/Local Areas,Maryland,2020,Age,24 Months,95.2,91.9 to 97.4,494
Rotavirus,,States/Local Areas,Maryland,2020,Age,8 Months,82.6,77.5 to 86.8,494
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2020,Age,0-3 Days,80.6,75.2 to 85.0,494
Influenza,,States/Local Areas,Maryland,2020,Age,24 Months,66.1,60.3 to 71.9,494
Hib,≥3 Doses,States/Local Areas,Maryland,2020,Age,19 Months,93.1,89.3 to 95.6,494
Polio,≥3 Doses,States/Local Areas,Maryland,2020,Age,19 Months,94.9,91.3 to 97.1,494
≥1 Dose MMR,,States/Local Areas,Maryland,2020,Age,19 Months,92.8,88.8 to 95.5,494
DTaP,≥4 Doses,States/Local Areas,Maryland,2020,Age,19 Months,81.8,76.6 to 86.0,494
DTaP,≥3 Doses,States/Local Areas,Maryland,2020,Age,19 Months,95.0,91.4 to 97.2,494
PCV,≥2 Doses,States/Local Areas,Maryland,2020,Age,5 Months,87.2,82.5 to 90.7,494
DTaP,≥3 Doses,States/Local Areas,Maryland,2020,Age,7 Months,80.9,75.4 to 85.3,494
PCV,≥3 Doses,States/Local Areas,Maryland,2020,Age,13 Months,92.6,88.7 to 95.3,494
≥1 Dose Varicella,,States/Local Areas,Maryland,2020,Age,13 Months,69.9,63.9 to 75.3,494
Hep B,≥3 Doses,States/Local Areas,Maryland,2020,Age,13 Months,91.7,87.8 to 94.4,494
Hep B,≥2 Doses,States/Local Areas,Maryland,2020,Age,13 Months,96.8,93.9 to 98.3,494
Hib,Primary Series,States/Local Areas,Maryland,2020,Age,13 Months,88.2,83.6 to 91.6,494
Hib,≥3 Doses,States/Local Areas,Maryland,2020,Age,13 Months,79.2,73.9 to 83.7,494
PCV,≥4 Doses,States/Local Areas,Maryland,2020,Age,35 Months,90.2,85.7 to 93.7,494
PCV,≥4 Doses,States/Local Areas,Maryland,2020,Age,19 Months,85.5,80.6 to 89.4,494
Polio,≥3 Doses,States/Local Areas,Maryland,2020,Age,35 Months,98.6,96.0 to 99.7,494
DTaP,≥4 Doses,States/Local Areas,Maryland,2020,Age,35 Months,92.5,88.5 to 95.5,494
PCV,≥3 Doses,States/Local Areas,Maryland,2020,Age,19 Months,94.9,91.3 to 97.1,494
≥1 Dose Varicella,,States/Local Areas,Maryland,2020,Age,19 Months,92.3,88.2 to 95.0,494
Hep B,≥3 Doses,States/Local Areas,Maryland,2020,Age,19 Months,94.1,90.9 to 96.2,494
Hib,Full Series,States/Local Areas,Maryland,2020,Age,19 Months,79.7,74.4 to 84.1,494
PCV,≥3 Doses,States/Local Areas,Maryland,2020,Age,35 Months,95.2,91.9 to 97.4,494
Hib,Primary Series,States/Local Areas,Maryland,2020,Age,19 Months,93.7,90.0 to 96.1,494
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.4,94.8 to 98.0,1186
Rotavirus,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.1,85.1 to 91.2,1186
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,94.0 to 97.4,1186
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.3,86.3 to 94.3,471
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,82.0,78.8 to 85.1,1716
Rotavirus,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.3,67.6 to 78.9,471
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.2,72.2 to 82.2,471
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.3,88.7 to 94.0,1186
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,75.7,71.2 to 80.1,716
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,88.2,79.9 to 96.5,52
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,90.1,85.6 to 94.5,471
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.5,87.9 to 95.0,471
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.5,85.7 to 97.3,382
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,92.2,89.5 to 94.9,716
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,97.5,96.1 to 99.0,1716
Rotavirus,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,88.9,86.6 to 91.2,1716
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,92.6,89.7 to 95.5,716
Influenza,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,48.5,43.3 to 53.6,716
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,80.4 to 91.9,382
Influenza,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,58.8,39.5 to 78.1,52
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,90.1,85.0 to 95.1,471
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,79.0,73.6 to 84.5,471
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.1,71.5 to 84.8,382
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,62.9,38.6 to 87.3,52
Rotavirus,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,79.3,63.5 to 95.1,52
Rotavirus,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,69.2,64.3 to 74.2,716
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.5,76.4 to 86.7,471
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,65.5,58.7 to 72.3,471
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.5,80.5 to 86.6,1186
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.2,65.2 to 77.1,471
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.6,65.1 to 80.1,382
Rotavirus,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,71.9,65.1 to 78.7,471
Rotavirus,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.1,80.1 to 90.0,382
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.7,88.2 to 93.2,1186
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,79.7,73.4 to 85.9,471
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.9,77.9 to 87.8,471
Influenza,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.6,70.3 to 78.9,1186
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,91.8,80.6 to 100.0,52
Influenza,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.2,56.3 to 72.1,382
Influenza,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",50.4,44.1 to 56.8,471
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.1,95.5 to 98.6,1186
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.4,91.3 to 97.4,471
Influenza,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,75.8,72.4 to 79.3,1716
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,96.6,93.2 to 100.0,52
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,90.4,86.1 to 94.7,471
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.5,96.2 to 98.8,1186
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,95.5,94.0 to 97.0,1716
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.4,90.2 to 96.6,471
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,77.7,73.3 to 82.0,716
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,83.3,71.5 to 95.1,52
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,91.5,88.5 to 94.4,716
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,96.6,93.2 to 100.0,52
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,88.4,83.9 to 92.9,471
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.5,82.0 to 91.0,471
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,84.7,71.4 to 98.1,52
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,79.5,65.8 to 93.2,52
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,77.1,72.8 to 81.5,716
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.2,86.6 to 91.7,1186
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,97.0,95.6 to 98.5,1716
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,92.0,89.1 to 95.0,716
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,85.7,72.8 to 98.6,52
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.8,89.4 to 94.2,1186
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.8,96.5 to 99.1,1186
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.7,95.5 to 99.8,382
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,90.4,85.3 to 95.4,471
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.7,91.7 to 97.7,471
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,89.5,86.8 to 92.2,1716
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.3,91.8 to 96.9,471
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,87.8,82.4 to 93.1,471
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.2,81.4 to 87.0,1811
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,87.0,73.3 to 100.0,35
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,83.6,78.5 to 88.7,664
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,92.8,79.1 to 100.0,35
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.5,93.7 to 97.2,1811
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,94.8,91.8 to 97.7,664
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.5,77.2 to 85.8,1811
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.5,92.6 to 96.3,1811
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,100.0,,35
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,95.9,93.3 to 98.5,664
Rotavirus,,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,68.1,62.2 to 74.1,484
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,94.4,91.5 to 97.2,664
Rotavirus,,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,79.8,75.2 to 84.4,685
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,93.0,90.6 to 95.4,1341
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,85.4,81.7 to 89.1,685
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,83.4,80.1 to 86.8,1341
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,78.9,74.6 to 83.3,685
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,78.3,71.3 to 85.2,484
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,96.4,94.6 to 98.3,1341
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,90.9,87.4 to 94.4,685
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,90.2,86.3 to 94.1,484
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,95.4,93.9 to 96.8,2510
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,93.8,92.3 to 95.3,2510
Influenza,,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,57.5,51.9 to 63.2,685
Influenza,,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,49.2,43.0 to 55.5,484
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,95.4,93.0 to 97.7,1341
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,91.7,88.7 to 94.8,685
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,90.9,87.4 to 94.4,484
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,91.2,88.5 to 93.9,1341
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,84.1,79.7 to 88.5,685
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,91.0,87.5 to 94.5,484
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,84.0,81.6 to 86.5,2510
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,90.7,86.8 to 94.5,484
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,90.7,88.1 to 93.3,1341
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,73.8,68.2 to 79.4,484
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,82.5,78.4 to 86.6,685
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,90.9,88.0 to 93.8,1341
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,76.2,70.7 to 81.8,484
Influenza,,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,78.9,75.1 to 82.6,1341
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,66.8,61.9 to 71.7,716
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,69.7,52.6 to 86.8,52
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.6,95.3 to 97.9,1186
DTaP,≥3 Doses,States/Local Areas,Maryland,2020,Age,13 Months,93.4,89.7 to 95.9,494
Hep B,≥1 Dose,States/Local Areas,Maryland,2020,Age,3 Months,95.5,92.0 to 97.5,494
Hep B,≥3 Doses,States/Local Areas,Maryland,2020,Age,24 Months,94.6,91.7 to 96.7,494
Hep B,≥3 Doses,States/Local Areas,Maryland,2020,Age,7 Months,67.9,62.3 to 73.1,494
Polio,≥1 Dose,States/Local Areas,Maryland,2020,Age,3 Months,89.4,84.8 to 92.7,494
Hib,≥1 Dose,States/Local Areas,Maryland,2020,Age,3 Months,84.6,79.6 to 88.6,494
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,84.8,81.0 to 88.6,1716
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,75.7,69.3 to 82.1,716
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.4 to 95.9,1716
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.1,89.9 to 98.3,382
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,76.0,69.7 to 82.4,471
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.1,75.9 to 86.3,471
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,96.6,93.2 to 100.0,52
DTaP,≥4 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.3,73.1 to 87.4,382
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,94.7,92.5 to 96.8,1716
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Any Medicaid,91.3,88.5 to 94.1,716
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,91.1,86.1 to 96.0,471
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,87.2,74.5 to 99.8,52
Influenza,,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,Hispanic,60.2,53.3 to 67.2,471
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Insurance Coverage,Other,82.2,68.9 to 95.6,52
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,94.9,93.4 to 96.4,2510
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Overall,Overall,88.8,86.7 to 90.8,2510
Rotavirus,,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,89.9,87.3 to 92.5,1341
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,94.9,93.4 to 96.4,2510
≥1 Dose MMR,,States/Local Areas,Maryland,2016-2019,Overall,Overall,93.1,91.4 to 94.8,2510
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,87.2,83.2 to 91.2,685
PCV,≥4 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,85.6,83.3 to 87.9,2510
Hep A,≥1 Dose,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,87.7,83.6 to 91.8,484
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,84.2,79.6 to 88.8,1341
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,79.0,71.3 to 86.6,685
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,95.5,93.3 to 97.6,685
PCV,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,90.8,87.0 to 94.6,484
Influenza,,States/Local Areas,Maryland,2016-2019,Overall,Overall,63.3,60.3 to 66.4,2510
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Overall,Overall,79.4,76.9 to 81.9,2510
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,89.3,85.3 to 93.3,484
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Overall,Overall,80.5,77.0 to 84.0,2510
Rotavirus,,States/Local Areas,Maryland,2016-2019,Overall,Overall,80.2,77.6 to 82.7,2510
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,84.6,81.3 to 87.9,1341
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Overall,Overall,92.9,91.2 to 94.6,2510
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,98.2,96.7 to 99.7,1341
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,73.6,68.7 to 78.5,685
DTaP,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,97.0,95.2 to 98.7,685
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,63.6,57.5 to 69.7,484
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Poverty,<133% FPL,74.8,69.3 to 80.3,484
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,96.9,95.6 to 98.3,1341
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,94.3,92.0 to 96.6,685
Hib,Full Series,States/Local Areas,Maryland,2016-2019,Overall,Overall,83.0,80.6 to 85.4,2510
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Overall,Overall,74.9,72.1 to 77.6,2510
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.7,76.8 to 82.7,1811
≥1 Dose Varicella,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,92.8,79.1 to 100.0,35
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,>400% FPL,97.9,96.4 to 99.5,1341
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Poverty,133% to <400% FPL,95.4,93.1 to 97.6,685
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,79.9,61.8 to 98.0,35
Combined 7 Series,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,74.8,69.3 to 80.3,664
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,78.4,73.3 to 83.6,664
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,96.5,90.0 to 100.0,35
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,93.2 to 96.8,1811
Polio,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,91.6 to 97.5,664
Influenza,,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a Non-MSA,51.5,24.8 to 78.1,35
Hep B,≥3 Doses,States/Local Areas,Maryland,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.1,91.2 to 95.0,1811
≥1 Dose Varicella,,States/Local Areas,Maryland,2020-2021,Age,35 Months,96.4,94.3 to 97.9,861
Rotavirus,,States/Local Areas,Maryland,2019-2020,Age,8 Months,80.0,76.3 to 83.2,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2020,Age,7 Months,77.8,72.1 to 82.5,494
PCV,≥3 Doses,States/Local Areas,Maryland,2021,Age,13 Months,93.4,88.5 to 96.3,367
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Maryland,2021,Age,0-1 Days,77.1,69.8 to 83.0,367
Hib,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,95.2,92.5 to 96.9,861
≥1 Dose MMR,,States/Local Areas,Maryland,2021,Age,35 Months,95.3,91.0 to 97.9,367
PCV,≥3 Doses,States/Local Areas,Maryland,2021,Age,35 Months,98.3,96.1 to 99.4,367
Hib,≥3 Doses,States/Local Areas,Maryland,2021,Age,19 Months,94.3,89.2 to 97.1,367
Hib,Primary Series,States/Local Areas,Maryland,2020-2021,Age,24 Months,95.4,93.0 to 97.2,861
Hib,≥3 Doses,States/Local Areas,Maryland,2021,Age,7 Months,70.4,63.0 to 76.9,367
Hib,≥2 Doses,States/Local Areas,Maryland,2021,Age,7 Months,91.9,86.2 to 95.4,367
Hep B,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,91.4,88.1 to 93.8,861
PCV,≥4 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,87.6,84.2 to 90.6,861
Hib,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,24 Months,95.0,92.6 to 96.9,861
Hep B,≥2 Doses,States/Local Areas,Maryland,2021,Age,7 Months,93.0,87.6 to 96.2,367
DTaP,≥3 Doses,States/Local Areas,Maryland,2021,Age,7 Months,80.2,73.2 to 85.8,367
DTaP,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,19 Months,94.6,91.6 to 96.5,861
PCV,≥2 Doses,States/Local Areas,Maryland,2021,Age,5 Months,86.6,80.4 to 91.0,367
Combined 7 Series,,States/Local Areas,Maryland,2021,Age,35 Months,75.2,67.9 to 81.9,367
Hep A,≥2 Doses,States/Local Areas,Maryland,2021,Age,35 Months,87.1,76.1 to 94.7,367
Polio,≥2 Doses,States/Local Areas,Maryland,2021,Age,7 Months,92.0,86.3 to 95.5,367
Polio,≥3 Doses,States/Local Areas,Maryland,2021,Age,19 Months,94.8,89.6 to 97.5,367
Hep A,≥1 Dose,States/Local Areas,Maryland,2021,Age,35 Months,95.4,91.0 to 98.0,367
Hib,Primary Series,States/Local Areas,Maryland,2021,Age,7 Months,78.6,71.6 to 84.2,367
Hep B,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,96.4,94.1 to 97.9,861
Hep B,≥3 Doses,States/Local Areas,Maryland,2021,Age,24 Months,93.8,89.0 to 97.0,367
DTaP,≥4 Doses,States/Local Areas,Maryland,2021,Age,19 Months,77.6,70.4 to 83.5,367
PCV,≥4 Doses,States/Local Areas,Maryland,2021,Age,19 Months,85.5,79.3 to 90.1,367
PCV,≥3 Doses,States/Local Areas,Maryland,2021,Age,19 Months,96.7,93.3 to 98.4,367
Hib,Full Series,States/Local Areas,Maryland,2021,Age,24 Months,81.9,75.5 to 87.5,367
Hib,Primary Series,States/Local Areas,Maryland,2021,Age,24 Months,95.9,91.5 to 98.4,367
Hib,≥3 Doses,States/Local Areas,Maryland,2021,Age,24 Months,95.7,91.3 to 98.3,367
≥1 Dose MMR,,States/Local Areas,Maryland,2021,Age,24 Months,95.3,91.0 to 97.9,367
Polio,≥3 Doses,States/Local Areas,Maryland,2021,Age,24 Months,96.1,91.6 to 98.5,367
Polio,≥1 Dose,States/Local Areas,Maryland,2021,Age,3 Months,87.6,81.2 to 92.0,367
DTaP,≥4 Doses,States/Local Areas,Maryland,2021,Age,24 Months,87.2,81.0 to 92.1,367
DTaP,≥1 Dose,States/Local Areas,Maryland,2021,Age,3 Months,88.1,81.7 to 92.4,367
DTaP,≥3 Doses,States/Local Areas,Maryland,2021,Age,13 Months,91.6,85.8 to 95.1,367
PCV,≥4 Doses,States/Local Areas,Maryland,2021,Age,35 Months,88.1,82.4 to 92.6,367
Hep A,≥2 Doses,States/Local Areas,Maryland,2021,Age,19 Months,24.3,18.4 to 31.2,367
Hep A,≥1 Dose,States/Local Areas,Maryland,2021,Age,19 Months,89.0,83.5 to 92.8,367
Polio,≥2 Doses,States/Local Areas,Maryland,2021,Age,13 Months,95.5,90.7 to 97.9,367
Combined 7 Series,,States/Local Areas,Maryland,2021,Age,24 Months,73.7,66.6 to 80.4,367
PCV,≥2 Doses,States/Local Areas,Maryland,2020-2021,Age,5 Months,86.9,83.2 to 89.9,861
Hib,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,13 Months,80.0,75.8 to 83.6,861
DTaP,≥3 Doses,States/Local Areas,Maryland,2021,Age,19 Months,94.1,88.7 to 97.0,367
Hep A,≥2 Doses,States/Local Areas,Maryland,2021,Age,24 Months,40.0,32.7 to 48.2,367
PCV,≥3 Doses,States/Local Areas,Maryland,2021,Age,7 Months,77.7,70.7 to 83.4,367
Hep A,≥1 Dose,States/Local Areas,Maryland,2021,Age,24 Months,93.9,89.8 to 96.8,367
PCV,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,96.7,94.8 to 98.0,861
Hep B,≥3 Doses,States/Local Areas,Maryland,2020-2021,Age,35 Months,97.8,94.0 to 99.5,861
PCV,≥4 Doses,States/Local Areas,Maryland,2021,Age,24 Months,87.1,81.5 to 91.6,367
PCV,≥3 Doses,States/Local Areas,Maryland,2021,Age,24 Months,98.3,96.1 to 99.4,367
≥1 Dose Varicella,,States/Local Areas,Maryland,2021,Age,24 Months,96.2,92.7 to 98.3,367
Hep B,≥3 Doses,States/Local Areas,Maryland,2021,Age,7 Months,56.6,48.8 to 64.0,367
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2021,Age,0-2 Days,79.2,71.9 to 84.9,367
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Maryland,2019-2020,Age,0-2 Days,79.1,75.4 to 82.4,1108
≥1 Dose Varicella,,States/Local Areas,Maryland,2019-2020,Age,24 Months,94.4,92.1 to 96.2,1108
Hep B,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,93.5,91.2 to 95.4,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,74.7,70.7 to 78.4,1108
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2019-2020,Age,0-3 Days,80.0,76.3 to 83.2,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,94.8,92.5 to 96.5,1108
PCV,≥4 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,86.0,82.8 to 88.9,1108
Hep A,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,30.9,27.1 to 34.9,1108
≥1 Dose MMR,,States/Local Areas,Maryland,2019-2020,Age,19 Months,91.0,88.1 to 93.2,1108
Hib,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,90.8,88.0 to 93.1,1108
Hib,Primary Series,States/Local Areas,Maryland,2019-2020,Age,19 Months,92.8,90.2 to 94.7,1108
Hib,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,95.3,92.5 to 97.3,1108
Hib,Full Series,States/Local Areas,Maryland,2019-2020,Age,19 Months,77.1,73.4 to 80.4,1108
≥1 Dose MMR,,States/Local Areas,Maryland,2019-2020,Age,35 Months,95.4,93.3 to 97.1,1108
Hep B,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,96.0,93.2 to 97.8,1108
Hib,Full Series,States/Local Areas,Maryland,2019-2020,Age,35 Months,85.2,81.8 to 88.4,1108
Hib,Primary Series,States/Local Areas,Maryland,2019-2020,Age,35 Months,96.0,93.6 to 97.7,1108
≥1 Dose Varicella,,States/Local Areas,Maryland,2019-2020,Age,35 Months,94.9,92.6 to 96.6,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,95.2,93.0 to 96.9,1108
PCV,≥4 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,88.1,84.6 to 91.1,1108
DTaP,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,95.8,93.7 to 97.3,1108
DTaP,≥4 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,84.7,81.3 to 87.7,1108
Polio,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,24 Months,95.2,93.1 to 96.9,1108
Hep B,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,3 Months,96.8,95.0 to 98.0,1108
≥1 Dose MMR,,States/Local Areas,Maryland,2019-2020,Age,24 Months,94.6,92.4 to 96.3,1108
PCV,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,3 Months,89.9,86.9 to 92.3,1108
DTaP,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,5 Months,85.3,81.8 to 88.2,1108
Polio,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,5 Months,85.2,81.7 to 88.1,1108
Hib,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,5 Months,82.1,78.6 to 85.2,1108
Polio,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,95.6,93.2 to 97.3,1108
≥1 Dose MMR,,States/Local Areas,Maryland,2019-2020,Age,13 Months,74.7,70.7 to 78.3,1108
Hib,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,78.6,74.9 to 81.9,1108
Hib,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,95.2,92.7 to 96.8,1108
Hep B,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,96.3,94.2 to 97.6,1108
Hib,Primary Series,States/Local Areas,Maryland,2019-2020,Age,13 Months,88.1,84.9 to 90.6,1108
Hep B,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,5 Months,90.1,87.1 to 92.5,1108
PCV,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,5 Months,84.5,81.0 to 87.4,1108
DTaP,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,78.3,74.4 to 81.8,1108
Polio,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,93.2,90.5 to 95.2,1108
Hep B,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,90.8,87.9 to 93.1,1108
Hib,≥2 Doses,States/Local Areas,Maryland,2019-2020,Age,7 Months,91.7,88.9 to 93.9,1108
≥1 Dose Varicella,,States/Local Areas,Maryland,2019-2020,Age,13 Months,69.1,65.0 to 72.9,1108
DTaP,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,94.2,91.7 to 96.0,1108
PCV,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,91.2,88.2 to 93.5,1108
DTaP,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,97.7,95.4 to 99.0,1108
Combined 7 Series,,States/Local Areas,Maryland,2019-2020,Age,24 Months,74.9,71.2 to 78.5,1108
DTaP,≥4 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,90.3,87.0 to 93.0,1108
Polio,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,35 Months,97.0,94.6 to 98.5,1108
DTaP,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,13 Months,92.8,90.0 to 94.9,1108
Hib,Primary Series,States/Local Areas,Maryland,2019-2020,Age,7 Months,75.2,71.2 to 78.8,1108
DTaP,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,3 Months,91.8,88.9 to 94.0,1108
Polio,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,3 Months,91.1,88.1 to 93.4,1108
Hib,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,3 Months,88.3,85.3 to 90.7,1108
PCV,≥4 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,83.6,80.2 to 86.6,1108
Hep A,≥1 Dose,States/Local Areas,Maryland,2019-2020,Age,19 Months,85.3,82.0 to 88.0,1108
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Maryland,2016-2019,Insurance Coverage,Private Insurance Only,82.7,79.8 to 85.6,1716
Hep A,≥2 Doses,States/Local Areas,Maryland,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.6,81.8 to 91.5,1186
≥1 Dose MMR,,States/Local Areas,Massachusetts,2020-2021,Age,19 Months,93.9,89.6 to 96.5,443
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,94.0,88.6 to 96.9,292
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,91.7,87.6 to 94.4,559
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,89.3,82.6 to 93.6,267
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,93.1,89.0 to 95.7,597
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,96.9,92.2 to 98.8,330
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,95.3,92.2 to 97.2,695
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,95.8,90.6 to 98.2,365
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,95.9,93.0 to 97.7,660
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,96.0,92.1 to 98.1,295
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,98.0,96.7 to 98.7,237
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,96.5,95.6 to 97.2,303
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,98.0,96.4 to 99.0,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,96.6,94.5 to 97.9,260
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,97.6,94.6 to 98.9,291
Polio,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,97.1,94.9 to 98.4,583
Polio,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,96.6,89.5 to 99.0,292
Polio,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,96.0,92.9 to 97.8,559
Polio,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,96.3,95.6 to 96.9,303
Polio,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,97.0,96.1 to 97.6,594
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,95.4,89.7 to 98.0,267
Polio,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,96.4,92.4 to 98.3,597
Polio,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,19 Months,97.4,92.4 to 99.2,330
Polio,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,19 Months,97.1,94.2 to 98.6,695
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,93.7,88.6 to 96.6,365
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,93.5,90.3 to 95.7,660
Polio,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,96.9,92.3 to 98.8,365
Polio,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,70.8,65.1 to 75.8,660
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,93.3,88.6 to 96.1,295
Hib,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,94.7,89.8 to 97.3,260
Hib,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,96.3,92.7 to 98.2,237
DTaP,≥4 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,79.1,75.5 to 82.3,1108
Polio,≥3 Doses,States/Local Areas,Maryland,2019-2020,Age,19 Months,93.5,90.9 to 95.4,1108
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,96.9,92.1 to 98.8,330
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,96.4,93.2 to 98.1,695
Hib,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,95.3,89.4 to 98.0,260
Hib,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,96.3,92.7 to 98.2,237
Hib,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,96.9,92.9 to 98.7,292
Hib,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,96.6,93.7 to 98.2,559
Hib,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,96.4,91.1 to 98.6,267
Hib,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,97.2,93.1 to 98.9,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,96.5,93.1 to 98.5,292
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,95.4,92.4 to 97.4,559
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,94.2,89.1 to 97.5,267
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,95.9,92.4 to 98.1,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,99.4,98.1 to 99.9,291
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,98.0,96.2 to 99.1,583
Hib,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,96.9,93.1 to 98.7,365
Hib,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,96.3,93.6 to 97.9,660
PCV,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,95.6,90.8 to 98.3,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.5,88.8 to 100.0,152
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,95.3,88.4 to 98.2,237
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,94.4,89.5 to 99.3,157
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,95.1,90.5 to 99.6,164
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,95.8,93.3 to 98.3,606
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,92.2,87.5 to 97.0,264
Hib,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,70.1,62.5 to 76.8,260
Hib,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,80.6,77.2 to 83.7,237
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,77.3,70.9 to 82.7,303
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,76.8,70.3 to 82.2,594
Polio,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,3 Months,92.2,85.6 to 95.9,291
Polio,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,3 Months,93.3,89.5 to 95.8,583
Polio,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,3 Months,94.3,89.4 to 97.0,292
Polio,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,3 Months,94.8,91.4 to 96.9,559
Polio,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,3 Months,95.2,89.6 to 97.9,267
Polio,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,3 Months,93.6,87.7 to 96.7,597
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2017,Age,0-3 Days,86.5,76.1 to 92.8,181
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2017-2018,Age,0-3 Days,85.3,80.8 to 89.0,695
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016,Age,0-3 Days,84.2,77.3 to 89.4,267
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2016-2017,Age,0-3 Days,86.4,81.7 to 90.0,597
Hib,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,93.9,88.1 to 97.0,267
Hib,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,94.1,88.2 to 97.1,597
Hib,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,94.2,85.6 to 97.8,330
Hib,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,95.6,91.2 to 97.8,695
PCV,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,3 Months,94.7,89.4 to 97.4,295
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,94.7,92.6 to 96.8,1034
Polio,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,3 Months,93.4,86.5 to 96.9,260
Polio,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,3 Months,94.8,89.9 to 97.4,237
Polio,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,3 Months,94.6,93.5 to 95.5,303
Polio,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,3 Months,93.4,91.8 to 94.7,594
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2013,Age,0-3 Days,73.5,65.8 to 79.9,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2013-2014,Age,0-3 Days,74.6,69.3 to 79.3,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,80.5,75.7 to 84.6,303
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,80.7,75.1 to 85.3,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,73.3,64.0 to 80.9,260
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,82.8,77.6 to 87.0,237
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014,Age,0-3 Days,75.8,67.8 to 82.3,291
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2015,Age,0-3 Days,73.8,68.2 to 78.7,583
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2015,Age,0-3 Days,71.8,63.5 to 78.8,292
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2015-2016,Age,0-3 Days,78.0,72.7 to 82.6,559
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2020,Age,24 Months,95.7,90.8 to 98.4,268
PCV,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,3 Months,91.5,85.0 to 95.4,291
PCV,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,3 Months,92.5,88.7 to 95.1,583
PCV,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,3 Months,93.5,88.4 to 96.4,292
PCV,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,3 Months,94.0,90.6 to 96.3,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",90.9,87.4 to 94.4,672
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.2,82.2 to 96.3,152
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,97.5,94.1 to 99.2,295
PCV,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,96.3,90.8 to 99.0,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,96.2,92.5 to 98.4,303
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,97.9,95.9 to 99.0,594
Hib,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,95.8,91.0 to 98.1,292
Hib,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,94.8,91.4 to 96.9,559
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,94.2,89.1 to 97.5,267
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,95.7,92.1 to 98.0,597
Hib,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,7 Months,92.1,82.0 to 96.8,260
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,97.2,93.1 to 99.1,330
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,95.9,92.6 to 98.0,695
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,94.5,89.0 to 97.8,365
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,95.9,92.9 to 98.0,660
Hib,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,5 Months,87.1,80.1 to 91.9,365
Hib,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,5 Months,88.0,83.5 to 91.5,660
Hib,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,5 Months,88.9,82.3 to 93.3,295
Hib,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,7 Months,93.6,88.4 to 96.5,237
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,92.5,86.9 to 98.1,212
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.4,93.0 to 97.7,672
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.4,93.2 to 97.7,807
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.7,82.4 to 100.0,53
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,92.5,86.3 to 96.0,267
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,94.7,90.7 to 97.1,597
Hib,≥2 Doses,States/Local Areas,Massachusetts,2020,Age,13 Months,94.3,89.1 to 97.1,268
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,78.8,70.7 to 85.2,330
Hib,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,78.9,73.3 to 83.6,695
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,79.0,70.7 to 85.4,365
Hib,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,79.1,73.6 to 83.7,660
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.3,90.2 to 100.0,152
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,96.1,92.8 to 99.5,157
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",97.3,93.6 to 100.0,53
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,95.7,92.1 to 99.3,219
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,97.1,95.3 to 98.8,780
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,97.6,94.1 to 99.2,295
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2018,Age,0-3 Days,82.1,74.9 to 87.6,365
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2018-2019,Age,0-3 Days,85.5,81.1 to 89.0,660
Polio,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,3 Months,96.6,92.7 to 98.5,295
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2019,Age,0-3 Days,88.9,83.2 to 92.9,295
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,79.1,75.0 to 83.2,780
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.8,66.1 to 93.6,53
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,80.2,72.9 to 87.5,219
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,84.9,77.1 to 90.4,365
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,84.2,79.1 to 88.3,660
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,83.6,76.3 to 88.9,295
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,7 Months,79.6,71.5 to 85.9,330
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,7 Months,82.2,76.8 to 86.6,695
Hib,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,99.1,96.1 to 99.8,291
Hib,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,98.0,95.9 to 99.0,583
Hib,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,97.3,95.6 to 98.3,303
Hib,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,98.2,96.3 to 99.1,594
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,97.9,94.2 to 99.5,330
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.1,94.1 to 98.8,695
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,96.4,91.0 to 99.0,365
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,96.7,93.7 to 98.5,660
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,76.2,68.3 to 82.7,291
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,79.3,74.0 to 83.8,583
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,82.4,75.0 to 88.0,292
Hib,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,78.4,72.6 to 83.3,559
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,74.4,65.2 to 81.9,267
Hib,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,76.6,70.3 to 82.0,597
Polio,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,3 Months,91.9,83.6 to 96.2,330
Polio,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,3 Months,93.6,89.2 to 96.3,695
Polio,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,3 Months,95.5,91.1 to 97.7,365
Polio,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,3 Months,96.0,93.4 to 97.6,660
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,7 Months,84.7,77.6 to 89.9,292
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,7 Months,82.7,77.3 to 87.0,559
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,80.9,73.2 to 86.7,291
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,82.8,77.8 to 86.9,583
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,7 Months,80.6,72.1 to 87.0,267
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,7 Months,80.1,74.0 to 85.1,597
Hib,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,95.6,91.0 to 97.9,295
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,80.3,72.1 to 88.4,164
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,97.6,95.6 to 99.7,164
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,96.7,95.1 to 98.3,1034
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,97.0,95.2 to 98.8,807
Hib,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,99.0,97.1 to 99.6,365
Hib,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,98.1,96.1 to 99.1,660
Hib,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,98.0,92.3 to 99.5,330
Hib,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,98.5,95.9 to 99.4,695
Hib,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,97.2,93.2 to 98.8,295
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,96.5,92.6 to 98.4,292
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,94.5,91.1 to 96.7,559
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,91.9,83.5 to 96.2,260
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,95.9,94.5 to 97.0,303
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,96.2,94.8 to 97.2,594
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,96.4,91.7 to 98.5,291
DTaP,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,96.5,93.8 to 98.0,583
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,76.8,67.7 to 85.8,157
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.9,75.4 to 84.3,672
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.5,74.5 to 90.4,152
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Overall,Overall,79.5,75.8 to 83.1,1034
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,73.9,65.3 to 82.5,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.6,77.7 to 85.6,807
Hib,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,79.2,71.4 to 85.3,295
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,91.4 to 99.4,212
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.2,95.2 to 99.2,672
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,93.4,91.2 to 95.1,303
Hib,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,93.6,89.9 to 95.9,594
Polio,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,95.0,89.3 to 97.8,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,98.0,96.2 to 99.9,606
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,93.5,88.9 to 98.2,264
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,93.7,88.5 to 96.6,291
Hib,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,93.8,90.4 to 96.1,583
Hib,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,94.7,87.7 to 97.8,237
Hib,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,89.6,78.9 to 95.3,260
Polio,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,94.9,91.3 to 97.0,260
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,80.9,76.3 to 85.4,606
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,76.2,68.8 to 83.6,264
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,95.5,93.4 to 97.6,780
PCV,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,3 Months,94.6,89.0 to 97.4,267
PCV,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,3 Months,92.9,87.2 to 96.2,597
PCV,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,3 Months,91.3,83.1 to 95.7,330
PCV,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,3 Months,91.3,86.4 to 94.5,695
PCV,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,3 Months,91.4,84.6 to 95.3,365
PCV,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,3 Months,93.0,89.0 to 95.6,660
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,92.8,87.8 to 97.8,219
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2011,Age,0-3 Days,78.3,70.0 to 84.8,237
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,91.4,86.5 to 96.4,212
Hib,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,7 Months,93.5,90.6 to 95.5,303
Hib,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,7 Months,95.4,91.6 to 97.5,594
Hib,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,7 Months,97.3,93.4 to 98.9,291
Hib,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,7 Months,96.5,93.8 to 98.1,583
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,94.3,91.4 to 97.2,606
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,85.9,79.5 to 92.2,264
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,90.1,84.9 to 95.3,164
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,90.9,88.3 to 93.4,1034
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.7,87.7 to 93.8,807
PCV,≥1 Dose,States/Local Areas,Massachusetts,2012,Age,3 Months,92.6,86.6 to 96.1,260
PCV,≥1 Dose,States/Local Areas,Massachusetts,2011,Age,3 Months,92.7,88.9 to 95.3,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,97.9,96.0 to 99.8,606
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Poverty,133% to <400% FPL,93.1,88.9 to 97.3,264
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Poverty,<133% FPL,96.1,92.7 to 99.4,164
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Overall,Overall,96.1,94.5 to 97.8,1034
PCV,≥4 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,93.0,82.5 to 98.2,365
PCV,≥4 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,94.1,88.9 to 97.4,660
PCV,≥4 Doses,States/Local Areas,Massachusetts,2019,Age,35 Months,95.0,88.9 to 98.3,295
PCV,≥4 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,92.0,86.3 to 96.0,330
PCV,≥4 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,92.0,87.1 to 95.6,695
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Massachusetts,2012,Age,0-3 Days,73.2,65.4 to 79.8,260
Hib,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,5 Months,85.8,82.9 to 88.2,303
Hib,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,5 Months,87.9,83.2 to 91.5,594
Hib,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,5 Months,90.1,84.6 to 93.8,291
Hib,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,5 Months,91.4,87.0 to 94.3,583
Hib,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,5 Months,82.6,73.8 to 88.9,260
Hib,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,5 Months,85.3,76.9 to 91.0,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,19 Months,94.2,87.8 to 97.3,365
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,19 Months,92.9,89.0 to 95.5,660
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,19 Months,97.5,93.4 to 99.0,295
PCV,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,24 Months,96.3,90.8 to 99.0,237
Hib,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,5 Months,92.6,87.2 to 95.9,292
Hib,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,5 Months,90.4,86.0 to 93.6,559
Hib,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,5 Months,88.3,80.6 to 93.2,267
Hib,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,5 Months,86.7,80.7 to 91.0,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,95.6,90.8 to 98.3,260
Hib,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,5 Months,85.0,77.0 to 90.6,330
Hib,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,5 Months,86.1,81.0 to 89.9,695
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,96.2,92.5 to 98.4,303
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,97.6,95.6 to 98.8,594
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,98.9,97.0 to 99.7,291
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,97.7,95.8 to 98.9,583
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,96.5,93.1 to 98.5,292
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,95.4,92.4 to 97.4,559
PCV,≥1 Dose,States/Local Areas,Massachusetts,2013,Age,3 Months,92.4,90.1 to 94.1,303
PCV,≥1 Dose,States/Local Areas,Massachusetts,2013-2014,Age,3 Months,91.9,90.3 to 93.3,594
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.7,91.9 to 100.0,53
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,89.8,84.1 to 95.5,157
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,87.2,81.4 to 93.0,219
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.6,92.4 to 100.0,152
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,Hispanic,95.3,91.6 to 99.0,157
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",95.6,91.0 to 100.0,53
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Any Medicaid,93.4,89.4 to 97.5,219
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,92.5,87.3 to 96.2,267
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,92.1,88.1 to 95.2,597
PCV,≥4 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,93.6,88.9 to 96.8,292
PCV,≥4 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,93.1,89.7 to 95.7,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,93.8,89.0 to 96.9,291
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,93.8,90.7 to 96.2,583
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Poverty,>400% FPL,98.7,97.3 to 100.0,606
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.0,94.0 to 98.0,807
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,96.2,93.3 to 99.2,212
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,94.4 to 98.6,672
Hib,≥1 Dose,States/Local Areas,Massachusetts,2018,Age,3 Months,92.4,86.1 to 96.0,365
Hib,≥1 Dose,States/Local Areas,Massachusetts,2018-2019,Age,3 Months,93.7,89.9 to 96.1,660
Hib,≥1 Dose,States/Local Areas,Massachusetts,2019,Age,3 Months,94.9,89.6 to 97.5,295
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.1,91.6 to 100.0,53
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016,Age,35 Months,95.1,90.2 to 98.0,267
≥1 Dose MMR,,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.5,93.0 to 98.5,597
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014,Age,35 Months,96.6,90.5 to 99.2,291
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,96.4,93.4 to 98.3,583
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015,Age,35 Months,96.5,93.2 to 98.4,292
≥1 Dose MMR,,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,95.8,93.0 to 97.7,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,90.7,85.1 to 94.8,330
PCV,≥4 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,89.2,85.0 to 92.6,695
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016,Age,24 Months,92.5,87.3 to 96.2,267
PCV,≥4 Doses,States/Local Areas,Massachusetts,2016-2017,Age,24 Months,91.6,87.6 to 94.7,597
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,7 Months,95.2,89.9 to 97.7,295
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2011,Age,13 Months,94.1,92.9 to 95.1,237
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2013,Age,13 Months,95.3,92.4 to 97.1,303
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2013-2014,Age,13 Months,95.3,93.3 to 96.8,594
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2012,Age,13 Months,94.0,89.7 to 96.6,260
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,96.4,91.8 to 98.5,330
PCV,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,93.4,89.4 to 96.0,695
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,90.3,83.3 to 94.5,365
PCV,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,92.9,89.0 to 95.5,660
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,95.2,90.7 to 98.0,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,35 Months,95.5,91.4 to 98.1,292
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,35 Months,95.7,92.9 to 97.7,559
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,35 Months,96.7,90.0 to 99.4,291
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,35 Months,96.3,92.6 to 98.5,583
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,94.7,91.0 to 97.3,303
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,95.7,92.4 to 97.9,594
Hib,Full Series,States/Local Areas,Massachusetts,2020,Age,24 Months,88.8,82.3 to 93.8,268
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,91.8,85.5 to 95.5,267
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,94.1,90.1 to 96.6,597
PCV,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,95.5,91.0 to 97.9,295
PCV,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,19 Months,94.7,91.4 to 96.7,237
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013,Age,19 Months,95.9,95.1 to 96.5,303
PCV,≥3 Doses,States/Local Areas,Massachusetts,2013-2014,Age,19 Months,97.3,96.0 to 98.1,594
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014,Age,19 Months,98.7,96.5 to 99.5,291
PCV,≥3 Doses,States/Local Areas,Massachusetts,2014-2015,Age,19 Months,97.6,95.5 to 98.7,583
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,35 Months,95.9,91.4 to 98.4,267
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.3,93.0 to 98.3,597
PCV,≥4 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,88.5,81.8 to 93.6,295
PCV,≥4 Doses,States/Local Areas,Massachusetts,2018,Age,24 Months,87.7,81.3 to 92.7,365
PCV,≥4 Doses,States/Local Areas,Massachusetts,2018-2019,Age,24 Months,88.2,83.7 to 91.9,660
PCV,≥4 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,91.3,83.8 to 96.3,237
PCV,≥4 Doses,States/Local Areas,Massachusetts,2012,Age,35 Months,87.8,81.0 to 93.0,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018,Age,35 Months,96.5,92.6 to 98.7,365
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,96.6,94.0 to 98.3,660
PCV,≥3 Doses,States/Local Areas,Massachusetts,2012,Age,19 Months,93.6,87.3 to 96.8,260
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,35 Months,96.8,93.1 to 98.8,330
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,96.9,94.3 to 98.5,695
Hib,≥1 Dose,States/Local Areas,Massachusetts,2014,Age,3 Months,92.4,85.7 to 96.1,291
Hib,≥1 Dose,States/Local Areas,Massachusetts,2014-2015,Age,3 Months,93.0,89.2 to 95.6,583
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2014,Age,13 Months,95.4,89.4 to 98.0,291
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2014-2015,Age,13 Months,95.5,92.1 to 97.5,583
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2015,Age,13 Months,95.6,90.9 to 97.9,292
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2015-2016,Age,13 Months,95.7,92.6 to 97.6,559
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2016,Age,13 Months,95.9,90.7 to 98.2,267
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2016-2017,Age,13 Months,96.5,92.7 to 98.4,597
Hib,≥1 Dose,States/Local Areas,Massachusetts,2015,Age,3 Months,93.7,88.5 to 96.6,292
Hib,≥1 Dose,States/Local Areas,Massachusetts,2015-2016,Age,3 Months,93.9,90.3 to 96.2,559
Hib,≥1 Dose,States/Local Areas,Massachusetts,2016,Age,3 Months,94.1,88.2 to 97.1,267
Hib,≥1 Dose,States/Local Areas,Massachusetts,2016-2017,Age,3 Months,93.1,87.3 to 96.3,597
Hib,≥1 Dose,States/Local Areas,Massachusetts,2017,Age,3 Months,92.1,83.8 to 96.3,330
Hib,≥1 Dose,States/Local Areas,Massachusetts,2017-2018,Age,3 Months,92.3,87.5 to 95.3,695
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2017,Age,13 Months,97.1,92.3 to 99.0,330
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2017-2018,Age,13 Months,96.8,94.0 to 98.3,695
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,13 Months,96.4,92.2 to 98.4,365
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,13 Months,96.5,93.6 to 98.1,660
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2019,Age,13 Months,96.5,91.6 to 98.6,295
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015,Age,19 Months,96.5,90.0 to 98.8,292
PCV,≥3 Doses,States/Local Areas,Massachusetts,2015-2016,Age,19 Months,95.2,92.0 to 97.2,559
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016,Age,19 Months,94.0,88.2 to 97.0,267
PCV,≥3 Doses,States/Local Areas,Massachusetts,2016-2017,Age,19 Months,95.6,91.6 to 97.7,597
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Urbanicity,Living In a MSA Principal City,95.4,92.2 to 98.6,212
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.9,95.2 to 98.7,672
≥1 Dose MMR,,States/Local Areas,Massachusetts,2014-2017,Insurance Coverage,Private Insurance Only,97.4,95.8 to 98.9,780
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.5,89.6 to 99.3,152
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019,Age,35 Months,95.3,91.0 to 98.0,295
PCV,≥4 Doses,States/Local Areas,Massachusetts,2013,Age,35 Months,90.3,85.0 to 94.4,303
PCV,≥4 Doses,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,92.3,88.8 to 95.0,594
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018,Age,35 Months,97.1,93.9 to 98.9,365
≥1 Dose MMR,,States/Local Areas,Massachusetts,2018-2019,Age,35 Months,96.5,93.8 to 98.2,660
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017,Age,35 Months,98.6,95.1 to 99.8,330
≥1 Dose MMR,,States/Local Areas,Massachusetts,2017-2018,Age,35 Months,97.9,95.6 to 99.2,695
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016,Age,35 Months,95.3,90.2 to 98.3,267
≥1 Dose Varicella,,States/Local Areas,Massachusetts,2016-2017,Age,35 Months,96.5,93.1 to 98.5,597
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013,Age,35 Months,99.4,97.0 to 99.9,303
≥1 Dose MMR,,States/Local Areas,Massachusetts,2013-2014,Age,35 Months,99.4,96.9 to 99.9,594
≥1 Dose MMR,,States/Local Areas,Massachusetts,2011,Age,35 Months,97.5,93.8 to 99.2,237
≥1 Dose MMR,,States/Local Areas,Massachusetts,2012,Age,35 Months,96.1,92.3 to 98.4,260
≥1 Dose MMR,,States/Local Areas,Massachusetts,2019,Age,24 Months,95.1,90.7 to 97.8,295
PCV,≥4 Doses,States/Local Areas,Massachusetts,2015,Age,24 Months,90.8,85.3 to 94.9,292
PCV,≥4 Doses,States/Local Areas,Massachusetts,2015-2016,Age,24 Months,91.7,88.0 to 94.6,559
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014,Age,24 Months,90.6,85.1 to 94.8,291
PCV,≥4 Doses,States/Local Areas,Massachusetts,2014-2015,Age,24 Months,90.9,87.1 to 93.9,583
PCV,≥4 Doses,States/Local Areas,Massachusetts,2013,Age,24 Months,90.3,85.0 to 94.4,303
PCV,≥4 Doses,States/Local Areas,Massachusetts,2013-2014,Age,24 Months,90.5,86.8 to 93.5,594
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2019,Age,24 Months,95.7,91.5 to 98.2,295
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017,Age,24 Months,96.8,93.1 to 98.8,330
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2017-2018,Age,24 Months,94.6,91.5 to 96.9,695
Hep B,≥3 Doses,States/Local Areas,Massachusetts,2011,Age,35 Months,92.4,85.7 to 96.8,237
PCV,≥4 Doses,States/Local Areas,Massachusetts,2012,Age,24 Months,82.5,75.4 to 88.5,260
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2017,Age,0-2 Days,86.6,80.4 to 91.1,330
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2017-2018,Age,0-2 Days,83.6,79.0 to 87.4,695
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2018,Age,0-2 Days,80.6,73.3 to 86.3,365
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2018-2019,Age,0-2 Days,84.7,80.1 to 88.3,660
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Massachusetts,2019,Age,0-2 Days,88.7,83.0 to 92.7,295
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2018,Age,7 Months,95.0,89.9 to 97.5,365
Hep B,≥2 Doses,States/Local Areas,Massachusetts,2018-2019,Age,7 Months,95.1,91.8 to 97.1,660
Hib,Primary Series,States/Local Areas,Mississippi,2016,Age,19 Months,90.2,83.3 to 94.4,307
Hib,Primary Series,States/Local Areas,Mississippi,2016-2017,Age,19 Months,90.7,86.6 to 93.6,628
Hib,Primary Series,States/Local Areas,Mississippi,2015,Age,19 Months,89.5,79.7 to 94.8,272
Hib,Primary Series,States/Local Areas,Mississippi,2015-2016,Age,19 Months,89.8,85.6 to 92.9,579
Hep A,≥1 Dose,States/Local Areas,Mississippi,2012,Age,19 Months,60.2,51.1 to 68.6,230
Hep A,≥1 Dose,States/Local Areas,Mississippi,2011,Age,19 Months,55.4,50.0 to 60.7,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,86.0,78.6 to 91.2,308
DTaP,≥1 Dose,States/Local Areas,Mississippi,2019,Age,3 Months,92.1,86.4 to 95.5,324
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,96.1,93.1 to 98.0,307
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,95.2,92.7 to 97.0,628
DTaP,≥1 Dose,States/Local Areas,Mississippi,2018,Age,3 Months,89.5,83.7 to 93.4,276
DTaP,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,3 Months,90.8,87.0 to 93.6,600
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,91.2,86.3 to 94.8,272
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,93.8,91.0 to 96.0,579
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014,Age,24 Months,92.4,87.0 to 96.2,239
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,24 Months,91.8,88.4 to 94.6,511
DTaP,≥1 Dose,States/Local Areas,Mississippi,2017,Age,3 Months,86.1,79.5 to 90.8,321
DTaP,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,3 Months,87.8,83.6 to 91.0,597
Hib,Primary Series,States/Local Areas,Mississippi,2013,Age,24 Months,91.9,86.0 to 96.0,217
Hib,Primary Series,States/Local Areas,Mississippi,2013-2014,Age,24 Months,92.2,88.5 to 95.1,456
Hib,Primary Series,States/Local Areas,Mississippi,2011,Age,24 Months,92.2,86.2 to 96.2,198
Hib,Primary Series,States/Local Areas,Mississippi,2012,Age,24 Months,93.8,88.5 to 97.2,230
Hib,Primary Series,States/Local Areas,Mississippi,2017,Age,19 Months,91.2,85.8 to 94.7,321
Hib,Primary Series,States/Local Areas,Mississippi,2017-2018,Age,19 Months,92.0,88.5 to 94.5,597
Hib,Primary Series,States/Local Areas,Mississippi,2018,Age,19 Months,92.8,87.7 to 95.9,276
Hib,Primary Series,States/Local Areas,Mississippi,2018-2019,Age,19 Months,86.3,82.0 to 89.7,600
Hep A,≥1 Dose,States/Local Areas,Mississippi,2013,Age,19 Months,66.8,63.3 to 70.2,217
Hep A,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,19 Months,66.2,61.5 to 70.5,456
Hep A,≥1 Dose,States/Local Areas,Mississippi,2015,Age,19 Months,67.3,61.5 to 72.7,272
Hep A,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,19 Months,66.0,60.8 to 70.9,579
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014,Age,19 Months,65.5,57.5 to 72.7,239
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,19 Months,66.4,61.1 to 71.3,511
DTaP,≥2 Doses,States/Local Areas,Mississippi,2017,Age,5 Months,74.1,66.2 to 80.8,321
DTaP,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,5 Months,76.3,71.0 to 80.8,597
DTaP,≥2 Doses,States/Local Areas,Mississippi,2018,Age,5 Months,78.4,71.2 to 84.3,276
DTaP,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,5 Months,78.9,73.8 to 83.2,600
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,92.1,89.1 to 95.1,478
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Overall,Overall,93.0,91.1 to 94.9,1007
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,92.4,89.4 to 95.5,393
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,92.4,89.3 to 95.5,392
Polio,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,96.3,93.8 to 98.8,222
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,93.7,89.0 to 96.8,276
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,93.4,90.2 to 95.9,600
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,94.2,90.0 to 97.1,321
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,94.1,91.1 to 96.3,597
DTaP,≥1 Dose,States/Local Areas,Mississippi,2016,Age,3 Months,89.8,84.4 to 93.5,307
DTaP,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,3 Months,88.0,83.9 to 91.1,628
DTaP,≥1 Dose,States/Local Areas,Mississippi,2015,Age,3 Months,88.6,83.0 to 92.5,272
DTaP,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,3 Months,89.2,85.5 to 92.0,579
DTaP,≥1 Dose,States/Local Areas,Mississippi,2014,Age,3 Months,88.3,81.5 to 92.9,239
DTaP,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,3 Months,88.4,84.3 to 91.6,511
DTaP,≥1 Dose,States/Local Areas,Mississippi,2013,Age,3 Months,87.4,79.2 to 92.7,217
DTaP,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,3 Months,87.9,83.3 to 91.3,456
DTaP,≥1 Dose,States/Local Areas,Mississippi,2011,Age,3 Months,86.7,84.0 to 89.1,198
DTaP,≥1 Dose,States/Local Areas,Mississippi,2012,Age,3 Months,88.8,81.3 to 93.6,230
≥1 Dose Varicella,,States/Local Areas,Mississippi,2021,Age,19 Months,85.4,75.5 to 91.7,197
Hep B,≥3 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,87.9,78.7 to 93.4,197
Hib,Primary Series,States/Local Areas,Mississippi,2019,Age,19 Months,92.4,86.9 to 95.7,324
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.0,73.9 to 82.1,699
Hib,≥3 Doses,States/Local Areas,Mississippi,2017,Age,24 Months,91.1,86.4 to 94.6,321
Hib,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,24 Months,90.6,87.2 to 93.5,597
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,93.2,88.2 to 96.6,324
Hib,≥3 Doses,States/Local Areas,Mississippi,2016,Age,24 Months,88.5,82.2 to 93.3,307
Hib,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,24 Months,89.7,85.9 to 92.9,628
Hib,≥3 Doses,States/Local Areas,Mississippi,2015,Age,24 Months,87.5,82.1 to 91.9,272
Hib,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,24 Months,88.0,84.0 to 91.4,579
Hib,≥1 Dose,States/Local Areas,Mississippi,2021,Age,3 Months,81.8,71.6 to 88.9,197
Hib,Full Series,States/Local Areas,Mississippi,2021,Age,19 Months,66.8,56.3 to 75.9,197
Hib,Primary Series,States/Local Areas,Mississippi,2021,Age,19 Months,85.2,75.2 to 91.6,197
DTaP,≥4 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,83.5,76.0 to 89.8,505
Hib,Primary Series,States/Local Areas,Mississippi,2020-2021,Age,24 Months,89.3,84.0 to 93.4,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,79.7,69.1 to 87.3,197
Hib,≥2 Doses,States/Local Areas,Mississippi,2021,Age,5 Months,70.3,59.4 to 79.2,197
PCV,≥3 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,93.6,85.4 to 98.0,197
≥1 Dose MMR,,States/Local Areas,Mississippi,2021,Age,35 Months,94.6,88.0 to 98.2,197
Hib,≥3 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,39.1,29.8 to 49.3,197
Hib,≥2 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,84.1,73.7 to 90.9,197
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,84.9,79.2 to 89.2,505
PCV,≥2 Doses,States/Local Areas,Mississippi,2021,Age,5 Months,73.4,62.6 to 81.9,197
PCV,≥4 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,77.8,71.5 to 83.6,505
Polio,≥2 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,83.7,73.3 to 90.5,197
Hib,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,24 Months,85.8,80.0 to 90.6,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,65.6,54.9 to 75.0,197
Hep B,≥2 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,90.5,81.7 to 95.3,197
Combined 7 Series,,States/Local Areas,Mississippi,2021,Age,35 Months,63.7,53.5 to 73.9,197
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016,Age,19 Months,64.7,57.0 to 71.7,307
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,19 Months,65.6,60.2 to 70.6,628
Hep A,≥1 Dose,States/Local Areas,Mississippi,2018,Age,19 Months,72.2,64.8 to 78.5,276
Hep A,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,19 Months,67.6,61.3 to 73.2,492
Hep A,≥1 Dose,States/Local Areas,Mississippi,2017,Age,19 Months,66.5,58.8 to 73.4,321
Hep A,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,19 Months,69.3,64.0 to 74.2,597
Hib,≥3 Doses,States/Local Areas,Mississippi,2019,Age,24 Months,89.4,84.0 to 93.6,324
Hib,≥3 Doses,States/Local Areas,Mississippi,2018,Age,24 Months,89.8,84.3 to 94.0,276
Hib,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,24 Months,89.6,85.9 to 92.7,600
Hep A,≥2 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,11.3,7.4 to 16.9,230
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,21.3,15.2 to 29.1,239
Hep A,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,17.5,13.7 to 22.1,511
Hep A,≥2 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,18.2,12.4 to 25.9,217
Hep A,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,19.8,15.0 to 25.5,456
DTaP,≥2 Doses,States/Local Areas,Mississippi,2019,Age,5 Months,79.3,71.8 to 85.2,324
Hep A,≥2 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,14.4,7.9 to 24.8,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,93.7,88.3 to 97.2,239
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,92.5,89.1 to 95.2,511
DTaP,≥3 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,96.5,91.1 to 99.1,198
DTaP,≥3 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,96.9,91.7 to 99.2,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,91.4,85.2 to 95.8,217
DTaP,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,92.6,88.5 to 95.6,456
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,19 Months,86.6,80.5 to 90.9,505
Hep B,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,92.5,88.1 to 95.4,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2011,Age,35 Months,96.4,90.7 to 99.0,198
Hib,≥3 Doses,States/Local Areas,Mississippi,2012,Age,35 Months,93.4,87.6 to 97.1,230
Hep A,≥1 Dose,States/Local Areas,Mississippi,2012,Age,24 Months,63.0,54.3 to 71.8,230
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014,Age,24 Months,68.4,60.7 to 75.8,239
Hep A,≥1 Dose,States/Local Areas,Mississippi,2014-2015,Age,24 Months,69.6,64.5 to 74.6,511
Hep A,≥1 Dose,States/Local Areas,Mississippi,2013,Age,24 Months,69.7,61.3 to 77.7,217
Hep A,≥1 Dose,States/Local Areas,Mississippi,2013-2014,Age,24 Months,69.0,63.5 to 74.5,456
Hep A,≥1 Dose,States/Local Areas,Mississippi,2011,Age,24 Months,59.5,50.4 to 68.8,198
Hep A,≥1 Dose,States/Local Areas,Mississippi,2019,Age,19 Months,61.9,53.9 to 69.3,324
PCV,≥4 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,74.4,63.9 to 82.6,197
Hib,Primary Series,States/Local Areas,Mississippi,2021,Age,7 Months,62.4,51.6 to 72.0,197
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,95.0,90.5 to 97.8,321
DTaP,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,94.6,91.5 to 96.8,597
DTaP,≥4 Doses,States/Local Areas,Mississippi,2011,Age,19 Months,69.3,61.9 to 75.8,198
DTaP,≥4 Doses,States/Local Areas,Mississippi,2012,Age,19 Months,65.4,62.3 to 68.4,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,96.3,93.4 to 98.2,307
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,95.7,93.2 to 97.5,628
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,91.2,86.3 to 94.8,272
DTaP,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,94.0,91.2 to 96.1,579
PCV,≥2 Doses,States/Local Areas,Mississippi,2011,Age,5 Months,75.7,70.9 to 80.0,198
PCV,≥2 Doses,States/Local Areas,Mississippi,2012,Age,5 Months,74.1,67.4 to 79.8,230
PCV,≥2 Doses,States/Local Areas,Mississippi,2013,Age,5 Months,79.7,75.8 to 83.1,217
PCV,≥2 Doses,States/Local Areas,Mississippi,2013-2014,Age,5 Months,80.0,78.5 to 81.5,456
Hep A,≥2 Doses,States/Local Areas,Mississippi,2011,Age,24 Months,34.1,25.2 to 45.1,198
Hep A,≥2 Doses,States/Local Areas,Mississippi,2019,Age,19 Months,20.7,15.3 to 27.3,324
Hep A,≥2 Doses,States/Local Areas,Mississippi,2018,Age,19 Months,17.9,12.7 to 24.6,276
Hep A,≥2 Doses,States/Local Areas,Mississippi,2018-2019,Age,19 Months,18.2,14.0 to 23.4,492
Hib,≥3 Doses,States/Local Areas,Mississippi,2017,Age,35 Months,92.5,87.6 to 96.0,321
Hib,≥3 Doses,States/Local Areas,Mississippi,2017-2018,Age,35 Months,92.6,89.3 to 95.3,597
Hib,≥3 Doses,States/Local Areas,Mississippi,2016,Age,35 Months,92.9,86.8 to 96.8,307
Hib,≥3 Doses,States/Local Areas,Mississippi,2016-2017,Age,35 Months,92.7,88.8 to 95.6,628
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,94.3,91.9 to 96.7,441
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,94.6,92.2 to 97.0,519
DTaP,≥4 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,63.3,59.4 to 67.0,272
DTaP,≥4 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,66.8,61.6 to 71.7,579
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014,Age,19 Months,70.2,62.3 to 77.0,239
DTaP,≥4 Doses,States/Local Areas,Mississippi,2014-2015,Age,19 Months,66.7,61.4 to 71.7,511
DTaP,≥4 Doses,States/Local Areas,Mississippi,2013,Age,19 Months,65.9,56.0 to 74.6,217
DTaP,≥4 Doses,States/Local Areas,Mississippi,2013-2014,Age,19 Months,68.0,60.8 to 74.5,456
Hep A,≥2 Doses,States/Local Areas,Mississippi,2012,Age,24 Months,25.4,18.6 to 34.1,230
DTaP,≥3 Doses,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,89.1,79.8 to 98.5,32
Hib,≥3 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,92.2,87.2 to 95.8,276
Hib,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,94.0,90.7 to 96.4,600
Hep A,≥2 Doses,States/Local Areas,Mississippi,2017,Age,19 Months,23.9,18.0 to 30.9,321
Hep A,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,19 Months,20.9,16.8 to 25.6,597
Hib,≥3 Doses,States/Local Areas,Mississippi,2015,Age,35 Months,87.6,82.2 to 92.0,272
Hib,≥3 Doses,States/Local Areas,Mississippi,2015-2016,Age,35 Months,90.2,86.3 to 93.4,579
Hib,≥3 Doses,States/Local Areas,Mississippi,2014,Age,35 Months,88.9,82.9 to 93.5,239
Hib,≥3 Doses,States/Local Areas,Mississippi,2014-2015,Age,35 Months,88.3,84.4 to 91.6,511
Hib,≥3 Doses,States/Local Areas,Mississippi,2013,Age,35 Months,87.2,80.1 to 92.7,217
Hib,≥3 Doses,States/Local Areas,Mississippi,2013-2014,Age,35 Months,88.0,83.5 to 91.8,456
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016,Age,19 Months,20.4,15.3 to 26.7,307
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,19 Months,22.1,18.1 to 26.7,628
Hep A,≥2 Doses,States/Local Areas,Mississippi,2015,Age,19 Months,13.7,8.8 to 20.6,272
Hep A,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,19 Months,17.0,13.7 to 21.0,579
Hep A,≥2 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,46.0,33.2 to 61.1,197
Combined 7 Series,,States/Local Areas,Mississippi,2019,Age,24 Months,71.0,63.7 to 78.1,324
Combined 7 Series,,States/Local Areas,Mississippi,2011,Age,24 Months,68.1,58.7 to 77.1,198
Hib,Primary Series,States/Local Areas,Mississippi,2016,Age,35 Months,95.0,91.2 to 97.5,307
Hib,Primary Series,States/Local Areas,Mississippi,2016-2017,Age,35 Months,95.0,92.2 to 97.0,628
Hib,Primary Series,States/Local Areas,Mississippi,2017,Age,35 Months,94.9,90.3 to 97.7,321
Hib,Primary Series,States/Local Areas,Mississippi,2017-2018,Age,35 Months,94.3,91.3 to 96.6,597
Hib,Primary Series,States/Local Areas,Mississippi,2019,Age,24 Months,93.9,89.5 to 96.9,324
Combined 7 Series,,States/Local Areas,Mississippi,2013,Age,24 Months,65.6,56.6 to 74.4,217
Combined 7 Series,,States/Local Areas,Mississippi,2013-2014,Age,24 Months,67.8,61.8 to 73.6,456
Combined 7 Series,,States/Local Areas,Mississippi,2012,Age,24 Months,72.0,63.5 to 80.0,230
Combined 7 Series,,States/Local Areas,Mississippi,2011,Age,35 Months,69.6,60.1 to 78.6,198
Combined 7 Series,,States/Local Areas,Mississippi,2014,Age,35 Months,74.9,67.2 to 82.1,239
Combined 7 Series,,States/Local Areas,Mississippi,2014-2015,Age,35 Months,69.6,64.2 to 74.8,511
Combined 7 Series,,States/Local Areas,Mississippi,2013,Age,35 Months,69.0,59.8 to 77.7,217
Combined 7 Series,,States/Local Areas,Mississippi,2013-2014,Age,35 Months,71.9,65.8 to 77.6,456
Combined 7 Series,,States/Local Areas,Mississippi,2012,Age,35 Months,81.8,73.1 to 89.1,230
Hib,Primary Series,States/Local Areas,Mississippi,2015,Age,24 Months,90.7,85.6 to 94.5,272
Hib,Primary Series,States/Local Areas,Mississippi,2015-2016,Age,24 Months,92.2,89.0 to 94.8,579
Hib,Primary Series,States/Local Areas,Mississippi,2014,Age,24 Months,92.6,87.5 to 96.2,239
Hib,Primary Series,States/Local Areas,Mississippi,2014-2015,Age,24 Months,91.7,88.2 to 94.4,511
Hib,Primary Series,States/Local Areas,Mississippi,2012,Age,35 Months,93.8,88.5 to 97.2,230
Hib,Primary Series,States/Local Areas,Mississippi,2014,Age,35 Months,92.6,87.5 to 96.2,239
Hib,Primary Series,States/Local Areas,Mississippi,2014-2015,Age,35 Months,91.7,88.2 to 94.4,511
Hib,Primary Series,States/Local Areas,Mississippi,2011,Age,35 Months,95.9,90.1 to 98.8,198
Hib,Primary Series,States/Local Areas,Mississippi,2017,Age,7 Months,70.7,62.9 to 77.5,321
Hib,Primary Series,States/Local Areas,Mississippi,2017-2018,Age,7 Months,71.7,66.3 to 76.6,597
Hib,Primary Series,States/Local Areas,Mississippi,2016,Age,7 Months,71.0,63.6 to 77.5,307
Hib,Primary Series,States/Local Areas,Mississippi,2016-2017,Age,7 Months,70.9,65.6 to 75.6,628
Hib,Primary Series,States/Local Areas,Mississippi,2011,Age,13 Months,87.5,84.4 to 90.1,198
Hib,Primary Series,States/Local Areas,Mississippi,2012,Age,13 Months,89.7,85.3 to 92.9,230
Hib,Primary Series,States/Local Areas,Mississippi,2013,Age,13 Months,82.9,81.2 to 84.5,217
Hib,Primary Series,States/Local Areas,Mississippi,2013-2014,Age,13 Months,85.0,81.3 to 88.1,456
Hib,Primary Series,States/Local Areas,Mississippi,2018,Age,7 Months,72.7,65.1 to 79.3,276
Hib,Primary Series,States/Local Areas,Mississippi,2018-2019,Age,7 Months,71.7,66.4 to 76.5,600
Hib,Primary Series,States/Local Areas,Mississippi,2019,Age,7 Months,70.7,63.1 to 77.3,324
Hib,Primary Series,States/Local Areas,Mississippi,2017,Age,24 Months,93.9,89.7 to 96.9,321
Hib,Primary Series,States/Local Areas,Mississippi,2017-2018,Age,24 Months,93.5,90.5 to 95.8,597
Hib,Primary Series,States/Local Areas,Mississippi,2016,Age,24 Months,93.8,89.5 to 96.7,307
Hib,Primary Series,States/Local Areas,Mississippi,2016-2017,Age,24 Months,93.9,91.0 to 96.0,628
Hib,Primary Series,States/Local Areas,Mississippi,2015,Age,13 Months,84.4,78.1 to 89.2,272
Hib,Primary Series,States/Local Areas,Mississippi,2015-2016,Age,13 Months,84.3,79.8 to 88.0,579
Hib,Primary Series,States/Local Areas,Mississippi,2014,Age,13 Months,87.1,80.6 to 91.7,239
Hib,Primary Series,States/Local Areas,Mississippi,2014-2015,Age,13 Months,85.8,81.4 to 89.2,511
Hib,Primary Series,States/Local Areas,Mississippi,2018,Age,24 Months,92.8,88.2 to 96.1,276
Hib,Primary Series,States/Local Areas,Mississippi,2018-2019,Age,24 Months,93.4,90.4 to 95.7,600
Hib,Primary Series,States/Local Areas,Mississippi,2014,Age,19 Months,91.6,85.9 to 95.2,239
Hib,Primary Series,States/Local Areas,Mississippi,2014-2015,Age,19 Months,90.6,86.7 to 93.4,511
Hib,Primary Series,States/Local Areas,Mississippi,2013,Age,19 Months,89.6,85.6 to 92.6,217
Hib,Primary Series,States/Local Areas,Mississippi,2013-2014,Age,19 Months,90.6,87.6 to 93.0,456
Hib,Primary Series,States/Local Areas,Mississippi,2018,Age,13 Months,86.8,80.1 to 91.5,276
Hib,Primary Series,States/Local Areas,Mississippi,2018-2019,Age,13 Months,86.3,82.0 to 89.7,600
Hib,Primary Series,States/Local Areas,Mississippi,2011,Age,19 Months,91.3,89.0 to 93.2,198
Hib,Primary Series,States/Local Areas,Mississippi,2012,Age,19 Months,93.8,90.7 to 96.0,230
Hib,Primary Series,States/Local Areas,Mississippi,2019,Age,13 Months,85.7,79.7 to 90.2,324
Hib,Primary Series,States/Local Areas,Mississippi,2017,Age,13 Months,86.8,80.8 to 91.2,321
Hib,Primary Series,States/Local Areas,Mississippi,2017-2018,Age,13 Months,86.8,82.5 to 90.2,597
Hib,Primary Series,States/Local Areas,Mississippi,2016,Age,13 Months,84.2,77.1 to 89.4,307
Hib,Primary Series,States/Local Areas,Mississippi,2016-2017,Age,13 Months,85.5,81.0 to 89.0,628
Hib,Primary Series,States/Local Areas,Mississippi,2013,Age,7 Months,72.4,70.0 to 74.7,217
Hib,Primary Series,States/Local Areas,Mississippi,2013-2014,Age,7 Months,75.5,72.4 to 78.4,456
Hib,Primary Series,States/Local Areas,Mississippi,2013,Age,35 Months,91.9,86.0 to 96.0,217
Hib,Primary Series,States/Local Areas,Mississippi,2013-2014,Age,35 Months,92.2,88.5 to 95.1,456
Hib,Primary Series,States/Local Areas,Mississippi,2015,Age,7 Months,67.6,60.3 to 74.3,272
Hib,Primary Series,States/Local Areas,Mississippi,2015-2016,Age,7 Months,69.3,64.1 to 74.2,579
Hib,Primary Series,States/Local Areas,Mississippi,2014,Age,7 Months,78.7,71.1 to 84.6,239
Hib,Primary Series,States/Local Areas,Mississippi,2014-2015,Age,7 Months,73.2,68.0 to 77.8,511
Rotavirus,,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,81.8,75.4 to 88.1,222
Hib,Full Series,States/Local Areas,Mississippi,2019,Age,19 Months,70.9,63.3 to 77.6,324
Hib,Full Series,States/Local Areas,Mississippi,2018,Age,19 Months,74.5,66.9 to 80.9,276
Hib,Full Series,States/Local Areas,Mississippi,2018-2019,Age,19 Months,95.2,92.5 to 97.0,600
≥1 Dose MMR,,States/Local Areas,Mississippi,2020,Age,13 Months,62.8,54.0 to 70.8,308
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Private Insurance Only,73.4,68.1 to 78.7,441
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Any Medicaid,66.4,61.3 to 71.6,519
Combined 7 Series,,States/Local Areas,Mississippi,2019,Age,35 Months,75.6,68.2 to 82.4,324
Combined 7 Series,,States/Local Areas,Mississippi,2018,Age,35 Months,69.7,61.8 to 77.3,276
Combined 7 Series,,States/Local Areas,Mississippi,2018-2019,Age,35 Months,72.7,67.3 to 77.8,600
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",65.4,58.4 to 72.3,246
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Insurance Coverage,Uninsured,47.6,26.1 to 69.1,32
Hib,Full Series,States/Local Areas,Mississippi,2012,Age,24 Months,81.6,73.8 to 88.2,230
Hib,Full Series,States/Local Areas,Mississippi,2011,Age,24 Months,78.3,69.4 to 86.0,198
Hib,Full Series,States/Local Areas,Mississippi,2013,Age,24 Months,72.9,64.4 to 80.8,217
Hib,Full Series,States/Local Areas,Mississippi,2013-2014,Age,24 Months,75.4,69.9 to 80.6,456
Hib,Full Series,States/Local Areas,Mississippi,2014,Age,24 Months,77.9,70.9 to 84.3,239
Hib,Full Series,States/Local Areas,Mississippi,2014-2015,Age,24 Months,76.2,71.4 to 80.8,511
Hib,Full Series,States/Local Areas,Mississippi,2014,Age,19 Months,70.6,62.8 to 77.4,239
Hib,Full Series,States/Local Areas,Mississippi,2014-2015,Age,19 Months,68.9,63.7 to 73.7,511
Hib,Full Series,States/Local Areas,Mississippi,2015,Age,19 Months,67.1,60.3 to 73.4,272
Hib,Full Series,States/Local Areas,Mississippi,2015-2016,Age,19 Months,70.4,65.3 to 75.0,579
Hib,Full Series,States/Local Areas,Mississippi,2016,Age,19 Months,73.6,66.1 to 79.9,307
Hib,Full Series,States/Local Areas,Mississippi,2016-2017,Age,19 Months,74.7,69.8 to 79.1,628
Hib,Full Series,States/Local Areas,Mississippi,2017,Age,19 Months,75.9,69.0 to 81.6,321
Hib,Full Series,States/Local Areas,Mississippi,2017-2018,Age,19 Months,75.2,70.2 to 79.6,597
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,Hispanic,52.9,37.7 to 68.1,87
Combined 7 Series,,States/Local Areas,Mississippi,2015,Age,35 Months,64.4,56.9 to 71.8,272
Combined 7 Series,,States/Local Areas,Mississippi,2015-2016,Age,35 Months,70.5,65.1 to 75.8,579
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Overall,Overall,68.1,64.3 to 71.9,1007
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a Non-MSA,68.0,62.6 to 73.4,478
Combined 7 Series,,States/Local Areas,Mississippi,2015,Age,24 Months,60.8,53.5 to 68.1,272
Combined 7 Series,,States/Local Areas,Mississippi,2015-2016,Age,24 Months,65.9,60.8 to 71.0,579
Hib,Primary Series,States/Local Areas,Mississippi,2018,Age,35 Months,93.2,88.6 to 96.4,276
Hib,Primary Series,States/Local Areas,Mississippi,2018-2019,Age,35 Months,95.0,91.9 to 97.2,600
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Poverty,<133% FPL,64.0,58.1 to 69.8,393
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Poverty,133% to <400% FPL,66.3,60.0 to 72.6,392
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Poverty,>400% FPL,84.4,79.1 to 89.7,222
Hib,Full Series,States/Local Areas,Mississippi,2011,Age,19 Months,71.3,68.3 to 74.2,198
Hib,Full Series,States/Local Areas,Mississippi,2012,Age,19 Months,73.5,69.8 to 76.9,230
Hib,Full Series,States/Local Areas,Mississippi,2013,Age,19 Months,65.2,62.0 to 68.3,217
Hib,Full Series,States/Local Areas,Mississippi,2013-2014,Age,19 Months,67.9,62.2 to 73.2,456
Hib,Primary Series,States/Local Areas,Mississippi,2015,Age,35 Months,90.7,85.6 to 94.5,272
Hib,Primary Series,States/Local Areas,Mississippi,2015-2016,Age,35 Months,92.9,89.9 to 95.3,579
Combined 7 Series,,States/Local Areas,Mississippi,2017,Age,24 Months,72.3,64.9 to 79.3,321
Combined 7 Series,,States/Local Areas,Mississippi,2017-2018,Age,24 Months,69.9,64.5 to 75.2,597
Combined 7 Series,,States/Local Areas,Mississippi,2018,Age,24 Months,67.4,59.6 to 75.0,276
Combined 7 Series,,States/Local Areas,Mississippi,2018-2019,Age,24 Months,69.2,63.8 to 74.5,600
Combined 7 Series,,States/Local Areas,Mississippi,2016,Age,24 Months,71.1,63.8 to 78.1,307
Combined 7 Series,,States/Local Areas,Mississippi,2016-2017,Age,24 Months,71.7,66.6 to 76.7,628
Hib,Primary Series,States/Local Areas,Mississippi,2019,Age,35 Months,96.0,91.9 to 98.3,324
Combined 7 Series,,States/Local Areas,Mississippi,2014,Age,24 Months,69.9,62.2 to 77.2,239
Combined 7 Series,,States/Local Areas,Mississippi,2014-2015,Age,24 Months,65.4,60.1 to 70.6,511
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.8,49.2 to 76.3,77
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.2,68.7 to 77.6,597
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Non-Principal City,67.4,60.8 to 74.0,334
Combined 7 Series,,States/Local Areas,Mississippi,2014-2017,Urbanicity,Living In a MSA Principal City,69.6,61.0 to 78.1,195
Combined 7 Series,,States/Local Areas,Mississippi,2016,Age,35 Months,76.7,68.9 to 83.8,307
Combined 7 Series,,States/Local Areas,Mississippi,2016-2017,Age,35 Months,77.2,71.7 to 82.3,628
Combined 7 Series,,States/Local Areas,Mississippi,2017,Age,35 Months,77.6,69.8 to 84.6,321
Combined 7 Series,,States/Local Areas,Mississippi,2017-2018,Age,35 Months,73.9,68.4 to 79.2,597
Rotavirus,,States/Local Areas,Mississippi,2019-2020,Age,8 Months,65.3,59.2 to 70.9,632
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020-2021,Age,35 Months,93.6,89.2 to 96.6,505
PCV,≥3 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,67.7,58.8 to 75.4,308
Hep A,≥1 Dose,States/Local Areas,Mississippi,2020-2021,Age,35 Months,70.8,63.7 to 77.5,505
PCV,≥3 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,87.6,77.7 to 94.5,197
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2021,Age,0-2 Days,79.1,69.8 to 86.2,197
Hib,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,91.7,86.9 to 94.8,505
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2021,Age,0-1 Days,75.5,65.6 to 83.3,197
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018,Age,35 Months,93.7,89.0 to 96.8,276
DTaP,≥3 Doses,States/Local Areas,Mississippi,2018-2019,Age,35 Months,95.3,92.3 to 97.4,600
PCV,≥2 Doses,States/Local Areas,Mississippi,2016,Age,5 Months,77.2,69.5 to 83.4,307
PCV,≥2 Doses,States/Local Areas,Mississippi,2016-2017,Age,5 Months,76.2,70.8 to 80.8,628
PCV,≥2 Doses,States/Local Areas,Mississippi,2015,Age,5 Months,75.3,68.4 to 81.1,272
PCV,≥2 Doses,States/Local Areas,Mississippi,2015-2016,Age,5 Months,76.2,71.1 to 80.7,579
PCV,≥2 Doses,States/Local Areas,Mississippi,2014,Age,5 Months,80.3,72.9 to 86.1,239
PCV,≥2 Doses,States/Local Areas,Mississippi,2014-2015,Age,5 Months,77.8,74.3 to 80.9,511
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016,Age,24 Months,71.0,63.9 to 77.7,307
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2017,Age,24 Months,72.3,67.6 to 76.9,628
Hep A,≥1 Dose,States/Local Areas,Mississippi,2015,Age,24 Months,70.9,64.2 to 77.3,272
Hep A,≥1 Dose,States/Local Areas,Mississippi,2015-2016,Age,24 Months,70.9,66.1 to 75.6,579
PCV,≥2 Doses,States/Local Areas,Mississippi,2017,Age,5 Months,75.1,67.2 to 81.6,321
PCV,≥2 Doses,States/Local Areas,Mississippi,2017-2018,Age,5 Months,75.6,70.3 to 80.2,597
Hib,≥2 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,89.1,82.0 to 93.7,308
Hep A,≥1 Dose,States/Local Areas,Mississippi,2011,Age,35 Months,69.1,57.4 to 80.2,198
Hep A,≥1 Dose,States/Local Areas,Mississippi,2019,Age,24 Months,64.9,57.2 to 72.6,324
Hep A,≥1 Dose,States/Local Areas,Mississippi,2018,Age,24 Months,74.8,68.1 to 81.1,276
Hep A,≥1 Dose,States/Local Areas,Mississippi,2018-2019,Age,24 Months,69.9,64.7 to 75.0,600
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019,Age,35 Months,96.1,92.2 to 98.4,324
Hep A,≥1 Dose,States/Local Areas,Mississippi,2021,Age,35 Months,64.4,54.4 to 74.4,197
PCV,≥3 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,83.7,73.3 to 90.5,197
Hib,Full Series,States/Local Areas,Mississippi,2021,Age,24 Months,69.9,59.8 to 79.4,197
Hep A,≥1 Dose,States/Local Areas,Mississippi,2017,Age,24 Months,73.7,67.3 to 79.8,321
Hep A,≥1 Dose,States/Local Areas,Mississippi,2017-2018,Age,24 Months,74.5,69.8 to 78.9,597
DTaP,≥4 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,68.6,57.9 to 77.7,197
Hep A,≥1 Dose,States/Local Areas,Mississippi,2012,Age,35 Months,68.9,59.7 to 77.7,230
Hib,Primary Series,States/Local Areas,Mississippi,2021,Age,24 Months,89.4,80.5 to 95.4,197
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,35 Months,91.3,86.6 to 94.8,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,85.1,74.9 to 92.8,197
≥1 Dose MMR,,States/Local Areas,Mississippi,2021,Age,24 Months,89.8,81.0 to 95.7,197
Polio,≥1 Dose,States/Local Areas,Mississippi,2021,Age,3 Months,84.8,74.9 to 91.2,197
DTaP,≥4 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,74.5,64.4 to 83.6,197
DTaP,≥1 Dose,States/Local Areas,Mississippi,2021,Age,3 Months,85.3,75.3 to 91.6,197
PCV,≥4 Doses,States/Local Areas,Mississippi,2021,Age,35 Months,77.4,67.5 to 86.0,197
Hep A,≥2 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,15.3,9.4 to 23.9,197
Polio,≥2 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,93.8,85.9 to 97.4,197
Hep A,≥1 Dose,States/Local Areas,Mississippi,2021,Age,19 Months,63.4,52.9 to 72.8,197
DTaP,≥3 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,80.3,69.6 to 87.9,197
PCV,≥3 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,65.5,54.8 to 74.9,197
Hep B,≥3 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,91.2,83.5 to 96.2,197
Polio,≥3 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,87.7,78.0 to 94.5,197
Hep B,≥3 Doses,States/Local Areas,Mississippi,2021,Age,7 Months,70.1,59.5 to 78.9,197
Hep A,≥2 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,23.4,15.3 to 35.0,197
PCV,≥2 Doses,States/Local Areas,Mississippi,2020-2021,Age,5 Months,73.7,66.9 to 79.5,505
Hib,≥3 Doses,States/Local Areas,Mississippi,2020-2021,Age,13 Months,56.9,50.0 to 63.4,505
DTaP,≥3 Doses,States/Local Areas,Mississippi,2021,Age,19 Months,84.3,73.9 to 91.1,197
Hep A,≥1 Dose,States/Local Areas,Mississippi,2021,Age,24 Months,64.2,54.2 to 74.2,197
PCV,≥4 Doses,States/Local Areas,Mississippi,2021,Age,24 Months,76.8,67.0 to 85.5,197
≥1 Dose Varicella,,States/Local Areas,Mississippi,2021,Age,24 Months,88.9,79.2 to 95.4,197
DTaP,≥4 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,69.8,64.0 to 75.1,632
Polio,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,90.1,85.7 to 93.3,632
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,88.4,83.9 to 91.8,632
Hib,Primary Series,States/Local Areas,Mississippi,2019-2020,Age,7 Months,70.5,64.7 to 75.7,632
Hib,Full Series,States/Local Areas,Mississippi,2020,Age,19 Months,69.8,61.3 to 77.2,308
Hib,Primary Series,States/Local Areas,Mississippi,2020,Age,19 Months,89.5,82.9 to 93.8,308
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020,Age,35 Months,92.9,86.8 to 96.8,308
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,91.9,85.8 to 96.1,308
Hib,Full Series,States/Local Areas,Mississippi,2020,Age,35 Months,80.1,71.0 to 87.7,308
Hib,≥3 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,87.6,81.1 to 92.8,308
Hib,Primary Series,States/Local Areas,Mississippi,2020,Age,35 Months,89.6,83.5 to 94.2,308
≥1 Dose MMR,,States/Local Areas,Mississippi,2020,Age,35 Months,92.8,87.3 to 96.6,308
Hib,Primary Series,States/Local Areas,Mississippi,2020,Age,24 Months,89.6,83.5 to 94.2,308
Hib,≥3 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,87.2,80.7 to 92.3,308
≥1 Dose MMR,,States/Local Areas,Mississippi,2020,Age,24 Months,86.8,80.0 to 92.2,308
DTaP,≥4 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,73.7,65.2 to 81.6,308
Polio,≥3 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,88.8,82.3 to 93.6,308
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,88.8,82.4 to 93.7,308
Hep B,≥2 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,89.5,82.9 to 93.8,308
Hib,Primary Series,States/Local Areas,Mississippi,2020,Age,7 Months,70.5,61.9 to 77.9,308
Hib,≥3 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,37.2,29.4 to 45.7,308
Hib,≥2 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,86.1,78.2 to 91.4,308
Polio,≥2 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,87.4,79.8 to 92.4,308
DTaP,≥1 Dose,States/Local Areas,Mississippi,2020,Age,3 Months,90.2,84.0 to 94.1,308
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2020,Age,0-2 Days,77.0,68.7 to 83.5,308
Hep A,≥1 Dose,States/Local Areas,Mississippi,2020,Age,19 Months,68.2,59.5 to 75.8,308
Hep A,≥2 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,21.4,15.2 to 29.4,308
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2020,Age,0-1 Days,75.4,67.1 to 82.1,308
Hep A,≥2 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,60.1,47.9 to 72.6,308
Combined 7 Series,,States/Local Areas,Mississippi,2020,Age,35 Months,77.4,68.1 to 85.5,308
Hep A,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,31.7,26.5 to 37.7,632
Polio,≥2 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,91.0,84.3 to 95.0,308
Hep A,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,24 Months,67.5,61.8 to 73.1,632
Hep A,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,35 Months,73.8,67.3 to 79.8,632
Hep A,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,56.2,48.8 to 63.8,632
Influenza,,States/Local Areas,Mississippi,2019-2020,Age,24 Months,34.2,29.1 to 40.0,632
Hib,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,88.3,84.2 to 91.8,632
Hib,Primary Series,States/Local Areas,Mississippi,2019-2020,Age,24 Months,91.8,88.2 to 94.7,632
Combined 7 Series,,States/Local Areas,Mississippi,2019-2020,Age,35 Months,76.2,70.2 to 81.7,632
Hib,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,37.2,31.8 to 43.0,632
Hib,Full Series,States/Local Areas,Mississippi,2019-2020,Age,19 Months,70.5,65.0 to 75.5,632
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,90.0,85.6 to 93.1,632
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019-2020,Age,19 Months,84.9,79.9 to 88.9,632
PCV,≥4 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,75.4,69.5 to 80.4,632
Hep A,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,19 Months,65.2,59.3 to 70.7,632
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Mississippi,2019-2020,Age,0-2 Days,79.6,74.4 to 84.0,632
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Mississippi,2019-2020,Age,0-1 Days,76.4,71.0 to 81.0,632
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019-2020,Age,24 Months,90.8,86.6 to 94.1,632
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,91.1,87.2 to 94.2,632
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2019-2020,Age,0-3 Days,79.6,74.5 to 84.0,632
PCV,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,68.2,62.2 to 73.7,632
Hib,Full Series,States/Local Areas,Mississippi,2019-2020,Age,24 Months,76.7,71.5 to 81.6,632
PCV,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,91.2,87.3 to 94.3,632
PCV,≥4 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,81.9,76.7 to 86.7,632
Hep A,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,21.2,16.9 to 26.1,632
≥1 Dose MMR,,States/Local Areas,Mississippi,2019-2020,Age,19 Months,85.6,80.8 to 89.4,632
Hib,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,85.7,80.9 to 89.4,632
Hib,Primary Series,States/Local Areas,Mississippi,2019-2020,Age,19 Months,91.0,86.8 to 93.9,632
Hib,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,92.2,88.1 to 95.2,632
≥1 Dose MMR,,States/Local Areas,Mississippi,2019-2020,Age,35 Months,94.1,90.7 to 96.6,632
Hib,Full Series,States/Local Areas,Mississippi,2019-2020,Age,35 Months,81.8,76.6 to 86.5,632
Hib,Primary Series,States/Local Areas,Mississippi,2019-2020,Age,35 Months,93.4,89.5 to 96.2,632
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,92.9,89.0 to 95.8,632
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019-2020,Age,35 Months,94.1,90.7 to 96.6,632
PCV,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,92.4,88.5 to 95.3,632
PCV,≥4 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,84.9,79.6 to 89.5,632
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,91.0,87.0 to 94.2,632
DTaP,≥4 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,78.2,72.8 to 83.2,632
Polio,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,24 Months,90.8,86.9 to 94.0,632
Hep B,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,3 Months,96.9,94.8 to 98.2,632
≥1 Dose MMR,,States/Local Areas,Mississippi,2019-2020,Age,24 Months,90.3,86.2 to 93.6,632
PCV,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,3 Months,89.2,84.9 to 92.4,632
DTaP,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,5 Months,77.1,71.3 to 82.1,632
Polio,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,5 Months,76.9,71.1 to 81.8,632
Hib,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,5 Months,74.7,68.9 to 79.8,632
Polio,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,93.2,89.3 to 95.8,632
≥1 Dose MMR,,States/Local Areas,Mississippi,2019-2020,Age,13 Months,62.8,56.9 to 68.3,632
Hib,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,57.6,51.7 to 63.2,632
Hib,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,92.3,88.2 to 95.1,632
Hep B,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,94.2,90.9 to 96.4,632
Hib,Primary Series,States/Local Areas,Mississippi,2019-2020,Age,13 Months,84.7,80.1 to 88.3,632
Hep B,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,5 Months,89.5,85.2 to 92.6,632
PCV,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,5 Months,75.9,70.1 to 80.9,632
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,70.5,64.5 to 75.8,632
Polio,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,89.3,84.8 to 92.6,632
Hep B,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,87.0,82.3 to 90.6,632
Hib,≥2 Doses,States/Local Areas,Mississippi,2019-2020,Age,7 Months,88.4,83.7 to 91.8,632
≥1 Dose Varicella,,States/Local Areas,Mississippi,2019-2020,Age,13 Months,65.8,59.9 to 71.2,632
PCV,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,13 Months,87.4,82.3 to 91.2,632
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,94.5,90.8 to 97.0,632
DTaP,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,19 Months,90.4,86.0 to 93.5,632
Combined 7 Series,,States/Local Areas,Mississippi,2019-2020,Age,24 Months,69.4,63.6 to 75.0,632
DTaP,≥4 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,86.1,80.8 to 90.6,632
Polio,≥3 Doses,States/Local Areas,Mississippi,2019-2020,Age,35 Months,93.4,89.5 to 96.2,632
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,68.5,59.7 to 76.1,308
Hep B,≥1 Dose,States/Local Areas,Mississippi,2020,Age,3 Months,95.9,91.7 to 98.0,308
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,90.0,83.9 to 94.5,308
Polio,≥1 Dose,States/Local Areas,Mississippi,2020,Age,3 Months,90.2,84.0 to 94.1,308
Hib,≥1 Dose,States/Local Areas,Mississippi,2020,Age,3 Months,86.6,80.0 to 91.3,308
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,61.9,54.9 to 69.0,541
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,57.2,50.1 to 64.3,519
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,92.1,89.1 to 95.2,541
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.8,87.5 to 100.0,79
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,63.7,47.5 to 79.8,97
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.8,71.4 to 84.2,245
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.0,65.3 to 92.7,79
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,93.9,91.3 to 96.5,541
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,78.1,60.5 to 95.7,34
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,90.3,87.1 to 93.5,519
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,84.1,68.3 to 100.0,34
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,78.9,75.3 to 82.4,1120
Influenza,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,43.9,29.2 to 58.6,97
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,93.3,91.3 to 95.3,1120
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Overall,Overall,71.5,67.9 to 75.2,1120
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,75.4,67.1 to 83.6,281
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,93.9,92.0 to 95.8,1120
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,75.8,70.0 to 81.7,354
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Overall,Overall,91.2,88.9 to 93.4,1120
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,73.6,68.1 to 79.1,485
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,80.8,77.4 to 84.2,1120
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,67.8,61.5 to 74.1,354
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,70.0,60.7 to 79.2,281
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,60.5,53.6 to 67.4,485
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,94.9,92.4 to 97.4,485
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,92.2,88.7 to 95.7,354
Influenza,,States/Local Areas,Mississippi,2016-2019,Overall,Overall,43.3,39.3 to 47.4,1120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Overall,Overall,78.0,74.7 to 81.4,1120
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,93.1,89.8 to 96.3,354
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,57.3,52.2 to 62.4,1120
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Overall,Overall,68.0,64.0 to 71.9,1120
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,76.9,69.1 to 84.6,281
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Overall,Overall,89.7,87.3 to 92.2,1120
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,96.4,93.3 to 99.4,281
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,71.8,66.3 to 77.4,485
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,95.1,92.7 to 97.6,485
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,67.3,60.8 to 73.7,354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,81.3,75.8 to 86.8,354
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,95.2,92.0 to 98.4,281
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,94.8,92.3 to 97.4,485
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Overall,Overall,77.8,74.3 to 81.2,1120
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Overall,Overall,70.7,66.9 to 74.5,1120
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.9,70.8 to 82.9,388
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,87.2,83.0 to 91.5,509
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,96.2,93.1 to 99.3,281
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,93.5,90.8 to 96.2,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,80.6,75.9 to 85.2,509
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,72.0,63.4 to 80.6,223
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,74.4,66.8 to 82.1,223
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,91.9,88.6 to 95.3,509
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.7,92.2 to 97.2,388
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,90.9 to 98.3,223
Influenza,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,38.8,32.9 to 44.7,509
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.6,93.1 to 98.1,388
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.5,79.2 to 89.8,388
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,73.9,68.4 to 79.5,509
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,81.0,73.2 to 88.8,223
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,89.3,85.6 to 93.1,509
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.4,94.0 to 98.8,388
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,94.7,91.0 to 98.3,223
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,60.9,52.8 to 68.9,388
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,79.6,71.7 to 87.5,223
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,86.9 to 96.5,223
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,92.5,89.2 to 95.8,509
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,93.1,88.6 to 97.6,223
PCV,≥3 Doses,States/Local Areas,Mississippi,2021,Age,13 Months,79.3,68.7 to 87.0,197
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,59.9,48.8 to 71.1,223
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.9,69.3 to 80.5,388
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,70.4,64.8 to 75.9,509
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,69.1,60.7 to 77.5,223
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,68.1,59.4 to 76.9,223
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,71.0,64.6 to 77.4,388
Influenza,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,45.9,38.9 to 52.9,388
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.7,70.9 to 82.6,388
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,66.0,60.1 to 71.8,509
Influenza,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,49.2,40.3 to 58.1,223
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,85.9,80.9 to 91.0,388
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,77.8,72.7 to 83.0,509
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,89.2 to 95.7,388
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,93.7,90.9 to 96.5,509
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.7,93.1 to 98.3,388
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,93.5,90.5 to 96.5,509
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,92.4,87.7 to 97.1,223
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,62.7,56.0 to 69.4,354
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,70.6,64.8 to 76.3,485
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,91.2,86.5 to 95.8,223
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,86.9,79.9 to 94.0,281
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,82.1,77.1 to 87.1,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,73.6,66.4 to 80.7,281
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,76.4,71.3 to 81.4,485
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,49.6,41.2 to 58.0,354
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,95.7,91.8 to 99.6,281
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,91.6,88.2 to 94.9,485
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,92.3,88.8 to 95.9,354
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,94.0,92.1 to 96.0,1120
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Overall,Overall,94.1,92.3 to 96.0,1120
Influenza,,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,46.8,40.7 to 52.9,485
Influenza,,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,35.4,28.8 to 42.1,354
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,92.1,88.2 to 96.0,281
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,89.9,86.2 to 93.7,485
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,88.7,84.5 to 92.9,354
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,84.2,76.7 to 91.7,281
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,79.7,74.4 to 85.1,485
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,89.5,85.6 to 93.3,354
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,92.2,88.6 to 95.8,354
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,84.8,79.4 to 90.3,281
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,74.4,68.4 to 80.4,354
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Poverty,133% to <400% FPL,78.3,73.1 to 83.6,485
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,76.5,70.5 to 82.4,281
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Poverty,<133% FPL,77.3,71.6 to 82.9,354
Influenza,,States/Local Areas,Mississippi,2016-2019,Poverty,>400% FPL,55.4,46.8 to 63.9,281
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,94.1,91.3 to 96.8,519
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,67.3,61.8 to 72.8,519
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.2,92.0 to 96.4,699
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,90.8 to 95.4,699
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.8,64.7 to 74.9,699
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.8,89.1 to 94.5,699
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.1,82.2 to 92.0,245
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,78.1,73.7 to 82.6,541
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",63.8,56.6 to 70.9,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.7,70.4 to 83.0,245
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.0,70.7 to 79.2,699
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,80.7,76.2 to 85.2,519
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,86.1,76.1 to 96.2,97
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",89.0,84.5 to 93.6,245
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,71.9,51.8 to 92.0,34
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.9,89.6 to 100.0,79
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,89.1,85.6 to 92.6,519
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.6 to 97.4,541
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,76.2,71.3 to 81.1,541
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,78.1,60.5 to 95.7,34
Influenza,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,39.3,33.7 to 44.8,519
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.8,70.7 to 94.8,79
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,84.5,73.9 to 95.2,97
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,79.2,65.9 to 92.5,97
Influenza,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,37.6,16.1 to 59.1,34
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.1,75.0 to 95.1,79
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,25.1,6.7 to 43.5,34
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,63.3,57.7 to 68.8,519
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.9,68.5 to 81.2,245
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,65.8,43.2 to 88.3,34
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,59.4,43.6 to 75.3,97
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",74.6,70.2 to 79.1,699
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.9,60.9 to 74.9,245
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.8,57.7 to 85.9,79
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,79.0,61.9 to 96.2,34
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,67.9,52.0 to 83.9,97
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.0,71.4 to 90.7,79
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.1,81.4 to 88.8,699
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,66.4,50.1 to 82.7,97
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.8,71.6 to 84.1,245
PCV,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,57.5,35.5 to 79.5,34
Influenza,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",43.5,38.4 to 48.5,699
Influenza,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",36.6,23.3 to 50.0,79
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.0,91.6 to 100.0,79
Influenza,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",44.1,36.7 to 51.5,245
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,91.4 to 96.2,699
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.5,89.9 to 97.0,245
Influenza,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,52.2,46.4 to 57.9,541
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,87.1,77.2 to 97.0,97
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.1,91.5 to 96.6,699
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,95.3,93.4 to 97.3,541
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.8,90.6 to 97.1,245
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,74.8,69.6 to 80.0,519
PCV,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,82.7,66.7 to 98.7,34
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,94.1,91.5 to 96.7,519
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,57.0,35.0 to 79.0,34
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,73.8,61.1 to 86.4,97
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",68.7,61.9 to 75.4,245
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,74.8,69.8 to 79.9,519
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.7,77.8 to 85.6,699
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,55.3,33.8 to 76.8,34
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,95.0,93.0 to 97.0,541
Polio,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Any Medicaid,93.2,90.4 to 96.0,519
Hep A,≥1 Dose,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,54.7,32.4 to 76.9,34
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.0,77.8 to 86.2,699
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.7,92.4 to 97.0,699
≥1 Dose Varicella,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,77.6,60.2 to 94.9,34
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.0,91.6 to 100.0,79
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,89.1,79.8 to 98.5,97
DTaP,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.5,89.9 to 97.0,245
DTaP,≥4 Doses,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,87.7,84.1 to 91.3,541
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.0,90.7 to 97.3,245
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,Hispanic,91.3,82.2 to 100.0,97
Polio,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,3 Months,90.8,86.8 to 93.7,632
Hib,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,3 Months,88.2,84.0 to 91.4,632
DTaP,≥1 Dose,States/Local Areas,Mississippi,2019-2020,Age,3 Months,91.1,87.1 to 93.9,632
Rotavirus,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,65.8,59.8 to 71.8,509
≥1 Dose MMR,,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.7,90.8 to 96.7,388
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.7,76.3 to 87.1,388
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,75.0,69.6 to 80.3,509
Hib,Full Series,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,70.5 to 85.5,223
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Urbanicity,Living In a Non-MSA,53.5,45.9 to 61.1,509
Combined 7 Series,,States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Uninsured,45.8,23.7 to 67.8,34
Hep B,≥3 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.0,91.6 to 100.0,79
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2016-2019,Insurance Coverage,Private Insurance Only,74.5,69.5 to 79.5,541
Hep A,≥2 Doses,States/Local Areas,Mississippi,2016-2019,Race and Ethnicity,"White, Non-Hispanic",59.5,53.4 to 65.6,699
Hep B,≥2 Doses,States/Local Areas,Mississippi,2020,Age,5 Months,86.5,79.4 to 91.4,308
Hib,≥2 Doses,States/Local Areas,Mississippi,2020,Age,5 Months,71.6,62.8 to 79.0,308
Polio,≥2 Doses,States/Local Areas,Mississippi,2020,Age,5 Months,75.0,66.3 to 82.1,308
DTaP,≥2 Doses,States/Local Areas,Mississippi,2020,Age,5 Months,75.0,66.3 to 82.1,308
Combined 7 Series,,States/Local Areas,Mississippi,2020,Age,24 Months,67.5,58.9 to 75.9,308
PCV,≥1 Dose,States/Local Areas,Mississippi,2020,Age,3 Months,88.1,81.5 to 92.6,308
Hep A,≥2 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,33.0,25.1 to 42.5,308
Hep A,≥1 Dose,States/Local Areas,Mississippi,2020,Age,24 Months,69.8,61.4 to 77.7,308
PCV,≥4 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,78.7,70.7 to 85.8,308
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,92.0,85.4 to 96.4,308
PCV,≥3 Doses,States/Local Areas,Mississippi,2020,Age,24 Months,90.6,84.6 to 94.9,308
Rotavirus,,States/Local Areas,Mississippi,2020,Age,8 Months,66.5,57.7 to 74.3,308
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Mississippi,2020,Age,0-3 Days,77.0,68.8 to 83.6,308
Influenza,,States/Local Areas,Mississippi,2020,Age,24 Months,33.3,25.8 to 42.2,308
Hib,≥3 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,85.6,78.5 to 90.7,308
Polio,≥3 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,88.5,81.5 to 93.1,308
≥1 Dose MMR,,States/Local Areas,Mississippi,2020,Age,19 Months,83.9,76.2 to 89.4,308
DTaP,≥4 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,67.1,58.1 to 74.9,308
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,88.8,81.7 to 93.3,308
DTaP,≥3 Doses,States/Local Areas,Mississippi,2020,Age,7 Months,69.4,60.5 to 77.1,308
PCV,≥2 Doses,States/Local Areas,Mississippi,2020,Age,5 Months,74.0,65.3 to 81.1,308
PCV,≥3 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,86.3,78.9 to 91.4,308
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020,Age,13 Months,66.5,57.7 to 74.3,308
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,82.2,74.4 to 88.0,308
Hep B,≥2 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,92.2,86.2 to 95.8,308
Hib,Primary Series,States/Local Areas,Mississippi,2020,Age,13 Months,83.7,76.3 to 89.1,308
Hib,≥3 Doses,States/Local Areas,Mississippi,2020,Age,13 Months,59.0,50.3 to 67.2,308
PCV,≥3 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,93.8,87.9 to 97.4,308
PCV,≥4 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,83.3,74.7 to 90.4,308
PCV,≥4 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,73.5,64.8 to 80.7,308
Polio,≥3 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,92.3,85.7 to 96.5,308
DTaP,≥4 Doses,States/Local Areas,Mississippi,2020,Age,35 Months,84.3,75.1 to 91.4,308
PCV,≥3 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,90.6,83.9 to 94.6,308
≥1 Dose Varicella,,States/Local Areas,Mississippi,2020,Age,19 Months,82.3,74.2 to 88.3,308
Hep B,≥3 Doses,States/Local Areas,Mississippi,2020,Age,19 Months,87.7,80.7 to 92.4,308
DTaP,≥3 Doses,States/Local Areas,Missouri,2017,Age,19 Months,89.6,84.4 to 93.3,384
DTaP,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,91.8,88.4 to 94.3,800
DTaP,≥3 Doses,States/Local Areas,Missouri,2018,Age,19 Months,93.9,88.8 to 96.8,416
DTaP,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,87.5,83.5 to 90.7,818
Polio,≥2 Doses,States/Local Areas,Missouri,2020,Age,13 Months,93.8,89.9 to 96.2,390
Polio,≥3 Doses,States/Local Areas,Missouri,2019,Age,19 Months,86.2,80.1 to 90.7,402
Polio,≥3 Doses,States/Local Areas,Missouri,2011,Age,24 Months,93.9,87.9 to 97.5,228
Polio,≥3 Doses,States/Local Areas,Missouri,2012,Age,24 Months,94.3,89.3 to 97.4,274
Hib,≥3 Doses,States/Local Areas,Missouri,2014,Age,19 Months,89.7,84.2 to 93.5,241
Hib,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,86.8,82.3 to 90.3,476
Hib,≥3 Doses,States/Local Areas,Missouri,2013,Age,19 Months,87.4,81.9 to 91.4,208
Hib,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,19 Months,88.6,84.7 to 91.6,449
Polio,≥3 Doses,States/Local Areas,Missouri,2013,Age,24 Months,87.9,81.6 to 92.8,208
Polio,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,90.8,87.1 to 93.7,449
Hib,≥3 Doses,States/Local Areas,Missouri,2015,Age,19 Months,83.8,81.9 to 85.6,235
Hib,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,82.4,77.2 to 86.6,473
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.5,76.3 to 86.7,336
DTaP,≥3 Doses,States/Local Areas,Missouri,2016,Age,19 Months,87.6,81.2 to 92.0,238
DTaP,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,88.6,84.6 to 91.6,622
DTaP,≥3 Doses,States/Local Areas,Missouri,2014,Age,19 Months,93.8,89.6 to 96.3,241
DTaP,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,19 Months,90.2,86.2 to 93.2,476
DTaP,≥3 Doses,States/Local Areas,Missouri,2015,Age,19 Months,86.7,85.5 to 87.8,235
DTaP,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,19 Months,87.1,82.4 to 90.7,473
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,64.5,49.2 to 79.7,54
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Poverty,133% to <400% FPL,77.2,71.7 to 82.8,381
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Poverty,<133% FPL,66.6,59.8 to 73.3,280
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a Non-MSA,65.0,56.3 to 73.8,194
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Overall,Overall,75.1,71.4 to 78.8,912
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,74.1,68.2 to 80.0,382
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.7,73.6 to 81.8,662
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.9,63.3 to 84.5,97
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,78.5,66.9 to 90.1,82
Hib,Primary Series,States/Local Areas,Missouri,2012,Age,7 Months,70.7,66.0 to 75.0,274
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Poverty,>400% FPL,86.3,81.0 to 91.7,251
Hib,Primary Series,States/Local Areas,Missouri,2011,Age,7 Months,75.4,68.7 to 81.1,228
Polio,≥3 Doses,States/Local Areas,Missouri,2014,Age,35 Months,93.9,90.0 to 96.7,241
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,35 Months,94.6,89.5 to 97.7,476
Polio,≥3 Doses,States/Local Areas,Missouri,2013,Age,35 Months,94.2,86.8 to 98.2,208
Polio,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,35 Months,94.4,89.9 to 97.4,449
Polio,≥3 Doses,States/Local Areas,Missouri,2012,Age,35 Months,94.6,89.7 to 97.7,274
DTaP,≥2 Doses,States/Local Areas,Missouri,2013,Age,5 Months,73.4,69.1 to 77.3,208
DTaP,≥2 Doses,States/Local Areas,Missouri,2013-2014,Age,5 Months,73.4,70.8 to 75.8,449
DTaP,≥2 Doses,States/Local Areas,Missouri,2012,Age,5 Months,73.8,65.4 to 80.9,274
DTaP,≥2 Doses,States/Local Areas,Missouri,2011,Age,5 Months,78.7,71.9 to 84.3,228
Hib,Full Series,States/Local Areas,Missouri,2019,Age,24 Months,72.8,66.3 to 79.0,402
Polio,≥3 Doses,States/Local Areas,Missouri,2019,Age,35 Months,88.4,82.5 to 93.1,402
Hib,Full Series,States/Local Areas,Missouri,2013,Age,35 Months,78.4,69.5 to 86.1,208
Hib,Full Series,States/Local Areas,Missouri,2013-2014,Age,35 Months,80.9,75.2 to 86.0,449
Hib,Full Series,States/Local Areas,Missouri,2011,Age,35 Months,82.9,73.8 to 90.3,228
Hib,Full Series,States/Local Areas,Missouri,2012,Age,35 Months,86.1,79.0 to 91.7,274
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.5,73.3 to 93.7,71
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.5,90.0 to 97.0,336
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Urbanicity,Living In a MSA Principal City,89.2,84.8 to 93.6,382
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.1,88.2 to 94.0,662
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,82.6 to 98.3,97
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,Hispanic,88.9,81.4 to 96.5,82
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.1,47.6 to 74.7,71
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,69.4,63.3 to 75.6,331
Hib,Full Series,States/Local Areas,Missouri,2018,Age,35 Months,82.1,75.9 to 87.5,416
Hib,Full Series,States/Local Areas,Missouri,2018-2019,Age,35 Months,78.9,74.4 to 83.1,818
Hib,Full Series,States/Local Areas,Missouri,2019,Age,35 Months,75.4,68.7 to 81.6,402
Hib,Full Series,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,82.2,77.8 to 86.7,509
Hib,Full Series,States/Local Areas,Missouri,2014,Age,35 Months,83.1,75.8 to 89.2,241
Hib,Full Series,States/Local Areas,Missouri,2014-2015,Age,35 Months,81.6,76.4 to 86.2,476
Hib,Full Series,States/Local Areas,Missouri,2015,Age,35 Months,80.0,72.4 to 86.6,235
Hib,Full Series,States/Local Areas,Missouri,2015-2016,Age,35 Months,76.9,71.2 to 82.3,473
Hib,Full Series,States/Local Areas,Missouri,2016,Age,35 Months,73.9,65.2 to 81.9,238
Hib,Full Series,States/Local Areas,Missouri,2016-2017,Age,35 Months,76.8,71.3 to 81.8,622
Polio,≥3 Doses,States/Local Areas,Missouri,2011,Age,35 Months,93.9,87.9 to 97.5,228
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Uninsured,83.7,74.3 to 93.0,54
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Any Medicaid,86.7,82.0 to 91.3,331
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2017,Insurance Coverage,Private Insurance Only,93.7,90.9 to 96.6,509
Polio,≥3 Doses,States/Local Areas,Missouri,2018,Age,35 Months,96.5,91.2 to 99.0,416
Polio,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,35 Months,92.9,88.3 to 96.2,818
Hib,Full Series,States/Local Areas,Missouri,2017,Age,35 Months,79.7,73.4 to 85.3,384
Hib,Full Series,States/Local Areas,Missouri,2017-2018,Age,35 Months,81.0,76.7 to 85.0,800
Hib,Full Series,States/Local Areas,Missouri,2016,Age,24 Months,69.3,60.9 to 77.3,238
Hib,Full Series,States/Local Areas,Missouri,2016-2017,Age,24 Months,72.4,67.1 to 77.5,622
Hib,Full Series,States/Local Areas,Missouri,2018,Age,24 Months,78.3,72.2 to 83.9,416
Hib,Full Series,States/Local Areas,Missouri,2018-2019,Age,24 Months,75.7,71.2 to 79.9,818
Hib,Full Series,States/Local Areas,Missouri,2017,Age,24 Months,75.6,69.3 to 81.4,384
Hib,Full Series,States/Local Areas,Missouri,2017-2018,Age,24 Months,76.9,72.6 to 81.0,800
Hib,≥3 Doses,States/Local Areas,Missouri,2013,Age,24 Months,89.4,83.2 to 94.0,208
Hib,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,91.6,88.0 to 94.4,449
Hib,≥3 Doses,States/Local Areas,Missouri,2012,Age,24 Months,89.5,83.5 to 94.0,274
Hib,≥3 Doses,States/Local Areas,Missouri,2011,Age,24 Months,90.3,83.6 to 95.1,228
Hib,≥3 Doses,States/Local Areas,Missouri,2014,Age,24 Months,93.7,89.6 to 96.5,241
Hib,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,89.2,85.1 to 92.5,476
DTaP,≥3 Doses,States/Local Areas,Missouri,2012,Age,24 Months,94.8,89.8 to 97.8,274
Polio,≥3 Doses,States/Local Areas,Missouri,2018,Age,24 Months,93.5,88.9 to 96.7,416
Polio,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,24 Months,89.9,86.3 to 92.9,818
Polio,≥3 Doses,States/Local Areas,Missouri,2019,Age,24 Months,86.2,80.5 to 90.9,402
Hib,≥3 Doses,States/Local Areas,Missouri,2019,Age,19 Months,82.0,75.7 to 86.9,402
Polio,≥3 Doses,States/Local Areas,Missouri,2017,Age,24 Months,88.6,83.6 to 92.6,384
Polio,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,24 Months,91.1,87.8 to 93.8,800
DTaP,≥3 Doses,States/Local Areas,Missouri,2011,Age,24 Months,94.8,88.9 to 98.1,228
DTaP,≥3 Doses,States/Local Areas,Missouri,2019,Age,19 Months,87.0,81.0 to 91.3,402
DTaP,≥3 Doses,States/Local Areas,Missouri,2013,Age,24 Months,90.1,84.0 to 94.6,208
DTaP,≥3 Doses,States/Local Areas,Missouri,2013-2014,Age,24 Months,92.8,89.3 to 95.4,449
Hib,Full Series,States/Local Areas,Missouri,2015,Age,24 Months,75.5,67.8 to 82.5,235
Hib,Full Series,States/Local Areas,Missouri,2015-2016,Age,24 Months,72.5,66.7 to 78.0,473
Hib,≥3 Doses,States/Local Areas,Missouri,2017,Age,19 Months,82.6,76.5 to 87.3,384
Hib,≥3 Doses,States/Local Areas,Missouri,2017-2018,Age,19 Months,87.0,83.2 to 90.0,800
Polio,≥3 Doses,States/Local Areas,Missouri,2016,Age,24 Months,88.4,82.6 to 92.9,238
Polio,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,24 Months,88.5,84.8 to 91.7,622
Hib,≥3 Doses,States/Local Areas,Missouri,2016,Age,19 Months,81.0,73.5 to 86.8,238
Hib,≥3 Doses,States/Local Areas,Missouri,2016-2017,Age,19 Months,81.8,77.1 to 85.7,622
Hib,≥3 Doses,States/Local Areas,Missouri,2018,Age,19 Months,91.3,86.2 to 94.6,416
Hib,≥3 Doses,States/Local Areas,Missouri,2018-2019,Age,19 Months,66.4,61.5 to 70.8,818
Polio,≥3 Doses,States/Local Areas,Missouri,2015,Age,24 Months,88.8,82.5 to 93.6,235
Polio,≥3 Doses,States/Local Areas,Missouri,2015-2016,Age,24 Months,88.6,84.4 to 92.2,473
Polio,≥3 Doses,States/Local Areas,Missouri,2014,Age,24 Months,93.9,90.0 to 96.7,241
Polio,≥3 Doses,States/Local Areas,Missouri,2014-2015,Age,24 Months,91.4,87.8 to 94.3,476
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,85.4,77.8 to 90.7,262
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2021,Age,35 Months,92.8,85.3 to 97.3,262
Combined 7 Series,,States/Local Areas,IL-Rest of state,2021,Age,35 Months,66.8,57.9 to 75.4,262
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,88.8,81.8 to 93.3,262
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,92.1,85.7 to 96.4,262
Hib,Primary Series,States/Local Areas,IL-Rest of state,2021,Age,19 Months,90.5,84.0 to 94.6,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.7,70.5 to 92.9,67
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,93.4,89.4 to 97.3,246
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,87.9,85.1 to 90.7,851
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,88.3 to 97.7,196
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.7,81.3 to 88.2,773
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,90.1,86.3 to 94.0,398
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,96.6,95.2 to 98.1,851
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.6,81.3 to 88.0,773
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",76.3,64.3 to 88.4,67
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,85.2,79.4 to 90.9,246
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,91.4,87.9 to 94.9,398
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,72.6,67.1 to 78.0,398
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.7,63.2 to 88.2,67
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.2,94.2 to 98.2,773
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,74.5,70.5 to 78.6,851
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,91.4,87.1 to 95.7,246
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",77.5,65.4 to 89.5,67
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.5,53.3 to 71.6,196
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",43.8,29.9 to 57.7,67
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",65.6,60.9 to 70.2,773
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",67.2,53.9 to 80.6,67
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",87.1,83.8 to 90.4,773
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,84.0,78.4 to 89.5,246
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.2,95.7 to 98.7,773
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,67.4 to 83.2,196
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,75.0,68.1 to 81.8,246
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",53.2,39.3 to 67.0,67
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.3,60.8 to 77.7,196
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,66.8,59.5 to 74.2,246
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,68.5,62.8 to 74.1,398
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",76.2,72.2 to 80.2,773
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",64.9,51.5 to 78.3,67
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.1,66.0 to 82.3,196
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,81.8,76.1 to 87.5,246
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,93.1,89.1 to 97.2,246
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.5,76.6 to 90.3,196
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,42.9,36.9 to 48.8,398
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,85.2,82.0 to 88.4,851
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,97.5,96.2 to 98.9,851
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,90.8,87.0 to 94.5,398
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,88.7,84.7 to 92.6,398
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.4,86.2 to 96.7,196
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,90.8,86.2 to 95.5,246
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",86.6,77.1 to 96.1,67
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,78.3,73.4 to 83.2,398
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.2,80.7 to 87.7,773
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",59.1,45.5 to 72.8,67
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,78.5,74.9 to 82.1,851
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,61.8,56.0 to 67.7,398
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.9,56.9 to 82.8,67
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",87.0,77.8 to 96.2,67
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.9,79.3 to 86.5,773
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.2,89.6 to 94.7,773
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.1,89.5 to 94.7,773
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,78.5,74.8 to 82.3,851
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.7,70.5 to 81.0,773
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.9,96.4 to 99.3,773
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,80.6,75.6 to 85.5,539
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,75.7,69.4 to 82.0,279
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,77.8,74.8 to 80.9,1282
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,91.1,88.1 to 94.2,539
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,71.8,65.2 to 78.4,279
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,78.1,73.2 to 82.9,464
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,90.0,86.8 to 93.3,539
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,88.9,84.1 to 93.8,279
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,81.7,78.8 to 84.5,1282
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,88.6,83.8 to 93.4,279
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,80.0,75.3 to 84.7,464
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,88.1,83.4 to 92.9,279
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,91.3,88.4 to 94.2,539
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,90.0,86.5 to 93.6,464
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,95.6,93.3 to 97.9,539
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,44.4,37.2 to 51.5,279
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,93.1,91.2 to 94.9,1282
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,53.2,47.2 to 59.1,464
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,94.6,92.9 to 96.4,1282
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,89.3,84.6 to 94.1,279
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,95.0,92.6 to 97.4,539
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,89.8,86.2 to 93.5,464
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,61.0,52.6 to 69.5,279
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,80.0,75.4 to 84.6,464
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,76.9,72.0 to 81.8,539
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,81.9,77.2 to 86.5,464
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,90.5,85.4 to 95.6,260
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,93.4,90.7 to 96.2,539
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,75.4,70.1 to 80.8,464
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,69.9,63.4 to 76.4,279
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,93.0,88.4 to 97.6,260
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,92.6,86.2 to 98.9,128
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.1,89.9 to 94.4,894
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,93.8,87.8 to 99.7,128
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,94.2,91.4 to 96.4,750
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,93.7,88.4 to 97.1,750
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,92.7,89.7 to 94.9,750
Combined 7 Series,,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,70.1,65.7 to 74.4,750
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,94.8,92.1 to 96.8,750
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,87.9,84.2 to 90.9,750
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,60.2,55.6 to 64.6,750
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,88.3,84.9 to 91.0,750
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,89.9,86.3 to 92.6,750
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,89.8,86.2 to 92.6,750
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,73.7,69.3 to 77.7,750
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,5 Months,78.1,73.8 to 81.9,750
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,5 Months,90.7,87.5 to 93.1,750
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,86.6,82.9 to 89.7,750
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,95.4,93.1 to 97.0,750
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,94.1,91.3 to 96.1,750
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,69.0,64.6 to 73.2,750
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,68.6,64.1 to 72.8,750
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,94.2,91.4 to 96.1,750
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,5 Months,78.0,73.7 to 81.7,750
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,5 Months,79.4,75.2 to 83.1,750
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,5 Months,80.4,76.1 to 84.0,750
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,3 Months,86.9,83.2 to 89.8,750
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,3 Months,96.2,94.0 to 97.6,750
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,90.6,87.4 to 93.3,750
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,92.7,89.7 to 95.1,750
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,82.2,78.3 to 85.8,750
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,85.8,81.8 to 89.4,750
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,94.0,91.2 to 96.1,750
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,94.0,90.9 to 96.3,750
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,94.5,91.5 to 96.7,750
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,93.7,90.6 to 96.0,750
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,94.7,92.0 to 96.7,750
Hib,Full Series,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,82.7,78.5 to 86.5,750
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,95.2,92.1 to 97.3,750
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,93.1,90.1 to 95.5,750
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,92.3,89.3 to 94.6,750
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,88.0,84.4 to 90.8,750
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,88.1,84.6 to 90.9,750
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,30.5,26.5 to 34.9,750
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,81.7,77.8 to 85.4,750
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,92.0,88.9 to 94.5,750
Hib,Full Series,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,78.9,74.8 to 82.8,750
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,70.2,65.7 to 74.3,750
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2019-2020,Age,0-3 Days,81.4,77.6 to 84.7,750
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,89.5,86.2 to 92.3,750
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,92.2,89.3 to 94.5,750
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2019-2020,Age,0-2 Days,80.4,76.5 to 83.7,750
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2019-2020,Age,0-1 Days,77.5,73.5 to 81.1,750
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,81.2,77.1 to 84.6,750
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,78.7,74.5 to 82.3,750
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,87.2,83.5 to 90.1,750
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,91.8,88.7 to 94.1,750
Hib,Full Series,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,73.1,68.7 to 77.1,750
Combined 7 Series,,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,76.0,71.4 to 80.4,750
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,54.0,49.4 to 58.6,750
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,93.4,90.6 to 95.6,750
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,91.7,88.6 to 94.2,750
Influenza,,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,61.8,57.3 to 66.4,750
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,79.5,74.3 to 84.1,750
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,35 Months,91.2,87.7 to 94.0,750
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,85.5,81.9 to 88.8,750
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,24 Months,46.1,41.5 to 51.0,750
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,95.3,91.9 to 97.4,376
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,78.6,70.8 to 85.5,376
Combined 7 Series,,States/Local Areas,IL-Rest of state,2020,Age,35 Months,77.5,71.1 to 83.2,376
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,19 Months,82.7,77.1 to 87.2,376
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,33.3,27.5 to 39.7,376
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2020,Age,0-2 Days,81.2,75.8 to 85.7,376
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2020,Age,0-1 Days,79.6,74.0 to 84.2,376
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,92.5,88.2 to 95.4,376
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,93.0,88.6 to 95.7,376
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,3 Months,88.8,83.8 to 92.4,376
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,55.2,48.8 to 61.4,376
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020,Age,7 Months,77.7,71.8 to 82.6,376
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,92.6,88.6 to 95.3,376
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,95.0,91.5 to 97.4,376
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,5 Months,79.5,73.6 to 84.4,376
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,93.4,89.4 to 96.3,376
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,84.5,79.1 to 89.1,376
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020,Age,24 Months,93.9,89.8 to 96.8,376
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,92.9,88.5 to 96.0,376
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020,Age,35 Months,97.2,94.3 to 98.8,376
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,95.1,91.4 to 97.6,376
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020,Age,35 Months,96.6,93.8 to 98.3,376
Hib,Full Series,States/Local Areas,IL-Rest of state,2020,Age,35 Months,82.8,77.2 to 87.6,376
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,94.3,90.0 to 97.1,376
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020,Age,35 Months,96.8,93.7 to 98.6,376
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020,Age,19 Months,92.5,88.2 to 95.3,376
Hib,Full Series,States/Local Areas,IL-Rest of state,2020,Age,19 Months,74.4,68.2 to 79.7,376
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,91.3,86.8 to 94.4,376
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,92.0,87.6 to 94.9,376
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020,Age,19 Months,88.6,83.3 to 92.4,376
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,96.3,90.4 to 99.1,376
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,95.1,91.4 to 97.5,376
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,79.3,73.4 to 84.1,376
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,86.5,81.3 to 90.9,376
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,95.4,92.1 to 97.7,376
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020,Age,13 Months,85.4,79.9 to 89.6,376
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,67.3,61.0 to 73.1,376
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,95.1,91.8 to 97.2,376
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,88.1,83.1 to 91.7,376
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020,Age,13 Months,62.7,56.4 to 68.7,376
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,88.5,83.2 to 92.2,376
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,7 Months,77.4,71.4 to 82.5,376
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,93.3,89.2 to 96.0,376
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,73.3,67.0 to 78.8,376
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020,Age,19 Months,89.8,84.8 to 93.3,376
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,91.8,87.2 to 94.9,376
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,19 Months,88.9,83.7 to 92.6,376
Combined 7 Series,,States/Local Areas,IL-Rest of state,2020,Age,24 Months,72.3,66.3 to 78.0,376
Influenza,,States/Local Areas,IL-Rest of state,2020,Age,24 Months,58.4,52.0 to 65.0,376
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2020,Age,0-3 Days,82.6,77.2 to 86.9,376
Rotavirus,,States/Local Areas,IL-Rest of state,2020,Age,8 Months,78.5,72.6 to 83.4,376
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,35 Months,96.6,93.7 to 98.4,376
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,93.5,89.6 to 96.2,376
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,83.3,78.0 to 88.0,376
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,48.1,41.8 to 54.9,376
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,24 Months,87.0,81.9 to 91.3,376
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,3 Months,96.5,93.4 to 98.2,376
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,3 Months,86.7,81.7 to 90.6,376
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,5 Months,81.7,75.8 to 86.4,376
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,5 Months,80.5,74.6 to 85.3,376
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,5 Months,78.8,72.8 to 83.8,376
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,5 Months,90.7,86.2 to 93.8,376
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,92.8,89.6 to 95.3,638
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,5 Months,72.6,64.2 to 79.7,262
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,49.0,40.9 to 57.1,262
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,86.8,79.6 to 91.8,262
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,3 Months,88.1,84.5 to 90.9,750
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,3 Months,86.9,83.3 to 89.9,750
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2019-2020,Age,3 Months,89.1,85.7 to 91.8,750
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,75.2,70.9 to 79.1,750
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,57.9,53.3 to 62.3,750
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,13 Months,89.9,86.5 to 92.6,750
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,91.1,87.9 to 93.6,750
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,72.3,67.9 to 76.3,750
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.2,90.8 to 95.5,894
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,80.4,73.9 to 86.8,260
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.8,81.6 to 87.9,894
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,80.7,71.9 to 89.5,128
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,65.3,57.4 to 73.3,260
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,62.3,58.0 to 66.5,894
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,72.1,68.2 to 76.0,894
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,67.0,56.6 to 77.5,128
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,77.0,70.1 to 84.0,260
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.6,75.0 to 82.2,894
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,84.2,78.3 to 90.2,260
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.2,83.2 to 89.3,894
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,73.4,63.3 to 83.4,128
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,78.3,71.4 to 85.1,260
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,81.1,77.7 to 84.5,894
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,89.6 to 94.3,894
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,80.4,71.8 to 89.0,128
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,78.6,69.5 to 87.7,260
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,93.8,90.0 to 97.6,246
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",81.4,70.6 to 92.3,67
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,87.2 to 97.0,196
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.0,93.0 to 96.9,773
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,94.0,89.6 to 98.4,260
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.0,93.0 to 97.0,894
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,93.8,88.5 to 99.1,128
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,89.7,82.6 to 96.8,128
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,78.5,69.4 to 87.6,128
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,82.6,79.2 to 86.0,894
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,93.6,89.5 to 97.7,260
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,74.6,64.8 to 84.5,128
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,58.6,45.0 to 72.2,128
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.3,69.6 to 79.1,894
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,83.8,77.4 to 90.1,260
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,89.8,84.4 to 95.1,260
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.8,90.6 to 95.0,894
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,92.7,88.1 to 97.4,260
Influenza,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,35.5,25.3 to 45.8,128
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.2,92.1 to 96.3,894
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,69.4,62.0 to 76.9,260
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,94.3,89.2 to 99.4,128
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Principal City,75.5,68.7 to 82.3,260
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,94.6,91.8 to 97.4,464
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,97.3,95.8 to 98.8,539
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,71.0,67.7 to 74.3,1282
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,88.5,81.0 to 95.9,128
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a Non-MSA,81.1,72.4 to 89.8,128
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.7,75.2 to 82.2,894
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Overall,Overall,80.4,77.5 to 83.3,1282
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,133% to <400% FPL,92.0,88.6 to 95.3,464
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,96.3,94.5 to 98.0,539
Combined 7 Series,,States/Local Areas,IL-Rest of state,2011,Age,35 Months,71.0,63.8 to 77.8,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.5,75.8 to 83.2,773
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,3 Months,83.3,75.9 to 88.7,262
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,19 Months,82.8,76.9 to 87.4,327
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,80.8,76.6 to 84.4,667
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,19 Months,81.2,76.0 to 85.5,371
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,75.8,71.5 to 79.7,694
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,19 Months,70.5,66.6 to 74.1,323
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,76.7,72.1 to 80.7,650
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,87.1,79.6 to 92.1,262
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,93.9,84.4 to 98.5,638
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,3 Months,87.8,84.7 to 90.4,330
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,3 Months,91.5,89.2 to 93.4,339
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,3 Months,90.2,87.4 to 92.3,349
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,3 Months,92.0,90.8 to 93.1,720
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,3 Months,93.9,90.8 to 96.0,371
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,3 Months,91.2,88.1 to 93.5,694
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,3 Months,88.4,83.0 to 92.3,323
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,3 Months,89.3,85.7 to 92.1,650
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,3 Months,90.1,84.8 to 93.8,327
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,3 Months,90.8,87.5 to 93.3,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2021,Age,7 Months,67.2,58.7 to 74.6,262
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,5 Months,74.2,65.7 to 81.2,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,69.1,60.5 to 76.6,262
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,93.3,89.8 to 95.6,638
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,7 Months,85.2,77.2 to 90.7,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,91.9,87.7 to 94.7,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,91.9,88.4 to 94.7,638
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,85.9,81.4 to 89.4,638
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,19 Months,78.8,72.4 to 84.1,340
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,79.3,75.0 to 83.0,723
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,19 Months,79.8,73.8 to 84.7,383
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,78.3,73.0 to 82.8,613
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,96.2,92.9 to 98.2,349
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,96.3,94.3 to 97.7,720
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,93.7,88.7 to 97.0,330
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,97.4,94.8 to 98.9,339
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,96.6,93.9 to 98.3,371
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,96.2,94.0 to 97.7,694
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,18.7,16.0 to 21.7,339
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,28.8,23.8 to 34.3,349
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,26.2,22.8 to 29.8,720
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,23.5,18.6 to 29.2,371
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,22.3,18.8 to 26.2,694
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,20.7,17.9 to 23.8,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,89.6,84.7 to 93.5,383
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,89.9,86.6 to 92.7,757
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,90.3,85.4 to 94.0,374
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,21.1,18.9 to 23.6,323
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,23.8,20.0 to 28.2,650
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,26.5,20.7 to 33.2,327
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,24.5,20.5 to 28.9,667
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,96.4,93.1 to 98.4,349
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,94.0,91.5 to 96.1,720
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,92.0,87.9 to 95.0,371
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,92.0,89.1 to 94.4,694
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,92.1,87.7 to 95.4,323
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,93.5,90.6 to 95.8,650
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,22.3,17.3 to 28.4,340
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,23.8,20.2 to 27.8,723
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,24 Months,78.8,72.5 to 84.5,323
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,83.1,79.0 to 86.8,650
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,24 Months,87.4,82.4 to 91.6,327
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,84.4,80.5 to 87.8,667
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,5 Months,80.4,75.1 to 84.8,371
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,5 Months,78.0,76.4 to 79.5,694
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,5 Months,75.6,68.9 to 81.2,323
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,5 Months,79.7,75.4 to 83.5,650
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,5 Months,83.8,77.7 to 88.5,327
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,5 Months,83.3,79.3 to 86.7,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,92.4,87.9 to 95.8,383
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,92.8,89.7 to 95.3,757
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,93.1,88.6 to 96.3,374
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,24 Months,81.3,75.3 to 86.5,340
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,82.9,79.0 to 86.5,723
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,24 Months,84.5,79.3 to 89.1,383
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,84.3,80.7 to 87.6,757
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,24 Months,84.1,78.8 to 88.7,374
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,35 Months,87.5,82.6 to 91.5,339
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,5 Months,82.7,77.0 to 87.3,340
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,5 Months,81.2,77.2 to 84.6,723
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,35 Months,85.5,79.8 to 90.3,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,91.8,86.9 to 95.4,383
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,91.4,88.0 to 94.1,757
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,35.0,28.9 to 41.9,330
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.9,82.8 to 98.9,66
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,73.2,67.2 to 78.5,349
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,74.8,70.5 to 78.6,720
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,76.3,70.9 to 81.1,371
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,73.4,69.0 to 77.4,694
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,70.4,67.8 to 72.9,323
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,69.8,64.9 to 74.2,650
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,95.1,92.6 to 97.5,412
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,97.2,95.6 to 98.7,754
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,95.2,91.2 to 97.8,327
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,94.5,91.7 to 96.6,667
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,93.8,89.7 to 96.7,340
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,92.8,89.7 to 95.2,723
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,25.3,20.5 to 30.9,383
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,26.1,21.5 to 31.2,613
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,27.4,22.0 to 33.5,374
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,40.2,33.2 to 48.1,339
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,91.8,87.4 to 95.1,323
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,92.4,89.4 to 94.8,650
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,92.9,88.7 to 96.0,327
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,92.7,89.8 to 95.1,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,93.1,88.6 to 96.3,374
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,92.6,88.2 to 95.7,340
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,91.1,87.9 to 93.7,723
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,5 Months,86.3,81.2 to 90.3,340
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,5 Months,84.0,80.3 to 87.1,723
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,96.8,93.8 to 98.5,340
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,94.6,92.0 to 96.6,723
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,92.4,87.9 to 95.8,383
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,92.8,89.7 to 95.2,757
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,5 Months,78.6,72.2 to 83.9,374
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,97.1,94.5 to 99.7,119
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,5 Months,81.7,76.1 to 86.2,383
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,5 Months,80.2,76.0 to 83.8,757
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,99.0,98.1 to 99.9,464
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,91.7,88.6 to 94.8,426
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,93.8,90.6 to 96.9,313
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,94.8,93.3 to 96.3,1203
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,19 Months,74.4,69.6 to 78.7,349
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,77.8,73.7 to 81.4,720
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,19 Months,76.2,74.4 to 77.9,330
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,95.6,91.6 to 98.0,327
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,96.2,93.8 to 97.8,667
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,3 Months,89.5,84.3 to 93.2,374
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,19 Months,77.7,72.0 to 82.5,339
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,3 Months,91.5,86.9 to 94.6,340
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,3 Months,89.1,85.7 to 91.7,723
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,96.0,93.3 to 97.9,371
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,95.5,93.3 to 97.1,694
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,95.0,91.4 to 97.4,323
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,95.3,92.8 to 97.2,650
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,3 Months,86.6,81.2 to 90.6,383
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,3 Months,88.0,84.5 to 90.9,757
Hib,Full Series,States/Local Areas,IL-Rest of state,2021,Age,19 Months,66.1,57.7 to 73.5,262
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,81.0,76.2 to 85.5,638
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014,Age,19 Months,93.3,89.3 to 95.8,371
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,93.4,90.8 to 95.3,694
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013,Age,19 Months,95.0,93.0 to 96.5,349
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,94.1,92.8 to 95.3,720
Hib,Primary Series,States/Local Areas,IL-Rest of state,2012,Age,19 Months,89.9,86.3 to 92.7,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,93.7,88.8 to 97.0,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,97.1,94.3 to 98.8,339
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,19 Months,79.9,73.9 to 84.8,374
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,24 Months,81.7,76.6 to 86.2,339
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,24 Months,78.9,73.2 to 84.1,349
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,82.7,79.1 to 86.0,720
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,24 Months,86.6,82.2 to 90.4,371
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,82.7,78.8 to 86.2,694
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,24 Months,81.9,76.2 to 87.0,330
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016,Age,13 Months,89.6,84.2 to 93.3,327
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,90.0,86.5 to 92.7,667
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,72.4,68.3 to 76.1,339
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,73.2,70.5 to 75.6,330
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,96.8,93.8 to 98.5,340
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,94.6,92.0 to 96.6,723
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,5 Months,76.1,74.1 to 77.9,349
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,5 Months,78.2,77.1 to 79.3,720
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,5 Months,75.1,71.4 to 78.5,330
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,5 Months,84.0,80.7 to 86.8,339
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,95.8,92.1 to 98.1,323
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,96.0,93.5 to 97.8,650
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,96.1,92.1 to 98.4,327
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,96.4,94.0 to 98.0,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2011,Age,19 Months,95.8,93.5 to 97.3,339
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018,Age,13 Months,87.8,82.9 to 91.5,383
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,87.9,84.4 to 90.7,757
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019,Age,13 Months,87.9,82.4 to 91.8,374
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017,Age,13 Months,90.4,85.2 to 93.9,340
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,89.1,85.8 to 91.8,723
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016,Age,19 Months,94.2,89.4 to 96.8,327
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,93.9,90.9 to 95.9,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017,Age,19 Months,93.6,89.1 to 96.3,340
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,93.0,90.1 to 95.1,723
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015,Age,19 Months,93.6,85.5 to 97.3,323
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,93.9,91.0 to 95.9,650
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019,Age,19 Months,92.2,87.4 to 95.3,374
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018,Age,19 Months,92.4,88.0 to 95.3,383
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,87.9,84.4 to 90.7,757
Hib,Primary Series,States/Local Areas,IL-Rest of state,2012,Age,24 Months,92.1,87.5 to 95.4,330
Hib,Primary Series,States/Local Areas,IL-Rest of state,2011,Age,24 Months,95.9,93.1 to 97.8,339
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013,Age,24 Months,95.2,91.7 to 97.5,349
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,94.4,92.0 to 96.3,720
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018,Age,7 Months,73.8,67.8 to 79.1,383
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,73.4,69.0 to 77.3,757
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013,Age,13 Months,90.0,87.6 to 92.0,349
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,90.4,89.0 to 91.6,720
Hib,Primary Series,States/Local Areas,IL-Rest of state,2012,Age,13 Months,84.0,82.0 to 85.7,330
Hib,Primary Series,States/Local Areas,IL-Rest of state,2011,Age,13 Months,92.0,91.4 to 92.5,339
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019,Age,7 Months,73.0,66.5 to 78.6,374
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014,Age,13 Months,90.8,86.4 to 93.9,371
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,87.7,84.1 to 90.6,694
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015,Age,13 Months,84.7,78.5 to 89.3,323
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,87.1,83.1 to 90.3,650
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016,Age,7 Months,78.2,71.7 to 83.5,327
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,79.3,75.0 to 83.0,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017,Age,7 Months,80.4,74.4 to 85.3,340
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,77.1,73.0 to 80.8,723
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016,Age,35 Months,96.7,93.2 to 98.7,327
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,96.0,93.6 to 97.7,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017,Age,35 Months,95.2,91.3 to 97.7,340
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,94.4,91.9 to 96.4,723
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015,Age,35 Months,94.1,90.4 to 96.7,323
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,95.3,93.0 to 97.1,650
Combined 7 Series,,States/Local Areas,IL-Rest of state,2011,Age,24 Months,64.9,57.9 to 71.8,339
Combined 7 Series,,States/Local Areas,IL-Rest of state,2012,Age,24 Months,64.2,57.4 to 70.9,330
Combined 7 Series,,States/Local Areas,IL-Rest of state,2013,Age,24 Months,67.8,61.2 to 74.3,349
Combined 7 Series,,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,70.8,66.4 to 75.0,720
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014,Age,7 Months,76.5,71.0 to 81.3,371
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,74.3,70.0 to 78.2,694
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015,Age,7 Months,72.1,65.2 to 78.1,323
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,75.2,70.5 to 79.3,650
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013,Age,7 Months,71.7,70.1 to 73.2,349
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,74.1,72.5 to 75.6,720
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013,Age,35 Months,96.4,93.1 to 98.3,349
Hib,Primary Series,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,95.0,92.6 to 96.8,720
Hib,Primary Series,States/Local Areas,IL-Rest of state,2011,Age,35 Months,97.0,94.2 to 98.7,339
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019,Age,24 Months,92.7,88.2 to 95.9,374
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014,Age,35 Months,93.9,90.3 to 96.5,371
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,94.0,91.5 to 95.9,694
Hib,Primary Series,States/Local Areas,IL-Rest of state,2012,Age,35 Months,93.6,88.5 to 96.9,330
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014,Age,24 Months,93.6,90.0 to 96.2,371
Hib,Primary Series,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,93.7,91.3 to 95.7,694
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015,Age,24 Months,93.8,90.2 to 96.4,323
Hib,Primary Series,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,94.8,92.4 to 96.7,650
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018,Age,24 Months,93.7,89.9 to 96.5,383
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,93.2,90.4 to 95.4,757
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016,Age,24 Months,95.8,92.2 to 98.1,327
Hib,Primary Series,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,94.9,92.3 to 96.8,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017,Age,24 Months,93.9,89.8 to 96.7,340
Hib,Primary Series,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,93.8,91.1 to 95.9,723
Combined 7 Series,,States/Local Areas,IL-Rest of state,2019,Age,24 Months,67.8,61.3 to 74.0,374
Combined 7 Series,,States/Local Areas,IL-Rest of state,2018,Age,24 Months,68.4,62.2 to 74.5,383
Combined 7 Series,,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,68.1,63.7 to 72.5,757
Combined 7 Series,,States/Local Areas,IL-Rest of state,2017,Age,24 Months,73.3,66.8 to 79.4,340
Combined 7 Series,,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,70.9,66.4 to 75.3,723
Hib,Primary Series,States/Local Areas,IL-Rest of state,2019,Age,35 Months,92.7,88.3 to 96.0,374
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016,Age,24 Months,72.4,66.0 to 78.4,327
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,72.8,68.3 to 77.2,667
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018,Age,35 Months,93.7,89.9 to 96.5,383
Hib,Primary Series,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,93.2,90.4 to 95.5,757
Combined 7 Series,,States/Local Areas,IL-Rest of state,2015,Age,24 Months,69.9,63.1 to 76.5,323
Combined 7 Series,,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,71.1,66.4 to 75.7,650
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014,Age,24 Months,73.8,68.4 to 79.0,371
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,71.9,67.5 to 76.1,694
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014,Age,35 Months,78.0,71.9 to 83.5,371
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,77.3,72.4 to 81.8,694
Combined 7 Series,,States/Local Areas,IL-Rest of state,2012,Age,35 Months,73.6,66.5 to 80.3,330
Combined 7 Series,,States/Local Areas,IL-Rest of state,2013,Age,35 Months,73.8,66.9 to 80.2,349
Combined 7 Series,,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,75.9,71.3 to 80.2,720
Combined 7 Series,,States/Local Areas,IL-Rest of state,2017,Age,35 Months,77.6,70.9 to 83.7,340
Combined 7 Series,,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,77.1,72.5 to 81.4,723
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016,Age,35 Months,77.4,71.1 to 83.2,327
Combined 7 Series,,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,77.5,72.9 to 81.8,667
Hib,Full Series,States/Local Areas,IL-Rest of state,2015,Age,19 Months,74.0,70.0 to 77.6,323
Hib,Full Series,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,74.3,69.6 to 78.5,650
Hib,Full Series,States/Local Areas,IL-Rest of state,2016,Age,19 Months,74.5,67.9 to 80.2,327
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,77.1,72.6 to 81.0,667
Hib,Full Series,States/Local Areas,IL-Rest of state,2014,Age,19 Months,79.4,74.0 to 83.9,371
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,76.7,72.4 to 80.5,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020,Age,13 Months,70.5,64.3 to 76.1,376
Hib,Full Series,States/Local Areas,IL-Rest of state,2018,Age,19 Months,69.2,62.7 to 75.0,383
Hib,Full Series,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,95.9,93.6 to 97.4,757
Hib,Full Series,States/Local Areas,IL-Rest of state,2019,Age,19 Months,71.9,65.4 to 77.5,374
Hib,Full Series,States/Local Areas,IL-Rest of state,2017,Age,19 Months,79.7,73.5 to 84.8,340
Hib,Full Series,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,74.5,70.1 to 78.5,723
Hib,Full Series,States/Local Areas,IL-Rest of state,2014,Age,24 Months,83.5,78.6 to 87.8,371
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,81.7,77.7 to 85.2,694
Hib,Full Series,States/Local Areas,IL-Rest of state,2013,Age,24 Months,81.9,76.6 to 86.6,349
Hib,Full Series,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,82.7,79.2 to 86.0,720
Hib,Full Series,States/Local Areas,IL-Rest of state,2011,Age,24 Months,84.8,79.9 to 89.1,339
Hib,Full Series,States/Local Areas,IL-Rest of state,2012,Age,24 Months,77.8,71.3 to 83.6,330
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,73.9,66.8 to 81.0,234
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,73.9,70.3 to 77.6,850
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.0,73.4 to 80.6,737
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.4,65.0 to 81.8,162
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,74.2,71.1 to 77.2,1203
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,76.3,67.3 to 85.2,119
Hib,Full Series,States/Local Areas,IL-Rest of state,2013,Age,19 Months,77.5,70.5 to 83.1,349
Hib,Full Series,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,78.4,74.3 to 82.1,720
Hib,Full Series,States/Local Areas,IL-Rest of state,2012,Age,19 Months,74.4,71.5 to 77.1,330
Hib,Full Series,States/Local Areas,IL-Rest of state,2011,Age,19 Months,76.2,74.5 to 77.8,339
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,85.3,81.4 to 89.1,464
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,68.2,62.8 to 73.5,426
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,68.6,62.3 to 74.9,313
Combined 7 Series,,States/Local Areas,IL-Rest of state,2015,Age,35 Months,76.9,69.0 to 84.0,323
Combined 7 Series,,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,77.1,72.1 to 81.8,650
Combined 7 Series,,States/Local Areas,IL-Rest of state,2018,Age,35 Months,76.9,70.5 to 82.8,383
Combined 7 Series,,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,75.7,71.0 to 80.0,757
Combined 7 Series,,States/Local Areas,IL-Rest of state,2019,Age,35 Months,74.3,67.5 to 80.6,374
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,69.7,64.4 to 74.9,412
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,78.0,74.4 to 81.7,754
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",56.9,42.8 to 70.9,66
Combined 7 Series,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,74.5,67.9 to 81.2,238
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,7 Months,92.4,89.4 to 94.6,750
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,>400% FPL,96.9,95.0 to 98.9,539
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,78.9,72.2 to 85.6,234
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.7,78.3 to 85.1,737
Rotavirus,,States/Local Areas,IL-Rest of state,2011,Age,8 Months,74.1,67.2 to 79.9,339
Rotavirus,,States/Local Areas,IL-Rest of state,2014,Age,8 Months,77.7,72.2 to 82.4,371
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2015,Age,8 Months,75.3,70.9 to 79.1,694
Rotavirus,,States/Local Areas,IL-Rest of state,2012,Age,8 Months,71.0,64.2 to 77.0,330
Rotavirus,,States/Local Areas,IL-Rest of state,2013,Age,8 Months,75.6,69.1 to 81.1,349
Rotavirus,,States/Local Areas,IL-Rest of state,2013-2014,Age,8 Months,76.6,72.4 to 80.4,720
Rotavirus,,States/Local Areas,IL-Rest of state,2015,Age,8 Months,72.8,65.9 to 78.8,323
Rotavirus,,States/Local Areas,IL-Rest of state,2015-2016,Age,8 Months,74.9,70.1 to 79.1,650
Rotavirus,,States/Local Areas,IL-Rest of state,2016,Age,8 Months,77.0,70.2 to 82.6,327
Rotavirus,,States/Local Areas,IL-Rest of state,2016-2017,Age,8 Months,76.7,72.2 to 80.7,667
Hib,Full Series,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,77.7,72.7 to 82.4,638
Rotavirus,,States/Local Areas,IL-Rest of state,2017,Age,8 Months,76.5,70.1 to 81.9,340
Rotavirus,,States/Local Areas,IL-Rest of state,2017-2018,Age,8 Months,76.1,71.7 to 80.0,723
Rotavirus,,States/Local Areas,IL-Rest of state,2019,Age,8 Months,78.4,72.1 to 83.6,374
Rotavirus,,States/Local Areas,IL-Rest of state,2018,Age,8 Months,75.7,69.4 to 81.0,383
Rotavirus,,States/Local Areas,IL-Rest of state,2018-2019,Age,8 Months,77.0,72.7 to 80.8,757
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,83.8,80.4 to 87.1,754
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.7,66.4 to 83.0,162
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,77.3,71.1 to 83.5,238
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,70.2,64.9 to 75.4,412
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",58.1,44.6 to 71.6,66
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,71.9,66.1 to 77.8,313
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,77.7,74.7 to 80.6,1203
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,74.5,64.9 to 84.1,119
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.8,74.3 to 81.3,850
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,72.7,67.4 to 78.0,426
Rotavirus,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,87.8,84.1 to 91.5,464
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,86.2,81.5 to 89.8,638
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,91.5,87.6 to 94.3,638
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2020-2021,Age,0-2 Days,77.1,72.1 to 81.4,638
Hib,Full Series,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,80.0,75.0 to 84.7,638
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,88.5,83.9 to 91.9,638
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,89.2,85.0 to 92.3,638
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,5 Months,81.7,73.7 to 87.6,262
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,30.3,25.8 to 35.3,638
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,70.5,65.3 to 75.3,638
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2021,Age,19 Months,85.0,77.2 to 90.5,262
Hib,Full Series,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,70.2,65.0 to 75.0,638
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,5 Months,75.7,70.5 to 80.2,638
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,93.2,89.6 to 95.6,638
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2021,Age,13 Months,55.2,46.9 to 63.1,262
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,83.7,75.8 to 89.4,262
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,5 Months,72.2,63.6 to 79.4,262
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,5 Months,74.9,66.4 to 81.8,262
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,19 Months,89.8,82.5 to 94.3,262
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,65.9,60.6 to 70.8,638
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.1,88.4 to 97.7,196
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,77.5,71.0 to 84.0,246
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,76.2,71.0 to 81.4,398
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Poverty,<133% FPL,72.0,65.3 to 78.7,279
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,90.2,87.7 to 92.8,851
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.8,88.2 to 97.5,196
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,3 Months,94.6,89.7 to 97.3,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,89.7,84.6 to 93.3,376
Influenza,,States/Local Areas,IL-Rest of state,2013,Age,24 Months,52.9,46.4 to 59.7,349
Influenza,,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,55.4,51.0 to 60.0,720
Influenza,,States/Local Areas,IL-Rest of state,2016,Age,24 Months,57.0,50.0 to 64.2,327
Influenza,,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,58.2,53.2 to 63.2,667
Influenza,,States/Local Areas,IL-Rest of state,2015,Age,24 Months,53.0,46.2 to 60.2,323
Influenza,,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,55.0,50.0 to 60.1,650
Influenza,,States/Local Areas,IL-Rest of state,2014,Age,24 Months,58.0,51.9 to 64.1,371
Influenza,,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,55.5,50.9 to 60.2,694
Influenza,,States/Local Areas,IL-Rest of state,2011,Age,24 Months,53.2,46.3 to 60.5,339
Influenza,,States/Local Areas,IL-Rest of state,2012,Age,24 Months,39.2,33.0 to 46.0,330
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,Hispanic,72.2,63.7 to 80.6,246
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,88.1,85.3 to 90.9,851
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,81.7,76.9 to 86.4,398
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",69.0,51.0 to 87.1,67
Influenza,,States/Local Areas,IL-Rest of state,2019,Age,24 Months,64.8,58.3 to 71.2,374
Influenza,,States/Local Areas,IL-Rest of state,2018,Age,24 Months,61.8,55.5 to 68.2,383
Influenza,,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,63.3,58.8 to 67.9,757
Influenza,,States/Local Areas,IL-Rest of state,2017,Age,24 Months,59.4,52.5 to 66.5,340
Influenza,,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,60.6,55.9 to 65.4,723
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,42.8,37.1 to 48.4,412
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,69.9,65.6 to 74.1,754
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.6,71.1 to 86.2,196
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,61.2,53.1 to 69.3,234
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",62.4,58.0 to 66.8,737
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,43.6,32.7 to 54.4,119
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,58.8,54.7 to 62.9,850
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,83.3 to 94.3,196
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,77.6,72.6 to 82.6,464
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,51.5,45.5 to 57.4,426
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,42.9,36.5 to 49.4,313
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,74.8,69.6 to 80.1,398
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,57.7,54.2 to 61.2,1203
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,85.7,82.7 to 88.8,851
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Any Medicaid,89.3,85.2 to 93.3,398
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.5 to 97.9,851
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.9,62.6 to 83.2,196
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,58.9,53.7 to 64.0,638
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2021,Age,3 Months,85.3,77.9 to 90.6,262
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",62.9,53.5 to 72.3,162
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,50.5,42.9 to 58.1,238
Influenza,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",36.0,23.0 to 49.0,66
Influenza,,States/Local Areas,IL-Rest of state,2021,Age,24 Months,55.7,47.2 to 64.6,262
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,89.0,84.6 to 92.2,638
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,24 Months,94.3,88.4 to 97.8,262
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,87.4,82.8 to 90.9,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,91.7,85.6 to 95.9,262
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,86.8,82.1 to 90.4,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,52.1,46.8 to 57.3,638
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,3 Months,86.0,81.8 to 89.4,638
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2021,Age,13 Months,61.3,52.9 to 69.1,262
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,85.3,80.9 to 89.2,638
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,73.3,68.0 to 78.0,638
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,3 Months,86.3,82.1 to 89.7,638
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,76.6,69.3 to 83.3,638
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,93.5,90.2 to 96.0,638
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,90.9,84.2 to 95.0,262
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,90.1,86.2 to 93.3,638
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,5 Months,78.3,73.1 to 82.7,638
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,72.4,67.2 to 77.1,638
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,43.2,38.1 to 48.6,638
Hib,Primary Series,States/Local Areas,IL-Rest of state,2021,Age,35 Months,92.1,86.1 to 96.1,262
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,5 Months,86.2,81.7 to 89.7,638
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,90.6,86.5 to 93.8,638
Combined 7 Series,,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,72.6,66.8 to 78.1,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,63.6,55.2 to 71.2,262
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,70.0,64.7 to 74.9,638
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,92.9,89.0 to 95.7,638
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2021,Age,0-3 Days,74.6,66.3 to 81.4,262
Rotavirus,,States/Local Areas,IL-Rest of state,2021,Age,8 Months,70.8,62.3 to 78.1,262
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,94.5,91.1 to 96.9,638
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,90.8,86.6 to 93.8,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,87.8,83.5 to 91.2,638
Hib,Full Series,States/Local Areas,IL-Rest of state,2021,Age,35 Months,77.5,69.0 to 85.0,262
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,3 Months,84.6,80.3 to 88.1,638
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020-2021,Age,13 Months,84.1,79.6 to 87.8,638
Combined 7 Series,,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,67.2,61.9 to 72.4,638
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,94.5,88.5 to 97.9,262
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,95.3,91.3 to 97.8,638
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,83.3,78.3 to 87.8,638
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,93.8,90.3 to 96.4,638
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,89.1,84.5 to 92.4,638
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,93.0,89.1 to 95.9,638
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,5 Months,76.3,71.1 to 80.9,638
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,90.7,86.9 to 93.5,638
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,90.1,85.7 to 93.2,638
Hib,Primary Series,States/Local Areas,IL-Rest of state,2021,Age,13 Months,82.9,75.5 to 88.4,262
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,76.8,71.6 to 81.3,638
Influenza,,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,57.0,51.7 to 62.4,638
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,89.6,82.7 to 94.6,262
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,80.0,70.1 to 88.3,262
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,7 Months,56.8,51.6 to 61.8,638
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,93.3,89.8 to 96.0,638
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2021,Age,13 Months,91.4,84.8 to 95.3,262
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,94.7,91.5 to 97.0,638
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,95.5,92.3 to 97.7,638
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2020-2021,Age,0-1 Days,74.3,69.2 to 78.8,638
Combined 7 Series,,States/Local Areas,IL-Rest of state,2021,Age,24 Months,62.0,53.6 to 70.4,262
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020-2021,Age,35 Months,94.3,91.0 to 96.7,638
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2021,Age,35 Months,93.8,87.8 to 97.5,262
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2021,Age,35 Months,92.5,84.8 to 97.1,262
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2020-2021,Age,24 Months,79.5,74.5 to 84.1,638
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2020-2021,Age,0-3 Days,78.6,73.7 to 82.8,638
Rotavirus,,States/Local Areas,IL-Rest of state,2020-2021,Age,8 Months,74.6,69.4 to 79.2,638
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,19 Months,80.2,75.3 to 84.3,638
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,3 Months,95.6,92.9 to 97.3,638
DTaP,≥1 Dose,States/Local Areas,IL-Rest of state,2020-2021,Age,3 Months,87.5,83.3 to 90.8,638
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,90.1,84.9 to 93.7,374
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,96.4,94.7 to 97.5,339
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,94.7,93.1 to 96.0,349
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,94.9,92.5 to 96.6,720
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,90.4,86.3 to 93.4,330
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019-2020,Age,19 Months,90.8,87.5 to 93.3,750
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,93.9,92.6 to 95.0,349
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,92.0,90.1 to 93.5,720
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,92.2,87.3 to 95.3,330
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,95.9,93.8 to 97.3,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2018,Age,0-3 Days,78.3,72.4 to 83.3,383
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2018-2019,Age,0-3 Days,79.4,75.4 to 82.9,757
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,72.0,65.1 to 77.9,323
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,74.6,69.9 to 78.8,650
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,77.2,70.7 to 82.6,327
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,78.4,74.1 to 82.1,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,79.6,73.7 to 84.5,340
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,97.2,96.4 to 97.8,349
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,96.7,94.4 to 98.0,720
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,96.5,93.6 to 98.4,340
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,94.7,92.1 to 96.7,723
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,92.9,88.3 to 96.1,383
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,92.8,89.4 to 95.4,757
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,57.6,51.4 to 63.5,371
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,54.8,50.2 to 59.3,694
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,52.0,45.1 to 58.9,323
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,55.5,50.5 to 60.3,650
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,58.9,51.8 to 65.6,327
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,60.9,56.0 to 65.6,667
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,3 Months,90.7,86.1 to 93.9,340
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,3 Months,88.5,85.1 to 91.2,723
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,3 Months,86.3,80.9 to 90.3,383
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,3 Months,87.4,83.7 to 90.3,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,92.7,87.2 to 96.4,374
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,96.1,92.7 to 97.9,371
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,3 Months,88.5,82.9 to 92.4,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2019,Age,0-3 Days,80.5,74.9 to 85.1,374
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,70.3,66.2 to 74.4,754
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2020,Age,24 Months,92.2,87.6 to 95.5,376
Hib,Primary Series,States/Local Areas,IL-Rest of state,2020,Age,24 Months,94.2,90.5 to 96.8,376
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,75.6,70.9 to 80.3,412
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.9,56.4 to 81.3,66
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,73.8,67.6 to 79.3,383
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,72.0,67.5 to 76.1,757
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,70.1,63.5 to 76.0,374
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,76.8,72.5 to 80.5,723
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,63.0,56.1 to 69.4,340
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,59.7,55.0 to 64.2,723
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,56.3,49.8 to 62.6,383
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,54.6,50.0 to 59.1,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.9,87.3 to 96.5,162
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,93.2,89.4 to 97.0,238
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.3,74.6 to 96.1,66
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,92.5,89.3 to 95.7,412
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,95.7,93.8 to 97.6,754
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.5,90.3 to 94.6,850
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,87.6,81.9 to 91.7,374
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,93.9,89.5 to 96.6,323
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,94.9,92.1 to 96.7,650
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,95.8,91.6 to 98.0,327
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,96.1,93.7 to 97.6,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,93.5,91.4 to 95.2,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,77.8,71.7 to 83.8,238
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,95.0,92.4 to 96.8,694
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,72.8,67.1 to 78.4,313
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,89.0,83.4 to 92.9,323
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,90.6,86.9 to 93.3,650
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,87.4,84.5 to 89.8,330
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,93.9,90.1 to 96.3,383
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,94.0,91.3 to 95.9,757
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,96.5,93.2 to 98.2,340
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,95.2,92.9 to 96.8,723
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,94.1,89.5 to 96.7,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,92.4,88.6 to 96.1,313
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,93.9,92.2 to 95.7,1203
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,96.5,93.6 to 99.4,119
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.8,91.7 to 95.8,850
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,93.5,91.7 to 94.9,349
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,93.9,91.5 to 95.6,720
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,94.3,90.5 to 96.6,371
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,91.6,88.4 to 94.0,694
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",71.7,67.8 to 75.6,737
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",67.5,58.7 to 76.2,162
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,72.0,69.0 to 75.1,1203
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,73.6,64.0 to 83.1,119
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,69.7,62.6 to 76.8,234
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.5,68.9 to 76.0,850
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,92.1,87.0 to 95.3,327
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,92.8,89.6 to 95.1,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,93.5,89.1 to 96.2,340
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,91.1,87.8 to 93.6,723
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,88.7,83.3 to 92.5,383
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,89.4,85.9 to 92.1,757
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,52.9,46.3 to 59.4,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,93.0,88.4 to 97.7,234
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.0,94.3 to 97.7,737
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,88.6,82.5 to 92.8,330
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,69.8,64.6 to 75.1,464
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,73.5,68.6 to 78.4,426
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,79.0,74.5 to 82.9,349
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,76.6,74.9 to 78.3,720
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,93.8,90.7 to 95.9,339
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,98.4,96.8 to 100.0,464
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,90.9,87.6 to 94.2,426
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,74.2,68.3 to 79.4,371
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,71.0,66.6 to 75.1,694
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,83.6,79.9 to 86.8,339
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,77.1,74.8 to 79.3,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,67.8,61.0 to 73.9,323
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,69.8,65.1 to 74.2,650
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,71.8,65.1 to 77.7,327
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,74.2,69.6 to 78.3,667
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,76.7,70.3 to 82.1,340
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,73.0,68.6 to 77.1,723
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,92.5,90.1 to 94.3,349
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,93.2,90.6 to 95.1,720
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,93.9,90.2 to 96.3,371
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,92.7,89.8 to 94.8,694
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,91.5,87.5 to 94.4,323
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,91.9,88.6 to 94.3,650
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,89.3,84.1 to 93.0,383
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,69.7,65.2 to 73.9,757
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,69.3,62.9 to 75.0,383
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,69.9,65.4 to 74.0,757
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,92.3,87.1 to 95.5,327
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,93.3,90.1 to 95.5,667
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,94.3,90.0 to 96.9,340
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,91.9,88.6 to 94.2,723
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,70.5,64.1 to 76.2,374
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2020,Age,13 Months,94.2,90.2 to 96.6,376
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,89.5,85.8 to 92.2,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,94.6,92.2 to 96.2,339
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016,Age,35 Months,96.4,92.9 to 98.5,327
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,94.5,91.8 to 96.5,667
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013,Age,35 Months,94.4,90.6 to 97.1,349
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,93.3,90.5 to 95.4,720
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2011,Age,35 Months,97.4,93.7 to 99.2,339
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2012,Age,35 Months,92.1,87.6 to 95.4,330
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019,Age,24 Months,87.6,82.6 to 91.7,374
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,78.1,71.8 to 83.9,323
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,82.0,77.8 to 85.8,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,84.6,79.9 to 88.8,371
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,81.4,77.4 to 85.1,694
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,82.6,76.7 to 87.7,349
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,83.6,79.9 to 87.0,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,92.3,87.9 to 95.5,374
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,93.4,90.6 to 95.6,723
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,93.0,88.3 to 96.3,339
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,82.1,76.3 to 87.2,330
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2017,Age,0-2 Days,76.5,69.9 to 82.0,340
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2017-2018,Age,0-2 Days,76.4,72.0 to 80.2,723
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2018,Age,0-2 Days,76.2,70.1 to 81.4,383
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2018-2019,Age,0-2 Days,78.0,73.9 to 81.6,757
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2019,Age,0-2 Days,79.8,74.2 to 84.5,374
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,88.1,84.3 to 91.2,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,89.3,84.3 to 92.9,383
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,88.9,85.5 to 91.6,757
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,88.5,83.4 to 92.3,374
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,87.8,84.9 to 90.3,339
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018,Age,35 Months,95.1,91.1 to 97.6,383
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,93.8,90.6 to 96.2,757
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017,Age,35 Months,92.7,88.3 to 95.9,340
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,93.8,90.9 to 96.0,723
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.7,87.0 to 96.3,162
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,92.5,88.3 to 96.7,238
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,3 Months,86.9,83.4 to 89.8,349
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,3 Months,89.4,86.6 to 91.7,720
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,3 Months,86.7,83.9 to 89.0,330
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,3 Months,90.7,87.2 to 93.3,339
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,95.9,91.6 to 98.0,327
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,96.3,93.9 to 97.8,667
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,94.9,91.2 to 97.2,323
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,95.4,92.8 to 97.1,650
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,3 Months,91.9,88.4 to 94.4,371
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,3 Months,90.0,86.9 to 92.4,694
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,96.2,93.7 to 97.7,371
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,95.6,93.5 to 97.0,694
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,87.4,81.6 to 91.5,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,93.0,91.5 to 94.3,339
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,91.1,88.3 to 93.3,349
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,91.8,89.6 to 93.6,720
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,92.5,88.3 to 95.3,371
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,91.8,88.6 to 94.1,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,92.5,87.9 to 95.8,327
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,92.9,89.8 to 95.2,667
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,80.2,74.4 to 85.5,374
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,83.0,77.4 to 87.9,383
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,81.7,77.7 to 85.4,757
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,82.3,76.0 to 87.8,339
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,84.1,78.4 to 89.1,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,95.3,91.8 to 97.6,383
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,94.3,91.6 to 96.4,757
Hib,Full Series,States/Local Areas,IL-Rest of state,2020,Age,24 Months,81.0,75.4 to 86.0,376
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,90.1,86.2 to 93.0,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,93.4,89.1 to 96.4,340
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,94.3,91.6 to 96.3,723
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019,Age,35 Months,92.3,86.9 to 96.1,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,91.8,88.8 to 94.8,412
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,94.0,91.8 to 96.2,754
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.2,82.8 to 99.6,66
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016,Age,35 Months,93.8,89.7 to 96.7,327
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,93.7,90.8 to 95.9,667
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014,Age,35 Months,92.9,89.1 to 95.8,371
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,92.5,89.5 to 94.8,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015,Age,35 Months,92.3,87.5 to 95.8,323
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,93.0,90.0 to 95.4,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,85.0,79.6 to 89.6,340
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,84.0,80.2 to 87.4,723
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,85.9,80.4 to 90.5,327
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,85.4,81.7 to 88.8,667
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,92.2,87.3 to 95.4,374
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,94.8,93.0 to 96.1,339
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,95.3,93.8 to 96.4,349
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,95.7,94.9 to 96.5,720
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,93.5,90.6 to 95.5,330
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,91.6,87.1 to 94.6,340
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,90.3,87.0 to 92.8,723
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,89.0,83.6 to 92.7,383
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,88.2,84.5 to 91.1,757
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,93.6,88.3 to 97.0,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,93.2,88.0 to 96.7,323
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,92.7,89.3 to 95.3,650
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,95.5,92.9 to 97.4,371
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,94.1,91.4 to 96.2,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,94.5,91.3 to 96.8,349
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,95.1,93.2 to 96.7,720
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,92.7,88.9 to 96.6,234
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.8,90.6 to 95.1,737
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,92.7,90.3 to 95.1,754
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019,Age,35 Months,93.5,88.0 to 97.0,374
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,87.9,82.0 to 92.6,349
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,87.0,83.3 to 90.3,720
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018,Age,35 Months,94.7,90.7 to 97.3,383
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,94.0,90.9 to 96.4,757
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017,Age,35 Months,93.6,89.1 to 96.7,340
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,94.1,91.2 to 96.3,723
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,3 Months,88.1,82.8 to 91.9,323
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,3 Months,88.1,84.5 to 91.0,650
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,3 Months,88.2,82.6 to 92.1,327
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,3 Months,89.4,85.9 to 92.1,667
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,3 Months,90.7,86.1 to 93.9,340
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,3 Months,87.7,84.2 to 90.5,723
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,96.7,93.6 to 98.4,340
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,96.4,94.3 to 97.7,723
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,96.0,92.8 to 97.9,383
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,95.9,93.6 to 97.4,757
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,95.7,91.8 to 97.8,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,91.0,89.4 to 92.4,323
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,91.6,87.9 to 94.2,650
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,92.2,86.7 to 95.5,327
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,93.6,90.4 to 95.8,667
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,88.8,85.0 to 92.5,426
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,92.4,89.2 to 95.7,313
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,92.5,90.6 to 94.3,1203
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,92.6,86.9 to 98.2,119
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.4,90.1 to 94.6,850
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,3 Months,84.6,79.0 to 89.0,383
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,3 Months,86.3,82.5 to 89.3,757
Hib,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,3 Months,88.0,82.5 to 91.9,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,96.1,93.9 to 98.3,464
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.3,89.0 to 93.6,850
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,93.7,90.0 to 97.4,234
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.6,90.3 to 94.8,737
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,95.0,91.2 to 97.3,340
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,92.8,89.7 to 95.0,723
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,92.5,88.2 to 95.7,374
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.7,88.3 to 97.1,162
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,90.6,86.1 to 95.2,238
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.4,81.7 to 99.2,66
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,92.8,90.1 to 95.4,412
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,87.3,81.9 to 91.8,327
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,87.0,83.2 to 90.3,667
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,84.3,77.0 to 90.3,323
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,85.8,81.2 to 89.7,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,86.5,81.7 to 90.6,371
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,85.1,80.9 to 88.8,694
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,92.1,87.5 to 95.4,323
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,92.8,89.5 to 95.3,650
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,93.4,90.0 to 96.0,371
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,92.8,90.0 to 95.0,694
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,90.7,85.5 to 94.6,330
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,5 Months,86.0,80.9 to 90.0,340
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,5 Months,82.9,79.2 to 86.2,723
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,91.1,85.8 to 95.1,349
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,92.3,89.2 to 94.8,720
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,3 Months,83.2,77.5 to 87.7,349
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,3 Months,87.1,83.9 to 89.8,720
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,82.7,77.2 to 88.2,238
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.3,52.8 to 79.8,66
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,79.6,75.0 to 84.2,412
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,5 Months,79.8,73.5 to 85.0,323
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,5 Months,80.6,76.3 to 84.3,650
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,5 Months,81.4,75.1 to 86.4,327
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,5 Months,83.7,79.7 to 87.0,667
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,90.6,85.3 to 94.1,383
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,88.2,84.5 to 91.1,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,89.7,84.3 to 93.4,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,93.0,89.1 to 96.0,339
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,5 Months,78.3,77.5 to 79.1,349
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,5 Months,80.5,78.1 to 82.6,720
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,5 Months,82.7,77.6 to 86.8,371
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,5 Months,81.2,78.2 to 84.0,694
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,3 Months,85.0,81.5 to 87.9,330
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,3 Months,88.5,85.9 to 90.7,339
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,95.8,93.6 to 98.0,464
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,88.0,84.2 to 91.7,426
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,92.0,88.6 to 95.4,313
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,92.0,90.1 to 93.8,1203
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,93.0,87.8 to 98.1,119
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,87.6,81.6 to 92.4,383
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,86.6,82.3 to 90.3,757
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,85.2,78.9 to 90.4,374
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,5 Months,78.1,75.9 to 80.2,330
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,5 Months,85.8,84.2 to 87.2,339
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,86.6,81.1 to 91.2,340
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,86.9,83.0 to 90.4,723
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,94.1,91.5 to 96.8,464
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,80.9,76.6 to 85.3,426
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,80.0,74.7 to 85.4,313
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,85.2,82.7 to 87.7,1203
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,87.3,80.6 to 94.0,119
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.2,82.3 to 88.1,850
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,92.1,86.8 to 95.4,349
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,92.9,89.2 to 95.4,720
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,93.7,89.9 to 96.1,371
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,91.6,88.5 to 94.0,694
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2012,Age,0-3 Days,69.3,62.5 to 75.3,330
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,84.0,77.9 to 90.2,234
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2011,Age,0-3 Days,63.1,55.8 to 69.9,339
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,3 Months,86.0,80.6 to 90.1,383
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,3 Months,86.5,82.7 to 89.6,757
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,92.5,89.6 to 95.4,412
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,5 Months,79.8,74.0 to 84.6,383
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,5 Months,78.3,74.0 to 82.0,757
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,5 Months,76.7,70.2 to 82.2,374
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,94.0,92.0 to 95.5,339
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,93.5,88.8 to 96.6,327
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,94.4,91.6 to 96.5,667
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,87.8,85.1 to 90.0,330
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,95.4,91.9 to 97.7,340
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,93.6,90.8 to 95.8,723
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,91.8,87.1 to 95.3,383
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,91.2,88.0 to 93.9,757
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2015,Age,0-3 Days,68.4,61.6 to 74.4,323
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2015-2016,Age,0-3 Days,71.4,66.8 to 75.6,650
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014,Age,0-3 Days,70.1,64.2 to 75.4,371
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2014-2015,Age,0-3 Days,69.2,64.8 to 73.3,694
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,73.7,69.9 to 77.3,349
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,74.5,72.8 to 76.2,720
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,68.2,65.7 to 70.7,330
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,80.9,78.6 to 83.0,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2013,Age,0-3 Days,64.9,58.1 to 71.1,349
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2013-2014,Age,0-3 Days,67.5,63.0 to 71.7,720
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,3 Months,86.4,83.0 to 89.3,349
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,3 Months,88.5,86.1 to 90.6,720
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,3 Months,87.0,81.3 to 91.2,374
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,92.2,88.7 to 95.6,313
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,93.1,91.4 to 94.7,1203
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,3 Months,85.8,81.4 to 89.3,330
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,3 Months,89.8,86.2 to 92.6,339
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,89.6,84.1 to 93.4,323
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,90.7,87.2 to 93.4,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,89.7,87.0 to 92.4,754
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,94.1,92.1 to 96.1,754
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.9,74.2 to 93.6,66
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,3 Months,89.4,83.9 to 93.1,327
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,3 Months,89.2,85.7 to 92.0,667
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,3 Months,89.1,84.0 to 92.7,340
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,3 Months,87.6,84.0 to 90.4,723
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.3,86.8 to 91.9,737
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.2,77.8 to 90.6,162
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,3 Months,91.1,87.6 to 93.8,371
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,3 Months,87.5,84.1 to 90.3,694
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,3 Months,83.9,77.9 to 88.6,323
PCV,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,3 Months,86.7,82.8 to 89.8,650
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,90.6,85.7 to 94.4,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,93.4,89.4 to 96.3,339
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,95.7,91.6 to 98.1,349
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,94.2,91.6 to 96.3,720
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,91.8,86.9 to 95.4,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.2,86.3 to 96.2,162
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,95.0,91.8 to 98.2,238
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,93.1,89.3 to 96.9,234
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.3,92.5 to 96.1,737
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,97.1,94.5 to 99.7,119
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,86.9,81.6 to 90.9,383
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,87.3,83.5 to 90.2,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,93.4,90.0 to 96.0,371
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,93.9,91.0 to 96.1,694
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,94.7,89.9 to 97.7,323
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,94.4,91.4 to 96.6,650
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,93.5,88.8 to 96.6,327
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,95.2,92.5 to 97.1,667
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,91.8,86.6 to 95.2,327
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,92.7,89.5 to 94.9,667
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,93.6,89.5 to 96.1,340
Hib,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,90.3,87.1 to 92.7,723
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,75.3,69.5 to 80.3,371
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,73.6,69.2 to 77.6,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,96.6,95.1 to 98.2,464
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,90.3,86.9 to 93.7,426
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,56.4,54.7 to 58.1,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,71.6,67.1 to 75.7,339
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,55.6,53.0 to 58.1,349
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,56.6,54.6 to 58.5,720
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,3 Months,90.7,87.0 to 93.4,371
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,3 Months,88.8,85.7 to 91.3,694
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,3 Months,87.0,81.7 to 90.9,323
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,3 Months,87.5,83.9 to 90.5,650
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,3 Months,88.1,82.5 to 92.1,327
Polio,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,3 Months,89.4,85.9 to 92.1,667
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2017,Age,0-3 Days,82.0,73.3 to 88.2,180
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2017-2018,Age,0-3 Days,78.4,74.1 to 82.1,723
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016,Age,0-3 Days,74.4,67.8 to 80.1,327
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-Rest of state,2016-2017,Age,0-3 Days,76.4,71.8 to 80.3,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,95.9,94.6 to 97.3,1203
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,40.2,33.4 to 47.8,323
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,44.2,39.2 to 49.5,650
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,41.5,35.4 to 48.2,371
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,40.8,36.2 to 45.8,694
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,35 Months,87.0,81.2 to 91.8,349
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,88.1,84.6 to 91.2,720
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,35 Months,89.5,85.2 to 93.0,371
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,89.0,85.3 to 92.2,694
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,83.1,77.4 to 88.0,327
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,83.8,80.0 to 87.3,667
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,80.7,74.4 to 86.3,323
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,81.9,77.6 to 85.8,650
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,5 Months,78.9,72.5 to 84.0,323
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,5 Months,80.6,76.3 to 84.3,650
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,54.9,47.9 to 61.7,327
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,55.7,50.8 to 60.5,667
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,43.6,37.1 to 50.8,374
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,73.0,64.9 to 80.6,339
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,71.7,63.0 to 79.9,330
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,66.6,59.0 to 74.0,349
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,72.1,67.0 to 77.0,720
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,35 Months,88.9,83.9 to 92.9,327
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,87.3,83.5 to 90.6,667
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,35 Months,85.5,79.5 to 90.4,340
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,87.1,83.2 to 90.4,723
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,35 Months,88.7,83.4 to 92.9,383
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,88.5,84.8 to 91.6,757
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2011,Age,13 Months,62.2,61.2 to 63.1,339
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,42.7,36.6 to 49.3,383
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,43.1,38.6 to 47.9,757
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,83.1,78.3 to 87.4,371
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,82.0,78.0 to 85.6,694
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,39.3,32.8 to 46.6,340
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,41.0,36.5 to 45.9,723
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,48.2,41.3 to 55.8,327
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,43.7,38.8 to 48.9,667
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,82.5,77.1 to 87.2,349
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,82.8,79.2 to 86.0,720
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,35 Months,88.6,82.4 to 93.4,323
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,88.9,85.1 to 92.1,650
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,5 Months,76.3,72.5 to 79.6,330
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,5 Months,84.1,80.9 to 86.9,339
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,5 Months,80.0,77.8 to 81.9,349
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,5 Months,81.2,79.1 to 83.2,720
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,5 Months,82.6,77.6 to 86.6,371
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,5 Months,80.7,77.8 to 83.3,694
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,94.9,92.2 to 97.6,313
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,99.7,99.1 to 100.0,464
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,93.2,90.2 to 96.2,426
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,46.7,43.5 to 49.9,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,51.0,40.9 to 61.1,339
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,55.5,50.4 to 60.4,349
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,55.7,51.0 to 60.2,720
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,71.1,64.7 to 76.8,374
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,87.5,82.8 to 91.4,339
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,82.2,76.4 to 87.4,330
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,5 Months,79.6,73.8 to 84.4,383
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,5 Months,78.0,73.8 to 81.8,757
PCV,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,5 Months,76.5,69.9 to 82.0,374
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,96.3,93.4 to 99.2,234
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",97.4,96.1 to 98.7,737
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,96.3,93.2 to 99.4,119
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.8,94.1 to 97.5,850
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,91.0 to 98.6,162
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,94.8,91.6 to 98.0,238
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,69.2,62.3 to 75.3,327
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,72.9,68.3 to 77.0,667
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,76.8,70.6 to 82.1,340
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,72.6,68.1 to 76.6,723
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,68.2,61.7 to 74.2,383
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,93.9,91.1 to 95.9,757
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,41.3,34.9 to 48.4,349
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,41.4,36.9 to 46.3,720
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,5 Months,82.3,76.1 to 87.2,327
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,5 Months,83.9,80.0 to 87.2,667
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,5 Months,85.6,80.4 to 89.5,340
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,5 Months,83.6,79.8 to 86.7,723
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,55.9,49.8 to 61.7,371
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,50.0,45.4 to 54.6,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,44.1,37.5 to 50.9,323
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,49.5,44.7 to 54.4,650
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014,Age,13 Months,57.6,51.6 to 63.5,371
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,56.4,51.8 to 60.8,694
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015,Age,13 Months,55.1,48.1 to 61.8,323
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,57.8,52.8 to 62.6,650
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2012,Age,13 Months,52.6,49.4 to 55.8,330
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,35 Months,88.1,82.7 to 92.4,374
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,84.7,80.5 to 88.9,412
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,86.3,83.2 to 89.5,754
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,5 Months,81.5,75.9 to 86.1,383
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,5 Months,79.8,75.6 to 83.4,757
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.6,71.8 to 95.5,66
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013,Age,13 Months,48.7,46.4 to 50.9,349
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,53.1,47.8 to 58.3,720
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,5 Months,78.1,71.6 to 83.4,374
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,89.4,84.6 to 94.2,238
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,85.5,80.8 to 89.3,330
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,93.1,88.7 to 95.8,339
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,56.5,49.6 to 63.2,340
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,53.4,48.7 to 58.1,723
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,50.2,43.8 to 56.6,383
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,52.9,48.3 to 57.4,757
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,78.4,71.2 to 84.9,327
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,75.3,70.1 to 80.3,667
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,72.7,64.7 to 80.1,323
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,75.6,70.2 to 80.6,650
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,93.1,90.4 to 95.0,349
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,93.7,92.1 to 95.0,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,55.6,49.1 to 62.0,374
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,76.9,70.2 to 83.0,371
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,74.9,69.7 to 79.8,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014,Age,13 Months,67.8,61.8 to 73.3,371
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,65.2,60.6 to 69.5,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015,Age,13 Months,62.6,55.5 to 69.1,323
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,65.2,60.3 to 69.8,650
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019,Age,13 Months,57.4,50.9 to 63.7,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2011,Age,19 Months,87.7,84.7 to 90.2,339
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013,Age,19 Months,86.4,83.1 to 89.2,349
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,87.4,83.7 to 90.3,720
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2012,Age,19 Months,85.0,81.9 to 87.6,330
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016,Age,13 Months,67.8,60.9 to 74.0,327
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,67.2,62.4 to 71.6,667
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018,Age,13 Months,64.1,57.6 to 70.1,383
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,60.8,56.2 to 65.2,757
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,87.2,80.6 to 92.4,330
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,88.0,80.8 to 93.5,323
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,88.7,84.4 to 92.3,650
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,89.5,84.3 to 93.5,371
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,88.8,84.6 to 92.4,694
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,80.5,73.4 to 86.6,374
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,85.6,83.0 to 87.8,330
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,89.7,84.7 to 93.6,349
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,89.4,85.9 to 92.3,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,91.4,88.3 to 93.8,349
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,91.5,89.8 to 92.9,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,91.5,88.1 to 94.0,371
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,87.0,83.4 to 89.9,694
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,71.7,64.1 to 78.8,383
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,75.8,70.6 to 80.7,757
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,72.7,65.1 to 79.8,340
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,72.1,66.8 to 77.2,723
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016,Age,13 Months,60.4,53.5 to 67.0,327
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,57.1,52.1 to 61.8,667
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017,Age,13 Months,53.5,46.5 to 60.4,340
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,58.7,54.0 to 63.4,723
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.0,79.8 to 92.2,162
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,35 Months,95.3,91.4 to 97.8,323
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,95.1,92.2 to 97.1,650
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.6,78.6 to 96.6,66
Hib,Full Series,States/Local Areas,IL-Rest of state,2017,Age,35 Months,86.2,80.2 to 91.1,340
Hib,Full Series,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,84.5,80.4 to 88.2,723
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,93.3,88.7 to 96.5,374
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,93.6,90.8 to 96.4,412
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,96.2,94.5 to 97.9,754
Hib,Full Series,States/Local Areas,IL-Rest of state,2016,Age,35 Months,87.4,82.2 to 91.7,327
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,86.8,82.9 to 90.2,667
Hib,Full Series,States/Local Areas,IL-Rest of state,2014,Age,35 Months,84.7,79.8 to 89.0,371
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,83.6,79.4 to 87.3,694
Hib,Full Series,States/Local Areas,IL-Rest of state,2015,Age,35 Months,82.6,75.7 to 88.4,323
Hib,Full Series,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,85.0,80.6 to 88.8,650
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,80.2,75.7 to 84.7,412
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",76.2,63.9 to 88.6,66
Hib,Full Series,States/Local Areas,IL-Rest of state,2018,Age,35 Months,82.9,77.1 to 87.9,383
Hib,Full Series,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,82.9,78.6 to 86.7,757
Hib,Full Series,States/Local Areas,IL-Rest of state,2019,Age,35 Months,82.8,76.2 to 88.4,374
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,86.8,83.7 to 89.9,754
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,94.3,90.6 to 98.1,234
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.2,94.6 to 97.7,737
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.9,89.9 to 97.9,162
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,94.7,91.4 to 97.9,238
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.6,92.7 to 96.4,850
Hib,Primary Series,States/Local Areas,IL-Rest of state,2012,Age,7 Months,66.3,64.1 to 68.4,330
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,93.3,90.4 to 96.2,464
Hib,Primary Series,States/Local Areas,IL-Rest of state,2011,Age,7 Months,82.2,77.6 to 86.0,339
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,83.0,76.7 to 89.3,234
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.7,82.7 to 88.7,737
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.3,74.0 to 88.7,162
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,83.1,77.6 to 88.6,238
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.1,81.2 to 87.1,850
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,77.1,72.3 to 81.8,426
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,80.6,75.3 to 85.9,313
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,83.7,81.1 to 86.3,1203
Hib,Full Series,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,82.3,74.1 to 90.4,119
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,92.3,87.8 to 95.5,383
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,92.7,89.7 to 95.1,757
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,95.8,92.3 to 98.0,340
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,94.0,91.3 to 96.1,723
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,94.4,89.9 to 97.4,327
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,95.0,92.3 to 97.0,667
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,5 Months,86.1,81.4 to 89.8,371
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,5 Months,83.5,80.2 to 86.4,694
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,95.8,92.3 to 98.0,340
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,94.0,91.3 to 96.1,723
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,96.3,93.0 to 98.3,339
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,87.1,81.5 to 91.2,383
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,69.9,65.4 to 74.0,757
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,92.0,87.2 to 95.1,340
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,89.6,86.1 to 92.3,723
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,93.9,89.3 to 96.9,327
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,94.8,92.1 to 96.8,667
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,90.4,85.5 to 94.2,330
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,92.3,87.8 to 95.5,383
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,92.1,89.0 to 94.6,757
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,92.0,87.2 to 95.4,374
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,86.9,81.5 to 90.9,374
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,35 Months,93.4,88.3 to 96.8,330
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,35 Months,95.5,92.6 to 97.5,371
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,95.3,93.0 to 97.1,694
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,35 Months,95.8,92.5 to 97.9,349
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,95.4,93.3 to 97.0,720
Hib,Full Series,States/Local Areas,IL-Rest of state,2013,Age,35 Months,88.2,83.1 to 92.4,349
Hib,Full Series,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,86.3,82.7 to 89.4,720
Hib,Full Series,States/Local Areas,IL-Rest of state,2011,Age,35 Months,88.5,83.4 to 92.6,339
Hib,Full Series,States/Local Areas,IL-Rest of state,2012,Age,35 Months,85.4,78.3 to 91.2,330
Hib,Full Series,States/Local Areas,IL-Rest of state,2019,Age,24 Months,76.7,70.6 to 82.4,374
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,5 Months,83.7,80.9 to 86.2,349
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,5 Months,84.9,83.0 to 86.6,720
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,5 Months,79.6,77.1 to 81.9,330
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,5 Months,87.3,85.1 to 89.2,339
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,5 Months,84.5,78.4 to 89.1,327
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,5 Months,85.4,81.5 to 88.6,667
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,5 Months,81.0,74.8 to 85.9,323
DTaP,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,5 Months,82.8,78.6 to 86.3,650
Hib,Full Series,States/Local Areas,IL-Rest of state,2018,Age,24 Months,76.1,70.2 to 81.5,383
Hib,Full Series,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,76.4,72.2 to 80.4,757
Hib,Full Series,States/Local Areas,IL-Rest of state,2017,Age,24 Months,83.1,77.4 to 88.1,340
Hib,Full Series,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,79.6,75.6 to 83.4,723
Hib,Full Series,States/Local Areas,IL-Rest of state,2016,Age,24 Months,85.1,79.8 to 89.7,327
Hib,Full Series,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,84.0,80.2 to 87.5,667
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,94.3,90.8 to 96.8,349
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,93.1,90.5 to 95.2,720
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,91.1,86.3 to 94.8,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,95.6,92.7 to 97.6,339
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,91.6,87.6 to 94.7,371
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,91.7,88.8 to 94.1,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2020,Age,24 Months,92.0,87.9 to 95.1,376
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,90.5,85.3 to 93.9,374
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,94.2,91.1 to 96.5,339
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,89.6,84.5 to 93.6,330
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,90.0,85.4 to 93.2,371
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,89.9,86.6 to 92.5,694
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,94.4,90.8 to 96.9,349
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,94.4,92.2 to 96.2,720
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,89.9,83.8 to 93.9,323
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,90.3,86.9 to 92.9,650
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,90.7,85.6 to 94.2,327
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,91.3,88.0 to 93.8,667
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,93.6,89.7 to 96.4,323
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,93.8,90.9 to 96.0,650
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,94.8,91.9 to 96.9,371
Polio,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,94.2,91.8 to 96.0,694
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,89.9,84.6 to 93.6,383
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,89.4,85.9 to 92.1,757
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,92.1,87.2 to 95.3,374
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,95.6,91.6 to 97.7,340
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,92.8,89.6 to 95.0,723
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,95.4,92.0 to 97.7,349
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,95.6,93.5 to 97.2,720
Hib,Full Series,States/Local Areas,IL-Rest of state,2015,Age,24 Months,79.9,73.6 to 85.4,323
Hib,Full Series,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,82.5,78.3 to 86.2,650
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,96.4,93.7 to 98.2,339
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,88.0,82.4 to 93.6,234
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.5,80.2 to 86.8,737
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,79.0,70.2 to 87.8,119
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.1,82.1 to 88.0,850
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,94.3,91.2 to 96.4,371
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,92.0,89.0 to 94.3,694
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,85.0,80.1 to 89.8,313
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,85.0,82.5 to 87.5,1203
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,89.7,84.3 to 93.4,323
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,91.1,87.6 to 93.6,650
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,92.4,87.4 to 95.5,327
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,93.0,90.0 to 95.1,667
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,79.0,74.2 to 83.8,426
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,86.0,83.6 to 88.1,339
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2019,Age,24 Months,79.8,73.9 to 85.1,374
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2011,Age,35 Months,93.6,88.9 to 96.8,339
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017,Age,13 Months,66.5,59.6 to 72.7,340
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,69.6,64.9 to 73.9,723
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018,Age,13 Months,72.7,66.3 to 78.4,383
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,69.7,65.2 to 73.9,757
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019,Age,13 Months,66.6,60.0 to 72.6,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014,Age,19 Months,88.4,83.9 to 91.8,371
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,86.9,83.2 to 89.8,694
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015,Age,19 Months,85.3,82.2 to 87.9,323
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,88.0,84.3 to 90.9,650
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016,Age,19 Months,90.7,85.6 to 94.1,327
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,89.6,86.1 to 92.3,667
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,91.4,85.3 to 95.1,330
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,96.1,94.3 to 97.3,339
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,96.4,94.7 to 97.5,349
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,96.8,95.2 to 97.9,720
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,97.3,95.0 to 98.5,371
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,95.5,93.1 to 97.1,694
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2015,Age,3 Months,94.6,90.7 to 97.0,323
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2015-2016,Age,3 Months,95.0,92.2 to 96.8,650
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2016,Age,3 Months,95.3,90.7 to 97.7,327
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2016-2017,Age,3 Months,96.1,93.6 to 97.7,667
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2017,Age,3 Months,97.0,93.9 to 98.6,340
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2017-2018,Age,3 Months,96.5,94.3 to 97.9,723
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.7,69.7 to 89.8,162
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013,Age,13 Months,47.0,41.6 to 52.5,349
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,57.3,48.4 to 65.9,720
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2012,Age,13 Months,50.2,46.4 to 54.0,330
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2011,Age,13 Months,58.5,54.7 to 62.2,339
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,78.6,72.6 to 84.0,383
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,79.1,75.0 to 83.0,757
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,84.6,79.3 to 89.2,340
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,81.6,77.7 to 85.3,723
Hib,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,90.8,85.9 to 94.5,374
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,79.0,70.9 to 87.0,234
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,87.1,81.0 to 91.4,374
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,76.7,72.9 to 80.4,1203
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,73.8,66.5 to 81.1,313
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,65.8,53.5 to 78.0,119
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2013,Age,3 Months,97.0,95.0 to 98.2,349
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2013-2014,Age,3 Months,96.4,95.2 to 97.3,720
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2012,Age,3 Months,93.7,91.5 to 95.4,330
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2011,Age,3 Months,94.3,91.4 to 96.3,339
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2014,Age,3 Months,95.8,93.1 to 97.4,371
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2015,Age,3 Months,95.2,93.0 to 96.8,694
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,93.6,89.5 to 96.1,340
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,90.8,87.6 to 93.2,723
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,87.9,82.6 to 91.7,383
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,87.5,83.7 to 90.5,757
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.2,70.3 to 80.1,737
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.6,73.1 to 82.0,850
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,73.3,67.3 to 79.4,412
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,81.2,76.5 to 86.0,754
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.2,51.3 to 81.1,66
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",86.5,83.6 to 89.5,737
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.6,75.4 to 89.9,162
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Overall,Overall,83.7,81.1 to 86.3,1203
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,83.7,75.9 to 91.4,119
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,83.6,77.5 to 89.8,234
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,83.7,80.6 to 86.9,850
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015,Age,19 Months,83.9,81.3 to 86.1,323
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,86.5,82.5 to 89.7,650
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016,Age,19 Months,89.1,83.7 to 92.9,327
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,89.7,86.1 to 92.4,667
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017,Age,19 Months,90.3,85.0 to 93.9,340
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,88.9,85.3 to 91.7,723
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,<133% FPL,78.1,72.5 to 83.7,313
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2011,Age,24 Months,88.8,84.5 to 92.3,339
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2012,Age,24 Months,88.0,82.6 to 92.3,330
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2018,Age,3 Months,96.0,92.1 to 98.0,383
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2018-2019,Age,3 Months,96.0,93.6 to 97.6,757
Hep B,≥1 Dose,States/Local Areas,IL-Rest of state,2019,Age,3 Months,96.1,92.4 to 98.0,374
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2012,Age,0-1 Days,60.9,55.3 to 66.3,330
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,70.3,63.8 to 76.8,426
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2011,Age,0-1 Days,55.0,51.9 to 58.0,339
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,5 Months,87.7,85.9 to 89.3,330
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,5 Months,87.4,84.9 to 89.5,339
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,5 Months,90.5,89.1 to 91.6,349
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,5 Months,90.9,89.5 to 92.2,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,94.2,92.2 to 95.6,349
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,94.2,92.8 to 95.3,720
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,5 Months,91.4,87.6 to 94.2,371
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,5 Months,88.0,86.2 to 89.6,694
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,86.6,81.6 to 91.7,464
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,94.3,91.3 to 96.2,371
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,91.8,88.8 to 94.1,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,89.4,84.9 to 92.7,323
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,90.5,87.0 to 93.1,650
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2019,Age,35 Months,89.6,83.5 to 94.2,374
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,79.3,74.6 to 84.0,412
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,87.5,84.5 to 90.5,754
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2011,Age,19 Months,89.7,85.7 to 92.7,339
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.6,54.3 to 80.9,66
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013,Age,19 Months,85.3,83.1 to 87.2,349
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,88.3,83.6 to 91.9,720
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014,Age,19 Months,91.5,87.2 to 94.4,371
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,87.7,84.0 to 90.6,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2012,Age,19 Months,84.7,80.5 to 88.1,330
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017,Age,19 Months,88.6,83.1 to 92.4,340
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,88.3,84.7 to 91.1,723
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018,Age,19 Months,87.9,82.7 to 91.8,383
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,60.8,56.2 to 65.2,757
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,83.7,78.0 to 89.4,238
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,93.8,89.2 to 96.5,323
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,95.1,92.4 to 97.0,650
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,96.5,92.4 to 98.4,327
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,96.5,94.2 to 98.0,667
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,96.6,93.3 to 98.3,340
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,95.6,93.4 to 97.2,723
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,66.9,62.0 to 71.4,349
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,67.9,65.3 to 70.5,720
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,74.0,68.1 to 79.2,339
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,91.5,86.5 to 94.8,327
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,92.2,88.9 to 94.5,667
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,69.0,63.0 to 74.4,371
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,67.8,63.3 to 72.1,694
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,93.6,90.9 to 96.3,464
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2017,Poverty,133% to <400% FPL,78.9,74.2 to 83.7,426
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,64.9,61.6 to 68.1,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,92.8,88.0 to 95.8,340
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,92.3,89.1 to 94.6,723
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,91.8,87.0 to 94.9,383
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,88.9,85.5 to 91.6,757
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,5 Months,91.2,86.4 to 94.5,327
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,5 Months,91.7,88.6 to 93.9,667
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2013,Age,0-1 Days,59.9,57.2 to 62.6,349
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2013-2014,Age,0-1 Days,61.8,60.5 to 63.1,720
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2014,Age,0-1 Days,63.7,57.7 to 69.4,371
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2014-2015,Age,0-1 Days,62.6,58.0 to 66.9,694
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2015,Age,0-1 Days,61.4,54.5 to 67.9,323
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2015-2016,Age,0-1 Days,64.9,60.1 to 69.4,650
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,89.1,83.9 to 92.8,327
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,89.6,86.2 to 92.2,667
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,82.5,76.2 to 87.4,323
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,85.8,81.8 to 89.1,650
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,13 Months,90.1,85.2 to 93.5,340
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,13 Months,89.7,86.4 to 92.3,723
Hep A,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2017,Race and Ethnicity,Hispanic,83.2,76.0 to 90.5,238
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2017,Age,35 Months,88.5,83.1 to 92.8,340
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,35 Months,88.2,84.2 to 91.5,723
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016,Age,35 Months,89.3,84.0 to 93.5,327
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,35 Months,88.8,85.1 to 92.0,667
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2014-2017,Poverty,>400% FPL,90.8,87.7 to 93.9,464
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2018,Age,35 Months,88.5,82.2 to 93.4,383
DTaP,≥4 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,35 Months,89.2,84.9 to 92.7,757
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,5 Months,84.5,78.5 to 89.1,323
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,5 Months,87.9,84.2 to 90.8,650
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,13 Months,94.7,90.9 to 97.0,383
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,13 Months,93.9,91.1 to 95.9,757
Polio,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,13 Months,93.1,88.3 to 96.0,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019,Age,19 Months,85.8,80.4 to 89.9,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014,Age,24 Months,91.1,87.4 to 94.1,371
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,91.2,88.4 to 93.6,694
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013,Age,24 Months,89.5,85.0 to 93.1,349
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,90.3,87.4 to 92.7,720
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2016,Age,0-1 Days,68.3,61.5 to 74.5,327
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2016-2017,Age,0-1 Days,69.5,64.8 to 73.9,667
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2017,Age,0-1 Days,70.8,63.9 to 76.8,340
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2017-2018,Age,0-1 Days,72.8,68.3 to 76.9,723
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2019,Age,5 Months,90.6,85.5 to 94.1,374
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2011,Age,7 Months,92.6,90.6 to 94.1,339
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,5 Months,92.1,87.9 to 94.9,340
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,5 Months,90.9,87.8 to 93.2,723
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,5 Months,89.6,84.7 to 93.0,383
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,5 Months,90.1,86.8 to 92.7,757
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2018,Age,0-1 Days,74.8,68.7 to 80.1,383
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2018-2019,Age,0-1 Days,75.2,71.0 to 79.0,757
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2013,Age,19 Months,78.5,72.9 to 83.2,349
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,19 Months,80.4,76.1 to 84.0,720
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2012,Age,19 Months,76.9,73.6 to 80.0,330
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2011,Age,19 Months,75.4,70.8 to 79.5,339
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018,Age,19 Months,87.6,82.1 to 91.5,383
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,94.0,91.3 to 95.9,757
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,82.3,77.0 to 86.5,371
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,77.9,73.6 to 81.6,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2019,Age,19 Months,86.5,81.1 to 90.5,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017,Age,24 Months,90.5,85.6 to 94.3,340
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,91.0,87.8 to 93.6,723
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016,Age,24 Months,94.4,90.9 to 96.8,327
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,92.4,89.5 to 94.8,667
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2011,Age,24 Months,92.6,89.1 to 95.3,339
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2012,Age,24 Months,88.8,83.9 to 92.8,330
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015,Age,24 Months,91.2,86.7 to 94.6,323
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,92.8,90.1 to 95.0,650
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2019,Age,24 Months,87.0,82.0 to 91.2,374
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2011,Age,35 Months,92.6,88.4 to 95.7,339
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2012,Age,35 Months,93.1,88.3 to 96.4,330
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018,Age,24 Months,91.5,87.2 to 94.8,383
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,89.4,86.1 to 92.1,757
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015,Age,24 Months,90.0,85.3 to 93.7,323
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,91.4,88.3 to 93.9,650
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014,Age,24 Months,92.3,88.4 to 95.2,371
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,91.1,88.2 to 93.6,694
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013,Age,24 Months,89.0,84.3 to 92.8,349
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,90.5,87.6 to 93.0,720
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,72.8,66.2 to 78.6,340
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,71.8,67.3 to 75.9,723
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,66.7,59.7 to 73.0,323
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,71.0,66.2 to 75.3,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,73.5,67.6 to 78.6,323
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,77.7,73.1 to 81.7,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,81.8,75.6 to 86.7,327
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,82.3,78.2 to 85.8,667
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,75.3,68.7 to 80.8,327
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,74.1,69.5 to 78.2,667
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,24 Months,90.3,85.5 to 94.1,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,24 Months,94.3,91.5 to 96.3,371
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,24 Months,91.8,89.0 to 94.2,694
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,24 Months,94.5,91.3 to 96.8,349
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,24 Months,94.3,92.3 to 96.0,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,92.3,87.6 to 95.3,374
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,90.5,85.8 to 94.1,339
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-Rest of state,2019,Age,0-1 Days,75.6,69.6 to 80.8,374
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2011,Age,0-2 Days,60.2,56.7 to 63.7,339
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2013,Age,0-2 Days,64.1,61.0 to 67.0,349
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2013-2014,Age,0-2 Days,66.9,64.7 to 68.9,720
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2012,Age,0-2 Days,65.6,59.6 to 71.0,330
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2013,Age,7 Months,93.5,92.4 to 94.4,349
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,7 Months,94.0,93.5 to 94.6,720
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2014,Age,7 Months,94.6,91.8 to 96.5,371
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,7 Months,92.8,90.1 to 94.8,694
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2015,Age,7 Months,91.0,86.2 to 94.2,323
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,7 Months,92.1,89.1 to 94.3,650
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2012,Age,7 Months,90.7,88.9 to 92.3,330
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,70.7,64.4 to 76.4,383
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,68.7,64.2 to 72.9,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2019,Age,7 Months,66.6,60.0 to 72.7,374
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2011,Age,13 Months,90.6,88.0 to 92.7,339
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2017,Age,19 Months,82.9,77.0 to 87.5,340
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,19 Months,80.8,76.6 to 84.4,723
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2018,Age,19 Months,78.6,72.4 to 83.7,383
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,19 Months,76.4,70.9 to 81.1,613
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017,Age,24 Months,92.0,87.5 to 95.4,340
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2017-2018,Age,24 Months,91.6,88.5 to 94.2,723
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016,Age,24 Months,92.7,88.6 to 95.8,327
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,92.4,89.4 to 94.7,667
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2012,Age,13 Months,86.4,84.3 to 88.2,330
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2017,Age,24 Months,93.4,89.1 to 96.4,340
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,24 Months,92.0,87.4 to 95.4,327
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,24 Months,92.7,89.7 to 95.1,667
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013,Age,13 Months,89.0,87.4 to 90.5,349
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2013-2014,Age,13 Months,90.0,88.0 to 91.6,720
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,24 Months,89.4,84.4 to 93.4,323
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,24 Months,90.7,87.5 to 93.4,650
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2014,Age,0-2 Days,69.7,63.8 to 75.1,371
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2014-2015,Age,0-2 Days,68.4,64.0 to 72.6,694
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2015,Age,0-2 Days,67.2,60.4 to 73.3,323
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2015-2016,Age,0-2 Days,69.7,65.1 to 74.0,650
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2011,Age,24 Months,80.2,74.0 to 85.8,339
Hep A,≥1 Dose,States/Local Areas,IL-Rest of state,2020,Age,35 Months,93.6,89.3 to 96.6,376
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015,Age,35 Months,93.1,88.4 to 96.3,323
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2015-2016,Age,35 Months,94.8,92.0 to 96.8,650
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014,Age,35 Months,92.6,88.9 to 95.4,371
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2014-2015,Age,35 Months,92.8,90.0 to 95.1,694
PCV,≥4 Doses,States/Local Areas,IL-Rest of state,2019,Age,19 Months,78.3,72.1 to 83.4,374
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018,Age,24 Months,91.2,86.5 to 94.7,383
≥1 Dose MMR,,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,89.5,86.2 to 92.3,757
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013,Age,35 Months,93.2,89.3 to 96.1,349
≥1 Dose Varicella,,States/Local Areas,IL-Rest of state,2013-2014,Age,35 Months,92.9,90.3 to 95.0,720
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2016,Age,0-2 Days,72.3,65.6 to 78.1,327
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-Rest of state,2016-2017,Age,0-2 Days,74.3,69.7 to 78.5,667
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2016,Age,7 Months,93.2,88.9 to 95.9,327
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,7 Months,94.1,91.5 to 95.9,667
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2017,Age,7 Months,95.0,91.5 to 97.1,340
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2017-2018,Age,7 Months,94.3,91.8 to 96.1,723
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2018,Age,7 Months,93.7,89.6 to 96.2,383
Hep B,≥2 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,7 Months,93.0,90.0 to 95.1,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,13 Months,90.9,86.5 to 94.0,371
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,13 Months,88.7,85.2 to 91.5,694
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,13 Months,86.6,80.6 to 90.9,323
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,13 Months,88.4,84.4 to 91.4,650
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018,Age,24 Months,93.3,89.4 to 96.2,383
Hep B,≥3 Doses,States/Local Areas,IL-Rest of state,2018-2019,Age,24 Months,92.9,90.1 to 95.1,757
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,13 Months,90.1,84.5 to 93.9,327
PCV,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,13 Months,90.8,87.4 to 93.4,667
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,70.4,63.1 to 76.8,347
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,92.5,87.6 to 95.6,347
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,89.6,84.1 to 93.4,347
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,66.5,59.2 to 73.0,347
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,3 Months,87.7,81.9 to 91.8,347
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,3 Months,84.2,78.1 to 88.8,347
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,3 Months,87.7,81.9 to 91.8,347
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,5 Months,86.0,77.0 to 91.9,173
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,5 Months,70.6,60.6 to 78.9,173
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,5 Months,74.3,64.3 to 82.2,173
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,5 Months,74.3,64.3 to 82.2,173
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,3 Months,84.6,75.5 to 90.7,173
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,3 Months,95.9,92.1 to 97.9,173
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,61.4,51.6 to 71.2,173
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,86.2,77.8 to 92.5,173
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,41.4,32.2 to 52.1,173
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,76.5,67.1 to 84.8,173
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,86.3,77.9 to 92.7,173
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,93.5,86.6 to 97.5,173
Rotavirus,,States/Local Areas,IL-City of Chicago,2020,Age,8 Months,74.0,64.2 to 81.9,173
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2020,Age,0-3 Days,82.9,74.1 to 89.2,173
Influenza,,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,65.6,55.7 to 75.3,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,86.7,77.5 to 92.4,173
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,89.7,81.5 to 94.5,173
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,85.4,76.1 to 91.4,173
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,71.5,61.3 to 80.0,173
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,87.7,78.6 to 93.2,173
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,64.4,54.0 to 73.6,173
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,82.6,73.0 to 89.3,173
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,57.7,47.8 to 67.1,173
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,83.6,74.4 to 90.0,173
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,95.7,91.9 to 97.8,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,71.4,61.5 to 79.6,173
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,76.7,67.0 to 84.3,173
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,88.4,80.3 to 94.3,173
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,79.3,69.2 to 87.8,173
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,75.8,65.8 to 83.7,173
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,92.8,86.1 to 97.0,173
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,81.1,71.5 to 89.0,173
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,89.3,81.0 to 94.3,173
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,86.3,77.0 to 92.2,173
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,88.5,80.5 to 93.5,173
Hib,Full Series,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,67.2,57.3 to 75.8,173
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,86.7,77.5 to 92.4,173
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,94.1,87.0 to 98.0,173
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,93.0,86.5 to 97.0,173
Hib,Full Series,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,75.3,65.3 to 84.3,173
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,90.8,83.0 to 95.9,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,89.6,81.9 to 95.0,173
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,92.6,83.9 to 97.5,173
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,89.6,81.9 to 95.0,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,89.6,81.9 to 95.0,173
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,87.0,79.1 to 93.0,173
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,78.5,69.3 to 86.5,173
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,91.3,84.8 to 95.8,173
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,5 Months,73.0,63.0 to 81.1,173
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,24 Months,89.3,81.7 to 94.7,173
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,88.2,79.3 to 93.6,173
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,61.9,51.6 to 71.2,173
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,55.2,45.2 to 64.8,173
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,3 Months,84.2,75.1 to 90.4,173
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,84.5,74.9 to 90.9,173
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,82.3,72.5 to 89.1,173
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2020,Age,0-1 Days,74.7,65.7 to 82.0,173
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2020,Age,0-2 Days,81.3,72.4 to 87.8,173
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,25.3,18.0 to 34.3,173
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,19 Months,83.1,73.8 to 89.6,173
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,67.5,56.7 to 77.8,173
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,35 Months,73.1,61.2 to 83.8,173
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2020,Age,13 Months,92.9,87.0 to 96.3,173
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,43.4,36.4 to 51.2,347
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,86.3,80.4 to 91.1,347
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,94.3,89.1 to 97.5,347
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,74.7,66.0 to 82.6,347
Influenza,,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,65.7,58.4 to 72.9,347
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,90.8,85.7 to 94.6,347
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,90.7,85.7 to 94.5,347
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,59.7,52.4 to 66.5,347
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,70.5,62.8 to 77.8,347
Hib,Full Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,69.4,62.3 to 75.7,347
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,90.8,85.6 to 94.2,347
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,87.4,81.2 to 91.8,347
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,75.2,67.9 to 81.3,347
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,83.3,76.8 to 88.2,347
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2019-2020,Age,0-1 Days,71.4,64.4 to 77.4,347
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2019-2020,Age,0-2 Days,79.9,73.3 to 85.1,347
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,91.7,87.2 to 95.1,347
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,90.9,85.9 to 94.7,347
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2019-2020,Age,0-3 Days,82.7,76.6 to 87.5,347
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,66.9,59.6 to 73.4,347
Hib,Full Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,74.4,67.8 to 80.5,347
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,90.6,85.6 to 94.4,347
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,78.9,72.1 to 85.0,347
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,24.2,18.9 to 30.6,347
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,85.8,79.5 to 90.4,347
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,88.7,83.0 to 92.7,347
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,88.9,83.2 to 92.8,347
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,91.6,86.5 to 95.3,347
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,92.7,87.2 to 96.5,347
Hib,Full Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,78.2,71.1 to 84.6,347
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,92.3,87.2 to 95.9,347
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,93.1,88.5 to 96.3,347
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,94.1,89.2 to 97.3,347
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,92.5,87.5 to 96.0,347
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,92.4,87.7 to 95.8,347
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,81.8,74.4 to 88.2,347
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,80.3,73.7 to 86.2,347
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,93.4,89.1 to 96.4,347
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,86.6,80.9 to 91.3,347
Hep B,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,3 Months,96.8,94.5 to 98.2,347
PCV,≥1 Dose,States/Local Areas,IL-City of Chicago,2019-2020,Age,3 Months,87.8,82.0 to 91.9,347
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,5 Months,78.8,72.2 to 84.2,347
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,5 Months,78.8,72.2 to 84.2,347
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,5 Months,74.6,67.7 to 80.4,347
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,93.9,89.7 to 96.5,347
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,62.7,55.3 to 69.6,347
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,78.2,71.8 to 83.5,347
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,91.9,86.9 to 95.2,347
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,94.8,91.0 to 97.1,347
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,82.5,76.2 to 87.4,347
Hep B,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,5 Months,86.8,80.9 to 91.1,347
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,5 Months,77.5,70.8 to 83.0,347
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,68.1,60.9 to 74.6,347
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,89.3,83.6 to 93.2,347
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,7 Months,86.9,81.0 to 91.2,347
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,86.8,80.9 to 91.0,347
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,54.8,47.6 to 61.8,347
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,13 Months,87.7,82.0 to 91.8,347
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,95.2,90.7 to 97.9,347
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,19 Months,91.6,86.2 to 95.0,347
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2019-2020,Age,24 Months,65.4,58.2 to 72.5,347
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,83.8,77.0 to 89.5,347
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2019-2020,Age,35 Months,94.8,90.5 to 97.6,347
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,79.7,75.1 to 84.3,586
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,91.0,88.1 to 93.9,586
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,79.5,74.9 to 84.0,586
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,63.1,57.5 to 68.7,586
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,76.3 to 85.3,586
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,94.2,91.9 to 96.6,586
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,69.9,62.3 to 77.5,206
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,82.9,73.2 to 92.5,117
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,91.2,85.4 to 96.9,263
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,92.6,89.8 to 95.4,586
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,79.4,69.1 to 89.8,117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,86.4,80.2 to 92.6,263
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,78.9,70.4 to 87.4,117
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,78.8,66.2 to 91.4,206
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,89.4,83.0 to 95.7,117
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,96.8,94.4 to 99.2,263
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,94.4,90.9 to 97.9,206
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,95.6,93.7 to 97.6,586
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,62.1,50.1 to 74.1,117
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,92.5,89.9 to 95.1,586
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,49.1,40.3 to 57.9,206
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,97.4,95.2 to 99.5,263
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,91.3,85.5 to 97.1,117
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,90.8,85.7 to 96.0,263
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,89.9,84.9 to 95.0,206
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,84.1,75.6 to 92.7,117
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,89.3,84.4 to 94.2,206
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,80.8,76.3 to 85.3,586
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,93.9,90.2 to 97.5,206
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,86.4,80.3 to 92.6,263
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,87.5,80.6 to 94.4,117
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,72.0,64.1 to 79.8,206
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,96.5,94.1 to 98.8,263
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,79.5,74.9 to 84.0,586
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,79.9,73.6 to 86.1,206
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,84.9,78.9 to 90.9,263
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",98.5,96.6 to 100.0,217
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.2,93.5 to 99.0,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,83.6,78.0 to 89.1,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.6,94.1 to 99.1,217
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.9,89.4 to 98.5,217
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.8,85.3 to 96.3,217
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.5,85.7 to 97.3,103
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.3,65.1 to 83.6,103
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,63.1,54.7 to 71.5,242
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,80.7,74.6 to 86.8,333
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",71.0,60.7 to 81.2,103
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.1,88.4 to 97.7,217
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,78.4,72.4 to 84.4,242
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",88.6,82.2 to 95.0,103
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,89.0,83.5 to 94.5,189
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.3,93.5 to 100.0,77
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,88.4,83.5 to 93.3,242
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,93.6,90.2 to 97.0,242
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,97.9,96.3 to 99.6,333
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,92.3,88.8 to 95.8,333
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,50.2,41.8 to 58.5,242
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.0,80.0 to 98.0,77
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,91.8,86.9 to 96.6,189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,78.4,70.9 to 85.8,189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.8,75.4 to 94.1,77
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.7,65.1 to 84.4,103
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.8,77.2 to 90.4,217
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,69.7,62.5 to 76.8,242
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,63.9,53.3 to 74.4,189
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,77.2 to 98.2,77
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",62.1,51.1 to 73.0,103
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,75.5,67.3 to 83.7,189
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.7,81.2 to 96.2,77
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",98.5,96.6 to 100.0,217
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,81.9,75.2 to 88.5,189
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.8,87.8 to 97.8,217
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.0,65.3 to 84.8,103
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.0,76.2 to 89.8,217
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",44.4,33.0 to 55.8,103
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.7,68.0 to 91.4,77
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.6,92.2 to 99.0,103
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,90.4,85.1 to 95.8,189
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,80.7,74.9 to 86.5,333
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",97.5,95.1 to 100.0,217
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",96.0,92.7 to 99.3,103
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,73.5,66.4 to 80.7,242
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,89.6,85.2 to 93.9,242
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,88.8,83.2 to 94.3,189
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",90.0,83.9 to 96.0,103
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",90.0,84.2 to 95.7,217
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,97.7,96.0 to 99.4,333
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,93.1,89.6 to 96.6,242
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.3,85.7 to 96.8,217
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.4,93.8 to 100.0,77
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,90.0,85.4 to 94.6,333
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,92.9,88.3 to 97.5,189
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",95.6,92.2 to 99.0,103
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",91.1,85.9 to 96.4,103
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,91.1,85.9 to 96.2,189
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,93.7,88.5 to 97.0,280
Hep B,"≥1 Dose, 1 Day",States/Local Areas,IL-City of Chicago,2021,Age,0-1 Days,76.5,65.0 to 85.1,107
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,95.6,93.7 to 97.6,586
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,81.5,73.8 to 89.2,586
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.4,84.2 to 100.0,77
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.8,74.8 to 92.9,217
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014,Age,19 Months,95.1,91.5 to 97.3,371
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2014-2015,Age,19 Months,94.4,91.7 to 96.3,694
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015,Age,19 Months,93.7,90.0 to 96.1,323
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2015-2016,Age,19 Months,93.9,90.8 to 96.0,650
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016,Age,19 Months,94.0,89.0 to 96.8,327
DTaP,≥3 Doses,States/Local Areas,IL-Rest of state,2016-2017,Age,19 Months,94.8,91.8 to 96.7,667
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,66.7,55.4 to 77.6,107
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,3 Months,87.2,73.7 to 94.3,157
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,3 Months,84.8,76.2 to 90.7,319
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,3 Months,87.7,78.4 to 93.3,144
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,3 Months,87.4,79.9 to 92.4,301
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,3 Months,91.6,82.6 to 96.2,122
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,3 Months,89.7,83.7 to 93.6,266
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,3 Months,83.1,78.1 to 87.1,188
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,3 Months,87.3,81.5 to 91.5,310
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,3 Months,85.4,77.0 to 91.1,244
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,3 Months,82.0,77.6 to 85.8,213
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,84.0,76.9 to 89.8,280
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,91.4,81.4 to 96.2,107
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,65.0,52.2 to 75.9,107
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,3 Months,83.0,71.4 to 90.5,107
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.9,85.7 to 94.1,217
Hib,Full Series,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,71.3,59.6 to 80.6,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,89.2,82.2 to 94.4,162
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,92.1,88.0 to 95.2,321
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2019,Age,24 Months,95.5,89.2 to 98.7,174
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,98.8,96.8 to 99.6,157
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,94.3,90.6 to 96.9,319
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,97.0,91.2 to 99.4,144
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,97.9,95.0 to 99.4,301
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018,Age,24 Months,96.3,92.1 to 98.6,159
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,24 Months,95.9,92.4 to 98.1,333
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017,Age,24 Months,92.0,85.2 to 96.5,162
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,24 Months,94.1,90.2 to 96.8,321
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2018,Age,5 Months,79.0,69.3 to 86.2,159
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2018-2019,Age,5 Months,81.1,74.6 to 86.2,333
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2019,Age,5 Months,83.3,74.0 to 89.8,174
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2017,Age,5 Months,76.6,66.8 to 84.3,162
DTaP,≥2 Doses,States/Local Areas,IL-City of Chicago,2017-2018,Age,5 Months,77.8,71.1 to 83.3,321
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Overall,Overall,95.8,93.8 to 97.7,517
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,<133% FPL,94.0,90.6 to 97.3,202
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,133% to <400% FPL,98.0,95.4 to 100.0,93
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2017,Poverty,>400% FPL,96.8,93.4 to 100.0,222
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2013,Age,19 Months,78.0,73.8 to 81.8,188
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2013-2014,Age,19 Months,78.1,68.5 to 85.3,310
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2015,Age,19 Months,87.3,83.4 to 90.5,144
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2015-2016,Age,19 Months,87.2,80.7 to 91.7,301
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014,Age,19 Months,78.1,66.2 to 86.7,122
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2014-2015,Age,19 Months,82.7,75.1 to 88.3,266
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016,Age,19 Months,87.1,77.7 to 92.9,157
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2017,Age,19 Months,86.8,81.0 to 91.0,319
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2018,Age,3 Months,89.4,81.9 to 94.0,159
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2018-2019,Age,3 Months,90.2,85.0 to 93.8,333
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015,Age,24 Months,97.6,91.5 to 99.6,144
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2015-2016,Age,24 Months,98.2,95.3 to 99.5,301
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014,Age,24 Months,96.7,90.5 to 99.3,122
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2014-2015,Age,24 Months,97.2,93.3 to 99.2,266
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2017,Age,3 Months,82.2,72.8 to 88.8,162
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2017-2018,Age,3 Months,85.7,79.9 to 90.1,321
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2011,Age,19 Months,78.0,72.4 to 82.7,244
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2019,Age,3 Months,91.1,82.5 to 95.7,174
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016,Age,24 Months,98.8,96.8 to 99.6,157
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2017,Age,24 Months,95.6,92.1 to 97.8,319
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2012,Age,19 Months,72.0,66.0 to 77.2,213
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,91.1,81.3 to 96.0,107
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,92.5,85.7 to 96.8,107
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,73.1,53.3 to 89.6,107
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,75.4,63.6 to 84.3,107
Hib,Full Series,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,76.9,66.4 to 86.0,107
Hib,Primary Series,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,92.6,84.2 to 97.4,107
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,89.0,77.1 to 95.1,107
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,92.6,84.2 to 97.4,107
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,3 Months,88.8,77.8 to 94.7,107
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,93.6,88.5 to 97.0,280
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,92.6,84.2 to 97.4,107
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,96.4,92.1 to 98.7,107
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,85.3,76.0 to 92.4,107
DTaP,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,3 Months,88.8,77.8 to 94.7,107
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2021,Age,35 Months,80.3,69.3 to 89.2,107
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,31.7,21.3 to 44.3,107
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,78.7,66.6 to 87.2,107
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,91.5,81.6 to 96.3,107
Polio,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,93.6,83.5 to 97.7,107
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,83.9,72.2 to 91.2,107
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,92.6,84.1 to 97.5,107
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,47.1,35.5 to 60.3,107
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,19 Months,92.6,82.6 to 97.0,107
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,92.5,85.7 to 96.8,107
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,80.3,69.3 to 89.2,107
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,97.0,92.7 to 99.1,107
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,67.6,55.2 to 78.0,107
PCV,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,5 Months,75.6,67.7 to 82.1,280
Hib,≥3 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,71.1,63.4 to 77.8,280
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,7 Months,67.2,54.1 to 78.1,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,24 Months,91.1,82.6 to 96.4,107
Hib,≥2 Doses,States/Local Areas,IL-City of Chicago,2020-2021,Age,13 Months,92.2,86.7 to 95.5,280
Hep B,"≥1 Dose, 2 Day",States/Local Areas,IL-City of Chicago,2021,Age,0-2 Days,80.1,68.4 to 88.2,107
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2021,Age,13 Months,88.1,77.4 to 94.1,107
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2020-2021,Age,35 Months,96.6,92.5 to 98.8,280
Rotavirus,,States/Local Areas,IL-City of Chicago,2019-2020,Age,8 Months,76.4,69.3 to 82.2,347
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,62.4,52.0 to 71.8,173
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2020,Age,7 Months,53.5,43.6 to 63.2,173
Hib,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,3 Months,79.6,70.4 to 86.5,173
Polio,≥1 Dose,States/Local Areas,IL-City of Chicago,2020,Age,3 Months,84.2,75.1 to 90.4,173
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,87.5,80.9 to 94.1,333
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,96.0,93.3 to 98.6,333
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,77.3,64.5 to 90.1,242
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.7,96.3 to 100.0,77
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,97.4,95.5 to 99.2,333
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",73.7,63.8 to 83.5,103
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,76.6,68.1 to 85.1,189
DTaP,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.9,79.8 to 98.0,77
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Private Insurance Only,95.7,93.1 to 98.3,333
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Insurance Coverage,Any Medicaid,88.1,83.3 to 92.8,242
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,89.4,83.9 to 94.8,189
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Race and Ethnicity,Hispanic,59.6,49.1 to 70.0,189
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,95.3,93.2 to 97.3,586
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,91.0,88.1 to 93.9,586
Rotavirus,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,91.6,87.3 to 96.0,263
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,91.7,88.9 to 94.5,586
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,94.2,91.9 to 96.6,586
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,83.3,79.2 to 87.4,586
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,90.5,84.8 to 96.3,117
Hep A,≥1 Dose,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,87.9,82.6 to 93.1,206
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,92.6,86.5 to 98.7,263
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,69.4,55.6 to 83.2,117
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,94.9,90.9 to 98.9,117
PCV,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,91.9,87.7 to 96.0,206
Influenza,,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,63.1,57.5 to 68.7,586
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,80.8,76.7 to 84.8,586
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,91.5,87.2 to 95.8,206
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,81.6,74.9 to 88.4,263
Hep A,≥2 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,81.5,73.8 to 89.2,586
≥1 Dose Varicella,,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,92.6,89.8 to 95.4,586
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,97.7,95.5 to 99.8,263
DTaP,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,95.2,91.2 to 99.2,117
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,71.5,60.6 to 82.4,117
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,63.9,54.8 to 73.0,206
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Poverty,<133% FPL,77.9,71.4 to 84.4,206
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,94.9,91.3 to 98.5,263
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,91.7,86.0 to 97.3,117
Hib,Full Series,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,79.7,75.1 to 84.3,586
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Overall,Overall,71.0,65.5 to 76.4,586
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,>400% FPL,97.3,95.1 to 99.6,263
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Poverty,133% to <400% FPL,95.2,91.2 to 99.2,117
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,80.8,76.7 to 84.8,586
Combined 7 Series,,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,71.0,65.5 to 76.4,586
Polio,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,95.3,93.2 to 97.3,586
PCV,≥4 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,83.3,79.2 to 87.4,586
≥1 Dose MMR,,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,91.7,88.9 to 94.5,586
Hep B,≥3 Doses,States/Local Areas,IL-City of Chicago,2016-2019,Urbanicity,Living In a MSA Principal City,92.5,89.9 to 95.1,586
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,93.3,91.0 to 95.0,926
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,93.5,91.8 to 94.8,1744
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,93.6,91.4 to 95.3,818
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,92.5,90.4 to 94.2,1622
Polio,≥3 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,93.0,90.4 to 95.1,818
Polio,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,92.3,90.2 to 94.0,1622
Polio,≥3 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,93.3,91.1 to 95.1,926
Polio,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,93.2,91.5 to 94.6,1744
Polio,≥3 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,92.3,89.8 to 94.3,1002
Polio,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,66.4,63.2 to 69.5,1918
Polio,≥3 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,88.9,84.9 to 91.9,916
Polio,≥3 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,93.3,90.5 to 95.5,730
Polio,≥3 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,93.6,91.3 to 95.5,780
Hib,≥3 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,90.1,87.3 to 92.2,926
Hib,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,90.2,88.2 to 91.9,1744
Hib,≥3 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,92.1,89.8 to 93.9,797
Hib,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,91.1,88.8 to 92.9,1723
Polio,≥3 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,94.5,92.3 to 96.2,797
Polio,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,93.9,92.4 to 95.2,1723
Hib,≥3 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,90.4,88.6 to 91.9,818
Hib,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,89.5,87.2 to 91.5,1622
Hib,≥3 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,91.0,88.2 to 93.1,1002
Hib,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,80.1,77.5 to 82.5,1918
Hib,≥3 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,90.7,87.5 to 93.1,911
Hib,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,90.8,88.8 to 92.5,1913
Polio,≥3 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,91.4,88.1 to 94.0,804
Polio,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,92.1,90.0 to 93.9,1715
Hib,≥3 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,88.7,85.0 to 91.6,804
Hib,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,89.7,87.3 to 91.6,1715
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,93.1,90.1 to 95.2,911
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,93.5,91.7 to 95.0,1913
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,91.4,87.9 to 93.9,804
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,92.2,90.0 to 94.0,1715
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,94.0,91.6 to 95.7,1002
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,90.2,87.9 to 92.1,1918
Polio,≥3 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,95.5,92.8 to 97.5,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,96.4,94.6 to 97.8,780
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,91.1,87.3 to 93.8,916
DTaP,≥3 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,96.0,93.8 to 97.6,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,96.2,94.2 to 97.6,797
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,95.4,94.0 to 96.5,1723
Hib,Full Series,HHS Regions/National,Region 2,2015,Age,24 Months,79.3,75.4 to 82.9,818
Hib,Full Series,HHS Regions/National,Region 2,2015-2016,Age,24 Months,79.2,76.3 to 82.0,1622
Hib,≥3 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,90.9,87.4 to 93.4,916
Polio,≥3 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,90.3,86.6 to 93.3,916
Polio,≥3 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,94.1,91.9 to 95.8,1002
Polio,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,92.2,90.1 to 94.0,1918
Polio,≥3 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,92.8,90.1 to 95.1,911
Polio,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,93.5,91.7 to 94.9,1913
Hib,Full Series,HHS Regions/National,Region 2,2017,Age,24 Months,81.4,77.6 to 85.0,911
Hib,Full Series,HHS Regions/National,Region 2,2017-2018,Age,24 Months,81.0,78.4 to 83.5,1913
Hib,Full Series,HHS Regions/National,Region 2,2016,Age,24 Months,79.1,74.8 to 83.2,804
Hib,Full Series,HHS Regions/National,Region 2,2016-2017,Age,24 Months,80.3,77.4 to 83.0,1715
Hib,Full Series,HHS Regions/National,Region 2,2018,Age,24 Months,80.6,77.0 to 83.9,1002
Hib,Full Series,HHS Regions/National,Region 2,2018-2019,Age,24 Months,80.0,77.2 to 82.6,1918
Hib,≥3 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,94.0,91.7 to 95.9,797
Hib,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,93.0,91.3 to 94.4,1723
Hib,≥3 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,94.7,92.5 to 96.4,780
Hib,≥3 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,93.2,90.3 to 95.4,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,95.2,93.2 to 96.6,797
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,94.2,92.4 to 95.6,1723
DTaP,≥2 Doses,HHS Regions/National,Region 2,2014,Age,5 Months,80.0,76.4 to 83.1,926
DTaP,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,5 Months,79.6,76.7 to 82.3,1744
Polio,≥3 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,94.2,91.8 to 96.0,780
Polio,≥3 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,93.1,90.5 to 95.2,818
Polio,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,93.5,91.4 to 95.3,1622
Polio,≥3 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,94.0,91.4 to 96.1,911
Polio,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,94.8,93.1 to 96.2,1913
Polio,≥3 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,93.3,90.0 to 95.8,804
Polio,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,93.8,91.7 to 95.5,1715
DTaP,≥2 Doses,HHS Regions/National,Region 2,2015,Age,5 Months,79.3,75.4 to 82.7,818
DTaP,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,5 Months,78.1,75.1 to 80.9,1622
DTaP,≥2 Doses,HHS Regions/National,Region 2,2013,Age,5 Months,76.6,72.9 to 80.0,797
DTaP,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,5 Months,78.3,75.4 to 80.9,1723
DTaP,≥2 Doses,HHS Regions/National,Region 2,2012,Age,5 Months,78.6,75.4 to 81.5,780
DTaP,≥2 Doses,HHS Regions/National,Region 2,2011,Age,5 Months,79.0,74.5 to 83.0,730
Hib,Full Series,HHS Regions/National,Region 2,2011,Age,35 Months,84.0,79.8 to 87.7,730
Hib,Full Series,HHS Regions/National,Region 2,2012,Age,35 Months,87.0,82.9 to 90.6,780
Hib,Full Series,HHS Regions/National,Region 2,2013,Age,35 Months,87.4,83.4 to 90.7,797
Hib,Full Series,HHS Regions/National,Region 2,2013-2014,Age,35 Months,86.3,83.7 to 88.7,1723
Polio,≥3 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,95.2,92.7 to 97.1,926
Polio,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,94.3,92.4 to 95.8,1744
Polio,≥3 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,96.2,94.0 to 97.7,797
Polio,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,95.8,94.1 to 97.1,1723
Hib,Full Series,HHS Regions/National,Region 2,2019,Age,24 Months,79.4,74.9 to 83.5,916
Polio,≥3 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,95.6,93.4 to 97.3,1002
Polio,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,94.0,91.8 to 95.8,1918
Hib,≥3 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,91.8,89.3 to 93.9,926
Hib,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,91.5,89.7 to 93.2,1744
Hib,Full Series,HHS Regions/National,Region 2,2015,Age,35 Months,85.0,81.2 to 88.3,818
Hib,Full Series,HHS Regions/National,Region 2,2015-2016,Age,35 Months,83.2,80.3 to 85.9,1622
Hib,Full Series,HHS Regions/National,Region 2,2017,Age,35 Months,86.1,82.3 to 89.5,911
Hib,Full Series,HHS Regions/National,Region 2,2017-2018,Age,35 Months,85.9,83.2 to 88.3,1913
Hib,Full Series,HHS Regions/National,Region 2,2014,Age,35 Months,85.4,81.9 to 88.5,926
Hib,Full Series,HHS Regions/National,Region 2,2014-2015,Age,35 Months,85.2,82.7 to 87.5,1744
Hib,Full Series,HHS Regions/National,Region 2,2018,Age,35 Months,85.6,81.8 to 89.0,1002
Hib,Full Series,HHS Regions/National,Region 2,2018-2019,Age,35 Months,85.0,81.9 to 87.7,1918
Hib,Full Series,HHS Regions/National,Region 2,2016,Age,35 Months,81.7,77.3 to 85.7,804
Hib,Full Series,HHS Regions/National,Region 2,2016-2017,Age,35 Months,83.9,81.0 to 86.6,1715
Polio,≥3 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,92.3,88.5 to 95.2,916
Hib,Full Series,HHS Regions/National,Region 2,2019,Age,35 Months,84.5,79.7 to 88.7,916
PCV,≥1 Dose,HHS Regions/National,Region 2,2012,Age,3 Months,79.4,75.1 to 83.2,780
PCV,≥4 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,86.7,82.7 to 90.1,797
PCV,≥4 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,85.8,83.2 to 88.1,1723
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020-2021,Age,13 Months,53.0,49.4 to 56.6,1462
Hib,Primary Series,HHS Regions/National,Region 2,2012,Age,7 Months,65.7,61.6 to 69.6,780
Hib,Primary Series,HHS Regions/National,Region 2,2011,Age,7 Months,66.4,61.4 to 71.1,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2017,Age,35 Months,87.4,83.8 to 90.5,911
Hep A,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,35 Months,88.2,85.8 to 90.4,1913
Polio,≥2 Doses,HHS Regions/National,Region 2,2016,Age,5 Months,73.7,68.9 to 78.0,804
Polio,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,5 Months,77.0,73.9 to 79.8,1715
Polio,≥2 Doses,HHS Regions/National,Region 2,2017,Age,5 Months,80.4,76.5 to 83.8,911
Polio,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,5 Months,80.5,77.9 to 82.8,1913
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,46.4,42.3 to 50.5,926
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,46.6,43.6 to 49.6,1744
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,46.8,42.4 to 51.3,818
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,46.5,43.2 to 49.8,1622
≥1 Dose MMR,,HHS Regions/National,Region 2,2012,Age,13 Months,50.2,42.6 to 57.7,780
≥1 Dose MMR,,HHS Regions/National,Region 2,2011,Age,13 Months,49.0,42.8 to 55.3,730
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016,Age,13 Months,52.8,47.9 to 57.7,804
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016-2017,Age,13 Months,53.8,50.5 to 57.2,1715
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017,Age,13 Months,54.9,50.3 to 59.5,911
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017-2018,Age,13 Months,57.5,54.4 to 60.7,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015,Age,13 Months,54.4,49.9 to 58.7,818
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015-2016,Age,13 Months,53.6,50.2 to 56.9,1622
Hep A,≥2 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,33.8,29.6 to 38.5,818
Hep A,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,34.7,31.5 to 38.2,1622
Hep A,≥2 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,32.5,28.8 to 36.7,926
Hep A,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,33.2,30.3 to 36.3,1744
Hep A,≥2 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,31.6,27.4 to 36.2,780
Hep A,≥1 Dose,HHS Regions/National,Region 2,2013,Age,35 Months,88.9,84.8 to 92.3,797
Hep A,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,35 Months,88.3,85.7 to 90.6,1723
Hep A,≥1 Dose,HHS Regions/National,Region 2,2014,Age,35 Months,88.0,84.5 to 91.0,926
Hep A,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,35 Months,87.9,85.2 to 90.3,1744
DTaP,≥4 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,81.1,77.7 to 84.3,926
DTaP,≥4 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,81.4,78.9 to 83.8,1744
DTaP,≥4 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,78.8,74.3 to 83.0,804
DTaP,≥4 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,80.8,77.9 to 83.6,1715
DTaP,≥4 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,81.6,77.8 to 85.2,818
DTaP,≥4 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,80.2,77.3 to 83.0,1622
Hep A,≥1 Dose,HHS Regions/National,Region 2,2016,Age,35 Months,83.7,79.0 to 87.8,804
Hep A,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,35 Months,85.5,82.6 to 88.1,1715
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,91.4,88.7 to 93.5,1002
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,86.5,84.0 to 88.7,1918
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,90.1,87.0 to 92.5,911
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,90.7,88.7 to 92.4,1913
Hep B,≥2 Doses,HHS Regions/National,Region 2,2016,Age,5 Months,83.1,78.8 to 86.6,804
Hep B,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,5 Months,85.5,82.9 to 87.8,1715
Hep B,≥2 Doses,HHS Regions/National,Region 2,2014,Age,5 Months,84.7,81.6 to 87.4,926
Hep B,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,5 Months,86.0,82.6 to 88.9,1744
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2012,Age,0-1 Days,54.2,46.4 to 61.7,780
PCV,≥3 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,57.5,52.0 to 62.9,797
PCV,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,58.6,54.9 to 62.3,1723
PCV,≥3 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,60.8,56.0 to 65.4,730
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,86.8,82.9 to 89.9,804
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,88.4,86.0 to 90.5,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,59.7,55.6 to 63.7,926
PCV,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,59.4,56.4 to 62.4,1744
PCV,≥3 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,57.8,53.0 to 62.4,780
≥1 Dose MMR,,HHS Regions/National,Region 2,2019,Age,13 Months,62.0,57.1 to 66.7,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016,Age,19 Months,82.9,78.6 to 86.5,804
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016-2017,Age,19 Months,85.5,82.8 to 87.8,1715
Polio,≥2 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,93.6,90.9 to 95.6,818
Polio,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,92.2,90.0 to 93.9,1622
Polio,≥2 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,90.8,87.2 to 93.4,804
Polio,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,92.4,90.3 to 94.1,1715
Hep B,≥1 Dose,HHS Regions/National,Region 2,2017,Age,3 Months,96.1,94.2 to 97.4,911
Hep B,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,3 Months,94.9,93.3 to 96.1,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018,Age,19 Months,87.8,84.4 to 90.5,1002
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018-2019,Age,19 Months,56.3,53.1 to 59.5,1918
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017,Age,19 Months,88.1,84.6 to 90.9,911
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017-2018,Age,19 Months,88.0,85.6 to 90.0,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2013,Age,19 Months,88.5,85.7 to 90.8,797
≥1 Dose MMR,,HHS Regions/National,Region 2,2013-2014,Age,19 Months,87.3,86.0 to 88.4,1723
≥1 Dose MMR,,HHS Regions/National,Region 2,2014,Age,19 Months,86.0,82.6 to 88.8,926
≥1 Dose MMR,,HHS Regions/National,Region 2,2014-2015,Age,19 Months,87.8,85.6 to 89.7,1744
≥1 Dose MMR,,HHS Regions/National,Region 2,2012,Age,19 Months,87.3,83.0 to 90.7,780
DTaP,≥4 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,91.2,87.3 to 94.3,1002
DTaP,≥4 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,88.6,85.6 to 91.3,1918
Hep B,≥1 Dose,HHS Regions/National,Region 2,2019,Age,3 Months,96.4,94.3 to 97.8,916
Polio,≥2 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,95.3,93.4 to 96.7,926
Polio,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,94.5,92.9 to 95.7,1744
Hep B,≥1 Dose,HHS Regions/National,Region 2,2018,Age,3 Months,93.7,91.0 to 95.6,1002
Hep B,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,3 Months,95.0,93.4 to 96.3,1918
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2011,Age,0-1 Days,52.2,48.4 to 56.1,730
Hep A,≥2 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,75.5,69.7 to 80.9,892
Hep B,≥2 Doses,HHS Regions/National,Region 2,2012,Age,5 Months,84.3,80.5 to 87.5,780
Hep B,≥2 Doses,HHS Regions/National,Region 2,2011,Age,5 Months,82.5,79.1 to 85.4,730
Hep B,≥2 Doses,HHS Regions/National,Region 2,2013,Age,5 Months,86.6,83.8 to 88.9,797
Hep B,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,5 Months,85.7,82.8 to 88.1,1723
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,92.2,90.3 to 93.7,797
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,91.1,89.3 to 92.6,1723
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,90.0,87.2 to 92.2,926
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,90.3,88.3 to 92.0,1744
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,90.6,87.5 to 93.0,818
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,88.7,86.2 to 90.7,1622
≥1 Dose MMR,,HHS Regions/National,Region 2,2015,Age,19 Months,89.6,87.3 to 91.5,818
≥1 Dose MMR,,HHS Regions/National,Region 2,2015-2016,Age,19 Months,86.6,84.1 to 88.7,1622
≥1 Dose MMR,,HHS Regions/National,Region 2,2016,Age,19 Months,83.7,79.5 to 87.1,804
≥1 Dose MMR,,HHS Regions/National,Region 2,2016-2017,Age,19 Months,86.9,84.4 to 89.1,1715
≥1 Dose MMR,,HHS Regions/National,Region 2,2017,Age,19 Months,90.4,87.3 to 92.8,911
≥1 Dose MMR,,HHS Regions/National,Region 2,2017-2018,Age,19 Months,90.7,88.6 to 92.4,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2011,Age,24 Months,91.0,88.0 to 93.5,730
≥1 Dose Varicella,,HHS Regions/National,Region 2,2012,Age,24 Months,90.0,87.0 to 92.6,780
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019,Age,19 Months,87.6,83.7 to 90.6,916
Polio,≥2 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,93.4,90.0 to 95.6,916
Polio,≥2 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,94.3,92.0 to 96.0,1002
Polio,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,93.9,91.9 to 95.3,1918
Polio,≥2 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,94.1,91.4 to 96.0,911
Polio,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,94.2,92.5 to 95.6,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013,Age,24 Months,91.4,88.6 to 93.8,797
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013-2014,Age,24 Months,90.1,88.1 to 91.9,1723
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2013,Age,0-1 Days,54.1,48.1 to 60.0,797
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2013-2014,Age,0-1 Days,56.4,51.6 to 61.1,1723
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2014,Age,0-1 Days,58.8,54.7 to 62.7,926
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2014-2015,Age,0-1 Days,60.5,57.5 to 63.3,1744
Hep B,≥2 Doses,HHS Regions/National,Region 2,2015,Age,5 Months,87.3,84.0 to 90.0,818
Hep B,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,5 Months,85.2,82.5 to 87.5,1622
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2015,Age,0-1 Days,62.2,57.8 to 66.4,818
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2015-2016,Age,0-1 Days,61.2,58.0 to 64.4,1622
DTaP,≥4 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,90.1,86.3 to 93.1,911
DTaP,≥4 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,90.5,87.9 to 92.7,1913
DTaP,≥4 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,86.5,81.8 to 90.5,804
DTaP,≥4 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,88.3,85.4 to 91.0,1715
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,84.3,80.2 to 87.7,804
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,85.4,82.8 to 87.7,1715
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,88.4,85.2 to 91.0,818
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,86.3,83.8 to 88.5,1622
DTaP,≥4 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,87.6,83.7 to 91.0,818
DTaP,≥4 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,87.2,84.1 to 89.9,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,86.5,83.1 to 89.3,911
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,87.4,85.2 to 89.4,1913
Polio,≥2 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,89.5,86.4 to 92.0,1002
Polio,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,89.1,86.7 to 91.1,1918
Hep B,≥1 Dose,HHS Regions/National,Region 2,2013,Age,3 Months,93.9,91.5 to 95.7,797
Hep B,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,3 Months,93.8,91.9 to 95.3,1723
Hep B,≥1 Dose,HHS Regions/National,Region 2,2012,Age,3 Months,92.8,90.4 to 94.6,780
Hep B,≥1 Dose,HHS Regions/National,Region 2,2011,Age,3 Months,91.5,87.1 to 94.5,730
Polio,≥2 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,85.0,80.7 to 88.4,804
Polio,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,88.1,85.6 to 90.3,1715
Polio,≥2 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,91.4,88.5 to 93.7,911
Polio,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,90.5,88.4 to 92.2,1913
Polio,≥2 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,88.6,84.9 to 91.6,916
Polio,≥2 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,94.9,93.2 to 96.2,797
Polio,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,95.1,93.8 to 96.1,1723
Hep B,≥1 Dose,HHS Regions/National,Region 2,2014,Age,3 Months,93.7,91.5 to 95.4,926
Hep B,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,3 Months,94.0,92.4 to 95.3,1744
Hep B,≥1 Dose,HHS Regions/National,Region 2,2015,Age,3 Months,94.3,91.7 to 96.1,818
Hep B,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,3 Months,93.4,91.4 to 94.9,1622
Hep B,≥1 Dose,HHS Regions/National,Region 2,2016,Age,3 Months,92.5,89.2 to 94.8,804
Hep B,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,3 Months,94.2,92.4 to 95.7,1715
≥1 Dose MMR,,HHS Regions/National,Region 2,2018,Age,13 Months,70.8,66.5 to 74.7,1002
≥1 Dose MMR,,HHS Regions/National,Region 2,2018-2019,Age,13 Months,66.4,63.2 to 69.5,1918
≥1 Dose MMR,,HHS Regions/National,Region 2,2016,Age,13 Months,55.1,50.2 to 60.0,804
≥1 Dose MMR,,HHS Regions/National,Region 2,2016-2017,Age,13 Months,57.4,54.0 to 60.7,1715
≥1 Dose MMR,,HHS Regions/National,Region 2,2017,Age,13 Months,59.8,55.2 to 64.3,911
≥1 Dose MMR,,HHS Regions/National,Region 2,2017-2018,Age,13 Months,65.2,62.1 to 68.3,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014,Age,19 Months,87.7,84.6 to 90.2,926
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014-2015,Age,19 Months,87.8,85.7 to 89.6,1744
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015,Age,19 Months,87.9,84.9 to 90.4,818
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015-2016,Age,19 Months,85.4,82.8 to 87.6,1622
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013,Age,19 Months,87.5,84.2 to 90.2,797
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013-2014,Age,19 Months,87.6,85.7 to 89.2,1723
Polio,≥2 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,95.4,93.9 to 96.6,780
Polio,≥2 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,95.0,91.4 to 97.2,730
DTaP,≥4 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,80.7,76.3 to 84.8,916
DTaP,≥4 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,90.4,86.3 to 93.6,730
DTaP,≥4 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,85.8,81.4 to 89.7,916
≥1 Dose MMR,,HHS Regions/National,Region 2,2011,Age,19 Months,90.2,86.8 to 92.8,730
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,84.7,80.7 to 88.0,916
Hep B,≥3 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,87.9,85.1 to 90.3,730
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,88.4,85.2 to 90.9,1002
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,86.5,84.0 to 88.7,1918
Hep B,≥3 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,90.3,87.5 to 92.6,780
DTaP,≥4 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,82.0,78.4 to 85.3,1002
DTaP,≥4 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,81.4,78.5 to 84.0,1918
DTaP,≥4 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,83.0,79.2 to 86.4,911
DTaP,≥4 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,82.5,79.9 to 84.9,1913
Polio,≥2 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,89.7,86.9 to 91.9,926
Polio,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,89.8,87.8 to 91.5,1744
Polio,≥2 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,88.8,86.1 to 91.0,797
Polio,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,89.2,87.3 to 90.8,1723
Polio,≥2 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,90.0,86.8 to 92.4,818
Polio,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,87.4,84.9 to 89.6,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,83.5,79.9 to 86.6,730
Hep A,≥2 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,80.4,75.3 to 85.0,1002
Hep A,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,79.5,75.0 to 83.7,1918
Hep A,≥2 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,73.7,68.3 to 78.8,911
Hep A,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,76.9,73.3 to 80.5,1913
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,87.6,86.0 to 89.2,797
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,86.3,84.4 to 88.0,1723
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,84.9,81.7 to 87.6,926
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,86.6,84.5 to 88.6,1744
Hep A,≥2 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,78.6,71.0 to 85.3,916
Hep B,≥3 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,85.6,82.6 to 88.1,780
DTaP,≥4 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,91.5,88.3 to 94.1,797
DTaP,≥4 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,90.2,88.0 to 92.2,1723
DTaP,≥4 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,92.0,88.3 to 94.8,780
DTaP,≥4 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,88.8,85.6 to 91.6,926
DTaP,≥4 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,88.3,85.9 to 90.5,1744
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018,Age,13 Months,60.2,55.9 to 64.4,1002
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018-2019,Age,13 Months,56.3,53.1 to 59.5,1918
≥1 Dose MMR,,HHS Regions/National,Region 2,2013,Age,13 Months,49.9,43.6 to 56.2,797
≥1 Dose MMR,,HHS Regions/National,Region 2,2013-2014,Age,13 Months,53.8,49.2 to 58.3,1723
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019,Age,13 Months,52.4,47.5 to 57.2,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2011,Age,19 Months,87.3,83.1 to 90.6,730
≥1 Dose Varicella,,HHS Regions/National,Region 2,2012,Age,19 Months,86.2,83.2 to 88.7,780
≥1 Dose MMR,,HHS Regions/National,Region 2,2014,Age,13 Months,57.7,53.6 to 61.7,926
≥1 Dose MMR,,HHS Regions/National,Region 2,2014-2015,Age,13 Months,59.1,56.1 to 62.0,1744
≥1 Dose MMR,,HHS Regions/National,Region 2,2015,Age,13 Months,60.5,56.1 to 64.7,818
≥1 Dose MMR,,HHS Regions/National,Region 2,2015-2016,Age,13 Months,57.8,54.5 to 61.0,1622
Hep A,≥2 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,34.8,30.5 to 39.4,911
Hep A,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,38.0,35.0 to 41.3,1913
Hep A,≥2 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,35.6,30.9 to 40.7,804
Hep A,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,35.2,32.0 to 38.6,1715
DTaP,≥4 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,83.9,80.4 to 87.0,797
DTaP,≥4 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,82.5,80.1 to 84.8,1723
DTaP,≥4 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,71.3,66.6 to 75.6,916
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,49.5,44.6 to 54.5,797
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,47.9,43.7 to 52.3,1723
DTaP,≥4 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,81.7,77.7 to 85.3,730
DTaP,≥4 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,84.0,80.5 to 87.2,780
Hep B,≥3 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,47.8,42.8 to 52.8,780
Hep B,≥3 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,41.8,37.8 to 45.8,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2015,Age,35 Months,87.8,83.5 to 91.4,818
Hep A,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,35 Months,85.5,82.4 to 88.3,1622
Polio,≥2 Doses,HHS Regions/National,Region 2,2012,Age,5 Months,73.7,69.6 to 77.4,780
Polio,≥2 Doses,HHS Regions/National,Region 2,2011,Age,5 Months,76.0,71.1 to 80.3,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2012,Age,35 Months,84.8,80.7 to 88.4,780
Polio,≥2 Doses,HHS Regions/National,Region 2,2013,Age,5 Months,72.5,69.2 to 75.6,797
Polio,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,5 Months,74.4,71.7 to 76.9,1723
Polio,≥2 Doses,HHS Regions/National,Region 2,2014,Age,5 Months,76.3,72.6 to 79.7,926
Polio,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,5 Months,76.3,73.2 to 79.1,1744
DTaP,≥4 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,69.4,65.2 to 73.3,1002
DTaP,≥4 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,93.9,91.9 to 95.3,1918
Hep A,≥2 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,32.5,28.4 to 37.0,797
Hep A,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,32.5,29.7 to 35.5,1723
DTaP,≥4 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,67.0,62.1 to 71.5,804
DTaP,≥4 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,70.0,66.8 to 73.0,1715
DTaP,≥4 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,73.2,69.0 to 76.9,911
DTaP,≥4 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,71.3,68.4 to 74.1,1913
PCV,≥2 Doses,HHS Regions/National,Region 2,2019,Age,5 Months,75.5,71.1 to 79.5,916
PCV,≥2 Doses,HHS Regions/National,Region 2,2017,Age,5 Months,76.5,72.4 to 80.2,911
PCV,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,5 Months,77.1,74.3 to 79.6,1913
PCV,≥2 Doses,HHS Regions/National,Region 2,2018,Age,5 Months,77.7,73.8 to 81.1,1002
PCV,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,5 Months,76.6,73.7 to 79.3,1918
Hib,≥3 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,93.5,90.2 to 96.1,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2011,Age,13 Months,52.8,47.1 to 58.4,730
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013,Age,13 Months,53.6,49.6 to 57.6,797
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013-2014,Age,13 Months,53.4,50.3 to 56.5,1723
Polio,≥2 Doses,HHS Regions/National,Region 2,2018,Age,5 Months,80.5,76.9 to 83.7,1002
Polio,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,5 Months,79.4,76.6 to 81.9,1918
Hep A,≥1 Dose,HHS Regions/National,Region 2,2019,Age,35 Months,88.6,84.0 to 92.3,916
Hep A,≥1 Dose,HHS Regions/National,Region 2,2018,Age,35 Months,89.2,85.9 to 92.1,1002
Hep A,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,35 Months,88.9,86.1 to 91.3,1918
≥1 Dose Varicella,,HHS Regions/National,Region 2,2012,Age,13 Months,52.6,47.1 to 58.0,780
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014,Age,13 Months,53.2,49.1 to 57.2,926
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014-2015,Age,13 Months,53.8,50.7 to 56.8,1744
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,44.1,39.4 to 49.0,916
Hep A,≥2 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,67.7,62.8 to 72.6,926
Hep A,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,70.1,66.3 to 73.9,1744
Hep A,≥2 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,70.1,64.2 to 75.8,804
Hep A,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,71.9,67.8 to 75.7,1715
Hep A,≥2 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,72.7,66.8 to 78.3,818
Hep A,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,71.2,67.0 to 75.2,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,51.9,47.6 to 56.2,1002
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,48.1,44.8 to 51.3,1918
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,47.3,42.7 to 51.8,911
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,49.6,46.4 to 52.7,1913
Polio,≥2 Doses,HHS Regions/National,Region 2,2019,Age,5 Months,78.3,73.9 to 82.1,916
Hib,Full Series,HHS Regions/National,Region 2,2020,Age,24 Months,78.7,74.7 to 82.5,892
Polio,≥2 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,88.8,85.2 to 91.6,780
Polio,≥2 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,88.8,85.3 to 91.6,730
Hep A,≥2 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,41.4,37.1 to 46.0,1002
Hep A,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,35.9,32.8 to 39.2,1918
Hep A,≥2 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,30.3,26.1 to 35.0,916
Polio,≥2 Doses,HHS Regions/National,Region 2,2015,Age,5 Months,76.2,72.1 to 79.8,818
Polio,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,5 Months,74.9,71.8 to 77.8,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,46.1,41.3 to 51.0,804
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,46.7,43.4 to 50.0,1715
Hep A,≥2 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,68.1,62.1 to 74.0,730
Hep A,≥2 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,66.8,61.1 to 72.4,780
Hep A,≥2 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,73.7,67.9 to 79.2,797
Hep A,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,70.9,67.0 to 74.7,1723
PCV,≥3 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,93.8,91.4 to 95.8,926
PCV,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,93.3,91.4 to 94.9,1744
PCV,≥3 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,92.5,89.3 to 95.1,818
PCV,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,92.1,89.9 to 93.9,1622
PCV,≥3 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,91.8,88.5 to 94.4,804
PCV,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,92.8,90.8 to 94.6,1715
Hib,≥3 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,55.1,52.0 to 58.2,780
Hib,≥3 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,60.9,55.4 to 66.1,730
Hib,≥3 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,50.9,47.3 to 54.4,797
Hib,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,53.7,50.9 to 56.3,1723
Polio,≥1 Dose,HHS Regions/National,Region 2,2014,Age,3 Months,86.7,83.7 to 89.3,926
Polio,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,3 Months,86.4,84.2 to 88.3,1744
Polio,≥1 Dose,HHS Regions/National,Region 2,2015,Age,3 Months,86.0,82.7 to 88.8,818
Polio,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,3 Months,84.5,82.0 to 86.8,1622
Polio,≥1 Dose,HHS Regions/National,Region 2,2016,Age,3 Months,83.1,79.0 to 86.5,804
Polio,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,3 Months,84.8,82.1 to 87.1,1715
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2017,Age,0-3 Days,72.8,66.3 to 78.5,476
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2017-2018,Age,0-3 Days,76.7,74.0 to 79.2,1913
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2016,Age,0-3 Days,69.7,64.9 to 74.0,804
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2016-2017,Age,0-3 Days,72.0,68.9 to 74.9,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,92.8,90.3 to 94.9,1002
PCV,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,92.4,90.4 to 94.1,1918
Hib,≥2 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,89.7,86.3 to 92.3,916
Hib,≥2 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,95.5,93.8 to 96.8,780
Hib,≥2 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,94.1,89.9 to 96.6,730
Hib,≥2 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,84.9,80.5 to 88.3,804
Hib,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,87.4,84.8 to 89.7,1715
Hib,≥2 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,90.2,87.0 to 92.6,911
Hib,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,90.0,87.9 to 91.8,1913
Hib,≥2 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,89.9,86.8 to 92.4,1002
Hib,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,89.8,87.6 to 91.7,1918
PCV,≥3 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,94.9,92.5 to 96.7,780
PCV,≥1 Dose,HHS Regions/National,Region 2,2019,Age,3 Months,85.4,81.6 to 88.6,916
Polio,≥1 Dose,HHS Regions/National,Region 2,2012,Age,3 Months,84.4,79.8 to 88.2,780
Polio,≥1 Dose,HHS Regions/National,Region 2,2011,Age,3 Months,84.8,79.6 to 88.9,730
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2013,Age,0-3 Days,63.4,59.2 to 67.4,797
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2013-2014,Age,0-3 Days,65.1,62.2 to 67.9,1723
Polio,≥1 Dose,HHS Regions/National,Region 2,2013,Age,3 Months,83.0,79.0 to 86.4,797
Polio,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,3 Months,84.9,81.9 to 87.4,1723
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2014,Age,0-3 Days,66.8,62.8 to 70.5,926
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2014-2015,Age,0-3 Days,68.4,65.5 to 71.1,1744
Hib,≥2 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,89.0,85.9 to 91.5,818
Hib,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,86.9,84.3 to 89.2,1622
PCV,≥3 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,92.0,88.8 to 94.5,916
PCV,≥3 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,94.1,91.2 to 96.2,730
PCV,≥3 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,94.9,92.5 to 96.6,797
PCV,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,94.3,92.7 to 95.7,1723
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,63.0,58.9 to 67.0,797
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,65.7,62.6 to 68.6,1723
DTaP,≥3 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,67.0,63.8 to 70.1,780
DTaP,≥3 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,69.1,63.8 to 73.9,730
PCV,≥1 Dose,HHS Regions/National,Region 2,2014,Age,3 Months,80.3,76.9 to 83.3,926
PCV,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,3 Months,81.2,78.7 to 83.4,1744
PCV,≥1 Dose,HHS Regions/National,Region 2,2015,Age,3 Months,82.0,78.4 to 85.1,818
PCV,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,3 Months,81.0,78.2 to 83.5,1622
PCV,≥3 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,92.4,89.6 to 94.7,911
PCV,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,92.6,90.8 to 94.2,1913
PCV,≥3 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,91.0,87.7 to 93.7,804
PCV,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,91.7,89.6 to 93.5,1715
Hib,≥2 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,89.5,85.8 to 92.3,780
PCV,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,91.1,88.9 to 93.0,1622
Hib,≥2 Doses,HHS Regions/National,Region 2,2019,Age,5 Months,77.6,73.3 to 81.4,916
Hib,≥2 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,88.7,86.0 to 90.9,730
Hib,≥2 Doses,HHS Regions/National,Region 2,2018,Age,5 Months,80.6,77.0 to 83.7,1002
Hib,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,5 Months,79.1,76.4 to 81.6,1918
Hib,≥2 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,89.7,86.9 to 92.0,797
Hib,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,89.9,87.8 to 91.8,1723
Hib,≥2 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,90.2,87.5 to 92.3,926
Hib,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,89.6,87.6 to 91.3,1744
PCV,≥1 Dose,HHS Regions/National,Region 2,2016,Age,3 Months,80.0,75.7 to 83.6,804
PCV,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,3 Months,81.5,78.7 to 84.1,1715
PCV,≥1 Dose,HHS Regions/National,Region 2,2017,Age,3 Months,83.2,79.3 to 86.5,911
PCV,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,3 Months,84.0,81.4 to 86.2,1913
PCV,≥1 Dose,HHS Regions/National,Region 2,2018,Age,3 Months,84.8,81.4 to 87.7,1002
PCV,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,3 Months,85.1,82.6 to 87.3,1918
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2011,Age,0-3 Days,59.3,54.5 to 63.9,730
PCV,≥3 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,90.6,87.1 to 93.2,916
PCV,≥3 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,93.4,90.6 to 95.6,730
PCV,≥3 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,92.2,89.5 to 94.2,1002
PCV,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,87.7,85.2 to 89.8,1918
Hep B,≥2 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,94.8,91.9 to 96.7,916
Hib,≥2 Doses,HHS Regions/National,Region 2,2012,Age,5 Months,73.4,71.0 to 75.7,780
Hib,≥2 Doses,HHS Regions/National,Region 2,2011,Age,5 Months,76.9,72.9 to 80.5,730
Hib,≥2 Doses,HHS Regions/National,Region 2,2013,Age,5 Months,72.2,68.5 to 75.6,797
Hib,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,5 Months,74.7,71.5 to 77.6,1723
Hib,≥2 Doses,HHS Regions/National,Region 2,2014,Age,5 Months,77.2,73.6 to 80.5,926
Hib,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,5 Months,77.0,73.7 to 79.9,1744
PCV,≥3 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,90.9,87.8 to 93.3,911
PCV,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,91.6,89.6 to 93.2,1913
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2012,Age,0-3 Days,63.0,58.7 to 67.1,780
PCV,≥1 Dose,HHS Regions/National,Region 2,2011,Age,3 Months,79.5,75.1 to 83.3,730
PCV,≥4 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,80.2,75.8 to 84.2,804
PCV,≥4 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,82.4,79.4 to 85.3,1715
PCV,≥4 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,87.0,83.6 to 90.0,1002
PCV,≥4 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,83.8,81.0 to 86.4,1918
Hib,≥2 Doses,HHS Regions/National,Region 2,2015,Age,5 Months,76.7,72.7 to 80.3,818
Hib,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,5 Months,75.3,72.2 to 78.2,1622
Hib,≥2 Doses,HHS Regions/National,Region 2,2016,Age,5 Months,73.9,69.1 to 78.2,804
Hib,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,5 Months,76.8,73.7 to 79.6,1715
PCV,≥1 Dose,HHS Regions/National,Region 2,2013,Age,3 Months,78.2,72.7 to 82.8,797
PCV,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,3 Months,79.2,75.2 to 82.8,1723
PCV,≥3 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,91.0,88.1 to 93.4,818
PCV,≥3 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,91.6,89.2 to 93.7,926
PCV,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,91.3,89.5 to 93.0,1744
PCV,≥3 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,93.7,91.2 to 95.7,780
Hib,≥2 Doses,HHS Regions/National,Region 2,2017,Age,5 Months,79.8,75.8 to 83.2,911
Hib,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,5 Months,80.2,77.5 to 82.6,1913
PCV,≥3 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,93.7,91.5 to 95.6,797
PCV,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,92.7,91.0 to 94.1,1723
Hib,≥1 Dose,HHS Regions/National,Region 2,2019,Age,3 Months,86.4,82.6 to 89.5,916
Hib,≥1 Dose,HHS Regions/National,Region 2,2018,Age,3 Months,88.1,85.1 to 90.6,1002
Hib,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,3 Months,87.3,84.9 to 89.3,1918
PCV,≥4 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,86.8,82.9 to 90.3,818
PCV,≥4 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,83.2,80.2 to 85.9,1622
PCV,≥4 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,85.0,81.6 to 88.0,926
PCV,≥4 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,85.8,83.3 to 88.2,1744
Hep B,≥2 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,94.4,92.0 to 96.2,1002
Hep B,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,94.6,92.8 to 96.0,1918
Hep B,≥2 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,91.6,88.1 to 94.1,804
Hep B,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,92.8,90.7 to 94.5,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,90.7,88.5 to 92.6,818
PCV,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,90.0,87.7 to 91.8,1622
PCV,≥3 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,89.2,85.6 to 92.0,804
PCV,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,90.0,87.7 to 92.0,1715
Hib,≥1 Dose,HHS Regions/National,Region 2,2015,Age,3 Months,85.0,81.6 to 87.9,818
Hib,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,3 Months,84.1,81.4 to 86.4,1622
Hib,≥1 Dose,HHS Regions/National,Region 2,2016,Age,3 Months,83.1,78.9 to 86.6,804
Hib,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,3 Months,84.5,81.8 to 86.9,1715
Hib,≥1 Dose,HHS Regions/National,Region 2,2017,Age,3 Months,86.0,82.3 to 89.1,911
Hib,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,3 Months,87.1,84.7 to 89.1,1913
Hep B,≥2 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,94.0,91.3 to 96.0,911
Hep B,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,94.2,92.5 to 95.6,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2018,Age,35 Months,95.5,93.0 to 97.3,1002
≥1 Dose MMR,,HHS Regions/National,Region 2,2018-2019,Age,35 Months,94.7,92.4 to 96.4,1918
≥1 Dose MMR,,HHS Regions/National,Region 2,2017,Age,35 Months,93.7,91.0 to 95.8,911
≥1 Dose MMR,,HHS Regions/National,Region 2,2017-2018,Age,35 Months,94.6,92.8 to 96.1,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2019,Age,35 Months,93.8,89.8 to 96.6,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019,Age,35 Months,94.6,90.0 to 97.5,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018,Age,35 Months,93.7,91.1 to 95.8,1002
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018-2019,Age,35 Months,94.0,91.7 to 95.9,1918
PCV,≥4 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,80.7,77.0 to 84.2,818
PCV,≥4 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,78.8,75.9 to 81.6,1622
≥1 Dose MMR,,HHS Regions/National,Region 2,2016,Age,35 Months,93.1,89.6 to 95.7,804
≥1 Dose MMR,,HHS Regions/National,Region 2,2016-2017,Age,35 Months,93.4,91.3 to 95.1,1715
≥1 Dose MMR,,HHS Regions/National,Region 2,2014,Age,35 Months,93.3,90.5 to 95.5,926
≥1 Dose MMR,,HHS Regions/National,Region 2,2014-2015,Age,35 Months,93.4,91.5 to 95.0,1744
≥1 Dose MMR,,HHS Regions/National,Region 2,2015,Age,35 Months,93.6,91.0 to 95.6,818
≥1 Dose MMR,,HHS Regions/National,Region 2,2015-2016,Age,35 Months,93.4,91.3 to 95.2,1622
PCV,≥4 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,81.6,77.8 to 85.2,911
PCV,≥4 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,83.0,80.5 to 85.3,1913
PCV,≥4 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,77.0,72.6 to 81.1,804
PCV,≥4 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,79.3,76.3 to 82.0,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,89.4,86.4 to 91.8,1002
PCV,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,87.7,85.2 to 89.8,1918
PCV,≥3 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,87.0,83.4 to 90.0,911
PCV,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,88.2,85.9 to 90.2,1913
Hep B,≥2 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,91.4,88.1 to 93.9,916
Hep B,≥2 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,92.3,89.1 to 94.6,730
Hep B,≥2 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,94.2,92.1 to 95.8,780
Hep B,≥3 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,93.2,90.5 to 95.4,780
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,92.8,90.2 to 94.9,926
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,92.6,90.7 to 94.2,1744
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,95.3,93.0 to 97.0,797
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,94.1,92.4 to 95.5,1723
PCV,≥3 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,84.4,80.2 to 87.7,804
PCV,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,85.7,83.0 to 88.0,1715
PCV,≥4 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,84.4,81.2 to 87.4,1002
PCV,≥4 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,80.9,78.2 to 83.6,1918
PCV,≥4 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,77.4,72.8 to 81.6,916
PCV,≥4 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,88.7,85.0 to 91.8,730
PCV,≥4 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,86.7,82.9 to 90.0,780
PCV,≥3 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,92.8,90.2 to 94.8,780
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,92.3,89.5 to 94.5,911
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,92.7,90.8 to 94.3,1913
PCV,≥3 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,85.9,81.8 to 89.2,916
PCV,≥3 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,91.7,88.6 to 94.0,730
PCV,≥3 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,92.4,88.9 to 94.8,797
PCV,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,90.9,88.5 to 92.8,1723
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,92.3,89.3 to 94.7,818
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,91.5,89.2 to 93.6,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,90.6,86.9 to 93.6,804
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,91.5,89.2 to 93.4,1715
PCV,≥4 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,84.8,80.6 to 88.5,911
PCV,≥4 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,85.8,83.1 to 88.3,1913
PCV,≥4 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,80.8,76.2 to 85.0,916
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,90.8,87.3 to 93.7,916
PCV,≥3 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,89.3,86.6 to 91.6,926
PCV,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,90.0,88.1 to 91.7,1744
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,93.2,90.5 to 95.4,1002
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,92.0,89.8 to 93.9,1918
Hib,≥1 Dose,HHS Regions/National,Region 2,2013,Age,3 Months,82.9,80.2 to 85.3,797
Hib,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,3 Months,84.4,82.0 to 86.4,1723
Hib,≥1 Dose,HHS Regions/National,Region 2,2012,Age,3 Months,85.5,81.2 to 88.9,780
Hib,≥1 Dose,HHS Regions/National,Region 2,2011,Age,3 Months,84.3,80.2 to 87.7,730
Hib,≥1 Dose,HHS Regions/National,Region 2,2014,Age,3 Months,85.9,82.8 to 88.5,926
Hib,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,3 Months,85.5,83.2 to 87.5,1744
Hep B,≥2 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,93.5,91.3 to 95.2,926
Hep B,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,93.8,92.2 to 95.1,1744
Hep B,≥2 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,94.1,91.5 to 95.9,818
Hep B,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,92.8,90.7 to 94.5,1622
Hep B,≥2 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,94.9,92.8 to 96.4,797
Hep B,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,94.2,92.4 to 95.6,1723
PCV,≥4 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,82.5,78.6 to 86.1,730
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,89.8,86.3 to 92.7,916
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,91.3,88.5 to 93.7,911
Hep B,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,91.6,89.7 to 93.3,1913
Hep B,≥3 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,93.2,90.0 to 95.6,730
PCV,≥4 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,81.7,78.1 to 85.1,780
PCV,≥4 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,80.7,77.3 to 83.8,926
PCV,≥4 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,80.7,78.2 to 83.0,1744
PCV,≥4 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,81.8,78.2 to 85.0,797
PCV,≥4 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,81.2,78.8 to 83.5,1723
≥1 Dose MMR,,HHS Regions/National,Region 2,2019,Age,24 Months,91.9,88.6 to 94.5,916
≥1 Dose MMR,,HHS Regions/National,Region 2,2011,Age,35 Months,96.5,94.2 to 98.1,730
≥1 Dose MMR,,HHS Regions/National,Region 2,2012,Age,35 Months,94.5,92.0 to 96.5,780
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016,Age,35 Months,91.5,87.9 to 94.4,804
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016-2017,Age,35 Months,92.9,90.5 to 94.8,1715
≥1 Dose MMR,,HHS Regions/National,Region 2,2013,Age,35 Months,95.2,92.7 to 97.0,797
≥1 Dose MMR,,HHS Regions/National,Region 2,2013-2014,Age,35 Months,94.2,92.4 to 95.8,1723
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,91.8,89.2 to 94.0,1002
Hep B,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,90.8,88.7 to 92.7,1918
Hep B,≥2 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,90.9,87.9 to 93.1,818
Hep B,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,89.5,87.3 to 91.5,1622
PCV,≥3 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,86.1,83.0 to 88.6,926
PCV,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,87.0,84.8 to 88.8,1744
PCV,≥3 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,87.8,84.7 to 90.4,818
PCV,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,86.1,83.5 to 88.3,1622
Hep B,≥2 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,91.9,89.1 to 94.1,1002
Hep B,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,91.7,89.6 to 93.4,1918
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2019,Age,0-2 Days,77.2,72.9 to 81.1,916
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2018,Age,0-2 Days,76.2,72.2 to 79.7,1002
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2018-2019,Age,0-2 Days,76.7,73.8 to 79.4,1918
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2017,Age,0-2 Days,71.9,67.7 to 75.7,911
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2017-2018,Age,0-2 Days,74.0,71.1 to 76.7,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017,Age,35 Months,94.3,91.3 to 96.6,911
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017-2018,Age,35 Months,94.1,92.2 to 95.7,1913
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2016,Age,0-2 Days,68.1,63.3 to 72.5,804
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2016-2017,Age,0-2 Days,70.0,66.8 to 72.9,1715
Hep B,≥2 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,88.3,84.6 to 91.2,804
Hep B,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,90.0,87.7 to 91.8,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,88.2,85.0 to 90.8,797
PCV,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,87.1,84.4 to 89.4,1723
Hep B,≥2 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,91.7,88.8 to 93.9,911
Hep B,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,91.8,89.9 to 93.4,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2018,Age,24 Months,93.7,91.2 to 95.7,1002
≥1 Dose MMR,,HHS Regions/National,Region 2,2018-2019,Age,24 Months,92.8,90.8 to 94.5,1918
PCV,≥4 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,72.9,68.2 to 77.2,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013,Age,35 Months,96.2,91.8 to 98.6,797
≥1 Dose Varicella,,HHS Regions/National,Region 2,2013-2014,Age,35 Months,94.0,91.9 to 95.7,1723
≥1 Dose Varicella,,HHS Regions/National,Region 2,2012,Age,35 Months,94.2,91.3 to 96.4,780
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015,Age,35 Months,94.1,91.3 to 96.2,818
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015-2016,Age,35 Months,92.7,90.4 to 94.5,1622
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014,Age,35 Months,93.0,90.3 to 95.2,926
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014-2015,Age,35 Months,93.5,91.6 to 95.1,1744
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2014,Age,0-2 Days,64.3,60.4 to 68.1,926
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2014-2015,Age,0-2 Days,66.0,63.1 to 68.8,1744
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2015,Age,0-2 Days,67.7,63.4 to 71.8,818
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2015-2016,Age,0-2 Days,67.9,64.7 to 71.0,1622
PCV,≥4 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,79.5,76.0 to 82.6,1002
PCV,≥4 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,76.2,72.7 to 79.3,1583
PCV,≥4 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,77.3,73.1 to 80.9,911
PCV,≥4 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,78.4,75.7 to 80.8,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2017,Age,24 Months,91.6,88.9 to 93.9,911
≥1 Dose MMR,,HHS Regions/National,Region 2,2017-2018,Age,24 Months,92.6,90.8 to 94.2,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2016,Age,24 Months,87.9,84.3 to 91.1,804
≥1 Dose MMR,,HHS Regions/National,Region 2,2016-2017,Age,24 Months,89.7,87.5 to 91.7,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,89.8,87.2 to 92.0,780
Hep A,≥1 Dose,HHS Regions/National,Region 2,2020,Age,35 Months,90.5,86.1 to 93.9,892
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,88.5,84.8 to 91.6,804
Hep B,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,89.9,87.6 to 91.9,1715
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,91.0,88.1 to 93.4,818
Hep B,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,89.7,87.4 to 91.8,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,90.9,88.4 to 93.1,926
Hep B,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,90.9,89.1 to 92.6,1744
PCV,≥3 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,61.8,57.0 to 66.4,916
PCV,≥3 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,88.6,84.8 to 91.5,730
PCV,≥3 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,67.5,63.3 to 71.5,1002
PCV,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,64.7,61.5 to 67.8,1918
Hep B,≥2 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,89.0,86.1 to 91.4,926
Hep B,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,89.9,88.0 to 91.6,1744
Hep B,≥2 Doses,HHS Regions/National,Region 2,2012,Age,7 Months,89.8,87.0 to 92.0,780
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2019,Age,0-1 Days,73.9,69.5 to 78.0,916
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2011,Age,0-2 Days,57.2,53.0 to 61.2,730
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2018,Age,0-1 Days,69.2,64.9 to 73.2,1002
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2018-2019,Age,0-1 Days,71.6,68.5 to 74.4,1918
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2013,Age,0-2 Days,61.8,56.1 to 67.1,797
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2013-2014,Age,0-2 Days,63.0,58.9 to 67.0,1723
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2012,Age,0-2 Days,61.2,54.1 to 67.8,780
Hep B,≥2 Doses,HHS Regions/National,Region 2,2013,Age,7 Months,91.2,88.6 to 93.3,797
Hep B,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,7 Months,90.1,87.8 to 92.0,1723
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,88.6,84.9 to 91.4,916
Hep B,≥3 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,90.7,87.3 to 93.4,730
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013,Age,24 Months,93.8,91.5 to 95.7,797
Hep B,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,24 Months,92.4,90.7 to 93.9,1723
PCV,≥3 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,59.3,54.3 to 64.1,804
PCV,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,61.7,58.3 to 65.0,1715
Hep B,≥3 Doses,HHS Regions/National,Region 2,2012,Age,24 Months,91.8,89.1 to 94.0,780
PCV,≥3 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,64.1,59.6 to 68.4,911
PCV,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,65.8,62.7 to 68.8,1913
PCV,≥3 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,59.1,54.7 to 63.4,818
PCV,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,59.2,55.9 to 62.5,1622
PCV,≥4 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,74.4,70.8 to 77.8,926
PCV,≥4 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,74.8,72.1 to 77.3,1744
PCV,≥4 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,75.1,70.6 to 79.1,818
PCV,≥4 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,72.9,69.7 to 75.8,1622
PCV,≥4 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,70.6,65.9 to 75.0,804
PCV,≥4 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,73.9,70.7 to 76.8,1715
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018,Age,24 Months,91.2,88.4 to 93.6,1002
≥1 Dose Varicella,,HHS Regions/National,Region 2,2018-2019,Age,24 Months,91.1,89.0 to 93.0,1918
≥1 Dose MMR,,HHS Regions/National,Region 2,2015,Age,24 Months,91.8,89.3 to 94.0,818
≥1 Dose MMR,,HHS Regions/National,Region 2,2015-2016,Age,24 Months,89.9,87.7 to 91.8,1622
≥1 Dose MMR,,HHS Regions/National,Region 2,2014,Age,24 Months,88.4,85.4 to 91.1,926
≥1 Dose MMR,,HHS Regions/National,Region 2,2014-2015,Age,24 Months,90.2,88.2 to 91.9,1744
≥1 Dose MMR,,HHS Regions/National,Region 2,2013,Age,24 Months,93.0,90.4 to 95.1,797
≥1 Dose MMR,,HHS Regions/National,Region 2,2013-2014,Age,24 Months,90.8,88.8 to 92.6,1723
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019,Age,24 Months,91.0,87.7 to 93.7,916
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017,Age,24 Months,90.5,87.4 to 93.1,911
≥1 Dose Varicella,,HHS Regions/National,Region 2,2017-2018,Age,24 Months,90.8,88.8 to 92.7,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2011,Age,35 Months,94.0,90.9 to 96.3,730
Hep B,≥2 Doses,HHS Regions/National,Region 2,2018,Age,5 Months,89.4,86.3 to 91.8,1002
Hep B,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,5 Months,89.0,86.7 to 91.0,1918
Hep B,≥2 Doses,HHS Regions/National,Region 2,2019,Age,5 Months,88.6,84.9 to 91.5,916
Hep B,≥2 Doses,HHS Regions/National,Region 2,2011,Age,7 Months,88.0,84.8 to 90.6,730
Hep B,≥2 Doses,HHS Regions/National,Region 2,2017,Age,5 Months,88.1,84.8 to 90.8,911
Hep B,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,5 Months,88.7,86.5 to 90.6,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014,Age,24 Months,88.7,85.8 to 91.2,926
≥1 Dose Varicella,,HHS Regions/National,Region 2,2014-2015,Age,24 Months,90.0,88.1 to 91.7,1744
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2016,Age,0-1 Days,60.4,55.5 to 65.0,804
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2016-2017,Age,0-1 Days,62.3,59.1 to 65.5,1715
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2017,Age,0-1 Days,64.4,60.0 to 68.5,911
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2017-2018,Age,0-1 Days,66.8,63.7 to 69.7,1913
≥1 Dose MMR,,HHS Regions/National,Region 2,2019,Age,19 Months,88.7,84.9 to 91.6,916
≥1 Dose MMR,,HHS Regions/National,Region 2,2018,Age,19 Months,91.0,87.9 to 93.3,1002
≥1 Dose MMR,,HHS Regions/National,Region 2,2018-2019,Age,19 Months,94.4,92.7 to 95.7,1918
PCV,≥4 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,76.1,70.3 to 81.1,797
PCV,≥4 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,75.3,71.1 to 79.0,1723
PCV,≥4 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,74.3,68.8 to 79.1,780
PCV,≥4 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,74.7,69.5 to 79.3,730
≥1 Dose MMR,,HHS Regions/National,Region 2,2011,Age,24 Months,93.6,91.3 to 95.5,730
≥1 Dose MMR,,HHS Regions/National,Region 2,2012,Age,24 Months,92.0,89.3 to 94.2,780
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015,Age,24 Months,91.2,88.5 to 93.5,818
≥1 Dose Varicella,,HHS Regions/National,Region 2,2015-2016,Age,24 Months,89.2,86.9 to 91.2,1622
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016,Age,24 Months,87.2,83.5 to 90.4,804
≥1 Dose Varicella,,HHS Regions/National,Region 2,2016-2017,Age,24 Months,88.8,86.4 to 90.9,1715
DTaP,≥3 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,91.9,88.9 to 94.1,780
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,89.2,85.5 to 92.0,804
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,89.5,87.0 to 91.5,1715
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,89.7,86.4 to 92.3,911
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,90.5,88.4 to 92.3,1913
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,92.1,89.3 to 94.2,818
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,90.6,88.4 to 92.4,1622
Hib,≥3 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,81.4,78.0 to 84.4,797
Hib,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,79.4,76.7 to 81.9,1723
Polio,≥3 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,90.4,87.4 to 92.8,730
Hib,≥3 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,77.4,73.8 to 80.7,926
Hib,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,79.1,76.6 to 81.5,1744
Hib,≥3 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,85.8,81.1 to 89.5,730
Hib,≥3 Doses,HHS Regions/National,Region 2,2012,Age,13 Months,82.7,79.0 to 85.8,780
Hib,≥2 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,94.1,91.5 to 95.9,892
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,92.2,90.7 to 93.5,797
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,91.1,88.7 to 93.0,1723
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,89.9,87.2 to 92.1,926
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,91.0,89.1 to 92.6,1744
Hib,≥2 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,94.1,91.2 to 96.0,916
Hib,≥2 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,94.6,92.4 to 96.3,1002
Hib,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,94.4,92.7 to 95.7,1918
Hib,≥2 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,92.9,90.0 to 95.0,911
Hib,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,93.8,92.0 to 95.2,1913
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020,Age,24 Months,92.0,89.3 to 94.2,892
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2019,Age,0-3 Days,79.6,75.4 to 83.2,916
Polio,≥1 Dose,HHS Regions/National,Region 2,2019,Age,3 Months,86.7,82.8 to 89.9,916
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2018,Age,0-3 Days,79.0,75.3 to 82.3,1002
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2018-2019,Age,0-3 Days,79.3,76.5 to 81.8,1918
PCV,≥3 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,93.9,89.7 to 96.8,916
Hib,≥3 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,61.1,56.8 to 65.2,1002
Hib,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,59.6,56.4 to 62.8,1918
Hib,≥3 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,57.2,52.6 to 61.7,911
Hib,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,59.1,56.0 to 62.2,1913
DTaP,≥3 Doses,HHS Regions/National,Region 2,2011,Age,13 Months,91.5,88.3 to 93.9,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,68.1,63.3 to 72.6,916
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017,Age,7 Months,69.1,64.6 to 73.3,911
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,7 Months,72.7,69.7 to 75.4,1913
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018,Age,7 Months,76.3,72.3 to 79.8,1002
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,7 Months,72.2,69.1 to 75.1,1918
Hib,≥2 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,93.2,90.4 to 95.2,818
Hib,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,91.8,89.5 to 93.5,1622
Hib,≥2 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,90.4,86.7 to 93.2,804
Hib,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,91.6,89.4 to 93.5,1715
Hib,≥2 Doses,HHS Regions/National,Region 2,2014,Age,13 Months,94.2,92.0 to 95.8,926
Hib,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,13 Months,93.7,92.0 to 95.0,1744
Polio,≥1 Dose,HHS Regions/National,Region 2,2018,Age,3 Months,89.5,86.7 to 91.9,1002
Polio,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,3 Months,88.2,85.8 to 90.2,1918
Polio,≥1 Dose,HHS Regions/National,Region 2,2017,Age,3 Months,86.5,82.9 to 89.4,911
Polio,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,3 Months,88.0,85.8 to 90.0,1913
Hib,≥3 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,54.1,49.6 to 58.6,818
Hib,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,53.6,50.2 to 56.9,1622
Hib,≥3 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,53.0,48.1 to 57.9,804
Hib,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,55.1,51.7 to 58.4,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,94.5,91.4 to 96.7,1002
PCV,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,94.1,91.7 to 96.0,1918
Hib,≥3 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,56.5,52.4 to 60.5,926
Hib,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,55.3,52.3 to 58.3,1744
Hib,≥2 Doses,HHS Regions/National,Region 2,2013,Age,13 Months,94.8,91.8 to 96.7,797
Hib,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,13 Months,94.5,92.6 to 95.9,1723
PCV,≥3 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,94.0,91.3 to 96.1,911
PCV,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,94.3,92.3 to 95.9,1913
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015,Age,7 Months,66.6,62.1 to 70.7,818
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,7 Months,67.0,63.7 to 70.1,1622
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014,Age,7 Months,68.4,64.4 to 72.1,926
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,7 Months,67.5,64.5 to 70.3,1744
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2015,Age,0-3 Days,70.0,65.8 to 73.9,818
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2015-2016,Age,0-3 Days,69.8,66.7 to 72.8,1622
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016,Age,7 Months,67.4,62.5 to 72.0,804
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,7 Months,68.2,64.9 to 71.4,1715
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,89.0,85.2 to 92.0,916
DTaP,≥3 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,95.0,92.5 to 96.7,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,94.9,92.5 to 96.6,780
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,91.3,88.6 to 93.5,1002
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,90.2,87.9 to 92.1,1918
PCV,≥3 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,96.1,93.7 to 97.6,1042
Hib,≥3 Doses,HHS Regions/National,Region 2,2019,Age,7 Months,58.2,53.3 to 62.9,916
Polio,≥3 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,89.6,86.6 to 92.0,780
Polio,≥3 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,91.2,88.8 to 93.1,818
Polio,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,89.9,87.6 to 91.8,1622
Polio,≥3 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,91.0,88.0 to 93.3,797
Polio,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,90.7,88.3 to 92.7,1723
Hib,≥3 Doses,HHS Regions/National,Region 2,2019,Age,13 Months,80.3,76.2 to 83.9,916
Hib,≥3 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,91.2,89.3 to 92.9,780
Hib,≥3 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,92.5,89.3 to 94.8,730
Hib,≥3 Doses,HHS Regions/National,Region 2,2018,Age,13 Months,79.9,76.4 to 83.1,1002
Hib,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,13 Months,80.1,77.5 to 82.5,1918
Polio,≥3 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,88.6,85.0 to 91.5,804
Polio,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,89.8,87.5 to 91.8,1715
Polio,≥3 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,91.1,88.1 to 93.4,911
Polio,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,91.7,89.8 to 93.3,1913
Hib,≥3 Doses,HHS Regions/National,Region 2,2015,Age,13 Months,80.9,77.1 to 84.2,818
Hib,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,13 Months,78.5,75.5 to 81.1,1622
Hib,≥3 Doses,HHS Regions/National,Region 2,2016,Age,13 Months,76.1,71.5 to 80.1,804
Hib,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,13 Months,75.9,72.8 to 78.7,1715
Hib,≥3 Doses,HHS Regions/National,Region 2,2017,Age,13 Months,75.7,71.5 to 79.5,911
Hib,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,13 Months,77.8,75.1 to 80.3,1913
Polio,≥3 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,90.5,87.9 to 92.5,926
Polio,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,90.8,89.0 to 92.4,1744
PCV,≥4 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,87.2,82.2 to 91.0,1042
≥1 Dose Varicella,,HHS Regions/National,Region 1,2020-2021,Age,35 Months,98.5,96.7 to 99.4,2578
Hep A,≥1 Dose,HHS Regions/National,Region 1,2021,Age,35 Months,93.0,89.0 to 96.0,1042
Hep A,≥2 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,94.3,85.3 to 98.6,1042
DTaP,≥4 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,94.3,91.8 to 96.2,2578
Hep B,≥3 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,96.8,95.3 to 97.9,1042
DTaP,≥4 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,79.8,74.3 to 84.3,1042
Hep B,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,96.4,95.0 to 97.4,2578
Hib,Primary Series,HHS Regions/National,Region 1,2021,Age,7 Months,80.6,76.1 to 84.4,1042
≥1 Dose MMR,,HHS Regions/National,Region 1,2021,Age,24 Months,94.6,91.4 to 96.9,1042
Polio,≥1 Dose,HHS Regions/National,Region 1,2021,Age,3 Months,95.2,92.9 to 96.8,1042
Hib,Primary Series,HHS Regions/National,Region 1,2021,Age,24 Months,96.4,94.4 to 97.9,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,96.2,94.1 to 97.7,1042
DTaP,≥3 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,97.1,95.2 to 98.3,1042
Hib,≥1 Dose,HHS Regions/National,Region 1,2021,Age,3 Months,93.6,90.2 to 95.8,1042
Hib,Full Series,HHS Regions/National,Region 1,2021,Age,24 Months,89.0,85.4 to 92.1,1042
DTaP,≥3 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,95.8,93.7 to 97.3,1042
Combined 7 Series,,HHS Regions/National,Region 1,2021,Age,24 Months,79.7,74.5 to 84.4,1042
Polio,≥2 Doses,HHS Regions/National,Region 1,2021,Age,13 Months,98.2,97.3 to 98.8,1042
Hep A,≥1 Dose,HHS Regions/National,Region 1,2021,Age,19 Months,87.8,83.3 to 91.2,1042
PCV,≥4 Doses,HHS Regions/National,Region 1,2021,Age,35 Months,94.4,90.9 to 96.8,1042
DTaP,≥1 Dose,HHS Regions/National,Region 1,2021,Age,3 Months,95.3,92.6 to 97.0,1042
Hep A,≥2 Doses,HHS Regions/National,Region 1,2021,Age,19 Months,31.9,27.0 to 37.3,1042
Polio,≥3 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,96.5,94.7 to 97.8,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,96.3,94.6 to 97.6,2578
Hep A,≥1 Dose,HHS Regions/National,Region 1,2021,Age,24 Months,91.5,87.8 to 94.5,1042
Hep A,≥2 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,51.1,45.5 to 57.0,1042
Hep B,≥3 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,74.8,70.1 to 78.9,1042
PCV,≥4 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,88.9,84.0 to 92.8,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2021,Age,7 Months,78.9,74.2 to 83.0,1042
Hep B,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,35 Months,96.5,95.2 to 97.6,2578
Hib,≥2 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,96.2,94.7 to 97.3,2578
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 1,2021,Age,0-2 Days,83.3,78.0 to 87.5,1042
≥1 Dose Varicella,,HHS Regions/National,Region 1,2021,Age,24 Months,95.1,92.5 to 97.0,1042
PCV,≥3 Doses,HHS Regions/National,Region 1,2021,Age,24 Months,96.5,94.2 to 98.1,1042
Hib,≥3 Doses,HHS Regions/National,Region 1,2020-2021,Age,13 Months,82.4,80.0 to 84.6,2578
Hib,Full Series,States/Local Areas,Arkansas,2017,Age,35 Months,81.4,74.7 to 87.2,390
Hib,Full Series,States/Local Areas,Arkansas,2017-2018,Age,35 Months,80.9,76.3 to 85.0,816
Polio,≥2 Doses,States/Local Areas,Arkansas,2021,Age,5 Months,67.1,55.8 to 76.7,190
Hep B,≥3 Doses,States/Local Areas,Arkansas,2021,Age,13 Months,84.2,74.1 to 90.8,190
DTaP,≥2 Doses,States/Local Areas,Arkansas,2021,Age,5 Months,67.2,55.8 to 76.8,190
≥1 Dose MMR,,States/Local Areas,Arkansas,2020-2021,Age,13 Months,63.2,56.4 to 69.5,513
PCV,≥1 Dose,States/Local Areas,Arkansas,2021,Age,3 Months,84.8,75.5 to 90.9,190
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,83.4,77.4 to 88.0,513
≥1 Dose MMR,,States/Local Areas,Arkansas,2021,Age,19 Months,76.7,65.2 to 85.3,190
Hep B,≥2 Doses,States/Local Areas,Arkansas,2021,Age,5 Months,85.6,76.4 to 91.6,190
Hep A,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,24.3,19.1 to 30.4,513
Polio,≥3 Doses,States/Local Areas,Arkansas,2021,Age,19 Months,82.1,71.5 to 89.4,190
Hib,Full Series,States/Local Areas,Arkansas,2020-2021,Age,35 Months,78.3,72.1 to 83.9,513
Hib,Full Series,States/Local Areas,Arkansas,2020-2021,Age,19 Months,68.4,61.7 to 74.4,513
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2020-2021,Age,0-2 Days,82.9,77.5 to 87.3,513
Polio,≥2 Doses,States/Local Areas,Arkansas,2020-2021,Age,13 Months,90.6,85.5 to 94.0,513
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,19 Months,86.5,80.9 to 90.6,513
PCV,≥3 Doses,States/Local Areas,Arkansas,2020-2021,Age,7 Months,60.5,53.8 to 66.9,513
≥1 Dose Varicella,,States/Local Areas,Arkansas,2021,Age,13 Months,61.5,50.2 to 71.8,190
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,51.6,35.4 to 67.8,53
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,76.1,70.0 to 82.2,387
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,77.1,72.1 to 82.0,423
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Overall,Overall,78.8,75.4 to 82.2,1008
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,79.1,73.6 to 84.5,331
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.1,86.5 to 95.7,279
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,77.0,68.3 to 85.8,142
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.0,68.1 to 81.9,279
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,81.0,75.6 to 86.5,398
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.6,72.2 to 81.0,669
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.2,70.1 to 88.3,115
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,82.7,74.7 to 90.8,130
Hib,Primary Series,States/Local Areas,Arkansas,2012,Age,7 Months,60.0,53.0 to 66.5,236
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,92.6,88.8 to 96.3,198
Hib,Primary Series,States/Local Areas,Arkansas,2011,Age,7 Months,53.8,49.7 to 57.8,230
Hib,Full Series,States/Local Areas,Arkansas,2019,Age,35 Months,84.1,77.5 to 89.7,357
Hib,Full Series,States/Local Areas,Arkansas,2018,Age,35 Months,80.2,74.1 to 85.6,426
Hib,Full Series,States/Local Areas,Arkansas,2018-2019,Age,35 Months,81.8,77.4 to 85.9,783
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,88.4 to 95.6,398
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.7,88.8 to 94.5,669
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.8,84.6 to 97.0,115
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,92.5,86.6 to 98.4,130
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,86.1,81.2 to 91.1,387
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.2,73.7 to 92.6,94
Hib,Full Series,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,78.6,73.7 to 83.5,426
Hib,Full Series,States/Local Areas,Arkansas,2016,Age,35 Months,83.4,76.0 to 89.5,272
Hib,Full Series,States/Local Areas,Arkansas,2016-2017,Age,35 Months,82.4,77.4 to 86.8,662
Hib,Full Series,States/Local Areas,Arkansas,2015,Age,35 Months,84.6,77.7 to 90.3,265
Hib,Full Series,States/Local Areas,Arkansas,2015-2016,Age,35 Months,83.6,78.6 to 88.1,537
Polio,≥3 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,92.7,88.2 to 95.9,426
Polio,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,92.2,88.4 to 95.2,783
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.6,87.8 to 99.3,94
DTaP,≥2 Doses,States/Local Areas,Arkansas,2016,Age,5 Months,74.1,66.7 to 80.2,272
DTaP,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,5 Months,71.4,66.4 to 75.9,662
DTaP,≥2 Doses,States/Local Areas,Arkansas,2015,Age,5 Months,69.3,62.0 to 75.7,265
DTaP,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,5 Months,71.7,66.5 to 76.3,537
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,78.0,64.1 to 92.0,53
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,90.7,84.6 to 96.9,142
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,93.4,90.6 to 96.2,426
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,92.8,89.2 to 96.4,387
Polio,≥3 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,92.1,84.6 to 96.7,357
Polio,≥3 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,91.0,85.7 to 94.9,390
Polio,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,91.9,88.5 to 94.5,816
Polio,≥3 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,92.1,86.2 to 96.1,272
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,91.6,87.8 to 94.6,662
Polio,≥3 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,93.5,88.9 to 96.6,265
Polio,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,92.7,89.0 to 95.5,537
Polio,≥3 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,96.1,91.2 to 98.7,236
Polio,≥3 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,92.3,87.6 to 95.7,239
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,92.8,89.6 to 95.3,504
Polio,≥3 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,97.9,92.9 to 99.7,212
Polio,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,94.3,90.9 to 96.8,451
DTaP,≥2 Doses,States/Local Areas,Arkansas,2014,Age,5 Months,62.1,54.0 to 69.5,239
DTaP,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,5 Months,65.7,60.7 to 70.3,504
DTaP,≥2 Doses,States/Local Areas,Arkansas,2013,Age,5 Months,70.9,68.4 to 73.3,212
DTaP,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,5 Months,66.5,61.9 to 70.9,451
DTaP,≥2 Doses,States/Local Areas,Arkansas,2012,Age,5 Months,71.9,61.2 to 80.6,236
DTaP,≥2 Doses,States/Local Areas,Arkansas,2011,Age,5 Months,66.6,58.3 to 74.0,230
Hib,Full Series,States/Local Areas,Arkansas,2014,Age,35 Months,77.9,70.1 to 84.8,239
Hib,Full Series,States/Local Areas,Arkansas,2014-2015,Age,35 Months,80.8,75.6 to 85.5,504
Hib,Full Series,States/Local Areas,Arkansas,2013,Age,35 Months,80.8,73.5 to 87.0,212
Hib,Full Series,States/Local Areas,Arkansas,2013-2014,Age,35 Months,79.5,74.2 to 84.3,451
Hib,Full Series,States/Local Areas,Arkansas,2012,Age,35 Months,77.3,69.2 to 84.5,236
Hib,Full Series,States/Local Areas,Arkansas,2011,Age,35 Months,78.3,66.2 to 88.4,230
Hib,Full Series,States/Local Areas,Arkansas,2019,Age,24 Months,79.2,72.8 to 85.0,357
Hib,≥2 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,90.8,85.4 to 94.4,323
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,90.7,85.6 to 94.0,265
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,91.3,87.5 to 94.0,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,91.8,86.7 to 95.0,239
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,91.2,87.7 to 93.8,504
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,91.9,85.7 to 95.5,272
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,90.2,86.3 to 93.1,662
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",73.5,60.0 to 87.1,115
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,64.9,42.9 to 86.9,53
DTaP,≥4 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,80.9,73.8 to 87.1,426
DTaP,≥4 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,82.8,77.7 to 87.3,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,87.6,81.8 to 91.7,357
Hib,≥3 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,85.1,79.1 to 89.6,357
Polio,≥3 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,88.6,83.3 to 92.9,357
Polio,≥3 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,90.9,86.3 to 94.4,426
Polio,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,89.8,86.3 to 92.7,783
Polio,≥3 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,90.2,85.0 to 94.1,390
Polio,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,90.6,87.2 to 93.3,816
Hib,≥3 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,84.9,78.9 to 89.5,390
Hib,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,86.6,82.7 to 89.6,816
Polio,≥3 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,91.9,86.0 to 95.9,272
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,91.1,87.3 to 94.1,662
Hib,≥3 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,88.2,83.0 to 92.0,426
Hib,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,71.4,66.7 to 75.7,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,89.7,84.4 to 93.3,426
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,86.1,82.1 to 89.4,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,88.4,82.7 to 92.4,390
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,89.1,85.4 to 91.9,816
Polio,≥3 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,91.8,87.1 to 95.2,265
Polio,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,91.9,88.3 to 94.8,537
Polio,≥3 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,90.9,85.8 to 94.7,239
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,91.4,88.0 to 94.1,504
Hib,≥3 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,85.8,79.1 to 90.6,239
Hib,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,83.6,79.1 to 87.4,504
Polio,≥3 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,92.0,87.0 to 95.7,212
Polio,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,91.5,88.0 to 94.2,451
Polio,≥3 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,91.6,86.4 to 95.3,236
Polio,≥3 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,92.8,87.5 to 96.4,230
Polio,≥3 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,87.0,81.2 to 91.2,357
Hib,≥3 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,89.4,83.3 to 93.4,272
Hib,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,87.2,83.1 to 90.4,662
Hib,≥3 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,81.5,78.1 to 84.4,265
Hib,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,85.5,81.1 to 89.0,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,92.6,87.5 to 96.2,236
Hib,Full Series,States/Local Areas,Arkansas,2015,Age,24 Months,75.6,68.6 to 82.0,265
Hib,Full Series,States/Local Areas,Arkansas,2015-2016,Age,24 Months,78.1,73.2 to 82.7,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,92.8,87.8 to 96.3,212
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,92.8,89.5 to 95.3,451
DTaP,≥3 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,94.5,89.6 to 97.6,230
Hib,Full Series,States/Local Areas,Arkansas,2018,Age,24 Months,77.8,71.8 to 83.3,426
Hib,Full Series,States/Local Areas,Arkansas,2018-2019,Age,24 Months,78.3,74.0 to 82.4,783
Hib,Full Series,States/Local Areas,Arkansas,2017,Age,24 Months,75.3,69.0 to 81.2,390
Hib,Full Series,States/Local Areas,Arkansas,2017-2018,Age,24 Months,76.5,72.2 to 80.7,816
Hib,Full Series,States/Local Areas,Arkansas,2016,Age,24 Months,80.5,73.4 to 86.7,272
Hib,Full Series,States/Local Areas,Arkansas,2016-2017,Age,24 Months,78.0,73.3 to 82.4,662
Polio,≥3 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,93.0,87.7 to 96.6,230
Hib,≥3 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,88.4,82.6 to 92.9,239
Hib,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,87.8,83.9 to 91.1,504
Hib,≥3 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,88.8,83.2 to 93.2,212
Hib,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,88.6,84.7 to 91.8,451
Hib,≥3 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,91.7,86.5 to 95.5,236
Hib,≥3 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,91.7,85.5 to 95.9,230
Hib,≥3 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,92.0,85.1 to 96.4,357
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,93.3,91.4 to 95.3,1008
Hep A,≥2 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,50.0,42.5 to 58.0,265
Hep A,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,43.0,37.6 to 48.8,537
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,44.3,36.6 to 52.7,239
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,47.1,41.7 to 52.9,504
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014,Age,35 Months,91.1,85.3 to 95.3,239
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,35 Months,91.9,88.1 to 94.8,504
Hep A,≥1 Dose,States/Local Areas,Arkansas,2013,Age,35 Months,91.6,85.3 to 95.9,212
Hep A,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,35 Months,91.2,87.1 to 94.4,451
Hep A,≥2 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,46.7,39.9 to 54.0,426
Hep A,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,43.1,38.2 to 48.3,783
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,77.0,69.8 to 83.6,239
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,75.3,70.2 to 80.1,504
Hep A,≥2 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,45.3,38.6 to 52.6,390
Hep A,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,46.0,41.1 to 51.1,816
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,35.8,28.6 to 44.1,272
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,40.5,35.5 to 45.9,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,76.7,68.1 to 84.4,212
DTaP,≥4 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,76.8,71.1 to 82.1,451
Hep A,≥2 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,44.5,35.1 to 55.2,212
Hep A,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,44.4,38.2 to 51.1,451
DTaP,≥4 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,67.6,61.0 to 73.6,426
DTaP,≥4 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,93.1,89.9 to 95.3,783
DTaP,≥4 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,61.5,54.5 to 68.0,390
DTaP,≥4 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,64.5,59.7 to 69.1,816
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,94.0,91.3 to 96.6,423
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,92.4,88.9 to 95.8,331
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.1,89.0 to 97.1,279
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,94.3,91.4 to 97.2,398
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.1,89.3 to 94.9,669
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,86.2 to 98.0,115
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,95.8,91.8 to 99.8,130
Polio,≥2 Doses,States/Local Areas,Arkansas,2011,Age,5 Months,66.2,58.0 to 73.5,230
Hep B,≥3 Doses,States/Local Areas,Arkansas,2020,Age,24 Months,88.7,83.5 to 92.9,323
PCV,≥2 Doses,States/Local Areas,Arkansas,2019,Age,5 Months,72.1,65.0 to 78.3,357
PCV,≥2 Doses,States/Local Areas,Arkansas,2018,Age,5 Months,73.1,66.6 to 78.8,426
PCV,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,5 Months,72.6,67.8 to 77.0,783
Hep B,≥3 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,85.6,80.8 to 89.4,230
Polio,≥2 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,87.7,81.9 to 91.9,272
Polio,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,85.6,81.6 to 88.9,662
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,85.4,80.3 to 90.5,387
Polio,≥2 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,84.9,78.8 to 89.5,265
Polio,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,86.3,82.3 to 89.6,537
Polio,≥2 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,83.9,76.7 to 89.2,239
Polio,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,84.4,79.9 to 88.1,504
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,89.6,86.0 to 93.2,423
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Overall,Overall,88.3,85.6 to 91.0,1008
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,88.3,83.9 to 92.6,331
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,85.9,80.1 to 91.6,279
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,89.9,85.8 to 94.1,398
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.1,83.6 to 90.7,669
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018,Age,13 Months,66.8,60.3 to 72.8,426
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018-2019,Age,13 Months,60.7,55.8 to 65.5,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017,Age,13 Months,62.4,55.3 to 69.1,390
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017-2018,Age,13 Months,64.6,59.8 to 69.2,816
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016,Age,13 Months,67.2,59.1 to 74.4,272
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2017,Age,13 Months,64.9,59.5 to 69.9,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,71.1,64.8 to 77.2,426
DTaP,≥4 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,73.6,68.9 to 78.1,783
DTaP,≥4 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,80.0,66.0 to 90.9,230
DTaP,≥4 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,76.6,69.7 to 82.8,357
Hib,Full Series,States/Local Areas,Arkansas,2020,Age,24 Months,77.9,71.3 to 83.8,323
≥1 Dose MMR,,States/Local Areas,Arkansas,2013,Age,13 Months,49.7,43.3 to 56.1,212
≥1 Dose MMR,,States/Local Areas,Arkansas,2013-2014,Age,13 Months,54.4,50.8 to 58.0,451
≥1 Dose MMR,,States/Local Areas,Arkansas,2012,Age,13 Months,56.0,53.2 to 58.7,236
≥1 Dose MMR,,States/Local Areas,Arkansas,2011,Age,13 Months,40.9,36.0 to 45.9,230
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,74.9,64.2 to 84.5,272
Hep A,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,75.8,68.9 to 82.1,662
Hep A,≥2 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,81.6,71.4 to 89.9,265
Hep A,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,78.2,70.6 to 85.0,537
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,72.6,65.6 to 78.7,357
Polio,≥2 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,85.5,80.4 to 89.4,212
Polio,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,84.7,82.0 to 87.0,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,74.3,68.1 to 79.7,426
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,73.5,68.8 to 77.7,783
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,71.7,64.6 to 77.9,390
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,73.0,68.3 to 77.3,816
Polio,≥2 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,87.5,80.0 to 92.4,236
Polio,≥2 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,83.3,79.9 to 86.3,230
Polio,≥2 Doses,States/Local Areas,Arkansas,2019,Age,5 Months,73.1,66.0 to 79.2,357
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.5,80.7 to 96.3,115
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,89.5,83.0 to 96.0,130
Polio,≥2 Doses,States/Local Areas,Arkansas,2018,Age,5 Months,73.5,67.0 to 79.2,426
Polio,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,5 Months,73.3,68.5 to 77.6,783
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",91.0,84.6 to 97.4,94
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,67.8,51.6 to 83.9,53
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,83.1,75.0 to 91.3,142
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,91.3,88.1 to 94.6,426
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,90.3,86.2 to 94.5,387
Hep A,≥1 Dose,States/Local Areas,Arkansas,2019,Age,35 Months,93.9,86.3 to 98.1,357
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015,Age,13 Months,60.6,52.9 to 67.9,265
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015-2016,Age,13 Months,64.0,58.5 to 69.1,537
≥1 Dose Varicella,,States/Local Areas,Arkansas,2012,Age,13 Months,59.6,57.3 to 61.9,236
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014,Age,13 Months,58.9,50.7 to 66.6,239
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2015,Age,13 Months,59.8,54.2 to 65.1,504
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013,Age,13 Months,52.3,49.7 to 54.9,212
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013-2014,Age,13 Months,55.6,50.1 to 60.9,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,68.2,60.9 to 74.7,265
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,65.3,59.8 to 70.4,537
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,68.1,60.2 to 75.2,239
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,68.2,62.8 to 73.1,504
Polio,≥2 Doses,States/Local Areas,Arkansas,2017,Age,5 Months,68.6,61.7 to 74.9,390
Polio,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,5 Months,71.1,66.3 to 75.4,816
Polio,≥2 Doses,States/Local Areas,Arkansas,2016,Age,5 Months,75.1,67.9 to 81.1,272
Polio,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,5 Months,71.9,67.0 to 76.4,662
Hep A,≥1 Dose,States/Local Areas,Arkansas,2018,Age,35 Months,91.6,86.5 to 95.4,426
Hep A,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,35 Months,92.4,88.4 to 95.4,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2011,Age,13 Months,44.4,39.7 to 49.3,230
Hep A,≥1 Dose,States/Local Areas,Arkansas,2017,Age,35 Months,88.3,82.7 to 92.7,390
Hep A,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,35 Months,89.9,86.2 to 93.1,816
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016,Age,35 Months,87.4,80.4 to 92.8,272
Hep A,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,35 Months,88.0,83.6 to 91.7,662
Hep A,≥2 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,68.0,55.8 to 79.6,212
Hep A,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,68.0,60.4 to 75.5,451
Hep A,≥2 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,63.6,53.0 to 74.1,236
Hep A,≥2 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,47.5,37.6 to 58.5,230
Hep A,≥2 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,39.3,32.5 to 46.9,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,62.4,54.2 to 69.9,272
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,67.0,61.6 to 72.0,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,78.2,71.0 to 84.7,272
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,75.4,70.4 to 80.0,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,73.5,66.3 to 80.3,265
DTaP,≥4 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,75.9,70.9 to 80.7,537
DTaP,≥4 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,72.5,65.7 to 78.8,390
DTaP,≥4 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,71.8,67.2 to 76.3,816
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,68.8,59.2 to 77.9,239
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,74.8,67.8 to 81.3,504
DTaP,≥4 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,75.6,67.7 to 82.8,236
DTaP,≥4 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,71.6,62.6 to 80.0,230
DTaP,≥4 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,60.1,52.8 to 67.0,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,71.8,69.2 to 74.3,212
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,70.0,66.1 to 73.6,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,66.9,63.2 to 70.4,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,59.5,53.9 to 64.8,230
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,96.3,93.3 to 99.3,198
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,91.1,87.3 to 94.8,387
Polio,≥2 Doses,States/Local Areas,Arkansas,2015,Age,5 Months,68.7,61.3 to 75.1,265
Polio,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,5 Months,71.9,66.8 to 76.5,537
Polio,≥2 Doses,States/Local Areas,Arkansas,2014,Age,5 Months,62.1,54.0 to 69.5,239
Polio,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,5 Months,65.3,60.7 to 69.7,504
Polio,≥2 Doses,States/Local Areas,Arkansas,2013,Age,5 Months,70.7,68.1 to 73.1,212
Polio,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,5 Months,66.4,61.8 to 70.7,451
Polio,≥2 Doses,States/Local Areas,Arkansas,2012,Age,5 Months,72.1,61.4 to 80.8,236
Hep A,≥1 Dose,States/Local Areas,Arkansas,2015,Age,35 Months,92.6,87.7 to 96.1,265
Hep A,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,35 Months,89.7,85.2 to 93.2,537
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,90.0,85.4 to 93.2,265
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,91.4,87.8 to 94.0,537
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,93.5,89.1 to 96.3,239
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,91.8,88.4 to 94.2,504
Hep B,≥2 Doses,States/Local Areas,Arkansas,2014,Age,5 Months,83.1,76.2 to 88.3,239
Hep B,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,5 Months,84.4,79.2 to 88.4,504
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,81.8,73.9 to 89.8,198
Hep B,≥2 Doses,States/Local Areas,Arkansas,2013,Age,5 Months,86.6,83.6 to 89.2,212
Hep B,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,5 Months,84.9,82.0 to 87.3,451
Hep B,≥2 Doses,States/Local Areas,Arkansas,2012,Age,5 Months,83.8,79.5 to 87.3,236
Hep B,≥2 Doses,States/Local Areas,Arkansas,2011,Age,5 Months,85.8,81.8 to 89.1,230
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,70.9,63.5 to 78.2,387
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2012,Age,0-1 Days,73.0,63.4 to 80.8,236
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2011,Age,0-1 Days,84.1,75.6 to 90.1,230
Hep B,≥1 Dose,States/Local Areas,Arkansas,2019,Age,3 Months,98.2,96.0 to 99.2,357
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019,Age,19 Months,82.2,75.9 to 87.1,357
Hep B,≥1 Dose,States/Local Areas,Arkansas,2018,Age,3 Months,96.2,92.7 to 98.1,426
Hep B,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,3 Months,97.2,95.3 to 98.3,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2012,Age,24 Months,91.4,86.3 to 95.1,236
≥1 Dose Varicella,,States/Local Areas,Arkansas,2011,Age,24 Months,89.8,83.1 to 94.6,230
≥1 Dose MMR,,States/Local Areas,Arkansas,2017,Age,19 Months,85.0,79.3 to 89.4,390
≥1 Dose MMR,,States/Local Areas,Arkansas,2017-2018,Age,19 Months,86.9,83.1 to 89.9,816
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,72.8,67.5 to 78.1,423
≥1 Dose MMR,,States/Local Areas,Arkansas,2016,Age,19 Months,87.4,80.0 to 92.3,272
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2017,Age,19 Months,86.2,81.8 to 89.7,662
≥1 Dose MMR,,States/Local Areas,Arkansas,2015,Age,19 Months,85.9,82.6 to 88.8,265
≥1 Dose MMR,,States/Local Areas,Arkansas,2015-2016,Age,19 Months,86.7,81.9 to 90.3,537
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,77.4,73.9 to 80.9,1008
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,77.4,71.6 to 83.2,331
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.4,67.3 to 81.6,279
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,79.3,73.9 to 84.7,398
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",77.0,72.6 to 81.3,669
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.6,71.7 to 89.6,115
PCV,≥3 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,52.5,46.5 to 58.3,230
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,92.8,87.4 to 96.0,272
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,92.0,88.5 to 94.5,662
Polio,≥2 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,89.5,84.0 to 93.3,390
Polio,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,91.8,88.5 to 94.3,816
Polio,≥2 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,93.2,88.2 to 96.1,272
Polio,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,91.4,87.9 to 93.9,662
Polio,≥2 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,91.3,86.1 to 94.7,265
Polio,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,92.2,88.9 to 94.6,537
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,82.2,73.9 to 90.5,130
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018,Age,19 Months,88.7,83.4 to 92.4,426
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018-2019,Age,19 Months,60.7,55.8 to 65.5,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017,Age,19 Months,86.3,80.7 to 90.5,390
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017-2018,Age,19 Months,87.5,83.8 to 90.4,816
≥1 Dose MMR,,States/Local Areas,Arkansas,2014,Age,19 Months,82.9,76.1 to 88.1,239
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2015,Age,19 Months,84.4,79.8 to 88.2,504
≥1 Dose MMR,,States/Local Areas,Arkansas,2012,Age,19 Months,85.0,82.2 to 87.5,236
≥1 Dose MMR,,States/Local Areas,Arkansas,2013,Age,19 Months,85.5,79.6 to 89.9,212
≥1 Dose MMR,,States/Local Areas,Arkansas,2013-2014,Age,19 Months,84.2,79.7 to 87.9,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,92.6,90.4 to 94.4,212
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,93.1,92.1 to 94.0,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,92.6,89.3 to 94.9,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,88.7,85.6 to 91.2,230
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,86.9,81.2 to 91.1,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,90.2,85.3 to 93.6,426
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,88.6,84.9 to 91.5,783
≥1 Dose MMR,,States/Local Areas,Arkansas,2011,Age,19 Months,77.9,71.6 to 83.2,230
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.6,62.6 to 84.5,94
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,55.0,38.1 to 71.9,53
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,72.7,63.5 to 82.0,142
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,75.7,70.5 to 80.8,426
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,87.8,83.4 to 92.1,387
DTaP,≥4 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,84.9,77.4 to 90.9,357
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,92.7,89.0 to 96.4,198
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,78.3,72.5 to 84.1,387
PCV,≥3 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,57.3,45.6 to 68.3,236
PCV,≥3 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,51.6,43.7 to 59.4,239
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,52.7,47.2 to 58.1,504
PCV,≥3 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,62.0,57.8 to 66.0,212
PCV,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,56.8,51.3 to 62.2,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,92.6,88.4 to 95.4,426
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,88.6,84.9 to 91.5,783
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,91.3,86.0 to 94.7,390
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,91.9,88.8 to 94.3,816
Hep B,≥2 Doses,States/Local Areas,Arkansas,2017,Age,5 Months,84.9,78.2 to 89.8,390
Hep B,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,5 Months,87.5,83.5 to 90.7,816
Hep B,≥2 Doses,States/Local Areas,Arkansas,2016,Age,5 Months,83.7,76.8 to 88.8,272
Hep B,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,5 Months,84.3,79.7 to 88.0,662
Hep B,≥2 Doses,States/Local Areas,Arkansas,2015,Age,5 Months,85.6,79.9 to 90.0,265
Hep B,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,5 Months,84.7,80.4 to 88.1,537
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2015,Age,0-1 Days,76.7,70.0 to 82.3,265
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2015-2016,Age,0-1 Days,74.9,69.8 to 79.3,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2020,Age,13 Months,86.2,80.1 to 90.6,323
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2014,Age,0-1 Days,75.0,67.3 to 81.4,239
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2014-2015,Age,0-1 Days,75.8,70.8 to 80.2,504
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2013,Age,0-1 Days,75.2,73.6 to 76.7,212
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2013-2014,Age,0-1 Days,75.1,72.7 to 77.4,451
Polio,≥2 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,91.9,86.9 to 95.1,357
Polio,≥2 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,94.2,89.8 to 96.8,426
Polio,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,93.1,89.9 to 95.3,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014,Age,24 Months,89.0,83.7 to 93.1,239
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2015,Age,24 Months,90.6,87.1 to 93.4,504
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013,Age,24 Months,86.1,79.0 to 91.7,212
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013-2014,Age,24 Months,87.6,83.0 to 91.4,451
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017,Age,24 Months,88.1,82.8 to 92.4,390
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017-2018,Age,24 Months,88.9,85.4 to 91.8,816
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016,Age,24 Months,91.8,86.0 to 95.9,272
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2017,Age,24 Months,90.1,86.3 to 93.2,662
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015,Age,24 Months,92.1,87.3 to 95.6,265
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015-2016,Age,24 Months,92.0,88.3 to 94.9,537
≥1 Dose MMR,,States/Local Areas,Arkansas,2012,Age,24 Months,90.6,85.2 to 94.7,236
PCV,≥3 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,53.8,46.2 to 61.2,265
PCV,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,53.7,48.2 to 59.2,537
≥1 Dose MMR,,States/Local Areas,Arkansas,2011,Age,24 Months,88.2,81.5 to 93.3,230
≥1 Dose MMR,,States/Local Areas,Arkansas,2019,Age,19 Months,81.3,75.0 to 86.3,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,67.6,59.4 to 74.9,239
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,68.9,63.4 to 73.9,504
≥1 Dose MMR,,States/Local Areas,Arkansas,2018,Age,19 Months,88.8,83.5 to 92.5,426
≥1 Dose MMR,,States/Local Areas,Arkansas,2018-2019,Age,19 Months,92.5,89.2 to 94.8,783
PCV,≥4 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,77.2,74.9 to 79.3,212
PCV,≥4 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,72.4,67.9 to 76.6,451
PCV,≥4 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,70.3,66.9 to 73.4,236
PCV,≥4 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,65.9,62.2 to 69.5,230
PCV,≥4 Doses,States/Local Areas,Arkansas,2020,Age,35 Months,79.3,72.7 to 85.2,323
Hep B,≥2 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,94.0,90.0 to 96.5,230
Hep B,≥2 Doses,States/Local Areas,Arkansas,2019,Age,5 Months,87.8,81.7 to 92.1,357
Hep B,≥2 Doses,States/Local Areas,Arkansas,2018,Age,5 Months,90.3,85.7 to 93.5,426
Hep B,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,5 Months,89.0,85.4 to 91.9,783
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2018,Age,0-1 Days,78.7,72.4 to 83.9,426
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2018-2019,Age,0-1 Days,77.9,73.5 to 81.8,783
Hep B,≥1 Dose,States/Local Areas,Arkansas,2017,Age,3 Months,95.1,91.0 to 97.4,390
Hep B,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,3 Months,95.7,93.2 to 97.3,816
Hep B,≥1 Dose,States/Local Areas,Arkansas,2016,Age,3 Months,93.7,88.8 to 96.5,272
Hep B,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,3 Months,94.4,91.4 to 96.4,662
Hep B,≥1 Dose,States/Local Areas,Arkansas,2015,Age,3 Months,94.5,91.0 to 96.7,265
Hep B,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,3 Months,94.1,91.3 to 96.0,537
Polio,≥2 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,93.6,88.9 to 96.4,239
Polio,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,92.5,89.2 to 94.8,504
Polio,≥2 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,95.4,92.7 to 97.2,212
Polio,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,94.5,93.0 to 95.8,451
Polio,≥2 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,94.3,93.0 to 95.3,236
Polio,≥2 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,95.0,91.9 to 97.0,230
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016,Age,19 Months,87.3,79.9 to 92.2,272
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2017,Age,19 Months,86.8,82.4 to 90.2,662
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015,Age,19 Months,85.5,79.5 to 90.0,265
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015-2016,Age,19 Months,86.4,81.7 to 90.0,537
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014,Age,19 Months,83.1,76.3 to 88.3,239
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2015,Age,19 Months,84.3,79.7 to 88.0,504
≥1 Dose MMR,,States/Local Areas,Arkansas,2018,Age,13 Months,66.9,60.4 to 72.8,426
≥1 Dose MMR,,States/Local Areas,Arkansas,2018-2019,Age,13 Months,59.9,54.9 to 64.7,783
≥1 Dose MMR,,States/Local Areas,Arkansas,2019,Age,13 Months,52.8,45.5 to 59.9,357
≥1 Dose MMR,,States/Local Areas,Arkansas,2017,Age,13 Months,59.8,52.7 to 66.5,390
≥1 Dose MMR,,States/Local Areas,Arkansas,2017-2018,Age,13 Months,63.3,58.4 to 67.9,816
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.1,52.4 to 79.8,94
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2017,Age,0-1 Days,77.7,70.9 to 83.3,390
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2017-2018,Age,0-1 Days,78.2,73.7 to 82.1,816
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2016,Age,0-1 Days,73.1,65.2 to 79.8,272
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2016-2017,Age,0-1 Days,75.4,70.2 to 79.8,662
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,92.6,88.7 to 95.6,426
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,91.3,88.2 to 93.8,783
PCV,≥3 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,86.6,79.9 to 91.3,272
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,85.0,80.6 to 88.5,662
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,77.7,69.7 to 85.7,423
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,75.8,70.7 to 80.9,1008
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,75.5,65.9 to 85.1,331
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,93.8,89.4 to 98.2,130
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.6,64.4 to 80.8,279
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,77.4,69.8 to 84.9,398
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.1,72.0 to 84.3,669
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,76.3,68.6 to 84.0,426
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,80.9,74.4 to 87.4,387
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,69.5,53.5 to 85.6,142
Polio,≥2 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,86.5,80.7 to 90.8,357
Hep A,≥1 Dose,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,90.3,85.3 to 95.4,198
Polio,≥2 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,88.2,83.0 to 92.0,426
Polio,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,87.4,83.5 to 90.4,783
Polio,≥2 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,83.5,77.4 to 88.2,390
Polio,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,85.8,81.8 to 89.1,816
Hep B,≥1 Dose,States/Local Areas,Arkansas,2014,Age,3 Months,96.6,92.6 to 98.5,239
Hep B,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,3 Months,95.5,93.2 to 97.1,504
Hep B,≥1 Dose,States/Local Areas,Arkansas,2013,Age,3 Months,96.5,93.3 to 98.2,212
Hep B,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,3 Months,96.5,93.7 to 98.1,451
Hep B,≥1 Dose,States/Local Areas,Arkansas,2012,Age,3 Months,94.6,88.5 to 97.5,236
Hep B,≥1 Dose,States/Local Areas,Arkansas,2011,Age,3 Months,98.1,97.3 to 98.6,230
Hep A,≥2 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,72.9,61.7 to 84.2,130
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,88.7,82.9 to 92.6,390
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,89.4,85.8 to 92.2,816
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,85.8,79.5 to 90.4,265
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,88.3,84.3 to 91.4,537
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,90.7,85.1 to 94.4,272
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,89.7,85.9 to 92.6,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,85.8,78.3 to 91.7,390
DTaP,≥4 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,83.4,78.4 to 87.8,816
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,87.2,79.3 to 93.1,272
DTaP,≥4 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,86.4,81.0 to 90.9,662
DTaP,≥4 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,89.8,82.5 to 95.0,265
DTaP,≥4 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,88.1,82.5 to 92.7,537
DTaP,≥4 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,83.9,76.1 to 90.2,236
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,86.8,80.0 to 92.3,239
DTaP,≥4 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,88.1,82.9 to 92.2,504
DTaP,≥4 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,79.5,70.6 to 87.2,212
DTaP,≥4 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,83.6,77.8 to 88.6,451
Hep A,≥2 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,70.6,60.1 to 80.4,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,87.9,84.6 to 90.6,236
Hep A,≥2 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,72.3,64.7 to 79.5,426
Hep A,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,71.1,64.9 to 77.0,783
Hep A,≥2 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,76.6,68.1 to 84.2,390
Hep A,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,74.3,68.8 to 79.6,816
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,91.1,86.2 to 94.4,239
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,88.5,84.6 to 91.4,504
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,92.1,89.8 to 94.0,212
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,91.6,90.2 to 92.8,451
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013,Age,19 Months,84.6,82.4 to 86.6,212
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013-2014,Age,19 Months,83.9,81.3 to 86.2,451
≥1 Dose Varicella,,States/Local Areas,Arkansas,2012,Age,19 Months,86.9,84.5 to 89.0,236
≥1 Dose Varicella,,States/Local Areas,Arkansas,2011,Age,19 Months,80.7,74.3 to 85.7,230
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019,Age,13 Months,54.5,47.2 to 61.6,357
≥1 Dose MMR,,States/Local Areas,Arkansas,2016,Age,13 Months,67.5,59.5 to 74.6,272
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2017,Age,13 Months,63.7,58.4 to 68.7,662
≥1 Dose MMR,,States/Local Areas,Arkansas,2015,Age,13 Months,59.2,51.5 to 66.5,265
≥1 Dose MMR,,States/Local Areas,Arkansas,2015-2016,Age,13 Months,63.4,57.9 to 68.6,537
≥1 Dose MMR,,States/Local Areas,Arkansas,2014,Age,13 Months,59.2,51.1 to 66.9,239
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2015,Age,13 Months,59.2,53.7 to 64.5,504
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,55.4,47.3 to 63.2,272
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,57.1,51.7 to 62.3,662
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,56.4,48.8 to 63.7,265
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,55.9,50.3 to 61.3,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2018,Age,0-3 Days,79.9,73.6 to 84.9,426
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2018-2019,Age,0-3 Days,79.3,75.0 to 83.1,783
Hib,≥2 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,94.3,92.9 to 95.4,236
Hib,≥2 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,94.3,92.1 to 95.9,230
Hib,≥3 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,77.0,68.6 to 83.7,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.3,88.2 to 96.4,279
Hib,≥3 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,48.1,41.0 to 55.3,357
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,91.9,88.0 to 95.7,398
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.1,85.8 to 92.4,669
Hib,≥2 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,85.4,79.3 to 90.0,357
DTaP,≥3 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,83.8,78.3 to 88.2,230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,87.1,77.0 to 97.2,53
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,81.8,74.5 to 89.1,130
Hib,Primary Series,States/Local Areas,Arkansas,2020,Age,24 Months,89.4,84.1 to 93.5,323
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,63.6,56.2 to 70.4,357
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,64.5,57.8 to 70.7,426
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,64.0,59.0 to 68.8,783
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",75.9,66.1 to 85.7,94
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,77.8,73.0 to 82.6,426
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,78.3,72.7 to 83.9,387
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,79.2,70.4 to 88.1,142
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2019,Age,0-3 Days,78.8,72.5 to 84.0,357
Polio,≥1 Dose,States/Local Areas,Arkansas,2019,Age,3 Months,84.2,78.1 to 88.9,357
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,90.3,84.1 to 96.5,142
Hib,≥2 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,93.6,88.9 to 96.4,239
Hib,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,92.6,89.4 to 94.9,504
PCV,≥3 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,91.7,84.5 to 96.4,357
Hib,≥3 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,45.2,38.7 to 51.8,426
Hib,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,46.6,41.8 to 51.6,783
Hib,≥3 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,44.7,38.0 to 51.5,390
Hib,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,44.9,40.2 to 49.7,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.3,81.7 to 96.8,115
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,95.8,91.8 to 99.8,130
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",96.6,92.7 to 100.0,94
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,78.0,64.1 to 92.0,53
Hib,≥2 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,89.6,84.0 to 93.3,390
Hib,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,91.8,88.4 to 94.2,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,93.1,90.5 to 95.8,426
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,91.3,86.8 to 95.7,387
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,86.9,81.3 to 91.0,426
DTaP,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,86.1,82.1 to 89.4,783
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,91.4,88.3 to 94.6,423
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,91.3,89.0 to 93.7,1008
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,89.9,86.0 to 93.8,331
Hib,≥2 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,90.9,85.7 to 94.3,357
Hib,≥2 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,94.0,89.6 to 96.6,426
Hib,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,92.5,89.2 to 94.8,783
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,83.8,77.2 to 88.7,265
DTaP,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,86.5,82.1 to 89.9,537
DTaP,≥3 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,86.9,79.6 to 91.8,236
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,84.7,78.7 to 89.3,390
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,85.8,81.8 to 89.1,816
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,89.1,82.9 to 93.3,272
DTaP,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,87.0,82.8 to 90.2,662
Polio,≥3 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,89.7,85.1 to 92.9,265
Polio,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,89.5,85.4 to 92.5,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,78.6,71.2 to 86.0,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,76.5,70.8 to 82.2,387
Polio,≥3 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,89.0,80.2 to 94.2,236
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,88.6,82.6 to 92.7,239
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,86.2,81.9 to 89.6,504
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,89.3,86.4 to 91.7,212
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,89.0,87.3 to 90.4,451
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Overall,Overall,78.8,75.5 to 82.0,1008
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,80.1,74.6 to 85.5,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,72.1,65.0 to 79.1,279
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,82.2,77.5 to 86.9,398
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.4,74.3 to 82.5,669
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.2,72.2 to 90.2,115
Polio,≥1 Dose,States/Local Areas,Arkansas,2018,Age,3 Months,82.4,76.4 to 87.2,426
Polio,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,3 Months,83.3,79.0 to 86.9,783
Polio,≥1 Dose,States/Local Areas,Arkansas,2017,Age,3 Months,79.9,73.5 to 85.1,390
Polio,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,3 Months,81.1,76.8 to 84.8,816
Hib,≥3 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,37.7,30.5 to 45.4,272
Hib,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,41.1,36.1 to 46.3,662
Hib,≥3 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,38.6,31.7 to 46.1,265
Hib,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,38.2,33.1 to 43.5,537
Hib,≥3 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,40.9,33.3 to 48.9,239
Hib,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,39.8,34.6 to 45.2,504
PCV,≥3 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,93.7,89.3 to 96.7,426
PCV,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,92.7,88.8 to 95.7,783
PCV,≥3 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,89.0,83.6 to 93.2,390
PCV,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,91.2,87.8 to 94.0,816
Hib,≥2 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,95.1,92.4 to 96.9,212
Hib,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,94.4,92.9 to 95.5,451
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,58.9,51.9 to 65.6,390
DTaP,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,61.7,56.8 to 66.3,816
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,92.0,90.0 to 93.7,212
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,91.9,90.6 to 93.0,451
DTaP,≥3 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,90.3,84.4 to 94.1,236
DTaP,≥3 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,90.8,86.6 to 93.8,230
DTaP,≥3 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,85.4,79.3 to 89.9,357
Hib,≥3 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,69.1,62.4 to 75.1,390
Hib,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,70.4,65.8 to 74.7,816
Hib,≥3 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,74.4,67.2 to 80.5,272
Hib,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,71.8,67.0 to 76.2,662
Polio,≥3 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,90.0,84.4 to 93.8,239
Polio,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,89.8,86.2 to 92.6,504
Polio,≥3 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,91.5,90.1 to 92.7,212
Polio,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,90.8,89.1 to 92.2,451
Hib,≥3 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,63.3,55.7 to 70.2,265
Hib,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,68.9,63.7 to 73.6,537
Hib,≥3 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,77.8,67.7 to 85.5,236
Hib,≥3 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,70.9,62.8 to 77.9,239
Hib,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,67.1,61.6 to 72.1,504
Hib,≥3 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,69.0,64.6 to 73.0,212
Hib,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,69.9,67.0 to 72.7,451
Polio,≥3 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,89.0,85.6 to 91.6,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,96.3,93.3 to 99.3,198
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,89.1,84.8 to 93.5,387
Hib,≥3 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,88.3,84.3 to 91.4,212
Hib,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,87.0,83.1 to 90.1,451
Hib,≥3 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,87.3,82.5 to 90.9,236
Hib,≥3 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,85.9,79.2 to 90.7,230
Hib,≥3 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,71.0,64.2 to 77.0,357
Hep B,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,86.1,80.3 to 90.8,437
Hib,Full Series,States/Local Areas,Arizona,2021,Age,24 Months,71.1,60.4 to 81.0,166
≥1 Dose Varicella,,States/Local Areas,Arizona,2021,Age,19 Months,87.2,78.0 to 92.9,166
Hib,≥3 Doses,States/Local Areas,Arizona,2021,Age,7 Months,58.2,47.0 to 68.5,166
PCV,≥3 Doses,States/Local Areas,Arizona,2021,Age,19 Months,88.9,79.1 to 94.4,166
Hep A,≥1 Dose,States/Local Areas,Arizona,2021,Age,35 Months,84.9,75.9 to 92.0,166
Polio,≥3 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,88.0,82.3 to 92.0,390
Polio,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,88.7,85.0 to 91.6,816
Polio,≥3 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,89.3,82.6 to 93.6,272
Polio,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,88.6,84.5 to 91.8,662
Hib,≥3 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,71.8,65.2 to 77.5,426
Hib,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,71.4,66.7 to 75.7,783
Polio,≥3 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,89.4,84.1 to 93.1,426
Polio,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,59.9,54.9 to 64.7,783
Hep B,≥2 Doses,States/Local Areas,Arizona,2021,Age,7 Months,84.1,73.3 to 91.0,166
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2021,Age,0-2 Days,79.5,68.4 to 87.4,166
PCV,≥3 Doses,States/Local Areas,Arizona,2021,Age,24 Months,88.9,80.3 to 94.8,166
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2021,Age,0-1 Days,78.2,67.2 to 86.3,166
PCV,≥3 Doses,States/Local Areas,Arizona,2021,Age,13 Months,83.2,72.6 to 90.3,166
≥1 Dose Varicella,,States/Local Areas,Arizona,2020-2021,Age,35 Months,90.7,85.1 to 94.8,437
Hib,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,88.4,82.5 to 92.4,437
PCV,≥4 Doses,States/Local Areas,Arizona,2021,Age,24 Months,77.7,67.5 to 86.5,166
≥1 Dose Varicella,,States/Local Areas,Arizona,2021,Age,24 Months,88.1,79.8 to 94.2,166
DTaP,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,90.1,85.1 to 94.0,437
Hep A,≥1 Dose,States/Local Areas,Arizona,2021,Age,24 Months,84.3,75.2 to 91.4,166
Hep A,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,26.3,20.8 to 32.5,437
Hep B,≥3 Doses,States/Local Areas,Arizona,2021,Age,7 Months,62.8,51.8 to 72.7,166
Hep A,≥2 Doses,States/Local Areas,Arizona,2021,Age,24 Months,40.0,30.2 to 51.6,166
PCV,≥3 Doses,States/Local Areas,Arizona,2021,Age,7 Months,62.2,50.8 to 72.5,166
DTaP,≥3 Doses,States/Local Areas,Arizona,2021,Age,13 Months,85.7,75.1 to 92.3,166
Hep A,≥1 Dose,States/Local Areas,Arizona,2021,Age,19 Months,79.6,69.4 to 87.0,166
PCV,≥3 Doses,States/Local Areas,Arizona,2021,Age,35 Months,88.9,80.3 to 94.8,166
Hep A,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,35 Months,88.8,83.1 to 93.3,437
DTaP,≥1 Dose,States/Local Areas,Arizona,2020-2021,Age,3 Months,83.4,77.4 to 88.0,437
PCV,≥4 Doses,States/Local Areas,Arizona,2021,Age,35 Months,86.3,72.1 to 95.5,166
DTaP,≥4 Doses,States/Local Areas,Arizona,2021,Age,24 Months,75.8,65.1 to 85.3,166
DTaP,≥1 Dose,States/Local Areas,Arizona,2021,Age,3 Months,87.3,77.0 to 93.4,166
Polio,≥3 Doses,States/Local Areas,Arizona,2021,Age,24 Months,89.6,80.9 to 95.5,166
Hep B,≥3 Doses,States/Local Areas,Arizona,2021,Age,24 Months,86.3,77.3 to 93.0,166
PCV,≥4 Doses,States/Local Areas,Arizona,2021,Age,19 Months,74.7,63.8 to 83.1,166
≥1 Dose MMR,,States/Local Areas,Arizona,2021,Age,24 Months,86.5,78.0 to 93.0,166
Hib,≥3 Doses,States/Local Areas,Arizona,2021,Age,24 Months,86.7,77.1 to 93.7,166
Polio,≥1 Dose,States/Local Areas,Arizona,2021,Age,3 Months,87.0,76.7 to 93.2,166
Hib,Primary Series,States/Local Areas,Arizona,2021,Age,24 Months,86.8,77.2 to 93.8,166
Hib,Primary Series,States/Local Areas,Arizona,2020-2021,Age,13 Months,83.1,77.1 to 87.8,437
DTaP,≥3 Doses,States/Local Areas,Arizona,2021,Age,19 Months,89.9,79.9 to 95.3,166
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2017,Age,0-3 Days,74.8,64.8 to 82.8,232
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2017-2018,Age,0-3 Days,80.6,76.3 to 84.4,816
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016,Age,0-3 Days,76.7,69.1 to 82.9,272
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2016-2017,Age,0-3 Days,79.0,74.1 to 83.2,662
Polio,≥1 Dose,States/Local Areas,Arkansas,2016,Age,3 Months,83.9,77.4 to 88.8,272
Polio,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,3 Months,81.9,77.5 to 85.6,662
Polio,≥1 Dose,States/Local Areas,Arkansas,2015,Age,3 Months,82.4,76.4 to 87.1,265
Polio,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,3 Months,83.1,78.9 to 86.7,537
Hib,≥3 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,43.7,40.3 to 47.2,212
Hib,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,42.3,40.3 to 44.4,451
Hib,≥3 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,49.3,39.4 to 59.3,236
Hib,≥3 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,45.5,40.5 to 50.7,230
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,94.8,91.2 to 98.3,198
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,90.0,86.1 to 93.9,387
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,53.1,45.2 to 60.9,239
DTaP,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,54.7,49.2 to 60.1,504
PCV,≥3 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,92.1,86.4 to 96.1,272
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,90.6,86.8 to 93.7,662
PCV,≥3 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,91.7,86.6 to 95.4,265
PCV,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,91.9,88.2 to 94.8,537
PCV,≥3 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,91.0,85.6 to 94.9,239
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,91.2,87.7 to 94.1,504
Hib,≥2 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,88.0,82.8 to 91.8,426
Hib,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,86.7,82.8 to 89.9,783
Hib,≥2 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,93.3,88.4 to 96.3,272
Hib,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,91.5,88.0 to 94.0,662
Hib,≥2 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,91.6,86.4 to 94.9,265
Hib,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,92.5,89.1 to 94.9,537
Hib,≥2 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,83.3,77.2 to 88.0,390
Hib,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,85.6,81.7 to 88.9,816
Hib,≥2 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,86.7,80.4 to 91.2,272
Hib,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,85.0,80.8 to 88.4,662
Polio,≥1 Dose,States/Local Areas,Arkansas,2014,Age,3 Months,78.0,70.5 to 84.1,239
Polio,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,3 Months,80.2,75.5 to 84.2,504
Polio,≥1 Dose,States/Local Areas,Arkansas,2013,Age,3 Months,81.3,75.5 to 86.0,212
Polio,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,3 Months,79.7,73.6 to 84.7,451
Polio,≥1 Dose,States/Local Areas,Arkansas,2012,Age,3 Months,84.3,77.3 to 89.4,236
Polio,≥1 Dose,States/Local Areas,Arkansas,2011,Age,3 Months,80.4,75.3 to 84.7,230
PCV,≥1 Dose,States/Local Areas,Arkansas,2019,Age,3 Months,84.0,77.9 to 88.6,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,94.4,92.0 to 96.8,423
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,93.0,91.0 to 94.9,1008
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,62.8,58.4 to 66.9,212
DTaP,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,58.0,52.8 to 63.0,451
DTaP,≥3 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,57.7,45.9 to 68.8,236
DTaP,≥3 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,52.0,46.8 to 57.1,230
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2015,Age,0-3 Days,78.1,71.5 to 83.6,265
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2015-2016,Age,0-3 Days,77.4,72.5 to 81.7,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014,Age,0-3 Days,77.6,70.0 to 83.8,239
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2015,Age,0-3 Days,77.9,72.9 to 82.1,504
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,94.1,91.4 to 96.7,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,80.3,75.7 to 84.9,423
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.3,90.8 to 97.8,279
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,91.1,87.6 to 94.7,398
PCV,≥3 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,95.1,90.2 to 98.0,236
PCV,≥3 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,94.8,89.7 to 97.8,212
PCV,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,92.6,89.0 to 95.4,451
PCV,≥3 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,91.8,85.6 to 96.0,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,88.8,83.5 to 93.0,357
Hib,≥2 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,85.3,79.2 to 89.9,265
Hib,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,86.0,81.8 to 89.4,537
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,92.1,87.9 to 96.3,198
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,76.9,70.8 to 82.9,387
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,74.7,69.5 to 79.9,423
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Overall,Overall,77.8,74.3 to 81.3,1008
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,75.5,69.6 to 81.5,331
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,81.0,67.8 to 94.3,53
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.0,69.1 to 83.0,279
Hib,≥2 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,83.7,76.5 to 89.1,239
Hib,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,84.5,80.0 to 88.2,504
Hib,≥2 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,85.4,80.1 to 89.4,212
Hib,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,84.6,81.9 to 86.9,451
PCV,≥1 Dose,States/Local Areas,Arkansas,2017,Age,3 Months,78.5,71.9 to 83.9,390
PCV,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,3 Months,80.1,75.6 to 83.9,816
PCV,≥1 Dose,States/Local Areas,Arkansas,2016,Age,3 Months,81.6,74.5 to 87.0,272
PCV,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,3 Months,80.0,75.4 to 84.0,662
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",94.3,89.1 to 99.5,94
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.7,90.2 to 95.2,669
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.6,85.8 to 97.5,115
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,91.9,88.2 to 95.7,387
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,92.4,87.2 to 97.6,142
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2013,Age,0-3 Days,77.6,69.2 to 84.2,212
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2013-2014,Age,0-3 Days,77.6,72.1 to 82.3,451
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2012,Age,0-3 Days,75.3,66.9 to 82.0,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,95.2,93.2 to 97.2,426
PCV,≥1 Dose,States/Local Areas,Arkansas,2018,Age,3 Months,81.7,75.6 to 86.5,426
PCV,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,3 Months,82.8,78.5 to 86.4,783
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arkansas,2011,Age,0-3 Days,88.4,83.1 to 92.1,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,92.2,88.0 to 95.4,426
PCV,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,90.6,87.3 to 93.4,783
PCV,≥3 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,88.5,83.2 to 92.8,390
PCV,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,90.4,87.1 to 93.2,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,92.1,86.4 to 96.1,272
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,90.4,86.6 to 93.5,662
Hib,≥2 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,86.3,78.7 to 91.5,236
Hib,≥2 Doses,States/Local Areas,Arkansas,2011,Age,7 Months,83.2,78.9 to 86.7,230
Hib,≥2 Doses,States/Local Areas,Arkansas,2019,Age,5 Months,70.7,63.5 to 77.1,357
Hib,≥2 Doses,States/Local Areas,Arkansas,2018,Age,5 Months,73.6,67.1 to 79.3,426
Hib,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,5 Months,72.2,67.3 to 76.6,783
PCV,≥1 Dose,States/Local Areas,Arkansas,2013,Age,3 Months,81.0,74.9 to 85.9,212
PCV,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,3 Months,79.3,73.6 to 84.1,451
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",78.4,68.0 to 88.7,94
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,82.9,74.9 to 90.8,130
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,59.9,43.8 to 76.0,53
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,72.3,63.1 to 81.6,142
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,77.2,72.1 to 82.4,426
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,85.6,80.5 to 90.8,387
PCV,≥3 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,91.2,86.0 to 95.1,212
PCV,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,91.1,87.5 to 94.0,451
Hib,≥2 Doses,States/Local Areas,Arkansas,2017,Age,5 Months,68.8,62.0 to 75.0,390
Hib,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,5 Months,71.2,66.5 to 75.5,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,91.0,85.6 to 94.9,239
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,90.4,86.9 to 93.4,504
PCV,≥3 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,89.9,84.8 to 93.8,265
PCV,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,91.1,87.4 to 94.1,537
PCV,≥1 Dose,States/Local Areas,Arkansas,2015,Age,3 Months,80.2,73.7 to 85.4,265
PCV,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,3 Months,80.9,76.3 to 84.8,537
PCV,≥1 Dose,States/Local Areas,Arkansas,2014,Age,3 Months,77.6,70.0 to 83.7,239
PCV,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,3 Months,78.9,74.0 to 83.1,504
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,80.9,75.3 to 86.4,398
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",76.5,72.0 to 80.9,669
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,68.1 to 87.0,115
Hib,≥2 Doses,States/Local Areas,Arkansas,2016,Age,5 Months,74.1,66.7 to 80.2,272
Hib,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,5 Months,71.5,66.5 to 76.0,662
Hib,≥2 Doses,States/Local Areas,Arkansas,2015,Age,5 Months,68.6,61.3 to 75.1,265
Hib,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,5 Months,71.4,66.2 to 76.0,537
Hib,≥2 Doses,States/Local Areas,Arkansas,2014,Age,5 Months,62.2,54.2 to 69.7,239
Hib,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,5 Months,65.4,61.2 to 69.5,504
Hib,≥2 Doses,States/Local Areas,Arkansas,2013,Age,5 Months,68.4,66.4 to 70.3,212
Hib,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,5 Months,65.3,61.7 to 68.8,451
Hib,≥2 Doses,States/Local Areas,Arkansas,2012,Age,5 Months,70.4,59.8 to 79.1,236
Hib,≥2 Doses,States/Local Areas,Arkansas,2011,Age,5 Months,65.1,55.9 to 73.2,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,91.5,85.4 to 95.8,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,87.9,82.3 to 91.9,357
PCV,≥3 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,90.6,85.6 to 94.0,426
PCV,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,85.6,81.6 to 88.9,783
PCV,≥1 Dose,States/Local Areas,Arkansas,2012,Age,3 Months,84.0,77.4 to 89.0,236
PCV,≥1 Dose,States/Local Areas,Arkansas,2011,Age,3 Months,79.5,73.4 to 84.5,230
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,97.4,94.9 to 99.8,198
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,88.9,84.5 to 93.3,387
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,91.8,88.7 to 94.8,423
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Overall,Overall,91.6,89.3 to 93.8,1008
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,90.2,86.2 to 94.1,331
PCV,≥4 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,82.4,75.6 to 88.2,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,79.7,73.8 to 85.1,426
PCV,≥4 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,80.8,76.3 to 84.9,783
PCV,≥4 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,79.5,73.0 to 85.4,390
PCV,≥4 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,79.7,75.2 to 83.8,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,89.9,83.3 to 94.1,272
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,88.3,84.1 to 91.5,662
PCV,≥3 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,87.9,80.2 to 92.9,265
PCV,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,88.9,84.8 to 92.1,537
Hep B,≥2 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,93.5,88.5 to 96.4,357
Hep A,≥1 Dose,States/Local Areas,Arkansas,2020,Age,35 Months,91.9,86.4 to 95.7,323
Hep B,≥2 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,95.1,91.3 to 97.3,426
Hep B,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,94.3,91.3 to 96.3,783
Hep B,≥2 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,92.0,86.9 to 95.2,390
Hep B,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,93.6,90.6 to 95.6,816
Hib,≥1 Dose,States/Local Areas,Arkansas,2017,Age,3 Months,78.3,71.8 to 83.6,390
Hib,≥1 Dose,States/Local Areas,Arkansas,2017-2018,Age,3 Months,80.4,76.0 to 84.1,816
Hib,≥1 Dose,States/Local Areas,Arkansas,2016,Age,3 Months,82.7,75.9 to 87.9,272
Hib,≥1 Dose,States/Local Areas,Arkansas,2016-2017,Age,3 Months,80.5,76.0 to 84.4,662
Hib,≥1 Dose,States/Local Areas,Arkansas,2015-2016,Age,3 Months,82.4,78.1 to 86.0,537
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,88.5 to 95.5,398
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.9,85.6 to 92.2,669
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,93.2,89.5 to 97.0,387
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,88.3,81.4 to 95.1,142
≥1 Dose MMR,,States/Local Areas,Arkansas,2019,Age,35 Months,96.2,90.1 to 99.0,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,81.2,73.6 to 87.8,212
PCV,≥4 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,80.5,75.2 to 85.3,451
≥1 Dose MMR,,States/Local Areas,Arkansas,2018,Age,35 Months,92.7,87.8 to 96.1,426
≥1 Dose MMR,,States/Local Areas,Arkansas,2018-2019,Age,35 Months,93.7,90.0 to 96.4,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.0,88.0 to 98.0,94
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,74.2,59.6 to 88.8,53
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Other,87.6,80.7 to 94.6,142
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,93.6,91.1 to 96.2,426
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Private Insurance Only,92.0,88.0 to 96.0,387
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019,Age,35 Months,97.2,91.4 to 99.4,357
≥1 Dose MMR,,States/Local Areas,Arkansas,2017,Age,35 Months,91.0,85.6 to 95.0,390
≥1 Dose MMR,,States/Local Areas,Arkansas,2017-2018,Age,35 Months,91.8,88.4 to 94.6,816
≥1 Dose MMR,,States/Local Areas,Arkansas,2016,Age,35 Months,93.3,87.4 to 97.1,272
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2017,Age,35 Months,92.2,88.3 to 95.2,662
≥1 Dose MMR,,States/Local Areas,Arkansas,2015,Age,35 Months,97.1,90.7 to 99.5,265
≥1 Dose MMR,,States/Local Areas,Arkansas,2015-2016,Age,35 Months,94.3,90.2 to 97.1,537
PCV,≥4 Doses,States/Local Areas,Arkansas,2018,Age,24 Months,78.8,72.9 to 84.1,426
PCV,≥4 Doses,States/Local Areas,Arkansas,2018-2019,Age,24 Months,78.5,74.1 to 82.6,783
PCV,≥4 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,75.7,69.3 to 81.6,390
PCV,≥4 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,77.2,72.9 to 81.3,816
PCV,≥4 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,77.2,69.8 to 83.9,272
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,76.5,71.6 to 81.0,662
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,92.7,87.6 to 96.3,265
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,92.7,89.3 to 95.3,537
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,94.4,90.5 to 97.1,239
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,93.5,90.4 to 95.9,504
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013,Age,35 Months,98.1,93.1 to 99.7,212
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,35 Months,95.8,92.6 to 97.9,451
PCV,≥3 Doses,States/Local Areas,Arkansas,2018,Age,13 Months,86.9,81.4 to 91.0,426
PCV,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,13 Months,85.6,81.6 to 88.9,783
PCV,≥3 Doses,States/Local Areas,Arkansas,2017,Age,13 Months,83.3,77.2 to 88.0,390
PCV,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,13 Months,85.1,81.0 to 88.4,816
Hep B,≥2 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,97.1,95.8 to 98.0,212
Hep B,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,96.1,94.3 to 97.3,451
Hep B,≥2 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,96.1,95.1 to 97.0,236
Hep B,≥2 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,95.5,91.3 to 97.7,230
Hep B,≥2 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,92.3,87.2 to 95.5,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,93.0,88.1 to 96.4,272
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,92.8,89.6 to 95.3,662
PCV,≥3 Doses,States/Local Areas,Arkansas,2014,Age,19 Months,88.9,82.5 to 93.2,239
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,19 Months,88.4,84.3 to 91.6,504
PCV,≥3 Doses,States/Local Areas,Arkansas,2013,Age,19 Months,90.2,87.8 to 92.3,212
PCV,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,19 Months,89.6,86.5 to 92.1,451
PCV,≥3 Doses,States/Local Areas,Arkansas,2011,Age,19 Months,89.1,84.2 to 92.6,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2019,Age,13 Months,84.3,78.3 to 89.0,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,77.2,69.2 to 84.4,236
PCV,≥4 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,81.4,69.1 to 90.9,230
PCV,≥4 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,78.4,71.9 to 84.3,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017,Age,35 Months,92.6,88.0 to 95.9,390
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,35 Months,92.9,90.0 to 95.3,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2012,Age,19 Months,89.7,83.6 to 93.7,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018,Age,35 Months,93.3,89.3 to 96.2,426
Hep B,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,35 Months,93.0,89.7 to 95.6,783
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Uninsured,75.9,61.4 to 90.4,53
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",93.6,88.8 to 98.5,94
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,86.1 to 98.1,115
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,95.1,90.9 to 99.3,130
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Insurance Coverage,Any Medicaid,93.4,90.9 to 96.0,426
PCV,≥4 Doses,States/Local Areas,Arkansas,2016,Age,35 Months,79.2,71.4 to 86.0,272
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2017,Age,35 Months,79.3,74.3 to 83.9,662
PCV,≥4 Doses,States/Local Areas,Arkansas,2015,Age,35 Months,82.4,75.2 to 88.5,265
PCV,≥4 Doses,States/Local Areas,Arkansas,2015-2016,Age,35 Months,80.5,75.2 to 85.2,537
PCV,≥4 Doses,States/Local Areas,Arkansas,2014,Age,35 Months,80.1,72.4 to 86.8,239
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2015,Age,35 Months,81.0,75.8 to 85.6,504
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Poverty,<133% FPL,92.6,89.7 to 95.5,423
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Overall,Overall,91.1,88.8 to 93.4,1008
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a Non-MSA,91.0,87.3 to 94.8,331
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.6,84.7 to 94.5,279
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Poverty,133% to <400% FPL,86.8,82.1 to 91.6,387
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019,Age,35 Months,93.9,87.3 to 97.7,357
PCV,≥3 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,86.6,80.6 to 90.9,390
PCV,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,88.6,84.9 to 91.4,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,92.3,87.2 to 96.0,236
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Poverty,>400% FPL,95.7,92.7 to 98.7,198
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.0,85.2 to 94.9,279
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Urbanicity,Living In a MSA Principal City,93.6,90.6 to 96.7,398
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.8,86.6 to 93.0,669
Hib,≥1 Dose,States/Local Areas,Arkansas,2019,Age,3 Months,83.2,77.0 to 88.0,357
Hib,≥1 Dose,States/Local Areas,Arkansas,2018,Age,3 Months,82.5,76.5 to 87.3,426
Hib,≥1 Dose,States/Local Areas,Arkansas,2018-2019,Age,3 Months,82.9,78.6 to 86.5,783
Hep B,≥2 Doses,States/Local Areas,Arkansas,2016,Age,13 Months,93.3,88.1 to 96.3,272
Hep B,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,13 Months,92.7,89.3 to 95.0,662
Hib,≥1 Dose,States/Local Areas,Arkansas,2015,Age,3 Months,82.1,76.1 to 86.8,265
Hep B,≥2 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,92.2,86.9 to 95.5,265
Hep B,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,92.7,89.3 to 95.1,537
Hep B,≥2 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,95.1,90.7 to 97.5,239
Hep B,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,93.6,90.4 to 95.8,504
Hib,≥1 Dose,States/Local Areas,Arkansas,2014,Age,3 Months,78.1,70.5 to 84.2,239
Hib,≥1 Dose,States/Local Areas,Arkansas,2014-2015,Age,3 Months,80.1,75.3 to 84.1,504
Hib,≥1 Dose,States/Local Areas,Arkansas,2013,Age,3 Months,80.3,74.8 to 84.9,212
Hib,≥1 Dose,States/Local Areas,Arkansas,2013-2014,Age,3 Months,79.2,73.8 to 83.7,451
Hib,≥1 Dose,States/Local Areas,Arkansas,2012,Age,3 Months,83.0,74.1 to 89.3,236
Hib,≥1 Dose,States/Local Areas,Arkansas,2011,Age,3 Months,78.6,73.4 to 83.1,230
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.3,86.3 to 98.2,115
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2017,Race and Ethnicity,Hispanic,95.5,91.4 to 99.5,130
PCV,≥3 Doses,States/Local Areas,Arkansas,2015,Age,13 Months,82.2,75.6 to 87.3,265
PCV,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,13 Months,84.4,79.9 to 88.1,537
PCV,≥3 Doses,States/Local Areas,Arkansas,2014,Age,13 Months,82.5,75.2 to 88.1,239
PCV,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,13 Months,82.4,77.6 to 86.3,504
Hep B,≥2 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,92.8,88.5 to 95.6,426
Hep B,≥2 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,92.6,89.4 to 94.9,783
Hep B,≥2 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,88.5,82.8 to 92.5,390
Hep B,≥2 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,90.6,87.1 to 93.3,816
Hep B,≥2 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,90.2,84.4 to 94.0,272
Hep B,≥2 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,89.4,85.5 to 92.3,662
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2016,Age,0-2 Days,76.7,69.1 to 82.9,272
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2016-2017,Age,0-2 Days,78.6,73.6 to 82.8,662
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015,Age,35 Months,92.9,88.1 to 96.3,265
≥1 Dose Varicella,,States/Local Areas,Arkansas,2015-2016,Age,35 Months,93.4,89.6 to 96.1,537
PCV,≥4 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,75.8,67.4 to 83.4,230
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014,Age,35 Months,91.3,86.4 to 95.0,239
≥1 Dose Varicella,,States/Local Areas,Arkansas,2014-2015,Age,35 Months,92.3,89.0 to 94.9,504
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013,Age,35 Months,90.1,82.7 to 95.3,212
≥1 Dose Varicella,,States/Local Areas,Arkansas,2013-2014,Age,35 Months,90.6,86.2 to 94.1,451
≥1 Dose MMR,,States/Local Areas,Arkansas,2018,Age,24 Months,89.9,85.2 to 93.6,426
≥1 Dose MMR,,States/Local Areas,Arkansas,2018-2019,Age,24 Months,89.0,85.6 to 91.9,783
PCV,≥4 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,70.2,63.0 to 76.5,357
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2015,Age,0-2 Days,77.8,71.1 to 83.2,265
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2015-2016,Age,0-2 Days,77.2,72.3 to 81.5,537
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2014,Age,0-2 Days,77.6,70.0 to 83.8,239
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2014-2015,Age,0-2 Days,77.7,72.8 to 81.9,504
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016,Age,35 Months,93.4,87.4 to 97.2,272
≥1 Dose Varicella,,States/Local Areas,Arkansas,2016-2017,Age,35 Months,92.3,88.4 to 95.2,662
≥1 Dose MMR,,States/Local Areas,Arkansas,2013,Age,35 Months,91.1,83.8 to 95.9,212
≥1 Dose MMR,,States/Local Areas,Arkansas,2013-2014,Age,35 Months,91.9,87.5 to 95.2,451
≥1 Dose MMR,,States/Local Areas,Arkansas,2012,Age,35 Months,93.4,87.8 to 97.0,236
≥1 Dose MMR,,States/Local Areas,Arkansas,2011,Age,35 Months,91.9,83.2 to 97.1,230
≥1 Dose MMR,,States/Local Areas,Arkansas,2019,Age,24 Months,88.1,83.0 to 92.3,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,76.3,69.4 to 82.7,265
PCV,≥4 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,76.8,71.7 to 81.5,537
PCV,≥4 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,76.5,69.0 to 83.4,239
PCV,≥4 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,76.3,71.2 to 81.1,504
PCV,≥4 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,79.2,71.7 to 85.9,212
PCV,≥4 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,77.7,72.4 to 82.7,451
PCV,≥4 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,75.5,67.4 to 82.8,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2011,Age,35 Months,91.6,86.2 to 95.5,230
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019,Age,24 Months,90.1,85.2 to 93.9,357
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2019,Age,0-2 Days,78.8,72.5 to 84.0,357
Hep B,≥3 Doses,States/Local Areas,Arkansas,2012,Age,35 Months,95.2,92.0 to 97.4,236
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2018,Age,0-2 Days,79.6,73.4 to 84.7,426
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2018-2019,Age,0-2 Days,79.2,74.9 to 83.0,783
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2017,Age,0-2 Days,80.5,73.9 to 85.8,390
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2017-2018,Age,0-2 Days,80.0,75.6 to 83.8,816
≥1 Dose MMR,,States/Local Areas,Arkansas,2014,Age,35 Months,92.6,87.8 to 96.1,239
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2015,Age,35 Months,94.6,90.8 to 97.2,504
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018,Age,35 Months,92.1,87.3 to 95.6,426
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018-2019,Age,35 Months,93.9,90.3 to 96.5,783
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017,Age,35 Months,90.9,85.6 to 94.9,390
≥1 Dose Varicella,,States/Local Areas,Arkansas,2017-2018,Age,35 Months,91.5,88.1 to 94.3,816
≥1 Dose MMR,,States/Local Areas,Arkansas,2017,Age,24 Months,87.2,81.8 to 91.7,390
≥1 Dose MMR,,States/Local Areas,Arkansas,2017-2018,Age,24 Months,88.6,85.1 to 91.6,816
≥1 Dose MMR,,States/Local Areas,Arkansas,2016,Age,24 Months,92.2,86.3 to 96.2,272
≥1 Dose MMR,,States/Local Areas,Arkansas,2016-2017,Age,24 Months,89.9,86.0 to 93.0,662
PCV,≥4 Doses,States/Local Areas,Arkansas,2018,Age,19 Months,76.3,70.0 to 81.6,426
PCV,≥4 Doses,States/Local Areas,Arkansas,2018-2019,Age,19 Months,73.2,67.5 to 78.2,662
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017,Age,24 Months,92.4,87.9 to 95.7,390
Hep B,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,24 Months,92.5,89.7 to 94.8,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2012,Age,13 Months,84.1,78.3 to 88.5,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016,Age,24 Months,92.8,87.9 to 96.2,272
Hep B,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,24 Months,92.6,89.4 to 95.1,662
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015,Age,24 Months,90.4,85.3 to 94.4,265
Hep B,≥3 Doses,States/Local Areas,Arkansas,2015-2016,Age,24 Months,91.6,88.2 to 94.3,537
PCV,≥3 Doses,States/Local Areas,Arkansas,2013,Age,13 Months,87.5,84.5 to 90.1,212
PCV,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,13 Months,85.1,81.3 to 88.2,451
PCV,≥3 Doses,States/Local Areas,Arkansas,2011,Age,13 Months,82.6,78.7 to 85.8,230
PCV,≥3 Doses,States/Local Areas,Arkansas,2019,Age,7 Months,62.4,55.0 to 69.2,357
PCV,≥3 Doses,States/Local Areas,Arkansas,2018,Age,7 Months,63.7,56.9 to 69.9,426
PCV,≥3 Doses,States/Local Areas,Arkansas,2018-2019,Age,7 Months,63.0,58.0 to 67.8,783
Hep B,≥2 Doses,States/Local Areas,Arkansas,2015,Age,7 Months,90.7,85.3 to 94.2,265
Hep B,≥2 Doses,States/Local Areas,Arkansas,2015-2016,Age,7 Months,90.4,86.7 to 93.2,537
Hep B,≥2 Doses,States/Local Areas,Arkansas,2012,Age,7 Months,91.9,86.4 to 95.3,236
Hep B,≥2 Doses,States/Local Areas,Arkansas,2014,Age,7 Months,89.4,82.7 to 93.7,239
Hep B,≥2 Doses,States/Local Areas,Arkansas,2014-2015,Age,7 Months,90.0,86.0 to 93.0,504
Hep B,≥2 Doses,States/Local Areas,Arkansas,2013,Age,7 Months,94.3,93.0 to 95.5,212
Hep B,≥2 Doses,States/Local Areas,Arkansas,2013-2014,Age,7 Months,91.9,87.9 to 94.6,451
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2013,Age,0-2 Days,77.6,73.7 to 81.0,212
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2013-2014,Age,0-2 Days,77.6,74.4 to 80.5,451
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2012,Age,0-2 Days,75.3,67.3 to 81.8,236
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arkansas,2011,Age,0-2 Days,88.4,82.7 to 92.3,230
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arkansas,2019,Age,0-1 Days,77.2,70.6 to 82.6,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2016,Age,19 Months,75.0,67.1 to 81.5,272
PCV,≥4 Doses,States/Local Areas,Arkansas,2016-2017,Age,19 Months,74.4,69.3 to 78.9,662
PCV,≥4 Doses,States/Local Areas,Arkansas,2015,Age,19 Months,70.2,68.1 to 72.1,265
PCV,≥4 Doses,States/Local Areas,Arkansas,2015-2016,Age,19 Months,72.6,67.3 to 77.3,537
PCV,≥3 Doses,States/Local Areas,Arkansas,2017,Age,7 Months,58.6,51.6 to 65.2,390
PCV,≥3 Doses,States/Local Areas,Arkansas,2017-2018,Age,7 Months,61.1,56.2 to 65.8,816
PCV,≥3 Doses,States/Local Areas,Arkansas,2016,Age,7 Months,53.7,45.7 to 61.6,272
PCV,≥3 Doses,States/Local Areas,Arkansas,2016-2017,Age,7 Months,56.1,50.8 to 61.3,662
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014,Age,24 Months,94.4,90.5 to 97.1,239
Hep B,≥3 Doses,States/Local Areas,Arkansas,2014-2015,Age,24 Months,92.4,89.2 to 94.9,504
Hep B,≥3 Doses,States/Local Areas,Arkansas,2012,Age,24 Months,94.9,91.7 to 97.2,236
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013,Age,24 Months,93.5,88.8 to 96.7,212
Hep B,≥3 Doses,States/Local Areas,Arkansas,2013-2014,Age,24 Months,94.0,91.1 to 96.2,451
Hep B,≥3 Doses,States/Local Areas,Arkansas,2011,Age,24 Months,91.4,86.1 to 95.3,230
Hep B,≥3 Doses,States/Local Areas,Arkansas,2019,Age,19 Months,88.8,83.5 to 92.6,357
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018,Age,24 Months,89.6,85.0 to 93.4,426
≥1 Dose Varicella,,States/Local Areas,Arkansas,2018-2019,Age,24 Months,89.3,85.9 to 92.2,783
≥1 Dose MMR,,States/Local Areas,Arkansas,2015,Age,24 Months,92.3,87.4 to 95.8,265
≥1 Dose MMR,,States/Local Areas,Arkansas,2015-2016,Age,24 Months,92.3,88.6 to 95.1,537
≥1 Dose MMR,,States/Local Areas,Arkansas,2014,Age,24 Months,89.8,84.6 to 93.8,239
≥1 Dose MMR,,States/Local Areas,Arkansas,2014-2015,Age,24 Months,91.1,87.6 to 93.9,504
≥1 Dose MMR,,States/Local Areas,Arkansas,2013,Age,24 Months,87.2,80.5 to 92.5,212
≥1 Dose MMR,,States/Local Areas,Arkansas,2013-2014,Age,24 Months,88.6,84.2 to 92.3,451
≥1 Dose Varicella,,States/Local Areas,Arkansas,2012,Age,35 Months,93.4,88.2 to 96.8,236
≥1 Dose Varicella,,States/Local Areas,Arkansas,2011,Age,35 Months,92.6,84.6 to 97.4,230
≥1 Dose Varicella,,States/Local Areas,Arkansas,2019,Age,24 Months,89.0,84.0 to 93.0,357
PCV,≥4 Doses,States/Local Areas,Arkansas,2017,Age,19 Months,73.8,67.1 to 79.5,390
PCV,≥4 Doses,States/Local Areas,Arkansas,2017-2018,Age,19 Months,75.0,70.4 to 79.1,816
Hep B,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,92.2,89.7 to 94.2,2587
Hib,Primary Series,HHS Regions/National,Region 9,2019-2020,Age,7 Months,68.4,64.8 to 71.8,2587
Rotavirus,,HHS Regions/National,Region 9,2018,Age,8 Months,79.4,74.9 to 83.4,1489
Rotavirus,,HHS Regions/National,Region 9,2018-2019,Age,8 Months,77.2,74.0 to 80.2,2847
Hib,≥2 Doses,HHS Regions/National,Region 9,2021,Age,5 Months,67.7,60.1 to 74.4,808
Rotavirus,,HHS Regions/National,Region 9,2011,Age,8 Months,72.6,65.8 to 78.5,1101
Rotavirus,,HHS Regions/National,Region 9,2015,Age,8 Months,66.3,57.8 to 73.8,1034
Rotavirus,,HHS Regions/National,Region 9,2015-2016,Age,8 Months,70.3,64.5 to 75.5,2154
Rotavirus,,HHS Regions/National,Region 9,2016,Age,8 Months,74.2,66.1 to 80.9,1120
Rotavirus,,HHS Regions/National,Region 9,2016-2017,Age,8 Months,74.3,69.3 to 78.7,2389
Rotavirus,,HHS Regions/National,Region 9,2014,Age,8 Months,66.5,59.5 to 72.9,1048
Rotavirus,,HHS Regions/National,Region 9,2014-2015,Age,8 Months,66.4,60.9 to 71.5,2082
Rotavirus,,HHS Regions/National,Region 9,2012,Age,8 Months,71.1,64.4 to 77.0,1139
Rotavirus,,HHS Regions/National,Region 9,2013,Age,8 Months,74.2,67.9 to 79.7,1078
Rotavirus,,HHS Regions/National,Region 9,2013-2014,Age,8 Months,70.4,65.7 to 74.7,2126
Rotavirus,,HHS Regions/National,Region 9,2017,Age,8 Months,74.4,68.3 to 79.7,1269
Rotavirus,,HHS Regions/National,Region 9,2017-2018,Age,8 Months,76.9,73.2 to 80.2,2758
Rotavirus,,HHS Regions/National,Region 9,2019,Age,8 Months,75.0,70.2 to 79.2,1358
Combined 7 Series,,HHS Regions/National,Region 9,2015,Age,35 Months,77.3,69.3 to 84.5,1034
Combined 7 Series,,HHS Regions/National,Region 9,2015-2016,Age,35 Months,75.5,69.5 to 81.1,2154
Hib,Full Series,HHS Regions/National,Region 9,2011,Age,19 Months,72.4,69.6 to 75.0,1101
Hib,Full Series,HHS Regions/National,Region 9,2012,Age,19 Months,70.2,66.1 to 74.0,1139
Hib,Full Series,HHS Regions/National,Region 9,2013,Age,19 Months,76.6,71.2 to 81.2,1078
Hib,Full Series,HHS Regions/National,Region 9,2013-2014,Age,19 Months,74.1,71.3 to 76.7,2126
Hib,Primary Series,HHS Regions/National,Region 9,2011,Age,13 Months,86.4,82.5 to 89.5,1101
Hib,Primary Series,HHS Regions/National,Region 9,2012,Age,13 Months,88.9,85.1 to 91.8,1139
Hib,Primary Series,HHS Regions/National,Region 9,2013,Age,13 Months,88.5,85.4 to 91.0,1078
Hib,Primary Series,HHS Regions/National,Region 9,2013-2014,Age,13 Months,88.0,85.0 to 90.4,2126
Hib,Primary Series,HHS Regions/National,Region 9,2017,Age,7 Months,66.9,60.5 to 72.7,1269
Hib,Primary Series,HHS Regions/National,Region 9,2017-2018,Age,7 Months,70.1,66.1 to 73.8,2758
Hib,Primary Series,HHS Regions/National,Region 9,2016,Age,7 Months,70.9,62.8 to 77.8,1120
Hib,Primary Series,HHS Regions/National,Region 9,2016-2017,Age,7 Months,68.9,63.8 to 73.6,2389
Hib,Primary Series,HHS Regions/National,Region 9,2016,Age,13 Months,84.9,77.3 to 90.3,1120
Hib,Primary Series,HHS Regions/National,Region 9,2016-2017,Age,13 Months,85.1,80.6 to 88.7,2389
Hib,Primary Series,HHS Regions/National,Region 9,2015,Age,7 Months,59.2,50.7 to 67.2,1034
Hib,Primary Series,HHS Regions/National,Region 9,2015-2016,Age,7 Months,65.0,59.2 to 70.5,2154
Hib,Primary Series,HHS Regions/National,Region 9,2014,Age,7 Months,67.1,59.9 to 73.6,1048
Hib,Primary Series,HHS Regions/National,Region 9,2014-2015,Age,7 Months,63.2,57.6 to 68.5,2082
Hib,Primary Series,HHS Regions/National,Region 9,2012,Age,7 Months,64.0,58.3 to 69.4,1139
Hib,Primary Series,HHS Regions/National,Region 9,2019,Age,13 Months,89.0,85.5 to 91.8,1358
Hib,Primary Series,HHS Regions/National,Region 9,2018,Age,19 Months,94.5,91.6 to 96.5,1489
Hib,Primary Series,HHS Regions/National,Region 9,2018-2019,Age,19 Months,90.1,87.7 to 92.0,2847
Hib,Primary Series,HHS Regions/National,Region 9,2011,Age,19 Months,89.7,85.5 to 92.8,1101
Hib,Primary Series,HHS Regions/National,Region 9,2013,Age,19 Months,92.6,90.9 to 94.0,1078
Hib,Primary Series,HHS Regions/National,Region 9,2013-2014,Age,19 Months,91.1,89.2 to 92.7,2126
Hib,Primary Series,HHS Regions/National,Region 9,2014,Age,19 Months,89.6,84.2 to 93.3,1048
Hib,Primary Series,HHS Regions/National,Region 9,2014-2015,Age,19 Months,90.8,87.3 to 93.4,2082
Hib,Primary Series,HHS Regions/National,Region 9,2012,Age,19 Months,92.5,88.6 to 95.2,1139
Hib,Primary Series,HHS Regions/National,Region 9,2017,Age,13 Months,85.3,79.9 to 89.4,1269
Hib,Primary Series,HHS Regions/National,Region 9,2017-2018,Age,13 Months,88.1,85.0 to 90.7,2758
Hib,Primary Series,HHS Regions/National,Region 9,2018,Age,13 Months,91.1,87.6 to 93.6,1489
Hib,Primary Series,HHS Regions/National,Region 9,2018-2019,Age,13 Months,90.1,87.7 to 92.0,2847
Hib,Primary Series,HHS Regions/National,Region 9,2020,Age,24 Months,88.4,84.3 to 91.9,1229
Hib,Primary Series,HHS Regions/National,Region 9,2015,Age,19 Months,92.1,90.4 to 93.5,1034
Hib,Primary Series,HHS Regions/National,Region 9,2015-2016,Age,19 Months,91.5,87.9 to 94.1,2154
Hib,Primary Series,HHS Regions/National,Region 9,2017,Age,19 Months,89.8,84.9 to 93.2,1269
Hib,Primary Series,HHS Regions/National,Region 9,2017-2018,Age,19 Months,92.1,89.4 to 94.2,2758
Hib,Primary Series,HHS Regions/National,Region 9,2019,Age,19 Months,95.0,92.9 to 96.5,1358
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,86.5,81.7 to 90.1,1229
Hib,Primary Series,HHS Regions/National,Region 9,2016,Age,19 Months,90.9,85.2 to 94.5,1120
Hib,Primary Series,HHS Regions/National,Region 9,2016-2017,Age,19 Months,90.3,86.8 to 93.0,2389
Hib,Primary Series,HHS Regions/National,Region 9,2011,Age,24 Months,90.8,85.6 to 94.7,1101
Hib,Primary Series,HHS Regions/National,Region 9,2012,Age,24 Months,94.1,91.3 to 96.2,1139
Hib,Full Series,HHS Regions/National,Region 9,2013,Age,24 Months,83.5,78.1 to 88.1,1078
Hib,Full Series,HHS Regions/National,Region 9,2013-2014,Age,24 Months,80.3,76.1 to 84.2,2126
Hib,Full Series,HHS Regions/National,Region 9,2014,Age,24 Months,77.3,70.8 to 83.3,1048
Hib,Full Series,HHS Regions/National,Region 9,2014-2015,Age,24 Months,80.1,75.5 to 84.3,2082
Hib,Full Series,HHS Regions/National,Region 9,2012,Age,24 Months,80.0,73.9 to 85.4,1139
Hib,Full Series,HHS Regions/National,Region 9,2011,Age,24 Months,78.6,72.4 to 84.3,1101
Hib,Full Series,HHS Regions/National,Region 9,2016,Age,19 Months,74.1,66.1 to 80.8,1120
Hib,Full Series,HHS Regions/National,Region 9,2016-2017,Age,19 Months,72.2,67.2 to 76.7,2389
Hib,Full Series,HHS Regions/National,Region 9,2015,Age,19 Months,75.9,70.3 to 80.8,1034
Hib,Full Series,HHS Regions/National,Region 9,2015-2016,Age,19 Months,75.0,69.7 to 79.7,2154
Hib,Full Series,HHS Regions/National,Region 9,2014,Age,19 Months,71.6,64.5 to 77.8,1048
Hib,Full Series,HHS Regions/National,Region 9,2014-2015,Age,19 Months,73.7,68.7 to 78.3,2082
Hib,Full Series,HHS Regions/National,Region 9,2019,Age,19 Months,72.1,67.2 to 76.5,1358
Hib,Full Series,HHS Regions/National,Region 9,2018,Age,19 Months,78.0,73.3 to 82.1,1489
Hib,Full Series,HHS Regions/National,Region 9,2018-2019,Age,19 Months,96.0,94.4 to 97.1,2847
Hib,Full Series,HHS Regions/National,Region 9,2017,Age,19 Months,70.2,63.9 to 75.8,1269
Hib,Full Series,HHS Regions/National,Region 9,2017-2018,Age,19 Months,74.0,70.1 to 77.6,2758
Combined 7 Series,,HHS Regions/National,Region 9,2018,Age,35 Months,76.7,71.6 to 81.5,1489
Combined 7 Series,,HHS Regions/National,Region 9,2018-2019,Age,35 Months,74.9,71.2 to 78.5,2847
Combined 7 Series,,HHS Regions/National,Region 9,2019,Age,35 Months,73.4,67.9 to 78.6,1358
Hib,≥3 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,93.1,87.7 to 96.7,1101
Hib,≥3 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,96.0,93.2 to 97.9,1139
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019,Age,35 Months,95.0,92.3 to 97.0,1358
Hep A,≥1 Dose,HHS Regions/National,Region 9,2018,Age,24 Months,92.2,89.1 to 94.7,1489
Hep A,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,24 Months,90.6,88.3 to 92.7,2847
Hep A,≥1 Dose,HHS Regions/National,Region 9,2011,Age,35 Months,90.6,84.2 to 95.2,1101
Hep A,≥1 Dose,HHS Regions/National,Region 9,2019,Age,24 Months,89.2,85.5 to 92.3,1358
Hep A,≥1 Dose,HHS Regions/National,Region 9,2017,Age,24 Months,86.8,82.2 to 90.7,1269
Hep A,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,24 Months,89.5,86.7 to 91.8,2758
Hib,Primary Series,HHS Regions/National,Region 9,2017,Age,35 Months,91.5,87.2 to 94.7,1269
Hib,Primary Series,HHS Regions/National,Region 9,2017-2018,Age,35 Months,93.4,90.9 to 95.5,2758
Combined 7 Series,,HHS Regions/National,Region 9,2016,Age,24 Months,64.5,56.6 to 72.4,1120
Combined 7 Series,,HHS Regions/National,Region 9,2016-2017,Age,24 Months,64.4,59.3 to 69.5,2389
Hib,Primary Series,HHS Regions/National,Region 9,2019,Age,35 Months,95.9,93.9 to 97.4,1358
Hib,≥3 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,88.3,82.8 to 92.6,1120
Hib,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,89.4,86.1 to 92.3,2389
Hib,≥3 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,91.6,86.9 to 95.2,1034
Hib,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,89.9,86.3 to 92.8,2154
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,24 Months,93.0,90.3 to 95.2,2389
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,92.6,88.8 to 95.5,1269
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,94.4,92.3 to 96.1,2758
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,96.3,94.2 to 97.7,1489
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,95.5,93.8 to 96.8,2847
DTaP,≥2 Doses,HHS Regions/National,Region 9,2016,Age,5 Months,76.7,68.7 to 83.2,1120
DTaP,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,5 Months,74.9,69.8 to 79.3,2389
DTaP,≥2 Doses,HHS Regions/National,Region 9,2018,Age,5 Months,81.2,76.5 to 85.2,1489
DTaP,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,5 Months,81.6,78.4 to 84.4,2847
DTaP,≥2 Doses,HHS Regions/National,Region 9,2017,Age,5 Months,72.9,66.5 to 78.5,1269
DTaP,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,5 Months,77.0,73.0 to 80.6,2758
Hep A,≥1 Dose,HHS Regions/National,Region 9,2013,Age,19 Months,79.6,74.5 to 83.9,1078
Hep A,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,19 Months,80.3,78.1 to 82.4,2126
Hep A,≥1 Dose,HHS Regions/National,Region 9,2015,Age,19 Months,84.1,80.7 to 87.0,1034
Hep A,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,19 Months,82.8,78.2 to 86.6,2154
Hep A,≥1 Dose,HHS Regions/National,Region 9,2014,Age,19 Months,81.1,74.9 to 86.0,1048
Hep A,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,19 Months,82.6,78.3 to 86.2,2082
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,24 Months,93.3,90.5 to 95.5,2126
Hep A,≥1 Dose,HHS Regions/National,Region 9,2011,Age,19 Months,80.8,75.0 to 85.6,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016,Age,24 Months,93.5,89.3 to 96.4,1120
DTaP,≥1 Dose,HHS Regions/National,Region 9,2019,Age,3 Months,92.2,89.3 to 94.4,1358
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,92.3,87.6 to 95.7,1048
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,93.3,90.4 to 95.5,2082
DTaP,≥1 Dose,HHS Regions/National,Region 9,2017,Age,3 Months,84.5,78.9 to 88.8,1269
DTaP,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,3 Months,87.7,84.5 to 90.3,2758
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015,Age,24 Months,94.1,90.5 to 96.8,1034
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,24 Months,93.8,91.1 to 95.9,2154
DTaP,≥1 Dose,HHS Regions/National,Region 9,2018,Age,3 Months,91.1,87.7 to 93.7,1489
DTaP,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,3 Months,91.7,89.5 to 93.4,2847
Hib,Primary Series,HHS Regions/National,Region 9,2021,Age,19 Months,88.2,82.5 to 92.2,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,94.6,92.0 to 96.6,1358
≥1 Dose MMR,,HHS Regions/National,Region 9,2021,Age,35 Months,92.3,85.5 to 96.7,808
Combined 7 Series,,HHS Regions/National,Region 9,2019,Age,24 Months,66.3,61.1 to 71.4,1358
Hep A,≥1 Dose,HHS Regions/National,Region 9,2012,Age,19 Months,77.1,74.3 to 79.6,1139
Hib,Primary Series,HHS Regions/National,Region 9,2020-2021,Age,24 Months,88.8,85.6 to 91.6,2037
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,84.2,80.2 to 87.5,2037
DTaP,≥4 Doses,HHS Regions/National,Region 9,2020-2021,Age,35 Months,82.3,76.8 to 87.2,2037
DTaP,≥1 Dose,HHS Regions/National,Region 9,2016,Age,3 Months,86.4,80.0 to 91.0,1120
DTaP,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,3 Months,85.5,81.4 to 88.8,2389
DTaP,≥1 Dose,HHS Regions/National,Region 9,2015,Age,3 Months,89.2,83.6 to 93.0,1034
DTaP,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,3 Months,87.8,83.8 to 91.0,2154
DTaP,≥1 Dose,HHS Regions/National,Region 9,2014,Age,3 Months,83.3,77.4 to 87.9,1048
DTaP,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,3 Months,86.2,82.3 to 89.4,2082
DTaP,≥1 Dose,HHS Regions/National,Region 9,2013,Age,3 Months,88.2,86.4 to 89.8,1078
DTaP,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,3 Months,85.8,83.3 to 87.9,2126
DTaP,≥1 Dose,HHS Regions/National,Region 9,2011,Age,3 Months,88.5,84.5 to 91.7,1101
DTaP,≥1 Dose,HHS Regions/National,Region 9,2012,Age,3 Months,85.9,81.3 to 89.5,1139
Hib,≥1 Dose,HHS Regions/National,Region 9,2021,Age,3 Months,78.3,71.6 to 83.8,808
DTaP,≥4 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,58.4,50.4 to 65.9,808
DTaP,≥4 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,73.2,68.2 to 77.9,2037
PCV,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,5 Months,73.2,68.5 to 77.3,2037
Hep B,≥2 Doses,HHS Regions/National,Region 9,2021,Age,5 Months,80.9,73.5 to 86.6,808
Combined 7 Series,,HHS Regions/National,Region 9,2017,Age,24 Months,64.3,58.0 to 70.6,1269
Combined 7 Series,,HHS Regions/National,Region 9,2017-2018,Age,24 Months,68.5,64.5 to 72.5,2758
Combined 7 Series,,HHS Regions/National,Region 9,2018,Age,24 Months,73.0,68.1 to 77.6,1489
Combined 7 Series,,HHS Regions/National,Region 9,2018-2019,Age,24 Months,69.6,66.1 to 73.1,2847
Hep A,≥1 Dose,HHS Regions/National,Region 9,2013,Age,24 Months,84.3,79.0 to 88.9,1078
Hep A,≥1 Dose,HHS Regions/National,Region 9,2013-2014,Age,24 Months,84.3,80.5 to 87.7,2126
Hep A,≥1 Dose,HHS Regions/National,Region 9,2011,Age,24 Months,84.9,79.3 to 89.7,1101
Hep A,≥1 Dose,HHS Regions/National,Region 9,2019,Age,19 Months,85.7,81.7 to 88.9,1358
Hep A,≥1 Dose,HHS Regions/National,Region 9,2012,Age,24 Months,86.4,80.8 to 91.1,1139
DTaP,≥2 Doses,HHS Regions/National,Region 9,2019,Age,5 Months,82.0,77.6 to 85.7,1358
Hep A,≥2 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,20.1,16.3 to 24.5,1139
Hep A,≥2 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,21.8,15.4 to 29.8,1078
Hep A,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,24.8,19.3 to 31.4,2126
Hib,≥3 Doses,HHS Regions/National,Region 9,2018,Age,24 Months,93.8,91.0 to 96.0,1489
Hib,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,24 Months,93.5,91.5 to 95.1,2847
Hib,≥3 Doses,HHS Regions/National,Region 9,2017,Age,24 Months,90.7,86.5 to 94.0,1269
Hib,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,24 Months,92.2,89.7 to 94.3,2758
Hib,≥3 Doses,HHS Regions/National,Region 9,2019,Age,24 Months,93.1,90.1 to 95.4,1358
Hib,≥3 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,91.6,86.8 to 95.1,1048
Hib,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,93.6,90.3 to 96.1,2082
Hib,≥3 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,94.7,91.4 to 97.1,1078
Hib,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,93.1,90.2 to 95.5,2126
Hep A,≥2 Doses,HHS Regions/National,Region 9,2016,Age,19 Months,27.9,21.6 to 35.3,1120
Hep A,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,19 Months,28.1,23.9 to 32.8,2389
Hep A,≥2 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,22.7,19.6 to 26.2,1034
Hep A,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,25.3,20.9 to 30.3,2154
Hib,≥3 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,96.3,92.7 to 98.4,1034
Hib,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,94.4,90.5 to 97.1,2154
Hep A,≥1 Dose,HHS Regions/National,Region 9,2016,Age,19 Months,81.5,74.4 to 87.0,1120
Hep A,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,19 Months,81.6,77.3 to 85.2,2389
Hep A,≥1 Dose,HHS Regions/National,Region 9,2017,Age,19 Months,81.7,76.3 to 86.0,1269
Hep A,≥1 Dose,HHS Regions/National,Region 9,2017-2018,Age,19 Months,84.9,81.8 to 87.6,2758
Hep A,≥1 Dose,HHS Regions/National,Region 9,2018,Age,19 Months,88.3,84.6 to 91.2,1489
Hep A,≥1 Dose,HHS Regions/National,Region 9,2018-2019,Age,19 Months,86.6,83.5 to 89.2,2372
DTaP,≥3 Doses,HHS Regions/National,Region 9,2011,Age,35 Months,94.0,88.5 to 97.4,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2012,Age,35 Months,96.8,94.2 to 98.4,1139
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013,Age,35 Months,95.4,92.2 to 97.6,1078
DTaP,≥3 Doses,HHS Regions/National,Region 9,2013-2014,Age,35 Months,94.8,92.2 to 96.8,2126
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014,Age,35 Months,94.1,89.9 to 97.0,1048
DTaP,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,35 Months,94.5,91.8 to 96.6,2082
Hep A,≥2 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,21.2,17.6 to 25.2,1101
PCV,≥2 Doses,HHS Regions/National,Region 9,2014,Age,5 Months,68.6,61.6 to 74.9,1048
PCV,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,5 Months,69.7,66.4 to 72.7,2082
Hep A,≥1 Dose,HHS Regions/National,Region 9,2016,Age,24 Months,86.4,80.4 to 91.3,1120
Hep A,≥1 Dose,HHS Regions/National,Region 9,2016-2017,Age,24 Months,86.5,82.8 to 89.8,2389
Hep A,≥1 Dose,HHS Regions/National,Region 9,2015,Age,24 Months,88.8,83.5 to 93.0,1034
Hep A,≥1 Dose,HHS Regions/National,Region 9,2015-2016,Age,24 Months,87.6,83.7 to 90.9,2154
Hep A,≥1 Dose,HHS Regions/National,Region 9,2014,Age,24 Months,84.4,78.8 to 89.2,1048
Hep A,≥1 Dose,HHS Regions/National,Region 9,2014-2015,Age,24 Months,86.5,82.7 to 89.8,2082
PCV,≥2 Doses,HHS Regions/National,Region 9,2016,Age,5 Months,75.5,67.5 to 82.1,1120
PCV,≥2 Doses,HHS Regions/National,Region 9,2016-2017,Age,5 Months,73.0,68.0 to 77.5,2389
PCV,≥2 Doses,HHS Regions/National,Region 9,2015,Age,5 Months,70.7,63.0 to 77.4,1034
PCV,≥2 Doses,HHS Regions/National,Region 9,2015-2016,Age,5 Months,73.1,67.7 to 77.9,2154
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,97.3,95.3 to 98.6,1489
DTaP,≥3 Doses,HHS Regions/National,Region 9,2018-2019,Age,35 Months,96.2,94.5 to 97.5,2847
Hib,≥3 Doses,HHS Regions/National,Region 9,2018,Age,35 Months,94.7,91.7 to 96.8,1489
Hep A,≥2 Doses,HHS Regions/National,Region 9,2017,Age,19 Months,28.4,23.1 to 34.2,1269
Hep A,≥2 Doses,HHS Regions/National,Region 9,2017-2018,Age,19 Months,28.1,24.6 to 31.9,2758
DTaP,≥4 Doses,HHS Regions/National,Region 9,2015,Age,19 Months,70.1,65.2 to 74.6,1034
DTaP,≥4 Doses,HHS Regions/National,Region 9,2015-2016,Age,19 Months,67.4,61.5 to 72.7,2154
DTaP,≥4 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,64.7,57.6 to 71.2,1048
DTaP,≥4 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,67.4,62.0 to 72.3,2082
DTaP,≥4 Doses,HHS Regions/National,Region 9,2013,Age,19 Months,72.6,67.4 to 77.2,1078
DTaP,≥4 Doses,HHS Regions/National,Region 9,2013-2014,Age,19 Months,68.6,65.8 to 71.3,2126
Hib,≥3 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,91.3,87.0 to 94.6,1269
Hib,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,92.9,90.4 to 95.0,2758
Hib,≥3 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,92.6,86.0 to 96.8,1120
Hib,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,91.7,88.1 to 94.6,2389
Hep A,≥2 Doses,HHS Regions/National,Region 9,2018,Age,19 Months,27.8,23.4 to 32.7,1489
Hep A,≥2 Doses,HHS Regions/National,Region 9,2018-2019,Age,19 Months,29.7,26.0 to 33.8,2372
Hep A,≥2 Doses,HHS Regions/National,Region 9,2011,Age,24 Months,46.3,39.3 to 54.0,1101
Hep A,≥2 Doses,HHS Regions/National,Region 9,2019,Age,19 Months,29.4,25.2 to 33.9,1358
Hib,≥3 Doses,HHS Regions/National,Region 9,2014,Age,24 Months,89.9,84.8 to 93.8,1048
Hib,≥3 Doses,HHS Regions/National,Region 9,2014-2015,Age,24 Months,90.7,87.3 to 93.5,2082
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016,Age,35 Months,94.0,89.7 to 97.0,1120
DTaP,≥3 Doses,HHS Regions/National,Region 9,2016-2017,Age,35 Months,93.5,90.7 to 95.6,2389
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015,Age,35 Months,94.3,90.7 to 96.9,1034
DTaP,≥3 Doses,HHS Regions/National,Region 9,2015-2016,Age,35 Months,94.2,91.5 to 96.3,2154
PCV,≥2 Doses,HHS Regions/National,Region 9,2011,Age,5 Months,73.6,69.7 to 77.1,1101
PCV,≥2 Doses,HHS Regions/National,Region 9,2012,Age,5 Months,74.2,72.2 to 76.2,1139
PCV,≥2 Doses,HHS Regions/National,Region 9,2013,Age,5 Months,72.1,69.3 to 74.7,1078
PCV,≥2 Doses,HHS Regions/National,Region 9,2013-2014,Age,5 Months,70.3,67.2 to 73.3,2126
DTaP,≥4 Doses,HHS Regions/National,Region 9,2012,Age,19 Months,67.2,61.6 to 72.3,1139
Hep A,≥2 Doses,HHS Regions/National,Region 9,2014,Age,19 Months,27.9,21.9 to 34.8,1048
Hep A,≥2 Doses,HHS Regions/National,Region 9,2014-2015,Age,19 Months,25.3,21.1 to 30.1,2082
DTaP,≥4 Doses,HHS Regions/National,Region 9,2011,Age,19 Months,73.1,69.0 to 76.9,1101
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017,Age,35 Months,93.0,89.1 to 95.8,1269
DTaP,≥3 Doses,HHS Regions/National,Region 9,2017-2018,Age,35 Months,94.9,92.7 to 96.6,2758
Combined 7 Series,,HHS Regions/National,Region 9,2014,Age,24 Months,64.3,57.5 to 71.0,1048
Combined 7 Series,,HHS Regions/National,Region 9,2014-2015,Age,24 Months,67.1,62.0 to 72.1,2082
Combined 7 Series,,HHS Regions/National,Region 9,2015,Age,24 Months,70.4,62.7 to 77.7,1034
Combined 7 Series,,HHS Regions/National,Region 9,2015-2016,Age,24 Months,67.4,61.8 to 72.8,2154
Hib,Primary Series,HHS Regions/National,Region 9,2018,Age,35 Months,95.5,92.7 to 97.4,1489
Hib,Primary Series,HHS Regions/National,Region 9,2018-2019,Age,35 Months,95.7,94.0 to 97.0,2847
Combined 7 Series,,HHS Regions/National,Region 9,2011,Age,35 Months,72.5,65.5 to 79.1,1101
Combined 7 Series,,HHS Regions/National,Region 9,2012,Age,35 Months,79.4,72.3 to 85.7,1139
Combined 7 Series,,HHS Regions/National,Region 9,2014,Age,35 Months,68.4,61.4 to 75.3,1048
Combined 7 Series,,HHS Regions/National,Region 9,2014-2015,Age,35 Months,72.3,67.1 to 77.3,2082
Hib,Primary Series,HHS Regions/National,Region 9,2016,Age,35 Months,92.5,87.2 to 96.1,1120
Hib,Primary Series,HHS Regions/National,Region 9,2016-2017,Age,35 Months,91.9,88.7 to 94.5,2389
Combined 7 Series,,HHS Regions/National,Region 9,2013,Age,35 Months,77.7,71.2 to 83.6,1078
Combined 7 Series,,HHS Regions/National,Region 9,2013-2014,Age,35 Months,72.6,67.7 to 77.3,2126
Combined 7 Series,,HHS Regions/National,Region 9,2016,Age,35 Months,73.5,64.8 to 81.5,1120
Combined 7 Series,,HHS Regions/National,Region 9,2016-2017,Age,35 Months,71.6,66.3 to 76.8,2389
Combined 7 Series,,HHS Regions/National,Region 9,2017,Age,35 Months,70.1,63.5 to 76.5,1269
Combined 7 Series,,HHS Regions/National,Region 9,2017-2018,Age,35 Months,73.4,69.2 to 77.4,2758
Hib,Primary Series,HHS Regions/National,Region 9,2015,Age,35 Months,96.5,92.8 to 98.6,1034
Hib,Primary Series,HHS Regions/National,Region 9,2015-2016,Age,35 Months,94.7,90.7 to 97.4,2154
Combined 7 Series,,HHS Regions/National,Region 9,2011,Age,24 Months,67.8,61.1 to 74.4,1101
Combined 7 Series,,HHS Regions/National,Region 9,2012,Age,24 Months,71.2,64.8 to 77.4,1139
Hib,Primary Series,HHS Regions/National,Region 9,2019,Age,7 Months,68.8,63.7 to 73.4,1358
Hib,Primary Series,HHS Regions/National,Region 9,2013,Age,7 Months,69.2,64.2 to 73.9,1078
Hib,Primary Series,HHS Regions/National,Region 9,2013-2014,Age,7 Months,68.2,64.3 to 71.8,2126
Hib,Primary Series,HHS Regions/National,Region 9,2013,Age,35 Months,95.1,91.7 to 97.4,1078
Hib,Primary Series,HHS Regions/National,Region 9,2013-2014,Age,35 Months,93.4,90.4 to 95.7,2126
Hib,Primary Series,HHS Regions/National,Region 9,2011,Age,35 Months,92.6,87.7 to 96.0,1101
Hib,Primary Series,HHS Regions/National,Region 9,2019,Age,24 Months,95.3,93.3 to 96.9,1358
Hib,Primary Series,HHS Regions/National,Region 9,2012,Age,35 Months,96.1,93.4 to 98.0,1139
Hib,Primary Series,HHS Regions/National,Region 9,2014,Age,35 Months,91.9,87.1 to 95.4,1048
Hib,Primary Series,HHS Regions/National,Region 9,2014-2015,Age,35 Months,93.9,90.6 to 96.3,2082
Combined 7 Series,,HHS Regions/National,Region 9,2013,Age,24 Months,70.0,63.5 to 76.2,1078
Combined 7 Series,,HHS Regions/National,Region 9,2013-2014,Age,24 Months,67.0,62.3 to 71.6,2126
Hib,Primary Series,HHS Regions/National,Region 9,2013,Age,24 Months,92.8,89.0 to 95.6,1078
Hib,Primary Series,HHS Regions/National,Region 9,2013-2014,Age,24 Months,91.5,88.5 to 94.0,2126
Hib,Primary Series,HHS Regions/National,Region 9,2018,Age,24 Months,95.1,92.3 to 97.1,1489
Hib,Primary Series,HHS Regions/National,Region 9,2018-2019,Age,24 Months,95.2,93.6 to 96.5,2847
Hib,Primary Series,HHS Regions/National,Region 9,2016,Age,24 Months,91.0,85.8 to 94.8,1120
Hib,Primary Series,HHS Regions/National,Region 9,2016-2017,Age,24 Months,91.0,87.7 to 93.7,2389
Hib,Primary Series,HHS Regions/National,Region 9,2017,Age,24 Months,91.0,86.8 to 94.3,1269
Hib,Primary Series,HHS Regions/National,Region 9,2017-2018,Age,24 Months,93.0,90.5 to 95.0,2758
Hib,Primary Series,HHS Regions/National,Region 9,2018,Age,7 Months,73.4,68.4 to 77.9,1489
Hib,Primary Series,HHS Regions/National,Region 9,2018-2019,Age,7 Months,71.1,67.6 to 74.4,2847
Hib,Primary Series,HHS Regions/National,Region 9,2015,Age,24 Months,92.2,87.6 to 95.6,1034
Hib,Primary Series,HHS Regions/National,Region 9,2015-2016,Age,24 Months,91.6,88.2 to 94.3,2154
Hib,Primary Series,HHS Regions/National,Region 9,2014,Age,24 Months,90.3,85.3 to 94.1,1048
Hib,Primary Series,HHS Regions/National,Region 9,2014-2015,Age,24 Months,91.2,87.9 to 94.0,2082
Hib,Primary Series,HHS Regions/National,Region 9,2015,Age,13 Months,87.5,81.7 to 91.7,1034
Hib,Primary Series,HHS Regions/National,Region 9,2015-2016,Age,13 Months,86.2,81.6 to 89.8,2154
Hib,Primary Series,HHS Regions/National,Region 9,2014,Age,13 Months,87.4,81.8 to 91.5,1048
Hib,Primary Series,HHS Regions/National,Region 9,2014-2015,Age,13 Months,87.5,83.6 to 90.6,2082
Polio,≥2 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,83.3,76.4 to 88.4,808
Hep B,≥3 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,87.4,81.3 to 91.6,808
Hib,Full Series,HHS Regions/National,Region 9,2021,Age,19 Months,65.7,57.9 to 72.7,808
PCV,≥4 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,75.1,70.4 to 79.6,2037
Hep A,≥2 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,78.2,59.1 to 92.5,808
Combined 7 Series,,HHS Regions/National,Region 9,2021,Age,35 Months,62.3,53.1 to 71.6,808
Hib,Primary Series,HHS Regions/National,Region 9,2021,Age,7 Months,57.8,50.2 to 65.2,808
≥1 Dose MMR,,HHS Regions/National,Region 9,2020-2021,Age,24 Months,88.2,84.8 to 91.1,2037
PCV,≥2 Doses,HHS Regions/National,Region 9,2021,Age,5 Months,72.1,64.6 to 78.5,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,58.2,50.5 to 65.6,808
Polio,≥3 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,91.6,84.3 to 96.4,808
Hib,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,24 Months,87.8,84.4 to 90.7,2037
Polio,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,3 Months,88.3,85.7 to 90.4,2587
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2019-2020,Age,0-3 Days,78.3,74.9 to 81.3,2587
DTaP,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,3 Months,88.5,85.8 to 90.7,2587
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,62.4,58.7 to 66.0,2587
DTaP,≥4 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,68.9,65.1 to 72.5,2587
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,92.2,89.8 to 94.1,2587
Polio,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,93.2,91.0 to 95.1,2587
DTaP,≥4 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,86.6,82.8 to 89.9,2587
Combined 7 Series,,HHS Regions/National,Region 9,2019-2020,Age,24 Months,66.8,62.9 to 70.5,2587
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,93.6,91.4 to 95.5,2587
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019-2020,Age,13 Months,59.7,56.0 to 63.4,2587
PCV,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,87.4,84.5 to 89.9,2587
Hep B,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,94.1,92.2 to 95.6,2587
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,87.0,84.0 to 89.5,2587
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,68.1,64.3 to 71.7,2587
Polio,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,90.2,87.8 to 92.2,2587
PCV,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,5 Months,77.3,74.0 to 80.4,2587
Hep B,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,5 Months,87.7,84.8 to 90.2,2587
Hib,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,5 Months,77.2,73.8 to 80.3,2587
Hib,Primary Series,HHS Regions/National,Region 9,2019-2020,Age,13 Months,86.6,83.8 to 89.1,2587
Hib,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,78.6,75.4 to 81.5,2587
Hib,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,93.3,91.2 to 95.0,2587
Polio,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,94.3,92.5 to 95.7,2587
≥1 Dose MMR,,HHS Regions/National,Region 9,2019-2020,Age,13 Months,63.3,59.5 to 67.0,2587
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,13 Months,89.0,86.2 to 91.4,2587
Polio,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,5 Months,78.1,74.7 to 81.1,2587
PCV,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,3 Months,86.9,84.1 to 89.2,2587
DTaP,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,5 Months,79.0,75.7 to 81.9,2587
Hep B,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,3 Months,94.8,92.8 to 96.2,2587
Hib,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,3 Months,86.3,83.5 to 88.7,2587
≥1 Dose MMR,,HHS Regions/National,Region 9,2019-2020,Age,24 Months,89.0,86.1 to 91.6,2587
DTaP,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,92.4,90.2 to 94.4,2587
Polio,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,92.0,89.7 to 93.9,2587
DTaP,≥4 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,77.6,73.9 to 81.1,2587
PCV,≥4 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,83.3,79.7 to 86.7,2587
PCV,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,92.3,89.8 to 94.3,2587
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019-2020,Age,35 Months,92.3,89.1 to 94.8,2587
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,93.0,90.4 to 95.1,2587
Hib,Full Series,HHS Regions/National,Region 9,2019-2020,Age,35 Months,81.6,78.1 to 84.8,2587
Hib,Primary Series,HHS Regions/National,Region 9,2019-2020,Age,35 Months,93.2,91.0 to 95.1,2587
Hib,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,91.8,89.4 to 93.9,2587
≥1 Dose MMR,,HHS Regions/National,Region 9,2019-2020,Age,35 Months,92.0,88.9 to 94.5,2587
Hib,Primary Series,HHS Regions/National,Region 9,2019-2020,Age,19 Months,91.7,89.3 to 93.6,2587
Hib,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,89.6,87.0 to 91.7,2587
≥1 Dose MMR,,HHS Regions/National,Region 9,2019-2020,Age,19 Months,86.4,83.3 to 89.1,2587
Polio,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,91.3,88.9 to 93.3,2587
Hep A,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,28.1,25.1 to 31.3,2587
≥1 Dose Varicella,,HHS Regions/National,Region 9,2019-2020,Age,24 Months,88.3,85.3 to 90.9,2587
PCV,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,91.4,89.0 to 93.4,2587
PCV,≥4 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,79.1,75.6 to 82.4,2587
Hib,Full Series,HHS Regions/National,Region 9,2019-2020,Age,24 Months,76.7,73.3 to 79.9,2587
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,91.1,88.6 to 93.3,2587
Hib,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,55.5,51.7 to 59.2,2587
PCV,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,65.4,61.6 to 69.0,2587
Hep A,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,19 Months,84.1,80.9 to 86.8,2587
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2019-2020,Age,0-2 Days,77.4,74.0 to 80.4,2587
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2019-2020,Age,0-1 Days,75.2,71.7 to 78.3,2587
PCV,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,90.7,88.1 to 92.8,2587
PCV,≥4 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,75.7,72.1 to 79.0,2587
Hep B,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,19 Months,89.8,87.0 to 92.0,2587
Hib,Full Series,HHS Regions/National,Region 9,2019-2020,Age,19 Months,71.7,68.2 to 75.0,2587
Combined 7 Series,,HHS Regions/National,Region 9,2019-2020,Age,35 Months,72.4,68.4 to 76.2,2587
Hib,Primary Series,HHS Regions/National,Region 9,2019-2020,Age,24 Months,91.9,89.6 to 93.9,2587
Hib,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,7 Months,89.4,86.8 to 91.5,2587
Hep A,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,52.1,48.2 to 56.0,2587
Hib,≥3 Doses,HHS Regions/National,Region 9,2019-2020,Age,24 Months,90.4,88.0 to 92.6,2587
Influenza,,HHS Regions/National,Region 9,2019-2020,Age,24 Months,66.0,62.3 to 69.6,2587
Hep A,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,35 Months,91.8,88.6 to 94.4,2587
Hep A,≥2 Doses,HHS Regions/National,Region 9,2019-2020,Age,35 Months,77.2,72.9 to 81.3,2587
Hep A,≥1 Dose,HHS Regions/National,Region 9,2019-2020,Age,24 Months,87.8,84.8 to 90.5,2587
Hep A,≥2 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,75.9,69.5 to 81.8,1229
Combined 7 Series,,HHS Regions/National,Region 9,2020,Age,35 Months,71.5,65.7 to 77.1,1229
≥1 Dose MMR,,HHS Regions/National,Region 9,2020,Age,13 Months,58.5,52.8 to 64.0,1229
Hep A,≥1 Dose,HHS Regions/National,Region 9,2020,Age,19 Months,82.6,77.3 to 86.9,1229
Hep A,≥2 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,26.7,22.6 to 31.2,1229
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 9,2020,Age,0-2 Days,74.5,69.1 to 79.2,1229
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2020,Age,0-1 Days,73.0,67.7 to 77.7,1229
Polio,≥2 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,88.7,84.8 to 91.7,1229
Hib,≥2 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,87.0,82.7 to 90.3,1229
Hib,≥3 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,53.3,47.7 to 58.7,1229
Hib,Primary Series,HHS Regions/National,Region 9,2020,Age,7 Months,68.1,62.7 to 73.0,1229
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,90.2,86.3 to 93.3,1229
DTaP,≥4 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,76.7,71.1 to 82.0,1229
Polio,≥3 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,89.8,86.0 to 93.0,1229
≥1 Dose MMR,,HHS Regions/National,Region 9,2020,Age,24 Months,87.4,82.6 to 91.4,1229
Hib,≥3 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,87.7,83.6 to 91.2,1229
Hib,≥3 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,89.8,85.8 to 93.0,1229
≥1 Dose MMR,,HHS Regions/National,Region 9,2020,Age,35 Months,90.9,85.9 to 94.6,1229
Hib,Primary Series,HHS Regions/National,Region 9,2020,Age,35 Months,90.4,86.5 to 93.6,1229
Hib,Full Series,HHS Regions/National,Region 9,2020,Age,35 Months,80.5,75.5 to 85.0,1229
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020,Age,35 Months,91.4,86.3 to 95.1,1229
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,89.6,85.0 to 93.3,1229
Hib,Full Series,HHS Regions/National,Region 9,2020,Age,19 Months,71.7,66.5 to 76.5,1229
Hib,Primary Series,HHS Regions/National,Region 9,2020,Age,19 Months,88.3,83.9 to 91.6,1229
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,86.7,81.6 to 90.5,1229
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020,Age,19 Months,84.4,79.2 to 88.5,1229
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,92.0,88.4 to 94.9,1229
PCV,≥3 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,89.0,84.7 to 92.2,1229
DTaP,≥4 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,85.5,79.5 to 90.4,1229
Polio,≥3 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,91.8,88.1 to 94.7,1229
PCV,≥4 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,72.7,66.9 to 77.8,1229
PCV,≥3 Doses,HHS Regions/National,Region 9,2020,Age,35 Months,91.2,87.4 to 94.3,1229
Hib,≥2 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,90.6,86.7 to 93.5,1229
Hib,Primary Series,HHS Regions/National,Region 9,2020,Age,13 Months,84.3,79.5 to 88.1,1229
Hib,≥3 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,76.2,71.2 to 80.7,1229
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,83.7,78.3 to 87.9,1229
Hep B,≥2 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,91.5,87.7 to 94.2,1229
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020,Age,13 Months,55.9,50.3 to 61.4,1229
PCV,≥2 Doses,HHS Regions/National,Region 9,2020,Age,5 Months,74.2,69.0 to 78.8,1229
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,65.3,59.4 to 70.7,1229
Hep B,≥2 Doses,HHS Regions/National,Region 9,2020,Age,5 Months,84.3,79.0 to 88.4,1229
PCV,≥3 Doses,HHS Regions/National,Region 9,2020,Age,13 Months,85.5,80.7 to 89.2,1229
DTaP,≥4 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,67.9,62.0 to 73.3,1229
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,89.9,85.7 to 92.9,1229
≥1 Dose MMR,,HHS Regions/National,Region 9,2020,Age,19 Months,84.5,79.2 to 88.6,1229
Polio,≥3 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,88.8,84.6 to 92.0,1229
Hib,≥3 Doses,HHS Regions/National,Region 9,2020,Age,19 Months,87.2,82.9 to 90.6,1229
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 9,2020,Age,0-3 Days,75.1,69.8 to 79.8,1229
Influenza,,HHS Regions/National,Region 9,2020,Age,24 Months,63.5,58.0 to 68.9,1229
Combined 7 Series,,HHS Regions/National,Region 9,2020,Age,24 Months,67.0,61.4 to 72.6,1229
≥1 Dose Varicella,,HHS Regions/National,Region 9,2020,Age,24 Months,86.9,82.1 to 90.9,1229
Rotavirus,,HHS Regions/National,Region 9,2020,Age,8 Months,73.0,67.3 to 78.0,1229
PCV,≥3 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,89.9,86.0 to 93.0,1229
PCV,≥4 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,76.3,70.7 to 81.4,1229
Hep A,≥1 Dose,HHS Regions/National,Region 9,2020,Age,24 Months,86.7,81.9 to 90.8,1229
Hep A,≥2 Doses,HHS Regions/National,Region 9,2020,Age,24 Months,53.4,47.8 to 59.2,1229
Hep B,≥1 Dose,HHS Regions/National,Region 9,2020,Age,3 Months,93.2,89.7 to 95.6,1229
DTaP,≥2 Doses,HHS Regions/National,Region 9,2020,Age,5 Months,75.8,70.6 to 80.3,1229
PCV,≥1 Dose,HHS Regions/National,Region 9,2020,Age,3 Months,83.4,78.7 to 87.2,1229
Polio,≥2 Doses,HHS Regions/National,Region 9,2020,Age,5 Months,75.3,70.2 to 79.9,1229
Hib,≥2 Doses,HHS Regions/National,Region 9,2020,Age,5 Months,74.3,69.1 to 78.9,1229
≥1 Dose MMR,,HHS Regions/National,Region 9,2020-2021,Age,13 Months,59.0,54.3 to 63.6,2037
Polio,≥1 Dose,HHS Regions/National,Region 9,2020,Age,3 Months,85.0,80.6 to 88.5,1229
DTaP,≥1 Dose,HHS Regions/National,Region 9,2020,Age,3 Months,84.7,80.1 to 88.3,1229
Hib,≥1 Dose,HHS Regions/National,Region 9,2020,Age,3 Months,83.1,78.4 to 86.9,1229
Hep B,≥2 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,89.5,84.8 to 93.0,1229
Rotavirus,,HHS Regions/National,Region 9,2019-2020,Age,8 Months,74.0,70.3 to 77.3,2587
PCV,≥3 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,62.7,57.0 to 68.2,1229
Hep B,≥3 Doses,HHS Regions/National,Region 9,2020,Age,7 Months,61.8,56.2 to 67.1,1229
DTaP,≥3 Doses,HHS Regions/National,Region 9,2021,Age,24 Months,90.7,85.7 to 94.5,808
PCV,≥3 Doses,HHS Regions/National,Region 9,2021,Age,35 Months,96.0,88.8 to 99.1,808
Hep B,≥2 Doses,HHS Regions/National,Region 9,2020-2021,Age,13 Months,89.8,86.2 to 92.5,2037
Hib,≥2 Doses,HHS Regions/National,Region 9,2021,Age,7 Months,84.7,78.4 to 89.5,808
Hib,≥3 Doses,HHS Regions/National,Region 9,2021,Age,19 Months,86.7,80.7 to 91.1,808
DTaP,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,90.1,86.9 to 92.6,2037
Polio,≥3 Doses,HHS Regions/National,Region 9,2020-2021,Age,19 Months,89.0,85.5 to 91.7,2037
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 9,2021,Age,0-1 Days,71.2,63.8 to 77.5,808
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,5 Months,83.8,76.8 to 89.0,238
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,88.7,82.4 to 92.9,238
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2021,Age,13 Months,63.5,54.6 to 71.5,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,94.3,89.4 to 97.0,426
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,94.4,91.4 to 96.3,832
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,5 Months,77.5,72.4 to 82.0,575
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,91.7,88.0 to 94.4,575
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2021,Age,19 Months,87.4,80.4 to 92.1,238
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,29.3,24.5 to 34.5,575
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,5 Months,90.6,85.1 to 94.1,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,89.8,85.9 to 92.7,575
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,5 Months,83.3,76.3 to 88.6,238
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,93.7,88.4 to 97.1,325
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,90.9,86.8 to 94.2,667
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,93.9,90.3 to 96.2,325
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,89.4,81.0 to 94.3,667
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,84.8,77.2 to 90.2,342
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,86.3,80.8 to 90.4,641
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,95.5,91.8 to 97.8,331
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,94.7,90.4 to 97.5,343
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,93.8,88.8 to 96.6,426
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,71.6,66.5 to 76.1,832
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,95.5,91.2 to 97.8,406
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,96.1,92.4 to 98.3,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,87.8,83.6 to 91.0,299
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,91.1,86.3 to 94.4,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,95.4,90.9 to 97.8,354
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,94.3,90.7 to 96.6,710
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,90.6,86.6 to 93.5,299
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,93.0,88.4 to 95.8,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,88.3,80.9 to 93.1,342
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,89.4,84.2 to 93.1,641
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,94.2,89.7 to 97.1,426
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,94.9,92.1 to 97.0,832
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,5 Months,77.4,68.4 to 84.4,299
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,5 Months,81.9,76.5 to 86.4,653
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.6,91.4 to 98.1,354
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,94.7,91.3 to 97.1,710
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,93.8,87.8 to 97.4,356
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,93.9,90.4 to 96.5,782
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,5 Months,81.5,74.1 to 87.2,342
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,5 Months,79.5,72.2 to 85.3,641
Hib,Full Series,States/Local Areas,PA-Rest of state,2019,Age,24 Months,83.1,77.2 to 88.2,406
Hib,Full Series,States/Local Areas,PA-Rest of state,2012,Age,35 Months,83.7,76.5 to 89.7,331
Hib,Full Series,States/Local Areas,PA-Rest of state,2011,Age,35 Months,88.3,82.8 to 92.7,343
Hib,Full Series,States/Local Areas,PA-Rest of state,2013,Age,35 Months,88.8,81.9 to 93.9,325
Hib,Full Series,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,83.8,78.7 to 88.2,667
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,95.0,91.2 to 97.6,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,93.9,89.7 to 96.8,331
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,95.9,91.6 to 98.4,325
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,91.7,87.8 to 94.8,667
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,90.9,83.6 to 95.8,299
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,93.3,89.2 to 96.2,653
Hib,Full Series,States/Local Areas,PA-Rest of state,2016,Age,24 Months,83.0,76.0 to 88.9,354
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,84.6,80.0 to 88.7,710
Hib,Full Series,States/Local Areas,PA-Rest of state,2017,Age,24 Months,86.1,79.7 to 91.4,356
Hib,Full Series,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,84.6,80.2 to 88.4,782
Hib,Full Series,States/Local Areas,PA-Rest of state,2018,Age,24 Months,82.9,76.8 to 88.3,426
Hib,Full Series,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,83.0,78.8 to 86.8,832
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,92.1,86.0 to 96.2,356
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,93.1,89.5 to 95.9,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,96.0,91.7 to 98.1,406
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,95.7,91.8 to 98.1,406
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,94.2,89.7 to 97.1,426
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,94.9,92.1 to 97.0,832
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,96.0,92.3 to 98.3,331
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,96.0,92.3 to 98.2,343
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,96.3,91.9 to 98.3,406
Hib,Full Series,States/Local Areas,PA-Rest of state,2015,Age,24 Months,75.1,66.0 to 83.4,299
Hib,Full Series,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,78.9,73.2 to 84.1,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,96.2,91.9 to 98.6,325
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,92.9,89.1 to 95.8,667
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,93.2,86.6 to 96.6,356
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,93.7,90.0 to 96.1,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,94.5,90.1 to 97.0,354
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,93.5,89.9 to 95.9,710
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,95.3,91.2 to 97.9,354
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,93.7,90.2 to 96.3,710
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,92.6,86.1 to 96.1,356
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,91.9,88.0 to 94.6,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,91.3,85.7 to 94.8,426
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,77.9,73.0 to 82.1,832
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,85.5,81.0 to 89.5,575
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,88.1,81.5 to 93.2,342
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,89.4,84.6 to 93.2,641
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,90.9,83.6 to 95.8,299
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,93.1,89.1 to 96.1,653
Hib,Full Series,States/Local Areas,PA-Rest of state,2019,Age,35 Months,88.9,83.2 to 93.4,406
Hib,Full Series,States/Local Areas,PA-Rest of state,2018,Age,35 Months,84.7,78.5 to 89.8,426
Hib,Full Series,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,86.7,82.4 to 90.4,832
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,96.6,92.8 to 98.7,325
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,92.9,89.0 to 95.8,667
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,89.7,83.2 to 94.4,342
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,90.5,85.8 to 94.2,641
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,95.5,91.8 to 97.8,331
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,87.5,80.8 to 92.7,342
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,89.4,84.7 to 93.2,641
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,5 Months,84.6,75.4 to 90.8,343
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,5 Months,78.7,73.4 to 83.2,331
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,5 Months,84.9,81.4 to 87.9,325
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,5 Months,83.2,80.5 to 85.7,667
Hib,Full Series,States/Local Areas,PA-Rest of state,2017,Age,35 Months,87.4,81.0 to 92.5,356
Hib,Full Series,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,86.1,81.8 to 89.9,782
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.2,80.2 to 88.1,945
Hib,Primary Series,States/Local Areas,PA-Rest of state,2011,Age,7 Months,75.7,70.7 to 80.1,343
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,89.0,85.0 to 93.1,578
Hib,Primary Series,States/Local Areas,PA-Rest of state,2012,Age,7 Months,72.4,65.5 to 78.3,331
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.6,73.1 to 98.1,72
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,95.8,91.7 to 99.9,127
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.3,84.4 to 98.2,172
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.8,89.7 to 95.8,813
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,90.7,85.2 to 96.1,191
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,78.6,64.1 to 93.1,62
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,74.8,67.6 to 82.0,301
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.3,42.4 to 76.2,72
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,88.8,85.6 to 92.0,797
Hib,Full Series,States/Local Areas,PA-Rest of state,2015,Age,35 Months,82.3,71.8 to 90.6,299
Hib,Full Series,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,84.7,78.7 to 89.8,653
Hib,Full Series,States/Local Areas,PA-Rest of state,2014,Age,35 Months,79.4,71.8 to 86.0,342
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,79.6,73.6 to 85.0,641
Hib,Full Series,States/Local Areas,PA-Rest of state,2016,Age,35 Months,87.7,80.6 to 93.1,354
Hib,Full Series,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,87.5,82.9 to 91.4,710
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,96.9,95.3 to 98.6,797
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,89.0,84.2 to 93.9,301
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,89.5,79.4 to 99.6,62
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,95.7,91.8 to 98.1,406
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,81.7,78.2 to 85.3,1184
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,75.9,61.4 to 90.4,48
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,67.9,59.3 to 76.6,225
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,85.3,80.1 to 90.5,381
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.5,70.7 to 92.3,172
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2011,Age,13 Months,61.2,52.1 to 69.6,343
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,81.3,70.8 to 91.8,127
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.1,80.8 to 95.3,172
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",83.0,78.9 to 87.2,813
Hib,Full Series,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,76.1,67.7 to 84.4,191
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,93.0,88.5 to 95.8,299
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,91.9,87.5 to 94.8,653
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,83.2,75.5 to 88.9,342
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,88.1,83.0 to 91.8,641
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,89.9,82.7 to 97.0,578
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,93.9,91.8 to 95.5,325
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,88.6,81.4 to 93.2,667
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,5 Months,91.2,86.8 to 94.2,325
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,5 Months,85.6,78.3 to 90.7,667
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,5 Months,88.5,85.2 to 91.2,343
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,5 Months,90.6,86.0 to 93.8,331
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2011,Age,0-1 Days,70.1,62.9 to 76.4,343
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,81.9,74.5 to 89.3,381
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,3 Months,98.4,95.9 to 99.4,406
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,90.8,84.1 to 94.9,342
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,91.7,86.9 to 94.9,641
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,3 Months,96.5,93.2 to 98.2,426
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,3 Months,97.5,95.6 to 98.6,832
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2012,Age,24 Months,90.7,85.5 to 94.6,331
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2011,Age,24 Months,90.1,84.7 to 94.2,343
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,73.6,65.4 to 81.8,225
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017,Age,19 Months,89.4,83.1 to 93.6,356
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,91.5,87.6 to 94.2,782
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016,Age,19 Months,90.8,84.5 to 94.7,354
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,90.1,85.9 to 93.2,710
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015,Age,19 Months,88.7,85.0 to 91.5,299
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,89.8,84.9 to 93.1,653
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,82.0,74.5 to 89.6,191
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.8,80.9 to 88.8,945
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,83.4,80.0 to 86.9,1184
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,75.2,60.4 to 90.1,48
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,82.3 to 96.5,172
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.4,80.3 to 88.6,813
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,83.3,73.5 to 93.2,127
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016,Age,24 Months,93.1,87.8 to 96.6,354
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,93.5,90.1 to 96.1,710
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015,Age,24 Months,87.2,79.7 to 93.0,299
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,90.2,85.7 to 93.7,653
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2012,Age,24 Months,89.8,83.9 to 94.2,331
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2011,Age,24 Months,92.8,88.1 to 96.2,343
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019,Age,19 Months,93.4,88.8 to 96.1,406
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018,Age,19 Months,93.5,88.3 to 96.5,426
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,95.3,92.3 to 97.1,832
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,84.6,81.4 to 87.4,343
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,80.6,69.6 to 88.3,331
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,84.0,79.7 to 87.6,325
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,82.5,78.9 to 85.6,667
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2011,Age,19 Months,89.2,82.4 to 93.6,343
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,76.0,59.9 to 92.2,62
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.2,45.0 to 79.5,72
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,90.1,86.9 to 93.3,797
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,76.8,69.9 to 83.7,301
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,90.7,84.7 to 95.1,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,90.0,87.5 to 92.0,343
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,93.6,89.1 to 96.4,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,89.7,84.2 to 93.4,426
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,91.6,88.3 to 94.1,832
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,91.9,88.6 to 94.4,331
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,92.3,85.8 to 96.5,354
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,91.8,87.5 to 95.0,710
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,91.2,85.0 to 95.6,356
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,89.0,84.6 to 92.6,782
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,87.0,79.8 to 92.0,356
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,88.4,84.0 to 91.6,782
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,84.4,74.6 to 92.0,299
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,88.3,82.5 to 92.8,653
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,89.4,81.4 to 94.2,299
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,89.6,85.0 to 92.9,653
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,89.8,83.8 to 93.7,354
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,88.4,84.0 to 91.7,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,87.1,82.6 to 91.6,797
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,71.0,60.3 to 81.7,301
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.7,28.8 to 90.6,72
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2017,Age,0-1 Days,78.0,70.8 to 83.9,356
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2017-2018,Age,0-1 Days,78.8,74.3 to 82.8,782
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2016,Age,0-1 Days,76.3,69.0 to 82.3,354
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2016-2017,Age,0-1 Days,77.1,72.0 to 81.6,710
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018,Age,35 Months,98.2,93.8 to 99.7,426
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,96.2,92.8 to 98.4,832
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,98.6,95.2 to 100.0,62
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,92.0,88.5 to 95.5,578
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,91.1,85.7 to 94.6,426
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,93.1,89.8 to 95.4,832
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,89.8,82.7 to 94.2,356
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,90.5,86.3 to 93.5,782
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,94.1,89.4 to 96.8,354
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,92.0,88.0 to 94.7,710
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,3 Months,95.3,91.1 to 97.6,343
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,3 Months,93.2,89.7 to 95.5,331
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,3 Months,94.4,93.3 to 95.3,325
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,3 Months,91.9,85.6 to 95.6,667
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,69.5,55.7 to 83.3,225
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,81.3,76.0 to 86.7,1184
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,95.1,90.4 to 97.6,406
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,89.5,75.4 to 100.0,48
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,3 Months,96.7,93.5 to 98.4,354
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,3 Months,97.4,95.2 to 98.6,710
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,3 Months,95.4,89.8 to 98.0,299
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,3 Months,96.1,93.2 to 97.8,653
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,3 Months,89.4,82.0 to 94.0,342
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,3 Months,92.4,88.0 to 95.3,641
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,95.2,92.9 to 96.8,325
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,93.0,88.7 to 95.8,667
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,97.1,95.4 to 98.2,343
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,95.4,92.7 to 97.1,331
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013,Age,19 Months,86.8,80.2 to 91.4,325
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,87.7,83.5 to 90.9,667
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015,Age,19 Months,85.4,77.1 to 91.1,299
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,87.9,82.9 to 91.6,653
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014,Age,19 Months,88.6,81.9 to 93.0,342
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,87.0,81.9 to 90.8,641
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018,Age,13 Months,72.6,65.4 to 78.8,426
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,71.6,66.5 to 76.1,832
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016,Age,13 Months,61.9,53.8 to 69.3,354
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,60.6,54.8 to 66.1,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,84.6,78.4 to 90.9,945
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.2,78.2 to 90.1,813
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,70.1,58.7 to 81.5,191
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,77.5,61.2 to 93.7,127
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,89.8,84.5 to 94.0,343
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,83.9,77.6 to 89.2,406
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,86.2,79.7 to 91.5,356
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,84.7,80.3 to 88.6,782
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,83.0,76.7 to 88.4,426
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,83.4,79.1 to 87.3,832
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2011,Age,13 Months,47.9,41.2 to 54.7,343
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2012,Age,13 Months,45.9,39.1 to 52.8,331
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,88.4,86.1 to 90.4,343
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,85.0,76.1 to 91.0,299
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,89.6,84.6 to 93.1,653
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,86.2,83.1 to 89.4,1184
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,81.5,74.2 to 88.7,225
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,93.1,91.0 to 94.7,325
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,90.7,87.5 to 93.1,667
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,88.2,81.3 to 92.8,342
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,86.6,81.2 to 90.7,641
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.8,81.8 to 89.7,813
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,83.0,75.6 to 90.5,191
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,90.2,80.6 to 99.9,48
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.8,83.2 to 90.5,945
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.5,83.9 to 97.1,172
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015,Age,13 Months,55.9,46.6 to 64.8,299
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,60.8,54.6 to 66.6,653
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017,Age,13 Months,64.3,56.1 to 71.8,356
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,66.8,61.4 to 71.9,782
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016,Age,13 Months,65.7,57.5 to 72.9,354
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,65.0,59.2 to 70.4,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,83.7,75.8 to 90.2,356
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,83.7,78.0 to 88.6,782
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,84.1,75.1 to 91.3,426
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,84.5,78.8 to 89.3,832
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,79.2,71.0 to 85.5,342
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,84.3,78.8 to 88.6,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,93.8,91.7 to 95.4,325
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,86.5,76.6 to 92.6,667
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,89.8,83.4 to 94.5,325
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,87.8,82.9 to 91.9,667
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,88.3,83.0 to 92.1,331
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,85.2,77.6 to 91.3,406
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,86.0,78.1 to 92.2,342
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,84.8,78.6 to 90.1,641
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,92.4,86.7 to 96.3,331
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018,Age,13 Months,69.4,62.1 to 75.8,426
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,69.4,64.3 to 74.1,832
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013,Age,13 Months,56.3,50.3 to 62.1,325
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,58.2,51.9 to 64.2,667
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,84.3,78.9 to 89.7,381
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2012,Age,19 Months,89.3,86.5 to 91.6,331
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2011,Age,19 Months,90.3,84.5 to 94.0,343
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019,Age,13 Months,69.5,62.3 to 75.7,406
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015,Age,13 Months,58.3,49.1 to 66.9,299
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,60.1,54.0 to 65.8,653
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014,Age,13 Months,60.0,51.7 to 67.9,342
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,59.2,53.0 to 65.1,641
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,84.3,77.5 to 90.0,325
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,83.7,78.8 to 88.0,667
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,53.6,45.5 to 62.1,354
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,53.8,48.1 to 59.7,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,54.2,46.4 to 62.5,356
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,54.3,49.0 to 59.8,782
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,54.4,47.3 to 61.9,426
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,55.5,50.4 to 60.8,832
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,85.4,78.5 to 91.0,331
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,85.7,80.0 to 90.5,343
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,76.8,70.0 to 82.4,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,63.1,53.9 to 71.4,325
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,58.6,53.0 to 64.0,667
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,50.4,47.4 to 53.3,343
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,54.0,46.6 to 61.2,331
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,94.0,90.3 to 97.6,381
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,97.8,96.4 to 99.3,578
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,89.4,83.7 to 95.0,225
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,5 Months,81.0,73.7 to 86.7,342
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,5 Months,79.0,71.9 to 84.7,641
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,5 Months,81.3,76.2 to 85.6,325
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,5 Months,81.2,78.8 to 83.3,667
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,35 Months,86.5,78.8 to 92.5,331
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,5 Months,83.9,75.1 to 90.0,343
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,5 Months,78.2,73.2 to 82.5,331
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,35 Months,90.5,81.9 to 96.1,299
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,90.0,84.7 to 94.0,653
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,46.9,38.7 to 56.0,325
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,44.6,38.9 to 50.8,667
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,76.4,69.3 to 82.3,426
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,95.4,92.4 to 97.2,832
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,76.8,69.0 to 83.1,356
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,76.6,71.5 to 81.0,782
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,78.4,70.8 to 84.5,354
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,77.6,72.3 to 82.2,710
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.6,73.1 to 98.1,72
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,95.8,91.7 to 99.9,127
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,90.0 to 99.3,172
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.6,92.0 to 97.2,813
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,91.9,86.6 to 97.1,191
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,92.3,84.2 to 100.0,48
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,95.0,92.5 to 97.4,945
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,5 Months,80.9,73.3 to 86.8,356
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,5 Months,81.2,76.3 to 85.3,782
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,5 Months,85.5,79.4 to 89.9,406
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,5 Months,81.5,74.7 to 86.7,426
PCV,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,5 Months,83.5,79.1 to 87.0,832
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013,Age,13 Months,60.6,54.4 to 66.4,325
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,61.2,55.6 to 66.5,667
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,5 Months,81.5,74.7 to 86.8,426
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,5 Months,83.9,79.6 to 87.5,832
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,75.6,59.2 to 92.0,62
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.6,57.5 to 87.8,72
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,91.3,88.5 to 94.1,797
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,84.7,79.0 to 90.4,301
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,35 Months,95.2,90.8 to 97.9,406
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,35 Months,93.3,83.4 to 98.3,426
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,94.1,89.3 to 97.3,832
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2012,Age,13 Months,59.9,49.8 to 69.2,331
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014,Age,13 Months,61.8,53.6 to 69.4,342
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,58.9,52.7 to 64.8,641
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,67.5,58.0 to 76.7,342
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,76.9,68.9 to 84.0,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,66.9,59.7 to 73.3,406
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,89.6,78.1 to 96.5,299
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,82.8,75.4 to 89.1,653
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,78.4,69.6 to 86.0,354
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,81.2,75.3 to 86.3,710
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,61.7,54.4 to 68.6,426
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,64.3,59.3 to 69.0,832
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,45.0,37.3 to 53.0,356
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,53.3,47.9 to 58.7,782
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,92.2,88.2 to 94.9,343
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,92.0,88.2 to 94.6,331
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,91.4,84.3 to 98.5,127
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,5 Months,86.4,80.5 to 90.7,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,52.2,43.1 to 61.1,299
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,53.4,47.3 to 59.3,653
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,54.1,45.9 to 62.2,342
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,53.2,47.0 to 59.3,641
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,5 Months,82.2,74.6 to 88.0,356
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,5 Months,81.9,76.9 to 85.9,782
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,5 Months,85.2,78.6 to 90.1,354
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,5 Months,83.7,78.8 to 87.7,710
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,35 Months,91.0,84.9 to 95.3,356
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,91.7,87.0 to 95.2,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,96.3,92.5 to 98.5,406
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,42.3,34.6 to 51.0,342
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,44.3,38.2 to 50.8,641
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,46.5,37.5 to 56.5,299
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,50.0,43.9 to 56.6,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,94.1,91.9 to 96.2,1184
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,35 Months,85.1,77.8 to 91.0,342
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,86.2,80.8 to 90.8,641
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,35 Months,85.9,78.1 to 92.1,325
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,85.4,80.2 to 89.9,667
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017,Age,13 Months,59.3,51.0 to 67.1,356
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,65.9,60.4 to 71.0,782
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,49.0,40.9 to 57.6,331
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,35 Months,91.0,84.8 to 95.5,354
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,91.1,86.9 to 94.4,710
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,73.6,63.5 to 82.7,325
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,70.3,63.5 to 76.9,667
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,83.2,69.1 to 93.3,331
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,76.4,68.0 to 84.0,343
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,56.6,49.3 to 64.1,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,54.6,46.6 to 62.3,354
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,49.8,44.2 to 55.5,710
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,5 Months,77.0,68.0 to 84.1,299
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,5 Months,81.1,75.6 to 85.6,653
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,77.3,68.2 to 85.3,299
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,81.3,75.6 to 86.3,653
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,85.4,78.6 to 91.0,354
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,85.9,81.3 to 89.9,710
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,83.0,75.8 to 89.1,342
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,79.9,74.2 to 85.1,641
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,70.5,64.9 to 75.5,575
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,90.1,86.3 to 93.0,575
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2020-2021,Age,0-2 Days,83.1,78.5 to 86.8,575
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,63.6,57.8 to 69.0,575
Influenza,,States/Local Areas,PA-Rest of state,2021,Age,24 Months,60.2,51.5 to 69.2,238
DTaP,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,3 Months,89.5,85.8 to 92.3,575
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,87.6,83.2 to 91.0,575
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,3 Months,94.5,91.5 to 96.5,575
Hib,Full Series,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,79.4,72.9 to 85.3,575
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,91.1,87.4 to 94.1,575
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,89.8,85.9 to 92.7,575
Combined 7 Series,,States/Local Areas,PA-Rest of state,2021,Age,24 Months,68.4,60.1 to 76.4,238
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,97.5,90.5 to 99.7,238
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2021,Age,35 Months,96.7,88.0 to 99.6,238
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,78.2,73.1 to 83.0,575
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,82.2,77.1 to 86.4,575
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,93.3,88.1 to 96.3,238
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,89.7,84.7 to 93.6,575
Hib,Full Series,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,70.5,64.9 to 75.5,575
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,79.6,74.5 to 83.8,575
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,59.9,54.2 to 65.3,575
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,90.3,86.3 to 93.5,575
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,82.8,73.6 to 90.2,238
Influenza,,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,61.5,55.7 to 67.3,575
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,89.9,84.3 to 94.1,238
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,90.5,86.7 to 93.3,575
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,91.3,87.8 to 94.2,575
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2020-2021,Age,0-3 Days,83.8,79.2 to 87.5,575
Rotavirus,,States/Local Areas,PA-Rest of state,2020-2021,Age,8 Months,79.7,74.8 to 83.8,575
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,83.3,78.4 to 87.5,575
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2020-2021,Age,0-1 Days,81.3,76.6 to 85.2,575
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,89.5,85.3 to 92.9,575
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,92.1,88.5 to 94.9,575
Hib,Primary Series,States/Local Areas,PA-Rest of state,2021,Age,13 Months,86.9,80.8 to 91.2,238
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020-2021,Age,13 Months,84.8,80.4 to 88.3,575
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,90.9,87.1 to 93.7,575
Combined 7 Series,,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,67.4,61.9 to 72.9,575
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,87.1,82.8 to 90.4,575
Hib,Full Series,States/Local Areas,PA-Rest of state,2021,Age,35 Months,83.0,71.1 to 92.1,238
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2021,Age,0-3 Days,85.0,78.0 to 90.1,238
Rotavirus,,States/Local Areas,PA-Rest of state,2021,Age,8 Months,82.1,75.4 to 87.4,238
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,35 Months,97.5,90.5 to 99.7,238
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,88.4,84.2 to 91.6,575
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,69.0,63.4 to 74.1,575
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,91.1,87.5 to 93.9,575
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,19 Months,90.7,86.9 to 93.5,575
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2020-2021,Age,3 Months,86.4,82.3 to 89.7,575
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,5 Months,80.1,75.1 to 84.3,575
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,88.4,84.3 to 91.9,575
Combined 7 Series,,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,74.0,67.1 to 80.5,575
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,5 Months,89.4,85.5 to 92.4,575
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2021,Age,13 Months,73.5,65.2 to 80.5,238
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,88.5,84.4 to 92.0,575
Hib,Primary Series,States/Local Areas,PA-Rest of state,2021,Age,35 Months,97.3,89.7 to 99.7,238
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,35 Months,92.4,88.8 to 95.1,575
Hib,Primary Series,States/Local Areas,PA-Rest of state,2020-2021,Age,7 Months,73.4,68.1 to 78.1,575
Hep A,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,45.9,40.1 to 52.1,575
DTaP,≥2 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,5 Months,80.5,75.5 to 84.6,575
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2020-2021,Age,24 Months,90.3,86.7 to 93.3,575
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,92.1,86.6 to 97.6,184
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,88.6,83.3 to 92.3,546
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2021,Age,0-1 Days,75.8,66.6 to 83.1,228
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,84.5,75.2 to 90.7,228
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,94.6,92.6 to 96.5,796
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,75.3,71.4 to 79.2,796
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,82.8,79.4 to 86.3,796
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,91.0,85.8 to 96.2,211
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,98.4,96.9 to 100.0,246
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,84.0,80.8 to 87.3,796
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,89.1,83.2 to 94.9,211
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,96.6,93.1 to 100.0,246
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,82.9,77.6 to 88.3,339
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,72.5,66.7 to 78.3,339
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,92.2,87.0 to 97.4,211
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,82.0,75.1 to 89.0,246
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,73.2,65.5 to 81.0,211
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,76.8,72.9 to 80.7,796
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,98.4,96.9 to 100.0,246
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,92.2,89.8 to 94.7,796
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,75.3,71.4 to 79.2,796
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,82.8,77.7 to 87.9,796
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,94.1,91.2 to 96.9,339
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,90.1,87.2 to 92.9,796
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,82.8,79.4 to 86.3,796
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,67.6,63.2 to 72.0,796
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,91.5,86.4 to 96.6,211
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,93.9,90.9 to 96.8,339
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,85.0,77.5 to 92.5,246
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,80.8,71.1 to 90.5,211
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,91.0,87.4 to 94.5,339
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,83.8,76.8 to 90.9,211
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,93.4,91.2 to 95.6,796
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,85.8,81.3 to 90.2,339
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,94.1,92.0 to 96.2,796
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,88.0,82.4 to 93.7,246
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,94.6,92.6 to 96.5,796
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,78.6,62.7 to 94.5,57
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,86.4,83.3 to 89.5,796
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,65.1,55.5 to 74.6,184
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,92.4,82.1 to 100.0,57
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,93.0,90.0 to 96.0,421
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,95.5,93.0 to 97.9,303
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,89.9,79.1 to 100.0,57
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.1,82.6 to 97.7,117
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.1,74.1 to 92.2,117
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",84.5,79.2 to 89.8,253
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,88.6,82.5 to 94.8,184
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,79.0 to 95.2,117
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,78.5,71.7 to 85.2,421
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,86.3,79.8 to 92.9,303
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,3 Months,88.6,82.2 to 92.9,318
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,3 Months,82.9,76.1 to 88.1,318
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,61.0,53.6 to 67.9,318
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,3 Months,97.8,95.1 to 99.0,318
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,96.0,92.3 to 98.2,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,60.6,52.8 to 67.8,318
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,88.9,82.4 to 93.1,318
Rotavirus,,States/Local Areas,PA-Philadelphia,2019-2020,Age,8 Months,72.9,67.3 to 77.8,553
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,94.0,86.3 to 98.1,546
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,92.2,88.5 to 95.9,303
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",96.3,93.6 to 98.9,253
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,95.6,92.2 to 98.9,184
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,91.8,88.5 to 95.0,421
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,88.7,76.8 to 100.0,57
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.5,88.8 to 98.2,242
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.2,83.8 to 94.7,242
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,93.5,90.9 to 96.2,421
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,97.8,96.1 to 99.6,303
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,83.7,68.0 to 99.4,57
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,83.7,79.5 to 87.8,421
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,83.1,70.4 to 95.8,57
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.2,83.3 to 95.0,242
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",93.6,90.3 to 96.8,253
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,90.2,78.6 to 100.0,57
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,83.4,67.5 to 99.2,57
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,94.2,91.5 to 96.8,421
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,90.1,79.2 to 100.0,57
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,85.2,81.1 to 89.3,421
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.9,91.8 to 97.9,253
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,97.6,96.0 to 99.2,303
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.4,87.6 to 97.2,242
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.1,56.0 to 80.1,117
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,90.6,84.9 to 96.4,184
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,89.9,79.1 to 100.0,57
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,94.3,91.8 to 96.8,421
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.8,89.2 to 98.4,242
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.9,92.0 to 97.8,253
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",61.6,53.9 to 69.3,253
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.2,88.2 to 98.1,117
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.8,71.7 to 85.9,242
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.8,78.4 to 89.2,253
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,83.3,76.1 to 90.5,184
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.9,80.9 to 92.8,242
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,74.6,66.2 to 82.9,184
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",75.9,69.7 to 82.1,253
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.4,70.4 to 84.5,242
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,70.4,61.6 to 79.2,184
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,62.5,46.1 to 79.0,57
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,75.1,69.9 to 80.3,421
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.5,78.1 to 88.8,253
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.9,69.5 to 90.3,117
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,95.6,86.4 to 100.0,57
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.1,77.8 to 90.3,242
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,61.5,44.6 to 78.5,57
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,59.7,53.6 to 65.8,421
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,95.6,92.2 to 98.9,184
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,79.3,71.1 to 87.5,184
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,87.4,82.0 to 92.8,303
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",79.8,70.1 to 89.5,117
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.3,57.1 to 81.4,117
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,87.1,82.2 to 92.1,303
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,97.8,96.1 to 99.6,303
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,88.0 to 99.1,117
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,97.3,95.4 to 99.2,303
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,76.1,62.3 to 89.8,57
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.9,91.8 to 97.9,253
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,93.1,88.3 to 97.9,184
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,84.3,79.9 to 88.7,421
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",83.2,77.5 to 88.9,253
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,85.4,80.3 to 90.4,303
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.7,68.1 to 81.3,253
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,82.8,77.1 to 88.4,303
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,87.6 to 97.4,242
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.6,91.5 to 97.7,253
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.9,92.9 to 100.0,117
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",85.4,79.4 to 91.5,242
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.9,87.1 to 96.7,242
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.5,67.5 to 87.5,117
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.6,86.9 to 100.0,117
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,75.6,70.7 to 80.6,421
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,95.0,92.6 to 97.5,421
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,83.9,80.6 to 87.3,796
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,85.4,78.8 to 92.1,246
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,81.0,76.0 to 86.0,339
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,82.9,78.3 to 87.5,339
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,95.1,91.0 to 99.1,246
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,82.8,75.7 to 89.9,211
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,86.8,81.1 to 92.5,246
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,94.5,92.1 to 97.0,339
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,88.3,82.3 to 94.2,211
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,95.1,92.9 to 97.3,339
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,91.7,88.2 to 95.3,339
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,92.3,87.8 to 96.7,246
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,87.6,81.5 to 93.7,211
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,98.1,96.4 to 99.8,246
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,57.6,50.9 to 64.4,339
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,67.5,58.8 to 76.1,211
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,93.3,91.0 to 95.6,796
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Overall,Overall,95.4,93.5 to 97.3,796
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,95.5,93.2 to 97.8,339
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,96.3,94.0 to 98.7,246
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,81.7,73.9 to 89.5,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,81.6,74.9 to 88.2,211
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,83.9,77.9 to 90.0,246
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,82.3,75.2 to 89.5,211
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,90.8,85.5 to 96.0,246
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,92.2,89.8 to 94.7,796
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,<133% FPL,71.4,65.3 to 77.5,339
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,74.7,66.7 to 82.7,211
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,94.1,92.0 to 96.2,796
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,83.9,80.6 to 87.3,796
Influenza,,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,67.6,63.2 to 72.0,796
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,76.8,72.9 to 80.7,796
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,87.2 to 92.9,796
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,93.4,91.2 to 95.6,796
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,84.0,80.8 to 87.3,796
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,82.8,77.7 to 87.9,796
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,81.5,72.1 to 88.3,228
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,3 Months,83.4,78.4 to 87.4,553
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,3 Months,87.4,82.4 to 91.1,553
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,3 Months,87.3,82.4 to 91.0,553
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,59.1,53.4 to 64.6,553
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,87.0,82.2 to 90.7,553
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,90.4,86.1 to 93.4,553
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,67.8,62.0 to 73.1,553
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",94.5,91.3 to 97.7,253
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Other,68.2,51.5 to 84.9,57
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.5,87.8 to 97.3,242
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,95.4,93.5 to 97.3,796
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,86.4,83.3 to 89.5,796
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Urbanicity,Living In a MSA Principal City,93.3,91.0 to 95.6,796
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2021,Age,0-2 Days,78.6,69.4 to 85.6,228
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,87.3,79.4 to 93.2,228
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,80.0,70.6 to 87.9,228
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,89.0,81.2 to 94.6,228
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,91.5,87.0 to 94.9,546
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,86.3,78.6 to 92.3,228
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,84.6,75.7 to 90.7,228
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,54.4,44.3 to 65.1,228
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,66.7,57.2 to 75.0,228
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,5 Months,75.2,69.1 to 80.4,546
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,81.3,75.6 to 85.9,546
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,65.1,54.9 to 75.1,228
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,82.1,72.7 to 88.7,228
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,91.0,84.3 to 95.0,228
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,91.6,87.1 to 95.0,546
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,85.1,76.6 to 90.9,228
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,29.9,22.1 to 39.0,228
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,66.0,56.0 to 74.7,228
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,80.1,70.7 to 88.1,228
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,79.6,69.9 to 87.7,228
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,3 Months,84.0,75.2 to 90.1,228
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,3 Months,84.0,75.2 to 90.1,228
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,88.5,80.8 to 94.1,228
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,84.6,76.5 to 91.1,228
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,82.3,73.6 to 89.4,228
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,82.3,73.6 to 89.4,228
Hib,Full Series,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,74.7,64.9 to 83.5,228
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,70.6,60.4 to 79.1,228
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,85.5,77.5 to 91.8,228
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,95.0,92.5 to 96.8,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,91.3,86.9 to 94.3,331
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,80.1,73.3 to 85.5,406
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,90.8,83.5 to 95.0,356
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,92.3,88.2 to 95.0,782
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,94.4,89.7 to 97.0,354
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,92.6,88.5 to 95.3,710
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,75.8,68.3 to 81.9,426
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,77.9,73.0 to 82.1,832
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,72.0,58.8 to 83.9,228
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,88.2,80.2 to 94.0,228
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,92.6,88.0 to 95.6,325
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,90.3,85.3 to 93.7,667
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,89.9,86.6 to 92.5,299
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,92.2,87.6 to 95.1,653
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,93.7,88.9 to 96.5,331
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,94.9,91.3 to 97.1,331
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,95.2,93.3 to 96.5,325
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,91.7,85.6 to 95.4,667
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,96.0,93.3 to 97.6,343
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,95.9,91.7 to 98.0,406
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,92.9,88.0 to 95.8,426
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,94.4,91.4 to 96.3,832
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,87.9,80.7 to 92.7,342
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,88.9,83.8 to 92.6,641
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,78.3,70.4 to 84.6,356
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,77.0,71.8 to 81.6,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,87.5,81.4 to 91.8,354
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,82.9,78.0 to 86.9,710
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,86.6,77.8 to 92.2,228
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,79.0,69.8 to 86.0,299
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,83.2,77.8 to 87.6,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.2,90.2 to 96.2,813
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,88.8,82.9 to 94.6,191
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,64.7,57.4 to 71.4,406
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,96.4,92.1 to 98.4,406
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,92.9,90.5 to 95.3,1184
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,85.8,79.4 to 92.3,225
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,89.8,80.0 to 99.6,48
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.5,91.8 to 97.2,945
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,93.0,86.5 to 96.5,356
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,93.6,89.8 to 96.0,782
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,94.1,89.2 to 96.8,426
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,95.3,92.3 to 97.1,832
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,82.8,77.2 to 87.2,331
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,89.3,83.6 to 93.2,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,70.1,61.5 to 77.5,342
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,74.6,68.4 to 79.9,641
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,94.0,90.4 to 97.6,381
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,97.2,95.5 to 98.9,578
Polio,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,94.5,91.6 to 96.5,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,83.8,78.4 to 88.1,325
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,77.0,70.0 to 82.7,667
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,82.0,70.5 to 93.6,127
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.2,78.5 to 93.9,172
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.4,75.3 to 83.5,813
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,78.3,70.4 to 86.2,191
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.2,78.3 to 86.2,945
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,80.9,77.5 to 84.3,1184
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,76.6,63.9 to 89.3,48
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,86.8,79.1 to 92.0,342
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,87.4,82.0 to 91.4,641
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,94.4,92.0 to 96.0,325
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,90.6,83.6 to 94.8,667
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,91.0,86.1 to 94.3,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,79.9,72.7 to 87.0,225
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,82.0,76.1 to 87.8,381
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,80.7,75.7 to 85.8,578
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,88.0,79.4 to 93.3,299
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,90.9,86.1 to 94.2,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,88.7,81.4 to 93.4,356
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,90.8,86.6 to 93.8,782
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,93.9,88.4 to 96.9,354
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,91.3,87.0 to 94.3,710
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2020,Age,13 Months,89.1,83.0 to 93.2,337
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,94.6,90.4 to 97.0,343
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,75.5,67.5 to 82.1,356
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,74.6,69.3 to 79.2,782
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,79.3,72.8 to 84.6,406
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,73.6,66.5 to 79.7,426
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,76.4,71.7 to 80.6,832
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,83.0,77.6 to 88.3,301
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.4,72.3 to 96.6,72
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,81.3,76.8 to 85.7,797
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,74.8,60.2 to 89.4,62
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2019,Age,0-3 Days,88.6,83.4 to 92.3,406
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,3 Months,93.3,88.3 to 96.2,406
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2018,Age,0-3 Days,83.5,78.0 to 87.9,426
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2018-2019,Age,0-3 Days,86.0,82.4 to 89.0,832
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,96.5,92.6 to 98.6,406
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2020,Age,24 Months,88.8,83.3 to 93.1,337
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,85.1,72.5 to 97.7,62
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,91.5,85.1 to 95.3,342
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,92.1,87.4 to 95.1,641
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,95.6,91.1 to 97.9,354
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,94.3,90.7 to 96.6,710
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,92.6,84.4 to 96.7,299
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,94.1,89.8 to 96.7,653
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,3 Months,89.4,83.7 to 93.3,426
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,3 Months,91.3,87.8 to 93.9,832
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,3 Months,89.2,82.3 to 93.6,356
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,3 Months,89.3,85.1 to 92.4,782
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,74.4,66.8 to 80.7,354
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,71.3,65.8 to 76.3,710
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,58.9,49.6 to 67.6,299
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,66.6,60.5 to 72.1,653
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,53.7,45.3 to 61.9,342
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,56.3,50.0 to 62.4,641
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,93.7,88.7 to 97.0,426
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,95.1,92.1 to 97.2,832
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,94.9,89.5 to 98.0,356
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,94.4,90.9 to 96.8,782
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,96.0,93.9 to 97.4,325
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,93.8,88.3 to 96.8,667
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,84.1,77.2 to 89.2,354
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,79.8,74.6 to 84.2,710
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2015,Age,0-3 Days,82.9,74.8 to 88.7,299
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2015-2016,Age,0-3 Days,83.3,78.3 to 87.4,653
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,67.2,58.6 to 74.8,342
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,67.3,61.0 to 73.1,641
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,67.4,58.1 to 75.6,299
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,75.7,69.9 to 80.8,653
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,96.7,94.3 to 98.1,343
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,93.8,89.4 to 96.4,331
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016,Age,0-3 Days,83.8,77.2 to 88.7,354
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2016-2017,Age,0-3 Days,84.6,80.0 to 88.3,710
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2017,Age,0-3 Days,85.4,75.8 to 91.6,183
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2017-2018,Age,0-3 Days,84.4,80.4 to 87.8,782
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,3 Months,93.4,88.9 to 96.2,354
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,3 Months,91.3,87.4 to 94.1,710
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,3 Months,84.2,75.4 to 90.3,299
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,3 Months,88.8,83.9 to 92.3,653
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,3 Months,85.6,78.3 to 90.7,342
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,3 Months,84.9,79.4 to 89.1,641
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,66.5,60.9 to 71.6,325
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,60.1,55.7 to 64.4,667
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,71.7,66.5 to 76.3,343
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,66.3,60.0 to 72.0,331
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,92.8,89.0 to 96.6,381
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,94.6,91.9 to 97.2,578
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,84.9,78.2 to 91.5,225
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,97.7,96.4 to 99.0,797
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,91.7,87.5 to 95.8,301
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,94.3,89.3 to 99.3,127
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.2,89.5 to 98.9,172
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.6,73.1 to 98.1,72
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,57.7,50.2 to 65.0,426
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,61.2,55.9 to 66.3,832
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,68.3,60.1 to 75.4,356
Hib,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,63.0,57.5 to 68.3,782
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,89.5,82.5 to 93.9,356
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,89.9,85.7 to 92.9,782
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,95.1,90.6 to 97.5,354
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,92.3,88.3 to 95.0,710
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.4,91.3 to 97.9,354
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,95.2,92.0 to 97.4,710
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,90.6,83.3 to 95.7,299
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,93.1,89.1 to 96.0,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,91.7,85.6 to 95.9,342
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,91.8,87.2 to 95.3,641
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,90.2,84.7 to 93.9,426
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,92.3,88.8 to 94.7,832
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,93.0,88.1 to 96.3,426
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,94.6,91.6 to 96.7,832
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,85.3,76.3 to 91.2,299
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,90.1,85.2 to 93.6,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,93.9,87.7 to 97.6,325
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,92.8,88.7 to 95.8,667
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,94.9,90.6 to 97.6,343
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,96.2,92.4 to 98.4,406
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,94.8,90.7 to 97.5,331
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,94.3,89.4 to 97.0,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.6,70.3 to 96.9,72
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,93.8,88.0 to 99.6,127
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.4,79.6 to 95.2,172
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,89.3 to 95.2,813
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,86.0,79.3 to 92.7,191
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,89.0,78.8 to 99.1,48
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,3 Months,90.8,85.9 to 94.1,343
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,3 Months,90.4,86.1 to 93.5,331
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,91.2,88.6 to 93.8,1184
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,3 Months,93.4,88.4 to 96.4,406
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,3 Months,86.8,78.8 to 92.1,325
Polio,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,3 Months,86.2,81.5 to 89.8,667
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2013,Age,0-3 Days,78.4,70.2 to 84.8,325
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2013-2014,Age,0-3 Days,72.1,66.2 to 77.2,667
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,74.3,69.5 to 78.5,343
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,74.1,68.4 to 79.1,331
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,76.2,71.0 to 80.8,325
DTaP,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,71.7,65.5 to 77.2,667
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014,Age,0-3 Days,65.7,57.2 to 73.4,342
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2014-2015,Age,0-3 Days,74.3,68.4 to 79.4,641
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.5,79.3 to 95.7,172
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",87.4,83.6 to 91.3,813
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,92.1,86.3 to 96.1,356
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,92.5,88.9 to 95.3,782
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,90.1,83.4 to 94.3,331
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,94.9,90.9 to 97.5,354
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,93.5,90.1 to 96.1,710
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,91.4,86.8 to 94.5,343
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,5 Months,83.0,76.8 to 87.9,406
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,5 Months,81.5,74.8 to 86.7,426
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,5 Months,82.3,77.8 to 86.0,832
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,3 Months,86.4,79.1 to 91.4,356
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,3 Months,87.5,83.1 to 90.8,782
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,3 Months,92.0,87.2 to 95.1,354
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,3 Months,89.2,85.0 to 92.3,710
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,94.9,92.7 to 97.1,797
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,89.2,79.3 to 99.1,62
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,3 Months,82.5,73.7 to 88.8,299
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,3 Months,87.2,82.3 to 90.9,653
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,3 Months,83.0,75.3 to 88.6,342
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,3 Months,82.7,77.1 to 87.2,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,93.0,90.3 to 95.8,945
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,88.3,83.3 to 93.2,301
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,87.3,81.0 to 93.5,191
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2012,Age,0-3 Days,77.6,70.3 to 83.5,331
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,88.5,81.6 to 93.1,342
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,86.9,81.5 to 90.9,641
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,93.5,89.9 to 95.8,325
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,91.0,87.2 to 93.8,667
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,86.1,82.8 to 89.4,1184
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,80.8,66.5 to 95.0,48
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.3,82.4 to 90.2,945
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,76.7,68.8 to 84.6,225
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,87.4,82.2 to 92.6,381
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,92.3,88.8 to 95.7,578
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,3 Months,88.6,82.9 to 92.5,426
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,3 Months,91.0,87.4 to 93.6,832
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Rest of state,2011,Age,0-3 Days,82.1,75.2 to 87.4,343
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,94.5,90.2 to 97.4,343
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,95.4,91.0 to 97.8,406
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,92.9,87.6 to 96.1,426
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,92.9,89.6 to 95.2,832
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,96.1,91.8 to 98.2,406
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,5 Months,84.0,75.1 to 90.1,343
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,5 Months,76.1,69.2 to 81.8,331
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,90.8,83.8 to 94.9,356
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,91.8,87.7 to 94.7,782
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,5 Months,82.5,75.2 to 88.0,342
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,5 Months,79.6,73.2 to 84.7,641
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,5 Months,80.8,75.9 to 84.8,325
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,5 Months,81.6,79.2 to 83.9,667
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,93.2,91.0 to 95.5,1184
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,91.0,85.8 to 96.3,225
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,88.0,76.4 to 99.5,48
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.0,91.4 to 96.7,945
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,92.2,88.2 to 96.2,381
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,96.0,93.7 to 98.2,578
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,3 Months,90.4,85.2 to 93.9,343
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,89.5,83.0 to 94.3,356
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,88.3,83.2 to 92.4,782
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,91.8,86.4 to 95.7,406
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,92.5,86.6 to 96.4,354
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,91.0,86.8 to 94.3,710
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,88.2,77.4 to 95.3,426
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,89.4,84.3 to 93.4,832
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,5 Months,83.8,76.9 to 89.0,354
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,5 Months,83.2,78.3 to 87.3,710
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,5 Months,76.6,67.5 to 83.7,299
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,5 Months,80.2,74.6 to 84.8,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,92.8,87.2 to 96.6,325
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,90.9,86.7 to 94.2,667
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,5 Months,82.7,75.0 to 88.3,356
Hib,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,5 Months,82.1,77.2 to 86.1,782
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,94.2,90.2 to 97.0,331
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,89.0,82.4 to 94.0,342
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,89.8,85.1 to 93.6,641
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,90.6,83.3 to 95.7,299
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,92.7,88.7 to 95.7,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,87.7,80.1 to 92.6,342
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,88.8,83.5 to 92.5,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,35 Months,96.7,92.8 to 98.8,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,95.7,91.7 to 98.1,426
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,96.1,93.5 to 97.8,832
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,84.4,77.2 to 90.3,342
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,85.6,80.2 to 90.2,641
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,90.1,81.0 to 96.0,299
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,91.0,85.9 to 94.8,653
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,92.5,88.5 to 96.5,301
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,95.3,93.2 to 97.3,797
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,96.3,92.6 to 100.0,127
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.7,90.1 to 99.3,172
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.8,78.1 to 99.6,72
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,94.8,90.3 to 97.3,354
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,92.8,88.9 to 95.4,710
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,89.9,82.3 to 94.4,299
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,92.3,87.9 to 95.2,653
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,94.6,90.4 to 97.0,354
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,94.2,90.7 to 96.4,710
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,95.2,90.9 to 97.6,426
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,95.7,92.9 to 97.4,832
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,93.8,87.3 to 97.1,356
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,94.5,91.0 to 96.7,782
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,3 Months,89.5,82.6 to 93.8,356
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,3 Months,89.3,85.1 to 92.4,782
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2016,Age,3 Months,92.3,87.5 to 95.4,354
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2016-2017,Age,3 Months,90.9,86.9 to 93.7,710
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2015,Age,3 Months,83.6,74.7 to 89.8,299
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2015-2016,Age,3 Months,87.9,83.0 to 91.6,653
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017,Age,35 Months,93.8,88.9 to 97.1,356
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,95.8,91.6 to 98.2,782
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018,Age,35 Months,98.6,94.6 to 99.8,426
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,97.0,93.3 to 99.0,832
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019,Age,35 Months,96.4,92.7 to 98.5,406
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.4,89.7 to 99.1,172
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,93.7,86.9 to 100.0,62
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.8,88.6 to 95.1,813
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,91.2,85.9 to 96.4,191
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,3 Months,88.2,81.8 to 92.6,331
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,81.5,75.1 to 87.9,301
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,76.1,60.0 to 92.2,62
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,90.8,84.0 to 97.7,127
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",62.3,45.4 to 79.2,72
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,3 Months,86.2,78.1 to 91.6,325
PCV,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,3 Months,84.6,77.4 to 89.8,667
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2019,Age,3 Months,89.9,84.4 to 93.6,406
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2018,Age,3 Months,89.1,83.5 to 93.0,426
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2018-2019,Age,3 Months,89.5,85.8 to 92.3,832
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.9,90.0 to 95.9,813
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Principal City,92.8,88.3 to 97.3,191
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,96.3,93.9 to 98.7,578
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,91.2,85.0 to 95.6,325
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,87.7,83.1 to 91.6,667
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,92.7,90.1 to 95.4,797
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Overall,Overall,92.1,89.6 to 94.6,1184
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,<133% FPL,90.0,84.6 to 95.4,225
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a Non-MSA,89.8,79.6 to 99.9,48
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,89.7 to 95.5,945
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Other,89.6,79.2 to 100.0,62
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.6,73.8 to 97.4,72
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Private Insurance Only,94.4,92.0 to 96.9,797
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Insurance Coverage,Any Medicaid,91.7,87.5 to 95.8,301
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019,Age,35 Months,95.7,91.7 to 98.2,406
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.4,90.1 to 98.3,354
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,94.6,91.3 to 97.0,710
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,83.5,75.2 to 90.3,299
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,85.6,80.5 to 89.9,653
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,87.9,81.8 to 92.7,354
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,87.2,82.8 to 91.0,710
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,86.4,79.6 to 91.8,356
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,84.4,79.9 to 88.4,782
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015,Age,35 Months,92.5,85.8 to 96.8,299
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,94.5,90.1 to 97.4,653
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014,Age,35 Months,91.7,86.1 to 95.6,342
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,91.6,87.3 to 94.9,641
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,92.1,86.4 to 95.5,354
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,90.1,85.7 to 93.3,710
Hib,Full Series,States/Local Areas,PA-Rest of state,2020,Age,24 Months,71.9,64.8 to 78.7,337
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,35 Months,94.0,89.3 to 97.1,325
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,90.6,86.3 to 94.0,667
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,35 Months,86.8,79.9 to 92.3,342
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,90.4,85.8 to 94.0,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,92.8,88.6 to 95.9,331
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,90.7,85.3 to 94.2,426
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,92.9,89.6 to 95.2,832
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,88.1,80.8 to 92.9,356
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,89.4,85.1 to 92.6,782
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,93.8,91.3 to 95.5,331
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,95.0,93.9 to 96.0,343
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,95.7,91.4 to 97.9,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,35 Months,94.0,88.4 to 97.4,356
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,94.9,91.7 to 97.1,782
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,19 Months,92.6,87.9 to 95.6,331
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2012,Age,35 Months,86.5,80.0 to 91.8,331
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,88.6,83.0 to 93.1,343
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,82.1,75.9 to 87.6,426
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,85.6,81.6 to 89.1,832
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,89.1,83.9 to 93.2,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,35 Months,91.1,85.8 to 95.1,354
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,92.5,88.8 to 95.3,710
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,35 Months,93.1,86.4 to 97.2,299
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,92.1,88.1 to 95.2,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,19 Months,91.8,88.7 to 94.1,325
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,89.7,84.2 to 93.5,667
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,19 Months,94.5,92.1 to 96.3,343
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,95.2,90.8 to 97.5,406
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,94.8,92.6 to 96.3,325
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,92.0,87.5 to 95.0,667
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,94.6,86.5 to 97.9,299
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,94.6,90.6 to 96.9,653
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,89.2,82.1 to 93.7,342
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,91.9,87.1 to 95.0,641
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2014,Age,3 Months,87.6,80.5 to 92.3,342
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2014-2015,Age,3 Months,85.6,80.1 to 89.7,641
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2011,Age,3 Months,90.6,85.1 to 94.2,343
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2012,Age,3 Months,89.2,83.5 to 93.1,331
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2013,Age,3 Months,88.0,80.9 to 92.7,325
Hib,≥1 Dose,States/Local Areas,PA-Rest of state,2013-2014,Age,3 Months,87.8,83.2 to 91.3,667
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,92.0,86.9 to 95.3,426
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,93.8,90.7 to 95.9,832
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2019,Age,0-2 Days,87.5,82.2 to 91.4,406
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2018,Age,0-2 Days,82.2,76.4 to 86.8,426
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2018-2019,Age,0-2 Days,84.8,81.1 to 87.9,832
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2017,Age,0-2 Days,84.4,78.0 to 89.2,356
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2017-2018,Age,0-2 Days,83.3,79.2 to 86.7,782
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,85.3,78.8 to 90.6,331
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,35 Months,91.5,86.3 to 95.4,343
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,24 Months,93.6,87.9 to 97.2,356
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,94.3,91.0 to 96.6,782
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,24 Months,95.9,92.0 to 98.2,406
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,88.8,82.4 to 93.6,325
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,86.4,81.7 to 90.4,667
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,84.0,76.8 to 90.0,342
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,83.5,78.1 to 88.2,641
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019,Age,24 Months,96.1,92.4 to 98.3,406
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2012,Age,35 Months,92.9,87.3 to 96.7,331
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2011,Age,35 Months,93.3,88.5 to 96.6,343
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013,Age,35 Months,95.9,92.7 to 98.0,325
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,93.5,90.2 to 96.0,667
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016,Age,35 Months,95.5,90.4 to 98.3,354
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2017,Age,35 Months,95.2,91.8 to 97.4,710
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,90.8,82.8 to 95.2,299
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,92.4,88.2 to 95.2,653
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,24 Months,95.0,91.1 to 97.5,426
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,95.4,92.9 to 97.3,832
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,85.9,77.2 to 91.6,299
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,89.0,84.0 to 92.5,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,13 Months,84.5,76.4 to 90.2,342
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,13 Months,85.2,79.5 to 89.5,641
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,93.0,86.6 to 96.5,356
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,92.5,88.8 to 95.1,782
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,13 Months,90.8,87.5 to 93.3,325
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,13 Months,87.7,81.5 to 92.0,667
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,94.1,90.0 to 96.6,354
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,93.5,90.1 to 95.9,710
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2016,Age,0-2 Days,81.6,74.7 to 87.0,354
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2016-2017,Age,0-2 Days,83.0,78.3 to 86.9,710
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,24 Months,84.5,77.5 to 90.3,342
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,88.9,84.3 to 92.6,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,24 Months,93.1,86.4 to 97.2,299
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,91.9,87.9 to 95.0,653
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,24 Months,90.7,85.4 to 94.7,354
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,92.2,88.5 to 95.0,710
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,13 Months,89.6,83.6 to 93.5,331
Hep A,≥1 Dose,States/Local Areas,PA-Rest of state,2020,Age,35 Months,88.8,82.7 to 93.5,337
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016,Age,24 Months,92.6,87.4 to 96.2,354
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2016-2017,Age,24 Months,92.9,89.4 to 95.6,710
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017,Age,24 Months,93.0,88.0 to 96.5,356
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,93.3,90.0 to 95.9,782
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,80.7,74.1 to 86.0,426
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,85.3,81.0 to 88.8,699
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,83.2,75.8 to 88.7,356
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,81.9,77.2 to 85.9,782
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,13 Months,93.0,88.6 to 95.8,343
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,7 Months,78.8,72.3 to 84.1,406
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,7 Months,72.5,65.3 to 78.7,426
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,7 Months,75.6,70.9 to 79.8,832
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,92.5,89.6 to 94.7,331
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,83.8,76.0 to 89.4,342
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,87.3,82.0 to 91.2,641
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,94.4,92.3 to 95.9,325
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,89.1,82.0 to 93.6,667
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2012,Age,0-2 Days,76.2,67.6 to 83.1,331
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2013,Age,0-2 Days,77.6,69.4 to 84.1,325
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2013-2014,Age,0-2 Days,71.5,63.4 to 78.4,667
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2011,Age,0-2 Days,81.2,76.9 to 84.9,343
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2019,Age,0-1 Days,84.8,79.3 to 89.1,406
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2018,Age,0-1 Days,79.7,73.8 to 84.5,426
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2018-2019,Age,0-1 Days,82.2,78.3 to 85.5,832
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,90.6,85.4 to 94.5,343
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,95.1,90.4 to 97.6,406
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,24 Months,94.0,89.3 to 97.1,325
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,89.3,85.1 to 92.8,667
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,24 Months,92.8,88.6 to 95.9,331
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,7 Months,81.0,74.0 to 86.5,354
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,7 Months,76.0,70.7 to 80.7,710
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,85.0,77.9 to 90.0,354
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,84.1,79.2 to 88.0,710
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2015,Age,19 Months,77.0,75.6 to 78.3,299
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,19 Months,81.0,75.2 to 85.6,653
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014,Age,19 Months,80.9,73.2 to 86.9,342
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,79.0,73.1 to 83.9,641
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015,Age,7 Months,62.3,53.2 to 70.7,299
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,7 Months,71.6,65.8 to 76.9,653
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,7 Months,71.0,62.9 to 78.0,356
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,7 Months,71.8,66.4 to 76.6,782
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013,Age,24 Months,92.6,87.8 to 96.1,325
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,91.8,88.3 to 94.6,667
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014,Age,24 Months,91.3,85.8 to 95.3,342
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,91.1,86.8 to 94.4,641
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015,Age,24 Months,91.4,84.5 to 96.0,299
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2015-2016,Age,24 Months,91.9,87.7 to 95.1,653
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018,Age,24 Months,93.1,88.4 to 96.4,426
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,93.8,90.8 to 96.1,832
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2012,Age,35 Months,95.4,91.6 to 97.8,331
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2011,Age,35 Months,90.8,85.3 to 94.9,343
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019,Age,24 Months,94.5,90.3 to 97.2,406
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017,Age,24 Months,93.9,88.8 to 97.2,356
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017-2018,Age,24 Months,93.6,90.3 to 96.1,782
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013,Age,35 Months,91.0,84.7 to 95.5,325
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013-2014,Age,35 Months,90.4,86.2 to 93.8,667
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018,Age,24 Months,93.5,88.9 to 96.7,426
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2018-2019,Age,24 Months,94.8,92.0 to 96.9,832
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2019,Age,19 Months,87.3,81.7 to 91.4,406
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014,Age,35 Months,89.7,83.6 to 94.2,342
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2015,Age,35 Months,88.5,83.8 to 92.4,641
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015,Age,35 Months,87.9,80.3 to 93.5,299
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2015-2016,Age,35 Months,92.7,87.8 to 96.1,653
PCV,≥4 Doses,States/Local Areas,PA-Rest of state,2011,Age,24 Months,87.5,81.9 to 92.0,343
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2015,Age,0-2 Days,80.3,71.9 to 86.7,299
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2015-2016,Age,0-2 Days,81.0,75.7 to 85.3,653
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2014,Age,0-2 Days,65.3,56.7 to 72.9,342
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Rest of state,2014-2015,Age,0-2 Days,72.8,66.8 to 78.0,641
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Race and Ethnicity,Hispanic,95.3,91.2 to 99.4,127
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,89.6,85.0 to 94.1,381
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017,Age,35 Months,94.7,89.8 to 97.8,356
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017-2018,Age,35 Months,96.0,92.1 to 98.4,782
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,5 Months,90.7,85.3 to 94.2,426
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,5 Months,92.3,89.0 to 94.7,832
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014,Age,24 Months,89.5,83.5 to 94.1,342
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2014-2015,Age,24 Months,88.3,83.5 to 92.2,641
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,5 Months,91.8,85.4 to 95.5,356
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,5 Months,91.2,87.4 to 94.0,782
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,90.2,86.4 to 93.1,343
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,5 Months,93.9,89.4 to 96.6,406
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2015,Age,0-1 Days,69.9,60.7 to 77.8,299
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2015-2016,Age,0-1 Days,73.1,67.3 to 78.2,653
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,5 Months,86.5,77.6 to 92.2,299
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,5 Months,89.0,84.0 to 92.5,653
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2014,Age,0-1 Days,61.0,52.5 to 68.8,342
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2014-2015,Age,0-1 Days,65.4,59.2 to 71.1,641
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2013,Age,0-1 Days,67.3,58.1 to 75.3,325
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2013-2014,Age,0-1 Days,64.1,56.7 to 71.0,667
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013,Age,24 Months,88.2,81.5 to 93.3,325
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2013-2014,Age,24 Months,88.9,84.5 to 92.5,667
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2017,Age,13 Months,93.3,86.7 to 96.8,356
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,13 Months,93.8,90.0 to 96.2,782
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2019,Age,19 Months,92.1,87.3 to 95.2,406
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2019,Age,13 Months,96.5,92.1 to 98.5,406
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2018,Age,13 Months,94.2,89.3 to 96.9,426
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,13 Months,95.4,92.4 to 97.2,832
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Rest of state,2012,Age,0-1 Days,68.7,57.2 to 78.3,331
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2014,Age,5 Months,79.9,71.8 to 86.2,342
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,5 Months,83.2,78.0 to 87.3,641
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,5 Months,91.4,86.1 to 94.8,354
Hep B,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,5 Months,91.6,87.8 to 94.3,710
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018,Age,19 Months,94.9,90.6 to 97.3,426
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,91.6,88.3 to 94.1,832
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017,Age,19 Months,92.9,86.6 to 96.4,356
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,93.9,90.4 to 96.2,782
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2012,Age,7 Months,70.4,59.2 to 79.6,331
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,133% to <400% FPL,85.6,80.1 to 91.0,381
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2014-2017,Poverty,>400% FPL,89.0,84.8 to 93.1,578
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014,Age,7 Months,59.7,51.1 to 67.7,342
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2014-2015,Age,7 Months,61.0,54.7 to 67.0,641
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016,Age,19 Months,90.7,84.9 to 94.5,354
Hep B,≥3 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,91.8,87.8 to 94.6,710
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2011,Age,7 Months,71.9,65.3 to 77.7,343
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013,Age,7 Months,72.5,68.4 to 76.2,325
PCV,≥3 Doses,States/Local Areas,PA-Rest of state,2013-2014,Age,7 Months,66.1,60.1 to 71.6,667
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2017,Age,3 Months,98.1,93.9 to 99.4,356
Hep B,≥1 Dose,States/Local Areas,PA-Rest of state,2017-2018,Age,3 Months,97.3,95.1 to 98.5,782
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2016,Age,13 Months,94.8,90.0 to 97.4,354
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2016-2017,Age,13 Months,94.1,90.4 to 96.4,710
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2015,Age,13 Months,92.6,84.4 to 96.7,299
Polio,≥2 Doses,States/Local Areas,PA-Rest of state,2015-2016,Age,13 Months,93.7,89.4 to 96.4,653
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016,Age,19 Months,90.4,83.9 to 94.4,354
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2016-2017,Age,19 Months,90.0,85.8 to 93.1,710
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2019,Age,13 Months,70.6,63.4 to 76.8,406
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018,Age,19 Months,93.1,87.8 to 96.2,426
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2018-2019,Age,19 Months,69.4,64.3 to 74.1,832
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017,Age,19 Months,89.6,83.2 to 93.8,356
≥1 Dose Varicella,,States/Local Areas,PA-Rest of state,2017-2018,Age,19 Months,91.3,87.5 to 94.1,782
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2012,Age,19 Months,88.6,87.1 to 90.0,331
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014,Age,19 Months,91.1,85.1 to 94.8,342
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2014-2015,Age,19 Months,89.9,85.2 to 93.2,641
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013,Age,19 Months,88.9,82.6 to 93.0,325
≥1 Dose MMR,,States/Local Areas,PA-Rest of state,2013-2014,Age,19 Months,90.0,86.5 to 92.6,667
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2018,Age,35 Months,86.1,79.8 to 91.3,426
DTaP,≥4 Doses,States/Local Areas,PA-Rest of state,2018-2019,Age,35 Months,88.3,83.9 to 91.9,832
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,92.8,88.1 to 96.2,553
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,81.6,75.9 to 86.6,553
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,93.6,89.2 to 96.7,553
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,66.3,60.7 to 71.9,553
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,86.1,81.3 to 89.8,553
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,90.7,86.5 to 93.7,553
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,62.4,56.6 to 67.8,553
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,86.8,81.9 to 90.4,553
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,88.3,83.4 to 91.8,553
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,87.0,82.0 to 90.7,553
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,60.6,54.8 to 66.1,553
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,5 Months,75.3,69.8 to 80.1,553
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,5 Months,89.7,85.1 to 93.0,553
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,84.3,79.6 to 88.1,553
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,93.9,89.8 to 96.4,553
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,91.8,87.6 to 94.7,553
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,84.1,79.4 to 87.9,553
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,62.3,56.6 to 67.8,553
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,13 Months,92.4,88.1 to 95.2,553
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,5 Months,72.9,67.4 to 77.7,553
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,5 Months,75.7,70.1 to 80.5,553
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,5 Months,75.7,70.1 to 80.5,553
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,3 Months,85.3,80.1 to 89.2,553
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,3 Months,95.2,91.3 to 97.4,553
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,90.8,87.1 to 93.9,553
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,90.7,86.8 to 93.9,553
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,75.5,70.0 to 80.7,553
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,91.7,87.8 to 94.6,553
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,84.1,78.3 to 89.1,553
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,93.5,89.0 to 96.7,553
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,91.9,87.9 to 95.0,553
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,93.7,89.3 to 96.7,553
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,90.1,86.0 to 93.5,553
Hib,Full Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,78.6,73.1 to 83.7,553
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,90.0,85.8 to 93.3,553
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,92.5,88.7 to 95.4,553
Hib,Full Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,69.9,64.3 to 75.0,553
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,89.4,85.0 to 92.6,553
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,89.2,84.8 to 92.5,553
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,26.5,22.2 to 31.3,553
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,88.1,83.7 to 91.5,553
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,79.8,74.6 to 84.5,553
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,90.3,86.1 to 93.6,553
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,59.5,53.8 to 65.0,553
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2019-2020,Age,0-3 Days,82.8,77.7 to 86.9,553
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,92.7,88.9 to 95.6,553
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,90.5,86.6 to 93.6,553
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2019-2020,Age,0-2 Days,82.3,77.3 to 86.4,553
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,84.9,80.2 to 88.6,553
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,74.0,68.4 to 78.9,553
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,91.3,87.0 to 94.3,553
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,87.8,83.3 to 91.2,553
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,57.0,51.3 to 62.5,553
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,71.0,65.1 to 76.7,553
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2019-2020,Age,0-1 Days,77.1,71.7 to 81.7,553
Hib,Full Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,75.1,69.8 to 80.1,553
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,89.8,85.6 to 93.1,553
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,89.6,85.4 to 93.0,553
Influenza,,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,64.6,58.9 to 70.3,553
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,93.1,88.9 to 96.2,553
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,35 Months,79.1,72.2 to 85.3,553
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,89.2,85.1 to 92.5,553
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,93.2,87.6 to 96.3,318
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,24 Months,48.4,42.7 to 54.5,553
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,81.2,71.6 to 89.1,318
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,72.2,64.3 to 79.6,318
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2020,Age,0-1 Days,80.6,74.0 to 85.8,318
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,27.6,21.9 to 34.2,318
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,84.7,78.0 to 89.7,318
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,3 Months,88.6,82.3 to 92.9,318
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2020,Age,0-2 Days,84.8,78.4 to 89.5,318
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,88.4,81.9 to 92.7,318
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,88.1,81.7 to 92.5,318
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,61.8,54.2 to 68.9,318
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,64.7,57.1 to 71.7,318
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,93.0,88.0 to 96.4,318
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,95.2,90.5 to 97.7,318
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,92.8,87.8 to 96.3,318
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,74.3,66.8 to 81.3,318
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,90.9,85.6 to 94.9,318
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,90.5,84.8 to 94.7,318
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,90.9,85.3 to 95.0,318
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,92.0,86.9 to 95.7,318
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,90.9,85.2 to 95.1,318
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,91.3,85.6 to 95.4,318
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,96.0,92.3 to 98.2,318
Hib,Full Series,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,79.6,72.3 to 85.9,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,93.4,88.2 to 96.9,318
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,90.5,84.3 to 94.4,318
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,94.6,87.1 to 98.4,318
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,94.9,90.2 to 97.4,318
Hib,Full Series,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,72.3,64.9 to 78.6,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,89.2,82.6 to 93.5,318
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,87.1,80.5 to 91.7,318
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,83.1,75.3 to 89.5,318
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,94.6,89.9 to 97.6,318
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,74.4,66.8 to 80.7,318
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,84.3,76.3 to 90.8,318
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,85.8,79.5 to 90.4,318
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,86.2,79.9 to 90.7,318
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,97.3,93.4 to 98.9,318
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,91.8,86.2 to 95.3,318
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,61.7,54.1 to 68.8,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,86.4,79.4 to 91.2,318
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,7 Months,64.9,57.2 to 71.9,318
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,5 Months,74.0,66.3 to 80.5,318
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,68.5,60.7 to 75.5,318
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,91.5,85.5 to 95.2,318
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,92.4,86.9 to 95.7,318
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,87.7,81.2 to 92.2,318
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,19 Months,90.1,83.9 to 94.1,318
Influenza,,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,66.6,59.2 to 74.0,318
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,90.7,85.0 to 94.8,318
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020,Age,35 Months,94.7,90.0 to 97.7,318
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2020,Age,0-3 Days,85.2,78.8 to 89.9,318
Rotavirus,,States/Local Areas,PA-Philadelphia,2020,Age,8 Months,76.5,69.0 to 82.6,318
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,79.5,72.5 to 85.7,318
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,88.8,83.1 to 93.3,318
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,66.3,58.8 to 73.7,318
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,24 Months,47.2,40.0 to 55.1,318
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2020,Age,3 Months,85.1,77.9 to 90.3,318
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,5 Months,75.1,67.5 to 81.4,318
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,5 Months,75.2,67.6 to 81.5,318
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,5 Months,92.8,87.4 to 96.0,318
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2020,Age,5 Months,71.7,64.2 to 78.2,318
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,97.0,94.2 to 98.7,226
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,94.8,91.9 to 96.9,430
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,87.9,80.8 to 92.6,226
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,87.0,82.0 to 90.7,430
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,96.2,91.8 to 100.0,53
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,92.4,85.2 to 96.9,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,91.3,84.8 to 95.8,224
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,90.4,86.1 to 93.8,459
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,89.4,83.3 to 94.0,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,93.0,86.8 to 96.9,283
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,93.6,89.2 to 96.7,214
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,91.2,87.6 to 94.0,432
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,89.1,83.3 to 93.5,218
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,89.9,86.0 to 93.1,444
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,90.7,85.1 to 94.9,226
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,89.5,85.1 to 93.0,430
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,5 Months,70.9,62.9 to 77.8,214
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,5 Months,72.9,68.2 to 77.1,432
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,5 Months,74.8,66.6 to 81.6,218
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,5 Months,77.9,72.4 to 82.5,444
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,5 Months,81.0,73.5 to 86.7,226
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,5 Months,81.2,76.1 to 85.4,430
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,98.0,93.4 to 99.6,224
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,95.1,91.0 to 97.8,459
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016,Age,13 Months,95.3,91.6 to 97.4,226
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,13 Months,92.7,89.3 to 95.0,430
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,95.2,91.6 to 97.6,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,97.0,93.1 to 99.0,283
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,84.7,77.4 to 90.0,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,87.5,81.6 to 92.2,283
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,90.5,84.8 to 94.7,236
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,92.0,88.5 to 94.7,450
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,92.6,88.5 to 95.7,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,97.4,93.0 to 99.3,224
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,93.6,89.6 to 96.5,459
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,75.1,72.4 to 77.6,236
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,76.1,73.7 to 78.3,450
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,77.1,70.0 to 82.9,214
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,74.5,69.2 to 79.2,432
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,71.9,65.4 to 77.6,218
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,77.2,71.8 to 81.7,444
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,94.3,92.0 to 96.6,440
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,98.6,97.2 to 100.0,280
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,31.8,24.0 to 40.7,204
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,30.9,25.6 to 36.7,428
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,97.0,94.2 to 98.7,226
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,95.5,92.5 to 97.5,430
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,94.2,88.7 to 97.6,204
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,95.8,92.5 to 98.0,428
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,29.9,23.2 to 37.7,224
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,27.3,21.8 to 33.5,361
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,25.4,19.3 to 32.7,235
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,52.1,44.4 to 60.3,283
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,94.3,90.2 to 97.1,218
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,95.6,93.3 to 97.4,444
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,97.0,94.2 to 98.7,226
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,95.0,92.1 to 97.1,430
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,90.5,84.5 to 94.9,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,87.9,80.8 to 93.2,204
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,89.6,85.0 to 93.3,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,95.7,91.8 to 98.1,204
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,95.1,91.6 to 97.4,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,94.7,88.9 to 98.1,224
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,92.6,88.7 to 95.6,459
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018,Age,13 Months,91.3,84.7 to 95.2,224
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,13 Months,86.9,82.2 to 90.5,459
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019,Age,13 Months,82.5,75.0 to 88.1,235
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017,Age,13 Months,90.0,84.0 to 94.0,204
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,13 Months,90.6,86.5 to 93.6,428
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020,Age,13 Months,62.8,55.1 to 69.9,318
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,96.7,92.3 to 99.0,204
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,97.3,94.3 to 98.9,428
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,5 Months,73.7,64.7 to 81.0,236
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,5 Months,72.3,66.2 to 77.7,450
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,5 Months,69.1,67.0 to 71.2,280
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,5 Months,74.7,68.4 to 80.1,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,96.0,92.8 to 98.1,218
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,96.7,94.7 to 98.1,444
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,97.4,94.6 to 99.0,226
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,96.9,94.4 to 98.5,430
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,94.0,91.4 to 95.9,236
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,93.9,92.0 to 95.4,450
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,95.7,92.8 to 97.4,283
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,94.4,89.3 to 97.1,280
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,93.7,89.3 to 96.4,214
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,94.0,91.1 to 96.0,432
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,88.3,81.2 to 92.9,235
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,93.3,86.6 to 96.8,224
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,86.9,82.2 to 90.5,459
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,86.0,78.3 to 91.3,204
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,87.1,82.1 to 90.9,428
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,88.3,80.9 to 93.0,224
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,88.8,83.8 to 92.5,361
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,98.5,94.6 to 99.8,236
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,98.5,95.8 to 99.6,450
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,96.8,93.7 to 98.6,280
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,96.6,92.7 to 98.8,283
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,98.4,94.6 to 99.7,214
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,96.7,94.4 to 98.2,432
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,16.7,13.0 to 21.1,283
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2019,Age,5 Months,77.0,68.7 to 83.6,235
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,13.5,10.6 to 17.0,236
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,18.8,15.0 to 23.4,450
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,24.4,18.1 to 32.0,214
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,21.0,16.8 to 26.0,432
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,21.3,17.9 to 25.1,280
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,94.0,88.2 to 97.5,224
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,91.4,87.2 to 94.6,459
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,88.8,82.3 to 93.7,235
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,93.1,87.9 to 96.6,204
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,93.4,89.7 to 96.1,428
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,17.6,13.9 to 22.1,218
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,24.0,19.3 to 29.4,444
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,30.5,23.2 to 39.1,226
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,31.2,25.7 to 37.2,430
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,96.0,91.7 to 98.5,236
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,96.0,93.3 to 97.8,450
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,96.1,92.0 to 98.4,214
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,95.4,92.7 to 97.4,432
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,95.0,90.8 to 97.7,218
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,96.0,93.5 to 97.7,444
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,97.8,96.0 to 99.6,210
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,94.0,89.8 to 98.2,170
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,94.6,92.4 to 96.9,411
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,95.2,93.5 to 96.8,791
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2016,Age,5 Months,83.8,76.6 to 89.1,226
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,5 Months,83.0,77.9 to 87.0,430
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2018,Age,5 Months,75.7,67.1 to 82.7,224
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2018-2019,Age,5 Months,76.3,70.5 to 81.3,459
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2017,Age,5 Months,82.2,74.7 to 87.8,204
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2017-2018,Age,5 Months,79.0,73.4 to 83.7,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,97.4,94.6 to 99.0,226
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,96.4,94.1 to 98.0,430
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2019,Age,3 Months,87.1,79.2 to 92.2,235
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,83.0,79.9 to 85.7,283
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2017,Age,3 Months,92.6,87.6 to 95.7,204
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2017-2018,Age,3 Months,91.9,87.8 to 94.7,428
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,96.3,93.1 to 98.3,214
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,96.2,94.0 to 97.7,432
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,96.0,92.8 to 98.1,218
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,96.7,94.7 to 98.1,444
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2018,Age,3 Months,91.2,83.8 to 95.4,224
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2018-2019,Age,3 Months,89.1,84.1 to 92.7,459
Hib,Full Series,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,68.0,58.0 to 76.6,228
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,86.9,80.6 to 91.4,214
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,85.8,81.3 to 89.4,432
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,84.8,78.1 to 89.7,218
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,86.3,81.6 to 90.0,444
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,83.6,81.0 to 85.9,236
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,85.2,83.1 to 87.1,450
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,89.5,86.1 to 92.1,280
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,82.0,75.9 to 87.4,546
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,84.3,75.3 to 90.5,228
Hib,Full Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,74.8,68.9 to 80.3,546
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,3 Months,77.9,68.5 to 85.1,228
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,88.1,79.4 to 93.5,228
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2012,Age,3 Months,87.7,83.6 to 91.0,280
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2011,Age,3 Months,88.9,84.7 to 92.0,283
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2013,Age,3 Months,87.8,86.4 to 89.0,236
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2013-2014,Age,3 Months,86.6,84.1 to 88.9,450
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2014,Age,3 Months,85.5,78.7 to 90.4,214
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2014-2015,Age,3 Months,87.0,82.5 to 90.5,432
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2015,Age,3 Months,88.6,82.0 to 93.0,218
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2015-2016,Age,3 Months,90.2,86.2 to 93.2,444
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2016,Age,3 Months,91.9,86.5 to 95.3,226
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2017,Age,3 Months,92.2,88.8 to 94.7,430
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,75.9,66.1 to 83.7,228
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,93.9,90.1 to 96.3,546
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,66.1,55.9 to 76.1,228
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,84.6,75.7 to 90.7,228
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,86.4,81.3 to 90.7,546
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,85.2,76.1 to 91.2,228
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,87.9,83.3 to 91.7,546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.9,82.0 to 91.8,242
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,61.9,51.9 to 70.9,228
PCV,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,5 Months,76.3,66.4 to 84.0,228
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,79.5,73.8 to 84.6,546
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,65.3,55.3 to 74.1,228
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,85.0,75.7 to 91.1,228
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,88.1,83.0 to 91.8,546
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,87.7,82.5 to 91.4,546
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,79.4,69.6 to 86.7,228
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,89.0,81.1 to 94.6,228
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,89.3,81.5 to 94.8,228
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,7 Months,60.7,50.8 to 69.8,228
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,86.6,81.5 to 90.9,546
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,5 Months,68.8,58.8 to 77.3,228
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,81.5,72.1 to 88.3,228
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,71.7,63.7 to 78.5,283
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,71.4,65.7 to 76.5,280
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,94.3,91.2 to 96.3,218
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,95.6,93.1 to 97.3,444
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,97.0,93.8 to 98.6,226
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,94.8,91.7 to 96.8,430
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,92.6,86.8 to 96.0,204
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,93.0,89.0 to 95.6,428
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,95.2,91.6 to 97.6,280
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,96.3,92.8 to 98.4,283
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014,Age,13 Months,88.5,82.3 to 92.7,214
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,13 Months,89.3,85.3 to 92.4,432
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015,Age,13 Months,90.2,84.2 to 94.0,218
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,13 Months,92.7,89.3 to 95.1,444
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018,Age,7 Months,64.9,56.2 to 72.7,224
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,7 Months,59.6,53.5 to 65.4,459
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016,Age,7 Months,72.1,63.7 to 79.1,226
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,7 Months,70.6,64.7 to 75.9,430
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017,Age,7 Months,69.2,60.5 to 76.7,204
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,7 Months,67.1,61.0 to 72.6,428
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013,Age,13 Months,90.0,84.8 to 93.6,236
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,13 Months,89.3,87.4 to 90.9,450
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2012,Age,13 Months,86.9,83.8 to 89.5,280
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2011,Age,13 Months,93.2,90.7 to 95.0,283
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019,Age,7 Months,54.3,45.7 to 62.6,235
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,94.0,88.2 to 97.5,224
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,91.4,87.2 to 94.6,459
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014,Age,7 Months,58.6,50.3 to 66.5,214
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,7 Months,63.5,57.7 to 69.0,432
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015,Age,7 Months,68.5,60.4 to 75.6,218
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,7 Months,70.3,64.5 to 75.4,444
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013,Age,7 Months,64.6,57.3 to 71.4,236
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,7 Months,61.7,57.9 to 65.3,450
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,96.0,91.7 to 98.5,236
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,96.0,93.3 to 97.8,450
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,88.8,82.3 to 93.7,235
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,97.7,93.8 to 99.4,283
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,96.1,92.0 to 98.4,214
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,95.4,92.7 to 97.4,432
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,95.2,91.6 to 97.6,280
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,79.5,73.4 to 85.0,283
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,70.2,63.2 to 76.8,280
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,75.5,68.4 to 82.0,236
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,77.6,72.8 to 82.1,450
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,97.0,94.2 to 98.7,226
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,95.3,92.3 to 97.4,430
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,93.9,88.3 to 97.4,204
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,95.8,92.4 to 97.9,428
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,95.0,90.8 to 97.7,218
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,96.0,93.5 to 97.7,444
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,95.0,90.5 to 97.8,236
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,95.0,92.3 to 97.0,450
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,94.9,91.3 to 97.4,214
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,94.6,92.0 to 96.6,432
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,94.3,90.2 to 97.1,218
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,95.6,93.3 to 97.4,444
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,92.6,87.4 to 96.2,204
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,93.3,89.6 to 96.0,428
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2011,Age,35 Months,86.1,80.7 to 90.7,283
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,74.1,66.0 to 81.6,224
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,70.4,64.7 to 76.0,459
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,74.6,66.9 to 81.8,204
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,74.4,68.8 to 79.7,428
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,66.8,58.5 to 74.9,235
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,97.4,93.0 to 99.3,224
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,93.6,89.6 to 96.5,459
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,75.7,68.5 to 82.4,218
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,77.5,72.6 to 82.1,444
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,79.8,73.1 to 85.7,214
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,77.7,72.8 to 82.2,432
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,89.1,82.6 to 94.0,235
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,79.6,72.8 to 85.7,226
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,77.2,72.1 to 82.0,430
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2015,Age,35 Months,83.2,73.7 to 90.8,218
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2015-2016,Age,35 Months,84.0,78.7 to 88.6,444
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2012,Age,35 Months,79.8,72.2 to 86.4,280
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2013,Age,35 Months,81.9,75.2 to 87.6,236
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2013-2014,Age,35 Months,83.3,78.8 to 87.3,450
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014,Age,35 Months,84.9,78.6 to 90.1,214
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2015,Age,35 Months,84.1,78.1 to 89.1,432
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2017,Age,35 Months,80.5,72.7 to 87.3,204
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2017-2018,Age,35 Months,78.3,72.7 to 83.5,428
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016,Age,35 Months,86.0,80.2 to 90.8,226
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2016-2017,Age,35 Months,83.3,78.6 to 87.5,430
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,68.9,52.7 to 85.0,53
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,74.1,68.8 to 79.3,411
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",77.8,71.5 to 84.1,248
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,73.6,66.0 to 81.1,196
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2018,Age,35 Months,75.9,67.8 to 83.3,224
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2018-2019,Age,35 Months,73.1,67.2 to 78.8,459
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2019,Age,35 Months,70.4,61.6 to 78.7,235
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,76.6,71.9 to 81.3,440
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,81.8,76.4 to 87.2,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2013,Age,19 Months,78.5,75.9 to 80.8,236
Hib,Full Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,19 Months,78.9,76.1 to 81.5,450
Hib,Full Series,States/Local Areas,PA-Philadelphia,2012,Age,19 Months,72.9,68.9 to 76.5,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2011,Age,19 Months,76.5,72.0 to 80.5,283
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,81.2,74.6 to 87.8,210
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,76.2,68.5 to 83.9,170
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,76.1,72.3 to 79.8,791
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.1,66.0 to 80.2,231
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.0,70.7 to 89.3,116
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,76.1,72.3 to 79.8,791
Hib,Full Series,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,86.2,80.8 to 90.6,283
Hib,Full Series,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,80.8,74.5 to 86.3,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,83.8,77.7 to 89.0,214
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,83.8,79.4 to 87.7,432
Hib,Full Series,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,82.9,76.3 to 88.6,236
Hib,Full Series,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,83.4,79.0 to 87.4,450
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,69.8,61.4 to 78.2,196
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",70.3,63.4 to 77.3,248
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,69.9,64.7 to 75.2,440
Hib,Full Series,States/Local Areas,PA-Philadelphia,2015,Age,19 Months,72.4,64.9 to 78.8,218
Hib,Full Series,States/Local Areas,PA-Philadelphia,2015-2016,Age,19 Months,75.7,70.4 to 80.4,444
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016,Age,19 Months,79.2,71.7 to 85.1,226
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2017,Age,19 Months,78.3,72.9 to 82.8,430
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014,Age,19 Months,79.4,72.5 to 84.9,214
Hib,Full Series,States/Local Areas,PA-Philadelphia,2014-2015,Age,19 Months,75.9,70.7 to 80.5,432
Hib,Full Series,States/Local Areas,PA-Philadelphia,2018,Age,19 Months,74.7,66.2 to 81.6,224
Hib,Full Series,States/Local Areas,PA-Philadelphia,2018-2019,Age,19 Months,94.9,91.0 to 97.1,459
Hib,Full Series,States/Local Areas,PA-Philadelphia,2019,Age,19 Months,67.8,59.3 to 75.3,235
Hib,Full Series,States/Local Areas,PA-Philadelphia,2017,Age,19 Months,77.4,69.2 to 83.9,204
Hib,Full Series,States/Local Areas,PA-Philadelphia,2017-2018,Age,19 Months,76.1,70.3 to 81.0,428
Rotavirus,,States/Local Areas,PA-Philadelphia,2018,Age,8 Months,76.9,68.3 to 83.7,224
Rotavirus,,States/Local Areas,PA-Philadelphia,2018-2019,Age,8 Months,73.5,67.6 to 78.7,459
Rotavirus,,States/Local Areas,PA-Philadelphia,2017,Age,8 Months,73.4,64.7 to 80.7,204
Rotavirus,,States/Local Areas,PA-Philadelphia,2017-2018,Age,8 Months,75.1,69.2 to 80.3,428
Rotavirus,,States/Local Areas,PA-Philadelphia,2019,Age,8 Months,70.1,61.6 to 77.4,235
Rotavirus,,States/Local Areas,PA-Philadelphia,2014,Age,8 Months,70.2,62.2 to 77.1,214
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2015,Age,8 Months,72.0,66.5 to 77.0,432
Rotavirus,,States/Local Areas,PA-Philadelphia,2016,Age,8 Months,83.2,76.6 to 88.2,226
Rotavirus,,States/Local Areas,PA-Philadelphia,2016-2017,Age,8 Months,78.3,72.9 to 82.9,430
Rotavirus,,States/Local Areas,PA-Philadelphia,2015,Age,8 Months,73.9,66.0 to 80.5,218
Rotavirus,,States/Local Areas,PA-Philadelphia,2015-2016,Age,8 Months,78.5,73.4 to 82.8,444
Rotavirus,,States/Local Areas,PA-Philadelphia,2011,Age,8 Months,72.7,65.3 to 79.1,283
Rotavirus,,States/Local Areas,PA-Philadelphia,2012,Age,8 Months,70.8,63.6 to 77.0,280
Rotavirus,,States/Local Areas,PA-Philadelphia,2013,Age,8 Months,76.1,68.8 to 82.2,236
Rotavirus,,States/Local Areas,PA-Philadelphia,2013-2014,Age,8 Months,73.2,67.9 to 77.9,450
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.3,59.4 to 81.1,116
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,73.4,69.5 to 77.4,791
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.1,78.5 to 89.6,231
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,65.7,59.9 to 71.5,411
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,73.4,69.5 to 77.4,791
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,80.9,74.0 to 87.8,170
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,87.1,82.2 to 92.0,280
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,66.3,50.0 to 82.6,53
Rotavirus,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,87.1,81.2 to 93.0,210
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,85.9,80.5 to 90.0,546
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,65.5,59.2 to 71.7,546
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,89.0,81.2 to 94.6,228
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,86.6,78.3 to 92.9,228
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,91.4,86.8 to 94.9,546
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,87.8,82.7 to 91.9,546
Hib,Full Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,77.9,71.8 to 83.4,546
DTaP,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,3 Months,86.4,81.2 to 90.3,546
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,86.1,80.7 to 90.2,546
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,63.2,57.0 to 69.0,546
Hep B,"≥1 Dose, 2 Day",States/Local Areas,PA-Philadelphia,2020-2021,Age,0-2 Days,81.7,76.3 to 86.1,546
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,89.7,84.7 to 93.2,546
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,90.7,86.2 to 94.2,546
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,84.9,79.8 to 89.0,546
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,76.3,70.3 to 81.9,546
Rotavirus,,States/Local Areas,PA-Philadelphia,2020-2021,Age,8 Months,75.0,69.0 to 80.1,546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2020-2021,Age,0-3 Days,82.2,76.8 to 86.5,546
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,89.2,84.6 to 93.0,546
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,87.9,82.7 to 91.7,546
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,87.2,79.0 to 93.3,228
Influenza,,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,62.9,56.7 to 69.0,546
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,79.6,69.9 to 87.7,228
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,87.6,82.5 to 91.8,546
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,63.8,57.9 to 69.3,546
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,75.2,69.2 to 80.3,546
Hib,Full Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,70.2,64.1 to 75.6,546
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,93.5,87.8 to 97.2,546
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,90.4,83.3 to 94.7,228
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,87.4,79.2 to 93.6,228
Rotavirus,,States/Local Areas,PA-Philadelphia,2021,Age,8 Months,73.5,63.7 to 81.3,228
Hib,Full Series,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,75.2,65.4 to 84.0,228
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,90.2,85.1 to 93.6,546
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,81.5,75.8 to 86.1,546
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,76.7,66.8 to 84.3,228
Hep B,"≥1 Dose, 1 Day",States/Local Areas,PA-Philadelphia,2020-2021,Age,0-1 Days,78.2,72.8 to 82.9,546
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,83.7,76.8 to 89.4,546
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,50.5,44.3 to 57.0,546
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,63.3,57.1 to 69.1,546
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,5 Months,74.9,68.9 to 80.1,546
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,89.9,85.3 to 93.5,546
Hib,Primary Series,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,84.5,75.6 to 91.5,228
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,76.7,66.8 to 84.3,228
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,90.9,86.4 to 94.3,546
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,5 Months,87.9,82.5 to 91.8,546
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,91.0,86.3 to 94.5,546
Combined 7 Series,,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,70.0,63.3 to 76.4,546
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,89.7,85.2 to 93.3,546
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,5 Months,74.9,68.9 to 80.0,546
Hib,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,3 Months,80.5,74.9 to 85.1,546
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,88.6,83.6 to 92.2,546
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,89.0,84.3 to 92.8,546
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,69.6,63.2 to 75.2,546
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,86.8,81.5 to 90.7,546
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,PA-Philadelphia,2021,Age,0-3 Days,79.1,69.9 to 86.1,228
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,3 Months,96.2,93.2 to 97.9,546
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,87.6,82.5 to 91.4,546
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,65.6,59.4 to 71.3,546
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,85.5,80.0 to 89.7,546
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,5 Months,82.8,73.2 to 89.5,228
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,28.7,23.8 to 34.3,546
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2021,Age,19 Months,86.8,78.2 to 92.3,228
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,5 Months,70.3,64.1 to 75.8,546
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,67.8,57.7 to 76.4,228
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,83.4,74.3 to 89.7,228
DTaP,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,5 Months,74.6,64.8 to 82.4,228
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,5 Months,74.6,64.8 to 82.4,228
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,>400% FPL,97.2,94.9 to 99.6,246
Hep B,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,61.9,56.3 to 67.2,553
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,86.2,80.1 to 92.3,184
Influenza,,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,58.6,49.1 to 68.4,228
Polio,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,92.1,88.1 to 94.8,546
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.3,79.8 to 96.8,117
DTaP,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Poverty,133% to <400% FPL,81.7,74.4 to 89.0,211
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,83.3,79.0 to 87.5,421
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,96.6,93.9 to 99.2,184
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,79.6,68.5 to 90.7,184
Hep B,≥2 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,7 Months,91.3,86.7 to 94.3,553
Hep B,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,3 Months,94.5,88.7 to 97.4,228
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,84.9,75.7 to 91.1,228
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",61.2,53.8 to 68.6,248
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Any Medicaid,56.8,51.0 to 62.6,440
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.0,54.2 to 77.8,116
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,Hispanic,61.9,52.5 to 71.2,196
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",82.6,74.6 to 90.7,253
≥1 Dose Varicella,,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,64.7,58.5 to 70.4,546
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2021,Age,13 Months,68.4,58.6 to 76.9,228
≥1 Dose MMR,,States/Local Areas,PA-Philadelphia,2020-2021,Age,19 Months,87.2,82.2 to 91.0,546
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,65.1,58.9 to 70.8,546
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,13 Months,85.4,80.0 to 89.6,546
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,61.3,55.1 to 67.1,546
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,3 Months,85.9,80.6 to 89.9,546
Polio,≥1 Dose,States/Local Areas,PA-Philadelphia,2020-2021,Age,3 Months,86.3,81.2 to 90.2,546
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,35 Months,79.7,71.1 to 87.1,546
Polio,≥3 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,24 Months,88.8,84.2 to 92.6,546
Hib,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,35 Months,84.5,75.6 to 91.5,228
Influenza,,States/Local Areas,PA-Philadelphia,2016,Age,24 Months,64.8,56.3 to 73.1,226
Influenza,,States/Local Areas,PA-Philadelphia,2016-2017,Age,24 Months,67.2,61.1 to 73.2,430
Influenza,,States/Local Areas,PA-Philadelphia,2018,Age,24 Months,69.9,61.9 to 77.5,224
Influenza,,States/Local Areas,PA-Philadelphia,2018-2019,Age,24 Months,66.4,60.5 to 72.1,459
Influenza,,States/Local Areas,PA-Philadelphia,2017,Age,24 Months,69.7,61.1 to 78.0,204
Influenza,,States/Local Areas,PA-Philadelphia,2017-2018,Age,24 Months,69.8,63.9 to 75.5,428
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,94.9,91.3 to 98.4,303
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Any Medicaid,88.3,84.2 to 92.3,421
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"White, Non-Hispanic",84.4,74.8 to 94.0,242
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Other,58.0,41.1 to 74.9,53
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Insurance Coverage,Private Insurance Only,87.4,82.7 to 92.1,280
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.1,71.5 to 90.6,117
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Urbanicity,Living In a MSA Principal City,64.8,60.5 to 69.2,791
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.8,66.9 to 80.7,231
PCV,≥4 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,91.7,87.4 to 96.0,303
Hep A,≥1 Dose,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,Hispanic,86.1,78.9 to 93.3,184
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,>400% FPL,84.3,77.4 to 91.3,210
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,133% to <400% FPL,70.0,61.4 to 78.7,170
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Poverty,<133% FPL,55.8,49.7 to 61.8,411
Influenza,,States/Local Areas,PA-Philadelphia,2014-2017,Overall,Overall,64.8,60.5 to 69.2,791
Hib,Full Series,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,87.1,82.5 to 91.7,303
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Insurance Coverage,Private Insurance Only,96.5,94.1 to 98.9,303
Hep A,≥2 Doses,States/Local Areas,PA-Philadelphia,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,74.8 to 96.9,117
DTaP,≥3 Doses,States/Local Areas,PA-Philadelphia,2021,Age,24 Months,85.4,77.3 to 91.8,228
PCV,≥1 Dose,States/Local Areas,PA-Philadelphia,2021,Age,3 Months,86.7,78.1 to 92.3,228
Hib,≥2 Doses,States/Local Areas,PA-Philadelphia,2020-2021,Age,7 Months,83.8,78.1 to 88.2,546
Influenza,,States/Local Areas,PA-Philadelphia,2013,Age,24 Months,63.8,56.2 to 71.3,236
Influenza,,States/Local Areas,PA-Philadelphia,2013-2014,Age,24 Months,65.8,60.4 to 71.1,450
Influenza,,States/Local Areas,PA-Philadelphia,2011,Age,24 Months,67.7,60.2 to 75.0,283
Influenza,,States/Local Areas,PA-Philadelphia,2012,Age,24 Months,62.8,55.5 to 70.1,280
Influenza,,States/Local Areas,PA-Philadelphia,2015,Age,24 Months,63.0,55.0 to 70.9,218
Influenza,,States/Local Areas,PA-Philadelphia,2015-2016,Age,24 Months,63.9,58.0 to 69.7,444
Influenza,,States/Local Areas,PA-Philadelphia,2014,Age,24 Months,67.9,60.4 to 75.2,214
Influenza,,States/Local Areas,PA-Philadelphia,2014-2015,Age,24 Months,65.4,59.9 to 70.9,432
Influenza,,States/Local Areas,PA-Philadelphia,2019,Age,24 Months,62.8,54.3 to 71.3,235
PCV,≥3 Doses,States/Local Areas,PA-Philadelphia,2019-2020,Age,19 Months,89.3,84.8 to 92.6,553
Hib,Full Series,HHS Regions/National,Region 2,2011,Age,24 Months,80.6,76.6 to 84.3,730
Hib,Full Series,HHS Regions/National,Region 2,2012,Age,24 Months,80.4,76.7 to 83.9,780
Hib,Full Series,HHS Regions/National,Region 2,2014,Age,24 Months,80.1,76.5 to 83.4,926
Hib,Full Series,HHS Regions/National,Region 2,2014-2015,Age,24 Months,79.7,77.1 to 82.2,1744
Hib,Full Series,HHS Regions/National,Region 2,2013,Age,24 Months,82.2,78.7 to 85.5,797
Hib,Full Series,HHS Regions/National,Region 2,2013-2014,Age,24 Months,81.2,78.7 to 83.5,1723
Hib,Full Series,HHS Regions/National,Region 2,2015,Age,19 Months,73.2,69.6 to 76.6,818
Hib,Full Series,HHS Regions/National,Region 2,2015-2016,Age,19 Months,72.6,69.5 to 75.6,1622
Hib,Full Series,HHS Regions/National,Region 2,2016,Age,19 Months,72.0,67.3 to 76.3,804
Hib,Full Series,HHS Regions/National,Region 2,2016-2017,Age,19 Months,73.8,70.6 to 76.7,1715
Hib,Primary Series,HHS Regions/National,Region 2,2012,Age,19 Months,92.8,91.2 to 94.2,780
Combined 7 Series,,HHS Regions/National,Region 2,2019,Age,35 Months,72.4,67.4 to 77.3,916
Combined 7 Series,,HHS Regions/National,Region 2,2018,Age,35 Months,76.3,71.8 to 80.6,1002
Combined 7 Series,,HHS Regions/National,Region 2,2018-2019,Age,35 Months,74.4,71.0 to 77.7,1918
Hib,Full Series,HHS Regions/National,Region 2,2013,Age,19 Months,73.3,69.5 to 76.9,797
Hib,Full Series,HHS Regions/National,Region 2,2013-2014,Age,19 Months,71.9,68.9 to 74.8,1723
Hib,Full Series,HHS Regions/National,Region 2,2012,Age,19 Months,72.1,67.2 to 76.6,780
Hib,Full Series,HHS Regions/National,Region 2,2011,Age,19 Months,72.1,66.8 to 76.8,730
Hep A,≥2 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,64.8,56.5 to 72.9,570
Hib,Full Series,HHS Regions/National,Region 2,2017,Age,19 Months,75.6,71.5 to 79.3,911
Hib,Full Series,HHS Regions/National,Region 2,2017-2018,Age,19 Months,75.0,72.2 to 77.6,1913
Hep A,≥1 Dose,HHS Regions/National,Region 2,2021,Age,35 Months,85.6,79.7 to 90.5,570
Hib,Primary Series,HHS Regions/National,Region 2,2021,Age,7 Months,70.7,65.2 to 75.6,570
PCV,≥3 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,89.9,85.3 to 93.2,570
Hep B,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,93.6,91.3 to 95.3,1462
PCV,≥4 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,73.8,68.2 to 78.7,570
Combined 7 Series,,HHS Regions/National,Region 2,2015,Age,35 Months,75.1,70.5 to 79.5,818
Combined 7 Series,,HHS Regions/National,Region 2,2015-2016,Age,35 Months,72.6,69.2 to 75.9,1622
Hep B,≥3 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,92.1,88.1 to 95.1,570
DTaP,≥4 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,69.5,63.8 to 74.7,570
Hib,Full Series,HHS Regions/National,Region 2,2021,Age,24 Months,78.1,72.6 to 83.2,570
Hib,Primary Series,HHS Regions/National,Region 2,2021,Age,24 Months,92.0,87.9 to 95.0,570
Hib,≥3 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,91.2,87.0 to 94.5,570
Hib,Full Series,HHS Regions/National,Region 2,2018,Age,19 Months,74.3,70.4 to 77.8,1002
Hib,Full Series,HHS Regions/National,Region 2,2018-2019,Age,19 Months,94.6,92.8 to 96.0,1918
Hib,Full Series,HHS Regions/National,Region 2,2014,Age,19 Months,70.5,66.5 to 74.2,926
Hib,Full Series,HHS Regions/National,Region 2,2014-2015,Age,19 Months,71.9,69.0 to 74.6,1744
Hib,Primary Series,HHS Regions/National,Region 2,2019,Age,19 Months,91.7,88.3 to 94.2,916
Hib,Primary Series,HHS Regions/National,Region 2,2012,Age,24 Months,95.0,92.9 to 96.7,780
Hib,Primary Series,HHS Regions/National,Region 2,2011,Age,24 Months,93.5,90.7 to 95.7,730
Hib,Primary Series,HHS Regions/National,Region 2,2016,Age,19 Months,90.2,86.6 to 93.0,804
Hib,Primary Series,HHS Regions/National,Region 2,2016-2017,Age,19 Months,91.0,88.7 to 92.9,1715
Hib,Primary Series,HHS Regions/National,Region 2,2019,Age,13 Months,87.5,83.8 to 90.5,916
Hib,Primary Series,HHS Regions/National,Region 2,2018,Age,13 Months,88.5,85.5 to 91.0,1002
Hib,Primary Series,HHS Regions/National,Region 2,2018-2019,Age,13 Months,88.0,85.7 to 90.0,1918
Hib,Primary Series,HHS Regions/National,Region 2,2017,Age,13 Months,86.4,82.7 to 89.4,911
Hib,Primary Series,HHS Regions/National,Region 2,2017-2018,Age,13 Months,87.4,85.1 to 89.4,1913
Hib,Primary Series,HHS Regions/National,Region 2,2018,Age,19 Months,92.9,90.4 to 94.8,1002
Hib,Primary Series,HHS Regions/National,Region 2,2018-2019,Age,19 Months,88.0,85.7 to 90.0,1918
Hib,Primary Series,HHS Regions/National,Region 2,2017,Age,19 Months,91.8,88.7 to 94.1,911
Hib,Primary Series,HHS Regions/National,Region 2,2017-2018,Age,19 Months,92.3,90.4 to 93.9,1913
Hib,Primary Series,HHS Regions/National,Region 2,2015,Age,19 Months,92.2,89.8 to 94.1,818
Hib,Primary Series,HHS Regions/National,Region 2,2015-2016,Age,19 Months,91.2,89.0 to 93.0,1622
Hib,Primary Series,HHS Regions/National,Region 2,2014,Age,19 Months,92.5,90.1 to 94.4,926
Hib,Primary Series,HHS Regions/National,Region 2,2014-2015,Age,19 Months,92.3,90.6 to 93.8,1744
Hib,Primary Series,HHS Regions/National,Region 2,2013,Age,19 Months,94.1,91.9 to 95.7,797
Hib,Primary Series,HHS Regions/National,Region 2,2013-2014,Age,19 Months,93.3,91.4 to 94.8,1723
Hib,Primary Series,HHS Regions/National,Region 2,2011,Age,19 Months,93.3,90.2 to 95.4,730
Hib,Primary Series,HHS Regions/National,Region 2,2016,Age,13 Months,85.5,81.4 to 88.8,804
Hib,Primary Series,HHS Regions/National,Region 2,2016-2017,Age,13 Months,85.9,83.3 to 88.2,1715
PCV,≥3 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,65.1,60.6 to 69.3,892
Rotavirus,,HHS Regions/National,Region 2,2019-2020,Age,8 Months,75.5,72.4 to 78.3,1808
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,90.6,87.6 to 93.0,892
Hep B,≥1 Dose,HHS Regions/National,Region 2,2020,Age,3 Months,94.5,91.8 to 96.3,892
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,92.8,90.2 to 94.9,892
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,47.8,43.4 to 52.3,892
Hib,≥1 Dose,HHS Regions/National,Region 2,2020,Age,3 Months,81.2,77.3 to 84.6,892
Polio,≥1 Dose,HHS Regions/National,Region 2,2020,Age,3 Months,83.2,79.4 to 86.4,892
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020-2021,Age,35 Months,95.0,91.1 to 97.6,1462
Hib,≥2 Doses,HHS Regions/National,Region 2,2020,Age,5 Months,74.2,69.8 to 78.1,892
Hep B,≥2 Doses,HHS Regions/National,Region 2,2020,Age,5 Months,86.7,83.1 to 89.6,892
DTaP,≥2 Doses,HHS Regions/National,Region 2,2020,Age,5 Months,76.0,71.7 to 79.8,892
Polio,≥2 Doses,HHS Regions/National,Region 2,2020,Age,5 Months,75.8,71.5 to 79.7,892
PCV,≥1 Dose,HHS Regions/National,Region 2,2020,Age,3 Months,81.1,77.2 to 84.5,892
Hep A,≥1 Dose,HHS Regions/National,Region 2,2020,Age,24 Months,83.1,79.6 to 86.3,892
Combined 7 Series,,HHS Regions/National,Region 2,2020,Age,24 Months,68.8,64.4 to 73.0,892
Hep A,≥2 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,30.9,26.9 to 35.3,892
PCV,≥4 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,81.6,77.7 to 85.3,892
Rotavirus,,HHS Regions/National,Region 2,2020,Age,8 Months,76.2,72.1 to 79.9,892
PCV,≥3 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,93.1,90.4 to 95.3,892
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,96.4,93.8 to 98.1,892
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2020,Age,0-3 Days,80.4,76.6 to 83.7,892
Influenza,,HHS Regions/National,Region 2,2020,Age,24 Months,63.7,59.3 to 68.1,892
Hib,Primary Series,HHS Regions/National,Region 2,2020,Age,19 Months,92.3,89.3 to 94.5,892
Hib,≥3 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,90.7,87.5 to 93.2,892
≥1 Dose MMR,,HHS Regions/National,Region 2,2020,Age,19 Months,86.2,82.7 to 89.1,892
Polio,≥3 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,91.1,87.9 to 93.5,892
DTaP,≥4 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,69.3,64.9 to 73.4,892
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,93.4,90.6 to 95.4,892
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,70.9,66.5 to 74.9,892
Polio,≥2 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,90.8,87.7 to 93.2,892
PCV,≥2 Doses,HHS Regions/National,Region 2,2020,Age,5 Months,73.6,69.3 to 77.5,892
PCV,≥3 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,87.9,84.5 to 90.7,892
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020,Age,13 Months,56.0,51.6 to 60.4,892
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,88.6,85.3 to 91.2,892
Hep B,≥2 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,93.5,90.9 to 95.5,892
Hib,Primary Series,HHS Regions/National,Region 2,2020,Age,13 Months,86.6,83.2 to 89.4,892
Hep A,≥1 Dose,HHS Regions/National,Region 2,2020,Age,19 Months,74.2,70.1 to 78.0,892
Hib,≥3 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,78.0,74.1 to 81.4,892
PCV,≥4 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,85.0,80.9 to 88.6,892
Polio,≥3 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,96.8,94.3 to 98.4,892
≥1 Dose MMR,,HHS Regions/National,Region 2,2020,Age,35 Months,96.2,93.7 to 97.9,892
PCV,≥4 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,74.6,70.3 to 78.5,892
DTaP,≥4 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,89.0,84.9 to 92.5,892
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020,Age,19 Months,85.4,81.8 to 88.5,892
PCV,≥3 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,90.5,87.3 to 93.0,892
Hib,Full Series,HHS Regions/National,Region 2,2020,Age,19 Months,71.1,66.7 to 75.1,892
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,91.6,88.7 to 93.8,892
≥1 Dose Varicella,,HHS Regions/National,Region 2,2020,Age,35 Months,96.2,93.2 to 98.1,892
PCV,≥3 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,95.6,92.2 to 97.8,892
Hib,Full Series,HHS Regions/National,Region 2,2020,Age,35 Months,84.9,80.8 to 88.5,892
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,95.7,93.2 to 97.5,892
Hib,≥3 Doses,HHS Regions/National,Region 2,2020,Age,35 Months,94.0,91.3 to 96.0,892
Hib,Primary Series,HHS Regions/National,Region 2,2020,Age,35 Months,95.2,92.7 to 97.1,892
Hib,Primary Series,HHS Regions/National,Region 2,2020,Age,24 Months,93.7,91.1 to 95.7,892
Hib,≥3 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,92.7,90.0 to 94.9,892
≥1 Dose MMR,,HHS Regions/National,Region 2,2020,Age,24 Months,92.5,89.9 to 94.6,892
DTaP,≥4 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,82.3,78.3 to 85.9,892
Polio,≥3 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,93.6,90.9 to 95.7,892
Hep B,≥2 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,90.9,87.8 to 93.2,892
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020,Age,24 Months,94.6,92.2 to 96.4,892
Hib,Primary Series,HHS Regions/National,Region 2,2020,Age,7 Months,69.8,65.4 to 73.8,892
Hib,≥3 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,59.8,55.3 to 64.1,892
Hib,≥2 Doses,HHS Regions/National,Region 2,2020,Age,7 Months,89.0,85.6 to 91.6,892
DTaP,≥1 Dose,HHS Regions/National,Region 2,2020,Age,3 Months,84.4,80.6 to 87.5,892
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2020,Age,0-2 Days,79.3,75.4 to 82.7,892
Hep A,≥2 Doses,HHS Regions/National,Region 2,2020,Age,19 Months,16.7,13.7 to 20.1,892
Combined 7 Series,,HHS Regions/National,Region 2,2020,Age,35 Months,75.1,70.4 to 79.5,892
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2020,Age,0-1 Days,77.4,73.5 to 80.9,892
Hep A,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,30.9,28.0 to 34.2,1808
Polio,≥2 Doses,HHS Regions/National,Region 2,2020,Age,13 Months,94.3,91.7 to 96.1,892
Hep A,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,24 Months,82.2,79.4 to 84.7,1808
Hep A,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,76.7,71.8 to 81.2,1808
Hep A,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,35 Months,89.1,86.0 to 91.8,1808
Hib,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,92.6,90.5 to 94.3,1808
Influenza,,HHS Regions/National,Region 2,2019-2020,Age,24 Months,66.1,62.9 to 69.3,1808
Hib,Primary Series,HHS Regions/National,Region 2,2019-2020,Age,24 Months,93.1,91.1 to 94.8,1808
Hib,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,58.6,55.3 to 61.9,1808
Hib,Full Series,HHS Regions/National,Region 2,2019-2020,Age,24 Months,79.1,76.1 to 82.0,1808
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2019-2020,Age,0-1 Days,75.9,73.0 to 78.6,1808
Combined 7 Series,,HHS Regions/National,Region 2,2019-2020,Age,35 Months,73.4,69.9 to 76.8,1808
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019-2020,Age,19 Months,86.9,84.3 to 89.1,1808
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,90.5,88.3 to 92.3,1808
PCV,≥4 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,73.7,70.5 to 76.6,1808
Hep A,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,19 Months,75.2,72.2 to 78.0,1808
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 2,2019-2020,Age,0-3 Days,80.2,77.4 to 82.7,1808
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2019-2020,Age,0-2 Days,78.5,75.7 to 81.1,1808
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019-2020,Age,24 Months,91.7,89.7 to 93.5,1808
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,91.6,89.6 to 93.4,1808
PCV,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,92.8,90.8 to 94.5,1808
PCV,≥4 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,79.3,76.3 to 82.2,1808
≥1 Dose MMR,,HHS Regions/National,Region 2,2019-2020,Age,19 Months,87.7,85.2 to 89.8,1808
Hep A,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,16.2,14.0 to 18.8,1808
Hib,Full Series,HHS Regions/National,Region 2,2019-2020,Age,19 Months,71.6,68.4 to 74.6,1808
Hib,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,90.8,88.5 to 92.7,1808
Hib,Primary Series,HHS Regions/National,Region 2,2019-2020,Age,19 Months,92.0,89.7 to 93.7,1808
Hib,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,93.7,91.6 to 95.5,1808
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,93.6,91.4 to 95.5,1808
Hib,Primary Series,HHS Regions/National,Region 2,2019-2020,Age,35 Months,94.4,92.3 to 96.0,1808
Hib,Full Series,HHS Regions/National,Region 2,2019-2020,Age,35 Months,84.6,81.5 to 87.4,1808
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019-2020,Age,35 Months,95.5,92.8 to 97.4,1808
PCV,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,94.7,92.4 to 96.5,1808
PCV,≥4 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,82.7,79.6 to 85.6,1808
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,93.7,91.7 to 95.3,1808
DTaP,≥4 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,81.6,78.6 to 84.3,1808
Polio,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,24 Months,92.0,89.7 to 93.9,1808
≥1 Dose MMR,,HHS Regions/National,Region 2,2019-2020,Age,24 Months,92.3,90.3 to 94.1,1808
Hep B,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,3 Months,95.5,94.0 to 96.7,1808
PCV,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,3 Months,83.5,80.8 to 85.8,1808
DTaP,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,5 Months,77.4,74.3 to 80.2,1808
Polio,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,5 Months,76.8,73.7 to 79.6,1808
Hib,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,5 Months,75.8,72.7 to 78.6,1808
Polio,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,93.9,91.9 to 95.4,1808
Hib,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,94.3,92.5 to 95.6,1808
≥1 Dose MMR,,HHS Regions/National,Region 2,2019-2020,Age,13 Months,62.8,59.5 to 66.0,1808
Hib,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,79.2,76.4 to 81.8,1808
Hep B,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,94.3,92.6 to 95.7,1808
Hep B,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,5 Months,87.8,85.4 to 89.9,1808
Hib,Primary Series,HHS Regions/National,Region 2,2019-2020,Age,13 Months,87.0,84.5 to 89.2,1808
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,69.1,65.9 to 72.2,1808
PCV,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,5 Months,74.5,71.4 to 77.4,1808
Polio,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,89.7,87.2 to 91.7,1808
≥1 Dose Varicella,,HHS Regions/National,Region 2,2019-2020,Age,13 Months,54.3,51.0 to 57.6,1808
Hep B,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,87.1,84.6 to 89.2,1808
Hib,≥2 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,89.3,87.0 to 91.3,1808
PCV,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,87.1,84.6 to 89.3,1808
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,92.3,90.0 to 94.1,1808
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,94.9,92.8 to 96.6,1808
Combined 7 Series,,HHS Regions/National,Region 2,2019-2020,Age,24 Months,67.2,63.9 to 70.5,1808
DTaP,≥4 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,87.3,84.3 to 89.9,1808
≥1 Dose MMR,,HHS Regions/National,Region 2,2019-2020,Age,35 Months,94.9,92.6 to 96.7,1808
Polio,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,35 Months,94.4,92.0 to 96.2,1808
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 2,2021,Age,0-2 Days,73.8,68.5 to 78.5,570
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 2,2021,Age,0-1 Days,69.9,64.4 to 74.9,570
≥1 Dose MMR,,HHS Regions/National,Region 2,2021,Age,24 Months,86.4,81.7 to 90.5,570
Polio,≥3 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,92.1,88.1 to 95.1,570
Hib,≥1 Dose,HHS Regions/National,Region 2,2021,Age,3 Months,85.3,80.5 to 89.0,570
Polio,≥1 Dose,HHS Regions/National,Region 2,2021,Age,3 Months,87.8,83.4 to 91.2,570
DTaP,≥4 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,82.0,76.5 to 86.8,570
DTaP,≥1 Dose,HHS Regions/National,Region 2,2021,Age,3 Months,88.3,83.9 to 91.7,570
Hep A,≥1 Dose,HHS Regions/National,Region 2,2021,Age,19 Months,73.5,68.0 to 78.4,570
Polio,≥2 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,93.2,88.9 to 95.9,570
PCV,≥4 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,83.7,77.9 to 88.7,570
Hep A,≥2 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,19.5,15.4 to 24.3,570
Combined 7 Series,,HHS Regions/National,Region 2,2021,Age,24 Months,66.3,60.6 to 71.9,570
DTaP,≥3 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,91.7,87.4 to 94.7,570
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,95.3,92.6 to 97.2,1462
PCV,≥3 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,91.1,86.8 to 94.5,570
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,92.4,90.1 to 94.3,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,78.3,75.1 to 81.2,1462
PCV,≥3 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,62.6,56.9 to 68.0,570
DTaP,≥3 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,87.9,83.1 to 91.5,570
Hep A,≥2 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,34.8,29.2 to 41.1,570
Hep A,≥1 Dose,HHS Regions/National,Region 2,2021,Age,24 Months,78.8,73.5 to 83.6,570
PCV,≥4 Doses,HHS Regions/National,Region 2,2021,Age,24 Months,78.5,73.3 to 83.3,570
≥1 Dose Varicella,,HHS Regions/National,Region 2,2021,Age,24 Months,86.7,81.9 to 90.8,570
PCV,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,94.8,91.3 to 97.2,1462
Hep B,≥3 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,47.6,42.0 to 53.3,570
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017,Age,35 Months,93.9,91.7 to 95.7,2626
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.6,92.9 to 96.1,5514
Hep B,≥3 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,88.5,86.0 to 90.7,2101
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,89.0,86.5 to 91.2,2888
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,89.9,88.3 to 91.4,5328
Hep B,≥3 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,90.1,87.6 to 92.1,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,90.8,88.6 to 92.7,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2011,Age,19 Months,88.3,83.9 to 91.6,1959
DTaP,≥4 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,88.9,86.0 to 91.4,2440
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2017,Age,0-2 Days,79.5,76.3 to 82.4,2626
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2017-2018,Age,0-2 Days,79.7,77.6 to 81.7,5514
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2018,Age,0-2 Days,80.0,77.2 to 82.5,2888
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2018-2019,Age,0-2 Days,81.6,79.7 to 83.3,5328
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2019,Age,0-2 Days,83.2,80.5 to 85.6,2440
Hep B,≥2 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,92.8,90.6 to 94.5,2888
Hep B,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,93.7,92.3 to 94.9,5328
Hep B,≥2 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,93.9,92.1 to 95.2,2037
Hep B,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,93.2,91.6 to 94.6,4108
Hep B,≥2 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,94.2,91.4 to 96.1,2071
Hep B,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,95.0,93.6 to 96.2,4326
Hep B,≥2 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,92.6,89.8 to 94.7,2071
Hep B,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,93.4,91.5 to 94.9,4142
Hib,≥1 Dose,HHS Regions/National,Region 3,2014,Age,3 Months,87.5,84.3 to 90.1,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2011,Age,35 Months,93.7,91.0 to 95.8,1959
PCV,≥4 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,84.4,80.9 to 87.6,1959
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2017,Age,0-1 Days,72.4,68.9 to 75.7,2626
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2017-2018,Age,0-1 Days,74.1,71.9 to 76.3,5514
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2016,Age,0-1 Days,70.3,66.7 to 73.7,2255
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2016-2017,Age,0-1 Days,71.3,68.8 to 73.7,4881
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014,Age,24 Months,91.7,89.1 to 93.8,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014-2015,Age,24 Months,91.2,89.3 to 92.9,4142
Hep B,≥2 Doses,HHS Regions/National,Region 3,2017,Age,5 Months,91.0,88.4 to 93.1,2626
Hep B,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,5 Months,91.0,89.2 to 92.5,5514
Hep B,≥2 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,90.2,88.0 to 92.1,1959
Hep B,≥2 Doses,HHS Regions/National,Region 3,2019,Age,5 Months,91.4,89.2 to 93.2,2440
Hep B,≥2 Doses,HHS Regions/National,Region 3,2018,Age,5 Months,91.0,88.7 to 92.9,2888
Hep B,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,5 Months,91.2,89.6 to 92.5,5328
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014,Age,35 Months,92.9,90.3 to 95.0,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014-2015,Age,35 Months,93.0,91.1 to 94.6,4142
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015,Age,35 Months,93.4,90.6 to 95.7,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015-2016,Age,35 Months,94.3,92.5 to 95.8,4326
≥1 Dose Varicella,,HHS Regions/National,Region 3,2012,Age,35 Months,92.3,89.3 to 94.7,2101
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013,Age,35 Months,91.8,88.8 to 94.2,2037
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013-2014,Age,35 Months,92.3,90.4 to 94.0,4108
PCV,≥4 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,83.9,81.3 to 86.3,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2018,Age,24 Months,91.8,89.6 to 93.7,2888
≥1 Dose MMR,,HHS Regions/National,Region 3,2018-2019,Age,24 Months,93.1,91.7 to 94.3,5328
Hep B,≥2 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,92.9,90.3 to 94.8,2626
Hep B,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,92.8,91.2 to 94.2,5514
PCV,≥3 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,89.3,86.2 to 91.8,2037
PCV,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,88.8,86.2 to 91.0,4108
Hep B,≥2 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,94.0,92.3 to 95.4,2255
Hep B,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,93.5,92.0 to 94.7,4881
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2016,Age,0-2 Days,77.1,73.7 to 80.2,2255
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2016-2017,Age,0-2 Days,78.3,76.0 to 80.5,4881
PCV,≥3 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,89.8,86.6 to 92.4,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,91.2,89.2 to 92.8,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,88.3,85.1 to 91.0,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,89.1,86.8 to 91.0,4142
Hep B,≥2 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,91.2,88.2 to 93.6,2071
Hep B,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,92.6,90.9 to 94.0,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,93.4,91.4 to 95.0,2888
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,93.5,92.1 to 94.7,5328
≥1 Dose MMR,,HHS Regions/National,Region 3,2013,Age,35 Months,93.2,90.8 to 95.1,2037
≥1 Dose MMR,,HHS Regions/National,Region 3,2013-2014,Age,35 Months,93.2,91.5 to 94.6,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016,Age,35 Months,95.1,92.8 to 96.8,2255
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016-2017,Age,35 Months,94.5,93.0 to 95.8,4881
≥1 Dose MMR,,HHS Regions/National,Region 3,2012,Age,35 Months,91.5,88.6 to 94.0,2101
≥1 Dose MMR,,HHS Regions/National,Region 3,2011,Age,35 Months,94.2,91.5 to 96.3,1959
≥1 Dose MMR,,HHS Regions/National,Region 3,2019,Age,24 Months,94.4,92.6 to 95.9,2440
PCV,≥4 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,83.5,80.1 to 86.5,2037
PCV,≥4 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,83.8,81.4 to 86.0,4108
PCV,≥4 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,84.1,80.7 to 87.2,2071
PCV,≥4 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,84.4,82.0 to 86.7,4142
PCV,≥4 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,81.4,77.8 to 84.7,2101
Hep B,≥3 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,92.5,89.7 to 94.8,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,92.4,90.0 to 94.5,2626
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,92.9,91.3 to 94.3,5514
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,93.6,91.6 to 95.3,2440
DTaP,≥4 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,90.1,86.9 to 92.7,2888
DTaP,≥4 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,89.5,87.4 to 91.4,5328
≥1 Dose MMR,,HHS Regions/National,Region 3,2012,Age,19 Months,86.7,84.2 to 88.8,2101
≥1 Dose MMR,,HHS Regions/National,Region 3,2014,Age,19 Months,90.4,87.7 to 92.6,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2014-2015,Age,19 Months,90.4,88.4 to 92.0,4142
≥1 Dose MMR,,HHS Regions/National,Region 3,2013,Age,19 Months,87.9,84.5 to 90.6,2037
≥1 Dose MMR,,HHS Regions/National,Region 3,2013-2014,Age,19 Months,89.1,86.7 to 91.1,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017,Age,19 Months,90.0,87.4 to 92.1,2626
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017-2018,Age,19 Months,89.6,87.8 to 91.2,5514
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018,Age,19 Months,89.2,86.7 to 91.3,2888
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018-2019,Age,19 Months,64.8,62.4 to 67.2,5328
Hep B,≥1 Dose,HHS Regions/National,Region 3,2017,Age,3 Months,97.5,96.2 to 98.4,2626
Hep B,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,3 Months,97.1,96.2 to 97.8,5514
Polio,≥2 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,95.9,94.1 to 97.2,2255
Polio,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,94.9,93.5 to 96.1,4881
Polio,≥2 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,94.5,91.7 to 96.4,2071
Polio,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,95.2,93.6 to 96.4,4326
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016,Age,19 Months,90.3,87.6 to 92.4,2255
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016-2017,Age,19 Months,90.1,88.4 to 91.7,4881
≥1 Dose MMR,,HHS Regions/National,Region 3,2019,Age,13 Months,70.6,67.3 to 73.7,2440
PCV,≥3 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,66.8,61.8 to 71.5,2101
PCV,≥3 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,65.2,61.0 to 69.2,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,66.1,63.1 to 69.0,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,91.9,89.6 to 93.7,2255
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,91.7,90.0 to 93.1,4881
PCV,≥3 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,69.4,64.7 to 73.8,1959
PCV,≥3 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,68.3,64.7 to 71.7,2037
PCV,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,66.8,63.8 to 69.6,4108
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2012,Age,0-1 Days,63.8,59.1 to 68.3,2101
Hep B,≥2 Doses,HHS Regions/National,Region 3,2014,Age,5 Months,84.9,81.4 to 87.9,2071
Hep B,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,5 Months,86.2,84.0 to 88.1,4142
Hep B,≥2 Doses,HHS Regions/National,Region 3,2016,Age,5 Months,90.3,87.9 to 92.2,2255
Hep B,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,5 Months,90.6,88.9 to 92.1,4881
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,91.4,88.8 to 93.5,2626
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,92.3,90.6 to 93.7,5514
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,93.2,91.1 to 94.8,2888
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,89.9,88.3 to 91.4,5328
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2015,Age,0-1 Days,64.8,60.5 to 68.8,2071
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2015-2016,Age,0-1 Days,67.5,64.8 to 70.2,4326
Hep B,≥2 Doses,HHS Regions/National,Region 3,2015,Age,5 Months,87.4,83.9 to 90.3,2071
Hep B,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,5 Months,88.8,86.7 to 90.6,4326
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2014,Age,0-1 Days,63.4,59.2 to 67.4,2071
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2014-2015,Age,0-1 Days,64.1,61.1 to 67.0,4142
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2013,Age,0-1 Days,65.7,61.5 to 69.6,2037
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2013-2014,Age,0-1 Days,64.5,61.7 to 67.3,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013,Age,24 Months,88.6,85.6 to 91.2,2037
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013-2014,Age,24 Months,90.1,88.2 to 91.9,4108
Polio,≥2 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,94.0,91.6 to 95.7,2626
Polio,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,94.3,92.7 to 95.6,5514
Polio,≥2 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,94.6,92.5 to 96.2,2888
Polio,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,95.1,93.8 to 96.2,5328
Polio,≥2 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,95.6,93.7 to 96.9,2440
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019,Age,19 Months,89.8,87.5 to 91.7,2440
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016,Age,24 Months,92.7,90.5 to 94.6,2255
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016-2017,Age,24 Months,92.6,91.1 to 94.0,4881
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015,Age,24 Months,90.7,87.8 to 93.2,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015-2016,Age,24 Months,91.7,89.9 to 93.3,4326
≥1 Dose MMR,,HHS Regions/National,Region 3,2012,Age,24 Months,89.4,86.4 to 92.0,2101
≥1 Dose MMR,,HHS Regions/National,Region 3,2011,Age,24 Months,91.8,88.9 to 94.1,1959
PCV,≥4 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,81.2,77.9 to 84.1,1959
PCV,≥4 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,76.9,72.3 to 81.0,2101
PCV,≥4 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,79.7,76.4 to 82.7,2037
PCV,≥4 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,80.1,77.9 to 82.2,4108
≥1 Dose MMR,,HHS Regions/National,Region 3,2018,Age,19 Months,90.1,87.7 to 92.1,2888
≥1 Dose MMR,,HHS Regions/National,Region 3,2018-2019,Age,19 Months,95.4,94.1 to 96.4,5328
≥1 Dose MMR,,HHS Regions/National,Region 3,2019,Age,19 Months,90.8,88.6 to 92.6,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2017,Age,19 Months,89.7,87.1 to 91.9,2626
≥1 Dose MMR,,HHS Regions/National,Region 3,2017-2018,Age,19 Months,89.9,88.1 to 91.5,5514
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017,Age,24 Months,92.5,90.3 to 94.4,2626
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017-2018,Age,24 Months,91.9,90.3 to 93.3,5514
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019,Age,24 Months,92.8,90.8 to 94.5,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2013,Age,24 Months,90.7,88.2 to 92.9,2037
≥1 Dose MMR,,HHS Regions/National,Region 3,2013-2014,Age,24 Months,91.4,89.7 to 92.9,4108
≥1 Dose MMR,,HHS Regions/National,Region 3,2014,Age,24 Months,92.0,89.6 to 94.1,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2014-2015,Age,24 Months,92.3,90.6 to 93.8,4142
≥1 Dose MMR,,HHS Regions/National,Region 3,2015,Age,24 Months,92.6,90.0 to 94.7,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2015-2016,Age,24 Months,92.5,90.8 to 93.9,4326
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018,Age,24 Months,91.2,88.9 to 93.2,2888
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018-2019,Age,24 Months,92.0,90.5 to 93.3,5328
PCV,≥4 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,84.6,81.6 to 87.2,2255
PCV,≥4 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,83.1,80.9 to 85.1,4881
PCV,≥4 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,80.4,77.5 to 83.1,2071
PCV,≥4 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,82.5,80.1 to 84.7,4326
PCV,≥4 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,80.5,76.8 to 83.6,2071
PCV,≥4 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,80.4,77.8 to 82.8,4142
PCV,≥3 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,67.1,62.8 to 71.1,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,71.5,68.7 to 74.1,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,70.9,67.0 to 74.4,2626
PCV,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,71.7,69.2 to 74.1,5514
Hep B,≥3 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,89.8,87.2 to 92.1,2101
PCV,≥3 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,75.9,72.4 to 79.0,2255
PCV,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,73.4,70.8 to 75.8,4881
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,92.0,89.6 to 94.0,2037
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,90.7,88.8 to 92.4,4108
Hep B,≥3 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,91.3,88.4 to 93.7,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,92.8,90.6 to 94.4,2440
Hep B,≥2 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,91.7,89.1 to 93.8,2037
Hep B,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,90.3,87.9 to 92.3,4108
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2012,Age,0-2 Days,71.7,67.2 to 75.9,2101
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2013,Age,0-2 Days,74.2,70.1 to 77.8,2037
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2013-2014,Age,0-2 Days,71.9,68.9 to 74.7,4108
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2018,Age,0-1 Days,75.9,73.0 to 78.6,2888
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2018-2019,Age,0-1 Days,77.6,75.6 to 79.5,5328
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2011,Age,0-2 Days,77.1,73.6 to 80.3,1959
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2019,Age,0-1 Days,79.3,76.4 to 81.9,2440
Hep B,≥2 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,89.4,86.0 to 92.1,2101
Hep B,≥2 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,88.9,85.7 to 91.4,2071
Hep B,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,90.1,87.9 to 91.9,4142
PCV,≥3 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,72.6,69.3 to 75.6,2888
PCV,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,73.5,71.2 to 75.6,5328
PCV,≥3 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,91.6,88.9 to 93.6,1959
PCV,≥3 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,74.4,71.2 to 77.4,2440
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,89.4,86.5 to 92.0,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,91.0,89.0 to 92.7,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,92.5,89.9 to 94.6,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,92.5,90.9 to 94.0,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,92.6,90.5 to 94.4,2255
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,92.5,90.9 to 93.9,4881
Hep A,≥1 Dose,HHS Regions/National,Region 3,2020,Age,35 Months,91.0,88.3 to 93.4,2390
PCV,≥3 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,87.1,84.1 to 89.6,2101
≥1 Dose MMR,,HHS Regions/National,Region 3,2016,Age,24 Months,92.4,90.1 to 94.3,2255
≥1 Dose MMR,,HHS Regions/National,Region 3,2016-2017,Age,24 Months,92.6,91.0 to 94.0,4881
≥1 Dose MMR,,HHS Regions/National,Region 3,2017,Age,24 Months,92.7,90.5 to 94.6,2626
≥1 Dose MMR,,HHS Regions/National,Region 3,2017-2018,Age,24 Months,92.3,90.7 to 93.7,5514
PCV,≥4 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,81.5,78.2 to 84.4,2626
PCV,≥4 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,80.7,78.5 to 82.8,5514
PCV,≥4 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,80.0,76.9 to 82.7,2888
PCV,≥4 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,82.0,79.7 to 84.0,4447
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2015,Age,0-2 Days,73.4,69.4 to 77.1,2071
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2015-2016,Age,0-2 Days,75.3,72.7 to 77.7,4326
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2014,Age,0-2 Days,69.6,65.5 to 73.5,2071
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2014-2015,Age,0-2 Days,71.5,68.7 to 74.2,4142
Hib,Full Series,HHS Regions/National,Region 3,2020,Age,24 Months,76.4,73.3 to 79.5,2390
Polio,≥2 Doses,HHS Regions/National,Region 3,2019,Age,5 Months,84.0,81.1 to 86.5,2440
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,50.3,46.4 to 54.1,2626
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,53.0,50.4 to 55.6,5514
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,55.8,52.4 to 59.2,2888
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,56.2,53.8 to 58.6,5328
Hep A,≥2 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,80.1,74.9 to 84.9,2071
Hep A,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,80.5,77.3 to 83.6,4326
Hep A,≥2 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,81.3,77.3 to 85.0,2255
Hep A,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,81.0,78.2 to 83.7,4881
Hep A,≥2 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,72.3,67.4 to 77.1,2071
Hep A,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,75.8,72.1 to 79.2,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,56.6,53.1 to 60.1,2440
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014,Age,13 Months,61.7,57.5 to 65.7,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014-2015,Age,13 Months,60.8,57.8 to 63.7,4142
≥1 Dose Varicella,,HHS Regions/National,Region 3,2012,Age,13 Months,56.2,50.7 to 61.6,2101
Hep A,≥1 Dose,HHS Regions/National,Region 3,2018,Age,35 Months,94.2,91.0 to 96.5,2888
Hep A,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,35 Months,94.1,92.3 to 95.6,5328
Hep A,≥1 Dose,HHS Regions/National,Region 3,2019,Age,35 Months,94.1,92.0 to 95.8,2440
Polio,≥2 Doses,HHS Regions/National,Region 3,2018,Age,5 Months,82.2,79.1 to 84.8,2888
Polio,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,5 Months,83.1,81.0 to 84.9,5328
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013,Age,13 Months,56.9,52.6 to 61.0,2037
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013-2014,Age,13 Months,59.3,56.0 to 62.5,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2011,Age,13 Months,58.1,50.8 to 65.0,1959
Hep A,≥2 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,75.8,70.8 to 80.4,2037
Hep A,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,74.1,70.6 to 77.4,4108
Hep A,≥2 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,77.7,72.2 to 82.8,2101
Hep A,≥2 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,73.2,68.3 to 78.0,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,51.6,47.7 to 55.6,2255
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,50.9,48.2 to 53.7,4881
Polio,≥2 Doses,HHS Regions/National,Region 3,2015,Age,5 Months,80.7,76.9 to 84.0,2071
Polio,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,5 Months,82.4,80.0 to 84.6,4326
Hep A,≥2 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,50.2,46.6 to 53.9,2440
Hep A,≥2 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,47.5,44.1 to 51.1,2888
Hep A,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,48.8,46.4 to 51.4,5328
Polio,≥2 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,92.3,90.5 to 93.8,1959
Polio,≥2 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,90.2,88.3 to 91.9,2101
Hep A,≥1 Dose,HHS Regions/National,Region 3,2016,Age,35 Months,91.7,88.8 to 94.1,2255
Hep A,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,35 Months,91.3,89.3 to 93.1,4881
DTaP,≥4 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,81.6,77.8 to 85.1,2071
DTaP,≥4 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,83.9,81.5 to 86.2,4326
DTaP,≥4 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,86.3,83.3 to 89.0,2255
DTaP,≥4 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,84.9,82.8 to 86.9,4881
DTaP,≥4 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,83.2,79.8 to 86.3,2071
DTaP,≥4 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,82.4,79.8 to 84.8,4142
Hep A,≥1 Dose,HHS Regions/National,Region 3,2014,Age,35 Months,90.9,87.6 to 93.6,2071
Hep A,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,35 Months,91.0,88.7 to 93.0,4142
Hep A,≥1 Dose,HHS Regions/National,Region 3,2013,Age,35 Months,89.6,86.1 to 92.5,2037
Hep A,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,35 Months,90.3,87.9 to 92.4,4108
Hep A,≥2 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,39.0,35.1 to 43.3,2101
Hib,≥3 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,94.9,93.1 to 96.3,2440
PCV,≥2 Doses,HHS Regions/National,Region 3,2018,Age,5 Months,81.4,78.3 to 84.1,2888
PCV,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,5 Months,82.2,80.1 to 84.1,5328
PCV,≥2 Doses,HHS Regions/National,Region 3,2017,Age,5 Months,81.2,77.9 to 84.2,2626
PCV,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,5 Months,81.3,79.1 to 83.3,5514
PCV,≥2 Doses,HHS Regions/National,Region 3,2019,Age,5 Months,83.1,80.1 to 85.6,2440
DTaP,≥4 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,76.2,72.7 to 79.4,2626
DTaP,≥4 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,75.0,72.6 to 77.3,5514
DTaP,≥4 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,78.1,74.6 to 81.2,2255
DTaP,≥4 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,77.1,74.7 to 79.4,4881
Hep A,≥2 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,42.0,37.9 to 46.3,2037
Hep A,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,41.7,38.8 to 44.8,4108
DTaP,≥4 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,73.8,70.5 to 76.9,2888
DTaP,≥4 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,95.1,93.8 to 96.2,5328
Polio,≥2 Doses,HHS Regions/National,Region 3,2014,Age,5 Months,80.8,77.2 to 83.9,2071
Polio,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,5 Months,80.7,77.9 to 83.3,4142
Polio,≥2 Doses,HHS Regions/National,Region 3,2013,Age,5 Months,78.5,74.8 to 81.8,2037
Polio,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,5 Months,79.6,77.3 to 81.8,4108
Hep A,≥1 Dose,HHS Regions/National,Region 3,2012,Age,35 Months,87.1,83.5 to 90.2,2101
Polio,≥2 Doses,HHS Regions/National,Region 3,2011,Age,5 Months,81.4,77.0 to 85.2,1959
Polio,≥2 Doses,HHS Regions/National,Region 3,2012,Age,5 Months,77.2,73.4 to 80.5,2101
Hep A,≥1 Dose,HHS Regions/National,Region 3,2015,Age,35 Months,91.3,88.1 to 93.9,2071
Hep A,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,35 Months,91.4,89.2 to 93.2,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,45.6,41.1 to 50.1,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,51.4,47.4 to 55.5,2101
DTaP,≥4 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,80.6,76.8 to 84.0,2101
DTaP,≥4 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,83.2,79.6 to 86.6,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,57.5,52.8 to 62.1,2037
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,55.2,52.1 to 58.4,4108
DTaP,≥4 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,75.1,71.8 to 78.0,2440
DTaP,≥4 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,82.4,79.0 to 85.4,2037
DTaP,≥4 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,82.8,80.4 to 85.0,4108
Hep A,≥2 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,45.2,41.3 to 49.3,2255
Hep A,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,45.3,42.6 to 48.1,4881
Hep A,≥2 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,45.4,41.7 to 49.3,2626
Hep A,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,46.5,43.9 to 49.1,5514
≥1 Dose MMR,,HHS Regions/National,Region 3,2015,Age,13 Months,62.7,58.4 to 66.7,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2015-2016,Age,13 Months,63.3,60.4 to 66.1,4326
≥1 Dose MMR,,HHS Regions/National,Region 3,2014,Age,13 Months,63.1,58.9 to 67.1,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2014-2015,Age,13 Months,62.9,59.9 to 65.8,4142
≥1 Dose Varicella,,HHS Regions/National,Region 3,2012,Age,19 Months,86.3,83.4 to 88.7,2101
≥1 Dose Varicella,,HHS Regions/National,Region 3,2011,Age,19 Months,89.9,86.9 to 92.3,1959
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019,Age,13 Months,65.8,62.4 to 69.1,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2013,Age,13 Months,53.4,47.8 to 58.9,2037
≥1 Dose MMR,,HHS Regions/National,Region 3,2013-2014,Age,13 Months,58.2,54.0 to 62.3,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018,Age,13 Months,63.8,60.4 to 67.1,2888
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018-2019,Age,13 Months,64.8,62.4 to 67.2,5328
DTaP,≥4 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,88.7,85.1 to 91.8,2071
DTaP,≥4 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,88.6,86.0 to 90.9,4142
DTaP,≥4 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,88.3,84.9 to 91.3,2101
DTaP,≥4 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,89.0,85.9 to 91.8,2037
DTaP,≥4 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,89.0,86.6 to 91.1,4108
Hep B,≥3 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,85.4,82.1 to 88.2,2101
Hep A,≥2 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,85.0,80.9 to 88.6,2440
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,84.0,80.5 to 87.1,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,86.4,84.1 to 88.5,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,89.9,87.2 to 92.0,2037
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,87.0,83.8 to 89.6,4108
Hep A,≥2 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,80.8,76.8 to 84.5,2626
Hep A,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,79.9,77.1 to 82.6,5514
Hep A,≥2 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,78.9,74.8 to 82.7,2888
Hep A,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,81.7,78.8 to 84.4,5328
Hep B,≥3 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,86.6,83.8 to 89.0,1959
Polio,≥2 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,90.0,86.6 to 92.6,2071
Polio,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,91.8,89.9 to 93.4,4326
Polio,≥2 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,91.7,89.4 to 93.5,2037
Polio,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,91.1,89.6 to 92.5,4108
Polio,≥2 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,90.6,87.7 to 92.8,2071
Polio,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,90.3,88.1 to 92.1,4142
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015,Age,13 Months,59.8,55.5 to 63.9,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015-2016,Age,13 Months,61.5,58.6 to 64.4,4326
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017,Age,13 Months,64.8,60.9 to 68.4,2626
≥1 Dose Varicella,,HHS Regions/National,Region 3,2017-2018,Age,13 Months,64.3,61.7 to 66.8,5514
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016,Age,13 Months,63.3,59.3 to 67.1,2255
≥1 Dose Varicella,,HHS Regions/National,Region 3,2016-2017,Age,13 Months,64.0,61.2 to 66.7,4881
≥1 Dose MMR,,HHS Regions/National,Region 3,2011,Age,13 Months,50.0,43.0 to 57.0,1959
≥1 Dose MMR,,HHS Regions/National,Region 3,2012,Age,13 Months,51.2,46.2 to 56.1,2101
Hep A,≥2 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,41.5,37.4 to 45.9,2071
Hep A,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,40.8,37.8 to 43.9,4142
Hep A,≥2 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,40.0,35.8 to 44.4,2071
Hep A,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,42.6,39.7 to 45.6,4326
DTaP,≥4 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,83.5,80.4 to 86.4,2626
DTaP,≥4 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,83.1,81.0 to 85.2,5514
DTaP,≥4 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,82.7,79.8 to 85.5,2888
DTaP,≥4 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,83.0,80.9 to 85.0,5328
≥1 Dose MMR,,HHS Regions/National,Region 3,2018,Age,13 Months,68.9,65.5 to 72.1,2888
≥1 Dose MMR,,HHS Regions/National,Region 3,2018-2019,Age,13 Months,69.7,67.4 to 72.0,5328
Hep B,≥1 Dose,HHS Regions/National,Region 3,2016,Age,3 Months,96.2,94.6 to 97.3,2255
Hep B,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,3 Months,96.8,95.8 to 97.6,4881
Hep B,≥1 Dose,HHS Regions/National,Region 3,2015,Age,3 Months,94.7,92.4 to 96.3,2071
Hep B,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,3 Months,95.4,94.1 to 96.5,4326
Hep B,≥1 Dose,HHS Regions/National,Region 3,2014,Age,3 Months,92.5,89.6 to 94.7,2071
Hep B,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,3 Months,93.6,91.8 to 95.0,4142
Polio,≥2 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,94.6,93.2 to 95.7,2037
Polio,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,94.1,92.7 to 95.3,4108
Polio,≥2 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,92.4,90.2 to 94.1,2440
Polio,≥2 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,90.5,87.6 to 92.8,2626
Polio,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,90.7,88.8 to 92.3,5514
Polio,≥2 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,93.6,91.5 to 95.3,2255
Polio,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,92.1,90.3 to 93.5,4881
Hep B,≥1 Dose,HHS Regions/National,Region 3,2011,Age,3 Months,94.9,93.2 to 96.2,1959
Hep B,≥1 Dose,HHS Regions/National,Region 3,2012,Age,3 Months,92.9,90.7 to 94.7,2101
Hep B,≥1 Dose,HHS Regions/National,Region 3,2013,Age,3 Months,93.4,91.3 to 95.1,2037
Hep B,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,3 Months,93.0,90.6 to 94.8,4108
Polio,≥2 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,90.9,88.4 to 93.0,2888
Polio,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,91.7,90.0 to 93.0,5328
DTaP,≥4 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,90.4,87.0 to 93.2,1959
DTaP,≥4 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,83.3,80.4 to 86.1,2440
Polio,≥2 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,96.5,94.7 to 97.8,1959
Polio,≥2 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,94.0,92.2 to 95.5,2101
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013,Age,19 Months,87.1,84.4 to 89.4,2037
≥1 Dose Varicella,,HHS Regions/National,Region 3,2013-2014,Age,19 Months,88.4,86.3 to 90.2,4108
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015,Age,19 Months,88.7,85.2 to 91.4,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2015-2016,Age,19 Months,89.5,87.5 to 91.2,4326
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014,Age,19 Months,89.7,86.8 to 92.0,2071
≥1 Dose Varicella,,HHS Regions/National,Region 3,2014-2015,Age,19 Months,89.2,87.1 to 91.0,4142
≥1 Dose MMR,,HHS Regions/National,Region 3,2017,Age,13 Months,63.0,59.1 to 66.7,2626
≥1 Dose MMR,,HHS Regions/National,Region 3,2017-2018,Age,13 Months,65.9,63.3 to 68.4,5514
≥1 Dose MMR,,HHS Regions/National,Region 3,2016,Age,13 Months,64.0,60.0 to 67.8,2255
≥1 Dose MMR,,HHS Regions/National,Region 3,2016-2017,Age,13 Months,63.5,60.7 to 66.2,4881
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,87.8,84.8 to 90.3,2626
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,88.4,86.5 to 90.1,5514
DTaP,≥4 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,88.3,84.6 to 91.5,2071
DTaP,≥4 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,89.8,87.5 to 91.9,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,88.8,85.6 to 91.3,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,89.3,87.4 to 91.0,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,89.9,87.3 to 91.9,2255
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,88.8,86.9 to 90.5,4881
DTaP,≥4 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,91.3,88.4 to 93.7,2255
DTaP,≥4 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,90.1,88.1 to 91.9,4881
DTaP,≥4 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,88.9,85.9 to 91.4,2626
DTaP,≥4 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,89.4,87.2 to 91.3,5514
≥1 Dose Varicella,,HHS Regions/National,Region 3,2012,Age,24 Months,89.0,86.0 to 91.6,2101
≥1 Dose Varicella,,HHS Regions/National,Region 3,2011,Age,24 Months,91.7,89.0 to 94.0,1959
≥1 Dose MMR,,HHS Regions/National,Region 3,2016,Age,19 Months,90.1,87.5 to 92.3,2255
≥1 Dose MMR,,HHS Regions/National,Region 3,2016-2017,Age,19 Months,89.9,88.1 to 91.5,4881
≥1 Dose MMR,,HHS Regions/National,Region 3,2015,Age,19 Months,90.3,87.6 to 92.5,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2015-2016,Age,19 Months,90.2,88.3 to 91.9,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,91.7,89.5 to 93.4,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,91.8,90.0 to 93.2,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,88.1,84.8 to 90.7,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,89.9,87.8 to 91.7,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,91.8,90.0 to 93.3,2037
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,90.0,87.7 to 91.8,4108
Hep B,≥2 Doses,HHS Regions/National,Region 3,2013,Age,5 Months,88.1,85.1 to 90.6,2037
Hep B,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,5 Months,86.5,84.0 to 88.7,4108
Hep B,≥2 Doses,HHS Regions/National,Region 3,2011,Age,5 Months,86.3,83.7 to 88.6,1959
Hep B,≥2 Doses,HHS Regions/National,Region 3,2012,Age,5 Months,84.2,79.2 to 88.2,2101
Hep A,≥2 Doses,HHS Regions/National,Region 3,2020,Age,35 Months,79.4,75.4 to 83.1,2390
Hep B,"≥1 Dose, 1 Day",HHS Regions/National,Region 3,2011,Age,0-1 Days,65.6,61.3 to 69.7,1959
Hep B,≥1 Dose,HHS Regions/National,Region 3,2018,Age,3 Months,96.7,95.3 to 97.7,2888
Hep B,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,3 Months,97.0,96.0 to 97.7,5328
Polio,≥2 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,93.6,91.0 to 95.5,2071
Polio,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,94.1,92.3 to 95.5,4142
Hep B,≥1 Dose,HHS Regions/National,Region 3,2019,Age,3 Months,97.3,95.9 to 98.2,2440
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,51.1,46.7 to 55.4,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,51.3,48.4 to 54.3,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,52.9,48.7 to 57.1,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,52.0,48.9 to 55.0,4142
Polio,≥2 Doses,HHS Regions/National,Region 3,2017,Age,5 Months,82.5,79.1 to 85.4,2626
Polio,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,5 Months,82.3,80.1 to 84.4,5514
Polio,≥2 Doses,HHS Regions/National,Region 3,2016,Age,5 Months,84.2,81.1 to 86.8,2255
Polio,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,5 Months,83.3,81.1 to 85.3,4881
Hep A,≥1 Dose,HHS Regions/National,Region 3,2017,Age,35 Months,90.9,88.0 to 93.4,2626
Hep A,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,35 Months,92.3,90.3 to 94.1,5514
Hib,Primary Series,HHS Regions/National,Region 3,2011,Age,7 Months,74.7,70.8 to 78.3,1959
Hib,Primary Series,HHS Regions/National,Region 3,2012,Age,7 Months,72.4,69.2 to 75.5,2101
Hib,Full Series,HHS Regions/National,Region 3,2019,Age,35 Months,87.4,83.8 to 90.5,2440
Hib,Full Series,HHS Regions/National,Region 2,2019,Age,19 Months,72.1,67.4 to 76.4,916
Polio,≥3 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,95.9,93.4 to 97.7,2440
Hib,Full Series,HHS Regions/National,Region 3,2018,Age,35 Months,86.7,83.6 to 89.5,2888
Hib,Full Series,HHS Regions/National,Region 3,2018-2019,Age,35 Months,87.0,84.7 to 89.1,5328
Polio,≥3 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,94.4,92.3 to 96.1,2888
Polio,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,95.1,93.4 to 96.5,5328
Hib,Full Series,HHS Regions/National,Region 3,2016,Age,35 Months,87.2,84.2 to 90.0,2255
Hib,Full Series,HHS Regions/National,Region 3,2016-2017,Age,35 Months,86.6,84.5 to 88.6,4881
Hib,Full Series,HHS Regions/National,Region 3,2014,Age,35 Months,84.3,80.6 to 87.6,2071
Hib,Full Series,HHS Regions/National,Region 3,2014-2015,Age,35 Months,84.6,82.0 to 87.1,4142
Hib,Full Series,HHS Regions/National,Region 3,2017,Age,35 Months,86.0,82.8 to 88.8,2626
Hib,Full Series,HHS Regions/National,Region 3,2017-2018,Age,35 Months,86.3,84.1 to 88.3,5514
Hib,Full Series,HHS Regions/National,Region 3,2015,Age,35 Months,85.1,81.2 to 88.6,2071
Hib,Full Series,HHS Regions/National,Region 3,2015-2016,Age,35 Months,86.1,83.7 to 88.3,4326
Hib,≥3 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,91.4,88.6 to 93.8,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,92.3,90.4 to 94.0,4142
Polio,≥3 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,93.4,90.9 to 95.4,2101
Hib,Full Series,HHS Regions/National,Region 3,2019,Age,24 Months,81.1,78.2 to 83.8,2440
Polio,≥3 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,95.5,93.3 to 97.1,2037
Polio,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,93.9,92.2 to 95.4,4108
Polio,≥3 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,92.7,90.0 to 95.0,2071
Polio,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,93.6,91.7 to 95.2,4142
Hib,Full Series,HHS Regions/National,Region 3,2013,Age,35 Months,85.0,81.6 to 88.0,2037
Hib,Full Series,HHS Regions/National,Region 3,2013-2014,Age,35 Months,84.7,82.2 to 87.0,4108
Hib,Full Series,HHS Regions/National,Region 3,2012,Age,35 Months,83.8,80.1 to 87.1,2101
Hib,Full Series,HHS Regions/National,Region 3,2011,Age,35 Months,89.4,86.2 to 92.1,1959
Hib,Full Series,HHS Regions/National,Region 3,2018,Age,24 Months,82.5,79.6 to 85.2,2888
Hib,Full Series,HHS Regions/National,Region 3,2018-2019,Age,24 Months,81.8,79.8 to 83.8,5328
DTaP,≥2 Doses,HHS Regions/National,Region 3,2011,Age,5 Months,82.7,78.6 to 86.1,1959
DTaP,≥2 Doses,HHS Regions/National,Region 3,2012,Age,5 Months,77.9,74.3 to 81.2,2101
DTaP,≥2 Doses,HHS Regions/National,Region 3,2013,Age,5 Months,80.6,77.4 to 83.4,2037
DTaP,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,5 Months,80.9,78.6 to 83.0,4108
Polio,≥3 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,94.7,92.0 to 96.6,2071
Polio,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,95.1,93.6 to 96.4,4326
DTaP,≥2 Doses,HHS Regions/National,Region 3,2015,Age,5 Months,80.8,76.9 to 84.1,2071
DTaP,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,5 Months,82.7,80.3 to 84.9,4326
Polio,≥3 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,95.7,93.9 to 97.1,2255
Polio,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,94.7,93.2 to 95.9,4881
Polio,≥3 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,93.6,91.2 to 95.6,2626
Polio,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.0,92.4 to 95.4,5514
Hib,≥3 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,95.0,92.8 to 96.8,1959
Hib,≥3 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,91.7,88.9 to 94.0,2101
Hib,≥3 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,94.0,92.0 to 95.6,2037
Hib,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,92.7,91.0 to 94.2,4108
DTaP,≥2 Doses,HHS Regions/National,Region 3,2014,Age,5 Months,81.2,77.6 to 84.3,2071
DTaP,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,5 Months,81.0,78.3 to 83.4,4142
Hib,Full Series,HHS Regions/National,Region 3,2016,Age,24 Months,83.9,80.8 to 86.7,2255
Hib,Full Series,HHS Regions/National,Region 3,2016-2017,Age,24 Months,83.2,81.0 to 85.3,4881
Hib,Full Series,HHS Regions/National,Region 3,2017,Age,24 Months,82.6,79.4 to 85.5,2626
Hib,Full Series,HHS Regions/National,Region 3,2017-2018,Age,24 Months,82.5,80.4 to 84.6,5514
Polio,≥3 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,96.2,94.1 to 97.7,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,93.5,91.1 to 95.5,2101
Polio,≥3 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,92.0,89.3 to 94.3,2626
Polio,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,92.9,91.2 to 94.4,5514
Polio,≥3 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,93.8,91.7 to 95.5,2888
Polio,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,93.9,92.5 to 95.1,5328
Polio,≥3 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,93.9,91.9 to 95.6,2440
Hib,≥3 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,93.3,91.4 to 94.8,2440
DTaP,≥3 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,95.9,93.8 to 97.5,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,94.4,92.4 to 95.9,2440
Hib,≥3 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,91.5,89.2 to 93.4,2888
Hib,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,79.6,77.5 to 81.7,5328
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,94.4,92.3 to 95.9,2888
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,92.0,90.4 to 93.3,5328
Hib,Full Series,HHS Regions/National,Region 3,2015,Age,24 Months,80.5,76.6 to 84.1,2071
Hib,Full Series,HHS Regions/National,Region 3,2015-2016,Age,24 Months,82.2,79.7 to 84.5,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,95.0,93.1 to 96.5,2037
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,94.0,92.4 to 95.4,4108
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,95.2,93.3 to 96.6,2255
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,94.1,92.6 to 95.3,4881
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,93.0,90.5 to 94.9,2626
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,93.7,92.1 to 95.0,5514
Polio,≥3 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,92.5,90.1 to 94.5,2037
Polio,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,92.0,90.2 to 93.5,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,92.2,90.3 to 93.7,2037
Hib,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,90.8,88.0 to 93.0,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,89.4,86.2 to 91.9,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,90.3,88.1 to 92.1,4142
Polio,≥3 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,92.9,90.5 to 94.9,2101
Polio,≥3 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,94.9,92.5 to 96.7,1959
Polio,≥3 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,93.0,90.9 to 94.7,2440
Polio,≥3 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,93.5,91.3 to 95.2,2888
Polio,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,69.7,67.4 to 72.0,5328
Polio,≥3 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,91.4,88.6 to 93.7,2071
Polio,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,92.4,90.5 to 94.1,4142
Polio,≥3 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,93.5,90.8 to 95.7,2071
Polio,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,94.5,92.9 to 95.8,4326
Hib,≥3 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,91.1,88.9 to 93.0,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,92.3,90.4 to 93.8,4326
Hib,≥3 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,93.4,91.3 to 95.0,2255
Hib,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,92.5,90.9 to 93.9,4881
Polio,≥3 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,95.4,93.6 to 96.8,2255
Polio,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,93.7,92.1 to 95.1,4881
Hib,≥3 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,91.6,89.1 to 93.6,2626
Hib,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,91.6,89.9 to 93.0,5514
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,93.7,91.7 to 95.2,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,94.4,92.7 to 95.7,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,92.3,89.4 to 94.4,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,93.0,91.0 to 94.5,4142
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,94.3,92.9 to 95.5,2037
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,93.3,91.2 to 94.9,4108
Hib,≥3 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,95.3,93.1 to 97.0,780
Hib,≥3 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,94.6,91.6 to 96.7,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2017,Age,24 Months,82.2,78.6 to 85.5,911
Hep A,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,24 Months,82.9,80.5 to 85.2,1913
Hep A,≥1 Dose,HHS Regions/National,Region 2,2019,Age,24 Months,81.3,77.1 to 85.1,916
Hep A,≥1 Dose,HHS Regions/National,Region 2,2011,Age,35 Months,85.9,81.3 to 89.8,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2018,Age,24 Months,83.7,80.4 to 86.8,1002
Hep A,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,24 Months,82.5,79.8 to 85.0,1918
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019,Age,35 Months,93.9,90.4 to 96.4,916
Hep A,≥1 Dose,HHS Regions/National,Region 2,2012,Age,24 Months,76.0,72.0 to 79.9,780
Hep A,≥1 Dose,HHS Regions/National,Region 2,2019,Age,19 Months,76.3,71.8 to 80.2,916
Hep A,≥1 Dose,HHS Regions/National,Region 2,2011,Age,24 Months,75.3,71.1 to 79.3,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2013,Age,24 Months,79.6,75.7 to 83.2,797
Hep A,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,24 Months,79.1,76.5 to 81.6,1723
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,94.9,92.3 to 96.8,911
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,95.6,93.9 to 97.0,1913
DTaP,≥4 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,68.0,62.8 to 72.8,730
DTaP,≥4 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,65.1,61.6 to 68.5,780
PCV,≥2 Doses,HHS Regions/National,Region 2,2013,Age,5 Months,69.0,63.9 to 73.8,797
PCV,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,5 Months,70.5,66.8 to 74.0,1723
PCV,≥2 Doses,HHS Regions/National,Region 2,2012,Age,5 Months,68.6,65.2 to 71.8,780
PCV,≥2 Doses,HHS Regions/National,Region 2,2011,Age,5 Months,71.0,66.2 to 75.4,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,94.2,91.7 to 96.1,818
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,94.2,92.1 to 95.8,1622
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,93.7,90.5 to 96.2,804
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,94.4,92.4 to 96.0,1715
Hib,≥3 Doses,HHS Regions/National,Region 2,2015,Age,35 Months,92.5,89.7 to 94.8,818
Hib,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,35 Months,91.8,89.6 to 93.7,1622
Hep A,≥2 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,18.7,16.2 to 21.4,818
Hep A,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,17.4,15.0 to 20.1,1622
Hep A,≥2 Doses,HHS Regions/National,Region 2,2016,Age,19 Months,16.1,12.8 to 20.1,804
Hep A,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,19 Months,17.5,15.1 to 20.2,1715
Hib,≥3 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,95.5,93.1 to 97.2,797
Hib,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,94.7,93.0 to 96.1,1723
Hib,≥3 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,94.0,91.4 to 96.0,926
Hib,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,93.3,91.4 to 95.0,1744
Hib,≥3 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,92.5,89.4 to 94.9,916
Hib,≥3 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,92.2,89.3 to 94.6,911
Hib,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,92.2,90.4 to 93.8,1913
Hib,≥3 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,92.3,89.8 to 94.3,1002
Hib,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,92.3,90.4 to 94.0,1918
Hep A,≥2 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,18.0,15.1 to 21.4,797
Hep A,≥2 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,16.8,14.8 to 19.0,1723
Hep A,≥2 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,15.6,12.9 to 18.7,926
Hep A,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,17.1,14.9 to 19.5,1744
Hep A,≥2 Doses,HHS Regions/National,Region 2,2012,Age,19 Months,15.8,13.0 to 19.1,780
DTaP,≥2 Doses,HHS Regions/National,Region 2,2019,Age,5 Months,79.1,74.7 to 82.9,916
≥1 Dose MMR,,HHS Regions/National,Region 2,2020,Age,13 Months,63.3,58.8 to 67.5,892
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,96.6,94.2 to 98.1,1002
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,95.2,93.1 to 96.8,1918
PCV,≥2 Doses,HHS Regions/National,Region 2,2015,Age,5 Months,73.2,69.0 to 76.9,818
PCV,≥2 Doses,HHS Regions/National,Region 2,2015-2016,Age,5 Months,71.5,68.3 to 74.5,1622
PCV,≥2 Doses,HHS Regions/National,Region 2,2016,Age,5 Months,69.8,64.9 to 74.3,804
PCV,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,5 Months,73.1,69.9 to 76.1,1715
Hep A,≥1 Dose,HHS Regions/National,Region 2,2014,Age,24 Months,78.6,75.1 to 81.9,926
Hep A,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,24 Months,78.2,75.6 to 80.6,1744
Hep A,≥1 Dose,HHS Regions/National,Region 2,2015,Age,24 Months,77.8,74.0 to 81.4,818
Hep A,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,24 Months,76.8,73.9 to 79.6,1622
Hep A,≥1 Dose,HHS Regions/National,Region 2,2016,Age,24 Months,75.9,71.5 to 80.1,804
Hep A,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,24 Months,79.0,76.1 to 81.7,1715
PCV,≥2 Doses,HHS Regions/National,Region 2,2014,Age,5 Months,72.0,68.2 to 75.5,926
PCV,≥2 Doses,HHS Regions/National,Region 2,2014-2015,Age,5 Months,72.6,68.7 to 76.2,1744
Hep A,≥2 Doses,HHS Regions/National,Region 2,2011,Age,19 Months,14.6,11.9 to 17.7,730
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014,Age,35 Months,96.6,94.2 to 98.1,926
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,35 Months,95.5,93.7 to 96.9,1744
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013,Age,35 Months,97.5,95.6 to 98.8,797
DTaP,≥3 Doses,HHS Regions/National,Region 2,2013-2014,Age,35 Months,97.2,95.6 to 98.3,1723
DTaP,≥3 Doses,HHS Regions/National,Region 2,2012,Age,35 Months,96.9,95.1 to 98.2,780
DTaP,≥3 Doses,HHS Regions/National,Region 2,2011,Age,35 Months,97.0,94.7 to 98.5,730
Hep A,≥1 Dose,HHS Regions/National,Region 2,2018,Age,19 Months,76.4,72.6 to 79.9,1002
Hep A,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,19 Months,76.4,73.0 to 79.4,1583
Hep A,≥1 Dose,HHS Regions/National,Region 2,2017,Age,19 Months,76.7,72.7 to 80.2,911
Hep A,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,19 Months,76.6,73.8 to 79.1,1913
Hep A,≥1 Dose,HHS Regions/National,Region 2,2016,Age,19 Months,70.0,65.3 to 74.3,804
Hep A,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,19 Months,73.3,70.2 to 76.1,1715
DTaP,≥4 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,70.5,67.3 to 73.5,1808
Polio,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,19 Months,90.1,87.6 to 92.1,1808
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,13 Months,90.0,87.6 to 91.9,1808
PCV,≥3 Doses,HHS Regions/National,Region 2,2019-2020,Age,7 Months,63.2,59.9 to 66.4,1808
Hib,Primary Series,HHS Regions/National,Region 2,2019-2020,Age,7 Months,68.0,64.7 to 71.1,1808
Polio,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,3 Months,85.4,82.7 to 87.6,1808
DTaP,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,3 Months,87.2,84.7 to 89.4,1808
Hib,≥1 Dose,HHS Regions/National,Region 2,2019-2020,Age,3 Months,84.4,81.7 to 86.7,1808
PCV,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,5 Months,74.2,70.7 to 77.3,1462
Hib,Primary Series,HHS Regions/National,Region 2,2021,Age,19 Months,91.4,87.1 to 94.4,570
PCV,≥3 Doses,HHS Regions/National,Region 2,2021,Age,13 Months,85.0,80.1 to 88.9,570
Hib,Primary Series,HHS Regions/National,Region 2,2020-2021,Age,24 Months,92.8,90.5 to 94.7,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,89.8,85.3 to 93.1,570
PCV,≥3 Doses,HHS Regions/National,Region 2,2021,Age,35 Months,92.5,88.1 to 95.8,570
Hib,≥2 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,87.0,82.0 to 90.8,570
≥1 Dose MMR,,HHS Regions/National,Region 2,2021,Age,35 Months,91.1,85.8 to 95.0,570
Hib,≥2 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,93.4,91.0 to 95.2,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,62.4,56.7 to 67.7,570
PCV,≥4 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,80.1,76.9 to 83.2,1462
Polio,≥2 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,89.1,84.3 to 92.5,570
Hep B,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,13 Months,88.3,85.5 to 90.5,1462
Hib,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,24 Months,91.9,89.5 to 94.0,1462
DTaP,≥3 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,71.7,66.1 to 76.6,570
PCV,≥2 Doses,HHS Regions/National,Region 2,2021,Age,5 Months,74.8,69.3 to 79.6,570
Polio,≥3 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,90.7,86.3 to 93.7,570
Combined 7 Series,,HHS Regions/National,Region 2,2021,Age,35 Months,72.0,65.6 to 78.0,570
DTaP,≥3 Doses,HHS Regions/National,Region 2,2020-2021,Age,19 Months,92.6,90.1 to 94.5,1462
DTaP,≥1 Dose,HHS Regions/National,Region 2,2012,Age,3 Months,88.8,85.2 to 91.6,780
DTaP,≥1 Dose,HHS Regions/National,Region 2,2011,Age,3 Months,87.9,84.2 to 90.8,730
DTaP,≥1 Dose,HHS Regions/National,Region 2,2013,Age,3 Months,86.4,82.8 to 89.3,797
DTaP,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,3 Months,88.3,85.6 to 90.6,1723
DTaP,≥1 Dose,HHS Regions/National,Region 2,2014,Age,3 Months,90.2,87.5 to 92.4,926
DTaP,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,3 Months,89.5,87.5 to 91.3,1744
DTaP,≥1 Dose,HHS Regions/National,Region 2,2015,Age,3 Months,88.9,85.7 to 91.4,818
DTaP,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,3 Months,87.3,84.8 to 89.4,1622
DTaP,≥1 Dose,HHS Regions/National,Region 2,2016,Age,3 Months,85.7,81.7 to 89.0,804
DTaP,≥1 Dose,HHS Regions/National,Region 2,2016-2017,Age,3 Months,87.0,84.4 to 89.2,1715
Hep A,≥1 Dose,HHS Regions/National,Region 2,2020-2021,Age,24 Months,81.0,77.9 to 83.9,1462
Hep B,≥3 Doses,HHS Regions/National,Region 2,2021,Age,19 Months,91.5,87.2 to 94.4,570
Hib,Full Series,HHS Regions/National,Region 2,2020-2021,Age,24 Months,78.3,75.0 to 81.5,1462
Hib,Full Series,HHS Regions/National,Region 2,2021,Age,19 Months,69.7,64.0 to 74.8,570
DTaP,≥1 Dose,HHS Regions/National,Region 2,2018,Age,3 Months,90.9,88.1 to 93.1,1002
DTaP,≥1 Dose,HHS Regions/National,Region 2,2018-2019,Age,3 Months,90.0,87.8 to 91.9,1918
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,94.2,91.7 to 96.1,818
DTaP,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,93.4,91.4 to 95.0,1622
DTaP,≥1 Dose,HHS Regions/National,Region 2,2017,Age,3 Months,88.3,84.7 to 91.1,911
DTaP,≥1 Dose,HHS Regions/National,Region 2,2017-2018,Age,3 Months,89.6,87.4 to 91.4,1913
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014,Age,24 Months,94.6,92.6 to 96.2,926
DTaP,≥3 Doses,HHS Regions/National,Region 2,2014-2015,Age,24 Months,94.4,92.8 to 95.7,1744
DTaP,≥1 Dose,HHS Regions/National,Region 2,2019,Age,3 Months,89.2,85.4 to 92.0,916
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,92.5,89.3 to 95.0,804
DTaP,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,93.3,91.3 to 95.0,1715
Hep A,≥1 Dose,HHS Regions/National,Region 2,2011,Age,19 Months,66.6,63.0 to 70.0,730
≥1 Dose Varicella,,HHS Regions/National,Region 2,2021,Age,19 Months,84.5,79.3 to 88.5,570
Hep B,≥2 Doses,HHS Regions/National,Region 2,2021,Age,7 Months,90.2,85.9 to 93.3,570
Hep A,≥1 Dose,HHS Regions/National,Region 2,2012,Age,19 Months,66.8,62.4 to 70.9,780
Hep A,≥1 Dose,HHS Regions/National,Region 2,2014,Age,19 Months,71.1,67.2 to 74.6,926
Hep A,≥1 Dose,HHS Regions/National,Region 2,2014-2015,Age,19 Months,72.1,69.3 to 74.7,1744
Hep A,≥1 Dose,HHS Regions/National,Region 2,2015,Age,19 Months,73.1,69.8 to 76.2,818
Hep A,≥1 Dose,HHS Regions/National,Region 2,2015-2016,Age,19 Months,71.5,68.4 to 74.4,1622
DTaP,≥2 Doses,HHS Regions/National,Region 2,2017,Age,5 Months,81.7,77.9 to 85.1,911
DTaP,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,5 Months,82.4,79.8 to 84.7,1913
DTaP,≥2 Doses,HHS Regions/National,Region 2,2018,Age,5 Months,83.0,79.5 to 86.0,1002
DTaP,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,5 Months,81.1,78.3 to 83.5,1918
DTaP,≥2 Doses,HHS Regions/National,Region 2,2016,Age,5 Months,77.0,72.3 to 81.1,804
DTaP,≥2 Doses,HHS Regions/National,Region 2,2016-2017,Age,5 Months,79.3,76.3 to 82.0,1715
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018,Age,24 Months,95.0,92.8 to 96.7,1002
DTaP,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,24 Months,93.8,91.9 to 95.4,1918
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017,Age,24 Months,94.2,91.5 to 96.2,911
DTaP,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,24 Months,94.6,92.9 to 96.0,1913
Hep A,≥1 Dose,HHS Regions/National,Region 2,2013,Age,19 Months,71.7,67.7 to 75.3,797
Hep A,≥1 Dose,HHS Regions/National,Region 2,2013-2014,Age,19 Months,71.4,67.8 to 74.7,1723
DTaP,≥4 Doses,HHS Regions/National,Region 2,2020-2021,Age,35 Months,89.1,85.7 to 92.0,1462
DTaP,≥3 Doses,HHS Regions/National,Region 2,2019,Age,24 Months,92.7,89.4 to 95.2,916
Hib,≥3 Doses,HHS Regions/National,Region 2,2015,Age,24 Months,91.3,88.3 to 93.7,818
Hib,≥3 Doses,HHS Regions/National,Region 2,2015-2016,Age,24 Months,90.9,88.7 to 92.9,1622
Hib,≥3 Doses,HHS Regions/National,Region 2,2016,Age,24 Months,90.5,87.1 to 93.4,804
Hib,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,24 Months,91.3,89.1 to 93.3,1715
Hep A,≥2 Doses,HHS Regions/National,Region 2,2019,Age,19 Months,15.3,12.2 to 19.0,916
Hep A,≥2 Doses,HHS Regions/National,Region 2,2011,Age,24 Months,31.5,27.2 to 36.3,730
Hep A,≥2 Doses,HHS Regions/National,Region 2,2018,Age,19 Months,20.7,17.5 to 24.4,1002
Hep A,≥2 Doses,HHS Regions/National,Region 2,2018-2019,Age,19 Months,18.4,15.6 to 21.5,1583
Hib,≥3 Doses,HHS Regions/National,Region 2,2016,Age,35 Months,91.0,87.5 to 93.8,804
Hib,≥3 Doses,HHS Regions/National,Region 2,2016-2017,Age,35 Months,92.1,89.9 to 94.0,1715
Hib,≥3 Doses,HHS Regions/National,Region 2,2017,Age,35 Months,93.2,90.4 to 95.4,911
Hib,≥3 Doses,HHS Regions/National,Region 2,2017-2018,Age,35 Months,93.2,91.4 to 94.8,1913
DTaP,≥4 Doses,HHS Regions/National,Region 2,2013,Age,19 Months,70.8,64.9 to 76.1,797
DTaP,≥4 Doses,HHS Regions/National,Region 2,2013-2014,Age,19 Months,69.1,64.8 to 73.0,1723
DTaP,≥4 Doses,HHS Regions/National,Region 2,2014,Age,19 Months,67.3,63.4 to 71.0,926
DTaP,≥4 Doses,HHS Regions/National,Region 2,2014-2015,Age,19 Months,68.4,65.5 to 71.1,1744
DTaP,≥4 Doses,HHS Regions/National,Region 2,2015,Age,19 Months,69.4,66.9 to 71.9,818
DTaP,≥4 Doses,HHS Regions/National,Region 2,2015-2016,Age,19 Months,68.2,65.0 to 71.2,1622
Hep A,≥2 Doses,HHS Regions/National,Region 2,2017,Age,19 Months,19.0,15.7 to 22.8,911
Hep A,≥2 Doses,HHS Regions/National,Region 2,2017-2018,Age,19 Months,19.8,17.5 to 22.4,1913
Hib,≥3 Doses,HHS Regions/National,Region 2,2018,Age,35 Months,93.1,90.7 to 95.2,1002
Hib,≥3 Doses,HHS Regions/National,Region 2,2018-2019,Age,35 Months,93.5,91.4 to 95.2,1918
Hib,≥2 Doses,States/Local Areas,California,2019,Age,7 Months,93.0,88.9 to 95.6,537
Hib,≥3 Doses,States/Local Areas,California,2019,Age,13 Months,83.3,77.9 to 87.6,537
PCV,≥2 Doses,States/Local Areas,California,2020-2021,Age,5 Months,72.9,67.0 to 78.2,687
Hib,≥3 Doses,States/Local Areas,California,2011,Age,19 Months,89.1,83.7 to 92.8,298
Hib,≥3 Doses,States/Local Areas,California,2012,Age,19 Months,94.1,89.5 to 96.8,320
Hib,≥3 Doses,States/Local Areas,California,2013,Age,19 Months,92.2,90.6 to 93.6,319
Hib,≥3 Doses,States/Local Areas,California,2013-2014,Age,19 Months,90.0,87.8 to 91.9,674
DTaP,≥3 Doses,States/Local Areas,California,2019,Age,13 Months,92.3,87.7 to 95.3,537
DTaP,≥3 Doses,States/Local Areas,California,2011,Age,19 Months,89.6,83.8 to 93.6,298
DTaP,≥3 Doses,States/Local Areas,California,2012,Age,19 Months,94.8,90.6 to 97.2,320
DTaP,≥3 Doses,States/Local Areas,California,2013,Age,19 Months,93.6,91.8 to 95.1,319
DTaP,≥3 Doses,States/Local Areas,California,2013-2014,Age,19 Months,91.2,88.6 to 93.3,674
Polio,≥3 Doses,States/Local Areas,California,2018,Age,19 Months,94.3,90.9 to 96.5,559
Polio,≥3 Doses,States/Local Areas,California,2018-2019,Age,19 Months,65.6,61.1 to 69.9,1096
Hib,≥3 Doses,States/Local Areas,California,2018,Age,13 Months,84.3,79.0 to 88.5,559
Hib,≥3 Doses,States/Local Areas,California,2018-2019,Age,13 Months,83.8,80.1 to 87.0,1096
Polio,≥3 Doses,States/Local Areas,California,2016,Age,19 Months,90.9,83.8 to 95.1,306
Polio,≥3 Doses,States/Local Areas,California,2016-2017,Age,19 Months,90.6,86.2 to 93.7,724
Polio,≥3 Doses,States/Local Areas,California,2017,Age,19 Months,90.3,84.2 to 94.2,418
Polio,≥3 Doses,States/Local Areas,California,2017-2018,Age,19 Months,92.3,88.9 to 94.6,977
DTaP,≥3 Doses,States/Local Areas,California,2016,Age,13 Months,85.9,76.2 to 92.1,306
DTaP,≥3 Doses,States/Local Areas,California,2016-2017,Age,13 Months,88.0,82.5 to 92.0,724
DTaP,≥3 Doses,States/Local Areas,California,2017,Age,13 Months,90.2,84.2 to 94.1,418
DTaP,≥3 Doses,States/Local Areas,California,2017-2018,Age,13 Months,91.4,88.0 to 93.9,977
Polio,≥3 Doses,States/Local Areas,California,2013,Age,19 Months,90.3,86.5 to 93.2,319
Polio,≥3 Doses,States/Local Areas,California,2013-2014,Age,19 Months,86.5,80.2 to 91.1,674
Polio,≥3 Doses,States/Local Areas,California,2014,Age,19 Months,82.8,74.7 to 88.6,355
Polio,≥3 Doses,States/Local Areas,California,2014-2015,Age,19 Months,86.8,81.5 to 90.8,648
Polio,≥3 Doses,States/Local Areas,California,2015,Age,19 Months,90.9,81.1 to 95.9,293
Polio,≥3 Doses,States/Local Areas,California,2015-2016,Age,19 Months,90.9,86.1 to 94.2,599
Hib,≥2 Doses,States/Local Areas,California,2018,Age,13 Months,94.6,90.5 to 97.0,559
Hib,≥2 Doses,States/Local Areas,California,2018-2019,Age,13 Months,95.8,93.5 to 97.3,1096
Hib,≥2 Doses,States/Local Areas,California,2019,Age,13 Months,97.0,94.4 to 98.4,537
Polio,≥3 Doses,States/Local Areas,California,2012,Age,19 Months,94.5,90.6 to 96.8,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,63.9,54.6 to 73.2,343
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Poverty,>400% FPL,74.3,67.0 to 81.7,583
Hib,≥3 Doses,States/Local Areas,California,2016,Age,13 Months,77.5,67.3 to 85.2,306
Hib,≥3 Doses,States/Local Areas,California,2016-2017,Age,13 Months,79.4,73.3 to 84.4,724
Hib,≥3 Doses,States/Local Areas,California,2017,Age,13 Months,81.4,74.1 to 87.1,418
Hib,≥3 Doses,States/Local Areas,California,2017-2018,Age,13 Months,82.9,78.4 to 86.5,977
DTaP,≥3 Doses,States/Local Areas,California,2018,Age,13 Months,92.6,88.7 to 95.2,559
DTaP,≥3 Doses,States/Local Areas,California,2018-2019,Age,13 Months,92.4,89.6 to 94.6,1096
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,88.2,81.6 to 94.8,343
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,93.1,88.8 to 97.4,583
Polio,≥3 Doses,States/Local Areas,California,2011,Age,19 Months,88.3,83.3 to 91.9,298
Hib,≥3 Doses,States/Local Areas,California,2013,Age,13 Months,85.3,81.7 to 88.3,319
Hib,≥3 Doses,States/Local Areas,California,2013-2014,Age,13 Months,83.4,77.4 to 88.0,674
Hib,≥3 Doses,States/Local Areas,California,2014,Age,13 Months,81.4,73.5 to 87.4,355
Hib,≥3 Doses,States/Local Areas,California,2014-2015,Age,13 Months,81.5,75.8 to 86.1,648
Hib,≥3 Doses,States/Local Areas,California,2012,Age,13 Months,89.1,84.9 to 92.2,320
Hib,≥3 Doses,States/Local Areas,California,2015,Age,13 Months,81.6,72.9 to 88.0,293
Hib,≥3 Doses,States/Local Areas,California,2015-2016,Age,13 Months,79.5,73.1 to 84.8,599
Hib,≥2 Doses,States/Local Areas,California,2011,Age,13 Months,91.8,87.5 to 94.7,298
Hib,≥2 Doses,States/Local Areas,California,2012,Age,13 Months,96.7,95.0 to 97.8,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2018,Age,0-3 Days,71.1,64.5 to 76.9,559
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2018-2019,Age,0-3 Days,76.3,72.1 to 80.1,1096
DTaP,≥3 Doses,States/Local Areas,California,2015,Age,7 Months,60.5,49.8 to 70.3,293
DTaP,≥3 Doses,States/Local Areas,California,2015-2016,Age,7 Months,64.9,57.5 to 71.7,599
DTaP,≥3 Doses,States/Local Areas,California,2016,Age,7 Months,69.3,58.9 to 78.1,306
DTaP,≥3 Doses,States/Local Areas,California,2016-2017,Age,7 Months,66.0,59.4 to 72.0,724
DTaP,≥3 Doses,States/Local Areas,California,2017,Age,7 Months,62.5,54.3 to 70.1,418
DTaP,≥3 Doses,States/Local Areas,California,2017-2018,Age,7 Months,67.5,62.2 to 72.4,977
Hib,≥2 Doses,States/Local Areas,California,2013,Age,13 Months,94.7,92.8 to 96.1,319
Hib,≥2 Doses,States/Local Areas,California,2013-2014,Age,13 Months,93.7,92.7 to 94.6,674
PCV,≥3 Doses,States/Local Areas,California,2017,Age,35 Months,90.8,85.2 to 94.8,418
PCV,≥3 Doses,States/Local Areas,California,2017-2018,Age,35 Months,93.3,90.2 to 95.7,977
PCV,≥3 Doses,States/Local Areas,California,2018,Age,35 Months,95.9,93.3 to 97.8,559
PCV,≥3 Doses,States/Local Areas,California,2018-2019,Age,35 Months,94.7,92.4 to 96.5,1096
Hib,≥3 Doses,States/Local Areas,California,2014,Age,7 Months,55.7,46.9 to 64.3,355
Hib,≥3 Doses,States/Local Areas,California,2014-2015,Age,7 Months,51.5,44.7 to 58.3,648
Hib,≥3 Doses,States/Local Areas,California,2015,Age,7 Months,47.2,37.1 to 57.5,293
Hib,≥3 Doses,States/Local Areas,California,2015-2016,Age,7 Months,53.0,45.7 to 60.2,599
Hib,≥3 Doses,States/Local Areas,California,2016,Age,7 Months,58.8,48.5 to 68.3,306
Hib,≥3 Doses,States/Local Areas,California,2016-2017,Age,7 Months,56.6,50.1 to 63.0,724
Polio,≥1 Dose,States/Local Areas,California,2017,Age,3 Months,81.6,74.3 to 87.2,418
Polio,≥1 Dose,States/Local Areas,California,2017-2018,Age,3 Months,85.8,81.6 to 89.2,977
Polio,≥1 Dose,States/Local Areas,California,2018,Age,3 Months,90.2,85.6 to 93.5,559
Polio,≥1 Dose,States/Local Areas,California,2018-2019,Age,3 Months,91.4,88.6 to 93.6,1096
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,90.9,86.5 to 95.4,820
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,88.4,83.5 to 93.3,283
Hib,≥2 Doses,States/Local Areas,California,2017,Age,13 Months,93.5,88.2 to 96.5,418
Hib,≥2 Doses,States/Local Areas,California,2017-2018,Age,13 Months,94.1,90.9 to 96.1,977
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",92.1,77.2 to 100.0,41
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,89.6,84.9 to 94.3,314
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.5,76.5 to 94.5,255
Hib,≥3 Doses,States/Local Areas,California,2017,Age,7 Months,54.4,46.3 to 62.2,418
Hib,≥3 Doses,States/Local Areas,California,2017-2018,Age,7 Months,58.3,53.0 to 63.4,977
Hib,≥3 Doses,States/Local Areas,California,2018,Age,7 Months,62.3,55.7 to 68.5,559
Hib,≥3 Doses,States/Local Areas,California,2018-2019,Age,7 Months,60.6,56.0 to 65.0,1096
PCV,≥3 Doses,States/Local Areas,California,2019,Age,35 Months,93.4,89.4 to 96.3,537
Hib,≥2 Doses,States/Local Areas,California,2014,Age,13 Months,92.7,86.8 to 96.1,355
Hib,≥2 Doses,States/Local Areas,California,2014-2015,Age,13 Months,94.0,89.8 to 96.5,648
Polio,≥1 Dose,States/Local Areas,California,2019,Age,3 Months,92.6,88.9 to 95.2,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2019,Age,0-3 Days,81.7,76.3 to 86.1,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,68.5,62.1 to 74.9,820
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,63.7,55.7 to 71.6,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",55.9,27.1 to 84.6,41
DTaP,≥3 Doses,States/Local Areas,California,2018,Age,7 Months,72.7,66.4 to 78.2,559
DTaP,≥3 Doses,States/Local Areas,California,2018-2019,Age,7 Months,71.4,67.0 to 75.4,1096
DTaP,≥3 Doses,States/Local Areas,California,2019,Age,7 Months,70.0,63.7 to 75.7,537
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,67.8,60.5 to 75.0,314
DTaP,≥3 Doses,States/Local Areas,California,2011,Age,13 Months,86.8,80.8 to 91.2,298
Hib,≥2 Doses,States/Local Areas,California,2018,Age,7 Months,91.2,86.6 to 94.3,559
Hib,≥2 Doses,States/Local Areas,California,2018-2019,Age,7 Months,92.1,89.2 to 94.2,1096
PCV,≥3 Doses,States/Local Areas,California,2014,Age,35 Months,88.9,82.0 to 94.0,355
PCV,≥3 Doses,States/Local Areas,California,2014-2015,Age,35 Months,91.7,86.9 to 95.3,648
PCV,≥3 Doses,States/Local Areas,California,2015,Age,35 Months,98.7,94.0 to 99.9,293
PCV,≥3 Doses,States/Local Areas,California,2015-2016,Age,35 Months,94.9,87.9 to 98.5,599
PCV,≥3 Doses,States/Local Areas,California,2016,Age,35 Months,91.2,84.9 to 95.7,306
PCV,≥3 Doses,States/Local Areas,California,2016-2017,Age,35 Months,91.0,86.9 to 94.2,724
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.4,83.5 to 93.2,533
Hib,≥2 Doses,States/Local Areas,California,2015,Age,13 Months,95.3,88.0 to 98.2,293
Hib,≥2 Doses,States/Local Areas,California,2015-2016,Age,13 Months,93.7,89.0 to 96.5,599
Hib,≥2 Doses,States/Local Areas,California,2016,Age,13 Months,92.2,84.6 to 96.2,306
Hib,≥2 Doses,States/Local Areas,California,2016-2017,Age,13 Months,92.8,88.5 to 95.6,724
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Poverty,<133% FPL,61.0,52.0 to 70.0,215
DTaP,≥3 Doses,States/Local Areas,California,2012,Age,13 Months,92.1,88.5 to 94.6,320
DTaP,≥3 Doses,States/Local Areas,California,2015,Age,13 Months,89.4,81.5 to 94.1,293
DTaP,≥3 Doses,States/Local Areas,California,2015-2016,Age,13 Months,87.6,81.7 to 91.8,599
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Overall,Overall,89.5,86.3 to 92.8,1141
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,87.1,81.4 to 92.9,215
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.5,86.4 to 96.6,531
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,89.4,84.8 to 93.9,588
Hib,≥3 Doses,States/Local Areas,California,2019,Age,7 Months,58.8,52.3 to 65.0,537
PCV,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.5,87.3 to 95.6,533
Hib,≥3 Doses,States/Local Areas,California,2011,Age,13 Months,85.6,80.8 to 89.3,298
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",66.3,54.3 to 78.3,255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",65.5,57.3 to 73.7,531
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,64.6,57.3 to 71.9,588
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,68.6,61.7 to 75.5,533
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2017,Overall,Overall,66.4,61.4 to 71.4,1141
DTaP,≥3 Doses,States/Local Areas,California,2013,Age,13 Months,90.6,86.1 to 93.7,319
DTaP,≥3 Doses,States/Local Areas,California,2013-2014,Age,13 Months,88.1,82.2 to 92.3,674
DTaP,≥3 Doses,States/Local Areas,California,2014,Age,13 Months,85.7,77.8 to 91.1,355
DTaP,≥3 Doses,States/Local Areas,California,2014-2015,Age,13 Months,87.5,82.2 to 91.4,648
Hib,Full Series,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,82.2,76.6 to 87.8,820
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.5,58.9 to 82.1,531
Polio,≥3 Doses,States/Local Areas,California,2019,Age,35 Months,95.1,91.6 to 97.5,537
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,93.5,90.1 to 97.0,820
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,87.1,82.0 to 92.3,283
Hib,Full Series,States/Local Areas,California,2020,Age,24 Months,76.9,70.5 to 82.8,434
DTaP,≥4 Doses,States/Local Areas,California,2019,Age,24 Months,77.9,71.8 to 83.4,537
DTaP,≥4 Doses,States/Local Areas,California,2011,Age,35 Months,85.3,77.4 to 91.6,298
DTaP,≥4 Doses,States/Local Areas,California,2018,Age,24 Months,88.6,84.2 to 92.2,559
DTaP,≥4 Doses,States/Local Areas,California,2018-2019,Age,24 Months,83.3,79.5 to 86.7,1096
DTaP,≥4 Doses,States/Local Areas,California,2016,Age,35 Months,87.7,77.7 to 94.6,306
DTaP,≥4 Doses,States/Local Areas,California,2016-2017,Age,35 Months,86.5,80.8 to 91.2,724
DTaP,≥4 Doses,States/Local Areas,California,2017,Age,35 Months,86.2,79.1 to 91.8,418
DTaP,≥4 Doses,States/Local Areas,California,2017-2018,Age,35 Months,88.6,84.3 to 92.1,977
Hep B,≥3 Doses,States/Local Areas,California,2016,Age,13 Months,87.0,78.8 to 92.3,306
Hep B,≥3 Doses,States/Local Areas,California,2016-2017,Age,13 Months,87.3,82.3 to 91.0,724
Hep B,≥3 Doses,States/Local Areas,California,2015,Age,13 Months,84.1,75.0 to 90.3,293
Hep B,≥3 Doses,States/Local Areas,California,2015-2016,Age,13 Months,85.5,79.7 to 89.9,599
Hep B,≥3 Doses,States/Local Areas,California,2017,Age,13 Months,87.5,81.2 to 91.9,418
Hep B,≥3 Doses,States/Local Areas,California,2017-2018,Age,13 Months,87.8,84.0 to 90.8,977
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,77.6,68.9 to 86.3,314
Hep B,≥1 Dose,States/Local Areas,California,2011,Age,3 Months,93.8,89.2 to 96.6,298
Hep B,≥1 Dose,States/Local Areas,California,2012,Age,3 Months,91.8,83.9 to 96.0,320
Hep B,≥1 Dose,States/Local Areas,California,2013,Age,3 Months,94.0,92.2 to 95.4,319
Hep B,≥1 Dose,States/Local Areas,California,2013-2014,Age,3 Months,91.7,87.7 to 94.5,674
Hep B,≥1 Dose,States/Local Areas,California,2014,Age,3 Months,89.4,82.2 to 93.9,355
Hep B,≥1 Dose,States/Local Areas,California,2014-2015,Age,3 Months,89.5,84.3 to 93.1,648
Polio,≥2 Doses,States/Local Areas,California,2017,Age,7 Months,87.2,80.2 to 91.9,418
Polio,≥2 Doses,States/Local Areas,California,2017-2018,Age,7 Months,89.4,85.5 to 92.4,977
Polio,≥2 Doses,States/Local Areas,California,2018,Age,7 Months,91.8,87.6 to 94.7,559
Polio,≥2 Doses,States/Local Areas,California,2018-2019,Age,7 Months,92.2,89.5 to 94.3,1096
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Poverty,>400% FPL,88.0,82.4 to 93.6,583
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,75.3,66.3 to 84.2,588
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,75.9,67.9 to 83.8,533
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Overall,Overall,75.3,69.3 to 81.4,1141
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,76.4,66.7 to 86.2,215
Hep A,≥1 Dose,States/Local Areas,California,2020,Age,35 Months,91.1,84.6 to 95.7,434
Polio,≥2 Doses,States/Local Areas,California,2019,Age,7 Months,92.7,88.6 to 95.4,537
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,77.9,69.4 to 86.3,820
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,73.9,64.8 to 83.0,283
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",73.3,50.5 to 96.1,41
≥1 Dose MMR,,States/Local Areas,California,2011,Age,13 Months,58.0,47.4 to 67.9,298
≥1 Dose MMR,,States/Local Areas,California,2012,Age,13 Months,48.2,42.5 to 53.9,320
≥1 Dose MMR,,States/Local Areas,California,2013,Age,13 Months,55.8,52.1 to 59.5,319
≥1 Dose MMR,,States/Local Areas,California,2013-2014,Age,13 Months,59.0,55.5 to 62.4,674
≥1 Dose Varicella,,States/Local Areas,California,2016,Age,13 Months,59.5,49.9 to 68.4,306
≥1 Dose Varicella,,States/Local Areas,California,2016-2017,Age,13 Months,60.3,54.0 to 66.2,724
≥1 Dose Varicella,,States/Local Areas,California,2017,Age,13 Months,61.1,53.1 to 68.6,418
≥1 Dose Varicella,,States/Local Areas,California,2017-2018,Age,13 Months,59.8,54.6 to 64.9,977
≥1 Dose Varicella,,States/Local Areas,California,2018,Age,13 Months,58.5,51.8 to 64.8,559
≥1 Dose Varicella,,States/Local Areas,California,2018-2019,Age,13 Months,60.3,55.7 to 64.7,1096
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.0,74.5 to 89.5,531
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,86.2,81.0 to 91.3,588
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,86.3,81.1 to 91.5,533
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Overall,Overall,85.6,81.8 to 89.3,1141
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Poverty,<133% FPL,88.2,82.8 to 93.6,215
Polio,≥2 Doses,States/Local Areas,California,2014,Age,7 Months,85.6,77.8 to 91.0,355
Polio,≥2 Doses,States/Local Areas,California,2014-2015,Age,7 Months,87.6,82.4 to 91.5,648
Polio,≥2 Doses,States/Local Areas,California,2015,Age,7 Months,89.7,81.6 to 94.4,293
Polio,≥2 Doses,States/Local Areas,California,2015-2016,Age,7 Months,87.9,81.8 to 92.2,599
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,79.3,71.1 to 87.5,343
Polio,≥2 Doses,States/Local Areas,California,2016,Age,7 Months,86.2,76.0 to 92.4,306
Polio,≥2 Doses,States/Local Areas,California,2016-2017,Age,7 Months,86.6,80.8 to 90.9,724
Hep B,≥3 Doses,States/Local Areas,California,2011,Age,13 Months,84.1,78.3 to 88.6,298
≥1 Dose MMR,,States/Local Areas,California,2017,Age,13 Months,64.4,56.3 to 71.7,418
≥1 Dose MMR,,States/Local Areas,California,2017-2018,Age,13 Months,64.4,59.1 to 69.3,977
≥1 Dose MMR,,States/Local Areas,California,2019,Age,13 Months,66.9,60.6 to 72.7,537
≥1 Dose MMR,,States/Local Areas,California,2018,Age,13 Months,64.4,57.8 to 70.4,559
≥1 Dose MMR,,States/Local Areas,California,2018-2019,Age,13 Months,65.6,61.1 to 69.9,1096
≥1 Dose Varicella,,States/Local Areas,California,2014,Age,19 Months,86.7,79.4 to 91.7,355
≥1 Dose Varicella,,States/Local Areas,California,2014-2015,Age,19 Months,87.6,82.6 to 91.3,648
≥1 Dose Varicella,,States/Local Areas,California,2015,Age,19 Months,88.4,85.0 to 91.2,293
≥1 Dose Varicella,,States/Local Areas,California,2015-2016,Age,19 Months,86.3,80.9 to 90.3,599
≥1 Dose Varicella,,States/Local Areas,California,2016,Age,19 Months,84.1,75.6 to 90.1,306
≥1 Dose Varicella,,States/Local Areas,California,2016-2017,Age,19 Months,83.5,78.2 to 87.7,724
Polio,≥2 Doses,States/Local Areas,California,2011,Age,13 Months,91.7,86.9 to 94.9,298
Polio,≥2 Doses,States/Local Areas,California,2012,Age,13 Months,96.6,95.0 to 97.7,320
Polio,≥2 Doses,States/Local Areas,California,2013,Age,13 Months,95.4,92.7 to 97.1,319
Polio,≥2 Doses,States/Local Areas,California,2013-2014,Age,13 Months,93.7,91.2 to 95.5,674
Polio,≥2 Doses,States/Local Areas,California,2014,Age,13 Months,91.9,86.1 to 95.4,355
Polio,≥2 Doses,States/Local Areas,California,2014-2015,Age,13 Months,92.7,88.3 to 95.6,648
Hep B,≥1 Dose,States/Local Areas,California,2015,Age,3 Months,89.6,81.1 to 94.6,293
Hep B,≥1 Dose,States/Local Areas,California,2015-2016,Age,3 Months,90.9,85.5 to 94.4,599
Hep B,≥1 Dose,States/Local Areas,California,2016,Age,3 Months,92.2,83.9 to 96.4,306
Hep B,≥1 Dose,States/Local Areas,California,2016-2017,Age,3 Months,92.6,88.2 to 95.5,724
Hep B,≥1 Dose,States/Local Areas,California,2017,Age,3 Months,93.0,88.0 to 96.0,418
Hep B,≥1 Dose,States/Local Areas,California,2017-2018,Age,3 Months,94.1,91.1 to 96.1,977
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.7,63.8 to 91.6,255
DTaP,≥4 Doses,States/Local Areas,California,2019,Age,35 Months,89.0,83.0 to 93.6,537
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,82.5,77.0 to 88.0,820
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,74.4,67.2 to 81.5,283
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",87.1,71.4 to 100.0,41
≥1 Dose MMR,,States/Local Areas,California,2011,Age,19 Months,87.5,80.7 to 92.1,298
≥1 Dose MMR,,States/Local Areas,California,2013,Age,19 Months,87.1,82.4 to 90.7,319
≥1 Dose MMR,,States/Local Areas,California,2013-2014,Age,19 Months,87.1,84.3 to 89.4,674
≥1 Dose MMR,,States/Local Areas,California,2012,Age,19 Months,88.4,86.9 to 89.8,320
≥1 Dose MMR,,States/Local Areas,California,2014,Age,19 Months,87.0,79.7 to 92.0,355
≥1 Dose MMR,,States/Local Areas,California,2014-2015,Age,19 Months,87.8,82.8 to 91.4,648
≥1 Dose Varicella,,States/Local Areas,California,2017,Age,19 Months,82.8,75.7 to 88.2,418
≥1 Dose Varicella,,States/Local Areas,California,2017-2018,Age,19 Months,86.1,81.9 to 89.4,977
≥1 Dose Varicella,,States/Local Areas,California,2018,Age,19 Months,89.4,84.7 to 92.8,559
≥1 Dose Varicella,,States/Local Areas,California,2018-2019,Age,19 Months,60.3,55.7 to 64.7,1096
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,76.7,69.8 to 83.5,314
Polio,≥2 Doses,States/Local Areas,California,2015,Age,13 Months,93.5,85.6 to 97.2,293
Polio,≥2 Doses,States/Local Areas,California,2015-2016,Age,13 Months,92.4,87.5 to 95.5,599
Polio,≥2 Doses,States/Local Areas,California,2016,Age,13 Months,91.3,83.7 to 95.6,306
Polio,≥2 Doses,States/Local Areas,California,2016-2017,Age,13 Months,92.4,88.1 to 95.2,724
Polio,≥2 Doses,States/Local Areas,California,2017,Age,13 Months,93.5,88.2 to 96.6,418
Polio,≥2 Doses,States/Local Areas,California,2017-2018,Age,13 Months,94.4,91.4 to 96.4,977
Hep B,≥3 Doses,States/Local Areas,California,2016,Age,19 Months,90.4,82.8 to 94.9,306
Hep B,≥3 Doses,States/Local Areas,California,2016-2017,Age,19 Months,90.5,86.0 to 93.7,724
PCV,≥3 Doses,States/Local Areas,California,2011,Age,7 Months,60.6,57.4 to 63.6,298
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.1,64.5 to 85.8,255
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",82.1,75.1 to 89.1,531
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,79.7,73.3 to 86.2,588
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,77.8,71.5 to 84.1,533
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Overall,Overall,78.3,73.8 to 82.8,1141
≥1 Dose MMR,,States/Local Areas,California,2015,Age,19 Months,88.5,84.9 to 91.3,293
≥1 Dose MMR,,States/Local Areas,California,2015-2016,Age,19 Months,86.9,81.6 to 90.9,599
≥1 Dose MMR,,States/Local Areas,California,2016,Age,19 Months,85.3,76.7 to 91.1,306
≥1 Dose MMR,,States/Local Areas,California,2016-2017,Age,19 Months,83.9,78.5 to 88.2,724
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,72.6,64.4 to 80.8,215
≥1 Dose MMR,,States/Local Areas,California,2017,Age,19 Months,82.5,75.1 to 88.0,418
≥1 Dose MMR,,States/Local Areas,California,2017-2018,Age,19 Months,87.1,82.9 to 90.4,977
≥1 Dose Varicella,,States/Local Areas,California,2011,Age,24 Months,88.9,82.0 to 94.1,298
≥1 Dose Varicella,,States/Local Areas,California,2012,Age,24 Months,94.6,90.8 to 97.2,320
Hep B,≥1 Dose,States/Local Areas,California,2018,Age,3 Months,95.1,91.4 to 97.3,559
Hep B,≥1 Dose,States/Local Areas,California,2018-2019,Age,3 Months,96.1,93.9 to 97.5,1096
≥1 Dose Varicella,,States/Local Areas,California,2019,Age,19 Months,87.0,81.8 to 90.9,537
Hep B,≥1 Dose,States/Local Areas,California,2019,Age,3 Months,97.0,94.3 to 98.5,537
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2011,Age,0-1 Days,60.9,54.0 to 67.5,298
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2012,Age,0-1 Days,57.4,47.0 to 67.2,320
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,67.9,55.9 to 79.9,343
Hep B,≥2 Doses,States/Local Areas,California,2011,Age,5 Months,82.5,78.5 to 86.0,298
Hep B,≥2 Doses,States/Local Areas,California,2012,Age,5 Months,86.4,80.2 to 90.9,320
Hep B,≥2 Doses,States/Local Areas,California,2013,Age,5 Months,83.1,79.4 to 86.3,319
Hep B,≥2 Doses,States/Local Areas,California,2013-2014,Age,5 Months,80.9,77.9 to 83.5,674
Hep A,≥2 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,80.9,71.4 to 90.4,583
Hep B,≥2 Doses,States/Local Areas,California,2014,Age,5 Months,78.6,70.3 to 85.1,355
Hep B,≥2 Doses,States/Local Areas,California,2014-2015,Age,5 Months,79.9,76.2 to 83.1,648
Hep B,≥3 Doses,States/Local Areas,California,2014,Age,19 Months,83.2,75.3 to 89.0,355
Hep B,≥3 Doses,States/Local Areas,California,2014-2015,Age,19 Months,85.1,79.5 to 89.4,648
Hep B,≥3 Doses,States/Local Areas,California,2015,Age,19 Months,87.1,83.1 to 90.2,293
Hep B,≥3 Doses,States/Local Areas,California,2015-2016,Age,19 Months,88.8,83.3 to 92.6,599
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2018,Age,0-1 Days,64.5,57.8 to 70.7,559
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2018-2019,Age,0-1 Days,70.9,66.5 to 74.9,1096
Hep B,≥2 Doses,States/Local Areas,California,2018,Age,5 Months,88.6,83.7 to 92.2,559
Hep B,≥2 Doses,States/Local Areas,California,2018-2019,Age,5 Months,90.4,87.4 to 92.7,1096
Hep B,≥2 Doses,States/Local Areas,California,2019,Age,5 Months,92.2,88.5 to 94.8,537
Hep B,≥2 Doses,States/Local Areas,California,2011,Age,7 Months,88.6,84.3 to 91.8,298
PCV,≥4 Doses,States/Local Areas,California,2020,Age,35 Months,81.9,74.4 to 88.3,434
PCV,≥4 Doses,States/Local Areas,California,2011,Age,19 Months,74.4,70.4 to 78.1,298
PCV,≥4 Doses,States/Local Areas,California,2012,Age,19 Months,80.0,72.0 to 86.2,320
PCV,≥4 Doses,States/Local Areas,California,2013,Age,19 Months,76.9,71.6 to 81.4,319
PCV,≥4 Doses,States/Local Areas,California,2013-2014,Age,19 Months,74.5,70.1 to 78.5,674
≥1 Dose MMR,,States/Local Areas,California,2018,Age,19 Months,92.0,87.7 to 94.9,559
≥1 Dose MMR,,States/Local Areas,California,2018-2019,Age,19 Months,95.8,93.5 to 97.3,1096
PCV,≥4 Doses,States/Local Areas,California,2014,Age,19 Months,72.1,63.3 to 79.5,355
PCV,≥4 Doses,States/Local Areas,California,2014-2015,Age,19 Months,73.3,66.9 to 78.9,648
≥1 Dose MMR,,States/Local Areas,California,2019,Age,19 Months,88.4,83.3 to 92.0,537
≥1 Dose MMR,,States/Local Areas,California,2011,Age,24 Months,89.3,82.4 to 94.3,298
PCV,≥3 Doses,States/Local Areas,California,2015,Age,7 Months,52.2,41.8 to 62.4,293
PCV,≥3 Doses,States/Local Areas,California,2015-2016,Age,7 Months,57.8,50.3 to 64.8,599
≥1 Dose MMR,,States/Local Areas,California,2012,Age,24 Months,93.7,89.4 to 96.6,320
≥1 Dose Varicella,,States/Local Areas,California,2015,Age,24 Months,92.8,87.2 to 96.5,293
≥1 Dose Varicella,,States/Local Areas,California,2015-2016,Age,24 Months,91.8,87.6 to 95.0,599
≥1 Dose Varicella,,States/Local Areas,California,2016,Age,24 Months,90.5,84.1 to 95.1,306
≥1 Dose Varicella,,States/Local Areas,California,2016-2017,Age,24 Months,89.0,84.7 to 92.6,724
≥1 Dose Varicella,,States/Local Areas,California,2017,Age,24 Months,87.6,81.5 to 92.5,418
≥1 Dose Varicella,,States/Local Areas,California,2017-2018,Age,24 Months,88.6,84.9 to 91.8,977
Hep B,≥3 Doses,States/Local Areas,California,2012,Age,19 Months,93.3,90.8 to 95.1,320
Hep B,≥3 Doses,States/Local Areas,California,2013,Age,19 Months,91.2,89.7 to 92.5,319
Hep B,≥3 Doses,States/Local Areas,California,2013-2014,Age,19 Months,87.2,81.0 to 91.6,674
Hep B,≥3 Doses,States/Local Areas,California,2018,Age,13 Months,88.0,83.1 to 91.7,559
Hep B,≥3 Doses,States/Local Areas,California,2018-2019,Age,13 Months,89.9,86.9 to 92.3,1096
Hep B,≥3 Doses,States/Local Areas,California,2019,Age,13 Months,91.8,88.0 to 94.5,537
Hep B,≥3 Doses,States/Local Areas,California,2011,Age,19 Months,88.5,83.2 to 92.3,298
DTaP,≥4 Doses,States/Local Areas,California,2018,Age,35 Months,91.3,86.5 to 94.9,559
DTaP,≥4 Doses,States/Local Areas,California,2018-2019,Age,35 Months,89.9,86.2 to 92.9,1096
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2016,Age,0-1 Days,64.3,54.4 to 73.1,306
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2016-2017,Age,0-1 Days,66.0,59.8 to 71.8,724
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2017,Age,0-1 Days,67.9,60.2 to 74.7,418
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2017-2018,Age,0-1 Days,66.2,61.2 to 70.9,977
≥1 Dose Varicella,,States/Local Areas,California,2013,Age,24 Months,87.6,81.2 to 92.7,319
≥1 Dose Varicella,,States/Local Areas,California,2013-2014,Age,24 Months,86.8,82.3 to 90.7,674
≥1 Dose Varicella,,States/Local Areas,California,2014,Age,24 Months,86.2,79.4 to 91.7,355
≥1 Dose Varicella,,States/Local Areas,California,2014-2015,Age,24 Months,89.2,84.8 to 92.7,648
Polio,≥2 Doses,States/Local Areas,California,2018,Age,13 Months,95.3,91.8 to 97.3,559
Polio,≥2 Doses,States/Local Areas,California,2018-2019,Age,13 Months,96.5,94.7 to 97.7,1096
Polio,≥2 Doses,States/Local Areas,California,2019,Age,13 Months,97.8,96.0 to 98.8,537
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2013,Age,0-1 Days,56.2,49.6 to 62.7,319
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2013-2014,Age,0-1 Days,54.4,48.4 to 60.3,674
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2014,Age,0-1 Days,52.6,43.5 to 61.5,355
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2014-2015,Age,0-1 Days,52.2,45.3 to 59.0,648
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2015,Age,0-1 Days,51.7,41.4 to 61.9,293
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2015-2016,Age,0-1 Days,58.0,50.8 to 64.9,599
Hep B,≥2 Doses,States/Local Areas,California,2015,Age,5 Months,81.2,71.8 to 87.9,293
Hep B,≥2 Doses,States/Local Areas,California,2015-2016,Age,5 Months,82.7,76.1 to 87.8,599
Hep B,≥2 Doses,States/Local Areas,California,2016,Age,5 Months,84.3,73.8 to 91.1,306
Hep B,≥2 Doses,States/Local Areas,California,2016-2017,Age,5 Months,84.3,78.3 to 88.9,724
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.0,63.6 to 100.0,41
Hib,Full Series,States/Local Areas,California,2017,Age,35 Months,77.9,70.0 to 84.9,418
Hib,Full Series,States/Local Areas,California,2017-2018,Age,35 Months,80.9,76.0 to 85.4,977
Polio,≥3 Doses,States/Local Areas,California,2018,Age,35 Months,96.2,93.3 to 98.1,559
Polio,≥3 Doses,States/Local Areas,California,2018-2019,Age,35 Months,95.7,93.5 to 97.4,1096
Hib,Full Series,States/Local Areas,California,2015,Age,35 Months,87.9,78.7 to 94.4,293
Hib,Full Series,States/Local Areas,California,2015-2016,Age,35 Months,85.5,78.2 to 91.3,599
Hib,Full Series,States/Local Areas,California,2016,Age,35 Months,82.3,71.2 to 91.0,306
Hib,Full Series,States/Local Areas,California,2016-2017,Age,35 Months,79.9,73.6 to 85.5,724
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.5,86.0 to 94.9,533
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,90.1,85.6 to 94.5,314
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.4,81.7 to 97.1,255
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",92.2,87.7 to 96.7,531
Polio,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,90.9,86.8 to 95.0,588
Hib,Full Series,States/Local Areas,California,2018,Age,35 Months,83.7,78.2 to 88.5,559
Hib,Full Series,States/Local Areas,California,2018-2019,Age,35 Months,83.5,79.4 to 87.2,1096
Hib,Full Series,States/Local Areas,California,2019,Age,35 Months,83.7,77.2 to 89.1,537
Hep A,≥1 Dose,States/Local Areas,California,2015,Age,35 Months,97.3,91.1 to 99.6,293
Hep A,≥1 Dose,States/Local Areas,California,2015-2016,Age,35 Months,94.2,88.3 to 97.7,599
Polio,≥2 Doses,States/Local Areas,California,2012,Age,5 Months,75.5,72.1 to 78.6,320
Polio,≥2 Doses,States/Local Areas,California,2013,Age,5 Months,71.5,67.1 to 75.4,319
Polio,≥2 Doses,States/Local Areas,California,2013-2014,Age,5 Months,71.3,68.4 to 74.1,674
Polio,≥2 Doses,States/Local Areas,California,2014,Age,5 Months,71.2,62.5 to 78.6,355
Polio,≥2 Doses,States/Local Areas,California,2014-2015,Age,5 Months,69.8,66.9 to 72.4,648
Polio,≥2 Doses,States/Local Areas,California,2015,Age,5 Months,68.3,58.2 to 76.9,293
Polio,≥2 Doses,States/Local Areas,California,2015-2016,Age,5 Months,71.1,64.0 to 77.3,599
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,89.9,84.6 to 95.1,215
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,92.8,87.6 to 98.1,343
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,97.2,94.8 to 99.7,583
Hep B,≥3 Doses,States/Local Areas,California,2011,Age,7 Months,52.3,50.1 to 54.4,298
Hep B,≥3 Doses,States/Local Areas,California,2012,Age,7 Months,60.2,52.6 to 67.4,320
Hep B,≥3 Doses,States/Local Areas,California,2013,Age,7 Months,62.8,58.8 to 66.7,319
Hep B,≥3 Doses,States/Local Areas,California,2013-2014,Age,7 Months,57.5,52.2 to 62.7,674
DTaP,≥4 Doses,States/Local Areas,California,2019,Age,19 Months,69.3,62.9 to 75.0,537
DTaP,≥4 Doses,States/Local Areas,California,2011,Age,24 Months,81.3,73.7 to 87.9,298
DTaP,≥4 Doses,States/Local Areas,California,2012,Age,24 Months,84.2,77.4 to 89.9,320
DTaP,≥4 Doses,States/Local Areas,California,2013,Age,24 Months,82.0,74.2 to 88.6,319
DTaP,≥4 Doses,States/Local Areas,California,2013-2014,Age,24 Months,77.8,72.2 to 83.0,674
Hep A,≥2 Doses,States/Local Areas,California,2016,Age,24 Months,54.8,44.6 to 65.7,306
Hep A,≥2 Doses,States/Local Areas,California,2016-2017,Age,24 Months,54.2,47.6 to 61.0,724
Hep A,≥2 Doses,States/Local Areas,California,2017,Age,24 Months,53.2,45.3 to 61.6,418
Hep A,≥2 Doses,States/Local Areas,California,2017-2018,Age,24 Months,54.6,49.2 to 60.1,977
DTaP,≥4 Doses,States/Local Areas,California,2014,Age,24 Months,74.3,66.1 to 81.8,355
DTaP,≥4 Doses,States/Local Areas,California,2014-2015,Age,24 Months,80.4,74.7 to 85.5,648
Hep A,≥2 Doses,States/Local Areas,California,2018,Age,24 Months,56.0,49.3 to 62.8,559
Hep A,≥2 Doses,States/Local Areas,California,2018-2019,Age,24 Months,53.5,48.8 to 58.4,1096
Hep A,≥1 Dose,States/Local Areas,California,2013,Age,35 Months,89.6,82.6 to 94.7,319
Hep A,≥1 Dose,States/Local Areas,California,2013-2014,Age,35 Months,87.2,82.4 to 91.3,674
Hep A,≥1 Dose,States/Local Areas,California,2014,Age,35 Months,85.9,78.6 to 91.7,355
Hep A,≥1 Dose,States/Local Areas,California,2014-2015,Age,35 Months,89.9,85.0 to 93.8,648
Hep A,≥2 Doses,States/Local Areas,California,2014,Age,24 Months,56.8,47.9 to 66.1,355
Hep A,≥2 Doses,States/Local Areas,California,2014-2015,Age,24 Months,55.9,48.9 to 63.1,648
Hep A,≥2 Doses,States/Local Areas,California,2015,Age,24 Months,55.1,44.7 to 66.1,293
Hep A,≥2 Doses,States/Local Areas,California,2015-2016,Age,24 Months,55.1,47.7 to 62.8,599
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Overall,Overall,93.2,90.6 to 95.9,1141
Hib,≥3 Doses,States/Local Areas,California,2019,Age,35 Months,94.8,90.7 to 97.5,537
PCV,≥2 Doses,States/Local Areas,California,2018,Age,5 Months,77.7,71.5 to 82.8,559
PCV,≥2 Doses,States/Local Areas,California,2018-2019,Age,5 Months,79.1,75.0 to 82.7,1096
PCV,≥2 Doses,States/Local Areas,California,2019,Age,5 Months,80.6,74.8 to 85.2,537
Polio,≥2 Doses,States/Local Areas,California,2011,Age,5 Months,79.5,76.4 to 82.3,298
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,92.7,88.6 to 96.7,314
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.0,85.3 to 98.8,255
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.3,91.9 to 98.8,531
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,95.1,91.6 to 98.7,588
DTaP,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,92.6,88.6 to 96.5,533
DTaP,≥4 Doses,States/Local Areas,California,2017,Age,19 Months,68.2,60.2 to 75.3,418
DTaP,≥4 Doses,States/Local Areas,California,2017-2018,Age,19 Months,73.3,68.3 to 77.7,977
DTaP,≥4 Doses,States/Local Areas,California,2018,Age,19 Months,78.5,72.6 to 83.4,559
DTaP,≥4 Doses,States/Local Areas,California,2018-2019,Age,19 Months,96.5,94.7 to 97.7,1096
Hep A,≥2 Doses,States/Local Areas,California,2013,Age,24 Months,45.2,36.7 to 54.7,319
Hep A,≥2 Doses,States/Local Areas,California,2013-2014,Age,24 Months,51.1,44.7 to 57.8,674
Hep A,≥2 Doses,States/Local Areas,California,2014,Age,35 Months,77.5,68.0 to 85.8,355
Hep A,≥2 Doses,States/Local Areas,California,2014-2015,Age,35 Months,79.5,71.3 to 86.7,648
DTaP,≥4 Doses,States/Local Areas,California,2017,Age,24 Months,81.4,74.4 to 87.5,418
DTaP,≥4 Doses,States/Local Areas,California,2017-2018,Age,24 Months,84.9,80.7 to 88.6,977
DTaP,≥4 Doses,States/Local Areas,California,2015,Age,24 Months,87.3,79.3 to 93.2,293
DTaP,≥4 Doses,States/Local Areas,California,2015-2016,Age,24 Months,82.4,76.2 to 87.8,599
DTaP,≥4 Doses,States/Local Areas,California,2016,Age,24 Months,77.8,68.1 to 86.2,306
DTaP,≥4 Doses,States/Local Areas,California,2016-2017,Age,24 Months,79.5,73.6 to 84.9,724
Hep B,≥3 Doses,States/Local Areas,California,2016,Age,7 Months,56.3,46.0 to 66.0,306
Hep B,≥3 Doses,States/Local Areas,California,2016-2017,Age,7 Months,56.1,49.5 to 62.4,724
≥1 Dose Varicella,,States/Local Areas,California,2013,Age,13 Months,55.0,47.7 to 62.2,319
≥1 Dose Varicella,,States/Local Areas,California,2013-2014,Age,13 Months,56.3,53.3 to 59.3,674
≥1 Dose Varicella,,States/Local Areas,California,2014,Age,13 Months,57.6,48.5 to 66.3,355
≥1 Dose Varicella,,States/Local Areas,California,2014-2015,Age,13 Months,55.0,48.1 to 61.7,648
≥1 Dose Varicella,,States/Local Areas,California,2012,Age,13 Months,55.3,51.9 to 58.7,320
≥1 Dose Varicella,,States/Local Areas,California,2015,Age,13 Months,52.4,42.1 to 62.4,293
≥1 Dose Varicella,,States/Local Areas,California,2015-2016,Age,13 Months,55.9,48.9 to 62.8,599
Hep A,≥1 Dose,States/Local Areas,California,2019,Age,35 Months,93.3,88.4 to 96.7,537
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,85.2,79.8 to 90.5,820
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,85.6,80.2 to 91.0,283
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",79.5,58.5 to 100.0,41
Polio,≥2 Doses,States/Local Areas,California,2018,Age,5 Months,78.4,72.2 to 83.5,559
Polio,≥2 Doses,States/Local Areas,California,2018-2019,Age,5 Months,79.6,75.5 to 83.1,1096
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,88.1,83.3 to 92.8,314
Hep A,≥1 Dose,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.4,75.9 to 94.9,255
Polio,≥2 Doses,States/Local Areas,California,2019,Age,5 Months,80.8,75.1 to 85.4,537
Polio,≥2 Doses,States/Local Areas,California,2011,Age,7 Months,87.7,84.5 to 90.3,298
Polio,≥2 Doses,States/Local Areas,California,2012,Age,7 Months,92.8,90.6 to 94.6,320
Hep B,≥3 Doses,States/Local Areas,California,2017,Age,7 Months,55.9,47.8 to 63.6,418
Hep B,≥3 Doses,States/Local Areas,California,2017-2018,Age,7 Months,60.3,55.2 to 65.2,977
Hep B,≥3 Doses,States/Local Areas,California,2018,Age,7 Months,64.9,58.5 to 70.9,559
Hep B,≥3 Doses,States/Local Areas,California,2018-2019,Age,7 Months,63.7,59.2 to 68.0,1096
Polio,≥2 Doses,States/Local Areas,California,2013,Age,7 Months,87.8,83.7 to 91.0,319
Polio,≥2 Doses,States/Local Areas,California,2013-2014,Age,7 Months,86.8,83.6 to 89.3,674
Hep B,≥3 Doses,States/Local Areas,California,2019,Age,7 Months,62.5,56.1 to 68.4,537
Hep A,≥2 Doses,States/Local Areas,California,2015,Age,35 Months,82.5,67.6 to 93.3,293
Hep A,≥2 Doses,States/Local Areas,California,2015-2016,Age,35 Months,78.3,68.8 to 86.5,599
Hep A,≥2 Doses,States/Local Areas,California,2016,Age,35 Months,73.2,61.7 to 83.6,306
Hep A,≥2 Doses,States/Local Areas,California,2016-2017,Age,35 Months,77.8,71.1 to 83.9,724
Hep A,≥1 Dose,States/Local Areas,California,2016,Age,35 Months,91.5,82.9 to 96.8,306
Hep A,≥1 Dose,States/Local Areas,California,2016-2017,Age,35 Months,90.7,86.1 to 94.2,724
Hep A,≥1 Dose,States/Local Areas,California,2017,Age,35 Months,90.5,84.9 to 94.7,418
Hep A,≥1 Dose,States/Local Areas,California,2017-2018,Age,35 Months,91.4,88.0 to 94.1,977
≥1 Dose Varicella,,States/Local Areas,California,2011,Age,13 Months,59.7,47.7 to 70.6,298
Hep A,≥1 Dose,States/Local Areas,California,2018,Age,35 Months,92.1,88.1 to 95.1,559
Hep A,≥1 Dose,States/Local Areas,California,2018-2019,Age,35 Months,92.5,89.5 to 94.9,1096
Polio,≥2 Doses,States/Local Areas,California,2016,Age,5 Months,73.9,63.4 to 82.2,306
Polio,≥2 Doses,States/Local Areas,California,2016-2017,Age,5 Months,72.1,65.5 to 77.8,724
Polio,≥2 Doses,States/Local Areas,California,2017,Age,5 Months,70.1,62.0 to 77.2,418
Polio,≥2 Doses,States/Local Areas,California,2017-2018,Age,5 Months,74.2,69.0 to 78.8,977
Hep B,≥3 Doses,States/Local Areas,California,2014,Age,7 Months,52.2,43.7 to 60.6,355
Hep B,≥3 Doses,States/Local Areas,California,2014-2015,Age,7 Months,53.5,46.7 to 60.2,648
Hep B,≥3 Doses,States/Local Areas,California,2015,Age,7 Months,54.9,44.4 to 65.0,293
Hep B,≥3 Doses,States/Local Areas,California,2015-2016,Age,7 Months,55.6,48.2 to 62.7,599
Hep A,≥2 Doses,States/Local Areas,California,2019,Age,24 Months,50.9,44.3 to 57.8,537
Hep A,≥2 Doses,States/Local Areas,California,2011,Age,35 Months,75.7,65.8 to 84.5,298
Hep A,≥2 Doses,States/Local Areas,California,2012,Age,35 Months,72.0,61.4 to 81.9,320
Hep A,≥2 Doses,States/Local Areas,California,2013,Age,35 Months,84.5,72.0 to 93.5,319
Hep A,≥2 Doses,States/Local Areas,California,2013-2014,Age,35 Months,79.2,71.7 to 85.8,674
≥1 Dose MMR,,States/Local Areas,California,2014,Age,13 Months,62.2,52.9 to 70.6,355
≥1 Dose MMR,,States/Local Areas,California,2014-2015,Age,13 Months,60.1,53.2 to 66.7,648
≥1 Dose MMR,,States/Local Areas,California,2015,Age,13 Months,58.1,47.7 to 67.8,293
≥1 Dose MMR,,States/Local Areas,California,2015-2016,Age,13 Months,60.4,53.3 to 67.1,599
≥1 Dose MMR,,States/Local Areas,California,2016,Age,13 Months,62.8,53.1 to 71.5,306
≥1 Dose MMR,,States/Local Areas,California,2016-2017,Age,13 Months,63.6,57.3 to 69.4,724
≥1 Dose Varicella,,States/Local Areas,California,2019,Age,13 Months,62.2,55.8 to 68.1,537
≥1 Dose Varicella,,States/Local Areas,California,2011,Age,19 Months,87.7,79.3 to 92.9,298
≥1 Dose Varicella,,States/Local Areas,California,2012,Age,19 Months,87.5,81.2 to 91.9,320
≥1 Dose Varicella,,States/Local Areas,California,2013,Age,19 Months,85.4,81.0 to 88.9,319
≥1 Dose Varicella,,States/Local Areas,California,2013-2014,Age,19 Months,86.1,83.4 to 88.4,674
Hep B,≥3 Doses,States/Local Areas,California,2013,Age,13 Months,88.3,85.3 to 90.8,319
Hep B,≥3 Doses,States/Local Areas,California,2013-2014,Age,13 Months,84.6,78.2 to 89.4,674
Hep B,≥3 Doses,States/Local Areas,California,2014,Age,13 Months,80.9,72.7 to 87.0,355
Hep B,≥3 Doses,States/Local Areas,California,2014-2015,Age,13 Months,82.5,76.5 to 87.1,648
Hep A,≥2 Doses,States/Local Areas,California,2017,Age,35 Months,80.0,72.3 to 86.6,418
Hep A,≥2 Doses,States/Local Areas,California,2017-2018,Age,35 Months,79.8,74.5 to 84.6,977
Hep A,≥2 Doses,States/Local Areas,California,2018,Age,35 Months,79.8,72.2 to 86.5,559
Hep A,≥2 Doses,States/Local Areas,California,2018-2019,Age,35 Months,79.3,74.1 to 84.2,1096
Hep B,≥3 Doses,States/Local Areas,California,2012,Age,13 Months,92.5,89.9 to 94.5,320
Hep A,≥2 Doses,States/Local Areas,California,2019,Age,35 Months,79.1,71.8 to 85.6,537
DTaP,≥4 Doses,States/Local Areas,California,2013,Age,35 Months,90.4,81.7 to 96.1,319
DTaP,≥4 Doses,States/Local Areas,California,2013-2014,Age,35 Months,90.7,81.5 to 96.5,674
DTaP,≥4 Doses,States/Local Areas,California,2014,Age,35 Months,88.8,77.1 to 96.2,355
DTaP,≥4 Doses,States/Local Areas,California,2014-2015,Age,35 Months,92.0,83.9 to 96.9,648
DTaP,≥4 Doses,States/Local Areas,California,2012,Age,35 Months,94.2,88.5 to 97.6,320
DTaP,≥4 Doses,States/Local Areas,California,2015,Age,35 Months,94.1,84.1 to 98.7,293
DTaP,≥4 Doses,States/Local Areas,California,2015-2016,Age,35 Months,91.3,84.5 to 95.9,599
≥1 Dose Varicella,,States/Local Areas,California,2019,Age,24 Months,89.0,84.1 to 93.0,537
≥1 Dose Varicella,,States/Local Areas,California,2011,Age,35 Months,91.1,83.7 to 96.0,298
≥1 Dose Varicella,,States/Local Areas,California,2012,Age,35 Months,97.7,95.0 to 99.1,320
≥1 Dose MMR,,States/Local Areas,California,2013,Age,24 Months,89.9,83.5 to 94.5,319
≥1 Dose MMR,,States/Local Areas,California,2013-2014,Age,24 Months,89.2,84.9 to 92.7,674
≥1 Dose MMR,,States/Local Areas,California,2014,Age,24 Months,88.6,82.2 to 93.5,355
≥1 Dose MMR,,States/Local Areas,California,2014-2015,Age,24 Months,90.4,86.3 to 93.7,648
≥1 Dose MMR,,States/Local Areas,California,2015,Age,24 Months,92.8,87.3 to 96.6,293
≥1 Dose MMR,,States/Local Areas,California,2015-2016,Age,24 Months,92.2,88.0 to 95.3,599
≥1 Dose Varicella,,States/Local Areas,California,2018,Age,24 Months,89.6,85.1 to 93.3,559
≥1 Dose Varicella,,States/Local Areas,California,2018-2019,Age,24 Months,89.3,86.1 to 92.1,1096
Hep B,≥3 Doses,States/Local Areas,California,2019,Age,19 Months,94.0,91.0 to 96.0,537
Hep B,≥3 Doses,States/Local Areas,California,2011,Age,24 Months,89.6,83.0 to 94.4,298
Hep B,≥3 Doses,States/Local Areas,California,2013,Age,24 Months,91.2,86.1 to 95.0,319
Hep B,≥3 Doses,States/Local Areas,California,2013-2014,Age,24 Months,88.7,84.5 to 92.2,674
Hep B,≥3 Doses,States/Local Areas,California,2012,Age,24 Months,94.1,90.0 to 97.0,320
Hep B,≥3 Doses,States/Local Areas,California,2014,Age,24 Months,86.0,79.2 to 91.5,355
Hep B,≥3 Doses,States/Local Areas,California,2014-2015,Age,24 Months,87.4,82.4 to 91.5,648
PCV,≥3 Doses,States/Local Areas,California,2016,Age,7 Months,63.3,52.8 to 72.7,306
PCV,≥3 Doses,States/Local Areas,California,2016-2017,Age,7 Months,60.2,53.6 to 66.5,724
PCV,≥3 Doses,States/Local Areas,California,2017,Age,7 Months,57.0,48.9 to 64.8,418
PCV,≥3 Doses,States/Local Areas,California,2017-2018,Age,7 Months,62.5,57.2 to 67.5,977
PCV,≥4 Doses,States/Local Areas,California,2015,Age,19 Months,74.6,69.0 to 79.4,293
PCV,≥4 Doses,States/Local Areas,California,2015-2016,Age,19 Months,74.0,67.1 to 79.9,599
PCV,≥4 Doses,States/Local Areas,California,2016,Age,19 Months,73.4,63.1 to 81.7,306
PCV,≥4 Doses,States/Local Areas,California,2016-2017,Age,19 Months,72.2,65.8 to 77.9,724
Hep B,"≥1 Dose, 1 Day",States/Local Areas,California,2019,Age,0-1 Days,77.4,71.7 to 82.2,537
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2011,Age,0-2 Days,68.6,63.9 to 73.0,298
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2012,Age,0-2 Days,65.2,53.4 to 75.4,320
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2013,Age,0-2 Days,66.4,58.6 to 73.3,319
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2013-2014,Age,0-2 Days,62.3,54.8 to 69.2,674
Hep B,≥2 Doses,States/Local Areas,California,2013,Age,7 Months,89.4,86.1 to 92.0,319
Hep B,≥2 Doses,States/Local Areas,California,2013-2014,Age,7 Months,87.1,83.5 to 90.0,674
Hep B,≥2 Doses,States/Local Areas,California,2014,Age,7 Months,84.7,76.9 to 90.2,355
Hep B,≥2 Doses,States/Local Areas,California,2014-2015,Age,7 Months,86.4,80.9 to 90.6,648
Hep B,≥2 Doses,States/Local Areas,California,2012,Age,7 Months,93.1,89.7 to 95.4,320
Hep B,≥2 Doses,States/Local Areas,California,2015,Age,7 Months,88.2,79.3 to 93.6,293
Hep B,≥2 Doses,States/Local Areas,California,2015-2016,Age,7 Months,88.5,82.9 to 92.5,599
PCV,≥3 Doses,States/Local Areas,California,2018,Age,7 Months,68.2,61.7 to 74.0,559
PCV,≥3 Doses,States/Local Areas,California,2018-2019,Age,7 Months,67.6,63.1 to 71.8,1096
PCV,≥3 Doses,States/Local Areas,California,2019,Age,7 Months,67.1,60.7 to 72.9,537
PCV,≥3 Doses,States/Local Areas,California,2011,Age,13 Months,82.9,78.8 to 86.4,298
PCV,≥3 Doses,States/Local Areas,California,2013,Age,13 Months,88.0,83.8 to 91.2,319
PCV,≥3 Doses,States/Local Areas,California,2013-2014,Age,13 Months,85.2,78.9 to 89.8,674
Hep B,≥3 Doses,States/Local Areas,California,2015,Age,24 Months,88.7,81.1 to 94.2,293
Hep B,≥3 Doses,States/Local Areas,California,2015-2016,Age,24 Months,89.8,84.9 to 93.7,599
Hep B,≥3 Doses,States/Local Areas,California,2016,Age,24 Months,90.9,84.0 to 95.6,306
Hep B,≥3 Doses,States/Local Areas,California,2016-2017,Age,24 Months,90.8,86.5 to 94.1,724
PCV,≥3 Doses,States/Local Areas,California,2012,Age,13 Months,89.9,84.0 to 93.8,320
Hep B,≥3 Doses,States/Local Areas,California,2017,Age,24 Months,90.6,85.2 to 94.7,418
Hep B,≥3 Doses,States/Local Areas,California,2017-2018,Age,24 Months,90.8,87.4 to 93.5,977
PCV,≥4 Doses,States/Local Areas,California,2018,Age,19 Months,81.8,76.3 to 86.3,559
PCV,≥4 Doses,States/Local Areas,California,2018-2019,Age,19 Months,80.5,75.9 to 84.4,920
≥1 Dose MMR,,States/Local Areas,California,2016,Age,24 Months,91.2,84.8 to 95.6,306
≥1 Dose MMR,,States/Local Areas,California,2016-2017,Age,24 Months,88.7,84.2 to 92.3,724
≥1 Dose MMR,,States/Local Areas,California,2017,Age,24 Months,86.3,79.8 to 91.5,418
≥1 Dose MMR,,States/Local Areas,California,2017-2018,Age,24 Months,89.7,85.9 to 92.8,977
Hep B,≥2 Doses,States/Local Areas,California,2017,Age,5 Months,84.3,77.5 to 89.3,418
Hep B,≥2 Doses,States/Local Areas,California,2017-2018,Age,5 Months,86.4,82.4 to 89.7,977
Hep B,≥3 Doses,States/Local Areas,California,2017,Age,19 Months,90.6,84.7 to 94.4,418
Hep B,≥3 Doses,States/Local Areas,California,2017-2018,Age,19 Months,90.4,86.9 to 93.1,977
Hep B,≥3 Doses,States/Local Areas,California,2018,Age,19 Months,90.2,85.6 to 93.5,559
Hep B,≥3 Doses,States/Local Areas,California,2018-2019,Age,19 Months,89.9,86.9 to 92.3,1096
PCV,≥3 Doses,States/Local Areas,California,2013,Age,7 Months,67.1,64.5 to 69.6,319
PCV,≥3 Doses,States/Local Areas,California,2013-2014,Age,7 Months,60.5,55.2 to 65.7,674
PCV,≥3 Doses,States/Local Areas,California,2014,Age,7 Months,54.0,45.1 to 62.6,355
PCV,≥3 Doses,States/Local Areas,California,2014-2015,Age,7 Months,53.1,46.3 to 59.8,648
PCV,≥3 Doses,States/Local Areas,California,2012,Age,7 Months,61.3,55.3 to 67.0,320
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,77.8,69.4 to 86.2,343
DTaP,≥4 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,85.1,78.9 to 91.2,583
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2014,Age,0-2 Days,58.2,48.7 to 67.0,355
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2014-2015,Age,0-2 Days,58.9,51.7 to 65.6,648
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2015,Age,0-2 Days,59.6,48.9 to 69.4,293
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2015-2016,Age,0-2 Days,64.9,57.6 to 71.6,599
PCV,≥4 Doses,States/Local Areas,California,2019,Age,19 Months,79.2,73.4 to 84.1,537
≥1 Dose MMR,,States/Local Areas,California,2018,Age,24 Months,93.2,89.4 to 96.1,559
≥1 Dose MMR,,States/Local Areas,California,2018-2019,Age,24 Months,91.9,89.0 to 94.3,1096
≥1 Dose Varicella,,States/Local Areas,California,2013,Age,35 Months,93.9,87.6 to 97.6,319
≥1 Dose Varicella,,States/Local Areas,California,2013-2014,Age,35 Months,95.4,87.8 to 98.9,674
≥1 Dose Varicella,,States/Local Areas,California,2014,Age,35 Months,94.8,85.5 to 98.9,355
≥1 Dose Varicella,,States/Local Areas,California,2014-2015,Age,35 Months,95.9,88.6 to 99.1,648
PCV,≥4 Doses,States/Local Areas,California,2011,Age,24 Months,79.4,71.5 to 86.3,298
Hib,Primary Series,States/Local Areas,California,2020,Age,24 Months,88.3,83.0 to 92.6,434
≥1 Dose Varicella,,States/Local Areas,California,2015,Age,35 Months,94.4,88.6 to 97.8,293
≥1 Dose Varicella,,States/Local Areas,California,2015-2016,Age,35 Months,94.8,90.5 to 97.6,599
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2016,Age,0-2 Days,70.2,60.2 to 78.6,306
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2016-2017,Age,0-2 Days,71.9,65.8 to 77.4,724
Hep B,≥2 Doses,States/Local Areas,California,2016,Age,7 Months,88.9,80.5 to 94.0,306
Hep B,≥2 Doses,States/Local Areas,California,2016-2017,Age,7 Months,89.0,84.0 to 92.5,724
Hep B,≥2 Doses,States/Local Areas,California,2017,Age,7 Months,89.1,82.7 to 93.3,418
Hep B,≥2 Doses,States/Local Areas,California,2017-2018,Age,7 Months,90.2,86.5 to 93.0,977
Hep B,≥2 Doses,States/Local Areas,California,2018,Age,7 Months,91.4,86.8 to 94.4,559
Hep B,≥2 Doses,States/Local Areas,California,2018-2019,Age,7 Months,93.5,90.9 to 95.3,1096
PCV,≥3 Doses,States/Local Areas,California,2014,Age,13 Months,82.3,74.0 to 88.4,355
PCV,≥3 Doses,States/Local Areas,California,2014-2015,Age,13 Months,84.5,78.9 to 88.9,648
PCV,≥3 Doses,States/Local Areas,California,2015,Age,13 Months,86.8,78.5 to 92.2,293
PCV,≥3 Doses,States/Local Areas,California,2015-2016,Age,13 Months,85.6,79.5 to 90.2,599
≥1 Dose Varicella,,States/Local Areas,California,2017,Age,35 Months,90.6,84.7 to 94.8,418
≥1 Dose Varicella,,States/Local Areas,California,2017-2018,Age,35 Months,90.5,86.8 to 93.4,977
≥1 Dose Varicella,,States/Local Areas,California,2018,Age,35 Months,89.9,85.4 to 93.5,559
≥1 Dose Varicella,,States/Local Areas,California,2018-2019,Age,35 Months,91.3,88.1 to 94.0,1096
≥1 Dose MMR,,States/Local Areas,California,2014,Age,35 Months,92.0,85.3 to 96.5,355
≥1 Dose MMR,,States/Local Areas,California,2014-2015,Age,35 Months,93.2,88.6 to 96.4,648
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2017,Age,0-2 Days,73.7,66.3 to 80.0,418
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2017-2018,Age,0-2 Days,71.7,66.8 to 76.1,977
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2018,Age,0-2 Days,69.5,62.9 to 75.4,559
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2018-2019,Age,0-2 Days,74.8,70.6 to 78.7,1096
Hib,≥1 Dose,States/Local Areas,California,2011,Age,3 Months,88.2,82.0 to 92.5,298
Hib,≥1 Dose,States/Local Areas,California,2012,Age,3 Months,85.8,80.9 to 89.6,320
Hib,≥1 Dose,States/Local Areas,California,2013,Age,3 Months,87.4,83.3 to 90.6,319
Hib,≥1 Dose,States/Local Areas,California,2013-2014,Age,3 Months,84.2,82.4 to 85.8,674
Hep B,≥3 Doses,States/Local Areas,California,2018,Age,35 Months,93.1,88.8 to 96.1,559
Hep B,≥3 Doses,States/Local Areas,California,2018-2019,Age,35 Months,95.4,93.0 to 97.2,1096
PCV,≥3 Doses,States/Local Areas,California,2012,Age,19 Months,91.8,89.1 to 94.0,320
Hep B,≥3 Doses,States/Local Areas,California,2017,Age,35 Months,92.5,87.1 to 96.2,418
Hep B,≥3 Doses,States/Local Areas,California,2017-2018,Age,35 Months,92.7,89.4 to 95.3,977
PCV,≥4 Doses,States/Local Areas,California,2019,Age,24 Months,82.8,77.1 to 87.8,537
PCV,≥4 Doses,States/Local Areas,California,2011,Age,35 Months,80.0,72.1 to 86.8,298
PCV,≥4 Doses,States/Local Areas,California,2012,Age,35 Months,89.2,81.3 to 94.7,320
PCV,≥3 Doses,States/Local Areas,California,2019,Age,13 Months,90.3,85.5 to 93.6,537
PCV,≥3 Doses,States/Local Areas,California,2011,Age,19 Months,87.2,83.0 to 90.4,298
PCV,≥3 Doses,States/Local Areas,California,2013,Age,19 Months,92.7,90.6 to 94.4,319
PCV,≥3 Doses,States/Local Areas,California,2013-2014,Age,19 Months,89.2,85.0 to 92.4,674
PCV,≥3 Doses,States/Local Areas,California,2014,Age,19 Months,85.7,77.6 to 91.2,355
PCV,≥3 Doses,States/Local Areas,California,2014-2015,Age,19 Months,87.6,82.1 to 91.6,648
Hep B,≥3 Doses,States/Local Areas,California,2016,Age,35 Months,91.1,84.2 to 95.8,306
Hep B,≥3 Doses,States/Local Areas,California,2016-2017,Age,35 Months,91.9,87.6 to 95.2,724
Hep B,≥2 Doses,States/Local Areas,California,2019,Age,7 Months,95.6,92.7 to 97.4,537
Hep B,≥2 Doses,States/Local Areas,California,2011,Age,13 Months,94.0,88.5 to 96.9,298
Hep B,≥2 Doses,States/Local Areas,California,2012,Age,13 Months,95.2,91.5 to 97.3,320
Hep B,≥2 Doses,States/Local Areas,California,2013,Age,13 Months,95.2,90.8 to 97.6,319
Hep B,≥2 Doses,States/Local Areas,California,2013-2014,Age,13 Months,92.5,87.6 to 95.6,674
PCV,≥3 Doses,States/Local Areas,California,2017,Age,13 Months,86.3,79.5 to 91.0,418
PCV,≥3 Doses,States/Local Areas,California,2017-2018,Age,13 Months,89.3,85.5 to 92.2,977
PCV,≥3 Doses,States/Local Areas,California,2018,Age,13 Months,92.4,88.6 to 95.1,559
PCV,≥3 Doses,States/Local Areas,California,2018-2019,Age,13 Months,91.4,88.5 to 93.6,1096
Hep B,≥3 Doses,States/Local Areas,California,2013,Age,35 Months,93.8,88.8 to 97.1,319
Hep B,≥3 Doses,States/Local Areas,California,2013-2014,Age,35 Months,90.1,86.0 to 93.5,674
Hep B,≥3 Doses,States/Local Areas,California,2014,Age,35 Months,86.9,80.0 to 92.3,355
Hep B,≥3 Doses,States/Local Areas,California,2014-2015,Age,35 Months,89.6,84.6 to 93.5,648
Hep B,≥3 Doses,States/Local Areas,California,2015,Age,35 Months,93.2,84.2 to 98.0,293
Hep B,≥3 Doses,States/Local Areas,California,2015-2016,Age,35 Months,91.9,86.7 to 95.6,599
PCV,≥4 Doses,States/Local Areas,California,2016,Age,24 Months,77.5,68.0 to 85.8,306
PCV,≥4 Doses,States/Local Areas,California,2016-2017,Age,24 Months,77.1,71.1 to 82.6,724
PCV,≥4 Doses,States/Local Areas,California,2017,Age,24 Months,76.5,69.0 to 83.2,418
PCV,≥4 Doses,States/Local Areas,California,2017-2018,Age,24 Months,81.5,77.1 to 85.6,977
PCV,≥4 Doses,States/Local Areas,California,2018,Age,24 Months,86.8,82.1 to 90.8,559
PCV,≥4 Doses,States/Local Areas,California,2018-2019,Age,24 Months,84.8,81.2 to 88.0,1096
≥1 Dose MMR,,States/Local Areas,California,2015,Age,35 Months,93.7,88.1 to 97.3,293
≥1 Dose MMR,,States/Local Areas,California,2015-2016,Age,35 Months,93.8,89.5 to 96.8,599
≥1 Dose MMR,,States/Local Areas,California,2016,Age,35 Months,93.5,86.7 to 97.6,306
≥1 Dose MMR,,States/Local Areas,California,2016-2017,Age,35 Months,89.5,85.1 to 93.1,724
≥1 Dose MMR,,States/Local Areas,California,2017,Age,35 Months,87.6,81.3 to 92.6,418
≥1 Dose MMR,,States/Local Areas,California,2017-2018,Age,35 Months,90.7,86.9 to 93.7,977
≥1 Dose Varicella,,States/Local Areas,California,2019,Age,35 Months,93.0,88.1 to 96.4,537
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,91.3,87.2 to 95.3,820
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,86.8,81.7 to 92.0,283
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",89.0,73.6 to 100.0,41
Hep B,≥3 Doses,States/Local Areas,California,2012,Age,35 Months,96.1,92.4 to 98.3,320
Hep B,"≥1 Dose, 2 Day",States/Local Areas,California,2019,Age,0-2 Days,80.3,74.8 to 84.9,537
Hep B,≥3 Doses,States/Local Areas,California,2019,Age,24 Months,95.1,92.4 to 97.1,537
Hep B,≥3 Doses,States/Local Areas,California,2011,Age,35 Months,90.8,83.9 to 95.6,298
PCV,≥4 Doses,States/Local Areas,California,2012,Age,24 Months,86.9,79.9 to 92.4,320
PCV,≥4 Doses,States/Local Areas,California,2013,Age,24 Months,82.5,75.1 to 88.7,319
PCV,≥4 Doses,States/Local Areas,California,2013-2014,Age,24 Months,79.9,74.5 to 84.7,674
PCV,≥4 Doses,States/Local Areas,California,2014,Age,24 Months,77.7,69.8 to 84.7,355
PCV,≥4 Doses,States/Local Areas,California,2014-2015,Age,24 Months,79.7,74.0 to 84.9,648
PCV,≥4 Doses,States/Local Areas,California,2015,Age,24 Months,83.1,74.0 to 90.3,293
PCV,≥4 Doses,States/Local Areas,California,2015-2016,Age,24 Months,80.0,73.6 to 85.7,599
≥1 Dose MMR,,States/Local Areas,California,2019,Age,24 Months,90.6,86.0 to 94.1,537
≥1 Dose MMR,,States/Local Areas,California,2011,Age,35 Months,91.3,84.0 to 96.2,298
≥1 Dose MMR,,States/Local Areas,California,2012,Age,35 Months,96.6,93.1 to 98.6,320
≥1 Dose MMR,,States/Local Areas,California,2013,Age,35 Months,95.5,88.9 to 98.8,319
≥1 Dose MMR,,States/Local Areas,California,2013-2014,Age,35 Months,93.2,88.5 to 96.4,674
≥1 Dose Varicella,,States/Local Areas,California,2016,Age,35 Months,93.9,88.2 to 97.5,306
≥1 Dose Varicella,,States/Local Areas,California,2016-2017,Age,35 Months,92.0,88.0 to 95.0,724
PCV,≥3 Doses,States/Local Areas,California,2016,Age,13 Months,84.5,74.5 to 91.0,306
PCV,≥3 Doses,States/Local Areas,California,2016-2017,Age,13 Months,85.3,79.5 to 89.7,724
Hep B,≥3 Doses,States/Local Areas,California,2018,Age,24 Months,90.9,86.7 to 94.3,559
Hep B,≥3 Doses,States/Local Areas,California,2018-2019,Age,24 Months,92.9,90.5 to 95.0,1096
Hep B,≥2 Doses,States/Local Areas,California,2016,Age,13 Months,94.8,87.5 to 97.9,306
Hep B,≥2 Doses,States/Local Areas,California,2016-2017,Age,13 Months,93.8,89.7 to 96.3,724
Hep B,≥2 Doses,States/Local Areas,California,2015,Age,13 Months,93.2,85.2 to 97.0,293
Hep B,≥2 Doses,States/Local Areas,California,2015-2016,Age,13 Months,94.0,89.2 to 96.8,599
Hib,≥1 Dose,States/Local Areas,California,2014,Age,3 Months,81.0,73.4 to 86.8,355
Hib,≥1 Dose,States/Local Areas,California,2014-2015,Age,3 Months,83.9,78.4 to 88.3,648
Hep B,≥2 Doses,States/Local Areas,California,2014,Age,13 Months,89.8,82.8 to 94.2,355
Hep B,≥2 Doses,States/Local Areas,California,2014-2015,Age,13 Months,91.5,86.6 to 94.7,648
≥1 Dose MMR,,States/Local Areas,California,2018,Age,35 Months,93.9,90.0 to 96.6,559
≥1 Dose MMR,,States/Local Areas,California,2018-2019,Age,35 Months,93.5,90.5 to 95.8,1096
PCV,≥4 Doses,States/Local Areas,California,2013,Age,35 Months,86.4,79.0 to 92.3,319
PCV,≥4 Doses,States/Local Areas,California,2013-2014,Age,35 Months,83.0,77.4 to 87.9,674
≥1 Dose MMR,,States/Local Areas,California,2019,Age,35 Months,93.4,88.2 to 96.8,537
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,91.6,87.6 to 95.6,820
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.5,82.6 to 94.5,531
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,89.8,85.7 to 93.9,588
Hib,≥1 Dose,States/Local Areas,California,2015,Age,3 Months,87.0,78.1 to 92.6,293
Hib,≥1 Dose,States/Local Areas,California,2015-2016,Age,3 Months,85.1,79.2 to 89.6,599
Hib,≥1 Dose,States/Local Areas,California,2016,Age,3 Months,83.3,74.5 to 89.5,306
Hib,≥1 Dose,States/Local Areas,California,2016-2017,Age,3 Months,82.9,77.5 to 87.3,724
Hib,≥1 Dose,States/Local Areas,California,2017,Age,3 Months,82.5,75.3 to 88.0,418
Hib,≥1 Dose,States/Local Areas,California,2017-2018,Age,3 Months,85.4,81.1 to 88.9,977
Hep B,≥2 Doses,States/Local Areas,California,2017,Age,13 Months,92.7,87.1 to 96.0,418
Hep B,≥2 Doses,States/Local Areas,California,2017-2018,Age,13 Months,93.6,90.4 to 95.8,977
Hep B,≥2 Doses,States/Local Areas,California,2018,Age,13 Months,94.4,90.5 to 96.8,559
Hep B,≥2 Doses,States/Local Areas,California,2018-2019,Age,13 Months,96.0,93.9 to 97.4,1096
Hep B,≥2 Doses,States/Local Areas,California,2019,Age,13 Months,97.6,95.6 to 98.7,537
PCV,≥3 Doses,States/Local Areas,California,2015,Age,19 Months,89.5,84.6 to 93.0,293
PCV,≥3 Doses,States/Local Areas,California,2015-2016,Age,19 Months,89.6,84.3 to 93.2,599
PCV,≥3 Doses,States/Local Areas,California,2016,Age,19 Months,89.6,82.0 to 94.2,306
PCV,≥3 Doses,States/Local Areas,California,2016-2017,Age,19 Months,89.6,84.9 to 92.9,724
PCV,≥4 Doses,States/Local Areas,California,2017,Age,19 Months,71.0,62.9 to 78.0,418
PCV,≥4 Doses,States/Local Areas,California,2017-2018,Age,19 Months,76.3,71.4 to 80.6,977
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,88.9,84.5 to 93.4,314
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",89.1,81.3 to 96.9,255
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,85.4,78.3 to 92.5,343
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.2,83.3 to 93.1,533
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Overall,Overall,89.0,85.8 to 92.2,1141
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Poverty,<133% FPL,86.8,81.3 to 92.4,215
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",88.3,82.3 to 94.3,531
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,90.1,86.0 to 94.2,588
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,89.9,85.2 to 94.5,533
≥1 Dose Varicella,,States/Local Areas,California,2014-2017,Poverty,>400% FPL,94.6,90.9 to 98.2,583
PCV,≥3 Doses,States/Local Areas,California,2017,Age,19 Months,89.6,83.2 to 93.7,418
PCV,≥3 Doses,States/Local Areas,California,2017-2018,Age,19 Months,92.5,89.1 to 95.0,977
Hep B,≥3 Doses,States/Local Areas,California,2019,Age,35 Months,98.0,95.4 to 99.3,537
PCV,≥4 Doses,States/Local Areas,California,2014,Age,35 Months,80.4,72.1 to 87.4,355
PCV,≥4 Doses,States/Local Areas,California,2014-2015,Age,35 Months,82.0,76.0 to 87.3,648
PCV,≥4 Doses,States/Local Areas,California,2015,Age,35 Months,84.7,75.5 to 91.8,293
PCV,≥4 Doses,States/Local Areas,California,2015-2016,Age,35 Months,84.3,77.2 to 90.1,599
PCV,≥4 Doses,States/Local Areas,California,2016,Age,35 Months,83.5,73.0 to 91.6,306
PCV,≥4 Doses,States/Local Areas,California,2016-2017,Age,35 Months,80.7,74.7 to 86.0,724
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,88.3,83.4 to 93.2,283
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,89.8,85.4 to 94.2,314
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",91.5,84.6 to 98.4,255
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.2,74.9 to 100.0,41
PCV,≥3 Doses,States/Local Areas,California,2015,Age,24 Months,91.1,84.1 to 95.9,293
PCV,≥3 Doses,States/Local Areas,California,2015-2016,Age,24 Months,91.2,86.6 to 94.7,599
PCV,≥3 Doses,States/Local Areas,California,2014,Age,24 Months,88.8,82.0 to 93.9,355
PCV,≥3 Doses,States/Local Areas,California,2014-2015,Age,24 Months,90.0,85.2 to 93.8,648
Hib,≥2 Doses,States/Local Areas,California,2017,Age,5 Months,70.4,62.2 to 77.5,418
Hib,≥2 Doses,States/Local Areas,California,2017-2018,Age,5 Months,73.9,68.7 to 78.5,977
PCV,≥3 Doses,States/Local Areas,California,2013,Age,24 Months,92.7,88.0 to 96.1,319
PCV,≥3 Doses,States/Local Areas,California,2013-2014,Age,24 Months,90.9,86.8 to 94.1,674
Hib,≥1 Dose,States/Local Areas,California,2018,Age,3 Months,88.4,83.4 to 92.1,559
Hib,≥1 Dose,States/Local Areas,California,2018-2019,Age,3 Months,89.4,86.3 to 92.0,1096
Hib,≥1 Dose,States/Local Areas,California,2019,Age,3 Months,90.5,86.1 to 93.6,537
Hib,≥2 Doses,States/Local Areas,California,2015,Age,5 Months,71.6,61.8 to 79.8,293
Hib,≥2 Doses,States/Local Areas,California,2015-2016,Age,5 Months,72.6,65.6 to 78.7,599
Hib,≥2 Doses,States/Local Areas,California,2016,Age,5 Months,73.6,63.2 to 81.9,306
Hib,≥2 Doses,States/Local Areas,California,2016-2017,Age,5 Months,72.1,65.5 to 77.8,724
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,82.2,76.8 to 87.7,820
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,74.9,67.8 to 82.0,283
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,76.8,70.0 to 83.6,314
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.4,59.8 to 100.0,41
PCV,≥1 Dose,States/Local Areas,California,2013,Age,3 Months,88.8,86.9 to 90.4,319
PCV,≥1 Dose,States/Local Areas,California,2013-2014,Age,3 Months,82.9,77.5 to 87.2,674
PCV,≥3 Doses,States/Local Areas,California,2018,Age,19 Months,95.6,92.7 to 97.4,559
PCV,≥3 Doses,States/Local Areas,California,2018-2019,Age,19 Months,91.4,88.5 to 93.6,1096
PCV,≥3 Doses,States/Local Areas,California,2019,Age,19 Months,92.9,88.6 to 95.7,537
PCV,≥3 Doses,States/Local Areas,California,2011,Age,24 Months,88.3,81.4 to 93.5,298
Hib,≥2 Doses,States/Local Areas,California,2011,Age,5 Months,79.7,76.8 to 82.2,298
Hib,≥2 Doses,States/Local Areas,California,2012,Age,5 Months,76.9,73.1 to 80.3,320
Hib,≥2 Doses,States/Local Areas,California,2013,Age,5 Months,71.3,64.3 to 77.4,319
Hib,≥2 Doses,States/Local Areas,California,2013-2014,Age,5 Months,71.1,68.3 to 73.8,674
Hib,≥2 Doses,States/Local Areas,California,2014,Age,5 Months,70.9,62.2 to 78.3,355
Hib,≥2 Doses,States/Local Areas,California,2014-2015,Age,5 Months,71.3,67.8 to 74.6,648
PCV,≥4 Doses,States/Local Areas,California,2017,Age,35 Months,78.9,71.5 to 85.5,418
PCV,≥4 Doses,States/Local Areas,California,2017-2018,Age,35 Months,84.0,79.5 to 87.9,977
PCV,≥4 Doses,States/Local Areas,California,2018,Age,35 Months,89.8,84.9 to 93.6,559
PCV,≥4 Doses,States/Local Areas,California,2018-2019,Age,35 Months,88.2,84.5 to 91.5,1096
PCV,≥4 Doses,States/Local Areas,California,2019,Age,35 Months,86.8,80.8 to 91.6,537
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Overall,Overall,89.9,86.8 to 93.0,1141
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Poverty,<133% FPL,87.4,81.9 to 92.9,215
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,87.2,80.4 to 94.0,343
≥1 Dose MMR,,States/Local Areas,California,2014-2017,Poverty,>400% FPL,95.0,91.5 to 98.5,583
PCV,≥1 Dose,States/Local Areas,California,2011,Age,3 Months,86.5,79.9 to 91.3,298
PCV,≥1 Dose,States/Local Areas,California,2012,Age,3 Months,82.2,78.8 to 85.2,320
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.0,67.8 to 88.1,255
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.1,74.4 to 87.7,531
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,80.5,74.2 to 86.9,588
PCV,≥1 Dose,States/Local Areas,California,2014,Age,3 Months,77.0,68.7 to 83.7,355
PCV,≥1 Dose,States/Local Areas,California,2014-2015,Age,3 Months,82.2,76.4 to 86.8,648
PCV,≥1 Dose,States/Local Areas,California,2015,Age,3 Months,87.4,79.0 to 92.8,293
PCV,≥1 Dose,States/Local Areas,California,2015-2016,Age,3 Months,85.4,79.6 to 89.7,599
Hib,≥2 Doses,States/Local Areas,California,2018,Age,5 Months,77.5,71.2 to 82.7,559
Hib,≥2 Doses,States/Local Areas,California,2018-2019,Age,5 Months,78.9,74.8 to 82.5,1096
Hib,≥2 Doses,States/Local Areas,California,2019,Age,5 Months,80.4,74.7 to 85.1,537
Hib,≥2 Doses,States/Local Areas,California,2011,Age,7 Months,87.9,85.2 to 90.1,298
Hib,≥2 Doses,States/Local Areas,California,2012,Age,7 Months,93.0,90.5 to 95.0,320
PCV,≥3 Doses,States/Local Areas,California,2016,Age,24 Months,91.2,84.9 to 95.7,306
PCV,≥3 Doses,States/Local Areas,California,2016-2017,Age,24 Months,91.0,86.9 to 94.2,724
PCV,≥3 Doses,States/Local Areas,California,2017,Age,24 Months,90.8,85.2 to 94.8,418
PCV,≥3 Doses,States/Local Areas,California,2017-2018,Age,24 Months,93.2,90.2 to 95.6,977
PCV,≥3 Doses,States/Local Areas,California,2018,Age,24 Months,95.8,93.1 to 97.7,559
PCV,≥3 Doses,States/Local Areas,California,2018-2019,Age,24 Months,94.6,92.3 to 96.4,1096
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2011,Age,0-3 Days,70.1,61.7 to 77.3,298
PCV,≥1 Dose,States/Local Areas,California,2018,Age,3 Months,88.6,83.8 to 92.1,559
PCV,≥1 Dose,States/Local Areas,California,2018-2019,Age,3 Months,89.9,86.9 to 92.3,1096
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,86.1,80.8 to 91.5,283
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2012,Age,0-3 Days,67.1,58.9 to 74.3,320
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2013,Age,0-3 Days,69.1,61.0 to 76.2,319
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2013-2014,Age,0-3 Days,64.0,57.7 to 69.9,674
PCV,≥3 Doses,States/Local Areas,California,2012,Age,24 Months,93.9,87.3 to 97.7,320
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Insurance Coverage,Private Insurance Only,90.3,85.9 to 94.6,820
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.1,60.4 to 100.0,41
Hib,≥2 Doses,States/Local Areas,California,2013,Age,7 Months,89.0,83.6 to 92.8,319
Hib,≥2 Doses,States/Local Areas,California,2013-2014,Age,7 Months,87.6,84.6 to 90.1,674
Hib,≥2 Doses,States/Local Areas,California,2014,Age,7 Months,86.2,78.4 to 91.5,355
Hib,≥2 Doses,States/Local Areas,California,2014-2015,Age,7 Months,87.6,82.3 to 91.5,648
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014,Age,0-3 Days,58.8,49.4 to 67.7,355
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2014-2015,Age,0-3 Days,60.1,53.0 to 66.8,648
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2015,Age,0-3 Days,61.4,50.7 to 71.1,293
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2015-2016,Age,0-3 Days,66.0,58.7 to 72.7,599
DTaP,≥3 Doses,States/Local Areas,California,2011,Age,7 Months,72.0,64.7 to 78.3,298
DTaP,≥3 Doses,States/Local Areas,California,2012,Age,7 Months,64.9,56.8 to 72.2,320
DTaP,≥3 Doses,States/Local Areas,California,2013,Age,7 Months,70.6,66.9 to 74.0,319
DTaP,≥3 Doses,States/Local Areas,California,2013-2014,Age,7 Months,64.8,60.8 to 68.6,674
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Overall,Overall,88.2,84.8 to 91.6,1141
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,85.5,79.4 to 91.7,215
PCV,≥1 Dose,States/Local Areas,California,2019,Age,3 Months,91.2,87.1 to 94.1,537
Polio,≥1 Dose,States/Local Areas,California,2011,Age,3 Months,88.2,82.6 to 92.2,298
Polio,≥1 Dose,States/Local Areas,California,2012,Age,3 Months,85.5,79.0 to 90.3,320
Polio,≥1 Dose,States/Local Areas,California,2013,Age,3 Months,87.0,85.3 to 88.5,319
Polio,≥1 Dose,States/Local Areas,California,2013-2014,Age,3 Months,84.4,80.9 to 87.4,674
Polio,≥1 Dose,States/Local Areas,California,2014,Age,3 Months,81.9,74.4 to 87.6,355
Polio,≥1 Dose,States/Local Areas,California,2014-2015,Age,3 Months,83.7,78.1 to 88.1,648
PCV,≥1 Dose,States/Local Areas,California,2016,Age,3 Months,83.3,74.5 to 89.5,306
PCV,≥1 Dose,States/Local Areas,California,2016-2017,Age,3 Months,82.5,77.0 to 86.9,724
PCV,≥1 Dose,States/Local Areas,California,2017,Age,3 Months,81.6,74.4 to 87.2,418
PCV,≥1 Dose,States/Local Areas,California,2017-2018,Age,3 Months,85.1,80.8 to 88.5,977
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.3,72.2 to 84.4,533
Hep B,≥3 Doses,States/Local Areas,California,2020,Age,24 Months,89.3,83.3 to 93.9,434
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Overall,Overall,78.4,74.0 to 82.9,1141
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Poverty,<133% FPL,73.0,64.7 to 81.3,215
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,75.9,67.6 to 84.2,343
PCV,≥4 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,86.5,81.0 to 92.0,583
Hib,≥2 Doses,States/Local Areas,California,2015,Age,7 Months,89.1,81.0 to 94.0,293
Hib,≥2 Doses,States/Local Areas,California,2015-2016,Age,7 Months,88.2,82.1 to 92.4,599
PCV,≥3 Doses,States/Local Areas,California,2019,Age,24 Months,93.4,89.4 to 96.3,537
PCV,≥3 Doses,States/Local Areas,California,2011,Age,35 Months,91.4,84.4 to 96.1,298
PCV,≥3 Doses,States/Local Areas,California,2013,Age,35 Months,95.0,90.3 to 97.9,319
PCV,≥3 Doses,States/Local Areas,California,2013-2014,Age,35 Months,91.5,87.4 to 94.7,674
PCV,≥3 Doses,States/Local Areas,California,2012,Age,35 Months,94.2,87.3 to 98.1,320
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,87.7,82.7 to 92.7,314
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.6,80.6 to 96.6,255
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.9,84.4 to 95.4,531
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,88.3,83.5 to 93.0,588
Hib,≥2 Doses,States/Local Areas,California,2016,Age,7 Months,87.2,77.1 to 93.3,306
Hib,≥2 Doses,States/Local Areas,California,2016-2017,Age,7 Months,87.8,82.1 to 91.9,724
Hib,≥2 Doses,States/Local Areas,California,2017,Age,7 Months,88.4,81.7 to 92.9,418
Hib,≥2 Doses,States/Local Areas,California,2017-2018,Age,7 Months,89.8,85.9 to 92.7,977
DTaP,≥3 Doses,States/Local Areas,California,2014,Age,7 Months,59.0,50.0 to 67.4,355
DTaP,≥3 Doses,States/Local Areas,California,2014-2015,Age,7 Months,59.7,52.8 to 66.3,648
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,83.8,76.4 to 91.2,343
Hep B,≥3 Doses,States/Local Areas,California,2014-2017,Poverty,>400% FPL,94.8,91.5 to 98.1,583
Hib,≥3 Doses,States/Local Areas,California,2011,Age,7 Months,69.0,62.7 to 74.8,298
Hib,≥3 Doses,States/Local Areas,California,2012,Age,7 Months,60.6,53.9 to 66.9,320
Hib,≥3 Doses,States/Local Areas,California,2013,Age,7 Months,63.1,56.1 to 69.6,319
Hib,≥3 Doses,States/Local Areas,California,2013-2014,Age,7 Months,59.4,56.6 to 62.2,674
Polio,≥1 Dose,States/Local Areas,California,2015,Age,3 Months,85.5,76.3 to 91.6,293
Polio,≥1 Dose,States/Local Areas,California,2015-2016,Age,3 Months,84.7,78.6 to 89.2,599
Polio,≥1 Dose,States/Local Areas,California,2016,Age,3 Months,83.8,75.0 to 89.9,306
Polio,≥1 Dose,States/Local Areas,California,2016-2017,Age,3 Months,82.7,77.3 to 87.1,724
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016,Age,0-3 Days,70.7,60.6 to 79.0,306
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2016-2017,Age,0-3 Days,72.7,66.6 to 78.1,724
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2017,Age,0-3 Days,75.4,62.1 to 85.1,182
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,California,2017-2018,Age,0-3 Days,73.0,68.2 to 77.4,977
Hib,Full Series,States/Local Areas,California,2014-2017,Insurance Coverage,Any Medicaid,76.1,69.0 to 83.3,283
Hib,Full Series,States/Local Areas,California,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",88.7,73.3 to 100.0,41
DTaP,≥2 Doses,States/Local Areas,California,2011,Age,5 Months,80.4,76.9 to 83.5,298
DTaP,≥2 Doses,States/Local Areas,California,2012,Age,5 Months,77.4,73.6 to 80.9,320
DTaP,≥2 Doses,States/Local Areas,California,2013,Age,5 Months,73.7,68.9 to 78.0,319
DTaP,≥2 Doses,States/Local Areas,California,2013-2014,Age,5 Months,72.9,70.1 to 75.6,674
DTaP,≥2 Doses,States/Local Areas,California,2014,Age,5 Months,72.2,63.4 to 79.5,355
DTaP,≥2 Doses,States/Local Areas,California,2014-2015,Age,5 Months,73.6,71.1 to 76.0,648
Hib,Full Series,States/Local Areas,California,2019,Age,24 Months,77.5,71.5 to 83.1,537
Hib,Full Series,States/Local Areas,California,2011,Age,35 Months,82.5,74.1 to 89.5,298
Hib,Full Series,States/Local Areas,California,2012,Age,35 Months,85.3,77.1 to 91.7,320
Hib,Full Series,States/Local Areas,California,2013,Age,35 Months,91.0,83.9 to 95.8,319
Hib,Full Series,States/Local Areas,California,2013-2014,Age,35 Months,87.2,79.2 to 93.2,674
Hib,Full Series,States/Local Areas,California,2014,Age,35 Months,84.0,71.9 to 93.0,355
Hib,Full Series,States/Local Areas,California,2014-2015,Age,35 Months,87.3,77.8 to 94.1,648
Polio,≥3 Doses,States/Local Areas,California,2013,Age,35 Months,94.0,88.8 to 97.3,319
Polio,≥3 Doses,States/Local Areas,California,2013-2014,Age,35 Months,92.6,88.3 to 95.7,674
Polio,≥3 Doses,States/Local Areas,California,2014,Age,35 Months,90.9,84.0 to 95.6,355
Polio,≥3 Doses,States/Local Areas,California,2014-2015,Age,35 Months,93.0,88.2 to 96.3,648
Polio,≥3 Doses,States/Local Areas,California,2012,Age,35 Months,97.3,94.1 to 99.0,320
Polio,≥3 Doses,States/Local Areas,California,2015,Age,35 Months,93.0,87.1 to 96.9,293
Polio,≥3 Doses,States/Local Areas,California,2015-2016,Age,35 Months,95.7,88.6 to 98.9,599
DTaP,≥2 Doses,States/Local Areas,California,2015,Age,5 Months,75.2,65.5 to 82.8,293
DTaP,≥2 Doses,States/Local Areas,California,2015-2016,Age,5 Months,75.6,68.8 to 81.4,599
DTaP,≥2 Doses,States/Local Areas,California,2016,Age,5 Months,76.1,65.7 to 84.1,306
DTaP,≥2 Doses,States/Local Areas,California,2016-2017,Age,5 Months,74.2,67.8 to 79.8,724
Polio,≥3 Doses,States/Local Areas,California,2016,Age,35 Months,95.6,86.1 to 99.3,306
Polio,≥3 Doses,States/Local Areas,California,2016-2017,Age,35 Months,93.5,89.3 to 96.5,724
Polio,≥3 Doses,States/Local Areas,California,2017,Age,35 Months,92.4,87.1 to 96.1,418
Polio,≥3 Doses,States/Local Areas,California,2017-2018,Age,35 Months,94.1,91.1 to 96.3,977
Polio,≥3 Doses,States/Local Areas,California,2017,Age,24 Months,92.0,86.7 to 95.7,418
Polio,≥3 Doses,States/Local Areas,California,2017-2018,Age,24 Months,93.6,90.6 to 95.8,977
Polio,≥3 Doses,States/Local Areas,California,2018,Age,24 Months,95.3,92.4 to 97.3,559
Polio,≥3 Doses,States/Local Areas,California,2018-2019,Age,24 Months,95.2,93.0 to 96.8,1096
Polio,≥3 Doses,States/Local Areas,California,2019,Age,24 Months,95.0,91.5 to 97.3,537
Hib,≥3 Doses,States/Local Areas,California,2019,Age,19 Months,93.2,89.1 to 95.8,537
Hib,≥3 Doses,States/Local Areas,California,2011,Age,24 Months,90.2,83.5 to 95.0,298
Hib,≥3 Doses,States/Local Areas,California,2012,Age,24 Months,95.7,92.1 to 98.0,320
Hib,≥3 Doses,States/Local Areas,California,2013,Age,24 Months,93.0,88.1 to 96.4,319
Hib,≥3 Doses,States/Local Areas,California,2013-2014,Age,24 Months,91.4,87.4 to 94.5,674
Hib,≥3 Doses,States/Local Areas,California,2014,Age,24 Months,89.6,83.1 to 94.4,355
Hib,≥3 Doses,States/Local Areas,California,2014-2015,Age,24 Months,90.9,86.5 to 94.4,648
Polio,≥3 Doses,States/Local Areas,California,2011,Age,35 Months,93.3,86.1 to 97.5,298
Hib,Full Series,States/Local Areas,California,2016,Age,24 Months,77.8,68.3 to 86.0,306
Hib,Full Series,States/Local Areas,California,2016-2017,Age,24 Months,76.0,70.0 to 81.6,724
Hib,Full Series,States/Local Areas,California,2017,Age,24 Months,74.1,66.4 to 81.2,418
Hib,Full Series,States/Local Areas,California,2017-2018,Age,24 Months,78.3,73.6 to 82.8,977
Hib,Full Series,States/Local Areas,California,2018,Age,24 Months,82.8,77.4 to 87.7,559
Hib,Full Series,States/Local Areas,California,2018-2019,Age,24 Months,80.2,76.2 to 83.9,1096
DTaP,≥3 Doses,States/Local Areas,California,2012,Age,24 Months,96.4,92.7 to 98.5,320
DTaP,≥3 Doses,States/Local Areas,California,2019,Age,19 Months,95.4,91.6 to 97.6,537
DTaP,≥3 Doses,States/Local Areas,California,2011,Age,24 Months,90.7,84.0 to 95.4,298
DTaP,≥3 Doses,States/Local Areas,California,2013,Age,24 Months,94.7,90.2 to 97.5,319
DTaP,≥3 Doses,States/Local Areas,California,2013-2014,Age,24 Months,93.4,89.8 to 96.1,674
Hib,Full Series,States/Local Areas,California,2015,Age,24 Months,85.7,77.4 to 92.1,293
Hib,Full Series,States/Local Areas,California,2015-2016,Age,24 Months,81.9,75.7 to 87.3,599
DTaP,≥3 Doses,States/Local Areas,California,2017,Age,19 Months,92.6,87.0 to 95.9,418
DTaP,≥3 Doses,States/Local Areas,California,2017-2018,Age,19 Months,94.0,91.0 to 96.1,977
DTaP,≥3 Doses,States/Local Areas,California,2018,Age,19 Months,95.5,92.5 to 97.4,559
DTaP,≥3 Doses,States/Local Areas,California,2018-2019,Age,19 Months,92.4,89.6 to 94.6,1096
DTaP,≥3 Doses,States/Local Areas,California,2016,Age,19 Months,93.4,87.3 to 96.7,306
DTaP,≥3 Doses,States/Local Areas,California,2016-2017,Age,19 Months,93.0,89.2 to 95.5,724
Polio,≥3 Doses,States/Local Areas,California,2014,Age,24 Months,86.1,79.2 to 91.7,355
Polio,≥3 Doses,States/Local Areas,California,2014-2015,Age,24 Months,89.7,85.2 to 93.3,648
Polio,≥3 Doses,States/Local Areas,California,2015,Age,24 Months,93.0,87.1 to 96.9,293
Polio,≥3 Doses,States/Local Areas,California,2015-2016,Age,24 Months,92.1,87.9 to 95.2,599
Polio,≥2 Doses,States/Local Areas,California,2020,Age,13 Months,92.9,88.2 to 95.9,434
Hib,≥3 Doses,States/Local Areas,California,2018,Age,19 Months,93.0,88.9 to 95.6,559
Hib,≥3 Doses,States/Local Areas,California,2018-2019,Age,19 Months,83.8,80.1 to 87.0,1096
Polio,≥3 Doses,States/Local Areas,California,2016,Age,24 Months,91.1,84.7 to 95.6,306
Polio,≥3 Doses,States/Local Areas,California,2016-2017,Age,24 Months,91.5,87.5 to 94.7,724
Hib,≥3 Doses,States/Local Areas,California,2017,Age,19 Months,88.8,82.4 to 93.1,418
Hib,≥3 Doses,States/Local Areas,California,2017-2018,Age,19 Months,90.9,87.2 to 93.6,977
DTaP,≥3 Doses,States/Local Areas,California,2014,Age,19 Months,88.8,81.3 to 93.5,355
DTaP,≥3 Doses,States/Local Areas,California,2014-2015,Age,19 Months,91.8,87.3 to 94.8,648
DTaP,≥3 Doses,States/Local Areas,California,2015,Age,19 Months,94.8,90.5 to 97.2,293
DTaP,≥3 Doses,States/Local Areas,California,2015-2016,Age,19 Months,94.1,90.3 to 96.5,599
Hib,≥3 Doses,States/Local Areas,California,2015,Age,19 Months,90.0,86.2 to 92.8,293
Hib,≥3 Doses,States/Local Areas,California,2015-2016,Age,19 Months,89.0,83.8 to 92.7,599
Hib,≥3 Doses,States/Local Areas,California,2016,Age,19 Months,88.0,80.2 to 93.0,306
Hib,≥3 Doses,States/Local Areas,California,2016-2017,Age,19 Months,88.4,83.6 to 91.9,724
Polio,≥3 Doses,States/Local Areas,California,2019,Age,19 Months,94.8,91.0 to 97.0,537
Polio,≥3 Doses,States/Local Areas,California,2011,Age,24 Months,90.0,83.3 to 94.8,298
Polio,≥3 Doses,States/Local Areas,California,2012,Age,24 Months,96.1,92.5 to 98.3,320
Polio,≥3 Doses,States/Local Areas,California,2013,Age,24 Months,91.6,86.4 to 95.3,319
Polio,≥3 Doses,States/Local Areas,California,2013-2014,Age,24 Months,88.9,84.6 to 92.4,674
Hib,≥3 Doses,States/Local Areas,California,2014,Age,19 Months,87.9,80.4 to 92.7,355
Hib,≥3 Doses,States/Local Areas,California,2014-2015,Age,19 Months,88.9,83.8 to 92.6,648
Hib,Full Series,States/Local Areas,California,2014-2017,Overall,Overall,79.0,74.5 to 83.5,1141
Hib,Full Series,States/Local Areas,California,2014-2017,Poverty,<133% FPL,72.7,64.2 to 81.3,215
Hib,Full Series,States/Local Areas,California,2014-2017,Poverty,133% to <400% FPL,78.5,70.5 to 86.5,343
Hib,Primary Series,States/Local Areas,California,2011,Age,7 Months,70.1,64.0 to 75.6,298
Hib,Full Series,States/Local Areas,California,2014-2017,Poverty,>400% FPL,86.3,80.4 to 92.1,583
Hib,Primary Series,States/Local Areas,California,2012,Age,7 Months,63.2,55.8 to 70.1,320
Hib,Full Series,States/Local Areas,California,2014-2017,Race and Ethnicity,Hispanic,76.7,69.7 to 83.7,314
Hib,Full Series,States/Local Areas,California,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.9,68.8 to 88.9,255
Hib,Full Series,States/Local Areas,California,2014-2017,Race and Ethnicity,"White, Non-Hispanic",81.8,74.8 to 88.8,531
Hib,Full Series,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Principal City,79.8,73.3 to 86.4,588
Hib,Full Series,States/Local Areas,California,2014-2017,Urbanicity,Living In a MSA Non-Principal City,80.2,74.2 to 86.3,533
Rotavirus,,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,79.0,74.7 to 83.4,753
Rotavirus,,States/Local Areas,New York,2013,Age,8 Months,71.7,66.6 to 76.2,545
Rotavirus,,States/Local Areas,New York,2013-2014,Age,8 Months,72.3,68.9 to 75.5,1137
Rotavirus,,States/Local Areas,New York,2012,Age,8 Months,68.7,63.3 to 73.7,492
Rotavirus,,States/Local Areas,New York,2014,Age,8 Months,73.0,68.3 to 77.2,592
Rotavirus,,States/Local Areas,New York,2016,Age,8 Months,70.4,64.4 to 75.7,506
Rotavirus,,States/Local Areas,New York,2016-2017,Age,8 Months,72.1,68.1 to 75.7,1154
Rotavirus,,States/Local Areas,New York,2014-2015,Age,8 Months,72.1,68.5 to 75.3,1095
Rotavirus,,States/Local Areas,New York,2015,Age,8 Months,71.2,65.8 to 76.0,503
Rotavirus,,States/Local Areas,New York,2015-2016,Age,8 Months,70.8,66.8 to 74.5,1009
Rotavirus,,States/Local Areas,New York,2011,Age,8 Months,67.9,62.0 to 73.2,466
Rotavirus,,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,67.9,62.6 to 73.3,523
Rotavirus,,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,63.0,54.3 to 71.7,203
Rotavirus,,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,79.4,76.0 to 82.8,1048
Rotavirus,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,76.9,63.8 to 90.1,75
Rotavirus,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.3,69.5 to 79.2,576
Rotavirus,,States/Local Areas,New York,2014-2017,Overall,Overall,71.8,69.1 to 74.5,1922
Rotavirus,,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,68.8,64.5 to 73.2,646
Rotavirus,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",70.7,66.8 to 74.6,955
Rotavirus,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,70.0,66.7 to 73.3,1271
Rotavirus,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",75.3,68.8 to 81.9,355
Rotavirus,,States/Local Areas,New York,2018,Age,8 Months,77.9,73.4 to 81.9,733
Rotavirus,,States/Local Areas,New York,2018-2019,Age,8 Months,77.9,74.5 to 81.0,1370
Rotavirus,,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,66.8,62.2 to 71.3,645
Rotavirus,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.3,57.3 to 75.3,160
Rotavirus,,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,74.1,69.0 to 79.1,452
Rotavirus,,States/Local Areas,New York,2019,Age,8 Months,77.8,72.5 to 82.4,637
Rotavirus,,States/Local Areas,New York,2017,Age,8 Months,73.9,68.6 to 78.6,648
Rotavirus,,States/Local Areas,New York,2017-2018,Age,8 Months,75.9,72.5 to 79.0,1381
Combined 7 Series,,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,71.7,68.0 to 75.5,1048
Combined 7 Series,,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,64.4,59.9 to 69.0,645
Combined 7 Series,,States/Local Areas,New York,2019,Age,35 Months,73.9,67.8 to 79.7,637
Combined 7 Series,,States/Local Areas,New York,2018,Age,35 Months,78.0,72.7 to 82.9,733
Combined 7 Series,,States/Local Areas,New York,2018-2019,Age,35 Months,76.0,72.0 to 79.9,1370
Hib,Primary Series,States/Local Areas,New York,2016,Age,13 Months,83.7,78.3 to 87.9,506
Hib,Primary Series,States/Local Areas,New York,2016-2017,Age,13 Months,86.0,82.7 to 88.8,1154
Hib,Full Series,States/Local Areas,New York,2013,Age,24 Months,80.9,76.5 to 84.9,545
Hib,Full Series,States/Local Areas,New York,2013-2014,Age,24 Months,81.3,78.3 to 84.1,1137
Hib,Full Series,States/Local Areas,New York,2014,Age,24 Months,81.8,77.5 to 85.7,592
Hib,Full Series,States/Local Areas,New York,2014-2015,Age,24 Months,79.8,76.6 to 82.9,1095
Hib,Full Series,States/Local Areas,New York,2012,Age,24 Months,80.5,75.7 to 84.8,492
Hib,Full Series,States/Local Areas,New York,2011,Age,24 Months,80.3,75.5 to 84.7,466
Hib,Full Series,States/Local Areas,New York,2017,Age,19 Months,78.0,73.2 to 82.2,648
Hib,Full Series,States/Local Areas,New York,2017-2018,Age,19 Months,75.1,71.8 to 78.1,1381
Hib,Full Series,States/Local Areas,New York,2018,Age,19 Months,72.1,67.5 to 76.3,733
Hib,Full Series,States/Local Areas,New York,2018-2019,Age,19 Months,93.8,91.6 to 95.5,1370
Combined 7 Series,,States/Local Areas,New York,2015,Age,35 Months,73.0,67.2 to 78.5,503
Combined 7 Series,,States/Local Areas,New York,2015-2016,Age,35 Months,70.8,66.6 to 75.0,1009
Combined 7 Series,,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,67.4,61.7 to 73.0,452
Hib,Full Series,States/Local Areas,New York,2019,Age,19 Months,72.0,66.3 to 77.1,637
Hib,Full Series,States/Local Areas,New York,2015,Age,19 Months,71.5,67.6 to 75.0,503
Hib,Full Series,States/Local Areas,New York,2015-2016,Age,19 Months,71.7,67.7 to 75.3,1009
Hib,Full Series,States/Local Areas,New York,2016,Age,19 Months,71.9,66.0 to 77.2,506
Hib,Full Series,States/Local Areas,New York,2016-2017,Age,19 Months,74.9,71.1 to 78.3,1154
Combined 7 Series,,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,65.1,59.6 to 70.5,523
Combined 7 Series,,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,75.4,71.0 to 79.8,753
Hib,Full Series,States/Local Areas,New York,2011,Age,19 Months,71.6,64.2 to 78.0,466
Hib,Full Series,States/Local Areas,New York,2012,Age,19 Months,72.0,65.6 to 77.7,492
Hib,Full Series,States/Local Areas,New York,2013,Age,19 Months,72.5,67.2 to 77.3,545
Hib,Full Series,States/Local Areas,New York,2013-2014,Age,19 Months,72.0,68.0 to 75.7,1137
Hib,Full Series,States/Local Areas,New York,2014,Age,19 Months,71.5,66.7 to 75.9,592
Hib,Full Series,States/Local Areas,New York,2014-2015,Age,19 Months,71.5,67.9 to 74.8,1095
Combined 7 Series,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",71.7,65.4 to 77.9,355
Combined 7 Series,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",67.8,63.8 to 71.8,955
Combined 7 Series,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,70.2,65.1 to 75.2,576
Combined 7 Series,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,64.6,61.1 to 68.1,1271
Combined 7 Series,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,79.9,69.6 to 90.2,75
Combined 7 Series,,States/Local Areas,New York,2014-2017,Overall,Overall,67.2,64.4 to 70.1,1922
Combined 7 Series,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",59.6,50.1 to 69.0,160
Combined 7 Series,,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,62.6,57.9 to 67.2,646
Combined 7 Series,,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,64.1,55.2 to 72.9,203
Hib,Primary Series,States/Local Areas,New York,2019,Age,19 Months,91.3,87.1 to 94.3,637
Hib,Primary Series,States/Local Areas,New York,2013,Age,19 Months,92.7,90.4 to 94.5,545
Hib,Primary Series,States/Local Areas,New York,2013-2014,Age,19 Months,93.0,90.6 to 94.8,1137
Hib,Primary Series,States/Local Areas,New York,2011,Age,24 Months,92.7,89.1 to 95.5,466
Hib,Primary Series,States/Local Areas,New York,2012,Age,24 Months,95.3,92.7 to 97.3,492
Hib,Primary Series,States/Local Areas,New York,2017,Age,7 Months,71.1,65.7 to 76.0,648
Hib,Primary Series,States/Local Areas,New York,2017-2018,Age,7 Months,70.1,66.5 to 73.4,1381
Hib,Primary Series,States/Local Areas,New York,2016,Age,7 Months,65.1,59.0 to 70.8,506
Hib,Primary Series,States/Local Areas,New York,2016-2017,Age,7 Months,68.0,63.9 to 71.9,1154
Hib,Primary Series,States/Local Areas,New York,2017,Age,19 Months,93.7,90.6 to 95.8,648
Hib,Primary Series,States/Local Areas,New York,2017-2018,Age,19 Months,92.7,90.6 to 94.4,1381
Hib,Primary Series,States/Local Areas,New York,2016,Age,19 Months,89.1,84.2 to 92.5,506
Hib,Primary Series,States/Local Areas,New York,2016-2017,Age,19 Months,91.3,88.5 to 93.5,1154
Hib,Primary Series,States/Local Areas,New York,2015,Age,19 Months,91.2,88.2 to 93.5,503
Hib,Primary Series,States/Local Areas,New York,2015-2016,Age,19 Months,90.1,87.1 to 92.5,1009
Hib,Primary Series,States/Local Areas,New York,2018,Age,19 Months,91.8,88.5 to 94.1,733
Hib,Primary Series,States/Local Areas,New York,2018-2019,Age,19 Months,86.8,83.8 to 89.2,1370
Hib,Primary Series,States/Local Areas,New York,2014,Age,19 Months,93.3,90.5 to 95.3,592
Hib,Primary Series,States/Local Areas,New York,2014-2015,Age,19 Months,92.2,90.0 to 94.0,1095
Hib,Primary Series,States/Local Areas,New York,2018,Age,13 Months,87.0,83.1 to 90.1,733
Hib,Primary Series,States/Local Areas,New York,2018-2019,Age,13 Months,86.8,83.8 to 89.2,1370
Hib,Primary Series,States/Local Areas,New York,2012,Age,19 Months,92.7,90.7 to 94.2,492
Hib,Primary Series,States/Local Areas,New York,2011,Age,19 Months,92.6,88.2 to 95.4,466
Hib,Primary Series,States/Local Areas,New York,2019,Age,13 Months,86.5,81.9 to 90.1,637
Hib,Primary Series,States/Local Areas,New York,2017,Age,13 Months,88.5,84.4 to 91.6,648
Hib,Primary Series,States/Local Areas,New York,2017-2018,Age,13 Months,87.8,85.0 to 90.0,1381
Hep B,≥2 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,91.6,89.1 to 93.6,1261
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Poverty,>400% FPL,96.6,94.8 to 98.4,975
Hep B,≥3 Doses,States/Local Areas,New York,2019-2020,Age,7 Months,50.5,46.5 to 54.5,1261
Hep B,≥1 Dose,States/Local Areas,New York,2021,Age,3 Months,89.3,83.6 to 93.2,402
≥1 Dose MMR,,States/Local Areas,New York,2020-2021,Age,19 Months,86.7,83.4 to 89.5,1026
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,75.8,68.8 to 82.9,566
Hib,Full Series,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,76.9,72.0 to 81.8,566
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,Hispanic,91.8,88.7 to 95.0,566
DTaP,≥4 Doses,States/Local Areas,New York,2016-2019,Poverty,133% to <400% FPL,77.5,72.5 to 82.6,644
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,72.6,68.0 to 77.2,701
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.6,82.4 to 90.7,466
Hib,≥2 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,88.6,85.2 to 91.3,1026
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"White, Non-Hispanic",67.4,60.7 to 74.0,1072
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Insurance Coverage,Any Medicaid,76.3,71.8 to 80.7,701
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",74.9,64.6 to 85.2,198
Influenza,,States/Local Areas,New York,2019,Age,24 Months,67.7,62.1 to 73.3,637
Influenza,,States/Local Areas,New York,2014-2017,Insurance Coverage,Private Insurance Only,73.2,69.6 to 76.7,1048
Hep A,≥1 Dose,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,83.6,80.4 to 86.8,1314
PCV,≥3 Doses,States/Local Areas,New York,2019-2020,Age,19 Months,90.9,88.1 to 93.1,1261
Influenza,,States/Local Areas,New York,2013,Age,24 Months,61.7,56.4 to 67.0,545
Influenza,,States/Local Areas,New York,2013-2014,Age,24 Months,61.8,58.2 to 65.5,1137
Influenza,,States/Local Areas,New York,2014,Age,24 Months,62.0,57.1 to 66.9,592
Influenza,,States/Local Areas,New York,2014-2015,Age,24 Months,63.3,59.6 to 66.9,1095
Influenza,,States/Local Areas,New York,2015,Age,24 Months,64.6,59.2 to 69.9,503
Influenza,,States/Local Areas,New York,2015-2016,Age,24 Months,62.0,57.9 to 66.1,1009
Influenza,,States/Local Areas,New York,2012,Age,24 Months,65.2,59.8 to 70.5,492
Influenza,,States/Local Areas,New York,2011,Age,24 Months,59.6,53.8 to 65.6,466
Polio,≥2 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,94.1,91.3 to 96.0,1026
Hep B,≥3 Doses,States/Local Areas,New York,2021,Age,13 Months,88.8,83.3 to 92.7,402
Hib,≥2 Doses,States/Local Areas,New York,2020-2021,Age,5 Months,76.5,72.5 to 80.1,1026
Influenza,,States/Local Areas,New York,2021,Age,24 Months,59.0,52.0 to 66.2,402
DTaP,≥4 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,70.1,65.8 to 74.0,1026
Hep B,≥2 Doses,States/Local Areas,New York,2021,Age,5 Months,85.3,79.3 to 89.8,402
Hep A,≥2 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,18.4,15.3 to 22.0,1026
DTaP,≥3 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,89.1,85.7 to 91.8,1026
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New York,2020-2021,Age,0-2 Days,75.0,70.9 to 78.7,1026
DTaP,≥1 Dose,States/Local Areas,New York,2020-2021,Age,3 Months,86.6,83.2 to 89.4,1026
≥1 Dose Varicella,,States/Local Areas,New York,2020-2021,Age,19 Months,86.0,82.5 to 88.8,1026
Hep B,≥1 Dose,States/Local Areas,New York,2020-2021,Age,3 Months,91.2,88.0 to 93.6,1026
PCV,≥3 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,63.6,59.2 to 67.7,1026
DTaP,≥2 Doses,States/Local Areas,New York,2021,Age,5 Months,80.0,73.5 to 85.2,402
≥1 Dose Varicella,,States/Local Areas,New York,2021,Age,13 Months,53.8,47.0 to 60.5,402
Polio,≥2 Doses,States/Local Areas,New York,2021,Age,5 Months,78.9,72.5 to 84.2,402
≥1 Dose MMR,,States/Local Areas,New York,2021,Age,19 Months,87.2,81.5 to 91.3,402
Hib,Primary Series,States/Local Areas,New York,2020-2021,Age,35 Months,93.6,90.9 to 95.8,1026
Influenza,,States/Local Areas,New York,2017,Age,24 Months,65.9,60.6 to 71.3,648
Influenza,,States/Local Areas,New York,2017-2018,Age,24 Months,68.2,64.6 to 71.8,1381
Influenza,,States/Local Areas,New York,2018,Age,24 Months,70.5,65.7 to 75.2,733
Influenza,,States/Local Areas,New York,2018-2019,Age,24 Months,69.2,65.5 to 72.8,1370
Influenza,,States/Local Areas,New York,2016,Age,24 Months,59.4,53.4 to 65.5,506
Influenza,,States/Local Areas,New York,2016-2017,Age,24 Months,62.6,58.5 to 66.6,1154
Influenza,,States/Local Areas,New York,2014-2017,Insurance Coverage,Other,49.8,40.8 to 58.8,203
Influenza,,States/Local Areas,New York,2014-2017,Insurance Coverage,Any Medicaid,56.6,51.9 to 61.4,645
Influenza,,States/Local Areas,New York,2014-2017,Race and Ethnicity,Hispanic,65.1,59.5 to 70.6,452
Influenza,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.7,61.9 to 75.4,355
Influenza,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",55.2,46.1 to 64.3,160
Influenza,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a Non-MSA,53.2,38.9 to 67.6,75
Influenza,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.3,64.3 to 74.3,576
Influenza,,States/Local Areas,New York,2014-2017,Race and Ethnicity,"White, Non-Hispanic",63.1,59.0 to 67.2,955
Influenza,,States/Local Areas,New York,2014-2017,Urbanicity,Living In a MSA Principal City,61.4,57.9 to 64.9,1271
Hib,Full Series,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.1,81.5 to 90.7,466
DTaP,≥3 Doses,States/Local Areas,New York,2021,Age,24 Months,91.9,86.9 to 95.5,402
Hib,≥3 Doses,States/Local Areas,New York,2021,Age,35 Months,92.1,86.9 to 95.7,402
PCV,≥1 Dose,States/Local Areas,New York,2021,Age,3 Months,81.5,75.3 to 86.4,402
Hep A,≥2 Doses,States/Local Areas,New York,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",84.3,76.8 to 91.9,466
PCV,≥4 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,86.6,83.7 to 89.5,1314
Polio,≥1 Dose,States/Local Areas,New York,2020-2021,Age,3 Months,86.0,82.5 to 88.8,1026
PCV,≥1 Dose,States/Local Areas,New York,2020-2021,Age,3 Months,82.2,78.4 to 85.3,1026
DTaP,≥3 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,70.6,66.4 to 74.5,1026
PCV,≥3 Doses,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,95.3,93.5 to 97.1,1314
Hib,Full Series,States/Local Areas,New York,2016-2019,Insurance Coverage,Private Insurance Only,85.7,82.8 to 88.7,1314
Influenza,,States/Local Areas,New York,2014-2017,Overall,Overall,63.6,60.7 to 66.4,1922
Influenza,,States/Local Areas,New York,2014-2017,Poverty,<133% FPL,59.8,55.2 to 64.4,646
Influenza,,States/Local Areas,New York,2014-2017,Poverty,133% to <400% FPL,56.2,50.6 to 61.9,523
Influenza,,States/Local Areas,New York,2014-2017,Poverty,>400% FPL,75.2,70.9 to 79.5,753
Hep A,≥2 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,72.2,66.1 to 78.0,1026
PCV,≥3 Doses,States/Local Areas,New York,2020-2021,Age,13 Months,87.0,83.5 to 89.8,1026
Hib,≥3 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,58.9,54.5 to 63.1,1026
≥1 Dose MMR,,States/Local Areas,New York,2021,Age,13 Months,59.0,52.2 to 65.6,402
Hib,Primary Series,States/Local Areas,New York,2020-2021,Age,13 Months,86.1,82.6 to 89.0,1026
PCV,≥3 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,91.6,88.4 to 94.1,1026
Hep B,≥2 Doses,States/Local Areas,New York,2020-2021,Age,5 Months,85.5,81.9 to 88.5,1026
Rotavirus,,States/Local Areas,New York,2021,Age,8 Months,72.8,66.1 to 78.6,402
Hib,Primary Series,States/Local Areas,New York,2020-2021,Age,7 Months,70.5,66.4 to 74.3,1026
Polio,≥3 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,94.9,91.6 to 97.1,1026
Hep A,≥2 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,32.0,27.9 to 36.5,1026
Polio,≥2 Doses,States/Local Areas,New York,2020-2021,Age,5 Months,77.6,73.6 to 81.2,1026
Hib,Primary Series,States/Local Areas,New York,2021,Age,35 Months,92.6,87.8 to 96.0,402
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2021,Age,0-3 Days,73.8,67.3 to 79.4,402
DTaP,≥2 Doses,States/Local Areas,New York,2020-2021,Age,5 Months,78.1,74.1 to 81.6,1026
Hib,≥2 Doses,States/Local Areas,New York,2021,Age,13 Months,93.8,88.7 to 96.7,402
Hib,≥3 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,90.7,87.6 to 93.2,1026
Polio,≥3 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,92.5,89.6 to 94.8,1026
≥1 Dose MMR,,States/Local Areas,New York,2020-2021,Age,13 Months,61.4,57.0 to 65.6,1026
Hib,Full Series,States/Local Areas,New York,2020-2021,Age,35 Months,83.7,79.7 to 87.4,1026
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New York,2020-2021,Age,0-3 Days,76.3,72.3 to 79.8,1026
DTaP,≥3 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,94.8,91.6 to 97.1,1026
Hib,Primary Series,States/Local Areas,New York,2020-2021,Age,19 Months,92.3,89.3 to 94.5,1026
Hep B,≥3 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,91.7,88.7 to 93.9,1026
Rotavirus,,States/Local Areas,New York,2020-2021,Age,8 Months,74.7,70.6 to 78.4,1026
≥1 Dose Varicella,,States/Local Areas,New York,2021,Age,35 Months,93.3,87.7 to 96.9,402
Polio,≥3 Doses,States/Local Areas,New York,2021,Age,35 Months,91.0,85.9 to 94.8,402
Hep A,≥1 Dose,States/Local Areas,New York,2020-2021,Age,19 Months,73.2,69.1 to 76.9,1026
DTaP,≥4 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,81.6,77.7 to 85.2,1026
Hep B,≥2 Doses,States/Local Areas,New York,2021,Age,13 Months,92.4,87.1 to 95.7,402
DTaP,≥3 Doses,States/Local Areas,New York,2020-2021,Age,24 Months,93.0,90.2 to 95.3,1026
Hib,Full Series,States/Local Areas,New York,2020-2021,Age,19 Months,72.2,68.1 to 76.0,1026
Hep A,≥1 Dose,States/Local Areas,New York,2020-2021,Age,35 Months,89.1,83.2 to 93.6,1026
Hib,≥3 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,92.9,90.0 to 95.2,1026
PCV,≥4 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,74.1,70.0 to 77.8,1026
DTaP,≥4 Doses,States/Local Areas,New York,2021,Age,35 Months,86.8,79.9 to 92.2,402
Hep B,≥3 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,50.4,46.1 to 54.7,1026
PCV,≥4 Doses,States/Local Areas,New York,2020-2021,Age,35 Months,85.1,81.1 to 88.6,1026
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New York,2020-2021,Age,0-1 Days,72.8,68.7 to 76.6,1026
Influenza,,States/Local Areas,New York,2020-2021,Age,24 Months,60.8,56.4 to 65.2,1026
PCV,≥3 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,90.4,87.1 to 93.0,1026
≥1 Dose MMR,,States/Local Areas,New York,2020-2021,Age,35 Months,95.1,92.1 to 97.3,1026
Hep B,≥3 Doses,States/Local Areas,New York,2021,Age,35 Months,97.0,89.5 to 99.6,402
Combined 7 Series,,States/Local Areas,New York,2020-2021,Age,24 Months,69.5,65.3 to 73.6,1026
Hep B,≥2 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,90.0,86.8 to 92.5,1026
Hib,Full Series,States/Local Areas,New York,2021,Age,35 Months,82.4,75.6 to 88.1,402
DTaP,≥3 Doses,States/Local Areas,New York,2021,Age,35 Months,91.9,86.9 to 95.5,402
Polio,≥2 Doses,States/Local Areas,New York,2020-2021,Age,7 Months,90.2,86.8 to 92.7,1026
Hib,≥3 Doses,States/Local Areas,New York,2021,Age,13 Months,77.1,70.6 to 82.5,402
Polio,≥3 Doses,States/Local Areas,New York,2020-2021,Age,19 Months,91.4,88.2 to 93.7,1026
Hib,Primary Series,States/Local Areas,New York,2021,Age,13 Months,85.6,79.7 to 90.1,402
≥1 Dose MMR,,States/Local Areas,New York,2020-2021,Age,24 Months,89.7,86.6 to 92.3,1026
Combined 7 Series,,States/Local Areas,New York,2020-2021,Age,35 Months,77.8,73.1 to 82.3,1026
Hib,≥1 Dose,States/Local Areas,New York,2020-2021,Age,3 Months,84.1,80.6 to 87.1,1026
≥1 Dose Varicella,,States/Local Areas,New York,2020-2021,Age,24 Months,89.7,86.5 to 92.4,1026
≥1 Dose MMR,,States/Local Areas,Arizona,2021,Age,35 Months,86.5,78.0 to 93.0,166
Combined 7 Series,,States/Local Areas,Arizona,2018,Age,35 Months,79.1,72.0 to 85.3,284
Combined 7 Series,,States/Local Areas,Arizona,2018-2019,Age,35 Months,75.2,69.8 to 80.3,519
Combined 7 Series,,States/Local Areas,Arizona,2019,Age,35 Months,70.7,62.6 to 78.4,235
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,71.0,66.0 to 76.0,493
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,65.3,59.4 to 71.3,356
Hib,Full Series,States/Local Areas,Arizona,2013,Age,24 Months,82.8,75.9 to 88.7,264
Hib,Full Series,States/Local Areas,Arizona,2013-2014,Age,24 Months,82.7,78.1 to 86.9,523
Hib,Full Series,States/Local Areas,Arizona,2014,Age,24 Months,82.7,76.2 to 88.3,259
Hib,Full Series,States/Local Areas,Arizona,2014-2015,Age,24 Months,77.9,72.8 to 82.7,507
Hib,Full Series,States/Local Areas,Arizona,2019,Age,19 Months,71.3,63.4 to 78.2,235
Hib,Full Series,States/Local Areas,Arizona,2016,Age,19 Months,78.2,71.3 to 83.8,257
Hib,Full Series,States/Local Areas,Arizona,2016-2017,Age,19 Months,74.3,69.2 to 78.8,535
Hib,Full Series,States/Local Areas,Arizona,2014,Age,19 Months,79.3,72.0 to 85.0,259
Hib,Full Series,States/Local Areas,Arizona,2014-2015,Age,19 Months,73.0,67.5 to 77.9,507
Hib,Full Series,States/Local Areas,Arizona,2015,Age,19 Months,66.7,60.0 to 72.7,248
Hib,Full Series,States/Local Areas,Arizona,2015-2016,Age,19 Months,72.4,67.0 to 77.2,505
Hib,Full Series,States/Local Areas,Arizona,2017,Age,19 Months,70.3,62.8 to 76.8,278
Hib,Full Series,States/Local Areas,Arizona,2017-2018,Age,19 Months,73.3,68.1 to 77.9,562
Hib,Full Series,States/Local Areas,Arizona,2018,Age,19 Months,76.4,68.8 to 82.6,284
Hib,Full Series,States/Local Areas,Arizona,2018-2019,Age,19 Months,96.6,94.0 to 98.1,519
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.2,61.6 to 82.9,125
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.9,61.4 to 72.5,441
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,69.1,64.2 to 74.0,537
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,61.3,54.6 to 68.0,345
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,64.7,58.6 to 70.8,329
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",68.4,50.0 to 86.7,35
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,44.9,26.6 to 63.2,47
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,59.8,38.1 to 81.5,34
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,65.2,59.3 to 71.1,379
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,73.5,65.0 to 82.0,225
Hib,Full Series,States/Local Areas,Arizona,2011,Age,19 Months,71.1,63.6 to 77.6,266
Hib,Full Series,States/Local Areas,Arizona,2012,Age,19 Months,66.7,61.0 to 71.9,277
Hib,Full Series,States/Local Areas,Arizona,2013,Age,19 Months,75.3,71.9 to 78.5,264
Hib,Full Series,States/Local Areas,Arizona,2013-2014,Age,19 Months,77.3,73.1 to 81.0,523
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,72.8,58.2 to 87.5,48
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Overall,Overall,66.5,62.6 to 70.3,930
Hep A,≥1 Dose,States/Local Areas,Arizona,2012,Age,19 Months,79.8,72.9 to 85.4,277
Hep A,≥1 Dose,States/Local Areas,Arizona,2016,Age,19 Months,88.0,82.1 to 92.2,257
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,19 Months,84.9,80.5 to 88.4,535
Hep A,≥1 Dose,States/Local Areas,Arizona,2014,Age,19 Months,82.5,75.6 to 87.8,259
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,19 Months,79.2,74.0 to 83.6,507
Hep A,≥1 Dose,States/Local Areas,Arizona,2015,Age,19 Months,75.8,70.9 to 80.1,248
Hep A,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,19 Months,81.9,76.8 to 86.0,505
Hep A,≥1 Dose,States/Local Areas,Arizona,2013,Age,19 Months,77.4,70.8 to 82.9,264
Hep A,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,19 Months,80.0,75.1 to 84.0,523
Hib,Full Series,States/Local Areas,Arizona,2011,Age,24 Months,77.3,70.1 to 83.9,266
Hib,Full Series,States/Local Areas,Arizona,2012,Age,24 Months,73.7,66.0 to 80.9,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2016,Age,24 Months,94.8,91.0 to 97.4,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,92.8,89.6 to 95.3,535
DTaP,≥1 Dose,States/Local Areas,Arizona,2019,Age,3 Months,88.2,81.1 to 92.9,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2011,Age,19 Months,78.2,74.0 to 81.9,266
DTaP,≥1 Dose,States/Local Areas,Arizona,2017,Age,3 Months,88.6,82.7 to 92.7,278
DTaP,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,3 Months,89.5,85.6 to 92.4,562
DTaP,≥3 Doses,States/Local Areas,Arizona,2014,Age,24 Months,94.9,91.0 to 97.5,259
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,24 Months,93.4,90.4 to 95.8,507
DTaP,≥3 Doses,States/Local Areas,Arizona,2015,Age,24 Months,92.1,87.0 to 95.7,248
DTaP,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,93.5,90.4 to 95.8,505
DTaP,≥1 Dose,States/Local Areas,Arizona,2018,Age,3 Months,90.3,84.6 to 94.1,284
DTaP,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,3 Months,89.3,85.0 to 92.5,519
DTaP,≥3 Doses,States/Local Areas,Arizona,2017,Age,24 Months,90.7,85.3 to 94.8,278
DTaP,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,94.5,91.4 to 96.7,562
DTaP,≥3 Doses,States/Local Areas,Arizona,2018,Age,24 Months,98.3,95.4 to 99.5,284
DTaP,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,95.1,91.9 to 97.3,519
DTaP,≥2 Doses,States/Local Areas,Arizona,2019,Age,5 Months,80.9,72.6 to 87.1,235
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,88.6,76.9 to 100.0,48
DTaP,≥2 Doses,States/Local Areas,Arizona,2018,Age,5 Months,87.5,81.4 to 91.8,284
DTaP,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,5 Months,84.2,79.2 to 88.2,519
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Overall,Overall,91.3,89.1 to 93.5,930
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,91.8,88.5 to 95.2,326
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,88.9,85.2 to 92.7,379
Polio,≥3 Doses,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,94.8,90.5 to 99.1,225
Hib,≥3 Doses,States/Local Areas,Arizona,2015,Age,24 Months,89.5,84.3 to 93.7,248
Hib,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,24 Months,90.7,87.4 to 93.4,505
Hib,≥3 Doses,States/Local Areas,Arizona,2016,Age,24 Months,91.8,87.4 to 95.1,257
Hib,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,24 Months,91.0,87.6 to 93.7,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2019,Age,24 Months,91.9,86.2 to 95.8,235
Hib,≥3 Doses,States/Local Areas,Arizona,2017,Age,24 Months,90.2,84.7 to 94.3,278
Hib,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,24 Months,93.0,89.8 to 95.5,562
DTaP,≥2 Doses,States/Local Areas,Arizona,2017,Age,5 Months,76.2,68.9 to 82.3,278
DTaP,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,5 Months,81.8,77.2 to 85.7,562
Hib,Primary Series,States/Local Areas,Arizona,2021,Age,19 Months,86.7,75.8 to 93.1,166
Hib,Primary Series,States/Local Areas,Arizona,2020-2021,Age,24 Months,88.0,82.6 to 92.4,437
Hep B,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,82.2,76.2 to 87.0,437
Hep B,≥3 Doses,States/Local Areas,Arizona,2021,Age,19 Months,86.3,76.2 to 92.5,166
PCV,≥4 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,76.3,70.1 to 82.1,437
DTaP,≥4 Doses,States/Local Areas,Arizona,2020-2021,Age,35 Months,83.3,75.0 to 90.1,437
Hib,≥1 Dose,States/Local Areas,Arizona,2021,Age,3 Months,85.9,75.8 to 92.2,166
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.9,74.4 to 83.3,468
DTaP,≥1 Dose,States/Local Areas,Arizona,2011,Age,3 Months,84.8,79.5 to 88.9,266
DTaP,≥1 Dose,States/Local Areas,Arizona,2012,Age,3 Months,85.6,83.4 to 87.5,277
DTaP,≥1 Dose,States/Local Areas,Arizona,2013,Age,3 Months,83.3,78.8 to 86.9,264
DTaP,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,3 Months,84.9,80.6 to 88.3,523
DTaP,≥1 Dose,States/Local Areas,Arizona,2014,Age,3 Months,86.4,79.6 to 91.2,259
DTaP,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,3 Months,85.9,81.5 to 89.4,507
DTaP,≥1 Dose,States/Local Areas,Arizona,2015,Age,3 Months,85.4,79.2 to 90.0,248
DTaP,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,3 Months,87.9,84.1 to 90.9,505
DTaP,≥1 Dose,States/Local Areas,Arizona,2016,Age,3 Months,90.5,85.5 to 93.9,257
DTaP,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,3 Months,89.6,85.9 to 92.4,535
DTaP,≥4 Doses,States/Local Areas,Arizona,2021,Age,19 Months,69.5,58.3 to 78.7,166
Hep A,≥2 Doses,States/Local Areas,Arizona,2021,Age,35 Months,90.1,61.4 to 99.6,166
Combined 7 Series,,States/Local Areas,Arizona,2021,Age,35 Months,70.8,56.5 to 83.8,166
Hib,Full Series,States/Local Areas,Arizona,2021,Age,19 Months,68.1,56.9 to 77.5,166
DTaP,≥4 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,75.7,69.3 to 81.6,437
PCV,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,5 Months,72.6,65.9 to 78.4,437
Hep B,≥2 Doses,States/Local Areas,Arizona,2021,Age,5 Months,81.3,70.6 to 88.7,166
Hib,Primary Series,States/Local Areas,Arizona,2021,Age,7 Months,63.1,51.8 to 73.1,166
PCV,≥2 Doses,States/Local Areas,Arizona,2021,Age,5 Months,71.6,60.4 to 80.6,166
≥1 Dose MMR,,States/Local Areas,Arizona,2020-2021,Age,24 Months,85.6,80.3 to 90.1,437
Polio,≥3 Doses,States/Local Areas,Arizona,2021,Age,35 Months,89.6,80.9 to 95.5,166
Hep B,≥2 Doses,States/Local Areas,Arizona,2020-2021,Age,13 Months,88.4,82.6 to 92.5,437
Polio,≥2 Doses,States/Local Areas,Arizona,2021,Age,7 Months,82.6,71.9 to 89.8,166
Hib,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,24 Months,87.0,81.5 to 91.6,437
Hib,≥2 Doses,States/Local Areas,Arizona,2021,Age,7 Months,82.9,72.2 to 90.1,166
DTaP,≥3 Doses,States/Local Areas,Arizona,2021,Age,24 Months,89.9,81.2 to 95.7,166
DTaP,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,89.4,83.9 to 93.1,437
Hib,≥3 Doses,States/Local Areas,Arizona,2021,Age,19 Months,86.4,75.6 to 92.9,166
DTaP,≥3 Doses,States/Local Areas,Arizona,2011,Age,35 Months,92.6,87.0 to 96.4,266
DTaP,≥3 Doses,States/Local Areas,Arizona,2012,Age,35 Months,95.5,86.4 to 99.2,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2013,Age,35 Months,92.3,86.5 to 96.3,264
DTaP,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,94.3,91.1 to 96.7,523
DTaP,≥3 Doses,States/Local Areas,Arizona,2014,Age,35 Months,96.3,93.3 to 98.3,259
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,94.1,91.1 to 96.3,507
DTaP,≥3 Doses,States/Local Areas,Arizona,2015,Age,35 Months,92.1,87.0 to 95.7,248
DTaP,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,94.2,91.1 to 96.4,505
Hep A,≥2 Doses,States/Local Areas,Arizona,2011,Age,19 Months,20.6,17.9 to 23.7,266
Hep A,≥2 Doses,States/Local Areas,Arizona,2013,Age,19 Months,23.1,18.4 to 28.6,264
Hep A,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,23.8,19.0 to 29.2,523
Hep A,≥2 Doses,States/Local Areas,Arizona,2012,Age,19 Months,16.0,13.0 to 19.6,277
Hep A,≥2 Doses,States/Local Areas,Arizona,2014,Age,19 Months,24.4,18.1 to 32.0,259
Hep A,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,26.1,21.3 to 31.5,507
Hib,≥3 Doses,States/Local Areas,Arizona,2018,Age,24 Months,96.0,92.1 to 98.3,284
Hib,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,24 Months,93.0,89.5 to 95.7,519
Hib,≥3 Doses,States/Local Areas,Arizona,2019,Age,24 Months,90.1,84.1 to 94.6,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2017,Age,19 Months,81.7,74.9 to 86.9,278
Hep A,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,19 Months,86.4,82.1 to 89.8,562
Hep A,≥1 Dose,States/Local Areas,Arizona,2018,Age,19 Months,91.2,85.1 to 94.9,284
Hep A,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,19 Months,87.2,81.6 to 91.3,430
Hib,≥3 Doses,States/Local Areas,Arizona,2011,Age,35 Months,90.3,84.7 to 94.5,266
Hib,≥3 Doses,States/Local Areas,Arizona,2012,Age,35 Months,92.6,83.4 to 97.7,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2017,Age,35 Months,93.1,87.9 to 96.6,278
DTaP,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.5,93.4 to 98.4,562
DTaP,≥4 Doses,States/Local Areas,Arizona,2011,Age,19 Months,64.4,57.4 to 70.8,266
DTaP,≥4 Doses,States/Local Areas,Arizona,2012,Age,19 Months,65.3,57.9 to 72.1,277
DTaP,≥4 Doses,States/Local Areas,Arizona,2013,Age,19 Months,69.2,61.9 to 75.7,264
DTaP,≥4 Doses,States/Local Areas,Arizona,2013-2014,Age,19 Months,69.6,64.5 to 74.3,523
PCV,≥2 Doses,States/Local Areas,Arizona,2011,Age,5 Months,70.9,64.5 to 76.5,266
PCV,≥2 Doses,States/Local Areas,Arizona,2012,Age,5 Months,73.8,66.2 to 80.3,277
PCV,≥2 Doses,States/Local Areas,Arizona,2013,Age,5 Months,65.0,58.0 to 71.5,264
PCV,≥2 Doses,States/Local Areas,Arizona,2013-2014,Age,5 Months,70.7,64.0 to 76.6,523
DTaP,≥3 Doses,States/Local Areas,Arizona,2016,Age,35 Months,96.4,92.5 to 98.6,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,94.9,91.7 to 97.1,535
Hep A,≥2 Doses,States/Local Areas,Arizona,2015,Age,19 Months,27.8,25.5 to 30.1,248
Hep A,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,28.3,23.3 to 33.9,505
Hep A,≥2 Doses,States/Local Areas,Arizona,2016,Age,19 Months,28.9,22.0 to 36.8,257
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,28.2,23.5 to 33.3,535
Hib,≥3 Doses,States/Local Areas,Arizona,2013,Age,35 Months,91.2,85.4 to 95.3,264
Hib,≥3 Doses,States/Local Areas,Arizona,2013-2014,Age,35 Months,92.3,88.7 to 95.0,523
Hib,≥3 Doses,States/Local Areas,Arizona,2014,Age,35 Months,93.4,88.9 to 96.6,259
Hib,≥3 Doses,States/Local Areas,Arizona,2014-2015,Age,35 Months,91.7,88.3 to 94.4,507
Hib,≥3 Doses,States/Local Areas,Arizona,2015,Age,35 Months,90.3,84.9 to 94.4,248
Hib,≥3 Doses,States/Local Areas,Arizona,2015-2016,Age,35 Months,92.0,88.6 to 94.7,505
Hep A,≥2 Doses,States/Local Areas,Arizona,2017,Age,19 Months,27.5,21.4 to 34.5,278
Hep A,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,19 Months,28.0,23.4 to 33.2,562
Hep A,≥1 Dose,States/Local Areas,Arizona,2015,Age,24 Months,83.7,76.4 to 89.8,248
Hep A,≥1 Dose,States/Local Areas,Arizona,2015-2016,Age,24 Months,86.5,82.0 to 90.4,505
Hep A,≥1 Dose,States/Local Areas,Arizona,2016,Age,24 Months,88.9,83.5 to 93.2,257
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2017,Age,24 Months,87.8,83.9 to 91.2,535
PCV,≥2 Doses,States/Local Areas,Arizona,2014,Age,5 Months,76.3,68.8 to 82.5,259
PCV,≥2 Doses,States/Local Areas,Arizona,2014-2015,Age,5 Months,73.4,69.7 to 76.9,507
PCV,≥2 Doses,States/Local Areas,Arizona,2015,Age,5 Months,70.5,62.5 to 77.4,248
PCV,≥2 Doses,States/Local Areas,Arizona,2015-2016,Age,5 Months,75.7,70.6 to 80.3,505
PCV,≥2 Doses,States/Local Areas,Arizona,2016,Age,5 Months,81.0,74.4 to 86.3,257
PCV,≥2 Doses,States/Local Areas,Arizona,2016-2017,Age,5 Months,76.7,71.7 to 81.0,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2018,Age,35 Months,99.6,98.5 to 99.9,284
DTaP,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,97.9,93.9 to 99.5,519
DTaP,≥3 Doses,States/Local Areas,Arizona,2019,Age,35 Months,91.9,86.2 to 95.8,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2017,Age,24 Months,86.6,80.6 to 91.4,278
Hep A,≥1 Dose,States/Local Areas,Arizona,2017-2018,Age,24 Months,91.3,87.7 to 94.2,562
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,87.8,76.0 to 99.6,47
DTaP,≥4 Doses,States/Local Areas,Arizona,2014,Age,19 Months,70.0,61.7 to 77.1,259
DTaP,≥4 Doses,States/Local Areas,Arizona,2014-2015,Age,19 Months,69.1,63.4 to 74.3,507
DTaP,≥4 Doses,States/Local Areas,Arizona,2015,Age,19 Months,68.2,66.1 to 70.2,248
DTaP,≥4 Doses,States/Local Areas,Arizona,2015-2016,Age,19 Months,71.8,66.4 to 76.6,505
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,93.7,91.1 to 96.4,493
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,93.3,90.3 to 96.3,356
DTaP,≥4 Doses,States/Local Areas,Arizona,2016,Age,19 Months,75.4,68.2 to 81.4,257
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2017,Age,19 Months,73.6,68.5 to 78.1,535
Hep A,≥2 Doses,States/Local Areas,Arizona,2018,Age,19 Months,28.6,22.0 to 36.3,284
Hep A,≥2 Doses,States/Local Areas,Arizona,2018-2019,Age,19 Months,24.9,19.5 to 31.2,430
Hep A,≥2 Doses,States/Local Areas,Arizona,2019,Age,19 Months,22.8,16.7 to 30.5,235
Hep A,≥2 Doses,States/Local Areas,Arizona,2011,Age,24 Months,39.3,31.6 to 48.2,266
Hib,≥3 Doses,States/Local Areas,Arizona,2016,Age,35 Months,93.4,89.1 to 96.4,257
Hib,≥3 Doses,States/Local Areas,Arizona,2016-2017,Age,35 Months,93.3,90.0 to 95.9,535
Hib,≥3 Doses,States/Local Areas,Arizona,2017,Age,35 Months,93.1,87.7 to 96.7,278
Hib,≥3 Doses,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.0,92.8 to 98.1,562
Hep A,≥2 Doses,States/Local Areas,Arizona,2012,Age,24 Months,36.0,28.6 to 44.5,277
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",98.2,94.5 to 100.0,35
DTaP,≥3 Doses,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,85.9,71.6 to 100.0,34
Hib,≥3 Doses,States/Local Areas,Arizona,2018,Age,35 Months,98.5,95.4 to 99.7,284
Hib,≥3 Doses,States/Local Areas,Arizona,2018-2019,Age,35 Months,96.0,91.5 to 98.5,519
Hep A,≥1 Dose,States/Local Areas,Arizona,2012,Age,35 Months,91.5,82.0 to 97.1,277
PCV,≥2 Doses,States/Local Areas,Arizona,2017,Age,5 Months,72.2,64.6 to 78.7,278
PCV,≥2 Doses,States/Local Areas,Arizona,2017-2018,Age,5 Months,78.1,73.0 to 82.4,562
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,90.9,88.1 to 93.7,547
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.8,85.9 to 93.7,468
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,77.3,71.5 to 83.1,547
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,76.7,68.9 to 84.5,335
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,62.9,40.6 to 85.1,48
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,93.5,91.2 to 95.8,547
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,82.4,77.4 to 87.4,335
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.7,74.8 to 92.7,133
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,93.8,91.6 to 96.0,547
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,94.4,87.3 to 100.0,35
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,91.4,87.6 to 95.1,335
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,88.6,75.3 to 100.0,48
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,92.9,89.7 to 96.1,335
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,97.1,93.6 to 100.0,35
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,70.7,53.7 to 87.7,48
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.0,73.7 to 84.3,468
Influenza,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.6,61.3 to 79.8,133
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,80.9,64.6 to 97.2,35
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,92.5,90.2 to 94.7,965
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Overall,Overall,89.5,86.9 to 92.1,965
Rotavirus,,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,83.2,77.3 to 89.2,257
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Overall,Overall,92.6,90.5 to 94.7,965
Rotavirus,,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,75.1,69.8 to 80.5,444
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,92.5,90.3 to 94.7,965
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,79.2,75.8 to 82.6,965
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,91.0,87.6 to 94.3,444
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,88.2,83.4 to 93.0,264
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,75.4,65.2 to 85.5,257
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,74.4,67.9 to 80.8,444
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,94.4,89.9 to 98.8,257
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,92.7,89.5 to 95.8,444
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,91.4,87.3 to 95.5,264
Influenza,,States/Local Areas,Arizona,2016-2019,Overall,Overall,57.7,53.6 to 61.7,965
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Overall,Overall,85.2,82.6 to 87.7,965
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,91.9,88.1 to 95.7,264
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,79.0,72.0 to 85.9,257
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,75.5,70.7 to 80.2,965
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Overall,Overall,92.6,90.4 to 94.7,965
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,94.7,90.6 to 98.9,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,92.8,89.5 to 96.2,444
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,70.9,65.5 to 76.2,444
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,64.0,57.0 to 71.0,264
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,89.8,85.8 to 93.8,264
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,92.0,87.2 to 96.7,257
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,91.3,88.4 to 94.3,444
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Overall,Overall,78.3,74.8 to 81.7,965
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Overall,Overall,69.7,66.0 to 73.5,965
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,93.9,89.4 to 98.3,257
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,91.5,88.1 to 95.0,444
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,90.0 to 95.6,564
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,91.6,82.5 to 100.0,45
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,91.3,80.7 to 100.0,45
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,84.3,80.2 to 88.4,356
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,85.3,81.9 to 88.8,564
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,65.0,58.7 to 71.3,356
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,72.0,67.1 to 76.9,564
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,91.3,80.7 to 100.0,45
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.7,88.4 to 95.1,356
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,92.9,89.9 to 95.9,564
Influenza,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,58.8,41.4 to 76.3,45
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,81.6,77.3 to 86.0,564
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,90.3,86.9 to 93.8,356
Hep A,≥1 Dose,States/Local Areas,Arizona,2019,Age,19 Months,86.7,80.1 to 91.4,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2011,Age,24 Months,83.6,76.9 to 89.3,266
Hep A,≥1 Dose,States/Local Areas,Arizona,2013,Age,24 Months,84.6,77.6 to 90.3,264
Hep A,≥1 Dose,States/Local Areas,Arizona,2013-2014,Age,24 Months,85.2,80.7 to 89.2,523
Hep A,≥1 Dose,States/Local Areas,Arizona,2012,Age,24 Months,83.4,76.7 to 89.2,277
Hep A,≥1 Dose,States/Local Areas,Arizona,2014,Age,24 Months,86.0,79.9 to 91.0,259
Hep A,≥1 Dose,States/Local Areas,Arizona,2014-2015,Age,24 Months,84.9,80.2 to 89.0,507
Hep A,≥1 Dose,States/Local Areas,Arizona,2018,Age,24 Months,95.8,91.4 to 98.4,284
Hep A,≥1 Dose,States/Local Areas,Arizona,2018-2019,Age,24 Months,93.5,90.0 to 96.1,519
Hep A,≥1 Dose,States/Local Areas,Arizona,2019,Age,24 Months,90.9,85.2 to 95.1,235
Hep A,≥1 Dose,States/Local Areas,Arizona,2011,Age,35 Months,93.8,88.1 to 97.4,266
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,90.0 to 95.6,564
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,92.1,89.3 to 94.9,564
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,92.7,82.4 to 100.0,45
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,93.3,90.2 to 96.4,356
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,93.5,90.6 to 96.5,564
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,81.2,64.7 to 97.7,45
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,78.5,73.0 to 84.1,356
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,91.3,80.7 to 100.0,45
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,89.7,86.2 to 93.2,564
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.3,88.9 to 95.7,356
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,89.7,77.6 to 100.0,45
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,73.0,67.1 to 78.9,356
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,80.6,76.2 to 85.1,564
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,63.6,41.9 to 85.4,45
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.2,88.8 to 95.7,356
Rotavirus,,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,71.7,65.1 to 78.3,264
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,83.2,76.6 to 89.9,257
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,82.5,77.9 to 87.1,444
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,80.6,74.3 to 86.9,257
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,83.0,79.0 to 86.9,444
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,77.1,68.3 to 85.9,264
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,91.9,87.1 to 96.7,257
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,93.1,90.4 to 95.9,444
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,93.4,89.8 to 97.0,264
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,93.4,91.3 to 95.6,965
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,91.7,89.6 to 93.8,965
Influenza,,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,54.4,48.3 to 60.6,444
Influenza,,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,55.3,48.1 to 62.5,264
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,93.0,88.4 to 97.7,257
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,93.2,90.5 to 95.9,444
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,91.7,87.6 to 95.7,264
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,86.8,80.5 to 93.2,257
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,81.8,77.2 to 86.4,444
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,92.4,88.5 to 96.4,264
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Overall,Overall,82.0,78.7 to 85.3,965
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,92.7,88.9 to 96.5,264
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,83.5,76.8 to 90.2,257
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Poverty,133% to <400% FPL,78.9,74.1 to 83.7,444
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,74.9,68.4 to 81.3,264
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,89.2,83.0 to 95.3,257
Rotavirus,,States/Local Areas,Arizona,2016-2019,Overall,Overall,75.4,71.8 to 79.0,965
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,73.6,67.2 to 80.0,264
Influenza,,States/Local Areas,Arizona,2016-2019,Poverty,>400% FPL,69.7,61.5 to 78.0,257
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,92.9,82.4 to 100.0,48
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.9,89.1 to 96.7,468
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,65.9,48.3 to 83.5,48
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.1,87.9 to 94.2,468
Polio,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,89.4,85.1 to 92.9,506
DTaP,≥4 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,85.0,78.9 to 90.1,506
DTaP,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,90.6,86.5 to 93.8,506
Combined 7 Series,,States/Local Areas,Arizona,2019-2020,Age,24 Months,65.7,60.1 to 71.3,506
PCV,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,85.6,80.7 to 89.4,506
≥1 Dose Varicella,,States/Local Areas,Arizona,2019-2020,Age,13 Months,65.8,60.1 to 71.1,506
Hep B,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,81.4,76.3 to 85.6,506
Hep B,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,92.4,88.8 to 95.0,506
Polio,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,86.3,81.4 to 90.0,506
DTaP,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,71.3,65.4 to 76.5,506
PCV,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,5 Months,76.2,70.6 to 81.0,506
Hep B,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,5 Months,86.0,81.3 to 89.7,506
Hib,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,5 Months,75.3,69.7 to 80.2,506
Hib,Primary Series,States/Local Areas,Arizona,2019-2020,Age,13 Months,83.2,78.1 to 87.3,506
Hib,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,75.0,69.6 to 79.7,506
Hib,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,90.3,86.1 to 93.3,506
≥1 Dose MMR,,States/Local Areas,Arizona,2019-2020,Age,13 Months,67.1,61.3 to 72.3,506
Polio,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,91.0,86.9 to 93.8,506
DTaP,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,13 Months,88.2,83.7 to 91.7,506
Polio,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,5 Months,77.7,72.1 to 82.4,506
DTaP,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,5 Months,77.9,72.4 to 82.6,506
PCV,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,3 Months,82.2,77.0 to 86.4,506
Hep B,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,3 Months,94.5,91.2 to 96.6,506
Hib,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,3 Months,80.9,75.7 to 85.3,506
Polio,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,88.4,84.2 to 91.9,506
≥1 Dose MMR,,States/Local Areas,Arizona,2019-2020,Age,24 Months,88.2,83.9 to 91.9,506
DTaP,≥4 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,78.4,73.3 to 83.2,506
DTaP,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,90.1,86.1 to 93.4,506
PCV,≥4 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,78.5,73.1 to 83.5,506
PCV,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,89.7,85.7 to 93.0,506
≥1 Dose Varicella,,States/Local Areas,Arizona,2019-2020,Age,35 Months,92.0,87.6 to 95.2,506
Hep B,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,87.9,83.5 to 91.6,506
Hib,Full Series,States/Local Areas,Arizona,2019-2020,Age,35 Months,79.9,73.5 to 85.5,506
Hib,Primary Series,States/Local Areas,Arizona,2019-2020,Age,35 Months,90.6,86.4 to 93.9,506
Hib,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,88.3,84.0 to 91.9,506
≥1 Dose MMR,,States/Local Areas,Arizona,2019-2020,Age,35 Months,91.1,86.7 to 94.5,506
Hib,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,87.4,82.8 to 90.9,506
Hib,Primary Series,States/Local Areas,Arizona,2019-2020,Age,19 Months,89.2,84.8 to 92.5,506
≥1 Dose MMR,,States/Local Areas,Arizona,2019-2020,Age,19 Months,86.3,81.6 to 89.9,506
Polio,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,87.9,83.4 to 91.3,506
Hep A,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,24.5,20.0 to 29.7,506
PCV,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,89.4,85.3 to 92.7,506
PCV,≥4 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,76.7,71.4 to 81.7,506
≥1 Dose Varicella,,States/Local Areas,Arizona,2019-2020,Age,24 Months,89.0,84.7 to 92.6,506
Hep B,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,86.6,82.2 to 90.3,506
Hib,Full Series,States/Local Areas,Arizona,2019-2020,Age,24 Months,74.8,69.4 to 79.9,506
PCV,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,67.6,61.7 to 73.0,506
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2019-2020,Age,0-2 Days,79.0,73.8 to 83.4,506
Hep A,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,19 Months,82.3,77.3 to 86.4,506
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2019-2020,Age,0-1 Days,77.7,72.4 to 82.2,506
PCV,≥4 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,74.3,68.7 to 79.2,506
PCV,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,89.2,84.9 to 92.4,506
Hep B,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,84.9,80.1 to 88.6,506
Combined 7 Series,,States/Local Areas,Arizona,2019-2020,Age,35 Months,71.0,64.4 to 77.2,506
Hib,Full Series,States/Local Areas,Arizona,2019-2020,Age,19 Months,69.2,63.5 to 74.3,506
Hib,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,84.9,79.8 to 88.8,506
Hib,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,88.3,84.0 to 91.9,506
Hib,Primary Series,States/Local Areas,Arizona,2019-2020,Age,24 Months,89.6,85.4 to 93.0,506
Hep A,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,24 Months,44.4,38.7 to 50.7,506
Influenza,,States/Local Areas,Arizona,2019-2020,Age,24 Months,55.8,50.1 to 61.7,506
Hep A,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,35 Months,91.5,87.1 to 94.9,506
Hep A,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,35 Months,81.7,72.2 to 89.5,506
Hep A,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,24 Months,88.3,83.9 to 91.9,506
≥1 Dose MMR,,States/Local Areas,Arizona,2020,Age,13 Months,63.5,55.5 to 70.8,271
Hep A,≥2 Doses,States/Local Areas,Arizona,2020,Age,35 Months,76.0,66.0 to 84.8,271
Combined 7 Series,,States/Local Areas,Arizona,2020,Age,35 Months,71.1,61.7 to 80.0,271
Hep A,≥1 Dose,States/Local Areas,Arizona,2020,Age,19 Months,78.0,70.5 to 84.0,271
Hep A,≥2 Doses,States/Local Areas,Arizona,2020,Age,19 Months,26.9,20.6 to 34.4,271
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Arizona,2020,Age,0-2 Days,80.8,74.2 to 86.0,271
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Arizona,2020,Age,0-1 Days,79.0,72.1 to 84.6,271
Polio,≥2 Doses,States/Local Areas,Arizona,2020,Age,7 Months,84.3,77.1 to 89.5,271
Hib,≥2 Doses,States/Local Areas,Arizona,2020,Age,7 Months,83.1,75.7 to 88.5,271
Hib,≥3 Doses,States/Local Areas,Arizona,2020,Age,7 Months,56.1,48.3 to 63.6,271
Hib,Primary Series,States/Local Areas,Arizona,2020,Age,7 Months,67.9,59.9 to 75.0,271
DTaP,≥3 Doses,States/Local Areas,Arizona,2020,Age,24 Months,89.1,83.1 to 93.6,271
DTaP,≥4 Doses,States/Local Areas,Arizona,2020,Age,24 Months,75.5,68.1 to 82.3,271
Polio,≥3 Doses,States/Local Areas,Arizona,2020,Age,24 Months,86.9,80.6 to 91.9,271
≥1 Dose MMR,,States/Local Areas,Arizona,2020,Age,24 Months,84.6,78.0 to 90.1,271
Hib,≥3 Doses,States/Local Areas,Arizona,2020,Age,24 Months,87.3,81.1 to 92.3,271
≥1 Dose MMR,,States/Local Areas,Arizona,2020,Age,35 Months,90.3,83.6 to 95.0,271
Hib,≥3 Doses,States/Local Areas,Arizona,2020,Age,35 Months,87.3,81.1 to 92.3,271
Hib,Primary Series,States/Local Areas,Arizona,2020,Age,35 Months,91.1,85.4 to 95.2,271
Hib,Full Series,States/Local Areas,Arizona,2020,Age,35 Months,79.6,70.6 to 87.3,271
Hep B,≥3 Doses,States/Local Areas,Arizona,2020,Age,35 Months,85.2,78.3 to 90.8,271
≥1 Dose Varicella,,States/Local Areas,Arizona,2020,Age,35 Months,91.1,84.5 to 95.7,271
Hib,Primary Series,States/Local Areas,Arizona,2020,Age,19 Months,89.3,82.9 to 93.5,271
Hib,Full Series,States/Local Areas,Arizona,2020,Age,19 Months,68.0,60.0 to 75.1,271
Hep B,≥3 Doses,States/Local Areas,Arizona,2020,Age,19 Months,81.9,74.8 to 87.4,271
≥1 Dose Varicella,,States/Local Areas,Arizona,2020,Age,19 Months,82.8,75.5 to 88.3,271
DTaP,≥3 Doses,States/Local Areas,Arizona,2020,Age,35 Months,89.8,83.9 to 94.2,271
DTaP,≥4 Doses,States/Local Areas,Arizona,2020,Age,35 Months,84.4,75.5 to 91.5,271
PCV,≥3 Doses,States/Local Areas,Arizona,2020,Age,19 Months,88.0,81.6 to 92.4,271
Polio,≥3 Doses,States/Local Areas,Arizona,2020,Age,35 Months,88.2,81.9 to 93.1,271
PCV,≥4 Doses,States/Local Areas,Arizona,2020,Age,19 Months,72.5,64.6 to 79.2,271
PCV,≥3 Doses,States/Local Areas,Arizona,2020,Age,35 Months,88.7,82.7 to 93.3,271
Hib,≥2 Doses,States/Local Areas,Arizona,2020,Age,13 Months,89.0,82.6 to 93.2,271
Hib,≥3 Doses,States/Local Areas,Arizona,2020,Age,13 Months,75.4,68.0 to 81.6,271
Hib,Primary Series,States/Local Areas,Arizona,2020,Age,13 Months,84.3,77.3 to 89.4,271
Hep B,≥2 Doses,States/Local Areas,Arizona,2020,Age,13 Months,90.7,84.7 to 94.5,271
Hep B,≥3 Doses,States/Local Areas,Arizona,2020,Age,13 Months,80.9,73.7 to 86.4,271
≥1 Dose Varicella,,States/Local Areas,Arizona,2020,Age,13 Months,65.6,57.6 to 72.8,271
PCV,≥2 Doses,States/Local Areas,Arizona,2020,Age,5 Months,73.5,65.6 to 80.1,271
DTaP,≥3 Doses,States/Local Areas,Arizona,2020,Age,7 Months,71.1,63.2 to 77.9,271
Hep B,≥2 Doses,States/Local Areas,Arizona,2020,Age,5 Months,85.0,78.3 to 89.9,271
PCV,≥3 Doses,States/Local Areas,Arizona,2020,Age,13 Months,85.8,79.2 to 90.5,271
DTaP,≥3 Doses,States/Local Areas,Arizona,2020,Age,19 Months,88.8,82.4 to 93.1,271
DTaP,≥4 Doses,States/Local Areas,Arizona,2020,Age,19 Months,68.5,60.5 to 75.5,271
Polio,≥3 Doses,States/Local Areas,Arizona,2020,Age,19 Months,86.6,79.8 to 91.4,271
Combined 7 Series,,States/Local Areas,Arizona,2020,Age,24 Months,62.9,55.3 to 70.6,271
Hib,≥3 Doses,States/Local Areas,Arizona,2020,Age,19 Months,86.5,79.7 to 91.3,271
≥1 Dose MMR,,States/Local Areas,Arizona,2020,Age,19 Months,81.9,74.7 to 87.5,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2020,Age,0-3 Days,81.6,75.0 to 86.8,271
Rotavirus,,States/Local Areas,Arizona,2020,Age,8 Months,71.2,63.4 to 78.0,271
Influenza,,States/Local Areas,Arizona,2020,Age,24 Months,51.0,43.3 to 59.1,271
≥1 Dose Varicella,,States/Local Areas,Arizona,2020,Age,24 Months,85.5,78.9 to 90.9,271
PCV,≥3 Doses,States/Local Areas,Arizona,2020,Age,24 Months,88.0,82.1 to 92.7,271
PCV,≥4 Doses,States/Local Areas,Arizona,2020,Age,24 Months,75.1,67.6 to 82.0,271
Hep A,≥2 Doses,States/Local Areas,Arizona,2020,Age,24 Months,43.1,35.6 to 51.3,271
Hep A,≥1 Dose,States/Local Areas,Arizona,2020,Age,24 Months,85.3,78.7 to 90.8,271
Hep B,≥1 Dose,States/Local Areas,Arizona,2020,Age,3 Months,96.5,93.5 to 98.2,271
PCV,≥1 Dose,States/Local Areas,Arizona,2020,Age,3 Months,77.9,70.2 to 84.0,271
DTaP,≥2 Doses,States/Local Areas,Arizona,2020,Age,5 Months,75.3,67.5 to 81.8,271
Polio,≥2 Doses,States/Local Areas,Arizona,2020,Age,5 Months,75.4,67.5 to 81.8,271
Hib,≥2 Doses,States/Local Areas,Arizona,2020,Age,5 Months,72.7,64.7 to 79.5,271
DTaP,≥1 Dose,States/Local Areas,Arizona,2020,Age,3 Months,79.4,71.7 to 85.4,271
Polio,≥1 Dose,States/Local Areas,Arizona,2020,Age,3 Months,79.4,71.7 to 85.4,271
Hib,≥1 Dose,States/Local Areas,Arizona,2020,Age,3 Months,77.1,69.3 to 83.4,271
Hep B,≥2 Doses,States/Local Areas,Arizona,2020,Age,7 Months,87.6,80.9 to 92.2,271
Hep B,≥3 Doses,States/Local Areas,Arizona,2020,Age,7 Months,56.6,48.8 to 64.2,271
PCV,≥3 Doses,States/Local Areas,Arizona,2020,Age,7 Months,66.3,58.2 to 73.5,271
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,81.2,77.4 to 85.0,547
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",92.4,89.1 to 95.7,468
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.9,88.4 to 95.4,468
Rotavirus,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.1,71.8 to 82.3,468
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,75.7,71.2 to 80.2,547
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,64.5,58.3 to 70.8,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,90.5,87.0 to 94.0,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,88.3,84.4 to 92.3,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,91.7,84.2 to 99.2,48
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,82.8,68.3 to 97.2,35
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,92.7,89.5 to 96.0,335
≥1 Dose MMR,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.8,88.5 to 99.0,133
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,91.3,87.6 to 95.0,335
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,94.7,92.4 to 97.1,547
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,92.1,88.4 to 95.9,335
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,94.4,87.3 to 100.0,35
Rotavirus,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,79.7,75.4 to 84.1,547
Influenza,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,50.1,43.6 to 56.5,335
Influenza,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,57.3,38.7 to 75.9,48
Influenza,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,40.2,21.0 to 59.5,35
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,93.2,90.0 to 96.4,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",86.6,79.8 to 93.4,133
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,55.3,30.2 to 80.5,35
Rotavirus,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,59.3,40.8 to 77.8,48
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",69.0,63.3 to 74.7,468
Rotavirus,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,78.6,62.5 to 94.7,35
Rotavirus,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,72.8,66.8 to 78.7,335
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,69.6,63.7 to 75.5,335
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.4,62.4 to 82.3,133
Rotavirus,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,73.9,68.3 to 79.5,335
Rotavirus,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",78.3,68.4 to 88.3,133
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,79.2,74.0 to 84.4,335
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.7,73.7 to 91.7,133
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.2,87.3 to 95.2,468
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,88.1,74.7 to 100.0,48
Influenza,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",58.3,52.2 to 64.3,468
Influenza,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,54.3,47.8 to 60.7,335
Influenza,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,67.3,62.1 to 72.5,547
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,93.2,90.0 to 96.4,335
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.8,88.5 to 99.0,133
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",91.9,88.0 to 95.7,468
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,93.6,86.0 to 100.0,35
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,77.2,62.4 to 92.0,48
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,87.5,74.1 to 100.0,35
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,92.5,89.1 to 95.8,335
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,92.9,82.6 to 100.0,48
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,88.4,77.0 to 99.8,35
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,90.3,86.2 to 94.4,335
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.7,72.4 to 83.0,468
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,98.4,96.1 to 100.0,35
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,74.4,58.2 to 90.7,48
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,75.2,57.2 to 93.2,35
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.0 to 96.1,547
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,91.6,87.8 to 95.5,335
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,89.2,77.6 to 100.0,48
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Other,88.6,75.3 to 100.0,48
≥1 Dose Varicella,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,98.2,95.6 to 100.0,35
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",81.5,76.3 to 86.7,468
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,93.7,90.6 to 96.7,335
DTaP,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.6,91.5 to 99.8,133
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,86.4,82.8 to 90.1,547
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,77.6,71.9 to 83.3,335
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,91.6,88.2 to 95.0,335
Rotavirus,,States/Local Areas,Arizona,2019-2020,Age,8 Months,70.5,64.6 to 75.7,506
Influenza,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,54.3,47.5 to 61.1,356
Influenza,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,59.5,54.2 to 64.8,564
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,77.2,60.2 to 94.2,45
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,88.6,77.0 to 100.0,45
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.2,68.4 to 80.1,356
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,84.0,79.7 to 88.2,564
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,91.3,80.7 to 100.0,45
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.0,88.5 to 95.5,356
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,92.8,89.9 to 95.8,564
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,97.9,94.0 to 100.0,45
Rotavirus,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,76.7,62.0 to 91.4,45
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a Non-MSA,82.1,66.0 to 98.2,45
Hep A,≥1 Dose,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.7,85.7 to 93.8,356
Rotavirus,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.2,68.4 to 80.0,356
Rotavirus,,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,76.0,71.2 to 80.7,564
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Principal City,77.1,70.8 to 83.3,564
DTaP,≥3 Doses,States/Local Areas,Arizona,2021,Age,7 Months,66.1,54.7 to 76.0,166
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Urbanicity,Living In a MSA Non-Principal City,74.0,66.4 to 81.6,356
Combined 7 Series,,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Uninsured,69.1,49.9 to 88.3,35
Hep B,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.0,87.8 to 98.3,133
≥1 Dose MMR,,States/Local Areas,Arizona,2020-2021,Age,13 Months,61.0,54.1 to 67.4,437
Polio,≥3 Doses,States/Local Areas,Arizona,2020-2021,Age,19 Months,88.1,82.6 to 92.1,437
Polio,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,3 Months,83.3,78.2 to 87.4,506
DTaP,≥1 Dose,States/Local Areas,Arizona,2019-2020,Age,3 Months,83.5,78.4 to 87.6,506
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Arizona,2019-2020,Age,0-3 Days,79.5,74.4 to 83.9,506
Hep B,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,56.2,50.3 to 61.9,506
Hib,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,56.2,50.3 to 61.9,506
DTaP,≥4 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,70.8,65.2 to 75.8,506
DTaP,≥3 Doses,States/Local Areas,Arizona,2019-2020,Age,19 Months,89.6,85.3 to 92.8,506
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"White, Non-Hispanic",75.3,68.1 to 82.4,468
Combined 7 Series,,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,64.8,58.6 to 71.0,326
Rotavirus,,States/Local Areas,Arizona,2015,Age,8 Months,64.6,56.5 to 72.0,248
Rotavirus,,States/Local Areas,Arizona,2015-2016,Age,8 Months,70.6,65.1 to 75.5,505
Rotavirus,,States/Local Areas,Arizona,2016,Age,8 Months,76.6,69.2 to 82.6,257
Rotavirus,,States/Local Areas,Arizona,2016-2017,Age,8 Months,73.6,68.4 to 78.2,535
DTaP,≥2 Doses,States/Local Areas,Arizona,2021,Age,5 Months,72.8,61.6 to 81.6,166
Rotavirus,,States/Local Areas,Arizona,2012,Age,8 Months,71.4,63.4 to 78.1,277
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",81.9,73.6 to 90.2,133
Hep B,≥2 Doses,States/Local Areas,Arizona,2019-2020,Age,7 Months,89.8,85.5 to 92.9,506
Rotavirus,,States/Local Areas,Arizona,2013,Age,8 Months,69.9,61.7 to 77.0,264
Rotavirus,,States/Local Areas,Arizona,2013-2014,Age,8 Months,70.6,65.0 to 75.7,523
Rotavirus,,States/Local Areas,Arizona,2014,Age,8 Months,71.4,63.3 to 78.3,259
Rotavirus,,States/Local Areas,Arizona,2014-2015,Age,8 Months,68.0,62.4 to 73.2,507
Polio,≥2 Doses,States/Local Areas,Arizona,2021,Age,5 Months,72.5,61.4 to 81.4,166
Hib,Primary Series,States/Local Areas,Arizona,2019-2020,Age,7 Months,67.9,62.0 to 73.2,506
Rotavirus,,States/Local Areas,Arizona,2018,Age,8 Months,84.2,77.8 to 89.0,284
Rotavirus,,States/Local Areas,Arizona,2018-2019,Age,8 Months,77.7,72.3 to 82.4,519
Rotavirus,,States/Local Areas,Arizona,2019,Age,8 Months,71.1,62.3 to 78.6,235
Rotavirus,,States/Local Areas,Arizona,2017,Age,8 Months,70.6,63.1 to 77.1,278
Rotavirus,,States/Local Areas,Arizona,2017-2018,Age,8 Months,77.3,72.5 to 81.6,562
Rotavirus,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Other,55.9,37.7 to 74.0,47
Rotavirus,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Private Insurance Only,77.8,73.2 to 82.4,493
Rotavirus,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Any Medicaid,67.9,62.0 to 73.8,356
Rotavirus,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",66.2,47.8 to 84.6,35
Rotavirus,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,Hispanic,68.9,62.9 to 74.9,329
Rotavirus,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",68.2,57.1 to 79.3,125
Rotavirus,,States/Local Areas,Arizona,2014-2017,Race and Ethnicity,"White, Non-Hispanic",75.7,70.9 to 80.6,441
Rotavirus,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Principal City,73.1,68.4 to 77.8,537
Rotavirus,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a MSA Non-Principal City,69.0,62.7 to 75.4,345
Rotavirus,,States/Local Areas,Arizona,2014-2017,Urbanicity,Living In a Non-MSA,62.6,45.0 to 80.2,48
Rotavirus,,States/Local Areas,Arizona,2014-2017,Overall,Overall,71.2,67.5 to 74.9,930
Rotavirus,,States/Local Areas,Arizona,2014-2017,Poverty,<133% FPL,67.9,61.8 to 74.0,326
Rotavirus,,States/Local Areas,Arizona,2014-2017,Poverty,133% to <400% FPL,72.2,66.6 to 77.7,379
Rotavirus,,States/Local Areas,Arizona,2014-2017,Insurance Coverage,Uninsured,61.6,44.6 to 78.6,34
Rotavirus,,States/Local Areas,Arizona,2011,Age,8 Months,72.4,64.1 to 79.3,266
Rotavirus,,States/Local Areas,Arizona,2014-2017,Poverty,>400% FPL,77.8,70.0 to 85.7,225
Hib,≥2 Doses,States/Local Areas,Arizona,2021,Age,5 Months,71.3,60.2 to 80.3,166
Polio,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.6,91.5 to 99.7,133
Hib,Primary Series,States/Local Areas,Arizona,2017,Age,19 Months,90.8,84.8 to 94.6,278
Hib,Primary Series,States/Local Areas,Arizona,2017-2018,Age,19 Months,94.7,91.5 to 96.8,562
Hib,Full Series,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,Hispanic,78.1,72.6 to 83.6,335
PCV,≥3 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,90.4 to 99.2,133
Hep A,≥2 Doses,States/Local Areas,Arizona,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.1,64.9 to 89.2,133
Hib,Primary Series,States/Local Areas,Arizona,2016,Age,19 Months,93.5,89.1 to 96.2,257
Hib,Primary Series,States/Local Areas,Arizona,2016-2017,Age,19 Months,92.1,88.6 to 94.6,535
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Private Insurance Only,84.7,80.9 to 88.5,547
DTaP,≥4 Doses,States/Local Areas,Arizona,2016-2019,Poverty,<133% FPL,79.8,73.7 to 85.9,264
PCV,≥4 Doses,States/Local Areas,Arizona,2016-2019,Insurance Coverage,Any Medicaid,74.8,69.1 to 80.6,335
Hib,Primary Series,States/Local Areas,Arizona,2019,Age,19 Months,89.8,83.2 to 94.0,235
Hib,Primary Series,States/Local Areas,Arizona,2018,Age,19 Months,98.7,96.0 to 99.6,284
Hib,Primary Series,States/Local Areas,Arizona,2018-2019,Age,19 Months,88.8,84.6 to 92.0,519
Hib,Primary Series,States/Local Areas,Arizona,2013,Age,7 Months,69.5,63.7 to 74.7,264
Hib,Primary Series,States/Local Areas,Arizona,2013-2014,Age,7 Months,71.1,67.2 to 74.8,523
Hib,Primary Series,States/Local Areas,Arizona,2014,Age,7 Months,72.8,65.0 to 79.5,259
Hib,Primary Series,States/Local Areas,Arizona,2014-2015,Age,7 Months,69.3,63.7 to 74.4,507
Hib,Primary Series,States/Local Areas,Arizona,2015,Age,7 Months,65.7,57.5 to 73.1,248
Hib,Primary Series,States/Local Areas,Arizona,2015-2016,Age,7 Months,72.2,66.7 to 77.0,505
Hib,Primary Series,States/Local Areas,Arizona,2019,Age,13 Months,83.1,75.6 to 88.7,235
Hib,Primary Series,States/Local Areas,Arizona,2011,Age,19 Months,90.1,81.8 to 94.8,266
Hib,Primary Series,States/Local Areas,Arizona,2016,Age,13 Months,89.6,84.6 to 93.1,257
Hib,Primary Series,States/Local Areas,Arizona,2016-2017,Age,13 Months,87.1,83.0 to 90.3,535
DTaP,≥3 Doses,States/Local Areas,Arizona,2020,Age,13 Months,88.2,81.8 to 92.6,271
Hib,Primary Series,States/Local Areas,Arizona,2011,Age,24 Months,90.6,85.0 to 94.7,266
Hib,Primary Series,States/Local Areas,Arizona,2012,Age,24 Months,86.3,79.8 to 91.5,277
Hib,Primary Series,States/Local Areas,Arizona,2013,Age,24 Months,89.9,83.8 to 94.5,264
Hib,Primary Series,States/Local Areas,Arizona,2013-2014,Age,24 Months,92.2,88.7 to 95.0,523
Hib,Primary Series,States/Local Areas,Arizona,2015,Age,19 Months,89.5,84.8 to 92.9,248
Hib,Primary Series,States/Local Areas,Arizona,2015-2016,Age,19 Months,91.5,88.0 to 94.0,505
Hib,Primary Series,States/Local Areas,Arizona,2012,Age,19 Months,85.0,80.9 to 88.3,277
Hib,Primary Series,States/Local Areas,Arizona,2013,Age,19 Months,89.2,86.8 to 91.2,264
Hib,Primary Series,States/Local Areas,Arizona,2013-2014,Age,19 Months,91.1,88.2 to 93.3,523
Hib,Primary Series,States/Local Areas,Arizona,2014,Age,19 Months,92.9,87.6 to 96.1,259
Hib,Primary Series,States/Local Areas,Arizona,2014-2015,Age,19 Months,91.2,87.6 to 93.9,507
Hib,Primary Series,States/Local Areas,Arizona,2018,Age,13 Months,94.3,90.1 to 96.8,284
Hib,Primary Series,States/Local Areas,Arizona,2018-2019,Age,13 Months,88.8,84.6 to 92.0,519
Combined 7 Series,,States/Local Areas,Arizona,2016,Age,35 Months,75.9,68.8 to 82.5,257
Combined 7 Series,,States/Local Areas,Arizona,2016-2017,Age,35 Months,75.3,69.6 to 80.6,535
Combined 7 Series,,States/Local Areas,Arizona,2017,Age,35 Months,74.1,65.9 to 81.7,278
Combined 7 Series,,States/Local Areas,Arizona,2017-2018,Age,35 Months,76.5,71.1 to 81.5,562
Combined 7 Series,,States/Local Areas,Arizona,2017,Age,24 Months,68.6,61.3 to 75.7,278
Combined 7 Series,,States/Local Areas,Arizona,2017-2018,Age,24 Months,72.8,67.8 to 77.6,562
Combined 7 Series,,States/Local Areas,Arizona,2018,Age,24 Months,76.9,70.1 to 83.1,284
Combined 7 Series,,States/Local Areas,Arizona,2018-2019,Age,24 Months,73.3,68.1 to 78.3,519
Combined 7 Series,,States/Local Areas,Arizona,2019,Age,24 Months,69.3,61.3 to 77.0,235
Combined 7 Series,,States/Local Areas,Arizona,2014,Age,24 Months,68.1,60.4 to 75.6,259
Combined 7 Series,,States/Local Areas,Arizona,2014-2015,Age,24 Months,63.6,57.9 to 69.2,507
Combined 7 Series,,States/Local Areas,Arizona,2015,Age,24 Months,58.8,50.7 to 67.1,248
Combined 7 Series,,States/Local Areas,Arizona,2015-2016,Age,24 Months,65.0,59.5 to 70.4,505
Hib,Primary Series,States/Local Areas,Arizona,2018,Age,35 Months,99.4,98.6 to 99.8,284
Hib,Primary Series,States/Local Areas,Arizona,2018-2019,Age,35 Months,95.1,92.0 to 97.3,519
Combined 7 Series,,States/Local Areas,Arizona,2016,Age,24 Months,71.1,64.1 to 77.9,257
Combined 7 Series,,States/Local Areas,Arizona,2016-2017,Age,24 Months,69.9,64.7 to 74.9,535
Hib,Primary Series,States/Local Areas,Arizona,2019,Age,35 Months,90.5,84.5 to 94.9,235
Hib,Primary Series,States/Local Areas,Arizona,2015,Age,13 Months,83.6,76.6 to 88.8,248
Hib,Primary Series,States/Local Areas,Arizona,2015-2016,Age,13 Months,86.6,82.4 to 89.9,505
Hib,Primary Series,States/Local Areas,Arizona,2017,Age,13 Months,84.5,77.8 to 89.5,278
Hib,Primary Series,States/Local Areas,Arizona,2017-2018,Age,13 Months,89.4,85.5 to 92.3,562
Hib,Primary Series,States/Local Areas,Arizona,2016,Age,7 Months,78.7,71.6 to 84.4,257
Hib,Primary Series,States/Local Areas,Arizona,2016-2017,Age,7 Months,73.9,68.7 to 78.5,535
Hib,Primary Series,States/Local Areas,Arizona,2017,Age,7 Months,69.0,61.4 to 75.7,278
Hib,Primary Series,States/Local Areas,Arizona,2017-2018,Age,7 Months,76.3,71.4 to 80.7,562
Hib,Primary Series,States/Local Areas,Arizona,2018,Age,7 Months,83.8,77.4 to 88.6,284
Hib,Primary Series,States/Local Areas,Arizona,2018-2019,Age,7 Months,76.7,71.3 to 81.4,519
Hib,Primary Series,States/Local Areas,Arizona,2020,Age,24 Months,89.3,83.4 to 93.7,271
Hib,Primary Series,States/Local Areas,Arizona,2019,Age,7 Months,69.6,61.0 to 77.0,235
Hib,Primary Series,States/Local Areas,Arizona,2011,Age,13 Months,86.9,80.5 to 91.4,266
Hib,Primary Series,States/Local Areas,Arizona,2012,Age,13 Months,78.6,75.2 to 81.7,277
Hib,Primary Series,States/Local Areas,Arizona,2013,Age,13 Months,86.3,83.0 to 89.1,264
Hib,Primary Series,States/Local Areas,Arizona,2013-2014,Age,13 Months,87.2,83.9 to 89.9,523
Hib,Primary Series,States/Local Areas,Arizona,2014,Age,13 Months,88.1,81.6 to 92.4,259
Hib,Primary Series,States/Local Areas,Arizona,2014-2015,Age,13 Months,85.8,81.3 to 89.4,507
Hib,Primary Series,States/Local Areas,Arizona,2017,Age,35 Months,93.1,88.0 to 96.6,278
Hib,Primary Series,States/Local Areas,Arizona,2017-2018,Age,35 Months,96.3,93.7 to 98.1,562
Combined 7 Series,,States/Local Areas,Arizona,2011,Age,35 Months,72.6,60.1 to 83.9,266
Hib,Primary Series,States/Local Areas,Arizona,2015,Age,35 Months,90.9,85.7 to 94.8,248
Hib,Primary Series,States/Local Areas,Arizona,2015-2016,Age,35 Months,92.8,89.5 to 95.3,505
Hib,Primary Series,States/Local Areas,Arizona,2016,Age,35 Months,94.5,90.4 to 97.2,257
Hib,Primary Series,States/Local Areas,Arizona,2016-2017,Age,35 Months,93.8,90.6 to 96.2,535
Hib,Primary Series,States/Local Areas,Arizona,2011,Age,35 Months,91.4,85.9 to 95.4,266
Hib,Primary Series,States/Local Areas,Arizona,2013,Age,35 Months,91.7,85.9 to 95.7,264
Hib,Primary Series,States/Local Areas,Arizona,2013-2014,Age,35 Months,93.7,90.5 to 96.2,523
Hib,Primary Series,States/Local Areas,Arizona,2012,Age,35 Months,93.0,84.1 to 97.8,277
Hib,Primary Series,States/Local Areas,Arizona,2014,Age,35 Months,95.9,92.7 to 97.9,259
Hib,Primary Series,States/Local Areas,Arizona,2014-2015,Age,35 Months,93.3,90.3 to 95.7,507
Combined 7 Series,,States/Local Areas,Arizona,2011,Age,24 Months,59.6,51.4 to 67.9,266
Combined 7 Series,,States/Local Areas,Arizona,2013,Age,24 Months,68.7,60.8 to 76.3,264
Combined 7 Series,,States/Local Areas,Arizona,2013-2014,Age,24 Months,68.4,62.9 to 73.8,523
Combined 7 Series,,States/Local Areas,Arizona,2012,Age,24 Months,63.1,55.0 to 71.1,277
Hib,Primary Series,States/Local Areas,Arizona,2019,Age,24 Months,90.5,84.5 to 94.9,235
Combined 7 Series,,States/Local Areas,Arizona,2012,Age,35 Months,70.1,61.9 to 78.0,277
Combined 7 Series,,States/Local Areas,Arizona,2013,Age,35 Months,73.7,65.1 to 81.6,264
Combined 7 Series,,States/Local Areas,Arizona,2013-2014,Age,35 Months,75.9,70.2 to 81.3,523
Combined 7 Series,,States/Local Areas,Arizona,2015,Age,35 Months,67.0,58.3 to 75.5,248
Combined 7 Series,,States/Local Areas,Arizona,2015-2016,Age,35 Months,71.5,65.7 to 77.0,505
Combined 7 Series,,States/Local Areas,Arizona,2014,Age,35 Months,77.7,70.0 to 84.7,259
Combined 7 Series,,States/Local Areas,Arizona,2014-2015,Age,35 Months,72.6,66.7 to 78.2,507
Hib,Primary Series,States/Local Areas,Arizona,2017,Age,24 Months,90.8,85.3 to 94.8,278
Hib,Primary Series,States/Local Areas,Arizona,2017-2018,Age,24 Months,95.2,92.3 to 97.3,562
Hib,Primary Series,States/Local Areas,Arizona,2018,Age,24 Months,99.4,98.6 to 99.8,284
Hib,Primary Series,States/Local Areas,Arizona,2018-2019,Age,24 Months,95.1,92.0 to 97.3,519
Hib,Primary Series,States/Local Areas,Arizona,2014,Age,24 Months,94.6,90.7 to 97.2,259
Hib,Primary Series,States/Local Areas,Arizona,2014-2015,Age,24 Months,92.4,89.3 to 94.9,507
Hib,Primary Series,States/Local Areas,Arizona,2015,Age,24 Months,90.2,85.0 to 94.2,248
Hib,Primary Series,States/Local Areas,Arizona,2015-2016,Age,24 Months,91.9,88.7 to 94.5,505
Hib,Primary Series,States/Local Areas,Arizona,2016,Age,24 Months,93.6,89.6 to 96.5,257
Hib,Primary Series,States/Local Areas,Arizona,2016-2017,Age,24 Months,92.2,88.9 to 94.8,535
Polio,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,89.0,82.9 to 93.1,483
Polio,≥2 Doses,States/Local Areas,South Dakota,2021,Age,5 Months,66.6,54.5 to 76.9,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,90.3,84.8 to 94.0,483
≥1 Dose MMR,,States/Local Areas,South Dakota,2021,Age,19 Months,88.4,79.0 to 93.9,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,87.6,77.0 to 93.7,194
Polio,≥3 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,85.5,74.5 to 92.2,194
DTaP,≥2 Doses,States/Local Areas,South Dakota,2021,Age,5 Months,66.8,54.7 to 77.0,194
PCV,≥1 Dose,States/Local Areas,South Dakota,2021,Age,3 Months,79.1,67.7 to 87.2,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020-2021,Age,24 Months,88.7,83.6 to 92.9,483
Hep A,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,48.1,40.6 to 56.1,483
Combined 7 Series,,States/Local Areas,South Dakota,2020-2021,Age,35 Months,76.4,65.8 to 85.7,483
DTaP,≥3 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,89.6,78.6 to 96.4,194
Hib,Full Series,States/Local Areas,South Dakota,2021,Age,35 Months,79.9,67.8 to 89.6,194
DTaP,≥4 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,75.7,65.2 to 85.0,194
Polio,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,5 Months,70.7,63.2 to 77.2,483
PCV,≥4 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,81.1,74.5 to 87.0,483
Polio,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,84.9,78.3 to 89.8,483
Influenza,,States/Local Areas,South Dakota,2020-2021,Age,24 Months,62.9,55.6 to 70.2,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,87.3,81.2 to 91.6,483
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,79.9,73.1 to 85.3,483
Hib,Primary Series,States/Local Areas,South Dakota,2021,Age,13 Months,81.5,69.8 to 89.4,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,89.7,81.2 to 95.5,194
≥1 Dose MMR,,States/Local Areas,South Dakota,2020-2021,Age,35 Months,91.8,86.8 to 95.4,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,66.3,58.8 to 73.1,483
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,81.7,74.8 to 87.0,483
Hib,Full Series,States/Local Areas,South Dakota,2020-2021,Age,35 Months,84.4,73.9 to 92.4,483
Hep A,≥2 Doses,States/Local Areas,South Dakota,2021,Age,19 Months,36.9,26.7 to 48.5,194
Hep B,"≥1 Dose, 2 Day",States/Local Areas,South Dakota,2020-2021,Age,0-2 Days,80.7,74.1 to 86.0,483
Hib,Full Series,States/Local Areas,South Dakota,2020-2021,Age,19 Months,68.0,60.6 to 74.6,483
Hep B,"≥1 Dose, 1 Day",States/Local Areas,South Dakota,2020-2021,Age,0-1 Days,78.1,71.4 to 83.7,483
Hib,Primary Series,States/Local Areas,South Dakota,2020-2021,Age,35 Months,90.3,84.8 to 94.4,483
Hib,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,88.7,82.8 to 93.3,483
Hib,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,86.3,80.1 to 90.8,483
Combined 7 Series,,States/Local Areas,South Dakota,2021,Age,24 Months,67.9,56.7 to 78.6,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2021,Age,35 Months,92.3,82.8 to 97.6,194
Hep B,≥2 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,92.2,83.4 to 96.5,194
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2020-2021,Age,0-3 Days,81.8,75.2 to 86.8,483
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,88.8,83.2 to 93.3,483
Rotavirus,,States/Local Areas,South Dakota,2020-2021,Age,8 Months,76.6,69.5 to 82.4,483
PCV,≥4 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,75.0,68.3 to 80.7,483
DTaP,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,5 Months,71.4,63.9 to 77.8,483
Hib,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,69.4,61.9 to 76.0,483
Hib,Full Series,States/Local Areas,South Dakota,2020-2021,Age,24 Months,72.6,65.5 to 79.2,483
Hep B,≥1 Dose,States/Local Areas,South Dakota,2021,Age,3 Months,90.6,80.9 to 95.6,194
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,93.6,91.0 to 96.3,790
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,79.5,75.6 to 83.4,790
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,89.5,81.0 to 98.1,75
Influenza,,States/Local Areas,South Dakota,2014-2017,Overall,Overall,70.0,66.2 to 73.8,873
Influenza,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,77.8,73.5 to 82.0,553
Influenza,,States/Local Areas,South Dakota,2021,Age,24 Months,61.1,50.0 to 72.3,194
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020-2021,Age,13 Months,64.6,57.4 to 71.1,483
≥1 Dose MMR,,States/Local Areas,South Dakota,2020-2021,Age,19 Months,87.8,82.4 to 91.7,483
Hib,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,53.9,46.6 to 61.0,483
Hep A,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,24 Months,85.9,80.6 to 90.4,483
≥1 Dose MMR,,States/Local Areas,South Dakota,2021,Age,13 Months,70.7,59.2 to 80.2,194
Polio,≥2 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,87.5,76.9 to 93.6,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,83.9,77.2 to 88.9,483
Hep B,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,3 Months,93.5,88.3 to 96.5,483
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2021,Age,0-3 Days,80.6,69.7 to 88.2,194
Hib,≥3 Doses,States/Local Areas,South Dakota,2021,Age,35 Months,89.6,78.4 to 96.4,194
PCV,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,3 Months,81.1,74.2 to 86.4,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,90.6,84.9 to 94.8,483
Hib,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,3 Months,81.4,74.6 to 86.7,483
Combined 7 Series,,States/Local Areas,South Dakota,2020-2021,Age,24 Months,63.9,56.6 to 71.1,483
Hep B,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,91.5,86.4 to 94.8,483
≥1 Dose Varicella,,States/Local Areas,South Dakota,2020-2021,Age,19 Months,87.3,81.9 to 91.3,483
Polio,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,90.7,84.7 to 95.0,483
Hib,Primary Series,States/Local Areas,South Dakota,2020-2021,Age,7 Months,69.3,61.8 to 75.9,483
Hib,Primary Series,States/Local Areas,South Dakota,2021,Age,35 Months,87.5,78.2 to 94.2,194
DTaP,≥4 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,65.2,57.8 to 71.9,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,88.6,83.1 to 93.0,483
Hib,≥3 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,66.9,54.6 to 77.2,194
Polio,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,19 Months,87.2,80.9 to 91.6,483
DTaP,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,7 Months,67.7,60.4 to 74.3,483
Hep B,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,5 Months,85.9,79.4 to 90.6,483
Hib,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,5 Months,70.0,62.3 to 76.6,483
Polio,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,3 Months,81.9,74.9 to 87.3,483
≥1 Dose Varicella,,States/Local Areas,South Dakota,2021,Age,13 Months,69.7,58.2 to 79.2,194
Hep A,≥1 Dose,States/Local Areas,South Dakota,2020-2021,Age,19 Months,84.7,79.1 to 89.1,483
Rotavirus,,States/Local Areas,South Dakota,2021,Age,8 Months,76.5,64.9 to 85.1,194
Hib,≥2 Doses,States/Local Areas,South Dakota,2021,Age,13 Months,87.4,76.9 to 93.6,194
Hep B,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,91.2,86.0 to 95.0,483
PCV,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,13 Months,83.5,76.9 to 88.5,483
Hep A,≥2 Doses,States/Local Areas,South Dakota,2020-2021,Age,35 Months,82.6,72.3 to 90.8,483
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,87.1,83.7 to 90.4,790
Influenza,,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,63.7,55.8 to 71.6,208
Influenza,,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,69.3,64.1 to 74.6,456
Influenza,,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,81.3,75.0 to 87.6,209
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",72.6,61.8 to 51.4,190
Influenza,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,78.0,64.6 to 91.4,56
Influenza,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.6,50.0 to 69.2,141
Influenza,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,62.8,55.8 to 69.8,264
Influenza,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.6,68.4 to 76.8,655
Influenza,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,75.1,68.8 to 81.4,265
Influenza,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,66.3,60.9 to 71.6,483
Influenza,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,71.6,61.6 to 81.5,125
Influenza,,States/Local Areas,South Dakota,2018,Age,24 Months,75.7,69.5 to 81.5,390
Influenza,,States/Local Areas,South Dakota,2018-2019,Age,24 Months,74.0,69.4 to 78.4,708
Influenza,,States/Local Areas,South Dakota,2017,Age,24 Months,77.2,70.9 to 83.0,335
Influenza,,States/Local Areas,South Dakota,2017-2018,Age,24 Months,76.4,72.0 to 80.6,725
Influenza,,States/Local Areas,South Dakota,2016,Age,24 Months,65.4,57.9 to 72.9,235
Influenza,,States/Local Areas,South Dakota,2016-2017,Age,24 Months,71.3,66.3 to 76.2,570
Influenza,,States/Local Areas,South Dakota,2019,Age,24 Months,72.0,65.1 to 78.6,318
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,86.3,81.4 to 91.1,324
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",78.4,73.7 to 83.0,882
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Private Insurance Only,88.9,85.9 to 91.9,790
Polio,≥3 Doses,States/Local Areas,South Dakota,2020-2021,Age,24 Months,87.8,82.0 to 92.4,483
Influenza,,States/Local Areas,South Dakota,2013,Age,24 Months,62.7,54.9 to 70.6,222
Influenza,,States/Local Areas,South Dakota,2013-2014,Age,24 Months,65.1,59.7 to 70.4,496
Influenza,,States/Local Areas,South Dakota,2015,Age,24 Months,76.7,69.9 to 82.9,219
Influenza,,States/Local Areas,South Dakota,2015-2016,Age,24 Months,71.1,66.0 to 76.1,454
Influenza,,States/Local Areas,South Dakota,2014,Age,24 Months,67.5,60.4 to 74.4,274
Influenza,,States/Local Areas,South Dakota,2014-2015,Age,24 Months,72.0,67.0 to 76.8,493
Influenza,,States/Local Areas,South Dakota,2011,Age,24 Months,71.1,62.3 to 79.3,194
Influenza,,States/Local Areas,South Dakota,2012,Age,24 Months,71.4,62.7 to 79.6,211
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,66.8,53.4 to 80.2,75
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,>400% FPL,95.3,92.4 to 98.2,332
Hep B,≥2 Doses,States/Local Areas,South Dakota,2019-2020,Age,7 Months,92.1,88.1 to 94.8,607
Hib,Primary Series,States/Local Areas,South Dakota,2019-2020,Age,7 Months,71.4,65.8 to 76.4,607
Hib,Full Series,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",74.9,66.3 to 83.6,190
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"White, Non-Hispanic",82.9,79.8 to 86.0,882
PCV,≥3 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,98.9,97.4 to 100.0,75
Hep A,≥2 Doses,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,Hispanic,93.6,81.3 to 100.0,75
DTaP,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Poverty,133% to <400% FPL,77.4,72.7 to 82.2,607
PCV,≥4 Doses,States/Local Areas,South Dakota,2016-2019,Insurance Coverage,Any Medicaid,77.3,71.3 to 83.4,324
Hep A,≥1 Dose,States/Local Areas,South Dakota,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.5,78.6 to 92.5,190
Hib,≥2 Doses,States/Local Areas,South Dakota,2021,Age,5 Months,64.2,52.0 to 74.9,194
Rotavirus,,States/Local Areas,South Dakota,2011,Age,8 Months,74.8,65.9 to 82.0,194
Rotavirus,,States/Local Areas,South Dakota,2014,Age,8 Months,73.6,66.4 to 79.7,274
Rotavirus,,States/Local Areas,South Dakota,2014-2015,Age,8 Months,75.3,70.3 to 79.7,493
Rotavirus,,States/Local Areas,South Dakota,2016,Age,8 Months,71.9,64.3 to 78.5,235
Rotavirus,,States/Local Areas,South Dakota,2016-2017,Age,8 Months,73.9,68.9 to 78.3,570
Rotavirus,,States/Local Areas,South Dakota,2015,Age,8 Months,77.0,69.7 to 83.0,219
Rotavirus,,States/Local Areas,South Dakota,2015-2016,Age,8 Months,74.5,69.3 to 79.1,454
Rotavirus,,States/Local Areas,South Dakota,2013,Age,8 Months,68.3,60.0 to 75.6,222
Rotavirus,,States/Local Areas,South Dakota,2013-2014,Age,8 Months,71.0,65.6 to 75.8,496
Rotavirus,,States/Local Areas,South Dakota,2012,Age,8 Months,69.1,59.7 to 77.2,211
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,82.5,78.7 to 86.4,553
Rotavirus,,States/Local Areas,South Dakota,2018,Age,8 Months,80.0,74.0 to 84.9,390
Rotavirus,,States/Local Areas,South Dakota,2018-2019,Age,8 Months,80.0,75.7 to 83.7,708
Rotavirus,,States/Local Areas,South Dakota,2019,Age,8 Months,79.9,73.3 to 85.3,318
Rotavirus,,States/Local Areas,South Dakota,2017,Age,8 Months,75.9,69.2 to 81.5,335
Rotavirus,,States/Local Areas,South Dakota,2017-2018,Age,8 Months,77.9,73.6 to 81.7,725
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Overall,Overall,73.5,69.8 to 77.1,873
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,57.1,49.3 to 65.0,208
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,70.3,65.1 to 75.5,483
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.0,68.6 to 87.4,125
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",79.2,75.4 to 82.9,655
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,76.4,70.5 to 82.3,265
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",59.4,49.8 to 68.9,141
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,63.6,56.7 to 70.5,264
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,72.2,59.3 to 85.1,56
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,78.3,73.6 to 82.9,456
Rotavirus,,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,87.4,82.8 to 91.9,209
Hib,Full Series,States/Local Areas,South Dakota,2019,Age,19 Months,66.2,59.1 to 72.7,318
Hib,Full Series,States/Local Areas,South Dakota,2014,Age,24 Months,81.5,75.4 to 86.8,274
Hib,Full Series,States/Local Areas,South Dakota,2014-2015,Age,24 Months,81.7,77.2 to 85.8,493
Hib,Full Series,States/Local Areas,South Dakota,2013,Age,24 Months,73.3,65.7 to 80.5,222
Hib,Full Series,States/Local Areas,South Dakota,2013-2014,Age,24 Months,77.4,72.5 to 82.0,496
Hib,Full Series,States/Local Areas,South Dakota,2017,Age,19 Months,71.5,64.4 to 77.7,335
Hib,Full Series,States/Local Areas,South Dakota,2017-2018,Age,19 Months,71.8,67.2 to 76.0,725
Hib,Full Series,States/Local Areas,South Dakota,2011,Age,24 Months,83.4,75.9 to 89.6,194
Hib,Full Series,States/Local Areas,South Dakota,2012,Age,24 Months,82.7,75.0 to 89.1,211
Hib,Full Series,States/Local Areas,South Dakota,2018,Age,19 Months,72.2,66.1 to 77.6,390
Hib,Full Series,States/Local Areas,South Dakota,2018-2019,Age,19 Months,96.1,93.9 to 97.5,708
Hib,Full Series,States/Local Areas,South Dakota,2014,Age,19 Months,72.9,65.6 to 79.1,274
Hib,Full Series,States/Local Areas,South Dakota,2014-2015,Age,19 Months,71.3,66.0 to 76.0,493
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,Hispanic,72.2,58.2 to 86.3,56
Combined 7 Series,,States/Local Areas,South Dakota,2019,Age,35 Months,73.5,65.7 to 80.7,318
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Private Insurance Only,79.3,75.1 to 83.5,553
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Insurance Coverage,Any Medicaid,60.5,53.3 to 67.7,264
Combined 7 Series,,States/Local Areas,South Dakota,2018,Age,35 Months,80.4,74.2 to 85.9,390
Combined 7 Series,,States/Local Areas,South Dakota,2018-2019,Age,35 Months,77.1,72.2 to 81.7,708
Combined 7 Series,,States/Local Areas,South Dakota,2015,Age,35 Months,80.3,71.8 to 87.6,219
Combined 7 Series,,States/Local Areas,South Dakota,2015-2016,Age,35 Months,77.8,72.1 to 83.0,454
Hib,Full Series,States/Local Areas,South Dakota,2015,Age,19 Months,69.7,67.7 to 71.6,219
Hib,Full Series,States/Local Areas,South Dakota,2015-2016,Age,19 Months,69.1,63.7 to 74.1,454
Hib,Full Series,States/Local Areas,South Dakota,2016,Age,19 Months,68.5,60.9 to 75.3,235
Hib,Full Series,States/Local Areas,South Dakota,2016-2017,Age,19 Months,70.0,64.9 to 74.7,570
Hib,Full Series,States/Local Areas,South Dakota,2013,Age,19 Months,67.7,64.7 to 70.7,222
Hib,Full Series,States/Local Areas,South Dakota,2013-2014,Age,19 Months,70.3,66.6 to 73.7,496
Hib,Full Series,States/Local Areas,South Dakota,2012,Age,19 Months,74.3,70.6 to 77.7,211
Hib,Full Series,States/Local Areas,South Dakota,2011,Age,19 Months,77.2,72.4 to 81.3,194
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Poverty,133% to <400% FPL,71.7,66.5 to 76.9,456
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Poverty,>400% FPL,82.5,76.4 to 88.5,209
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Poverty,<133% FPL,58.6,50.4 to 66.8,208
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a Non-MSA,67.4,62.0 to 72.9,483
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Overall,Overall,69.8,65.9 to 73.7,873
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",60.8,50.8 to 70.7,141
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Race and Ethnicity,"White, Non-Hispanic",72.9,68.7 to 77.1,655
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Principal City,69.6,62.8 to 76.3,265
Combined 7 Series,,States/Local Areas,South Dakota,2014-2017,Urbanicity,Living In a MSA Non-Principal City,78.6,69.9 to 87.4,125
Polio,≥3 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,91.4,88.7 to 93.4,2037
Polio,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,91.2,89.1 to 93.0,4108
Polio,≥3 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,91.9,89.8 to 93.6,2071
Polio,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,93.2,91.3 to 94.6,4326
Polio,≥3 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,91.3,88.9 to 93.2,2101
Polio,≥3 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,91.1,88.1 to 93.4,2626
Polio,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,92.3,90.5 to 93.8,5514
Polio,≥3 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,94.4,92.4 to 95.9,2255
Polio,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,92.8,91.0 to 94.2,4881
Hib,≥3 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,78.6,75.4 to 81.5,2888
Hib,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,79.6,77.5 to 81.7,5328
Hib,≥3 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,94.8,93.3 to 96.0,1959
Hib,≥3 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,89.8,87.4 to 91.8,2101
Hib,≥3 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,80.7,77.6 to 83.4,2440
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,91.1,88.7 to 93.1,2888
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,92.0,90.4 to 93.3,5328
DTaP,≥3 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,92.5,90.4 to 94.2,2101
DTaP,≥3 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,95.4,94.0 to 96.5,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,92.8,90.8 to 94.5,2440
Polio,≥3 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,91.1,88.2 to 93.4,2071
Polio,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,91.5,89.4 to 93.2,4142
Hib,≥3 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,78.5,75.0 to 81.6,2626
Hib,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,78.5,76.2 to 80.7,5514
Hib,≥3 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,82.9,79.8 to 85.7,2255
Hib,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,80.7,78.4 to 82.9,4881
Hib,≥3 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,80.1,76.2 to 83.5,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,81.5,79.1 to 83.7,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,91.6,88.5 to 94.0,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,92.8,91.0 to 94.3,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,90.0,87.1 to 92.3,2626
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,90.6,88.7 to 92.2,5514
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,94.0,91.9 to 95.6,2255
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,92.0,90.3 to 93.5,4881
Hib,≥2 Doses,HHS Regions/National,Region 3,2020,Age,13 Months,91.3,88.9 to 93.2,2390
Hib,≥3 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,82.2,79.1 to 84.9,2101
Hib,≥3 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,88.8,86.1 to 91.1,1959
Hib,≥3 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,76.0,72.0 to 79.6,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,78.0,75.3 to 80.6,4142
Polio,≥3 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,93.9,92.0 to 95.4,1959
Hib,≥3 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,81.1,77.7 to 84.1,2037
Hib,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,78.6,75.3 to 81.5,4108
Hib,≥2 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,93.7,91.3 to 95.5,2626
Hib,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,94.4,92.8 to 95.6,5514
Hib,≥2 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,95.0,93.0 to 96.4,2888
Hib,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,95.4,94.1 to 96.4,5328
Hib,≥2 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,95.7,93.9 to 97.0,2440
Hib,≥2 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,96.0,94.7 to 97.1,1959
Hib,≥2 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,93.4,91.4 to 95.0,2101
Hib,≥2 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,92.5,90.3 to 94.2,2440
DTaP,≥3 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,89.6,87.1 to 91.7,2101
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,89.0,85.9 to 91.5,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,90.3,88.2 to 92.1,4142
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,91.7,89.8 to 93.3,2037
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,90.4,87.8 to 92.4,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,64.1,60.6 to 67.5,2440
PCV,≥3 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,93.0,90.8 to 94.8,2888
PCV,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,93.9,92.6 to 95.1,5328
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2016,Age,0-3 Days,79.1,75.8 to 82.0,2255
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2016-2017,Age,0-3 Days,80.0,77.7 to 82.1,4881
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2017,Age,0-3 Days,82.2,78.1 to 85.7,1462
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2017-2018,Age,0-3 Days,81.4,79.4 to 83.3,5514
Polio,≥1 Dose,HHS Regions/National,Region 3,2016,Age,3 Months,91.1,88.7 to 93.1,2255
Polio,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,3 Months,89.9,88.0 to 91.5,4881
Polio,≥1 Dose,HHS Regions/National,Region 3,2015,Age,3 Months,87.7,84.1 to 90.6,2071
Polio,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,3 Months,89.4,87.3 to 91.2,4326
Polio,≥1 Dose,HHS Regions/National,Region 3,2014,Age,3 Months,87.2,84.0 to 89.8,2071
Polio,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,3 Months,87.5,85.1 to 89.5,4142
Hib,≥3 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,62.4,58.6 to 66.1,2037
Hib,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,60.4,57.6 to 63.1,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,69.6,65.2 to 73.7,1959
Hib,≥3 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,65.4,61.4 to 69.3,2101
PCV,≥3 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,95.1,93.2 to 96.5,2255
PCV,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,94.6,93.1 to 95.8,4881
PCV,≥3 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,93.7,91.1 to 95.8,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,94.4,92.8 to 95.7,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,93.3,90.6 to 95.5,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,93.6,91.7 to 95.1,4142
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2014,Age,0-3 Days,70.9,66.7 to 74.7,2071
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2014-2015,Age,0-3 Days,73.2,70.4 to 75.9,4142
Polio,≥1 Dose,HHS Regions/National,Region 3,2013,Age,3 Months,86.1,82.3 to 89.3,2037
Polio,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,3 Months,86.7,84.2 to 88.8,4108
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2013,Age,0-3 Days,75.8,72.0 to 79.3,2037
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2013-2014,Age,0-3 Days,73.4,70.6 to 76.0,4108
Polio,≥1 Dose,HHS Regions/National,Region 3,2011,Age,3 Months,90.1,86.6 to 92.7,1959
Polio,≥1 Dose,HHS Regions/National,Region 3,2012,Age,3 Months,88.0,85.2 to 90.4,2101
PCV,≥1 Dose,HHS Regions/National,Region 3,2019,Age,3 Months,91.3,89.0 to 93.1,2440
PCV,≥1 Dose,HHS Regions/National,Region 3,2018,Age,3 Months,88.8,86.2 to 90.9,2888
PCV,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,3 Months,90.0,88.3 to 91.5,5328
PCV,≥3 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,92.2,89.6 to 94.4,2101
PCV,≥3 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,93.9,91.3 to 96.0,2037
PCV,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,93.6,91.8 to 95.2,4108
PCV,≥3 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,94.5,92.0 to 96.4,1959
PCV,≥3 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,94.9,93.1 to 96.3,2440
Hib,≥2 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,89.6,86.1 to 92.2,2071
Hib,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,91.7,89.7 to 93.3,4326
Hib,≥2 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,90.6,88.1 to 92.6,2888
Hib,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,91.5,89.9 to 92.9,5328
Hib,≥2 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,90.3,87.3 to 92.6,2626
Hib,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,90.4,88.5 to 92.1,5514
Hib,≥2 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,93.8,91.8 to 95.3,2255
Hib,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,92.0,90.3 to 93.5,4881
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,78.2,74.8 to 81.2,2255
DTaP,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,76.4,73.9 to 78.8,4881
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2015,Age,0-3 Days,75.6,71.8 to 79.1,2071
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2015-2016,Age,0-3 Days,77.3,74.8 to 79.7,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,71.2,67.1 to 74.9,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,71.3,68.4 to 74.1,4142
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,71.5,67.2 to 75.4,2071
DTaP,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,74.8,72.1 to 77.4,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,94.0,91.6 to 95.8,2626
PCV,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.3,92.7 to 95.6,5514
Hib,≥2 Doses,HHS Regions/National,Region 3,2013,Age,13 Months,94.8,93.7 to 95.8,2037
Hib,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,13 Months,94.3,92.4 to 95.7,4108
Hib,≥3 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,58.3,54.0 to 62.5,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,59.4,56.4 to 62.4,4142
PCV,≥3 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,94.6,92.4 to 96.3,2888
PCV,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,95.0,93.6 to 96.1,5328
Hib,≥3 Doses,HHS Regions/National,Region 3,2016,Age,7 Months,67.3,63.5 to 70.8,2255
Hib,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,7 Months,66.4,63.7 to 69.0,4881
Hib,≥3 Doses,HHS Regions/National,Region 3,2015,Age,7 Months,60.5,56.1 to 64.7,2071
Hib,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,7 Months,63.9,61.0 to 66.7,4326
Polio,≥1 Dose,HHS Regions/National,Region 3,2017,Age,3 Months,88.7,85.7 to 91.1,2626
Polio,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,3 Months,89.1,87.2 to 90.8,5514
Polio,≥1 Dose,HHS Regions/National,Region 3,2018,Age,3 Months,89.6,87.1 to 91.7,2888
Polio,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,3 Months,90.9,89.3 to 92.4,5328
Hib,≥3 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,65.5,61.6 to 69.1,2626
Hib,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,63.5,60.9 to 66.1,5514
Hib,≥3 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,61.6,58.0 to 65.0,2888
Hib,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,62.8,60.3 to 65.3,5328
PCV,≥3 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,95.4,93.6 to 96.8,2440
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2018,Age,0-3 Days,81.9,79.2 to 84.3,2888
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2018-2019,Age,0-3 Days,82.9,81.1 to 84.6,5328
Polio,≥1 Dose,HHS Regions/National,Region 3,2019,Age,3 Months,92.3,90.1 to 94.0,2440
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2019,Age,0-3 Days,84.0,81.3 to 86.3,2440
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020,Age,24 Months,90.7,88.4 to 92.7,2390
Hib,≥2 Doses,HHS Regions/National,Region 3,2014,Age,13 Months,93.7,91.2 to 95.5,2071
Hib,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,13 Months,94.0,92.2 to 95.4,4142
Hib,≥2 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,96.0,94.3 to 97.3,2255
Hib,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,94.9,93.5 to 96.0,4881
Hib,≥2 Doses,HHS Regions/National,Region 3,2015,Age,13 Months,94.2,91.3 to 96.2,2071
Hib,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,13 Months,95.1,93.5 to 96.3,4326
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018,Age,7 Months,74.8,71.5 to 77.8,2888
DTaP,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,7 Months,75.8,73.6 to 77.9,5328
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017,Age,7 Months,74.6,70.9 to 78.0,2626
DTaP,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,7 Months,74.7,72.2 to 77.0,5514
DTaP,≥3 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,76.9,73.7 to 79.7,2440
DTaP,≥3 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,94.0,92.2 to 95.4,1959
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,93.2,91.1 to 94.9,2255
Hep B,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,93.6,92.1 to 95.0,4881
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,93.0,90.5 to 95.1,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,93.1,91.5 to 94.5,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2013,Age,19 Months,91.7,89.2 to 93.6,2037
PCV,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,19 Months,91.5,89.3 to 93.3,4108
PCV,≥3 Doses,HHS Regions/National,Region 3,2011,Age,19 Months,94.0,92.4 to 95.3,1959
PCV,≥3 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,91.7,89.6 to 93.4,2440
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,94.1,91.9 to 95.9,2626
Hep B,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.4,92.9 to 95.8,5514
PCV,≥3 Doses,HHS Regions/National,Region 3,2012,Age,19 Months,90.8,88.3 to 92.9,2101
PCV,≥4 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,83.9,80.3 to 87.2,2101
PCV,≥4 Doses,HHS Regions/National,Region 3,2011,Age,35 Months,87.8,84.2 to 90.8,1959
PCV,≥4 Doses,HHS Regions/National,Region 3,2019,Age,24 Months,86.5,83.9 to 88.8,2440
PCV,≥4 Doses,HHS Regions/National,Region 3,2018,Age,24 Months,83.6,80.7 to 86.2,2888
PCV,≥4 Doses,HHS Regions/National,Region 3,2018-2019,Age,24 Months,85.0,83.1 to 86.8,5328
PCV,≥3 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,92.5,90.2 to 94.3,2255
PCV,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,90.7,88.8 to 92.2,4881
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,93.1,90.8 to 95.1,2037
Hep B,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,92.0,90.1 to 93.7,4108
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,90.8,87.8 to 93.3,2071
Hep B,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,92.0,90.0 to 93.7,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2012,Age,35 Months,90.2,87.5 to 92.5,2101
Hep B,≥2 Doses,HHS Regions/National,Region 3,2012,Age,13 Months,93.1,91.1 to 94.6,2101
Hep B,≥2 Doses,HHS Regions/National,Region 3,2011,Age,13 Months,95.5,94.5 to 96.3,1959
Hep B,≥2 Doses,HHS Regions/National,Region 3,2019,Age,7 Months,94.7,92.8 to 96.0,2440
PCV,≥3 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,88.8,85.8 to 91.2,2626
PCV,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,89.2,87.2 to 90.8,5514
PCV,≥3 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,89.5,87.0 to 91.6,2888
PCV,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,90.6,89.0 to 92.0,5328
PCV,≥4 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,88.3,85.8 to 90.6,2255
PCV,≥4 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,86.6,84.6 to 88.4,4881
PCV,≥4 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,84.8,81.8 to 87.6,2626
PCV,≥4 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,84.2,82.1 to 86.2,5514
≥1 Dose MMR,,HHS Regions/National,Region 3,2015,Age,35 Months,94.4,92.0 to 96.3,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2015-2016,Age,35 Months,94.7,93.0 to 96.1,4326
≥1 Dose MMR,,HHS Regions/National,Region 3,2014,Age,35 Months,93.2,90.7 to 95.2,2071
≥1 Dose MMR,,HHS Regions/National,Region 3,2014-2015,Age,35 Months,93.7,92.0 to 95.2,4142
≥1 Dose MMR,,HHS Regions/National,Region 3,2016,Age,35 Months,94.9,92.5 to 96.7,2255
≥1 Dose MMR,,HHS Regions/National,Region 3,2016-2017,Age,35 Months,94.5,93.0 to 95.9,4881
PCV,≥4 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,84.8,81.2 to 88.0,2071
PCV,≥4 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,86.6,84.4 to 88.6,4326
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018,Age,35 Months,95.6,92.8 to 97.5,2888
≥1 Dose Varicella,,HHS Regions/National,Region 3,2018-2019,Age,35 Months,95.2,93.6 to 96.6,5328
≥1 Dose Varicella,,HHS Regions/National,Region 3,2019,Age,35 Months,95.0,93.0 to 96.5,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2019,Age,35 Months,95.2,93.5 to 96.7,2440
≥1 Dose MMR,,HHS Regions/National,Region 3,2017,Age,35 Months,94.2,92.0 to 96.0,2626
≥1 Dose MMR,,HHS Regions/National,Region 3,2017-2018,Age,35 Months,94.8,93.2 to 96.2,5514
≥1 Dose MMR,,HHS Regions/National,Region 3,2018,Age,35 Months,95.4,92.9 to 97.2,2888
≥1 Dose MMR,,HHS Regions/National,Region 3,2018-2019,Age,35 Months,95.4,93.8 to 96.6,5328
Hep B,≥2 Doses,HHS Regions/National,Region 3,2017,Age,13 Months,94.7,92.2 to 96.4,2626
Hep B,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,13 Months,95.1,93.7 to 96.2,5514
Hib,≥1 Dose,HHS Regions/National,Region 3,2017,Age,3 Months,88.5,85.4 to 90.9,2626
Hib,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,3 Months,88.9,87.0 to 90.6,5514
Hib,≥1 Dose,HHS Regions/National,Region 3,2016,Age,3 Months,90.5,88.0 to 92.5,2255
Hib,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,3 Months,89.5,87.6 to 91.1,4881
Hib,≥1 Dose,HHS Regions/National,Region 3,2015,Age,3 Months,86.8,83.1 to 89.7,2071
Hib,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,3 Months,88.6,86.4 to 90.5,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2016,Age,19 Months,94.3,92.3 to 95.8,2255
PCV,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,19 Months,93.0,91.4 to 94.4,4881
PCV,≥3 Doses,HHS Regions/National,Region 3,2015,Age,19 Months,92.6,90.0 to 94.5,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,19 Months,93.4,91.7 to 94.8,4326
Hep B,≥2 Doses,HHS Regions/National,Region 3,2016,Age,13 Months,95.9,94.5 to 97.0,2255
Hep B,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,13 Months,95.3,93.9 to 96.4,4881
Hep B,≥2 Doses,HHS Regions/National,Region 3,2018,Age,13 Months,95.6,93.8 to 96.9,2888
Hep B,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,13 Months,95.7,94.5 to 96.7,5328
PCV,≥4 Doses,HHS Regions/National,Region 3,2014,Age,35 Months,86.0,82.5 to 89.2,2071
PCV,≥4 Doses,HHS Regions/National,Region 3,2014-2015,Age,35 Months,87.1,84.6 to 89.4,4142
PCV,≥4 Doses,HHS Regions/National,Region 3,2015,Age,35 Months,88.5,85.0 to 91.6,2071
PCV,≥4 Doses,HHS Regions/National,Region 3,2015-2016,Age,35 Months,89.9,87.8 to 91.8,4326
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,94.8,92.4 to 96.6,2888
Hep B,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,95.3,93.7 to 96.7,5328
PCV,≥3 Doses,HHS Regions/National,Region 3,2014,Age,19 Months,91.3,88.2 to 93.6,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,19 Months,91.9,89.9 to 93.6,4142
Hep B,≥3 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,95.8,93.4 to 97.5,2440
Hib,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,3 Months,87.1,84.8 to 89.2,4142
Hib,≥1 Dose,HHS Regions/National,Region 3,2011,Age,3 Months,90.7,87.7 to 93.1,1959
Hib,≥1 Dose,HHS Regions/National,Region 3,2012,Age,3 Months,87.5,84.3 to 90.1,2101
Hib,≥1 Dose,HHS Regions/National,Region 3,2013,Age,3 Months,86.4,83.1 to 89.1,2037
Hib,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,3 Months,87.0,84.6 to 89.0,4108
PCV,≥4 Doses,HHS Regions/National,Region 3,2013,Age,35 Months,87.5,84.3 to 90.3,2037
PCV,≥4 Doses,HHS Regions/National,Region 3,2013-2014,Age,35 Months,86.8,84.4 to 88.9,4108
Hib,≥1 Dose,HHS Regions/National,Region 3,2018,Age,3 Months,89.4,86.9 to 91.5,2888
Hib,≥1 Dose,HHS Regions/National,Region 3,2018-2019,Age,3 Months,89.8,88.2 to 91.3,5328
Hib,≥1 Dose,HHS Regions/National,Region 3,2019,Age,3 Months,90.3,87.9 to 92.2,2440
PCV,≥3 Doses,HHS Regions/National,Region 3,2013,Age,24 Months,92.5,90.1 to 94.6,2037
PCV,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,24 Months,92.3,90.5 to 93.9,4108
Hib,≥2 Doses,HHS Regions/National,Region 3,2017,Age,5 Months,82.4,79.0 to 85.3,2626
Hib,≥2 Doses,HHS Regions/National,Region 3,2017-2018,Age,5 Months,82.0,79.8 to 84.1,5514
PCV,≥3 Doses,HHS Regions/National,Region 3,2012,Age,24 Months,91.7,89.1 to 93.9,2101
PCV,≥3 Doses,HHS Regions/National,Region 3,2014,Age,24 Months,92.1,89.3 to 94.4,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2014-2015,Age,24 Months,92.6,90.7 to 94.3,4142
PCV,≥1 Dose,HHS Regions/National,Region 3,2013,Age,3 Months,85.3,81.3 to 88.5,2037
PCV,≥1 Dose,HHS Regions/National,Region 3,2013-2014,Age,3 Months,85.1,82.3 to 87.5,4108
PCV,≥4 Doses,HHS Regions/National,Region 3,2019,Age,35 Months,90.0,86.7 to 92.8,2440
Hib,≥2 Doses,HHS Regions/National,Region 3,2016,Age,5 Months,83.2,80.0 to 85.9,2255
Hib,≥2 Doses,HHS Regions/National,Region 3,2016-2017,Age,5 Months,82.8,80.5 to 84.8,4881
Hib,≥2 Doses,HHS Regions/National,Region 3,2015,Age,5 Months,79.7,75.8 to 83.1,2071
Hib,≥2 Doses,HHS Regions/National,Region 3,2015-2016,Age,5 Months,81.4,79.0 to 83.7,4326
PCV,≥3 Doses,HHS Regions/National,Region 3,2017,Age,19 Months,91.7,89.0 to 93.8,2626
PCV,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,19 Months,92.3,90.5 to 93.8,5514
Hib,≥2 Doses,HHS Regions/National,Region 3,2014,Age,5 Months,81.1,77.5 to 84.1,2071
Hib,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,5 Months,80.4,77.8 to 82.7,4142
Hib,≥2 Doses,HHS Regions/National,Region 3,2013,Age,5 Months,77.8,74.6 to 80.7,2037
Hib,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,5 Months,79.4,77.0 to 81.7,4108
Hib,≥2 Doses,HHS Regions/National,Region 3,2011,Age,5 Months,82.2,78.3 to 85.6,1959
Hib,≥2 Doses,HHS Regions/National,Region 3,2012,Age,5 Months,77.0,73.3 to 80.3,2101
PCV,≥4 Doses,HHS Regions/National,Region 3,2018,Age,35 Months,88.0,84.6 to 91.0,2888
PCV,≥4 Doses,HHS Regions/National,Region 3,2018-2019,Age,35 Months,89.1,86.7 to 91.2,5328
PCV,≥4 Doses,HHS Regions/National,Region 3,2016,Age,35 Months,91.5,89.0 to 93.6,2255
PCV,≥4 Doses,HHS Regions/National,Region 3,2016-2017,Age,35 Months,89.4,87.5 to 91.1,4881
PCV,≥4 Doses,HHS Regions/National,Region 3,2017,Age,35 Months,87.3,84.3 to 89.9,2626
PCV,≥4 Doses,HHS Regions/National,Region 3,2017-2018,Age,35 Months,87.6,85.4 to 89.6,5514
PCV,≥1 Dose,HHS Regions/National,Region 3,2012,Age,3 Months,85.6,82.1 to 88.5,2101
PCV,≥1 Dose,HHS Regions/National,Region 3,2011,Age,3 Months,89.4,86.3 to 91.8,1959
Hep B,≥2 Doses,HHS Regions/National,Region 3,2019,Age,13 Months,95.9,94.1 to 97.1,2440
PCV,≥3 Doses,HHS Regions/National,Region 3,2018,Age,19 Months,92.9,90.7 to 94.7,2888
PCV,≥3 Doses,HHS Regions/National,Region 3,2018-2019,Age,19 Months,90.6,89.0 to 92.0,5328
PCV,≥3 Doses,HHS Regions/National,Region 3,2011,Age,24 Months,94.2,91.7 to 96.1,1959
PCV,≥3 Doses,HHS Regions/National,Region 3,2019,Age,19 Months,93.8,91.9 to 95.3,2440
Hib,≥2 Doses,HHS Regions/National,Region 3,2014,Age,7 Months,90.3,87.5 to 92.6,2071
Hib,≥2 Doses,HHS Regions/National,Region 3,2014-2015,Age,7 Months,90.0,87.8 to 91.8,4142
Hib,≥2 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,91.2,88.7 to 93.2,2037
Hib,≥2 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,90.8,88.8 to 92.4,4108
PCV,≥1 Dose,HHS Regions/National,Region 3,2017,Age,3 Months,86.9,83.8 to 89.5,2626
PCV,≥1 Dose,HHS Regions/National,Region 3,2017-2018,Age,3 Months,87.8,85.9 to 89.5,5514
PCV,≥1 Dose,HHS Regions/National,Region 3,2016,Age,3 Months,89.9,87.4 to 92.0,2255
PCV,≥1 Dose,HHS Regions/National,Region 3,2016-2017,Age,3 Months,88.4,86.5 to 90.1,4881
Hib,≥2 Doses,HHS Regions/National,Region 3,2018,Age,5 Months,81.6,78.6 to 84.3,2888
Hib,≥2 Doses,HHS Regions/National,Region 3,2018-2019,Age,5 Months,81.6,79.5 to 83.5,5328
Hib,≥2 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,91.5,89.0 to 93.4,1959
Hib,≥2 Doses,HHS Regions/National,Region 3,2019,Age,5 Months,81.6,78.6 to 84.3,2440
PCV,≥3 Doses,HHS Regions/National,Region 3,2015,Age,24 Months,93.2,90.4 to 95.4,2071
PCV,≥3 Doses,HHS Regions/National,Region 3,2015-2016,Age,24 Months,94.0,92.4 to 95.3,4326
Hib,≥2 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,89.5,87.1 to 91.5,2101
PCV,≥3 Doses,HHS Regions/National,Region 3,2016,Age,24 Months,94.8,92.9 to 96.3,2255
PCV,≥3 Doses,HHS Regions/National,Region 3,2016-2017,Age,24 Months,93.7,92.2 to 95.0,4881
PCV,≥3 Doses,HHS Regions/National,Region 3,2017,Age,24 Months,92.7,90.2 to 94.7,2626
PCV,≥3 Doses,HHS Regions/National,Region 3,2017-2018,Age,24 Months,92.8,91.2 to 94.3,5514
PCV,≥1 Dose,HHS Regions/National,Region 3,2015,Age,3 Months,85.9,82.1 to 88.9,2071
PCV,≥1 Dose,HHS Regions/National,Region 3,2015-2016,Age,3 Months,87.9,85.7 to 89.8,4326
PCV,≥1 Dose,HHS Regions/National,Region 3,2014,Age,3 Months,85.0,81.5 to 87.9,2071
PCV,≥1 Dose,HHS Regions/National,Region 3,2014-2015,Age,3 Months,85.4,82.9 to 87.6,4142
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2012,Age,0-3 Days,73.9,70.0 to 77.5,2101
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2011,Age,0-3 Days,78.9,75.0 to 82.4,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2011,Age,7 Months,74.3,71.0 to 77.3,1959
DTaP,≥3 Doses,HHS Regions/National,Region 3,2012,Age,7 Months,71.3,67.6 to 74.6,2101
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013,Age,7 Months,71.3,67.7 to 74.7,2037
DTaP,≥3 Doses,HHS Regions/National,Region 3,2013-2014,Age,7 Months,71.3,68.2 to 74.2,4108
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,92.3,90.7 to 93.7,3970
PCV,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,70.7,68.1 to 73.2,3970
Hep B,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,3 Months,94.7,93.3 to 95.8,3970
Hib,Full Series,HHS Regions/National,Region 3,2020-2021,Age,35 Months,80.6,77.7 to 83.4,3970
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,89.0,87.1 to 90.6,3970
Influenza,,HHS Regions/National,Region 3,2021,Age,24 Months,62.5,58.3 to 66.7,1580
Hib,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,5 Months,77.9,75.4 to 80.1,3970
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020-2021,Age,19 Months,87.8,85.8 to 89.5,3970
≥1 Dose MMR,,HHS Regions/National,Region 3,2021,Age,19 Months,87.1,83.9 to 89.7,1580
Hep A,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,28.0,25.7 to 30.4,3970
Hep B,≥2 Doses,HHS Regions/National,Region 3,2021,Age,5 Months,89.1,86.3 to 91.4,1580
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,90.2,88.5 to 91.7,3970
≥1 Dose MMR,,HHS Regions/National,Region 3,2020-2021,Age,13 Months,66.4,63.8 to 69.0,3970
DTaP,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,3 Months,88.2,86.3 to 89.8,3970
Hep B,"≥1 Dose, 2 Day",HHS Regions/National,Region 3,2020-2021,Age,0-2 Days,79.1,76.8 to 81.2,3970
≥1 Dose Varicella,,HHS Regions/National,Region 3,2021,Age,13 Months,64.7,60.6 to 68.6,1580
Polio,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,92.4,90.7 to 93.7,3970
DTaP,≥4 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,72.2,69.6 to 74.6,3970
DTaP,≥2 Doses,HHS Regions/National,Region 3,2021,Age,5 Months,82.3,78.7 to 85.4,1580
Hib,Primary Series,HHS Regions/National,Region 3,2020-2021,Age,35 Months,92.2,90.2 to 93.9,3970
PCV,≥1 Dose,HHS Regions/National,Region 3,2021,Age,3 Months,88.7,85.9 to 91.0,1580
Hep B,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,91.0,89.3 to 92.5,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,77.0,73.2 to 80.4,1580
Hep A,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,44.7,41.9 to 47.5,3970
Polio,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,93.7,91.7 to 95.3,3970
PCV,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,91.8,90.2 to 93.3,3970
≥1 Dose MMR,,HHS Regions/National,Region 3,2020-2021,Age,24 Months,89.9,88.0 to 91.6,3970
Combined 7 Series,,HHS Regions/National,Region 3,2020-2021,Age,35 Months,74.7,71.6 to 77.8,3970
≥1 Dose Varicella,,HHS Regions/National,Region 3,2020-2021,Age,24 Months,90.4,88.6 to 92.0,3970
Hib,Primary Series,HHS Regions/National,Region 3,2021,Age,35 Months,92.5,89.8 to 94.7,1580
Influenza,,HHS Regions/National,Region 3,2017,Age,24 Months,65.7,62.0 to 69.4,2626
Influenza,,HHS Regions/National,Region 3,2017-2018,Age,24 Months,67.7,65.2 to 70.2,5514
Influenza,,HHS Regions/National,Region 3,2018,Age,24 Months,69.6,66.4 to 72.8,2888
Influenza,,HHS Regions/National,Region 3,2018-2019,Age,24 Months,71.2,68.9 to 73.5,5328
DTaP,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,72.9,70.3 to 75.4,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,60.9,58.2 to 63.6,3970
Polio,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,3 Months,87.9,86.0 to 89.5,3970
PCV,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,3 Months,87.6,85.7 to 89.3,3970
DTaP,≥3 Doses,HHS Regions/National,Region 3,2021,Age,24 Months,92.2,89.7 to 94.3,1580
Hep A,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,35 Months,79.6,76.2 to 82.8,3970
Rotavirus,,HHS Regions/National,Region 3,2021,Age,8 Months,78.9,75.3 to 82.1,1580
Hep B,"≥1 Dose, 3 Day (Birth Dose)",HHS Regions/National,Region 3,2021,Age,0-3 Days,80.4,76.8 to 83.5,1580
PCV,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,13 Months,88.7,86.8 to 90.3,3970
Hib,≥2 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,92.2,89.7 to 94.2,1580
Hib,Primary Series,HHS Regions/National,Region 3,2020-2021,Age,7 Months,71.0,68.4 to 73.5,3970
≥1 Dose MMR,,HHS Regions/National,Region 3,2021,Age,13 Months,65.9,61.7 to 69.9,1580
Hep B,≥3 Doses,HHS Regions/National,Region 3,2021,Age,13 Months,88.2,85.2 to 90.6,1580
Polio,≥2 Doses,HHS Regions/National,Region 3,2021,Age,5 Months,82.1,78.5 to 85.2,1580
Influenza,,HHS Regions/National,Region 3,2019,Age,24 Months,72.8,69.6 to 76.0,2440
Influenza,,HHS Regions/National,Region 3,2016,Age,24 Months,66.8,63.1 to 70.4,2255
Influenza,,HHS Regions/National,Region 3,2016-2017,Age,24 Months,66.3,63.6 to 68.9,4881
Hib,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,87.7,85.7 to 89.5,3970
≥1 Dose MMR,,HHS Regions/National,Region 3,2020-2021,Age,19 Months,87.4,85.3 to 89.2,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,92.0,89.2 to 94.4,1580
Polio,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,24 Months,92.1,90.5 to 93.6,3970
DTaP,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,5 Months,80.9,78.5 to 83.1,3970
Hib,≥1 Dose,HHS Regions/National,Region 3,2020-2021,Age,3 Months,85.0,82.9 to 86.8,3970
Polio,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,5 Months,80.7,78.3 to 82.9,3970
Hib,Primary Series,HHS Regions/National,Region 3,2020-2021,Age,13 Months,84.4,82.3 to 86.3,3970
Hep B,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,5 Months,88.9,87.1 to 90.5,3970
Polio,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,90.7,88.9 to 92.3,3970
Polio,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,88.7,86.7 to 90.4,3970
Hib,≥3 Doses,HHS Regions/National,Region 3,2020-2021,Age,19 Months,88.4,86.5 to 90.1,3970
Combined 7 Series,,HHS Regions/National,Region 3,2020-2021,Age,24 Months,69.0,66.5 to 71.6,3970
Hib,Full Series,HHS Regions/National,Region 3,2021,Age,35 Months,80.7,76.5 to 84.6,1580
Hep B,≥2 Doses,HHS Regions/National,Region 3,2020-2021,Age,7 Months,91.2,89.5 to 92.6,3970
DTaP,≥3 Doses,HHS Regions/National,Region 3,2021,Age,35 Months,93.1,90.5 to 95.3,1580
Hib,Primary Series,HHS Regions/National,Region 3,2021,Age,13 Months,84.8,81.7 to 87.5,1580
PCV,≥3 Doses,States/Local Areas,Wisconsin,2019-2020,Age,19 Months,89.3,85.1 to 92.5,511
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,90.2,87.4 to 93.0,548
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,90.1,85.8 to 94.4,303
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,79.9,71.5 to 88.3,125
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,68.8,62.6 to 75.0,332
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",64.5,48.4 to 80.6,45
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,79.5,74.6 to 84.4,404
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.0,73.8 to 82.2,661
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.6,74.1 to 91.2,92
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,66.4,59.1 to 73.7,236
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,77.8,74.3 to 81.2,923
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.4,75.7 to 87.2,307
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,67.5,59.2 to 75.9,212
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,78.1,72.8 to 83.4,384
Rotavirus,,States/Local Areas,Wisconsin,2019,Age,8 Months,76.2,68.0 to 82.9,224
Rotavirus,,States/Local Areas,Wisconsin,2017,Age,8 Months,76.5,68.2 to 83.1,238
Rotavirus,,States/Local Areas,Wisconsin,2017-2018,Age,8 Months,76.6,71.2 to 81.4,479
Rotavirus,,States/Local Areas,Wisconsin,2012,Age,8 Months,72.3,63.9 to 79.4,226
Rotavirus,,States/Local Areas,Wisconsin,2013,Age,8 Months,75.1,67.5 to 81.4,235
Rotavirus,,States/Local Areas,Wisconsin,2013-2014,Age,8 Months,75.6,70.0 to 80.5,459
Rotavirus,,States/Local Areas,Wisconsin,2018,Age,8 Months,76.8,69.1 to 83.1,241
Rotavirus,,States/Local Areas,Wisconsin,2018-2019,Age,8 Months,76.5,71.0 to 81.2,465
Rotavirus,,States/Local Areas,Wisconsin,2014,Age,8 Months,76.2,67.7 to 83.0,224
Rotavirus,,States/Local Areas,Wisconsin,2014-2015,Age,8 Months,76.1,70.6 to 80.8,486
Rotavirus,,States/Local Areas,Wisconsin,2016,Age,8 Months,80.4,73.6 to 85.8,275
Rotavirus,,States/Local Areas,Wisconsin,2016-2017,Age,8 Months,78.5,73.2 to 82.9,513
Rotavirus,,States/Local Areas,Wisconsin,2015,Age,8 Months,76.0,69.2 to 81.7,262
Rotavirus,,States/Local Areas,Wisconsin,2015-2016,Age,8 Months,78.2,73.5 to 82.3,537
Rotavirus,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,25.8,9.8 to 41.7,34
Rotavirus,,States/Local Areas,Wisconsin,2011,Age,8 Months,79.1,70.8 to 85.5,225
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Poverty,133% to <400% FPL,81.4,75.7 to 87.2,373
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.1,77.9 to 96.2,116
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,5 Months,78.4,69.1 to 85.4,198
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,70.5,64.4 to 75.9,485
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,31.6,26.3 to 37.3,485
≥1 Dose MMR,,States/Local Areas,Wisconsin,2021,Age,19 Months,87.7,79.7 to 92.8,198
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,5 Months,89.1,81.6 to 93.8,198
Polio,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,19 Months,88.9,80.8 to 93.9,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,89.9,85.5 to 93.2,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,88.2,83.4 to 91.7,485
Polio,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,5 Months,78.4,69.1 to 85.4,198
Hib,Primary Series,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,74.7,69.0 to 79.7,485
Hib,Primary Series,States/Local Areas,Wisconsin,2021,Age,35 Months,92.3,82.5 to 97.7,198
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,89.1,84.9 to 92.6,485
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,49.6,43.5 to 56.0,485
Hib,Primary Series,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,92.2,87.9 to 95.4,485
Hib,Primary Series,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,88.7,83.9 to 92.2,485
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,86.5,81.7 to 90.2,485
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,89.8,84.6 to 93.9,485
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,83.1,78.1 to 87.2,485
Hep B,"≥1 Dose, 1 Day",States/Local Areas,Wisconsin,2020-2021,Age,0-1 Days,78.1,72.4 to 82.9,485
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2021,Age,13 Months,55.8,46.2 to 65.0,198
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,69.7,63.8 to 75.0,485
Hib,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,5 Months,75.9,70.1 to 80.9,485
PCV,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,3 Months,86.1,77.7 to 91.7,198
Polio,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,92.0,87.8 to 94.8,485
Hep B,"≥1 Dose, 2 Day",States/Local Areas,Wisconsin,2020-2021,Age,0-2 Days,81.6,76.1 to 86.1,485
Hib,Full Series,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,74.6,68.9 to 79.5,485
Hib,Full Series,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,80.5,74.9 to 85.6,485
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,86.7,78.4 to 92.2,198
PCV,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,3 Months,85.2,80.1 to 89.2,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,24 Months,90.0,83.1 to 94.9,198
Hib,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,85.1,79.8 to 89.1,485
Hib,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,89.2,81.4 to 94.0,198
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2021,Age,0-3 Days,81.8,72.5 to 88.5,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,92.0,88.3 to 94.8,485
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,20.8,16.5 to 25.7,485
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,88.8,84.2 to 92.2,485
DTaP,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,5 Months,77.6,71.9 to 82.4,485
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,88.0,83.3 to 91.5,485
Polio,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,91.1,87.1 to 94.3,485
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,Wisconsin,2020-2021,Age,0-3 Days,83.8,78.4 to 88.0,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,94.2,89.7 to 97.2,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,70.3,64.2 to 75.8,485
Rotavirus,,States/Local Areas,Wisconsin,2020-2021,Age,8 Months,77.6,72.0 to 82.3,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,91.5,87.7 to 94.6,485
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,80.0,74.7 to 84.8,485
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2021,Age,35 Months,90.2,83.2 to 95.1,198
Polio,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,90.6,83.7 to 95.4,198
PCV,≥4 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,80.9,75.6 to 85.2,485
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,89.4,84.7 to 92.7,485
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,98.1,92.2 to 99.8,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,95.7,90.4 to 98.5,198
Hep B,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,77.9,72.3 to 82.6,485
Influenza,,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,69.1,63.2 to 74.8,485
Hib,Primary Series,States/Local Areas,Wisconsin,2021,Age,13 Months,82.1,73.5 to 88.3,198
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,89.3,84.9 to 92.5,485
PCV,≥4 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,89.8,83.9 to 94.3,485
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,91.2,86.8 to 94.5,485
DTaP,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,90.0,83.1 to 94.9,198
Polio,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,7 Months,86.3,81.2 to 90.1,485
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,91.6,84.9 to 95.5,198
Polio,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,5 Months,77.4,71.7 to 82.2,485
Combined 7 Series,,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,74.3,68.0 to 80.3,485
Hib,Primary Series,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,83.0,77.7 to 87.2,485
Hib,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,3 Months,84.0,78.8 to 88.1,485
Hib,Full Series,States/Local Areas,Wisconsin,2021,Age,35 Months,75.6,67.1 to 83.3,198
DTaP,≥4 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,72.8,67.0 to 77.9,485
PCV,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,90.6,86.3 to 94.0,485
Polio,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,89.2,84.6 to 92.6,485
Combined 7 Series,,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,68.4,62.7 to 74.0,485
Hep B,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,5 Months,88.1,83.6 to 91.5,485
≥1 Dose MMR,,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,92.8,88.8 to 95.8,485
Hib,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,13 Months,37.6,29.2 to 46.7,198
Hib,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,19 Months,83.7,78.6 to 87.8,485
Polio,≥3 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,93.6,89.2 to 96.7,485
Rotavirus,,States/Local Areas,Wisconsin,2021,Age,8 Months,79.6,71.0 to 86.2,198
Combined 7 Series,,States/Local Areas,Wisconsin,2021,Age,24 Months,69.9,61.1 to 78.3,198
Influenza,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Private Insurance Only,77.5,73.1 to 81.9,548
Influenza,,States/Local Areas,Wisconsin,2014-2017,Poverty,133% to <400% FPL,64.5,58.4 to 70.5,384
Influenza,,States/Local Areas,Wisconsin,2014-2017,Poverty,<133% FPL,48.3,40.9 to 55.8,236
Influenza,,States/Local Areas,Wisconsin,2014-2017,Poverty,>400% FPL,84.5,79.3 to 89.8,303
≥1 Dose Varicella,,States/Local Areas,Wisconsin,2020-2021,Age,13 Months,55.9,49.8 to 61.8,485
Hib,Full Series,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,78.0,72.6 to 82.9,485
Influenza,,States/Local Areas,Wisconsin,2021,Age,24 Months,71.6,62.1 to 80.5,198
Influenza,,States/Local Areas,Wisconsin,2014-2017,Overall,Overall,65.0,61.1 to 68.9,923
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,88.1,84.8 to 91.4,543
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,Hispanic,86.8,77.8 to 95.8,111
Hib,Full Series,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",76.6,65.7 to 87.5,116
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,96.8,94.9 to 98.6,543
PCV,≥3 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",96.1,92.6 to 99.6,116
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",77.4,63.4 to 91.4,116
Influenza,,States/Local Areas,Wisconsin,2016,Age,24 Months,61.1,53.7 to 68.6,275
Influenza,,States/Local Areas,Wisconsin,2016-2017,Age,24 Months,63.5,57.9 to 69.1,513
PCV,≥4 Doses,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,92.4,89.5 to 95.2,543
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2020-2021,Age,35 Months,85.6,78.9 to 91.0,485
Polio,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,3 Months,85.4,80.4 to 89.2,485
≥1 Dose MMR,,States/Local Areas,Wisconsin,2021,Age,13 Months,71.3,62.1 to 79.1,198
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,24 Months,85.1,80.5 to 89.2,485
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2020-2021,Age,3 Months,93.7,90.4 to 96.0,485
Hib,≥3 Doses,States/Local Areas,Wisconsin,2021,Age,35 Months,90.0,78.2 to 96.9,198
Influenza,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Uninsured,23.0,6.9 to 39.2,34
Influenza,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Principal City,69.6,64.0 to 75.3,404
Influenza,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"White, Non-Hispanic",66.4,61.8 to 71.1,661
Influenza,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a MSA Non-Principal City,65.8,59.2 to 72.5,307
Influenza,,States/Local Areas,Wisconsin,2014-2017,Urbanicity,Living In a Non-MSA,52.6,44.2 to 61.0,212
Influenza,,States/Local Areas,Wisconsin,2014-2017,Insurance Coverage,Any Medicaid,54.0,47.6 to 60.5,332
Influenza,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",56.7,40.2 to 73.2,45
Influenza,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,Hispanic,63.1,52.7 to 73.5,125
Influenza,,States/Local Areas,Wisconsin,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",64.0,52.4 to 75.5,92
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Any Medicaid,82.3,76.3 to 88.3,301
Hep A,≥1 Dose,States/Local Areas,Wisconsin,2016-2019,Insurance Coverage,Private Insurance Only,89.8,86.1 to 93.5,543
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"Black, Non-Hispanic",66.1,43.7 to 88.5,45
Influenza,,States/Local Areas,Wisconsin,2017,Age,24 Months,66.1,57.7 to 74.2,238
Influenza,,States/Local Areas,Wisconsin,2017-2018,Age,24 Months,69.4,63.8 to 74.9,479
Influenza,,States/Local Areas,Wisconsin,2018,Age,24 Months,72.6,65.0 to 79.7,241
Influenza,,States/Local Areas,Wisconsin,2018-2019,Age,24 Months,70.0,64.4 to 75.5,465
Influenza,,States/Local Areas,Wisconsin,2019,Age,24 Months,67.4,59.1 to 75.5,224
Hep A,≥2 Doses,States/Local Areas,Wisconsin,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.5,72.0 to 83.0,611
Hep B,≥1 Dose,States/Local Areas,Wisconsin,2021,Age,3 Months,95.7,90.6 to 98.1,198
Influenza,,States/Local Areas,Wisconsin,2011,Age,24 Months,63.6,54.9 to 72.4,225
Influenza,,States/Local Areas,Wisconsin,2012,Age,24 Months,56.1,48.2 to 64.2,226
Influenza,,States/Local Areas,Wisconsin,2015,Age,24 Months,68.3,61.5 to 74.8,262
Influenza,,States/Local Areas,Wisconsin,2015-2016,Age,24 Months,64.7,59.6 to 69.7,537
Influenza,,States/Local Areas,Wisconsin,2014,Age,24 Months,62.6,54.3 to 70.9,224
Influenza,,States/Local Areas,Wisconsin,2014-2015,Age,24 Months,65.4,59.9 to 70.8,486
Influenza,,States/Local Areas,Wisconsin,2013,Age,24 Months,61.9,54.4 to 69.5,235
Influenza,,States/Local Areas,Wisconsin,2013-2014,Age,24 Months,62.3,56.6 to 68.0,459
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,93.8,88.2 to 96.8,298
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,91.9,87.6 to 94.8,561
DTaP,≥3 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,97.4,94.1 to 99.1,264
Hib,Primary Series,States/Local Areas,New Hampshire,2013,Age,24 Months,96.1,92.0 to 98.4,222
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,96.3,93.9 to 97.8,315
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,95.1,92.1 to 97.0,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,93.0,88.0 to 96.1,334
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,94.7,91.8 to 96.6,649
Polio,≥3 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,94.8,90.9 to 97.3,252
Polio,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,93.5,90.6 to 95.8,586
Hib,≥3 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,95.5,92.9 to 97.1,252
Hib,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,92.7,90.1 to 94.7,586
Hib,≥3 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,89.9,84.4 to 93.6,334
Hib,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,91.0,87.5 to 93.5,649
Polio,≥3 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,93.3,88.7 to 96.5,288
Polio,≥3 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,94.3,89.7 to 97.3,264
Polio,≥3 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,87.7,79.5 to 92.9,279
Hib,≥3 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,92.1,89.1 to 94.3,315
Hib,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,92.4,88.9 to 94.8,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,90.1,82.7 to 94.5,263
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,93.2,89.0 to 95.8,532
Polio,≥3 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,92.4,87.7 to 95.7,334
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,93.7,90.9 to 95.9,649
Polio,≥3 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,94.9,91.2 to 97.4,315
Polio,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,94.5,91.6 to 96.6,613
Hib,≥3 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,92.6,87.0 to 95.9,298
Hib,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,90.1,85.7 to 93.3,561
Polio,≥3 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,93.9,89.1 to 97.1,298
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,91.6,87.7 to 94.7,561
Hib,≥3 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,87.5,80.0 to 92.5,263
Hib,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,91.4,87.1 to 94.4,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,95.4,90.5 to 97.8,269
Hib,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,88.5,84.2 to 91.8,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,96.3,91.5 to 98.4,269
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,91.8,87.3 to 94.8,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,89.9,82.0 to 94.6,279
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020-2021,Age,13 Months,49.5,43.1 to 56.0,436
Hib,Full Series,States/Local Areas,New Jersey,2015,Age,24 Months,82.3,76.3 to 87.5,315
Hib,Full Series,States/Local Areas,New Jersey,2015-2016,Age,24 Months,81.7,77.0 to 86.0,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,97.8,95.5 to 99.1,252
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,95.5,93.0 to 97.4,586
Polio,≥3 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,89.4,82.9 to 94.3,263
Polio,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,92.6,88.8 to 95.4,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,92.4,85.5 to 96.2,279
Polio,≥3 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,91.4,84.6 to 96.0,279
Polio,≥3 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,95.7,91.7 to 98.1,269
Polio,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,93.5,89.8 to 96.3,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,95.1,91.2 to 97.7,288
Polio,≥3 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,96.0,91.1 to 98.7,264
Hib,Full Series,States/Local Areas,New Jersey,2016,Age,24 Months,80.9,73.4 to 87.5,298
Hib,Full Series,States/Local Areas,New Jersey,2016-2017,Age,24 Months,78.9,73.5 to 83.8,561
Hib,Full Series,States/Local Areas,New Jersey,2017,Age,24 Months,77.0,69.2 to 84.0,263
Hib,Full Series,States/Local Areas,New Jersey,2017-2018,Age,24 Months,79.7,74.6 to 84.4,532
Hib,Full Series,States/Local Areas,New Jersey,2018,Age,24 Months,82.2,75.6 to 88.0,269
Hib,Full Series,States/Local Areas,New Jersey,2018-2019,Age,24 Months,82.4,77.4 to 86.9,548
Polio,≥3 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,95.4,91.7 to 97.7,315
Polio,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,95.8,92.9 to 97.7,613
Hib,≥3 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,90.6,85.6 to 94.5,334
Hib,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,91.8,88.6 to 94.4,649
Hib,≥3 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,95.0,90.3 to 97.9,264
Hib,≥3 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,94.4,90.4 to 97.0,288
Hib,≥3 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,96.5,93.6 to 98.3,252
Hib,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,93.6,90.8 to 95.8,586
Polio,≥3 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,95.8,91.3 to 98.4,298
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,93.7,89.9 to 96.4,561
Polio,≥3 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,91.8,85.6 to 96.1,263
Polio,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,94.3,90.6 to 96.8,532
DTaP,≥2 Doses,States/Local Areas,New Jersey,2015,Age,5 Months,80.9,74.4 to 86.0,315
DTaP,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,5 Months,80.1,75.1 to 84.3,613
DTaP,≥2 Doses,States/Local Areas,New Jersey,2016,Age,5 Months,79.3,71.4 to 85.5,298
DTaP,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,5 Months,78.6,73.0 to 83.3,561
DTaP,≥2 Doses,States/Local Areas,New Jersey,2014,Age,5 Months,82.5,76.1 to 87.5,334
DTaP,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,5 Months,81.7,78.8 to 84.3,649
Polio,≥3 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,93.6,89.0 to 96.7,288
Polio,≥3 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,96.3,92.3 to 98.5,269
Polio,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,96.8,92.3 to 99.0,548
Polio,≥3 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,96.6,93.1 to 98.6,252
Polio,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,95.0,92.2 to 97.0,586
Polio,≥3 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,93.0,88.3 to 96.3,334
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,94.2,91.4 to 96.4,649
Hib,Full Series,States/Local Areas,New Jersey,2012,Age,35 Months,89.0,81.7 to 94.3,288
Hib,Full Series,States/Local Areas,New Jersey,2011,Age,35 Months,85.0,76.4 to 91.8,264
Hib,Full Series,States/Local Areas,New Jersey,2013,Age,35 Months,89.3,83.3 to 93.8,252
Hib,Full Series,States/Local Areas,New Jersey,2013-2014,Age,35 Months,86.0,81.3 to 90.0,586
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,84.8,81.2 to 88.3,756
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,96.0,94.2 to 97.8,756
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,90.4,86.5 to 94.4,321
Hib,Full Series,States/Local Areas,New Jersey,2019,Age,24 Months,82.5,74.6 to 89.0,279
Polio,≥3 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,96.6,88.1 to 99.6,279
DTaP,≥2 Doses,States/Local Areas,New Jersey,2011,Age,5 Months,85.9,79.3 to 90.6,264
DTaP,≥2 Doses,States/Local Areas,New Jersey,2012,Age,5 Months,80.4,77.6 to 82.9,288
DTaP,≥2 Doses,States/Local Areas,New Jersey,2013,Age,5 Months,77.5,67.4 to 85.1,252
DTaP,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,5 Months,80.0,75.3 to 84.0,586
Hib,Full Series,States/Local Areas,New Jersey,2017,Age,35 Months,83.7,75.4 to 90.4,263
Hib,Full Series,States/Local Areas,New Jersey,2017-2018,Age,35 Months,84.7,79.3 to 89.3,532
Hib,Full Series,States/Local Areas,New Jersey,2016,Age,35 Months,85.0,77.8 to 90.9,298
Hib,Full Series,States/Local Areas,New Jersey,2016-2017,Age,35 Months,84.7,79.0 to 89.5,561
Hib,Full Series,States/Local Areas,New Jersey,2019,Age,35 Months,88.6,78.1 to 95.6,279
Hib,Full Series,States/Local Areas,New Jersey,2018,Age,35 Months,84.9,78.4 to 90.4,269
Hib,Full Series,States/Local Areas,New Jersey,2018-2019,Age,35 Months,87.0,81.0 to 91.8,548
Hib,Full Series,States/Local Areas,New Jersey,2015,Age,35 Months,90.1,85.1 to 94.0,315
Hib,Full Series,States/Local Areas,New Jersey,2015-2016,Age,35 Months,87.9,83.8 to 91.5,613
Hib,Full Series,States/Local Areas,New Jersey,2014,Age,35 Months,82.5,75.2 to 88.6,334
Hib,Full Series,States/Local Areas,New Jersey,2014-2015,Age,35 Months,86.3,81.8 to 90.1,649
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,73.6,67.5 to 79.8,321
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",72.1,58.8 to 85.3,71
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,92.8,89.1 to 96.6,299
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.8,92.7 to 99.0,206
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",95.4,92.9 to 97.8,538
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,95.8,92.3 to 99.2,162
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",86.1,77.1 to 95.1,71
Hib,Primary Series,States/Local Areas,New Jersey,2011,Age,7 Months,75.8,69.2 to 81.4,264
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,86.1,81.9 to 90.4,529
Hib,Primary Series,States/Local Areas,New Jersey,2012,Age,7 Months,63.7,57.3 to 69.6,288
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,73.3,66.8 to 79.7,299
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.8,79.4 to 92.3,206
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.8,80.2 to 89.4,538
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,81.7,74.3 to 89.1,162
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,79.4,75.8 to 83.1,952
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,79.5,66.3 to 92.7,162
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",70.4,58.4 to 82.3,206
≥1 Dose MMR,,States/Local Areas,New Jersey,2011,Age,13 Months,41.8,35.2 to 48.7,264
≥1 Dose MMR,,States/Local Areas,New Jersey,2012,Age,13 Months,41.8,30.6 to 53.9,288
≥1 Dose MMR,,States/Local Areas,New Jersey,2013,Age,13 Months,46.0,38.4 to 53.9,252
≥1 Dose MMR,,States/Local Areas,New Jersey,2013-2014,Age,13 Months,48.0,44.6 to 51.4,586
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Overall,Overall,79.9,76.6 to 83.2,1114
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,72.3,65.5 to 79.1,257
Hib,Full Series,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,80.2,74.2 to 86.1,328
DTaP,≥4 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,84.3,77.8 to 89.8,252
DTaP,≥4 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,82.2,77.7 to 86.2,586
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,34.6,27.0 to 43.7,298
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,29.4,24.3 to 35.2,561
Hep A,≥2 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,24.2,18.1 to 31.9,263
Hep A,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,31.5,26.5 to 37.2,532
Hep A,≥2 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,39.0,31.3 to 47.7,269
Hep A,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,34.1,28.7 to 40.3,548
Hib,≥3 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,97.0,89.3 to 99.6,279
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,29.9,23.6 to 37.5,334
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,28.0,23.6 to 33.0,649
Hep A,≥2 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,25.8,20.3 to 32.5,315
Hep A,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,30.3,25.4 to 35.9,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,95.0,93.3 to 96.7,1114
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014,Age,35 Months,88.9,82.2 to 93.9,334
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,35 Months,88.2,83.9 to 91.8,649
Hep A,≥1 Dose,States/Local Areas,New Jersey,2013,Age,35 Months,87.9,81.4 to 92.9,252
Hep A,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,35 Months,88.5,83.9 to 92.2,586
DTaP,≥4 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,86.2,80.8 to 90.7,288
DTaP,≥4 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,84.0,77.2 to 89.6,264
DTaP,≥4 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,71.1,62.6 to 78.4,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,39.6,34.9 to 44.6,252
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,39.4,33.4 to 45.6,586
Hep B,≥3 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,39.9,36.0 to 43.9,264
Hep B,≥3 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,42.6,32.7 to 53.0,288
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,95.4,92.9 to 97.9,328
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,98.2,96.9 to 99.5,529
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,90.9,86.4 to 95.5,257
Polio,≥2 Doses,States/Local Areas,New Jersey,2014,Age,5 Months,75.0,68.1 to 80.8,334
Polio,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,5 Months,75.5,72.9 to 77.9,649
Polio,≥2 Doses,States/Local Areas,New Jersey,2013,Age,5 Months,71.7,65.0 to 77.6,252
Polio,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,5 Months,73.3,70.4 to 76.1,586
Hep A,≥1 Dose,States/Local Areas,New Jersey,2012,Age,35 Months,86.6,79.8 to 92.0,288
Polio,≥2 Doses,States/Local Areas,New Jersey,2011,Age,5 Months,84.8,76.5 to 90.5,264
Polio,≥2 Doses,States/Local Areas,New Jersey,2012,Age,5 Months,72.8,66.2 to 78.5,288
Hep A,≥1 Dose,States/Local Areas,New Jersey,2015,Age,35 Months,87.1,81.5 to 91.6,315
Hep A,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,35 Months,86.9,82.5 to 90.6,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,84.0,75.8 to 89.8,263
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,89.4,84.7 to 92.8,532
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,92.7,87.0 to 96.0,298
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,88.3,83.5 to 91.9,561
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,73.2,66.6 to 79.7,257
Hib,≥3 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,86.6,81.1 to 90.7,315
Hib,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,85.2,81.0 to 88.7,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,94.5,90.0 to 97.1,264
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,64.9,56.4 to 72.5,263
DTaP,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,72.8,67.1 to 77.8,532
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,68.7,59.8 to 76.5,279
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,80.7,73.2 to 86.5,269
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,74.8,69.0 to 79.8,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,70.6,64.5 to 76.6,321
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.3,73.9 to 92.6,71
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,61.3,56.6 to 66.0,756
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2019,Age,0-3 Days,81.3,73.7 to 87.2,279
Polio,≥1 Dose,States/Local Areas,New Jersey,2019,Age,3 Months,84.2,75.9 to 90.0,279
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2018,Age,0-3 Days,80.6,73.6 to 86.1,269
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2018-2019,Age,0-3 Days,81.0,76.0 to 85.1,548
PCV,≥3 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,99.0,93.6 to 100.0,279
Hib,≥2 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,93.0,87.8 to 96.0,334
Hib,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,94.7,91.8 to 96.6,649
Hib,≥2 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,93.6,88.0 to 96.7,298
Hib,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,92.0,87.8 to 94.9,561
Hib,≥2 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,96.4,93.2 to 98.1,315
Hib,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,95.0,92.0 to 96.9,613
Polio,≥1 Dose,States/Local Areas,New Jersey,2018,Age,3 Months,92.7,87.8 to 95.7,269
Polio,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,3 Months,88.5,83.8 to 91.9,548
Polio,≥1 Dose,States/Local Areas,New Jersey,2017,Age,3 Months,81.2,73.3 to 87.2,263
Polio,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,3 Months,86.9,82.3 to 90.5,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,56.4,48.0 to 64.5,298
Hib,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,58.1,52.3 to 63.8,561
Hib,≥3 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,62.0,54.9 to 68.6,315
Hib,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,59.2,53.7 to 64.5,613
Hib,≥3 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,58.0,50.8 to 65.0,334
Hib,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,60.0,54.9 to 64.9,649
PCV,≥3 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,96.8,92.7 to 98.9,269
PCV,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,98.1,93.0 to 99.7,548
PCV,≥3 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,92.3,85.8 to 96.5,263
PCV,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,94.8,91.0 to 97.3,532
Hib,≥2 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,98.4,97.4 to 99.0,252
Hib,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,95.7,92.6 to 97.5,586
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,68.2,59.8 to 75.6,298
DTaP,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,66.5,60.6 to 72.0,561
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2015,Age,0-3 Days,65.6,58.5 to 72.1,315
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2015-2016,Age,0-3 Days,66.0,60.6 to 71.1,613
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,66.2,58.9 to 72.8,334
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,70.3,65.3 to 74.7,649
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,74.3,67.7 to 80.0,315
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,71.2,66.0 to 76.0,613
Hib,≥2 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,97.5,94.0 to 99.0,264
Hib,≥2 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,94.6,89.7 to 97.2,288
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016,Age,0-3 Days,66.4,58.1 to 73.9,298
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2016-2017,Age,0-3 Days,67.1,61.3 to 72.4,561
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2017,Age,0-3 Days,66.9,56.2 to 76.1,163
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2017-2018,Age,0-3 Days,74.2,68.8 to 78.9,532
Polio,≥1 Dose,States/Local Areas,New Jersey,2016,Age,3 Months,83.5,76.1 to 88.9,298
Polio,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,3 Months,82.3,77.1 to 86.5,561
Polio,≥1 Dose,States/Local Areas,New Jersey,2015,Age,3 Months,89.5,84.2 to 93.2,315
Polio,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,3 Months,86.5,82.1 to 89.9,613
Polio,≥1 Dose,States/Local Areas,New Jersey,2014,Age,3 Months,85.3,79.5 to 89.7,334
Polio,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,3 Months,87.4,83.6 to 90.4,649
Hib,≥3 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,51.5,42.1 to 60.7,252
Hib,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,54.7,47.7 to 61.6,586
Hib,≥3 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,71.0,61.7 to 78.9,264
Hib,≥3 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,57.3,52.3 to 62.2,288
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,89.7,85.6 to 93.9,328
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,94.9,92.5 to 97.3,529
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,87.9,83.0 to 92.8,257
Hib,≥2 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,88.2,80.7 to 93.0,263
Hib,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,90.7,86.3 to 93.8,532
Hib,≥2 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,90.0,83.7 to 94.1,298
Hib,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,89.1,84.5 to 92.5,561
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,94.6,92.6 to 96.7,756
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,87.8,83.5 to 92.1,321
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,90.1,85.7 to 94.5,299
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",95.3,92.1 to 98.5,206
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",81.4,71.5 to 91.4,71
Hib,≥3 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,72.7,64.7 to 79.4,269
Hib,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,68.9,63.0 to 74.2,548
Hib,≥3 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,59.9,51.6 to 67.6,263
Hib,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,66.3,60.5 to 71.6,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,94.4,89.7 to 97.4,298
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,93.4,89.6 to 96.2,561
PCV,≥3 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,95.4,92.1 to 97.6,315
PCV,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,94.9,92.2 to 96.9,613
PCV,≥3 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,90.9,85.3 to 95.0,334
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,93.2,90.0 to 95.6,649
Hib,≥2 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,93.2,87.8 to 96.3,269
Hib,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,91.5,87.3 to 94.4,548
≥1 Dose Varicella,,States/Local Areas,New Jersey,2020,Age,24 Months,94.9,91.0 to 97.4,268
Hib,≥2 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,89.9,82.7 to 94.3,279
PCV,≥3 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,94.8,90.5 to 97.5,288
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,89.7,85.2 to 94.1,299
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,74.4,68.2 to 80.6,299
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.8,61.3 to 78.4,206
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",51.5,45.8 to 57.2,538
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,65.3,61.3 to 69.3,952
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,63.9,54.6 to 73.2,162
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Overall,Overall,65.0,61.3 to 68.7,1114
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,89.5,83.8 to 93.3,334
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,92.3,89.1 to 94.6,649
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,93.7,91.8 to 95.3,252
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,91.6,89.2 to 93.6,586
Polio,≥3 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,86.8,79.6 to 91.8,263
Polio,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,91.1,87.0 to 94.0,532
Polio,≥3 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,90.9,85.0 to 94.6,298
Polio,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,88.9,84.4 to 92.1,561
Hib,≥3 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,89.8,84.5 to 93.5,269
Hib,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,88.5,84.2 to 91.8,548
Polio,≥3 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,95.4,91.0 to 97.7,269
Polio,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,63.2,57.1 to 68.9,548
Polio,≥3 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,92.3,88.5 to 95.0,315
Polio,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,91.6,88.1 to 94.1,613
Polio,≥3 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,86.7,80.3 to 91.3,288
Polio,≥3 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,88.1,82.4 to 92.1,334
Polio,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,90.2,86.7 to 92.8,649
Polio,≥3 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,87.5,83.3 to 90.7,252
Polio,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,87.8,84.1 to 90.7,586
Hib,≥3 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,75.2,66.9 to 81.9,263
Hib,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,82.5,77.4 to 86.6,532
Hib,≥3 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,83.9,76.9 to 89.0,298
Hib,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,79.5,74.2 to 84.0,561
DTaP,≥3 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,94.5,89.4 to 97.2,288
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,97.5,94.3 to 98.9,252
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,95.3,93.7 to 96.5,586
DTaP,≥3 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,97.3,94.4 to 98.7,264
DTaP,≥3 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,88.6,80.4 to 93.6,279
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,94.9,90.2 to 97.4,269
DTaP,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,91.8,87.3 to 94.8,548
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",94.8,92.2 to 97.3,538
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,92.6,88.1 to 97.1,162
Hib,≥3 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,65.0,56.1 to 72.9,279
Hib,≥2 Doses,States/Local Areas,New Jersey,2020,Age,13 Months,94.2,89.2 to 97.0,268
Hib,≥2 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,94.3,87.1 to 97.6,279
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,91.8,89.5 to 94.2,952
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,92.0,89.9 to 94.1,1114
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,87.3,82.3 to 92.3,257
Hib,≥2 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,90.5,83.2 to 94.8,263
Hib,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,93.3,89.3 to 95.9,532
Hib,≥2 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,96.3,91.7 to 98.4,269
Hib,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,95.3,91.5 to 97.4,548
DTaP,≥3 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,92.0,85.5 to 95.7,288
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,95.1,91.7 to 97.2,315
DTaP,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,93.9,90.8 to 96.0,613
Hib,≥3 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,86.9,80.7 to 91.3,288
Hib,≥3 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,89.4,82.3 to 93.8,264
Hib,≥3 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,81.5,75.2 to 86.5,334
Hib,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,84.0,80.0 to 87.4,649
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,91.2,87.6 to 94.9,328
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,96.7,94.7 to 98.7,529
Polio,≥3 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,91.4,85.1 to 95.2,264
Hib,≥3 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,88.2,86.4 to 89.9,252
Hib,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,84.9,82.6 to 86.9,586
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,60.0,53.0 to 66.9,328
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,62.7,57.0 to 68.3,529
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",92.1,86.2 to 98.0,206
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,90.5,88.1 to 93.0,952
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",93.3,90.9 to 95.7,538
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,93.3,88.1 to 98.5,162
PCV,≥3 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,96.3,93.5 to 98.1,252
PCV,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,93.6,90.6 to 95.9,586
PCV,≥3 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,96.2,91.9 to 98.5,264
PCV,≥3 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,91.5,85.3 to 95.8,279
Hib,≥2 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,90.3,85.1 to 93.9,315
Hib,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,90.2,86.3 to 93.0,613
Polio,≥1 Dose,States/Local Areas,New Jersey,2011,Age,3 Months,91.3,89.4 to 92.9,264
Polio,≥1 Dose,States/Local Areas,New Jersey,2012,Age,3 Months,78.6,68.3 to 86.2,288
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,91.1,88.9 to 93.3,1114
PCV,≥1 Dose,States/Local Areas,New Jersey,2019,Age,3 Months,80.0,71.5 to 86.5,279
Polio,≥1 Dose,States/Local Areas,New Jersey,2013,Age,3 Months,82.7,73.7 to 89.1,252
Polio,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,3 Months,84.0,79.8 to 87.5,586
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2013,Age,0-3 Days,66.7,58.9 to 73.8,252
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2013-2014,Age,0-3 Days,65.5,60.3 to 70.4,586
DTaP,≥3 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,77.7,70.4 to 83.6,264
DTaP,≥3 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,69.4,62.8 to 75.3,288
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,63.6,53.2 to 72.9,252
DTaP,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,64.9,60.5 to 69.1,586
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014,Age,0-3 Days,64.3,57.3 to 70.7,334
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2014-2015,Age,0-3 Days,65.0,60.0 to 69.6,649
PCV,≥1 Dose,States/Local Areas,New Jersey,2015,Age,3 Months,83.6,77.9 to 88.0,315
PCV,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,3 Months,81.5,76.9 to 85.4,613
PCV,≥1 Dose,States/Local Areas,New Jersey,2014,Age,3 Months,77.0,70.6 to 82.4,334
PCV,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,3 Months,80.3,76.1 to 83.9,649
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",88.8,83.4 to 94.2,206
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",84.9,80.5 to 89.4,538
PCV,≥3 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,96.7,92.7 to 98.9,269
PCV,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,94.1,90.6 to 96.7,548
PCV,≥3 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,88.4,81.7 to 93.6,263
PCV,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,92.6,88.7 to 95.5,532
Hib,≥2 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,86.8,78.9 to 92.1,288
PCV,≥3 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,93.4,88.5 to 96.7,298
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,90.9,86.8 to 94.1,561
Hib,≥2 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,92.9,88.9 to 95.5,264
Hib,≥2 Doses,States/Local Areas,New Jersey,2019,Age,5 Months,76.2,67.6 to 83.2,279
Hib,≥2 Doses,States/Local Areas,New Jersey,2018,Age,5 Months,82.3,75.4 to 87.6,269
Hib,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,5 Months,79.3,73.9 to 83.8,548
PCV,≥1 Dose,States/Local Areas,New Jersey,2017,Age,3 Months,80.8,73.2 to 86.6,263
PCV,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,3 Months,84.3,79.5 to 88.1,532
PCV,≥1 Dose,States/Local Areas,New Jersey,2016,Age,3 Months,79.5,71.8 to 85.5,298
PCV,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,3 Months,80.1,74.9 to 84.5,561
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,93.5,91.0 to 95.9,756
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",85.1,75.8 to 94.5,71
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,82.0,74.7 to 89.4,162
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2012,Age,0-3 Days,64.0,56.7 to 70.7,288
Hib,≥2 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,89.7,84.5 to 93.3,334
Hib,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,90.0,86.5 to 92.7,649
Hib,≥2 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,93.3,90.1 to 95.5,252
Hib,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,91.5,89.1 to 93.4,586
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,81.6,78.2 to 85.0,952
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,81.7,78.6 to 84.8,1114
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,73.6,66.8 to 80.3,257
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,81.7,76.3 to 87.1,328
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,88.6,84.8 to 92.4,529
Hib,≥2 Doses,States/Local Areas,New Jersey,2011,Age,5 Months,82.1,72.8 to 88.8,264
Hib,≥2 Doses,States/Local Areas,New Jersey,2012,Age,5 Months,73.0,70.0 to 75.9,288
PCV,≥3 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,87.2,79.6 to 92.2,263
PCV,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,91.8,87.6 to 94.7,532
Hib,≥2 Doses,States/Local Areas,New Jersey,2014,Age,5 Months,78.4,71.7 to 83.8,334
Hib,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,5 Months,78.0,73.5 to 81.9,649
Hib,≥2 Doses,States/Local Areas,New Jersey,2013,Age,5 Months,72.6,62.7 to 80.7,252
Hib,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,5 Months,75.5,70.5 to 79.9,586
PCV,≥3 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,95.7,91.6 to 98.2,264
PCV,≥3 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,91.5,84.5 to 95.5,279
PCV,≥3 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,96.5,91.9 to 98.6,269
PCV,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,89.7,84.9 to 93.0,548
PCV,≥1 Dose,States/Local Areas,New Jersey,2012,Age,3 Months,73.6,69.5 to 77.3,288
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Overall,Overall,90.1,87.7 to 92.4,1114
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,86.8,81.8 to 91.8,257
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,89.0,84.6 to 93.3,328
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,93.7,90.9 to 96.4,529
PCV,≥1 Dose,States/Local Areas,New Jersey,2011,Age,3 Months,81.8,72.7 to 88.4,264
PCV,≥4 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,76.8,68.1 to 84.6,279
PCV,≥4 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,91.2,85.8 to 95.1,269
PCV,≥4 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,83.8,78.6 to 88.4,548
PCV,≥4 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,79.5,72.0 to 86.1,263
PCV,≥4 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,85.0,80.3 to 89.0,532
Hib,≥2 Doses,States/Local Areas,New Jersey,2016,Age,5 Months,74.9,66.7 to 81.6,298
Hib,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,5 Months,76.2,70.6 to 81.0,561
Hib,≥2 Doses,States/Local Areas,New Jersey,2015,Age,5 Months,77.6,71.0 to 83.1,315
Hib,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,5 Months,76.3,71.1 to 80.7,613
PCV,≥3 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,95.4,92.4 to 97.5,252
PCV,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,92.1,89.0 to 94.6,586
Hib,≥2 Doses,States/Local Areas,New Jersey,2017,Age,5 Months,77.5,69.4 to 84.0,263
Hib,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,5 Months,79.9,74.7 to 84.2,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,93.1,88.6 to 96.3,288
PCV,≥3 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,88.7,83.2 to 93.0,334
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,91.4,88.3 to 94.0,649
PCV,≥3 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,94.1,90.8 to 96.6,315
PCV,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,93.8,90.9 to 96.0,613
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,74.2,68.1 to 80.2,321
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,77.2,71.2 to 83.3,299
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",71.8,58.6 to 85.0,71
PCV,≥1 Dose,States/Local Areas,New Jersey,2013,Age,3 Months,75.3,66.1 to 82.6,252
PCV,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,3 Months,76.1,70.0 to 81.4,586
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,91.3,84.1 to 96.1,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,94.0,89.5 to 97.0,269
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,92.6,88.6 to 95.6,548
PCV,≥4 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,83.0,76.8 to 88.4,334
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,87.0,82.2 to 91.0,649
PCV,≥4 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,90.7,83.2 to 95.8,315
PCV,≥4 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,88.0,81.9 to 92.8,613
PCV,≥4 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,83.2,75.7 to 89.4,298
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,81.1,75.9 to 85.9,561
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,87.0,82.7 to 91.4,321
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,92.4,89.8 to 94.9,756
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,87.8,83.0 to 92.7,299
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,91.2 to 98.5,206
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",83.9,74.1 to 93.6,71
PCV,≥1 Dose,States/Local Areas,New Jersey,2018,Age,3 Months,87.8,81.6 to 92.1,269
PCV,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,3 Months,83.9,78.8 to 88.0,548
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Jersey,2011,Age,0-3 Days,55.6,47.2 to 63.7,264
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,88.0,85.0 to 91.0,756
Hib,≥1 Dose,States/Local Areas,New Jersey,2019,Age,3 Months,85.5,77.5 to 91.0,279
Hib,≥1 Dose,States/Local Areas,New Jersey,2018,Age,3 Months,90.4,85.0 to 94.0,269
Hib,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,3 Months,88.0,83.4 to 91.5,548
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",84.7,74.8 to 94.6,71
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,91.9,89.4 to 94.5,756
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,85.3,80.6 to 90.0,321
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019,Age,35 Months,97.0,87.5 to 99.7,279
≥1 Dose MMR,,States/Local Areas,New Jersey,2016,Age,35 Months,94.0,89.3 to 97.1,298
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2017,Age,35 Months,93.8,89.5 to 96.7,561
PCV,≥4 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,83.9,78.2 to 88.8,315
PCV,≥4 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,82.2,77.5 to 86.4,613
PCV,≥4 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,80.3,72.6 to 87.0,298
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,79.8,74.5 to 84.7,561
PCV,≥4 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,79.4,71.9 to 86.0,263
PCV,≥4 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,83.9,79.3 to 88.0,532
≥1 Dose MMR,,States/Local Areas,New Jersey,2015,Age,35 Months,97.0,93.5 to 98.8,315
≥1 Dose MMR,,States/Local Areas,New Jersey,2015-2016,Age,35 Months,95.3,92.6 to 97.3,613
≥1 Dose MMR,,States/Local Areas,New Jersey,2014,Age,35 Months,89.0,83.3 to 93.4,334
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2015,Age,35 Months,92.9,89.5 to 95.5,649
PCV,≥3 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,88.8,82.1 to 93.1,298
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,85.0,79.9 to 89.0,561
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,96.2,92.9 to 98.2,252
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,92.6,89.5 to 95.1,586
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,88.9,83.4 to 93.2,334
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,91.9,88.4 to 94.6,649
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,95.0,90.6 to 97.8,315
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,93.0,89.4 to 95.8,613
Hep B,≥3 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,91.9,86.8 to 95.6,288
PCV,≥3 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,95.3,90.7 to 97.6,269
PCV,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,89.7,84.9 to 93.0,548
PCV,≥3 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,81.3,73.1 to 87.4,263
PCV,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,88.2,83.5 to 91.7,532
Hep B,≥2 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,94.0,89.8 to 96.5,288
Hep B,≥2 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,96.7,93.7 to 98.3,252
Hep B,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,94.8,92.3 to 96.5,586
Hep B,≥2 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,94.9,92.7 to 96.4,264
Hep B,≥2 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,89.3,81.8 to 94.0,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,91.3,85.4 to 95.6,263
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,93.0,89.2 to 95.8,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,92.2,86.9 to 95.5,288
PCV,≥4 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,88.9,83.0 to 93.5,288
PCV,≥4 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,91.5,85.2 to 95.8,264
PCV,≥4 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,88.5,83.3 to 92.7,269
PCV,≥4 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,81.2,76.1 to 85.9,548
PCV,≥4 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,73.9,65.4 to 81.7,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,91.4,85.5 to 95.7,298
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,91.4,87.4 to 94.6,561
PCV,≥3 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,87.5,81.7 to 91.7,334
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,90.6,87.3 to 93.2,649
PCV,≥3 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,95.4,92.1 to 97.4,252
PCV,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,91.5,89.9 to 92.9,586
PCV,≥3 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,94.3,90.7 to 96.6,264
PCV,≥3 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,83.9,75.5 to 89.8,279
Hep B,≥2 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,94.1,88.5 to 97.1,298
Hep B,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,93.4,89.5 to 96.0,561
Hep B,≥2 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,97.4,94.8 to 98.8,315
Hep B,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,95.8,92.9 to 97.5,613
Hep B,≥2 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,92.8,87.6 to 95.9,334
Hep B,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,95.1,92.3 to 96.9,649
Hib,≥1 Dose,States/Local Areas,New Jersey,2014,Age,3 Months,84.7,78.7 to 89.2,334
Hib,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,3 Months,85.4,81.4 to 88.7,649
Hib,≥1 Dose,States/Local Areas,New Jersey,2011,Age,3 Months,87.8,80.4 to 92.6,264
Hib,≥1 Dose,States/Local Areas,New Jersey,2012,Age,3 Months,80.9,73.2 to 86.7,288
Hib,≥1 Dose,States/Local Areas,New Jersey,2013,Age,3 Months,80.9,75.5 to 85.3,252
Hib,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,3 Months,82.8,80.6 to 84.7,586
PCV,≥3 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,92.2,86.7 to 95.6,298
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,89.7,85.2 to 93.0,561
PCV,≥3 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,93.7,89.2 to 96.4,315
PCV,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,93.0,89.9 to 95.2,613
Hep B,≥2 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,95.1,88.8 to 98.0,279
Hep B,≥2 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,97.3,92.9 to 99.0,269
Hep B,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,96.2,92.8 to 98.1,548
Hep B,≥2 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,92.7,86.3 to 96.3,263
Hep B,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,95.0,91.4 to 97.2,532
Hib,≥1 Dose,States/Local Areas,New Jersey,2017,Age,3 Months,82.7,75.0 to 88.4,263
Hib,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,3 Months,86.6,81.9 to 90.2,532
Hib,≥1 Dose,States/Local Areas,New Jersey,2016,Age,3 Months,84.7,77.4 to 89.9,298
Hib,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,3 Months,83.7,78.6 to 87.8,561
Hib,≥1 Dose,States/Local Areas,New Jersey,2015,Age,3 Months,86.1,80.2 to 90.5,315
Hib,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,3 Months,85.4,80.9 to 89.0,613
≥1 Dose MMR,,States/Local Areas,New Jersey,2017,Age,35 Months,93.2,86.2 to 97.4,263
≥1 Dose MMR,,States/Local Areas,New Jersey,2017-2018,Age,35 Months,94.3,89.5 to 97.4,532
≥1 Dose MMR,,States/Local Areas,New Jersey,2018,Age,35 Months,95.8,88.7 to 99.0,269
≥1 Dose MMR,,States/Local Areas,New Jersey,2018-2019,Age,35 Months,97.3,90.3 to 99.6,548
PCV,≥4 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,87.3,80.9 to 92.4,252
PCV,≥4 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,85.2,80.7 to 89.1,586
≥1 Dose MMR,,States/Local Areas,New Jersey,2019,Age,35 Months,91.8,85.3 to 96.2,279
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",94.8,90.7 to 98.9,206
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",89.6,86.2 to 93.0,538
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,92.0,87.2 to 96.7,162
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",91.6,88.5 to 94.7,538
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,95.6,92.3 to 98.9,162
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.6,85.8 to 91.4,952
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,91.7,88.3 to 95.1,529
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,88.5,85.7 to 91.3,952
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Overall,Overall,89.2,86.8 to 91.6,1114
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,83.9,78.3 to 89.4,257
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,91.6,88.0 to 95.2,328
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,88.0,83.8 to 92.1,321
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,87.2,82.3 to 92.2,299
PCV,≥4 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,80.7,74.5 to 86.2,288
Hep B,≥3 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,94.8,88.3 to 98.3,264
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,89.8,83.5 to 94.4,263
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,91.8,88.1 to 94.8,532
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,89.0,82.1 to 94.2,279
PCV,≥4 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,83.1,76.5 to 88.7,252
PCV,≥4 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,81.1,76.6 to 85.2,586
PCV,≥4 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,79.0,72.9 to 84.6,334
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,81.5,77.3 to 85.3,649
≥1 Dose MMR,,States/Local Areas,New Jersey,2019,Age,24 Months,91.0,84.6 to 95.5,279
≥1 Dose MMR,,States/Local Areas,New Jersey,2012,Age,35 Months,92.8,88.4 to 96.0,288
≥1 Dose MMR,,States/Local Areas,New Jersey,2011,Age,35 Months,97.7,93.9 to 99.4,264
≥1 Dose MMR,,States/Local Areas,New Jersey,2013,Age,35 Months,96.3,92.6 to 98.4,252
≥1 Dose MMR,,States/Local Areas,New Jersey,2013-2014,Age,35 Months,92.7,89.3 to 95.3,586
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016,Age,35 Months,91.7,86.0 to 95.8,298
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2017,Age,35 Months,92.7,88.0 to 96.0,561
Hep B,≥2 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,96.0,91.9 to 98.1,269
Hep B,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,92.7,88.6 to 95.4,548
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2019,Age,0-2 Days,79.1,71.1 to 85.3,279
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2018,Age,0-2 Days,77.8,70.3 to 83.9,269
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2018-2019,Age,0-2 Days,78.4,73.1 to 83.0,548
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2017,Age,0-2 Days,64.5,56.3 to 71.9,263
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2017-2018,Age,0-2 Days,71.1,65.6 to 76.1,532
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017,Age,35 Months,93.2,85.9 to 97.5,263
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017-2018,Age,35 Months,93.7,88.9 to 96.9,532
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018,Age,35 Months,92.9,87.5 to 96.5,269
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018-2019,Age,35 Months,94.4,87.2 to 98.3,548
Hep B,≥2 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,94.0,90.4 to 96.3,315
Hep B,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,93.0,89.9 to 95.2,613
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,94.0,89.5 to 97.0,269
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,91.5,87.5 to 94.7,548
PCV,≥3 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,92.0,88.1 to 94.8,315
PCV,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,90.4,86.7 to 93.1,613
PCV,≥3 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,83.6,77.4 to 88.3,334
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,87.8,84.2 to 90.7,649
Hep B,≥2 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,91.5,85.0 to 95.4,263
Hep B,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,93.8,90.1 to 96.1,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,91.6,88.4 to 93.9,252
PCV,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,87.6,84.8 to 90.0,586
Hep B,≥2 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,92.0,86.4 to 95.4,298
Hep B,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,91.8,87.8 to 94.5,561
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2016,Age,0-2 Days,64.0,55.6 to 71.6,298
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2016-2017,Age,0-2 Days,64.2,58.4 to 69.6,561
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,88.1,82.6 to 92.5,334
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,90.0,86.5 to 92.9,649
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,91.9,87.3 to 95.3,315
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,91.1,87.5 to 94.0,613
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,90.4,84.5 to 94.7,298
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,90.0,85.9 to 93.4,561
PCV,≥3 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,89.3,83.0 to 93.5,288
≥1 Dose MMR,,States/Local Areas,New Jersey,2016,Age,24 Months,90.6,85.1 to 94.8,298
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2017,Age,24 Months,89.1,85.0 to 92.6,561
≥1 Dose MMR,,States/Local Areas,New Jersey,2017,Age,24 Months,87.8,81.3 to 92.8,263
≥1 Dose MMR,,States/Local Areas,New Jersey,2017-2018,Age,24 Months,90.0,85.9 to 93.3,532
PCV,≥4 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,86.6,80.8 to 90.9,269
PCV,≥4 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,78.0,71.3 to 83.5,443
PCV,≥4 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,73.5,65.4 to 80.3,263
PCV,≥4 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,80.0,75.1 to 84.2,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,88.8,82.8 to 92.9,264
PCV,≥3 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,58.9,50.1 to 67.2,279
PCV,≥3 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,70.8,62.6 to 77.8,269
PCV,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,64.9,58.9 to 70.5,548
Hep B,≥2 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,89.2,79.7 to 94.6,288
Hep B,≥2 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,89.2,83.7 to 92.9,334
Hep B,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,91.6,88.4 to 93.9,649
Hep B,≥2 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,95.1,92.2 to 96.9,252
Hep B,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,92.1,88.8 to 94.5,586
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2012,Age,0-2 Days,61.2,53.4 to 68.4,288
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2013,Age,0-2 Days,63.5,54.7 to 71.5,252
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2013-2014,Age,0-2 Days,62.3,59.5 to 65.1,586
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2011,Age,0-2 Days,53.2,45.3 to 61.0,264
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2019,Age,0-1 Days,76.3,68.3 to 82.8,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,91.7,86.2 to 95.7,264
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,86.4,78.6 to 91.6,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,94.9,91.2 to 97.4,252
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,91.6,88.3 to 94.2,586
Hep B,≥3 Doses,States/Local Areas,New Jersey,2012,Age,24 Months,90.5,85.6 to 94.3,288
Hep A,≥1 Dose,States/Local Areas,New Jersey,2020,Age,35 Months,95.0,89.1 to 98.2,268
PCV,≥3 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,59.7,51.3 to 67.6,298
PCV,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,58.8,52.9 to 64.5,561
PCV,≥4 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,69.7,61.1 to 77.1,298
PCV,≥4 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,71.6,65.8 to 76.8,561
PCV,≥4 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,78.5,72.2 to 83.6,315
PCV,≥4 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,74.1,68.8 to 78.7,613
PCV,≥4 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,73.1,66.4 to 79.0,334
PCV,≥4 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,75.8,71.2 to 79.8,649
PCV,≥3 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,64.9,58.0 to 71.2,315
PCV,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,62.3,56.9 to 67.4,613
PCV,≥3 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,57.9,49.7 to 65.8,263
PCV,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,64.3,58.6 to 69.7,532
≥1 Dose MMR,,States/Local Areas,New Jersey,2013,Age,24 Months,94.3,90.1 to 97.1,252
≥1 Dose MMR,,States/Local Areas,New Jersey,2013-2014,Age,24 Months,91.0,87.5 to 93.8,586
≥1 Dose MMR,,States/Local Areas,New Jersey,2014,Age,24 Months,87.7,82.1 to 92.3,334
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2015,Age,24 Months,90.2,86.9 to 93.0,649
≥1 Dose MMR,,States/Local Areas,New Jersey,2015,Age,24 Months,92.7,88.8 to 95.7,315
≥1 Dose MMR,,States/Local Areas,New Jersey,2015-2016,Age,24 Months,91.7,88.4 to 94.4,613
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018,Age,24 Months,92.2,87.0 to 95.9,269
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018-2019,Age,24 Months,89.6,85.2 to 93.1,548
≥1 Dose Varicella,,States/Local Areas,New Jersey,2012,Age,35 Months,94.5,88.9 to 97.8,288
≥1 Dose Varicella,,States/Local Areas,New Jersey,2011,Age,35 Months,96.6,91.9 to 99.0,264
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019,Age,24 Months,86.8,79.5 to 92.5,279
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2015,Age,0-1 Days,52.5,45.5 to 59.5,315
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2015-2016,Age,0-1 Days,53.3,47.9 to 58.8,613
Hep B,≥2 Doses,States/Local Areas,New Jersey,2015,Age,5 Months,91.2,86.7 to 94.3,315
Hep B,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,5 Months,89.0,85.0 to 92.0,613
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2014,Age,0-1 Days,52.2,45.1 to 59.3,334
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2014-2015,Age,0-1 Days,52.4,47.4 to 57.4,649
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2013,Age,0-1 Days,51.6,43.4 to 59.8,252
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2013-2014,Age,0-1 Days,51.9,48.6 to 55.3,586
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013,Age,24 Months,88.5,82.4 to 93.2,252
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013-2014,Age,24 Months,90.0,86.3 to 93.1,586
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014,Age,24 Months,91.5,86.9 to 95.0,334
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2015,Age,24 Months,91.3,88.3 to 93.9,649
Polio,≥2 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,92.5,85.8 to 96.2,263
Polio,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,94.5,90.7 to 96.7,532
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019,Age,19 Months,82.3,73.8 to 88.5,279
Polio,≥2 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,94.1,87.1 to 97.4,279
Polio,≥2 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,96.4,91.8 to 98.5,269
Polio,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,95.3,91.5 to 97.4,548
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2012,Age,0-1 Days,53.7,45.4 to 61.7,288
Hep B,≥2 Doses,States/Local Areas,New Jersey,2014,Age,5 Months,85.9,80.0 to 90.2,334
Hep B,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,5 Months,88.6,86.9 to 90.0,649
Hep B,≥2 Doses,States/Local Areas,New Jersey,2016,Age,5 Months,86.7,79.7 to 91.6,298
Hep B,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,5 Months,86.1,81.3 to 89.9,561
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,93.7,88.7 to 96.6,269
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,85.8,80.7 to 89.8,548
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,89.3,82.4 to 93.7,263
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,91.5,87.4 to 94.3,532
PCV,≥3 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,59.2,54.8 to 63.4,288
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,86.3,81.3 to 91.3,328
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,87.1,83.1 to 91.2,529
PCV,≥3 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,58.1,50.9 to 65.0,334
PCV,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,61.5,56.5 to 66.3,649
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,89.6,83.2 to 93.8,298
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,89.4,85.0 to 92.7,561
PCV,≥3 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,65.1,55.3 to 73.7,264
PCV,≥3 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,55.1,42.6 to 66.9,252
PCV,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,56.6,48.5 to 64.4,586
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013,Age,35 Months,92.5,86.6 to 96.5,252
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013-2014,Age,35 Months,92.9,89.2 to 95.7,586
≥1 Dose MMR,,States/Local Areas,New Jersey,2018,Age,24 Months,92.2,86.6 to 96.0,269
≥1 Dose MMR,,States/Local Areas,New Jersey,2018-2019,Age,24 Months,91.6,87.6 to 94.8,548
PCV,≥4 Doses,States/Local Areas,New Jersey,2019,Age,19 Months,71.4,62.5 to 78.9,279
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014,Age,35 Months,93.4,88.4 to 96.7,334
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2015,Age,35 Months,95.4,92.3 to 97.5,649
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015,Age,35 Months,96.7,93.2 to 98.7,315
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015-2016,Age,35 Months,94.6,91.3 to 97.0,613
PCV,≥4 Doses,States/Local Areas,New Jersey,2011,Age,24 Months,86.0,79.6 to 91.2,264
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2015,Age,0-2 Days,63.1,55.9 to 69.8,315
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2015-2016,Age,0-2 Days,63.5,58.1 to 68.7,613
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2014,Age,0-2 Days,61.2,54.1 to 67.8,334
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Jersey,2014-2015,Age,0-2 Days,62.1,57.1 to 66.9,649
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017,Age,24 Months,87.2,80.7 to 92.3,263
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017-2018,Age,24 Months,89.7,85.6 to 93.0,532
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016,Age,24 Months,87.4,81.0 to 92.5,298
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2017,Age,24 Months,87.3,82.8 to 91.0,561
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015,Age,24 Months,91.1,86.6 to 94.6,315
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015-2016,Age,24 Months,89.3,85.5 to 92.5,613
≥1 Dose MMR,,States/Local Areas,New Jersey,2012,Age,24 Months,90.9,86.4 to 94.5,288
≥1 Dose MMR,,States/Local Areas,New Jersey,2011,Age,24 Months,93.9,89.7 to 96.9,264
≥1 Dose MMR,,States/Local Areas,New Jersey,2019,Age,19 Months,86.3,78.4 to 91.7,279
≥1 Dose MMR,,States/Local Areas,New Jersey,2018,Age,19 Months,91.6,85.4 to 95.3,269
≥1 Dose MMR,,States/Local Areas,New Jersey,2018-2019,Age,19 Months,95.3,91.5 to 97.4,548
PCV,≥4 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,76.1,67.0 to 83.4,264
PCV,≥4 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,71.0,63.5 to 77.5,288
PCV,≥4 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,76.9,71.1 to 81.9,252
PCV,≥4 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,75.0,70.1 to 79.4,586
Hep B,≥1 Dose,States/Local Areas,New Jersey,2017,Age,3 Months,96.9,92.8 to 98.7,263
Hep B,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,3 Months,97.5,95.3 to 98.7,532
Polio,≥2 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,93.2,87.6 to 96.4,298
Polio,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,92.9,88.9 to 95.5,561
Polio,≥2 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,96.0,91.8 to 98.0,315
Polio,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,94.6,91.4 to 96.6,613
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016,Age,19 Months,83.4,75.8 to 88.9,298
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2017,Age,19 Months,84.1,78.9 to 88.1,561
Hep A,≥2 Doses,States/Local Areas,New Jersey,2020,Age,35 Months,78.3,66.9 to 87.9,268
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,80.5,74.6 to 86.4,299
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018,Age,19 Months,92.6,86.9 to 96.0,269
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018-2019,Age,19 Months,55.0,49.1 to 60.7,548
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017,Age,19 Months,84.7,77.2 to 90.1,263
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017-2018,Age,19 Months,88.7,84.1 to 92.0,532
≥1 Dose MMR,,States/Local Areas,New Jersey,2012,Age,19 Months,87.9,82.4 to 91.9,288
≥1 Dose MMR,,States/Local Areas,New Jersey,2014,Age,19 Months,87.0,80.9 to 91.3,334
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2015,Age,19 Months,88.3,84.6 to 91.2,649
≥1 Dose MMR,,States/Local Areas,New Jersey,2013,Age,19 Months,91.3,87.4 to 94.0,252
≥1 Dose MMR,,States/Local Areas,New Jersey,2013-2014,Age,19 Months,89.1,87.5 to 90.6,586
≥1 Dose MMR,,States/Local Areas,New Jersey,2011,Age,19 Months,91.6,84.4 to 95.6,264
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",74.3,61.4 to 87.2,71
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,87.6,84.5 to 90.8,756
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,76.7,70.8 to 82.6,321
DTaP,≥4 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,83.3,75.0 to 90.0,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015,Age,19 Months,91.5,86.9 to 94.7,315
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,19 Months,90.6,86.8 to 93.4,613
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014,Age,19 Months,87.0,81.0 to 91.3,334
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,19 Months,89.3,85.6 to 92.1,649
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,77.5,68.4 to 86.6,529
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013,Age,19 Months,94.2,91.9 to 95.9,252
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,19 Months,90.6,87.7 to 92.9,586
Hep B,≥2 Doses,States/Local Areas,New Jersey,2013,Age,5 Months,91.0,88.6 to 92.9,252
Hep B,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,5 Months,88.5,86.4 to 90.3,586
Hep B,≥2 Doses,States/Local Areas,New Jersey,2011,Age,5 Months,86.4,85.6 to 87.1,264
Hep B,≥2 Doses,States/Local Areas,New Jersey,2012,Age,5 Months,84.8,76.0 to 90.8,288
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2011,Age,0-1 Days,45.8,41.8 to 49.8,264
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,75.6,63.1 to 88.1,328
Hep B,≥1 Dose,States/Local Areas,New Jersey,2019,Age,3 Months,96.2,91.8 to 98.3,279
Hep B,≥1 Dose,States/Local Areas,New Jersey,2018,Age,3 Months,98.2,95.4 to 99.3,269
Hep B,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,3 Months,97.2,94.9 to 98.5,548
≥1 Dose Varicella,,States/Local Areas,New Jersey,2012,Age,24 Months,87.4,81.1 to 92.4,288
≥1 Dose Varicella,,States/Local Areas,New Jersey,2011,Age,24 Months,91.7,86.6 to 95.4,264
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,75.1,68.4 to 81.8,257
≥1 Dose MMR,,States/Local Areas,New Jersey,2017,Age,19 Months,84.4,76.8 to 89.9,263
≥1 Dose MMR,,States/Local Areas,New Jersey,2017-2018,Age,19 Months,88.0,83.3 to 91.5,532
≥1 Dose MMR,,States/Local Areas,New Jersey,2016,Age,19 Months,86.3,79.8 to 90.9,298
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2017,Age,19 Months,85.3,80.5 to 89.1,561
≥1 Dose MMR,,States/Local Areas,New Jersey,2015,Age,19 Months,89.6,84.5 to 93.2,315
≥1 Dose MMR,,States/Local Areas,New Jersey,2015-2016,Age,19 Months,88.0,84.1 to 91.0,613
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,82.9,79.5 to 86.3,952
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,84.0,77.0 to 90.9,162
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,83.2,80.1 to 86.2,1114
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",87.7,81.2 to 94.1,206
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",85.6,81.3 to 89.8,538
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,72.9,65.2 to 80.6,756
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,81.6,70.5 to 92.7,321
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",69.0,49.6 to 88.5,71
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2018,Age,0-1 Days,66.7,58.2 to 74.2,269
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2018-2019,Age,0-1 Days,71.4,65.7 to 76.6,548
Hep B,≥2 Doses,States/Local Areas,New Jersey,2018,Age,5 Months,93.1,87.6 to 96.2,269
Hep B,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,5 Months,89.5,84.8 to 92.9,548
Hep B,≥2 Doses,States/Local Areas,New Jersey,2017,Age,5 Months,85.5,78.2 to 90.7,263
Hep B,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,5 Months,89.3,84.9 to 92.5,532
Hep B,≥2 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,90.4,88.3 to 92.2,264
Hep B,≥2 Doses,States/Local Areas,New Jersey,2019,Age,5 Months,85.9,77.7 to 91.4,279
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2017,Age,0-1 Days,54.9,46.8 to 62.8,263
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2017-2018,Age,0-1 Days,60.8,54.9 to 66.3,532
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2016,Age,0-1 Days,54.1,45.8 to 62.3,298
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Jersey,2016-2017,Age,0-1 Days,54.5,48.7 to 60.2,561
Polio,≥2 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,93.9,88.7 to 96.8,269
Polio,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,91.6,87.2 to 94.5,548
Polio,≥2 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,88.9,81.8 to 93.5,263
Polio,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,91.4,87.2 to 94.3,532
Polio,≥2 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,90.0,83.7 to 94.1,298
Polio,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,89.5,85.0 to 92.7,561
Hep B,≥1 Dose,States/Local Areas,New Jersey,2014,Age,3 Months,95.1,90.9 to 97.4,334
Hep B,≥1 Dose,States/Local Areas,New Jersey,2014-2015,Age,3 Months,96.4,94.0 to 97.8,649
Hep B,≥1 Dose,States/Local Areas,New Jersey,2011,Age,3 Months,96.1,90.8 to 98.4,264
Hep B,≥1 Dose,States/Local Areas,New Jersey,2012,Age,3 Months,91.8,86.5 to 95.2,288
Hep B,≥1 Dose,States/Local Areas,New Jersey,2013,Age,3 Months,96.5,94.4 to 97.8,252
Hep B,≥1 Dose,States/Local Areas,New Jersey,2013-2014,Age,3 Months,95.8,94.4 to 96.9,586
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,81.8,71.2 to 92.5,299
Hep B,≥1 Dose,States/Local Areas,New Jersey,2016,Age,3 Months,97.5,94.5 to 98.8,298
Hep B,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,3 Months,97.2,94.9 to 98.4,561
Hep B,≥1 Dose,States/Local Areas,New Jersey,2015,Age,3 Months,97.7,94.7 to 99.0,315
Hep B,≥1 Dose,States/Local Areas,New Jersey,2015-2016,Age,3 Months,97.6,95.7 to 98.6,613
Polio,≥2 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,95.0,90.5 to 97.4,334
Polio,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,95.4,92.7 to 97.2,649
Polio,≥2 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,97.5,96.2 to 98.3,252
Polio,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,96.2,94.9 to 97.2,586
Polio,≥2 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,98.0,95.6 to 99.1,264
Polio,≥2 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,95.7,91.2 to 97.9,288
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013,Age,19 Months,89.5,83.0 to 93.7,252
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013-2014,Age,19 Months,90.1,87.6 to 92.2,586
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015,Age,19 Months,88.4,83.9 to 91.7,315
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015-2016,Age,19 Months,85.9,81.4 to 89.4,613
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014,Age,19 Months,90.8,85.7 to 94.1,334
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2015,Age,19 Months,89.6,86.1 to 92.3,649
≥1 Dose MMR,,States/Local Areas,New Jersey,2019,Age,13 Months,55.4,46.6 to 63.9,279
≥1 Dose MMR,,States/Local Areas,New Jersey,2018,Age,13 Months,70.8,62.8 to 77.7,269
≥1 Dose MMR,,States/Local Areas,New Jersey,2018-2019,Age,13 Months,63.2,57.1 to 68.9,548
≥1 Dose MMR,,States/Local Areas,New Jersey,2017,Age,13 Months,48.2,40.3 to 56.2,263
≥1 Dose MMR,,States/Local Areas,New Jersey,2017-2018,Age,13 Months,59.5,53.7 to 65.0,532
Hep B,≥3 Doses,States/Local Areas,New Jersey,2011,Age,13 Months,87.2,84.4 to 89.5,264
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Poverty,133% to <400% FPL,78.6,73.1 to 84.1,328
Polio,≥2 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,89.6,83.6 to 93.5,315
Polio,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,89.8,85.7 to 92.8,613
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Overall,Overall,77.8,74.6 to 81.0,1114
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,74.4,67.9 to 80.9,257
Polio,≥2 Doses,States/Local Areas,New Jersey,2013,Age,7 Months,89.0,81.6 to 93.7,252
Polio,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,7 Months,88.5,85.3 to 91.0,586
Polio,≥2 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,87.9,82.3 to 91.9,334
Polio,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,88.7,84.9 to 91.7,649
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,76.4,72.7 to 80.0,952
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",78.5,73.9 to 83.2,538
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,83.6,77.2 to 90.1,162
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",83.1,75.7 to 90.4,206
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015,Age,13 Months,54.2,47.1 to 61.2,315
≥1 Dose Varicella,,States/Local Areas,New Jersey,2015-2016,Age,13 Months,50.8,45.4 to 56.3,613
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017,Age,13 Months,44.9,37.2 to 52.8,263
≥1 Dose Varicella,,States/Local Areas,New Jersey,2017-2018,Age,13 Months,54.7,48.9 to 60.4,532
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016,Age,13 Months,47.5,39.3 to 55.8,298
≥1 Dose Varicella,,States/Local Areas,New Jersey,2016-2017,Age,13 Months,46.2,40.5 to 51.9,561
DTaP,≥4 Doses,States/Local Areas,New Jersey,2017,Age,24 Months,76.6,68.9 to 83.5,263
DTaP,≥4 Doses,States/Local Areas,New Jersey,2017-2018,Age,24 Months,78.9,73.7 to 83.7,532
DTaP,≥4 Doses,States/Local Areas,New Jersey,2018,Age,24 Months,81.0,73.8 to 87.2,269
DTaP,≥4 Doses,States/Local Areas,New Jersey,2018-2019,Age,24 Months,80.7,75.4 to 85.5,548
DTaP,≥4 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,90.5,83.3 to 95.5,264
DTaP,≥4 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,80.3,72.1 to 87.3,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017,Age,13 Months,84.0,76.3 to 89.6,263
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,13 Months,87.3,82.6 to 90.9,532
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015,Age,13 Months,89.0,83.9 to 92.6,315
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,13 Months,88.2,84.2 to 91.3,613
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016,Age,13 Months,87.5,80.8 to 92.1,298
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,13 Months,85.8,80.9 to 89.6,561
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,90.6,84.4 to 95.0,298
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,88.4,83.0 to 92.7,561
DTaP,≥4 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,86.1,77.9 to 92.4,263
DTaP,≥4 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,86.7,81.0 to 91.4,532
DTaP,≥4 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,86.2,78.7 to 92.1,269
DTaP,≥4 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,84.7,79.3 to 89.4,548
Hep B,≥3 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,90.2,88.5 to 91.6,264
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,80.9,72.3 to 87.3,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018,Age,13 Months,90.6,84.7 to 94.4,269
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,13 Months,85.8,80.7 to 89.8,548
Hep B,≥3 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,88.5,81.1 to 93.3,288
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Poverty,>400% FPL,80.0,75.3 to 84.7,529
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,74.9,67.0 to 82.8,952
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Poverty,<133% FPL,71.0,60.5 to 81.5,257
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Overall,Overall,75.7,68.9 to 82.6,1114
Polio,≥2 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,89.1,81.5 to 93.9,279
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",73.5,64.0 to 83.0,538
Hep A,≥2 Doses,States/Local Areas,New Jersey,2017,Age,35 Months,66.6,55.3 to 77.5,263
Hep A,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,35 Months,75.3,67.7 to 82.3,532
Hep A,≥2 Doses,States/Local Areas,New Jersey,2018,Age,35 Months,84.9,75.6 to 92.0,269
Hep A,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,35 Months,80.9,72.3 to 88.2,548
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014,Age,13 Months,82.8,76.5 to 87.8,334
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,13 Months,85.9,82.0 to 89.1,649
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013,Age,13 Months,90.4,89.2 to 91.4,252
Hep B,≥3 Doses,States/Local Areas,New Jersey,2013-2014,Age,13 Months,86.6,84.0 to 88.9,586
DTaP,≥4 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,91.4,86.2 to 95.2,252
DTaP,≥4 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,89.3,85.0 to 92.8,586
Hep B,≥3 Doses,States/Local Areas,New Jersey,2012,Age,13 Months,85.9,76.1 to 92.1,288
Hep A,≥2 Doses,States/Local Areas,New Jersey,2019,Age,35 Months,77.4,63.4 to 89.0,279
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,87.1,79.9 to 92.6,334
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,89.2,84.8 to 92.8,649
DTaP,≥4 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,91.7,85.9 to 95.7,315
DTaP,≥4 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,91.0,87.0 to 94.2,613
DTaP,≥4 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,91.3,85.3 to 95.5,288
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018,Age,13 Months,64.6,56.6 to 71.9,269
≥1 Dose Varicella,,States/Local Areas,New Jersey,2018-2019,Age,13 Months,55.0,49.1 to 60.7,548
≥1 Dose MMR,,States/Local Areas,New Jersey,2016,Age,13 Months,49.8,41.6 to 58.1,298
≥1 Dose MMR,,States/Local Areas,New Jersey,2016-2017,Age,13 Months,49.0,43.3 to 54.8,561
≥1 Dose Varicella,,States/Local Areas,New Jersey,2012,Age,19 Months,86.0,80.1 to 90.3,288
≥1 Dose Varicella,,States/Local Areas,New Jersey,2011,Age,19 Months,89.9,82.8 to 94.2,264
≥1 Dose Varicella,,States/Local Areas,New Jersey,2019,Age,13 Months,45.1,36.8 to 53.6,279
≥1 Dose MMR,,States/Local Areas,New Jersey,2015,Age,13 Months,53.8,46.7 to 60.8,315
≥1 Dose MMR,,States/Local Areas,New Jersey,2015-2016,Age,13 Months,51.8,46.4 to 57.3,613
≥1 Dose MMR,,States/Local Areas,New Jersey,2014,Age,13 Months,49.9,42.9 to 57.0,334
≥1 Dose MMR,,States/Local Areas,New Jersey,2014-2015,Age,13 Months,51.9,46.9 to 56.9,649
≥1 Dose Varicella,,States/Local Areas,New Jersey,2011,Age,13 Months,55.5,50.0 to 60.9,264
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013,Age,13 Months,56.5,50.0 to 62.8,252
≥1 Dose Varicella,,States/Local Areas,New Jersey,2013-2014,Age,13 Months,54.4,49.2 to 59.5,586
Polio,≥2 Doses,States/Local Areas,New Jersey,2018,Age,5 Months,82.9,76.1 to 88.1,269
Polio,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,5 Months,78.9,73.4 to 83.5,548
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",67.8,55.0 to 80.5,71
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Private Insurance Only,78.9,75.0 to 82.8,756
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Insurance Coverage,Any Medicaid,76.4,70.9 to 81.9,321
Hep A,≥1 Dose,States/Local Areas,New Jersey,2019,Age,35 Months,86.2,74.9 to 94.1,279
≥1 Dose Varicella,,States/Local Areas,New Jersey,2012,Age,13 Months,48.4,37.1 to 59.8,288
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014,Age,13 Months,52.3,45.3 to 59.2,334
≥1 Dose Varicella,,States/Local Areas,New Jersey,2014-2015,Age,13 Months,53.3,48.3 to 58.2,649
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014,Age,35 Months,69.1,60.4 to 77.5,334
Hep A,≥2 Doses,States/Local Areas,New Jersey,2014-2015,Age,35 Months,70.5,64.1 to 76.7,649
Hep B,≥3 Doses,States/Local Areas,New Jersey,2019,Age,7 Months,30.0,22.8 to 38.3,279
Hep A,≥2 Doses,States/Local Areas,New Jersey,2015,Age,35 Months,72.5,63.0 to 81.4,315
Hep A,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,35 Months,76.4,69.6 to 82.6,613
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016,Age,35 Months,80.6,71.0 to 88.5,298
Hep A,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,35 Months,73.8,66.2 to 80.9,561
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018,Age,7 Months,48.5,40.4 to 56.7,269
Hep B,≥3 Doses,States/Local Areas,New Jersey,2018-2019,Age,7 Months,39.4,33.7 to 45.3,548
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017,Age,7 Months,40.8,33.3 to 48.8,263
Hep B,≥3 Doses,States/Local Areas,New Jersey,2017-2018,Age,7 Months,44.7,39.0 to 50.4,532
Polio,≥2 Doses,States/Local Areas,New Jersey,2011,Age,7 Months,94.9,92.6 to 96.6,264
Polio,≥2 Doses,States/Local Areas,New Jersey,2012,Age,7 Months,87.9,77.8 to 93.7,288
Hep A,≥1 Dose,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,77.7,71.9 to 83.4,299
Hib,Full Series,States/Local Areas,New Jersey,2020,Age,24 Months,79.9,72.6 to 86.4,268
Polio,≥2 Doses,States/Local Areas,New Jersey,2019,Age,5 Months,74.7,65.9 to 81.8,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015,Age,7 Months,40.3,33.5 to 47.4,315
Hep B,≥3 Doses,States/Local Areas,New Jersey,2015-2016,Age,7 Months,40.3,35.1 to 45.8,613
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014,Age,7 Months,39.1,32.4 to 46.3,334
Hep B,≥3 Doses,States/Local Areas,New Jersey,2014-2015,Age,7 Months,39.7,34.8 to 44.7,649
Polio,≥2 Doses,States/Local Areas,New Jersey,2017,Age,5 Months,76.0,67.8 to 82.7,263
Polio,≥2 Doses,States/Local Areas,New Jersey,2017-2018,Age,5 Months,79.5,74.2 to 83.9,532
Polio,≥2 Doses,States/Local Areas,New Jersey,2016,Age,5 Months,74.4,66.0 to 81.3,298
Polio,≥2 Doses,States/Local Areas,New Jersey,2016-2017,Age,5 Months,75.2,69.5 to 80.2,561
Hep A,≥1 Dose,States/Local Areas,New Jersey,2018,Age,35 Months,92.7,87.6 to 96.3,269
Hep A,≥1 Dose,States/Local Areas,New Jersey,2018-2019,Age,35 Months,89.6,83.3 to 94.3,548
Hep A,≥1 Dose,States/Local Areas,New Jersey,2017,Age,35 Months,85.0,77.7 to 90.8,263
Hep A,≥1 Dose,States/Local Areas,New Jersey,2017-2018,Age,35 Months,88.8,84.4 to 92.4,532
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016,Age,35 Months,86.6,79.7 to 92.1,298
Hep A,≥1 Dose,States/Local Areas,New Jersey,2016-2017,Age,35 Months,85.8,80.9 to 90.0,561
Hep A,≥2 Doses,States/Local Areas,New Jersey,2013,Age,35 Months,68.0,59.0 to 76.7,252
Hep A,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,35 Months,68.3,62.1 to 74.4,586
Hep A,≥2 Doses,States/Local Areas,New Jersey,2012,Age,35 Months,70.4,60.7 to 79.6,288
Hep A,≥2 Doses,States/Local Areas,New Jersey,2011,Age,35 Months,71.1,61.1 to 80.5,264
Hep A,≥2 Doses,States/Local Areas,New Jersey,2019,Age,24 Months,29.2,21.9 to 38.2,279
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016,Age,7 Months,40.4,32.6 to 48.7,298
Hep B,≥3 Doses,States/Local Areas,New Jersey,2016-2017,Age,7 Months,40.6,35.1 to 46.3,561
Polio,≥2 Doses,States/Local Areas,New Jersey,2015,Age,5 Months,76.1,69.2 to 81.8,315
Polio,≥2 Doses,States/Local Areas,New Jersey,2015-2016,Age,5 Months,75.2,70.0 to 79.9,613
DTaP,≥4 Doses,States/Local Areas,New Jersey,2015,Age,24 Months,84.0,77.9 to 89.2,315
DTaP,≥4 Doses,States/Local Areas,New Jersey,2015-2016,Age,24 Months,85.0,80.4 to 89.0,613
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016,Age,24 Months,86.1,79.0 to 91.7,298
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2017,Age,24 Months,81.0,75.8 to 85.7,561
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014,Age,24 Months,79.9,73.7 to 85.4,334
DTaP,≥4 Doses,States/Local Areas,New Jersey,2014-2015,Age,24 Months,81.9,77.7 to 85.8,649
Hep A,≥2 Doses,States/Local Areas,New Jersey,2013,Age,24 Months,31.6,24.3 to 40.3,252
Hep A,≥2 Doses,States/Local Areas,New Jersey,2013-2014,Age,24 Months,30.7,25.8 to 36.3,586
DTaP,≥4 Doses,States/Local Areas,New Jersey,2018,Age,19 Months,70.5,62.3 to 77.5,269
DTaP,≥4 Doses,States/Local Areas,New Jersey,2018-2019,Age,19 Months,95.3,91.5 to 97.4,548
DTaP,≥4 Doses,States/Local Areas,New Jersey,2017,Age,19 Months,66.0,57.7 to 73.3,263
DTaP,≥4 Doses,States/Local Areas,New Jersey,2017-2018,Age,19 Months,68.2,62.5 to 73.4,532
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016,Age,19 Months,68.0,59.6 to 75.4,298
DTaP,≥4 Doses,States/Local Areas,New Jersey,2016-2017,Age,19 Months,67.0,61.2 to 72.3,561
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,Hispanic,93.1,89.4 to 96.7,299
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,95.4 to 99.8,206
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"Black, Non-Hispanic",90.8,83.2 to 98.4,71
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Non-Principal City,94.8,92.8 to 96.8,952
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Race and Ethnicity,"White, Non-Hispanic",96.5,94.2 to 98.7,538
DTaP,≥3 Doses,States/Local Areas,New Jersey,2014-2017,Urbanicity,Living In a MSA Principal City,95.9,92.6 to 99.2,162
PCV,≥2 Doses,States/Local Areas,New Jersey,2019,Age,5 Months,69.5,60.7 to 77.0,279
PCV,≥2 Doses,States/Local Areas,New Jersey,2018,Age,5 Months,80.7,73.5 to 86.4,269
PCV,≥2 Doses,States/Local Areas,New Jersey,2018-2019,Age,5 Months,75.2,69.5 to 80.1,548
Combined 7 Series,,States/Local Areas,New Hampshire,2017,Age,35 Months,87.5,79.9 to 93.2,244
Combined 7 Series,,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,85.4,80.7 to 89.5,513
Combined 7 Series,,States/Local Areas,New Hampshire,2016,Age,35 Months,82.3,72.2 to 90.3,231
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,85.1,78.8 to 90.2,475
Combined 7 Series,,States/Local Areas,New Hampshire,2014,Age,24 Months,80.2,73.7 to 85.9,219
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,79.7,75.0 to 84.0,442
Hib,Primary Series,States/Local Areas,New Hampshire,2019,Age,35 Months,94.5,89.8 to 97.5,214
Combined 7 Series,,States/Local Areas,New Hampshire,2016,Age,24 Months,71.0,63.4 to 78.3,231
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,76.1,70.9 to 80.9,475
Hib,Primary Series,States/Local Areas,New Hampshire,2018,Age,24 Months,96.7,93.6 to 98.5,269
Hib,Primary Series,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,95.6,93.0 to 97.5,483
Combined 7 Series,,States/Local Areas,New Hampshire,2012,Age,35 Months,82.8,75.0 to 89.3,225
Combined 7 Series,,States/Local Areas,New Hampshire,2013,Age,35 Months,78.1,69.6 to 85.6,222
Combined 7 Series,,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,80.3,75.0 to 85.1,441
Combined 7 Series,,States/Local Areas,New Hampshire,2014,Age,35 Months,82.9,76.4 to 88.5,219
Combined 7 Series,,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,83.0,78.2 to 87.3,442
Hib,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,95.5,91.2 to 98.1,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,97.0,92.8 to 99.1,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,97.9,95.5 to 99.1,513
PCV,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,5 Months,78.4,73.0 to 82.9,222
PCV,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,5 Months,79.8,76.3 to 83.0,441
PCV,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,5 Months,83.4,80.3 to 86.1,225
PCV,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,5 Months,83.2,72.4 to 90.3,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,96.6,91.5 to 99.1,223
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,96.2,93.1 to 98.2,454
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,95.7,91.8 to 98.1,231
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,96.4,93.7 to 98.2,475
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,81.3,77.0 to 84.9,244
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,82.0,76.4 to 86.5,225
Combined 7 Series,,States/Local Areas,New Hampshire,2018,Age,24 Months,78.9,72.5 to 84.6,269
Combined 7 Series,,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,76.6,71.6 to 81.3,483
Combined 7 Series,,States/Local Areas,New Hampshire,2017,Age,24 Months,80.9,73.9 to 87.0,244
Combined 7 Series,,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,79.9,75.2 to 84.1,513
Combined 7 Series,,States/Local Areas,New Hampshire,2019,Age,24 Months,74.1,66.5 to 81.1,214
Hib,Primary Series,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,97.1,94.8 to 98.6,441
Hib,Primary Series,States/Local Areas,New Hampshire,2014,Age,24 Months,98.2,95.5 to 99.4,219
Hib,Primary Series,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,97.2,95.0 to 98.6,442
Hib,Primary Series,States/Local Areas,New Hampshire,2015,Age,24 Months,96.0,92.3 to 98.2,223
Hib,Primary Series,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,94.9,92.1 to 96.9,454
Hib,Primary Series,States/Local Areas,New Hampshire,2013,Age,35 Months,96.1,92.0 to 98.4,222
Hib,Primary Series,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,97.3,94.9 to 98.7,441
Hib,Primary Series,States/Local Areas,New Hampshire,2019,Age,24 Months,94.5,89.8 to 97.5,214
Hib,Primary Series,States/Local Areas,New Hampshire,2011,Age,35 Months,95.5,91.2 to 98.1,244
Hib,Primary Series,States/Local Areas,New Hampshire,2014,Age,35 Months,98.4,95.6 to 99.6,219
Hib,Primary Series,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,97.8,95.5 to 99.1,442
Hib,Primary Series,States/Local Areas,New Hampshire,2012,Age,35 Months,96.3,91.9 to 98.7,225
Hib,Primary Series,States/Local Areas,New Hampshire,2018,Age,35 Months,97.8,94.7 to 99.3,269
Hib,Primary Series,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,96.5,93.6 to 98.3,483
Combined 7 Series,,States/Local Areas,New Hampshire,2015,Age,24 Months,79.2,72.2 to 85.4,223
Combined 7 Series,,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,75.2,70.0 to 80.0,454
Hib,Primary Series,States/Local Areas,New Hampshire,2016,Age,24 Months,93.8,89.4 to 96.7,231
Hib,Primary Series,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,94.6,91.6 to 96.8,475
Hib,Primary Series,States/Local Areas,New Hampshire,2017,Age,24 Months,95.5,90.7 to 98.2,244
Hib,Primary Series,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,96.1,93.4 to 97.9,513
Combined 7 Series,,States/Local Areas,New Hampshire,2012,Age,24 Months,75.6,68.1 to 82.5,225
Combined 7 Series,,States/Local Areas,New Hampshire,2013,Age,24 Months,71.3,63.8 to 78.4,222
Combined 7 Series,,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,75.6,70.7 to 80.3,441
Hib,Primary Series,States/Local Areas,New Hampshire,2017,Age,35 Months,95.5,90.7 to 98.2,244
Hib,Primary Series,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,97.0,94.0 to 98.8,513
Combined 7 Series,,States/Local Areas,New Hampshire,2011,Age,24 Months,75.0,67.9 to 81.5,244
Hib,Primary Series,States/Local Areas,New Hampshire,2015,Age,35 Months,97.1,93.0 to 99.1,223
Hib,Primary Series,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,95.9,93.1 to 97.8,454
Hib,Primary Series,States/Local Areas,New Hampshire,2016,Age,35 Months,94.6,90.3 to 97.4,231
Hib,Primary Series,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,95.1,92.1 to 97.2,475
Hib,Primary Series,States/Local Areas,New Hampshire,2016,Age,13 Months,93.0,88.2 to 96.0,231
Hib,Primary Series,States/Local Areas,New Hampshire,2016-2017,Age,13 Months,93.7,90.3 to 95.9,475
Hib,Primary Series,States/Local Areas,New Hampshire,2017,Age,13 Months,94.2,88.8 to 97.1,244
Hib,Primary Series,States/Local Areas,New Hampshire,2017-2018,Age,13 Months,94.9,91.8 to 96.8,513
Hib,Primary Series,States/Local Areas,New Hampshire,2019,Age,13 Months,90.5,84.6 to 94.3,214
Hib,Primary Series,States/Local Areas,New Hampshire,2011,Age,19 Months,95.5,91.2 to 97.8,244
Hib,Primary Series,States/Local Areas,New Hampshire,2012,Age,19 Months,96.3,90.5 to 98.6,225
Hib,Primary Series,States/Local Areas,New Hampshire,2013,Age,19 Months,96.1,93.5 to 97.6,222
Hib,Primary Series,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,96.5,94.8 to 97.6,441
Hib,Primary Series,States/Local Areas,New Hampshire,2018,Age,13 Months,95.5,91.8 to 97.6,269
Hib,Primary Series,States/Local Areas,New Hampshire,2018-2019,Age,13 Months,93.0,89.6 to 95.4,483
Hib,Primary Series,States/Local Areas,New Hampshire,2014,Age,19 Months,96.9,92.8 to 98.7,219
Hib,Primary Series,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,96.4,93.8 to 97.9,442
Hib,Primary Series,States/Local Areas,New Hampshire,2017,Age,19 Months,95.5,90.0 to 98.0,244
Hib,Primary Series,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,95.8,92.9 to 97.6,513
Hib,Primary Series,States/Local Areas,New Hampshire,2018,Age,19 Months,96.2,92.6 to 98.1,269
Hib,Primary Series,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,93.0,89.6 to 95.4,483
Hib,Primary Series,States/Local Areas,New Hampshire,2019,Age,19 Months,92.0,86.3 to 95.5,214
Hib,Primary Series,States/Local Areas,New Hampshire,2015,Age,19 Months,96.0,93.7 to 97.5,223
Hib,Primary Series,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,94.9,91.9 to 96.8,454
Hib,Primary Series,States/Local Areas,New Hampshire,2016,Age,19 Months,93.8,88.9 to 96.6,231
Hib,Primary Series,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,94.6,91.4 to 96.7,475
Combined 7 Series,,States/Local Areas,New Hampshire,2020,Age,35 Months,80.4,72.1 to 87.5,189
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020,Age,13 Months,66.1,57.3 to 74.0,189
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2020,Age,0-1 Days,78.9,70.8 to 85.3,189
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,27.4,21.1 to 34.6,189
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2020,Age,0-2 Days,82.5,74.7 to 88.3,189
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,3 Months,94.4,88.3 to 97.4,189
Hib,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,94.9,89.9 to 97.5,189
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,78.3,69.4 to 85.1,189
Hib,Primary Series,States/Local Areas,New Hampshire,2020,Age,7 Months,79.8,71.3 to 86.3,189
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,94.6,89.9 to 97.1,189
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,98.8,96.8 to 99.7,189
Polio,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,98.8,96.8 to 99.7,189
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,90.5,84.8 to 94.7,189
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020,Age,24 Months,94.4,89.1 to 97.7,189
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,96.6,92.8 to 98.7,189
Hib,Primary Series,States/Local Areas,New Hampshire,2020,Age,24 Months,96.6,92.8 to 98.7,189
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,96.6,92.8 to 98.7,189
Hib,Full Series,States/Local Areas,New Hampshire,2020,Age,35 Months,87.6,80.4 to 93.1,189
Hib,Primary Series,States/Local Areas,New Hampshire,2020,Age,35 Months,96.6,92.8 to 98.7,189
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,96.3,92.7 to 98.4,189
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020,Age,35 Months,93.4,86.3 to 97.5,189
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,97.2,93.5 to 99.0,189
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,96.3,92.3 to 98.3,189
Hib,Full Series,States/Local Areas,New Hampshire,2020,Age,19 Months,82.8,74.4 to 88.9,189
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,95.9,91.1 to 98.2,189
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020,Age,19 Months,90.5,82.6 to 95.0,189
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,93.5,88.6 to 96.9,189
Polio,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,98.8,96.8 to 99.7,189
PCV,≥4 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,85.7,77.6 to 91.1,189
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020,Age,35 Months,94.4,89.1 to 97.7,189
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,95.1,90.1 to 97.6,189
PCV,≥4 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,91.2,84.7 to 95.7,189
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,19 Months,89.5,82.4 to 94.0,189
Hib,Primary Series,States/Local Areas,New Hampshire,2020,Age,13 Months,95.1,90.1 to 97.6,189
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,95.4,90.9 to 97.8,189
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,93.2,88.2 to 96.2,189
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020,Age,13 Months,61.7,52.8 to 70.0,189
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,81.3,73.0 to 87.5,189
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,93.9,89.0 to 96.7,189
PCV,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,5 Months,89.0,81.2 to 93.8,189
Polio,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,94.8,89.6 to 97.5,189
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,98.8,96.4 to 99.6,189
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,87.8,80.9 to 92.4,189
Polio,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,5 Months,87.2,82.5 to 90.8,403
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,5 Months,87.8,83.2 to 91.3,403
PCV,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,3 Months,91.9,87.9 to 94.6,403
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,3 Months,96.8,94.3 to 98.3,403
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,93.6,90.1 to 96.2,403
Polio,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,96.5,94.0 to 98.2,403
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,83.4,78.6 to 87.7,403
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,96.5,94.0 to 98.2,403
PCV,≥4 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,88.3,83.5 to 92.3,403
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,95.0,91.7 to 97.2,403
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,94.6,90.7 to 97.2,403
Hib,Primary Series,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,95.7,92.9 to 97.6,403
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,95.6,92.7 to 97.6,403
Hib,Full Series,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,84.4,79.2 to 88.9,403
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,95.4,92.5 to 97.4,403
Hib,Full Series,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,78.7,73.1 to 83.4,403
Hib,Primary Series,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,94.5,91.2 to 96.6,403
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,94.2,90.9 to 96.4,403
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,27.8,23.1 to 32.9,403
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,92.6,88.6 to 95.2,403
PCV,≥4 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,85.1,80.2 to 89.3,403
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,94.3,90.9 to 96.7,403
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2019-2020,Age,0-3 Days,85.1,80.2 to 89.0,403
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,95.0,92.0 to 97.1,403
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,91.3,87.1 to 94.6,403
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2019-2020,Age,0-2 Days,83.4,78.4 to 87.5,403
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,87.2,82.6 to 90.7,403
PCV,≥4 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,82.8,77.5 to 87.1,403
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,95.0,91.7 to 97.0,403
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,90.3,85.7 to 93.6,403
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2019-2020,Age,0-1 Days,80.4,75.1 to 84.7,403
Combined 7 Series,,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,79.5,73.8 to 84.7,403
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,77.7,72.0 to 82.5,403
Hib,Primary Series,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,95.7,92.9 to 97.6,403
Hib,Full Series,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,82.2,77.0 to 86.7,403
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,95.4,92.5 to 97.4,403
Influenza,,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,70.1,64.3 to 75.7,403
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,95.5,90.5 to 98.3,403
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,79.0,71.9 to 85.4,403
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,89.7,85.6 to 93.0,403
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,39.8,34.3 to 45.9,403
Polio,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,98.0,94.3 to 99.3,189
PCV,≥4 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,86.9,81.6 to 91.4,315
Polio,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,91.3,83.0 to 95.7,126
Hib,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,90.6,82.4 to 95.2,126
Hib,Primary Series,States/Local Areas,New Hampshire,2021,Age,19 Months,91.3,83.0 to 95.7,126
Hib,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,96.0,91.6 to 98.5,225
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,19 Months,79.4,71.8 to 85.4,231
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,86.7,82.3 to 90.1,475
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,24 Months,94.9,91.5 to 97.3,244
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,94.3,92.0 to 96.2,513
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,95.5,91.8 to 97.9,223
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,94.7,91.9 to 96.7,454
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,93.8,89.4 to 96.7,231
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,94.6,91.6 to 96.8,475
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,94.0,89.1 to 97.2,214
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,95.5,90.7 to 98.2,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,96.1,93.4 to 97.9,513
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,97.8,94.7 to 99.3,269
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,96.3,93.3 to 98.2,483
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,24 Months,43.9,36.3 to 52.4,225
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,79.9,69.8 to 87.2,222
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,80.7,75.0 to 85.3,441
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,81.6,74.7 to 86.9,219
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,82.0,77.2 to 86.0,442
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,82.5,76.6 to 87.1,223
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,80.2,75.1 to 84.5,454
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Any Medicaid,93.7,90.1 to 97.4,286
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Insurance Coverage,Private Insurance Only,98.3,96.9 to 99.6,484
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,35 Months,94.6,90.3 to 97.4,231
Hib,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,35 Months,95.1,92.1 to 97.2,475
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,35 Months,95.5,90.7 to 98.2,244
Hib,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,35 Months,97.0,94.0 to 98.8,513
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,19 Months,30.8,24.5 to 37.9,269
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,28.3,23.2 to 33.9,410
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,19 Months,27.9,21.5 to 35.4,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,24 Months,34.8,27.8 to 43.0,244
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,19 Months,93.6,89.3 to 96.2,244
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,92.7,89.9 to 94.7,513
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,19 Months,91.7,87.6 to 94.5,269
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,19 Months,89.3,85.1 to 92.5,410
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,97.1,93.3 to 99.0,222
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,98.0,96.0 to 99.2,441
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2012,Age,35 Months,98.5,96.4 to 99.5,225
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2011,Age,35 Months,98.1,95.5 to 99.4,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,99.1,96.4 to 99.9,219
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,98.0,95.3 to 99.3,442
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2011,Age,19 Months,24.0,19.4 to 29.4,244
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2019,Age,5 Months,84.0,77.1 to 89.1,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2013,Age,19 Months,23.4,17.5 to 30.5,222
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,25.0,20.3 to 30.4,441
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,19 Months,26.7,20.2 to 34.3,219
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,27.6,22.9 to 32.9,442
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2012,Age,19 Months,22.8,17.0 to 30.0,225
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,96.7,93.6 to 98.5,269
Hib,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,95.3,92.6 to 97.3,483
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,24 Months,94.0,89.1 to 97.2,214
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,19 Months,28.6,23.6 to 34.1,223
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,26.7,22.1 to 31.8,454
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,19 Months,24.6,18.5 to 32.1,231
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,19 Months,29.9,25.1 to 35.3,475
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013,Age,35 Months,96.1,92.0 to 98.4,222
Hib,≥3 Doses,States/Local Areas,New Hampshire,2013-2014,Age,35 Months,97.3,94.9 to 98.7,441
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,35 Months,98.4,95.6 to 99.6,219
Hib,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,35 Months,97.6,95.3 to 98.9,442
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,35 Months,96.6,92.6 to 98.7,223
Hib,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,35 Months,95.6,92.8 to 97.6,454
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,19 Months,35.0,27.9 to 42.7,244
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,19 Months,32.9,28.1 to 38.1,513
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,19 Months,84.9,78.4 to 89.7,214
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,24 Months,77.5,70.8 to 83.6,244
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,24 Months,79.7,72.7 to 85.8,222
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,24 Months,84.4,80.1 to 88.2,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,24 Months,89.3,84.3 to 93.2,219
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,87.8,84.0 to 91.1,442
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,24 Months,85.6,79.4 to 90.7,225
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,24 Months,86.3,80.4 to 91.2,223
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,84.1,79.6 to 88.1,454
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,24 Months,81.7,74.8 to 87.7,231
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,88.5,84.6 to 91.8,475
PCV,≥2 Doses,States/Local Areas,New Hampshire,2014,Age,5 Months,81.3,74.5 to 86.7,219
PCV,≥2 Doses,States/Local Areas,New Hampshire,2014-2015,Age,5 Months,83.3,80.5 to 85.7,442
PCV,≥2 Doses,States/Local Areas,New Hampshire,2015,Age,5 Months,85.2,77.9 to 90.4,223
PCV,≥2 Doses,States/Local Areas,New Hampshire,2015-2016,Age,5 Months,83.3,78.5 to 87.3,454
PCV,≥2 Doses,States/Local Areas,New Hampshire,2016,Age,5 Months,81.4,74.3 to 86.8,231
PCV,≥2 Doses,States/Local Areas,New Hampshire,2016-2017,Age,5 Months,85.7,81.3 to 89.3,475
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,35 Months,98.6,96.6 to 99.5,269
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,35 Months,96.4,93.8 to 98.1,483
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019,Age,35 Months,94.0,89.1 to 97.2,214
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,24 Months,93.7,90.2 to 96.3,269
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,91.3,88.1 to 93.9,483
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,24 Months,88.9,83.4 to 93.2,214
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,35 Months,84.3,77.9 to 89.7,244
PCV,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,5 Months,89.9,83.6 to 93.9,244
PCV,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,5 Months,89.0,85.1 to 91.9,513
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2017,Age,5 Months,90.4,84.1 to 94.4,244
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2017-2018,Age,5 Months,89.9,86.0 to 92.8,513
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a Non-MSA,97.9,96.1 to 99.7,344
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Urbanicity,Living In a MSA Non-Principal City,96.7,94.7 to 98.8,328
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2018,Age,5 Months,89.5,84.1 to 93.2,269
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2018-2019,Age,5 Months,86.8,82.5 to 90.1,483
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017,Age,24 Months,97.0,92.8 to 99.1,244
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2017-2018,Age,24 Months,97.3,94.9 to 98.7,513
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018,Age,24 Months,97.6,94.6 to 99.1,269
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2018-2019,Age,24 Months,95.8,93.1 to 97.7,483
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,>400% FPL,98.2,96.8 to 99.6,315
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,133% to <400% FPL,97.1,95.1 to 99.0,329
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Poverty,<133% FPL,89.9,83.6 to 96.2,173
Polio,≥3 Doses,States/Local Areas,New Hampshire,2014-2017,Overall,Overall,95.9,94.1 to 97.7,817
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,19 Months,75.9,70.8 to 80.3,222
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,19 Months,80.4,76.5 to 83.8,441
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,19 Months,82.3,77.5 to 86.2,225
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016,Age,24 Months,94.9,90.8 to 97.5,231
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2017,Age,24 Months,96.0,93.3 to 97.8,475
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2019,Age,3 Months,91.2,85.8 to 94.7,214
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,19 Months,69.9,62.0 to 76.8,244
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2017,Age,3 Months,96.9,92.0 to 98.8,244
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2017-2018,Age,3 Months,97.1,94.5 to 98.5,513
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014,Age,24 Months,98.8,96.4 to 99.7,219
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2014-2015,Age,24 Months,97.2,94.6 to 98.8,442
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015,Age,24 Months,95.3,90.3 to 98.1,223
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2015-2016,Age,24 Months,95.1,92.0 to 97.3,454
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2018,Age,3 Months,97.4,94.0 to 98.9,269
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2018-2019,Age,3 Months,94.3,91.4 to 96.3,483
Hib,Full Series,States/Local Areas,New Hampshire,2021,Age,19 Months,80.8,70.5 to 88.0,126
Hib,Full Series,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,84.7,78.8 to 89.7,315
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,19 Months,85.2,79.0 to 89.8,219
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,19 Months,85.0,80.7 to 88.5,442
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,19 Months,84.9,82.2 to 87.3,223
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,19 Months,82.2,77.4 to 86.2,454
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,65.8,59.1 to 71.9,315
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2021,Age,19 Months,92.5,85.0 to 96.4,126
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",79.8,76.2 to 83.4,728
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2012,Age,3 Months,94.9,91.6 to 96.9,225
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2011,Age,3 Months,92.9,87.0 to 96.2,244
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2013,Age,3 Months,93.5,89.6 to 95.9,222
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2013-2014,Age,3 Months,92.9,91.1 to 94.4,441
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2014,Age,3 Months,92.4,87.0 to 95.7,219
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2014-2015,Age,3 Months,92.0,87.9 to 94.8,442
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2015,Age,3 Months,91.6,84.5 to 95.6,223
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2015-2016,Age,3 Months,92.0,87.9 to 94.8,454
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2016,Age,3 Months,92.4,87.2 to 95.5,231
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2016-2017,Age,3 Months,94.7,91.5 to 96.7,475
Combined 7 Series,,States/Local Areas,New Hampshire,2021,Age,35 Months,86.3,75.5 to 94.0,126
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,91.4,87.0 to 94.8,315
Polio,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,93.5,87.3 to 96.8,126
PCV,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,5 Months,84.7,76.3 to 90.6,126
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,77.4,67.3 to 85.1,126
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,91.0,82.6 to 95.5,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,92.1,87.4 to 95.1,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,93.2,88.6 to 96.4,315
≥1 Dose MMR,,States/Local Areas,New Hampshire,2021,Age,35 Months,96.6,93.2 to 98.6,126
Polio,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,98.8,96.4 to 99.6,189
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.5,93.8 to 97.1,728
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,94.3 to 100.0,72
Polio,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,96.9,94.3 to 98.4,403
Hib,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,5 Months,86.2,81.3 to 90.0,403
Combined 7 Series,,States/Local Areas,New Hampshire,2011,Age,35 Months,82.2,73.9 to 89.1,244
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,94.7,89.7 to 97.4,126
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,90.1,87.0 to 93.1,563
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,94.2,88.5 to 99.8,67
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",96.2,94.3 to 98.0,728
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.4,83.3 to 89.5,728
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,92.8,88.7 to 97.0,275
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,97.1,95.3 to 98.9,563
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,82.5,76.9 to 88.1,275
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.0,82.8 to 89.2,728
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,91.7,85.5 to 97.9,67
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,95.1,92.0 to 98.2,275
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,82.0,76.5 to 87.5,275
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,95.1,92.6 to 97.5,563
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,94.2,89.1 to 99.2,67
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",94.5,92.3 to 96.7,728
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,93.8,88.4 to 99.2,67
Influenza,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",69.5,56.3 to 82.7,72
Influenza,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,78.3,73.9 to 82.7,563
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.7,93.8 to 97.6,728
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.3,93.5 to 100.0,72
Influenza,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",72.8,68.7 to 76.9,728
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,90.1,83.1 to 97.2,67
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",85.1,75.9 to 94.3,72
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",88.8,85.9 to 91.7,728
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,82.3,71.8 to 92.8,67
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",77.3,73.4 to 81.1,728
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,79.7,68.9 to 90.4,67
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,79.0,73.1 to 84.9,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",82.4,71.8 to 93.0,72
Influenza,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,68.0,61.3 to 74.6,275
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,81.8,70.8 to 92.8,67
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,94.2,88.5 to 99.8,67
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",90.7,82.4 to 98.9,72
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,89.8,86.8 to 92.8,563
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,97.6,96.0 to 99.3,563
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,94.0,90.8 to 97.2,275
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,94.3 to 100.0,72
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,92.4,86.4 to 98.4,67
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,80.3,74.3 to 86.2,275
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",89.9,87.4 to 92.5,728
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,79.4,75.4 to 83.5,563
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,79.3,75.1 to 83.6,563
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",93.4,91.3 to 95.6,728
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",86.2,83.0 to 89.3,728
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",98.8,96.3 to 100.0,72
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",83.1,78.6 to 87.5,728
≥1 Dose MMR,,States/Local Areas,New Hampshire,2020,Age,19 Months,94.4,88.3 to 97.4,189
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,19 Months,96.6,92.2 to 98.6,189
Hib,Primary Series,States/Local Areas,New Hampshire,2020,Age,19 Months,96.6,92.2 to 98.6,189
Influenza,,States/Local Areas,New Hampshire,2020,Age,24 Months,68.2,59.7 to 76.4,189
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2020,Age,0-3 Days,83.2,75.5 to 88.9,189
Rotavirus,,States/Local Areas,New Hampshire,2020,Age,8 Months,81.6,73.5 to 87.7,189
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,95.9,91.8 to 98.3,189
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,35 Months,98.8,96.8 to 99.7,189
PCV,≥4 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,87.7,80.6 to 93.0,189
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,24 Months,90.5,84.2 to 95.0,189
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,41.2,33.2 to 50.3,189
Combined 7 Series,,States/Local Areas,New Hampshire,2020,Age,24 Months,77.2,69.1 to 84.4,189
DTaP,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,5 Months,91.0,83.7 to 95.2,189
PCV,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,3 Months,91.9,84.9 to 95.8,189
Polio,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,5 Months,89.5,81.9 to 94.1,189
Hib,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,5 Months,87.6,79.4 to 92.8,189
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2020,Age,5 Months,93.9,89.1 to 96.6,189
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,95.9,92.7 to 98.0,403
Polio,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,96.5,94.0 to 98.2,403
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,87.5,82.8 to 91.5,403
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,35 Months,96.5,94.0 to 98.2,403
Combined 7 Series,,States/Local Areas,New Hampshire,2019-2020,Age,24 Months,75.6,70.1 to 80.8,403
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,95.3,92.3 to 97.2,403
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,91.4,87.5 to 94.2,403
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,92.3,88.7 to 94.9,403
Hib,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,94.5,91.1 to 96.6,403
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,62.0,56.0 to 67.8,403
Polio,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,94.4,91.0 to 96.5,403
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,79.6,74.1 to 84.1,403
PCV,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,5 Months,87.4,82.7 to 91.0,403
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,5 Months,93.6,90.3 to 95.8,403
Hib,Primary Series,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,93.0,89.4 to 95.4,403
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,96.0,93.2 to 97.7,403
Hib,≥2 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,96.5,93.7 to 98.1,403
Hib,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,92.7,89.1 to 95.2,403
≥1 Dose MMR,,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,69.3,63.4 to 74.6,403
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,79.6,74.3 to 84.1,403
Hib,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,3 Months,92.0,88.2 to 94.7,403
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,3 Months,92.9,89.2 to 95.4,403
Polio,≥1 Dose,States/Local Areas,New Hampshire,2019-2020,Age,3 Months,92.2,88.3 to 94.8,403
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,13 Months,93.5,90.2 to 95.8,403
PCV,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,76.3,70.6 to 81.1,403
Hib,Primary Series,States/Local Areas,New Hampshire,2019-2020,Age,7 Months,78.9,73.3 to 83.5,403
Polio,≥3 Doses,States/Local Areas,New Hampshire,2019-2020,Age,19 Months,95.2,92.2 to 97.1,403
PCV,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,95.8,89.4 to 98.9,126
Hib,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,73.4,62.9 to 81.8,126
Hib,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,89.2,79.8 to 94.5,126
Hib,Primary Series,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,94.3,90.3 to 97.0,315
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,74.9,68.7 to 81.1,275
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,93.3,89.3 to 97.4,275
Influenza,,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,77.7,72.2 to 83.2,394
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,75.2,66.5 to 83.8,159
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,94.1,91.3 to 96.9,394
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,74.9,66.3 to 83.6,159
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,88.2,83.9 to 92.4,335
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,88.5,84.3 to 92.8,394
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,86.4,79.1 to 93.7,159
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,89.6,83.3 to 95.9,159
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,87.5,83.2 to 91.8,335
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,90.4,86.8 to 94.0,394
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,90.2,84.3 to 96.1,159
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,89.9,85.6 to 94.2,335
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,95.9,93.5 to 98.2,394
Influenza,,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,65.7,56.8 to 74.6,159
Influenza,,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,68.6,62.5 to 74.7,335
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,94.3,92.3 to 96.3,888
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,95.2,93.2 to 97.1,888
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,94.1,91.1 to 97.1,335
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,87.3,80.1 to 94.4,159
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,96.9,95.2 to 98.7,394
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,65.4,54.8 to 76.1,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,80.6,75.5 to 85.6,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,78.6,73.4 to 83.7,394
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,89.9,86.2 to 93.6,335
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,92.4,89.0 to 95.8,394
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,90.1,83.6 to 96.5,165
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,73.1,64.5 to 81.6,159
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,82.9,78.0 to 87.9,335
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,85.5,78.0 to 93.1,165
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,94.2,90.9 to 97.5,339
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,96.8,94.7 to 98.8,384
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,95.8,93.2 to 98.4,339
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,94.3,91.6 to 97.1,384
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,87.9,83.3 to 92.4,339
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,91.9,88.7 to 95.0,384
Influenza,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,62.8,53.7 to 71.9,165
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,76.2,70.3 to 82.1,339
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.1,74.2 to 84.1,384
Influenza,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,76.4,71.2 to 81.6,384
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.6,86.0 to 93.1,384
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,78.1,69.8 to 86.5,165
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,87.0,80.2 to 93.9,165
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,88.1,84.0 to 92.3,339
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,92.5,89.5 to 95.4,384
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,78.9,71.5 to 86.2,339
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,81.9,73.9 to 89.9,165
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,87.0,82.3 to 91.7,339
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,86.1,81.9 to 90.4,384
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.9,93.6 to 98.1,384
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,82.4,77.1 to 87.6,339
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,95.7,93.5 to 97.9,339
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,80.9,71.9 to 89.9,165
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,87.0,79.6 to 94.4,165
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,85.6,80.8 to 90.3,339
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.9,96.3 to 99.5,384
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,96.2,93.5 to 98.9,339
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,79.5,71.2 to 87.7,165
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,89.8,86.3 to 93.2,384
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,88.9,82.2 to 95.6,165
Influenza,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,71.4,65.0 to 77.7,339
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,85.5,77.9 to 93.1,165
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,97.5,95.9 to 99.2,384
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,96.2,93.5 to 98.9,339
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,72.2,63.5 to 81.0,165
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,81.4,76.1 to 86.7,339
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,76.7,73.2 to 80.3,888
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,96.0,93.4 to 98.6,335
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,97.5,95.6 to 99.4,394
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a Non-MSA,91.4,87.5 to 95.3,339
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,79.4,74.5 to 84.3,384
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,78.0,70.0 to 86.0,165
Hib,Full Series,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,85.7,82.6 to 88.7,888
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,94.8,91.9 to 97.7,335
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,81.1,73.4 to 88.8,159
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,96.4,93.9 to 99.0,394
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,66.2,56.9 to 75.4,159
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,80.7,75.7 to 85.7,394
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,96.5,94.1 to 99.0,335
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,77.9,72.5 to 83.4,335
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,97.8,96.0 to 99.6,394
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,92.5,90.2 to 94.7,888
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,84.7,81.7 to 87.7,888
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,83.2,79.2 to 87.2,888
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,88.8,82.4 to 95.2,159
Hep B,"≥1 Dose, 3 Day (Birth Dose)",States/Local Areas,New Hampshire,2016-2019,Overall,Overall,79.8,76.6 to 83.1,888
Influenza,,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,71.9,68.2 to 75.7,888
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,86.2,78.9 to 93.5,159
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,94.8,91.9 to 97.6,335
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,83.4,77.1 to 89.6,335
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,89.8,87.4 to 92.3,888
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,89.7,84.5 to 95.0,394
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,83.8,77.0 to 90.7,159
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,88.0,85.3 to 90.8,888
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2016-2019,Poverty,133% to <400% FPL,88.3,84.2 to 92.5,335
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,94.3,92.5 to 96.2,888
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Poverty,<133% FPL,75.0,66.5 to 83.5,159
PCV,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,93.6,91.5 to 95.8,888
Rotavirus,,States/Local Areas,New Hampshire,2016-2019,Poverty,>400% FPL,91.8,88.4 to 95.3,394
Polio,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,94.7,92.7 to 96.7,888
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Overall,Overall,86.2,83.4 to 89.1,888
Influenza,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,74.7,63.5 to 85.9,67
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,93.4,89.9 to 96.9,275
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,96.2,94.3 to 98.1,563
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",93.5,87.3 to 99.7,72
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,Hispanic,85.3,75.5 to 95.1,67
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,94.0,91.4 to 96.6,563
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",97.6,94.3 to 100.0,72
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Any Medicaid,77.2,69.2 to 85.3,275
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Insurance Coverage,Private Insurance Only,88.6,84.3 to 92.8,563
Polio,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,3 Months,92.7,86.2 to 96.2,189
Hib,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,3 Months,93.3,87.1 to 96.7,189
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,75.6,67.4 to 82.2,189
Hep B,≥1 Dose,States/Local Areas,New Hampshire,2020,Age,3 Months,95.5,91.2 to 97.7,189
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,24 Months,96.3,92.7 to 98.4,189
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,7 Months,75.1,66.2 to 82.2,189
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020,Age,13 Months,96.7,93.1 to 98.5,189
Rotavirus,,States/Local Areas,New Hampshire,2019-2020,Age,8 Months,80.9,75.5 to 85.3,403
Hep B,"≥1 Dose, 1 Day",States/Local Areas,New Hampshire,2021,Age,0-1 Days,77.2,67.4 to 84.8,126
Hib,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,95.6,92.2 to 97.6,315
Combined 7 Series,,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"Other or Multiple Races, Non-Hispanic",80.4,68.6 to 92.1,72
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Race and Ethnicity,"White, Non-Hispanic",95.2,93.3 to 97.2,728
≥1 Dose MMR,,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,88.4,81.7 to 95.2,165
PCV,≥4 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Principal City,79.7,71.5 to 87.9,165
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,95.5,92.8 to 98.2,384
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2016-2019,Urbanicity,Living In a MSA Non-Principal City,87.4,82.0 to 92.7,384
Hep B,"≥1 Dose, 2 Day",States/Local Areas,New Hampshire,2021,Age,0-2 Days,79.6,69.9 to 86.8,126
Hib,≥3 Doses,States/Local Areas,New Jersey,2011,Age,19 Months,94.7,91.3 to 96.9,264
Hib,≥3 Doses,States/Local Areas,New Jersey,2012,Age,19 Months,92.0,88.9 to 94.3,288
Hib,≥3 Doses,States/Local Areas,New Jersey,2019,Age,13 Months,87.2,79.7 to 92.2,279
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,81.7,65.5 to 93.4,126
PCV,≥4 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,85.4,76.0 to 91.5,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,94.7,90.3 to 97.6,126
Hep B,≥2 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,95.1,91.7 to 97.1,315
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,19 Months,96.9,94.3 to 98.3,315
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,94.5,89.9 to 97.5,315
Hib,Primary Series,States/Local Areas,New Hampshire,2021,Age,7 Months,76.8,66.7 to 84.6,126
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,35 Months,95.2,88.0 to 98.7,126
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,91.3,83.0 to 95.7,126
Polio,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,13 Months,94.2,88.2 to 97.3,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,95.5,92.5 to 97.5,315
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,19 Months,91.8,84.3 to 95.9,126
DTaP,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,3 Months,93.7,88.3 to 96.7,126
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,31.7,23.2 to 41.7,126
PCV,≥4 Doses,States/Local Areas,New Hampshire,2021,Age,35 Months,86.2,77.8 to 92.6,126
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,89.1,80.1 to 95.2,126
Polio,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,94.2,88.9 to 97.5,126
Polio,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,3 Months,91.6,85.0 to 95.4,126
≥1 Dose MMR,,States/Local Areas,New Hampshire,2021,Age,24 Months,96.6,93.2 to 98.6,126
Hib,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,89.9,81.6 to 95.5,126
Hib,Primary Series,States/Local Areas,New Hampshire,2021,Age,24 Months,92.0,84.8 to 96.6,126
Hib,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,3 Months,91.5,84.9 to 95.3,126
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,94.6,91.2 to 97.1,315
DTaP,≥4 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,78.7,68.5 to 86.3,126
Hib,Full Series,States/Local Areas,New Hampshire,2021,Age,24 Months,82.4,73.0 to 90.0,126
PCV,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,91.5,83.4 to 95.9,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,78.6,68.8 to 86.0,126
≥1 Dose Varicella,,States/Local Areas,New Hampshire,2021,Age,24 Months,93.3,86.9 to 97.3,126
PCV,≥4 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,86.2,77.8 to 92.6,126
PCV,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,92.3,85.2 to 96.8,126
PCV,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,35 Months,96.4,93.1 to 98.4,315
Hib,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,13 Months,90.9,85.7 to 94.3,315
Hep A,≥1 Dose,States/Local Areas,New Hampshire,2021,Age,24 Months,92.3,85.7 to 96.6,126
Hep A,≥2 Doses,States/Local Areas,New Hampshire,2021,Age,24 Months,46.7,36.7 to 58.0,126
DTaP,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,19 Months,95.0,90.2 to 97.5,126
Hep B,≥3 Doses,States/Local Areas,New Hampshire,2020-2021,Age,24 Months,95.5,92.5 to 97.5,315
PCV,≥3 Doses,States/Local Areas,New Hampshire,2021,Age,7 Months,70.0,59.6 to 78.7,126
Combined 7 Series,,States/Local Areas,New Hampshire,2021,Age,24 Months,77.2,67.6 to 85.6,126